<SEC-DOCUMENT>0001564590-14-000660.txt : 20140310
<SEC-HEADER>0001564590-14-000660.hdr.sgml : 20140310
<ACCEPTANCE-DATETIME>20140310161408
ACCESSION NUMBER:		0001564590-14-000660
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		29
CONFORMED PERIOD OF REPORT:	20131231
FILED AS OF DATE:		20140310
DATE AS OF CHANGE:		20140310

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DYNAVAX TECHNOLOGIES CORP
		CENTRAL INDEX KEY:			0001029142
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				330728374
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34207
		FILM NUMBER:		14681055

	BUSINESS ADDRESS:	
		STREET 1:		2929 SEVENTH STREET
		STREET 2:		SUITE 100
		CITY:			BERKELEY
		STATE:			CA
		ZIP:			94710
		BUSINESS PHONE:		5108485100

	MAIL ADDRESS:	
		STREET 1:		2929 SEVENTH STREET
		STREET 2:		SUITE 100
		CITY:			BERKELEY
		STATE:			CA
		ZIP:			94710
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>dvax-10k_20131231.htm
<DESCRIPTION>10-K
<TEXT>
<html>
<body>
<p style="border-top:Solid 0.75pt;margin-bottom:0pt;margin-top:0pt;text-align:center;margin-top:1pt;line-height:1pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;text-align:center;border-top:Solid 1pt;margin-top:1pt;line-height:1pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:;font-size:10pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:3pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:14pt;;"><font style="font-weight:bold;font-size:14pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SECURITIES AND EXCHANGE COMMISSION </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Washington, D.C. 20549 </font></p><p style="margin-bottom:0pt;margin-top:1pt;text-align:center;border-bottom:Solid 1pt;margin-bottom:0pt;line-height:4pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:2pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:3pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:15pt;;"><font style="font-weight:bold;font-size:15pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Form 10-K </font></p><p style="margin-bottom:0pt;margin-top:1pt;text-align:center;border-bottom:Solid 1pt;margin-bottom:0pt;line-height:4pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:2pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:3pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Mark One) </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-size:9pt;;"><font style="font-size:9pt;font-family:'Wingdings';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:9pt;font-family:'Wingdings'">&#120;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:9pt;;"><font style="font-size:9pt;font-family:'Wingdings';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:3pt;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:3pt;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the fiscal year ended December&#160;31, 2013 </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:3pt;font-size:9pt;;"><font style="font-size:9pt;font-family:'Wingdings';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:9pt;font-family:'Wingdings'">&#168;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:3pt;font-size:9pt;;"><font style="font-size:9pt;font-family:'Wingdings';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:3pt;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:3pt;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160; </font></p></td></tr></table></div><p style="text-align:center;margin-bottom:0pt;margin-top:3pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Commission file number: 001-34207 </font></p><p style="margin-bottom:0pt;margin-top:1pt;text-align:center;border-bottom:Solid 1pt;margin-bottom:0pt;line-height:4pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:2pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:3pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:20pt;;"><font style="font-weight:bold;font-size:20pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Dynavax Technologies Corporation </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:8pt;;"><font style="font-style:italic;;font-size:8pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">(Exact name of registrant as specified in its charter)</font><font style="font-weight:bold;font-style:italic;;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"> </font></p><p style="margin-bottom:0pt;margin-top:1pt;text-align:center;border-bottom:Solid 1pt;margin-bottom:0pt;line-height:4pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:2pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:4pt;;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:49%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Delaware</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:9pt;;"><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="width:49%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">33-0728374</font></p></td>
</tr>
<tr>
<td valign="top" style="width:49%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-style:italic;;font-size:8pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">(State or other jurisdiction of</font></p><p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-style:italic;;font-size:8pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">incorporation or organization)</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:49%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-style:italic;;font-size:8pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">(IRS Employer</font></p><p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-style:italic;;font-size:8pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Identification No.)</font></p></td>
</tr>
</table></div><p style="text-align:center;margin-bottom:0pt;margin-top:3pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2929 Seventh Street, Suite 100 </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Berkeley, CA 94710-2753 </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(510) 848-5100 </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:8pt;font-family:Times New Roman;"><font style="font-style:italic;;font-size:8pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">(Address, including Zip Code, and telephone number, including area code, of the registrant&#8217;s principal executive offices) </font></p><p style="margin-bottom:0pt;margin-top:1pt;text-align:center;border-bottom:Solid 1pt;margin-bottom:0pt;line-height:4pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:2pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:4pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Securities registered pursuant to Section&#160;12(b) of the Act: </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:4pt;;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:49%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:9pt;;"><font style="font-weight:bold;text-decoration:underline;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Title&#160;of&#160;Each&#160;Class:</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:9pt;;"><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="width:49%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:9pt;;"><font style="font-weight:bold;text-decoration:underline;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Name&#160;of&#160;Each&#160;Exchange&#160;on&#160;Which&#160;Registered:</font></p></td>
</tr>
<tr>
<td valign="bottom" style="width:49%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common Stock, $0.001 Par Value</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Preferred Shares Purchase Rights</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:49%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The&#160;NASDAQ&#160;Stock&#160;Market&#160;LLC</font></p></td>
</tr>
</table></div><p style="text-align:center;margin-bottom:0pt;margin-top:3pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Securities Registered Pursuant to Section&#160;12(g) of the Act: </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">None </font></p><p style="margin-bottom:0pt;margin-top:0pt;text-align:center;border-bottom:Solid 1pt;margin-bottom:0pt;line-height:4pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:2pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:3pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:9pt;;"><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;&#160;&#160;&#160;Yes&#160;&#160;</font><font style="font-size:9pt;font-family:'Wingdings';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:9pt;font-family:'Wingdings'">&#168;</font></font><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;No&#160;&#160;</font><font style="font-size:9pt;font-family:'Wingdings';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:9pt;font-family:'Wingdings'">&#120;</font></font><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p><p style="margin-bottom:0pt;margin-top:3pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:9pt;;"><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section&#160;15(d) of the Act.&#160;&#160;&#160;&#160;Yes&#160;&#160;</font><font style="font-size:9pt;font-family:'Wingdings';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:9pt;font-family:'Wingdings'">&#168;</font></font><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;No&#160;&#160;</font><font style="font-size:9pt;font-family:'Wingdings';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:9pt;font-family:'Wingdings'">&#120;</font></font><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p><p style="margin-bottom:0pt;margin-top:3pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:9pt;;"><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requiremen</font><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ts for the past 90 days.&#160;&#160;&#160;&#160;Yes&#160;&#160;</font><font style="font-size:9pt;font-family:'Wingdings';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:9pt;font-family:'Wingdings'">&#120;</font></font><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;No&#160;&#160;</font><font style="font-size:9pt;font-family:'Wingdings';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:9pt;font-family:'Wingdings'">&#168;</font></font><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p><p style="margin-bottom:0pt;margin-top:3pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:9pt;;"><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registration was required to submit and post such files).&#160;&#160;&#160;&#160;Yes&#160;&#160;</font><font style="font-size:9pt;font-family:'Wingdings';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:9pt;font-family:'Wingdings'">&#120;</font></font><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;No&#160;&#160;</font><font style="font-size:9pt;font-family:'Wingdings';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:9pt;font-family:'Wingdings'">&#168;</font></font><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p><p style="margin-bottom:0pt;margin-top:3pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:9pt;;"><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Indicate by check mark if disclosure of delinquent filers pursuant to Item&#160;405 of Regulation S-K is not contained herein, and will not be contained, to the best of the registrant&#8217;s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form </font><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10-K.&#160;&#160;</font><font style="font-size:9pt;font-family:'Wingdings';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:9pt;font-family:'Wingdings'">&#120;</font></font><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p><p style="margin-bottom:0pt;margin-top:3pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:9pt;;"><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221; and &#8220;smaller reporting company&#8221; in Rule 12b-2 of the Exchange Act. </font><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Check one): </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:3pt;;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:9pt;;"><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Large&#160;accelerated&#160;filer&#160;</font><font style="font-size:9pt;font-family:'Wingdings';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:9pt;font-family:'Wingdings'">&#168;</font></font></p></td>
<td valign="bottom" style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:9pt;;"><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="top" style="width:auto;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:9pt;;"><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accelerated&#160;filer&#160;</font><font style="font-size:9pt;font-family:'Wingdings';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:9pt;font-family:'Wingdings'">&#120;</font></font></p></td>
<td valign="bottom" style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:9pt;;"><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="top" style="width:auto;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:9pt;;"><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-accelerated&#160;filer&#160;</font><font style="font-size:9pt;font-family:'Wingdings';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:9pt;font-family:'Wingdings'">&#168;</font></font></p></td>
<td valign="bottom" style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:9pt;;"><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="top" style="width:auto;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:9pt;;"><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Smaller&#160;reporting&#160;company&#160;</font><font style="font-size:9pt;font-family:'Wingdings';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:9pt;font-family:'Wingdings'">&#168;</font></font></p></td>
</tr>
<tr>
<td valign="top" style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:9pt;;"><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="width:auto;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:9pt;;"><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td colspan="5" valign="top" style="width:auto;"><p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:9pt;;"><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Do not check if a smaller reporting company)</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:3pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:9pt;;"><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;</font><font style="font-size:9pt;font-family:'Wingdings';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:9pt;font-family:'Wingdings'">&#168;</font></font><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;No&#160;&#160;</font><font style="font-size:9pt;font-family:'Wingdings';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:9pt;font-family:'Wingdings'">&#120;</font></font><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p><p style="margin-bottom:0pt;margin-top:3pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:9pt;;"><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The aggregate market value of the voting and non-voting stock held by non-affiliates of the registrant, based upon the closing sale price of the common stock on </font><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">June&#160;28, 2013 as reported on the NASDAQ Capital Market, was approximately $105,519,624. Shares of common stock held by each officer and director and by each person known to the Company who owns 5% or more of the outstanding common stock have been excluded in that such persons may be deemed to be affiliates. This determination of affiliate status is not necessarily a conclusive determination for other purposes. </font></p><p style="margin-bottom:0pt;margin-top:3pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:9pt;;"><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">As of February&#160;28, 2014, the </font><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">registrant had outstanding 262,855,958 shares of common stock. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:3pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">DOCUMENTS INCORPORATED BY REFERENCE </font></p><p style="margin-bottom:0pt;margin-top:3pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:9pt;;"><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Portions of the Definitive Proxy Statement for the registrant&#8217;s 2014 Annual Meeting of Stockholders are incorporated by reference into Part III, Items 10-14 of this Form 10-K. </font></p><p style="border-top:Solid 0.75pt;margin-bottom:0pt;margin-top:4pt;text-align:center;line-height:1pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;text-align:center;border-top:Solid 1pt;margin-top:1pt;line-height:1pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:;font-weight:bold;;font-size:10pt;;">&nbsp;</p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">INDEX </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:10pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">DYNAVAX TECHNOLOGIES CORPORATION </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:;font-size:9pt;;"><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:4%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="width:90%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom" style="padding-left:0.7 pt;padding-Right:0.7 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:2%; border-bottom:solid 1pt #000000;white-space:nowrap;"><p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Page&#160;No.</font></p></td>
</tr>
<tr>
<td colspan="5" valign="bottom" style="width:2%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">PART I</font></p></td>
</tr>
<tr>
<td valign="top" style="width:4%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:12pt;;margin-right:0%;text-indent:-12pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;1.</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="width:90%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><a href="#ITEM_1"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">BUSINESS</font></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom" style="width:2%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</font></p></td>
</tr>
<tr>
<td valign="top" style="width:4%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:12pt;;margin-right:0%;text-indent:-12pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;1A.</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="width:90%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><a href="#ITEM_1A"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">RISK FACTORS</font></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom" style="width:2%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12</font></p></td>
</tr>
<tr>
<td valign="top" style="width:4%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:12pt;;margin-right:0%;text-indent:-12pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;1B.</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="width:90%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><a href="#ITEM_1B"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">UNRESOLVED STAFF COMMENTS</font></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom" style="width:2%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25</font></p></td>
</tr>
<tr>
<td valign="top" style="width:4%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:12pt;;margin-right:0%;text-indent:-12pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 2.</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="width:90%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><a href="#ITEM_2"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PROPERTIES</font></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom" style="width:2%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25</font></p></td>
</tr>
<tr>
<td valign="top" style="width:4%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:12pt;;margin-right:0%;text-indent:-12pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 3.</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="width:90%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><a href="#ITEM_3"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LEGAL PROCEEDINGS</font></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom" style="width:2%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25</font></p></td>
</tr>
<tr>
<td valign="top" style="width:4%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:12pt;;margin-right:0%;text-indent:-12pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 4.</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="width:90%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><a href="#ITEM_4"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MINE SAFETY DISCLOSURE</font></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom" style="width:2%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26</font></p></td>
</tr>
<tr>
<td colspan="5" valign="bottom" style="width:2%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">PART II</font></p></td>
</tr>
<tr>
<td valign="top" style="width:4%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:12pt;;margin-right:0%;text-indent:-12pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 5.</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="width:90%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:;"><a href="#ITEM_5"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MARKET FOR THE REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</font></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom" style="width:2%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27</font></p></td>
</tr>
<tr>
<td valign="top" style="width:4%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:12pt;;margin-right:0%;text-indent:-12pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 6.</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="width:90%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:;"><a href="#ITEM_6"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SELECTED FINANCIAL DATA</font></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom" style="width:2%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28</font></p></td>
</tr>
<tr>
<td valign="top" style="width:4%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:12pt;;margin-right:0%;text-indent:-12pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 7.</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="width:90%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:;"><a href="#ITEM_7"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</font></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom" style="width:2%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29</font></p></td>
</tr>
<tr>
<td valign="top" style="width:4%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:12pt;;margin-right:0%;text-indent:-12pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;7A.</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="width:90%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:;"><a href="#ITEM_7A"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</font></a></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom" style="width:2%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38</font></p></td>
</tr>
<tr>
<td valign="top" style="width:4%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:12pt;;margin-right:0%;text-indent:-12pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 8.</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="width:90%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:;"><a href="#ITEM_8"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</font></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom" style="width:2%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39</font></p></td>
</tr>
<tr>
<td valign="top" style="width:4%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:12pt;;margin-right:0%;text-indent:-12pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 9.</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="width:90%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:;"><a href="#ITEM_9"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</font></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom" style="width:2%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66</font></p></td>
</tr>
<tr>
<td valign="top" style="width:4%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:12pt;;margin-right:0%;text-indent:-12pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 9A.</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="width:90%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:;"><a href="#ITEM_9A"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">CONTROLS AND PROCEDURES</font></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom" style="width:2%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66</font></p></td>
</tr>
<tr>
<td valign="top" style="width:4%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:12pt;;margin-right:0%;text-indent:-12pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 9B.</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="width:90%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:;"><a href="#ITEM_9B"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">OTHER INFORMATION</font></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom" style="width:2%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">68</font></p></td>
</tr>
<tr>
<td colspan="5" valign="bottom" style="width:2%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">PART III</font></p></td>
</tr>
<tr>
<td valign="top" style="width:4%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:12pt;;margin-right:0%;text-indent:-12pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 10.</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="width:90%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:;"><a href="#ITEM_10"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</font></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom" style="width:2%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69</font></p></td>
</tr>
<tr>
<td valign="top" style="width:4%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:12pt;;margin-right:0%;text-indent:-12pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 11.</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="width:90%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:;"><a href="#ITEM_11"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXECUTIVE COMPENSATION</font></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom" style="width:2%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69</font></p></td>
</tr>
<tr>
<td valign="top" style="width:4%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:12pt;;margin-right:0%;text-indent:-12pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 12.</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="width:90%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:;"><a href="#ITEM_12"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</font></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom" style="width:2%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69</font></p></td>
</tr>
<tr>
<td valign="top" style="width:4%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:12pt;;margin-right:0%;text-indent:-12pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 13.</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="width:90%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:;"><a href="#ITEM_13"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</font></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom" style="width:2%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69</font></p></td>
</tr>
<tr>
<td valign="top" style="width:4%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:12pt;;margin-right:0%;text-indent:-12pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 14.</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="width:90%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:;"><a href="#ITEM_14"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PRINCIPAL ACCOUNTING FEES AND SERVICES</font></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom" style="width:2%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69</font></p></td>
</tr>
<tr>
<td colspan="5" valign="bottom" style="width:2%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">PART IV</font></p></td>
</tr>
<tr>
<td valign="top" style="width:4%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:12pt;;margin-right:0%;text-indent:-12pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Item 15.</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="width:90%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><a href="#ITEM_15"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EXHIBITS, FINANCIAL STATEMENT SCHEDULES</font></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom" style="width:2%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70</font></p></td>
</tr>
<tr>
<td valign="top" style="width:4%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="width:90%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><a href="#SIGNATURES"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SIGNATURES</font></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom" style="width:2%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FORWARD-LOOKING STATEMENTS </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;text-indent:4.54%">This Annual Report on Form 10-K contains forward-looking statements within the meaning of Section&#160;27A of the Securities Act of 1933 and Section&#160;21E of the Securities Exchange Act of 1934 which are subject to a number of risks and uncertainties. All statements that are not historical facts are forward-looking statements, including statements about our </font><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">ability to successfully develop and achieve regulatory approval for HEPLISAV-B&#8482;, our business strategy, our intellectual property position, our product development efforts, our ability to commercialize our product candidates, our ability to manufacture commercial supply and meet regulatory requirements, the timing of the introduction of our products, uncertainty regarding our capital needs and future operating results and profitability, anticipated sources of funds as well as our plans, objectives, expectations and intentions. These statements appear throughout our document and can be identified by the use of forward-looking language such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;future,&#8221; or &#8220;intend,&#8221; or the negative of these terms or other variations or comparable terminology. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Actual results may vary materially from those in our forward-looking statements as a result of various factors that are identified in &#8220;Item 1A&#8212;Risk Factors&#8221; and &#8220;Item 7&#8212;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and elsewhere in this document. No assurance can be given that the risk factors desc</font><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">ribed in this Annual Report on Form 10-K are all of the factors that could cause actual results to vary materially from the forward-looking statements. All forward-looking statements speak only as of the date of this Annual Report on Form 10-K. Readers should not place undue reliance on these forward-looking statements and are cautioned that any such forward-looking statements are not guarantees of future performance. We assume no obligation to update any forward-looking statements. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;text-indent:4.54%">This Annual Report on Form 10-K includes trademarks and registered trademarks of Dynavax Technologies Corporation. Products or service names of other companies mentioned in this Annual Report on Form 10-K may be trademarks or registered trademarks of their respective owners. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="PART_I"></a>PART I</font></p><p style="margin-bottom:0pt;margin-top:2pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:11.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_1"></a>I</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TEM</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1.</font></p></td><td valign="top" style="width:88.67%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_1"></a>BUSINESS </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">OVERVIEW </font></p><p style="margin-bottom:0pt;margin-top:4pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Dynavax Technologies Corporation (&#8220;we,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; &#8220;Dynavax&#8221; or the &#8220;Company&#8221;), a clinical-stage biopharmaceutical company, develops products to prevent and treat infectious and inflammatory diseases and cancer based on Toll-like Receptor (&#8220;TLR&#8221;) biology and its ability to modulate the innate immune system. Our lead product candidate is HEPLISAV-B</font><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">TM </sup></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(also known as &#8220;HEPLISAV&#8221;), an investigational adult hepatitis B vaccine in Phase 3 clinical development. HEPLISAV-B combines our proprietary TLR 9 agonist adjuvant and hepatitis B surface antigen (&#8220;HBsAg&#8221;) to elicit an immune response after two doses. In the spring of 2014 we expect to initiate a Phase 3 study of HEPLISAV-B compared with Engerix-B<sup style="font-size:85%; vertical-align:top">&#174;</sup> in adults 18-70 years of age in order to provide a sufficiently-sized safety database for the U.S. Food and Drug Administration (&#8220;FDA&#8221;) to complete its review of Dynavax&#8217;s biologics license application (&#8220;BLA&#8221;).</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In addition to HEPLISAV-B, we are conducting clinical and preclinical programs that utilize our expertise in TLR biology. Our product candidates include both TLR agonists and TLR inhibitors. Our clinical stage programs include our autoimmune program partnered with GlaxoSmithKline (&#8220;GSK&#8221;), our asthma therapeu</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">tic program partnered with AstraZeneca AB (&#8220;AstraZeneca&#8221;), and our cancer immunotherapy program. We also are advancing preclinical development programs in adjuvant technology and TLR 7, 8, and 9 inhibition. We compete with pharmaceutical companies, biotechnology companies, academic institutions and research organizations in developing therapies to prevent or treat infectious and inflammatory diseases and cancer.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">THE COMPANY AND BACKGROUND </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We were incorporated in California in August&#160;1996 under the name Double Helix Corporation, and we changed our name to Dynavax Technologies Corporation in September&#160;1996. We reincorporated in Delaware in 2000. Dynavax Technologies Corporation is listed on the NASDAQ Capital Market under the ticker symbol &#8220;DVAX.&#8221; </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our principal executive offices are located at 2929 Seventh Street, Suite&#160;100, Berkeley, California, 94710-2753. Our telephone number is (510)&#160;848-5100. We make available, free of charge on our website located at www.dynavax.com, our annual report on Form&#160;10-K, quar</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">terly reports on Form&#160;10-Q, current reports on Form&#160;8-K, and any amendments to those reports, as soon as reasonably practicable after filing such reports with the Securities and Exchange Commission. Our code of conduct, audit committee charter, nominating and corporate governance committee charter, compensation committee charter and audit committee complaint procedures are also posted on our website and are each available in print to any stockholder upon request by writing to: 2929 Seventh Street, Suite&#160;100, Berkeley, California 94710-2753. The contents of our website are not incorporated by reference into this report. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">PROPRIETARY TECHNOLOGY </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Toll-like Receptors</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">TLRs, structures located on different immune cell types, are activated by the binding of certain pathogens and other ligands and their activity is essential to generation of innate immunity.</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> By either activating or inhibiting specific TLRs, it is possible to selectively modulate elements of the innate immune response on the cellular level to address dysfunction associated with both excessive immune activity (autoimmunity) and suboptimal immune function. Dynavax research has resulted in the identification of proprietary synthetic oligonucleotides (short segments of the deoxyribonucleic acid (&#8220;DNA&#8221;), that selectively activate or inhibit specific TLRs, allowing their use in a range of immune-mediated therapeutic and preventative applications.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:4.54%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TLR Agonists</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">TLR agonists bind to receptors on specific cell types activating a cascade that enhances the ability of the immune system to identify and fight disease. TLR agonists work by enhancing or reprogramming the innate immune response. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Currently, our development programs focus on TLR 9 agonists. Since </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TLR 9 is found exclusively in a specialized subset of dendritic and B cells, TLR 9 agonists do not cause a generalized activation of the immune system but rather redirect the response of only those T-cells involved in a given disease. We have developed a number of proprietary TLR 9 agonist compositions and formulations that make use of the different ways in which the innate immune system responds to stimulation. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">TLR 9 agonists can be administered therapeutically to stimulate immune responses for the treatment of cancer and infectious diseases. They can also be combined with vaccine antigens to enhance the specific immune response to the vaccine. TLR 9 agonists help generate memory T Helper (&#8220;Th&#8221;) 1 cells that can stimulate the immune system to induce long-lasting effects. We use this approach in HEPLISAV-B by combin</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ing the TLR 9 agonist adjuvant with HBsAg. This combination induces a highly specific Th1 immune response and durable levels of protective antibodies. HEPLISAV-B has been shown to provide significantly greater seroprotection in persons with reduced immune function due to disease processes (diabetes, chronic kidney disease), overall health (smoking, obesity), and advanced age.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">TLR 9 agonists can also be used alone to modify the course of the viral and respiratory disease by modulating the immune system. TLR 9 agonists have the potential to suppress the Th2 inflammatory response to modify the underlying cause of allergic inflammation. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">For several programs, we have used our advanced proprietary knowledge to design modifications of the molecular structure of CPG oligonucleotide TLR 9 agonists to significantly increase their versatility and potency. These second-generation TLR 9 agonists stimulate specific immune responses, including potent interferon-alpha induction.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:4.54%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TLR Inhibitors</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">TLR inhibitors are short DNA sequences that selectively block the abnormal activation of TLRs associated with autoimmune and inflammatory diseases. In animal studies, our TLR inhibitors have demonstrated broad potential to reduce such inflammatory responses characteristic of multiple autoimmune diseases, including lupus, inflammatory skin disorders and rheumatoid arthritis. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">DEVELOPMENT PROGRAMS </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our pipeline of product candidates includes the following: </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:446.3pt;">
<tr>
<td style="width:16.5%;"></td>
<td style="width:20.39%;"></td>
<td style="width:32.27%;"></td>
<td style="width:11.68%;"></td>
<td style="width:19.16%;"></td>
</tr>
<tr>
<td colspan="0" style=auto;></td>
</tr>
<tr style="height:16.65pt;">
<td valign="middle"  BGCOLOR="#FFFFFF"style="white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;text-decoration:underline;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Product Candidate</font></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF"style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-size:8pt;;"><font style="font-weight:bold;text-decoration:underline;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</font></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF"style="padding-left:7.2 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;text-decoration:underline;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Clinical&#160;Indication(s)</font></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF"style="padding-left:7.2 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;text-decoration:underline;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Phase</font></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF"style="padding-left:7.2 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;text-decoration:underline;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Partnership/Funding</font></p></td>
</tr>
<tr style="height:13.05pt;">
<td valign="middle"  BGCOLOR="#FFFFFF"style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HEPLISAV-B</font></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF"style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TLR 9 agonist &amp; HBsAg</font></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF"style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:5.45pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Hepatitis B prevention</font></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF"style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:5.7pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Phase 3</font></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF"style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:6.45pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dynavax</font></p></td>
</tr>
<tr style="height:13.5pt;">
<td valign="middle"  BGCOLOR="#FFFFFF"style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">DV1179</font></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF"style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TLR 7/9 inhibitor</font></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF"style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:5.45pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Autoimmune and inflammatory diseases</font></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF"style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:5.7pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Phase 1</font></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF"style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:6.45pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">GSK</font></p></td>
</tr>
<tr style="height:13.95pt;">
<td valign="middle"  BGCOLOR="#FFFFFF"style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">AZD1419</font></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF"style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TLR 9 agonist</font></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF"style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:5.45pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Asthma</font></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF"style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:5.7pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Phase 1</font></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF"style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:6.45pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">AstraZeneca</font></p></td>
</tr>
<tr style="height:13.5pt;">
<td valign="middle"  BGCOLOR="#FFFFFF"style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SD-101</font></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF"style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TLR 9 agonist</font></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF"style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:5.45pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cancer immunotherapy</font></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF"style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:5.7pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Phase 1</font></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF"style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:6.45pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dynavax</font></p></td>
</tr>
<tr style="height:13.05pt;">
<td valign="middle"  BGCOLOR="#FFFFFF"style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">DV230</font></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF"style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TLR 9 agonist</font></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF"style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:5.45pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adjuvant technology</font></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF"style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:5.7pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Preclinical</font></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF"style=""><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:6.45pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">NIAID</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:18pt;margin-left:4.53%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">HEPLISAV-B Hepatitis B Vaccine </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">HEPLISAV-B is an investigational adult hepatitis B vaccine that combines our proprietary TLR agonist, 1018, with HBsAg manufactured in our Dynavax facility in D&#252;sseldorf, Germany (&#8220;Rhein&#8221; or &#8220;Dynavax Europe&#8221;). In Phase 3 trials, HEPLISAV-B demonstrated higher and earlier protection with fewer doses than currently-licensed vaccines. Dynavax has worldwide commercial ri</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ghts to HEPLISAV-B.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">On February&#160;25, 2013, we received a complete response letter (&#8220;CRL&#8221;) from the FDA indicating that it would not approve HEPLISAV-B for the indication proposed in our BLA. Following </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">extensive discussions with the FDA, we finalized the design of an additional clinical study of HEPLISAV-B that is intended to provide a sufficiently-sized safety database for the FDA to complete its review of our BLA and make a final determination regarding the safety and immunogenicity of the product. The planned study will be a Phase 3, observer-blinded, randomized, active-controlled, multicenter trial of the safety and immunogenicity of HEPLISAV-B compared with Engerix-B in adults 18 to 70 years of age. The study will include 5,500 HEPLISAV-B subjects and 2,500 Engerix-B subjects, stratified by age and diabetes diagnosis. HEPLISAV-B subjects will receive two doses at 0 and 1 month, while Engerix-B subjects will receive three doses at 0, 1 and 6 months. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The primary objectives of the study will be: (1) to evaluate the overall safety of </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HEPLISAV-B with respect to clinically significant adverse events and (2) to demonstrate the noninferiority of the peak seroprotection rate (&#8220;SPR&#8221;) induced by HEPLISAV-B versus Engerix-B in subjects with type 2 diabetes mellitus. HEPLISAV-B subjects will be evaluated for safety for one year following the second dose, all potential autoimmune events will be adjudicated by a Safety Evaluation and Adjudication Committee and safety will be monitored by a Data and Safety Monitoring Board. We intend to initiate this study in the first quarter of 2014 and conclude subject visits by the end of 2015. We estimate the external costs of the study to be in the range of $50-55 million.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We submitted our Marketing Authorization Application (&#8220;MAA&#8221;) for HEPLISAV-B </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to the European Medicines Agency&#8217;s (&#8220;EMA&#8221;) in July of 2012. In late 2012 we received the Day 120 List of Questions issued by the Committee for Medicinal Products for Human Use of the EMA regarding our MAA, which related primarily to the suitability of different patient populations, the safety database size, and Good Manufacturing Practices (&#8220;GMP&#8221;) and Good Clinical Practices (&#8220;GCP&#8221;) matters. In the early summer of 2013, EMA added to the list of questions, resetting the clock for our response. EMA also inspected several study sites, Dynavax and our clinical contract research organization. The focus of the GCP inspection was HBV-17, a 500 patient study in Chronic Kidney Disease (&#8220;CKD&#8221;) patients that is part of the EMA application but not the U.S. application. In the fourth quarter of 2013, we submitted our responses to the 120-Day Questions. The Day 180 List of Outstanding Issues (&#8220;LOI&#8221;) provided by the EMA in February 2014 indicated that, based primarily on the GCP inspection findings, HBV-17 was not acceptable and because some of the findings were related to the Dynavax&#8217;s overall systems, the other pivotal HEPLISAV-B studies (HBV-10 and HBV-16) were questioned. The LOI also noted that the HEPLISAV-B safety database was considered to be too small to rule out a risk of less common serious adverse events, particularly in light of the GCP concerns. On February 18, 2014 we announced the withdrawal of the MAA for HEPLISAV-B under review by the EMA. We withdrew the application, in part, because the required time frame for response under the MAA procedure was not long enough to permit the collection of the necessary clinical data. The Phase 3 study to be initiated in the U.S. in 2014 is expected to provide additional data to support the safety of HEPLISAV-B.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:9.06%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Commercial Opportunity </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Hepatitis B infection can become a chronic disease that, in some patients, leads to cirrhosis of the liver, hepatocellular carcinoma and death. There is no cure for chronic hepatitis B infection, and disease prevention through effective vaccines is critical to reducing the spread of the disease. Available hepatitis B vaccines for adults have several limitations, including: </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Slow onset of protection&#8212;the current regimen for adults is usually 3 doses given over 6 months to provide seroprotection of approximately 30%, 75% and 90% after the first, second and third doses respectively; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Poor protection in populations that are hypo-responders&#8212;current vaccines provide a lower seroprotection rate for persons over 40 years of age including males, the obese, smokers, diabetics and immunocompromised persons, such as end-stage renal disease patients; and </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Poor compliance&#8212;in certain settings only 30% of people receive all 3 doses. </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">HEPLISAV-B is designed to address the limitations of currently-licensed vaccines by providing higher and earlier protection with fewer doses. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We estimate the total worldwide market for adult hepatitis B vaccines approximates $680 million</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> annually. This market is primarily comprised of GSK&#8217;s Engerix-B and Twinrix<sup style="font-size:85%; vertical-align:top">&#174;</sup> as well as Merck&#160;&amp; Co.&#8217;s (&#8220;Merck&#8221;) Recombivax-HB<sup style="font-size:85%; vertical-align:top">&#174;</sup>. Key market segments consisting of persons considered to be at high risk for hepatitis B virus (&#8220;HBV&#8221;) infection include chronic kidney disease patients, people with multiple sexual partners or injection drug use, healthcare workers and first responders, travelers, chronic liver disease patients and, in the U.S., people with diabetes mellitus (type 1 and type 2). </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We intend to focus our initial commercialization efforts on the U.S.</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> market. Currently, the U.S. market for adult hepatitis B vaccines is approximately $270 million annually. In late 2012 the Advisory Committee on Immunization Practices (&#8220;ACIP&#8221;) expanded its recommendation for adults who should be vaccinated against hepatitis B to include people with diabetes mellitus (type 1 and type 2). According to the Centers for Disease Control and Prevention (&#8220;CDC&#8221;) there are 20 million adults diagnosed with diabetes and another 1.5 million new cases diagnosed each year. This population represents a significant increase in the number of adults recommended for vaccination against hepatitis B in the U.S.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:18pt;margin-left:4.54%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">DV1179 TLR Inhibitor for Autoimmune and Inflammatory Diseases </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">DV1179 is a novel inhibitor of TLR 7 and TLR 9 that is being evaluated as a therapeutic for autoimmune and inflammatory diseases, under a worldwide strategic alliance with GSK. In late 2011, we initiated a proof-of-mechanism clinical trial of DV1179 in systemic lupus erythematosus (&#8220;SLE&#8221;) patients. This indication was selected because </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SLE is characterized by spontaneous lymphoproliferation, expansion of autoreactive B and T cells, and production of polyclonal autoantibodies against numerous nuclear antigens. TLR 7 and TLR 9 have been implicated in the chronic inflammatory response in this disease. GSK has an exclusive option to obtain a license to this program following completion of this trial expected in the second half of 2014.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:4.53%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">AZD1419 TLR Agonist for Asthma Therapy </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We are developing AZD1419, a novel candidate drug for asthma, under our collaboration agreement with AstraZeneca. AZD1419 is a proprietary second-generation TLR agonist and represents a new disease-modifying approach to the treatment of allergic respiratory diseases. AZD1419 is designed to change the basic immune response to environmental allergens, such as </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">house dust and pollens, leading to prolonged reduction in asthma symptoms by converting the response from one primarily mediated by type-2 helper T cells (Th2) to type-1 helper T cells (Th1).</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In October 2013 we initiated dosing in a Phase 1 study to assess the safety of AZD1419. In the first part of the study, up to approximately 45 healthy subjects will receive inhaled doses of AZD1419 or a placebo in single and multiple ascending doses, followed by up to approximately 24 patients with mild asthma in the s</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">econd (Phase 1b) part of the study. Safety data from the first part of the study is expected in mid-2014.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">SD-101 for Immunotherapy of Cancer</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">SD-101 is a proprietary second-generation TLR 9 agonist that was designed to stimulate a specific immune response, including potent interferon-alpha induction. This product candidate has been evaluated in two phase 1 studies to assess its safety and tolerability and is currently being tested in an investigator-sponsored study in patients with relapsed</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> lymphoma after allogeneic bone marrow transplant. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">DV230 Adjuvant Technology</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We have developed a new adjuvant platform, DV230, with funding received from the National Institute of Allergy and Infectious Diseases (&#8220;NIAID&#8221;)</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. Oligonucleotide TLR 9 agonists are strong activators of innate immunity and highly effective adjuvants. However, in situations where an extraordinarily rapid development of protective antibody titers is desired, it is beneficial to enhance the adjuvant function further by means of a nanoparticle formulation. The nanoparticle form of molecule DV230, covalently linked to the highly cross-linked sucrose polymer Ficoll, has demonstrated significant potency advantages in enhancing the magnitude and durability of the primary immune response in preclinical models of anthrax infection. We are currently evaluating this technology for a range of potential applications.&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">PARTNERSHIPS AND OTHER FUNDING AGREEMENTS </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our objective is to discover novel therapies based on our proprietary technologies and develop a diversified pipeline of product candidates to build a product-based commercial business. To reach this objective, an important part of our strategy is to establish partnerships with leading pharmaceutical and biotechnology companies and enter into funding </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">agreements. Our pharmaceutical partners provide valuable resources, expertise and abilities that allow us to further advance the development of our product candidate programs. We also have funding agreements with U.S. government institutions. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">GlaxoSmithKline </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In December 2008, we entered into a worldwide strategic alliance with GSK to discover, develop and commercialize TLR</font><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> inhibitors. Under the terms of the arrangement, we agreed to conduct research and early clinical development in up to four programs: the Lead TLR 7/9 program, a Follow-On TLR 7/9 program, and up to two other TLR programs. In 2011 we began development of a TLR 8 program as one of the two additional programs under the collaboration. </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">GSK subsequently returned all rights to this program to us. In December 2013, we amended our agreement with GSK to extend the research term until conclusion of the ongoing phase 1 study of DV1179. In addition, the exclusivity provisions of the agreement were modified, giving us rights to immediately begin preclinical and clinical research on inhibitors of TLR 7 and 9 (other than DV1179) for oncology indications.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We are currently conducting a Phase 1 clinical trial in the Lead TLR 7/9 program with DV1179 in systemic lupus erythematosus patients. The Company is not currently performing any activities on the Follow-On TLR 7/9 program. GSK has not yet chosen to initiate development of the remaining program under the agreement.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">GSK can exercise its exclusive option to license each program. If GSK exercises an option, GSK would carry out further development and commercialization of the corresponding products. If GSK exercises their option on the Lead TLR 7/9 program, then we are eligible to receive payments of up to approximately $125 million, comprised of contingent opt</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ion exercise payments and additional payments based on GSK&#8217;s achievement of certain development, regulatory and commercial objectives.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We are also eligible to receive up to $60 million if aggregate worldwide annual net sales milestones are achieved and tiered royalties ranging from the mid&#8211;single digit to mid-teens on sales of any products originating from the collaboration. We have retained an option to co-develop and co-promote one product under this agreement.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We received an initial payment of $10 million in 2008. In 2011, we earned and recognized $12 million in substantive development milestone payments related to the initiation of Phase I and proof-of-mechanism clinical trials of DV1179 in systemic lupus erythematosus patients. In 2011, we earned and re</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">cognized $3 million in substantive development milestone payments related to the initiation of development of the TLR 8 program.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Absent early termination, the agreement will expire when all of GSK&#8217;s payment obligations expire. Either party may terminate the agreement early upon written notice if the other party commits an uncured material breach of the agreement. Either party may terminate the agreement in the event of insolvency of the other party. GSK also has the option to terminate the agreement without</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> cause upon prior written notice within a specified window of time dependent upon the stage of clinical development of the programs. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:4.54%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">AstraZeneca AB </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In September 2006, we entered into a three-year research collaboration and license agreement with AstraZeneca for the discovery and development of TLR 9 agonist-based therapies for the treatment of asthma and chronic obstructive pulmonary disease. The research term of this agreement was extended through July 2010. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In October 2011, we amended our agreement with AstraZeneca to provide that we would conduct initial clinical development of AZD1419. Under the terms of the amended agreement, AstraZeneca will fund all program expenses to cover the cost of development activities through Phase 2a. A Phase 1 study was initiated in 2013 and is expected to conclude in 2015. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-weight:bold;;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In March, 2014 we announced a $5.4 million milestone payment and amendment</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of our AstraZeneca agreement to transfer responsibility for all clinical development to AstraZeneca following conclusion of the ongoing Phase 1 clinical trial of AZD1419. If AstraZeneca continues development of AZD1419, we will receive milestones upon initiation of the first Phase 2 trial and the first Phase 3 trial. Additionally, we are eligible to receive potential future development payments and, upon commercialization, we are eligible to receive royalties based on product sales of any products originating from the collaboration. We have the option to co-promote in the U.S. products arising from the collaboration, if any. AstraZeneca has the right to sublicense its rights upon our prior consent. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Absent early termination, the agreement will expire when all of AstraZeneca&#8217;s payment obligations expire. AstraZeneca has the right to terminate the agreement at any time upon prior written notice and either party may terminate the agreement early upon written notice if the other party commits an uncured material breach of the agreem</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ent. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:4.54%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">National Institutes of Health and Other Funding </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In September 2008, we were awarded a $17 million contract to develop our advanced TLR 9 agonist technology as vaccine adjuvants. This five-year contract was awarded by the National Institute of Health&#8217;s (&#8220;NIH&#8221;) NIAID and supports adjuvant development for biodefense vaccines, including anthrax as well as other diseases. NIAID is funding 100% of the total $17 million cost of our program under Contract No. HHSN272200800038C. The NIH may terminate performan</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ce of work under the contract if the contracting officer determines that a termination is in the government&#8217;s interest or if we default in performing and fail to cure after notice. In 2013, the NIAID agreed to extend the contract term by one year to continue the research efforts as defined in the original contract. The activities under this agreement are expected to conclude in the second half of 2014.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">During 2010, we were awarded a grant from the NIAID to take a systems biology approach to study the differ</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ences between individuals who do or do not respond to vaccination against hepatitis B. This study will be one of several projects conducted under a grant to the Baylor Institute of Immunology Research in Dallas as part of the Human Immune Phenotyping Centers program, from which we were awarded $0.2 million in 2013, $0.3 million in 2012, $0.3 million in 2011 and $0.5 million in 2010. We were also awarded a $0.6 million grant in 2010 from the NIH to explore the feasibility of developing a universal vaccine to prevent infection by human papilloma virus. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">During 2011, 2012 and 2013, we were awarded grants from the NIH to fund research in the amounts of $0.6 million, $1.0 million, and $0.2 million, respectively. The 2012 grant included $0.4 to fund research in screening for inhibitors of TLR 8 for treatment of rheumatoid arthritis and $0.6 million to fund development of TLR 8 inhibitors.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">INTELLECTUAL PROPERTY </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our commercial success depends in part on our ability to obtain and maintain proprietary protection for our drug candidates, technology and know-how, to operate without infringing the proprietary rights of others and to prevent others from infringing our proprietary rights. In addition to seeking patent protection in the </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S., we generally file patent applications in Australia, Canada, Japan, Western European countries and additional foreign countries on a selective basis to further protect the inventions that we or our partners consider important to the development of our business. We also rely on trade secrets and contracts to protect our proprietary information. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">As of December&#160;31, 2013, our intellectual property portfolio included 28 issued U.S. patents, over 200 issued or granted foreign patents and over 50 additional pending U.S. and foreign patent applic</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ations claiming compositions and formulations of TLR agonist and inhibitors, their methods of use or processes for their manufacture. We also have exclusive licenses under two agreements to several patents and applications owned by the Regents of the University of California. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We have an issued U.S. patent covering the TLR agonist contained in our HEPLISAV-B investigational vaccine that will expire in 2018, and have</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> correspondingly issued patents in several major European and other countries. We own or have an exclusive license to U.S. and foreign patent applications pending for each of our other product candidates and/or their uses. At present, it is not known or determinable whether patents will issue from any of these applications or what the specific expiration dates would be for any patents that do issue. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Individual patents extend for varying periods depending on the date of filing of the patent application or the date of patent issuance and the legal term of patents in the countries in which they are obtained. Generally, patents issued in the </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. are effective for: </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.33%;margin-left:5.67%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:4pt;font-size:10pt;;"><font style="font-size:9pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:4pt;font-size:10pt;;"><font style="font-size:9pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the longer of 17 years from the issue date or 20 years from the earliest effective filing date, if the patent application was filed prior to June&#160;8, 1995; and </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.33%;margin-left:5.67%;margin-right:0%"><tr><td valign="top" style="width:3.4%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:4pt;font-size:10pt;;"><font style="font-size:9pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.6%;"><p style="margin-bottom:0pt;margin-top:4pt;font-size:10pt;;"><font style="font-size:9pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20 years from the earliest effective filing date, if the patent application was filed on or after June&#160;8, 1995. </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In addition, in certain instances, a patent term can be extended to recapture a portion of the term effectively lost as a result of the FDA regulatory review period. The duration of foreign patents varies in accordance with provisions of applicable local law, but typically is 20 years from the earliest effective filing date. Our patent estate, based on patents existing now and expected by us to i</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ssue based on pending applications, will expire on dates ranging from 2017 to 2033. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Th</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">e actual protection afforded by a patent varies on a product-by-product basis, from country-to-country and depends upon many factors, including the type of patent, the scope of its coverage, the availability of regulatory related extensions, the availability of legal remedies in a particular country and the validity and enforceability of the patents. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Because patent applications in the U.S.</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and many foreign jurisdictions typically are not published until 18 months after filing and publications of discoveries in the scientific literature often lag behind actual discoveries, we cannot be certain that we were the first to make the inventions claimed in each of our issued patents or pending patent applications or that we were the first to invent and/or the first to file for protection of the inventions set forth in these patent applications. The U.S. Patent and Trademark Office (&#8220;PTO&#8221;) may declare interference proceedings to determine the priority of inventions with respect to our patent applications and those of other parties or reexamination or reissue proceedings to determine if the scope of a patent should be narrowed. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our commercial success depends significantly on our ability to operate without infringing patents and proprietary rights of third parties. A number of pharmaceutical companies and biotechnology companies, including Pfizer, Inc. (&#8220;Pfizer&#8221;), as well as universities and research institutions, may have filed paten</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">t applications or may have been granted patents that cover inventions similar to the inventions owned or licensed to us. We cannot determine with certainty whether patents or patent applications of other parties may materially affect our ability to make, use or sell any products. If another party controls patents or patent applications covering our products, we may not be able to obtain the rights we need to those patents or patent applications in order to commercialize our products. Two of our potential competitors, Merck and GSK, are exclusive licensees of broad patents covering recombinant HBsAg, a component of HEPLISAV-B. In addition, the Institut Pasteur owns or has exclusive licenses to patents covering HBsAg. While some of these patents have expired or will soon expire outside the U.S., they remain in force in the U.S.. To the extent we are able to commercialize HEPLISAV-B in the U.S. while these patents remain in force, Merck, GSK, their licensors or the Institut Pasteur may bring claims against us. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Litigation may be necessary to enforce patents issued or licensed to us or to determine the scope or validity of another party&#8217;s proprietary rights. The existence of third-party patent applications and patents could significantly reduce the coverage of the patents owned by or licensed to us and limit our ability to obtain meaningful patent protection. For example, Pfizer has issued U.S. and foreign patent claims as well as patent claims pending with the PTO and foreign patent offices that, if held to be val</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">id, could require us to obtain a license in order to commercialize one or more of our formulations of TLR agonist other than with respect to HEPLISAV-B, for which we have a license. Litigation or any other proceedings, such as patent interferences, could result in substantial costs to and diversion of effort by us, and an adverse outcome in a court or patent office could subject us to significant liabilities, require disputed rights to be licensed from other parties, or require us to cease using some of our technology. We may not prevail of these actions or proceedings, if any. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In addition, other parties may duplicate, design around or independently develop similar or alternative technologies to ours or our licensors. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We may rely, in some circumstances, on trade secrets and confidentiality agreements to protect our technology. Although trade secrets are difficult to protect, wherever possible, we use confidential disclosure agreements to protect the proprietary nature of our technology. Our policy is to req</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">uire each of our commercial partners, employees, consultants and advisors to enter into an agreement before beginning their employment, consulting or advisory relationship with us that in general provides that the individuals must keep confidential and not disclose to other parties any of our confidential information developed or learned by the individuals during the course of their relationship with us except in limited circumstances. These agreements also generally provide that we own all inventions conceived by the individuals in the course of rendering their employment or services to us. However, there can be no assurance that these agreements will not be breached, that we will have adequate remedies for any breach, or that our trade secrets and/or proprietary information will not otherwise become known or be independently discovered by competitors. To the extent that our employees, consultants or contractors use intellectual property owned by others in their work for us, disputes may also arise as to the rights in related or resulting know-how and inventions. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Under the terms of our license agreements with the Regents of the University of California, we are required to pay license fees, make milestone payments, share a portion of fees from third party partnerships up to a specified amount and pay low single-digit royalties on net sales resulting from successful products originating from the licensed technologies. To date, we have paid the University of California a total of </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$1.9 million in license fees and shared third party partnership fees and milestone payments under these agreements. We estimate the total potential milestone payments payable for each such product will total approximately $3.1 million, not including royalties. We may terminate these agreements in whole or in part on 60 days advance notice. The Regents of the University of California may terminate these agreements if we are in breach for failure to make payments, meet diligence requirements, produce required reports or fund internal research and we do not cure such breach within 60 days after being notified of the breach. Otherwise, the agreements generally continue in effect until the last patent claiming a product licensed under the agreement or its manufacture or use expires, or in the absence of patents, until the date the last patent application claiming a licensed product is abandoned. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">COMPETITION </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The biotechnology and pharmaceutical industries are characterized by rapidly advancing technologies, intense competition and a strong emphasis on proprietary products. Our products and development programs target a number of areas including viral, respiratory, autoimmune and inflammatory diseases. There are many commercially available products for the treatment of these diseases. Many compan</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ies and institutions are making substantial investments in developing additional products to treat these diseases that could compete directly or indirectly with our products under development. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">HEPLISAV-B, a two-dose hepatitis B vaccine, if approved and commercialized, will compete directly with conventional three-dose marketed vaccines produced by GSK and Merck, among others. There are also modified schedules of conventional hepatitis B vaccines for limited age ranges that are approved in the European Unio</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">n and U.S.. In addition, HEPLISAV-B will compete against a multivalent vaccine produced by GSK that simultaneously protect against hepatitis B and hepatitis A. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our therapy for autoimmune and inflammatory diseases, DV1179, if developed, approved and commercialized will compete with key biologic therapies from companies such as F. Hoffman-La Roche Ltd. and its subsidiary Genentech, Inc. (&#8220;Roche/Genentech&#8221;), Amgen Inc., Biogen Idec, AbbVie and GSK. In addition, our product would compete with generic drugs com</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">monly used to treat autoimmune diseases, including corticosteroids, non-steroidal anti-inflammatory drugs, antimalarials and immunosuppressive agents. Other companies, such as AstraZeneca and its subsidiary MedImmune, LLC, Roche/Genentech, Idera Pharmaceuticals, Pfizer and UCB S.A. and its partner Immunomedics, Inc., are developing anti-IFN-alpha-antibodies, B-cell targeted antibodies, immunosuppressants, and other TLR inhibitors that may compete directly with our product candidate. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our asthma therapy, AZD1419, if developed, approved and commercialized, will compete indirectly with existing asthma therapies, such as inhaled beta-agonists, corticosteroids, leukotriene inhibitors and IgE monoclonal antibodies, including those marketed by Merck, Roche/Genentec</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">h, Novartis International AG, AstraZeneca and GSK. In addition, directly competing products may be in development by Sanofi-Aventis and Idera Pharmaceuticals. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our cancer immunotherapy, SD101, if developed, approved and commercialized will compete with a range of biological therapies being used or studie</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">d to treat blood cancer including:</font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Monoclonal antibody therapy, including radioimmunotherapy</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interferons and interleukins</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Donor lymphocyte infusion</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reduced-intensity allogeneic stem cell transplantation</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Therapeutic cancer vaccines</font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Approved and late-stage investigational cancer immunotherapeutics are marketed or being developed by numerous companies, including Bristol-Myers Squibb, Roche/Genentech, Merck, GSK, Gilead, and Pharmacyclics.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Many of the entities developing and marketing these competing products have significantly greater financial resources and expertise in research and development, manufacturing, preclinical testing, conducting clinical trials, obtaining regulatory approvals and marketing than we do. Smaller or early-stage companies may also prove to be significant competitors, particularly through collaborative agreements with large, established c</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ompanies and access to capital. These entities may also compete with us in recruiting and retaining qualified scientific and management personnel, as well as in acquiring technologies complementary to or necessary for our programs. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">REGULATORY CONSIDERATIONS </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In the U.S.</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, pharmaceutical and biological products are subject to rigorous review and approval by the FDA under the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act and other federal statutes and regulations. In Europe, under the centralized procedure, a company submits a single application to the European Medicines Agency. The steps ordinarily required by the regulatory authorities before a new drug or biological product may be marketed in the U.S. and in most other countries include but are not limited to the following: </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.33%;margin-left:5.67%;margin-right:0%"><tr><td valign="top" style="width:3.4%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.6%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">completion of preclinical laboratory tests, preclinical studies and formulation studies; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.33%;margin-left:5.67%;margin-right:0%"><tr><td valign="top" style="width:3.4%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.6%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">submission to the regulatory authority of a clinical application for a new drug or biologic which must become effective before clinical trials may begin; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.33%;margin-left:5.67%;margin-right:0%"><tr><td valign="top" style="width:3.4%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.6%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">performance of adequate and well-controlled human clinical trials to establish the safety and efficacy of the drug or biologic for each proposed indication; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.33%;margin-left:5.67%;margin-right:0%"><tr><td valign="top" style="width:3.4%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.6%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">demonstration of the consistent manufacturing of drug substance and drug product; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.33%;margin-left:5.67%;margin-right:0%"><tr><td valign="top" style="width:3.4%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.6%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the submission of a new drug application to the regulatory authority; and </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.33%;margin-left:5.67%;margin-right:0%"><tr><td valign="top" style="width:3.4%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.6%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">regulatory review and approval of the application before any commercial marketing, sale or shipment of the drug. </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">If applicable requirements are not met, regulatory authorities may issue fines, require that a company recall its products, seize products, require that a company totally or partially suspend the production of its products, refuse to approve a marketing application, pursue criminal prosecution and/or revoke previously granted marketing authorizations. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">To secure regulatory authority approval, we must submit extensive non-clinical and clinical data, adequate evidence of a product manufactured by a well-controlled process that is safe and effective for its intended use, and other supporting information to the regulatory authority. The number of preclinical studies and clinical trials that will be required for FDA and foreign regulatory agency approvals varies </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">depending on the product candidate, the disease or condition for which the product candidate is in development and regulations applicable to any particular drug candidate. Data obtained from preclinical and clinical activities are susceptible to varying interpretations, which could delay, limit or prevent regulatory approval or clearance. Further, the results from preclinical testing and early clinical trials may not be predictive of results obtained in later clinical trials. In addition, the development of the drug substance and drug product may require manufacturing modifications to ensure future regulatory acceptance. The approval process takes many years, requires the expenditures of substantial resources, and involves post-marketing surveillance. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Delays experienced during the approval process may materially reduce the period during which we will have exclusive rights to exploit patented products or technologies. Delays can occur at any stage of drug development and as a result of many factors, certain o</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">f which are not under our control, including but not limited to the following: </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.33%;margin-left:5.67%;margin-right:0%"><tr><td valign="top" style="width:3.4%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.6%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">lack of efficacy, or incomplete or inconclusive results from clinical trials; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.33%;margin-left:5.67%;margin-right:0%"><tr><td valign="top" style="width:3.4%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.6%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">unforeseen safety issues; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.33%;margin-left:5.67%;margin-right:0%"><tr><td valign="top" style="width:3.4%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.6%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">failure by investigators to adhere to protocol requirements, including patient enrollment criteria; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.33%;margin-left:5.67%;margin-right:0%"><tr><td valign="top" style="width:3.4%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.6%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">slower than expected rate of patient recruitment; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.33%;margin-left:5.67%;margin-right:0%"><tr><td valign="top" style="width:3.4%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.6%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">failure by subjects to comply with trial protocol requirements; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.33%;margin-left:5.67%;margin-right:0%"><tr><td valign="top" style="width:3.4%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.6%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">inability to follow patients adequately after treatment; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.33%;margin-left:5.67%;margin-right:0%"><tr><td valign="top" style="width:3.4%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.6%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">inability to qualify and enter into arrangements with third parties to manufacture sufficient quality and quantities of materials for use in clinical trials; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.33%;margin-left:5.67%;margin-right:0%"><tr><td valign="top" style="width:3.4%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.6%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">failure by a contract research organization to fulfill contractual obligations; and </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.33%;margin-left:5.67%;margin-right:0%"><tr><td valign="top" style="width:3.4%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.6%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">adverse changes in regulatory policy during the period of product development or the period of review of any application for regulatory approval or clearance. </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The FDA or foreign regulatory agency may also require post-marketing testing and surveillance to monitor the effects of approved products or place conditions on any approvals that could restrict the commercial applications of these products. Following approval, we may be required to conduct additional post-marketing studies. The regulatory authority may withdraw</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> product approvals if we do not continue to comply with regulatory standards or if problems occur following initial marketing. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Non-clinical studies involve laboratory evaluation of product characteristics or animal studies to assess the initial efficacy and safety of the product. The FDA or other foreign regulatory agency, under its good laboratory practices regulations, regulates certain non-clinical studies. Research and preclinical studies do not involve the introduction of a product candidate in human </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">subjects. These activities involve identification of potential product candidates, modification of promising candidates to optimize their biological activity, as well as preclinical studies to assess safety and effectiveness in animals. In clinical trials, the product candidate is administered to humans. Violations of these regulations can, in some cases, lead to invalidation of those studies, requiring these studies to be repeated. The results of these tests, together with manufacturing information and analytical data, are submitted to the regulatory authority as part of a clinical application, which must be approved by the regulatory authority before we can commence clinical investigations in humans. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Clinical trials involve the administration of the investigational product to humans under the supervision of a qualified principal investigator. We must conduct our clinical trials in accordance with GCP regulations under protocols submitted to applicable regulatory authorities as part of the clinical applicat</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ion. GCP regulations mandate comprehensive documentation for the clinical protocol, record keeping, training, and facilities including computers. Quality assurance and inspections are designed to ensure that these GCP standards are achieved. Additionally, each clinical trial must be approved and conducted under the auspices of an Institutional Review Board (&#8220;IRB&#8221;) or Independent Ethics Committee and with patient informed consent. The IRB will consider, among other matters, ethical factors, the safety of human subjects and the possibility of liability of the institution conducting the trial. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The stages of the regulatory process include clinical trials in three sequential phases that may overlap. Phase 1 clinical trials typically involve the administration of a product candidate into a small group of healthy human subjects. These trials are the first attempt to evaluate a drug&#8217;s safety, determine a safe dose range and identify side effects. During Phase 2 trials, the product candidate is introduced into patien</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ts who suffer from the medical condition that the product candidate is intended to treat. Phase 2 studies are designed to evaluate whether a product candidate shows evidence of effectiveness, to further evaluate dosage, and to identify possible adverse effects and safety risks. When Phase 2 evaluations demonstrate that a product candidate appears to be both safe and effective, Phase 3 trials are undertaken to confirm a product candidate&#8217;s effectiveness and to test for safety in an expanded patient population. If the results of Phase 3 trials appear to confirm effectiveness and safety, the data gathered in all phases of clinical trials form the basis for an application for regulatory approval of the product candidate. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We and all of our contract manufacturers are required to comply with the applicable FDA or foreign regulatory agency current GMP regulations. Manufacturers of biologics also must comply with a regulatory authority&#8217;s general biological product standards. Failure to comply with the statutory and r</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">egulatory requirements subjects the manufacturer to possible legal or regulatory action, such as suspension of manufacturing, seizure of product or voluntary recall of a product. Good manufacturing practice regulations require quality control and quality assurance as well as the corresponding maintenance of records and documentation. Before granting product approval, the regulatory authority must determine that our or our third party contractor&#8217;s manufacturing facilities meet GMP requirements before we can use them in the commercial manufacture of our products. In addition, our facilities are subject to periodic inspections by the regulatory authority for continued compliance with GMP requirements during clinical development as well as following product approval. Adverse experiences with the product must be reported to the FDA or foreign regulatory agency and could result in the imposition of market restriction through labeling changes or in product removal. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">If our products are approved for sale, we will be subject to further regulatory requirements under federal and state provisions such as federal &#8220;sunshine&#8221; laws, anti-kickback laws, false claims laws and state law equivalents of those and other regulations. We are also subject to various federal, state, local and foreign laws, regulations and recommendations relating to safe working conditions, laboratory and manufacturing practices, the experimental use of animals and the use and disposal of hazardous or po</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">tentially hazardous substances, including radioactive compounds and infectious disease agents, used in connection with our research. We cannot accurately predict the extent of government regulation that might result from any future legislation or administrative action. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">MANUFACTURING </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We rely on our facility in Dusseldorf, Germany and third parties to perform the multiple processes involved in manufacturing our product candidates, including the manufacturing of TLR agonist and inhibitors, antigens, the combination of the TLR agonist and the antigens, and the formulation, fill and finish of these products. The process for manufacturing oligonucleotides is well-established and uses commercially available equipment and raw materials. We have relied on a limited</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> number of suppliers to produce products for clinical trials and a single supplier to produce our 1018 for HEPLISAV-B. To date, we have manufactured only small quantities of TLR agonist and inhibitors ourselves for development purposes. We currently manufacture the HBsAg for HEPLISAV-B at our Dynavax Europe facility. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">RESEARCH AND DEVELOPMENT </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Conducting a significant amount of research and development has been central to our business model. Our research and development expenses were $50.9 million</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, $49.1 million and $51.3 million for the years ended December&#160;31, 2013, 2012 and 2011, respectively. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ENVIRONMENT </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We have made, and will continue to make, expenditures for environmental compliance and protection. We do not expect that expenditures for compliance with environmental laws will have a material effect on our capital expenditures or results of operations in the future. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">EMPLOYEES </font></p><p style="margin-bottom:0pt;margin-top:4pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-weight:bold;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">As of December&#160;31, 2013, we had </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">151 full-time employees, including 21 Ph.D.s, 1 M.D. and 17 others with advanced degrees. Of the 151 employees, 122 were dedicated to research and development activities. None of our employees is subject to a collective bargaining agreement and we believe our relations with our employees are good. </font></p><p style="margin-bottom:0pt;margin-top:4pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:10pt;;">&nbsp;</p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:11.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_1A"></a>I</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TEM 1A.</font></p></td><td valign="top" style="width:88.67%;"><p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_1A"></a>RISK FACTORS </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;text-indent:4.54%">This Annual Report on Form 10-K contains forward-looking statements concerning our future products, product candidates, timing of development activities, regulatory strategies, intellectual property position, expenses, revenues, liquidity and cash needs, as well as our plans and s</font><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">trategies. These forward-looking statements are based on current expectations and we assume no obligation to update this information. Numerous factors could cause our actual results to differ significantly from the results described in these forward-looking statements, including the following risk factors. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Risks Related to our Business </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">The success of our product candidates, in particular HEPLISAV-B, depends on regulatory approval. The FDA or foreign regulatory agencies may determine our clinical trials or other data regarding safety, efficacy, consistency of manufacture or compliance with GMP regulations are insufficient for regulatory approval. Failure to obtain regulatory approvals could require us to discontinue operations. </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">None of our product candidates has been approved for sale by any regulatory agency. Any product candidate we develop is subject to extensive regulation by federal, state and local governmental authorities in the </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S., including the FDA, and foreign regulatory agencies. Our success is primarily dependent on our ability to obtain regulatory approvals for our most advanced product candidates. Approval processes in the U.S. and in other countries are uncertain, can take many years and require the expenditure of substantial resources and we are unable to predict the timing of when regulatory approval may be received, if ever, in any jurisdiction.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">For our lead product, HEPLISAV-B</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, our BLA must be approved by the FDA and corresponding applications to foreign regulatory agencies must be approved by those agencies before we may sell the product in their respective geographic area. Obtaining approval of a BLA and corresponding foreign applications is highly uncertain and we may fail to obtain approval. The BLA review process is extensive, lengthy, expensive and uncertain, and the FDA or foreign regulatory agencies may delay, limit or deny approval of our application for many reasons, including: whether the data from our clinical trials, including the Phase 3 results, or the development program is satisfactory to the FDA or foreign regulatory agency; disagreement with the number, design, size, conduct or implementation of our clinical trials or a conclusion that the data fails to meet statistical or clinical significance; acceptability of data generated at our clinical trial sites that are monitored by third party clinical research organizations; the results of an FDA or other advisory committee that may recommend against approval of our BLA or may recommend that the FDA or other agencies require, as a condition for approval, additional preclinical studies or clinical trials; and deficiencies in our manufacturing processes or facilities or those of our third party contract manufacturers and suppliers, if any. For example, in our 2013 CRL, HEPLISAV-B was not approvable for the proposed indication based on insufficient patient safety data for an indication in adults 18-70 years of age without further evaluation of safety. While we are undertaking a study intended to obtain additional safety data information to the FDA, there can be no assurance that this additional clinical study will support approval, or that the data will provide acceptable immunogenicity data for patients with diabetes. The FDA also requested additional data from our manufacturing process validation program as well as clarifying information on the manufacturing controls and facilities in our D&#252;sseldorf manufacturing facility with respect to quality assurance of commercial product. There can be no assurance that Dynavax can successfully produce the requisite data in a timely manner or that the data will be sufficient for approval in the U.S.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In addition, we recently announced </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our withdrawal of our Marketing Authorization Application for approval to the EMA based in part upon our determination that </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">in the required timeframe for response under the MAA procedure we would not be able to collect the necessary clinical data in a timely manner to respond to the EMA&#8217;s list of outstanding issues regarding the safety database. While we expect to begin shortly an additional HEPLISAV clinical trial, HBV-23, that is intended to provide a safety database sufficient to support licensure, t</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">here can be no assurance that we can timely initiate or complete such study in a timely manner, nor that our safety database will be sufficient or acceptable to support MAA approval. Moreover, our withdrawal means that additional questions raised by the EMA in the continuing review process were not completed and there can be no assurance that we would be able to respond sufficiently to satisfy the other outstanding questions from the EMA with respect to our MAA.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In addition, we obtain guidance from regulatory authorities on certain aspects of our clinical development activities and seek to comply with written guidelines provided by the authorities. These discussions and written guidelines are not binding obligations on the part of the regulatory authorities and </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the regulatory authorities may require additional patient data or studies to be conducted. Regulatory authorities may revise or retract previous guidance during the course of a clinical trial or after completion of the trial. The authorities may also disqualify a clinical trial from consideration in support of approval of a potential product if they deem the guidelines have not been met. The FDA or foreign regulatory agencies may determine our clinical trials or other data regarding safety, efficacy or consistency of manufacture or compliance with GMP regulations are insufficient for regulatory approval.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Failure to receive approval or significant delay in being able to provide the safety and manufacturing information required for approval of our BLA for HEPL</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ISAV-B would have a material adverse effect on our business and results of operations. Even if approved, the labeling approved by the relevant regulatory authority for a product may restrict to whom we and our potential partners, if any, may market the product or the manner in which our product may be administered and sold, which could significantly limit the commercial opportunity for such product.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Before granting product approval, the FDA must determine that our or our third party contractor&#8217;s manufacturing facilities meet current GMP requirements before we can use them in the commercial manufacture of our products. We and all of our contract manufacturers are required to comply with the applicable current GMP regulations. Manufacturers of biological produ</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">cts must also comply with the FDA&#8217;s general biological product standards. In addition, GMP regulations require quality control and quality assurance as well as the corresponding maintenance of records and documentation sufficient to ensure the quality of the approved product. Failure to comply with the statutory and regulatory requirements subjects the manufacturer to possible legal or regulatory action, such as delay of approval, suspension of manufacturing, seizure of product or voluntary recall of a product.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">The FDA may require more clinical trials for our product candidate than we currently expect or are conducting before granting regulatory approval, if regulatory approval is granted at all. Our clinical trials may be extended which may lead to substantial delays in the regulatory approval process for our product candidates, which will impair our ability to generate revenues.</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our registration and commercial timelines depend on further discussions with the FDA and corresponding foreign regulatory agencies and requirements and requests they may make for additional data or completion of additional clinical trials. Any such requirements or requests could:</font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">adversely affect our ability to timely and successfully commercialize or market these product candidates;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">result in significant additional costs;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">potentially diminish any competitive advantages for those products;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">potentially limit the markets for those products;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">adversely affect our ability to enter into collaborations or receive milestone payments or royalties from potential collaborators;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">cause us to abandon the development of the affected product candidate; or</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">limit our ability to obtain additional financing on acceptable terms, if at all. Clinical trials for our product candidates are expensive and time consuming, may take longer than we expect or may not be completed at all, and their outcomes are uncertain.</font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We are undertaking an</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> additional trial of HEPLISAV-B and expect to commence clinical trials for our other product candidates in the future. Each of our clinical trials requires the investment of substantial planning, expense and time and the timing of the commencement, continuation and completion of these clinical trials may be subject to significant delays relating to various causes, including scheduling conflicts with participating clinicians and clinical institutions, difficulties in identifying and enrolling participants who meet trial eligibility criteria, failure of participants to complete the clinical trial, delay or failure to obtain institutional review board, or IRB, or other regulatory approval to conduct a clinical trial at a prospective site, unexpected adverse events and shortages of available drug supply. Participant enrollment is a function of many factors, including the size of the relevant population, the proximity of participants to clinical sites, the eligibility criteria for the trial, the existence of competing clinical trials and the availability of alternative or new treatments.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-weight:bold;;"><font style="font-weight:bold;font-style:italic;;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Failure by us or our </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">clinical research organizations</font><font style="font-weight:bold;font-style:italic;;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> (&#8220;CROs&#8221;) to conduct a clinical study to GCP standards could result in disqualification of the clinical trial from consideration in support of approval of a potential product.</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We are responsible for conducting our clinical trials consistent with GCP standards and for oversight of our vendors to ensure that they comply with such standards. </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We depend on medical institutions and clinical research organizations, or CROs, to conduct our clinical trials in compliance with GCP. To the extent that they fail to comply with GCP standards, fail to enroll participants for our clinical trials, or are delayed for a significant time in the execution of our trials, including achieving full enrollment, we may be affected by increased costs, program delays or both, which may harm our business.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In addition, we conduct clinical trials in foreign countries which may subject us to further delays and expenses as a result of increased drug shipment costs, additional regulatory requirements and the engagement of foreign CROs, as well as expose us to risks associated with less experienced clinical investigators who are unknown to the FDA, and different standards of medical care. Foreign currency transactions insofar as changes in the relative value of the U.S. dollar to the fore</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ign currency where the trial is being conducted may also unfavorably impact our actual costs.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Clinical trials must be conducted in accordance with FDA or other applicable foreign government guidelines and are subject to oversight by the FDA, other foreign governmental agencies and IRBs at the medical institutions where the clinical trials are conducted. In addition, clinical trials must be conducted with supplies of our product candidates produced under cGMP and other requirements in foreign countries, and </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">may require large numbers of participants.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The FDA or other foreign governmental agencies or we ourselves could delay, suspend or halt our clinical trials of a product candidate for numerous reasons, including:</font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">deficiencies in the trial design;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">deficiencies in the conduct of the clinical trial including failure to conduct the clinical trial in accordance with regulatory requirements or clinical protocols;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">deficiencies in the clinical trial operations or trial sites resulting in the imposition of a clinical hold;</font></p></td></tr></table></div><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the product candidate may have unforeseen adverse side effects, including fatalities, or a determination may be made that a clinical trial presents unacceptable health risks;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the time required to determine whether the product candidate is effective may be longer than expected;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">fatalities or other adverse events arising during a clinical trial that may not be related to clinical trial treatments;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the product candidate may appear to be no more effective than current therapies;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the quality or stability of the product candidate may fail to conform to acceptable standards;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our inability to produce or obtain sufficient quantities of the product candidate to complete the trials;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our inability to reach agreement on acceptable terms with prospective CROs and trial sites, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and trial sites;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our inability to obtain IRB approval to conduct a clinical trial at a prospective site;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our liability to obtain regulatory approval to conduct a clinical trial;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">lack of adequate funding to continue the clinical trial, including the occurrence of unforeseen costs due to enrollment delays, requirements to conduct additional trials and studies and increased expenses associated with the services of our CROs and other third parties;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our inability to recruit and enroll individuals to participate in clinical trials for reasons including competition from other clinical trial programs for the same or similar indications; or</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our inability to retain participants who have initiated a clinical trial but may be prone to withdraw due to side effects from the therapy, lack of efficacy or personal issues, or who are lost to further follow-up.</font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In addition, we may experience significant setbacks in advanced clinical trials, even after promising results in earlier trials, such as unexpected adverse events that occur when our product candidates are combined with other therapies and drugs or given to larger populations, which often occur in later-s</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">tage clinical trials. In addition, clinical results are frequently susceptible to varying interpretations that may delay, limit or prevent regulatory approvals. Also, patient advocacy groups and parents of trial participants may demand additional clinical trials or continued access to drug even if our interpretation of clinical results received thus far leads us to determine that additional clinical trials or continued access are unwarranted. Any disagreement with patient advocacy groups or parents of trial participants may require management&#8217;s time and attention and may result in legal proceedings being instituted against us, which could be expensive, time-consuming and distracting, and may result in delay of the program. Negative or inconclusive results or adverse medical events, including participant fatalities that may be attributable to our product candidates, during a clinical trial may necessitate that it be redesigned, repeated or terminated. Further, some of our clinical trials may be overseen by an independent data safety monitoring board (&#8220;DSMB&#8221;), and the DSMB may determine to delay or suspend one or more of these trials due to safety or futility findings based on events occurring during a clinical trial. Any such delay, suspension, termination or request to repeat or redesign a trial could increase our costs and prevent or significantly delay our ability to commercialize our product candidates.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">HEPLISAV-B and most of our earlier stage programs rely on oligonucleotide TLR agonists. Serious adverse event data relating to either 1018 or other TLR agonists may require us to reduce the scope of or discontinue our operations.</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">HEPLISAV-B incorporates 1018</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, a TLR 9 agonist CPG oligonucleotide, and most of our research and development programs use similar oligonucleotides. If any of our product candidates in clinical trials produce serious adverse event data, we may be required to delay, discontinue or modify our clinical trials or our clinical trial strategy. Most of our clinical product candidates contain oligonucleotides, and if a common safety risk across therapeutic areas were identified, it may hinder our ability to enter into potential collaboration arrangements or commercialize our product candidates. If adverse event data are found to apply to our TLR agonist and/or inhibitor technology as a whole, we may be required to significantly reduce or discontinue our operations.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We have no commercialization experience, and the time and resources to develop sales, marketing and distribution capabilities for HEPLISAV-B are significant. If we fail to achieve and sustain commercial success for HEPLISAV-B, either directly or with a partner, our business would be harmed.</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our lead product candidate, HEPLISAV-B</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, if approved, would require us to establish sales, marketing and distribution capabilities, or make arrangements with third parties to perform these services. These efforts will require resources and time and we may not be able to enter into these arrangements on acceptable terms. In particular, significant resources may be necessary to successfully market, sell and distribute HEPLISAV-B to patients with diabetes, a group recently recommended by the CDC and ACIP to receive hepatitis B vaccination. Moreover, our pricing and reimbursement strategies with respect to our initial approval plans for HEPLISAV-B may significantly impact our ability to achieve commercial success in this potential patient population.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">If we, or our partners, if any, are not successful in setting our marketing, pricing and reimbursement strategy, recruiting sales and marketing personnel or in building a sales and marketing infrastructure, we will have difficulty commercializing </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HEPLISAV-B, which would adversely affect our business and financial condition. To the extent we rely on other pharmaceutical or biotechnology companies with established sales, marketing and distribution systems to market HEPLISAV-B, we will need to establish and maintain partnership arrangements, and we may not be able to enter into these arrangements on acceptable terms or at all. To the extent that we enter into co-promotion or other arrangements, certain revenues we receive will depend upon the efforts of third parties, which may not be successful and are only partially in our control.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We rely on our facility in D&#252;sseldorf, Germany and third parties to supply materials or perform processes necessary to manufacture our product candidates. We rely on a limited number of suppliers to produce the oligonucleotide we will require for commercialization. Additionally, we have limited experience in manufacturing our product candidates in commercial quantities.</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We rely on our facility in D&#252;sseldorf and third parties to perform the multiple processes involved in manufacturing our product candidates, including </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1018, certain antigens, the combination of the oligonucleotide and the antigens, and the formulation, fill and finish. Termination or interruption of these relationships may occur due to circumstances that are outside of our control, resulting in higher cost or delays in our product development or commercialization efforts.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We have relied on a limited number of suppliers to produce oligonucleotides </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">for clinical trials and a single supplier to produce our 1018 ISS for HEPLISAV-B. To date, we have manufactured only small quantities of oligonucleotides ourselves for development purposes. If we were unable to maintain our existing supplier for 1018, we would have to establish an alternate qualified manufacturing capability, which would result in significant additional operating costs and delays in developing and commercializing our product candidates, particularly HEPLISAV-B. We or other third parties may not be able to produce 1018 at a cost, quantity and quality that are available from our current third-party supplier.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We currently utilize our facility in D&#252;sseldorf to manufacture the hepatitis B surface antigen for HEPLISAV-B</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. The commercial manufacturing of biological products is a time-consuming and complex process, which must be performed in compliance with current GMP regulations. As part of the review of our BLA filing for HEPLISAV-B, the FDA requested additional data regarding our manufacturing process validation program as well as clarifying information on the manufacturing controls and facilities and there can be no assurance that our responses will be sufficient to meet the FDA requirements for GMP manufacturing.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In addition, we may not be able to comply with ongoing and comparable foreign regulations, and our manufacturing process may be subject to delays, disruptions or quality control/quality assurance problems. Noncompliance with these regulations or other problems with our manufacturing process may limit, delay or disrupt the commercialization of </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HEPLISAV-B and could result in significant expense. Moreover, depending on the level of market acceptance of HEPLISAV-B, if approved, we may not have the capacity in our existing facility to meet all of our future commercial supply needs. Our current manufacturing capacity could supply up to approximately 2&#160;million doses of hepatitis B surface antigen annually, and our ability to expand D&#252;sseldorf manufacturing capacity by improving utilization in our existing facility, improving upon our current production yields or using a new facility will take time to implement and could result in substantial cost. In the event that demand exceeds our current capacity plans, we may experience a shortage in supply of HEPLISAV-B, which could have a material adverse effect on the success of HEPLISAV-B. Likewise, in the event that HEPLISAV-B is not approved, we would have to consider other alternatives for the facility in D&#252;sseldorf, including its sale or closure, and any such efforts would be complex, expensive, and time-consuming.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">If we receive regulatory approval for our product candidates, we will be subject to ongoing FDA and foreign regulatory obligations and continued regulatory review.</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We and our third party suppliers are required to comply with applicable current GMP regulations and other international regulatory requirements. The regulations require that our product candidates be manufactured and our records maintained in a prescribed manner with respect to manufacturing, testing and quality control/quality assurance activities. Su</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ppliers of key components and materials must be named in a BLA submitted to the FDA for any product candidate for which we are seeking FDA approval. Additionally, these third parties and our manufacturing facility must undergo a pre-approval inspection before we can obtain marketing authorization for any of our product candidates. Even after a manufacturer has been qualified by the FDA, the manufacturer must continue to expend time, money and effort in the area of production and quality control to ensure full compliance with GMP. Manufacturers are subject to regular, periodic inspections by the FDA following initial approval. Further, to the extent that we contract with third parties for the manufacture of our products, our ability to control third-party compliance with FDA requirements will be limited to contractual remedies and rights of inspection.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">If, as a result of their inspections, the FDA determines that the equipment, facilities, laboratories or processes do not comply with applicable FDA regulations and conditions of product approval, the FDA may not approve the product or may suspend the manufacturing operations. If the manufacturing operations of any of the suppliers for our product candidates are suspended, we may be unable to generate sufficient </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">quantities of commercial or clinical supplies of product to meet market demand, which would harm our business. In addition, if delivery of material from our suppliers were interrupted for any reason, we might be unable to ship our approved product for commercial supply or to supply our products in development for clinical trials. Significant and costly delays can occur if the qualification of a new supplier is required.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Any regulatory approvals that we receive for our product candidates are likely to contain requirements for post-marketing follow-up studies, which may be costly. Product approvals, once granted, may be modified based on data from subsequent studies or commercial use. As a result, limitations on labeling indications or marketing claims, or wit</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">hdrawal from the market may be required if problems occur after commercialization.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Failure to comply with regulatory requirements could prevent or delay marketing approval or require the expenditure of money or other resources to correct. Failure to comply with applicable requirements may also result in warning letters, fines, injunctions, civil penalties, recall or seizure of products, total or partial suspension of production, refusal of the government to renew marketing applications and criminal prosecut</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ion, any of which could be harmful to our ability to generate revenues and our stock price.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We may develop, seek regulatory approval for and market our product candidates outside the U.S., requiring a significant commitment of resources. Failure to successfully manage our international operations could result in significant unanticipated costs and delays in regulatory approval or commercialization of our product candidates.</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We may introduce certain of our product candidates, including HEPLISAV-B</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, in various markets outside the U.S.. Developing, seeking regulatory approval for and marketing our product candidates outside the U.S. could impose substantial burdens on our resources and divert management&#8217;s attention from domestic operations. International operations are subject to risk, including:</font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the difficulty of managing geographically distant operations, including recruiting and retaining qualified employees, locating adequate facilities and establishing useful business support relationships in the local community;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">compliance with varying international regulatory requirements, laws and treaties;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">securing international distribution, marketing and sales capabilities;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">adequate protection of our intellectual property rights;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">obtaining regulatory and pricing approvals at a level sufficient to justify commercialization;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">legal uncertainties and potential timing delays associated with tariffs, export licenses and other trade barriers;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">diverse tax consequences;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the fluctuation of conversion rates between foreign currencies and the U.S. dollar; and</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">regional and geopolitical risks.</font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We have withdrawn our MAA in Europe and we may not be able to timely </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">initiate our planned clinical trial or provide sufficient data from such trial or respond to other comments to our previously filed MAA sufficient to obtain foreign regulatory approvals in Europe in a reasonable time period or at all. Any failure or delay in obtaining regulatory approval in one jurisdiction may have a negative effect on the regulatory approval process in other jurisdictions. If we are unable to successfully manage our international operations, we may incur significant unanticipated costs and delays in regulatory approval or commercialization of our product candidates, which would impair our ability to generate revenues.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">If any products we develop are not accepted by the market or if regulatory agencies limit our labeling indications or marketing claims, we may be unable to generate significant revenues, if any.</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Even if we obtain regulatory approval for our product candidates and are able to commercialize them, our products may not gain market acceptance among physicians, patients, healthcare payors and the medical community.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The degree of market acceptance of any of our approved products will depend upon a number of factors, including:</font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the indication for which the product is approved and its approved labeling;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the presence of other competing approved therapies;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the potential advantages of the product over existing and future treatment methods;</font></p></td></tr></table></div><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the relative convenience and ease of administration of the product;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the strength of our sales, marketing and distribution support;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the price and cost-effectiveness of the product; and</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">sufficient third-party reimbursement.&#160;</font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The FDA or other regulatory agencies could limit the labeling indication for which our product candidates may be marketed or could otherwise limit marketing efforts for our products. If we are unable to achieve approval or successfully market any of our product candidates, or marketing efforts are res</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">tricted by regulatory limits, our ability to generate revenues could be significantly impaired.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We face uncertainty regarding coverage, pricing and reimbursement and the practices of third party payors, which may make it difficult or impossible to sell our product candidates on commercially reasonable terms.</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In both domestic and foreign markets, our ability to achieve profitability will depend in part on the negotiation of a favorable price or the availability of appropriate reimbursement from third party payors, in particular for </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HEPLISAV-B where existing products are already marketed. Existing laws affecting the pricing and coverage of pharmaceuticals and other medical products by government programs and other third party payors may change before any of our product candidates are approved for marketing. In addition, third party payors are increasingly challenging the price and cost-effectiveness of medical products and services, and pricing and reimbursement decisions may not allow our products to compete effectively with existing or competitive products. Because we intend to offer products, if approved, that involve new technologies and new approaches to treating disease, the willingness of third party payors to reimburse for our products is uncertain. We will have to charge a price for our products that is sufficient to enable us to recover our considerable investment in product development and our operating costs. Adequate third-party reimbursement may not be available to enable us to maintain price levels sufficient to achieve profitability and could harm our future prospects and reduce our stock price.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We are unable to predict what impact the Health Care and Education Reconciliation Act of 2010 or other reform legislation will have on our business or future prospects. The uncertainty as to the nature and scope of the implementation of any proposed reforms limits our ability to forecast changes that may affect our business. In Europe, the success of our products, in particular </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HEPLISAV-B, will depend largely on obtaining and maintaining government reimbursement because many providers in European countries are unlikely to use medical products that are not reimbursed by their governments. Many countries in Europe have adopted legislation and increased efforts to control prices of healthcare products. We are unable to predict the impact these actions will have on our business or future prospects.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We rely on contract research organizations to conduct our clinical trials. If these third parties do not fulfill their contractual obligations or meet expected deadlines, our planned clinical trials may be delayed and we may fail to obtain the regulatory approvals necessary to commercialize our product candidates.</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We rely on third parties to conduct our clinical trials. If these third parties do not perform their obligations or meet expected deadlines our planned clinical trials may be extended, delayed, modified or terminated. While we conduct regular reviews of the data, we are dependent on the processes and quality con</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">trol efforts of our third party contractors to ensure that detailed, quality records are maintained to support the results of the clinical trials that they are conducting on our behalf. Any extension, delay, modification or termination of our clinical trials or failure to ensure adequate documentation and the quality of the results in the clinical trials could delay or otherwise adversely affect our ability to commercialize our product candidates and could have a material adverse effect on our business and operations.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">A key part of our business strategy is to establish collaborative relationships to commercialize and fund development of our product candidates. We may not succeed in establishing and maintaining collaborative relationships, which may significantly limit our ability to develop and commercialize our products successfully, if at all.</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We will need to establish collaborative relationships to obtain domestic and international sales, marketing and distribution capabilities for our product candidates, in particular with respect to the commercialization of </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HEPLISAV-B, if approved. Failure to obtain a collaborative relationship for HEPLISAV-B, particularly in the European Union and for other markets requiring extensive sales efforts, may significantly impair the potential for this product, and our recent withdrawal of our MAA increases the risk that we may be unable to enter into a collaborative relationship prior to regulatory approval. The process of establishing and maintaining collaborative relationships is difficult, time-consuming and involves significant uncertainty, including:</font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our partners may seek to renegotiate or terminate their relationships with us due to unsatisfactory clinical results, manufacturing issues, a change in business strategy, a change of control or other reasons;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our shortage of capital resources may impact the willingness of companies to collaborate with us; </font></p></td></tr></table></div><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our contracts for collaborative arrangements are terminable at will on written notice and may otherwise expire or terminate and we may not have alternative funding available;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our partners may choose to pursue alternative technologies, including those of our competitors;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">we may have disputes with a partner that could lead to litigation or arbitration;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">we have limited control over the decisions of our partners and they may change the priority of our programs in a manner that would result in termination of the agreement or add significant delay in the partnered program;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our ability to generate future payments and royalties from our partners depends upon the abilities of our partners to establish the safety and efficacy of our drug candidates, obtain regulatory approvals and successfully manufacture and achieve market acceptance of products developed from our drug candidates; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">we or our partners may fail to properly initiate, maintain or defend our intellectual property rights, where applicable, or a party may use our proprietary information in such a way as to invite litigation that could jeopardize or potentially invalidate our proprietary information or expose us to potential liability;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our partners may not devote sufficient capital or resources towards our product candidates; and</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our partners may not comply with applicable government regulatory requirements.</font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">If any collaborator fails to fulfill its responsibilities in a timely manner, or at all, our research, clinical development, manufacturing or commercialization efforts pursuant to that collaboration could be delayed or terminated, or it may be necessary for us to assume respons</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ibility for expenses or activities that would otherwise have been the responsibility of our collaborator. If we are unable to establish and maintain collaborative relationships on acceptable terms or to successfully transition terminated collaborative agreements, we may have to delay or discontinue further development of one or more of our product candidates, undertake development and commercialization activities at our own expense or find alternative sources of capital.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Many of our competitors have greater financial resources and expertise than we do. If we are unable to successfully compete with existing or potential competitors despite these disadvantages we may be unable to generate revenues and our business will be harmed.</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We compete with pharmaceutical companies, biotechnology companies, academic institutions and research organizations, in developing therapies to prevent or treat infectious and inflammatory diseases. For example, if it is approved in the future, </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HEPLISAV-B will compete in the U.S. with established hepatitis B vaccines marketed by Merck and GSK and outside the U.S. with vaccines from those companies and several additional established pharmaceutical companies. Competitors may develop more effective, more affordable or more convenient products or may achieve earlier patent protection or commercialization of their products. These competitive products may render our product candidates obsolete or limit our ability to generate revenues from our product candidates.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Existing and potential competitors may also compete with us for qualified scientific and management personnel, as well as for technology that would be advantageous to our business. Although certain of our employees have commercialization experience, as a company we currently have</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> limited sales, marketing and distribution capabilities. Our success in developing marketable products and achieving a competitive position will depend, in part, on our ability to attract and retain qualified personnel. If we do not succeed in attracting new personnel and retaining and motivating existing personnel, our operations may suffer and we may be unable to obtain financing, enter into collaborative arrangements, sell our product candidates or generate revenues.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">As we evolve from a company primarily involved in research and development to a company potentially involved in commercialization, we may encounter difficulties in managing our growth and expanding our operations successfully.</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">If we are successful in advancing HEPLISAV-B</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> through the development stage towards commercialization, we will need to expand our organization, including adding marketing and sales capabilities or contracting with third parties to provide these capabilities for us. As our operations expand, we expect that we will also need to manage additional relationships with various collaborative partners, suppliers and other third parties. Future growth will impose significant added responsibilities on our organization, in particular on management. Our future financial performance and our ability to commercialize HEPLISAV-B and to compete effectively will depend, in part, on our ability to manage any future growth effectively. To that end, we may not be able to manage our growth efforts effectively, and hire, train and integrate additional management, administrative and sales and marketing personnel, and our failure to accomplish any of these activities could prevent us from successfully growing our company.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">If we fail to comply with the extensive requirements applicable to biopharmaceutical manufacturers and marketers under the healthcare fraud laws of the jurisdictions in which we conduct our business, we may be subject to significant liability.</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our activities, and the activities of our agents, including some contracted third parties, are subject to extensive government regulation and oversight both in the U.S. and in foreign jurisdictions. If we obtain approval for and commercialize a vaccine or other product, our interactions with physicians and others in a position to prescribe or pu</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">rchase our products will be subject to a legal regime designed to prevent healthcare fraud and abuse. Relevant U.S. laws include:</font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the Anti-Kickback Statute, which prohibits persons from, among other things, knowingly and willfully soliciting, receiving, offering or paying remuneration, directly or indirectly, in exchange for or to induce either the referral of an individual for, or the purchase, order or recommendation of, any good or service for which payment may be made under federal health care programs, such as the Medicare and Medicaid programs;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">federal false claims laws which prohibit individuals or entities from, among other things, knowingly presenting, or causing to be presented, claims for payment to the government or its agents that are false or fraudulent;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">laws that require transparency regarding financial arrangements with health care professionals, such as the reporting and disclosure requirements imposed by the Patient Protection and Affordable Care Act (&#8220;PPACA&#8221;) and state laws; and</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">state law equivalents of each of the above federal laws, such as anti-kickback and false claims laws which may apply to items or services reimbursed by state health insurance programs or any third-party payer, including commercial insurers.</font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The Office of Inspector General for the Department of Health and Human Services, the Department of Justice, states&#8217; Attorneys General and other governmental authorities actively enforce the laws and regulations discussed above. These entities also coordinate extensively with the </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">FDA, using legal theories that connect violations of the Federal Food, Drug and Cosmetic Act (such as off-label promotion) to the eventual submission of false claims to government healthcare programs. Prosecution of such promotion cases under the healthcare fraud laws provides the potential for private parties (qui tam relators, or &#8220;whistleblowers&#8221;) to initiate cases on behalf of the government and provides for significantly higher penalties upon conviction.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In the U.S., pharmaceutical and biotechnology companies have been the target of numerous government prosecutions and investigations alleging violations of law, including claims asserting impermissible off-label promotion of pharmaceutical products, payments intended to influence the referral of federal o</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">r state health care business, submission of false claims for government reimbursement, or submission of incorrect pricing information.</font></p><p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Violations of any of the laws described above or any other applicable governmental regulations and other similar foreign laws may subject us, our employees or our agents to criminal and/or civil sanctions, including fines, civil monetary penalties, exclusion from participation in government health care programs (including Medicare and Medicaid), and the restriction or restru</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">cturing of our operations, any of which could adversely affect our ability to operate our business and our financial results. Additionally, whether or not we have complied with the law, an investigation into alleged unlawful conduct may incur significant expense, cause reputational damage, divert management time and attention, and otherwise adversely affect our business. While we have developed and instituted a corporate compliance program, we cannot guarantee that we, our employees, our consultants, contractors, or other agents are or will be in compliance with all applicable U.S. or foreign laws.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We expect there will continue to be federal and state laws and/or regulations, proposed and implemented, that could impact our operations and business. The extent to which future legislation or regulations, if any, relating to health care fraud abuse laws and/or enforcement, may be enacted or what effect such legislation or regulation would have on our business remains uncertain.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">The loss of key personnel, including our Chief Executive Officer, could delay or prevent achieving our objectives.</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We depend on our senior executive officers, as well as key scientific and other personnel. Our research, product development and business efforts could be adversely affected by the loss of one or more key members of our scientific or management staff, including our Chief Executive Officer. We currently have no key person insurance on any of our employees.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We face product liability exposure, which, if not covered by insurance, could result in significant financial liability.</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">While we have not experienced any product liability claims to date, the use of any of our product candidates in clinical trials and the sale of any approved products will subject us to potential product liability claims and may raise questions about a product&#8217;s safety and efficacy. As a result, we could experience a delay in our ability to commercialize one or more of our product candidates or reduced sales of any approved product candidates. In addition, a pro</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">duct liability claim may exceed the limits of our insurance policies and exhaust our internal resources. We have obtained limited clinical trial liability and umbrella insurance coverage for our clinical trials. This coverage may not be adequate or may not continue to be available in sufficient amounts, at an acceptable cost or at all. We also may not be able to obtain commercially reasonable product liability insurance for any product approved for marketing in the future. A product liability claim, product recalls or other claims, as well as any claims for uninsured liabilities or in excess of insured liabilities, would divert our management&#8217;s attention from our business and could result in significant financial liability.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We are involved in legal actions that are expensive and time consuming, and, if resolved adversely, could harm our business, financial condition, or results of operations.</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Two class action complaints brought by purported stockholders and one purported stockholder derivative complaint have been brought against us. Any negative outcome from such lawsuits could result in payments of monetary damages or fines, or adversely affect our products, and accordingly our business, financial condition, or results of operations could be materially and ad</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">versely affected.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">There can be no assurance that a favorable final outcome will be obtained in these cases, and defending any lawsuit is costly and can impose a significant burden on management and employees. Any litigation to which we are a party may result in an onerous or unfavorable judgment that may not be reversed upon appeal or in payments of monetary damages or fines</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> not covered by insurance, or we may decide to settle lawsuits on unfavorable terms, which could adversely affect our business, financial conditions, or results of operations.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We use hazardous materials in our business. Any claims or liabilities relating to improper handling, storage or disposal of these materials could be time consuming and costly to resolve.</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our research and product development activities involve the controlled storage, use and disposal of hazardous and radioactive materials and biological waste. We are subject to federal, state and local laws and regulations governing the use, manufacture, storage, handling and dispo</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">sal of these materials and certain waste products. We believe we are currently in compliance with all government permits that are required for the storage, use and disposal of these materials. However, we cannot eliminate the risk of accidental contamination or injury to persons or property from these materials. In the event of an accident related to hazardous materials, we could be held liable for damages, cleanup costs or penalized with fines, and this liability could exceed the limits of our insurance policies and exhaust our internal resources. We may have to incur significant costs to comply with future environmental laws and regulations.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Risks Related to our Finances and Capital Requirements</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We have incurred substantial losses since inception and do not have any commercial products that generate revenue.</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We have experienced significant net losses in each year since our inception. Our accumulated deficit was $502.2</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million as of December&#160;31, 2013. To date, our revenue has resulted from collaboration agreements, government and private agency grants and services and license fees from our customers, including the customers of Rhein. We anticipate that we will incur substantial additional net losses in future years as a result of our continuing investment in research and development activities and our addition of infrastructure and operations to support further development and regulatory approval of HEPLISAV-B.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We do not have any products that generate revenue. There can be no assurance whether </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HEPLISAV-B can be successfully developed, financed or commercialized in a timely manner based on our current plans. The 2013 CRL from the FDA for HEPLISAV-B means that our efforts to achieve product revenues are delayed significantly and there can be no assurance that we will be able to achieve approval or generate meaningful sales without significant additional resources. Our ability to generate revenue depends upon obtaining regulatory approvals for our product candidates, generating product sales and entering into and maintaining successful collaborative relationships.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">If we are unable to generate significant revenues or achieve profitability, we may be required to reduce or discontinue our current and planned operations, enter into a transaction that constitutes a change in control of the company or raise additional capital on less than favorable terms.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">If we are unable to generate significant revenues or achieve profitability, we will require substantial additional capital to continue development of our product candidates and if our most advanced candidate, HEPLISAV-B, is approved, to commence sales and marketing activities.</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">To continue development of our product candidates and, if it is approved, to launch </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HEPLISAV-B, we will need significant additional funds. Addressing this need may occur through strategic alliance and licensing arrangements and/or future public or private financings. We expect to continue to spend substantial funds in connection with:</font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">development, manufacturing and, if approved, commercialization of our product candidates, particularly HEPLISAV-B;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">various human clinical trials for our product candidates; and</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">protection of our intellectual property.</font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We currently estimate that we have sufficient resources to meet our anticipated cash needs through at least the next 12 months based on cash, cash equivalents and marketable securities on hand as well as anticipated revenues and funding from existing agreements.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Sufficient additional financing through future public or private financings, strategic alliance and licensing arrangements or other financing sources may not be available on acceptable terms or at all. Additional equity financings, if completed, could result in </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">significant dilution or otherwise adversely affect the rights of existing stockholders. If adequate funds are not available in the future, we may need to delay, reduce the scope of, or put on hold the HEPLISAV-B program or other development programs while we seek strategic alternatives.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Risks Related to our Intellectual Property</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We rely on licenses to intellectual property from third parties. Impairment of these licenses or our inability to maintain them would severely harm our business.</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our current research and development efforts depend in part upon our license arrangements for intellectual property owned by third parties. Our dependence on these licenses subjects us to numerous risks, such as disputes regarding the use of the licensed intellectual propert</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">y and the creation and ownership of new discoveries under such license agreements. In addition, these license arrangements require us to make timely payments to maintain our licenses and typically contain diligence or milestone-based termination provisions. Our failure to meet any obligations pursuant to these agreements could allow our licensors to terminate our agreements or undertake other remedies such as converting exclusive to non-exclusive licenses if we are unable to cure or obtain waivers for such failures or amend such agreements on terms acceptable to us. In addition, our license agreements may be terminated or may expire by their terms, and we may not be able to maintain the exclusivity of these licenses. If we cannot obtain and maintain licenses that are advantageous or necessary to the development or the commercialization of our product candidates, we may be required to expend significant time and resources to develop or license similar technology or to find other alternatives to maintaining the competitive position of our products. If such alternatives are not available to us in a timely manner or on acceptable terms, we may be unable to continue development or commercialize our product candidates. In addition, we must make timely payments or meet diligence obligations to maintain any such licenses in effect. In the absence of a current license, we may be required to redesign our technology so it does not infringe a third party&#8217;s patents, which may not be possible or could require substantial funds and time.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">If third parties successfully assert that we have infringed their patents and proprietary rights or challenge our patents and proprietary rights, we may become involved in intellectual property disputes and litigation that would be costly, time consuming and delay or prevent development or commercialization of our product candidates.</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We may be exposed to future litigation by third parties based on claims that our product candidates or proprietary technologies infringe their intellectual property rights, or we may be required to enter into litigation to enforce patents issued or licensed to us or to determine the ownership, scope or validity of our or another party&#8217;s proprietary rights, including a challenge as to the validity of our issued and p</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ending claims. From time to time we are involved in various interference and other administrative proceedings related to our intellectual property which has caused us to incur certain legal expenses. If we become involved in any litigation and/or other significant interference proceedings related to our intellectual property or the intellectual property of others, we will incur substantial additional expenses and it will divert the efforts of our technical and management personnel.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Two of our potential competitors, Merck and GSK, are exclusive licensees of broad patents covering methods of production of recombinant HBsAg, a component of </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HEPLISAV-B. In addition, the Institut Pasteur also owns or has exclusive licenses to patents relating to aspects of production of recombinant HBsAg. While some of these patents have expired or will soon expire outside the U.S., they remain in force in the U.S. To the extent we are able to commercialize HEPLISAV-B in the U.S. while these patents remain in force, Merck, GSK or their respective licensors or the Institut Pasteur may bring claims against us.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">If we or our collaborators are unsuccessful in defending or prosecuting our issued and pending claims or in defending potential claims against our products, for example, as may arise in the commercialization of </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HEPLISAV-B or any similar product candidate, we or our collaborator could be required to pay substantial damages or be unable to commercialize our product candidates or use our proprietary technologies without a license from such third party. A license may require the payment of substantial fees or royalties, require a grant of a cross-license to our technology or may not be available on acceptable terms, if at all. Any of these outcomes could require us to change our business strategy and could materially impact our business and operations.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">One of our potential competitors, Pfizer, has issued patent claims, as well as patent claims pending with the PTO and foreign patent offices, that may be asserted against our </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TLR agonist products and our TLR inhibitor products. We may need to obtain a license to one or more of these patent claims held by Pfizer by paying fees or royalties or offering rights to our own proprietary technologies to commercialize one or more of our formulations other than with respect to HEPLISAV-B, for which we have a license. A license for other uses may not be available to us on acceptable terms, if at all, which could preclude or limit our ability to commercialize our products.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-weight:bold;;"><font style="font-weight:bold;font-style:italic;;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">If the combination of patents, trade secrets and contractual provisions that we rely on to protect our intellectual property is inadequate, the value of our product candidates will decrease.</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our success depends on our ability to:</font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">obtain and protect commercially valuable patents or the rights to patents both domestically and abroad;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">operate without infringing upon the proprietary rights of others; and</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">prevent others from successfully challenging or infringing our proprietary rights.</font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We will be able to protect our proprietary rights from unauthorized use only to the extent that these rights are covered by valid and enforceable patents or are effectively maintained as trade secrets. We try to protect our proprietary rights by filing and prosecuting U.S. and foreign patent applications. However, in certain cases such protection may be limited, depending in part on existing patents held by third parties, which may only allow us to obtain relatively narrow patent protection. In the </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S., legal standards relating to the validity and scope of patent claims in the biopharmaceutical field can be highly uncertain, are still evolving and involve complex legal and factual questions for which important legal principles remain unresolved.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The biopharmaceutical patent environment outside the </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. is even more uncertain. We may be particularly affected by this uncertainty since several of our product candidates may initially address market opportunities outside the U.S., where we may only be able to obtain limited patent protection.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The risks and uncertainties that we face with respect to our patents and other proprietary rights include the following:</font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">we may not receive an issued patent for any of our patent applications or for any patent applications that we have exclusively licensed;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the pending patent applications we have filed or to which we have exclusive rights may take longer than we expect to result in issued patents;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the claims of any patents that are issued may not provide meaningful protection or may not be valid or enforceable;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">we might not be able to develop additional proprietary technologies that are patentable;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the patents licensed or issued to us or our collaborators may not provide a competitive advantage;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">patents issued to other parties may limit our intellectual property protection or harm our ability to do business;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">other parties may independently develop similar or alternative technologies or duplicate our technologies and commercialize discoveries that we attempt to patent; and</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">other parties may design around technologies we have licensed, patented or developed.</font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We also rely on trade secret protection and confidentiality agreements to protect our interests in proprietary know-how that is not patentable and for processes for which patents are difficult to enforce. We cannot be certain that we will be able to protect our trade secrets adequately. Any disclosure of confidential data in the public domain or to third parties could allow our competitors to learn our trade secrets. If we are </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">unable to adequately obtain or enforce proprietary rights we may be unable to commercialize our products, enter into collaborations, generate revenues or maintain any advantage we may have with respect to existing or potential competitors.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Risks Related to an Investment in our Common Stock</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Our stock price is subject to volatility, and your investment may suffer a decline in value.</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The market prices for securities of biopharmaceutical companies have in the past been, and are likely to continue in the future, to be, very volatile. The market price of our common stock is subject to substantial volatility depending upon many factors, many of which are beyond our control, including:</font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">progress or results of any of our clinical trials or regulatory or manufacturing efforts, in particular any announcements regarding the progress or results of our planned trials and communications from the FDA or other regulatory agencies;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our ability to establish and maintain collaborations for the development and commercialization of our product candidates;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our ability to raise additional capital to fund our operations;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">technological innovations, new commercial products or drug discovery efforts and preclinical and clinical activities by us or our competitors;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">changes in our intellectual property portfolio or developments or disputes concerning the proprietary rights of our products or product candidates;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our ability to obtain component materials and successfully enter into manufacturing relationships for our product candidates or establish manufacturing capacity on our own;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our ability to establish and maintain licensing agreements for intellectual property necessary for the development of our product candidates;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">changes in government regulations, general economic conditions or industry announcements;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">issuance of new or changed securities analysts&#8217; reports or recommendations;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">actual or anticipated fluctuations in our quarterly financial and operating results;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our ability to maintain continued listing on the NASDAQ markets or similar exchanges; and</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the volume of trading in our common stock.</font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">One or more of these factors could cause a substantial decline in the price of our common stock. In addition, securities class action litigation has often been brought against a company following a dec</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">line in the market price of its securities. We are currently the target of such securities litigation, resulting from the decline in our common stock following the disclosure in 2013 that the FDA would not approve HEPLISAV-B for sale without a significant additional clinical study. We may in the future be the target of additional such litigation. Securities litigation could result in substantial costs, and divert management&#8217;s attention and resources, which could harm our business, operating results and financial condition.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">The anti-takeover provisions of our certificate of incorporation, our bylaws, Delaware law and our share purchase rights plan may prevent or frustrate a change in control, even if an acquisition would be beneficial to our stockholders, which could affect our stock price adversely and prevent attempts by our stockholders to replace or remove our current management.</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Provisions of our certificate of incorporation and bylaws may delay or prevent a change in control, discourage bids at a premium over the market price of our common stock and adversely affect the market price of our common stock and the voting or other rights of the holders of our common stock. These provisions include:</font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">authorizing our Board of Directors to issue additional preferred stock with voting rights to be determined by the Board of Directors;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">limiting the persons who can call special meetings of stockholders;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">prohibiting stockholder actions by written consent;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">creating a classified board of directors pursuant to which our directors are elected for staggered three year terms;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">providing that a supermajority vote of our stockholders is required for amendment to certain provisions of our certificate of incorporation and bylaws; and </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;"><font style="color:#000000;font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">establishing advance notice requirements for nominations for election to our Board of Directors or for proposing matters that can be acted on by stockholders at stockholder meetings.</font></p></td></tr></table></div><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our share purchase rights plan may have certain anti-takeover effects. Specifically, the rights issued pursuant to the plan will cause substantial dilution to a person or group that attempts to acquire the Company on terms not approved by our Board of Directors. Although the rights should not interfere with any merger or other business combination approved by the Board of </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Directors since the rights issued may be amended to permit such acquisition or redeemed by the Company at $0.001 per right prior to the earliest of (i)&#160;the time that a person or group has acquired beneficial ownership of 20% or more of our common stock or (ii)&#160;the final expiration date of the rights, the effect of the rights plan may deter a potential acquisition of the Company.&#160;In addition, we remain subject to the provisions of the Delaware corporation law that, in general, prohibit any business combination with a beneficial owner of 15% or more of our common stock for three years unless the holder&#8217;s acquisition of our stock was approved in advance by our Board of Directors.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">We will continue to incur increased costs and demands upon management as a result of complying with the laws and regulations affecting public companies, which could affect our operating results.</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">As a public company, we will continue to incur legal, accounting and other expenses associated with reporting requirements and corporate governance requirements, including requirements under the Sarbanes-Oxley Act of 2002, the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, as well as new rules implemented by the Securities and Exchange Commission and the NASDAQ Stock Market LL</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">C. We may need to continue to implement additional financial and accounting systems, procedures and controls to accommodate changes in our business and organization and to comply with new reporting requirements. There can be no assurance that we will be able to maintain a favorable assessment as to the adequacy of our internal control over financial reporting. If we are unable to reach an unqualified assessment, or our independent registered public accounting firm is unable to issue an unqualified attestation as to the effectiveness of our internal control over financial reporting as of the end of our fiscal year, investors could lose confidence in the reliability of our financial reporting which could harm our business and could impact the price of our common stock.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Future sales of our common stock or the perception that such sales may occur in the public market could cause our stock price to fall.</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Sales of a substantial number of shares of our common stock in the public market, or the perception that these sales might occur, could depress the market price of our common stock and could impair our ability to raise capital through the sale of additional equity securities. As of December&#160;31, 2013, we had 262,796,285 shares of common stock outstanding, all of whi</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ch shares were eligible for sale in the public market, subject in some cases to the volume limitations and manner of sale requirements under Rule 144 of the Securities Act of 1933, as amended.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In addition, we have filed shelf registration statements on Form S-3 under the Securities Act of 1933, as amended, to register securities that we may choose to issue in the future and on Form S-8 to register the shares of our common stock reserved for issuance under our stock option plans.</font></p><p style="margin-bottom:0pt;margin-top:8pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:11.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_1B"></a>I</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TEM</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1B.</font></p></td><td valign="top" style="width:88.67%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_1B"></a>UNRESOLVED STAFF COMMENTS </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">None. </font></p><p style="margin-bottom:0pt;margin-top:8pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:11.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_2"></a>I</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TEM&#160;2.</font></p></td><td valign="top" style="width:88.67%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_2"></a>PROPERTIES </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">As of December&#160;31, 2013, we leased approximately 55,200 square feet of laboratory and office space in Berkeley, California under agreements expiring in June 2018. We also lease approximately 5,600 square meters of laboratory and office space in D&#252;sseldorf, Germany under lease agreements expiring in March 2023. </font></p><p style="margin-bottom:0pt;margin-top:8pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><a name="ITEM_3"></a>&nbsp;</p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:11.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ITEM</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">3</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">.</font></p></td><td valign="top" style="width:88.67%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">LEGAL PROCEEDINGS </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">From time to time in the ordinary course of business, we receive claims or allegations regarding various matters, including employment, vendor and other similar situations in the conduct of our operations. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">On June 18, 2013, the first of two substantially similar securities class action complaints was filed in the U.S. District Court for the Northern District of California against the Company and certain of its former executive officers. The second was filed on June 26, 2013.&#160;On August 22, 2013, these two complaints and all related actions that subsequently may be filed in, or transferred to, the District Court were cons</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">olidated into a single case entitled In re Dynavax Technologies Securities Litigation. On September 27, 2013, the Court appointed a lead plaintiff and lead counsel. On November 12, 2013, the Lead Plaintiff in the In re Dynavax Technologies Securities Litigation filed his Consolidated Class Action Complaint (&#8220;Complaint&#8221;).&#160;The Complaint alleges that between April 26, 2012 and June 10, 2013, the Company and certain current and former officers and directors violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, in connection with statements related to our product candidate, HEPLISAV.&#160;The Complaint seeks unspecified damages, interest, attorneys&#8217; fees, and other costs.&#160;On January 10, 2014, the Company filed a motion to dismiss the Complaint.&#160;The hearing on the motion is set for May 2, 2014.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Additionally, o</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">n July 3, 2013, a purported stockholder derivative complaint was filed in the Superior Court of California for the County of Alameda against certain of our former and current directors.&#160;On August 9, 2013, a substantially similar purported stockholder derivative complaint was filed in the U.S. District Court for the Northern District of California. The derivative complaint alleges breaches of fiduciary duties by the defendants and other violations of law.&#160;In general, the complaints allege that certain of our current and former executive officers and directors caused or allowed for the dissemination of materially false and misleading statements regarding our product, HEPLISAV-B. Plaintiff is seeking unspecified monetary damages, including restitution from defendants and attorneys&#8217; fees and costs, and other relief.&#160;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">On August 21, 2013, pursuant to a stipulation between the parties, the State Court stayed the state derivative case pending a decision on the Company&#8217;s motion to dismiss in the In re Dynavax Technologies Securities Litigation. On October 17, 2013, pursuant to a stipulation between the parties, the federal court stayed the federal derivative case pending a decision on the Company&#8217;s motion to dismiss in the In re Dynavax Technologies Securities Litigati</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">on. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The Company believes that it has meritorious defenses and intends to defend these lawsuits vigorously. </font></p><p style="margin-bottom:0pt;margin-top:8pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:11.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_4"></a>I</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TEM</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">4.</font></p></td><td valign="top" style="width:88.67%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_4"></a>MINE SAFETY DISCLOSURE </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Not applicable. </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:;font-weight:bold;;font-size:10pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">PART II </font></p><p style="margin-bottom:0pt;margin-top:2pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:11.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_5"></a>I</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TEM&#160; 5.</font></p></td><td valign="top" style="width:88.67%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_5"></a>MARKET FOR THE REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Market Information and Holders </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our common stock is traded on the NASDAQ Capital Market under the ticker symbol DVAX. Public trading of our common stock commenced on February&#160;19, 2004. The following table sets forth for the periods indicated the high and low </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">intra-day sale prices per share of our common stock. </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:75%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:24%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Common Stock</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:75%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:24%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Price</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:75%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:10%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">High</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:3%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:10%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Low</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:75%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:3%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:75%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">First Quarter</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.39</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.74</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:75%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Second Quarter</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.68</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.98</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:75%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Third Quarter</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.46</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.02</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:75%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fourth Quarter</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.05</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.10</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:75%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:75%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">First Quarter</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.08</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.24</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:75%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Second Quarter</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.34</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.33</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:75%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Third Quarter</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.99</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.48</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:75%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fourth Quarter</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.10</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.22</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-weight:bold;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">As of February&#160;28, 2014, there were approximately 84 holders of</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">  record of our common stock, as shown on the records of our transfer agent. We believe that our stockholders exceed 14,200 as the number of record holders excludes shares held in &#8220;street name&#8221; through brokers. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Dividends </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We have never paid any cash dividends on our common stock. We currently expect to retain future earnings, if any, for use in the operation and expansion of our business and do not anticipate paying any cash dividends in the foreseeable future. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recent Sales of Unregistered Securities </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">None. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Issuer Purchases of Equity Securities </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:13%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:14%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:15%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:23%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(d)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:13%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:14%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:17%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(c)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:23%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Maximum&#160;Number</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:13%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:14%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:17%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Total&#160;Number&#160;of&#160; Shares</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:23%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(or&#160;Approximate&#160;Dollar&#160;Value)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:15%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(a)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:14%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:17%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(or Units) Purchased as</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:23%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">of Shares (or Units) that</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:15%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Total&#160;Number&#160;of&#160; Shares</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:16%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(b)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:17%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Part of Publicly</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:23%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">May Yet Be Purchased</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:15%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(or Units) Purchased<sup style="font-size:85%; vertical-align:top">(1)</sup></font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:11pt;font-family:Calibri;"><font style="color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:16%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Average&#160;Price&#160;Paid</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:17%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Announced Plans or</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:23%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Under the Plans or</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:20%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Period</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:15%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(In thousands)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:16%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">per Share (or Unit)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:17%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Programs</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:23%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Programs</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:20%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">October&#160;1, 2013 to</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:13%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:14%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:15%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:21%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:20%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">October&#160;31, 2013</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:13%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:14%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:15%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:21%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:20%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">November&#160;1, 2013 to</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:13%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:14%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:15%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:21%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:20%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">November&#160;30, 2013</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:13%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:14%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:15%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:21%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:20%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December&#160;1, 2013 to</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:13%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:14%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:15%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:21%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:20%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2013</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:13%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:14%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:15%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:21%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:20%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:13%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:14%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:15%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:21%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the 3 months ended December 31, 2013, no securities were purchased by the Company.</font></p></td></tr></table></div><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:11.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ITEM&#160;6. </font></p></td><td valign="top" style="width:88.67%;"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;;"><a name="ITEM_6"></a><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SELECTED FINANCIAL DATA </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The following selected financial data should be read in conjunction with Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, and with the Consolidated Financial Statements and Notes thereto which are included elsewhere in this Form 10-K. The Consolidated Statements of Operations Data for the years ended December&#160;31, 201</font><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">3, 2012 and 2011 and the Consolidated Balance Sheets Data as of December&#160;31, 2013 and 2012 are derived from the audited Consolidated Financial Statements included elsewhere in this Form 10-K. The Consolidated Statements of Operations Data for the years ended December&#160;31, 2010 and 2009 and the Consolidated Balance Sheets Data as of December&#160;31, 2011, 2010 and 2009 are derived from audited Consolidated Financial Statements that are not included in this Form 10-K. Historical results are not necessarily indicative of results to be anticipated in the future.</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:45%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="18" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:45%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2010</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2009</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:45%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="18" valign="bottom" style="width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(In thousands, except per share data)</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:45%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Consolidated Statements of Operations Data:</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:45%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenues</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,251</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,714</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,614</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,950</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,318</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:45%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating expenses:</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:45%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:32.4pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50,870</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49,146</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51,322</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53,680</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,708</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:45%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:32.4pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,943</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,164</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,570</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,879</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,745</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:45%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:32.4pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unoccupied facility expense</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">926</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:45%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:32.4pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization of intangible assets</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">299</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">980</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">980</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:45%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating expenses</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">77,739</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">77,310</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69,191</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">71,539</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55,433</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:45%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss from operations</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(66,488</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(67,596</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(47,577</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(47,589</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,115</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:45%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other income (expense):</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:45%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:32.4pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest income</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">116</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">291</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">85</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">178</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:45%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:32.4pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest expense</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,351</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,957</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,654</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(124</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:45%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:32.4pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other income (expense)<sup style="font-size:85%; vertical-align:top">(1)</sup></font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(348</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(293</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">834</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,150</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(66</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:45%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(66,720</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(69,949</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(48,597</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(57,308</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,127</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:45%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Consideration paid in excess of carrying value of the noncontrolling interest in Symphony Dynamo, Inc. (&#8220;SDI&#8221;)<sup style="font-size:85%; vertical-align:top">(2)</sup></font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19,671</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:45%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Add: Losses attributable to noncontrolling interest in SDI</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,233</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:45%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss attributable to Dynavax</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(66,720</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(69,949</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(48,597</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(57,308</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(30,565</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:40%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Preferred stock deemed dividend<sup style="font-size:85%; vertical-align:top">(3)</sup></font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,469</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:40%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss allocable to Dynavax common stockholders</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(75,189</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(69,949</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(48,597</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(57,308</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(30,565</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:45%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic and diluted net loss per share allocable to Dynavax common stockholders</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.38</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.41</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.39</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.69</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.76</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:45%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares used to compute basic and diluted net loss per share allocable to Dynavax common stockholders</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">196,275</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">170,469</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">125,101</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">82,463</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,350</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;border-bottom:Solid 0.75pt;margin-bottom:3pt;margin-left:0%;margin-right:66.67%;text-indent:0%;font-size:6pt;font-family:Times New Roman;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Includes the impact of the anti-dilution provision associated with the common stock and warrants issued to Symphony Capital Partners, L.P. and Symphony Strategic Partners, LLC (collectively, &#8220;Symphony&#8221;) and the change in fair value of the Symphony-related long-term contingent and warrant liabilities for the year ended December&#160;31, 2010. See Note 8 to the Consolidated Financial Statements. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Represents the consideration paid in excess of the carrying value of the noncontrolling interest in SDI that was treated as a deemed dividend for purposes of reporting earnings per share, increasing net loss per share for the year ended December&#160;31, 2009. See Note 8 to the Consolidated Financial Statements.</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deemed dividend related to beneficial conversion feature of convertible preferred stock. </font><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value of the common stock into which the Series B Preferred Stock is convertible exceeded the allocated purchase price of the Series B Preferred Stock by $8.5 million on the date of issuance, resulting in a deemed dividend. The Company recognized the deemed dividend as a one-time, non-cash, deemed dividend to the holders of Series B Preferred Stock on the date of issuance, which is the date the stock first became convertible.</font></p></td></tr></table></div><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:45%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="18" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:45%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2010</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2009</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:45%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="18" valign="bottom" style="width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(In thousands)</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:45%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Consolidated Balance Sheets Data:</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:45%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash, cash equivalents and marketable securities</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">189,376</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">125,130</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">113,961</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72,154</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,720</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:45%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Working capital</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">176,186</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">109,173</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">97,399</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60,598</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,583</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:45%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">204,622</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">139,752</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">134,102</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">84,249</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50,470</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:45%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Note payable to Symphony Dynamo Holdings LLC<sup style="font-size:85%; vertical-align:top">(1)</sup></font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,810</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,939</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,342</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:45%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated deficit</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(502,211</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(435,491</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(365,542</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(316,945</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(259,637</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:45%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total Dynavax stockholders&#8217; equity</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">186,294</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">114,826</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99,880</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">52,111</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,376</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;border-bottom:Solid 0.75pt;margin-bottom:3pt;margin-left:0%;margin-right:66.67%;text-indent:0%;font-size:6pt;font-family:Times New Roman;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The note payable to Symphony Dynamo Holdings LLC (&#8220;Holdings&#8221;) was paid in cash on December&#160;31, 2012. </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:8pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:11.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_7"></a>I</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TEM</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">7.</font></p></td><td valign="top" style="width:88.67%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_7"></a>MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The following Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations contains forward-looking statements that involve a number of risks and uncertainties. Our actual results could differ materially from those indicated by forward-looking statements as a result of various factors, including but not limited to, the period for which we estimate our cash resources are sufficient, the availability of additional funds, as well as those set forth under &#8220;Risk Factors&#8221; and those that m</font><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">ay be identified from time to time in our reports and registration statements filed with the Securities and Exchange Commission.</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The following discussion and analysis is intended to provide an investor with a narrative of our financial results and an evaluation of our financial condition and results of operations. The discussion should be read in conjunction with &#8220;Item 6&#8212;Selected Financial Data&#8221; and the Consolidated Financial Statements and the related notes thereto set forth in &#8220;Item 8&#8212;Financial Statement</font><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">s and Supplementary Data.&#8221;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Overview</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Dynavax Technologies Corporation (&#8220;we,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; &#8220;Dynavax&#8221; or the &#8220;Company&#8221;), a clinical-stage biopharmaceutical company, develops products to prevent and treat infectious and inflammatory diseases and cancer based on Toll-like Receptor (&#8220;TLR&#8221;) biology and its ability to modulate the innate immune system. Our lead product candidate is </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HEPLISAV-B<sup style="font-size:85%; vertical-align:top">TM </sup>(also known as &#8220;HEPLISAV&#8221;), an investigational adult hepatitis B vaccine in Phase 3 clinical development. HEPLISAV-B combines our proprietary TLR 9 agonist adjuvant and hepatitis B surface antigen (&#8220;HBsAg&#8221;) to elicit an immune response after two doses. In the spring of 2014 we expect to initiate a Phase 3 study of HEPLISAV-B compared with Engerix-B<sup style="font-size:85%; vertical-align:top">&#174;</sup> in adults 18-70 years of age in order to provide a sufficiently-sized safety database for the U.S. Food and Drug Administration (&#8220;FDA&#8221;) to complete its review of Dynavax&#8217;s Biologics License Application (&#8220;BLA&#8221;).</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In addition to HEPLISAV-B</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, we are conducting clinical and preclinical programs that utilize our expertise in TLR biology. Our product candidates include both TLR agonists and TLR inhibitors. Our clinical stage programs include our autoimmune program partnered with GlaxoSmithKline (&#8220;GSK&#8221;), our asthma therapeutic program partnered with AstraZeneca AB (&#8220;AstraZeneca&#8221;), and our cancer immunotherapy program. We also are advancing preclinical development programs in adjuvant technology and TLR 7, 8, and 9 inhibition. We compete with pharmaceutical companies, biotechnology companies, academic institutions and research organizations in developing therapies to prevent or treat infectious and inflammatory diseases and cancer.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our revenues consist of amounts earned from collaborations, grants and fees from services and licenses. Prod</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">uct revenue will depend on our ability to receive regulatory approvals for, and successfully market, our drug candidates. We have yet to generate any revenues from product sales and have recorded an accumulated deficit of $502.2 million at December 31, 2013. These losses have resulted principally from costs incurred in connection with research and development activities, compensation and other related personnel costs and general corporate expenses. Research and development activities include costs of outside contracted services including clinical trial costs, manufacturing and process development costs, research costs and other consulting services. Salaries and other personnel-related costs include non-cash stock-based compensation associated with options and other equity awards granted to employees. General corporate expenses include outside services such as accounting, consulting, business development, investor relations, insurance services and legal costs. Our operating results may fluctuate substantially from period to period principally as a result of the timing of preclinical activities and other activities related to clinical trials for our drug candidates. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">As of December&#160;31, 2013, we had $189.4 million in cash, cash equivalents and marketable securities. Since our inception, we have relied primarily on the proceeds from public and private sales of our equity securities and revenues from collaboration agreements to fund our operations. We expect to continue to spend substantial funds in connection with </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the development and manufacturing of our product candidates, particularly HEPLISAV-B, human clinical trials for our product candidates and additional applications and advancement of our technology. In order to continue these activities, we may need to raise additional funds. This may occur through strategic alliance and licensing arrangements and/or future public or private financings. If adequate funds are not available in the future, we may need to delay, reduce the scope of or put on hold the HEPLISAV-B program or other development programs while we seek strategic alternatives. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:4.54%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Recent Developments </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">On February&#160;25, 2013, we received a complete response letter (&#8220;CRL&#8221;) from the FDA indicating that it would not approve HEPLISAV-B</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for the indication proposed in our BLA. Following extensive discussions with the FDA, we finalized the design of an additional clinical study of HEPLISAV-B that is intended to provide a sufficiently-sized safety database for the FDA to complete its review of our BLA and make a final determination regarding the safety and immunogenicity of the product. The planned study will be a Phase 3, observer-blinded, randomized, active-controlled, multicenter trial of the safety and immunogenicity of HEPLISAV-B compared with Engerix-B in adults 18 to 70 years of age. The study will include 5,500 HEPLISAV-B subjects and 2,500 Engerix-B subjects, stratified by age and diabetes diagnosis. HEPLISAV-B subjects will receive two doses at 0 and 1 month, while Engerix-B subjects will receive three doses at 0, 1 and 6 months. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The primary objectives of the study will be: (1) to evaluate the overall safety of HEPLISAV-B</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> with respect to clinically significant adverse events and (2) to demonstrate the noninferiority of the peak seroprotection rate (&#8220;SPR&#8221;) induced by HEPLISAV-B versus Engerix-B in subjects with type 2 diabetes mellitus. All HEPLISAV-B subjects will be evaluated for safety for one year following the second dose, all potential autoimmune events will be adjudicated by a Safety Evaluation and Adjudication Committee and safety will be monitored by a Data and Safety Monitoring Board. We intend to initiate this study in the first quarter of 2014 and conclude subject visits by the end of 2015. We estimate the external costs of the study to be in the range of $50-55 million.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We submitted our Marketing Authorization Application (&#8220;MAA&#8221;) for HEPLISAV-B </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to the European Medicines Agency&#8217;s (&#8220;EMA&#8221;) in July of 2012. In late 2012 we received the Day 120 List of Questions issued by the Committee for Medicinal Products for Human Use of the EMA regarding our MAA, which related primarily to the suitability of different patient populations, the safety database size, and Good Manufacturing Practices (&#8220;GMP&#8221;) and Good Clinical Practices (&#8220;GCP&#8221;) matters. In the early summer of 2013, EMA added to the list of questions, resetting the clock for our response. EMA also inspected several study sites, Dynavax and our clinical contract research organization. The focus of the GCP inspection was HBV-17, a 500 patient study in CKD patients that is part of the EMA application but not the U.S. application. In the fourth quarter of 2013, we submitted our responses to the 120-Day Questions. The Day 180 List of Outstanding Issues (&#8220;LOI&#8221;) provided by the EMA in February 2014 indicated that, based primarily on the GCP inspection findings, HBV-17 was not acceptable and because some of the findings were related to the Dynavax&#8217;s overall systems, the other pivotal HEPLISAV-B studies (HBV-10 and HBV-16) were questioned. The LOI also noted that the HEPLISAV-B safety database was considered to be too small to rule out a risk of less common serious adverse events, particularly in light of the GCP concerns. On February 18, 2014 we announced the withdrawal of the MAA for HEPLISAV-B under review by the EMA. We withdrew the application, in part, because the required time frame for response under the MAA procedure was not long enough to permit the collection of the necessary clinical data. The Phase 3 study to be initiated in the U.S. in 2014 is expected to provide additional data to support the safety of HEPLISAV-B.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Critical Accounting Policies and the Use of Estimates </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The accompanying discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements and the related disclosures, which have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;). The preparation of these financial statements requires us to make estimates, assumptions and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">at the balance sheet dates and the reported amounts of revenues and expenses for the periods presented. On an ongoing basis, we evaluate our estimates, assumptions and judgments described below that have the greatest potential impact on our consolidated financial statements, including those related to revenue recognition, research and development activities and stock-based compensation. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Accounting assumptions and estimates are inherently uncertain and actual results may differ materially from these estimates under different assumptions or conditions. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">While our significant accounting policies are more fully described in Note 2 to the Consolidated Financial Statements, we believe the following critical accounting policies reflect the more significant judgments and estimates used in the preparation of our financial statements. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:18pt;margin-left:4.54%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Revenue Recognition </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our revenues consist of amounts earned from collaborations, grants and fees from services and licenses. We enter into license and manufacturing agreements and collaborative research and development arrangements with pharmaceutical and biotechnology partners that may involve multiple deliverables. Our arrangements may include one or more of the following elements: upfront license payments, cost reimbursement for the performance of research and development activities, milestone payments, other contingent paym</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ents, contract manufacturing service fees, royalties and license fees. Each deliverable in the arrangement is evaluated to determine whether it meets the criteria to be accounted for as a separate unit of accounting or whether it should be combined with other deliverables. In order to account for the multiple-element arrangements, the Company identifies the deliverables included within the arrangement and evaluates which deliverables represent separate units of accounting. Analyzing the arrangement to identify deliverables requires the use of judgment, and each deliverable may be an obligation to deliver services, a right or license to use an asset, or another performance obligation. We recognize revenue when there is persuasive evidence that an arrangement exists, delivery has occurred or services have been rendered, the price is fixed or determinable and collectability is reasonably assured. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">On January&#160;1, 2011, we adopted on a prospective basis Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Update (&#8220;ASU&#8221;) 2009-13, </font><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Multiple-Deliverable Revenue Arrangements</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, which amends the criteria related to identifying separate units of accounting and provides guidance on whether multiple deliverables exist, how an arrangement should be separated and the consideration allocated. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Non-refundable upfront fees received for license and collaborative agreements entered into prior to January&#160;1, 2011 and other payments under collaboration agreements where we have continuing performance obligations related to the payments are deferred and recognized over our expected performance period. Revenue is recognized on a ratable basis, unless we determine that another method is more appropriate, through the date at which our performance obligations are completed. Manage</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ment makes its best estimate of the period over which we expect to fulfill our performance obligations, which may include clinical development activities. Given the uncertainties of research and development collaborations, significant judgment is required to determine the duration of the performance period. We recognize cost reimbursement revenue under collaborative agreements as the related research and development costs are incurred, as provided for under the terms of these agreements. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Under the milestone method, contingent consideration received for the achievement of a substantive milestone is recognized in its entirety in the period in which the milestone is achieved. A milestone is defined as an event having all of the following characteristics: (i)&#160;t</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">here is substantive uncertainty at the date the arrangement is entered into that the event will be achieved, (ii)&#160;the event can only be achieved based in whole or in part on either the entity&#8217;s performance or a specific outcome resulting from the entity&#8217;s performance and (iii)&#160;if achieved, the event would result in additional payments being due to the entity. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our license and collaboration agreements with our partners provide for payments to be paid to us upon the achievement of development milestones. Given the challenges inherent in developing biologic products, there is substantial uncertainty whether any such milestones will be achieved at the time we entered into these agreements. In addition, we evaluate whether the development milestones meet the crit</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">eria to be considered substantive. The conditions include: (i)&#160;the development work is contingent on either of the following: (a)&#160;the vendor&#8217;s performance to achieve the milestone or (b)&#160;the enhancement of the value of the deliverable item or items as a result of a specific outcome resulting from the vendor&#8217;s performance to achieve the milestone; (ii)&#160;it relates solely to past performance and (iii)&#160;it is reasonable relative to all the deliverable and payment terms within the arrangement. As a result of our analysis, we consider our development milestones to be substantive and, accordingly, we expect to recognize as revenue future payments received from such milestones as we achieve each milestone. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Milestone payments that are contingent upon the achievement of substantive at-risk performance criteria are recognized in full upon achievement of those milestone events in accordance with the terms of the agreement and assuming all other revenue recognition criteria have been met. All revenue recognized to date un</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">der our collaborative agreements has been nonrefundable. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our license and collaboration agreements with certain partners also provide for contingent payments to be paid to us based solely upon the performance of our partner. For such contingent payments we expect to recognize the payments as revenue upon receipt and </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">when the other revenue recognition criteria have been satisfied. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Revenues from manufacturing services are recognized upon meeting the criteria for substantial performance and acceptance by the customer. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Revenue from royalty payments is contingent on future sales activities by our licensees. As a result, we recognize royalty revenue when reported by our licensees and when collection is reasonably assured. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Revenue from government and private agency grants are recognized as the related research expenses are incurred and to the extent that funding is approved. Additionally, we recognize revenue based on the facilities and administrative cost rate reimbursable per the terms of the grant awards. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;text-indent:4.54%">Research and Development Expenses and Accruals </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Research and development expenses include personnel and facility-related expenses, outside contracted services including clinical trial costs, manufacturing and process development costs, research costs and other consulting services and non-cash stock-based compensation. Research and development costs are expensed as incurred. Amounts due under such arrangements may be either fixed fee or fee for service, and may include upfront payments, monthly payments and </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">payments upon the completion of milestones or receipt of deliverables. Non-refundable advance payments under agreements are capitalized and expensed as the related goods are delivered or services are performed. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We contract with third parties to perform various clinical trial activities in the on-going development of potential products. The financial terms of these agreements are subject to negotiation, vary from contract to contract and may result in uneven payment flows to our vendors. Payments under the </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">contracts depend on factors such as the achievement of certain events, successful enrollment of patients, completion of portions of the clinical trial or similar conditions. Our accruals for clinical trials are based on estimates of the services received and efforts expended pursuant to contracts with clinical trial centers and clinical research organizations. We may terminate these contracts upon written notice and we are generally only liable for actual effort expended by the organizations to the date of termination, although in certain instances we may be further responsible for termination fees and penalties. The Company makes estimates of its accrued expenses as of each balance sheet date based on the facts and circumstances known to the Company at that time. There have been no material adjustments to the Company&#8217;s prior period accrued estimates for clinical trial activities through December 31, 2013.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:4.53%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Stock-Based Compensation </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Stock-based compensation expense for stock options and other stock awards is estimated at the grant date based on the award&#8217;s fair value-based measurement and is recognized on a straight-line basis over the award&#8217;s vesting period, assuming </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">appropriate forfeiture rates. Our determination of the fair value-based measurement of stock options on the date of grant using an option-pricing model is affected by our stock price, as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, our expected stock price volatility over the term of the awards, and actual and projected employee stock option exercise behaviors. In the future, as additional empirical evidence regarding these input estimates becomes available, we may change or refine our approach of deriving these input estimates. These changes could impact our fair value-based measurement of stock options granted in the future. Changes in the fair value-based measurement of stock awards could materially impact our operating results. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We selected the Black-Scholes option pricing model as the most appropriate method for determining the estimated fair value-based measurement of our stock options. The Black-Scholes model requires the use of highly subjective and complex assumptions which determine the fair value-based me</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">asurement of stock options, including the option&#8217;s expected term and the price volatility of the underlying stock. Our current estimate of volatility is based on the historical volatility of our stock price. To the extent volatility in our stock price increases in the future, our estimates of the fair value of options granted in the future could increase, thereby increasing stock-based compensation cost recognized in future periods. We derive the expected term assumption primarily based on our historical settlement experience, while giving consideration to options that have not yet completed a full life cycle. Stock-based compensation cost is recognized only for awards ultimately expected to vest. Our estimate of the forfeiture rate is based primarily on our historical experience. To the extent we revise this estimate in the future, our share-based compensation cost could be materially impacted in the quarter of revision, as well as in the following quarters. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Results of Operations </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:4.53%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Revenues </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Revenues consist of amounts earned from collaborations, grants and services and license fees. Collaboration revenue includes amounts recognized under our collaboration agreements. Grant revenue includes amounts earned under government and private agency grants. Service an</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">d license fees include revenues related to research and development and contract manufacturing services, license fees and royalty payments. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The following is a summary of our revenues for the years ended December&#160;31, 2013, 2012 and 2011 (in thousands, except for percentages):</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:39%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Increase</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:39%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Increase</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(Decrease)</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:39%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(Decrease)&#160;from</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">from</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:39%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012 to 2013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011 to 2012</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:39%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Revenues:</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:39%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Collaboration revenue</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,929</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,610</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,190</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">319</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(12,580</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(73</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:39%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Grant revenue</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,138</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,939</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,110</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,199</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">829</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:39%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Service and license revenue</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,184</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,165</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,314</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:5%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(149</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:5%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(11</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:39%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenues</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,251</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,714</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,614</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,537</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:5%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(11,900</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:5%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(55</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:18pt;margin-left:4.54%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">2013 versus 2012</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Total revenues for the year ended December&#160;31, 2013, increased by $1.5</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million, or 16%, as compared to the same period in 2012 principally due to an increase in grant revenue. Grant revenue for the year ended December 31, 2013, increased by $1.2 million from the same period in 2012 primarily due to an increase in revenue recognized from our National Institute of Health&#8217;s National Institute of Allergy and Infectious Diseases (&#8220;NIAID&#8221;) contract for adjuvant development and other programs funded by grants. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:4.54%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">2012 versus 2011</font><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"> </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Total revenues for the year ended December&#160;31, 2012, decreased by $11.9 million, or 55%, as compared to the same period in 2011 primarily due to </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a reduction in collaboration revenue. Collaboration revenue for the year ended December&#160;31, 2012, included $3.2 million earned from our partnership with AstraZeneca for work on asthma therapies, compared to $0.8 million earned for the year ended December&#160;31, 2011. Additionally, total collaboration revenue for the year ended December&#160;31, 2011, included recognition of $15 million from GSK for milestones earned in 2011. Grant revenue for the year ended December&#160;31, 2012, increased by $0.8 million from the same period in 2011 primarily due to an increase in revenue recognized from our NIAID contract related to adjuvant development. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;text-indent:4.54%">Research and Development </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Research and development expense consists primarily of compensation and related personnel costs, which include benefits, recruitment, travel and supply costs,</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> outside services, allocated facility costs and non-cash stock-based compensation. Outside services relate to our preclinical experiments and clinical trials, regulatory filings and manufacturing of our product candidates. For the years ended December&#160;31, 2013, 2012 and 2011, approximately 73%, 73% and 79%, respectively, of our total research and development expense, excluding non-cash stock-based compensation, is related to our lead product candidate, HEPLISAV-B. The remainder of our research and development expense results primarily from earlier-stage programs. The following is a summary of our research and development expense (in thousands, except for percentages): </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:37%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Increase</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:37%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Increase</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(Decrease)</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:37%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(Decrease) from</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">from</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:37%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012 to 2013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011 to 2012</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:37%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Research and Development:</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:37%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Compensation and related personnel costs</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,649</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,134</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,106</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(485</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,028</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:37%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outside services</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,247</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,371</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,811</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">876</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,440</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(22</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:37%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Facility costs</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,746</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,127</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,302</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">619</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(175</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:37%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-cash stock-based compensation</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,228</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,514</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,103</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">714</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:5%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,411</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:5%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">67</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:37%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total research and development</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50,870</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49,146</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51,322</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,724</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:5%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,176</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:5%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</font></p></td>
</tr>
</table></div><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;text-indent:4.54%">2013 versus 2012</font><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;text-indent:4.54%"> </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Research and development expense for the year ended December&#160;31, 2013, increased by $1.7</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million, or 4%, as compared to 2012. Outside services increased by $0.9 million compared to 2012 primarily due to additional development work related to our adjuvant studies and collaboration with AstraZeneca. Facility costs increased by $0.6 million compared to 2012 primarily due </font><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to repairs and maintenance of our manufacturing facility and depreciation on recently purchased manufacturing equipment. Non-cash stock-based compensation expense increased by $0.7 million due to accelerated vesting of stock options and modifications of stock options related to management continuity and severance agreements. Compensation and related personnel costs decreased by $0.5 million primarily due to </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a decrease in employee headcount.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;text-indent:4.54%">2012 versus 2011</font><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;text-indent:4.54%"> </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Research and development expense for the year ended December&#160;31, 2012, decreased by $2.2 million, or 4%, as compared to 2011. The decrease in costs was primarily due to the decline in outside services during 2012 as compared to 2011 due to lower </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HEPLISAV-B clinical trial expenses, partially offset by an increase in compensation and related personnel costs, including non-cash stock-based compensation, from an increase in employee headcount and related expense incurred for option grants. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:4.53%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">General and Administrative </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">General and administrative expense consists primarily of compensation and related personnel costs; outside services such as accounting, consulting, business development, investor relations and insurance services; legal costs that include corporate and patent-related expenses; allocated facility costs and non-cash stock-based compensation. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The following is a summary of our general and administrative expenses (in thousands, except for percentages): </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:37%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Increase</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Increase</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:37%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(Decrease)&#160;from</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(Decrease)&#160;from</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:37%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012 to 2013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011 to 2012</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:37%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">General and Administrative:</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:37%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Compensation and related personnel costs</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,521</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,468</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,398</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,053</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,070</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:37%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outside services</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,319</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,730</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,548</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,411</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(51</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,182</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">92</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:37%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Legal costs</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,361</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,437</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,894</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(76</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">543</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:37%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Facility costs</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">630</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">604</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">644</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(40</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(6</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:37%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-cash stock-based compensation</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,112</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,925</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,086</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,187</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:5%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,839</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:5%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">124</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:37%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total general and administrative</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,943</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,164</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,570</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,221</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:5%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,594</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:5%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;text-indent:4.54%">2013 versus 2012</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"> </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">General and administrative expenses for the year ended December&#160;31, 2013, decreased by $2.2</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million, or 8%, compared to the same period in 2012. Outside services expense decreased $4.4 million due to reduced marketing expenses. Compensation costs and non-cash stock-based compensation increased due to </font><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">severance expense and other one-time compensation costs as well as accelerated vesting of stock options related to the transition of our former Chief Executive Officer and certain other employees and executive officers. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;text-indent:4.54%">2012 versus 2011</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"> </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">General and administrative expenses for the year ended December&#160;31, 2012, increased by $10.6 million, or 60%, compared to the same period in 2011. This increase is primarily due to higher legal and outside costs, including consulting costs for corporate development activities and market research for </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HEPLISAV-B. Compensation costs and non-cash stock-based compensation increased due to growth in the number of administrative employees to support the organization and an amended management continuity and severance agreement with one of our executive officers. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:4.53%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Amortization of Intangible Assets </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Intangible assets consisted of the manufacturing process and customer relationships resulting from our April 2006 acquisition of Rhein and were amortized over five years from the date of acquisition through the second quarter of 2011. Amortization of intangible assets was $0.3 million for the year ended December&#160;31, 2011. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:18pt;margin-left:4.53%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Interest Income, Interest Expense and Other Income (Expense) </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Interest income is reported net of amortization of premiums and discounts on marketable securities</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, realized gains and losses on investments, and fees related to investment portfolio management. Interest expense in 2012 was related to the $15 million note payable held by Symphony Dynamo Holdings LLC (&#8220;Holdings&#8221;), which was paid in cash on December&#160;31, 2012. Other expense includes gains and losses on foreign currency transactions as well as gains and losses on disposals of property and equipment. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The following is a summary of our interest income, interest expense and other income (expense) (in thousands, except for percentages</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">): </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:37%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Increase</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Increase</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:37%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(Decrease)&#160;from</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(Decrease) from</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:37%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012 to 2013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011 to 2012</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:37%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:37%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest income</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">116</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">291</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(175</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(60</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">188</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">183</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:37%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest expense</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,351</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,957</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,351</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(100</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">394</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:37%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other income (expense)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(348</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(293</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">834</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,127</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(135</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Interest income for the year ended December&#160;31, 2013, decreas</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ed by $0.2 million, or 60%, compared to the same period in 2012 due to lower average marketable securities balance. Interest income for the year ended December 31, 2012, increased by $0.2 million, or 183%, compared to the same period in 2011 due to higher investment balances primarily as a result of our May 2012 common stock offering which resulted in net proceeds of approximately $69.6 million. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Interest expense for the year ended December&#160;31, 2013 </font><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">decreased </font><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">compared to the same period in 2012 due to the interest recorded for the note payable to Holdings which was repaid in cash on December&#160;31, 2012. Interest expense for the year ended December 31, 2012 increased over the same period in 2012 due to the accretion of interest expense related to the note payable to Holdings.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Other income (expense) for the year ended December&#160;31, 2013 increased by 19</font><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%, compared to the same period in 2012 due to losses on foreign currency transactions in 2013 related to fluctuations in the value of the Euro compared to the U.S. dollar. </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other income (expense) for the year ended December&#160;31, 2012 decreased by $1.1 million, or 135%, compared to the same period in 2011 due to losses on foreign currency transactions in 2012 related to fluctuations in the value of the Euro compared to the U.S. dollar and the recognition of a one-time gain of $0.8 million for the change in fair value of the long-term contingent and warrant liabilities to Holdings in 2011. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Liquidity and Capital Resources </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">As of December&#160;31, 2013, we had $189.4 million in cash, cash equivalents and marketable securities. Since our inception, we have relied primarily on the proceeds from public and private sales of our equity securities</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and revenues from collaboration agreements to fund our operations. Our funds are currently invested in short-term money market funds, U.S. government agency securities and U.S. treasury securities. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">On October 30, 2013, we sold 79,570,000 shares of our common stock and </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43,430 shares of the Company&#8217;s Series B Convertible Preferred Stock (&#8220;Series B&#8221;), resulting in aggregate net proceeds to us of $125.1 million after deducting commissions and offering expenses. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">On March&#160;29, 2013, we entered into an At Market Issuance Sales Agreement (the &#8220;Agreement&#8221;) with MLV&#160;&amp; Co. LLC (&#8220;MLV&#8221;) under which we may offer and sell our common stock having aggregate sales proceeds of up to $50</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million from time to time through MLV as our sales agent. Sales of our common stock through MLV, if any, will be made by means of ordinary brokers&#8217; transactions on The NASDAQ Capital Market or otherwise at market prices prevailing at the time of sale, in block transactions, or as otherwise agreed upon by us and MLV. MLV will use commercially reasonable efforts to sell our common stock from time to time, based upon instructions from us (including any price, time or size limits or other customary parameters or conditions we may impose). We will pay MLV a commission of up to 3.0% of the gross sales proceeds of any common stock sold through MLV under the Agreement. No sales of our common stock have taken place under this Agreement as of December&#160;31, 2013. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">During the year ended December&#160;31, 2013, we used $58.7</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million of cash for our operations and had a net loss of $66.7 million, of which $15.5 million consisted of non-cash charges such as stock-based compensation, depreciation and amortization, accretion and amortization on marketable securities and unoccupied facility expense. By comparison, during the year ended December&#160;31, 2012, we used $43.8 million of cash for our operations with a net loss of $69.9 million, of which $15.1 million consisted of non-cash charges such as stock-based compensation, depreciation and amortization, accretion and amortization on marketable securities and non-cash interest on borrowings. Cash used in our operations during 2013 increased by $14.9 million, totaling $58.7 million for the year ended December 31, 2013 compared to $43.8 million for the same period in 2012. The increase was primarily due to a $9.1 million change in accounts receivable related to a decrease in </font><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">payments received from our collaborations with GSK and AstraZeneca in the prior year</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and an increase in stock based compensation of $1.9 million related to employee severance arrangements and awards for non-employees.  </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">During the year ended </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2013, we used $51.4 million of cash in investing activities compared to $39.7 million for the year ended December&#160;31, 2012. Cash provided by investing activities during 2013 included $49.7 million of net purchases of marketable securities versus $36.8 million of net purchases of marketable securities during 2012. Cash used in investing activities decreased an additional $1.3 million compared to the prior year due to purchases of property and equipment which totaled $1.6 million and $2.9 million in 2013 and 2012, respectively. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">During the year ended December&#160;31, 2013, cash provided by financing activities increased by $66.4 million, totaling $125.4 million, compared to $59.0 million for the year ended December 31, 2012. Cash provided by financing activities in 2013 included the sale of 79,570,000 shares of common stock and 43,</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">430 shares of Series B Convertible Preferred Stock in separate underwritten public offerings for net proceeds of $125.1 million. Cash provided by financing activities for the year ended&#160;December 31, 2012 included net proceeds of $69.6 million from a public stock offering of common stock. These proceeds were partially offset by our $15.0 million repayment of the note payable to Holdings on December&#160;31, 2012. Additionally, proceeds from stock option and warrant exercises for the year ended December 31, 2013 decreased $1.8 million as compared to the same period in 2012. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">During the year ended December&#160;31, 2012, we used $43.8 million of cash for our operations and had a net loss of $69.9 million, of which $15.1 million consisted of non-cash charges such as depreciation and amortization, non-cash interest expense related to our long-term note payable to Holdings and stock based compensation. By comparison, during the year ended D</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ecember&#160;31, 2011, we used $47.1 million of cash, and had a net loss of $48.6 million, of which $9.0 million consisted of non-cash charges such as depreciation and amortization, non-cash interest expense related to our long-term note payable to Holdings and stock based compensation. Cash used in operating activities for the year ended December&#160;31, 2012, decreased by $3.3 million compared to cash used for year ended December&#160;31, 2011, due primarily to a decrease in accounts receivable in 2012 related to payments received from our collaborations with GSK and AstraZeneca. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">During the year ended December&#160;31, 2012, we used $39.7 million of cash in investing activities which was a $5.1 million increase compared to $34.6 million used during the year ended&#160;December 31, 2011. Cash used in investing activities during the year ended&#160;December 31, 2012, primarily related to $36.8 million of cash used for net purchases of marketable securities compared to $33.5 million in the prior year, a $3.3 million increase. Cash used i</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">n investing activities increased an additional $1.8 million compared to the prior year due to purchases of property and equipment which totaled $2.9 million and $1.1 million in 2012 and 2011, respectively. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">During the year ended&#160;December 31, 2012, cash provided by financing activities was $59.0 million compared to $91.4 million for the same period in 2011. Cash provided for the year ended&#160;December 31, 2012 included net proceeds of $69.6 million from a public stock offering as well as proceeds from stock opt</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ion and warrant exercises of $4.1 million. These proceeds were partially offset by our $15 million repayment of our note payable to Holdings on December&#160;31, 2012. By comparison, during the year ended December&#160;31, 2011, we completed a public offering which resulted in aggregate net proceeds of $64.5 million, and raised additional funding from Aspire Capital totaling $26.7 million. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We currently estimate that we have sufficient cash resources to meet our anticipated cash needs through at least the next 12 months based on cash and cash equivalents and marketable securities on hand as of December&#160;31, 2013 and anticipated revenues and funding from existing agreements. We expect to continue to spend substantial funds in connection with the development and manufact</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">uring of our product candidates, particularly HEPLISAV-B, human clinical trials for our other product candidates and additional applications and advancement of our technology. In order to continue these activities, we may need to raise additional funds. This may occur through strategic alliance and licensing arrangements and/or future public or private financings. Sufficient funding may not be available, or if available, may be on terms that significantly dilute or otherwise adversely affect the rights of existing stockholders. If adequate funds are not available in the future, we may need to delay, reduce the scope of or put on hold the HEPLISAV-B program or other development programs while we seek strategic alternatives. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:18pt;margin-left:4.53%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Contractual Obligations </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The following summarizes our significant contractual obligations at December&#160;31, 2013 and the effect those obligations are expected to have on our liquidity and cash flows in future periods (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:41.5%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Contractual Obligations:</font></p></td>
<td valign="bottom" style="width:0.68%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="3" valign="bottom" style="width:9.66%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom" style="width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1.88%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="3" valign="bottom" style="width:9.64%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2014</font></p></td>
<td valign="bottom" style="width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1.88%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="3" valign="bottom" style="width:8.7%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2015-2016</font></p></td>
<td valign="bottom" style="width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1.9%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="3" valign="bottom" style="width:9.64%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2017-2018</font></p></td>
<td valign="bottom" style="width:0.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1.9%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="3" valign="bottom" style="width:8.7%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2019 and Thereafter</font></p></td>
<td valign="bottom" style="width:0.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="font-weight:bold;color:#000000;;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr style="height:2.25pt;">
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:41.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Future minimum payments under our operating leases</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:0.68%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:0.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,080</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:0.94%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1.88%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:0.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,233</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1.88%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:0.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,615</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1.9%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:0.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,733</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1.9%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:0.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,499</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr style="height:11.6pt;">
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:41.5%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom" style="width:0.68%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:0.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1.04%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:7.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,080</font></p></td>
<td valign="bottom" style="width:0.94%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1.88%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:0.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1.02%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:7.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,233</font></p></td>
<td valign="bottom" style="width:0.94%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1.88%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:0.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1.02%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:6.74%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,615</font></p></td>
<td valign="bottom" style="width:0.94%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1.9%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:0.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1.02%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:7.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,733</font></p></td>
<td valign="bottom" style="width:0.94%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1.9%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:0.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1.04%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:6.74%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,499</font></p></td>
<td valign="bottom" style="width:0.18%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:;"><font style="color:#000000;;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We lease our facilities in Berkeley, California (the &#8220;Berkeley Lease&#8221;), and D&#252;sseldorf, Germany (the &#8220;D&#252;sseldorf Lease&#8221;) under operating leases that expire in June 2018 and March 2023, respectively.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">During September 2013, we decided not to occupy a portion of our facility in Berkeley, California. As a result, we recorded a one-time estimated unoccupied facility expense of $0.9 million, representing the present value of the rent payments and other costs associated with the lease, net of estimated sublease income, for the remaining life of the operating lease. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">During the fourth quarter of 2004, we established a letter of credit with Silicon Valley Bank as security for the Berkeley Lease in the amount of $0.4 million. The letter of credit remained outstanding as of December&#160;31, 2013 and is collateralized by a certificate of deposit</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for $0.4 million which has been included in restricted cash in the consolidated balance sheets as of December&#160;31, 2013 and 2012. Under the terms of the Berkeley Lease, if the total amount of our cash, cash equivalents and marketable securities falls below $20 million for a period of more than 30 consecutive days during the lease term, the amount of the required security deposit will increase to $1.1 million, until such time as our projected cash and cash equivalents will exceed $20 million for the remainder of the lease term, or until our actual cash and cash equivalents remains above $20 million for a period of 12 consecutive months. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We established a letter of credit with Deutsche Bank as security for our D&#252;sseldorf Lease in the amount of approximately 0.2&#160;million Euros. The letter of credit remained outstanding through December&#160;31, 2013 and is collateralized by a certificate of deposit</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for 0.2 million Euros which has been included in restricted cash in the consolidated balance sheets as of December&#160;31, 2013 and 2012. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In addition to the non-cancelable commitments included above, we have entered into contractual arrangements that obligate us to make payments to the contractual counterparties upon the occurrence of future events. Also, in the normal course of operations, we have entered into license and other agreements and intend to continue to seek</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> additional rights relating to compounds or technologies in connection with our discovery, manufacturing and development programs. Under the terms of the agreements, we may be required to pay future upfront fees, milestones, royalties on net sales of products originating from the licensed technologies or other payments contingent upon the occurrence of an event that cannot reasonably be estimated. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We rely on research institutions, contract research organizations, clinical investigators and clinical material manufacturers. As of December&#160;31, 2013, under the terms of our agreements, we are obligated to make future payments as services are provided of approximately $4.5 million through 2015. These agreements are terminable by us upon written notice. Generally,</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> we are liable only for actual effort expended by the organizations at any point in time during the contract through the notice period.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Under the terms of our exclusive license agreements with The Regents of the University of California, as amended, for certain technology and related patent rights and materials, we pay annual license or maintenance fees and will be required to pay milestones and royalties on net sales of certain products, if any, originating from the licensed technologies. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:4.53%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Off-balance Sheet Arrangements </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We do not have any off-balance sheet arrangements as defined by rules enacted by the SEC and accordingly, no such arrangements are likely to have a current or future effect on our financial position. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:11.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_7A"></a>I</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TEM&#160;7A. </font></p></td><td valign="top" style="width:88.67%;"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_7A"></a>QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Quantitative and Qualitative Disclosure About Market Risk </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Interest Rate Risk </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We are subject to interest rate risk. Our investment portfolio is maintained in accordance with our investment policy, which defines allowable investments, specifies credit quality standards and limits the credit exposure of any single issuer. The primary </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">objective of our investment activities is to preserve principal and, secondarily, to maximize income we receive from our investments without significantly increasing risk. Some of the securities that we invest in may have market risk. This means that a change in prevailing interest rates may cause the principal amount of the investment to fluctuate. To minimize this risk, we maintain our portfolio of cash equivalents and investments in a variety of securities, including short-term money market funds, U.S. government agency securities, U.S. treasury securities and municipal securities. We do not invest in auction rate securities or securities collateralized by home mortgages, mortgage bank debt or home equity loans. We do not have derivative financial instruments in our investment portfolio. To assess our risk, we calculate that if interest rates were to rise or fall from current levels by 100 basis points or by 125 basis points, the pro forma change in fair value of our net unrealized loss on investments would be $2.1 million or $2.6 million, respectively. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Due to the short duration and conservative nature of our cash equivalents and marketable securities, as well as our intention to hold the investments to maturity, </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">we do not expect any material loss with respect to our investment portfolio. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Foreign Currency Risk </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We have certain investments outside the U.S.</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for the operations of Dynavax Europe with exposure to foreign exchange rate fluctuations. The cumulative translation adjustment reported in the consolidated balance sheet as of December&#160;31, 2013 was $0.1 million primarily related to translation of Dynavax Europe assets, liabilities and operating results from Euros to U.S. dollars. As of December 31, 2013, the effect of our exposure to these exchange rate fluctuations has not been material, and we do not expect it to become material in the foreseeable future. We do not hedge our foreign currency exposures and have not used derivative financial instruments for speculation or trading purposes.</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:8pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:11.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-family:;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_8"></a>I</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TEM&#160;8. </font></p></td><td valign="top" style="width:88.67%;"><p style="margin-bottom:0pt;margin-top:0pt;font-family:;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_8"></a>FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA </font></p></td></tr></table></div><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:96%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom" style="padding-left:0.7 pt;padding-Right:0.7 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:3%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Page&#160;No.</font></p></td>
</tr>
<tr>
<td valign="bottom" style="width:96%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><a href="#REPORT_INDEPENDENT_REGISTERED_PUBLIC_ACC"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Report of Independent Registered Public Accounting Firm</font></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom" style="width:3%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40</font></p></td>
</tr>
<tr>
<td valign="bottom" style="width:96%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:12pt;;margin-right:0%;text-indent:-12pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Audited Consolidated Financial Statements:</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom" style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom" style="width:96%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><a href="#CONSOLIDATED_BALANCE_SHEETS"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Consolidated Balance Sheets</font></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom" style="width:3%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41</font></p></td>
</tr>
<tr>
<td valign="bottom" style="width:96%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><a href="#STATEMENTS_OF_OPERATIONS"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Consolidated Statements of Operations</font></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom" style="width:3%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42</font></p></td>
</tr>
<tr>
<td valign="bottom" style="width:96%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><a href="#COMPREHENSIVE_LOSS"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Consolidated Statements of Comprehensive Loss</font></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom" style="width:3%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42</font></p></td>
</tr>
<tr>
<td valign="bottom" style="width:96%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><a href="#STATEMENTS_OF_STOCKHOLDERS_EQUITY"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Consolidated Statements of Stockholders&#8217; Equity</font></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom" style="width:3%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43</font></p></td>
</tr>
<tr>
<td valign="bottom" style="width:96%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><a href="#STATEMENTS_OF_CASH_FLOWS"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Consolidated Statements of Cash Flows</font></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom" style="width:3%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44</font></p></td>
</tr>
<tr>
<td valign="bottom" style="width:96%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:8pt;;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><a href="#NOTES_TO_CONSOLIDATED_FINANCIAL_STATEMEN"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Notes to Consolidated Financial Statements</font></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="bottom" style="width:3%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:;font-weight:bold;;font-size:10pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="REPORT_INDEPENDENT_REGISTERED_PUBLIC_ACC"></a>Report of Independent Registered Public Accounting Firm </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Board of Directors and Stockholders of Dynavax Technologies Corporation </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We have audited the accompanying consolidated balance sheets of Dynavax Technologies Corporation as of December&#160;31, 2013 and 2012, and the related consolidated statements of operations, comprehensive loss, stockholders&#8217; equity and cash flows for each of the three years in the period ended December&#160;31, 2013. These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on these financial statements based on our audits. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatemen</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">t. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of Dynavax Technologies Corporation at December&#160;31, 2013 and 2012, and the consolidated results of its operations and its cash flows for each of the three years in the period ended December&#160;31, 2013, in conformity with U.S. generally accepted accounting p</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">rinciples. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), Dynavax Technologies Corporation&#8217;s internal control over financial reporting as of December&#160;31, 2013, based on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commiss</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ion (1992 Framework) and our report dated March&#160;10, 2014 expressed an unqualified opinion thereon. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:61.19%;margin-right:0%;text-indent:-2.27%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;Ernst&#160;&amp; Young LLP </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Redwood City, California </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 10, 2014 </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:;font-weight:bold;;font-size:10pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">DYNAVAX TECHNOLOGIES CORPORATION </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="CONSOLIDATED_BALANCE_SHEETS"></a>CONSOLIDATED BALANCE SHEETS </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(In thousands, except per share amounts) </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:76%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom"  BGCOLOR="#FFFFFF"style="width:20%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:76%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:76%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Assets</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:76%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current assets:</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:76%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,122</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,599</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:76%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Marketable securities available-for-sale</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">166,254</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">117,531</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:76%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,627</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,005</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:76%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid expenses and other current assets</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,375</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,052</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:76%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current assets</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">192,378</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">128,187</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:76%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,706</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,965</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:76%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,579</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,475</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:76%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted cash</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">662</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">652</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:76%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other assets</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">297</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">473</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:76%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">204,622</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">139,752</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:76%; border-top:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Liabilities and stockholders&#8217; equity</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:76%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current liabilities:</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:76%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,901</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,166</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:76%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued liabilities</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,166</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,063</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:76%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenues</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,125</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,785</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:76%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current liabilities</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,192</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,014</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:76%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenues, net of current portion</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,173</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,283</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:76%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other long-term liabilities</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">963</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">629</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:76%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total liabilities</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,328</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,926</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:76%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commitments and contingencies (Note 9)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:76%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stockholders&#8217; equity:</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:76%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Preferred stock: $0.001 par value</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:76%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Authorized: 5,000 shares; Issued and outstanding:</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr style="height:19.95pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:76%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Series B Convertible Preferred Stock &#8212; 43 shares at December 31, 2013 and zero shares at December 31, 2012</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:9%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:76%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.4pt;;margin-right:0%;text-indent:-13.65pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock: $0.001 par value; 350,000 and 250,000 shares authorized at December&#160;31, 2013 and 2012, respectively; 262,796 and 182,792 shares issued and outstanding at December&#160;31, 2013 and 2012, respectively</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">263</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">183</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:76%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additional paid-in capital</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">688,390</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">550,729</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:76%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total accumulated other comprehensive loss</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(148</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(595</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:76%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated deficit</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(502,211</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(435,491</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:76%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total stockholders&#8217; equity</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">186,294</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">114,826</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:76%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total liabilities and stockholders&#8217; equity</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">204,622</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">139,752</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">See accompanying notes. </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:;font-weight:bold;;font-size:10pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">DYNAVAX TECHNOLOGIES CORPORATION </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="STATEMENTS_OF_OPERATIONS"></a>CONSOLIDATED STATEMENTS OF OPERATIONS </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(In thousands, except per share amounts) </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:69%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="10" valign="bottom" style="width:33%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:69%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:69%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenues:</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:69%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Collaboration revenue</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,929</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,610</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,190</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:69%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Grant revenue</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,138</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,939</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,110</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:69%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Service and license revenue</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,184</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,165</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,314</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:69%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenues</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,251</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,714</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,614</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:69%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating expenses:</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:69%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50,870</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49,146</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51,322</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:69%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,943</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,164</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,570</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:69%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unoccupied facility expense</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">926</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:69%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization of intangible assets</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">299</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:69%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating expenses</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">77,739</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">77,310</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69,191</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:69%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss from operations</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(66,488</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(67,596</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(47,577</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:69%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other income (expense):</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:69%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest income</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">116</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">291</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:69%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest expense</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,351</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,957</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:69%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other income (expense)</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(348</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(293</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">834</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:69%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(66,720</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(69,949</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(48,597</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:66%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Preferred stock deemed dividend</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,469</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:66%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss allocable to common stockholders</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(75,189</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(69,949</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(48,597</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:66%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share allocable to common stockholders - basic and diluted</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:7%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.38</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:2%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:7%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.41</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:2%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:7%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.39</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:66%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average shares outstanding used to compute basic and diluted net loss per share allocable to common stockholders</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">196,275</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">170,469</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">125,101</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="COMPREHENSIVE_LOSS"></a>CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(In thousands) </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:69%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="10" valign="bottom" style="width:35%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:69%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:69%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(66,720</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(69,949</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(48,597</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:69%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other comprehensive income (loss):</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:7%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:7%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:7%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:64%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unrealized (loss) gain on marketable securities available-for-sale</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(76</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:69%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cumulative translation adjustment</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">523</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">366</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(277</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:69%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total other comprehensive income (loss)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">447</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">414</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(263</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:69%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total comprehensive loss</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(66,273</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(69,535</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(48,860</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">See accompanying notes. </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:;font-weight:bold;;font-size:10pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">DYNAVAX TECHNOLOGIES CORPORATION </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="STATEMENTS_OF_STOCKHOLDERS_EQUITY"></a>CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(In thousands) </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;"><font style="font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:25%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:3pt;;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:3pt;;"><font style="font-weight:bold;color:#000000;font-size:3pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:3pt;;"><font style="font-weight:bold;color:#000000;font-size:3pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:3pt;;"><font style="font-weight:bold;color:#000000;font-size:3pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:3pt;;"><font style="font-weight:bold;color:#000000;font-size:3pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:3pt;;"><font style="font-weight:bold;color:#000000;font-size:3pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:3pt;;"><font style="font-weight:bold;color:#000000;font-size:3pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:3pt;;"><font style="font-weight:bold;color:#000000;font-size:3pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:3pt;;"><font style="font-weight:bold;color:#000000;font-size:3pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:3pt;;"><font style="font-weight:bold;color:#000000;font-size:3pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:3pt;;"><font style="font-weight:bold;color:#000000;font-size:3pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:3pt;;"><font style="font-weight:bold;color:#000000;font-size:3pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:3pt;;"><font style="font-weight:bold;color:#000000;font-size:3pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:3pt;;"><font style="font-weight:bold;color:#000000;font-size:3pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:3pt;;"><font style="font-weight:bold;color:#000000;font-size:3pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:3pt;;"><font style="font-weight:bold;color:#000000;font-size:3pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:3pt;;"><font style="font-weight:bold;color:#000000;font-size:3pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:3pt;;"><font style="font-size:3pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:3pt;;"><font style="font-size:3pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:3pt;;"><font style="font-weight:bold;color:#000000;font-size:3pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:9%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:3pt;;"><font style="font-size:3pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:3pt;;"><font style="font-size:3pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:3%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:3pt;;"><font style="font-weight:bold;color:#000000;font-size:3pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:3pt;;"><font style="font-size:3pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:3pt;;"><font style="font-size:3pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:3pt;;"><font style="font-weight:bold;color:#000000;font-size:3pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:3pt;;"><font style="font-size:3pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:3pt;;"><font style="font-size:3pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:25%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:9pt;;"><font style="color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:9%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:3%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:25%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:9pt;;"><font style="color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom"  BGCOLOR="#FFFFFF"style="width:13%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Common Stock</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom"  BGCOLOR="#FFFFFF"style="width:14%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Preferred Stock</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Additional</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:9%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Other</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:3%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:25%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:9pt;;"><font style="color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Par</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Par</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Paid-In</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:9%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Comprehensive</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:3%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Stockholders&#8217;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:25%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:9pt;;"><font style="color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Amount</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Amount</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Capital</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:9%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Income (Loss)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:3%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Deficit</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Equity</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:25%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balances at December&#160;31, 2010</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">115,611</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">116</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">369,686</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(746</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:3%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(316,945</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">52,111</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:25%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:19.45pt;;margin-right:0%;text-indent:-12.25pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock upon exercise of stock options and restricted stock awards</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">308</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:25%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:19.45pt;;margin-right:0%;text-indent:-12.25pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock under Employee Stock Purchase Plan</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">106</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">132</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">132</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:25%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:19.45pt;;margin-right:0%;text-indent:-12.25pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from issuances of common stock and warrants, net of issuance costs</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,601</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">91,259</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">91,298</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:25%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:19.45pt;;margin-right:0%;text-indent:-12.25pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock compensation expense</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,189</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,189</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:25%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:19.45pt;;margin-right:0%;text-indent:-12.25pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total other comprehensive income (loss)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(263</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(263</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:25%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:19.45pt;;margin-right:0%;text-indent:-12.25pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:3%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(48,597</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(48,597</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:25%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balances at December&#160;31, 2011</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">154,626</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">155</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">466,276</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,009</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:3%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(365,542</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99,880</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:25%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:19.45pt;;margin-right:0%;text-indent:-12.25pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock upon exercise of stock options and restricted stock awards</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,222</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,954</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,955</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:25%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:19.45pt;;margin-right:0%;text-indent:-12.25pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock under Employee Stock Purchase Plan</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">141</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">307</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">307</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:25%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:19.45pt;;margin-right:0%;text-indent:-12.25pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from issuances of common stock and warrants, net of issuance costs</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,803</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">71,753</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">71,780</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:25%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:19.45pt;;margin-right:0%;text-indent:-12.25pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock compensation expense</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,439</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,439</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:25%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:19.45pt;;margin-right:0%;text-indent:-12.25pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total other comprehensive income (loss)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">414</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">414</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:25%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:19.45pt;;margin-right:0%;text-indent:-12.25pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:3%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(69,949</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(69,949</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:25%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balances at December&#160;31, 2012</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">182,792</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">183</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">550,729</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(595</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:3%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(435,491</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">114,826</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:25%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:19.45pt;;margin-right:0%;text-indent:-12.25pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock upon exercise of stock options and restricted stock awards</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">106</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">112</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">112</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:25%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:19.45pt;;margin-right:0%;text-indent:-12.25pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock under Employee stock purchase plan</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">129</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">224</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">224</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:25%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:19.45pt;;margin-right:0%;text-indent:-12.25pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock award delivered</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">115</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:25%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:19.45pt;;margin-right:0%;text-indent:-12.25pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock, net of issuance costs</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">79,570</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80,919</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80,999</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:25%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:19.45pt;;margin-right:0%;text-indent:-12.25pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of Series B convertible preferred stock, net of issuance costs</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44,209</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44,209</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:25%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:19.45pt;;margin-right:0%;text-indent:-12.25pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beneficial conversion feature of Series B convertible preferred stock</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:25%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:19.45pt;;margin-right:0%;text-indent:-12.25pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deemed dividend to holders of Series B convertible preferred stock</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:25%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:19.45pt;;margin-right:0%;text-indent:-12.25pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Initial expenses related to ATM agreement</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(143</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(143</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:25%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:19.45pt;;margin-right:0%;text-indent:-12.25pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants exercised</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">84</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:25%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:19.45pt;;margin-right:0%;text-indent:-12.25pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock compensation expense</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,340</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,340</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:25%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:19.45pt;;margin-right:0%;text-indent:-12.25pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total other comprehensive income (loss)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">447</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">447</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:25%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:19.45pt;;margin-right:0%;text-indent:-12.25pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%; border-bottom:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:3%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(66,720</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(66,720</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:25%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balances at December&#160;31, 2013</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">262,796</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">263</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">688,390</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(148</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:3%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(502,211</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">186,294</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:8.5pt;;"><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">See accompanying notes. </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:10pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">DYNAVAX TECHNOLOGIES CORPORATION </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="STATEMENTS_OF_CASH_FLOWS"></a>CONSOLIDATED STATEMENTS OF CASH FLOWS </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(In thousands) </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:71%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="10" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:71%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Operating activities</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(66,720</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(69,949</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(48,597</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adjustments to reconcile net loss to net cash used in operating activities:</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation and amortization</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,327</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,207</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,303</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization of intangible assets</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">299</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss (gain) on disposal of property and equipment</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accretion of discounts and amortization of premiums of marketable securities</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">923</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,298</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,172</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest associated with long-term note payable to Symphony Dynamo Holdings LLC (&#8220;Holdings)</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,190</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,871</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value adjustment of the warrant and contingent liabilities to Holdings, including the impact of the anti-dilution provision associated with the common stock and warrants issued to Symphony Capital Partners, L.P. and Symphony Strategic Partners, LLC (collectively, &#8220;Symphony&#8221;)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(843</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unoccupied facility expense</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">926</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock compensation expense</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,340</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,439</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,189</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes in operating assets and liabilities:</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(622</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,522</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,526</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid expenses and other current assets</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">677</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(922</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">230</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted cash and other assets</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">176</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(116</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(290</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(657</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">126</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(289</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued liabilities and other long term liabilities</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,291</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,916</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,167</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:71%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenues</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,770</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,472</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,512</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:71%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash used in operating activities</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(58,673</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(43,809</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(47,116</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Investing activities</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Purchases of marketable securities</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(192,044</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(206,149</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(111,205</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from maturities of marketable securities</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">142,321</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">169,387</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">77,729</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:71%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Purchases of property and equipment, net</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,629</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,931</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,142</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:71%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash used in investing activities</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(51,352</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(39,693</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(34,618</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Financing activities</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from issuances of common stock</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80,856</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">71,780</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">91,298</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from issuances of preferred stock</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44,209</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from issuances of warrants</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from exercise of stock options and restricted stock awards</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">112</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,955</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from employee stock purchase plan</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">224</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">307</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">132</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:71%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Payment of notes payable to Holdings</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,000</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:71%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash provided by financing activities</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">125,401</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59,042</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">91,440</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:71%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Effect of exchange rate changes on cash and cash equivalents</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">147</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(218</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net increase (decrease) in cash and cash equivalents</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,523</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(24,342</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,488</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:71%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents at beginning of year</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,599</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31,941</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,453</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:71%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents at end of year</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,122</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,599</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31,941</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%; border-top:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Supplemental disclosure of cash flow information</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-cash investing and financing activities:</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:71%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Disposal of fully depreciated property and equipment</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">86</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">169</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,181</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:71%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net change in unrealized (loss) gain on marketable securities</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(76</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">See accompanying notes. </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:;font-weight:bold;;font-size:10pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">DYNAVAX TECHNOLOGIES CORPORATION </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="NOTES_TO_CONSOLIDATED_FINANCIAL_STATEMEN"></a>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Organization </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Dynavax Technologies Corporation (&#8220;we,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; &#8220;Dynavax&#8221; or the &#8220;Company&#8221;), a clinical-stage biopharmaceutical company, develops products to prevent and treat infectious and inflammatory diseases and cancer based on Toll-like Receptor (&#8220;TLR&#8221;) biology and its ability to modulate the innate immune system. Our lead product candidate is </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HEPLISAV-B<sup style="font-size:85%; vertical-align:top">TM </sup>(also known as &#8220;HEPLISAV&#8221;), an investigational adult hepatitis B vaccine in Phase 3 clinical development. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In addition to HEPLISAV-B</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, we are conducting clinical and preclinical programs that utilize our expertise in TLR biology. Our product candidates include both TLR agonists and TLR inhibitors. Our clinical stage programs include our autoimmune program partnered with GlaxoSmithKline (&#8220;GSK&#8221;), our asthma therapeutic program partnered with AstraZeneca AB (&#8220;AstraZeneca&#8221;), and our cancer immunotherapy program. We also are advancing preclinical development programs in adjuvant technology and TLR 7, 8, and 9 inhibition. We compete with pharmaceutical companies, biotechnology companies, academic institutions and research organizations in developing therapies to prevent or treat infectious and inflammatory diseases and cancer. We were incorporated in California in August&#160;1996 under the name Double Helix Corporation, and we changed our name to Dynavax Technologies Corporation in September&#160;1996. We reincorporated in Delaware in 2000.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Subsidiaries </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In April 2006, we completed the acquisition of Rhein Biotech GmbH (&#8220;Rhein&#8221; or &#8220;Dynavax Europe&#8221;), a wholly-owned subsidiary in D&#252;sseldorf, Germany. In October 2011, we formed Dynavax International, B.V., a wholly-owned subsidiary in Amsterdam, Netherlands. </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Summary of Significant Accounting Policies </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Basis of Presentation </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The consolidated financial statements include our accounts and those of our wholly-owned subsidiaries. All significant intercompany accounts and transactions among the entities have been eliminated from the consolidated financial statements. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Liquidity and Financial Condition </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We have incurred significant operating losses and negative cash flows from operations since our inception. As of December&#160;31, 2013, we had cash, cash equivalents and marketable securities of $189.4 million. We currently estimate that we have sufficient cash resources to meet our anticipated cash needs through at least the next 12 months based on cash, cash equivalents and marketable securities on hand as of December&#160;31, 2013 and anticipated revenues and funding from existing agr</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">eements.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We expect to continue to spend substantial funds in connection with the development and manufacturing of our product candidates, particularly HEPLISAV-B</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, human clinical trials for our product candidates and additional applications and advancement of our technology. In order to continue these activities, we may need to raise additional funds. This may occur through strategic alliance and licensing arrangements and/or future public or private financings. Sufficient additional funding may not be available on acceptable terms, or at all. If adequate funds are not available in the future, we may need to delay, reduce the scope of or put on hold the HEPLISAV-B program or our other development programs while we seek strategic alternatives.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The preparation of financial statements in conformity with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) requires management to make informed </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results may differ materially from these estimates.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Foreign Currency Translation</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We consider the local currency to be the functional currency for our international subsidiary, Rhein. Accordingly, assets and liabilities denominated in foreign currencies are translated into U.S. dollars using the exchange rate in effect on the balance sheet date. Revenues and expenses are translated at average exchange rates prevailing throughout the year. Currency translation adjustments arising from period to period are charged or credited to accumulated other comprehensive income (loss) in </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">stockholders&#8217; equity. For the years ended December&#160;31, 2013, 2012 and 2011, we reported an unrealized gain of $0.5 million, an unrealized gain of $0.4 million and an unrealized loss of $0.3 million, respectively. Realized gains and losses resulting from currency transactions are included in the consolidated statements of operations. For the years ended December&#160;31, 2013, 2012 and 2011, we reported a loss of $0.2 million, a loss of $0.2 million and a gain of $0.2 million, respectively, resulting from currency transactions in our consolidated statements of operations. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cash, Cash Equivalents and Marketable Securities </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We consider all highly liquid investments purchased with an original maturity of three months or less and that can be liquidated without prior notice or penalty, to be cash equivalents. Management determines the appropriate classification of marketable securities at the time of purchase. We invest in short-term money market funds, U.S. government agency securities, U.S. treasury securities and municipal secur</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ities. We believe these types of investments are subject to minimal credit and market risk. We do not invest in auction rate securities or securities collateralized by home mortgages, mortgage bank debt, or home equity loans. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We have classified our entire</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> investment portfolio as available-for-sale and available for use in current operations and accordingly have classified all investments as short-term. Available-for-sale securities are carried at fair value based on inputs that are observable, either directly or indirectly, such as quoted market prices for similar securities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the securities, with unrealized gains and losses included in accumulated other comprehensive income (loss) in stockholders&#8217; equity. Realized gains and losses and declines in value, if any, judged to be other than temporary on available-for-sale securities are included in interest income or expense. The cost of securities sold is based on the specific identification method. Management assesses whether declines in the fair value of investment securities are other than temporary. In determining whether a decline is other than temporary, management considers the following factors: </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Whether the investment has been in a continuous realized loss position for over 12 months; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the duration to maturity of our investments; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our intention and ability to hold the investments to maturity and if it is not more likely than not that we will be required to sell the investment before recovery of the amortized cost bases; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the credit rating, financial condition and near-term prospects of the issuer; and </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the type of investments made. </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">To date, there have been no declines in fair value that have been iden</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">tified as other than temporary. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk and Other Risks and Uncertainties </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We operate in one business segment, which is the discovery and development of biopharmaceutical products. We determine our segments based on the way we organize our business by making operating decisions and assessing performance. In fiscal years 2013, 2012 and 2011, 89%, 88% and 94% of our revenues were earned in the United States, respectively, and the</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> remaining revenues were earned in Germany. As of December&#160;31, 2013 and 2012, 9% and 10%, respectively, of our long-lived assets were located in the United States and the remaining long-lived assets were located in Germany. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Financial instruments that are subject to concentration of credit risk consist primarily of cash equivalents, marketable securities and accounts receivable. Our policy is to invest cash in institutional money market funds and marketable securities of U.S. government and corporate issuer</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s with high credit quality to limit the amount of credit exposure. We currently maintain a portfolio of cash equivalents and marketable securities in a variety of securities, including short-term money market funds, U.S. government agency securities, U.S. treasury securities and municipal securities. We have not experienced any losses on our cash equivalents and marketable securities. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Accounts receivable are recorded at invoice value. We review our exposure to accounts receivable, including the </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">requirement for allowances based on management&#8217;s judgment. We have not historically experienced any significant losses. We do not currently require collateral for any of our accounts receivable. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our products will require approval from the U.S. Food and Drug Administration (&#8220;FDA&#8221;) and foreign regulatory agencies before commercial sales can commence. There can be no assurance that our products will receive any of these required approvals. The denial or delay o</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">f such approvals would have a material adverse impact on our business. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We have relied on a limited number of suppliers to produce oligonucleotides </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">for clinical trials and a single contract manufacturer to produce our first generation TLR 9 agonist, 1018 for HEPLISAV-B. The loss of our current supplier would have a significant effect on our ability to produce HEPLISAV-B for commercialization and development of our other product candidates. To date, we have manufactured only small quantities of oligonucleotides and 1018 ourselves for development purposes. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We are subject to risks common to companies in the biopharmaceutical industry, including, but not limited to, new technological innovations, clinical development risk, establishing appropriate commercial partnerships, protection of proprietary technology, compliance with government and environmental regulations, uncertainty of market acceptance of products, product liability, the volatility of our stock price and the need to obtain additional financing</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Long-Lived Assets </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Property and equipment are recorded at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets. Repair and maintenance costs are charged to expense as incurred. Leasehold improvements in both of our facilities are amortized over the remaining life of the initial lease term or the estimated useful lives of the assets, whichever is shorter. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We evaluate the carrying value of long-lived assets, including intangible assets, whenever events or changes in business circumstances or our planned use of long-lived assets indicate</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, based on undiscounted future operating cash flows, that their carrying amounts may not be fully recoverable or that their useful lives are no longer appropriate. When an indicator of impairment exists, long-lived assets are written down to their respective fair values. Fair value is determined primarily using the anticipated cash flows discounted at a rate commensurate with the risk involved. Significant management judgment is required in the forecast of future operating results that are used in the preparation of expected undiscounted cash flows. No impairments of purchased intangible assets have been identified during the years presented. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Goodwill</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our goodwill balance relates to our April 2006 acquisition of Rhein. Goodwill was recorded as the excess purchase price over tangible and intangible assets acquired </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and liabilities assumed based on their estimated fair value, by applying the acquisition method of accounting. Goodwill is not amortized but is subject to an annual impairment test which consists of a comparison of the fair value of the related reporting unit against its carrying amount including goodwill. If the carrying amount exceeds the fair value, impairment is calculated and recorded as a charge in the consolidated statements of operations. We determined that we have only one operating segment and there are no components of that operating segment that are deemed to be separate reporting units such that we have one reporting unit for purposes of our goodwill impairment testing. We evaluate goodwill for impairment on an annual basis and on an interim basis if events or changes in circumstances between annual impairment tests indicate that the asset might be impaired.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Revenue Recognition </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our revenues consist of amounts earned from collaborations, grants and fees from services and licenses. We enter into license and manufacturing agreements and collaborative research and development arrangements with pharmaceutical and biotechnology partners that may involve multiple deliverables. Our arrangements may include one or more of the following elements: upfront license payments, cost reimbursement for the performance of research and development activities, milestone</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> payments, other contingent payments, contract manufacturing service fees, royalties and license fees. Each deliverable in the arrangement is evaluated to determine whether it meets the criteria to be accounted for as a separate unit of accounting or whether it should be combined with other deliverables. In order to account for the multiple-element arrangements, the Company identifies the deliverables included within the arrangement and evaluates which deliverables represent separate units of accounting. Analyzing the arrangement to identify deliverables requires the use of judgment, and each deliverable may be an obligation to deliver services, a right or license to use an asset, or another performance obligation. We recognize revenue when there is persuasive evidence that an arrangement exists, delivery has occurred or services have been rendered, the price is fixed or determinable and collectability is reasonably assured. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">On January&#160;1, 2011, we adopted on a prospective basis Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Update (&#8220;ASU&#8221;) 2009-13, </font><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Multiple-Deliverable Revenue Arrangements</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, which amends the criteria related to identifying separate units of accounting and provides guidance on whether multiple deliverables exist, how an arrangement should be separated and the consideration allocated. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Non-refundable upfront fees received for license and collaborative agreements entered into prior to January&#160;1, 2011 and other payments under collaboration agreements where we have continuing performance obligations related to the payments are deferred and recognized over our expected performance period. Revenue is recognized on a ratable basis, unless we determine that another method is more appropriate, through the date at which our performance o</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">bligations are completed. Management makes its best estimate of the period over which we expect to fulfill our performance obligations, which may include clinical development activities. Given the uncertainties of research and development collaborations, significant judgment is required to determine the duration of the performance period. We recognize cost reimbursement revenue under collaborative agreements as the related research and development costs are incurred, as provided for under the terms of these agreements. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Contingent consideration received for the achievement of a substantive milestone is recognized in its entirety in the period in which the milestone is achieved. A milestone is defined as an event having all of the following characteristics: (i)&#160;there is substantive uncertainty at the date the arrangement is entered into that the event will be achieved, (ii)&#160;the event can only be achieved based in whole or in part on either the entity&#8217;s performance or a specific outcome resulting from the entit</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">y&#8217;s performance and (iii)&#160;if achieved, the event would result in additional payments being due to the entity. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our license and collaboration agreements with our partners provide for payments to be paid to us upon the achievement of development milestones. Given the challenges inherent in developing biologic products, there is substantial uncertainty whether any such milestones will be achieved at the time we entered into these agreements. In addition, we evaluate whether the development milestones meet the </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">criteria to be considered substantive. The conditions include: (i)&#160;the development work is contingent on either of the following: (a)&#160;the vendor&#8217;s performance to achieve the milestone or (b)&#160;the enhancement of the value of the deliverable item or items as a result of a specific outcome resulting from the vendor&#8217;s performance to achieve the milestone; (ii)&#160;it relates solely to past performance and (iii)&#160;it is reasonable relative to all the deliverable and payment terms within the arrangement. As a result of our analysis, we consider our development milestones to be substantive and, accordingly, we expect to recognize as revenue future payments received from such milestones as we achieve each milestone. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Milestone payments that are contingent upon the achievement of substantive at-risk performance criteria are recognized in full upon achievement of those milestone events in accordance with the terms of the agreement and assuming all other revenue recognition criteria have been met. All revenue recognized to dat</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">e under our collaborative agreements has been nonrefundable. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our license and collaboration agreements with certain partners also provide for contingent payments to be paid to us based solely upon the performance of our partner. For such contingent payments we expect to recognize the payments as revenue upon receipt, provided that collection is reasonably assured and the other revenue recognition criteria have been satisfied. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Revenues from manufacturing services are recognized upon meeting the criteria for substantial performance and acceptance by the customer. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Revenue from royalty payments is contingent on future sales activities by our licensees. As a result, we recognize royalty revenue when reported by our licensees and when collection is reasonably assured. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Revenue from government and private agency grants are recognized as the related research expenses are incurred and to the extent that funding is approved. Additionally, we recognize revenue based on the facilities and administrative cost rate reimbursable per the terms of the grant awards. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Research and Development Expenses and Accruals </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Research and development expenses include personnel and facility-related expenses, outside contracted services including clinical trial costs, manufacturing and process development costs, research costs and other consulting services and non-cash stock-based compensation. Research and development costs are expensed as incurred. Amounts due under such arrangements may be either fixed fee or fee for service, and may include upfront payments, monthly payments and payments upon the completion of milestones or re</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ceipt of deliverables. Non-refundable advance payments under agreements are capitalized and expensed as the related goods are delivered or services are performed. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We contract with third parties to perform various clinical trial activities in the on-going development of potential products. The financial terms of these agreements are subject to negotiation, vary from contract to contract and may result in uneven payment flows to our vendors. Payments under the contracts depend on factors such as the achievement of certain events, successful enrollment of patients, completion of portions of the clinical trial or similar conditions. Our accruals for clinical trials are b</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ased on estimates of the services received and efforts expended pursuant to contracts with clinical trial centers and clinical research organizations. We may terminate these contracts upon written notice and we are generally only liable for actual effort expended by the organizations to the date of termination, although in certain instances we may be further responsible for termination fees and penalties. The Company makes estimates of its accrued expenses as of each balance sheet date based on the facts and circumstances known to the Company at that time. There have been no material adjustments to the Company&#8217;s prior period accrued estimates for clinical trial activities through December 31, 2013.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stock-Based Compensation </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Stock-based compensation expense for stock options and other stock awards is estimated at the grant date based on the award&#8217;s fair value-based measurement and is recognized on a straight-line basis over the award&#8217;s vesting period, assuming </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">appropriate forfeiture rates. Our determination of the fair value-based measurement of stock options on the date of grant using an option-pricing model is affected by our stock price, as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, our expected stock price volatility over the term of the awards, and actual and projected employee stock option exercise behaviors. In the future, as additional empirical evidence regarding these input estimates becomes available, we may change or refine our approach of deriving these input estimates. These changes could impact our fair value-based measurement of stock options granted in the future. Changes in the fair value-based measurement of stock awards could materially impact our operating results. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We selected the Black-Scholes option pricing model as the most appropriate method for determining the estimated fair value-based measurement of our stock options. The Black-Scholes model requires the use of highly subjective and complex assumptions which determine the fair value-based measurement of stock options, including the option&#8217;s expected term and the price volatility of the underlying stock. Our current estimate of volatility is based on the historical volatility of our stock price. To t</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">he extent volatility in our stock price increases in the future, our estimates of the fair value of options granted in the future could increase, thereby increasing stock-based compensation cost recognized in future periods. We derive the expected term assumption primarily based on our historical settlement experience, while giving consideration to options that have not yet completed a full life cycle. Stock-based compensation cost is recognized only for awards ultimately expected to vest. Our estimate of the forfeiture rate is based primarily on our historical experience. To the extent we revise this estimate in the future, our share-based compensation cost could be materially impacted in the quarter of revision, as well as in the following quarters. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Income Taxes </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We account for income taxes using the asset and liability method, under which deferred tax assets and liabilities are determined based on the differences between the financial reporting and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Additionally, we assess the likelihood that deferred tax assets will be recovered as deductions from future taxable income. We have provided a full valuation allowance on our defer</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">red tax assets at December&#160;31, 2013 and 2012 because we believe it is more likely than not that our deferred tax assets will not be realized as of December&#160;31, 2013, and 2012. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We have no unrecognized tax benefits as of December&#160;31, 2013, including no accrued amounts for interest and penalties. We do not anticipate that total unrecognized tax benefits will significantly change prior to December&#160;31, 2014. Our policy will be to recognize interest and penalties related to income taxes, if any, as a component o</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">f general and administrative expense. We are subject to income tax examinations for U.S. federal and state income taxes from 1996 forward. We are subject to tax examination in Germany from 2010 forward.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recent Accounting Pronouncements </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;text-indent:4.54%">Accounting Standards Update 2013-02 </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In February&#160;2013, the FASB issued ASU 2013-02, &#8220;</font><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Reporting of Amounts Reclassified out of Accumulated Other Comprehensive Income.&#8221;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;This ASU expands the presentation of changes in accumulated other comprehensive income.&#160;The new guidance requires an entity to disaggregate the total change of each component of other comprehensive income either on the face of the statement of operations or as a separate disclosure in the financial statement footnotes. ASU 2013-02 is effective for fiscal years beginning after December&#160;15, 2012. The Company adopted this guidance on a prospective basis in the first quarter of 2013 and the adoption did not have any impact on our financial position, results of operations or cash flows as there were no amounts reclassified out of accumulated other comprehensive (loss) income during the year ended December 31, 2013.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">3.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value Measurements </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The Company defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and m</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">inimize the use of unobservable inputs. The accounting standard describes a fair value hierarchy based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value which are the following: </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 1&#8212;Observable inputs, such as quoted prices in active markets for identical assets or liabilities; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2&#8212;Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 3&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities, therefore requiring an entity to develop its own assumptions. </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recurring Fair Value Measurements </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The following table represents the fair value hierarchy for our financial assets (cash equivalents and marketable securities) measured at fair value on a recurring basis as of December&#160;31, 2013 and 2012 (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:54%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Level 1</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Level 2</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Level&#160;3</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2013</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:54%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government agency securities</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">167,597</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">167,597</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:54%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">167,597</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">187,610</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%; border-top:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:54%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Level 1</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Level 2</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Level&#160;3</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2012</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,140</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,140</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government agency securities</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">119,233</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">119,233</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. treasury securities</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">500</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">500</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:54%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Municipal securities</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">715</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">715</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:54%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,140</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">120,448</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">123,588</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Money market funds are highly liquid investments and are actively traded. The pricing information on these investment instruments are readily available and can be independently validated as of the measurement date. This approach results in the classification of these securities as Level 1 of the fair value hierarchy. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">U.S. Government agency securities, U.S. treasury securities and municipal securities are measured at fair value using Level 2 inputs. We review trading activity and pricing for these investments as of each measurement date. When sufficient quoted pricing for identical securities is not available, we use market pricing and other observable market inputs for similar securities obtained from various third party data providers. These inputs repres</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ent quoted prices for similar assets in active markets or these inputs have been derived from observable market data. This approach results in the classification of these securities as Level 2 of the fair value hierarchy. </font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:9pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:8pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">4.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:8pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cash, Cash Equivalents and Marketable Securities </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The following is a summary of cash, cash equivalents and marketable securities as of December&#160;31, 2013, and 2012 (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Amortized Cost</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Unrealized Gains</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Unrealized Losses</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Estimated Fair&#160;Value</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2013</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents:</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,766</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,766</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,013</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,013</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government agency securities</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,343</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,343</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash and cash equivalents</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,122</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,122</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Marketable securities available-for-sale:</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government agency securities</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">166,285</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(47</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">166,254</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total marketable securities available-for-sale</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">166,285</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(47</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">166,254</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash, cash equivalents and marketable securities</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">189,407</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(47</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">189,376</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%; border-top:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2012</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents:</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,542</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,542</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,140</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,140</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Municipal securities</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">715</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">715</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government agency securities</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,202</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,202</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash and cash equivalents</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,599</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,599</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Marketable securities available-for-sale:</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government agency securities</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">116,986</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">117,031</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. treasury securities</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">500</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">500</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total marketable securities available-for-sale</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">117,486</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">117,531</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash, cash equivalents and marketable securities</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">125,085</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">125,130</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The maturities of our marketable securities available-for-sale are as follows (in thousands) </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:75%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:75%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Amortized Cost</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Estimated Fair Value</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:75%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mature in one year or less</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">93,691</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">93,701</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:75%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mature after one year through two years</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72,594</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72,553</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:75%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">166,285</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">166,254</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We invest in short-term money market funds, U.S. government agency securities, U.S treasury securities and</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> municipal securities. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">There were no realized gains or losses from the sale of marketable securities in the years ended December&#160;31, 2013, 2012 and 2011. All of our investments are classified as short-term and available-for-sale, as we may not hold our investments until maturity. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">5.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Property and Equipment </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Property and equipment as of December&#160;31, 2013, and 2012 consist of the following (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:66%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:8%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Estimated&#160;Useful<br>Life</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:66%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(In years)</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:66%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Manufacturing equipment</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5-14</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,968</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,574</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:66%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lab equipment</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5-13</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,227</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,755</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:66%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computer equipment</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,962</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,807</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:66%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furniture and fixtures</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,056</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">983</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:66%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5-7</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,048</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,445</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:66%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets in progress</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:8%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">762</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,047</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:66%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,023</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,611</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:66%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less accumulated depreciation and amortization</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:8%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,317</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,646</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:66%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:8%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,706</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,965</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Depreciation and amortization expense on property and equipment was $1.3 million, $1.2 million and $1.3&#160;million for the years ended December&#160;31, 2013, 2012 and 2011, respectively. </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">6.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intangible Assets </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Intangible assets consisted primarily of manufacturing process and customer relationships related to our 2006 acquisition of Rhein. The manufacturing process derives from the methods for making proteins in Hansenula yeast, which is a process we use to make a key component in the production of hepatitis B vaccine. The customer relationships derive from Rhein&#8217;s ability to sell existing, in-process and future pro</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ducts to its existing customers. Purchased intangible assets other than goodwill are amortized on a straight-line basis over their respective useful lives. The manufacturing process and customer relationships were amortized over their estimated useful lives of five years. Both the manufacturing process and customer relationships intangible assets were fully amortized as of the year ended December&#160;31, 2011. Amortization of intangible assets was zero for the years ended December&#160;31, 2013 and 2012, and $0.3 million for the year ended December&#160;31, 2011. </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">7.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Current Accrued Liabilities </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Current accrued liabilities as of December&#160;31, 2013, and 2012 consist of the following (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:75%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="6" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:75%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:75%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Payroll and related expenses</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,639</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,538</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:75%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Legal expenses</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">338</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">396</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:75%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Third party research and development expenses</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,403</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,207</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:75%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other accrued liabilities</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,786</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,922</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:75%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,166</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,063</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:8pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">8.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Symphony Dynamo, Inc. </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">On April&#160;18, 2006, we, Symphony and Holdings entered into a transaction involving a series of related agreements providing for the advancement of certain of our immunostimulatory sequences-based programs for cancer, hepatitis B and hepatitis C therapy (collectively, the &#8220;Programs&#8221;). Pursuant to these agreements, Symphony formed SDI and invested $50&#160;million to fund the Programs, and we licensed to Holdings our intellectual property rights related to the Programs, which were assigned to SDI. As a result of th</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ese agreements, Symphony owned 100% of the equity of Holdings, which owned 100% of the equity of SDI. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">52</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In connection with the transaction described above, Holdings granted to us an exclusive purchase option that gave us the right, but not the obligation, to acquire the outstanding equity securities of SDI, which would result in our reacquisition of the intellectual property rights that we licensed to Holdings (the &#8220;Original Purchase Option&#8221;). In exchange for the Original Purchase Option, we granted Holdings</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> five-year warrants to purchase up to 2,000,000 shares of our common stock at an exercise price of $7.32 per share pursuant to a warrant purchase agreement (the &#8220;Original Warrants&#8221;), and granted certain registration rights to Holdings pursuant to a registration rights agreement. We also received an exclusive option to purchase either the hepatitis B or hepatitis&#160;C therapy program (the &#8220;Program Option&#8221;) during the first year of the arrangement. In April 2007, we exercised the Program Option for the hepatitis B program which resulted in the recognition of a $15 million liability to Symphony. We remained primarily responsible for the development of the cancer and hepatitis C therapy programs in accordance with a development plan and related development budgets that we agreed to with Holdings. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Prior to the acquisition of all of the outstanding equity of SDI on December&#160;30, 2009, we consolidated the financial position and results of operations of SDI. In November&#160;2009, we entered into an agreement with Holdings to modify the provisions of and to exercise the Original Purchase Option (the &#8220;Amended Purchase Option&#8221;). We completed the acquisition of all of the outstanding equity of SDI on December&#160;30, 2009. In exchange for all of the outstanding equity of SDI, we iss</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ued to Symphony and certain of its co-investors: (i)&#160;13,000,000 shares of common stock (the &#8220;Shares&#8221;); (ii)&#160;5-year warrants to purchase 2,000,000 shares of common stock with an exercise price of $1.94 per share (the &#8220;Warrants&#8221;); and (iii)&#160;a non-interest bearing note in the principal amount of $15 million, due December&#160;31, 2012, payable in cash, our common stock or a combination thereof at our discretion, which obligation was previously payable solely in cash on April&#160;18, 2011 (the &#8220;Note&#8221;). In addition, we&#160;agreed to contingent cash payments from us equal to 50% of the first $50 million from any upfront, pre-commercialization milestone or similar payments received by us from any agreement with any third party with respect to the development and/or commercialization of the cancer and hepatitis C therapies originally licensed to SDI. The Original Warrants held by Symphony were cancelled as part of this transaction. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We were obligated to make future contingent cash payments to the former Holdings shareholders related to certain payments received by us, if any, from future partnering agreements pertaining to our hepatitis C and cancer therapy programs. We estimated the valuation of this contingent liability using a discounted cash flow model. The discounted cash flo</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">w model was derived from management&#8217;s assumptions regarding the timing, amounts, and probability of potential upfront and milestone payments for the development and/or commercialization of the hepatitis C program based on transactions for similar stage programs by other companies. These cash flows were discounted at a rate of 16% for the fiscal year ended December&#160;31, 2010. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Changes in the fair value of the contingent consideration liability were recognized in &#8220;other income (expense)&#8221; in the consolidated statements of operations in the period of the change. During the fiscal year ended December&#160;31, 2010, we reduced the assumed probability of our receipt of upfront and milestone payments from a potential partnership and extended the timing of when these expec</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ted receipts would occur. In addition, based on our assumptions regarding our beta and risk free interest rate used in the discounted cash flow model, the change in fair value of the contingent consideration liability resulted in other income of $2.2 million for the fiscal year ended December&#160;31, 2010. During the year ended December&#160;31, 2011, we determined that we would not receive any upfront or milestone payments from a potential partnership for our hepatitis C therapy program and, therefore, estimated the fair value of the liability to be zero as of December&#160;31, 2011 resulting in other income of $0.8 million. These fair value measurements were based on significant inputs not observed in the market and thus represented a Level 3 measurement. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We recorded the acquisition of all of the outstanding equity of SDI pursuant to the Amended Purchase Option as a return of equity to the noncontrolling interest. The acquisition was accounted for as a capital transaction that did not affect our consolidated net loss. H</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">owever, because the acquisition was accounted for as a capital transaction, the consideration paid in excess of the carrying value of the noncontrolling interest in SDI is treated as a deemed dividend at the time for purposes of reporting net loss and earnings per share. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The estimated fair values of the warrants transferred were calculated using the Black-Scholes valuation model. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We estimated the fair value of the Note using a net present value model with a discount rate of 17%. Imputed interest was recorded as interest expense over the term of the loan using the interest rate method. We paid in cash the $15 million principal balance of the Note on December&#160;31, 2012. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The Shares and Warrants were subject to certain anti-dilution protection in the event that we issued other equity securities within six months from December&#160;30, 2009. As a result of an equity offering completed in April 2010 prior to the expiration of the anti-dilution provision, Symphony received an additional 1,076,420&#160;shares of common stock</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (&#8220;April 2010 Shares&#8221;) and warrants to purchase 7,038,210 shares of common stock (&#8220;April 2010 Warrants&#8221;) having the same terms as the warrants sold in the offering, which have an exercise price of $1.50 per share and a term of five years. The Warrants issued on December&#160;30, 2009 were cancelled upon the issuance of the April 2010 Warrants. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The fair value of the April 2010 Shares and incremental fair value of the April 2010 Warrants provided to Symphony, as measured upon issuance and remeasured at June&#160;30, 2010, resulted in non-operating expense of $11.1 million in the second quarter of 2010. This also resulted in an increase of $9.5 million to the warrant liability and an increase of $1.6 million to additional paid in capital as of June&#160;30, 2010. Following t</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">he expiration date of Symphony&#8217;s anti-dilution protection, on June&#160;30, 2010, the value of the April 2010 Warrants of $12.0 million was reclassified into stockholders&#8217; equity in the consolidated balance sheets. As of December&#160;31, 2013, warrants to purchase 6,765,128 shares remained outstanding. </font></p><p style="margin-bottom:0pt;margin-top:8pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">9</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Commitments and Contingencies </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We lease our facilities in Berkeley, California (&#8220;Berkeley Lease&#8221;) and D&#252;sseldorf, Germany (&#8220;D&#252;sseldorf Lease&#8221;) under operating leases that expire in June 2018 and March 2023, respectively. The Berkeley Lease provides for periods of escalating rent. The total cash payments over the life of the lease are divided by the total number of months in the lease period and the average rent is charged to expense each month during the lease per</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">iod. We entered into sublease agreements under the D&#252;sseldorf Lease for a certain portion of the leased space. The sublease income is offset against our rent expense. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">During September 2013, we decided not to occupy a portion of our facility in Berkeley, California. As a result, we recorded a one-time estimated unoccupied facility expense of $0.9 million for the year ended December 31, 2013, representing the present value of the rent payments and other costs associated with the lease, net of estimated subl</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ease income, for the remaining life of the operating lease. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Total net rent expense related to our operating leases for the years ended December&#160;31, 2013, 2012 and 2011, was $1.9 million, $1.7 million and $1.7 million, respectively. Deferred rent was $0.6 million as of December&#160;31, 2013 and 2012.&nbsp;&nbsp; </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Future minimum payments under the non-cancelable portion of our operating leases at December&#160;31, 2013, excluding payments from sublease payments, are as follows (in thousands):</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Years ending December&#160;31,</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:10%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2014</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,233</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2015</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,282</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2016</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,333</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2017</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,382</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2018</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,351</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:88%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Thereafter</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,499</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:88%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,080</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">During the fourth quarter of 2004, we established a letter of credit with Silicon Valley Bank as security for our Berkeley Lease in the amount of $0.4 million. The letter of credit remained outstanding as of December&#160;31, 2013, and is collateralized by a certificate of deposit for $0.4 million, which has been included in restricted cash in the consolidated balance shee</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ts as of December&#160;31, 2013 and 2012. Under the terms of the Berkeley Lease, if the total amount of our cash, cash equivalents and marketable securities falls below $20 million for a period of more than 30 consecutive days during the lease term, the amount of the required security deposit will increase to $1.1 million, until such time as our projected cash and cash equivalents will exceed $20 million for the remainder of the lease term, or until our actual cash and cash equivalents remains above $20 million for a period of 12 consecutive months. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We established a letter of credit with Deutsche Bank as security for our D&#252;sseldorf Lease in the amount of approximately 0.2&#160;million Euros. The letter of credit remained outstanding through December&#160;31, 2013 and is collateralized by a certificate of deposit for 0.2 </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">million Euros, which has been included in restricted cash in the consolidated balance sheets as of December&#160;31, 2013 and 2012.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In addition to the non-cancelable commitments included above, we have entered into contractual arrangements that obligate us to make payments to the contractual counterparties upon the occurrence of future events. In </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">addition, in the normal course of operations, we have entered into license and other agreements and intend to continue to seek additional rights relating to compounds or technologies in connection with our discovery, manufacturing and development programs. Under the terms of the agreements, we may be required to pay future up-front fees, milestones and royalties on net sales of products originating from the licensed technologies, if any, or other payments contingent upon the occurrence of future events that cannot reasonably be estimated.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We rely on research institutions, contract research organizations, clinical investigators as well as clinical and material manufacturers of our product candidates. As of December&#160;31, 2013, under the terms of our agreements, we are obligated to make future payments as services are provided of approximately $4.5 million through 2015. These a</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">greements are terminable by us upon written notice. Generally, we are liable only for actual effort expended by the organizations at any point in time during the contract through the notice period.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Under the terms of our exclusive license agreements with the Regents of the University of California, as amended, for certain technology and related patent rights and materials, we pay annual license or maintenance fees and will be required to pay milestones and royalties on net sales</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, if any, of certain products originating from the licensed technologies.</font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">0</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Collaborative Research, Development and License Agreements </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:2.67%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;text-indent:2.67%">GlaxoSmithKline </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In December 2008, we entered into a worldwide strategic alliance with GSK to discover, develop and commercialize TLR inhibitors. Under the terms of the arrangement, we agreed to conduct research and early clinical development in up to four programs: the Lead TLR 7/9 program, a Follow-On TLR 7/9 program, and up to two other TLR programs. In 2011 we began development of a TLR 8 program as one of the two additional programs under the collaboration.&nbsp;&nbsp;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">GSK subsequently returned all rights to this program to us. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We are currently conducting a Phase 1 clinical trial in the Lead TLR 7/9 program with DV1179 in systemic lupus erythematosus patients. The Company is not currently performing any activities on the Follow-On TLR 7/9 program. GSK has not yet chosen to initiate development of the remaining program under the agreement.</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2013, we amended our agreement with GSK to extend the research term until conclusion of the ongoing phase 1 study of DV1179. In addition, the exclusivity provisions of the agreement were modified, giving us rights to immediately begin preclinical and clinical research on inhibitors of TLR 7 and 9 (other than DV1179) for oncology indications.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">GSK can exercise its exclusive option to license each program. If GSK exercises an option, GSK would carry out further development and commercialization of the corresponding products. If GSK exercises their option on the Lead TLR 7/9 program, then we are eligible to receive payments of up to approximately $125 million, comprised of contingent option</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> exercise payments and additional payments based on GSK&#8217;s achievement of certain development, regulatory and commercial objectives. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We are also eligible to receive up to $60 million if aggregate worldwide annual net sales milestones are achieved and tiered royalties ranging from the mid&#8211;single digit to mid-teens on sales of any products originating from the collaboration. We have retained an option to co-develop and co-promote one product under this agreement.</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We received an initial payment of $10 million in 2008. The deliverables under this arrangement did not have stand-alone value and so did not qualify as separate units of accounting. In 2011, we earned and recognized $12 million in substantive development milestone payments related to the initiation o</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">f Phase I and proof-of-mechanism clinical trials of DV1179 in systemic lupus erythematosus patients. In 2011, we earned and recognized $3 million in substantive development milestone payments related to the initiation of development of the TLR 8 program. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Revenue from the initial payment from GSK was deferred and is being recognized over the expected period of performance under the agreement, initially estimated to be seven years. In the fourth quarter of 2013 we ree</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">valuated and revised the expected period of performance under the agreement from seven years to six years resulting in the recognition of $0.3 million of additional revenue in 2013. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The following table summarizes the revenues recognized under our agreement with GSK (in thousands):</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31,</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:67%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Initial payment</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,702</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,428</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,428</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Milestone revenue</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,000</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,702</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,428</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,428</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">As of December 31, 2013 and 2012, deferred revenue relating to the initial payment was $2.5 million and $4.2 million, respectively. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Absent early termination, the agreement will expire when all of GSK&#8217;s payment obligations expire. Either party may terminate the agreement early upon written notice if the other party commits an uncured material breach of the agreement. Either party may terminate the agreement in the event of insolvency of the other party. GSK also has the option to terminate the agreement without cause upon prior written notice within a specified window of time dependent upon the stage of clinical development of the progra</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ms. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:2.67%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">AstraZeneca </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In September 2006, we entered into a three-year research collaboration and license agreement with AstraZeneca for the discovery and development of TLR 9 agonist-based therapies for the treatment of asthma and chronic obstructive pulmonary disease.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In October 2011, we amended our agreement with AstraZeneca to provide that we will conduct initial clinical development of AZD1419. Under the terms of the amended agreement, AstraZeneca will fund all program expenses to cover the cost of development activities through Phase 2a, estimated to total approximately $20 million. We received an initial payment of $3 million to begin the clinical development program. In the first quarter of 2012, we received a $2.6 million payment to advance AZD1419 into </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">preclinical toxicology studies and these toxicology studies were completed in the third quarter of 2012. We and AstraZeneca have agreed to advance AZD1419 towards a Phase 1 clinical trial, which resulted in a development funding payment of $6 million, received in the fourth quarter of 2012. If AstraZeneca chooses to advance the program following completion of Phase 2a, we will receive a $20 million milestone payment and AstraZeneca will retain its rights to develop the candidate therapy and to commercialize the resulting asthma product. We are eligible to receive additional milestone payments, which we have determined to be substantive milestones, of up to approximately $100 million, based on the achievement of certain development and regulatory objectives. Additionally, upon commercialization, we are eligible to receive tiered royalties ranging from the mid to high single-digits based on product sales of any products originating from the collaboration. We have the option to co-promote in the United States products arising from the collaboration, if any. AstraZeneca has the right to sublicense its rights upon our prior consent. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Revenue from the initial payment was deferred and is being recognized over the expected period of performance under the agreement, which is approximately 50 months. Revenue from the development funding payment is being recognized as the development work is performed.</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">  </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The following table summarizes the revenues earned under our agreement with AstraZeneca (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31,</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:67%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Initial payments</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">720</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">720</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">120</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Performance of research activities</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,507</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,462</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">642</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,227</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,182</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">762</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">As of December 31, 2013 and 2012, total deferred revenue from the initial payment and development funding payments was $4.8 million and $7.7 million, respectively.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-weight:bold;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Absent early termination, the agreement will expire when all of AstraZeneca&#8217;s payment obligations expire. AstraZeneca has the right to terminate the agreement at any time upon prior written notice and either party may terminate the agreement early upon written notice if the other party commits an uncured material breach of the agreement. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:2.67%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;text-indent:2.67%">National Institutes of Health (&#8220;NIH&#8221;) and Other Funding </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We have been awarded various grants from the NIH and the NIH&#8217;s National Institute of Allergy and Infectious Disease (&#8220;NIAID&#8221;) in order to fund research. The awards are related to specific research objectives and we earn revenue as the related research expenses are incurred. We have earned revenue during the periods ended December&#160;31, 2013 and 2012 from the follo</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">wing awards:</font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">September 2013, NIH awarded us $0.2 million to fund research in developing TLR antagonists for therapy of hepatic fibrosis and cirrhosis.</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">June 2012, NIH awarded us $0.6 million to fund research in screening for inhibitors of TLR 8 for treatment of autoimmune diseases. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">May 2012, NIH awarded us $0.4 million to fund development of TLR 8 inhibitors for treatment of rheumatoid arthritis. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">July 2011, NIH awarded us $0.6 million to fund research in preclinical models of skin autoimmune inflammation. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">August 2010, NIAID awarded us a grant to take a systems biology approach to study the differences between individuals who do or do not respond to vaccination against the hepatitis B virus. This study will be one of several projects conducted under a grant to the Baylor Institute of Immunology Research in Dallas as part of the Human Immune Phenotyping Centers program. We have been awarded a total of $1.4 million under this grant. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">July 2010, NIH awarded us $0.6 million to explore the feasibility of developing a universal vaccine to prevent infection by human papilloma virus. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">September 2008, NIAID awarded us a five-year $17 million contract to develop our oligonucleotide technology using TLR 9 agonists as vaccine adjuvants. The contract supports adjuvant development for anthrax as well as other disease models.</font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The following table summarizes the revenues recognized under the various arrangements with the NIH and NIAID (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31,</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:67%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">NIAID contracts</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,103</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,571</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,730</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All other NIH contracts</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,035</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">368</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">380</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total grant revenue</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,138</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,939</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,110</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:8pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Net Loss Per Share </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Basic net loss per share allocable to common stockholders</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> is calculated by dividing the net loss allocable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net loss per share allocable to common stockholders is computed by dividing the net loss allocable to common stockholders by the weighted-average number of common shares outstanding during the period and giving effect to all potentially dilutive common shares using the treasury-stock method. For purposes of this calculation, common stock subject to repurchase by us, outstanding stock options, stock awards, warrants and Series B Convertible Preferred Stock are considered to be potentially dilutive common shares and are only included in the calculation of diluted net loss per share allocable to common stockholders when their effect is dilutive. </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="10" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Basic and diluted net loss per share (in thousands, except per share&#160;amounts):</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Numerator:</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(66,720</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(69,949</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(48,597</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Preferred stock deemed dividend</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,469</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss allocable to common stockholders</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(75,189</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(69,949</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(48,597</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%; border-top:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Denominator for basic and diluted net loss per share allocable to common stockholders:</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average common shares outstanding</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">196,275</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">170,469</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">125,101</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic and diluted net loss per share allocable to common stockholders</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.38</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.41</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.39</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Outstanding warrants, stock options, Series B Convertible Preferred Stock</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and stock subject to repurchase by us under stock awards were excluded from the calculation of net loss per share allocable to common stockholders as the effect of their inclusion would have been anti-dilutive. </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding securities not included in diluted net loss per share calculation (in thousands):</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options and stock awards</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,040</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,561</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,101</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Series B Convertible Preferred Stock (as converted to common stock)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43,430</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,464</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,714</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,729</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72,934</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,275</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,830</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:8pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">12.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Preferred Stock, Common Stock and Warrants </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Authorized Shares</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">On May 29, 2013 the stockholders approved an increase in the number of authorized shares of common stock from 250,000,000 to 350,000,000. </font><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The increase in authorized shares was effected pursuant to a Certificate of Amendment to the Sixth Amended and Restate</font><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">d Certificate of Incorporation (the "Certificate of Amendment"), filed with the Secretary of State of the State of Delaware on May 30, 2013.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Preferred Stock Outstanding</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">As of December 31, 2013 there were 5,000,000 shares of preferred stock authorized and 4</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,430 shares outstanding.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In October 2013 the Company sold 43,430 shares of $0.001 par value Series B Convertible Preferred Stock for a purchase price of $1,075 per share and gross proceeds of approximately $46.7 million in an underwritten public offering. After issuance costs of approximately $2.5 million, the net proceeds from the offering were approximately $44.2 million.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Each share of Series B Convertible Preferred Stock is convertible into 1,000 shares of common stock at any time at the holder&#8217;s option. However, the holder is prohibited from converting the Series B Convertible Preferred Stock into shares of common stock if, as a result of such conversion, the holder and its affiliates would own more than 9.98% of the total number of shares of common sto</font><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ck then issued and outstanding. In the event of the Company&#8217;s liquidation, dissolution, or winding up, holders of Series B Convertible Preferred Stock will receive a payment equal to $0.001 per share before any proceeds are distributed to the common stockholders. Shares of Series B Convertible Preferred Stock generally have no voting rights, except as required by law and except that the consent of holders of a majority of the outstanding Series B Convertible Preferred Stock is required to amend the terms of the Series B Convertible Preferred Stock. Holders of Series B Convertible Preferred Stock are not entitled to receive any dividends, unless and until specifically declared by the</font><font style="color:#000000;font-size:13.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Company&#8217;s board of directors. The Series B Convertible Preferred Stock ranks senior to the Company&#8217;s common stock as to distributions of assets upon the Company&#8217;s liquidation, dissolution or winding up, whether voluntarily or involuntarily. The Series B Convertible Preferred Stock may rank senior to, on parity with or junior to any class or series of the Company&#8217;s capital stock created in the future depending upon the specific terms of such future stock issuance.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:13.5pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The fair value of the common stock into which the Series B Convertible Preferred Stock is convertible exceeded the allocated purchase price of the Series B Convertible Preferred Stock by $8.5 million on the date of issuance, for which the Company recorded a deemed dividend. The Company recognized the deemed dividend equal to the number of shares of Series B Convertible Pref</font><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">erred Stock sold on October 30, 2013 multiplied by the difference between the value of the common stock and the Series B Convertible Preferred Stock conversion price per share on that date. The dividend was reflected as a one-time, non-cash, deemed dividend to the holders of Series B Convertible Preferred Stock on the date of issuance, which is the date the stock first became convertible.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-weight:bold;;font-size:13.5pt;;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;text-indent:4.54%">Preferred Stock Rights </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-weight:bold;;font-size:13.5pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">On November&#160;4, 2008, our Board of Directors declared a dividend of one preferred share purchase right (a &#8220;Right&#8221;) for each outstanding share of our Common Stock, par value $0.001 per share (the &#8220;Common Shares&#8221;). The dividend was payable on November&#160;17, 2008 to the stockholders of record on that date. Each Right entitles the registered holder to purch</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ase from us one one-hundredth of a share of Series A Junior Participating Preferred Stock, par value $0.001 per share (the &#8220;Preferred Shares&#8221;), at a price of $6.00 per one one-hundredth of a Preferred Share, subject to adjustment. Upon the acquisition of, or announcement of the intent to acquire, 20 percent or more of our outstanding Common Shares by a person, entity or group of affiliated or associated persons (&#8220;Acquiring Person&#8221;), each holder of a Right, other than Rights held by the Acquiring Person, will have the right to purchase that number of Common Shares having a market value of two times the exercise price of the Right. If we are acquired in a merger or other business combination transaction or 50 percent or more of our assets or earning power are sold to an Acquiring Person, each holder of a Right will thereafter have the right to purchase, at the then current exercise price of the Right, that number of shares of common stock of the acquiring company which at the time of such transaction will have a market value of two times the exercise price of the Right. The Rights plan is intended to maximize the value of the Company in the event of an unsolicited attempt to take over the Company in a manner or on terms not approved by the Company&#8217;s Board of Directors. The Rights will expire on November&#160;17, 2018, unless the Rights are earlier redeemed or exchanged by the Company. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Common Stock Outstanding</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In October 2013 we completed an underwritten public offering of 79,57</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0,000 shares of our common stock to the public at $1.075 per share. The gross proceeds to us from this offering were approximately $85.5 million. After deducting issuance costs of approximately $4.5 million, the net proceeds from the offering were approximately $80.9 million.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">On March&#160;29, 2013, we entered into an At Market Issuance Sales Agreement (the &#8220;Agreement&#8221;) with MLV&#160;&amp; Co. LLC (&#8220;MLV&#8221;) under which we may offer and sell our common stock having aggregate sales proceeds of up to $50,000,000 from time to time through MLV as our sales agent. Sales of our common stock through MLV, if any, will be made by means of ordinary brokers&#8217; transactions on the NASDAQ Capital Market or otherwise at market prices prevailing at the time of sale, in block transactions, or as o</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">therwise agreed upon by us and MLV. MLV will use commercially reasonable efforts to sell our common stock from time to time, based upon instructions from us (including any price, time or size limits or other customary parameters or conditions we may impose). We will pay MLV a commission of up to 3.0% of the gross sales proceeds of any common stock sold through MLV under the Agreement. No sales of our common stock have taken place under this Agreement as of December&#160;31, 2013. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">On May&#160;9, 2012, we completed an underwritten public offering of 17,500,000 shares of our common stock to the public at $4.25 per share. The net proceeds to us from this offering were $69.6 million, after deducting offering expenses. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">On November&#160;3, 2011, we completed an underwritten public offering of 27,600,000 shares of our common stock including 3,600,000 shares sold pursuant to the full exercise of an overallotment option previously granted to the underwriters at a price to the public of $2.50 per share. The net proceeds to us from t</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">his offering were $64.5 million, after deducting offering expenses. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:13.5pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">On November&#160;2, 2010, we completed an underwritten public offering of 26,450,000 shares of our common stock including 3,450,000 shares sold pursuant to the full exercise of an overallotment option previously granted to the underwriters at a price to the public of $1.70 per share. The net proceeds to us from this offering were $42.0 million, after deducting offering expenses.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:13.5pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">On September&#160;20, 2010, we entered into a Purchase Agreement with Aspire Capital, which provided that, upon the terms and subject to the conditions and limitations set forth therein, Aspire Capital was committed to purchase up to an aggregate of $30.0 million of shares of our common stock (the &#8220;Purchase Shares&#8221;) over the </font><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25-month term of the Purchase Agreement. Under the Purchase Agreement, we agreed to pay Aspire Capital a commitment fee equal to 4% of $30 million in consideration for Aspire Capital&#8217;s obligation to purchase up to $30 million of our common stock. We paid this commitment fee of $1.2 million by the issuance of 600,000 shares of our common stock and this fee was recorded as a cost of raising capital and netted against the gross proceeds from the Purchase Agreement in September 2010. During 2010, we sold 2,350,000 shares of common stock to Aspire Capital for $3.3 million and during 2011 we sold 10,995,210 shares of common stock for $26.7 million, which totaled the proceeds available to us of $30 million under the Purchase Agreement.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">On April&#160;16, 2010, we completed an underwritten public offering resulting in net proceeds of $41.1 million, after deducting offering expenses of approximately $3.0 million, from the sale of 30,293,000 units at a per unit price of $1.4525. Each unit consisted of one share of common sto</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ck and one warrant to purchase 0.5 of a share of common stock. Each warrant has an exercise price of $1.50 per share, and is exercisable for a period of five years from the date of issuance. From this offering, warrants to purchase an aggregate of 10,913,873 shares of our common stock were outstanding as of December&#160;31, 2013 (including the warrants to purchase 6,765,128 shares provided to Symphony as described in Note 8 &#8220;Symphony Dynamo, Inc.&#8221;). </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Warrants </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In connection with a 2007 loan agreement that was subsequently terminated in 2008, we issued warrants to purchase up to </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,550,000 shares of our common stock as follows: </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:39%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Warrant Issuance Date</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Shares Issuable <br>(in thousands)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Expiration <br>Date</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price <br>per Share</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding as of <br>December 31, 2013 <br>(in thousands)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:39%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">July 18, 2007</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,250</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2/26/2014</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.13</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:15%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,250</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:39%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">October 18, 2007</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,300</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2/26/2014</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.68</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:15%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:39%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December 27, 2007</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">300</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2/26/2014</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.65</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:15%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">300</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:39%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December 27, 2007</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">700</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:12%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2/26/2014</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:12%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.68</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:15%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:39%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,550</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:12%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:12%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:15%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,550</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:6pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:6pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">As of December&#160;31, 2013, warrants to purchase an aggregate of approximately 12,500,000 shares of our common stock were outstanding. The warrants are exercisable </font><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">at a weighted average price of $1.96 per share</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. During the years ended December&#160;31, 2013, and 2012, warrants were exercised to purchase an aggregate of approximately 250,000 and 13,000,000 shares, respectively, of our common stock. </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">13.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Equity Plans and Stock-Based Compensation</font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stock Plans </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">As of December&#160;31, 2013, we had three share-based compensation plans. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:9.06%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">2004 Stock Incentive Plan (&#8220;2004 Plan&#8221;) </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The 2004 Plan was adopted in January 2004 by the Board of Directors and stockholders and became effective on February&#160;11, 2004. This plan provided for the issuance of up to 3,500,000 shares of our common stock plus an annual increase. Subsequently, we discontinued granting stock options under the 1997 Plan. Options under the 2004 Plan were granted for periods of up to ten years and the exercise price of all stock options granted under the 2004 Plan was at least equal to 100% of the fair market value of the common stock on the date of grant. If, however, incentive stock options were granted to an employee who owns stock possessing more than 10% of the voting power of all classes of the Company&#8217;s stock or the stock of any parent or subsidiary of the Company, the exercise price of any incentive stock option granted must equal at least 110% of the fair market value on the grant date and the maximum term of these incentive stock options must not exceed five years. The maximum term of an incentive stock option granted to any other participant must not exceed ten years. The 2004 Plan authorizes the issuance of various forms of stock-based awards including stock options, restricted stock, restricted stock units and other equity awards to employees, consultants and members of the board of directors. As of December&#160;31, 2013, options to purchase 4,066,277 shares of common stock remained outstanding under the 2004 Plan.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:9.06%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">2010 Employment Inducement Award Plan (&#8220;Inducement Plan&#8221;) </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The Inducement Plan was adopted in January 2010 by our Board of Directors to induce qualified individuals to join Dynavax. This Inducement Plan provided for the issuance of up to 1,500,000 shares of our common stock and became effective on January&#160;8, 2010. Stockholder approval of the Inducement Plan is not required under NASDAQ Marketplace Rule 5635(c)(4). As of December&#160;31, 2013, options to purchase 743,625 shares of common stock</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> remained outstanding under the Inducement Plan. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:9.06%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">2011 Equity Incentive Plan (&#8220;2011 Plan&#8221;) </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The 2011 Plan was approved by the Company&#8217;s stockholders and adopted in January 2011. On May 29, 2013, the stockholders of the Company approved an amendment to the 2011 Plan to increase the number of shares of common stock authorized for issuance under the plan by 10,000,000. The 2011 Plan, as amended, provides for the issuance of up to 25,000,000 shares of our common stock to employees and non-employees of the Compa</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ny and became effective on January&#160;6, 2011. The 2011 Plan is administered by our Board of Directors, or a designated committee of the Board of Directors, and awards granted under the 2011 Plan have a term of 10&#160;years unless earlier terminated by the Board of Directors. After the adoption of the 2011 Plan, no additional awards were granted under either the 2004 Plan or the Inducement Plan. As of January&#160;6, 2011, all shares subject to awards outstanding under the 2004 Plan and Inducement Plan that expire or are forfeited will be included in the reserve for the 2011 Plan to the extent such shares would otherwise return to such plans. As of December&#160;31, 2013, options to purchase 10,954,940 shares of common stock remained outstanding under the 2011 Plan. As of December&#160;31, 2013, there were 13,666,964&#160;shares of common stock reserved for issuance under the 2011 Plan.&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Activity under our stock plans is set forth below: </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52.08%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.18%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:11.5%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Shares Underlying&nbsp;&nbsp;Outstanding Options (in thousands)</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.18%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:14.3%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted-Average Exercise Price&#160;Per&#160;Share</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.18%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9.3%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted-Average Remaining Contractual Term (years)</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.18%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:10.8%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Aggregate Intrinsic Value (in thousands)</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52.08%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December&#160;31, 2012</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.18%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1.08%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:10.42%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,806</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.72%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.18%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1.02%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:13.26%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.38</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.18%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.18%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1.04%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8.26%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.18%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.18%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1.02%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9.76%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.18%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52.08%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options granted</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.18%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1.08%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:10.42%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,614</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.72%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.18%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1.02%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:13.26%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.69</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.18%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.18%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1.04%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8.26%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.18%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.18%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1.02%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9.76%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.18%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52.08%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercised</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.18%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1.08%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:10.42%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(131</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.72%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.18%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1.02%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:13.26%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.43</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.18%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.18%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1.04%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8.26%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.18%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.18%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1.02%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9.76%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.18%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52.08%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options cancelled:</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.18%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1.08%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:10.42%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.72%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.18%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1.02%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:13.26%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.18%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.18%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1.04%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8.26%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.18%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.18%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1.02%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9.76%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.18%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52.08%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options forfeited (unvested)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.18%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1.08%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:10.42%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,555</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.72%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.18%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1.02%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:13.26%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.31</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.18%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.18%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1.04%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8.26%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.18%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.18%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1.02%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9.76%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:0.18%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52.08%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options cancelled (vested)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.18%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1.08%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:10.42%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(969</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.18%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:13.26%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.34</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.18%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1.04%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:8.26%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.18%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1.02%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:9.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52.08%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December&#160;31, 2013</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.18%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1.08%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:10.42%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,765</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.72%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.18%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1.02%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:13.26%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.17</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.18%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.18%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1.04%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8.26%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.26</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.18%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.18%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1.02%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9.76%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,427</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.18%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52.08%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested and expected to vest at December 31, 2013</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.18%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1.08%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:10.42%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,765</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.72%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.18%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1.02%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:13.26%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.17</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.18%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.18%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1.04%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8.26%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.26</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.18%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.18%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1.02%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,427</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.18%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52.08%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercisable at December 31, 2013</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.18%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1.08%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:10.42%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,628</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.72%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.18%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1.02%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:13.26%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.36</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.18%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.18%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1.04%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8.26%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.61</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.18%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.18%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1.02%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,289</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:0.18%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:6pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:6pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The total intrinsic value of stock options exercised during the years ended December&#160;31, 2013, 2012 and 2011 was, $0.3 million, $2.7 million and $0.1 million, respectively. The total intrinsic value of exercised stock options is calculated based on the difference between the exercise price and the quoted market price of our common stock as of the close of the exercise date. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The total fair value of stock options vested during the years ended December&#160;31, 2013, 2012 and 2011 was, $1</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.1 million, $9.6 million and $2.8 million, respectively. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our non-vested stock awards are comprised of restricted stock units granted with performance-based vesting criteria. A summary of the status of non-vested restricted stock units as of December&#160;31, 2013, and activities during 2013 is summarized as follows: </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Number of Shares (In&#160;thousands)</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted-Average Grant-Date&#160;Fair Value</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-vested as of December 31, 2012</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,755</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.23</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">250</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.23</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(115</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.10</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited or expired</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(615</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.23</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-vested as of December 31, 2013</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,275</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.93</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:6pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:6pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Stock-based compensation expense related to restricted stock units was approximately $0.1 million for the year ended December&#160;31, 2013. The aggregate intrinsic value of the restricted stock units outstanding as of December&#160;31, 2013, based on our stock price on that date, was $2.5 million. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">61</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The weighted average grant-date fair value of restricted stock units granted during the years ended December&#160;31, 2013 and 2012 was, $1.23 and $4.23, respectively. No restricted stock units were granted during 2011. The total fair value of restricted stock units vested during the years ended December&#160;31, 2013,</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> 2012, and 2011 was, $0.1 million, $0.2 million, and $0.8 million, respectively. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stock-Based Compensation </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Under our stock-based compensation plans, option awards generally vest over a four-year period contingent upon continuous service and expire ten years from the date of grant (or earlier upon termination of continuous service). The Company has also granted performance-based equity awards to certain of our employees under the 2011 Plan, the 2004 Plan and the Inducement Plan. As of December&#160;31, </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2013, 1,922,466 shares were outstanding related to options and restricted stock units subject to these performance-based vesting criteria. The fair value of each option is estimated on the date of grant using the Black-Scholes option valuation model and the following weighted-average assumptions: </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:35%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Stock&#160;Options</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Employee&#160;Stock Purchase&#160;Plan</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:35%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:35%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:35%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average fair value</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.41</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.30</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.76</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.93</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.54</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.09</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:35%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.5</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.3</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.2</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.2</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.3</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:35%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected life (in years)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.9</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.2</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.0</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.3</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.2</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:35%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Volatility</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.4</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.6</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.6</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.8</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.6</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.6</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Expected volatility is based on historical volatility of our stock price. The expected life of options granted is estimated based on historical option exercise and employee termination data, while giving consideration to options that have not yet completed a full life cycle. Our senior management, who hold a majority of the options outstanding, and other employees were grouped and considered separately for v</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">aluation purposes. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant. The dividend yield is zero percent for all years and is based on our history and expectation of dividend payouts. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Compensation expense is based on awards ultimately expected to vest and reflects estimated forfeitures. For equity awards with time-based vesting, the fair value is amortized to expense on a straight-line basis over the vesting periods. For equity awards with performance-based vesting criteria, the fair value is amortized to expense when the achievement of the vesting criteria becomes probable. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We recognized the following amounts of stock-based compensation expense (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employees and directors stock-based compensation expense</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,828</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,439</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,185</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-employees stock-based compensation expense</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">512</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,340</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,439</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,189</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%; border-top:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,228</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,514</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,103</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,112</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,925</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,086</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,340</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,439</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,189</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Stock based compensation expense recognized in 2013 and 2012 includes $4.9 million related to employee severance arrangements and $0.5 million for awards to non-employees for the year ended December 31, 2013 and $1.5 million related to employee severance arrangements for the same period in 2012. During the year ended December 31, 2013, we recognized $1.3 million in additional stock-based compensation expense due to the modification of the terms of stock options for</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> five employees. During the year ended December 31, 2012, we recognized $0.7 million in additional stock-based compensation expense due to the modification of the terms of stock options for one employee.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">As of December&#160;31, 2013, the total unrecognized compensation cost related to non-vested stock options deemed probable of vesting, including all stock options with time-based vesting, net of estimated forfeitures, amounted to $10.3 million, which is expected to be recognized over the remaining weighted-avera</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ge vesting period of 2.8 years. As of December&#160;31, 2013, the total unrecognized compensation cost related to non-vested stock options not deemed probable of vesting, net of estimated forfeitures, amounted to $3.8 million. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">As of December&#160;31, 2013, the total unrecognized compensation cost related to shares of our common stock under the Purchase Plan, amounted to $0.1 million, which is expected to be recognized over the remaining weighted-average vesting period of 1.4 years. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Employee Stock Purchase Plan </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In January 2004, the Board of Directors and stockholders adopted the 2004 Employee Stock Purchase Plan (the &#8220;Purchase Plan&#8221;). The Purchase Plan provides for the purchase of common stock by eligible employees and became effective on February&#160;11, 2004. The purc</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">hase price per share is the lesser of (i)&#160;85% of the fair market value of the common stock on the commencement of the offer period (generally, the fifteenth day in February or August) or (ii)&#160;85% of the fair market value of the common stock on the exercise date, which is the last day of a purchase period (generally, the fourteenth day in February or August). </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">As of December&#160;31, 2013, 996,000 shares were approved for issuance under the Purchase Plan, subject to adjustment for a stock split, or any future stock dividend or other similar change in our common stock or capital structure. To date, employees have acquired 828,414 shares of our common stock under the Purchase Plan. As of December&#160;31, 2013, 167,586 shares of our common stock remained available for fu</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ture purchases.</font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">14.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Employee Benefit Plan </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We maintain a 401(k) Plan, which qualifies as a deferred salary arrangement under Section&#160;401(k) of the Internal Revenue Code. Under the 401(k) Plan, participating employees may defer a portion of their pretax earnings. We may, at our discretion, contribute for the benefit of eligible employees. To date, we have not contributed to the 401(k) Plan</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">15.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Income Taxes </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Consolidated income (loss) before provision for income taxes consisted of the following (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S.</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(67,004</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(70,792</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(49,990</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non U.S.</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">284</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">843</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,393</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(66,720</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(69,949</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(48,597</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">63</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">No income tax expense was recorded for the years ended December&#160;31, 2013, 2012 and 2011 due to net operating loss carryforwards to offset the net income at Dynavax Europe and a valuation allowance which offsets the deferred tax assets. The difference between the consolidated income tax benefit and the amount computed by applying the federal statutory income tax rate to the consolidated loss before income taxes was as follows (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax benefit at federal statutory rate</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(22,678</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(23,650</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(16,523</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State tax</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(178</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(89</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,586</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Business credits</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,515</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,394</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred compensation charges</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,072</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,002</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">595</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in valuation allowance</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,354</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,966</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,099</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in foreign tax rates</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(34</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in the fair value measurements</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">286</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-deductible debt discount</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">509</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deemed dividend</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">273</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prior year true up</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(55</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">771</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">775</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total income tax expense</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Deferred tax assets and liabilities as of December&#160;31, 2013 and 2012 consisted of the following (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax assets:</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net operating loss carry forwards</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">147,655</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">127,529</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research tax credit carry forwards</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,336</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,163</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accruals and reserves</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,501</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,529</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Capitalized research costs</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,662</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,757</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,486</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,180</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,222</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,221</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">192,862</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">170,379</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less valuation allowance</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(192,733</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(170,232</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred tax assets</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">129</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">147</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax liabilities:</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fixed Assets</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(162</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(86</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(61</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred tax liabilities</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(129</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(147</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred tax assets</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The tax benefit of net operating losses, temporary differences and credit carryforwards is required to be recorded as an asset to the extent that management assesses that realization is &#8220;more likely than not.&#8221; Realization of the future tax benefits is dependent on our ability to generate sufficient taxable income within the carryforward period. Because of our recent history of operating losses, management believes that reco</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">gnition of the deferred tax assets arising from the above-mentioned future tax benefits is currently not likely to be realized and, accordingly, has provided a full valuation allowance. The valuation allowance increased by $22.5 million, $22.0 million and $18.1 million during the years ended December&#160;31, 2013, 2012 and 2011, respectively. The amount of the valuation allowance for deferred tax assets associated with excess tax deductions from stock based compensation arrangements that will be allocated to contributed capital if the future tax benefits are subsequently recognized is $0.3 million. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We have not recorded deferred income taxes applicable to undistributed earnings of a foreign subsidiary that are indefinitely reinvested in foreign operations. Generally, such earnings become subject to U.S. tax upon the remittance of dividends and under certain other circumstances. It is not practicable to estimate the amount of the deferred tax liability on such undistributed earnings. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">As of December&#160;31, 2013, we had federal net operating loss carryforwards of approximately $3</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">84.1 million, which will expire in the years 2018 through 2033 and federal research and development tax credits of approximately $13.8 million, which expire in the years 2018 through 2033. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">As of December&#160;31, 2013, we had </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">potential net operating loss carryforwards for California state income tax purposes of approximately $219.7 million, which expire in the years 2014 through 2033, and California state research and development tax credits of approximately $11.5 million which do not expire. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">As of December&#160;31, 2013, we had net operating loss carryforwards for foreign income tax purposes of approximately $27</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.8 million, which do not expire. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The Tax Reform Act of 1986 limits the annual use of net operating loss and tax credit carryforwards in certain situations where changes occur in stock ownership of a company. In the event the Company has a change in ownership, as defined, the annual utilization of such carryforwards could be limited. Due to past e</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">quity issuances and changes in ownership of Dynavax common stock, we believe that our ability to use some of our net operating losses and tax credits in the future may be limited. </font></p><p style="margin-bottom:0pt;margin-top:8pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">16.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Selected Quarterly Financial Data (Unaudited; in thousands, except per share amounts) </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="14" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31, 2013</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Q1</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Q2</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Q3</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Q4</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenues</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,085</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,392</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,927</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,847</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net&#160;loss</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20,825</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,164</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,675</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(13,056</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss allocable to common stockholders</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20,825</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,164</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,675</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(21,525</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic and diluted net loss per share allocable to common stockholders</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.11</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.09</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.09</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.09</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares used to compute basic and diluted net loss per share allocable to common stockholders</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">182,847</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">182,913</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">183,022</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">235,879</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="14" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31, 2012</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Q1</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Q2</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Q3</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Q4</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenues</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,350</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,684</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,874</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,806</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net&#160;loss</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(16,505</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,110</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,791</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20,543</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss allocable to common stockholders</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(16,505</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,110</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,791</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20,543</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic and diluted net loss per share allocable to common stockholders</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.11</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.09</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.10</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.11</font></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares used to compute basic and diluted net loss per share allocable to common stockholders</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">155,431</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">167,697</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">177,870</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">180,685</font></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC"style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:8pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:11.33%;margin-right:0%;text-indent:-11.33%;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">17. Subsequent Events</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In March, 2014 we announced a $5.4</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million milestone payment and amendment of our AstraZeneca agreement to transfer responsibility for all clinical development to AstraZeneca following conclusion of the ongoing Phase 1 clinical trial of AZD1419. </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:10pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:11.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_9"></a>I</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TEM&#160;9.</font></p></td><td valign="top" style="width:88.67%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_9"></a>CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">None.</font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:11.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_9A"></a>I</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TEM</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">9A.</font></p></td><td valign="top" style="width:88.67%;"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_9A"></a>CONTROLS AND PROCEDURES </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(a) Evaluation of Disclosure Controls and Procedures </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We maintain disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (&#8220;the Exchange Act&#8221;)) that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the time periods specified in the Securities and Exchange Commission rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Principal Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can only provide reasonable, not absolute, assurance of achieving the desired control objectives. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Based on their evaluation as of the end of the period covered by this report, our management, with the participation of our Chief Executive Officer and our Principal Financial Officer, concluded that our disclosure controls and procedures are effective at the reasonable assurance level to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> within the time periods specified in the Securities and Exchange Commission rules and forms. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(b) Management&#8217;s Annual Report on Internal Control Over Financial Reporting </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Our management, with the participation of our Chief Executive Officer and Principal Financial Officer, conducted an evaluation of the effectiveness of our</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> internal control over financial reporting based on the framework in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (1992 Framework). Based on that evaluation, our management concluded that our internal control over financial reporting was effective as of December&#160;31, 2013. The Company&#8217;s independent registered public accountants, Ernst&#160;&amp; Young LLP, audited the consolidated financial statements included in this Annual Report on Form 10-K and have issued an attestation report on the Company&#8217;s internal control over financial reporting. The report on the audit of internal control over financial reporting appears below. </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:10pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Report of Independent Registered Public Accounting Firm </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Board of Directors and Stockholders of Dynavax Technologies Corporation </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We have audited Dynavax Technologies Corporation&#8217;s internal control over financial reporting as of December&#160;31, 2013, based on criteria established in </font><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Internal Control&#8212;Integrated </font><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Framework</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> issued by the Committee of Sponsoring Organizations of the Treadway Commission (1992 Framework) (the COSO criteria). Dynavax Technologies Corporation&#8217;s management is responsible for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management&#8217;s Annual Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakne</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ss exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1)&#160;pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the tra</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">nsactions and dispositions of the assets of the company; (2)&#160;provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3)&#160;provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In our opinion, Dynavax Technologies Corporation maintained, in all material respects, effective internal control over financial reporting as of December&#160;31, 2013, based on the COSO criteria. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets of Dynavax Technologies Corporation as of December&#160;31, 2013 and 2012, and the related consolidated statements of operations, comprehensive loss, stockholders&#8217; equity, and cash flows for each of the three years in the p</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">eriod ended December&#160;31, 2013 of Dynavax Technologies Corporation and our report dated March 10, 2014 expressed an unqualified opinion thereon. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Ernst&#160;&amp; Young LLP </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Redwood City, California </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 10, 2014 </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">67</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(c)&#160;Changes in Internal Control Over Financial Reporting </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">There has been no change in our internal control over financial reporting during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:11.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_9B"></a>I</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TEM</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">9B.</font></p></td><td valign="top" style="width:88.67%;"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_9B"></a>OTHER INFORMATION </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">None. </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:10pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">68</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">PART III </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:11.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_10"></a>I</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TEM</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">10.</font></p></td><td valign="top" style="width:88.67%;"><p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_10"></a>DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Information required by this Item is incorporated by reference to the sections entitled &#8220;Proposal 1&#8212;Elections of Directors,&#8221; &#8220;Executive Officers,&#8221; &#8220;Corporate Governance&#8221; and &#8220;Section 16(a) Beneficial Ownership Reporting Compliance&#8221; in our Definitive Proxy Statement in connection with the 2014 Annual Meeting of Stockholders (the &#8220;Proxy Statement&#8221;)</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> which will be filed with the Securities and Exchange Commission within 120 days after the fiscal year ended December&#160;31, 2013. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We have adopted the Dynavax Code of Conduct, a code of ethics that applies to our employees, including our Chief Executive Officer, Principal Financial Officer and to our non-employee directors. </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Code of Conduct is publicly available on our website under the Investor Relations section at www.dynavax.com. This website address is intended to be an inactive, textual reference only; none of the material on this website is part of this report. If any substantive amendments are made to the Code of Conduct or any waiver granted, including any implicit waiver, from a provision of the Code of Conduct to our Chief Executive Officer or Principal Financial Officer, we will disclose the nature of such amendment or waiver on that website or in a report on Form 8-K. We will provide a written copy of the Dynavax Code of Conduct to anyone without charge, upon request written to Dynavax, Attention: Corporate Secretary, 2929 Seventh Street, Suite 100, Berkeley, CA 94710-2753, (510)&#160;848-5100. </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:11.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_11"></a>I</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TEM&#160;11.</font></p></td><td valign="top" style="width:88.67%;"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_11"></a>EXECUTIVE COMPENSATION </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Information required by this Item is incorporated by reference to the section entitled &#8220;Executive Compensation,&#8221; &#8220;Director Compensation,&#8221;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> &#8220;Compensation Discussion and Analysis,&#8221; &#8220;Report of the Compensation Committee of the Board of Directors,&#8221; and &#8220;Compensation Committee Interlocks and Insider Participation&#8221; in the Proxy Statement. </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:11.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_12"></a>I</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TEM&#160;12.</font></p></td><td valign="top" style="width:88.67%;"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_12"></a>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Information regarding security ownership of certain beneficial owners and management is incorporated by reference to the section entitled &#8220;Security Ownership of Certain Beneficial Owners and Management&#8221; in the Proxy Statement. Information regarding our stockholder approved and non-approved equity compensation plans are incorporated by reference to the section entitled &#8220;Equity Compensation Plans&#8221; in the Proxy Statement. </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:11.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_13"></a>I</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TEM</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">13.</font></p></td><td valign="top" style="width:88.67%;"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_13"></a>CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Information required by this Item is incorporated by reference to the sections entitled &#8220;Transactions with Related Persons&#8221; and &#8220;Independence of the Board of Directors&#8221; in the Proxy Statement. </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:11.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_14"></a>I</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TEM</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">14.</font></p></td><td valign="top" style="width:88.67%;"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_14"></a>PRINCIPAL ACCOUNTING FEES AND SERVICES </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Information required by this Item is incorporated by reference to the section entitled &#8220;Audit Fees&#8221; in the Proxy Statement. </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:10pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:24pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">PART IV </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:11.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_15"></a>I</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TEM</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">15.</font></p></td><td valign="top" style="width:88.67%;"><p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="ITEM_15"></a>EXHIBITS, FINANCIAL STATEMENT SCHEDULES </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:4.53%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(a) Documents filed as part of this report: </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:4.53%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1. Financial Statements </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:6.8%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Report of Independent Registered Public Accounting Firm </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:6.8%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Consolidated Balance Sheets </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:6.8%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Consolidated Statements of Operations </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:6.8%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Consolidated Statements of Comprehensive Loss </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:6.8%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Consolidated Statements of Stockholders&#8217; Equity </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:6.8%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Consolidated Statements of Cash Flows </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:6.8%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Notes to Consolidated Financial Statements </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:4.53%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2. Financial Statement Schedules </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">None, as all required disclosures have been made in the Consolidated Financial Statements and notes thereto or are not applicable. </font></p><p style="margin-bottom:0pt;margin-top:8pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:4.53%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(b) Exhibits</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:12.88%; border-bottom:solid 1pt #000000;white-space:nowrap;"><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit<br>Number</font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="padding-left:0.7 pt;padding-Right:0.7 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:86.44%; border-bottom:solid 1pt #000000;"><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Document</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.1</font><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(</sup><sup style="font-size:85%; vertical-align:top">1</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sixth Amended and Restated Certificate of Incorporation.</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.2</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(1</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amended and Restated Bylaws</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.3</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(2)</sup></font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Form of Certificate of Designation of Series A Junior Participating Preferred Stock</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.4</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(</sup><sup style="font-size:85%; vertical-align:top">3</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certificate of Amendment of Amended and Restated Certificate of Incorporation</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.5</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(</sup><sup style="font-size:85%; vertical-align:top">4</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certificate of Amendment of Amended and Restated Certificate of Incorporation</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.6</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(</sup><sup style="font-size:85%; vertical-align:top">5</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certificate of Amendment of Amended and Restated Certificate of Incorporation</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.7</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(</sup><sup style="font-size:85%; vertical-align:top">6</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certificate of Designation of Series B Convertible Preferred Stock</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.1</font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reference is made to Exhibits 3.1, 3.2, 3.3, 3.4, 3.5, 3.6 and 3.7 above</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.2</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(7</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Registration Rights Agreement, dated as of July 18, 2007, by and between the Company and Deerfield Entities </font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.3</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(7</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Form of Warrant to Purchase Common Stock</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.4</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(</sup><sup style="font-size:85%; vertical-align:top">8</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Form of Specimen Common Stock Certificate</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.5</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(2)</sup></font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Rights Agreement, dated as of November 5, 2008, by and between the Company and Mellon Investor Services LLC</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.6</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(2)</sup></font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Form of Right Certificate</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.7</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(</sup><sup style="font-size:85%; vertical-align:top">9</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Form of Restricted Stock Unit Award Agreement under the 2004 Stock Incentive Plan</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.8</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(</sup><sup style="font-size:85%; vertical-align:top">10</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Form of Warrant to Purchase Common Stock </font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.9</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(1</sup><sup style="font-size:85%; vertical-align:top">1</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Form of Warrant to Purchase Common Stock</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.11</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(6)</sup></font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Form of Specimen Preferred Stock Certificate</font></p></td>
</tr>
</table></div><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><div><table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:12.88%; border-bottom:solid 1pt #000000;white-space:nowrap;"><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit<br>Number</font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="padding-left:0.7 pt;padding-Right:0.7 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:86.44%; border-bottom:solid 1pt #000000;"><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Document</font></p></td>
</tr><tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.30</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(1</sup><sup style="font-size:85%; vertical-align:top">3</sup><sup style="font-size:85%; vertical-align:top">)</sup></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8224;</font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research Collaboration and License Agreement, dated September 1, 2006, by and between the Company and AstraZeneca AB</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.32</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(</sup><sup style="font-size:85%; vertical-align:top">14</sup><sup style="font-size:85%; vertical-align:top">)</sup></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8224;</font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">License Agreement, dated June 26, 2007, between Coley Pharmaceuticals Group, Inc. and the Company </font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.38</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(</sup><sup style="font-size:85%; vertical-align:top">9</sup><sup style="font-size:85%; vertical-align:top">)</sup></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">+</font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Form of Amended Management Continuity Agreement between the Company and certain of its executive officers</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.39&#8224;</font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and Development Collaboration and License Agreement, dated December 15, 2008, between Glaxo Group Limited and the Company</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.40</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(</sup><sup style="font-size:85%; vertical-align:top">15</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amendment No. 2 to the Research Collaboration and License Agreement, dated September 1, 2006, by and between the Company and AstraZeneca AB, dated February 3, 2009</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.43</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(</sup><sup style="font-size:85%; vertical-align:top">17</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Equity Distribution Agreement, dated August&#160;17, 2009, between the Company and Wedbush Morgan Securities, Inc.</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.44</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(1</sup><sup style="font-size:85%; vertical-align:top">8</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amendment to Equity Distribution Agreement, dated September 10, 2009, between the Company and Wedbush Morgan Securities, Inc.</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.47</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(1</sup><sup style="font-size:85%; vertical-align:top">0</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amended and Restated Purchase Option Agreement, dated November 9, 2009, between the Company and Symphony Dynamo Holdings LLC and Symphony Dynamo, Inc.</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.48</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(1</sup><sup style="font-size:85%; vertical-align:top">0</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrant Purchase Agreement, dated as of November 9, 2009, between the Company and Symphony Dynamo Holdings LLC</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.49</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(1</sup><sup style="font-size:85%; vertical-align:top">0</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amended and Restated Registration Rights Agreement, dated as of November 9, 2009, between the Company and Symphony Dynamo Holdings LLC</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.50</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(1</sup><sup style="font-size:85%; vertical-align:top">0</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Standstill and Corporate Governance Agreement, dated as of December 30, 2009, between the Company and Symphony Dynamo Holdings LLC</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.54</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(</sup><sup style="font-size:85%; vertical-align:top">20</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amendment No. 3 to the Research Collaboration and License Agreement, dated September 1, 2006, by and between the Company and AstraZeneca AB, dated September 30, 2010</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.55</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(</sup><sup style="font-size:85%; vertical-align:top">21</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">First Amendment to Lease, dated as of May 21, 2004, between the Company and 2929 Seventh Street, LLC</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.56</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(</sup><sup style="font-size:85%; vertical-align:top">21</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Second Amendment to Lease, dated as of October 12, 2010, between the Company and 2929 Seventh Street, LLC</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.58</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(2</sup><sup style="font-size:85%; vertical-align:top">2</sup><sup style="font-size:85%; vertical-align:top">)</sup></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">+</font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amended and Restated Management Continuity and Severance Agreement, dated as of November&#160;12, 2010, by and between the Company and Dino Dina, M.D.</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.59</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(2</sup><sup style="font-size:85%; vertical-align:top">2</sup><sup style="font-size:85%; vertical-align:top">)</sup></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">+</font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amended and Restated Management Continuity and Severance Agreement, dated as of November&#160;12, 2010 by and between the Company and J. Tyler Martin, M.D.</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.61</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(23)</sup></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">+</font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Form of Amended to Amended Management Continuity Agreement between the Company and certain of its executive officers</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.62</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(24)</sup></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">+</font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2011 Equity Incentive Plan</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.63</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(2</sup><sup style="font-size:85%; vertical-align:top">4</sup><sup style="font-size:85%; vertical-align:top">)</sup></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">+</font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Form of Restricted Stock Unit Award Notice and Restricted Stock Unit Award Agreement under the 2011 Equity Incentive Plan</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.64</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(2</sup><sup style="font-size:85%; vertical-align:top">4</sup><sup style="font-size:85%; vertical-align:top">)</sup></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">+</font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Form of Stock Option Grant Notice and Option Agreement under the 2011 Equity Incentive Plan</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.65</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(2</sup><sup style="font-size:85%; vertical-align:top">5</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Third Amendment to Lease, dated as of April 1, 2011, between the Company and 2929 Seventh Street, LLC</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.66</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(2</sup><sup style="font-size:85%; vertical-align:top">5</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amended and Restated 2004 Non-Employee Director Option Program and Amended and Restated 2005 Non-Employee Director Cash Compensation Program, effective April 14, 2005, and amended April 6, 2011</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.67</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(26</sup><sup style="font-size:85%; vertical-align:top">)</sup></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8224;</font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amendment No. 4 to the Research Collaboration and License Agreement, dated&nbsp;&nbsp;September 1, 2006, by and between AstraZeneca AB and the Company, dated September 23, 2011</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.69</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(2</sup><sup style="font-size:85%; vertical-align:top">7</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amended and Restated 2004 Non-Employee Director Option Program and Amended and Restated 2005 Non-Employee Director Cash Compensation Program, amended April 17, 2012</font></p></td>
</tr>
</table></div><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">71</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><div><table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:12.88%; border-bottom:solid 1pt #000000;white-space:nowrap;"><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit<br>Number</font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="padding-left:0.7 pt;padding-Right:0.7 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:86.44%; border-bottom:solid 1pt #000000;"><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Document</font></p></td>
</tr><tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.70</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(</sup><sup style="font-size:85%; vertical-align:top">28</sup><sup style="font-size:85%; vertical-align:top">)</sup></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> +</font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employment Offer Letter to Christine R. Larson, dated August&#160;1, 2012</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.72</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(29</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fourth Amendment to Lease, dated as of December 14, 2012, between the Company and 2929 Seventh Street, LLC</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.73</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(29</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">New Lease, dated as of December 14, 2012, between the Company and 2929 Seventh Street, LLC</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.74</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(29</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Consulting Agreement, dated as of November&#160;14, 2012, by and between the Company and Stanley A. Plotkin</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.75</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(29</sup><sup style="font-size:85%; vertical-align:top">)</sup></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">+</font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amended and Restated Management Continuity and Severance Agreement, dated October 31, 2012, between the Company and J. Tyler Martin.</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.77</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(30)</sup></font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Consulting Agreement, dated as of March&#160;29, 2013, by and between Solutio Partners and the Company</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.78</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(30</sup></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">+</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Termination letter, dated as of March&#160;29, 2013, by and between Stephen Tuck and the Company</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.79</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(31)</sup></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> +</font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employment Agreement, dated as of April 3, 2013, by and between Eddie Gray and the Company</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.80</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(31)</sup></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> +</font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Management Continuity and Severance Agreement, dated as of April 3, 2013, by and between Eddie Gray and the Company</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.81</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(31)</sup></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> +</font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Consulting Agreement, dated as of May 1, 2013, by and between Dino Dina, M.D. and the Company</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.82</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(32)</sup></font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At Market Issuance Sales Agreement, dated March&#160;29, 2013, by and between the Company and MLV &amp; Co. LLC</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.83</font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amended and Restated 2004 Non-Employee Director Option Program and Amended and Restated 2005 Non-Employee Director Cash Compensation Program, Amended February 4, 2014</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.84+</font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employment Agreement, dated March 21, 2013, by and between David Novack and the Company</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.85+</font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employment Agreement, dated July&#160;11, 2013, by and between Robert Janssen, M.D. and the company </font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.86+</font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employment Agreement, dated February 5, 2014, by and between David L. Johnson and the Company</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.87&#8224;</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top"> </sup></font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amendment No. 1 to the Agreement, dated December 15, 2008, by and between Glaxo Group Limited and the Company, dated December 13, 2013</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.88&#8224;</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top"> </sup></font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amendment No. 5 to the Agreement, dated September 1, 2006, by and between AstraZeneca AB and the Company, dated January 7, 2014</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.1</font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Statement of Computation of Ratio of Earnings to Fixed Charges</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.1</font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">List of Subsidiaries</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23.1</font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Consent of Independent Registered Public Accounting Firm</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31.1</font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31.2</font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32.1*</font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certification of Chief Executive Officer to Section 906 of the Sarbanes-Oxley Act of 2002</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32.2*</font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.INS</font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">XBRL Instance Document</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.SCH</font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">XBRL Taxonomy Extension Schema Document</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.CAL</font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">XBRL Taxonomy Extension Calculation Linkbase Document</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.DEF</font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">XBRL Taxonomy Extension Definition Linkbase</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.LAB</font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">XBRL Taxonomy Extension Labels Linkbase Document</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.PRE</font></p></td>
<td valign="bottom" style="width:0.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">XBRL Taxonomy Extension Presentation Linkbase Document</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;border-bottom:Solid 0.75pt;margin-bottom:3pt;line-height:6pt;margin-left:0%;margin-right:66.67%;text-indent:0%;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times;font-size:12pt;;"><font style="font-family:Times;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</font><font style="font-size:12pt;font-family:Times;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:5%;margin-right:0%;text-indent:0%;font-family:Times;font-size:12pt;;"><font style="font-family:Times;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The certifications attached as Exhibits&#160;32.1 and 32.2 that accompany this Annual Report on Form&#160;10-K, are not deemed filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of this Form&#160;10-K), irrespective of any general incorporation language contained in such filing. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Amendment No. 4 to Registration Statement on Form S-1/A, as filed with the SEC on February 5, 2004 (File No. 000-50577) and such document filed with the SEC as an exhibit to Dynavax&#8217;s Current Report on Form 8-K, as filed with the SEC on January 1, 2011. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Current Report on Form 8-K (File No. 000-50577), as filed with the SEC on November 6, 2008. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Current Report on Form 8-K, as filed with the SEC on January 4, 2010. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Current Report on Form 8-K, as filed with the SEC on January 5, 2011.</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Current Report on Form 8-K, as filed with the SEC on May 30, 2013.</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(6)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Current Report on Form 8-K, as filed with the SEC on November 1, 2013. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference to Dynavax&#8217;s Registration Statement (File No. 333-145836) on Form S-3 filed on August 31, 2007. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference to Dynavax&#8217;s Registration Statement (File No. 333-109965) on Form S-1/A filed on January 16, 2004. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Annual Report on Form 10-K for the year ended December 31, 2008&nbsp;&nbsp;(File No. 000-50577), as filed with the SEC. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(10)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Annual Report on Form 10-K, for the fiscal year ended December 31, 2009. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(11)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Current Report on Form 8-K, as filed with the SEC on April 13, 2010. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(13)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2006&nbsp;&nbsp;(File No. 000-50577), as filed with the SEC. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(14)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2007&nbsp;&nbsp;(File No. 000-50577), as filed with the SEC. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2009, as filed with the SEC.</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Current Report on Form 8-K, as filed with the SEC on August 17, 2009. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(18)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Quarterly Report on Form 10-Q for the quarter ended September&#160;30, 2009, as filed with the SEC. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Current Report on Form 8-K, as filed with the SEC on October 4, 2010.</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(21)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Current Report on Form 8-K, as filed with the SEC on October 13, 2010.</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(22)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Current Report on Form 8-K, as filed with the SEC on November 23, 2010.</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(23)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2011, as filed with the SEC.</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(24)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Registration Statement (File No. 333-171552) on Form S-8, as filed with the SEC on January 6, 2011.</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(25)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2011, as filed with the SEC.</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(26)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Annual Report on Form 10-K, for the fiscal year ended December 31, 2011. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(27)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2012, as filed with the SEC.</font></p></td></tr></table></div><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(28)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2012, as filed with the SEC.</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(29)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Annual Report on Form 10-K, for the fiscal year ended December 31, 2012. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(30)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Current Report on Form 8-K, as filed with the SEC on April 4, 2013.</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(31)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Current Report on Form 8-K, as filed with the SEC on May 3, 2013.</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(32)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Current Report on Form 8-K, as filed with the SEC on March 29, 2013.</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8224;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have been granted confidential treatment with respect to certain portions of this agreement. Omitted portions have been filed separately with the Securities and Exchange Commission. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">+</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicates management contract or compensatory plan. </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">74</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="SIGNATURES"></a>SIGNATURES </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Berkeley, State of California. </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div align="right">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:40%;">
<tr>
<td colspan="3" valign="bottom" style="width:2%;white-space:nowrap;"><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-variant: small-caps;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;">Dynavax Technologies Corporation</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom" style="width:2%;white-space:nowrap;"><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="padding-left:0.7 pt;padding-Right:0.7 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:37%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;EDDIE GRAY&#160;</font></p></td>
</tr>
<tr>
<td valign="top" style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="width:37%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman Bold;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman Bold;font-style:normal;text-transform:none;font-variant: normal;">Eddie Gray</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman Bold;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman Bold;font-style:normal;text-transform:none;font-variant: normal;">Chief Executive Officer</font></p><p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman Bold;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman Bold;font-style:normal;text-transform:none;font-variant: normal;">(Principal Executive Officer)</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: March 10, 2014 </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div align="right">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:40%;">
<tr>
<td valign="bottom" style="width:2%;white-space:nowrap;"><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="padding-left:0.7 pt;padding-Right:0.7 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:37%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;MICHAEL OSTRACH&#160;</font></p></td>
</tr>
<tr>
<td valign="top" style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="width:37%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman Bold;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman Bold;font-style:normal;text-transform:none;font-variant: normal;">Michael Ostrach</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman Bold;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman Bold;font-style:normal;text-transform:none;font-variant: normal;">Vice President</font></p><p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman Bold;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman Bold;font-style:normal;text-transform:none;font-variant: normal;">(Principal Financial Officer)</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: March 10, 2014 </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div align="right">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:40%;">
<tr>
<td valign="bottom" style="width:2%;white-space:nowrap;"><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="padding-left:0.7 pt;padding-Right:0.7 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:37%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;DAVID JOHNSON&#160;</font></p></td>
</tr>
<tr>
<td valign="top" style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="width:37%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman Bold;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman Bold;font-style:normal;text-transform:none;font-variant: normal;">David Johnson</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman Bold;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman Bold;font-style:normal;text-transform:none;font-variant: normal;">Vice President</font></p><p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman Bold;font-style:normal;text-transform:none;font-variant: normal;">(Principal Accounting Officer)</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: March 10, 2014 </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:36%;white-space:nowrap;"><p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;text-decoration:underline;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Signature</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0.7 pt;padding-Right:0.7 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:30%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;text-decoration:underline;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Title</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="padding-left:0.7 pt;padding-Right:0.7 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:30%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;text-decoration:underline;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Date</font></p></td>
</tr>
<tr>
<td valign="bottom" style="width:36%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;EDDIE GRAY</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:30%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief&#160;Executive&#160;Officer</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:30%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 10, 2014</font></p></td>
</tr>
<tr>
<td valign="top" style="width:36%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman Bold;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman Bold;font-style:normal;text-transform:none;font-variant: normal;">Eddie Gray</font></p></td>
<td valign="top" style="width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="width:30%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">(Principal Executive Officer)</font></p></td>
<td valign="top" style="width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="width:30%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom" style="width:36%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;MICHAEL OSTRACH</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:30%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vice&#160;President</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:30%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 10, 2014</font></p></td>
</tr>
<tr>
<td valign="top" style="width:36%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman Bold;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman Bold;font-style:normal;text-transform:none;font-variant: normal;">Michael Ostrach</font></p></td>
<td valign="top" style="width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="width:30%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">(Principal Financial Officer)</font></p></td>
<td valign="top" style="width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="width:30%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom" style="width:36%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;DAVID JOHNSON</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:30%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vice&#160;President</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:30%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 10, 2014</font></p></td>
</tr>
<tr>
<td valign="top" style="width:36%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman Bold;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman Bold;font-style:normal;text-transform:none;font-variant: normal;">David Johnson</font></p></td>
<td valign="top" style="width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="width:30%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">(Principal Accounting Officer)</font></p></td>
<td valign="top" style="width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="width:30%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom" style="width:36%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/</font><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/&#160;ARNOLD&#160;L. ORONSKY, PH.D.</font><font style="color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:30%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chairman of the Board</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:30%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 10, 2014</font></p></td>
</tr>
<tr>
<td valign="top" style="width:36%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman Bold;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman Bold;font-style:normal;text-transform:none;font-variant: normal;">Arnold L. Oronsky, Ph.D.</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="width:30%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="top" style="width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="width:30%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom" style="width:36%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/</font><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/&#160;FRANCIS R. CANO, PH.D.</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:30%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:30%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 10, 2014</font></p></td>
</tr>
<tr>
<td valign="top" style="width:36%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman Bold;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman Bold;font-style:normal;text-transform:none;font-variant: normal;">Francis R. Cano, Ph.D.</font></p></td>
<td valign="top" style="width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="width:30%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="top" style="width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="width:30%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom" style="width:36%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/</font><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/&#160;DENNIS A. CARSON, M.D.</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:30%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:30%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 10, 2014</font></p></td>
</tr>
<tr>
<td valign="top" style="width:36%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman Bold;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman Bold;font-style:normal;text-transform:none;font-variant: normal;">Dennis A. Carson, M.D.</font></p></td>
<td valign="top" style="width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="width:30%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="top" style="width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="width:30%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom" style="width:36%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/</font><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/&#160;DINO DINA, MD.</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:30%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:30%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 10, 2014</font></p></td>
</tr>
<tr>
<td valign="top" style="width:36%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman Bold;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman Bold;font-style:normal;text-transform:none;font-variant: normal;">Dino Dina, M.D.</font></p></td>
<td valign="top" style="width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="width:30%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="top" style="width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="width:30%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom" style="width:36%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/</font><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/&#160;DENISE M. GILBERT, PH.D.</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:30%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:30%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 10, 2014</font></p></td>
</tr>
<tr>
<td valign="top" style="width:36%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman Bold;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman Bold;font-style:normal;text-transform:none;font-variant: normal;">Denise M. Gilbert, Ph.D.</font></p></td>
<td valign="top" style="width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="width:30%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="top" style="width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="width:30%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom" style="width:36%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/</font><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/&#160;DANIEL L. KISNER, M.D.</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:30%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:30%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 10, 2014</font></p></td>
</tr>
<tr>
<td valign="top" style="width:36%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman Bold;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman Bold;font-style:normal;text-transform:none;font-variant: normal;">Daniel L. Kisner, M.D.</font></p></td>
<td valign="top" style="width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="width:30%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="top" style="width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="width:30%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom" style="width:36%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/</font><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/&#160;PEGGY V. PHILLIPS</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:30%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:30%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 10, 2014</font></p></td>
</tr>
<tr>
<td valign="top" style="width:36%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman Bold;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman Bold;font-style:normal;text-transform:none;font-variant: normal;">Peggy V. Phillips</font></p></td>
<td valign="top" style="width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="width:30%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="top" style="width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="width:30%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom" style="width:36%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/</font><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/&#160;STANLEY A. PLOTKIN, M.D.</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:30%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:30%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 10, 2014</font></p></td>
</tr>
<tr>
<td valign="top" style="width:36%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman Bold;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman Bold;font-style:normal;text-transform:none;font-variant: normal;">Stanley A. Plotkin, M.D.</font></p></td>
<td valign="top" style="width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="width:30%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="top" style="width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="width:30%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom" style="width:36%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/</font><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/&#160;NATALE S. RICCIARDI</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:30%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:30%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 10, 2014</font></p></td>
</tr>
<tr>
<td valign="top" style="width:36%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman Bold;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman Bold;font-style:normal;text-transform:none;font-variant: normal;">Natale S. Ricciardi</font></p></td>
<td valign="top" style="width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="width:30%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="top" style="width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="width:30%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT INDEX</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:12.88%; border-bottom:solid 1pt #000000;white-space:nowrap;"><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit<br>Number</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="padding-left:0.7 pt;padding-Right:0.7 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:86.44%; border-bottom:solid 1pt #000000;"><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Document</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.1</font><font style="color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(</sup><sup style="font-size:85%; vertical-align:top">1</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sixth Amended and Restated Certificate of Incorporation.</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.2</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(1</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amended and Restated Bylaws</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.3</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(2)</sup></font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Form of Certificate of Designation of Series A Junior Participating Preferred Stock</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.4</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(</sup><sup style="font-size:85%; vertical-align:top">3</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certificate of Amendment of Amended and Restated Certificate of Incorporation</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.5</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(</sup><sup style="font-size:85%; vertical-align:top">4</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certificate of Amendment of Amended and Restated Certificate of Incorporation</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.6</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(</sup><sup style="font-size:85%; vertical-align:top">5</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certificate of Amendment of Amended and Restated Certificate of Incorporation</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.7</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(</sup><sup style="font-size:85%; vertical-align:top">6</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certificate of Designation of Series B Convertible Preferred Stock</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.1</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reference is made to Exhibits 3.1, 3.2, 3.3, 3.4, 3.5, 3.6 and 3.7 above</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.2</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(7</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Registration Rights Agreement, dated as of July 18, 2007, by and between the Company and Deerfield Entities </font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.3</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(7</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Form of Warrant to Purchase Common Stock</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.4</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(</sup><sup style="font-size:85%; vertical-align:top">8</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Form of Specimen Common Stock Certificate</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.5</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(2)</sup></font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Rights Agreement, dated as of November 5, 2008, by and between the Company and Mellon Investor Services LLC</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.6</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(2)</sup></font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Form of Right Certificate</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.7</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(</sup><sup style="font-size:85%; vertical-align:top">9</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Form of Restricted Stock Unit Award Agreement under the 2004 Stock Incentive Plan</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.8</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(</sup><sup style="font-size:85%; vertical-align:top">10</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Form of Warrant to Purchase Common Stock </font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.9</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(1</sup><sup style="font-size:85%; vertical-align:top">1</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Form of Warrant to Purchase Common Stock</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.11</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(6)</sup></font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Form of Specimen Preferred Stock Certificate</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.30</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(1</sup><sup style="font-size:85%; vertical-align:top">3</sup><sup style="font-size:85%; vertical-align:top">)</sup></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8224;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research Collaboration and License Agreement, dated September 1, 2006, by and between the Company and AstraZeneca AB</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.32</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(</sup><sup style="font-size:85%; vertical-align:top">14</sup><sup style="font-size:85%; vertical-align:top">)</sup></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8224;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">License Agreement, dated June 26, 2007, between Coley Pharmaceuticals Group, Inc. and the Company </font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.38</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(</sup><sup style="font-size:85%; vertical-align:top">9</sup><sup style="font-size:85%; vertical-align:top">)</sup></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">+</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Form of Amended Management Continuity Agreement between the Company and certain of its executive officers</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.39&#8224;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and Development Collaboration and License Agreement, dated December 15, 2008, between Glaxo Group Limited and the Company</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.40</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(</sup><sup style="font-size:85%; vertical-align:top">15</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amendment No. 2 to the Research Collaboration and License Agreement, dated September 1, 2006, by and between the Company and AstraZeneca AB, dated February 3, 2009</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.43</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(</sup><sup style="font-size:85%; vertical-align:top">17</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Equity Distribution Agreement, dated August&#160;17, 2009, between the Company and Wedbush Morgan Securities, Inc.</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.44</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(1</sup><sup style="font-size:85%; vertical-align:top">8</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amendment to Equity Distribution Agreement, dated September 10, 2009, between the Company and Wedbush Morgan Securities, Inc.</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.47</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(1</sup><sup style="font-size:85%; vertical-align:top">0</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amended and Restated Purchase Option Agreement, dated November 9, 2009, between the Company and Symphony Dynamo Holdings LLC and Symphony Dynamo, Inc.</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.48</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(1</sup><sup style="font-size:85%; vertical-align:top">0</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrant Purchase Agreement, dated as of November 9, 2009, between the Company and Symphony Dynamo Holdings LLC</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.49</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(1</sup><sup style="font-size:85%; vertical-align:top">0</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amended and Restated Registration Rights Agreement, dated as of November 9, 2009, between the Company and Symphony Dynamo Holdings LLC</font></p></td>
</tr>
</table></div><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">77</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><div><table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:12.88%; border-bottom:solid 1pt #000000;white-space:nowrap;"><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit<br>Number</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="padding-left:0.7 pt;padding-Right:0.7 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:86.44%; border-bottom:solid 1pt #000000;"><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Document</font></p></td>
</tr><tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.50</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(1</sup><sup style="font-size:85%; vertical-align:top">0</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Standstill and Corporate Governance Agreement, dated as of December 30, 2009, between the Company and Symphony Dynamo Holdings LLC</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.54</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(</sup><sup style="font-size:85%; vertical-align:top">20</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amendment No. 3 to the Research Collaboration and License Agreement, dated September 1, 2006, by and between the Company and AstraZeneca AB, dated September 30, 2010</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.55</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(</sup><sup style="font-size:85%; vertical-align:top">21</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">First Amendment to Lease, dated as of May 21, 2004, between the Company and 2929 Seventh Street, LLC</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.56</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(</sup><sup style="font-size:85%; vertical-align:top">21</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Second Amendment to Lease, dated as of October 12, 2010, between the Company and 2929 Seventh Street, LLC</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.58</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(2</sup><sup style="font-size:85%; vertical-align:top">2</sup><sup style="font-size:85%; vertical-align:top">)</sup></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">+</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amended and Restated Management Continuity and Severance Agreement, dated as of November&#160;12, 2010, by and between the Company and Dino Dina, M.D.</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.59</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(2</sup><sup style="font-size:85%; vertical-align:top">2</sup><sup style="font-size:85%; vertical-align:top">)</sup></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">+</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amended and Restated Management Continuity and Severance Agreement, dated as of November&#160;12, 2010 by and between the Company and J. Tyler Martin, M.D.</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.61</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(23)</sup></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">+</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Form of Amended to Amended Management Continuity Agreement between the Company and certain of its executive officers</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.62</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(24)</sup></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">+</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2011 Equity Incentive Plan</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.63</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(2</sup><sup style="font-size:85%; vertical-align:top">4</sup><sup style="font-size:85%; vertical-align:top">)</sup></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">+</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Form of Restricted Stock Unit Award Notice and Restricted Stock Unit Award Agreement under the 2011 Equity Incentive Plan</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.64</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(2</sup><sup style="font-size:85%; vertical-align:top">4</sup><sup style="font-size:85%; vertical-align:top">)</sup></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">+</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Form of Stock Option Grant Notice and Option Agreement under the 2011 Equity Incentive Plan</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.65</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(2</sup><sup style="font-size:85%; vertical-align:top">5</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Third Amendment to Lease, dated as of April 1, 2011, between the Company and 2929 Seventh Street, LLC</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.66</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(2</sup><sup style="font-size:85%; vertical-align:top">5</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amended and Restated 2004 Non-Employee Director Option Program and Amended and Restated 2005 Non-Employee Director Cash Compensation Program, effective April 14, 2005, and amended April 6, 2011</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.67</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(26</sup><sup style="font-size:85%; vertical-align:top">)</sup></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8224;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amendment No. 4 to the Research Collaboration and License Agreement, dated&nbsp;&nbsp;September 1, 2006, by and between AstraZeneca AB and the Company, dated September 23, 2011</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.69</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(2</sup><sup style="font-size:85%; vertical-align:top">7</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amended and Restated 2004 Non-Employee Director Option Program and Amended and Restated 2005 Non-Employee Director Cash Compensation Program, amended April 17, 2012</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.70</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(</sup><sup style="font-size:85%; vertical-align:top">28</sup><sup style="font-size:85%; vertical-align:top">)</sup></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> +</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employment Offer Letter to Christine R. Larson, dated August&#160;1, 2012</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.72</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(29</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fourth Amendment to Lease, dated as of December 14, 2012, between the Company and 2929 Seventh Street, LLC</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.73</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(29</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">New Lease, dated as of December 14, 2012, between the Company and 2929 Seventh Street, LLC</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.74</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(29</sup><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Consulting Agreement, dated as of November&#160;14, 2012, by and between the Company and Stanley A. Plotkin</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.75</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(29</sup><sup style="font-size:85%; vertical-align:top">)</sup></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">+</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amended and Restated Management Continuity and Severance Agreement, dated October 31, 2012, between the Company and J. Tyler Martin</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.77</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(30)</sup></font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Consulting Agreement, dated as of March&#160;29, 2013, by and between Solutio Partners and the Company</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.78</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(30</sup></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">+</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">)</sup></font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Termination letter, dated as of March&#160;29, 2013, by and between Stephen Tuck and the Company</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.79</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(31)</sup></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> +</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employment Agreement, dated as of April 3, 2013, by and between Eddie Gray and the Company</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.80</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(31)</sup></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> +</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Management Continuity and Severance Agreement, dated as of April 3, 2013, by and between Eddie Gray and the Company</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.81</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(31)</sup></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> +</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Consulting Agreement, dated as of May 1, 2013, by and between Dino Dina, M.D. and the Company</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.82</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">(32)</sup></font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At Market Issuance Sales Agreement, dated March&#160;29, 2013, by and between the Company and MLV &amp; Co. LLC</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
</table></div><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">78</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><div><table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:12.88%; border-bottom:solid 1pt #000000;white-space:nowrap;"><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit<br>Number</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="padding-left:0.7 pt;padding-Right:0.7 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:86.44%; border-bottom:solid 1pt #000000;"><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Document</font></p></td>
</tr><tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.83</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amended and Restated 2004 Non-Employee Director Option Program and Amended and Restated 2005 Non-Employee Director Cash Compensation Program, Amended February 4, 2014</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.84+</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employment Agreement, dated March 21, 2013, by and between David Novack and the Company</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.85+</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employment Agreement, dated July&#160;11, 2013, by and between Robert Janssen, M.D. and the company </font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.86+</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employment Agreement, dated February 5, 2014, by and between David L. Johnson and the Company</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.87&#8224;</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top"> </sup></font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amendment No. 1 to the Agreement, dated December 15, 2008, by and between Glaxo Group Limited and the Company, dated December 13, 2013</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.88&#8224;</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top"> </sup></font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amendment No. 5 to the Agreement, dated September 1, 2006, by and between AstraZeneca AB and the Company, dated January 7, 2014</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.1</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:4pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Statement of Computation of Ratio of Earnings to Fixed Charges</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.1</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">List of Subsidiaries</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23.1</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Consent of Independent Registered Public Accounting Firm</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31.1</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31.2</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32.1*</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certification of Chief Executive Officer to Section 906 of the Sarbanes-Oxley Act of 2002</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32.2*</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.INS</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">XBRL Instance Document</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.SCH</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">XBRL Taxonomy Extension Schema Document</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.CAL</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">XBRL Taxonomy Extension Calculation Linkbase Document</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.DEF</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">XBRL Taxonomy Extension Definition Linkbase</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.LAB</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">XBRL Taxonomy Extension Labels Linkbase Document</font></p></td>
</tr>
<tr>
<td valign="top" style="width:12.88%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.PRE</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="top" style="width:86.44%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:6pt;;"><font style="font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">XBRL Taxonomy Extension Presentation Linkbase Document</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;border-bottom:Solid 0.75pt;margin-bottom:3pt;line-height:6pt;margin-left:0%;margin-right:66.67%;text-indent:0%;font-size:4pt;;"><font style="font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times;font-size:12pt;;"><font style="font-family:Times;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</font><font style="font-size:12pt;font-family:Times;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:4.54%;margin-right:0%;text-indent:0%;font-family:Times;font-size:12pt;;"><font style="font-family:Times;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The certifications attached as Exhibits&#160;32.1 and 32.2 that accompany this Annual Report on Form&#160;10-K, are not deemed filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of this Form&#160;10-K), irrespective of any general incorporation language contained in such filing. </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Amendment No.  4 to Registration Statement on Form S-1/A, as filed with the SEC on February 5, 2004 (File No. 000-50577) and such document filed with the SEC as an exhibit to Dynavax&#8217;s Current Report on Form 8-K, as filed with the SEC on January 1, 2011. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Current Report on Form 8-K (File No. 000-50577), as filed with the SEC on November 6, 2008. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Current Report on Form 8-K, as filed with the SEC on January 4, 2010. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Current Report on Form 8-K, as filed with the SEC on January 5, 2011.</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Current Report on Form 8-K, as filed with the SEC on May 30, 2013.</font></p></td></tr></table></div><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">79</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(6)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Current Report on Form 8-K, as filed with the SEC on November 1, 2013. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference to Dynavax&#8217;s Registration Statement (File No. 333-145836) on Form S-3 filed on August 31, 2007. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference to Dynavax&#8217;s Registration Statement (File No. 333-109965) on Form S-1/A filed on January 16, 2004. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Annual Report on Form 10-K for the year ended December 31, 2008&nbsp;&nbsp;(File No. 000-50577), as filed with the SEC. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(10)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Annual Report on Form 10-K, for the fiscal year ended December 31, 2009. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(11)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Current Report on Form 8-K, as filed with the SEC on April 13, 2010. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(13)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Quarterly Report &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; on Form 10-Q for the quarter ended September 30, 2006&nbsp;&nbsp;(File No. 000-50577), as filed with the SEC. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(14)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2007&nbsp;&nbsp;(File No. 000-50577), as filed with the SEC. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2009, as filed with the SEC.</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Current Report on Form 8-K, as filed with the SEC on August 17, 2009. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(18)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Quarterly Report on Form 10-Q for the quarter ended September&#160;30, 2009, as filed with the SEC. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Current Report on Form 8-K, as filed with the SEC on October 4, 2010.</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(21)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Current Report on Form 8-K, as filed with the SEC on October 13, 2010.</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(22)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Current Report on Form 8-K, as filed with the SEC on November 23, 2010.</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(23)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2011, as filed with the SEC.</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(24)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Registration Statement (File No. 333-171552) on Form S-8, as filed with the SEC on January 6, 2011.</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(25)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2011, as filed with the SEC.</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(26)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Annual Report on Form 10-K, for the fiscal year ended December 31, 2011. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(27)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2012, as filed with the SEC.</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(28)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2012, as filed with the SEC.</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(29)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Annual Report on Form 10-K, for the fiscal year ended December 31, 2012. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(30)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Current Report on Form 8-K, as filed with the SEC on April 4, 2013.</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(31)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Current Report on Form 8-K, as filed with the SEC on May 3, 2013.</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(32)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Incorporated by reference from such document filed with the SEC as an exhibit to Dynavax&#8217;s Current Report on Form 8-K, as filed with the SEC on March 29, 2013.</font></p></td></tr></table></div><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8224;</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have been granted confidential treatment with respect to certain portions of this agreement. Omitted portions have been filed separately with the Securities and Exchange Commission. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">+</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicates management contract or compensatory plan. </font></p></td></tr></table></div><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">81</font></p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>2
<FILENAME>dvax-ex10_20131231592.htm
<DESCRIPTION>EX-10.39
<TEXT>
<html>
<body>
<p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:10pt;;">&nbsp;</p><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">Exhibit 10.39</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman Bold;font-weight:bold;;"><font style="font-weight:bold;font-family:Times New Roman Bold;font-variant: small-caps;font-size:10pt;font-style:normal;text-transform:none;">Research and Development Collaboration and License Agreement</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-variant: small-caps;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;">Between</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman Bold;font-weight:bold;;"><font style="font-weight:bold;font-family:Times New Roman Bold;font-variant: small-caps;font-size:10pt;font-style:normal;text-transform:none;">Glaxo Group Limited</font></p><p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman Bold;font-weight:bold;;"><font style="font-weight:bold;font-family:Times New Roman Bold;font-variant: small-caps;font-size:10pt;font-style:normal;text-transform:none;">and</font></p><p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-weight:bold;;"><font style="font-weight:bold;font-family:Times New Roman;font-variant: small-caps;font-size:10pt;font-style:normal;text-transform:none;">Dynavax Technologies Corporation</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">RESEARCH AND DEVELOPMENT COLLABORATION</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">AND LICENSE AGREEMENT</font></p><p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">This </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">RESEARCH </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">AND DEVELOPMENT COLLABORATION AND LICENSE AGREEMENT</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (the &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Agreement</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;) is entered into and made effective as of the 15th day of December, 2008 (the &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Effective Date</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;) by and between Dynavax Technologies Corporation, a Delaware corporation having its principal place of business at 2929 Seventh Street, Suite 100, Berkeley, CA 94710 (&#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Dynavax</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;), and Glaxo Group Limited, a company existing under the laws of England and Wales, having its registered office at Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex, UB6 0NN, England (&#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">GSK</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;).&nbsp;&nbsp;Dynavax and GSK are each referred to herein by name or as a &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Party</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221; or, collectively, as &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Parties.</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221; </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;">RECITALS</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-variant: small-caps;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;text-indent:6.67%">Whereas,</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%"> Dynavax possesses proprietary technology and know-how related to the discovery, identification, synthesis and development of oligonucleotides as drug candidates;</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-variant: small-caps;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;text-indent:6.67%">Whereas,</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%"> GSK possesses expertise in the research, development, manufacturing and commercialization of human pharmaceuticals, and GSK is interested in developing such oligonucleotides as drug products;</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-variant: small-caps;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;text-indent:6.67%">Whereas,</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%"><a name="OLE_LINK11"></a> GSK desires to engage in a collaborative effort with Dynavax pursuant to which Dynavax will carry out up to three (3) different research and development programs to discover and develop </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">oligonucleotides as inhibitors of certain toll-like receptors (or combinations thereof), and pursuant to which GSK will have certain options, exercisable at GSK&#8217;s sole discretion, to further develop and commercialize such oligonucleotides for any and all uses in the Territory (as defined below), all on the terms and conditions set forth herein.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-variant: small-caps;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;text-indent:6.67%">Now, therefore,</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> in consideration of the premises and mutual covenants herein contained, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto agree as follows:</font></p><p style="margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:18pt;text-align:center;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974774"></a><font style="font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;">ARTICLE 1</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br><br></font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">DEFINITIONS</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc140974776"></a>As used in this Agreement, the following terms will have the meanings set forth in this Article 1 unless context dictates otherwise:</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.1 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Acceptance</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221; means with respect to an NDA or MAA filed for a Product, (a) in the United States, the receipt by GSK or its Affiliate or Sublicensee of written notice from the FDA in accordance with 21 CFR<a name="OLE_LINK13"></a> 314.101(a)(2) that such NDA is officially &#8220;filed&#8221;, (b) in the European Union, receipt by GSK or its Affiliate or Sublicensee of written notice of acceptance by the EMEA of such MAA for filing under the centralized European procedure in accordance with any feedback received from European Regulatory Authorities; provided, that if the centralized filing procedure is not used, then Acceptance shall be determined upon the acceptance of such MAA by the applicable Regulatory Authority in the third Major Country in the EU, and (c) in Japan, receipt by GSK or its Affiliate or Sublicensee of written notice of acceptance of filing of such MAA from the MHLW.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.2 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Affiliate&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means any Person, whether </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">de jure</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">de facto</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, which, directly or indirectly through one (1) or more intermediaries, controls, is controlled by or is under common control with a Party to this Agreement, regardless of whether such Affiliate is or becomes an Affiliate on or after the Effective Date.&nbsp;&nbsp;A Person shall be deemed to &#8220;control&#8221; another Person if it (a) owns, directly or indirectly, beneficially or legally, at least fifty percent (50%) of the outstanding voting securities or capital stock (or such lesser percentage which is the maximum allowed to be owned by a Person in a particular jurisdiction) of such other Person, or has other comparable ownership interest with respect to any Person other than a corporation; or (b) has the power, whether pursuant to contract, ownership of securities or otherwise, to direct the management and policies of the Person.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974777"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.3 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Alliance Manager&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> has the meaning assigned to such term in Section&#160;3.2.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.4 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Annual Net Sales&#8221; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">means total Net Sales in the Territory in a particular Calendar Year.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.5 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Arbitration Request&#8221; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">has the meaning assigned to such term in Section 13.2.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.6 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means that certain </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, as amended from time to time.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.7 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Back-up Compound</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc197434712"></a>&#8221; means, with respect to a lead Compound in a Dynavax Program, a Compound in such Dynavax Program that (i) may or may not be a </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> to such lead Compound, (ii) has been or is expected to be advanced to the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> stage by Dynavax, (iii) is expected to reasonably address </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> associated with such lead Compound, and (iv) is not a </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974780"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.8 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Breaching Party&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> has the meaning assigned to such term in Section 12.2.1.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974782"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.9 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Business Day&#8221; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">means a day on which banking institutions in New York, New York, United States, and London, England are open for business, excluding any Saturday or Sunday.&nbsp;&nbsp;</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-2-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.10 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Calendar Day&#8221; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">means any day, including a Saturday, Sunday, Business Day or public or company holiday.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.11 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Calendar Quarter&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means a period of three (3) consecutive months ending on the last day of March, June, September, or December, respectively.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974789"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.12 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Calendar Year&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means a period of twelve (12) consecutive months beginning on January 1 and ending on December 31.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.13 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">cGMP</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221; means all applicable standards relating to manufacturing practicves for fine chemicals, intermediates, bulk products or Products, including (i) the principles detailed in the U.S. Current Good Manufacturing Practices, 21 CFR Parts 210 and 211 and The Rules Governing Medicinal Products in the European Community, Volume IV, Good Manufacturing Practice for Medicinal Products, as each may be amended from time to time or (ii) standards promulgated by any governmental body having jurisdiction over the manufacture of a Compound, in the form of laws or regulations.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.14 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Chairperson&#8221; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">has the meaning assigned to such term in Section 3.1.1.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.15 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Change of Control Event&#8221; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">has the meaning assigned to such term in Section 13.4.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.16 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Claims&#8221; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc140974798"></a>has the meaning assigned to such term in Section 11.1.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.17 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Clinical Trial&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means a Phase 1 Clinical Trial, Phase 2 Clinical Trial, Phase 3 Clinical Trial, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or Proof of Concept Study.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.18 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Co-Development Costs&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc144026543"></a> means<a name="_Toc144026544"></a>, with respect to a GSK Product, the sum of the following costs to the extent incurred after the exercise by GSK of an Option with respect to the GSK Development Program containing such GSK Product:</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">1.18.1 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All direct internal and external Research and Development costs incurred by or on behalf of GSK or its Affiliates or Sublicensees or Dynavax and/or their respective Affiliates during such period in the conduct of the GSK Development Program&nbsp;&nbsp;(including but not limited to both Clinical Trials and any non-clinical activities or studies) that are required by a Regulatory Authority to support and obtain Regulatory Approval for such GSK Product in the U.S. (collectively, the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Co-Development Studies&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">), and for product material, comparator drug and placebo used in the Co-Development Studies.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">1.18.2 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allocable overhead as included </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, for </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> costs described in Section 1.18.1, to the extent </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> described in Section 1.18.1, where allocable overhead shall mean costs incurred by GSK or its Affiliates or Sublicensees or Dynavax or its Affiliates that are attributable to the costs of </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or such other generally accepted methods, in all cases as applied by the Party in accordance with its accounting standards on a consistent basis.&nbsp;&nbsp;Without limitation, allocable overhead shall not include the costs of </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, including, by way of example, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0.52%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Such costs as described in Section 1.18.1 and 1.18.2 shall be determined in accordance with applicable Generally Accepted Accounting Principles (GAAP) and in accordance with the Party&#8217;s accounting standards applied on a consistent basis.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-3-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.19 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Co-Development Option&#8221; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">has the meaning assigned to such term in Section 5.5.1(a).</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.20 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Collaboration IP&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means the Collaboration Know-How and the Collaboration Patents.&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.21 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Collaboration Know-How&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means any Information pertaining to a Compound that is discovered, developed, invented or created solely by a Party or jointly by both Parties, or their respective agents, contractors, or Affiliates, during the Research Term and pursuant to a Dynavax Program, but prior to the earlier of GSK&#8217;s exercise of the Option or expiration of the Option with respect to such Dynavax Program.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974796"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.22 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Collaboration Patent&#8221; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">means any Patent that claims or covers Collaboration Know-How that is not specifically disclosed, included, claimed or covered in the Dynavax Compound IP or the GSK Development IP.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974804"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.23 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Commercially Reasonable Efforts</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221; means the following: (a) with respect to Dynavax, such efforts that are consistent with the efforts and resources normally used by </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> in the exercise of its reasonable business discretion relating to the research,&nbsp;&nbsp;development and commercial progression of a potential pharmaceutical product owned by it or to which it has exclusive rights, with similar product characteristics as the relevant Compound or Product, which is of similar market potential at a similar stage in its development or product life as the relevant Compound or Product, taking into account issues of patent coverage, safety and efficacy, product profile, competitiveness of the marketplace, proprietary position, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, and profitability (including pricing and reimbursement status achieved or likely to be achieved); and (b) with respect to GSK, such efforts that are consistent with the efforts and resources normally used by </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> in the exerc ise of its reasonable business discretion relating to the development and commercialization of a prescription pharmaceutical product or over-the-counter product as appropriate owned by it or to which it has exclusive rights, with similar product characteristics as the relevant Compound or Product, which is of similar market potential at a similar stage in its development or product life as the relevant Compound or Product, taking into account issues of patent coverage, safety and efficacy, product profile, the competitiveness of the marketplace, the proprietary position, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and profitability (including pricing and reimbursement status achieved or likely to be achieved).</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.24 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Competitive Infringement&#8221; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">has the meaning assigned to such term in Section 8.5.1.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.25 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Compound</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221; means each compound comprising an oligonucleotide-based immunoregulatory sequence (&#8220;IRS&#8221;) that inhibits (</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="OLE_LINK17"></a> unless otherwise mutually agreed by the JSC without escalation pursuant to Section 3.1.4) in a </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (such </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> to be mutually agreed by the Parties through the JSC) for </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, as applicable for that Program, and all derivatives and improvements of such compound, (a) that are existing as of the Effective Date or (b) that are Researched and/or Developed by Dynavax under a Dynavax Program or (c) as identified, further modified, optimized or otherwise Researched or Developed by GSK under a GSK Development Program.&nbsp;&nbsp;In particular, for the TLR 7/9 directed compounds, the oligonucleotide-based IRS must have </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> unless otherwise mutually agreed by the JSC without escalation pursuant to Section 3.1.4.&nbsp;&nbsp;For those Programs involving </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, the JSC may establish criteria by mutual agreement for </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of a Compound with respect to </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> TLR in such Program.&nbsp;&nbsp;For clarity, nothing in this Section 1.25 or elsewhere in this Agreement shall require Dynavax to measure the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.26 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Confidential Information&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> has the meaning assigned to such term in Section 9.1.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-4-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974806"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.27 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Control,&#8221; &#8220;Controls,&#8221; &#8220;Controlled&#8221; or &#8220;Controlling&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means, with respect to any intellectual property, possession of the ability to grant the licenses or sublicenses as provided herein without violating the terms of any agreement or other arrangement with any Third Party.&nbsp;&nbsp;A Party shall be deemed to Control Collaboration IP to the extent of its individual or joint interest therein, as applicable.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc197434731"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.28 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Co-Promotion Agreement&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> has the meaning assigned to such term in Section 5.5.2(a).</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.29 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Develop&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Development&#8221; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">means pre-clinical and clinical drug development activities relating to the development of Compounds, Products and/or processes and submission of information to a Regulatory Authority for the purpose of obtaining Regulatory Approval of a product, and activities to develop manufacturing capabilities for products.&nbsp;&nbsp;Development includes, but is not limited to, pre-clinical activities, pharmacology studies, toxicology studies, formulation, manufacturing process development and scale-up (including bulk compound production), manufacturing Compound or Product for Clinical Trials, quality assurance and quality control, technical support, pharmacokinetic studies, clinical studies and regulatory affairs activities.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974890"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.30 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Development Plan&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> has the meaning assigned to such term in Section&#160;2.2.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.31 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Disclosing Party&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> has the meaning assigned to such term in Section 9.1.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974815"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.32 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Dollars&#8221; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;$&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means the legal tender of the U.S.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974822"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.33 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Dynavax Compound IP&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means Dynavax&#8217;s and its Affiliates&#8217; interest in any: (a) Patents in the Territory that claim or cover the composition of matter or any method of making, use or sale of a Compound in the Field; and (b) Information that </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for the making, use or sale of a Compound in the Field, in each case to the extent such Patents or Information are Controlled by Dynavax or its Affiliates (i) on the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, or (ii) thereafter </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for any Patents which claim priority to any Patent filed during the Research Term.&nbsp;&nbsp;The Dynavax Compound IP excludes the Collaboration IP.&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.34 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Dynavax Compound Patents&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means Patents in the Dynavax Compound IP.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.35 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Dynavax Development Program&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means a Dynavax Program for which GSK fails to exercise its Option before expiration or GSK declines its Option, a Dynavax Program that is terminated by the JSC or GSK, or a terminated GSK Development Program containing Compounds and Products that Dynavax elects to further Develop and commercialize.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.36 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Dynavax Product&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means a Product Developed and commercialized by Dynavax under a Dynavax Development Program.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.37 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Dynavax Program&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means Dynavax&#8217;s Research and Development of Compounds through to either the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or completion of a </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or Proof of Concept Study, as applicable.&nbsp;&nbsp;For clarity, there will be a maximum of </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> potential Dynavax Programs under this Agreement, which shall be the TLR 7/9 Program </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, each of which is subject to the relevant diligence provisions and milestones as if separate programs hereunder) and up to two (2) additional Dynavax Programs as identified pursuant to Section 2.5.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.38 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;EMEA&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means the European Medicines Evaluation Agency, and any successor entity thereto.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-5-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc197434738"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.39 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">European Commission</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221; means the executive body of the European Union that has legal authority to grant marketing authorization approvals for pharmaceutical products in the European Union following scientific evaluation and recommendation from the EMEA or other applicable Regulatory Authorities.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.40 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;European Union&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;EU&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means all countries that are officially recognized as member states of the European Union at any particular time during the Term.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc197434740"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.41 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Exclusively Licensed IP&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means, with respect to each Compound in a Dynavax Program for which GSK exercises the Option and receives rights upon exercise pursuant to Section 4.1, (a) Information in the Dynavax Compound IP and Dynavax&#8217;s and its Affiliates&#8217; interest in the Collaboration Know-How, in each case that </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for the making, use or sale of such Compound </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, and (b) Dynavax Compound Patents and Dynavax&#8217;s and its Affiliates&#8217; interest in the Collaboration Patents, in each case that claims or covers the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of such Compound.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.42 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Executive Officers&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> has the meaning assigned to such term in Section 3.1.4.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974825"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.43 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;FDA&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means the U.S. Food and Drug Administration, and any successor entity thereto.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974826"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.44 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Field&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc140974828"></a> the treatment, palliation, prevention and/or diagnosis of </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974827"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.45 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;First Commercial Sale&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means, with respect to each Product, the first sale for which revenue has been recognized by GSK or Dynavax or their respective Affiliate or Sublicensees for use or consumption by the general public of such Product in any country in the Territory after all required Regulatory Approvals (including, where applicable, pricing and reimbursement approval which is acceptable to GSK or Dynavax, as applicable depending upon which Party is going to be selling Product) have been granted, or such sale is otherwise permitted, by the Regulatory Authority in such country, provided, that, the following shall not constitute a First Commercial Sale: (a) any sale to an Affiliate or Sublicensee unless the Affiliate or Sublicensee is the last entity in the distribution chain of the Product, (b)</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">any</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">use of such Product in Clinical Trials, preclinical activities or other Research or Development activities, or disposal or transfer of Products for a bona fide charitable purpose, (c) compassionate use, (d) so called &#8220;treatment IND sales&#8221; and &#8220;named patient sales,&#8221; and (e) use under the ATU system in France or other equivalent systems.&nbsp;&nbsp; </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.46 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc197434749"></a>&#8220;[ * ]&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means a Compound in Development in the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> that (a) is or is reasonably expected to be </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and (b) has </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="OLE_LINK39"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.47 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;[ * ]&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means the Research and Development, within the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, of </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> to Compounds in the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.48 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;FTC&#8221; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">has the meaning assigned to such term in Section 4.1.5.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.49 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;FTE&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means a full-time individual&#8217;s work time dedicated by Dynavax to the Dynavax Programs or by GSK to the GSK Development Programs, or in the case of less than a full-time dedicated individual, a full-time equivalent person year, based upon a total of </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> hours per year of Research, Development, manufacturing and commercialization work on or directly related to the Dynavax Programs or GSK Development Programs. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-6-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974830"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.50 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Generic Product</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221; has the meaning assigned to such term in Section 6.4.2(b).</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.51 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">GSK Development Compound</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221; means any Compound, including Back-up Compounds, within a Dynavax Program that has become a GSK Development Program upon GSK&#8217;s exercise of the Option.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc197434757"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.52 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">GSK Development IP</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221; means any (a) Patents that claim or cover the composition of matter of a GSK Development Compound or GSK Product or the making, use, sale, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of a GSK Development Compound or GSK Product; and (b) any Information that </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of a GSK Development Compound or GSK Product </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, in each case to the extent such Patents or Information are Controlled by GSK or its Affiliates, but excluding any Collaboration IP and any Dynavax Compound IP or Exclusively Licensed IP.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.53 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;GSK Development Patent&#8221; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">has the meaning assigned to such term in Section 8.2.2.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.54 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;GSK Development Plan and Budget&#8221; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">has the meaning assigned to such term in Section 5.5.1(a).</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.55 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">GSK Development Program</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221; means a Dynavax Program for which GSK exercises its Option and that has not been terminated by GSK.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.56 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;GSK Product&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means a Product Developed and commercialized by GSK or its Affiliate or Sublicensee under a GSK Development Program.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.57 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;HSR&#8221; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">has the meaning assigned to such term in Section 4.1.5.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.58 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;IND&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means an investigational new drug application filed with the FDA pursuant to Part 312 of Title 21 of the U.S. Code of Federal Regulations, including any amendments thereto. References herein to IND shall include, to the extent applicable, any comparable filing(s) outside the U.S. (such as a clinical trial application in the European Union).</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.59 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Indemnitee&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> has the meaning assigned to such term in Section&#160;11.3.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974841"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.60 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Information&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means all tangible and intangible (a)&#160;information, techniques, technology, practices, trade secrets, inventions (whether patentable or not), methods, knowledge, know-how, skill, experience, data, results (including pharmacological, toxicological and clinical test data and results, and Research or Development data, reports and batch records), analytical and quality control data, analytical methods (including applicable reference standards), full batch documentation, packaging records, release, stability, storage and shelf-life data, and manufacturing process information, results or descriptions, software and algorithms and (b)&#160;compositions of matter, cells, cell lines, assays, animal models and physical, biological or chemical material.&nbsp;&nbsp;As used in this Section 1.60, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;clinical test data&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shall be deemed to include all information related to the clinical or pre-clinical testing of a Compound or Product, including without limitation patient report forms, investigators&#8217; reports, biostatistical, pharmaco-economic and other related analyses, regulatory filings and communications, and the like.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974846"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.61 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Joint Steering Committee&#8221; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;JSC&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> has the meaning assigned to such term in Section 3.1.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974848"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.62 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Know-How Royalty&#8221; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">has the meaning assigned to such term in Section 6.4.2(a).</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-7-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.63 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;[ * ]&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means the research and development of </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, as of the Effective Date, in the TLR 7/9 Program and its Back-up Compounds.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.64 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> &#8220;Losses&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> has the meaning assigned to such term in Section 11.1.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974853"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.65 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Major EU Country&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means any of the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.66 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;MAA&#8221; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">means a regulatory application filed with the EMEA or MHLW seeking Regulatory Approval of a Product, and all amendments and supplements thereto filed with the EMEA or MHLW.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.67 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Materials&#8221; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">has the meaning assigned to such term in Section 2.10.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.68 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;MHLW&#8221; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">means the Ministry of Health, Labour and Welfare of Japan, or the Pharmaceuticals and Medical Devices Agency (the &#8220;PMDA,&#8221; formerly known as IYAKUHIN SOGO KIKO), or any successor to either of them, as the case may be.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974854"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.69 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;NDA&#8221; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">means a New Drug Application (as more fully defined in 21 C.F.R. 314.5 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">et seq.</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or its successor regulation) and all amendments and supplements thereto filed with the FDA.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974855"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.70 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Net Sales&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means, with respect to any Product, the gross invoiced sales price of such Product sold by GSK or Dynavax or their respective Affiliates or Sublicensees (the &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Selling Party</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;) in finished product form, packaged and labeled for sale, under this Agreement in arm&#8217;s length sales to Third Parties, less deductions allowed to the Third Party customer by the Selling Party and actually incurred, allowed, paid, accrued or specifically allocated as reported by the Selling Party in its financial statements in accordance with the International Financial Reporting Standards (&#8220;IFRS&#8221;) for GSK (or any other Selling Party which accounts in accordance with IFRS) or US (as appropriate) Generally Accepted Accounting Principles for Dynavax (or any other Selling Party which accounts in accordance with US or UK (as appropriate) Generally Accepted Accounting Principles), applied on a consistent basis, for: </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.70.1 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">customary and reasonable trade, quantity, and cash discounts and wholesaler allowances; provided that, in the case of pharmacy incentive research programs, hospital performance incentive research program chargebacks, disease management research programs, similar research programs or discounts and wholesaler allowances on &#8220;bundles&#8221; of products, all discounts, wholesaler allowances and the like shall be </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.70.2 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">customary and reasonable credits, rebates and chargebacks (including those to managed-care entities and government agencies), and allowances or credits to customers on account of rejection or returns (including, but not limited to, wholesaler and retailer returns) or on account of retroactive price reductions affecting such Product;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.70.3 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">freight, postage and duties, and transportation charges relating to such Product, including handling and insurance thereto; </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-8-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.70.4 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">sales (such as VAT or its equivalent) and excise taxes, other consumption taxes, customs duties and compulsory payments to governmental authorities and any other governmental charges imposed upon the importation, use or sale of such Product to Third Parties (excluding any taxes paid on the income from such sales) to the extent the Selling Party is not otherwise entitled to a credit or a refund for such taxes, duties or payments made;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.70.5 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">; and</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.70.6 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">other items actually deducted from gross sales in relation to changes in accounting guidelines as per IFRS and to the extent that such deductions are consistently applied across the relevant Party&#8217;s business.&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Sales between GSK and its Affiliates or Sublicensees, or Dynavax and its Affiliates or Sublicensees, as applicable, shall be excluded from the computation of Net Sales, and no payments will be payable on such sales except where such Affiliate or Sublicensee is the last entity in the distribution chain for the Product and is purchasing it for its own commercial use, in which case such sales shall be deemed to be at </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;In addition, Product provided to patients for compassionate use will not be included in Net Sales.&nbsp;&nbsp;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For purposes of determining Royalties and sales milestones payable on Combination Products, Net Sales will be calculated as follows, in each calendar quarter:&nbsp;&nbsp; </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the event that Compound is sold as part of a Combination Product (as defined below), the Net Sales from the Combination Product will be determined by multiplying the Net Sales (as determined without reference to this paragraph) of the Combination Product by the fraction [ * ], where [ * ] is the [ * ] of the Compound [ * ] when sold separately in finished form and [ * ] is the [ * ] of the other therapeutically active pharmaceutical compound(s) included in the Combination Product when sold separately in finished [ * ], each during the applicable royalty period or, if sales of all compounds did not occur in such period, then [ * ].&nbsp;&nbsp;In the event that such [ * ] cannot be determined for both the Compound and all other therapeutically active pharmaceutical compounds included in the Combination Product [ * ], Net Sales for the purposes of determining royalty payments will be calculated as above, but the [ * ] in the above equation will be replaced by [ * ] of the compound(s) for which no such price exists.&nbsp;&nbsp;As used above, the term &#8220;Combination Product&#8221; shall mean any pharmaceutical product which contains a Compound together with at least one other therapeutically active pharmaceutical compound (whether or not co-formulated or co-packaged with the Compound in such Product) which is not a Compound.&nbsp;&nbsp;To be a Combination Product, products must be invoiced as one product.&nbsp;&nbsp;Notwithstanding the foregoing, drug delivery vehicles, adjuvants and excipients shall not be deemed to be active pharmaceutical compounds and their presence shall not be deemed to create a Combination Product.&nbsp;&nbsp;[ * ].</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">To the extent the Net Sales is used herein with respect to Dynavax Products, Net Sales shall have the meaning set forth above, with all references to &#8220;GSK&#8221; replaced by &#8220;Dynavax.&#8221;</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974856"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.71 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> &#8220;Non-breaching Party&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> has the meaning assigned to such term in Section&#160;12.2.1.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974859"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.72 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;[ * ]&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> has the meaning assigned to such term in Section 2.8.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.73 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Option</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221; has the meaning assigned to such term in Section 4.1.1.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-9-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974860"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.74 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Option Deadline Extension Period&#8221; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">has the meaning assigned to such term in Section 4.1.5.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.75 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Option Deadline Period&#8221; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">has the meaning assigned to such term in Section 4.1.5.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.76 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Option Period Start&#8221; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">has the meaning assigned to such term in Section 4.1.2.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.77 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Party&#8221; or &#8220;Parties&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> has the meaning assigned to such term in the Preamble.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974861"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.78 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Patent&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means (a) all patents and patent applications in any country or supranational jurisdiction in the Territory, (b) any substitutions, divisions, continuations, continuations-in-part, provisional applications, reissues, renewals, registrations, confirmations, re-examinations, extensions, supplementary protection certificates and the like of any such patents or patent applications, and (c) foreign counterparts of any of the foregoing.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.79 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Patent Costs&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means the reasonable fees and expenses paid to outside legal counsel, and filing, maintenance and other out-of-pocket expenses paid to Third Parties, incurred in connection with the Prosecution and Maintenance of Patents.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974863"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.80 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Patent Royalty&#8221; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">has the meaning assigned to such term in Section 6.4.1.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.81 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Payee&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> has the meaning assigned to such term in Section 6.9.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974864"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.82 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Payor&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> has the meaning assigned to such term in Section 6.9.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974865"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.83 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Person&#8221; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">means any individual, partnership, joint venture, limited liability company, corporation, firm, trust, association, unincorporated organization, governmental authority or agency, or any other entity not specifically listed herein.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc197434789"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.84 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Phase 1 Clinical Trial&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means a human clinical trial of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a), or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.85 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Phase 2 Clinical Trial&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.86 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Phase 3 Clinical Trial&#8221; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(c) and is intended to (a) establish that the product is safe and efficacious for its intended use, (b) define warnings, precautions and adverse reactions that are associated with the product in the dosage range to be prescribed, and (c) support Regulatory Approval for such product.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-10-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.87 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Phase I Ready Compound&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means a Compound (including all Back-up Compounds if progressed to this stage) from a Dynavax Program that has met the applicable Phase I Ready Criteria, or is </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> such criteria.&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.88 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Phase I Ready Criteria&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="OLE_LINK26"></a> means the clinical and/or non-clinical criteria (a) set forth in </font><font style="text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibit C</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and as modified by the JSC </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> TLR 7/9 Program and (b) established and as modified by the JSC pursuant to Section 2.6.2 for the other Dynavax Programs (including the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">), <a name="OLE_LINK24"></a>for advancement of a Pre-Candidate Selection Compound from a Dynavax Program into clinical Development.&nbsp;&nbsp;In general, Phase I Ready Criteria for a particular Compound will be reasonable and appropriate for </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and generally may include: </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.89 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Phase I Ready Report&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> has the meaning assigned to such term in Section 2.7.2.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.90 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Pre-Candidate Selection Criteria&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means the criteria established by the JSC pursuant to Section 2.6.1 for </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> in the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> TLR 7/9 Program and for Compounds in the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and the other Dynavax Programs, for advancement of a Compound from a Dynavax Program into IND-enabling studies.&nbsp;&nbsp;In general, the Pre-Candidate Selection Criteria for a particular Compound will be reasonable and appropriate for </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and may include </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.91 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Pre-Candidate Selection Report</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">has the meaning assigned to such term in Section 2.7.1.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.92 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Product&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means any product that includes a Compound, whether or not as the sole active ingredient and in any dosage form or formulation.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.93 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Product Marketing Plan&#8221; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">has the meaning assigned to such term in Section 5.5.2.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.94 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Program&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means a Dynavax Program, Dynavax Development Program, or GSK Development Program, as applicable.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.95 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Proof of Concept&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;PoC&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means the stage of Development at which a Phase I Ready Compound has successfully satisfied the Proof of Concept Criteria, as such criteria are determined by GSK.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.96 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Proof of Concept Criteria&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="OLE_LINK41"></a> means the clinical and/or non-clinical criteria established </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, pursuant to Section 2.6.5 and in accordance with the guidelines attached hereto as </font><font style="text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibit D</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, to determine whether a Phase I Ready Compound demonstrates </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;This shall include </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and any other reasonable parameters.&nbsp;&nbsp; The Proof of Concept Criteria shall include, without limitation, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;The criteria may be different for each Dynavax Program.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.97 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Proof of Concept Study&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means a human clinical trial for a particular Phase I Ready Compound that meets the requirements of 21 C.F.R. Section 312.21(b) and is intended to explore </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.98 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Proof of Concept Study Design&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;PoC Study Design&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means the design, content and endpoints for a Proof of Concept Study.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974881"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.99 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Proof of Concept Study Report&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;PoC Study Report&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> has the meaning assigned to such term in Section 2.7.4.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-11-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.100 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;[ * ]&#8221; or &#8220;[ * ]&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means the stage of Development at which a Phase I Ready Compound has successfully satisfied the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Criteria, as such criteria are determined by </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.101 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;[ * ] Criteria&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means the criteria established by </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> pursuant to Section 2.6.3 and in accordance with the guidelines attached hereto as </font><font style="text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibit E</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.102 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;[ * ]&#8221; or &#8220;[ * ] Study&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means a study performed in humans in order to </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of a particular Phase I Ready Compound in humans and to guide </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.103 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;[ * ] Design&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;[ * ] Study Design&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means the design, content and endpoints for a </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.104 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;[ * ] Report&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;[ * ] Study Report&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> has the meaning assigned to such term in Section 2.7.3.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.105 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Prosecuting Party&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> has the meaning assigned to such term in Section&#160;8.2.3.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974882"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.106 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Prosecution and Maintenance&#8221; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> &#8220;Prosecute and Maintain&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means, with regard to a Patent, the preparing, filing, prosecuting and maintenance of such Patent, as well as re-examinations, reissues, and requests for patent term adjustments and patent term extensions with respect to such Patent, together with the initiation or defense of interferences, the initiation or defense of oppositions and other similar proceedings with respect to the particular Patent, and any appeals therefrom.&nbsp;&nbsp;For clarification, &#8220;Prosecution and Maintenance&#8221; or &#8220;Prosecute and Maintain&#8221; shall not include any other enforcement actions taken with respect to a Patent.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974884"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.107 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Receiving Party&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> has the meaning assigned to such term in Section&#160;9.1.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974886"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.108 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Regulatory Approval&#8221; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">means any and all approvals, licenses, registrations, or authorizations of any country, federal, supranational, state or local regulatory agency, department, bureau or other government entity that are necessary for the manufacture, use, storage, import, transport and/or sale of a particular Product in the applicable jurisdiction.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974887"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.109 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Regulatory Authority&#8221; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">means the FDA in the U.S. or any health regulatory authority in another country in the Territory that is a counterpart to the FDA and holds responsibility for granting regulatory marketing approval for a Product in such country, including the European Commission and the MHLW, and any successor(s) thereto.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974892"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.110 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Research&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means the discovery, identification, research, characterization, modification, derivatization, optimization, and pre-clinical testing of pharmaceutical compounds.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.111 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Research Term&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> has the meaning assigned to such term in Section 2.3.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974898"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.112 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Senior Executive Officers&#8221; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">has the meaning assigned to such term in Section 5.1.2.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.113 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Subcommittee&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> has the meaning assigned to such term in Section&#160;3.1.7.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-12-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974899"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.114 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Sublicensee&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means, with respect to a particular Product, a Third Party to whom GSK or Dynavax, as applicable, has granted a sublicense or license under any Dynavax Compound IP and/or Collaboration IP and/or Exclusively Licensed IP and/or GSK Development IP licensed to such Party pursuant to this Agreement, but excluding any Third Party acting solely as a distributor.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974902"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.115 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221; means </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.116 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221; means that certain </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, as amended from time to time, to the extent pertaining to </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of TLRs. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.117 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Term&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> has the meaning assigned to such term in Section 12.1.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974903"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.118 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Territory&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means the entire world. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974904"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.119 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Third Party&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means any entity other than Dynavax or GSK or an Affiliate of Dynavax or GSK.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974905"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.120 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;TLR&#8221; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">means any of the human toll-like receptors </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.121 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;TLR 7/9 Program&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means, collectively, the Dynavax Program directed toward the discovery, Research and Development of Compounds that inhibit both TLR 7 and TLR 9, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.122 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;United States&#8221; or &#8220;U.S.&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> means the United States of America and all of its territories and possessions.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc197434822"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">1.123 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Valid Claim&#8221; </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">means any claim within a pending (</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">), allowed or issued U.S. patent application or patent, or pending, accepted or issued patent application or patent in a jurisdiction outside the U.S., that has not expired, lapsed, been cancelled or abandoned, or been dedicated to the public, disclaimed, or held unenforceable, invalid, or cancelled by a court or administrative agency of competent jurisdiction in an order or decision from which no appeal has been or can be taken, including without limitation through opposition, reexamination, reissue or disclaimer.</font></p><p style="margin-bottom:0pt;margin-top:18pt;text-align:center;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974912"></a><font style="font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;">ARTICLE 2</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br><br></font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">RESEARCH AND DEVELOPMENT</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974908"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">2.1 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Overview</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Pursuant to this Agreement and as further provided in this Article 2, Dynavax will undertake the TLR 7/9 Program and, if identified and agreed pursuant to Section 2.5, one (1) or two (2) additional Dynavax Programs under the supervision of the JSC during the Research Term.&nbsp;&nbsp;The objective of the Dynavax Programs is the identification, optimization, Research and Development of Compounds, which Compounds GSK shall have Options to exclusively license on a worldwide basis, as provided in Article 4.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-13-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974913"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">2.2 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Development Plans.&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Each Dynavax Program will be carried out by Dynavax pursuant to a development plan (each, a </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Development Plan&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">) that will outline anticipated Research and Development activities to be conducted by Dynavax and </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any estimates regarding </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shall be intended as a general guide only, and Dynavax shall continue to progress each Dynavax Program with Commercially Reasonable Efforts, even if Commercially Reasonable Efforts would require a </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> set forth in the Development Plan.&nbsp;&nbsp;The initial Development Plan for the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> TLR 7/9 Program has been agreed to by the Parties and is attached hereto as </font><font style="text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibit A</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Development Plans for the other Dynavax Programs will be prepared in accordance with Section 2.5.&nbsp;&nbsp;The Development Plan for the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> will be prepared within </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> after the Effective Date, unless otherwise agreed by the JSC.&nbsp;&nbsp;From time to time during the Research Term </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, Dynavax shall update each Development Plan (or applicable portion thereof) and shall submit such updated Development Plan to the JSC for review and comment.&nbsp;&nbsp;Dynavax shall consider all such comments in good faith before preparing an updated Development Plan, however each such Development Plan will be designed with the objective of enabling a determination upon completion of the Development Plan as to whether all of the criteria (either Pre-Candidate Selection Criteria, Phase I Ready Criteria, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Criteria or PoC Criteria) have been met.&nbsp;&nbsp;Each updated Development Plan shall replace the Development Plan previously in effect.&nbsp;&nbsp;Each Development Plan will be reviewed as necessary at each meeting of the JSC, and at any other time upon the request of either Party, and the JSC may suggest modifications, as appropriate, to reflect material scientific or commercial developments.&nbsp;&nbsp;In the event of any inconsistency between any Development Plan and this Agreement, the terms of this Agreement shall prevail and any such inconsistent portion of a Development Plan is hereby expressly rejected.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">2.3 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Research Term</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;The Research term shall commence on the Effective Date and shall expire five (5) years thereafter (the &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Initial Research Term</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;), subject to extension (a) for up to </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of the Parties, or (b) </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> no later than </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> prior to expiration of the Initial Research Term, if </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, as applicable, before the expiration of the Initial Research Term (as may be extended, the &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Research Term</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;), and in such case, the Research Term shall be extended </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974915"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">2.4 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Dynavax Programs.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">2.4.1 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Dynavax Responsibility.&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prior to GSK&#8217;s exercise of an Option with respect to a Dynavax Program, Dynavax shall have primary responsibility for the Research and Development of each Compound (including, but not limited to, clinical trials and submissions to regulatory agencies) under such Dynavax Program in accordance with the applicable Development Plan.&nbsp;&nbsp;Subject to Sections 2.6.4 and 2.6.6, Dynavax shall be solely responsible for all internal and external expenses in connection with the Dynavax Programs.&nbsp;&nbsp;Subject to Section 5.2, Dynavax&#8217;s obligation to conduct each Dynavax Program shall terminate at the earlier of (a) GSK&#8217;s exercise of the Option with respect to such Dynavax Program, (b) expiration of the Research Term, as may be extended pursuant to Section 2.3, or (c) </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> decision to terminate such Dynavax Program.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-14-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">2.4.2 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Diligence.</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;The objective of each Dynavax Program is to discover and Develop </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and, if applicable under </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, Compounds satisfying the Proof of Concept Criteria or </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Criteria, as applicable.&nbsp;&nbsp;During the Research Term, Dynavax shall use Commercially Reasonable Efforts to conduct each Dynavax Program and related Research and Development activities for such Dynavax Program in accordance with the applicable Development Plan.&nbsp;&nbsp;In particular and without limiting the generality of the foregoing, and subject to Sections 2.6.4 and 2.6.6, for each Dynavax Program, Dynavax shall use Commercially Reasonable Efforts to conduct Research and Development activities to identify </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> that satisfy the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for each Dynavax Program and, if determined pursuant to </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, progress </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> through to either (i) completion of a </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Study in an effort to achieve the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Criteria, or (ii) completion of a Proof of Concept Study in an effort to achieve the Proof of Concept Criteria, as determined pursuant to Section 2.6.5.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">2.4.3 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">TLR 7/9 Program</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. The TLR 7/9 Program shall include efforts to discover, Research and Develop Compounds for </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> dual inhibitors of TLR 7 and TLR 9.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">2.4.4 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">GSK Research Activities</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;GSK shall, upon Dynavax&#8217;s request, consult with Dynavax regarding the Research and Development of Compounds under each Dynavax Program.&nbsp;&nbsp;On a Dynavax Program-by-Dynavax Program basis, the Parties shall discuss and consider in good faith </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, prior to GSK&#8217;s exercise of an Option with respect to such Dynavax Program in order to </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Dynavax shall </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc197434828"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">2.5 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Identification of Additional Programs.</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> may propose to the JSC up to two (2) additional Dynavax Programs to be conducted by Dynavax during the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Upon GSK&#8217;s request during the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, GSK and Dynavax will identify and agree upon, through the JSC, such additional two (2) Dynavax Programs to include under this Agreement, which during the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, would involve Research and Development of inhibitors of </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, and during the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, would involve Research and Development of inhibitors of </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;If the JSC cannot reach consensus on the selection of one or both of such additional Dynavax Programs, then </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> in accordance with Section 3.1.4(c).&nbsp;&nbsp;Promptly after each such Dynavax Program is selected, Dynavax shall prepare a Development Plan for such Program for submission to the JSC for review and comment.&nbsp;&nbsp;Dynavax shall consider all such comments in good faith before finalizing such Development Plan, after which Dynavax shall promptly commence and conduct such Program with its Commercially Reasonable Efforts.&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">2.6 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Compound Criteria; [ * ] and Proof of Concept Study Designs.&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">2.6.1 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Pre-Candidate Selection Criteria</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;The JSC shall establish the Pre-Candidate Selection Criteria&nbsp;&nbsp;for each Dynavax Program within (a) </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of the Effective Date for Back-up Compounds in the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> TLR 7/9 Program and for the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, or (b) </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of the identification of each other Dynavax Program under Section 2.5.&nbsp;&nbsp;Such Pre-Candidate Selection Criteria shall be consistent with the generic criteria attached in </font><font style="text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibit B</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, modified as necessary by mutual agreement of the JSC </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">2.6.2 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Phase I Ready Criteria</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;As of the Effective Date, the Parties have agreed upon the Phase I Ready Criteria for the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> TLR 7/9 Program, which criteria may be modified by mutual agreement of the JSC </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;The JSC shall establish the Phase I Ready Criteria for the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> within </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> TLR 7/9 Program.&nbsp;&nbsp;Within </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> after the identification of a Dynavax Program under Section 2.5, the JSC shall establish Phase I Ready Criteria for such Dynavax Program, which shall be substantially similar to the example of Phase I Ready Criteria set forth in </font><font style="text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibit C</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-15-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">2.6.3 </font><font style="font-weight:bold;font-style:italic;;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"> Criteria</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Prior to the determination by the JSC of a Phase 1 Ready Compound for a given Dynavax Program, GSK or Dynavax may propose that Dynavax </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for such Program, by submitting to the JSC proposed </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Criteria and </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Study Design that are reasonably consistent with the guidelines attached hereto as </font><font style="text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibit E</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;The JSC shall consider such proposal and determine, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, whether such Dynavax Program will include a </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Promptly following a decision by the JSC to conduct a </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Study, but in no event later than </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> over the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Criteria.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">2.6.4 </font><font style="font-weight:bold;font-style:italic;;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"> Design.</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;The JSC shall be responsible for establishing the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Design for each Dynavax Program for which a </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Study will be conducted.&nbsp;&nbsp;Notwithstanding </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> with respect to the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Study Design, as set forth in Section 3.1.4(c), in no event shall Dynavax be obligated to </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for any single </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Study and all Development activities required specifically for such </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Study.&nbsp;&nbsp;In the event that the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Study conducted in accordance with the applicable </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Study Design and Development Plan, and all Development activities required specifically for such </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Study, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, then </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, except to the extent due to </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;In the event that Dynavax </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for a PoC Study and all Development activities required specifically for such PoC Study, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, as such PoC Study and all Development activities required specifically for such </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> at the time of a JSC decision </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for any single </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Study and all Development activities required specifically for such </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Study, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for such </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Study and all Development activities required specifically for such </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Study against </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for such Dynavax Program after the completion of such </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Study.&nbsp;&nbsp;In the event that Dynavax </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for any single </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Study and all Development activities required specifically for such </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Study, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Calendar Days after </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> provided by Dynavax setting forth </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for such </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Study in the preceding Calendar Quarter.&nbsp;&nbsp;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of such </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> against </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of each milestone set forth in Sections </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, up to a </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In any event, Dynavax shall be obligated to complete any </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Study </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> pursuant to this Section 2.6.4.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><a name="OLE_LINK28"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">2.6.5 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Proof of Concept Criteria.</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;Prior to the initiation of the first applicable </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for a Program, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shall establish the provisional clinical trial design, including planned </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, for the Proof of Concept Study, and shall </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, collectively, as the Proof of Concept Criteria, prior to initiation of the PoC Study.&nbsp;&nbsp;All such Proof of Concept Criteria shall be established reasonably in accordance with the guidelines and examples attached hereto as </font><font style="text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibit D</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">2.6.6 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">PoC Study Design</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;The JSC shall be responsible for </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for each Dynavax Program.&nbsp;&nbsp;Notwithstanding </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="OLE_LINK5"></a> with respect to the PoC Study Design, as set forth in Section 3.1.4(c), in no event shall Dynavax be obligated to </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for any single Proof of Concept Study and all Development activities required specifically for such Proof of Concept Study.&nbsp;&nbsp;In the event that the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for any Proof of Concept Study conducted in accordance with the applicable PoC Study Design and Development Plan, and all Development activities required specifically for such Proof of Concept Study, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, then </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, except to the extent due to </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> within </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> after </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> provided by Dynavax setting forth the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for such Proof of Concept Study in the preceding Calendar Quarter.&nbsp;&nbsp;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of such </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> against </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of each milestone set forth in Sections 6.2.1 and 6.2.2, up to a </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In any event, Dynavax shall be obligated to complete any PoC Study funded by GSK pursuant to this Section 2.6.6. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-16-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974917"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">2.7 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Evaluation of Pre-Candidate Selection Criteria, Phase I Ready Criteria, [ * ] Criteria and Proof of Concept Criteria.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">2.7.1 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Pre-Candidate Selection Criteria</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;In the event that a Compound achieves </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of the Pre-Candidate Selection Criteria after Dynavax has completed the activities required to make such an assessment, it being understood by the Parties that drug discovery is an iterative problem-solving process and that multiple Compounds may be expected to be progressed in order to identify a Compound that merits advancement into IND-enabling studies, Dynavax shall promptly notify GSK in writing of such event and shall provide to the JSC a completed data package containing the complete set of the analyses, results and raw data from the Dynavax Program for such Compound (the &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Pre-Candidate Selection Report</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;).&nbsp;&nbsp;Unless otherwise agreed to by the Parties, the JSC will schedule an ad hoc meeting not more than </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> after receipt by GSK&#8217;s JSC representatives of such complete Pre-Candidate Selection Report to review such Pre-Candidate Selection Report and to confirm whether or not such Compound meets </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of the Pre-Candidate Selection Criteria.&nbsp;&nbsp;In the event that the JSC agrees that all or substantially all of the Pre-Candidate Selection Criteria have been met, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="OLE_LINK43"></a>, and Dynavax shall use its Commercially Reasonable Efforts to continue to progress the Dynavax Program through to completion of the PoC Study or </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Study, as applicable, subject to Section 2.7.2 below.&nbsp;&nbsp;If the JSC fails to agree that </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of the Pre-Candidate Selection Criteria have been met, then the matter shall be resolved by </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> determines that all or substantially all of the Pre-Candidate Selection Criteria have been met, then the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, and Dynavax shall use its Commercially Reasonable Efforts to continue to progress the Dynavax Program through to completion of the PoC Study or </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Study, as applicable under the relevant provisions of&nbsp;&nbsp;Articles 2 and 3.&nbsp;&nbsp;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of the Pre-Candidate Selection Criteria have been met, then Dynavax shall complete any additional studies as are </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Pre-Candidate Selection Criteria and progress such Compound through completion of the PoC study or </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Study, as applicable under the relevant provisions of Articles 2 and 3.&nbsp;&nbsp;If the achievement of such criteria is </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, Dynavax shall instead progress a Backup Compound in place of the Compound that failed to meet the criteria, and Dynavax shall use its Commercially Reasonable Efforts to progress such Backup Compound through to completion of the PoC Study or </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Study, as applicable under the relevant provisions of Articles 2 and 3.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><a name="OLE_LINK35"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">2.7.2 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Phase I Ready Criteria</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;In the event that a Compound achieves </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="OLE_LINK21"></a> of the Phase I Ready Criteria after Dynavax has completed the activities required to make such an assessment, it being understood by the Parties that drug discovery is an iterative problem-solving process, and that multiple Compounds may be expected to be progressed in order to identify a Compound that merits advancement into clinical Development, Dynavax shall promptly notify GSK in writing of such event and shall provide to the JSC a complete data package containing all analyses, results and raw data from the Dynavax Program for such Compound (the &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Phase I Ready Report</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;).&nbsp;&nbsp;Unless otherwise agreed to by the Parties, the JSC will schedule an ad hoc meeting not more than </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> after receipt by GSK&#8217;s JSC representatives of any such complete Phase I Ready Report to review such Phase I Ready Report and to confirm whether or not such Compound meets </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of the Phase I Ready Criteria.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(a) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the JSC agrees that such Compound has achieved </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of the Phase I Ready Criteria, then if such Compound is </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, the Parties shall determine whether GSK shall </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> as to such Dynavax Program pursuant to </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-17-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(b) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the JSC fails to agree that the Compound has satisfied </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of the Phase I Ready Criteria, then the matter shall be resolved by </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of the Phase I Ready Criteria have been met, then Dynavax shall complete any additional studies as are necessary </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> the Phase I Ready Criteria and progress such Compound through completion of the PoC study or </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Study, as applicable under the relevant provisions of Articles 2 and 3.&nbsp;&nbsp;If the achievement of such criteria is not </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, Dynavax shall instead progress a Backup Compound in place of the Compound that failed to meet the criteria, and Dynavax shall use its Commercially Reasonable Efforts to progress such Backup Compound through to completion of the PoC Study or </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Study, as applicable under the relevant provisions of Articles 2 and 3.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(c) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If either (i) the JSC agrees that such Compound has </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of the Phase I Ready Criteria, and GSK either </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> in accordance with the applicable provisions of this Agreement, or (ii) </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of the Phase I Ready Criteria, and GSK either </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> in accordance with the applicable provisions of this Agreement, then Dynavax shall progress such Compound into a Phase 1 Clinical Trial </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;A Compound that either the JSC, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of the Phase I Ready Criteria shall be considered to be at the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Phase I Ready&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> stage.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">2.7.3</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%"> </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_DV_C472"></a>[ * ] Criteria.&nbsp;&nbsp;Upon the completion of any [ * ] Study, Dynavax shall promptly notify GSK in writing of such event and shall provide to the JSC a complete data package containing all analyses, results and raw data from the completion of the [ * ] Study for such Phase I Ready Compound, and any related correspondence and information received from or sent to any Regulatory Authority relating to such Phase I Ready Compound (the &#8220;[ * ] Study Report&#8221;).&nbsp;&nbsp;GSK shall [ * ] upon the completion of the [ * ] Study pursuant to [ * ].&nbsp;&nbsp;Unless otherwise agreed by the Parties, if requested by GSK, the JSC will schedule an ad hoc meeting not more than [ * ] after receipt of any such [ * ] Study Report to review such [ * ] Study Report and confirm whether or not such Phase I Ready Compound satisfies the [ * ] Criteria.&nbsp;&nbsp;If the JSC (or the Executive Officers or GSK pursuant to Section 3.1.4(c)) decides that the Phase I Ready Compound did not satisfy the [ * ] Criteria, then, except as provided in Section 5.3, [ * ] with respect to such Dynavax Program a<a name="_DV_X467"></a>nd GSK [ * ] with respect to such Dynavax Program at [ * ].&nbsp;&nbsp;In the event that the Compound fails to satisfy the <a name="_DV_C474"></a>[ * ] Criteria after completion of the [ * ] Study, but GSK [ * ] to such Dynavax Program, and GSK determines to [ * ] Study, in such case [ * ] for such GSK Development Program shall all be [ * ] from the [ * ] otherwise applicable, and the applicable [ * ].&nbsp;&nbsp;If at any time after [ * ] the Compound that [ * ] Study [ * ], as applicable, then GSK shall [ * ].</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">2.7.4</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%"> </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;Proof of Concept Criteria.&nbsp;&nbsp;Upon the completion of any Proof of Concept Study, Dynavax shall promptly notify GSK in writing of such event and shall provide to the JSC a complete data package containing all analyses, results and raw data from the completion of the Proof of Concept Study for such Phase I Ready Compound, and any related correspondence and information received from or sent to any Regulatory Authority relating to such Phase I Ready Compound (the &#8220;PoC Study Report&#8221;).&nbsp;&nbsp; GSK shall have the right to exercise its Option to such Dynavax Program upon the completion of the Proof of Concept Study pursuant to Section 4.1 (whether or not such criteria have been satisfied).&nbsp;&nbsp;Unless otherwise agreed by the Parties, if requested by GSK, the JSC will schedule an ad hoc meeting not more than [ * ] Calendar Days after receipt of any such PoC Study Report to review such PoC Study Report and confirm whether or not such Phase I Ready Compound satisfies the Proof of Concept Criteria.&nbsp;&nbsp;If&nbsp;&nbsp;the JSC [ * ] decides that the Phase I Ready Compound did not satisfy the Proof of Concept Criteria, then, except as provided in Section 5.3, Dynavax will [ * ] with respect to such Dynavax Program, and GSK may, [ * ].&nbsp;&nbsp;In the event that the Compound fails to satisfy the Proof of Concept Criteria after completion of the Proof of Concept Study, [ * ] which completed the PoC Study, in such case the [ * ] and all other [ * ] for such GSK Development Program shall all be [ * ] from the [ * ] otherwise applicable, </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-18-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and the applicable [ * ].&nbsp;&nbsp;If at any time after Option exercise the Compound that completed the PoC Study [ * ], as applicable, then GSK shall [ * ].</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">2.8 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;[ * ].</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;During the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, the JSC will review the progress of each Dynavax Program and </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;The JSC may, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> decide to </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Dynavax Program(s) </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Dynavax Program(s) that </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Dynavax Programs, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;For clarity, if prior to the exercise by GSK of an Option with respect to a given Dynavax Program, the JSC is not in agreement, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. All such decisions shall be based on </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Notwithstanding the above, after GSK exercises an Option with respect to a Dynavax Program, GSK may, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, GSK shall be obligated to </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;For the purposes of determining whether there is </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, the TLR 7/9 Program shall </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (for example, if a Compound in the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> is being progressed, then the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> may be rendered </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, either prior to or after Option exercise by GSK). </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">2.9 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Reports</font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dynavax shall provide written progress reports on the status of each Dynavax Program, including without limitation summaries of data associated with Dynavax&#8217;s Research and Development activities and a timetable for completion of the respective Dynavax Program.&nbsp;&nbsp;Dynavax shall provide such written report to JSC members at least </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Business Days in advance of the applicable JSC meeting.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">2.10 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Material Transfer</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">.</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To facilitate the conduct of the Programs, either Party may provide to the other Party certain biological materials or chemical compounds, such as cell-based assays or specific Compounds, owned by or licensed to the supplying Party for use by the other Party in furtherance of the Development Plans (such materials or compounds provided hereunder are referred to, collectively, as &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Materials</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;).&nbsp;&nbsp;Except as otherwise provided under this Agreement, all such Materials delivered to the other Party shall remain the sole property of the supplying Party, shall be used only in furtherance of the Programs and solely under the control of the other Party (or its Affiliates), shall not be used or delivered to or for the benefit of any Third Party without the prior written consent of the supplying Party, and shall not be used in Research or testing involving human subjects, unless expressly agreed.&nbsp;&nbsp;The Materials supplied under this Section 2.9 are supplied &#8220;as is&#8221; and must be used with prudence and appropriate caution in any experimental work, since not all of their characteristics may be known. For the avoidance of doubt, this Section 2.10 shall not apply to any materials and/or Compounds supplied to GSK by Dynavax in accordance with Section 4.3 pursuant to the exercise by GSK of its Option for a Dynavax Program.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">2.11 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Regulatory Matters; Compliance.&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">2.11.1 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Compliance</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Dynavax shall conduct all pre-clinical activities and Clinical Trials under this Agreement in good scientific manner and in compliance in all material respects with applicable laws, rules and regulations and all other applicable requirements of cGMP, good laboratory practice and current good clinical practice.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">2.11.2 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Data Integrity</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(a) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dynavax acknowledges the importance to GSK of ensuring that the Dynavax Programs are undertaken in accordance with the following good data management practices:</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:26.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:26.67%">(i) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">data are being generated using sound scientific techniques and processes;</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-19-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:26.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:26.67%">(ii) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">data are being accurately and reasonably contemporaneously recorded in accordance with good scientific practices by Persons conducting Research hereunder;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:26.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:26.67%">(iii) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">data are being analyzed appropriately without bias in accordance with good scientific practices; and</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:26.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:26.67%">(iv) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">data and results are being stored securely and can be easily retrieved.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(b) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dynavax agrees that it shall use Commercially Reasonable Efforts to carry out the Dynavax Programs so as to collect and record any data generated therefrom in a manner consistent with the above requirements as set forth in subsection (a) above. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">2.11.3 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Ownership</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> all regulatory filings for Compounds </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Upon </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> with respect to a Dynavax Program, Dynavax shall </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> as soon as reasonably practicable of all regulatory filings for the resulting GSK Development Compounds (including Back-up Compounds), including all relevant INDs, and provide GSK with copies of such INDs and other regulatory filings and all pre-clinical and clinical data and results (including pharmacology, toxicology, formulation, and stability studies).&nbsp;&nbsp;Thereafter, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and maintain all regulatory filings and Regulatory Approvals for GSK Development Compounds.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">2.11.4 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Adverse Event Reporting</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. Beginning on the Effective Date and continuing until such time, if any, that GSK exercises its Option with respect to a Dynavax Program, Dynavax shall be responsible for reporting all adverse drug reaction experiences related to Compounds in such Dynavax Program in connection with the activities of Dynavax under this Agreement to the appropriate Regulatory Authorities in the countries in the Territory in which such Compounds are being Developed, in accordance with the appropriate laws and regulations of the relevant countries and Regulatory Authorities.&nbsp;&nbsp;Dynavax shall provide GSK notice of such event within five (5) days and provide copies of all reports to GSK as soon as possible, including using Commercially Reasonable Efforts to provide such copies. Through the JSC, GSK shall have the right to review from time to time Dynavax&#8217;s pharmacovigilance policies and procedures.&nbsp;&nbsp;GSK and Dynavax agree to cooperate and use good faith efforts to ensure that Dynavax&#8217;s adverse event database is organized in a format that is compatible with GSK&#8217;s adverse event databases.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974919"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">2.12 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Dynavax Program Costs.</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;Except as set forth in this Article 2, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shall </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> in connection with performing activities under a Dynavax Program.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974921"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">2.13 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Subcontracting</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Subject to the terms of this Agreement, each Party shall have the right to engage Affiliates or Third Party subcontractors to perform certain of its obligations under this Agreement.&nbsp;&nbsp;Any Affiliate or subcontractor to be engaged by a Party to perform a Party&#8217;s obligations set forth in the Agreement shall meet the qualifications typically required by such Party for the performance of work similar in scope and complexity to the subcontracted activity.&nbsp;&nbsp;Notwithstanding the preceding, any Party engaging an Affiliate or subcontractor hereunder shall remain principally responsible and obligated for such activities.&nbsp;&nbsp;In addition, each Party engaging a subcontractor with respect to its obligations under a Dynavax Program shall in all cases retain or obtain exclusive Control of any and all intellectual property created by or used with the relevant Party&#8217;s permission by such subcontractor directly related to such subcontracted activity under the Dynavax Program.&nbsp;&nbsp;The Party engaging a subcontractor under a Dynavax Program shall be solely responsible for all costs associated with obtaining such exclusive Control and rights to such intellectual property.&nbsp;&nbsp; For example and not </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-20-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">by limitation, Dynavax shall ensure that it retains or obtains exclusive Control of any intellectual property created by or used with the relevant Party&#8217;s permission by any academic or any contract research, manufacturing or development organization appointed by Dynavax to fulfill any of its obligations under this Agreement.&nbsp;&nbsp;However, it is understood that, in some cases, it may not be commercially reasonable for such Party </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;To the extent that such </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> from any such subcontractor under a Dynavax Program, prior to entering into such arrangement with such subcontractor, such Party shall bring such matter to the JSC for the prior approval of the JSC to enter into such arrangement and for approval by the JSC of the licensing terms and conditions with respect to such arrangement.</font></p><p style="margin-bottom:0pt;margin-top:18pt;text-align:center;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;">ARTICLE 3</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br><br></font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">MANAGEMENT OF THE COLLABORATION</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974910"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">3.1 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Joint Steering Committee</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Promptly and in any event within </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> days after the Effective Date, the Parties shall establish a committee (the &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Joint Steering Committee</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221; or </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;JSC&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">) as more fully described in this Section 3.1.&nbsp;&nbsp;The JSC shall have review, oversight and decision-making responsibilities for all Research and Development activities performed under this Agreement, as more specifically provided herein.&nbsp;&nbsp;Each Party agrees to keep the JSC informed of its progress and activities under the Programs.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">3.1.1 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Membership</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;The JSC shall be comprised of three (3) representatives (or such other number of representatives as the Parties may agree) from each of GSK and Dynavax.&nbsp;&nbsp;Each Party shall provide the other with a list of its initial members of the JSC no later than thirty (30) days prior to the first scheduled meeting of the JSC, which shall be no later than ninety (90) days after the Effective Date.&nbsp;&nbsp;Each Party may replace any or all of its representatives on the JSC at any time upon written notice to the other Party in accordance with Section 13.7 of this Agreement.&nbsp;&nbsp;Each representative of a Party shall have relevant expertise (either individually or collectively) in pharmaceutical drug discovery and development.&nbsp;&nbsp;Any member of the JSC may designate a substitute to attend and perform the functions of that member at any meeting of the JSC.&nbsp;&nbsp;Each Party may, in its reasonable discretion, invite non-member representatives of such Party to attend meetings of the JSC as non-voting participants, subject to the confidentiality obligations of Article 9.&nbsp;&nbsp;The Parties shall designate a chairperson (each, a &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Chairperson</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;) to oversee the operation of the JSC and prepare minutes as set forth in Section 3.1.3, each such Chairperson to serve a twelve (12) month term. The right to name the Chairperson shall alternate between the Parties, with </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> designating the first such Chairperson.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">3.1.2 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Meetings</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;During the Research Term, the JSC shall meet in person or otherwise at least once each Calendar Quarter, and more or less frequently as the Parties mutually deem appropriate, on such dates and at such places and times as provided herein or as the Parties shall agree.&nbsp;&nbsp;Subject to Section 5.5, upon conclusion of the Research Term, the JSC shall meet, in person or otherwise, at least once every Calendar Year to provide Dynavax an update regarding GSK&#8217;s efforts to Develop and commercialize Compounds and GSK Products in the GSK Development Programs, including without limitation, material changes in the clinical development plans for GSK Products, status of regulatory filings, anticipated indications, anticipated launch dates, manufacturing issues, and the like.&nbsp;&nbsp;Meetings of the JSC that are held in person shall alternate between the offices of the Parties, or such other place as the Parties may agree.&nbsp;&nbsp;The members of the JSC also may convene or be polled or consulted from time to time by means of telecommunications, video conferences, electronic mail or correspondence, as deemed necessary or appropriate.&nbsp;&nbsp;Each Party will bear all expenses it incurs in regard to participating in all meetings of the JSC, including all travel and living expenses.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-21-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">3.1.3 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Minutes</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;The Alliance Manager from the Party other than the Party of the Chairman, shall be responsible for preparing and circulating minutes of each meeting of the JSC, setting forth, </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">inter alia</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, an overview of the discussions at the meeting and a list of any actions, decisions or determinations approved by the JSC and a list of any issues to be resolved by the Executive Officers pursuant to Section 3.1.4.&nbsp;&nbsp;Such minutes shall be effective only after approved by both Parties.&nbsp;&nbsp;With the sole exception of specific items of the meeting minutes to which the members cannot agree and that are escalated to the Executive Officers as provided in Section 3.1.4 below, definitive minutes of all JSC meetings shall be finalized no later than thirty (30) days after the meeting to which the minutes pertain.&nbsp;&nbsp;If at any time during the preparation and finalization of the JSC minutes, the Parties do not agree on any issue with respect to the minutes, such issue shall be resolved by the escalation process as provided in Section 3.1.4.&nbsp;&nbsp;The decision resulting from the escalation process shall be recorded by the Alliance Manager in amended finalized minutes for such meeting.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">3.1.4 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Decisions</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Except as otherwise provided herein, with respect to a given Program, all decisions of the JSC prior to Option exercise by GSK shall be made by </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, with each Party having </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;In the event that the JSC </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> on a matter regarding a Dynavax Program within </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Calendar Days after it has met and attempted to reach such decision, then, except for matters expressly identified in this Agreement as not subject to escalation to the Executive Officers pursuant to this Section 3.1.4, either Party may, by written notice to the other, have such issue referred to </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> from time to time </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, for resolution.&nbsp;&nbsp;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, which shall in no case be more than </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> after the matter was referred to </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, the issue shall be finally resolved as follows:</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(a) </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shall have final decision-making authority with respect to any disputes concerning </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(b) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the dispute concerns whether </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, the disputed issue shall be </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(c) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">GSK shall have final decision-making authority with respect to any disputes concerning </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">3.1.5 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Responsibilities</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;The JSC shall perform the following functions, subject to the final decision-making authority of the respective Parties as set forth in Section 3.1.4(a), (b) and (c), some or all of which may be addressed directly at any given meeting of the JSC:</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(a) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">review and comment on the Development Plan for each Dynavax Program and monitor progress of activities under such Development Plan;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(b) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">oversee and guide the progress of each Dynavax Program in accordance with the applicable Pre-Candidate Selection Criteria, Phase I Ready Criteria, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Criteria and Proof of Concept Criteria;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(c) </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(d) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">prepare, review, modify, update and approve each Proof of Concept Study Design and </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Study Design;</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-22-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(e) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">identify the Dynavax Programs to be conducted by Dynavax under this Agreement;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(f) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">assess the Proof of Concept Criteria and, if applicable, the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Criteria, for each Dynavax Program;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(g) </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> that a Compound has satisfied the Pre-Candidate Selection Criteria, Phase I Ready Criteria, Proof of Concept Criteria, or </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Criteria;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(h) </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> all Dynavax Programs and decide whether to </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> a Dynavax Program; </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(i) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">except as otherwise provided in Section 3.1.8 below, discuss and attempt to resolve any deadlock issues submitted to it by any Subcommittee (as defined in Section 3.1.7), in accordance with the procedures established in Section 3.1.4;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(j) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">serve as an information transfer vehicle, from time to time, to facilitate the discussion of Development and commercialization of GSK Products under GSK Development Programs;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(k) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">periodically review the Development and commercialization of any GSK Product and GSK Development Plan and </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">; and</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(l) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">such other responsibilities as may be assigned to the JSC pursuant to this Agreement or as may be mutually agreed upon by the Parties from time to time.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For clarity, the JSC shall not have any authority beyond the specific matters set forth above in this Section 3.1.5, and in particular shall not have any power to amend or modify the terms or provisions of this Agreement.&nbsp;&nbsp;In addition, GSK (and not Dynavax or the JSC) shall have the sole right to make decisions with respect to (i) the exercise of an Option; or (ii) subject to Section 5.5 and GSK&#8217;s diligence obligations in Section 5.1.3, the Research, Development, progression, manufacture, and commercialization of Compounds or Products in GSK Development Programs.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">3.1.6 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Dynavax&#8217;s Right to Withdraw</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Dynavax will have the right to withdraw from participation on and thereby terminate any of its rights and obligations to participate in the JSC at any time after the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> anniversary of the Effective Date upon written notice to GSK.&nbsp;&nbsp;Upon withdrawal by Dynavax from participation in the JSC, GSK will have the sole decision-making authority with respect to any matters that would otherwise have been subject to Sections 3.1.4(a) or 3.1.4(b) and GSK shall have the right in such event, in its sole discretion, to immediately terminate all of Dynavax&#8217;s Co-Development and Co-Promotion rights, whether previously exercised or not, under this Agreement.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">3.1.7 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Subcommittee(s).</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;From time to time, the JSC may establish subcommittees to oversee particular projects or activities, as it deems necessary or advisable (each, a &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Subcommittee</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;).&nbsp;&nbsp;Each Subcommittee shall consist of such number of members as the JSC determines is appropriate from time to time.&nbsp;&nbsp;Such members shall be individuals with expertise and responsibilities in the areas of pre-clinical development, </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-23-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">clinical development, patents, process sciences, manufacturing, regulatory affairs, product development and/or product commercialization, as applicable to the stage of development of the project or activity.&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc197434836"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">3.1.8 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Joint Patent Subcommittee</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Within two (2) months after the Effective Date, the JSC shall establish a Subcommittee (the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Joint Patent Subcommittee&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or&nbsp;&nbsp;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;JPS&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">) to be responsible for the coordination of the Parties&#8217; efforts in accordance with Article 8 of this Agreement, including the review and filing of patent applications and assessments of inventorship of inventions created during the Research Term under the Dynavax Programs.&nbsp;&nbsp;The JPS shall be comprised of an equal number of representatives from each of GSK and Dynavax and shall meet on such dates and at such places and times agreed to by the Parties.&nbsp;&nbsp;All decisions of the JPS on matters for which it has responsibility shall be made by consensus, with each Party having collectively one (1) vote in all decisions.&nbsp;&nbsp;In the event that the JPS is unable to reach a consensus decision within fifteen (15) Calendar Days after it has met and attempted to reach such decision, then either Party may, by written notice to the other, have such issue submitted to the chief patent counsel of GSK and of Dynavax (together, the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Chief Patent Counsel&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">), or such other person holding a similar position designated by GSK or Dynavax from time to time, for resolution.&nbsp;&nbsp;The Chief Patent Counsel shall meet promptly to discuss the matter submitted and to determine a resolution.&nbsp;&nbsp;Prior to exercise of an Option for a Dynavax Program, if the Chief Patent Counsel are unable to determine a resolution in a timely manner: (a) with respect to </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> related to such Program, then the decision of the chief patent counsel </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shall be binding upon the Parties without further review, and (b) with respect to </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> related to such Program, then the decision of the chief patent counsel of </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shall be binding upon the Parties without further review.&nbsp;&nbsp;Each Party will bear all expenses it incurs in regard to participating in all meetings of the JPS, including all travel and living expenses.</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">After exercise of an Option hereunder for a Dynavax Program, if the Chief Patent Counsel are unable to determine a resolution in a timely manner with respect to any Patents related to such Program, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974911"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">3.2 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Alliance Managers</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Promptly after the Effective Date, each Party shall appoint an individual (who may not be an existing member of the JSC) to act as alliance manager for such Party (each, an &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Alliance Manager</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;). Each Alliance Manager shall thereafter be permitted to attend meetings of the JSC as a nonvoting observer, subject to the confidentiality provisions of Article 9.&nbsp;&nbsp;The Alliance Managers shall be the primary point of contact for the Parties regarding the activities contemplated by this Agreement and shall facilitate all such activities hereunder including, but not limited to, the exchange of Information described in Section 2.9.&nbsp;&nbsp;The Alliance Managers shall also be responsible for assisting the JSC in performing its oversight responsibilities.&nbsp;&nbsp;The name and contact information for each Party&#8217;s Alliance Manager, as well as any replacement(s) chosen by Dynavax or GSK, in their sole discretion, from time to time, shall be promptly provided to the other Party in accordance with Section 13.7 of this Agreement. </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-align:center;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026659"></a><font style="font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;">ARTICLE 4</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br><br></font><font style="font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;">GRANT OF RIGHTS</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026660"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">4.1 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Options</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">4.1.1 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Grant</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Dynavax hereby grants to GSK the exclusive option, exercisable on a Dynavax Program-by-Dynavax Program basis at GSK&#8217;s sole discretion, to obtain the exclusive license set forth in Section 4.2.1 (each, an &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Option</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;), subject to the terms and conditions described in Sections 4.1.2 - 4.1.6 below.&nbsp;&nbsp;GSK shall be limited to exercising one Option per Dynavax Program, and on exercise of an Option and </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-24-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">payment of the applicable Option exercise fee, GSK shall have rights to such Dynavax Program consisting of all Compounds under a given Dynavax Program.&nbsp;&nbsp;For the purposes of this Section 4.1, the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shall be considered distinct Dynavax Programs, each subject to a separate Option.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">4.1.2 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"> Period</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;For the two (2) Dynavax Programs other than </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, the Parties will determine whether GSK may exercise the Option </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> after a Phase I Ready Compound has completed the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Proof of Concept Study, as applicable, as follows.&nbsp;&nbsp;Within </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> after the JSC determines that a Compound has reached the Phase I Ready stage pursuant to Section 2.7.2(a), the Parties shall </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or Dynavax shall </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, as applicable.&nbsp;&nbsp;If the Parties do not agree within such </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> period, or if the Parties do agree that </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, as applicable, then Dynavax shall continue to progress the Dynavax Program, and the Option for such Dynavax Program may be exercised only following completion of </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> the Proof of Concept Study, as applicable; </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">provided</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, however, that if in GSK&#8217;s reasonable judgment as specified in a reasonably detailed written notice to Dynavax delivered within </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> after attainment of the Phase I Ready stage, Dynavax does not </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, as applicable, then GSK </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;For clarity, GSK may exercise the Option with respect to the TLR 7/9 Program under any of the following circumstances, at the sole discretion of GSK, but in any event </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">:&nbsp;&nbsp;(i) after completion of the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or Proof of Concept Study, as determined pursuant to Section 2.6.3, or (ii) pursuant to Section 4.1.3(b) or 4.1.3(c).</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026662"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">4.1.3 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Exercise</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(a) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Option Period Start&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> with respect to a Dynavax Program will commence upon the receipt by GSK of written notice from Dynavax of the complete PoC Study Report, complete </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Study Report, or </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, as the case may be, as well as access to GSK to the Dynavax data room containing the complete set of material or relevant clinical and preclinical information related to the applicable Dynavax Program.&nbsp;&nbsp;GSK shall decide whether or not to exercise the Option and may exercise the Option with respect to a Dynavax Program by written notice to Dynavax at any time within </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> after the Option Period Start, unless extended pursuant to Section 4.1.5 or otherwise extended by the mutual written agreement of the Parties.&nbsp;&nbsp;Upon GSK&#8217;s exercise of an Option and receipt by Dynavax of the applicable Option exercise fee set forth in Section 6.2.1(a) or 6.2.2(a) pursuant to the procedure set forth in Section 6.7, the Dynavax Program will become a GSK Development Program.&nbsp;&nbsp;Subject to Section 5.3.2, any Option exercise shall be irrevocable. GSK shall have the right, at any time after exercising the Option with respect to a Dynavax Program and at its sole discretion, to </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> from the same Dynavax Program.&nbsp;&nbsp;</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-25-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(b) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, in the event that either (i) a </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, or (ii) a </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> occurs (as defined below), GSK shall have the right to exercise its Options to any and all Dynavax Programs, and to terminate Dynavax&#8217;s </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> rights to participate in the JSC and related Subcommittees, at GSK&#8217;s sole discretion, by providing written notice to Dynavax within </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of (A) the event described in (i) above; or (B) the event described in (ii) above, provided that within </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Business Days after Dynavax notifies GSK pursuant to Section 10.2.9, Dynavax shall provide to GSK a written plan for </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and the Parties shall meet to discuss such plan, and if such plan is not reasonably acceptable to GSK (as reasonably detailed in written notice to Dynavax) then a </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shall have occurred.&nbsp;&nbsp;Upon the exercise by GSK of its Option to a Dynavax Program pursuant to this Section 4.1.3(b), the Option exercise fee and the applicable milestone payments and royalty payments due under Article 6 shall all be </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> as follows on a Program-by-Program basis for each Program with respect to which GSK exercises its Option:</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:33.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:33.33%">(1) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">if Option exercise occurs for a Dynavax Program with a lead Compound (other than the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">) that has not yet satisfied the Pre-Candidate Selection Criteria, then the Option exercise fee and the milestone and royalty payments shall be </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:33.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:33.33%">(2) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">if Option exercise occurs for a Dynavax Program with a lead Compound that has satisfied the Pre-Candidate Selection Criteria but is prior to the Phase I Ready stage, then the Option exercise fee and the milestone payments and the royalty payments either (i) shall be </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, for a Program other than </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, or (ii) shall be </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:33.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:33.33%">(3) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">if Option exercise occurs for a Dynavax Program with a lead Compound at the Phase I Ready stage, but prior to initiation of a Phase 2 Clinical Trial, then the Option exercise fee and the milestone payments and royalty payments shall all be [ * ] from the payments that would have been payable under Article 6 had GSK exercised its Option after completion of the Proof of Concept Study;&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:33.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:33.33%">(4) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">if Option exercise occurs for a Dynavax Program after the initiation of a Phase 2 Clinical Trial for such Program, then the Option exercise fee and the milestone payments and royalty payments shall be [ * ] that would have been payable under Article 6 had GSK exercised its Option after the Proof of Concept Study; and</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:33.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:33.33%">(5) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">if Option exercise occurs for a Dynavax Program pursuant to Section 4.1.3(b)(ii) wherein Dynavax has [ * ] (i) within [ * ] of the Effective Date of this Agreement, then,&nbsp;&nbsp;[ * ] above of this Section 4.1.3(b), in the total amount of [ * ], and, if such Option exercise occurs (ii) more than [ * ] after the Effective Date but prior to [ * ] after the Effective Date of this Agreement, then, [ * ] above of this Section 4.1.3(b), in the total amount of&nbsp;&nbsp;[ * ].</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The respective obligations of the Parties with respect to exclusivity under Article 7 shall remain unchanged.&nbsp;&nbsp;&nbsp;&nbsp; </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(c) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the event that a </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, then within </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> after the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, and quarterly thereafter, the Parties and the acquiror shall meet to discuss, in good faith and in as much detail and specifics as is practicable at the time, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> under this Agreement.&nbsp;&nbsp;If at any time in the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> following the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, GSK has a reasonable, good faith basis to believe, based on the plans, documents, actions or inactions of Dynavax </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> that Dynavax </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> has not or will not, with respect to any Program, employ diligent efforts or human and material resources that are at least equivalent to the diligent efforts and human and material </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-26-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">resources that were employed by Dynavax for the Program prior to (and without any allowance for) any delay, disruption or de-prioritization of such Program as a result of or in contemplation of such </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, then GSK shall provide written notice to Dynavax </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, such notice to allege the specific basis for GSK&#8217;s view that the diligent efforts or human and material resources being applied or to be applied to the Program in question are or are expected to be less than those that were applied to the Program by Dynavax </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Dynavax </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shall notify GSK whether or not it plans to cure such deficiency, and if it so elects to cure, shall have a </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> to cure any such deficiencies in efforts or resources so alleged by GSK.&nbsp;&nbsp;In the event that Dynavax </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> notifies GSK that it does not intend to cure such deficiencies or GSK reasonably believes that such deficiency has not been corrected or cured within such </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, GSK shall have the right to exercise its Options to any and all Dynavax Programs, and to terminate Dynavax&#8217;s </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> rights to participate in the JSC and related Subcommittees, at GSK&#8217;s sole discretion, by providing written notice to Dynavax within thirty (30) days after such </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or such notice from Dynavax </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Upon the exercise by GSK of its Option to a Dynavax Program pursuant to this Section 4.1.3(c), the Option exercise fee and the applicable milestone payments and royalty payments due under Article 6 shall all be </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> as set forth in Section 4.1.3(b)(1)-(5) as applicable, on a Program-by-Program basis for each Program with respect to which GSK exercises its Option.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">4.1.4 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Expiration or Termination of Option</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;If GSK does not exercise the Option with respect to a particular Dynavax Program within the applicable </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or GSK elects not to exercise the Option, then, subject to Section 4.1.5, the Option shall terminate with respect to such Dynavax Program, which shall become a Dynavax Development Program, and Dynavax will thereafter have all rights, itself or with or through an Affiliate or Third Party, (a) to Develop and commercialize all Compounds within the Dynavax Program, subject to any applicable&nbsp;&nbsp;royalty payments set forth in Section 6.5, and (b) to use any data, regulatory filings and know-how generated or used in the course of the Dynavax Program, to the extent such </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> that are included in the Dynavax Development Program.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">4.1.5 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">HSR and Equivalent Foreign Laws.&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If GSK reasonably determines in good faith prior to the expiration of the applicable period for exercise of an Option for a particular Dynavax Program (the &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Option Deadline Period</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;) that the exercise of such Option is required to be filed with the Federal Trade Commission (the &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">FTC</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;) under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (15 U.S.C. &#167;18a) (&#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">HSR</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;) or with equivalent foreign governmental authorities under any similar foreign law, GSK shall provide written notice of exercise of the Option to Dynavax prior to the end of the Option Deadline Period, which notice shall include GSK&#8217;s binding commitment to complete the exercise of the Option, subject only to HSR or other governmental clearance by the FTC or other governmental authority, and the Option Deadline Period automatically shall be extended for </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (the &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Option Deadline Extension Period</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;).&nbsp;&nbsp;If the exercise of the Option does not comply with the requirements of Section 4.1 and this Section 4.1.5, including, for example, because it includes other conditions to the completion of the exercise of the Option other than the grant of HSR or other governmental clearance, then the Parties shall negotiate in good faith to determine an appropriate way to proceed.&nbsp;&nbsp;If HSR or other governmental clearance is not granted within the Option Deadline Extension Period, or if GSK receives a &#8220;Second Request&#8221; from the FTC or similar request for additional information from a governmental authority in connection with such filing, the Option Deadline Extension Period shall be extended for an additional period of time (not to exceed an additional </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">) to permit GSK to obtain FTC or other governmental clearance or to respond to the Second Request or provide additional information to the governmental authority.&nbsp;&nbsp;If GSK elects not to respond to the Second Request or to withdraw its request for HSR or other governmental clearance or HSR, the Option shall terminate, and Dynavax shall have the same rights as are set forth in Section 4.1.4 in respect of the Compounds resulting from the applicable Dynavax Program.&nbsp;&nbsp;If </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-27-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HSR or other governmental clearance has not been granted by the end of the extended Option Deadline Extension Period, Dynavax and GSK shall promptly meet to discuss in good faith whether an additional extension of the Option Deadline Extension Period is reasonable under the circumstances, and to discuss and consider in good faith, where appropriate, the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, with the objective of placing each Party</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> if the Program in question had not been included in the Agreement from the beginning as of the Effective Date.&nbsp;&nbsp;Notwithstanding the foregoing, nothing in this paragraph or the Agreement shall require either Party to divest any assets or to take action (beyond cooperation with the other Party) to respond to any Second Request.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc179679531"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">4.1.6 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Tolling of Payment Obligations</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;If the exercise by GSK of any Option under Section 4.1 requires the making of filings under HSR, or under any similar premerger notification provision in the European Union or any other jurisdiction, then all rights and obligations related to the exercise of such Option (including payment of any Option exercise fee or other milestone) shall be tolled until the applicable waiting period has expired or been terminated or until approval or clearance from the reviewing authority has been received, and each Party agrees to cooperate at the request of the Party which decides in its sole discretion to respond to any such request for information to expedite review of such transaction.&nbsp;&nbsp;In the event that HSR clearance is not reasonably achievable within </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> days from notification, the Parties shall discuss in good faith potential alternatives, including, without limitation, termination of the relevant Program or the Agreement, as may be mutually agreed between the Parties in good faith, and, where appropriate, to discuss and consider in good faith the renegotiation of their financial and other obligations under the Agreement with respect to the affected Program.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026664"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">4.2 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">License Grants</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">4.2.1 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">License to GSK</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Subject to the terms and conditions of this Agreement and upon GSK&#8217;s exercise of the relevant Option in accordance with Section 4.1 and Dynavax&#8217;s receipt of the applicable Option exercise fee, Dynavax and its Affiliates shall be hereby deemed to have granted and hereby grant to GSK the exclusive right and license (even as to Dynavax and its Affiliates, except for the limited purpose of conducting Research and Development activities with respect to Back-up Compounds or formulations as expressly contemplated under Section 5.2) in the Territory, with the right to grant sublicenses, under all of Dynavax&#8217;s and its Affiliates&#8217; right, title and interest in and to the Exclusively Licensed IP to make, have made, use, sell, offer for sale and import Compounds under such Dynavax Program as and into GSK Products in the Field during the Term. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">4.2.2 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">No Grant of Rights to Third Parties</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Until such time as the Option Deadline Period, including any Option Deadline Extension Period (as may be extended), for an Option granted to GSK pursuant to Section 4.1 with respect to a given Dynavax Program has expired or terminated (including, for example, because </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> terminated a Dynavax Program), Dynavax and its Affiliates shall not grant to any Third Party rights to any Exclusively Licensed IP that are inconsistent with or that would interfere with the grant of the licenses that may result from the exercise of such Option by GSK hereunder.&nbsp;&nbsp;For the avoidance of doubt, the Parties understand and agree that for so long as an Option is in effect, such Option shall be exclusive as to the Compounds that are the subject of the relevant Dynavax Program, and Dynavax and its Affiliates shall have no right to offer or negotiate with any Third Party with respect to the grant to such Third Party of any right or license, or with respect to any settlement, consent judgment or other disposition of any action or proceeding under Article 8, or with respect to any other encumbrance of any kind, in or to any of such Compounds or any Exclusively Licensed IP that would interfere with the grant of the licenses resulting from the exercise of such </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-28-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Option to GSK hereunder.&nbsp;&nbsp;The grant of the Options by Dynavax hereunder is irrevocable except as provided under Article 12.&nbsp;&nbsp;GSK acknowledges that certain of the Exclusively Licensed IP to the extent that it pertains to compounds which are not Compounds or Products hereunder is subject to the terms and conditions of the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and that such grant of rights, so long as such grant is consistent with and does not interfere with the grant of exclusive licenses in the Field and in the Territory from the exercise of an affected Option hereunder, shall not be deemed a breach of this Agreement.&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026667"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">4.3 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Technology Transfer after Option Exercise. </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> As soon as reasonably practicable after GSK exercises its Option for a Dynavax Program pursuant to Section 4.1 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, Dynavax shall deliver to GSK, at no cost to GSK, all Information and material in its possession and Control relating to the Compounds in such GSK Development Program, including those documents and materials set out in Exhibit G, and any other such Information as may be in Dynavax&#8217;s Control and in the possession of any subcontractors (including third party manufacturers) appointed by Dynavax under Section 2.13, in each case in a format to be agreed between the Parties but which is in an electronically editable format suitable for eCTD submission.&nbsp;&nbsp;Dynavax shall</font><font style="font-family:SimSun;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="OLE_LINK47"></a> provide such technology transfer services as may be reasonably necessary to </font><font style="font-weight:bold;font-family:SimSun;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:SimSun;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> the Compound manufacturing processes at GSK&#8217;s or GSK&#8217;s Third Party manufacturer&#8217;s site; provided that GSK shall be responsible for </font><font style="font-weight:bold;font-family:SimSun;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:SimSun;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> to provide those services reasonably necessary to </font><font style="font-weight:bold;font-family:SimSun;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:SimSun;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of the Compound manufacturing processes by GSK, and </font><font style="font-weight:bold;font-family:SimSun;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:SimSun;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">from Dynavax therefor.&nbsp;&nbsp;</font><font style="font-weight:bold;font-family:SimSun;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Dynavax shall use Commercially Reasonable Efforts with respect to those activities for which it is responsible to ensure orderly transition and uninterrupted Development of the GSK Development Program.&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">4.4 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Third Party Licenses</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">4.4.1 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the Term, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (a) required for the exploitation of Dynavax&#8217;s proprietary platform technology or any other technology used by Dynavax in conducting a Dynavax Program or Dynavax Development Program, (b) obtained by Dynavax prior to the Effective Date, or (c) to the extent related to the composition of matter or method of use of a Compound as contemplated under a Dynavax Program.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">4.4.2 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">With respect to any Third Party license necessary for the manufacture, formulation or commercialization of a GSK Product in a GSK Development Program (other than any license described in Section 4.4.1), after GSK exercises the Option with respect to such GSK Development Program, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> obligation to pay any amounts for Third Party licenses as set forth above shall terminate immediately if GSK or Dynavax (in the case of an uncured material breach by GSK) </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:18pt;text-align:center;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026663"></a><font style="font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;">ARTICLE 5</font><font style="text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;font-variant: normal;"><br></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br></font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">POST-EXERCISE ACTIVITIES </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026668"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">5.1 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">GSK Development and Commercialization</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">5.1.1 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Following exercise of an Option with respect to a Dynavax Program, subject to Sections 5.2 and 5.5, GSK, either itself and/or by and through its Affiliates, Sublicensees or contractors, shall be responsible for all Research, Development, regulatory, manufacturing, marketing, advertising, promotional, launch and sales activities in connection with GSK Products containing Compounds from such Program.&nbsp;&nbsp;Except as set forth in Section </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-29-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">5.1.2 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Subject to Section 5.5.1(c), GSK shall have sole decision-making authority with respect to the Research, Development, progression, regulatory activities, manufacturing and commercialization of any Compound within a GSK Development Program, without submitting such matter to the JSC or Senior Executive Officers.&nbsp;&nbsp;In the event that the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for resolution.&nbsp;&nbsp;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> determine a resolution.&nbsp;&nbsp;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> in a timely manner, which shall in no case be </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">5.1.3 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">GSK Diligence.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(a) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Following GSK&#8217;s exercise of an Option with respect to a Dynavax Program, GSK shall use its Commercially Reasonable Efforts to Develop and commercialize </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> in such GSK Development Program in </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, subject to the provisions of Section 2.8.&nbsp;&nbsp;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> provided, however, that the Parties acknowledge and agree that, for the purposes solely of this Section 5.1.3(a), </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, it is appropriate for </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;In the event that, as a result of any such </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Country, such right of Dynavax shall be exercised in a manner </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (collectively, the &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Coordination Conditions</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;); provided that if the Coordination Conditions apply, if such Product is commercialized by Dynavax or any Affiliate or sublicensee thereof in such country </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, and GSK </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, then Dynavax or any Affiliate or licensee thereof shall, to the extent permitted under applicable law, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, as the case may be, or shall </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> under this Section 5.1.3 in </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;For clarity, and without limiting any other provision of this Agreement, any dispute regarding the application or enforcement of this Section 5.1.3 shall be </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(b) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Notwithstanding the foregoing Section 5.1.3(a) and for the avoidance of doubt, Dynavax acknowledges and agrees that in the event it (or its Affiliates or sublicensee) commercializes a Product </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> then, subject to applicable law, Dynavax shall not, and shall ensure that its Affiliates or any sublicensee shall not, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> unless mutually agreed in writing by the Parties, provided that </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;With respect to&nbsp;&nbsp;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;If Dynavax (or its Affiliate or licensee) becomes aware that </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, Dynavax shall, or shall cause its Affiliates and licensees to, to the extent permitted under applicable law, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026670"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">5.2 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Dynavax Post-Exercise Activities</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">5.2.1 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Back-up Compounds</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;If, upon exercise of the Option with respect to a Dynavax Program, there are not </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Back-up Compounds in such Dynavax Program that </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, then Dynavax shall continue, until </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> after GSK exercises such Option, to Develop </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Back-up Compounds that </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for such Dynavax Program, at Dynavax&#8217;s sole cost and responsibility.&nbsp;&nbsp;Such Back-up Compounds shall be subject to GSK&#8217;s Option and included within the applicable GSK Development Program.&nbsp;&nbsp;For clarity, efforts undertaken pursuant to this Section 5.2.1 following expiration of the Research Term shall not be deemed to extend the Research Term, but shall be subject to Dynavax&#8217;s obligation to use Commercially Reasonable Efforts.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">5.2.2 </font><font style="font-weight:bold;font-style:italic;;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"> Development</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If, after completion of a Proof of Concept Study for a Phase I Ready Compound from a Dynavax Program or GSK Development Program, Dynavax has not </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for such Compound for </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> in the applicable Development Plan, then Dynavax shall continue to develop such </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, at its sole cost and expense, notwithstanding GSK&#8217;s exercise of the Option for the Dynavax Program; </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">provided</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, however, that an </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of a Compound that is </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shall be considered a </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, provided that it meets GSK&#8217;s then current requirements for </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-30-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">5.3 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Dynavax Development Compounds</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">5.3.1 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Option Expiration; Dynavax Program Termination</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;In the event that the Option Deadline Period, including any Option Deadline Extension Period (as may be extended), for an Option with respect to a particular Dynavax Program that is not </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> expires without exercise, or in the event that the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> terminates a Dynavax Program, then such Dynavax Program shall become a Dynavax Development Program, and Dynavax shall have the exclusive right, at its sole discretion, to Research, Develop and commercialize all Compounds within such Dynavax Program as Dynavax Products in the Territory in the Field, alone or with any Third Party or through any Sublicensee, Affiliate or subcontractor.&nbsp;&nbsp;GSK will have no further obligations to make any milestone, royalty or other payments to Dynavax of any kind under Article 6 with respect to such Compounds or to make any milestone, royalty or other payments of any kind to Dynavax, its Affiliate or any Third Party on account of any Third Party licenses for any such Compounds, except for any </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Dynavax shall have the right to use, in connection with such Development and commercialization, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> without limitation if such materials are </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, but for any Information that is </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, Dynavax may only use the Information </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;If Dynavax or its Affiliate or Sublicensee Develops and commercializes a Dynavax Product pursuant to such Dynavax Development Program, Dynavax shall pay to GSK the applicable royalty payments as set forth in Section 6.5 for such Dynavax Products.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">5.3.2 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">GSK Development Termination</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;After exercising an Option with respect to a particular Dynavax Program, GSK may, at its sole discretion and without any penalty or liability (other than the transfer of any data, regulatory filings and other Information and grant of rights contemplated under this Section 5.3.2), terminate its Development or commercialization of all the Compounds or GSK Products within such Program upon written notice to Dynavax.&nbsp;&nbsp;In such event, provided that such Program is </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">: (a) all licenses in and to the Exclusively Licensed IP for such Compounds granted to GSK by Dynavax shall immediately terminate, (b) Dynavax shall have the right to continue Development and commercialization of such Compounds under a Dynavax Development Program, (c) the obligations of Dynavax and rights of GSK under </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> with respect to such Program will terminate, and (d) GSK (i) hereby grants, conditional upon the occurrence of such termination, an </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> to such Compounds and </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> as of the time of such termination, to further Develop and commercialize such Compounds as Dynavax Products in the Territory in the Field, (ii) shall transfer to Dynavax, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and as soon as reasonably practicable after such termination, (a) all material Information </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> to such Compounds </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, and (b) all </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, (iii) shall reasonably cooperate with Dynavax </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;In the event of such termination, Dynavax shall pay to GSK the applicable royalty payments as set forth in Section 6.6 for Dynavax Products containing any such Compounds.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">5.4 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Safety Data Exchange.</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;The Parties shall negotiate in good faith a safety data exchange agreement with respect to GSK Products within </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> days of GSK&#8217;s exercise of an Option.&nbsp;&nbsp;The safety data exchange agreement shall facilitate management of safety for all GSK Products covered under such agreement in accordance with standards that are no less stringent than in the ICH guidelines, such that the Parties would be able to comply with all regulatory and legal requirements regarding the management of safety data, by providing for the exchange of relevant information in appropriate format within applicable timeframes.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">5.5 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Co-Development and Co-Promotion by Dynavax</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;GSK hereby grants Dynavax an option to co-develop one (1) GSK Product and a related right to co-promote in the U.S. the GSK Product that Dynavax has elected to co-develop, as set forth in this Section 5.5.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-31-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">5.5.1 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Co-Development Option</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(a) </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Generally</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Within </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> days following GSK&#8217;s exercise of an Option with respect to a Dynavax Program, GSK shall provide to Dynavax </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, and shall have the option (the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Co-Development Option&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">), exercisable by written notice to GSK within </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> after receipt of the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, to co-Develop such GSK Product.&nbsp;&nbsp;If Dynavax elects to co-Develop a GSK Product, Dynavax shall be responsible for </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of the Co-Development Costs incurred by GSK from and after GSK&#8217;s exercise of the Option for the applicable Dynavax Program, and the royalty rate applicable to such GSK Product shall be adjusted as set forth in Section 6.4.2(d).</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(b) </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Co-Development Costs.&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Upon exercise of the Co-Development Option, Dynavax shall pay to GSK a one-time </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> payment equal to </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of the total Co-Development Costs incurred by GSK up to such date for such GSK Product (but not for other Compounds or GSK Products in such GSK Development Program) from and after its exercise of the Option.&nbsp;&nbsp;For clarity, any payments made by GSK to Dynavax under Article 6 of this Agreement prior to Dynavax&#8217;s exercise of the Co-Development Option shall not be considered Co-Development Costs.&nbsp;&nbsp;In addition, following exercise of the Co-Development Option, Dynavax shall be responsible for </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of the ongoing Co-Development Costs with respect to such GSK Product through and including approval of the NDA.&nbsp;&nbsp;The Parties shall make reconciling payments for such Co-Development Costs on a Calendar Quarter basis such that each Party bears its respective share (i.e., </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">) of the Co-Development Costs incurred during the applicable Calendar Quarter.&nbsp;&nbsp;In the event that the actual Co-Development Costs are reasonably expected to exceed, as determined by the summation of actual costs to date and official GSK forecasts over the course of the remaining development plan, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of the estimated costs for the Co-Development Costs as set forth in the GSK Development Plan and Budget, Dynavax shall have </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026666"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(c) </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Co-Development Governance</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;After Dynavax exercises the Co-Development Option as to a particular GSK Product, the JSC or such Subcommittee designated by the JSC shall continue to oversee and make decisions with respect to the Development of the applicable GSK Product, and shall continue to meet on a Calendar Quarter basis or as mutually determined by the Parties.&nbsp;&nbsp;GSK shall continue to update the GSK Development Plan and Budget for such GSK Product, and shall submit such updated GSK Development Plan and Budget to the JSC for review and approval.</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the event that the JSC cannot reach consensus on any decision with respect to the Development of such GSK Product, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;For clarity, GSK shall not </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(d) </font><font style="font-weight:bold;font-style:italic;;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">of Dynavax</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;In the event of a </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> in which </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, GSK shall have the right, at its sole discretion, to </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-32-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">5.5.2 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Co-Promotion Option</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(a) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On or before the date which is </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for a GSK Product for which Dynavax has exercised the Co-Development Option, GSK shall provide to Dynavax a written commercialization plan for such GSK Product (the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Product Marketing Plan&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">).&nbsp;&nbsp;Dynavax shall have the option, exercisable by written notice to GSK within </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> after receipt of the Product Marketing Plan, to co-promote such GSK Product to </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Promptly following Dynavax&#8217;s exercise of such option, the Parties shall engage in good faith negotiations to prepare and execute a definitive co-promotion agreement describing the co-promotion activities of the Parties for such GSK Product in the United States (the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Co-Promotion Agreement&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">).&nbsp;&nbsp;The Co-Promotion Agreement will have </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> after Dynavax exercises such option.&nbsp;&nbsp;In addition, where appropriate, the Parties shall enter into a supply and quality agreement.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(b) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Co-Promotion Agreement shall incorporate the terms and conditions set forth in this Section 5.5.2(b).&nbsp;&nbsp;Dynavax shall have the right to provide between </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;All details contributed by Dynavax shall be conducted by Dynavax employees, and Dynavax may not use contract sales representatives to conduct such details.&nbsp;&nbsp;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;GSK shall be responsible for receiving and filling orders, booking of sales, controlling invoicing, collection of payments, returns, charge-backs and rebates on sales of the GSK Product in the United States, and shall have sole control over pricing strategies and distribution of the GSK Product in the United States.&nbsp;&nbsp;GSK shall have responsibility for preparing and producing all promotional materials for the GSK Product at its sole expense, provided, however, that the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;GSK shall provide samples and promotional materials to Dynavax for distribution to physicians to whom it details the GSK Product.&nbsp;&nbsp;GSK shall develop and provide equivalent training programs and materials for the GSK Product to sales representatives of both Parties, which programs and materials shall be provided at cost to Dynavax for its sales representatives.&nbsp;&nbsp;Dynavax may terminate its co-promotion of the GSK Product at any time upon </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> written notice to GSK, upon which termination Dynavax and GSK shall reasonably cooperate to transition to GSK Dynavax&#8217;s co-promotion activities so as to minimize disruption to sales activity. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(c) </font><font style="font-weight:bold;font-style:italic;;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"> Dynavax</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;In the event of a </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> in which </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, GSK shall have the right, at its sole discretion, to </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:18pt;text-align:center;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974935"></a><font style="font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;">ARTICLE 6</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br><br></font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">MILESTONES AND ROYALTIES; PAYMENTS</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><a name="_Toc140974936"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">6.1 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Program Funding.&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In partial consideration for the Options granted to GSK hereunder,</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="OLE_LINK7"></a>GSK shall pay to Dynavax a non-refundable, non-creditable payment of Ten Million Dollars ($10,000,000) </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> after receipt of an invoice from Dynavax on or after the Effective Date.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-33-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">6.2 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Development Milestones</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp; </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">6.2.1 </font><font style="font-weight:bold;font-style:italic;;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(a) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Subject to</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the terms and conditions set forth in Section 6.2.1(b) and 6.2.3, GSK shall make the non-refundable, non-creditable milestone payments to Dynavax that are set forth below </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> after receipt of an invoice following occurrence of the corresponding milestone event with respect to Compounds and GSK Products resulting from the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-34-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;width:80%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Event</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Payment</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:80%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:80%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:80%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">First Dosing in Phase 1 Clinical Trial</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$6 million</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:80%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:80%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">* </font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:80%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]<br></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(see paragraph b below)</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:80%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> <br>(see paragraph b below)</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:80%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:80%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:80%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:80%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:80%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:80%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:80%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp; </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:80%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:80%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:80%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:80%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:80%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:80%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:80%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">TOTAL</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*&nbsp;&nbsp;for the purposes of this Section 6.2.1(a) milestone table, the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Study] would qualify for the milestone event for </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">(b)</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%"> </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All of the milestones in Section 6.2.1(a), including the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> payment or the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> payment, are payable only once for the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and only once for the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;If, upon achievement of a milestone for the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, any previous milestone has not been paid for such Program, then each such previous milestone shall be payable along with the payment for the milestone then achieved (it being understood that the &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221; payment is </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-35-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">not payable for the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and that &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221; payment is payable for either </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and not both).&nbsp;&nbsp;If, when GSK exercises its Option for the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, it has not exercised its Option for the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, then the payment for the &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221; shall be increased to </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, or, if the Option is exercised at </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, the payment for the &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221; shall be increased to </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;If Development of a lead Compound in either the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> is terminated and such Compound is replaced by a Back-up Compound or other Compound, then milestone payments will be paid for such Back-up Compound or other Compound only if the corresponding milestone payment was not already made for the lead Compound.&nbsp;&nbsp;For clarity, the milestones listed for the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> may be achieved by </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> that achieves the milestones for the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, but not for any additional </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;If the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Option is exercised, the difference between the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Payment and the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Payment will become payable as a further milestone upon </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for such Compound, as determined by GSK, or upon the occurrence of </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">6.2.2 </font><font style="font-weight:bold;font-style:italic;;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(a) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Subject to</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the terms and conditions set forth in Sections 6.2.2(b) and 6.2.3, GSK shall make the non-refundable, non-creditable milestone payments to Dynavax that are set forth below within </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:MS Mincho;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">after</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> receipt of an invoice following the occurrence of the corresponding milestone event with respect to Compounds and GSK Products resulting from the Dynavax Programs </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;width:80%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Event</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Payment</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:80%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:80%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
</table></div><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-36-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"><tr>
<td valign="bottom" style="width:20%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Event</font></p></td>
<td valign="bottom" style="width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Payment if Option Exercised at [ * ]</font></p></td>
<td valign="bottom" style="width:60%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Payment if Option Exercised after Proof of Concept Study (or if exercised after [ * ] Study)</font></p></td>
</tr>
<tr>
<td valign="top" style="width:20%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="width:60%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
<tr>
<td valign="top" style="width:20%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:60%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="width:20%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="width:60%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
<tr>
<td valign="top" style="width:20%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">* </font></p></td>
<td valign="top" style="width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="width:60%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
<tr>
<td valign="top" style="width:20%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="width:60%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
<tr>
<td valign="top" style="width:20%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="width:60%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
<tr>
<td valign="top" style="width:20%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="width:60%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
<tr>
<td valign="top" style="width:20%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="width:60%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
<tr>
<td valign="top" style="width:20%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="width:60%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
<tr>
<td valign="top" style="width:20%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="width:60%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
<tr>
<td valign="top" style="width:20%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="width:60%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
<tr>
<td valign="top" style="width:20%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="width:60%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp; </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
<tr>
<td valign="top" style="width:20%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:60%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="width:20%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="width:60%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
<tr>
<td valign="top" style="width:20%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="width:60%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
<tr>
<td valign="top" style="width:20%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="width:60%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
<tr>
<td valign="top" style="width:20%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="width:60%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
<tr>
<td valign="top" style="width:20%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="width:60%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
<tr>
<td valign="top" style="width:20%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">TOTAL</font></p></td>
<td valign="top" style="width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="width:60%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*for the purposes of this Section 6.2.2(a) milestone table, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Study] would qualify for the milestone event for </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">(b)</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%"> </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The milestones in Sections 6.2.2(a) are payable only once for each Dynavax Program </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, provided that in each row, either the amount for exercise of Option </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or the amount for exercise of Option after Proof of Concept Study (or, if applicable, after </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Study, as shown in parentheses above) will be payable for each Program depending upon which Option is exercised by GSK, but not for both in a given Program.&nbsp;&nbsp;If, upon achievement of a milestone for a Dynavax Program, any previous milestone has not been paid for such Program, then each such previous milestone (for the applicable Option exercise time only) shall be payable along with the payment for the milestone then achieved.&nbsp;&nbsp;For clarity, the milestone event &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221; will be payable only if GSK does not exercise its Option at the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;&nbsp;&nbsp;For clarity, the milestones listed for the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> may be achieved by either the same or a different Product that achieves the milestones for the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, but not for any </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;If the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Option is exercised, the difference between the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Payment and the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Payment will </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-37-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">become payable as a further milestone upon </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for such Compound, as determined by GSK, or upon the occurrence of the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">6.2.3</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%"> </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Credit</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;GSK may offset up to </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> in the aggregate of any amounts paid to Dynavax under Section 2.6.4 or 2.6.6 against the milestone payments in Sections 6.2.1 and 6.2.2, provided that such offset may reduce each milestone payment thereunder by no more than </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, up to a cumulative total of </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:MS Mincho;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">6.2.4</font><font style="font-weight:bold;font-family:MS Mincho;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%"> </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Milestone Event Definitions</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:MS Mincho;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">(a)</font><font style="font-weight:bold;font-family:MS Mincho;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%"> </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The phrase &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221; as used in this Article 6 and elsewhere in this Agreement means </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:MS Mincho;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">(b)</font><font style="font-weight:bold;font-family:MS Mincho;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%"> </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The phrase &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221; as used in this Article 6 means </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;In the event that GSK or its Affiliate or Sublicensee </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp; The phrase &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221; as used in this Article 6 means </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;In the event that GSK or its Affiliate or Sublicensee </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">(c)</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%"> </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The phrase &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221; as used in this Article 6 means </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">6.3 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Commercialization Milestones.&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">GSK shall pay to Dynavax, on a GSK Development Program-by-GSK Development Program basis, each of the one-time (per GSK Development Program), non-refundable, non-creditable milestone payments indicated below no later than </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> after receipt of an invoice when the aggregate Annual Net Sales of all GSK Products in a GSK Development Program in the Territory (for all indications and without regard to formulation) first reaches the corresponding dollar values.</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:80%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Aggregate Annual Net Sales (Worldwide)</font></p></td>
<td valign="bottom" style="width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Payment</font></p></td>
</tr>
<tr>
<td valign="top" style="width:80%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
<tr>
<td valign="top" style="width:80%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="top" style="width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-38-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">6.4 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Royalties</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">6.4.1 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Patent Royalty</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">GSK shall pay to Dynavax incremental royalties on Annual Net Sales of GSK Products, on a country-by-country and GSK Product-by-GSK Product basis, in those countries of the Territory in which </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of such GSK Product is covered by a Valid Claim of a Patent within the Exclusively Licensed IP as of the First Commercial Sale of such GSK Product, or the GSK Product </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Patent Royalty&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">) at royalty rates as set forth in the table below, except that </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> GSK exercised the Option with respect to the applicable Dynavax Program, the royalty rates shall be </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> from the rates that are otherwise applicable below.&nbsp;&nbsp;The penultimate sentence of Section 6.4.2(a) shall apply upon the issuance of a Valid Claim of a Patent within the Exclusively Licensed IP that covers </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of a GSK Product, subject to the terms of this Section 6.4.&nbsp;&nbsp;The applicable royalty rates for a particular GSK Product shall depend on whether the GSK Product contains a Compound (a) </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, (b) </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and GSK exercised the Option </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, or (c) from another Program and GSK exercised the Option after the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr style="height:17pt;">
<td valign="bottom" style="width:40%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="3" valign="bottom" style="width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Royalty Rate</font></p></td>
</tr>
<tr>
<td valign="bottom" style="width:40%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Annual Net Sales</font></p></td>
<td valign="bottom" style="width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="bottom" style="width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-weight:bold;text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> &#8211; [ * ]</font></p></td>
<td valign="bottom" style="width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-weight:bold;text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> &#8211;&nbsp;&nbsp; [ * ]</font></p></td>
</tr>
<tr>
<td valign="bottom" style="width:40%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">First </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="bottom" style="width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:11pt;;"><font style="font-weight:bold;font-size:11pt;font-family:MS Mincho;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="bottom" style="width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:11pt;;"><font style="font-weight:bold;font-size:11pt;font-family:MS Mincho;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="bottom" style="width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:11pt;;"><font style="font-weight:bold;font-size:11pt;font-family:MS Mincho;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
<tr>
<td valign="bottom" style="width:40%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Portion above </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and up to and including </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="bottom" style="width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:11pt;;"><font style="font-weight:bold;font-size:11pt;font-family:MS Mincho;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="bottom" style="width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:11pt;;"><font style="font-weight:bold;font-size:11pt;font-family:MS Mincho;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="bottom" style="width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:11pt;;"><font style="font-weight:bold;font-size:11pt;font-family:MS Mincho;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
<tr>
<td valign="bottom" style="width:40%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Portion above </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="bottom" style="width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:11pt;;"><font style="font-weight:bold;font-size:11pt;font-family:MS Mincho;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="bottom" style="width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:11pt;;"><font style="font-weight:bold;font-size:11pt;font-family:MS Mincho;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
<td valign="bottom" style="width:20%;"><p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:11pt;;"><font style="font-weight:bold;font-size:11pt;font-family:MS Mincho;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The royalty rates above are incremental rates that apply only for the respective increment of worldwide Annual Net Sales described in the Annual Net Sales column and, thus, once a total Annual Net Sales figure is achieved for the year, the royalties owed on any lower tier portion of Annual Net Sales are not adjusted up to the higher tier rate.&nbsp;&nbsp;The Patent Royalty as provided in this Section 6.4.1. shall be adjusted as provided in Section 6.4.2.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-39-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">6.4.2 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Royalty Adjustments</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(a) </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Know-How Royalty.</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;If, on a country-by-country and GSK Product-by-GSK Product basis, there is no Valid Claim of a Patent in the Exclusively Licensed IP that covers </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of the GSK Product at the time of First Commercial Sale (or such Valid Claim exists at the time of First Commercial Sale and subsequently expires) and no applicable data exclusivity exists under statute, regulation or other governmental action at the time of sale, but such </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> is covered by either (i) a pending claim of a patent application within the Exclusively Licensed IP or (ii) Information within the Exclusively Licensed IP that has been maintained as a trade secret as evidenced by Dynavax&#8217;s, or for jointly owned Information, both Dynavax&#8217;s and GSK&#8217;s, written records up until the time of such Net Sales of such GSK Product, then GSK shall pay to Dynavax a know-how royalty on Net Sales of such GSK Product in such country at royalty rates equal to </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of the rates set forth in the table in Section 6.4.1 above (the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Know-How Royalty&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">), subject to the remainder of this Section 6.4.2 and Section 6.4.3, and subject to a further reduction (in addition to the reductions set forth in the remainder of Section 6.4.2 and 6.4.3) of </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> from the Know-How Royalty rates that would otherwise be applicable if the only pending claim of a patent application within the Exclusively Licensed IP or the only Information within the Exclusively Licensed IP qualifying under this paragraph is </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> with respect to the applicable Dynavax Program.&nbsp;&nbsp;If such pending claim subsequently issues, then the rates set forth in the table in Section 6.4.1 and as adjusted under Section 6.4.1 above shall thereafter apply, and GSK shall pay to Dynavax an amount equal to the amounts previously paid with respect to GSK Products covered by such claim under this Section 6.4.2(a).&nbsp;&nbsp;In no event shall a Know-How Royalty be payable for Net Sales of a GSK Product in a country during any period in which a Patent Royalty is payable for such GSK Product in such country.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(b) </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Royalty Reduction for Competition.</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;If at any such time that a Third Party product that has been approved for sale by the relevant Regulatory Authority in reliance on the MAA or NDA or their equivalent of a GSK Product (a &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Generic Product</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;) enters the market in a given country, and such Generic Product accounts for more than </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of aggregate unit sales of GSK Products and Generic Product in the given country, as measured by IMS Health or its successor, the Patent Royalty or Know-How Royalty, as applicable as set forth in Section 6.4.1 or 6.4.2(a), respectively, shall be reduced by </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> in such country.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(c) </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Third Party Licenses.</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">GSK shall be entitled to a credit against the royalty payments due to Dynavax on Net Sales of a GSK Product in a particular country of an amount equal to </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> that are paid by GSK or its Affiliates or Sublicensees to a Third Party with respect to such GSK Product in such country for any license obtained after the exercise of the Option with respect to such GSK Product that is necessary for the commercialization of such GSK Product, as and to the extent set forth in Section 4.4.2, such credit not to exceed </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of the royalty that would otherwise be due to Dynavax on Net Sales of such GSK Product, provided that GSK shall have the right to carry forward for application in future periods any uncredited amount.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(d) </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Co-Development</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;If Dynavax exercises its option to co-develop a GSK Product under Section 5.5, the royalty rate applicable to such GSK Product shall be increased by </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> above the applicable royalty rate set forth under Section 6.4.1, as adjusted pursuant to this Section 6.4.2.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-40-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">6.4.3 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Royalty Term</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;GSK&#8217;s obligation to pay a Patent Royalty with respect to a GSK Product shall commence upon the First Commercial Sale of such GSK Product in a particular country in the Territory and will expire on a country&#8209;by&#8209;country and GSK Product-by-GSK Product basis upon the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of (a) the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of the GSK Product, or (b) </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> with respect to such GSK Product.&nbsp;&nbsp;GSK&#8217;s obligation to pay a Know-How Royalty with respect to a GSK Product shall commence upon the First Commercial Sale of such GSK Product in a particular country in the Territory and will expire on a country&#8209;by&#8209;country and GSK Product-by-GSK Product basis </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> after First Commercial Sale in such country. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">6.5 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Royalty Payments by Dynavax &#8211; No Exercise of Option by GSK</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;With respect to any Dynavax Program that becomes a Dynavax Development Program upon GSK&#8217;s failure to exercise or termination of its Option with respect thereto, or upon the JSC&#8217;s or GSK&#8217;s termination of such Dynavax Program, if Dynavax elects to Develop and/or commercialize Dynavax Products from such Program, Dynavax shall pay to GSK a royalty on Net Sales of such Dynavax Products at the following rates:&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(a) </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> if </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> before such Dynavax Program became a Dynavax Development Program; and </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(b) </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> if </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> before such Dynavax Program became a Dynavax Development Program.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><a name="OLE_LINK30"></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dynavax&#8217;s obligation to pay royalties under this Section 6.5 with respect to a Dynavax Product shall commence upon the First Commercial Sale of such Dynavax Product in a particular country in the Territory and will expire on a country-by-country and Dynavax Product-by-Dynavax Product basis at the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">6.6 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Royalty Payments by Dynavax &#8211; Post-Option Termination by GSK</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;With respect to any GSK Development Program that becomes a Dynavax Development Program upon GSK&#8217;s termination of its rights with respect thereto following Option exercise, if Dynavax elects to Develop and/or commercialize Dynavax Products from such Program, Dynavax shall pay to GSK a royalty on Net Sales of such Dynavax Products at the following rates:</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(a) </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> if GSK terminated such GSK Development Program </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> from such Program anywhere in the Territory; and</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(b) </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> if GSK terminated such GSK Development Program </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> from such Program anywhere in the Territory.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dynavax&#8217;s obligation to pay royalties under this Section 6.6 with respect to a Dynavax Product shall commence upon the First Commercial Sale of such Dynavax Product in a particular country in the Territory and will expire on a country-by-country and Dynavax Product-by-Dynavax Product basis upon the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Dynavax Product,&nbsp;&nbsp;or (ii) </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> after the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> in such country.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-41-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">6.7 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Reports and Payment of Milestones</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;GSK</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">shall make all milestone payments&nbsp;&nbsp;within </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> after receipt by GSK of an invoice from Dynavax with respect to the achievement of such milestone event after GSK has notified Dynavax of achievement of the milestone event in accordance with the terms of this Section 6.7.&nbsp;&nbsp;Upon exercise of an Option by GSK, GSK shall pay the applicable Option exercise fee within </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of receipt of an invoice from Dynavax after notice from GSK of Option exercise pursuant to Section 4.1.3.&nbsp;&nbsp;Dynavax shall notify GSK in writing promptly, but in no event later than </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="OLE_LINK37"></a>, after each achievement of the &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221; and, if GSK has not exercised the Option at the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221; milestones set out in Section&#160;6.2 (it being understood that if Dynavax is conducting a </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Study, the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Study shall qualify as the milestone event for </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;).&nbsp;&nbsp;GSK shall notify Dynavax in writing promptly, but in no event later than </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, after the achievement of (a) the earlier of (i) the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or (ii) the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, as applicable, for a Program for which GSK exercised the Option after a </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Study, (b) all other milestones in Section 6.2 and (c) each milestone event set forth in Section 6.3.&nbsp;&nbsp;Subject to Section 4.1.5, GSK shall pay all milestone payments due (other than for Option exercise) within </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> after receipt of an invoice for such payment from Dynavax following the achievement of the corresponding milestone event.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">6.8 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Reports; Royalty Payments.</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;Until the expiration of a Party&#8217;s royalty obligations under this Article 6, such Party agrees to make written reports to the other Party within </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> days after the end of each Calendar Quarter covering all sales of Products in the Territory by such Party and its Affiliates and Sublicensees for which invoices were sent during such Calendar Quarter, each such written report in reasonable detail as available to such Party stating for the period in question:&nbsp;&nbsp;(a) the total Net Sales for each Product and (b) a calculation of the royalty payment due on such Net Sales pursuant to Article 6.&nbsp;&nbsp;The information contained in each report under this Section 6.8 shall be considered Confidential Information of the Party providing the report.&nbsp;&nbsp;Concurrent with the delivery of each such report, the Party delivering such report shall make the royalty payment due the other Party under Article 6 for the Calendar Quarter covered by such report.&nbsp;&nbsp; In the case of transfers or sales of any Product between the royalty-paying Party and an Affiliate or Sublicensee of such Party, a royalty shall be payable only with respect to the sale of such Product to an independent Third Party and not an Affiliate or Sublicensee of the seller.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">6.9 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Methods of Payments.</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;All payments due from one Party (the &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Payor</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;) to the other Party (the &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Payee</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;) under this Agreement shall be paid in Dollars by wire transfer to a bank in the United States designated in writing by the Payee. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-42-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">6.10 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Accounting.&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Payor agrees to keep full, clear and accurate records for a maximum period of </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> after the relevant payment is owed pursuant to this Agreement, setting forth the sales and other disposition of Product sold or otherwise disposed of in sufficient detail to enable royalties and compensation payable to the Payee hereunder to be determined.&nbsp;&nbsp;Payor further agrees, upon not less than </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Calendar Days prior written notice, to permit the books and records relating to such </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> to be examined by an independent accounting firm selected by Payee and reasonably acceptable to Payor for the purpose of verifying reports provided by Payor under Section 6.8.&nbsp;&nbsp;Such audit shall not be performed more frequently than </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and shall be conducted under appropriate confidentiality provisions, for the sole purpose of verifying the accuracy and completeness of all financial, accounting and numerical information and calculations provided under this Agreement.&nbsp;&nbsp;Such examination is to be made at the expense of Payee, except in the event that the results of the audit reveal an underpayment of royalties, milestones, or other payments to Payee under this Agreement of </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or more per annum over the period being audited, in which case reasonable audit fees for such examination shall be paid by Payor.&nbsp;&nbsp;When calculating Net Sales, the amount of such sales in foreign currencies shall be converted into Dollars using the standard methodologies employed by Payor for consolidation purposes.&nbsp;&nbsp;Payor shall provide reasonable documentation of the calculation and reconciliation of the conversion figures on a country-by-country basis as part of its report of Net Sales for the period covered under the report.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">6.11 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="OLE_LINK34"></a>Taxes.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">6.11.1 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Subject to Section 6.11.2, any tax paid or required to be withheld by GSK for the benefit of Dynavax on account of any royalties or other payments payable to Dynavax under this Agreement shall be deducted from the amount of royalties or other payments otherwise due.&nbsp;&nbsp;GSK shall secure and send to Dynavax proof of any such taxes withheld and paid by GSK for the benefit of Dynavax, and shall, at Dynavax's request, provide reasonable assistance to Dynavax in recovering such taxes.&nbsp;&nbsp;Pending receipt of formal certification from the UK Inland Revenue, GSK may pay royalty income and any other payments under this Agreement to Dynavax by deducting tax at a rate specified in the double tax treaty between the UK and US.&nbsp;&nbsp;Dynavax&#160;shall provide the appropriate documentation necessary for GSK not to withhold amounts under the applicable&#160; terms of the double tax agreement between the UK and US.&nbsp;&nbsp;Dynavax&#160;agrees to indemnify and hold harmless GSK against any loss, damage, expense or liability arising in any way from a breach of the&#160;foregoing or&#160;any breach of Section 10.2.7 with respect to any claim by a UK tax authority or other similar body alleging that GSK was not entitled to deduct withholding tax on such payments at source at the treaty rate.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">6.11.2 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If GSK or any GSK Affiliate is or becomes liable to withhold any taxes from payments made to Dynavax under Section 6.11.1 as a result of any permitted assignment by GSK pursuant to Section 13.4, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Dynavax shall provide GSK with such reasonable evidence as GSK may reasonably request to determine whether the taxes are creditable against taxes payable by Dynavax.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">6.11.3 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If Dynavax is required to withhold any taxes from payments made to GSK under Section 6.11.1, as a result of an assignment pursuant to Section 13.4, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. &#160;GSK shall provide Dynavax with such reasonable evidence as Dynavax may reasonably request to determine whether the taxes are creditable against taxes payable by GSK.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-43-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">6.12 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Late Payments.&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any undisputed amount owed by Payor to Payee under this Agreement that is not paid within the applicable time period set forth herein shall accrue interest at the rate of </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> above the then-applicable prime commercial lending rate of Citibank, N.A., San Francisco, California, or, if lower, the highest rate permitted under applicable law.</font></p><p style="margin-bottom:0pt;margin-top:18pt;text-align:center;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;">ARTICLE 7</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br><br></font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">EXCLUSIVITY</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026686"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">7.1 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Dynavax Exclusivity</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Except pursuant to this Agreement, on a Program-by Program basis during the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> thereafter, Dynavax and/or its Affiliates shall not, either alone or with or for any Third Party, Research, Develop or commercialize any compound in the Field that is </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> as a Compound any TLRs or combinations thereof that are the subject of </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For clarity, nothing in this Section 7.1 shall limit Dynavax&#8217;s rights to Develop or commercialize on its own or with or for a Third Party Compounds and Dynavax Products within a Dynavax Development Program, if such Program results from termination or expiration of the Option Deadline Period, including any Option Deadline Extension Period (as may be extended), for an Option without exercise by GSK, the JSC&#8217;s or GSK&#8217;s decision to terminate a Dynavax Program, or the termination of a GSK Development Program.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">7.2 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">GSK Exclusivity</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Except pursuant to this Agreement, on a Program-by-Program basis during the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> thereafter, GSK and/or its Affiliates shall not, either alone or with or for any Third Party, Research, Develop or commercialize any </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> as a Compound, any TLRs or combinations thereof that are the subject of any </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">7.3 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Clarification</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;For clarity, if </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> is the subject of a Dynavax Program, then the restrictions in Sections 7.1 and 7.2 shall not apply to a Party&#8217;s Research, Development, or commercialization, whether alone or together with or for the benefit of a Third Party, of a </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> that is the subject of such Dynavax Program, provided that </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Notwithstanding the above, GSK shall have the right to in-license rights from a Third Party, or to conduct research, development or commercialization with respect to any </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, provided that the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> is not itself the subject of a </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> to develop </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Upon GSK&#8217;s in-license or commencement of research, development or commercialization of such a </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, the restrictions set forth in Section 7.1 shall not apply to </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;In the event that the limitation on a TLR does not apply as set forth in the preceding sentence, Dynavax and/or its Affiliates shall nevertheless </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> any Research, Development or commercialization activities, either on its own or together with or for the benefit of any Third Party, (i) with respect to a </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">) during the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, or (ii) with respect to a </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> during the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, if such TLR is not then the subject of a Dynavax Program.&nbsp;&nbsp;If GSK </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, Dynavax shall </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;If Dynavax has not, as may be permitted above in this Section 7.3, previously entered into an agreement with a Third Party regarding a TLR released from the limitations of Section 7.1 as set forth above, GSK may request pursuant to Sections 2.5 and 3.1.4(c) at any time during the respective </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> periods that Dynavax initiate and conduct such activities exclusively with GSK as a Dynavax Program under this Agreement.</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">7.4 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Dynavax Exclusivity Exceptions</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Notwithstanding the foregoing in Section 7.1, Dynavax will have the right to perform the following activities:</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-44-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">7.4.1 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Continue to research, develop, manufacture and commercialize compounds which do not qualify under the definition of Compounds hereunder in accordance with </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;For the avoidance of doubt, nothing herein will impair or interfere with Dynavax&#8217;s obligations under </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">7.4.2 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Continue to research, develop, manufacture and commercialize compounds which do not qualify under the definition of Compounds hereunder in accordance with </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:18pt;text-align:center;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026689"></a><font style="font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;">ARTICLE 8</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br><br></font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">OWNERSHIP OF INTELLECTUAL PROPERTY RIGHTS</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026690"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">8.1 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Ownership</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">8.1.1 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Dynavax Compound IP and GSK Development IP.</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;Dynavax shall retain all of its rights, title and interest in and to the Dynavax Compound IP, and GSK shall retain all of its rights, title and interest in and to the GSK Development IP, except to the extent that any rights or licenses are expressly granted by one Party to the other Party under this Agreement.&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">8.1.2 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Intellectual Property Arising During Research &amp; Development Activities.&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">GSK shall be the sole owner of any Patents and Information discovered, developed, invented or created solely by or on behalf of GSK personnel under this Agreement, and GSK shall retain all of its rights, title and interest thereto, except to the extent that any rights or licenses are expressly granted thereunder by GSK to Dynavax under this Agreement.&nbsp;&nbsp;Dynavax shall be the sole owner of any Patents or Information discovered, developed, invented or created solely by or on behalf of Dynavax personnel under this Agreement, and Dynavax shall retain all of its rights, title and interest thereto, except to the extent that any rights or licenses are expressly granted thereunder to GSK under this Agreement. Any Patents or Information that are discovered, developed, invented or created jointly by or on behalf of GSK and Dynavax under this Agreement shall be owned jointly by GSK and Dynavax, and all rights, title and interest thereto shall be jointly owned by the Parties, subject to any exclusive rights or licenses that are expressly granted to a Party under this Agreement.&nbsp;&nbsp;Except as expressly provided in this Agreement, neither Party shall have </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, by reason of joint ownership thereof, and each Party hereby waives any right it may have under the laws of any jurisdiction to require any such consent or accounting.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-45-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026691"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">8.2 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Prosecution and Maintenance of Patents</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">8.2.1 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Dynavax Compound Patents</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;As between the Parties, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shall be responsible for the Prosecution and Maintenance of the Dynavax Compound Patents.&nbsp;&nbsp;Notwithstanding the foregoing, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> will use Commercially Reasonable Efforts to obtain a reasonable scope of patent protection for Compounds that satisfy the Pre-Candidate Selection Criteria covered by claims of Dynavax Compound Patents, using counsel of its own choice but reasonably acceptable to </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> informed as to material developments with respect to the Prosecution and Maintenance of such Dynavax Compound Patents, including without limitation by providing copies of all substantive office actions or any other substantive documents that </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> receives from any patent office, including without limitation notice of all interferences, reissues, re-examinations, oppositions or requests for patent term extensions, and by providing </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> the timely opportunity to have input into all substantive aspects of such Prosecution and Maintenance.&nbsp;&nbsp;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> in good faith, with respect to the Prosecution and Maintenance of any Dynavax Compound Patents.&nbsp;&nbsp;Any dispute regarding the Prosecution and Maintenance of any Dynavax Compound Patents shall be referred </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for resolution.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">8.2.2 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">GSK Development Patents</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="OLE_LINK3"></a>.&nbsp;&nbsp;As between the Parties, GSK shall control the Prosecution and Maintenance of any Patents in the GSK Development IP (&#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">GSK Development Patents</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;).&nbsp;&nbsp;Notwithstanding the foregoing, GSK shall use Commercially Reasonable Efforts to consult with Dynavax in connection with the Prosecution and Maintenance of the GSK Development Patents; provided, however, that GSK shall not be required to disclose any confidential information that is not specific to the Programs.&nbsp;&nbsp;Input shall be provided and consideration undertaken and concluded by the Parties in a timely manner so as not to jeopardize the pendency of the application under review or otherwise negatively affect or limit the rights of any Party hereto.&nbsp;&nbsp;Should the Parties fail to agree on any matter in this Section 8.2.2, GSK shall have the final say on such matter.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">8.2.3 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Collaboration Patents</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(a) </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shall be responsible for the Prosecution and Maintenance of the Collaboration Patents solely </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Notwithstanding the foregoing, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> will use Commercially Reasonable Efforts to obtain a reasonable scope of patent protection for Compounds that satisfy the Pre-Candidate Selection Criteria covered by claims of such Collaboration Patents, using counsel of its own choice but reasonably acceptable to </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> informed as to material developments with respect to the Prosecution and Maintenance of such Patents, including without limitation by providing copies of all substantive office actions or any other substantive documents that </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> receives from any patent office, including without limitation notice of all interferences, reissues, re-examinations, oppositions or requests for patent term extensions, and by providing </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> the timely opportunity to have input into all substantive aspects of such Prosecution and Maintenance.&nbsp;&nbsp;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, with respect to the Prosecution and Maintenance of any such Patents.&nbsp;&nbsp;Any dispute regarding the Prosecution and Maintenance of any Collaboration Patents </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(b) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">GSK shall be responsible for the Prosecution and Maintenance of the Collaboration Patents solely owned by GSK.&nbsp;&nbsp;Notwithstanding the foregoing, GSK shall use Commercially Reasonable Efforts to consult with Dynavax in connection with the Prosecution and Maintenance of such Collaboration Patents.&nbsp;&nbsp;Any dispute regarding the Prosecution and Maintenance of any Collaboration Patents owned solely by GSK shall be </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-46-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(c) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">GSK shall be responsible for the Prosecution and Maintenance of the Collaboration Patents jointly owned by GSK and Dynavax.&nbsp;&nbsp;GSK shall keep Dynavax informed as to material developments with respect to the Prosecution and Maintenance of such Patents, including without limitation by providing copies of all substantive office actions or any other substantive documents that GSK receives from any patent office, including without limitation notice of all interferences, reissues, re-examinations, oppositions or requests for patent term extensions, and by providing Dynavax the timely opportunity to have input into all substantive aspects of such Prosecution and Maintenance.&nbsp;&nbsp;GSK shall consult with Dynavax and shall take into account any comments from Dynavax in good faith, with respect to the Prosecution and Maintenance of any such Patents.&nbsp;&nbsp;Any dispute regarding the Prosecution and Maintenance of such Collaboration Patents shall be </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">8.2.4 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Filing Decision or Prosecution Lapse</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;If, during the Term, the Party responsible Prosecuting and Maintaining a Patent in the Dynavax Compound Patents or Collaboration Patents in any country decides not to file such Patent or intends to allow such Patent to lapse or become abandoned without having first filed a substitute, the prosecuting or maintaining Party shall, whenever practicable, notify the other Party of such decision or intention at least </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Calendar Days prior to the date upon which the subject matter of such Patent shall become unpatentable or such Patent shall lapse or become abandoned, and such other Party shall thereupon have the right, but not the obligation, to assume responsibility for the Prosecution and Maintenance thereof at its own expense with counsel of its own choice.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">8.2.5 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Prosecution and Maintenance Following GSK&#8217;s Exercise of an Option</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Notwithstanding the foregoing, following GSK&#8217;s exercise of an Option, GSK will be solely responsible for the Prosecution and Maintenance of all Patents in the Dynavax Compound IP and Collaboration Patents that contain claims covering GSK Development Compounds and GSK Products.&nbsp;&nbsp;Notwithstanding the foregoing in this Section 8.2, following GSK&#8217;s termination of a GSK Development Program, Dynavax will be solely responsible for the Prosecution and Maintenance of the Dynavax Compound Patents and the Collaboration Patents owned solely by Dynavax or jointly by Dynavax and GSK.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc197434870"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">8.3 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Patent Costs</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">8.3.1 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Collaboration Patents</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shall be responsible for all Patent Costs associated with the Prosecution and Maintenance of Collaboration Patents owned solely by Dynavax.&nbsp;&nbsp;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shall be responsible for all Patent Costs associated with the Prosecution and Maintenance of Collaboration Patents owned solely by GSK or owned jointly by GSK and Dynavax.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">8.3.2 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Dynavax Compound IP and GSK Development IP</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Dynavax shall be responsible for all Patent Costs incurred by Dynavax prior to and after the Effective Date with respect to any Dynavax Compound IP.&nbsp;&nbsp;GSK shall be responsible for all Patent Costs incurred by GSK prior to and after the Effective Date with respect to GSK Development IP.&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">8.3.3 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Patent Costs Following GSK&#8217;s Exercise of an Option.&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Notwithstanding the foregoing, following GSK&#8217;s exercise of an Option, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> will be responsible for all Patent Costs going forward that are associated with the Prosecution and Maintenance of all Patents in the Dynavax Compound IP and Collaboration Patents that contain claims covering GSK Development Compounds and GSK Products.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-47-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc197434871"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">8.4 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Defense of Claims Brought by Third Parties</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">8.4.1 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Compounds.</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;If a Third Party asserts that a Patent or other right owned by it is infringed by the manufacture, use, sale or importation of any Compound in a Dynavax Program as to which GSK has not exercised its Option, or any Compound within a Dynavax Development Program, Dynavax shall have the primary right but not the obligation to defend against any such assertions at its cost and expense.&nbsp;&nbsp;In the event Dynavax elects to defend against any such Third Party claims, Dynavax shall have the sole right to direct the defense of any such Third Party claims and to elect to settle such claims, but only with the prior written consent of GSK for a proposed settlement, not to be unreasonably withheld.&nbsp;&nbsp;In the event that Dynavax elects not to defend against such Third Party claims within </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Calendar Days of learning of same, GSK shall have the right, but not the duty, to defend against such action and thereafter shall have the right to direct the defense of any such Third Party claim(s), including the right to settle such claims, but only with the prior written consent of Dynavax for a proposed settlement, not to be unreasonably withheld.&nbsp;&nbsp;In any event, the Parties shall reasonably assist one another and cooperate in any such litigation at the other&#8217;s request without expense to the requesting Party.&nbsp;&nbsp;Each Party may at its own expense and with its own counsel join any defense brought by the other Party.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">8.4.2 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">GSK Development Compounds</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;If a Third Party asserts that a Patent or other right owned by it is infringed by the manufacture, use, sale or importation of any GSK Development Compound or GSK Product, GSK shall have the primary right but not the obligation to defend against any such assertions at its cost and expense.&nbsp;&nbsp;In the event GSK elects to defend against any such Third Party claims, GSK shall have the sole right to direct the defense of such Third Party claims and to elect to settle such claims.&nbsp;&nbsp;In the event that GSK elects not to defend against such Third Party claims within </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Calendar Days of learning of same, Dynavax shall have the right, but not the duty, to defend against such an action and thereafter shall have the sole right to direct the defense of any such Third Party claim(s), including the right to settle such claims.&nbsp;&nbsp;In any event, the Parties shall reasonably assist one another and cooperate in any such litigation at the other&#8217;s request without expense to the requesting Party.&nbsp;&nbsp;Each Party may at its own expense and with its own counsel join any defense brought by the other Party.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><a name="_Toc197434872"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">8.5 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Enforcement of Dynavax or GSK Intellectual Property Rights.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">8.5.1 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Duty to Notify of Infringement</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;If any Party learns of an infringement, unauthorized use, misappropriation or threatened infringement or other such activity by a Third Party with respect to any Collaboration IP, Dynavax Compound IP, or GSK Development IP (&#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Competitive Infringement</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;), such Party shall promptly notify the other Party and shall provide such other Party with available evidence of such Competitive Infringement.&nbsp;&nbsp;</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-48-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">8.5.2 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Prior to Exercise of Option.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(a) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prior to GSK&#8217;s exercise of an Option, with respect to any Collaboration IP solely owned by Dynavax or any Dynavax Compound IP that is the subject of such Competitive Infringement, Dynavax shall have the first right to bring and control any such action.&nbsp;&nbsp;Unless subject to an agreement between Dynavax and a Third Party in existence as of the Effective Date that would preclude Dynavax from granting such right to GSK, if Dynavax fails to bring any such action or proceeding within a period of </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Calendar Days after first being notified of such Competitive Infringement, then GSK shall have the right, but not the obligation, to bring and control any such action by counsel of its own choice, and Dynavax shall have the right to be represented in any such action by counsel of its own choice at its own expense.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(b) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prior to GSK&#8217;s exercise of an Option, except as provided in Section 8.5.2(a), the Party responsible for Prosecuting and Maintaining a Collaboration Patent shall have the primary right, but not the obligation, to institute, prosecute, and control any action or proceeding with respect thereto by counsel of its own choice, and the other Party shall have the right, at its own expense, to be represented in that action by counsel of its own choice.&nbsp;&nbsp;If the Party having the primary right fails to bring any such action or proceeding within a period of </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Calendar Days after first being notified of such Competitive Infringement, then the other Party shall have the right, but not the obligation, to bring and control any such action by counsel of its own choice, and the Party not bringing the action shall have the right to be represented in any such action by counsel of its own choice at its own expense.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">8.5.3 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Following Exercise of Option. </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Following GSK&#8217;s exercise of an Option, and before GSK&#8217;s termination of Development and commercialization, with respect to the Program containing Compounds that are the subject of any Competitive Infringement, GSK shall have the primary right, but not the obligation, to institute, prosecute, and control any action or proceeding with respect thereto by counsel of its own choice, and Dynavax shall have the right, at its own expense, to be represented in that action by counsel of its own choice.&nbsp;&nbsp;If GSK fails to bring an action or proceeding within a period of </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Calendar Days after first being notified of such Competitive Infringement, Dynavax shall have the right to bring and control any such action by counsel of its own choice, and GSK shall have the right to be represented in any such action by counsel of its own choice at its own expense.&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">8.5.4 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">After GSK&#8217;s Termination of a Program. </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">After GSK&#8217;s termination of Development and commercialization with respect to a Program containing Compounds that are the subject of any Competitive Infringement of a Collaboration Patent, Dynavax shall have the sole right, but not the obligation, to institute, prosecute, and control any action or proceeding with respect thereto by counsel of its own choice.&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">8.5.5 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Settlement</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. Any settlement, consent judgment or other disposition of any action or proceeding under this Article 8 shall not (a) include the grant of any license, covenant or other rights to any Third Party that would limit or interfere with or reduce the scope of the subject matter included under the exclusive licenses to be granted or granted to GSK pursuant to the exercise of any of its Options to Programs under Section 4.2.1, or (b) limit or interfere with or reduce the scope of the subject matter claimed in any patent owned (solely or jointly) by the other Party.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-49-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">8.5.6 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Share of Recoveries.&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If one Party brings any such action or proceeding in accordance with this Section 8.5, the second Party agrees to be joined as a party plaintiff where necessary and to give the first Party reasonable assistance and authority to file and prosecute the suit.&nbsp;&nbsp;The costs and expenses of the Party bringing suit under this Section 8.5 shall be borne by such Party, and any damages or other monetary awards recovered shall be shared as follows: (i) the amount of such recovery actually received by the Party controlling such action shall first be applied to the out-of-pocket costs of such action; and then (ii) any remaining proceeds shall be allocated between the Parties such that the Party bringing suit under this Section 8.5 retains </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and other Party retains </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of such amount.</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any such damages or other monetary awards as recovery shall be </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of Net Sales for the purpose of determining royalties due under Article 6 hereunder. </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A settlement or consent judgment or other voluntary final disposition of a suit under this Section&#160;8.5 may be entered into without the consent of the Party not bringing the suit; </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">provided that </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">such settlement, consent judgment or other disposition does not admit the invalidity or unenforceability of the relevant Patent in the Dynavax Compound Patents, GSK Development Patents, or Collaboration IP, and </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">provided further</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, that any rights granted under the relevant Patent to continue the infringing activity in such settlement, consent judgment or other disposition shall be limited to those rights that the granting Party otherwise has the right to grant, and </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">provided further</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, that any settlement, consent judgment or other disposition shall not include the grant of any license, covenant or other rights to any Third Party that would limit or interfere with or reduce the scope of the subject matter included under the exclusive licenses to be granted to GSK pursuant to the exercise of any of its Options to Programs under Section 4.2.1. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">8.5.7 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">35 USC 271(e)(2) Infringement.&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Notwithstanding anything to the contrary in this Section 8.5, for infringement under 35 USC 271(e)(2) where GSK has exercised its Option and where GSK is the holder of the applicable NDA, and for so long as GSK maintains or retains its exclusive license under such Option, GSK shall have the sole right to initiate legal action to enforce all Collaboration IP, GSK Development IP and Dynavax Compound IP licensed to it against infringement or misappropriation by Third Parties or defend any declaratory judgment action relating thereto at its sole expense.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">8.5.8 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Regulatory Data Protection.&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To the extent required by law or permitted by law, each Party will use Commercially Reasonable Efforts to promptly, accurately and completely list, with the applicable Regulatory Authorities during the Term, all applicable Patents for any Product that such Party intends to, or has begun to, commercialize and that have become the subject of a marketing application submitted to FDA, such listings to include all so called &#8220;Orange Book&#8221; listings required under the Hatch-Waxman Act and all so called &#8220;Patent Register&#8221; listings as required in Canada.&nbsp;&nbsp;Prior to such listings, the Parties will meet to evaluate and identify all applicable Patents.&nbsp;&nbsp;Notwithstanding the preceding sentence, the Party holding the NDA for the applicable Product will retain final decision-making authority as to the listing of all applicable Patents for such Product, regardless of which Party owns such Patent. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc197434873"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">8.6 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Other Agreement(s)</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">GSK&#8217;s rights under this Article 8 with respect to any Dynavax Compound Patents or Collaboration Patents shall be subject to the rights that one or more Third Parties may have, or the obligations that Dynavax may have, in each case to file, prosecute, maintain, and/or enforce such Patents under the agreement(s) listed in Schedule 8.6, but only to the extent that any of such rights or obligations with respect to any Third Party under any of the Agreements listed in Schedule 8.6 pertain solely to compounds that do not qualify under the definition of Compounds hereunder.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-50-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:18pt;text-align:center;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;">ARTICLE 9</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br><br></font><font style="font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;">CONFIDENTIALITY</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026696"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">9.1 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Confidentiality; Exceptions</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Except to the extent expressly authorized by this Agreement or otherwise agreed in writing, the Parties agree that the receiving Party (the &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Receiving Party</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;) shall keep confidential and shall not publish or otherwise disclose or use for any purpose other than as provided for in this Agreement any Information or other confidential and proprietary information and materials, patentable or otherwise, in any form (written, oral, photographic, electronic, magnetic, or otherwise) which is disclosed to it by the other Party (the &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Disclosing Party</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;) or otherwise received or accessed by a Receiving Party in the course of performing its obligations or exercising its rights under this Agreement, including but not limited to trade secrets, know-how, inventions or discoveries, proprietary information, formulae, processes, techniques and information relating to a Party&#8217;s past, present and future marketing, financial, and Research and Development activities of any product or potential product or useful technology of the Disclosing Party and the pricing thereof (collectively, &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Confidential Information</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;), except to the extent that it can be established by the Receiving Party that such Confidential Information:</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">9.1.1 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">was in the lawful knowledge and possession of the Receiving Party prior to the time it was disclosed to, or learned by, the Receiving Party, or was otherwise developed independently by the Receiving Party, as evidenced by written records kept in the ordinary course of business, or other documentary proof of actual use by the Receiving Party;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">9.1.2 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">was generally available to the public or otherwise part of the public domain at the time of its disclosure to the Receiving Party;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">9.1.3 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">became generally available to the public or otherwise part of the public domain after its disclosure and other than through any act or omission of the Receiving Party in breach of this Agreement; or</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">9.1.4 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">was disclosed to the Receiving Party, other than under an obligation of confidentiality, by a Third Party who had no obligation to the Disclosing Party not to disclose such information to others.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-51-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026697"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">9.2 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Authorized Disclosure</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Except as expressly provided otherwise in this Agreement, a Receiving Party may use and disclose Confidential Information of the Disclosing Party as follows: (i)&#160;under appropriate confidentiality provisions similar to those in this Agreement, in connection with the performance of its obligations or exercise of rights granted or reserved in this Agreement (including, without limitation, the rights to commercialize Products and to grant licenses and sublicenses hereunder); or (ii)&#160;to the extent such disclosure is reasonably necessary in filing or prosecuting patent, copyright and trademark applications, prosecuting or defending litigation, complying with applicable governmental regulations, obtaining regulatory approval, conducting pre-clinical activities or clinical trials, marketing Products, or otherwise required by law; </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">provided, however</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, that if a Receiving Party is required by law or regulation to make any such disclosure of a Disclosing Party&#8217;s Confidential Information it will, except where impracticable for necessary disclosures, for example in the event of medical emergency, give reasonable advance notice to the Disclosing Party of such disclosure requirement and, except to the extent inappropriate in the case of patent applications, will use its reasonable efforts to secure confidential treatment of such Confidential Information required to be disclosed; or (iii)&#160;in communication with investors, consultants, advisors or others on a need to know basis, in each case under appropriate confidentiality provisions substantially equivalent to those of this Agreement; or (iv)&#160;to the extent mutually agreed to in writing by the Parties; provided, however, that, in each of the above situations, the Receiving Party shall remain responsible for any failure by any Person who receives the Confidential Information pursuant to this Section 9.2 to treat such Confidential Information as required under this Article 9. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-52-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026698"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">9.3 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Press Release; Disclosure of Agreement</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On or promptly after the Effective Date, the Parties shall jointly issue a public announcement of the execution of this Agreement in the form attached hereto as </font><font style="text-decoration:underline;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibit F</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Neither Party shall be free to issue any press release or other public disclosure regarding the Agreement or the Parties&#8217; activities hereunder, or any results or data arising hereunder, except (a) with the other Party&#8217;s prior written consent, or (b) for any disclosure that is reasonably necessary to comply with applicable national securities exchange listing requirements or laws, rules or regulations, with the other Party&#8217;s consent not to be unreasonably withheld or delayed beyond a time reasonably in advance of the required disclosure deadline necessary to comply with applicable national securities exchange listing requirements or laws, rules or regulations.&nbsp;&nbsp;The Parties agree to consult with each other reasonably and in good faith with respect to the text and timing of any such press releases prior to the issuance thereof, and a Party may not unreasonably withhold consent to such releases.&nbsp;&nbsp;Except to the extent required by law or as otherwise permitted in accordance with this Section 9.3, neither Party shall make any public announcements concerning this Agreement or the subject matter hereof without the prior written consent of the other, which shall not be unreasonably withheld.&nbsp;&nbsp;Each Party agrees to provide to the other Party a copy of any public announcement regarding this Agreement or the subject matter thereof as soon as reasonably practicable under the circumstances prior to its scheduled release.&nbsp;&nbsp;Except under extraordinary circumstances, when the following notice may not be possible but in which event the press release will still be provided to the other Party for comment before release, each Party shall provide the other with an advance copy of any such announcements at least </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> prior to its scheduled release.&nbsp;&nbsp;Each Party shall have the right to expeditiously review and recommend changes to any such announcement and, except as otherwise required by laws, rules or regulations, the Party whose announcement has been reviewed shall remove any Confidential Information of the reviewing Party that the reviewing Party reasonably deems to be inappropriate for disclosure.&nbsp;&nbsp;The principles to be observed by Dynavax and GSK in any such permitted public disclosures with respect to this Agreement shall be: accuracy and completeness, the requirements of confidentiality under this Article 9, and the normal business practice in the pharmaceutical and biotechnology industries for disclosures by companies comparable to Dynavax and GSK.&nbsp;&nbsp;Notwithstanding the foregoing, to the extent information regarding this Agreement has already been publicly disclosed in the same context, either Party may subsequently disclose the same information to the public without the consent of the other Party.&nbsp;&nbsp;Each Party shall be permitted to disclose the terms of this Agreement, in each case under appropriate confidentiality provisions substantially equivalent to those of this Agreement, to any actual or potential acquirers, merger partners, and professional advisors.&nbsp;&nbsp;Each Party shall give the other Party a reasonable opportunity to review all filings with the United States Securities and Exchange Commission describing the terms of this Agreement prior to submission of such filings, and shall give due consideration to any reasonable comments by the non-filing Party relating to such filing, including without limitation the provisions of this Agreement for which confidential treatment should be sought.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026699"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">9.4 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Termination of Prior Agreement</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This Agreement supersedes the Confidentiality Agreement between Dynavax and GSK dated </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (including any and all amendments thereto).&nbsp;&nbsp;All information exchanged between the Parties under that agreement shall be deemed Confidential Information hereunder and shall be subject to the terms of this Article&#160;9.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026700"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">9.5 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Remedies</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Each Party shall be entitled to seek, in addition to any other right or remedy it may have, at law or in equity, a temporary injunction, without the posting of any bond or other security, enjoining or restraining the other Party from any violation or threatened violation of this Article&#160;9.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-53-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026701"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">9.6 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Publications</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Neither Party or its Affiliates shall publish or publicly disclose the results of any of the Research and/or Development activities conducted by either Party under this Agreement without the prior written consent of the other Party, except as expressly permitted in this Section 9.6 or otherwise in this Agreement.&nbsp;&nbsp;The Parties recognize that it may be useful or required to publish or publicly disclose the results of Research and Development work on Programs, and each Party (and its Affiliates and Sublicensees) shall be free to publish or publicly disclose such results, subject to the prior review by the other Party for patentability and protection of its Confidential Information as described in this Section 9.6.&nbsp;&nbsp;For Dynavax, the publication right conveyed by the preceding sentence shall apply solely to Compounds prior to the exercise of an Option by GSK to the relevant Dynavax Program, if approved by GSK, such approval not to be unreasonably withheld or delayed.&nbsp;&nbsp;The Party that desires to publish results hereunder shall provide to the other Party a copy of such proposed abstract, manuscript, or presentation no less than </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> prior to its intended submission for publication.&nbsp;&nbsp;The reviewing Party shall respond in writing promptly and in no event later than </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> after receipt of the proposed material, with one or more of the following:&nbsp;&nbsp;(i) comments on the proposed material, which the publishing Party must consider in good faith, (ii) a specific statement of concern, based upon the need to seek patent protection or to block publication if the reviewing Party determines that the proposed disclosure is intellectual property that should be maintained as a trade secret to protect a Compound or any Research and/or Development activities conducted under this Agreement, or (iii) an identification of the reviewing Party&#8217;s Confidential Information that is contained in the material reviewed.&nbsp;&nbsp;In the event of concern over patent protection or whether maintaining a trade secret would be a priority, the publishing Party agrees not to submit such publication or to make such presentation that contains such information until the reviewing Party is given a reasonable period of time (</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">) to seek patent protection for any material in such publication or presentation which it believes is patentable or to resolve any other issues or to abandon such proposed publication if the reviewing Party reasonably determines in good faith that maintaining such information as a trade secret is a commercially-reasonable priority.&nbsp;&nbsp;Any Confidential Information of such other Party shall be removed.&nbsp;&nbsp;Furthermore, with respect to any proposed abstracts, manuscripts or summaries of presentations by investigators or other Third Parties, such materials shall be subject to review under this Section 9.6 to the extent that GSK or Dynavax (as the case may be) has the right to do so.&nbsp;&nbsp;&nbsp;&nbsp;For clarity, (a) prior to the exercise of the relevant Option to a given Program by GSK, any proposed publication by Dynavax relating to a Dynavax Program or any Compounds shall be subject to review by GSK in accordance with the terms of this Section 9.6, but after the expiration of the relevant Option without exercise by GSK or after the termination of a Program which then reverts to Dynavax, Dynavax shall then be free to publish or publicly disclose any results that relate to any Compounds or Dynavax Products in such Dynavax Program or Dynavax Development Program without any review by GSK under this Section 9.6, unless such proposed disclosure or publication contains any GSK Development IP, in which case GSK shall have the right to review and approve such disclosure as stated under this Section 9.6 above, and (b) after the exercise by GSK of its Option to a Program, except as required by law or securities regulations, Dynavax shall not have the right to make any publication relating to such Dynavax Program or any Compounds or GSK Development Compounds or GSK Products without the prior written consent of GSK, and GSK shall have the right to make any such publication relating to such Dynavax Program or any Compounds or GSK Development Compounds or GSK Products without any review by Dynavax under this Section 9.6.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-54-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">9.7 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Clinical Trial Register</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp; Each of GSK and Dynavax shall have the right to publish summaries of results from any human clinical trials conducted by such Party under this Agreement on its clinical trials registry, without requiring the consent of the other Party, subject to the last sentence of this Section 9.7; provided, however, that GSK shall have no right, without the consent of Dynavax, to so publish data generated by Dynavax prior to GSK&#8217;s exercise of its Option with respect to the relevant Compounds under the relevant Dynavax Program, and, after the exercise of its Option to such Dynavax Program, GSK shall have the right to so publish any previously existing and/or any subsequently arising data that is or may be generated by either Dynavax or GSK or by their respective Affiliates or Sublicensees with respect to the relevant Compound(s) without obtaining the consent of Dynavax, except with respect to any Compounds which are being pursued under a Dynavax Development Program after termination by GSK of such Compounds as GSK Development Compounds or after GSK declines to exercise its Option with respect to such Dynavax Program.&nbsp;&nbsp; In addition, after the exercise of its Option by GSK to a particular Dynavax Program, Dynavax shall not have the right to publish any of such data, without the prior consent of GSK, pertaining to the relevant Compounds or the Dynavax Program, except with respect to any Compounds which are being pursued under a Dynavax Development Program after termination by GSK of such Compounds as GSK Development Compounds.&nbsp;&nbsp;The Parties shall discuss and reasonably cooperate in order to facilitate the process to be employed in order to ensure the publication of any such summaries of human clinical trials data and results as required on the clinical trial registry of each respective Party, and shall provide the other Party via submission to the Joint Patent Subcommittee established under Section 3.1.8, at least </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Calendar Days prior notice to review the clinical trials results to be published for the purposes of preparing any necessary Patent filings.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:center;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026702"></a><font style="font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;">ARTICLE 10</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br><br></font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">REPRESENTATIONS AND WARRANTIES</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026703"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">10.1 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Representations and Warranties of Both Parties</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Each Party hereby represents and warrants to the other Party, as of the Effective Date, that:</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">10.1.1 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">such Party is duly organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation and has full corporate power and authority to enter into this Agreement and to carry out the provisions hereof;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">10.1.2 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">such Party has taken all necessary action on its part to authorize the execution and delivery of this Agreement and the performance of its obligations hereunder;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">10.1.3 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">this Agreement has been duly executed and delivered on behalf of such Party, and constitutes a legal, valid, binding obligation, enforceable against it in accordance with the terms hereof;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">10.1.4 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the execution, delivery and performance of this Agreement by such Party does not conflict with any agreement or any provision thereof, or any instrument or understanding, oral or written, to which it is a party or by which it is bound, nor violate any law or regulation of any court, governmental body or administrative or other agency having jurisdiction over such Party;</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-55-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">10.1.5 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">no government authorization, consent, approval, license, exemption of or filing or registration with any court or governmental department, commission, board, bureau, agency or instrumentality, domestic or foreign, under any applicable laws, rules or regulations currently in effect, is or will be necessary for, or in connection with, the transaction contemplated by this Agreement or any other agreement or instrument executed in connection herewith, or for the performance by it of its obligations under this Agreement and such other agreements except as may be required to obtain HSR clearance; and</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">10.1.6 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">it has not employed (and, to the best of its knowledge without further duty of inquiry, has not used a contractor or consultant that has employed) any individual or entity debarred by the FDA (or subject to a similar sanction of EMEA), or, to the best of its knowledge without further duty of inquiry, any individual who or entity that is the subject of an FDA debarment investigation or proceeding (or similar proceeding of EMEA), in the conduct of any pre-clinical activities or clinical studies of Compounds.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026704"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">10.2 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Representations, Warranties and Covenants of Dynavax</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Dynavax hereby represents, warrants, and covenants to GSK, as of the Effective Date, and covenants to GSK&nbsp;&nbsp;during the Term (or the applicable portion thereof) as applicable for Sections 10.2.3 and 10.2.6-10.2.9, that: </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">10.2.1 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To its knowledge, Dynavax is the owner of, or has Control via a license to, the Dynavax Compound IP;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">10.2.2 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To its knowledge, Dynavax has the right to grant all rights and licenses it purports to grant to GSK with respect to the Dynavax Compound IP under this Agreement; </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">10.2.3 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc144026707"></a>Except as set forth on Schedule 10.2 only with respect to compounds that do not qualify as Compounds as defined under this Agreement, Dynavax has not granted as of the Effective Date, and during the Term Dynavax shall not grant, any right or license, encumbrance, lien or other interest of any kind (other than general liens arising in the ordinary course of business which are not specific to any of the Dynavax Compound IP or to any Collaboration IP) to any Third Party relating to any of the Dynavax Compound IP or any of Dynavax&#8217;s right, title or interest in any of the Collaboration IP that would conflict or interfere with or limit the scope of any of the rights or licenses granted or to be granted to GSK hereunder pursuant to the exercise of any Option to any Program; </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">10.2.4 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dynavax has not granted any liens or security interests on the Dynavax Compound IP or Collaboration IP under the Symphony Agreement or the AstraZeneca Agreement or any other collaboration or license agreement;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">10.2.5 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dynavax has not withheld from GSK any material data or any material correspondence, including without limitation any correspondence to or from any Regulatory Authority, in existence as of the Effective Date with respect to the Dynavax Programs or Compounds that it is aware would have a material adverse effect upon GSK&#8217;s scientific, commercial, safety and regulatory assessment of the liabilities of the collaboration between the Parties as contemplated under this Agreement;&nbsp;&nbsp;&nbsp;&nbsp;</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-56-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">10.2.6 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To its knowledge, Dynavax has disclosed or provided access to as of the Effective Date, and thereafter until the exercise or expiration of the Option with respect to a Dynavax Program shall disclose to GSK and exchange, all data and information and all correspondence to or from any Regulatory Authority then available, regardless of whether such data, correspondence and information would have a positive or negative impact on the potential commercial, scientific or strategic value or attractiveness of the Compounds, that is in Dynavax&#8217;s reasonable business judgment material to a reasonable assessment by GSK of the scientific, commercial, safety, and regulatory liabilities of the Compounds to be considered by GSK in deciding whether or not to exercise its Option with respect to such Dynavax Program; </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">10.2.7 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dynavax is resident for tax purposes in the US and is entitled to relief from United Kingdom income tax under the terms of the double tax agreement between the UK and US and, during the Term, Dynavax shall notify GSK immediately in writing in the event that Dynavax ceases to be entitled to such relief and in such event, the withholding rights of GSK pursuant to Section 6.11.1 shall apply.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">10.2.8 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the Term until the exercise or expiration of an Option with respect to a Dynavax Program, Dynavax will not knowingly use any compound in such Dynavax Program that, to its knowledge, is encumbered by any Third Party lien (other than general liens created in the ordinary course of business which are not specific to any of the Dynavax Compound IP or to any Collaboration IP) or restriction or any Third Party right or obligation that would conflict or interfere with any of the rights or licenses granted or to be granted to GSK hereunder pursuant to the exercise of such Option or by operation of the provisions of Article 12; </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">10.2.9 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the Term, Dynavax shall notify GSK in writing within ten (10) Calendar Days in the event that it has </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, based upon then-current or reasonable </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">; and</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">10.2.10 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> During the Term, Dynavax shall use its reasonable business judgment to </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, to the extent necessary for GSK to make, have made, use, sell, offer for sale or import GSK Products.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc197434885"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">10.3 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Mutual Covenants</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Each Party hereby covenants to the other Party that:</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">10.3.1 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All employees of such Party or its Affiliates working under this Agreement will be under the obligation to assign all right, title and interest in and to their inventions and discoveries, whether or not patentable, to such Party as the sole owner thereof;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">10.3.2 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Such Party will not employ (or, to the best of its knowledge without further duty of inquiry, will not use any contractor or consultant that employs) any individual or entity debarred by the FDA (or subject to a similar sanction of EMEA) or, to the best of its knowledge without further duty of inquiry, any individual who or entity that is the subject of an FDA debarment investigation or proceeding (or similar proceeding of EMEA), in the conduct of its activities under any Program; </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-57-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">10.3.3 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Such Party shall (a) perform its activities pursuant to this Agreement in compliance with good laboratory and clinical practices and cGMP, in each case as applicable under the laws and regulations of the country and the state and local government wherein such activities are conducted; (b) with respect to the care, handling and use in Research and Development activities hereunder of any non-human animals by or on behalf of such Party, at all times comply (and shall ensure compliance by any of its subcontractors) with all applicable federal, state and local laws, regulations and ordinances, and also with the most current best practices for comparable-sized pharmaceutical or biotechnology companies for the proper care, handling and use of animals in pharmaceutical Research and Development activities, and at all times with the &#8220;3R Principles&#8221; (reducing the number of animals used, replacing animals with non-animal methods whenever possible and refining the Research techniques used), subject to the other Party&#8217;s reasonable right of inspection; (c) promptly and in good faith undertake reasonable corrective steps and measures to remedy the situation to the extent that any significant deficiencies are identified as a result of such inspection; and (d) with respect to any biological samples obtained from humans, obtain the appropriate informed consents in advance for the use of all such human biological samples, and use such samples at all times within the scope of the relevant informed consents;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">10.3.4 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Neither Party shall, during the Term, grant any right or license or encumbrance or lien of any kind (other than general liens created in the ordinary course of business which are not specific to any of the Dynavax Compound IP, the GSK Development IP, or to any Collaboration IP) to any Third Party relating to any of the intellectual property rights it owns or Controls which would conflict or interfere with any of the rights or licenses granted or to be granted to the other Party hereunder pursuant to the provisions of Article 4 or by operation of the provisions of Article 12; and </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">10.3.5 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Each Party will notify the other Party in writing promptly in the event that it has actual knowledge of the material breach of any covenant under Section 10.2 or this Section 10.3 or the material breach of any representation or warranty provided by either Party under Section 10.1 or by Dynavax under Section 10.2.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">10.4 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Disclaimer</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Except as otherwise expressly set forth in this Agreement, NEITHER PARTY MAKES ANY REPRESENTATION OR EXTENDS ANY WARRANTY OF ANY KIND, EITHER EXPRESS OR IMPLIED, INCLUDING ANY WARRANTY THAT ANY PATENTS ARE VALID OR ENFORCEABLE OR THAT THEIR EXERCISE DOES NOT INFRINGE ANY PATENT RIGHTS OF THIRD PARTIES, AND EXPRESSLY DISCLAIMS ALL WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. Without limiting the generality of the foregoing, each Party disclaims any warranties with regards to:&nbsp;&nbsp;(a) the success of any study or test commenced under this Agreement, (b) the safety or usefulness for any purpose of the technology or materials, including any Compounds, it provides or discovers under this Agreement; and/or (c) the validity, enforceability, or non-infringement of any intellectual property rights or technology it provides or licenses to the other Party under this Agreement.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-58-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:18pt;text-align:center;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026708"></a><font style="font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;">ARTICLE 11</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br><br></font><font style="font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;">INDEMNIFICATION; INSURANCE</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026709"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">11.1 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Indemnification by GSK</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;GSK shall indemnify, defend and hold harmless Dynavax and its Affiliates, and its or their respective directors, officers, employees and agents, from and against any and all liabilities, damages, losses, costs and expenses, including, but not limited to, the reasonable fees of attorneys and other professional Third Parties (collectively, &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Losses</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;), arising out of or resulting from any and all Third Party</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">suits, claims, actions, proceedings or demands (</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Claims&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">) based upon: </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">11.1.1 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the negligence, recklessness or wrongful intentional acts or omissions of GSK and/or its Affiliates and its or their respective directors, officers, employees and agents, in connection with GSK&#8217;s performance of its obligations or exercise of its rights under this Agreement; </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">11.1.2 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">any breach of any representation or warranty or express covenant made by GSK under Article&#160;10 or any other provision under this Agreement;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">11.1.3 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the Development that is actually conducted by and/or on behalf of GSK (excluding any Development carried out by and/or on behalf of Dynavax hereunder), the handling and storage by and/or on behalf of GSK of any chemical agents or other compounds for the purpose of conducting Development by or on behalf of GSK, and the manufacture, marketing, commercialization and sale by GSK, its Affiliate or Sublicensee of any Compound or GSK Product; or</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">11.1.4 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the alleged infringement or misappropriation of the intellectual property rights of any Third party or a claim or defense of unenforceability due to inequitable conduct brought before the United States Patent and Trademark Office or a United States District Court and any resulting antitrust claims arising therefrom, in each case, to the extent based upon or attributable to the Patents for which and to the extent GSK is responsible for the Prosecution and Maintenance under Article 8;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">except</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, in each case above, to the extent such Claim arose out of or resulted from or is attributable to the negligence, recklessness or wrongful intentional acts or omissions of Dynavax and/or its Affiliates, or their respective directors, officers, employees or agents. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026710"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">11.2 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Indemnification by Dynavax</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Dynavax shall indemnify, defend and hold harmless GSK and its Affiliates, and its or their respective directors, officers, employees and agents, from and against any and all Losses, arising out of or resulting from any and all Third Party</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Claims</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">based upon:</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">11.2.1 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the negligence, recklessness or wrongful intentional acts or omissions of Dynavax and/or its Affiliates and/or its or their respective directors, officers, employees and agents, in connection with Dynavax&#8217;s performance of its obligations or exercise of its rights under this Agreement; </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">11.2.2 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">any breach of any representation or warranty or express covenant made by Dynavax under Article 10 or any other provision under this Agreement;</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-59-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">11.2.3 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the Research and/or Development actually conducted by or on behalf of Dynavax (excluding any Research and Development carried out by or on behalf of GSK or its Affiliate, Sublicensee or subcontractor, provided however that the Research and Development which is to be carried out by or on behalf of Dynavax hereunder shall not be considered or interpreted to be Research and Development carried out by or on behalf of GSK), the handling and storage by and/or on behalf of Dynavax of any chemical agents or other compounds for the purpose of conducting Research and/or Development by or on behalf of Dynavax, and the manufacture, marketing, commercialization and sale by Dynavax, its Affiliate or Sublicensee of any Compound or Dynavax Product; or</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">11.2.4 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the alleged infringement or misappropriation of the intellectual property rights of any Third Party or a claim or defense of unenforceability due to inequitable conduct brought before the United States Patent and Trademark Office or a United States District Court and any resulting antitrust claims arising therefrom, in each case, to the extent based upon or attributable to the Patents in the Exclusively Licensed IP for which and to the extent Dynavax is responsible for the Prosecution and Maintenance under Article 8;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">except</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, in each case above, to the extent such Claim arose out of or resulted from or is attributable to the negligence, recklessness or wrongful intentional acts or omissions of GSK and/or its Affiliate, or their respective directors, officers, employees and agents.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026711"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">11.3 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Procedure</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;In the event that any person (an &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Indemnitee</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;) entitled to indemnification under Section 11.1 or Section 11.2 is seeking such indemnification, such Indemnitee shall (i) inform, in writing, the indemnifying Party of the claim as soon as reasonably practicable after such Indemnitee receives notice of such claim, (ii) permit the indemnifying Party to assume direction and control of the defense of the claim (including the sole right to settle it at the sole discretion of the indemnifying Party, taking into consideration in good faith any reasonable concerns or objections raised by the Indemnitee; </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">provided that</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> such settlement does not impose any obligation on, or otherwise adversely affect, the Indemnitee or other Party), (iii) cooperate as reasonably requested (at the expense of the indemnifying Party) in the defense of the claim, and (iv) undertake all reasonable steps to mitigate any loss, damage or expense with respect to the claim(s).</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026712"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">11.4 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Insurance</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">11.4.1 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Dynavax&#8217;s Insurance Obligations</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Dynavax shall maintain, at its cost, with effect from </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (including, without limitation, all Products and any product based thereon) </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> hereunder and during the Term thereafter, adequate insurance against liability and other risks associated with its activities contemplated by this Agreement, including but not limited to its Clinical Trials and its indemnification obligations herein, in such amounts and on such terms as are customary for prudent practices in the biotechnology industry for the activities to be conducted by it under this Agreement; provided, however, that in no event shall such insurance coverage be less than </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> per claim and annual aggregate prior to the date of first administration of any Compound or Product to humans by GSK or any Dynavax Product to humans by Dynavax hereunder, and further provided that such coverage is increased to at least </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> at least </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> before Dynavax or its Affiliate or Sublicensee initiates the First Commercial Sale of any Dynavax Product hereunder.&nbsp;&nbsp;Dynavax shall furnish to GSK evidence of such insurance upon request. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-60-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">11.4.2 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">GSK&#8217;s Insurance Obligations</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;GSK hereby represents and warrants to Dynavax that it is self-insured against liability and other risks associated with its activities and obligations under this Agreement in such amounts and on such terms as are customary for prudent practices for large pharmaceutical companies in the pharmaceutical industry for the activities to be conducted by it under this Agreement. GSK shall furnish to Dynavax evidence of such self-insurance upon request.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026713"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">11.5 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">LIMITATION OF LIABILITY</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. EXCEPT FOR A BREACH OF ARTICLE 9 OR FOR CLAIMS OF A THIRD PARTY THAT ARE SUBJECT TO INDEMNIFICATION UNDER THIS ARTICLE 11 OR AS OTHERWISE EXPRESSLY STATED IN THIS AGREEMENT, NEITHER DYNAVAX NOR GSK, NOR ANY OF THEIR AFFILIATES OR SUBLICENSEES, WILL BE LIABLE TO THE OTHER PARTY TO THIS AGREEMENT, ITS AFFILIATES OR ANY OF THEIR SUBLICENSEES FOR ANY INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL, RELIANCE OR PUNITIVE DAMAGES OR LOST OR IMPUTED PROFITS OR ROYALTIES, LOST DATA OR COST OF PROCUREMENT OF SUBSTITUTE GOODS OR SERVICES, WHETHER LIABILITY IS ASSERTED IN CONTRACT, TORT (INCLUDING NEGLIGENCE AND STRICT PRODUCT LIABILITY), INDEMNITY OR CONTRIBUTION, AND IRRESPECTIVE OF WHETHER THAT PARTY OR ANY REPRESENTATIVE OF THAT PARTY HAS<a name="_DV_M359"></a> BEEN ADVISED OF, OR OTHERWISE MIGHT HAVE ANTICIPATED THE POSSIBILITY OF, ANY SUCH LOSS OR DAMAGE.&nbsp;&nbsp; </font></p><p style="margin-bottom:0pt;margin-top:18pt;text-align:center;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026714"></a><font style="font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;">ARTICLE 12</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br><br></font><font style="font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;">TERM AND TERMINATION</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc197434895"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">12.1 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Term; Expiration</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. This Agreement shall become effective as of the Effective Date and, unless earlier terminated pursuant to the other provisions of this Article 12, shall expire as follows:</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">12.1.1 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On a Product-by-Product and country-by-country basis, on the date of the expiration of all payment obligations under this Agreement with respect to such Product in such country; </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">12.1.2 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In its entirety upon the expiration of all payment obligations under this Agreement with respect to the last Product in all countries in the Territory; and</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">12.1.3 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On a Program-by-Program basis when no Compound or Product is being Researched, Developed or commercialized by either Party hereunder with Commercially Reasonable Efforts pursuant to a given Dynavax Program or GSK Development Program or Dynavax Development Program, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The period from the Effective Date until the date of expiration of this Agreement in its entirety, or as the case may be, until the date of the expiration of this Agreement in part with respect to a given Product or Program, may be referred to herein as the &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Term.</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-61-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc197434896"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">12.2 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Termination for Cause</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">12.2.1 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Termination for Material Breach</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Either Party (the &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Non-breaching Party</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;) may, without prejudice to any other remedies available to it at law or in equity, terminate this Agreement, either on a Program-by-Program basis or in its entirety, as may be appropriate to protect the interest of the Non-breaching Party arising from such alleged breach, in the event the other Party (the &#8220;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Breaching Party</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;) shall have materially breached or defaulted in the performance of any of its material obligations hereunder either with respect to a particular Program or the Agreement as a whole, and such default shall have continued for </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> after written notice thereof was provided to the Breaching Party by the Non-breaching Party, such notice describing with particularity and in detail the alleged material breach.&nbsp;&nbsp;Subject to Section 12.2.2, any such termination of the Agreement under this Section 12.2 shall become effective at the end of such </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> period, unless the Breaching Party has cured any such breach or default prior to the expiration of such </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> period, or if such breach is not susceptible to cure within such </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> period even with the use of Commercially Reasonable Efforts, the Non-Breaching Party&#8217;s right to termination shall be suspended only if and for so long as the Breaching Party has provided to the Non-Breaching Party a written plan that is reasonably calculated to effect a cure, such plan is acceptable to the Non-Breaching Party (or to the arbitrators, in the event of arbitration pursuant to Section 13.1), and the Breaching Party commits to and does carry out such plan.&nbsp;&nbsp;The right of either Party to terminate this Agreement, or a portion of this Agreement, as provided in this Section 12.2 shall not be affected in any way by such Party&#8217;s waiver or failure to take action with respect to any previous default.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">12.2.2 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Disagreement.</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;If the Parties reasonably and in good faith disagree as to whether there has been a material breach, the Party that seeks to dispute that there has been a material breach may contest the allegation in accordance with Section 13.1.&nbsp;&nbsp;The cure period for any allegation made in good faith as to a material breach under this Agreement will run from the date that written notice was first provided to the Breaching Party by the Non-breaching Party, but shall be suspended pursuant to Section 13.2.</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc197434897"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">12.3 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">GSK Unilateral Termination Rights</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;GSK shall have the right, at its sole discretion and without any penalty or liability, exercisable at any time during the Term, to terminate this Agreement either in its entirety or on a Program-by-Program basis, for any reason or for no reason at all, upon (a) </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> prior written notice to Dynavax if such notice is given </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, or (b) </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> prior written notice to Dynavax if such notice is given </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, in each case subject to the obligations set forth in Section 12.5.2.&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><a name="_Toc197434898"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">12.4 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Termination for Insolvency. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">12.4.1 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Either Party may terminate this Agreement if, at any time, the other Party shall file in any court or agency pursuant to any statute or regulation of any state or country, a petition in bankruptcy or insolvency or for reorganization or for an arrangement or for the appointment of a receiver or trustee of the Party or of substantially all of its assets, or if the other Party proposes a written agreement of composition or extension of substantially all of its debts, or if the other Party shall be served with an involuntary petition against it, filed in any insolvency proceeding, and such petition shall not be dismissed </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Calendar Days after the filing thereof, or if the other Party shall propose or be a party to any dissolution or liquidation, or if the other Party shall make an assignment of substantially all of its assets for the benefit of creditors.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-62-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">12.4.2 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All rights and licenses granted under or pursuant to any section of this Agreement are and shall otherwise be deemed to be for purposes of Section 365(n) of Title 11, United States Code (the &#8220;</font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Bankruptcy Code</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;) licenses of rights to &#8220;intellectual property&#8221; as defined in Section 101(56) of the Bankruptcy Code.&nbsp;&nbsp;The Parties shall retain and may fully exercise all of their respective rights and elections under the Bankruptcy Code.&nbsp;&nbsp;Upon the bankruptcy of any Party, the non-bankrupt Party shall further be entitled to a complete duplicate of, or complete access to, any such intellectual property, and such, if not already in its possession, shall be promptly delivered to the non-bankrupt Party, unless the bankrupt Party elects to continue, and continues, to perform all of its obligations under this Agreement. </font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><a name="_Toc197434899"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">12.5 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Effect of Termination or Expiration.&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">12.5.1 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Upon Expiration.</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Following the expiration of the Term pursuant to Section 12.1, the following terms shall apply:</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(a) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Subject to the terms and conditions of this Agreement, following expiration of the Term with respect to a GSK Product in a country pursuant to Section 12.1.1, GSK shall have an exclusive, fully-paid and royalty-free right and license, with the right to grant sublicenses, under the Exclusively Licensed IP, to continue to make, have made, use, sell, offer to sell and import such GSK Product in the Field in such country, for so long as it continues to do so.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(b) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Subject to the terms and conditions of this Agreement, following expiration of the Term with respect to a Dynavax Product in a country pursuant to Section 12.1.1, Dynavax shall have an exclusive, fully-paid and royalty-free right and license, with the right to grant sublicenses, under the GSK Development IP and GSK&#8217;s interest in the Collaboration IP, solely to continue to make, have made, use, sell, offer to sell and import such Dynavax Product in the Field in such country, for so long as it continues to do so.&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(c) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Subject to the terms and conditions of this Agreement, following expiration of the Term with respect to this Agreement in its entirety pursuant to Section 12.1.2, GSK shall have an exclusive, fully-paid and royalty-free right and license, with the right to grant sublicenses, under the Exclusively Licensed IP, to continue to make, have made, use, sell, offer to sell and import GSK Products in the Field in the Territory, for so long as it continues to do so. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(d) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Subject to the terms and conditions of this Agreement, following expiration of the Term with respect to this Agreement in its entirety pursuant to Section 12.1.2, Dynavax shall have an exclusive, fully-paid and royalty-free right and license, with the right to grant sublicenses, under the GSK Development IP and GSK&#8217;s interest in the Collaboration IP, solely to continue to make, have made, use, sell, offer to sell and import Dynavax Products in the Field in the Territory, for so long as it continues to do so.&nbsp;&nbsp;</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-63-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">12.5.2 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Upon Unilateral Termination by GSK.</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;In the event of a unilateral termination of this Agreement in its entirety or any Program by GSK pursuant to Section&#160;12.3, the following terms shall apply:</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(a) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Notwithstanding anything contained herein to the contrary, all licenses granted to GSK with respect to Compounds and GSK Products in the terminated Program (or, in the case of termination of the entire Agreement, all Compounds and GSK Products) shall terminate, each such GSK Product shall be deemed to be a Dynavax Product, and the terms and conditions of Sections 5.3, 6.5 and 6.6 shall apply with respect to such Dynavax Products;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(b) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">as of the date of notice of such termination, GSK shall not be required to use Commercially Reasonable Efforts to progress any GSK Products in the terminated Program(s) under this Agreement, and as of the effective date of such termination, GSK will cease any and all Development and commercialization activities with respect to Compounds included in a terminated Program (or in the case of termination of the entire Agreement, all Programs); provided, however, that nothing in this Section 12.5.2 is intended to limit GSK&#8217;s obligations under Section 12.5.5;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(c) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All unexercised Options with respect to the terminated Program(s) as of the date that Dynavax receives such notice from GSK shall be cancelled and of no force and effect; </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(d) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">With respect to any Compound in a terminated Program (or in the case of termination of the entire Agreement, all Programs), GSK shall grant, and hereby grants, to Dynavax an exclusive right and license, with the right to grant sublicenses, under GSK&#8217;s (including its Affiliate&#8217;s and Sublicensee&#8217;s) interest in any Collaboration IP and GSK Development IP </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, solely to Develop, make, have made, use, sell, offer to sell and import such Compound as a Dynavax Product in the Field in the Territory, for so long as it continues to do so, subject to the royalty obligations set forth in Sections 6.5 and 6.6; and</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(e) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the event of termination of the Agreement in its entirety or on a Program-by-Program basis pursuant to Section 12.3, all of Dynavax&#8217;s and GSK&#8217;s respective </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> with respect to TLRs in the terminated Program(s) shall immediately terminate and no longer be of any force or effect.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">12.5.3 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Upon Termination by GSK for Cause or Dynavax&#8217;s Insolvency.&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the event of a termination of this Agreement in its entirety or any Program by GSK pursuant to Section&#160;12.2.1 for a material breach by Dynavax, or the entire Agreement pursuant to Section 12.4:&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(a) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All Options with respect to the terminated Programs (or in the case of termination of the entire Agreement, all Options) that are unexercised as of the effective date of termination shall be cancelled and of no force and effect;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(b) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For each terminated Program for which GSK has not exercised the Option, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;GSK will </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, and (ii) all </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shall not apply.&nbsp;&nbsp;Notwithstanding the above, in no event shall </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-64-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(c) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the case of termination by GSK of a Program for an uncured material breach or insolvency of Dynavax that occurred after the exercise by GSK of its Option with respect to such Program or a termination by GSK of the entire Agreement, in each case pursuant to Section 12.2.1 or Section 12.4, GSK shall retain any license granted in Section 4.2.1 with respect to the Compounds in each terminated Program for which GSK has already exercised its Option, provided that GSK continues to comply with all </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> with respect to such GSK Products, except that </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(d) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the event of termination of the Agreement in its entirety or on a Program-by-Program basis by GSK pursuant to Section 12.2.1, all of GSK&#8217;s exclusivity obligations under Article 7 with respect to the TLRs in the terminated Program(s) shall </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, but the exclusivity obligations of Dynavax under Article 7 shall continue in full force and effect as follows: (i) </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Dynavax&#8217;s obligations shall continue in accordance with the terms of Article 7, and (ii) </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Dynavax&#8217;s obligations under Article 7 shall </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, and (iii) </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Dynavax&#8217;s obligations under Article 7 shall </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(e) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">GSK shall no longer have any obligations with respect to diligence or to use Commercially Reasonable Efforts with respect to (i) any Compounds or GSK Products resulting from any Dynavax Program or GSK Development Program that was terminated by GSK pursuant to Section 12.2.1, or (ii) all Compounds and GSK Products if the entire Agreement was terminated pursuant to Section 12.2.1.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(f) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Notwithstanding the foregoing, to the extent that termination by GSK of this Agreement for insolvency of Dynavax does not, as a result of the outcome of bankruptcy or insolvency proceedings, result in GSK having the right to exercise its rights pursuant to the foregoing Section 12.5.3(b) or (c), then GSK shall also have the remedy set forth in Section </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shall have occurred.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">12.5.4 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Upon Termination by Dynavax for Cause or GSK&#8217;s Insolvency.</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;In the event that Dynavax terminates a Program or this Agreement pursuant to Section 12.2.1 or the entire Agreement pursuant to Section 12.4:</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(a) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All Options with respect to the terminated Programs (or in the case of termination of the entire Agreement, all Options) that are unexercised as of the effective date of termination shall be cancelled and of no force and effect.&nbsp;&nbsp;For clarity, GSK shall not be permitted to exercise any Option after receiving notice of Dynavax&#8217;s termination under Section 12.2.1 without Dynavax&#8217;s prior written consent, unless and until Dynavax agrees, or it is determined pursuant to the process set forth under Section 13.1 or Section 13.2, that GSK has cured the applicable breach in a timely manner or GSK has not been in material breach or GSK has been in breach but the matter has been resolved in favor of allowing GSK to exercise its Option;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(b) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">With respect to any Compound in a terminated Program (or in the case of termination of the entire Agreement, any Program), at Dynavax&#8217;s option, GSK will grant, and hereby grants, to Dynavax an exclusive right and license, with the right to grant sublicenses, under GSK&#8217;s (including its Affiliate&#8217;s and Sublicensee&#8217;s) interest in any Collaboration IP and any GSK Development IP </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, solely to Develop, make, have made, use, sell, offer to sell and import such Compounds as Dynavax </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-65-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Products in the Field in the Territory, for so long as it continues to do so, subject to the royalty obligations as set forth in Sections 6.5 and 6.6; and</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(c) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the event of termination by Dynavax of the Agreement in its entirety or on a Program-by-Program basis, the respective </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of Dynavax and GSK under Article </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shall continue in full force and effect for </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">12.5.5 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Obligations of GSK with Respect to Compounds in Dynavax Products.&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Upon termination of a Program or this Agreement by Dynavax pursuant to Section </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or the termination of the entire Agreement by Dynavax pursuant to Section </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, or termination of a Program or this Agreement by GSK pursuant to Section </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">:</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(a) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">GSK shall complete any ongoing trials of GSK Products with regard to </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">; provided, however, that if Dynavax terminates this Agreement pursuant to Section </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, Dynavax may instead elect to have GSK (i) transition oversight of such ongoing trials to Dynavax as soon as reasonably practicable and (ii) </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> associated with Dynavax completing such trials with regard to </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Notwithstanding the foregoing, GSK may prematurely suspend or terminate any such trial if (A) a priori protocol defined stopping rules are met for safety or efficacy or (B) unacceptable safety signals are observed by GSK or the Data and Safety Monitoring Board with respect to the Product or related Compound that present an unacceptable risk to patients participating in such trials;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(b) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">GSK shall promptly return to Dynavax, </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, all Information and materials transferred by Dynavax to GSK with respect to each such Compound and shall transfer stocks of Product </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> to Dynavax;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(c) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">GSK shall transfer to Dynavax, at Dynavax&#8217;s request, any and all data and Information pertaining directly and solely to the applicable Compounds that are necessary for the continued Development and commercialization of such Compounds in its possession and other related materials, including without limitation copies of all clinical study data and results, and all other Information and the like developed by or for the benefit of GSK relating to such Compounds and other documents to the extent directly and solely relating to such Compounds that are necessary in the continued Development and commercialization of such Compounds as Dynavax Products (including without limitation material documents and agreements relating to the sourcing, manufacture, promotion, distribution, sale or use of a Product) throughout the Territory; and</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:20%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:20%">(d) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">GSK shall wherever practical assign (and where not practical shall permit use of the same) to Dynavax any and all regulatory filings relating to such Compounds, including, without limitation, any NDAs.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><a name="_Toc197434900"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">12.6 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Accrued Rights; Surviving Provisions of the Agreement.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">12.6.1 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Termination, relinquishment or expiration of this Agreement for any reason shall be without prejudice to any rights that shall have accrued to the benefit of any Party prior to such termination, relinquishment or expiration including the payment obligations under Article&#160;6 hereof and any and all damages </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-66-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or remedies arising from any breach hereunder.&nbsp;&nbsp;Such termination, relinquishment or expiration shall not relieve any Party from obligations which are expressly indicated to survive termination of this Agreement.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">12.6.2 </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The provisions of Articles 9, 11 and 13 and Sections 2.10, 4.2 (in accordance with Section 12.5, as applicable), 5.3 (in accordance with Section 12.5, as applicable), 6.10, 8.1, 10.4, 12.5 and 12.6 as well as any applicable definitions in Article 1, shall survive the termination or expiration of this Agreement for any reason, in accordance with their respective terms and conditions, and for the duration stated, and where no duration is stated, shall survive indefinitely.&nbsp;&nbsp;Article 9 shall survive for a period of </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="margin-bottom:0pt;margin-top:18pt;text-align:center;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026722"></a><font style="font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;">ARTICLE 13</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br><br></font><font style="font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;">miscellaneous</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026723"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">13.1 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Dispute Resolution</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc144026724"></a>.&nbsp;&nbsp;Unless otherwise expressly provided in Section 3.1.4 as not being subject to further review under Section 13.1, in the event of a dispute arising under this Agreement between the Parties, either Party shall have the right to refer such dispute to the respective Executive Officers, and such Executive Officers shall attempt in good faith to resolve such dispute.&nbsp;&nbsp;If the Parties are unable to resolve a given dispute pursuant to this Section 13.1 within </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> days of referring such dispute to the Executive Officers, either Party may have the given dispute settled by binding arbitration pursuant to Section 13.2.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">13.2 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Arbitration Request</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;If a Party intends to begin an arbitration to resolve a dispute arising under this Agreement, such Party shall provide written notice (the </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Arbitration Request&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">) to the other Party of such intention and the issues for resolution.&nbsp;&nbsp;From the date of the Arbitration Request and until such time as the dispute has become finally settled, the running of the time periods as to which Party must cure a breach of this Agreement becomes suspended as to any breach that is the subject matter of the dispute. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">13.2.1 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Additional Issues</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Within </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Business Days after the receipt of the Arbitration Request, the other Party may, by written notice, add additional issues for resolution.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">13.2.2 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"> No Arbitration of Patent Issues.</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;Any dispute, controversy or claim relating to the scope, validity, enforceability or infringement of any Patents covering the manufacture, use, importation, offer for sale or sale of Products shall be submitted to a court of competent jurisdiction in the country in which such patent rights were granted or arose</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-67-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">13.2.3 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Arbitration Procedure</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Any arbitration pursuant to this Article 13 will be held in the continental United States at a location to be agreed by the Parties and under the rules of the American Arbitration Association (</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;AAA&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">).&nbsp;&nbsp;The arbitration will be governed by the United States Arbitration Act, 9 U.S.C. &#167;&#167; 1-16, to the exclusion of any inconsistent state laws.&nbsp;&nbsp;The Parties shall mutually agree the rules to govern discovery and the rules of evidence for the arbitration.&nbsp;&nbsp;In the event the parties fail to agree promptly to such rules, The United States Federal Rules of Civil Procedure will govern discovery and the rules of evidence for the arbitration.&nbsp;&nbsp;The arbitration will be conducted by three (3) arbitrators who are knowledgeable in the subject matter at issue in the dispute.&nbsp;&nbsp;The Parties will attempt to select three (3) arbitrators that are each acceptable to both Parties.&nbsp;&nbsp;In the event the Parties fail to agree promptly on three mutually-acceptable arbitrators, one (1) arbitrator will be selected by Dynavax, one (1) arbitrator will be selected by GSK, and the third arbitrator will be selected by mutual agreement of the two (2) arbitrators selected by the Parties.&nbsp;&nbsp;The arbitrators may proceed to an award, notwithstanding the failure of either Party to participate in the proceedings.&nbsp;&nbsp;The arbitrators shall, within fifteen (15) days after the conclusion of the arbitration hearing, issue a written award and statement of decision describing the essential findings and conclusions on which the award is based, including the calculation of any damages awarded.&nbsp;&nbsp;The arbitrators shall be limited in the scope of their authority to resolving only the specific matter which the Parties have referred to arbitration for resolution and shall not have authority to render any decision or award on any other issues.&nbsp;&nbsp;The arbitrators shall be authorized to award compensatory damages, but shall not be authorized to award punitive, special, consequential, or any other similar form of damages, or to reform, modify or materially change this Agreement.&nbsp;&nbsp;The arbitrators also shall be authorized to grant any temporary, preliminary or permanent equitable remedy or relief the arbitrators deem just and equitable and within the scope of this Agreement, including, without limitation, an injunction or order for specific performance.&nbsp;&nbsp;The award of the arbitrators shall be the sole and exclusive remedy of the Parties, except for those remedies that are set forth in this Agreement or which apply to a Party by operation of the applicable provisions of this Agreement, and the Parties hereby expressly agree to waive the right to appeal from the decisions of the arbitrators, and there shall be no appeal to any court or other authority (government or private) from the decision of the arbitrators.&nbsp;&nbsp;Judgment on the award rendered by the arbitrators may be enforced in any court having competent jurisdiction thereof, subject only to revocation on grounds of fraud or clear bias on the part of the arbitrators.&nbsp;&nbsp;Notwithstanding anything contained in this Section 13.2 to the contrary, each Party shall have the right to institute judicial proceedings against the other Party or anyone acting by, through or under such other Party, in order to seek to enforce the instituting Party&#8217;s rights hereunder through specific performance, injunction or similar equitable relief.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">13.2.4 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Costs</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Each Party shall bear its own attorneys&#8217; fees, costs, and disbursements arising out of the arbitration, and shall pay an equal share of the fees and costs of the arbitrators; provided, however, that the arbitrators shall be authorized to determine whether a Party is the prevailing Party, and if so, to award to that prevailing Party reimbursement for its reasonable attorneys&#8217; fees, costs and disbursements (including, for example, expert witness fees and expenses, photocopy charges and travel expenses).</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">13.2.5 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Preliminary Injunctions</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Notwithstanding anything in this Agreement to the contrary, a Party may seek a temporary restraining order or a preliminary injunction from any court of competent jurisdiction in order to prevent immediate and irreparable injury, loss, or damage on a provisions basis, pending the decision of the arbitrators on the ultimate merits of any dispute.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:13.33%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:13.33%">13.2.6 </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Confidentiality</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;All proceedings and decisions of the arbitrators shall be deemed Confidential Information of each of the Parties, and shall be subject to Article 9.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-68-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">13.3 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Governing Law</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;This Agreement and any dispute arising from the performance or breach hereof shall be governed by and construed and enforced in accordance with the laws of the State of Delaware without reference to conflicts of laws principles.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026725"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">13.4 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Assignment.</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;Either Party may assign this Agreement to any Affiliate of such Party without the consent of the other Party; provided, that such Party provides the other Party with written notice of such assignment and remains fully liable for the performance of such Party&#8217;s obligations hereunder by such Affiliate.&nbsp;&nbsp;Further, each Party may assign this Agreement without the consent of the other Party to its successor in interest by way of merger, acquisition, or sale of all or substantially all of its assets to which this Agreement relates; provided, that such Party provides the other Party with written notice of such assignment; provided further, that if such assignment involves a transaction in which Dynavax: (a) merges or consolidates with any other entity (other than a wholly-owned subsidiary of Dynavax); or (b) effects any other transaction or series of transactions, such that the stockholders of Dynavax immediately prior thereto, in the aggregate, no longer own, directly or indirectly, beneficially or legally, at least fifty percent (50%) of the outstanding voting securities or capital stock of the surviving entity following the closing of such merger, consolidation, other transaction or series of transactions (a </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Change of Control Event&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">), then Dynavax will notify GSK prior to the closing of such Change of Control Event, and </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font><font style="font-family:MS Mincho;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The terms and conditions of this Agreement shall be binding upon and shall inure to the benefit of the successors, heirs, administrators and permitted assigns of the Parties.&nbsp;&nbsp;Any purported assignment in violation of this Section 13.4 shall be null and void.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026726"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">13.5 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Performance Warranty</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Each Party hereby acknowledges and agrees that it shall be responsible for the full and timely performance as and when due under, and observance of all the covenants, terms, conditions and agreements set forth in this, Agreement by its Affiliate(s) and Sublicensees.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026727"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">13.6 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Force Majeure</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;No Party shall be held liable or responsible to the other Party nor be deemed to be in default under, or in breach of any provision of, this Agreement for failure or delay in fulfilling or performing any obligation (other than a payment obligation) of this Agreement when such failure or delay is due to </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">force majeure,</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and without the fault or negligence of the Party so failing or delaying.&nbsp;&nbsp;For purposes of this Agreement, </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">force majeure</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> is defined as causes beyond the control of the Party, including, without limitation, acts of God; acts, regulations, or laws of any government; war; civil commotion; destruction of production facilities or materials by fire, flood, earthquake, explosion or storm; labor disturbances; epidemic; and failure of public utilities or common carriers.&nbsp;&nbsp;In such event Dynavax or GSK, as the case may be, shall immediately notify the other Party of such inability and of the period for which such inability is expected to continue.&nbsp;&nbsp;The Party giving such notice shall thereupon be excused from such of its obligations under this Agreement as it is thereby disabled from performing for so long as it is so disabled for up to a maximum of ninety (90) days, after which time Dynavax and GSK shall promptly meet to discuss in good faith how to best proceed in a manner that maintains and abides by the Agreement.&nbsp;&nbsp;To the extent possible, each Party shall use reasonable efforts to minimize the duration of any </font><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">force majeure.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026728"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">13.7 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Notices</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Any notice or request required or permitted to be given under or in connection with this Agreement shall be deemed to have been sufficiently given if in writing and personally delivered or sent by certified mail (return receipt requested), facsimile transmission (receipt verified), or overnight express courier service (signature required), prepaid, to the Party for which such notice is intended, at the address set forth for such Party below:&nbsp;&nbsp;</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-69-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:28%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If to Dynavax, addressed to:</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dynavax Technologies Corporation</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:28%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2929 Seventh Street, Suite 100</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:28%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Berkeley, CA 94710</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:28%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Attention:&nbsp;&nbsp;Chief Executive Officer</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:28%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Telephone:&nbsp;&nbsp;(510) 665-4601</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:28%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Facsimile:&nbsp;&nbsp; (510) 848-1376</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:28%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:28%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">with a copy to:</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cooley Godward Kronish LLP</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:28%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Five Palo Alto Square</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:28%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3000 El Camino Real</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:28%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Palo Alto, CA 94306</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:28%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Attention: Glen Y. Sato, Esq.</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:28%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Telephone:&nbsp;&nbsp;(650) 843-5502</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:28%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Facsimile:&nbsp;&nbsp; (650) 849-7400</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:28%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:28%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If to GSK, addressed to:</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Attention: Business Development</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:28%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">GlaxoSmithKline</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:28%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Greenford Road</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:28%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Greenford</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:28%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Middlesex</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:28%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">UB6 0HE, United Kingdom</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:28%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:28%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:28%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">with a copy to:</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Attention: Vice President and Associate General Counsel,</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:28%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">R&amp;D Legal Operations</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:28%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">GlaxoSmithKline</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:28%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2301 Renaissance Boulevard</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:28%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mail Code RN0220</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:28%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">King of Prussia, PA&nbsp;&nbsp;19406</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:28%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or to such other address for such Party as it shall have specified by like notice to the other Parties, provided that notices of a change of address shall be effective only upon receipt thereof.&nbsp;&nbsp;If delivered personally or by facsimile transmission, the date of delivery shall be deemed to be the date on which such notice or request was given.&nbsp;&nbsp;If sent by overnight express courier service, the date of delivery shall be deemed to be the next business day after such notice or request was deposited with such service.&nbsp;&nbsp;If sent by certified mail, the date of delivery shall be deemed to be the third (3<sup style="font-size:85%; vertical-align:top">rd</sup>) Business Day after such notice or request was deposited with the U.S. Postal Service.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026729"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">13.8 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Export Clause</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Each Party acknowledges that the laws and regulations of the United States restrict the export and re-export of commodities and technical data of United States origin.&nbsp;&nbsp;Each Party agrees that it will not export or re-export restricted commodities or the technical data of the other party in any form without the appropriate United States and foreign government licenses.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-70-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026730"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">13.9 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Waiver</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Neither Party may waive or release any of its rights or interests in this Agreement except in writing.&nbsp;&nbsp;The failure of either Party to assert a right hereunder or to insist upon compliance with any term or condition of this Agreement shall not constitute a waiver of that right or excuse a similar subsequent failure to perform any such term or condition.&nbsp;&nbsp;No waiver by either Party of any condition or term in any one or more instances shall be construed as a continuing waiver of such condition or term or of another condition or term.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026731"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">13.10 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Severability</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;If any provision hereof should be held invalid, illegal or unenforceable in any jurisdiction, the Parties shall negotiate in good faith a valid, legal and enforceable substitute provision that most nearly reflects the original intent of the Parties and all other provisions hereof shall remain in full force and effect in such jurisdiction and shall be liberally construed in order to carry out the intentions of the Parties hereto as nearly as may be possible.&nbsp;&nbsp;Such invalidity, illegality or unenforceability shall not affect the validity, legality or enforceability of such provision in any other jurisdiction.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026732"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">13.11 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Entire Agreement</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;This Agreement, together with the Schedules and Exhibits hereto, set forth all the covenants, promises, agreements, warranties, representations, conditions and understandings between the Parties hereto and supersede and terminate all prior agreements and understanding between the Parties.&nbsp;&nbsp;There are no covenants, promises, agreements, warranties, representations, conditions or understandings, either oral or written, between the Parties other than as set forth herein and therein.&nbsp;&nbsp;No subsequent alteration, amendment, change or addition to this Agreement shall be binding upon the Parties hereto unless reduced to writing and signed by the respective authorized officers of the Parties.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026733"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">13.12 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Independent Contractors</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Nothing herein shall be construed to create any relationship of employer and employee, agent and principal, partnership or joint venture between the Parties.&nbsp;&nbsp;Each Party is an independent contractor.&nbsp;&nbsp;Neither Party shall assume, either directly or indirectly, any liability of or for the other Party.&nbsp;&nbsp;Neither Party shall have the authority to bind or obligate the other Party and neither Party shall represent that it has such authority.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026734"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">13.13 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Headings; Interpretation</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Headings used herein are for convenience only and shall not in any way affect the construction of or be taken into consideration in interpreting this Agreement.&nbsp;&nbsp;Further, in this Agreement: (a) the word &#8220;including&#8221; shall be deemed to be followed by the phrase &#8220;without limitation&#8221; or like expression; (b) the singular shall include the plural and vice versa; and (c) masculine, feminine and neuter pronouns and expressions shall be interchangeable.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026735"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">13.14 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Books and Records</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Any books and records to be maintained under this Agreement by a Party or its Affiliates or Sublicensees shall be maintained in accordance with U.S. generally accepted accounting principles in the case of Dynavax, and shall be maintained in accordance with International Financial Reporting Standards (IFRS) in the case of GSK, consistently applied, except that the same need not be audited.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026736"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">13.15 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Further Actions</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Each Party shall execute, acknowledge and deliver such further instruments, and do all such other acts, as may be necessary or appropriate in order to carry out the expressly stated purposes and the clear intent of this Agreement.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-71-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026737"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">13.16 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Parties in Interest</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;All of the terms and provisions of this Agreement shall be binding upon, and shall inure to the benefit of and be enforceable by the Parties hereto and their respective successors, heirs, administrators and permitted assigns.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026738"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">13.17 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Construction of Agreement</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;The terms and provisions of this Agreement represent the results of negotiations between the Parties and their representatives, each of which has been represented by counsel of its own choosing, and neither of which has acted under duress or compulsion, whether legal, economic or otherwise.&nbsp;&nbsp;Accordingly, the terms and provisions of this Agreement shall be interpreted and construed in accordance with their usual and customary meanings, and each of the Parties hereto hereby waives the application in connection with the interpretation and construction of this Agreement of any rule of law to the effect that ambiguous or conflicting terms or provisions contained in this Agreement shall be interpreted or construed against the Party whose attorney prepared the executed draft or any earlier draft of this Agreement.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026739"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">13.18 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Supremacy</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;In the event of any express conflict or inconsistency between this Agreement and a Development Plan or any Schedule or Exhibit hereto, the terms of this Agreement shall control.&nbsp;&nbsp;The Parties understand and agree that the Schedules and Exhibits hereto are not intended to be the final and complete embodiment of any terms or provisions of this Agreement, and are to be updated from time to time during the Term, as appropriate and in accordance with the provisions of this Agreement.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;"><a name="_Toc144026740"></a><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;text-indent:6.67%">13.19 </font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Counterparts</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;This Agreement may be signed in counterparts, each and every one of which shall be deemed an original, notwithstanding variations in format or file designation which may result from the electronic transmission, storage and printing of copies of this Agreement from separate computers or printers.&nbsp;&nbsp;Facsimile signatures and signatures transmitted via PDF shall be treated as original signatures.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">* - * - * - *</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-72-</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">IN WITNESS WHEREOF,</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and intending to be legally bound hereby, the Parties have caused this Agreement to be executed by their duly authorized representatives as of the Effective Date.</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:40%;">
<tr>
<td colspan="3" valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:100%;white-space:nowrap;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Dynavax Technologies Corporation</font></p></td>
</tr>
<tr>
<td colspan="3" valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:100%;white-space:nowrap;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:14.82%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:2.78%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:82.4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Dino Dina</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:14.82%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:2.78%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:82.4%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dino Dina, M.D.</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:14.82%;white-space:nowrap;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:2.78%;white-space:nowrap;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:82.4%;white-space:nowrap;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">President and CEO</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:14.82%;white-space:nowrap;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:2.78%;white-space:nowrap;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:82.4%;white-space:nowrap;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="3" valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:100%;white-space:nowrap;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Glaxo Group Limited</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:14.82%;white-space:nowrap;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:2.78%;white-space:nowrap;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:82.4%;white-space:nowrap;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:14.82%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:2.78%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:82.4%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Paul Williamson</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:14.82%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:2.78%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:82.4%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Paul Williamson</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:14.82%;white-space:nowrap;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:2.78%;white-space:nowrap;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:82.4%;white-space:nowrap;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For and on behalf of Edinburgh</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:14.82%;white-space:nowrap;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:2.78%;white-space:nowrap;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:82.4%;white-space:nowrap;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pharmaceutical Industries Limited</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:14.82%;white-space:nowrap;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:2.78%;white-space:nowrap;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;width:82.4%;white-space:nowrap;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate Director</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT A</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT B</font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:96.67%;margin-left:3.33%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;margin-bottom:0pt;font-family:'Symbol';font-size:10pt;"><font style="font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-bottom:0pt;font-family:'Symbol';font-size:10pt;"><font style="font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#32;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:3pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT C</font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:96.67%;margin-left:3.33%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;margin-bottom:0pt;font-family:'Symbol';font-size:10pt;"><font style="font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;margin-bottom:0pt;font-family:'Symbol';font-size:10pt;"><font style="font-family:'Symbol';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#32;</font><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT D</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT E</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ] Criteria </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dose Ranging &#8211; Safety and [ * ].<br><a name="_DV_M1281"></a>It is expected that the [ * ] would be i) in healthy volunteers undergoing immunological challenge relevant to the mechanism or ii)&nbsp;&nbsp;in patients with gain in function/activation of the relevant pathway, where a short term intervention is anticipated to be able to demonstrate efficacy on the mechanism. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><a name="_DV_M1282"></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Maximum anticipated duration of treatment &#8211; 2-4 weeks, </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Maximum anticipated subjects &#8211; placebo, and 3 dose group</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><a name="_DV_M1283"></a><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4 x 10-15 subjects = 40-60 subjects.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depending on the mechanism and disease [ * ] could be within FTIH study (including FTIH being in patients) or could follow a separate FTIH study </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Evidence for Proof of Mechanistic Effect</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_DV_M1290"></a>Quantitative measurements of multiple immunological parameters will be taken from treated subjects for example, cytokine/chemokine profiles, leukocyte CD antigens and genome-wide gene expression profiling, impact on signaling pathways and if appropriate on tissue pathology. Assays will be performed to determine extent of target binding. Criteria for positive [ * ] would be based on evidence of pharmacology, PK/PD relationship and resulting relevant&nbsp;&nbsp;mechanistic efficacy, with supportive trends in clinical markers if the study is within a patient population. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The desired goal is to achieve an early proof of pharmacological and mechanistic activity to develop PD markers, PK/PD modeling, and safety information,&nbsp;&nbsp;that will allow informed decision-making on progression of the asset and selection of smaller numbers of&nbsp;&nbsp;dose groups for the larger Phase IIb PoC trial, thus enabling that study to be up to 25% smaller]</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial Unicode MS;font-weight:bold;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial Unicode MS;"><a name="_DV_M1284"></a>&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT F</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Press Release</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<tr style="height:59.35pt;">
<td valign="top" style="width:50%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:11pt;;"><img src="g2014031017064504835.jpg" alt="logo" style="width:135pt;height:39pt;"><font style="font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
<td valign="top" style="width:50%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:MS Mincho;"><img src="g2014031017064506336.jpg" alt="logo" style="width:118pt;height:40pt;"><font style="font-family:MS Mincho;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-weight:bold;;font-size:11pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">GlaxoSmithKline and Dynavax Announce Worldwide Strategic Alliance</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:3.33%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-- Developing First-in-Class Endosomal TLR Inhibitors for </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:3.33%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Autoimmune and Inflammatory Diseases --</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_msoanchor_1"></a>London, United Kingdom, Philadelphia, PA, and Berkeley, CA &#8211; December 16, 2008 &#8211; GlaxoSmithKline (LSE and NYSE: GSK) and Dynavax Technologies Corporation (NASDAQ: DVAX) today announced a worldwide strategic alliance to discover, develop and commercialize novel inhibitors of endosomal Toll-like Receptors (TLRs) for the treatment of immuno-inflammatory diseases.&nbsp;&nbsp;TLRs are key receptors of the innate immune system that can induce strong inflammatory responses.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the terms of the alliance, Dynavax will receive an initial payment of $10 million for which GSK will receive an exclusive option over four programs targeting autoimmune and inflammatory diseases such as lupus, psoriasis, and rheumatoid arthritis.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> &#8220;Our alliance with GSK provides an opportunity to create an entirely new product franchise for Dynavax,&#8221; commented Dino Dina, M.D., President and Chief Executive Officer of Dynavax.&nbsp;&nbsp;&#8220;Our TLR inhibitors have the potential to create significant value for our newest collaborator GSK as well as for our stockholders.&#160; Alliances with major pharmaceutical companies have enabled Dynavax to establish a diverse pipeline of innovative products, while contributing valuable cash for our programs.&#8221; </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dynavax is to conduct research and early clinical development in up to four programs and is eligible to receive future potential development and commercialization milestones totaling approximately $200 million per program.&nbsp;&nbsp;GSK can exercise its exclusive option to license each program upon achievement of proof-of-concept or earlier upon certain circumstances.&nbsp;&nbsp;After exercising its option, GSK will carry out further development and commercialization of these products.&nbsp;&nbsp;Dynavax will receive tiered, up to double-digit royalties on sales and has retained an option to co-develop and co-promote one specified product.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dynavax has pioneered a new approach to treating autoimmune and inflammatory diseases with its first-in-class oligonucleotide-based endosomal TLR inhibitors, called immunoregulatory sequences (IRS).&nbsp;&nbsp;Dynavax&#8217;s lead inhibitor drug candidate, DV1079, is a bifunctional inhibitor of TLR7 and TLR9, and is expected to enter clinical development in the fourth quarter of 2009.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> &#8220;We are committed to using our expertise, in collaboration with Dynavax, to research and develop new therapeutics that can improve the lives of patients with conditions like systemic lupus erythematosus, psoriasis and rheumatoid arthritis,&#8221; commented Jose Carlos Gutierrez-Ramos, Ph.D., Senior Vice President and Head of </font></p><p style="margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the Immuno-Inflammation Centre of Excellence for Drug Discovery at GSK.&nbsp;&nbsp;&#8220;Dynavax is a recognized pioneer in the scientific community for its innovation of endosomal TLR inhibitors which prevent immune signaling in autoimmune and inflammatory diseases.&#8221;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Dynavax Conference Call </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dynavax will webcast a conference call today at 9:00 a.m. ET (6:00 a.m. PT) to discuss this alliance. The live and archived webcast can be accessed by visiting the investor relations section of the Company's Web site at http://investors.dynavax.com/events.cfm.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">About TLR Inhibitors</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dynavax&#8217;s endosomal TLR inhibitors are a novel class of oligonucleotides, called immunoregulatory sequences (IRS), that specifically inhibit the TLR-induced inflammatory response associated with autoimmune and inflammatory diseases.&nbsp;&nbsp;Preclinical data from animal model studies show Dynavax&#8217;s TLR inhibitors block IFN-alpha and also reduce symptoms in multiple autoimmune diseases models, such as lupus, inflammatory skin disorders, and rheumatoid arthritis.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">About Dynavax</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops a diversified, well-funded pipeline of novel Toll-like Receptor (TLR) product candidates.&nbsp;&nbsp;Based on Dynavax&#8217;s proprietary technology platform, these products specifically modify the innate immune response to infectious, respiratory, autoimmune, and inflammatory diseases.&nbsp;&nbsp; Dynavax&#8217;s product programs are supported by global partnerships with leading pharmaceutical companies such as Merck &amp; Co., Inc., GlaxoSmithKline, and AstraZeneca AB, as well as funding from Symphony Dynamo, Inc. and the National Institutes of Health. For more information visit www.dynavax.com.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Dynavax Forward-Looking Statement </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This press release contains &#8220;forward-looking statements,&#8221; including statements related to the potential value of payments that may be received under our collaboration with GSK, the anticipated development of our inhibitors of endosomal TLRs, the future responsibilities of the parties under the collaboration agreement and Dynavax&#8217;s ability to perform under the terms of the collaboration agreement. Actual results may differ materially from those set forth in this press release due to the risks and uncertainties inherent in our business, including difficulties or delays in discovery or development, initiation and completion of preclinical or clinical studies, the results of those studies and the impact of those results on the initiation and completion of subsequent studies and issues arising in the regulatory process; achieving our GSK collaborative agreement objectives; our ability to obtain additional financing to support our operations; and other risks detailed in the &#8221;Risk Factors&#8221; section of our Quarterly Report on Form 10-Q. We undertake no obligation to revise or update information herein to reflect events or circumstances in the future, even if new information becomes available. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">About GlaxoSmithKline</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">GlaxoSmithKline - one of the world&#8217;s leading research-based pharmaceutical and healthcare companies &#8211; is committed to improving the quality of human life by enabling people to do more, feel better and live longer.&#160; For company information, visit GlaxoSmithKline at www.gsk.com.</font></p><p style="margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">GlaxoSmithKline Forward-Looking Statement</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-style:italic;;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Factors that may affect GSK' s operations are described under &#8217;Risk Factors&#8217; in the &#8216;Business Review&#8217; in the company's Annual Report on Form 20-F for 2007.</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Dynavax Contacts:</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Michael Ostrach<br>VP and Chief Business Officer<br>1-510-665-7257<br>mostrach@dynavax.com</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amy Figueroa<br>Investor Relations and Corporate Communications<br>1-510-665-7211<br>afigueroa@dynavax.com</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">GSK Contacts:</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:300pt;">
<tr>
<td style="width:43.12%;"></td>
<td style="width:30%;"></td>
<td style="width:26.88%;"></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">GSK UK Media enquiries:</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Philip Thomson</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(020) 8047 5502</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stephen Rae</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(020) 8047 5502</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Alice Hunt</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(020) 8047 5502</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gwenan White</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(020) 8047 5502</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">GSK US Media enquiries:</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nancy Pekarek</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(215) 751 7709</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mary Anne Rhyne</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(919) 483 2839</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sarah Alspach</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(215) 751 7709</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">GSK European Analyst/<br>Investor enquiries:</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">David Mawdsley</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(020) 8047 5564</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sally Ferguson</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(020) 8047 5543</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gary Davies</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(020) 8047 5503</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">GSK US Analyst/<br>Investor enquiries:</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tom Curry</font></p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;"><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(215) 751 5419</font></p></td>
</tr>
</table></div><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"># # #</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:6pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:6pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">EXHIBIT G</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">SCHEDULE 7.2</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[ * ]</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><br></font></p><p style="margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">SCHEDULE 8.6</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Agreements Granting Third Parties Rights to Prosecute and Maintain Dynavax Compound Patents</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research Collaboration and License Agreement, dated as of September 1, 2006, by and between AstraZeneca AB and Dynavax, as amended from time to time.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Novated and Restated Technology License Agreement, dated as of April 18, 2006, by and among Dynavax, Symphony Dynamo, Inc. and Symphony Holdings LLC, as amended from time to time</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">SCHEDULE 10.2</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Rights Granted to Third Parties Under Dynavax Compound IP</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research Collaboration and License Agreement, dated as of September 1, 2006, by and between AstraZeneca AB and Dynavax, as amended from time to time.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:justify;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Novated and Restated Technology License Agreement, dated as of April 18, 2006, by and among Dynavax, Symphony Dynamo, Inc. and Symphony Holdings LLC, as amended from time to time</font></p><p style="margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:9pt;;"><font style="font-weight:bold;font-size:9pt;text-transform:uppercase;font-variant: small-caps;font-family:Times New Roman;font-style:normal;">[ ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-bottom:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>3
<FILENAME>dvax-ex10_20131231593.htm
<DESCRIPTION>EX-10.83
<TEXT>
<html>
<body>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 10.83</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">DYNAVAX TECHNOLOGIES CORPORATION</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">AMENDED AND RESTATED 2004 NON-EMPLOYEE DIRECTOR OPTION PROGRAM </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">AND</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">AMENDED AND RESTATED 2005 NON-EMPLOYEE DIRECTOR CASH COMPENSATION PROGRAM</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">EFFECTIVE APRIL 14, 2005</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">AMENDED February 4, 2014</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(REVISION VERSION 5.0)</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE I</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">ESTABLISHMENT AND PURPOSE OF THE PROGRAM</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">1.1</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Establishment of Program</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Dynavax Technologies Corporation 2004 Non-Employee Director Option Program, as revised herein, including the Non-Employee Director Cash Compensation Program (collectively, the &#8220;Director Program&#8221;) is adopted pursuant to the Dynavax Technologies Corporation 2011 Equity Incentive Plan (the &#8220;2011 Plan&#8221;), in addition to the terms and conditions set forth below, is subject to the provisions of the Plan.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">1.2</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Purpose of Program</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The purpose of the Director Program is to enhance the ability of the Company to attract and retain directors who are not Employees (&#8220;Non-Employee Directors&#8221;) through an Option and Cash Compensation program.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">1.3</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Effective Date of the Program</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Director Program is effective as of the Registration Date, and as revised on February 4, 2014.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE II</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">DEFINITIONS</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Capitalized terms in this Director Program, unless otherwise defined herein, have the meaning given to them in the Plan.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE III</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">OPTION TERMS</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">3.1</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Date of Grant and Number of Shares</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Effective April&#160;14, 2005, a Non-Qualified Stock Option to purchase 20,000 shares of Common Stock shall be granted (the &#8220;Initial Grant&#8221;) to each Non-Employee Director and 30,000 shares shall be granted to the Non-Employee Chairman of the Board (the &#8220;Initial Grant&#8221;), and such Initial Grant to be made to Non-Employee Directors elected or appointed to the Board upon the date each such Non-Employee Director first becomes a Non-Employee Director.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, immediately following each annual meeting of the Company&#8217;s stockholders, commencing with the annual meeting of the Company&#8217;s stockholders in 2012, each Non-Employee Director who continues as a Non-Employee Director following such annual meeting shall be granted a Non-Qualified Stock Option to purchase 17,500 shares of Common Stock (a &#8220;Subsequent Grant&#8221;). Based on the Non-Employee Director&#8217;s election date, the first subsequent grant shall be pro-rated as follows:</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr style="height:1pt;">
<td valign="top" style="padding-Right:0.7 pt;width:1.32%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0.7 pt;width:32.46%; border-top:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="width:1%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:32.46%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:1.3%; border-top:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:1pt;;">&nbsp;</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="padding-Right:0.7 pt;width:1.32%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0.7 pt;width:32.46%; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Service Period from Election Date</font></p></td>
<td valign="top" style="width:1%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:32.46%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Option Grant Schedule</font></p></td>
<td valign="top" style="padding-Right:0.7 pt;width:1.3%; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="padding-Right:0.7 pt;width:1.32%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="padding-left:0 pt;padding-Right:0.7 pt;width:32.46%; border-top:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="width:1%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:32.46%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:1.3%; border-top:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:1pt;;">&nbsp;</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="padding-Right:0.7 pt;width:1.32%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:32.46%; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">More than 10 up to 12 months</font></p></td>
<td valign="top" style="width:1%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:32.46%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100% of grant (17,500 shares)</font></p></td>
<td valign="top" style="padding-Right:0.7 pt;width:1.3%; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="padding-Right:0.7 pt;width:1.32%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:32.46%; border-top:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="width:1%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:32.46%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:1.3%; border-top:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:1pt;;">&nbsp;</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="padding-Right:0.7 pt;width:1.32%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:32.46%; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">More than 7 months, but less than 10</font></p></td>
<td valign="top" style="width:1%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:32.46%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75% of grant (13,125 shares)</font></p></td>
<td valign="top" style="padding-Right:0.7 pt;width:1.3%; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="padding-Right:0.7 pt;width:1.32%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:32.46%; border-top:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="width:1%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:32.46%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:1.3%; border-top:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:1pt;;">&nbsp;</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="padding-Right:0.7 pt;width:1.32%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:32.46%; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">More than 4 months, but less than 7</font></p></td>
<td valign="top" style="width:1%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:32.46%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50% of grant (8,750 shares)</font></p></td>
<td valign="top" style="padding-Right:0.7 pt;width:1.3%; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="padding-Right:0.7 pt;width:1.32%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:32.46%; border-top:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="width:1%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:32.46%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:1.3%; border-top:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:1pt;;">&nbsp;</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="padding-Right:0.7 pt;width:1.32%; border-left:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:32.46%; border-right:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;text-align:center;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">More than 1 month, but less than 4</font></p></td>
<td valign="top" style="width:1%; border-left:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:32.46%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25% of grant (4,375 shares)</font></p></td>
<td valign="top" style="padding-Right:0.7 pt;width:1.3%; border-right:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="padding-Right:0.7 pt;width:1.32%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:32.46%; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="width:1%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:32.46%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:1.3%; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:1pt;;">&nbsp;</p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Each such Subsequent Grant shall be made on the date of the annual stockholders&#8217; meeting in question.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:2pt;;">&nbsp;</p><p style="border-top:Solid 0.75pt;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:1pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:2pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:2pt;;"><font style="font-size:2pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br></font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">3.2</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Vesting</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Each Initial Grant of Common Stock subject to the Option under the Director Program shall vest twenty-five percent (25%) twelve (12)&#160;months after the grant date and an additional twenty-five percent (25%) of the shares of Common Stock subject to the Option shall vest on each yearly anniversary of the grant date thereafter, such that the Option will be fully exercisable four (4) years after its date of grant.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Each Subsequent Grant under the Director Program will vest and become exercisable as to all of the shares of Common Stock subject to the Option twelve (12)&#160;months after the grant date.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">3.3</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The exercise price per share of Common Stock of each Initial Grant and Subsequent Grant shall be one hundred percent (100%) of the Fair Market Value per share on the date of grant.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">3.4</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Corporate Transaction/Change in Control</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Each Option under the Director Program shall be subject to the provisions of Section&#160;9 of the 2011 Plan relating to the exercise or termination of the Option in the event of a Corporate Transaction or a Change in Control.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">3.5</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;&#160;</font><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Other Terms</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Administrator (the &#8220;Dynavax Board of Directors&#8221;) of the Plan shall determine the remaining terms and conditions of the Options awarded under the Program.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE IV</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">CASH COMPENSATION TERMS</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">4.1&#160;&#160;&#160;&#160;&#160;Annual Fees</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Each Non-Employee Director currently on the Company&#8217;s board, or elected in 2012 and thereafter, shall receive an annual retainer fee of $40,000. The Chairman of the Board shall receive an annual retainer fee of $65,000. Such annual retainer fees will be paid in quarterly installments at the end of each fiscal quarter where such person is an active director of the board (&#8220;active director&#8221; requires attendance at 75% of the annually scheduled board meetings) and is inclusive of 5 scheduled board meetings.&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><a name="page_0_2_3"></a><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">4.2&#160;&#160;&#160;&#160;&#160;[Intentionally Removed]</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">4.3&#160;&#160;&#160;&#160;&#160;Committee Meeting Fees</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Chairman of the Audit Committee shall receive an annual retainer of $20,000. Each member of the audit committee shall receive an annual retainer of $7,500.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Chairman of the Compensation Committee shall receive an annual retainer of $15,000. Each member of the compensation committee shall receive an annual retainer of $7,000.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Chairman of the Nominating and Governance Committee shall receive an annual retainer of $10,000. Each member of the nominating committee shall receive an annual retainer of $5,000.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Such annual retainer fees will be paid quarterly at the end of each fiscal quarter where such person is an active Chairman or member of the Committee and an Active Director. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">4.4&#160;&#160;&#160;&#160;&#160;Travel and Related Costs</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reasonable travel and related costs associated with attending Board and committee meetings shall be reimbursed. The Board member needs to submit proper documentation for reimbursement.</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:2pt;;">&nbsp;</p><p style="border-top:Solid 0.75pt;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:1pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:2pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:2pt;;"><font style="font-size:2pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br></font></p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>4
<FILENAME>dvax-ex10_20131231594.htm
<DESCRIPTION>EX-10.84
<TEXT>
<html>
<body>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Century Schoolbook;font-weight:bold;;font-size:8pt;;font-family:Century Schoolbook;font-weight:bold;;font-size:8pt;;font-family:Century Schoolbook;font-weight:bold;;font-size:8pt;;font-family:Century Schoolbook;font-weight:bold;;font-size:8pt;;"><font style="font-weight:bold;color:#4F6061;font-size:8pt;font-family:Century Schoolbook;font-variant: small-caps;font-style:normal;text-transform:none;">2929 Seventh Street, Suite 100Berkeley, California&nbsp;&nbsp; 94710</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;;">&nbsp;</p><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 10.84</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-weight:bold;;font-size:10pt;;">&nbsp;</p><div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:auto;">
<tr>
<td style="width:50.1%;"></td>
<td style="width:49.9%;"></td>
</tr>
<tr>
<td valign="top" style=""><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;"><img src="g2014031017063188233.jpg" alt="logo" style="position:absolute;margin-left:-7.6pt;margin-top:.1pt;width:151.9pt;height:45.7pt;z-index:251662336;mso-position-horizontal-relative:text;mso-position-vertical-relative:text"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;"></font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style=""><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style=""><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Century Schoolbook;font-weight:bold;;font-size:8pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Century Schoolbook;font-weight:bold;;font-size:8pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Century Schoolbook;font-weight:bold;;font-size:8pt;;"><font style="font-weight:bold;color:#4F6061;font-size:8pt;font-family:Century Schoolbook;font-variant: small-caps;font-style:normal;text-transform:none;">2929 Seventh Street, Suite 100</font></p><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Century Schoolbook;font-weight:bold;;font-size:8pt;;"><font style="font-weight:bold;color:#4F6061;font-size:8pt;font-family:Century Schoolbook;font-variant: small-caps;font-style:normal;text-transform:none;">Berkeley, California&nbsp;&nbsp; 94710</font></p><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style=""><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-size:10pt;;">&nbsp;</p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-weight:bold;;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Sent via USPS</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 27, 2013</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">David Novack</font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:12pt;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Re:</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:12pt;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amended Employment Terms</font></p></td></tr></table></div><p style="text-align:left;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dear David:</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dynavax Technologies Corporation (&#8220;Dynavax&#8221; or the &#8220;Company&#8221;) is pleased to offer you the position of Senior Vice President, Operations and Quality, on the following terms.</font></p><p style="text-align:left;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">You will be responsible for providing strategic leadership and operational management oversight of the technical operations and quality organizations of the Company, and other duties as assigned. You will report to J. Tyler Martin, MD, President and Chief Medical Officer and work at our facility located at 2929 Seventh Street, Suite 100 in Berkeley, California.&nbsp;&nbsp;The Company may change your position, duties, and work location from time to time as it deems necessary.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Your compensation will be $25,000 per month, annualized to $300,000, less payroll deductions and all required withholdings.&nbsp;&nbsp;You will be paid semi-monthly, and will be eligible for the following standard Company benefits:&nbsp;&nbsp;medical insurance for yourself and your family (there will be an employee contribution for dependent coverage), 12 holidays per year, life insurance, disability insurance, long-term care insurance, Flexible Spending Account, 401(k), and Employee Stock Purchase Plan.&nbsp;&nbsp;The Company may modify compensation and benefits from time to time as it deems necessary.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Personal time off is not accrued or tracked for members of the executive team.&nbsp;&nbsp;The attached Personal Time-Off Policy highlights the time off you have to use each year.&nbsp;&nbsp;Also, you and your eligible dependents will be covered under the Exec-U-Care medical reimbursement plan.&nbsp;&nbsp;This plan supplements your health insurance up to $50,000 per employee or family unit for unreimbursed medical expenses during a calendar year.  Please be advised, the Exec-U-Care plan will be available through year end December 2013 due to the Health Care Reform Act.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As a member of the executive team, you are eligible for a 50% target annual incentive bonus, based on your performance measured against corporate, individual and project milestones to be proposed by the company and mutually agreed upon by the parties by no later than thirty days from your start date with Dynavax.&nbsp;&nbsp;Annual incentive bonus&#160;targets are typically reviewed and approved by the Company's Compensation Committee in the first quarter of the following year, and payout of the bonuses are at the discretion of the Company&#8217;s board of directors.&#160;To receive an incentive bonus payment,&#160;an eligible participant in the program must be an active employee on the date the bonus is paid.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company will grant you a stock option to purchase 300,000 shares of the Common Stock of the Company, with an exercise price equal to the fair market value of the Common Stock on the date of grant. This stock option is subject to all of the terms and conditions set forth in the applicable award agreement and applicable stock incentive plan.&#160; Your stock option grant of 300,000 shares of the Common Stock of the Company will vest as follows: 25% of the Shares subject to the Option shall vest twelve months after the Vesting Commencement Date, and 1/48 of the Shares subject to the Option shall vest on the last day of each month thereafter, provided that vesting shall cease upon termination of your continuous service to the Company.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Century Schoolbook;font-weight:bold;;font-size:8pt;;font-family:Century Schoolbook;font-weight:bold;;font-size:8pt;;font-family:Century Schoolbook;font-weight:bold;;font-size:8pt;;font-family:Century Schoolbook;font-weight:bold;;font-size:8pt;;"><font style="font-weight:bold;color:#4F6061;font-size:8pt;font-family:Century Schoolbook;font-variant: small-caps;font-style:normal;text-transform:none;">2929 Seventh Street, Suite 100Berkeley, California&nbsp;&nbsp; 94710</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="color:#4F6061;font-size:9pt;font-variant: small-caps;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;">Phone: 510-848-5100 &#160;&#160;&#160;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Toll-free: 877-848-5100&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fax: 510-848-1327&#160;&#160;&#160;www.dynavax.com</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-weight:bold;;font-size:10pt;;">&nbsp;</p><div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:auto;">
<tr>
<td style="width:50.1%;"></td>
<td style="width:49.9%;"></td>
</tr>
<tr>
<td valign="top" style=""><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;"><img src="g2014031017063211734.jpg" alt="logo" style="position:absolute;margin-left:-7.6pt;margin-top:.1pt;width:151.9pt;height:45.7pt;z-index:251664384;mso-position-horizontal-relative:text;mso-position-vertical-relative:text"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;"></font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style=""><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style=""><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Century Schoolbook;font-weight:bold;;font-size:8pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Century Schoolbook;font-weight:bold;;font-size:8pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Century Schoolbook;font-weight:bold;;font-size:8pt;;"><font style="font-weight:bold;color:#4F6061;font-size:8pt;font-family:Century Schoolbook;font-variant: small-caps;font-style:normal;text-transform:none;">2929 Seventh Street, Suite 100</font></p><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Century Schoolbook;font-weight:bold;;font-size:8pt;;"><font style="font-weight:bold;color:#4F6061;font-size:8pt;font-family:Century Schoolbook;font-variant: small-caps;font-style:normal;text-transform:none;">Berkeley, California&nbsp;&nbsp; 94710</font></p><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style=""><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-size:10pt;;">&nbsp;</p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-weight:bold;;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As agreed upon, we will provide you with a $75,000 sign-on bonus, less applicable withholding deductions. This bonus will be paid in the pay cycle after completing four weeks of full-time employment.&nbsp;&nbsp;If you voluntarily terminate your employment within twelve months of your start date, this amount must be reimbursed to the Company.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This offer is subject to your submission, no later than three days after your employment begins, of an I-9 form and satisfactory documentation regarding your identification and right to work in the United States.&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Your employment is contingent upon the acceptable results of a background check, including Social Security number, education, and employment verification. Any falsification of an applicant&#8217;s employment history or educational background will result in withdrawal of the offer and/or termination of employment, if hired.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As an employee of the Company, you will be expected to abide by Company rules and regulations, and to sign and comply with a Proprietary Information and Inventions Agreement, which prohibits unauthorized use or disclosure of the Company&#8217;s proprietary information.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Normal working hours are from 8:00 a.m. to 5:00 p.m., Monday through Friday.&nbsp;&nbsp;As an exempt salaried employee, you will be expected to work additional hours as required by the nature of your work assignments.</font></p><p style="text-align:left;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">You may terminate your employment with the Company at any time and for any reason whatsoever simply by notifying the Company.&nbsp;&nbsp;Likewise, the Company may terminate your employment at any time and for any reason whatsoever, with or without cause or advance notice.&nbsp;&nbsp;This at-will employment relationship cannot be changed except by written agreement signed by a Company officer.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The employment terms in this letter and your management continuity and severance agreement supersede any other agreements or promises made to you by anyone, whether oral or written.&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Please sign and date one copy of this letter and return it in the enclosed envelope to Cecilia Vitug, VP of Human Resources, if you accept our offer of employment.&nbsp;&nbsp;A mutually acceptable start date can be agreed upon after you accept our offer of employment.&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">David, we look forward to a positive reply and productive and enjoyable work relationship if you join the Company.</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sincerely,</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:12pt;;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:45%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Cecilia Vitug</font></p></td>
<td valign="top" style="width:50%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="width:45%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cecilia Vitug</font></p></td>
<td valign="top" style="width:50%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="width:45%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vice President, Human Resources &amp; Corporate Services</font></p></td>
<td valign="top" style="width:50%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="width:45%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:12pt;;">&nbsp;</p><p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Accepted:</font></p></td>
<td valign="top" style="width:50%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="width:45%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:12pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ David Novack</font></p></td>
<td valign="top" style="width:50%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="width:45%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">David Novack</font></p></td>
<td valign="top" style="width:50%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="width:45%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:12pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March, 6, 2013</font></p></td>
<td valign="top" style="width:50%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="width:45%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date</font></p></td>
<td valign="top" style="width:50%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;">&nbsp;</p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:12pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>5
<FILENAME>dvax-ex10_20131231596.htm
<DESCRIPTION>EX-10.85
<TEXT>
<html>
<body>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 10.85</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;;"><img src="g2014031017063104127.jpg" alt="logo" style="position:absolute;margin-left:-3.1pt;margin-top:9.85pt;width:151.9pt;height:45.7pt;z-index:251659264;mso-position-horizontal-relative:text;mso-position-vertical-relative:text"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;"></font></p><div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:auto;">
<tr>
<td style="width:50.05%;"></td>
<td style="width:49.95%;"></td>
</tr>
<tr>
<td valign="top" style=""><p style="margin-bottom:0pt;margin-top:24pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style=""><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style=""><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Century Schoolbook;font-weight:bold;;font-size:8pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Century Schoolbook;font-weight:bold;;font-size:8pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Century Schoolbook;font-weight:bold;;font-size:8pt;;"><font style="font-weight:bold;color:#4F6061;font-size:8pt;font-family:Century Schoolbook;font-variant: small-caps;font-style:normal;text-transform:none;">2929 Seventh Street, Suite 100</font></p><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-weight:bold;color:#4F6061;font-size:8pt;font-family:Century Schoolbook;font-variant: small-caps;font-style:normal;text-transform:none;">Berkeley, California&nbsp;&nbsp; 94710</font></p></td>
<td valign="top" style=""><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-size:10pt;;">&nbsp;</p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Hand Delivered</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">July 11, 2013</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Rob Janssen, MD</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dear Rob:</font></p><p style="text-align:left;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Congratulations on your promotion to Vice President and Chief Medical Officer.&nbsp;&nbsp;Your new compensation package will be: </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;;">&nbsp;</p><div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="padding-Right:0.7 pt;width:1.38%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:3pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:1pt;;">&nbsp;</p></td>
<td colspan="3" valign="top" style="padding-Right:0.7 pt;width:73.32%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:1%; border-top:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:1pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="padding-Right:0.7 pt;width:1.38%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:3pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;">&nbsp;</p></td>
<td colspan="3" valign="top" style="padding-Right:0.7 pt;width:73.32%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:3pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Effective July 9, 2013</font></p></td>
<td valign="top" style="padding-Right:0.7 pt;width:1%; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:3pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="padding-Right:0.7 pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:3pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:24.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:3pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:23.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:3pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">New </font></p></td>
<td valign="top" style="padding-Right:0.7 pt;width:25.3%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:3pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current </font></p></td>
<td valign="top" style="padding-Right:0.7 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:3pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="padding-Right:0.7 pt;width:1.38%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:24.56%; border-top:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:23.46%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:25.3%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:1%; border-top:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:1pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="padding-Right:0.7 pt;width:1.38%; border-left:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:24.56%; border-right:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Base Salary </font></p><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any salary increase you may be eligible to receive in January 2014 will be pro-rated based on your mid-year 2013 salary increase.</font></p></td>
<td valign="top" style="padding-Right:0.7 pt;width:23.46%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$350,000</font></p><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">($14,583.33 per pay period)</font></p><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Breakdown: </font></p><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-family:Arial;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;&#160;&#160;</font><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$10,918 (or 4% merit)</font></p><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-family:Arial;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;&#160;&#160;</font><font style="text-decoration:underline;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$16,132</font><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (or 5.9% promo)</font></p><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:25.2pt;;margin-right:0%;text-indent:-18pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;$27,050</font></p></td>
<td valign="top" style="padding-Right:0.7 pt;width:25.3%; border-left:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$300,000</font></p><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">($12,500 per pay period)</font></p><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:1%; border-right:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="padding-Right:0.7 pt;width:1.38%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:24.56%; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:23.46%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:25.3%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:1%; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:1pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="padding-Right:0.7 pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:24.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Target Annual Bonus </font></p><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Your 2013 target bonus will be pro-rated based on the change in your salary mid-year.&nbsp;&nbsp;This means your target bonus from January 1 through June 30, 2013 will be based on 40% of your previous salary - $300,000.&nbsp;&nbsp;The target bonus from July 1 through December 31, 2013, will be based on 50% of your current salary of $350,000.</font></p></td>
<td valign="top" style="padding-Right:0.7 pt;width:23.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50% or $175,000</font></p><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weight Distribution is:</font></p><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate 50%</font></p><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Individual 50%</font></p></td>
<td valign="top" style="padding-Right:0.7 pt;width:25.3%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40% or $120,000</font></p><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weight Distribution was:</font></p><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate 40%</font></p><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Individual 50%</font></p></td>
<td valign="top" style="padding-Right:0.7 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="padding-Right:0.7 pt;width:1.38%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:24.56%; border-top:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:23.46%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:25.3%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:1%; border-top:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:1pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="padding-Right:0.7 pt;width:1.38%; border-left:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:24.56%; border-right:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Total Target Cash Compensation</font></p></td>
<td valign="top" style="padding-Right:0.7 pt;width:23.46%; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$525,000</font></p></td>
<td valign="top" style="padding-Right:0.7 pt;width:25.3%; border-left:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$420,000</font></p></td>
<td valign="top" style="padding-Right:0.7 pt;width:1%; border-right:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="padding-Right:0.7 pt;width:1.38%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:24.56%; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:23.46%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:25.3%; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:1%; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:1pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="padding-Right:0.7 pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:24.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Performance-Based Equity Grant </font></p></td>
<td colspan="2" valign="top" style="padding-Right:0.7 pt;width:48.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150,000 restricted stock units (RSU)</font></p></td>
<td valign="top" style="padding-Right:0.7 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:3pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="padding-Right:0.7 pt;width:1.38%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:24.56%; border-top:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:1pt;;">&nbsp;</p></td>
<td colspan="2" valign="top" style="padding-Right:0.7 pt;width:48.76%; border-top:solid 0.75pt #000000; border-left:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:1pt;;">&nbsp;</p></td>
<td valign="top" style="padding-Right:0.7 pt;width:1%; border-top:solid 0.75pt #000000; border-right:solid 0.75pt #000000;"><p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:7.2pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:1pt;;">&nbsp;</p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Your RSU is subject to all of the terms and conditions set forth in the 2011 Equity Plan and shall vest as follows:</font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50,000 shares shall vest upon submission of the safety study data in support of the CRL.&nbsp;&nbsp;</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:0pt;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:'Symbol';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100,000 shall vest upon approval of HEPLISAV.&nbsp;&nbsp;</font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Board and the Administrator of the Plan shall have full power and authority to interpret or modify the above vesting terms in their discretion.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:center;margin-left:6.67%;margin-right:0%;text-indent:-6.67%;font-family:Times New Roman;font-size:9pt;;"><font style="color:#4F6061;font-size:9pt;font-family:Times New Roman;font-variant: small-caps;text-transform:uppercase;font-weight:normal;font-style:normal;">Phone: 510-848-5100&#160;&#160;&#160;&#160;Toll-free: 877-848-5100&#160;&#160;&#160;&#160;Fax: 510-848-1327&#160;&#160;&#160;&#160;www.dynavax.com</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;;">&nbsp;</p><div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:auto;">
<tr>
<td style="width:50.05%;"></td>
<td style="width:49.95%;"></td>
</tr>
<tr>
<td valign="top" style=""><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><img src="g2014031017063151028.jpg" alt="logo" style="position:absolute;margin-left:-3.85pt;margin-top:7.1pt;width:151.9pt;height:45.7pt;z-index:251661312;mso-position-horizontal-relative:text;mso-position-vertical-relative:text"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;"></font></p><p style="margin-bottom:0pt;margin-top:24pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style=""><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style=""><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Century Schoolbook;font-weight:bold;;font-size:8pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Century Schoolbook;font-weight:bold;;font-size:8pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Century Schoolbook;font-weight:bold;;font-size:8pt;;"><font style="font-weight:bold;color:#4F6061;font-size:8pt;font-family:Century Schoolbook;font-variant: small-caps;font-style:normal;text-transform:none;">2929 Seventh Street, Suite 100</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-weight:bold;color:#4F6061;font-size:8pt;font-family:Century Schoolbook;font-variant: small-caps;font-style:normal;text-transform:none;">Berkeley, California&nbsp;&nbsp; 94710</font></p></td>
<td valign="top" style=""><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-size:10pt;;">&nbsp;</p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Your award is subject to the terms of the Dynavax 2011 Incentive Stock Option Plan.&nbsp;&nbsp;You will receive the restricted stock unit agreement in the next few weeks. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The at-will employment terms of your offer letter dated March 19, 2010 and your current management continuity and severance agreement remains the same.&nbsp;&nbsp;</font></p><p style="text-align:left;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Rob, I look forward to working with you in ensuring Dynavax&#8217;s success today and in the future.&nbsp;&nbsp;If you have any questions regarding the terms of your compensation, see Cecilia Vitug.&nbsp;&nbsp; Please sign and return one copy of this letter to Cecilia.</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;;">&nbsp;</p><div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:auto;">
<tr>
<td style="width:100%;"></td>
</tr>
<tr>
<td valign="top" style=""><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sincerely,</font></p></td>
</tr>
<tr>
<td valign="top" style=""><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:12pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style=""><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Eddie Gray</font></p></td>
</tr>
<tr>
<td valign="top" style=""><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Eddie Gray</font></p></td>
</tr>
<tr>
<td valign="top" style=""><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Executive Officer</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;;">&nbsp;</p><div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:40%;">
<tr>
<td valign="top" style="width:100%;"><p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Acknowledgement:</font></p></td>
</tr>
<tr>
<td valign="top" style="width:100%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:12pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="width:100%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Rob Janssen&nbsp;&nbsp;&nbsp;&nbsp; July 12, 2013</font></p></td>
</tr>
<tr>
<td valign="top" style="width:100%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Rob Janssen/Date</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>6
<FILENAME>dvax-ex10_20131231595.htm
<DESCRIPTION>EX-10.86
<TEXT>
<html>
<body>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 10.86</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Arial;"><img src="g2014031017063222033.jpg" alt="logo" style="position:absolute;margin-left:-3.85pt;margin-top:4.6pt;width:151.9pt;height:45.7pt;z-index:251658240;mso-position-horizontal-relative:text;mso-position-vertical-relative:text"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;"></font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:50%;"><p style="margin-bottom:0pt;margin-top:24pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="width:50%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom" style="width:50%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Century Schoolbook;font-weight:bold;;font-size:8pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Century Schoolbook;font-weight:bold;;font-size:8pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Century Schoolbook;font-weight:bold;;font-size:8pt;;"><font style="font-weight:bold;color:#4F6061;font-size:8pt;font-family:Century Schoolbook;font-variant: small-caps;font-style:normal;text-transform:none;">2929 Seventh Street, Suite 100</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-weight:bold;color:#4F6061;font-size:8pt;font-family:Century Schoolbook;font-variant: small-caps;font-style:normal;text-transform:none;">Berkeley, California&nbsp;&nbsp; 94710</font></p></td>
<td valign="top" style="width:50%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-size:10pt;;">&nbsp;</p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Hand-delivered</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 4, 2014</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">David L. Johnson</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Re:&#160;&#160;&#160;Employment Terms</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dear Dave:</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dynavax Technologies Corporation is pleased to offer you the position of Vice President and Chief Accounting Officer on the following terms.</font></p><p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">You will provide leadership and management oversight on a global basis for accounting, financial planning and analyses, external reporting, and information technologies, and other duties as assigned.&nbsp;&nbsp;You will report to Michael Ostrach &#8211; Vice President, General Counsel, Chief Business and Principal Financial Officer and work at our facility located at 2929 Seventh Street, Suite 100 in Berkeley, California.&nbsp;&nbsp;The Company may change your position, duties, and work location from time to time as it deems necessary.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Your compensation will be $22,916.66 per month, annualized to $275,000.00, less payroll deductions and all required withholdings.&nbsp;&nbsp;You will be paid semi-monthly, and will be eligible for the following standard Company benefits:&nbsp;&nbsp;medical insurance for yourself and your qualified dependents (there will be an employee contribution for dependent coverage), 12 holidays per year, life insurance, disability insurance, long-term care insurance, Flexible Spending Account, 401(k), and Employee Stock Purchase Plan.&nbsp;&nbsp;The Company may modify compensation and benefits from time to time as it deems necessary.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Personal time-off (PTO) is not accrued and tracked for members of the executive team and management at the director and senior director level.&nbsp;&nbsp;The attached Personal Time-Off Policy highlights the time you have available to use each year.&nbsp;&nbsp;The Company may modify compensation and benefits from time to time as it deems necessary.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">You are eligible to participate in the Company&#8217;s Annual Incentive Bonus program with a target incentive bonus of 40% of your annual base salary.&nbsp;&nbsp;Payment of the Company&#8217;s annual incentive bonus is determined by achievement of your individual goals and the Company&#8217;s approved corporate goals.&nbsp;&nbsp;To receive an annual incentive bonus payment, an eligible participant in the program must be an active employee in good standing on the date the bonus is paid. Payout of bonuses is at the discretion of the Dynavax Board of Directors.&nbsp;&nbsp;If your start date is in the 4<sup style="font-size:85%; vertical-align:top">th</sup> quarter of the current calendar year, you are eligible effective the 1<sup style="font-size:85%; vertical-align:top">st</sup> day of the New Year.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company will grant you a stock option to purchase 200,000 shares of the Common Stock of the Company, with an exercise price equal to the fair market value of the Common Stock on the date of grant. This stock option is subject to all of the terms and conditions set forth in the applicable award agreement and applicable stock incentive plan.&#160; Your stock option grant 200,000 shares of the Common Stock of the Company will vest as follows: 25% of the Shares subject to the Option shall vest twelve months after the Vesting Commencement Date, and 1/48 of the Shares subject to the Option shall vest on the last day of each month, provided that vesting shall cease upon termination of your continuous service to the Company.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As we discussed, the Company is developing a corporate continuity and severance program.&nbsp;&nbsp;You will be eligible for benefits defined for vice presidents.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-align:center;margin-left:6.67%;margin-right:0%;text-indent:-6.67%;font-size:9pt;font-family:Times New Roman;"><font style="color:#4F6061;font-size:9pt;font-family:Times New Roman;font-variant: small-caps;text-transform:uppercase;font-weight:normal;font-style:normal;">Phone: 510-848-5100&#160;&#160;&#160;&#160;Toll-free: 877-848-5100&#160;&#160;&#160;&#160;Fax: 510-848-1327&#160;&#160;&#160;&#160;www.dynavax.com</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:50%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;"><img src="g2014031017063245434.jpg" alt="logo" style="position:absolute;margin-left:-4.6pt;margin-top:1.6pt;width:151.9pt;height:45.7pt;z-index:251660288;mso-position-horizontal-relative:text;mso-position-vertical-relative:text"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;"></font></p><p style="margin-bottom:0pt;margin-top:24pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;">&nbsp;</p></td>
<td valign="top" style="width:50%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom" style="width:50%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Century Schoolbook;font-weight:bold;;font-size:8pt;;"><font style="font-weight:bold;color:#4F6061;font-size:8pt;font-family:Century Schoolbook;font-variant: small-caps;font-style:normal;text-transform:none;">2929 Seventh Street, Suite 100</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-weight:bold;color:#4F6061;font-size:8pt;font-family:Century Schoolbook;font-variant: small-caps;font-style:normal;text-transform:none;">Berkeley, California&nbsp;&nbsp; 94710</font></p></td>
<td valign="top" style="width:50%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-size:10pt;;">&nbsp;</p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This offer is subject to your submission of a completed and signed I-9 form within 3 days of your employment, along with satisfactory documentation(s) verifying your identification and right to work in the United States.&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Your employment is contingent upon the acceptable results of a background check, including but not limited to your Social Security number, education, employment, and criminal verification. Any falsification in your employment history, educational and criminal background will result in withdrawal of the offer and/or termination of employment, if hired.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As an employee of the Company, you will be expected to abide by Company rules and regulations, and to sign and comply with a Proprietary Information and Inventions Agreement, which prohibits unauthorized use or disclosure of the Company&#8217;s proprietary information.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Normal working hours are from 8:00 a.m. to 5:00 p.m., Monday through Friday.&nbsp;&nbsp;As an exempt salaried employee, you will be expected to work additional hours as required by the nature of your work assignments.</font></p><p style="text-align:left;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">You may terminate your employment with the Company at any time and for any reason whatsoever simply by notifying the Company.&nbsp;&nbsp;Likewise, the Company may terminate your employment at any time and for any reason whatsoever, with or without cause or advance notice.&nbsp;&nbsp;This at-will employment relationship cannot be changed except by written agreement signed by a Company officer.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The employment terms in this letter supersede any other agreements or promises made to you by anyone, whether oral or written.&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dave, your employment will be converted from consultant to regulatory full-time employee effective February 5, 2014.&nbsp;&nbsp;We look forward to a productive and enjoyable work relationship.</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;;">&nbsp;</p><div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:auto;">
<tr>
<td style="width:100%;"></td>
</tr>
<tr>
<td valign="top" style=""><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sincerely,</font></p></td>
</tr>
<tr>
<td valign="top" style=""><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:12pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style=""><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Cecilia Vitug</font></p></td>
</tr>
<tr>
<td valign="top" style=""><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cecilia Vitug</font></p></td>
</tr>
<tr>
<td valign="top" style=""><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">VP of Human Resources</font></p></td>
</tr>
</table></div><p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:50%;">
<tr>
<td valign="top" style="width:100%;"><p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Accepted:</font></p></td>
</tr>
<tr>
<td valign="top" style="width:100%;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:12pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="width:100%; border-bottom:solid 0.75pt #000000;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ David Johnson</font></p></td>
</tr>
<tr>
<td valign="top" style="width:100%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">David L. Johnson</font></p></td>
</tr>
<tr>
<td valign="top" style="width:100%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:12pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" style="width:100%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">February 4, 2014</font></p></td>
</tr>
<tr>
<td valign="top" style="width:100%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>7
<FILENAME>dvax-ex10_201312311308.htm
<DESCRIPTION>EX-10.87
<TEXT>
<html>
<body>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman Bold;"><font style="font-weight:bold;font-family:Times New Roman Bold;font-variant: small-caps;font-size:10pt;font-style:normal;text-transform:none;">[***] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-weight:bold;;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 10.87</font></p><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:6.67%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:11pt;;"><font style="font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">AMENDMENT TO RESEARCH AND DEVELOPMENT COLLABORATION AND LICENSE AGREEMENT</font></p><p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;margin-left:6.67%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:11pt;;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1. This letter agreement (the &#8220;Letter Agreement&#8221;) is made as of the date of last signature below (the &#8220;Letter Agreement Effective Date&#8221;) by and between Dynavax Technologies Corporation (&#8220;Dynavax&#8221;) and Glaxo Group Limited (&#8220;GSK&#8221;).&nbsp;&nbsp;Reference is made to the Research and Development Collaboration and License Agreement dated 15 December 2008 between Dynavax and GSK, as amended (the &#8220;Research Agreement&#8221;).&nbsp;&nbsp;Capitalized terms used but not defined in this Letter Agreement shall have the meaning assigned to such terms in the Research Agreement.</font></p><p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;margin-left:6.67%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:11pt;;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2. In accordance with clause 2.3 of the Research Agreement, the Initial Research Term is scheduled to expire on 15 December 2013.&nbsp;&nbsp;Dynavax and GSK hereby agree that the Research Term should be extended, as described in greater detail below, and that simultaneously specific elements of the Research Agreement shall be modified and clarified.</font></p><p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;margin-left:6.67%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:11pt;;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3. The Research Term shall be extended until the conclusion of the Option Deadline Period for the TLR 7/9 Program (DV1179), which shall be either the date on which GSK exercises its Option to license in accordance with clause 4.1.3 or the Option expires or is terminated under clause 4.1.4.</font></p><p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;margin-left:6.67%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:11pt;;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4. Dynavax&#8217;s obligation to provide [***] Back-up Compounds, defined in clause 5.2.1, is modified as follows.&nbsp;&nbsp;GSK acknowledges that [***] required Back-up Compounds [***] by Dynavax, [***], the originally-adopted Compound for the TLR 7/9 Program, [***].&nbsp;&nbsp;Before the end of the Option Deadline Period, GSK will decide whether [***] Back-up Compound [***], assuming the Option is exercised, and will notify Dynavax of the decision on the date of Option exercise.&nbsp;&nbsp;GSK agrees that, if [***], the Compound [***].&nbsp;&nbsp;GSK will review the preclinical characterization work completed as of the date of this Letter Agreement and within [***] of the Letter Agreement Effective Date will either: (1) notify Dynavax whether the data are [***] and are therefore [***] to [***]; or (2) will delineate the [***] present in the [***].&nbsp;&nbsp;If [***] are identified necessitating [***] efforts for [***], Dynavax will use Commercially Reasonable Efforts to complete such activities during, and if the Option for DV1179 is exercised after, the Research Term, but in no event shall be obligated to continue such work for more than [***] following [***].</font></p><p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;margin-left:6.67%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:11pt;;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5. As of the Letter Agreement Effective Date, exclusivity obligations applicable to Dynavax pursuant to clause 7.1 shall be modified to exclude from the prohibited activities any Research, Development, or Commercialization of TLR 7/9 inhibitors, other than DV1179 and any adopted Back-up Compound, in the [***] field.&nbsp;&nbsp;For the avoidance of doubt, such activities shall not be considered to be part of a Dynavax Program under the Research Agreement and any inventions that may occur will not be considered Collaboration Know-How or Collaboration Patents.&nbsp;&nbsp;Data generated by Dynavax during the Research Term related to [***] applications of TLR 7/9 inhibitors [***] and, if GSK exercises the Option to license DV1179, GSK will [***] for the further development of DV1179 [***] or [***] defined under the Research Agreement.  If requested by GSK and authorized by the JSC, Dynavax may include DV1179 and/or a Back-up Compound in [***] Research activities that occur during the Research Term.</font></p><p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;margin-left:6.67%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:11pt;;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6. The obligation described in clause 2.6.4 for [***] with the [***] that [***] is eliminated.&nbsp;&nbsp;In the event that the [***] for the [***] and all Development activities required [***], all [***] be [***].</font></p><p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;margin-left:6.67%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:11pt;;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7. This Letter Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Delaware without reference to conflicts of law principles. Any dispute arising from the performance or breach hereof shall be treated in accordance with Sections 13.1 and 13.2 of the Research Agreement.</font></p><p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;margin-left:6.67%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:11pt;;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8. This Letter Agreement forms an addition to the Research Agreement and the Research Agreement shall remain in full force and effect according to its terms and shall not be modified except as set out in this Letter Agreement.</font></p><p style="margin-bottom:0pt;margin-top:12pt;line-height:10pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1217869 v4/HN </font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;margin-left:6.67%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:11pt;;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">IN WITNESS HEREOF, and intending to be legally bound hereby, the Parties have caused this Letter Agreement to be executed by their duly authorized representatives as of the Letter Agreement Effective Date.</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:12pt;;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:40%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-weight:bold;;font-size:11pt;;"><font style="font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Dynavax Technologies Corporation</font></p></td>
<td valign="top" style="width:20%;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-weight:bold;;font-size:11pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:40%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-weight:bold;;font-size:11pt;;"><font style="font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Glaxo Group Limited </font></p></td>
</tr>
<tr>
<td valign="top" style="width:40%;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;;">&nbsp;</p></td>
<td valign="top" style="width:20%;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;;">&nbsp;</p></td>
<td valign="top" style="width:40%;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom" style="width:40%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Michael Ostrach</font></p></td>
<td valign="top" style="width:20%; border-bottom:solid 0.75pt transparent;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:40%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Beverley Carr</font></p></td>
</tr>
<tr>
<td valign="top" style="width:40%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name: Michael Ostrach</font></p></td>
<td valign="top" style="width:20%; border-top:solid 0.75pt transparent;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;;">&nbsp;</p></td>
<td valign="top" style="width:40%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name: Beverley Carr</font></p></td>
</tr>
<tr>
<td valign="bottom" style="width:40%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title: Vice President</font></p></td>
<td valign="top" style="width:20%;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:40%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title: VP Business Development</font></p></td>
</tr>
<tr>
<td valign="bottom" style="width:40%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: December 13, 2013</font></p></td>
<td valign="top" style="width:20%;"><p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:40%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;;"><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: 13<sup style="font-size:85%; vertical-align:top">th</sup> December 2013</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:12pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman Bold;font-weight:bold;;"><font style="font-weight:bold;font-family:Times New Roman Bold;font-variant: small-caps;font-size:10pt;font-style:normal;text-transform:none;">[</font><font style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">***</font><font style="font-weight:bold;font-family:Times New Roman Bold;font-variant: small-caps;font-size:10pt;font-style:normal;text-transform:none;">] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:0pt;line-height:10pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman Bold;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1217869 v4/HN </font></p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>8
<FILENAME>dvax-ex10_201312311309.htm
<DESCRIPTION>EX-10.88
<TEXT>
<html>
<body>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman Bold;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-variant: small-caps;font-family:Arial;font-style:normal;text-transform:none;">[</font><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">***</font><font style="font-weight:bold;font-size:10pt;font-variant: small-caps;font-family:Arial;font-style:normal;text-transform:none;">]&nbsp;&nbsp;= Certain confidential information contained in this document, marked by brackets, is filed with </font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman Bold;font-variant: small-caps;font-style:normal;text-transform:none;">the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 10.88</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman Bold;font-weight:bold;;"><font style="font-weight:bold;font-family:Times New Roman Bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">AMENDMENT No. 5</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This Amendment No. 5</font><font style="font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(the &#8220;</font><font style="font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Amendment</font><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;) to the Agreement dated 1 September 2006 by and between </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Arial;font-size:10pt;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Arial;font-size:10pt;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ASTRAZENECA AB, a company incorporated in Sweden under no. 556011-7482 with offices at S-151 85 S&#246;dert&#228;lje, Sweden (&#8220;</font><font style="font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">AstraZeneca</font><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;); and </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-weight:bold;;font-family:Arial;font-size:10pt;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-weight:bold;;font-family:Arial;font-size:10pt;"><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">DYNAVAX TECHNOLOGIES CORPORATION, a Delaware corporation with offices at 2929 Seventh Street, Suite 100, Berkeley, California 94710-2753, USA (&#8220;</font><font style="font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Dynavax</font><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;)&nbsp;&nbsp;</font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">as amended (the &#8220;</font><font style="font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Agreement</font><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;) is made effective as of the 7 day of January 2014 (the &#8220;</font><font style="font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Amendment Effective Date</font><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;).</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;;"><font style="font-size:12pt;font-weight:bold;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Recitals</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">WHEREAS, the Research Term has expired and the Joint Research has been completed; and</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">WHEREAS, under the Agreement AstraZeneca has nominated AZD 1419 as a Lead CD; and</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">WHEREAS, under the Agreement AstraZeneca has the responsibility, as set forth therein, for Developing Candidate Drugs selected and Commercialising Products and Combination Products and for costs associated with the Development and Commercialisation; and</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">WHEREAS, in furtherance of the Development of AZD 1419 the Parties agreed in Amendment Agreement&nbsp;&nbsp;No 4 that Dynavax would carry out a certain portion of the Development, primarily consisting of the Phase I Study and the Phase II a Study, as more closely described and on the terms set forth in the Amendment No4 ; and</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">WHEREAS, the Parties now wish to further change the allocation of the Development work to be carried out between the Parties under the Agreement by in particular agreeing that after completion by Dynavax of the Phase I Study AstraZeneca shall assume responsibility for carrying out the Phase II a Study and all subsequent Development of AZD 1419 under the Agreement as envisaged prior to the adoption of the changes set out in Amendment No 4; and </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Parties as a consequence desire to further amend, modify and restate certain terms and conditions of the Agreement.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;;"><font style="font-size:12pt;font-weight:bold;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Agreement</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:10.67%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">NOW, THEREFORE, in consideration of the mutual covenants contained in this Amendment, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties, intending to be legally bound, agree as follows:</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:10.67%;margin-right:0%;text-indent:-10.67%;font-size:12pt;;"><font style="font-size:12pt;font-weight:bold;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc63668339"></a> </font><font style="text-decoration:underline;font-size:12pt;font-weight:bold;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Definitions</font><font style="font-size:12pt;font-weight:bold;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any capitalized term not separately defined in this Amendment shall have the meaning ascribed to it in the Agreement.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:6.67%;margin-right:0%;text-indent:-6.67%;font-size:12pt;;"><font style="font-size:12pt;font-weight:bold;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="text-decoration:underline;font-size:12pt;font-weight:bold;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Modifications</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;"><font style="font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2.1 </font><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following Sections shall be inserted immediately after Section 1.123 of the Agreement as new Sections 1.124 through 1.138.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:10.67%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Arial;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.124</font></p></td><td valign="top" style="width:89.33%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Arial;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8216;</font><font style="font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Aggregate Amount</font><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221; has the meaning defined in Section 9.4.1. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:10.67%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Arial;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.13</font><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</font></p></td><td valign="top" style="width:89.33%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Arial;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8216;</font><font style="font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Phase I Study</font><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8217;</font><font style="font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">means the clinical study regarding AZD 1419 with the design, endpoint, number of subjects and time plan described, and otherwise as described, in the Amendment Development Phase I Study Plan, attached hereto as a Schedule 1 </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:10.67%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Arial;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.13</font><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</font></p></td><td valign="top" style="width:89.33%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Arial;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8216;</font><font style="font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Phase II a Studies</font><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8217; means the clinical study regarding AZD 1419 with the design, endpoint, number of subjects and time plan described, and otherwise as described, in the Amendment Development Phase II a Study Plan, attached hereto as a Schedule 2. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:10.67%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Arial;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.13</font><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</font><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p></td><td valign="top" style="width:89.33%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Arial;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8216;</font><font style="font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Dynavax Development Work</font><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8217; means the Phase I Study.&#8221;</font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Arial;font-size:10pt;"><font style="font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2.2 </font><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Sections 8.2.B and 8.2.C are hereby deleted and shall be replaced by new Sections 8.2.B and 8.2.C as set out below:</font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:10.67%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Arial;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;</font><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.2. B</font></p></td><td valign="top" style="width:89.33%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Arial;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Notwithstanding what is stated in Section 8.2 (as amended); Dynavax shall be responsible for completing<a name="OLE_LINK5"></a> the Dynavax Development Work in accordance with what is stated herein. Upon completion of the Dynavax Development Work and payment of the milestone in Section 9.4.1 (as amended), such Regulatory Documentation, Regulatory Filing and, as applicable, Health Registration Approvals, generated by Dynavax shall be transferred to AstraZeneca free of charge in a format useful and suitable for AstraZeneca for the purpose of being be able to continue the Development and carry out Commercialisation in accordance with this Agreement. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:10.67%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Arial;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.2.D</font></p></td><td valign="top" style="width:89.33%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Arial;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Immediately upon completion of the Dynavax Development Work, or at any time before such completion as decided from time to time by the JSC, Dynavax shall make available and transfer to AstraZeneca any Dynavax Know-How, compounds and other materials generated by or on behalf of Dynavax, solely or jointly with AstraZeneca or any Third Party, in the course of the Dynavax Development Work in a format useful and suitable for AstraZeneca to be able to continue the Development and carry out Commercialisation in accordance with this Agreement.&#8221;</font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;"><font style="font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2.3 </font><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the avoidance of doubt all milestone payments set out in the deleted Sections 8.9.B and 8.9.C (other than those which have already been paid as at the Amendment Effective Date) will not become due. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;"><font style="font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2.4 </font><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sections 9.4.1 and 9.4.2 are hereby deleted and shall be replaced by new Sections 9.4.1 and 9.4.2 as set out below:</font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:89.33%;margin-left:10.67%;margin-right:0%"><tr><td valign="top" style="width:10.67%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Arial;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;9.4.1</font></p></td><td valign="top" style="width:89.33%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Arial;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Five million four hundred thousand U.S. Dollars ($5,400,000) upon signature of this Amendment Agreement No 5 .  Upon completion of the Phase I Study and payment of the milestone in Section 9.4.1, such Regulatory Documentation, Regulatory Filing and, as applicable, Health Registration Approvals, shall be transferred to AstraZeneca free of charge in a format useful and suitable for AstraZeneca for the purpose of being be able to continue the Development and carry out Commercialisation in accordance with this Agreement.</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:89.33%;margin-left:10.67%;margin-right:0%"><tr><td valign="top" style="width:10.67%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Arial;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.4.</font><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</font></p></td><td valign="top" style="width:89.33%;"><p style="margin-bottom:0pt;margin-top:6pt;font-family:Arial;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[***] US Dollars ($[***]) within [***] days following [***]. </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Arial;font-size:10pt;"><font style="font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">3 </font><font style="font-weight:bold;text-decoration:underline;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Amendment Effective Date</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This Amendment shall become effective on the Amendment Effective Date.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman Bold;font-weight:bold;;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman Bold;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman Bold;font-variant: small-caps;font-style:normal;text-transform:none;">[</font><font style="font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">***</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman Bold;font-variant: small-caps;font-style:normal;text-transform:none;">] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;;"><font style="font-size:12pt;font-weight:bold;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">4 </font><font style="text-decoration:underline;font-size:12pt;font-weight:bold;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Entire Agreement</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This Amendment, together with the Agreement, constitutes the entire agreement between the Parties with respect to the subject matter of the Agreement.&nbsp;&nbsp;The Agreement together with this Amendment supersedes all prior agreements, whether written or oral, with respect to the subject matter of the Agreement, as amended. Each Party confirms that it is not relying on any statements, representations, warranties or covenants of any person (whether a Party to this Agreement or not) except as specifically set out in the Agreement as amended. Nothing in this Amendment is intended to limit or exclude any liability for fraud. All Schedules referred to in this Amendment are intended to be and are hereby specifically incorporated into and made a part of the Agreement. The Parties hereby agree that subject to the modifications specifically stated in this Amendment, all terms and conditions of the Agreement shall remain in full force and effect.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;"><font style="font-weight:bold;text-decoration:underline;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Execution</font><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">AB"<a name="sidfot"></a><br></font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THIS AGREEMENT IS EXECUTED by the authorised representatives of the Parties as of the date first written above.</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr style="height:9pt;">
<td valign="top" style="width:49%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SIGNED for and on behalf of </font></p></td>
<td valign="top" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:49%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SIGNED for and on behalf of </font></p></td>
</tr>
<tr style="height:9pt;">
<td valign="top" style="width:49%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Arial;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:49%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Arial;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr style="height:9pt;">
<td valign="top" style="width:49%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;"><font style="font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">AstraZeneca AB (publ)</font></p></td>
<td valign="top" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:49%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;"><font style="font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Dynavax Technologies Corporation</font></p></td>
</tr>
<tr style="height:9pt;">
<td valign="top" style="width:49%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Arial;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:49%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Arial;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr style="height:4pt;">
<td valign="top" style="width:49%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:31.85%;text-indent:0pt;;font-family:Arial;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&nbsp;&nbsp;Maarten Kraan</font></p></td>
<td valign="top" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:49%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:34.63%;text-indent:0pt;;font-family:Arial;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&nbsp;&nbsp;Eddie Gray</font></p></td>
</tr>
<tr style="height:8.1pt;">
<td valign="top" style="width:49%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Maarten Kraan</font></p></td>
<td valign="top" style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:49%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Eddie Gray</font></p></td>
</tr>
<tr style="height:4pt;">
<td valign="top" style="width:49%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">VP iMed RIA</font></p></td>
<td valign="top" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:49%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Arial;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">CEO</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman Bold;font-weight:bold;;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman Bold;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman Bold;font-variant: small-caps;font-style:normal;text-transform:none;">[</font><font style="font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">***</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman Bold;font-variant: small-caps;font-style:normal;text-transform:none;">] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Schedule 1</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Phase 1 Study Plan</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">[</font><font style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">***]</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Arial;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman Bold;font-weight:bold;;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman Bold;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman Bold;font-variant: small-caps;font-style:normal;text-transform:none;">[</font><font style="font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">***</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman Bold;font-variant: small-caps;font-style:normal;text-transform:none;">] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p>

<div style="width:100%;"><hr style="page-break-after:always"></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Arial;font-size:10pt;"><font style="font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Schedule 3</font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-family:Arial;font-size:10pt;"><font style="font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Phase II a Study Plan [to be agreed]<sup style="font-size:85%; vertical-align:top">1</sup><font style="font-size:10pt;font-family:'Symbol'">&#42;</font></font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;"><font style="font-weight:bold;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">[</font><font style="font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">***] </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Arial;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman Bold;font-weight:bold;;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman Bold;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman Bold;font-variant: small-caps;font-style:normal;text-transform:none;">[</font><font style="font-size:8pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">***</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman Bold;font-variant: small-caps;font-style:normal;text-transform:none;">] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.</font></p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12
<SEQUENCE>9
<FILENAME>dvax-ex12_20131231683.htm
<DESCRIPTION>EX-12.1
<TEXT>
<html>
<body>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 12.1 </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:52%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="18" valign="bottom" style="width:45%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the 12 Months Ended December 31</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:52%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2010</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2009</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:52%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="17" valign="bottom" style="width:38%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(In thousands)</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:52%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> Earnings</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:52%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Loss from continuing operations before income taxes</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(66,720</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(69,949</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(48,597</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(57,308</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,127</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:52%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Fixed charges</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">509</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,795</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,420</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,341</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">796</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:52%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Amount attributable to noncontrolling interest in Symphony Dynamo, Inc.</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,233</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:52%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Earnings, as defined</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(66,211</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(67,154</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(46,177</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(54,967</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(10,098</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:52%; border-top:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:52%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> Fixed charges:</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:52%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Interest expense</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,351</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,957</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,654</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">124</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:52%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Estimated interest component of rent expenses</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">509</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">444</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">463</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">687</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">672</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:52%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Total fixed charges</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">509</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2,795</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2,420</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2,341</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">796</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:52%; border-top:double 2.5pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:52%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> Deficiency of earnings available to cover fixed charges (1)</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(66,720</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(69,949</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(48,597</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(57,308</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,127</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:52%; border-top:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:6%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:12pt;;"><font style="color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td colspan="22" valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:100%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> (1</font><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">):&nbsp;&nbsp;Adjusted earnings, as described above, were insufficient to cover fixed charges in each year.</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21
<SEQUENCE>10
<FILENAME>dvax-ex21_201312316.htm
<DESCRIPTION>EX-21.1
<TEXT>
<html>
<body>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 21.1 </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;text-decoration:underline;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">List of Subsidiaries </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Rhein Biotech GmbH </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dynavax International, B.V. </font></p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>11
<FILENAME>dvax-ex23_201312317.htm
<DESCRIPTION>EX-23.1
<TEXT>
<html>
<body>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 23.1 </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Consent of Independent Registered Public Accounting Firm </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We consent to the incorporation by reference in the following Registration Statements: </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1) Registration Statements (Form S-3 Nos. 333-164254, 333-165663, 333-169576, 333-175645 and 333-191610) of Dynavax Technologies Corporation and in the related Prospectuses, </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2) Registration Statement (Form S-3/A Nos.&#160;333-164254 and 333-191610) of Dynavax Technologies Corporation and in the related Prospectus, and </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3) Registration Statements (Form S-8 Nos. 333-113220, 333-136345, 333-145094, 333-152819, 333-157741, 333-164255, 333-171552 and 333-190313) pertaining to the 1997 Equity Incentive Plan, the 2004 Stock Incentive Plan, the 2004 Employee Stock Purchase Plan, the 2010 Employment Inducement Award Plan and/or the 2011 Equity Incentive Plan of Dynavax Technologies Corporation; of our reports dated March&#160;10, 2014, with respect to the consolidated financial statements of Dynavax Technologies Corporation and the effectiveness of internal control over financial reporting of Dynavax Technologies Corporation included in this Annual Report (Form 10-K) of Dynavax Technologies Corporation for the year ended December&#160;31, 2013. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:61.2%;margin-right:0%;text-indent:-2.27%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;Ernst&#160;&amp; Young LLP </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Redwood City, California </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March&#160;10, 2014 </font></p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31
<SEQUENCE>12
<FILENAME>dvax-ex31_20131231198.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html>
<body>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 31.1 </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Rule 13a-14(a) Certification of Chief Executive Officer </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">CERTIFICATIONS </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">I, Eddie Gray, certify that: </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">I have reviewed this annual report on Form 10-K of Dynavax Technologies Corporation (the &#8220;registrant&#8221;); </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:90.94%;margin-left:9.06%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:90.94%;margin-left:9.06%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">b)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:90.94%;margin-left:9.06%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">c)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:90.94%;margin-left:9.06%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">d)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions): </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:90.94%;margin-left:9.06%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:90.94%;margin-left:9.06%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">b)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting. </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;;">&nbsp;</p><div align="right">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:40%;">
<tr>
<td valign="bottom" style="width:6.68%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</font></p></td>
<td valign="bottom" style="width:1.64%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:91.66%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/</font><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/&#160;EDDIE GRAY&#160;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="width:6.68%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:1.64%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:91.66%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Eddie Gray</font></p></td>
</tr>
<tr style="height:18pt;">
<td valign="top" style="width:6.68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:1.64%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="top" style="width:91.66%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Chief Executive Officer<br>(Principal Executive Officer)</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: March&#160;10, 2014 </font></p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31
<SEQUENCE>13
<FILENAME>dvax-ex31_20131231199.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html>
<body>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 31.2 </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Rule 13a-14(a) Certification of Principal Financial Officer </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">CERTIFICATIONS </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">I, Michael Ostrach, certify that: </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">I have reviewed this annual report on Form 10-K of Dynavax Technologies Corporation (the &#8220;registrant&#8221;); </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:90.94%;margin-left:9.06%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:90.94%;margin-left:9.06%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">b)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:90.94%;margin-left:9.06%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">c)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:90.94%;margin-left:9.06%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">d)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:95.46%;margin-left:4.54%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions): </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:90.94%;margin-left:9.06%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:90.94%;margin-left:9.06%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">b)</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting. </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><div align="right">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:40%;">
<tr>
<td valign="bottom" style="width:2%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:37%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/</font><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/ MICHAEL OSTRACH</font></p></td>
</tr>
<tr>
<td valign="bottom" style="width:2%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:37%; border-top:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Michael Ostrach</font></p></td>
</tr>
<tr style="height:18pt;">
<td valign="top" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="top" style="width:37%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Vice President<br>(Principal Financial Officer)</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: March&#160;10, 2014 </font></p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>14
<FILENAME>dvax-ex32_2013123110.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html>
<body>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 32.1 </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Certification Pursuant to Section&#160;1350 of Chapter 63 </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of Title 18 of the United States Code </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">I, Eddie Gray, hereby certify, pursuant to 18 U.S.C &#167; 1350, as adopted pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) and to &#167; 906 of the Sarbanes-Oxley Act of 2002, in my capacity as an officer of Dynavax Technologies Corporation (the &#8220;Company&#8221;), that, to the best of my knowledge: </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:4.53%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">(i) The Annual Report of the Company on Form 10-K for the period ended December&#160;31, 2013 as filed with the Securities and Exchange Commission on the date hereof and to which this Certificate is attached as Exhibit 32.1 (the &#8220;Report&#8221;), fully complies with the requirements of section 13(a) or 15(d) of the Exchange Act; and </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:4.53%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">(ii) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">In Witness Whereof</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, the undersigned have set their hands hereto as of the 10</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">th</sup></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> day of March, 2014. </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><div align="right">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:40%;">
<tr>
<td valign="bottom" style="width:2%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:37%; border-bottom:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/</font><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/&#160;EDDIE GRAY</font></p></td>
</tr>
<tr>
<td valign="bottom" style="width:2%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:37%; border-top:solid 1pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Eddie Gray</font></p></td>
</tr>
<tr style="height:18pt;">
<td valign="top" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom" style="width:37%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Chief Executive Officer<br>(Principal Executive Officer)</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This certification accompanies the Form 10-K to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Dynavax Technologies Corporation under the Securities Act of 1933, as amended, or the Exchange Act (whether made before or after the date of the Form 10-K), irrespective of any general incorporation language contained in such filing. </font></p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>15
<FILENAME>dvax-ex32_2013123111.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html>
<body>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 32.2 </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Certification Pursuant to Section&#160;1350 of Chapter 63 </font></p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of Title 18 of the United States Code </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">I, Michael Ostrach, hereby certify, pursuant to 18 U.S.C &#167; 1350, as adopted pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) and to &#167; 906 of the Sarbanes-Oxley Act of 2002, in my capacity as an officer of Dynavax Technologies Corporation (the &#8220;Company&#8221;), that, to the best of my knowledge: </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:4.53%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">(i) The Annual Report of the Company on Form 10-K for the period ended December&#160;31,2013 as filed with the Securities and Exchange Commission on the date hereof and to which this Certificate is attached as Exhibit 32.2 (the &#8220;Report&#8221;), fully complies with the requirements of section 13(a) or 15(d) of the Exchange Act; and </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:4.53%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">(ii) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">In Witness Whereof</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, the undersigned have set their hands hereto as of the 10</font><font style="font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%; vertical-align:top">th</sup></font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> day of March, 2014. </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><div align="right">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:40%;">
<tr>
<td valign="bottom" style="width:2%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</font></p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;"><font style="font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p></td>
<td valign="bottom" style="padding-left:0.7 pt;padding-Right:0.7 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:37%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/</font><font style="font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">S</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/&#160;MICHAEL OSTRACH</font></p></td>
</tr>
<tr>
<td valign="bottom" style="width:2%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="top" style="padding-left:0.7 pt;padding-Right:0.7 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:37%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Michael Ostrach</font></p></td>
</tr>
<tr style="height:18pt;">
<td valign="top" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:10pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;">&nbsp;</p></td>
<td valign="bottom" style="width:37%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:8pt;;"><font style="font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Vice President<br>(Principal Financial Officer)</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This certification accompanies the Form 10-K to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Dynavax Technologies Corporation under the Securities Act of 1933, as amended, or the Exchange Act (whether made before or after the date of the Form 10-K), irrespective of any general incorporation language contained in such filing. </font></p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>g2014031017064504835.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g2014031017064504835.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+#`Q-#0T'R<Y/3@R/"XS-#+_
MVP!#`0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P``1"`!W`9P#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#W^BBFR2)#
M$TDKJB(,LS'``]:`'45@7/C30K8D?;/-8=HD+?KT_6LZ3XBZ6I_=VUT_U51_
M6@+G845P[?$FV'W=.F/UD`_I3?\`A94'_0,D_P"_H_PHL*YW5%<7'\1]/)_>
M65RH]5*G^HK9L/%NBZ@P2.[$<A_@F&P_F>/UH'<VZ*.M%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!5>^M$O[&>TD9E29"C%>H!
M]*L44`<F/A_HR1-EKECC@F0<?D*\O8;6(]#BO>G^XWT->#/_`*QOJ::)9U?@
M*PM+_4KD7=O',$B#*)!D`Y]*]$_LG3<8_L^TQZ>2O^%<'\-_^0G>_P#7$?\`
MH5>D4,:,&_\`!VBWZ'_15MW/1X/EQ^'3]*\Z\0>&[K0)QYA\VV<_NY@.#['T
M->QU4U+3X=4T^:SG4%)%QG'W3V(]Q1<&CS#P]XNN]&D2&9FGLLX,;')0>J_X
M5ZI:W4-[:QW-O()(I!E6%>'75O):7<UM*,21.4;Z@XKK?`.M-;Z@=+E;,,^3
M'G^%P/ZC^E`DSTJBJ&KZ8-6LOLQN9K?Y@V^%L'CM]*\TUZTUCPY>B/\`M&Z:
M%^8I5E9=WZ\&D.YZU17C=CK.KW-W#;-K5S"LC!?,>5B%SZUZ3H>BWNF322WF
MKSWK.NW:^=J\]1DF@+FW117#^*])N+"*ZU:+7+J$,^5@#$`L3T!!_IVH&=Q1
M7GVA:+XAU:UCN[G6KRV@;E%\UF9QZXR.*[+5M-?4['[,EW-:L&#"2(X/';Z4
M`7Z*\P\0:-KFA1"Y&JW-Q;9VF02LI7/J,U@VVMZG:W27,=[.9%.?G<L#[$'K
M3L*Y[;16)X=\26^O6O&([I!^\BS^H]16W2&%%,FC,L$D8=D+J5W*<%<CJ/>O
M/O$'AS5-*TZ6]CUNYN(HR-R.[`X)QZG/6@#T2BO-?#OABZURS6^NM4FCA8E5
M56+,<'GDGC]:]&@B$%O'"I)$:A06/)P,<T`2444$@`D\`4`,:6-6"LZACT!/
M-/KQ;7]3;4]=N+Q6.W?B(^BC@?XUZMX?U,:OHEO=Y'F%=L@]&'!_Q_&@5S3H
MHK@-9\&7-C:W%[I^HSL4S(T1X)'4X(/]*!G?T5X:-5U$#`O[H#T\YO\`&NLT
M#PJVNZ;'?7>J3E7)`C0Y(P<<D_X4["N>C4=:CMX5MK:*!22L:!`6ZD`8YKC-
M6\&0V=G<WMIJ=S"T:-(0[<<#.,C&*0SMZ*\G\.Z1J7B.24&_FBMH\;W+ELD]
M@,UZ3H^DPZ+8"T@>1UW%BTAR23_^J@1?IKR)'C>ZKGIDXIU>3>-]3^W^('B1
MLQ6H\I?K_$?SX_"@&>L]1D45S?@G5?[1T%(W;,UJ?*;/4C^$_EQ^%=)0,***
MS-;TEM8LT@6[EM65]X>/J>",'D>M`&G17E.NZ?K?AJ5&&IW+P2\++'*R\^A&
M>#69'KNJS31I+K%Y&A8!G$K?*.YX/-.PKGM-%8?A_0WTOS)Y-3FOC,HPSG@#
MU')JIKWAZZN[J>_379[.(("8QG:N!R<AA]>E(9T]%>0Z-_;VL7QMK+4KL`<O
M(9W"J/4\UWNA^'+K2[PW5UJT]XY0KL?.T9(YY)]*!7.AHHHH&%%%%`#7^XWT
M->#/_K&^IKWE_N-]#7@S_P"L;ZFFA,[#X<?\AFZ_Z]__`&85Z77F_P`-R/[4
MO!GGR1_Z%7I%)@@HHHH&>1^-X!#XJN2!@2!7_-1G]16+97#6E];W"'#12*X_
M`UO^/'#>*)0.JQH#^6?ZUS:*7D5!U8@"J)/>@0P!'0\UFZ]H\6MZ7):O@/\`
M>B<_PL.A_I6B@VQJOH`*=4E'@]Q;RVES);SH4EC8JRGL17IO@GQ"=4LOL5R^
M;JW48)/+IZ_4=#^%5/'?A[[3#_:MJF98QB90/O+_`'OP_E]*X+3K^;3+^&\@
M.)(VSCL1W!^M,G8]S)P,GI7#3Y\9^)1"A)TFQ/SL.DC?_7_E]:=K'B5M<@M=
M+T4DSWJCS6_YY+W4_KGV^M=1H^E0:-IT=I`,[>7?N[=R:0R\JA%"J`%`P`.U
M+110,P_&`!\*7^1T53_X\*\U?P_='08=7@_>P-N$H4<QD$C\1[UZ=XK`/A?4
M`1_RRS^HJIX&P?"=N#@C<X(_X$:8CRRTNY[&ZCN;:1HY4.585ZOX:\30:[;[
M&VQWB#]Y%GK[K[?RKF_%G@WR0^H:7'^[Y:6!1]WW7V]JXJVN9K.X2XMY&CE0
MY5E/(HW%L>\5C>*X_,\+Z@OI'N_(@_TJMX8\4PZY`(9ML=\@^9.SCU7_``K0
M\0`MX=U$#K]G?^1I%&;X$_Y%6#_??_T(UTE<M\/VW>&L?W9W'\C_`%KJ:`05
M@>,=3_LWP]/M;$L_[E/QZG\LUOUYWXJD?7O%UIH\))CB(5L=B>6/X#^5`F<?
M=6-Q9I;O.A5;B,2QGU7)']*ZSX>:KY%_+ILC?).-\>?[XZC\1_*MSQQI"3^'
MDFA0!K+!4`?P="/Y'\*\TM;F2SNX;F(XDB<.I]Q3%L>[T$9&#TJO8W<=_8P7
M<1^25`X]L]JL4BCQKQ/I7]D:Y/`HQ"Q\R+_=/;\.1^%='\.M4V37&F2-P_[V
M+/J.&'Y8/X5J>/\`2OM>DI?1KF2U/S8[H>OY''ZUYSI][+IU_!=PG#Q.&'OZ
MC\1Q3)V9[I7*>/M0^RZ$+5&_>73A<#KM')_H/QKI;2YCO;2&YA.8Y4#J?8UP
M]T/^$C^(*0?>M;'[WH=O)_-CC\*0V=/X9TL:3H-O`5Q*P\R7_>/^'`_"M>BB
M@91UG4%TO2+F\.,QH=H/=CP!^>*\:FM+H6<>H2J3%/(RASW8=?Y_H:[CX@WS
MS2V>CP99Y&$C*.Y/"C^?Z5L:IX>1_!W]F1*#);QAHR!U<<G\^?SIB9Q'@O5?
M[-UZ.-VQ#<_NGST!_A/Y_P`Z]:KP,$@@@X(KVCP[J?\`:VAVUT3F3;LD_P!X
M<'_'\:&"-2BBBD,JZEI\&J6$MG<KF.0=>ZGL1[UXQJ>G3:5J,UG./GC/![,.
MQ'UKW&N<\6^'1K=CYL``O8`2A_OC^Z?Z4T)HQ?`OB3<%TB[?D?\`'NY/7_9_
MPJ3Q?JT^I7J>'=,^>1V`F*GOUV_0=37GRF2"4,I9)$;((X*D?UKT'X=K8O%=
M3;BVHEOG+]0GM]3UH$=-H6BP:'IRVT6&D/,LF.7;_"M.BBD4%%%%`!1110`U
M_N-]#7@S_P"L;ZFO=+VZAL[.6>>14C1226.*\*8[F)]3FFA,[/X;J#JUXW<0
M8_\`'A_A7I->0>$=8BT;6A+<$B"5#&Y`SMR00?S%>MP7$-S$LL$J2QMR&1L@
MT,$24$X&3TIKR)$A>1U1!R68X`KAO%7C.`VTEAI<GF/("LDZ]%'<+ZGWI#..
MUZ]&HZ[>72G*/(0I_P!D<#]!5KPIIK:GXAMDVYBB;S9#Z`<_J<"LNSL[B_N4
MM[6)I97/"K7K?AKP_'H.G["0]S)@RN/7T'L*9*-NBBBD4!`(P1D&O&/$UE%I
M_B&\MH!MB5@RKZ`@''ZU[/7D/C3_`)&N]_X!_P"@BFA,UOAN@.IWCE02L(`.
M.F3_`/6KTBO._AK_`,?>H?[B?S->B4F""BBB@9B^+B5\*WY']P#_`,>%4_`7
M_(KQ_P#75_YU;\7G'A2__P!Q?_0A5#X?/N\-E<_=G8?H#3%U.JK@O%W@[=YF
MHZ7'S]Z6!1U_VE']*[VBD,\&AFEMITFA=HY4.593@@UZ/IOBF+7-`O;6YVI?
M+;297H)!M/(]_:H?%O@X7'F:CID>)?O2P*/O^Z^_MWKSP%HWR"58=QP13)V/
M3?AVQ/A^4'H+AL?DM==7&_#C_D"W7_7P?_05KLJ0T5K^\CT_3Y[N7[D*%C[^
MU>7:+IVOZE<S:OIK!93(P:4L!DGDXS]:Z3XAZGY5E!IL;?/.V]P/[HZ?F?Y5
MTF@:<-*T2UM,8=4R_P#O'D_K3`Y.73?'$T3Q274;(ZE64LG(/7M7$7UE/IU[
M+:7*;9HSAAG/O7NM>??$72]LEOJ<:\-^ZEQZ]5/\Q^%`-%SX>:IYUA-IKM\\
M!WQC_9/7\C_.NUKQ?PYJ?]DZY;71.(]VR3_=/!_Q_"O9P0P!!R#R"*&"&S1)
M/"\,BAHW4JP/<'K7B6KZ<^E:K<6;Y_=M\I/=>Q_*O<*X;XB:4'MX-4C7YHSY
M4O\`NGH?S_G0@93\*^)EL/#M_!.WSVJF2`'OGC'_`'T1^=:_@'3VATR749@3
M-=N2">NT'^IS^E><6%G)J%_!:1#YYG"CV]Z]PMK>.UM8K>(8CB0(H]@,4,$2
MTC,J(SL0%49)/84M<WXVU/\`L_P_)&C8EN3Y2_3^(_EQ^-(9Q<<6J^)O$-WJ
M.FC#QN&5F8#8.B]>^!6Y]B\=_P#/XG_?2?X5L>"-.%AX=BD8?O+D^:WT_A_3
M^==)3%8\1U;3+S2KTPWR!97'F?*000?I^-=/\.]4\F]FTV1OEG&^/_>'7\Q_
M*MCX@:7]JTE+Y%_>6S?-_N'_``./UKSFQNY+"_@NXC\\3AQ[X[4"V/=:*AM;
MF.\M(KF$YCE0.I]C4U(H*Q?$NOQZ%IY<8:YDR(4]_4^PJ[JNJ6VCV#W=RV%7
MA5'5SV`KB_#UA-XJUF37-2Y@B?$478D<@?0?J?QH$8NH>&-2311K5P2\DK&2
M:,CYE4]&/]?3-9.E:E/I.H17EN?F0\KV8=P:]P=%D1D=0RL,$$<$5Y'XL\/G
M0]1S$#]DFRT1_N^J_A3$T>IZ=J$&J6$5Y;MF.09QW4]P?<5:KRCP=XB_L>_^
MSW#G[%.<-G^!NS?X_P#UJ]6!#`$$$'D$4AH6BBB@856U&*XGTZXBM9/+N'C*
MQN21M;'!R*LTR6:*!-\LB1KG&78`4`>=2^`]=NGW76H6\A]7E=C^JT?\*WOO
M^?ZW_P"^6KO_`.T;+_G\M_\`OZO^-']HV7_/Y;_]_5_QJK,FZ.`_X5O??\_U
MO_WRU*OP_P!8MR3;ZC`A]5=US^0KOO[1LO\`G\M_^_J_XT?VC9?\_EO_`-_5
M_P`:+,+H\_D\!Z]/@37]LX_VIG;^:U9L_ANVX&]OQM[K"G7\3_A7;_VC9?\`
M/Y;_`/?U?\:/[1LO^?RW_P"_J_XT6871#I>C6.CP^59P!,_><\LWU-7ZK?VC
M9?\`/Y;_`/?U?\:/[1LO^?RW_P"_J_XTK,=T6:*K?VC9?\_EO_W]7_&C^T;+
M_G\M_P#OZO\`C1RL+HRM9MO$EQ<XTJ\M+>VVC.\?/GO_``FN8N/`6L7MR\]U
MJ-O)*_WG)8D_I7>?VC9?\_EO_P!_5_QH_M&R_P"?RW_[^K_C19]A71Q%EX/\
M1:/*\NG:C:HS##=>1]"I%=;HB:O':.-8EAEFW_*T0Q\N._`[YJU_:-E_S^6_
M_?U?\:/[1LO^?RW_`._J_P"-%GV"Z[EFH+P7!LIQ:%1<;#Y1;INQQFF_VC9?
M\_EO_P!_5_QH_M&R_P"?RW_[^K_C1ROL.Z.0O='\8:M9M:W=Y9"%\%EZ9P?4
M+4&G^&_%FBQLEA>V@1SN9`<@G_@2UVW]HV7_`#^6_P#W]7_&C^T;+_G\M_\`
MOZO^-.S["NNY!HPU,6`&K-&UUN/,>,8[=*T*K?VC9?\`/Y;_`/?U?\:/[1LO
M^?RW_P"_J_XTN5]AW19KB_%O@_[<6O\`3(P+DG,D0.!)[CW_`)UU?]HV7_/Y
M;_\`?U?\:/[1LO\`G\M_^_J_XT6871@^!]-O-+TJXBO8&A=I]P!(.1M'I6AK
MMOK=PD*Z-=06_P![S3*.3TQCY3[U>_M&R_Y_+?\`[^K_`(T?VC9?\_EO_P!_
M5_QHL^P77<X:Y\!:M?3&XN]4ADG;JS;C^M;VCZ9XDLKV+[9JL5Q9KD.A&6(P
M<<D9ZX[UM_VC9?\`/Y;_`/?U?\:/[1LO^?RW_P"_J_XT68KHDN!,;:46[*LQ
M0^66Z!L<9_&N+O\`POXFU90E_J]N\><[%R%S]`HKL/[1LO\`G\M_^_J_XT?V
MC9?\_EO_`-_5_P`:+/L.Z[GGY^&]_CB^MB?<-_A6YHVC>)]-NH$FU.WEL4(#
M1EBQV^@RO]:Z3^T;+_G\M_\`OZO^-']HV7_/Y;_]_5_QIV8KHLU5U&R34=.N
M+.3[LR%<^A['\#S2_P!HV7_/Y;_]_5_QH_M&R_Y_+?\`[^K_`(TK,=T<?X1\
M)WNEZLUY?QHH1"(]KAOF/&?RS^==S5;^T;+_`)_+?_OZO^-']HV7_/Y;_P#?
MU?\`&BS"Z(=8CU.6QV:3/##<[A\\HXV]^QYZ=JX^[\%:YJCB74-5ADE`PH.X
M@?3@8_*NV_M&R_Y_+?\`[^K_`(T?VC9?\_EO_P!_5_QHL^PKHYG3-!\3::\,
M2:O`UHC#,;`GY>X&1Q^==?5;^T;+_G\M_P#OZO\`C1_:-E_S^6__`']7_&BS
M[#NCE=0T#Q5JB/%<ZM;"%SS&F0,>G"\_C65_PK>^_P"?ZW_)J[_^T;+_`)_+
M?_OZO^-']HV7_/Y;_P#?U?\`&G9BNCD--\.>*M*,<=KJEL+=6R8V9B,9YP"I
MKI]9757LU&D20I<;QN,O3;@Y['G.*L?VC9?\_EO_`-_5_P`:/[1LO^?RW_[^
MK_C2L^P[KN</?>$/$NKR+)J&HVLA4?*"S87Z`+BI+#PSXJT;BPU&U\O.3&6)
M4_@5KM/[1LO^?RW_`._J_P"-']HV7_/Y;_\`?U?\:=GV%==R.Y746TG%LT":
M@47YGSY8;C=[XZXKD-1\+^*-8"K?ZE:.BG<J@D`'Z!179_VC9?\`/Y;_`/?U
M?\:/[1LO^?RW_P"_J_XTK/L.Z[GGS_#C40OR7EJ3Z'</Z5LZ-I'BK3)X(7OK
M>2Q1@&0L6PO<#*YKJ/[1LO\`G\M_^_J_XTJW]F[!5NX&8G``D!)HLQ718HHH
MI%!534-,L=6MA;ZA:Q7,(8,$E7(R._ZFK=07KM'87#J2&6)B".QQ3C>^@G9K
M4R/^$)\,?]`*Q_[\BC_A"?#'_0"L?^_(KS#PHOC3Q1I=Y?V7B>=);9]JPR$D
M2'&>O0?E7;?#CQ?=>);"YMM1`_M"R8+(P7&]3G!(['((-=M6E5IIOGO;?5Z'
M'2JTJC2Y+7VT1L_\(3X8_P"@%8_]^11_PA/AC_H!6/\`WY%9?Q(BUF/P_P#V
MEHM]<V\MF2TJ0MC?'W/U'7Z9KE&\;ZIXOBT'1M%N)+749CNOYHN/+"\''L1E
MOR%*G3JSBIJ6G75Z#J5*4).#CKTT6IW_`/PA/AC_`*`5C_WY%'_"$^&/^@%8
M_P#?D5MQ1^5"D>YFVJ%W.<DX[D]S7A^E^/M6TKQM,=1O;B?2OM4D$BR$E8UW
M'!'N.#],U-&%:LI<LMO,JM*E2:YH[GJO_"$^&/\`H!6/_?D4?\(3X8_Z`5C_
M`-^16)X;U:]O/B-XBLY+R26SA1&@C+95<XY%=M+(D,3RR,%1%+,3V`ZUG4=6
M#LY/I^)=-4YJZBO^&,3_`(0GPQ_T`K'_`+\BC_A"?#'_`$`K'_OR*\GT[QYK
M?_"86NHW5Y<#1[F]=%B9OW80G!&/]D,IKW:M*\*U%KFEOYD4)TJR?+';R,'_
M`(0GPQ_T`K'_`+\BC_A"?#'_`$`K'_OR*Y#4-;U30OB[;6=Q?3OI5]MV0NV4
M7>-HQ]'%7TU;4-6^+;Z?:WDR:;IT&9XD;"NV._XL!_P&FZ=6U^;2U]V2JE*]
MN76]NAT'_"$^&/\`H!6/_?D4?\(3X8_Z`5C_`-^16\3@9/2O"+OQ]K:^+CJL
M=Y<?V(+[RUB#?NV1<9&/=>?QI4(5JU^66WF.O.C1MS1W\CUG_A"?#'_0"L?^
M_(H_X0GPQ_T`K'_OR*W597174@JPR".XKS[XER:]HZ6NNZ1?W"6\+*MS;AOD
MZ\,1Z'H?PJ*3J5)J'-:_F755.G!RY;G2?\(3X8_Z`5C_`-^11_PA/AC_`*`5
MC_WY%<CX>U_5O'/C$7=I/<66B6,:&2)6QYLA&=I]><_@/>O3**OM:3Y92U]=
M@I>SJ+FC'3T,'_A"?#'_`$`K'_OR*/\`A"?#'_0"L?\`OR*WJYGQ?I&N:I%;
MMHVLG3O)#F7!/[SICIZ8/YU,)SE*SG;[RIPA&-U&_P!Q8_X0GPQ_T`K'_OR*
M/^$)\,?]`*Q_[\BO-O`A\6^*9&O!XEG2"TG02Q2.Q\P=2/R&*]=U.1XM)O)(
MV*ND#LK#J"%.#6M95*4^3GN_F9T73JQY^2R^1E_\(3X8_P"@%8_]^11_PA/A
MC_H!6/\`WY%>4^&[[7->LI;BX\>_V:R2;!'<3<L,`Y'(XYQ^%>N>&;.\LM$B
MCOM4_M.5B9%NNS*>1CD\8IUX5*6\[OYDT9PJ[0T^1#_PA/AC_H!6/_?D4?\`
M"$^&/^@%8_\`?D5R?COQ3JY\367A;0I_LT\^SS9Q]X%CP`>P`Y)'-5[8^,?"
M7BVRM+B\N];TRYV^;)Y3/Y8)P3GDJ1UZX(IJE5<4W.S:NE=B=2DI-*%TM&[(
M[3_A"?#'_0"L?^_(H_X0GPQ_T`K'_OR*W)"1$Y'4`UY?\-/%[31ZI_;^MIN6
M1!#]KG`X^;.,_A6</:SA*2D]+=^IK/V4)QBXK4[3_A"?#'_0"L?^_(H_X0GP
MQ_T`K'_OR*Y3X4:WJ6LG6/[0OIKH1/'Y?F-G:#NZ?D*TOBGJE]I/A6*XT^ZE
MMIC=(A>-L'&UN/TJW"JJWL>;7U9"G2=+VO+H;/\`PA/AC_H!6/\`WY%'_"$^
M&/\`H!6/_?D5Y[I_CG4+SX<ZS!/=RQ:WIX4B4G$C(9%&?J,D'\*],\-3RW7A
MC2[B>1I)I+6-W=CDL2HR32JPK4E>4GO;<=*5&H[1CTOL5?\`A"?#'_0"L?\`
MOR*/^$)\,?\`0"L?^_(KD/%?B'6M6\<0^$="O#8X`\ZX7[V=NX\^@'IU-0Z/
MK6O>%?'L/AK6]1;4;6["^5-)]X%L[2,\]001FK5*MRWY];7M=[$.K2YK<NE[
M7LMSM?\`A"?#'_0"L?\`OR*/^$)\,?\`0"L?^_(K3U21XM)O)(V*ND#LK#J"
M%.#7&?"?5M0UCP]>3:C=RW,J7116E;)`V*<?K6,75=-SYGIYFLE34U#EW.@_
MX0GPQ_T`K'_OR*/^$)\,?]`*Q_[\BMZO)YM7\0^./&=]I.D:H^EV%CN!DCSE
MMK;<G&"<GMG&*=+VE2_O62WU8JOLZ=O=NWY([K_A"?#'_0"L?^_(H_X0GPQ_
MT`K'_OR*Y7P+XDU>+Q1?^%-=N?M4]ON,,Y^\<8R,]P0<C/-=?XJUP>'/#5YJ
M@0.\2@1H>A<D`9]LFG-5HS4.:]]M>X0=&4'/EM;?3L1?\(3X8_Z`5C_WY%'_
M``A/AC_H!6/_`'Y%>>6=GX]U7PY_PD]OKTYG?+Q6*#AU!QP.GK@8Z5Z;X<O-
M0OM!M9]5M&M;XKB:(C'(.,X[9Z_C3JQJ4U?GOTW8J4H5';DMUV15_P"$)\,?
M]`*Q_P"_(H_X0GPQ_P!`*Q_[\BN5^(>M:GIOBOP];V5[-!#.X$J1M@/\ZCG\
M#7I%1-U8QC)R>OF5!4Y2E%1V,'_A"?#'_0"L?^_(H_X0GPQ_T`K'_OR*\KT_
M5-<UG7M6MY?&;:5';S,$\^7`8;B,#D=,5Z;X-L;^TL)I;SQ`-:29@8IE.54#
M((!R>_\`*M:U.I25W/7YF=*=.J](:?(G_P"$)\,?]`*Q_P"_(I\'A#P[;3QS
MP:-91RQL&1UB`*D="*Y3XH^*-1T5M.T^PN39K=DF6Z"Y*J"!Q^>3CGI4/A3^
MWDUZ#[#XLM-=TQEW7"RR_.@]E.6![^GK0J=5T_:.>_J#J4E4Y%';T/3****X
MCL"J^H?\@VZ_ZXO_`"-6**:=F#/!O`7CFR\*:)J%O);7$]Y-+OA2-1M/RXY.
M>.?8UV/PHT"^L;>_UC48FAEOV&Q'7!V@DEL=LD_I7HHAB4Y$2`^H44^NNMBE
M-2Y8VYM]3CI85P<>:5^78:Z+(C(ZAD8892,@CTKR7X.6T(UCQ!*(UWQ&.-&_
MNJ6?('_?(_*O7*:L:)G:BKGK@8S6,*O)3E#O8VG2YIQGVN.KQGPYX<B\3Z=X
MQL&"B<7V^W<_PR`OC\#T/UKV:FJBIG:H&>N!UHI5G332W=OP"K151IO97_$\
M>^#R7$?B36(KL.)XH%C</U4JV,?AC%=G\3-7_LGP3=A&Q-=D6R?\"^]_XZ#7
M7!$5BP503U('6AD1QAU##W&:N>(4ZRJM=M/0B%!PHNFGWU/`M;\'^*+'P7;R
M7ILSIUE^^2./_6IYA&<_+SR1GGM[5[#X,U?^V_"6G7K-NE,027_?7Y3^>,_C
M6Z5##!`(/8T*JH,*H4>@&*=;$NK#EDM;A1PRI3YHO2QYI\8]-=M+T_6H,K-9
M3;&8=0K<@_@P'YU8^$]K-/I^I^(+H9N-2N2=W^R"<X_X$6_*O0V57&&`(]"*
M%55&%``]`*7UE^P]E;Y^0?5U[;VM_D<[X[U?^Q/!NH7*MMF>/R8O7<_&1]`2
M?PKR.?P?XHC\`K+(;/\`LJ,?;_*'^M&5Y/W?[O;/:O?F17&&4,/0C-&`5VX&
M.F*='%.C&T5UN*MAE5E=OI8Y;X=:O_;'@FQD9LS6Z_9Y/JO`_P#'=I_&L+XC
M:K<:I?6?@S2FS=7C*URP_@3J`?RW'V`]:]%5%0810H]`,4>6F_?L7=_>QS41
MJQC5=1+T+E2E*DJ;?J>/^&;B;X=^/)_#U]*3IMZ08I6X&3]Q_;^Z?_K5[%36
MC1SED5B.Y&:=2K5?:M2:UZ^8Z-+V2<;Z=/(*CN/^/:7_`'#_`"J2BL38\L^"
M7_(*U;_KNG_H)KT;5_\`D"W_`/U[R?\`H)JVJ(GW%5<^@Q3B,C!K:M5]I5=2
MQC2I>SIJG<^;O#%]X0M;&9/$.F75U<F7,;PL0`F!Q]X=\U[MX3U:PUGP[;3Z
M9#+#9Q#R(TE^\`@`'<UK_9X?^>,?_?(IZJJ#"J%'H!BM<1B56Z._K^AGA\.Z
M/5?<>2^/;2Z\/?$#3_%B6TDUEE#,4&=I4;2#Z97&,UHP?$+4?$GBFRL?#-H?
ML.0;J6YB^Z,_,>#Q@?F:])(#`@@$'J#38X8H5VQ1HB^BJ`*7UB+@E*-VE9?\
M,'U>2DW&5DW=A+_J7_W37BGPQ\*Z-XCCU9]4M//:&5!&?,9<`[L]"/05[=35
MC1,[$5<]<#%12KNG"48[NVOH74H*I.,I;*YY3\%0%_MU1T#Q`?\`C]:WQD_Y
M$V'_`*_$_P#06KT!8T3.Q%7/7`Q2LBN,,H8>A&:N6)O7]M8F.'M0]C<\2^*'
MAE]/:'7K$%;>\C6*Z5.`'P,$^S8_,>]>K>$_^10T?_KSB_\`016NRJR[64$>
MA%`````P!V%34Q#J4XP?0=/#JG4<UU/)/$YG\'?%*+Q--;RRZ;<KAWC&=OR;
M"/KP#[U#:SOX_P#BG9:M86TR:;8!"9I%Q]PEAGMDL<8].:]A=%=2KJ&4]01D
M4D<:1($C144=`HP*T6+M'X?>M:_EZ$/"^]O[M[V\RIK'_($O_P#KVD_]!->,
M?#WQ[I?A31[FSOH+J226X,JF%5(QM`[D>E>Z$9&#4?V>'_GC'_WR*SI5HP@X
M2C=/SL75HRE-3B[->17TK48=7TJVU"!76*XC$B!Q@@'UKR6SOS\-_B!JS:K;
MSM87VYHI8USD%MP(]<9(->R@!0```!V%-DBCF7;+&CKZ,,BE2K*#DFKICJTG
M/E:=FCRGP';W/B'X@ZEXL^S20V)WB$N,;B0%`]\*.?>NT\?:-/KO@V]L[5-]
MP`LL:#^(J0<?4C-=(JA5"J``.@%+3GB'*HII6M:WR"%!1IN#=[WO\SY[N=7T
M_5/"6GZ/<P:FFMZ>'AMX8%`20L>-P(SQCH/_`-7I_P`*MX\"6PDW;A-*#NZC
MYC79>3%YOF^4GF=-^T9_.G*H484`#V%:5L4JD.11MK?<SHX9TY\[=]+;'E/Q
M1_Y'3PO_`-=!_P"C%KU>FM&C$%D4D="1TIU8U*O/",;;&T*7+.4K[GSE877A
MNU\1ZR?$=C<7<;3OY(A8C:=[9S\P]J]A\`ZUHFIZ/):Z%:W%M:6;[=DW7+$M
MP<GOFNH,$).3$F?]T4Y41,[$5<^@Q6U?$JK&UG]^GW&-##.E*]U]VOWG`?$G
M58+-[*WU7P\+_2'.Y[H.0T39P0N,8.,'KS^%<!IUI87GCS2V\%)J"Q)(CS-,
M.(QN^;G^[MXYZ]*]_90RE6`(/4$4V*&*%=L4:1CT50**6+5.'*E^.GW"JX5U
M)\S?X:_>/HHHKC.P****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
<B@`HHHH`****`"BBB@`HHHH`****`"BBB@#_V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>g2014031017064506336.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g2014031017064506336.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+#`Q-#0T'R<Y/3@R/"XS-#+_
MVP!#`0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P``1"``V`)X#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#W^H+N]M;"
M`S7<\<,8_B=L5G>)-?A\/:4UU(N^5CLACS]]O\.]>-W^JWNL79N;Z=I9#T'\
M*#T4=A7'B<6J.BU9ZV795/%KGD[1_/T/3+SXB:7"2MI#-=$=P-BG\3S^E9DO
MQ#O)#B"QBC'JSDFN$B%7HEKQJV8UWL['N+*<)37PW]6=1_PFVKL20(@/3:/\
M*GA\<:C&1YT$4J]^<&L[1=*34FN`TOE^3$9.!G=[54>'`Z5R2QV*@E-R=GM\
MC)X;"2DX<BT.[TKQA8:C,L$H:VG;A0Y^5CZ`UT5>+3+BO3_"M_)J'A^WDF):
M5,QLQ_BP<9_+%>UEN/E7;A4W/*S+`0H156GMV-JBBBO6/'"BBB@`HHHH`***
M*`"BBB@`HHHH`\K^*%P[:W9VQ/R1V^\#W9B#_P"@BLPV5CHNB:?=W5H+VYOP
M717<K'&@^G))K=^*6GOYMCJ*KE-I@<^ASE?ZU2TR"6^\%Q-=V$FI117!2V2W
M.)(1_%D^GM7C5H-UIKKT/L<-42P-%IZ7L];/KUTZZ[H;<6VD-X<BU>WL98VD
MD,#)Y^5C?L1QR*MWUK9:"+:&33OM?FQ*[7#R%0Q/4+CTK%U2\NFM+;3QIDFG
MV,392)@27<]RQZFM72]0UBS:/3;S3Y;NU+!3!+$25!_NFN2?*Y-6MMK;KZ>8
MYPJ*"E>ZNW;FUMTUOT^XTO#3PO>ZDT",D7V9BJL<D?C5=K>"RLA-J`8SRK^Y
MMU."!_>;T'M6CIMK#IOB+5X;)\QQ6A8<YV'T_"LZ<+XELS>VP`U.%?\`2(0?
M]:H_B6LIX?\`=I-7DN:RZ;ZV[^2_X8XU*]5RVB^77KMI?]6<_,P.:]*\&V[0
M>&K<MP92TGX$\?IBO.=.L9=5U2&QC!#.WSDC[JCJ:]BBB2"%(HQA$4*H]`*Z
MLGH-2=1^AGG551A&DMWJ/HHHKWSYT****`"BBB@`HHHH`****`"BBB@"IJFG
MV^J:=-9W4?F12+@@=<]B/>O)8M)OK*XE70]>C4;L/%)-Y$B$=F!XS[U[+7$^
M-/!7]KDZCIRJ+X#YXSP)@/\`V:N/%T7)<\5JOO/8RK%JE)TJDK1EWU5_-?J<
MU)J-]::3?P:WJD5ZT\>R"W602LKY^_N[`5D1:_JT<(A74[H1@8V^8<8K'DBD
MMIVAFC:*5#AD<8(I5>O&J3D]G8^LAA*:3ND[Z[*WR1IQ7LT)<QS.A<8<JW+#
MWHBNI89E>!W24'Y2AP<^U48M\TJQ1(TDCG"H@R2?85Z=X0\&&P9-1U-0;KK'
M#U$?N?5OY5-#"SK2M'_ACGQN(HX6#E/=].YI^%-$ETZU:\OB6U"Y&9"W)1>R
M_P"-/@DN+^VDU&;47M8`[!$0#"JIQ\V>IXKH*R9]`AE,RI<W$,,QW20HPVL>
M_!''X5]'3IJG%1B?$UJTJTW.6[(!JTEM%=/(R/BZ:-!(^W"[0>..?_KT[_A(
M<K;%+1V^U(#!SU;."I],=:FDT*)I?-2XFCD\QI`RXXW``CD>U-'AVUV1+YLQ
M,*!8FW<Q\YR/<U6IEH(-;=G5A:D6SRF!)BW\?3D>F>*H6VJ3V27$M])<M>1I
MN:V<`(PW8RA].:TUT.%9@WG3&)9/-$)8;0_KZ^^.E-;08YBS7-W<3L5V*7(^
M49!XP/84:AH02:_/!Y_FV!7[.%>7$@.%;ICU--DU2[2Y5+6(RJ]XT3>8X[+G
M`]!W_"K]QI$%S]KWLX^U(J/@]`O3%(^CQ,OR32QN)_M`=2,AL8_+%/4-"A8:
MO=!B+B$O$]VT`EW#*DG@8]!TJO8:I>W\5R?/""T60OP-TAR=OT`Q6RFDP)$L
M8=\+<?:,D_Q9S^50C0;95C"/(C*'4L",LK$D@^HYI68710M]:DBA5F22>9E@
M7!<`%F!Y'I5B3Q#Y0\J2W"70E,91G^48&<[L=*G30;9-G[R4E3&<DC^#IVIT
M^B032O,LLL<QD\P2*1E3C&.1T^M&H:%G3KU=1L(KI4*!\_*>V"1_2K51V\1@
M@6,R-(5_B;J:DJA!1110!FZIH.F:RN+ZSCE(Z.1AA]#UK!/PUT`ON`N@O]WS
MC1164J-.;O**.FEC,127+3FTO4W-*\.Z5HHS8VB(YZR'YF/XGFM2BBM(Q45:
I*L8SJ3J2YIN[\PHHHID!1110`4444`%%%%`!1110`4444`%%%%`'_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>g2014031017063188233.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g2014031017063188233.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+#`Q-#0T'R<Y/3@R/"XS-#+_
MVP!#`0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P``1"`$9`Z<#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#W^BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`**9+-%"`994C!Z%V`S6?+XAT:#[^IVO7&%E#'
M]*`-.BL%_&?A]&*G41D>D3D?F%JM_P`)]H?_`#TG_P"_1H"YT]%<G)\0]&1L
M+%>2#^\L:X_5A3/^%C:1_P`^U]_WPG_Q5`7.OHKD/^%C:1_S[7W_`'PG_P`5
M4D7Q"T:0D,EW'CNT8Y_(F@+G5T5S<?CO07;#7$D8QU:)L?IFKL'BC0[C&S4X
M!G_GH=G_`*%B@#7HIJ2)*@>-U=3T93D&G4`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`'G_B'QOJ-EJES8VD4$:Q-M\Q@68_T_2N6N?$>LW>?-U*XP<Y
M"/L!S[+@5U6J^!]1U37+N[$UO%!+(2NYB6QCT`_K3(?AK*2?.U-%';9$6S^9
M&*9.IPKNTC%G8LQZDG)-)79Z]X%&F:9+>VUXTHB`+QNH!(SU!_I7&4P"BBB@
M04^*&68D11/(1U"J3BO0/`&EV%SI4UU<6D,LZW!17D4-@!5(QGIR>M=RB+&@
M5%"J.@`P!2N.QX7]AO/^?6?_`+]FHY8)H,>;$\>>F]2,U[S2,H=2K`%2,$$<
M$47'8\#HKV:^\,:-J`/G6,2N>=\0V-^G7\:X_5_A[<0`RZ7-]H0?\LI"`_X'
MH?THN*QQ]M>7-G)YEM<2POZQN5/Z5T^F?$#4K3"7J)>1CN?D?\QQ^8_&N4DB
MDAE:.5&213AE88(/H13:8'LVC^)--UL;;:7;/C)ADX8?X_A6O7@:.T;JZ,59
M3D,#@@^M=[X9\<G*6>L2<=$N3_)O\?S]:5AIG?T4`@@$'(/0BBD,****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`R/%/_(KZA_UR/\Z\9KV;Q3_R*^H?]<C_`#KQ
MFFB6%%%%,1Z=\.?^1>N/^OIO_0$KKZY#X<_\B]<?]?3?^@)77U):"BBB@`HH
MHH`P_$7AFUUVW+86*\4?NYL?HWJ/Y5Y+>6=QI]W):W49CFC.&4_S^E>[5ROC
M7P^NI:<U[`G^EVRD\=73N/?'4?CZTT)H\LHHHIDG:^#?%C6LD>F7\G^C-Q%*
MQ_U9]"?3^7TZ>D5X%7J/@CQ`VIV365R^ZZMQP3U=.F3[@\?E2929UE%%%(84
M5YGK_B[6K37;RWMKORH8I"BKY2'@?4&L]/&_B!6!-\&`_A,*8/Y"G85SURBO
M*D\?ZXA4LUNX'4-%U_(BK*?$;5`X,EK9LO<*K`_GN-%@N>F45YS_`,+)O/\`
MH'P?]]FD;XD7I4[;"W#8X)9B,T6"YZ/17GVC>-]3U+7+.UFCMDBD?:PC0@G(
M]237H-(84444`%%<9XT\0:EHU_:+93A$>,LRE%8,<^XS7.?\)]KG_/2#_OT*
M=A7/5J*\S3XC:H'!DM;-E[A58'\]QHD^(^J%OW=I9JOHP8G\]PHL%STRBN2\
M)>)K[7KRYCND@18HPP$2D<Y]R:ZVD,**\OO/'&N6][/#NA7RY&3!BY&#BH3X
M]UT@CS81[^4*=A7/5J*\H3QYKJJ`9H6(_B,0R?RI)/'>O.N%N(HS_>6)<_KF
MBP7/6**\IL_'>M07<<ES.+B$'YXC&BY'U`R#7I6FZG::M:+<V<H=#P1W4^A'
M8T@N7****!A1110`4444`%%>5O\`$#6W<LIMD!_A6/@?F33'\>:ZRD":%2?X
MA$,C\Z=A7/5Z*\A_X37Q#_T$/_(,?_Q-12>+=>E?<VI2@_[(51^0%%@N>QT5
MY#9>)=<FO[>,ZA.X:105]1FO7J07"BBB@84444`%%%%`!17B_B34O[5UZZN5
M;,>[9'Z;1P,?7K^-+X:U0Z3KMO<%ML3'RY?38>N?IP?PIV%<]GHHHI#"BBB@
M`HK@?B!J%[97UFMK>7$"M$21%*R@G/L:Y:+Q1KD(4+J=P=IR-[;OSSG-.PKG
ML]%>0_\`":^(?^@A_P"08_\`XFK`\>ZZ`!YL)]_*%%@N>K45Y0_CS764@30J
M3_$(AD?G59_&7B"1"K:BP!_NQHI_,"BP7/8**\4D\0ZS(VYM4O`?]F9E'Y`U
MZ%X"N[F\T*>2ZN)9W%RRAI7+$#:O&3]:+!<ZFBBN*^($M]!_9TUF]Q'L\W>\
M)8;?N]2/Q_6D,[6BO%HO$FM1`A=4NCG^](6_G5I?&GB!5"C4#@#',2$_GMIV
M%<]?HKR'_A-?$/\`T$/_`"#'_P#$U#-XLUV?._4I1D8^0!/_`$$#\Z+!<]DH
MKS#P?<:M?^([66:>]N+:+?O=W9T7*'&2>!SBO3Z0PHHHH`***\[^(VI"2YMM
M-0\1#S9.>,G@#Z@9_P"^J`/1**\$C=HI%D1BKJ0RL.H(KVS1=175='MKT?>D
M3YQZ,.&'Y@T"3+]%%%`PHHHH`****`"BF3>9Y,GE8\S:=N>F>U>2?\)KXA_Z
M"'_D&/\`^)H%<]>HKR(>-O$((/V_/MY,?_Q-7(_B'K*+AHK.0_WFC;/Z,*=@
MN>HT5YPOQ(O0HW6%N6QR0S`9J.7XCZD2/*L[11WW!F_J*+!<]+HKRN7X@:W(
M<K]FBXQA(_UY)K8\&>(-6U?6I(+V\\R)(&DV^6@R<J.H`/>BP7.\HHK@O%'B
M[4=+UV6SLY(O+C5<AH\D$C/7\12&=[17E/\`PGVN?\](/^_0H_X3[7/^>D'_
M`'Z%.PKGJU%>8#XBZP`!]GLC[E&_^*J.7X@ZU(056UCQV6,\_F318+GJ=%>?
M^$/$NK:GKJVUY=>;"8V.WRU7D>X`KT"D,****`"BBB@`HHHH`****`"BBB@#
M(\4_\BOJ'_7(_P`Z\9KV;Q3_`,BOJ'_7(_SKQFFB6%%%%,1Z=\.?^1>N/^OI
MO_0$KKZXOX;R$Z3=Q8&U9]P]<E1_@*[2I+04444`%%%%`!1110!XYXJTI=(U
MZ:",8AD_>Q#T4]OP((_"L6O1OB/9;[&TOE',<AC8CT89'ZC]:\YIDL*N:5J$
MFE:G!>Q=8FR1_>'<?B*IT4Q'O4,R7$$<T;;HY%#J?4$9%/KE_`5_]K\.B!C\
M]LYC_P"`GD?S(_"NHJ2R&XL[6[7;<VT,P])$#?SKA/%W@Z&WMFU'2XMB1C,T
M(R0!_>'T[BO0:"`001D'J#0!X%170^+]"_L75=T*XM+C+Q8Z*>Z_A_(USU40
M%>CZ9X$T>YM(;HW5S<)*H=<$("".XP3G\:\XKNO`&N^5*VD7#`(Y+P,3T;NO
MX]?S]:3&CK;#PSH^FR)+;62"5>DCDL0?7D\?A6M112*"BBB@"K>:;9:@`+RT
MAGP,`R("1]#VKF/$/A?0++1;N\6W,$B(61DD;ES]T8)(QDBNQKS/Q[K9N[\:
M9"W[FV.9,'AG_P#K?U-`F<>B-(ZHBEF8X"@9)/I7H&B_#Z(P1SZM(YD89,$9
MP%]B>_X8IG@'0/\`F,W*>JVZG\BW]!^/M7?TVP2*.GZ-I^E;OL-JD)8`,1DD
MCZGFKU%%(9FW>@:3?%FN-/MV=R2SA-K$GN2.:Y[5?A[931.^FR/;R@?+&[;D
M/MSR/KDUV=%`'A-Y9W&GW<EK=1F.:,X93_/Z5!7H'Q)M$V6-X%P^6B8XZCJ.
M?;G\Z\_JB0K2T76KK0[X7%N<J>)(R?E<>A_H:S:*!'M^E:K:ZS8K=6KY4\,I
M^\A]#5ZO%-%UJZT.^%Q;G*GB2,GY7'H?Z&O7=*U6UUFQ6ZM7RIX93]Y#Z&I*
M3+U%%%`PHHHH`R;OPSHMZQ:?3H=QZE`4)_[YQ7,Z]X#LX-/GO-/EE1X4,AB<
M[@P`R0#U!_.N\JO?_P#(/N?^N3?R-`K'A5>@^&_`UM):0WVIGS?-0.D"D@`$
M9&3US[?SKSZO;M$8MH&G,Q)8VL1))Y)VBFQ(EL]-LK`8M+2&#(P2B`$_4]ZM
M444B@HHHH`****`"L7Q7J1TOP]<RH<2R#RH^<<MQD>X&3^%;5>;?$34?.U*#
M3T(VVZ;WP?XF['Z`#\Z!,XNBBBJ)/7_!^J#4_#T&YLS0#R9,]>.A_$8Y]<UO
M5Y;X"U3[%K9M'/[J[&WKT<<C^H_$5ZE4E(****!D-Q:6UVFRYMXIE_NR(&'Z
MUC:AX.T6^B8+:+;R'.V2'Y<'Z=/TK?HH`\-U+3YM*U":RN`/,C.,CH1V(JI7
MH?Q$T@R0PZM$.8\13?[I/RG\SC\17GE,EA75^#/#5KK;3W%ZS-#"P41*<;B?
M4^GTKE*ZOP#J7V/73:N<1W:;?^!#D?U'XT`CT2#1M,MAB'3[5.,9$2Y/U/>K
MU%%(H****`*UQI]E=AOM%I!+NZ[XP<_G7F?C70K/1KRW:R^1)U8F(MG:01R.
M^#G]#7JM>2^-]0^W>))45LQVP$*\\9'+?J2/PIH3,"""6YN(X(4+RR,%11W)
MKT_2/`NFV*))>+]KN!@G?]P'V7N/K7/_``]TK[1J,NI2#]W;C8GNY']!_,5Z
M50P2&QQI%&J1HJ(HP%48`%.HHI#"BBB@!LDB11M([!44%F8]`!7B&JW[ZGJE
MS>OG,KE@#V'0#\!@5Z9XXU+[!X>>)&Q+='RACKM_B_3C\:\GIHEA7=_#K5-D
MMQIDC</^]BR>XX8?E@_@:X2K>F7TFF:G;WL>=T+AB!W'<?B,C\:8'N5%,AF2
MX@CFC;='(H=3Z@C(I]24%%%%`!1110`5DS^&-$N,[],MQD8_=KL_]!Q6M10!
MY_K_`(!2&WDNM)=R4&YK=SG([[3_`$/Y]JX*O?:\O\;^'O[.O/[0MU_T6X;Y
M@!_JW]/H>3^?M30FCDJ***9)Z3X:\,>'[_1[:\,+7$C*/,WR'Y7'WA@8XSZ]
ML5U5GIECI^?LEI!`2,$QH`2/<]37F?@O7_[)U+[/.^+2Y(#9Z(W9OZ'_`.M7
MJU)E(*R]0\.Z3JLXGO;,22@8W;V4X_`BM2BD,Y:^\$^'UM99?*DMEC0LSI*3
M@`9S\V:\KKT#Q]KX"?V/;L"3AK@@].X7^OY5Q6FZ=/JM_%9VRYDD.,GHH[D^
MPIHEEK0M`N]>NS%!\D:<R3,/E3_$^U=]:_#_`$:``S^?<GOO?:/_`!W'\ZV]
M(TFVT;3X[2W4<#+OCEV[DU?HN.Q2LM'T[3B&M+*"%\8WJ@W8]-W6KM%%(844
M44`%%%%`!1110`4444`%%%%`&1XI_P"17U#_`*Y'^=>,U[-XI_Y%?4/^N1_G
M7C--$L****8CT;X;?\@^^_ZZK_*NWKB_AO&PTJ\D/W6G"CZA1G^8KM*EE(**
M**!A1110`4444`8/C.W%QX5O.FZ,+("3TPPS^F:\@KVOQ`BR>'=25AD"VD;\
M0I(_45XI31+"BBBF([7X;W)35+RVSQ)"'_%3C_V8UZ17DW@641^*K=2,^8CJ
M/;Y2?Z5ZS292"BBBD,S==TB+6]*ELY,!C\T;G^%QT/\`3\:\8G@EMKB2"9"D
ML;%74]B*]YKAO'OA_P`Z/^V+9,R(`+A0.J]F_#H?;'I30FCSNE1VC=71BK*<
MA@<$'UI**9)[#X6UY==TL.YQ=0X6=??LWT./YUN5XOX>UE]#U:.Z`W1'Y)5]
M5/7\1UKV6&:.X@2:%P\;J&5AT(-2RD/HHJ.>>*VMY)YG"11J6=CV`H&97B;7
M%T/2FE!!N9,I"I&?F]?H*\QT#1Y=>U=8"6\O.^:0\X7OSZFEUW5Y_$.L&54;
M:2(X(NX&>/Q->F^&=#70]*6(@&YDP\S`Y^;T^@IBW-:&&.W@2&%`D:*%51T`
M%/HHI#"BBB@`HHHH`Y#XC?\`(O6__7TO_H#UP.C:3+K5\;2&14D\MG7=T)';
MVKOOB-_R+UO_`-?2_P#H#UR7@AV3Q;:*IP'$BM[C83_,"F2]S#N;::TN)+>X
MC:.6,X96Z@U%7L/B+PU;:];$X6*\4?NYL?HWJ/Y5Y/?Z?=:9=M:WD1BE7G![
MCU![B@&BM6EHNM76AWPN+<Y4\21D_*X]#_0UFT4Q'M^E:K:ZS8K=6KY4\,I^
M\A]#5ZO%-%UJZT.^%Q;G*GB2,GY7'H?Z&O7=*U6UUFQ6ZM7RIX93]Y#Z&I*3
M+U%%%`PHHHH`\$D1HI&C<8925(]"*]KT+_D7M-_Z]8O_`$`5X[JD9AU:]B8@
MLD[J<=,AC7L.@L&\.Z:5((^RQC@]PHILE&C1112*"BBB@`HHHH`CGFCMK>6>
M4XCB0NQ]`!DUX=?7<E_?3W<OWYG+D>F>U>E>/M2^QZ$MJIQ)=OM_X".3_0?C
M7G.E6#ZGJEM9)G,KA21V'4G\!DTT)E1E*G#`@X!Y'8TE=M\0-'6UGMM0@C5(
MG40N%'1E'R_^.C'_``&N)IB'Q2R03)-$Q22-@RL.H(Y!KV[2K]=3TNVO4QB5
M`2!V/0C\#FO#J[_X=:IQ<:7(W_3:+)^@8?R/YTF".^HHHI%!1110!!>6L=]9
M3VLH_=S(4/MD=:\0O;22PO9K2;_61.4..^.]>[5YQ\1-+,-]#J2+\DX\N0C^
M^.F?J/\`T&FA,XFI()I+:XBGB.V2)PZGT(.14=%,D]TT^]CU'3[>\B^Y,@<#
M.<>H_#I5FN'^'>J&6UGTN1LM%^]B'^R3R/S.?^!5W%26%%%%`%>^NEL;"XNG
M(VPQL_/?`Z5X9)(\TKRR-N=V+,?4GK7IGQ!U(6VCQV*-^\NF^8?["\_SQ^M<
M;X2TW^T_$5O&PS'%^^D^B_\`U\"FA,],\.:9_9.A6UJ1B7;OE_WSR?RZ?A6K
M112&%%%%`!11574;V/3M.N+R3[L*%L>I[#\3@4`>:>.]2^VZ^;=&)BM%\L#M
MN/+'^0_"N7P<9QQZT^662>9YI6+R2,69CU)/)-=]/X8_XM]$JQ@WD8^U\#DY
MY(_[YP/JHID[GGU%%%,1Z?\`#_5!=:,UB[9EM6X![H>1^N1^5==7COA35?[)
MUZ"5SB&7]U+[`]_P.#7L5)E(****0PHHHH`****`"H+RTAO[.6UN%W12KM85
M/10!XGK>DRZ+JDMG(2P7YHW(QO4]#_3Z@UG5ZSXQ\/G6M-$L"YO+?+1C^^.Z
M_P!1[_6O)B""01@CJ*9+"O2O`_B/[;;C2[I_](B7]RQ_C0=OJ/U'TKS6I;:X
MEM+F.X@<I+&P96'8B@#WBLCQ'KD>A:6TYPT[_+#&3]YO7Z#K_P#KI-)\0VFH
M:%_:4LB0B,8N`>B,.OY]OJ.]>8^(]<DUW5&G.5@3Y88R?NKZ_4]?_P!5`VS-
M=YKRZ9W+RSRODGJ68FO6/"GAU=#L-TRJ;V89E8<[1V4'^?O6)X&\->6BZO>1
M_.PS;HPZ#^_^/;\_2N[H8)!1112&%%%%`!1110`4444`%%%%`!1110`4444`
M9'BG_D5]0_ZY'^=>,U[-XI_Y%?4/^N1_G7C--$L****8CT[X<_\`(O7'_7TW
M_H"5U]<?\.74Z#<H#\PN22/8JN/Y&NPJ2T%%%%`!1110`4444`9^N_\`(O:E
M_P!>LO\`Z`:\2KV?Q/-Y'AG47W`9A*9/^UQ_6O&*:)84444Q'0>"03XNLL#I
MYF?^^&KUVO+/A]&7\2E@1B.!V.?3(']:]3I,I!1112&%(Z+(C(ZAD8892,@C
MTI:*`/&_$VAOH>JM$`3;29>%B<_+Z'W%8U>S^(=%CUS2GMC@3+\T3_W6_P`#
MTKQN:&2WG>&9"DB,593U!%-$L97H/P_UW<K:/._*Y>W)/4=2O\S^=>?5)!/+
M;7$<\+E)8V#(P[$4P/>:\U\<^(OMEP=+M7S;Q-^]8'[[CM]!_/Z5?U3QRDGA
MN(VC;-0G!1PO_+''4_CV_P#K5S7A70#KFIA9`PM(OFF8=_1?Q_QI#;.A\!^'
M>FL72^UNI_5C_3\?:N_I$18T5$4*BC"J!@`>E+2&%%%%`!1110`4444`<M\0
M$5_#.YADI.C+['D?R)KBO!7_`"-UC_VT_P#1;5V_C[_D6'_ZZI_.N(\%?\C=
M8_\`;3_T6U,3W/7JR=>T"UUZS\J;Y)5YBF`R4/\`4>U:U%(9XAJNE76CWS6M
MTF&'*L/NN/451KVO6M%M=<L3;W`PPYCE`^9#ZC^HKR+5=*NM'OFM;I,,.58?
M=<>HIDM%&M+1=:NM#OA<6YRIXDC)^5QZ'^AK-HIB/;]*U6UUFQ6ZM7RIX93]
MY#Z&KU>*:+K5UH=\+BW.5/$D9/RN/0_T->NZ5JMKK-BMU:OE3PRG[R'T-24F
M7J***!GB6N_\C#J7_7U+_P"AFO5?"C!O"^GE2"/*QP>X)KRWQ#&8O$>I*Q&3
M<.W'H23_`%KTOP5_R*-C_P!M/_1C4V2C?HHHI%!1110`4451UC4!I>D75Z1D
MQ)E1ZL>!^I%`'F?C;4O[0\12QJ?W=M^Y7ZC[WZY'X5K?#G3?,NKG4G7Y8QY4
M9/\`>/)_3'YUP[,68LQ)8G))/)->S>&]-_LK0;6V9<2[=\GKN/)S].GX4R42
M:]IO]K:)=68`,CIF//9QR/IR,?C7BA!!((P1U%>^UY%XSTW^SO$4Y12(;C]\
MGX_>_7/Z4(;.?JYI5^^EZK;7J=8GR1ZCH1^()JG13)/>XI$FB26-MR.H93Z@
M]*=7+>`]3^W:"+9VS+:-L_X">5_J/PKJ:DL****`"LOQ%I@U?0[FU'^LV[XS
MCHXY'Y]/QK4HH`\"(()!&".HHKH/&6E?V9K\I10(;C]ZF.V>H_//Z5S]407]
M%U)])U>WO$/"-\X_O*>"/RKVR.1)8UD1@R,`RL.A!KP2O4O`>J_;M%-I(?WM
MH=@]T/W?ZC\!292.KHHK/UO41I6C75X3AHT.SC/S'A?U(I#/,?&.HG4?$=QA
MLQ0?N4Q[=?US76_#W3?L^DRWSKA[E\+D?P+_`(G/Y"O.;6WDO;V&WCYDFD"#
M/J3BO<;.UCLK.&UA&(XD"+^`IL2)J***0PHHHH`*XCXBZEY5E;Z<A^:9O,D_
MW1T'XG_T&NWKQGQ/J7]J>(+J=3F)6\N/_=7C/X\G\::$QGAS3O[5UZUMB`8]
M^^3(XVKR1^.,?C7M)`(((R#U!KA?ASIVRWNM2<#,A\F/CD`<G\SC\J[JA@CQ
M7Q!IO]DZY<V@'[L-NC_W3R/\/PK,KT3XC:;YEK;:DB_-&?*D(_NGD?KG\Z\[
MH$PKV/PIJ?\`:OAZWE8YEC'DR?[R]_Q&#^->.5V'P]U/[-JTM@[?)=+E?]]>
M?U&?R%#!'IM%%%(H****`"BBB@`HHHH`*\V\=>'OLEQ_:MJF()3B90,!']?H
M?Y_6O2:CG@BN;>2"9`\4BE74]P:`/!J*U_$FB2:%JKP?,;=_GA<]U]/J.GZ]
MZR*H@>LTJ121+(RQR8WJ#PV.F:Z3P?X;.L7GVFY7_086^8$?ZQO[H]O7_P"O
M7,5V/@;Q#]BNAIET_P#H\S?NB3]QSV^A_G2&CTP````8`Z`4444B@HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`R/%/\`R*^H?]<C_.O&:]F\4_\`(KZA
M_P!<C_.O&::)84444Q'HWPV_Y!]]_P!=5_E7;UQ_PY4#0+AL#<;I@3CG&U?\
M3785+*04444#"BBB@`HHHH`Y?Q]<^1X9:+O/*B?E\W_LM>55V_Q'OA)?6EBI
M_P!4AD?ZMP/T'ZUQ%-$L****8CO_`(;6AVW]X<[25B7TSU/\UKOJR/#.FG2M
M`MK=UVRE?,E!Z[FYP?IP/PK7J2T%%%%`!1110`5Q/CSP\MQ;'5[9`)HA^_`_
MC7IGZC^7TKMJ;)&DL;1NH9&!5E/0@T`>"45)<1"&YEB!R$<J#ZX-1U1`5[/X
M<TR'2]$MX8@-SH))&_O,1R?Z5XQ7NMA_R#[;_KDO\A28T6****104444`%%%
M%`!1110!RWQ`=4\,[6."\Z*ON>3_`"!K@O"W_(SZ?_UU'\J[?XC?\B];_P#7
MTO\`Z`]<1X6_Y&?3_P#KJ/Y4T2]SV:BBBD4%9NM:+:ZY8FWN!AAS'*!\R'U'
M]16E10!XAJNE76CWS6MTF&'*L/NN/451KVO6M%M=<L3;W`PPYCE`^9#ZC^HK
MR+5=*NM'OFM;I,,.58?=<>HIDM%&M+1=:NM#OA<6YRIXDC)^5QZ'^AK-HIB/
M;]*U6UUFQ6ZM7RIX93]Y#Z&KU>*:+K5UH=\+BW.5/$D9/RN/0_T->NZ5JMKK
M-BMU:OE3PRG[R'T-24F>5>+HS%XJOU8@DN&X]"H/]:]"\$.K^$[15.2AD5O8
M[R?Y$5P7C7_D;K[_`+9_^BUKM_`/_(L)_P!=7_G3!;G3T444AA1110`5P7Q&
MU+"6NFHW4^=(!^2C^?Y"N])`!).`.I->*:_J)U77+J[SE&?$?^X.!^@S^--"
M97TV6V@U*VFO%=[>.0,ZH`2P'.,&O2D\?Z(R@DW"D_PF+D?D:\\M=!U6^MUN
M+:QFEA;.UU'!QQ4W_"+:Y_T#)_R%`CO_`/A/M#_YZ3_]^C7->,==TG7+2W:U
M>3[3"YQNC(!4]?Y"L7_A%M<_Z!D_Y"C_`(1;7/\`H&3_`)"@-3(HJ2>"6VG>
M">-HY4.UE88(-1TQ'2^!]2-AXACB8XBNAY39/?JI^N>/QKUBO`T=HW5U.&4Y
M!]#7MNC:BNK:1;7J]9$^8>C#@C\P:3*1?HHHI#"BBB@#FO&^E?VCH331INGM
M3YBXZ[?XA^7/X5Y/7OC*'4JP!4C!!'!%>+>(-+.D:U<6@!$8;=$3W0\C_#\*
M:$S,K;\*:K_9.O02N<0R_NI?8'O^!P:Q**9)[[7!_$?4=L5KIJ$Y8^<_/;D*
M/SS^0K?\)ZL-4\/PR2-F6']U*6]0.OXC!_.O,O$&I?VMKES=@_NRVV/_`'1P
M/\?QI(IF[\/M-^TZO)?.I,=LGRGMO;C\>,_I7IM87A#3?[-\.VZLN)9AYTGX
M]!^6*W:0(****!A1110!C^*=2_LOP_<S*P65QY47^\W''T&3^%>-5VWQ$U+S
M;^#3D8%8%\R0#^\>@/X<_P#`JY2QTR]U)G6SMGF*`%M@Z4T2SN]%\9Z)I^E6
M]EMN8_)C"DF(89NI(P3WR?QK0_X3[0_^>D__`'Z-<!_PBVN?]`R?\A1_PBVN
M?]`R?\A0%V=EJ_B_0=3TFZLR\V98R%S%T;J#^>*\VK7_`.$6US_H&3_D*IWV
MF7NFLBWEL\)<$KO'6@"I4UI=265Y#=0G$D3AU_`U#13$>[VES'>6<-S$<QRH
M'7Z$9J:N.^'NJ?:=*DL';]Y;-E/]QN?YY_,5V-26%%%%`!1110`4444`%%%9
M/B'7(M"TUKAL-,WRPQG^)O\``=__`*]`'-_$/4;,VT6G[%DNPPD#`_ZH?_7]
M/Q]*\\JTQN]6U'/SSW5P_P"+$_Y_"NPUKP,+30(I[0F2\@7,X!SY@[X^G\O>
MF3N<+1113$>K^#?$/]L6'V>X;-Y;@!B?XUZ!OKZ__7KIJ\,TW4)]+U"&\MSB
M2)LX/1AW!]B*]ITW4(-4T^&\MSF.5<X/53W!]P:3*3+5%%%(84444`%%%%`!
M1110`4444`%%%%`!1110!D>*?^17U#_KD?YUXS7LGBQU3PMJ!8X'EX_$D`5X
MW31+"BBBF(]+^'$H.C746.5N-V?JH']*[*O,?A]J26NL2V<AP+M`%/\`M+D@
M?D37IU2RD%%%%`PHHHH`*CN)X[6VDN)FVQQJ78^@%2$@`DG`'4FO-O&?BI+_
M`/XEVGR[K8<RR+T<^@]J`.7U6_?5-5N;U^LKY`]!T`_``53HHJB`KI?!>BG5
M-96>1<VUJ1(^?XF_A'YC/T%8NF:=<:K?Q6ELFYW/)[*.['V%>R:1I<&C:;%9
MP<A>68]78]328TB]1112*"BBB@`HHHH`****`/"K[_D(7/\`UU;^9JO5B^_Y
M"%S_`-=6_F:KU1`5[XB+&BHHPJC`'H*\#KWVDRD%%%%(84444`%%%%`!1110
M!R'Q&_Y%ZW_Z^E_]`>N(\+D#Q/I^3C]\*[?XC?\`(O6__7TO_H#UP.A?\C#I
MO_7U%_Z&*:)>Y[;1112*"BBB@`K-UK1;77+$V]P,,.8Y0/F0^H_J*TJ*`/$-
M5TJZT>^:UNDPPY5A]UQZBJ->UZUHMKKEB;>X&&',<H'S(?4?U%>1:KI5UH]\
MUK=)AARK#[KCU%,EHHUI:+K5UH=\+BW.5/$D9/RN/0_T-9M%,1K^)KZWU/6Y
M+ZV9BDZ(Q5A@J0H!'Z5WGP_D5_#6T=4G=3]>#_45Y97IWPY_Y%ZX_P"OIO\`
MT!*3&CKZ***104444`8/C'4O[-\.SE6*S3_N8\>_7],_I7DD$,ES<101#=)*
MX11ZDG`KK/B#J7VG5X[%&)CMD^8=M[<_CQC]:A\`Z=]LU[[2P/EVB;^G!8\`
M?S/X4R7N>EV-I'86$%I%]R%`@/KCO5BBBD4%%%%`'FWQ#TSR-2AU%!\EPNQ_
M]]>GYC'_`'R:XNO9O$^F?VMH%S;JFZ91YD7'.X=A]1D?C7C--$L*[WX<ZGA[
MG3';@_OHOKT8?R_(UP57]&U`Z7K%K>`G;&XW@=U/!'Y9I@CVZBD5@ZAE(*D9
M!!X(I:DH****`"N,^(6E?:-.BU*,?O+<[']T)_H?YFNSJ*YMX[NUEMY1F.5"
MC#V(Q0!X/15G4+*33=0GLY>7A<J2._H?Q'-5JH@T],UJXTRRU"VB^[>1;"?[
MISU_(L/Q'I2^'=,_M;7;:U(S'NWR_P"X.3^?3\:RZ]$^'.F^7:W.I.OS2'RH
MR?[HY/ZX_*D-'<T444B@HHHH`*9-,EO!)-(VV.-2['T`&33ZY;QYJ7V+0?LR
M-B2[;9[[1RW]!^-`'FFHWCZAJ-Q>2?>FD+X]!V'X#BO3/`FF_8M`%PZ@2W;>
M83WVCA1_,_C7F>GVCW^HV]HG#32!,^F3UKW&&%+>".&-=L<:A%'H`,"FQ(?1
M112&%<SXYTS[?X?>95S+:GS1C^[_`!?IS^%=-2.BR(R,,JPP1ZB@#P.BKVLZ
M>VE:O<V;=(W.T^JGD'\L51JB#9\+:G_97B"WF9L1.?*D_P!UO\#@_A7LE>!5
M[/X9U+^U=`M;AF+2A?+E)Z[AP3^/7\:3*1K4444AA1110`444$@`DG`'4F@"
M"\O(+"TENKF01PQC+,:\<UW6I]<U)[J7Y4'RQ1YR$7_'UK5\8^)?[8NA:VK'
M[%">#_ST;^]]/2CP?X:.L7?VJY3_`$&%N0?^6C?W?IZTR7J=#X%\._8[<:I=
M)B>4?N5/5$/?ZG^7UKM*````!@#H!12*/+?&GAS^RKO[;;)BSG;D#_EF_I]#
MR?TKE*]WN[2&^M);6X3?#*NUEKQG6](GT34I+2;E>L;XX=>QIHEHSJZ?P9K_
M`/9.H_9IWQ:7!`;/\#=F_H?_`*U<Q13`]]HKD/`VO_;[+^SKA\W-NOR$_P`<
M?^(Z?3'O77U)04444`%%%%`!1110`4444`%%%%`!4<]Q!:Q&2XFCBC'\4C!1
M^9KS'Q1XCU=-;O+2*^EB@BDVHL7R$#CN.?UKEY9I9WWS2O(W]YV)/ZT["N=M
MXS\56M_:?V;I\AD0L&EE&0IQ_"/7G!KAJ**8@HHHH$*CM&ZNC%64Y#`X(/K7
MH.@^/XV1;?6!M<8`N$&0?]X=C[C\A7GM%`SW6UOK2^0/:W,4RXS^[<''U]*L
M5X%5C[=>?\_4_P#W\-*P[GNC,$4LQ`4#))/`%8NI^+-(TL$/=+-+CB*#YS^)
MZ#\37D$LTLQ!EE>0CH68G%,HL%SH]=\8W^LJT$?^BVIX,:'EQ_M'O].E<Y14
MUK:7-[,(;6"2:0_PHI)IB(:T-(T6]UJZ$%I'D#[\AX5!ZD_TZUU&C?#Z>4K-
MJTGE1]?)C.6/U/0?K^%=]:6=M86ZV]K"D42]%44KA8HZ%H%IH-H8H/GE?F29
MA\S_`.`]JU:**104444`%%%%`!1110`45Q=U\1[&/(M;*>8CNY"`_P`_Y5BW
M7Q$U27(MX+>`'O@LP_/C]*+"N<Q??\A"Y_ZZM_,U7ITCM+(TCG+,2Q/J33:H
MD*]]KP*NRLOB'>6T$44UE!*(U"Y5BI(`Q[\TF-'I=%<1;?$BTD=1<V$L()P6
M1P^!Z]!7;TB@HHHH`****`"BL;Q!XBM_#\4#31/*TS$*JD#@=3^HK!_X639_
M]`^?_OL4!<F^(\BC0[6/^)KD,/H%;/\`,5YW8R>5J%M)OV;)5;=G&,$<YK9\
M3^*&\0&&-+?R((22`6W%B>Y]/I7/4R6>^T5YO9_$:[AA2.YL8YRJ[2RR%2Q]
M3D&M!/B3:D+YFG3*>X60''\J5AW.XHJ&TN4O+."ZC#!)HUD4-U`(R,_G4U`P
MHHHH`*S=:T6UURQ-O<###F.4#YD/J/ZBM*B@#Q#5=*NM'OFM;I,,.58?=<>H
MJC7M>M:+:ZY8FWN!AAS'*!\R'U']17D6JZ5=:/?-:W288<JP^ZX]13):*->G
M?#G_`)%ZX_Z^F_\`0$KS&O3OAS_R+UQ_U]-_Z`E#!'7T45#=W*6=G/=2!BD,
M;2,%ZD`9./RI%$U5[Z\BT^QFNYCB.)"Q]_:N&NOB3(<BTTY5]&EDS^@`_G7-
M:QXEU+7%$=U(BPJ=PBC7"Y]?4_B:=A7,Z[N9+R\FN93F25R[?4G->G>`;-;?
MPXMP`-]S(S$]\`[0/T/YUY76UH_BG4]$C\FVD1X,D^5*NY0?;H1^=`D>QT5Y
M]!\2I!@7&FHW(R8Y2,#OP0?YUZ#2*"BBLC7]?@\/VT4LT,DOFMM4)@?GF@#7
MKQSQ7IG]E>(;B)1B*0^='_NMV_`Y'X5M7?Q'OI!BTLX(,]W8R'^@_2N5U#4;
MK5+IKF\E,DI&,D8P/0`4T2V5:***8CU7P+JPO]$%J[?OK3"')ZI_"?Z?A745
MX;IVIWFDW/VBRF,4F,'@$$>A!X-=1;?$?44(^TV=M*H'.S*$_CDC]*5BDSTJ
MBJNFWRZEIT%XB%%F7<%)Y%6J0PHHHH`\Z^(NF^7=V^I(IVRCRI#VW#I^8S_W
MS7#U[1XCTT:KH-U;`9DV[X\#)WCD?GT_&O%Z:)8^&%[B>.&-=TDC!%`[DG`K
MW#3K&+3-.@LH?N0H%SZGN?Q.3^->9>!=/^V^(TE89CME,ISZ]!^IS^%>KT,:
M"BBBD,***X_6O'D>F7T]G#8O+)$=I9W"C/X`Y_2@#L*\E\:ZHNI>('6)@T-L
MOE*0>">I/YG'X5)J'CK5[Z)XHS%;1L,'RE.['U/],5S%-$MG8?#NT2;6YKEL
M$P1?*/=N,_EG\Z]-KP[3=4O-(NOM%E+Y;XP>`0P]"#756_Q(O4"BXL8)<==C
M%,_GFAC3/1Z*S="U==;TQ+U83%EBI0MG!'O6E2&%%5[Z\BT^QFNYMWEPH68*
M,D^PKAKKXDR'(M-.5?1I9,_H`/YT!<7XCZ:`;74D`!8^3)[GDK_[-^E<%6KK
M'B/4M;"K=RKY2MN6)%PH/\S^)K*IDL*[+X?:L+74I-.E;$=R,QY/1QV_$?R%
M<;2H[1NKHQ5E.0P."#ZTP/?**\MM/B!K$"JLRV]P!U+H0Q_$$#]*[7PUXD7Q
M%#.?LY@D@*[EW;@<YP0<#T-2.YNT45Q4WQ(L%SY%C<OQQO*KS^&:!G:UY[XU
M\5>89=(L6^0?+/*#][_9'MZ_E]<_5?'NHW\+0VT:6<;`@E#N?'^]V_`5RE.P
MFR>RM)+^]AM(?]9*X09[9[U[=864.G6,-I`N(XEVCW]3]2>:\+1VC=71BK*<
MA@<$'UKK-.^(&J6H5+N..[0#&6^1_P`QQ^E#$CU"BL30O%%EKSO%`DD<R+N9
M)`.G3((//6MND4%8'BS0EUK26,:9NX`7B(')]5_'^>*IZGX]L+"YGMH[:>:>
M%V1NBKD9!YZ]1Z5@7?Q&U"566UM((,]&8ER/Y#]*8KG&44K,68L3DDY-)3))
M[.[FL+R*ZMVVRQ-N4U[)H>LV^N:<ES"<..)8^Z-W'T]#7BE7M+U>]T>X,]E,
M48C#*>58>XI#3/;Z*\_L_B2V`+[3P3W>!\?^.G_&NXL;R+4+&&[AW>7,@90P
MP1[&D5<L4444`%%%%`!1110`4444`<S?^!M,U&_FO)I[M9)6W,$=0`?;*U77
MX=:.&!,]ZP!Z&1<'_P`=KKJ*`L<TG@/0D<,T$K@?PM*<'\L5-_PA7A[_`*!_
M_D:3_P"*K?HH"Q@?\(5X>_Z!_P#Y&D_^*H_X0KP]_P!`_P#\C2?_`!5;]%`&
M!_PA7A[_`*!__D:3_P"*I#X)\/$$?8,>XFD_^*KH**`.8_X0'0_^><__`']-
M0O\`#O1G<LLUX@/\*R+@?FIKK:*`L<A_PKG2/^?F^_[[3_XFGQ_#S1D;+27<
M@QT:08_117644!8P[;P?H5L05L$D8=Y6+Y_`G'Z5L0P0VT8C@B2)!T5%"C\A
M4E%`!1110`4444`%%%%`!1110`4C*'4JP!4C!!'!%+10!R'_``KG2/\`GYOO
M^^T_^)J6/X?:*BX8W4ASU:09_0"NJHH"QS'_``@.A_\`/.?_`+^FIQX)\/``
M?8,^YFD_^*KH**`L<T_@/0G<LL$J`_PK*<#\\U3D^'&EE?W=W>*WJQ5A^6T5
MV-%`6.,A^'=I#/'*+^8E&#`;!S@UV=%%`!1110`4444`87B7PVOB**W7[3Y#
M0LQ#>7OR#CCJ/05A1_#6`+^]U*1FSU6(*,?F:[JB@+''I\.=*"`/=7I;N0R@
M?EMI?^%<Z1_S\WW_`'VG_P`377T4"L<2_P`-[(EO+O[A1V#*IQ_*J_\`PK/_
M`*B__DM_]G7?447"Q7L;;[%I]M:;]_D1+'NQC=M`&<?A5BBB@84444`%%%%`
M!65K^A6^O6'D2G9*F6BD'\!_J/:M6B@#R-_!'B!7918A@#@,)DP??DYKN?!>
MEWFDZ/-!?0^5*UPSA=P;C:HSP3Z&NCHHN*P5#=VR7EG/:R%@DT;1L5Z@$8./
MSJ:B@9R'_"N=(_Y^;[_OM/\`XFKL'@?086W&U>4Y!'F2M@?@"/UKHJ*`L83^
M#?#\CEFTY03_`'9'4?D#4,O@;0)``MH\>.Z3-S^9-='10%CF/^$!T/\`YYS_
M`/?TUT]%%`!65K>@6NO0Q174DR+$Q9?*(!S^(-:M%`'+CP#H8`&R<^_FU+%X
M%T"/.ZUDDS_?F;C\B*Z.B@+&!_PA7A[_`*!__D:3_P"*I&\$^'RI`L"I(ZB9
M\C_QZN@HH`Y9_A_HCH547*$_Q+)R/S!J'_A7.D?\_-]_WVG_`,377T4!8J:9
MI\.E:?#96Y<Q1`X+G).22<_B:MT44`%%%%`!7`ZA\/9KG4;B>"\BCBED+JC*
M25R<XKOJ*`,'POX=_P"$?M9U>999IG!9E&``!P/U/YUO444`%%%%`!7,7_@;
M3-1OIKR:XO!),Q9@KJ`/I\M=/10!R\/@#0XL;UN)L'^.7&?^^0*N-X.T!D5#
MIR87IB1P?Q.<FMRB@+'/MX)\/E2!8%21U$SY'_CU0?\`"`Z'_P`\Y_\`OZ:Z
M>B@+%/3-,MM)LEM+166($M\S9.35RBB@"M?V4>HV$UG,SK'*NUBA`('MFN>C
M^'^B(N&^TR'^\TG/Z`5U5%`',IX#T)6!,,S`?PF4X/Y5/_PA7A[_`*!__D:3
M_P"*K?HH"Q@?\(5X>_Z!_P#Y&D_^*J!_`>A,Q(AF4'^$2G`_.NFHH"QR)^'6
MCDD_:+T>V]/_`(FM?0_#EGX?\_[))._G[=WFL#C;G&,`>IK7HH`*XC_A6UG_
M`-!"?_O@5V]%`'')\.-+"`275XS=RK*!^6TU/'\/M%1<,;J0YZM(,_H!7544
M"L<L_P`/]$="JBY0G^)9.1^8-5I/AQIA7]U=W:MGJQ5AC\A7944#L<[H'A*W
MT&]DNHKF65GC,>&```)!_I71444`<M=^`M+O+R>ZDN+P/-(TC!77`).3CY?>
MH?\`A7.D?\_-]_WVG_Q-=?10%CEQX!T,`#9.??S:L#P3X>``^P9]S-)_\570
M44!8YB3P#H;[ML<Z9SC;*?E^F<_K55_AQI90B.ZO%;L692/RVBNQHH"QQ'_"
MMK/_`*"$_P#WP*["RM5L;"WM$.Y88UC!(QG`QFIZ*`"BBB@`HHHH`****`"B
MBLCQ1KG_``C?AVZU;[/]H^S[/W6_9NW.J]<''WL]*<8N345NQ2DHIR>R->BO
M(O\`A>'_`%+O_D[_`/:Z/^%X?]2[_P"3O_VNNOZAB/Y?Q7^9R_7L/_-^#_R/
M7:*\B_X7A_U+O_D[_P#:Z/\`A>'_`%+O_D[_`/:Z/J&(_E_%?YA]>P_\WX/_
M`"/7:*\B_P"%X?\`4N_^3O\`]KH_X7A_U+O_`).__:Z/J&(_E_%?YA]>P_\`
M-^#_`,CUVBO(O^%X?]2[_P"3O_VNC_A>'_4N_P#D[_\`:Z/J&(_E_%?YA]>P
M_P#-^#_R/7:*\B_X7A_U+O\`Y.__`&NC_A>'_4N_^3O_`-KH^H8C^7\5_F'U
M[#_S?@_\CUVBO(O^%X?]2[_Y._\`VNC_`(7A_P!2[_Y._P#VNCZAB/Y?Q7^8
M?7L/_-^#_P`CUVBO(O\`A>'_`%+O_D[_`/:Z/^%X?]2[_P"3O_VNCZAB/Y?Q
M7^8?7L/_`#?@_P#(]=HKR+_A>'_4N_\`D[_]KH_X7A_U+O\`Y.__`&NCZAB/
MY?Q7^8?7L/\`S?@_\CUVBO(O^%X?]2[_`.3O_P!KH_X7A_U+O_D[_P#:Z/J&
M(_E_%?YA]>P_\WX/_(]=HKR+_A>'_4N_^3O_`-KH_P"%X?\`4N_^3O\`]KH^
MH8C^7\5_F'U[#_S?@_\`(]=HKR+_`(7A_P!2[_Y._P#VNC_A>'_4N_\`D[_]
MKH^H8C^7\5_F'U[#_P`WX/\`R/7:*\B_X7A_U+O_`).__:Z/^%X?]2[_`.3O
M_P!KH^H8C^7\5_F'U[#_`,WX/_(]=HKR+_A>'_4N_P#D[_\`:Z/^%X?]2[_Y
M._\`VNCZAB/Y?Q7^8?7L/_-^#_R/7:*\B_X7A_U+O_D[_P#:Z/\`A>'_`%+O
M_D[_`/:Z/J&(_E_%?YA]>P_\WX/_`"/7:*\B_P"%X?\`4N_^3O\`]KH_X7A_
MU+O_`).__:Z/J&(_E_%?YA]>P_\`-^#_`,CUVBO(O^%X?]2[_P"3O_VNC_A>
M'_4N_P#D[_\`:Z/J&(_E_%?YA]>P_P#-^#_R/7:*\B_X7A_U+O\`Y.__`&NC
M_A>'_4N_^3O_`-KH^H8C^7\5_F'U[#_S?@_\CUVBO(O^%X?]2[_Y._\`VNC_
M`(7A_P!2[_Y._P#VNCZAB/Y?Q7^8?7L/_-^#_P`CUVBO(O\`A>'_`%+O_D[_
M`/:Z/^%X?]2[_P"3O_VNCZAB/Y?Q7^8?7L/_`#?@_P#(]=HKR+_A>'_4N_\`
MD[_]KH_X7A_U+O\`Y.__`&NCZAB/Y?Q7^8?7L/\`S?@_\CUVBO(O^%X?]2[_
M`.3O_P!KH_X7A_U+O_D[_P#:Z/J&(_E_%?YA]>P_\WX/_(]=HKR+_A>'_4N_
M^3O_`-KH_P"%X?\`4N_^3O\`]KH^H8C^7\5_F'U[#_S?@_\`(]=HKR+_`(7A
M_P!2[_Y._P#VNC_A>'_4N_\`D[_]KH^H8C^7\5_F'U[#_P`WX/\`R/7:*\B_
MX7A_U+O_`).__:Z/^%X?]2[_`.3O_P!KH^H8C^7\5_F'U[#_`,WX/_(]=HKR
M+_A>'_4N_P#D[_\`:Z/^%X?]2[_Y._\`VNCZAB/Y?Q7^8?7L/_-^#_R/7:*\
MB_X7A_U+O_D[_P#:Z/\`A>'_`%+O_D[_`/:Z/J&(_E_%?YA]>P_\WX/_`"/7
M:*\B_P"%X?\`4N_^3O\`]KH_X7A_U+O_`).__:Z/J&(_E_%?YA]>P_\`-^#_
M`,CUVBO(O^%X?]2[_P"3O_VNC_A>'_4N_P#D[_\`:Z/J&(_E_%?YA]>P_P#-
M^#_R/7:*\B_X7A_U+O\`Y.__`&NC_A>'_4N_^3O_`-KH^H8C^7\5_F'U[#_S
M?@_\CUVBO(O^%X?]2[_Y._\`VNC_`(7A_P!2[_Y._P#VNCZAB/Y?Q7^8?7L/
M_-^#_P`CUVBO(O\`A>'_`%+O_D[_`/:Z/^%X?]2[_P"3O_VNCZAB/Y?Q7^8?
M7L/_`#?@_P#(]=HKR+_A>'_4N_\`D[_]KH_X7A_U+O\`Y.__`&NCZAB/Y?Q7
M^8?7L/\`S?@_\CUVBO(O^%X?]2[_`.3O_P!KH_X7A_U+O_D[_P#:Z/J&(_E_
M%?YA]>P_\WX/_(]=HKR+_A>'_4N_^3O_`-KH_P"%X?\`4N_^3O\`]KH^H8C^
M7\5_F'U[#_S?@_\`(]=HKR+_`(7A_P!2[_Y._P#VNC_A>'_4N_\`D[_]KH^H
M8C^7\5_F'U[#_P`WX/\`R/7:*\B_X7A_U+O_`).__:Z/^%X?]2[_`.3O_P!K
MH^H8C^7\5_F'U[#_`,WX/_(]=HKR+_A>'_4N_P#D[_\`:Z/^%X?]2[_Y._\`
MVNCZAB/Y?Q7^8?7L/_-^#_R/7:*\B_X7A_U+O_D[_P#:Z/\`A>'_`%+O_D[_
M`/:Z/J&(_E_%?YA]>P_\WX/_`"/7:*\B_P"%X?\`4N_^3O\`]KH_X7A_U+O_
M`).__:Z/J&(_E_%?YA]>P_\`-^#_`,CUVBO(O^%X?]2[_P"3O_VNC_A>'_4N
M_P#D[_\`:Z/J&(_E_%?YA]>P_P#-^#_R/7:*\B_X7A_U+O\`Y.__`&NC_A>'
M_4N_^3O_`-KH^H8C^7\5_F'U[#_S?@_\CUVBO(O^%X?]2[_Y._\`VNC_`(7A
M_P!2[_Y._P#VNCZAB/Y?Q7^8?7L/_-^#_P`CUVBO(O\`A>'_`%+O_D[_`/:Z
M/^%X?]2[_P"3O_VNCZAB/Y?Q7^8?7L/_`#?@_P#(]=HKR+_A>'_4N_\`D[_]
MKH_X7A_U+O\`Y.__`&NCZAB/Y?Q7^8?7L/\`S?@_\CUVBO(O^%X?]2[_`.3O
M_P!KH_X7A_U+O_D[_P#:Z/J&(_E_%?YA]>P_\WX/_(]=HKR+_A>'_4N_^3O_
M`-KH_P"%X?\`4N_^3O\`]KH^H8C^7\5_F'U[#_S?@_\`(]=HKR+_`(7A_P!2
M[_Y._P#VNC_A>'_4N_\`D[_]KH^H8C^7\5_F'U[#_P`WX/\`R/7:*\B_X7A_
MU+O_`).__:Z/^%X?]2[_`.3O_P!KH^H8C^7\5_F'U[#_`,WX/_(]=HKR+_A>
M'_4N_P#D[_\`:Z/^%X?]2[_Y._\`VNCZAB/Y?Q7^8?7L/_-^#_R/7:*\B_X7
MA_U+O_D[_P#:Z/\`A>'_`%+O_D[_`/:Z/J&(_E_%?YA]>P_\WX/_`"/7:*\B
M_P"%X?\`4N_^3O\`]KH_X7A_U+O_`).__:Z/J&(_E_%?YA]>P_\`-^#_`,CU
MVBO(O^%X?]2[_P"3O_VNC_A>'_4N_P#D[_\`:Z/J&(_E_%?YA]>P_P#-^#_R
M/7:*\B_X7A_U+O\`Y.__`&NC_A>'_4N_^3O_`-KH^H8C^7\5_F'U[#_S?@_\
MCUVBO(O^%X?]2[_Y._\`VNC_`(7A_P!2[_Y._P#VNCZAB/Y?Q7^8?7L/_-^#
M_P`CUVBO(O\`A>'_`%+O_D[_`/:Z],T#5?[<T*SU/R?(^TQ[_+W;MOMG`S^5
M95<-5I*\U8UI8BG5=H.YHT445@;!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`>?
M?$3QUJGA*_LH+""SD2>(NQG1B00<<885QG_"Z/$?_/EI7_?J3_XNK?QL_P"0
MSI?_`%[M_P"A54^%?A?1O$G]K?VM9_:/L_D^5^]=-N[?G[I&?NCK7LTJ=".&
M56<;_P##GCU:E:6)=*$K?\,7;'XV7ZNHU#2;:5,_,;=V0X]@=W^?2O4/#WB7
M3/$]A]KTV8N%P)(W&'C)'1A_49'H:\U^('PTL=,TB35]"CDB6#!GMBY==G=E
M)R<COD]/3'/%>!_$4OAOQ/;7`<"VE80W(8X7RR>3]1U_"IEAJ->DYT59HJ.(
MK4*BA6=T?2U%%%>0>L>3^+OB-XG\+^([C3FLM,:$'S+=VBD)>,_=)^<<]0>.
MH-=#\/?'3^+8KJ"^2WAOX#O"0@@/&>,@$D\'@_45%\4_#*ZUX<:_@CS>Z>#(
M".K1_P`:_P!?P/K7B_AK7)?#OB"TU.+)$3_O$'\:'AE_+./?!KUZ5"EB,/[J
MM)?G_P`$\JI6J4,1[SO%_P!?@?0_B_Q$GA?PY<:B0C3#$=O&_1Y#T!]AR3[`
MUP_@[XA>)_%7B&&P%IIB6Z_O+B18I,K&#SCY^IS@?6N6^*'BN+Q#K4-K8SB7
M3[1/E=3Q([`%F_`8'X'UKT?X8>&/[!\-K=3KB]OPLK@CE$_@7\CD^YQVK)T8
M4<-S37O/8T56=;$<L'[J.WHHHKS3T3Q*]^,/B&VO[B!+/3"L4K("8I,X!(_O
MUWO@#QH?%VFS&Z6&+4('Q)'%D`H>C`$D^H//;WKP#5?^0Q??]?$G_H1K1\)>
M(9?#/B*VU!"?*SY<Z#^.,D;A^@(]P*]ZM@J<J7N*S/"I8RI&K[[NCW+X@^)[
MWPIH,%_816\DLETL)$ZL5VE7/8CGY14'P[\6W_BVPO9[^&VC:"5440*P!!&>
M<L:R?C#/%<^!]/G@D62*6]C='4Y#*8Y""/;%5_@G_P`@?5?^OA/_`$&N!4H?
M5'.VMSN=67UM0OI8]1HHHK@.\1W6-&=V"HHRS$X`'K7A\_QHUW[1)Y%CIPAW
M'RQ)&Y;;GC.'QG%>B_$G5_['\$7K(Q66ZQ:QD>K_`'O_`!T-7SO':3S6L]S'
M&3#!M$CY'R[C@?G@UZN7X>$XN=17/+Q^(G"2A!GT#\._&5SXNL+U[Z*WCN;:
M51M@4A=C#C@D\Y#5V=?/WPGU4Z?XUBMF($5[&T+9[$#<I^N5Q^-?0-<N-HJE
M5:CLSIP=5U:5WN@KF_'.MZCX=\-2:IIL5O(\,B"43J2-C';Q@@YW%?UKI*HZ
MSIR:OHM[I[XQ<PM'DG&"1P?P.#7/3:4TY;'143<&H[GEGA[XN:MJ'B&PLM0M
M-/2UN)EB=HD=6!;@')8CJ1VZ5[#7R21+;7!!W1RQ-C@X*L#_`#S7U/HNHKJ^
MAV.HJ`/M,"2$#H"1R/P.17?F&'A3Y905DSAP%>53FC-W9P?C[XD7_AG7TTW3
M8+.4+"KS-.KL58DX'##M@]^M=7X+UC4=?\,P:GJ4,,4L[,46%64;`<`X))YP
M3],5\_Z_>R>(_%]Y<1?.UW=;(1DG*YVH/RQ7TMIEC'IFEVEA$<I;0I$IQC(4
M`9_2EBZ4*5&$;>\QX6K.K5E*_NHM4445YQZ!P_Q$\;W7A&.P2PBMY;FY+EA.
M"P5%QV#`Y)/'T-<59?&76WO[9+NTTU;9I5$S)&X8)D;L$N><9K#^)VK_`-K>
M-[M58F*SQ:H/0K][_P`>+?I7*7=I/8W3VUS&8YH^&0D''&>U>]A\'2]DN=:L
M\/$8NI[5\CT1]:45S?@+53K'@K3;ER#*D?DR?5#MR?<@`_C725X<XN$G%]#V
MH24XJ2ZA7GWQ`\8^(?"-[;O:6EC+I]PN%DEC<LKCJI(8#IR/Q]*]!K(\3Z#!
MXDT"YTV;`9US$Y_@D'W6_/K[9K2A*$:B<U=$5HRE!J#LSAO!'Q0O-?\`$"Z9
MJT%G")D/D/`K+EQS@[F/49_'`[UU_C3Q.GA7P_+>@1O=,0EO$_1W/J!S@#D_
M_7KYQD2\T;5F0[H+RSFZCJCJ>H_$5L^,/%]UXNO+6:=!%';PA%C'3>0-[?B?
MT`KU9X",JL91^'K_`%YGE0QTHTI1E\73^O(]`\'_`!#\3^*?$,%@++35MQ^\
MN)%B?*1CKC+]3P!UY/I7JU<=\./"O_"-^'5>XCVZA>8EFW+AD&/E3\/YDUV-
M>9BI4W4:IJR1Z6&C-4TZCNV%%%%<YT!1110!D^)M4GT7PU?ZE;+&TUO%O19`
M2I.>^"#^M>0_\+H\1_\`/EI7_?J3_P"+KVG4].M]7TVXT^Z#&"==CA3@X^M<
M!KWPO\-:?X>U.]@BN1-;VDLL9,Q(W*A(X^HKNPDZ"7+55VV<6*A7;YJ;LK'*
M_P#"Z/$?_/EI7_?J3_XNC_A='B/_`)\M*_[]2?\`Q=<#80I<:C;0R9V22JC8
M]"0*]X_X5'X5_P">5U_W_-=]>.%H64X[G#0EBJU^66QW5%%%>$>V>7^.?B/K
M'AGQ*^FV5M8R0K$CAID<MDCV8#]*YO\`X71XC_Y\M*_[]2?_`!=4_BY_R/<O
M_7O'_*MWX8^#=`\0^&[B[U6P^T3I>-$K>=(F%"(<85@.I->TJ>'IX>-2<;['
MC.=>I7E3A*VYG?\`"Z/$?_/EI7_?J3_XNO0?AWXMO_%MA>SW\-M&T$JHH@5@
M"",\Y8U+_P`*P\'?]`?_`,F9O_BZVM$\.:3X<AEATJU^SI*P9QYC/DCC^(FN
M2O6PTH-4XV?]>9UT*6(C-.I*Z_KR-2BBL'QGK3:!X2O]0C8"=4V0^N]B%!'K
MC.?PKBA%RDHKJ=DI*,7)]#G_`!A\3['P[<R:?8PB]OTX?YL1Q'T)')(]!^>:
MX"7XO^*))"RFRB!_@2#@?F2?UKB((9[^^CACW2W%Q($7/)9F.!^))KZ!L?AA
MX9M](2SN;`7,VT>9<,[!V;N001@>P_7G/L3IX;"Q2FKMGDPJ8C%2;@[)'.^&
MOC"EY>1VNNVL-L)#M%U"2$4]MRG)`]\UZH"&4,I!!Y!'>OESQ-HQ\/\`B2^T
MO<66"3",V,E"`RDX[X(KW/X8ZN^K>"+7S6+RVC-;,Q[[<%?_`!UE%88W#0C!
M5:>S-L'B9RFZ53='8UD^)M4GT7PU?ZE;+&TUO%O19`2I.>^"#^M:U<YX]_Y$
M36/^O<_S%<%))SBGW1WU6U!M=CSS1/BWKVI:]IUA-:::L5S=10N4CD#!68`X
MR_7FO9J^7/"G_(XZ)_V$(/\`T8M?4==F84H4Y14%8X\!5G4BW-W/&=;^+>O:
M;KVHV$-IIK16UU+"A>.0L55B!G#]>*]0\,ZI/K7AJPU*Y6-9KB+>ZQ@A0<]L
MDG]:^<O%?_(XZW_V$)__`$8U?0'@+_D1-'_Z]Q_,UIC:-.%&,HJS_P"`9X.M
M.=649.Z_X)T=9/B;5)]%\-7^I6RQM-;Q;T60$J3GO@@_K6M7.>/?^1$UC_KW
M/\Q7GTDG.*?='H56U!M=CR[_`(71XC_Y\M*_[]2?_%U[#X?UJ#Q!H=KJ5N1B
M9`74'.Q_XE/T-?+%>C?"3Q/_`&9K3:-<RA;2^.8]QX6;@#_OH#'UVUZ^,P</
M9\U-6:/(PF,G[3EJ.Z9U?Q!^(.K>%->@L+"WLI(I+59B9T<MN+..S#CY179^
M&=4GUKPU8:E<K&LUQ%O=8P0H.>V23^M>0_&C_D<;3_L'I_Z,DKU'P%_R(FC_
M`/7N/YFN.O2A'#0FEJSLHU)RQ,XMZ(Z.BBL+QEK1T#PGJ&H(<3+'LAY&=[':
MI]\$Y^@-<48N4E%=3LE)1BY/H<YXR^)]KX=NFT_3X$O;Y.)"6Q'$?0XY)]AC
M'KVK@S\7_%!G\P?8@N<^6(#M^G7./QKC=/L[C6-6M[.(E[BZF"!FR>6/4_S)
MKWQ/A=X572Q9-8LSX&;GS&\PMC[V<X'TQCVKV)PPV%2C-7;/)A/$XEN4'9(R
M?!_Q6@UN\CT_5X(K.ZDXCE1CY3MV7!Y4GMR<UZ17RKK6FRZ'KMYISD[[:8H&
MZ$@'Y6_$8/XU]$>!M:?7O!]A>3.7N`IBF8]2ZG&3[D`'\:YL;AH02J4]F=&"
MQ,YMTZFZ.BK)\3:I/HOAJ_U*V6-IK>+>BR`E2<]\$']:UJYSQ[_R(FL?]>Y_
MF*XJ23G%/NCMJMJ#:['GFB?%O7M2U[3K":TTU8KFZBA<I'(&"LP!QE^O->S5
M\N>%/^1QT3_L(0?^C%KZCKLS"E"G**@K''@*LZD6YNX4445YYWA7G_C+XGVO
MAVZ;3]/@2]ODXD);$<1]#CDGV&,>O:NC\9:T=`\)ZAJ"'$RQ[(>1G>QVJ??!
M.?H#7S=I]G<:QJUO9Q$O<74P0,V3RQZG^9->C@<+&HG4J;(\_&XF5.T(;L[(
M_%_Q09_,'V(+G/EB`[?IUSC\:[3P?\5H-;O(]/U>"*SNI.(Y48^4[=EP>5)[
M<G-:R?"[PJNEBR:Q9GP,W/F-YA;'WLYP/IC'M7@^M:;+H>NWFG.3OMIB@;H2
M`?E;\1@_C733AA<2G&$;-'/.6)PS4IRNF?55%<[X&UI]>\'V%Y,Y>X"F*9CU
M+J<9/N0`?QKHJ\><7"3B^AZT)*<5)=0KS_QE\3[7P[=-I^GP)>WR<2$MB.(^
MAQR3[#&/7M71>,]:;0/"5_J$;`3JFR'UWL0H(]<9S^%?.&E:?-K.LVEA$V);
MJ98][<XR>6/TZUWX+"QJ)U*FR.'&XF5-JG3W9V)^+_B@S^8/L07.?+$!V_3K
MG'XUVOA#XK6^MWL>GZM!'9W4G$<J-^[=O3GE2>W)]*UH_AAX572ULGL"[A<&
MY,C"0MC[V<XSWQC'M7B.K^&-0T[7[S2X+:XNC!-Y2O'"QWYP5X`ZD$''O71"
M.%Q*<8JS1SSEBL.U*3NF?3]%8WA2ZOKSPMI\VI0S0WOE;9EG0H^Y25R0>><9
M_&MFO(E'E;78]>,N9)E#6[V33=!U&_A5&EMK669`X)4LJDC..W%>0V7QA\0W
M-_;P/9Z8%EE5"1%)G!(']^O5O%?_`")VM_\`8/G_`/1;5\SZ5_R&+'_KXC_]
M"%>E@*-.I"3DKGFXZM.$XJ+L?5]%%%>6>F<9\1/%M_X2L+*>PAMI&GE9&$ZL
M0`!GC#"O/O\`A='B/_GRTK_OU)_\771_&S_D#Z5_U\/_`.@UQ7PQT'3?$/B2
MXM-5MOM$"6;2JN]DPP=!G*D'H37L8:E16&]I.-SR<14K/$>SA*QI?\+H\1_\
M^6E?]^I/_BZZ3P-\1]8\3>)4TV]MK&.%HG<M"CAL@>[$?I71?\*P\'?]`?\`
M\F9O_BZO:1X(\.Z%?B]TW3_(N`I4/YTC<'KPS$5A4KX1P:C"S_KS-J='%*:<
MIZ?UY'0445!>3FVL;BX4!C%&S@'O@9KSDKGH/0X7QI\3[;P[<OIVFPI>7Z<2
M,S?NX3Z''+'U`(QZYXK@C\7O%)E+AK,*3G8(.![=<X_&N&EEDGF>:5R\DC%G
M8]23R37O6B>&_AYJNGPPZ?#979:/!W3'S^0>6&0P/![#VKVYTJ&%@N:/-YGC
M0JU\3-\LK>1F>%_B]#J-W'9:W:QVLDK!4N(2?+R3C#`\J/?)_#K7J%>-M\%K
MF36;@+J,4&F!_P!RQ!>4KC/(X'MG/;.*];TZS_L_3+6R,SS?9XEB\R3[S[1C
M)]^*X,6J%TZ+^1W85U[-55\RS1117&=84444`%%%%`!1110!XM\;/^0SI?\`
MU[M_Z%5SX'_\Q[_MW_\`:E4_C9_R&=+_`.O=O_0J/@[JVG:9_;7]H:A:VGF>
M1L^T3+'NQYF<9(SC(_.O9:;P%E_6IXZ:6.N_ZT/6M<$3>']2$^WRC:RA]QP-
MNPYS[8KY4KV;XB_$33I=$FTC1;H7,UT-DTT6=J1]QGN3TX[$^U>:^$=#D\0^
M)K.P5<QEP\QQP(UY;_#ZD5>`@Z-*4YZ$XZ:JU8PAJ?2]F9FL;<W&?/,:F3(Q
M\V.?UJ>BBO#9[2"OF_X@^&O^$:\3S11*!9W.9[<#^%2>5_`Y'TQ7TA7BWQL_
MY#.E_P#7NW_H5=^73:K<JV9P9A!.CS/='.?#KPT/$?BB)9XP]E:_OIP1D-C[
MJGZGMZ`U]&5Y%\#_`/F/?]N__M2O7:68S<JSB]D/+X*-%274****X3N/ES_F
M</\`M_\`_:E;/Q'\+_\`"-^)':",+87F9;<*,!>?F3\"?R(K&_YG#_M__P#:
ME?07C7PVOBCPW/9+@7*?O;9CVD`X'T/(_'/:O?KU_8U(-[-:GA4:'MJ<TMUL
M>%3^)FO/A_%H%RY:6TOEEMR1_P`LBD@(S[,1_P!]>U>B_!/_`)`^J_\`7PG_
M`*#7C$D;PRO%*C)(A*LK#!4CJ".QKV?X)_\`('U7_KX3_P!!HQL%'#RMU88*
M3E7C?HCU&BBD)"J68@`<DGM7@'NGB_QIU7SM6T_2D;Y;>(S.!_>8X'Y!?_'O
MRN^!O"HO_A;K&4)GU/=Y78'R_P#5_P#CX-><>)-3?Q!XIOK]`7^T3D1``Y*C
MY4&/7`%'_"*>(_\`H`:K_P"`<G^%?0*ART(T^;E>C_7\SP/;7K2J<MUM^GY&
M?9W4MC?6]Y`0)8)%E0GLRG(_45]66-W'?V%M>1?ZN>)94^C`$?SKY3N[*[T^
M<P7MK-;3``F.:,HV#WP>:]W^$NK'4/!JVKG,EC*T/3JI^93^I'X5CF=/FIJH
MNAMEL^6;@^IWE%%%>*>R?./Q)TK^RO'-^`"([HBZ3.>=_+=?]K=76^%_%/V3
MX/ZLC2`3V1:WBR0?];]W'K@LW'/W?2K?QJTDR66G:O&G,3M;RD#/#<KGT`(;
M_OJO(4NIDM);57(AE=7=0>"5#`?^A&O?I16)P\;]+?@>#5D\/7E;K?\`$ZWX
M7:2-4\;VKNFZ*S4W+<<9'"_^/$'\*^AZ\P^"^E>1HU_JC@;KF41)TX5!S],E
MO_'17I]>;F%3GK-=M#T<!3Y**??4*HZSJ*:1HM[J#XQ;0M)@C.2!P/Q.!5ZO
M-_C)J_V3PW;Z8C#S+V7+#_IFF"?_`![;^1KGH4_:5%#N=%>I[.FY=CR?PSIS
M>(/%UA9S$N+BX#3'N5'S/^@-=9\8]*^R>*8-05<)>P#<?5T^4_\`CNRN&L='
MU34T=[#3;R[5#AF@@:0*?0X'%37'AS7+2!Y[G1M1AA09>22U=54>I)&!7T,H
MKVJES;:6/`C)^R<>7?6YZ3\%-5.[4](8C&!=1C\E;_V2O7J^9O`VK'1?&6FW
M1.(VE$,G&?E?Y2?PSG\*^F:\C,:?+6YNYZV7U.:ER]@HHKG/&_B5?"_AR:\1
MD^UO^[MD;NY[X]`.?_UUQ0@YR48[L[)S4(N3V1Y!\5[K3[KQM-]B0^;%&L=T
MX/#R#T]P,`_3';GG?"]U867B?3KG5(C)9QS!I%]/0GU`."1W`Q5OP?X?F\5^
M)X+1][0[O.NY">0@///J>GU.:B\7>'I?#'B.XTY\F+_60/\`WXST/U'(/N#7
MTD.2*^KWUL?/3YY/V]M+GTZ"&4,I!!Y!'>EKSOX3>*/[5T0Z/<R`W=@H$>3R
M\/0?]\_=^FVO1*^=K4G2FX/H>_2J*I!374****S-`HHHH`*R/%?_`")VM_\`
M8/G_`/1;5KUD>*_^1.UO_L'S_P#HMJNG\:]2*GP,^9]*_P"0Q8_]?$?_`*$*
M^KZ^4-*_Y#%C_P!?$?\`Z$*^KZ]/-=X_,\[+-I?(****\D]0^?\`XN?\CW+_
M`->\?\JY.R_M7R3]A^V^5NY\C=MW?AWZ5UGQ<_Y'N7_KWC_E72?"OQ-HNB^&
M+FVU+48;:9KUI`DA.2I1!G\P?RKZ"-1T\-&2C?1'@RIJIB91;MJSSC_BHO\`
MJ*?^1*^HZYS_`(3WPK_T'+7\S_A6II>MZ;K<4DFFWD=RD9VN8ST->9BZLZJ3
M<+6/1PM*%)M*=[E^O/\`XQ-*/!*",95KR,2<=%VM_7;7H%<WX]T=];\&:A:Q
M#,Z()HAR<LAW8`'<@$?C6&'DHU8M]S?$1<J4DNQX1X(CCD\;Z,LH&T72,,G'
M(.1^H%?3=?)VG7KZ;JEI?1J&>VF290>Y5@1_*OI*S\:^'+W3!?IJ]K'$%#.L
MLJJZ$]BI.<]?KCC->AF=.3E&26AP9;4BHRBV:;Z3ITES)<OI]JT\N/,E:%2S
MX&!DXR<#BK$%O!;(4@ACB0G)6-0HSZ\5\]^+/'FI:IXCN;C2=4O[6P!"0I%<
M/&&`&-Q`/4G)_*O6OALVJ2^#H+G5;F>XFN':2-IV+,(^`O)YQP3SZURUL+.E
M34Y/?H=-'%0J5'"*^9UU<YX]_P"1$UC_`*]S_,5T=<YX]_Y$36/^O<_S%<]'
M^)'U1T5OX<O1GS7%YGG)Y._S=PV;,[MW;&.]:G_%1?\`44_\B4>%/^1QT3_L
M(0?^C%KZCKW,7BO822Y;W/%PF%]M%OFM8^2)?,\Y_.W^;N._?G=N[YSWKZ4\
M!?\`(B:/_P!>X_F:^?\`Q7_R..M_]A"?_P!&-7T!X"_Y$31_^O<?S-8YB[T8
MO^MC;+E:M)?UN='7.>/?^1$UC_KW/\Q71USGCW_D1-8_Z]S_`#%>31_B1]4>
MI6_AR]&>+?#G3+?6?$LFG7:!H;BTE1N.G`P1[@X(]Q6!JVFW>@:W<6%P2ES:
MR8W*2,]U8>Q&"/K75_"/_D>XO^O>3^5=E\7O"YOM.CUZU0F>T&RX51RT6>&_
MX"3^1)[5[DJ_)B>1[-?B>+&ASX;G6Z?X'FWC#Q'_`,)/<Z9>N?\`28[!(;GY
M<#S%=\D?4$'CUQ7NG@+_`)$31_\`KW'\S7S17TOX"_Y$31_^O<?S-89C!0HQ
MBMKFV7S<ZLI/>QT=<+\7/^1$E_Z^(_YFNZKGO'.C2:[X/U"RA3?<;!)".Y93
MNP/<X(_&O,P\E&K%ON>G7BY4I)=CP[X=)$_C_2!,Y5?,8@C^\$8J/Q.!7TE7
MRGHNI/HVMV6HQC<;:99-O]X`\C\1D5]'1>-/#DNEKJ/]L6B0$`D/*`ZG&=I7
MKN]L5Z&9TY.<9)'!EU2*A*+9XC\3_P#DHNJ_]L?_`$4E>C_!@D^#KH$D@7[@
M>W[N.O'O$>K'7?$5_J9#!;B4L@;J$Z*#R>0`*]\^'.DOH_@FQBE4K-.#<.I[
M;N1_X[MZUIC/<PL8/?3\C/!^_B936VIU5<YX]_Y$36/^O<_S%='7.>/?^1$U
MC_KW/\Q7DT?XD?5'J5OX<O1GS_X4_P"1QT3_`+"$'_HQ:^HZ^6/#EQ%:>)])
MN9W$<,5[#)(YZ*H<$G\J^A/^$]\*_P#0<M?S/^%>GF4)2G'E5SSLNG&,9<SL
M='163I?B;1=:N6MM-U&&YF5#(4C)R%!`S^9'YUK5Y,HN+LU8]2,E)73.%^+G
M_(B2_P#7Q'_,UY1\.5B;X@:0)CA/,8CG^((Q7]<5[AXYT:37?!^H64*;[C8)
M(1W+*=V![G!'XU\Z:+J3Z-K=EJ,8W&VF63;_`'@#R/Q&17L8'W\/*"WU_%'D
M8WW,1&;VT_!GU97SG\3_`/DHNJ_]L?\`T4E>W1>-/#DNEKJ/]L6B0$`D/*`Z
MG&=I7KN]L5\[^(]6.N^(K_4R&"W$I9`W4)T4'D\@`5GEM.<:DI-=+&F8U(NF
MDGU/8?@P2?!UT"20+]P/;]W'7HM<K\.=)?1_!-C%*I6:<&X=3VW<C_QW;UKJ
MJX<3)2K2:[G=AHN-**?8\]^,DDB>"X50G:]ZBOQGC:Y_F!7FOPQ`;XB:4"`1
M^]//_7)Z]C^(NE2:OX(OXH0S2P@3HJ_Q;#DCWXS^.*^?]`U:30M>LM3C!8V\
MH9E!P67HRY]P2/QKT\%[^%E!;Z_D>;C/<Q,9O;0]H^(GCK5/"5_906$%G(D\
M1=C.C$@@XXPPKC/^%T>(_P#GRTK_`+]2?_%UW^J/X"\5VD.J:G=V<\<285GN
MVB9`><%0P.?8C->%:Y)ITNMW;:3#Y.G^81`F6/RC@'YB3SC//K2P=*E./+*&
MJW;#%U:L)<T9Z/:Q]&^#=:N?$/A2RU6[2))Y]^Y8@0HVNRC`))Z`=ZW:Y'X8
M?\DZTK_MM_Z->NNKRZZ4:LDN[/4HMRIQ;[(R/%?_`")VM_\`8/G_`/1;5\SZ
M5_R&+'_KXC_]"%?3'BO_`)$[6_\`L'S_`/HMJ^9]*_Y#%C_U\1_^A"O4RW^'
M,\S,?XD3ZOHHHKQCUSR[XV?\@?2O^OA__0:\?LOMOG'[#]H\W;SY&=VW\.W2
MO8/C9_R!]*_Z^'_]!KC_`(5ZOI^B^)[FYU*ZCMH6LFC#R="Q=#C\@?RKW<))
MPPG,E??\SP\5%2Q7*W;8YW_BHO\`J*?^1*]Z^'/VG_A`]-^U^;Y_[W=YN=W^
MM?&<\],5-_PGOA7_`*#EK^9_PJWIWBK0M7NQ:Z?J<%Q.06"(3G`ZUQ8FO4JP
MLX6MJ=N&HPI3NIWN;%%%9?B+5WT'0+O5$M&NC;J'\E6V[AD`G.#@`$GIVK@C
M%R:2.Z344VSQ+QA\-M4T.^EFTVVFO-,;+(T2[FB']U@.>/7I7#D%6((((X(/
M:O5;'XSWDNM6XO;&V@TPOB7RPS2*"",YS@X.#T[5Z'=7/A'6K(W%Y/H]U`1D
MR3/&=O'J>5(S[$5[?UJM12C6C?S1XWU:C6;=*5O)GAGA[QYKOAZXB,=Y+<6J
M\-:SN60KGD#/W3[BOH;1]5M];T>UU*T),-P@<`]5/0J?<$$'Z5\Q:VFGQZW>
MKI3L]@)6$#-G)7MUYQ]:][^%]K-:^`=/\XOF4R2*K#[JESC'L?O?\"K/,:<.
M15$K,TR^I/G=-NZ.PHHHKQSU@HHHH`****`"BBB@#S#XH^$M<\1ZE83:59?:
M(XH65SYJ)@DY_B(K@O\`A6'C'_H#_P#DS#_\77T917=2Q]2G!025E_7<XJN!
MIU)N;;U_KL>!V'PA\373+]J%K9(1EC)*'(Y]%SSWZUZWX4\'Z=X2LFBM-TEQ
M+CSKA_O28SCCH`,]!^M=#16=;&5:RM)Z&E'"4J3O%:A1117*=(5YA\4?"6N>
M(]2L)M*LOM$<4+*Y\U$P2<_Q$5Z?16M&K*E/GCN95J4:L.21YS\*_"^L^&_[
M6_M:S^S_`&CR?*_>H^[;OS]TG'WAUKT:BBE6JNK-SENQTJ2I04([(****S-#
MP7_A7/BO_A)/M?\`97[C[9YN[[1%]W?G.-V>E>]445T5\1*M;FZ&%##QHWY>
MIY#\0_AQJ6H^(/[2T&T$ZW0+7$?F(FR0=_F(X8?7D'U%=#\+O#FK>'--OX=5
MM?L[RS*R#S%?(`Q_"37>T54L74E2]D]OQ)CA81J^U6X5D^)TU"7PSJ$6E0>=
M>RPF.)-P7EOE)R2!P"3U[5K45S1?*TSHDKIH\1\&_#?Q!9^+-/O-5T\06EO)
MYS.9HV^91E0`K$_>Q7MU%%;5\1.O+FD94*$:,>6)YA\4/!.J>(-1L;_1[07$
MHB,4X\Q4(`.5/S$`]6_*H_ACX9\2^&=9NQJ6G>397,(#/YT;8=3\O"L3T+=N
M]>IT5?UN?LO8M*Q'U2'M?:INX4445RG28?B_13X@\*W^G(H:9X]T.<?ZQ>5Y
M/3)&,^A->'_\*P\8_P#0'_\`)F'_`.+KZ,HKJH8RI0BXQL<M?"4ZTN:5S(\+
MZ3_8?AC3M-90LD,($@!R/,/+X/IN)K7HHKFE)R;D^ITQBHI)=`KR/XD>%/%/
MB7Q,);'3/-LH(5CB?SXUW'[S'!8'J<=.U>N45K0K2HRYXK4SK456CRR>ARWP
M^\/W'AOPG#9WD8CNY)'FF0,&PQ.`,C@_*%KH-1LH]2TRZL9L>7<1-$V1GAAB
MK-%1.I*4W-[E1@HP4%L?.A^%_C$,0-(!`[BYBY_\>KW[1VO7T:S.I1>5>^2H
MG3<&P^.>02.OO5VBML1BIUTE)+0QH86%!MQ;U"O'_B!X:\8>*?$+26^E.=/M
MAY=L#<Q#(_B?!?C<?QP!FO8**BA6=&7-%*_F76HJM'ED]#C?ASX1?POH;->1
MA=2NCNG&X-L`)VJ"..G/U/M3/B1X1D\3Z+')8PJ^I6S9B&0I=3]Y<G`]^?3W
MKM:*/K$_:^UZA["'LO9=#P?P]X*\<^'M=M=3M](.Z%OG7[5#AT/#*?G[C_&O
M=T8LBL5*$C)4XR/;CBEHJJ^(E7:<DKBH8>-%-1;"BBBN<W"BBB@`K.\06LU]
MX;U6TMDWSSV<L4:Y`W,R$`9/`Y-:-%.+L[B:NK'SYI_PT\70:E:S2:3M1)D9
MC]IB.`""?XJ^@Z**WQ&)G7:<NAA0PT*%U'J%%%%<YT'C_P`1?!'B+7?%DE[I
MNG^?;F%%#^=&O('/#,#7)_\`"L/&/_0'_P#)F'_XNOHRBN^GF%6$5%):?UW.
M&>`I3DY-O7^NQ\Y_\*P\8_\`0'_\F8?_`(NO3_A=X<U;PYIM_#JMK]G>6960
M>8KY`&/X2:[VBHK8ZI5AR22L51P5.E/GBV%%%%<9V'EGC'X3G4;V74=!DBAD
ME.Z2UDX4MW*GMGTZ>_:N`?X=>+8YQ"=%F+'`!5T*\_[0./UKZ2HKNI9A5A'E
MW.*I@*4WS;'BWAKX/WTUPD_B!TM[=2";:)PSO[$C@#Z$GZ=:]GCC2&)(HD5(
MT`5548"@=`!V%.HK"OB)UG>9O1P\**M`*Q?%UA<ZIX3U*RLXO-N)H2L:;@N3
MD=S@5M45E&3C)270TE%2BXOJ>"^'_ASXKL?$FE7=SI6R""\BED;[1$=JJX).
M`V3P*]ZHHK;$8B5=IRZ&5##QH)J/4\%\0?#GQ7?>)-5N[;2M\$]Y++&WVB(;
ME9R0<%LC@U[!X1L+G2_">FV5Y%Y5Q#"%D3<&P<GN,BMJBG6Q4ZL%"26A-'"P
MI2<XMZA6+XNL+G5/">I65G%YMQ-"5C3<%R<CN<"MJBL(R<9*2Z&\HJ47%]3Q
M_P"'7@CQ%H7BR.]U+3_(MQ"ZE_.C;DCCA6)KUV6*.>%X94#QR*5=3T(/!%/H
MK2O7E6GSRW,Z-"-&/+'8\!UCX5>(H-8NH]+L#<V(<F"4SQJ2IY`(+`Y'0\=J
M]D\(V%SI?A/3;*\B\JXAA"R)N#8.3W&16U15UL74K149="*.%A1DY1ZA1117
M,=)Y3XU^%,E_>R:EX?,2/*=TMHYV@L>I0]!GT.!Z'M7!GX=>+1<>0=%FW],A
MT*_]]9Q^M?25%=U/,*L(\NYPU,!2G+FV/(_!_P`))8+J'4/$+Q_NR'6RC.[)
M[;V'''H,Y]>U>N445SUJ\ZTN:;.FC0A1C:`5B^+K"YU3PGJ5E9Q>;<30E8TW
M!<G([G`K:HK.,G&2DNA<HJ47%]3YS_X5AXQ_Z`__`),P_P#Q='_"L/&/_0'_
M`/)F'_XNOHRBN_\`M.MV7X_YG#_9M+N_P_R/*/ACX-U_P]XDN+O5;#[/`]FT
M2MYT;Y8NAQA6)Z`UZO117'6K2K3YY'71HQHQY8A7E/C7X4R7][)J7A\Q(\IW
M2VCG:"QZE#T&?0X'H>U>K444:TZ,N:`5J,*L>69\VGX=>+1<>0=%FW],AT*_
M]]9Q^M=MX/\`A)+!=0ZAXA>/]V0ZV49W9/;>PXX]!G/KVKURBNJIF-:<>5:'
M-3R^E"5WJ%%%%<!W!7D'B_X23RWLE[X<$7EO\S6;-MVM_L$\8]CC'TZ>OT5M
M1KSHRYH&-:A"M&TSYN7X<^+6G,(T67>.YD0+_P!];L?K713_``>U6#PXTZ2)
M<:L9%*VT3@($YR-S8!;D'TX/7->WT5U2S*L[6LCFCEU)7O=G.>`]+O-&\%Z?
MI^H0^3=1>9OCW!L9D9AR"1T(KHZ**X9R<Y.3ZG;"*A%170SO$%K-?>&]5M+9
M-\\]G+%&N0-S,A`&3P.37ANG_#3Q=!J5K-)I.U$F1F/VF(X`()_BKZ#HK>AB
MIT8N,4M3"MA85FI2;T"BBBN8Z3@OBCX<U;Q'IMA#I5K]H>*9F<>8J8!&/XB*
M\P_X5AXQ_P"@/_Y,P_\`Q=?1E%=E''5*4.2*5CCK8*G5GSR;/G/_`(5AXQ_Z
M`_\`Y,P__%UUGPZ\$>(M"\61WNI:?Y%N(74OYT;<D<<*Q->P45=3,*LXN+2U
M_KN3#`4H24DWI_78*9+%'/"\,J!XY%*NIZ$'@BGT5P'<>+>)?@_?0W#S^'W2
MXMV)(MI7"NGL">"/J0?KUKE?^%=^+?/\G^Q9]^<9WIM_[ZSC]:^DZ*]"&95H
MJSLS@GEU*3NKH\6\-?!Z_FN8Y_$$B6]NI!-M&^YY/8L.%'N"3].M>S111P0I
M#$@2.-0J*.@`X`I]%<U?$5*SO,Z:.'A15H!1116!L%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
..4444`%%%%`!1110!_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>g2014031017063211734.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g2014031017063211734.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+#`Q-#0T'R<Y/3@R/"XS-#+_
MVP!#`0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P``1"`$9`Z<#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#W^BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`**9+-%"`994C!Z%V`S6?+XAT:#[^IVO7&%E#'
M]*`-.BL%_&?A]&*G41D>D3D?F%JM_P`)]H?_`#TG_P"_1H"YT]%<G)\0]&1L
M+%>2#^\L:X_5A3/^%C:1_P`^U]_WPG_Q5`7.OHKD/^%C:1_S[7W_`'PG_P`5
M4D7Q"T:0D,EW'CNT8Y_(F@+G5T5S<?CO07;#7$D8QU:)L?IFKL'BC0[C&S4X
M!G_GH=G_`*%B@#7HIJ2)*@>-U=3T93D&G4`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`'G_B'QOJ-EJES8VD4$:Q-M\Q@68_T_2N6N?$>LW>?-U*XP<Y
M"/L!S[+@5U6J^!]1U37+N[$UO%!+(2NYB6QCT`_K3(?AK*2?.U-%';9$6S^9
M&*9.IPKNTC%G8LQZDG)-)79Z]X%&F:9+>VUXTHB`+QNH!(SU!_I7&4P"BBB@
M04^*&68D11/(1U"J3BO0/`&EV%SI4UU<6D,LZW!17D4-@!5(QGIR>M=RB+&@
M5%"J.@`P!2N.QX7]AO/^?6?_`+]FHY8)H,>;$\>>F]2,U[S2,H=2K`%2,$$<
M$47'8\#HKV:^\,:-J`/G6,2N>=\0V-^G7\:X_5_A[<0`RZ7-]H0?\LI"`_X'
MH?THN*QQ]M>7-G)YEM<2POZQN5/Z5T^F?$#4K3"7J)>1CN?D?\QQ^8_&N4DB
MDAE:.5&213AE88(/H13:8'LVC^)--UL;;:7;/C)ADX8?X_A6O7@:.T;JZ,59
M3D,#@@^M=[X9\<G*6>L2<=$N3_)O\?S]:5AIG?T4`@@$'(/0BBD,****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`R/%/_(KZA_UR/\Z\9KV;Q3_R*^H?]<C_`#KQ
MFFB6%%%%,1Z=\.?^1>N/^OIO_0$KKZY#X<_\B]<?]?3?^@)77U):"BBB@`HH
MHH`P_$7AFUUVW+86*\4?NYL?HWJ/Y5Y+>6=QI]W):W49CFC.&4_S^E>[5ROC
M7P^NI:<U[`G^EVRD\=73N/?'4?CZTT)H\LHHHIDG:^#?%C6LD>F7\G^C-Q%*
MQ_U9]"?3^7TZ>D5X%7J/@CQ`VIV365R^ZZMQP3U=.F3[@\?E2929UE%%%(84
M5YGK_B[6K37;RWMKORH8I"BKY2'@?4&L]/&_B!6!-\&`_A,*8/Y"G85SURBO
M*D\?ZXA4LUNX'4-%U_(BK*?$;5`X,EK9LO<*K`_GN-%@N>F45YS_`,+)O/\`
MH'P?]]FD;XD7I4[;"W#8X)9B,T6"YZ/17GVC>-]3U+7+.UFCMDBD?:PC0@G(
M]237H-(84444`%%<9XT\0:EHU_:+93A$>,LRE%8,<^XS7.?\)]KG_/2#_OT*
M=A7/5J*\S3XC:H'!DM;-E[A58'\]QHD^(^J%OW=I9JOHP8G\]PHL%STRBN2\
M)>)K[7KRYCND@18HPP$2D<Y]R:ZVD,**\OO/'&N6][/#NA7RY&3!BY&#BH3X
M]UT@CS81[^4*=A7/5J*\H3QYKJJ`9H6(_B,0R?RI)/'>O.N%N(HS_>6)<_KF
MBP7/6**\IL_'>M07<<ES.+B$'YXC&BY'U`R#7I6FZG::M:+<V<H=#P1W4^A'
M8T@N7****!A1110`4444`%%>5O\`$#6W<LIMD!_A6/@?F33'\>:ZRD":%2?X
MA$,C\Z=A7/5Z*\A_X37Q#_T$/_(,?_Q-12>+=>E?<VI2@_[(51^0%%@N>QT5
MY#9>)=<FO[>,ZA.X:105]1FO7J07"BBB@84444`%%%%`!17B_B34O[5UZZN5
M;,>[9'Z;1P,?7K^-+X:U0Z3KMO<%ML3'RY?38>N?IP?PIV%<]GHHHI#"BBB@
M`HK@?B!J%[97UFMK>7$"M$21%*R@G/L:Y:+Q1KD(4+J=P=IR-[;OSSG-.PKG
ML]%>0_\`":^(?^@A_P"08_\`XFK`\>ZZ`!YL)]_*%%@N>K45Y0_CS764@30J
M3_$(AD?G59_&7B"1"K:BP!_NQHI_,"BP7/8**\4D\0ZS(VYM4O`?]F9E'Y`U
MZ%X"N[F\T*>2ZN)9W%RRAI7+$#:O&3]:+!<ZFBBN*^($M]!_9TUF]Q'L\W>\
M)8;?N]2/Q_6D,[6BO%HO$FM1`A=4NCG^](6_G5I?&GB!5"C4#@#',2$_GMIV
M%<]?HKR'_A-?$/\`T$/_`"#'_P#$U#-XLUV?._4I1D8^0!/_`$$#\Z+!<]DH
MKS#P?<:M?^([66:>]N+:+?O=W9T7*'&2>!SBO3Z0PHHHH`***\[^(VI"2YMM
M-0\1#S9.>,G@#Z@9_P"^J`/1**\$C=HI%D1BKJ0RL.H(KVS1=175='MKT?>D
M3YQZ,.&'Y@T"3+]%%%`PHHHH`****`"BF3>9Y,GE8\S:=N>F>U>2?\)KXA_Z
M"'_D&/\`^)H%<]>HKR(>-O$((/V_/MY,?_Q-7(_B'K*+AHK.0_WFC;/Z,*=@
MN>HT5YPOQ(O0HW6%N6QR0S`9J.7XCZD2/*L[11WW!F_J*+!<]+HKRN7X@:W(
M<K]FBXQA(_UY)K8\&>(-6U?6I(+V\\R)(&DV^6@R<J.H`/>BP7.\HHK@O%'B
M[4=+UV6SLY(O+C5<AH\D$C/7\12&=[17E/\`PGVN?\](/^_0H_X3[7/^>D'_
M`'Z%.PKGJU%>8#XBZP`!]GLC[E&_^*J.7X@ZU(056UCQV6,\_F318+GJ=%>?
M^$/$NK:GKJVUY=>;"8V.WRU7D>X`KT"D,****`"BBB@`HHHH`****`"BBB@#
M(\4_\BOJ'_7(_P`Z\9KV;Q3_`,BOJ'_7(_SKQFFB6%%%%,1Z=\.?^1>N/^OI
MO_0$KKZXOX;R$Z3=Q8&U9]P]<E1_@*[2I+04444`%%%%`!1110!XYXJTI=(U
MZ:",8AD_>Q#T4]OP((_"L6O1OB/9;[&TOE',<AC8CT89'ZC]:\YIDL*N:5J$
MFE:G!>Q=8FR1_>'<?B*IT4Q'O4,R7$$<T;;HY%#J?4$9%/KE_`5_]K\.B!C\
M]LYC_P"`GD?S(_"NHJ2R&XL[6[7;<VT,P])$#?SKA/%W@Z&WMFU'2XMB1C,T
M(R0!_>'T[BO0:"`001D'J#0!X%170^+]"_L75=T*XM+C+Q8Z*>Z_A_(USU40
M%>CZ9X$T>YM(;HW5S<)*H=<$("".XP3G\:\XKNO`&N^5*VD7#`(Y+P,3T;NO
MX]?S]:3&CK;#PSH^FR)+;62"5>DCDL0?7D\?A6M112*"BBB@"K>:;9:@`+RT
MAGP,`R("1]#VKF/$/A?0++1;N\6W,$B(61DD;ES]T8)(QDBNQKS/Q[K9N[\:
M9"W[FV.9,'AG_P#K?U-`F<>B-(ZHBEF8X"@9)/I7H&B_#Z(P1SZM(YD89,$9
MP%]B>_X8IG@'0/\`F,W*>JVZG\BW]!^/M7?TVP2*.GZ-I^E;OL-JD)8`,1DD
MCZGFKU%%(9FW>@:3?%FN-/MV=R2SA-K$GN2.:Y[5?A[931.^FR/;R@?+&[;D
M/MSR/KDUV=%`'A-Y9W&GW<EK=1F.:,X93_/Z5!7H'Q)M$V6-X%P^6B8XZCJ.
M?;G\Z\_JB0K2T76KK0[X7%N<J>)(R?E<>A_H:S:*!'M^E:K:ZS8K=6KY4\,I
M^\A]#5ZO%-%UJZT.^%Q;G*GB2,GY7'H?Z&O7=*U6UUFQ6ZM7RIX93]Y#Z&I*
M3+U%%%`PHHHH`R;OPSHMZQ:?3H=QZE`4)_[YQ7,Z]X#LX-/GO-/EE1X4,AB<
M[@P`R0#U!_.N\JO?_P#(/N?^N3?R-`K'A5>@^&_`UM):0WVIGS?-0.D"D@`$
M9&3US[?SKSZO;M$8MH&G,Q)8VL1))Y)VBFQ(EL]-LK`8M+2&#(P2B`$_4]ZM
M444B@HHHH`****`"L7Q7J1TOP]<RH<2R#RH^<<MQD>X&3^%;5>;?$34?.U*#
M3T(VVZ;WP?XF['Z`#\Z!,XNBBBJ)/7_!^J#4_#T&YLS0#R9,]>.A_$8Y]<UO
M5Y;X"U3[%K9M'/[J[&WKT<<C^H_$5ZE4E(****!D-Q:6UVFRYMXIE_NR(&'Z
MUC:AX.T6^B8+:+;R'.V2'Y<'Z=/TK?HH`\-U+3YM*U":RN`/,C.,CH1V(JI7
MH?Q$T@R0PZM$.8\13?[I/RG\SC\17GE,EA75^#/#5KK;3W%ZS-#"P41*<;B?
M4^GTKE*ZOP#J7V/73:N<1W:;?^!#D?U'XT`CT2#1M,MAB'3[5.,9$2Y/U/>K
MU%%(H****`*UQI]E=AOM%I!+NZ[XP<_G7F?C70K/1KRW:R^1)U8F(MG:01R.
M^#G]#7JM>2^-]0^W>))45LQVP$*\\9'+?J2/PIH3,"""6YN(X(4+RR,%11W)
MKT_2/`NFV*))>+]KN!@G?]P'V7N/K7/_``]TK[1J,NI2#]W;C8GNY']!_,5Z
M50P2&QQI%&J1HJ(HP%48`%.HHI#"BBB@!LDB11M([!44%F8]`!7B&JW[ZGJE
MS>OG,KE@#V'0#\!@5Z9XXU+[!X>>)&Q+='RACKM_B_3C\:\GIHEA7=_#K5-D
MMQIDC</^]BR>XX8?E@_@:X2K>F7TFF:G;WL>=T+AB!W'<?B,C\:8'N5%,AF2
MX@CFC;='(H=3Z@C(I]24%%%%`!1110`5DS^&-$N,[],MQD8_=KL_]!Q6M10!
MY_K_`(!2&WDNM)=R4&YK=SG([[3_`$/Y]JX*O?:\O\;^'O[.O/[0MU_T6X;Y
M@!_JW]/H>3^?M30FCDJ***9)Z3X:\,>'[_1[:\,+7$C*/,WR'Y7'WA@8XSZ]
ML5U5GIECI^?LEI!`2,$QH`2/<]37F?@O7_[)U+[/.^+2Y(#9Z(W9OZ'_`.M7
MJU)E(*R]0\.Z3JLXGO;,22@8W;V4X_`BM2BD,Y:^\$^'UM99?*DMEC0LSI*3
M@`9S\V:\KKT#Q]KX"?V/;L"3AK@@].X7^OY5Q6FZ=/JM_%9VRYDD.,GHH[D^
MPIHEEK0M`N]>NS%!\D:<R3,/E3_$^U=]:_#_`$:``S^?<GOO?:/_`!W'\ZV]
M(TFVT;3X[2W4<#+OCEV[DU?HN.Q2LM'T[3B&M+*"%\8WJ@W8]-W6KM%%(844
M44`%%%%`!1110`4444`%%%%`&1XI_P"17U#_`*Y'^=>,U[-XI_Y%?4/^N1_G
M7C--$L****8CT;X;?\@^^_ZZK_*NWKB_AO&PTJ\D/W6G"CZA1G^8KM*EE(**
M**!A1110`4444`8/C.W%QX5O.FZ,+("3TPPS^F:\@KVOQ`BR>'=25AD"VD;\
M0I(_45XI31+"BBBF([7X;W)35+RVSQ)"'_%3C_V8UZ17DW@641^*K=2,^8CJ
M/;Y2?Z5ZS292"BBBD,S==TB+6]*ELY,!C\T;G^%QT/\`3\:\8G@EMKB2"9"D
ML;%74]B*]YKAO'OA_P`Z/^V+9,R(`+A0.J]F_#H?;'I30FCSNE1VC=71BK*<
MA@<$'UI**9)[#X6UY==TL.YQ=0X6=??LWT./YUN5XOX>UE]#U:.Z`W1'Y)5]
M5/7\1UKV6&:.X@2:%P\;J&5AT(-2RD/HHJ.>>*VMY)YG"11J6=CV`H&97B;7
M%T/2FE!!N9,I"I&?F]?H*\QT#1Y=>U=8"6\O.^:0\X7OSZFEUW5Y_$.L&54;
M:2(X(NX&>/Q->F^&=#70]*6(@&YDP\S`Y^;T^@IBW-:&&.W@2&%`D:*%51T`
M%/HHI#"BBB@`HHHH`Y#XC?\`(O6__7TO_H#UP.C:3+K5\;2&14D\MG7=T)';
MVKOOB-_R+UO_`-?2_P#H#UR7@AV3Q;:*IP'$BM[C83_,"F2]S#N;::TN)+>X
MC:.6,X96Z@U%7L/B+PU;:];$X6*\4?NYL?HWJ/Y5Y/?Z?=:9=M:WD1BE7G![
MCU![B@&BM6EHNM76AWPN+<Y4\21D_*X]#_0UFT4Q'M^E:K:ZS8K=6KY4\,I^
M\A]#5ZO%-%UJZT.^%Q;G*GB2,GY7'H?Z&O7=*U6UUFQ6ZM7RIX93]Y#Z&I*3
M+U%%%`PHHHH`\$D1HI&C<8925(]"*]KT+_D7M-_Z]8O_`$`5X[JD9AU:]B8@
MLD[J<=,AC7L.@L&\.Z:5((^RQC@]PHILE&C1112*"BBB@`HHHH`CGFCMK>6>
M4XCB0NQ]`!DUX=?7<E_?3W<OWYG+D>F>U>E>/M2^QZ$MJIQ)=OM_X".3_0?C
M7G.E6#ZGJEM9)G,KA21V'4G\!DTT)E1E*G#`@X!Y'8TE=M\0-'6UGMM0@C5(
MG40N%'1E'R_^.C'_``&N)IB'Q2R03)-$Q22-@RL.H(Y!KV[2K]=3TNVO4QB5
M`2!V/0C\#FO#J[_X=:IQ<:7(W_3:+)^@8?R/YTF".^HHHI%!1110!!>6L=]9
M3VLH_=S(4/MD=:\0O;22PO9K2;_61.4..^.]>[5YQ\1-+,-]#J2+\DX\N0C^
M^.F?J/\`T&FA,XFI()I+:XBGB.V2)PZGT(.14=%,D]TT^]CU'3[>\B^Y,@<#
M.<>H_#I5FN'^'>J&6UGTN1LM%^]B'^R3R/S.?^!5W%26%%%%`%>^NEL;"XNG
M(VPQL_/?`Z5X9)(\TKRR-N=V+,?4GK7IGQ!U(6VCQV*-^\NF^8?["\_SQ^M<
M;X2TW^T_$5O&PS'%^^D^B_\`U\"FA,],\.:9_9.A6UJ1B7;OE_WSR?RZ?A6K
M112&%%%%`!11574;V/3M.N+R3[L*%L>I[#\3@4`>:>.]2^VZ^;=&)BM%\L#M
MN/+'^0_"N7P<9QQZT^662>9YI6+R2,69CU)/)-=]/X8_XM]$JQ@WD8^U\#DY
MY(_[YP/JHID[GGU%%%,1Z?\`#_5!=:,UB[9EM6X![H>1^N1^5==7COA35?[)
MUZ"5SB&7]U+[`]_P.#7L5)E(****0PHHHH`****`"H+RTAO[.6UN%W12KM85
M/10!XGK>DRZ+JDMG(2P7YHW(QO4]#_3Z@UG5ZSXQ\/G6M-$L"YO+?+1C^^.Z
M_P!1[_6O)B""01@CJ*9+"O2O`_B/[;;C2[I_](B7]RQ_C0=OJ/U'TKS6I;:X
MEM+F.X@<I+&P96'8B@#WBLCQ'KD>A:6TYPT[_+#&3]YO7Z#K_P#KI-)\0VFH
M:%_:4LB0B,8N`>B,.OY]OJ.]>8^(]<DUW5&G.5@3Y88R?NKZ_4]?_P!5`VS-
M=YKRZ9W+RSRODGJ68FO6/"GAU=#L-TRJ;V89E8<[1V4'^?O6)X&\->6BZO>1
M_.PS;HPZ#^_^/;\_2N[H8)!1112&%%%%`!1110`4444`%%%%`!1110`4444`
M9'BG_D5]0_ZY'^=>,U[-XI_Y%?4/^N1_G7C--$L****8CT[X<_\`(O7'_7TW
M_H"5U]<?\.74Z#<H#\PN22/8JN/Y&NPJ2T%%%%`!1110`4444`9^N_\`(O:E
M_P!>LO\`Z`:\2KV?Q/-Y'AG47W`9A*9/^UQ_6O&*:)84444Q'0>"03XNLL#I
MYF?^^&KUVO+/A]&7\2E@1B.!V.?3(']:]3I,I!1112&%(Z+(C(ZAD8892,@C
MTI:*`/&_$VAOH>JM$`3;29>%B<_+Z'W%8U>S^(=%CUS2GMC@3+\T3_W6_P`#
MTKQN:&2WG>&9"DB,593U!%-$L97H/P_UW<K:/._*Y>W)/4=2O\S^=>?5)!/+
M;7$<\+E)8V#(P[$4P/>:\U\<^(OMEP=+M7S;Q-^]8'[[CM]!_/Z5?U3QRDGA
MN(VC;-0G!1PO_+''4_CV_P#K5S7A70#KFIA9`PM(OFF8=_1?Q_QI#;.A\!^'
M>FL72^UNI_5C_3\?:N_I$18T5$4*BC"J!@`>E+2&%%%%`!1110`4444`<M\0
M$5_#.YADI.C+['D?R)KBO!7_`"-UC_VT_P#1;5V_C[_D6'_ZZI_.N(\%?\C=
M8_\`;3_T6U,3W/7JR=>T"UUZS\J;Y)5YBF`R4/\`4>U:U%(9XAJNE76CWS6M
MTF&'*L/NN/451KVO6M%M=<L3;W`PPYCE`^9#ZC^HKR+5=*NM'OFM;I,,.58?
M=<>HIDM%&M+1=:NM#OA<6YRIXDC)^5QZ'^AK-HIB/;]*U6UUFQ6ZM7RIX93]
MY#Z&KU>*:+K5UH=\+BW.5/$D9/RN/0_T->NZ5JMKK-BMU:OE3PRG[R'T-24F
M7J***!GB6N_\C#J7_7U+_P"AFO5?"C!O"^GE2"/*QP>X)KRWQ#&8O$>I*Q&3
M<.W'H23_`%KTOP5_R*-C_P!M/_1C4V2C?HHHI%!1110`4451UC4!I>D75Z1D
MQ)E1ZL>!^I%`'F?C;4O[0\12QJ?W=M^Y7ZC[WZY'X5K?#G3?,NKG4G7Y8QY4
M9/\`>/)_3'YUP[,68LQ)8G))/)->S>&]-_LK0;6V9<2[=\GKN/)S].GX4R42
M:]IO]K:)=68`,CIF//9QR/IR,?C7BA!!((P1U%>^UY%XSTW^SO$4Y12(;C]\
MGX_>_7/Z4(;.?JYI5^^EZK;7J=8GR1ZCH1^()JG13)/>XI$FB26-MR.H93Z@
M]*=7+>`]3^W:"+9VS+:-L_X">5_J/PKJ:DL****`"LOQ%I@U?0[FU'^LV[XS
MCHXY'Y]/QK4HH`\"(()!&".HHKH/&6E?V9K\I10(;C]ZF.V>H_//Z5S]407]
M%U)])U>WO$/"-\X_O*>"/RKVR.1)8UD1@R,`RL.A!KP2O4O`>J_;M%-I(?WM
MH=@]T/W?ZC\!292.KHHK/UO41I6C75X3AHT.SC/S'A?U(I#/,?&.HG4?$=QA
MLQ0?N4Q[=?US76_#W3?L^DRWSKA[E\+D?P+_`(G/Y"O.;6WDO;V&WCYDFD"#
M/J3BO<;.UCLK.&UA&(XD"+^`IL2)J***0PHHHH`*XCXBZEY5E;Z<A^:9O,D_
MW1T'XG_T&NWKQGQ/J7]J>(+J=3F)6\N/_=7C/X\G\::$QGAS3O[5UZUMB`8]
M^^3(XVKR1^.,?C7M)`(((R#U!KA?ASIVRWNM2<#,A\F/CD`<G\SC\J[JA@CQ
M7Q!IO]DZY<V@'[L-NC_W3R/\/PK,KT3XC:;YEK;:DB_-&?*D(_NGD?KG\Z\[
MH$PKV/PIJ?\`:OAZWE8YEC'DR?[R]_Q&#^->.5V'P]U/[-JTM@[?)=+E?]]>
M?U&?R%#!'IM%%%(H****`"BBB@`HHHH`*\V\=>'OLEQ_:MJF()3B90,!']?H
M?Y_6O2:CG@BN;>2"9`\4BE74]P:`/!J*U_$FB2:%JKP?,;=_GA<]U]/J.GZ]
MZR*H@>LTJ121+(RQR8WJ#PV.F:Z3P?X;.L7GVFY7_086^8$?ZQO[H]O7_P"O
M7,5V/@;Q#]BNAIET_P#H\S?NB3]QSV^A_G2&CTP````8`Z`4444B@HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`R/%/\`R*^H?]<C_.O&:]F\4_\`(KZA
M_P!<C_.O&::)84444Q'HWPV_Y!]]_P!=5_E7;UQ_PY4#0+AL#<;I@3CG&U?\
M3785+*04444#"BBB@`HHHH`Y?Q]<^1X9:+O/*B?E\W_LM>55V_Q'OA)?6EBI
M_P!4AD?ZMP/T'ZUQ%-$L****8CO_`(;6AVW]X<[25B7TSU/\UKOJR/#.FG2M
M`MK=UVRE?,E!Z[FYP?IP/PK7J2T%%%%`!1110`5Q/CSP\MQ;'5[9`)HA^_`_
MC7IGZC^7TKMJ;)&DL;1NH9&!5E/0@T`>"45)<1"&YEB!R$<J#ZX-1U1`5[/X
M<TR'2]$MX8@-SH))&_O,1R?Z5XQ7NMA_R#[;_KDO\A28T6****104444`%%%
M%`!1110!RWQ`=4\,[6."\Z*ON>3_`"!K@O"W_(SZ?_UU'\J[?XC?\B];_P#7
MTO\`Z`]<1X6_Y&?3_P#KJ/Y4T2]SV:BBBD4%9NM:+:ZY8FWN!AAS'*!\R'U'
M]16E10!XAJNE76CWS6MTF&'*L/NN/451KVO6M%M=<L3;W`PPYCE`^9#ZC^HK
MR+5=*NM'OFM;I,,.58?=<>HIDM%&M+1=:NM#OA<6YRIXDC)^5QZ'^AK-HIB/
M;]*U6UUFQ6ZM7RIX93]Y#Z&KU>*:+K5UH=\+BW.5/$D9/RN/0_T->NZ5JMKK
M-BMU:OE3PRG[R'T-24F>5>+HS%XJOU8@DN&X]"H/]:]"\$.K^$[15.2AD5O8
M[R?Y$5P7C7_D;K[_`+9_^BUKM_`/_(L)_P!=7_G3!;G3T444AA1110`5P7Q&
MU+"6NFHW4^=(!^2C^?Y"N])`!).`.I->*:_J)U77+J[SE&?$?^X.!^@S^--"
M97TV6V@U*VFO%=[>.0,ZH`2P'.,&O2D\?Z(R@DW"D_PF+D?D:\\M=!U6^MUN
M+:QFEA;.UU'!QQ4W_"+:Y_T#)_R%`CO_`/A/M#_YZ3_]^C7->,==TG7+2W:U
M>3[3"YQNC(!4]?Y"L7_A%M<_Z!D_Y"C_`(1;7/\`H&3_`)"@-3(HJ2>"6VG>
M">-HY4.UE88(-1TQ'2^!]2-AXACB8XBNAY39/?JI^N>/QKUBO`T=HW5U.&4Y
M!]#7MNC:BNK:1;7J]9$^8>C#@C\P:3*1?HHHI#"BBB@#FO&^E?VCH331INGM
M3YBXZ[?XA^7/X5Y/7OC*'4JP!4C!!'!%>+>(-+.D:U<6@!$8;=$3W0\C_#\*
M:$S,K;\*:K_9.O02N<0R_NI?8'O^!P:Q**9)[[7!_$?4=L5KIJ$Y8^<_/;D*
M/SS^0K?\)ZL-4\/PR2-F6']U*6]0.OXC!_.O,O$&I?VMKES=@_NRVV/_`'1P
M/\?QI(IF[\/M-^TZO)?.I,=LGRGMO;C\>,_I7IM87A#3?[-\.VZLN)9AYTGX
M]!^6*W:0(****!A1110!C^*=2_LOP_<S*P65QY47^\W''T&3^%>-5VWQ$U+S
M;^#3D8%8%\R0#^\>@/X<_P#`JY2QTR]U)G6SMGF*`%M@Z4T2SN]%\9Z)I^E6
M]EMN8_)C"DF(89NI(P3WR?QK0_X3[0_^>D__`'Z-<!_PBVN?]`R?\A1_PBVN
M?]`R?\A0%V=EJ_B_0=3TFZLR\V98R%S%T;J#^>*\VK7_`.$6US_H&3_D*IWV
MF7NFLBWEL\)<$KO'6@"I4UI=265Y#=0G$D3AU_`U#13$>[VES'>6<-S$<QRH
M'7Z$9J:N.^'NJ?:=*DL';]Y;-E/]QN?YY_,5V-26%%%%`!1110`4444`%%%9
M/B'7(M"TUKAL-,WRPQG^)O\``=__`*]`'-_$/4;,VT6G[%DNPPD#`_ZH?_7]
M/Q]*\\JTQN]6U'/SSW5P_P"+$_Y_"NPUKP,+30(I[0F2\@7,X!SY@[X^G\O>
MF3N<+1113$>K^#?$/]L6'V>X;-Y;@!B?XUZ!OKZ__7KIJ\,TW4)]+U"&\MSB
M2)LX/1AW!]B*]ITW4(-4T^&\MSF.5<X/53W!]P:3*3+5%%%(84444`%%%%`!
M1110`4444`%%%%`!1110!D>*?^17U#_KD?YUXS7LGBQU3PMJ!8X'EX_$D`5X
MW31+"BBBF(]+^'$H.C746.5N-V?JH']*[*O,?A]J26NL2V<AP+M`%/\`M+D@
M?D37IU2RD%%%%`PHHHH`*CN)X[6VDN)FVQQJ78^@%2$@`DG`'4FO-O&?BI+_
M`/XEVGR[K8<RR+T<^@]J`.7U6_?5-5N;U^LKY`]!T`_``53HHJB`KI?!>BG5
M-96>1<VUJ1(^?XF_A'YC/T%8NF:=<:K?Q6ELFYW/)[*.['V%>R:1I<&C:;%9
MP<A>68]78]328TB]1112*"BBB@`HHHH`****`/"K[_D(7/\`UU;^9JO5B^_Y
M"%S_`-=6_F:KU1`5[XB+&BHHPJC`'H*\#KWVDRD%%%%(84444`%%%%`!1110
M!R'Q&_Y%ZW_Z^E_]`>N(\+D#Q/I^3C]\*[?XC?\`(O6__7TO_H#UP.A?\C#I
MO_7U%_Z&*:)>Y[;1112*"BBB@`K-UK1;77+$V]P,,.8Y0/F0^H_J*TJ*`/$-
M5TJZT>^:UNDPPY5A]UQZBJ->UZUHMKKEB;>X&&',<H'S(?4?U%>1:KI5UH]\
MUK=)AARK#[KCU%,EHHUI:+K5UH=\+BW.5/$D9/RN/0_T-9M%,1K^)KZWU/6Y
M+ZV9BDZ(Q5A@J0H!'Z5WGP_D5_#6T=4G=3]>#_45Y97IWPY_Y%ZX_P"OIO\`
MT!*3&CKZ***104444`8/C'4O[-\.SE6*S3_N8\>_7],_I7DD$,ES<101#=)*
MX11ZDG`KK/B#J7VG5X[%&)CMD^8=M[<_CQC]:A\`Z=]LU[[2P/EVB;^G!8\`
M?S/X4R7N>EV-I'86$%I%]R%`@/KCO5BBBD4%%%%`'FWQ#TSR-2AU%!\EPNQ_
M]]>GYC'_`'R:XNO9O$^F?VMH%S;JFZ91YD7'.X=A]1D?C7C--$L*[WX<ZGA[
MG3';@_OHOKT8?R_(UP57]&U`Z7K%K>`G;&XW@=U/!'Y9I@CVZBD5@ZAE(*D9
M!!X(I:DH****`"N,^(6E?:-.BU*,?O+<[']T)_H?YFNSJ*YMX[NUEMY1F.5"
MC#V(Q0!X/15G4+*33=0GLY>7A<J2._H?Q'-5JH@T],UJXTRRU"VB^[>1;"?[
MISU_(L/Q'I2^'=,_M;7;:U(S'NWR_P"X.3^?3\:RZ]$^'.F^7:W.I.OS2'RH
MR?[HY/ZX_*D-'<T444B@HHHH`*9-,EO!)-(VV.-2['T`&33ZY;QYJ7V+0?LR
M-B2[;9[[1RW]!^-`'FFHWCZAJ-Q>2?>FD+X]!V'X#BO3/`FF_8M`%PZ@2W;>
M83WVCA1_,_C7F>GVCW^HV]HG#32!,^F3UKW&&%+>".&-=L<:A%'H`,"FQ(?1
M112&%<SXYTS[?X?>95S+:GS1C^[_`!?IS^%=-2.BR(R,,JPP1ZB@#P.BKVLZ
M>VE:O<V;=(W.T^JGD'\L51JB#9\+:G_97B"WF9L1.?*D_P!UO\#@_A7LE>!5
M[/X9U+^U=`M;AF+2A?+E)Z[AP3^/7\:3*1K4444AA1110`444$@`DG`'4F@"
M"\O(+"TENKF01PQC+,:\<UW6I]<U)[J7Y4'RQ1YR$7_'UK5\8^)?[8NA:VK'
M[%">#_ST;^]]/2CP?X:.L7?VJY3_`$&%N0?^6C?W?IZTR7J=#X%\._8[<:I=
M)B>4?N5/5$/?ZG^7UKM*````!@#H!12*/+?&GAS^RKO[;;)BSG;D#_EF_I]#
MR?TKE*]WN[2&^M);6X3?#*NUEKQG6](GT34I+2;E>L;XX=>QIHEHSJZ?P9K_
M`/9.H_9IWQ:7!`;/\#=F_H?_`*U<Q13`]]HKD/`VO_;[+^SKA\W-NOR$_P`<
M?^(Z?3'O77U)04444`%%%%`!1110`4444`%%%%`!4<]Q!:Q&2XFCBC'\4C!1
M^9KS'Q1XCU=-;O+2*^EB@BDVHL7R$#CN.?UKEY9I9WWS2O(W]YV)/ZT["N=M
MXS\56M_:?V;I\AD0L&EE&0IQ_"/7G!KAJ**8@HHHH$*CM&ZNC%64Y#`X(/K7
MH.@^/XV1;?6!M<8`N$&0?]X=C[C\A7GM%`SW6UOK2^0/:W,4RXS^[<''U]*L
M5X%5C[=>?\_4_P#W\-*P[GNC,$4LQ`4#))/`%8NI^+-(TL$/=+-+CB*#YS^)
MZ#\37D$LTLQ!EE>0CH68G%,HL%SH]=\8W^LJT$?^BVIX,:'EQ_M'O].E<Y14
MUK:7-[,(;6"2:0_PHI)IB(:T-(T6]UJZ$%I'D#[\AX5!ZD_TZUU&C?#Z>4K-
MJTGE1]?)C.6/U/0?K^%=]:6=M86ZV]K"D42]%44KA8HZ%H%IH-H8H/GE?F29
MA\S_`.`]JU:**104444`%%%%`!1110`45Q=U\1[&/(M;*>8CNY"`_P`_Y5BW
M7Q$U27(MX+>`'O@LP_/C]*+"N<Q??\A"Y_ZZM_,U7ITCM+(TCG+,2Q/J33:H
MD*]]KP*NRLOB'>6T$44UE!*(U"Y5BI(`Q[\TF-'I=%<1;?$BTD=1<V$L()P6
M1P^!Z]!7;TB@HHHH`****`"BL;Q!XBM_#\4#31/*TS$*JD#@=3^HK!_X639_
M]`^?_OL4!<F^(\BC0[6/^)KD,/H%;/\`,5YW8R>5J%M)OV;)5;=G&,$<YK9\
M3^*&\0&&-+?R((22`6W%B>Y]/I7/4R6>^T5YO9_$:[AA2.YL8YRJ[2RR%2Q]
M3D&M!/B3:D+YFG3*>X60''\J5AW.XHJ&TN4O+."ZC#!)HUD4-U`(R,_G4U`P
MHHHH`*S=:T6UURQ-O<###F.4#YD/J/ZBM*B@#Q#5=*NM'OFM;I,,.58?=<>H
MJC7M>M:+:ZY8FWN!AAS'*!\R'U']17D6JZ5=:/?-:W288<JP^ZX]13):*->G
M?#G_`)%ZX_Z^F_\`0$KS&O3OAS_R+UQ_U]-_Z`E#!'7T45#=W*6=G/=2!BD,
M;2,%ZD`9./RI%$U5[Z\BT^QFNYCB.)"Q]_:N&NOB3(<BTTY5]&EDS^@`_G7-
M:QXEU+7%$=U(BPJ=PBC7"Y]?4_B:=A7,Z[N9+R\FN93F25R[?4G->G>`;-;?
MPXMP`-]S(S$]\`[0/T/YUY76UH_BG4]$C\FVD1X,D^5*NY0?;H1^=`D>QT5Y
M]!\2I!@7&FHW(R8Y2,#OP0?YUZ#2*"BBLC7]?@\/VT4LT,DOFMM4)@?GF@#7
MKQSQ7IG]E>(;B)1B*0^='_NMV_`Y'X5M7?Q'OI!BTLX(,]W8R'^@_2N5U#4;
MK5+IKF\E,DI&,D8P/0`4T2V5:***8CU7P+JPO]$%J[?OK3"')ZI_"?Z?A745
MX;IVIWFDW/VBRF,4F,'@$$>A!X-=1;?$?44(^TV=M*H'.S*$_CDC]*5BDSTJ
MBJNFWRZEIT%XB%%F7<%)Y%6J0PHHHH`\Z^(NF^7=V^I(IVRCRI#VW#I^8S_W
MS7#U[1XCTT:KH-U;`9DV[X\#)WCD?GT_&O%Z:)8^&%[B>.&-=TDC!%`[DG`K
MW#3K&+3-.@LH?N0H%SZGN?Q.3^->9>!=/^V^(TE89CME,ISZ]!^IS^%>KT,:
M"BBBD,***X_6O'D>F7T]G#8O+)$=I9W"C/X`Y_2@#L*\E\:ZHNI>('6)@T-L
MOE*0>">I/YG'X5)J'CK5[Z)XHS%;1L,'RE.['U/],5S%-$MG8?#NT2;6YKEL
M$P1?*/=N,_EG\Z]-KP[3=4O-(NOM%E+Y;XP>`0P]"#756_Q(O4"BXL8)<==C
M%,_GFAC3/1Z*S="U==;TQ+U83%EBI0MG!'O6E2&%%5[Z\BT^QFNYMWEPH68*
M,D^PKAKKXDR'(M-.5?1I9,_H`/YT!<7XCZ:`;74D`!8^3)[GDK_[-^E<%6KK
M'B/4M;"K=RKY2MN6)%PH/\S^)K*IDL*[+X?:L+74I-.E;$=R,QY/1QV_$?R%
M<;2H[1NKHQ5E.0P."#ZTP/?**\MM/B!K$"JLRV]P!U+H0Q_$$#]*[7PUXD7Q
M%#.?LY@D@*[EW;@<YP0<#T-2.YNT45Q4WQ(L%SY%C<OQQO*KS^&:!G:UY[XU
M\5>89=(L6^0?+/*#][_9'MZ_E]<_5?'NHW\+0VT:6<;`@E#N?'^]V_`5RE.P
MFR>RM)+^]AM(?]9*X09[9[U[=864.G6,-I`N(XEVCW]3]2>:\+1VC=71BK*<
MA@<$'UKK-.^(&J6H5+N..[0#&6^1_P`QQ^E#$CU"BL30O%%EKSO%`DD<R+N9
M)`.G3((//6MND4%8'BS0EUK26,:9NX`7B(')]5_'^>*IZGX]L+"YGMH[:>:>
M%V1NBKD9!YZ]1Z5@7?Q&U"566UM((,]&8ER/Y#]*8KG&44K,68L3DDY-)3))
M[.[FL+R*ZMVVRQ-N4U[)H>LV^N:<ES"<..)8^Z-W'T]#7BE7M+U>]T>X,]E,
M48C#*>58>XI#3/;Z*\_L_B2V`+[3P3W>!\?^.G_&NXL;R+4+&&[AW>7,@90P
MP1[&D5<L4444`%%%%`!1110`4444`<S?^!M,U&_FO)I[M9)6W,$=0`?;*U77
MX=:.&!,]ZP!Z&1<'_P`=KKJ*`L<TG@/0D<,T$K@?PM*<'\L5-_PA7A[_`*!_
M_D:3_P"*K?HH"Q@?\(5X>_Z!_P#Y&D_^*H_X0KP]_P!`_P#\C2?_`!5;]%`&
M!_PA7A[_`*!__D:3_P"*I#X)\/$$?8,>XFD_^*KH**`.8_X0'0_^><__`']-
M0O\`#O1G<LLUX@/\*R+@?FIKK:*`L<A_PKG2/^?F^_[[3_XFGQ_#S1D;+27<
M@QT:08_117644!8P[;P?H5L05L$D8=Y6+Y_`G'Z5L0P0VT8C@B2)!T5%"C\A
M4E%`!1110`4444`%%%%`!1110`4C*'4JP!4C!!'!%+10!R'_``KG2/\`GYOO
M^^T_^)J6/X?:*BX8W4ASU:09_0"NJHH"QS'_``@.A_\`/.?_`+^FIQX)\/``
M?8,^YFD_^*KH**`L<T_@/0G<LL$J`_PK*<#\\U3D^'&EE?W=W>*WJQ5A^6T5
MV-%`6.,A^'=I#/'*+^8E&#`;!S@UV=%%`!1110`4444`87B7PVOB**W7[3Y#
M0LQ#>7OR#CCJ/05A1_#6`+^]U*1FSU6(*,?F:[JB@+''I\.=*"`/=7I;N0R@
M?EMI?^%<Z1_S\WW_`'VG_P`377T4"L<2_P`-[(EO+O[A1V#*IQ_*J_\`PK/_
M`*B__DM_]G7?447"Q7L;;[%I]M:;]_D1+'NQC=M`&<?A5BBB@84444`%%%%`
M!65K^A6^O6'D2G9*F6BD'\!_J/:M6B@#R-_!'B!7918A@#@,)DP??DYKN?!>
MEWFDZ/-!?0^5*UPSA=P;C:HSP3Z&NCHHN*P5#=VR7EG/:R%@DT;1L5Z@$8./
MSJ:B@9R'_"N=(_Y^;[_OM/\`XFKL'@?086W&U>4Y!'F2M@?@"/UKHJ*`L83^
M#?#\CEFTY03_`'9'4?D#4,O@;0)``MH\>.Z3-S^9-='10%CF/^$!T/\`YYS_
M`/?TUT]%%`!65K>@6NO0Q174DR+$Q9?*(!S^(-:M%`'+CP#H8`&R<^_FU+%X
M%T"/.ZUDDS_?F;C\B*Z.B@+&!_PA7A[_`*!__D:3_P"*I&\$^'RI`L"I(ZB9
M\C_QZN@HH`Y9_A_HCH547*$_Q+)R/S!J'_A7.D?\_-]_WVG_`,377T4!8J:9
MI\.E:?#96Y<Q1`X+G).22<_B:MT44`%%%%`!7`ZA\/9KG4;B>"\BCBED+JC*
M25R<XKOJ*`,'POX=_P"$?M9U>999IG!9E&``!P/U/YUO444`%%%%`!7,7_@;
M3-1OIKR:XO!),Q9@KJ`/I\M=/10!R\/@#0XL;UN)L'^.7&?^^0*N-X.T!D5#
MIR87IB1P?Q.<FMRB@+'/MX)\/E2!8%21U$SY'_CU0?\`"`Z'_P`\Y_\`OZ:Z
M>B@+%/3-,MM)LEM+166($M\S9.35RBB@"M?V4>HV$UG,SK'*NUBA`('MFN>C
M^'^B(N&^TR'^\TG/Z`5U5%`',IX#T)6!,,S`?PF4X/Y5/_PA7A[_`*!__D:3
M_P"*K?HH"Q@?\(5X>_Z!_P#Y&D_^*J!_`>A,Q(AF4'^$2G`_.NFHH"QR)^'6
MCDD_:+T>V]/_`(FM?0_#EGX?\_[))._G[=WFL#C;G&,`>IK7HH`*XC_A6UG_
M`-!"?_O@5V]%`'')\.-+"`275XS=RK*!^6TU/'\/M%1<,;J0YZM(,_H!7544
M"L<L_P`/]$="JBY0G^)9.1^8-5I/AQIA7]U=W:MGJQ5AC\A7944#L<[H'A*W
MT&]DNHKF65GC,>&```)!_I71444`<M=^`M+O+R>ZDN+P/-(TC!77`).3CY?>
MH?\`A7.D?\_-]_WVG_Q-=?10%CEQX!T,`#9.??S:L#P3X>``^P9]S-)_\570
M44!8YB3P#H;[ML<Z9SC;*?E^F<_K55_AQI90B.ZO%;L692/RVBNQHH"QQ'_"
MMK/_`*"$_P#WP*["RM5L;"WM$.Y88UC!(QG`QFIZ*`"BBB@`HHHH`****`"B
MBLCQ1KG_``C?AVZU;[/]H^S[/W6_9NW.J]<''WL]*<8N345NQ2DHIR>R->BO
M(O\`A>'_`%+O_D[_`/:Z/^%X?]2[_P"3O_VNNOZAB/Y?Q7^9R_7L/_-^#_R/
M7:*\B_X7A_U+O_D[_P#:Z/\`A>'_`%+O_D[_`/:Z/J&(_E_%?YA]>P_\WX/_
M`"/7:*\B_P"%X?\`4N_^3O\`]KH_X7A_U+O_`).__:Z/J&(_E_%?YA]>P_\`
M-^#_`,CUVBO(O^%X?]2[_P"3O_VNC_A>'_4N_P#D[_\`:Z/J&(_E_%?YA]>P
M_P#-^#_R/7:*\B_X7A_U+O\`Y.__`&NC_A>'_4N_^3O_`-KH^H8C^7\5_F'U
M[#_S?@_\CUVBO(O^%X?]2[_Y._\`VNC_`(7A_P!2[_Y._P#VNCZAB/Y?Q7^8
M?7L/_-^#_P`CUVBO(O\`A>'_`%+O_D[_`/:Z/^%X?]2[_P"3O_VNCZAB/Y?Q
M7^8?7L/_`#?@_P#(]=HKR+_A>'_4N_\`D[_]KH_X7A_U+O\`Y.__`&NCZAB/
MY?Q7^8?7L/\`S?@_\CUVBO(O^%X?]2[_`.3O_P!KH_X7A_U+O_D[_P#:Z/J&
M(_E_%?YA]>P_\WX/_(]=HKR+_A>'_4N_^3O_`-KH_P"%X?\`4N_^3O\`]KH^
MH8C^7\5_F'U[#_S?@_\`(]=HKR+_`(7A_P!2[_Y._P#VNC_A>'_4N_\`D[_]
MKH^H8C^7\5_F'U[#_P`WX/\`R/7:*\B_X7A_U+O_`).__:Z/^%X?]2[_`.3O
M_P!KH^H8C^7\5_F'U[#_`,WX/_(]=HKR+_A>'_4N_P#D[_\`:Z/^%X?]2[_Y
M._\`VNCZAB/Y?Q7^8?7L/_-^#_R/7:*\B_X7A_U+O_D[_P#:Z/\`A>'_`%+O
M_D[_`/:Z/J&(_E_%?YA]>P_\WX/_`"/7:*\B_P"%X?\`4N_^3O\`]KH_X7A_
MU+O_`).__:Z/J&(_E_%?YA]>P_\`-^#_`,CUVBO(O^%X?]2[_P"3O_VNC_A>
M'_4N_P#D[_\`:Z/J&(_E_%?YA]>P_P#-^#_R/7:*\B_X7A_U+O\`Y.__`&NC
M_A>'_4N_^3O_`-KH^H8C^7\5_F'U[#_S?@_\CUVBO(O^%X?]2[_Y._\`VNC_
M`(7A_P!2[_Y._P#VNCZAB/Y?Q7^8?7L/_-^#_P`CUVBO(O\`A>'_`%+O_D[_
M`/:Z/^%X?]2[_P"3O_VNCZAB/Y?Q7^8?7L/_`#?@_P#(]=HKR+_A>'_4N_\`
MD[_]KH_X7A_U+O\`Y.__`&NCZAB/Y?Q7^8?7L/\`S?@_\CUVBO(O^%X?]2[_
M`.3O_P!KH_X7A_U+O_D[_P#:Z/J&(_E_%?YA]>P_\WX/_(]=HKR+_A>'_4N_
M^3O_`-KH_P"%X?\`4N_^3O\`]KH^H8C^7\5_F'U[#_S?@_\`(]=HKR+_`(7A
M_P!2[_Y._P#VNC_A>'_4N_\`D[_]KH^H8C^7\5_F'U[#_P`WX/\`R/7:*\B_
MX7A_U+O_`).__:Z/^%X?]2[_`.3O_P!KH^H8C^7\5_F'U[#_`,WX/_(]=HKR
M+_A>'_4N_P#D[_\`:Z/^%X?]2[_Y._\`VNCZAB/Y?Q7^8?7L/_-^#_R/7:*\
MB_X7A_U+O_D[_P#:Z/\`A>'_`%+O_D[_`/:Z/J&(_E_%?YA]>P_\WX/_`"/7
M:*\B_P"%X?\`4N_^3O\`]KH_X7A_U+O_`).__:Z/J&(_E_%?YA]>P_\`-^#_
M`,CUVBO(O^%X?]2[_P"3O_VNC_A>'_4N_P#D[_\`:Z/J&(_E_%?YA]>P_P#-
M^#_R/7:*\B_X7A_U+O\`Y.__`&NC_A>'_4N_^3O_`-KH^H8C^7\5_F'U[#_S
M?@_\CUVBO(O^%X?]2[_Y._\`VNC_`(7A_P!2[_Y._P#VNCZAB/Y?Q7^8?7L/
M_-^#_P`CUVBO(O\`A>'_`%+O_D[_`/:Z/^%X?]2[_P"3O_VNCZAB/Y?Q7^8?
M7L/_`#?@_P#(]=HKR+_A>'_4N_\`D[_]KH_X7A_U+O\`Y.__`&NCZAB/Y?Q7
M^8?7L/\`S?@_\CUVBO(O^%X?]2[_`.3O_P!KH_X7A_U+O_D[_P#:Z/J&(_E_
M%?YA]>P_\WX/_(]=HKR+_A>'_4N_^3O_`-KH_P"%X?\`4N_^3O\`]KH^H8C^
M7\5_F'U[#_S?@_\`(]=HKR+_`(7A_P!2[_Y._P#VNC_A>'_4N_\`D[_]KH^H
M8C^7\5_F'U[#_P`WX/\`R/7:*\B_X7A_U+O_`).__:Z/^%X?]2[_`.3O_P!K
MH^H8C^7\5_F'U[#_`,WX/_(]=HKR+_A>'_4N_P#D[_\`:Z/^%X?]2[_Y._\`
MVNCZAB/Y?Q7^8?7L/_-^#_R/7:*\B_X7A_U+O_D[_P#:Z/\`A>'_`%+O_D[_
M`/:Z/J&(_E_%?YA]>P_\WX/_`"/7:*\B_P"%X?\`4N_^3O\`]KH_X7A_U+O_
M`).__:Z/J&(_E_%?YA]>P_\`-^#_`,CUVBO(O^%X?]2[_P"3O_VNC_A>'_4N
M_P#D[_\`:Z/J&(_E_%?YA]>P_P#-^#_R/7:*\B_X7A_U+O\`Y.__`&NC_A>'
M_4N_^3O_`-KH^H8C^7\5_F'U[#_S?@_\CUVBO(O^%X?]2[_Y._\`VNC_`(7A
M_P!2[_Y._P#VNCZAB/Y?Q7^8?7L/_-^#_P`CUVBO(O\`A>'_`%+O_D[_`/:Z
M/^%X?]2[_P"3O_VNCZAB/Y?Q7^8?7L/_`#?@_P#(]=HKR+_A>'_4N_\`D[_]
MKH_X7A_U+O\`Y.__`&NCZAB/Y?Q7^8?7L/\`S?@_\CUVBO(O^%X?]2[_`.3O
M_P!KH_X7A_U+O_D[_P#:Z/J&(_E_%?YA]>P_\WX/_(]=HKR+_A>'_4N_^3O_
M`-KH_P"%X?\`4N_^3O\`]KH^H8C^7\5_F'U[#_S?@_\`(]=HKR+_`(7A_P!2
M[_Y._P#VNC_A>'_4N_\`D[_]KH^H8C^7\5_F'U[#_P`WX/\`R/7:*\B_X7A_
MU+O_`).__:Z/^%X?]2[_`.3O_P!KH^H8C^7\5_F'U[#_`,WX/_(]=HKR+_A>
M'_4N_P#D[_\`:Z/^%X?]2[_Y._\`VNCZAB/Y?Q7^8?7L/_-^#_R/7:*\B_X7
MA_U+O_D[_P#:Z/\`A>'_`%+O_D[_`/:Z/J&(_E_%?YA]>P_\WX/_`"/7:*\B
M_P"%X?\`4N_^3O\`]KH_X7A_U+O_`).__:Z/J&(_E_%?YA]>P_\`-^#_`,CU
MVBO(O^%X?]2[_P"3O_VNC_A>'_4N_P#D[_\`:Z/J&(_E_%?YA]>P_P#-^#_R
M/7:*\B_X7A_U+O\`Y.__`&NC_A>'_4N_^3O_`-KH^H8C^7\5_F'U[#_S?@_\
MCUVBO(O^%X?]2[_Y._\`VNC_`(7A_P!2[_Y._P#VNCZAB/Y?Q7^8?7L/_-^#
M_P`CUVBO(O\`A>'_`%+O_D[_`/:Z],T#5?[<T*SU/R?(^TQ[_+W;MOMG`S^5
M95<-5I*\U8UI8BG5=H.YHT445@;!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`>?
M?$3QUJGA*_LH+""SD2>(NQG1B00<<885QG_"Z/$?_/EI7_?J3_XNK?QL_P"0
MSI?_`%[M_P"A54^%?A?1O$G]K?VM9_:/L_D^5^]=-N[?G[I&?NCK7LTJ=".&
M56<;_P##GCU:E:6)=*$K?\,7;'XV7ZNHU#2;:5,_,;=V0X]@=W^?2O4/#WB7
M3/$]A]KTV8N%P)(W&'C)'1A_49'H:\U^('PTL=,TB35]"CDB6#!GMBY==G=E
M)R<COD]/3'/%>!_$4OAOQ/;7`<"VE80W(8X7RR>3]1U_"IEAJ->DYT59HJ.(
MK4*BA6=T?2U%%%>0>L>3^+OB-XG\+^([C3FLM,:$'S+=VBD)>,_=)^<<]0>.
MH-=#\/?'3^+8KJ"^2WAOX#O"0@@/&>,@$D\'@_45%\4_#*ZUX<:_@CS>Z>#(
M".K1_P`:_P!?P/K7B_AK7)?#OB"TU.+)$3_O$'\:'AE_+./?!KUZ5"EB,/[J
MM)?G_P`$\JI6J4,1[SO%_P!?@?0_B_Q$GA?PY<:B0C3#$=O&_1Y#T!]AR3[`
MUP_@[XA>)_%7B&&P%IIB6Z_O+B18I,K&#SCY^IS@?6N6^*'BN+Q#K4-K8SB7
M3[1/E=3Q([`%F_`8'X'UKT?X8>&/[!\-K=3KB]OPLK@CE$_@7\CD^YQVK)T8
M4<-S37O/8T56=;$<L'[J.WHHHKS3T3Q*]^,/B&VO[B!+/3"L4K("8I,X!(_O
MUWO@#QH?%VFS&Z6&+4('Q)'%D`H>C`$D^H//;WKP#5?^0Q??]?$G_H1K1\)>
M(9?#/B*VU!"?*SY<Z#^.,D;A^@(]P*]ZM@J<J7N*S/"I8RI&K[[NCW+X@^)[
MWPIH,%_816\DLETL)$ZL5VE7/8CGY14'P[\6W_BVPO9[^&VC:"5440*P!!&>
M<L:R?C#/%<^!]/G@D62*6]C='4Y#*8Y""/;%5_@G_P`@?5?^OA/_`$&N!4H?
M5'.VMSN=67UM0OI8]1HHHK@.\1W6-&=V"HHRS$X`'K7A\_QHUW[1)Y%CIPAW
M'RQ)&Y;;GC.'QG%>B_$G5_['\$7K(Q66ZQ:QD>K_`'O_`!T-7SO':3S6L]S'
M&3#!M$CY'R[C@?G@UZN7X>$XN=17/+Q^(G"2A!GT#\._&5SXNL+U[Z*WCN;:
M51M@4A=C#C@D\Y#5V=?/WPGU4Z?XUBMF($5[&T+9[$#<I^N5Q^-?0-<N-HJE
M5:CLSIP=5U:5WN@KF_'.MZCX=\-2:IIL5O(\,B"43J2-C';Q@@YW%?UKI*HZ
MSIR:OHM[I[XQ<PM'DG&"1P?P.#7/3:4TY;'143<&H[GEGA[XN:MJ'B&PLM0M
M-/2UN)EB=HD=6!;@')8CJ1VZ5[#7R21+;7!!W1RQ-C@X*L#_`#S7U/HNHKJ^
MAV.HJ`/M,"2$#H"1R/P.17?F&'A3Y905DSAP%>53FC-W9P?C[XD7_AG7TTW3
M8+.4+"KS-.KL58DX'##M@]^M=7X+UC4=?\,P:GJ4,,4L[,46%64;`<`X))YP
M3],5\_Z_>R>(_%]Y<1?.UW=;(1DG*YVH/RQ7TMIEC'IFEVEA$<I;0I$IQC(4
M`9_2EBZ4*5&$;>\QX6K.K5E*_NHM4445YQZ!P_Q$\;W7A&.P2PBMY;FY+EA.
M"P5%QV#`Y)/'T-<59?&76WO[9+NTTU;9I5$S)&X8)D;L$N><9K#^)VK_`-K>
M-[M58F*SQ:H/0K][_P`>+?I7*7=I/8W3VUS&8YH^&0D''&>U>]A\'2]DN=:L
M\/$8NI[5\CT1]:45S?@+53K'@K3;ER#*D?DR?5#MR?<@`_C725X<XN$G%]#V
MH24XJ2ZA7GWQ`\8^(?"-[;O:6EC+I]PN%DEC<LKCJI(8#IR/Q]*]!K(\3Z#!
MXDT"YTV;`9US$Y_@D'W6_/K[9K2A*$:B<U=$5HRE!J#LSAO!'Q0O-?\`$"Z9
MJT%G")D/D/`K+EQS@[F/49_'`[UU_C3Q.GA7P_+>@1O=,0EO$_1W/J!S@#D_
M_7KYQD2\T;5F0[H+RSFZCJCJ>H_$5L^,/%]UXNO+6:=!%';PA%C'3>0-[?B?
MT`KU9X",JL91^'K_`%YGE0QTHTI1E\73^O(]`\'_`!#\3^*?$,%@++35MQ^\
MN)%B?*1CKC+]3P!UY/I7JU<=\./"O_"-^'5>XCVZA>8EFW+AD&/E3\/YDUV-
M>9BI4W4:IJR1Z6&C-4TZCNV%%%%<YT!1110!D^)M4GT7PU?ZE;+&TUO%O19`
M2I.>^"#^M>0_\+H\1_\`/EI7_?J3_P"+KVG4].M]7TVXT^Z#&"==CA3@X^M<
M!KWPO\-:?X>U.]@BN1-;VDLL9,Q(W*A(X^HKNPDZ"7+55VV<6*A7;YJ;LK'*
M_P#"Z/$?_/EI7_?J3_XNC_A='B/_`)\M*_[]2?\`Q=<#80I<:C;0R9V22JC8
M]"0*]X_X5'X5_P">5U_W_-=]>.%H64X[G#0EBJU^66QW5%%%>$>V>7^.?B/K
M'AGQ*^FV5M8R0K$CAID<MDCV8#]*YO\`X71XC_Y\M*_[]2?_`!=4_BY_R/<O
M_7O'_*MWX8^#=`\0^&[B[U6P^T3I>-$K>=(F%"(<85@.I->TJ>'IX>-2<;['
MC.=>I7E3A*VYG?\`"Z/$?_/EI7_?J3_XNO0?AWXMO_%MA>SW\-M&T$JHH@5@
M"",\Y8U+_P`*P\'?]`?_`,F9O_BZVM$\.:3X<AEATJU^SI*P9QYC/DCC^(FN
M2O6PTH-4XV?]>9UT*6(C-.I*Z_KR-2BBL'QGK3:!X2O]0C8"=4V0^N]B%!'K
MC.?PKBA%RDHKJ=DI*,7)]#G_`!A\3['P[<R:?8PB]OTX?YL1Q'T)')(]!^>:
MX"7XO^*))"RFRB!_@2#@?F2?UKB((9[^^CACW2W%Q($7/)9F.!^))KZ!L?AA
MX9M](2SN;`7,VT>9<,[!V;N001@>P_7G/L3IX;"Q2FKMGDPJ8C%2;@[)'.^&
MOC"EY>1VNNVL-L)#M%U"2$4]MRG)`]\UZH"&4,I!!Y!'>OESQ-HQ\/\`B2^T
MO<66"3",V,E"`RDX[X(KW/X8ZN^K>"+7S6+RVC-;,Q[[<%?_`!UE%88W#0C!
M5:>S-L'B9RFZ53='8UD^)M4GT7PU?ZE;+&TUO%O19`2I.>^"#^M:U<YX]_Y$
M36/^O<_S%<%))SBGW1WU6U!M=CSS1/BWKVI:]IUA-:::L5S=10N4CD#!68`X
MR_7FO9J^7/"G_(XZ)_V$(/\`T8M?4==F84H4Y14%8X\!5G4BW-W/&=;^+>O:
M;KVHV$-IIK16UU+"A>.0L55B!G#]>*]0\,ZI/K7AJPU*Y6-9KB+>ZQ@A0<]L
MDG]:^<O%?_(XZW_V$)__`$8U?0'@+_D1-'_Z]Q_,UIC:-.%&,HJS_P"`9X.M
M.=649.Z_X)T=9/B;5)]%\-7^I6RQM-;Q;T60$J3GO@@_K6M7.>/?^1$UC_KW
M/\Q7GTDG.*?='H56U!M=CR[_`(71XC_Y\M*_[]2?_%U[#X?UJ#Q!H=KJ5N1B
M9`74'.Q_XE/T-?+%>C?"3Q/_`&9K3:-<RA;2^.8]QX6;@#_OH#'UVUZ^,P</
M9\U-6:/(PF,G[3EJ.Z9U?Q!^(.K>%->@L+"WLI(I+59B9T<MN+..S#CY179^
M&=4GUKPU8:E<K&LUQ%O=8P0H.>V23^M>0_&C_D<;3_L'I_Z,DKU'P%_R(FC_
M`/7N/YFN.O2A'#0FEJSLHU)RQ,XMZ(Z.BBL+QEK1T#PGJ&H(<3+'LAY&=[':
MI]\$Y^@-<48N4E%=3LE)1BY/H<YXR^)]KX=NFT_3X$O;Y.)"6Q'$?0XY)]AC
M'KVK@S\7_%!G\P?8@N<^6(#M^G7./QKC=/L[C6-6M[.(E[BZF"!FR>6/4_S)
MKWQ/A=X572Q9-8LSX&;GS&\PMC[V<X'TQCVKV)PPV%2C-7;/)A/$XEN4'9(R
M?!_Q6@UN\CT_5X(K.ZDXCE1CY3MV7!Y4GMR<UZ17RKK6FRZ'KMYISD[[:8H&
MZ$@'Y6_$8/XU]$>!M:?7O!]A>3.7N`IBF8]2ZG&3[D`'\:YL;AH02J4]F=&"
MQ,YMTZFZ.BK)\3:I/HOAJ_U*V6-IK>+>BR`E2<]\$']:UJYSQ[_R(FL?]>Y_
MF*XJ23G%/NCMJMJ#:['GFB?%O7M2U[3K":TTU8KFZBA<I'(&"LP!QE^O->S5
M\N>%/^1QT3_L(0?^C%KZCKLS"E"G**@K''@*LZD6YNX4445YYWA7G_C+XGVO
MAVZ;3]/@2]ODXD);$<1]#CDGV&,>O:NC\9:T=`\)ZAJ"'$RQ[(>1G>QVJ??!
M.?H#7S=I]G<:QJUO9Q$O<74P0,V3RQZG^9->C@<+&HG4J;(\_&XF5.T(;L[(
M_%_Q09_,'V(+G/EB`[?IUSC\:[3P?\5H-;O(]/U>"*SNI.(Y48^4[=EP>5)[
M<G-:R?"[PJNEBR:Q9GP,W/F-YA;'WLYP/IC'M7@^M:;+H>NWFG.3OMIB@;H2
M`?E;\1@_C733AA<2G&$;-'/.6)PS4IRNF?55%<[X&UI]>\'V%Y,Y>X"F*9CU
M+J<9/N0`?QKHJ\><7"3B^AZT)*<5)=0KS_QE\3[7P[=-I^GP)>WR<2$MB.(^
MAQR3[#&/7M71>,]:;0/"5_J$;`3JFR'UWL0H(]<9S^%?.&E:?-K.LVEA$V);
MJ98][<XR>6/TZUWX+"QJ)U*FR.'&XF5-JG3W9V)^+_B@S^8/L07.?+$!V_3K
MG'XUVOA#XK6^MWL>GZM!'9W4G$<J-^[=O3GE2>W)]*UH_AAX572ULGL"[A<&
MY,C"0MC[V<XSWQC'M7B.K^&-0T[7[S2X+:XNC!-Y2O'"QWYP5X`ZD$''O71"
M.%Q*<8JS1SSEBL.U*3NF?3]%8WA2ZOKSPMI\VI0S0WOE;9EG0H^Y25R0>><9
M_&MFO(E'E;78]>,N9)E#6[V33=!U&_A5&EMK669`X)4LJDC..W%>0V7QA\0W
M-_;P/9Z8%EE5"1%)G!(']^O5O%?_`")VM_\`8/G_`/1;5\SZ5_R&+'_KXC_]
M"%>E@*-.I"3DKGFXZM.$XJ+L?5]%%%>6>F<9\1/%M_X2L+*>PAMI&GE9&$ZL
M0`!GC#"O/O\`A='B/_GRTK_OU)_\771_&S_D#Z5_U\/_`.@UQ7PQT'3?$/B2
MXM-5MOM$"6;2JN]DPP=!G*D'H37L8:E16&]I.-SR<14K/$>SA*QI?\+H\1_\
M^6E?]^I/_BZZ3P-\1]8\3>)4TV]MK&.%HG<M"CAL@>[$?I71?\*P\'?]`?\`
M\F9O_BZO:1X(\.Z%?B]TW3_(N`I4/YTC<'KPS$5A4KX1P:C"S_KS-J='%*:<
MIZ?UY'0445!>3FVL;BX4!C%&S@'O@9KSDKGH/0X7QI\3[;P[<OIVFPI>7Z<2
M,S?NX3Z''+'U`(QZYXK@C\7O%)E+AK,*3G8(.![=<X_&N&EEDGF>:5R\DC%G
M8]23R37O6B>&_AYJNGPPZ?#979:/!W3'S^0>6&0P/![#VKVYTJ&%@N:/-YGC
M0JU\3-\LK>1F>%_B]#J-W'9:W:QVLDK!4N(2?+R3C#`\J/?)_#K7J%>-M\%K
MF36;@+J,4&F!_P!RQ!>4KC/(X'MG/;.*];TZS_L_3+6R,SS?9XEB\R3[S[1C
M)]^*X,6J%TZ+^1W85U[-55\RS1117&=84444`%%%%`!1110!XM\;/^0SI?\`
MU[M_Z%5SX'_\Q[_MW_\`:E4_C9_R&=+_`.O=O_0J/@[JVG:9_;7]H:A:VGF>
M1L^T3+'NQYF<9(SC(_.O9:;P%E_6IXZ:6.N_ZT/6M<$3>']2$^WRC:RA]QP-
MNPYS[8KY4KV;XB_$33I=$FTC1;H7,UT-DTT6=J1]QGN3TX[$^U>:^$=#D\0^
M)K.P5<QEP\QQP(UY;_#ZD5>`@Z-*4YZ$XZ:JU8PAJ?2]F9FL;<W&?/,:F3(Q
M\V.?UJ>BBO#9[2"OF_X@^&O^$:\3S11*!9W.9[<#^%2>5_`Y'TQ7TA7BWQL_
MY#.E_P#7NW_H5=^73:K<JV9P9A!.CS/='.?#KPT/$?BB)9XP]E:_OIP1D-C[
MJGZGMZ`U]&5Y%\#_`/F/?]N__M2O7:68S<JSB]D/+X*-%274****X3N/ES_F
M</\`M_\`_:E;/Q'\+_\`"-^)':",+87F9;<*,!>?F3\"?R(K&_YG#_M__P#:
ME?07C7PVOBCPW/9+@7*?O;9CVD`X'T/(_'/:O?KU_8U(-[-:GA4:'MJ<TMUL
M>%3^)FO/A_%H%RY:6TOEEMR1_P`LBD@(S[,1_P!]>U>B_!/_`)`^J_\`7PG_
M`*#7C$D;PRO%*C)(A*LK#!4CJ".QKV?X)_\`('U7_KX3_P!!HQL%'#RMU88*
M3E7C?HCU&BBD)"J68@`<DGM7@'NGB_QIU7SM6T_2D;Y;>(S.!_>8X'Y!?_'O
MRN^!O"HO_A;K&4)GU/=Y78'R_P#5_P#CX-><>)-3?Q!XIOK]`7^T3D1``Y*C
MY4&/7`%'_"*>(_\`H`:K_P"`<G^%?0*ART(T^;E>C_7\SP/;7K2J<MUM^GY&
M?9W4MC?6]Y`0)8)%E0GLRG(_45]66-W'?V%M>1?ZN>)94^C`$?SKY3N[*[T^
M<P7MK-;3``F.:,HV#WP>:]W^$NK'4/!JVKG,EC*T/3JI^93^I'X5CF=/FIJH
MNAMEL^6;@^IWE%%%>*>R?./Q)TK^RO'-^`"([HBZ3.>=_+=?]K=76^%_%/V3
MX/ZLC2`3V1:WBR0?];]W'K@LW'/W?2K?QJTDR66G:O&G,3M;RD#/#<KGT`(;
M_OJO(4NIDM);57(AE=7=0>"5#`?^A&O?I16)P\;]+?@>#5D\/7E;K?\`$ZWX
M7:2-4\;VKNFZ*S4W+<<9'"_^/$'\*^AZ\P^"^E>1HU_JC@;KF41)TX5!S],E
MO_'17I]>;F%3GK-=M#T<!3Y**??4*HZSJ*:1HM[J#XQ;0M)@C.2!P/Q.!5ZO
M-_C)J_V3PW;Z8C#S+V7+#_IFF"?_`![;^1KGH4_:5%#N=%>I[.FY=CR?PSIS
M>(/%UA9S$N+BX#3'N5'S/^@-=9\8]*^R>*8-05<)>P#<?5T^4_\`CNRN&L='
MU34T=[#3;R[5#AF@@:0*?0X'%37'AS7+2!Y[G1M1AA09>22U=54>I)&!7T,H
MKVJES;:6/`C)^R<>7?6YZ3\%-5.[4](8C&!=1C\E;_V2O7J^9O`VK'1?&6FW
M1.(VE$,G&?E?Y2?PSG\*^F:\C,:?+6YNYZV7U.:ER]@HHKG/&_B5?"_AR:\1
MD^UO^[MD;NY[X]`.?_UUQ0@YR48[L[)S4(N3V1Y!\5[K3[KQM-]B0^;%&L=T
MX/#R#T]P,`_3';GG?"]U867B?3KG5(C)9QS!I%]/0GU`."1W`Q5OP?X?F\5^
M)X+1][0[O.NY">0@///J>GU.:B\7>'I?#'B.XTY\F+_60/\`WXST/U'(/N#7
MTD.2*^KWUL?/3YY/V]M+GTZ"&4,I!!Y!'>EKSOX3>*/[5T0Z/<R`W=@H$>3R
M\/0?]\_=^FVO1*^=K4G2FX/H>_2J*I!374****S-`HHHH`*R/%?_`")VM_\`
M8/G_`/1;5KUD>*_^1.UO_L'S_P#HMJNG\:]2*GP,^9]*_P"0Q8_]?$?_`*$*
M^KZ^4-*_Y#%C_P!?$?\`Z$*^KZ]/-=X_,\[+-I?(****\D]0^?\`XN?\CW+_
M`->\?\JY.R_M7R3]A^V^5NY\C=MW?AWZ5UGQ<_Y'N7_KWC_E72?"OQ-HNB^&
M+FVU+48;:9KUI`DA.2I1!G\P?RKZ"-1T\-&2C?1'@RIJIB91;MJSSC_BHO\`
MJ*?^1*^HZYS_`(3WPK_T'+7\S_A6II>MZ;K<4DFFWD=RD9VN8ST->9BZLZJ3
M<+6/1PM*%)M*=[E^O/\`XQ-*/!*",95KR,2<=%VM_7;7H%<WX]T=];\&:A:Q
M#,Z()HAR<LAW8`'<@$?C6&'DHU8M]S?$1<J4DNQX1X(CCD\;Z,LH&T72,,G'
M(.1^H%?3=?)VG7KZ;JEI?1J&>VF290>Y5@1_*OI*S\:^'+W3!?IJ]K'$%#.L
MLJJZ$]BI.<]?KCC->AF=.3E&26AP9;4BHRBV:;Z3ITES)<OI]JT\N/,E:%2S
MX&!DXR<#BK$%O!;(4@ACB0G)6-0HSZ\5\]^+/'FI:IXCN;C2=4O[6P!"0I%<
M/&&`&-Q`/4G)_*O6OALVJ2^#H+G5;F>XFN':2-IV+,(^`O)YQP3SZURUL+.E
M34Y/?H=-'%0J5'"*^9UU<YX]_P"1$UC_`*]S_,5T=<YX]_Y$36/^O<_S%<]'
M^)'U1T5OX<O1GS7%YGG)Y._S=PV;,[MW;&.]:G_%1?\`44_\B4>%/^1QT3_L
M(0?^C%KZCKW,7BO822Y;W/%PF%]M%OFM8^2)?,\Y_.W^;N._?G=N[YSWKZ4\
M!?\`(B:/_P!>X_F:^?\`Q7_R..M_]A"?_P!&-7T!X"_Y$31_^O<?S-8YB[T8
MO^MC;+E:M)?UN='7.>/?^1$UC_KW/\Q71USGCW_D1-8_Z]S_`#%>31_B1]4>
MI6_AR]&>+?#G3+?6?$LFG7:!H;BTE1N.G`P1[@X(]Q6!JVFW>@:W<6%P2ES:
MR8W*2,]U8>Q&"/K75_"/_D>XO^O>3^5=E\7O"YOM.CUZU0F>T&RX51RT6>&_
MX"3^1)[5[DJ_)B>1[-?B>+&ASX;G6Z?X'FWC#Q'_`,)/<Z9>N?\`28[!(;GY
M<#S%=\D?4$'CUQ7NG@+_`)$31_\`KW'\S7S17TOX"_Y$31_^O<?S-89C!0HQ
MBMKFV7S<ZLI/>QT=<+\7/^1$E_Z^(_YFNZKGO'.C2:[X/U"RA3?<;!)".Y93
MNP/<X(_&O,P\E&K%ON>G7BY4I)=CP[X=)$_C_2!,Y5?,8@C^\$8J/Q.!7TE7
MRGHNI/HVMV6HQC<;:99-O]X`\C\1D5]'1>-/#DNEKJ/]L6B0$`D/*`ZG&=I7
MKN]L5Z&9TY.<9)'!EU2*A*+9XC\3_P#DHNJ_]L?_`$4E>C_!@D^#KH$D@7[@
M>W[N.O'O$>K'7?$5_J9#!;B4L@;J$Z*#R>0`*]\^'.DOH_@FQBE4K-.#<.I[
M;N1_X[MZUIC/<PL8/?3\C/!^_B936VIU5<YX]_Y$36/^O<_S%='7.>/?^1$U
MC_KW/\Q7DT?XD?5'J5OX<O1GS_X4_P"1QT3_`+"$'_HQ:^HZ^6/#EQ%:>)])
MN9W$<,5[#)(YZ*H<$G\J^A/^$]\*_P#0<M?S/^%>GF4)2G'E5SSLNG&,9<SL
M='163I?B;1=:N6MM-U&&YF5#(4C)R%!`S^9'YUK5Y,HN+LU8]2,E)73.%^+G
M_(B2_P#7Q'_,UY1\.5B;X@:0)CA/,8CG^((Q7]<5[AXYT:37?!^H64*;[C8)
M(1W+*=V![G!'XU\Z:+J3Z-K=EJ,8W&VF63;_`'@#R/Q&17L8'W\/*"WU_%'D
M8WW,1&;VT_!GU97SG\3_`/DHNJ_]L?\`T4E>W1>-/#DNEKJ/]L6B0$`D/*`Z
MG&=I7KN]L5\[^(]6.N^(K_4R&"W$I9`W4)T4'D\@`5GEM.<:DI-=+&F8U(NF
MDGU/8?@P2?!UT"20+]P/;]W'7HM<K\.=)?1_!-C%*I6:<&X=3VW<C_QW;UKJ
MJX<3)2K2:[G=AHN-**?8\]^,DDB>"X50G:]ZBOQGC:Y_F!7FOPQ`;XB:4"`1
M^]//_7)Z]C^(NE2:OX(OXH0S2P@3HJ_Q;#DCWXS^.*^?]`U:30M>LM3C!8V\
MH9E!P67HRY]P2/QKT\%[^%E!;Z_D>;C/<Q,9O;0]H^(GCK5/"5_906$%G(D\
M1=C.C$@@XXPPKC/^%T>(_P#GRTK_`+]2?_%UW^J/X"\5VD.J:G=V<\<285GN
MVB9`><%0P.?8C->%:Y)ITNMW;:3#Y.G^81`F6/RC@'YB3SC//K2P=*E./+*&
MJW;#%U:L)<T9Z/:Q]&^#=:N?$/A2RU6[2))Y]^Y8@0HVNRC`))Z`=ZW:Y'X8
M?\DZTK_MM_Z->NNKRZZ4:LDN[/4HMRIQ;[(R/%?_`")VM_\`8/G_`/1;5\SZ
M5_R&+'_KXC_]"%?3'BO_`)$[6_\`L'S_`/HMJ^9]*_Y#%C_U\1_^A"O4RW^'
M,\S,?XD3ZOHHHKQCUSR[XV?\@?2O^OA__0:\?LOMOG'[#]H\W;SY&=VW\.W2
MO8/C9_R!]*_Z^'_]!KC_`(5ZOI^B^)[FYU*ZCMH6LFC#R="Q=#C\@?RKW<))
MPPG,E??\SP\5%2Q7*W;8YW_BHO\`J*?^1*]Z^'/VG_A`]-^U^;Y_[W=YN=W^
MM?&<\],5-_PGOA7_`*#EK^9_PJWIWBK0M7NQ:Z?J<%Q.06"(3G`ZUQ8FO4JP
MLX6MJ=N&HPI3NIWN;%%%9?B+5WT'0+O5$M&NC;J'\E6V[AD`G.#@`$GIVK@C
M%R:2.Z344VSQ+QA\-M4T.^EFTVVFO-,;+(T2[FB']U@.>/7I7#D%6((((X(/
M:O5;'XSWDNM6XO;&V@TPOB7RPS2*"",YS@X.#T[5Z'=7/A'6K(W%Y/H]U`1D
MR3/&=O'J>5(S[$5[?UJM12C6C?S1XWU:C6;=*5O)GAGA[QYKOAZXB,=Y+<6J
M\-:SN60KGD#/W3[BOH;1]5M];T>UU*T),-P@<`]5/0J?<$$'Z5\Q:VFGQZW>
MKI3L]@)6$#-G)7MUYQ]:][^%]K-:^`=/\XOF4R2*K#[JESC'L?O?\"K/,:<.
M15$K,TR^I/G=-NZ.PHHHKQSU@HHHH`****`"BBB@#S#XH^$M<\1ZE83:59?:
M(XH65SYJ)@DY_B(K@O\`A6'C'_H#_P#DS#_\77T917=2Q]2G!025E_7<XJN!
MIU)N;;U_KL>!V'PA\373+]J%K9(1EC)*'(Y]%SSWZUZWX4\'Z=X2LFBM-TEQ
M+CSKA_O28SCCH`,]!^M=#16=;&5:RM)Z&E'"4J3O%:A1117*=(5YA\4?"6N>
M(]2L)M*LOM$<4+*Y\U$P2<_Q$5Z?16M&K*E/GCN95J4:L.21YS\*_"^L^&_[
M6_M:S^S_`&CR?*_>H^[;OS]TG'WAUKT:BBE6JNK-SENQTJ2I04([(****S-#
MP7_A7/BO_A)/M?\`97[C[9YN[[1%]W?G.-V>E>]445T5\1*M;FZ&%##QHWY>
MIY#\0_AQJ6H^(/[2T&T$ZW0+7$?F(FR0=_F(X8?7D'U%=#\+O#FK>'--OX=5
MM?L[RS*R#S%?(`Q_"37>T54L74E2]D]OQ)CA81J^U6X5D^)TU"7PSJ$6E0>=
M>RPF.)-P7EOE)R2!P"3U[5K45S1?*TSHDKIH\1\&_#?Q!9^+-/O-5T\06EO)
MYS.9HV^91E0`K$_>Q7MU%%;5\1.O+FD94*$:,>6)YA\4/!.J>(-1L;_1[07$
MHB,4X\Q4(`.5/S$`]6_*H_ACX9\2^&=9NQJ6G>397,(#/YT;8=3\O"L3T+=N
M]>IT5?UN?LO8M*Q'U2'M?:INX4445RG28?B_13X@\*W^G(H:9X]T.<?ZQ>5Y
M/3)&,^A->'_\*P\8_P#0'_\`)F'_`.+KZ,HKJH8RI0BXQL<M?"4ZTN:5S(\+
MZ3_8?AC3M-90LD,($@!R/,/+X/IN)K7HHKFE)R;D^ITQBHI)=`KR/XD>%/%/
MB7Q,);'3/-LH(5CB?SXUW'[S'!8'J<=.U>N45K0K2HRYXK4SK456CRR>ARWP
M^\/W'AOPG#9WD8CNY)'FF0,&PQ.`,C@_*%KH-1LH]2TRZL9L>7<1-$V1GAAB
MK-%1.I*4W-[E1@HP4%L?.A^%_C$,0-(!`[BYBY_\>KW[1VO7T:S.I1>5>^2H
MG3<&P^.>02.OO5VBML1BIUTE)+0QH86%!MQ;U"O'_B!X:\8>*?$+26^E.=/M
MAY=L#<Q#(_B?!?C<?QP!FO8**BA6=&7-%*_F76HJM'ED]#C?ASX1?POH;->1
MA=2NCNG&X-L`)VJ"..G/U/M3/B1X1D\3Z+')8PJ^I6S9B&0I=3]Y<G`]^?3W
MKM:*/K$_:^UZA["'LO9=#P?P]X*\<^'M=M=3M](.Z%OG7[5#AT/#*?G[C_&O
M=T8LBL5*$C)4XR/;CBEHJJ^(E7:<DKBH8>-%-1;"BBBN<W"BBB@`K.\06LU]
MX;U6TMDWSSV<L4:Y`W,R$`9/`Y-:-%.+L[B:NK'SYI_PT\70:E:S2:3M1)D9
MC]IB.`""?XJ^@Z**WQ&)G7:<NAA0PT*%U'J%%%%<YT'C_P`1?!'B+7?%DE[I
MNG^?;F%%#^=&O('/#,#7)_\`"L/&/_0'_P#)F'_XNOHRBN^GF%6$5%):?UW.
M&>`I3DY-O7^NQ\Y_\*P\8_\`0'_\F8?_`(NO3_A=X<U;PYIM_#JMK]G>6960
M>8KY`&/X2:[VBHK8ZI5AR22L51P5.E/GBV%%%%<9V'EGC'X3G4;V74=!DBAD
ME.Z2UDX4MW*GMGTZ>_:N`?X=>+8YQ"=%F+'`!5T*\_[0./UKZ2HKNI9A5A'E
MW.*I@*4WS;'BWAKX/WTUPD_B!TM[=2";:)PSO[$C@#Z$GZ=:]GCC2&)(HD5(
MT`5548"@=`!V%.HK"OB)UG>9O1P\**M`*Q?%UA<ZIX3U*RLXO-N)H2L:;@N3
MD=S@5M45E&3C)270TE%2BXOJ>"^'_ASXKL?$FE7=SI6R""\BED;[1$=JJX).
M`V3P*]ZHHK;$8B5=IRZ&5##QH)J/4\%\0?#GQ7?>)-5N[;2M\$]Y++&WVB(;
ME9R0<%LC@U[!X1L+G2_">FV5Y%Y5Q#"%D3<&P<GN,BMJBG6Q4ZL%"26A-'"P
MI2<XMZA6+XNL+G5/">I65G%YMQ-"5C3<%R<CN<"MJBL(R<9*2Z&\HJ47%]3Q
M_P"'7@CQ%H7BR.]U+3_(MQ"ZE_.C;DCCA6)KUV6*.>%X94#QR*5=3T(/!%/H
MK2O7E6GSRW,Z-"-&/+'8\!UCX5>(H-8NH]+L#<V(<F"4SQJ2IY`(+`Y'0\=J
M]D\(V%SI?A/3;*\B\JXAA"R)N#8.3W&16U15UL74K149="*.%A1DY1ZA1117
M,=)Y3XU^%,E_>R:EX?,2/*=TMHYV@L>I0]!GT.!Z'M7!GX=>+1<>0=%FW],A
MT*_]]9Q^M?25%=U/,*L(\NYPU,!2G+FV/(_!_P`))8+J'4/$+Q_NR'6RC.[)
M[;V'''H,Y]>U>N445SUJ\ZTN:;.FC0A1C:`5B^+K"YU3PGJ5E9Q>;<30E8TW
M!<G([G`K:HK.,G&2DNA<HJ47%]3YS_X5AXQ_Z`__`),P_P#Q='_"L/&/_0'_
M`/)F'_XNOHRBN_\`M.MV7X_YG#_9M+N_P_R/*/ACX-U_P]XDN+O5;#[/`]FT
M2MYT;Y8NAQA6)Z`UZO117'6K2K3YY'71HQHQY8A7E/C7X4R7][)J7A\Q(\IW
M2VCG:"QZE#T&?0X'H>U>K444:TZ,N:`5J,*L>69\VGX=>+1<>0=%FW],AT*_
M]]9Q^M=MX/\`A)+!=0ZAXA>/]V0ZV49W9/;>PXX]!G/KVKURBNJIF-:<>5:'
M-3R^E"5WJ%%%%<!W!7D'B_X23RWLE[X<$7EO\S6;-MVM_L$\8]CC'TZ>OT5M
M1KSHRYH&-:A"M&TSYN7X<^+6G,(T67>.YD0+_P!];L?K713_``>U6#PXTZ2)
M<:L9%*VT3@($YR-S8!;D'TX/7->WT5U2S*L[6LCFCEU)7O=G.>`]+O-&\%Z?
MI^H0^3=1>9OCW!L9D9AR"1T(KHZ**X9R<Y.3ZG;"*A%170SO$%K-?>&]5M+9
M-\\]G+%&N0-S,A`&3P.37ANG_#3Q=!J5K-)I.U$F1F/VF(X`()_BKZ#HK>AB
MIT8N,4M3"MA85FI2;T"BBBN8Z3@OBCX<U;Q'IMA#I5K]H>*9F<>8J8!&/XB*
M\P_X5AXQ_P"@/_Y,P_\`Q=?1E%=E''5*4.2*5CCK8*G5GSR;/G/_`(5AXQ_Z
M`_\`Y,P__%UUGPZ\$>(M"\61WNI:?Y%N(74OYT;<D<<*Q->P45=3,*LXN+2U
M_KN3#`4H24DWI_78*9+%'/"\,J!XY%*NIZ$'@BGT5P'<>+>)?@_?0W#S^'W2
MXMV)(MI7"NGL">"/J0?KUKE?^%=^+?/\G^Q9]^<9WIM_[ZSC]:^DZ*]"&95H
MJSLS@GEU*3NKH\6\-?!Z_FN8Y_$$B6]NI!-M&^YY/8L.%'N"3].M>S111P0I
M#$@2.-0J*.@`X`I]%<U?$5*SO,Z:.'A15H!1116!L%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
..4444`%%%%`!1110!_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>g2014031017063104127.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g2014031017063104127.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+#`Q-#0T'R<Y/3@R/"XS-#+_
MVP!#`0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P``1"`$9`Z<#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#W^BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`**9+-%"`994C!Z%V`S6?+XAT:#[^IVO7&%E#'
M]*`-.BL%_&?A]&*G41D>D3D?F%JM_P`)]H?_`#TG_P"_1H"YT]%<G)\0]&1L
M+%>2#^\L:X_5A3/^%C:1_P`^U]_WPG_Q5`7.OHKD/^%C:1_S[7W_`'PG_P`5
M4D7Q"T:0D,EW'CNT8Y_(F@+G5T5S<?CO07;#7$D8QU:)L?IFKL'BC0[C&S4X
M!G_GH=G_`*%B@#7HIJ2)*@>-U=3T93D&G4`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`'G_B'QOJ-EJES8VD4$:Q-M\Q@68_T_2N6N?$>LW>?-U*XP<Y
M"/L!S[+@5U6J^!]1U37+N[$UO%!+(2NYB6QCT`_K3(?AK*2?.U-%';9$6S^9
M&*9.IPKNTC%G8LQZDG)-)79Z]X%&F:9+>VUXTHB`+QNH!(SU!_I7&4P"BBB@
M04^*&68D11/(1U"J3BO0/`&EV%SI4UU<6D,LZW!17D4-@!5(QGIR>M=RB+&@
M5%"J.@`P!2N.QX7]AO/^?6?_`+]FHY8)H,>;$\>>F]2,U[S2,H=2K`%2,$$<
M$47'8\#HKV:^\,:-J`/G6,2N>=\0V-^G7\:X_5_A[<0`RZ7-]H0?\LI"`_X'
MH?THN*QQ]M>7-G)YEM<2POZQN5/Z5T^F?$#4K3"7J)>1CN?D?\QQ^8_&N4DB
MDAE:.5&213AE88(/H13:8'LVC^)--UL;;:7;/C)ADX8?X_A6O7@:.T;JZ,59
M3D,#@@^M=[X9\<G*6>L2<=$N3_)O\?S]:5AIG?T4`@@$'(/0BBD,****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`R/%/_(KZA_UR/\Z\9KV;Q3_R*^H?]<C_`#KQ
MFFB6%%%%,1Z=\.?^1>N/^OIO_0$KKZY#X<_\B]<?]?3?^@)77U):"BBB@`HH
MHH`P_$7AFUUVW+86*\4?NYL?HWJ/Y5Y+>6=QI]W):W49CFC.&4_S^E>[5ROC
M7P^NI:<U[`G^EVRD\=73N/?'4?CZTT)H\LHHHIDG:^#?%C6LD>F7\G^C-Q%*
MQ_U9]"?3^7TZ>D5X%7J/@CQ`VIV365R^ZZMQP3U=.F3[@\?E2929UE%%%(84
M5YGK_B[6K37;RWMKORH8I"BKY2'@?4&L]/&_B!6!-\&`_A,*8/Y"G85SURBO
M*D\?ZXA4LUNX'4-%U_(BK*?$;5`X,EK9LO<*K`_GN-%@N>F45YS_`,+)O/\`
MH'P?]]FD;XD7I4[;"W#8X)9B,T6"YZ/17GVC>-]3U+7+.UFCMDBD?:PC0@G(
M]237H-(84444`%%<9XT\0:EHU_:+93A$>,LRE%8,<^XS7.?\)]KG_/2#_OT*
M=A7/5J*\S3XC:H'!DM;-E[A58'\]QHD^(^J%OW=I9JOHP8G\]PHL%STRBN2\
M)>)K[7KRYCND@18HPP$2D<Y]R:ZVD,**\OO/'&N6][/#NA7RY&3!BY&#BH3X
M]UT@CS81[^4*=A7/5J*\H3QYKJJ`9H6(_B,0R?RI)/'>O.N%N(HS_>6)<_KF
MBP7/6**\IL_'>M07<<ES.+B$'YXC&BY'U`R#7I6FZG::M:+<V<H=#P1W4^A'
M8T@N7****!A1110`4444`%%>5O\`$#6W<LIMD!_A6/@?F33'\>:ZRD":%2?X
MA$,C\Z=A7/5Z*\A_X37Q#_T$/_(,?_Q-12>+=>E?<VI2@_[(51^0%%@N>QT5
MY#9>)=<FO[>,ZA.X:105]1FO7J07"BBB@84444`%%%%`!17B_B34O[5UZZN5
M;,>[9'Z;1P,?7K^-+X:U0Z3KMO<%ML3'RY?38>N?IP?PIV%<]GHHHI#"BBB@
M`HK@?B!J%[97UFMK>7$"M$21%*R@G/L:Y:+Q1KD(4+J=P=IR-[;OSSG-.PKG
ML]%>0_\`":^(?^@A_P"08_\`XFK`\>ZZ`!YL)]_*%%@N>K45Y0_CS764@30J
M3_$(AD?G59_&7B"1"K:BP!_NQHI_,"BP7/8**\4D\0ZS(VYM4O`?]F9E'Y`U
MZ%X"N[F\T*>2ZN)9W%RRAI7+$#:O&3]:+!<ZFBBN*^($M]!_9TUF]Q'L\W>\
M)8;?N]2/Q_6D,[6BO%HO$FM1`A=4NCG^](6_G5I?&GB!5"C4#@#',2$_GMIV
M%<]?HKR'_A-?$/\`T$/_`"#'_P#$U#-XLUV?._4I1D8^0!/_`$$#\Z+!<]DH
MKS#P?<:M?^([66:>]N+:+?O=W9T7*'&2>!SBO3Z0PHHHH`***\[^(VI"2YMM
M-0\1#S9.>,G@#Z@9_P"^J`/1**\$C=HI%D1BKJ0RL.H(KVS1=175='MKT?>D
M3YQZ,.&'Y@T"3+]%%%`PHHHH`****`"BF3>9Y,GE8\S:=N>F>U>2?\)KXA_Z
M"'_D&/\`^)H%<]>HKR(>-O$((/V_/MY,?_Q-7(_B'K*+AHK.0_WFC;/Z,*=@
MN>HT5YPOQ(O0HW6%N6QR0S`9J.7XCZD2/*L[11WW!F_J*+!<]+HKRN7X@:W(
M<K]FBXQA(_UY)K8\&>(-6U?6I(+V\\R)(&DV^6@R<J.H`/>BP7.\HHK@O%'B
M[4=+UV6SLY(O+C5<AH\D$C/7\12&=[17E/\`PGVN?\](/^_0H_X3[7/^>D'_
M`'Z%.PKGJU%>8#XBZP`!]GLC[E&_^*J.7X@ZU(056UCQV6,\_F318+GJ=%>?
M^$/$NK:GKJVUY=>;"8V.WRU7D>X`KT"D,****`"BBB@`HHHH`****`"BBB@#
M(\4_\BOJ'_7(_P`Z\9KV;Q3_`,BOJ'_7(_SKQFFB6%%%%,1Z=\.?^1>N/^OI
MO_0$KKZXOX;R$Z3=Q8&U9]P]<E1_@*[2I+04444`%%%%`!1110!XYXJTI=(U
MZ:",8AD_>Q#T4]OP((_"L6O1OB/9;[&TOE',<AC8CT89'ZC]:\YIDL*N:5J$
MFE:G!>Q=8FR1_>'<?B*IT4Q'O4,R7$$<T;;HY%#J?4$9%/KE_`5_]K\.B!C\
M]LYC_P"`GD?S(_"NHJ2R&XL[6[7;<VT,P])$#?SKA/%W@Z&WMFU'2XMB1C,T
M(R0!_>'T[BO0:"`001D'J#0!X%170^+]"_L75=T*XM+C+Q8Z*>Z_A_(USU40
M%>CZ9X$T>YM(;HW5S<)*H=<$("".XP3G\:\XKNO`&N^5*VD7#`(Y+P,3T;NO
MX]?S]:3&CK;#PSH^FR)+;62"5>DCDL0?7D\?A6M112*"BBB@"K>:;9:@`+RT
MAGP,`R("1]#VKF/$/A?0++1;N\6W,$B(61DD;ES]T8)(QDBNQKS/Q[K9N[\:
M9"W[FV.9,'AG_P#K?U-`F<>B-(ZHBEF8X"@9)/I7H&B_#Z(P1SZM(YD89,$9
MP%]B>_X8IG@'0/\`F,W*>JVZG\BW]!^/M7?TVP2*.GZ-I^E;OL-JD)8`,1DD
MCZGFKU%%(9FW>@:3?%FN-/MV=R2SA-K$GN2.:Y[5?A[931.^FR/;R@?+&[;D
M/MSR/KDUV=%`'A-Y9W&GW<EK=1F.:,X93_/Z5!7H'Q)M$V6-X%P^6B8XZCJ.
M?;G\Z\_JB0K2T76KK0[X7%N<J>)(R?E<>A_H:S:*!'M^E:K:ZS8K=6KY4\,I
M^\A]#5ZO%-%UJZT.^%Q;G*GB2,GY7'H?Z&O7=*U6UUFQ6ZM7RIX93]Y#Z&I*
M3+U%%%`PHHHH`R;OPSHMZQ:?3H=QZE`4)_[YQ7,Z]X#LX-/GO-/EE1X4,AB<
M[@P`R0#U!_.N\JO?_P#(/N?^N3?R-`K'A5>@^&_`UM):0WVIGS?-0.D"D@`$
M9&3US[?SKSZO;M$8MH&G,Q)8VL1))Y)VBFQ(EL]-LK`8M+2&#(P2B`$_4]ZM
M444B@HHHH`****`"L7Q7J1TOP]<RH<2R#RH^<<MQD>X&3^%;5>;?$34?.U*#
M3T(VVZ;WP?XF['Z`#\Z!,XNBBBJ)/7_!^J#4_#T&YLS0#R9,]>.A_$8Y]<UO
M5Y;X"U3[%K9M'/[J[&WKT<<C^H_$5ZE4E(****!D-Q:6UVFRYMXIE_NR(&'Z
MUC:AX.T6^B8+:+;R'.V2'Y<'Z=/TK?HH`\-U+3YM*U":RN`/,C.,CH1V(JI7
MH?Q$T@R0PZM$.8\13?[I/RG\SC\17GE,EA75^#/#5KK;3W%ZS-#"P41*<;B?
M4^GTKE*ZOP#J7V/73:N<1W:;?^!#D?U'XT`CT2#1M,MAB'3[5.,9$2Y/U/>K
MU%%(H****`*UQI]E=AOM%I!+NZ[XP<_G7F?C70K/1KRW:R^1)U8F(MG:01R.
M^#G]#7JM>2^-]0^W>))45LQVP$*\\9'+?J2/PIH3,"""6YN(X(4+RR,%11W)
MKT_2/`NFV*))>+]KN!@G?]P'V7N/K7/_``]TK[1J,NI2#]W;C8GNY']!_,5Z
M50P2&QQI%&J1HJ(HP%48`%.HHI#"BBB@!LDB11M([!44%F8]`!7B&JW[ZGJE
MS>OG,KE@#V'0#\!@5Z9XXU+[!X>>)&Q+='RACKM_B_3C\:\GIHEA7=_#K5-D
MMQIDC</^]BR>XX8?E@_@:X2K>F7TFF:G;WL>=T+AB!W'<?B,C\:8'N5%,AF2
MX@CFC;='(H=3Z@C(I]24%%%%`!1110`5DS^&-$N,[],MQD8_=KL_]!Q6M10!
MY_K_`(!2&WDNM)=R4&YK=SG([[3_`$/Y]JX*O?:\O\;^'O[.O/[0MU_T6X;Y
M@!_JW]/H>3^?M30FCDJ***9)Z3X:\,>'[_1[:\,+7$C*/,WR'Y7'WA@8XSZ]
ML5U5GIECI^?LEI!`2,$QH`2/<]37F?@O7_[)U+[/.^+2Y(#9Z(W9OZ'_`.M7
MJU)E(*R]0\.Z3JLXGO;,22@8W;V4X_`BM2BD,Y:^\$^'UM99?*DMEC0LSI*3
M@`9S\V:\KKT#Q]KX"?V/;L"3AK@@].X7^OY5Q6FZ=/JM_%9VRYDD.,GHH[D^
MPIHEEK0M`N]>NS%!\D:<R3,/E3_$^U=]:_#_`$:``S^?<GOO?:/_`!W'\ZV]
M(TFVT;3X[2W4<#+OCEV[DU?HN.Q2LM'T[3B&M+*"%\8WJ@W8]-W6KM%%(844
M44`%%%%`!1110`4444`%%%%`&1XI_P"17U#_`*Y'^=>,U[-XI_Y%?4/^N1_G
M7C--$L****8CT;X;?\@^^_ZZK_*NWKB_AO&PTJ\D/W6G"CZA1G^8KM*EE(**
M**!A1110`4444`8/C.W%QX5O.FZ,+("3TPPS^F:\@KVOQ`BR>'=25AD"VD;\
M0I(_45XI31+"BBBF([7X;W)35+RVSQ)"'_%3C_V8UZ17DW@641^*K=2,^8CJ
M/;Y2?Z5ZS292"BBBD,S==TB+6]*ELY,!C\T;G^%QT/\`3\:\8G@EMKB2"9"D
ML;%74]B*]YKAO'OA_P`Z/^V+9,R(`+A0.J]F_#H?;'I30FCSNE1VC=71BK*<
MA@<$'UI**9)[#X6UY==TL.YQ=0X6=??LWT./YUN5XOX>UE]#U:.Z`W1'Y)5]
M5/7\1UKV6&:.X@2:%P\;J&5AT(-2RD/HHJ.>>*VMY)YG"11J6=CV`H&97B;7
M%T/2FE!!N9,I"I&?F]?H*\QT#1Y=>U=8"6\O.^:0\X7OSZFEUW5Y_$.L&54;
M:2(X(NX&>/Q->F^&=#70]*6(@&YDP\S`Y^;T^@IBW-:&&.W@2&%`D:*%51T`
M%/HHI#"BBB@`HHHH`Y#XC?\`(O6__7TO_H#UP.C:3+K5\;2&14D\MG7=T)';
MVKOOB-_R+UO_`-?2_P#H#UR7@AV3Q;:*IP'$BM[C83_,"F2]S#N;::TN)+>X
MC:.6,X96Z@U%7L/B+PU;:];$X6*\4?NYL?HWJ/Y5Y/?Z?=:9=M:WD1BE7G![
MCU![B@&BM6EHNM76AWPN+<Y4\21D_*X]#_0UFT4Q'M^E:K:ZS8K=6KY4\,I^
M\A]#5ZO%-%UJZT.^%Q;G*GB2,GY7'H?Z&O7=*U6UUFQ6ZM7RIX93]Y#Z&I*3
M+U%%%`PHHHH`\$D1HI&C<8925(]"*]KT+_D7M-_Z]8O_`$`5X[JD9AU:]B8@
MLD[J<=,AC7L.@L&\.Z:5((^RQC@]PHILE&C1112*"BBB@`HHHH`CGFCMK>6>
M4XCB0NQ]`!DUX=?7<E_?3W<OWYG+D>F>U>E>/M2^QZ$MJIQ)=OM_X".3_0?C
M7G.E6#ZGJEM9)G,KA21V'4G\!DTT)E1E*G#`@X!Y'8TE=M\0-'6UGMM0@C5(
MG40N%'1E'R_^.C'_``&N)IB'Q2R03)-$Q22-@RL.H(Y!KV[2K]=3TNVO4QB5
M`2!V/0C\#FO#J[_X=:IQ<:7(W_3:+)^@8?R/YTF".^HHHI%!1110!!>6L=]9
M3VLH_=S(4/MD=:\0O;22PO9K2;_61.4..^.]>[5YQ\1-+,-]#J2+\DX\N0C^
M^.F?J/\`T&FA,XFI()I+:XBGB.V2)PZGT(.14=%,D]TT^]CU'3[>\B^Y,@<#
M.<>H_#I5FN'^'>J&6UGTN1LM%^]B'^R3R/S.?^!5W%26%%%%`%>^NEL;"XNG
M(VPQL_/?`Z5X9)(\TKRR-N=V+,?4GK7IGQ!U(6VCQV*-^\NF^8?["\_SQ^M<
M;X2TW^T_$5O&PS'%^^D^B_\`U\"FA,],\.:9_9.A6UJ1B7;OE_WSR?RZ?A6K
M112&%%%%`!11574;V/3M.N+R3[L*%L>I[#\3@4`>:>.]2^VZ^;=&)BM%\L#M
MN/+'^0_"N7P<9QQZT^662>9YI6+R2,69CU)/)-=]/X8_XM]$JQ@WD8^U\#DY
MY(_[YP/JHID[GGU%%%,1Z?\`#_5!=:,UB[9EM6X![H>1^N1^5==7COA35?[)
MUZ"5SB&7]U+[`]_P.#7L5)E(****0PHHHH`****`"H+RTAO[.6UN%W12KM85
M/10!XGK>DRZ+JDMG(2P7YHW(QO4]#_3Z@UG5ZSXQ\/G6M-$L"YO+?+1C^^.Z
M_P!1[_6O)B""01@CJ*9+"O2O`_B/[;;C2[I_](B7]RQ_C0=OJ/U'TKS6I;:X
MEM+F.X@<I+&P96'8B@#WBLCQ'KD>A:6TYPT[_+#&3]YO7Z#K_P#KI-)\0VFH
M:%_:4LB0B,8N`>B,.OY]OJ.]>8^(]<DUW5&G.5@3Y88R?NKZ_4]?_P!5`VS-
M=YKRZ9W+RSRODGJ68FO6/"GAU=#L-TRJ;V89E8<[1V4'^?O6)X&\->6BZO>1
M_.PS;HPZ#^_^/;\_2N[H8)!1112&%%%%`!1110`4444`%%%%`!1110`4444`
M9'BG_D5]0_ZY'^=>,U[-XI_Y%?4/^N1_G7C--$L****8CT[X<_\`(O7'_7TW
M_H"5U]<?\.74Z#<H#\PN22/8JN/Y&NPJ2T%%%%`!1110`4444`9^N_\`(O:E
M_P!>LO\`Z`:\2KV?Q/-Y'AG47W`9A*9/^UQ_6O&*:)84444Q'0>"03XNLL#I
MYF?^^&KUVO+/A]&7\2E@1B.!V.?3(']:]3I,I!1112&%(Z+(C(ZAD8892,@C
MTI:*`/&_$VAOH>JM$`3;29>%B<_+Z'W%8U>S^(=%CUS2GMC@3+\T3_W6_P`#
MTKQN:&2WG>&9"DB,593U!%-$L97H/P_UW<K:/._*Y>W)/4=2O\S^=>?5)!/+
M;7$<\+E)8V#(P[$4P/>:\U\<^(OMEP=+M7S;Q-^]8'[[CM]!_/Z5?U3QRDGA
MN(VC;-0G!1PO_+''4_CV_P#K5S7A70#KFIA9`PM(OFF8=_1?Q_QI#;.A\!^'
M>FL72^UNI_5C_3\?:N_I$18T5$4*BC"J!@`>E+2&%%%%`!1110`4444`<M\0
M$5_#.YADI.C+['D?R)KBO!7_`"-UC_VT_P#1;5V_C[_D6'_ZZI_.N(\%?\C=
M8_\`;3_T6U,3W/7JR=>T"UUZS\J;Y)5YBF`R4/\`4>U:U%(9XAJNE76CWS6M
MTF&'*L/NN/451KVO6M%M=<L3;W`PPYCE`^9#ZC^HKR+5=*NM'OFM;I,,.58?
M=<>HIDM%&M+1=:NM#OA<6YRIXDC)^5QZ'^AK-HIB/;]*U6UUFQ6ZM7RIX93]
MY#Z&KU>*:+K5UH=\+BW.5/$D9/RN/0_T->NZ5JMKK-BMU:OE3PRG[R'T-24F
M7J***!GB6N_\C#J7_7U+_P"AFO5?"C!O"^GE2"/*QP>X)KRWQ#&8O$>I*Q&3
M<.W'H23_`%KTOP5_R*-C_P!M/_1C4V2C?HHHI%!1110`4451UC4!I>D75Z1D
MQ)E1ZL>!^I%`'F?C;4O[0\12QJ?W=M^Y7ZC[WZY'X5K?#G3?,NKG4G7Y8QY4
M9/\`>/)_3'YUP[,68LQ)8G))/)->S>&]-_LK0;6V9<2[=\GKN/)S].GX4R42
M:]IO]K:)=68`,CIF//9QR/IR,?C7BA!!((P1U%>^UY%XSTW^SO$4Y12(;C]\
MGX_>_7/Z4(;.?JYI5^^EZK;7J=8GR1ZCH1^()JG13)/>XI$FB26-MR.H93Z@
M]*=7+>`]3^W:"+9VS+:-L_X">5_J/PKJ:DL****`"LOQ%I@U?0[FU'^LV[XS
MCHXY'Y]/QK4HH`\"(()!&".HHKH/&6E?V9K\I10(;C]ZF.V>H_//Z5S]407]
M%U)])U>WO$/"-\X_O*>"/RKVR.1)8UD1@R,`RL.A!KP2O4O`>J_;M%-I(?WM
MH=@]T/W?ZC\!292.KHHK/UO41I6C75X3AHT.SC/S'A?U(I#/,?&.HG4?$=QA
MLQ0?N4Q[=?US76_#W3?L^DRWSKA[E\+D?P+_`(G/Y"O.;6WDO;V&WCYDFD"#
M/J3BO<;.UCLK.&UA&(XD"+^`IL2)J***0PHHHH`*XCXBZEY5E;Z<A^:9O,D_
MW1T'XG_T&NWKQGQ/J7]J>(+J=3F)6\N/_=7C/X\G\::$QGAS3O[5UZUMB`8]
M^^3(XVKR1^.,?C7M)`(((R#U!KA?ASIVRWNM2<#,A\F/CD`<G\SC\J[JA@CQ
M7Q!IO]DZY<V@'[L-NC_W3R/\/PK,KT3XC:;YEK;:DB_-&?*D(_NGD?KG\Z\[
MH$PKV/PIJ?\`:OAZWE8YEC'DR?[R]_Q&#^->.5V'P]U/[-JTM@[?)=+E?]]>
M?U&?R%#!'IM%%%(H****`"BBB@`HHHH`*\V\=>'OLEQ_:MJF()3B90,!']?H
M?Y_6O2:CG@BN;>2"9`\4BE74]P:`/!J*U_$FB2:%JKP?,;=_GA<]U]/J.GZ]
MZR*H@>LTJ121+(RQR8WJ#PV.F:Z3P?X;.L7GVFY7_086^8$?ZQO[H]O7_P"O
M7,5V/@;Q#]BNAIET_P#H\S?NB3]QSV^A_G2&CTP````8`Z`4444B@HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`R/%/\`R*^H?]<C_.O&:]F\4_\`(KZA
M_P!<C_.O&::)84444Q'HWPV_Y!]]_P!=5_E7;UQ_PY4#0+AL#<;I@3CG&U?\
M3785+*04444#"BBB@`HHHH`Y?Q]<^1X9:+O/*B?E\W_LM>55V_Q'OA)?6EBI
M_P!4AD?ZMP/T'ZUQ%-$L****8CO_`(;6AVW]X<[25B7TSU/\UKOJR/#.FG2M
M`MK=UVRE?,E!Z[FYP?IP/PK7J2T%%%%`!1110`5Q/CSP\MQ;'5[9`)HA^_`_
MC7IGZC^7TKMJ;)&DL;1NH9&!5E/0@T`>"45)<1"&YEB!R$<J#ZX-1U1`5[/X
M<TR'2]$MX8@-SH))&_O,1R?Z5XQ7NMA_R#[;_KDO\A28T6****104444`%%%
M%`!1110!RWQ`=4\,[6."\Z*ON>3_`"!K@O"W_(SZ?_UU'\J[?XC?\B];_P#7
MTO\`Z`]<1X6_Y&?3_P#KJ/Y4T2]SV:BBBD4%9NM:+:ZY8FWN!AAS'*!\R'U'
M]16E10!XAJNE76CWS6MTF&'*L/NN/451KVO6M%M=<L3;W`PPYCE`^9#ZC^HK
MR+5=*NM'OFM;I,,.58?=<>HIDM%&M+1=:NM#OA<6YRIXDC)^5QZ'^AK-HIB/
M;]*U6UUFQ6ZM7RIX93]Y#Z&KU>*:+K5UH=\+BW.5/$D9/RN/0_T->NZ5JMKK
M-BMU:OE3PRG[R'T-24F>5>+HS%XJOU8@DN&X]"H/]:]"\$.K^$[15.2AD5O8
M[R?Y$5P7C7_D;K[_`+9_^BUKM_`/_(L)_P!=7_G3!;G3T444AA1110`5P7Q&
MU+"6NFHW4^=(!^2C^?Y"N])`!).`.I->*:_J)U77+J[SE&?$?^X.!^@S^--"
M97TV6V@U*VFO%=[>.0,ZH`2P'.,&O2D\?Z(R@DW"D_PF+D?D:\\M=!U6^MUN
M+:QFEA;.UU'!QQ4W_"+:Y_T#)_R%`CO_`/A/M#_YZ3_]^C7->,==TG7+2W:U
M>3[3"YQNC(!4]?Y"L7_A%M<_Z!D_Y"C_`(1;7/\`H&3_`)"@-3(HJ2>"6VG>
M">-HY4.UE88(-1TQ'2^!]2-AXACB8XBNAY39/?JI^N>/QKUBO`T=HW5U.&4Y
M!]#7MNC:BNK:1;7J]9$^8>C#@C\P:3*1?HHHI#"BBB@#FO&^E?VCH331INGM
M3YBXZ[?XA^7/X5Y/7OC*'4JP!4C!!'!%>+>(-+.D:U<6@!$8;=$3W0\C_#\*
M:$S,K;\*:K_9.O02N<0R_NI?8'O^!P:Q**9)[[7!_$?4=L5KIJ$Y8^<_/;D*
M/SS^0K?\)ZL-4\/PR2-F6']U*6]0.OXC!_.O,O$&I?VMKES=@_NRVV/_`'1P
M/\?QI(IF[\/M-^TZO)?.I,=LGRGMO;C\>,_I7IM87A#3?[-\.VZLN)9AYTGX
M]!^6*W:0(****!A1110!C^*=2_LOP_<S*P65QY47^\W''T&3^%>-5VWQ$U+S
M;^#3D8%8%\R0#^\>@/X<_P#`JY2QTR]U)G6SMGF*`%M@Z4T2SN]%\9Z)I^E6
M]EMN8_)C"DF(89NI(P3WR?QK0_X3[0_^>D__`'Z-<!_PBVN?]`R?\A1_PBVN
M?]`R?\A0%V=EJ_B_0=3TFZLR\V98R%S%T;J#^>*\VK7_`.$6US_H&3_D*IWV
MF7NFLBWEL\)<$KO'6@"I4UI=265Y#=0G$D3AU_`U#13$>[VES'>6<-S$<QRH
M'7Z$9J:N.^'NJ?:=*DL';]Y;-E/]QN?YY_,5V-26%%%%`!1110`4444`%%%9
M/B'7(M"TUKAL-,WRPQG^)O\``=__`*]`'-_$/4;,VT6G[%DNPPD#`_ZH?_7]
M/Q]*\\JTQN]6U'/SSW5P_P"+$_Y_"NPUKP,+30(I[0F2\@7,X!SY@[X^G\O>
MF3N<+1113$>K^#?$/]L6'V>X;-Y;@!B?XUZ!OKZ__7KIJ\,TW4)]+U"&\MSB
M2)LX/1AW!]B*]ITW4(-4T^&\MSF.5<X/53W!]P:3*3+5%%%(84444`%%%%`!
M1110`4444`%%%%`!1110!D>*?^17U#_KD?YUXS7LGBQU3PMJ!8X'EX_$D`5X
MW31+"BBBF(]+^'$H.C746.5N-V?JH']*[*O,?A]J26NL2V<AP+M`%/\`M+D@
M?D37IU2RD%%%%`PHHHH`*CN)X[6VDN)FVQQJ78^@%2$@`DG`'4FO-O&?BI+_
M`/XEVGR[K8<RR+T<^@]J`.7U6_?5-5N;U^LKY`]!T`_``53HHJB`KI?!>BG5
M-96>1<VUJ1(^?XF_A'YC/T%8NF:=<:K?Q6ELFYW/)[*.['V%>R:1I<&C:;%9
MP<A>68]78]328TB]1112*"BBB@`HHHH`****`/"K[_D(7/\`UU;^9JO5B^_Y
M"%S_`-=6_F:KU1`5[XB+&BHHPJC`'H*\#KWVDRD%%%%(84444`%%%%`!1110
M!R'Q&_Y%ZW_Z^E_]`>N(\+D#Q/I^3C]\*[?XC?\`(O6__7TO_H#UP.A?\C#I
MO_7U%_Z&*:)>Y[;1112*"BBB@`K-UK1;77+$V]P,,.8Y0/F0^H_J*TJ*`/$-
M5TJZT>^:UNDPPY5A]UQZBJ->UZUHMKKEB;>X&&',<H'S(?4?U%>1:KI5UH]\
MUK=)AARK#[KCU%,EHHUI:+K5UH=\+BW.5/$D9/RN/0_T-9M%,1K^)KZWU/6Y
M+ZV9BDZ(Q5A@J0H!'Z5WGP_D5_#6T=4G=3]>#_45Y97IWPY_Y%ZX_P"OIO\`
MT!*3&CKZ***104444`8/C'4O[-\.SE6*S3_N8\>_7],_I7DD$,ES<101#=)*
MX11ZDG`KK/B#J7VG5X[%&)CMD^8=M[<_CQC]:A\`Z=]LU[[2P/EVB;^G!8\`
M?S/X4R7N>EV-I'86$%I%]R%`@/KCO5BBBD4%%%%`'FWQ#TSR-2AU%!\EPNQ_
M]]>GYC'_`'R:XNO9O$^F?VMH%S;JFZ91YD7'.X=A]1D?C7C--$L*[WX<ZGA[
MG3';@_OHOKT8?R_(UP57]&U`Z7K%K>`G;&XW@=U/!'Y9I@CVZBD5@ZAE(*D9
M!!X(I:DH****`"N,^(6E?:-.BU*,?O+<[']T)_H?YFNSJ*YMX[NUEMY1F.5"
MC#V(Q0!X/15G4+*33=0GLY>7A<J2._H?Q'-5JH@T],UJXTRRU"VB^[>1;"?[
MISU_(L/Q'I2^'=,_M;7;:U(S'NWR_P"X.3^?3\:RZ]$^'.F^7:W.I.OS2'RH
MR?[HY/ZX_*D-'<T444B@HHHH`*9-,EO!)-(VV.-2['T`&33ZY;QYJ7V+0?LR
M-B2[;9[[1RW]!^-`'FFHWCZAJ-Q>2?>FD+X]!V'X#BO3/`FF_8M`%PZ@2W;>
M83WVCA1_,_C7F>GVCW^HV]HG#32!,^F3UKW&&%+>".&-=L<:A%'H`,"FQ(?1
M112&%<SXYTS[?X?>95S+:GS1C^[_`!?IS^%=-2.BR(R,,JPP1ZB@#P.BKVLZ
M>VE:O<V;=(W.T^JGD'\L51JB#9\+:G_97B"WF9L1.?*D_P!UO\#@_A7LE>!5
M[/X9U+^U=`M;AF+2A?+E)Z[AP3^/7\:3*1K4444AA1110`444$@`DG`'4F@"
M"\O(+"TENKF01PQC+,:\<UW6I]<U)[J7Y4'RQ1YR$7_'UK5\8^)?[8NA:VK'
M[%">#_ST;^]]/2CP?X:.L7?VJY3_`$&%N0?^6C?W?IZTR7J=#X%\._8[<:I=
M)B>4?N5/5$/?ZG^7UKM*````!@#H!12*/+?&GAS^RKO[;;)BSG;D#_EF_I]#
MR?TKE*]WN[2&^M);6X3?#*NUEKQG6](GT34I+2;E>L;XX=>QIHEHSJZ?P9K_
M`/9.H_9IWQ:7!`;/\#=F_H?_`*U<Q13`]]HKD/`VO_;[+^SKA\W-NOR$_P`<
M?^(Z?3'O77U)04444`%%%%`!1110`4444`%%%%`!4<]Q!:Q&2XFCBC'\4C!1
M^9KS'Q1XCU=-;O+2*^EB@BDVHL7R$#CN.?UKEY9I9WWS2O(W]YV)/ZT["N=M
MXS\56M_:?V;I\AD0L&EE&0IQ_"/7G!KAJ**8@HHHH$*CM&ZNC%64Y#`X(/K7
MH.@^/XV1;?6!M<8`N$&0?]X=C[C\A7GM%`SW6UOK2^0/:W,4RXS^[<''U]*L
M5X%5C[=>?\_4_P#W\-*P[GNC,$4LQ`4#))/`%8NI^+-(TL$/=+-+CB*#YS^)
MZ#\37D$LTLQ!EE>0CH68G%,HL%SH]=\8W^LJT$?^BVIX,:'EQ_M'O].E<Y14
MUK:7-[,(;6"2:0_PHI)IB(:T-(T6]UJZ$%I'D#[\AX5!ZD_TZUU&C?#Z>4K-
MJTGE1]?)C.6/U/0?K^%=]:6=M86ZV]K"D42]%44KA8HZ%H%IH-H8H/GE?F29
MA\S_`.`]JU:**104444`%%%%`!1110`45Q=U\1[&/(M;*>8CNY"`_P`_Y5BW
M7Q$U27(MX+>`'O@LP_/C]*+"N<Q??\A"Y_ZZM_,U7ITCM+(TCG+,2Q/J33:H
MD*]]KP*NRLOB'>6T$44UE!*(U"Y5BI(`Q[\TF-'I=%<1;?$BTD=1<V$L()P6
M1P^!Z]!7;TB@HHHH`****`"BL;Q!XBM_#\4#31/*TS$*JD#@=3^HK!_X639_
M]`^?_OL4!<F^(\BC0[6/^)KD,/H%;/\`,5YW8R>5J%M)OV;)5;=G&,$<YK9\
M3^*&\0&&-+?R((22`6W%B>Y]/I7/4R6>^T5YO9_$:[AA2.YL8YRJ[2RR%2Q]
M3D&M!/B3:D+YFG3*>X60''\J5AW.XHJ&TN4O+."ZC#!)HUD4-U`(R,_G4U`P
MHHHH`*S=:T6UURQ-O<###F.4#YD/J/ZBM*B@#Q#5=*NM'OFM;I,,.58?=<>H
MJC7M>M:+:ZY8FWN!AAS'*!\R'U']17D6JZ5=:/?-:W288<JP^ZX]13):*->G
M?#G_`)%ZX_Z^F_\`0$KS&O3OAS_R+UQ_U]-_Z`E#!'7T45#=W*6=G/=2!BD,
M;2,%ZD`9./RI%$U5[Z\BT^QFNYCB.)"Q]_:N&NOB3(<BTTY5]&EDS^@`_G7-
M:QXEU+7%$=U(BPJ=PBC7"Y]?4_B:=A7,Z[N9+R\FN93F25R[?4G->G>`;-;?
MPXMP`-]S(S$]\`[0/T/YUY76UH_BG4]$C\FVD1X,D^5*NY0?;H1^=`D>QT5Y
M]!\2I!@7&FHW(R8Y2,#OP0?YUZ#2*"BBLC7]?@\/VT4LT,DOFMM4)@?GF@#7
MKQSQ7IG]E>(;B)1B*0^='_NMV_`Y'X5M7?Q'OI!BTLX(,]W8R'^@_2N5U#4;
MK5+IKF\E,DI&,D8P/0`4T2V5:***8CU7P+JPO]$%J[?OK3"')ZI_"?Z?A745
MX;IVIWFDW/VBRF,4F,'@$$>A!X-=1;?$?44(^TV=M*H'.S*$_CDC]*5BDSTJ
MBJNFWRZEIT%XB%%F7<%)Y%6J0PHHHH`\Z^(NF^7=V^I(IVRCRI#VW#I^8S_W
MS7#U[1XCTT:KH-U;`9DV[X\#)WCD?GT_&O%Z:)8^&%[B>.&-=TDC!%`[DG`K
MW#3K&+3-.@LH?N0H%SZGN?Q.3^->9>!=/^V^(TE89CME,ISZ]!^IS^%>KT,:
M"BBBD,***X_6O'D>F7T]G#8O+)$=I9W"C/X`Y_2@#L*\E\:ZHNI>('6)@T-L
MOE*0>">I/YG'X5)J'CK5[Z)XHS%;1L,'RE.['U/],5S%-$MG8?#NT2;6YKEL
M$P1?*/=N,_EG\Z]-KP[3=4O-(NOM%E+Y;XP>`0P]"#756_Q(O4"BXL8)<==C
M%,_GFAC3/1Z*S="U==;TQ+U83%EBI0MG!'O6E2&%%5[Z\BT^QFNYMWEPH68*
M,D^PKAKKXDR'(M-.5?1I9,_H`/YT!<7XCZ:`;74D`!8^3)[GDK_[-^E<%6KK
M'B/4M;"K=RKY2MN6)%PH/\S^)K*IDL*[+X?:L+74I-.E;$=R,QY/1QV_$?R%
M<;2H[1NKHQ5E.0P."#ZTP/?**\MM/B!K$"JLRV]P!U+H0Q_$$#]*[7PUXD7Q
M%#.?LY@D@*[EW;@<YP0<#T-2.YNT45Q4WQ(L%SY%C<OQQO*KS^&:!G:UY[XU
M\5>89=(L6^0?+/*#][_9'MZ_E]<_5?'NHW\+0VT:6<;`@E#N?'^]V_`5RE.P
MFR>RM)+^]AM(?]9*X09[9[U[=864.G6,-I`N(XEVCW]3]2>:\+1VC=71BK*<
MA@<$'UKK-.^(&J6H5+N..[0#&6^1_P`QQ^E#$CU"BL30O%%EKSO%`DD<R+N9
M)`.G3((//6MND4%8'BS0EUK26,:9NX`7B(')]5_'^>*IZGX]L+"YGMH[:>:>
M%V1NBKD9!YZ]1Z5@7?Q&U"566UM((,]&8ER/Y#]*8KG&44K,68L3DDY-)3))
M[.[FL+R*ZMVVRQ-N4U[)H>LV^N:<ES"<..)8^Z-W'T]#7BE7M+U>]T>X,]E,
M48C#*>58>XI#3/;Z*\_L_B2V`+[3P3W>!\?^.G_&NXL;R+4+&&[AW>7,@90P
MP1[&D5<L4444`%%%%`!1110`4444`<S?^!M,U&_FO)I[M9)6W,$=0`?;*U77
MX=:.&!,]ZP!Z&1<'_P`=KKJ*`L<TG@/0D<,T$K@?PM*<'\L5-_PA7A[_`*!_
M_D:3_P"*K?HH"Q@?\(5X>_Z!_P#Y&D_^*H_X0KP]_P!`_P#\C2?_`!5;]%`&
M!_PA7A[_`*!__D:3_P"*I#X)\/$$?8,>XFD_^*KH**`.8_X0'0_^><__`']-
M0O\`#O1G<LLUX@/\*R+@?FIKK:*`L<A_PKG2/^?F^_[[3_XFGQ_#S1D;+27<
M@QT:08_117644!8P[;P?H5L05L$D8=Y6+Y_`G'Z5L0P0VT8C@B2)!T5%"C\A
M4E%`!1110`4444`%%%%`!1110`4C*'4JP!4C!!'!%+10!R'_``KG2/\`GYOO
M^^T_^)J6/X?:*BX8W4ASU:09_0"NJHH"QS'_``@.A_\`/.?_`+^FIQX)\/``
M?8,^YFD_^*KH**`L<T_@/0G<LL$J`_PK*<#\\U3D^'&EE?W=W>*WJQ5A^6T5
MV-%`6.,A^'=I#/'*+^8E&#`;!S@UV=%%`!1110`4444`87B7PVOB**W7[3Y#
M0LQ#>7OR#CCJ/05A1_#6`+^]U*1FSU6(*,?F:[JB@+''I\.=*"`/=7I;N0R@
M?EMI?^%<Z1_S\WW_`'VG_P`377T4"L<2_P`-[(EO+O[A1V#*IQ_*J_\`PK/_
M`*B__DM_]G7?447"Q7L;;[%I]M:;]_D1+'NQC=M`&<?A5BBB@84444`%%%%`
M!65K^A6^O6'D2G9*F6BD'\!_J/:M6B@#R-_!'B!7918A@#@,)DP??DYKN?!>
MEWFDZ/-!?0^5*UPSA=P;C:HSP3Z&NCHHN*P5#=VR7EG/:R%@DT;1L5Z@$8./
MSJ:B@9R'_"N=(_Y^;[_OM/\`XFKL'@?086W&U>4Y!'F2M@?@"/UKHJ*`L83^
M#?#\CEFTY03_`'9'4?D#4,O@;0)``MH\>.Z3-S^9-='10%CF/^$!T/\`YYS_
M`/?TUT]%%`!65K>@6NO0Q174DR+$Q9?*(!S^(-:M%`'+CP#H8`&R<^_FU+%X
M%T"/.ZUDDS_?F;C\B*Z.B@+&!_PA7A[_`*!__D:3_P"*I&\$^'RI`L"I(ZB9
M\C_QZN@HH`Y9_A_HCH547*$_Q+)R/S!J'_A7.D?\_-]_WVG_`,377T4!8J:9
MI\.E:?#96Y<Q1`X+G).22<_B:MT44`%%%%`!7`ZA\/9KG4;B>"\BCBED+JC*
M25R<XKOJ*`,'POX=_P"$?M9U>999IG!9E&``!P/U/YUO444`%%%%`!7,7_@;
M3-1OIKR:XO!),Q9@KJ`/I\M=/10!R\/@#0XL;UN)L'^.7&?^^0*N-X.T!D5#
MIR87IB1P?Q.<FMRB@+'/MX)\/E2!8%21U$SY'_CU0?\`"`Z'_P`\Y_\`OZ:Z
M>B@+%/3-,MM)LEM+166($M\S9.35RBB@"M?V4>HV$UG,SK'*NUBA`('MFN>C
M^'^B(N&^TR'^\TG/Z`5U5%`',IX#T)6!,,S`?PF4X/Y5/_PA7A[_`*!__D:3
M_P"*K?HH"Q@?\(5X>_Z!_P#Y&D_^*J!_`>A,Q(AF4'^$2G`_.NFHH"QR)^'6
MCDD_:+T>V]/_`(FM?0_#EGX?\_[))._G[=WFL#C;G&,`>IK7HH`*XC_A6UG_
M`-!"?_O@5V]%`'')\.-+"`275XS=RK*!^6TU/'\/M%1<,;J0YZM(,_H!7544
M"L<L_P`/]$="JBY0G^)9.1^8-5I/AQIA7]U=W:MGJQ5AC\A7944#L<[H'A*W
MT&]DNHKF65GC,>&```)!_I71444`<M=^`M+O+R>ZDN+P/-(TC!77`).3CY?>
MH?\`A7.D?\_-]_WVG_Q-=?10%CEQX!T,`#9.??S:L#P3X>``^P9]S-)_\570
M44!8YB3P#H;[ML<Z9SC;*?E^F<_K55_AQI90B.ZO%;L692/RVBNQHH"QQ'_"
MMK/_`*"$_P#WP*["RM5L;"WM$.Y88UC!(QG`QFIZ*`"BBB@`HHHH`****`"B
MBLCQ1KG_``C?AVZU;[/]H^S[/W6_9NW.J]<''WL]*<8N345NQ2DHIR>R->BO
M(O\`A>'_`%+O_D[_`/:Z/^%X?]2[_P"3O_VNNOZAB/Y?Q7^9R_7L/_-^#_R/
M7:*\B_X7A_U+O_D[_P#:Z/\`A>'_`%+O_D[_`/:Z/J&(_E_%?YA]>P_\WX/_
M`"/7:*\B_P"%X?\`4N_^3O\`]KH_X7A_U+O_`).__:Z/J&(_E_%?YA]>P_\`
M-^#_`,CUVBO(O^%X?]2[_P"3O_VNC_A>'_4N_P#D[_\`:Z/J&(_E_%?YA]>P
M_P#-^#_R/7:*\B_X7A_U+O\`Y.__`&NC_A>'_4N_^3O_`-KH^H8C^7\5_F'U
M[#_S?@_\CUVBO(O^%X?]2[_Y._\`VNC_`(7A_P!2[_Y._P#VNCZAB/Y?Q7^8
M?7L/_-^#_P`CUVBO(O\`A>'_`%+O_D[_`/:Z/^%X?]2[_P"3O_VNCZAB/Y?Q
M7^8?7L/_`#?@_P#(]=HKR+_A>'_4N_\`D[_]KH_X7A_U+O\`Y.__`&NCZAB/
MY?Q7^8?7L/\`S?@_\CUVBO(O^%X?]2[_`.3O_P!KH_X7A_U+O_D[_P#:Z/J&
M(_E_%?YA]>P_\WX/_(]=HKR+_A>'_4N_^3O_`-KH_P"%X?\`4N_^3O\`]KH^
MH8C^7\5_F'U[#_S?@_\`(]=HKR+_`(7A_P!2[_Y._P#VNC_A>'_4N_\`D[_]
MKH^H8C^7\5_F'U[#_P`WX/\`R/7:*\B_X7A_U+O_`).__:Z/^%X?]2[_`.3O
M_P!KH^H8C^7\5_F'U[#_`,WX/_(]=HKR+_A>'_4N_P#D[_\`:Z/^%X?]2[_Y
M._\`VNCZAB/Y?Q7^8?7L/_-^#_R/7:*\B_X7A_U+O_D[_P#:Z/\`A>'_`%+O
M_D[_`/:Z/J&(_E_%?YA]>P_\WX/_`"/7:*\B_P"%X?\`4N_^3O\`]KH_X7A_
MU+O_`).__:Z/J&(_E_%?YA]>P_\`-^#_`,CUVBO(O^%X?]2[_P"3O_VNC_A>
M'_4N_P#D[_\`:Z/J&(_E_%?YA]>P_P#-^#_R/7:*\B_X7A_U+O\`Y.__`&NC
M_A>'_4N_^3O_`-KH^H8C^7\5_F'U[#_S?@_\CUVBO(O^%X?]2[_Y._\`VNC_
M`(7A_P!2[_Y._P#VNCZAB/Y?Q7^8?7L/_-^#_P`CUVBO(O\`A>'_`%+O_D[_
M`/:Z/^%X?]2[_P"3O_VNCZAB/Y?Q7^8?7L/_`#?@_P#(]=HKR+_A>'_4N_\`
MD[_]KH_X7A_U+O\`Y.__`&NCZAB/Y?Q7^8?7L/\`S?@_\CUVBO(O^%X?]2[_
M`.3O_P!KH_X7A_U+O_D[_P#:Z/J&(_E_%?YA]>P_\WX/_(]=HKR+_A>'_4N_
M^3O_`-KH_P"%X?\`4N_^3O\`]KH^H8C^7\5_F'U[#_S?@_\`(]=HKR+_`(7A
M_P!2[_Y._P#VNC_A>'_4N_\`D[_]KH^H8C^7\5_F'U[#_P`WX/\`R/7:*\B_
MX7A_U+O_`).__:Z/^%X?]2[_`.3O_P!KH^H8C^7\5_F'U[#_`,WX/_(]=HKR
M+_A>'_4N_P#D[_\`:Z/^%X?]2[_Y._\`VNCZAB/Y?Q7^8?7L/_-^#_R/7:*\
MB_X7A_U+O_D[_P#:Z/\`A>'_`%+O_D[_`/:Z/J&(_E_%?YA]>P_\WX/_`"/7
M:*\B_P"%X?\`4N_^3O\`]KH_X7A_U+O_`).__:Z/J&(_E_%?YA]>P_\`-^#_
M`,CUVBO(O^%X?]2[_P"3O_VNC_A>'_4N_P#D[_\`:Z/J&(_E_%?YA]>P_P#-
M^#_R/7:*\B_X7A_U+O\`Y.__`&NC_A>'_4N_^3O_`-KH^H8C^7\5_F'U[#_S
M?@_\CUVBO(O^%X?]2[_Y._\`VNC_`(7A_P!2[_Y._P#VNCZAB/Y?Q7^8?7L/
M_-^#_P`CUVBO(O\`A>'_`%+O_D[_`/:Z/^%X?]2[_P"3O_VNCZAB/Y?Q7^8?
M7L/_`#?@_P#(]=HKR+_A>'_4N_\`D[_]KH_X7A_U+O\`Y.__`&NCZAB/Y?Q7
M^8?7L/\`S?@_\CUVBO(O^%X?]2[_`.3O_P!KH_X7A_U+O_D[_P#:Z/J&(_E_
M%?YA]>P_\WX/_(]=HKR+_A>'_4N_^3O_`-KH_P"%X?\`4N_^3O\`]KH^H8C^
M7\5_F'U[#_S?@_\`(]=HKR+_`(7A_P!2[_Y._P#VNC_A>'_4N_\`D[_]KH^H
M8C^7\5_F'U[#_P`WX/\`R/7:*\B_X7A_U+O_`).__:Z/^%X?]2[_`.3O_P!K
MH^H8C^7\5_F'U[#_`,WX/_(]=HKR+_A>'_4N_P#D[_\`:Z/^%X?]2[_Y._\`
MVNCZAB/Y?Q7^8?7L/_-^#_R/7:*\B_X7A_U+O_D[_P#:Z/\`A>'_`%+O_D[_
M`/:Z/J&(_E_%?YA]>P_\WX/_`"/7:*\B_P"%X?\`4N_^3O\`]KH_X7A_U+O_
M`).__:Z/J&(_E_%?YA]>P_\`-^#_`,CUVBO(O^%X?]2[_P"3O_VNC_A>'_4N
M_P#D[_\`:Z/J&(_E_%?YA]>P_P#-^#_R/7:*\B_X7A_U+O\`Y.__`&NC_A>'
M_4N_^3O_`-KH^H8C^7\5_F'U[#_S?@_\CUVBO(O^%X?]2[_Y._\`VNC_`(7A
M_P!2[_Y._P#VNCZAB/Y?Q7^8?7L/_-^#_P`CUVBO(O\`A>'_`%+O_D[_`/:Z
M/^%X?]2[_P"3O_VNCZAB/Y?Q7^8?7L/_`#?@_P#(]=HKR+_A>'_4N_\`D[_]
MKH_X7A_U+O\`Y.__`&NCZAB/Y?Q7^8?7L/\`S?@_\CUVBO(O^%X?]2[_`.3O
M_P!KH_X7A_U+O_D[_P#:Z/J&(_E_%?YA]>P_\WX/_(]=HKR+_A>'_4N_^3O_
M`-KH_P"%X?\`4N_^3O\`]KH^H8C^7\5_F'U[#_S?@_\`(]=HKR+_`(7A_P!2
M[_Y._P#VNC_A>'_4N_\`D[_]KH^H8C^7\5_F'U[#_P`WX/\`R/7:*\B_X7A_
MU+O_`).__:Z/^%X?]2[_`.3O_P!KH^H8C^7\5_F'U[#_`,WX/_(]=HKR+_A>
M'_4N_P#D[_\`:Z/^%X?]2[_Y._\`VNCZAB/Y?Q7^8?7L/_-^#_R/7:*\B_X7
MA_U+O_D[_P#:Z/\`A>'_`%+O_D[_`/:Z/J&(_E_%?YA]>P_\WX/_`"/7:*\B
M_P"%X?\`4N_^3O\`]KH_X7A_U+O_`).__:Z/J&(_E_%?YA]>P_\`-^#_`,CU
MVBO(O^%X?]2[_P"3O_VNC_A>'_4N_P#D[_\`:Z/J&(_E_%?YA]>P_P#-^#_R
M/7:*\B_X7A_U+O\`Y.__`&NC_A>'_4N_^3O_`-KH^H8C^7\5_F'U[#_S?@_\
MCUVBO(O^%X?]2[_Y._\`VNC_`(7A_P!2[_Y._P#VNCZAB/Y?Q7^8?7L/_-^#
M_P`CUVBO(O\`A>'_`%+O_D[_`/:Z],T#5?[<T*SU/R?(^TQ[_+W;MOMG`S^5
M95<-5I*\U8UI8BG5=H.YHT445@;!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`>?
M?$3QUJGA*_LH+""SD2>(NQG1B00<<885QG_"Z/$?_/EI7_?J3_XNK?QL_P"0
MSI?_`%[M_P"A54^%?A?1O$G]K?VM9_:/L_D^5^]=-N[?G[I&?NCK7LTJ=".&
M56<;_P##GCU:E:6)=*$K?\,7;'XV7ZNHU#2;:5,_,;=V0X]@=W^?2O4/#WB7
M3/$]A]KTV8N%P)(W&'C)'1A_49'H:\U^('PTL=,TB35]"CDB6#!GMBY==G=E
M)R<COD]/3'/%>!_$4OAOQ/;7`<"VE80W(8X7RR>3]1U_"IEAJ->DYT59HJ.(
MK4*BA6=T?2U%%%>0>L>3^+OB-XG\+^([C3FLM,:$'S+=VBD)>,_=)^<<]0>.
MH-=#\/?'3^+8KJ"^2WAOX#O"0@@/&>,@$D\'@_45%\4_#*ZUX<:_@CS>Z>#(
M".K1_P`:_P!?P/K7B_AK7)?#OB"TU.+)$3_O$'\:'AE_+./?!KUZ5"EB,/[J
MM)?G_P`$\JI6J4,1[SO%_P!?@?0_B_Q$GA?PY<:B0C3#$=O&_1Y#T!]AR3[`
MUP_@[XA>)_%7B&&P%IIB6Z_O+B18I,K&#SCY^IS@?6N6^*'BN+Q#K4-K8SB7
M3[1/E=3Q([`%F_`8'X'UKT?X8>&/[!\-K=3KB]OPLK@CE$_@7\CD^YQVK)T8
M4<-S37O/8T56=;$<L'[J.WHHHKS3T3Q*]^,/B&VO[B!+/3"L4K("8I,X!(_O
MUWO@#QH?%VFS&Z6&+4('Q)'%D`H>C`$D^H//;WKP#5?^0Q??]?$G_H1K1\)>
M(9?#/B*VU!"?*SY<Z#^.,D;A^@(]P*]ZM@J<J7N*S/"I8RI&K[[NCW+X@^)[
MWPIH,%_816\DLETL)$ZL5VE7/8CGY14'P[\6W_BVPO9[^&VC:"5440*P!!&>
M<L:R?C#/%<^!]/G@D62*6]C='4Y#*8Y""/;%5_@G_P`@?5?^OA/_`$&N!4H?
M5'.VMSN=67UM0OI8]1HHHK@.\1W6-&=V"HHRS$X`'K7A\_QHUW[1)Y%CIPAW
M'RQ)&Y;;GC.'QG%>B_$G5_['\$7K(Q66ZQ:QD>K_`'O_`!T-7SO':3S6L]S'
M&3#!M$CY'R[C@?G@UZN7X>$XN=17/+Q^(G"2A!GT#\._&5SXNL+U[Z*WCN;:
M51M@4A=C#C@D\Y#5V=?/WPGU4Z?XUBMF($5[&T+9[$#<I^N5Q^-?0-<N-HJE
M5:CLSIP=5U:5WN@KF_'.MZCX=\-2:IIL5O(\,B"43J2-C';Q@@YW%?UKI*HZ
MSIR:OHM[I[XQ<PM'DG&"1P?P.#7/3:4TY;'143<&H[GEGA[XN:MJ'B&PLM0M
M-/2UN)EB=HD=6!;@')8CJ1VZ5[#7R21+;7!!W1RQ-C@X*L#_`#S7U/HNHKJ^
MAV.HJ`/M,"2$#H"1R/P.17?F&'A3Y905DSAP%>53FC-W9P?C[XD7_AG7TTW3
M8+.4+"KS-.KL58DX'##M@]^M=7X+UC4=?\,P:GJ4,,4L[,46%64;`<`X))YP
M3],5\_Z_>R>(_%]Y<1?.UW=;(1DG*YVH/RQ7TMIEC'IFEVEA$<I;0I$IQC(4
M`9_2EBZ4*5&$;>\QX6K.K5E*_NHM4445YQZ!P_Q$\;W7A&.P2PBMY;FY+EA.
M"P5%QV#`Y)/'T-<59?&76WO[9+NTTU;9I5$S)&X8)D;L$N><9K#^)VK_`-K>
M-[M58F*SQ:H/0K][_P`>+?I7*7=I/8W3VUS&8YH^&0D''&>U>]A\'2]DN=:L
M\/$8NI[5\CT1]:45S?@+53K'@K3;ER#*D?DR?5#MR?<@`_C725X<XN$G%]#V
MH24XJ2ZA7GWQ`\8^(?"-[;O:6EC+I]PN%DEC<LKCJI(8#IR/Q]*]!K(\3Z#!
MXDT"YTV;`9US$Y_@D'W6_/K[9K2A*$:B<U=$5HRE!J#LSAO!'Q0O-?\`$"Z9
MJT%G")D/D/`K+EQS@[F/49_'`[UU_C3Q.GA7P_+>@1O=,0EO$_1W/J!S@#D_
M_7KYQD2\T;5F0[H+RSFZCJCJ>H_$5L^,/%]UXNO+6:=!%';PA%C'3>0-[?B?
MT`KU9X",JL91^'K_`%YGE0QTHTI1E\73^O(]`\'_`!#\3^*?$,%@++35MQ^\
MN)%B?*1CKC+]3P!UY/I7JU<=\./"O_"-^'5>XCVZA>8EFW+AD&/E3\/YDUV-
M>9BI4W4:IJR1Z6&C-4TZCNV%%%%<YT!1110!D^)M4GT7PU?ZE;+&TUO%O19`
M2I.>^"#^M>0_\+H\1_\`/EI7_?J3_P"+KVG4].M]7TVXT^Z#&"==CA3@X^M<
M!KWPO\-:?X>U.]@BN1-;VDLL9,Q(W*A(X^HKNPDZ"7+55VV<6*A7;YJ;LK'*
M_P#"Z/$?_/EI7_?J3_XNC_A='B/_`)\M*_[]2?\`Q=<#80I<:C;0R9V22JC8
M]"0*]X_X5'X5_P">5U_W_-=]>.%H64X[G#0EBJU^66QW5%%%>$>V>7^.?B/K
M'AGQ*^FV5M8R0K$CAID<MDCV8#]*YO\`X71XC_Y\M*_[]2?_`!=4_BY_R/<O
M_7O'_*MWX8^#=`\0^&[B[U6P^T3I>-$K>=(F%"(<85@.I->TJ>'IX>-2<;['
MC.=>I7E3A*VYG?\`"Z/$?_/EI7_?J3_XNO0?AWXMO_%MA>SW\-M&T$JHH@5@
M"",\Y8U+_P`*P\'?]`?_`,F9O_BZVM$\.:3X<AEATJU^SI*P9QYC/DCC^(FN
M2O6PTH-4XV?]>9UT*6(C-.I*Z_KR-2BBL'QGK3:!X2O]0C8"=4V0^N]B%!'K
MC.?PKBA%RDHKJ=DI*,7)]#G_`!A\3['P[<R:?8PB]OTX?YL1Q'T)')(]!^>:
MX"7XO^*))"RFRB!_@2#@?F2?UKB((9[^^CACW2W%Q($7/)9F.!^))KZ!L?AA
MX9M](2SN;`7,VT>9<,[!V;N001@>P_7G/L3IX;"Q2FKMGDPJ8C%2;@[)'.^&
MOC"EY>1VNNVL-L)#M%U"2$4]MRG)`]\UZH"&4,I!!Y!'>OESQ-HQ\/\`B2^T
MO<66"3",V,E"`RDX[X(KW/X8ZN^K>"+7S6+RVC-;,Q[[<%?_`!UE%88W#0C!
M5:>S-L'B9RFZ53='8UD^)M4GT7PU?ZE;+&TUO%O19`2I.>^"#^M:U<YX]_Y$
M36/^O<_S%<%))SBGW1WU6U!M=CSS1/BWKVI:]IUA-:::L5S=10N4CD#!68`X
MR_7FO9J^7/"G_(XZ)_V$(/\`T8M?4==F84H4Y14%8X\!5G4BW-W/&=;^+>O:
M;KVHV$-IIK16UU+"A>.0L55B!G#]>*]0\,ZI/K7AJPU*Y6-9KB+>ZQ@A0<]L
MDG]:^<O%?_(XZW_V$)__`$8U?0'@+_D1-'_Z]Q_,UIC:-.%&,HJS_P"`9X.M
M.=649.Z_X)T=9/B;5)]%\-7^I6RQM-;Q;T60$J3GO@@_K6M7.>/?^1$UC_KW
M/\Q7GTDG.*?='H56U!M=CR[_`(71XC_Y\M*_[]2?_%U[#X?UJ#Q!H=KJ5N1B
M9`74'.Q_XE/T-?+%>C?"3Q/_`&9K3:-<RA;2^.8]QX6;@#_OH#'UVUZ^,P</
M9\U-6:/(PF,G[3EJ.Z9U?Q!^(.K>%->@L+"WLI(I+59B9T<MN+..S#CY179^
M&=4GUKPU8:E<K&LUQ%O=8P0H.>V23^M>0_&C_D<;3_L'I_Z,DKU'P%_R(FC_
M`/7N/YFN.O2A'#0FEJSLHU)RQ,XMZ(Z.BBL+QEK1T#PGJ&H(<3+'LAY&=[':
MI]\$Y^@-<48N4E%=3LE)1BY/H<YXR^)]KX=NFT_3X$O;Y.)"6Q'$?0XY)]AC
M'KVK@S\7_%!G\P?8@N<^6(#M^G7./QKC=/L[C6-6M[.(E[BZF"!FR>6/4_S)
MKWQ/A=X572Q9-8LSX&;GS&\PMC[V<X'TQCVKV)PPV%2C-7;/)A/$XEN4'9(R
M?!_Q6@UN\CT_5X(K.ZDXCE1CY3MV7!Y4GMR<UZ17RKK6FRZ'KMYISD[[:8H&
MZ$@'Y6_$8/XU]$>!M:?7O!]A>3.7N`IBF8]2ZG&3[D`'\:YL;AH02J4]F=&"
MQ,YMTZFZ.BK)\3:I/HOAJ_U*V6-IK>+>BR`E2<]\$']:UJYSQ[_R(FL?]>Y_
MF*XJ23G%/NCMJMJ#:['GFB?%O7M2U[3K":TTU8KFZBA<I'(&"LP!QE^O->S5
M\N>%/^1QT3_L(0?^C%KZCKLS"E"G**@K''@*LZD6YNX4445YYWA7G_C+XGVO
MAVZ;3]/@2]ODXD);$<1]#CDGV&,>O:NC\9:T=`\)ZAJ"'$RQ[(>1G>QVJ??!
M.?H#7S=I]G<:QJUO9Q$O<74P0,V3RQZG^9->C@<+&HG4J;(\_&XF5.T(;L[(
M_%_Q09_,'V(+G/EB`[?IUSC\:[3P?\5H-;O(]/U>"*SNI.(Y48^4[=EP>5)[
M<G-:R?"[PJNEBR:Q9GP,W/F-YA;'WLYP/IC'M7@^M:;+H>NWFG.3OMIB@;H2
M`?E;\1@_C733AA<2G&$;-'/.6)PS4IRNF?55%<[X&UI]>\'V%Y,Y>X"F*9CU
M+J<9/N0`?QKHJ\><7"3B^AZT)*<5)=0KS_QE\3[7P[=-I^GP)>WR<2$MB.(^
MAQR3[#&/7M71>,]:;0/"5_J$;`3JFR'UWL0H(]<9S^%?.&E:?-K.LVEA$V);
MJ98][<XR>6/TZUWX+"QJ)U*FR.'&XF5-JG3W9V)^+_B@S^8/L07.?+$!V_3K
MG'XUVOA#XK6^MWL>GZM!'9W4G$<J-^[=O3GE2>W)]*UH_AAX572ULGL"[A<&
MY,C"0MC[V<XSWQC'M7B.K^&-0T[7[S2X+:XNC!-Y2O'"QWYP5X`ZD$''O71"
M.%Q*<8JS1SSEBL.U*3NF?3]%8WA2ZOKSPMI\VI0S0WOE;9EG0H^Y25R0>><9
M_&MFO(E'E;78]>,N9)E#6[V33=!U&_A5&EMK669`X)4LJDC..W%>0V7QA\0W
M-_;P/9Z8%EE5"1%)G!(']^O5O%?_`")VM_\`8/G_`/1;5\SZ5_R&+'_KXC_]
M"%>E@*-.I"3DKGFXZM.$XJ+L?5]%%%>6>F<9\1/%M_X2L+*>PAMI&GE9&$ZL
M0`!GC#"O/O\`A='B/_GRTK_OU)_\771_&S_D#Z5_U\/_`.@UQ7PQT'3?$/B2
MXM-5MOM$"6;2JN]DPP=!G*D'H37L8:E16&]I.-SR<14K/$>SA*QI?\+H\1_\
M^6E?]^I/_BZZ3P-\1]8\3>)4TV]MK&.%HG<M"CAL@>[$?I71?\*P\'?]`?\`
M\F9O_BZO:1X(\.Z%?B]TW3_(N`I4/YTC<'KPS$5A4KX1P:C"S_KS-J='%*:<
MIZ?UY'0445!>3FVL;BX4!C%&S@'O@9KSDKGH/0X7QI\3[;P[<OIVFPI>7Z<2
M,S?NX3Z''+'U`(QZYXK@C\7O%)E+AK,*3G8(.![=<X_&N&EEDGF>:5R\DC%G
M8]23R37O6B>&_AYJNGPPZ?#979:/!W3'S^0>6&0P/![#VKVYTJ&%@N:/-YGC
M0JU\3-\LK>1F>%_B]#J-W'9:W:QVLDK!4N(2?+R3C#`\J/?)_#K7J%>-M\%K
MF36;@+J,4&F!_P!RQ!>4KC/(X'MG/;.*];TZS_L_3+6R,SS?9XEB\R3[S[1C
M)]^*X,6J%TZ+^1W85U[-55\RS1117&=84444`%%%%`!1110!XM\;/^0SI?\`
MU[M_Z%5SX'_\Q[_MW_\`:E4_C9_R&=+_`.O=O_0J/@[JVG:9_;7]H:A:VGF>
M1L^T3+'NQYF<9(SC(_.O9:;P%E_6IXZ:6.N_ZT/6M<$3>']2$^WRC:RA]QP-
MNPYS[8KY4KV;XB_$33I=$FTC1;H7,UT-DTT6=J1]QGN3TX[$^U>:^$=#D\0^
M)K.P5<QEP\QQP(UY;_#ZD5>`@Z-*4YZ$XZ:JU8PAJ?2]F9FL;<W&?/,:F3(Q
M\V.?UJ>BBO#9[2"OF_X@^&O^$:\3S11*!9W.9[<#^%2>5_`Y'TQ7TA7BWQL_
MY#.E_P#7NW_H5=^73:K<JV9P9A!.CS/='.?#KPT/$?BB)9XP]E:_OIP1D-C[
MJGZGMZ`U]&5Y%\#_`/F/?]N__M2O7:68S<JSB]D/+X*-%274****X3N/ES_F
M</\`M_\`_:E;/Q'\+_\`"-^)':",+87F9;<*,!>?F3\"?R(K&_YG#_M__P#:
ME?07C7PVOBCPW/9+@7*?O;9CVD`X'T/(_'/:O?KU_8U(-[-:GA4:'MJ<TMUL
M>%3^)FO/A_%H%RY:6TOEEMR1_P`LBD@(S[,1_P!]>U>B_!/_`)`^J_\`7PG_
M`*#7C$D;PRO%*C)(A*LK#!4CJ".QKV?X)_\`('U7_KX3_P!!HQL%'#RMU88*
M3E7C?HCU&BBD)"J68@`<DGM7@'NGB_QIU7SM6T_2D;Y;>(S.!_>8X'Y!?_'O
MRN^!O"HO_A;K&4)GU/=Y78'R_P#5_P#CX-><>)-3?Q!XIOK]`7^T3D1``Y*C
MY4&/7`%'_"*>(_\`H`:K_P"`<G^%?0*ART(T^;E>C_7\SP/;7K2J<MUM^GY&
M?9W4MC?6]Y`0)8)%E0GLRG(_45]66-W'?V%M>1?ZN>)94^C`$?SKY3N[*[T^
M<P7MK-;3``F.:,HV#WP>:]W^$NK'4/!JVKG,EC*T/3JI^93^I'X5CF=/FIJH
MNAMEL^6;@^IWE%%%>*>R?./Q)TK^RO'-^`"([HBZ3.>=_+=?]K=76^%_%/V3
MX/ZLC2`3V1:WBR0?];]W'K@LW'/W?2K?QJTDR66G:O&G,3M;RD#/#<KGT`(;
M_OJO(4NIDM);57(AE=7=0>"5#`?^A&O?I16)P\;]+?@>#5D\/7E;K?\`$ZWX
M7:2-4\;VKNFZ*S4W+<<9'"_^/$'\*^AZ\P^"^E>1HU_JC@;KF41)TX5!S],E
MO_'17I]>;F%3GK-=M#T<!3Y**??4*HZSJ*:1HM[J#XQ;0M)@C.2!P/Q.!5ZO
M-_C)J_V3PW;Z8C#S+V7+#_IFF"?_`![;^1KGH4_:5%#N=%>I[.FY=CR?PSIS
M>(/%UA9S$N+BX#3'N5'S/^@-=9\8]*^R>*8-05<)>P#<?5T^4_\`CNRN&L='
MU34T=[#3;R[5#AF@@:0*?0X'%37'AS7+2!Y[G1M1AA09>22U=54>I)&!7T,H
MKVJES;:6/`C)^R<>7?6YZ3\%-5.[4](8C&!=1C\E;_V2O7J^9O`VK'1?&6FW
M1.(VE$,G&?E?Y2?PSG\*^F:\C,:?+6YNYZV7U.:ER]@HHKG/&_B5?"_AR:\1
MD^UO^[MD;NY[X]`.?_UUQ0@YR48[L[)S4(N3V1Y!\5[K3[KQM-]B0^;%&L=T
MX/#R#T]P,`_3';GG?"]U867B?3KG5(C)9QS!I%]/0GU`."1W`Q5OP?X?F\5^
M)X+1][0[O.NY">0@///J>GU.:B\7>'I?#'B.XTY\F+_60/\`WXST/U'(/N#7
MTD.2*^KWUL?/3YY/V]M+GTZ"&4,I!!Y!'>EKSOX3>*/[5T0Z/<R`W=@H$>3R
M\/0?]\_=^FVO1*^=K4G2FX/H>_2J*I!374****S-`HHHH`*R/%?_`")VM_\`
M8/G_`/1;5KUD>*_^1.UO_L'S_P#HMJNG\:]2*GP,^9]*_P"0Q8_]?$?_`*$*
M^KZ^4-*_Y#%C_P!?$?\`Z$*^KZ]/-=X_,\[+-I?(****\D]0^?\`XN?\CW+_
M`->\?\JY.R_M7R3]A^V^5NY\C=MW?AWZ5UGQ<_Y'N7_KWC_E72?"OQ-HNB^&
M+FVU+48;:9KUI`DA.2I1!G\P?RKZ"-1T\-&2C?1'@RIJIB91;MJSSC_BHO\`
MJ*?^1*^HZYS_`(3WPK_T'+7\S_A6II>MZ;K<4DFFWD=RD9VN8ST->9BZLZJ3
M<+6/1PM*%)M*=[E^O/\`XQ-*/!*",95KR,2<=%VM_7;7H%<WX]T=];\&:A:Q
M#,Z()HAR<LAW8`'<@$?C6&'DHU8M]S?$1<J4DNQX1X(CCD\;Z,LH&T72,,G'
M(.1^H%?3=?)VG7KZ;JEI?1J&>VF290>Y5@1_*OI*S\:^'+W3!?IJ]K'$%#.L
MLJJZ$]BI.<]?KCC->AF=.3E&26AP9;4BHRBV:;Z3ITES)<OI]JT\N/,E:%2S
MX&!DXR<#BK$%O!;(4@ACB0G)6-0HSZ\5\]^+/'FI:IXCN;C2=4O[6P!"0I%<
M/&&`&-Q`/4G)_*O6OALVJ2^#H+G5;F>XFN':2-IV+,(^`O)YQP3SZURUL+.E
M34Y/?H=-'%0J5'"*^9UU<YX]_P"1$UC_`*]S_,5T=<YX]_Y$36/^O<_S%<]'
M^)'U1T5OX<O1GS7%YGG)Y._S=PV;,[MW;&.]:G_%1?\`44_\B4>%/^1QT3_L
M(0?^C%KZCKW,7BO822Y;W/%PF%]M%OFM8^2)?,\Y_.W^;N._?G=N[YSWKZ4\
M!?\`(B:/_P!>X_F:^?\`Q7_R..M_]A"?_P!&-7T!X"_Y$31_^O<?S-8YB[T8
MO^MC;+E:M)?UN='7.>/?^1$UC_KW/\Q71USGCW_D1-8_Z]S_`#%>31_B1]4>
MI6_AR]&>+?#G3+?6?$LFG7:!H;BTE1N.G`P1[@X(]Q6!JVFW>@:W<6%P2ES:
MR8W*2,]U8>Q&"/K75_"/_D>XO^O>3^5=E\7O"YOM.CUZU0F>T&RX51RT6>&_
MX"3^1)[5[DJ_)B>1[-?B>+&ASX;G6Z?X'FWC#Q'_`,)/<Z9>N?\`28[!(;GY
M<#S%=\D?4$'CUQ7NG@+_`)$31_\`KW'\S7S17TOX"_Y$31_^O<?S-89C!0HQ
MBMKFV7S<ZLI/>QT=<+\7/^1$E_Z^(_YFNZKGO'.C2:[X/U"RA3?<;!)".Y93
MNP/<X(_&O,P\E&K%ON>G7BY4I)=CP[X=)$_C_2!,Y5?,8@C^\$8J/Q.!7TE7
MRGHNI/HVMV6HQC<;:99-O]X`\C\1D5]'1>-/#DNEKJ/]L6B0$`D/*`ZG&=I7
MKN]L5Z&9TY.<9)'!EU2*A*+9XC\3_P#DHNJ_]L?_`$4E>C_!@D^#KH$D@7[@
M>W[N.O'O$>K'7?$5_J9#!;B4L@;J$Z*#R>0`*]\^'.DOH_@FQBE4K-.#<.I[
M;N1_X[MZUIC/<PL8/?3\C/!^_B936VIU5<YX]_Y$36/^O<_S%='7.>/?^1$U
MC_KW/\Q7DT?XD?5'J5OX<O1GS_X4_P"1QT3_`+"$'_HQ:^HZ^6/#EQ%:>)])
MN9W$<,5[#)(YZ*H<$G\J^A/^$]\*_P#0<M?S/^%>GF4)2G'E5SSLNG&,9<SL
M='163I?B;1=:N6MM-U&&YF5#(4C)R%!`S^9'YUK5Y,HN+LU8]2,E)73.%^+G
M_(B2_P#7Q'_,UY1\.5B;X@:0)CA/,8CG^((Q7]<5[AXYT:37?!^H64*;[C8)
M(1W+*=V![G!'XU\Z:+J3Z-K=EJ,8W&VF63;_`'@#R/Q&17L8'W\/*"WU_%'D
M8WW,1&;VT_!GU97SG\3_`/DHNJ_]L?\`T4E>W1>-/#DNEKJ/]L6B0$`D/*`Z
MG&=I7KN]L5\[^(]6.N^(K_4R&"W$I9`W4)T4'D\@`5GEM.<:DI-=+&F8U(NF
MDGU/8?@P2?!UT"20+]P/;]W'7HM<K\.=)?1_!-C%*I6:<&X=3VW<C_QW;UKJ
MJX<3)2K2:[G=AHN-**?8\]^,DDB>"X50G:]ZBOQGC:Y_F!7FOPQ`;XB:4"`1
M^]//_7)Z]C^(NE2:OX(OXH0S2P@3HJ_Q;#DCWXS^.*^?]`U:30M>LM3C!8V\
MH9E!P67HRY]P2/QKT\%[^%E!;Z_D>;C/<Q,9O;0]H^(GCK5/"5_906$%G(D\
M1=C.C$@@XXPPKC/^%T>(_P#GRTK_`+]2?_%UW^J/X"\5VD.J:G=V<\<285GN
MVB9`><%0P.?8C->%:Y)ITNMW;:3#Y.G^81`F6/RC@'YB3SC//K2P=*E./+*&
MJW;#%U:L)<T9Z/:Q]&^#=:N?$/A2RU6[2))Y]^Y8@0HVNRC`))Z`=ZW:Y'X8
M?\DZTK_MM_Z->NNKRZZ4:LDN[/4HMRIQ;[(R/%?_`")VM_\`8/G_`/1;5\SZ
M5_R&+'_KXC_]"%?3'BO_`)$[6_\`L'S_`/HMJ^9]*_Y#%C_U\1_^A"O4RW^'
M,\S,?XD3ZOHHHKQCUSR[XV?\@?2O^OA__0:\?LOMOG'[#]H\W;SY&=VW\.W2
MO8/C9_R!]*_Z^'_]!KC_`(5ZOI^B^)[FYU*ZCMH6LFC#R="Q=#C\@?RKW<))
MPPG,E??\SP\5%2Q7*W;8YW_BHO\`J*?^1*]Z^'/VG_A`]-^U^;Y_[W=YN=W^
MM?&<\],5-_PGOA7_`*#EK^9_PJWIWBK0M7NQ:Z?J<%Q.06"(3G`ZUQ8FO4JP
MLX6MJ=N&HPI3NIWN;%%%9?B+5WT'0+O5$M&NC;J'\E6V[AD`G.#@`$GIVK@C
M%R:2.Z344VSQ+QA\-M4T.^EFTVVFO-,;+(T2[FB']U@.>/7I7#D%6((((X(/
M:O5;'XSWDNM6XO;&V@TPOB7RPS2*"",YS@X.#T[5Z'=7/A'6K(W%Y/H]U`1D
MR3/&=O'J>5(S[$5[?UJM12C6C?S1XWU:C6;=*5O)GAGA[QYKOAZXB,=Y+<6J
M\-:SN60KGD#/W3[BOH;1]5M];T>UU*T),-P@<`]5/0J?<$$'Z5\Q:VFGQZW>
MKI3L]@)6$#-G)7MUYQ]:][^%]K-:^`=/\XOF4R2*K#[JESC'L?O?\"K/,:<.
M15$K,TR^I/G=-NZ.PHHHKQSU@HHHH`****`"BBB@#S#XH^$M<\1ZE83:59?:
M(XH65SYJ)@DY_B(K@O\`A6'C'_H#_P#DS#_\77T917=2Q]2G!025E_7<XJN!
MIU)N;;U_KL>!V'PA\373+]J%K9(1EC)*'(Y]%SSWZUZWX4\'Z=X2LFBM-TEQ
M+CSKA_O28SCCH`,]!^M=#16=;&5:RM)Z&E'"4J3O%:A1117*=(5YA\4?"6N>
M(]2L)M*LOM$<4+*Y\U$P2<_Q$5Z?16M&K*E/GCN95J4:L.21YS\*_"^L^&_[
M6_M:S^S_`&CR?*_>H^[;OS]TG'WAUKT:BBE6JNK-SENQTJ2I04([(****S-#
MP7_A7/BO_A)/M?\`97[C[9YN[[1%]W?G.-V>E>]445T5\1*M;FZ&%##QHWY>
MIY#\0_AQJ6H^(/[2T&T$ZW0+7$?F(FR0=_F(X8?7D'U%=#\+O#FK>'--OX=5
MM?L[RS*R#S%?(`Q_"37>T54L74E2]D]OQ)CA81J^U6X5D^)TU"7PSJ$6E0>=
M>RPF.)-P7EOE)R2!P"3U[5K45S1?*TSHDKIH\1\&_#?Q!9^+-/O-5T\06EO)
MYS.9HV^91E0`K$_>Q7MU%%;5\1.O+FD94*$:,>6)YA\4/!.J>(-1L;_1[07$
MHB,4X\Q4(`.5/S$`]6_*H_ACX9\2^&=9NQJ6G>397,(#/YT;8=3\O"L3T+=N
M]>IT5?UN?LO8M*Q'U2'M?:INX4445RG28?B_13X@\*W^G(H:9X]T.<?ZQ>5Y
M/3)&,^A->'_\*P\8_P#0'_\`)F'_`.+KZ,HKJH8RI0BXQL<M?"4ZTN:5S(\+
MZ3_8?AC3M-90LD,($@!R/,/+X/IN)K7HHKFE)R;D^ITQBHI)=`KR/XD>%/%/
MB7Q,);'3/-LH(5CB?SXUW'[S'!8'J<=.U>N45K0K2HRYXK4SK456CRR>ARWP
M^\/W'AOPG#9WD8CNY)'FF0,&PQ.`,C@_*%KH-1LH]2TRZL9L>7<1-$V1GAAB
MK-%1.I*4W-[E1@HP4%L?.A^%_C$,0-(!`[BYBY_\>KW[1VO7T:S.I1>5>^2H
MG3<&P^.>02.OO5VBML1BIUTE)+0QH86%!MQ;U"O'_B!X:\8>*?$+26^E.=/M
MAY=L#<Q#(_B?!?C<?QP!FO8**BA6=&7-%*_F76HJM'ED]#C?ASX1?POH;->1
MA=2NCNG&X-L`)VJ"..G/U/M3/B1X1D\3Z+')8PJ^I6S9B&0I=3]Y<G`]^?3W
MKM:*/K$_:^UZA["'LO9=#P?P]X*\<^'M=M=3M](.Z%OG7[5#AT/#*?G[C_&O
M=T8LBL5*$C)4XR/;CBEHJJ^(E7:<DKBH8>-%-1;"BBBN<W"BBB@`K.\06LU]
MX;U6TMDWSSV<L4:Y`W,R$`9/`Y-:-%.+L[B:NK'SYI_PT\70:E:S2:3M1)D9
MC]IB.`""?XJ^@Z**WQ&)G7:<NAA0PT*%U'J%%%%<YT'C_P`1?!'B+7?%DE[I
MNG^?;F%%#^=&O('/#,#7)_\`"L/&/_0'_P#)F'_XNOHRBN^GF%6$5%):?UW.
M&>`I3DY-O7^NQ\Y_\*P\8_\`0'_\F8?_`(NO3_A=X<U;PYIM_#JMK]G>6960
M>8KY`&/X2:[VBHK8ZI5AR22L51P5.E/GBV%%%%<9V'EGC'X3G4;V74=!DBAD
ME.Z2UDX4MW*GMGTZ>_:N`?X=>+8YQ"=%F+'`!5T*\_[0./UKZ2HKNI9A5A'E
MW.*I@*4WS;'BWAKX/WTUPD_B!TM[=2";:)PSO[$C@#Z$GZ=:]GCC2&)(HD5(
MT`5548"@=`!V%.HK"OB)UG>9O1P\**M`*Q?%UA<ZIX3U*RLXO-N)H2L:;@N3
MD=S@5M45E&3C)270TE%2BXOJ>"^'_ASXKL?$FE7=SI6R""\BED;[1$=JJX).
M`V3P*]ZHHK;$8B5=IRZ&5##QH)J/4\%\0?#GQ7?>)-5N[;2M\$]Y++&WVB(;
ME9R0<%LC@U[!X1L+G2_">FV5Y%Y5Q#"%D3<&P<GN,BMJBG6Q4ZL%"26A-'"P
MI2<XMZA6+XNL+G5/">I65G%YMQ-"5C3<%R<CN<"MJBL(R<9*2Z&\HJ47%]3Q
M_P"'7@CQ%H7BR.]U+3_(MQ"ZE_.C;DCCA6)KUV6*.>%X94#QR*5=3T(/!%/H
MK2O7E6GSRW,Z-"-&/+'8\!UCX5>(H-8NH]+L#<V(<F"4SQJ2IY`(+`Y'0\=J
M]D\(V%SI?A/3;*\B\JXAA"R)N#8.3W&16U15UL74K149="*.%A1DY1ZA1117
M,=)Y3XU^%,E_>R:EX?,2/*=TMHYV@L>I0]!GT.!Z'M7!GX=>+1<>0=%FW],A
MT*_]]9Q^M?25%=U/,*L(\NYPU,!2G+FV/(_!_P`))8+J'4/$+Q_NR'6RC.[)
M[;V'''H,Y]>U>N445SUJ\ZTN:;.FC0A1C:`5B^+K"YU3PGJ5E9Q>;<30E8TW
M!<G([G`K:HK.,G&2DNA<HJ47%]3YS_X5AXQ_Z`__`),P_P#Q='_"L/&/_0'_
M`/)F'_XNOHRBN_\`M.MV7X_YG#_9M+N_P_R/*/ACX-U_P]XDN+O5;#[/`]FT
M2MYT;Y8NAQA6)Z`UZO117'6K2K3YY'71HQHQY8A7E/C7X4R7][)J7A\Q(\IW
M2VCG:"QZE#T&?0X'H>U>K444:TZ,N:`5J,*L>69\VGX=>+1<>0=%FW],AT*_
M]]9Q^M=MX/\`A)+!=0ZAXA>/]V0ZV49W9/;>PXX]!G/KVKURBNJIF-:<>5:'
M-3R^E"5WJ%%%%<!W!7D'B_X23RWLE[X<$7EO\S6;-MVM_L$\8]CC'TZ>OT5M
M1KSHRYH&-:A"M&TSYN7X<^+6G,(T67>.YD0+_P!];L?K713_``>U6#PXTZ2)
M<:L9%*VT3@($YR-S8!;D'TX/7->WT5U2S*L[6LCFCEU)7O=G.>`]+O-&\%Z?
MI^H0^3=1>9OCW!L9D9AR"1T(KHZ**X9R<Y.3ZG;"*A%170SO$%K-?>&]5M+9
M-\\]G+%&N0-S,A`&3P.37ANG_#3Q=!J5K-)I.U$F1F/VF(X`()_BKZ#HK>AB
MIT8N,4M3"MA85FI2;T"BBBN8Z3@OBCX<U;Q'IMA#I5K]H>*9F<>8J8!&/XB*
M\P_X5AXQ_P"@/_Y,P_\`Q=?1E%=E''5*4.2*5CCK8*G5GSR;/G/_`(5AXQ_Z
M`_\`Y,P__%UUGPZ\$>(M"\61WNI:?Y%N(74OYT;<D<<*Q->P45=3,*LXN+2U
M_KN3#`4H24DWI_78*9+%'/"\,J!XY%*NIZ$'@BGT5P'<>+>)?@_?0W#S^'W2
MXMV)(MI7"NGL">"/J0?KUKE?^%=^+?/\G^Q9]^<9WIM_[ZSC]:^DZ*]"&95H
MJSLS@GEU*3NKH\6\-?!Z_FN8Y_$$B6]NI!-M&^YY/8L.%'N"3].M>S111P0I
M#$@2.-0J*.@`X`I]%<U?$5*SO,Z:.'A15H!1116!L%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
..4444`%%%%`!1110!_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>g2014031017063151028.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g2014031017063151028.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+#`Q-#0T'R<Y/3@R/"XS-#+_
MVP!#`0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P``1"`$9`Z<#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#W^BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`**9+-%"`994C!Z%V`S6?+XAT:#[^IVO7&%E#'
M]*`-.BL%_&?A]&*G41D>D3D?F%JM_P`)]H?_`#TG_P"_1H"YT]%<G)\0]&1L
M+%>2#^\L:X_5A3/^%C:1_P`^U]_WPG_Q5`7.OHKD/^%C:1_S[7W_`'PG_P`5
M4D7Q"T:0D,EW'CNT8Y_(F@+G5T5S<?CO07;#7$D8QU:)L?IFKL'BC0[C&S4X
M!G_GH=G_`*%B@#7HIJ2)*@>-U=3T93D&G4`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`'G_B'QOJ-EJES8VD4$:Q-M\Q@68_T_2N6N?$>LW>?-U*XP<Y
M"/L!S[+@5U6J^!]1U37+N[$UO%!+(2NYB6QCT`_K3(?AK*2?.U-%';9$6S^9
M&*9.IPKNTC%G8LQZDG)-)79Z]X%&F:9+>VUXTHB`+QNH!(SU!_I7&4P"BBB@
M04^*&68D11/(1U"J3BO0/`&EV%SI4UU<6D,LZW!17D4-@!5(QGIR>M=RB+&@
M5%"J.@`P!2N.QX7]AO/^?6?_`+]FHY8)H,>;$\>>F]2,U[S2,H=2K`%2,$$<
M$47'8\#HKV:^\,:-J`/G6,2N>=\0V-^G7\:X_5_A[<0`RZ7-]H0?\LI"`_X'
MH?THN*QQ]M>7-G)YEM<2POZQN5/Z5T^F?$#4K3"7J)>1CN?D?\QQ^8_&N4DB
MDAE:.5&213AE88(/H13:8'LVC^)--UL;;:7;/C)ADX8?X_A6O7@:.T;JZ,59
M3D,#@@^M=[X9\<G*6>L2<=$N3_)O\?S]:5AIG?T4`@@$'(/0BBD,****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`R/%/_(KZA_UR/\Z\9KV;Q3_R*^H?]<C_`#KQ
MFFB6%%%%,1Z=\.?^1>N/^OIO_0$KKZY#X<_\B]<?]?3?^@)77U):"BBB@`HH
MHH`P_$7AFUUVW+86*\4?NYL?HWJ/Y5Y+>6=QI]W):W49CFC.&4_S^E>[5ROC
M7P^NI:<U[`G^EVRD\=73N/?'4?CZTT)H\LHHHIDG:^#?%C6LD>F7\G^C-Q%*
MQ_U9]"?3^7TZ>D5X%7J/@CQ`VIV365R^ZZMQP3U=.F3[@\?E2929UE%%%(84
M5YGK_B[6K37;RWMKORH8I"BKY2'@?4&L]/&_B!6!-\&`_A,*8/Y"G85SURBO
M*D\?ZXA4LUNX'4-%U_(BK*?$;5`X,EK9LO<*K`_GN-%@N>F45YS_`,+)O/\`
MH'P?]]FD;XD7I4[;"W#8X)9B,T6"YZ/17GVC>-]3U+7+.UFCMDBD?:PC0@G(
M]237H-(84444`%%<9XT\0:EHU_:+93A$>,LRE%8,<^XS7.?\)]KG_/2#_OT*
M=A7/5J*\S3XC:H'!DM;-E[A58'\]QHD^(^J%OW=I9JOHP8G\]PHL%STRBN2\
M)>)K[7KRYCND@18HPP$2D<Y]R:ZVD,**\OO/'&N6][/#NA7RY&3!BY&#BH3X
M]UT@CS81[^4*=A7/5J*\H3QYKJJ`9H6(_B,0R?RI)/'>O.N%N(HS_>6)<_KF
MBP7/6**\IL_'>M07<<ES.+B$'YXC&BY'U`R#7I6FZG::M:+<V<H=#P1W4^A'
M8T@N7****!A1110`4444`%%>5O\`$#6W<LIMD!_A6/@?F33'\>:ZRD":%2?X
MA$,C\Z=A7/5Z*\A_X37Q#_T$/_(,?_Q-12>+=>E?<VI2@_[(51^0%%@N>QT5
MY#9>)=<FO[>,ZA.X:105]1FO7J07"BBB@84444`%%%%`!17B_B34O[5UZZN5
M;,>[9'Z;1P,?7K^-+X:U0Z3KMO<%ML3'RY?38>N?IP?PIV%<]GHHHI#"BBB@
M`HK@?B!J%[97UFMK>7$"M$21%*R@G/L:Y:+Q1KD(4+J=P=IR-[;OSSG-.PKG
ML]%>0_\`":^(?^@A_P"08_\`XFK`\>ZZ`!YL)]_*%%@N>K45Y0_CS764@30J
M3_$(AD?G59_&7B"1"K:BP!_NQHI_,"BP7/8**\4D\0ZS(VYM4O`?]F9E'Y`U
MZ%X"N[F\T*>2ZN)9W%RRAI7+$#:O&3]:+!<ZFBBN*^($M]!_9TUF]Q'L\W>\
M)8;?N]2/Q_6D,[6BO%HO$FM1`A=4NCG^](6_G5I?&GB!5"C4#@#',2$_GMIV
M%<]?HKR'_A-?$/\`T$/_`"#'_P#$U#-XLUV?._4I1D8^0!/_`$$#\Z+!<]DH
MKS#P?<:M?^([66:>]N+:+?O=W9T7*'&2>!SBO3Z0PHHHH`***\[^(VI"2YMM
M-0\1#S9.>,G@#Z@9_P"^J`/1**\$C=HI%D1BKJ0RL.H(KVS1=175='MKT?>D
M3YQZ,.&'Y@T"3+]%%%`PHHHH`****`"BF3>9Y,GE8\S:=N>F>U>2?\)KXA_Z
M"'_D&/\`^)H%<]>HKR(>-O$((/V_/MY,?_Q-7(_B'K*+AHK.0_WFC;/Z,*=@
MN>HT5YPOQ(O0HW6%N6QR0S`9J.7XCZD2/*L[11WW!F_J*+!<]+HKRN7X@:W(
M<K]FBXQA(_UY)K8\&>(-6U?6I(+V\\R)(&DV^6@R<J.H`/>BP7.\HHK@O%'B
M[4=+UV6SLY(O+C5<AH\D$C/7\12&=[17E/\`PGVN?\](/^_0H_X3[7/^>D'_
M`'Z%.PKGJU%>8#XBZP`!]GLC[E&_^*J.7X@ZU(056UCQV6,\_F318+GJ=%>?
M^$/$NK:GKJVUY=>;"8V.WRU7D>X`KT"D,****`"BBB@`HHHH`****`"BBB@#
M(\4_\BOJ'_7(_P`Z\9KV;Q3_`,BOJ'_7(_SKQFFB6%%%%,1Z=\.?^1>N/^OI
MO_0$KKZXOX;R$Z3=Q8&U9]P]<E1_@*[2I+04444`%%%%`!1110!XYXJTI=(U
MZ:",8AD_>Q#T4]OP((_"L6O1OB/9;[&TOE',<AC8CT89'ZC]:\YIDL*N:5J$
MFE:G!>Q=8FR1_>'<?B*IT4Q'O4,R7$$<T;;HY%#J?4$9%/KE_`5_]K\.B!C\
M]LYC_P"`GD?S(_"NHJ2R&XL[6[7;<VT,P])$#?SKA/%W@Z&WMFU'2XMB1C,T
M(R0!_>'T[BO0:"`001D'J#0!X%170^+]"_L75=T*XM+C+Q8Z*>Z_A_(USU40
M%>CZ9X$T>YM(;HW5S<)*H=<$("".XP3G\:\XKNO`&N^5*VD7#`(Y+P,3T;NO
MX]?S]:3&CK;#PSH^FR)+;62"5>DCDL0?7D\?A6M112*"BBB@"K>:;9:@`+RT
MAGP,`R("1]#VKF/$/A?0++1;N\6W,$B(61DD;ES]T8)(QDBNQKS/Q[K9N[\:
M9"W[FV.9,'AG_P#K?U-`F<>B-(ZHBEF8X"@9)/I7H&B_#Z(P1SZM(YD89,$9
MP%]B>_X8IG@'0/\`F,W*>JVZG\BW]!^/M7?TVP2*.GZ-I^E;OL-JD)8`,1DD
MCZGFKU%%(9FW>@:3?%FN-/MV=R2SA-K$GN2.:Y[5?A[931.^FR/;R@?+&[;D
M/MSR/KDUV=%`'A-Y9W&GW<EK=1F.:,X93_/Z5!7H'Q)M$V6-X%P^6B8XZCJ.
M?;G\Z\_JB0K2T76KK0[X7%N<J>)(R?E<>A_H:S:*!'M^E:K:ZS8K=6KY4\,I
M^\A]#5ZO%-%UJZT.^%Q;G*GB2,GY7'H?Z&O7=*U6UUFQ6ZM7RIX93]Y#Z&I*
M3+U%%%`PHHHH`R;OPSHMZQ:?3H=QZE`4)_[YQ7,Z]X#LX-/GO-/EE1X4,AB<
M[@P`R0#U!_.N\JO?_P#(/N?^N3?R-`K'A5>@^&_`UM):0WVIGS?-0.D"D@`$
M9&3US[?SKSZO;M$8MH&G,Q)8VL1))Y)VBFQ(EL]-LK`8M+2&#(P2B`$_4]ZM
M444B@HHHH`****`"L7Q7J1TOP]<RH<2R#RH^<<MQD>X&3^%;5>;?$34?.U*#
M3T(VVZ;WP?XF['Z`#\Z!,XNBBBJ)/7_!^J#4_#T&YLS0#R9,]>.A_$8Y]<UO
M5Y;X"U3[%K9M'/[J[&WKT<<C^H_$5ZE4E(****!D-Q:6UVFRYMXIE_NR(&'Z
MUC:AX.T6^B8+:+;R'.V2'Y<'Z=/TK?HH`\-U+3YM*U":RN`/,C.,CH1V(JI7
MH?Q$T@R0PZM$.8\13?[I/RG\SC\17GE,EA75^#/#5KK;3W%ZS-#"P41*<;B?
M4^GTKE*ZOP#J7V/73:N<1W:;?^!#D?U'XT`CT2#1M,MAB'3[5.,9$2Y/U/>K
MU%%(H****`*UQI]E=AOM%I!+NZ[XP<_G7F?C70K/1KRW:R^1)U8F(MG:01R.
M^#G]#7JM>2^-]0^W>))45LQVP$*\\9'+?J2/PIH3,"""6YN(X(4+RR,%11W)
MKT_2/`NFV*))>+]KN!@G?]P'V7N/K7/_``]TK[1J,NI2#]W;C8GNY']!_,5Z
M50P2&QQI%&J1HJ(HP%48`%.HHI#"BBB@!LDB11M([!44%F8]`!7B&JW[ZGJE
MS>OG,KE@#V'0#\!@5Z9XXU+[!X>>)&Q+='RACKM_B_3C\:\GIHEA7=_#K5-D
MMQIDC</^]BR>XX8?E@_@:X2K>F7TFF:G;WL>=T+AB!W'<?B,C\:8'N5%,AF2
MX@CFC;='(H=3Z@C(I]24%%%%`!1110`5DS^&-$N,[],MQD8_=KL_]!Q6M10!
MY_K_`(!2&WDNM)=R4&YK=SG([[3_`$/Y]JX*O?:\O\;^'O[.O/[0MU_T6X;Y
M@!_JW]/H>3^?M30FCDJ***9)Z3X:\,>'[_1[:\,+7$C*/,WR'Y7'WA@8XSZ]
ML5U5GIECI^?LEI!`2,$QH`2/<]37F?@O7_[)U+[/.^+2Y(#9Z(W9OZ'_`.M7
MJU)E(*R]0\.Z3JLXGO;,22@8W;V4X_`BM2BD,Y:^\$^'UM99?*DMEC0LSI*3
M@`9S\V:\KKT#Q]KX"?V/;L"3AK@@].X7^OY5Q6FZ=/JM_%9VRYDD.,GHH[D^
MPIHEEK0M`N]>NS%!\D:<R3,/E3_$^U=]:_#_`$:``S^?<GOO?:/_`!W'\ZV]
M(TFVT;3X[2W4<#+OCEV[DU?HN.Q2LM'T[3B&M+*"%\8WJ@W8]-W6KM%%(844
M44`%%%%`!1110`4444`%%%%`&1XI_P"17U#_`*Y'^=>,U[-XI_Y%?4/^N1_G
M7C--$L****8CT;X;?\@^^_ZZK_*NWKB_AO&PTJ\D/W6G"CZA1G^8KM*EE(**
M**!A1110`4444`8/C.W%QX5O.FZ,+("3TPPS^F:\@KVOQ`BR>'=25AD"VD;\
M0I(_45XI31+"BBBF([7X;W)35+RVSQ)"'_%3C_V8UZ17DW@641^*K=2,^8CJ
M/;Y2?Z5ZS292"BBBD,S==TB+6]*ELY,!C\T;G^%QT/\`3\:\8G@EMKB2"9"D
ML;%74]B*]YKAO'OA_P`Z/^V+9,R(`+A0.J]F_#H?;'I30FCSNE1VC=71BK*<
MA@<$'UI**9)[#X6UY==TL.YQ=0X6=??LWT./YUN5XOX>UE]#U:.Z`W1'Y)5]
M5/7\1UKV6&:.X@2:%P\;J&5AT(-2RD/HHJ.>>*VMY)YG"11J6=CV`H&97B;7
M%T/2FE!!N9,I"I&?F]?H*\QT#1Y=>U=8"6\O.^:0\X7OSZFEUW5Y_$.L&54;
M:2(X(NX&>/Q->F^&=#70]*6(@&YDP\S`Y^;T^@IBW-:&&.W@2&%`D:*%51T`
M%/HHI#"BBB@`HHHH`Y#XC?\`(O6__7TO_H#UP.C:3+K5\;2&14D\MG7=T)';
MVKOOB-_R+UO_`-?2_P#H#UR7@AV3Q;:*IP'$BM[C83_,"F2]S#N;::TN)+>X
MC:.6,X96Z@U%7L/B+PU;:];$X6*\4?NYL?HWJ/Y5Y/?Z?=:9=M:WD1BE7G![
MCU![B@&BM6EHNM76AWPN+<Y4\21D_*X]#_0UFT4Q'M^E:K:ZS8K=6KY4\,I^
M\A]#5ZO%-%UJZT.^%Q;G*GB2,GY7'H?Z&O7=*U6UUFQ6ZM7RIX93]Y#Z&I*3
M+U%%%`PHHHH`\$D1HI&C<8925(]"*]KT+_D7M-_Z]8O_`$`5X[JD9AU:]B8@
MLD[J<=,AC7L.@L&\.Z:5((^RQC@]PHILE&C1112*"BBB@`HHHH`CGFCMK>6>
M4XCB0NQ]`!DUX=?7<E_?3W<OWYG+D>F>U>E>/M2^QZ$MJIQ)=OM_X".3_0?C
M7G.E6#ZGJEM9)G,KA21V'4G\!DTT)E1E*G#`@X!Y'8TE=M\0-'6UGMM0@C5(
MG40N%'1E'R_^.C'_``&N)IB'Q2R03)-$Q22-@RL.H(Y!KV[2K]=3TNVO4QB5
M`2!V/0C\#FO#J[_X=:IQ<:7(W_3:+)^@8?R/YTF".^HHHI%!1110!!>6L=]9
M3VLH_=S(4/MD=:\0O;22PO9K2;_61.4..^.]>[5YQ\1-+,-]#J2+\DX\N0C^
M^.F?J/\`T&FA,XFI()I+:XBGB.V2)PZGT(.14=%,D]TT^]CU'3[>\B^Y,@<#
M.<>H_#I5FN'^'>J&6UGTN1LM%^]B'^R3R/S.?^!5W%26%%%%`%>^NEL;"XNG
M(VPQL_/?`Z5X9)(\TKRR-N=V+,?4GK7IGQ!U(6VCQV*-^\NF^8?["\_SQ^M<
M;X2TW^T_$5O&PS'%^^D^B_\`U\"FA,],\.:9_9.A6UJ1B7;OE_WSR?RZ?A6K
M112&%%%%`!11574;V/3M.N+R3[L*%L>I[#\3@4`>:>.]2^VZ^;=&)BM%\L#M
MN/+'^0_"N7P<9QQZT^662>9YI6+R2,69CU)/)-=]/X8_XM]$JQ@WD8^U\#DY
MY(_[YP/JHID[GGU%%%,1Z?\`#_5!=:,UB[9EM6X![H>1^N1^5==7COA35?[)
MUZ"5SB&7]U+[`]_P.#7L5)E(****0PHHHH`****`"H+RTAO[.6UN%W12KM85
M/10!XGK>DRZ+JDMG(2P7YHW(QO4]#_3Z@UG5ZSXQ\/G6M-$L"YO+?+1C^^.Z
M_P!1[_6O)B""01@CJ*9+"O2O`_B/[;;C2[I_](B7]RQ_C0=OJ/U'TKS6I;:X
MEM+F.X@<I+&P96'8B@#WBLCQ'KD>A:6TYPT[_+#&3]YO7Z#K_P#KI-)\0VFH
M:%_:4LB0B,8N`>B,.OY]OJ.]>8^(]<DUW5&G.5@3Y88R?NKZ_4]?_P!5`VS-
M=YKRZ9W+RSRODGJ68FO6/"GAU=#L-TRJ;V89E8<[1V4'^?O6)X&\->6BZO>1
M_.PS;HPZ#^_^/;\_2N[H8)!1112&%%%%`!1110`4444`%%%%`!1110`4444`
M9'BG_D5]0_ZY'^=>,U[-XI_Y%?4/^N1_G7C--$L****8CT[X<_\`(O7'_7TW
M_H"5U]<?\.74Z#<H#\PN22/8JN/Y&NPJ2T%%%%`!1110`4444`9^N_\`(O:E
M_P!>LO\`Z`:\2KV?Q/-Y'AG47W`9A*9/^UQ_6O&*:)84444Q'0>"03XNLL#I
MYF?^^&KUVO+/A]&7\2E@1B.!V.?3(']:]3I,I!1112&%(Z+(C(ZAD8892,@C
MTI:*`/&_$VAOH>JM$`3;29>%B<_+Z'W%8U>S^(=%CUS2GMC@3+\T3_W6_P`#
MTKQN:&2WG>&9"DB,593U!%-$L97H/P_UW<K:/._*Y>W)/4=2O\S^=>?5)!/+
M;7$<\+E)8V#(P[$4P/>:\U\<^(OMEP=+M7S;Q-^]8'[[CM]!_/Z5?U3QRDGA
MN(VC;-0G!1PO_+''4_CV_P#K5S7A70#KFIA9`PM(OFF8=_1?Q_QI#;.A\!^'
M>FL72^UNI_5C_3\?:N_I$18T5$4*BC"J!@`>E+2&%%%%`!1110`4444`<M\0
M$5_#.YADI.C+['D?R)KBO!7_`"-UC_VT_P#1;5V_C[_D6'_ZZI_.N(\%?\C=
M8_\`;3_T6U,3W/7JR=>T"UUZS\J;Y)5YBF`R4/\`4>U:U%(9XAJNE76CWS6M
MTF&'*L/NN/451KVO6M%M=<L3;W`PPYCE`^9#ZC^HKR+5=*NM'OFM;I,,.58?
M=<>HIDM%&M+1=:NM#OA<6YRIXDC)^5QZ'^AK-HIB/;]*U6UUFQ6ZM7RIX93]
MY#Z&KU>*:+K5UH=\+BW.5/$D9/RN/0_T->NZ5JMKK-BMU:OE3PRG[R'T-24F
M7J***!GB6N_\C#J7_7U+_P"AFO5?"C!O"^GE2"/*QP>X)KRWQ#&8O$>I*Q&3
M<.W'H23_`%KTOP5_R*-C_P!M/_1C4V2C?HHHI%!1110`4451UC4!I>D75Z1D
MQ)E1ZL>!^I%`'F?C;4O[0\12QJ?W=M^Y7ZC[WZY'X5K?#G3?,NKG4G7Y8QY4
M9/\`>/)_3'YUP[,68LQ)8G))/)->S>&]-_LK0;6V9<2[=\GKN/)S].GX4R42
M:]IO]K:)=68`,CIF//9QR/IR,?C7BA!!((P1U%>^UY%XSTW^SO$4Y12(;C]\
MGX_>_7/Z4(;.?JYI5^^EZK;7J=8GR1ZCH1^()JG13)/>XI$FB26-MR.H93Z@
M]*=7+>`]3^W:"+9VS+:-L_X">5_J/PKJ:DL****`"LOQ%I@U?0[FU'^LV[XS
MCHXY'Y]/QK4HH`\"(()!&".HHKH/&6E?V9K\I10(;C]ZF.V>H_//Z5S]407]
M%U)])U>WO$/"-\X_O*>"/RKVR.1)8UD1@R,`RL.A!KP2O4O`>J_;M%-I(?WM
MH=@]T/W?ZC\!292.KHHK/UO41I6C75X3AHT.SC/S'A?U(I#/,?&.HG4?$=QA
MLQ0?N4Q[=?US76_#W3?L^DRWSKA[E\+D?P+_`(G/Y"O.;6WDO;V&WCYDFD"#
M/J3BO<;.UCLK.&UA&(XD"+^`IL2)J***0PHHHH`*XCXBZEY5E;Z<A^:9O,D_
MW1T'XG_T&NWKQGQ/J7]J>(+J=3F)6\N/_=7C/X\G\::$QGAS3O[5UZUMB`8]
M^^3(XVKR1^.,?C7M)`(((R#U!KA?ASIVRWNM2<#,A\F/CD`<G\SC\J[JA@CQ
M7Q!IO]DZY<V@'[L-NC_W3R/\/PK,KT3XC:;YEK;:DB_-&?*D(_NGD?KG\Z\[
MH$PKV/PIJ?\`:OAZWE8YEC'DR?[R]_Q&#^->.5V'P]U/[-JTM@[?)=+E?]]>
M?U&?R%#!'IM%%%(H****`"BBB@`HHHH`*\V\=>'OLEQ_:MJF()3B90,!']?H
M?Y_6O2:CG@BN;>2"9`\4BE74]P:`/!J*U_$FB2:%JKP?,;=_GA<]U]/J.GZ]
MZR*H@>LTJ121+(RQR8WJ#PV.F:Z3P?X;.L7GVFY7_086^8$?ZQO[H]O7_P"O
M7,5V/@;Q#]BNAIET_P#H\S?NB3]QSV^A_G2&CTP````8`Z`4444B@HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`R/%/\`R*^H?]<C_.O&:]F\4_\`(KZA
M_P!<C_.O&::)84444Q'HWPV_Y!]]_P!=5_E7;UQ_PY4#0+AL#<;I@3CG&U?\
M3785+*04444#"BBB@`HHHH`Y?Q]<^1X9:+O/*B?E\W_LM>55V_Q'OA)?6EBI
M_P!4AD?ZMP/T'ZUQ%-$L****8CO_`(;6AVW]X<[25B7TSU/\UKOJR/#.FG2M
M`MK=UVRE?,E!Z[FYP?IP/PK7J2T%%%%`!1110`5Q/CSP\MQ;'5[9`)HA^_`_
MC7IGZC^7TKMJ;)&DL;1NH9&!5E/0@T`>"45)<1"&YEB!R$<J#ZX-1U1`5[/X
M<TR'2]$MX8@-SH))&_O,1R?Z5XQ7NMA_R#[;_KDO\A28T6****104444`%%%
M%`!1110!RWQ`=4\,[6."\Z*ON>3_`"!K@O"W_(SZ?_UU'\J[?XC?\B];_P#7
MTO\`Z`]<1X6_Y&?3_P#KJ/Y4T2]SV:BBBD4%9NM:+:ZY8FWN!AAS'*!\R'U'
M]16E10!XAJNE76CWS6MTF&'*L/NN/451KVO6M%M=<L3;W`PPYCE`^9#ZC^HK
MR+5=*NM'OFM;I,,.58?=<>HIDM%&M+1=:NM#OA<6YRIXDC)^5QZ'^AK-HIB/
M;]*U6UUFQ6ZM7RIX93]Y#Z&KU>*:+K5UH=\+BW.5/$D9/RN/0_T->NZ5JMKK
M-BMU:OE3PRG[R'T-24F>5>+HS%XJOU8@DN&X]"H/]:]"\$.K^$[15.2AD5O8
M[R?Y$5P7C7_D;K[_`+9_^BUKM_`/_(L)_P!=7_G3!;G3T444AA1110`5P7Q&
MU+"6NFHW4^=(!^2C^?Y"N])`!).`.I->*:_J)U77+J[SE&?$?^X.!^@S^--"
M97TV6V@U*VFO%=[>.0,ZH`2P'.,&O2D\?Z(R@DW"D_PF+D?D:\\M=!U6^MUN
M+:QFEA;.UU'!QQ4W_"+:Y_T#)_R%`CO_`/A/M#_YZ3_]^C7->,==TG7+2W:U
M>3[3"YQNC(!4]?Y"L7_A%M<_Z!D_Y"C_`(1;7/\`H&3_`)"@-3(HJ2>"6VG>
M">-HY4.UE88(-1TQ'2^!]2-AXACB8XBNAY39/?JI^N>/QKUBO`T=HW5U.&4Y
M!]#7MNC:BNK:1;7J]9$^8>C#@C\P:3*1?HHHI#"BBB@#FO&^E?VCH331INGM
M3YBXZ[?XA^7/X5Y/7OC*'4JP!4C!!'!%>+>(-+.D:U<6@!$8;=$3W0\C_#\*
M:$S,K;\*:K_9.O02N<0R_NI?8'O^!P:Q**9)[[7!_$?4=L5KIJ$Y8^<_/;D*
M/SS^0K?\)ZL-4\/PR2-F6']U*6]0.OXC!_.O,O$&I?VMKES=@_NRVV/_`'1P
M/\?QI(IF[\/M-^TZO)?.I,=LGRGMO;C\>,_I7IM87A#3?[-\.VZLN)9AYTGX
M]!^6*W:0(****!A1110!C^*=2_LOP_<S*P65QY47^\W''T&3^%>-5VWQ$U+S
M;^#3D8%8%\R0#^\>@/X<_P#`JY2QTR]U)G6SMGF*`%M@Z4T2SN]%\9Z)I^E6
M]EMN8_)C"DF(89NI(P3WR?QK0_X3[0_^>D__`'Z-<!_PBVN?]`R?\A1_PBVN
M?]`R?\A0%V=EJ_B_0=3TFZLR\V98R%S%T;J#^>*\VK7_`.$6US_H&3_D*IWV
MF7NFLBWEL\)<$KO'6@"I4UI=265Y#=0G$D3AU_`U#13$>[VES'>6<-S$<QRH
M'7Z$9J:N.^'NJ?:=*DL';]Y;-E/]QN?YY_,5V-26%%%%`!1110`4444`%%%9
M/B'7(M"TUKAL-,WRPQG^)O\``=__`*]`'-_$/4;,VT6G[%DNPPD#`_ZH?_7]
M/Q]*\\JTQN]6U'/SSW5P_P"+$_Y_"NPUKP,+30(I[0F2\@7,X!SY@[X^G\O>
MF3N<+1113$>K^#?$/]L6'V>X;-Y;@!B?XUZ!OKZ__7KIJ\,TW4)]+U"&\MSB
M2)LX/1AW!]B*]ITW4(-4T^&\MSF.5<X/53W!]P:3*3+5%%%(84444`%%%%`!
M1110`4444`%%%%`!1110!D>*?^17U#_KD?YUXS7LGBQU3PMJ!8X'EX_$D`5X
MW31+"BBBF(]+^'$H.C746.5N-V?JH']*[*O,?A]J26NL2V<AP+M`%/\`M+D@
M?D37IU2RD%%%%`PHHHH`*CN)X[6VDN)FVQQJ78^@%2$@`DG`'4FO-O&?BI+_
M`/XEVGR[K8<RR+T<^@]J`.7U6_?5-5N;U^LKY`]!T`_``53HHJB`KI?!>BG5
M-96>1<VUJ1(^?XF_A'YC/T%8NF:=<:K?Q6ELFYW/)[*.['V%>R:1I<&C:;%9
MP<A>68]78]328TB]1112*"BBB@`HHHH`****`/"K[_D(7/\`UU;^9JO5B^_Y
M"%S_`-=6_F:KU1`5[XB+&BHHPJC`'H*\#KWVDRD%%%%(84444`%%%%`!1110
M!R'Q&_Y%ZW_Z^E_]`>N(\+D#Q/I^3C]\*[?XC?\`(O6__7TO_H#UP.A?\C#I
MO_7U%_Z&*:)>Y[;1112*"BBB@`K-UK1;77+$V]P,,.8Y0/F0^H_J*TJ*`/$-
M5TJZT>^:UNDPPY5A]UQZBJ->UZUHMKKEB;>X&&',<H'S(?4?U%>1:KI5UH]\
MUK=)AARK#[KCU%,EHHUI:+K5UH=\+BW.5/$D9/RN/0_T-9M%,1K^)KZWU/6Y
M+ZV9BDZ(Q5A@J0H!'Z5WGP_D5_#6T=4G=3]>#_45Y97IWPY_Y%ZX_P"OIO\`
MT!*3&CKZ***104444`8/C'4O[-\.SE6*S3_N8\>_7],_I7DD$,ES<101#=)*
MX11ZDG`KK/B#J7VG5X[%&)CMD^8=M[<_CQC]:A\`Z=]LU[[2P/EVB;^G!8\`
M?S/X4R7N>EV-I'86$%I%]R%`@/KCO5BBBD4%%%%`'FWQ#TSR-2AU%!\EPNQ_
M]]>GYC'_`'R:XNO9O$^F?VMH%S;JFZ91YD7'.X=A]1D?C7C--$L*[WX<ZGA[
MG3';@_OHOKT8?R_(UP57]&U`Z7K%K>`G;&XW@=U/!'Y9I@CVZBD5@ZAE(*D9
M!!X(I:DH****`"N,^(6E?:-.BU*,?O+<[']T)_H?YFNSJ*YMX[NUEMY1F.5"
MC#V(Q0!X/15G4+*33=0GLY>7A<J2._H?Q'-5JH@T],UJXTRRU"VB^[>1;"?[
MISU_(L/Q'I2^'=,_M;7;:U(S'NWR_P"X.3^?3\:RZ]$^'.F^7:W.I.OS2'RH
MR?[HY/ZX_*D-'<T444B@HHHH`*9-,EO!)-(VV.-2['T`&33ZY;QYJ7V+0?LR
M-B2[;9[[1RW]!^-`'FFHWCZAJ-Q>2?>FD+X]!V'X#BO3/`FF_8M`%PZ@2W;>
M83WVCA1_,_C7F>GVCW^HV]HG#32!,^F3UKW&&%+>".&-=L<:A%'H`,"FQ(?1
M112&%<SXYTS[?X?>95S+:GS1C^[_`!?IS^%=-2.BR(R,,JPP1ZB@#P.BKVLZ
M>VE:O<V;=(W.T^JGD'\L51JB#9\+:G_97B"WF9L1.?*D_P!UO\#@_A7LE>!5
M[/X9U+^U=`M;AF+2A?+E)Z[AP3^/7\:3*1K4444AA1110`444$@`DG`'4F@"
M"\O(+"TENKF01PQC+,:\<UW6I]<U)[J7Y4'RQ1YR$7_'UK5\8^)?[8NA:VK'
M[%">#_ST;^]]/2CP?X:.L7?VJY3_`$&%N0?^6C?W?IZTR7J=#X%\._8[<:I=
M)B>4?N5/5$/?ZG^7UKM*````!@#H!12*/+?&GAS^RKO[;;)BSG;D#_EF_I]#
MR?TKE*]WN[2&^M);6X3?#*NUEKQG6](GT34I+2;E>L;XX=>QIHEHSJZ?P9K_
M`/9.H_9IWQ:7!`;/\#=F_H?_`*U<Q13`]]HKD/`VO_;[+^SKA\W-NOR$_P`<
M?^(Z?3'O77U)04444`%%%%`!1110`4444`%%%%`!4<]Q!:Q&2XFCBC'\4C!1
M^9KS'Q1XCU=-;O+2*^EB@BDVHL7R$#CN.?UKEY9I9WWS2O(W]YV)/ZT["N=M
MXS\56M_:?V;I\AD0L&EE&0IQ_"/7G!KAJ**8@HHHH$*CM&ZNC%64Y#`X(/K7
MH.@^/XV1;?6!M<8`N$&0?]X=C[C\A7GM%`SW6UOK2^0/:W,4RXS^[<''U]*L
M5X%5C[=>?\_4_P#W\-*P[GNC,$4LQ`4#))/`%8NI^+-(TL$/=+-+CB*#YS^)
MZ#\37D$LTLQ!EE>0CH68G%,HL%SH]=\8W^LJT$?^BVIX,:'EQ_M'O].E<Y14
MUK:7-[,(;6"2:0_PHI)IB(:T-(T6]UJZ$%I'D#[\AX5!ZD_TZUU&C?#Z>4K-
MJTGE1]?)C.6/U/0?K^%=]:6=M86ZV]K"D42]%44KA8HZ%H%IH-H8H/GE?F29
MA\S_`.`]JU:**104444`%%%%`!1110`45Q=U\1[&/(M;*>8CNY"`_P`_Y5BW
M7Q$U27(MX+>`'O@LP_/C]*+"N<Q??\A"Y_ZZM_,U7ITCM+(TCG+,2Q/J33:H
MD*]]KP*NRLOB'>6T$44UE!*(U"Y5BI(`Q[\TF-'I=%<1;?$BTD=1<V$L()P6
M1P^!Z]!7;TB@HHHH`****`"BL;Q!XBM_#\4#31/*TS$*JD#@=3^HK!_X639_
M]`^?_OL4!<F^(\BC0[6/^)KD,/H%;/\`,5YW8R>5J%M)OV;)5;=G&,$<YK9\
M3^*&\0&&-+?R((22`6W%B>Y]/I7/4R6>^T5YO9_$:[AA2.YL8YRJ[2RR%2Q]
M3D&M!/B3:D+YFG3*>X60''\J5AW.XHJ&TN4O+."ZC#!)HUD4-U`(R,_G4U`P
MHHHH`*S=:T6UURQ-O<###F.4#YD/J/ZBM*B@#Q#5=*NM'OFM;I,,.58?=<>H
MJC7M>M:+:ZY8FWN!AAS'*!\R'U']17D6JZ5=:/?-:W288<JP^ZX]13):*->G
M?#G_`)%ZX_Z^F_\`0$KS&O3OAS_R+UQ_U]-_Z`E#!'7T45#=W*6=G/=2!BD,
M;2,%ZD`9./RI%$U5[Z\BT^QFNYCB.)"Q]_:N&NOB3(<BTTY5]&EDS^@`_G7-
M:QXEU+7%$=U(BPJ=PBC7"Y]?4_B:=A7,Z[N9+R\FN93F25R[?4G->G>`;-;?
MPXMP`-]S(S$]\`[0/T/YUY76UH_BG4]$C\FVD1X,D^5*NY0?;H1^=`D>QT5Y
M]!\2I!@7&FHW(R8Y2,#OP0?YUZ#2*"BBLC7]?@\/VT4LT,DOFMM4)@?GF@#7
MKQSQ7IG]E>(;B)1B*0^='_NMV_`Y'X5M7?Q'OI!BTLX(,]W8R'^@_2N5U#4;
MK5+IKF\E,DI&,D8P/0`4T2V5:***8CU7P+JPO]$%J[?OK3"')ZI_"?Z?A745
MX;IVIWFDW/VBRF,4F,'@$$>A!X-=1;?$?44(^TV=M*H'.S*$_CDC]*5BDSTJ
MBJNFWRZEIT%XB%%F7<%)Y%6J0PHHHH`\Z^(NF^7=V^I(IVRCRI#VW#I^8S_W
MS7#U[1XCTT:KH-U;`9DV[X\#)WCD?GT_&O%Z:)8^&%[B>.&-=TDC!%`[DG`K
MW#3K&+3-.@LH?N0H%SZGN?Q.3^->9>!=/^V^(TE89CME,ISZ]!^IS^%>KT,:
M"BBBD,***X_6O'D>F7T]G#8O+)$=I9W"C/X`Y_2@#L*\E\:ZHNI>('6)@T-L
MOE*0>">I/YG'X5)J'CK5[Z)XHS%;1L,'RE.['U/],5S%-$MG8?#NT2;6YKEL
M$P1?*/=N,_EG\Z]-KP[3=4O-(NOM%E+Y;XP>`0P]"#756_Q(O4"BXL8)<==C
M%,_GFAC3/1Z*S="U==;TQ+U83%EBI0MG!'O6E2&%%5[Z\BT^QFNYMWEPH68*
M,D^PKAKKXDR'(M-.5?1I9,_H`/YT!<7XCZ:`;74D`!8^3)[GDK_[-^E<%6KK
M'B/4M;"K=RKY2MN6)%PH/\S^)K*IDL*[+X?:L+74I-.E;$=R,QY/1QV_$?R%
M<;2H[1NKHQ5E.0P."#ZTP/?**\MM/B!K$"JLRV]P!U+H0Q_$$#]*[7PUXD7Q
M%#.?LY@D@*[EW;@<YP0<#T-2.YNT45Q4WQ(L%SY%C<OQQO*KS^&:!G:UY[XU
M\5>89=(L6^0?+/*#][_9'MZ_E]<_5?'NHW\+0VT:6<;`@E#N?'^]V_`5RE.P
MFR>RM)+^]AM(?]9*X09[9[U[=864.G6,-I`N(XEVCW]3]2>:\+1VC=71BK*<
MA@<$'UKK-.^(&J6H5+N..[0#&6^1_P`QQ^E#$CU"BL30O%%EKSO%`DD<R+N9
M)`.G3((//6MND4%8'BS0EUK26,:9NX`7B(')]5_'^>*IZGX]L+"YGMH[:>:>
M%V1NBKD9!YZ]1Z5@7?Q&U"566UM((,]&8ER/Y#]*8KG&44K,68L3DDY-)3))
M[.[FL+R*ZMVVRQ-N4U[)H>LV^N:<ES"<..)8^Z-W'T]#7BE7M+U>]T>X,]E,
M48C#*>58>XI#3/;Z*\_L_B2V`+[3P3W>!\?^.G_&NXL;R+4+&&[AW>7,@90P
MP1[&D5<L4444`%%%%`!1110`4444`<S?^!M,U&_FO)I[M9)6W,$=0`?;*U77
MX=:.&!,]ZP!Z&1<'_P`=KKJ*`L<TG@/0D<,T$K@?PM*<'\L5-_PA7A[_`*!_
M_D:3_P"*K?HH"Q@?\(5X>_Z!_P#Y&D_^*H_X0KP]_P!`_P#\C2?_`!5;]%`&
M!_PA7A[_`*!__D:3_P"*I#X)\/$$?8,>XFD_^*KH**`.8_X0'0_^><__`']-
M0O\`#O1G<LLUX@/\*R+@?FIKK:*`L<A_PKG2/^?F^_[[3_XFGQ_#S1D;+27<
M@QT:08_117644!8P[;P?H5L05L$D8=Y6+Y_`G'Z5L0P0VT8C@B2)!T5%"C\A
M4E%`!1110`4444`%%%%`!1110`4C*'4JP!4C!!'!%+10!R'_``KG2/\`GYOO
M^^T_^)J6/X?:*BX8W4ASU:09_0"NJHH"QS'_``@.A_\`/.?_`+^FIQX)\/``
M?8,^YFD_^*KH**`L<T_@/0G<LL$J`_PK*<#\\U3D^'&EE?W=W>*WJQ5A^6T5
MV-%`6.,A^'=I#/'*+^8E&#`;!S@UV=%%`!1110`4444`87B7PVOB**W7[3Y#
M0LQ#>7OR#CCJ/05A1_#6`+^]U*1FSU6(*,?F:[JB@+''I\.=*"`/=7I;N0R@
M?EMI?^%<Z1_S\WW_`'VG_P`377T4"L<2_P`-[(EO+O[A1V#*IQ_*J_\`PK/_
M`*B__DM_]G7?447"Q7L;;[%I]M:;]_D1+'NQC=M`&<?A5BBB@84444`%%%%`
M!65K^A6^O6'D2G9*F6BD'\!_J/:M6B@#R-_!'B!7918A@#@,)DP??DYKN?!>
MEWFDZ/-!?0^5*UPSA=P;C:HSP3Z&NCHHN*P5#=VR7EG/:R%@DT;1L5Z@$8./
MSJ:B@9R'_"N=(_Y^;[_OM/\`XFKL'@?086W&U>4Y!'F2M@?@"/UKHJ*`L83^
M#?#\CEFTY03_`'9'4?D#4,O@;0)``MH\>.Z3-S^9-='10%CF/^$!T/\`YYS_
M`/?TUT]%%`!65K>@6NO0Q174DR+$Q9?*(!S^(-:M%`'+CP#H8`&R<^_FU+%X
M%T"/.ZUDDS_?F;C\B*Z.B@+&!_PA7A[_`*!__D:3_P"*I&\$^'RI`L"I(ZB9
M\C_QZN@HH`Y9_A_HCH547*$_Q+)R/S!J'_A7.D?\_-]_WVG_`,377T4!8J:9
MI\.E:?#96Y<Q1`X+G).22<_B:MT44`%%%%`!7`ZA\/9KG4;B>"\BCBED+JC*
M25R<XKOJ*`,'POX=_P"$?M9U>999IG!9E&``!P/U/YUO444`%%%%`!7,7_@;
M3-1OIKR:XO!),Q9@KJ`/I\M=/10!R\/@#0XL;UN)L'^.7&?^^0*N-X.T!D5#
MIR87IB1P?Q.<FMRB@+'/MX)\/E2!8%21U$SY'_CU0?\`"`Z'_P`\Y_\`OZ:Z
M>B@+%/3-,MM)LEM+166($M\S9.35RBB@"M?V4>HV$UG,SK'*NUBA`('MFN>C
M^'^B(N&^TR'^\TG/Z`5U5%`',IX#T)6!,,S`?PF4X/Y5/_PA7A[_`*!__D:3
M_P"*K?HH"Q@?\(5X>_Z!_P#Y&D_^*J!_`>A,Q(AF4'^$2G`_.NFHH"QR)^'6
MCDD_:+T>V]/_`(FM?0_#EGX?\_[))._G[=WFL#C;G&,`>IK7HH`*XC_A6UG_
M`-!"?_O@5V]%`'')\.-+"`275XS=RK*!^6TU/'\/M%1<,;J0YZM(,_H!7544
M"L<L_P`/]$="JBY0G^)9.1^8-5I/AQIA7]U=W:MGJQ5AC\A7944#L<[H'A*W
MT&]DNHKF65GC,>&```)!_I71444`<M=^`M+O+R>ZDN+P/-(TC!77`).3CY?>
MH?\`A7.D?\_-]_WVG_Q-=?10%CEQX!T,`#9.??S:L#P3X>``^P9]S-)_\570
M44!8YB3P#H;[ML<Z9SC;*?E^F<_K55_AQI90B.ZO%;L692/RVBNQHH"QQ'_"
MMK/_`*"$_P#WP*["RM5L;"WM$.Y88UC!(QG`QFIZ*`"BBB@`HHHH`****`"B
MBLCQ1KG_``C?AVZU;[/]H^S[/W6_9NW.J]<''WL]*<8N345NQ2DHIR>R->BO
M(O\`A>'_`%+O_D[_`/:Z/^%X?]2[_P"3O_VNNOZAB/Y?Q7^9R_7L/_-^#_R/
M7:*\B_X7A_U+O_D[_P#:Z/\`A>'_`%+O_D[_`/:Z/J&(_E_%?YA]>P_\WX/_
M`"/7:*\B_P"%X?\`4N_^3O\`]KH_X7A_U+O_`).__:Z/J&(_E_%?YA]>P_\`
M-^#_`,CUVBO(O^%X?]2[_P"3O_VNC_A>'_4N_P#D[_\`:Z/J&(_E_%?YA]>P
M_P#-^#_R/7:*\B_X7A_U+O\`Y.__`&NC_A>'_4N_^3O_`-KH^H8C^7\5_F'U
M[#_S?@_\CUVBO(O^%X?]2[_Y._\`VNC_`(7A_P!2[_Y._P#VNCZAB/Y?Q7^8
M?7L/_-^#_P`CUVBO(O\`A>'_`%+O_D[_`/:Z/^%X?]2[_P"3O_VNCZAB/Y?Q
M7^8?7L/_`#?@_P#(]=HKR+_A>'_4N_\`D[_]KH_X7A_U+O\`Y.__`&NCZAB/
MY?Q7^8?7L/\`S?@_\CUVBO(O^%X?]2[_`.3O_P!KH_X7A_U+O_D[_P#:Z/J&
M(_E_%?YA]>P_\WX/_(]=HKR+_A>'_4N_^3O_`-KH_P"%X?\`4N_^3O\`]KH^
MH8C^7\5_F'U[#_S?@_\`(]=HKR+_`(7A_P!2[_Y._P#VNC_A>'_4N_\`D[_]
MKH^H8C^7\5_F'U[#_P`WX/\`R/7:*\B_X7A_U+O_`).__:Z/^%X?]2[_`.3O
M_P!KH^H8C^7\5_F'U[#_`,WX/_(]=HKR+_A>'_4N_P#D[_\`:Z/^%X?]2[_Y
M._\`VNCZAB/Y?Q7^8?7L/_-^#_R/7:*\B_X7A_U+O_D[_P#:Z/\`A>'_`%+O
M_D[_`/:Z/J&(_E_%?YA]>P_\WX/_`"/7:*\B_P"%X?\`4N_^3O\`]KH_X7A_
MU+O_`).__:Z/J&(_E_%?YA]>P_\`-^#_`,CUVBO(O^%X?]2[_P"3O_VNC_A>
M'_4N_P#D[_\`:Z/J&(_E_%?YA]>P_P#-^#_R/7:*\B_X7A_U+O\`Y.__`&NC
M_A>'_4N_^3O_`-KH^H8C^7\5_F'U[#_S?@_\CUVBO(O^%X?]2[_Y._\`VNC_
M`(7A_P!2[_Y._P#VNCZAB/Y?Q7^8?7L/_-^#_P`CUVBO(O\`A>'_`%+O_D[_
M`/:Z/^%X?]2[_P"3O_VNCZAB/Y?Q7^8?7L/_`#?@_P#(]=HKR+_A>'_4N_\`
MD[_]KH_X7A_U+O\`Y.__`&NCZAB/Y?Q7^8?7L/\`S?@_\CUVBO(O^%X?]2[_
M`.3O_P!KH_X7A_U+O_D[_P#:Z/J&(_E_%?YA]>P_\WX/_(]=HKR+_A>'_4N_
M^3O_`-KH_P"%X?\`4N_^3O\`]KH^H8C^7\5_F'U[#_S?@_\`(]=HKR+_`(7A
M_P!2[_Y._P#VNC_A>'_4N_\`D[_]KH^H8C^7\5_F'U[#_P`WX/\`R/7:*\B_
MX7A_U+O_`).__:Z/^%X?]2[_`.3O_P!KH^H8C^7\5_F'U[#_`,WX/_(]=HKR
M+_A>'_4N_P#D[_\`:Z/^%X?]2[_Y._\`VNCZAB/Y?Q7^8?7L/_-^#_R/7:*\
MB_X7A_U+O_D[_P#:Z/\`A>'_`%+O_D[_`/:Z/J&(_E_%?YA]>P_\WX/_`"/7
M:*\B_P"%X?\`4N_^3O\`]KH_X7A_U+O_`).__:Z/J&(_E_%?YA]>P_\`-^#_
M`,CUVBO(O^%X?]2[_P"3O_VNC_A>'_4N_P#D[_\`:Z/J&(_E_%?YA]>P_P#-
M^#_R/7:*\B_X7A_U+O\`Y.__`&NC_A>'_4N_^3O_`-KH^H8C^7\5_F'U[#_S
M?@_\CUVBO(O^%X?]2[_Y._\`VNC_`(7A_P!2[_Y._P#VNCZAB/Y?Q7^8?7L/
M_-^#_P`CUVBO(O\`A>'_`%+O_D[_`/:Z/^%X?]2[_P"3O_VNCZAB/Y?Q7^8?
M7L/_`#?@_P#(]=HKR+_A>'_4N_\`D[_]KH_X7A_U+O\`Y.__`&NCZAB/Y?Q7
M^8?7L/\`S?@_\CUVBO(O^%X?]2[_`.3O_P!KH_X7A_U+O_D[_P#:Z/J&(_E_
M%?YA]>P_\WX/_(]=HKR+_A>'_4N_^3O_`-KH_P"%X?\`4N_^3O\`]KH^H8C^
M7\5_F'U[#_S?@_\`(]=HKR+_`(7A_P!2[_Y._P#VNC_A>'_4N_\`D[_]KH^H
M8C^7\5_F'U[#_P`WX/\`R/7:*\B_X7A_U+O_`).__:Z/^%X?]2[_`.3O_P!K
MH^H8C^7\5_F'U[#_`,WX/_(]=HKR+_A>'_4N_P#D[_\`:Z/^%X?]2[_Y._\`
MVNCZAB/Y?Q7^8?7L/_-^#_R/7:*\B_X7A_U+O_D[_P#:Z/\`A>'_`%+O_D[_
M`/:Z/J&(_E_%?YA]>P_\WX/_`"/7:*\B_P"%X?\`4N_^3O\`]KH_X7A_U+O_
M`).__:Z/J&(_E_%?YA]>P_\`-^#_`,CUVBO(O^%X?]2[_P"3O_VNC_A>'_4N
M_P#D[_\`:Z/J&(_E_%?YA]>P_P#-^#_R/7:*\B_X7A_U+O\`Y.__`&NC_A>'
M_4N_^3O_`-KH^H8C^7\5_F'U[#_S?@_\CUVBO(O^%X?]2[_Y._\`VNC_`(7A
M_P!2[_Y._P#VNCZAB/Y?Q7^8?7L/_-^#_P`CUVBO(O\`A>'_`%+O_D[_`/:Z
M/^%X?]2[_P"3O_VNCZAB/Y?Q7^8?7L/_`#?@_P#(]=HKR+_A>'_4N_\`D[_]
MKH_X7A_U+O\`Y.__`&NCZAB/Y?Q7^8?7L/\`S?@_\CUVBO(O^%X?]2[_`.3O
M_P!KH_X7A_U+O_D[_P#:Z/J&(_E_%?YA]>P_\WX/_(]=HKR+_A>'_4N_^3O_
M`-KH_P"%X?\`4N_^3O\`]KH^H8C^7\5_F'U[#_S?@_\`(]=HKR+_`(7A_P!2
M[_Y._P#VNC_A>'_4N_\`D[_]KH^H8C^7\5_F'U[#_P`WX/\`R/7:*\B_X7A_
MU+O_`).__:Z/^%X?]2[_`.3O_P!KH^H8C^7\5_F'U[#_`,WX/_(]=HKR+_A>
M'_4N_P#D[_\`:Z/^%X?]2[_Y._\`VNCZAB/Y?Q7^8?7L/_-^#_R/7:*\B_X7
MA_U+O_D[_P#:Z/\`A>'_`%+O_D[_`/:Z/J&(_E_%?YA]>P_\WX/_`"/7:*\B
M_P"%X?\`4N_^3O\`]KH_X7A_U+O_`).__:Z/J&(_E_%?YA]>P_\`-^#_`,CU
MVBO(O^%X?]2[_P"3O_VNC_A>'_4N_P#D[_\`:Z/J&(_E_%?YA]>P_P#-^#_R
M/7:*\B_X7A_U+O\`Y.__`&NC_A>'_4N_^3O_`-KH^H8C^7\5_F'U[#_S?@_\
MCUVBO(O^%X?]2[_Y._\`VNC_`(7A_P!2[_Y._P#VNCZAB/Y?Q7^8?7L/_-^#
M_P`CUVBO(O\`A>'_`%+O_D[_`/:Z],T#5?[<T*SU/R?(^TQ[_+W;MOMG`S^5
M95<-5I*\U8UI8BG5=H.YHT445@;!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`>?
M?$3QUJGA*_LH+""SD2>(NQG1B00<<885QG_"Z/$?_/EI7_?J3_XNK?QL_P"0
MSI?_`%[M_P"A54^%?A?1O$G]K?VM9_:/L_D^5^]=-N[?G[I&?NCK7LTJ=".&
M56<;_P##GCU:E:6)=*$K?\,7;'XV7ZNHU#2;:5,_,;=V0X]@=W^?2O4/#WB7
M3/$]A]KTV8N%P)(W&'C)'1A_49'H:\U^('PTL=,TB35]"CDB6#!GMBY==G=E
M)R<COD]/3'/%>!_$4OAOQ/;7`<"VE80W(8X7RR>3]1U_"IEAJ->DYT59HJ.(
MK4*BA6=T?2U%%%>0>L>3^+OB-XG\+^([C3FLM,:$'S+=VBD)>,_=)^<<]0>.
MH-=#\/?'3^+8KJ"^2WAOX#O"0@@/&>,@$D\'@_45%\4_#*ZUX<:_@CS>Z>#(
M".K1_P`:_P!?P/K7B_AK7)?#OB"TU.+)$3_O$'\:'AE_+./?!KUZ5"EB,/[J
MM)?G_P`$\JI6J4,1[SO%_P!?@?0_B_Q$GA?PY<:B0C3#$=O&_1Y#T!]AR3[`
MUP_@[XA>)_%7B&&P%IIB6Z_O+B18I,K&#SCY^IS@?6N6^*'BN+Q#K4-K8SB7
M3[1/E=3Q([`%F_`8'X'UKT?X8>&/[!\-K=3KB]OPLK@CE$_@7\CD^YQVK)T8
M4<-S37O/8T56=;$<L'[J.WHHHKS3T3Q*]^,/B&VO[B!+/3"L4K("8I,X!(_O
MUWO@#QH?%VFS&Z6&+4('Q)'%D`H>C`$D^H//;WKP#5?^0Q??]?$G_H1K1\)>
M(9?#/B*VU!"?*SY<Z#^.,D;A^@(]P*]ZM@J<J7N*S/"I8RI&K[[NCW+X@^)[
MWPIH,%_816\DLETL)$ZL5VE7/8CGY14'P[\6W_BVPO9[^&VC:"5440*P!!&>
M<L:R?C#/%<^!]/G@D62*6]C='4Y#*8Y""/;%5_@G_P`@?5?^OA/_`$&N!4H?
M5'.VMSN=67UM0OI8]1HHHK@.\1W6-&=V"HHRS$X`'K7A\_QHUW[1)Y%CIPAW
M'RQ)&Y;;GC.'QG%>B_$G5_['\$7K(Q66ZQ:QD>K_`'O_`!T-7SO':3S6L]S'
M&3#!M$CY'R[C@?G@UZN7X>$XN=17/+Q^(G"2A!GT#\._&5SXNL+U[Z*WCN;:
M51M@4A=C#C@D\Y#5V=?/WPGU4Z?XUBMF($5[&T+9[$#<I^N5Q^-?0-<N-HJE
M5:CLSIP=5U:5WN@KF_'.MZCX=\-2:IIL5O(\,B"43J2-C';Q@@YW%?UKI*HZ
MSIR:OHM[I[XQ<PM'DG&"1P?P.#7/3:4TY;'143<&H[GEGA[XN:MJ'B&PLM0M
M-/2UN)EB=HD=6!;@')8CJ1VZ5[#7R21+;7!!W1RQ-C@X*L#_`#S7U/HNHKJ^
MAV.HJ`/M,"2$#H"1R/P.17?F&'A3Y905DSAP%>53FC-W9P?C[XD7_AG7TTW3
M8+.4+"KS-.KL58DX'##M@]^M=7X+UC4=?\,P:GJ4,,4L[,46%64;`<`X))YP
M3],5\_Z_>R>(_%]Y<1?.UW=;(1DG*YVH/RQ7TMIEC'IFEVEA$<I;0I$IQC(4
M`9_2EBZ4*5&$;>\QX6K.K5E*_NHM4445YQZ!P_Q$\;W7A&.P2PBMY;FY+EA.
M"P5%QV#`Y)/'T-<59?&76WO[9+NTTU;9I5$S)&X8)D;L$N><9K#^)VK_`-K>
M-[M58F*SQ:H/0K][_P`>+?I7*7=I/8W3VUS&8YH^&0D''&>U>]A\'2]DN=:L
M\/$8NI[5\CT1]:45S?@+53K'@K3;ER#*D?DR?5#MR?<@`_C725X<XN$G%]#V
MH24XJ2ZA7GWQ`\8^(?"-[;O:6EC+I]PN%DEC<LKCJI(8#IR/Q]*]!K(\3Z#!
MXDT"YTV;`9US$Y_@D'W6_/K[9K2A*$:B<U=$5HRE!J#LSAO!'Q0O-?\`$"Z9
MJT%G")D/D/`K+EQS@[F/49_'`[UU_C3Q.GA7P_+>@1O=,0EO$_1W/J!S@#D_
M_7KYQD2\T;5F0[H+RSFZCJCJ>H_$5L^,/%]UXNO+6:=!%';PA%C'3>0-[?B?
MT`KU9X",JL91^'K_`%YGE0QTHTI1E\73^O(]`\'_`!#\3^*?$,%@++35MQ^\
MN)%B?*1CKC+]3P!UY/I7JU<=\./"O_"-^'5>XCVZA>8EFW+AD&/E3\/YDUV-
M>9BI4W4:IJR1Z6&C-4TZCNV%%%%<YT!1110!D^)M4GT7PU?ZE;+&TUO%O19`
M2I.>^"#^M>0_\+H\1_\`/EI7_?J3_P"+KVG4].M]7TVXT^Z#&"==CA3@X^M<
M!KWPO\-:?X>U.]@BN1-;VDLL9,Q(W*A(X^HKNPDZ"7+55VV<6*A7;YJ;LK'*
M_P#"Z/$?_/EI7_?J3_XNC_A='B/_`)\M*_[]2?\`Q=<#80I<:C;0R9V22JC8
M]"0*]X_X5'X5_P">5U_W_-=]>.%H64X[G#0EBJU^66QW5%%%>$>V>7^.?B/K
M'AGQ*^FV5M8R0K$CAID<MDCV8#]*YO\`X71XC_Y\M*_[]2?_`!=4_BY_R/<O
M_7O'_*MWX8^#=`\0^&[B[U6P^T3I>-$K>=(F%"(<85@.I->TJ>'IX>-2<;['
MC.=>I7E3A*VYG?\`"Z/$?_/EI7_?J3_XNO0?AWXMO_%MA>SW\-M&T$JHH@5@
M"",\Y8U+_P`*P\'?]`?_`,F9O_BZVM$\.:3X<AEATJU^SI*P9QYC/DCC^(FN
M2O6PTH-4XV?]>9UT*6(C-.I*Z_KR-2BBL'QGK3:!X2O]0C8"=4V0^N]B%!'K
MC.?PKBA%RDHKJ=DI*,7)]#G_`!A\3['P[<R:?8PB]OTX?YL1Q'T)')(]!^>:
MX"7XO^*))"RFRB!_@2#@?F2?UKB((9[^^CACW2W%Q($7/)9F.!^))KZ!L?AA
MX9M](2SN;`7,VT>9<,[!V;N001@>P_7G/L3IX;"Q2FKMGDPJ8C%2;@[)'.^&
MOC"EY>1VNNVL-L)#M%U"2$4]MRG)`]\UZH"&4,I!!Y!'>OESQ-HQ\/\`B2^T
MO<66"3",V,E"`RDX[X(KW/X8ZN^K>"+7S6+RVC-;,Q[[<%?_`!UE%88W#0C!
M5:>S-L'B9RFZ53='8UD^)M4GT7PU?ZE;+&TUO%O19`2I.>^"#^M:U<YX]_Y$
M36/^O<_S%<%))SBGW1WU6U!M=CSS1/BWKVI:]IUA-:::L5S=10N4CD#!68`X
MR_7FO9J^7/"G_(XZ)_V$(/\`T8M?4==F84H4Y14%8X\!5G4BW-W/&=;^+>O:
M;KVHV$-IIK16UU+"A>.0L55B!G#]>*]0\,ZI/K7AJPU*Y6-9KB+>ZQ@A0<]L
MDG]:^<O%?_(XZW_V$)__`$8U?0'@+_D1-'_Z]Q_,UIC:-.%&,HJS_P"`9X.M
M.=649.Z_X)T=9/B;5)]%\-7^I6RQM-;Q;T60$J3GO@@_K6M7.>/?^1$UC_KW
M/\Q7GTDG.*?='H56U!M=CR[_`(71XC_Y\M*_[]2?_%U[#X?UJ#Q!H=KJ5N1B
M9`74'.Q_XE/T-?+%>C?"3Q/_`&9K3:-<RA;2^.8]QX6;@#_OH#'UVUZ^,P</
M9\U-6:/(PF,G[3EJ.Z9U?Q!^(.K>%->@L+"WLI(I+59B9T<MN+..S#CY179^
M&=4GUKPU8:E<K&LUQ%O=8P0H.>V23^M>0_&C_D<;3_L'I_Z,DKU'P%_R(FC_
M`/7N/YFN.O2A'#0FEJSLHU)RQ,XMZ(Z.BBL+QEK1T#PGJ&H(<3+'LAY&=[':
MI]\$Y^@-<48N4E%=3LE)1BY/H<YXR^)]KX=NFT_3X$O;Y.)"6Q'$?0XY)]AC
M'KVK@S\7_%!G\P?8@N<^6(#M^G7./QKC=/L[C6-6M[.(E[BZF"!FR>6/4_S)
MKWQ/A=X572Q9-8LSX&;GS&\PMC[V<X'TQCVKV)PPV%2C-7;/)A/$XEN4'9(R
M?!_Q6@UN\CT_5X(K.ZDXCE1CY3MV7!Y4GMR<UZ17RKK6FRZ'KMYISD[[:8H&
MZ$@'Y6_$8/XU]$>!M:?7O!]A>3.7N`IBF8]2ZG&3[D`'\:YL;AH02J4]F=&"
MQ,YMTZFZ.BK)\3:I/HOAJ_U*V6-IK>+>BR`E2<]\$']:UJYSQ[_R(FL?]>Y_
MF*XJ23G%/NCMJMJ#:['GFB?%O7M2U[3K":TTU8KFZBA<I'(&"LP!QE^O->S5
M\N>%/^1QT3_L(0?^C%KZCKLS"E"G**@K''@*LZD6YNX4445YYWA7G_C+XGVO
MAVZ;3]/@2]ODXD);$<1]#CDGV&,>O:NC\9:T=`\)ZAJ"'$RQ[(>1G>QVJ??!
M.?H#7S=I]G<:QJUO9Q$O<74P0,V3RQZG^9->C@<+&HG4J;(\_&XF5.T(;L[(
M_%_Q09_,'V(+G/EB`[?IUSC\:[3P?\5H-;O(]/U>"*SNI.(Y48^4[=EP>5)[
M<G-:R?"[PJNEBR:Q9GP,W/F-YA;'WLYP/IC'M7@^M:;+H>NWFG.3OMIB@;H2
M`?E;\1@_C733AA<2G&$;-'/.6)PS4IRNF?55%<[X&UI]>\'V%Y,Y>X"F*9CU
M+J<9/N0`?QKHJ\><7"3B^AZT)*<5)=0KS_QE\3[7P[=-I^GP)>WR<2$MB.(^
MAQR3[#&/7M71>,]:;0/"5_J$;`3JFR'UWL0H(]<9S^%?.&E:?-K.LVEA$V);
MJ98][<XR>6/TZUWX+"QJ)U*FR.'&XF5-JG3W9V)^+_B@S^8/L07.?+$!V_3K
MG'XUVOA#XK6^MWL>GZM!'9W4G$<J-^[=O3GE2>W)]*UH_AAX572ULGL"[A<&
MY,C"0MC[V<XSWQC'M7B.K^&-0T[7[S2X+:XNC!-Y2O'"QWYP5X`ZD$''O71"
M.%Q*<8JS1SSEBL.U*3NF?3]%8WA2ZOKSPMI\VI0S0WOE;9EG0H^Y25R0>><9
M_&MFO(E'E;78]>,N9)E#6[V33=!U&_A5&EMK669`X)4LJDC..W%>0V7QA\0W
M-_;P/9Z8%EE5"1%)G!(']^O5O%?_`")VM_\`8/G_`/1;5\SZ5_R&+'_KXC_]
M"%>E@*-.I"3DKGFXZM.$XJ+L?5]%%%>6>F<9\1/%M_X2L+*>PAMI&GE9&$ZL
M0`!GC#"O/O\`A='B/_GRTK_OU)_\771_&S_D#Z5_U\/_`.@UQ7PQT'3?$/B2
MXM-5MOM$"6;2JN]DPP=!G*D'H37L8:E16&]I.-SR<14K/$>SA*QI?\+H\1_\
M^6E?]^I/_BZZ3P-\1]8\3>)4TV]MK&.%HG<M"CAL@>[$?I71?\*P\'?]`?\`
M\F9O_BZO:1X(\.Z%?B]TW3_(N`I4/YTC<'KPS$5A4KX1P:C"S_KS-J='%*:<
MIZ?UY'0445!>3FVL;BX4!C%&S@'O@9KSDKGH/0X7QI\3[;P[<OIVFPI>7Z<2
M,S?NX3Z''+'U`(QZYXK@C\7O%)E+AK,*3G8(.![=<X_&N&EEDGF>:5R\DC%G
M8]23R37O6B>&_AYJNGPPZ?#979:/!W3'S^0>6&0P/![#VKVYTJ&%@N:/-YGC
M0JU\3-\LK>1F>%_B]#J-W'9:W:QVLDK!4N(2?+R3C#`\J/?)_#K7J%>-M\%K
MF36;@+J,4&F!_P!RQ!>4KC/(X'MG/;.*];TZS_L_3+6R,SS?9XEB\R3[S[1C
M)]^*X,6J%TZ+^1W85U[-55\RS1117&=84444`%%%%`!1110!XM\;/^0SI?\`
MU[M_Z%5SX'_\Q[_MW_\`:E4_C9_R&=+_`.O=O_0J/@[JVG:9_;7]H:A:VGF>
M1L^T3+'NQYF<9(SC(_.O9:;P%E_6IXZ:6.N_ZT/6M<$3>']2$^WRC:RA]QP-
MNPYS[8KY4KV;XB_$33I=$FTC1;H7,UT-DTT6=J1]QGN3TX[$^U>:^$=#D\0^
M)K.P5<QEP\QQP(UY;_#ZD5>`@Z-*4YZ$XZ:JU8PAJ?2]F9FL;<W&?/,:F3(Q
M\V.?UJ>BBO#9[2"OF_X@^&O^$:\3S11*!9W.9[<#^%2>5_`Y'TQ7TA7BWQL_
MY#.E_P#7NW_H5=^73:K<JV9P9A!.CS/='.?#KPT/$?BB)9XP]E:_OIP1D-C[
MJGZGMZ`U]&5Y%\#_`/F/?]N__M2O7:68S<JSB]D/+X*-%274****X3N/ES_F
M</\`M_\`_:E;/Q'\+_\`"-^)':",+87F9;<*,!>?F3\"?R(K&_YG#_M__P#:
ME?07C7PVOBCPW/9+@7*?O;9CVD`X'T/(_'/:O?KU_8U(-[-:GA4:'MJ<TMUL
M>%3^)FO/A_%H%RY:6TOEEMR1_P`LBD@(S[,1_P!]>U>B_!/_`)`^J_\`7PG_
M`*#7C$D;PRO%*C)(A*LK#!4CJ".QKV?X)_\`('U7_KX3_P!!HQL%'#RMU88*
M3E7C?HCU&BBD)"J68@`<DGM7@'NGB_QIU7SM6T_2D;Y;>(S.!_>8X'Y!?_'O
MRN^!O"HO_A;K&4)GU/=Y78'R_P#5_P#CX-><>)-3?Q!XIOK]`7^T3D1``Y*C
MY4&/7`%'_"*>(_\`H`:K_P"`<G^%?0*ART(T^;E>C_7\SP/;7K2J<MUM^GY&
M?9W4MC?6]Y`0)8)%E0GLRG(_45]66-W'?V%M>1?ZN>)94^C`$?SKY3N[*[T^
M<P7MK-;3``F.:,HV#WP>:]W^$NK'4/!JVKG,EC*T/3JI^93^I'X5CF=/FIJH
MNAMEL^6;@^IWE%%%>*>R?./Q)TK^RO'-^`"([HBZ3.>=_+=?]K=76^%_%/V3
MX/ZLC2`3V1:WBR0?];]W'K@LW'/W?2K?QJTDR66G:O&G,3M;RD#/#<KGT`(;
M_OJO(4NIDM);57(AE=7=0>"5#`?^A&O?I16)P\;]+?@>#5D\/7E;K?\`$ZWX
M7:2-4\;VKNFZ*S4W+<<9'"_^/$'\*^AZ\P^"^E>1HU_JC@;KF41)TX5!S],E
MO_'17I]>;F%3GK-=M#T<!3Y**??4*HZSJ*:1HM[J#XQ;0M)@C.2!P/Q.!5ZO
M-_C)J_V3PW;Z8C#S+V7+#_IFF"?_`![;^1KGH4_:5%#N=%>I[.FY=CR?PSIS
M>(/%UA9S$N+BX#3'N5'S/^@-=9\8]*^R>*8-05<)>P#<?5T^4_\`CNRN&L='
MU34T=[#3;R[5#AF@@:0*?0X'%37'AS7+2!Y[G1M1AA09>22U=54>I)&!7T,H
MKVJES;:6/`C)^R<>7?6YZ3\%-5.[4](8C&!=1C\E;_V2O7J^9O`VK'1?&6FW
M1.(VE$,G&?E?Y2?PSG\*^F:\C,:?+6YNYZV7U.:ER]@HHKG/&_B5?"_AR:\1
MD^UO^[MD;NY[X]`.?_UUQ0@YR48[L[)S4(N3V1Y!\5[K3[KQM-]B0^;%&L=T
MX/#R#T]P,`_3';GG?"]U867B?3KG5(C)9QS!I%]/0GU`."1W`Q5OP?X?F\5^
M)X+1][0[O.NY">0@///J>GU.:B\7>'I?#'B.XTY\F+_60/\`WXST/U'(/N#7
MTD.2*^KWUL?/3YY/V]M+GTZ"&4,I!!Y!'>EKSOX3>*/[5T0Z/<R`W=@H$>3R
M\/0?]\_=^FVO1*^=K4G2FX/H>_2J*I!374****S-`HHHH`*R/%?_`")VM_\`
M8/G_`/1;5KUD>*_^1.UO_L'S_P#HMJNG\:]2*GP,^9]*_P"0Q8_]?$?_`*$*
M^KZ^4-*_Y#%C_P!?$?\`Z$*^KZ]/-=X_,\[+-I?(****\D]0^?\`XN?\CW+_
M`->\?\JY.R_M7R3]A^V^5NY\C=MW?AWZ5UGQ<_Y'N7_KWC_E72?"OQ-HNB^&
M+FVU+48;:9KUI`DA.2I1!G\P?RKZ"-1T\-&2C?1'@RIJIB91;MJSSC_BHO\`
MJ*?^1*^HZYS_`(3WPK_T'+7\S_A6II>MZ;K<4DFFWD=RD9VN8ST->9BZLZJ3
M<+6/1PM*%)M*=[E^O/\`XQ-*/!*",95KR,2<=%VM_7;7H%<WX]T=];\&:A:Q
M#,Z()HAR<LAW8`'<@$?C6&'DHU8M]S?$1<J4DNQX1X(CCD\;Z,LH&T72,,G'
M(.1^H%?3=?)VG7KZ;JEI?1J&>VF290>Y5@1_*OI*S\:^'+W3!?IJ]K'$%#.L
MLJJZ$]BI.<]?KCC->AF=.3E&26AP9;4BHRBV:;Z3ITES)<OI]JT\N/,E:%2S
MX&!DXR<#BK$%O!;(4@ACB0G)6-0HSZ\5\]^+/'FI:IXCN;C2=4O[6P!"0I%<
M/&&`&-Q`/4G)_*O6OALVJ2^#H+G5;F>XFN':2-IV+,(^`O)YQP3SZURUL+.E
M34Y/?H=-'%0J5'"*^9UU<YX]_P"1$UC_`*]S_,5T=<YX]_Y$36/^O<_S%<]'
M^)'U1T5OX<O1GS7%YGG)Y._S=PV;,[MW;&.]:G_%1?\`44_\B4>%/^1QT3_L
M(0?^C%KZCKW,7BO822Y;W/%PF%]M%OFM8^2)?,\Y_.W^;N._?G=N[YSWKZ4\
M!?\`(B:/_P!>X_F:^?\`Q7_R..M_]A"?_P!&-7T!X"_Y$31_^O<?S-8YB[T8
MO^MC;+E:M)?UN='7.>/?^1$UC_KW/\Q71USGCW_D1-8_Z]S_`#%>31_B1]4>
MI6_AR]&>+?#G3+?6?$LFG7:!H;BTE1N.G`P1[@X(]Q6!JVFW>@:W<6%P2ES:
MR8W*2,]U8>Q&"/K75_"/_D>XO^O>3^5=E\7O"YOM.CUZU0F>T&RX51RT6>&_
MX"3^1)[5[DJ_)B>1[-?B>+&ASX;G6Z?X'FWC#Q'_`,)/<Z9>N?\`28[!(;GY
M<#S%=\D?4$'CUQ7NG@+_`)$31_\`KW'\S7S17TOX"_Y$31_^O<?S-89C!0HQ
MBMKFV7S<ZLI/>QT=<+\7/^1$E_Z^(_YFNZKGO'.C2:[X/U"RA3?<;!)".Y93
MNP/<X(_&O,P\E&K%ON>G7BY4I)=CP[X=)$_C_2!,Y5?,8@C^\$8J/Q.!7TE7
MRGHNI/HVMV6HQC<;:99-O]X`\C\1D5]'1>-/#DNEKJ/]L6B0$`D/*`ZG&=I7
MKN]L5Z&9TY.<9)'!EU2*A*+9XC\3_P#DHNJ_]L?_`$4E>C_!@D^#KH$D@7[@
M>W[N.O'O$>K'7?$5_J9#!;B4L@;J$Z*#R>0`*]\^'.DOH_@FQBE4K-.#<.I[
M;N1_X[MZUIC/<PL8/?3\C/!^_B936VIU5<YX]_Y$36/^O<_S%='7.>/?^1$U
MC_KW/\Q7DT?XD?5'J5OX<O1GS_X4_P"1QT3_`+"$'_HQ:^HZ^6/#EQ%:>)])
MN9W$<,5[#)(YZ*H<$G\J^A/^$]\*_P#0<M?S/^%>GF4)2G'E5SSLNG&,9<SL
M='163I?B;1=:N6MM-U&&YF5#(4C)R%!`S^9'YUK5Y,HN+LU8]2,E)73.%^+G
M_(B2_P#7Q'_,UY1\.5B;X@:0)CA/,8CG^((Q7]<5[AXYT:37?!^H64*;[C8)
M(1W+*=V![G!'XU\Z:+J3Z-K=EJ,8W&VF63;_`'@#R/Q&17L8'W\/*"WU_%'D
M8WW,1&;VT_!GU97SG\3_`/DHNJ_]L?\`T4E>W1>-/#DNEKJ/]L6B0$`D/*`Z
MG&=I7KN]L5\[^(]6.N^(K_4R&"W$I9`W4)T4'D\@`5GEM.<:DI-=+&F8U(NF
MDGU/8?@P2?!UT"20+]P/;]W'7HM<K\.=)?1_!-C%*I6:<&X=3VW<C_QW;UKJ
MJX<3)2K2:[G=AHN-**?8\]^,DDB>"X50G:]ZBOQGC:Y_F!7FOPQ`;XB:4"`1
M^]//_7)Z]C^(NE2:OX(OXH0S2P@3HJ_Q;#DCWXS^.*^?]`U:30M>LM3C!8V\
MH9E!P67HRY]P2/QKT\%[^%E!;Z_D>;C/<Q,9O;0]H^(GCK5/"5_906$%G(D\
M1=C.C$@@XXPPKC/^%T>(_P#GRTK_`+]2?_%UW^J/X"\5VD.J:G=V<\<285GN
MVB9`><%0P.?8C->%:Y)ITNMW;:3#Y.G^81`F6/RC@'YB3SC//K2P=*E./+*&
MJW;#%U:L)<T9Z/:Q]&^#=:N?$/A2RU6[2))Y]^Y8@0HVNRC`))Z`=ZW:Y'X8
M?\DZTK_MM_Z->NNKRZZ4:LDN[/4HMRIQ;[(R/%?_`")VM_\`8/G_`/1;5\SZ
M5_R&+'_KXC_]"%?3'BO_`)$[6_\`L'S_`/HMJ^9]*_Y#%C_U\1_^A"O4RW^'
M,\S,?XD3ZOHHHKQCUSR[XV?\@?2O^OA__0:\?LOMOG'[#]H\W;SY&=VW\.W2
MO8/C9_R!]*_Z^'_]!KC_`(5ZOI^B^)[FYU*ZCMH6LFC#R="Q=#C\@?RKW<))
MPPG,E??\SP\5%2Q7*W;8YW_BHO\`J*?^1*]Z^'/VG_A`]-^U^;Y_[W=YN=W^
MM?&<\],5-_PGOA7_`*#EK^9_PJWIWBK0M7NQ:Z?J<%Q.06"(3G`ZUQ8FO4JP
MLX6MJ=N&HPI3NIWN;%%%9?B+5WT'0+O5$M&NC;J'\E6V[AD`G.#@`$GIVK@C
M%R:2.Z344VSQ+QA\-M4T.^EFTVVFO-,;+(T2[FB']U@.>/7I7#D%6((((X(/
M:O5;'XSWDNM6XO;&V@TPOB7RPS2*"",YS@X.#T[5Z'=7/A'6K(W%Y/H]U`1D
MR3/&=O'J>5(S[$5[?UJM12C6C?S1XWU:C6;=*5O)GAGA[QYKOAZXB,=Y+<6J
M\-:SN60KGD#/W3[BOH;1]5M];T>UU*T),-P@<`]5/0J?<$$'Z5\Q:VFGQZW>
MKI3L]@)6$#-G)7MUYQ]:][^%]K-:^`=/\XOF4R2*K#[JESC'L?O?\"K/,:<.
M15$K,TR^I/G=-NZ.PHHHKQSU@HHHH`****`"BBB@#S#XH^$M<\1ZE83:59?:
M(XH65SYJ)@DY_B(K@O\`A6'C'_H#_P#DS#_\77T917=2Q]2G!025E_7<XJN!
MIU)N;;U_KL>!V'PA\373+]J%K9(1EC)*'(Y]%SSWZUZWX4\'Z=X2LFBM-TEQ
M+CSKA_O28SCCH`,]!^M=#16=;&5:RM)Z&E'"4J3O%:A1117*=(5YA\4?"6N>
M(]2L)M*LOM$<4+*Y\U$P2<_Q$5Z?16M&K*E/GCN95J4:L.21YS\*_"^L^&_[
M6_M:S^S_`&CR?*_>H^[;OS]TG'WAUKT:BBE6JNK-SENQTJ2I04([(****S-#
MP7_A7/BO_A)/M?\`97[C[9YN[[1%]W?G.-V>E>]445T5\1*M;FZ&%##QHWY>
MIY#\0_AQJ6H^(/[2T&T$ZW0+7$?F(FR0=_F(X8?7D'U%=#\+O#FK>'--OX=5
MM?L[RS*R#S%?(`Q_"37>T54L74E2]D]OQ)CA81J^U6X5D^)TU"7PSJ$6E0>=
M>RPF.)-P7EOE)R2!P"3U[5K45S1?*TSHDKIH\1\&_#?Q!9^+-/O-5T\06EO)
MYS.9HV^91E0`K$_>Q7MU%%;5\1.O+FD94*$:,>6)YA\4/!.J>(-1L;_1[07$
MHB,4X\Q4(`.5/S$`]6_*H_ACX9\2^&=9NQJ6G>397,(#/YT;8=3\O"L3T+=N
M]>IT5?UN?LO8M*Q'U2'M?:INX4445RG28?B_13X@\*W^G(H:9X]T.<?ZQ>5Y
M/3)&,^A->'_\*P\8_P#0'_\`)F'_`.+KZ,HKJH8RI0BXQL<M?"4ZTN:5S(\+
MZ3_8?AC3M-90LD,($@!R/,/+X/IN)K7HHKFE)R;D^ITQBHI)=`KR/XD>%/%/
MB7Q,);'3/-LH(5CB?SXUW'[S'!8'J<=.U>N45K0K2HRYXK4SK456CRR>ARWP
M^\/W'AOPG#9WD8CNY)'FF0,&PQ.`,C@_*%KH-1LH]2TRZL9L>7<1-$V1GAAB
MK-%1.I*4W-[E1@HP4%L?.A^%_C$,0-(!`[BYBY_\>KW[1VO7T:S.I1>5>^2H
MG3<&P^.>02.OO5VBML1BIUTE)+0QH86%!MQ;U"O'_B!X:\8>*?$+26^E.=/M
MAY=L#<Q#(_B?!?C<?QP!FO8**BA6=&7-%*_F76HJM'ED]#C?ASX1?POH;->1
MA=2NCNG&X-L`)VJ"..G/U/M3/B1X1D\3Z+')8PJ^I6S9B&0I=3]Y<G`]^?3W
MKM:*/K$_:^UZA["'LO9=#P?P]X*\<^'M=M=3M](.Z%OG7[5#AT/#*?G[C_&O
M=T8LBL5*$C)4XR/;CBEHJJ^(E7:<DKBH8>-%-1;"BBBN<W"BBB@`K.\06LU]
MX;U6TMDWSSV<L4:Y`W,R$`9/`Y-:-%.+L[B:NK'SYI_PT\70:E:S2:3M1)D9
MC]IB.`""?XJ^@Z**WQ&)G7:<NAA0PT*%U'J%%%%<YT'C_P`1?!'B+7?%DE[I
MNG^?;F%%#^=&O('/#,#7)_\`"L/&/_0'_P#)F'_XNOHRBN^GF%6$5%):?UW.
M&>`I3DY-O7^NQ\Y_\*P\8_\`0'_\F8?_`(NO3_A=X<U;PYIM_#JMK]G>6960
M>8KY`&/X2:[VBHK8ZI5AR22L51P5.E/GBV%%%%<9V'EGC'X3G4;V74=!DBAD
ME.Z2UDX4MW*GMGTZ>_:N`?X=>+8YQ"=%F+'`!5T*\_[0./UKZ2HKNI9A5A'E
MW.*I@*4WS;'BWAKX/WTUPD_B!TM[=2";:)PSO[$C@#Z$GZ=:]GCC2&)(HD5(
MT`5548"@=`!V%.HK"OB)UG>9O1P\**M`*Q?%UA<ZIX3U*RLXO-N)H2L:;@N3
MD=S@5M45E&3C)270TE%2BXOJ>"^'_ASXKL?$FE7=SI6R""\BED;[1$=JJX).
M`V3P*]ZHHK;$8B5=IRZ&5##QH)J/4\%\0?#GQ7?>)-5N[;2M\$]Y++&WVB(;
ME9R0<%LC@U[!X1L+G2_">FV5Y%Y5Q#"%D3<&P<GN,BMJBG6Q4ZL%"26A-'"P
MI2<XMZA6+XNL+G5/">I65G%YMQ-"5C3<%R<CN<"MJBL(R<9*2Z&\HJ47%]3Q
M_P"'7@CQ%H7BR.]U+3_(MQ"ZE_.C;DCCA6)KUV6*.>%X94#QR*5=3T(/!%/H
MK2O7E6GSRW,Z-"-&/+'8\!UCX5>(H-8NH]+L#<V(<F"4SQJ2IY`(+`Y'0\=J
M]D\(V%SI?A/3;*\B\JXAA"R)N#8.3W&16U15UL74K149="*.%A1DY1ZA1117
M,=)Y3XU^%,E_>R:EX?,2/*=TMHYV@L>I0]!GT.!Z'M7!GX=>+1<>0=%FW],A
MT*_]]9Q^M?25%=U/,*L(\NYPU,!2G+FV/(_!_P`))8+J'4/$+Q_NR'6RC.[)
M[;V'''H,Y]>U>N445SUJ\ZTN:;.FC0A1C:`5B^+K"YU3PGJ5E9Q>;<30E8TW
M!<G([G`K:HK.,G&2DNA<HJ47%]3YS_X5AXQ_Z`__`),P_P#Q='_"L/&/_0'_
M`/)F'_XNOHRBN_\`M.MV7X_YG#_9M+N_P_R/*/ACX-U_P]XDN+O5;#[/`]FT
M2MYT;Y8NAQA6)Z`UZO117'6K2K3YY'71HQHQY8A7E/C7X4R7][)J7A\Q(\IW
M2VCG:"QZE#T&?0X'H>U>K444:TZ,N:`5J,*L>69\VGX=>+1<>0=%FW],AT*_
M]]9Q^M=MX/\`A)+!=0ZAXA>/]V0ZV49W9/;>PXX]!G/KVKURBNJIF-:<>5:'
M-3R^E"5WJ%%%%<!W!7D'B_X23RWLE[X<$7EO\S6;-MVM_L$\8]CC'TZ>OT5M
M1KSHRYH&-:A"M&TSYN7X<^+6G,(T67>.YD0+_P!];L?K713_``>U6#PXTZ2)
M<:L9%*VT3@($YR-S8!;D'TX/7->WT5U2S*L[6LCFCEU)7O=G.>`]+O-&\%Z?
MI^H0^3=1>9OCW!L9D9AR"1T(KHZ**X9R<Y.3ZG;"*A%170SO$%K-?>&]5M+9
M-\\]G+%&N0-S,A`&3P.37ANG_#3Q=!J5K-)I.U$F1F/VF(X`()_BKZ#HK>AB
MIT8N,4M3"MA85FI2;T"BBBN8Z3@OBCX<U;Q'IMA#I5K]H>*9F<>8J8!&/XB*
M\P_X5AXQ_P"@/_Y,P_\`Q=?1E%=E''5*4.2*5CCK8*G5GSR;/G/_`(5AXQ_Z
M`_\`Y,P__%UUGPZ\$>(M"\61WNI:?Y%N(74OYT;<D<<*Q->P45=3,*LXN+2U
M_KN3#`4H24DWI_78*9+%'/"\,J!XY%*NIZ$'@BGT5P'<>+>)?@_?0W#S^'W2
MXMV)(MI7"NGL">"/J0?KUKE?^%=^+?/\G^Q9]^<9WIM_[ZSC]:^DZ*]"&95H
MJSLS@GEU*3NKH\6\-?!Z_FN8Y_$$B6]NI!-M&^YY/8L.%'N"3].M>S111P0I
M#$@2.-0J*.@`X`I]%<U?$5*SO,Z:.'A15H!1116!L%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
..4444`%%%%`!1110!_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>g2014031017063222033.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g2014031017063222033.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+#`Q-#0T'R<Y/3@R/"XS-#+_
MVP!#`0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P``1"`$9`Z<#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#W^BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`**9+-%"`994C!Z%V`S6?+XAT:#[^IVO7&%E#'
M]*`-.BL%_&?A]&*G41D>D3D?F%JM_P`)]H?_`#TG_P"_1H"YT]%<G)\0]&1L
M+%>2#^\L:X_5A3/^%C:1_P`^U]_WPG_Q5`7.OHKD/^%C:1_S[7W_`'PG_P`5
M4D7Q"T:0D,EW'CNT8Y_(F@+G5T5S<?CO07;#7$D8QU:)L?IFKL'BC0[C&S4X
M!G_GH=G_`*%B@#7HIJ2)*@>-U=3T93D&G4`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`'G_B'QOJ-EJES8VD4$:Q-M\Q@68_T_2N6N?$>LW>?-U*XP<Y
M"/L!S[+@5U6J^!]1U37+N[$UO%!+(2NYB6QCT`_K3(?AK*2?.U-%';9$6S^9
M&*9.IPKNTC%G8LQZDG)-)79Z]X%&F:9+>VUXTHB`+QNH!(SU!_I7&4P"BBB@
M04^*&68D11/(1U"J3BO0/`&EV%SI4UU<6D,LZW!17D4-@!5(QGIR>M=RB+&@
M5%"J.@`P!2N.QX7]AO/^?6?_`+]FHY8)H,>;$\>>F]2,U[S2,H=2K`%2,$$<
M$47'8\#HKV:^\,:-J`/G6,2N>=\0V-^G7\:X_5_A[<0`RZ7-]H0?\LI"`_X'
MH?THN*QQ]M>7-G)YEM<2POZQN5/Z5T^F?$#4K3"7J)>1CN?D?\QQ^8_&N4DB
MDAE:.5&213AE88(/H13:8'LVC^)--UL;;:7;/C)ADX8?X_A6O7@:.T;JZ,59
M3D,#@@^M=[X9\<G*6>L2<=$N3_)O\?S]:5AIG?T4`@@$'(/0BBD,****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`R/%/_(KZA_UR/\Z\9KV;Q3_R*^H?]<C_`#KQ
MFFB6%%%%,1Z=\.?^1>N/^OIO_0$KKZY#X<_\B]<?]?3?^@)77U):"BBB@`HH
MHH`P_$7AFUUVW+86*\4?NYL?HWJ/Y5Y+>6=QI]W):W49CFC.&4_S^E>[5ROC
M7P^NI:<U[`G^EVRD\=73N/?'4?CZTT)H\LHHHIDG:^#?%C6LD>F7\G^C-Q%*
MQ_U9]"?3^7TZ>D5X%7J/@CQ`VIV365R^ZZMQP3U=.F3[@\?E2929UE%%%(84
M5YGK_B[6K37;RWMKORH8I"BKY2'@?4&L]/&_B!6!-\&`_A,*8/Y"G85SURBO
M*D\?ZXA4LUNX'4-%U_(BK*?$;5`X,EK9LO<*K`_GN-%@N>F45YS_`,+)O/\`
MH'P?]]FD;XD7I4[;"W#8X)9B,T6"YZ/17GVC>-]3U+7+.UFCMDBD?:PC0@G(
M]237H-(84444`%%<9XT\0:EHU_:+93A$>,LRE%8,<^XS7.?\)]KG_/2#_OT*
M=A7/5J*\S3XC:H'!DM;-E[A58'\]QHD^(^J%OW=I9JOHP8G\]PHL%STRBN2\
M)>)K[7KRYCND@18HPP$2D<Y]R:ZVD,**\OO/'&N6][/#NA7RY&3!BY&#BH3X
M]UT@CS81[^4*=A7/5J*\H3QYKJJ`9H6(_B,0R?RI)/'>O.N%N(HS_>6)<_KF
MBP7/6**\IL_'>M07<<ES.+B$'YXC&BY'U`R#7I6FZG::M:+<V<H=#P1W4^A'
M8T@N7****!A1110`4444`%%>5O\`$#6W<LIMD!_A6/@?F33'\>:ZRD":%2?X
MA$,C\Z=A7/5Z*\A_X37Q#_T$/_(,?_Q-12>+=>E?<VI2@_[(51^0%%@N>QT5
MY#9>)=<FO[>,ZA.X:105]1FO7J07"BBB@84444`%%%%`!17B_B34O[5UZZN5
M;,>[9'Z;1P,?7K^-+X:U0Z3KMO<%ML3'RY?38>N?IP?PIV%<]GHHHI#"BBB@
M`HK@?B!J%[97UFMK>7$"M$21%*R@G/L:Y:+Q1KD(4+J=P=IR-[;OSSG-.PKG
ML]%>0_\`":^(?^@A_P"08_\`XFK`\>ZZ`!YL)]_*%%@N>K45Y0_CS764@30J
M3_$(AD?G59_&7B"1"K:BP!_NQHI_,"BP7/8**\4D\0ZS(VYM4O`?]F9E'Y`U
MZ%X"N[F\T*>2ZN)9W%RRAI7+$#:O&3]:+!<ZFBBN*^($M]!_9TUF]Q'L\W>\
M)8;?N]2/Q_6D,[6BO%HO$FM1`A=4NCG^](6_G5I?&GB!5"C4#@#',2$_GMIV
M%<]?HKR'_A-?$/\`T$/_`"#'_P#$U#-XLUV?._4I1D8^0!/_`$$#\Z+!<]DH
MKS#P?<:M?^([66:>]N+:+?O=W9T7*'&2>!SBO3Z0PHHHH`***\[^(VI"2YMM
M-0\1#S9.>,G@#Z@9_P"^J`/1**\$C=HI%D1BKJ0RL.H(KVS1=175='MKT?>D
M3YQZ,.&'Y@T"3+]%%%`PHHHH`****`"BF3>9Y,GE8\S:=N>F>U>2?\)KXA_Z
M"'_D&/\`^)H%<]>HKR(>-O$((/V_/MY,?_Q-7(_B'K*+AHK.0_WFC;/Z,*=@
MN>HT5YPOQ(O0HW6%N6QR0S`9J.7XCZD2/*L[11WW!F_J*+!<]+HKRN7X@:W(
M<K]FBXQA(_UY)K8\&>(-6U?6I(+V\\R)(&DV^6@R<J.H`/>BP7.\HHK@O%'B
M[4=+UV6SLY(O+C5<AH\D$C/7\12&=[17E/\`PGVN?\](/^_0H_X3[7/^>D'_
M`'Z%.PKGJU%>8#XBZP`!]GLC[E&_^*J.7X@ZU(056UCQV6,\_F318+GJ=%>?
M^$/$NK:GKJVUY=>;"8V.WRU7D>X`KT"D,****`"BBB@`HHHH`****`"BBB@#
M(\4_\BOJ'_7(_P`Z\9KV;Q3_`,BOJ'_7(_SKQFFB6%%%%,1Z=\.?^1>N/^OI
MO_0$KKZXOX;R$Z3=Q8&U9]P]<E1_@*[2I+04444`%%%%`!1110!XYXJTI=(U
MZ:",8AD_>Q#T4]OP((_"L6O1OB/9;[&TOE',<AC8CT89'ZC]:\YIDL*N:5J$
MFE:G!>Q=8FR1_>'<?B*IT4Q'O4,R7$$<T;;HY%#J?4$9%/KE_`5_]K\.B!C\
M]LYC_P"`GD?S(_"NHJ2R&XL[6[7;<VT,P])$#?SKA/%W@Z&WMFU'2XMB1C,T
M(R0!_>'T[BO0:"`001D'J#0!X%170^+]"_L75=T*XM+C+Q8Z*>Z_A_(USU40
M%>CZ9X$T>YM(;HW5S<)*H=<$("".XP3G\:\XKNO`&N^5*VD7#`(Y+P,3T;NO
MX]?S]:3&CK;#PSH^FR)+;62"5>DCDL0?7D\?A6M112*"BBB@"K>:;9:@`+RT
MAGP,`R("1]#VKF/$/A?0++1;N\6W,$B(61DD;ES]T8)(QDBNQKS/Q[K9N[\:
M9"W[FV.9,'AG_P#K?U-`F<>B-(ZHBEF8X"@9)/I7H&B_#Z(P1SZM(YD89,$9
MP%]B>_X8IG@'0/\`F,W*>JVZG\BW]!^/M7?TVP2*.GZ-I^E;OL-JD)8`,1DD
MCZGFKU%%(9FW>@:3?%FN-/MV=R2SA-K$GN2.:Y[5?A[931.^FR/;R@?+&[;D
M/MSR/KDUV=%`'A-Y9W&GW<EK=1F.:,X93_/Z5!7H'Q)M$V6-X%P^6B8XZCJ.
M?;G\Z\_JB0K2T76KK0[X7%N<J>)(R?E<>A_H:S:*!'M^E:K:ZS8K=6KY4\,I
M^\A]#5ZO%-%UJZT.^%Q;G*GB2,GY7'H?Z&O7=*U6UUFQ6ZM7RIX93]Y#Z&I*
M3+U%%%`PHHHH`R;OPSHMZQ:?3H=QZE`4)_[YQ7,Z]X#LX-/GO-/EE1X4,AB<
M[@P`R0#U!_.N\JO?_P#(/N?^N3?R-`K'A5>@^&_`UM):0WVIGS?-0.D"D@`$
M9&3US[?SKSZO;M$8MH&G,Q)8VL1))Y)VBFQ(EL]-LK`8M+2&#(P2B`$_4]ZM
M444B@HHHH`****`"L7Q7J1TOP]<RH<2R#RH^<<MQD>X&3^%;5>;?$34?.U*#
M3T(VVZ;WP?XF['Z`#\Z!,XNBBBJ)/7_!^J#4_#T&YLS0#R9,]>.A_$8Y]<UO
M5Y;X"U3[%K9M'/[J[&WKT<<C^H_$5ZE4E(****!D-Q:6UVFRYMXIE_NR(&'Z
MUC:AX.T6^B8+:+;R'.V2'Y<'Z=/TK?HH`\-U+3YM*U":RN`/,C.,CH1V(JI7
MH?Q$T@R0PZM$.8\13?[I/RG\SC\17GE,EA75^#/#5KK;3W%ZS-#"P41*<;B?
M4^GTKE*ZOP#J7V/73:N<1W:;?^!#D?U'XT`CT2#1M,MAB'3[5.,9$2Y/U/>K
MU%%(H****`*UQI]E=AOM%I!+NZ[XP<_G7F?C70K/1KRW:R^1)U8F(MG:01R.
M^#G]#7JM>2^-]0^W>))45LQVP$*\\9'+?J2/PIH3,"""6YN(X(4+RR,%11W)
MKT_2/`NFV*))>+]KN!@G?]P'V7N/K7/_``]TK[1J,NI2#]W;C8GNY']!_,5Z
M50P2&QQI%&J1HJ(HP%48`%.HHI#"BBB@!LDB11M([!44%F8]`!7B&JW[ZGJE
MS>OG,KE@#V'0#\!@5Z9XXU+[!X>>)&Q+='RACKM_B_3C\:\GIHEA7=_#K5-D
MMQIDC</^]BR>XX8?E@_@:X2K>F7TFF:G;WL>=T+AB!W'<?B,C\:8'N5%,AF2
MX@CFC;='(H=3Z@C(I]24%%%%`!1110`5DS^&-$N,[],MQD8_=KL_]!Q6M10!
MY_K_`(!2&WDNM)=R4&YK=SG([[3_`$/Y]JX*O?:\O\;^'O[.O/[0MU_T6X;Y
M@!_JW]/H>3^?M30FCDJ***9)Z3X:\,>'[_1[:\,+7$C*/,WR'Y7'WA@8XSZ]
ML5U5GIECI^?LEI!`2,$QH`2/<]37F?@O7_[)U+[/.^+2Y(#9Z(W9OZ'_`.M7
MJU)E(*R]0\.Z3JLXGO;,22@8W;V4X_`BM2BD,Y:^\$^'UM99?*DMEC0LSI*3
M@`9S\V:\KKT#Q]KX"?V/;L"3AK@@].X7^OY5Q6FZ=/JM_%9VRYDD.,GHH[D^
MPIHEEK0M`N]>NS%!\D:<R3,/E3_$^U=]:_#_`$:``S^?<GOO?:/_`!W'\ZV]
M(TFVT;3X[2W4<#+OCEV[DU?HN.Q2LM'T[3B&M+*"%\8WJ@W8]-W6KM%%(844
M44`%%%%`!1110`4444`%%%%`&1XI_P"17U#_`*Y'^=>,U[-XI_Y%?4/^N1_G
M7C--$L****8CT;X;?\@^^_ZZK_*NWKB_AO&PTJ\D/W6G"CZA1G^8KM*EE(**
M**!A1110`4444`8/C.W%QX5O.FZ,+("3TPPS^F:\@KVOQ`BR>'=25AD"VD;\
M0I(_45XI31+"BBBF([7X;W)35+RVSQ)"'_%3C_V8UZ17DW@641^*K=2,^8CJ
M/;Y2?Z5ZS292"BBBD,S==TB+6]*ELY,!C\T;G^%QT/\`3\:\8G@EMKB2"9"D
ML;%74]B*]YKAO'OA_P`Z/^V+9,R(`+A0.J]F_#H?;'I30FCSNE1VC=71BK*<
MA@<$'UI**9)[#X6UY==TL.YQ=0X6=??LWT./YUN5XOX>UE]#U:.Z`W1'Y)5]
M5/7\1UKV6&:.X@2:%P\;J&5AT(-2RD/HHJ.>>*VMY)YG"11J6=CV`H&97B;7
M%T/2FE!!N9,I"I&?F]?H*\QT#1Y=>U=8"6\O.^:0\X7OSZFEUW5Y_$.L&54;
M:2(X(NX&>/Q->F^&=#70]*6(@&YDP\S`Y^;T^@IBW-:&&.W@2&%`D:*%51T`
M%/HHI#"BBB@`HHHH`Y#XC?\`(O6__7TO_H#UP.C:3+K5\;2&14D\MG7=T)';
MVKOOB-_R+UO_`-?2_P#H#UR7@AV3Q;:*IP'$BM[C83_,"F2]S#N;::TN)+>X
MC:.6,X96Z@U%7L/B+PU;:];$X6*\4?NYL?HWJ/Y5Y/?Z?=:9=M:WD1BE7G![
MCU![B@&BM6EHNM76AWPN+<Y4\21D_*X]#_0UFT4Q'M^E:K:ZS8K=6KY4\,I^
M\A]#5ZO%-%UJZT.^%Q;G*GB2,GY7'H?Z&O7=*U6UUFQ6ZM7RIX93]Y#Z&I*3
M+U%%%`PHHHH`\$D1HI&C<8925(]"*]KT+_D7M-_Z]8O_`$`5X[JD9AU:]B8@
MLD[J<=,AC7L.@L&\.Z:5((^RQC@]PHILE&C1112*"BBB@`HHHH`CGFCMK>6>
M4XCB0NQ]`!DUX=?7<E_?3W<OWYG+D>F>U>E>/M2^QZ$MJIQ)=OM_X".3_0?C
M7G.E6#ZGJEM9)G,KA21V'4G\!DTT)E1E*G#`@X!Y'8TE=M\0-'6UGMM0@C5(
MG40N%'1E'R_^.C'_``&N)IB'Q2R03)-$Q22-@RL.H(Y!KV[2K]=3TNVO4QB5
M`2!V/0C\#FO#J[_X=:IQ<:7(W_3:+)^@8?R/YTF".^HHHI%!1110!!>6L=]9
M3VLH_=S(4/MD=:\0O;22PO9K2;_61.4..^.]>[5YQ\1-+,-]#J2+\DX\N0C^
M^.F?J/\`T&FA,XFI()I+:XBGB.V2)PZGT(.14=%,D]TT^]CU'3[>\B^Y,@<#
M.<>H_#I5FN'^'>J&6UGTN1LM%^]B'^R3R/S.?^!5W%26%%%%`%>^NEL;"XNG
M(VPQL_/?`Z5X9)(\TKRR-N=V+,?4GK7IGQ!U(6VCQV*-^\NF^8?["\_SQ^M<
M;X2TW^T_$5O&PS'%^^D^B_\`U\"FA,],\.:9_9.A6UJ1B7;OE_WSR?RZ?A6K
M112&%%%%`!11574;V/3M.N+R3[L*%L>I[#\3@4`>:>.]2^VZ^;=&)BM%\L#M
MN/+'^0_"N7P<9QQZT^662>9YI6+R2,69CU)/)-=]/X8_XM]$JQ@WD8^U\#DY
MY(_[YP/JHID[GGU%%%,1Z?\`#_5!=:,UB[9EM6X![H>1^N1^5==7COA35?[)
MUZ"5SB&7]U+[`]_P.#7L5)E(****0PHHHH`****`"H+RTAO[.6UN%W12KM85
M/10!XGK>DRZ+JDMG(2P7YHW(QO4]#_3Z@UG5ZSXQ\/G6M-$L"YO+?+1C^^.Z
M_P!1[_6O)B""01@CJ*9+"O2O`_B/[;;C2[I_](B7]RQ_C0=OJ/U'TKS6I;:X
MEM+F.X@<I+&P96'8B@#WBLCQ'KD>A:6TYPT[_+#&3]YO7Z#K_P#KI-)\0VFH
M:%_:4LB0B,8N`>B,.OY]OJ.]>8^(]<DUW5&G.5@3Y88R?NKZ_4]?_P!5`VS-
M=YKRZ9W+RSRODGJ68FO6/"GAU=#L-TRJ;V89E8<[1V4'^?O6)X&\->6BZO>1
M_.PS;HPZ#^_^/;\_2N[H8)!1112&%%%%`!1110`4444`%%%%`!1110`4444`
M9'BG_D5]0_ZY'^=>,U[-XI_Y%?4/^N1_G7C--$L****8CT[X<_\`(O7'_7TW
M_H"5U]<?\.74Z#<H#\PN22/8JN/Y&NPJ2T%%%%`!1110`4444`9^N_\`(O:E
M_P!>LO\`Z`:\2KV?Q/-Y'AG47W`9A*9/^UQ_6O&*:)84444Q'0>"03XNLL#I
MYF?^^&KUVO+/A]&7\2E@1B.!V.?3(']:]3I,I!1112&%(Z+(C(ZAD8892,@C
MTI:*`/&_$VAOH>JM$`3;29>%B<_+Z'W%8U>S^(=%CUS2GMC@3+\T3_W6_P`#
MTKQN:&2WG>&9"DB,593U!%-$L97H/P_UW<K:/._*Y>W)/4=2O\S^=>?5)!/+
M;7$<\+E)8V#(P[$4P/>:\U\<^(OMEP=+M7S;Q-^]8'[[CM]!_/Z5?U3QRDGA
MN(VC;-0G!1PO_+''4_CV_P#K5S7A70#KFIA9`PM(OFF8=_1?Q_QI#;.A\!^'
M>FL72^UNI_5C_3\?:N_I$18T5$4*BC"J!@`>E+2&%%%%`!1110`4444`<M\0
M$5_#.YADI.C+['D?R)KBO!7_`"-UC_VT_P#1;5V_C[_D6'_ZZI_.N(\%?\C=
M8_\`;3_T6U,3W/7JR=>T"UUZS\J;Y)5YBF`R4/\`4>U:U%(9XAJNE76CWS6M
MTF&'*L/NN/451KVO6M%M=<L3;W`PPYCE`^9#ZC^HKR+5=*NM'OFM;I,,.58?
M=<>HIDM%&M+1=:NM#OA<6YRIXDC)^5QZ'^AK-HIB/;]*U6UUFQ6ZM7RIX93]
MY#Z&KU>*:+K5UH=\+BW.5/$D9/RN/0_T->NZ5JMKK-BMU:OE3PRG[R'T-24F
M7J***!GB6N_\C#J7_7U+_P"AFO5?"C!O"^GE2"/*QP>X)KRWQ#&8O$>I*Q&3
M<.W'H23_`%KTOP5_R*-C_P!M/_1C4V2C?HHHI%!1110`4451UC4!I>D75Z1D
MQ)E1ZL>!^I%`'F?C;4O[0\12QJ?W=M^Y7ZC[WZY'X5K?#G3?,NKG4G7Y8QY4
M9/\`>/)_3'YUP[,68LQ)8G))/)->S>&]-_LK0;6V9<2[=\GKN/)S].GX4R42
M:]IO]K:)=68`,CIF//9QR/IR,?C7BA!!((P1U%>^UY%XSTW^SO$4Y12(;C]\
MGX_>_7/Z4(;.?JYI5^^EZK;7J=8GR1ZCH1^()JG13)/>XI$FB26-MR.H93Z@
M]*=7+>`]3^W:"+9VS+:-L_X">5_J/PKJ:DL****`"LOQ%I@U?0[FU'^LV[XS
MCHXY'Y]/QK4HH`\"(()!&".HHKH/&6E?V9K\I10(;C]ZF.V>H_//Z5S]407]
M%U)])U>WO$/"-\X_O*>"/RKVR.1)8UD1@R,`RL.A!KP2O4O`>J_;M%-I(?WM
MH=@]T/W?ZC\!292.KHHK/UO41I6C75X3AHT.SC/S'A?U(I#/,?&.HG4?$=QA
MLQ0?N4Q[=?US76_#W3?L^DRWSKA[E\+D?P+_`(G/Y"O.;6WDO;V&WCYDFD"#
M/J3BO<;.UCLK.&UA&(XD"+^`IL2)J***0PHHHH`*XCXBZEY5E;Z<A^:9O,D_
MW1T'XG_T&NWKQGQ/J7]J>(+J=3F)6\N/_=7C/X\G\::$QGAS3O[5UZUMB`8]
M^^3(XVKR1^.,?C7M)`(((R#U!KA?ASIVRWNM2<#,A\F/CD`<G\SC\J[JA@CQ
M7Q!IO]DZY<V@'[L-NC_W3R/\/PK,KT3XC:;YEK;:DB_-&?*D(_NGD?KG\Z\[
MH$PKV/PIJ?\`:OAZWE8YEC'DR?[R]_Q&#^->.5V'P]U/[-JTM@[?)=+E?]]>
M?U&?R%#!'IM%%%(H****`"BBB@`HHHH`*\V\=>'OLEQ_:MJF()3B90,!']?H
M?Y_6O2:CG@BN;>2"9`\4BE74]P:`/!J*U_$FB2:%JKP?,;=_GA<]U]/J.GZ]
MZR*H@>LTJ121+(RQR8WJ#PV.F:Z3P?X;.L7GVFY7_086^8$?ZQO[H]O7_P"O
M7,5V/@;Q#]BNAIET_P#H\S?NB3]QSV^A_G2&CTP````8`Z`4444B@HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`R/%/\`R*^H?]<C_.O&:]F\4_\`(KZA
M_P!<C_.O&::)84444Q'HWPV_Y!]]_P!=5_E7;UQ_PY4#0+AL#<;I@3CG&U?\
M3785+*04444#"BBB@`HHHH`Y?Q]<^1X9:+O/*B?E\W_LM>55V_Q'OA)?6EBI
M_P!4AD?ZMP/T'ZUQ%-$L****8CO_`(;6AVW]X<[25B7TSU/\UKOJR/#.FG2M
M`MK=UVRE?,E!Z[FYP?IP/PK7J2T%%%%`!1110`5Q/CSP\MQ;'5[9`)HA^_`_
MC7IGZC^7TKMJ;)&DL;1NH9&!5E/0@T`>"45)<1"&YEB!R$<J#ZX-1U1`5[/X
M<TR'2]$MX8@-SH))&_O,1R?Z5XQ7NMA_R#[;_KDO\A28T6****104444`%%%
M%`!1110!RWQ`=4\,[6."\Z*ON>3_`"!K@O"W_(SZ?_UU'\J[?XC?\B];_P#7
MTO\`Z`]<1X6_Y&?3_P#KJ/Y4T2]SV:BBBD4%9NM:+:ZY8FWN!AAS'*!\R'U'
M]16E10!XAJNE76CWS6MTF&'*L/NN/451KVO6M%M=<L3;W`PPYCE`^9#ZC^HK
MR+5=*NM'OFM;I,,.58?=<>HIDM%&M+1=:NM#OA<6YRIXDC)^5QZ'^AK-HIB/
M;]*U6UUFQ6ZM7RIX93]Y#Z&KU>*:+K5UH=\+BW.5/$D9/RN/0_T->NZ5JMKK
M-BMU:OE3PRG[R'T-24F>5>+HS%XJOU8@DN&X]"H/]:]"\$.K^$[15.2AD5O8
M[R?Y$5P7C7_D;K[_`+9_^BUKM_`/_(L)_P!=7_G3!;G3T444AA1110`5P7Q&
MU+"6NFHW4^=(!^2C^?Y"N])`!).`.I->*:_J)U77+J[SE&?$?^X.!^@S^--"
M97TV6V@U*VFO%=[>.0,ZH`2P'.,&O2D\?Z(R@DW"D_PF+D?D:\\M=!U6^MUN
M+:QFEA;.UU'!QQ4W_"+:Y_T#)_R%`CO_`/A/M#_YZ3_]^C7->,==TG7+2W:U
M>3[3"YQNC(!4]?Y"L7_A%M<_Z!D_Y"C_`(1;7/\`H&3_`)"@-3(HJ2>"6VG>
M">-HY4.UE88(-1TQ'2^!]2-AXACB8XBNAY39/?JI^N>/QKUBO`T=HW5U.&4Y
M!]#7MNC:BNK:1;7J]9$^8>C#@C\P:3*1?HHHI#"BBB@#FO&^E?VCH331INGM
M3YBXZ[?XA^7/X5Y/7OC*'4JP!4C!!'!%>+>(-+.D:U<6@!$8;=$3W0\C_#\*
M:$S,K;\*:K_9.O02N<0R_NI?8'O^!P:Q**9)[[7!_$?4=L5KIJ$Y8^<_/;D*
M/SS^0K?\)ZL-4\/PR2-F6']U*6]0.OXC!_.O,O$&I?VMKES=@_NRVV/_`'1P
M/\?QI(IF[\/M-^TZO)?.I,=LGRGMO;C\>,_I7IM87A#3?[-\.VZLN)9AYTGX
M]!^6*W:0(****!A1110!C^*=2_LOP_<S*P65QY47^\W''T&3^%>-5VWQ$U+S
M;^#3D8%8%\R0#^\>@/X<_P#`JY2QTR]U)G6SMGF*`%M@Z4T2SN]%\9Z)I^E6
M]EMN8_)C"DF(89NI(P3WR?QK0_X3[0_^>D__`'Z-<!_PBVN?]`R?\A1_PBVN
M?]`R?\A0%V=EJ_B_0=3TFZLR\V98R%S%T;J#^>*\VK7_`.$6US_H&3_D*IWV
MF7NFLBWEL\)<$KO'6@"I4UI=265Y#=0G$D3AU_`U#13$>[VES'>6<-S$<QRH
M'7Z$9J:N.^'NJ?:=*DL';]Y;-E/]QN?YY_,5V-26%%%%`!1110`4444`%%%9
M/B'7(M"TUKAL-,WRPQG^)O\``=__`*]`'-_$/4;,VT6G[%DNPPD#`_ZH?_7]
M/Q]*\\JTQN]6U'/SSW5P_P"+$_Y_"NPUKP,+30(I[0F2\@7,X!SY@[X^G\O>
MF3N<+1113$>K^#?$/]L6'V>X;-Y;@!B?XUZ!OKZ__7KIJ\,TW4)]+U"&\MSB
M2)LX/1AW!]B*]ITW4(-4T^&\MSF.5<X/53W!]P:3*3+5%%%(84444`%%%%`!
M1110`4444`%%%%`!1110!D>*?^17U#_KD?YUXS7LGBQU3PMJ!8X'EX_$D`5X
MW31+"BBBF(]+^'$H.C746.5N-V?JH']*[*O,?A]J26NL2V<AP+M`%/\`M+D@
M?D37IU2RD%%%%`PHHHH`*CN)X[6VDN)FVQQJ78^@%2$@`DG`'4FO-O&?BI+_
M`/XEVGR[K8<RR+T<^@]J`.7U6_?5-5N;U^LKY`]!T`_``53HHJB`KI?!>BG5
M-96>1<VUJ1(^?XF_A'YC/T%8NF:=<:K?Q6ELFYW/)[*.['V%>R:1I<&C:;%9
MP<A>68]78]328TB]1112*"BBB@`HHHH`****`/"K[_D(7/\`UU;^9JO5B^_Y
M"%S_`-=6_F:KU1`5[XB+&BHHPJC`'H*\#KWVDRD%%%%(84444`%%%%`!1110
M!R'Q&_Y%ZW_Z^E_]`>N(\+D#Q/I^3C]\*[?XC?\`(O6__7TO_H#UP.A?\C#I
MO_7U%_Z&*:)>Y[;1112*"BBB@`K-UK1;77+$V]P,,.8Y0/F0^H_J*TJ*`/$-
M5TJZT>^:UNDPPY5A]UQZBJ->UZUHMKKEB;>X&&',<H'S(?4?U%>1:KI5UH]\
MUK=)AARK#[KCU%,EHHUI:+K5UH=\+BW.5/$D9/RN/0_T-9M%,1K^)KZWU/6Y
M+ZV9BDZ(Q5A@J0H!'Z5WGP_D5_#6T=4G=3]>#_45Y97IWPY_Y%ZX_P"OIO\`
MT!*3&CKZ***104444`8/C'4O[-\.SE6*S3_N8\>_7],_I7DD$,ES<101#=)*
MX11ZDG`KK/B#J7VG5X[%&)CMD^8=M[<_CQC]:A\`Z=]LU[[2P/EVB;^G!8\`
M?S/X4R7N>EV-I'86$%I%]R%`@/KCO5BBBD4%%%%`'FWQ#TSR-2AU%!\EPNQ_
M]]>GYC'_`'R:XNO9O$^F?VMH%S;JFZ91YD7'.X=A]1D?C7C--$L*[WX<ZGA[
MG3';@_OHOKT8?R_(UP57]&U`Z7K%K>`G;&XW@=U/!'Y9I@CVZBD5@ZAE(*D9
M!!X(I:DH****`"N,^(6E?:-.BU*,?O+<[']T)_H?YFNSJ*YMX[NUEMY1F.5"
MC#V(Q0!X/15G4+*33=0GLY>7A<J2._H?Q'-5JH@T],UJXTRRU"VB^[>1;"?[
MISU_(L/Q'I2^'=,_M;7;:U(S'NWR_P"X.3^?3\:RZ]$^'.F^7:W.I.OS2'RH
MR?[HY/ZX_*D-'<T444B@HHHH`*9-,EO!)-(VV.-2['T`&33ZY;QYJ7V+0?LR
M-B2[;9[[1RW]!^-`'FFHWCZAJ-Q>2?>FD+X]!V'X#BO3/`FF_8M`%PZ@2W;>
M83WVCA1_,_C7F>GVCW^HV]HG#32!,^F3UKW&&%+>".&-=L<:A%'H`,"FQ(?1
M112&%<SXYTS[?X?>95S+:GS1C^[_`!?IS^%=-2.BR(R,,JPP1ZB@#P.BKVLZ
M>VE:O<V;=(W.T^JGD'\L51JB#9\+:G_97B"WF9L1.?*D_P!UO\#@_A7LE>!5
M[/X9U+^U=`M;AF+2A?+E)Z[AP3^/7\:3*1K4444AA1110`444$@`DG`'4F@"
M"\O(+"TENKF01PQC+,:\<UW6I]<U)[J7Y4'RQ1YR$7_'UK5\8^)?[8NA:VK'
M[%">#_ST;^]]/2CP?X:.L7?VJY3_`$&%N0?^6C?W?IZTR7J=#X%\._8[<:I=
M)B>4?N5/5$/?ZG^7UKM*````!@#H!12*/+?&GAS^RKO[;;)BSG;D#_EF_I]#
MR?TKE*]WN[2&^M);6X3?#*NUEKQG6](GT34I+2;E>L;XX=>QIHEHSJZ?P9K_
M`/9.H_9IWQ:7!`;/\#=F_H?_`*U<Q13`]]HKD/`VO_;[+^SKA\W-NOR$_P`<
M?^(Z?3'O77U)04444`%%%%`!1110`4444`%%%%`!4<]Q!:Q&2XFCBC'\4C!1
M^9KS'Q1XCU=-;O+2*^EB@BDVHL7R$#CN.?UKEY9I9WWS2O(W]YV)/ZT["N=M
MXS\56M_:?V;I\AD0L&EE&0IQ_"/7G!KAJ**8@HHHH$*CM&ZNC%64Y#`X(/K7
MH.@^/XV1;?6!M<8`N$&0?]X=C[C\A7GM%`SW6UOK2^0/:W,4RXS^[<''U]*L
M5X%5C[=>?\_4_P#W\-*P[GNC,$4LQ`4#))/`%8NI^+-(TL$/=+-+CB*#YS^)
MZ#\37D$LTLQ!EE>0CH68G%,HL%SH]=\8W^LJT$?^BVIX,:'EQ_M'O].E<Y14
MUK:7-[,(;6"2:0_PHI)IB(:T-(T6]UJZ$%I'D#[\AX5!ZD_TZUU&C?#Z>4K-
MJTGE1]?)C.6/U/0?K^%=]:6=M86ZV]K"D42]%44KA8HZ%H%IH-H8H/GE?F29
MA\S_`.`]JU:**104444`%%%%`!1110`45Q=U\1[&/(M;*>8CNY"`_P`_Y5BW
M7Q$U27(MX+>`'O@LP_/C]*+"N<Q??\A"Y_ZZM_,U7ITCM+(TCG+,2Q/J33:H
MD*]]KP*NRLOB'>6T$44UE!*(U"Y5BI(`Q[\TF-'I=%<1;?$BTD=1<V$L()P6
M1P^!Z]!7;TB@HHHH`****`"BL;Q!XBM_#\4#31/*TS$*JD#@=3^HK!_X639_
M]`^?_OL4!<F^(\BC0[6/^)KD,/H%;/\`,5YW8R>5J%M)OV;)5;=G&,$<YK9\
M3^*&\0&&-+?R((22`6W%B>Y]/I7/4R6>^T5YO9_$:[AA2.YL8YRJ[2RR%2Q]
M3D&M!/B3:D+YFG3*>X60''\J5AW.XHJ&TN4O+."ZC#!)HUD4-U`(R,_G4U`P
MHHHH`*S=:T6UURQ-O<###F.4#YD/J/ZBM*B@#Q#5=*NM'OFM;I,,.58?=<>H
MJC7M>M:+:ZY8FWN!AAS'*!\R'U']17D6JZ5=:/?-:W288<JP^ZX]13):*->G
M?#G_`)%ZX_Z^F_\`0$KS&O3OAS_R+UQ_U]-_Z`E#!'7T45#=W*6=G/=2!BD,
M;2,%ZD`9./RI%$U5[Z\BT^QFNYCB.)"Q]_:N&NOB3(<BTTY5]&EDS^@`_G7-
M:QXEU+7%$=U(BPJ=PBC7"Y]?4_B:=A7,Z[N9+R\FN93F25R[?4G->G>`;-;?
MPXMP`-]S(S$]\`[0/T/YUY76UH_BG4]$C\FVD1X,D^5*NY0?;H1^=`D>QT5Y
M]!\2I!@7&FHW(R8Y2,#OP0?YUZ#2*"BBLC7]?@\/VT4LT,DOFMM4)@?GF@#7
MKQSQ7IG]E>(;B)1B*0^='_NMV_`Y'X5M7?Q'OI!BTLX(,]W8R'^@_2N5U#4;
MK5+IKF\E,DI&,D8P/0`4T2V5:***8CU7P+JPO]$%J[?OK3"')ZI_"?Z?A745
MX;IVIWFDW/VBRF,4F,'@$$>A!X-=1;?$?44(^TV=M*H'.S*$_CDC]*5BDSTJ
MBJNFWRZEIT%XB%%F7<%)Y%6J0PHHHH`\Z^(NF^7=V^I(IVRCRI#VW#I^8S_W
MS7#U[1XCTT:KH-U;`9DV[X\#)WCD?GT_&O%Z:)8^&%[B>.&-=TDC!%`[DG`K
MW#3K&+3-.@LH?N0H%SZGN?Q.3^->9>!=/^V^(TE89CME,ISZ]!^IS^%>KT,:
M"BBBD,***X_6O'D>F7T]G#8O+)$=I9W"C/X`Y_2@#L*\E\:ZHNI>('6)@T-L
MOE*0>">I/YG'X5)J'CK5[Z)XHS%;1L,'RE.['U/],5S%-$MG8?#NT2;6YKEL
M$P1?*/=N,_EG\Z]-KP[3=4O-(NOM%E+Y;XP>`0P]"#756_Q(O4"BXL8)<==C
M%,_GFAC3/1Z*S="U==;TQ+U83%EBI0MG!'O6E2&%%5[Z\BT^QFNYMWEPH68*
M,D^PKAKKXDR'(M-.5?1I9,_H`/YT!<7XCZ:`;74D`!8^3)[GDK_[-^E<%6KK
M'B/4M;"K=RKY2MN6)%PH/\S^)K*IDL*[+X?:L+74I-.E;$=R,QY/1QV_$?R%
M<;2H[1NKHQ5E.0P."#ZTP/?**\MM/B!K$"JLRV]P!U+H0Q_$$#]*[7PUXD7Q
M%#.?LY@D@*[EW;@<YP0<#T-2.YNT45Q4WQ(L%SY%C<OQQO*KS^&:!G:UY[XU
M\5>89=(L6^0?+/*#][_9'MZ_E]<_5?'NHW\+0VT:6<;`@E#N?'^]V_`5RE.P
MFR>RM)+^]AM(?]9*X09[9[U[=864.G6,-I`N(XEVCW]3]2>:\+1VC=71BK*<
MA@<$'UKK-.^(&J6H5+N..[0#&6^1_P`QQ^E#$CU"BL30O%%EKSO%`DD<R+N9
M)`.G3((//6MND4%8'BS0EUK26,:9NX`7B(')]5_'^>*IZGX]L+"YGMH[:>:>
M%V1NBKD9!YZ]1Z5@7?Q&U"566UM((,]&8ER/Y#]*8KG&44K,68L3DDY-)3))
M[.[FL+R*ZMVVRQ-N4U[)H>LV^N:<ES"<..)8^Z-W'T]#7BE7M+U>]T>X,]E,
M48C#*>58>XI#3/;Z*\_L_B2V`+[3P3W>!\?^.G_&NXL;R+4+&&[AW>7,@90P
MP1[&D5<L4444`%%%%`!1110`4444`<S?^!M,U&_FO)I[M9)6W,$=0`?;*U77
MX=:.&!,]ZP!Z&1<'_P`=KKJ*`L<TG@/0D<,T$K@?PM*<'\L5-_PA7A[_`*!_
M_D:3_P"*K?HH"Q@?\(5X>_Z!_P#Y&D_^*H_X0KP]_P!`_P#\C2?_`!5;]%`&
M!_PA7A[_`*!__D:3_P"*I#X)\/$$?8,>XFD_^*KH**`.8_X0'0_^><__`']-
M0O\`#O1G<LLUX@/\*R+@?FIKK:*`L<A_PKG2/^?F^_[[3_XFGQ_#S1D;+27<
M@QT:08_117644!8P[;P?H5L05L$D8=Y6+Y_`G'Z5L0P0VT8C@B2)!T5%"C\A
M4E%`!1110`4444`%%%%`!1110`4C*'4JP!4C!!'!%+10!R'_``KG2/\`GYOO
M^^T_^)J6/X?:*BX8W4ASU:09_0"NJHH"QS'_``@.A_\`/.?_`+^FIQX)\/``
M?8,^YFD_^*KH**`L<T_@/0G<LL$J`_PK*<#\\U3D^'&EE?W=W>*WJQ5A^6T5
MV-%`6.,A^'=I#/'*+^8E&#`;!S@UV=%%`!1110`4444`87B7PVOB**W7[3Y#
M0LQ#>7OR#CCJ/05A1_#6`+^]U*1FSU6(*,?F:[JB@+''I\.=*"`/=7I;N0R@
M?EMI?^%<Z1_S\WW_`'VG_P`377T4"L<2_P`-[(EO+O[A1V#*IQ_*J_\`PK/_
M`*B__DM_]G7?447"Q7L;;[%I]M:;]_D1+'NQC=M`&<?A5BBB@84444`%%%%`
M!65K^A6^O6'D2G9*F6BD'\!_J/:M6B@#R-_!'B!7918A@#@,)DP??DYKN?!>
MEWFDZ/-!?0^5*UPSA=P;C:HSP3Z&NCHHN*P5#=VR7EG/:R%@DT;1L5Z@$8./
MSJ:B@9R'_"N=(_Y^;[_OM/\`XFKL'@?086W&U>4Y!'F2M@?@"/UKHJ*`L83^
M#?#\CEFTY03_`'9'4?D#4,O@;0)``MH\>.Z3-S^9-='10%CF/^$!T/\`YYS_
M`/?TUT]%%`!65K>@6NO0Q174DR+$Q9?*(!S^(-:M%`'+CP#H8`&R<^_FU+%X
M%T"/.ZUDDS_?F;C\B*Z.B@+&!_PA7A[_`*!__D:3_P"*I&\$^'RI`L"I(ZB9
M\C_QZN@HH`Y9_A_HCH547*$_Q+)R/S!J'_A7.D?\_-]_WVG_`,377T4!8J:9
MI\.E:?#96Y<Q1`X+G).22<_B:MT44`%%%%`!7`ZA\/9KG4;B>"\BCBED+JC*
M25R<XKOJ*`,'POX=_P"$?M9U>999IG!9E&``!P/U/YUO444`%%%%`!7,7_@;
M3-1OIKR:XO!),Q9@KJ`/I\M=/10!R\/@#0XL;UN)L'^.7&?^^0*N-X.T!D5#
MIR87IB1P?Q.<FMRB@+'/MX)\/E2!8%21U$SY'_CU0?\`"`Z'_P`\Y_\`OZ:Z
M>B@+%/3-,MM)LEM+166($M\S9.35RBB@"M?V4>HV$UG,SK'*NUBA`('MFN>C
M^'^B(N&^TR'^\TG/Z`5U5%`',IX#T)6!,,S`?PF4X/Y5/_PA7A[_`*!__D:3
M_P"*K?HH"Q@?\(5X>_Z!_P#Y&D_^*J!_`>A,Q(AF4'^$2G`_.NFHH"QR)^'6
MCDD_:+T>V]/_`(FM?0_#EGX?\_[))._G[=WFL#C;G&,`>IK7HH`*XC_A6UG_
M`-!"?_O@5V]%`'')\.-+"`275XS=RK*!^6TU/'\/M%1<,;J0YZM(,_H!7544
M"L<L_P`/]$="JBY0G^)9.1^8-5I/AQIA7]U=W:MGJQ5AC\A7944#L<[H'A*W
MT&]DNHKF65GC,>&```)!_I71444`<M=^`M+O+R>ZDN+P/-(TC!77`).3CY?>
MH?\`A7.D?\_-]_WVG_Q-=?10%CEQX!T,`#9.??S:L#P3X>``^P9]S-)_\570
M44!8YB3P#H;[ML<Z9SC;*?E^F<_K55_AQI90B.ZO%;L692/RVBNQHH"QQ'_"
MMK/_`*"$_P#WP*["RM5L;"WM$.Y88UC!(QG`QFIZ*`"BBB@`HHHH`****`"B
MBLCQ1KG_``C?AVZU;[/]H^S[/W6_9NW.J]<''WL]*<8N345NQ2DHIR>R->BO
M(O\`A>'_`%+O_D[_`/:Z/^%X?]2[_P"3O_VNNOZAB/Y?Q7^9R_7L/_-^#_R/
M7:*\B_X7A_U+O_D[_P#:Z/\`A>'_`%+O_D[_`/:Z/J&(_E_%?YA]>P_\WX/_
M`"/7:*\B_P"%X?\`4N_^3O\`]KH_X7A_U+O_`).__:Z/J&(_E_%?YA]>P_\`
M-^#_`,CUVBO(O^%X?]2[_P"3O_VNC_A>'_4N_P#D[_\`:Z/J&(_E_%?YA]>P
M_P#-^#_R/7:*\B_X7A_U+O\`Y.__`&NC_A>'_4N_^3O_`-KH^H8C^7\5_F'U
M[#_S?@_\CUVBO(O^%X?]2[_Y._\`VNC_`(7A_P!2[_Y._P#VNCZAB/Y?Q7^8
M?7L/_-^#_P`CUVBO(O\`A>'_`%+O_D[_`/:Z/^%X?]2[_P"3O_VNCZAB/Y?Q
M7^8?7L/_`#?@_P#(]=HKR+_A>'_4N_\`D[_]KH_X7A_U+O\`Y.__`&NCZAB/
MY?Q7^8?7L/\`S?@_\CUVBO(O^%X?]2[_`.3O_P!KH_X7A_U+O_D[_P#:Z/J&
M(_E_%?YA]>P_\WX/_(]=HKR+_A>'_4N_^3O_`-KH_P"%X?\`4N_^3O\`]KH^
MH8C^7\5_F'U[#_S?@_\`(]=HKR+_`(7A_P!2[_Y._P#VNC_A>'_4N_\`D[_]
MKH^H8C^7\5_F'U[#_P`WX/\`R/7:*\B_X7A_U+O_`).__:Z/^%X?]2[_`.3O
M_P!KH^H8C^7\5_F'U[#_`,WX/_(]=HKR+_A>'_4N_P#D[_\`:Z/^%X?]2[_Y
M._\`VNCZAB/Y?Q7^8?7L/_-^#_R/7:*\B_X7A_U+O_D[_P#:Z/\`A>'_`%+O
M_D[_`/:Z/J&(_E_%?YA]>P_\WX/_`"/7:*\B_P"%X?\`4N_^3O\`]KH_X7A_
MU+O_`).__:Z/J&(_E_%?YA]>P_\`-^#_`,CUVBO(O^%X?]2[_P"3O_VNC_A>
M'_4N_P#D[_\`:Z/J&(_E_%?YA]>P_P#-^#_R/7:*\B_X7A_U+O\`Y.__`&NC
M_A>'_4N_^3O_`-KH^H8C^7\5_F'U[#_S?@_\CUVBO(O^%X?]2[_Y._\`VNC_
M`(7A_P!2[_Y._P#VNCZAB/Y?Q7^8?7L/_-^#_P`CUVBO(O\`A>'_`%+O_D[_
M`/:Z/^%X?]2[_P"3O_VNCZAB/Y?Q7^8?7L/_`#?@_P#(]=HKR+_A>'_4N_\`
MD[_]KH_X7A_U+O\`Y.__`&NCZAB/Y?Q7^8?7L/\`S?@_\CUVBO(O^%X?]2[_
M`.3O_P!KH_X7A_U+O_D[_P#:Z/J&(_E_%?YA]>P_\WX/_(]=HKR+_A>'_4N_
M^3O_`-KH_P"%X?\`4N_^3O\`]KH^H8C^7\5_F'U[#_S?@_\`(]=HKR+_`(7A
M_P!2[_Y._P#VNC_A>'_4N_\`D[_]KH^H8C^7\5_F'U[#_P`WX/\`R/7:*\B_
MX7A_U+O_`).__:Z/^%X?]2[_`.3O_P!KH^H8C^7\5_F'U[#_`,WX/_(]=HKR
M+_A>'_4N_P#D[_\`:Z/^%X?]2[_Y._\`VNCZAB/Y?Q7^8?7L/_-^#_R/7:*\
MB_X7A_U+O_D[_P#:Z/\`A>'_`%+O_D[_`/:Z/J&(_E_%?YA]>P_\WX/_`"/7
M:*\B_P"%X?\`4N_^3O\`]KH_X7A_U+O_`).__:Z/J&(_E_%?YA]>P_\`-^#_
M`,CUVBO(O^%X?]2[_P"3O_VNC_A>'_4N_P#D[_\`:Z/J&(_E_%?YA]>P_P#-
M^#_R/7:*\B_X7A_U+O\`Y.__`&NC_A>'_4N_^3O_`-KH^H8C^7\5_F'U[#_S
M?@_\CUVBO(O^%X?]2[_Y._\`VNC_`(7A_P!2[_Y._P#VNCZAB/Y?Q7^8?7L/
M_-^#_P`CUVBO(O\`A>'_`%+O_D[_`/:Z/^%X?]2[_P"3O_VNCZAB/Y?Q7^8?
M7L/_`#?@_P#(]=HKR+_A>'_4N_\`D[_]KH_X7A_U+O\`Y.__`&NCZAB/Y?Q7
M^8?7L/\`S?@_\CUVBO(O^%X?]2[_`.3O_P!KH_X7A_U+O_D[_P#:Z/J&(_E_
M%?YA]>P_\WX/_(]=HKR+_A>'_4N_^3O_`-KH_P"%X?\`4N_^3O\`]KH^H8C^
M7\5_F'U[#_S?@_\`(]=HKR+_`(7A_P!2[_Y._P#VNC_A>'_4N_\`D[_]KH^H
M8C^7\5_F'U[#_P`WX/\`R/7:*\B_X7A_U+O_`).__:Z/^%X?]2[_`.3O_P!K
MH^H8C^7\5_F'U[#_`,WX/_(]=HKR+_A>'_4N_P#D[_\`:Z/^%X?]2[_Y._\`
MVNCZAB/Y?Q7^8?7L/_-^#_R/7:*\B_X7A_U+O_D[_P#:Z/\`A>'_`%+O_D[_
M`/:Z/J&(_E_%?YA]>P_\WX/_`"/7:*\B_P"%X?\`4N_^3O\`]KH_X7A_U+O_
M`).__:Z/J&(_E_%?YA]>P_\`-^#_`,CUVBO(O^%X?]2[_P"3O_VNC_A>'_4N
M_P#D[_\`:Z/J&(_E_%?YA]>P_P#-^#_R/7:*\B_X7A_U+O\`Y.__`&NC_A>'
M_4N_^3O_`-KH^H8C^7\5_F'U[#_S?@_\CUVBO(O^%X?]2[_Y._\`VNC_`(7A
M_P!2[_Y._P#VNCZAB/Y?Q7^8?7L/_-^#_P`CUVBO(O\`A>'_`%+O_D[_`/:Z
M/^%X?]2[_P"3O_VNCZAB/Y?Q7^8?7L/_`#?@_P#(]=HKR+_A>'_4N_\`D[_]
MKH_X7A_U+O\`Y.__`&NCZAB/Y?Q7^8?7L/\`S?@_\CUVBO(O^%X?]2[_`.3O
M_P!KH_X7A_U+O_D[_P#:Z/J&(_E_%?YA]>P_\WX/_(]=HKR+_A>'_4N_^3O_
M`-KH_P"%X?\`4N_^3O\`]KH^H8C^7\5_F'U[#_S?@_\`(]=HKR+_`(7A_P!2
M[_Y._P#VNC_A>'_4N_\`D[_]KH^H8C^7\5_F'U[#_P`WX/\`R/7:*\B_X7A_
MU+O_`).__:Z/^%X?]2[_`.3O_P!KH^H8C^7\5_F'U[#_`,WX/_(]=HKR+_A>
M'_4N_P#D[_\`:Z/^%X?]2[_Y._\`VNCZAB/Y?Q7^8?7L/_-^#_R/7:*\B_X7
MA_U+O_D[_P#:Z/\`A>'_`%+O_D[_`/:Z/J&(_E_%?YA]>P_\WX/_`"/7:*\B
M_P"%X?\`4N_^3O\`]KH_X7A_U+O_`).__:Z/J&(_E_%?YA]>P_\`-^#_`,CU
MVBO(O^%X?]2[_P"3O_VNC_A>'_4N_P#D[_\`:Z/J&(_E_%?YA]>P_P#-^#_R
M/7:*\B_X7A_U+O\`Y.__`&NC_A>'_4N_^3O_`-KH^H8C^7\5_F'U[#_S?@_\
MCUVBO(O^%X?]2[_Y._\`VNC_`(7A_P!2[_Y._P#VNCZAB/Y?Q7^8?7L/_-^#
M_P`CUVBO(O\`A>'_`%+O_D[_`/:Z],T#5?[<T*SU/R?(^TQ[_+W;MOMG`S^5
M95<-5I*\U8UI8BG5=H.YHT445@;!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`>?
M?$3QUJGA*_LH+""SD2>(NQG1B00<<885QG_"Z/$?_/EI7_?J3_XNK?QL_P"0
MSI?_`%[M_P"A54^%?A?1O$G]K?VM9_:/L_D^5^]=-N[?G[I&?NCK7LTJ=".&
M56<;_P##GCU:E:6)=*$K?\,7;'XV7ZNHU#2;:5,_,;=V0X]@=W^?2O4/#WB7
M3/$]A]KTV8N%P)(W&'C)'1A_49'H:\U^('PTL=,TB35]"CDB6#!GMBY==G=E
M)R<COD]/3'/%>!_$4OAOQ/;7`<"VE80W(8X7RR>3]1U_"IEAJ->DYT59HJ.(
MK4*BA6=T?2U%%%>0>L>3^+OB-XG\+^([C3FLM,:$'S+=VBD)>,_=)^<<]0>.
MH-=#\/?'3^+8KJ"^2WAOX#O"0@@/&>,@$D\'@_45%\4_#*ZUX<:_@CS>Z>#(
M".K1_P`:_P!?P/K7B_AK7)?#OB"TU.+)$3_O$'\:'AE_+./?!KUZ5"EB,/[J
MM)?G_P`$\JI6J4,1[SO%_P!?@?0_B_Q$GA?PY<:B0C3#$=O&_1Y#T!]AR3[`
MUP_@[XA>)_%7B&&P%IIB6Z_O+B18I,K&#SCY^IS@?6N6^*'BN+Q#K4-K8SB7
M3[1/E=3Q([`%F_`8'X'UKT?X8>&/[!\-K=3KB]OPLK@CE$_@7\CD^YQVK)T8
M4<-S37O/8T56=;$<L'[J.WHHHKS3T3Q*]^,/B&VO[B!+/3"L4K("8I,X!(_O
MUWO@#QH?%VFS&Z6&+4('Q)'%D`H>C`$D^H//;WKP#5?^0Q??]?$G_H1K1\)>
M(9?#/B*VU!"?*SY<Z#^.,D;A^@(]P*]ZM@J<J7N*S/"I8RI&K[[NCW+X@^)[
MWPIH,%_816\DLETL)$ZL5VE7/8CGY14'P[\6W_BVPO9[^&VC:"5440*P!!&>
M<L:R?C#/%<^!]/G@D62*6]C='4Y#*8Y""/;%5_@G_P`@?5?^OA/_`$&N!4H?
M5'.VMSN=67UM0OI8]1HHHK@.\1W6-&=V"HHRS$X`'K7A\_QHUW[1)Y%CIPAW
M'RQ)&Y;;GC.'QG%>B_$G5_['\$7K(Q66ZQ:QD>K_`'O_`!T-7SO':3S6L]S'
M&3#!M$CY'R[C@?G@UZN7X>$XN=17/+Q^(G"2A!GT#\._&5SXNL+U[Z*WCN;:
M51M@4A=C#C@D\Y#5V=?/WPGU4Z?XUBMF($5[&T+9[$#<I^N5Q^-?0-<N-HJE
M5:CLSIP=5U:5WN@KF_'.MZCX=\-2:IIL5O(\,B"43J2-C';Q@@YW%?UKI*HZ
MSIR:OHM[I[XQ<PM'DG&"1P?P.#7/3:4TY;'143<&H[GEGA[XN:MJ'B&PLM0M
M-/2UN)EB=HD=6!;@')8CJ1VZ5[#7R21+;7!!W1RQ-C@X*L#_`#S7U/HNHKJ^
MAV.HJ`/M,"2$#H"1R/P.17?F&'A3Y905DSAP%>53FC-W9P?C[XD7_AG7TTW3
M8+.4+"KS-.KL58DX'##M@]^M=7X+UC4=?\,P:GJ4,,4L[,46%64;`<`X))YP
M3],5\_Z_>R>(_%]Y<1?.UW=;(1DG*YVH/RQ7TMIEC'IFEVEA$<I;0I$IQC(4
M`9_2EBZ4*5&$;>\QX6K.K5E*_NHM4445YQZ!P_Q$\;W7A&.P2PBMY;FY+EA.
M"P5%QV#`Y)/'T-<59?&76WO[9+NTTU;9I5$S)&X8)D;L$N><9K#^)VK_`-K>
M-[M58F*SQ:H/0K][_P`>+?I7*7=I/8W3VUS&8YH^&0D''&>U>]A\'2]DN=:L
M\/$8NI[5\CT1]:45S?@+53K'@K3;ER#*D?DR?5#MR?<@`_C725X<XN$G%]#V
MH24XJ2ZA7GWQ`\8^(?"-[;O:6EC+I]PN%DEC<LKCJI(8#IR/Q]*]!K(\3Z#!
MXDT"YTV;`9US$Y_@D'W6_/K[9K2A*$:B<U=$5HRE!J#LSAO!'Q0O-?\`$"Z9
MJT%G")D/D/`K+EQS@[F/49_'`[UU_C3Q.GA7P_+>@1O=,0EO$_1W/J!S@#D_
M_7KYQD2\T;5F0[H+RSFZCJCJ>H_$5L^,/%]UXNO+6:=!%';PA%C'3>0-[?B?
MT`KU9X",JL91^'K_`%YGE0QTHTI1E\73^O(]`\'_`!#\3^*?$,%@++35MQ^\
MN)%B?*1CKC+]3P!UY/I7JU<=\./"O_"-^'5>XCVZA>8EFW+AD&/E3\/YDUV-
M>9BI4W4:IJR1Z6&C-4TZCNV%%%%<YT!1110!D^)M4GT7PU?ZE;+&TUO%O19`
M2I.>^"#^M>0_\+H\1_\`/EI7_?J3_P"+KVG4].M]7TVXT^Z#&"==CA3@X^M<
M!KWPO\-:?X>U.]@BN1-;VDLL9,Q(W*A(X^HKNPDZ"7+55VV<6*A7;YJ;LK'*
M_P#"Z/$?_/EI7_?J3_XNC_A='B/_`)\M*_[]2?\`Q=<#80I<:C;0R9V22JC8
M]"0*]X_X5'X5_P">5U_W_-=]>.%H64X[G#0EBJU^66QW5%%%>$>V>7^.?B/K
M'AGQ*^FV5M8R0K$CAID<MDCV8#]*YO\`X71XC_Y\M*_[]2?_`!=4_BY_R/<O
M_7O'_*MWX8^#=`\0^&[B[U6P^T3I>-$K>=(F%"(<85@.I->TJ>'IX>-2<;['
MC.=>I7E3A*VYG?\`"Z/$?_/EI7_?J3_XNO0?AWXMO_%MA>SW\-M&T$JHH@5@
M"",\Y8U+_P`*P\'?]`?_`,F9O_BZVM$\.:3X<AEATJU^SI*P9QYC/DCC^(FN
M2O6PTH-4XV?]>9UT*6(C-.I*Z_KR-2BBL'QGK3:!X2O]0C8"=4V0^N]B%!'K
MC.?PKBA%RDHKJ=DI*,7)]#G_`!A\3['P[<R:?8PB]OTX?YL1Q'T)')(]!^>:
MX"7XO^*))"RFRB!_@2#@?F2?UKB((9[^^CACW2W%Q($7/)9F.!^))KZ!L?AA
MX9M](2SN;`7,VT>9<,[!V;N001@>P_7G/L3IX;"Q2FKMGDPJ8C%2;@[)'.^&
MOC"EY>1VNNVL-L)#M%U"2$4]MRG)`]\UZH"&4,I!!Y!'>OESQ-HQ\/\`B2^T
MO<66"3",V,E"`RDX[X(KW/X8ZN^K>"+7S6+RVC-;,Q[[<%?_`!UE%88W#0C!
M5:>S-L'B9RFZ53='8UD^)M4GT7PU?ZE;+&TUO%O19`2I.>^"#^M:U<YX]_Y$
M36/^O<_S%<%))SBGW1WU6U!M=CSS1/BWKVI:]IUA-:::L5S=10N4CD#!68`X
MR_7FO9J^7/"G_(XZ)_V$(/\`T8M?4==F84H4Y14%8X\!5G4BW-W/&=;^+>O:
M;KVHV$-IIK16UU+"A>.0L55B!G#]>*]0\,ZI/K7AJPU*Y6-9KB+>ZQ@A0<]L
MDG]:^<O%?_(XZW_V$)__`$8U?0'@+_D1-'_Z]Q_,UIC:-.%&,HJS_P"`9X.M
M.=649.Z_X)T=9/B;5)]%\-7^I6RQM-;Q;T60$J3GO@@_K6M7.>/?^1$UC_KW
M/\Q7GTDG.*?='H56U!M=CR[_`(71XC_Y\M*_[]2?_%U[#X?UJ#Q!H=KJ5N1B
M9`74'.Q_XE/T-?+%>C?"3Q/_`&9K3:-<RA;2^.8]QX6;@#_OH#'UVUZ^,P</
M9\U-6:/(PF,G[3EJ.Z9U?Q!^(.K>%->@L+"WLI(I+59B9T<MN+..S#CY179^
M&=4GUKPU8:E<K&LUQ%O=8P0H.>V23^M>0_&C_D<;3_L'I_Z,DKU'P%_R(FC_
M`/7N/YFN.O2A'#0FEJSLHU)RQ,XMZ(Z.BBL+QEK1T#PGJ&H(<3+'LAY&=[':
MI]\$Y^@-<48N4E%=3LE)1BY/H<YXR^)]KX=NFT_3X$O;Y.)"6Q'$?0XY)]AC
M'KVK@S\7_%!G\P?8@N<^6(#M^G7./QKC=/L[C6-6M[.(E[BZF"!FR>6/4_S)
MKWQ/A=X572Q9-8LSX&;GS&\PMC[V<X'TQCVKV)PPV%2C-7;/)A/$XEN4'9(R
M?!_Q6@UN\CT_5X(K.ZDXCE1CY3MV7!Y4GMR<UZ17RKK6FRZ'KMYISD[[:8H&
MZ$@'Y6_$8/XU]$>!M:?7O!]A>3.7N`IBF8]2ZG&3[D`'\:YL;AH02J4]F=&"
MQ,YMTZFZ.BK)\3:I/HOAJ_U*V6-IK>+>BR`E2<]\$']:UJYSQ[_R(FL?]>Y_
MF*XJ23G%/NCMJMJ#:['GFB?%O7M2U[3K":TTU8KFZBA<I'(&"LP!QE^O->S5
M\N>%/^1QT3_L(0?^C%KZCKLS"E"G**@K''@*LZD6YNX4445YYWA7G_C+XGVO
MAVZ;3]/@2]ODXD);$<1]#CDGV&,>O:NC\9:T=`\)ZAJ"'$RQ[(>1G>QVJ??!
M.?H#7S=I]G<:QJUO9Q$O<74P0,V3RQZG^9->C@<+&HG4J;(\_&XF5.T(;L[(
M_%_Q09_,'V(+G/EB`[?IUSC\:[3P?\5H-;O(]/U>"*SNI.(Y48^4[=EP>5)[
M<G-:R?"[PJNEBR:Q9GP,W/F-YA;'WLYP/IC'M7@^M:;+H>NWFG.3OMIB@;H2
M`?E;\1@_C733AA<2G&$;-'/.6)PS4IRNF?55%<[X&UI]>\'V%Y,Y>X"F*9CU
M+J<9/N0`?QKHJ\><7"3B^AZT)*<5)=0KS_QE\3[7P[=-I^GP)>WR<2$MB.(^
MAQR3[#&/7M71>,]:;0/"5_J$;`3JFR'UWL0H(]<9S^%?.&E:?-K.LVEA$V);
MJ98][<XR>6/TZUWX+"QJ)U*FR.'&XF5-JG3W9V)^+_B@S^8/L07.?+$!V_3K
MG'XUVOA#XK6^MWL>GZM!'9W4G$<J-^[=O3GE2>W)]*UH_AAX572ULGL"[A<&
MY,C"0MC[V<XSWQC'M7B.K^&-0T[7[S2X+:XNC!-Y2O'"QWYP5X`ZD$''O71"
M.%Q*<8JS1SSEBL.U*3NF?3]%8WA2ZOKSPMI\VI0S0WOE;9EG0H^Y25R0>><9
M_&MFO(E'E;78]>,N9)E#6[V33=!U&_A5&EMK669`X)4LJDC..W%>0V7QA\0W
M-_;P/9Z8%EE5"1%)G!(']^O5O%?_`")VM_\`8/G_`/1;5\SZ5_R&+'_KXC_]
M"%>E@*-.I"3DKGFXZM.$XJ+L?5]%%%>6>F<9\1/%M_X2L+*>PAMI&GE9&$ZL
M0`!GC#"O/O\`A='B/_GRTK_OU)_\771_&S_D#Z5_U\/_`.@UQ7PQT'3?$/B2
MXM-5MOM$"6;2JN]DPP=!G*D'H37L8:E16&]I.-SR<14K/$>SA*QI?\+H\1_\
M^6E?]^I/_BZZ3P-\1]8\3>)4TV]MK&.%HG<M"CAL@>[$?I71?\*P\'?]`?\`
M\F9O_BZO:1X(\.Z%?B]TW3_(N`I4/YTC<'KPS$5A4KX1P:C"S_KS-J='%*:<
MIZ?UY'0445!>3FVL;BX4!C%&S@'O@9KSDKGH/0X7QI\3[;P[<OIVFPI>7Z<2
M,S?NX3Z''+'U`(QZYXK@C\7O%)E+AK,*3G8(.![=<X_&N&EEDGF>:5R\DC%G
M8]23R37O6B>&_AYJNGPPZ?#979:/!W3'S^0>6&0P/![#VKVYTJ&%@N:/-YGC
M0JU\3-\LK>1F>%_B]#J-W'9:W:QVLDK!4N(2?+R3C#`\J/?)_#K7J%>-M\%K
MF36;@+J,4&F!_P!RQ!>4KC/(X'MG/;.*];TZS_L_3+6R,SS?9XEB\R3[S[1C
M)]^*X,6J%TZ+^1W85U[-55\RS1117&=84444`%%%%`!1110!XM\;/^0SI?\`
MU[M_Z%5SX'_\Q[_MW_\`:E4_C9_R&=+_`.O=O_0J/@[JVG:9_;7]H:A:VGF>
M1L^T3+'NQYF<9(SC(_.O9:;P%E_6IXZ:6.N_ZT/6M<$3>']2$^WRC:RA]QP-
MNPYS[8KY4KV;XB_$33I=$FTC1;H7,UT-DTT6=J1]QGN3TX[$^U>:^$=#D\0^
M)K.P5<QEP\QQP(UY;_#ZD5>`@Z-*4YZ$XZ:JU8PAJ?2]F9FL;<W&?/,:F3(Q
M\V.?UJ>BBO#9[2"OF_X@^&O^$:\3S11*!9W.9[<#^%2>5_`Y'TQ7TA7BWQL_
MY#.E_P#7NW_H5=^73:K<JV9P9A!.CS/='.?#KPT/$?BB)9XP]E:_OIP1D-C[
MJGZGMZ`U]&5Y%\#_`/F/?]N__M2O7:68S<JSB]D/+X*-%274****X3N/ES_F
M</\`M_\`_:E;/Q'\+_\`"-^)':",+87F9;<*,!>?F3\"?R(K&_YG#_M__P#:
ME?07C7PVOBCPW/9+@7*?O;9CVD`X'T/(_'/:O?KU_8U(-[-:GA4:'MJ<TMUL
M>%3^)FO/A_%H%RY:6TOEEMR1_P`LBD@(S[,1_P!]>U>B_!/_`)`^J_\`7PG_
M`*#7C$D;PRO%*C)(A*LK#!4CJ".QKV?X)_\`('U7_KX3_P!!HQL%'#RMU88*
M3E7C?HCU&BBD)"J68@`<DGM7@'NGB_QIU7SM6T_2D;Y;>(S.!_>8X'Y!?_'O
MRN^!O"HO_A;K&4)GU/=Y78'R_P#5_P#CX-><>)-3?Q!XIOK]`7^T3D1``Y*C
MY4&/7`%'_"*>(_\`H`:K_P"`<G^%?0*ART(T^;E>C_7\SP/;7K2J<MUM^GY&
M?9W4MC?6]Y`0)8)%E0GLRG(_45]66-W'?V%M>1?ZN>)94^C`$?SKY3N[*[T^
M<P7MK-;3``F.:,HV#WP>:]W^$NK'4/!JVKG,EC*T/3JI^93^I'X5CF=/FIJH
MNAMEL^6;@^IWE%%%>*>R?./Q)TK^RO'-^`"([HBZ3.>=_+=?]K=76^%_%/V3
MX/ZLC2`3V1:WBR0?];]W'K@LW'/W?2K?QJTDR66G:O&G,3M;RD#/#<KGT`(;
M_OJO(4NIDM);57(AE=7=0>"5#`?^A&O?I16)P\;]+?@>#5D\/7E;K?\`$ZWX
M7:2-4\;VKNFZ*S4W+<<9'"_^/$'\*^AZ\P^"^E>1HU_JC@;KF41)TX5!S],E
MO_'17I]>;F%3GK-=M#T<!3Y**??4*HZSJ*:1HM[J#XQ;0M)@C.2!P/Q.!5ZO
M-_C)J_V3PW;Z8C#S+V7+#_IFF"?_`![;^1KGH4_:5%#N=%>I[.FY=CR?PSIS
M>(/%UA9S$N+BX#3'N5'S/^@-=9\8]*^R>*8-05<)>P#<?5T^4_\`CNRN&L='
MU34T=[#3;R[5#AF@@:0*?0X'%37'AS7+2!Y[G1M1AA09>22U=54>I)&!7T,H
MKVJES;:6/`C)^R<>7?6YZ3\%-5.[4](8C&!=1C\E;_V2O7J^9O`VK'1?&6FW
M1.(VE$,G&?E?Y2?PSG\*^F:\C,:?+6YNYZV7U.:ER]@HHKG/&_B5?"_AR:\1
MD^UO^[MD;NY[X]`.?_UUQ0@YR48[L[)S4(N3V1Y!\5[K3[KQM-]B0^;%&L=T
MX/#R#T]P,`_3';GG?"]U867B?3KG5(C)9QS!I%]/0GU`."1W`Q5OP?X?F\5^
M)X+1][0[O.NY">0@///J>GU.:B\7>'I?#'B.XTY\F+_60/\`WXST/U'(/N#7
MTD.2*^KWUL?/3YY/V]M+GTZ"&4,I!!Y!'>EKSOX3>*/[5T0Z/<R`W=@H$>3R
M\/0?]\_=^FVO1*^=K4G2FX/H>_2J*I!374****S-`HHHH`*R/%?_`")VM_\`
M8/G_`/1;5KUD>*_^1.UO_L'S_P#HMJNG\:]2*GP,^9]*_P"0Q8_]?$?_`*$*
M^KZ^4-*_Y#%C_P!?$?\`Z$*^KZ]/-=X_,\[+-I?(****\D]0^?\`XN?\CW+_
M`->\?\JY.R_M7R3]A^V^5NY\C=MW?AWZ5UGQ<_Y'N7_KWC_E72?"OQ-HNB^&
M+FVU+48;:9KUI`DA.2I1!G\P?RKZ"-1T\-&2C?1'@RIJIB91;MJSSC_BHO\`
MJ*?^1*^HZYS_`(3WPK_T'+7\S_A6II>MZ;K<4DFFWD=RD9VN8ST->9BZLZJ3
M<+6/1PM*%)M*=[E^O/\`XQ-*/!*",95KR,2<=%VM_7;7H%<WX]T=];\&:A:Q
M#,Z()HAR<LAW8`'<@$?C6&'DHU8M]S?$1<J4DNQX1X(CCD\;Z,LH&T72,,G'
M(.1^H%?3=?)VG7KZ;JEI?1J&>VF290>Y5@1_*OI*S\:^'+W3!?IJ]K'$%#.L
MLJJZ$]BI.<]?KCC->AF=.3E&26AP9;4BHRBV:;Z3ITES)<OI]JT\N/,E:%2S
MX&!DXR<#BK$%O!;(4@ACB0G)6-0HSZ\5\]^+/'FI:IXCN;C2=4O[6P!"0I%<
M/&&`&-Q`/4G)_*O6OALVJ2^#H+G5;F>XFN':2-IV+,(^`O)YQP3SZURUL+.E
M34Y/?H=-'%0J5'"*^9UU<YX]_P"1$UC_`*]S_,5T=<YX]_Y$36/^O<_S%<]'
M^)'U1T5OX<O1GS7%YGG)Y._S=PV;,[MW;&.]:G_%1?\`44_\B4>%/^1QT3_L
M(0?^C%KZCKW,7BO822Y;W/%PF%]M%OFM8^2)?,\Y_.W^;N._?G=N[YSWKZ4\
M!?\`(B:/_P!>X_F:^?\`Q7_R..M_]A"?_P!&-7T!X"_Y$31_^O<?S-8YB[T8
MO^MC;+E:M)?UN='7.>/?^1$UC_KW/\Q71USGCW_D1-8_Z]S_`#%>31_B1]4>
MI6_AR]&>+?#G3+?6?$LFG7:!H;BTE1N.G`P1[@X(]Q6!JVFW>@:W<6%P2ES:
MR8W*2,]U8>Q&"/K75_"/_D>XO^O>3^5=E\7O"YOM.CUZU0F>T&RX51RT6>&_
MX"3^1)[5[DJ_)B>1[-?B>+&ASX;G6Z?X'FWC#Q'_`,)/<Z9>N?\`28[!(;GY
M<#S%=\D?4$'CUQ7NG@+_`)$31_\`KW'\S7S17TOX"_Y$31_^O<?S-89C!0HQ
MBMKFV7S<ZLI/>QT=<+\7/^1$E_Z^(_YFNZKGO'.C2:[X/U"RA3?<;!)".Y93
MNP/<X(_&O,P\E&K%ON>G7BY4I)=CP[X=)$_C_2!,Y5?,8@C^\$8J/Q.!7TE7
MRGHNI/HVMV6HQC<;:99-O]X`\C\1D5]'1>-/#DNEKJ/]L6B0$`D/*`ZG&=I7
MKN]L5Z&9TY.<9)'!EU2*A*+9XC\3_P#DHNJ_]L?_`$4E>C_!@D^#KH$D@7[@
M>W[N.O'O$>K'7?$5_J9#!;B4L@;J$Z*#R>0`*]\^'.DOH_@FQBE4K-.#<.I[
M;N1_X[MZUIC/<PL8/?3\C/!^_B936VIU5<YX]_Y$36/^O<_S%='7.>/?^1$U
MC_KW/\Q7DT?XD?5'J5OX<O1GS_X4_P"1QT3_`+"$'_HQ:^HZ^6/#EQ%:>)])
MN9W$<,5[#)(YZ*H<$G\J^A/^$]\*_P#0<M?S/^%>GF4)2G'E5SSLNG&,9<SL
M='163I?B;1=:N6MM-U&&YF5#(4C)R%!`S^9'YUK5Y,HN+LU8]2,E)73.%^+G
M_(B2_P#7Q'_,UY1\.5B;X@:0)CA/,8CG^((Q7]<5[AXYT:37?!^H64*;[C8)
M(1W+*=V![G!'XU\Z:+J3Z-K=EJ,8W&VF63;_`'@#R/Q&17L8'W\/*"WU_%'D
M8WW,1&;VT_!GU97SG\3_`/DHNJ_]L?\`T4E>W1>-/#DNEKJ/]L6B0$`D/*`Z
MG&=I7KN]L5\[^(]6.N^(K_4R&"W$I9`W4)T4'D\@`5GEM.<:DI-=+&F8U(NF
MDGU/8?@P2?!UT"20+]P/;]W'7HM<K\.=)?1_!-C%*I6:<&X=3VW<C_QW;UKJ
MJX<3)2K2:[G=AHN-**?8\]^,DDB>"X50G:]ZBOQGC:Y_F!7FOPQ`;XB:4"`1
M^]//_7)Z]C^(NE2:OX(OXH0S2P@3HJ_Q;#DCWXS^.*^?]`U:30M>LM3C!8V\
MH9E!P67HRY]P2/QKT\%[^%E!;Z_D>;C/<Q,9O;0]H^(GCK5/"5_906$%G(D\
M1=C.C$@@XXPPKC/^%T>(_P#GRTK_`+]2?_%UW^J/X"\5VD.J:G=V<\<285GN
MVB9`><%0P.?8C->%:Y)ITNMW;:3#Y.G^81`F6/RC@'YB3SC//K2P=*E./+*&
MJW;#%U:L)<T9Z/:Q]&^#=:N?$/A2RU6[2))Y]^Y8@0HVNRC`))Z`=ZW:Y'X8
M?\DZTK_MM_Z->NNKRZZ4:LDN[/4HMRIQ;[(R/%?_`")VM_\`8/G_`/1;5\SZ
M5_R&+'_KXC_]"%?3'BO_`)$[6_\`L'S_`/HMJ^9]*_Y#%C_U\1_^A"O4RW^'
M,\S,?XD3ZOHHHKQCUSR[XV?\@?2O^OA__0:\?LOMOG'[#]H\W;SY&=VW\.W2
MO8/C9_R!]*_Z^'_]!KC_`(5ZOI^B^)[FYU*ZCMH6LFC#R="Q=#C\@?RKW<))
MPPG,E??\SP\5%2Q7*W;8YW_BHO\`J*?^1*]Z^'/VG_A`]-^U^;Y_[W=YN=W^
MM?&<\],5-_PGOA7_`*#EK^9_PJWIWBK0M7NQ:Z?J<%Q.06"(3G`ZUQ8FO4JP
MLX6MJ=N&HPI3NIWN;%%%9?B+5WT'0+O5$M&NC;J'\E6V[AD`G.#@`$GIVK@C
M%R:2.Z344VSQ+QA\-M4T.^EFTVVFO-,;+(T2[FB']U@.>/7I7#D%6((((X(/
M:O5;'XSWDNM6XO;&V@TPOB7RPS2*"",YS@X.#T[5Z'=7/A'6K(W%Y/H]U`1D
MR3/&=O'J>5(S[$5[?UJM12C6C?S1XWU:C6;=*5O)GAGA[QYKOAZXB,=Y+<6J
M\-:SN60KGD#/W3[BOH;1]5M];T>UU*T),-P@<`]5/0J?<$$'Z5\Q:VFGQZW>
MKI3L]@)6$#-G)7MUYQ]:][^%]K-:^`=/\XOF4R2*K#[JESC'L?O?\"K/,:<.
M15$K,TR^I/G=-NZ.PHHHKQSU@HHHH`****`"BBB@#S#XH^$M<\1ZE83:59?:
M(XH65SYJ)@DY_B(K@O\`A6'C'_H#_P#DS#_\77T917=2Q]2G!025E_7<XJN!
MIU)N;;U_KL>!V'PA\373+]J%K9(1EC)*'(Y]%SSWZUZWX4\'Z=X2LFBM-TEQ
M+CSKA_O28SCCH`,]!^M=#16=;&5:RM)Z&E'"4J3O%:A1117*=(5YA\4?"6N>
M(]2L)M*LOM$<4+*Y\U$P2<_Q$5Z?16M&K*E/GCN95J4:L.21YS\*_"^L^&_[
M6_M:S^S_`&CR?*_>H^[;OS]TG'WAUKT:BBE6JNK-SENQTJ2I04([(****S-#
MP7_A7/BO_A)/M?\`97[C[9YN[[1%]W?G.-V>E>]445T5\1*M;FZ&%##QHWY>
MIY#\0_AQJ6H^(/[2T&T$ZW0+7$?F(FR0=_F(X8?7D'U%=#\+O#FK>'--OX=5
MM?L[RS*R#S%?(`Q_"37>T54L74E2]D]OQ)CA81J^U6X5D^)TU"7PSJ$6E0>=
M>RPF.)-P7EOE)R2!P"3U[5K45S1?*TSHDKIH\1\&_#?Q!9^+-/O-5T\06EO)
MYS.9HV^91E0`K$_>Q7MU%%;5\1.O+FD94*$:,>6)YA\4/!.J>(-1L;_1[07$
MHB,4X\Q4(`.5/S$`]6_*H_ACX9\2^&=9NQJ6G>397,(#/YT;8=3\O"L3T+=N
M]>IT5?UN?LO8M*Q'U2'M?:INX4445RG28?B_13X@\*W^G(H:9X]T.<?ZQ>5Y
M/3)&,^A->'_\*P\8_P#0'_\`)F'_`.+KZ,HKJH8RI0BXQL<M?"4ZTN:5S(\+
MZ3_8?AC3M-90LD,($@!R/,/+X/IN)K7HHKFE)R;D^ITQBHI)=`KR/XD>%/%/
MB7Q,);'3/-LH(5CB?SXUW'[S'!8'J<=.U>N45K0K2HRYXK4SK456CRR>ARWP
M^\/W'AOPG#9WD8CNY)'FF0,&PQ.`,C@_*%KH-1LH]2TRZL9L>7<1-$V1GAAB
MK-%1.I*4W-[E1@HP4%L?.A^%_C$,0-(!`[BYBY_\>KW[1VO7T:S.I1>5>^2H
MG3<&P^.>02.OO5VBML1BIUTE)+0QH86%!MQ;U"O'_B!X:\8>*?$+26^E.=/M
MAY=L#<Q#(_B?!?C<?QP!FO8**BA6=&7-%*_F76HJM'ED]#C?ASX1?POH;->1
MA=2NCNG&X-L`)VJ"..G/U/M3/B1X1D\3Z+')8PJ^I6S9B&0I=3]Y<G`]^?3W
MKM:*/K$_:^UZA["'LO9=#P?P]X*\<^'M=M=3M](.Z%OG7[5#AT/#*?G[C_&O
M=T8LBL5*$C)4XR/;CBEHJJ^(E7:<DKBH8>-%-1;"BBBN<W"BBB@`K.\06LU]
MX;U6TMDWSSV<L4:Y`W,R$`9/`Y-:-%.+L[B:NK'SYI_PT\70:E:S2:3M1)D9
MC]IB.`""?XJ^@Z**WQ&)G7:<NAA0PT*%U'J%%%%<YT'C_P`1?!'B+7?%DE[I
MNG^?;F%%#^=&O('/#,#7)_\`"L/&/_0'_P#)F'_XNOHRBN^GF%6$5%):?UW.
M&>`I3DY-O7^NQ\Y_\*P\8_\`0'_\F8?_`(NO3_A=X<U;PYIM_#JMK]G>6960
M>8KY`&/X2:[VBHK8ZI5AR22L51P5.E/GBV%%%%<9V'EGC'X3G4;V74=!DBAD
ME.Z2UDX4MW*GMGTZ>_:N`?X=>+8YQ"=%F+'`!5T*\_[0./UKZ2HKNI9A5A'E
MW.*I@*4WS;'BWAKX/WTUPD_B!TM[=2";:)PSO[$C@#Z$GZ=:]GCC2&)(HD5(
MT`5548"@=`!V%.HK"OB)UG>9O1P\**M`*Q?%UA<ZIX3U*RLXO-N)H2L:;@N3
MD=S@5M45E&3C)270TE%2BXOJ>"^'_ASXKL?$FE7=SI6R""\BED;[1$=JJX).
M`V3P*]ZHHK;$8B5=IRZ&5##QH)J/4\%\0?#GQ7?>)-5N[;2M\$]Y++&WVB(;
ME9R0<%LC@U[!X1L+G2_">FV5Y%Y5Q#"%D3<&P<GN,BMJBG6Q4ZL%"26A-'"P
MI2<XMZA6+XNL+G5/">I65G%YMQ-"5C3<%R<CN<"MJBL(R<9*2Z&\HJ47%]3Q
M_P"'7@CQ%H7BR.]U+3_(MQ"ZE_.C;DCCA6)KUV6*.>%X94#QR*5=3T(/!%/H
MK2O7E6GSRW,Z-"-&/+'8\!UCX5>(H-8NH]+L#<V(<F"4SQJ2IY`(+`Y'0\=J
M]D\(V%SI?A/3;*\B\JXAA"R)N#8.3W&16U15UL74K149="*.%A1DY1ZA1117
M,=)Y3XU^%,E_>R:EX?,2/*=TMHYV@L>I0]!GT.!Z'M7!GX=>+1<>0=%FW],A
MT*_]]9Q^M?25%=U/,*L(\NYPU,!2G+FV/(_!_P`))8+J'4/$+Q_NR'6RC.[)
M[;V'''H,Y]>U>N445SUJ\ZTN:;.FC0A1C:`5B^+K"YU3PGJ5E9Q>;<30E8TW
M!<G([G`K:HK.,G&2DNA<HJ47%]3YS_X5AXQ_Z`__`),P_P#Q='_"L/&/_0'_
M`/)F'_XNOHRBN_\`M.MV7X_YG#_9M+N_P_R/*/ACX-U_P]XDN+O5;#[/`]FT
M2MYT;Y8NAQA6)Z`UZO117'6K2K3YY'71HQHQY8A7E/C7X4R7][)J7A\Q(\IW
M2VCG:"QZE#T&?0X'H>U>K444:TZ,N:`5J,*L>69\VGX=>+1<>0=%FW],AT*_
M]]9Q^M=MX/\`A)+!=0ZAXA>/]V0ZV49W9/;>PXX]!G/KVKURBNJIF-:<>5:'
M-3R^E"5WJ%%%%<!W!7D'B_X23RWLE[X<$7EO\S6;-MVM_L$\8]CC'TZ>OT5M
M1KSHRYH&-:A"M&TSYN7X<^+6G,(T67>.YD0+_P!];L?K713_``>U6#PXTZ2)
M<:L9%*VT3@($YR-S8!;D'TX/7->WT5U2S*L[6LCFCEU)7O=G.>`]+O-&\%Z?
MI^H0^3=1>9OCW!L9D9AR"1T(KHZ**X9R<Y.3ZG;"*A%170SO$%K-?>&]5M+9
M-\\]G+%&N0-S,A`&3P.37ANG_#3Q=!J5K-)I.U$F1F/VF(X`()_BKZ#HK>AB
MIT8N,4M3"MA85FI2;T"BBBN8Z3@OBCX<U;Q'IMA#I5K]H>*9F<>8J8!&/XB*
M\P_X5AXQ_P"@/_Y,P_\`Q=?1E%=E''5*4.2*5CCK8*G5GSR;/G/_`(5AXQ_Z
M`_\`Y,P__%UUGPZ\$>(M"\61WNI:?Y%N(74OYT;<D<<*Q->P45=3,*LXN+2U
M_KN3#`4H24DWI_78*9+%'/"\,J!XY%*NIZ$'@BGT5P'<>+>)?@_?0W#S^'W2
MXMV)(MI7"NGL">"/J0?KUKE?^%=^+?/\G^Q9]^<9WIM_[ZSC]:^DZ*]"&95H
MJSLS@GEU*3NKH\6\-?!Z_FN8Y_$$B6]NI!-M&^YY/8L.%'N"3].M>S111P0I
M#$@2.-0J*.@`X`I]%<U?$5*SO,Z:.'A15H!1116!L%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
..4444`%%%%`!1110!_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>g2014031017063245434.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g2014031017063245434.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+#`Q-#0T'R<Y/3@R/"XS-#+_
MVP!#`0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P``1"`$9`Z<#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#W^BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`**9+-%"`994C!Z%V`S6?+XAT:#[^IVO7&%E#'
M]*`-.BL%_&?A]&*G41D>D3D?F%JM_P`)]H?_`#TG_P"_1H"YT]%<G)\0]&1L
M+%>2#^\L:X_5A3/^%C:1_P`^U]_WPG_Q5`7.OHKD/^%C:1_S[7W_`'PG_P`5
M4D7Q"T:0D,EW'CNT8Y_(F@+G5T5S<?CO07;#7$D8QU:)L?IFKL'BC0[C&S4X
M!G_GH=G_`*%B@#7HIJ2)*@>-U=3T93D&G4`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`'G_B'QOJ-EJES8VD4$:Q-M\Q@68_T_2N6N?$>LW>?-U*XP<Y
M"/L!S[+@5U6J^!]1U37+N[$UO%!+(2NYB6QCT`_K3(?AK*2?.U-%';9$6S^9
M&*9.IPKNTC%G8LQZDG)-)79Z]X%&F:9+>VUXTHB`+QNH!(SU!_I7&4P"BBB@
M04^*&68D11/(1U"J3BO0/`&EV%SI4UU<6D,LZW!17D4-@!5(QGIR>M=RB+&@
M5%"J.@`P!2N.QX7]AO/^?6?_`+]FHY8)H,>;$\>>F]2,U[S2,H=2K`%2,$$<
M$47'8\#HKV:^\,:-J`/G6,2N>=\0V-^G7\:X_5_A[<0`RZ7-]H0?\LI"`_X'
MH?THN*QQ]M>7-G)YEM<2POZQN5/Z5T^F?$#4K3"7J)>1CN?D?\QQ^8_&N4DB
MDAE:.5&213AE88(/H13:8'LVC^)--UL;;:7;/C)ADX8?X_A6O7@:.T;JZ,59
M3D,#@@^M=[X9\<G*6>L2<=$N3_)O\?S]:5AIG?T4`@@$'(/0BBD,****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`R/%/_(KZA_UR/\Z\9KV;Q3_R*^H?]<C_`#KQ
MFFB6%%%%,1Z=\.?^1>N/^OIO_0$KKZY#X<_\B]<?]?3?^@)77U):"BBB@`HH
MHH`P_$7AFUUVW+86*\4?NYL?HWJ/Y5Y+>6=QI]W):W49CFC.&4_S^E>[5ROC
M7P^NI:<U[`G^EVRD\=73N/?'4?CZTT)H\LHHHIDG:^#?%C6LD>F7\G^C-Q%*
MQ_U9]"?3^7TZ>D5X%7J/@CQ`VIV365R^ZZMQP3U=.F3[@\?E2929UE%%%(84
M5YGK_B[6K37;RWMKORH8I"BKY2'@?4&L]/&_B!6!-\&`_A,*8/Y"G85SURBO
M*D\?ZXA4LUNX'4-%U_(BK*?$;5`X,EK9LO<*K`_GN-%@N>F45YS_`,+)O/\`
MH'P?]]FD;XD7I4[;"W#8X)9B,T6"YZ/17GVC>-]3U+7+.UFCMDBD?:PC0@G(
M]237H-(84444`%%<9XT\0:EHU_:+93A$>,LRE%8,<^XS7.?\)]KG_/2#_OT*
M=A7/5J*\S3XC:H'!DM;-E[A58'\]QHD^(^J%OW=I9JOHP8G\]PHL%STRBN2\
M)>)K[7KRYCND@18HPP$2D<Y]R:ZVD,**\OO/'&N6][/#NA7RY&3!BY&#BH3X
M]UT@CS81[^4*=A7/5J*\H3QYKJJ`9H6(_B,0R?RI)/'>O.N%N(HS_>6)<_KF
MBP7/6**\IL_'>M07<<ES.+B$'YXC&BY'U`R#7I6FZG::M:+<V<H=#P1W4^A'
M8T@N7****!A1110`4444`%%>5O\`$#6W<LIMD!_A6/@?F33'\>:ZRD":%2?X
MA$,C\Z=A7/5Z*\A_X37Q#_T$/_(,?_Q-12>+=>E?<VI2@_[(51^0%%@N>QT5
MY#9>)=<FO[>,ZA.X:105]1FO7J07"BBB@84444`%%%%`!17B_B34O[5UZZN5
M;,>[9'Z;1P,?7K^-+X:U0Z3KMO<%ML3'RY?38>N?IP?PIV%<]GHHHI#"BBB@
M`HK@?B!J%[97UFMK>7$"M$21%*R@G/L:Y:+Q1KD(4+J=P=IR-[;OSSG-.PKG
ML]%>0_\`":^(?^@A_P"08_\`XFK`\>ZZ`!YL)]_*%%@N>K45Y0_CS764@30J
M3_$(AD?G59_&7B"1"K:BP!_NQHI_,"BP7/8**\4D\0ZS(VYM4O`?]F9E'Y`U
MZ%X"N[F\T*>2ZN)9W%RRAI7+$#:O&3]:+!<ZFBBN*^($M]!_9TUF]Q'L\W>\
M)8;?N]2/Q_6D,[6BO%HO$FM1`A=4NCG^](6_G5I?&GB!5"C4#@#',2$_GMIV
M%<]?HKR'_A-?$/\`T$/_`"#'_P#$U#-XLUV?._4I1D8^0!/_`$$#\Z+!<]DH
MKS#P?<:M?^([66:>]N+:+?O=W9T7*'&2>!SBO3Z0PHHHH`***\[^(VI"2YMM
M-0\1#S9.>,G@#Z@9_P"^J`/1**\$C=HI%D1BKJ0RL.H(KVS1=175='MKT?>D
M3YQZ,.&'Y@T"3+]%%%`PHHHH`****`"BF3>9Y,GE8\S:=N>F>U>2?\)KXA_Z
M"'_D&/\`^)H%<]>HKR(>-O$((/V_/MY,?_Q-7(_B'K*+AHK.0_WFC;/Z,*=@
MN>HT5YPOQ(O0HW6%N6QR0S`9J.7XCZD2/*L[11WW!F_J*+!<]+HKRN7X@:W(
M<K]FBXQA(_UY)K8\&>(-6U?6I(+V\\R)(&DV^6@R<J.H`/>BP7.\HHK@O%'B
M[4=+UV6SLY(O+C5<AH\D$C/7\12&=[17E/\`PGVN?\](/^_0H_X3[7/^>D'_
M`'Z%.PKGJU%>8#XBZP`!]GLC[E&_^*J.7X@ZU(056UCQV6,\_F318+GJ=%>?
M^$/$NK:GKJVUY=>;"8V.WRU7D>X`KT"D,****`"BBB@`HHHH`****`"BBB@#
M(\4_\BOJ'_7(_P`Z\9KV;Q3_`,BOJ'_7(_SKQFFB6%%%%,1Z=\.?^1>N/^OI
MO_0$KKZXOX;R$Z3=Q8&U9]P]<E1_@*[2I+04444`%%%%`!1110!XYXJTI=(U
MZ:",8AD_>Q#T4]OP((_"L6O1OB/9;[&TOE',<AC8CT89'ZC]:\YIDL*N:5J$
MFE:G!>Q=8FR1_>'<?B*IT4Q'O4,R7$$<T;;HY%#J?4$9%/KE_`5_]K\.B!C\
M]LYC_P"`GD?S(_"NHJ2R&XL[6[7;<VT,P])$#?SKA/%W@Z&WMFU'2XMB1C,T
M(R0!_>'T[BO0:"`001D'J#0!X%170^+]"_L75=T*XM+C+Q8Z*>Z_A_(USU40
M%>CZ9X$T>YM(;HW5S<)*H=<$("".XP3G\:\XKNO`&N^5*VD7#`(Y+P,3T;NO
MX]?S]:3&CK;#PSH^FR)+;62"5>DCDL0?7D\?A6M112*"BBB@"K>:;9:@`+RT
MAGP,`R("1]#VKF/$/A?0++1;N\6W,$B(61DD;ES]T8)(QDBNQKS/Q[K9N[\:
M9"W[FV.9,'AG_P#K?U-`F<>B-(ZHBEF8X"@9)/I7H&B_#Z(P1SZM(YD89,$9
MP%]B>_X8IG@'0/\`F,W*>JVZG\BW]!^/M7?TVP2*.GZ-I^E;OL-JD)8`,1DD
MCZGFKU%%(9FW>@:3?%FN-/MV=R2SA-K$GN2.:Y[5?A[931.^FR/;R@?+&[;D
M/MSR/KDUV=%`'A-Y9W&GW<EK=1F.:,X93_/Z5!7H'Q)M$V6-X%P^6B8XZCJ.
M?;G\Z\_JB0K2T76KK0[X7%N<J>)(R?E<>A_H:S:*!'M^E:K:ZS8K=6KY4\,I
M^\A]#5ZO%-%UJZT.^%Q;G*GB2,GY7'H?Z&O7=*U6UUFQ6ZM7RIX93]Y#Z&I*
M3+U%%%`PHHHH`R;OPSHMZQ:?3H=QZE`4)_[YQ7,Z]X#LX-/GO-/EE1X4,AB<
M[@P`R0#U!_.N\JO?_P#(/N?^N3?R-`K'A5>@^&_`UM):0WVIGS?-0.D"D@`$
M9&3US[?SKSZO;M$8MH&G,Q)8VL1))Y)VBFQ(EL]-LK`8M+2&#(P2B`$_4]ZM
M444B@HHHH`****`"L7Q7J1TOP]<RH<2R#RH^<<MQD>X&3^%;5>;?$34?.U*#
M3T(VVZ;WP?XF['Z`#\Z!,XNBBBJ)/7_!^J#4_#T&YLS0#R9,]>.A_$8Y]<UO
M5Y;X"U3[%K9M'/[J[&WKT<<C^H_$5ZE4E(****!D-Q:6UVFRYMXIE_NR(&'Z
MUC:AX.T6^B8+:+;R'.V2'Y<'Z=/TK?HH`\-U+3YM*U":RN`/,C.,CH1V(JI7
MH?Q$T@R0PZM$.8\13?[I/RG\SC\17GE,EA75^#/#5KK;3W%ZS-#"P41*<;B?
M4^GTKE*ZOP#J7V/73:N<1W:;?^!#D?U'XT`CT2#1M,MAB'3[5.,9$2Y/U/>K
MU%%(H****`*UQI]E=AOM%I!+NZ[XP<_G7F?C70K/1KRW:R^1)U8F(MG:01R.
M^#G]#7JM>2^-]0^W>))45LQVP$*\\9'+?J2/PIH3,"""6YN(X(4+RR,%11W)
MKT_2/`NFV*))>+]KN!@G?]P'V7N/K7/_``]TK[1J,NI2#]W;C8GNY']!_,5Z
M50P2&QQI%&J1HJ(HP%48`%.HHI#"BBB@!LDB11M([!44%F8]`!7B&JW[ZGJE
MS>OG,KE@#V'0#\!@5Z9XXU+[!X>>)&Q+='RACKM_B_3C\:\GIHEA7=_#K5-D
MMQIDC</^]BR>XX8?E@_@:X2K>F7TFF:G;WL>=T+AB!W'<?B,C\:8'N5%,AF2
MX@CFC;='(H=3Z@C(I]24%%%%`!1110`5DS^&-$N,[],MQD8_=KL_]!Q6M10!
MY_K_`(!2&WDNM)=R4&YK=SG([[3_`$/Y]JX*O?:\O\;^'O[.O/[0MU_T6X;Y
M@!_JW]/H>3^?M30FCDJ***9)Z3X:\,>'[_1[:\,+7$C*/,WR'Y7'WA@8XSZ]
ML5U5GIECI^?LEI!`2,$QH`2/<]37F?@O7_[)U+[/.^+2Y(#9Z(W9OZ'_`.M7
MJU)E(*R]0\.Z3JLXGO;,22@8W;V4X_`BM2BD,Y:^\$^'UM99?*DMEC0LSI*3
M@`9S\V:\KKT#Q]KX"?V/;L"3AK@@].X7^OY5Q6FZ=/JM_%9VRYDD.,GHH[D^
MPIHEEK0M`N]>NS%!\D:<R3,/E3_$^U=]:_#_`$:``S^?<GOO?:/_`!W'\ZV]
M(TFVT;3X[2W4<#+OCEV[DU?HN.Q2LM'T[3B&M+*"%\8WJ@W8]-W6KM%%(844
M44`%%%%`!1110`4444`%%%%`&1XI_P"17U#_`*Y'^=>,U[-XI_Y%?4/^N1_G
M7C--$L****8CT;X;?\@^^_ZZK_*NWKB_AO&PTJ\D/W6G"CZA1G^8KM*EE(**
M**!A1110`4444`8/C.W%QX5O.FZ,+("3TPPS^F:\@KVOQ`BR>'=25AD"VD;\
M0I(_45XI31+"BBBF([7X;W)35+RVSQ)"'_%3C_V8UZ17DW@641^*K=2,^8CJ
M/;Y2?Z5ZS292"BBBD,S==TB+6]*ELY,!C\T;G^%QT/\`3\:\8G@EMKB2"9"D
ML;%74]B*]YKAO'OA_P`Z/^V+9,R(`+A0.J]F_#H?;'I30FCSNE1VC=71BK*<
MA@<$'UI**9)[#X6UY==TL.YQ=0X6=??LWT./YUN5XOX>UE]#U:.Z`W1'Y)5]
M5/7\1UKV6&:.X@2:%P\;J&5AT(-2RD/HHJ.>>*VMY)YG"11J6=CV`H&97B;7
M%T/2FE!!N9,I"I&?F]?H*\QT#1Y=>U=8"6\O.^:0\X7OSZFEUW5Y_$.L&54;
M:2(X(NX&>/Q->F^&=#70]*6(@&YDP\S`Y^;T^@IBW-:&&.W@2&%`D:*%51T`
M%/HHI#"BBB@`HHHH`Y#XC?\`(O6__7TO_H#UP.C:3+K5\;2&14D\MG7=T)';
MVKOOB-_R+UO_`-?2_P#H#UR7@AV3Q;:*IP'$BM[C83_,"F2]S#N;::TN)+>X
MC:.6,X96Z@U%7L/B+PU;:];$X6*\4?NYL?HWJ/Y5Y/?Z?=:9=M:WD1BE7G![
MCU![B@&BM6EHNM76AWPN+<Y4\21D_*X]#_0UFT4Q'M^E:K:ZS8K=6KY4\,I^
M\A]#5ZO%-%UJZT.^%Q;G*GB2,GY7'H?Z&O7=*U6UUFQ6ZM7RIX93]Y#Z&I*3
M+U%%%`PHHHH`\$D1HI&C<8925(]"*]KT+_D7M-_Z]8O_`$`5X[JD9AU:]B8@
MLD[J<=,AC7L.@L&\.Z:5((^RQC@]PHILE&C1112*"BBB@`HHHH`CGFCMK>6>
M4XCB0NQ]`!DUX=?7<E_?3W<OWYG+D>F>U>E>/M2^QZ$MJIQ)=OM_X".3_0?C
M7G.E6#ZGJEM9)G,KA21V'4G\!DTT)E1E*G#`@X!Y'8TE=M\0-'6UGMM0@C5(
MG40N%'1E'R_^.C'_``&N)IB'Q2R03)-$Q22-@RL.H(Y!KV[2K]=3TNVO4QB5
M`2!V/0C\#FO#J[_X=:IQ<:7(W_3:+)^@8?R/YTF".^HHHI%!1110!!>6L=]9
M3VLH_=S(4/MD=:\0O;22PO9K2;_61.4..^.]>[5YQ\1-+,-]#J2+\DX\N0C^
M^.F?J/\`T&FA,XFI()I+:XBGB.V2)PZGT(.14=%,D]TT^]CU'3[>\B^Y,@<#
M.<>H_#I5FN'^'>J&6UGTN1LM%^]B'^R3R/S.?^!5W%26%%%%`%>^NEL;"XNG
M(VPQL_/?`Z5X9)(\TKRR-N=V+,?4GK7IGQ!U(6VCQV*-^\NF^8?["\_SQ^M<
M;X2TW^T_$5O&PS'%^^D^B_\`U\"FA,],\.:9_9.A6UJ1B7;OE_WSR?RZ?A6K
M112&%%%%`!11574;V/3M.N+R3[L*%L>I[#\3@4`>:>.]2^VZ^;=&)BM%\L#M
MN/+'^0_"N7P<9QQZT^662>9YI6+R2,69CU)/)-=]/X8_XM]$JQ@WD8^U\#DY
MY(_[YP/JHID[GGU%%%,1Z?\`#_5!=:,UB[9EM6X![H>1^N1^5==7COA35?[)
MUZ"5SB&7]U+[`]_P.#7L5)E(****0PHHHH`****`"H+RTAO[.6UN%W12KM85
M/10!XGK>DRZ+JDMG(2P7YHW(QO4]#_3Z@UG5ZSXQ\/G6M-$L"YO+?+1C^^.Z
M_P!1[_6O)B""01@CJ*9+"O2O`_B/[;;C2[I_](B7]RQ_C0=OJ/U'TKS6I;:X
MEM+F.X@<I+&P96'8B@#WBLCQ'KD>A:6TYPT[_+#&3]YO7Z#K_P#KI-)\0VFH
M:%_:4LB0B,8N`>B,.OY]OJ.]>8^(]<DUW5&G.5@3Y88R?NKZ_4]?_P!5`VS-
M=YKRZ9W+RSRODGJ68FO6/"GAU=#L-TRJ;V89E8<[1V4'^?O6)X&\->6BZO>1
M_.PS;HPZ#^_^/;\_2N[H8)!1112&%%%%`!1110`4444`%%%%`!1110`4444`
M9'BG_D5]0_ZY'^=>,U[-XI_Y%?4/^N1_G7C--$L****8CT[X<_\`(O7'_7TW
M_H"5U]<?\.74Z#<H#\PN22/8JN/Y&NPJ2T%%%%`!1110`4444`9^N_\`(O:E
M_P!>LO\`Z`:\2KV?Q/-Y'AG47W`9A*9/^UQ_6O&*:)84444Q'0>"03XNLL#I
MYF?^^&KUVO+/A]&7\2E@1B.!V.?3(']:]3I,I!1112&%(Z+(C(ZAD8892,@C
MTI:*`/&_$VAOH>JM$`3;29>%B<_+Z'W%8U>S^(=%CUS2GMC@3+\T3_W6_P`#
MTKQN:&2WG>&9"DB,593U!%-$L97H/P_UW<K:/._*Y>W)/4=2O\S^=>?5)!/+
M;7$<\+E)8V#(P[$4P/>:\U\<^(OMEP=+M7S;Q-^]8'[[CM]!_/Z5?U3QRDGA
MN(VC;-0G!1PO_+''4_CV_P#K5S7A70#KFIA9`PM(OFF8=_1?Q_QI#;.A\!^'
M>FL72^UNI_5C_3\?:N_I$18T5$4*BC"J!@`>E+2&%%%%`!1110`4444`<M\0
M$5_#.YADI.C+['D?R)KBO!7_`"-UC_VT_P#1;5V_C[_D6'_ZZI_.N(\%?\C=
M8_\`;3_T6U,3W/7JR=>T"UUZS\J;Y)5YBF`R4/\`4>U:U%(9XAJNE76CWS6M
MTF&'*L/NN/451KVO6M%M=<L3;W`PPYCE`^9#ZC^HKR+5=*NM'OFM;I,,.58?
M=<>HIDM%&M+1=:NM#OA<6YRIXDC)^5QZ'^AK-HIB/;]*U6UUFQ6ZM7RIX93]
MY#Z&KU>*:+K5UH=\+BW.5/$D9/RN/0_T->NZ5JMKK-BMU:OE3PRG[R'T-24F
M7J***!GB6N_\C#J7_7U+_P"AFO5?"C!O"^GE2"/*QP>X)KRWQ#&8O$>I*Q&3
M<.W'H23_`%KTOP5_R*-C_P!M/_1C4V2C?HHHI%!1110`4451UC4!I>D75Z1D
MQ)E1ZL>!^I%`'F?C;4O[0\12QJ?W=M^Y7ZC[WZY'X5K?#G3?,NKG4G7Y8QY4
M9/\`>/)_3'YUP[,68LQ)8G))/)->S>&]-_LK0;6V9<2[=\GKN/)S].GX4R42
M:]IO]K:)=68`,CIF//9QR/IR,?C7BA!!((P1U%>^UY%XSTW^SO$4Y12(;C]\
MGX_>_7/Z4(;.?JYI5^^EZK;7J=8GR1ZCH1^()JG13)/>XI$FB26-MR.H93Z@
M]*=7+>`]3^W:"+9VS+:-L_X">5_J/PKJ:DL****`"LOQ%I@U?0[FU'^LV[XS
MCHXY'Y]/QK4HH`\"(()!&".HHKH/&6E?V9K\I10(;C]ZF.V>H_//Z5S]407]
M%U)])U>WO$/"-\X_O*>"/RKVR.1)8UD1@R,`RL.A!KP2O4O`>J_;M%-I(?WM
MH=@]T/W?ZC\!292.KHHK/UO41I6C75X3AHT.SC/S'A?U(I#/,?&.HG4?$=QA
MLQ0?N4Q[=?US76_#W3?L^DRWSKA[E\+D?P+_`(G/Y"O.;6WDO;V&WCYDFD"#
M/J3BO<;.UCLK.&UA&(XD"+^`IL2)J***0PHHHH`*XCXBZEY5E;Z<A^:9O,D_
MW1T'XG_T&NWKQGQ/J7]J>(+J=3F)6\N/_=7C/X\G\::$QGAS3O[5UZUMB`8]
M^^3(XVKR1^.,?C7M)`(((R#U!KA?ASIVRWNM2<#,A\F/CD`<G\SC\J[JA@CQ
M7Q!IO]DZY<V@'[L-NC_W3R/\/PK,KT3XC:;YEK;:DB_-&?*D(_NGD?KG\Z\[
MH$PKV/PIJ?\`:OAZWE8YEC'DR?[R]_Q&#^->.5V'P]U/[-JTM@[?)=+E?]]>
M?U&?R%#!'IM%%%(H****`"BBB@`HHHH`*\V\=>'OLEQ_:MJF()3B90,!']?H
M?Y_6O2:CG@BN;>2"9`\4BE74]P:`/!J*U_$FB2:%JKP?,;=_GA<]U]/J.GZ]
MZR*H@>LTJ121+(RQR8WJ#PV.F:Z3P?X;.L7GVFY7_086^8$?ZQO[H]O7_P"O
M7,5V/@;Q#]BNAIET_P#H\S?NB3]QSV^A_G2&CTP````8`Z`4444B@HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`R/%/\`R*^H?]<C_.O&:]F\4_\`(KZA
M_P!<C_.O&::)84444Q'HWPV_Y!]]_P!=5_E7;UQ_PY4#0+AL#<;I@3CG&U?\
M3785+*04444#"BBB@`HHHH`Y?Q]<^1X9:+O/*B?E\W_LM>55V_Q'OA)?6EBI
M_P!4AD?ZMP/T'ZUQ%-$L****8CO_`(;6AVW]X<[25B7TSU/\UKOJR/#.FG2M
M`MK=UVRE?,E!Z[FYP?IP/PK7J2T%%%%`!1110`5Q/CSP\MQ;'5[9`)HA^_`_
MC7IGZC^7TKMJ;)&DL;1NH9&!5E/0@T`>"45)<1"&YEB!R$<J#ZX-1U1`5[/X
M<TR'2]$MX8@-SH))&_O,1R?Z5XQ7NMA_R#[;_KDO\A28T6****104444`%%%
M%`!1110!RWQ`=4\,[6."\Z*ON>3_`"!K@O"W_(SZ?_UU'\J[?XC?\B];_P#7
MTO\`Z`]<1X6_Y&?3_P#KJ/Y4T2]SV:BBBD4%9NM:+:ZY8FWN!AAS'*!\R'U'
M]16E10!XAJNE76CWS6MTF&'*L/NN/451KVO6M%M=<L3;W`PPYCE`^9#ZC^HK
MR+5=*NM'OFM;I,,.58?=<>HIDM%&M+1=:NM#OA<6YRIXDC)^5QZ'^AK-HIB/
M;]*U6UUFQ6ZM7RIX93]Y#Z&KU>*:+K5UH=\+BW.5/$D9/RN/0_T->NZ5JMKK
M-BMU:OE3PRG[R'T-24F>5>+HS%XJOU8@DN&X]"H/]:]"\$.K^$[15.2AD5O8
M[R?Y$5P7C7_D;K[_`+9_^BUKM_`/_(L)_P!=7_G3!;G3T444AA1110`5P7Q&
MU+"6NFHW4^=(!^2C^?Y"N])`!).`.I->*:_J)U77+J[SE&?$?^X.!^@S^--"
M97TV6V@U*VFO%=[>.0,ZH`2P'.,&O2D\?Z(R@DW"D_PF+D?D:\\M=!U6^MUN
M+:QFEA;.UU'!QQ4W_"+:Y_T#)_R%`CO_`/A/M#_YZ3_]^C7->,==TG7+2W:U
M>3[3"YQNC(!4]?Y"L7_A%M<_Z!D_Y"C_`(1;7/\`H&3_`)"@-3(HJ2>"6VG>
M">-HY4.UE88(-1TQ'2^!]2-AXACB8XBNAY39/?JI^N>/QKUBO`T=HW5U.&4Y
M!]#7MNC:BNK:1;7J]9$^8>C#@C\P:3*1?HHHI#"BBB@#FO&^E?VCH331INGM
M3YBXZ[?XA^7/X5Y/7OC*'4JP!4C!!'!%>+>(-+.D:U<6@!$8;=$3W0\C_#\*
M:$S,K;\*:K_9.O02N<0R_NI?8'O^!P:Q**9)[[7!_$?4=L5KIJ$Y8^<_/;D*
M/SS^0K?\)ZL-4\/PR2-F6']U*6]0.OXC!_.O,O$&I?VMKES=@_NRVV/_`'1P
M/\?QI(IF[\/M-^TZO)?.I,=LGRGMO;C\>,_I7IM87A#3?[-\.VZLN)9AYTGX
M]!^6*W:0(****!A1110!C^*=2_LOP_<S*P65QY47^\W''T&3^%>-5VWQ$U+S
M;^#3D8%8%\R0#^\>@/X<_P#`JY2QTR]U)G6SMGF*`%M@Z4T2SN]%\9Z)I^E6
M]EMN8_)C"DF(89NI(P3WR?QK0_X3[0_^>D__`'Z-<!_PBVN?]`R?\A1_PBVN
M?]`R?\A0%V=EJ_B_0=3TFZLR\V98R%S%T;J#^>*\VK7_`.$6US_H&3_D*IWV
MF7NFLBWEL\)<$KO'6@"I4UI=265Y#=0G$D3AU_`U#13$>[VES'>6<-S$<QRH
M'7Z$9J:N.^'NJ?:=*DL';]Y;-E/]QN?YY_,5V-26%%%%`!1110`4444`%%%9
M/B'7(M"TUKAL-,WRPQG^)O\``=__`*]`'-_$/4;,VT6G[%DNPPD#`_ZH?_7]
M/Q]*\\JTQN]6U'/SSW5P_P"+$_Y_"NPUKP,+30(I[0F2\@7,X!SY@[X^G\O>
MF3N<+1113$>K^#?$/]L6'V>X;-Y;@!B?XUZ!OKZ__7KIJ\,TW4)]+U"&\MSB
M2)LX/1AW!]B*]ITW4(-4T^&\MSF.5<X/53W!]P:3*3+5%%%(84444`%%%%`!
M1110`4444`%%%%`!1110!D>*?^17U#_KD?YUXS7LGBQU3PMJ!8X'EX_$D`5X
MW31+"BBBF(]+^'$H.C746.5N-V?JH']*[*O,?A]J26NL2V<AP+M`%/\`M+D@
M?D37IU2RD%%%%`PHHHH`*CN)X[6VDN)FVQQJ78^@%2$@`DG`'4FO-O&?BI+_
M`/XEVGR[K8<RR+T<^@]J`.7U6_?5-5N;U^LKY`]!T`_``53HHJB`KI?!>BG5
M-96>1<VUJ1(^?XF_A'YC/T%8NF:=<:K?Q6ELFYW/)[*.['V%>R:1I<&C:;%9
MP<A>68]78]328TB]1112*"BBB@`HHHH`****`/"K[_D(7/\`UU;^9JO5B^_Y
M"%S_`-=6_F:KU1`5[XB+&BHHPJC`'H*\#KWVDRD%%%%(84444`%%%%`!1110
M!R'Q&_Y%ZW_Z^E_]`>N(\+D#Q/I^3C]\*[?XC?\`(O6__7TO_H#UP.A?\C#I
MO_7U%_Z&*:)>Y[;1112*"BBB@`K-UK1;77+$V]P,,.8Y0/F0^H_J*TJ*`/$-
M5TJZT>^:UNDPPY5A]UQZBJ->UZUHMKKEB;>X&&',<H'S(?4?U%>1:KI5UH]\
MUK=)AARK#[KCU%,EHHUI:+K5UH=\+BW.5/$D9/RN/0_T-9M%,1K^)KZWU/6Y
M+ZV9BDZ(Q5A@J0H!'Z5WGP_D5_#6T=4G=3]>#_45Y97IWPY_Y%ZX_P"OIO\`
MT!*3&CKZ***104444`8/C'4O[-\.SE6*S3_N8\>_7],_I7DD$,ES<101#=)*
MX11ZDG`KK/B#J7VG5X[%&)CMD^8=M[<_CQC]:A\`Z=]LU[[2P/EVB;^G!8\`
M?S/X4R7N>EV-I'86$%I%]R%`@/KCO5BBBD4%%%%`'FWQ#TSR-2AU%!\EPNQ_
M]]>GYC'_`'R:XNO9O$^F?VMH%S;JFZ91YD7'.X=A]1D?C7C--$L*[WX<ZGA[
MG3';@_OHOKT8?R_(UP57]&U`Z7K%K>`G;&XW@=U/!'Y9I@CVZBD5@ZAE(*D9
M!!X(I:DH****`"N,^(6E?:-.BU*,?O+<[']T)_H?YFNSJ*YMX[NUEMY1F.5"
MC#V(Q0!X/15G4+*33=0GLY>7A<J2._H?Q'-5JH@T],UJXTRRU"VB^[>1;"?[
MISU_(L/Q'I2^'=,_M;7;:U(S'NWR_P"X.3^?3\:RZ]$^'.F^7:W.I.OS2'RH
MR?[HY/ZX_*D-'<T444B@HHHH`*9-,EO!)-(VV.-2['T`&33ZY;QYJ7V+0?LR
M-B2[;9[[1RW]!^-`'FFHWCZAJ-Q>2?>FD+X]!V'X#BO3/`FF_8M`%PZ@2W;>
M83WVCA1_,_C7F>GVCW^HV]HG#32!,^F3UKW&&%+>".&-=L<:A%'H`,"FQ(?1
M112&%<SXYTS[?X?>95S+:GS1C^[_`!?IS^%=-2.BR(R,,JPP1ZB@#P.BKVLZ
M>VE:O<V;=(W.T^JGD'\L51JB#9\+:G_97B"WF9L1.?*D_P!UO\#@_A7LE>!5
M[/X9U+^U=`M;AF+2A?+E)Z[AP3^/7\:3*1K4444AA1110`444$@`DG`'4F@"
M"\O(+"TENKF01PQC+,:\<UW6I]<U)[J7Y4'RQ1YR$7_'UK5\8^)?[8NA:VK'
M[%">#_ST;^]]/2CP?X:.L7?VJY3_`$&%N0?^6C?W?IZTR7J=#X%\._8[<:I=
M)B>4?N5/5$/?ZG^7UKM*````!@#H!12*/+?&GAS^RKO[;;)BSG;D#_EF_I]#
MR?TKE*]WN[2&^M);6X3?#*NUEKQG6](GT34I+2;E>L;XX=>QIHEHSJZ?P9K_
M`/9.H_9IWQ:7!`;/\#=F_H?_`*U<Q13`]]HKD/`VO_;[+^SKA\W-NOR$_P`<
M?^(Z?3'O77U)04444`%%%%`!1110`4444`%%%%`!4<]Q!:Q&2XFCBC'\4C!1
M^9KS'Q1XCU=-;O+2*^EB@BDVHL7R$#CN.?UKEY9I9WWS2O(W]YV)/ZT["N=M
MXS\56M_:?V;I\AD0L&EE&0IQ_"/7G!KAJ**8@HHHH$*CM&ZNC%64Y#`X(/K7
MH.@^/XV1;?6!M<8`N$&0?]X=C[C\A7GM%`SW6UOK2^0/:W,4RXS^[<''U]*L
M5X%5C[=>?\_4_P#W\-*P[GNC,$4LQ`4#))/`%8NI^+-(TL$/=+-+CB*#YS^)
MZ#\37D$LTLQ!EE>0CH68G%,HL%SH]=\8W^LJT$?^BVIX,:'EQ_M'O].E<Y14
MUK:7-[,(;6"2:0_PHI)IB(:T-(T6]UJZ$%I'D#[\AX5!ZD_TZUU&C?#Z>4K-
MJTGE1]?)C.6/U/0?K^%=]:6=M86ZV]K"D42]%44KA8HZ%H%IH-H8H/GE?F29
MA\S_`.`]JU:**104444`%%%%`!1110`45Q=U\1[&/(M;*>8CNY"`_P`_Y5BW
M7Q$U27(MX+>`'O@LP_/C]*+"N<Q??\A"Y_ZZM_,U7ITCM+(TCG+,2Q/J33:H
MD*]]KP*NRLOB'>6T$44UE!*(U"Y5BI(`Q[\TF-'I=%<1;?$BTD=1<V$L()P6
M1P^!Z]!7;TB@HHHH`****`"BL;Q!XBM_#\4#31/*TS$*JD#@=3^HK!_X639_
M]`^?_OL4!<F^(\BC0[6/^)KD,/H%;/\`,5YW8R>5J%M)OV;)5;=G&,$<YK9\
M3^*&\0&&-+?R((22`6W%B>Y]/I7/4R6>^T5YO9_$:[AA2.YL8YRJ[2RR%2Q]
M3D&M!/B3:D+YFG3*>X60''\J5AW.XHJ&TN4O+."ZC#!)HUD4-U`(R,_G4U`P
MHHHH`*S=:T6UURQ-O<###F.4#YD/J/ZBM*B@#Q#5=*NM'OFM;I,,.58?=<>H
MJC7M>M:+:ZY8FWN!AAS'*!\R'U']17D6JZ5=:/?-:W288<JP^ZX]13):*->G
M?#G_`)%ZX_Z^F_\`0$KS&O3OAS_R+UQ_U]-_Z`E#!'7T45#=W*6=G/=2!BD,
M;2,%ZD`9./RI%$U5[Z\BT^QFNYCB.)"Q]_:N&NOB3(<BTTY5]&EDS^@`_G7-
M:QXEU+7%$=U(BPJ=PBC7"Y]?4_B:=A7,Z[N9+R\FN93F25R[?4G->G>`;-;?
MPXMP`-]S(S$]\`[0/T/YUY76UH_BG4]$C\FVD1X,D^5*NY0?;H1^=`D>QT5Y
M]!\2I!@7&FHW(R8Y2,#OP0?YUZ#2*"BBLC7]?@\/VT4LT,DOFMM4)@?GF@#7
MKQSQ7IG]E>(;B)1B*0^='_NMV_`Y'X5M7?Q'OI!BTLX(,]W8R'^@_2N5U#4;
MK5+IKF\E,DI&,D8P/0`4T2V5:***8CU7P+JPO]$%J[?OK3"')ZI_"?Z?A745
MX;IVIWFDW/VBRF,4F,'@$$>A!X-=1;?$?44(^TV=M*H'.S*$_CDC]*5BDSTJ
MBJNFWRZEIT%XB%%F7<%)Y%6J0PHHHH`\Z^(NF^7=V^I(IVRCRI#VW#I^8S_W
MS7#U[1XCTT:KH-U;`9DV[X\#)WCD?GT_&O%Z:)8^&%[B>.&-=TDC!%`[DG`K
MW#3K&+3-.@LH?N0H%SZGN?Q.3^->9>!=/^V^(TE89CME,ISZ]!^IS^%>KT,:
M"BBBD,***X_6O'D>F7T]G#8O+)$=I9W"C/X`Y_2@#L*\E\:ZHNI>('6)@T-L
MOE*0>">I/YG'X5)J'CK5[Z)XHS%;1L,'RE.['U/],5S%-$MG8?#NT2;6YKEL
M$P1?*/=N,_EG\Z]-KP[3=4O-(NOM%E+Y;XP>`0P]"#756_Q(O4"BXL8)<==C
M%,_GFAC3/1Z*S="U==;TQ+U83%EBI0MG!'O6E2&%%5[Z\BT^QFNYMWEPH68*
M,D^PKAKKXDR'(M-.5?1I9,_H`/YT!<7XCZ:`;74D`!8^3)[GDK_[-^E<%6KK
M'B/4M;"K=RKY2MN6)%PH/\S^)K*IDL*[+X?:L+74I-.E;$=R,QY/1QV_$?R%
M<;2H[1NKHQ5E.0P."#ZTP/?**\MM/B!K$"JLRV]P!U+H0Q_$$#]*[7PUXD7Q
M%#.?LY@D@*[EW;@<YP0<#T-2.YNT45Q4WQ(L%SY%C<OQQO*KS^&:!G:UY[XU
M\5>89=(L6^0?+/*#][_9'MZ_E]<_5?'NHW\+0VT:6<;`@E#N?'^]V_`5RE.P
MFR>RM)+^]AM(?]9*X09[9[U[=864.G6,-I`N(XEVCW]3]2>:\+1VC=71BK*<
MA@<$'UKK-.^(&J6H5+N..[0#&6^1_P`QQ^E#$CU"BL30O%%EKSO%`DD<R+N9
M)`.G3((//6MND4%8'BS0EUK26,:9NX`7B(')]5_'^>*IZGX]L+"YGMH[:>:>
M%V1NBKD9!YZ]1Z5@7?Q&U"566UM((,]&8ER/Y#]*8KG&44K,68L3DDY-)3))
M[.[FL+R*ZMVVRQ-N4U[)H>LV^N:<ES"<..)8^Z-W'T]#7BE7M+U>]T>X,]E,
M48C#*>58>XI#3/;Z*\_L_B2V`+[3P3W>!\?^.G_&NXL;R+4+&&[AW>7,@90P
MP1[&D5<L4444`%%%%`!1110`4444`<S?^!M,U&_FO)I[M9)6W,$=0`?;*U77
MX=:.&!,]ZP!Z&1<'_P`=KKJ*`L<TG@/0D<,T$K@?PM*<'\L5-_PA7A[_`*!_
M_D:3_P"*K?HH"Q@?\(5X>_Z!_P#Y&D_^*H_X0KP]_P!`_P#\C2?_`!5;]%`&
M!_PA7A[_`*!__D:3_P"*I#X)\/$$?8,>XFD_^*KH**`.8_X0'0_^><__`']-
M0O\`#O1G<LLUX@/\*R+@?FIKK:*`L<A_PKG2/^?F^_[[3_XFGQ_#S1D;+27<
M@QT:08_117644!8P[;P?H5L05L$D8=Y6+Y_`G'Z5L0P0VT8C@B2)!T5%"C\A
M4E%`!1110`4444`%%%%`!1110`4C*'4JP!4C!!'!%+10!R'_``KG2/\`GYOO
M^^T_^)J6/X?:*BX8W4ASU:09_0"NJHH"QS'_``@.A_\`/.?_`+^FIQX)\/``
M?8,^YFD_^*KH**`L<T_@/0G<LL$J`_PK*<#\\U3D^'&EE?W=W>*WJQ5A^6T5
MV-%`6.,A^'=I#/'*+^8E&#`;!S@UV=%%`!1110`4444`87B7PVOB**W7[3Y#
M0LQ#>7OR#CCJ/05A1_#6`+^]U*1FSU6(*,?F:[JB@+''I\.=*"`/=7I;N0R@
M?EMI?^%<Z1_S\WW_`'VG_P`377T4"L<2_P`-[(EO+O[A1V#*IQ_*J_\`PK/_
M`*B__DM_]G7?447"Q7L;;[%I]M:;]_D1+'NQC=M`&<?A5BBB@84444`%%%%`
M!65K^A6^O6'D2G9*F6BD'\!_J/:M6B@#R-_!'B!7918A@#@,)DP??DYKN?!>
MEWFDZ/-!?0^5*UPSA=P;C:HSP3Z&NCHHN*P5#=VR7EG/:R%@DT;1L5Z@$8./
MSJ:B@9R'_"N=(_Y^;[_OM/\`XFKL'@?086W&U>4Y!'F2M@?@"/UKHJ*`L83^
M#?#\CEFTY03_`'9'4?D#4,O@;0)``MH\>.Z3-S^9-='10%CF/^$!T/\`YYS_
M`/?TUT]%%`!65K>@6NO0Q174DR+$Q9?*(!S^(-:M%`'+CP#H8`&R<^_FU+%X
M%T"/.ZUDDS_?F;C\B*Z.B@+&!_PA7A[_`*!__D:3_P"*I&\$^'RI`L"I(ZB9
M\C_QZN@HH`Y9_A_HCH547*$_Q+)R/S!J'_A7.D?\_-]_WVG_`,377T4!8J:9
MI\.E:?#96Y<Q1`X+G).22<_B:MT44`%%%%`!7`ZA\/9KG4;B>"\BCBED+JC*
M25R<XKOJ*`,'POX=_P"$?M9U>999IG!9E&``!P/U/YUO444`%%%%`!7,7_@;
M3-1OIKR:XO!),Q9@KJ`/I\M=/10!R\/@#0XL;UN)L'^.7&?^^0*N-X.T!D5#
MIR87IB1P?Q.<FMRB@+'/MX)\/E2!8%21U$SY'_CU0?\`"`Z'_P`\Y_\`OZ:Z
M>B@+%/3-,MM)LEM+166($M\S9.35RBB@"M?V4>HV$UG,SK'*NUBA`('MFN>C
M^'^B(N&^TR'^\TG/Z`5U5%`',IX#T)6!,,S`?PF4X/Y5/_PA7A[_`*!__D:3
M_P"*K?HH"Q@?\(5X>_Z!_P#Y&D_^*J!_`>A,Q(AF4'^$2G`_.NFHH"QR)^'6
MCDD_:+T>V]/_`(FM?0_#EGX?\_[))._G[=WFL#C;G&,`>IK7HH`*XC_A6UG_
M`-!"?_O@5V]%`'')\.-+"`275XS=RK*!^6TU/'\/M%1<,;J0YZM(,_H!7544
M"L<L_P`/]$="JBY0G^)9.1^8-5I/AQIA7]U=W:MGJQ5AC\A7944#L<[H'A*W
MT&]DNHKF65GC,>&```)!_I71444`<M=^`M+O+R>ZDN+P/-(TC!77`).3CY?>
MH?\`A7.D?\_-]_WVG_Q-=?10%CEQX!T,`#9.??S:L#P3X>``^P9]S-)_\570
M44!8YB3P#H;[ML<Z9SC;*?E^F<_K55_AQI90B.ZO%;L692/RVBNQHH"QQ'_"
MMK/_`*"$_P#WP*["RM5L;"WM$.Y88UC!(QG`QFIZ*`"BBB@`HHHH`****`"B
MBLCQ1KG_``C?AVZU;[/]H^S[/W6_9NW.J]<''WL]*<8N345NQ2DHIR>R->BO
M(O\`A>'_`%+O_D[_`/:Z/^%X?]2[_P"3O_VNNOZAB/Y?Q7^9R_7L/_-^#_R/
M7:*\B_X7A_U+O_D[_P#:Z/\`A>'_`%+O_D[_`/:Z/J&(_E_%?YA]>P_\WX/_
M`"/7:*\B_P"%X?\`4N_^3O\`]KH_X7A_U+O_`).__:Z/J&(_E_%?YA]>P_\`
M-^#_`,CUVBO(O^%X?]2[_P"3O_VNC_A>'_4N_P#D[_\`:Z/J&(_E_%?YA]>P
M_P#-^#_R/7:*\B_X7A_U+O\`Y.__`&NC_A>'_4N_^3O_`-KH^H8C^7\5_F'U
M[#_S?@_\CUVBO(O^%X?]2[_Y._\`VNC_`(7A_P!2[_Y._P#VNCZAB/Y?Q7^8
M?7L/_-^#_P`CUVBO(O\`A>'_`%+O_D[_`/:Z/^%X?]2[_P"3O_VNCZAB/Y?Q
M7^8?7L/_`#?@_P#(]=HKR+_A>'_4N_\`D[_]KH_X7A_U+O\`Y.__`&NCZAB/
MY?Q7^8?7L/\`S?@_\CUVBO(O^%X?]2[_`.3O_P!KH_X7A_U+O_D[_P#:Z/J&
M(_E_%?YA]>P_\WX/_(]=HKR+_A>'_4N_^3O_`-KH_P"%X?\`4N_^3O\`]KH^
MH8C^7\5_F'U[#_S?@_\`(]=HKR+_`(7A_P!2[_Y._P#VNC_A>'_4N_\`D[_]
MKH^H8C^7\5_F'U[#_P`WX/\`R/7:*\B_X7A_U+O_`).__:Z/^%X?]2[_`.3O
M_P!KH^H8C^7\5_F'U[#_`,WX/_(]=HKR+_A>'_4N_P#D[_\`:Z/^%X?]2[_Y
M._\`VNCZAB/Y?Q7^8?7L/_-^#_R/7:*\B_X7A_U+O_D[_P#:Z/\`A>'_`%+O
M_D[_`/:Z/J&(_E_%?YA]>P_\WX/_`"/7:*\B_P"%X?\`4N_^3O\`]KH_X7A_
MU+O_`).__:Z/J&(_E_%?YA]>P_\`-^#_`,CUVBO(O^%X?]2[_P"3O_VNC_A>
M'_4N_P#D[_\`:Z/J&(_E_%?YA]>P_P#-^#_R/7:*\B_X7A_U+O\`Y.__`&NC
M_A>'_4N_^3O_`-KH^H8C^7\5_F'U[#_S?@_\CUVBO(O^%X?]2[_Y._\`VNC_
M`(7A_P!2[_Y._P#VNCZAB/Y?Q7^8?7L/_-^#_P`CUVBO(O\`A>'_`%+O_D[_
M`/:Z/^%X?]2[_P"3O_VNCZAB/Y?Q7^8?7L/_`#?@_P#(]=HKR+_A>'_4N_\`
MD[_]KH_X7A_U+O\`Y.__`&NCZAB/Y?Q7^8?7L/\`S?@_\CUVBO(O^%X?]2[_
M`.3O_P!KH_X7A_U+O_D[_P#:Z/J&(_E_%?YA]>P_\WX/_(]=HKR+_A>'_4N_
M^3O_`-KH_P"%X?\`4N_^3O\`]KH^H8C^7\5_F'U[#_S?@_\`(]=HKR+_`(7A
M_P!2[_Y._P#VNC_A>'_4N_\`D[_]KH^H8C^7\5_F'U[#_P`WX/\`R/7:*\B_
MX7A_U+O_`).__:Z/^%X?]2[_`.3O_P!KH^H8C^7\5_F'U[#_`,WX/_(]=HKR
M+_A>'_4N_P#D[_\`:Z/^%X?]2[_Y._\`VNCZAB/Y?Q7^8?7L/_-^#_R/7:*\
MB_X7A_U+O_D[_P#:Z/\`A>'_`%+O_D[_`/:Z/J&(_E_%?YA]>P_\WX/_`"/7
M:*\B_P"%X?\`4N_^3O\`]KH_X7A_U+O_`).__:Z/J&(_E_%?YA]>P_\`-^#_
M`,CUVBO(O^%X?]2[_P"3O_VNC_A>'_4N_P#D[_\`:Z/J&(_E_%?YA]>P_P#-
M^#_R/7:*\B_X7A_U+O\`Y.__`&NC_A>'_4N_^3O_`-KH^H8C^7\5_F'U[#_S
M?@_\CUVBO(O^%X?]2[_Y._\`VNC_`(7A_P!2[_Y._P#VNCZAB/Y?Q7^8?7L/
M_-^#_P`CUVBO(O\`A>'_`%+O_D[_`/:Z/^%X?]2[_P"3O_VNCZAB/Y?Q7^8?
M7L/_`#?@_P#(]=HKR+_A>'_4N_\`D[_]KH_X7A_U+O\`Y.__`&NCZAB/Y?Q7
M^8?7L/\`S?@_\CUVBO(O^%X?]2[_`.3O_P!KH_X7A_U+O_D[_P#:Z/J&(_E_
M%?YA]>P_\WX/_(]=HKR+_A>'_4N_^3O_`-KH_P"%X?\`4N_^3O\`]KH^H8C^
M7\5_F'U[#_S?@_\`(]=HKR+_`(7A_P!2[_Y._P#VNC_A>'_4N_\`D[_]KH^H
M8C^7\5_F'U[#_P`WX/\`R/7:*\B_X7A_U+O_`).__:Z/^%X?]2[_`.3O_P!K
MH^H8C^7\5_F'U[#_`,WX/_(]=HKR+_A>'_4N_P#D[_\`:Z/^%X?]2[_Y._\`
MVNCZAB/Y?Q7^8?7L/_-^#_R/7:*\B_X7A_U+O_D[_P#:Z/\`A>'_`%+O_D[_
M`/:Z/J&(_E_%?YA]>P_\WX/_`"/7:*\B_P"%X?\`4N_^3O\`]KH_X7A_U+O_
M`).__:Z/J&(_E_%?YA]>P_\`-^#_`,CUVBO(O^%X?]2[_P"3O_VNC_A>'_4N
M_P#D[_\`:Z/J&(_E_%?YA]>P_P#-^#_R/7:*\B_X7A_U+O\`Y.__`&NC_A>'
M_4N_^3O_`-KH^H8C^7\5_F'U[#_S?@_\CUVBO(O^%X?]2[_Y._\`VNC_`(7A
M_P!2[_Y._P#VNCZAB/Y?Q7^8?7L/_-^#_P`CUVBO(O\`A>'_`%+O_D[_`/:Z
M/^%X?]2[_P"3O_VNCZAB/Y?Q7^8?7L/_`#?@_P#(]=HKR+_A>'_4N_\`D[_]
MKH_X7A_U+O\`Y.__`&NCZAB/Y?Q7^8?7L/\`S?@_\CUVBO(O^%X?]2[_`.3O
M_P!KH_X7A_U+O_D[_P#:Z/J&(_E_%?YA]>P_\WX/_(]=HKR+_A>'_4N_^3O_
M`-KH_P"%X?\`4N_^3O\`]KH^H8C^7\5_F'U[#_S?@_\`(]=HKR+_`(7A_P!2
M[_Y._P#VNC_A>'_4N_\`D[_]KH^H8C^7\5_F'U[#_P`WX/\`R/7:*\B_X7A_
MU+O_`).__:Z/^%X?]2[_`.3O_P!KH^H8C^7\5_F'U[#_`,WX/_(]=HKR+_A>
M'_4N_P#D[_\`:Z/^%X?]2[_Y._\`VNCZAB/Y?Q7^8?7L/_-^#_R/7:*\B_X7
MA_U+O_D[_P#:Z/\`A>'_`%+O_D[_`/:Z/J&(_E_%?YA]>P_\WX/_`"/7:*\B
M_P"%X?\`4N_^3O\`]KH_X7A_U+O_`).__:Z/J&(_E_%?YA]>P_\`-^#_`,CU
MVBO(O^%X?]2[_P"3O_VNC_A>'_4N_P#D[_\`:Z/J&(_E_%?YA]>P_P#-^#_R
M/7:*\B_X7A_U+O\`Y.__`&NC_A>'_4N_^3O_`-KH^H8C^7\5_F'U[#_S?@_\
MCUVBO(O^%X?]2[_Y._\`VNC_`(7A_P!2[_Y._P#VNCZAB/Y?Q7^8?7L/_-^#
M_P`CUVBO(O\`A>'_`%+O_D[_`/:Z],T#5?[<T*SU/R?(^TQ[_+W;MOMG`S^5
M95<-5I*\U8UI8BG5=H.YHT445@;!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110
M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`>?
M?$3QUJGA*_LH+""SD2>(NQG1B00<<885QG_"Z/$?_/EI7_?J3_XNK?QL_P"0
MSI?_`%[M_P"A54^%?A?1O$G]K?VM9_:/L_D^5^]=-N[?G[I&?NCK7LTJ=".&
M56<;_P##GCU:E:6)=*$K?\,7;'XV7ZNHU#2;:5,_,;=V0X]@=W^?2O4/#WB7
M3/$]A]KTV8N%P)(W&'C)'1A_49'H:\U^('PTL=,TB35]"CDB6#!GMBY==G=E
M)R<COD]/3'/%>!_$4OAOQ/;7`<"VE80W(8X7RR>3]1U_"IEAJ->DYT59HJ.(
MK4*BA6=T?2U%%%>0>L>3^+OB-XG\+^([C3FLM,:$'S+=VBD)>,_=)^<<]0>.
MH-=#\/?'3^+8KJ"^2WAOX#O"0@@/&>,@$D\'@_45%\4_#*ZUX<:_@CS>Z>#(
M".K1_P`:_P!?P/K7B_AK7)?#OB"TU.+)$3_O$'\:'AE_+./?!KUZ5"EB,/[J
MM)?G_P`$\JI6J4,1[SO%_P!?@?0_B_Q$GA?PY<:B0C3#$=O&_1Y#T!]AR3[`
MUP_@[XA>)_%7B&&P%IIB6Z_O+B18I,K&#SCY^IS@?6N6^*'BN+Q#K4-K8SB7
M3[1/E=3Q([`%F_`8'X'UKT?X8>&/[!\-K=3KB]OPLK@CE$_@7\CD^YQVK)T8
M4<-S37O/8T56=;$<L'[J.WHHHKS3T3Q*]^,/B&VO[B!+/3"L4K("8I,X!(_O
MUWO@#QH?%VFS&Z6&+4('Q)'%D`H>C`$D^H//;WKP#5?^0Q??]?$G_H1K1\)>
M(9?#/B*VU!"?*SY<Z#^.,D;A^@(]P*]ZM@J<J7N*S/"I8RI&K[[NCW+X@^)[
MWPIH,%_816\DLETL)$ZL5VE7/8CGY14'P[\6W_BVPO9[^&VC:"5440*P!!&>
M<L:R?C#/%<^!]/G@D62*6]C='4Y#*8Y""/;%5_@G_P`@?5?^OA/_`$&N!4H?
M5'.VMSN=67UM0OI8]1HHHK@.\1W6-&=V"HHRS$X`'K7A\_QHUW[1)Y%CIPAW
M'RQ)&Y;;GC.'QG%>B_$G5_['\$7K(Q66ZQ:QD>K_`'O_`!T-7SO':3S6L]S'
M&3#!M$CY'R[C@?G@UZN7X>$XN=17/+Q^(G"2A!GT#\._&5SXNL+U[Z*WCN;:
M51M@4A=C#C@D\Y#5V=?/WPGU4Z?XUBMF($5[&T+9[$#<I^N5Q^-?0-<N-HJE
M5:CLSIP=5U:5WN@KF_'.MZCX=\-2:IIL5O(\,B"43J2-C';Q@@YW%?UKI*HZ
MSIR:OHM[I[XQ<PM'DG&"1P?P.#7/3:4TY;'143<&H[GEGA[XN:MJ'B&PLM0M
M-/2UN)EB=HD=6!;@')8CJ1VZ5[#7R21+;7!!W1RQ-C@X*L#_`#S7U/HNHKJ^
MAV.HJ`/M,"2$#H"1R/P.17?F&'A3Y905DSAP%>53FC-W9P?C[XD7_AG7TTW3
M8+.4+"KS-.KL58DX'##M@]^M=7X+UC4=?\,P:GJ4,,4L[,46%64;`<`X))YP
M3],5\_Z_>R>(_%]Y<1?.UW=;(1DG*YVH/RQ7TMIEC'IFEVEA$<I;0I$IQC(4
M`9_2EBZ4*5&$;>\QX6K.K5E*_NHM4445YQZ!P_Q$\;W7A&.P2PBMY;FY+EA.
M"P5%QV#`Y)/'T-<59?&76WO[9+NTTU;9I5$S)&X8)D;L$N><9K#^)VK_`-K>
M-[M58F*SQ:H/0K][_P`>+?I7*7=I/8W3VUS&8YH^&0D''&>U>]A\'2]DN=:L
M\/$8NI[5\CT1]:45S?@+53K'@K3;ER#*D?DR?5#MR?<@`_C725X<XN$G%]#V
MH24XJ2ZA7GWQ`\8^(?"-[;O:6EC+I]PN%DEC<LKCJI(8#IR/Q]*]!K(\3Z#!
MXDT"YTV;`9US$Y_@D'W6_/K[9K2A*$:B<U=$5HRE!J#LSAO!'Q0O-?\`$"Z9
MJT%G")D/D/`K+EQS@[F/49_'`[UU_C3Q.GA7P_+>@1O=,0EO$_1W/J!S@#D_
M_7KYQD2\T;5F0[H+RSFZCJCJ>H_$5L^,/%]UXNO+6:=!%';PA%C'3>0-[?B?
MT`KU9X",JL91^'K_`%YGE0QTHTI1E\73^O(]`\'_`!#\3^*?$,%@++35MQ^\
MN)%B?*1CKC+]3P!UY/I7JU<=\./"O_"-^'5>XCVZA>8EFW+AD&/E3\/YDUV-
M>9BI4W4:IJR1Z6&C-4TZCNV%%%%<YT!1110!D^)M4GT7PU?ZE;+&TUO%O19`
M2I.>^"#^M>0_\+H\1_\`/EI7_?J3_P"+KVG4].M]7TVXT^Z#&"==CA3@X^M<
M!KWPO\-:?X>U.]@BN1-;VDLL9,Q(W*A(X^HKNPDZ"7+55VV<6*A7;YJ;LK'*
M_P#"Z/$?_/EI7_?J3_XNC_A='B/_`)\M*_[]2?\`Q=<#80I<:C;0R9V22JC8
M]"0*]X_X5'X5_P">5U_W_-=]>.%H64X[G#0EBJU^66QW5%%%>$>V>7^.?B/K
M'AGQ*^FV5M8R0K$CAID<MDCV8#]*YO\`X71XC_Y\M*_[]2?_`!=4_BY_R/<O
M_7O'_*MWX8^#=`\0^&[B[U6P^T3I>-$K>=(F%"(<85@.I->TJ>'IX>-2<;['
MC.=>I7E3A*VYG?\`"Z/$?_/EI7_?J3_XNO0?AWXMO_%MA>SW\-M&T$JHH@5@
M"",\Y8U+_P`*P\'?]`?_`,F9O_BZVM$\.:3X<AEATJU^SI*P9QYC/DCC^(FN
M2O6PTH-4XV?]>9UT*6(C-.I*Z_KR-2BBL'QGK3:!X2O]0C8"=4V0^N]B%!'K
MC.?PKBA%RDHKJ=DI*,7)]#G_`!A\3['P[<R:?8PB]OTX?YL1Q'T)')(]!^>:
MX"7XO^*))"RFRB!_@2#@?F2?UKB((9[^^CACW2W%Q($7/)9F.!^))KZ!L?AA
MX9M](2SN;`7,VT>9<,[!V;N001@>P_7G/L3IX;"Q2FKMGDPJ8C%2;@[)'.^&
MOC"EY>1VNNVL-L)#M%U"2$4]MRG)`]\UZH"&4,I!!Y!'>OESQ-HQ\/\`B2^T
MO<66"3",V,E"`RDX[X(KW/X8ZN^K>"+7S6+RVC-;,Q[[<%?_`!UE%88W#0C!
M5:>S-L'B9RFZ53='8UD^)M4GT7PU?ZE;+&TUO%O19`2I.>^"#^M:U<YX]_Y$
M36/^O<_S%<%))SBGW1WU6U!M=CSS1/BWKVI:]IUA-:::L5S=10N4CD#!68`X
MR_7FO9J^7/"G_(XZ)_V$(/\`T8M?4==F84H4Y14%8X\!5G4BW-W/&=;^+>O:
M;KVHV$-IIK16UU+"A>.0L55B!G#]>*]0\,ZI/K7AJPU*Y6-9KB+>ZQ@A0<]L
MDG]:^<O%?_(XZW_V$)__`$8U?0'@+_D1-'_Z]Q_,UIC:-.%&,HJS_P"`9X.M
M.=649.Z_X)T=9/B;5)]%\-7^I6RQM-;Q;T60$J3GO@@_K6M7.>/?^1$UC_KW
M/\Q7GTDG.*?='H56U!M=CR[_`(71XC_Y\M*_[]2?_%U[#X?UJ#Q!H=KJ5N1B
M9`74'.Q_XE/T-?+%>C?"3Q/_`&9K3:-<RA;2^.8]QX6;@#_OH#'UVUZ^,P</
M9\U-6:/(PF,G[3EJ.Z9U?Q!^(.K>%->@L+"WLI(I+59B9T<MN+..S#CY179^
M&=4GUKPU8:E<K&LUQ%O=8P0H.>V23^M>0_&C_D<;3_L'I_Z,DKU'P%_R(FC_
M`/7N/YFN.O2A'#0FEJSLHU)RQ,XMZ(Z.BBL+QEK1T#PGJ&H(<3+'LAY&=[':
MI]\$Y^@-<48N4E%=3LE)1BY/H<YXR^)]KX=NFT_3X$O;Y.)"6Q'$?0XY)]AC
M'KVK@S\7_%!G\P?8@N<^6(#M^G7./QKC=/L[C6-6M[.(E[BZF"!FR>6/4_S)
MKWQ/A=X572Q9-8LSX&;GS&\PMC[V<X'TQCVKV)PPV%2C-7;/)A/$XEN4'9(R
M?!_Q6@UN\CT_5X(K.ZDXCE1CY3MV7!Y4GMR<UZ17RKK6FRZ'KMYISD[[:8H&
MZ$@'Y6_$8/XU]$>!M:?7O!]A>3.7N`IBF8]2ZG&3[D`'\:YL;AH02J4]F=&"
MQ,YMTZFZ.BK)\3:I/HOAJ_U*V6-IK>+>BR`E2<]\$']:UJYSQ[_R(FL?]>Y_
MF*XJ23G%/NCMJMJ#:['GFB?%O7M2U[3K":TTU8KFZBA<I'(&"LP!QE^O->S5
M\N>%/^1QT3_L(0?^C%KZCKLS"E"G**@K''@*LZD6YNX4445YYWA7G_C+XGVO
MAVZ;3]/@2]ODXD);$<1]#CDGV&,>O:NC\9:T=`\)ZAJ"'$RQ[(>1G>QVJ??!
M.?H#7S=I]G<:QJUO9Q$O<74P0,V3RQZG^9->C@<+&HG4J;(\_&XF5.T(;L[(
M_%_Q09_,'V(+G/EB`[?IUSC\:[3P?\5H-;O(]/U>"*SNI.(Y48^4[=EP>5)[
M<G-:R?"[PJNEBR:Q9GP,W/F-YA;'WLYP/IC'M7@^M:;+H>NWFG.3OMIB@;H2
M`?E;\1@_C733AA<2G&$;-'/.6)PS4IRNF?55%<[X&UI]>\'V%Y,Y>X"F*9CU
M+J<9/N0`?QKHJ\><7"3B^AZT)*<5)=0KS_QE\3[7P[=-I^GP)>WR<2$MB.(^
MAQR3[#&/7M71>,]:;0/"5_J$;`3JFR'UWL0H(]<9S^%?.&E:?-K.LVEA$V);
MJ98][<XR>6/TZUWX+"QJ)U*FR.'&XF5-JG3W9V)^+_B@S^8/L07.?+$!V_3K
MG'XUVOA#XK6^MWL>GZM!'9W4G$<J-^[=O3GE2>W)]*UH_AAX572ULGL"[A<&
MY,C"0MC[V<XSWQC'M7B.K^&-0T[7[S2X+:XNC!-Y2O'"QWYP5X`ZD$''O71"
M.%Q*<8JS1SSEBL.U*3NF?3]%8WA2ZOKSPMI\VI0S0WOE;9EG0H^Y25R0>><9
M_&MFO(E'E;78]>,N9)E#6[V33=!U&_A5&EMK669`X)4LJDC..W%>0V7QA\0W
M-_;P/9Z8%EE5"1%)G!(']^O5O%?_`")VM_\`8/G_`/1;5\SZ5_R&+'_KXC_]
M"%>E@*-.I"3DKGFXZM.$XJ+L?5]%%%>6>F<9\1/%M_X2L+*>PAMI&GE9&$ZL
M0`!GC#"O/O\`A='B/_GRTK_OU)_\771_&S_D#Z5_U\/_`.@UQ7PQT'3?$/B2
MXM-5MOM$"6;2JN]DPP=!G*D'H37L8:E16&]I.-SR<14K/$>SA*QI?\+H\1_\
M^6E?]^I/_BZZ3P-\1]8\3>)4TV]MK&.%HG<M"CAL@>[$?I71?\*P\'?]`?\`
M\F9O_BZO:1X(\.Z%?B]TW3_(N`I4/YTC<'KPS$5A4KX1P:C"S_KS-J='%*:<
MIZ?UY'0445!>3FVL;BX4!C%&S@'O@9KSDKGH/0X7QI\3[;P[<OIVFPI>7Z<2
M,S?NX3Z''+'U`(QZYXK@C\7O%)E+AK,*3G8(.![=<X_&N&EEDGF>:5R\DC%G
M8]23R37O6B>&_AYJNGPPZ?#979:/!W3'S^0>6&0P/![#VKVYTJ&%@N:/-YGC
M0JU\3-\LK>1F>%_B]#J-W'9:W:QVLDK!4N(2?+R3C#`\J/?)_#K7J%>-M\%K
MF36;@+J,4&F!_P!RQ!>4KC/(X'MG/;.*];TZS_L_3+6R,SS?9XEB\R3[S[1C
M)]^*X,6J%TZ+^1W85U[-55\RS1117&=84444`%%%%`!1110!XM\;/^0SI?\`
MU[M_Z%5SX'_\Q[_MW_\`:E4_C9_R&=+_`.O=O_0J/@[JVG:9_;7]H:A:VGF>
M1L^T3+'NQYF<9(SC(_.O9:;P%E_6IXZ:6.N_ZT/6M<$3>']2$^WRC:RA]QP-
MNPYS[8KY4KV;XB_$33I=$FTC1;H7,UT-DTT6=J1]QGN3TX[$^U>:^$=#D\0^
M)K.P5<QEP\QQP(UY;_#ZD5>`@Z-*4YZ$XZ:JU8PAJ?2]F9FL;<W&?/,:F3(Q
M\V.?UJ>BBO#9[2"OF_X@^&O^$:\3S11*!9W.9[<#^%2>5_`Y'TQ7TA7BWQL_
MY#.E_P#7NW_H5=^73:K<JV9P9A!.CS/='.?#KPT/$?BB)9XP]E:_OIP1D-C[
MJGZGMZ`U]&5Y%\#_`/F/?]N__M2O7:68S<JSB]D/+X*-%274****X3N/ES_F
M</\`M_\`_:E;/Q'\+_\`"-^)':",+87F9;<*,!>?F3\"?R(K&_YG#_M__P#:
ME?07C7PVOBCPW/9+@7*?O;9CVD`X'T/(_'/:O?KU_8U(-[-:GA4:'MJ<TMUL
M>%3^)FO/A_%H%RY:6TOEEMR1_P`LBD@(S[,1_P!]>U>B_!/_`)`^J_\`7PG_
M`*#7C$D;PRO%*C)(A*LK#!4CJ".QKV?X)_\`('U7_KX3_P!!HQL%'#RMU88*
M3E7C?HCU&BBD)"J68@`<DGM7@'NGB_QIU7SM6T_2D;Y;>(S.!_>8X'Y!?_'O
MRN^!O"HO_A;K&4)GU/=Y78'R_P#5_P#CX-><>)-3?Q!XIOK]`7^T3D1``Y*C
MY4&/7`%'_"*>(_\`H`:K_P"`<G^%?0*ART(T^;E>C_7\SP/;7K2J<MUM^GY&
M?9W4MC?6]Y`0)8)%E0GLRG(_45]66-W'?V%M>1?ZN>)94^C`$?SKY3N[*[T^
M<P7MK-;3``F.:,HV#WP>:]W^$NK'4/!JVKG,EC*T/3JI^93^I'X5CF=/FIJH
MNAMEL^6;@^IWE%%%>*>R?./Q)TK^RO'-^`"([HBZ3.>=_+=?]K=76^%_%/V3
MX/ZLC2`3V1:WBR0?];]W'K@LW'/W?2K?QJTDR66G:O&G,3M;RD#/#<KGT`(;
M_OJO(4NIDM);57(AE=7=0>"5#`?^A&O?I16)P\;]+?@>#5D\/7E;K?\`$ZWX
M7:2-4\;VKNFZ*S4W+<<9'"_^/$'\*^AZ\P^"^E>1HU_JC@;KF41)TX5!S],E
MO_'17I]>;F%3GK-=M#T<!3Y**??4*HZSJ*:1HM[J#XQ;0M)@C.2!P/Q.!5ZO
M-_C)J_V3PW;Z8C#S+V7+#_IFF"?_`![;^1KGH4_:5%#N=%>I[.FY=CR?PSIS
M>(/%UA9S$N+BX#3'N5'S/^@-=9\8]*^R>*8-05<)>P#<?5T^4_\`CNRN&L='
MU34T=[#3;R[5#AF@@:0*?0X'%37'AS7+2!Y[G1M1AA09>22U=54>I)&!7T,H
MKVJES;:6/`C)^R<>7?6YZ3\%-5.[4](8C&!=1C\E;_V2O7J^9O`VK'1?&6FW
M1.(VE$,G&?E?Y2?PSG\*^F:\C,:?+6YNYZV7U.:ER]@HHKG/&_B5?"_AR:\1
MD^UO^[MD;NY[X]`.?_UUQ0@YR48[L[)S4(N3V1Y!\5[K3[KQM-]B0^;%&L=T
MX/#R#T]P,`_3';GG?"]U867B?3KG5(C)9QS!I%]/0GU`."1W`Q5OP?X?F\5^
M)X+1][0[O.NY">0@///J>GU.:B\7>'I?#'B.XTY\F+_60/\`WXST/U'(/N#7
MTD.2*^KWUL?/3YY/V]M+GTZ"&4,I!!Y!'>EKSOX3>*/[5T0Z/<R`W=@H$>3R
M\/0?]\_=^FVO1*^=K4G2FX/H>_2J*I!374****S-`HHHH`*R/%?_`")VM_\`
M8/G_`/1;5KUD>*_^1.UO_L'S_P#HMJNG\:]2*GP,^9]*_P"0Q8_]?$?_`*$*
M^KZ^4-*_Y#%C_P!?$?\`Z$*^KZ]/-=X_,\[+-I?(****\D]0^?\`XN?\CW+_
M`->\?\JY.R_M7R3]A^V^5NY\C=MW?AWZ5UGQ<_Y'N7_KWC_E72?"OQ-HNB^&
M+FVU+48;:9KUI`DA.2I1!G\P?RKZ"-1T\-&2C?1'@RIJIB91;MJSSC_BHO\`
MJ*?^1*^HZYS_`(3WPK_T'+7\S_A6II>MZ;K<4DFFWD=RD9VN8ST->9BZLZJ3
M<+6/1PM*%)M*=[E^O/\`XQ-*/!*",95KR,2<=%VM_7;7H%<WX]T=];\&:A:Q
M#,Z()HAR<LAW8`'<@$?C6&'DHU8M]S?$1<J4DNQX1X(CCD\;Z,LH&T72,,G'
M(.1^H%?3=?)VG7KZ;JEI?1J&>VF290>Y5@1_*OI*S\:^'+W3!?IJ]K'$%#.L
MLJJZ$]BI.<]?KCC->AF=.3E&26AP9;4BHRBV:;Z3ITES)<OI]JT\N/,E:%2S
MX&!DXR<#BK$%O!;(4@ACB0G)6-0HSZ\5\]^+/'FI:IXCN;C2=4O[6P!"0I%<
M/&&`&-Q`/4G)_*O6OALVJ2^#H+G5;F>XFN':2-IV+,(^`O)YQP3SZURUL+.E
M34Y/?H=-'%0J5'"*^9UU<YX]_P"1$UC_`*]S_,5T=<YX]_Y$36/^O<_S%<]'
M^)'U1T5OX<O1GS7%YGG)Y._S=PV;,[MW;&.]:G_%1?\`44_\B4>%/^1QT3_L
M(0?^C%KZCKW,7BO822Y;W/%PF%]M%OFM8^2)?,\Y_.W^;N._?G=N[YSWKZ4\
M!?\`(B:/_P!>X_F:^?\`Q7_R..M_]A"?_P!&-7T!X"_Y$31_^O<?S-8YB[T8
MO^MC;+E:M)?UN='7.>/?^1$UC_KW/\Q71USGCW_D1-8_Z]S_`#%>31_B1]4>
MI6_AR]&>+?#G3+?6?$LFG7:!H;BTE1N.G`P1[@X(]Q6!JVFW>@:W<6%P2ES:
MR8W*2,]U8>Q&"/K75_"/_D>XO^O>3^5=E\7O"YOM.CUZU0F>T&RX51RT6>&_
MX"3^1)[5[DJ_)B>1[-?B>+&ASX;G6Z?X'FWC#Q'_`,)/<Z9>N?\`28[!(;GY
M<#S%=\D?4$'CUQ7NG@+_`)$31_\`KW'\S7S17TOX"_Y$31_^O<?S-89C!0HQ
MBMKFV7S<ZLI/>QT=<+\7/^1$E_Z^(_YFNZKGO'.C2:[X/U"RA3?<;!)".Y93
MNP/<X(_&O,P\E&K%ON>G7BY4I)=CP[X=)$_C_2!,Y5?,8@C^\$8J/Q.!7TE7
MRGHNI/HVMV6HQC<;:99-O]X`\C\1D5]'1>-/#DNEKJ/]L6B0$`D/*`ZG&=I7
MKN]L5Z&9TY.<9)'!EU2*A*+9XC\3_P#DHNJ_]L?_`$4E>C_!@D^#KH$D@7[@
M>W[N.O'O$>K'7?$5_J9#!;B4L@;J$Z*#R>0`*]\^'.DOH_@FQBE4K-.#<.I[
M;N1_X[MZUIC/<PL8/?3\C/!^_B936VIU5<YX]_Y$36/^O<_S%='7.>/?^1$U
MC_KW/\Q7DT?XD?5'J5OX<O1GS_X4_P"1QT3_`+"$'_HQ:^HZ^6/#EQ%:>)])
MN9W$<,5[#)(YZ*H<$G\J^A/^$]\*_P#0<M?S/^%>GF4)2G'E5SSLNG&,9<SL
M='163I?B;1=:N6MM-U&&YF5#(4C)R%!`S^9'YUK5Y,HN+LU8]2,E)73.%^+G
M_(B2_P#7Q'_,UY1\.5B;X@:0)CA/,8CG^((Q7]<5[AXYT:37?!^H64*;[C8)
M(1W+*=V![G!'XU\Z:+J3Z-K=EJ,8W&VF63;_`'@#R/Q&17L8'W\/*"WU_%'D
M8WW,1&;VT_!GU97SG\3_`/DHNJ_]L?\`T4E>W1>-/#DNEKJ/]L6B0$`D/*`Z
MG&=I7KN]L5\[^(]6.N^(K_4R&"W$I9`W4)T4'D\@`5GEM.<:DI-=+&F8U(NF
MDGU/8?@P2?!UT"20+]P/;]W'7HM<K\.=)?1_!-C%*I6:<&X=3VW<C_QW;UKJ
MJX<3)2K2:[G=AHN-**?8\]^,DDB>"X50G:]ZBOQGC:Y_F!7FOPQ`;XB:4"`1
M^]//_7)Z]C^(NE2:OX(OXH0S2P@3HJ_Q;#DCWXS^.*^?]`U:30M>LM3C!8V\
MH9E!P67HRY]P2/QKT\%[^%E!;Z_D>;C/<Q,9O;0]H^(GCK5/"5_906$%G(D\
M1=C.C$@@XXPPKC/^%T>(_P#GRTK_`+]2?_%UW^J/X"\5VD.J:G=V<\<285GN
MVB9`><%0P.?8C->%:Y)ITNMW;:3#Y.G^81`F6/RC@'YB3SC//K2P=*E./+*&
MJW;#%U:L)<T9Z/:Q]&^#=:N?$/A2RU6[2))Y]^Y8@0HVNRC`))Z`=ZW:Y'X8
M?\DZTK_MM_Z->NNKRZZ4:LDN[/4HMRIQ;[(R/%?_`")VM_\`8/G_`/1;5\SZ
M5_R&+'_KXC_]"%?3'BO_`)$[6_\`L'S_`/HMJ^9]*_Y#%C_U\1_^A"O4RW^'
M,\S,?XD3ZOHHHKQCUSR[XV?\@?2O^OA__0:\?LOMOG'[#]H\W;SY&=VW\.W2
MO8/C9_R!]*_Z^'_]!KC_`(5ZOI^B^)[FYU*ZCMH6LFC#R="Q=#C\@?RKW<))
MPPG,E??\SP\5%2Q7*W;8YW_BHO\`J*?^1*]Z^'/VG_A`]-^U^;Y_[W=YN=W^
MM?&<\],5-_PGOA7_`*#EK^9_PJWIWBK0M7NQ:Z?J<%Q.06"(3G`ZUQ8FO4JP
MLX6MJ=N&HPI3NIWN;%%%9?B+5WT'0+O5$M&NC;J'\E6V[AD`G.#@`$GIVK@C
M%R:2.Z344VSQ+QA\-M4T.^EFTVVFO-,;+(T2[FB']U@.>/7I7#D%6((((X(/
M:O5;'XSWDNM6XO;&V@TPOB7RPS2*"",YS@X.#T[5Z'=7/A'6K(W%Y/H]U`1D
MR3/&=O'J>5(S[$5[?UJM12C6C?S1XWU:C6;=*5O)GAGA[QYKOAZXB,=Y+<6J
M\-:SN60KGD#/W3[BOH;1]5M];T>UU*T),-P@<`]5/0J?<$$'Z5\Q:VFGQZW>
MKI3L]@)6$#-G)7MUYQ]:][^%]K-:^`=/\XOF4R2*K#[JESC'L?O?\"K/,:<.
M15$K,TR^I/G=-NZ.PHHHKQSU@HHHH`****`"BBB@#S#XH^$M<\1ZE83:59?:
M(XH65SYJ)@DY_B(K@O\`A6'C'_H#_P#DS#_\77T917=2Q]2G!025E_7<XJN!
MIU)N;;U_KL>!V'PA\373+]J%K9(1EC)*'(Y]%SSWZUZWX4\'Z=X2LFBM-TEQ
M+CSKA_O28SCCH`,]!^M=#16=;&5:RM)Z&E'"4J3O%:A1117*=(5YA\4?"6N>
M(]2L)M*LOM$<4+*Y\U$P2<_Q$5Z?16M&K*E/GCN95J4:L.21YS\*_"^L^&_[
M6_M:S^S_`&CR?*_>H^[;OS]TG'WAUKT:BBE6JNK-SENQTJ2I04([(****S-#
MP7_A7/BO_A)/M?\`97[C[9YN[[1%]W?G.-V>E>]445T5\1*M;FZ&%##QHWY>
MIY#\0_AQJ6H^(/[2T&T$ZW0+7$?F(FR0=_F(X8?7D'U%=#\+O#FK>'--OX=5
MM?L[RS*R#S%?(`Q_"37>T54L74E2]D]OQ)CA81J^U6X5D^)TU"7PSJ$6E0>=
M>RPF.)-P7EOE)R2!P"3U[5K45S1?*TSHDKIH\1\&_#?Q!9^+-/O-5T\06EO)
MYS.9HV^91E0`K$_>Q7MU%%;5\1.O+FD94*$:,>6)YA\4/!.J>(-1L;_1[07$
MHB,4X\Q4(`.5/S$`]6_*H_ACX9\2^&=9NQJ6G>397,(#/YT;8=3\O"L3T+=N
M]>IT5?UN?LO8M*Q'U2'M?:INX4445RG28?B_13X@\*W^G(H:9X]T.<?ZQ>5Y
M/3)&,^A->'_\*P\8_P#0'_\`)F'_`.+KZ,HKJH8RI0BXQL<M?"4ZTN:5S(\+
MZ3_8?AC3M-90LD,($@!R/,/+X/IN)K7HHKFE)R;D^ITQBHI)=`KR/XD>%/%/
MB7Q,);'3/-LH(5CB?SXUW'[S'!8'J<=.U>N45K0K2HRYXK4SK456CRR>ARWP
M^\/W'AOPG#9WD8CNY)'FF0,&PQ.`,C@_*%KH-1LH]2TRZL9L>7<1-$V1GAAB
MK-%1.I*4W-[E1@HP4%L?.A^%_C$,0-(!`[BYBY_\>KW[1VO7T:S.I1>5>^2H
MG3<&P^.>02.OO5VBML1BIUTE)+0QH86%!MQ;U"O'_B!X:\8>*?$+26^E.=/M
MAY=L#<Q#(_B?!?C<?QP!FO8**BA6=&7-%*_F76HJM'ED]#C?ASX1?POH;->1
MA=2NCNG&X-L`)VJ"..G/U/M3/B1X1D\3Z+')8PJ^I6S9B&0I=3]Y<G`]^?3W
MKM:*/K$_:^UZA["'LO9=#P?P]X*\<^'M=M=3M](.Z%OG7[5#AT/#*?G[C_&O
M=T8LBL5*$C)4XR/;CBEHJJ^(E7:<DKBH8>-%-1;"BBBN<W"BBB@`K.\06LU]
MX;U6TMDWSSV<L4:Y`W,R$`9/`Y-:-%.+L[B:NK'SYI_PT\70:E:S2:3M1)D9
MC]IB.`""?XJ^@Z**WQ&)G7:<NAA0PT*%U'J%%%%<YT'C_P`1?!'B+7?%DE[I
MNG^?;F%%#^=&O('/#,#7)_\`"L/&/_0'_P#)F'_XNOHRBN^GF%6$5%):?UW.
M&>`I3DY-O7^NQ\Y_\*P\8_\`0'_\F8?_`(NO3_A=X<U;PYIM_#JMK]G>6960
M>8KY`&/X2:[VBHK8ZI5AR22L51P5.E/GBV%%%%<9V'EGC'X3G4;V74=!DBAD
ME.Z2UDX4MW*GMGTZ>_:N`?X=>+8YQ"=%F+'`!5T*\_[0./UKZ2HKNI9A5A'E
MW.*I@*4WS;'BWAKX/WTUPD_B!TM[=2";:)PSO[$C@#Z$GZ=:]GCC2&)(HD5(
MT`5548"@=`!V%.HK"OB)UG>9O1P\**M`*Q?%UA<ZIX3U*RLXO-N)H2L:;@N3
MD=S@5M45E&3C)270TE%2BXOJ>"^'_ASXKL?$FE7=SI6R""\BED;[1$=JJX).
M`V3P*]ZHHK;$8B5=IRZ&5##QH)J/4\%\0?#GQ7?>)-5N[;2M\$]Y++&WVB(;
ME9R0<%LC@U[!X1L+G2_">FV5Y%Y5Q#"%D3<&P<GN,BMJBG6Q4ZL%"26A-'"P
MI2<XMZA6+XNL+G5/">I65G%YMQ-"5C3<%R<CN<"MJBL(R<9*2Z&\HJ47%]3Q
M_P"'7@CQ%H7BR.]U+3_(MQ"ZE_.C;DCCA6)KUV6*.>%X94#QR*5=3T(/!%/H
MK2O7E6GSRW,Z-"-&/+'8\!UCX5>(H-8NH]+L#<V(<F"4SQJ2IY`(+`Y'0\=J
M]D\(V%SI?A/3;*\B\JXAA"R)N#8.3W&16U15UL74K149="*.%A1DY1ZA1117
M,=)Y3XU^%,E_>R:EX?,2/*=TMHYV@L>I0]!GT.!Z'M7!GX=>+1<>0=%FW],A
MT*_]]9Q^M?25%=U/,*L(\NYPU,!2G+FV/(_!_P`))8+J'4/$+Q_NR'6RC.[)
M[;V'''H,Y]>U>N445SUJ\ZTN:;.FC0A1C:`5B^+K"YU3PGJ5E9Q>;<30E8TW
M!<G([G`K:HK.,G&2DNA<HJ47%]3YS_X5AXQ_Z`__`),P_P#Q='_"L/&/_0'_
M`/)F'_XNOHRBN_\`M.MV7X_YG#_9M+N_P_R/*/ACX-U_P]XDN+O5;#[/`]FT
M2MYT;Y8NAQA6)Z`UZO117'6K2K3YY'71HQHQY8A7E/C7X4R7][)J7A\Q(\IW
M2VCG:"QZE#T&?0X'H>U>K444:TZ,N:`5J,*L>69\VGX=>+1<>0=%FW],AT*_
M]]9Q^M=MX/\`A)+!=0ZAXA>/]V0ZV49W9/;>PXX]!G/KVKURBNJIF-:<>5:'
M-3R^E"5WJ%%%%<!W!7D'B_X23RWLE[X<$7EO\S6;-MVM_L$\8]CC'TZ>OT5M
M1KSHRYH&-:A"M&TSYN7X<^+6G,(T67>.YD0+_P!];L?K713_``>U6#PXTZ2)
M<:L9%*VT3@($YR-S8!;D'TX/7->WT5U2S*L[6LCFCEU)7O=G.>`]+O-&\%Z?
MI^H0^3=1>9OCW!L9D9AR"1T(KHZ**X9R<Y.3ZG;"*A%170SO$%K-?>&]5M+9
M-\\]G+%&N0-S,A`&3P.37ANG_#3Q=!J5K-)I.U$F1F/VF(X`()_BKZ#HK>AB
MIT8N,4M3"MA85FI2;T"BBBN8Z3@OBCX<U;Q'IMA#I5K]H>*9F<>8J8!&/XB*
M\P_X5AXQ_P"@/_Y,P_\`Q=?1E%=E''5*4.2*5CCK8*G5GSR;/G/_`(5AXQ_Z
M`_\`Y,P__%UUGPZ\$>(M"\61WNI:?Y%N(74OYT;<D<<*Q->P45=3,*LXN+2U
M_KN3#`4H24DWI_78*9+%'/"\,J!XY%*NIZ$'@BGT5P'<>+>)?@_?0W#S^'W2
MXMV)(MI7"NGL">"/J0?KUKE?^%=^+?/\G^Q9]^<9WIM_[ZSC]:^DZ*]"&95H
MJSLS@GEU*3NKH\6\-?!Z_FN8Y_$$B6]NI!-M&^YY/8L.%'N"3].M>S111P0I
M#$@2.-0J*.@`X`I]%<U?$5*SO,Z:.'A15H!1116!L%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
..4444`%%%%`!1110!_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>24
<FILENAME>dvax-20131231.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- RRD ActiveDisclosure(SM) XBRL Instance Document - http://www.financial.rrd.com/ -->
<!-- Creation Date      : 2014-03-07T19:36:08.4678359+00:00 -->
<!-- Version            : 1.7.0.24 -->
<!-- Package ID         : E885B71DE92DEB30D85162C832B40C82-0001029142-001401 -->
<!-- Copyright (c) 2014 R. R. Donnelley & Sons Company. All Rights Reserved. -->
<xbrl xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns="http://www.xbrl.org/2003/instance" xmlns:dvax="http://www.dynavax.com/20131231" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-gaap="http://fasb.org/us-gaap/2013-01-31" xmlns:us-types="http://fasb.org/us-types/2013-01-31" xmlns:country="http://xbrl.sec.gov/country/2013-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2012-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2013-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2013-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31">
  <xbrll:schemaRef xlink:type="simple" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xlink:href="dvax-20131231.xsd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" />
  <unit id="U_shares">
    <measure>shares</measure>
  </unit>
  <unit id="U_iso4217USD">
    <measure>iso4217:USD</measure>
  </unit>
  <unit id="U_iso4217USD_shares">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>shares</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="U_dvaxSegment">
    <measure>dvax:Segment</measure>
  </unit>
  <unit id="U_pure">
    <measure>pure</measure>
  </unit>
  <unit id="U_iso4217USD_dvaxRight">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>dvax:Right</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="U_iso4217EUR">
    <measure>iso4217:EUR</measure>
  </unit>
  <unit id="U_dvaxProject">
    <measure>dvax:Project</measure>
  </unit>
  <unit id="U_dvaxCompensationPlan">
    <measure>dvax:CompensationPlan</measure>
  </unit>
  <unit id="U_dvaxEmployee">
    <measure>dvax:Employee</measure>
  </unit>
  <context id="C_0001029142_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_20140228">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
    </entity>
    <period>
      <instant>2014-02-28</instant>
    </period>
  </context>
  <context id="C_0001029142_20130628">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
    </entity>
    <period>
      <instant>2013-06-28</instant>
    </period>
  </context>
  <context id="C_0001029142_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:ConvertiblePreferredStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:ConvertiblePreferredStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_20120101_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_20110101_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20101231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20101231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:PreferredStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20101231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20101231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedOtherComprehensiveIncomeMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20101231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:RetainedEarningsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_20101231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20110101_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20110101_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:PreferredStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20110101_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20110101_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedOtherComprehensiveIncomeMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20110101_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:RetainedEarningsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:PreferredStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedOtherComprehensiveIncomeMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:RetainedEarningsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20120101_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20120101_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:PreferredStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20120101_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20120101_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedOtherComprehensiveIncomeMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20120101_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:RetainedEarningsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:PreferredStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedOtherComprehensiveIncomeMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:RetainedEarningsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:PreferredStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedOtherComprehensiveIncomeMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:RetainedEarningsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedOtherComprehensiveIncomeMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:RetainedEarningsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:PreferredStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_deiLegalEntityAxis_dvaxAgreementWithGskMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="dei:LegalEntityAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:AgreementWithGskMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_deiLegalEntityAxis_dvaxAstraZenecaMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="dei:LegalEntityAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:AstraZenecaMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_deiLegalEntityAxis_dvaxNationalInstitutesOfHealthMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="dei:LegalEntityAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:NationalInstitutesOfHealthMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapBusinessAcquisitionAxis_dvaxRheinBiotechGmbhMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:BusinessAcquisitionAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:RheinBiotechGmbhMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapBusinessAcquisitionAxis_dvaxRheinBiotechGmbhMember_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:BusinessAcquisitionAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:RheinBiotechGmbhMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapBusinessAcquisitionAxis_dvaxRheinBiotechGmbhMember_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:BusinessAcquisitionAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:RheinBiotechGmbhMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapBusinessAcquisitionAxis_dvaxRheinBiotechGmbhMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:BusinessAcquisitionAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:RheinBiotechGmbhMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapBusinessAcquisitionAxis_dvaxRheinBiotechGmbhMember_20120101_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:BusinessAcquisitionAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:RheinBiotechGmbhMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapBusinessAcquisitionAxis_dvaxRheinBiotechGmbhMember_20110101_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:BusinessAcquisitionAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:RheinBiotechGmbhMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapRangeAxis_us-gaapMaximumMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MaximumMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementGeographicalAxis_countryUS_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementGeographicalAxis" xmlns="http://xbrl.org/2006/xbrldi">country:US</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementGeographicalAxis_countryUS_20120101_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementGeographicalAxis" xmlns="http://xbrl.org/2006/xbrldi">country:US</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementGeographicalAxis_countryUS_20110101_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementGeographicalAxis" xmlns="http://xbrl.org/2006/xbrldi">country:US</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementGeographicalAxis_countryUS_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementGeographicalAxis" xmlns="http://xbrl.org/2006/xbrldi">country:US</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementGeographicalAxis_countryUS_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementGeographicalAxis" xmlns="http://xbrl.org/2006/xbrldi">country:US</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:InvestmentTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MoneyMarketFundsMember</explicitMember>
        <explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel1Member</explicitMember>
        <explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:InvestmentTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MoneyMarketFundsMember</explicitMember>
        <explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:InvestmentTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</explicitMember>
        <explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel2Member</explicitMember>
        <explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:InvestmentTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</explicitMember>
        <explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel1Member</explicitMember>
        <explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel2Member</explicitMember>
        <explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:InvestmentTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MoneyMarketFundsMember</explicitMember>
        <explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel1Member</explicitMember>
        <explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:InvestmentTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MoneyMarketFundsMember</explicitMember>
        <explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:InvestmentTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</explicitMember>
        <explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel2Member</explicitMember>
        <explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:InvestmentTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</explicitMember>
        <explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSTreasurySecuritiesMember_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:InvestmentTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:USTreasurySecuritiesMember</explicitMember>
        <explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel2Member</explicitMember>
        <explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSTreasurySecuritiesMember_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:InvestmentTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:USTreasurySecuritiesMember</explicitMember>
        <explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_dvaxMunicipalSecuritiesMember_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:InvestmentTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:MunicipalSecuritiesMember</explicitMember>
        <explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel2Member</explicitMember>
        <explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_dvaxMunicipalSecuritiesMember_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:InvestmentTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:MunicipalSecuritiesMember</explicitMember>
        <explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel1Member</explicitMember>
        <explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel2Member</explicitMember>
        <explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapCashAndCashEquivalentsMember_us-gaapInvestmentTypeAxis_us-gaapCashMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:InformationByFinancialStatementLineItemAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CashAndCashEquivalentsMember</explicitMember>
        <explicitMember dimension="us-gaap:InvestmentTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CashMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapCashAndCashEquivalentsMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:InformationByFinancialStatementLineItemAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CashAndCashEquivalentsMember</explicitMember>
        <explicitMember dimension="us-gaap:InvestmentTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MoneyMarketFundsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapCashAndCashEquivalentsMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:InformationByFinancialStatementLineItemAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CashAndCashEquivalentsMember</explicitMember>
        <explicitMember dimension="us-gaap:InvestmentTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapCashAndCashEquivalentsMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:InformationByFinancialStatementLineItemAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CashAndCashEquivalentsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapAvailableforsaleSecuritiesMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:InformationByFinancialStatementLineItemAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AvailableforsaleSecuritiesMember</explicitMember>
        <explicitMember dimension="us-gaap:InvestmentTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapAvailableforsaleSecuritiesMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:InformationByFinancialStatementLineItemAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AvailableforsaleSecuritiesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapCashAndCashEquivalentsMember_us-gaapInvestmentTypeAxis_us-gaapCashMember_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:InformationByFinancialStatementLineItemAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CashAndCashEquivalentsMember</explicitMember>
        <explicitMember dimension="us-gaap:InvestmentTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CashMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapCashAndCashEquivalentsMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:InformationByFinancialStatementLineItemAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CashAndCashEquivalentsMember</explicitMember>
        <explicitMember dimension="us-gaap:InvestmentTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MoneyMarketFundsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapCashAndCashEquivalentsMember_us-gaapInvestmentTypeAxis_dvaxMunicipalSecuritiesMember_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:InformationByFinancialStatementLineItemAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CashAndCashEquivalentsMember</explicitMember>
        <explicitMember dimension="us-gaap:InvestmentTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:MunicipalSecuritiesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapCashAndCashEquivalentsMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:InformationByFinancialStatementLineItemAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CashAndCashEquivalentsMember</explicitMember>
        <explicitMember dimension="us-gaap:InvestmentTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapCashAndCashEquivalentsMember_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:InformationByFinancialStatementLineItemAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CashAndCashEquivalentsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapAvailableforsaleSecuritiesMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:InformationByFinancialStatementLineItemAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AvailableforsaleSecuritiesMember</explicitMember>
        <explicitMember dimension="us-gaap:InvestmentTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapAvailableforsaleSecuritiesMember_us-gaapInvestmentTypeAxis_us-gaapUSTreasurySecuritiesMember_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:InformationByFinancialStatementLineItemAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AvailableforsaleSecuritiesMember</explicitMember>
        <explicitMember dimension="us-gaap:InvestmentTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:USTreasurySecuritiesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapAvailableforsaleSecuritiesMember_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:InformationByFinancialStatementLineItemAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:AvailableforsaleSecuritiesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapPropertyPlantAndEquipmentByTypeAxis_dvaxManufacturingEquipmentMember_us-gaapRangeAxis_us-gaapMinimumMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:ManufacturingEquipmentMember</explicitMember>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MinimumMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapPropertyPlantAndEquipmentByTypeAxis_dvaxManufacturingEquipmentMember_us-gaapRangeAxis_us-gaapMaximumMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:ManufacturingEquipmentMember</explicitMember>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MaximumMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapPropertyPlantAndEquipmentByTypeAxis_dvaxLaboratoryMember_us-gaapRangeAxis_us-gaapMinimumMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:LaboratoryMember</explicitMember>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MinimumMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapPropertyPlantAndEquipmentByTypeAxis_dvaxLaboratoryMember_us-gaapRangeAxis_us-gaapMaximumMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:LaboratoryMember</explicitMember>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MaximumMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapComputerEquipmentMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:ComputerEquipmentMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapFurnitureAndFixturesMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FurnitureAndFixturesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_us-gaapRangeAxis_us-gaapMinimumMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:LeaseholdImprovementsMember</explicitMember>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MinimumMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_us-gaapRangeAxis_us-gaapMaximumMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:LeaseholdImprovementsMember</explicitMember>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MaximumMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapPropertyPlantAndEquipmentByTypeAxis_dvaxLaboratoryMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:LaboratoryMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapPropertyPlantAndEquipmentByTypeAxis_dvaxLaboratoryMember_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:LaboratoryMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapComputerEquipmentMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:ComputerEquipmentMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapComputerEquipmentMember_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:ComputerEquipmentMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_dvaxManufacturingMember_20110101_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:ManufacturingMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapCustomerRelationshipsMember_20110101_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CustomerRelationshipsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_dvaxSymphonyDynamoIncMember_20060418">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:SymphonyDynamoIncMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-04-18</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_dvaxSymphonyDynamoHoldingsLlcMember_20060418">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:SymphonyDynamoHoldingsLlcMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2006-04-18</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapRangeAxis_us-gaapMaximumMember_20060319_20060418">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MaximumMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-03-19</startDate>
      <endDate>2006-04-18</endDate>
    </period>
  </context>
  <context id="C_0001029142_20060319_20060418">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
    </entity>
    <period>
      <startDate>2006-03-19</startDate>
      <endDate>2006-04-18</endDate>
    </period>
  </context>
  <context id="C_0001029142_20060418">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
    </entity>
    <period>
      <instant>2006-04-18</instant>
    </period>
  </context>
  <context id="C_0001029142_20070430">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
    </entity>
    <period>
      <instant>2007-04-30</instant>
    </period>
  </context>
  <context id="C_0001029142_20091101_20091130">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
    </entity>
    <period>
      <startDate>2009-11-01</startDate>
      <endDate>2009-11-30</endDate>
    </period>
  </context>
  <context id="C_0001029142_20091130">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
    </entity>
    <period>
      <instant>2009-11-30</instant>
    </period>
  </context>
  <context id="C_0001029142_20100401_20100430">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
    </entity>
    <period>
      <startDate>2010-04-01</startDate>
      <endDate>2010-04-30</endDate>
    </period>
  </context>
  <context id="C_0001029142_20100430">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
    </entity>
    <period>
      <instant>2010-04-30</instant>
    </period>
  </context>
  <context id="C_0001029142_20100401_20100630">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
    </entity>
    <period>
      <startDate>2010-04-01</startDate>
      <endDate>2010-06-30</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapClassOfWarrantOrRightAxis_dvaxWarrantLiabilityMember_20100601_20100630">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:WarrantLiabilityMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-06-01</startDate>
      <endDate>2010-06-30</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_dvaxSymphonyDynamoIncMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:SymphonyDynamoIncMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_20100101_20101231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_20100101_20101231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel3Member</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_20110101_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel3Member</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel3Member</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementGeographicalAxis_stprCA_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementGeographicalAxis" xmlns="http://xbrl.org/2006/xbrldi">stpr:CA</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementGeographicalAxis_countryGC_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementGeographicalAxis" xmlns="http://xbrl.org/2006/xbrldi">country:GC</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementGeographicalAxis_dvaxCaliforniaMember_20041231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementGeographicalAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:CaliforniaMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementGeographicalAxis_dvaxCaliforniaMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementGeographicalAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:CaliforniaMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementGeographicalAxis_dvaxCaliforniaMember_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementGeographicalAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:CaliforniaMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementGeographicalAxis_dvaxCaliforniaMember_20041001_20041231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementGeographicalAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:CaliforniaMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapLossContingenciesByNatureOfContingencyAxis_dvaxContingencyBMember_us-gaapRangeAxis_us-gaapMinimumMember_us-gaapStatementGeographicalAxis_dvaxCaliforniaMember_20041231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementGeographicalAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:CaliforniaMember</explicitMember>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MinimumMember</explicitMember>
        <explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:ContingencyBMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapLossContingenciesByNatureOfContingencyAxis_dvaxContingencyAMember_us-gaapRangeAxis_us-gaapMaximumMember_us-gaapStatementGeographicalAxis_dvaxCaliforniaMember_20041231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementGeographicalAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:CaliforniaMember</explicitMember>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MaximumMember</explicitMember>
        <explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:ContingencyAMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2004-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapLossContingenciesByNatureOfContingencyAxis_dvaxContingencyAMember_us-gaapRangeAxis_us-gaapMinimumMember_us-gaapStatementGeographicalAxis_dvaxCaliforniaMember_20041001_20041231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementGeographicalAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:CaliforniaMember</explicitMember>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MinimumMember</explicitMember>
        <explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:ContingencyAMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapLossContingenciesByNatureOfContingencyAxis_dvaxContingencyBMember_us-gaapStatementGeographicalAxis_dvaxCaliforniaMember_20041001_20041231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementGeographicalAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:CaliforniaMember</explicitMember>
        <explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:ContingencyBMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapLossContingenciesByNatureOfContingencyAxis_dvaxContingencyAMember_us-gaapStatementGeographicalAxis_dvaxCaliforniaMember_20041001_20041231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementGeographicalAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:CaliforniaMember</explicitMember>
        <explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:ContingencyAMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-10-01</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapLossContingenciesByNatureOfContingencyAxis_dvaxDeutscheBankSecuritiesMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:DeutscheBankSecuritiesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapLossContingenciesByNatureOfContingencyAxis_dvaxDeutscheBankSecuritiesMember_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:DeutscheBankSecuritiesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxGlaxoSmithKlineMember_20081201_20081231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:TypeOfArrangementAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:GlaxoSmithKlineMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-12-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapRangeAxis_us-gaapMaximumMember_us-gaapTypeOfArrangementAxis_dvaxGlaxoSmithKlineMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:TypeOfArrangementAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:GlaxoSmithKlineMember</explicitMember>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MaximumMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_dvaxCollaborativeAgreementAxis_dvaxConditionTwoMember_us-gaapRangeAxis_us-gaapMaximumMember_us-gaapTypeOfArrangementAxis_dvaxGlaxoSmithKlineMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:TypeOfArrangementAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:GlaxoSmithKlineMember</explicitMember>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MaximumMember</explicitMember>
        <explicitMember dimension="dvax:CollaborativeAgreementAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:ConditionTwoMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementBusinessSegmentsAxis_dvaxExpansionMember_us-gaapTypeOfArrangementAxis_dvaxGlaxoSmithKlineMember_20110101_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:TypeOfArrangementAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:GlaxoSmithKlineMember</explicitMember>
        <explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:ExpansionMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapRangeAxis_us-gaapMinimumMember_us-gaapTypeOfArrangementAxis_dvaxGlaxoSmithKlineMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:TypeOfArrangementAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:GlaxoSmithKlineMember</explicitMember>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MinimumMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxGlaxoSmithKlineMember_20131001_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:TypeOfArrangementAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:GlaxoSmithKlineMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxGlaxoSmithKlineMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:TypeOfArrangementAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:GlaxoSmithKlineMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxGlaxoSmithKlineMember_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:TypeOfArrangementAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:GlaxoSmithKlineMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxAstraZenecaMember_20060901_20060930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:TypeOfArrangementAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:AstraZenecaMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2006-09-01</startDate>
      <endDate>2006-09-30</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxAmendmentMember_20111001_20111031">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:TypeOfArrangementAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:AmendmentMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2011-10-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapContingentConsiderationByTypeAxis_dvaxContingentConsiderationMember_us-gaapTypeOfArrangementAxis_dvaxAmendmentMember_20120101_20120331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:TypeOfArrangementAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:AmendmentMember</explicitMember>
        <explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:ContingentConsiderationMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-03-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapContingentConsiderationByTypeAxis_dvaxContingentConsiderationMember_us-gaapTypeOfArrangementAxis_dvaxAmendmentMember_20121001_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:TypeOfArrangementAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:AmendmentMember</explicitMember>
        <explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:ContingentConsiderationMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapContingentConsiderationByTypeAxis_dvaxContingentConsiderationMember_us-gaapTypeOfArrangementAxis_dvaxAmendmentMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:TypeOfArrangementAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:AmendmentMember</explicitMember>
        <explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:ContingentConsiderationMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapContingentConsiderationByTypeAxis_dvaxContingentConsiderationMember_us-gaapRangeAxis_us-gaapMaximumMember_us-gaapTypeOfArrangementAxis_dvaxAmendmentMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:TypeOfArrangementAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:AmendmentMember</explicitMember>
        <explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:ContingentConsiderationMember</explicitMember>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MaximumMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxAmendmentMember_20110101_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:TypeOfArrangementAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:AmendmentMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxAstraZenecaMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:TypeOfArrangementAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:AstraZenecaMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxAstraZenecaMember_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:TypeOfArrangementAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:AstraZenecaMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_dvaxDifferentTypesOfCollaborationAgreementsAxis_dvaxNationalInstitutesOfHealthMember_us-gaapTypeOfArrangementAxis_dvaxHepaticFibrosisAndCirrhosisMember_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:TypeOfArrangementAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:HepaticFibrosisAndCirrhosisMember</explicitMember>
        <explicitMember dimension="dvax:DifferentTypesOfCollaborationAgreementsAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:NationalInstitutesOfHealthMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-09-30</instant>
    </period>
  </context>
  <context id="C_0001029142_dvaxDifferentTypesOfCollaborationAgreementsAxis_dvaxNationalInstitutesOfHealthMember_us-gaapTypeOfArrangementAxis_dvaxAutoimmuneDiseaseMember_20120630">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="dvax:DifferentTypesOfCollaborationAgreementsAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:NationalInstitutesOfHealthMember</explicitMember>
        <explicitMember dimension="us-gaap:TypeOfArrangementAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:AutoimmuneDiseaseMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-06-30</instant>
    </period>
  </context>
  <context id="C_0001029142_dvaxDifferentTypesOfCollaborationAgreementsAxis_dvaxNationalInstitutesOfHealthMember_us-gaapTypeOfArrangementAxis_dvaxRheumatoidArthritisMember_20120531">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:TypeOfArrangementAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:RheumatoidArthritisMember</explicitMember>
        <explicitMember dimension="dvax:DifferentTypesOfCollaborationAgreementsAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:NationalInstitutesOfHealthMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-05-31</instant>
    </period>
  </context>
  <context id="C_0001029142_dvaxDifferentTypesOfCollaborationAgreementsAxis_dvaxNationalInstitutesOfHealthMember_us-gaapTypeOfArrangementAxis_dvaxSkinAutoimmuneInflammationMember_20110731">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:TypeOfArrangementAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:SkinAutoimmuneInflammationMember</explicitMember>
        <explicitMember dimension="dvax:DifferentTypesOfCollaborationAgreementsAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:NationalInstitutesOfHealthMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2011-07-31</instant>
    </period>
  </context>
  <context id="C_0001029142_dvaxDifferentTypesOfCollaborationAgreementsAxis_dvaxNationalInstitutesOfHealthMember_us-gaapTypeOfArrangementAxis_dvaxHepatitisBVirusMember_20100831">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:TypeOfArrangementAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:HepatitisBVirusMember</explicitMember>
        <explicitMember dimension="dvax:DifferentTypesOfCollaborationAgreementsAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:NationalInstitutesOfHealthMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-08-31</instant>
    </period>
  </context>
  <context id="C_0001029142_dvaxDifferentTypesOfCollaborationAgreementsAxis_dvaxNationalInstitutesOfHealthMember_us-gaapTypeOfArrangementAxis_dvaxHumanPapillomaVirusMember_20100731">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:TypeOfArrangementAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:HumanPapillomaVirusMember</explicitMember>
        <explicitMember dimension="dvax:DifferentTypesOfCollaborationAgreementsAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:NationalInstitutesOfHealthMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2010-07-31</instant>
    </period>
  </context>
  <context id="C_0001029142_dvaxDifferentTypesOfCollaborationAgreementsAxis_dvaxNationalInstitutesOfHealthMember_us-gaapTypeOfArrangementAxis_dvaxIssTechnologyMember_20080901_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="dvax:DifferentTypesOfCollaborationAgreementsAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:NationalInstitutesOfHealthMember</explicitMember>
        <explicitMember dimension="us-gaap:TypeOfArrangementAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:IssTechnologyMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-09-01</startDate>
      <endDate>2008-09-30</endDate>
    </period>
  </context>
  <context id="C_0001029142_dvaxDifferentTypesOfCollaborationAgreementsAxis_dvaxNationalInstitutesOfHealthMember_us-gaapTypeOfArrangementAxis_dvaxIssTechnologyMember_20080930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="dvax:DifferentTypesOfCollaborationAgreementsAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:NationalInstitutesOfHealthMember</explicitMember>
        <explicitMember dimension="us-gaap:TypeOfArrangementAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:IssTechnologyMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-09-30</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxGlaxoSmithKlineMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:TypeOfArrangementAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:GlaxoSmithKlineMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxGlaxoSmithKlineMember_20120101_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:TypeOfArrangementAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:GlaxoSmithKlineMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxGlaxoSmithKlineMember_20110101_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:TypeOfArrangementAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:GlaxoSmithKlineMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxAstraZenecaMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:TypeOfArrangementAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:AstraZenecaMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxAstraZenecaMember_20120101_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:TypeOfArrangementAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:AstraZenecaMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxAstraZenecaMember_20110101_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:TypeOfArrangementAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:AstraZenecaMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxNationalInstituteOfAllergyAndInfectiousDiseasesMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:TypeOfArrangementAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:NationalInstituteOfAllergyAndInfectiousDiseasesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxNationalInstituteOfAllergyAndInfectiousDiseasesMember_20120101_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:TypeOfArrangementAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:NationalInstituteOfAllergyAndInfectiousDiseasesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxNationalInstituteOfAllergyAndInfectiousDiseasesMember_20110101_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:TypeOfArrangementAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:NationalInstituteOfAllergyAndInfectiousDiseasesMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_dvaxDifferentTypesOfCollaborationAgreementsAxis_dvaxNationalInstitutesOfHealthMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="dvax:DifferentTypesOfCollaborationAgreementsAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:NationalInstitutesOfHealthMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_dvaxDifferentTypesOfCollaborationAgreementsAxis_dvaxNationalInstitutesOfHealthMember_20120101_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="dvax:DifferentTypesOfCollaborationAgreementsAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:NationalInstitutesOfHealthMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_dvaxDifferentTypesOfCollaborationAgreementsAxis_dvaxNationalInstitutesOfHealthMember_20110101_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="dvax:DifferentTypesOfCollaborationAgreementsAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:NationalInstitutesOfHealthMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_dvaxStockOptionsAndShareAwardsMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:StockOptionsAndShareAwardsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_dvaxStockOptionsAndShareAwardsMember_20120101_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:StockOptionsAndShareAwardsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_dvaxStockOptionsAndShareAwardsMember_20110101_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:StockOptionsAndShareAwardsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:ConvertiblePreferredStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapWarrantMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:WarrantMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapWarrantMember_20120101_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:WarrantMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapWarrantMember_20110101_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:WarrantMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_20130529">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
    </entity>
    <period>
      <instant>2013-05-29</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20131001_20131031">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:ConvertiblePreferredStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2013-10-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20131031">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementClassOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:ConvertiblePreferredStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-10-31</instant>
    </period>
  </context>
  <context id="C_0001029142_20081104">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
    </entity>
    <period>
      <instant>2008-11-04</instant>
    </period>
  </context>
  <context id="C_0001029142_20081001_20081104">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2008-11-04</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapRangeAxis_us-gaapMinimumMember_20081001_20081104">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MinimumMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2008-10-01</startDate>
      <endDate>2008-11-04</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapRangeAxis_us-gaapMinimumMember_20081104">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MinimumMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2008-11-04</instant>
    </period>
  </context>
  <context id="C_0001029142_20131001_20131031">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2013-10-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20131001_20131031">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2013-10-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_deiLegalEntityAxis_dvaxMlvMember_us-gaapRangeAxis_us-gaapMaximumMember_20130301_20130329">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="dei:LegalEntityAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:MlvMember</explicitMember>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MaximumMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-03-01</startDate>
      <endDate>2013-03-29</endDate>
    </period>
  </context>
  <context id="C_0001029142_deiLegalEntityAxis_dvaxMlvMember_us-gaapRangeAxis_us-gaapMaximumMember_20130329">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="dei:LegalEntityAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:MlvMember</explicitMember>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MaximumMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-03-29</instant>
    </period>
  </context>
  <context id="C_0001029142_20120401_20120509">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
    </entity>
    <period>
      <startDate>2012-04-01</startDate>
      <endDate>2012-05-09</endDate>
    </period>
  </context>
  <context id="C_0001029142_20111001_20111103">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
    </entity>
    <period>
      <startDate>2011-10-01</startDate>
      <endDate>2011-11-03</endDate>
    </period>
  </context>
  <context id="C_0001029142_20101001_20101102">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
    </entity>
    <period>
      <startDate>2010-10-01</startDate>
      <endDate>2010-11-02</endDate>
    </period>
  </context>
  <context id="C_0001029142_deiLegalEntityAxis_dvaxAspireCapitalFundLlcMember_us-gaapRangeAxis_us-gaapMaximumMember_20100821_20100920">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="dei:LegalEntityAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:AspireCapitalFundLlcMember</explicitMember>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MaximumMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-08-21</startDate>
      <endDate>2010-09-20</endDate>
    </period>
  </context>
  <context id="C_0001029142_deiLegalEntityAxis_dvaxAspireCapitalFundLlcMember_20100821_20100920">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="dei:LegalEntityAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:AspireCapitalFundLlcMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-08-21</startDate>
      <endDate>2010-09-20</endDate>
    </period>
  </context>
  <context id="C_0001029142_deiLegalEntityAxis_dvaxAspireCapitalFundLlcMember_20100901_20100930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="dei:LegalEntityAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:AspireCapitalFundLlcMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-09-01</startDate>
      <endDate>2010-09-30</endDate>
    </period>
  </context>
  <context id="C_0001029142_deiLegalEntityAxis_dvaxAspireCapitalFundLlcMember_20100101_20101231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="dei:LegalEntityAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:AspireCapitalFundLlcMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_deiLegalEntityAxis_dvaxAspireCapitalFundLlcMember_20110101_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="dei:LegalEntityAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:AspireCapitalFundLlcMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_20100317_20100416">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
    </entity>
    <period>
      <startDate>2010-03-17</startDate>
      <endDate>2010-04-16</endDate>
    </period>
  </context>
  <context id="C_0001029142_20100416">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
    </entity>
    <period>
      <instant>2010-04-16</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapDebtInstrumentAxis_dvaxLoanAgreementMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:DebtInstrumentAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:LoanAgreementMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapClassOfWarrantOrRightAxis_dvaxWarrantOneMember_us-gaapDebtInstrumentAxis_dvaxLoanAgreementMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:WarrantOneMember</explicitMember>
        <explicitMember dimension="us-gaap:DebtInstrumentAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:LoanAgreementMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapClassOfWarrantOrRightAxis_dvaxWarrantTwoMember_us-gaapDebtInstrumentAxis_dvaxLoanAgreementMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:WarrantTwoMember</explicitMember>
        <explicitMember dimension="us-gaap:DebtInstrumentAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:LoanAgreementMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapClassOfWarrantOrRightAxis_dvaxWarrantThreeMember_us-gaapDebtInstrumentAxis_dvaxLoanAgreementMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:WarrantThreeMember</explicitMember>
        <explicitMember dimension="us-gaap:DebtInstrumentAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:LoanAgreementMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapClassOfWarrantOrRightAxis_dvaxWarrantFourMember_us-gaapDebtInstrumentAxis_dvaxLoanAgreementMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:WarrantFourMember</explicitMember>
        <explicitMember dimension="us-gaap:DebtInstrumentAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:LoanAgreementMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapClassOfWarrantOrRightAxis_dvaxWarrantOneMember_us-gaapDebtInstrumentAxis_dvaxLoanAgreementMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:WarrantOneMember</explicitMember>
        <explicitMember dimension="us-gaap:DebtInstrumentAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:LoanAgreementMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapClassOfWarrantOrRightAxis_dvaxWarrantTwoMember_us-gaapDebtInstrumentAxis_dvaxLoanAgreementMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:WarrantTwoMember</explicitMember>
        <explicitMember dimension="us-gaap:DebtInstrumentAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:LoanAgreementMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapClassOfWarrantOrRightAxis_dvaxWarrantThreeMember_us-gaapDebtInstrumentAxis_dvaxLoanAgreementMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:WarrantThreeMember</explicitMember>
        <explicitMember dimension="us-gaap:DebtInstrumentAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:LoanAgreementMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapClassOfWarrantOrRightAxis_dvaxWarrantFourMember_us-gaapDebtInstrumentAxis_dvaxLoanAgreementMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:WarrantFourMember</explicitMember>
        <explicitMember dimension="us-gaap:DebtInstrumentAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:LoanAgreementMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapDebtInstrumentAxis_dvaxLoanAgreementMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:DebtInstrumentAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:LoanAgreementMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapPlanNameAxis_dvaxStockIncentivePlanTwentyZeroFourMember_us-gaapRangeAxis_us-gaapMaximumMember_20040101_20040131">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MaximumMember</explicitMember>
        <explicitMember dimension="us-gaap:PlanNameAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:StockIncentivePlanTwentyZeroFourMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-01-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapPlanNameAxis_dvaxStockIncentivePlanTwentyZeroFourMember_us-gaapRangeAxis_us-gaapMaximumMember_us-gaapTypeOfArrangementAxis_dvaxOtherParticipantsMember_20040101_20040131">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MaximumMember</explicitMember>
        <explicitMember dimension="us-gaap:PlanNameAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:StockIncentivePlanTwentyZeroFourMember</explicitMember>
        <explicitMember dimension="us-gaap:TypeOfArrangementAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:OtherParticipantsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-01-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapPlanNameAxis_dvaxStockIncentivePlanTwentyZeroFourMember_20040101_20040131">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PlanNameAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:StockIncentivePlanTwentyZeroFourMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-01-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapPlanNameAxis_dvaxStockIncentivePlanTwentyZeroFourMember_us-gaapRangeAxis_us-gaapMinimumMember_us-gaapTypeOfArrangementAxis_dvaxGroupTwoMember_20040101_20040131">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MinimumMember</explicitMember>
        <explicitMember dimension="us-gaap:PlanNameAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:StockIncentivePlanTwentyZeroFourMember</explicitMember>
        <explicitMember dimension="us-gaap:TypeOfArrangementAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:GroupTwoMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-01-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapPlanNameAxis_dvaxStockIncentivePlanTwentyZeroFourMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PlanNameAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:StockIncentivePlanTwentyZeroFourMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapPlanNameAxis_dvaxEmploymentInducementAwardPlanTwentyTenMember_us-gaapRangeAxis_us-gaapMaximumMember_20100101_20100131">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MaximumMember</explicitMember>
        <explicitMember dimension="us-gaap:PlanNameAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:EmploymentInducementAwardPlanTwentyTenMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-01-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapPlanNameAxis_dvaxEmploymentInducementAwardPlanTwentyTenMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PlanNameAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:EmploymentInducementAwardPlanTwentyTenMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapPlanNameAxis_dvaxEquityIncentivePlanTwentyElevenMember_us-gaapRangeAxis_us-gaapMaximumMember_20110101_20110131">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PlanNameAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:EquityIncentivePlanTwentyElevenMember</explicitMember>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MaximumMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-01-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapPlanNameAxis_dvaxEquityIncentivePlanTwentyElevenMember_us-gaapRangeAxis_us-gaapMaximumMember_20130501_20130529">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PlanNameAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:EquityIncentivePlanTwentyElevenMember</explicitMember>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MaximumMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-05-01</startDate>
      <endDate>2013-05-29</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapPlanNameAxis_dvaxEquityIncentivePlanTwentyElevenMember_20110101_20110131">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PlanNameAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:EquityIncentivePlanTwentyElevenMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-01-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapPlanNameAxis_dvaxEquityIncentivePlanTwentyElevenMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PlanNameAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:EquityIncentivePlanTwentyElevenMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapAwardTypeAxis_dvaxUnvestedMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:AwardTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:UnvestedMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapAwardTypeAxis_dvaxVestedMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:AwardTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:VestedMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:AwardTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:RestrictedStockUnitsRSUMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:AwardTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:RestrictedStockUnitsRSUMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:AwardTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:RestrictedStockUnitsRSUMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20120101_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:AwardTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:RestrictedStockUnitsRSUMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20110101_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:AwardTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:RestrictedStockUnitsRSUMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:AwardTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:EmployeeStockOptionMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20120101_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:AwardTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:EmployeeStockOptionMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20110101_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:AwardTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:EmployeeStockOptionMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:EmployeeStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20120101_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:EmployeeStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20110101_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:EmployeeStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapIncomeStatementLocationAxis_dvaxEmployeesAndDirectorsMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:IncomeStatementLocationAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:EmployeesAndDirectorsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapIncomeStatementLocationAxis_dvaxEmployeesAndDirectorsMember_20120101_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:IncomeStatementLocationAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:EmployeesAndDirectorsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapIncomeStatementLocationAxis_dvaxEmployeesAndDirectorsMember_20110101_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:IncomeStatementLocationAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:EmployeesAndDirectorsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapIncomeStatementLocationAxis_dvaxNonEmployeeMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:IncomeStatementLocationAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:NonEmployeeMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapIncomeStatementLocationAxis_dvaxNonEmployeeMember_20110101_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:IncomeStatementLocationAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:NonEmployeeMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:IncomeStatementLocationAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:ResearchAndDevelopmentExpenseMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20120101_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:IncomeStatementLocationAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:ResearchAndDevelopmentExpenseMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20110101_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:IncomeStatementLocationAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:ResearchAndDevelopmentExpenseMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:IncomeStatementLocationAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:GeneralAndAdministrativeExpenseMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20120101_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:IncomeStatementLocationAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:GeneralAndAdministrativeExpenseMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20110101_20111231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:IncomeStatementLocationAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:GeneralAndAdministrativeExpenseMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapDeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_dvaxNonEmployeeAwardsMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:NonEmployeeAwardsMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapDeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_dvaxAdditionalMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:AdditionalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapDeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_dvaxAdditionalMember_20120101_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:AdditionalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapPlanNameAxis_dvaxTimeBasedVestingScheduleMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PlanNameAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:TimeBasedVestingScheduleMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapPlanNameAxis_dvaxTimeBasedVestingScheduleMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:PlanNameAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:TimeBasedVestingScheduleMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:EmployeeStockMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_dvaxPeriodAxis_dvaxPeriodOneMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20040101_20040131">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:EmployeeStockMember</explicitMember>
        <explicitMember dimension="dvax:PeriodAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:PeriodOneMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-01-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_dvaxPeriodAxis_dvaxPeriodTwoMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20040101_20040131">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:EmployeeStockMember</explicitMember>
        <explicitMember dimension="dvax:PeriodAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:PeriodTwoMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2004-01-01</startDate>
      <endDate>2004-01-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapIncomeTaxAuthorityAxis_dvaxFederalMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:FederalMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapIncomeTaxAuthorityAxis_dvaxFederalMember_us-gaapRangeAxis_us-gaapMinimumMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:FederalMember</explicitMember>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MinimumMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapIncomeTaxAuthorityAxis_dvaxFederalMember_us-gaapRangeAxis_us-gaapMaximumMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:FederalMember</explicitMember>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MaximumMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapIncomeTaxAuthorityAxis_dvaxFederalMember_us-gaapTaxCreditCarryforwardAxis_dvaxResearchAndDevelopmentMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:FederalMember</explicitMember>
        <explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:ResearchAndDevelopmentMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapIncomeTaxAuthorityAxis_dvaxFederalMember_us-gaapRangeAxis_us-gaapMinimumMember_us-gaapTaxCreditCarryforwardAxis_dvaxResearchAndDevelopmentMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:FederalMember</explicitMember>
        <explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:ResearchAndDevelopmentMember</explicitMember>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MinimumMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapIncomeTaxAuthorityAxis_dvaxFederalMember_us-gaapRangeAxis_us-gaapMaximumMember_us-gaapTaxCreditCarryforwardAxis_dvaxResearchAndDevelopmentMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:FederalMember</explicitMember>
        <explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:ResearchAndDevelopmentMember</explicitMember>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MaximumMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapIncomeTaxAuthorityAxis_dvaxCaliforniaStateMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:CaliforniaStateMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapIncomeTaxAuthorityAxis_dvaxCaliforniaStateMember_us-gaapRangeAxis_us-gaapMinimumMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:CaliforniaStateMember</explicitMember>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MinimumMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapIncomeTaxAuthorityAxis_dvaxCaliforniaStateMember_us-gaapRangeAxis_us-gaapMaximumMember_20130101_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:CaliforniaStateMember</explicitMember>
        <explicitMember dimension="us-gaap:RangeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:MaximumMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapIncomeTaxAuthorityAxis_dvaxCaliforniaStateMember_us-gaapTaxCreditCarryforwardAxis_dvaxResearchAndDevelopmentMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:CaliforniaStateMember</explicitMember>
        <explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:ResearchAndDevelopmentMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_us-gaapIncomeTaxAuthorityAxis_us-gaapForeignCountryMember_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:ForeignCountryMember</explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="C_0001029142_20130101_20130331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-03-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_20130401_20130630">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
    </entity>
    <period>
      <startDate>2013-04-01</startDate>
      <endDate>2013-06-30</endDate>
    </period>
  </context>
  <context id="C_0001029142_20130701_20130930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
    </entity>
    <period>
      <startDate>2013-07-01</startDate>
      <endDate>2013-09-30</endDate>
    </period>
  </context>
  <context id="C_0001029142_20131001_20131231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
    </entity>
    <period>
      <startDate>2013-10-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_20120101_20120331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-03-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_20120401_20120630">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
    </entity>
    <period>
      <startDate>2012-04-01</startDate>
      <endDate>2012-06-30</endDate>
    </period>
  </context>
  <context id="C_0001029142_20120701_20120930">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
    </entity>
    <period>
      <startDate>2012-07-01</startDate>
      <endDate>2012-09-30</endDate>
    </period>
  </context>
  <context id="C_0001029142_20121001_20121231">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
    </entity>
    <period>
      <startDate>2012-10-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="C_0001029142_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_us-gaapTypeOfArrangementAxis_dvaxAstraZenecaMember_20140301_20140331">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
      <segment>
        <explicitMember dimension="us-gaap:TypeOfArrangementAxis" xmlns="http://xbrl.org/2006/xbrldi">dvax:AstraZenecaMember</explicitMember>
        <explicitMember dimension="us-gaap:SubsequentEventTypeAxis" xmlns="http://xbrl.org/2006/xbrldi">us-gaap:SubsequentEventMember</explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-03-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <dei:DocumentType id="F_000000" contextRef="C_0001029142_20130101_20131231">10-K</dei:DocumentType>
  <dei:AmendmentFlag id="F_000001" contextRef="C_0001029142_20130101_20131231">false</dei:AmendmentFlag>
  <dei:DocumentPeriodEndDate id="F_000002" contextRef="C_0001029142_20130101_20131231">2013-12-31</dei:DocumentPeriodEndDate>
  <dei:DocumentFiscalYearFocus id="F_000003" contextRef="C_0001029142_20130101_20131231">2013</dei:DocumentFiscalYearFocus>
  <dei:DocumentFiscalPeriodFocus id="F_000004" contextRef="C_0001029142_20130101_20131231">FY</dei:DocumentFiscalPeriodFocus>
  <dei:TradingSymbol id="F_000005" contextRef="C_0001029142_20130101_20131231">DVAX</dei:TradingSymbol>
  <dei:EntityRegistrantName id="F_000006" contextRef="C_0001029142_20130101_20131231">DYNAVAX TECHNOLOGIES CORP</dei:EntityRegistrantName>
  <dei:EntityCentralIndexKey id="F_000007" contextRef="C_0001029142_20130101_20131231">0001029142</dei:EntityCentralIndexKey>
  <dei:CurrentFiscalYearEndDate id="F_000008" contextRef="C_0001029142_20130101_20131231">--12-31</dei:CurrentFiscalYearEndDate>
  <dei:EntityWellKnownSeasonedIssuer id="F_000009" contextRef="C_0001029142_20130101_20131231">No</dei:EntityWellKnownSeasonedIssuer>
  <dei:EntityCurrentReportingStatus id="F_000010" contextRef="C_0001029142_20130101_20131231">Yes</dei:EntityCurrentReportingStatus>
  <dei:EntityVoluntaryFilers id="F_000011" contextRef="C_0001029142_20130101_20131231">No</dei:EntityVoluntaryFilers>
  <dei:EntityFilerCategory id="F_000012" contextRef="C_0001029142_20130101_20131231">Accelerated Filer</dei:EntityFilerCategory>
  <dei:EntityCommonStockSharesOutstanding id="F_000013" contextRef="C_0001029142_20140228" decimals="INF" unitRef="U_shares">262855958</dei:EntityCommonStockSharesOutstanding>
  <dei:EntityPublicFloat id="F_000014" contextRef="C_0001029142_20130628" decimals="0" unitRef="U_iso4217USD">105519624</dei:EntityPublicFloat>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="F_000015" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">23122000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="F_000016" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">7599000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:AvailableForSaleSecuritiesCurrent id="F_000017" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">166254000</us-gaap:AvailableForSaleSecuritiesCurrent>
  <us-gaap:AvailableForSaleSecuritiesCurrent id="F_000018" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">117531000</us-gaap:AvailableForSaleSecuritiesCurrent>
  <us-gaap:AccountsReceivableNetCurrent id="F_000019" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">1627000</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:AccountsReceivableNetCurrent id="F_000020" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">1005000</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent id="F_000021" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">1375000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent id="F_000022" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">2052000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:AssetsCurrent id="F_000023" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">192378000</us-gaap:AssetsCurrent>
  <us-gaap:AssetsCurrent id="F_000024" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">128187000</us-gaap:AssetsCurrent>
  <us-gaap:PropertyPlantAndEquipmentNet id="F_000025" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">8706000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentNet id="F_000026" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">7965000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:Goodwill id="F_000027" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">2579000</us-gaap:Goodwill>
  <us-gaap:Goodwill id="F_000028" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">2475000</us-gaap:Goodwill>
  <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent id="F_000029" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">662000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
  <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent id="F_000030" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">652000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
  <us-gaap:OtherAssetsNoncurrent id="F_000031" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">297000</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:OtherAssetsNoncurrent id="F_000032" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">473000</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:Assets id="F_000033" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">204622000</us-gaap:Assets>
  <us-gaap:Assets id="F_000034" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">139752000</us-gaap:Assets>
  <us-gaap:AccountsPayableCurrent id="F_000035" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">1901000</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccountsPayableCurrent id="F_000036" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">2166000</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccruedLiabilitiesCurrent id="F_000037" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">8166000</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AccruedLiabilitiesCurrent id="F_000038" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">10063000</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:DeferredRevenueCurrent id="F_000039" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">6125000</us-gaap:DeferredRevenueCurrent>
  <us-gaap:DeferredRevenueCurrent id="F_000040" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">6785000</us-gaap:DeferredRevenueCurrent>
  <us-gaap:LiabilitiesCurrent id="F_000041" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">16192000</us-gaap:LiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent id="F_000042" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">19014000</us-gaap:LiabilitiesCurrent>
  <us-gaap:DeferredRevenueNoncurrent id="F_000043" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">1173000</us-gaap:DeferredRevenueNoncurrent>
  <us-gaap:DeferredRevenueNoncurrent id="F_000044" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">5283000</us-gaap:DeferredRevenueNoncurrent>
  <us-gaap:OtherLiabilitiesNoncurrent id="F_000045" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">963000</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:OtherLiabilitiesNoncurrent id="F_000046" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">629000</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:Liabilities id="F_000047" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">18328000</us-gaap:Liabilities>
  <us-gaap:Liabilities id="F_000048" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">24926000</us-gaap:Liabilities>
  <us-gaap:CommitmentsAndContingencies id="F_000049" xsi:nil="true" contextRef="C_0001029142_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:CommitmentsAndContingencies id="F_000050" xsi:nil="true" contextRef="C_0001029142_20121231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:PreferredStockValue id="F_000051" xsi:nil="true" contextRef="C_0001029142_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:PreferredStockValue id="F_000052" xsi:nil="true" contextRef="C_0001029142_20121231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:PreferredStockValue id="F_000053" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:PreferredStockValue id="F_000054" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20121231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:CommonStockValue id="F_000055" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">263000</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue id="F_000056" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">183000</us-gaap:CommonStockValue>
  <us-gaap:AdditionalPaidInCapital id="F_000057" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">688390000</us-gaap:AdditionalPaidInCapital>
  <us-gaap:AdditionalPaidInCapital id="F_000058" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">550729000</us-gaap:AdditionalPaidInCapital>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax id="F_000059" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">-148000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax id="F_000060" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">-595000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="F_000061" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">-502211000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="F_000062" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">-435491000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:StockholdersEquity id="F_000063" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">186294000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000064" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">114826000</us-gaap:StockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity id="F_000065" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">204622000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity id="F_000066" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">139752000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="F_000067" contextRef="C_0001029142_20131231" decimals="INF" unitRef="U_iso4217USD_shares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="F_000068" contextRef="C_0001029142_20121231" decimals="INF" unitRef="U_iso4217USD_shares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized id="F_000069" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_shares">5000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesAuthorized id="F_000070" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_shares">5000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesIssued id="F_000071" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesIssued id="F_000072" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding id="F_000073" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockSharesOutstanding id="F_000074" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockSharesAuthorized id="F_000075" contextRef="C_0001029142_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20131231" decimals="-3" unitRef="U_shares">43000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesAuthorized id="F_000076" contextRef="C_0001029142_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20121231" decimals="-3" unitRef="U_shares">0</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesIssued id="F_000077" contextRef="C_0001029142_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20131231" decimals="-3" unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesIssued id="F_000078" contextRef="C_0001029142_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20121231" decimals="-3" unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding id="F_000079" contextRef="C_0001029142_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20131231" decimals="-3" unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockSharesOutstanding id="F_000080" contextRef="C_0001029142_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20121231" decimals="-3" unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:CommonStockParOrStatedValuePerShare id="F_000081" contextRef="C_0001029142_20131231" decimals="INF" unitRef="U_iso4217USD_shares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockParOrStatedValuePerShare id="F_000082" contextRef="C_0001029142_20121231" decimals="INF" unitRef="U_iso4217USD_shares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized id="F_000083" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_shares">350000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesAuthorized id="F_000084" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_shares">250000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued id="F_000085" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_shares">262796000</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued id="F_000086" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_shares">182792000</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding id="F_000087" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_shares">262796000</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockSharesOutstanding id="F_000088" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_shares">182792000</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:ContractsRevenue id="F_000089" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">4929000</us-gaap:ContractsRevenue>
  <us-gaap:ContractsRevenue id="F_000090" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">4610000</us-gaap:ContractsRevenue>
  <us-gaap:ContractsRevenue id="F_000091" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">17190000</us-gaap:ContractsRevenue>
  <us-gaap:RevenueFromGrants id="F_000092" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">5138000</us-gaap:RevenueFromGrants>
  <us-gaap:RevenueFromGrants id="F_000093" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">3939000</us-gaap:RevenueFromGrants>
  <us-gaap:RevenueFromGrants id="F_000094" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">3110000</us-gaap:RevenueFromGrants>
  <us-gaap:LicenseAndServicesRevenue id="F_000095" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">1184000</us-gaap:LicenseAndServicesRevenue>
  <us-gaap:LicenseAndServicesRevenue id="F_000096" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">1165000</us-gaap:LicenseAndServicesRevenue>
  <us-gaap:LicenseAndServicesRevenue id="F_000097" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">1314000</us-gaap:LicenseAndServicesRevenue>
  <us-gaap:Revenues id="F_000098" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">11251000</us-gaap:Revenues>
  <us-gaap:Revenues id="F_000099" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">9714000</us-gaap:Revenues>
  <us-gaap:Revenues id="F_000100" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">21614000</us-gaap:Revenues>
  <us-gaap:ResearchAndDevelopmentExpense id="F_000101" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">50870000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense id="F_000102" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">49146000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense id="F_000103" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">51322000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="F_000104" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">25943000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="F_000105" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">28164000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="F_000106" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">17570000</us-gaap:GeneralAndAdministrativeExpense>
  <dvax:UnoccupiedFacilityExpense id="F_000107" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">926000</dvax:UnoccupiedFacilityExpense>
  <us-gaap:AmortizationOfIntangibleAssets id="F_000108" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">299000</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:CostsAndExpenses id="F_000109" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">77739000</us-gaap:CostsAndExpenses>
  <us-gaap:CostsAndExpenses id="F_000110" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">77310000</us-gaap:CostsAndExpenses>
  <us-gaap:CostsAndExpenses id="F_000111" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">69191000</us-gaap:CostsAndExpenses>
  <us-gaap:OperatingIncomeLoss id="F_000112" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">-66488000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss id="F_000113" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">-67596000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss id="F_000114" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">-47577000</us-gaap:OperatingIncomeLoss>
  <us-gaap:InvestmentIncomeInterest id="F_000115" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">116000</us-gaap:InvestmentIncomeInterest>
  <us-gaap:InvestmentIncomeInterest id="F_000116" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">291000</us-gaap:InvestmentIncomeInterest>
  <us-gaap:InvestmentIncomeInterest id="F_000117" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">103000</us-gaap:InvestmentIncomeInterest>
  <us-gaap:InterestExpense id="F_000118" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">2351000</us-gaap:InterestExpense>
  <us-gaap:InterestExpense id="F_000119" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">1957000</us-gaap:InterestExpense>
  <us-gaap:OtherNonoperatingIncomeExpense id="F_000120" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">-348000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:OtherNonoperatingIncomeExpense id="F_000121" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">-293000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:OtherNonoperatingIncomeExpense id="F_000122" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">834000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:NetIncomeLoss id="F_000123" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">-66720000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="F_000124" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">-69949000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="F_000125" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">-48597000</us-gaap:NetIncomeLoss>
  <us-gaap:PreferredStockDividendsIncomeStatementImpact id="F_000126" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">8469000</us-gaap:PreferredStockDividendsIncomeStatementImpact>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="F_000127" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">-75189000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="F_000128" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">-69949000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="F_000129" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">-48597000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:EarningsPerShareBasicAndDiluted id="F_000130" contextRef="C_0001029142_20130101_20131231" decimals="2" unitRef="U_iso4217USD_shares">-0.38</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted id="F_000131" contextRef="C_0001029142_20120101_20121231" decimals="2" unitRef="U_iso4217USD_shares">-0.41</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted id="F_000132" contextRef="C_0001029142_20110101_20111231" decimals="2" unitRef="U_iso4217USD_shares">-0.39</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="F_000133" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_shares">196275000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="F_000134" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_shares">170469000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="F_000135" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_shares">125101000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax id="F_000136" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">-76000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax id="F_000137" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">48000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax id="F_000138" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">14000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax id="F_000139" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">523000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax id="F_000140" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">366000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax id="F_000141" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">-277000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="F_000142" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">447000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="F_000143" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">414000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="F_000144" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">-263000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:ComprehensiveIncomeNetOfTax id="F_000145" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">-66273000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:ComprehensiveIncomeNetOfTax id="F_000146" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">-69535000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:ComprehensiveIncomeNetOfTax id="F_000147" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">-48860000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:StockholdersEquity id="F_000148" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20101231" decimals="-3" unitRef="U_iso4217USD">116000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000149" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20101231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockholdersEquity id="F_000150" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20101231" decimals="-3" unitRef="U_iso4217USD">369686000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000151" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20101231" decimals="-3" unitRef="U_iso4217USD">-746000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000152" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20101231" decimals="-3" unitRef="U_iso4217USD">-316945000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000153" contextRef="C_0001029142_20101231" decimals="-3" unitRef="U_iso4217USD">52111000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding id="F_000154" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20101231" decimals="-3" unitRef="U_shares">115611000</us-gaap:SharesOutstanding>
  <dvax:IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue id="F_000155" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20110101_20111231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <dvax:IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue id="F_000156" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20110101_20111231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <dvax:IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue id="F_000157" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">10000</dvax:IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue>
  <dvax:IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue id="F_000158" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20110101_20111231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <dvax:IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue id="F_000159" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20110101_20111231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <dvax:IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue id="F_000160" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">10000</dvax:IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue>
  <dvax:IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsShares id="F_000161" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20110101_20111231" decimals="-3" unitRef="U_shares">308000</dvax:IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsShares>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan id="F_000162" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20110101_20111231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan id="F_000163" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20110101_20111231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan id="F_000164" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">132000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan id="F_000165" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20110101_20111231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan id="F_000166" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20110101_20111231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan id="F_000167" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">132000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans id="F_000168" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20110101_20111231" decimals="-3" unitRef="U_shares">106000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <dvax:IssuanceOfCommonStockAndWarrantsValue id="F_000169" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">39000</dvax:IssuanceOfCommonStockAndWarrantsValue>
  <dvax:IssuanceOfCommonStockAndWarrantsValue id="F_000170" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20110101_20111231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <dvax:IssuanceOfCommonStockAndWarrantsValue id="F_000171" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">91259000</dvax:IssuanceOfCommonStockAndWarrantsValue>
  <dvax:IssuanceOfCommonStockAndWarrantsValue id="F_000172" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20110101_20111231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <dvax:IssuanceOfCommonStockAndWarrantsValue id="F_000173" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20110101_20111231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <dvax:IssuanceOfCommonStockAndWarrantsValue id="F_000174" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">91298000</dvax:IssuanceOfCommonStockAndWarrantsValue>
  <dvax:IssuanceOfCommonStockAndWarrantsShares id="F_000175" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20110101_20111231" decimals="-3" unitRef="U_shares">38601000</dvax:IssuanceOfCommonStockAndWarrantsShares>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000176" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20110101_20111231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000177" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20110101_20111231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000178" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">5189000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000179" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20110101_20111231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000180" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20110101_20111231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000181" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">5189000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="F_000182" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20110101_20111231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="F_000183" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20110101_20111231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="F_000184" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20110101_20111231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="F_000185" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">-263000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="F_000186" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20110101_20111231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:NetIncomeLoss id="F_000187" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20110101_20111231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:NetIncomeLoss id="F_000188" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20110101_20111231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:NetIncomeLoss id="F_000189" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20110101_20111231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:NetIncomeLoss id="F_000190" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20110101_20111231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:NetIncomeLoss id="F_000191" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">-48597000</us-gaap:NetIncomeLoss>
  <us-gaap:StockholdersEquity id="F_000192" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111231" decimals="-3" unitRef="U_iso4217USD">155000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000193" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20111231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockholdersEquity id="F_000194" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20111231" decimals="-3" unitRef="U_iso4217USD">466276000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000195" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20111231" decimals="-3" unitRef="U_iso4217USD">-1009000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000196" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20111231" decimals="-3" unitRef="U_iso4217USD">-365542000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000197" contextRef="C_0001029142_20111231" decimals="-3" unitRef="U_iso4217USD">99880000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding id="F_000198" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20111231" decimals="-3" unitRef="U_shares">154626000</us-gaap:SharesOutstanding>
  <dvax:IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue id="F_000199" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">1000</dvax:IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue>
  <dvax:IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue id="F_000200" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20120101_20121231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <dvax:IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue id="F_000201" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">1954000</dvax:IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue>
  <dvax:IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue id="F_000202" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20120101_20121231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <dvax:IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue id="F_000203" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20120101_20121231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <dvax:IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue id="F_000204" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">1955000</dvax:IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue>
  <dvax:IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsShares id="F_000205" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20120101_20121231" decimals="-3" unitRef="U_shares">1222000</dvax:IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsShares>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan id="F_000206" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20120101_20121231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan id="F_000207" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20120101_20121231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan id="F_000208" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">307000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan id="F_000209" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20120101_20121231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan id="F_000210" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20120101_20121231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan id="F_000211" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">307000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans id="F_000212" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20120101_20121231" decimals="-3" unitRef="U_shares">141000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <dvax:IssuanceOfCommonStockAndWarrantsValue id="F_000213" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">27000</dvax:IssuanceOfCommonStockAndWarrantsValue>
  <dvax:IssuanceOfCommonStockAndWarrantsValue id="F_000214" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20120101_20121231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <dvax:IssuanceOfCommonStockAndWarrantsValue id="F_000215" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">71753000</dvax:IssuanceOfCommonStockAndWarrantsValue>
  <dvax:IssuanceOfCommonStockAndWarrantsValue id="F_000216" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20120101_20121231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <dvax:IssuanceOfCommonStockAndWarrantsValue id="F_000217" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20120101_20121231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <dvax:IssuanceOfCommonStockAndWarrantsValue id="F_000218" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">71780000</dvax:IssuanceOfCommonStockAndWarrantsValue>
  <dvax:IssuanceOfCommonStockAndWarrantsShares id="F_000219" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20120101_20121231" decimals="-3" unitRef="U_shares">26803000</dvax:IssuanceOfCommonStockAndWarrantsShares>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000220" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20120101_20121231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000221" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20120101_20121231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000222" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">10439000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000223" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20120101_20121231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000224" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20120101_20121231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000225" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">10439000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="F_000226" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20120101_20121231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="F_000227" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20120101_20121231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="F_000228" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20120101_20121231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="F_000229" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">414000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="F_000230" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20120101_20121231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:NetIncomeLoss id="F_000231" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20120101_20121231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:NetIncomeLoss id="F_000232" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20120101_20121231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:NetIncomeLoss id="F_000233" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20120101_20121231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:NetIncomeLoss id="F_000234" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20120101_20121231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:NetIncomeLoss id="F_000235" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">-69949000</us-gaap:NetIncomeLoss>
  <us-gaap:StockholdersEquity id="F_000236" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121231" decimals="-3" unitRef="U_iso4217USD">183000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000237" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20121231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockholdersEquity id="F_000238" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20121231" decimals="-3" unitRef="U_iso4217USD">550729000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000239" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20121231" decimals="-3" unitRef="U_iso4217USD">-595000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000240" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20121231" decimals="-3" unitRef="U_iso4217USD">-435491000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding id="F_000241" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20121231" decimals="-3" unitRef="U_shares">182792000</us-gaap:SharesOutstanding>
  <dvax:IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue id="F_000242" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20130101_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <dvax:IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue id="F_000243" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">112000</dvax:IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue>
  <dvax:IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue id="F_000244" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20130101_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <dvax:IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue id="F_000245" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">112000</dvax:IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue>
  <dvax:IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsShares id="F_000246" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20130101_20131231" decimals="-3" unitRef="U_shares">106000</dvax:IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsShares>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan id="F_000247" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20130101_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan id="F_000248" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">224000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan id="F_000249" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20130101_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan id="F_000250" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">224000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans id="F_000251" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20130101_20131231" decimals="-3" unitRef="U_shares">129000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross id="F_000252" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20130101_20131231" decimals="-3" unitRef="U_shares">115000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000253" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">80000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000254" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">80919000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000255" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20130101_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000256" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">80999000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000257" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20130101_20131231" decimals="-3" unitRef="U_shares">79570000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="F_000258" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20130101_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="F_000259" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">44209000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="F_000260" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20130101_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities id="F_000261" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">44209000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities id="F_000262" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20130101_20131231" decimals="-3" unitRef="U_shares">43000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
  <us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature id="F_000263" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20130101_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature id="F_000264" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20130101_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature id="F_000265" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20130101_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature id="F_000266" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20130101_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature id="F_000267" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20130101_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature id="F_000268" xsi:nil="true" contextRef="C_0001029142_20130101_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ConvertiblePreferredDividendsNetOfTax id="F_000269" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20130101_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ConvertiblePreferredDividendsNetOfTax id="F_000270" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20130101_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ConvertiblePreferredDividendsNetOfTax id="F_000271" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20130101_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ConvertiblePreferredDividendsNetOfTax id="F_000272" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20130101_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ConvertiblePreferredDividendsNetOfTax id="F_000273" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20130101_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ConvertiblePreferredDividendsNetOfTax id="F_000274" xsi:nil="true" contextRef="C_0001029142_20130101_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts id="F_000275" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">-143000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts id="F_000276" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">-143000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
  <us-gaap:DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1 id="F_000277" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20130101_20131231" decimals="-3" unitRef="U_shares">84000</us-gaap:DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000278" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20130101_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000279" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20130101_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000280" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20130101_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000281" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20130101_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000282" xsi:nil="true" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20130101_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="F_000283" xsi:nil="true" contextRef="C_0001029142_20130101_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000284" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">12340000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="F_000285" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">12340000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="F_000286" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">447000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:NetIncomeLoss id="F_000287" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">-66720000</us-gaap:NetIncomeLoss>
  <us-gaap:StockholdersEquity id="F_000288" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20131231" decimals="-3" unitRef="U_iso4217USD">263000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000289" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20131231" decimals="-3" unitRef="U_iso4217USD">688390000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000290" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20131231" decimals="-3" unitRef="U_iso4217USD">-148000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="F_000291" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20131231" decimals="-3" unitRef="U_iso4217USD">-502211000</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding id="F_000292" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20131231" decimals="-3" unitRef="U_shares">262796000</us-gaap:SharesOutstanding>
  <us-gaap:SharesOutstanding id="F_000293" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapPreferredStockMember_20131231" decimals="-3" unitRef="U_shares">43000</us-gaap:SharesOutstanding>
  <us-gaap:DepreciationAndAmortization id="F_000294" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">1327000</us-gaap:DepreciationAndAmortization>
  <us-gaap:DepreciationAndAmortization id="F_000295" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">1207000</us-gaap:DepreciationAndAmortization>
  <us-gaap:DepreciationAndAmortization id="F_000296" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">1303000</us-gaap:DepreciationAndAmortization>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment id="F_000297" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">-18000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment id="F_000298" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">-8000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment id="F_000299" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">-20000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments id="F_000300" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">-923000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
  <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments id="F_000301" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">-1298000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
  <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments id="F_000302" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">-1172000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
  <us-gaap:AmortizationOfFinancingCosts id="F_000303" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">2190000</us-gaap:AmortizationOfFinancingCosts>
  <us-gaap:AmortizationOfFinancingCosts id="F_000304" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">1871000</us-gaap:AmortizationOfFinancingCosts>
  <us-gaap:OtherNoncashIncomeExpense id="F_000305" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">843000</us-gaap:OtherNoncashIncomeExpense>
  <us-gaap:BusinessExitCosts1 id="F_000306" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">926000</us-gaap:BusinessExitCosts1>
  <us-gaap:ShareBasedCompensation id="F_000307" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">12340000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation id="F_000308" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">10439000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation id="F_000309" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">5189000</us-gaap:ShareBasedCompensation>
  <us-gaap:IncreaseDecreaseInAccountsReceivable id="F_000310" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">622000</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:IncreaseDecreaseInAccountsReceivable id="F_000311" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">-8522000</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:IncreaseDecreaseInAccountsReceivable id="F_000312" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">8526000</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:IncreaseDecreaseInOtherCurrentAssets id="F_000313" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">-677000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
  <us-gaap:IncreaseDecreaseInOtherCurrentAssets id="F_000314" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">922000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
  <us-gaap:IncreaseDecreaseInOtherCurrentAssets id="F_000315" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">-230000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
  <dvax:IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities id="F_000316" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">-176000</dvax:IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities>
  <dvax:IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities id="F_000317" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">116000</dvax:IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities>
  <dvax:IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities id="F_000318" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">290000</dvax:IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities>
  <us-gaap:IncreaseDecreaseInAccountsPayable id="F_000319" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">-657000</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccountsPayable id="F_000320" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">126000</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccountsPayable id="F_000321" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">-289000</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities id="F_000322" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">-2291000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities id="F_000323" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">1916000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities id="F_000324" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">-2167000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <us-gaap:IncreaseDecreaseInDeferredRevenue id="F_000325" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">-4770000</us-gaap:IncreaseDecreaseInDeferredRevenue>
  <us-gaap:IncreaseDecreaseInDeferredRevenue id="F_000326" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">1472000</us-gaap:IncreaseDecreaseInDeferredRevenue>
  <us-gaap:IncreaseDecreaseInDeferredRevenue id="F_000327" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">3512000</us-gaap:IncreaseDecreaseInDeferredRevenue>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities id="F_000328" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">-58673000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities id="F_000329" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">-43809000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities id="F_000330" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">-47116000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:PaymentsToAcquireMarketableSecurities id="F_000331" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">192044000</us-gaap:PaymentsToAcquireMarketableSecurities>
  <us-gaap:PaymentsToAcquireMarketableSecurities id="F_000332" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">206149000</us-gaap:PaymentsToAcquireMarketableSecurities>
  <us-gaap:PaymentsToAcquireMarketableSecurities id="F_000333" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">111205000</us-gaap:PaymentsToAcquireMarketableSecurities>
  <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities id="F_000334" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">142321000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
  <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities id="F_000335" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">169387000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
  <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities id="F_000336" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">77729000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="F_000337" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">1629000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="F_000338" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">2931000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="F_000339" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">1142000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities id="F_000340" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">-51352000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities id="F_000341" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">-39693000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities id="F_000342" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">-34618000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="F_000343" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">80856000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="F_000344" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">71780000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="F_000345" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">91298000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock id="F_000346" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">44209000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
  <us-gaap:ProceedsFromIssuanceOfWarrants id="F_000347" xsi:nil="true" contextRef="C_0001029142_20130101_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ProceedsFromIssuanceOfWarrants id="F_000348" xsi:nil="true" contextRef="C_0001029142_20120101_20121231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ProceedsFromIssuanceOfWarrants id="F_000349" xsi:nil="true" contextRef="C_0001029142_20110101_20111231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ProceedsFromStockOptionsExercised id="F_000350" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">112000</us-gaap:ProceedsFromStockOptionsExercised>
  <us-gaap:ProceedsFromStockOptionsExercised id="F_000351" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">1955000</us-gaap:ProceedsFromStockOptionsExercised>
  <us-gaap:ProceedsFromStockOptionsExercised id="F_000352" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">10000</us-gaap:ProceedsFromStockOptionsExercised>
  <us-gaap:ProceedsFromStockPlans id="F_000353" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">224000</us-gaap:ProceedsFromStockPlans>
  <us-gaap:ProceedsFromStockPlans id="F_000354" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">307000</us-gaap:ProceedsFromStockPlans>
  <us-gaap:ProceedsFromStockPlans id="F_000355" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">132000</us-gaap:ProceedsFromStockPlans>
  <us-gaap:RepaymentsOfNotesPayable id="F_000356" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">15000000</us-gaap:RepaymentsOfNotesPayable>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities id="F_000357" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">125401000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities id="F_000358" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">59042000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities id="F_000359" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">91440000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents id="F_000360" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">147000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
  <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents id="F_000361" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">118000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
  <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents id="F_000362" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">-218000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease id="F_000363" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">15523000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease id="F_000364" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">-24342000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease id="F_000365" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">9488000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="F_000366" contextRef="C_0001029142_20111231" decimals="-3" unitRef="U_iso4217USD">31941000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="F_000367" contextRef="C_0001029142_20101231" decimals="-3" unitRef="U_iso4217USD">22453000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <dvax:SupplementalDisposalOfAssets id="F_000368" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">86000</dvax:SupplementalDisposalOfAssets>
  <dvax:SupplementalDisposalOfAssets id="F_000369" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">169000</dvax:SupplementalDisposalOfAssets>
  <dvax:SupplementalDisposalOfAssets id="F_000370" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">1181000</dvax:SupplementalDisposalOfAssets>
  <us-gaap:MarketableSecuritiesUnrealizedGainLoss id="F_000371" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">-76000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
  <us-gaap:MarketableSecuritiesUnrealizedGainLoss id="F_000372" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">48000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
  <us-gaap:MarketableSecuritiesUnrealizedGainLoss id="F_000373" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">14000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
  <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock id="F_000374" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"&gt;&lt;tr&gt;&lt;td valign="top" style="width:4.54%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:95.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Organization &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Dynavax Technologies Corporation (&amp;#8220;we,&amp;#8221; &amp;#8220;our,&amp;#8221; &amp;#8220;us,&amp;#8221; &amp;#8220;&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Dynavax&amp;#8221; or the &amp;#8220;Company&amp;#8221;), a clinical-stage biopharmaceutical company, develops products to prevent and treat infectious and inflammatory diseases and cancer based on Toll-like Receptor (&amp;#8220;TLR&amp;#8221;) biology and its ability to modulate the innate immune system. Our lead product candidate is HEPLISAV-B&lt;sup style="font-size:85%; vertical-align:top"&gt;TM &lt;/sup&gt;(also known as &amp;#8220;HEPLISAV&amp;#8221;), an investigational adult hepatitis B vaccine in Phase 3 clinical development. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;In addition to HEPLISAV-B&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, we are conducting clinical and preclinical programs that utilize our expertise in TLR biology. Our product candidates include both TLR agonists and TLR inhibitors. Our clinical stage programs include our autoimmune program partnered with GlaxoSmithKline (&amp;#8220;GSK&amp;#8221;), our asthma therapeutic program partnered with AstraZeneca AB (&amp;#8220;AstraZeneca&amp;#8221;), and our cancer immunotherapy program. We also are advancing preclinical development programs in adjuvant technology and TLR 7, 8, and 9 inhibition. We compete with pharmaceutical companies, biotechnology companies, academic institutions and research organizations in developing therapies to prevent or treat infectious and inflammatory diseases and cancer. We were incorporated in California in August&amp;#160;1996 under the name Double Helix Corporation, and we changed our name to Dynavax Technologies Corporation in September&amp;#160;1996. We reincorporated in Delaware in 2000.&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Subsidiaries &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;In April 2006, we completed the acquisition of Rhein&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; Biotech GmbH (&amp;#8220;Rhein&amp;#8221; or &amp;#8220;Dynavax Europe&amp;#8221;), a wholly-owned subsidiary in D&amp;#252;sseldorf, Germany. In October 2011, we formed Dynavax International, B.V., a wholly-owned subsidiary in Amsterdam, Netherlands. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
  <us-gaap:SignificantAccountingPoliciesTextBlock id="F_000375" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"&gt;&lt;tr&gt;&lt;td valign="top" style="width:4.54%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:95.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Summary of Significant Accounting Policies &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basis of Presentation &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;The consolidated financial statements include our accounts and those of our wholly-owned subsidiaries. All significant intercompany accounts and transactions among the entities have been eliminated from the consolidated financial statements. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Liquidity and Financial Condition &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We have incurred significant operating losses and negative cash flows from operations since our inception. As of December&amp;#160;31, 2013, we had cash, cash equivalents and marketable securities of $189.4&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million. We currently estimate that we have sufficient cash resources to meet our anticipated cash needs through at least the next 12 months based on cash, cash equivalents and marketable securities on hand as of December&amp;#160;31, 2013 and anticipated revenues and funding from existing agreements.&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We expect to continue to spend substantial funds in connection with the development and manufacturing of our product candidates, particularly HEPLISAV-B&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, human clinical trials for our product candidates and additional applications and advancement of our technology. In order to continue these activities, we may need to raise additional funds. This may occur through strategic alliance and licensing arrangements and/or future public or private financings. Sufficient additional funding may not be available on acceptable terms, or at all. If adequate funds are not available in the future, we may need to delay, reduce the scope of or put on hold the HEPLISAV-B program or our other development programs while we seek strategic alternatives.&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Use of Estimates &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;The preparation of financial statements in conformity with U.S. generally accepted accounting principles (&amp;#8220;U.S. GAAP&amp;#8221;) requires management to make informed &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results may differ materially from these estimates.&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:10pt;;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Foreign Currency Translation&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We consider the local currency to be the functional currency for our international subsidiary, Rhein&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;. Accordingly, assets and liabilities denominated in foreign currencies are translated into U.S. dollars using the exchange rate in effect on the balance sheet date. Revenues and expenses are translated at average exchange rates prevailing throughout the year. Currency translation adjustments arising from period to period are charged or credited to accumulated other comprehensive income (loss) in the equity. For the years ended December&amp;#160;31, 2013, 2012 and 2011, we reported an unrealized gain of $0.5 million, an unrealized gain of $0.4 million and an unrealized loss of $0.3 million, respectively. Realized gains and losses resulting from currency transactions are included in the consolidated statements of operations. For the years ended December&amp;#160;31, 2013, 2012 and 2011, we reported a loss of $0.2 million, a loss of $0.2 million and a gain of $0.2 million, respectively, resulting from currency transactions in our consolidated statements of operations. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash, Cash Equivalents and Marketable Securities &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We consider all highly liquid investments purchased with an original maturity of three&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; months or less and that can be liquidated without prior notice or penalty, to be cash equivalents. Management determines the appropriate classification of marketable securities at the time of purchase. We invest in short-term money market funds, U.S. government agency securities, U.S. treasury securities and municipal securities. We believe these types of investments are subject to minimal credit and market risk. We do not invest in auction rate securities or securities collateralized by home mortgages, mortgage bank debt, or home equity loans. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We have classified our entire investment portfolio as available-for-sale a&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;nd available for use in current operations and accordingly have classified all investments as short-term. Available-for-sale securities are carried at fair value based on inputs that are observable, either directly or indirectly, such as quoted market prices for similar securities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the securities, with unrealized gains and losses included in accumulated other comprehensive income (loss) in stockholders&amp;#8217; equity. Realized gains and losses and declines in value, if any, judged to be other than temporary on available-for-sale securities are included in interest income or expense. The cost of securities sold is based on the specific identification method. Management assesses whether declines in the fair value of investment securities are other than temporary. In determining whether a decline is other than temporary, management considers the following factors: &lt;/font&gt;&lt;/p&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"&gt;&lt;tr&gt;&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-family:&apos;Symbol&apos;;font-size:10pt;"&gt;&amp;#183;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:96.67%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Whether the investment has been in a continuous realized loss position for over 12 months; &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"&gt;&lt;tr&gt;&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-family:&apos;Symbol&apos;;font-size:10pt;"&gt;&amp;#183;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:96.67%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;the duration to maturity of our investments; &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"&gt;&lt;tr&gt;&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-family:&apos;Symbol&apos;;font-size:10pt;"&gt;&amp;#183;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:96.67%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;our intention and ability to hold the investments to maturity and if it is not more likely than not that we will be required to sell the investment before recovery of the amortized cost bases; &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"&gt;&lt;tr&gt;&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-family:&apos;Symbol&apos;;font-size:10pt;"&gt;&amp;#183;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:96.67%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;the credit rating, financial condition and near-term prospects of the issuer; and &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"&gt;&lt;tr&gt;&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-family:&apos;Symbol&apos;;font-size:10pt;"&gt;&amp;#183;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:96.67%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;the type of investments made. &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;To date, there have been no declines in fair value that have been identified as other than temporary&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Concentration of Credit Risk and Other Risks and Uncertainties &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We operate in one&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; business segment, which is the discovery and development of biopharmaceutical products. We determine our segments based on the way we organize our business by making operating decisions and assessing performance. In fiscal years 2013, 2012 and 2011, 89%, 88% and 94% of our revenues were earned in the United States, respectively, and the remaining revenues were earned in Germany. As of December&amp;#160;31, 2013 and 2012, 9% and 10%, respectively, of our long-lived assets were located in the United States and the remaining long-lived assets were located in Germany. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Financial instruments that are subject to concentration of credit risk consist primarily of cash equivalents, marketable securities and accounts receivable. Our policy is to invest cash in institutional money market funds and marketable securities of U.S. government and corporate issuers with high credit quality to limit the amount of credit exposure. We currently maintain a portfolio of cash equivalents and marketable securities in a variety of securities, including short-term &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;money market funds, U.S. government agency securities, U.S. treasury securities and municipal securities. We have not experienced any losses on our cash equivalents and marketable securities. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Accounts receivable are recorded at invoice value. We review our exposure to accounts receivable, including the requirement&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; for allowances based on management&amp;#8217;s judgment. We have not historically experienced any significant losses. We do not currently require collateral for any of our accounts receivable. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Our products will require approval from the U.S. Food and Drug Administration (&amp;#8220;FDA&amp;#8221;) and foreign regulatory agencies before commercial sales can commence. There can be no assurance that our products will receive any of these required approvals. The denial or delay of such approvals would have a material adverse impact on our business. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We have relied on a limited number of suppliers to produce oligonucleotides &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;for clinical trials and a single contract manufacturer to produce our first generation TLR 9 agonist, 1018 for HEPLISAV-B. The loss of our current supplier would have a significant effect on our ability to produce HEPLISAV-B for commercialization and development of our other product candidates. To date, we have manufactured only small quantities of oligonucleotides and 1018 ourselves for development purposes. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We are subject to risks common to companies in the biopharmaceutical industry, including, but not limited to, new technological innovations, clinical development risk, establishing appropriate commercial partnerships, protection of proprietary technology, compliance with government and environmental regulations, uncertainty of market acceptance of products, product liability, the volatility of our stock price and the need to obtain additional financing.&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Long-Lived Assets &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Property and equipment are recorded at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets. Repair and maintenance costs are charged to expense as incurred. Leasehold improvements in both of our facilities are amortized over the remaining life of the initial lease term or the estimated useful lives of the assets, whichever is shorter. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We evaluate the carrying value of long-lived assets, including intangible assets, whenever events or changes in business circumstances or our planned use of long-lived assets indicate, based on undiscounted future operating cash flows,&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; that their carrying amounts may not be fully recoverable or that their useful lives are no longer appropriate. When an indicator of impairment exists, long-lived assets are written down to their respective fair values. Fair value is determined primarily using the anticipated cash flows discounted at a rate commensurate with the risk involved. Significant management judgment is required in the forecast of future operating results that are used in the preparation of expected undiscounted cash flows. No impairments of purchased intangible assets have been identified during the years presented. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Goodwill&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Our goodwill balance relates to our April 2006 acquisition of Rhein&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;. Goodwill was recorded as the excess purchase price over tangible and intangible assets acquired and liabilities assumed based on their estimated fair value, by applying the acquisition method of accounting. Goodwill is not amortized but is subject to an annual impairment test which consists of a comparison of the fair value of the related reporting unit against its carrying amount including goodwill. If the carrying amount exceeds the fair value, impairment is calculated and recorded as a charge in the consolidated statements of operations. We determined that we have only one operating segment and there are no components of that operating segment that are deemed to be separate reporting units such that we have one reporting unit for purposes of our goodwill impairment testing. We evaluate goodwill for impairment on an annual basis and on an interim basis if events or changes in circumstances between annual impairment tests indicate that the asset might be impaired.&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:10pt;;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue Recognition &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Our revenues consist of amounts earned from collaborations, grants and fees from services and licenses. We enter into license and manufacturing agreements and collaborative research and development arrangements with pharmaceutical and biotechnology partners that may involve multiple deliverables. Our arrangements may include one or more of the following elements: upfront license payments, cost reimbursement for the performance of research and development activities, milestone payments, other contingent payments, contract manufacturing service fees, royalties and license fees. Each deliverable in the arrangement is evaluated to determine whether it meets the criteria to be accounted for as a separate unit of accounting or whether it should be combined with other deliverables. In order to account for the multiple-element arrangements, the Company identifies the deliverables included within the arrangement and evaluates which deliverables represent separate units of accounting. Analyzing the arrangement to identify deliverables requires the use of judgment, and each deliverable may be an obligation to deliver services, a right or license to use an asset, or another performance obligation. We recognize revenue when there is persuasive evidence that an arrangement exists, delivery has occurred or services have been rendered, the price is fixed or determinable and collectability is reasonably assured. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;On January&amp;#160;1, 2011, we adopted on a prospective basis Financial Accounting Standards Board (&amp;#8220;FASB&amp;#8221;) Accounting Standards Update (&amp;#8220;ASU&amp;#8221;) 2009-13, &lt;/font&gt;&lt;font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Multiple-Deliverable Revenue Arrangements&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, which amends the criteria related to identifying separate units of accounting and provides guidance on whether multiple deliverables exist, how an arrangement should be separated and the consideration allocated. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Non-refundable upfront fees received for license and collaborative agreements entered into prior to January&amp;#160;1, 2011 and other payments under collaboration agreements where we have continuing performance obligations related to the payments are deferred and recognized over our expected performance period. Revenue is recognized on a ratable basis, unless we determine that another method is more appropriate, through the date at which our performance obligations are completed. Management makes its best estimate of the period over which we expect to fulfill our performance obligations, which may include clinical development activities. Given the uncertainties of research and development collaborations, significant judgment is required to determine the duration of the performance period. We recognize cost reimbursement revenue under collaborative agreements as the related research and development costs are incurred, as provided for under the terms of these agreements. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Contingent consideration received for the achievement of a substantive milestone is recognized in its entirety in the period in which the milestone is achieved. A milestone is defined as an event having all of the following characteristics: (i&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&amp;#160;there is substantive uncertainty at the date the arrangement is entered into that the event will be achieved, (ii)&amp;#160;the event can only be achieved based in whole or in part on either the entity&amp;#8217;s performance or a specific outcome resulting from the entity&amp;#8217;s performance and (iii)&amp;#160;if achieved, the event would result in additional payments being due to the entity. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Our license and collaboration agreements with our partners provide for payments to be paid to us upon the achievement of development milestones. Given the challenges inherent in developing biologic products, there is substantial uncertainty whether any such milestones will be achieved at the time we entered into these agreements. In addition, we evaluate whether the development milestones meet the criteria to be considered substantive. The conditions include: (i&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&amp;#160;the development work is contingent on either of the following: (a)&amp;#160;the vendor&amp;#8217;s performance to achieve the milestone or (b)&amp;#160;the enhancement of the value of the deliverable item or items as a result of a specific outcome resulting from the vendor&amp;#8217;s performance to achieve the milestone; (ii)&amp;#160;it relates solely to past performance and (iii)&amp;#160;it is reasonable relative to all the deliverable and payment terms within the arrangement. As a result of our analysis, we consider our development milestones to be substantive and, accordingly, we expect to recognize as revenue future payments received from such milestones as we achieve each milestone. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Milestone payments that are contingent upon the achievement of substantive at-risk performance criteria are recognized in full upon achievement of those milestone events in accordance with the terms of the agreement and assuming all other revenue recognition criteria have been met. All revenue recognized to date under our collaborative agreements has been nonrefundable. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Our license and collaboration agreements with certain partners also provide for contingent payments to be paid to us based solely upon the performance of our partner. For such contingent payments we expect to recognize the payments as revenue upon receipt, provided that collection is reasonably assured and the other revenue recognition criteria have been satisfied. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Revenues from manufacturing services are recognized upon meeting the criteria for substantial performance and acceptance by the customer. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Revenue from royalty payments is contingent on future sales activities by our licensees. As a result, we recognize royalty revenue when reported by our licensees and when collection is reasonably assured. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Revenue from government and private agency grants are recognized as the related research expenses are incurred and to the extent that funding is approved. Additionally, we recognize revenue based on the facilities and administrative cost rate reimbursable per the terms of the grant awards. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and Development Expenses and Accruals &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Research and development expenses include personnel and facility-related expenses, outside contracted services including clinical trial costs, manufacturing and process development costs, research costs and other consulting services and non-cash stock-based compensation. Research and development costs are expensed as incurred. Amounts due under such arrangements may be either fixed fee or fee for service, and may include upfront payments, monthly payments and payments upon the completion of milestones or receipt of deliverables. Non-refundable advance payments under agreements are capitalized and expensed as the related goods are delivered or services are performed. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We contract with third parties to perform various clinical trial activities in the on-going development of potential products. The financial terms of these agreements are subject to negotiation, vary from contract to contract and may result in uneven payment flows to our vendors. Payments under the contracts depend on factors such as the achievement of certain events, successful enrollment of patients, completion&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; of portions of the clinical trial or similar conditions. Our accruals for clinical trials are based on estimates of the services received and efforts expended pursuant to contracts with clinical trial centers and clinical research organizations. We may terminate these contracts upon written notice and we are generally only liable for actual effort expended by the organizations to the date of termination, although in certain instances we may be further responsible for termination fees and penalties. The Company makes estimates of its accrued expenses as of each balance sheet date based on the facts and circumstances known to the Company at that time. There have been no material adjustments to the Company&amp;#8217;s prior period accrued estimates for clinical trial activities through December 31, 2013.&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock-Based Compensation &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Stock-based compensation expense for stock options and other stock awards is estimated at the grant date based on the award&amp;#8217;s fair value-based measurement and is recognized on a straight-line basis over the award&amp;#8217;s vesting period, assuming appropriate forfeiture rates&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;. Our determination of the fair value-based measurement of stock options on the date of grant using an option-pricing model is affected by our stock price, as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, our expected stock price volatility over the term of the awards, and actual and projected employee stock option exercise behaviors. In the future, as additional empirical evidence regarding these input estimates becomes available, we may change or refine our approach of deriving these input estimates. These changes could impact our fair value-based measurement of stock options granted in the future. Changes in the fair value-based measurement of stock awards could materially impact our operating results. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We selected the Black-Scholes option pricing model as the most appropriate method for determining the estimated fair value-based measurement of our stock options. The Black-Scholes model requires the use of highly subjective and complex assumptions which determine the fair value-based measurement of stock options, including the option&amp;#8217;s expected term and the price volatility of the underlying stock. Our current estimate of volatility is based on the historical volatility of our stock price. To the extent volatility in our stock price increases in the future, our estimates of the fair value of options granted in the future could increase, thereby increasing stock-based compensation cost recognized in future periods. We derive the expected term assumption primarily based on our historical settlement experience, while giving consideration to options that have not yet completed a full life cycle. Stock-based compensation cost is recognized only for awards ultimately expected to vest. Our estimate of the forfeiture rate is based primarily on our historical experience. To the extent we revise this estimate in the future,&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; our share-based compensation cost could be materially impacted in the quarter of revision, as well as in the following quarters. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Income Taxes &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We account for income taxes using the asset and liability method, under which deferred tax assets and liabilities are determined based on the differences between the financial reporting and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Additionally, we assess the likelihood that deferred tax assets will be recovered as deductions from future taxable income. We have provided a full valuation allowance on our deferred tax assets at December&amp;#160;31, 2013 and 2012 because we believe it is more likely than not that our deferred tax assets will not be realized as of December&amp;#160;31, 2013, and 2012. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We have no&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; unrecognized tax benefits as of December&amp;#160;31, 2013, including no accrued amounts for interest and penalties. We do not anticipate that total unrecognized tax benefits will significantly change prior to December&amp;#160;31, 2014. Our policy will be to recognize interest and penalties related to income taxes, if any, as a component of general and administrative expense. We are subject to income tax examinations for U.S. federal and state income taxes from 1996 forward. We are subject to tax examination in Germany from 2010 forward.&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Recent Accounting Pronouncements &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Accounting Standards Update 2013-02 &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;In February&amp;#160;2013, the FASB issued ASU 2013-02, &amp;#8220;&lt;/font&gt;&lt;font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Reporting of Amounts Reclassified out of Accumulated Other Comprehensive Income.&amp;#8221;&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;This ASU expands the presentation of changes in accumulated other comprehensive income.&amp;#160;The new guidance requires an entity to disaggregate the total change of each component of other comprehensive income either on the face of the statement of operations or as a separate disclosure in the financial statement footnotes. ASU 2013-02 is effective for fiscal years beginning after December&amp;#160;15, 2012. The Company adopted this guidance on a prospective basis in the first quarter of 2013 and the adoption did not have any impact on our financial position, results of operations or cash flows as there were no amounts reclassified out of accumulated other comprehensive (loss) income during the year ended December 31, 2013.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
  <us-gaap:FairValueDisclosuresTextBlock id="F_000376" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"&gt;&lt;tr&gt;&lt;td valign="top" style="width:4.54%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:95.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair Value Measurements &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;The Company defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The accounting &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;standard describes a fair value hierarchy based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value which are the following: &lt;/font&gt;&lt;/p&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"&gt;&lt;tr&gt;&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-family:&apos;Symbol&apos;;font-size:10pt;"&gt;&amp;#183;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:96.67%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1&amp;#8212;Observable inputs, such as quoted prices in active markets for identical assets or liabilities; &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"&gt;&lt;tr&gt;&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-family:&apos;Symbol&apos;;font-size:10pt;"&gt;&amp;#183;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:96.67%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&amp;#8212;Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"&gt;&lt;tr&gt;&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-family:&apos;Symbol&apos;;font-size:10pt;"&gt;&amp;#183;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:96.67%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 3&amp;#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities, therefore requiring an entity to develop its own assumptions. &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Recurring Fair Value Measurements &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;The following table represents the fair value hierarchy for our financial assets (cash equivalents and marketable securities) measured at fair value on a recurring basis as of December&amp;#160;31, 2013 and 2012 (in thousands): &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:54%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level&amp;#160;3&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&amp;#160;31, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Money market funds&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:54%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. government agency securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;167,597&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;167,597&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;167,597&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;187,610&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:54%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level&amp;#160;3&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&amp;#160;31, 2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Money market funds&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,140&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,140&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. government agency securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;119,233&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;119,233&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. treasury securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;500&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;500&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:54%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Municipal securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;715&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;715&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:54%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,140&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;120,448&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;123,588&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Money market funds are highly liquid investments and are actively traded. The pricing information on these investment instruments are readily available and can be independently validated as of the measurement date. This approach results in the classification of these securities as Level 1 of the fair value hierarchy. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;U.S. Government agency securities, U.S. treasury securities and municipal securities are measured at fair value using Level 2 inputs. We review trading activity and pricing for these investments as of each measurement date. When sufficient quoted pricing for identical securities is not available, we use market pricing and other observable market inputs for similar securities obtained from various third party data providers. These inputs represent quoted prices for similar assets in active markets or these inputs have been derived from observable market data. This approach results in the classification of these securities as Level 2 of the fair value hierarchy. &lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:9pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"&gt;&lt;font style="color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
  <us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock id="F_000377" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"&gt;&lt;tr&gt;&lt;td valign="top" style="width:4.54%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:95.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash, Cash Equivalents and Marketable Securities &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;The following is a summary of cash, cash equivalents and marketable securities as of December&amp;#160;31, 2013, and 2012 (in thousands): &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized Cost&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized Gains&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized Losses&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Estimated Fair&amp;#160;Value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&amp;#160;31, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash and cash equivalents:&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,766&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,766&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Money market funds&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. government agency securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,343&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,343&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total cash and cash equivalents&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;23,122&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;23,122&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Marketable securities available-for-sale:&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. government agency securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;166,285&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(47&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;166,254&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total marketable securities available-for-sale&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;166,285&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(47&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;166,254&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total cash, cash equivalents and marketable securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;189,407&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(47&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;189,376&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%; border-top:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&amp;#160;31, 2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash and cash equivalents:&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,542&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,542&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Money market funds&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,140&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,140&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Municipal securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;715&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;715&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. government agency securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,202&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,202&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total cash and cash equivalents&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,599&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,599&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Marketable securities available-for-sale:&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. government agency securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;116,986&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;46&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;117,031&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. treasury securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;500&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;500&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total marketable securities available-for-sale&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;117,486&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;46&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;117,531&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total cash, cash equivalents and marketable securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;125,085&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;46&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;125,130&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;The maturities of our marketable securities available-for-sale are as follows (in thousands) &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:62%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:3%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:33%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&amp;#160;31, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:62%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:3%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized Cost&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:3%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Estimated Fair Value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:62%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Mature in one year or less&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:3%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;93,691&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:3%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:14%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;93,701&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:62%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Mature after one year through two years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:3%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;72,594&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:3%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;72,553&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:62%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:3%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;166,285&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:3%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;166,254&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We invest in short-term money market funds, U.S. government agency securities, U.S treasury securities and&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; municipal securities. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;There were no&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; realized gains or losses from the sale of marketable securities in the years ended December&amp;#160;31, 2013, 2012 and 2011. All of our investments are classified as short-term and available-for-sale, as we may not hold our investments until maturity. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock>
  <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock id="F_000378" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"&gt;&lt;tr&gt;&lt;td valign="top" style="width:4.54%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:95.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property and Equipment &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Property and equipment as of December&amp;#160;31, 2013, and 2012 consist of the following (in thousands): &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:70%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:8%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Estimated&amp;#160;Useful&lt;br /&gt;Life&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&amp;#160;31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:70%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;(In years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:70%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Manufacturing equipment&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5-14&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,968&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,574&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:70%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Lab equipment&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5-13&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,227&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,755&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:70%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Computer equipment&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,962&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,807&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:70%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Furniture and fixtures&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,056&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;983&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:70%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Leasehold improvements&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5-7&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,048&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,445&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:70%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Assets in progress&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:8%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;762&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,047&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:70%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;26,023&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;23,611&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:70%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less accumulated depreciation and amortization&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:8%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(17,317&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(15,646&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:70%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:8%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,706&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,965&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Depreciation and amortization expense on property and equipment was $1.3&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million, $1.2 million and $1.3&amp;#160;million for the years ended December&amp;#160;31, 2013, 2012 and 2011, respectively. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
  <us-gaap:IntangibleAssetsDisclosureTextBlock id="F_000379" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"&gt;&lt;tr&gt;&lt;td valign="top" style="width:4.54%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;6.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:95.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Intangible Assets &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Intangible assets consisted primarily of manufacturing process and customer relationships related to our 2006 acquisition of Rhein&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;. The manufacturing process derives from the methods for making proteins in Hansenula yeast, which is a process we use to make a key component in the production of hepatitis B vaccine. The customer relationships derive from Rhein&amp;#8217;s ability to sell existing, in-process and future products to its existing customers. Purchased intangible assets other than goodwill are amortized on a straight-line basis over their respective useful lives. The manufacturing process and customer relationships were amortized over their estimated useful lives of five years. Both the manufacturing process and customer relationships intangible assets were fully amortized as of the year ended December&amp;#160;31, 2011. Amortization of intangible assets was zero for the years ended December&amp;#160;31, 2013 and 2012, and $0.3 million for the year ended December&amp;#160;31, 2011. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
  <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock id="F_000380" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"&gt;&lt;tr&gt;&lt;td valign="top" style="width:4.54%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;7.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:95.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Current Accrued Liabilities &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Current accrued liabilities as of December&amp;#160;31, 2013, and 2012 consist of the following (in thousands): &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:71%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" valign="bottom" style="width:28%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&amp;#160;31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:71%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:3%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:13%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Payroll and related expenses&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,639&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:3%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:11%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,538&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Legal expenses&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;338&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:3%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:11%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;396&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Third party research and development expenses&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,403&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:3%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:11%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,207&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:71%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other accrued liabilities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,786&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:3%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:11%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,922&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:71%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,166&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:3%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:11%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,063&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
  <us-gaap:MinorityInterestDisclosureTextBlock id="F_000381" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"&gt;&lt;tr&gt;&lt;td valign="top" style="width:4.54%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;8.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:95.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Symphony Dynamo, Inc. &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;On April&amp;#160;18, 2006, we, Symphony and Holdings entered into a transaction involving a series of related agreements providing for the advancement of certain of our immunostimulatory&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; sequences-based programs for cancer, hepatitis B and hepatitis C therapy (collectively, the &amp;#8220;Programs&amp;#8221;). Pursuant to these agreements, Symphony formed SDI and invested $50&amp;#160;million to fund the Programs, and we licensed to Holdings our intellectual property rights related to the Programs, which were assigned to SDI. As a result of these agreements, Symphony owned 100% of the equity of Holdings, which owned 100% of the equity of SDI. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;In connection with the transaction described above, Holdings granted to us an exclusive purchase option that gave us the right, but not the obligation, to acquire the outstanding equity securities of SDI, which would result in our reacquisition of the intellectual property rights that we licensed to Holdings (the &amp;#8220;Original Purchase Option&amp;#8221;). In exchange for the Original Purchase Option, we granted Holdings five-year&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; warrants to purchase up to 2,000,000 shares of our common stock at an exercise price of $7.32 per share pursuant to a warrant purchase agreement (the &amp;#8220;Original Warrants&amp;#8221;), and granted certain registration rights to Holdings pursuant to a registration rights agreement. We also received an exclusive option to purchase either the hepatitis B or hepatitis&amp;#160;C therapy program (the &amp;#8220;Program Option&amp;#8221;) during the first year of the arrangement. In April 2007, we exercised the Program Option for the hepatitis B program which resulted in the recognition of a $15 million liability to Symphony. We remained primarily responsible for the development of the cancer and hepatitis C therapy programs in accordance with a development plan and related development budgets that we agreed to with Holdings. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Prior to the acquisition of all of the outstanding equity of SDI on December&amp;#160;30, 2009, we consolidated the financial position and results of operations of SDI. In November&amp;#160;2009, we entered into an agreement with Holdings to modify the provisions of and to exercise the Original Purchase Option (the &amp;#8220;Amended Purchase Option&amp;#8221;). We completed the acquisition of all of the outstanding equity of SDI on December&amp;#160;30, 2009. In exchange for all of the outstanding equity of SDI, we issued to Symphony and certain of its co-investors: (i&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&amp;#160;13,000,000 shares of common stock (the &amp;#8220;Shares&amp;#8221;); (ii)&amp;#160;5-year warrants to purchase 2,000,000 shares of common stock with an exercise price of $1.94 per share (the &amp;#8220;Warrants&amp;#8221;); and (iii)&amp;#160;a non-interest bearing note in the principal amount of $15 million, due December&amp;#160;31, 2012, payable in cash, our common stock or a combination thereof at our discretion, which obligation was previously payable solely in cash on April&amp;#160;18, 2011 (the &amp;#8220;Note&amp;#8221;). In addition, we&amp;#160;agreed to contingent cash payments from us equal to 50% of the first $50 million from any upfront, pre-commercialization milestone or similar payments received by us from any agreement with any third party with respect to the development and/or commercialization of the cancer and hepatitis C therapies originally licensed to SDI. The Original Warrants held by Symphony were cancelled as part of this transaction. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We were obligated to make future contingent cash payments to the former Holdings shareholders related to certain payments received by us, if any, from future partnering agreements pertaining to our hepatitis C and cancer therapy programs. We estimated the valuation of this contingent liability using a discounted cash flow model. The discounted cash flow model was derived from management&amp;#8217;s assumptions regarding the timing, amounts, and probability of potential upfront and milestone payments for the development and/or commercialization of the hepatitis C program based on transactions for similar stage programs by other companies. These cash flows were discounted at a rate of 16&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;% for the fiscal year ended December&amp;#160;31, 2010. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Changes in the fair value of the contingent consideration liability were recognized in &amp;#8220;other income (expense)&amp;#8221; in the consolidated statements of operations in the period of the change. During the fiscal year ended December&amp;#160;31, 2010, we reduced the assumed probability of our receipt of upfront and milestone payments from a potential partnership and extended the timing of when these expected receipts would occur. In addition, based on our assumptions regarding our beta and risk free interest rate used in the discounted cash flow model, the change in fair value of the contingent consideration liability resulted in other income of $2.2&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million for the fiscal year ended December&amp;#160;31, 2010. During the year ended December&amp;#160;31, 2011, we determined that we would not receive any upfront or milestone payments from a potential partnership for our hepatitis C therapy program and, therefore, estimated the fair value of the liability to be zero as of December&amp;#160;31, 2011 resulting in other income of $0.8 million. These fair value measurements were based on significant inputs not observed in the market and thus represented a Level 3 measurement. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We recorded the acquisition of all of the outstanding equity of SDI pursuant to the Amended Purchase Option as a return of equity to the noncontrolling&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; interest. The acquisition was accounted for as a capital transaction that did not affect our consolidated net loss. However, because the acquisition was accounted for as a capital transaction, the consideration paid in excess of the carrying value of the noncontrolling interest in SDI is treated as a deemed dividend at the time for purposes of reporting net loss and earnings per share. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;The estimated fair values of the warrants transferred were calculated using the Black-Scholes valuation model. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We estimated the fair value of the Note using a net present value model with a discount rate of 17&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%. Imputed interest was recorded as interest expense over the term of the loan using the interest rate method. We paid in cash the $15 million principal balance of the Note on December&amp;#160;31, 2012. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;The Shares and Warrants were subject to certain anti-dilution protection in the event that we issued other equity securities within six months from December&amp;#160;30, 2009. As a result of an equity offering completed in April 2010 prior to the expiration of the anti-dilution provision, Symphony received an additional &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,076,420&amp;#160;shares of common stock (&amp;#8220;April 2010 Shares&amp;#8221;) and warrants to purchase 7,038,210 shares of common stock (&amp;#8220;April 2010 Warrants&amp;#8221;) having the same terms as the warrants sold in the offering, which have an exercise price of $1.50 per share and a term of five years. The Warrants issued on December&amp;#160;30, 2009 were cancelled upon the issuance of the April 2010 Warrants. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;The fair value of the April 2010 Shares and incremental fair value of the April 2010 Warrants&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; provided to Symphony, as measured upon issuance and remeasured at June&amp;#160;30, 2010, resulted in non-operating expense of $11.1 million in the second quarter of 2010. This also resulted in an increase of $9.5 million to the warrant liability and an increase of $1.6 million to additional paid in capital as of June&amp;#160;30, 2010. Following the expiration date of Symphony&amp;#8217;s anti-dilution protection, on June&amp;#160;30, 2010, the value of the April 2010 Warrants of $12.0 million was reclassified into stockholders&amp;#8217; equity in the consolidated balance sheets. As of December&amp;#160;31, 2013, warrants to purchase 6,765,128 shares remained outstanding. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:MinorityInterestDisclosureTextBlock>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock id="F_000382" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"&gt;&lt;tr&gt;&lt;td valign="top" style="width:4.54%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;9&lt;/font&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:95.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Commitments and Contingencies &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We lease our facilities in Berkeley, California (&amp;#8220;Berkeley Lease&amp;#8221;) and D&amp;#252;sseldorf, Germany (&amp;#8220;D&amp;#252;sseldorf Lease&amp;#8221;) under operating leases that expire in June 2018&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; and March 2023, respectively. The Berkeley Lease provides for periods of escalating rent. The total cash payments over the life of the lease are divided by the total number of months in the lease period and the average rent is charged to expense each month during the lease period. We entered into sublease agreements under the D&amp;#252;sseldorf Lease for a certain portion of the leased space. The sublease income is offset against our rent expense. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;During September 2013, we decided not to occupy a portion of our facility in Berkeley, California. As a result, we recorded a one-time estimated unoccupied facility expense of $0.9&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million for the year ended December 31, 2013, representing the present value of the rent payments and other costs associated with the lease, net of estimated sublease income, for the remaining life of the operating lease. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Total net rent expense related to our operating leases for the years ended December&amp;#160;31, 2013, 2012 and 2011, was $1.9&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million, $1.7 million and $1.7 million, respectively. Deferred rent was $0.6 million as of December&amp;#160;31, 2013 and 2012.&amp;nbsp;&amp;nbsp; &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Future minimum payments under the non-cancelable portion of our operating leases at December&amp;#160;31, 2013, excluding payments from sublease payments, are as follows (in thousands):&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Years ending December&amp;#160;31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:3%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:14%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:3%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:14%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,233&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2015&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:3%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:14%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,282&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2016&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:3%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:14%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,333&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2017&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:3%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:14%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,382&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:3%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:14%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,351&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Thereafter&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:3%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,499&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:3%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13,080&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;During the fourth quarter of 2004, we established a letter of credit with Silicon Valley Bank as security for our Berkeley Lease in the amount of $0.4&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million. The letter of credit remained outstanding as of December&amp;#160;31, 2013, and is collateralized by a certificate of deposit for $0.4 million, which has been included in restricted cash in the consolidated balance sheets as of December&amp;#160;31, 2013 and 2012. Under the terms of the Berkeley Lease, if the total amount of our cash, cash equivalents and marketable securities falls below $20 million for a period of more than 30 consecutive days during the lease term, the amount of the required security deposit will increase to $1.1 million, until such time as our projected cash and cash equivalents will exceed $20 million for the remainder of the lease term, or until our actual cash and cash equivalents remains above $20 million for a period of 12 consecutive months. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We established a letter of credit with Deutsche Bank as security for our D&amp;#252;sseldorf Lease in the amount of approximately 0.2&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;million Euros. The letter of credit remained outstanding through December&amp;#160;31, 2013 and is collateralized by a certificate of deposit for $0.2 million, which has been included in restricted cash in the consolidated balance sheets as of December&amp;#160;31, 2013 and 2012.&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;In addition to the non-cancelable commitments included above, we have entered into contractual arrangements that obligate us to make payments to the contractual counterparties upon the occurrence of future events. In addition, in &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;the normal course of operations, we have entered into license and other agreements and intend to continue to seek additional rights relating to compounds or technologies in connection with our discovery, manufacturing and development programs. Under the terms of the agreements, we may be required to pay future up-front fees, milestones and royalties on net sales of products originating from the licensed technologies, if any, or other payments contingent upon the occurrence of future events that cannot reasonably be estimated.&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We rely on research institutions, contract research organizations, clinical investigators as well as clinical and material manufacturers of our product candidates. As of December&amp;#160;31, 2013, under the terms of our agreements, we are obligated to make future payments as services are provided of approximately $4.5&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million through 2015. These agreements are terminable by us upon written notice. Generally, we are liable only for actual effort expended by the organizations at any point in time during the contract through the notice period.&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Under the terms of our exclusive license agreements with the Regents of the University of California, as amended, for certain technology and related patent rights and materials, we pay annual license or maintenance fees and will be required to pay milestones and royalties on net sales, if any,&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; of certain products originating from the licensed technologies.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <us-gaap:CollaborativeArrangementDisclosureTextBlock id="F_000383" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"&gt;&lt;tr&gt;&lt;td valign="top" style="width:4.54%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/font&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;0&lt;/font&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:95.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Collaborative Research, Development and License Agreements &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:2.67%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;text-indent:2.67%"&gt;GlaxoSmithKline &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;In December 2008, we entered into a worldwide strategic alliance with GSK to discover, develop and commercialize TLR inhibitors. Under the terms of the arrangement, we agreed to conduct research and early clinical development in up to four&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; programs: the Lead TLR 7/9 program, a Follow-On TLR 7/9 program, and up to two other TLR programs. In 2011 we began development of a TLR 8 program as one of the two additional programs under the collaboration.&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;GSK subsequently returned all rights to this program to us. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We are currently conducting a Phase 1 clinical trial in the Lead TLR 7/9 program with DV1179 in systemic lupus erythematosus&lt;/font&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; patients. The Company is not currently performing any activities on the Follow-On TLR 7/9 program. GSK has not yet chosen to initiate development of the remaining program under the agreement. &lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In December 2013, we amended our agreement with GSK to extend the research term until conclusion of the ongoing phase 1 study of DV1179. In addition, the exclusivity provisions of the agreement were modified, giving us rights to immediately begin preclinical and clinical research on inhibitors of TLR 7 and 9 (other than DV1179) for oncology indications.&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;GSK can exercise its exclusive option to license each program. If GSK exercises an option, GSK would carry out further development and commercialization of the corresponding products. If GSK exercises their option on the Lead TLR 7/9 program, then we are eligible to receive payments of up to approximately $125&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million, comprised of contingent option exercise payments and additional payments based on GSK&amp;#8217;s achievement of certain development, regulatory and commercial objectives. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We are also eligible to receive up to $60&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million if aggregate worldwide annual net sales milestones are achieved and tiered royalties ranging from the mid&amp;#8211;single digit to mid-teens on sales of any products originating from the collaboration. We have retained an option to co-develop and co-promote one product under this agreement. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We received an initial payment of $10&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million in 2008. The deliverables under this arrangement did not have stand-alone value and so did not qualify as separate units of accounting. In 2011, we earned and recognized $12 million in substantive development milestone payments related to the initiation of Phase I and proof-of-mechanism clinical trials of DV1179 in systemic lupus erythematosus patients. In 2011, we earned and recognized $3 million in substantive development milestone payments related to the initiation of development of the TLR 8 program. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Revenue from the initial payment from GSK was deferred and is being recognized over the expected period of performance under the agreement, initially estimated to be seven years. In the fourth quarter of 2013 we ree&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;valuated and revised the expected period of performance under the agreement from seven years to six years resulting in the recognition of $0.3 million of additional revenue in 2013. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;The following table summarizes the revenues recognized under our agreement with GSK (in thousands):&lt;/font&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year ended December 31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2011&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:67%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Initial payment&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,702&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,428&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,428&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Milestone revenue&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,702&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,428&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16,428&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;As of December 31, 2013 and 2012, deferred revenue relating to the initial payment was $2.5&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million and $4.2 million, respectively. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Absent early termination, the agreement will expire when all of GSK&amp;#8217;s payment obligations expire. Either party may terminate the agreement early upon written notice if the other party commits an uncured material breach of the agreement. Either party may terminate the agreement in the event of insolvency of the other party. GSK also has the option to terminate the agreement without cause upon prior written notice within a specified window of time dependent upon the stage of clinical development of the programs. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;margin-left:2.67%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;AstraZeneca &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;In September 2006, we entered into a three&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-year research collaboration and license agreement with AstraZeneca for the discovery and development of TLR 9 agonist-based therapies for the treatment of asthma and chronic obstructive pulmonary disease.&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;In October 2011, we amended our agreement with AstraZeneca to provide that we will conduct initial clinical development of AZD 1419. Under the terms of the amended agreement, AstraZeneca will fund all program expenses to cover the cost of development activities through Phase 2a, estimated to total approximately $20&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million. We received an initial payment of $3 million to begin the clinical development program. In the first quarter of 2012, we received a $2.6 million payment to advance AZD1419 into preclinical toxicology studies and these toxicology studies were completed in the third quarter of 2012. We and AstraZeneca have agreed to advance AZD 1419 towards a Phase 1 clinical trial, which resulted in a development funding payment of $6 million, received in the fourth quarter of 2012. If AstraZeneca chooses to advance the program following completion of Phase 2a, we will receive a $20 million milestone payment and AstraZeneca will retain its rights to develop the candidate therapy and to commercialize the resulting asthma product. We are eligible to receive additional milestone payments, which we have determined to be substantive milestones, of up to approximately $100 million, based on the achievement of certain development and regulatory objectives. Additionally, upon commercialization, we are eligible to receive tiered royalties ranging from the mid to high single-digits based on product sales of any products originating from the collaboration. We have the option to co-promote in the United States products arising from the collaboration, if any. AstraZeneca has the right to sublicense its rights upon our prior consent. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Revenue from the initial payment was deferred and is being recognized over the expected period of performance under the agreement, which is approximately 50&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; months. Revenue from the development funding payment is being recognized as the development work is performed.  &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;The following table summarizes the revenues earned under our agreement with AstraZeneca (in thousands): &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year ended December 31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2011&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:67%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Initial payments&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;720&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;720&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;120&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Performance of research activities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,507&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,462&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;642&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,227&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,182&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;762&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;As of December 31, 2013 and 2012, total deferred revenue from the initial payment and development funding payments was $4.8&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million and $7.7 million, respectively.&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-weight:bold;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Absent early termination, the agreement will expire when all of AstraZeneca&amp;#8217;s payment obligations expire. AstraZeneca has the right to terminate the agreement at any time upon prior written notice and either party may terminate the agreement early upon written notice if the other party commits an uncured material breach of the agreement. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:2.67%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;text-indent:2.67%"&gt;National Institutes of Health (&amp;#8220;NIH&amp;#8221;) and Other Funding &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We have been awarded various grants from the NIH and the NIH&amp;#8217;s National Institute of Allergy and Infectious Disease (&amp;#8220;NIAID&amp;#8221;) in order to fund research. The awards are related to specific research objectives and we earn revenue as the related research expenses are incurred. We have earned revenue during the periods ended December&amp;#160;31, 2013 and 2012 from the following awards:&lt;/font&gt;&lt;/p&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"&gt;&lt;tr&gt;&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"&gt;&lt;font style="font-family:&apos;Symbol&apos;;font-size:10pt;"&gt;&amp;#183;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:96.67%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;September 2013, NIH awarded us $0.2 million to fund research in developing TLR antagonists for therapy of hepatic fibrosis and cirrhosis.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"&gt;&lt;tr&gt;&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-family:&apos;Symbol&apos;;font-size:10pt;"&gt;&amp;#183;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:96.67%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;June 2012, NIH awarded us $0.6 million to fund research in screening for inhibitors of TLR 8 for treatment of autoimmune diseases. &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"&gt;&lt;tr&gt;&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-family:&apos;Symbol&apos;;font-size:10pt;"&gt;&amp;#183;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:96.67%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;May 2012, NIH awarded us $0.4 million to fund development of TLR 8 inhibitors for treatment of rheumatoid arthritis. &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"&gt;&lt;tr&gt;&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-family:&apos;Symbol&apos;;font-size:10pt;"&gt;&amp;#183;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:96.67%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;July 2011, NIH awarded us $0.6 million to fund research in preclinical models of skin autoimmune inflammation. &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"&gt;&lt;tr&gt;&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-family:&apos;Symbol&apos;;font-size:10pt;"&gt;&amp;#183;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:96.67%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;August 2010, NIAID awarded us a grant to take a systems biology approach to study the differences between individuals who do or do not respond to vaccination against the hepatitis B virus. This study will be one of several projects conducted under a grant to the Baylor Institute of Immunology Research in Dallas as part of the Human Immune Phenotyping Centers program. We have been awarded a total of $1.4 million under this grant. &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"&gt;&lt;tr&gt;&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-family:&apos;Symbol&apos;;font-size:10pt;"&gt;&amp;#183;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:96.67%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;July 2010, NIH awarded us $0.6 million to explore the feasibility of developing a universal vaccine to prevent infection by human papilloma virus. &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"&gt;&lt;tr&gt;&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-family:&apos;Symbol&apos;;font-size:10pt;"&gt;&amp;#183;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:96.67%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;September 2008, NIAID awarded us a five-year $17 million contract to develop our oligonucleotide technology using TLR 9 agonists as vaccine adjuvants. The contract supports adjuvant development for anthrax as well as other disease models.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;The following table summarizes the revenues recognized under the various arrangements with the NIH and NIAID (in thousands): &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year ended December 31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2011&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:67%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;NIAID contracts&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,103&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,571&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,730&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;All other NIH contracts&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,035&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;368&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;380&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total grant revenue&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,138&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,939&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,110&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
  <us-gaap:EarningsPerShareTextBlock id="F_000384" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"&gt;&lt;tr&gt;&lt;td valign="top" style="width:4.54%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/font&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/font&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:95.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net Loss Per Share &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Basic net loss per share allocable to common stockholders&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; is calculated by dividing the net loss allocable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net loss per share allocable to common stockholders is computed by dividing the net loss allocable to common stockholders by the weighted-average number of common shares outstanding during the period and giving effect to all potentially dilutive common shares using the treasury-stock method. For purposes of this calculation, common stock subject to repurchase by us, outstanding stock options, stock awards, warrants and Series B Convertible Preferred Stock are considered to be potentially dilutive common shares and are only included in the calculation of diluted net loss per share allocable to common stockholders when their effect is dilutive. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&amp;#160;31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2011&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basic and diluted net loss per share (in thousands, except per share&amp;#160;amounts):&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Numerator:&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(66,720&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(69,949&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(48,597&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Preferred stock deemed dividend&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(8,469&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss allocable to common stockholders&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(75,189&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(69,949&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(48,597&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%; border-top:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Denominator for basic and diluted net loss per share allocable to common stockholders:&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-average common shares outstanding&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;196,275&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;170,469&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;125,101&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basic and diluted net loss per share allocable to common stockholders&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.38&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.41&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.39&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Outstanding warrants, stock options, Series B Convertible Preferred Stock&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; and stock subject to repurchase by us under stock awards were excluded from the calculation of net loss per share allocable to common stockholders as the effect of their inclusion would have been anti-dilutive. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&amp;#160;31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2011&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding securities not included in diluted net loss per share calculation (in thousands):&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock options and stock awards&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17,040&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,561&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,101&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Series B Convertible Preferred Stock (as converted to common stock)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;43,430&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Warrants&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12,464&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12,714&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;25,729&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;72,934&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;28,275&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;36,830&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:8pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
  <us-gaap:StockholdersEquityNoteDisclosureTextBlock id="F_000385" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"&gt;&lt;tr&gt;&lt;td valign="top" style="width:4.54%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;12.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:95.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Preferred Stock, Common Stock and Warrants &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:10pt;;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Authorized Shares&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;On May 29, 2013 the stockholders approved an increase in the number of authorized shares of common stock from 250,000,000&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; to 350,000,000. &lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The increase in authorized shares was effected pursuant to a Certificate of Amendment to the Sixth Amended and Restated Certificate of Incorporation (the "Certificate of Amendment"), filed with the Secretary of State of the State of Delaware on May 30, 2013&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:10pt;;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Preferred Stock Outstanding&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;As of December 31, 2013 there were 5,000,000&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; shares of preferred stock authorized and no shares outstanding.&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;In October 2013 the Company sold 43,430&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; shares of $0.001 par value Series B Convertible Preferred Stock for a purchase price of $1,075 per share and gross proceeds of approximately $46.7 million in an underwritten public offering. After issuance costs of approximately $2.5 million, the net proceeds from the offering were approximately $44.2 million.&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Each share of Series B Convertible Preferred Stock is convertible into 1,000&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; shares of common stock at any time at the holder&amp;#8217;s option. However, the holder is prohibited from converting the Series B Convertible Preferred Stock into shares of common stock if, as a result of such conversion, the holder and its affiliates would own more than 9.98% of the total number of shares of common stock then issued and outstanding. In the event of the Company&amp;#8217;s liquidation, dissolution, or winding up, holders of Series B Convertible Preferred Stock will receive a payment equal to $0.001 per share before any proceeds are distributed to the common stockholders. Shares of Series B Convertible Preferred Stock generally have no voting rights, except as required by law and except that the consent of holders of a majority of the outstanding Series B Convertible Preferred Stock is required to amend the terms of the Series B Convertible Preferred Stock. Holders of Series B Convertible Preferred Stock are not entitled to receive any dividends, unless and until specifically declared by the&lt;/font&gt;&lt;font style="color:#000000;font-size:13.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Company&amp;#8217;s board of directors. The Series B Convertible Preferred Stock ranks senior to the Company&amp;#8217;s common stock as to distributions of assets upon the Company&amp;#8217;s liquidation, dissolution or winding up, whether voluntarily or involuntarily. The Series B Convertible Preferred Stock may rank senior to, on parity with or junior to any class or series of the Company&amp;#8217;s capital stock created in the future depending upon the specific terms of such future stock issuance.&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:13.5pt;;"&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;The fair value of the common stock into which the Series B Convertible Preferred Stock is convertible exceeded the allocated purchase price of the Series B Convertible Preferred Stock by $8.5&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million on the date of issuance, for which the Company recorded a deemed dividend. The Company recognized the deemed dividend equal to the number of shares of Series B Convertible Preferred Stock sold on October 30, 2013 multiplied by the difference between the value of the common stock and the Series B Convertible Preferred Stock conversion price per share on that date. The dividend was reflected as a one-time, non-cash, deemed dividend to the holders of Series B Convertible Preferred Stock on the date of issuance, which is the date the stock first became convertible.&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-weight:bold;;font-size:13.5pt;;"&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Preferred Stock Rights &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-weight:bold;;font-size:13.5pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;On November&amp;#160;4, 2008, our Board of Directors declared a dividend of one preferred share purchase right (a &amp;#8220;Right&amp;#8221;) for each outstanding share of our Common Stock, par value $0.001&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; per share (the &amp;#8220;Common Shares&amp;#8221;). The dividend was payable on November&amp;#160;17, 2008 to the stockholders of record on that date. Each Right entitles the registered holder to purchase from us one one-hundredth of a share of Series A Junior Participating Preferred Stock, par value $0.001 per share (the &amp;#8220;Preferred Shares&amp;#8221;), at a price of $6.00 per one one-hundredth of a Preferred Share, subject to adjustment. Upon the acquisition of, or announcement of the intent to acquire, 20 percent or more of our outstanding Common Shares by a person, entity or group of affiliated or associated persons (&amp;#8220;Acquiring Person&amp;#8221;), each holder of a Right, other than Rights held by the Acquiring Person, will have the right to purchase that number of Common Shares having a market value of two times the exercise price of the Right. If we are acquired in a merger or other business combination transaction or 50 percent or more of our assets or earning power are sold to an Acquiring Person, each holder of a Right will thereafter have the right to purchase, at the then current exercise price of the Right, that number of shares of common stock of the acquiring company which at the time of such transaction will have a market value of two times the exercise price of the Right. The Rights plan is intended to maximize the value of the Company in the event of an unsolicited attempt to take over the Company in a manner or on terms not approved by the Company&amp;#8217;s Board of Directors. The Rights will expire on November&amp;#160;17, 2018, unless the Rights are earlier redeemed or exchanged by the Company. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:10pt;;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Common Stock Outstanding&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;In October 2013 we completed an underwritten public offering of 79&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;,570,000 shares of our common stock to the public at $1.075 per share. The gross proceeds to us from this offering were approximately $85.5 million. After deducting issuance costs of approximately $4.5 million, the net proceeds from the offering were approximately $80.9 million.&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;On March&amp;#160;29, 2013, we entered into an At Market Issuance Sales Agreement (the &amp;#8220;Agreement&amp;#8221;) with MLV&amp;#160;&amp;amp; Co. LLC (&amp;#8220;MLV&amp;#8221;) under which we may offer and sell our common stock having aggregate sales proceeds of up to $50,000,000&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; from time to time through MLV as our sales agent. Sales of our common stock through MLV, if any, will be made by means of ordinary brokers&amp;#8217; transactions on the NASDAQ Capital Market or otherwise at market prices prevailing at the time of sale, in block transactions, or as otherwise agreed upon by us and MLV. MLV will use commercially reasonable efforts to sell our common stock from time to time, based upon instructions from us (including any price, time or size limits or other customary parameters or conditions we may impose). We will pay MLV a commission of up to 3.0% of the gross sales proceeds of any common stock sold through MLV under the Agreement. No sales of our common stock have taken place under this Agreement as of December&amp;#160;31, 2013. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;On May&amp;#160;9, 2012, we completed an underwritten public offering of 17,500,000&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; shares of our common stock to the public at $4.25 per share. The net proceeds to us from this offering were $69.6 million, after deducting offering expenses. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;On November&amp;#160;3, 2011, we completed an underwritten public offering of 27,600,000&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; shares of our common stock including 3,600,000 shares sold pursuant to the full exercise of an overallotment option previously granted to the underwriters at a price to the public of $2.50 per share. The net proceeds to us from this offering were $64.5 million, after deducting offering expenses. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:13.5pt;;"&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;On November&amp;#160;2, 2010, we completed an underwritten public offering of 26,450,000&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; shares of our common stock including 3,450,000 shares sold pursuant to the full exercise of an overallotment option previously granted to the underwriters at a price to the public of $1.70 per share. The net proceeds to us from this offering were $42.0 million, after deducting offering expenses.&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:13.5pt;;"&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;On September&amp;#160;20, 2010, we entered into a Purchase Agreement with Aspire Capital, which provided that, upon the terms and subject to the conditions and limitations set forth therein, Aspire Capital was committed to purchase up to an aggregate of $30.0&lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million of shares of our common stock (the &amp;#8220;Purchase Shares&amp;#8221;) over the 25-month term of the Purchase Agreement. Under the Purchase Agreement, we agreed to pay Aspire Capital a commitment fee equal to 4% of $30 million in consideration for Aspire Capital&amp;#8217;s obligation to purchase up to $30 million of our common stock. We paid this commitment fee of $1.2 million by the issuance of 600,000 shares of our common stock and this fee was recorded as a cost of raising capital and netted against the gross proceeds from the Purchase Agreement in September 2010. During 2010, we sold 2,350,000 shares of common stock to Aspire Capital for $3.3 million and during 2011 we sold 10,995,210 shares of common stock for $26.7 million, which totaled the proceeds available to us of $30 million under the Purchase Agreement.&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;On April&amp;#160;16, 2010, we completed an underwritten public offering resulting in net proceeds of $41.1&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million, after deducting offering expenses of approximately $3.0 million, from the sale of 30,293,000 units at a per unit price of $1.4525. Each unit consisted of one share of common stock and one warrant to purchase 0.5 of a share of common stock. Each warrant has an exercise price of $1.50 per share, and is exercisable for a period of five years from the date of issuance. From this offering, warrants to purchase an aggregate of 10,913,873 shares of our common stock were outstanding as of December&amp;#160;31, 2013 (including the warrants to purchase 6,765,128 shares provided to Symphony as described in Note 8 &amp;#8220;Symphony Dynamo, Inc.&amp;#8221;). &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Warrants &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;In connection with a 2007 loan agreement that was subsequently terminated in 2008, we issued warrants to purchase up to 3,550,000&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; shares of our common stock as follows: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:39%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Warrant Issuance Date&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares Issuable &lt;br /&gt;(in thousands)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expiration &lt;br /&gt;Date&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercise Price &lt;br /&gt;per Share&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding as of &lt;br /&gt;December 31, 2013 &lt;br /&gt;(in thousands)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:39%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;July 18, 2007&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,250&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2/26/2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.13&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:15%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,250&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:39%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;October 18, 2007&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,300&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2/26/2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.68&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:15%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:39%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 27, 2007&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;300&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2/26/2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.65&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:15%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;300&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:39%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 27, 2007&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;700&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:12%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2/26/2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:12%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.68&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:15%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:39%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,550&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:12%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:12%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:15%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,550&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:6pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:6pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;As of December&amp;#160;31, 2013, warrants to purchase an aggregate of approximately 12,500,000&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; shares of our common stock were outstanding. The warrants are exercisable &lt;/font&gt;&lt;font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;at a weighted average price of $1.96 per share&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;. During the years ended December&amp;#160;31, 2013, and 2012, warrants were exercised to purchase an aggregate of approximately 250,000 and 13,000,000 shares, respectively, of our common stock. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
  <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock id="F_000386" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"&gt;&lt;tr&gt;&lt;td valign="top" style="width:4.54%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;13.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:95.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Equity Plans and Stock-Based Compensation&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock Plans &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;As of December&amp;#160;31, 2013, we had three&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; share-based compensation plans. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;margin-left:9.06%;margin-right:0%;text-indent:0%;font-size:10pt;;"&gt;&lt;font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;2004 Stock Incentive Plan (&amp;#8220;2004 Plan&amp;#8221;) &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:1.33%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:1.33%"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;  &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The 2004 Plan was adopted in January 2004 by the Board of Directors and stockholders and became effective on February&amp;#160;11, 2004. This plan provided for the issuance of up to 3,500,000 shares of our common stock plus an annual increase. Subsequently, we discontinued granting stock options under the 1997 Plan. Options under the 2004 Plan were granted for periods of up to ten years and the exercise price of all stock options granted under the 2004 Plan was at least equal to 100% of the fair market value of the common stock on the date of grant. If, however, incentive stock options were granted to an employee who owns stock possessing more than 10% of the voting power of all classes of the Company&amp;#8217;s stock or the stock of any parent or subsidiary of the Company, the exercise price of any incentive stock option granted must equal at least 110% of the fair market value on the grant date and the maximum term of these incentive stock options must not exceed five years. The maximum term of an incentive stock option granted to any other participant must not exceed ten years. The 2004 Plan authorizes the issuance of various forms of stock-based awards including stock options, restricted stock, restricted stock units and other equity awards to employees, consultants and members of the board of directors. As of December&amp;#160;31, 2013, options to purchase 4,066,277 shares of common stock remained outstanding under the 2004 Plan.&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;margin-left:9.06%;margin-right:0%;text-indent:0%;font-size:10pt;;"&gt;&lt;font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;2010 Employment Inducement Award Plan (&amp;#8220;Inducement Plan&amp;#8221;) &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;The Inducement Plan was adopted in January 2010 by our Board of Directors to induce qualified individuals to join Dynavax&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;. This Inducement Plan provided for the issuance of up to 1,500,000 shares of our common stock and became effective on January&amp;#160;8, 2010. Stockholder approval of the Inducement Plan is not required under NASDAQ Marketplace Rule 5635(c)(4). As of December&amp;#160;31, 2013, options to purchase 743,625 shares of common stock remained outstanding under the Inducement Plan. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;margin-left:9.06%;margin-right:0%;text-indent:0%;font-size:10pt;;"&gt;&lt;font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"&gt;2011 Equity Incentive Plan (&amp;#8220;2011 Plan&amp;#8221;) &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;The 2011 Plan was approved by the Company&amp;#8217;s stockholders and adopted in January 2011. On May 29, 2013, the stockholders of the Company approved an amendment to the 2011 Plan to increase the number of shares of common stock authorized for issuance under the plan by 10,000,000&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;. The 2011 Plan, as amended, provides for the issuance of up to 25,000,000 shares of our common stock to employees and non-employees of the Company and became effective on January&amp;#160;6, 2011. The 2011 Plan is administered by our Board of Directors, or a designated committee of the Board of Directors, and awards granted under the 2011 Plan have a term of 10&amp;#160;years unless earlier terminated by the Board of Directors. After the adoption of the 2011 Plan, no additional awards were granted under either the 2004 Plan or the Inducement Plan. As of January&amp;#160;6, 2011, all shares subject to awards outstanding under the 2004 Plan and Inducement Plan that expire or are forfeited will be included in the reserve for the 2011 Plan to the extent such shares would otherwise return to such plans. As of December&amp;#160;31, 2013, options to purchase 10,954,940 shares of common stock remained outstanding under the 2011 Plan. As of December&amp;#160;31, 2013, there were 13,666,964&amp;#160;shares of common stock reserved for issuance under the 2011 Plan.&amp;nbsp;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Activity under our stock plans is set forth below: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares Underlying&amp;nbsp;&amp;nbsp;Outstanding Options (in thousands)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-Average Exercise Price&amp;#160;Per&amp;#160;Share (in thousands)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-Average Remaining Contractual Term (years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Aggregate Intrinsic Value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at December&amp;#160;31, 2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13,806&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.38&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options granted&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,614&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.69&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options exercised&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(131&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.43&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options cancelled:&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options forfeited (unvested)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2,555&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.31&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options cancelled (vested)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(969&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.34&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:8%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:8%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at December&amp;#160;31, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,765&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.17&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.26&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,427&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Vested and expected to vest at December 31, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,765&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.17&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.26&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,427&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercisable at December 31, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,628&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.36&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.61&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,289&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:6pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:6pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;The total intrinsic value of stock options exercised during the years ended December&amp;#160;31, 2013, 2012 and 2011 was, $0.3&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million, $2.7 million and $0.1 million, respectively. The total intrinsic value of exercised stock options is calculated based on the difference between the exercise price and the quoted market price of our common stock as of the close of the exercise date. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;The total fair value of stock options vested during the years ended December&amp;#160;31, 2013, 2012 and 2011 was, $1&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.1 million, $9.6 million and $2.8 million, respectively. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Our non-vested stock awards are comprised of restricted stock units granted with performance-based vesting criteria. A summary of the status of non-vested restricted stock units as of December&amp;#160;31, 2013, and activities during 2013 is summarized as follows: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number of Shares (In&amp;#160;thousands)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-Average Grant-Date&amp;#160;Fair Value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Non-vested as of December 31, 2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,755&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.23&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Granted&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;250&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.23&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Vested&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(115&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.10&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Forfeited or expired&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(615&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.23&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Non-vested as of December 31, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,275&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.93&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:6pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:6pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Stock-based compensation expense related to restricted&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; stock units was approximately $0.1 million for the year ended December&amp;#160;31, 2013. The aggregate intrinsic value of the restricted stock units outstanding as of December&amp;#160;31, 2013, based on our stock price on that date, was $2.5 million. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;The weighted average grant-date fair value of restricted stock units granted during the years ended December&amp;#160;31, 2013 and 2012 was, $1.23&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; and $4.23, respectively. No restricted stock units were granted during 2011. The total fair value of restricted stock units vested during the years ended December&amp;#160;31, 2013, 2012, and 2011 was, $0.1 million, $0.2 million, and $0.8 million, respectively. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock-Based Compensation &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Under our stock-based compensation plans, option awards generally vest over a &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;four-year period contingent upon continuous service and expire ten years from the date of grant (or earlier upon termination of continuous service). The Company has also granted performance-based equity awards to certain of our employees under the 2011 Plan, the 2004 Plan and the Inducement Plan. As of December&amp;#160;31, 2013, 2,047,466 shares were outstanding related to options and restricted stock units subject to these performance-based vesting criteria. The fair value of each option is estimated on the date of grant using the Black-Scholes option valuation model and the following weighted-average assumptions: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:35%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock&amp;#160;Options&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Employee&amp;#160;Stock Purchase&amp;#160;Plan&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:35%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&amp;#160;31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&amp;#160;31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:35%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2011&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2011&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:35%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-average fair value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.41&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.30&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.76&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.93&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.54&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.09&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:35%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Risk-free interest rate&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.1&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.5&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.3&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.2&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.2&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.3&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:35%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected life (in years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.9&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.2&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.0&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.3&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.1&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.2&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:35%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Volatility&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.4&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.6&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.6&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.8&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.6&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.6&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Expected volatility is based on historical volatility of our stock price. The expected life of options granted is estimated based on historical option exercise and employee termination data, while giving consideration to options that have not yet completed a full life cycle. Our senior management, who hold a majority of the options outstanding, and other employees were grouped and considered separately for valuation purposes. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant. The dividend yield is zero&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; percent for all years and is based on our history and expectation of dividend payouts. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Compensation expense is based on awards ultimately expected to vest and reflects estimated forfeitures. For equity awards with time-based vesting, the fair value is amortized to expense on a straight-line basis over the vesting periods. For equity awards with performance-based vesting criteria, the fair value is amortized to expense when the achievement of the vesting criteria becomes probable. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We recognized the following amounts of stock-based compensation expense (in thousands): &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&amp;#160;31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2011&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Employees and directors stock-based compensation expense&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,828&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,439&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,185&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Non-employees stock-based compensation expense&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;512&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12,340&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,439&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,189&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%; border-top:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&amp;#160;31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2011&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and development&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,228&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,514&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,103&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;General and administrative&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,112&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,925&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,086&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12,340&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,439&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,189&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Stock based compensation expense recognized in 2013 and 2012 includes $4.9&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million related to employee severance arrangements and $0.5 million for awards to non-employees for the year ended December 31, 2013 and $1.5 million related to employee severance arrangements for the same period in 2012. During the year ended December 31, 2013, we recognized $1.3 million in additional stock-based compensation expense due to the modification of the terms of stock options for five employees. During the year ended December 31, 2012, we recognized $0.7 million in additional stock-based compensation expense due to the modification of the terms of stock options for one employee.&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;As of December&amp;#160;31, 2013, the total unrecognized compensation cost related to non-vested stock options deemed probable of vesting, including all stock options with time-based vesting, net of estimated forfeitures, amounted to $10.3&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million, which is expected to be recognized over the remaining weighted-average vesting period of 2.8 years. As of December&amp;#160;31, 2013, the total unrecognized compensation cost related to non-vested stock options not deemed probable of vesting, net of estimated forfeitures, amounted to $3.8 million. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;As of December&amp;#160;31, 2013, the total unrecognized compensation cost related to shares of our common stock under the Purchase Plan, amounted to $0.1&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million, which is expected to be recognized over the remaining weighted-average vesting period of 1.4 years. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Employee Stock Purchase Plan &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;In January 2004, the Board of Directors and stockholders adopted the 2004 Employee Stock Purchase Plan (the &amp;#8220;Purchase Plan&amp;#8221;). The Purchase Plan provides for the purchase of common stock by eligible employees and became effective on February&amp;#160;11, 2004. The purchase price per share is the lesser of (i&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&amp;#160;85% of the fair market value of the common stock on the commencement of the offer period (generally, the fifteenth day in February or August) or (ii)&amp;#160;85% of the fair market value of the common stock on the exercise date, which is the last day of a purchase period (generally, the fourteenth day in February or August). &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;As of December&amp;#160;31, 2013, 996,000&lt;/font&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; shares were approved for issuance under the Purchase Plan, subject to adjustment for a stock split, or any future stock dividend or other similar change in our common stock or capital structure. To date, employees have acquired 828,414 shares of our common stock under the Purchase Plan. As of December&amp;#160;31, 2013, 167,586 shares of our common stock remained available for future purchases.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
  <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock id="F_000387" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"&gt;&lt;tr&gt;&lt;td valign="top" style="width:4.54%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;14.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:95.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Employee Benefit Plan &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We maintain a 401(k) Plan, which qualifies as a deferred salary arrangement under Section&amp;#160;401(k) of the Internal Revenue Code. Under the 401(k) Plan, participating employees may defer a portion of their pretax earnings. We may, at our discretion, contribute for the benefit of eligible employees. To date, we have not contributed to the 401(k) Plan. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
  <us-gaap:IncomeTaxDisclosureTextBlock id="F_000388" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"&gt;&lt;tr&gt;&lt;td valign="top" style="width:4.54%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;15.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:95.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Income Taxes &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Consolidated income (loss) before provision for income taxes consisted of the following (in thousands): &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&amp;#160;31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2011&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(67,004&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(70,792&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(49,990&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Non U.S.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;284&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;843&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,393&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(66,720&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(69,949&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(48,597&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;No income tax expense was recorded for the years ended December&amp;#160;31, 2013, 2012 and 2011 due to net operating loss &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;carryforwards to offset the net income at Dynavax Europe and a valuation allowance which offsets the deferred tax assets. The difference between the consolidated income tax benefit and the amount computed by applying the federal statutory income tax rate to the consolidated loss before income taxes was as follows (in thousands): &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&amp;#160;31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2011&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Income tax benefit at federal statutory rate&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(22,678&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(23,650&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(16,523&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;State tax&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(178&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(89&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2,586&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Business credits&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2,515&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,394&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred compensation charges&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,072&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,002&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;595&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Change in valuation allowance&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22,354&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21,966&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18,099&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Change in foreign tax rates&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(34&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Change in the fair value measurements&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;286&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Non-deductible debt discount&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;509&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deemed dividend&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;273&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prior year true up&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(55&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;771&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;775&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total income tax expense&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Deferred tax assets and liabilities as of December&amp;#160;31, 2013 and 2012 consisted of the following (in thousands): &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&amp;#160;31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred tax assets:&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net operating loss carry forwards&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;147,655&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;127,529&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research tax credit carry forwards&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21,336&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18,163&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accruals and reserves&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,501&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,529&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Capitalized research costs&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,662&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12,757&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred revenue&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,486&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,180&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,222&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,221&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;192,862&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;170,379&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less valuation allowance&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(192,733&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(170,232&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total deferred tax assets&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;129&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;147&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred tax liabilities:&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fixed Assets&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(162&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(86&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;33&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(61&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total deferred tax liabilities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(129&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(147&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net deferred tax assets&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;The tax benefit of net operating losses, temporary differences and credit carryforwards&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; is required to be recorded as an asset to the extent that management assesses that realization is &amp;#8220;more likely than not.&amp;#8221; Realization of the future tax benefits is dependent on our ability to generate sufficient taxable income within the carryforward period. Because of our recent history of operating losses, management believes that recognition of the deferred tax assets arising from the above-mentioned future tax benefits is currently not likely to be realized and, accordingly, has provided a full valuation allowance. The valuation allowance increased by $22.5 million, $22.0 million and $18.1 million during the years ended December&amp;#160;31, 2013, 2012 and 2011, respectively. The amount of the valuation allowance for deferred tax assets associated with excess tax deductions from stock based compensation arrangements that will be allocated to contributed capital if the future tax benefits are subsequently recognized is $0.3 million. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We have not recorded deferred income taxes applicable to undistributed earnings of a foreign subsidiary that are indefinitely reinvested in foreign operations. Generally, such earnings become subject to U.S. tax upon the remittance of dividends and under certain other circumstances. It is not practicable to estimate the amount of the deferred tax liability on such undistributed earnings. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;As of December&amp;#160;31, 2013, we had federal net operating loss carryforwards&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; of approximately $384.1 million, which will expire in the years 2018 through 2037 and federal research and development tax credits of approximately $13.8 million, which expire in the years 2018 through 2033. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;As of December&amp;#160;31, 2013, we had potential &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;net operating loss carryforwards for California state income tax purposes of approximately $219.7 million, which expire in the years 2013 through 2033, and California state research and development tax credits of approximately $11.5 million which do not expire. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;As of December&amp;#160;31, 2013, we had net operating loss carryforwards&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; for foreign income tax purposes of approximately $27.8 million, which do not expire. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;The Tax Reform Act of 1986 limits the annual use of net operating loss and tax credit carryforwards&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; in certain situations where changes occur in stock ownership of a company. In the event the Company has a change in ownership, as defined, the annual utilization of such carryforwards could be limited. Due to past equity issuances and changes in ownership of Dynavax common stock, we believe that our ability to use some of our net operating losses and tax credits in the future may be limited. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
  <us-gaap:QuarterlyFinancialInformationTextBlock id="F_000389" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"&gt;&lt;tr&gt;&lt;td valign="top" style="width:4.54%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;16.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:95.46%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Selected Quarterly Financial Data (Unaudited; in thousands, except per share amounts) &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="14" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&amp;#160;31, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Q1&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Q2&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Q3&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Q4&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenues&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,085&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,392&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,927&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,847&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net&amp;#160;loss&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(20,825&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(17,164&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(15,675&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(13,056&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss allocable to common stockholders&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(20,825&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(17,164&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(15,675&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(21,525&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basic and diluted net loss per share allocable to common stockholders&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.11&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.09&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.09&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.09&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares used to compute basic and diluted net loss per share allocable to common stockholders&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;182,847&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;182,913&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;183,022&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;235,879&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="14" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&amp;#160;31, 2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Q1&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Q2&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Q3&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Q4&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenues&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,350&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,684&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,874&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,806&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net&amp;#160;loss&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(16,505&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(15,110&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(17,791&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(20,543&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss allocable to common stockholders&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(16,505&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(15,110&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(17,791&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(20,543&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basic and diluted net loss per share allocable to common stockholders&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.11&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.09&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.10&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.11&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares used to compute basic and diluted net loss per share allocable to common stockholders&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;155,431&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;167,697&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;177,870&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;180,685&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:8pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:QuarterlyFinancialInformationTextBlock>
  <us-gaap:SubsequentEventsTextBlock id="F_000390" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:11.33%;margin-right:0%;text-indent:-11.33%;font-weight:bold;;font-size:10pt;;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;17. Subsequent Events&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-weight:bold;;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;In March, 2014 we announced a $5.4&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million milestone payment and amendment of our AstraZeneca agreement to transfer responsibility for all clinical development to AstraZeneca following conclusion of the ongoing Phase 1 clinical trial of AZD 1419. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
  <us-gaap:BasisOfAccountingPolicyPolicyTextBlock id="F_000391" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basis of Presentation &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;The consolidated financial statements include our accounts and those of our wholly-owned subsidiaries. All significant intercompany accounts and transactions among the entities have been eliminated from the consolidated financial statements. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
  <us-gaap:LiquidityDisclosureTextBlock id="F_000392" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Liquidity and Financial Condition &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We have incurred significant operating losses and negative cash flows from operations since our inception. As of December&amp;#160;31, 2013, we had cash, cash equivalents and marketable securities of $189.4&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million. We currently estimate that we have sufficient cash resources to meet our anticipated cash needs through at least the next 12 months based on cash, cash equivalents and marketable securities on hand as of December&amp;#160;31, 2013 and anticipated revenues and funding from existing agreements.&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We expect to continue to spend substantial funds in connection with the development and manufacturing of our product candidates, particularly HEPLISAV-B&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, human clinical trials for our product candidates and additional applications and advancement of our technology. In order to continue these activities, we may need to raise additional funds. This may occur through strategic alliance and licensing arrangements and/or future public or private financings. Sufficient additional funding may not be available on acceptable terms, or at all. If adequate funds are not available in the future, we may need to delay, reduce the scope of or put on hold the HEPLISAV-B program or our other development programs while we seek strategic alternatives.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:LiquidityDisclosureTextBlock>
  <us-gaap:UseOfEstimates id="F_000393" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Use of Estimates &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;The preparation of financial statements in conformity with U.S. generally accepted accounting principles (&amp;#8220;U.S. GAAP&amp;#8221;) requires management to make informed &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results may differ materially from these estimates.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
  <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock id="F_000394" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:10pt;;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Foreign Currency Translation&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We consider the local currency to be the functional currency for our international subsidiary, Rhein&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;. Accordingly, assets and liabilities denominated in foreign currencies are translated into U.S. dollars using the exchange rate in effect on the balance sheet date. Revenues and expenses are translated at average exchange rates prevailing throughout the year. Currency translation adjustments arising from period to period are charged or credited to accumulated other comprehensive income (loss) in the equity. For the years ended December&amp;#160;31, 2013, 2012 and 2011, we reported an unrealized gain of $0.5 million, an unrealized gain of $0.4 million and an unrealized loss of $0.3 million, respectively. Realized gains and losses resulting from currency transactions are included in the consolidated statements of operations. For the years ended December&amp;#160;31, 2013, 2012 and 2011, we reported a loss of $0.2 million, a loss of $0.2 million and a gain of $0.2 million, respectively, resulting from currency transactions in our consolidated statements of operations. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
  <us-gaap:InvestmentPolicyTextBlock id="F_000395" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash, Cash Equivalents and Marketable Securities &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We consider all highly liquid investments purchased with an original maturity of three&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; months or less and that can be liquidated without prior notice or penalty, to be cash equivalents. Management determines the appropriate classification of marketable securities at the time of purchase. We invest in short-term money market funds, U.S. government agency securities, U.S. treasury securities and municipal securities. We believe these types of investments are subject to minimal credit and market risk. We do not invest in auction rate securities or securities collateralized by home mortgages, mortgage bank debt, or home equity loans. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We have classified our entire investment portfolio as available-for-sale a&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;nd available for use in current operations and accordingly have classified all investments as short-term. Available-for-sale securities are carried at fair value based on inputs that are observable, either directly or indirectly, such as quoted market prices for similar securities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the securities, with unrealized gains and losses included in accumulated other comprehensive income (loss) in stockholders&amp;#8217; equity. Realized gains and losses and declines in value, if any, judged to be other than temporary on available-for-sale securities are included in interest income or expense. The cost of securities sold is based on the specific identification method. Management assesses whether declines in the fair value of investment securities are other than temporary. In determining whether a decline is other than temporary, management considers the following factors: &lt;/font&gt;&lt;/p&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"&gt;&lt;tr&gt;&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-family:&apos;Symbol&apos;;font-size:10pt;"&gt;&amp;#183;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:96.67%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Whether the investment has been in a continuous realized loss position for over 12 months; &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"&gt;&lt;tr&gt;&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-family:&apos;Symbol&apos;;font-size:10pt;"&gt;&amp;#183;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:96.67%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;the duration to maturity of our investments; &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"&gt;&lt;tr&gt;&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-family:&apos;Symbol&apos;;font-size:10pt;"&gt;&amp;#183;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:96.67%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;our intention and ability to hold the investments to maturity and if it is not more likely than not that we will be required to sell the investment before recovery of the amortized cost bases; &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"&gt;&lt;tr&gt;&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-family:&apos;Symbol&apos;;font-size:10pt;"&gt;&amp;#183;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:96.67%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;the credit rating, financial condition and near-term prospects of the issuer; and &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"&gt;&lt;tr&gt;&lt;td valign="top" style="width:3.33%;white-space:nowrap"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-family:&apos;Symbol&apos;;font-size:10pt;"&gt;&amp;#183;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td valign="top" style="width:96.67%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;the type of investments made. &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;To date, there have been no declines in fair value that have been identified as other than temporary&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:InvestmentPolicyTextBlock>
  <us-gaap:ConcentrationRiskCreditRisk id="F_000396" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Concentration of Credit Risk and Other Risks and Uncertainties &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We operate in one&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; business segment, which is the discovery and development of biopharmaceutical products. We determine our segments based on the way we organize our business by making operating decisions and assessing performance. In fiscal years 2013, 2012 and 2011, 89%, 88% and 94% of our revenues were earned in the United States, respectively, and the remaining revenues were earned in Germany. As of December&amp;#160;31, 2013 and 2012, 9% and 10%, respectively, of our long-lived assets were located in the United States and the remaining long-lived assets were located in Germany. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Financial instruments that are subject to concentration of credit risk consist primarily of cash equivalents, marketable securities and accounts receivable. Our policy is to invest cash in institutional money market funds and marketable securities of U.S. government and corporate issuers with high credit quality to limit the amount of credit exposure. We currently maintain a portfolio of cash equivalents and marketable securities in a variety of securities, including short-term &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;money market funds, U.S. government agency securities, U.S. treasury securities and municipal securities. We have not experienced any losses on our cash equivalents and marketable securities. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Accounts receivable are recorded at invoice value. We review our exposure to accounts receivable, including the requirement&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; for allowances based on management&amp;#8217;s judgment. We have not historically experienced any significant losses. We do not currently require collateral for any of our accounts receivable. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Our products will require approval from the U.S. Food and Drug Administration (&amp;#8220;FDA&amp;#8221;) and foreign regulatory agencies before commercial sales can commence. There can be no assurance that our products will receive any of these required approvals. The denial or delay of such approvals would have a material adverse impact on our business. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We have relied on a limited number of suppliers to produce oligonucleotides &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;for clinical trials and a single contract manufacturer to produce our first generation TLR 9 agonist, 1018 for HEPLISAV-B. The loss of our current supplier would have a significant effect on our ability to produce HEPLISAV-B for commercialization and development of our other product candidates. To date, we have manufactured only small quantities of oligonucleotides and 1018 ourselves for development purposes. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We are subject to risks common to companies in the biopharmaceutical industry, including, but not limited to, new technological innovations, clinical development risk, establishing appropriate commercial partnerships, protection of proprietary technology, compliance with government and environmental regulations, uncertainty of market acceptance of products, product liability, the volatility of our stock price and the need to obtain additional financing.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
  <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock id="F_000397" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Long-Lived Assets &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Property and equipment are recorded at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets. Repair and maintenance costs are charged to expense as incurred. Leasehold improvements in both of our facilities are amortized over the remaining life of the initial lease term or the estimated useful lives of the assets, whichever is shorter. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We evaluate the carrying value of long-lived assets, including intangible assets, whenever events or changes in business circumstances or our planned use of long-lived assets indicate, based on undiscounted future operating cash flows,&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; that their carrying amounts may not be fully recoverable or that their useful lives are no longer appropriate. When an indicator of impairment exists, long-lived assets are written down to their respective fair values. Fair value is determined primarily using the anticipated cash flows discounted at a rate commensurate with the risk involved. Significant management judgment is required in the forecast of future operating results that are used in the preparation of expected undiscounted cash flows. No impairments of purchased intangible assets have been identified during the years presented. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
  <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy id="F_000398" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Goodwill&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Our goodwill balance relates to our April 2006 acquisition of Rhein&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;. Goodwill was recorded as the excess purchase price over tangible and intangible assets acquired and liabilities assumed based on their estimated fair value, by applying the acquisition method of accounting. Goodwill is not amortized but is subject to an annual impairment test which consists of a comparison of the fair value of the related reporting unit against its carrying amount including goodwill. If the carrying amount exceeds the fair value, impairment is calculated and recorded as a charge in the consolidated statements of operations. We determined that we have only one operating segment and there are no components of that operating segment that are deemed to be separate reporting units such that we have one reporting unit for purposes of our goodwill impairment testing. We evaluate goodwill for impairment on an annual basis and on an interim basis if events or changes in circumstances between annual impairment tests indicate that the asset might be impaired.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
  <us-gaap:RevenueRecognitionPolicyTextBlock id="F_000399" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:10pt;;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue Recognition &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Our revenues consist of amounts earned from collaborations, grants and fees from services and licenses. We enter into license and manufacturing agreements and collaborative research and development arrangements with pharmaceutical and biotechnology partners that may involve multiple deliverables. Our arrangements may include one or more of the following elements: upfront license payments, cost reimbursement for the performance of research and development activities, milestone payments, other contingent payments, contract manufacturing service fees, royalties and license fees. Each deliverable in the arrangement is evaluated to determine whether it meets the criteria to be accounted for as a separate unit of accounting or whether it should be combined with other deliverables. In order to account for the multiple-element arrangements, the Company identifies the deliverables included within the arrangement and evaluates which deliverables represent separate units of accounting. Analyzing the arrangement to identify deliverables requires the use of judgment, and each deliverable may be an obligation to deliver services, a right or license to use an asset, or another performance obligation. We recognize revenue when there is persuasive evidence that an arrangement exists, delivery has occurred or services have been rendered, the price is fixed or determinable and collectability is reasonably assured. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;On January&amp;#160;1, 2011, we adopted on a prospective basis Financial Accounting Standards Board (&amp;#8220;FASB&amp;#8221;) Accounting Standards Update (&amp;#8220;ASU&amp;#8221;) 2009-13, &lt;/font&gt;&lt;font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Multiple-Deliverable Revenue Arrangements&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, which amends the criteria related to identifying separate units of accounting and provides guidance on whether multiple deliverables exist, how an arrangement should be separated and the consideration allocated. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Non-refundable upfront fees received for license and collaborative agreements entered into prior to January&amp;#160;1, 2011 and other payments under collaboration agreements where we have continuing performance obligations related to the payments are deferred and recognized over our expected performance period. Revenue is recognized on a ratable basis, unless we determine that another method is more appropriate, through the date at which our performance obligations are completed. Management makes its best estimate of the period over which we expect to fulfill our performance obligations, which may include clinical development activities. Given the uncertainties of research and development collaborations, significant judgment is required to determine the duration of the performance period. We recognize cost reimbursement revenue under collaborative agreements as the related research and development costs are incurred, as provided for under the terms of these agreements. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Contingent consideration received for the achievement of a substantive milestone is recognized in its entirety in the period in which the milestone is achieved. A milestone is defined as an event having all of the following characteristics: (i&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&amp;#160;there is substantive uncertainty at the date the arrangement is entered into that the event will be achieved, (ii)&amp;#160;the event can only be achieved based in whole or in part on either the entity&amp;#8217;s performance or a specific outcome resulting from the entity&amp;#8217;s performance and (iii)&amp;#160;if achieved, the event would result in additional payments being due to the entity. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Our license and collaboration agreements with our partners provide for payments to be paid to us upon the achievement of development milestones. Given the challenges inherent in developing biologic products, there is substantial uncertainty whether any such milestones will be achieved at the time we entered into these agreements. In addition, we evaluate whether the development milestones meet the criteria to be considered substantive. The conditions include: (i&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&amp;#160;the development work is contingent on either of the following: (a)&amp;#160;the vendor&amp;#8217;s performance to achieve the milestone or (b)&amp;#160;the enhancement of the value of the deliverable item or items as a result of a specific outcome resulting from the vendor&amp;#8217;s performance to achieve the milestone; (ii)&amp;#160;it relates solely to past performance and (iii)&amp;#160;it is reasonable relative to all the deliverable and payment terms within the arrangement. As a result of our analysis, we consider our development milestones to be substantive and, accordingly, we expect to recognize as revenue future payments received from such milestones as we achieve each milestone. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Milestone payments that are contingent upon the achievement of substantive at-risk performance criteria are recognized in full upon achievement of those milestone events in accordance with the terms of the agreement and assuming all other revenue recognition criteria have been met. All revenue recognized to date under our collaborative agreements has been nonrefundable. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Our license and collaboration agreements with certain partners also provide for contingent payments to be paid to us based solely upon the performance of our partner. For such contingent payments we expect to recognize the payments as revenue upon receipt, provided that collection is reasonably assured and the other revenue recognition criteria have been satisfied. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Revenues from manufacturing services are recognized upon meeting the criteria for substantial performance and acceptance by the customer. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Revenue from royalty payments is contingent on future sales activities by our licensees. As a result, we recognize royalty revenue when reported by our licensees and when collection is reasonably assured. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Revenue from government and private agency grants are recognized as the related research expenses are incurred and to the extent that funding is approved. Additionally, we recognize revenue based on the facilities and administrative cost rate reimbursable per the terms of the grant awards. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
  <us-gaap:ResearchAndDevelopmentExpensePolicy id="F_000400" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and Development Expenses and Accruals &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Research and development expenses include personnel and facility-related expenses, outside contracted services including clinical trial costs, manufacturing and process development costs, research costs and other consulting services and non-cash stock-based compensation. Research and development costs are expensed as incurred. Amounts due under such arrangements may be either fixed fee or fee for service, and may include upfront payments, monthly payments and payments upon the completion of milestones or receipt of deliverables. Non-refundable advance payments under agreements are capitalized and expensed as the related goods are delivered or services are performed. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We contract with third parties to perform various clinical trial activities in the on-going development of potential products. The financial terms of these agreements are subject to negotiation, vary from contract to contract and may result in uneven payment flows to our vendors. Payments under the contracts depend on factors such as the achievement of certain events, successful enrollment of patients, completion&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; of portions of the clinical trial or similar conditions. Our accruals for clinical trials are based on estimates of the services received and efforts expended pursuant to contracts with clinical trial centers and clinical research organizations. We may terminate these contracts upon written notice and we are generally only liable for actual effort expended by the organizations to the date of termination, although in certain instances we may be further responsible for termination fees and penalties. The Company makes estimates of its accrued expenses as of each balance sheet date based on the facts and circumstances known to the Company at that time. There have been no material adjustments to the Company&amp;#8217;s prior period accrued estimates for clinical trial activities through December 31, 2013.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
  <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy id="F_000401" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock-Based Compensation &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Stock-based compensation expense for stock options and other stock awards is estimated at the grant date based on the award&amp;#8217;s fair value-based measurement and is recognized on a straight-line basis over the award&amp;#8217;s vesting period, assuming appropriate forfeiture rates&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;. Our determination of the fair value-based measurement of stock options on the date of grant using an option-pricing model is affected by our stock price, as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, our expected stock price volatility over the term of the awards, and actual and projected employee stock option exercise behaviors. In the future, as additional empirical evidence regarding these input estimates becomes available, we may change or refine our approach of deriving these input estimates. These changes could impact our fair value-based measurement of stock options granted in the future. Changes in the fair value-based measurement of stock awards could materially impact our operating results. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We selected the Black-Scholes option pricing model as the most appropriate method for determining the estimated fair value-based measurement of our stock options. The Black-Scholes model requires the use of highly subjective and complex assumptions which determine the fair value-based measurement of stock options, including the option&amp;#8217;s expected term and the price volatility of the underlying stock. Our current estimate of volatility is based on the historical volatility of our stock price. To the extent volatility in our stock price increases in the future, our estimates of the fair value of options granted in the future could increase, thereby increasing stock-based compensation cost recognized in future periods. We derive the expected term assumption primarily based on our historical settlement experience, while giving consideration to options that have not yet completed a full life cycle. Stock-based compensation cost is recognized only for awards ultimately expected to vest. Our estimate of the forfeiture rate is based primarily on our historical experience. To the extent we revise this estimate in the future,&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; our share-based compensation cost could be materially impacted in the quarter of revision, as well as in the following quarters. &lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
  <us-gaap:IncomeTaxPolicyTextBlock id="F_000402" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Income Taxes &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We account for income taxes using the asset and liability method, under which deferred tax assets and liabilities are determined based on the differences between the financial reporting and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Additionally, we assess the likelihood that deferred tax assets will be recovered as deductions from future taxable income. We have provided a full valuation allowance on our deferred tax assets at December&amp;#160;31, 2013 and 2012 because we believe it is more likely than not that our deferred tax assets will not be realized as of December&amp;#160;31, 2013, and 2012. &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We have no&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; unrecognized tax benefits as of December&amp;#160;31, 2013, including no accrued amounts for interest and penalties. We do not anticipate that total unrecognized tax benefits will significantly change prior to December&amp;#160;31, 2014. Our policy will be to recognize interest and penalties related to income taxes, if any, as a component of general and administrative expense. We are subject to income tax examinations for U.S. federal and state income taxes from 1996 forward. We are subject to tax examination in Germany from 2010 forward.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
  <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock id="F_000403" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Recent Accounting Pronouncements &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Accounting Standards Update 2013-02 &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;In February&amp;#160;2013, the FASB issued ASU 2013-02, &amp;#8220;&lt;/font&gt;&lt;font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Reporting of Amounts Reclassified out of Accumulated Other Comprehensive Income.&amp;#8221;&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;This ASU expands the presentation of changes in accumulated other comprehensive income.&amp;#160;The new guidance requires an entity to disaggregate the total change of each component of other comprehensive income either on the face of the statement of operations or as a separate disclosure in the financial statement footnotes. ASU 2013-02 is effective for fiscal years beginning after December&amp;#160;15, 2012. The Company adopted this guidance on a prospective basis in the first quarter of 2013 and the adoption did not have any impact on our financial position, results of operations or cash flows as there were no amounts reclassified out of accumulated other comprehensive (loss) income during the year ended December 31, 2013.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
  <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock id="F_000404" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;The following table represents the fair value hierarchy for our financial assets (cash equivalents and marketable securities) measured at fair value on a recurring basis as of December&amp;#160;31, 2013 and 2012 (in thousands): &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:54%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level&amp;#160;3&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&amp;#160;31, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Money market funds&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:54%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. government agency securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;167,597&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;167,597&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;167,597&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;187,610&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:54%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level&amp;#160;3&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&amp;#160;31, 2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Money market funds&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,140&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,140&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. government agency securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;119,233&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;119,233&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. treasury securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;500&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;500&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:54%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Municipal securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;715&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;715&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:54%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,140&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;120,448&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;123,588&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
  <us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock id="F_000405" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;The following is a summary of cash, cash equivalents and marketable securities as of December&amp;#160;31, 2013, and 2012 (in thousands): &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized Cost&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized Gains&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized Losses&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Estimated Fair&amp;#160;Value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&amp;#160;31, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash and cash equivalents:&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,766&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,766&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Money market funds&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. government agency securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,343&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,343&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total cash and cash equivalents&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;23,122&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;23,122&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Marketable securities available-for-sale:&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. government agency securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;166,285&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(47&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;166,254&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total marketable securities available-for-sale&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;166,285&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(47&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;166,254&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total cash, cash equivalents and marketable securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;189,407&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(47&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;189,376&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%; border-top:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&amp;#160;31, 2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash and cash equivalents:&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,542&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,542&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Money market funds&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,140&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,140&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Municipal securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;715&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;715&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. government agency securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,202&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,202&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total cash and cash equivalents&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,599&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,599&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Marketable securities available-for-sale:&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. government agency securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;116,986&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;46&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;117,031&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. treasury securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;500&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;500&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total marketable securities available-for-sale&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;117,486&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;46&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;117,531&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total cash, cash equivalents and marketable securities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;125,085&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;46&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;125,130&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock>
  <us-gaap:AvailableForSaleSecuritiesTextBlock id="F_000406" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;The maturities of our marketable securities available-for-sale are as follows (in thousands) &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:62%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:3%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:33%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&amp;#160;31, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:62%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:3%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized Cost&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:3%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Estimated Fair Value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:62%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Mature in one year or less&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:3%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;93,691&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:3%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:14%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;93,701&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:62%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Mature after one year through two years&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:3%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;72,594&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:3%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;72,553&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:62%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:3%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;166,285&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:3%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;166,254&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:AvailableForSaleSecuritiesTextBlock>
  <us-gaap:PropertyPlantAndEquipmentTextBlock id="F_000407" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Property and equipment as of December&amp;#160;31, 2013, and 2012 consist of the following (in thousands): &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:70%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:8%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Estimated&amp;#160;Useful&lt;br /&gt;Life&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&amp;#160;31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:70%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;(In years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:70%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Manufacturing equipment&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5-14&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,968&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,574&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:70%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Lab equipment&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5-13&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,227&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,755&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:70%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Computer equipment&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,962&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,807&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:70%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Furniture and fixtures&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,056&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;983&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:70%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Leasehold improvements&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5-7&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,048&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,445&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:70%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Assets in progress&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:8%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;762&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,047&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:70%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;26,023&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;23,611&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:70%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less accumulated depreciation and amortization&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:8%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(17,317&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(15,646&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:70%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:8%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,706&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,965&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
  <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock id="F_000408" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Current accrued liabilities as of December&amp;#160;31, 2013, and 2012 consist of the following (in thousands): &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:71%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" valign="bottom" style="width:28%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&amp;#160;31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:71%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:3%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:13%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Payroll and related expenses&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,639&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:3%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:11%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,538&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Legal expenses&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;338&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:3%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:11%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;396&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Third party research and development expenses&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,403&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:3%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:11%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,207&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:71%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other accrued liabilities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,786&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:3%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:11%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,922&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:71%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,166&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:3%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:11%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,063&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
  <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock id="F_000409" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Future minimum payments under the non-cancelable portion of our operating leases at December&amp;#160;31, 2013, excluding payments from sublease payments, are as follows (in thousands):&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Years ending December&amp;#160;31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:3%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:14%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:3%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:14%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,233&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2015&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:3%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:14%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,282&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2016&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:3%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:14%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,333&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2017&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:3%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:14%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,382&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:3%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:14%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,351&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Thereafter&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:3%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,499&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:3%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13,080&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
  <us-gaap:RevenueRecognitionMultipleDeliverableArrangementsTableTextBlock id="F_000410" contextRef="C_0001029142_deiLegalEntityAxis_dvaxAgreementWithGskMember_20130101_20131231">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;The following table summarizes the revenues recognized under our agreement with GSK (in thousands):&lt;/font&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year ended December 31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2011&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:67%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Initial payment&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,702&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,428&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,428&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Milestone revenue&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,000&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,702&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,428&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;16,428&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionMultipleDeliverableArrangementsTableTextBlock>
  <us-gaap:RevenueRecognitionMultipleDeliverableArrangementsTableTextBlock id="F_000411" contextRef="C_0001029142_deiLegalEntityAxis_dvaxAstraZenecaMember_20130101_20131231">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;The following table summarizes the revenues earned under our agreement with AstraZeneca (in thousands): &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year ended December 31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2011&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:67%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Initial payments&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;720&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;720&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;120&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Performance of research activities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,507&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,462&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;642&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,227&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,182&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;762&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionMultipleDeliverableArrangementsTableTextBlock>
  <us-gaap:RevenueRecognitionMultipleDeliverableArrangementsTableTextBlock id="F_000412" contextRef="C_0001029142_deiLegalEntityAxis_dvaxNationalInstitutesOfHealthMember_20130101_20131231">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;The following table summarizes the revenues recognized under the various arrangements with the NIH and NIAID (in thousands): &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year ended December 31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2011&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:67%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;NIAID contracts&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,103&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,571&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,730&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;All other NIH contracts&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,035&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;368&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;380&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total grant revenue&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,138&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,939&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,110&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionMultipleDeliverableArrangementsTableTextBlock>
  <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock id="F_000413" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&amp;#160;31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2011&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basic and diluted net loss per share (in thousands, except per share&amp;#160;amounts):&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Numerator:&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(66,720&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(69,949&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(48,597&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Preferred stock deemed dividend&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(8,469&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss allocable to common stockholders&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(75,189&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(69,949&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(48,597&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%; border-top:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Denominator for basic and diluted net loss per share allocable to common stockholders:&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-average common shares outstanding&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;196,275&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;170,469&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;125,101&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basic and diluted net loss per share allocable to common stockholders&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.38&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.41&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.39&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&amp;#160;31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2011&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding securities not included in diluted net loss per share calculation (in thousands):&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock options and stock awards&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17,040&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,561&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,101&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Series B Convertible Preferred Stock (as converted to common stock)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;43,430&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Warrants&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12,464&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12,714&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;25,729&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;72,934&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;28,275&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;36,830&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
  <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock id="F_000414" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;In connection with a 2007 loan agreement that was subsequently terminated in 2008, we issued warrants to purchase up to 3,550,000&lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; shares of our common stock as follows: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:39%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Warrant Issuance Date&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares Issuable &lt;br /&gt;(in thousands)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expiration &lt;br /&gt;Date&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercise Price &lt;br /&gt;per Share&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding as of &lt;br /&gt;December 31, 2013 &lt;br /&gt;(in thousands)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:39%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;July 18, 2007&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,250&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2/26/2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.13&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:15%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,250&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:39%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;October 18, 2007&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,300&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2/26/2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.68&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:15%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:39%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 27, 2007&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;300&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2/26/2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.65&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:15%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;300&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:39%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 27, 2007&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;700&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:12%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2/26/2014&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:12%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.68&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:15%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:39%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,550&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:12%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:12%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:15%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,550&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:6pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
  <us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock id="F_000415" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Activity under our stock plans is set forth below: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares Underlying&amp;nbsp;&amp;nbsp;Outstanding Options (in thousands)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-Average Exercise Price&amp;#160;Per&amp;#160;Share (in thousands)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-Average Remaining Contractual Term (years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Aggregate Intrinsic Value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at December&amp;#160;31, 2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13,806&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.38&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options granted&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,614&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.69&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options exercised&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(131&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.43&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options cancelled:&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options forfeited (unvested)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2,555&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.31&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options cancelled (vested)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(969&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.34&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:8%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:8%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at December&amp;#160;31, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,765&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.17&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.26&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,427&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Vested and expected to vest at December 31, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,765&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.17&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.26&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,427&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercisable at December 31, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,628&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.36&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.61&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,289&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:6pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock>
  <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock id="F_000416" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Our non-vested stock awards are comprised of restricted stock units granted with performance-based vesting criteria. A summary of the status of non-vested restricted stock units as of December&amp;#160;31, 2013, and activities during 2013 is summarized as follows: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number of Shares (In&amp;#160;thousands)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-Average Grant-Date&amp;#160;Fair Value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Non-vested as of December 31, 2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,755&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.23&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Granted&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;250&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.23&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Vested&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(115&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.10&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Forfeited or expired&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(615&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.23&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Non-vested as of December 31, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,275&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.93&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:6pt;;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
  <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock id="F_000417" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Under our stock-based compensation plans, option awards generally vest over a &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;four-year period contingent upon continuous service and expire ten years from the date of grant (or earlier upon termination of continuous service). The Company has also granted performance-based equity awards to certain of our employees under the 2011 Plan, the 2004 Plan and the Inducement Plan. As of December&amp;#160;31, 2013, 2,047,466 shares were outstanding related to options and restricted stock units subject to these performance-based vesting criteria. The fair value of each option is estimated on the date of grant using the Black-Scholes option valuation model and the following weighted-average assumptions: &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:35%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock&amp;#160;Options&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Employee&amp;#160;Stock Purchase&amp;#160;Plan&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:35%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&amp;#160;31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&amp;#160;31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:35%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2011&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2011&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:35%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-average fair value&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.41&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.30&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.76&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.93&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.54&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.09&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:35%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Risk-free interest rate&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.1&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.5&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.3&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.2&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.2&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.3&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:35%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected life (in years)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.9&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.2&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.0&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.3&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.1&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.2&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:35%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Volatility&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.4&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.6&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.6&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.8&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.6&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.6&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
  <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock id="F_000418" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;We recognized the following amounts of stock-based compensation expense (in thousands): &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&amp;#160;31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2011&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Employees and directors stock-based compensation expense&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;11,828&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,439&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,185&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Non-employees stock-based compensation expense&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;512&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12,340&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,439&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,189&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%; border-top:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&amp;#160;31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2011&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and development&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,228&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,514&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,103&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;General and administrative&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,112&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,925&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,086&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12,340&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,439&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,189&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
  <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock id="F_000419" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Consolidated income (loss) before provision for income taxes consisted of the following (in thousands): &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&amp;#160;31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2011&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(67,004&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(70,792&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(49,990&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Non U.S.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;284&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;843&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,393&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(66,720&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(69,949&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(48,597&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
  <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock id="F_000420" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;No income tax expense was recorded for the years ended December&amp;#160;31, 2013, 2012 and 2011 due to net operating loss &lt;/font&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;carryforwards to offset the net income at Dynavax Europe and a valuation allowance which offsets the deferred tax assets. The difference between the consolidated income tax benefit and the amount computed by applying the federal statutory income tax rate to the consolidated loss before income taxes was as follows (in thousands): &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&amp;#160;31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2011&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Income tax benefit at federal statutory rate&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(22,678&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(23,650&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(16,523&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;State tax&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(178&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(89&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2,586&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Business credits&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2,515&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,394&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred compensation charges&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,072&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,002&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;595&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Change in valuation allowance&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22,354&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21,966&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18,099&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Change in foreign tax rates&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(34&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Change in the fair value measurements&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;286&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Non-deductible debt discount&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;509&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deemed dividend&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;273&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prior year true up&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(55&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;771&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;775&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total income tax expense&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
  <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock id="F_000421" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%"&gt;Deferred tax assets and liabilities as of December&amp;#160;31, 2013 and 2012 consisted of the following (in thousands): &lt;/font&gt;&lt;/p&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&amp;#160;31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred tax assets:&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net operating loss carry forwards&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;147,655&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;127,529&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research tax credit carry forwards&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21,336&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18,163&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accruals and reserves&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,501&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,529&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Capitalized research costs&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,662&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12,757&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred revenue&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,486&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,180&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,222&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,221&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;192,862&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;170,379&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less valuation allowance&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(192,733&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(170,232&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total deferred tax assets&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;129&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;147&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred tax liabilities:&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fixed Assets&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(162&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(86&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;33&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(61&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total deferred tax liabilities&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(129&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(147&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net deferred tax assets&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;-&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
  <us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock id="F_000422" contextRef="C_0001029142_20130101_20131231">&lt;div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"&gt;&lt;font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&lt;div&gt;
&lt;table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="14" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&amp;#160;31, 2013&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Q1&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Q2&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Q3&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Q4&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenues&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,085&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,392&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,927&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,847&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net&amp;#160;loss&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(20,825&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(17,164&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(15,675&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(13,056&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss allocable to common stockholders&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(20,825&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(17,164&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(15,675&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(21,525&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basic and diluted net loss per share allocable to common stockholders&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.11&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.09&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.09&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.09&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares used to compute basic and diluted net loss per share allocable to common stockholders&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;182,847&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;182,913&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;183,022&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;235,879&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="14" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December&amp;#160;31, 2012&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Q1&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Q2&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Q3&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"&gt;&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Q4&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenues&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,350&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,684&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,874&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,806&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net&amp;#160;loss&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(16,505&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(15,110&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(17,791&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(20,543&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss allocable to common stockholders&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(16,505&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(15,110&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(17,791&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(20,543&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basic and diluted net loss per share allocable to common stockholders&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.11&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.09&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.10&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.11&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Shares used to compute basic and diluted net loss per share allocable to common stockholders&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;155,431&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;167,697&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;177,870&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"&gt;&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;180,685&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&lt;font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;&lt;p style="margin-bottom:0pt;margin-top:8pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;</us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock>
  <us-gaap:CashCashEquivalentsAndShortTermInvestments id="F_000423" contextRef="C_0001029142_20131231" decimals="-5" unitRef="U_iso4217USD">189400000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax id="F_000424" contextRef="C_0001029142_us-gaapBusinessAcquisitionAxis_dvaxRheinBiotechGmbhMember_20131231" decimals="-5" unitRef="U_iso4217USD">500000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax id="F_000425" contextRef="C_0001029142_us-gaapBusinessAcquisitionAxis_dvaxRheinBiotechGmbhMember_20121231" decimals="-5" unitRef="U_iso4217USD">400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax id="F_000426" contextRef="C_0001029142_us-gaapBusinessAcquisitionAxis_dvaxRheinBiotechGmbhMember_20111231" decimals="-5" unitRef="U_iso4217USD">-300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
  <us-gaap:ForeignCurrencyTransactionGainLossRealized id="F_000427" contextRef="C_0001029142_us-gaapBusinessAcquisitionAxis_dvaxRheinBiotechGmbhMember_20130101_20131231" decimals="-5" unitRef="U_iso4217USD">-200000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
  <us-gaap:ForeignCurrencyTransactionGainLossRealized id="F_000428" contextRef="C_0001029142_us-gaapBusinessAcquisitionAxis_dvaxRheinBiotechGmbhMember_20120101_20121231" decimals="-5" unitRef="U_iso4217USD">-200000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
  <us-gaap:ForeignCurrencyTransactionGainLossRealized id="F_000429" contextRef="C_0001029142_us-gaapBusinessAcquisitionAxis_dvaxRheinBiotechGmbhMember_20110101_20111231" decimals="-5" unitRef="U_iso4217USD">200000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
  <dvax:CashEquivalentsMaturityPeriod id="F_000430" contextRef="C_0001029142_us-gaapRangeAxis_us-gaapMaximumMember_20130101_20131231">P3M</dvax:CashEquivalentsMaturityPeriod>
  <dvax:NumberOfReportingUnits id="F_000431" contextRef="C_0001029142_20130101_20131231" decimals="INF" unitRef="U_dvaxSegment">1</dvax:NumberOfReportingUnits>
  <us-gaap:UnrecognizedTaxBenefits id="F_000432" contextRef="C_0001029142_20131231" decimals="0" unitRef="U_iso4217USD">0</us-gaap:UnrecognizedTaxBenefits>
  <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued id="F_000433" contextRef="C_0001029142_20131231" decimals="0" unitRef="U_iso4217USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
  <dvax:ReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncome id="F_000434" contextRef="C_0001029142_20130101_20131231" decimals="0" unitRef="U_iso4217USD">0</dvax:ReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncome>
  <us-gaap:NumberOfOperatingSegments id="F_000435" contextRef="C_0001029142_20130101_20131231" decimals="INF" unitRef="U_dvaxSegment">1</us-gaap:NumberOfOperatingSegments>
  <dvax:PercentageOfRevenueEarned id="F_000436" contextRef="C_0001029142_us-gaapStatementGeographicalAxis_countryUS_20130101_20131231" decimals="INF" unitRef="U_pure">0.89</dvax:PercentageOfRevenueEarned>
  <dvax:PercentageOfRevenueEarned id="F_000437" contextRef="C_0001029142_us-gaapStatementGeographicalAxis_countryUS_20120101_20121231" decimals="INF" unitRef="U_pure">0.88</dvax:PercentageOfRevenueEarned>
  <dvax:PercentageOfRevenueEarned id="F_000438" contextRef="C_0001029142_us-gaapStatementGeographicalAxis_countryUS_20110101_20111231" decimals="INF" unitRef="U_pure">0.94</dvax:PercentageOfRevenueEarned>
  <dvax:PercentageOfLongLivedAssets id="F_000439" contextRef="C_0001029142_us-gaapStatementGeographicalAxis_countryUS_20131231" decimals="INF" unitRef="U_pure">0.09</dvax:PercentageOfLongLivedAssets>
  <dvax:PercentageOfLongLivedAssets id="F_000440" contextRef="C_0001029142_us-gaapStatementGeographicalAxis_countryUS_20121231" decimals="INF" unitRef="U_pure">0.10</dvax:PercentageOfLongLivedAssets>
  <us-gaap:AssetsFairValueDisclosureRecurring id="F_000441" contextRef="C_0001029142_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20131231" decimals="-3" unitRef="U_iso4217USD">20013000</us-gaap:AssetsFairValueDisclosureRecurring>
  <us-gaap:AssetsFairValueDisclosureRecurring id="F_000442" contextRef="C_0001029142_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20131231" decimals="-3" unitRef="U_iso4217USD">20013000</us-gaap:AssetsFairValueDisclosureRecurring>
  <us-gaap:AssetsFairValueDisclosureRecurring id="F_000443" contextRef="C_0001029142_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20131231" decimals="-3" unitRef="U_iso4217USD">167597000</us-gaap:AssetsFairValueDisclosureRecurring>
  <us-gaap:AssetsFairValueDisclosureRecurring id="F_000444" contextRef="C_0001029142_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20131231" decimals="-3" unitRef="U_iso4217USD">167597000</us-gaap:AssetsFairValueDisclosureRecurring>
  <us-gaap:AssetsFairValueDisclosureRecurring id="F_000445" contextRef="C_0001029142_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20131231" decimals="-3" unitRef="U_iso4217USD">20013000</us-gaap:AssetsFairValueDisclosureRecurring>
  <us-gaap:AssetsFairValueDisclosureRecurring id="F_000446" contextRef="C_0001029142_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20131231" decimals="-3" unitRef="U_iso4217USD">167597000</us-gaap:AssetsFairValueDisclosureRecurring>
  <us-gaap:AssetsFairValueDisclosureRecurring id="F_000447" contextRef="C_0001029142_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20131231" decimals="-3" unitRef="U_iso4217USD">187610000</us-gaap:AssetsFairValueDisclosureRecurring>
  <us-gaap:AssetsFairValueDisclosureRecurring id="F_000448" contextRef="C_0001029142_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20121231" decimals="-3" unitRef="U_iso4217USD">3140000</us-gaap:AssetsFairValueDisclosureRecurring>
  <us-gaap:AssetsFairValueDisclosureRecurring id="F_000449" contextRef="C_0001029142_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20121231" decimals="-3" unitRef="U_iso4217USD">3140000</us-gaap:AssetsFairValueDisclosureRecurring>
  <us-gaap:AssetsFairValueDisclosureRecurring id="F_000450" contextRef="C_0001029142_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20121231" decimals="-3" unitRef="U_iso4217USD">119233000</us-gaap:AssetsFairValueDisclosureRecurring>
  <us-gaap:AssetsFairValueDisclosureRecurring id="F_000451" contextRef="C_0001029142_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20121231" decimals="-3" unitRef="U_iso4217USD">119233000</us-gaap:AssetsFairValueDisclosureRecurring>
  <us-gaap:AssetsFairValueDisclosureRecurring id="F_000452" contextRef="C_0001029142_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSTreasurySecuritiesMember_20121231" decimals="-3" unitRef="U_iso4217USD">500000</us-gaap:AssetsFairValueDisclosureRecurring>
  <us-gaap:AssetsFairValueDisclosureRecurring id="F_000453" contextRef="C_0001029142_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_us-gaapUSTreasurySecuritiesMember_20121231" decimals="-3" unitRef="U_iso4217USD">500000</us-gaap:AssetsFairValueDisclosureRecurring>
  <us-gaap:AssetsFairValueDisclosureRecurring id="F_000454" contextRef="C_0001029142_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_dvaxMunicipalSecuritiesMember_20121231" decimals="-3" unitRef="U_iso4217USD">715000</us-gaap:AssetsFairValueDisclosureRecurring>
  <us-gaap:AssetsFairValueDisclosureRecurring id="F_000455" contextRef="C_0001029142_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapInvestmentTypeAxis_dvaxMunicipalSecuritiesMember_20121231" decimals="-3" unitRef="U_iso4217USD">715000</us-gaap:AssetsFairValueDisclosureRecurring>
  <us-gaap:AssetsFairValueDisclosureRecurring id="F_000456" contextRef="C_0001029142_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20121231" decimals="-3" unitRef="U_iso4217USD">3140000</us-gaap:AssetsFairValueDisclosureRecurring>
  <us-gaap:AssetsFairValueDisclosureRecurring id="F_000457" contextRef="C_0001029142_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20121231" decimals="-3" unitRef="U_iso4217USD">120448000</us-gaap:AssetsFairValueDisclosureRecurring>
  <us-gaap:AssetsFairValueDisclosureRecurring id="F_000458" contextRef="C_0001029142_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20121231" decimals="-3" unitRef="U_iso4217USD">123588000</us-gaap:AssetsFairValueDisclosureRecurring>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="F_000459" contextRef="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapCashAndCashEquivalentsMember_us-gaapInvestmentTypeAxis_us-gaapCashMember_20131231" decimals="-3" unitRef="U_iso4217USD">1766000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="F_000460" contextRef="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapCashAndCashEquivalentsMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20131231" decimals="-3" unitRef="U_iso4217USD">20013000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="F_000461" contextRef="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapCashAndCashEquivalentsMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20131231" decimals="-3" unitRef="U_iso4217USD">1343000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="F_000462" contextRef="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapCashAndCashEquivalentsMember_20131231" decimals="-3" unitRef="U_iso4217USD">23122000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="F_000463" contextRef="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapAvailableforsaleSecuritiesMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20131231" decimals="-3" unitRef="U_iso4217USD">166285000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="F_000464" contextRef="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapAvailableforsaleSecuritiesMember_20131231" decimals="-3" unitRef="U_iso4217USD">166285000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="F_000465" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">189407000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="F_000466" contextRef="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapCashAndCashEquivalentsMember_us-gaapInvestmentTypeAxis_us-gaapCashMember_20121231" decimals="-3" unitRef="U_iso4217USD">1542000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="F_000467" contextRef="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapCashAndCashEquivalentsMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20121231" decimals="-3" unitRef="U_iso4217USD">3140000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="F_000468" contextRef="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapCashAndCashEquivalentsMember_us-gaapInvestmentTypeAxis_dvaxMunicipalSecuritiesMember_20121231" decimals="-3" unitRef="U_iso4217USD">715000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="F_000469" contextRef="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapCashAndCashEquivalentsMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20121231" decimals="-3" unitRef="U_iso4217USD">2202000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="F_000470" contextRef="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapCashAndCashEquivalentsMember_20121231" decimals="-3" unitRef="U_iso4217USD">7599000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="F_000471" contextRef="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapAvailableforsaleSecuritiesMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20121231" decimals="-3" unitRef="U_iso4217USD">116986000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="F_000472" contextRef="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapAvailableforsaleSecuritiesMember_us-gaapInvestmentTypeAxis_us-gaapUSTreasurySecuritiesMember_20121231" decimals="-3" unitRef="U_iso4217USD">500000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="F_000473" contextRef="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapAvailableforsaleSecuritiesMember_20121231" decimals="-3" unitRef="U_iso4217USD">117486000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="F_000474" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">125085000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <dvax:AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments id="F_000475" contextRef="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapAvailableforsaleSecuritiesMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20131231" decimals="-3" unitRef="U_iso4217USD">16000</dvax:AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments>
  <dvax:AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments id="F_000476" contextRef="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapAvailableforsaleSecuritiesMember_20131231" decimals="-3" unitRef="U_iso4217USD">16000</dvax:AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments>
  <dvax:AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments id="F_000477" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">16000</dvax:AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments>
  <dvax:AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments id="F_000478" contextRef="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapAvailableforsaleSecuritiesMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20121231" decimals="-3" unitRef="U_iso4217USD">46000</dvax:AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments>
  <dvax:AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments id="F_000479" contextRef="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapAvailableforsaleSecuritiesMember_20121231" decimals="-3" unitRef="U_iso4217USD">46000</dvax:AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments>
  <dvax:AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments id="F_000480" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">46000</dvax:AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments>
  <dvax:AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments id="F_000481" contextRef="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapAvailableforsaleSecuritiesMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20131231" decimals="-3" unitRef="U_iso4217USD">47000</dvax:AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments>
  <dvax:AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments id="F_000482" contextRef="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapAvailableforsaleSecuritiesMember_20131231" decimals="-3" unitRef="U_iso4217USD">47000</dvax:AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments>
  <dvax:AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments id="F_000483" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">47000</dvax:AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments>
  <dvax:AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments id="F_000484" contextRef="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapAvailableforsaleSecuritiesMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20121231" decimals="-3" unitRef="U_iso4217USD">1000</dvax:AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments>
  <dvax:AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments id="F_000485" contextRef="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapAvailableforsaleSecuritiesMember_20121231" decimals="-3" unitRef="U_iso4217USD">1000</dvax:AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments>
  <dvax:AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments id="F_000486" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">1000</dvax:AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments>
  <us-gaap:AvailableForSaleSecurities id="F_000487" contextRef="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapCashAndCashEquivalentsMember_us-gaapInvestmentTypeAxis_us-gaapCashMember_20131231" decimals="-3" unitRef="U_iso4217USD">1766000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities id="F_000488" contextRef="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapCashAndCashEquivalentsMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20131231" decimals="-3" unitRef="U_iso4217USD">20013000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities id="F_000489" contextRef="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapCashAndCashEquivalentsMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20131231" decimals="-3" unitRef="U_iso4217USD">1343000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities id="F_000490" contextRef="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapCashAndCashEquivalentsMember_20131231" decimals="-3" unitRef="U_iso4217USD">23122000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities id="F_000491" contextRef="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapAvailableforsaleSecuritiesMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20131231" decimals="-3" unitRef="U_iso4217USD">166254000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities id="F_000492" contextRef="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapAvailableforsaleSecuritiesMember_20131231" decimals="-3" unitRef="U_iso4217USD">166254000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities id="F_000493" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">189376000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities id="F_000494" contextRef="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapCashAndCashEquivalentsMember_us-gaapInvestmentTypeAxis_us-gaapCashMember_20121231" decimals="-3" unitRef="U_iso4217USD">1542000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities id="F_000495" contextRef="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapCashAndCashEquivalentsMember_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20121231" decimals="-3" unitRef="U_iso4217USD">3140000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities id="F_000496" contextRef="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapCashAndCashEquivalentsMember_us-gaapInvestmentTypeAxis_dvaxMunicipalSecuritiesMember_20121231" decimals="-3" unitRef="U_iso4217USD">715000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities id="F_000497" contextRef="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapCashAndCashEquivalentsMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20121231" decimals="-3" unitRef="U_iso4217USD">2202000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities id="F_000498" contextRef="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapCashAndCashEquivalentsMember_20121231" decimals="-3" unitRef="U_iso4217USD">7599000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities id="F_000499" contextRef="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapAvailableforsaleSecuritiesMember_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentAgenciesDebtSecuritiesMember_20121231" decimals="-3" unitRef="U_iso4217USD">117031000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities id="F_000500" contextRef="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapAvailableforsaleSecuritiesMember_us-gaapInvestmentTypeAxis_us-gaapUSTreasurySecuritiesMember_20121231" decimals="-3" unitRef="U_iso4217USD">500000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities id="F_000501" contextRef="C_0001029142_us-gaapInformationByFinancialStatementLineItemAxis_us-gaapAvailableforsaleSecuritiesMember_20121231" decimals="-3" unitRef="U_iso4217USD">117531000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities id="F_000502" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">125130000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost id="F_000503" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">93691000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost id="F_000504" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">72594000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost id="F_000505" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">166285000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue id="F_000506" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">93701000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue id="F_000507" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">72553000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
  <us-gaap:AvailableForSaleSecuritiesDebtSecurities id="F_000508" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">166254000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
  <us-gaap:MarketableSecuritiesRealizedGainLoss id="F_000509" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">0</us-gaap:MarketableSecuritiesRealizedGainLoss>
  <us-gaap:MarketableSecuritiesRealizedGainLoss id="F_000510" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">0</us-gaap:MarketableSecuritiesRealizedGainLoss>
  <us-gaap:MarketableSecuritiesRealizedGainLoss id="F_000511" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">0</us-gaap:MarketableSecuritiesRealizedGainLoss>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife id="F_000512" contextRef="C_0001029142_us-gaapPropertyPlantAndEquipmentByTypeAxis_dvaxManufacturingEquipmentMember_us-gaapRangeAxis_us-gaapMinimumMember_20130101_20131231">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife id="F_000513" contextRef="C_0001029142_us-gaapPropertyPlantAndEquipmentByTypeAxis_dvaxManufacturingEquipmentMember_us-gaapRangeAxis_us-gaapMaximumMember_20130101_20131231">P14Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife id="F_000514" contextRef="C_0001029142_us-gaapPropertyPlantAndEquipmentByTypeAxis_dvaxLaboratoryMember_us-gaapRangeAxis_us-gaapMinimumMember_20130101_20131231">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife id="F_000515" contextRef="C_0001029142_us-gaapPropertyPlantAndEquipmentByTypeAxis_dvaxLaboratoryMember_us-gaapRangeAxis_us-gaapMaximumMember_20130101_20131231">P13Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife id="F_000516" contextRef="C_0001029142_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapComputerEquipmentMember_20130101_20131231">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife id="F_000517" contextRef="C_0001029142_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapFurnitureAndFixturesMember_20130101_20131231">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife id="F_000518" contextRef="C_0001029142_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_us-gaapRangeAxis_us-gaapMinimumMember_20130101_20131231">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife id="F_000519" contextRef="C_0001029142_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_us-gaapRangeAxis_us-gaapMaximumMember_20130101_20131231">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:MachineryAndEquipmentGross id="F_000520" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">8968000</us-gaap:MachineryAndEquipmentGross>
  <us-gaap:MachineryAndEquipmentGross id="F_000521" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">7574000</us-gaap:MachineryAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="F_000522" contextRef="C_0001029142_us-gaapPropertyPlantAndEquipmentByTypeAxis_dvaxLaboratoryMember_20131231" decimals="-3" unitRef="U_iso4217USD">7227000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="F_000523" contextRef="C_0001029142_us-gaapPropertyPlantAndEquipmentByTypeAxis_dvaxLaboratoryMember_20121231" decimals="-3" unitRef="U_iso4217USD">6755000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="F_000524" contextRef="C_0001029142_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapComputerEquipmentMember_20131231" decimals="-3" unitRef="U_iso4217USD">1962000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="F_000525" contextRef="C_0001029142_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapComputerEquipmentMember_20121231" decimals="-3" unitRef="U_iso4217USD">1807000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:FurnitureAndFixturesGross id="F_000526" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">1056000</us-gaap:FurnitureAndFixturesGross>
  <us-gaap:FurnitureAndFixturesGross id="F_000527" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">983000</us-gaap:FurnitureAndFixturesGross>
  <us-gaap:LeaseholdImprovementsGross id="F_000528" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">6048000</us-gaap:LeaseholdImprovementsGross>
  <us-gaap:LeaseholdImprovementsGross id="F_000529" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">5445000</us-gaap:LeaseholdImprovementsGross>
  <us-gaap:PropertyPlantAndEquipmentOther id="F_000530" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">762000</us-gaap:PropertyPlantAndEquipmentOther>
  <us-gaap:PropertyPlantAndEquipmentOther id="F_000531" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">1047000</us-gaap:PropertyPlantAndEquipmentOther>
  <us-gaap:PropertyPlantAndEquipmentGross id="F_000532" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">26023000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="F_000533" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">23611000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="F_000534" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">17317000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="F_000535" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">15646000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife id="F_000536" contextRef="C_0001029142_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_dvaxManufacturingMember_20110101_20111231">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife id="F_000537" contextRef="C_0001029142_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis_us-gaapCustomerRelationshipsMember_20110101_20111231">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:AmortizationOfIntangibleAssets id="F_000538" contextRef="C_0001029142_20130101_20131231" decimals="-6" unitRef="U_iso4217USD">0</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:AmortizationOfIntangibleAssets id="F_000539" contextRef="C_0001029142_20120101_20121231" decimals="-6" unitRef="U_iso4217USD">0</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:AccruedEmployeeBenefitsCurrent id="F_000540" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">3639000</us-gaap:AccruedEmployeeBenefitsCurrent>
  <us-gaap:AccruedEmployeeBenefitsCurrent id="F_000541" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">4538000</us-gaap:AccruedEmployeeBenefitsCurrent>
  <us-gaap:AccruedProfessionalFeesCurrent id="F_000542" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">338000</us-gaap:AccruedProfessionalFeesCurrent>
  <us-gaap:AccruedProfessionalFeesCurrent id="F_000543" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">396000</us-gaap:AccruedProfessionalFeesCurrent>
  <dvax:AccruedThirdPartyResearchAndDevelopmentExpensesCurrent id="F_000544" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">2403000</dvax:AccruedThirdPartyResearchAndDevelopmentExpensesCurrent>
  <dvax:AccruedThirdPartyResearchAndDevelopmentExpensesCurrent id="F_000545" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">3207000</dvax:AccruedThirdPartyResearchAndDevelopmentExpensesCurrent>
  <us-gaap:OtherAccruedLiabilitiesCurrent id="F_000546" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">1786000</us-gaap:OtherAccruedLiabilitiesCurrent>
  <us-gaap:OtherAccruedLiabilitiesCurrent id="F_000547" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">1922000</us-gaap:OtherAccruedLiabilitiesCurrent>
  <us-gaap:EquityMethodInvestments id="F_000548" contextRef="C_0001029142_us-gaapScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_dvaxSymphonyDynamoIncMember_20060418" decimals="-6" unitRef="U_iso4217USD">50000000</us-gaap:EquityMethodInvestments>
  <us-gaap:MinorityInterestOwnershipPercentageByParent id="F_000549" contextRef="C_0001029142_us-gaapScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_dvaxSymphonyDynamoIncMember_20060418" decimals="INF" unitRef="U_pure">1.00</us-gaap:MinorityInterestOwnershipPercentageByParent>
  <us-gaap:MinorityInterestOwnershipPercentageByParent id="F_000550" contextRef="C_0001029142_us-gaapScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_dvaxSymphonyDynamoHoldingsLlcMember_20060418" decimals="INF" unitRef="U_pure">1.00</us-gaap:MinorityInterestOwnershipPercentageByParent>
  <dvax:IssueOfWarrantsToPurchaseSharesOfCommonStock id="F_000551" contextRef="C_0001029142_us-gaapRangeAxis_us-gaapMaximumMember_20060319_20060418" decimals="INF" unitRef="U_shares">2000000</dvax:IssueOfWarrantsToPurchaseSharesOfCommonStock>
  <dvax:WarrantsExercisablePeriod id="F_000552" contextRef="C_0001029142_20060319_20060418">P5Y</dvax:WarrantsExercisablePeriod>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="F_000553" contextRef="C_0001029142_20060418" decimals="INF" unitRef="U_iso4217USD_dvaxRight">7.32</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:OtherCommitment id="F_000554" contextRef="C_0001029142_20070430" decimals="-6" unitRef="U_iso4217USD">15000000</us-gaap:OtherCommitment>
  <dvax:IssueOfWarrantsToPurchaseSharesOfCommonStock id="F_000555" contextRef="C_0001029142_20091101_20091130" decimals="INF" unitRef="U_shares">2000000</dvax:IssueOfWarrantsToPurchaseSharesOfCommonStock>
  <dvax:WarrantsExercisablePeriod id="F_000556" contextRef="C_0001029142_20091101_20091130">P5Y</dvax:WarrantsExercisablePeriod>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="F_000557" contextRef="C_0001029142_20091130" decimals="INF" unitRef="U_iso4217USD_dvaxRight">1.94</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:StockIssuedDuringPeriodSharesAcquisitions id="F_000558" contextRef="C_0001029142_20091101_20091130" decimals="INF" unitRef="U_shares">13000000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
  <us-gaap:DebtInstrumentFaceAmount id="F_000559" contextRef="C_0001029142_20091130" decimals="-6" unitRef="U_iso4217USD">15000000</us-gaap:DebtInstrumentFaceAmount>
  <us-gaap:SubordinatedBorrowingDueDate id="F_000560" contextRef="C_0001029142_20091101_20091130">2012-12-31</us-gaap:SubordinatedBorrowingDueDate>
  <dvax:BusinessAcquisitionContingentConsiderationPercentage id="F_000561" contextRef="C_0001029142_20091130" decimals="2" unitRef="U_pure">0.50</dvax:BusinessAcquisitionContingentConsiderationPercentage>
  <us-gaap:PaymentsToAcquireBusinessesGross id="F_000562" contextRef="C_0001029142_20091101_20091130" decimals="-6" unitRef="U_iso4217USD">50000000</us-gaap:PaymentsToAcquireBusinessesGross>
  <us-gaap:FairValueInputsDiscountRate id="F_000563" contextRef="C_0001029142_20130101_20131231" decimals="2" unitRef="U_pure">0.17</us-gaap:FairValueInputsDiscountRate>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000564" contextRef="C_0001029142_20100401_20100430" decimals="INF" unitRef="U_shares">1076420</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <dvax:IssueOfWarrantsToPurchaseSharesOfCommonStock id="F_000565" contextRef="C_0001029142_20100401_20100430" decimals="INF" unitRef="U_shares">7038210</dvax:IssueOfWarrantsToPurchaseSharesOfCommonStock>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="F_000566" contextRef="C_0001029142_20100430" decimals="INF" unitRef="U_iso4217USD_dvaxRight">1.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <dvax:WarrantsExercisablePeriod id="F_000567" contextRef="C_0001029142_20100401_20100430">P5Y</dvax:WarrantsExercisablePeriod>
  <us-gaap:NonoperatingIncomeExpense id="F_000568" contextRef="C_0001029142_20100401_20100630" decimals="-5" unitRef="U_iso4217USD">11100000</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:LiabilitiesFairValueAdjustment id="F_000569" contextRef="C_0001029142_us-gaapClassOfWarrantOrRightAxis_dvaxWarrantLiabilityMember_20100601_20100630" decimals="-5" unitRef="U_iso4217USD">9500000</us-gaap:LiabilitiesFairValueAdjustment>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued id="F_000570" contextRef="C_0001029142_us-gaapClassOfWarrantOrRightAxis_dvaxWarrantLiabilityMember_20100601_20100630" decimals="-5" unitRef="U_iso4217USD">1600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
  <dvax:ReclassificationOfWarrantLiabilitiesToEquity id="F_000571" contextRef="C_0001029142_us-gaapClassOfWarrantOrRightAxis_dvaxWarrantLiabilityMember_20100601_20100630" decimals="-5" unitRef="U_iso4217USD">12000000</dvax:ReclassificationOfWarrantLiabilitiesToEquity>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="F_000572" contextRef="C_0001029142_us-gaapScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_dvaxSymphonyDynamoIncMember_20131231" decimals="INF" unitRef="U_shares">6765128</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:MalpracticeLossContingencyDiscountRate id="F_000573" contextRef="C_0001029142_20100101_20101231" decimals="2" unitRef="U_pure">0.16</us-gaap:MalpracticeLossContingencyDiscountRate>
  <us-gaap:LiabilitiesFairValueAdjustment id="F_000574" contextRef="C_0001029142_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_20100101_20101231" decimals="-5" unitRef="U_iso4217USD">2200000</us-gaap:LiabilitiesFairValueAdjustment>
  <us-gaap:LiabilitiesFairValueAdjustment id="F_000575" contextRef="C_0001029142_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_20110101_20111231" decimals="-5" unitRef="U_iso4217USD">800000</us-gaap:LiabilitiesFairValueAdjustment>
  <us-gaap:BusinessCombinationContingentConsiderationLiability id="F_000576" contextRef="C_0001029142_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_20111231" decimals="-6" unitRef="U_iso4217USD">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent id="F_000577" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">2233000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears id="F_000578" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">2282000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears id="F_000579" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">2333000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears id="F_000580" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">2382000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears id="F_000581" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">1351000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter id="F_000582" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">2499000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDue id="F_000583" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">13080000</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
  <dvax:LeaseExpirationMonthAndYear id="F_000584" contextRef="C_0001029142_us-gaapStatementGeographicalAxis_stprCA_20130101_20131231">2018-06</dvax:LeaseExpirationMonthAndYear>
  <dvax:LeaseExpirationMonthAndYear id="F_000585" contextRef="C_0001029142_us-gaapStatementGeographicalAxis_countryGC_20130101_20131231">2023-03</dvax:LeaseExpirationMonthAndYear>
  <us-gaap:BusinessExitCosts1 id="F_000586" contextRef="C_0001029142_us-gaapStatementGeographicalAxis_stprCA_20130101_20131231" decimals="-5" unitRef="U_iso4217USD">900000</us-gaap:BusinessExitCosts1>
  <us-gaap:OperatingLeasesRentExpenseNet id="F_000587" contextRef="C_0001029142_20130101_20131231" decimals="-5" unitRef="U_iso4217USD">1900000</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:OperatingLeasesRentExpenseNet id="F_000588" contextRef="C_0001029142_20120101_20121231" decimals="-5" unitRef="U_iso4217USD">1700000</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:OperatingLeasesRentExpenseNet id="F_000589" contextRef="C_0001029142_20110101_20111231" decimals="-5" unitRef="U_iso4217USD">1700000</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:DeferredRentCredit id="F_000590" contextRef="C_0001029142_20131231" decimals="-5" unitRef="U_iso4217USD">600000</us-gaap:DeferredRentCredit>
  <us-gaap:DeferredRentCredit id="F_000591" contextRef="C_0001029142_20121231" decimals="-5" unitRef="U_iso4217USD">600000</us-gaap:DeferredRentCredit>
  <us-gaap:PledgedAssetsSeparatelyReportedSecuritiesPledgedUnderLetterOfCreditFacilitiesAtFairValue id="F_000592" contextRef="C_0001029142_us-gaapStatementGeographicalAxis_dvaxCaliforniaMember_20041231" decimals="-5" unitRef="U_iso4217USD">400000</us-gaap:PledgedAssetsSeparatelyReportedSecuritiesPledgedUnderLetterOfCreditFacilitiesAtFairValue>
  <us-gaap:SecurityOwnedAndPledgedAsCollateralFairValue id="F_000593" contextRef="C_0001029142_us-gaapStatementGeographicalAxis_dvaxCaliforniaMember_20131231" decimals="-5" unitRef="U_iso4217USD">400000</us-gaap:SecurityOwnedAndPledgedAsCollateralFairValue>
  <us-gaap:SecurityOwnedAndPledgedAsCollateralFairValue id="F_000594" contextRef="C_0001029142_us-gaapStatementGeographicalAxis_dvaxCaliforniaMember_20121231" decimals="-5" unitRef="U_iso4217USD">400000</us-gaap:SecurityOwnedAndPledgedAsCollateralFairValue>
  <us-gaap:LoansAndLeasesReceivableDescription id="F_000595" contextRef="C_0001029142_us-gaapStatementGeographicalAxis_dvaxCaliforniaMember_20041001_20041231">If the total amount of our cash, cash equivalents and marketable securities falls below $20 million for a period of more than 30 consecutive days during the lease term, the amount of the required security deposit will increase to $1.1 million, until such time as our projected cash and cash equivalents will exceed $20 million for the remainder of the lease term, or until our actual cash and cash equivalents remains above $20 million for a period of 12 consecutive months.</us-gaap:LoansAndLeasesReceivableDescription>
  <us-gaap:CashCashEquivalentsAndShortTermInvestments id="F_000596" contextRef="C_0001029142_us-gaapLossContingenciesByNatureOfContingencyAxis_dvaxContingencyBMember_us-gaapRangeAxis_us-gaapMinimumMember_us-gaapStatementGeographicalAxis_dvaxCaliforniaMember_20041231" decimals="-6" unitRef="U_iso4217USD">20000000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
  <us-gaap:CashCashEquivalentsAndShortTermInvestments id="F_000597" contextRef="C_0001029142_us-gaapLossContingenciesByNatureOfContingencyAxis_dvaxContingencyAMember_us-gaapRangeAxis_us-gaapMaximumMember_us-gaapStatementGeographicalAxis_dvaxCaliforniaMember_20041231" decimals="-6" unitRef="U_iso4217USD">20000000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
  <dvax:ContingencyPeriod id="F_000598" contextRef="C_0001029142_us-gaapLossContingenciesByNatureOfContingencyAxis_dvaxContingencyAMember_us-gaapRangeAxis_us-gaapMinimumMember_us-gaapStatementGeographicalAxis_dvaxCaliforniaMember_20041001_20041231">P30D</dvax:ContingencyPeriod>
  <dvax:ContingencyPeriod id="F_000599" contextRef="C_0001029142_us-gaapLossContingenciesByNatureOfContingencyAxis_dvaxContingencyBMember_us-gaapStatementGeographicalAxis_dvaxCaliforniaMember_20041001_20041231">P12M</dvax:ContingencyPeriod>
  <us-gaap:IncreaseDecreaseInSecurityDeposits id="F_000600" contextRef="C_0001029142_us-gaapLossContingenciesByNatureOfContingencyAxis_dvaxContingencyAMember_us-gaapStatementGeographicalAxis_dvaxCaliforniaMember_20041001_20041231" decimals="-5" unitRef="U_iso4217USD">1100000</us-gaap:IncreaseDecreaseInSecurityDeposits>
  <us-gaap:PledgedAssetsSeparatelyReportedSecuritiesPledgedUnderLetterOfCreditFacilitiesAtFairValue id="F_000601" contextRef="C_0001029142_us-gaapLossContingenciesByNatureOfContingencyAxis_dvaxDeutscheBankSecuritiesMember_20131231" decimals="-5" unitRef="U_iso4217EUR">200000</us-gaap:PledgedAssetsSeparatelyReportedSecuritiesPledgedUnderLetterOfCreditFacilitiesAtFairValue>
  <us-gaap:SecurityOwnedAndPledgedAsCollateralFairValue id="F_000602" contextRef="C_0001029142_us-gaapLossContingenciesByNatureOfContingencyAxis_dvaxDeutscheBankSecuritiesMember_20131231" decimals="-5" unitRef="U_iso4217USD">200000</us-gaap:SecurityOwnedAndPledgedAsCollateralFairValue>
  <us-gaap:SecurityOwnedAndPledgedAsCollateralFairValue id="F_000603" contextRef="C_0001029142_us-gaapLossContingenciesByNatureOfContingencyAxis_dvaxDeutscheBankSecuritiesMember_20121231" decimals="-5" unitRef="U_iso4217USD">200000</us-gaap:SecurityOwnedAndPledgedAsCollateralFairValue>
  <us-gaap:LongTermPurchaseCommitmentAmount id="F_000604" contextRef="C_0001029142_20130101_20131231" decimals="-5" unitRef="U_iso4217USD">4500000</us-gaap:LongTermPurchaseCommitmentAmount>
  <dvax:NumberOfProjects id="F_000605" contextRef="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxGlaxoSmithKlineMember_20081201_20081231" decimals="INF" unitRef="U_dvaxProject">4</dvax:NumberOfProjects>
  <dvax:PotentialMilestonePaymentAmount id="F_000606" contextRef="C_0001029142_us-gaapRangeAxis_us-gaapMaximumMember_us-gaapTypeOfArrangementAxis_dvaxGlaxoSmithKlineMember_20131231" decimals="-6" unitRef="U_iso4217USD">125000000</dvax:PotentialMilestonePaymentAmount>
  <dvax:PotentialMilestonePaymentAmount id="F_000607" contextRef="C_0001029142_dvaxCollaborativeAgreementAxis_dvaxConditionTwoMember_us-gaapRangeAxis_us-gaapMaximumMember_us-gaapTypeOfArrangementAxis_dvaxGlaxoSmithKlineMember_20131231" decimals="-6" unitRef="U_iso4217USD">60000000</dvax:PotentialMilestonePaymentAmount>
  <us-gaap:DeferredRevenueAdditions id="F_000608" contextRef="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxGlaxoSmithKlineMember_20081201_20081231" decimals="-6" unitRef="U_iso4217USD">10000000</us-gaap:DeferredRevenueAdditions>
  <us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized id="F_000609" contextRef="C_0001029142_20110101_20111231" decimals="-6" unitRef="U_iso4217USD">12000000</us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized>
  <us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized id="F_000610" contextRef="C_0001029142_us-gaapStatementBusinessSegmentsAxis_dvaxExpansionMember_us-gaapTypeOfArrangementAxis_dvaxGlaxoSmithKlineMember_20110101_20111231" decimals="-6" unitRef="U_iso4217USD">3000000</us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized>
  <dvax:RevenueRecognitionPeriod id="F_000611" contextRef="C_0001029142_us-gaapRangeAxis_us-gaapMaximumMember_us-gaapTypeOfArrangementAxis_dvaxGlaxoSmithKlineMember_20131231">P7Y</dvax:RevenueRecognitionPeriod>
  <dvax:RevenueRecognitionPeriod id="F_000612" contextRef="C_0001029142_us-gaapRangeAxis_us-gaapMinimumMember_us-gaapTypeOfArrangementAxis_dvaxGlaxoSmithKlineMember_20131231">P6Y</dvax:RevenueRecognitionPeriod>
  <us-gaap:NewAccountingPronouncementOrChangeInAccountingPrincipleCurrentPeriodDisclosuresRevenueRecognizedAmount id="F_000613" contextRef="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxGlaxoSmithKlineMember_20131001_20131231" decimals="-5" unitRef="U_iso4217USD">300000</us-gaap:NewAccountingPronouncementOrChangeInAccountingPrincipleCurrentPeriodDisclosuresRevenueRecognizedAmount>
  <us-gaap:DeferredRevenue id="F_000614" contextRef="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxGlaxoSmithKlineMember_20131231" decimals="-5" unitRef="U_iso4217USD">2500000</us-gaap:DeferredRevenue>
  <us-gaap:DeferredRevenue id="F_000615" contextRef="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxGlaxoSmithKlineMember_20121231" decimals="-5" unitRef="U_iso4217USD">4200000</us-gaap:DeferredRevenue>
  <dvax:ResearchCollaborationAndLicenseAgreementPeriod id="F_000616" contextRef="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxAstraZenecaMember_20060901_20060930">P3Y</dvax:ResearchCollaborationAndLicenseAgreementPeriod>
  <us-gaap:DeferredRevenueAdditions id="F_000617" contextRef="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxAmendmentMember_20111001_20111031" decimals="-6" unitRef="U_iso4217USD">3000000</us-gaap:DeferredRevenueAdditions>
  <us-gaap:DeferredRevenueAdditions id="F_000618" contextRef="C_0001029142_us-gaapContingentConsiderationByTypeAxis_dvaxContingentConsiderationMember_us-gaapTypeOfArrangementAxis_dvaxAmendmentMember_20120101_20120331" decimals="-5" unitRef="U_iso4217USD">2600000</us-gaap:DeferredRevenueAdditions>
  <us-gaap:DeferredRevenueAdditions id="F_000619" contextRef="C_0001029142_us-gaapContingentConsiderationByTypeAxis_dvaxContingentConsiderationMember_us-gaapTypeOfArrangementAxis_dvaxAmendmentMember_20121001_20121231" decimals="-6" unitRef="U_iso4217USD">6000000</us-gaap:DeferredRevenueAdditions>
  <us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized id="F_000620" contextRef="C_0001029142_us-gaapContingentConsiderationByTypeAxis_dvaxContingentConsiderationMember_us-gaapTypeOfArrangementAxis_dvaxAmendmentMember_20130101_20131231" decimals="-6" unitRef="U_iso4217USD">20000000</us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized>
  <us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized id="F_000621" contextRef="C_0001029142_us-gaapContingentConsiderationByTypeAxis_dvaxContingentConsiderationMember_us-gaapRangeAxis_us-gaapMaximumMember_us-gaapTypeOfArrangementAxis_dvaxAmendmentMember_20130101_20131231" decimals="-6" unitRef="U_iso4217USD">100000000</us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized>
  <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost id="F_000622" contextRef="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxAmendmentMember_20110101_20111231" decimals="-6" unitRef="U_iso4217USD">20000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
  <dvax:RevenueRecognitionPeriod id="F_000623" contextRef="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxAstraZenecaMember_20131231">P50M</dvax:RevenueRecognitionPeriod>
  <us-gaap:DeferredRevenue id="F_000624" contextRef="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxAstraZenecaMember_20131231" decimals="-5" unitRef="U_iso4217USD">4800000</us-gaap:DeferredRevenue>
  <us-gaap:DeferredRevenue id="F_000625" contextRef="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxAstraZenecaMember_20121231" decimals="-5" unitRef="U_iso4217USD">7700000</us-gaap:DeferredRevenue>
  <us-gaap:GrantsReceivable id="F_000626" contextRef="C_0001029142_dvaxDifferentTypesOfCollaborationAgreementsAxis_dvaxNationalInstitutesOfHealthMember_us-gaapTypeOfArrangementAxis_dvaxHepaticFibrosisAndCirrhosisMember_20130930" decimals="-5" unitRef="U_iso4217USD">200000</us-gaap:GrantsReceivable>
  <us-gaap:GrantsReceivable id="F_000627" contextRef="C_0001029142_dvaxDifferentTypesOfCollaborationAgreementsAxis_dvaxNationalInstitutesOfHealthMember_us-gaapTypeOfArrangementAxis_dvaxAutoimmuneDiseaseMember_20120630" decimals="-5" unitRef="U_iso4217USD">600000</us-gaap:GrantsReceivable>
  <us-gaap:GrantsReceivable id="F_000628" contextRef="C_0001029142_dvaxDifferentTypesOfCollaborationAgreementsAxis_dvaxNationalInstitutesOfHealthMember_us-gaapTypeOfArrangementAxis_dvaxRheumatoidArthritisMember_20120531" decimals="-5" unitRef="U_iso4217USD">400000</us-gaap:GrantsReceivable>
  <us-gaap:GrantsReceivable id="F_000629" contextRef="C_0001029142_dvaxDifferentTypesOfCollaborationAgreementsAxis_dvaxNationalInstitutesOfHealthMember_us-gaapTypeOfArrangementAxis_dvaxSkinAutoimmuneInflammationMember_20110731" decimals="-5" unitRef="U_iso4217USD">600000</us-gaap:GrantsReceivable>
  <us-gaap:GrantsReceivable id="F_000630" contextRef="C_0001029142_dvaxDifferentTypesOfCollaborationAgreementsAxis_dvaxNationalInstitutesOfHealthMember_us-gaapTypeOfArrangementAxis_dvaxHepatitisBVirusMember_20100831" decimals="-5" unitRef="U_iso4217USD">1400000</us-gaap:GrantsReceivable>
  <us-gaap:GrantsReceivable id="F_000631" contextRef="C_0001029142_dvaxDifferentTypesOfCollaborationAgreementsAxis_dvaxNationalInstitutesOfHealthMember_us-gaapTypeOfArrangementAxis_dvaxHumanPapillomaVirusMember_20100731" decimals="-5" unitRef="U_iso4217USD">600000</us-gaap:GrantsReceivable>
  <dvax:ContractTerm id="F_000632" contextRef="C_0001029142_dvaxDifferentTypesOfCollaborationAgreementsAxis_dvaxNationalInstitutesOfHealthMember_us-gaapTypeOfArrangementAxis_dvaxIssTechnologyMember_20080901_20080930">P5Y</dvax:ContractTerm>
  <us-gaap:AccountsReceivableBilledForLongTermContractsOrPrograms id="F_000633" contextRef="C_0001029142_dvaxDifferentTypesOfCollaborationAgreementsAxis_dvaxNationalInstitutesOfHealthMember_us-gaapTypeOfArrangementAxis_dvaxIssTechnologyMember_20080930" decimals="-6" unitRef="U_iso4217USD">17000000</us-gaap:AccountsReceivableBilledForLongTermContractsOrPrograms>
  <us-gaap:DeferredRevenueAdditions id="F_000634" contextRef="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxGlaxoSmithKlineMember_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">1702000</us-gaap:DeferredRevenueAdditions>
  <us-gaap:DeferredRevenueAdditions id="F_000635" contextRef="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxGlaxoSmithKlineMember_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">1428000</us-gaap:DeferredRevenueAdditions>
  <us-gaap:DeferredRevenueAdditions id="F_000636" contextRef="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxGlaxoSmithKlineMember_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">1428000</us-gaap:DeferredRevenueAdditions>
  <us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized id="F_000637" contextRef="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxGlaxoSmithKlineMember_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">15000000</us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized>
  <us-gaap:Revenues id="F_000638" contextRef="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxGlaxoSmithKlineMember_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">1702000</us-gaap:Revenues>
  <us-gaap:Revenues id="F_000639" contextRef="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxGlaxoSmithKlineMember_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">1428000</us-gaap:Revenues>
  <us-gaap:Revenues id="F_000640" contextRef="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxGlaxoSmithKlineMember_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">16428000</us-gaap:Revenues>
  <us-gaap:DeferredRevenueAdditions id="F_000641" contextRef="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxAstraZenecaMember_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">720000</us-gaap:DeferredRevenueAdditions>
  <us-gaap:DeferredRevenueAdditions id="F_000642" contextRef="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxAstraZenecaMember_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">720000</us-gaap:DeferredRevenueAdditions>
  <us-gaap:DeferredRevenueAdditions id="F_000643" contextRef="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxAstraZenecaMember_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">120000</us-gaap:DeferredRevenueAdditions>
  <us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized id="F_000644" contextRef="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxAstraZenecaMember_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">2507000</us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized>
  <us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized id="F_000645" contextRef="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxAstraZenecaMember_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">2462000</us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized>
  <us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized id="F_000646" contextRef="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxAstraZenecaMember_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">642000</us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized>
  <us-gaap:Revenues id="F_000647" contextRef="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxAstraZenecaMember_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">3227000</us-gaap:Revenues>
  <us-gaap:Revenues id="F_000648" contextRef="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxAstraZenecaMember_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">3182000</us-gaap:Revenues>
  <us-gaap:Revenues id="F_000649" contextRef="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxAstraZenecaMember_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">762000</us-gaap:Revenues>
  <us-gaap:RevenueFromGrants id="F_000650" contextRef="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxNationalInstituteOfAllergyAndInfectiousDiseasesMember_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">4103000</us-gaap:RevenueFromGrants>
  <us-gaap:RevenueFromGrants id="F_000651" contextRef="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxNationalInstituteOfAllergyAndInfectiousDiseasesMember_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">3571000</us-gaap:RevenueFromGrants>
  <us-gaap:RevenueFromGrants id="F_000652" contextRef="C_0001029142_us-gaapTypeOfArrangementAxis_dvaxNationalInstituteOfAllergyAndInfectiousDiseasesMember_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">2730000</us-gaap:RevenueFromGrants>
  <us-gaap:RevenueFromGrants id="F_000653" contextRef="C_0001029142_dvaxDifferentTypesOfCollaborationAgreementsAxis_dvaxNationalInstitutesOfHealthMember_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">1035000</us-gaap:RevenueFromGrants>
  <us-gaap:RevenueFromGrants id="F_000654" contextRef="C_0001029142_dvaxDifferentTypesOfCollaborationAgreementsAxis_dvaxNationalInstitutesOfHealthMember_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">368000</us-gaap:RevenueFromGrants>
  <us-gaap:RevenueFromGrants id="F_000655" contextRef="C_0001029142_dvaxDifferentTypesOfCollaborationAgreementsAxis_dvaxNationalInstitutesOfHealthMember_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">380000</us-gaap:RevenueFromGrants>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="F_000656" contextRef="C_0001029142_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_dvaxStockOptionsAndShareAwardsMember_20130101_20131231" decimals="-3" unitRef="U_shares">17040000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="F_000657" contextRef="C_0001029142_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_dvaxStockOptionsAndShareAwardsMember_20120101_20121231" decimals="-3" unitRef="U_shares">15561000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="F_000658" contextRef="C_0001029142_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_dvaxStockOptionsAndShareAwardsMember_20110101_20111231" decimals="-3" unitRef="U_shares">11101000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="F_000659" contextRef="C_0001029142_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20130101_20131231" decimals="-3" unitRef="U_shares">43430000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="F_000660" contextRef="C_0001029142_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapWarrantMember_20130101_20131231" decimals="-3" unitRef="U_shares">12464000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="F_000661" contextRef="C_0001029142_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapWarrantMember_20120101_20121231" decimals="-3" unitRef="U_shares">12714000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="F_000662" contextRef="C_0001029142_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapWarrantMember_20110101_20111231" decimals="-3" unitRef="U_shares">25729000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="F_000663" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_shares">72934000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="F_000664" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_shares">28275000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="F_000665" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_shares">36830000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:CommonStockSharesAuthorized id="F_000666" contextRef="C_0001029142_20130529" decimals="INF" unitRef="U_shares">350000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000667" contextRef="C_0001029142_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20131001_20131031" decimals="INF" unitRef="U_shares">43430</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="F_000668" contextRef="C_0001029142_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20131031" decimals="INF" unitRef="U_iso4217USD_shares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:EquityIssuancePerShareAmount id="F_000669" contextRef="C_0001029142_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20131001_20131031" decimals="0" unitRef="U_iso4217USD_shares">1075</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity id="F_000670" contextRef="C_0001029142_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20131001_20131031" decimals="-5" unitRef="U_iso4217USD">46700000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:PaymentsOfStockIssuanceCosts id="F_000671" contextRef="C_0001029142_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20131001_20131031" decimals="-5" unitRef="U_iso4217USD">2500000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:ProceedsFromIssuanceInitialPublicOffering id="F_000672" contextRef="C_0001029142_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20131001_20131031" decimals="-5" unitRef="U_iso4217USD">44200000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
  <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion id="F_000673" contextRef="C_0001029142_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20131231" decimals="INF" unitRef="U_shares">1000</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
  <us-gaap:ConvertiblePreferredStockTermsOfConversion id="F_000674" contextRef="C_0001029142_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20130101_20131231">The holder is prohibited from converting the Series B Convertible Preferred Stock into shares of common stock if, as a result of such conversion, the holder and its affiliates would own more than 9.98% of the total number of shares of common stock then issued and outstanding.</us-gaap:ConvertiblePreferredStockTermsOfConversion>
  <us-gaap:ConvertiblePreferredStockSettlementTerms id="F_000675" contextRef="C_0001029142_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20130101_20131231">In the event of the Company&#8217;s liquidation, dissolution, or winding up, holders of Series B Convertible Preferred Stock will receive a payment equal to $0.001 per share before any proceeds are distributed to the common stockholders.</us-gaap:ConvertiblePreferredStockSettlementTerms>
  <dvax:DeemedDividend id="F_000676" contextRef="C_0001029142_us-gaapStatementClassOfStockAxis_us-gaapConvertiblePreferredStockMember_20131231" decimals="-5" unitRef="U_iso4217USD">8500000</dvax:DeemedDividend>
  <us-gaap:CommonStockParOrStatedValuePerShare id="F_000677" contextRef="C_0001029142_20081104" decimals="INF" unitRef="U_iso4217USD_shares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:DividendPayableDateToBePaidDayMonthAndYear id="F_000678" contextRef="C_0001029142_20081001_20081104">2008-11-17</us-gaap:DividendPayableDateToBePaidDayMonthAndYear>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="F_000679" contextRef="C_0001029142_20081104" decimals="INF" unitRef="U_iso4217USD_shares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:SharePrice id="F_000680" contextRef="C_0001029142_20081104" decimals="INF" unitRef="U_iso4217USD_shares">6.00</us-gaap:SharePrice>
  <dvax:PercentageOfCommonSharesOutstanding id="F_000681" contextRef="C_0001029142_us-gaapRangeAxis_us-gaapMinimumMember_20081001_20081104" decimals="INF" unitRef="U_pure">0.20</dvax:PercentageOfCommonSharesOutstanding>
  <dvax:PercentageOfCompanyAssets id="F_000682" contextRef="C_0001029142_us-gaapRangeAxis_us-gaapMinimumMember_20081104" decimals="INF" unitRef="U_pure">0.50</dvax:PercentageOfCompanyAssets>
  <dvax:RightsExpirationDate id="F_000683" contextRef="C_0001029142_20081001_20081104">2008-11-17</dvax:RightsExpirationDate>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000684" contextRef="C_0001029142_20131001_20131031" decimals="INF" unitRef="U_shares">79570000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:EquityIssuancePerShareAmount id="F_000685" contextRef="C_0001029142_20131001_20131031" decimals="3" unitRef="U_iso4217USD_shares">1.075</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity id="F_000686" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20131001_20131031" decimals="-5" unitRef="U_iso4217USD">85500000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:PaymentsOfStockIssuanceCosts id="F_000687" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20131001_20131031" decimals="-5" unitRef="U_iso4217USD">4500000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:ProceedsFromIssuanceInitialPublicOffering id="F_000688" contextRef="C_0001029142_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20131001_20131031" decimals="-5" unitRef="U_iso4217USD">80900000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="F_000689" contextRef="C_0001029142_deiLegalEntityAxis_dvaxMlvMember_us-gaapRangeAxis_us-gaapMaximumMember_20130301_20130329" decimals="INF" unitRef="U_iso4217USD">50000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <dvax:SellingCommissionPercentageFromGrossOfferingProceedsOfSalesOfStock id="F_000690" contextRef="C_0001029142_deiLegalEntityAxis_dvaxMlvMember_us-gaapRangeAxis_us-gaapMaximumMember_20130329" decimals="INF" unitRef="U_pure">0.030</dvax:SellingCommissionPercentageFromGrossOfferingProceedsOfSalesOfStock>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000691" contextRef="C_0001029142_20120401_20120509" decimals="INF" unitRef="U_shares">17500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:EquityIssuancePerShareAmount id="F_000692" contextRef="C_0001029142_20120401_20120509" decimals="2" unitRef="U_iso4217USD_shares">4.25</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:ProceedsFromIssuanceInitialPublicOffering id="F_000693" contextRef="C_0001029142_20120401_20120509" decimals="-5" unitRef="U_iso4217USD">69600000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000694" contextRef="C_0001029142_20111001_20111103" decimals="INF" unitRef="U_shares">27600000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices id="F_000695" contextRef="C_0001029142_20111001_20111103" decimals="INF" unitRef="U_shares">3600000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <us-gaap:EquityIssuancePerShareAmount id="F_000696" contextRef="C_0001029142_20111001_20111103" decimals="2" unitRef="U_iso4217USD_shares">2.50</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:ProceedsFromIssuanceInitialPublicOffering id="F_000697" contextRef="C_0001029142_20111001_20111103" decimals="-5" unitRef="U_iso4217USD">64500000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000698" contextRef="C_0001029142_20101001_20101102" decimals="INF" unitRef="U_shares">26450000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices id="F_000699" contextRef="C_0001029142_20101001_20101102" decimals="INF" unitRef="U_shares">3450000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <us-gaap:EquityIssuancePerShareAmount id="F_000700" contextRef="C_0001029142_20101001_20101102" decimals="2" unitRef="U_iso4217USD_shares">1.70</us-gaap:EquityIssuancePerShareAmount>
  <us-gaap:ProceedsFromIssuanceInitialPublicOffering id="F_000701" contextRef="C_0001029142_20101001_20101102" decimals="-5" unitRef="U_iso4217USD">42000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
  <us-gaap:SaleOfStockConsiderationReceivedPerTransaction id="F_000702" contextRef="C_0001029142_deiLegalEntityAxis_dvaxAspireCapitalFundLlcMember_us-gaapRangeAxis_us-gaapMaximumMember_20100821_20100920" decimals="-5" unitRef="U_iso4217USD">30000000</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
  <dvax:PurchaseAgreementPeriod id="F_000703" contextRef="C_0001029142_deiLegalEntityAxis_dvaxAspireCapitalFundLlcMember_20100821_20100920">P25M</dvax:PurchaseAgreementPeriod>
  <dvax:PercentageOfCommitmentToPurchaseSharesValue id="F_000704" contextRef="C_0001029142_deiLegalEntityAxis_dvaxAspireCapitalFundLlcMember_20100821_20100920" decimals="INF" unitRef="U_pure">0.04</dvax:PercentageOfCommitmentToPurchaseSharesValue>
  <dvax:CommitmentFeePaid id="F_000705" contextRef="C_0001029142_deiLegalEntityAxis_dvaxAspireCapitalFundLlcMember_20100901_20100930" decimals="-5" unitRef="U_iso4217USD">1200000</dvax:CommitmentFeePaid>
  <us-gaap:StockIssuedDuringPeriodSharesOther id="F_000706" contextRef="C_0001029142_deiLegalEntityAxis_dvaxAspireCapitalFundLlcMember_20100901_20100930" decimals="INF" unitRef="U_shares">600000</us-gaap:StockIssuedDuringPeriodSharesOther>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000707" contextRef="C_0001029142_deiLegalEntityAxis_dvaxAspireCapitalFundLlcMember_20100101_20101231" decimals="INF" unitRef="U_shares">2350000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="F_000708" contextRef="C_0001029142_deiLegalEntityAxis_dvaxAspireCapitalFundLlcMember_20100101_20101231" decimals="-5" unitRef="U_iso4217USD">3300000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000709" contextRef="C_0001029142_deiLegalEntityAxis_dvaxAspireCapitalFundLlcMember_20110101_20111231" decimals="INF" unitRef="U_shares">10995210</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="F_000710" contextRef="C_0001029142_deiLegalEntityAxis_dvaxAspireCapitalFundLlcMember_20110101_20111231" decimals="-5" unitRef="U_iso4217USD">26700000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceInitialPublicOffering id="F_000711" contextRef="C_0001029142_20100317_20100416" decimals="-5" unitRef="U_iso4217USD">41100000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
  <us-gaap:PaymentsOfStockIssuanceCosts id="F_000712" contextRef="C_0001029142_20100317_20100416" decimals="-5" unitRef="U_iso4217USD">3000000</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="F_000713" contextRef="C_0001029142_20100317_20100416" decimals="INF" unitRef="U_shares">30293000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:EquityIssuancePerShareAmount id="F_000714" contextRef="C_0001029142_20100317_20100416" decimals="4" unitRef="U_iso4217USD_shares">1.4525</us-gaap:EquityIssuancePerShareAmount>
  <dvax:NumberOfSharesOfCommonStockInEachUnit id="F_000715" contextRef="C_0001029142_20100317_20100416" decimals="INF" unitRef="U_shares">1</dvax:NumberOfSharesOfCommonStockInEachUnit>
  <dvax:NumberOfWarrantsInEachUnit id="F_000716" contextRef="C_0001029142_20100317_20100416" decimals="INF" unitRef="U_shares">1</dvax:NumberOfWarrantsInEachUnit>
  <dvax:CommonStockIssuableUponExerciseOfWarrantsConversionRatio id="F_000717" contextRef="C_0001029142_20100317_20100416" decimals="INF" unitRef="U_pure">0.5</dvax:CommonStockIssuableUponExerciseOfWarrantsConversionRatio>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="F_000718" contextRef="C_0001029142_20100416" decimals="2" unitRef="U_iso4217USD_dvaxRight">1.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <dvax:WarrantsExercisablePeriod id="F_000719" contextRef="C_0001029142_20100317_20100416">P5Y</dvax:WarrantsExercisablePeriod>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="F_000720" contextRef="C_0001029142_20131231" decimals="INF" unitRef="U_shares">10913873</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ConversionOfStockSharesConverted1 id="F_000721" contextRef="C_0001029142_us-gaapDebtInstrumentAxis_dvaxLoanAgreementMember_20130101_20131231" decimals="INF" unitRef="U_shares">3550000</us-gaap:ConversionOfStockSharesConverted1>
  <dvax:WarrantIssueDate id="F_000722" contextRef="C_0001029142_us-gaapClassOfWarrantOrRightAxis_dvaxWarrantOneMember_us-gaapDebtInstrumentAxis_dvaxLoanAgreementMember_20131231">2007-07-18</dvax:WarrantIssueDate>
  <dvax:WarrantIssueDate id="F_000723" contextRef="C_0001029142_us-gaapClassOfWarrantOrRightAxis_dvaxWarrantTwoMember_us-gaapDebtInstrumentAxis_dvaxLoanAgreementMember_20131231">2007-10-18</dvax:WarrantIssueDate>
  <dvax:WarrantIssueDate id="F_000724" contextRef="C_0001029142_us-gaapClassOfWarrantOrRightAxis_dvaxWarrantThreeMember_us-gaapDebtInstrumentAxis_dvaxLoanAgreementMember_20131231">2007-12-27</dvax:WarrantIssueDate>
  <dvax:WarrantIssueDate id="F_000725" contextRef="C_0001029142_us-gaapClassOfWarrantOrRightAxis_dvaxWarrantFourMember_us-gaapDebtInstrumentAxis_dvaxLoanAgreementMember_20131231">2007-12-27</dvax:WarrantIssueDate>
  <us-gaap:ConversionOfStockSharesConverted1 id="F_000726" contextRef="C_0001029142_us-gaapClassOfWarrantOrRightAxis_dvaxWarrantOneMember_us-gaapDebtInstrumentAxis_dvaxLoanAgreementMember_20130101_20131231" decimals="-3" unitRef="U_shares">1250000</us-gaap:ConversionOfStockSharesConverted1>
  <us-gaap:ConversionOfStockSharesConverted1 id="F_000727" contextRef="C_0001029142_us-gaapClassOfWarrantOrRightAxis_dvaxWarrantTwoMember_us-gaapDebtInstrumentAxis_dvaxLoanAgreementMember_20130101_20131231" decimals="-3" unitRef="U_shares">1300000</us-gaap:ConversionOfStockSharesConverted1>
  <us-gaap:ConversionOfStockSharesConverted1 id="F_000728" contextRef="C_0001029142_us-gaapClassOfWarrantOrRightAxis_dvaxWarrantThreeMember_us-gaapDebtInstrumentAxis_dvaxLoanAgreementMember_20130101_20131231" decimals="-3" unitRef="U_shares">300000</us-gaap:ConversionOfStockSharesConverted1>
  <us-gaap:ConversionOfStockSharesConverted1 id="F_000729" contextRef="C_0001029142_us-gaapClassOfWarrantOrRightAxis_dvaxWarrantFourMember_us-gaapDebtInstrumentAxis_dvaxLoanAgreementMember_20130101_20131231" decimals="-3" unitRef="U_shares">700000</us-gaap:ConversionOfStockSharesConverted1>
  <dvax:WarrantExpirationDate id="F_000730" contextRef="C_0001029142_us-gaapClassOfWarrantOrRightAxis_dvaxWarrantOneMember_us-gaapDebtInstrumentAxis_dvaxLoanAgreementMember_20131231">2014-02-26</dvax:WarrantExpirationDate>
  <dvax:WarrantExpirationDate id="F_000731" contextRef="C_0001029142_us-gaapClassOfWarrantOrRightAxis_dvaxWarrantTwoMember_us-gaapDebtInstrumentAxis_dvaxLoanAgreementMember_20131231">2014-02-26</dvax:WarrantExpirationDate>
  <dvax:WarrantExpirationDate id="F_000732" contextRef="C_0001029142_us-gaapClassOfWarrantOrRightAxis_dvaxWarrantThreeMember_us-gaapDebtInstrumentAxis_dvaxLoanAgreementMember_20131231">2014-02-26</dvax:WarrantExpirationDate>
  <dvax:WarrantExpirationDate id="F_000733" contextRef="C_0001029142_us-gaapClassOfWarrantOrRightAxis_dvaxWarrantFourMember_us-gaapDebtInstrumentAxis_dvaxLoanAgreementMember_20131231">2014-02-26</dvax:WarrantExpirationDate>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="F_000734" contextRef="C_0001029142_us-gaapClassOfWarrantOrRightAxis_dvaxWarrantOneMember_us-gaapDebtInstrumentAxis_dvaxLoanAgreementMember_20131231" decimals="2" unitRef="U_iso4217USD_dvaxRight">5.13</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="F_000735" contextRef="C_0001029142_us-gaapClassOfWarrantOrRightAxis_dvaxWarrantTwoMember_us-gaapDebtInstrumentAxis_dvaxLoanAgreementMember_20131231" decimals="2" unitRef="U_iso4217USD_dvaxRight">1.68</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="F_000736" contextRef="C_0001029142_us-gaapClassOfWarrantOrRightAxis_dvaxWarrantThreeMember_us-gaapDebtInstrumentAxis_dvaxLoanAgreementMember_20131231" decimals="2" unitRef="U_iso4217USD_dvaxRight">5.65</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="F_000737" contextRef="C_0001029142_us-gaapClassOfWarrantOrRightAxis_dvaxWarrantFourMember_us-gaapDebtInstrumentAxis_dvaxLoanAgreementMember_20131231" decimals="2" unitRef="U_iso4217USD_dvaxRight">1.68</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="F_000738" contextRef="C_0001029142_us-gaapClassOfWarrantOrRightAxis_dvaxWarrantOneMember_us-gaapDebtInstrumentAxis_dvaxLoanAgreementMember_20131231" decimals="-3" unitRef="U_shares">1250000</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="F_000739" contextRef="C_0001029142_us-gaapClassOfWarrantOrRightAxis_dvaxWarrantThreeMember_us-gaapDebtInstrumentAxis_dvaxLoanAgreementMember_20131231" decimals="-3" unitRef="U_shares">300000</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="F_000740" contextRef="C_0001029142_us-gaapDebtInstrumentAxis_dvaxLoanAgreementMember_20131231" decimals="-3" unitRef="U_shares">1550000</us-gaap:ClassOfWarrantOrRightOutstanding>
  <dvax:WarrantToPurchaseCommonStock id="F_000741" contextRef="C_0001029142_20131231" decimals="INF" unitRef="U_shares">12500000</dvax:WarrantToPurchaseCommonStock>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights id="F_000742" contextRef="C_0001029142_20131231" decimals="2" unitRef="U_iso4217USD_dvaxRight">1.96</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <dvax:NumberOfWarrantsExercisedDuringPeriod id="F_000743" contextRef="C_0001029142_20131231" decimals="INF" unitRef="U_shares">250000</dvax:NumberOfWarrantsExercisedDuringPeriod>
  <dvax:NumberOfWarrantsExercisedDuringPeriod id="F_000744" contextRef="C_0001029142_20121231" decimals="INF" unitRef="U_shares">13000000</dvax:NumberOfWarrantsExercisedDuringPeriod>
  <dvax:NumberOfShareBasedCompensationPlans id="F_000745" contextRef="C_0001029142_20131231" decimals="INF" unitRef="U_dvaxCompensationPlan">3</dvax:NumberOfShareBasedCompensationPlans>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod id="F_000746" contextRef="C_0001029142_us-gaapPlanNameAxis_dvaxStockIncentivePlanTwentyZeroFourMember_us-gaapRangeAxis_us-gaapMaximumMember_20040101_20040131" decimals="INF" unitRef="U_shares">3500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod id="F_000747" contextRef="C_0001029142_us-gaapPlanNameAxis_dvaxStockIncentivePlanTwentyZeroFourMember_us-gaapRangeAxis_us-gaapMaximumMember_us-gaapTypeOfArrangementAxis_dvaxOtherParticipantsMember_20040101_20040131">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent id="F_000748" contextRef="C_0001029142_us-gaapPlanNameAxis_dvaxStockIncentivePlanTwentyZeroFourMember_20040101_20040131" decimals="INF" unitRef="U_pure">1.00</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent id="F_000749" contextRef="C_0001029142_us-gaapPlanNameAxis_dvaxStockIncentivePlanTwentyZeroFourMember_us-gaapRangeAxis_us-gaapMinimumMember_us-gaapTypeOfArrangementAxis_dvaxGroupTwoMember_20040101_20040131" decimals="INF" unitRef="U_pure">1.10</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod id="F_000750" contextRef="C_0001029142_us-gaapPlanNameAxis_dvaxStockIncentivePlanTwentyZeroFourMember_us-gaapRangeAxis_us-gaapMinimumMember_us-gaapTypeOfArrangementAxis_dvaxGroupTwoMember_20040101_20040131">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="F_000751" contextRef="C_0001029142_us-gaapPlanNameAxis_dvaxStockIncentivePlanTwentyZeroFourMember_20131231" decimals="INF" unitRef="U_shares">4066277</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod id="F_000752" contextRef="C_0001029142_us-gaapPlanNameAxis_dvaxEmploymentInducementAwardPlanTwentyTenMember_us-gaapRangeAxis_us-gaapMaximumMember_20100101_20100131" decimals="INF" unitRef="U_shares">1500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="F_000753" contextRef="C_0001029142_us-gaapPlanNameAxis_dvaxEmploymentInducementAwardPlanTwentyTenMember_20131231" decimals="INF" unitRef="U_shares">743625</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod id="F_000754" contextRef="C_0001029142_us-gaapPlanNameAxis_dvaxEquityIncentivePlanTwentyElevenMember_us-gaapRangeAxis_us-gaapMaximumMember_20110101_20110131" decimals="INF" unitRef="U_shares">25000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized id="F_000755" contextRef="C_0001029142_us-gaapPlanNameAxis_dvaxEquityIncentivePlanTwentyElevenMember_us-gaapRangeAxis_us-gaapMaximumMember_20130501_20130529" decimals="INF" unitRef="U_shares">10000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod id="F_000756" contextRef="C_0001029142_us-gaapPlanNameAxis_dvaxEquityIncentivePlanTwentyElevenMember_20110101_20110131">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="F_000757" contextRef="C_0001029142_us-gaapPlanNameAxis_dvaxEquityIncentivePlanTwentyElevenMember_20131231" decimals="INF" unitRef="U_shares">10954940</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized id="F_000758" contextRef="C_0001029142_us-gaapPlanNameAxis_dvaxEquityIncentivePlanTwentyElevenMember_20131231" decimals="INF" unitRef="U_shares">13666964</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="F_000759" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_shares">13806000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod id="F_000760" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_shares">5614000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="F_000761" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_shares">131000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod id="F_000762" contextRef="C_0001029142_us-gaapAwardTypeAxis_dvaxUnvestedMember_20130101_20131231" decimals="-3" unitRef="U_shares">2555000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod id="F_000763" contextRef="C_0001029142_us-gaapAwardTypeAxis_dvaxVestedMember_20130101_20131231" decimals="-3" unitRef="U_shares">969000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="F_000764" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_shares">15765000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber id="F_000765" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_shares">15765000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber id="F_000766" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_shares">10628000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
  <dvax:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice id="F_000767" contextRef="C_0001029142_20121231" decimals="2" unitRef="U_iso4217USD_shares">3.38</dvax:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice id="F_000768" contextRef="C_0001029142_20130101_20131231" decimals="2" unitRef="U_iso4217USD_shares">2.69</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice id="F_000769" contextRef="C_0001029142_20130101_20131231" decimals="2" unitRef="U_iso4217USD_shares">1.43</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice id="F_000770" contextRef="C_0001029142_us-gaapAwardTypeAxis_dvaxUnvestedMember_20130101_20131231" decimals="2" unitRef="U_iso4217USD_shares">3.31</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice id="F_000771" contextRef="C_0001029142_us-gaapAwardTypeAxis_dvaxVestedMember_20130101_20131231" decimals="2" unitRef="U_iso4217USD_shares">3.34</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
  <dvax:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice id="F_000772" contextRef="C_0001029142_20131231" decimals="2" unitRef="U_iso4217USD_shares">3.17</dvax:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice id="F_000773" contextRef="C_0001029142_20131231" decimals="2" unitRef="U_iso4217USD_shares">3.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice id="F_000774" contextRef="C_0001029142_20131231" decimals="2" unitRef="U_iso4217USD_shares">3.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 id="F_000775" contextRef="C_0001029142_20130101_20131231">P5Y3M4D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 id="F_000776" contextRef="C_0001029142_20130101_20131231">P5Y3M4D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 id="F_000777" contextRef="C_0001029142_20130101_20131231">P3Y7M10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue id="F_000778" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">1427000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue id="F_000779" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">1427000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 id="F_000780" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">1289000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue id="F_000781" contextRef="C_0001029142_20130101_20131231" decimals="-5" unitRef="U_iso4217USD">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue id="F_000782" contextRef="C_0001029142_20120101_20121231" decimals="-5" unitRef="U_iso4217USD">2700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue id="F_000783" contextRef="C_0001029142_20110101_20111231" decimals="-5" unitRef="U_iso4217USD">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 id="F_000784" contextRef="C_0001029142_20130101_20131231" decimals="-5" unitRef="U_iso4217USD">12100000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 id="F_000785" contextRef="C_0001029142_20120101_20121231" decimals="-5" unitRef="U_iso4217USD">9600000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 id="F_000786" contextRef="C_0001029142_20110101_20111231" decimals="-5" unitRef="U_iso4217USD">2800000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber id="F_000787" contextRef="C_0001029142_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20121231" decimals="-3" unitRef="U_shares">1755000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod id="F_000788" contextRef="C_0001029142_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20130101_20131231" decimals="-3" unitRef="U_shares">250000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod id="F_000789" contextRef="C_0001029142_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20130101_20131231" decimals="-3" unitRef="U_shares">115000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod id="F_000790" contextRef="C_0001029142_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20130101_20131231" decimals="-3" unitRef="U_shares">615000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber id="F_000791" contextRef="C_0001029142_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20131231" decimals="-3" unitRef="U_shares">1275000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue id="F_000792" contextRef="C_0001029142_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20121231" decimals="2" unitRef="U_iso4217USD_shares">4.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="F_000793" contextRef="C_0001029142_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20130101_20131231" decimals="2" unitRef="U_iso4217USD_shares">1.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue id="F_000794" contextRef="C_0001029142_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20130101_20131231" decimals="2" unitRef="U_iso4217USD_shares">1.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue id="F_000795" contextRef="C_0001029142_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20130101_20131231" decimals="2" unitRef="U_iso4217USD_shares">4.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue id="F_000796" contextRef="C_0001029142_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20131231" decimals="2" unitRef="U_iso4217USD_shares">3.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
  <us-gaap:RestrictedStockExpense id="F_000797" contextRef="C_0001029142_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20130101_20131231" decimals="-5" unitRef="U_iso4217USD">100000</us-gaap:RestrictedStockExpense>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested id="F_000798" contextRef="C_0001029142_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20131231" decimals="-5" unitRef="U_iso4217USD">2500000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="F_000799" contextRef="C_0001029142_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20120101_20121231" decimals="2" unitRef="U_iso4217USD_shares">4.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="F_000800" contextRef="C_0001029142_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20110101_20111231" decimals="0" unitRef="U_iso4217USD_shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue id="F_000801" contextRef="C_0001029142_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20130101_20131231" decimals="-5" unitRef="U_iso4217USD">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue id="F_000802" contextRef="C_0001029142_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20120101_20121231" decimals="-5" unitRef="U_iso4217USD">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue id="F_000803" contextRef="C_0001029142_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20110101_20111231" decimals="-5" unitRef="U_iso4217USD">800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 id="F_000804" contextRef="C_0001029142_20130101_20131231">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod id="F_000805" contextRef="C_0001029142_20130101_20131231">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
  <dvax:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndRsuOutstandingNumber id="F_000806" contextRef="C_0001029142_20130101_20131231" decimals="INF" unitRef="U_shares">2047466</dvax:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndRsuOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="F_000807" contextRef="C_0001029142_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20130101_20131231" decimals="2" unitRef="U_iso4217USD_shares">2.41</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="F_000808" contextRef="C_0001029142_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20120101_20121231" decimals="2" unitRef="U_iso4217USD_shares">3.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="F_000809" contextRef="C_0001029142_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20110101_20111231" decimals="2" unitRef="U_iso4217USD_shares">2.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate id="F_000810" contextRef="C_0001029142_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20130101_20131231" decimals="3" unitRef="U_pure">0.011</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate id="F_000811" contextRef="C_0001029142_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20120101_20121231" decimals="3" unitRef="U_pure">0.005</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate id="F_000812" contextRef="C_0001029142_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20110101_20111231" decimals="3" unitRef="U_pure">0.013</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 id="F_000813" contextRef="C_0001029142_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20130101_20131231">P5Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 id="F_000814" contextRef="C_0001029142_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20120101_20121231">P4Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 id="F_000815" contextRef="C_0001029142_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20110101_20111231">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate id="F_000816" contextRef="C_0001029142_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20130101_20131231" decimals="3" unitRef="U_pure">0.014</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate id="F_000817" contextRef="C_0001029142_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20120101_20121231" decimals="3" unitRef="U_pure">0.016</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate id="F_000818" contextRef="C_0001029142_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20110101_20111231" decimals="3" unitRef="U_pure">0.016</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="F_000819" contextRef="C_0001029142_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20130101_20131231" decimals="2" unitRef="U_iso4217USD_shares">0.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="F_000820" contextRef="C_0001029142_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20120101_20121231" decimals="2" unitRef="U_iso4217USD_shares">3.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="F_000821" contextRef="C_0001029142_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20110101_20111231" decimals="2" unitRef="U_iso4217USD_shares">2.09</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate id="F_000822" contextRef="C_0001029142_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20130101_20131231" decimals="3" unitRef="U_pure">0.002</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate id="F_000823" contextRef="C_0001029142_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20120101_20121231" decimals="3" unitRef="U_pure">0.002</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate id="F_000824" contextRef="C_0001029142_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20110101_20111231" decimals="3" unitRef="U_pure">0.003</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 id="F_000825" contextRef="C_0001029142_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20130101_20131231">P1Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 id="F_000826" contextRef="C_0001029142_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20120101_20121231">P1Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 id="F_000827" contextRef="C_0001029142_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20110101_20111231">P1Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate id="F_000828" contextRef="C_0001029142_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20130101_20131231" decimals="3" unitRef="U_pure">0.008</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate id="F_000829" contextRef="C_0001029142_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20120101_20121231" decimals="3" unitRef="U_pure">0.016</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate id="F_000830" contextRef="C_0001029142_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20110101_20111231" decimals="3" unitRef="U_pure">0.016</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate id="F_000831" contextRef="C_0001029142_20130101_20131231" decimals="2" unitRef="U_pure">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:ShareBasedCompensation id="F_000832" contextRef="C_0001029142_us-gaapIncomeStatementLocationAxis_dvaxEmployeesAndDirectorsMember_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">11828000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation id="F_000833" contextRef="C_0001029142_us-gaapIncomeStatementLocationAxis_dvaxEmployeesAndDirectorsMember_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">10439000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation id="F_000834" contextRef="C_0001029142_us-gaapIncomeStatementLocationAxis_dvaxEmployeesAndDirectorsMember_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">5185000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation id="F_000835" contextRef="C_0001029142_us-gaapIncomeStatementLocationAxis_dvaxNonEmployeeMember_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">512000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation id="F_000836" contextRef="C_0001029142_us-gaapIncomeStatementLocationAxis_dvaxNonEmployeeMember_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">4000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation id="F_000837" contextRef="C_0001029142_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">4228000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation id="F_000838" contextRef="C_0001029142_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">3514000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation id="F_000839" contextRef="C_0001029142_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">2103000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation id="F_000840" contextRef="C_0001029142_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">8112000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation id="F_000841" contextRef="C_0001029142_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">6925000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation id="F_000842" contextRef="C_0001029142_us-gaapIncomeStatementLocationAxis_us-gaapGeneralAndAdministrativeExpenseMember_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">3086000</us-gaap:ShareBasedCompensation>
  <us-gaap:AllocatedShareBasedCompensationExpense id="F_000843" contextRef="C_0001029142_20130101_20131231" decimals="-5" unitRef="U_iso4217USD">4900000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="F_000844" contextRef="C_0001029142_20120101_20121231" decimals="-5" unitRef="U_iso4217USD">1500000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:ShareBasedCompensation id="F_000845" contextRef="C_0001029142_us-gaapDeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_dvaxNonEmployeeAwardsMember_20130101_20131231" decimals="-5" unitRef="U_iso4217USD">500000</us-gaap:ShareBasedCompensation>
  <us-gaap:AllocatedShareBasedCompensationExpense id="F_000846" contextRef="C_0001029142_us-gaapDeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_dvaxAdditionalMember_20130101_20131231" decimals="-5" unitRef="U_iso4217USD">1300000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="F_000847" contextRef="C_0001029142_us-gaapDeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_dvaxAdditionalMember_20120101_20121231" decimals="-5" unitRef="U_iso4217USD">700000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:DefinedContributionPlanNumberOfEmployeesCovered id="F_000848" contextRef="C_0001029142_20130101_20131231" decimals="INF" unitRef="U_dvaxEmployee">5</us-gaap:DefinedContributionPlanNumberOfEmployeesCovered>
  <us-gaap:DefinedContributionPlanNumberOfEmployeesCovered id="F_000849" contextRef="C_0001029142_20120101_20121231" decimals="INF" unitRef="U_dvaxEmployee">1</us-gaap:DefinedContributionPlanNumberOfEmployeesCovered>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized id="F_000850" contextRef="C_0001029142_us-gaapPlanNameAxis_dvaxTimeBasedVestingScheduleMember_20131231" decimals="-5" unitRef="U_iso4217USD">10300000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized id="F_000851" contextRef="C_0001029142_20131231" decimals="-5" unitRef="U_iso4217USD">3800000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 id="F_000852" contextRef="C_0001029142_us-gaapPlanNameAxis_dvaxTimeBasedVestingScheduleMember_20130101_20131231">P2Y9M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized id="F_000853" contextRef="C_0001029142_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20131231" decimals="-5" unitRef="U_iso4217USD">100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 id="F_000854" contextRef="C_0001029142_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20130101_20131231">P1Y4M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent id="F_000855" contextRef="C_0001029142_dvaxPeriodAxis_dvaxPeriodOneMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20040101_20040131" decimals="2" unitRef="U_pure">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent id="F_000856" contextRef="C_0001029142_dvaxPeriodAxis_dvaxPeriodTwoMember_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20040101_20040131" decimals="2" unitRef="U_pure">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized id="F_000857" contextRef="C_0001029142_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20131231" decimals="INF" unitRef="U_shares">996000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward id="F_000858" contextRef="C_0001029142_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20130101_20131231" decimals="INF" unitRef="U_shares">828414</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant id="F_000859" contextRef="C_0001029142_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20131231" decimals="INF" unitRef="U_shares">167586</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic id="F_000860" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">-67004000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic id="F_000861" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">-70792000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic id="F_000862" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">-49990000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign id="F_000863" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">284000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign id="F_000864" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">843000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign id="F_000865" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">1393000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments id="F_000866" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">-66720000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments id="F_000867" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">-69949000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments id="F_000868" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">-48597000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate id="F_000869" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">-22678000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
  <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate id="F_000870" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">-23650000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
  <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate id="F_000871" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">-16523000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
  <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes id="F_000872" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">-178000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes id="F_000873" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">-89000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes id="F_000874" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">-2586000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:IncomeTaxReconciliationTaxCredits id="F_000875" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">2515000</us-gaap:IncomeTaxReconciliationTaxCredits>
  <us-gaap:IncomeTaxReconciliationTaxCredits id="F_000876" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">1394000</us-gaap:IncomeTaxReconciliationTaxCredits>
  <dvax:IncomeTaxReconciliationDeferredCompensationCharges id="F_000877" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">3072000</dvax:IncomeTaxReconciliationDeferredCompensationCharges>
  <dvax:IncomeTaxReconciliationDeferredCompensationCharges id="F_000878" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">1002000</dvax:IncomeTaxReconciliationDeferredCompensationCharges>
  <dvax:IncomeTaxReconciliationDeferredCompensationCharges id="F_000879" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">595000</dvax:IncomeTaxReconciliationDeferredCompensationCharges>
  <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance id="F_000880" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">22354000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance id="F_000881" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">21966000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance id="F_000882" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">18099000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
  <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential id="F_000883" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">-34000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
  <dvax:IncomeTaxReconciliationChangeInFairValueMeasurement id="F_000884" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">286000</dvax:IncomeTaxReconciliationChangeInFairValueMeasurement>
  <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther id="F_000885" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">509000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
  <us-gaap:IncomeTaxReconciliationDeductionsDividends id="F_000886" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">273000</us-gaap:IncomeTaxReconciliationDeductionsDividends>
  <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes id="F_000887" xsi:nil="true" contextRef="C_0001029142_20130101_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes id="F_000888" xsi:nil="true" contextRef="C_0001029142_20120101_20121231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes id="F_000889" xsi:nil="true" contextRef="C_0001029142_20110101_20111231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:IncomeTaxReconciliationOtherAdjustments id="F_000890" contextRef="C_0001029142_20130101_20131231" decimals="-3" unitRef="U_iso4217USD">-55000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
  <us-gaap:IncomeTaxReconciliationOtherAdjustments id="F_000891" contextRef="C_0001029142_20120101_20121231" decimals="-3" unitRef="U_iso4217USD">771000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
  <us-gaap:IncomeTaxReconciliationOtherAdjustments id="F_000892" contextRef="C_0001029142_20110101_20111231" decimals="-3" unitRef="U_iso4217USD">775000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
  <us-gaap:IncomeTaxExpenseBenefit id="F_000893" xsi:nil="true" contextRef="C_0001029142_20130101_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:IncomeTaxExpenseBenefit id="F_000894" xsi:nil="true" contextRef="C_0001029142_20120101_20121231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:IncomeTaxExpenseBenefit id="F_000895" xsi:nil="true" contextRef="C_0001029142_20110101_20111231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards id="F_000896" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">147655000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards id="F_000897" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">127529000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
  <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards id="F_000898" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">21336000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
  <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards id="F_000899" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">18163000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves id="F_000900" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">9501000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves id="F_000901" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">8529000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves>
  <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch id="F_000902" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">10662000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
  <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch id="F_000903" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">12757000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
  <us-gaap:DeferredTaxAssetsDeferredIncome id="F_000904" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">2486000</us-gaap:DeferredTaxAssetsDeferredIncome>
  <us-gaap:DeferredTaxAssetsDeferredIncome id="F_000905" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">2180000</us-gaap:DeferredTaxAssetsDeferredIncome>
  <us-gaap:DeferredTaxAssetsOther id="F_000906" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">1222000</us-gaap:DeferredTaxAssetsOther>
  <us-gaap:DeferredTaxAssetsOther id="F_000907" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">1221000</us-gaap:DeferredTaxAssetsOther>
  <us-gaap:DeferredTaxAssetsGross id="F_000908" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">192862000</us-gaap:DeferredTaxAssetsGross>
  <us-gaap:DeferredTaxAssetsGross id="F_000909" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">170379000</us-gaap:DeferredTaxAssetsGross>
  <us-gaap:DeferredTaxAssetsValuationAllowance id="F_000910" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">192733000</us-gaap:DeferredTaxAssetsValuationAllowance>
  <us-gaap:DeferredTaxAssetsValuationAllowance id="F_000911" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">170232000</us-gaap:DeferredTaxAssetsValuationAllowance>
  <us-gaap:DeferredTaxAssetsNet id="F_000912" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">129000</us-gaap:DeferredTaxAssetsNet>
  <us-gaap:DeferredTaxAssetsNet id="F_000913" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">147000</us-gaap:DeferredTaxAssetsNet>
  <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment id="F_000914" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">162000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
  <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment id="F_000915" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">86000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
  <us-gaap:DeferredTaxLiabilitiesOther id="F_000916" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">-33000</us-gaap:DeferredTaxLiabilitiesOther>
  <us-gaap:DeferredTaxLiabilitiesOther id="F_000917" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">61000</us-gaap:DeferredTaxLiabilitiesOther>
  <us-gaap:DeferredTaxLiabilities id="F_000918" contextRef="C_0001029142_20131231" decimals="-3" unitRef="U_iso4217USD">129000</us-gaap:DeferredTaxLiabilities>
  <us-gaap:DeferredTaxLiabilities id="F_000919" contextRef="C_0001029142_20121231" decimals="-3" unitRef="U_iso4217USD">147000</us-gaap:DeferredTaxLiabilities>
  <us-gaap:DeferredTaxAssetsLiabilitiesNet id="F_000920" xsi:nil="true" contextRef="C_0001029142_20131231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:DeferredTaxAssetsLiabilitiesNet id="F_000921" xsi:nil="true" contextRef="C_0001029142_20121231" unitRef="U_iso4217USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount id="F_000922" contextRef="C_0001029142_20130101_20131231" decimals="-5" unitRef="U_iso4217USD">22500000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
  <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount id="F_000923" contextRef="C_0001029142_20120101_20121231" decimals="-5" unitRef="U_iso4217USD">22000000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
  <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount id="F_000924" contextRef="C_0001029142_20110101_20111231" decimals="-5" unitRef="U_iso4217USD">18100000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
  <us-gaap:DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital id="F_000925" contextRef="C_0001029142_20131231" decimals="-5" unitRef="U_iso4217USD">300000</us-gaap:DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital>
  <us-gaap:OperatingLossCarryforwards id="F_000926" contextRef="C_0001029142_us-gaapIncomeTaxAuthorityAxis_dvaxFederalMember_20131231" decimals="-5" unitRef="U_iso4217USD">384100000</us-gaap:OperatingLossCarryforwards>
  <dvax:OperatingLossCarryforwardExpirationYear id="F_000927" contextRef="C_0001029142_us-gaapIncomeTaxAuthorityAxis_dvaxFederalMember_us-gaapRangeAxis_us-gaapMinimumMember_20130101_20131231">2018</dvax:OperatingLossCarryforwardExpirationYear>
  <dvax:OperatingLossCarryforwardExpirationYear id="F_000928" contextRef="C_0001029142_us-gaapIncomeTaxAuthorityAxis_dvaxFederalMember_us-gaapRangeAxis_us-gaapMaximumMember_20130101_20131231">2037</dvax:OperatingLossCarryforwardExpirationYear>
  <us-gaap:TaxCreditCarryforwardAmount id="F_000929" contextRef="C_0001029142_us-gaapIncomeTaxAuthorityAxis_dvaxFederalMember_us-gaapTaxCreditCarryforwardAxis_dvaxResearchAndDevelopmentMember_20131231" decimals="-5" unitRef="U_iso4217USD">13800000</us-gaap:TaxCreditCarryforwardAmount>
  <dvax:TaxCreditCarryforwardExpirationYear id="F_000930" contextRef="C_0001029142_us-gaapIncomeTaxAuthorityAxis_dvaxFederalMember_us-gaapRangeAxis_us-gaapMinimumMember_us-gaapTaxCreditCarryforwardAxis_dvaxResearchAndDevelopmentMember_20130101_20131231">2018</dvax:TaxCreditCarryforwardExpirationYear>
  <dvax:TaxCreditCarryforwardExpirationYear id="F_000931" contextRef="C_0001029142_us-gaapIncomeTaxAuthorityAxis_dvaxFederalMember_us-gaapRangeAxis_us-gaapMaximumMember_us-gaapTaxCreditCarryforwardAxis_dvaxResearchAndDevelopmentMember_20130101_20131231">2033</dvax:TaxCreditCarryforwardExpirationYear>
  <us-gaap:OperatingLossCarryforwards id="F_000932" contextRef="C_0001029142_us-gaapIncomeTaxAuthorityAxis_dvaxCaliforniaStateMember_20131231" decimals="-5" unitRef="U_iso4217USD">219700000</us-gaap:OperatingLossCarryforwards>
  <dvax:OperatingLossCarryforwardExpirationYear id="F_000933" contextRef="C_0001029142_us-gaapIncomeTaxAuthorityAxis_dvaxCaliforniaStateMember_us-gaapRangeAxis_us-gaapMinimumMember_20130101_20131231">2013</dvax:OperatingLossCarryforwardExpirationYear>
  <dvax:OperatingLossCarryforwardExpirationYear id="F_000934" contextRef="C_0001029142_us-gaapIncomeTaxAuthorityAxis_dvaxCaliforniaStateMember_us-gaapRangeAxis_us-gaapMaximumMember_20130101_20131231">2033</dvax:OperatingLossCarryforwardExpirationYear>
  <us-gaap:TaxCreditCarryforwardAmount id="F_000935" contextRef="C_0001029142_us-gaapIncomeTaxAuthorityAxis_dvaxCaliforniaStateMember_us-gaapTaxCreditCarryforwardAxis_dvaxResearchAndDevelopmentMember_20131231" decimals="-5" unitRef="U_iso4217USD">11500000</us-gaap:TaxCreditCarryforwardAmount>
  <us-gaap:OperatingLossCarryforwards id="F_000936" contextRef="C_0001029142_us-gaapIncomeTaxAuthorityAxis_us-gaapForeignCountryMember_20131231" decimals="-5" unitRef="U_iso4217USD">27800000</us-gaap:OperatingLossCarryforwards>
  <us-gaap:Revenues id="F_000937" contextRef="C_0001029142_20130101_20130331" decimals="-3" unitRef="U_iso4217USD">2085000</us-gaap:Revenues>
  <us-gaap:Revenues id="F_000938" contextRef="C_0001029142_20130401_20130630" decimals="-3" unitRef="U_iso4217USD">3392000</us-gaap:Revenues>
  <us-gaap:Revenues id="F_000939" contextRef="C_0001029142_20130701_20130930" decimals="-3" unitRef="U_iso4217USD">2927000</us-gaap:Revenues>
  <us-gaap:Revenues id="F_000940" contextRef="C_0001029142_20131001_20131231" decimals="-3" unitRef="U_iso4217USD">2847000</us-gaap:Revenues>
  <us-gaap:NetIncomeLoss id="F_000941" contextRef="C_0001029142_20130101_20130331" decimals="-3" unitRef="U_iso4217USD">-20825000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="F_000942" contextRef="C_0001029142_20130401_20130630" decimals="-3" unitRef="U_iso4217USD">-17164000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="F_000943" contextRef="C_0001029142_20130701_20130930" decimals="-3" unitRef="U_iso4217USD">-15675000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="F_000944" contextRef="C_0001029142_20131001_20131231" decimals="-3" unitRef="U_iso4217USD">-13056000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="F_000945" contextRef="C_0001029142_20130101_20130331" decimals="-3" unitRef="U_iso4217USD">-20825000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="F_000946" contextRef="C_0001029142_20130401_20130630" decimals="-3" unitRef="U_iso4217USD">-17164000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="F_000947" contextRef="C_0001029142_20130701_20130930" decimals="-3" unitRef="U_iso4217USD">-15675000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="F_000948" contextRef="C_0001029142_20131001_20131231" decimals="-3" unitRef="U_iso4217USD">-21525000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:EarningsPerShareBasicAndDiluted id="F_000949" contextRef="C_0001029142_20130101_20130331" decimals="2" unitRef="U_iso4217USD_shares">-0.11</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted id="F_000950" contextRef="C_0001029142_20130401_20130630" decimals="2" unitRef="U_iso4217USD_shares">-0.09</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted id="F_000951" contextRef="C_0001029142_20130701_20130930" decimals="2" unitRef="U_iso4217USD_shares">-0.09</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted id="F_000952" contextRef="C_0001029142_20131001_20131231" decimals="2" unitRef="U_iso4217USD_shares">-0.09</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="F_000953" contextRef="C_0001029142_20130101_20130331" decimals="-3" unitRef="U_shares">182847000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="F_000954" contextRef="C_0001029142_20130401_20130630" decimals="-3" unitRef="U_shares">182913000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="F_000955" contextRef="C_0001029142_20130701_20130930" decimals="-3" unitRef="U_shares">183022000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="F_000956" contextRef="C_0001029142_20131001_20131231" decimals="-3" unitRef="U_shares">235879000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:Revenues id="F_000957" contextRef="C_0001029142_20120101_20120331" decimals="-3" unitRef="U_iso4217USD">2350000</us-gaap:Revenues>
  <us-gaap:Revenues id="F_000958" contextRef="C_0001029142_20120401_20120630" decimals="-3" unitRef="U_iso4217USD">2684000</us-gaap:Revenues>
  <us-gaap:Revenues id="F_000959" contextRef="C_0001029142_20120701_20120930" decimals="-3" unitRef="U_iso4217USD">2874000</us-gaap:Revenues>
  <us-gaap:Revenues id="F_000960" contextRef="C_0001029142_20121001_20121231" decimals="-3" unitRef="U_iso4217USD">1806000</us-gaap:Revenues>
  <us-gaap:NetIncomeLoss id="F_000961" contextRef="C_0001029142_20120101_20120331" decimals="-3" unitRef="U_iso4217USD">-16505000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="F_000962" contextRef="C_0001029142_20120401_20120630" decimals="-3" unitRef="U_iso4217USD">-15110000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="F_000963" contextRef="C_0001029142_20120701_20120930" decimals="-3" unitRef="U_iso4217USD">-17791000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="F_000964" contextRef="C_0001029142_20121001_20121231" decimals="-3" unitRef="U_iso4217USD">-20543000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="F_000965" contextRef="C_0001029142_20120101_20120331" decimals="-3" unitRef="U_iso4217USD">-16505000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="F_000966" contextRef="C_0001029142_20120401_20120630" decimals="-3" unitRef="U_iso4217USD">-15110000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="F_000967" contextRef="C_0001029142_20120701_20120930" decimals="-3" unitRef="U_iso4217USD">-17791000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic id="F_000968" contextRef="C_0001029142_20121001_20121231" decimals="-3" unitRef="U_iso4217USD">-20543000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:EarningsPerShareBasicAndDiluted id="F_000969" contextRef="C_0001029142_20120101_20120331" decimals="2" unitRef="U_iso4217USD_shares">-0.11</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted id="F_000970" contextRef="C_0001029142_20120401_20120630" decimals="2" unitRef="U_iso4217USD_shares">-0.09</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted id="F_000971" contextRef="C_0001029142_20120701_20120930" decimals="2" unitRef="U_iso4217USD_shares">-0.10</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted id="F_000972" contextRef="C_0001029142_20121001_20121231" decimals="2" unitRef="U_iso4217USD_shares">-0.11</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="F_000973" contextRef="C_0001029142_20120101_20120331" decimals="-3" unitRef="U_shares">155431000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="F_000974" contextRef="C_0001029142_20120401_20120630" decimals="-3" unitRef="U_shares">167697000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="F_000975" contextRef="C_0001029142_20120701_20120930" decimals="-3" unitRef="U_shares">177870000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="F_000976" contextRef="C_0001029142_20121001_20121231" decimals="-3" unitRef="U_shares">180685000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized id="F_000977" contextRef="C_0001029142_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_us-gaapTypeOfArrangementAxis_dvaxAstraZenecaMember_20140301_20140331" decimals="-5" unitRef="U_iso4217USD">5400000</us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized>
</xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>25
<FILENAME>dvax-20131231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- RRD ActiveDisclosure(SM) XBRL Schema Document - http://www.financial.rrd.com/ -->
<!-- Creation Date      : 2014-03-07T19:36:08.4834606+00:00 -->
<!-- Version            : 1.7.0.24 -->
<!-- Package ID         : E885B71DE92DEB30D85162C832B40C82-0001029142-001401 -->
<!-- Copyright (c) 2014 R. R. Donnelley & Sons Company. All Rights Reserved. -->
<schema xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:us-types="http://fasb.org/us-types/2013-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:dvax="http://www.dynavax.com/20131231" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-gaap="http://fasb.org/us-gaap/2013-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2013-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2013-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:currency="http://xbrl.sec.gov/currency/2012-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2013-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.dynavax.com/20131231" xmlns="http://www.w3.org/2001/XMLSchema">
  <import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
  <import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
  <import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
  <import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
  <import schemaLocation="http://xbrl.fasb.org/us-gaap/2013/elts/us-types-2013-01-31.xsd" namespace="http://fasb.org/us-types/2013-01-31" />
  <import schemaLocation="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd" namespace="http://fasb.org/us-gaap/2013-01-31" />
  <import schemaLocation="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2013-01-31" />
  <import schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd" namespace="http://xbrl.sec.gov/invest/2013-01-31" />
  <import schemaLocation="http://xbrl.sec.gov/country/2013/country-2013-01-31.xsd" namespace="http://xbrl.sec.gov/country/2013-01-31" />
  <import schemaLocation="http://xbrl.sec.gov/currency/2012/currency-2012-01-31.xsd" namespace="http://xbrl.sec.gov/currency/2012-01-31" />
  <import schemaLocation="http://xbrl.sec.gov/exch/2013/exch-2013-01-31.xsd" namespace="http://xbrl.sec.gov/exch/2013-01-31" />
  <import schemaLocation="http://xbrl.sec.gov/naics/2011/naics-2011-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2011-01-31" />
  <import schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2011-01-31" />
  <import schemaLocation="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd" namespace="http://xbrl.sec.gov/stpr/2011-01-31" />
  <annotation>
    <appinfo>
      <link:roleType id="TemplateLink" roleURI="http://www.dynavax.com/20131231/role/TemplateLink" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>00000 - Document - Template Link</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dvax-20131231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:title="Calculation Links, all" xlink:type="simple" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dvax-20131231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dvax-20131231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dvax-20131231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedBalanceSheets" id="Role_StatementConsolidatedBalanceSheets">
        <link:definition>100010 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" id="Role_StatementConsolidatedBalanceSheetsParenthetical">
        <link:definition>100020 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedStatementsOfOperations" id="Role_StatementConsolidatedStatementsOfOperations">
        <link:definition>100030 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss" id="Role_StatementConsolidatedStatementsOfComprehensiveLoss">
        <link:definition>100040 - Statement - Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" id="Role_StatementConsolidatedStatementsOfStockholdersEquity">
        <link:definition>100050 - Statement - Consolidated Statements of Stockholders&apos; Equity</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" id="Role_StatementConsolidatedStatementsOfCashFlows">
        <link:definition>100060 - Statement - Consolidated Statements Of Cash Flows</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureOrganization" id="Role_DisclosureOrganization">
        <link:definition>100070 - Disclosure - Organization</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPolicies">
        <link:definition>100080 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureFairValueMeasurements" id="Role_DisclosureFairValueMeasurements">
        <link:definition>100090 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecurities" id="Role_DisclosureCashCashEquivalentsAndMarketableSecurities">
        <link:definition>100100 - Disclosure - Cash, Cash Equivalents and Marketable Securities</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosurePropertyAndEquipment" id="Role_DisclosurePropertyAndEquipment">
        <link:definition>100110 - Disclosure - Property and Equipment</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureIntangibleAssets" id="Role_DisclosureIntangibleAssets">
        <link:definition>100120 - Disclosure - Intangible Assets</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCurrentAccruedLiabilities" id="Role_DisclosureCurrentAccruedLiabilities">
        <link:definition>100130 - Disclosure - Current Accrued Liabilities</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSymphonyDynamoInc" id="Role_DisclosureSymphonyDynamoInc">
        <link:definition>100140 - Disclosure - Symphony Dynamo, Inc.</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCommitmentsAndContingencies" id="Role_DisclosureCommitmentsAndContingencies">
        <link:definition>100150 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreements" id="Role_DisclosureCollaborativeResearchDevelopmentAndLicenseAgreements">
        <link:definition>100160 - Disclosure - Collaborative Research, Development and License Agreements</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureNetLossPerShare" id="Role_DisclosureNetLossPerShare">
        <link:definition>100170 - Disclosure - Net Loss Per Share</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosurePreferredStockCommonStockAndWarrants" id="Role_DisclosurePreferredStockCommonStockAndWarrants">
        <link:definition>100180 - Disclosure - Preferred Stock, Common Stock and Warrants</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureEquityPlansAndStockBasedCompensation" id="Role_DisclosureEquityPlansAndStockBasedCompensation">
        <link:definition>100190 - Disclosure - Equity Plans and Stock-Based Compensation</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureEmployeeBenefitPlan" id="Role_DisclosureEmployeeBenefitPlan">
        <link:definition>100200 - Disclosure - Employee Benefit Plan</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureIncomeTaxes" id="Role_DisclosureIncomeTaxes">
        <link:definition>100210 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSelectedQuarterlyFinancialData" id="Role_DisclosureSelectedQuarterlyFinancialData">
        <link:definition>100220 - Disclosure - Selected Quarterly Financial Data</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSubsequentEvents" id="Role_DisclosureSubsequentEvents">
        <link:definition>100230 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>100240 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureFairValueMeasurementsTables" id="Role_DisclosureFairValueMeasurementsTables">
        <link:definition>100250 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesTables" id="Role_DisclosureCashCashEquivalentsAndMarketableSecuritiesTables">
        <link:definition>100260 - Disclosure - Cash, Cash Equivalents and Marketable Securities (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosurePropertyAndEquipmentTables" id="Role_DisclosurePropertyAndEquipmentTables">
        <link:definition>100270 - Disclosure - Property and Equipment (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCurrentAccruedLiabilitiesTables" id="Role_DisclosureCurrentAccruedLiabilitiesTables">
        <link:definition>100280 - Disclosure - Current Accrued Liabilities (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables" id="Role_DisclosureCommitmentsAndContingenciesTables">
        <link:definition>100290 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCollaborativeResearchAndDevelopmentAgreementsTables" id="Role_DisclosureCollaborativeResearchAndDevelopmentAgreementsTables">
        <link:definition>100300 - Disclosure - Collaborative Research and Development Agreements (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureNetLossPerShareTables" id="Role_DisclosureNetLossPerShareTables">
        <link:definition>100310 - Disclosure - Net Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosurePreferredStockCommonStockAndWarrantsTables" id="Role_DisclosurePreferredStockCommonStockAndWarrantsTables">
        <link:definition>100320 - Disclosure - Preferred Stock, Common Stock and Warrants (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureEquityPlansAndStockBasedCompensationTables" id="Role_DisclosureEquityPlansAndStockBasedCompensationTables">
        <link:definition>100330 - Disclosure - Equity Plans and Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureIncomeTaxesTables" id="Role_DisclosureIncomeTaxesTables">
        <link:definition>100340 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSelectedQuarterlyFinancialDataTables" id="Role_DisclosureSelectedQuarterlyFinancialDataTables">
        <link:definition>100350 - Disclosure - Selected Quarterly Financial Data (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail">
        <link:definition>100360 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureFairValueHierarchyForFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" id="Role_DisclosureFairValueHierarchyForFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail">
        <link:definition>100370 - Disclosure - Fair Value Hierarchy for Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfCashCashEquivalentsAndMarketableSecuritiesAvailableForSaleDetail" id="Role_DisclosureSummaryOfCashCashEquivalentsAndMarketableSecuritiesAvailableForSaleDetail">
        <link:definition>100380 - Disclosure - Summary of Cash, Cash Equivalents and Marketable Securities Available-for-sale (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfAmortizedCostAndEstimatedFairValueOfMarketableSecuritiesAvailableForSaleDetail" id="Role_DisclosureSummaryOfAmortizedCostAndEstimatedFairValueOfMarketableSecuritiesAvailableForSaleDetail">
        <link:definition>100390 - Disclosure - Summary of Amortized Cost and Estimated Fair Value of Marketable Securities Available-for-sale (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAdditionalInformationDetail" id="Role_DisclosureCashCashEquivalentsAndMarketableSecuritiesAdditionalInformationDetail">
        <link:definition>100400 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureComponentOfPropertyAndEquipmentDetail" id="Role_DisclosureComponentOfPropertyAndEquipmentDetail">
        <link:definition>100410 - Disclosure - Component of Property and Equipment (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetail" id="Role_DisclosurePropertyAndEquipmentAdditionalInformationDetail">
        <link:definition>100420 - Disclosure - Property and Equipment - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureIntangibleAssetsAdditionalInformationDetail" id="Role_DisclosureIntangibleAssetsAdditionalInformationDetail">
        <link:definition>100430 - Disclosure - Intangible Assets - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureComponentOfCurrentAccruedLiabilitiesDetail" id="Role_DisclosureComponentOfCurrentAccruedLiabilitiesDetail">
        <link:definition>100440 - Disclosure - Component of Current Accrued Liabilities (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSymphonyDynamoIncAdditionalInformationDetail" id="Role_DisclosureSymphonyDynamoIncAdditionalInformationDetail">
        <link:definition>100450 - Disclosure - Symphony Dynamo, Inc. - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureFutureMinimumPaymentsUnderNonCancelablePortionOfOperatingLeasesDetail" id="Role_DisclosureFutureMinimumPaymentsUnderNonCancelablePortionOfOperatingLeasesDetail">
        <link:definition>100460 - Disclosure - Future Minimum Payments Under Non-Cancelable Portion of Operating Leases (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" id="Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail">
        <link:definition>100470 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetail" id="Role_DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetail">
        <link:definition>100480 - Disclosure - Collaborative Research, Development, and License Agreements - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfRevenueRecognizedUnderAgreementWithGSKDetail" id="Role_DisclosureSummaryOfRevenueRecognizedUnderAgreementWithGSKDetail">
        <link:definition>100490 - Disclosure - Summary of Revenue Recognized under Agreement with GSK (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureComputationOfBasicAndDilutedEarningsPerShareDetail" id="Role_DisclosureComputationOfBasicAndDilutedEarningsPerShareDetail">
        <link:definition>100500 - Disclosure - Computation of Basic and Diluted Earnings Per Share (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosurePreferredStockCommonStockAndWarrantsAdditionalInformationDetail" id="Role_DisclosurePreferredStockCommonStockAndWarrantsAdditionalInformationDetail">
        <link:definition>100510 - Disclosure - Preferred Stock, Common Stock and Warrants - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureWarrantsIssuedToPurchaseCommonStockDetail" id="Role_DisclosureWarrantsIssuedToPurchaseCommonStockDetail">
        <link:definition>100520 - Disclosure - Warrants Issued to Purchase Common Stock (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureEquityPlansAndStockBasedCompensationAdditionalInformationDetail" id="Role_DisclosureEquityPlansAndStockBasedCompensationAdditionalInformationDetail">
        <link:definition>100530 - Disclosure - Equity Plans and Stock-Based Compensation - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureOptionActivityUnderStockPlansDetail" id="Role_DisclosureOptionActivityUnderStockPlansDetail">
        <link:definition>100540 - Disclosure - Option Activity under Stock Plans (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfRestrictedStockUnitsActivityDetail" id="Role_DisclosureSummaryOfRestrictedStockUnitsActivityDetail">
        <link:definition>100550 - Disclosure - Summary of Restricted Stock Units Activity (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureFairValueBasedMeasurementsAndWeightedAverageAssumptionsDetail" id="Role_DisclosureFairValueBasedMeasurementsAndWeightedAverageAssumptionsDetail">
        <link:definition>100560 - Disclosure - Fair Value-Based Measurements and Weighted-Average Assumptions (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureStockBasedCompensationExpenseDetail" id="Role_DisclosureStockBasedCompensationExpenseDetail">
        <link:definition>100570 - Disclosure - Stock-Based Compensation Expense (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureComponentOfConsolidatedIncomeLossBeforeProvisionForIncomeTaxesDetail" id="Role_DisclosureComponentOfConsolidatedIncomeLossBeforeProvisionForIncomeTaxesDetail">
        <link:definition>100580 - Disclosure - Component of Consolidated Income (Loss) Before Provision for Income Taxes (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureDifferenceBetweenConsolidatedIncomeTaxBenefitAndAmountComputedByFederalStatutoryIncomeTaxRateDetail" id="Role_DisclosureDifferenceBetweenConsolidatedIncomeTaxBenefitAndAmountComputedByFederalStatutoryIncomeTaxRateDetail">
        <link:definition>100590 - Disclosure - Difference between Consolidated Income Tax Benefit and Amount Computed by Federal Statutory Income Tax Rate (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureComponentOfDeferredTaxAssetsAndLiabilitiesDetail" id="Role_DisclosureComponentOfDeferredTaxAssetsAndLiabilitiesDetail">
        <link:definition>100600 - Disclosure - Component of Deferred Tax Assets and Liabilities (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" id="Role_DisclosureIncomeTaxesAdditionalInformationDetail">
        <link:definition>100610 - Disclosure - Income Taxes - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSelectedQuarterlyFinancialDataDetail" id="Role_DisclosureSelectedQuarterlyFinancialDataDetail">
        <link:definition>100620 - Disclosure - Selected Quarterly Financial Data (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetail" id="Role_DisclosureSubsequentEventAdditionalInformationDetail">
        <link:definition>100630 - Disclosure - Subsequent Event - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </appinfo>
  </annotation>
  <element id="dvax_DocumentDocumentAndEntityInformationAbstract" name="DocumentDocumentAndEntityInformationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_UnoccupiedFacilityExpense" name="UnoccupiedFacilityExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="dvax_IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue" name="IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="dvax_IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsShares" name="IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="dvax_BeneficialConversionFeatureOfSeriesBConvertiblePreferredStock" name="BeneficialConversionFeatureOfSeriesBConvertiblePreferredStock" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="dvax_AdjustmentsToAdditionalPaidInCapitalInitialExpensesRelatedToAtmAgreement" name="AdjustmentsToAdditionalPaidInCapitalInitialExpensesRelatedToAtmAgreement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="dvax_IssuanceOfCommonStockAndWarrantsValue" name="IssuanceOfCommonStockAndWarrantsValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="dvax_IssuanceOfCommonStockAndWarrantsShares" name="IssuanceOfCommonStockAndWarrantsShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="dvax_IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities" name="IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="dvax_SupplementalDisposalOfAssets" name="SupplementalDisposalOfAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="dvax_AgreementWithGskMember" name="AgreementWithGskMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_AstraZenecaMember" name="AstraZenecaMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_NationalInstitutesOfHealthMember" name="NationalInstitutesOfHealthMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationAbstract" name="DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" name="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" name="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_RheinBiotechGmbhMember" name="RheinBiotechGmbhMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_CashEquivalentsMaturityPeriod" name="CashEquivalentsMaturityPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="dvax_NumberOfReportingUnits" name="NumberOfReportingUnits" type="xbrli:positiveIntegerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="dvax_ReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncome" name="ReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncome" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="dvax_PercentageOfRevenueEarned" name="PercentageOfRevenueEarned" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="dvax_PercentageOfLongLivedAssets" name="PercentageOfLongLivedAssets" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <element id="dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems" name="FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable" name="FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_MunicipalSecuritiesMember" name="MunicipalSecuritiesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" name="AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="dvax_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" name="AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="dvax_CashCashEquivalentsAndMarketableSecuritiesLineItems" name="CashCashEquivalentsAndMarketableSecuritiesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_CashCashEquivalentsAndMarketableSecuritiesTable" name="CashCashEquivalentsAndMarketableSecuritiesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_DisclosureAvailableforsaleSecuritiesAdditionalInformationAbstract" name="DisclosureAvailableforsaleSecuritiesAdditionalInformationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_DisclosureComponentOfPropertyAndEquipmentAbstract" name="DisclosureComponentOfPropertyAndEquipmentAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_ManufacturingEquipmentMember" name="ManufacturingEquipmentMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_LaboratoryMember" name="LaboratoryMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_DisclosurePropertyAndEquipmentAdditionalInformationAbstract" name="DisclosurePropertyAndEquipmentAdditionalInformationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_DisclosureIntangibleAssetsAdditionalInformationAbstract" name="DisclosureIntangibleAssetsAdditionalInformationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_ManufacturingMember" name="ManufacturingMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_AccruedThirdPartyResearchAndDevelopmentExpensesCurrent" name="AccruedThirdPartyResearchAndDevelopmentExpensesCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="dvax_DisclosureComponentOfCurrentAccruedLiabilitiesAbstract" name="DisclosureComponentOfCurrentAccruedLiabilitiesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_AccruedLiabilitiesLineItems" name="AccruedLiabilitiesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_AccruedLiabilitiesTable" name="AccruedLiabilitiesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_DisclosureSymphonyDynamoIncAdditionalInformationAbstract" name="DisclosureSymphonyDynamoIncAdditionalInformationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_SymphonyDynamoIncMember" name="SymphonyDynamoIncMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_SymphonyDynamoHoldingsLlcMember" name="SymphonyDynamoHoldingsLlcMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_IssueOfWarrantsToPurchaseSharesOfCommonStock" name="IssueOfWarrantsToPurchaseSharesOfCommonStock" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="dvax_WarrantsExercisablePeriod" name="WarrantsExercisablePeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="dvax_BusinessAcquisitionContingentConsiderationPercentage" name="BusinessAcquisitionContingentConsiderationPercentage" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <element id="dvax_ReclassificationOfWarrantLiabilitiesToEquity" name="ReclassificationOfWarrantLiabilitiesToEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="dvax_WarrantLiabilityMember" name="WarrantLiabilityMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_LeaseExpirationMonthAndYear" name="LeaseExpirationMonthAndYear" type="xbrli:gYearMonthItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="dvax_ContingencyPeriod" name="ContingencyPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="dvax_CaliforniaMember" name="CaliforniaMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_ContingencyBMember" name="ContingencyBMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_ContingencyAMember" name="ContingencyAMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_DeutscheBankSecuritiesMember" name="DeutscheBankSecuritiesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_NumberOfProjects" name="NumberOfProjects" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="dvax_GlaxoSmithKlineMember" name="GlaxoSmithKlineMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_PotentialMilestonePaymentAmount" name="PotentialMilestonePaymentAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="dvax_CollaborativeAgreementAxis" name="CollaborativeAgreementAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_CollaborativeAgreementDomain" name="CollaborativeAgreementDomain" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_ConditionTwoMember" name="ConditionTwoMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_ExpansionMember" name="ExpansionMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_RevenueRecognitionPeriod" name="RevenueRecognitionPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <element id="dvax_ResearchCollaborationAndLicenseAgreementPeriod" name="ResearchCollaborationAndLicenseAgreementPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="dvax_AmendmentMember" name="AmendmentMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_ContingentConsiderationMember" name="ContingentConsiderationMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_HepaticFibrosisAndCirrhosisMember" name="HepaticFibrosisAndCirrhosisMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_DifferentTypesOfCollaborationAgreementsAxis" name="DifferentTypesOfCollaborationAgreementsAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_DifferentTypesOfCollaborationAgreementsDomain" name="DifferentTypesOfCollaborationAgreementsDomain" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_AutoimmuneDiseaseMember" name="AutoimmuneDiseaseMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_RheumatoidArthritisMember" name="RheumatoidArthritisMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_SkinAutoimmuneInflammationMember" name="SkinAutoimmuneInflammationMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_HepatitisBVirusMember" name="HepatitisBVirusMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_HumanPapillomaVirusMember" name="HumanPapillomaVirusMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_ContractTerm" name="ContractTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="dvax_IssTechnologyMember" name="IssTechnologyMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_NationalInstituteOfAllergyAndInfectiousDiseasesMember" name="NationalInstituteOfAllergyAndInfectiousDiseasesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_EarningsPerShareBasicAndDilutedDenominatorAbstract" name="EarningsPerShareBasicAndDilutedDenominatorAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_DisclosureComputationOfBasicAndDilutedEarningsPerShareAbstract" name="DisclosureComputationOfBasicAndDilutedEarningsPerShareAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_EarningsPerShareDisclosureLineItems" name="EarningsPerShareDisclosureLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_EarningsPerShareDisclosureTable" name="EarningsPerShareDisclosureTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_AntidilutiveSecuritiesExcludedFromComputationOfEarningPerShareAbstract" name="AntidilutiveSecuritiesExcludedFromComputationOfEarningPerShareAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_StockOptionsAndShareAwardsMember" name="StockOptionsAndShareAwardsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_PreferredStockCommonStockAndWarrantsAbstract" name="PreferredStockCommonStockAndWarrantsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_PreferredStockCommonStockAndWarrantsLineItems" name="PreferredStockCommonStockAndWarrantsLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_PreferredStockCommonStockAndWarrantsTable" name="PreferredStockCommonStockAndWarrantsTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_DeemedDividend" name="DeemedDividend" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <element id="dvax_PercentageOfCommonSharesOutstanding" name="PercentageOfCommonSharesOutstanding" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="dvax_PercentageOfCompanyAssets" name="PercentageOfCompanyAssets" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <element id="dvax_RightsExpirationDate" name="RightsExpirationDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="dvax_SellingCommissionPercentageFromGrossOfferingProceedsOfSalesOfStock" name="SellingCommissionPercentageFromGrossOfferingProceedsOfSalesOfStock" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <element id="dvax_MlvMember" name="MlvMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_PurchaseAgreementPeriod" name="PurchaseAgreementPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="dvax_PercentageOfCommitmentToPurchaseSharesValue" name="PercentageOfCommitmentToPurchaseSharesValue" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="dvax_CommitmentFeePaid" name="CommitmentFeePaid" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="dvax_AspireCapitalFundLlcMember" name="AspireCapitalFundLlcMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_NumberOfSharesOfCommonStockInEachUnit" name="NumberOfSharesOfCommonStockInEachUnit" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="dvax_NumberOfWarrantsInEachUnit" name="NumberOfWarrantsInEachUnit" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="dvax_CommonStockIssuableUponExerciseOfWarrantsConversionRatio" name="CommonStockIssuableUponExerciseOfWarrantsConversionRatio" type="xbrli:pureItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="dvax_LoanAgreementMember" name="LoanAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_WarrantIssueDate" name="WarrantIssueDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <element id="dvax_WarrantExpirationDate" name="WarrantExpirationDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <element id="dvax_DisclosureWarrantsIssuedToPurchaseCommonStockAbstract" name="DisclosureWarrantsIssuedToPurchaseCommonStockAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_WarrantOneMember" name="WarrantOneMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_WarrantTwoMember" name="WarrantTwoMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_WarrantThreeMember" name="WarrantThreeMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_WarrantFourMember" name="WarrantFourMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_WarrantToPurchaseCommonStock" name="WarrantToPurchaseCommonStock" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <element id="dvax_NumberOfWarrantsExercisedDuringPeriod" name="NumberOfWarrantsExercisedDuringPeriod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <element id="dvax_NumberOfShareBasedCompensationPlans" name="NumberOfShareBasedCompensationPlans" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <element id="dvax_StockIncentivePlanTwentyZeroFourMember" name="StockIncentivePlanTwentyZeroFourMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_OtherParticipantsMember" name="OtherParticipantsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_GroupTwoMember" name="GroupTwoMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_EmploymentInducementAwardPlanTwentyTenMember" name="EmploymentInducementAwardPlanTwentyTenMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_EquityIncentivePlanTwentyElevenMember" name="EquityIncentivePlanTwentyElevenMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_UnvestedMember" name="UnvestedMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_VestedMember" name="VestedMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice" type="num:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <element id="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndRsuOutstandingNumber" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndRsuOutstandingNumber" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="dvax_EmployeesAndDirectorsMember" name="EmployeesAndDirectorsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_NonEmployeeMember" name="NonEmployeeMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_NonEmployeeAwardsMember" name="NonEmployeeAwardsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_AdditionalMember" name="AdditionalMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_TimeBasedVestingScheduleMember" name="TimeBasedVestingScheduleMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_PeriodAxis" name="PeriodAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_PeriodDomain" name="PeriodDomain" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_PeriodOneMember" name="PeriodOneMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_PeriodTwoMember" name="PeriodTwoMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_DisclosureComponentOfConsolidatedIncomeLossBeforeProvisionForIncomeTaxesAbstract" name="DisclosureComponentOfConsolidatedIncomeLossBeforeProvisionForIncomeTaxesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" name="ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" name="ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_IncomeTaxReconciliationDeferredCompensationCharges" name="IncomeTaxReconciliationDeferredCompensationCharges" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="dvax_IncomeTaxReconciliationChangeInFairValueMeasurement" name="IncomeTaxReconciliationChangeInFairValueMeasurement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <element id="dvax_DisclosureDifferenceBetweenConsolidatedIncomeTaxBenefitAndAmountComputedByFederalStatutoryIncomeTaxRateAbstract" name="DisclosureDifferenceBetweenConsolidatedIncomeTaxBenefitAndAmountComputedByFederalStatutoryIncomeTaxRateAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_IncomeTaxRateReconciliationLineItems" name="IncomeTaxRateReconciliationLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_IncomeTaxRateReconciliationTable" name="IncomeTaxRateReconciliationTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_DisclosureComponentOfDeferredTaxAssetsAndLiabilitiesAbstract" name="DisclosureComponentOfDeferredTaxAssetsAndLiabilitiesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_ScheduleOfDeferredTaxAssetsAndLiabilitiesLineItems" name="ScheduleOfDeferredTaxAssetsAndLiabilitiesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_ScheduleOfDeferredTaxAssetsAndLiabilitiesTable" name="ScheduleOfDeferredTaxAssetsAndLiabilitiesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_DisclosureIncomeTaxesAdditionalInformationAbstract" name="DisclosureIncomeTaxesAdditionalInformationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_IncomeTaxDisclosureLineItems" name="IncomeTaxDisclosureLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_IncomeTaxDisclosureTable" name="IncomeTaxDisclosureTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_OperatingLossCarryforwardExpirationYear" name="OperatingLossCarryforwardExpirationYear" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="dvax_TaxCreditCarryforwardExpirationYear" name="TaxCreditCarryforwardExpirationYear" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <element id="dvax_FederalMember" name="FederalMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_ResearchAndDevelopmentMember" name="ResearchAndDevelopmentMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_CaliforniaStateMember" name="CaliforniaStateMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_DisclosureSelectedQuarterlyFinancialDataAbstract" name="DisclosureSelectedQuarterlyFinancialDataAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_SelectedQuarterlyFinancialDataLineItems" name="SelectedQuarterlyFinancialDataLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <element id="dvax_SelectedQuarterlyFinancialDataTable" name="SelectedQuarterlyFinancialDataTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>26
<FILENAME>dvax-20131231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- RRD ActiveDisclosure(SM) XBRL Linkbase Document - http://www.financial.rrd.com/ -->
<!-- Creation Date      : 2014-03-07T19:36:08.4834606+00:00 -->
<!-- Version            : 1.7.0.24 -->
<!-- Package ID         : E885B71DE92DEB30D85162C832B40C82-0001029142-001401 -->
<!-- Copyright (c) 2014 R. R. Donnelley & Sons Company. All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="dvax-20131231.xsd#TemplateLink" roleURI="http://www.dynavax.com/20131231/role/TemplateLink" />
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedBalanceSheets" xlink:href="dvax-20131231.xsd#Role_StatementConsolidatedBalanceSheets" xlink:type="simple" />
  <calculationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedBalanceSheets">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesCurrent" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Goodwill" xlink:type="locator" xlink:label="us-gaap_Goodwill" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrent" xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Assets" xlink:type="locator" xlink:label="us-gaap_Assets" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:type="locator" xlink:label="us-gaap_DeferredRevenueCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:type="locator" xlink:label="us-gaap_DeferredRevenueNoncurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockValue" xlink:type="locator" xlink:label="us-gaap_CommonStockValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockValue" xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Liabilities" xlink:type="locator" xlink:label="us-gaap_Liabilities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="10010.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="10020.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="10030.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="10050.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapital" order="10060.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="10070.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="10080.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="10090.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_DeferredRevenueNoncurrent" order="10100.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="10110.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="10120.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="10130.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_DeferredRevenueCurrent" order="10140.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="10150.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="10160.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Goodwill" order="10170.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" order="10180.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="10190.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="10200.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesCurrent" order="10210.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="10220.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="10230.00" priority="2" use="optional" weight="1.00" />
  </calculationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedStatementsOfOperations" xlink:href="dvax-20131231.xsd#Role_StatementConsolidatedStatementsOfOperations" xlink:type="simple" />
  <calculationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedStatementsOfOperations">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LicenseAndServicesRevenue" xlink:type="locator" xlink:label="us-gaap_LicenseAndServicesRevenue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenueFromGrants" xlink:type="locator" xlink:label="us-gaap_RevenueFromGrants" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ContractsRevenue" xlink:type="locator" xlink:label="us-gaap_ContractsRevenue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
    <loc xlink:href="dvax-20131231.xsd#dvax_UnoccupiedFacilityExpense" xlink:type="locator" xlink:label="dvax_UnoccupiedFacilityExpense" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CostsAndExpenses" xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Revenues" xlink:type="locator" xlink:label="us-gaap_Revenues" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestExpense" xlink:type="locator" xlink:label="us-gaap_InterestExpense" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLoss" order="10010.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_PreferredStockDividendsIncomeStatementImpact" order="10020.00" priority="2" use="optional" weight="-1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss" order="10030.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_InvestmentIncomeInterest" order="10040.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_InterestExpense" order="10050.00" priority="2" use="optional" weight="-1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="10060.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_Revenues" order="10070.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_CostsAndExpenses" order="10080.00" priority="2" use="optional" weight="-1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="10090.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="10100.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="dvax_UnoccupiedFacilityExpense" order="10110.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="10120.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_ContractsRevenue" order="10130.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_RevenueFromGrants" order="10140.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_LicenseAndServicesRevenue" order="10150.00" priority="2" use="optional" weight="1.00" />
  </calculationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss" xlink:href="dvax-20131231.xsd#Role_StatementConsolidatedStatementsOfComprehensiveLoss" xlink:type="simple" />
  <calculationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_NetIncomeLoss" order="10010.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" order="10020.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" order="10030.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" order="10040.00" priority="2" use="optional" weight="1.00" />
  </calculationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:href="dvax-20131231.xsd#Role_StatementConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <calculationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
    <loc xlink:href="dvax-20131231.xsd#dvax_IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities" xlink:type="locator" xlink:label="dvax_IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessExitCosts1" xlink:type="locator" xlink:label="us-gaap_BusinessExitCosts1" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:type="locator" xlink:label="us-gaap_OtherNoncashIncomeExpense" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCosts" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="locator" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromStockPlans" xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockPlans" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="10010.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="10020.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="10030.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" order="10040.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="10050.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" order="10060.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="10070.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="10080.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockPlans" order="10090.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfNotesPayable" order="10100.00" priority="2" use="optional" weight="-1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities" order="10110.00" priority="2" use="optional" weight="-1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" order="10120.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="10130.00" priority="2" use="optional" weight="-1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetIncomeLoss" order="10140.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DepreciationAndAmortization" order="10150.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="10160.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="10170.00" priority="2" use="optional" weight="-1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="10180.00" priority="2" use="optional" weight="-1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AmortizationOfFinancingCosts" order="10190.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_OtherNoncashIncomeExpense" order="10200.00" priority="2" use="optional" weight="-1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_BusinessExitCosts1" order="10210.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="10220.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="10230.00" priority="2" use="optional" weight="-1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets" order="10240.00" priority="2" use="optional" weight="-1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="dvax_IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities" order="10250.00" priority="2" use="optional" weight="-1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="10260.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" order="10270.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" order="10280.00" priority="2" use="optional" weight="1.00" />
  </calculationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfCashCashEquivalentsAndMarketableSecuritiesAvailableForSaleDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureSummaryOfCashCashEquivalentsAndMarketableSecuritiesAvailableForSaleDetail" xlink:type="simple" />
  <calculationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfCashCashEquivalentsAndMarketableSecuritiesAvailableForSaleDetail">
    <loc xlink:href="dvax-20131231.xsd#dvax_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" xlink:type="locator" xlink:label="dvax_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" />
    <loc xlink:href="dvax-20131231.xsd#dvax_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" xlink:type="locator" xlink:label="dvax_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAmortizedCost" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesAmortizedCost" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecurities" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecurities" xlink:to="us-gaap_AvailableForSaleSecuritiesAmortizedCost" order="10010.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecurities" xlink:to="dvax_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" order="10020.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecurities" xlink:to="dvax_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" order="10030.00" priority="2" use="optional" weight="-1.00" />
  </calculationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfAmortizedCostAndEstimatedFairValueOfMarketableSecuritiesAvailableForSaleDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureSummaryOfAmortizedCostAndEstimatedFairValueOfMarketableSecuritiesAvailableForSaleDetail" xlink:type="simple" />
  <calculationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfAmortizedCostAndEstimatedFairValueOfMarketableSecuritiesAvailableForSaleDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" order="10010.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" order="10020.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" order="10260.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" order="10270.00" priority="2" use="optional" weight="1.00" />
  </calculationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureComponentOfPropertyAndEquipmentDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureComponentOfPropertyAndEquipmentDetail" xlink:type="simple" />
  <calculationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureComponentOfPropertyAndEquipmentDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="10740.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="10750.00" priority="2" use="optional" weight="-1.00" />
  </calculationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureComponentOfCurrentAccruedLiabilitiesDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureComponentOfCurrentAccruedLiabilitiesDetail" xlink:type="simple" />
  <calculationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureComponentOfCurrentAccruedLiabilitiesDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
    <loc xlink:href="dvax-20131231.xsd#dvax_AccruedThirdPartyResearchAndDevelopmentExpensesCurrent" xlink:type="locator" xlink:label="dvax_AccruedThirdPartyResearchAndDevelopmentExpensesCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccruedEmployeeBenefitsCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedEmployeeBenefitsCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedEmployeeBenefitsCurrent" order="10010.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="10020.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="dvax_AccruedThirdPartyResearchAndDevelopmentExpensesCurrent" order="10030.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="10040.00" priority="2" use="optional" weight="1.00" />
  </calculationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureFutureMinimumPaymentsUnderNonCancelablePortionOfOperatingLeasesDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureFutureMinimumPaymentsUnderNonCancelablePortionOfOperatingLeasesDetail" xlink:type="simple" />
  <calculationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureFutureMinimumPaymentsUnderNonCancelablePortionOfOperatingLeasesDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" order="10010.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" order="10020.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" order="10030.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" order="10040.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" order="10050.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" order="10060.00" priority="2" use="optional" weight="1.00" />
  </calculationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfRevenueRecognizedUnderAgreementWithGSKDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureSummaryOfRevenueRecognizedUnderAgreementWithGSKDetail" xlink:type="simple" />
  <calculationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfRevenueRecognizedUnderAgreementWithGSKDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRevenueAdditions" xlink:type="locator" xlink:label="us-gaap_DeferredRevenueAdditions" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Revenues" xlink:type="locator" xlink:label="us-gaap_Revenues" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_DeferredRevenueAdditions" order="10010.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" order="10020.00" priority="2" use="optional" weight="1.00" />
  </calculationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureComponentOfConsolidatedIncomeLossBeforeProvisionForIncomeTaxesDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureComponentOfConsolidatedIncomeLossBeforeProvisionForIncomeTaxesDetail" xlink:type="simple" />
  <calculationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureComponentOfConsolidatedIncomeLossBeforeProvisionForIncomeTaxesDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="10010.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="10020.00" priority="2" use="optional" weight="1.00" />
  </calculationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureDifferenceBetweenConsolidatedIncomeTaxBenefitAndAmountComputedByFederalStatutoryIncomeTaxRateDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureDifferenceBetweenConsolidatedIncomeTaxBenefitAndAmountComputedByFederalStatutoryIncomeTaxRateDetail" xlink:type="simple" />
  <calculationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureDifferenceBetweenConsolidatedIncomeTaxBenefitAndAmountComputedByFederalStatutoryIncomeTaxRateDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationDeductionsDividends" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationDeductionsDividends" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" />
    <loc xlink:href="dvax-20131231.xsd#dvax_IncomeTaxReconciliationChangeInFairValueMeasurement" xlink:type="locator" xlink:label="dvax_IncomeTaxReconciliationChangeInFairValueMeasurement" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <loc xlink:href="dvax-20131231.xsd#dvax_IncomeTaxReconciliationDeferredCompensationCharges" xlink:type="locator" xlink:label="dvax_IncomeTaxReconciliationDeferredCompensationCharges" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCredits" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationTaxCredits" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="10010.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" order="10020.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationTaxCredits" order="10030.00" priority="2" use="optional" weight="-1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="dvax_IncomeTaxReconciliationDeferredCompensationCharges" order="10040.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="10050.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" order="10060.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="dvax_IncomeTaxReconciliationChangeInFairValueMeasurement" order="10070.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" order="10080.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationDeductionsDividends" order="10090.00" priority="2" use="optional" weight="-1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" order="10100.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments" order="10110.00" priority="2" use="optional" weight="1.00" />
  </calculationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureComponentOfDeferredTaxAssetsAndLiabilitiesDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureComponentOfDeferredTaxAssetsAndLiabilitiesDetail" xlink:type="simple" />
  <calculationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureComponentOfDeferredTaxAssetsAndLiabilitiesDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesOther" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsNet" order="10010.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxLiabilities" order="10020.00" priority="2" use="optional" weight="-1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" order="10030.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilitiesOther" order="10040.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsGross" order="10050.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="10060.00" priority="2" use="optional" weight="-1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="10070.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" order="10080.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" order="10090.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="10100.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome" order="10110.00" priority="2" use="optional" weight="1.00" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOther" order="10120.00" priority="2" use="optional" weight="1.00" />
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>27
<FILENAME>dvax-20131231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- RRD ActiveDisclosure(SM) XBRL Linkbase Document - http://www.financial.rrd.com/ -->
<!-- Creation Date      : 2014-03-07T19:36:08.4834606+00:00 -->
<!-- Version            : 1.7.0.24 -->
<!-- Package ID         : E885B71DE92DEB30D85162C832B40C82-0001029142-001401 -->
<!-- Copyright (c) 2014 R. R. Donnelley & Sons Company. All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <roleRef xlink:type="simple" xlink:href="dvax-20131231.xsd#TemplateLink" roleURI="http://www.dynavax.com/20131231/role/TemplateLink" />
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="dvax-20131231.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DocumentDocumentAndEntityInformation">
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityPublicFloat" xlink:type="locator" xlink:label="dei_EntityPublicFloat" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityFilerCategory" xlink:type="locator" xlink:label="dei_EntityFilerCategory" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityVoluntaryFilers" xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain_2" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntitiesTable" xlink:type="locator" xlink:label="dei_EntitiesTable" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentInformationLineItems" xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitiesTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_EntitiesTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain_2" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="10090.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="10170.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="10250.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="10330.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="10410.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="10490.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="10570.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="10650.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="10730.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="10810.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="10890.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="10970.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="11050.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="11130.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityPublicFloat" order="11210.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedBalanceSheets" xlink:href="dvax-20131231.xsd#Role_StatementConsolidatedBalanceSheets" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedBalanceSheets">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockValue" xlink:type="locator" xlink:label="us-gaap_CommonStockValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockValue" xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Liabilities" xlink:type="locator" xlink:label="us-gaap_Liabilities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:type="locator" xlink:label="us-gaap_DeferredRevenueNoncurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:type="locator" xlink:label="us-gaap_DeferredRevenueCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Assets" xlink:type="locator" xlink:label="us-gaap_Assets" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Goodwill" xlink:type="locator" xlink:label="us-gaap_Goodwill" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrent" xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesCurrent" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10270.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_2" order="10290.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="10290.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="10310.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10330.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10340.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10350.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="10370.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="10450.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="10530.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesCurrent" order="10610.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="10690.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="10770.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="10850.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="10930.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Goodwill" order="11010.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" order="11090.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="11170.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="11250.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="11330.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="11410.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="11490.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="11570.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRevenueCurrent" order="11650.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="11730.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_DeferredRevenueNoncurrent" order="11810.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="11890.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="11970.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="12050.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="12130.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="12210.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="12370.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="12450.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="12530.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="12610.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="12690.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="12770.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" xlink:href="dvax-20131231.xsd#Role_StatementConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10040.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="10080.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10140.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10150.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10160.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="10180.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="10260.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="10340.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="10420.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="10740.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="10820.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="10900.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="10980.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedStatementsOfOperations" xlink:href="dvax-20131231.xsd#Role_StatementConsolidatedStatementsOfOperations" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedStatementsOfOperations">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestExpense" xlink:type="locator" xlink:label="us-gaap_InterestExpense" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CostsAndExpenses" xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
    <loc xlink:href="dvax-20131231.xsd#dvax_UnoccupiedFacilityExpense" xlink:type="locator" xlink:label="dvax_UnoccupiedFacilityExpense" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:type="locator" xlink:label="us-gaap_CostsAndExpensesAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Revenues" xlink:type="locator" xlink:label="us-gaap_Revenues" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LicenseAndServicesRevenue" xlink:type="locator" xlink:label="us-gaap_LicenseAndServicesRevenue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenueFromGrants" xlink:type="locator" xlink:label="us-gaap_RevenueFromGrants" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ContractsRevenue" xlink:type="locator" xlink:label="us-gaap_ContractsRevenue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenuesAbstract" xlink:type="locator" xlink:label="us-gaap_RevenuesAbstract" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10200.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10210.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10220.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenuesAbstract" order="10240.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_ContractsRevenue" order="10360.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenueFromGrants" order="10480.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_LicenseAndServicesRevenue" order="10600.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_Revenues" order="10720.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CostsAndExpensesAbstract" order="10840.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="10960.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="11080.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="dvax_UnoccupiedFacilityExpense" order="11200.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="11280.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_CostsAndExpenses" order="11360.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="11480.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract" order="11600.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InvestmentIncomeInterest" order="11720.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InterestExpense" order="11840.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="11940.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="12060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockDividendsIncomeStatementImpact" order="12180.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="12260.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="12380.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="12500.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss" xlink:href="dvax-20131231.xsd#Role_StatementConsolidatedStatementsOfComprehensiveLoss" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10090.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10100.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10110.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="10130.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" order="10190.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" order="10310.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" order="10430.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" order="10550.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="10670.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" xlink:href="dvax-20131231.xsd#Role_StatementConsolidatedStatementsOfStockholdersEquity" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <loc xlink:href="dvax-20131231.xsd#dvax_IssuanceOfCommonStockAndWarrantsShares" xlink:type="locator" xlink:label="dvax_IssuanceOfCommonStockAndWarrantsShares" />
    <loc xlink:href="dvax-20131231.xsd#dvax_IssuanceOfCommonStockAndWarrantsValue" xlink:type="locator" xlink:label="dvax_IssuanceOfCommonStockAndWarrantsValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
    <loc xlink:href="dvax-20131231.xsd#dvax_AdjustmentsToAdditionalPaidInCapitalInitialExpensesRelatedToAtmAgreement" xlink:type="locator" xlink:label="dvax_AdjustmentsToAdditionalPaidInCapitalInitialExpensesRelatedToAtmAgreement" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockDividendsShares" xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendsShares" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredDividendsNetOfTax" xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredDividendsNetOfTax" />
    <loc xlink:href="dvax-20131231.xsd#dvax_BeneficialConversionFeatureOfSeriesBConvertiblePreferredStock" xlink:type="locator" xlink:label="dvax_BeneficialConversionFeatureOfSeriesBConvertiblePreferredStock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" />
    <loc xlink:href="dvax-20131231.xsd#dvax_IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsShares" xlink:type="locator" xlink:label="dvax_IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsShares" />
    <loc xlink:href="dvax-20131231.xsd#dvax_IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue" xlink:type="locator" xlink:label="dvax_IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharesOutstanding" xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockMember" xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10040.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_2" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10080.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_PreferredStockMember" order="10120.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="10160.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="10180.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="10200.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10220.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10230.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10240.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="10260.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="10560.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dvax_IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue" order="10760.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dvax_IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsShares" order="11060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" order="11260.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="11560.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" order="11760.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="11940.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="12120.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="12300.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="12480.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="12660.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" order="12840.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dvax_BeneficialConversionFeatureOfSeriesBConvertiblePreferredStock" order="13020.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ConvertiblePreferredDividendsNetOfTax" order="13200.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockDividendsShares" order="13380.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dvax_AdjustmentsToAdditionalPaidInCapitalInitialExpensesRelatedToAtmAgreement" order="13560.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="13740.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" order="13920.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dvax_IssuanceOfCommonStockAndWarrantsValue" order="14100.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="dvax_IssuanceOfCommonStockAndWarrantsShares" order="14400.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="14600.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" order="14900.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="15180.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" order="19720.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" order="21980.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:href="dvax-20131231.xsd#Role_StatementConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesUnrealizedGainLoss" />
    <loc xlink:href="dvax-20131231.xsd#dvax_SupplementalDisposalOfAssets" xlink:type="locator" xlink:label="dvax_SupplementalDisposalOfAssets" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromStockPlans" xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockPlans" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
    <loc xlink:href="dvax-20131231.xsd#dvax_IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities" xlink:type="locator" xlink:label="dvax_IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessExitCosts1" xlink:type="locator" xlink:label="us-gaap_BusinessExitCosts1" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:type="locator" xlink:label="us-gaap_OtherNoncashIncomeExpense" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCosts" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="locator" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10330.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10340.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10350.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="10370.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="10490.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="10550.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationAndAmortization" order="10670.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="10790.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="10850.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="10970.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfFinancingCosts" order="11090.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OtherNoncashIncomeExpense" order="11190.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_BusinessExitCosts1" order="11270.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="11350.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="11470.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="11590.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets" order="11710.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="dvax_IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities" order="11830.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="11950.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" order="12070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" order="12190.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="12310.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="12430.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities" order="12550.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" order="12670.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="12790.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="12910.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="13030.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="13150.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" order="13270.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="13350.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="13470.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockPlans" order="13590.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfNotesPayable" order="13710.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="13790.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" order="13910.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" order="14030.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="14150.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="14310.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" order="14430.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="dvax_SupplementalDisposalOfAssets" order="14550.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_MarketableSecuritiesUnrealizedGainLoss" order="14670.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureOrganization" xlink:href="dvax-20131231.xsd#Role_DisclosureOrganization" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureOrganization">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="10090.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies" xlink:href="dvax-20131231.xsd#Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="10090.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureFairValueMeasurements" xlink:href="dvax-20131231.xsd#Role_DisclosureFairValueMeasurements" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureFairValueMeasurements">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="10090.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecurities" xlink:href="dvax-20131231.xsd#Role_DisclosureCashCashEquivalentsAndMarketableSecurities" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecurities">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" order="10090.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosurePropertyAndEquipment" xlink:href="dvax-20131231.xsd#Role_DisclosurePropertyAndEquipment" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosurePropertyAndEquipment">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" order="10090.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureIntangibleAssets" xlink:href="dvax-20131231.xsd#Role_DisclosureIntangibleAssets" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureIntangibleAssets">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock" order="10090.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCurrentAccruedLiabilities" xlink:href="dvax-20131231.xsd#Role_DisclosureCurrentAccruedLiabilities" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCurrentAccruedLiabilities">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:type="locator" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" order="10090.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSymphonyDynamoInc" xlink:href="dvax-20131231.xsd#Role_DisclosureSymphonyDynamoInc" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSymphonyDynamoInc">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinorityInterestDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_MinorityInterestDisclosureTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_MinorityInterestDisclosureTextBlock" order="10090.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCommitmentsAndContingencies" xlink:href="dvax-20131231.xsd#Role_DisclosureCommitmentsAndContingencies" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCommitmentsAndContingencies">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="10090.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreements" xlink:href="dvax-20131231.xsd#Role_DisclosureCollaborativeResearchDevelopmentAndLicenseAgreements" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreements">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CollaborativeArrangementDisclosureTextBlock" order="10090.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureNetLossPerShare" xlink:href="dvax-20131231.xsd#Role_DisclosureNetLossPerShare" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureNetLossPerShare">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareTextBlock" order="10090.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosurePreferredStockCommonStockAndWarrants" xlink:href="dvax-20131231.xsd#Role_DisclosurePreferredStockCommonStockAndWarrants" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosurePreferredStockCommonStockAndWarrants">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="10090.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureEquityPlansAndStockBasedCompensation" xlink:href="dvax-20131231.xsd#Role_DisclosureEquityPlansAndStockBasedCompensation" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureEquityPlansAndStockBasedCompensation">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="10090.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureEmployeeBenefitPlan" xlink:href="dvax-20131231.xsd#Role_DisclosureEmployeeBenefitPlan" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureEmployeeBenefitPlan">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" order="10090.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureIncomeTaxes" xlink:href="dvax-20131231.xsd#Role_DisclosureIncomeTaxes" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureIncomeTaxes">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="10090.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSelectedQuarterlyFinancialData" xlink:href="dvax-20131231.xsd#Role_DisclosureSelectedQuarterlyFinancialData" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSelectedQuarterlyFinancialData">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock" xlink:type="locator" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_QuarterlyFinancialInformationTextBlock" order="10090.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSubsequentEvents" xlink:href="dvax-20131231.xsd#Role_DisclosureSubsequentEvents" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSubsequentEvents">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SubsequentEventsTextBlock" order="10090.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="dvax-20131231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_UseOfEstimates" xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiquidityDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_LiquidityDisclosureTextBlock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="10090.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiquidityDisclosureTextBlock" order="10170.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_UseOfEstimates" order="10250.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" order="10330.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InvestmentPolicyTextBlock" order="10410.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="10490.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="10570.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" order="10650.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="10730.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="10810.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="10890.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="10970.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="11050.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureFairValueMeasurementsTables" xlink:href="dvax-20131231.xsd#Role_DisclosureFairValueMeasurementsTables" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureFairValueMeasurementsTables">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" order="10090.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesTables" xlink:href="dvax-20131231.xsd#Role_DisclosureCashCashEquivalentsAndMarketableSecuritiesTables" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesTables">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesTextBlock" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesTextBlock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" order="10090.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesTextBlock" order="10170.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosurePropertyAndEquipmentTables" xlink:href="dvax-20131231.xsd#Role_DisclosurePropertyAndEquipmentTables" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosurePropertyAndEquipmentTables">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="10090.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCurrentAccruedLiabilitiesTables" xlink:href="dvax-20131231.xsd#Role_DisclosureCurrentAccruedLiabilitiesTables" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCurrentAccruedLiabilitiesTables">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" order="10090.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables" xlink:href="dvax-20131231.xsd#Role_DisclosureCommitmentsAndContingenciesTables" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" order="10090.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCollaborativeResearchAndDevelopmentAgreementsTables" xlink:href="dvax-20131231.xsd#Role_DisclosureCollaborativeResearchAndDevelopmentAgreementsTables" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCollaborativeResearchAndDevelopmentAgreementsTables">
    <loc xlink:href="dvax-20131231.xsd#dvax_NationalInstitutesOfHealthMember" xlink:type="locator" xlink:label="dvax_NationalInstitutesOfHealthMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_AstraZenecaMember" xlink:type="locator" xlink:label="dvax_AstraZenecaMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenueRecognitionMultipleDeliverableArrangementsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionMultipleDeliverableArrangementsTableTextBlock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="dvax-20131231.xsd#dvax_AgreementWithGskMember" xlink:type="locator" xlink:label="dvax_AgreementWithGskMember" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10030.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10050.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="dvax_AgreementWithGskMember" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10100.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenueRecognitionMultipleDeliverableArrangementsTableTextBlock" order="10140.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="dvax_AstraZenecaMember" order="10200.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="dvax_NationalInstitutesOfHealthMember" order="10330.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureNetLossPerShareTables" xlink:href="dvax-20131231.xsd#Role_DisclosureNetLossPerShareTables" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureNetLossPerShareTables">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="10090.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosurePreferredStockCommonStockAndWarrantsTables" xlink:href="dvax-20131231.xsd#Role_DisclosurePreferredStockCommonStockAndWarrantsTables" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosurePreferredStockCommonStockAndWarrantsTables">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" order="10090.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureEquityPlansAndStockBasedCompensationTables" xlink:href="dvax-20131231.xsd#Role_DisclosureEquityPlansAndStockBasedCompensationTables" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureEquityPlansAndStockBasedCompensationTables">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock" order="10090.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" order="10170.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="10250.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" order="10330.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureIncomeTaxesTables" xlink:href="dvax-20131231.xsd#Role_DisclosureIncomeTaxesTables" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureIncomeTaxesTables">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" order="10090.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="10170.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="10250.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSelectedQuarterlyFinancialDataTables" xlink:href="dvax-20131231.xsd#Role_DisclosureSelectedQuarterlyFinancialDataTables" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSelectedQuarterlyFinancialDataTables">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" order="10090.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail">
    <loc xlink:href="dvax-20131231.xsd#dvax_PercentageOfLongLivedAssets" xlink:type="locator" xlink:label="dvax_PercentageOfLongLivedAssets" />
    <loc xlink:href="dvax-20131231.xsd#dvax_PercentageOfRevenueEarned" xlink:type="locator" xlink:label="dvax_PercentageOfRevenueEarned" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:type="locator" xlink:label="us-gaap_NumberOfOperatingSegments" />
    <loc xlink:href="http://xbrl.sec.gov/country/2013/country-2013-01-31.xsd#country_US" xlink:type="locator" xlink:label="country_US" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:type="locator" xlink:label="us-gaap_SegmentGeographicalDomain_2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:type="locator" xlink:label="us-gaap_SegmentGeographicalDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:type="locator" xlink:label="us-gaap_StatementGeographicalAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncome" xlink:type="locator" xlink:label="dvax_ReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncome" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits" />
    <loc xlink:href="dvax-20131231.xsd#dvax_NumberOfReportingUnits" xlink:type="locator" xlink:label="dvax_NumberOfReportingUnits" />
    <loc xlink:href="dvax-20131231.xsd#dvax_CashEquivalentsMaturityPeriod" xlink:type="locator" xlink:label="dvax_CashEquivalentsMaturityPeriod" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" xlink:label="us-gaap_MaximumMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" xlink:label="us-gaap_RangeMember_2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" xlink:label="us-gaap_RangeMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" xlink:label="us-gaap_RangeAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossRealized" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" />
    <loc xlink:href="dvax-20131231.xsd#dvax_RheinBiotechGmbhMember" xlink:type="locator" xlink:label="dvax_RheinBiotechGmbhMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:type="locator" xlink:label="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" />
    <loc xlink:href="dvax-20131231.xsd#dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:type="locator" xlink:label="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments" order="10090.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="10140.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_2" order="10160.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="10160.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="dvax_RheinBiotechGmbhMember" order="10180.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" order="10260.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossRealized" order="10440.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:to="us-gaap_RangeAxis" order="10630.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember_2" order="10650.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="10650.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="10670.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="dvax_CashEquivalentsMaturityPeriod" order="10730.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="dvax_NumberOfReportingUnits" order="10830.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="10930.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" order="10970.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="dvax_ReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncome" order="11070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:to="us-gaap_StatementGeographicalAxis" order="11120.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain_2" order="11140.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain" order="11140.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="country_US" order="11160.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" order="11240.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="dvax_PercentageOfRevenueEarned" order="11360.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="dvax_PercentageOfLongLivedAssets" order="11520.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureFairValueHierarchyForFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureFairValueHierarchyForFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureFairValueHierarchyForFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsFairValueDisclosureRecurring" xlink:type="locator" xlink:label="us-gaap_AssetsFairValueDisclosureRecurring" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems" xlink:type="locator" xlink:label="dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_MunicipalSecuritiesMember" xlink:type="locator" xlink:label="dvax_MunicipalSecuritiesMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_USTreasurySecuritiesMember" xlink:type="locator" xlink:label="us-gaap_USTreasurySecuritiesMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember_2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable" xlink:type="locator" xlink:label="dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="10040.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_2" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="10080.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable" xlink:to="us-gaap_InvestmentTypeAxis" order="10090.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember_2" order="10110.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="10110.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_MoneyMarketFundsMember" order="10130.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" order="10150.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USTreasurySecuritiesMember" order="10210.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="dvax_MunicipalSecuritiesMember" order="10230.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="10240.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2" order="10260.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="10260.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="10280.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="10300.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="10320.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems" xlink:to="dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable" order="10340.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable" xlink:to="dei_LegalEntityAxis" order="10350.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10360.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosureRecurring" order="10380.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfCashCashEquivalentsAndMarketableSecuritiesAvailableForSaleDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureSummaryOfCashCashEquivalentsAndMarketableSecuritiesAvailableForSaleDetail" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfCashCashEquivalentsAndMarketableSecuritiesAvailableForSaleDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecurities" />
    <loc xlink:href="dvax-20131231.xsd#dvax_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" xlink:type="locator" xlink:label="dvax_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" />
    <loc xlink:href="dvax-20131231.xsd#dvax_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" xlink:type="locator" xlink:label="dvax_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAmortizedCost" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesAmortizedCost" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_CashCashEquivalentsAndMarketableSecuritiesLineItems" xlink:type="locator" xlink:label="dvax_CashCashEquivalentsAndMarketableSecuritiesLineItems" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_USTreasurySecuritiesMember" xlink:type="locator" xlink:label="us-gaap_USTreasurySecuritiesMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_MunicipalSecuritiesMember" xlink:type="locator" xlink:label="dvax_MunicipalSecuritiesMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashMember" xlink:type="locator" xlink:label="us-gaap_CashMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableforsaleSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_AvailableforsaleSecuritiesMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsMember" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FinancialStatementLineItemsWithDifferencesInReportedAmountAndReportingCurrencyDenominatedAmountsDomain" xlink:type="locator" xlink:label="us-gaap_FinancialStatementLineItemsWithDifferencesInReportedAmountAndReportingCurrencyDenominatedAmountsDomain_2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FinancialStatementLineItemsWithDifferencesInReportedAmountAndReportingCurrencyDenominatedAmountsDomain" xlink:type="locator" xlink:label="us-gaap_FinancialStatementLineItemsWithDifferencesInReportedAmountAndReportingCurrencyDenominatedAmountsDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InformationByFinancialStatementLineItemAxis" xlink:type="locator" xlink:label="us-gaap_InformationByFinancialStatementLineItemAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_CashCashEquivalentsAndMarketableSecuritiesTable" xlink:type="locator" xlink:label="dvax_CashCashEquivalentsAndMarketableSecuritiesTable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dvax_CashCashEquivalentsAndMarketableSecuritiesTable" xlink:to="us-gaap_InformationByFinancialStatementLineItemAxis" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_InformationByFinancialStatementLineItemAxis" xlink:to="us-gaap_FinancialStatementLineItemsWithDifferencesInReportedAmountAndReportingCurrencyDenominatedAmountsDomain_2" order="10090.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_InformationByFinancialStatementLineItemAxis" xlink:to="us-gaap_FinancialStatementLineItemsWithDifferencesInReportedAmountAndReportingCurrencyDenominatedAmountsDomain" order="10090.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FinancialStatementLineItemsWithDifferencesInReportedAmountAndReportingCurrencyDenominatedAmountsDomain" xlink:to="us-gaap_CashAndCashEquivalentsMember" order="10110.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FinancialStatementLineItemsWithDifferencesInReportedAmountAndReportingCurrencyDenominatedAmountsDomain" xlink:to="us-gaap_AvailableforsaleSecuritiesMember" order="10190.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dvax_CashCashEquivalentsAndMarketableSecuritiesTable" xlink:to="us-gaap_InvestmentTypeAxis" order="10380.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="10400.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CashMember" order="10420.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_MoneyMarketFundsMember" order="10440.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" order="10460.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="dvax_MunicipalSecuritiesMember" order="10540.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USTreasurySecuritiesMember" order="10600.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dvax_CashCashEquivalentsAndMarketableSecuritiesLineItems" xlink:to="dvax_CashCashEquivalentsAndMarketableSecuritiesTable" order="10620.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dvax_CashCashEquivalentsAndMarketableSecuritiesTable" xlink:to="dei_LegalEntityAxis" order="10630.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10640.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_CashCashEquivalentsAndMarketableSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesAmortizedCost" order="10660.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_CashCashEquivalentsAndMarketableSecuritiesLineItems" xlink:to="dvax_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" order="11340.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_CashCashEquivalentsAndMarketableSecuritiesLineItems" xlink:to="dvax_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" order="11820.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_CashCashEquivalentsAndMarketableSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecurities" order="12300.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfAmortizedCostAndEstimatedFairValueOfMarketableSecuritiesAvailableForSaleDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureSummaryOfAmortizedCostAndEstimatedFairValueOfMarketableSecuritiesAvailableForSaleDetail" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfAmortizedCostAndEstimatedFairValueOfMarketableSecuritiesAvailableForSaleDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" order="10070.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="dei_LegalEntityAxis" order="10080.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10090.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" order="10110.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" order="10150.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" order="10190.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" order="10230.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" order="10350.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" order="10390.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" order="10430.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="10470.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAdditionalInformationDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureCashCashEquivalentsAndMarketableSecuritiesAdditionalInformationDetail" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAdditionalInformationDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MarketableSecuritiesRealizedGainLoss" xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesRealizedGainLoss" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_MarketableSecuritiesRealizedGainLoss" order="10090.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureComponentOfPropertyAndEquipmentDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureComponentOfPropertyAndEquipmentDetail" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureComponentOfPropertyAndEquipmentDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentOther" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentOther" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LeaseholdImprovementsGross" xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsGross" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FurnitureAndFixturesGross" xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesGross" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MachineryAndEquipmentGross" xlink:type="locator" xlink:label="us-gaap_MachineryAndEquipmentGross" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" xlink:label="us-gaap_MaximumMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:type="locator" xlink:label="us-gaap_MinimumMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" xlink:label="us-gaap_RangeMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" xlink:label="us-gaap_RangeAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_LaboratoryMember" xlink:type="locator" xlink:label="dvax_LaboratoryMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ManufacturingEquipmentMember" xlink:type="locator" xlink:label="dvax_ManufacturingEquipmentMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10040.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_2" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="dvax_ManufacturingEquipmentMember" order="10080.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="dvax_LaboratoryMember" order="10100.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" order="10120.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="10140.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="10160.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_RangeAxis" order="10170.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="10190.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" order="10210.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="10230.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="10250.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="dei_LegalEntityAxis" order="10260.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10270.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="10290.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_MachineryAndEquipmentGross" order="10900.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="10980.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_FurnitureAndFixturesGross" order="11140.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_LeaseholdImprovementsGross" order="11220.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentOther" order="11300.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="11460.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="11540.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetail" xlink:href="dvax-20131231.xsd#Role_DisclosurePropertyAndEquipmentAdditionalInformationDetail" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_DepreciationAndAmortization" order="10090.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureIntangibleAssetsAdditionalInformationDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureIntangibleAssetsAdditionalInformationDetail" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureIntangibleAssetsAdditionalInformationDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:type="locator" xlink:label="us-gaap_CustomerRelationshipsMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ManufacturingMember" xlink:type="locator" xlink:label="dvax_ManufacturingMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="10040.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="dvax_ManufacturingMember" order="10080.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_CustomerRelationshipsMember" order="10100.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" order="10120.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="dei_LegalEntityAxis" order="10130.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10140.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" order="10160.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="10300.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureComponentOfCurrentAccruedLiabilitiesDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureComponentOfCurrentAccruedLiabilitiesDetail" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureComponentOfCurrentAccruedLiabilitiesDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
    <loc xlink:href="dvax-20131231.xsd#dvax_AccruedThirdPartyResearchAndDevelopmentExpensesCurrent" xlink:type="locator" xlink:label="dvax_AccruedThirdPartyResearchAndDevelopmentExpensesCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccruedEmployeeBenefitsCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedEmployeeBenefitsCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrentAbstract" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_AccruedLiabilitiesTable" xlink:type="locator" xlink:label="dvax_AccruedLiabilitiesTable" />
    <loc xlink:href="dvax-20131231.xsd#dvax_AccruedLiabilitiesLineItems" xlink:type="locator" xlink:label="dvax_AccruedLiabilitiesLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dvax_AccruedLiabilitiesLineItems" xlink:to="dvax_AccruedLiabilitiesTable" order="10090.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dvax_AccruedLiabilitiesTable" xlink:to="dei_LegalEntityAxis" order="10100.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10110.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_AccruedLiabilitiesLineItems" xlink:to="us-gaap_AccruedLiabilitiesCurrentAbstract" order="10130.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedEmployeeBenefitsCurrent" order="10210.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="10290.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="dvax_AccruedThirdPartyResearchAndDevelopmentExpensesCurrent" order="10370.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="10450.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="10530.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSymphonyDynamoIncAdditionalInformationDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureSymphonyDynamoIncAdditionalInformationDetail" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSymphonyDynamoIncAdditionalInformationDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MalpracticeLossContingencyDiscountRate" xlink:type="locator" xlink:label="us-gaap_MalpracticeLossContingencyDiscountRate" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ReclassificationOfWarrantLiabilitiesToEquity" xlink:type="locator" xlink:label="dvax_ReclassificationOfWarrantLiabilitiesToEquity" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesFairValueAdjustment" xlink:type="locator" xlink:label="us-gaap_LiabilitiesFairValueAdjustment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" />
    <loc xlink:href="dvax-20131231.xsd#dvax_WarrantLiabilityMember" xlink:type="locator" xlink:label="dvax_WarrantLiabilityMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsDiscountRate" xlink:type="locator" xlink:label="us-gaap_FairValueInputsDiscountRate" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross" />
    <loc xlink:href="dvax-20131231.xsd#dvax_BusinessAcquisitionContingentConsiderationPercentage" xlink:type="locator" xlink:label="dvax_BusinessAcquisitionContingentConsiderationPercentage" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubordinatedBorrowingDueDate" xlink:type="locator" xlink:label="us-gaap_SubordinatedBorrowingDueDate" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherCommitment" xlink:type="locator" xlink:label="us-gaap_OtherCommitment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" />
    <loc xlink:href="dvax-20131231.xsd#dvax_WarrantsExercisablePeriod" xlink:type="locator" xlink:label="dvax_WarrantsExercisablePeriod" />
    <loc xlink:href="dvax-20131231.xsd#dvax_IssueOfWarrantsToPurchaseSharesOfCommonStock" xlink:type="locator" xlink:label="dvax_IssueOfWarrantsToPurchaseSharesOfCommonStock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" xlink:label="us-gaap_MaximumMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" xlink:label="us-gaap_RangeMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" xlink:label="us-gaap_RangeAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:type="locator" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:type="locator" xlink:label="us-gaap_EquityMethodInvestments" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" />
    <loc xlink:href="dvax-20131231.xsd#dvax_SymphonyDynamoHoldingsLlcMember" xlink:type="locator" xlink:label="dvax_SymphonyDynamoHoldingsLlcMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_SymphonyDynamoIncMember" xlink:type="locator" xlink:label="dvax_SymphonyDynamoIncMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityMethodInvesteeNameDomain" xlink:type="locator" xlink:label="us-gaap_EquityMethodInvesteeNameDomain_2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityMethodInvesteeNameDomain" xlink:type="locator" xlink:label="us-gaap_EquityMethodInvesteeNameDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="10040.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="us-gaap_EquityMethodInvesteeNameDomain_2" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="us-gaap_EquityMethodInvesteeNameDomain" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityMethodInvesteeNameDomain" xlink:to="dvax_SymphonyDynamoIncMember" order="10080.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityMethodInvesteeNameDomain" xlink:to="dvax_SymphonyDynamoHoldingsLlcMember" order="10120.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable" order="10140.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable" xlink:to="dei_LegalEntityAxis" order="10150.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10160.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="us-gaap_EquityMethodInvestments" order="10180.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent" order="10220.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable" xlink:to="us-gaap_RangeAxis" order="10310.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="10330.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="10350.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="dvax_IssueOfWarrantsToPurchaseSharesOfCommonStock" order="10410.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="dvax_WarrantsExercisablePeriod" order="10470.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" order="10530.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="us-gaap_OtherCommitment" order="10590.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" order="10890.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="10950.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="us-gaap_SubordinatedBorrowingDueDate" order="11010.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="dvax_BusinessAcquisitionContingentConsiderationPercentage" order="11070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross" order="11130.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="us-gaap_FairValueInputsDiscountRate" order="11250.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="us-gaap_RepaymentsOfNotesPayable" order="11310.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="11410.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="11580.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_2" order="11600.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="11600.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="dvax_WarrantLiabilityMember" order="11620.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="us-gaap_NonoperatingIncomeExpense" order="11770.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="us-gaap_LiabilitiesFairValueAdjustment" order="11830.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" order="11890.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="dvax_ReclassificationOfWarrantLiabilitiesToEquity" order="11950.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="12010.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="us-gaap_MalpracticeLossContingencyDiscountRate" order="12130.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="12180.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="12200.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="12220.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiability" order="12420.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureFutureMinimumPaymentsUnderNonCancelablePortionOfOperatingLeasesDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureFutureMinimumPaymentsUnderNonCancelablePortionOfOperatingLeasesDetail" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureFutureMinimumPaymentsUnderNonCancelablePortionOfOperatingLeasesDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfOperatingLeasedAssetsTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems" xlink:type="locator" xlink:label="us-gaap_OperatingLeasedAssetsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_ScheduleOfOperatingLeasedAssetsTable" order="10110.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="dei_LegalEntityAxis" order="10120.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10130.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" order="10150.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" order="10190.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" order="10230.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" order="10270.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" order="10310.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" order="10350.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" order="10390.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermPurchaseCommitmentAmount" xlink:type="locator" xlink:label="us-gaap_LongTermPurchaseCommitmentAmount" />
    <loc xlink:href="dvax-20131231.xsd#dvax_DeutscheBankSecuritiesMember" xlink:type="locator" xlink:label="dvax_DeutscheBankSecuritiesMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInSecurityDeposits" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInSecurityDeposits" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ContingencyPeriod" xlink:type="locator" xlink:label="dvax_ContingencyPeriod" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LoansAndLeasesReceivableDescription" xlink:type="locator" xlink:label="us-gaap_LoansAndLeasesReceivableDescription" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SecurityOwnedAndPledgedAsCollateralFairValue" xlink:type="locator" xlink:label="us-gaap_SecurityOwnedAndPledgedAsCollateralFairValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PledgedAssetsSeparatelyReportedSecuritiesPledgedUnderLetterOfCreditFacilitiesAtFairValue" xlink:type="locator" xlink:label="us-gaap_PledgedAssetsSeparatelyReportedSecuritiesPledgedUnderLetterOfCreditFacilitiesAtFairValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" xlink:label="us-gaap_MaximumMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:type="locator" xlink:label="us-gaap_MinimumMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" xlink:label="us-gaap_RangeMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" xlink:label="us-gaap_RangeAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ContingencyAMember" xlink:type="locator" xlink:label="dvax_ContingencyAMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ContingencyBMember" xlink:type="locator" xlink:label="dvax_ContingencyBMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:type="locator" xlink:label="us-gaap_LossContingencyNatureDomain_2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:type="locator" xlink:label="us-gaap_LossContingencyNatureDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="locator" xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_CaliforniaMember" xlink:type="locator" xlink:label="dvax_CaliforniaMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRentCredit" xlink:type="locator" xlink:label="us-gaap_DeferredRentCredit" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesRentExpenseNet" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessExitCosts1" xlink:type="locator" xlink:label="us-gaap_BusinessExitCosts1" />
    <loc xlink:href="dvax-20131231.xsd#dvax_LeaseExpirationMonthAndYear" xlink:type="locator" xlink:label="dvax_LeaseExpirationMonthAndYear" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:type="locator" xlink:label="us-gaap_LossContingenciesLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/country/2013/country-2013-01-31.xsd#country_GC" xlink:type="locator" xlink:label="country_GC" />
    <loc xlink:href="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd#stpr_CA" xlink:type="locator" xlink:label="stpr_CA" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:type="locator" xlink:label="us-gaap_SegmentGeographicalDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:type="locator" xlink:label="us-gaap_StatementGeographicalAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LossContingenciesTable" xlink:type="locator" xlink:label="us-gaap_LossContingenciesTable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_StatementGeographicalAxis" order="10040.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="stpr_CA" order="10080.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="country_GC" order="10100.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LossContingenciesTable" order="10120.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LossContingenciesTable" xlink:to="dei_LegalEntityAxis" order="10130.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10140.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="dvax_LeaseExpirationMonthAndYear" order="10160.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_BusinessExitCosts1" order="10350.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_OperatingLeasesRentExpenseNet" order="10450.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_DeferredRentCredit" order="10570.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="dvax_CaliforniaMember" order="10720.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_LossContingenciesByNatureOfContingencyAxis" order="10730.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="us-gaap_LossContingencyNatureDomain_2" order="10750.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="us-gaap_LossContingencyNatureDomain" order="10750.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingencyNatureDomain" xlink:to="dvax_ContingencyBMember" order="10770.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingencyNatureDomain" xlink:to="dvax_ContingencyAMember" order="10790.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_RangeAxis" order="10860.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="10880.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" order="10900.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="10940.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_PledgedAssetsSeparatelyReportedSecuritiesPledgedUnderLetterOfCreditFacilitiesAtFairValue" order="11000.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_SecurityOwnedAndPledgedAsCollateralFairValue" order="11180.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LoansAndLeasesReceivableDescription" order="11380.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments" order="11560.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="dvax_ContingencyPeriod" order="11760.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_IncreaseDecreaseInSecurityDeposits" order="11960.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingencyNatureDomain" xlink:to="dvax_DeutscheBankSecuritiesMember" order="12190.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LongTermPurchaseCommitmentAmount" order="12470.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetail" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:type="locator" xlink:label="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ContractTerm" xlink:type="locator" xlink:label="dvax_ContractTerm" />
    <loc xlink:href="dvax-20131231.xsd#dvax_IssTechnologyMember" xlink:type="locator" xlink:label="dvax_IssTechnologyMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_HumanPapillomaVirusMember" xlink:type="locator" xlink:label="dvax_HumanPapillomaVirusMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_HepatitisBVirusMember" xlink:type="locator" xlink:label="dvax_HepatitisBVirusMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_SkinAutoimmuneInflammationMember" xlink:type="locator" xlink:label="dvax_SkinAutoimmuneInflammationMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_RheumatoidArthritisMember" xlink:type="locator" xlink:label="dvax_RheumatoidArthritisMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_AutoimmuneDiseaseMember" xlink:type="locator" xlink:label="dvax_AutoimmuneDiseaseMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GrantsReceivable" xlink:type="locator" xlink:label="us-gaap_GrantsReceivable" />
    <loc xlink:href="dvax-20131231.xsd#dvax_NationalInstitutesOfHealthMember" xlink:type="locator" xlink:label="dvax_NationalInstitutesOfHealthMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_DifferentTypesOfCollaborationAgreementsDomain" xlink:type="locator" xlink:label="dvax_DifferentTypesOfCollaborationAgreementsDomain_2" />
    <loc xlink:href="dvax-20131231.xsd#dvax_DifferentTypesOfCollaborationAgreementsDomain" xlink:type="locator" xlink:label="dvax_DifferentTypesOfCollaborationAgreementsDomain" />
    <loc xlink:href="dvax-20131231.xsd#dvax_DifferentTypesOfCollaborationAgreementsAxis" xlink:type="locator" xlink:label="dvax_DifferentTypesOfCollaborationAgreementsAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_HepaticFibrosisAndCirrhosisMember" xlink:type="locator" xlink:label="dvax_HepaticFibrosisAndCirrhosisMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ContingentConsiderationMember" xlink:type="locator" xlink:label="dvax_ContingentConsiderationMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:type="locator" xlink:label="us-gaap_ContingentConsiderationTypeDomain_2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:type="locator" xlink:label="us-gaap_ContingentConsiderationTypeDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis" xlink:type="locator" xlink:label="us-gaap_ContingentConsiderationByTypeAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_AmendmentMember" xlink:type="locator" xlink:label="dvax_AmendmentMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ResearchCollaborationAndLicenseAgreementPeriod" xlink:type="locator" xlink:label="dvax_ResearchCollaborationAndLicenseAgreementPeriod" />
    <loc xlink:href="dvax-20131231.xsd#dvax_AstraZenecaMember" xlink:type="locator" xlink:label="dvax_AstraZenecaMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRevenue" xlink:type="locator" xlink:label="us-gaap_DeferredRevenue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleCurrentPeriodDisclosuresRevenueRecognizedAmount" xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleCurrentPeriodDisclosuresRevenueRecognizedAmount" />
    <loc xlink:href="dvax-20131231.xsd#dvax_RevenueRecognitionPeriod" xlink:type="locator" xlink:label="dvax_RevenueRecognitionPeriod" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:type="locator" xlink:label="us-gaap_MinimumMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRevenueAdditions" xlink:type="locator" xlink:label="us-gaap_DeferredRevenueAdditions" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ExpansionMember" xlink:type="locator" xlink:label="dvax_ExpansionMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SegmentDomain" xlink:type="locator" xlink:label="us-gaap_SegmentDomain_2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SegmentDomain" xlink:type="locator" xlink:label="us-gaap_SegmentDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementBusinessSegmentsAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ConditionTwoMember" xlink:type="locator" xlink:label="dvax_ConditionTwoMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_CollaborativeAgreementDomain" xlink:type="locator" xlink:label="dvax_CollaborativeAgreementDomain_2" />
    <loc xlink:href="dvax-20131231.xsd#dvax_CollaborativeAgreementDomain" xlink:type="locator" xlink:label="dvax_CollaborativeAgreementDomain" />
    <loc xlink:href="dvax-20131231.xsd#dvax_CollaborativeAgreementAxis" xlink:type="locator" xlink:label="dvax_CollaborativeAgreementAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_PotentialMilestonePaymentAmount" xlink:type="locator" xlink:label="dvax_PotentialMilestonePaymentAmount" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" xlink:label="us-gaap_MaximumMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" xlink:label="us-gaap_RangeMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" xlink:label="us-gaap_RangeAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_NumberOfProjects" xlink:type="locator" xlink:label="dvax_NumberOfProjects" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:type="locator" xlink:label="us-gaap_ProductInformationLineItems" />
    <loc xlink:href="dvax-20131231.xsd#dvax_GlaxoSmithKlineMember" xlink:type="locator" xlink:label="dvax_GlaxoSmithKlineMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfProductInformationTable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10040.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_2" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dvax_GlaxoSmithKlineMember" order="10080.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_ScheduleOfProductInformationTable" order="10100.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="dei_LegalEntityAxis" order="10110.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10120.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="dvax_NumberOfProjects" order="10140.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="us-gaap_RangeAxis" order="10260.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="10280.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="10300.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="dvax_PotentialMilestonePaymentAmount" order="10360.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="dvax_CollaborativeAgreementAxis" order="10530.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dvax_CollaborativeAgreementAxis" xlink:to="dvax_CollaborativeAgreementDomain_2" order="10550.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dvax_CollaborativeAgreementAxis" xlink:to="dvax_CollaborativeAgreementDomain" order="10550.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_CollaborativeAgreementDomain" xlink:to="dvax_ConditionTwoMember" order="10570.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" order="10770.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain_2" order="10790.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" order="10790.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="dvax_ExpansionMember" order="10810.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_DeferredRevenueAdditions" order="10870.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" order="10930.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" order="11190.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="dvax_RevenueRecognitionPeriod" order="11250.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleCurrentPeriodDisclosuresRevenueRecognizedAmount" order="11370.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_DeferredRevenue" order="11600.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dvax_AstraZenecaMember" order="11770.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="dvax_ResearchCollaborationAndLicenseAgreementPeriod" order="11830.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dvax_AmendmentMember" order="11940.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="us-gaap_ContingentConsiderationByTypeAxis" order="12100.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="us-gaap_ContingentConsiderationTypeDomain_2" order="12120.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="us-gaap_ContingentConsiderationTypeDomain" order="12120.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="dvax_ContingentConsiderationMember" order="12140.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" order="12560.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dvax_HepaticFibrosisAndCirrhosisMember" order="13090.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="dvax_DifferentTypesOfCollaborationAgreementsAxis" order="13100.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dvax_DifferentTypesOfCollaborationAgreementsAxis" xlink:to="dvax_DifferentTypesOfCollaborationAgreementsDomain_2" order="13120.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dvax_DifferentTypesOfCollaborationAgreementsAxis" xlink:to="dvax_DifferentTypesOfCollaborationAgreementsDomain" order="13120.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_DifferentTypesOfCollaborationAgreementsDomain" xlink:to="dvax_NationalInstitutesOfHealthMember" order="13140.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_GrantsReceivable" order="13200.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dvax_AutoimmuneDiseaseMember" order="13310.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dvax_RheumatoidArthritisMember" order="13530.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dvax_SkinAutoimmuneInflammationMember" order="13750.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dvax_HepatitisBVirusMember" order="13970.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dvax_HumanPapillomaVirusMember" order="14190.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dvax_IssTechnologyMember" order="14410.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="dvax_ContractTerm" order="14560.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" order="14620.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfRevenueRecognizedUnderAgreementWithGSKDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureSummaryOfRevenueRecognizedUnderAgreementWithGSKDetail" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfRevenueRecognizedUnderAgreementWithGSKDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenueFromGrants" xlink:type="locator" xlink:label="us-gaap_RevenueFromGrants" />
    <loc xlink:href="dvax-20131231.xsd#dvax_NationalInstitutesOfHealthMember" xlink:type="locator" xlink:label="dvax_NationalInstitutesOfHealthMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_DifferentTypesOfCollaborationAgreementsDomain" xlink:type="locator" xlink:label="dvax_DifferentTypesOfCollaborationAgreementsDomain" />
    <loc xlink:href="dvax-20131231.xsd#dvax_DifferentTypesOfCollaborationAgreementsAxis" xlink:type="locator" xlink:label="dvax_DifferentTypesOfCollaborationAgreementsAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_NationalInstituteOfAllergyAndInfectiousDiseasesMember" xlink:type="locator" xlink:label="dvax_NationalInstituteOfAllergyAndInfectiousDiseasesMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_AstraZenecaMember" xlink:type="locator" xlink:label="dvax_AstraZenecaMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Revenues" xlink:type="locator" xlink:label="us-gaap_Revenues" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRevenueAdditions" xlink:type="locator" xlink:label="us-gaap_DeferredRevenueAdditions" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:type="locator" xlink:label="us-gaap_ProductInformationLineItems" />
    <loc xlink:href="dvax-20131231.xsd#dvax_GlaxoSmithKlineMember" xlink:type="locator" xlink:label="dvax_GlaxoSmithKlineMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfProductInformationTable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10080.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dvax_GlaxoSmithKlineMember" order="10100.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_ScheduleOfProductInformationTable" order="10120.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="dei_LegalEntityAxis" order="10130.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10140.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_DeferredRevenueAdditions" order="10160.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" order="10280.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_Revenues" order="10360.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dvax_AstraZenecaMember" order="10550.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dvax_NationalInstituteOfAllergyAndInfectiousDiseasesMember" order="11020.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="dvax_DifferentTypesOfCollaborationAgreementsAxis" order="11030.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dvax_DifferentTypesOfCollaborationAgreementsAxis" xlink:to="dvax_DifferentTypesOfCollaborationAgreementsDomain" order="11050.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_DifferentTypesOfCollaborationAgreementsDomain" xlink:to="dvax_NationalInstitutesOfHealthMember" order="11070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_RevenueFromGrants" order="11130.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureComputationOfBasicAndDilutedEarningsPerShareDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureComputationOfBasicAndDilutedEarningsPerShareDetail" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureComputationOfBasicAndDilutedEarningsPerShareDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <loc xlink:href="dvax-20131231.xsd#dvax_AntidilutiveSecuritiesExcludedFromComputationOfEarningPerShareAbstract" xlink:type="locator" xlink:label="dvax_AntidilutiveSecuritiesExcludedFromComputationOfEarningPerShareAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WarrantMember" xlink:type="locator" xlink:label="us-gaap_WarrantMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_StockOptionsAndShareAwardsMember" xlink:type="locator" xlink:label="dvax_StockOptionsAndShareAwardsMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <loc xlink:href="dvax-20131231.xsd#dvax_EarningsPerShareBasicAndDilutedDenominatorAbstract" xlink:type="locator" xlink:label="dvax_EarningsPerShareBasicAndDilutedDenominatorAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_EarningsPerShareDisclosureTable" xlink:type="locator" xlink:label="dvax_EarningsPerShareDisclosureTable" />
    <loc xlink:href="dvax-20131231.xsd#dvax_EarningsPerShareDisclosureLineItems" xlink:type="locator" xlink:label="dvax_EarningsPerShareDisclosureLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dvax_EarningsPerShareDisclosureLineItems" xlink:to="dvax_EarningsPerShareDisclosureTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dvax_EarningsPerShareDisclosureTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_EarningsPerShareDisclosureLineItems" xlink:to="us-gaap_EarningsPerShareAbstract" order="10090.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_NetIncomeLoss" order="10210.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_PreferredStockDividendsIncomeStatementImpact" order="10270.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="10330.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_EarningsPerShareDisclosureLineItems" xlink:to="dvax_EarningsPerShareBasicAndDilutedDenominatorAbstract" order="10390.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_EarningsPerShareBasicAndDilutedDenominatorAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="10510.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_EarningsPerShareBasicAndDilutedDenominatorAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="10570.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dvax_EarningsPerShareDisclosureTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="10640.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_2" order="10660.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="10660.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="dvax_StockOptionsAndShareAwardsMember" order="10680.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" order="10700.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dvax_EarningsPerShareDisclosureTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10710.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="10730.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="10750.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_EarningsPerShareDisclosureLineItems" xlink:to="dvax_AntidilutiveSecuritiesExcludedFromComputationOfEarningPerShareAbstract" order="10810.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_AntidilutiveSecuritiesExcludedFromComputationOfEarningPerShareAbstract" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="10930.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosurePreferredStockCommonStockAndWarrantsAdditionalInformationDetail" xlink:href="dvax-20131231.xsd#Role_DisclosurePreferredStockCommonStockAndWarrantsAdditionalInformationDetail" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosurePreferredStockCommonStockAndWarrantsAdditionalInformationDetail">
    <loc xlink:href="dvax-20131231.xsd#dvax_NumberOfWarrantsExercisedDuringPeriod" xlink:type="locator" xlink:label="dvax_NumberOfWarrantsExercisedDuringPeriod" />
    <loc xlink:href="dvax-20131231.xsd#dvax_WarrantToPurchaseCommonStock" xlink:type="locator" xlink:label="dvax_WarrantToPurchaseCommonStock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesConverted1" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
    <loc xlink:href="dvax-20131231.xsd#dvax_WarrantsExercisablePeriod" xlink:type="locator" xlink:label="dvax_WarrantsExercisablePeriod" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" />
    <loc xlink:href="dvax-20131231.xsd#dvax_CommonStockIssuableUponExerciseOfWarrantsConversionRatio" xlink:type="locator" xlink:label="dvax_CommonStockIssuableUponExerciseOfWarrantsConversionRatio" />
    <loc xlink:href="dvax-20131231.xsd#dvax_NumberOfWarrantsInEachUnit" xlink:type="locator" xlink:label="dvax_NumberOfWarrantsInEachUnit" />
    <loc xlink:href="dvax-20131231.xsd#dvax_NumberOfSharesOfCommonStockInEachUnit" xlink:type="locator" xlink:label="dvax_NumberOfSharesOfCommonStockInEachUnit" />
    <loc xlink:href="dvax-20131231.xsd#dvax_SymphonyDynamoIncMember" xlink:type="locator" xlink:label="dvax_SymphonyDynamoIncMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityMethodInvesteeNameDomain" xlink:type="locator" xlink:label="us-gaap_EquityMethodInvesteeNameDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_LoanAgreementMember" xlink:type="locator" xlink:label="dvax_LoanAgreementMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain_2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" />
    <loc xlink:href="dvax-20131231.xsd#dvax_CommitmentFeePaid" xlink:type="locator" xlink:label="dvax_CommitmentFeePaid" />
    <loc xlink:href="dvax-20131231.xsd#dvax_PercentageOfCommitmentToPurchaseSharesValue" xlink:type="locator" xlink:label="dvax_PercentageOfCommitmentToPurchaseSharesValue" />
    <loc xlink:href="dvax-20131231.xsd#dvax_PurchaseAgreementPeriod" xlink:type="locator" xlink:label="dvax_PurchaseAgreementPeriod" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" />
    <loc xlink:href="dvax-20131231.xsd#dvax_AspireCapitalFundLlcMember" xlink:type="locator" xlink:label="dvax_AspireCapitalFundLlcMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
    <loc xlink:href="dvax-20131231.xsd#dvax_SellingCommissionPercentageFromGrossOfferingProceedsOfSalesOfStock" xlink:type="locator" xlink:label="dvax_SellingCommissionPercentageFromGrossOfferingProceedsOfSalesOfStock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" xlink:label="us-gaap_MaximumMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_MlvMember" xlink:type="locator" xlink:label="dvax_MlvMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_RightsExpirationDate" xlink:type="locator" xlink:label="dvax_RightsExpirationDate" />
    <loc xlink:href="dvax-20131231.xsd#dvax_PercentageOfCompanyAssets" xlink:type="locator" xlink:label="dvax_PercentageOfCompanyAssets" />
    <loc xlink:href="dvax-20131231.xsd#dvax_PercentageOfCommonSharesOutstanding" xlink:type="locator" xlink:label="dvax_PercentageOfCommonSharesOutstanding" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharePrice" xlink:type="locator" xlink:label="us-gaap_SharePrice" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DividendPayableDateToBePaidDayMonthAndYear" xlink:type="locator" xlink:label="us-gaap_DividendPayableDateToBePaidDayMonthAndYear" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:type="locator" xlink:label="us-gaap_MinimumMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" xlink:label="us-gaap_RangeMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" xlink:label="us-gaap_RangeAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_DeemedDividend" xlink:type="locator" xlink:label="dvax_DeemedDividend" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredStockSettlementTerms" xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockSettlementTerms" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredStockTermsOfConversion" xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockTermsOfConversion" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityIssuancePerShareAmount" xlink:type="locator" xlink:label="us-gaap_EquityIssuancePerShareAmount" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_PreferredStockCommonStockAndWarrantsTable" xlink:type="locator" xlink:label="dvax_PreferredStockCommonStockAndWarrantsTable" />
    <loc xlink:href="dvax-20131231.xsd#dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:type="locator" xlink:label="dvax_PreferredStockCommonStockAndWarrantsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="dvax_PreferredStockCommonStockAndWarrantsTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dvax_PreferredStockCommonStockAndWarrantsTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="10090.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="10210.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="10230.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dvax_PreferredStockCommonStockAndWarrantsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10260.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="10280.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="10300.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="10360.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="10420.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_EquityIssuancePerShareAmount" order="10480.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" order="10540.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="10600.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="10660.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" order="10830.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_ConvertiblePreferredStockTermsOfConversion" order="10890.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_ConvertiblePreferredStockSettlementTerms" order="10950.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="dvax_DeemedDividend" order="11120.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dvax_PreferredStockCommonStockAndWarrantsTable" xlink:to="us-gaap_RangeAxis" order="11170.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="11190.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" order="11210.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="11290.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_DividendPayableDateToBePaidDayMonthAndYear" order="11350.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_SharePrice" order="11470.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="dvax_PercentageOfCommonSharesOutstanding" order="11530.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="dvax_PercentageOfCompanyAssets" order="11590.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="dvax_RightsExpirationDate" order="11650.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dvax_PreferredStockCommonStockAndWarrantsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="11720.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="11740.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="11760.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="dvax_MlvMember" order="12210.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="12260.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="12320.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="dvax_SellingCommissionPercentageFromGrossOfferingProceedsOfSalesOfStock" order="12380.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" order="12720.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="dvax_AspireCapitalFundLlcMember" order="13110.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" order="13220.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="dvax_PurchaseAgreementPeriod" order="13280.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="dvax_PercentageOfCommitmentToPurchaseSharesValue" order="13340.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="dvax_CommitmentFeePaid" order="13400.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther" order="13460.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="13580.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dvax_PreferredStockCommonStockAndWarrantsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="13770.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_2" order="13790.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="13790.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="dvax_LoanAgreementMember" order="13810.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dvax_PreferredStockCommonStockAndWarrantsTable" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="13820.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="us-gaap_EquityMethodInvesteeNameDomain" order="13840.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityMethodInvesteeNameDomain" xlink:to="dvax_SymphonyDynamoIncMember" order="13860.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="dvax_NumberOfSharesOfCommonStockInEachUnit" order="14160.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="dvax_NumberOfWarrantsInEachUnit" order="14220.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="dvax_CommonStockIssuableUponExerciseOfWarrantsConversionRatio" order="14280.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" order="14340.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="dvax_WarrantsExercisablePeriod" order="14400.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="14460.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_ConversionOfStockSharesConverted1" order="14560.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="dvax_WarrantToPurchaseCommonStock" order="14680.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="dvax_NumberOfWarrantsExercisedDuringPeriod" order="14800.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureWarrantsIssuedToPurchaseCommonStockDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureWarrantsIssuedToPurchaseCommonStockDetail" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureWarrantsIssuedToPurchaseCommonStockDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" />
    <loc xlink:href="dvax-20131231.xsd#dvax_WarrantExpirationDate" xlink:type="locator" xlink:label="dvax_WarrantExpirationDate" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesConverted1" />
    <loc xlink:href="dvax-20131231.xsd#dvax_WarrantIssueDate" xlink:type="locator" xlink:label="dvax_WarrantIssueDate" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems" />
    <loc xlink:href="dvax-20131231.xsd#dvax_LoanAgreementMember" xlink:type="locator" xlink:label="dvax_LoanAgreementMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_WarrantFourMember" xlink:type="locator" xlink:label="dvax_WarrantFourMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_WarrantThreeMember" xlink:type="locator" xlink:label="dvax_WarrantThreeMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_WarrantTwoMember" xlink:type="locator" xlink:label="dvax_WarrantTwoMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_WarrantOneMember" xlink:type="locator" xlink:label="dvax_WarrantOneMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightTable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="10040.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="dvax_WarrantOneMember" order="10080.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="dvax_WarrantTwoMember" order="10100.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="dvax_WarrantThreeMember" order="10120.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="dvax_WarrantFourMember" order="10140.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10150.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10170.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="dvax_LoanAgreementMember" order="10190.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightTable" order="10290.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="dei_LegalEntityAxis" order="10300.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10310.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="dvax_WarrantIssueDate" order="10330.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ConversionOfStockSharesConverted1" order="10530.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="dvax_WarrantExpirationDate" order="10730.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" order="10930.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="11130.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureEquityPlansAndStockBasedCompensationAdditionalInformationDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureEquityPlansAndStockBasedCompensationAdditionalInformationDetail" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureEquityPlansAndStockBasedCompensationAdditionalInformationDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" />
    <loc xlink:href="dvax-20131231.xsd#dvax_PeriodTwoMember" xlink:type="locator" xlink:label="dvax_PeriodTwoMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_PeriodOneMember" xlink:type="locator" xlink:label="dvax_PeriodOneMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_PeriodDomain" xlink:type="locator" xlink:label="dvax_PeriodDomain_2" />
    <loc xlink:href="dvax-20131231.xsd#dvax_PeriodDomain" xlink:type="locator" xlink:label="dvax_PeriodDomain" />
    <loc xlink:href="dvax-20131231.xsd#dvax_PeriodAxis" xlink:type="locator" xlink:label="dvax_PeriodAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeStockMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
    <loc xlink:href="dvax-20131231.xsd#dvax_TimeBasedVestingScheduleMember" xlink:type="locator" xlink:label="dvax_TimeBasedVestingScheduleMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DefinedContributionPlanNumberOfEmployeesCovered" xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanNumberOfEmployeesCovered" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <loc xlink:href="dvax-20131231.xsd#dvax_AdditionalMember" xlink:type="locator" xlink:label="dvax_AdditionalMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_NonEmployeeAwardsMember" xlink:type="locator" xlink:label="dvax_NonEmployeeAwardsMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TypeOfDeferredCompensationDomain" xlink:type="locator" xlink:label="us-gaap_TypeOfDeferredCompensationDomain_2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TypeOfDeferredCompensationDomain" xlink:type="locator" xlink:label="us-gaap_TypeOfDeferredCompensationDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" xlink:type="locator" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndRsuOutstandingNumber" xlink:type="locator" xlink:label="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndRsuOutstandingNumber" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestrictedStockExpense" xlink:type="locator" xlink:label="us-gaap_RestrictedStockExpense" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
    <loc xlink:href="dvax-20131231.xsd#dvax_EquityIncentivePlanTwentyElevenMember" xlink:type="locator" xlink:label="dvax_EquityIncentivePlanTwentyElevenMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_EmploymentInducementAwardPlanTwentyTenMember" xlink:type="locator" xlink:label="dvax_EmploymentInducementAwardPlanTwentyTenMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" />
    <loc xlink:href="dvax-20131231.xsd#dvax_GroupTwoMember" xlink:type="locator" xlink:label="dvax_GroupTwoMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_OtherParticipantsMember" xlink:type="locator" xlink:label="dvax_OtherParticipantsMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_StockIncentivePlanTwentyZeroFourMember" xlink:type="locator" xlink:label="dvax_StockIncentivePlanTwentyZeroFourMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:type="locator" xlink:label="us-gaap_MinimumMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" xlink:label="us-gaap_MaximumMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" xlink:label="us-gaap_RangeMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" xlink:label="us-gaap_RangeAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_NumberOfShareBasedCompensationPlans" xlink:type="locator" xlink:label="dvax_NumberOfShareBasedCompensationPlans" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="dvax_NumberOfShareBasedCompensationPlans" order="10090.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_RangeAxis" order="10140.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="10160.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="10180.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" order="10220.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="10250.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_2" order="10270.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="10270.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="dvax_StockIncentivePlanTwentyZeroFourMember" order="10290.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10400.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10420.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dvax_OtherParticipantsMember" order="10440.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dvax_GroupTwoMember" order="10460.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" order="10540.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="10600.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" order="10660.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="10840.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="dvax_EmploymentInducementAwardPlanTwentyTenMember" order="11000.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="dvax_EquityIncentivePlanTwentyElevenMember" order="11250.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" order="11540.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="11780.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="11920.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" order="12100.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="12230.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="12250.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="12270.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_RestrictedStockExpense" order="12350.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" order="12410.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="12620.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" order="12720.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="12900.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndRsuOutstandingNumber" order="12980.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="13080.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" order="13130.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" xlink:to="us-gaap_TypeOfDeferredCompensationDomain_2" order="13150.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" xlink:to="us-gaap_TypeOfDeferredCompensationDomain" order="13150.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfDeferredCompensationDomain" xlink:to="dvax_NonEmployeeAwardsMember" order="13170.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfDeferredCompensationDomain" xlink:to="dvax_AdditionalMember" order="13190.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="13250.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensation" order="13330.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_DefinedContributionPlanNumberOfEmployeesCovered" order="13470.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="dvax_TimeBasedVestingScheduleMember" order="13600.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" order="13680.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="13780.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="13870.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="13890.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_EmployeeStockMember" order="13910.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="dvax_PeriodAxis" order="14120.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dvax_PeriodAxis" xlink:to="dvax_PeriodDomain_2" order="14140.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dvax_PeriodAxis" xlink:to="dvax_PeriodDomain" order="14140.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PeriodDomain" xlink:to="dvax_PeriodOneMember" order="14160.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_PeriodDomain" xlink:to="dvax_PeriodTwoMember" order="14180.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" order="14540.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="14580.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureOptionActivityUnderStockPlansDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureOptionActivityUnderStockPlansDetail" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureOptionActivityUnderStockPlansDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:type="locator" xlink:label="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:type="locator" xlink:label="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice" xlink:type="locator" xlink:label="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <loc xlink:href="dvax-20131231.xsd#dvax_VestedMember" xlink:type="locator" xlink:label="dvax_VestedMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_UnvestedMember" xlink:type="locator" xlink:label="dvax_UnvestedMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10040.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="dvax_UnvestedMember" order="10080.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="dvax_VestedMember" order="10100.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10120.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="dei_LegalEntityAxis" order="10130.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10140.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" order="10160.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="10360.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" order="10480.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="10600.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="10720.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="11080.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="11200.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" order="11450.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice" order="11650.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="11770.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="11890.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="12010.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" order="12370.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="12490.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" order="12670.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="12870.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" order="12990.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="13110.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" order="13290.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="13490.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" order="13610.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="13730.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfRestrictedStockUnitsActivityDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureSummaryOfRestrictedStockUnitsActivityDetail" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfRestrictedStockUnitsActivityDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10040.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="10080.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10100.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="dei_LegalEntityAxis" order="10110.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10120.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" order="10140.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="10260.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="10340.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="10420.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="10500.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" order="10770.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="10890.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="10970.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="11050.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="11130.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureFairValueBasedMeasurementsAndWeightedAverageAssumptionsDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureFairValueBasedMeasurementsAndWeightedAverageAssumptionsDetail" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureFairValueBasedMeasurementsAndWeightedAverageAssumptionsDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeStockMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10040.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10080.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10100.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="dei_LegalEntityAxis" order="10110.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10120.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="10140.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="10260.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="10380.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="10500.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10630.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_2" order="10650.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="10650.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_EmployeeStockMember" order="10670.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureStockBasedCompensationExpenseDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureStockBasedCompensationExpenseDetail" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureStockBasedCompensationExpenseDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" xlink:type="locator" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_NonEmployeeMember" xlink:type="locator" xlink:label="dvax_NonEmployeeMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_EmployeesAndDirectorsMember" xlink:type="locator" xlink:label="dvax_EmployeesAndDirectorsMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain_2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10040.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_2" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="dvax_EmployeesAndDirectorsMember" order="10080.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="dvax_NonEmployeeMember" order="10100.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="10120.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="10140.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" xlink:to="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTable" order="10160.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTable" xlink:to="dei_LegalEntityAxis" order="10170.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10180.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" xlink:to="us-gaap_ShareBasedCompensation" order="10200.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureComponentOfConsolidatedIncomeLossBeforeProvisionForIncomeTaxesDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureComponentOfConsolidatedIncomeLossBeforeProvisionForIncomeTaxesDetail" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureComponentOfConsolidatedIncomeLossBeforeProvisionForIncomeTaxesDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" xlink:type="locator" xlink:label="dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" xlink:type="locator" xlink:label="dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" xlink:to="dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" order="10070.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" xlink:to="dei_LegalEntityAxis" order="10080.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10090.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="10110.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="10230.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" order="10350.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureDifferenceBetweenConsolidatedIncomeTaxBenefitAndAmountComputedByFederalStatutoryIncomeTaxRateDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureDifferenceBetweenConsolidatedIncomeTaxBenefitAndAmountComputedByFederalStatutoryIncomeTaxRateDetail" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureDifferenceBetweenConsolidatedIncomeTaxBenefitAndAmountComputedByFederalStatutoryIncomeTaxRateDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationDeductionsDividends" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationDeductionsDividends" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" />
    <loc xlink:href="dvax-20131231.xsd#dvax_IncomeTaxReconciliationChangeInFairValueMeasurement" xlink:type="locator" xlink:label="dvax_IncomeTaxReconciliationChangeInFairValueMeasurement" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <loc xlink:href="dvax-20131231.xsd#dvax_IncomeTaxReconciliationDeferredCompensationCharges" xlink:type="locator" xlink:label="dvax_IncomeTaxReconciliationDeferredCompensationCharges" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCredits" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationTaxCredits" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_IncomeTaxRateReconciliationTable" xlink:type="locator" xlink:label="dvax_IncomeTaxRateReconciliationTable" />
    <loc xlink:href="dvax-20131231.xsd#dvax_IncomeTaxRateReconciliationLineItems" xlink:type="locator" xlink:label="dvax_IncomeTaxRateReconciliationLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dvax_IncomeTaxRateReconciliationLineItems" xlink:to="dvax_IncomeTaxRateReconciliationTable" order="10160.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dvax_IncomeTaxRateReconciliationTable" xlink:to="dei_LegalEntityAxis" order="10170.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10180.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_IncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="10200.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_IncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" order="10320.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_IncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_IncomeTaxReconciliationTaxCredits" order="10440.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_IncomeTaxRateReconciliationLineItems" xlink:to="dvax_IncomeTaxReconciliationDeferredCompensationCharges" order="10540.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_IncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="10660.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_IncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" order="10780.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_IncomeTaxRateReconciliationLineItems" xlink:to="dvax_IncomeTaxReconciliationChangeInFairValueMeasurement" order="10860.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_IncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" order="10940.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_IncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_IncomeTaxReconciliationDeductionsDividends" order="11020.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_IncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" order="11100.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_IncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments" order="11220.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_IncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="11340.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureComponentOfDeferredTaxAssetsAndLiabilitiesDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureComponentOfDeferredTaxAssetsAndLiabilitiesDetail" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureComponentOfDeferredTaxAssetsAndLiabilitiesDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesOther" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsGrossAbstract" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGrossAbstract" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ScheduleOfDeferredTaxAssetsAndLiabilitiesTable" xlink:type="locator" xlink:label="dvax_ScheduleOfDeferredTaxAssetsAndLiabilitiesTable" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ScheduleOfDeferredTaxAssetsAndLiabilitiesLineItems" xlink:type="locator" xlink:label="dvax_ScheduleOfDeferredTaxAssetsAndLiabilitiesLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dvax_ScheduleOfDeferredTaxAssetsAndLiabilitiesLineItems" xlink:to="dvax_ScheduleOfDeferredTaxAssetsAndLiabilitiesTable" order="10170.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dvax_ScheduleOfDeferredTaxAssetsAndLiabilitiesTable" xlink:to="dei_LegalEntityAxis" order="10180.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10190.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_ScheduleOfDeferredTaxAssetsAndLiabilitiesLineItems" xlink:to="us-gaap_DeferredTaxAssetsGrossAbstract" order="10210.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="10290.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" order="10370.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" order="10450.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="10530.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome" order="10610.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsOther" order="10690.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="10770.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="10850.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsNet" order="10930.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_ScheduleOfDeferredTaxAssetsAndLiabilitiesLineItems" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract" order="11010.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" order="11090.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesOther" order="11170.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilities" order="11250.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet" order="11330.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureIncomeTaxesAdditionalInformationDetail" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ForeignCountryMember" xlink:type="locator" xlink:label="us-gaap_ForeignCountryMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_CaliforniaStateMember" xlink:type="locator" xlink:label="dvax_CaliforniaStateMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_TaxCreditCarryforwardExpirationYear" xlink:type="locator" xlink:label="dvax_TaxCreditCarryforwardExpirationYear" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAmount" />
    <loc xlink:href="dvax-20131231.xsd#dvax_OperatingLossCarryforwardExpirationYear" xlink:type="locator" xlink:label="dvax_OperatingLossCarryforwardExpirationYear" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" xlink:label="us-gaap_MaximumMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:type="locator" xlink:label="us-gaap_MinimumMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" xlink:label="us-gaap_RangeMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" xlink:label="us-gaap_RangeAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ResearchAndDevelopmentMember" xlink:type="locator" xlink:label="dvax_ResearchAndDevelopmentMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_FederalMember" xlink:type="locator" xlink:label="dvax_FederalMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain_2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" xlink:type="locator" xlink:label="us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="locator" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_IncomeTaxDisclosureTable" xlink:type="locator" xlink:label="dvax_IncomeTaxDisclosureTable" />
    <loc xlink:href="dvax-20131231.xsd#dvax_IncomeTaxDisclosureLineItems" xlink:type="locator" xlink:label="dvax_IncomeTaxDisclosureLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dvax_IncomeTaxDisclosureLineItems" xlink:to="dvax_IncomeTaxDisclosureTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dvax_IncomeTaxDisclosureTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="10090.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" order="10210.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" order="10330.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dvax_IncomeTaxDisclosureTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="10420.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain_2" order="10440.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="10440.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="dvax_FederalMember" order="10460.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dvax_IncomeTaxDisclosureTable" xlink:to="us-gaap_TaxCreditCarryforwardAxis" order="10570.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain_2" order="10590.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain" order="10590.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="dvax_ResearchAndDevelopmentMember" order="10610.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dvax_IncomeTaxDisclosureTable" xlink:to="us-gaap_RangeAxis" order="10660.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="10680.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" order="10700.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="10720.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="10820.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_IncomeTaxDisclosureLineItems" xlink:to="dvax_OperatingLossCarryforwardExpirationYear" order="10860.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_TaxCreditCarryforwardAmount" order="10940.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_IncomeTaxDisclosureLineItems" xlink:to="dvax_TaxCreditCarryforwardExpirationYear" order="10980.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="dvax_CaliforniaStateMember" order="11110.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_ForeignCountryMember" order="11560.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSelectedQuarterlyFinancialDataDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureSelectedQuarterlyFinancialDataDetail" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSelectedQuarterlyFinancialDataDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Revenues" xlink:type="locator" xlink:label="us-gaap_Revenues" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_SelectedQuarterlyFinancialDataTable" xlink:type="locator" xlink:label="dvax_SelectedQuarterlyFinancialDataTable" />
    <loc xlink:href="dvax-20131231.xsd#dvax_SelectedQuarterlyFinancialDataLineItems" xlink:type="locator" xlink:label="dvax_SelectedQuarterlyFinancialDataLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dvax_SelectedQuarterlyFinancialDataLineItems" xlink:to="dvax_SelectedQuarterlyFinancialDataTable" order="10050.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dvax_SelectedQuarterlyFinancialDataTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_SelectedQuarterlyFinancialDataLineItems" xlink:to="us-gaap_Revenues" order="10090.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_SelectedQuarterlyFinancialDataLineItems" xlink:to="us-gaap_NetIncomeLoss" order="10250.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_SelectedQuarterlyFinancialDataLineItems" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="10410.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_SelectedQuarterlyFinancialDataLineItems" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="10570.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dvax_SelectedQuarterlyFinancialDataLineItems" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="10730.00" priority="2" use="optional" />
  </definitionLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureSubsequentEventAdditionalInformationDetail" xlink:type="simple" />
  <definitionLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:type="locator" xlink:label="us-gaap_SubsequentEventLineItems" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventMember" xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain_2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_AstraZenecaMember" xlink:type="locator" xlink:label="dvax_AstraZenecaMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTable" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10040.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10060.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dvax_AstraZenecaMember" order="10080.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="10090.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_2" order="10110.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="10110.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="10130.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventTable" order="10150.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="dei_LegalEntityAxis" order="10160.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10170.00" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" order="10190.00" priority="2" use="optional" />
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>28
<FILENAME>dvax-20131231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- RRD ActiveDisclosure(SM) XBRL Linkbase Document - http://www.financial.rrd.com/ -->
<!-- Creation Date      : 2014-03-07T19:36:08.4834606+00:00 -->
<!-- Version            : 1.7.0.24 -->
<!-- Package ID         : E885B71DE92DEB30D85162C832B40C82-0001029142-001401 -->
<!-- Copyright (c) 2014 R. R. Donnelley & Sons Company. All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <loc xlink:href="dvax-20131231.xsd#dvax_DocumentDocumentAndEntityInformationAbstract" xlink:type="locator" xlink:label="dvax_DocumentDocumentAndEntityInformationAbstract" />
    <label xml:lang="en-US" xlink:label="dvax_DocumentDocumentAndEntityInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Document Document and Entity Information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_DocumentDocumentAndEntityInformationAbstract" xlink:to="dvax_DocumentDocumentAndEntityInformationAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_DocumentDocumentAndEntityInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Document And Entity Information [Abstract]</label>
    <label xml:lang="en-US" xlink:label="dvax_DocumentDocumentAndEntityInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Document And Entity Information [Abstract]</label>
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntitiesTable" xlink:type="locator" xlink:label="dei_EntitiesTable" />
    <label xml:lang="en-US" xlink:label="dei_EntitiesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entities [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitiesTable" xlink:to="dei_EntitiesTable_lbl" />
    <label xml:lang="en-US" xlink:label="dei_EntitiesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entities [Table]</label>
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <label xml:lang="en-US" xlink:label="dei_LegalEntityAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Legal Entity [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" />
    <label xml:lang="en-US" xlink:label="dei_LegalEntityAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Legal Entity [Axis]</label>
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <label xml:lang="en-US" xlink:label="dei_EntityDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain_lbl" />
    <label xml:lang="en-US" xlink:label="dei_EntityDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity [Domain]</label>
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentInformationLineItems" xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" />
    <label xml:lang="en-US" xlink:label="dei_DocumentInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Information [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems_lbl" />
    <label xml:lang="en-US" xlink:label="dei_DocumentInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Information [Line Items]</label>
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</label>
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</label>
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</label>
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" />
    <label xml:lang="en-US" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" />
    <label xml:lang="en-US" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Year Focus</label>
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" />
    <label xml:lang="en-US" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" />
    <label xml:lang="en-US" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Period Focus</label>
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</label>
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</label>
    <label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</label>
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" />
    <label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</label>
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
    <label xml:lang="en-US" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Well-known Seasoned Issuer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" />
    <label xml:lang="en-US" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Well Known Seasoned Issuer</label>
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" />
    <label xml:lang="en-US" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" />
    <label xml:lang="en-US" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Current Reporting Status</label>
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityVoluntaryFilers" xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" />
    <label xml:lang="en-US" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Voluntary Filers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" />
    <label xml:lang="en-US" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Voluntary Filers</label>
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityFilerCategory" xlink:type="locator" xlink:label="dei_EntityFilerCategory" />
    <label xml:lang="en-US" xlink:label="dei_EntityFilerCategory_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" />
    <label xml:lang="en-US" xlink:label="dei_EntityFilerCategory_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Filer Category</label>
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" />
    <label xml:lang="en-US" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" />
    <label xml:lang="en-US" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Common Stock Shares Outstanding</label>
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityPublicFloat" xlink:type="locator" xlink:label="dei_EntityPublicFloat" />
    <label xml:lang="en-US" xlink:label="dei_EntityPublicFloat_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Public Float</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" />
    <label xml:lang="en-US" xlink:label="dei_EntityPublicFloat_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Public Float</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Financial Position [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement Of Financial Position [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <label xml:lang="en-US" xlink:label="us-gaap_StatementTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StatementTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Table]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Class Of Stock [Axis]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Stock [Domain]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series B Convertible Preferred Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockMember" xlink:to="us-gaap_ConvertiblePreferredStockMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Preferred Stock [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <label xml:lang="en-US" xlink:label="us-gaap_StatementLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StatementLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Line Items]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets Current [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents At Carrying Value</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesCurrent" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesCurrent" />
    <label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketable securities available-for-sale</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesCurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesCurrent_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Current</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
    <label xml:lang="en-US" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Receivable Net Current</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <label xml:lang="en-US" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses and other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense And Other Assets Current</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrent" xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" />
    <label xml:lang="en-US" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets Current</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Net</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Goodwill" xlink:type="locator" xlink:label="us-gaap_Goodwill" />
    <label xml:lang="en-US" xlink:label="us-gaap_Goodwill_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_Goodwill_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" />
    <label xml:lang="en-US" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash And Cash Equivalents Noncurrent</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" />
    <label xml:lang="en-US" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets Noncurrent</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Assets" xlink:type="locator" xlink:label="us-gaap_Assets" />
    <label xml:lang="en-US" xlink:label="us-gaap_Assets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_Assets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities and stockholders&#8217; equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities And Stockholders Equity [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities Current [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" />
    <label xml:lang="en-US" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable Current</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <label xml:lang="en-US" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities Current</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:type="locator" xlink:label="us-gaap_DeferredRevenueCurrent" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Revenue Current</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" />
    <label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities Current</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:type="locator" xlink:label="us-gaap_DeferredRevenueNoncurrent" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredRevenueNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenues, net of current portion</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="us-gaap_DeferredRevenueNoncurrent_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredRevenueNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Revenue Noncurrent</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" />
    <label xml:lang="en-US" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other long-term liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Liabilities Noncurrent</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Liabilities" xlink:type="locator" xlink:label="us-gaap_Liabilities" />
    <label xml:lang="en-US" xlink:label="us-gaap_Liabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_Liabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" />
    <label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and contingencies (Note 9)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders&#8217; equity:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders Equity [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockValue" xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" />
    <label xml:lang="en-US" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Value</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockValue" xlink:type="locator" xlink:label="us-gaap_CommonStockValue" />
    <label xml:lang="en-US" xlink:label="us-gaap_CommonStockValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock: $0.001 par value; 350,000 and 250,000 shares authorized at December 31, 2013 and 2012, respectively; 262,796 and 182,792 shares issued and outstanding at December 31, 2013 and 2012, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_CommonStockValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Value</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" />
    <label xml:lang="en-US" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional paid-in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid In Capital</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <label xml:lang="en-US" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total accumulated other comprehensive loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Other Comprehensive Income Loss Net Of Tax</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <label xml:lang="en-US" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings Accumulated Deficit</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total stockholders&#8217; equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders Equity</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities and stockholders&#8217; equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities And Stockholders Equity</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <label xml:lang="en-US" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, par value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Par Or Stated Value Per Share</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Shares Authorized</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" />
    <label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Shares Issued</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Shares Outstanding</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <label xml:lang="en-US" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, par value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Par Or Stated Value Per Share</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Shares Authorized</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" />
    <label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Shares Issued</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Shares Outstanding</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_UnoccupiedFacilityExpense" xlink:type="locator" xlink:label="dvax_UnoccupiedFacilityExpense" />
    <label xml:lang="en-US" xlink:label="dvax_UnoccupiedFacilityExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Unoccupied facility expense.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_UnoccupiedFacilityExpense" xlink:to="dvax_UnoccupiedFacilityExpense_lbl" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenuesAbstract" xlink:type="locator" xlink:label="us-gaap_RevenuesAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_RevenuesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenues:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_RevenuesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenues [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ContractsRevenue" xlink:type="locator" xlink:label="us-gaap_ContractsRevenue" />
    <label xml:lang="en-US" xlink:label="us-gaap_ContractsRevenue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaboration revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractsRevenue" xlink:to="us-gaap_ContractsRevenue_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ContractsRevenue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contracts Revenue</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenueFromGrants" xlink:type="locator" xlink:label="us-gaap_RevenueFromGrants" />
    <label xml:lang="en-US" xlink:label="us-gaap_RevenueFromGrants_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Grant revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromGrants" xlink:to="us-gaap_RevenueFromGrants_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_RevenueFromGrants_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenue From Grants</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LicenseAndServicesRevenue" xlink:type="locator" xlink:label="us-gaap_LicenseAndServicesRevenue" />
    <label xml:lang="en-US" xlink:label="us-gaap_LicenseAndServicesRevenue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Service and license revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LicenseAndServicesRevenue" xlink:to="us-gaap_LicenseAndServicesRevenue_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_LicenseAndServicesRevenue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">License And Services Revenue</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Revenues" xlink:type="locator" xlink:label="us-gaap_Revenues" />
    <label xml:lang="en-US" xlink:label="us-gaap_Revenues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_Revenues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenues</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:type="locator" xlink:label="us-gaap_CostsAndExpensesAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_CostsAndExpensesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating expenses:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_CostsAndExpensesAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_CostsAndExpensesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Costs And Expenses [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Expense</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
    <label xml:lang="en-US" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and administrative</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">General And Administrative Expense</label>
    <label xml:lang="en-US" xlink:label="dvax_UnoccupiedFacilityExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unoccupied facility expense</label>
    <label xml:lang="en-US" xlink:label="dvax_UnoccupiedFacilityExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unoccupied Facility Expense</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
    <label xml:lang="en-US" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization of intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amortization Of Intangible Assets</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CostsAndExpenses" xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" />
    <label xml:lang="en-US" xlink:label="us-gaap_CostsAndExpenses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_CostsAndExpenses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Costs And Expenses</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" />
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss from operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Income Loss</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other income (expense):</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Nonoperating Income Expense [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" />
    <label xml:lang="en-US" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Investment Income Interest</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestExpense" xlink:type="locator" xlink:label="us-gaap_InterestExpense" />
    <label xml:lang="en-US" xlink:label="us-gaap_InterestExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Interest expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_InterestExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Interest Expense</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
    <label xml:lang="en-US" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other income (expense)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Nonoperating Income Expense</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Income Loss</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact" />
    <label xml:lang="en-US" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Preferred stock deemed dividend</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:to="us-gaap_PreferredStockDividendsIncomeStatementImpact_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Dividends Income Statement Impact</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
    <label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss allocable to common stockholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Income Loss Available To Common Stockholders Basic</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
    <label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per share allocable to common stockholders - basic and diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share Basic And Diluted</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average shares outstanding used to compute basic and diluted net loss per share allocable to common stockholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number Of Share Outstanding Basic And Diluted</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Income And Comprehensive Income [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement Of Income And Comprehensive Income [Abstract]</label>
    <label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other comprehensive income (loss):</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income Loss Net Of Tax Period Increase Decrease [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" />
    <label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized (loss) gain on marketable securities available-for-sale</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
    <label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cumulative translation adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax" />
    <label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total other comprehensive income (loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income Loss Net Of Tax</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
    <label xml:lang="en-US" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total comprehensive loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income Net Of Tax</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue" xlink:type="locator" xlink:label="dvax_IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue" />
    <label xml:lang="en-US" xlink:label="dvax_IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance Of Common Stock Upon Exercise Of Options Vesting Of Restricted Stock Units and Vesting of Early Exercised Options Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue" xlink:to="dvax_IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue_lbl" />
    <loc xlink:href="dvax-20131231.xsd#dvax_IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsShares" xlink:type="locator" xlink:label="dvax_IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsShares" />
    <label xml:lang="en-US" xlink:label="dvax_IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance Of Common Stock Upon Exercise Of Options Vesting Of Restricted Stock Units and Vesting of Early Exercised Options Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsShares" xlink:to="dvax_IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsShares_lbl" />
    <loc xlink:href="dvax-20131231.xsd#dvax_BeneficialConversionFeatureOfSeriesBConvertiblePreferredStock" xlink:type="locator" xlink:label="dvax_BeneficialConversionFeatureOfSeriesBConvertiblePreferredStock" />
    <label xml:lang="en-US" xlink:label="dvax_BeneficialConversionFeatureOfSeriesBConvertiblePreferredStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Beneficial conversion feature of series b convertible preferred stock.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_BeneficialConversionFeatureOfSeriesBConvertiblePreferredStock" xlink:to="dvax_BeneficialConversionFeatureOfSeriesBConvertiblePreferredStock_lbl" />
    <loc xlink:href="dvax-20131231.xsd#dvax_AdjustmentsToAdditionalPaidInCapitalInitialExpensesRelatedToAtmAgreement" xlink:type="locator" xlink:label="dvax_AdjustmentsToAdditionalPaidInCapitalInitialExpensesRelatedToAtmAgreement" />
    <label xml:lang="en-US" xlink:label="dvax_AdjustmentsToAdditionalPaidInCapitalInitialExpensesRelatedToAtmAgreement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Adjustments to additional paid in capital initial expenses related to ATM agreement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_AdjustmentsToAdditionalPaidInCapitalInitialExpensesRelatedToAtmAgreement" xlink:to="dvax_AdjustmentsToAdditionalPaidInCapitalInitialExpensesRelatedToAtmAgreement_lbl" />
    <loc xlink:href="dvax-20131231.xsd#dvax_IssuanceOfCommonStockAndWarrantsValue" xlink:type="locator" xlink:label="dvax_IssuanceOfCommonStockAndWarrantsValue" />
    <label xml:lang="en-US" xlink:label="dvax_IssuanceOfCommonStockAndWarrantsValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Value of issuance of common stock and warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_IssuanceOfCommonStockAndWarrantsValue" xlink:to="dvax_IssuanceOfCommonStockAndWarrantsValue_lbl" />
    <loc xlink:href="dvax-20131231.xsd#dvax_IssuanceOfCommonStockAndWarrantsShares" xlink:type="locator" xlink:label="dvax_IssuanceOfCommonStockAndWarrantsShares" />
    <label xml:lang="en-US" xlink:label="dvax_IssuanceOfCommonStockAndWarrantsShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance Of Common Stock And Warrants, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_IssuanceOfCommonStockAndWarrantsShares" xlink:to="dvax_IssuanceOfCommonStockAndWarrantsShares_lbl" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Stockholders Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement Of Stockholders Equity [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <label xml:lang="en-US" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Components</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Equity Components [Axis]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <label xml:lang="en-US" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Component</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equity Component [Domain]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockMember" xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_PreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional Paid-in Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid In Capital [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Other Comprehensive Income (Loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Other Comprehensive Income [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings [Member]</label>
    <label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balances</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharesOutstanding" xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" />
    <label xml:lang="en-US" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balances (in shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Shares Outstanding</label>
    <label xml:lang="en-US" xlink:label="dvax_IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon exercise of stock options and restricted stock awards</label>
    <label xml:lang="en-US" xlink:label="dvax_IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Stock Upon Exercise Of Options Vesting Of Restricted Stock Units And Vesting Of Early Exercised Options Value</label>
    <label xml:lang="en-US" xlink:label="dvax_IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon exercise of stock options and restricted stock awards (In Shares)</label>
    <label xml:lang="en-US" xlink:label="dvax_IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Stock Upon Exercise Of Options Vesting Of Restricted Stock Units And Vesting Of Early Exercised Options Shares</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock under Employee Stock Purchase Plan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Employee Stock Purchase Plan</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock under Employee Stock Purchase Plan (in shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Employee Stock Purchase Plans</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Stock Award Delivered</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Share Based Compensation Gross</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Stock Award Delivered (in shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Restricted Stock Award Gross</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock, net of issuance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value New Issues</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Issuance of common stock, net of issuance costs (in shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares New Issues</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of Series B convertible preferred stock, net of issuance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Conversion Of Convertible Securities</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of Series B convertible preferred stock, net of issuance costs (in shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Conversion Of Convertible Securities</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" />
    <label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Beneficial conversion feature of Series B convertible preferred stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" xlink:to="us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Convertible Beneficial Conversion Feature</label>
    <label xml:lang="en-US" xlink:label="dvax_BeneficialConversionFeatureOfSeriesBConvertiblePreferredStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Beneficial conversion feature of Series B convertible preferred stock (in shares)</label>
    <label xml:lang="en-US" xlink:label="dvax_BeneficialConversionFeatureOfSeriesBConvertiblePreferredStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Beneficial Conversion Feature Of Series B Convertible Preferred Stock</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredDividendsNetOfTax" xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredDividendsNetOfTax" />
    <label xml:lang="en-US" xlink:label="us-gaap_ConvertiblePreferredDividendsNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deemed dividend to holders of Series B convertible preferred stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredDividendsNetOfTax" xlink:to="us-gaap_ConvertiblePreferredDividendsNetOfTax_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ConvertiblePreferredDividendsNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Preferred Dividends Net Of Tax</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockDividendsShares" xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendsShares" />
    <label xml:lang="en-US" xlink:label="us-gaap_PreferredStockDividendsShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deemed dividend to holders of Series B convertible preferred stock (in shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendsShares" xlink:to="us-gaap_PreferredStockDividendsShares_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PreferredStockDividendsShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Dividends Shares</label>
    <label xml:lang="en-US" xlink:label="dvax_AdjustmentsToAdditionalPaidInCapitalInitialExpensesRelatedToAtmAgreement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Initial expenses related to ATM agreement</label>
    <label xml:lang="en-US" xlink:label="dvax_AdjustmentsToAdditionalPaidInCapitalInitialExpensesRelatedToAtmAgreement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Additional Paid In Capital Initial Expenses Related To Atm Agreement</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Stock Options Exercised</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" />
    <label xml:lang="en-US" xlink:label="us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants exercised (in shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" xlink:to="us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Conversion Converted Instrument Warrants Or Options Issued1</label>
    <label xml:lang="en-US" xlink:label="dvax_IssuanceOfCommonStockAndWarrantsValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuances of common stock and warrants, net of issuance costs</label>
    <label xml:lang="en-US" xlink:label="dvax_IssuanceOfCommonStockAndWarrantsValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Stock And Warrants Value</label>
    <label xml:lang="en-US" xlink:label="dvax_IssuanceOfCommonStockAndWarrantsShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuances of common stock and warrants, net of issuance costs (in shares)</label>
    <label xml:lang="en-US" xlink:label="dvax_IssuanceOfCommonStockAndWarrantsShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Stock And Warrants Shares</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock compensation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value</label>
    <label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total other comprehensive income (loss)</label>
    <label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balances</label>
    <label xml:lang="en-US" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balances (in shares)</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted stock award delivered</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Restricted Stock Award Gross</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" />
    <label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Initial expenses related to ATM agreement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Additional Paid In Capital Stock Issued Issuance Costs</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities" xlink:type="locator" xlink:label="dvax_IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities" />
    <label xml:lang="en-US" xlink:label="dvax_IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase (Decrease) In other assets and restricted cash or funds that are not available for withdrawal or use (such as funds held in escrow) and are associated with underlying transactions that are classified as operating activities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities" xlink:to="dvax_IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities_lbl" />
    <loc xlink:href="dvax-20131231.xsd#dvax_SupplementalDisposalOfAssets" xlink:type="locator" xlink:label="dvax_SupplementalDisposalOfAssets" />
    <label xml:lang="en-US" xlink:label="dvax_SupplementalDisposalOfAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Disposal of fully depreciated assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_SupplementalDisposalOfAssets" xlink:to="dvax_SupplementalDisposalOfAssets_lbl" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Cash Flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement Of Cash Flows [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Operating Activities [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustments to reconcile net loss to net cash used in operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" />
    <label xml:lang="en-US" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation and amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation And Amortization</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" />
    <label xml:lang="en-US" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Loss (gain) on disposal of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Gain Loss On Sale Of Property Plant Equipment</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="locator" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" />
    <label xml:lang="en-US" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accretion of discounts and amortization of premiums of marketable securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accretion Amortization Of Discounts And Premiums Investments</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCosts" />
    <label xml:lang="en-US" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest associated with long-term note payable to Symphony Dynamo Holdings LLC (&#8220;Holdings)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCosts" xlink:to="us-gaap_AmortizationOfFinancingCosts_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amortization Of Financing Costs</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:type="locator" xlink:label="us-gaap_OtherNoncashIncomeExpense" />
    <label xml:lang="en-US" xlink:label="us-gaap_OtherNoncashIncomeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Fair value adjustment of the warrant and contingent liabilities to Holdings, including the impact of the anti-dilution provision associated with the common stock and warrants issued to Symphony Capital Partners, L.P. and Symphony Strategic Partners, LLC (collectively, "Symphony")</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncashIncomeExpense" xlink:to="us-gaap_OtherNoncashIncomeExpense_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_OtherNoncashIncomeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Noncash Income Expense</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessExitCosts1" xlink:type="locator" xlink:label="us-gaap_BusinessExitCosts1" />
    <label xml:lang="en-US" xlink:label="us-gaap_BusinessExitCosts1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unoccupied facility expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessExitCosts1" xlink:to="us-gaap_BusinessExitCosts1_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_BusinessExitCosts1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Exit Costs1</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock compensation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in operating assets and liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Operating Capital [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accounts receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Accounts Receivable</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Prepaid expenses and other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Other Current Assets</label>
    <label xml:lang="en-US" xlink:label="dvax_IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Restricted cash and other assets</label>
    <label xml:lang="en-US" xlink:label="dvax_IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Restricted Cash And Other Assets For Operating Activities</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Accounts Payable</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued liabilities and other long term liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Other Operating Liabilities</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Deferred Revenue</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Operating Activities</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Investing Activities [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities" />
    <label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of marketable securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments To Acquire Marketable Securities</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" />
    <label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from maturities of marketable securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Sale And Maturity Of Available For Sale Securities</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of property and equipment, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments To Acquire Property Plant And Equipment</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Investing Activities</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Financing Activities [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuances of common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Of Common Stock</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
    <label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuances of preferred stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Of Preferred Stock And Preference Stock</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" />
    <label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuances of warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Of Warrants</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
    <label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from exercise of stock options and restricted stock awards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Stock Options Exercised</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromStockPlans" xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockPlans" />
    <label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromStockPlans_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from employee stock purchase plan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockPlans" xlink:to="us-gaap_ProceedsFromStockPlans_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromStockPlans_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Stock Plans</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
    <label xml:lang="en-US" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Payment of notes payable to Holdings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Repayments Of Notes Payable</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Financing Activities</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" />
    <label xml:lang="en-US" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Effect of exchange rate changes on cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:to="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Effect Of Exchange Rate On Cash And Cash Equivalents</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
    <label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net increase (decrease) in cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents Period Increase Decrease</label>
    <label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash and cash equivalents at beginning of year</label>
    <label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash and cash equivalents at end of year</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental disclosure of cash flow information</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Cash Flow Information [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-cash investing and financing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Flow Noncash Investing And Financing Activities Disclosure [Abstract]</label>
    <label xml:lang="en-US" xlink:label="dvax_SupplementalDisposalOfAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Disposal of fully depreciated property and equipment</label>
    <label xml:lang="en-US" xlink:label="dvax_SupplementalDisposalOfAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Disposal Of Assets</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesUnrealizedGainLoss" />
    <label xml:lang="en-US" xlink:label="us-gaap_MarketableSecuritiesUnrealizedGainLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net change in unrealized (loss) gain on marketable securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:to="us-gaap_MarketableSecuritiesUnrealizedGainLoss_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_MarketableSecuritiesUnrealizedGainLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities Unrealized Gain Loss</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_TextBlockAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Text Block [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_TextBlockAbstract_lbl" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Organization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Organization Consolidation And Presentation Of Financial Statements Disclosure [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Significant Accounting Policies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Significant Accounting Policies [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash, Cash Equivalents and Marketable Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:to="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Cash Equivalents And Marketable Securities [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Disclosure [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Intangible Assets Disclosure [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:type="locator" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Accrued Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable Accrued Liabilities And Other Liabilities Disclosure Current [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinorityInterestDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_MinorityInterestDisclosureTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_MinorityInterestDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Symphony Dynamo, Inc.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDisclosureTextBlock" xlink:to="us-gaap_MinorityInterestDisclosureTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_MinorityInterestDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Minority Interest Disclosure [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and Contingencies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies Disclosure [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Research, Development and License Agreements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement Disclosure [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Loss Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred Stock, Common Stock and Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders Equity Note Disclosure [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Plans and Stock-Based Compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure Of Compensation Related Costs Share Based Payments [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee Benefit Plan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pension And Other Postretirement Benefits Disclosure [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock" xlink:type="locator" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Selected Quarterly Financial Data</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_QuarterlyFinancialInformationTextBlock" xlink:to="us-gaap_QuarterlyFinancialInformationTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Quarterly Financial Information [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Events</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basis of Presentation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Basis Of Accounting Policy Policy [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiquidityDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_LiquidityDisclosureTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_LiquidityDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liquidity and Financial Condition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiquidityDisclosureTextBlock" xlink:to="us-gaap_LiquidityDisclosureTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_LiquidityDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liquidity Disclosure [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_UseOfEstimates" xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" />
    <label xml:lang="en-US" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Use of Estimates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Use Of Estimates</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign Currency Translation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Foreign Currency Transactions And Translations Policy [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash, Cash Equivalents, and Marketable Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Investment Policy [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
    <label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration of Credit Risk and Other Risks and Uncertainties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Credit Risk</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Policy [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" />
    <label xml:lang="en-US" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill And Intangible Assets Goodwill Policy</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue Recognition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenue Recognition Policy [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
    <label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Expenses and Accruals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Expense Policy</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Option And Incentive Plans Policy</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Policy [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recent Accounting Pronouncements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncements Policy Policy [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy For Financial Assets And Liabilities Measured At Fair Value On Recurring Basis</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Cash, Cash Equivalents and Marketable Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:to="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Cash Cash Equivalents And Short Term Investments Table [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesTextBlock" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maturities of Marketable Securities Available-for-Sale</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesTextBlock" xlink:to="us-gaap_AvailableForSaleSecuritiesTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Component of Property and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Component of Current Accrued Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Accrued Liabilities Table [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Future Minimum Payments Under Non-Cancelable Portion of Operating Leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Future Minimum Rental Payments For Operating Leases Table [Text Block]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_AgreementWithGskMember" xlink:type="locator" xlink:label="dvax_AgreementWithGskMember" />
    <label xml:lang="en-US" xlink:label="dvax_AgreementWithGskMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Agreement With Gsk [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_AgreementWithGskMember" xlink:to="dvax_AgreementWithGskMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_AgreementWithGskMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Agreement With Gsk</label>
    <label xml:lang="en-US" xlink:label="dvax_AgreementWithGskMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Agreement With Gsk [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenueRecognitionMultipleDeliverableArrangementsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionMultipleDeliverableArrangementsTableTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_RevenueRecognitionMultipleDeliverableArrangementsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Revenues Recognized by Major Customer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionMultipleDeliverableArrangementsTableTextBlock" xlink:to="us-gaap_RevenueRecognitionMultipleDeliverableArrangementsTableTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_RevenueRecognitionMultipleDeliverableArrangementsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenue Recognition Multiple Deliverable Arrangements Table [Text Block]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_AstraZenecaMember" xlink:type="locator" xlink:label="dvax_AstraZenecaMember" />
    <label xml:lang="en-US" xlink:label="dvax_AstraZenecaMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Astra Zeneca [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_AstraZenecaMember" xlink:to="dvax_AstraZenecaMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_AstraZenecaMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Astra Zeneca</label>
    <label xml:lang="en-US" xlink:label="dvax_AstraZenecaMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Astra Zeneca [Member]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_NationalInstitutesOfHealthMember" xlink:type="locator" xlink:label="dvax_NationalInstitutesOfHealthMember" />
    <label xml:lang="en-US" xlink:label="dvax_NationalInstitutesOfHealthMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">National Institutes of Health [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_NationalInstitutesOfHealthMember" xlink:to="dvax_NationalInstitutesOfHealthMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_NationalInstitutesOfHealthMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">National Institutes of Health</label>
    <label xml:lang="en-US" xlink:label="dvax_NationalInstitutesOfHealthMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">National Institutes Of Health [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Computation of Basic and Diluted Earnings Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Earnings Per Share Basic And Diluted Table [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants Issued to Purchase Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Stockholders Equity Note Warrants Or Rights [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Option Activity under Stock-Based Compensation Plans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Table [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Restricted Stock Units Activity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Compensation Restricted Stock Units Award Activity Table [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value-Based Measurements and Weighted-Average Assumptions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Compensation Cost For Share Based Payment Arrangements Allocation Of Share Based Compensation Costs By Plan Table [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Component of Consolidated Income (Loss) Before Provision for Income Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Income Before Income Tax Domestic And Foreign Table [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Difference Between Consolidated Income Tax Benefit and Amount Computed by Federal Statutory Income Tax Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Effective Income Tax Rate Reconciliation Table [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Component of Deferred Tax Assets and Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Deferred Tax Assets And Liabilities Table [Text Block]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Selected Quarterly Financial Data</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:to="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Quarterly Financial Information Table [Text Block]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationAbstract" xlink:type="locator" xlink:label="dvax_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationAbstract" />
    <label xml:lang="en-US" xlink:label="dvax_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure Summary Of Significant Accounting Policies Additional Information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationAbstract" xlink:to="dvax_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure Summary Of Significant Accounting Policies Additional Information [Abstract]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:type="locator" xlink:label="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" />
    <label xml:lang="en-US" xlink:label="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Disclosure Summary Of Significant Accounting Policies Additional Information [Abstract]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:type="locator" xlink:label="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" />
    <label xml:lang="en-US" xlink:label="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Organization, Consolidation and Presentation of Financial Statements Disclosure [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:to="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Organization Consolidation And Presentation Of Financial Statements Disclosure [Table]</label>
    <label xml:lang="en-US" xlink:label="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Organization Consolidation And Presentation Of Financial Statements Disclosure [Table]</label>
    <label xml:lang="en-US" xlink:label="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]</label>
    <label xml:lang="en-US" xlink:label="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments" />
    <label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash, cash equivalents and marketable securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Cash Equivalents And Short Term Investments</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" />
    <label xml:lang="en-US" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business Acquisition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition [Axis]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" />
    <label xml:lang="en-US" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business Acquisition, Acquiree</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition Acquiree [Domain]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_RheinBiotechGmbhMember" xlink:type="locator" xlink:label="dvax_RheinBiotechGmbhMember" />
    <label xml:lang="en-US" xlink:label="dvax_RheinBiotechGmbhMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Rhein Biotech Gmbh [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_RheinBiotechGmbhMember" xlink:to="dvax_RheinBiotechGmbhMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_RheinBiotechGmbhMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Rhein</label>
    <label xml:lang="en-US" xlink:label="dvax_RheinBiotechGmbhMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Rhein Biotech Gmbh [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" />
    <label xml:lang="en-US" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Currency translation adjustments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossRealized" />
    <label xml:lang="en-US" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossRealized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Currency transaction gain (loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossRealized_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossRealized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Foreign Currency Transaction Gain Loss Realized</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_CashEquivalentsMaturityPeriod" xlink:type="locator" xlink:label="dvax_CashEquivalentsMaturityPeriod" />
    <label xml:lang="en-US" xlink:label="dvax_CashEquivalentsMaturityPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Cash Equivalents, Maturity Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_CashEquivalentsMaturityPeriod" xlink:to="dvax_CashEquivalentsMaturityPeriod_lbl" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" xlink:label="us-gaap_RangeAxis" />
    <label xml:lang="en-US" xlink:label="us-gaap_RangeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Range</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeAxis_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_RangeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Range [Axis]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" xlink:label="us-gaap_RangeMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_RangeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Range</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_RangeMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_RangeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Range [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" xlink:label="us-gaap_MaximumMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_MaximumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MaximumMember" xlink:to="us-gaap_MaximumMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_MaximumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Maximum [Member]</label>
    <label xml:lang="en-US" xlink:label="dvax_CashEquivalentsMaturityPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash equivalents original maturity period</label>
    <label xml:lang="en-US" xlink:label="dvax_CashEquivalentsMaturityPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Equivalents Maturity Period</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_NumberOfReportingUnits" xlink:type="locator" xlink:label="dvax_NumberOfReportingUnits" />
    <label xml:lang="en-US" xlink:label="dvax_NumberOfReportingUnits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Number Of Reporting Units</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_NumberOfReportingUnits" xlink:to="dvax_NumberOfReportingUnits_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_NumberOfReportingUnits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of reporting units</label>
    <label xml:lang="en-US" xlink:label="dvax_NumberOfReportingUnits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Reporting Units</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits" />
    <label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized tax benefits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
    <label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized tax benefits, accrued amounts for interest and penalties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_ReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncome" xlink:type="locator" xlink:label="dvax_ReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncome" />
    <label xml:lang="en-US" xlink:label="dvax_ReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncome_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Reclassification Adjustments from Accumulated Other Comprehensive Income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_ReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncome" xlink:to="dvax_ReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncome_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_ReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncome_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amount reclassified out of accumulated other comprehensive (loss) income</label>
    <label xml:lang="en-US" xlink:label="dvax_ReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncome_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Reclassification Adjustments From Accumulated Other Comprehensive Income</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_PercentageOfRevenueEarned" xlink:type="locator" xlink:label="dvax_PercentageOfRevenueEarned" />
    <label xml:lang="en-US" xlink:label="dvax_PercentageOfRevenueEarned_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of revenue earned.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_PercentageOfRevenueEarned" xlink:to="dvax_PercentageOfRevenueEarned_lbl" />
    <loc xlink:href="dvax-20131231.xsd#dvax_PercentageOfLongLivedAssets" xlink:type="locator" xlink:label="dvax_PercentageOfLongLivedAssets" />
    <label xml:lang="en-US" xlink:label="dvax_PercentageOfLongLivedAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of Long Lived Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_PercentageOfLongLivedAssets" xlink:to="dvax_PercentageOfLongLivedAssets_lbl" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:type="locator" xlink:label="us-gaap_StatementGeographicalAxis" />
    <label xml:lang="en-US" xlink:label="us-gaap_StatementGeographicalAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Geographical</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_StatementGeographicalAxis_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StatementGeographicalAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Geographical [Axis]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:type="locator" xlink:label="us-gaap_SegmentGeographicalDomain" />
    <label xml:lang="en-US" xlink:label="us-gaap_SegmentGeographicalDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Geographical</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="us-gaap_SegmentGeographicalDomain_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SegmentGeographicalDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Segment Geographical [Domain]</label>
    <loc xlink:href="http://xbrl.sec.gov/country/2013/country-2013-01-31.xsd#country_US" xlink:type="locator" xlink:label="country_US" />
    <label xml:lang="en-US" xlink:label="country_US_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">United States</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl" />
    <label xml:lang="en-US" xlink:label="country_US_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">U S</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:type="locator" xlink:label="us-gaap_NumberOfOperatingSegments" />
    <label xml:lang="en-US" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Operating Segment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Operating Segments</label>
    <label xml:lang="en-US" xlink:label="dvax_PercentageOfRevenueEarned_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of revenue earned</label>
    <label xml:lang="en-US" xlink:label="dvax_PercentageOfRevenueEarned_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Revenue Earned</label>
    <label xml:lang="en-US" xlink:label="dvax_PercentageOfLongLivedAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of long lived assets</label>
    <label xml:lang="en-US" xlink:label="dvax_PercentageOfLongLivedAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Long Lived Assets</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl" />
    <loc xlink:href="dvax-20131231.xsd#dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems" xlink:type="locator" xlink:label="dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems" />
    <label xml:lang="en-US" xlink:label="dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems" xlink:to="dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Disclosures [Abstract]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable" xlink:type="locator" xlink:label="dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable" />
    <label xml:lang="en-US" xlink:label="dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Fair Value, Assets and Liabilities Measured on Recurring Basis [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable" xlink:to="dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Assets And Liabilities Measured On Recurring Basis [Table]</label>
    <label xml:lang="en-US" xlink:label="dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Assets And Liabilities Measured On Recurring Basis [Table]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
    <label xml:lang="en-US" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Frequency</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value By Measurement Frequency [Axis]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" />
    <label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value, Measurement Frequency</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurement Frequency [Domain]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value, Measurements, Recurring</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurements Recurring [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" />
    <label xml:lang="en-US" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeAxis_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Investment Type [Axis]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_InvestmentTypeCategorizationMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Investment Type Categorization [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Money market funds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Money Market Funds [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">US Government Agencies Debt Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">U S Government Agencies Debt Securities [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_USTreasurySecuritiesMember" xlink:type="locator" xlink:label="us-gaap_USTreasurySecuritiesMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">US Treasury Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USTreasurySecuritiesMember" xlink:to="us-gaap_USTreasurySecuritiesMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">U S Treasury Securities [Member]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_MunicipalSecuritiesMember" xlink:type="locator" xlink:label="dvax_MunicipalSecuritiesMember" />
    <label xml:lang="en-US" xlink:label="dvax_MunicipalSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Municipal Securities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_MunicipalSecuritiesMember" xlink:to="dvax_MunicipalSecuritiesMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_MunicipalSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Municipal Securities</label>
    <label xml:lang="en-US" xlink:label="dvax_MunicipalSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Municipal Securities [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <label xml:lang="en-US" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value, Hierarchy</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value By Fair Value Hierarchy Level [Axis]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurements Fair Value Hierarchy [Domain]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" />
    <label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value, Inputs, Level 1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Inputs Level1 [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" />
    <label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value, Inputs, Level 2</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Inputs Level2 [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" />
    <label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value, Inputs, Level 3</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Inputs Level3 [Member]</label>
    <label xml:lang="en-US" xlink:label="dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]</label>
    <label xml:lang="en-US" xlink:label="dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsFairValueDisclosureRecurring" xlink:type="locator" xlink:label="us-gaap_AssetsFairValueDisclosureRecurring" />
    <label xml:lang="en-US" xlink:label="us-gaap_AssetsFairValueDisclosureRecurring_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosureRecurring" xlink:to="us-gaap_AssetsFairValueDisclosureRecurring_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AssetsFairValueDisclosureRecurring_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets Fair Value Disclosure Recurring</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" xlink:type="locator" xlink:label="dvax_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" />
    <label xml:lang="en-US" xlink:label="dvax_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Amount of accumulated pre-tax unrealized gain before deducting pre-tax unrealized losses on investments in available-for-sale securities impacting investments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" xlink:to="dvax_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments_lbl" />
    <loc xlink:href="dvax-20131231.xsd#dvax_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" xlink:type="locator" xlink:label="dvax_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" />
    <label xml:lang="en-US" xlink:label="dvax_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Amount of accumulated pre-tax unrealized loss before deducting pre-tax unrealized gain on investments in available-for-sale securities impacting investments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" xlink:to="dvax_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments_lbl" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="locator" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Investments Debt And Equity Securities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" />
    <loc xlink:href="dvax-20131231.xsd#dvax_CashCashEquivalentsAndMarketableSecuritiesLineItems" xlink:type="locator" xlink:label="dvax_CashCashEquivalentsAndMarketableSecuritiesLineItems" />
    <label xml:lang="en-US" xlink:label="dvax_CashCashEquivalentsAndMarketableSecuritiesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Cash, cash equivalents and marketable securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_CashCashEquivalentsAndMarketableSecuritiesLineItems" xlink:to="dvax_CashCashEquivalentsAndMarketableSecuritiesLineItems_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments Debt And Equity Securities [Abstract]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_CashCashEquivalentsAndMarketableSecuritiesTable" xlink:type="locator" xlink:label="dvax_CashCashEquivalentsAndMarketableSecuritiesTable" />
    <label xml:lang="en-US" xlink:label="dvax_CashCashEquivalentsAndMarketableSecuritiesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Cash, cash equivalents and marketable securities [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_CashCashEquivalentsAndMarketableSecuritiesTable" xlink:to="dvax_CashCashEquivalentsAndMarketableSecuritiesTable_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_CashCashEquivalentsAndMarketableSecuritiesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash Cash Equivalents And Marketable Securities [Table]</label>
    <label xml:lang="en-US" xlink:label="dvax_CashCashEquivalentsAndMarketableSecuritiesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Cash Equivalents And Marketable Securities [Table]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InformationByFinancialStatementLineItemAxis" xlink:type="locator" xlink:label="us-gaap_InformationByFinancialStatementLineItemAxis" />
    <label xml:lang="en-US" xlink:label="us-gaap_InformationByFinancialStatementLineItemAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Information by Financial Statement Line Item</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InformationByFinancialStatementLineItemAxis" xlink:to="us-gaap_InformationByFinancialStatementLineItemAxis_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_InformationByFinancialStatementLineItemAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Information By Financial Statement Line Item [Axis]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FinancialStatementLineItemsWithDifferencesInReportedAmountAndReportingCurrencyDenominatedAmountsDomain" xlink:type="locator" xlink:label="us-gaap_FinancialStatementLineItemsWithDifferencesInReportedAmountAndReportingCurrencyDenominatedAmountsDomain" />
    <label xml:lang="en-US" xlink:label="us-gaap_FinancialStatementLineItemsWithDifferencesInReportedAmountAndReportingCurrencyDenominatedAmountsDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financial Statement Line Items with Differences in Reported Amount and Reporting Currency Denominated Amounts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialStatementLineItemsWithDifferencesInReportedAmountAndReportingCurrencyDenominatedAmountsDomain" xlink:to="us-gaap_FinancialStatementLineItemsWithDifferencesInReportedAmountAndReportingCurrencyDenominatedAmountsDomain_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_FinancialStatementLineItemsWithDifferencesInReportedAmountAndReportingCurrencyDenominatedAmountsDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Financial Statement Line Items With Differences In Reported Amount And Reporting Currency Denominated Amounts [Domain]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsMember" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and Cash Equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsMember" xlink:to="us-gaap_CashAndCashEquivalentsMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableforsaleSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_AvailableforsaleSecuritiesMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_AvailableforsaleSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Available-for-sale Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableforsaleSecuritiesMember" xlink:to="us-gaap_AvailableforsaleSecuritiesMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AvailableforsaleSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Availableforsale Securities [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashMember" xlink:type="locator" xlink:label="us-gaap_CashMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_CashMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashMember" xlink:to="us-gaap_CashMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_CashMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash [Member]</label>
    <label xml:lang="en-US" xlink:label="dvax_CashCashEquivalentsAndMarketableSecuritiesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash Cash Equivalents And Marketable Securities [Line Items]</label>
    <label xml:lang="en-US" xlink:label="dvax_CashCashEquivalentsAndMarketableSecuritiesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Cash Equivalents And Marketable Securities [Line Items]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAmortizedCost" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesAmortizedCost" />
    <label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesAmortizedCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortized Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesAmortizedCost" xlink:to="us-gaap_AvailableForSaleSecuritiesAmortizedCost_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesAmortizedCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Amortized Cost</label>
    <label xml:lang="en-US" xlink:label="dvax_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized Gains</label>
    <label xml:lang="en-US" xlink:label="dvax_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Gross Unrealized Gain Accumulated In Investments</label>
    <label xml:lang="en-US" xlink:label="dvax_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Unrealized Losses</label>
    <label xml:lang="en-US" xlink:label="dvax_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Gross Unrealized Loss Accumulated In Investments</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecurities" />
    <label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Estimated Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecurities" xlink:to="us-gaap_AvailableForSaleSecurities_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Available For Sale Securities [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Available For Sale Securities [Table]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Available For Sale Securities [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Available For Sale Securities [Line Items]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortized Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Maturities Amortized Cost [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" />
    <label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Mature in one year or less</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Maturities Within One Year Amortized Cost</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" />
    <label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Mature after one year through two years</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" />
    <label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total amortized cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Maturities Amortized Cost</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Maturities Fair Value [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" />
    <label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Mature in one year or less</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Maturities Within One Year Fair Value</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" />
    <label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Mature after one year through two years</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Maturities After One Through Five Years Fair Value</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
    <label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total estimated fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Securities</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_DisclosureAvailableforsaleSecuritiesAdditionalInformationAbstract" xlink:type="locator" xlink:label="dvax_DisclosureAvailableforsaleSecuritiesAdditionalInformationAbstract" />
    <label xml:lang="en-US" xlink:label="dvax_DisclosureAvailableforsaleSecuritiesAdditionalInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure Availableforsale Securities Additional Information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_DisclosureAvailableforsaleSecuritiesAdditionalInformationAbstract" xlink:to="dvax_DisclosureAvailableforsaleSecuritiesAdditionalInformationAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_DisclosureAvailableforsaleSecuritiesAdditionalInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure Availableforsale Securities Additional Information [Abstract]</label>
    <label xml:lang="en-US" xlink:label="dvax_DisclosureAvailableforsaleSecuritiesAdditionalInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Disclosure Availableforsale Securities Additional Information [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MarketableSecuritiesRealizedGainLoss" xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesRealizedGainLoss" />
    <label xml:lang="en-US" xlink:label="us-gaap_MarketableSecuritiesRealizedGainLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Realized gains or losses from the sale of marketable securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesRealizedGainLoss" xlink:to="us-gaap_MarketableSecuritiesRealizedGainLoss_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_MarketableSecuritiesRealizedGainLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities Realized Gain Loss</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_DisclosureComponentOfPropertyAndEquipmentAbstract" xlink:type="locator" xlink:label="dvax_DisclosureComponentOfPropertyAndEquipmentAbstract" />
    <label xml:lang="en-US" xlink:label="dvax_DisclosureComponentOfPropertyAndEquipmentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure - Component of Property and Equipment [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_DisclosureComponentOfPropertyAndEquipmentAbstract" xlink:to="dvax_DisclosureComponentOfPropertyAndEquipmentAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_DisclosureComponentOfPropertyAndEquipmentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure Component Of Property And Equipment [Abstract]</label>
    <label xml:lang="en-US" xlink:label="dvax_DisclosureComponentOfPropertyAndEquipmentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Disclosure Component Of Property And Equipment [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Property Plant And Equipment [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Property Plant And Equipment [Table]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property, Plant and Equipment, Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment By Type [Axis]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property, Plant and Equipment, Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Type [Domain]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_ManufacturingEquipmentMember" xlink:type="locator" xlink:label="dvax_ManufacturingEquipmentMember" />
    <label xml:lang="en-US" xlink:label="dvax_ManufacturingEquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Manufacturing Equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_ManufacturingEquipmentMember" xlink:to="dvax_ManufacturingEquipmentMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_ManufacturingEquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Manufacturing Equipment</label>
    <label xml:lang="en-US" xlink:label="dvax_ManufacturingEquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Manufacturing Equipment [Member]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_LaboratoryMember" xlink:type="locator" xlink:label="dvax_LaboratoryMember" />
    <label xml:lang="en-US" xlink:label="dvax_LaboratoryMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Laboratory [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_LaboratoryMember" xlink:to="dvax_LaboratoryMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_LaboratoryMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lab Equipment</label>
    <label xml:lang="en-US" xlink:label="dvax_LaboratoryMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Laboratory [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Computer Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Computer Equipment [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Furniture and Fixtures</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Furniture And Fixtures [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leasehold Improvements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Leasehold Improvements [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:type="locator" xlink:label="us-gaap_MinimumMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_MinimumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinimumMember" xlink:to="us-gaap_MinimumMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_MinimumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Minimum [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property Plant And Equipment [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment [Line Items]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated Useful Lives (In years)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Useful Life</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MachineryAndEquipmentGross" xlink:type="locator" xlink:label="us-gaap_MachineryAndEquipmentGross" />
    <label xml:lang="en-US" xlink:label="us-gaap_MachineryAndEquipmentGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Manufacturing equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MachineryAndEquipmentGross" xlink:to="us-gaap_MachineryAndEquipmentGross_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_MachineryAndEquipmentGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Machinery And Equipment Gross</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property, Plant and Equipment, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Gross</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FurnitureAndFixturesGross" xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesGross" />
    <label xml:lang="en-US" xlink:label="us-gaap_FurnitureAndFixturesGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Furniture and fixtures</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesGross" xlink:to="us-gaap_FurnitureAndFixturesGross_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_FurnitureAndFixturesGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Furniture And Fixtures Gross</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LeaseholdImprovementsGross" xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsGross" />
    <label xml:lang="en-US" xlink:label="us-gaap_LeaseholdImprovementsGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leasehold improvements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsGross" xlink:to="us-gaap_LeaseholdImprovementsGross_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_LeaseholdImprovementsGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Leasehold Improvements Gross</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentOther" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentOther" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentOther_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets in progress</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentOther" xlink:to="us-gaap_PropertyPlantAndEquipmentOther_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentOther_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Other</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <label xml:lang="en-US" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less accumulated depreciation and amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Depreciation Depletion And Amortization Property Plant And Equipment</label>
    <label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_DisclosurePropertyAndEquipmentAdditionalInformationAbstract" xlink:type="locator" xlink:label="dvax_DisclosurePropertyAndEquipmentAdditionalInformationAbstract" />
    <label xml:lang="en-US" xlink:label="dvax_DisclosurePropertyAndEquipmentAdditionalInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure Property And Equipment Additional Information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_DisclosurePropertyAndEquipmentAdditionalInformationAbstract" xlink:to="dvax_DisclosurePropertyAndEquipmentAdditionalInformationAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_DisclosurePropertyAndEquipmentAdditionalInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure Property And Equipment Additional Information [Abstract]</label>
    <label xml:lang="en-US" xlink:label="dvax_DisclosurePropertyAndEquipmentAdditionalInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Disclosure Property And Equipment Additional Information [Abstract]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_DisclosureIntangibleAssetsAdditionalInformationAbstract" xlink:type="locator" xlink:label="dvax_DisclosureIntangibleAssetsAdditionalInformationAbstract" />
    <label xml:lang="en-US" xlink:label="dvax_DisclosureIntangibleAssetsAdditionalInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure Intangible Assets Additional Information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_DisclosureIntangibleAssetsAdditionalInformationAbstract" xlink:to="dvax_DisclosureIntangibleAssetsAdditionalInformationAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_DisclosureIntangibleAssetsAdditionalInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure Intangible Assets Additional Information [Abstract]</label>
    <label xml:lang="en-US" xlink:label="dvax_DisclosureIntangibleAssetsAdditionalInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Disclosure Intangible Assets Additional Information [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Finite Lived Intangible Assets [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Finite Lived Intangible Assets [Table]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finite-Lived Intangible Assets by Major Class</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finite Lived Intangible Assets By Major Class [Axis]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finite-Lived Intangible Assets, Major Class Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finite Lived Intangible Assets Major Class Name [Domain]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_ManufacturingMember" xlink:type="locator" xlink:label="dvax_ManufacturingMember" />
    <label xml:lang="en-US" xlink:label="dvax_ManufacturingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Manufacturing [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_ManufacturingMember" xlink:to="dvax_ManufacturingMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_ManufacturingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Manufacturing Process</label>
    <label xml:lang="en-US" xlink:label="dvax_ManufacturingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Manufacturing [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:type="locator" xlink:label="us-gaap_CustomerRelationshipsMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_CustomerRelationshipsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Customer Relationships</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerRelationshipsMember" xlink:to="us-gaap_CustomerRelationshipsMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_CustomerRelationshipsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Customer Relationships [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" />
    <label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finite Lived Intangible Assets [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finite Lived Intangible Assets [Line Items]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
    <label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated useful life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Finite Lived Intangible Asset Useful Life</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_AccruedThirdPartyResearchAndDevelopmentExpensesCurrent" xlink:type="locator" xlink:label="dvax_AccruedThirdPartyResearchAndDevelopmentExpensesCurrent" />
    <label xml:lang="en-US" xlink:label="dvax_AccruedThirdPartyResearchAndDevelopmentExpensesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued Third Party Research and Development Expenses, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_AccruedThirdPartyResearchAndDevelopmentExpensesCurrent" xlink:to="dvax_AccruedThirdPartyResearchAndDevelopmentExpensesCurrent_lbl" />
    <loc xlink:href="dvax-20131231.xsd#dvax_DisclosureComponentOfCurrentAccruedLiabilitiesAbstract" xlink:type="locator" xlink:label="dvax_DisclosureComponentOfCurrentAccruedLiabilitiesAbstract" />
    <label xml:lang="en-US" xlink:label="dvax_DisclosureComponentOfCurrentAccruedLiabilitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure - Component of Current Accrued Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_DisclosureComponentOfCurrentAccruedLiabilitiesAbstract" xlink:to="dvax_DisclosureComponentOfCurrentAccruedLiabilitiesAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_DisclosureComponentOfCurrentAccruedLiabilitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure Component Of Current Accrued Liabilities [Abstract]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_AccruedLiabilitiesLineItems" xlink:type="locator" xlink:label="dvax_AccruedLiabilitiesLineItems" />
    <label xml:lang="en-US" xlink:label="dvax_AccruedLiabilitiesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued Liabilities [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_AccruedLiabilitiesLineItems" xlink:to="dvax_AccruedLiabilitiesLineItems_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_DisclosureComponentOfCurrentAccruedLiabilitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Disclosure Component Of Current Accrued Liabilities [Abstract]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_AccruedLiabilitiesTable" xlink:type="locator" xlink:label="dvax_AccruedLiabilitiesTable" />
    <label xml:lang="en-US" xlink:label="dvax_AccruedLiabilitiesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued Liabilities [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_AccruedLiabilitiesTable" xlink:to="dvax_AccruedLiabilitiesTable_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_AccruedLiabilitiesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued Liabilities [Table]</label>
    <label xml:lang="en-US" xlink:label="dvax_AccruedLiabilitiesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities [Table]</label>
    <label xml:lang="en-US" xlink:label="dvax_AccruedLiabilitiesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued Liabilities [Line Items]</label>
    <label xml:lang="en-US" xlink:label="dvax_AccruedLiabilitiesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities [Line Items]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrentAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_AccruedLiabilitiesCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued Liabilities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrentAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AccruedLiabilitiesCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities Current [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccruedEmployeeBenefitsCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedEmployeeBenefitsCurrent" />
    <label xml:lang="en-US" xlink:label="us-gaap_AccruedEmployeeBenefitsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payroll and related expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedEmployeeBenefitsCurrent" xlink:to="us-gaap_AccruedEmployeeBenefitsCurrent_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AccruedEmployeeBenefitsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Employee Benefits Current</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" />
    <label xml:lang="en-US" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Legal expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Professional Fees Current</label>
    <label xml:lang="en-US" xlink:label="dvax_AccruedThirdPartyResearchAndDevelopmentExpensesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Third party research and development expenses</label>
    <label xml:lang="en-US" xlink:label="dvax_AccruedThirdPartyResearchAndDevelopmentExpensesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Third Party Research And Development Expenses Current</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
    <label xml:lang="en-US" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other accrued liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Accrued Liabilities Current</label>
    <label xml:lang="en-US" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_DisclosureSymphonyDynamoIncAdditionalInformationAbstract" xlink:type="locator" xlink:label="dvax_DisclosureSymphonyDynamoIncAdditionalInformationAbstract" />
    <label xml:lang="en-US" xlink:label="dvax_DisclosureSymphonyDynamoIncAdditionalInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure - Symphony Dynamo, Inc. - Additional Information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_DisclosureSymphonyDynamoIncAdditionalInformationAbstract" xlink:to="dvax_DisclosureSymphonyDynamoIncAdditionalInformationAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_DisclosureSymphonyDynamoIncAdditionalInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure Symphony Dynamo Inc Additional Information [Abstract]</label>
    <label xml:lang="en-US" xlink:label="dvax_DisclosureSymphonyDynamoIncAdditionalInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Disclosure Symphony Dynamo Inc Additional Information [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Business Acquisitions By Acquisition Equity Interest Issued Or Issuable [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Business Acquisitions By Acquisition Equity Interest Issued Or Issuable [Table]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment, Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Equity Method Investment Equity Method Investee Name [Axis]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityMethodInvesteeNameDomain" xlink:type="locator" xlink:label="us-gaap_EquityMethodInvesteeNameDomain" />
    <label xml:lang="en-US" xlink:label="us-gaap_EquityMethodInvesteeNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment, Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvesteeNameDomain" xlink:to="us-gaap_EquityMethodInvesteeNameDomain_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_EquityMethodInvesteeNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equity Method Investee Name [Domain]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_SymphonyDynamoIncMember" xlink:type="locator" xlink:label="dvax_SymphonyDynamoIncMember" />
    <label xml:lang="en-US" xlink:label="dvax_SymphonyDynamoIncMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Symphony Dynamo, Inc [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_SymphonyDynamoIncMember" xlink:to="dvax_SymphonyDynamoIncMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_SymphonyDynamoIncMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">SDI</label>
    <label xml:lang="en-US" xlink:label="dvax_SymphonyDynamoIncMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Symphony Dynamo Inc [Member]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_SymphonyDynamoHoldingsLlcMember" xlink:type="locator" xlink:label="dvax_SymphonyDynamoHoldingsLlcMember" />
    <label xml:lang="en-US" xlink:label="dvax_SymphonyDynamoHoldingsLlcMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Symphony Dynamo Holdings Llc [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_SymphonyDynamoHoldingsLlcMember" xlink:to="dvax_SymphonyDynamoHoldingsLlcMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_SymphonyDynamoHoldingsLlcMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Holdings</label>
    <label xml:lang="en-US" xlink:label="dvax_SymphonyDynamoHoldingsLlcMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Symphony Dynamo Holdings Llc [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" />
    <label xml:lang="en-US" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business Acquisition Equity Interests Issued Or Issuable [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition Equity Interests Issued Or Issuable [Line Items]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:type="locator" xlink:label="us-gaap_EquityMethodInvestments" />
    <label xml:lang="en-US" xlink:label="us-gaap_EquityMethodInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments in SDI</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestments" xlink:to="us-gaap_EquityMethodInvestments_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_EquityMethodInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equity Method Investments</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:type="locator" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent" />
    <label xml:lang="en-US" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Ownership percentage by parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Minority Interest Ownership Percentage By Parent</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_IssueOfWarrantsToPurchaseSharesOfCommonStock" xlink:type="locator" xlink:label="dvax_IssueOfWarrantsToPurchaseSharesOfCommonStock" />
    <label xml:lang="en-US" xlink:label="dvax_IssueOfWarrantsToPurchaseSharesOfCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Issue Of Warrants To Purchase Shares Of Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_IssueOfWarrantsToPurchaseSharesOfCommonStock" xlink:to="dvax_IssueOfWarrantsToPurchaseSharesOfCommonStock_lbl" />
    <loc xlink:href="dvax-20131231.xsd#dvax_WarrantsExercisablePeriod" xlink:type="locator" xlink:label="dvax_WarrantsExercisablePeriod" />
    <label xml:lang="en-US" xlink:label="dvax_WarrantsExercisablePeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Warrants Exercisable Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_WarrantsExercisablePeriod" xlink:to="dvax_WarrantsExercisablePeriod_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_IssueOfWarrantsToPurchaseSharesOfCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants issued to purchase common stock</label>
    <label xml:lang="en-US" xlink:label="dvax_IssueOfWarrantsToPurchaseSharesOfCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Issue Of Warrants To Purchase Shares Of Common Stock</label>
    <label xml:lang="en-US" xlink:label="dvax_WarrantsExercisablePeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants exercisable period</label>
    <label xml:lang="en-US" xlink:label="dvax_WarrantsExercisablePeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Warrants Exercisable Period</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" />
    <label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants exercise price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right Exercise Price Of Warrants Or Rights</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherCommitment" xlink:type="locator" xlink:label="us-gaap_OtherCommitment" />
    <label xml:lang="en-US" xlink:label="us-gaap_OtherCommitment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitment" xlink:to="us-gaap_OtherCommitment_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_OtherCommitment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Commitment</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_BusinessAcquisitionContingentConsiderationPercentage" xlink:type="locator" xlink:label="dvax_BusinessAcquisitionContingentConsiderationPercentage" />
    <label xml:lang="en-US" xlink:label="dvax_BusinessAcquisitionContingentConsiderationPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Business Acquisition Contingent Consideration Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_BusinessAcquisitionContingentConsiderationPercentage" xlink:to="dvax_BusinessAcquisitionContingentConsiderationPercentage_lbl" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock issue on acquisition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Acquisitions</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
    <label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issued note to Holdings, principal amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Face Amount</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubordinatedBorrowingDueDate" xlink:type="locator" xlink:label="us-gaap_SubordinatedBorrowingDueDate" />
    <label xml:lang="en-US" xlink:label="us-gaap_SubordinatedBorrowingDueDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Principal amount, due date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubordinatedBorrowingDueDate" xlink:to="us-gaap_SubordinatedBorrowingDueDate_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SubordinatedBorrowingDueDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subordinated Borrowing Due Date</label>
    <label xml:lang="en-US" xlink:label="dvax_BusinessAcquisitionContingentConsiderationPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business acquisition contingent consideration percentage</label>
    <label xml:lang="en-US" xlink:label="dvax_BusinessAcquisitionContingentConsiderationPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition Contingent Consideration Percentage</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross" />
    <label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business acquisition upfront payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments To Acquire Businesses Gross</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsDiscountRate" xlink:type="locator" xlink:label="us-gaap_FairValueInputsDiscountRate" />
    <label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsDiscountRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net present value model, discount rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsDiscountRate" xlink:to="us-gaap_FairValueInputsDiscountRate_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsDiscountRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Inputs Discount Rate</label>
    <label xml:lang="en-US" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Repayment of note payable</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_ReclassificationOfWarrantLiabilitiesToEquity" xlink:type="locator" xlink:label="dvax_ReclassificationOfWarrantLiabilitiesToEquity" />
    <label xml:lang="en-US" xlink:label="dvax_ReclassificationOfWarrantLiabilitiesToEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Reclassification Of Warrant Liabilities To Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_ReclassificationOfWarrantLiabilitiesToEquity" xlink:to="dvax_ReclassificationOfWarrantLiabilitiesToEquity_lbl" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
    <label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Warrant or Right</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right [Axis]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" />
    <label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Warrant or Right</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right [Domain]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_WarrantLiabilityMember" xlink:type="locator" xlink:label="dvax_WarrantLiabilityMember" />
    <label xml:lang="en-US" xlink:label="dvax_WarrantLiabilityMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Warrant Liability [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_WarrantLiabilityMember" xlink:to="dvax_WarrantLiabilityMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_WarrantLiabilityMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant Liability</label>
    <label xml:lang="en-US" xlink:label="dvax_WarrantLiabilityMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Warrant Liability [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" />
    <label xml:lang="en-US" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non operating income expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Nonoperating Income Expense</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesFairValueAdjustment" xlink:type="locator" xlink:label="us-gaap_LiabilitiesFairValueAdjustment" />
    <label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesFairValueAdjustment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in warrant and contingent consideration liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesFairValueAdjustment" xlink:to="us-gaap_LiabilitiesFairValueAdjustment_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesFairValueAdjustment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities Fair Value Adjustment</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
    <label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase in additional paid in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Additional Paid In Capital Warrant Issued</label>
    <label xml:lang="en-US" xlink:label="dvax_ReclassificationOfWarrantLiabilitiesToEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reclassification of warranty liability into equity</label>
    <label xml:lang="en-US" xlink:label="dvax_ReclassificationOfWarrantLiabilitiesToEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Reclassification Of Warrant Liabilities To Equity</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
    <label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right Outstanding</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MalpracticeLossContingencyDiscountRate" xlink:type="locator" xlink:label="us-gaap_MalpracticeLossContingencyDiscountRate" />
    <label xml:lang="en-US" xlink:label="us-gaap_MalpracticeLossContingencyDiscountRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows discounted rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MalpracticeLossContingencyDiscountRate" xlink:to="us-gaap_MalpracticeLossContingencyDiscountRate_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_MalpracticeLossContingencyDiscountRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Malpractice Loss Contingency Discount Rate</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability" />
    <label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated fair value of contingent liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Contingent Consideration Liability</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments And Contingencies Disclosure [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfOperatingLeasedAssetsTable" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfOperatingLeasedAssetsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Operating Leased Assets [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="us-gaap_ScheduleOfOperatingLeasedAssetsTable_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfOperatingLeasedAssetsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Operating Leased Assets [Table]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems" xlink:type="locator" xlink:label="us-gaap_OperatingLeasedAssetsLineItems" />
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasedAssetsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating Leased Assets [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_OperatingLeasedAssetsLineItems_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasedAssetsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leased Assets [Line Items]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" />
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2014</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases Future Minimum Payments Due Current</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2015</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases Future Minimum Payments Due In Two Years</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2016</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases Future Minimum Payments Due In Three Years</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" />
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2017</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases Future Minimum Payments Due In Four Years</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" />
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2018</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases Future Minimum Payments Due In Five Years</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" />
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Thereafter</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases Future Minimum Payments Due Thereafter</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" />
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases Future Minimum Payments Due</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_LeaseExpirationMonthAndYear" xlink:type="locator" xlink:label="dvax_LeaseExpirationMonthAndYear" />
    <label xml:lang="en-US" xlink:label="dvax_LeaseExpirationMonthAndYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease Expiration, Month and Year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_LeaseExpirationMonthAndYear" xlink:to="dvax_LeaseExpirationMonthAndYear_lbl" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LossContingenciesTable" xlink:type="locator" xlink:label="us-gaap_LossContingenciesTable" />
    <label xml:lang="en-US" xlink:label="us-gaap_LossContingenciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss Contingencies [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_LossContingenciesTable_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_LossContingenciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingencies [Table]</label>
    <loc xlink:href="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd#stpr_CA" xlink:type="locator" xlink:label="stpr_CA" />
    <label xml:lang="en-US" xlink:label="stpr_CA_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Berkeley, California (the "Berkeley Lease")</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="stpr_CA" xlink:to="stpr_CA_lbl" />
    <label xml:lang="en-US" xlink:label="stpr_CA_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">C A</label>
    <loc xlink:href="http://xbrl.sec.gov/country/2013/country-2013-01-31.xsd#country_GC" xlink:type="locator" xlink:label="country_GC" />
    <label xml:lang="en-US" xlink:label="country_GC_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dusseldorf, Germany (the "Dusseldorf Lease")</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_GC" xlink:to="country_GC_lbl" />
    <label xml:lang="en-US" xlink:label="country_GC_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">G C</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:type="locator" xlink:label="us-gaap_LossContingenciesLineItems" />
    <label xml:lang="en-US" xlink:label="us-gaap_LossContingenciesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss Contingencies [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LossContingenciesLineItems_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_LossContingenciesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingencies [Line Items]</label>
    <label xml:lang="en-US" xlink:label="dvax_LeaseExpirationMonthAndYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating leases expiration date</label>
    <label xml:lang="en-US" xlink:label="dvax_LeaseExpirationMonthAndYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lease Expiration Month And Year</label>
    <label xml:lang="en-US" xlink:label="us-gaap_BusinessExitCosts1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Unoccupied facility expense</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesRentExpenseNet" />
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesRentExpenseNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Rent expense, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesRentExpenseNet" xlink:to="us-gaap_OperatingLeasesRentExpenseNet_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesRentExpenseNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases Rent Expense Net</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRentCredit" xlink:type="locator" xlink:label="us-gaap_DeferredRentCredit" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredRentCredit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred rent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRentCredit" xlink:to="us-gaap_DeferredRentCredit_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredRentCredit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Rent Credit</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_ContingencyPeriod" xlink:type="locator" xlink:label="dvax_ContingencyPeriod" />
    <label xml:lang="en-US" xlink:label="dvax_ContingencyPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Contingency Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_ContingencyPeriod" xlink:to="dvax_ContingencyPeriod_lbl" />
    <loc xlink:href="dvax-20131231.xsd#dvax_CaliforniaMember" xlink:type="locator" xlink:label="dvax_CaliforniaMember" />
    <label xml:lang="en-US" xlink:label="dvax_CaliforniaMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">California [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_CaliforniaMember" xlink:to="dvax_CaliforniaMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_CaliforniaMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Berkeley, California (the "Berkeley Lease")</label>
    <label xml:lang="en-US" xlink:label="dvax_CaliforniaMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">California [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="locator" xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis" />
    <label xml:lang="en-US" xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss Contingency Nature</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="us-gaap_LossContingenciesByNatureOfContingencyAxis_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingencies By Nature Of Contingency [Axis]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:type="locator" xlink:label="us-gaap_LossContingencyNatureDomain" />
    <label xml:lang="en-US" xlink:label="us-gaap_LossContingencyNatureDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss Contingency, Nature</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyNatureDomain" xlink:to="us-gaap_LossContingencyNatureDomain_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_LossContingencyNatureDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingency Nature [Domain]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_ContingencyBMember" xlink:type="locator" xlink:label="dvax_ContingencyBMember" />
    <label xml:lang="en-US" xlink:label="dvax_ContingencyBMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Contingency, B [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_ContingencyBMember" xlink:to="dvax_ContingencyBMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_ContingencyBMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contingency, B</label>
    <label xml:lang="en-US" xlink:label="dvax_ContingencyBMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contingency B [Member]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_ContingencyAMember" xlink:type="locator" xlink:label="dvax_ContingencyAMember" />
    <label xml:lang="en-US" xlink:label="dvax_ContingencyAMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Contingency, A [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_ContingencyAMember" xlink:to="dvax_ContingencyAMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_ContingencyAMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contingency, A</label>
    <label xml:lang="en-US" xlink:label="dvax_ContingencyAMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contingency A [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PledgedAssetsSeparatelyReportedSecuritiesPledgedUnderLetterOfCreditFacilitiesAtFairValue" xlink:type="locator" xlink:label="us-gaap_PledgedAssetsSeparatelyReportedSecuritiesPledgedUnderLetterOfCreditFacilitiesAtFairValue" />
    <label xml:lang="en-US" xlink:label="us-gaap_PledgedAssetsSeparatelyReportedSecuritiesPledgedUnderLetterOfCreditFacilitiesAtFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Letter of credit pledged as security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PledgedAssetsSeparatelyReportedSecuritiesPledgedUnderLetterOfCreditFacilitiesAtFairValue" xlink:to="us-gaap_PledgedAssetsSeparatelyReportedSecuritiesPledgedUnderLetterOfCreditFacilitiesAtFairValue_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PledgedAssetsSeparatelyReportedSecuritiesPledgedUnderLetterOfCreditFacilitiesAtFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pledged Assets Separately Reported Securities Pledged Under Letter Of Credit Facilities At Fair Value</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SecurityOwnedAndPledgedAsCollateralFairValue" xlink:type="locator" xlink:label="us-gaap_SecurityOwnedAndPledgedAsCollateralFairValue" />
    <label xml:lang="en-US" xlink:label="us-gaap_SecurityOwnedAndPledgedAsCollateralFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collateralized certificate of deposit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecurityOwnedAndPledgedAsCollateralFairValue" xlink:to="us-gaap_SecurityOwnedAndPledgedAsCollateralFairValue_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SecurityOwnedAndPledgedAsCollateralFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Owned And Pledged As Collateral Fair Value</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LoansAndLeasesReceivableDescription" xlink:type="locator" xlink:label="us-gaap_LoansAndLeasesReceivableDescription" />
    <label xml:lang="en-US" xlink:label="us-gaap_LoansAndLeasesReceivableDescription_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Terms of the lease</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansAndLeasesReceivableDescription" xlink:to="us-gaap_LoansAndLeasesReceivableDescription_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_LoansAndLeasesReceivableDescription_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Loans And Leases Receivable Description</label>
    <label xml:lang="en-US" xlink:label="dvax_ContingencyPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contingency period for cash, cash equivalents and marketable securities</label>
    <label xml:lang="en-US" xlink:label="dvax_ContingencyPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contingency Period</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInSecurityDeposits" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInSecurityDeposits" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInSecurityDeposits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase in amount of the security deposit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInSecurityDeposits" xlink:to="us-gaap_IncreaseDecreaseInSecurityDeposits_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInSecurityDeposits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Security Deposits</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_DeutscheBankSecuritiesMember" xlink:type="locator" xlink:label="dvax_DeutscheBankSecuritiesMember" />
    <label xml:lang="en-US" xlink:label="dvax_DeutscheBankSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Deutsche Bank Securities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_DeutscheBankSecuritiesMember" xlink:to="dvax_DeutscheBankSecuritiesMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_DeutscheBankSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deutsche Bank Securities</label>
    <label xml:lang="en-US" xlink:label="dvax_DeutscheBankSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deutsche Bank Securities [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermPurchaseCommitmentAmount" xlink:type="locator" xlink:label="us-gaap_LongTermPurchaseCommitmentAmount" />
    <label xml:lang="en-US" xlink:label="us-gaap_LongTermPurchaseCommitmentAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Future payments obligation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermPurchaseCommitmentAmount" xlink:to="us-gaap_LongTermPurchaseCommitmentAmount_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_LongTermPurchaseCommitmentAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Purchase Commitment Amount</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_NumberOfProjects" xlink:type="locator" xlink:label="dvax_NumberOfProjects" />
    <label xml:lang="en-US" xlink:label="dvax_NumberOfProjects_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of Projects</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_NumberOfProjects" xlink:to="dvax_NumberOfProjects_lbl" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Organization Consolidation And Presentation Of Financial Statements [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Organization Consolidation And Presentation Of Financial Statements [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfProductInformationTable" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfProductInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Product Information [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="us-gaap_ScheduleOfProductInformationTable_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfProductInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Product Information [Table]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <label xml:lang="en-US" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Type of Arrangement and Non-arrangement Transactions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Type Of Arrangement [Axis]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Arrangements and Non-arrangement Transactions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Arrangements And Nonarrangement Transactions [Member]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_GlaxoSmithKlineMember" xlink:type="locator" xlink:label="dvax_GlaxoSmithKlineMember" />
    <label xml:lang="en-US" xlink:label="dvax_GlaxoSmithKlineMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Glaxo, Smith, Kline [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_GlaxoSmithKlineMember" xlink:to="dvax_GlaxoSmithKlineMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_GlaxoSmithKlineMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Glaxo, Smith, Kline</label>
    <label xml:lang="en-US" xlink:label="dvax_GlaxoSmithKlineMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Glaxo Smith Kline [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:type="locator" xlink:label="us-gaap_ProductInformationLineItems" />
    <label xml:lang="en-US" xlink:label="us-gaap_ProductInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Product Information [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_ProductInformationLineItems_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ProductInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Product Information [Line Items]</label>
    <label xml:lang="en-US" xlink:label="dvax_NumberOfProjects_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of programs for research and early clinical development</label>
    <label xml:lang="en-US" xlink:label="dvax_NumberOfProjects_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Projects</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_PotentialMilestonePaymentAmount" xlink:type="locator" xlink:label="dvax_PotentialMilestonePaymentAmount" />
    <label xml:lang="en-US" xlink:label="dvax_PotentialMilestonePaymentAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Potential Milestone Payment Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_PotentialMilestonePaymentAmount" xlink:to="dvax_PotentialMilestonePaymentAmount_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_PotentialMilestonePaymentAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Potential milestone payment</label>
    <label xml:lang="en-US" xlink:label="dvax_PotentialMilestonePaymentAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Potential Milestone Payment Amount</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_CollaborativeAgreementAxis" xlink:type="locator" xlink:label="dvax_CollaborativeAgreementAxis" />
    <label xml:lang="en-US" xlink:label="dvax_CollaborativeAgreementAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Collaborative Agreement [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_CollaborativeAgreementAxis" xlink:to="dvax_CollaborativeAgreementAxis_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_CollaborativeAgreementAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Agreement</label>
    <label xml:lang="en-US" xlink:label="dvax_CollaborativeAgreementAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Agreement [Axis]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_CollaborativeAgreementDomain" xlink:type="locator" xlink:label="dvax_CollaborativeAgreementDomain" />
    <label xml:lang="en-US" xlink:label="dvax_CollaborativeAgreementDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Collaborative Agreement [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_CollaborativeAgreementDomain" xlink:to="dvax_CollaborativeAgreementDomain_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_CollaborativeAgreementDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Agreement</label>
    <label xml:lang="en-US" xlink:label="dvax_CollaborativeAgreementDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Agreement [Domain]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_ConditionTwoMember" xlink:type="locator" xlink:label="dvax_ConditionTwoMember" />
    <label xml:lang="en-US" xlink:label="dvax_ConditionTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Condition Two [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_ConditionTwoMember" xlink:to="dvax_ConditionTwoMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_ConditionTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Annual net sales milestones achieved</label>
    <label xml:lang="en-US" xlink:label="dvax_ConditionTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Condition Two [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementBusinessSegmentsAxis" />
    <label xml:lang="en-US" xlink:label="us-gaap_StatementBusinessSegmentsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Segments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_StatementBusinessSegmentsAxis_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StatementBusinessSegmentsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Business Segments [Axis]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SegmentDomain" xlink:type="locator" xlink:label="us-gaap_SegmentDomain" />
    <label xml:lang="en-US" xlink:label="us-gaap_SegmentDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Segments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentDomain" xlink:to="us-gaap_SegmentDomain_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SegmentDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Segment [Domain]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_ExpansionMember" xlink:type="locator" xlink:label="dvax_ExpansionMember" />
    <label xml:lang="en-US" xlink:label="dvax_ExpansionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Expansion [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_ExpansionMember" xlink:to="dvax_ExpansionMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_ExpansionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expansion</label>
    <label xml:lang="en-US" xlink:label="dvax_ExpansionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Expansion [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRevenueAdditions" xlink:type="locator" xlink:label="us-gaap_DeferredRevenueAdditions" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredRevenueAdditions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaboration Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueAdditions" xlink:to="us-gaap_DeferredRevenueAdditions_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredRevenueAdditions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Revenue Additions</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" />
    <label xml:lang="en-US" xlink:label="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Revenue from milestone payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" xlink:to="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenue Recognition Milestone Method Revenue Recognized</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_RevenueRecognitionPeriod" xlink:type="locator" xlink:label="dvax_RevenueRecognitionPeriod" />
    <label xml:lang="en-US" xlink:label="dvax_RevenueRecognitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Revenue Recognition, Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_RevenueRecognitionPeriod" xlink:to="dvax_RevenueRecognitionPeriod_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_RevenueRecognitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue recognition period</label>
    <label xml:lang="en-US" xlink:label="dvax_RevenueRecognitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenue Recognition Period</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleCurrentPeriodDisclosuresRevenueRecognizedAmount" xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleCurrentPeriodDisclosuresRevenueRecognizedAmount" />
    <label xml:lang="en-US" xlink:label="us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleCurrentPeriodDisclosuresRevenueRecognizedAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional revenue recognized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleCurrentPeriodDisclosuresRevenueRecognizedAmount" xlink:to="us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleCurrentPeriodDisclosuresRevenueRecognizedAmount_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleCurrentPeriodDisclosuresRevenueRecognizedAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncement Or Change In Accounting Principle Current Period Disclosures Revenue Recognized Amount</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRevenue" xlink:type="locator" xlink:label="us-gaap_DeferredRevenue" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredRevenue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenue" xlink:to="us-gaap_DeferredRevenue_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredRevenue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Revenue</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_ResearchCollaborationAndLicenseAgreementPeriod" xlink:type="locator" xlink:label="dvax_ResearchCollaborationAndLicenseAgreementPeriod" />
    <label xml:lang="en-US" xlink:label="dvax_ResearchCollaborationAndLicenseAgreementPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Research Collaboration and License Agreement Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_ResearchCollaborationAndLicenseAgreementPeriod" xlink:to="dvax_ResearchCollaborationAndLicenseAgreementPeriod_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_ResearchCollaborationAndLicenseAgreementPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research collaboration and license agreement period</label>
    <label xml:lang="en-US" xlink:label="dvax_ResearchCollaborationAndLicenseAgreementPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research Collaboration And License Agreement Period</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_AmendmentMember" xlink:type="locator" xlink:label="dvax_AmendmentMember" />
    <label xml:lang="en-US" xlink:label="dvax_AmendmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Amendment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_AmendmentMember" xlink:to="dvax_AmendmentMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_AmendmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment</label>
    <label xml:lang="en-US" xlink:label="dvax_AmendmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis" xlink:type="locator" xlink:label="us-gaap_ContingentConsiderationByTypeAxis" />
    <label xml:lang="en-US" xlink:label="us-gaap_ContingentConsiderationByTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contingent Consideration by Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="us-gaap_ContingentConsiderationByTypeAxis_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ContingentConsiderationByTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contingent Consideration By Type [Axis]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:type="locator" xlink:label="us-gaap_ContingentConsiderationTypeDomain" />
    <label xml:lang="en-US" xlink:label="us-gaap_ContingentConsiderationTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contingent Consideration Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="us-gaap_ContingentConsiderationTypeDomain_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ContingentConsiderationTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contingent Consideration Type [Domain]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_ContingentConsiderationMember" xlink:type="locator" xlink:label="dvax_ContingentConsiderationMember" />
    <label xml:lang="en-US" xlink:label="dvax_ContingentConsiderationMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Contingent Consideration [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_ContingentConsiderationMember" xlink:to="dvax_ContingentConsiderationMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_ContingentConsiderationMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Advance the program following completion of Phase 2a</label>
    <label xml:lang="en-US" xlink:label="dvax_ContingentConsiderationMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contingent Consideration [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" />
    <label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost of clinical development activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:to="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Expense Excluding Acquired In Process Cost</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_HepaticFibrosisAndCirrhosisMember" xlink:type="locator" xlink:label="dvax_HepaticFibrosisAndCirrhosisMember" />
    <label xml:lang="en-US" xlink:label="dvax_HepaticFibrosisAndCirrhosisMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Hepatic fibrosis and cirrhosis.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_HepaticFibrosisAndCirrhosisMember" xlink:to="dvax_HepaticFibrosisAndCirrhosisMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_HepaticFibrosisAndCirrhosisMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Hepatic Fibrosis and Cirrhosis</label>
    <label xml:lang="en-US" xlink:label="dvax_HepaticFibrosisAndCirrhosisMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Hepatic Fibrosis And Cirrhosis [Member]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_DifferentTypesOfCollaborationAgreementsAxis" xlink:type="locator" xlink:label="dvax_DifferentTypesOfCollaborationAgreementsAxis" />
    <label xml:lang="en-US" xlink:label="dvax_DifferentTypesOfCollaborationAgreementsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Different Types Of Collaboration Agreements [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_DifferentTypesOfCollaborationAgreementsAxis" xlink:to="dvax_DifferentTypesOfCollaborationAgreementsAxis_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_DifferentTypesOfCollaborationAgreementsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Different Types Of Collaboration Agreements</label>
    <label xml:lang="en-US" xlink:label="dvax_DifferentTypesOfCollaborationAgreementsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Different Types Of Collaboration Agreements [Axis]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_DifferentTypesOfCollaborationAgreementsDomain" xlink:type="locator" xlink:label="dvax_DifferentTypesOfCollaborationAgreementsDomain" />
    <label xml:lang="en-US" xlink:label="dvax_DifferentTypesOfCollaborationAgreementsDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Different Types Of Collaboration Agreements [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_DifferentTypesOfCollaborationAgreementsDomain" xlink:to="dvax_DifferentTypesOfCollaborationAgreementsDomain_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_DifferentTypesOfCollaborationAgreementsDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Different Types Of Collaboration Agreements</label>
    <label xml:lang="en-US" xlink:label="dvax_DifferentTypesOfCollaborationAgreementsDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Different Types Of Collaboration Agreements [Domain]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GrantsReceivable" xlink:type="locator" xlink:label="us-gaap_GrantsReceivable" />
    <label xml:lang="en-US" xlink:label="us-gaap_GrantsReceivable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Grants receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrantsReceivable" xlink:to="us-gaap_GrantsReceivable_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_GrantsReceivable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Grants Receivable</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_AutoimmuneDiseaseMember" xlink:type="locator" xlink:label="dvax_AutoimmuneDiseaseMember" />
    <label xml:lang="en-US" xlink:label="dvax_AutoimmuneDiseaseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Autoimmune Disease [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_AutoimmuneDiseaseMember" xlink:to="dvax_AutoimmuneDiseaseMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_AutoimmuneDiseaseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Autoimmune Disease</label>
    <label xml:lang="en-US" xlink:label="dvax_AutoimmuneDiseaseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Autoimmune Disease [Member]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_RheumatoidArthritisMember" xlink:type="locator" xlink:label="dvax_RheumatoidArthritisMember" />
    <label xml:lang="en-US" xlink:label="dvax_RheumatoidArthritisMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Rheumatoid arthritis member.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_RheumatoidArthritisMember" xlink:to="dvax_RheumatoidArthritisMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_RheumatoidArthritisMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Rheumatoid Arthritis</label>
    <label xml:lang="en-US" xlink:label="dvax_RheumatoidArthritisMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Rheumatoid Arthritis [Member]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_SkinAutoimmuneInflammationMember" xlink:type="locator" xlink:label="dvax_SkinAutoimmuneInflammationMember" />
    <label xml:lang="en-US" xlink:label="dvax_SkinAutoimmuneInflammationMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Skin Autoimmune Inflammation [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_SkinAutoimmuneInflammationMember" xlink:to="dvax_SkinAutoimmuneInflammationMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_SkinAutoimmuneInflammationMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Skin Autoimmune Inflammation</label>
    <label xml:lang="en-US" xlink:label="dvax_SkinAutoimmuneInflammationMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Skin Autoimmune Inflammation [Member]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_HepatitisBVirusMember" xlink:type="locator" xlink:label="dvax_HepatitisBVirusMember" />
    <label xml:lang="en-US" xlink:label="dvax_HepatitisBVirusMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Hepatitis B Virus [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_HepatitisBVirusMember" xlink:to="dvax_HepatitisBVirusMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_HepatitisBVirusMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">HBV</label>
    <label xml:lang="en-US" xlink:label="dvax_HepatitisBVirusMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Hepatitis B Virus [Member]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_HumanPapillomaVirusMember" xlink:type="locator" xlink:label="dvax_HumanPapillomaVirusMember" />
    <label xml:lang="en-US" xlink:label="dvax_HumanPapillomaVirusMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Human Papilloma Virus [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_HumanPapillomaVirusMember" xlink:to="dvax_HumanPapillomaVirusMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_HumanPapillomaVirusMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">HPV</label>
    <label xml:lang="en-US" xlink:label="dvax_HumanPapillomaVirusMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Human Papilloma Virus [Member]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_ContractTerm" xlink:type="locator" xlink:label="dvax_ContractTerm" />
    <label xml:lang="en-US" xlink:label="dvax_ContractTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Contract Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_ContractTerm" xlink:to="dvax_ContractTerm_lbl" />
    <loc xlink:href="dvax-20131231.xsd#dvax_IssTechnologyMember" xlink:type="locator" xlink:label="dvax_IssTechnologyMember" />
    <label xml:lang="en-US" xlink:label="dvax_IssTechnologyMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Iss Technology [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_IssTechnologyMember" xlink:to="dvax_IssTechnologyMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_IssTechnologyMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ISS Technology</label>
    <label xml:lang="en-US" xlink:label="dvax_IssTechnologyMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Iss Technology [Member]</label>
    <label xml:lang="en-US" xlink:label="dvax_ContractTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contract agreement period</label>
    <label xml:lang="en-US" xlink:label="dvax_ContractTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contract Term</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:type="locator" xlink:label="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" />
    <label xml:lang="en-US" xlink:label="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contract awarded to develop technology</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:to="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Receivable Billed For Long Term Contracts Or Programs</label>
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredRevenueAdditions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Initial payment</label>
    <label xml:lang="en-US" xlink:label="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Milestone revenue</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_NationalInstituteOfAllergyAndInfectiousDiseasesMember" xlink:type="locator" xlink:label="dvax_NationalInstituteOfAllergyAndInfectiousDiseasesMember" />
    <label xml:lang="en-US" xlink:label="dvax_NationalInstituteOfAllergyAndInfectiousDiseasesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">National Institute Of Allergy And Infectious Diseases [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_NationalInstituteOfAllergyAndInfectiousDiseasesMember" xlink:to="dvax_NationalInstituteOfAllergyAndInfectiousDiseasesMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_NationalInstituteOfAllergyAndInfectiousDiseasesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">National Institute Of Allergy And Infectious Diseases</label>
    <label xml:lang="en-US" xlink:label="dvax_NationalInstituteOfAllergyAndInfectiousDiseasesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">National Institute Of Allergy And Infectious Diseases [Member]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_EarningsPerShareBasicAndDilutedDenominatorAbstract" xlink:type="locator" xlink:label="dvax_EarningsPerShareBasicAndDilutedDenominatorAbstract" />
    <label xml:lang="en-US" xlink:label="dvax_EarningsPerShareBasicAndDilutedDenominatorAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Earnings Per Share Basic And Diluted Denominator [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_EarningsPerShareBasicAndDilutedDenominatorAbstract" xlink:to="dvax_EarningsPerShareBasicAndDilutedDenominatorAbstract_lbl" />
    <loc xlink:href="dvax-20131231.xsd#dvax_DisclosureComputationOfBasicAndDilutedEarningsPerShareAbstract" xlink:type="locator" xlink:label="dvax_DisclosureComputationOfBasicAndDilutedEarningsPerShareAbstract" />
    <label xml:lang="en-US" xlink:label="dvax_DisclosureComputationOfBasicAndDilutedEarningsPerShareAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure Computation Of Basic And Diluted Earnings Per Share [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_DisclosureComputationOfBasicAndDilutedEarningsPerShareAbstract" xlink:to="dvax_DisclosureComputationOfBasicAndDilutedEarningsPerShareAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_DisclosureComputationOfBasicAndDilutedEarningsPerShareAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure Computation Of Basic And Diluted Earnings Per Share [Abstract]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_EarningsPerShareDisclosureLineItems" xlink:type="locator" xlink:label="dvax_EarningsPerShareDisclosureLineItems" />
    <label xml:lang="en-US" xlink:label="dvax_EarningsPerShareDisclosureLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Earnings Per Share Disclosure [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_EarningsPerShareDisclosureLineItems" xlink:to="dvax_EarningsPerShareDisclosureLineItems_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_DisclosureComputationOfBasicAndDilutedEarningsPerShareAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Disclosure Computation Of Basic And Diluted Earnings Per Share [Abstract]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_EarningsPerShareDisclosureTable" xlink:type="locator" xlink:label="dvax_EarningsPerShareDisclosureTable" />
    <label xml:lang="en-US" xlink:label="dvax_EarningsPerShareDisclosureTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Earnings Per Share Disclosure [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_EarningsPerShareDisclosureTable" xlink:to="dvax_EarningsPerShareDisclosureTable_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_EarningsPerShareDisclosureTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Earnings Per Share Disclosure [Table]</label>
    <label xml:lang="en-US" xlink:label="dvax_EarningsPerShareDisclosureTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share Disclosure [Table]</label>
    <label xml:lang="en-US" xlink:label="dvax_EarningsPerShareDisclosureLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Earnings Per Share Disclosure [Line Items]</label>
    <label xml:lang="en-US" xlink:label="dvax_EarningsPerShareDisclosureLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share Disclosure [Line Items]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basic and diluted net loss per share (in thousands, except per share amounts):</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Abstract]</label>
    <label xml:lang="en-US" xlink:label="dvax_EarningsPerShareBasicAndDilutedDenominatorAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Denominator for basic and diluted net loss per share allocable to common stockholders:</label>
    <label xml:lang="en-US" xlink:label="dvax_EarningsPerShareBasicAndDilutedDenominatorAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share Basic And Diluted Denominator [Abstract]</label>
    <label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted-average common shares outstanding</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_AntidilutiveSecuritiesExcludedFromComputationOfEarningPerShareAbstract" xlink:type="locator" xlink:label="dvax_AntidilutiveSecuritiesExcludedFromComputationOfEarningPerShareAbstract" />
    <label xml:lang="en-US" xlink:label="dvax_AntidilutiveSecuritiesExcludedFromComputationOfEarningPerShareAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Antidilutive Securities Excluded From Computation Of Earning Per Share [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_AntidilutiveSecuritiesExcludedFromComputationOfEarningPerShareAbstract" xlink:to="dvax_AntidilutiveSecuritiesExcludedFromComputationOfEarningPerShareAbstract_lbl" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" />
    <label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities, Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Name [Domain]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_StockOptionsAndShareAwardsMember" xlink:type="locator" xlink:label="dvax_StockOptionsAndShareAwardsMember" />
    <label xml:lang="en-US" xlink:label="dvax_StockOptionsAndShareAwardsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock Options And Share Awards [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_StockOptionsAndShareAwardsMember" xlink:to="dvax_StockOptionsAndShareAwardsMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_StockOptionsAndShareAwardsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Options and Stock Awards</label>
    <label xml:lang="en-US" xlink:label="dvax_StockOptionsAndShareAwardsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Options And Share Awards [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WarrantMember" xlink:type="locator" xlink:label="us-gaap_WarrantMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_WarrantMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_WarrantMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Warrant [Member]</label>
    <label xml:lang="en-US" xlink:label="dvax_AntidilutiveSecuritiesExcludedFromComputationOfEarningPerShareAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstanding securities not included in diluted net loss per share calculation (in thousands):</label>
    <label xml:lang="en-US" xlink:label="dvax_AntidilutiveSecuritiesExcludedFromComputationOfEarningPerShareAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded From Computation Of Earning Per Share [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstanding securities not included in diluted net loss per share calculation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_PreferredStockCommonStockAndWarrantsAbstract" xlink:type="locator" xlink:label="dvax_PreferredStockCommonStockAndWarrantsAbstract" />
    <label xml:lang="en-US" xlink:label="dvax_PreferredStockCommonStockAndWarrantsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Preferred stock common Stock and warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_PreferredStockCommonStockAndWarrantsAbstract" xlink:to="dvax_PreferredStockCommonStockAndWarrantsAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_PreferredStockCommonStockAndWarrantsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Common Stock And Warrants [Abstract]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:type="locator" xlink:label="dvax_PreferredStockCommonStockAndWarrantsLineItems" />
    <label xml:lang="en-US" xlink:label="dvax_PreferredStockCommonStockAndWarrantsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Preferred stock common stock and warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="dvax_PreferredStockCommonStockAndWarrantsLineItems_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_PreferredStockCommonStockAndWarrantsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred Stock Common Stock And Warrants [Abstract]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_PreferredStockCommonStockAndWarrantsTable" xlink:type="locator" xlink:label="dvax_PreferredStockCommonStockAndWarrantsTable" />
    <label xml:lang="en-US" xlink:label="dvax_PreferredStockCommonStockAndWarrantsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Preferred stock common stock and warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_PreferredStockCommonStockAndWarrantsTable" xlink:to="dvax_PreferredStockCommonStockAndWarrantsTable_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_PreferredStockCommonStockAndWarrantsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred Stock Common Stock And Warrants [Table]</label>
    <label xml:lang="en-US" xlink:label="dvax_PreferredStockCommonStockAndWarrantsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Common Stock And Warrants [Table]</label>
    <label xml:lang="en-US" xlink:label="dvax_PreferredStockCommonStockAndWarrantsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred Stock Common Stock And Warrants [Line Items]</label>
    <label xml:lang="en-US" xlink:label="dvax_PreferredStockCommonStockAndWarrantsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Common Stock And Warrants [Line Items]</label>
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock issued during period, shares</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityIssuancePerShareAmount" xlink:type="locator" xlink:label="us-gaap_EquityIssuancePerShareAmount" />
    <label xml:lang="en-US" xlink:label="us-gaap_EquityIssuancePerShareAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Public offering net price per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityIssuancePerShareAmount" xlink:to="us-gaap_EquityIssuancePerShareAmount_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_EquityIssuancePerShareAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equity Issuance Per Share Amount</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" />
    <label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gross proceeds from issuance of stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Or Sale Of Equity</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
    <label xml:lang="en-US" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments Of Stock Issuance Costs</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" />
    <label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net proceeds from offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Initial Public Offering</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" />
    <label xml:lang="en-US" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible common stock shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Preferred Stock Shares Issued Upon Conversion</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredStockTermsOfConversion" xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockTermsOfConversion" />
    <label xml:lang="en-US" xlink:label="us-gaap_ConvertiblePreferredStockTermsOfConversion_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible preferred stock, terms of conversion</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockTermsOfConversion" xlink:to="us-gaap_ConvertiblePreferredStockTermsOfConversion_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ConvertiblePreferredStockTermsOfConversion_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Preferred Stock Terms Of Conversion</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredStockSettlementTerms" xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockSettlementTerms" />
    <label xml:lang="en-US" xlink:label="us-gaap_ConvertiblePreferredStockSettlementTerms_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible preferred stock, settlement terms</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockSettlementTerms" xlink:to="us-gaap_ConvertiblePreferredStockSettlementTerms_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ConvertiblePreferredStockSettlementTerms_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Preferred Stock Settlement Terms</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_DeemedDividend" xlink:type="locator" xlink:label="dvax_DeemedDividend" />
    <label xml:lang="en-US" xlink:label="dvax_DeemedDividend_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Deemed dividend.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_DeemedDividend" xlink:to="dvax_DeemedDividend_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_DeemedDividend_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible common stock exceeded allocated purchase price of preferred stock</label>
    <label xml:lang="en-US" xlink:label="dvax_DeemedDividend_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deemed Dividend</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_PercentageOfCommonSharesOutstanding" xlink:type="locator" xlink:label="dvax_PercentageOfCommonSharesOutstanding" />
    <label xml:lang="en-US" xlink:label="dvax_PercentageOfCommonSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of Common Shares Outstanding.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_PercentageOfCommonSharesOutstanding" xlink:to="dvax_PercentageOfCommonSharesOutstanding_lbl" />
    <loc xlink:href="dvax-20131231.xsd#dvax_PercentageOfCompanyAssets" xlink:type="locator" xlink:label="dvax_PercentageOfCompanyAssets" />
    <label xml:lang="en-US" xlink:label="dvax_PercentageOfCompanyAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of Company Assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_PercentageOfCompanyAssets" xlink:to="dvax_PercentageOfCompanyAssets_lbl" />
    <loc xlink:href="dvax-20131231.xsd#dvax_RightsExpirationDate" xlink:type="locator" xlink:label="dvax_RightsExpirationDate" />
    <label xml:lang="en-US" xlink:label="dvax_RightsExpirationDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Rights Expiration Date.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_RightsExpirationDate" xlink:to="dvax_RightsExpirationDate_lbl" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DividendPayableDateToBePaidDayMonthAndYear" xlink:type="locator" xlink:label="us-gaap_DividendPayableDateToBePaidDayMonthAndYear" />
    <label xml:lang="en-US" xlink:label="us-gaap_DividendPayableDateToBePaidDayMonthAndYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dividends payable date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendPayableDateToBePaidDayMonthAndYear" xlink:to="us-gaap_DividendPayableDateToBePaidDayMonthAndYear_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DividendPayableDateToBePaidDayMonthAndYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Dividend Payable Date To Be Paid Day Month And Year</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharePrice" xlink:type="locator" xlink:label="us-gaap_SharePrice" />
    <label xml:lang="en-US" xlink:label="us-gaap_SharePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred shares price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SharePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Price</label>
    <label xml:lang="en-US" xlink:label="dvax_PercentageOfCommonSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of common shares outstanding</label>
    <label xml:lang="en-US" xlink:label="dvax_PercentageOfCommonSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Common Shares Outstanding</label>
    <label xml:lang="en-US" xlink:label="dvax_PercentageOfCompanyAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of assets</label>
    <label xml:lang="en-US" xlink:label="dvax_PercentageOfCompanyAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Company Assets</label>
    <label xml:lang="en-US" xlink:label="dvax_RightsExpirationDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Rights expiration date</label>
    <label xml:lang="en-US" xlink:label="dvax_RightsExpirationDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Rights Expiration Date</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_SellingCommissionPercentageFromGrossOfferingProceedsOfSalesOfStock" xlink:type="locator" xlink:label="dvax_SellingCommissionPercentageFromGrossOfferingProceedsOfSalesOfStock" />
    <label xml:lang="en-US" xlink:label="dvax_SellingCommissionPercentageFromGrossOfferingProceedsOfSalesOfStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Selling Commission Percentage from Gross Offering Proceeds of Sales of Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_SellingCommissionPercentageFromGrossOfferingProceedsOfSalesOfStock" xlink:to="dvax_SellingCommissionPercentageFromGrossOfferingProceedsOfSalesOfStock_lbl" />
    <loc xlink:href="dvax-20131231.xsd#dvax_MlvMember" xlink:type="locator" xlink:label="dvax_MlvMember" />
    <label xml:lang="en-US" xlink:label="dvax_MlvMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Mlv Member.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_MlvMember" xlink:to="dvax_MlvMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_MlvMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">MLV</label>
    <label xml:lang="en-US" xlink:label="dvax_MlvMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Mlv [Member]</label>
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common stock aggregate offering price</label>
    <label xml:lang="en-US" xlink:label="dvax_SellingCommissionPercentageFromGrossOfferingProceedsOfSalesOfStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commission on gross sales proceeds of common stock</label>
    <label xml:lang="en-US" xlink:label="dvax_SellingCommissionPercentageFromGrossOfferingProceedsOfSalesOfStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Selling Commission Percentage From Gross Offering Proceeds Of Sales Of Stock</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of stock pursuant to exercise of underwriters overallotment option</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Issued For Services</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_PurchaseAgreementPeriod" xlink:type="locator" xlink:label="dvax_PurchaseAgreementPeriod" />
    <label xml:lang="en-US" xlink:label="dvax_PurchaseAgreementPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Purchase Agreement Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_PurchaseAgreementPeriod" xlink:to="dvax_PurchaseAgreementPeriod_lbl" />
    <loc xlink:href="dvax-20131231.xsd#dvax_PercentageOfCommitmentToPurchaseSharesValue" xlink:type="locator" xlink:label="dvax_PercentageOfCommitmentToPurchaseSharesValue" />
    <label xml:lang="en-US" xlink:label="dvax_PercentageOfCommitmentToPurchaseSharesValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of Commitment To Purchase Shares Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_PercentageOfCommitmentToPurchaseSharesValue" xlink:to="dvax_PercentageOfCommitmentToPurchaseSharesValue_lbl" />
    <loc xlink:href="dvax-20131231.xsd#dvax_CommitmentFeePaid" xlink:type="locator" xlink:label="dvax_CommitmentFeePaid" />
    <label xml:lang="en-US" xlink:label="dvax_CommitmentFeePaid_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Commitment Fee Paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_CommitmentFeePaid" xlink:to="dvax_CommitmentFeePaid_lbl" />
    <loc xlink:href="dvax-20131231.xsd#dvax_AspireCapitalFundLlcMember" xlink:type="locator" xlink:label="dvax_AspireCapitalFundLlcMember" />
    <label xml:lang="en-US" xlink:label="dvax_AspireCapitalFundLlcMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Aspire Capital Fund Llc Member.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_AspireCapitalFundLlcMember" xlink:to="dvax_AspireCapitalFundLlcMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_AspireCapitalFundLlcMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aspire Capital Fund Llc</label>
    <label xml:lang="en-US" xlink:label="dvax_AspireCapitalFundLlcMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Aspire Capital Fund Llc [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" />
    <label xml:lang="en-US" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitment to purchase shares value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedPerTransaction_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sale Of Stock Consideration Received Per Transaction</label>
    <label xml:lang="en-US" xlink:label="dvax_PurchaseAgreementPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase agreement term</label>
    <label xml:lang="en-US" xlink:label="dvax_PurchaseAgreementPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Purchase Agreement Period</label>
    <label xml:lang="en-US" xlink:label="dvax_PercentageOfCommitmentToPurchaseSharesValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of commitment to purchase shares value as commitment fee</label>
    <label xml:lang="en-US" xlink:label="dvax_PercentageOfCommitmentToPurchaseSharesValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Commitment To Purchase Shares Value</label>
    <label xml:lang="en-US" xlink:label="dvax_CommitmentFeePaid_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitment fee paid</label>
    <label xml:lang="en-US" xlink:label="dvax_CommitmentFeePaid_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitment Fee Paid</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of shares of common stock for commitment fee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Other</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_NumberOfSharesOfCommonStockInEachUnit" xlink:type="locator" xlink:label="dvax_NumberOfSharesOfCommonStockInEachUnit" />
    <label xml:lang="en-US" xlink:label="dvax_NumberOfSharesOfCommonStockInEachUnit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of Shares of Common Stock in Each Unit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_NumberOfSharesOfCommonStockInEachUnit" xlink:to="dvax_NumberOfSharesOfCommonStockInEachUnit_lbl" />
    <loc xlink:href="dvax-20131231.xsd#dvax_NumberOfWarrantsInEachUnit" xlink:type="locator" xlink:label="dvax_NumberOfWarrantsInEachUnit" />
    <label xml:lang="en-US" xlink:label="dvax_NumberOfWarrantsInEachUnit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of Warrants in Each Unit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_NumberOfWarrantsInEachUnit" xlink:to="dvax_NumberOfWarrantsInEachUnit_lbl" />
    <loc xlink:href="dvax-20131231.xsd#dvax_CommonStockIssuableUponExerciseOfWarrantsConversionRatio" xlink:type="locator" xlink:label="dvax_CommonStockIssuableUponExerciseOfWarrantsConversionRatio" />
    <label xml:lang="en-US" xlink:label="dvax_CommonStockIssuableUponExerciseOfWarrantsConversionRatio_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Common Stock Issuable Upon Exercise of Warrants Conversion Ratio</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_CommonStockIssuableUponExerciseOfWarrantsConversionRatio" xlink:to="dvax_CommonStockIssuableUponExerciseOfWarrantsConversionRatio_lbl" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Axis]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument, Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Name [Domain]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_LoanAgreementMember" xlink:type="locator" xlink:label="dvax_LoanAgreementMember" />
    <label xml:lang="en-US" xlink:label="dvax_LoanAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Loan Agreement Member.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_LoanAgreementMember" xlink:to="dvax_LoanAgreementMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_LoanAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2007 Loan Agreement</label>
    <label xml:lang="en-US" xlink:label="dvax_LoanAgreementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Loan Agreement [Member]</label>
    <label xml:lang="en-US" xlink:label="dvax_NumberOfSharesOfCommonStockInEachUnit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares of common stock in each unit</label>
    <label xml:lang="en-US" xlink:label="dvax_NumberOfSharesOfCommonStockInEachUnit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Shares Of Common Stock In Each Unit</label>
    <label xml:lang="en-US" xlink:label="dvax_NumberOfWarrantsInEachUnit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of warrants in each unit</label>
    <label xml:lang="en-US" xlink:label="dvax_NumberOfWarrantsInEachUnit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Warrants In Each Unit</label>
    <label xml:lang="en-US" xlink:label="dvax_CommonStockIssuableUponExerciseOfWarrantsConversionRatio_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of share per warrant</label>
    <label xml:lang="en-US" xlink:label="dvax_CommonStockIssuableUponExerciseOfWarrantsConversionRatio_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Issuable Upon Exercise Of Warrants Conversion Ratio</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesConverted1" />
    <label xml:lang="en-US" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of warrants for common shares to be purchased</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Conversion Of Stock Shares Converted1</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_WarrantIssueDate" xlink:type="locator" xlink:label="dvax_WarrantIssueDate" />
    <label xml:lang="en-US" xlink:label="dvax_WarrantIssueDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Warrant Issue Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_WarrantIssueDate" xlink:to="dvax_WarrantIssueDate_lbl" />
    <loc xlink:href="dvax-20131231.xsd#dvax_WarrantExpirationDate" xlink:type="locator" xlink:label="dvax_WarrantExpirationDate" />
    <label xml:lang="en-US" xlink:label="dvax_WarrantExpirationDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Warrant, Expiration Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_WarrantExpirationDate" xlink:to="dvax_WarrantExpirationDate_lbl" />
    <loc xlink:href="dvax-20131231.xsd#dvax_DisclosureWarrantsIssuedToPurchaseCommonStockAbstract" xlink:type="locator" xlink:label="dvax_DisclosureWarrantsIssuedToPurchaseCommonStockAbstract" />
    <label xml:lang="en-US" xlink:label="dvax_DisclosureWarrantsIssuedToPurchaseCommonStockAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure Warrants Issued To Purchase Common Stock [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_DisclosureWarrantsIssuedToPurchaseCommonStockAbstract" xlink:to="dvax_DisclosureWarrantsIssuedToPurchaseCommonStockAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_DisclosureWarrantsIssuedToPurchaseCommonStockAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Disclosure Warrants Issued To Purchase Common Stock [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightTable" />
    <label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class Of Warrant Or Right [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightTable_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right [Table]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_WarrantOneMember" xlink:type="locator" xlink:label="dvax_WarrantOneMember" />
    <label xml:lang="en-US" xlink:label="dvax_WarrantOneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Warrant One Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_WarrantOneMember" xlink:to="dvax_WarrantOneMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_WarrantOneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant One</label>
    <label xml:lang="en-US" xlink:label="dvax_WarrantOneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Warrant One [Member]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_WarrantTwoMember" xlink:type="locator" xlink:label="dvax_WarrantTwoMember" />
    <label xml:lang="en-US" xlink:label="dvax_WarrantTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Warrant Two Member.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_WarrantTwoMember" xlink:to="dvax_WarrantTwoMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_WarrantTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant Two</label>
    <label xml:lang="en-US" xlink:label="dvax_WarrantTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Warrant Two [Member]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_WarrantThreeMember" xlink:type="locator" xlink:label="dvax_WarrantThreeMember" />
    <label xml:lang="en-US" xlink:label="dvax_WarrantThreeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Warrant Three Member.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_WarrantThreeMember" xlink:to="dvax_WarrantThreeMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_WarrantThreeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant Three</label>
    <label xml:lang="en-US" xlink:label="dvax_WarrantThreeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Warrant Three [Member]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_WarrantFourMember" xlink:type="locator" xlink:label="dvax_WarrantFourMember" />
    <label xml:lang="en-US" xlink:label="dvax_WarrantFourMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Warrant Four Member.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_WarrantFourMember" xlink:to="dvax_WarrantFourMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_WarrantFourMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant Four</label>
    <label xml:lang="en-US" xlink:label="dvax_WarrantFourMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Warrant Four [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems" />
    <label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class Of Warrant Or Right [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right [Line Items]</label>
    <label xml:lang="en-US" xlink:label="dvax_WarrantIssueDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant Issuance Date</label>
    <label xml:lang="en-US" xlink:label="dvax_WarrantIssueDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Warrant Issue Date</label>
    <label xml:lang="en-US" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Shares Issuable</label>
    <label xml:lang="en-US" xlink:label="dvax_WarrantExpirationDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expiration Date</label>
    <label xml:lang="en-US" xlink:label="dvax_WarrantExpirationDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Warrant Expiration Date</label>
    <label xml:lang="en-US" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Outstanding</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_WarrantToPurchaseCommonStock" xlink:type="locator" xlink:label="dvax_WarrantToPurchaseCommonStock" />
    <label xml:lang="en-US" xlink:label="dvax_WarrantToPurchaseCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Warrant To Purchase Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_WarrantToPurchaseCommonStock" xlink:to="dvax_WarrantToPurchaseCommonStock_lbl" />
    <loc xlink:href="dvax-20131231.xsd#dvax_NumberOfWarrantsExercisedDuringPeriod" xlink:type="locator" xlink:label="dvax_NumberOfWarrantsExercisedDuringPeriod" />
    <label xml:lang="en-US" xlink:label="dvax_NumberOfWarrantsExercisedDuringPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of warrants exercised during period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_NumberOfWarrantsExercisedDuringPeriod" xlink:to="dvax_NumberOfWarrantsExercisedDuringPeriod_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_WarrantToPurchaseCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants to purchase common stock</label>
    <label xml:lang="en-US" xlink:label="dvax_WarrantToPurchaseCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Warrant To Purchase Common Stock</label>
    <label xml:lang="en-US" xlink:label="dvax_NumberOfWarrantsExercisedDuringPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number Of Warrants Exercised During Period</label>
    <label xml:lang="en-US" xlink:label="dvax_NumberOfWarrantsExercisedDuringPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Warrants Exercised During Period</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_NumberOfShareBasedCompensationPlans" xlink:type="locator" xlink:label="dvax_NumberOfShareBasedCompensationPlans" />
    <label xml:lang="en-US" xlink:label="dvax_NumberOfShareBasedCompensationPlans_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of share based compensation plans.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_NumberOfShareBasedCompensationPlans" xlink:to="dvax_NumberOfShareBasedCompensationPlans_lbl" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</label>
    <label xml:lang="en-US" xlink:label="dvax_NumberOfShareBasedCompensationPlans_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of share-based compensation plans</label>
    <label xml:lang="en-US" xlink:label="dvax_NumberOfShareBasedCompensationPlans_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Share Based Compensation Plans</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <label xml:lang="en-US" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Axis]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <label xml:lang="en-US" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Domain]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_StockIncentivePlanTwentyZeroFourMember" xlink:type="locator" xlink:label="dvax_StockIncentivePlanTwentyZeroFourMember" />
    <label xml:lang="en-US" xlink:label="dvax_StockIncentivePlanTwentyZeroFourMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock Incentive Plan Twenty Zero Four Member.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_StockIncentivePlanTwentyZeroFourMember" xlink:to="dvax_StockIncentivePlanTwentyZeroFourMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_StockIncentivePlanTwentyZeroFourMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2004 Plan</label>
    <label xml:lang="en-US" xlink:label="dvax_StockIncentivePlanTwentyZeroFourMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Incentive Plan Twenty Zero Four [Member]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_OtherParticipantsMember" xlink:type="locator" xlink:label="dvax_OtherParticipantsMember" />
    <label xml:lang="en-US" xlink:label="dvax_OtherParticipantsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Other Participants Member.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_OtherParticipantsMember" xlink:to="dvax_OtherParticipantsMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_OtherParticipantsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other Participants</label>
    <label xml:lang="en-US" xlink:label="dvax_OtherParticipantsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Participants [Member]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_GroupTwoMember" xlink:type="locator" xlink:label="dvax_GroupTwoMember" />
    <label xml:lang="en-US" xlink:label="dvax_GroupTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Group Two Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_GroupTwoMember" xlink:to="dvax_GroupTwoMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_GroupTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock possessing more than 10% of the voting power of all classes of the Company&apos;s stock or the stock of any parent or subsidiary of the Company</label>
    <label xml:lang="en-US" xlink:label="dvax_GroupTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Group Two [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expiration period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" />
    <label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase price per share as percentage of fair market value of common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares of Common Stock outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_EmploymentInducementAwardPlanTwentyTenMember" xlink:type="locator" xlink:label="dvax_EmploymentInducementAwardPlanTwentyTenMember" />
    <label xml:lang="en-US" xlink:label="dvax_EmploymentInducementAwardPlanTwentyTenMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Employment Inducement Award Plan Twenty Ten Member .</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_EmploymentInducementAwardPlanTwentyTenMember" xlink:to="dvax_EmploymentInducementAwardPlanTwentyTenMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_EmploymentInducementAwardPlanTwentyTenMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Inducement Plan</label>
    <label xml:lang="en-US" xlink:label="dvax_EmploymentInducementAwardPlanTwentyTenMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employment Inducement Award Plan Twenty Ten [Member]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_EquityIncentivePlanTwentyElevenMember" xlink:type="locator" xlink:label="dvax_EquityIncentivePlanTwentyElevenMember" />
    <label xml:lang="en-US" xlink:label="dvax_EquityIncentivePlanTwentyElevenMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Equity Incentive Plan Twenty Eleven Member.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_EquityIncentivePlanTwentyElevenMember" xlink:to="dvax_EquityIncentivePlanTwentyElevenMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_EquityIncentivePlanTwentyElevenMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2011 Plan</label>
    <label xml:lang="en-US" xlink:label="dvax_EquityIncentivePlanTwentyElevenMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equity Incentive Plan Twenty Eleven [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase in the aggregate number of shares of common stock authorized for issuance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares reserved and approved for issuance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <label xml:lang="en-US" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Award Type [Axis]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Award</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_UnvestedMember" xlink:type="locator" xlink:label="dvax_UnvestedMember" />
    <label xml:lang="en-US" xlink:label="dvax_UnvestedMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Unvested.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_UnvestedMember" xlink:to="dvax_UnvestedMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_UnvestedMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unvested</label>
    <label xml:lang="en-US" xlink:label="dvax_UnvestedMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unvested [Member]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_VestedMember" xlink:type="locator" xlink:label="dvax_VestedMember" />
    <label xml:lang="en-US" xlink:label="dvax_VestedMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Vested.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_VestedMember" xlink:to="dvax_VestedMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_VestedMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested</label>
    <label xml:lang="en-US" xlink:label="dvax_VestedMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Vested [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Options Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Roll Forward</label>
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning balance</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Options exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Stock Options Exercised</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Options cancelled</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period</label>
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending balance</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested and expected to vest at end of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercisable at end of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice" xlink:type="locator" xlink:label="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice" />
    <label xml:lang="en-US" xlink:label="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award options and equity instruments other than options nonvested weighted average price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice" xlink:to="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice_lbl" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-Average Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Rollforward</label>
    <label xml:lang="en-US" xlink:label="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning balance</label>
    <label xml:lang="en-US" xlink:label="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options And Equity Instruments Other Than Options Nonvested Weighted Average Price</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options cancelled</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price</label>
    <label xml:lang="en-US" xlink:label="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending balance</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested and expected to vest at end of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercisable at end of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:type="locator" xlink:label="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" />
    <label xml:lang="en-US" xlink:label="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Remaining Contractual Life (In years)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Balance at December 31, 2013</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" />
    <label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstanding options vested and expected to vest at end of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
    <label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options exercisable at end of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:type="locator" xlink:label="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" />
    <label xml:lang="en-US" xlink:label="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate Intrinsic Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Balance at December 31, 2013</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstanding options (vested and expected to vest) at end of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
    <label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options exercisable at end of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total intrinsic value of options exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
    <label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total fair value of stock options vested</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Stock Units (RSUs)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Stock Units R S U [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Roll Forward</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Vested</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Forfeited or expired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period</label>
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Grant Date Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Roll Forward</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Forfeited or expired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value</label>
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestrictedStockExpense" xlink:type="locator" xlink:label="us-gaap_RestrictedStockExpense" />
    <label xml:lang="en-US" xlink:label="us-gaap_RestrictedStockExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock based compensation expense related to restricted stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockExpense" xlink:to="us-gaap_RestrictedStockExpense_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_RestrictedStockExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Stock Expense</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" />
    <label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate intrinsic value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested</label>
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Grant date fair value of restricted stock</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total fair value of restricted stock units</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndRsuOutstandingNumber" xlink:type="locator" xlink:label="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndRsuOutstandingNumber" />
    <label xml:lang="en-US" xlink:label="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndRsuOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award options and Rsu outstanding number.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndRsuOutstandingNumber" xlink:to="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndRsuOutstandingNumber_lbl" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options vesting period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1</label>
    <label xml:lang="en-US" xlink:label="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndRsuOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options and restricted stock units outstanding</label>
    <label xml:lang="en-US" xlink:label="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndRsuOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options And Rsu Outstanding Number</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock Option [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected life (in year)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Volatility</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <label xml:lang="en-US" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsidiary, Sale of Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsidiary Sale Of Stock [Axis]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <label xml:lang="en-US" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock, Name of Transaction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sale Of Stock Name Of Transaction [Domain]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeStockMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_EmployeeStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee Stock Purchase Plan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockMember" xlink:to="us-gaap_EmployeeStockMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_EmployeeStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected dividend yield</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTable" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Deferred Compensation Arrangement With Individual Share Based Payments [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTable" xlink:to="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTable_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Deferred Compensation Arrangement With Individual Share Based Payments [Table]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Axis]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Domain]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_EmployeesAndDirectorsMember" xlink:type="locator" xlink:label="dvax_EmployeesAndDirectorsMember" />
    <label xml:lang="en-US" xlink:label="dvax_EmployeesAndDirectorsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Employees and Directors.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_EmployeesAndDirectorsMember" xlink:to="dvax_EmployeesAndDirectorsMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_EmployeesAndDirectorsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employees And Directors</label>
    <label xml:lang="en-US" xlink:label="dvax_EmployeesAndDirectorsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employees And Directors [Member]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_NonEmployeeMember" xlink:type="locator" xlink:label="dvax_NonEmployeeMember" />
    <label xml:lang="en-US" xlink:label="dvax_NonEmployeeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Non Employee.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_NonEmployeeMember" xlink:to="dvax_NonEmployeeMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_NonEmployeeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non Employee</label>
    <label xml:lang="en-US" xlink:label="dvax_NonEmployeeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Non Employee [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Expense [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and Administrative Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">General And Administrative Expense [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" xlink:type="locator" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred Compensation Arrangement With Individual Share Based Payments [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Compensation Arrangement With Individual Share Based Payments [Line Items]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" xlink:type="locator" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Type of Deferred Compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Compensation Arrangement With Individual Share Based Payments By Type Of Deferred Compensation [Axis]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TypeOfDeferredCompensationDomain" xlink:type="locator" xlink:label="us-gaap_TypeOfDeferredCompensationDomain" />
    <label xml:lang="en-US" xlink:label="us-gaap_TypeOfDeferredCompensationDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Type of Deferred Compensation, All Types</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfDeferredCompensationDomain" xlink:to="us-gaap_TypeOfDeferredCompensationDomain_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_TypeOfDeferredCompensationDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Type Of Deferred Compensation [Domain]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_NonEmployeeAwardsMember" xlink:type="locator" xlink:label="dvax_NonEmployeeAwardsMember" />
    <label xml:lang="en-US" xlink:label="dvax_NonEmployeeAwardsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Non Employee Awards Member.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_NonEmployeeAwardsMember" xlink:to="dvax_NonEmployeeAwardsMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_NonEmployeeAwardsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non Employee Awards</label>
    <label xml:lang="en-US" xlink:label="dvax_NonEmployeeAwardsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Non Employee Awards [Member]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_AdditionalMember" xlink:type="locator" xlink:label="dvax_AdditionalMember" />
    <label xml:lang="en-US" xlink:label="dvax_AdditionalMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Additional Member.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_AdditionalMember" xlink:to="dvax_AdditionalMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_AdditionalMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional</label>
    <label xml:lang="en-US" xlink:label="dvax_AdditionalMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Additional [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <label xml:lang="en-US" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Recognized stock-based compensation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Allocated Share Based Compensation Expense</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DefinedContributionPlanNumberOfEmployeesCovered" xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanNumberOfEmployeesCovered" />
    <label xml:lang="en-US" xlink:label="us-gaap_DefinedContributionPlanNumberOfEmployeesCovered_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of employees under stock option</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanNumberOfEmployeesCovered" xlink:to="us-gaap_DefinedContributionPlanNumberOfEmployeesCovered_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DefinedContributionPlanNumberOfEmployeesCovered_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan Number Of Employees Covered</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_TimeBasedVestingScheduleMember" xlink:type="locator" xlink:label="dvax_TimeBasedVestingScheduleMember" />
    <label xml:lang="en-US" xlink:label="dvax_TimeBasedVestingScheduleMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Time Based Vesting Schedule Member.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_TimeBasedVestingScheduleMember" xlink:to="dvax_TimeBasedVestingScheduleMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_TimeBasedVestingScheduleMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Time Based Vesting Schedule</label>
    <label xml:lang="en-US" xlink:label="dvax_TimeBasedVestingScheduleMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Time Based Vesting Schedule [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
    <label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total unrecognized compensation cost related to non-vested equity awards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total unrecognized compensation cost, weighted-average vesting period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_PeriodAxis" xlink:type="locator" xlink:label="dvax_PeriodAxis" />
    <label xml:lang="en-US" xlink:label="dvax_PeriodAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Period Axis.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_PeriodAxis" xlink:to="dvax_PeriodAxis_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_PeriodAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Period</label>
    <label xml:lang="en-US" xlink:label="dvax_PeriodAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Period [Axis]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_PeriodDomain" xlink:type="locator" xlink:label="dvax_PeriodDomain" />
    <label xml:lang="en-US" xlink:label="dvax_PeriodDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Period Domain.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_PeriodDomain" xlink:to="dvax_PeriodDomain_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_PeriodDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Period</label>
    <label xml:lang="en-US" xlink:label="dvax_PeriodDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Period [Domain]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_PeriodOneMember" xlink:type="locator" xlink:label="dvax_PeriodOneMember" />
    <label xml:lang="en-US" xlink:label="dvax_PeriodOneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Period One Member.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_PeriodOneMember" xlink:to="dvax_PeriodOneMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_PeriodOneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">The commencement of the offer period (generally, the fifteenth day in February or August)</label>
    <label xml:lang="en-US" xlink:label="dvax_PeriodOneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Period One [Member]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_PeriodTwoMember" xlink:type="locator" xlink:label="dvax_PeriodTwoMember" />
    <label xml:lang="en-US" xlink:label="dvax_PeriodTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Period Two Member.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_PeriodTwoMember" xlink:to="dvax_PeriodTwoMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_PeriodTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">The exercise date, which is the last day of a purchase period (generally, the fourteenth day in February or August)</label>
    <label xml:lang="en-US" xlink:label="dvax_PeriodTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Period Two [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares issued to employees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Shares Purchased For Award</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares remaining available for future purchases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_DisclosureComponentOfConsolidatedIncomeLossBeforeProvisionForIncomeTaxesAbstract" xlink:type="locator" xlink:label="dvax_DisclosureComponentOfConsolidatedIncomeLossBeforeProvisionForIncomeTaxesAbstract" />
    <label xml:lang="en-US" xlink:label="dvax_DisclosureComponentOfConsolidatedIncomeLossBeforeProvisionForIncomeTaxesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure - Component of Consolidated Income (Loss) Before Provision for Income Taxes [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_DisclosureComponentOfConsolidatedIncomeLossBeforeProvisionForIncomeTaxesAbstract" xlink:to="dvax_DisclosureComponentOfConsolidatedIncomeLossBeforeProvisionForIncomeTaxesAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_DisclosureComponentOfConsolidatedIncomeLossBeforeProvisionForIncomeTaxesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure Component Of Consolidated Income Loss Before Provision For Income Taxes [Abstract]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" xlink:type="locator" xlink:label="dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" />
    <label xml:lang="en-US" xlink:label="dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of Components of Income Before Income Tax Expense (Benefit) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" xlink:to="dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_DisclosureComponentOfConsolidatedIncomeLossBeforeProvisionForIncomeTaxesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Disclosure Component Of Consolidated Income Loss Before Provision For Income Taxes [Abstract]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" xlink:type="locator" xlink:label="dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" />
    <label xml:lang="en-US" xlink:label="dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of Components of Income Before Income Tax Expense (Benefit) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" xlink:to="dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Components Of Income Before Income Tax Expense Benefit [Table]</label>
    <label xml:lang="en-US" xlink:label="dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Components Of Income Before Income Tax Expense Benefit [Table]</label>
    <label xml:lang="en-US" xlink:label="dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Components Of Income Before Income Tax Expense Benefit [Line Items]</label>
    <label xml:lang="en-US" xlink:label="dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Components Of Income Before Income Tax Expense Benefit [Line Items]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Loss From Continuing Operations Before Income Taxes Domestic</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non U.S.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Loss From Continuing Operations Before Income Taxes Foreign</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_IncomeTaxReconciliationDeferredCompensationCharges" xlink:type="locator" xlink:label="dvax_IncomeTaxReconciliationDeferredCompensationCharges" />
    <label xml:lang="en-US" xlink:label="dvax_IncomeTaxReconciliationDeferredCompensationCharges_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Income Tax Reconciliation, Deferred Compensation Charges</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_IncomeTaxReconciliationDeferredCompensationCharges" xlink:to="dvax_IncomeTaxReconciliationDeferredCompensationCharges_lbl" />
    <loc xlink:href="dvax-20131231.xsd#dvax_IncomeTaxReconciliationChangeInFairValueMeasurement" xlink:type="locator" xlink:label="dvax_IncomeTaxReconciliationChangeInFairValueMeasurement" />
    <label xml:lang="en-US" xlink:label="dvax_IncomeTaxReconciliationChangeInFairValueMeasurement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Income Tax Reconciliation Change In Fair Value Measurement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_IncomeTaxReconciliationChangeInFairValueMeasurement" xlink:to="dvax_IncomeTaxReconciliationChangeInFairValueMeasurement_lbl" />
    <loc xlink:href="dvax-20131231.xsd#dvax_DisclosureDifferenceBetweenConsolidatedIncomeTaxBenefitAndAmountComputedByFederalStatutoryIncomeTaxRateAbstract" xlink:type="locator" xlink:label="dvax_DisclosureDifferenceBetweenConsolidatedIncomeTaxBenefitAndAmountComputedByFederalStatutoryIncomeTaxRateAbstract" />
    <label xml:lang="en-US" xlink:label="dvax_DisclosureDifferenceBetweenConsolidatedIncomeTaxBenefitAndAmountComputedByFederalStatutoryIncomeTaxRateAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure - Difference between Consolidated Income Tax Benefit and Amount Computed by Federal Statutory Income Tax Rate [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_DisclosureDifferenceBetweenConsolidatedIncomeTaxBenefitAndAmountComputedByFederalStatutoryIncomeTaxRateAbstract" xlink:to="dvax_DisclosureDifferenceBetweenConsolidatedIncomeTaxBenefitAndAmountComputedByFederalStatutoryIncomeTaxRateAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_DisclosureDifferenceBetweenConsolidatedIncomeTaxBenefitAndAmountComputedByFederalStatutoryIncomeTaxRateAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure Difference Between Consolidated Income Tax Benefit And Amount Computed By Federal Statutory Income Tax Rate [Abstract]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_IncomeTaxRateReconciliationLineItems" xlink:type="locator" xlink:label="dvax_IncomeTaxRateReconciliationLineItems" />
    <label xml:lang="en-US" xlink:label="dvax_IncomeTaxRateReconciliationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Income Tax Rate Reconciliation [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_IncomeTaxRateReconciliationLineItems" xlink:to="dvax_IncomeTaxRateReconciliationLineItems_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_DisclosureDifferenceBetweenConsolidatedIncomeTaxBenefitAndAmountComputedByFederalStatutoryIncomeTaxRateAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Disclosure Difference Between Consolidated Income Tax Benefit And Amount Computed By Federal Statutory Income Tax Rate [Abstract]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_IncomeTaxRateReconciliationTable" xlink:type="locator" xlink:label="dvax_IncomeTaxRateReconciliationTable" />
    <label xml:lang="en-US" xlink:label="dvax_IncomeTaxRateReconciliationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Income Tax Rate Reconciliation [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_IncomeTaxRateReconciliationTable" xlink:to="dvax_IncomeTaxRateReconciliationTable_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_IncomeTaxRateReconciliationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Rate Reconciliation [Table]</label>
    <label xml:lang="en-US" xlink:label="dvax_IncomeTaxRateReconciliationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Rate Reconciliation [Table]</label>
    <label xml:lang="en-US" xlink:label="dvax_IncomeTaxRateReconciliationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Rate Reconciliation [Line Items]</label>
    <label xml:lang="en-US" xlink:label="dvax_IncomeTaxRateReconciliationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Rate Reconciliation [Line Items]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income tax benefit at federal statutory rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Reconciliation State And Local Income Taxes</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCredits" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationTaxCredits" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationTaxCredits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Business credits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationTaxCredits" xlink:to="us-gaap_IncomeTaxReconciliationTaxCredits_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationTaxCredits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Reconciliation Tax Credits</label>
    <label xml:lang="en-US" xlink:label="dvax_IncomeTaxReconciliationDeferredCompensationCharges_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred compensation charges</label>
    <label xml:lang="en-US" xlink:label="dvax_IncomeTaxReconciliationDeferredCompensationCharges_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Reconciliation Deferred Compensation Charges</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in foreign tax rates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Reconciliation Foreign Income Tax Rate Differential</label>
    <label xml:lang="en-US" xlink:label="dvax_IncomeTaxReconciliationChangeInFairValueMeasurement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in the fair value measurements</label>
    <label xml:lang="en-US" xlink:label="dvax_IncomeTaxReconciliationChangeInFairValueMeasurement_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Reconciliation Change In Fair Value Measurement</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-deductible debt discount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Reconciliation Nondeductible Expense Other</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationDeductionsDividends" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationDeductionsDividends" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationDeductionsDividends_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deemed dividend</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationDeductionsDividends" xlink:to="us-gaap_IncomeTaxReconciliationDeductionsDividends_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationDeductionsDividends_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Reconciliation Deductions Dividends</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prior year true up</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Reconciliation Prior Year Income Taxes</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Reconciliation Other Adjustments</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total income tax expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Expense Benefit</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_DisclosureComponentOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:type="locator" xlink:label="dvax_DisclosureComponentOfDeferredTaxAssetsAndLiabilitiesAbstract" />
    <label xml:lang="en-US" xlink:label="dvax_DisclosureComponentOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure - Component of Deferred Tax Assets and Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_DisclosureComponentOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="dvax_DisclosureComponentOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_DisclosureComponentOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure Component Of Deferred Tax Assets And Liabilities [Abstract]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_ScheduleOfDeferredTaxAssetsAndLiabilitiesLineItems" xlink:type="locator" xlink:label="dvax_ScheduleOfDeferredTaxAssetsAndLiabilitiesLineItems" />
    <label xml:lang="en-US" xlink:label="dvax_ScheduleOfDeferredTaxAssetsAndLiabilitiesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of Deferred Tax Assets and Liabilities [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_ScheduleOfDeferredTaxAssetsAndLiabilitiesLineItems" xlink:to="dvax_ScheduleOfDeferredTaxAssetsAndLiabilitiesLineItems_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_DisclosureComponentOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Disclosure Component Of Deferred Tax Assets And Liabilities [Abstract]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_ScheduleOfDeferredTaxAssetsAndLiabilitiesTable" xlink:type="locator" xlink:label="dvax_ScheduleOfDeferredTaxAssetsAndLiabilitiesTable" />
    <label xml:lang="en-US" xlink:label="dvax_ScheduleOfDeferredTaxAssetsAndLiabilitiesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of Deferred Tax Assets and Liabilities [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_ScheduleOfDeferredTaxAssetsAndLiabilitiesTable" xlink:to="dvax_ScheduleOfDeferredTaxAssetsAndLiabilitiesTable_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_ScheduleOfDeferredTaxAssetsAndLiabilitiesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Deferred Tax Assets And Liabilities [Table]</label>
    <label xml:lang="en-US" xlink:label="dvax_ScheduleOfDeferredTaxAssetsAndLiabilitiesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Deferred Tax Assets And Liabilities [Table]</label>
    <label xml:lang="en-US" xlink:label="dvax_ScheduleOfDeferredTaxAssetsAndLiabilitiesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Deferred Tax Assets And Liabilities [Line Items]</label>
    <label xml:lang="en-US" xlink:label="dvax_ScheduleOfDeferredTaxAssetsAndLiabilitiesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Deferred Tax Assets And Liabilities [Line Items]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsGrossAbstract" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGrossAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsGrossAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsGrossAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsGrossAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Gross [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carry forwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Operating Loss Carryforwards</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research tax credit carry forwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Tax Credit Carryforwards</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accruals and reserves</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Capitalized research costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Tax Credit Carryforwards Research</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Deferred Income</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Other</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Assets, Gross, Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Gross</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Valuation Allowance</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Net</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Fixed Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities Property Plant And Equipment</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesOther" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxLiabilitiesOther_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesOther" xlink:to="us-gaap_DeferredTaxLiabilitiesOther_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxLiabilitiesOther_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities Other</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilities" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Total deferred tax liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Liabilities Net</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_DisclosureIncomeTaxesAdditionalInformationAbstract" xlink:type="locator" xlink:label="dvax_DisclosureIncomeTaxesAdditionalInformationAbstract" />
    <label xml:lang="en-US" xlink:label="dvax_DisclosureIncomeTaxesAdditionalInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure Income Taxes Additional Information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_DisclosureIncomeTaxesAdditionalInformationAbstract" xlink:to="dvax_DisclosureIncomeTaxesAdditionalInformationAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_DisclosureIncomeTaxesAdditionalInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure Income Taxes Additional Information [Abstract]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_IncomeTaxDisclosureLineItems" xlink:type="locator" xlink:label="dvax_IncomeTaxDisclosureLineItems" />
    <label xml:lang="en-US" xlink:label="dvax_IncomeTaxDisclosureLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Income Tax Disclosure [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_IncomeTaxDisclosureLineItems" xlink:to="dvax_IncomeTaxDisclosureLineItems_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_DisclosureIncomeTaxesAdditionalInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Disclosure Income Taxes Additional Information [Abstract]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_IncomeTaxDisclosureTable" xlink:type="locator" xlink:label="dvax_IncomeTaxDisclosureTable" />
    <label xml:lang="en-US" xlink:label="dvax_IncomeTaxDisclosureTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Income Tax Disclosure [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_IncomeTaxDisclosureTable" xlink:to="dvax_IncomeTaxDisclosureTable_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_IncomeTaxDisclosureTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Disclosure [Table]</label>
    <label xml:lang="en-US" xlink:label="dvax_IncomeTaxDisclosureTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Table]</label>
    <label xml:lang="en-US" xlink:label="dvax_IncomeTaxDisclosureLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Disclosure [Line Items]</label>
    <label xml:lang="en-US" xlink:label="dvax_IncomeTaxDisclosureLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Line Items]</label>
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income tax expense</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="locator" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <label xml:lang="en-US" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase (decrease) in valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Valuation Allowance Deferred Tax Asset Change In Amount</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" xlink:type="locator" xlink:label="us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amount of valuation allowance for deferred tax assets allocated to contributed capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" xlink:to="us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Taxes Business Combination Valuation Allowance Allocated To Contributed Capital</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_OperatingLossCarryforwardExpirationYear" xlink:type="locator" xlink:label="dvax_OperatingLossCarryforwardExpirationYear" />
    <label xml:lang="en-US" xlink:label="dvax_OperatingLossCarryforwardExpirationYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating Loss Carryforward, Expiration Year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_OperatingLossCarryforwardExpirationYear" xlink:to="dvax_OperatingLossCarryforwardExpirationYear_lbl" />
    <loc xlink:href="dvax-20131231.xsd#dvax_TaxCreditCarryforwardExpirationYear" xlink:type="locator" xlink:label="dvax_TaxCreditCarryforwardExpirationYear" />
    <label xml:lang="en-US" xlink:label="dvax_TaxCreditCarryforwardExpirationYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Tax Credit Carryforward, Expiration Year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_TaxCreditCarryforwardExpirationYear" xlink:to="dvax_TaxCreditCarryforwardExpirationYear_lbl" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority [Axis]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority [Domain]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_FederalMember" xlink:type="locator" xlink:label="dvax_FederalMember" />
    <label xml:lang="en-US" xlink:label="dvax_FederalMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Federal [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_FederalMember" xlink:to="dvax_FederalMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_FederalMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal</label>
    <label xml:lang="en-US" xlink:label="dvax_FederalMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Federal [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAxis" />
    <label xml:lang="en-US" xlink:label="us-gaap_TaxCreditCarryforwardAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax Credit Carryforward</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardAxis_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_TaxCreditCarryforwardAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward [Axis]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain" />
    <label xml:lang="en-US" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax Credit Carryforward, Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward Name [Domain]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_ResearchAndDevelopmentMember" xlink:type="locator" xlink:label="dvax_ResearchAndDevelopmentMember" />
    <label xml:lang="en-US" xlink:label="dvax_ResearchAndDevelopmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Research And Development [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_ResearchAndDevelopmentMember" xlink:to="dvax_ResearchAndDevelopmentMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_ResearchAndDevelopmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research And Development</label>
    <label xml:lang="en-US" xlink:label="dvax_ResearchAndDevelopmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" />
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards</label>
    <label xml:lang="en-US" xlink:label="dvax_OperatingLossCarryforwardExpirationYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards, expiration year</label>
    <label xml:lang="en-US" xlink:label="dvax_OperatingLossCarryforwardExpirationYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforward Expiration Year</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAmount" />
    <label xml:lang="en-US" xlink:label="us-gaap_TaxCreditCarryforwardAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax credit carryforward amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAmount" xlink:to="us-gaap_TaxCreditCarryforwardAmount_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_TaxCreditCarryforwardAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward Amount</label>
    <label xml:lang="en-US" xlink:label="dvax_TaxCreditCarryforwardExpirationYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax credit carryforward amount, expiration year</label>
    <label xml:lang="en-US" xlink:label="dvax_TaxCreditCarryforwardExpirationYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward Expiration Year</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_CaliforniaStateMember" xlink:type="locator" xlink:label="dvax_CaliforniaStateMember" />
    <label xml:lang="en-US" xlink:label="dvax_CaliforniaStateMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">California State [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_CaliforniaStateMember" xlink:to="dvax_CaliforniaStateMember_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_CaliforniaStateMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">California State</label>
    <label xml:lang="en-US" xlink:label="dvax_CaliforniaStateMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">California State [Member]</label>
    <label xml:lang="en-US" xlink:label="dvax_CaliforniaStateMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">California State</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ForeignCountryMember" xlink:type="locator" xlink:label="us-gaap_ForeignCountryMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_ForeignCountryMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCountryMember" xlink:to="us-gaap_ForeignCountryMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_ForeignCountryMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Foreign Country [Member]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_DisclosureSelectedQuarterlyFinancialDataAbstract" xlink:type="locator" xlink:label="dvax_DisclosureSelectedQuarterlyFinancialDataAbstract" />
    <label xml:lang="en-US" xlink:label="dvax_DisclosureSelectedQuarterlyFinancialDataAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure - Selected Quarterly Financial Data [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_DisclosureSelectedQuarterlyFinancialDataAbstract" xlink:to="dvax_DisclosureSelectedQuarterlyFinancialDataAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_DisclosureSelectedQuarterlyFinancialDataAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure Selected Quarterly Financial Data [Abstract]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_SelectedQuarterlyFinancialDataLineItems" xlink:type="locator" xlink:label="dvax_SelectedQuarterlyFinancialDataLineItems" />
    <label xml:lang="en-US" xlink:label="dvax_SelectedQuarterlyFinancialDataLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Selected Quarterly Financial Data [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_SelectedQuarterlyFinancialDataLineItems" xlink:to="dvax_SelectedQuarterlyFinancialDataLineItems_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_DisclosureSelectedQuarterlyFinancialDataAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Disclosure Selected Quarterly Financial Data [Abstract]</label>
    <loc xlink:href="dvax-20131231.xsd#dvax_SelectedQuarterlyFinancialDataTable" xlink:type="locator" xlink:label="dvax_SelectedQuarterlyFinancialDataTable" />
    <label xml:lang="en-US" xlink:label="dvax_SelectedQuarterlyFinancialDataTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Selected Quarterly Financial Data [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dvax_SelectedQuarterlyFinancialDataTable" xlink:to="dvax_SelectedQuarterlyFinancialDataTable_lbl" />
    <label xml:lang="en-US" xlink:label="dvax_SelectedQuarterlyFinancialDataTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Selected Quarterly Financial Data [Table]</label>
    <label xml:lang="en-US" xlink:label="dvax_SelectedQuarterlyFinancialDataTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Selected Quarterly Financial Data [Table]</label>
    <label xml:lang="en-US" xlink:label="dvax_SelectedQuarterlyFinancialDataLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Selected Quarterly Financial Data [Line Items]</label>
    <label xml:lang="en-US" xlink:label="dvax_SelectedQuarterlyFinancialDataLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Selected Quarterly Financial Data [Line Items]</label>
    <label xml:lang="en-US" xlink:label="us-gaap_Revenues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenues</label>
    <label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss allocable to common stockholders</label>
    <label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Basic and diluted net loss per share allocable to common stockholders</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" />
    <label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Events [Abstract]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTable" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTable" />
    <label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Table]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" />
    <label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Axis]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" />
    <label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Domain]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventMember" xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" />
    <label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Member]</label>
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:type="locator" xlink:label="us-gaap_SubsequentEventLineItems" />
    <label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" />
    <label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Line Items]</label>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>29
<FILENAME>dvax-20131231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- RRD ActiveDisclosure(SM) XBRL Linkbase Document - http://www.financial.rrd.com/ -->
<!-- Creation Date      : 2014-03-07T19:36:08.4834606+00:00 -->
<!-- Version            : 1.7.0.24 -->
<!-- Package ID         : E885B71DE92DEB30D85162C832B40C82-0001029142-001401 -->
<!-- Copyright (c) 2014 R. R. Donnelley & Sons Company. All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef roleURI="http://www.dynavax.com/20131231/role/TemplateLink" xlink:href="dvax-20131231.xsd#TemplateLink" xlink:type="simple" />
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="dvax-20131231.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DocumentDocumentAndEntityInformation">
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityPublicFloat" xlink:type="locator" xlink:label="dei_EntityPublicFloat" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityFilerCategory" xlink:type="locator" xlink:label="dei_EntityFilerCategory" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityVoluntaryFilers" xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentInformationLineItems" xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntitiesTable" xlink:type="locator" xlink:label="dei_EntitiesTable" />
    <loc xlink:href="dvax-20131231.xsd#dvax_DocumentDocumentAndEntityInformationAbstract" xlink:type="locator" xlink:label="dvax_DocumentDocumentAndEntityInformationAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_DocumentDocumentAndEntityInformationAbstract" xlink:to="dei_EntitiesTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntitiesTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntitiesTable" xlink:to="dei_DocumentInformationLineItems" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="10480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="10560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="10640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="10720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="10800.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="10880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="10960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="11040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="11120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityPublicFloat" order="11200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedBalanceSheets" xlink:href="dvax-20131231.xsd#Role_StatementConsolidatedBalanceSheets" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedBalanceSheets">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockValue" xlink:type="locator" xlink:label="us-gaap_CommonStockValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockValue" xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Liabilities" xlink:type="locator" xlink:label="us-gaap_Liabilities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:type="locator" xlink:label="us-gaap_DeferredRevenueNoncurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:type="locator" xlink:label="us-gaap_DeferredRevenueCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Assets" xlink:type="locator" xlink:label="us-gaap_Assets" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:type="locator" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Goodwill" xlink:type="locator" xlink:label="us-gaap_Goodwill" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrent" xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesCurrent" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10250.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="10520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesCurrent" order="10600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="10680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="10760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="10840.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="10920.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Goodwill" order="11000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" order="11080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="11160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="11240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="11320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="11400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="11480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="11560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DeferredRevenueCurrent" order="11640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="11720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_DeferredRevenueNoncurrent" order="11800.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="11880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="11960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="12040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="12120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="12200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="12360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="12440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="12520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="12600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="12680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="12760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" xlink:href="dvax-20131231.xsd#Role_StatementConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10020.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="10730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="10810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="10890.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="10970.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedStatementsOfOperations" xlink:href="dvax-20131231.xsd#Role_StatementConsolidatedStatementsOfOperations" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedStatementsOfOperations">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestExpense" xlink:type="locator" xlink:label="us-gaap_InterestExpense" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CostsAndExpenses" xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
    <loc xlink:href="dvax-20131231.xsd#dvax_UnoccupiedFacilityExpense" xlink:type="locator" xlink:label="dvax_UnoccupiedFacilityExpense" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:type="locator" xlink:label="us-gaap_CostsAndExpensesAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Revenues" xlink:type="locator" xlink:label="us-gaap_Revenues" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LicenseAndServicesRevenue" xlink:type="locator" xlink:label="us-gaap_LicenseAndServicesRevenue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenueFromGrants" xlink:type="locator" xlink:label="us-gaap_RevenueFromGrants" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ContractsRevenue" xlink:type="locator" xlink:label="us-gaap_ContractsRevenue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenuesAbstract" xlink:type="locator" xlink:label="us-gaap_RevenuesAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenuesAbstract" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_ContractsRevenue" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenueFromGrants" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_LicenseAndServicesRevenue" order="10590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_Revenues" order="10710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CostsAndExpensesAbstract" order="10830.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="10950.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="11070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="dvax_UnoccupiedFacilityExpense" order="11190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="11270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_CostsAndExpenses" order="11350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="11470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract" order="11590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InvestmentIncomeInterest" order="11710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InterestExpense" order="11830.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="11930.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="12050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockDividendsIncomeStatementImpact" order="12170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="12250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="12370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="12490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss" xlink:href="dvax-20131231.xsd#Role_StatementConsolidatedStatementsOfComprehensiveLoss" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_StatementTable" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" order="10420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" order="10540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="10660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" xlink:href="dvax-20131231.xsd#Role_StatementConsolidatedStatementsOfStockholdersEquity" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharesOutstanding" xlink:type="locator" xlink:label="us-gaap_SharesOutstanding_li0l2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity_li0l2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <loc xlink:href="dvax-20131231.xsd#dvax_IssuanceOfCommonStockAndWarrantsShares" xlink:type="locator" xlink:label="dvax_IssuanceOfCommonStockAndWarrantsShares" />
    <loc xlink:href="dvax-20131231.xsd#dvax_IssuanceOfCommonStockAndWarrantsValue" xlink:type="locator" xlink:label="dvax_IssuanceOfCommonStockAndWarrantsValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
    <loc xlink:href="dvax-20131231.xsd#dvax_AdjustmentsToAdditionalPaidInCapitalInitialExpensesRelatedToAtmAgreement" xlink:type="locator" xlink:label="dvax_AdjustmentsToAdditionalPaidInCapitalInitialExpensesRelatedToAtmAgreement" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockDividendsShares" xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendsShares" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredDividendsNetOfTax" xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredDividendsNetOfTax" />
    <loc xlink:href="dvax-20131231.xsd#dvax_BeneficialConversionFeatureOfSeriesBConvertiblePreferredStock" xlink:type="locator" xlink:label="dvax_BeneficialConversionFeatureOfSeriesBConvertiblePreferredStock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" />
    <loc xlink:href="dvax-20131231.xsd#dvax_IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsShares" xlink:type="locator" xlink:label="dvax_IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsShares" />
    <loc xlink:href="dvax-20131231.xsd#dvax_IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue" xlink:type="locator" xlink:label="dvax_IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharesOutstanding" xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockMember" xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10020.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_PreferredStockMember" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="10550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="dvax_IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue" order="10750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="dvax_IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsShares" order="11050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" order="11250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="11550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" order="11750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="11930.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="12110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="12290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="12470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="12650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" order="12830.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="dvax_BeneficialConversionFeatureOfSeriesBConvertiblePreferredStock" order="13010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ConvertiblePreferredDividendsNetOfTax" order="13190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockDividendsShares" order="13370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="dvax_AdjustmentsToAdditionalPaidInCapitalInitialExpensesRelatedToAtmAgreement" order="13550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="13730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" order="13910.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="dvax_IssuanceOfCommonStockAndWarrantsValue" order="14090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="dvax_IssuanceOfCommonStockAndWarrantsShares" order="14390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="14590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" order="14890.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="15170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_li0l2" order="15450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding_li0l2" order="15750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" order="19710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" order="21970.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:href="dvax-20131231.xsd#Role_StatementConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesUnrealizedGainLoss" />
    <loc xlink:href="dvax-20131231.xsd#dvax_SupplementalDisposalOfAssets" xlink:type="locator" xlink:label="dvax_SupplementalDisposalOfAssets" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_li0l2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromStockPlans" xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockPlans" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
    <loc xlink:href="dvax-20131231.xsd#dvax_IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities" xlink:type="locator" xlink:label="dvax_IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentAssets" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessExitCosts1" xlink:type="locator" xlink:label="us-gaap_BusinessExitCosts1" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:type="locator" xlink:label="us-gaap_OtherNoncashIncomeExpense" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCosts" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="locator" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementTable" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="10480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="10540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationAndAmortization" order="10660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="10780.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="10840.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="10960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfFinancingCosts" order="11080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OtherNoncashIncomeExpense" order="11180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_BusinessExitCosts1" order="11260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="11340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="11460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="11580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentAssets" order="11700.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="dvax_IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities" order="11820.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="11940.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" order="12060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" order="12180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="12300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="12420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities" order="12540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" order="12660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="12780.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="12900.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="13020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="13140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" order="13260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="13340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="13460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockPlans" order="13580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfNotesPayable" order="13700.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="13780.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" order="13900.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" order="14020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="14140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_li0l2" order="14240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="14300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" order="14420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="dvax_SupplementalDisposalOfAssets" order="14540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_MarketableSecuritiesUnrealizedGainLoss" order="14660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureOrganization" xlink:href="dvax-20131231.xsd#Role_DisclosureOrganization" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureOrganization">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies" xlink:href="dvax-20131231.xsd#Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureFairValueMeasurements" xlink:href="dvax-20131231.xsd#Role_DisclosureFairValueMeasurements" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureFairValueMeasurements">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecurities" xlink:href="dvax-20131231.xsd#Role_DisclosureCashCashEquivalentsAndMarketableSecurities" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecurities">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosurePropertyAndEquipment" xlink:href="dvax-20131231.xsd#Role_DisclosurePropertyAndEquipment" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosurePropertyAndEquipment">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureIntangibleAssets" xlink:href="dvax-20131231.xsd#Role_DisclosureIntangibleAssets" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureIntangibleAssets">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCurrentAccruedLiabilities" xlink:href="dvax-20131231.xsd#Role_DisclosureCurrentAccruedLiabilities" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCurrentAccruedLiabilities">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:type="locator" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSymphonyDynamoInc" xlink:href="dvax-20131231.xsd#Role_DisclosureSymphonyDynamoInc" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSymphonyDynamoInc">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinorityInterestDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_MinorityInterestDisclosureTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_MinorityInterestDisclosureTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCommitmentsAndContingencies" xlink:href="dvax-20131231.xsd#Role_DisclosureCommitmentsAndContingencies" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCommitmentsAndContingencies">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreements" xlink:href="dvax-20131231.xsd#Role_DisclosureCollaborativeResearchDevelopmentAndLicenseAgreements" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreements">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CollaborativeArrangementDisclosureTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureNetLossPerShare" xlink:href="dvax-20131231.xsd#Role_DisclosureNetLossPerShare" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureNetLossPerShare">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosurePreferredStockCommonStockAndWarrants" xlink:href="dvax-20131231.xsd#Role_DisclosurePreferredStockCommonStockAndWarrants" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosurePreferredStockCommonStockAndWarrants">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureEquityPlansAndStockBasedCompensation" xlink:href="dvax-20131231.xsd#Role_DisclosureEquityPlansAndStockBasedCompensation" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureEquityPlansAndStockBasedCompensation">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureEmployeeBenefitPlan" xlink:href="dvax-20131231.xsd#Role_DisclosureEmployeeBenefitPlan" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureEmployeeBenefitPlan">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureIncomeTaxes" xlink:href="dvax-20131231.xsd#Role_DisclosureIncomeTaxes" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureIncomeTaxes">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSelectedQuarterlyFinancialData" xlink:href="dvax-20131231.xsd#Role_DisclosureSelectedQuarterlyFinancialData" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSelectedQuarterlyFinancialData">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock" xlink:type="locator" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_QuarterlyFinancialInformationTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSubsequentEvents" xlink:href="dvax-20131231.xsd#Role_DisclosureSubsequentEvents" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSubsequentEvents">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SubsequentEventsTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="dvax-20131231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_UseOfEstimates" xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiquidityDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_LiquidityDisclosureTextBlock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiquidityDisclosureTextBlock" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_UseOfEstimates" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InvestmentPolicyTextBlock" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="10480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="10560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" order="10640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="10720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="10800.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="10880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="10960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="11040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureFairValueMeasurementsTables" xlink:href="dvax-20131231.xsd#Role_DisclosureFairValueMeasurementsTables" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureFairValueMeasurementsTables">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesTables" xlink:href="dvax-20131231.xsd#Role_DisclosureCashCashEquivalentsAndMarketableSecuritiesTables" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesTables">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesTextBlock" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesTextBlock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesTextBlock" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosurePropertyAndEquipmentTables" xlink:href="dvax-20131231.xsd#Role_DisclosurePropertyAndEquipmentTables" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosurePropertyAndEquipmentTables">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCurrentAccruedLiabilitiesTables" xlink:href="dvax-20131231.xsd#Role_DisclosureCurrentAccruedLiabilitiesTables" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCurrentAccruedLiabilitiesTables">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables" xlink:href="dvax-20131231.xsd#Role_DisclosureCommitmentsAndContingenciesTables" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCollaborativeResearchAndDevelopmentAgreementsTables" xlink:href="dvax-20131231.xsd#Role_DisclosureCollaborativeResearchAndDevelopmentAgreementsTables" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCollaborativeResearchAndDevelopmentAgreementsTables">
    <loc xlink:href="dvax-20131231.xsd#dvax_NationalInstitutesOfHealthMember" xlink:type="locator" xlink:label="dvax_NationalInstitutesOfHealthMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_AstraZenecaMember" xlink:type="locator" xlink:label="dvax_AstraZenecaMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenueRecognitionMultipleDeliverableArrangementsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionMultipleDeliverableArrangementsTableTextBlock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="dvax-20131231.xsd#dvax_AgreementWithGskMember" xlink:type="locator" xlink:label="dvax_AgreementWithGskMember" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="dvax_AgreementWithGskMember" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenueRecognitionMultipleDeliverableArrangementsTableTextBlock" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="dvax_AstraZenecaMember" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="dvax_NationalInstitutesOfHealthMember" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureNetLossPerShareTables" xlink:href="dvax-20131231.xsd#Role_DisclosureNetLossPerShareTables" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureNetLossPerShareTables">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosurePreferredStockCommonStockAndWarrantsTables" xlink:href="dvax-20131231.xsd#Role_DisclosurePreferredStockCommonStockAndWarrantsTables" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosurePreferredStockCommonStockAndWarrantsTables">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureEquityPlansAndStockBasedCompensationTables" xlink:href="dvax-20131231.xsd#Role_DisclosureEquityPlansAndStockBasedCompensationTables" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureEquityPlansAndStockBasedCompensationTables">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureIncomeTaxesTables" xlink:href="dvax-20131231.xsd#Role_DisclosureIncomeTaxesTables" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureIncomeTaxesTables">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSelectedQuarterlyFinancialDataTables" xlink:href="dvax-20131231.xsd#Role_DisclosureSelectedQuarterlyFinancialDataTables" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSelectedQuarterlyFinancialDataTables">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail">
    <loc xlink:href="dvax-20131231.xsd#dvax_PercentageOfLongLivedAssets" xlink:type="locator" xlink:label="dvax_PercentageOfLongLivedAssets" />
    <loc xlink:href="dvax-20131231.xsd#dvax_PercentageOfRevenueEarned" xlink:type="locator" xlink:label="dvax_PercentageOfRevenueEarned" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:type="locator" xlink:label="us-gaap_NumberOfOperatingSegments" />
    <loc xlink:href="http://xbrl.sec.gov/country/2013/country-2013-01-31.xsd#country_US" xlink:type="locator" xlink:label="country_US" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:type="locator" xlink:label="us-gaap_SegmentGeographicalDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:type="locator" xlink:label="us-gaap_StatementGeographicalAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncome" xlink:type="locator" xlink:label="dvax_ReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncome" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits" />
    <loc xlink:href="dvax-20131231.xsd#dvax_NumberOfReportingUnits" xlink:type="locator" xlink:label="dvax_NumberOfReportingUnits" />
    <loc xlink:href="dvax-20131231.xsd#dvax_CashEquivalentsMaturityPeriod" xlink:type="locator" xlink:label="dvax_CashEquivalentsMaturityPeriod" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" xlink:label="us-gaap_MaximumMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" xlink:label="us-gaap_RangeMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" xlink:label="us-gaap_RangeAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossRealized" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" />
    <loc xlink:href="dvax-20131231.xsd#dvax_RheinBiotechGmbhMember" xlink:type="locator" xlink:label="dvax_RheinBiotechGmbhMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments" />
    <loc xlink:href="dvax-20131231.xsd#dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:type="locator" xlink:label="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:type="locator" xlink:label="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" />
    <loc xlink:href="dvax-20131231.xsd#dvax_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationAbstract" xlink:type="locator" xlink:label="dvax_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationAbstract" xlink:to="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:to="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="10020.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="dvax_RheinBiotechGmbhMember" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossRealized" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:to="us-gaap_RangeAxis" order="10020.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="10640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="10660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="dvax_CashEquivalentsMaturityPeriod" order="10720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="dvax_NumberOfReportingUnits" order="10820.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="10920.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" order="10960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="dvax_ReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncome" order="11060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTable" xlink:to="us-gaap_StatementGeographicalAxis" order="10020.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain" order="11130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="country_US" order="11150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" order="11230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="dvax_PercentageOfRevenueEarned" order="11350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems" xlink:to="dvax_PercentageOfLongLivedAssets" order="11510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureFairValueHierarchyForFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureFairValueHierarchyForFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureFairValueHierarchyForFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsFairValueDisclosureRecurring" xlink:type="locator" xlink:label="us-gaap_AssetsFairValueDisclosureRecurring" />
    <loc xlink:href="dvax-20131231.xsd#dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems" xlink:type="locator" xlink:label="dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_MunicipalSecuritiesMember" xlink:type="locator" xlink:label="dvax_MunicipalSecuritiesMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_USTreasurySecuritiesMember" xlink:type="locator" xlink:label="us-gaap_USTreasurySecuritiesMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable" xlink:type="locator" xlink:label="dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="10020.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable" xlink:to="us-gaap_InvestmentTypeAxis" order="10020.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_MoneyMarketFundsMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USTreasurySecuritiesMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="dvax_MunicipalSecuritiesMember" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="10020.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTable" xlink:to="dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosureRecurring" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfCashCashEquivalentsAndMarketableSecuritiesAvailableForSaleDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureSummaryOfCashCashEquivalentsAndMarketableSecuritiesAvailableForSaleDetail" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfCashCashEquivalentsAndMarketableSecuritiesAvailableForSaleDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecurities" />
    <loc xlink:href="dvax-20131231.xsd#dvax_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" xlink:type="locator" xlink:label="dvax_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" />
    <loc xlink:href="dvax-20131231.xsd#dvax_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" xlink:type="locator" xlink:label="dvax_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAmortizedCost" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesAmortizedCost" />
    <loc xlink:href="dvax-20131231.xsd#dvax_CashCashEquivalentsAndMarketableSecuritiesLineItems" xlink:type="locator" xlink:label="dvax_CashCashEquivalentsAndMarketableSecuritiesLineItems" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_USTreasurySecuritiesMember" xlink:type="locator" xlink:label="us-gaap_USTreasurySecuritiesMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_MunicipalSecuritiesMember" xlink:type="locator" xlink:label="dvax_MunicipalSecuritiesMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashMember" xlink:type="locator" xlink:label="us-gaap_CashMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableforsaleSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_AvailableforsaleSecuritiesMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsMember" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FinancialStatementLineItemsWithDifferencesInReportedAmountAndReportingCurrencyDenominatedAmountsDomain" xlink:type="locator" xlink:label="us-gaap_FinancialStatementLineItemsWithDifferencesInReportedAmountAndReportingCurrencyDenominatedAmountsDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InformationByFinancialStatementLineItemAxis" xlink:type="locator" xlink:label="us-gaap_InformationByFinancialStatementLineItemAxis" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_CashCashEquivalentsAndMarketableSecuritiesTable" xlink:type="locator" xlink:label="dvax_CashCashEquivalentsAndMarketableSecuritiesTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="locator" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="dvax_CashCashEquivalentsAndMarketableSecuritiesTable" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_CashCashEquivalentsAndMarketableSecuritiesTable" xlink:to="dei_LegalEntityAxis" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_CashCashEquivalentsAndMarketableSecuritiesTable" xlink:to="us-gaap_InformationByFinancialStatementLineItemAxis" order="10050.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InformationByFinancialStatementLineItemAxis" xlink:to="us-gaap_FinancialStatementLineItemsWithDifferencesInReportedAmountAndReportingCurrencyDenominatedAmountsDomain" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialStatementLineItemsWithDifferencesInReportedAmountAndReportingCurrencyDenominatedAmountsDomain" xlink:to="us-gaap_CashAndCashEquivalentsMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialStatementLineItemsWithDifferencesInReportedAmountAndReportingCurrencyDenominatedAmountsDomain" xlink:to="us-gaap_AvailableforsaleSecuritiesMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_CashCashEquivalentsAndMarketableSecuritiesTable" xlink:to="us-gaap_InvestmentTypeAxis" order="10050.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CashMember" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_MoneyMarketFundsMember" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="dvax_MunicipalSecuritiesMember" order="10530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USTreasurySecuritiesMember" order="10590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_CashCashEquivalentsAndMarketableSecuritiesTable" xlink:to="dvax_CashCashEquivalentsAndMarketableSecuritiesLineItems" order="10610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_CashCashEquivalentsAndMarketableSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesAmortizedCost" order="10650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_CashCashEquivalentsAndMarketableSecuritiesLineItems" xlink:to="dvax_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments" order="11330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_CashCashEquivalentsAndMarketableSecuritiesLineItems" xlink:to="dvax_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments" order="11810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_CashCashEquivalentsAndMarketableSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecurities" order="12290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfAmortizedCostAndEstimatedFairValueOfMarketableSecuritiesAvailableForSaleDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureSummaryOfAmortizedCostAndEstimatedFairValueOfMarketableSecuritiesAvailableForSaleDetail" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfAmortizedCostAndEstimatedFairValueOfMarketableSecuritiesAvailableForSaleDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="locator" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="dei_LegalEntityAxis" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" order="10420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="10460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAdditionalInformationDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureCashCashEquivalentsAndMarketableSecuritiesAdditionalInformationDetail" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAdditionalInformationDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MarketableSecuritiesRealizedGainLoss" xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesRealizedGainLoss" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" />
    <loc xlink:href="dvax-20131231.xsd#dvax_DisclosureAvailableforsaleSecuritiesAdditionalInformationAbstract" xlink:type="locator" xlink:label="dvax_DisclosureAvailableforsaleSecuritiesAdditionalInformationAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_DisclosureAvailableforsaleSecuritiesAdditionalInformationAbstract" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_MarketableSecuritiesRealizedGainLoss" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureComponentOfPropertyAndEquipmentDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureComponentOfPropertyAndEquipmentDetail" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureComponentOfPropertyAndEquipmentDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentOther" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentOther" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LeaseholdImprovementsGross" xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsGross" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FurnitureAndFixturesGross" xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesGross" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MachineryAndEquipmentGross" xlink:type="locator" xlink:label="us-gaap_MachineryAndEquipmentGross" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" xlink:label="us-gaap_MaximumMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:type="locator" xlink:label="us-gaap_MinimumMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" xlink:label="us-gaap_RangeMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" xlink:label="us-gaap_RangeAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_LaboratoryMember" xlink:type="locator" xlink:label="dvax_LaboratoryMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ManufacturingEquipmentMember" xlink:type="locator" xlink:label="dvax_ManufacturingEquipmentMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <loc xlink:href="dvax-20131231.xsd#dvax_DisclosureComponentOfPropertyAndEquipmentAbstract" xlink:type="locator" xlink:label="dvax_DisclosureComponentOfPropertyAndEquipmentAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_DisclosureComponentOfPropertyAndEquipmentAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10020.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="dvax_ManufacturingEquipmentMember" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="dvax_LaboratoryMember" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_RangeAxis" order="10020.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_MachineryAndEquipmentGross" order="10890.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="10970.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_FurnitureAndFixturesGross" order="11130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_LeaseholdImprovementsGross" order="11210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentOther" order="11290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="11450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="11530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetail" xlink:href="dvax-20131231.xsd#Role_DisclosurePropertyAndEquipmentAdditionalInformationDetail" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <loc xlink:href="dvax-20131231.xsd#dvax_DisclosurePropertyAndEquipmentAdditionalInformationAbstract" xlink:type="locator" xlink:label="dvax_DisclosurePropertyAndEquipmentAdditionalInformationAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_DisclosurePropertyAndEquipmentAdditionalInformationAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_DepreciationAndAmortization" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureIntangibleAssetsAdditionalInformationDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureIntangibleAssetsAdditionalInformationDetail" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureIntangibleAssetsAdditionalInformationDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:type="locator" xlink:label="us-gaap_CustomerRelationshipsMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ManufacturingMember" xlink:type="locator" xlink:label="dvax_ManufacturingMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
    <loc xlink:href="dvax-20131231.xsd#dvax_DisclosureIntangibleAssetsAdditionalInformationAbstract" xlink:type="locator" xlink:label="dvax_DisclosureIntangibleAssetsAdditionalInformationAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_DisclosureIntangibleAssetsAdditionalInformationAbstract" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="10020.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="dvax_ManufacturingMember" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_CustomerRelationshipsMember" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureComponentOfCurrentAccruedLiabilitiesDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureComponentOfCurrentAccruedLiabilitiesDetail" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureComponentOfCurrentAccruedLiabilitiesDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
    <loc xlink:href="dvax-20131231.xsd#dvax_AccruedThirdPartyResearchAndDevelopmentExpensesCurrent" xlink:type="locator" xlink:label="dvax_AccruedThirdPartyResearchAndDevelopmentExpensesCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccruedEmployeeBenefitsCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedEmployeeBenefitsCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrentAbstract" />
    <loc xlink:href="dvax-20131231.xsd#dvax_AccruedLiabilitiesLineItems" xlink:type="locator" xlink:label="dvax_AccruedLiabilitiesLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_AccruedLiabilitiesTable" xlink:type="locator" xlink:label="dvax_AccruedLiabilitiesTable" />
    <loc xlink:href="dvax-20131231.xsd#dvax_DisclosureComponentOfCurrentAccruedLiabilitiesAbstract" xlink:type="locator" xlink:label="dvax_DisclosureComponentOfCurrentAccruedLiabilitiesAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_DisclosureComponentOfCurrentAccruedLiabilitiesAbstract" xlink:to="dvax_AccruedLiabilitiesTable" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_AccruedLiabilitiesTable" xlink:to="dei_LegalEntityAxis" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_AccruedLiabilitiesTable" xlink:to="dvax_AccruedLiabilitiesLineItems" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_AccruedLiabilitiesLineItems" xlink:to="us-gaap_AccruedLiabilitiesCurrentAbstract" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedEmployeeBenefitsCurrent" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="dvax_AccruedThirdPartyResearchAndDevelopmentExpensesCurrent" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="10520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSymphonyDynamoIncAdditionalInformationDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureSymphonyDynamoIncAdditionalInformationDetail" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSymphonyDynamoIncAdditionalInformationDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="locator" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MalpracticeLossContingencyDiscountRate" xlink:type="locator" xlink:label="us-gaap_MalpracticeLossContingencyDiscountRate" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ReclassificationOfWarrantLiabilitiesToEquity" xlink:type="locator" xlink:label="dvax_ReclassificationOfWarrantLiabilitiesToEquity" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesFairValueAdjustment" xlink:type="locator" xlink:label="us-gaap_LiabilitiesFairValueAdjustment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" />
    <loc xlink:href="dvax-20131231.xsd#dvax_WarrantLiabilityMember" xlink:type="locator" xlink:label="dvax_WarrantLiabilityMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsDiscountRate" xlink:type="locator" xlink:label="us-gaap_FairValueInputsDiscountRate" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross" />
    <loc xlink:href="dvax-20131231.xsd#dvax_BusinessAcquisitionContingentConsiderationPercentage" xlink:type="locator" xlink:label="dvax_BusinessAcquisitionContingentConsiderationPercentage" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubordinatedBorrowingDueDate" xlink:type="locator" xlink:label="us-gaap_SubordinatedBorrowingDueDate" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherCommitment" xlink:type="locator" xlink:label="us-gaap_OtherCommitment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" />
    <loc xlink:href="dvax-20131231.xsd#dvax_WarrantsExercisablePeriod" xlink:type="locator" xlink:label="dvax_WarrantsExercisablePeriod" />
    <loc xlink:href="dvax-20131231.xsd#dvax_IssueOfWarrantsToPurchaseSharesOfCommonStock" xlink:type="locator" xlink:label="dvax_IssueOfWarrantsToPurchaseSharesOfCommonStock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" xlink:label="us-gaap_MaximumMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" xlink:label="us-gaap_RangeMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" xlink:label="us-gaap_RangeAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:type="locator" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:type="locator" xlink:label="us-gaap_EquityMethodInvestments" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" />
    <loc xlink:href="dvax-20131231.xsd#dvax_SymphonyDynamoHoldingsLlcMember" xlink:type="locator" xlink:label="dvax_SymphonyDynamoHoldingsLlcMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_SymphonyDynamoIncMember" xlink:type="locator" xlink:label="dvax_SymphonyDynamoIncMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityMethodInvesteeNameDomain" xlink:type="locator" xlink:label="us-gaap_EquityMethodInvesteeNameDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable" />
    <loc xlink:href="dvax-20131231.xsd#dvax_DisclosureSymphonyDynamoIncAdditionalInformationAbstract" xlink:type="locator" xlink:label="dvax_DisclosureSymphonyDynamoIncAdditionalInformationAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_DisclosureSymphonyDynamoIncAdditionalInformationAbstract" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="10020.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="us-gaap_EquityMethodInvesteeNameDomain" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityMethodInvesteeNameDomain" xlink:to="dvax_SymphonyDynamoIncMember" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityMethodInvesteeNameDomain" xlink:to="dvax_SymphonyDynamoHoldingsLlcMember" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="us-gaap_EquityMethodInvestments" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable" xlink:to="us-gaap_RangeAxis" order="10020.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="dvax_IssueOfWarrantsToPurchaseSharesOfCommonStock" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="dvax_WarrantsExercisablePeriod" order="10460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" order="10520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="us-gaap_OtherCommitment" order="10580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" order="10880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="10940.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="us-gaap_SubordinatedBorrowingDueDate" order="11000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="dvax_BusinessAcquisitionContingentConsiderationPercentage" order="11060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross" order="11120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="us-gaap_FairValueInputsDiscountRate" order="11240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="us-gaap_RepaymentsOfNotesPayable" order="11300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="11400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="10020.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="11590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="dvax_WarrantLiabilityMember" order="11610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="us-gaap_NonoperatingIncomeExpense" order="11760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="us-gaap_LiabilitiesFairValueAdjustment" order="11820.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" order="11880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="dvax_ReclassificationOfWarrantLiabilitiesToEquity" order="11940.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="12000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="us-gaap_MalpracticeLossContingencyDiscountRate" order="12120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="10020.08" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="12190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="12210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiability" order="12410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureFutureMinimumPaymentsUnderNonCancelablePortionOfOperatingLeasesDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureFutureMinimumPaymentsUnderNonCancelablePortionOfOperatingLeasesDetail" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureFutureMinimumPaymentsUnderNonCancelablePortionOfOperatingLeasesDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems" xlink:type="locator" xlink:label="us-gaap_OperatingLeasedAssetsLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfOperatingLeasedAssetsTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_ScheduleOfOperatingLeasedAssetsTable" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="dei_LegalEntityAxis" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="us-gaap_OperatingLeasedAssetsLineItems" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermPurchaseCommitmentAmount" xlink:type="locator" xlink:label="us-gaap_LongTermPurchaseCommitmentAmount" />
    <loc xlink:href="dvax-20131231.xsd#dvax_DeutscheBankSecuritiesMember" xlink:type="locator" xlink:label="dvax_DeutscheBankSecuritiesMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInSecurityDeposits" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInSecurityDeposits" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ContingencyPeriod" xlink:type="locator" xlink:label="dvax_ContingencyPeriod" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LoansAndLeasesReceivableDescription" xlink:type="locator" xlink:label="us-gaap_LoansAndLeasesReceivableDescription" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SecurityOwnedAndPledgedAsCollateralFairValue" xlink:type="locator" xlink:label="us-gaap_SecurityOwnedAndPledgedAsCollateralFairValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PledgedAssetsSeparatelyReportedSecuritiesPledgedUnderLetterOfCreditFacilitiesAtFairValue" xlink:type="locator" xlink:label="us-gaap_PledgedAssetsSeparatelyReportedSecuritiesPledgedUnderLetterOfCreditFacilitiesAtFairValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" xlink:label="us-gaap_MaximumMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:type="locator" xlink:label="us-gaap_MinimumMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" xlink:label="us-gaap_RangeMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" xlink:label="us-gaap_RangeAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ContingencyAMember" xlink:type="locator" xlink:label="dvax_ContingencyAMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ContingencyBMember" xlink:type="locator" xlink:label="dvax_ContingencyBMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LossContingencyNatureDomain" xlink:type="locator" xlink:label="us-gaap_LossContingencyNatureDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="locator" xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_CaliforniaMember" xlink:type="locator" xlink:label="dvax_CaliforniaMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRentCredit" xlink:type="locator" xlink:label="us-gaap_DeferredRentCredit" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesRentExpenseNet" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessExitCosts1" xlink:type="locator" xlink:label="us-gaap_BusinessExitCosts1" />
    <loc xlink:href="dvax-20131231.xsd#dvax_LeaseExpirationMonthAndYear" xlink:type="locator" xlink:label="dvax_LeaseExpirationMonthAndYear" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:type="locator" xlink:label="us-gaap_LossContingenciesLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/country/2013/country-2013-01-31.xsd#country_GC" xlink:type="locator" xlink:label="country_GC" />
    <loc xlink:href="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd#stpr_CA" xlink:type="locator" xlink:label="stpr_CA" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:type="locator" xlink:label="us-gaap_SegmentGeographicalDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:type="locator" xlink:label="us-gaap_StatementGeographicalAxis" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LossContingenciesTable" xlink:type="locator" xlink:label="us-gaap_LossContingenciesTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LossContingenciesTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_StatementGeographicalAxis" order="10020.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="stpr_CA" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="country_GC" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_LossContingenciesLineItems" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="dvax_LeaseExpirationMonthAndYear" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_BusinessExitCosts1" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_OperatingLeasesRentExpenseNet" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_DeferredRentCredit" order="10560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="dvax_CaliforniaMember" order="10710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_LossContingenciesByNatureOfContingencyAxis" order="10020.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="us-gaap_LossContingencyNatureDomain" order="10740.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingencyNatureDomain" xlink:to="dvax_ContingencyBMember" order="10760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingencyNatureDomain" xlink:to="dvax_ContingencyAMember" order="10780.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_RangeAxis" order="10020.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="10870.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" order="10890.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="10930.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_PledgedAssetsSeparatelyReportedSecuritiesPledgedUnderLetterOfCreditFacilitiesAtFairValue" order="10990.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_SecurityOwnedAndPledgedAsCollateralFairValue" order="11170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LoansAndLeasesReceivableDescription" order="11370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments" order="11550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="dvax_ContingencyPeriod" order="11750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_IncreaseDecreaseInSecurityDeposits" order="11950.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingencyNatureDomain" xlink:to="dvax_DeutscheBankSecuritiesMember" order="12180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LongTermPurchaseCommitmentAmount" order="12460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetail" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:type="locator" xlink:label="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ContractTerm" xlink:type="locator" xlink:label="dvax_ContractTerm" />
    <loc xlink:href="dvax-20131231.xsd#dvax_IssTechnologyMember" xlink:type="locator" xlink:label="dvax_IssTechnologyMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_HumanPapillomaVirusMember" xlink:type="locator" xlink:label="dvax_HumanPapillomaVirusMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_HepatitisBVirusMember" xlink:type="locator" xlink:label="dvax_HepatitisBVirusMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_SkinAutoimmuneInflammationMember" xlink:type="locator" xlink:label="dvax_SkinAutoimmuneInflammationMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_RheumatoidArthritisMember" xlink:type="locator" xlink:label="dvax_RheumatoidArthritisMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_AutoimmuneDiseaseMember" xlink:type="locator" xlink:label="dvax_AutoimmuneDiseaseMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GrantsReceivable" xlink:type="locator" xlink:label="us-gaap_GrantsReceivable" />
    <loc xlink:href="dvax-20131231.xsd#dvax_NationalInstitutesOfHealthMember" xlink:type="locator" xlink:label="dvax_NationalInstitutesOfHealthMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_DifferentTypesOfCollaborationAgreementsDomain" xlink:type="locator" xlink:label="dvax_DifferentTypesOfCollaborationAgreementsDomain" />
    <loc xlink:href="dvax-20131231.xsd#dvax_DifferentTypesOfCollaborationAgreementsAxis" xlink:type="locator" xlink:label="dvax_DifferentTypesOfCollaborationAgreementsAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_HepaticFibrosisAndCirrhosisMember" xlink:type="locator" xlink:label="dvax_HepaticFibrosisAndCirrhosisMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ContingentConsiderationMember" xlink:type="locator" xlink:label="dvax_ContingentConsiderationMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:type="locator" xlink:label="us-gaap_ContingentConsiderationTypeDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis" xlink:type="locator" xlink:label="us-gaap_ContingentConsiderationByTypeAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_AmendmentMember" xlink:type="locator" xlink:label="dvax_AmendmentMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ResearchCollaborationAndLicenseAgreementPeriod" xlink:type="locator" xlink:label="dvax_ResearchCollaborationAndLicenseAgreementPeriod" />
    <loc xlink:href="dvax-20131231.xsd#dvax_AstraZenecaMember" xlink:type="locator" xlink:label="dvax_AstraZenecaMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRevenue" xlink:type="locator" xlink:label="us-gaap_DeferredRevenue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleCurrentPeriodDisclosuresRevenueRecognizedAmount" xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleCurrentPeriodDisclosuresRevenueRecognizedAmount" />
    <loc xlink:href="dvax-20131231.xsd#dvax_RevenueRecognitionPeriod" xlink:type="locator" xlink:label="dvax_RevenueRecognitionPeriod" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:type="locator" xlink:label="us-gaap_MinimumMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRevenueAdditions" xlink:type="locator" xlink:label="us-gaap_DeferredRevenueAdditions" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ExpansionMember" xlink:type="locator" xlink:label="dvax_ExpansionMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SegmentDomain" xlink:type="locator" xlink:label="us-gaap_SegmentDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementBusinessSegmentsAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ConditionTwoMember" xlink:type="locator" xlink:label="dvax_ConditionTwoMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_CollaborativeAgreementDomain" xlink:type="locator" xlink:label="dvax_CollaborativeAgreementDomain" />
    <loc xlink:href="dvax-20131231.xsd#dvax_CollaborativeAgreementAxis" xlink:type="locator" xlink:label="dvax_CollaborativeAgreementAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_PotentialMilestonePaymentAmount" xlink:type="locator" xlink:label="dvax_PotentialMilestonePaymentAmount" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" xlink:label="us-gaap_MaximumMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" xlink:label="us-gaap_RangeMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" xlink:label="us-gaap_RangeAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_NumberOfProjects" xlink:type="locator" xlink:label="dvax_NumberOfProjects" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:type="locator" xlink:label="us-gaap_ProductInformationLineItems" />
    <loc xlink:href="dvax-20131231.xsd#dvax_GlaxoSmithKlineMember" xlink:type="locator" xlink:label="dvax_GlaxoSmithKlineMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfProductInformationTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ScheduleOfProductInformationTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10020.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dvax_GlaxoSmithKlineMember" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="us-gaap_ProductInformationLineItems" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="dvax_NumberOfProjects" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="us-gaap_RangeAxis" order="10020.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="dvax_PotentialMilestonePaymentAmount" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="dvax_CollaborativeAgreementAxis" order="10020.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_CollaborativeAgreementAxis" xlink:to="dvax_CollaborativeAgreementDomain" order="10540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_CollaborativeAgreementDomain" xlink:to="dvax_ConditionTwoMember" order="10560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" order="10020.08" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" order="10780.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentDomain" xlink:to="dvax_ExpansionMember" order="10800.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_DeferredRevenueAdditions" order="10860.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" order="10920.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" order="11180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="dvax_RevenueRecognitionPeriod" order="11240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleCurrentPeriodDisclosuresRevenueRecognizedAmount" order="11360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_DeferredRevenue" order="11590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dvax_AstraZenecaMember" order="11760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="dvax_ResearchCollaborationAndLicenseAgreementPeriod" order="11820.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dvax_AmendmentMember" order="11930.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="us-gaap_ContingentConsiderationByTypeAxis" order="10020.10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="us-gaap_ContingentConsiderationTypeDomain" order="12110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="dvax_ContingentConsiderationMember" order="12130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" order="12550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dvax_HepaticFibrosisAndCirrhosisMember" order="13080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="dvax_DifferentTypesOfCollaborationAgreementsAxis" order="10020.12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_DifferentTypesOfCollaborationAgreementsAxis" xlink:to="dvax_DifferentTypesOfCollaborationAgreementsDomain" order="13110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_DifferentTypesOfCollaborationAgreementsDomain" xlink:to="dvax_NationalInstitutesOfHealthMember" order="13130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_GrantsReceivable" order="13190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dvax_AutoimmuneDiseaseMember" order="13300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dvax_RheumatoidArthritisMember" order="13520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dvax_SkinAutoimmuneInflammationMember" order="13740.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dvax_HepatitisBVirusMember" order="13960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dvax_HumanPapillomaVirusMember" order="14180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dvax_IssTechnologyMember" order="14400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="dvax_ContractTerm" order="14550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" order="14610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfRevenueRecognizedUnderAgreementWithGSKDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureSummaryOfRevenueRecognizedUnderAgreementWithGSKDetail" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfRevenueRecognizedUnderAgreementWithGSKDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenueFromGrants" xlink:type="locator" xlink:label="us-gaap_RevenueFromGrants" />
    <loc xlink:href="dvax-20131231.xsd#dvax_NationalInstitutesOfHealthMember" xlink:type="locator" xlink:label="dvax_NationalInstitutesOfHealthMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_DifferentTypesOfCollaborationAgreementsDomain" xlink:type="locator" xlink:label="dvax_DifferentTypesOfCollaborationAgreementsDomain" />
    <loc xlink:href="dvax-20131231.xsd#dvax_DifferentTypesOfCollaborationAgreementsAxis" xlink:type="locator" xlink:label="dvax_DifferentTypesOfCollaborationAgreementsAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_NationalInstituteOfAllergyAndInfectiousDiseasesMember" xlink:type="locator" xlink:label="dvax_NationalInstituteOfAllergyAndInfectiousDiseasesMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_AstraZenecaMember" xlink:type="locator" xlink:label="dvax_AstraZenecaMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Revenues" xlink:type="locator" xlink:label="us-gaap_Revenues" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredRevenueAdditions" xlink:type="locator" xlink:label="us-gaap_DeferredRevenueAdditions" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProductInformationLineItems" xlink:type="locator" xlink:label="us-gaap_ProductInformationLineItems" />
    <loc xlink:href="dvax-20131231.xsd#dvax_GlaxoSmithKlineMember" xlink:type="locator" xlink:label="dvax_GlaxoSmithKlineMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfProductInformationTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ScheduleOfProductInformationTable" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="dei_LegalEntityAxis" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10040.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dvax_GlaxoSmithKlineMember" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="us-gaap_ProductInformationLineItems" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_DeferredRevenueAdditions" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_Revenues" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dvax_AstraZenecaMember" order="10540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dvax_NationalInstituteOfAllergyAndInfectiousDiseasesMember" order="11010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="dvax_DifferentTypesOfCollaborationAgreementsAxis" order="10040.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_DifferentTypesOfCollaborationAgreementsAxis" xlink:to="dvax_DifferentTypesOfCollaborationAgreementsDomain" order="11040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_DifferentTypesOfCollaborationAgreementsDomain" xlink:to="dvax_NationalInstitutesOfHealthMember" order="11060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_RevenueFromGrants" order="11120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureComputationOfBasicAndDilutedEarningsPerShareDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureComputationOfBasicAndDilutedEarningsPerShareDetail" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureComputationOfBasicAndDilutedEarningsPerShareDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <loc xlink:href="dvax-20131231.xsd#dvax_AntidilutiveSecuritiesExcludedFromComputationOfEarningPerShareAbstract" xlink:type="locator" xlink:label="dvax_AntidilutiveSecuritiesExcludedFromComputationOfEarningPerShareAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WarrantMember" xlink:type="locator" xlink:label="us-gaap_WarrantMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_StockOptionsAndShareAwardsMember" xlink:type="locator" xlink:label="dvax_StockOptionsAndShareAwardsMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <loc xlink:href="dvax-20131231.xsd#dvax_EarningsPerShareBasicAndDilutedDenominatorAbstract" xlink:type="locator" xlink:label="dvax_EarningsPerShareBasicAndDilutedDenominatorAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <loc xlink:href="dvax-20131231.xsd#dvax_EarningsPerShareDisclosureLineItems" xlink:type="locator" xlink:label="dvax_EarningsPerShareDisclosureLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_EarningsPerShareDisclosureTable" xlink:type="locator" xlink:label="dvax_EarningsPerShareDisclosureTable" />
    <loc xlink:href="dvax-20131231.xsd#dvax_DisclosureComputationOfBasicAndDilutedEarningsPerShareAbstract" xlink:type="locator" xlink:label="dvax_DisclosureComputationOfBasicAndDilutedEarningsPerShareAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_DisclosureComputationOfBasicAndDilutedEarningsPerShareAbstract" xlink:to="dvax_EarningsPerShareDisclosureTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_EarningsPerShareDisclosureTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_EarningsPerShareDisclosureTable" xlink:to="dvax_EarningsPerShareDisclosureLineItems" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_EarningsPerShareDisclosureLineItems" xlink:to="us-gaap_EarningsPerShareAbstract" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_NetIncomeLoss" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_PreferredStockDividendsIncomeStatementImpact" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_EarningsPerShareDisclosureLineItems" xlink:to="dvax_EarningsPerShareBasicAndDilutedDenominatorAbstract" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_EarningsPerShareBasicAndDilutedDenominatorAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="10500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_EarningsPerShareBasicAndDilutedDenominatorAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="10560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_EarningsPerShareDisclosureTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="10020.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="10650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="dvax_StockOptionsAndShareAwardsMember" order="10670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" order="10690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_EarningsPerShareDisclosureTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10020.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="10720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="10740.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_EarningsPerShareDisclosureLineItems" xlink:to="dvax_AntidilutiveSecuritiesExcludedFromComputationOfEarningPerShareAbstract" order="10800.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_AntidilutiveSecuritiesExcludedFromComputationOfEarningPerShareAbstract" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="10920.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosurePreferredStockCommonStockAndWarrantsAdditionalInformationDetail" xlink:href="dvax-20131231.xsd#Role_DisclosurePreferredStockCommonStockAndWarrantsAdditionalInformationDetail" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosurePreferredStockCommonStockAndWarrantsAdditionalInformationDetail">
    <loc xlink:href="dvax-20131231.xsd#dvax_NumberOfWarrantsExercisedDuringPeriod" xlink:type="locator" xlink:label="dvax_NumberOfWarrantsExercisedDuringPeriod" />
    <loc xlink:href="dvax-20131231.xsd#dvax_WarrantToPurchaseCommonStock" xlink:type="locator" xlink:label="dvax_WarrantToPurchaseCommonStock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesConverted1" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
    <loc xlink:href="dvax-20131231.xsd#dvax_WarrantsExercisablePeriod" xlink:type="locator" xlink:label="dvax_WarrantsExercisablePeriod" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" />
    <loc xlink:href="dvax-20131231.xsd#dvax_CommonStockIssuableUponExerciseOfWarrantsConversionRatio" xlink:type="locator" xlink:label="dvax_CommonStockIssuableUponExerciseOfWarrantsConversionRatio" />
    <loc xlink:href="dvax-20131231.xsd#dvax_NumberOfWarrantsInEachUnit" xlink:type="locator" xlink:label="dvax_NumberOfWarrantsInEachUnit" />
    <loc xlink:href="dvax-20131231.xsd#dvax_NumberOfSharesOfCommonStockInEachUnit" xlink:type="locator" xlink:label="dvax_NumberOfSharesOfCommonStockInEachUnit" />
    <loc xlink:href="dvax-20131231.xsd#dvax_SymphonyDynamoIncMember" xlink:type="locator" xlink:label="dvax_SymphonyDynamoIncMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityMethodInvesteeNameDomain" xlink:type="locator" xlink:label="us-gaap_EquityMethodInvesteeNameDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_LoanAgreementMember" xlink:type="locator" xlink:label="dvax_LoanAgreementMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" />
    <loc xlink:href="dvax-20131231.xsd#dvax_CommitmentFeePaid" xlink:type="locator" xlink:label="dvax_CommitmentFeePaid" />
    <loc xlink:href="dvax-20131231.xsd#dvax_PercentageOfCommitmentToPurchaseSharesValue" xlink:type="locator" xlink:label="dvax_PercentageOfCommitmentToPurchaseSharesValue" />
    <loc xlink:href="dvax-20131231.xsd#dvax_PurchaseAgreementPeriod" xlink:type="locator" xlink:label="dvax_PurchaseAgreementPeriod" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" />
    <loc xlink:href="dvax-20131231.xsd#dvax_AspireCapitalFundLlcMember" xlink:type="locator" xlink:label="dvax_AspireCapitalFundLlcMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
    <loc xlink:href="dvax-20131231.xsd#dvax_SellingCommissionPercentageFromGrossOfferingProceedsOfSalesOfStock" xlink:type="locator" xlink:label="dvax_SellingCommissionPercentageFromGrossOfferingProceedsOfSalesOfStock" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" xlink:label="us-gaap_MaximumMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_MlvMember" xlink:type="locator" xlink:label="dvax_MlvMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_RightsExpirationDate" xlink:type="locator" xlink:label="dvax_RightsExpirationDate" />
    <loc xlink:href="dvax-20131231.xsd#dvax_PercentageOfCompanyAssets" xlink:type="locator" xlink:label="dvax_PercentageOfCompanyAssets" />
    <loc xlink:href="dvax-20131231.xsd#dvax_PercentageOfCommonSharesOutstanding" xlink:type="locator" xlink:label="dvax_PercentageOfCommonSharesOutstanding" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharePrice" xlink:type="locator" xlink:label="us-gaap_SharePrice" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DividendPayableDateToBePaidDayMonthAndYear" xlink:type="locator" xlink:label="us-gaap_DividendPayableDateToBePaidDayMonthAndYear" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:type="locator" xlink:label="us-gaap_MinimumMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" xlink:label="us-gaap_RangeMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" xlink:label="us-gaap_RangeAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_DeemedDividend" xlink:type="locator" xlink:label="dvax_DeemedDividend" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredStockSettlementTerms" xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockSettlementTerms" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredStockTermsOfConversion" xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockTermsOfConversion" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityIssuancePerShareAmount" xlink:type="locator" xlink:label="us-gaap_EquityIssuancePerShareAmount" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <loc xlink:href="dvax-20131231.xsd#dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:type="locator" xlink:label="dvax_PreferredStockCommonStockAndWarrantsLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_PreferredStockCommonStockAndWarrantsTable" xlink:type="locator" xlink:label="dvax_PreferredStockCommonStockAndWarrantsTable" />
    <loc xlink:href="dvax-20131231.xsd#dvax_PreferredStockCommonStockAndWarrantsAbstract" xlink:type="locator" xlink:label="dvax_PreferredStockCommonStockAndWarrantsAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsAbstract" xlink:to="dvax_PreferredStockCommonStockAndWarrantsTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsTable" xlink:to="dvax_PreferredStockCommonStockAndWarrantsLineItems" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10020.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_EquityIssuancePerShareAmount" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" order="10530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="10590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="10650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" order="10820.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_ConvertiblePreferredStockTermsOfConversion" order="10880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_ConvertiblePreferredStockSettlementTerms" order="10940.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="dvax_DeemedDividend" order="11110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsTable" xlink:to="us-gaap_RangeAxis" order="10020.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="11180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" order="11200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="11280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_DividendPayableDateToBePaidDayMonthAndYear" order="11340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_SharePrice" order="11460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="dvax_PercentageOfCommonSharesOutstanding" order="11520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="dvax_PercentageOfCompanyAssets" order="11580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="dvax_RightsExpirationDate" order="11640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10020.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="11730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="11750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="dvax_MlvMember" order="12200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="12250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="12310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="dvax_SellingCommissionPercentageFromGrossOfferingProceedsOfSalesOfStock" order="12370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" order="12710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="dvax_AspireCapitalFundLlcMember" order="13100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" order="13210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="dvax_PurchaseAgreementPeriod" order="13270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="dvax_PercentageOfCommitmentToPurchaseSharesValue" order="13330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="dvax_CommitmentFeePaid" order="13390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther" order="13450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="13570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10020.08" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="13780.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="dvax_LoanAgreementMember" order="13800.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsTable" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="10020.10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="us-gaap_EquityMethodInvesteeNameDomain" order="13830.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityMethodInvesteeNameDomain" xlink:to="dvax_SymphonyDynamoIncMember" order="13850.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="dvax_NumberOfSharesOfCommonStockInEachUnit" order="14150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="dvax_NumberOfWarrantsInEachUnit" order="14210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="dvax_CommonStockIssuableUponExerciseOfWarrantsConversionRatio" order="14270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" order="14330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="dvax_WarrantsExercisablePeriod" order="14390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="14450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="us-gaap_ConversionOfStockSharesConverted1" order="14550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="dvax_WarrantToPurchaseCommonStock" order="14670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PreferredStockCommonStockAndWarrantsLineItems" xlink:to="dvax_NumberOfWarrantsExercisedDuringPeriod" order="14790.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureWarrantsIssuedToPurchaseCommonStockDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureWarrantsIssuedToPurchaseCommonStockDetail" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureWarrantsIssuedToPurchaseCommonStockDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" />
    <loc xlink:href="dvax-20131231.xsd#dvax_WarrantExpirationDate" xlink:type="locator" xlink:label="dvax_WarrantExpirationDate" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesConverted1" />
    <loc xlink:href="dvax-20131231.xsd#dvax_WarrantIssueDate" xlink:type="locator" xlink:label="dvax_WarrantIssueDate" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems" />
    <loc xlink:href="dvax-20131231.xsd#dvax_LoanAgreementMember" xlink:type="locator" xlink:label="dvax_LoanAgreementMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_WarrantFourMember" xlink:type="locator" xlink:label="dvax_WarrantFourMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_WarrantThreeMember" xlink:type="locator" xlink:label="dvax_WarrantThreeMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_WarrantTwoMember" xlink:type="locator" xlink:label="dvax_WarrantTwoMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_WarrantOneMember" xlink:type="locator" xlink:label="dvax_WarrantOneMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightTable" />
    <loc xlink:href="dvax-20131231.xsd#dvax_DisclosureWarrantsIssuedToPurchaseCommonStockAbstract" xlink:type="locator" xlink:label="dvax_DisclosureWarrantsIssuedToPurchaseCommonStockAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_DisclosureWarrantsIssuedToPurchaseCommonStockAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="10020.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="dvax_WarrantOneMember" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="dvax_WarrantTwoMember" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="dvax_WarrantThreeMember" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="dvax_WarrantFourMember" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10020.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="dvax_LoanAgreementMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="dvax_WarrantIssueDate" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ConversionOfStockSharesConverted1" order="10520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="dvax_WarrantExpirationDate" order="10720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" order="10920.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="11120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureEquityPlansAndStockBasedCompensationAdditionalInformationDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureEquityPlansAndStockBasedCompensationAdditionalInformationDetail" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureEquityPlansAndStockBasedCompensationAdditionalInformationDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" />
    <loc xlink:href="dvax-20131231.xsd#dvax_PeriodTwoMember" xlink:type="locator" xlink:label="dvax_PeriodTwoMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_PeriodOneMember" xlink:type="locator" xlink:label="dvax_PeriodOneMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_PeriodDomain" xlink:type="locator" xlink:label="dvax_PeriodDomain" />
    <loc xlink:href="dvax-20131231.xsd#dvax_PeriodAxis" xlink:type="locator" xlink:label="dvax_PeriodAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeStockMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
    <loc xlink:href="dvax-20131231.xsd#dvax_TimeBasedVestingScheduleMember" xlink:type="locator" xlink:label="dvax_TimeBasedVestingScheduleMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DefinedContributionPlanNumberOfEmployeesCovered" xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanNumberOfEmployeesCovered" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <loc xlink:href="dvax-20131231.xsd#dvax_AdditionalMember" xlink:type="locator" xlink:label="dvax_AdditionalMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_NonEmployeeAwardsMember" xlink:type="locator" xlink:label="dvax_NonEmployeeAwardsMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TypeOfDeferredCompensationDomain" xlink:type="locator" xlink:label="us-gaap_TypeOfDeferredCompensationDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" xlink:type="locator" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndRsuOutstandingNumber" xlink:type="locator" xlink:label="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndRsuOutstandingNumber" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestrictedStockExpense" xlink:type="locator" xlink:label="us-gaap_RestrictedStockExpense" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
    <loc xlink:href="dvax-20131231.xsd#dvax_EquityIncentivePlanTwentyElevenMember" xlink:type="locator" xlink:label="dvax_EquityIncentivePlanTwentyElevenMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_EmploymentInducementAwardPlanTwentyTenMember" xlink:type="locator" xlink:label="dvax_EmploymentInducementAwardPlanTwentyTenMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" />
    <loc xlink:href="dvax-20131231.xsd#dvax_GroupTwoMember" xlink:type="locator" xlink:label="dvax_GroupTwoMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_OtherParticipantsMember" xlink:type="locator" xlink:label="dvax_OtherParticipantsMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_StockIncentivePlanTwentyZeroFourMember" xlink:type="locator" xlink:label="dvax_StockIncentivePlanTwentyZeroFourMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:type="locator" xlink:label="us-gaap_MinimumMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" xlink:label="us-gaap_MaximumMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" xlink:label="us-gaap_RangeMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" xlink:label="us-gaap_RangeAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_NumberOfShareBasedCompensationPlans" xlink:type="locator" xlink:label="dvax_NumberOfShareBasedCompensationPlans" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="dvax_NumberOfShareBasedCompensationPlans" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_RangeAxis" order="10020.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="10020.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="dvax_StockIncentivePlanTwentyZeroFourMember" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10020.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dvax_OtherParticipantsMember" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dvax_GroupTwoMember" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" order="10530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="10590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" order="10650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="10830.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="dvax_EmploymentInducementAwardPlanTwentyTenMember" order="10990.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="dvax_EquityIncentivePlanTwentyElevenMember" order="11240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" order="11530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="11770.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="11910.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" order="12090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10020.08" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="12240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="12260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_RestrictedStockExpense" order="12340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" order="12400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="12610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" order="12710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="12890.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndRsuOutstandingNumber" order="12970.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="13070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" order="10020.10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsByTypeOfDeferredCompensationAxis" xlink:to="us-gaap_TypeOfDeferredCompensationDomain" order="13140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfDeferredCompensationDomain" xlink:to="dvax_NonEmployeeAwardsMember" order="13160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfDeferredCompensationDomain" xlink:to="dvax_AdditionalMember" order="13180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="13240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensation" order="13320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_DefinedContributionPlanNumberOfEmployeesCovered" order="13460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="dvax_TimeBasedVestingScheduleMember" order="13590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" order="13670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="13770.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10020.12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="13880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_EmployeeStockMember" order="13900.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="dvax_PeriodAxis" order="10020.14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PeriodAxis" xlink:to="dvax_PeriodDomain" order="14130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PeriodDomain" xlink:to="dvax_PeriodOneMember" order="14150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_PeriodDomain" xlink:to="dvax_PeriodTwoMember" order="14170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" order="14530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="14570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureOptionActivityUnderStockPlansDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureOptionActivityUnderStockPlansDetail" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureOptionActivityUnderStockPlansDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:type="locator" xlink:label="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:type="locator" xlink:label="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice" xlink:type="locator" xlink:label="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice_li0l2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice" xlink:type="locator" xlink:label="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <loc xlink:href="dvax-20131231.xsd#dvax_VestedMember" xlink:type="locator" xlink:label="dvax_VestedMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_UnvestedMember" xlink:type="locator" xlink:label="dvax_UnvestedMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10020.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="dvax_UnvestedMember" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="dvax_VestedMember" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="10590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="10710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="10950.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="11070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="11190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" order="11440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice" order="11640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="11760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="11880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="12000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice_li0l2" order="12240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" order="12360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="12480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" order="12660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="12860.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" order="12980.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="13100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" order="13280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="13480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" order="13600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="13720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfRestrictedStockUnitsActivityDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureSummaryOfRestrictedStockUnitsActivityDetail" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfRestrictedStockUnitsActivityDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_li0l2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_li0l2" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10020.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_li0l2" order="10570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" order="10760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="10880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="10960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="11040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="11120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_li0l2" order="11200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureFairValueBasedMeasurementsAndWeightedAverageAssumptionsDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureFairValueBasedMeasurementsAndWeightedAverageAssumptionsDetail" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureFairValueBasedMeasurementsAndWeightedAverageAssumptionsDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeStockMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10020.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10020.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="10640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_EmployeeStockMember" order="10660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureStockBasedCompensationExpenseDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureStockBasedCompensationExpenseDetail" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureStockBasedCompensationExpenseDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" xlink:type="locator" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_NonEmployeeMember" xlink:type="locator" xlink:label="dvax_NonEmployeeMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_EmployeesAndDirectorsMember" xlink:type="locator" xlink:label="dvax_EmployeesAndDirectorsMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10020.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="dvax_EmployeesAndDirectorsMember" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="dvax_NonEmployeeMember" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTable" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems" xlink:to="us-gaap_ShareBasedCompensation" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureComponentOfConsolidatedIncomeLossBeforeProvisionForIncomeTaxesDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureComponentOfConsolidatedIncomeLossBeforeProvisionForIncomeTaxesDetail" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureComponentOfConsolidatedIncomeLossBeforeProvisionForIncomeTaxesDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" xlink:type="locator" xlink:label="dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" xlink:type="locator" xlink:label="dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" />
    <loc xlink:href="dvax-20131231.xsd#dvax_DisclosureComponentOfConsolidatedIncomeLossBeforeProvisionForIncomeTaxesAbstract" xlink:type="locator" xlink:label="dvax_DisclosureComponentOfConsolidatedIncomeLossBeforeProvisionForIncomeTaxesAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_DisclosureComponentOfConsolidatedIncomeLossBeforeProvisionForIncomeTaxesAbstract" xlink:to="dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" xlink:to="dei_LegalEntityAxis" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitTable" xlink:to="dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureDifferenceBetweenConsolidatedIncomeTaxBenefitAndAmountComputedByFederalStatutoryIncomeTaxRateDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureDifferenceBetweenConsolidatedIncomeTaxBenefitAndAmountComputedByFederalStatutoryIncomeTaxRateDetail" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureDifferenceBetweenConsolidatedIncomeTaxBenefitAndAmountComputedByFederalStatutoryIncomeTaxRateDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationDeductionsDividends" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationDeductionsDividends" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" />
    <loc xlink:href="dvax-20131231.xsd#dvax_IncomeTaxReconciliationChangeInFairValueMeasurement" xlink:type="locator" xlink:label="dvax_IncomeTaxReconciliationChangeInFairValueMeasurement" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <loc xlink:href="dvax-20131231.xsd#dvax_IncomeTaxReconciliationDeferredCompensationCharges" xlink:type="locator" xlink:label="dvax_IncomeTaxReconciliationDeferredCompensationCharges" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCredits" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationTaxCredits" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
    <loc xlink:href="dvax-20131231.xsd#dvax_IncomeTaxRateReconciliationLineItems" xlink:type="locator" xlink:label="dvax_IncomeTaxRateReconciliationLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_IncomeTaxRateReconciliationTable" xlink:type="locator" xlink:label="dvax_IncomeTaxRateReconciliationTable" />
    <loc xlink:href="dvax-20131231.xsd#dvax_DisclosureDifferenceBetweenConsolidatedIncomeTaxBenefitAndAmountComputedByFederalStatutoryIncomeTaxRateAbstract" xlink:type="locator" xlink:label="dvax_DisclosureDifferenceBetweenConsolidatedIncomeTaxBenefitAndAmountComputedByFederalStatutoryIncomeTaxRateAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_DisclosureDifferenceBetweenConsolidatedIncomeTaxBenefitAndAmountComputedByFederalStatutoryIncomeTaxRateAbstract" xlink:to="dvax_IncomeTaxRateReconciliationTable" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_IncomeTaxRateReconciliationTable" xlink:to="dei_LegalEntityAxis" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_IncomeTaxRateReconciliationTable" xlink:to="dvax_IncomeTaxRateReconciliationLineItems" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_IncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_IncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_IncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_IncomeTaxReconciliationTaxCredits" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_IncomeTaxRateReconciliationLineItems" xlink:to="dvax_IncomeTaxReconciliationDeferredCompensationCharges" order="10530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_IncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="10650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_IncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" order="10770.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_IncomeTaxRateReconciliationLineItems" xlink:to="dvax_IncomeTaxReconciliationChangeInFairValueMeasurement" order="10850.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_IncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" order="10930.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_IncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_IncomeTaxReconciliationDeductionsDividends" order="11010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_IncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" order="11090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_IncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments" order="11210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_IncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="11330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureComponentOfDeferredTaxAssetsAndLiabilitiesDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureComponentOfDeferredTaxAssetsAndLiabilitiesDetail" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureComponentOfDeferredTaxAssetsAndLiabilitiesDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilities" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesOther" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxAssetsGrossAbstract" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGrossAbstract" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ScheduleOfDeferredTaxAssetsAndLiabilitiesLineItems" xlink:type="locator" xlink:label="dvax_ScheduleOfDeferredTaxAssetsAndLiabilitiesLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ScheduleOfDeferredTaxAssetsAndLiabilitiesTable" xlink:type="locator" xlink:label="dvax_ScheduleOfDeferredTaxAssetsAndLiabilitiesTable" />
    <loc xlink:href="dvax-20131231.xsd#dvax_DisclosureComponentOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:type="locator" xlink:label="dvax_DisclosureComponentOfDeferredTaxAssetsAndLiabilitiesAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_DisclosureComponentOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="dvax_ScheduleOfDeferredTaxAssetsAndLiabilitiesTable" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_ScheduleOfDeferredTaxAssetsAndLiabilitiesTable" xlink:to="dei_LegalEntityAxis" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_ScheduleOfDeferredTaxAssetsAndLiabilitiesTable" xlink:to="dvax_ScheduleOfDeferredTaxAssetsAndLiabilitiesLineItems" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_ScheduleOfDeferredTaxAssetsAndLiabilitiesLineItems" xlink:to="us-gaap_DeferredTaxAssetsGrossAbstract" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="10520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome" order="10600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsOther" order="10680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="10760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="10840.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsNet" order="10920.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_ScheduleOfDeferredTaxAssetsAndLiabilitiesLineItems" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract" order="11000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" order="11080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesOther" order="11160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilities" order="11240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet" order="11320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureIncomeTaxesAdditionalInformationDetail" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ForeignCountryMember" xlink:type="locator" xlink:label="us-gaap_ForeignCountryMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_CaliforniaStateMember" xlink:type="locator" xlink:label="dvax_CaliforniaStateMember_li0l2" />
    <loc xlink:href="dvax-20131231.xsd#dvax_CaliforniaStateMember" xlink:type="locator" xlink:label="dvax_CaliforniaStateMember" />
    <loc xlink:href="dvax-20131231.xsd#dvax_TaxCreditCarryforwardExpirationYear" xlink:type="locator" xlink:label="dvax_TaxCreditCarryforwardExpirationYear" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAmount" />
    <loc xlink:href="dvax-20131231.xsd#dvax_OperatingLossCarryforwardExpirationYear" xlink:type="locator" xlink:label="dvax_OperatingLossCarryforwardExpirationYear" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" xlink:label="us-gaap_MaximumMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinimumMember" xlink:type="locator" xlink:label="us-gaap_MinimumMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" xlink:label="us-gaap_RangeMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" xlink:label="us-gaap_RangeAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_ResearchAndDevelopmentMember" xlink:type="locator" xlink:label="dvax_ResearchAndDevelopmentMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_FederalMember" xlink:type="locator" xlink:label="dvax_FederalMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" xlink:type="locator" xlink:label="us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="locator" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <loc xlink:href="dvax-20131231.xsd#dvax_IncomeTaxDisclosureLineItems" xlink:type="locator" xlink:label="dvax_IncomeTaxDisclosureLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_IncomeTaxDisclosureTable" xlink:type="locator" xlink:label="dvax_IncomeTaxDisclosureTable" />
    <loc xlink:href="dvax-20131231.xsd#dvax_DisclosureIncomeTaxesAdditionalInformationAbstract" xlink:type="locator" xlink:label="dvax_DisclosureIncomeTaxesAdditionalInformationAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_DisclosureIncomeTaxesAdditionalInformationAbstract" xlink:to="dvax_IncomeTaxDisclosureTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_IncomeTaxDisclosureTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_IncomeTaxDisclosureTable" xlink:to="dvax_IncomeTaxDisclosureLineItems" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_IncomeTaxDisclosureTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="10020.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="dvax_FederalMember" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_IncomeTaxDisclosureTable" xlink:to="us-gaap_TaxCreditCarryforwardAxis" order="10020.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain" order="10580.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="dvax_ResearchAndDevelopmentMember" order="10600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_IncomeTaxDisclosureTable" xlink:to="us-gaap_RangeAxis" order="10020.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" order="10670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" order="10690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" order="10710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="10810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_IncomeTaxDisclosureLineItems" xlink:to="dvax_OperatingLossCarryforwardExpirationYear" order="10850.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_TaxCreditCarryforwardAmount" order="10930.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_IncomeTaxDisclosureLineItems" xlink:to="dvax_TaxCreditCarryforwardExpirationYear" order="10970.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="dvax_CaliforniaStateMember" order="11100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="dvax_CaliforniaStateMember_li0l2" order="11120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_ForeignCountryMember" order="11550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSelectedQuarterlyFinancialDataDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureSelectedQuarterlyFinancialDataDetail" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSelectedQuarterlyFinancialDataDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Revenues" xlink:type="locator" xlink:label="us-gaap_Revenues" />
    <loc xlink:href="dvax-20131231.xsd#dvax_SelectedQuarterlyFinancialDataLineItems" xlink:type="locator" xlink:label="dvax_SelectedQuarterlyFinancialDataLineItems" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_SelectedQuarterlyFinancialDataTable" xlink:type="locator" xlink:label="dvax_SelectedQuarterlyFinancialDataTable" />
    <loc xlink:href="dvax-20131231.xsd#dvax_DisclosureSelectedQuarterlyFinancialDataAbstract" xlink:type="locator" xlink:label="dvax_DisclosureSelectedQuarterlyFinancialDataAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_DisclosureSelectedQuarterlyFinancialDataAbstract" xlink:to="dvax_SelectedQuarterlyFinancialDataTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_SelectedQuarterlyFinancialDataTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_SelectedQuarterlyFinancialDataTable" xlink:to="dvax_SelectedQuarterlyFinancialDataLineItems" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_SelectedQuarterlyFinancialDataLineItems" xlink:to="us-gaap_Revenues" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_SelectedQuarterlyFinancialDataLineItems" xlink:to="us-gaap_NetIncomeLoss" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_SelectedQuarterlyFinancialDataLineItems" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_SelectedQuarterlyFinancialDataLineItems" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="10560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dvax_SelectedQuarterlyFinancialDataLineItems" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="10720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <roleRef roleURI="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetail" xlink:href="dvax-20131231.xsd#Role_DisclosureSubsequentEventAdditionalInformationDetail" xlink:type="simple" />
  <presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20131231/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetail">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:type="locator" xlink:label="us-gaap_SubsequentEventLineItems" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventMember" xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" />
    <loc xlink:href="dvax-20131231.xsd#dvax_AstraZenecaMember" xlink:type="locator" xlink:label="dvax_AstraZenecaMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:type="locator" xlink:label="dei_EntityDomain" />
    <loc xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" xlink:label="dei_LegalEntityAxis" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventTable" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTable" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventTable" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="dei_LegalEntityAxis" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10020.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="dvax_AstraZenecaMember" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="10020.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventLineItems" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E1VBG">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Summary of Cash, Cash Equivalents and Marketable Securities Available-for-sale (Detail) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_CashCashEquivalentsAndMarketableSecuritiesLineItems', window );"><strong>Cash Cash Equivalents And Marketable Securities [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized Cost</a></td>
        <td class="nump">$ 189,407<span></span></td>
        <td class="nump">$ 125,085<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments', window );">Unrealized Gains</a></td>
        <td class="nump">16<span></span></td>
        <td class="nump">46<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments', window );">Unrealized Losses</a></td>
        <td class="num">(47)<span></span></td>
        <td class="num">(1)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Estimated Fair Value</a></td>
        <td class="nump">189,376<span></span></td>
        <td class="nump">125,130<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Cash and Cash Equivalents</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_CashCashEquivalentsAndMarketableSecuritiesLineItems', window );"><strong>Cash Cash Equivalents And Marketable Securities [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized Cost</a></td>
        <td class="nump">23,122<span></span></td>
        <td class="nump">7,599<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Estimated Fair Value</a></td>
        <td class="nump">23,122<span></span></td>
        <td class="nump">7,599<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Cash and Cash Equivalents | Cash</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_CashCashEquivalentsAndMarketableSecuritiesLineItems', window );"><strong>Cash Cash Equivalents And Marketable Securities [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized Cost</a></td>
        <td class="nump">1,766<span></span></td>
        <td class="nump">1,542<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Estimated Fair Value</a></td>
        <td class="nump">1,766<span></span></td>
        <td class="nump">1,542<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Cash and Cash Equivalents | Money market funds</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_CashCashEquivalentsAndMarketableSecuritiesLineItems', window );"><strong>Cash Cash Equivalents And Marketable Securities [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized Cost</a></td>
        <td class="nump">20,013<span></span></td>
        <td class="nump">3,140<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Estimated Fair Value</a></td>
        <td class="nump">20,013<span></span></td>
        <td class="nump">3,140<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Cash and Cash Equivalents | US Government Agencies Debt Securities</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_CashCashEquivalentsAndMarketableSecuritiesLineItems', window );"><strong>Cash Cash Equivalents And Marketable Securities [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized Cost</a></td>
        <td class="nump">1,343<span></span></td>
        <td class="nump">2,202<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Estimated Fair Value</a></td>
        <td class="nump">1,343<span></span></td>
        <td class="nump">2,202<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Cash and Cash Equivalents | Municipal Securities</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_CashCashEquivalentsAndMarketableSecuritiesLineItems', window );"><strong>Cash Cash Equivalents And Marketable Securities [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized Cost</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">715<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Estimated Fair Value</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">715<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Available-for-sale Securities</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_CashCashEquivalentsAndMarketableSecuritiesLineItems', window );"><strong>Cash Cash Equivalents And Marketable Securities [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized Cost</a></td>
        <td class="nump">166,285<span></span></td>
        <td class="nump">117,486<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments', window );">Unrealized Gains</a></td>
        <td class="nump">16<span></span></td>
        <td class="nump">46<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments', window );">Unrealized Losses</a></td>
        <td class="num">(47)<span></span></td>
        <td class="num">(1)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Estimated Fair Value</a></td>
        <td class="nump">166,254<span></span></td>
        <td class="nump">117,531<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Available-for-sale Securities | US Government Agencies Debt Securities</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_CashCashEquivalentsAndMarketableSecuritiesLineItems', window );"><strong>Cash Cash Equivalents And Marketable Securities [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized Cost</a></td>
        <td class="nump">166,285<span></span></td>
        <td class="nump">116,986<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments', window );">Unrealized Gains</a></td>
        <td class="nump">16<span></span></td>
        <td class="nump">46<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments', window );">Unrealized Losses</a></td>
        <td class="num">(47)<span></span></td>
        <td class="num">(1)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Estimated Fair Value</a></td>
        <td class="nump">166,254<span></span></td>
        <td class="nump">117,031<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Available-for-sale Securities | US Treasury Securities</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_CashCashEquivalentsAndMarketableSecuritiesLineItems', window );"><strong>Cash Cash Equivalents And Marketable Securities [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized Cost</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">500<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Estimated Fair Value</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 500<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of accumulated pre-tax unrealized gain before deducting pre-tax unrealized losses on investments in available-for-sale securities impacting investments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of accumulated pre-tax unrealized loss before deducting pre-tax unrealized gain on investments in available-for-sale securities impacting investments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_CashCashEquivalentsAndMarketableSecuritiesLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_CashCashEquivalentsAndMarketableSecuritiesLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecurities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of investment in debt and equity securities categorized neither as held-to-maturity nor trading.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 25<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28360136&amp;loc=d3e22054-111558<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -Subparagraph (aa)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27232-111563<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6871852&amp;loc=d3e26610-111562<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecurities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This item represents the cost of debt and equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecuritiesAmortizedCost</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EBHEK">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Equity Plans and Stock-Based Compensation - Additional Information (Detail) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="4">12 Months Ended</th>
        <th class="th" colspan="2">1 Months Ended</th>
        <th class="th" colspan="6">12 Months Ended</th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="2"></th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1">12 Months Ended</th>
        <th class="th" colspan="6">1 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Employee

</div>
          <div>CompensationPlan</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Employee</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Employee Stock Purchase Plan</div>
        </th>
        <th class="th">
          <div>Jan. 31, 2004

</div>
          <div>Employee Stock Purchase Plan

</div>
          <div>The commencement of the offer period (generally, the fifteenth day in February or August)</div>
        </th>
        <th class="th">
          <div>Jan. 31, 2004

</div>
          <div>Employee Stock Purchase Plan

</div>
          <div>The exercise date, which is the last day of a purchase period (generally, the fourteenth day in February or August)</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Non Employee Awards</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Additional</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Additional</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Restricted Stock Units (RSUs)</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Restricted Stock Units (RSUs)</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011

</div>
          <div>Restricted Stock Units (RSUs)</div>
        </th>
        <th class="th">
          <div>Jan. 31, 2004

</div>
          <div>2004 Plan</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>2004 Plan</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Inducement Plan</div>
        </th>
        <th class="th">
          <div>Jan. 31, 2011

</div>
          <div>2011 Plan</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>2011 Plan</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Time Based Vesting Schedule</div>
        </th>
        <th class="th">
          <div>Jan. 31, 2004

</div>
          <div>Maximum

</div>
          <div>2004 Plan</div>
        </th>
        <th class="th">
          <div>Jan. 31, 2004

</div>
          <div>Maximum

</div>
          <div>2004 Plan

</div>
          <div>Other Participants</div>
        </th>
        <th class="th">
          <div>Jan. 31, 2010

</div>
          <div>Maximum

</div>
          <div>Inducement Plan</div>
        </th>
        <th class="th">
          <div>May 29, 2013

</div>
          <div>Maximum

</div>
          <div>2011 Plan</div>
        </th>
        <th class="th">
          <div>Jan. 31, 2011

</div>
          <div>Maximum

</div>
          <div>2011 Plan</div>
        </th>
        <th class="th">
          <div>Jan. 31, 2004

</div>
          <div>Minimum

</div>
          <div>2004 Plan

</div>
          <div>Stock possessing more than 10% of the voting power of all classes of the Company's stock or the stock of any parent or subsidiary of the Company</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_NumberOfShareBasedCompensationPlans', window );">Number of share-based compensation plans</a></td>
        <td class="nump">3<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Issuance of common stock shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">25,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period</a></td>
        <td class="text">10 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">10 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">10 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">5 years<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Purchase price per share as percentage of fair market value of common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">85.00%<span></span></td>
        <td class="nump">85.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">100.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">110.00%<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of shares of Common Stock outstanding</a></td>
        <td class="nump">15,765,000<span></span></td>
        <td class="nump">13,806,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">4,066,277<span></span></td>
        <td class="nump">743,625<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">10,954,940<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Increase in the aggregate number of shares of common stock authorized for issuance</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">10,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares reserved and approved for issuance</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">996,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">13,666,964<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Total intrinsic value of options exercised</a></td>
        <td class="nump">$ 300,000<span></span></td>
        <td class="nump">$ 2,700,000<span></span></td>
        <td class="nump">$ 100,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Total fair value of stock options vested</a></td>
        <td class="nump">12,100,000<span></span></td>
        <td class="nump">9,600,000<span></span></td>
        <td class="nump">2,800,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockExpense', window );">Stock based compensation expense related to restricted stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">100,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested', window );">Aggregate intrinsic value</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Grant date fair value of restricted stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 1.23<span></span></td>
        <td class="nump">$ 4.23<span></span></td>
        <td class="nump">$ 0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total fair value of restricted stock units</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">100,000<span></span></td>
        <td class="nump">200,000<span></span></td>
        <td class="nump">800,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Options vesting period</a></td>
        <td class="text">4 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndRsuOutstandingNumber', window );">Options and restricted stock units outstanding</a></td>
        <td class="nump">2,047,466<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
        <td class="nump">0.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Recognized stock-based compensation expense</a></td>
        <td class="nump">4,900,000<span></span></td>
        <td class="nump">1,500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,300,000<span></span></td>
        <td class="nump">700,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock compensation expense</a></td>
        <td class="nump">12,340,000<span></span></td>
        <td class="nump">10,439,000<span></span></td>
        <td class="nump">5,189,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanNumberOfEmployeesCovered', window );">Number of employees under stock option</a></td>
        <td class="nump">5<span></span></td>
        <td class="nump">1<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total unrecognized compensation cost related to non-vested equity awards</a></td>
        <td class="nump">$ 3,800,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 100,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 10,300,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Total unrecognized compensation cost, weighted-average vesting period</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">1 year 4 months 24 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">2 years 9 months 18 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward', window );">Shares issued to employees</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">828,414<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares remaining available for future purchases</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">167,586<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_NumberOfShareBasedCompensationPlans">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of share based compensation plans.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_NumberOfShareBasedCompensationPlans</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:integerItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndRsuOutstandingNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Share based compensation arrangement by share based payment award options and Rsu outstanding number.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndRsuOutstandingNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 14.F)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (h)(1)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br> -Section F<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AllocatedShareBasedCompensationExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanNumberOfEmployeesCovered">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of employees eligible to participate in the defined contribution plan or plans described.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DefinedContributionPlanNumberOfEmployeesCovered</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:integerItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Unrecognized cost of unvested share-based compensation awards.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedStockExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The noncash expense that represents the cost of restricted stock or unit distributed to employees as compensation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RestrictedStockExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Intrinsic value of equity-based compensation awards not vested. Excludes stock and unit options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(iii)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (d)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(iii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of additional shares authorized for issuance under an established share-based compensation plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (d)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of options outstanding, including both vested and non-vested options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(i)-(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Purchase price of common stock expressed as a percentage of its fair value.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of share instruments newly issued under a share-based compensation plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of shares purchased on the open market during the period for issuance to employees under the plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EW2AI">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Commitments and Contingencies - Additional Information (Detail)<br></strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
        <th class="th" colspan="2"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="2">12 Months Ended</th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Deutsche Bank Securities

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Deutsche Bank Securities

</div>
          <div>EUR (&#x20AC;)</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Deutsche Bank Securities

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Berkeley, California (the "Berkeley Lease")

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Dusseldorf, Germany (the "Dusseldorf Lease")</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2004

</div>
          <div>Berkeley, California (the "Berkeley Lease")

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Berkeley, California (the "Berkeley Lease")

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Berkeley, California (the "Berkeley Lease")

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2004

</div>
          <div>Berkeley, California (the "Berkeley Lease")

</div>
          <div>Contingency, B</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2004

</div>
          <div>Berkeley, California (the "Berkeley Lease")

</div>
          <div>Contingency, B

</div>
          <div>Minimum

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2004

</div>
          <div>Berkeley, California (the "Berkeley Lease")

</div>
          <div>Contingency, A

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2004

</div>
          <div>Berkeley, California (the "Berkeley Lease")

</div>
          <div>Contingency, A

</div>
          <div>Minimum</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2004

</div>
          <div>Berkeley, California (the "Berkeley Lease")

</div>
          <div>Contingency, A

</div>
          <div>Maximum

</div>
          <div>USD ($)</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_LeaseExpirationMonthAndYear', window );">Operating leases expiration date</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">2018-06<span></span></td>
        <td class="text">2023-03<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Unoccupied facility expense</a></td>
        <td class="nump">$ 926,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 900,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Rent expense, net</a></td>
        <td class="nump">1,900,000<span></span></td>
        <td class="nump">1,700,000<span></span></td>
        <td class="nump">1,700,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRentCredit', window );">Deferred rent</a></td>
        <td class="nump">600,000<span></span></td>
        <td class="nump">600,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PledgedAssetsSeparatelyReportedSecuritiesPledgedUnderLetterOfCreditFacilitiesAtFairValue', window );">Letter of credit pledged as security</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">200,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">400,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecurityOwnedAndPledgedAsCollateralFairValue', window );">Collateralized certificate of deposit</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">200,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">200,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">400,000<span></span></td>
        <td class="nump">400,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansAndLeasesReceivableDescription', window );">Terms of the lease</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">If the total amount of our cash, cash equivalents and marketable securities falls below $20 million for a period of more than 30 consecutive days during the lease term, the amount of the required security deposit will increase to $1.1 million, until such time as our projected cash and cash equivalents will exceed $20 million for the remainder of the lease term, or until our actual cash and cash equivalents remains above $20 million for a period of 12 consecutive months.<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Cash, cash equivalents and marketable securities</a></td>
        <td class="nump">189,400,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">20,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">20,000,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_ContingencyPeriod', window );">Contingency period for cash, cash equivalents and marketable securities</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">12 months<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">30 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInSecurityDeposits', window );">Increase in amount of the security deposit</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,100,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentAmount', window );">Future payments obligation</a></td>
        <td class="nump">$ 4,500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_ContingencyPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Contingency Period</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_ContingencyPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_LeaseExpirationMonthAndYear">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Lease Expiration, Month and Year</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_LeaseExpirationMonthAndYear</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gYearMonthItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessExitCosts1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 420<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 420<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SAB TOPIC 5.P.4(b))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140904-122747<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 420<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 5.P.3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140864-122747<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 5<br><br> -Section P<br><br> -Subsection 3, 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BusinessExitCosts1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash Equivalents<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashCashEquivalentsAndShortTermInvestments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRentCredit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cumulative difference between the rental payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense over the term of the leased property by the lessor or lessee, respectively.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 20<br><br> -Section 25<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7501430&amp;loc=d3e39896-112707<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredRentCredit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInSecurityDeposits">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in security deposits.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInSecurityDeposits</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansAndLeasesReceivableDescription">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Describes the major category and subcategories of loans held, any unusual risk concentration relating thereto, and the related loans receivable carrying amounts as of the balance sheet date. Such descriptions may include information pertaining to: (i) type of borrower, (ii) purpose of the loan, (iii) loan maturity, (iv) credit and other risk associated with the loan, and (v) other terms of importance (secured or unsecured, variable or fixed interest).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 310<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 7<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28368275&amp;loc=d3e5111-111524<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 310<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28368275&amp;loc=d3e5066-111524<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 7<br><br> -Subparagraph a, b<br><br> -Article 9<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 210<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.9-03.7(a),(b))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LoansAndLeasesReceivableDescription</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The minimum amount the entity agreed to spend under the long-term purchase commitment.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LongTermPurchaseCommitmentAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LossContingenciesLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41499-112717<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingLeasesRentExpenseNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PledgedAssetsSeparatelyReportedSecuritiesPledgedUnderLetterOfCreditFacilitiesAtFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The fair value, as of the date of each statement of financial position presented, of securities that are restricted as collateral under letter of credit agreements, and that are reclassified and separately reported in the statement of financial position because the transferee has the right by contract or custom to sell or re-pledge them.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 860<br><br> -SubTopic 30<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6467456&amp;loc=d3e113888-111728<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PledgedAssetsSeparatelyReportedSecuritiesPledgedUnderLetterOfCreditFacilitiesAtFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityOwnedAndPledgedAsCollateralFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value of financial instrument held by the entity for its own account (proprietary securities) for trading or investment purposes that are carried at fair value and pledged to counterparties as collateral for financing transactions.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 860<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 1A<br><br> -Subparagraph (b)(1)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7523297&amp;loc=SL6224234-111729<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 860<br><br> -SubTopic 30<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6467456&amp;loc=d3e113888-111728<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SecurityOwnedAndPledgedAsCollateralFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>33
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0`!@`(````(0#JK5)2/0(``#\F```3``@"6T-O;G1E;G1?5'EP97-=
M+GAM;""B!`(HH``"````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M``````````````````````````````````````#,VM]NVC`4!O#[27N'R+<3
M,;;CK)N`7NS/Y59IW0-XR8%$)'9DNQV\_9S05E7%J-"0]MT00>QS/JSH=Y.S
MN-[U779//K3.+IG(YRPC6[FZM9LE^WG[=7;%LA"-K4WG+"W9G@*[7KU]L[C=
M#Q2RM-N&)6MB'#YR'JJ&>A-R-Y!-=];.]R:FKW[#!U-MS8:XG,]+7CD;R<99
M'&NPU>(SK<U=%[,ON_3S(8FG+K#LTV'AV&O)S#!T;65B2LKO;?VBR^RA0YYV
M3FM"TP[A78K!^-$.XYV_-WC8]ST=C6]KRFZ,C]],GV+P7<=_.[_]Y=PV/UWD
M2$JW7K<5U:ZZZ],)Y&'P9.K0$,6^RZ=KWIO6/N8^T7]:'/AT$1<.,OZ_J?"9
M.21(#@62HP#)H4%RE"`YWH/DN`+)\0$DAYBC!$$15:"0*E!,%2BH"A15!0JK
M`L55@0*K0)%5HL@J4625*+)*%%DEBJP215:)(JM$D56BR"I19%4HLBH4616*
MK`I%5H4BJT*15:'(JE!D52BR*A19"Q19"Q19"Q19"Q19"Q19"Q19"Q19"Q19
M"Q19"Q19-8JL&D56C2*K1I%5H\BJ4635*+)J%%DUBJP:1=821=821=821=82
M1=;R?\D:TW@.\>GSWY^.J<PK\R$A[CL*%WZG>RCZ6N?&>*I_1)\&F2X>X'GM
M4SG2F,^-=T-(`T^>SC^%QXFF<?=L2(7(QY:>9IJ.S08]=4S#4N<W?#&<1.,X
M5DWUD=Y\&O]:_0$``/__`P!02P,$%``&``@````A`+55,"/U````3`(```L`
M"`)?<F5L<R\N<F5L<R"B!`(HH``"````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M``````````````````````````````````````````````````",DL].PS`,
MQN](O$/D^^IN2`BAI;M,2+LA5![`).X?M8VC)$#W]H0#@DICV]'VY\\_6][N
MYFE4'QQB+T[#NBA!L3-B>]=J>*V?5@^@8B)G:13'&HX<85?=WFQ?>*24FV+7
M^ZBRBXL:NI3\(V(T'4\4"_'L<J61,%'*86C1DQFH9=R4Y3V&OQY0+3S5P6H(
M!WL'JC[Z//FRMS1-;W@OYGUBETZ,0)X3.\MVY4-F"ZG/VZB:0LM)@Q7SG-,1
MR?LB8P.>)MI<3_3_MCAQ(DN)T$C@\SS?BG-`Z^N!+I]HJ?B]SCSBIX3A363X
M8<'%#U1?````__\#`%!+`P04``8`"````"$`C?RA+X,"``#>)0``&@`(`7AL
M+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS(*($`2B@``$`````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````O)K-BMLP%(7WA;Z#T;Y1KOYFIHPSFU*8;3M]
M`!,K<9C$-I;ZD[>O2(LG`^V9C3F;@&4B'="YY[NR??_PZW2L?L0I'8:^5K):
MJRKVVZ$]]/M:?7OZ_.%652DW?=L<AS[6ZAR3>MB\?W?_)1Z;7/Z4NL.8JC)+
MGVK5Y3Q^U#IMNWAJTFH88U_N[(;IU.1R.>WUV&R?FWW49KT.>KJ>0VU>S5D]
MMK6:'EL35/5T'LO2;T\^[':';?PT;+^?8I__L8;^.4S/J8LQETF;:1]SK>:A
MI"]W3%@5S4K_1XZPY0B28QU9CG5(CC-D.<Y`.3=L.3=(CB_%1;6R7T,YGBW'
M(SG!DN4$B^2PK0.=PRXK6%7"3F3!B7Q']HVY0[X1-B`$`L*P`6$@("S;R19:
MV;*KW,(R=VQ`.`@(QP:$@X#P;$!X"`A?.F,NS6]1[H1%4SGE\[%T^G.3_.<:
MK<_V"K1*8(=P@"$L;$0)1A2;"0*98-A,,)`)ALT$`YE@V4RPD`F67><6%KIC
M,\%!)C@V$QQD@E^4"?.#DA<LS$-_GYUXV*D'=NX$F#OLO<);Q2:6A\1BEQ6L
M*F$#0B`@A`T(@8`P[$0V,)$MW3K0.Y9=Y1:6N6,GLH.)[-F-J8>-:5BTLE+7
M3+']FJ?R+N/Z*',]C$XTAMUY&=AY.38A'"2$9\/<0Y@'-B,"9@3YV0#<*G;F
MP,@1-JX$XLJP<64@K@P;5P;BRK*M8Z%W'!M7#N+*+XJK^2P%CE>P$10VKP3R
MRK)Y96$(.C:O'.259_/*0UX%MG<"]$Y8%!*Y?(T27ZKJ<JDOO]@Q9(9#O["3
M#P:?L*$I$)K"AJ9@:++WRLZ;I5]]E;7Y#0``__\#`%!+`P04``8`"````"$`
M%^J;MK4%``!F$P``#P```'AL+W=O<FMB;V]K+GAM;)2875/;.A"&[\_,^0^9
MW)\F=KY(I]`!`E-F2LEI^G&I$8Y"--B2*\E`^NN[LDMX905/>P4BZ,WNZMG7
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M6*YV1;G5:L<6.VI?39V:X69$.CE`8U%(UW2#SY^:UI%;DVNW8D"FDP,XYCF_
MU89(>A#LL[""FVS+%N)!Y+K$<)#J)`+RDW#LH[:6+84AK^`&FW.&6"81ETLC
M-H+JN6;41]D]I5(46OU>H%?,D,LD`M/31#0LR;!LS40M=\8M*9]C@\Z03S+D
MEO]=%&6N=T*P,Z'$1KI:$4IQA%BF$99TC+H0[`M_"F`X0AC3",:5R$7F#??_
MBALG3+YCEU*1]4J>LP5^.Y*91F2NJELK?E0>SHL'WUBX%7E,8QX[_8'"KWW,
M/SZ.D,TT8O,5AZ"24*\%`2&<S1,T\,I.HP@"0CK3B,[#3G$@'@0UC4`]?[WK
M20OK@Z"F$:@>\%=[EZ$.@CJ*0#W7!YO7VP$U,.C,D=A11&S<O'%IYHCO*,*W
MNX?QJ.;([RCBM[N)`R&D>131C&UX(!TDF*:PE@5T=V,0!2(\BORU^YE+I=CW
MU`C9HT4K(NBI#U(8[]([1I-=XQ*@,\=6&$4,0T`'GL.H$\03,0PZIX4V3OZL
M7=:ZVGE1!WMA'#/<V>-8H#$22(M6@:BI2KJ;D._1?!,U/`0T1@!IT=*)MM93
M!3M=TY4AF*''R!\M6CK1=/$LH<C0KS`>1'$<<1SD%3D0Z,S1+,8QTO&T`1&!
M#EU!8&P91TA?5HYF/G8ME2RJ@J;Y73.%?%5K>O8'0L&)14AWVR`V63(,SBR"
M^A4C_#W%A$K!J75A_9EF($5#[F>1:9J6/=]!<GALDYAKPK&B"PO=2#V0-(7(
MK&Z-A<PK!T(3+!(M6AAU&ROV1^(OCOMQ>1*!_9T;0_.^95?6^IG5:;:LR$9H
M/@K'HV2(%C*)R.ZVZ#`D-)%)Q/9-6=?G-*/ITX]N58U0,P4NZ:J^-\=)D%K,
M]LOD0B.L,[*>I!J=K_1JX44GR"Q&>W^U::9&O-\PCCI!7A'9P>!9T#L0VX!P
M\>1_1QTTQ\D!KL'3@FNY?[JA#O;^)*)Z(3<T8=/=0+!;X1Z%4'3B^TL^Z$RQ
M]6G1@C'PHL7SU$Z3;GV!`IUDB(E-(ZJ#A_-O:ZU]L7Y9`4)3;'Q:M`+J?DXC
MBE/L>UJTA5IC,U@CW<L@H&2(I9[62`]JONA=3,;SC%X2^1]^3*[K-WA^17;R
M"P``__\#`%!+`P04``8`"````"$`(C\&03@%``!)%```&````'AL+W=O<FMS
M:&5E=',O<VAE970T+GAM;)18VXZC1A!]CY1_0+S;T-RQ;*\6T"0K9:4HRN69
MP6T;C7%;P%SV[U--8>AJ=ACF9<9VG2Z?NG0=4]LO;]7%>.%U4XKKSF1KVS3X
MM1"'\GK:F?_\_;"*3*-I\^LAOX@KWYD_>&-^V?_ZR_95U$_-F?/6``_79F>>
MV_:VL:RF./,J;];BQJ]@.8JZREMX6Y^LYE;S_-`=JBZ68]N!5>7EU40/FWJ)
M#W$\E@7/1/%<\6N+3FI^R5O@WYS+6W/W5A5+W%5Y_?1\6Q6BNH&+Q_)2MC\Z
MIZ91%9MOIZNH\\<+Q/W&O+RX^^[>3-Q795&+1AS;-;BSD.@TYMB*+?"TWQY*
MB$"FW:CY<6=^99O,<4UKO^T2]&_)7QOEM=&<Q>MO=7GXH[QRR#;425;@48@G
M"?UVD!_!86MR^J&KP)^U<>#'_/G2_B5>?^?EZ=Q"N7V(2`:V.?S(>%-`1L'-
MVO&EIT)<@`#\-:I2M@9D)'_K_K^6A_:\,]U@[8>VRP!N//*F?2BE2],HGIM6
M5/\AB/6NT(G3._&`?6]WUD[D,S_XV(N%C+H`L[S-]]M:O!K0-?"=S2V7/<@V
MX/D>&?(88GTO5(A1.ODJO72^((H&ZO.R#_VM]0(I+7I(@A"X$0.$441Z1\C\
M2:^9\H$%=`?.D`F=LPLU_7DU[A3E(8UB0`DD4XA#$>D4X6IQ9E-(&`Y>2!@N
M#6.>O@1#VRCI"Z/!;9>N!"%0Q"'#6H#IAXAL#D'(P]>H-9@G+\$[$S(S,`MC
MC3Q"PJYWO-C1S"DQ!\RFIS/5S$(6CW9"&B[;<M(23$E'HUO,.$*"CK3/7*T@
MJ6IV8U>+*2-FIL1$.`>?X2S!&F?MEB4(0<Z,11[-9$K-@=[=Q.RR\33A''Z&
MLP1KG+5KER#DSMGQM9A2U1Z'"BN<(ZK988%B)ZRE6BNC<+ZE)9C>Q\BEJ4P0
M`JTY=+U^'S]$9',(0C[^#'D)UE(^5A);&R%]:]M1J+5^JMJ]F'E::)EJAZOA
MC"4EM!G,[>5)[]`:<:U#DQZ#S!T_]K2RI!00L4`+/2,`%H).#X6EW*4^+6X8
MAFJF#L%(2UK28[QNH,2.9DX'\[L=E<U"*'LI5,O9HZP1]J.L8<LPQ"#[,6>=
M,9TS9L3HQ..@I(RE."UGC%)&&&L#.F&(P5X)PU`?T:D&<)4AC:.%`(*8Q>-H
MHMRE0BWGCGI&N(])Z;.-&.2^"@(OTJ)+&46$?JPU5$81'K3Z6%-*7VK5<OJH
M;)#<8?(IBMS31PQ0'#`:NU3^PH8Q-0/)9B$T`JE<RR-`G5,+H%2VCP`QV.Z,
M3=BK9D<_G3'5S.QQ2%'64KJ6LT:A(ZS'N=NS1LQ,4E.FZN7*<76YS2B`Q?Y[
M72/5:SE[U#K"?DQ+S_ZNA_(18^5ZDY8G=B?6SF=,M4?N./EIUJ5X+>>-4D=X
MCXY[WJH<PF4-G<E\I(@X]K0+GS&"\"(_?B?MSJ<TM4-338UU3>TQ_:R)O$#C
MEO:`F:[*9B$D_8ZFJ_*9=,'SW51?]7F7=)YW)CYEK$*?19-`T$N/"'Y2!NIC
MK@S0$6H7+0Q#GM+*,=89N\E!3-S]3%C9Z\F#AP[P1E7J/&0Z0!$^6@I-<F4,
MP<>/VE/IC;6;FL"Z1L:)+<7BP-$7!BE%A/:DZ^3*1_$!CP7V&">&@1L=7'A4
MO#[QE%\NC5&(9[FM89#`X5/<)"6P2>K6+M9@@$7.+3_Q[WE]*J^-<>%'.&JO
M0U"G&E=!^*85MVZ_\"A:6.%T+\^PLN.PR;#7`#X*T=[?R&73L`3<_P\``/__
M`P!02P,$%``&``@````A`$A?PR_<`@``_`<``!D```!X;"]W;W)K<VAE971S
M+W-H965T-#<N>&ULE%5=;YLP%'V?M/^`_%[`$$(2A53-JFZ3-FF:]O'L@`&K
M&"/;:=I_OVN;4$*;KGD),3X^YYY[KR_KZT?>>`]4*B;:#&$_1!YM<U&PMLK0
M[U]W5POD*4W:@C2BI1EZH@I=;SY^6!^$O%<UI=H#AE9EJ-:Z6P6!RFO*B?)%
M1UO8*87D1,-25H'J)"6%/<2;(`K#><`):Y%C6,GW<(BR9#F]%?F>TU8[$DD;
MHB%^5;-.'=EX_AXZ3N3]OKO*!>^`8L<:II\L*?)XOOI:M4*270.^'_&,Y$=N
MNWA!SUDNA1*E]H$N<(&^]+P,E@$P;=8%`P<F[9ZD989N\&J+0Q1LUC9!?Q@]
MJ-%_3]7B\%FRXAMK*60;ZF0JL!/BWD"_%N85'`Y>G+ZS%?@AO8*69-_HG^+P
MA;*JUE#N!!P98ZOBZ9:J'#(*-'Z4&*9<-!``_'J<F=:`C)!'^SRP0M<9BN=^
MDH8Q!KBWHTK?,4.)O'ROM.!_'0CW5(XDZDG@V9/@R(\6"4[F_V<)7$36X"W1
M9+.6XN!!UX"FZHCI0;P"9N-L=M896#)G;LPA>Q30"LKQL$G#=!T\0`KS'K-U
M&+@!`R8:$`&(#Q&`ZC2"&"KT>FZ/$9A#IQ'$LX'>!KEUD(4M[%@O/M5[6\>`
MH5HC%VFXF`@YS&R$F0^($Z<`&3M]6]F`,Q39[$8AGKISVZG;CN+X=46HY/L5
M#7BDF`R4+I]N>]XK+LY4<WZ)H@&/%)_3YA3==J\8G_.87J)HP"/%:=.Z[:/B
M.8]FK(_NS-MU-."1XK1YW+93Q'&"AZ2?=,[R$D4#-HK/-R_&4UF'Z8W.ELO7
M96&F7N#4HD^%<3BM:0]RC8OC<!%.I-T0=C.*4UG13[1IE)>+O1FP&-IO>.N&
M_Q:&?V1O^;`!L[<C%?U.9,5:Y36TA*.AGT(+2S>]W4*+S@Z1G=`P=>W?&KZR
M%&9<Z`.X%$(?%^;[,'RW-_\```#__P,`4$L#!!0`!@`(````(0`?)^X$.P<`
M`/HN```9````>&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;)S:77.BRA8&X/M3
M=?Z#Y?V.HHDD5I)=HWQ_<VKO<ZZ)DH0:%0O(9.;?GVX;C+U@>''?S$S6/"P^
M^@6QTX]__MSO1C_2HLSRP]-8N9F.1^EADV^SP]O3^.^_C#_NQZ.R2@[;9)<?
MTJ?QK[0<__G\[W\]?N;%]_(]3:L1ZW`HG\;O575<3B;EYCW=)^5-?DP/[']>
M\V*?5.S'XFU2'HLTV9XVVN\FL^ET,=DGV6$L.BR+(3WRU]=LDVKYYF.?'BK1
MI$AW2<6.OWS/CF73;;\9TFZ?%-\_CG]L\OV1M7C)=EGUZ]1T/-IOEO;;(2^2
MEQT[[Y_*;;)I>I]^:+7?9YLB+_/7ZH:UFX@#;9_SP^1APCH]/VXS=@;\LH^*
M]/5I_$U9QLK]>/+\>+I`_\W2S_+BWZ/R/?\TBVSK98>476TV3GP$7O+\.Z?V
MEI?8QI/6UL9I!*)BM$U?DX]=]9_\TTJSM_>*#?<=.R-^8LOM+RTM-^R*LC8W
MLSO>:9/OV`&P/T?[C$>#79'DY^GOSVQ;O3^-YXN;.W4Z5Q@?O:1E962\Y7BT
M^2BK?/\_@92ZE6@RJYO<LJ.O_W]V,[N_4^X65W1A^SL=BGKN,IM??2@LU^)\
MOKH,/Z&)N#BG:ZTE5?+\6.2?(Q9@=OKE,>&W@[)46.?F*HMK<K[NO[OL['KS
M+M]XFZ<Q.T1V14N6E1_/ZO3A<?*#C>^F-JNV462Q;@0?3-Y6HP6=%@Q:,$5!
MC"+O837BZ]#(;NU&-+MUFAY?FRQ4LI';F&8CCQ;\IM#3)6A,TR44A<L+V=IU
MU)AFH_BBRX2-ZWEP67JEP>V^=9HQY)J/8=-V)0JL^7E09V3`VF)^)Q.M3515
M)GJ;D/T84)AM08_$:A.R&QL*IRU4A9RQVS9D/UY;T(/UVZ2UHV"`"0>8:(")
M^XV4NCE)'7^DS-GCOS]]?"LI?:)PF3Y5F<K)60\PV@"C=QERPQL#C#G`6%UF
M+I^7W65N9>-T&=+''6"\`<8?8((!)AQ@H@$F[C=2&MDG]Q7/0*ZE%(K"U\?)
MFA8T6M";PM=CLQ5<H\N0IX399<@-8`TP=F.:Y[K3%'H.T!U@O`'&[S(+.<G!
M`!-VF7NY3S3`Q/U&2@Y[:[LB.5Q+R1&%B^30@D8+.BT8M&#2@D4+-BTXM.#2
M@D<+/BT$3>$R,>13/.PR)*Y1ER%]XK997+Q*2B.TN&J$N)9&2!0N1H@6-%K0
M:<&@!9,6+%JP:<&A!9<6/%KP:2%H"I<C1*Y^V)CF01#10MP4NKM(UYY]5[CB
M[N":O05<O$JJ"OU^(`R[0<^OF^1!L89"@T*'PH#"A,*"PH;"@<*%PH/"AR*`
M(H0B@B+N$U+P^/S.Y3?6_M=*KI_&[.WU'"IU1NZ+E3!]P8-"@T*'PH#"A,)J
M"W5&WF3M+D->/IRV(3>C"X4'A0]%`$4(101%W">D\#U<%3ZNY?#=DZNX$D0]
M39D\S!;3*0GG6H"><&I0Z%`84)A06$+4I\).A)Z*#5LX4+A0>%#X4`10A%!$
M4,1]0DJ=PKX]7_',.W$Y=^J,?#5<U6AQ2I[RT#%>:YFH'43#1*])3X(-3$Q,
M+$QL3!Q,7$P\3'Q,`DQ"3"),XEXB1Y'/-0[_^%7$U*3\^4MF,E8U$E'DCT#Z
MY%A#H=6B)V4Z)@8F)B86)C8F#B8N)AXF/B8!)B$F$29Q+Y&#R&<DKPBBF,"4
M@TAF;E>*0#TA6F.B8:)C8M1$W!3L5X^MF\+$32Q,;$P<Z5!N.P[%Q4T\3'Q,
M`DQ"3"),XEXB!Y%/1EX11#%W*0>1OA4J`O4&$1(-=]%K\ON4&;B)"9M8N(F-
MB8.)*QU*5U0]*'R\FP"3$),(D[B7R#%D89%B>/I-[@.;3>O_@JSP[>C+(IF3
M6]6H-X^B3P_1<!<=$P,3$Q,+$QL3IX.H,S(M[78@<K][F/B8!)B$F$28Q+U$
M3B6?S;U\.`[[92!?YT%"R=X+Y>G^58WJ;S#W#UVW^[I&O;$4.^LA.NYB8&)B
M8F%B8^)@XF+B8>)C$M3D\A.&CF2(VT28Q/U[DF/))[K_02S%_+C\V4VGL16!
M>N*TQD3#1,?$P,3$Q,+$QL3!Q,7$P\3O(.J</#R"#D0>RB$F40=1YV2Z->Y`
M7[N28\DGP?]!+,7<N13+.9G07?'%7>R1VAM+2#3<1<?$P,3$Q,+$QL3!Q,7$
MP\3'),`DK$G]H:=T?!F+<)>XE\B1Y%/CEY$$;Y-B)EV.8FOJ42`Q4WQ[UW$.
M:[:P%*15PT3'Q,#$Q,3"Q,;$P<3%Q,/$QR3`),0DPH0O(?[]2(LHBB7"8MGJ
M/BW>TG6ZVY6C3?[!E__>L1GL<_6\-/G;@J]C)/65LF1+2MMU75FRA:3MNJ4L
MV>+0=CU4EFP1)JM/SCM@*X^/R5OJ)\5;=BA'N_25'=KT1F7OEH58NRQ^J/+C
M:='M2UZQ-<>G?[ZS->8I6ZDZO6'X-<^KY@>^@_.J]>?_`P``__\#`%!+`P04
M``8`"````"$`4#7,>J`*```M3```&0```'AL+W=O<FMS:&5E=',O<VAE970T
M.2YX;6R<W%MSHDH7!N#[K^K[#Y;W.XHG,E:277C`\_GLG6-(8FV5E#J3F7^_
M5].TT@LV+\Y<9)*5AZ9I>BT1.SS]_>NP3_UT3N>=>WQ.&P_9=,HY;MW7W?']
M.3V;VG\]IE/GR^;XNMF[1^<Y_=LYI_]^^?__GK[<TS_G#\>YI*B%X_DY_7&Y
M?)8SF?/VPSELS@_NIW.DW[RYI\/F0C^>WC/GSY.S>?4V.NPSN6RVE#EL=L>T
M;*%\2M*&^_:VVSHU=_OCX!POLI&3L]]<J/_GC]WG6;5VV"9I[K`Y_?/C\Z^M
M>_BD)K[O]KO+;Z_1=.JP+;?>C^YI\WU/Q_W+*&RVJFWOAU#SA]WVY)[=M\L#
M-9>1'0T?\[?,MPRU]/+TNJ,C$,.>.CEOSVG+*%L5XS&=>7GR1FB^<[[.@>]3
MYP_WJW':O79W1X>&FTZ4.`7?7?<?05NO(D0;9T);V]XI&)Y2K\[;YL?^,G:_
MFL[N_>-"Y[M(AR2.K/SZN^:<MS2DU,Q#KBA:VKI[Z@!]31UV8F[0D&Q^>?]_
M[5XO'\_I?.FA:&;S!O'4=^=\L7>BR71J^^-\<0\+B0R_*=E(SF^$_O<;,4H/
MA5S1?+RGE;S?RK=;*X\/1B%;NJ,G!@V@/!XQDOX!%>]NY3HJ](TZHOO[HH;%
M"(Q+\?YQ,=3`B/.J>I-[R#T6C>)=8U-28T/?J';^I#^F:H>^4>W\P?FFM)#G
M*G<;Y3^9?&J8<[=ASIGW#W-.#7.N<#VLW!_D`ITD;P:*6>N/3IXF8])44B<I
M1Z/C;YZ\%QF9W5ZQJ&TNFY>GD_N5HA),(WS^W(B";I1%RZI,R*2^%H[_JAM4
M,$0KEFCF.4W;4TDX4[7[^6+F"T^9GU2@MKZI2$-?K\;0134L2F96-[4HP]JI
M2Q/L#1.V$J+NB0-H\$"3!UH\T.:!#@]T98"^7H\X=#P]M='-L+[VE5!]'?#`
M4`;HZW_O9Q0V;#]CU6RP%68FRJB^3%7@MA';9*:$VF0N`_*%0HS]@@>6/+#B
M@34/6/X,O+5*KZ[>G*2OD:.2H02X9@$5""T+HE\DU6076DQV=405%;CMR33U
M:5N5)-@9,U_432UL<KJH0V&'!=]-(TQX;YN8M,*$=;8-10>*;EB8!581>F'#
M>M(/"SXH@S#A@S*,(`4VV4<1ALV$<9CPSDS"Q"RP:CH-&W;4,RCF86$6V*1<
M1!EV2$O?%`I>Y2\8V1([1ZN(5HK,K*,,.R;+BD)L:"P_'[5D*Y:NJ:1E/KVV
MWY'Y0FN9SP-5&=!VG;_MVGNMJ24P]03&3F`:"4PS@6DE,.T$II/`=,.F^,@F
M0B^!Z2<P@P1F&#9F@?5GE,",$YA)`C--8&8)S#S*L+FZB#*/UU3RYO,RRGS3
MS2K"%%GQ7$>9O-Z.944A5K.L2A2Z%2VM`-`UO58`Q`6PN"R/OP006VF%@`>J
M,J`7@EL79"%01EU(U'G`YH$&#S15('#MD6<GJ!4VI2P[0>T$IA,VIL&.J:N,
M.J8>#_1Y8,`#0QX8\<!8!0)'76!399+`3!.86=B$1F\>-L5'UI]%`K-,8%8)
MS#J!L:PDJ!*/M%2B][5_D$IB*RV5>*`J`[=+^QH/U'G`YH$&#S1YH,4#;14(
MS+$\RYJ.,FJV=WF@QP-]'ACPP)`'1CPPYH$)#TQY8*8"@:/A&3-71AW-@@>6
M/+#B@34/6%8H4@E$M`E$MSBT"11?@X6F6AUX?V<66>6K2$-S^/8>4']!J4)1
M@Z(.A0U%`XHF%"THVE!TH.A"T8.B#\4`BB$4(RC&4$R@F$(Q@V(.Q0**)10K
M*-906!8FL5FG)3S=)]82/MG%E]CJ.4WO!*]);1998:Y($Y?X2HB;E>P=9$W]
M[K8'=EU<A\*&H@%%$XH6%&TH.E!TH>A!T8=B`,40BA$48R@F4$RAF$$QAV(!
MQ1**%11K*"P+D]A\TU*>[LIK*1__&B\T2W5^;ZDB35RJ0U&#H@Z%#44#BB84
M+2E,[TX;?8B:]?[IUS3MH"E)P6ZV=>".NE#TH.A#,8!B",4(BC$4$RBF4,R@
MF$.Q@&()Q0J*-126A4ELXFDY3Q_<WY'S0O.<9[>**M+$Y;P4)9DGD3E0@XW4
MM4;,+*UA87ED:Z*0>PR)!A1-V(\6%&TH.E!TH>A)(0?5%*/!AJ./P"`(C(@6
MAD&0%WO@^QA)$7/NQ\$V_/JG5\A)4.0DT<44[F4&Q1R*!11+*%90K*&P+$QB
M<TY+=['6YHY\]SA/>'9_O>(C/Y^]B<,G1M4W,3.CADD=$QN3AD_\_D:^3#<U
M$SG76WA/;4PZF'0QZ?E$'A)=>9BAU.SKI%`*%\R!1DJ%L!CBKHPP&6,RP63J
M$_^8O6K$I]U,,X9O6&&<XWTM,%EBLL)DC0DMIQ`Y_)R.R25:8!%G](I`GX/<
M4Q$$YQ6!W4ZO&!+%]+"*20V3.B8V)@U,FIBTH@A_0]2.0OJK6R>"F"5V%Z0;
M@=AMD%X$,4OLX[A^!&+M##`98C+"9(S)!),I)C-,YI@L,%EBLL)DC0G5!)AQ
M5!/BC%X3Q%*.X-+#^#L!8JULJ":P:53Q46Q-D.W$D)K?BBSZ\G593Y\ZWH^-
M20.3)B8M3-J8=##I8M+#I(_)`),A)B-,QIA,,)EB,L-DCLD"DR4F*TS6F%`Q
M@'E$Q2#.Z,5`K-BXHQC(!1[4_/4C@*+![Q&(Y?'QES!53&H^N5[UBNL[7@WD
MCF*(K;7B7?3R5AJX+TU,6IBT,>E@TL6DYQ,Y+@5Q:X0?=%\CIGA'P<D`[VB(
MR0B3,2833*:8S#"98[+`9(G)"I,U)E0-8*Y1-8@S>C6@5V>M&B3[7-`0F_&W
M#6Q]4L5',:__54QJF-0QL3%I8-+$I(5)&Y,.)MTH$EAZZRU[ZT4AO:3V,1E@
M,L1DA,D8DPDF4TQFF,PQ66"RQ&2%R1H3J@LR)6.RC>I"G-'K@E@X=,=5@EQG
M%+Q*,$M\A9#XVSETE0!)#;=2Q\3&I(%)$Y,6)FU,.IAT,>EATL=D@,D0DY%/
M_"LY[VJ$7X^,<3,33*:8S#"98[+`9(G)"I,U)E0.8"91.8@S>CD02Y'N*`=R
MY9)>#OBZ(0,N;ZIB4L.DCHF-20.3)B8M3-J8=##I8M+#I(_)`),A)B-,QIA,
M,)EB,L-D[I-@]=(OJQ::B/K8<ZF)0L3[L94FHMI8:X+^3E_\TSM"E4#FF>QK
M5"M4".)242\$8H'2'85`KF?2"@'_.^.*`1<]53&I85+'Q,:D@4D3DQ8F;4PZ
MF'0QZ6'2QV2`R1"3$29C3":83#&983+'9(')$I,5)FM,J!C`7*-J$&$*MXMY
MO1Z(Q4O!>I#P_H%<\Z37A=!=1;@PJBJ>7Q'_EJ*&21T3&Y,&)DU,6IBT,>E@
MTL6DATD?DP$F0TQ&F(PQF6`RQ62&R1R3!29+3%:8K#&AN@`3B>J"-/Z"6'D'
M^7:U(<N"?$B2?.[)P3F].U5GOS^GMNX/\0`DL>DU>GLZD_=0)!:O&V5Z,`C]
M>12+MXPR/?TC'.\997I:1S@^-LKT*(UP?&J4Z7D9X7@E5Z8_FJ)XYKIC>E;3
MY^;=Z6U.[[OC.;5WWNA0L@\FO7LZR:<]R1\N[J?WE)?O[H6>TN1]^T&/Y7+H
MP1O9!\)OKGM1/X@=7!_T]?(O````__\#`%!+`P04``8`"````"$`>\U=ZH<&
M``!:(0``&0```'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6RDFEF3HD@0Q]\W
M8K^#P?N(%"I*M#VQWO=]/M**+3$B!M#3,]]^$TIL*LLQ=;<?//[Y(^O*+#"K
M7[[_<H^9G[8?.-ZIHFC9G)*Q3UMOYYS>*\IBWOQ64C)!:)UVUM$[V17EMQTH
MWU___NOET_-_!`?;#C/@X114E$,8GDU5#;8'V[6"K'>V3V#9>[YKA?#5?U>#
MLV];N_@B]ZBR7*ZHNI9S4K@'TW_$A[??.UN[[FT_7/L4<B>^?;1"Z']P<,Y!
MXLW=/N+.M?P?'^=O6\\]@XLWY^B$OV.G2L;=FIWWD^=;;T<8]R\M;VT3W_$7
MR;WK;'TO\/9A%MRIO*/RF,MJ605/KR\[!T8037O&M_<5Y1_-W)04]?4EGI^E
M8W\&J<^9X.!]MGQGUW=.-DPV+%.T`&^>]R-".[M(@HM5Z>IFO`!C/[.S]];'
M,9QZGVW;>3^$L-H%&%`T+G/WNVX'6YA0<)-EA<C3UCM"!^`UXSI19,"$6+_B
M]T]G%QXJBE[,%HR<K@&>>;.#L.E$+I7,]B,(/7?%(>WBBCMA%R<Z]/YB9UE6
M*FB%XA->\A<O\'[U\G`7H+/Q..#]>O'3XRA>G!AI)T^/`S(K[@J\7[OR\#C*
MEXOA_7KQT^/0((SXJL+*?+EY>B0:+"CW\S6M[/GPT))YU5*C*F6U?.Z9\&#)
MH-C_&Q1+!A6%YF5R'H]YE>=/G(YU*[1>7WSO,P-;'&1(<+:B#5,S(\])(O*T
MN:;FGS(34C+R\D_D)G8&21?`;O+SU3#8B_H3MH#MA:ER!L+KRA0-361J"1-E
M?.2XCH4&%II8:&&AC84.%KJ)\-4UU+%>0B0=ZV-A@(4A%D98&',!7E,SDA-G
M9))<],6@KDT3(NG:#`MS+"RPL,3""@MK+&Q2@@K!=(TH"',IHG1(@MM;>Q)`
MT55B`.EY<2:J'$G'#XJPFDP8^8+HI7Z#,721:=QB4&^:,J.CIEHR8AB(:=]@
M\H;8G<XM!G6G*S-H<GHR@3O<EQ$#]67`$5C[:\BB=H8R@=L9R0AN9WP#P6XF
M,H/Z,I4)[&0F([@O<QE![2QD`K>SE!'<SDI&4#MKF<#M;&0DU8Z0J'!#^0^)
M&ET5)6JRVU2Y$#\KQEMV#0MU+#2PT,1""PMM+'2PT,5"#PM]+`RXD`[F0@GM
M!<,'F-$#S%AF#+TH)OKD`6;Z`#-[@)G+3*&$PFWQ`+-\@%G)C&&@L:\?8#;W
M&2&XX6E<".[[=Y^(AI\0J5W-*)3$Q:ER!EZO.Q\:0HTDZB31((DF2;1(HDT2
M'9+HDD2/)/HD,2")(4F,2&),$A.2F)+$C"3F)+$@B25)K$AB31*;>X20B/";
MXHE$C.B*`O>P:Y+I^`Y7Y0QTX,K@1"2).DDT2*))$BV2:)-$AR2Z)-$CB3Y)
M#$AB2!(CDAASPHA_06HY^!,WX8E@-W+HAC45S'F&MO#9??,\;388:GIQU[I,
M6S5\[8I;[X3LFB0V]P@AXZ!L\43&133..)1/5<[<Z7Z-).HDT2"))DFT2*)-
M$AV2Z))$CR3ZG"CR2(?B,PJW`>EA2!(CDAB3Q(0DIB0QX\1EK`5IK/.TG15R
MZ#?G0C#GBRCIETG[4=6IF$?656+]X]UB31*;>X20>E"!?2+U(EI,/?P$7N4(
MGSE6PI6!FF`N,S1Q];19U\MH:AII,\N54&FBF39KI1S:%%II,RL9J"#1%LS%
M$C)W!+->0-'?39LUJ.FCFE<O;2\;&O+>3YN95L3V`;??V="&)#$BB3%)3#AQ
M20SY=B:8Y=N98(;(1[>[>=JN,QP="\&LX=!;<G.>%W-QTJT2ZY_3BB0V]P@A
MK:#F]T1:131**Q1>58[<6?\:2=1)HD$239)HD42;)#HDT>4$?^PJ:#H*I%[:
MK)?ULOA0UA?,FH8F>Y`V:SG\.#],F_4B:GHD6$O(]9A;[ZSCA"2F)#$CB3E)
M+$AB21(K3O!5RL-,BLNP3IOU`CY:@=/<*"WXU<S0OZ:2IQH_JN5G0Z[MO]LU
M^W@,,EOO(SJ&U:)]X"KS(^(.,Z$*!W5`I'>9"<4X6>\Q$VIRLMYG)I3F9+VJ
MF7!2(^M=S82C%%F?P)'U+;W*3"A2RGR-F5"KE/4Z,Z%D*>L-9D+E4M:;S(0"
MIJRWF`EU3%EO,Q/*F:"KUXF#H^VS]6X/+/_=.069H[V'.<]E#7CF]_GA./\2
M>N?XD.3-"^%0._YX@/]AL.&D+)<%>.]Y8?(E:N#Z7Q&O_P(``/__`P!02P,$
M%``&``@````A`-DH<O8A!P``=BD``!D```!X;"]W;W)K<VAE971S+W-H965T
M-3$N>&ULG)I=<^HX$H;OMVK_`\7]`6QC&U))I@;\;6_5UM3L[C4!)W$=P!1V
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MMFE$:F`/FU]>7JUI1LG,R+25I76YI0[0W\&N4$N#9F3UL_G\+#;U^]/0<D:V
M.[$,P@<O>54'A3(Y'*P_JKK<_4]#1FM*&S%;(Q;UOJTW1^;,-FSG"U:FK17Z
M/%NYNPO4V68<]'EN_.5Q.*T1]]K(E\=!KM5TA3[/7;E['/.V,7V>&W]Y'`8M
M(ZTJ*7,Q<^](QGJ--$O.6]6KY\=C^3D@/Z954!U6*BH8#P:9/BTVO33.R^__
MK3Y:=LK*[\I,8XP65D4N\^/9==W'\0]:YNN666B&IO#,.*[!F>6)4:M:&?9D
M@2\+`ED0RH)(%L2R(#D57+HF.I:>B%/'LJN",<WE>4)I#CL3:I%XM[WW-'^J
ME9@_AT_-HHN8G%AV"7=J<\:[P;@69_Q;S)0S09>QQ*/"+N*Z@HEN,%.Q;N);
MC.A.TF7$Y*1=0G8XZR)7:YB)3%'Q;XBL6E$POG(`UYWQ>5UHAN+EQ4DXL82$
M!PD?$@$D0DA$D(@AD4`BA4361S!9:=J9K/T^J^BG(2V:LU1SL2P7&G&;@/C-
ML":V<.HE!VQ'.HC'`==PQ"-\!IB3F2E<+!"`/17N'C+`<-VYB'T1!VS#F/`E
M&7/`L2>B#PD#',<UA864`_/Y=,X?D3%@.K/GERC!)*3#PA<D5+204'1]H1%Z
M_%EEJ2$D/$CXD`@@$4(B@D0,B403CE[2LZDCA$JAA:R/8%K2V8UIJ<XF>"M5
MK82F0K&%1EJW-`U;^LR2`73D[;@E!VZX)0-NN:4`NF[)@%MNR8$;;LF!&V[)
M`-<V9E),!C@WW)(!/6Y)Q^^.E%-:"/T15K7B&Z8E3XP+S?3Y)R0\2/B0""`1
M0B*"1`R)!!(I)+(^@GFH2CG(MP?LH:H5]U#+%<>UA69TF#$M>^:*I;F\!HR9
M-3&%!8\#YMP0^YXO@)D\>`8<F#@SL3>$#*"SG"NVM8@!CNM<[5K-ZTW,`)N"
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MC(08B3`28R3!2(J1K!?ATJH4Q+6TZE7FCN"L,Q?T]_SR:74R1D9?>J/9`9<8
M\3#B8R3`2(B1"",Q1A*,I!C)>A&N,7E91V-\&#94,WZ"NA&<-=3KQQ#QVD?U
M6/$Q$F`DQ$B$D1@C28OHX#RUIE>AM5GY*;:1]2)<896YN/9B$*!UHH-MN[-+
M[&\ZN%`_[)'\/9HL,>)AQ,=(@)$0(Q%&8HPD&$DQDO4B7%N5R;C6]LX(K1,@
M($)KJ%=CB'@&1'R,!!@),1)A),9(@I$4(UDOPC56>0VI\1T16J=#F!]WC\]]
M.9-V%X:(9T#$QTB`D1`C$49BC"0MHB.T0?D)$0!3#MBV(]]_.4`_/EP`KJY*
M=%RK"Z*SSHLP56<7TVUTUE"OYT+$,R#B8R3`2(B1"",Q1A*,I!C)>A&NK4J"
M7&M[9W36N1,0G374JS%$/`,B/D8"C(08B3`28R3!2(J1K!=A&M.5JJ[&.#HW
MS=#YN87Z-,:(AQ$?(P%&0HQ$&(DQDK1(&YW-J?QU.16`:XCLA[H(I\ZOVH)I
M4X)$)#?T-3=]YVB7']_R9;[=5H-U^:&NL)F4%3Z7ZNMU"^.!+NC0/1M1GM"U
MNZ9\?*Z@6V^'U5O^K]7QK=A7@VW^2B8G(Y?.U$=];TY_J<M#<[GFI:SIOEOS
M[SO=;\SI@M%D1/!K6=:G+_3@\?G&Y/-?````__\#`%!+`P04``8`"````"$`
MG^Z#[NL3``"PKP``&0```'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6RDW5MS
MXL;6@.'[7;7_@\OWL9'`G&IF=H%U%A(G@8`[Q\/,N&*;*>-DDG__M6@)TRU9
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MA+DR;[)(][M'L0'BWQ=/#UG?$(?D[N_#?W\]?'W]\?FRV;ZZZ32:AN`7OV_W
MK\Y#%O+RXO[/_>ON*97(R$/)(&8>1/PW#V*(/S_XXF;^8O'?XL6-*Z/5:)^Q
M`:T\AMCD(H9Y]EZT\R"=TR!G;H@85X?#V3N-<>[A-$0OD"<EZP[Y`3?//2;&
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M#8[>X.H-GM[@ZPV!WA`6#6_[8ZA;.BI$L:61WA#+!GFQR?9EK#=,BH9WUS(M
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M8%`V[:YVY1CDX_(T`W2Z;RM3,H"X#I^1`3*M9`"]X58V9!VMR!*6;FR]P=$;
M7+W!TQM\O2'0&T*]8:0W1'I#+!M.-WZ<-YT,BW972SR3LNGH9EHV1D,[N;,/
MF'G9=`PM3E(V;:W++I@LF:1ETNEJV7159;0LN/Z`V7S`#`8?0<-ZI(P.,<\\
M8W1D6AD=>L.M;#CM8)9N;+W!T1M<O<'3&WR](=`;0KUAI#=$>D,L&TXW?IPW
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MH5BCV*`8#)C4CCUEU(O[SV>,^DRKH[ZMS8J'DM2->A06"AN%@\)%X:'P400H
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M*>3A,!J]WHUI:#LS&)P:4[[G4O=WD`^]ZIZJC/JL1N>,87_@ZKAO:[??A[FI
M7OGA7N0M$XN)S<1AXC+QF/@YZ1W><1OV;]KCQ8!#A!!B!,LC7D7,9,QDPF3*
M9,9DSB3)R7O'?<$AEDQ2)BLF:R8;)J+B(1NRGR]KQI>H@:@S:@+(:BQ.RW[J
M[]9EU7BE"[_V7'F8H_RD7#4ZVN.W6P6T1$6GFK\L9;FH@%07V\IBXTI+0$Z^
MN.8`N5J$UHW9ZIW\HZ[/XX`^DX!)R&3$)&(2,QDSF3"9,IDQF3-)<M*1";C4
MY18<8LDD9;)BLF:R82(2@1R+-?U<)((ZHR:"K+3BC$0@*S&4^_8][:HWS,JG
MZU/5+1.+B<W$8>(R\9CX3`(F(9,1DXA)S&3,9,)DFA,Y0D4E;\4[N1F'F3-)
ME#6U1/5?]H^:TQ<<9LDD9;)BLF:R82+R`8XVD0_JC)H/LCJ1,_*!+"M1\X%6
M*30T)*K)6+=,+"8V$X>)FQ/Y;BR['U#J1AY'\9D$3$(F(R81DYC)F,F$R30G
M\NC*FS;:()UQE#F31%E1_J13SP;8,9>\HI3)BLF:R8:)R`:X2R(;U!DU&X@Q
M>TXVR+AZGT#<`50/^C#[(`[-#B21?:3=J[K[9^5A<E/9D6S%B'M_%4/9X<UQ
MU3"&41'&XS`^DX!)R&3$)&(2,QDSF3"9YD2>R6ZC5W%X9QQFSB11UM3*.X3:
M/1<<9LDD9;)BLF:R82)R`HXXD1/JC)H3LJ*A,V8(LL9(G2%H#T2'V6<^*2<@
ML3B*S<1AXC+QF/A,`B8ADQ&3B$G,9,QDPF3*9,9DSB1ALLB)S$U9XE>SQ9)#
MI$Q63-9,-DQ$*L!1)%)!G5%3059)=)H*#A\>S#Z\";<39062FA.T^WG#[".R
ME!.06!S%9N(P<9EX3'PF`9.0R8A)Q"1F,F8R83)E,F,R9Y(P65203D\K8UM6
M(.VBES)9,5DSV3`1B0&'DD@,=49-#%GI42DQ-$1B@<0@2Y;4Q*!]I&%H8%W3
M+1.+B<W$8>(R\9CX3`(F(9,1DXA)S&3,9,)DRF3&9,XD8;*H(-WRC`%[;UH1
M1\L=*R9K)ALF(C'@]HK$4&?4Q)#5+NF)07QLDO*"+'DZS0O=AEYXE'V'!4T8
MD%@<Q6;B,'&9>$Q\)@&3D,F(2<0D9C)F,F$R93)C,F>2,%GD)+_!4?4$9,E1
M4B8K)FLF&R8B*^!`$EFASJA9(:MM.LT*,$N0I5"GV:!32@;2B+L:QP\8:3GT
MUD!B,;&9.$Q<)AX3/R?OE<4$'"*$$"-8'O$J8B9C)A,F4R8S)G,F"9,%DR63
ME,F*R9K)AHG(`3A^1`ZH,TH.R.X:G)$##EQ]U-!MZ!5).:I+`DPL)C83AXG+
MQ&/BYT1^\TRSUVEK[Y\"CA$R&3&)F,1,QDPF3*9,9DSF3!(F"R9+)BF3%9,U
MDPT3\04M=96'\AO"AK5&S07G52>:Y>K$;D,O2LI1;2ZHJYJ2WT;&46PF#A.7
MB<?$SXDLOM'F/P&_/F0R8A(QB9F,F4R83)G,F,R9)$P63)9,4B8K)FLF&R8B
M#^`0$M_35&?4/""F^,J<X&-?)F)F+]/G!GI14HYJ\X&,4T,LCF(S<9BX3#PF
M/I.`2<ADQ"1B$C,9,YDPF3*9,9GGQ&@U#^7(XGM=U:>%"<=8,%DR29FLF*R9
M;)B(G(##2.2$.J/FA*QXZ>/W"K*O7"WE`KTD*4<U`_V6B<7$9N(P<9EX3'PF
M`9.0R8A)Q"1F,F8R83)E,F,RS\E;+M#Z7,(Q%DR63%(F*R9K)ALF(A?4E1X6
M[Q/JC)H+Q(@])Q=D7)\7:+/B8?8MR_`4@8G%Q&;B,'&9>$S\G-3<,\"C$O)J
M1DPB)C&3,9,)DRF3&9,YDX3)@LF22<IDQ63-9,-$Y`+L4V)>4&?47)!5+9TQ
M+Y!%3F+:<7P^T-6_FG28_88#Y0(D%D>QF3A,7"8>$Y])P"3,R;&HMY>5]:K3
MX1&'B9C$3,9,)DRF3&8Y*?:ZM,MSCI$P63!9,DES(C=6/I743]&*PZR9;)B(
M;(`#262#.J-F@ZQ4Z30;?/#.@:QP4K."5MHU-.O*H.0W'3"QF-A,'"8N$X^)
MSR1@$C(9,8F8Q$S&3"9,IDQF3.9,$B8+)DLF:4[>WKGHM])7'&3-9,-$)`4<
M:B(IU!DU*61E2O\B*<CJ)C4I:`_5AF9="52>%)!8>129DIM5GWNR55+YK4>\
M+2X3CXG/)&`2,ADQB9C$3,9,)DRF3&9,YDP2)@LF2R8IDQ63-9,-$Y$5<"")
MK%!GU*R0E2F=9H7ZXB-35C4IV4#_LJ9ACL2;E^.["^T^PRT3BXG-Q&'B,O&8
M^$P")B&3$9.(2<QDS&3"9,IDQF3.)&&R8+)DDC)9,5DSV3`1V:"NS+"XI2A-
M?ET]?,#TY*V.F@ZRBJ4STH$L<%+3@5Z,:-950>63`R061[&9.$Q<)AX3GTG`
M)&0R8A(QB9F,F4R83)G,F,R9)$P63)9,4B8K)NL*(G[+4KUEM*E`VH55)`0<
M2F)Z4&>4?)#]=HF2#[(["?R)A</+M&<-AEZ3E*.Z:0(3BXG-Q&'B,O&8^$P"
M)B&3$9.(2<QDS&3"9,IDQF3.)&&R8+)DDC)9,5GGY.1^A%;*L^$@XC>R/E"@
M6&O4I)"5,'U\DM"4%4_J)$';BV&.:I-!7>7481YA<12;B</$9>(Q\9D$3$(F
M(R81DYC)F,F$R93)C,F<2<)DP63))&6RRHF<I1ORZWK4Z_^:HVR8B&R``VE0
M/Q[5;"`&MI(-/O:PH9F]3)\B:&4BPQS59@49IX98',5FXC!QF7A,?"8!DY#)
MB$G$)&8R9C)A,F4R8S)GDC!9,%DR29FL<B*S0M4M\34'V3`120''D4@*=49-
M"GJ=X@>30KE>T;@I)86Z"BEY/Z&)Q&)B,W&8N$P\)CZ3@$F8D_SK2!O=FZQ'
MJ1>9D6+$#\V*#_'K)E),SS![&5+CQ+PY8R83)E,F,R9S)@F3!9,EDY3)BLF:
MR28GLC^8E5\:*S*#'$P2->57@JKG6F2&N@&G9@9QI?XWTX7L9?IT0;OY,6Q*
M5#,7N&5B,;&9.$S<(\E^BT>[:^H=%[[[$,5G$C`)F8R81$QB)F,F$R93)C,F
M<R8)DP63)9.4R8K)FLF&B<@'.,I$/J@S:C[(JIK.N)D@BZ#$1.3X;+&K_QCZ
ML%E7*97/$)!8',5FXC!QCZ0R#^"&^L?7OQT3+3,&3$(F(R81DYC)F,F$R93)
MC,F<2<)DP63))&6R8K)FLF$B\@#V3)$'ZHR:![)"IC/R@*Q[4O.`7JO8K"N.
MRO,`$HNCV$P<)NZ1''Z;3_\%&.^X^-UA[C,)F(1,1DPB)C&3,9,)DRF3&9,Y
MDX3)@LF22<IDQ63-9,-$9`(<1"(3U!DU$V3%2V=D`EGK=)H)VJ6?96S6%43E
MF0")Q5%L)LZ1'"[W^C!WZQ=[VN*>]B#%/RY_-TL$1Y)M0.>JJ3UF#I7EQE5/
MFTR,CLO?747$)&8R9C)A,F4R8S)GDC!9,%DR29FLF*R9;)B(P8_C1@S^.J,.
M_O/J$9OE>L1V3[L3-<Q1[6T!+*.R.(K-Q*DB+6W>XGX$>1]!?A52[]T$543?
MHK`*J7%&3"(F,9,QDPF3*9,9DSF3A,F"R9))RF3%9,UDPT1D!1Q0(BO4&34K
M9`5+9TP)9'W3Z92@T]`NE,-F71%4/B5`8G$4FXG#Q&7B,?&9!$S"G.2/JAL]
MH]GM:-5=(PX3,8F9C)6-:7?:-X:IY=.)0L0#I?(3C2FO:,9DSB1ALF"R9)(R
M63%9,]DP$>D`1Y)(!W5&20>MJJK$K'ZI_L,+AY?ISQ#TCS+EJ&ZRP,1B8C-Q
MF+A,/"8^DX!)R&3$)&(2,QDSF>0D+XNOS`H<9<9DSB1ALF"R9)(R63%9,]DP
M&0P^8(:U1LT*YY4EMBK*$DW]K4..:K,!5E-9',5FXC!QF7A,?"8!DS`G13U;
MU1=_CSA,Q"1F,F8R83)E,F,R9Y(P63!9,DF9K)BLF6R8B'2`(VDPK#5J.A#3
M?^4]P\=*D%K9R[1)@JD]G!_FJ#8MR#@UQ.(H-A.'B<O$8^(S"9B$.9%I0?XP
MJ78C01%&Y4_01KRBF,F8R83)E,F,R9Q)PF3!9,DD9;)BLF:R82*R`@XDD17J
MC,P*U_L?V^VK=?=Z]^73T_;E^_9V^_BXO[C?_?DL*@G$-[6?-%^\;+]]OAR9
M_5'K\KK4'IG]J*H]-OMQ5;MC]IVJ=M?LNU7MGMGWJMI]L^]7M0=F/ZAJ#\U^
M6-4^,/J#JO:AT0^,BOT-C7Y4U3XW^DE5>VKTUU7M&['>0=6"H=D?5FW0K=F_
MK6JWS+Y5U6Z;??O0?OUV@K]\^GGW?1O=O7Q_>-Y?/&Z_B9/=N.J(Q](O#]^S
M*X+\G]?=3]$)+B]^W[V^[IX.?_[8WGW=OF1`X&^[W6OQ/Z)'7/_:O?QQZ%!?
M_D\`````__\#`%!+`P04``8`"````"$`*S0H.O@*``")4P``&0```'AL+W=O
M<FMS:&5E=',O<VAE970T-BYX;6R<W-ERXKH6!N#[4W7>@>)^`S8SE617$\_S
M>,XU39R$VH!30'>ZWWY+R$Z0[.B'SD4&\7G%MK0D8QG=_?UKM^W\+`['3;F_
M[RJ]0;=3[-?ETV;_<M_-,^.O6;=S/*WV3ZMMN2_NN[^+8_?OA__^Y^Z]//QS
M?"V*4X=$V!_ONZ^GT]NBWS^N7XO=ZM@KWXH]>>6Y/.Q6)_+GX:5_?#L4JZ?S
M1KMM7QT,)OW=:K/OL@B+PS4QRN?GS;K0RO6/7;$_L2"'8KLZD?T_OF[>CG6T
MW?J:<+O5X9\?;W^MR]T;"?%]L]V<?I^#=CN[]<)^V9>'U?<M.>Y?RFBUKF.?
M_VB$WVW6A_)8/I]Z)%R?[6CSF.?]>9]$>KA[VI`CH*>]<RB>[[O?E$6NCKO]
MA[OS"?K?IG@_7OS>.;Z6[^9A\^1M]@4YVZ2>:`U\+\M_*+6?:!'9N-_8VCC7
M0'3H/!7/JQ_;4U*^6\7FY?5$JGM,CH@>V.+IMU8<U^2,DC`]MAOK<DMV@'SO
M[#:T:9`SLOIU_OF^>3J]WG>'D]YX.A@JA'>^%\>3L:$ANYWUC^.IW/V?(87N
MU$<0M0I"?E9!%/+KE1L/JXW)SWKC04\9#28W[,"HBD%VN8ZAWGP4DRK(]#+(
MC3M"TNI\.LG//]^1>16$_/P,<N..**0EL8JE3:JJM'%OI(ZGLUNJ5OEH(!?U
MH_;4V5@9WU)#2EU%])=Z?]1;ZYFV;'94I+*J*"H)>&534TC5LLTOZGC<FXW'
MH\EL>GU[5^IJIK_\^<'4]:QP%7WSJ57KJE9)7=VZ-WW6'YR[%VUU6CW<'<KW
M#NFS2:SCVXJ.`,J"!JX[%M8-?'0U7_4TI'>@4;[1,/==<II()W(DW>//A\ED
M?M?_2;JT=666+68ZX,UC;6BW0P-K8H$N%AAB@2D66&*!+18XK(!\_]S]J<+O
MFEMO]&D$X=6BWGE?+`A8`>M5Z>&%M?@R:%2+.FA<%WQN,A%/8U*;>J.4%7S^
MXTP4^45!G[2-CP9">GBN@;2/.'4[H)JV@_H?+^N"R[U5^3/[R(PR&I\;SD@9
M#&>\T-JB#'FCMYD1;XPV,^:-V68FO+':S)0W=IL1CLMI,T+:N$TCG#^O*8;"
M0?E-,ID)N1>T&:&)A\R0MO*1*%/AN*,F:?RKN,5,A>-.VHQP_M*F$<Y-UA23
MJ1`EEQLN&\CH>$,V4,UE@UCPR`IHTZ\S1A.-+A888H$I%EAB@2T6.&*!*Q9X
M8H$O%@1B0<@*+EO'9"942'2%B=N,D.Y)BQD(32AM,3.A2\BN,'F;^<PPKH&0
MJQ2N@=#Q=$A&;GFW2;<B[B*M)C.ASUDR0[Y_I)X@'J'0H-"A,*`PH;"@L*%P
MH'"A\*#PH0B@"*&(H(BA2*!(H<B@R&6"2P1RF<TE@CP!J+[ODH[XLW'/A(%E
MR0S9@4_##[F/4&A0Z%`84)A06%#84#A0N%!X4/A0!%"$4$10Q%`D4*109$Q,
MSQ>BXP'[XAM9+@O"90!Y[WI#!E`M9H!PH;)D1I8!4&A0Z%`84)A06%#84#A0
MN%!X4/A0!%"$4$10Q%`D4*109$PHH^$Y!X3K__RK5[F&3^ZZ<`W_NFL@NI68
M`,(%W9(960)`H4&A0V$P,3F?(G(3=:8JPILI$\:P+F.0N^GTB^]I;!C#@<*%
MPH/"AR*`(H0B@B*&(F&"U4OK.4UAC`R*7":X1"#WP[A$D%\#42TDP%QH$DMF
M9`D`A0:%#H71(D;":&5>8:PKC'V%<5H,GTPN%!X4/A0!%"$4$10Q%`D4*109
M%+E,<(E`[GS?D`A4BXD@#$1+9F2)`(4&A0Z%40MZRUOI?=X4.-^]-J6O6ORK
M<^'.A'WY\K0W%&ZD./7+7[X=<FO!]FTNW"[PZI>_#.!#$4`10A%!$4.10)%"
MD4&1RP37WNFTW`T-_LS%%B_4][)"LB:/B8:)CHF!B8F)A8F-B8.)BXF'B8])
M4!%V`:)4;R#Y@2C$82),8DP23%),,DQR*>'S@LXR74XWRJ^(Z*QT8R00;@0O
M*R3-"Q9'0C0<1<?$P,3$Q*I(U8J&K>\-<!@'$Q<3#Q,?DP"3$),(DQB3!),4
MDPR37$KXO*!34)=Y<=U;9OKX32,_A,N(984DC?\1$PT3'1,#$Q,3JR*R7M;&
M81Q,7$P\3'Q,`DQ"3"),8DP23%),,DQR*>'S@\[`7>8'&#?8A!TWG3`7KLV7
M"D/2O(!$PU%T3`Q,3$RLBM2/4:A3H2NP<0P'$Q<3#Q,?DP"3$),(DQB3!),4
MDPR37$KXI"!-ETN**P<-NIGX9D-X;[BDC^\1)$T.2#0<1<?$P,3$Q*I(?6-[
M(+Y7MW$,!Q,7$P\3'Y,`DQ"3"),8DP23%),,DUQ*^.2@TW0WC!AL5H\?,<0)
M:/I8*DH*2#0<1<?$P,3$Q*H(NY)JG^^T<1@'$Q<3#Q,?DP"3$),(DQB3!),4
MDPR37$KXO*`S>#?D!9OPX_-"N-&_5!B2#A:0:#B*CHF!B8F)A8F-B8.)6Y'/
M44D1.AT/!_$Q"3`),8DPB3%),$DQR3#)I83/"CJE=T-6L!E`/BO$N6KZ*00T
M6D"BX2@Z)@8F)B86)C8F#B8N)EY%9/<`?!PFP"3$),(DQB3!),4DPR27$CXO
MZ`S?95Y<^1:#30Q>YH>B"AW;DGZHAN0'J\'IG'P8K?$$Q"-GE"F[0N'OIVN<
M4:>3\^U2WNB\F8S.@7AC<$893"<C59A]-SDR'*AS>F^6#V-51C(8VI@XF+B8
M>)CXF`28A)A$F,28))BDF&28Y%+"YPB=%;S,$7!OBDTB7N8&:?E\(UK2CXJA
ML0,2#4?1,3$P,3&Q,+$Q<2I2]?J*TI+K+@[C8>)C$F`28A)A$F.28))BDF&2
M2PF7%_3SBEQ>7#=VG#?C;T]-!^+3'Q62=+*/F&B8Z)@8F)B86)C8F#B8N)AX
MF/B8!)B$%6'I/&M)YH@3*GNDC^\K8X[,VRX1$KPK*289)KF4\-EQVTPX_6@N
M&1#X44-\0J1"TJS`,^$XBHZ)@8F)B86)C8F#B8N)AXF/28!)B$F$25R1:JAL
MNRI.<)04DPR37$KXM"`M_$\&#;J9F![B@R(J0]+T@$3#471,#$Q,3"Q,;$P<
M3%Q,/$Q\3`),0DPB3.**5.G1^JQX@L.DF&28Y%+"Y\=M$^%J<R)\.A!FA9<5
MDN8%G@C'471,#$Q,3"Q,;$P<3-R*5*UH,%>&LZG0[7@XC(])@$F(281)C$F"
M25H1=F(FT\E84859@PQ'R:6$SPO2>KEQ0_XFG"XFTQ@OQ`=$*B3-"Q9'0C0<
M1<?$P,3$Q,+$QL3!Q,7$P\2OR,7DB/"80H"#A)A$F,28))BDF&28Y%+"9X4X
M"7[E6_#F9/AT()SZ)5VV"]RBPD3#1,?$P,3$Q,+$QL3!Q,7$P\3'),`DK`C[
MQ+-P&S+"V\>8))BDF&28T`7XOFZ2+#'8`GML!:Q=<7@I'HOM]MA9ES_HXGGD
MYM;#W4<Q6]G/4Q=D*12R.HM0[JL+LB)*LSQ0%V1AE&:YH2[(PBW-<E-=D/5;
MFN66NB#+N#3+;75!5G-IECOJ@BSJTBQWU059VZ593E8L_-96OE069'VLIG>5
M!5G/JED>*@NR1E6S/%8625MY1E9*;"M?JHMEV_X\J@NR2DXSOJ8NR%(YS7)=
M79`5<TAY_Z/"R$*(;ZN7PE\=7C;[8V=;/).Z'O3H2G`'MI0B^^-4OIT71/M>
MGL@2B.=?7\F2EP59J(L\+M;M/)?EJ?Z#_H./130?_@4``/__`P!02P,$%``&
M``@````A`/D^;\[Y`@``,@@``!D```!X;"]W;W)K<VAE971S+W-H965T-#4N
M>&ULE%7;CILP$'VOU']`O"_70!(4LMJPVG:E5JJJ7IX=,&`M8&0[F]V_[]A.
M`),J35\2[#ES?.;B\>;^K6VL5\PXH5UJ^XYG6[C+:4&Z*K5__GBZ6]D6%Z@K
M4$,[G-KOF-OWVX\?-D?*7GB-L;"`H>.I70O1)Z[+\QJWB#NTQQU82LI:)&#)
M*I?W#*-".;6-&WA>[+:(=+9F2-@M'+0L28X?:7YH<2<T"<,-$J"?UZ3G9[8V
MOX6N1>SET-_EM.V!8D\:(MX5J6VU>?)<=92A?0-QO_D+E)^YU>*"OB4YHYR6
MP@$Z5PN]C'GMKEU@VFX*`A'(M%L,EZG]X"?9RG:W&Y6?7P0?^>3;XC4]?F*D
M^$(Z#,F&,LD"["E]D=#G0FZ!LWOA_:0*\(U9!2[1H1'?Z?$S)E4MH-H1!"3C
M2HKW1\QS2"C0.$$DF7+:@`#XM5HB.P,2@M[4_Y$4HD[M,':BI1?Z`+?VF(LG
M(BEM*S]P0=O?&N2?J#1)<"()0?W)'CC!*O*C^-\LKE:D`GQ$`FTWC!XM:!HX
MD_=(MJ"?`+.,+(3\_#TR"$GZ/$@GY0IH#M5XW<;Q<N.^0@KS$V:G,7`!!DQ@
M(K)+1!@-$!?T#2(A]/\7*9U,D>%BH%=Q[#1$-8[:R"8;A@#(S%3`]>Q(,&1Q
M$GD<KV8G:\QBBC$1V36$H0U(;M<FP:D-88Y568])UUG1F*6J:QB'ZYFPJ7D1
MA6-DABKHZ]M52?!<56P>N].8A58U.547SK"N1U]#4VQJNJW7I=-<V[S7-296
MVH*%%YK2LZDY#+S1VU"W--5=[S$)GJL:*Z'KJ#%:E;]<C4G1*3/,ZV"\G88J
M^8)-YL-U51)LJO*]V;$[C='=M?+CF1FFN*309A\>N3&76I:>T7J$M9A5.,--
MPZV<'N3\#:`$PZY^&G9^`O<<9O)L/X,G0^V[@P%&=H\J_!6QBG3<:G`)E)ZS
MA.9B>NCKA:"]&BQ[*F!8J\\:WF8,H]%S`%Q2*LX+^:P,K_WV#P```/__`P!0
M2P,$%``&``@````A`'$@#Y@D`P``X`H``!D```!X;"]W;W)K<VAE971S+W-H
M965T-#0N>&ULG)9;;YLP&(;O)^T_(.[+,2$'A51-4+=)FS1-.UP[8,`J8&0[
M3?OO]QDG+(;.9+MI`W[\\GX'\+>Y?ZDKZQDS3F@3V[[CV19N4IJ1IHCM']\?
M[Y:VQ05J,E31!L?V*^;V_?;]N\V)LB=>8BPL4&AX;)="M&O7Y6F):\0=VN(&
M5G+*:B3@DA4N;QE&6;>IKMS`\R*W1J2QE<*:W:)!\YRD.*'IL<:-4"(,5TB`
M?UZ2EE_4ZO06N1JQIV-[E]*Z!8D#J8AX[41MJT[7GXJ&,G2H(.X7?X;2BW9W
M,9*O2<HHI[EP0,Y51L<QK]R5"TK;348@`IEVB^$\MA_\=>)[MKO==`GZ2?")
M7_VV>$E/'QC)/I,&0[:A3K("!TJ?)/HID[=@LSO:_=A5X"NS,IRC8R6^T=-'
M3(I20+GG$)$,;)V])IBGD%&0<8*Y5$II!0;@KU43V1J0$?32_3^13)2Q'4;.
M?.&%/N#6`7/Q2*2D;:5'+FC]2T'^64J)!&>1&;@_KP=.L)S[\VA:Q56.N@`3
M)-!VP^C)@JZ!9_(6R1[TUZ!\B4SYZ&/]6Z@0HQ1YD"J=%D3!H3[/VR@*-NXS
MY#0],SO%P"O1,[Y.["^$3*"43:YNN."W-PVI&)H.H:AOE^/B46[2/88SW<!N
MC`R"V(^)<*Z+)&-DL>@1+8SP?\*0FZ!_KM(816&OW^5MIQ@H9Y_J2"?VDT1B
M(K0HX#'7Q3`70<*Q#2GJG2W_)$>95\BBZR)O8-NPEERO!:M5OU,S"Z_;[68E
MK)N-HF'+*`:>W0<T3/4DD9@(S7VDNY<OZW3?RTU3#:,84Q231&(BM"@6>A3F
MAI'PL`:#-VZG&)/[22)Y@Y@MW^XA>:I??3+-_B4\]#_HD)UB3/XGB<1$:-E?
MZ>YOZR&Y::J'%&.*8I)(3(06!9SV_U"$CAY68=A%9\@4P#0BQQ"9*DUEU$AJ
MT%#G<(U9@?>XJKB5TJ,<(GSX]/5WU8"SDP-.-Z+T"S!?M*C`7Q`K2,.M"N>P
MU7,6\#%A:D)1%X*VW:EWH`(FB^YG"9,DAO/5<P#.*167"SD#];/I]C<```#_
M_P,`4$L#!!0`!@`(````(0#VQ8=3&`8``!4>```9````>&PO=V]R:W-H965T
M<R]S:&5E=#,Y+GAM;)Q9VXZC.!!]7VG_`?'>`9M++NKT:$)K=D?:E5:KO3S3
MA"2H0XB`GN[^^RV[G$#9P9!]Z9F$X\IQU:DZ@!^_?)1'YT=>-T5U6KMLYKM.
M?LJJ;7':K]V___KVL'"=IDU/V_18G?*U^YDW[I>GGW]Z?*_JU^:0YZT#$4[-
MVCVT[7GE>4UVR,NTF57G_`17=E5=IBU\K/=><Z[S="L7E4>/^W[LE6EQ<C'"
MJIX2H]KMBBQ_KK*W,C^U&*3.CVD+_)M#<6XNT<IL2K@RK5_?S@]959XAQ$MQ
M+-I/&=1URFSU?7^JZO3E"/O^8&&:76++#T;XLLCJJJEV[0S">4C4W//26WH0
MZ>EQ6\`.1-J=.M^MW:]LE82!ZST]R@3]4^3O3>__3G.HWG^IB^UOQ2F';$.=
M1`5>JNI50+]OQ5>PV#-6?Y,5^*-VMODN?3NV?U;OO^;%_M!"N2/8D=C8:OOY
MG#<99!3"S'@D(F75$0C`7Z<LA#0@(^F'_/>]V+:'M1O$LVCN!PS@SDO>M-\*
M$=)ULK>FK<I_$<14*`S"59``V*OK?,87$8OB\2@>,I(;?$[;].FQKMX=4`W\
M9G-.A0;9"B*+G86#.X,MB35?Q2*Y%-`-E./'4\SGC]X/2&&F,!O$0`=<,9PB
M$A,11%>(!_RN)&'K.LD`BG@[_1>28A$E&837\'(?&X0L9)K%QI+>%X0`9.9^
M`F(15+J7@9@O-`:("?L8BDAL",(1@O0YVI,CP&L7MMM5)PKH+V\0,Y?U98ME
MZ&LE3@B`1_YBH'R@I^G,!%AGIM<-,2$RBRGMI'\Q["Z27,7W,!)@G5&W4U02
M8I#10Z@GBEQE5[Z$TOP>2@*L48JU']T@)KZ4+YAWN9"<$P+@$0O\V\R$B_5&
MA%U8`DR9Q7QYC8O)0@RHYRH^G9H-0;*VI-S$^!J?#&+16&,BQL;1AB`<&8RJ
MZ0F4:)I!;K2F`F%Q.=B(,5O%;ZY=!,RC95<"2DT;__;:,IS89&H8LE,@"S6,
M,DI-S.+)LF,XN?O4XIZ>47<*9"NJ%4)3)P9SC]\TZ3$<Y_"WT[YA"@IDY3G9
M%AB$Z?,<*;%`CZH/05A!-H_U[I4_>1$?B\).G#2#=_F"N-_2F9GB0]`P,W)]
MF)GF#Q-K:QI%''337FGPX@4]`=#QF#`;A&90,XV)/''PCV@0058-VB"4YUT6
MPDP/N3$!$:3&C.\S[>XE45$0$+!PP-R8YB`C[8%#OS]FN"E"!%FH]0'#U+CF
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M>;CH[A@I.\U)1MBA@Q`%1OJK@@!!`^\*R-6AEP6!<(+>#!QA)=!ZSK2,;&1(
MX6M"].;[`GJYNX6DR1(3?#HMG/<D6<:=2X"@KI1Z.A.*8/.H=X-+V8G1W6,W
MK2$"L8HF+^Z]%,2;%P6R-8050GG^+^,(IAB'`EEY3C:.X"[CD&B:QQN-BZ[0
M5=ML7()@\7*P<>^RCN"&=>A*VRC04./V76.P<>\RC<`T#1X9C7MQA('&)9>'
M&E?SBI%Y@K-]I'$1U)523V<2$`039P_7&VG2$*'F$-,:5ZZB@HN#;LICXRJ0
MK2&L$,I3\XJ)/-$.[(X;7CQC^!G="J$\[W*/\)9[Z'?."F3-(\;![HG\@8=?
M.#,C0]JN1(FF-38??A7(R@U=!@\63&YX"H>'5&5>[_,D/QX;)ZO>Q`D;!\N\
M?HNG?QNVVG!QAJ-]G\"IH/S>NUZ`0[ESNL]_3^M]<6J<8[Z#D/YL#F.XQF,]
M_-!69WET]%*U<!PG_WN`X]<<SHC\&8!W5=5>/HB#P^N![M-_````__\#`%!+
M`P04``8`"````"$`^7S3O>@"```O"```&0```'AL+W=O<FMS:&5E=',O<VAE
M970T,"YX;6R455UOFS`4?9^T_X#\7CZ+"5%(U:SJ5FF3IFD?SPX8L`H8V4[3
M_OM=VPD%LJ7I2PAP[CGWW'NY7MT\MXWS1(5DO,M0X/K(H5W."]95&?KU\_YJ
M@1RI2%>0AG<T0R]4HIOUQP^K/1>/LJ94.<#0R0S52O5+SY-Y35LB7=[3#MZ4
M7+1$P:VH/-D+2@H3U#9>Z/O8:PGKD&58BDLX>%FRG-[Q?-?23ED201NB(']9
MLUX>V=K\$KJ6B,==?Y7SM@>*+6N8>C&DR&GSY4/5<4&V#?A^#JY)?N0V-R?T
M+<L%E[Q4+M!Y-M%3SZF7>L"T7A4,'.BR.X*6&;H-EIO`1]YZ90KTF]&]'/UW
M9,WWGP4KOK*.0K6A3[H#6\X?-?2AT(\@V#N)OC<=^"Z<@I9DUZ@??/^%LJI6
MT.X8'&ECR^+ECLH<*@HT;AAKIIPWD`#\.BW3HP$5(<_FNF>%JC,483=._"@`
MN+.E4MTS38F<?"<5;_]84'"@LB3A@02N!Y(@=,-%',3X;1;/9F0,WA%%UBO!
M]PY,#6C*GN@9#);`K)UAJ,^_G8$E'7.K@TPHH"6TXVF-HV3E/4$)\P-F8S'P
M!0R8<$!X(#YD`*KS#*(W,]!!TPRBZX'>)+FQD(5I[%@OFNJ==ZK!T*VQBSB:
M"5G,]0B#!\3$*4#&3L\K:W"&P,1K_?!BX+46+28Q'4@CG`;#^XDNS-A85_?X
M[0KKH+E^.O!;?8O!1C\)X_2U!1-]/-4_[UN#I[HXFONV&*L;8`P?P9#81#AY
MC[`&SUJ-YT-M,1>T6F_^T6=UWK(&3RV')ZVV&&LYC1+_/ZU.I[J7M5H'S?7G
MK;:8H=6CCV!2<=C"[S!NT%-E',V5#R`[Y;K;\7S,[-ZV:ZVEHJ*?:--()^<[
MO9,#&,_AJ3TO-G!>A&8Q#"]@7?>DHM^(J%@GG8:6$.J["8RXL`O?WBC>F[VS
MY0H6M?E;P\%,82WZ+H!+SM7Q1A\IPU&__@L``/__`P!02P,$%``&``@````A
M`%Q50GV-`@``608``!D```!X;"]W;W)K<VAE971S+W-H965T-#$N>&ULG%5=
M;]HP%'V?M/]@^;UQ`@%:1*@*$5NE39JF?3P;QTFLQG%D&VC__:YMR!K8VFXO
M$,?G'I][[KW.XO91-FC/M1&JS7`2Q1CQEJE"M%6&OW_;7%UC9"QM"]JHEF?X
MB1M\NWS_;G%0^L'4G%L$#*W)<&UM-R?$L)I+:B+5\19V2J4EM;#4%3&=YK3P
M0;(AHSB>$DE%BP/#7+^%0Y6E8#Q7;"=Y:P.)Y@VUH-_4HC,G-LG>0B>I?MAU
M5TS)#BBVHA'VR9-B)-G\OFJ5IML&\GY,4LI.W'YQ02\%T\JHTD9`1X+0RYQO
MR`T!IN6B$)"!LQUI7F;X+IGG*2;+A??GA^`'\^P9F5H=/FA1?!(M![.A3*X`
M6Z4>'/2^<*\@F%Q$;WP!OFA4\)+N&OM5'3YR4=46JCV!A%Q>\^(IYX:!H4`3
MC2:.B:D&!,`ODL)U!AA"'_W_012VSO!X&DUF\3@!.-IR8S?"46+$=L8J^3.`
MDB-5(!D=25)0?]P?1:/K23*9OLY"@B*?8$XM72ZT.B!H&CC3=-2U8#('YE-F
M04>?Z]]2A1P=R9UC\5R0A8'R[)?3-%Z0/7C*CIA5P,!$])ADB%B?$,Y`1YL_
M>T%`;R\:K#@7/8:B_KD<)XTN:*AQG`X%K"XAHR%B?8D83X:0_!(RF_6001KC
M_TG#!4'_/+-QFIX9N0H8*&=O];17X)U=OXK(7T(,LH!C_KT8+BC#8-5OA>F9
MUZN`F?EV.FNF]0M[<!$X[O.XH#F,>)@`R77%U[QI#&)JY\8W@;/ZM^%F6<'-
MXN>0]!LPV1VM^&>J*]$:U/`20N-H!J.LP]T0%E9UOM^VRL),^\<:KG`.G1U'
M`"Z5LJ>%NWWZC\+R%P```/__`P!02P,$%``&``@````A`(5F\O6`!0``0!L`
M`!D```!X;"]W;W)K<VAE971S+W-H965T-#(N>&ULG%G;CJ,X$'U?:?\!\=[A
M#DF49#1)JW='VI%6J[T\TX0DJ`..@+[,WV_9Y0!E:`/STH3V<7%\JER'R^;+
M1WXUWM*RREBQ-9V%;1IID;!C5IRWYC]_/STL3:.JX^(87UF1;LT?:65^V?WZ
MR^:=E2_5)4UK`R(4U=:\U/5M;5E5<DGSN%JP6UK`R(F5>5S#:7FVJEN9QD<Q
M*;]:KFV'5AYGA8D1UN64&.QTRI+TD26O>5K4&*1,KW$-_*M+=JONT?)D2K@\
M+E]>;P\)RV\0XCF[9O4/$=0T\F3][5RP,GZ^PKH_'#].[K'%22]\GB4EJ]BI
M7D`X"XGVU[RR5A9$VFV.&:R`RVZ4Z6EK?G76!V]I6KN-$.C?+'VO.K^-ZL+>
M?RNSXQ]9D8+:D">>@6?&7CCTVY'_"R9;O=E/(@-_EL8Q/<6OU_HO]OY[FITO
M-:0[@!7QA:V//Q[3*@%%(<S"#7BDA%V!`/PU\HR7!B@2?XCC>W:L+UO3"Q=!
M9'L.P(WGM*J?,A[2-)+7JF;Y?PAR9"@,XLH@<)1!G'#ANT&TG!/%DU'@>(_B
M+MQEX`3A.!<+UR5D>HSK>+<IV;L!M0?,JUO,*]E90V2NCP<J#^L#PO`Y7_DD
M,170%23U;1?ZWL9Z@T0D$K/O8QR*.-P1/'_`IJ$$,LVGQ"=12IY/K[?O0UR*
M./017M!`"$>0:CY'/@GD-8V.;"I)Q/A=3,-`B'_0(0A'"-+EJ$\I!V]-$*#A
MYD8K>N4]8B*1\.4J7-+A0W<X"J)V9805;)OIK#B8L@K]-B-"CSUB0L'*#6U7
M*<0#&?="IRU#PBN<PXN#*2]WJ133'C'(R[&#4%$+AWU!>[5L21-2T1Q2'*R2
M:N.B6(A!4J'MJRGL#@=^1VK"BIMCIV?H"XN#559M:2`KQ*`64:@(><#1NY!^
MU`A)2*THJ6F-C$]2R:GUA1B\_(,3>4Y+`#<D!02AWZ::,'2@KT[73:`I-\=N
M(Z-P$H3DEI$Z?B#CT2ILUT:9*2Z@SZB#C;O;*[IKELP0!#VA:2@*^8.,,PRA
M_'AC[E3<M.0ZV,[U_5:"ADE@?K40RI/WY@[/$1VQDU,=E>+:.P/MOK=MAT##
MN\3A37HZ0XZF-1CZJBN(D%M3JR#&&890!15[F)AI[/$CF4;0,`F9:1V$\IQE
M%T[?+\).'Y,[YNX(G1T3V$T:)<,!4`.A#&=YA],WCS!HG5(R1)!601V$\E-<
M9&*FT0Q&,GWWDXZ2C4A21QV$\E2,961/]QVE?\?B=!TC<EUESQ_(>!@%GW1M
M=Y:?"+2REP/%:O<2I,NP%D*4<Q57F99A,6OL+EF"M#QU!D1Y*NZBS["+KJ+O
MVA)$^/6Z]A"H*5/*D)O`Y*[MHF40AH%Z(RA!A&%S<=PC6@CE!V&Z_"9FFL\:
MS32"M#QU$,I3<9>13*,;$!U[79L_>L,B"+]`N;\]#($:L2G#6;[B#OA*IUM@
MUY8@PK"YN,ST9%=Q%5>9F&ET!7W7%J$5)56>D]W%5=QE)-/H!B.9'K",WE.=
MN.YGBZ"9GN4K[A1?D2!\0'=6O0<I.KZT6]\AS/C[G^YNUFLGT*JOM)&Q!B5(
M5X-:".7W4[[BH1_H:U""M#PG^XH']31#1XY6=.QU&Q%2*:]>#0Z!FHU$E9SE
M*]Z0KRAO$/82I%40XPQ#*#_`=!6<UFT\/FO,5R1HF`1V12V$\ISE*]X47Y$@
MPJ]W!S$$^B33LWS%&_(5];E/@@C#YN)2P<F^XOV4KXA9HYG6F8;DJ8/03,_R
M%?BR,6%/#_A*J#[WR4C#8B-#_`:"+_=O\3G]'I?GK*B,:WJ"5S#V(H*R*_$+
M")[4[";>F#^S&KY<B)\7^%*5PAM^>P'@$V/U_82_HV^^?>W^!P``__\#`%!+
M`P04``8`"````"$`Q%^%8Y8"``!:!@``&0```'AL+W=O<FMS:&5E=',O<VAE
M970T,RYX;6R<55MOFS`8?9^T_V#YO9A+0MHHI&J#NE5:I6G:Y=DQ!JQBC&RG
M:?_]/N/`0K*UU5X2C,]W?,YW,:OK9]F@)ZZ-4&V&HR#$B+=,%:*M,OSC^]W%
M)4;&TK:@C6IYAE^XP=?KCQ]6>Z4?3<VY1<#0F@S7UG9+0@RKN:0F4!UO8:=4
M6E(+2UT1TVE.BSY(-B0.PY1(*EKL&9;Z/1RJ+`7CN6([R5OK231OJ`7]IA:=
M&=@D>P^=I/IQUUTP)3N@V(I&V)>>%"/)EO=5JS3=-N#[.9I1-G#WBS-Z*9A6
M1I4V`#KBA9Y[OB)7!)C6JT*``Y=VI'F9X9MHF<\P6:_Z_/P4?&^.GI&IU?Z3
M%L47T7)(-I3)%6"KU*.#WA?N%023L^B[O@!?-2IX27>-_:;VG[FH:@O5GH,A
MYVM9O.3<,$@HT`3QW#$QU8``^$52N,Z`A-#G_G\O"EMG.$F#^2),(H"C+3?V
M3CA*C-C.6"5_>5!TH/(D\8%D!NH/^W$07\ZC>?HV"_&*>H,YM72]TFJ/H&G@
M3--1UX+1$I@'9U['Z/5?5L&C([EQ+#T7N#!0GJ=UFD8K\@0Y90?,K<?`1(R8
M$\1F0+@$.MK\Z`4!O:-H2,6IZ`2*^O=R#!I=T%1C,CN1>`Z)IXC-.2*93R'Y
M.62Q&"$3&\G_V'!!T#]':4QGISX\!LHYICH=%?29W;R)R%]#3%S`,<?%>+T(
M#IQA2-&H+)J%4VVW'K/HVRA*XC_)\](GVW%XL@W7@#MAB`Z3D=R+]C/N1T!R
M7?$-;QJ#F-JY^8W@T/&MOUINX6KI!Y&,&S#:':WX`]65:`UJ>`FA8;"`6=;^
M<O`+J[J^X;;*PE#WCS7<X1Q:.PP`7"IEAX6[?L:OPOHW````__\#`%!+`P04
M``8`"````"$`)ZY#L6H$```.$P``&0```'AL+W=O<FMS:&5E=',O<VAE970U
M,RYX;6R4F%V/LC@4Q^\WV>]`N'^`HB`2]<D@X-MNLMGLRS5B53)`#67&F6__
MG%)U:&6L>"%RSH^_[?FWI3#Y^5'DVCNN:$;*J8X,2]=PF9)=5AZF^K__Q#\\
M7:-U4NZ2G)1XJG]BJO^<_?[;Y$RJ5WK$N-9`H:13_5C7)]\T:7K$14(-<L(E
M9/:D*I(:3JN#24\53G;-145NVI;EFD62E3I7\*MG-,A^GZ4X).E;@<N:BU0X
M3VIH/SUF)WI5*])GY(JD>GT[_4A)<0*);99G]6<CJFM%ZJ\.):F2;0[]_D##
M)+UJ-R=W\D665H22?6V`G,D;>M_GL3DV06DVV670`U9VK<+[J?Z"_,U8-V>3
MIC[_9?A,6[\U>B3G197M_LA*#,4&FY@!6T)>&;K:L1!<;-Y='3<&_%5I.[Q/
MWO+Z;W)>XNQPK,%M!SK$^N7O/D-,4R@HR!BVPY12DD,#X%LK,C8RH"#)1W,\
M9[OZ.-4'KN&,K`$"7-MB6L<9D]2U](W6I/B?0^@BQ47LBP@<+R+(-FS/08[;
M0V5P41FV5=#0ZJ,!;6ZZ`\>OEO3MCGL1@>.72,^&C"X:""IW$;'!@B=K8G*7
M&M/#I$YFDXJ<-9A(H$9/"9N6R&?2W3:#OPQ^8?14AYD.#E(8FN\SS[8GYCN,
MI_3"!/>,1,SO"7?DB"IA%^.*3-3%C$0F[F(\D5EP!KYOO9):O%02*R6Q5A*;
M1X0)?MU,@VG1PS1&,]/87&4N!G)@+@=".1#)@5@.+'@`NG`KXL@;BH5>WC.>
M/1"951<CZ:R[&&D`;;J8KP$DE!/6B1[E9+103CDPEP.A'(CD0"P'%CS`5T5F
MVO(:>%#?U1/,^@EF\Y@1:@=K:X_:,1IN"*U!XMG2C`TX`]^W@?1E6S-^YTHB
M5!*1DHB5Q$))+)7$2DFLE<3F$2&8!3>Q'F8Q>JK#/+H9,;2DV1IP!AIP8V2S
ME$2H)"(E$2N)A9)8<L)I;FN#L>TA:642\X.15(NUF!\.I?SF^[Q@$FP2>IC$
M:-DD:;D,.//()"41*HE(2<1*8L$)EUO@.!9\1!.6;0)VE/?$2B`&#)`TUFVB
M"]BT@9&H(%@%>[(>5C%:M,JSI:U(P)E'5BF)4$E$2B)6$@LEL>0$GT]#Y(ZE
ME6&ER*\5^<WW><$D]ESZ_`Z7T:))[EA:"`+.#)M1B@RY7W,Q+>U+PH?92,R.
MI9D<M],C8R!M4Q?7]+>K\?)*L*V[8R!IB5JUT\API=&Y;J<=PY6ZMFFGA:L%
M/\:]_&"TZ(=GC\4U(>`,7S60-48#3UZ;YQQY,*]")1$IB5A)+#AQ:6KG`B<0
MG0N<\E_6;8W.!>Z1!#>+OQ_@CXH%K@YXCO.<:BEY8\_^K`.WZ.VUQ,N`/6-(
M\0#Y05=\CGS8*-_S(?)AOWP?CY`/V^;[>(Q\V#U#W+S],;R.."4'_&=2';*2
M:CG>0Y,M8P0WX(J_T.`G-3DU#\!;4L.+B.;G$=X[8=AN6P;`>T+JZPG[@]N;
MK-DO````__\#`%!+`P04``8`"````"$`<8!JE;L-``!^;@``&0```'AL+W=O
M<FMS:&5E=',O<VAE970U-"YX;6R<W=ERXD@6@.'[B9AW<'`_ML5N1[DZFD5(
M[`B)Y9*RL4VT;1Q`=76__60B"<@CE7YP791Q\NEHRY.I)2U]^^.?][>KOY>;
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MW@,_UNN_-'6?=)&:^"8QM;W?`\/-U=/R>?'S;>>M?SG+U<OK3NWNDEHCO6+W
M3_\VEMM'M455F.M\24=Z7+^I!5#_7[VO=-506V3QS_[GK]73[O4A5RA?ERJW
M!4OQJQ_+[<Y>Z9"YJ\>?V]WZ?1HB*PH5!LE'0=3/*(BEZM>9$Q>BB8O'B?/7
M^6K)*I4O6`2UL/OU4#^C1<A7+X]2CJ)4#E&^L#74JN\71?V,%\6Z+N9+E>HE
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M\SF*Q,(%L8G#3F3!5!;,9,'\I.!&U<%#152Y:E3$]".*N+YIK>M;O"2UL$`%
M/VS;O*A<25$HF:011ST&J51,TDQ&$?.QDZ):*)I16F<8)VG$G%P4[:20Z]Q)
M$C&;;E+((+TDD1NNGR2)S3)(&K$L0Q2CI*@6110O:808H_"3(K$^P1EFDF**
M9;.Z3"-3+.Y;UJ)5S!=,,4N+(M9IGF).*J:1C*K+NR`9M3:2,2PX3<9J0;0W
M]3-,0P9NIDTD-H5]AFF=89PT(UH#-\U4S5W3/L-TTLR=&:=[ANF=8?HIIBAZ
MS,$99IAFQ$X>I1FQO[PSS#C-B#;53YKRK=B&P1EF<H:9GF%F9YAYTE2L8QTS
M4E(=/1HIJ0_4BNJ`+;N?U%,9J1D6F*DI&HIZ;.+.M2&C-*6PXX)CSUF5G40K
MS8B6SHE-/&M7%K1E04<6=&5!3Q;T9<%`%@QEP4@6>+)@+`O\N.!DF\A$"\XP
MDS0C$FV:9D2BS<XP\S1S;!R,"JGJ7J)"EM498':%U%,9%3(L""_PZ&/^NBQH
MR$F:4MBRH"4+'%G@RH*V+.C(@JXLZ,F"OBP8R(*A+!C)`D\6C&6!+PN"N."T
MHHE#VTELXL2:RH*9+)C'!:=A?],XJ<LBB;K`C9.>2ET`/#EFKQ9%[UD+C:J6
MA^-ZT6344310-%'8*%HH'!0NBC:*#HHNBAZ*/HH!BB&*$0H/Q1B%CR)`,4$Q
M13%#,<\21N.LKC`F$K*`C;.>ZB&GSA,.R58MBD.H6FC",Q'1P]3C[X[3BV1M
MH&BBL%&T4#@H7!1M%!T4710]%'T4`Q1#%",4'HHQ"A]%@&*"8HIBAF*>)8Q4
M5!=%C53,/C[26J1@Z7@`MK\J6@M-5I^(HH&BB<)&T4+AH'!1M%%T4'11]%#T
M40Q0#%&,4'@HQBC\4)3W%YP*I5O]S[P>$6",R6D,*RW&%&/,3F/DPQAB0>99
M08Q,5+>Y+LA$K64FBM.N6FA.,[%:DF?322,[111-%#:*%@H'A8NBC:*#HHNB
MAZ*/8H!BB&*4%(G][R6-V/]C%#Z*("D22S))&K$D4Q0S%/,4<7)69R2D'FQ@
M9*2^J,6'J?O)9&J*8]%:A$YS4ZQMG4F#29.)'1&K6-BWI[?JWKC9F+90.#P;
METF;28=)ETF/23\B\581;>N`(PR9C)AX3,9,?"8!DPF3*9,9DWE$#AO_VMKW
M\8?_CGO#S%A]^U:.%S@C8_5D,F/%!?R:'CND4'C,894J9=W=FWE2-TVA>EM.
MF$9D,C*_R<1FTF+B,'&9M)ETF'29])CTF0PB$NY(-?*KG)=W@X<&J10+:G28
MN:='/!_/"&+=WI6*=_("^YC#^$P")A,F4R8S)O-,8B:KON,KDY4ORUKAC6+C
M,E!)[)Y:A#*2K,ZDP:3)Q&;28N(P<9FTF728=)GTF/29#)@,F8R8>$S&3'PF
M`9,)DVE$HKXHZA7-%FK&8>:9Q,Q5?2M8YNH9'6MX!]G,57&<6[-"E)FK2!H<
MI1F1<*O=W27[9IN#M)@X3%PF;28=)ETF/29])@,F0R8C)EY$HKI?*)?+=V5Q
MK#;F,#Z3@,F$R93)C,D\DYBIJA+I*ZFJ)Y/'P,?[J>&E73WR7:%*>-UMW^Z8
MK4[=$/E*"FD8)#RN-X,T(Y'1(MA,6DP<)BZ3-I,.DRZ3'I,^DP&3(9,1$X_)
MF(G/)&`R83)E,F,RSR1FHNH1#*=]:O:M%_W7(HD$E>,1(A0UCOFT[*H;9M\+
MRO/8AD'RU90L;D8D,T?#)<X@+8[B,'&9M)ETF'29])CTF0R8#)F,F'A,QDQ\
M)@&3"9,IDQF3>28Q<U0/:3C-T3,O`8<C(<SC7CE40?^UEDKHC/2H,VDP:3*Q
MF;28.$Q<)FTFG8B<GO^8AQ!=#M)CTF<R8#)D,F+B,1DS\9D$3"9,IDQF3.:9
MQ,Q4/>+A-%.A-PT'2!@96A:7<VM6UBB*_1%QG4F#29.)S:3%Q&'B,FDSZ40D
MS-#HSKA,4=RZ/9Y1G\F`R9#)B(G'9,S$9Q(PF3"9,IDQF6<2,T7U4(@+4C0<
M.6&FZ/'&3W1&FC6\(DI1)`W]I\K977&3B<VDQ<1AXC)I,^E$Y&Y_,F]=RS_:
MZAK?%]7WT77&\(>XY-*+='AI0#2D?5Z:`9,ADQ$3C\F8B<\D8#)A,F4R8S+/
M)&:2Z@$2%R1I.)["3%(QQJAFI0RZ,#N#.I,&DR83FTF+B</$9=)FTHE(UI%N
MN'&CGC;E5+UGQ$@[F>_S@@R8#)F,F'A,QDQ\)@&3"9,IDQF3>28Q\E,_Q>*"
M_-QS<5FW+`<C1>CT3+0JKZG74Y"XD]-@TF1B,VDQ<9BX3-I,.DRZ3'I,^DP&
M3(9,1DP\)F,F/I.`R83)E,F,R3R3F$GZM7%(^LDR\A)O60YMB%#<WA<KQ;+(
MPWI$3O-9D`:3)A.;28N)P\1ETF;28=)ETF/29S)@,F0R8N(Q&3/QF01,)DRF
M3&9,YIG$3%5UZ'I)?ZJY[$]%<M7T(YX4BD<OBK.A>O1U9GJ&$3)(DZ/83%I,
M'"8NDS:3#I,NDQZ3/I,!DR&3$1./R9B)SR1@,F$R93)C,L\D9GI^;>"1?BI:
M(DWE:(8(A3UI\2[EU*END-0_$FI$)#-5<?B2S5%:3!PF;D2B$\KPFHYY+MXV
M2-H0C@[/I\NDQZ3/9,!DR&3$Q&,R9N(S"9A,F$R9S)C,,XF9J2H#+NE(-3<[
M4BLO>LJ:?BBA0E%ES1>*.D?-VEHWS6VQH!/9-`W#E*QJDC0CDI'&-I,6$\=<
MEI1&Q^4@;28=)ETF/29])@,F0R8C)AZ3,1.?2<!DPF3*9,9DGDG,')5#CLX;
MSJ"?O"ERM5J60X\B%#YZ09RTUHTOQ3V<QN'+WSZ8H<G$9M)BXC!QF;29=)AT
MF?28])D,F`R9C)AX3,9,?"8!DPF3*9,9DWDF,=/S:Z.-\BFCC<IRM%&$HJ&[
M:7<!ZA')Z`(;3)K&C-(&(-H<I,7$8>(R:3/I,.DRZ3'I,QDP&3(9,?&8C",2
MUBCK-NU4PN<P`9,)DRF3&9-Y)C%350XW.K,G31EV)!\(7<OCP)@ZDP:39@JI
M5D3O;*<@<;VKQ<1AXC)I,^DPZ3+I,>DS&3`9,ADQ\9B,4TBU(F[4^RE([.N`
MR83)E,F,R3R3F.FJ!_B</ZHA'XX'4A=ACX\:JR3NFN*@H7H4)[-'Q2C-*$IX
M%ES-5]43ELWS6YOGTV+B,'&9M)ETF'29])CTF0R8#)F,F'A,QDQ\)@&3"9,I
MDQF3>28Q,U2..SJS0TT9?U01Z5%3KQS2YZ\9:5AGTF#2C$ATO:I<*55%\VES
MD!83AXG+I,VDPZ3+I,>DSV3`9,ADQ,1C,F;B,PF83)A,F<R8Z-=R_3Y'PDP-
M7[L5OI_E?;EY6=:7;V_;J\?U3_U*+7T><"@]O.[KS_UKMD1YS;I7KTI1S_H5
MY;9UK]Z&DBQWK'OUNI)D^<"Z5R\@29;[ZC5C:>6-_+UZ7+/R-X<9J[=_?2Y>
MEKW%YF7UL;UZ6SZK5;F]UN\%VH3O#PM_V:T_]V^C^;'>J?=^[3^^JO>\+=4C
MH6^O%7Y>KW?Q+WH&AS?'??\_````__\#`%!+`P04``8`"````"$`I$=-4X0$
M``#*$P``&0```'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6R46-MNJS@4?1]I
M_@'Q7L#<XD1)CDY5=>9(,]+1:"[/A#@):L`1T*;]^]GV=@";7,Q+V[2+O?;:
MEX7KY;?/\NA\L+HI>+5RB1>X#JMROBVJ_<K]Y^_7)^HZ39M5V^S(*[9ROUCC
M?EO_^LORS.NWYL!8ZT"$JEFYA[8]+7R_R0^LS!J/GU@%?]GQNLQ:^%CO_>94
MLVPK'RJ/?A@$J5]F1>5BA$5M$X/O=D7.7GC^7K*JQ2`U.V8MY-\<BE-SB5;F
M-N'*K'Y[/SWEO#Q!B$UQ+-HO&=1URGSQ8U_Q.ML<0?<GB;/\$EM^&(4OB[SF
M#=^U'H3S,=&QYKD_]R'2>KDM0($HNU.SW<K]3A;/4>SZZZ4LT+\%.S>#GYWF
MP,^_U<7VCZ)B4&WHD^C`AO,W`?VQ%;^"A_W1TZ^R`S]K9\MVV?NQ_8N??V?%
M_M!"NQ-0)(0MME\OK,FAHA#&"Q,1*>='2`"^.F4A1@,JDGW*[^=BVQY6;I1Z
MR2R(","=#6O:UT*$=)W\O6EY^1^"B`J%04(5!+ZK(&'DQ6$RHQ91?,Q("GS)
MVFR]K/G9@:D!SN:4B1DD"X@LE$50G^O*0))XYKMX2#X*Z`;:\;&FLV3I?T`)
M<X5Y'F-(A_"!O,L`6*=G(!XR,TB[^#++YS$F[!!:!I&>P7WM`@PU<IV!]ED7
M%YD1$P\P?6X:,T"&VN\S"_#*!54#9FHP(R:5/2$1#=(@"#J(1@V#9T\MP#IU
M')JB$8/424KBF\SI%&8!-IE-T8A!YB<2D9O,LRG,`JPST]F\JR4V&C&JW,DL
M36Y2BU?!Y#T3#QDIT+Z=F`)B;%*8ZRG<'S8!-JG[!49JQ"CJ(`WI3?4$+&4H
M_SZW1!L[1OO=17(%LE@R8GC<`W(TKOMK)D.NW+G<L\B+^HG4=HP("QIT_0$S
M&M:0>;QE,N2%.?32?B)UYDF>1M"P=.9>DRHX@E`S\>*HVP6=>9*GD6NFUFM2
MS`BZ5)OTSJ,S&Y9F^2X;>QL=+9EXV<,Z/,Q@DK61L;=1:NZ8`EV8HQLO$F)8
MFZ5V]"]H;/]*H7U?5?419+-HALD]&/=K[A9W0Z7($30DI[0_:NC]-PS.L@;7
MG*ZOLDH#059IA).\3J)-H^T''.D52*?O]U.K0CC)[21:MUHX4AI-4*`A?5\@
MG7R2X85CPZ/4G``%FN&19FB(.K-A>';-#\?&1ZEI/PJDWG.W,X#ZV)M]*-`/
M^XX@I3T<9*9K-XSO_MZ)?SE,YKEYJE`@FY9/\KP0/4]SG-EHW!%D0V[8W@/E
MZ&3#UQR=FX8;(@B[_10FR>TS73C)[R1:7S4Z.M4HD(UTP^T>2+_B<F/I".K>
M-7UIM'$3_Q_:#[I$ZX,>QZ;#*)"%[&B2O4FT4?/1N"F0#?DD>XNNV-NHY@JD
MQFV>SF^>H2/#X>XW7*(-Y:-I4R`;Y8"9T'.!UGL^7C2XL!F>J:+>^'':\#8&
M+RM.V9[]F=7[HFJ<(]O!:27P9N!C-=[%X(>6G^25P(:W<(<B?SS`G1F#&XO`
M`_".\_;R0=SV=+=PZ_\!``#__P,`4$L#!!0`!@`(````(0`'/3R.'@,``$$)
M```9````>&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;)16VXZ;,!!]K]1_0+PO
M]TN"DJPV(;0K;:6JZN79`1.L!8QL9[/[]QWC0("TV>Q+$L;'ASEGQN,L[E^K
M4GO!C!-:+W7;L'0-URG-2+U?ZK]^)G<S7>,"U1DJ:8V7^AOF^OWJ\Z?%D;)G
M7F`L-&"H^5(OA&@BT^1I@2O$#=K@&E9RRBHDX)'M3=XPC+)V4U6:CF4%9H5(
MK2N&B-W"0?.<I#BFZ:'"M5`D#)=(0/Z\(`WOV*KT%KH*L>=#<Y?2J@&*'2F)
M>&M)=:U*H\=]31G:E:#[U?90VG&W#Q?T%4D9Y307!M"9*M%+S7-S;@+3:I$1
M4"!MUQC.E_J#'26!;JX6K3^_"3[RP6^-%_3XA9'LB=08S(8RR0+L*'V6T,=,
MAF"S>;$[:0OPG6D9SM&A%#_H\2LF^T)`M7T0)'5%V5N,>0J&`HWA^)(II24D
M`)]:161G@"'HM?T^DDP42]T-##^T7!O@V@YSD1!)J6OI@0M:_5$@^T2E2)P3
M">PXD=B.X<Q\VP\^P!*<6."[8PEO9C&5KM:F&`FT6C!ZU*#U('/>(-G(=@3,
MG3]*3>_8_PP#IR3)@V1IN<`+#D5^6<T]=V&^0&72$V:M,'"N>HP]1FPZA"R#
MI(VG@>TTD*@`?/:D06CUM":([)5"%:9*7>BG?W=")TQN&@MSO9Z^37*M($-=
M83B&;"Y9G#$BOD2X_ABRO81,WY-<0N;>.=V1&^[8C>LN2+!TH2O,6@5F?6#3
M(<YU\&=3C3=@MC=@DNN8D4KO(RHE>*12!08JIXAX&MA.`TD7.!LS]\Z5'24+
MXV'8H-=+(L$PC`:-/_>"<<>L%08R.!^.,6+S+B)^%[%]%Y%<0XP<@`%TNP,2
MO-2AY7MUKCMU0&'"=B+9</.>1T-[=C?#=<>W)N<V'BU[P:2AM\/EP)NLPJTF
M\U/O]KW!JY5D=66I65QAML<;7)9<2^E!7D<.I-Q'U4VYMB.8?W`$IW$G6GLR
M;O8+<(,U:(^_(;8G-==*G`.E9810"*;N0/4@:-,.MQT5<'>U/POXJX)A]EH&
M@'-*1?<@7]#_^5G]!0``__\#`%!+`P04``8`"````"$`^V*E;90&``"G&P``
M$P```'AL+W1H96UE+W1H96UE,2YX;6SL64]OVS84OP_8=R!T;VTGMAL'=8K8
ML9NM31O$;H<>:9F66%.B0-))?1O:XX`!P[IAEP&[[3!L*]`"NW2?)EN'K0/Z
M%?9(2K(8RTO2!AO6U8=$(G]\_]_C(W7UVH.(H4,B).5QVZM=KGJ(Q#X?TSAH
M>W>&_4L;'I(*QV/,>$S:WIQ([]K6^^]=Q9LJ)!%!L#Z6F[CMA4HEFY6*]&$8
MR\L\(3',3;B(L()7$53&`A\!W8A5UJK59B7"-/90C",@>WLRH3Y!0TW2V\J(
M]QB\QDKJ`9^)@29-G!4&.Y[6-$+.99<)=(A9VP,^8WXT)`^4AQB6"B;:7M7\
MO,K6U0K>3!<QM6)M85W?_-)UZ8+Q=,WP%,$H9UKKUUM7=G+Z!L#4,J[7ZW5[
MM9R>`6#?!TVM+$6:]?Y&K9/1+(#LXS+M;K51K;OX`OWU)9E;G4ZGT4IEL40-
MR#[6E_`;U69]>\W!&Y#%-Y;P]<YVM]MT\`9D\<TE?/]*JUEW\084,AI/E]#:
MH?U^2CV'3#C;+85O`'RCFL(7*(B&/+HTBPF/U:I8B_!]+OH`T$"&%8V1FB=D
M@GV(XBZ.1H)BS0!O$ER8L4.^7!K2O)#T!4U4V_LPP9`1"WJOGG__ZOE3].KY
MD^.'SXX?_G3\Z-'QPQ\M+6?A+HZ#XL*7WW[VY]<?HS^>?O/R\1?E>%G$__K#
M)[_\_'DY$#)H(=&++Y_\]NS)BZ\^_?V[QR7P;8%'1?B01D2B6^0('?`(=#.&
M<24G(W&^%<,04V<%#H%V">F>"AW@K3EF9;@.<8UW5T#Q*`->G]UW9!V$8J9H
M"><;8>0`]SAG'2Y*#7!#\RI8>#B+@W+F8E;$'6!\6,:[BV/'M;U9`E4S"TK'
M]MV0.&+N,QPK')"8**3G^)20$NWN4>K8=8_Z@DL^4>@>11U,2TTRI",GD!:+
M=FD$?IF7Z0RN=FRS=Q=U."O3>H<<NDA(",Q*A!\2YICQ.IXI')61'.*(%0U^
M$ZNP3,C!7/A%7$\J\'1`&$>],9&R;,UM`?H6G'X#0[TJ=?L>FT<N4B@Z+:-Y
M$W->1.[P:3?$45*&'=`X+&(_D%,(48SVN2J#[W$W0_0[^`''*]U]EQ+'W:<7
M@CLT<$1:!(B>F8D27UXGW(G?P9Q-,#%5!DJZ4ZDC&O]=V684ZK;E\*YLM[UM
MV,3*DF?W1+%>A?L/EN@=/(OW"63%\A;UKD*_J]#>6U^A5^7RQ=?E12F&*JT;
M$MMKF\X[6MEX3RAC`S5GY*8TO;>$#6C<AT&]SAPZ27X02T)XU)D,#!Q<(+!9
M@P17'U$5#D*<0-]>\S210*:D`XD2+N&\:(9+:6L\]/[*GC8;^AQB*X?$:H^/
M[?"Z'LZ.&SD9(U5@SK09HW5-X*S,UJ^D1$&WUV%6TT*=F5O-B&:*HL,M5UF;
MV)S+P>2Y:C"86Q,Z&P3]$%BY"<=^S1K..YB1L;:[]5'F%N.%BW21#/&8I#[2
M>B_[J&:<E,7*DB):#QL,^NQXBM4*W%J:[!MP.XN3BNSJ*]AEWGL3+V41O/`2
M4#N9CBPN)B>+T5';:S76&A[R<=+V)G!4AL<H`:]+W4QB%L!]DZ^$#?M3D]ED
M^<*;K4PQ-PEJ</MA[;ZDL%,'$B'5#I:A#0TSE88`BS4G*_]:`\QZ40J45*.S
M2;&^`<'PKTD!=G1=2R83XJNBLPLCVG;V-2VE?*:(&(3C(S1B,W&`P?TZ5$&?
M,95PXV$J@GZ!ZSEM;3/E%N<TZ8J78@9GQS%+0IR66YVB629;N"E(N0SFK2`>
MZ%8JNU'N_*J8E+\@58IA_#]31>\G<`6Q/M8>\.%V6&"D,Z7M<:%"#E4H":G?
M%]`XF-H!T0)7O#`-005WU.:_((?ZO\TY2\.D-9PDU0$-D*"P'ZE0$+(/9<E$
MWRG$:NG>94FRE)")J(*X,K%BC\@A84-=`YMZ;_=0"*%NJDE:!@SN9/RY[VD&
MC0+=Y!3SS:ED^=YK<^"?[GQL,H-2;ATV#4UF_US$O#U8[*IVO5F>[;U%1?3$
MHLVJ9UD!S`I;02M-^]<4X9Q;K:U82QJO-3+AP(O+&L-@WA`E<)&$]!_8_ZCP
MF?W@H3?4(3^`VHK@^X4F!F$#47W)-AY(%T@[.(+&R0[:8-*DK&G3UDE;+=NL
M+[C3S?F>,+:6["S^/J>Q\^;,9>?DXD4:.[6P8VL[MM+4X-F3*0I#D^P@8QQC
MOI05/V;QT7UP]`Y\-I@Q)4TPP:<J@:&''I@\@.2W',W2K;\```#__P,`4$L#
M!!0`!@`(````(0`"KK\_@0\``(N;```-````>&PO<W1Y;&5S+GAM;.1=^V_C
MQA'^O4#_!T%IBP:HK;=M.;:#L^[8!DBO0>Z*%FB*@I(HFSD^5))*[!3]WSN[
M?,V(V@>II:A#:S0G4>+,M_/X9G:Y(N^^?O&]WD].%+MA<-\?70[[/2=8A6LW
M>+KO__6C=7'3[\6)':QM+PR<^_ZK$_>_?OCUK^[BY-5S/CP[3M(#$4%\WW].
MDNWM8!"OGAW?CB_#K1/`)YLP\NT$WD9/@W@;.?8Z9B?YWF`\'%X-?-L-^JF$
M6W^E(\2WHT^[[<4J]+=VXBY=STU>N:Q^SU_=?O,4A)&]]`#JRVAJKW+9_$U%
MO.^NHC`.-\DEB!N$FXV[<JHHYX/Y`"0]W`4[W_*3N+<*=T%RWQ\7AWKI)]^L
M[_M7_5XZY$6X!A"_^_<N3+[Z3?K/%W_XXHOAO[[\ZA_?.^M__O#[ZF<_?-D?
MY&J03/"!7.;E4"H6/DXE#[(1/-QMP@`-9`YF8M:Z_12$/P<6^PR"`8;'OO9P
M%__2^\GVX,B(P5N%7ACU$O`RC(\?"6S?2;^QL#UW&;GL:QO;=[W7]/"8'>"!
MD7W/=\%-[.`@U7!:/4N&)A_3#8-!QC1A1_"8?!B2S0[*QV3_>&!,1-=,K>L8
M^Q%=?!3R<1G358V+B@V/T57X"NF)GI;W?<L"#AD-A\RLV&$M*9LOAJ#O9,JN
M9B<;V<2:6-=&1T9BL>HWIG!BF32E0J'UYOKMR<QI7IEH=!D-GRH#6,*9M:(+
MJ2O)[VN+_9TB3DY<T-KQ&)=*2)^G7LF-'UW?B7OOG9][WX>^'3##XJ+&OTUJ
M,@D\\^)SU\\O)]7B>"SV7/A(B?O#J[\,O8/66#W;40Q=+N^`>"-#[$/B5ZFG
MD?E/H.*0I8H*6TWYVL,XE?PY<V$:_ZW`Y_XWFE^%92:7*`',@.>!&D.&NYY7
MS%H@S](C#W<P@4J<*+#@XU[V^N/K%KKZ`.9ZS)(#=J;RVT^1_3H:<_1Z)\2A
MYZX9BJ<%GTMDHUU<O;,6[[A>A$P7A4"H92VN6Q#Z[G&^,(]T,><!/#`X_+$%
M?X:1OIFQ/\-"+?C?PIA-LVH^-06RD-=+7#;W'UY>S^?SF]'5S<W-?#H93:?<
MR,LLHMU@[;PX;#G`F)FJ"&:`8#ZYF5^-`<AP>L-5G13!!`!<SV8WL]%\/(7_
M\X+=/@+3-IWUN_8J0M"15Q&"CKS*IY\FJ"_+%%B)ZSA7$8*.O(H0=.35:\,,
M?-VY5Q&"CKR*$'3D5;YH:C!7886[XUQ%"#KR*D+0D5>--9\9`\-EA8Z]BA!T
MY%6$X-1>S:=5L&AG\<:ZVID9ZX\S7:R)M_AR71U=?-8(\]1E&*WA4F1^?6UT
M#7/$]-C#G>=L$IB11N[3,_LW";?PWV68)'#A[N%N[=I/86![\'*0GY'_*SD3
M+FW"5<S[?O+LKCZ!,C*S3VV3JFA+0Y$?4S:;F%Y/A]?3V?@JG;`94NT[:W?G
M5T=7Z#X8EV!&9EOUP)$-@T))%@[EZNV`>2%SG^89W-7<TYHG0$SD(:%YAHDQ
MEE<R=,>(SM`;(SI!<XSH#-TQ0NH<2J[<DNMP!U?5]QUL63?#8;IHK*M'+A`!
M/Q`QAT&@<ZKV5)YRP*+*<^J.%?BEDAN/8_;'N^,#(U6<41VGXH0#HU2<H3M&
M&C>Y=XGP8NF"T?,!)'OV)E]O!@,4I2<>Q).Q$UO73B]F:9.=QF"KPM&(X?QZ
MI4H3/U*1G[%GU"JL9I;-Q1,'5X4?`*0XXS@XRM$B0+6=4(DFI;;3#2;WQU&0
MLIX)6K"5XWD?6%/T]TW1A\'2YL/=RP9M2()=8FS'#MOOQ%["18+L9=ISI6_`
M:J*3QL*3>O9VZ[V^W_E+)[+XUC&N@A]EURG*=X^\62S?O_'<I\!W^.)L/Q7S
M710FSBKA6]OXI3D1GHD`SR@3I(/G&/U3@7ZPD[8]CM$/BW\'G0AVZ50_!)>V
M?I/QP#;Q94$-+L!!+<-C$@$L\>0(P`E=(&";#C,;0'AV@0"FSCD""-`2`<"1
M1,4Q>0`;!0J5$`.E2M#?EDK@F'R41&6+HQ31+^B7C-(B]'N4F1'?0J"79H8W
M$@!'J111;%<4@]P.F5::`-Y(3&!!U353\D8BSN_,((AT`4-I$:`!F47,127B
M7-!9`I!;Y-%@'X*"@E%1UQ``3B<0D"-&'=5?6'LL:'G4407&T=!1"<802`T^
M84Y@3Y`*V1$&P--)5J"`)!7CA&9`$+IB2!0-XZXH$F/HBB-+5XR[HD@$H2N&
MQ)[HBB(QAJXX$KFB*XI$$,`BG3`D]D17%(DQ=,61I2LF75$D@M`50R)/3%JF
MR`%>-DT74='ZZ6AZU6@!M?>R4:ZDCD2S)G!\?GHZ?4JGCN`,/IE"<VGV.T\[
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M%`*4[(0PS@`F1S?97]:1V=_B%V)J69_M>Z/M?(_]<"ZM[*IB#3\X+1B$`H7;
MU$@CA2(MXT;B)K$RH=.S65=FE39E*WJ@6MF'C&J$BW`X&G.W'K)]DZ-I"7:G
M7-CA9E>SY<*#YSLV^6Y/60>J#ZPQA'JUJ<UXJ&\2FN>:J:=(#^PD8Q%*@:I*
MEU%":JJLAIG.SW$I(G5H"SA`Y2X=%A`YL56[$O)2U3UQI1.812%=QRJESG.T
M0ZN8]H*J85-R0HCF^51"%(*0HT:K(-().9J(PD4"S/L2G`!ADRWB"8LSVZ0B
M:XW+)&C2DU2EZUBAU-EJ!%&*T+:#>4RB>:RJ'#:R4WYAI%9K7?M*S7ZPZ(1B
M)6,T^\1:(T%-H2)?J?8&F2GIR-+?9W;63;>#C.TU:Y%**M+/EDHJ2&DH-4K;
M8VE>D5PEIOW,%10[2IX5Z6?KFPK23GQ#J4>5.)1[:KM*I4S'5R((YHNAD*";
M6NF4$*&2RQA09,7]G(,@W1QHW*@C%9%,=6FUDI*RD/[8]QP+EAJ9<)U:?])9
M(X8:]5?"#E`Q\RJYH`V$`NJG85@UXN?")XJ.GR90:>G]9-6S4D79>5E)&(!M
M]#*-4@1MB0/F6_(K9MDO=V64*R0^Y:R![WM1LG!GX:]M1-$XY%;4"4^A;?'Z
MA#;.CHK>L?CD9J3=I5F#B1Q+^1GPT?S0\2SE/K.PD9^%E;D"NDT[(D#"*_B?
M#Z#]\H1'AWIK.'P"#L7*A26FTQ['+$*9\47C!P0T06FLEXU'&RV>8/@*"J$(
M-<E"67`Q%A2I$S"<=JA^AEAPL93,P/A3::1;0/$:?R.C[4>OJ+.5.Z2E^E)_
M`:R-(#Z!LZK73&3I5M)#(^]5E=5W7PFA!D/IN1,W"(U"6H'(#">IKM-04BK-
MM>\Q+0)LJDQA"1S8$M]H44(5XED%%>%)&%!97*K9H)=Z9FR+W=^P61!VZF8"
M'1#*6A4:YT(L.-0D!4_]ZRSB2'E1DOE1"Z@D)[#?6NY;L.E21.I]0P@>>ZGU
MNPPMDU1]!X0F[5`PG0.6,O'@C2RPM.!D$WD5AE,&3=5"Q2;A>E>`:>T;0:S+
MS$7SL'Z]H9P((6U"F:AR*)2=;>4@\<N68F1&JNV#AM);+40T"!4I2V.P3@(W
M930*K]J#4$2E1Q0VJU4Y4=FF<#2MM=\1XM_$$N*B65-903E1UDCX35"]&75M
MSG=17;>F"OTB[T+JNT4K<0RZH1/\1UN=9$,EU<[?ZIW@U[4ZV+/(V&/Y[21<
M>X#Z@7'*7UQ_#H5`82@\#VAR`8OY-)L(T#IUP';DMW&?8=G4C]F6B**)@_"%
M**6'3$3WL1%%NA-Y%3EZ+BZI=^K=0`0H(5Y6U&5-?$/>P)9-.;?Y%%4USQ!!
MW.\K8=P%IPN7+*K*ZB>(-E^<@Y5JD&X#1])84TP8CW6D0MGY.E(!7,8=;<::
ML(A4]_\8AVBX?H"%6V:Y1H!A@US>DD!WLFQ_?Q?N:Q$'$N4J[VJ'7*U5A-;1
M8+)MY"R$<*\[J>QS-)X.#:B7]",JGQY+O0IEYTN]%'A#FMCO-`19MA<U#969
M*=ALSI-W0^REUA62PVX4+M<H\Q^O*/&-?4>@H"DGQ'2(!<I[`6GSPF>%G-_M
M$NYOB9X61)\55-P-LQ?8/CQ><3S\;>^B]V;%S%$LL[*;K2UWK@=/"&5;D-F=
M2E>[&!XY^)@>S&XM*9-5\"2[A1*6!5E85U:1/6/8)(UEP9VBZLH"]6EW,('1
M(EGP(*7:LJ!*9++@%98%S6]=7$6_/*&VGVG:?GK(C_PNW,B/,&0=7%A6Z4=&
MGT@6#+FNK-*/X#@L"X9<5U;I1T"(9$U!25U9I1_!"U@6A%M=684?I^`X)&NF
M:?NK@WZDL<INF:N#"\LJ_4AC=:(9JUA6Z4<:JVS(=7&5?@2IR%Y3^*"NK-*/
ME">FFCR!QUCZD=I^IFG[?4:E$3_6C/A42ND[>(5LQ#8`ZM@HE5)ZC4;Y1#/*
M4RFEOVA\3S7C.Y52>@KDH1%-X0/]$14^FE#K3C6M^VBO<P:G`</JC`Z,A>VM
M=I[-GF*7"V+=-QH0>P"`EJ1G9_6IMX`G_!6":#ZP,JHCZ-W+UK,#.PFCUQZ[
M"W0ACCI]IBGNCV%8V(A*&,-;'4!_<NRU&SSUP"YIL:0QS'K!.F**7*#F8<^$
MJ2,&SD[1T/AC&WCJB(&S4S&45%G_I"/FFV"[*SQ$N925;AT1W[K!)V=-(X=:
MF"VUZTAZ[^R2R"[BCZ;46-,P[]ES(0L9E"+X8Q[W>\;W\!C(W(BLTT:YP^8M
M.L#_LDN0&=E92`B[F:F.D(]N`H]0SKQ)<YC!TA(1PIW9"Q%[C*(IXV]V%+!L
M(:F[%Z."$94WNH?N?_U2/B.4VSVQX1'1_.FAQ7P`#+5V-O;.2SX6'][WR]=_
MY@\GAV#*OO6=^U.8<!'W_?+UM^RI[Y#%,#$&NODVAB>)P[^]7>3>]__S[O%Z
M_O:=-;ZX&3[>7$PGSNQB/GM\>S&;+A[?OK7FP_%P\5\PF>\%\>W+:'K??TZ2
M[>U@$*^>'=^.+WUW%85QN$DN5_`P^7"S<5?.(-Y&0"KQL^,DOC<8#X?SP7S@
MV_PYSB#D-O;@6U$VV`S\A_+8?1^]2>'SF_\!;-C?EP]B$+-'K7Y@2A[^!P``
M__\#`%!+`P04``8`"````"$`M/<&*3>/``#!T`$`%````'AL+W-H87)E9%-T
M<FEN9W,N>&ULQ)U;;UQ'MM_?`^0[;`@>6`)(FI0]'LL7'E"49/.,9`FB-)-)
MD(?-[DVRQ]V]>_HBB?,T"/(-DI<!$L`XSWG/2YY\D"_B3Y+??ZVJVK4O3;5\
M/`APCH?JWKMJU:IU^:]+57_]3^]FT^)-M5Q-ZODW=XX.#N\4U7Q4CR?SJV_N
MO'[U9/^+.\5J7<['Y;2>5]_<N:E6=_[I^-__NZ]7JW7!N_/5-W>NU^O%EY]\
MLAI=5[-R=5`OJCG?7-;+6;GFG\NK3U:+956.5]=5M9Y-/[E_>/CY)[-R,K]3
MC.K-?/W-G<\//S^Z4VSFD[]LJE/_Z,%GO[MS_/5J<OSU^OA1/=K,JOFZ@([B
M\7P]6=\49W.?`+J+NZ_/'Q4?W?OZD_7QUY_H%7_MZ'[QK)ZOKU>\,Z[&W:\?
M5:.#XM.CO>+^X=&GW2^?5!<'Q?TO[,O/NE_^\V:>ONR]F8C-*?Q/3R?SJCA;
M5[/5?^Z.]G'W@S3"JYM%U?WRXZ/#_=]W/SR!.V/CT)-I>=7]]N/+<KKJ#91F
M>5$M)[7X.BX>E>OMSSV9K$;EM/A352Z+)^S(JC?/$"/3-.'U,-OP`$_^U!WS
MU;*4+!;G-[.+>MK]]N-'?SCY#]T/@X"\K*XFJ_6R1&R^+V>]97W\Z$_?G_!V
M\>KQZ7??/W_Z_-NSQ^?%Z?.7+[:,=XH`+EG_&;+TKOA]==-][N/#P\.CP_L/
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M0\5M%`Y_%[5D.BDO)E/C9V][$O<6Y<T0Z_A^N8&N;(PN>8^JRPHFCMF`-]5\
MT]>X-A<_9"3C8E%?IBTP=:_G71*<0SCXJ_UUM9S=1JT3<PL14M7)6GOH<C+"
M`Z.A@`K)X]WOZW55/.BYZH]_^O&G'[MDF;I?U],Q]N5?_^7G__*_?OZO_V(B
MLK[I;00R&MBXDI'H#A4,B'WW9?'1X0&FNEC@R-"F3?55\>EO#_<PWR:$]\/?
M*S<SY69]72\G?V6'RG4!:*AF%\A3!`[^RN'1_3TV4"9@/7E336^^*NY_?G_O
M=P\^M^^/OM#?]XLPY$3VFN&D1HT1^Y#AN^L[&8\1T'J.NDE5]R=S5&$Q0?VZ
M3_H&EB,0U69JQB]H<CU;+*MK%!SZBVF]ZED89#F],ZXN)Z-)3T-]<./R\+X-
M4Y.)DS'E`P8X![P@5P\+[#DP=CV1`6R$X7Q8&&XQ_2_P+6#&:CT![-S;Y@J:
M&8S6O4:6NBOL/=D3JUW?<*G9]>E,L+JOY,IP"^7MQ]Y+]N#CPS0//GHKP=F&
MG0-5*K<O6+;G.(]2DK^CUZ[>C:K%N@"%XNS9Z@(`4/Y29][#:"^#">^9I]-Z
MBANNG=0B6/KNOGQK8'7+EPCZFPD0148#4"-'O&T<U\)M[B1P#$P=_7F/6APJ
M('_DP&/,FJ:U>>4>P=4<[D^-IG(\F\P-<,L`=I]\/:^Q'@O`47%9CN1-;^+T
MW4=/9L*D?[5-E>^:`#/G5Z;7PW[:ERL4P3O9LKH#/\6F%9?+>E:$9Q&:[C/N
M"2=$P+.JN!L8=*_'H+,Y?A+4`7%ZLCM*^CH,T/U^>);N4]]7ZT$[W+$HQ;A"
M'<;%>/)F,B8,W#9,44ZG]<@`XKHF\#9$G5O:K2_"6?=<[QVBV"\NRA606U(Z
MGDPW8++NL'^L)E?7PFHE]KJ\`JZZG\WTO]BL^-ZI7#!&?U#!0V-.L3MQ74):
M$4#;JF"@%HTS-,'9DF/PK82;V?-1?.1$^[+S>DXN9&IXXJX]45R1"BD(;V:_
M$,*?NEN6WU:\N\*M*RM2CO^\61D2ZZX\:(SAXEM('WZM_8)6T'WN%L::/P[0
MX./B,7`?0["%M49E?^PF$NQ^URC&H-O/,-*+@)%.AS%2CG1\@]L"<1;L@P2C
M!V7SE\'V0S#I(:F)^5RV*@2>0&6#EBD?==A=V\`K=Y$:UYU[[WU=&0*+<!4,
M9*I?;!9(2O6N6HX4PO*M600LI/M4Z;$,70BO_,OR;;D<]W;]'S!%<9>0V]QT
MG\W;IR,_LRP>SQ;3^J8BI!<"+%YL<&<E*WQ!H-_E[;]AJ"+;A.ZP1+:CJAH'
MGS,).T#&H+,%XC$<E?,GK2##)J\7-VQ4K_K!_J\X]&TK<-Y)X8$;;E2V>#22
M6;>)<P\H=9_/V-B5Y?>^VU&=7H;E`^;JO0L2BK+OS#B1[!,%3K&V"MHSPKO[
MOTVL=MSC#WQ]5TI2P$1@G@(FG->E)R%,PW\!A?^&86^C_"$(4R94:22C5W6*
MXK(B6PEV1T]VF;>[,8_:@$E`([BD7SKB'X/Z)DO:1SV])VY;]MF<:)XU1X2.
M#?98'5)/7CTKRJNEUC#O!>!=6>_HQJ==5G2?S\2YJX>]=[>Y^>>7)'Q)5I)V
M?;LU*FNBD%(9$\NN=8D[20!FI3TB05F312*^3^"/3_6WY48-,PI(I4"@&;D'
MX!]5B#QBY4`)`UQF44>7#KGYXJY0VCW!M/%DM:A)I4I8%H/9R^X`0((E"07>
MY15>#QE7&?Y\7A^PFDTV,_,2@WBP.W:*-0B.:JT(H_1VLKX&'<=TWEPYMY"@
M%".II2RNZ_E-\>AFSOS%=Z38L-ZKXNG3T^*N9=K^[W^+'_;PS9-R$M)F&<(4
MZ<#)Z,<,_[-;GOD#J3<I5!$0Q]Y3_#3=F.O0VY/9@CV+8^$/)_L61(AS</K-
MQ+2_NU"]V<(TN4,U1^K!1%IV0'T%J9XU`2Q.]^G!BP.C.3US#I*F:$$HDSTE
M]HR(Y&.2;Z^X$U^XT^/3Z35A*ZFIMDA:EM^FRGC2$\_,[9AL:T6UP?7A$%@"
MUDDSVQS^CB2A>%]B]_M=]*@O?&]PD/+\C:YUGXG0:W>1;J,;BLBQFH&0[:03
MK2F'5=1<7)?4'@\FN,CWK>_)9`ZR?@\/=H."77K:C(B0T!C9\=@?\&:$FK>_
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MO\8=.R]G;.>1/ED^`7?X0Z\F,Q;W??6V>%G/RKF^O2QG$\33QK#'/[%AK9>I
M+Q5`[:T4'!W^X^>_2^-.77BW1[F28$76!'F9L[_FHJY,"@&E);Q?%]=4[&F3
M@I</6>L(]P1CY\4+RX%\FJ0L"I%L[4&SU*R'ZDQY1*\M&G)+.[-7O*4801`&
MS)/XR0%&X35)D_X'8=8N7RU+4.WZ&I%$DI7_I/:YM`B'=#_&$O*0K2A7+B)!
MM!OI$)P28D0SP#;V0GE5J^[@0JP1)O/KR<4$>5WY((D*5ZE$2QQ)9%#DK8.(
MAN]5T1,Z1!D,3G\[+=_5YY2VKW_/JK#M;,:WY[_W?;`A5NOK62F97Y8+T]:X
M[.Y0)^04RO](9#LJBY.'-E+V4=Q9E!#"T`MII=%F:*Y<W,1Q#XH_L@62$.U#
M.7X3<$C.^:QZ$U\S2*KD,,^OP87!H+DJBX&_VRMH?!/F?!"9"0*WV2P7A)(:
M2P8M$W9Q3YN8C>LFR[XH1^68`&?$N."J-9*@RIVFDB6VFA/]@LET&ZEA"1(P
M9ZY,;V;KI/^_Q-39@MZRPY*I8,G9;>3PE/P\_3+S2:E_G6RN-JOU3S\>/:":
MO['LHD(.0J>J>%338E05WY$/>I>[`V<?&N(8PO?2WH#PX`>V^Q(F/<?B6J.!
MSVNT+JLNH>2AE(PUY:&K\O"@[;FV6+7SS<5J,IZ45CG?Z8TSN+!83J:T2AY^
M;IJO/9U6"C;%BW)$)G]E'0B"%R^OH;1XZ$)0?#N[^,Z$W#Y&O.7]T)[(AL<;
M!=%![(NWU_B=FWWZVQA[%2F]T48\^M?_0_@T'=?+R[WB6QI5\(,'].,5ST?K
M6CT9]!_2S@G7U1K*ZW$&BY%Q0PA;.=TK'A[\X4"^]I:I3F;XJ>6XG.WA/B1U
M8-0Q]J3#K>/S#;X43\JBSR=7<]J_4-AU03RFIBJ)[`N:S-3ZTGES&(7L/ER7
MDN'Q'E*,LW#AA=2+0JHE(78BY95%U5G=/0!!7`QV-%;@6S8T=I))G>F9\7J"
MC-@PHV'*07$R9;R,<Q-55@/&0:RR3(F5MA1FFL6@'=#,`=W*\G-8A&OJB:#C
MBG+&=$(M&AI!KRKW2D+Q4DV[W]!2>GL[S-&GM"BC.Z%?[8E'%_#D%"_H\M_A
M[C$VVDB#56J60ZBSY3;)*A72`A*;5_+FK,;@^*6ET3IU:P91OZ*8JS^L6@,S
M;:\?A1:EGWZ,/4JF$]>@+0VXY\-FK81F?P<#:\GU1T=?/#CXK``V39,7\*X_
M<)2B8\"DH!Z.'<VSI:XVETK:LC4^%\('I2,WVS-:+(UPY7=&$W`*/+&5SJU:
MLKY>UILK>@](&X%.\5`RMM6[=4$_-]NN?NX$4C]\07-(1#Y!4ZRMSRKC14Y9
M;*.P+RXQ_U)JVXWJ';!#_TK9V%77_FKSE<,ENL3N>T)L`[-J-8M"A>P;W0V6
MZ]78YN]X#&A@FFIN5NO/W;C(Q_1M:*109@0"6(DDH8^6K+L'+@/'E^Q6!(_[
M#_>*ZPUC-(B-*@=(0H9SRU#.F*;-K%PL,&QF4-R!._ZPK'0DJ,$`9J;KI2IS
M+49<8Y:RW)$)ZJR\8;\1"IY<EH*&$8&B9\:E`_IPL6MZ4&TEBJ5<9@2L/&M'
ML\-$T,G(]GX9VRJ5V:Y"^Q",_(3U7FZLF+#P9F$^P-.]D4RGT!<[==Z(=(<:
M#6LDUPK.FXY;Q5`8,'33>R[P5R`CAD>PH0Z.7+(PU-"FLLV7)Y\S3.K:E=?3
M]CN)/>Z,<?]$@AB5#2O5@Z26%U87T3(VZ!GB3G;7OFMV/R)!42/!\31A+F,)
M)+^]5L(=Q5Y5U0]8_H:_V&FY5**/KM0/6\[7;"2"^CA8C%77@QV_@GZ@*[C;
MW10/#QEJ\005D8N7&385>7UP?E#08ZIN).3<V8X$!0>B+6)3R=*!64CE`S[L
MC6]/3EX(=\!!K#I62GI%V&VI)Z1O5A+]$C$[FHBV+H@[!=I9J)*;\2L]BZ1=
M(*F.]U=+]8)>)N@(VPC9MSLA5S*\GL7X(AMQ,#>)JB/]D$ATYY(_GC#A$AK9
M"'2794=G!Z,3K=V].7Y2`R.OP+AFPT<WQ:NF9:3CNH;W$9.F=9!@\QR&FHIB
MDS?#P3:TP(5V;E8L_S;:%W/S$9%E,&_/L2.N#"8L96NG"+@GO8,JIV9LC.*\
MCHX>#C.VK<S<K+<;2Z$,-R@=H6V`.MOYL?KQEBL:C<1D4=M._3%<%;*"KH$7
MX82`G6%2TV!U4+P,W7Y&6"K5=>:4ME-G53*G-87R-I6Z\YT`LU^T0!DM2NL=
M-#L45X#[Q6+$IA[$<`GFAGS;=ZI>.L7#`L-?HH/H8WG%PM%S$I$`%/[F"=0B
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M:(7"DP5W``QZB0+Z1`'LZ(_'.2@X,9^,G@]OED9>2=J,U^%IC+A:=_D+U%=.
MUY@T-Y,&>S,D?E`\:QS0F/`:'S<7;)936>"4&8_Q@6V81`LV#28B#L/P'=KT
M*AC=?&]<K&43G`MR32O.-ZS]Y`<KK&["8(ZU]MQ@7M48L;DY1DS9'$/?G#(*
MCR@)L]H0##??V#Z2^#6<3Z"7MM$HN"!0PX2*1%S6FL..IKSY]LB(`9+_'!"T
M6HQG\B=FS'QTDY("4_B##3JF)0`(U:RN5'(2RRGDDE&@W6CH0:9Q"/`[V(:+
M&W`33%-7P!4+7NVE/PD^YC_@>RXXI,08]IBV$"S".3/I^:XB:K%2W$I9:71+
MX:Q9F"BBQ0(2+DDB8+:Q5KWS7*[C\6,#\!NXR;:Z_0(#)A/DSS:>U:.UC`+I
M2HO]JTPX<,IQFG2:+&>A.1S:7-3DC>!=-GT"*5R;S`&E(0NLQ^L+E5^$C_>*
M"I4!4HQ9_FB-LL+;"=&6_VL/*1@1$ZZ*OVQ`1`J`=-Q-^J6P4K!B1="/3\\H
M^BH^')Z")_Y:1H%DQ6K7'`)B$/>&V\G4,T';P2?+VEKZ(0=Y:=82B0,EE$Y:
M$^:Q,&FDBF1>DD=W]4$CBJ!\M6]T'&3+4>7^YX-]N55?%130^?#SW_X>#E3=
MYA=EY\:6S(?5,-'.3-&[0?RB0M2?-V-A#+=HSD``,;")@B_5,67'P"WO%9U\
M408/L=',9D@$K@=\I=!/`)3OX%S#M0)@C3_.4@/&53^22;H9K+AN#.:,G%X]
M;EE;84S+P+SE[(\)8K9BC97),S,W6I(383)M;[<Y8.%OM.=RLG&2,C)6I`_Q
M#KO3>(2(N]TA8!1(#9G+1H(I=WS9M3S'/_WOW6Q16+*6F2V,8I$GU-AS*I/6
MSK-1(1%#[PWL!CIHAO+,EX%[W$23J/FJ2]%P2*%YQYL0]B%'N>>546QH6NTX
MHK^UUJ9+^)3P:>J3*2+.QI7XIFGU/-(]0?Y6YDUP`W+O/W"P#VU%MF4V+.HC
M,M:15+G_$$2:)I"F1K_;[+RH%*'PV$B^-,`*"Q9UW@4-,JF6K=QUE9H@N$(Q
M;WZUET7,[%?(2&HY<]"ZNWA0A,%A\[5&(I%LM?S*N+23N.@E>6MI8,["&>F,
M';W?J]IB*'`0JA:RAI:[G?-%IGB9TAF[FR1OU&CXIER>QO&M269G1U).:2I$
M3IJDPZF#BY<@"N/)<QM;_W0C_)KGEVN"!TL[[\0Q\*A[87/,8*SB0I&GSH^O
MJBNA*JS^]00/A\")O53F@Y2X\4U'L,1SJFN+=E-`R/R!/9@IVAGF1'?"^!W#
M^);4&:(;:FW^9"()9T;F0X8E0`?^8E.L^\Y9X,923X`MD&ILU(BM/R,(]TLB
M/#C4?1"]0/"+![^AOOC%;XRW#S[[C58D0E.BU4IRB*L*0%@>L>,U_;#\ZUR%
M!Z!8'M`I4D3E>&C)[2/@0XC:-E2J&9V8\/>C5AL+JCG,^\`)/#J$VO9\@5[K
MKU0;N`109_=AJ*P$Z1#1.D3Y`*GO'R41O9.D-14)55B7&X]R3'<Z6!K[T);[
M:$DD]WQ)Y<CP%9!)'1.LNANMR#<-7CH@<PO*W'@.+%XK$$KZJH=1SD/.ZV`]
M?&`8EA6%`?G]6,3X-SPGY'D2,(M3("/5=9E05HY-$KA2/!@M)PE8.XX(.:H;
MR:Z;489Z6[1;`^!'37"#D*-A`5G#%4F<3`'^$:P3</H`JVZAW%Y^HV(L$02O
M-I@F;X_]_Q6CF<&5MQ/^@D9DALVE=SCD3/"N4MZN:&Q?[XY66?F_COQ8EX.\
M)V4$:,`YS]_4BJL-C]K&H/@3NGU$4=PPB=F`,.:\=>-A&6`+<(5CB(3JM[)J
MF>%LD!BX>66X5\_;S(E/%";`8FKA0CRZ3,M+?\Y`M]@>LS9B%:`$XANC4HLC
MQ'<D1,L;6-*.G'W.V]%?.':)LUF&`6:F1+*KU!.NW;#]?+3<7!4GV3E?-E^Y
M]">/3BR++D,LB*/T\K*Z4@^8NLPL7Z`*;0!`(/H9-5Z=;UAQ(<G*`BK[T)S(
M*T,$(<@"#F!<@89\A6*RZ5I\EWQ9&'36N<-N$O\F,!87A6]D9/P871VT[A-H
MJGAB"F>1I;(KK!T#46^()&P_2T%"RZZKNP;K@?L.+>HN]M%E[LAZ3(>-RVD.
M!<E"IFYS^,=\8]=*R`!L5%J3K4)T?:DXZ.F$/J?-:%J12QK#-`EIZFP*U3MM
M0*G2\!4U&TPXH(;*(V(;:H45$"D;$DY>3I98>:^<&%16_\\#MLQZJO:*H\.C
M+VRJIGCD?(SI1FU'D-M$>)N%N<PW.763X0:2QV4VT_@"DZC$`^$#<$A#.?X+
M<B&!\F9";7I$FL`=8W[&#FT!6KHBI30E5Z!"K&$ZZ5B7WYK8N,%TH'O2,T9A
MJVBVH1T4]-Z3!I6!.]Y7^2HDWX]BLBG\M:#MB5$#<.B#/+(A&UPZ$;>'RFPS
MG58D&66>S74A1NM:G>UOF[8N62)>F"/<VN`5Y?_8E9?3+GK(P9#-Y<JDU;50
M5"OAF#8B-K/QS(+!8/DZ%*OA&O\BU\(U1*@]'WNG+`1K=:$>:_XWSR;"UVK^
M9K*L+;L(L<%T.+$;%-_!MNFJ.W]9/]55911\5FN`-6KT%]P(X9X%&,6;&E/D
MEPYH:Y$72X)`KMR'=E8N(-:<ZPOWZ$VM.Q6"N]6TX7#VJ4[>/#5D>.+(<"?H
M]F+P+%'/ZRE*/*#BLL`5A@-,@"EQ6*?MLXJ6BK4Z:D\3+P&'ISP*P2-;+5MM
MG1MZHR(=!<\DT_!'O&@0;P"WR@]QLPR.!VX9ZB&3+?[;^50C,A:;D&;Y/5U0
M062&K%K;RT'Q5+W&%GMC1#&VH0J/O%LO9]B9<#V$-$$J$\Y'R5I&RAN<3Y>>
M"8`H!OE;&X5Z1G`5NL8("ZEO;E^I8_<0?I&-)ML0DIX5-;B=-@[MII(WM4*^
M)AR1!+V1!ADP$4M[*#_382CO7'`A8JAEBQ95&(DL9.NM-=[,0_0ZQ6BRI)"'
MSK(1]I!$6\<I%#HI"SPT-?.-U;A!RC7E9>D^"*?2>#'T0S2QGX$[:T.2.GE-
M`4E(RXSE[JP+P@\!A%2']3_89J1W6S*G?<;1BTDL.3,[@",8@<A%FAF$)<D'
M3VCP`Z!;#PYFJ,=@$YZWW()&#J@8Z[8\Q)+-@>Y,MIOT`D;[29.P1@12%*T>
M=33%@J"F7)RW"#7\28?[8"-K+<,Y$AG/N5`,%0BS?Y(265S6A6TBA*3!).L*
M:X!F`IF2RH1I@HL0UF)N,!&=$M[$TFP:J[16@13ZP?(4E6([%EF;A=35KD]K
MR4&SK(/B>V*UQ'6S$K&6I#$[\NM^UM(Y69:&!)]T0DOW[`!$J"=1B^^HV?%S
MY/@JW/:&E"+16!H_`VNH2'+>-*3B#@#OG?;3@R)>%\>A1+O=+L0-GF#1/4!D
M7^(J@BMP&Y.NF\'4]1=GDQ$4FB6,CL;,E3I"^#QIE8M;8WX::4/UP,7`/#,3
M8DF^A&BJR:][%`3?LN4@"?+XC644!I#1:NID:`Q&0!TCS:YA$Q$5SS*%\-XV
M4IE=MA9Q5"SGYK^A-'X2#R![#5\;254/(JR(SO08J8X]@'7Q;&?<2NMYTFJ[
MCVHW=%."OFOFQD@FF=,"03+J9).7DQ=J0D%<16AU8%(;1`L$PJE/@RX[I8UD
M+FR]046L(H_ESO3<5"7"1$.&RM0U*A52:38YE,H[N>42`WDT3.!ABA?=X%-\
M*REBN*\'>W2ANH\IHJ1;"83(6.TFV<`.1=VG#($BPH8ZM5/2B\CLG'G:>A.B
MW%6E!Q5*9)Q66)+D!V&&\V*W?XP^$!#-).1\3I)\T$.U'=-%M7ZKOMQAD91+
M<X?DRS5M$&RBNP'T(B8Y<1B*CIT8AE\O11)=EB])%="2;6'-3B_*ZJ3485`1
M<37ZMY"3M'8;B\SCA5XX((ZW:/O%J,L*9VP/J;AI]4E][$V(B@ZT"6*CC(N2
M3J3AA)5XIHE-)`A-7ZE]F4U)M"OC.71'%S()*;'%T;S-HITLUD1$%PT^3Y#>
M-T!N//BE@CL"UVJ:4[0,/ES*E;,"<:HUC[_C)W-,:6A,4[$CVI-4JN*Z5]/$
M+[EY!A[APN/Z.:!NWRA:P%"11IA=*-32AR;H$HPLW:RQMS.!FK]?*D"2D@Y&
M\#ZJW$SA\2)[++70!,U7^K`3-VLSPE[:[I(1KF_HXS"KWVRM?7=0/"[1W(Q?
MT29E#),UBY!1,5MCA5)E$..J3FFWB2.`C/(0>A1]"&X!TR;5Q;L1]$<[8F99
M0IM<A]!CK#<R*IE$)3@8!K-U06@06E^<)1G=[/.9VF'&2"KSA@'35D31V`];
MVA((C[M.Y5C(RB04X*O)YX`YH9=*HAJL=\XI26MD%<D9*Y*T!L!P.I!H\\!]
M6V("S0MTWMS\55MI%J;1$BTN4*ASJXV<(UZ6%'2JP4\2.56[)9)>=ZBZ>RU%
MT`[!.`)I/Y7G&VSC1C'"8@`.S;ZQ.U$%($2S\+)%)=XMC*]7;:LE^6EH,R9R
MA!@Z3M0%ZZ7M-C^(!B)IO,KM3W:O)_E1,F"`*?=&3)3Q(8+IP`-:8!`M:[`6
MW('.9,\LD6(`C\LRD8]J[!ON`3537D[>^2O1O5H,H+V4%0-LQG(LSZIMB(,Y
M%V1B+-?7!X0Z@3MLZY_/BW\FO46^@7-25FKR`T#EF!NL1`$K5%8B-@`&O]54
M24Z2A*BZQ#7WW&Q5/*QUR8^E-D_.'UIN<_"YUPL!#'OPY/RU/<<!J0?[JGJY
MQ\E.KDXX?1I/K_ZZ9T>/GP4KO?^HD5[<G[O!DV:'PR&DC*A_#$'#>Q5+G)R;
MTTD':6&R:Q%>9JKH1G>A,*4RL-G1:/.)RB,@T:OBBE,YG@^:)V,7+51;J4W*
M.?]0OS5%:[B36<9H31UH&J4JB"'IWIJNZH"5^6+H`DN;0[/#R]?Y>JY9(L0R
M78CNS]`"&JP4MMOS:`VBMH1[0Y7ACM?^J.\6A\`+!B%0.[03WG5UP7@4[$=P
MK[!2!CT#$]*19F!,!U8CHF#WD!OMQ;`!DOHZ)&=Z,2HZ4BR+4,-E96>>M)9D
MIE!+Y38$5E/DF8_.W[0R*^/D$FPV(IBXH-+L@W'18&BZOA6JH[U)%LY7'T(J
M1C)8DN489+C\\(BH-WTF<G<_(PISPAJ3CLME><+]=@BRU4FD4P.`6ESWA2(N
M06^5$2(6\M4Y"WP:R'8^:`O)G%RJH>26N:,BY:!K,*EKC6V6TB9\1+X\-FI2
MJL(OMZ&HEI#@LO)4?O2#<C`I,0']^0;`3R4]U(+#-"8=3;N`.&O;#!Q.H@%+
M>]@O.K6>X+8U`E^E&:(X;H6&3<(RIB;QQ>K&#Y>&"%+Y5!H.+?/+F/B'7'-2
ME*CYZ>=&AK7^M(&8Z%)F0EHJKYE`$NJ&-;@K_*9X7JD].PG88-BV,@"8)&A8
M`QHEJ1\'`!5DC'^YA&G\UA!A,I3LI/V%+O86)!2HY`P$,L-E`N4;&0`52<(V
M-JUG2OHB9FPE8CZB!>WNY-Y//S*?0X]\#8W<X>B]S&[J9HO/S#`K;%DW@RIZ
MR*F)[59Q"7M,&>8,3ZAV:.'[1>)JS,H81VKB&3:9O_$N:V&$T'MJDZ@(Q'4<
M?S?<A#`0DX&7>)X=B>V$M':C^Q:$Y5WSM[PO`PB=(E1]D[[7`36%=1DL1VP9
M4;1EQ\R23;W@7#6].'Z$L)EM1UE4U+;%N71\@'HDS`"%&[*B=GC"(7H2M!T.
MZ[YY&:X-IVD6C".R.K*<%YJ2&*YRFX08`0L)Q90-D/`@=O`@O*A%$['JUI61
M2`G5'F;J2%DY176;@E&,>A2#6#ZEF3QU[<6MB")IO?*RR+F#9::.\I\U&X0Y
MEFR&`D"<4VP87K?%=<:F!'^<D]%`H'Z9WE#"9"B^\VX^,<@BID;56O.\K9>D
ME5402K%M(^!=]66,TM65WX":<["^)_=0%CAD%"<&2B'N7H1WJSG%"7X70;L6
MIDBE#^=#"JHP5Y559O2_V!C%KD'FW>CMH&(?2.I7P4`0^[IS(+F&"2#<8'$+
MY<]S'Y\K*C*8A2?!M^!']:*L87=M>C?H:G`<PT$M5K>];ND:;;[3&Y)J)DY1
M%$P+MXB1"TTF*4)[^#(BFG1RK@4M&B\+VZ-7C:=?HU(W?DE'Y[M:PXL,&27"
MHM\D$CM:H6>]=`Q\5+$$7<Z$=ILM::UWO6]5E'S_DDYIO+1B`65ONK=Q._;)
M+RM("W$W(D4+S#0/D`HW.21H`(%!;<6OG%$)OA+Q2`G%2(J!H41C$T<#4)$*
M9"KN2T8Z&VV.TE&)9"4#9FT0E%JVYS47:,5@8\>=^3#_$,RL^5#=HHA&<!--
M@%'F*++=3![,A3;S&5XM"0J9-CW?4>Q"YHO\&)W)Y=#X6P1>FIIHR*3?)C21
M7Y#121C0!%),#JT-N1E(60K;<0WL(49GX[9M]`H\O-*O1.VX*2^%#OA5(,\H
MMQ/$*1_3D75;E;*'$D51F`1.X#9I$-XRY[.L%\8C-E90H;)7-^1.Z=?Z,'*=
M6L^2<E]1-"X]OQ2LC_>!->&*G:=IT(J=@&XLIEG(I!]%G"5N@"6_O)R")V49
MDIZ`>^"CEFF/O&]_?\F*.XTM!.9VDT`X,A>+!&W+A#B*T;W`)3110+%03KP]
M1.2C1'J#.S'D<4U8I>K:;3ALP:W5E$]2"XM.4:,:&=-<K%K%ROC3'#&MW?Y)
M#XR.0C-%LC$W;R$X(F34M,RBK;3PB^)WYF-6T'@$>>%'1XK'WDSB.T<>;DE=
MLW=[P'#T]1+8-E@D2;P-8$J*L-*]&U.3C_@;)21L/+D1GR<ERP$V$D'FJBSR
M`:S%,H\/IFU(X;AUYAGK<.QM[=5.8G&L#IV[>`M0K>G<:0\!*T^[H<'L*4;0
M-&EFC87)]PL<K;EIWPVK4A3Q\G9E5+;PHPF*PTHM`HQ"AV<*-QHH]'`W9!8X
MRQ[[I0072"7!`R+A&6"R6T**^A\S/<XI0`KTYNF+F`V+E@)>@5]U9C=^8J^D
M?R1'$5(P(<607#AY#;E>LFK\V`\.)$_KJYNAE8H+-Y<T4_D*FUC?L8G_5H2=
MU!'Y.:-R_559U74V3(H1DM6-0B)M#F9WP`FH55!^S2I0`7),2$8K4I5>HOKA
M9;J+R)]L0/JQG\]E+;.B`!A1QFJO:HE++F4P94$-D"!!;B#$5!YKA'8W/L]U
MNA4`&4=P)/%@+E<6T9=JJ9X]$18NHT@K@>ST=]S[)M3E9DB<7.1_X3<>\8H,
MMX-]@L47T8GX[FAA<4AUZR#E\!F0Q_HY"^?(-9C6#MP;>4=A@'EVM%1*J":X
M:K[$Z\=`9L&"X!":VQ:SA2KU:&$,=CH[H-T.AU&A,(1MH6@:S9>TH?V:RXQK
MK2*VD#9,DR0!,K&V8R>2PDM&4@9(1G*,J-$.H)_ZP"TT+`^G'MKS%3K]8;B-
M8=)7;(I;G=8U?%9FDKY*(.QJ+0D6$M'L@&ED;+BB9A4[*Q4N(/'-Y2R6F5'?
M#%D8<8']4J.*+Z191X`?+3*BXS,TC`!':M@+3,I41^XYUX'4QQW6@1*!=XM:
M0FGN<K.$=F\#4T8NTI$-YB5\R2E,]3JO:\9I*&AZBK>U178':KB&.WH+A;>0
M:6%2[&)J+A#I^5ZV47.VFR?\\D\V4P(?Y[?TF?[#P7ZC#`XWL02]=%G?>G-?
M2'L0#_4Q(9;CUMTA@#^[1;Q95U]*M5VAL@Y%GCB/YZC2;R+NUJ=QKE]FV7](
MN^;8%A;=5+<;;-BU^]M])Q?MLOL;^_&7_,=LW(6:APSP1)`IKA@>"$\AKFKG
M\*@K::0^-T1CG&O:E(*GG5'&W-";*DBF;;28H5VU:'?D,C#/I+;69F@=_9>Y
MQM"S+4AVBBH7&&HPI3`86W.)JV5&PV082(5O,?O>2KK?2BKRZ=R(7`HIO*AC
MS@EO?%1>U:X\VE>A5R1RU2^02:#3;LMI\+:/J<?H,T4-WNI`+/]K:PG7)M'H
M39U5PY39\8=P5X=;W'?&RN!HE'F1TY/I8+VOS`*E#P21=2N+]\3+YF"%P/T<
MZ8(L]<7+G4@UK=4Q([#5'Z[*E'9:YB#:=\>QK(-M#>;*C,.REO]C],[5YLXD
MYM(Q%ZSD1:44NEU(>^8NV>,>XTR6YV68B1T=PC6%.GW#(XAB*+N:(,FK2DPP
M2E'-F_!#OX;S9>J\8=AQD'+ZMGR+#7"'CHF(3L3]P9$C?V/?,<>Q=,">AHX1
MB`I.?IA4F1C!J0!)?/W<<=1T-8OINXWIVX'O$471T@$5,^*:ICU'&8B+%^3?
M4ZX!?7&XPS=5!#V<EMBH\Q%MZS`Y[&M;^`/&F"DZRNJ*L>%>)C1J96!VVC[J
MO:GG>,"*H)IB=$L]W0^UR7(E'&I6";J4Z8\Y&"M;HEJR*T$78V.->T%53W?=
MC6`W\HYVO>P?FZE,.F<Z)0KT@-F&ENIYB=#@G3?&VLK=L,4S1M%22X"S8QU8
MH):=;D[AY4^U&&KSP\Y6+)T/B;%+W'=BL3!J5D$26F(<+$L7L#5[*V(#F]RS
M=!4AR'(<WYIIEA40*'PBP3%F#$1UO*NX//8`A4RG.09W(,@^8CW&F2AS#><[
M^Y&D0%L2&MT3,\6"C)FT9:Z]@\]&\0.AF!R[)?#*S0F8,*MS`CKBTBU183!%
MEOF&#D\W\K*@7)2B*U'L1,?HAF-N=,0;/G!*]&#"![;@KGM%_PU-<ATRX9?B
M8UD&/FU66Q-,Z.S,<]:4RY')>MN=RJ7YS`U/<(P=;FAH9T%7CD"]I*-D^VEJ
M:_#%D-RLJ*!66_?5C=P%Y5M6@^O3J5*W<XT,<7*-6P;M:(1-ZG"X\;E16(EL
M_+Z0\,*N1O',+V%Y5;Y#\G<UHRI#;(!"VA2D6-72M0V0G:&P+E_9@]A&SX%J
MNYE%'1T(;*A>IRX2!I#14E=D_I;EJ_#WT<S"F22_VEN_*5%M;_*7WHML>YYN
M[VV:K\TZ,0T#L&_H[9;Y?!5$!^;_19@R8V88PB%'+5RSZ+"#]KVIQ.?T"*?D
M$JHD)DVO9%RZN3L1PHD%#6DWD4RN=2[7=&J(0;%,+L/`D%(QA<DJG5KH:@W*
M(?T*^1:.^3Z9N3`U!6WZ#ZD$[?0:)Z^K^N7'HQ5R2RN&2`!+Q]"@N8O8=DY7
M+`BZE!LT!%VYT(%8K!,E.KB^_;:5;3/98F544)1T.0WK9?_Z%#B.$PD]4)`N
M:R:$T@5,";YK@R\XDW5I8=[6@6%@^#DK!HCA5&P?=TU`4;$]QH4LN)2!]D/@
M:OCP6Y%];]<U/^)^"S&V]*PQ!_L0D!^62R+(??/="Z$_<QNX\*L8HJ3P9%HQ
M`CM$*`],$7/!Z992X_S1%%T&)8AO9MW.0V@#0N1O*^YDE"7XM+Z;P$D1LH12
M8S)0#WZSP^\*]3.W=M'#986!@#-26()\(J+F%?30Q-MN[(?M\@E#DVA7L]&E
MI>&V#7\?&3F4`;/W=S)\+V$U1H\LM8R?W/8+FMSYVZOC.YK/[/6F*34TFT+3
MI_N']SMV6!VRQV?SXDEU07I<W;!ZSG!$\80>5M2*ZR_&!6VJNB5?(^SI#GY?
M5-80^@_L4GU96=X,GB`5,:$,P\)=AE"G&Q/U778]Z7/LW=+2`\WUI&?F3@[H
MM^V1_X_I9SW^Z4>[<%K<0V81.;?#"V7+XJWZ$!YC)>0(Y=_ABM4##:R3QV^;
M!M:$XTN2@,@075UH&^<SRRN:S^@H=Q#G=B&H.G-;DDDP*2E>K!8,W.P:<O0A
MU"=E"EYW]&VJ%/.?S5$IA9&FVK$SUDXZ<@F`\@\L5UZI21LW@US6]1J[;`6\
M1O1DY-U+"I+*+K:N#;I(/W%57F*%,OMU]%N_3LBCH-.0C8O-W@:U\D;@H=;O
M1*PN/LB0D[3"C(F68B/*SW&-@*41S!W:4880`+O7:Y8<+T&SN@WHTUQ$FW_-
M>4JQ4G(MW\=_Y"O2C=%]=7B?*(5?$0_FKW/,$A'"Z2<6=E-TK;[EXR>*1O]`
M(U-5/&NR6;O]=,66=SMV:DL;OY0@[J9W(&+!4V@<V(7J-9X-B37HX[=U7,CM
M9RW4J([A-HEM[#6@I#)?72).NG,C'C^X*R5[!^RP`.]>%&7^I<O"<2\,X)&]
M?EU'/\FEBDNXA4"":])B.)9_-./*`B`B.CN#0[:IE3A%HB(`#6-874=3V>%!
M5Z0\DZ@TW('MB:?TUKI5@6ML<7%@)W/$X?&<8;,-PCTKWY'\XE2(:!300L6S
M2RK#)9?RGW:M:N?)S;SWK&L=XAA]&WIN)R9`?RM:#"X@"J38[!L-K=S_.+KF
M2(QE><W>Z"+=J<J[IB).!1'T90:0_5:2]5OT`O6(\:0<Q(6J((951;<6AO?@
M%Z4R8N7T0)XAVW\+DQR0:P:-DUI:>[<H#N>?GVH)Q='/?_OOSQNBXFJ\.)HN
M*S7A"OU$WLYK]V8YFE&B#\@G*..A329(1#8[7GCHY-R'G#._8]6M/ZR8<_&"
MD>I\T7H;-G[HM:MA)9+\6.(:I'KO@ZY>E98YO4$H;0?;E.J9?\C-JX/T?\!M
MB,[=3^'\ZTP*L23MJVYUJP^5.H28M`X7CI%&T9*L5F-7V<H^<&21]B*3;$18
M#,B0O6"`26JC8,%I#RXA))'8*AE''603')6]:T"%!*->6`NYKDA@G)@0[(5&
MPUH`?.-V#PW\;[;_20')$Z@FE\[U.=8:-"N20\6$C1\.K+AKSC:[6=NXZC;7
M1F]N6;M'SL$J-T3(I"LRYL(0N96P0,\(;`LJ;7PPQ'V:367%<1/LX^I>SYH<
M!VWLA!/AX]X/T-O31,_=QWLQ7>^)9P!!75!GPF4_F](=XZ/N!_O=#WI7ZA',
MM:[^[K[0(ZNW(!MRX*KP[DC/.,CJ+KC9JLXSPR+97[<ITO8KX*5O4C530&L+
M7I9@)O=V,G@2;_\5D%!6,S>-0VTN/^7/YK9%#486@I^N1IG?A+J,"4@P8!QX
MMWX%-)%'R*J$BPI<N*3C?0A@`4@JWX2J!M.:28B@D3-IPAAN%B"P89TP5/0#
MP6IDHIX<]8YJ;YOXK?)*O]Z5\+8'6U31LVU._WT6+=-J`;WRG;KMBATSZY;;
MT+AU`::U]@N@8O##.Y@;K&LE7T;6^=GL5ZS"I>/YB(W;SIA,7#/7U1QQTZT8
M)^@5T5Z0)HF<.[S&%<=G@N/(76PV@U].A1>Q!$=L`2+R"3U"G&#6K>,A<Z>?
MP'S5U`W5];WPF+7CG_/9@@D5A!4[(_'PR^"N\=%\FP5%=@H8F,N#@:C^DD22
M"($]OX8$WX_!ZDX2?'SZ@3\QL9.5@:L-9%0\J_-:Z;<`Y7UH&M*O6NSD@X(T
M]JPG&1R)RDY^A8Q*N$?ZE()09Q''KYO?4_Z6^TJ[,5W^_5/[);KN`(]77E$9
MFZ?_Z4<+$[L/B=7!T+67WOO%:#W9??N5I3J-:UIUEWW=QY\-7SX;=2_]1D%O
M[KN?_:X[UKWN!T[+(&!HU#M-,?RV%O`A4M`=Y>Y1YY-AAR=1I#JTX8X(54*P
M[H)$NY+NKD^AB%+Z_#A6"[YTP_?CMAA88%IUJ#Q^)F(L+:1+-ZS^@>F@@-Z3
MNO"DIWG2P[&O2`&@7175F6"8#:30W1_+*?XJU^7B5LPS[/B+)CM1R6;!FICV
M2;4*_RTB<<F4SZW[FHU59[RV='@[@_OW^[3:F9ZFXM*Y@=N/F00I:1`,%@S"
M(I#`EN,@,RX:2.JIEN7[J=\HV)[C^.QV/TE?/NZ&>(/;G%U"^<'6#I^.R9!3
M1@V!SV,"E87RCYVGAO=\^-7N##N\*RMMT^YBB2TA0=8AXJA45VWK3A_Z)^7Y
MZ<?7=NEB9Y''3[G0L/M9RRETO[Q[-G<5Z1FP9^G65P&CM+[N`$_+B^U?*B7'
MI9)4RR-[NJ\_V?`KR:;M$A!ZOO5W3\V';W[LCG7BZ0]D&O1"JKMO+IZJ`)JG
M0X'1!&CA%DP347>"!H.[X]\]^MW>IT<]TW^7I/+GGWW>>7I89EJW;G;G4VE`
MY2R51%E!(].)>W83W4='^6^3\:_TFUSF.?7U3S_2R*Y?6[7<N,S`!VFXY:#5
MY@8FFPXHW%ES89_S?*>U]][:3<VRUP*P#.J#B0%/8]?"[?+MPQ$PD'(]NRT@
M0#931Y!`KU/;6;M[UO_%**1%9'+TT]0(!Y+:NPG0/62\!5GZ$(=WX!K*A6*T
M]Q]X9B[\"`+/KCEW;?F[[\@A<QQK6FI'5AP9\R2BX;\X)O90D!^RU"8,,/R!
M.+RIS`2;S=.A%B\[<LWU391Z&.<A\>"(D).LK\C>LG:GV]U$^%GMO\.LYD)E
M^P$2N^J$Y:HWBY;-AJ.A[A]H(,%".9>217P^S4KX\"+]0!HEX70S8LA4PC'%
M!"25TF5R%DDG*(H(`XP)SYJ+:$-G!;&C0M?V?9SP35WX.BWLD0LL'-JV6Z3"
M7"OEE("%8WLM\U0)P>;3B/N7BG),Q0ZX^X>S[R8)'SISGS]&B_J:R`,DBIH@
M7S-VZC/):Q_9F1LM(H7T`^,SUE^K)9>&>&CV'C.18@F/*O(?26R-<`M-'4MQ
M?*J[?;W@;:WC3T-E!2#:>738H-[R_F[F)0Z`SA@!L01C/4$&AEO^TXK?65#U
MBUTYIU%T4L18&ILB@OWOKIS4WA79_6W?$A:GV%VQ^:WGU3I,/7YN&CBP^.Z#
MYS>SQ77-/0B/;N;(XAY7NXUV;-,?>G.WS7D^]UM:N9OK"Z'0P\^5$-DK$C'2
MX^_XX2YL%-8GOW&!J^Y4KPM%,^`DU^3*<&--U')G.QOYGAW4PJ+1L:0'HTIT
M?I8ZG@R)^'?&KQ,2+D^X*\I_K6"%M[96L="2QXCT+G-5@08D?\<`7!Z5F6NM
MH?GWJ6S'LES<%'?C^5(Y8>_$H.'B11A.EX69<4V'=7@/K]&L)6,34^MBV?-'
M9R9O#J[YX*/?'C90`1NN+*_9KCB+2SH.*1Q_-6>9&.Y`G29)-3SK#`YK==1B
M-],I6P13W,/*(C:CNM=S4\L/45[IQACFAT#,%GZ(-^T:$T?(VY9%R8'WC@X/
M?Q.AM)`2@0"O12*CA[WM69NV(_##Y@:TC,;W?ET]%[58RB0`NL!Y["5*4N<N
M"]T(F*#1='O9M7KI&F%O=64/*"5<\;N_>E*L,X8VM_7KH^8R*81#W6*LG0C,
MOB*]J=*JY#BP)$\!7HK1D3%>``_\!EMH4PDKVSA(@^(^MN^T$;Q-3N[J=63W
M>?QEU(@)BN?6/>ZR#&]3@3XJW[8W9`82/^-6FQO>-Z=(PY4.X!@P2;S=+,2G
M^WN'AX?Z?Z)3L$;*=P"P.#(:FN55/!,YX?S%_V/NS9;CNLXT[5O)4%`=4`0(
M(S$2565$@(-LNF22(FDI7&<8DB0L$$`!2$OT4=]#WP`OI(_8=])7TL_[?FO:
M0P))2N6N_Z^N$I%[K[W6-\]+<5M[T?=VUS8WU%<3+W>:Y0ZQSOW5.A2Z,.-D
M`((?TPYU]N"RW.&0)0RU.LQ$2N.O$D.Q_W):SE5X7PPS?+I\/FK7-%ZA5#ET
MR"]3';VAR5K+7;C"7!5.#Q7"+?_\]+$**SA?4JZ<,[%Z@V"-\A(]:L7(SQM3
MP>'$#L!7#)WUU-`RG'O7J,Z8Z$BGM'B1U&5CV,!Y/R%H@KJ1%<EV!@IELB\;
M.)S<FVYKC)5=IFP!N&PJ:YJ4+-#%!2Q3_0Y6IF"J:0+D=+TN61TXY+Z%;]WE
M`'HIPZ_Q*W5BB&YX=);5154:SN]ELFAM?SS219HB>DD/&,3XMV!U(W"FG$$$
M95S6O<CEGSI`3QYH>$W"G/K9>[*&7Z1JX*;&=EJW`M\S.F4UE>G:01"Z#,*=
MQ/DR2*G%P%NP*$P7OIL^;(F-P'B&A-6U-RI77(^UNU8`P,H3UV)R?@:"1`%]
M+Z=O0#/G@UZHML=C]L?T;7[/5.<G%HFB0O('($BE4J/"[4>5H:1A?U[N-P.H
MV:4C.)=!CM&0:CHY:29SDU860,!93MWQQ?TP&'Q#J,>S41DZ%*(=`9KEW2O+
M6`FY/$5I^Q8)/2:;.\N:CL<E\W1M;ZN1S'D#K9R-HHPT18V60?K:I=2@,A5^
M$TA`/)WCJV<Q`9NG*BXLWCE>"A!I),6J!ZDU)!X#9"F,9<Q`JH=W$B+Z>SH'
M08ZZS/DH%2:+)JYFK`_G2@/K.@T&\D&08,HSBZNZ=Q3H4IE+B@1P#?/78"EE
MGY%QSGS`?I:BV7B>3@NI/N.01>GF_D&1Q*>/56;`I#=`1-Z9U^,S$D$IUH%=
M@F6!S0?U;%<#+"0[=F41I\XSJO(QC6@`.K2K"!A2KKH'-AS4,GI!.B;7!I5O
M%KU%\0N?+HOVN%O?:7.9IA?):`Q4[52LWDI,&/UW,LL'NP$3>O96N6TO(IDT
MP+TUD2V?7K-`D1J9#E&?&I[]H;*<K6!_"#O:8?-+3Q74#HCG-+;EDH(;6>,U
M$\6P)B=W*"F%;19B-D'([L)5M31L*+V+&Y^1R<6FSX)B`99J4;_1E6-&,1)0
MO%:0YU&)NC3)!D*$XUH]*7F<4"$^D7>4%/RU%7.-S`AIM<O$6`2&S8&K=H^:
M`-1KO;G&=*[I$=&7'!&TQ;^;$2.2EE+71)LH\12;N'&1@&6NAP)N;P^C65E[
MQ&'DK!A^4;<;%B!G.LHA.+9>QVODZ2:"0^63`O9L+7\.9;?@S<92+;*LKG/X
MK9D?T?1OK2S#I86,HPH!!KKT[6,&&?Y:@:2ZR/!*&B#*MHXQ0)QQNO-UL=^:
M&NY%$:3U)5G@$2'%F`5I-F[R_)FQ&^'6:3>L].%])TM1MRLC5_%AXKRI5GHE
MQ62^09AFI=&Q;8#7Z,TA^6&,&@U.R)ORKKF;J[64KU79>5ND#\,*6X\&K;FN
MUA1QF>SX[QX]A6=71MK<150:WZ=;2<N,EV!<Q<YM)GAZE`R>2L\ZB$=C\2>(
M0-!Q>YNE]R6J(YQ-CX2WW5)U3Z$][7*<;_0+U<^'8?_J]J,WJ@4N*MRCI0C-
M%C._(;I"C\'9$4XY-KR%BR\BD+!.XW,=L@`*]S::M$SFS^4(O,'^;6B/.?5-
MRV*V^@/&V#'0A$O:@5?1OE*N8Q+D-F1K^X)]*S)`<"N&A1+#E)F!U(M2%5QB
MY:*.(7@KFZ%SCF81A8[(]L"@FG*0/+`*7`U`O;[V(%L;6?PT'VPJX9(L*J36
MUL:FJBF!+>J/*AE%ZMQ4=_,.XZ/40/'(82J*VVPK[I844NAIB1??1BLH?8E+
MT`8!M,8")T19:<4(R*ZZNB\%A9*^QQ"6AE0\6@HX,U2HOW97N@B+6+%L8<XN
MNO"ZQS'9JC55$`K(^=S]$L,]3$0=\7A."[<*%M:P-7[&RR4R>I2:.OL`6?[3
MB;<[4MT]'-`.?I*2@EG>$G7HWK.GKRZ`AL2$O%J;9#.'-7WX=!O3";77%.)#
M$1B:K(*"5X$7[2/-]4I0CO)*<C/2R4U5N!ZR?&P%16!I20IZS8<JIU6B+R?\
M.469`C4TKZB/-QF<Y2ZL,(2TZ>Y8B&I'>4#$DGN"JNN6M&C=5H:[W`^L>,$!
M+PQ(7,+@\C/T15*HG@D3KEXQ'*K%L/LUJB-=5IE)U99882;P4GY(&KJ.R<'?
M*W-9SB[P)>OQRTO6))')M7V9R<=:1&=JO$`VG[W$/*(ID9>/V0V")`]Q25`*
MO>%`FTR*"V$$-KVNV0Y7Z^]]JH;G+N)%^]\HA\\.(%WM&@X#R%E/).\_Q.DP
M2BSX\][UZ2\@A%%ZR>EJI'.*Z`PB]O+/<QP>DA.:91_ZH@-M)<?VZ(T%=K!(
M$D.@ZC2%.Q,$!P>*&$V3V4@J#K8CTE,ZWB?3U?7=G=6M#=(;=E[,$/+R`(;G
M8,2=*WS^3!F]]01F^<0&=>6;)B2ZN[J^^6!U@Z>76S/CRZM2ZRI`"`W77&"2
M)N-!J?I+^1PN?+%>+IB().#E`$!J(:Q1*7:?HM+3-1SN&I66FT#^*Q%ZFYP6
M1>5MY9;>+H4FI&8A0;K*7FF9ERBJ<7`RH:A!9E[X,ZA[*!N:]1K2A\-B,A:V
M\*WOY#W(]HW1`Q!7CF[A9=%[EYLU?*1R',%,GZB='']BJB#I=`-DRO]NS3V%
MCE)S)D@M,D;AH>G:-%LCF>_(O3#&K]<LBBM#YA9]&F%Y&3AA<D#)/JZNH07(
M]_;6:FPZ<4JB%T(.V5TTRGLO3M=VRDYXL6&/*L\N3S4=`+#PI>Z!-2<YS_NP
M\*C<J9Y"O9#A&K[N`N%#\(L[EGJPU((A[!>3D0_/C(4:2DKW<-9^;P3V1?!S
MBDZPDRQ[DLSKV!M90'N&WK4%%]]O1%K(YTU8KBC.1@#LK.[N;*].-QYD`1`W
M"8.V)@@^H/[]1\B=TYN(G0E/C[+O>;QTE<-M*RR72D<MQ\W&LN1IV-9MU@I@
M`::',UI\SF8?5B>/",=ALW##O>5C_@$;%V(LPO'Q__G?E.^<,>W_S6J9=Z#+
MKIH?FE?(*<]P(")^#[=X&RE)89'O>*LH1*+X@>7OGUW$L+&^`2K@NZ8631*L
MNZ_,ZA&I"(_:]$Q/*3>_VMQ2C4F8LZGMG<KJ/"Z49[$\+8?;^Z`#6JI&"M/.
M03O1;:QP/E?>032:M&.BMW@M^?7"MEXAD7NEP$E<2T$\BJCX6\@&ZLVR(QI)
MI&C;1%F[6D2ZVAH'3("TRYSCH*G7T-9'!]@(@[W,MK0I"F\F#O1*C,*XI)D_
M0%663]$.A!4Z21=KYEM;14L^4SK%@/;',TO)PWW%I'!G;X1W\9QBL\=8T=$R
M#W`4*"#6IR@$9G/LM:%?Q[HS,;34VS%)4G@D.5J'B*/9?5OGU4REA$-?8JAZ
M9HT8^^1B3$3P^MI>D:2RZ07>$=^\-,>+:"_#ILU*/_VS*_4,NQ+&$[6$-9:F
M*5]?7Z@VE5W9&-97C:55&\W@K9Z@AZO5$E0+$:5=M,3=X\8E\18]#3+86Z3S
M#[@LJ%G(Z:T=;)DAIBH=(7A,YKI+14#@/Q3=0"M1S%H@OZI_[18\Z,'V#WU!
M\3A?'>:]>K'U1B&&RAMNP^)'.V&TQJ>/?=FZ_VU<D^V&]_G[*D(JV\DTB&B^
M4T`]RAT`!W=QN`GB)RH-<?U&(0\'T0N>\Y^Q:1!1G&:\_V+0N_)7G$TC0231
M^?*__>ZFO81N_[4R4NZLZ/UR*U,+T6\@`^189SC&^I;Y$(H%+*<H8)FHN`18
MJ9)`F'?,.0XZ?X5N0FVK-P2M-'EX>/Z3#I@J6&),FP@M<W[HFFQL-:FZ];6M
M3"XAT0;?&U/@R1KJP"9)*-&<TPEGHGBF!WF8-U%P<GET()R^H0T_3",*RY7(
M-ALB/LH^`(*S>>6>#62KAH[:ZD=B,(+;$5-[FG>;,`OW6LEX\I>B$>016#,*
M25WH.5>C/X=VJT`4H+69S^E#0HB>,9WAB-[PGXF$5@/.$:,TEC94)[2+/WH^
MV5Q7DD8H=L?@R>$'AHW5,'BH.>T_HCMU?]ISN3ZND$@&OT=3%6L:C8+$*.:Y
MAL2IL\3#%JP1)!0X+[Y#FLMJ-`CK_@]YM5BMV!)$$G7'GL))H*Y_Q-B3:D5.
M@KKUA_8(J)#XM+Y&B:+RJ(L_%42*IZ!ZLL''4(ZXB9%$H'N\A6)8)@/AKB%E
MR_#AXQFE'<<BE44<.#0Q$LE6_+A?DSDB\`4YTO6UC5IP^&3.O:J?PYBYKVO(
MFB;W+^+,TCSQS^?,GEC5^*WLH^602$^9*(*1/8DB.%*9(=:3(P10)W);\@1R
MAQK('P>!-256R?K."6(7&:84<=8K>0?M"A'XO5)Z6JY#B0FD*WZ)%8BI4Y[7
MP2;0VYQ*;02VG<YU*QXD#_F'DYO4(A+`6F)XD)1<-Y[#1FJ2QQ;+'!L^36<^
MU?WM_/?U;(;NJ'&A5$9GB\66F4#$R"O4-ZR/8:?I.+XG+EPC3M\I]A2_.JN$
M08^_U&TNT#;:%"QBQ&G2M44BN![!ITX39XHT8_]@(\-S?GD?"X#XG2Y\Y=/Y
M%BSD`M^M]XFC.&6A72.G+.O9A:^[XWBG;UUM@N*W+6&I1`@)L0O@FI/7Q#T@
M"6@7LA`]`#FH;"G\2[JK?N3\W/FH<E$S*9]BO/;+R"6?P!"YY7/^;RIHUWP$
M&L7D!7#Z3)7U]\Z<?Q[(=UI$Z9(NTM:E#@CX/$B\/"'P23QI.&J#4=UL`#4G
M?2`0ZAAD-'CTUM!!-06EK\HB/63+:LO\9[)M"S0*M&WV7/T=)+%WW@"9$=5B
M9UW)>F^K#1.EP?K8L=L6L'!9_;Y7TMZ@!@U*B9(:<W/W_@4N6&1D)69.NOU'
M.U#(21VEY^#'ZOPS;E^`$I2*O.0ND1N+`N5(&BU?L)H%O2@4PE&8,Y3<@%1&
MC!MAS.:S*ZN+X*@N<G&F7LY$Q\:0OO27<]IXKK#:7$!>8R$.&Q*SE>,2CE4.
MN!>FP0(4$R9'B%8L\4<2-BU]A7@35\,1TOIY>S":[`7><W#5ESKKQ3Q;LR\4
MEF+_AH^QL#%0^8)(Z'/EP0#JCX@,HG84K,<B>9EX=!5_HE:J:O??A729'!3@
M]W3>N"OQY<OW_;7Q]?]P=OC+Q2LTZ;M_1TS,>B_E49C9RL#V7Z?[!/W:4:V4
M>U]<G9W\3+S"#6HW%&`?:Z[M::W=_<.K?Y<6RAJ#@L$`D*E%RCR7P,TFK[][
M"4N\.STZE:!:K#)JG;2W9*[.:L]"JDA,(0!G#SXMHJ[53I!"%,3+6Q-56%?]
MB_7S=PR?\8YV?[>7?X(+4D3X_O/SD1_Y6JRGKOM0&CI37MB&@!Q[`?*(6JAR
M.:L"HY*TAU[T07[#KHUN'8A*/`]SJXH\+]O$NXXK45Z<VWL/8FN&D_[73/=<
M0&3@'F\]VH$TIB>R[ZA::"3+!HC#17[I."*6.<@O&R]WPHLHQ[^#LI1<UI0I
M`"ELDVM`6\F\.9R\P-&<3::5!.*.IV2'C>$Y?/#'/TRGNWL2TM<?KHG20=IG
M\\LYD8.K#\A*]"6C.TE8(P'X*EM^C0`ET'TI`8\ACM1NMH3P1E>HX@W*1_:Q
M.R:5N7XR#,)(-8P0%BH(.,I;UHH>^?[N@ERQ($6YH*Z,4M2PBIU$+C7LE4%;
MU7+1A`V@120O^%__-10BT[X1)RG8F52*38RRIP!_$AQ18F66+&PMQ9V\1S#M
M!B+LI'3LB_.XJ.LRH?WZ9GYB;1;X[%GC4GI94TKK`:JF"%Z_-MM2%9\+YHF2
MKD[2J'Y((&DYX0-Y=B*$0(1P.+1S27HV&V(21^4?Y31LO4H]G4(R8]?R<6^R
M$F+$`8(XP#>V.52NPEW."O^>*.(BFS#I*%!8>&8!PPBV6'*</'7W1.>R(8DV
MJ[TP63<[-)_("`B^,4GFMV5^IW=(AK!TE%\=J[0$S&*N*Q8VTX#S2J2&12/^
M?82,0P+5@.=2%W_!+WS7ZGKDPRQ+5W+:+X`4PL8XVB$3YL>'H&!2^EO?607&
M4O:\AC%!0`CQGG$YW2@Y2!G?3`3F:@*BU9@5U1](.\F0J:OJN(T35JS;4H@%
MW"*'V+W"/ILL#>@4Y7T[/XM6RRX8,:<5M8G6[Y"@=U_6(M'I#.P86`(4]W9J
M`$M3RLL4Y:K_DS%7_:[6/-,7TG7MIFODGOSSZK&I\TFH+D[9^].3__L__Y?J
M8["T3T#7C<0=?[U_,\-;DU]4W#L;U+>:=%V]J*L\[%ZCCC`'I8XR_>HC-'LD
M:'NO_!,"?*]Z'4W72<18E"Z"ODB(+$SOAGE;LQ$RG,[1:"X01=VCP`+XN1<+
M&2+K*]3+"3A2(@W_H^:YM(5J$P&M9MZR^Y+N'YYIZ\3M"`F(8NB"RT^I@4$=
M0':S+@^C@!2M8I<@%;J!A6*[A!5(M9;!)H._#/B_1^RMV;4T/UU1$<QL.+\0
M1C[QH$DV:;64[0K]_=0;!_H7;^[S/^_QU:FVOGY?!:K5NK?]V9H;W902+FB#
M\;-1W5@1\EL=K>'J+/HD_(L!N"1!O02ZBO84[NF3E'^P9`;-Y9H)40*T<\1@
MCK<M'DLN6"E-A^)K>#69,;;O1\P)A;=DD6A<0PENB*F.-$A1%U0J9XBM!,0E
MJ\?2),P01TY3UBQZ196*/45GZ&7^6V]]_KX"-,T.M"?5=7D[+-X4U^H+B:IS
MPK4SY@'^;"0Y^S+LS:;3S3[&9+3NO_9)2R6)HP<QZ8[D290_I67$"H6?`KYR
M38J$J:91;TY2,9<'5MS&5[_;_S<9"\[9OI_]_JNI_G+UK0)I@/CW7[TF!G$]
M><8,R)<7A//TZQNNBP"%_MF/_\ZFX0U3_,N7JI&QKXQ:+ZNI1'!/`V$"FC8R
MW_=__G..YPG9`FKO@7'C_R!8GCIO5R/P66>J3#1*8LKC?!-5GQE7;>Q3V.ZS
MBS.E&TTP201(=*F(MWZB=;F-X@@!<D`%9%/L2026TCDY/A#Q#DA<G>SN))"S
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M/8CK`H5\DV9^@!FZ(^3?YB4T"=`E8((F@Y_>O8\VEF,BM<PI5L_!S96\=CR0
MR_D9F3O=@<R'57G5C[^-RP*TRO/CFPM5)15]?HN+V1X4\@%)BBQ#5$1I44$.
M/*900I$1B[!\\!^/)].MZ=[BL%5$3RL/KC+FHZ+9'_/P$;%[HA=K.G(3$+KL
M4BP_4[PO;P.(+:$U`84<.@[#:>.PTXH"EWA$:,^[J1GJU.:?;H*`Y?O2D0_?
MJ]80&PM'5ZPX"IQTEJKS3X?7AB"EK?/S5]4\5"LWL\3C6_F><<`M:+,Y(Z[Z
MV#<7OU`Y8==8GK\(4!3+[@@"C?P8G0!M;;8.0D2*@4*=Z@U==?5CF,\MWJ(D
M67+5(<AF?R8'/DD=)9FU17$H#NYJB#!!6,0"J,6LB$(66H:"X%]@(TV4@);D
MZ*A)Q=YQVMM]<QTG02035MZS#IX)+TII]%FYNA2-=(QQT51FD/1]#MC6``R,
M?&.AW8`)/CPP]]C7($HZ?)`ZR'.^2?]RNY6QZ9QE$SK6UJL1=QC"A;,H;A!H
M0YF.^;>-)3?8LC(5Q@U'-9K;3K,P:1L7I[S.:Z!H/(;`R!6>DU]'FP]BC?A!
M:+_D'N=`\(C;;P`VGG_KZA^4J+#25%9PTMDYM&XCP1B3KS\&AJ4<<@DAC8#'
M<)9;3IL%;GF^XY%S)'C_!HZYT%F#4(T'GFB<-)7\@E<WN`=$8+/OS_@"=]04
M/ZBC\G(J2)615>YF*\+DIQ.JO"SE;'2Z1):&:60)9#B@%63,]:W]!>&VE\E'
M*/OJBU09G,5*%8'_YFY9$+(B!9>`JQ2C:$@!?L`[/++!)F^306/[2^98^QKA
MH9]TEN0UZD*`I>R?U^"_2J"XRV*1PX0EJUC$0F>I17;/:>IOIN^@#*;0O8@@
M?F[^**955;Z]X^W?[9V$.B[8SS[*0EH1>;0P[JD'LOL@`F>E-(1:<#"UJ=2-
M]KR7WI;'+:N#7^F\-%APF+,HLQ$GIGD6N9O\8PV_%'LNLO%38MU6^F(+7\!+
M%[?]=_"1E@+],XMO$N5/4_T'(@\%\\?9X1D5IFHZ>/;TCZ4SX;GTY.3;9#/T
M/E#NYCPBB#KQ'>"P3KX!`0^ES#:1!&;9;#OIOXVWX6:TEP.J5*](1@B\3\_?
M*`2M.[X>A^V>]GCP]+%WB0SWI5["IHA7BALF/GX7(<YT,[DT52XFD%0.C^RX
M/-R$NOU9=+0D`;]'/";33:I'R-^H%K4^0`&9<H:()2R[J+@*:9)7:2HS(@:V
MN'C;NU#`H8;AJ@B+0PTJD5M'3ADQ0USVH@0:7$RM8+87!M"2H9CD@,PT^6"@
M+SEAQ>NRR02&HG']F+%C1U0<2@\`^./3JRM2B:<Y<W1'W#KWIV"L#S=:+-+1
MC6J2S\RC3>0-#M-=#\)+['B(\YL+TFGJB4D^($JJ1\_CLNK/Q#TB\C/<9JE"
M+MML92F`BOAKLT.[K^W&KM[-YDK^$F8GS/).5P8LN[,_S0G]A&<ZW-KM$+S$
MSLYY1'<'6PA<_P05'%9(<<7.V2%7:,A<7Q):!_.W<X8_L2L:_)X]A4N+8(`$
M#V/$H*!U$Y.8(QF.V7<:7I8-"H6`Q*7.M4IVM/<S'Z7[HI6JQ,$FX8"2>D<*
M@B()DH)Q9R\,JGR?5HGAS3X#WC(9&K:G->OP!08\GUZI2L#M@_'57":D3`=X
M5*R7LBT9ATJ)>0".O(%B*K0G8_&'AQ\4(BTR5FL\]613^Y(O:Q'>Y#$>.N*%
M_Y$.T8/:W1\ABO-XA3&?7'YS<?/A4ISY"$-1E73L1#&@*FLZ0IAF5?OEK$:!
M=B73L&M<(6'YO"16,Z49IXCQCE#I4!JA0PX>\<$WA%HHOZ$OSAGS1KP<8F`I
M\T32+>%'WC1GBK`==&>AS]V,'R;O#(E+HC^$O`GR)%SU>'>_%7ZJ+AJA/?7M
M1A3KWK28+S*^7=&K#:0MNH"`<7J$H.9<?$^]G.(XN9Y3\[*RC"QQ*B,PS0DG
MK/"WN2ZG-$D1Q\A?2#?.\6QZ('_0CII$`R^]N^(.9*@AEU5&Z#0)+14,<$_C
M<O&KU]!151JWV[V#1(&(,*OR)A_(O@A_FD0M<^"Q@/1=QG`\E4$QL(71^2E(
MK&47/O;:5&W2S;JY3PC/J-75A3D3S.OH0N\],2[FAZ\MIQX>0N/'=?H$>CUZ
M6564=''LY`R$)?]92>:;B^.?\MPOU.;Q89D9`:5;GHFR!'NEOC7)X^YU>%,O
M_#R343L[N9][(VM#9?YZ&L_:S)<<6"3,2M*X`^1:V<!G'HD`C]__;W(@FR:I
MN"9N.!:C@YPZB`DM&C,>"!5W054G6>2+9^['L(,\RN);>+:=1V+)FK'JN$Q>
M4)A7-$#J0SN@GW&.E:IB,B`UOR;,T^`EOA)!"WZ*?X;91^3%_(@2DM7UBC)K
M3/B':H)&HMZX$N4%4X,B2?7*WY5U"D]=(\>4;N'S1P3G\B"JQ>?7!_2NBY-+
M?T0*FS3'E-8R"+^0;O*(*]T)P)`&(`1S9)P,=-1^\)PV=\M'.P+)_7]TQRIV
M$/SYZ6.TU'`A9$\^[#^;$^M20<S@EY4=.M8WUOLOK.SLK>YM[0W^O/5@=7MO
M>+W)@]6MG>'#NS3"/QC\^3&:7V7E[,9&+6$^%<7>?O2[1,_@7#_V94>FVH'$
MZ)]Q*53<M9_^HBOK:YL/1OZXU;]^:U]/]F$V+M^?-]R5&2@S5N&SY9@)X`=#
MWL+.*8+4,BX2&E:*/E3XI(1D>GST)7(WN:>)=\*$A)?,L9K!FVKH[).&G5AG
M2_R=1&\?UBVP4@N@A,PY%:.M%+B%^]I#=3AQR&XAHA(.3-HMU/I;6PI%*P`$
M>2=Y&.(NT[.DX3?])7],\K3_]YX4I1\^M'AL6#RXX,UQ"EQ^N0$^#N:DG*_<
M&QLS7+I;55G(^#>?GT_LOS+)&9=LTX:"H9N-$/M;NB@2;P/4XIFBD)*`KP8$
M/F'^_G42"2I4K#9-4//&MN?`>Q8\.F:S_C.3F.I);BD,OGI[]/NOOOV64<C\
M?[^BKD26;WN:X?X5U@QVX>SMS+=#/*Q.X_&!,JTVT#F2#*U7W*GUKLR%$QG@
MSBEWP""2[JM/*:N]NG17!SSH`<I?]1XIJW_U#9TPE*RH2"`9V*]FX.-&:6LX
MVMF)[!V6?SPF((4TDX8VHM-PG<V@#T#=E-7TZ&_2,'F7G&X6QIDY/M^R'-L>
M&5A]6<R.Q,&5;`0F;M;.U%.%<=^5465WDW4/DH7Q+E6722G'R61K<W6+[N:\
M%![N^MKZ^E3N,QZ+BA*7DA%VMX3Z8QMAE'`<V]6_IU%7V]50L$1Z2YC+/K?:
MDQTKZ68^[FWMU(BX^`=VLJ^=:T(NG0<"?]AEF/ADC=[@QF/FI.%/,:`"//?6
M;>J&HK)'Z@'?/_91=$A>-W#36V.KJ37J@5N28_^)XBT&IPEM&8-2ODMC;SIO
M#MPZ=T!TY$,;4.>_Q4<A@AP'#N'?#"VLOSOA<W7A/AZ8PR?.GTZNTE+H]A8K
MS70V=\K8'>2!YCGF2U+<PA[?D0(-V,>.31`N8'H#PZH\'Z?X8@YEZL9V;I52
M]`/\[ZWM/?@Z<VR$8ZI$7;`3SHT<AB@XJEBF\0E*Q4/$2$+)YPX10_'LE';Z
MDY2>)6``M[B]$]>"XB3%RP#8_)++<M+D:8F59;"=DNMI]FDI':![G_@-4C$S
M8+:M\2[@+E4WN`4B:%52BDU15WMD_S!)TQ81:5]K:7C<TM1(TZ&B<_@QMG"0
M,W\G9L-A(]U:C']P7-K^<+H0G0:RA@[@&KA01X0'VEU;!W@:2!U2I?8WE'`$
ML_1<@YSEX`C7E.]S?-<2F164AK)4T;++H$2L<H8SYY>6><%NW#GV&^'#TQNI
M&390BBW`DX,/:#J\S?FY;H8U:.8\S3R'E"XQB$^('(/+/+VI:)J!7M]<VZ[%
MHK^19A^W<I*]I!W\$XR+I(S,<D<7I%=$IR<43!Y'H^'K)7'(`,[SGS2%Y;P9
MV=@NWK*&Y!,8*PR$3`HU%/?^.4<IXFG?7R0/^N(`[YM749[("W(^<?VCO(?F
M#Y%-6XK25"BJH]63(8"HYV!A>,?6#?+H;T2`^3]B`ZC/M]QJ7]<ACT:D6YZ)
M&Z:%+%597,E432,2F%(""8>8XY,"2*9=IWH-,HOV]$(LEK5P4HX046,V"9W#
M"8D=W%BW1$V$/KD4E'H:5#)H=B*V9('PEW6\H7FR]`<0</<>-%7'"1[H!YLY
M^<S1?UTWGPA(LB$&*>NZ',8X*M:B>L9STIL"2?O<VW.[)MI:[]EZI85^'%-_
M2P'+=A\'R(9A-G,G7!)W<WIYIMI:SNL-G,K$TGUQ:*&;GY69UI_#,$QDU4&>
MU*R>6&HCU2+`"$M=]-ETTH<P;03@`%$&F&LH,(UUJ1L;M:619Z8Q><SCK30/
MJ`\[>$,;:W304GM<B.A2M6,XB0[T'\$"<<W($27"3!#(]A5]03U[<8&;^:(8
M_J\<;WRI4/1UWXT=%][/VTN'F&D5S>$JCGJ8A>OC+%P!45(^NF4BR%'2-UJI
M<LPS3-G".E&+M7*HRP:\,=<-R/R/6O/JBV1,QI`**%PQ>Y]HM?$N!M9.OADG
MOV`/61\9(0,J5=*XA^:JI2EW<NG8DH8%)0W:@Q<E1!L*L]7N\V2=GFI;?&^9
MX[RQA%8MP+#]3";6>4WF]KW#2T&9XW$"1DK5M??&[CK0H%')Z1<:47-\JO9D
M[*H>OI>"3O-.`1!F]PU?K;[7#IZ<7:\%^^LM0@"O1M255+MV23A5TY>)"]IA
MZQ>8^1Q%HU-H//"E(CJJ((X$QS"R-HI;_X00;>18?^8EF_6B-.BRM?LZ.)<,
M\O2H:WD,O&EC\8JD]P4%G`)P]ABP&=A('4?(EWCG.H8H>P<&L_\J2F(U.6D)
MH4:54<^!V+[JN'$X_)=K$MMQ'X[.==!;B^0!:=0PD_7[52Z$*@1B"JN"NGL^
MS&OM2Z8P$T[S>''!D!$%*I8*$JP-J]FIUK>\/5<.4UTC,C-N9$G*7V:,,!,\
M`2[_XR,=*?DB._3XXOU1N=0)PR)?0<J3,:1Y#$?`=H8$XAG5\6C3EPS$!^9\
MU]K$AL<(?,;A'&#3OF*`WRT0-$WKO/P_+HZ**0*$?54^2VRMT+H>23CLP7R!
M;R@P\TY`32<",)<RGD*N)Z_:)6L\&C/8&G!5Q/\J]+W.VR8<HJOSL&/,/+9=
M-/**:E"L`6^UHW2A).\V66S%BW6D!)0@7:P=&6#X7MX8!*42D=*FT+RO`S!&
M*H@%H6CO2<Y-B68F8R"]8U-]J$U"/">N,7A2GQ2RH]Z#%\)9U^4FOZ@@#A<)
M:H*^L#\TMC7I;]'<+\<PI`;2=C>2PZ"E-,JCC+.2N2TB][0:/P[DPD)"?XR`
M-PCQ!A<$FR1Y=O=6MW?OO*4SZ9\4K(*B*![I!,,"9+UH&&^A45(L"GJX-1CU
M8+O:I#D*!NW,*?*#I+-5RN&NQ;Z#>%@SE.F+XV$/FNFSR]DWSQ5=)5#(K8@I
MDN[Z=R2\]:SM?Y!P<*/')!B?YKC>*T\-.RB=<ME6*'^Q,6*GZ,_?_?#IX_\X
M?'_YKQC7:Y/OOGMD=<"?_0R*&BH+7@?[\K(,:/09^2B&RELW012ET$!"RN*Z
M--A?>S<E?`AX4T=^C=0G/*H]3=3@_YN&7[$3&:]2@;$0K6JJ6H\SLIA^Z6P@
M]P[Q9JZ73QKH2">@J@;^8$1\^++X&\CY*V9=7%W\A.J#;=L;4/ARV/+/#EX]
M/OB>V=HQ:SV!/"N.GR5E(=VDHBQO%;JE`9AHG;07PD7B64=CTSJ*&HTG1]1K
M_-3Y8)@+?)?GKV+=:,VQN\W6(7M!G^.MZ7^%EICS?4%!`M\1$R55:#_3E"]2
M#@Q>MBL_CK+@H@;ZN;/#GU3QFIO:9"MD4X[T6AYM&P$W_!)XP\<#4Q+&9\CD
MT(:A6X\QE*BE`M27].A3S.!(DAL1&!KKV$(BL5-F^5W/L&1_3!UL&+`^JB];
M?`^_*KU8"&ES;?UK_4L`#BDQ)#G[^RV9ACYNB"Q(76L4-EE#(M=6D`&A.>XG
M?4&<X8QYVRG]ZG*,LH:)=VPZ_4`L+_142*9]^A@B()K,/DL(HTJV[[XJ>2B$
MB=\W"8F0P9T\P.T2^-[.7FU_PSQQYJ'*W"*NT7X:77B]/#BJEMQT@E%#IC]3
M,6WLKN[<#9-*XIO]QTT]F*_EZF;1S9LY\K#87!`DTEF6!/QXD;I&+]V$)KF0
M;OUT51DJ.\'?1"B-*MY`9F0WI8L>EJ:YL+TLY`O0TU%JGX^>?=13Q01T&=6W
MGXT)[G<)/1!NH-7O@--:3/0>__^/"<:9-]>V?#XFMIK+,99AE'[>%$24.E3=
MH-R@HFLKU#N-JW2R$7!P[4[]I-M@)[<,HK$5[(`VB3"EECR1.;1)WL`&0/6#
M]0,1G"S(]:OEOQ-#BC<S0@DEY"+.*Z9UJ'.X_:C#55)@IYCB9H?B'*8V1-RU
M8E*(`39)P);.`OY0'9@!^63[YT7.N[XJP8!JZF]LWW<?F<^7U4EYHT"L;8X>
M_FI1=%A:::6W>N=,*BSD`0,B:[!RRTJ,<Y5381\`4Q?012FYXD?=]>QE-)<*
M(RAZ@&L7!$Q]X%C)^B:9*",T"J(TF,T)T-.F@P/S0Y@N%C._+R%(10U>7>?]
MV0FQ'.>%D#@CU?&L='48O8\YZ*[7T#BBA[:&ON<()!>`@O6,W8(K&5B%-2R@
MRJV<15I9?FRLIK*1AHJZ-N5%#^ZNB[NWN5:[R+7;5-G*XAZ0Z+7I2=C;V[[M
MPBEA]=Y&D\O/'.C\K1E0+GQ*OQ_*I,PEO@JJF1<*S50S9@B/I?T.7]_$C=,[
MC2Q9WNB(A+8]JYAB7/:NO6YU9K??J7ATOEYI`?9>/BZ)!-UY*9J4S:>'"=-O
M[/EF<^PQ9\RM1G%C],\:"E&+PO;&-E,^%.3R;V8VYB0ZN:9@H&6*%NT0@S"M
M7ZF!(=1Q(]U=>&X=1U,['G\U?2R_J,Y`;(1B,I0P#7MKM3M:@4_BY*8GC7U1
MC>-^:6I\O2"LPJ2?=^$VJ`!7XS!#;+FTMST(^^K(6Y$Q_5T/=C<;'ND+DZ@$
M:4.5<MW&K-])XT`(>Z-[&-S45%52O0Y,!O8)EP21X@=Q</PSS3E[H,![OMEJ
M\OC#.86WJ[3&'*]%C+RG1,=M[Q\S8)9Z^JFE=6?0^"%"9WV7DGI#D_ZQ*.GR
M<`ZV31RY#A:56E7$,0X1"0FL*8E:_C0*G]",FZO;=UM0?"VZ,J[_I9\AV4_'
MK/&#Q^RB=^3]4)GQ#$YE_^=NN67_UR?EUK'^+V.?>I+#EB\4R>V_H6)J;Z;_
MP_,FIV*RZSY`@G5!(NE@`8TNR1E=Z<2TIB7<+5>S-7P25F-!LD-\`07S>ISD
MGU1J8+<C-W:42Z]:V;2W4RO5EMH:'/XKIW:-,VA1YQ(A,0=MIOG>94PK-_^E
M85HA0]',<J$S7QL-6?QVK<Z^_.MB.16=6BXC%:E!:^K0NLWIQ'/&K*X"MR;K
M_R3NVWQQIMB41+[3@/<I=^=(CXB\XBG;$.Q2]@*RCJQH++;4"[?P@5J+9<,A
MPD+\IQ%),@KRIAR:OU[2CT>^;<7Q))25M:(/1GMU^-&_ZE\.0O8VSP"W^/]=
M$E`>!:L`[82JOI"@?SID-#O!)C^0[-9A.-Y@)BY5.Z0$]Y22CEI=[8QPT[>S
MHRLMB%EDDEK?$M.B2"^UZZ*9I)9%C:V)7.1TATS&Z(+%'-YC6QXLC^.K0!ZY
M_5>-KH""7=:&O4(`6^K!80197#Y*&CQ2QVLR.WIO;]?P79L\=Q"B_;&!(:'E
M6(Q%=12D+?:%!62<@I1EXC0!2B?-_%--*P(>O8WD,$>U3IMO"F_TG7%.*L5R
M>=]TO0;U7`F30JN=]$['+`-'VDZV>?Q)9?Y4>IBNI0:<B=2Z<+(<R'O$"@*A
MY(/.+C[(7Z'-EQI+M+6K#(A,$JUR+V:MNIS6O:8BP$C\R1($%BXTFAF(VJ$X
MF7BD7;>TCZ"9]`\%CAPD9:]*)LI,.&4D,\3,@LT*D8P8@3^OCQ^UX/:]&J8#
MV`7VT^88(R`/\!I*`>1,`$Z_<8V:+)BT0Z+1XQO@YE9]^5Q%@7'M4K5;0PGV
M5P,7XTN5LQAAP`;(0+"Y9@#8]3]5:#>^5$FPE.I'*KGEW=R."C-$M:21E,1?
M-,=I?^F:MX3!X##K@7P5F'\9_B7[*/!2[!^<*(&?5N9HF1"ID91_0NV1FGPA
MD1.2&)H76>AJK"YPL4S/O2^MT;^UNDZSV<;N;F/C=WAL]*:U$:9>SM.4$SYY
M8D:S8?Q4(^_#1CY`1Y]4A=#\LD@MC%L(K^&WWLN+%06[05'(J1E1%,"):F;V
MIYEJS!M6^1=_*.,`^/UO%[@?\C7^?OA+4@[];R^A)Z;+&)"+M%32>I\^DCH6
M>%$<5;FE5#7UTTF.]'>'-A-GEGKAP&Q*?47*"VT'"%[.<;:W=S:W5XZ_6=DB
M4_-Y=+9+.\4.Z07[UZ;?SZ&RWJZ7MC@(RB0+ZVG1`Z*F9'+P\R+:VA<9.:KC
MYVUI7`J5T$`R+09"/9=2"5.C9@EW3$^(W;:M4B'0+2KRZUV)7XL-V+9+N=LF
MH;I#$VN8#E88M;9F`<B+!`RU7R1@Y6T0[]$(!`*2N9NE:`(<%C9BB?U@@%.<
M%=%CN9V+#**-L7:>04B!HQ01:*FGVL7ZESY\@/:8]5;X(D):@+Z+4BC_\`3_
MFUX!9]<7RH%(SRKB</HVO'61KJ+6CCZA@T:$1S@?2:9G.Z."MN+-*<5ZZ?MT
M_=/'<&M2&4BN^VB"!8G^AA(K%SIH2R;`E#35O\L750K*KQ&W1S"D/78,HMAH
MFCD5;V.\FQ,2;@<<&>*@#W3`(,O0P?=.$9V$/6*@<>!;X.2/B9-Z7X*X,5]R
M!4U46D%P;]@LK.GRFB.;(N5V3NV?`.7L"JL^DV:!1D[#^<8.;E^;YQZETFS#
MZY&4ITENSJPFJ--/B3NN/U<,*J:VO447=]M8]CF2L&S\MB]KRYBQ^E^XJCLH
M^+V=K4\?%PB"!)N%8J!^4DY8SS4;U\$'&H@KHR:0*@X/.\E`4URSIH>.=-OH
M,$3U*FCF+RI'.?N`HZ./MP&?[-3<'H<J+><'2LN^G4VZH:9/'U_,KCY]],<4
MH(2ZF`$&V5T/VW=S\WI>Z26WZ2`^<,$>I<DKZE-Z+9-XQ2P\6.*@I+.>,@R&
M*@MZ[']0*V$/J$P>@+A0NE!ZOGZFQ#4V^@]G0"0IL^CG[#2<]!]8F6X.&M[S
MFMRW<DS-S^QDT,N?GZB\MS*G$UJQ],&Y5XB0;6_WOYM7*-^8K"QZ?V\XR.`V
M$*6^U%K^]H/W95VBZ@/7Q\/'^EP+XW(/>'^KB6@<F6MPLNCY<:9XC1R*_CP*
MN1+VBV\;['&1'/6"JYQ?D@R[*]H%GV[XB&98+!8NWF9N04V<4$%0YQ%)M/+S
MM/Z,'!!H"'Z<?0AEN7"W=7_=?</8Q\VL&4>QLI,^WC"15TJA!.U*9_W/.2%]
MW)TH<RN1R(&I@/V1S(%CIM@4?5Q656A@26NQHL>>\`+,!(7^6K0PEKD!_+VF
M;L8(!%%E$&8WM+CD69XC<&4TI=T&DI*B5Z09C0-,TTU`X+WCLB8'-1LMKA<@
M*`2C4PY[/$N.L):6[",+@VER>H@^0B\RQ>VJQ"S4K1[IRF8O"[X6B!P(N\UD
M1X4^T7"(FG#=M![Q)]T7Q!(+$Q[/YKYG`5I)>F7EZ?FGCY\A[/^@O-]]Y2X^
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M`)I7*\=&+8)2G<DM*E'/85V`*80+^MRPXH8"KY>]R^0P#I=/368IYD%N"._Y
MC!NY,L4-%<0@K'G,U!(,9BELP:DZ]*WG5R(+8M<F7)OL@IXS>)L3M+&ZOK7+
M"*R=['Z:1EM6;T13-KP$Q`6424P^#U5C;TBVX9&'.E%<W:5[-_XD&L!<DA;5
MM306+#JSF1T0!:+J9+B'1.%^NO^*&Q!\/W@0D8R4J!/SP$;3@!8)/2CUG$5*
M&=='Q]*<QA<57X\X79+FN%GQ>U_]/$D)$OPE)T9RN1%.%.Y*_^F_2EX_&<KK
M_G/%0\L#!2N\^H^^/+W^B<O4B;L@W_%N81A=_=9_[.O^'YYDFY\@[LQNGJ7B
MP$_YX0)=Y4&BO17&=5]9]N_E/9DD14^0*J15GXLNF3Y:GTCD'S:9+=M07E*8
M=DR\23T56"@LUJ&6L8\DJBK&KR5"3FJU'`Z-Z2Z,=\P!RA>"PO%-U2&^4?ZZ
M-9N#5.?$B7V1*\9C:@B*`FAO^/@#(TP);\K5G[F7$VL1AUO12GV+6Q@T54<]
M5;WQ%NF8#6>&D$[9D70`32K%<G6/(]RBL^4]\\_KF3H,?(.I0CR5+RC34F<!
M@1JQ(C9O(B!?&:A'0\#&O%'[_ZYJ]:A6N?,9&>*J!-\6Q?KS7]9>L;J2MG-L
MWP^GZHND'X]H$^NE66E8!WHT-X.8N6-+3B=@UJ076?P?LRO*RVCKD+37%A5"
M"S6N4[>?EQP-*HLQYD%#(1&@H+(V5:D"[Y*FB(1\2?%K2=EQ[6>3[E)3O&07
M`U$*\1:OVH+4O>BMD.,XBM3-X5TJTZ2%.LDO^QH"4M?)B"!YE0O:#-5=M`K_
M`]SSR;Q)C#/J\$">^DWO^XYP&(6G2WM?%M$)[0LW<;=P7WI3>>IDODW4\7NP
M(X+(V\E>E"+9%^IO)9A^I'##DBC[4;9MN8-/*U<5D`902N]:Z(S9)AF`W1#8
M4$%D%0#\07"91G+GPCUYNB_OHQH`=VVK__8KJY\0@7)E!\3:P`(>Q"X,H]81
MDDC=`F*NF]C+T0^@=V8M+&+*(C.F<3L.5V\JC9-C0):+=8-'(Z#-Z_)U\Q(U
M%R+^[7DOV2>,O:D`]$MV(P$A?%]KHD)0M>2.CCJHE5JT`5>7-#!C+R5LI,6:
M;,%=J,(_5Y3+6XI;I^.>YQRFD1IRS,8+%2VC4[@LH$!NV<U'?U2[^?4FRO5/
MV[RJ@_/>ETN%'Q@,8Q$/:PI/H)Z?-P?K4+HKZ!NB%=5)F$@7FCNR_D[=PEF>
M"`])Z*@;,5<Q#.MW%HIB=82Q2#5<&YF.XG[/T(/D[W,A<*4CVQLD5Q#&K;(X
MZ@BN(J;K-?`#`S:+S$3K;$71,NO'V]R!WQ2H,H5N`^QGP&BS>J)+ROK?EG!J
M4DC&!#16^WJK7Y8M?:<`>TCNQ)"CC^B_`,>Z72#AN*<-%MCF68B'KN@<H%\.
M/;["T_-)6U`8ZGZ8<[4B-,OE_'U._8OB[,$^N6TO@TXE^5)1L?Z:!;H;'Z38
M,6^//5<2-NC@CAQQN3(MRZ5074<Q?&>)2D?T25X^(O"P7#C3XF(=3P/<^!L?
M7SG]A@J4[:^SG+>QMFP!GW:N44JM911-YXG)5\KHO61UG=)<BGG\#G=9A6^E
M5%/%<W$WR#?ZSY737[.MXDBEP)Y[Y/+)5;JHCW-V>C(*G%P\.1GL%]ZZ<\,#
M]N_-1VUCD7M[.TWY<;A&92J%E.E(.4>'E!:,M`E;)JF0:R9>X;NQFJH3.Z/,
MBF?!C^&G7=/[S<"^">1(G$HX&<@3GLV-7M%?CAN`$\2X.4PO1L\43R]J(F)"
MSLGDP0:3S*=;.8P#P`<K+Y!4M^F#Z0Y=T@]*<&ALU5+Z5ANP;*?,Y;\4G`]N
MR=@O_/Z0X-X;.I!&PB/C,F?TS>7$%1Z`TM&.L!U.MM:G*S]]D\1U".5<PX84
MX']07\POTU0<NJB4LW&!?+CK*6O/7&"%B3Y]3(L!(O'\4X5>SG&-7VJV"M;>
M(^X*:7LD.]\NQ9E.%E44:ZZ$MR#ND2>GN+H_0&[E4O.(?\DC=?`4?;@/*!Y,
M#[04XPFI=-([KI`D>Z59GZ9=[?`H@9WUAC*P(;B?5>..FRYMKHAG;V1H<XXA
M:U)/AI\V>7WXRZQ_R<@X:A\18&'ZC$A=581^>T4W;WS#?B$K"$KU4YYS8`:.
M1X`#KHHC'3;N$A*J=W>7QZ;H1$]C[J]`^U3C#_[,Y);=O4&*:F6+:P?VUOM/
MX\(Y]-'[^_CIR1RD,QNQ*::@5(D,7%\=ID,+>Q'I("("G,:L8SMQ\C[YCVEV
M-VQPH2P(?1#T](4FQU#T!Q8MCAD:154G^H8>3_M1.C_J-R=/YE<7EQ%(Y_Z?
M$EK%-N8Z7+F!P4BQ3BC`PD4Z5@R#RF&=T?F`0F2?"O1J)EF=2QL,,UHJO=QR
M@GAW'8Q_?\,4(*8,(*A)L1)D=/6W"%*+.;:5?+#.!PV71&T5'="74W`E?=HK
MA!E&`9X6VJP;)U0UV),VTB./_96-C=6=W>&U"V2;=K8'1+9"0^KV1C\5N1^#
MR3GK8/7IR-+#ZRY4D/)@I__RPS(*#+E('VG_=[TU3*2N3%<W]P:\]#B+5Z&P
MQ"=0CDP?&RS\J.C,$:KK[Z(^+*E!26+!^6#=E<W!ONK;(K,FI,9X'.*7-L$&
MZRA:`SO.T0>:+G,R.\+V00;+U>MO[W%WBF?_YQ>^PM[1$$;,,$#ELO_$<S9V
MU?_CRK!\Z+4]Y$K&.0C8>W5<'A7T5+ZU(<^<;=\DYANX%SCH?M!2Z%>(Y9$-
M#$JLGLG3'A%J4G26:KVC[K_,][WI5&A(B!B+"S&X\(V#XV-:G,[",R`HJR+)
M`?K3E`@'6_6,1E0AFIB<U=]`.95O6!O6M7VG07M+T/C*=&]C=7=SL[_^RA05
MM;$Y4%%!"R>9YRI2^PN4#>J1!MD#V'][^@OZY\#C_?J+()0&.U@9BA.J+OIO
MCNRSV43_Z97IQM[P;UN#FWY$)W>??9P17B,%!(NL@+`OAKIT=HW;A>W&%1/0
M4GM+HO152VB9,N4@EIX"5%$*\UC1R_PDIBC0YDAAJKYUKJFFC?R,>J]0>:AI
M,BQGI_^(Y`;+T^WM=JRSTY^4@>`11@]<W*C;&].T/IHMIK#:F[,R45!]Y$CG
M$V5:4F%'\#_KD=MV;A[#\GK.0,WC4SW%^ZX"3')'43)<'<G2UMY(@=BUR4.<
M[3G9$S8APQ5C1XODE(W^VN%O`;HY_Q'F*T9V.;\#_(VI/(9U#/G>?>*'1X35
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M,.<;W3PO'M<8(85_`09,EU]++`20UR9_R.4TBF^@I<J'CIQ7$S1R$8?3MD)2
M%,!``E@_='78TH<,<H@C=&-$&$H)"R1',./TZGC^'A,<WX!O/\6GB&ZJRRO=
MK5[.GD/E%A-=.BN@TT:R*B"HQ!V.VOXXU);$U<$"^\79'C5W9X-]*/`[PBRP
M=`F7UP*]S0=;E0]S:+^=;9J$8K`EQA)#I]/DO8WUS5WS<OY\,2FD3-J+C063
M4"YC6Y@VD?.\`S(+S/`6<529T/_XYF\%OLM\L>&(QNP!4*+CD5H(+Z![9:AA
M:$F^[+$1/W25@J.)74AO3/=J/NN.<VZV0-Y$4@/0P6>_%-QM?C(<X9.X!#F`
M_EM!]4YB%"PSZR\)PMV:8\D0_)*]2TV\AB9?*E[SGJ'.3H1-]X@BILF7HKK4
MQY^T_LAQA)5*VCU*@72SD+FF3L+6#OZY&WKP'@FMP@O'Z&H1><KT_<R,XNMW
MIS'ZVS$#XK6]>WRTLT>XHHKDNGBO#=3F!:`8643(6_7SM8=1550RO1"-EDVM
MO:,(E6XFPLPS)'0Y_>-(!%^F'G]U`^6@=(C4?!P.0K=]/4(.Q\`=)1<%VA37
MLSG$QE(<L+'5!.YKL9-L*J`SA+M44@?RFBCM0R;5J9!D>X"^Z?UJEFY6^'Y.
MQ[FZDB;?,K[G7.-7N5[[YK#WPK@&O7.5R<I?S@_GN&ZSDW^-'::.)"+D<8,0
M)F-*PX0R(838^_3^7U%\8\5WKH7H/_S]P$_Y?N#??#_PQ;X?Q!920'C@%3Z;
MW7SZJ-A3_\,KC"Y\L#$H:<?+6YWN#)9?F6X3.1IYFFDLVX-@SLH&7=4C:Y.N
M'!R7ZSW7!Y[6JVA`@["2Z>50G*K[?OW-J'U`W(:N`2H<$UL?@0,WNTY'(FB[
M!'7_'VUGEAM7<J7AK5P8;E`%2&Y14KFZ7@K@H($V:1),R0;<Z`<RF:*(2HD"
M4Y1<@)\:O1(_>Q?>2:^DO__$F"?BWB2)ZA=!S!MSG#CST&Z9H__^17.IG$0[
MQ"RSD,-+5/ZMV+_]0YVMI-^H_QH.8L9K"UU_H4>>RB9(FOCM]U5-><Q+,%+R
ML\";S2R%>LXE(CH^_!VY?_T5-G!^1CJSG(`+CQ0EJ<?F`9NW^@RSF$K&BY[(
M_6&.NYCY:JZQ(,H"6`8L:G<X<7PG4E9BH<KK3Y<D`Z!HA=ECM\MX<.P@"):W
M\]?]8?L%]+QYKK,2.#-#HT>J`8+BOD!A3,5FHUKF>G#8HY/XO\9[=3=XNKU7
MV0Q<,.$QD/<\I!U:\3;+-\'I%?RUES)Y^@[O@O3Z,OHI-V]X[TPU9?2OA=HC
M.`E"`N\1\@>8"(`QZ99((?1J?@)FEE`LU7VP`>T%Q96<?0UCFT*0&@8KJECI
MRM_1WCS)>Z,=<@U/#HEA&U/>)*O5:1"%>F=TRO&9CDNS[2.`+Z\_&\"]#':+
ML(RD.O/[F<G]9G,&)Y1UI@NH[_CFNI0,:<[I58XZ&HXJ7>WPZ*T.N(U7K=J_
MH7"`-@3!`MC+I0?UUK##-@\KQ6<<GA/\,E2C'%/Z0[>HPI*#`9O?>A\6[-*Z
MH#"Z]NH]W'=,OZ8C#"0!\/0$^\O8^1H3;#X!&3R9`<)^E!-9AFZ4I86S4DJ)
M`!!C9R]."TPEK9*>8Z^OGV$O5O`PL`)ZZPNYTS03`S1S6?X"@70`99Y@B"Y!
MQP6&&0.HH$$[`DU^)/?/2<#"JQCZ(AO!GB3AD*GTI-ATC[.*ZQ"X[2&`)7VL
M?"W&V-''EW.\CJ\P-QG^HN*VKU<_^YU7@)6X%0%U4HJ<DW1>[NG#WBVDAM3Z
MOK\1@R&0%__M3X;!0/4'I,^'=U?!3J[_#;K(+Q^:QB@_#U7L]02*9*S&Z+D+
MF&X#-M=X>GES@\/]*PIO`BHODS8EC^5G@R)$:[]AIXD2TZ.K^(NIJ`"8@Y">
M$IU.=BAAA>+4;6P_M1X+[T8N$`'8QO#CZ,S'%B`@<:O.*3`ZC,WD5[%V[Q#T
M*XNTL#&`7^6,3</[G@4!1IR^AGR%#G(`2TH,`%J]C2$V?K3154?2XML?!!T!
M4N?$PUS#-KSE8F&.W1\)TKY#&0UZPZ5LS<^@GL'/OE]BMG=CD;O>\)*)DZN+
M#F3'?$!-W#3XY%6]BK9A&6Z#O;K,.YQVS,1K>]I/T*N9(M'21!6.]$N_@Y@U
M@N8J4-G$BST9=DH>E8-/G"[A$.)B'NWCP'*U_`Y9;K8__+9AU8YO+L\H9A@:
MER-5UQWV53-PP_'[BF*;X3L@[GT,L`A5<D7ZST,D=O2/BX^K__('$>CG7/R9
M8BV^!O[,\$=PSS/V;#7*GI7(Z9N%.>I`_)4ZN>%/WM6^RM)O1)/2W1N::0&C
ML+AZF9:#]WP.]=*-8ZP!FW:XR`AS-RK<1ZX^R]5%R(L0YAGJ$@HXF@X]^*K-
MP:@W"^IFK93I,7KA7-E3\\=7ME_(V&QQJ2OP385'6+M=4;-I4+/8/64@84G1
M/&KJZ3;X>[WM$HX6K8HX6G9&M3$_[Y%J8=U^]#_KXM>NG%"T2_052RQ,QA*1
M<-"\%7W'+8P",`0?FHE./Z!_]ZT#VS''8";YBE,6$)<:><T@Z^VE)Z?]I>)"
MPSWX\0O^'0H;RTNK'D4?(R0NF6-;8V.9SK&QU7,MLSU._>VU/2Y]'@_]-UVZ
M)A2EIURAJ#3@A7*`^25,/>&PO_&#499K.`2$KD,)*T,C[)>E^::-<N$(MI5:
M22'OQGOL#ZOA[Y40X/LW4[V;#:_EQ?])QT9='=QZQ5/NRV5D7`:\6Z_)E30[
M8<P<E#<Y<Z?5_68Z`A^J9N5R8H>]-O>;I:)+]Y6)AG4!!X]/L-X&$F7HP_X1
M!Y?(AD"Z+T--`;`-(_3MQ_,P/=J0H]*W^[1O(?D^O>\&D?<9L0<!OG_GGL9!
M=[(Q!_:P+=QAU,Z#\1NI@!7*'`,U]U3U0V"0E$DHH(I2`[+8AZS.BC8!;_"S
M@8N(,\M9R2\QM$&E&./OWVLIP'GKM23(:U5<MI/^BA_,%Q+>CYL=KQ.F+V_;
ME#922E3H99+E"]XO\`LBJ\B@-^80"Q9N*F<$/+^!`UQCQ?O*C(W8)'>3=`9=
M$!!D+<H4ZD@='YL$&<$G]7P\O+[IF!6.R`/^'LX"O0^L4YGG[T/477A0*/"(
MMA,7%JBVO&[($13\2AK^?>O[\,$/-#%SGTG;(J[!;.1^I,.S\[+RR8^\])%M
MK8VA9F-K>-Y?@RX>`0Y#4CIPOQ!8Q>[J7Y$HT:*\[9'@2Z>(B885-'60904X
M@!^':PB"S?A^I#[JMA_9V`_]U268"K@H[6UX\*LE(@+#K+G&1E;TP4.AFT6(
M,/B[@*OSXTZ]E'788X_R0O(75B#]-D"Z\AOX1DGY!9,:^'D9EYNAUM#"A/)Q
M(V[H:3QWSF5UF3=(NUO?Y>$WMSW`)2#I!%.I/X?GDU^/Y]0D3;4F?%?JY/UN
M>/K<S%H-CQP^Q@)ZON?.YQN&C27=NA]3C2;_T88-/5MKI@VKZL)$)#:V4HJO
MC\])#$;>9V-=K%;[M/%++<3=BPW/_=JC=C&+2[_X!K/]`__3&_*)@.`;P,QN
M_%:5'"\*29A"8:@A+7@)FI_5F,<WN<#-)$T],,>S@*"053O+.<X^#(C52=9'
M]44$5$=9D-6I\HF`5*-.S4&$J"<0P(-WA]]T[A>#$XUV]^5XWU011IWJ.NGH
M4[3CA9^2AYZ78RX<LG6B5>%$P^'Z#E%#_$E5F=A7NB=EB$;)8H(2K-EMJT$A
M.&#M^V,+[[GHJ`?S'5?+,.](`$*"YUP&7H7(V.67"_%+[8YS^QE&B4&BG=GW
MP9V!G6`CI(GQBZA++A9+%AM#(KI)B4[)4!/,UC"Z=C3\K=MKAN=P93!BZ7`O
M02LU$MOPTU[T"`(BOP7]O-$T=A_L.?X@EM'*USRO@^B%*X>3*MN#50GDI^AK
MZI>*$B-JVTJ2A[B.7RIO1C1X9-6P!^A'R#!:9?_Q;4PH?$\,%KY)\81Y,)Q/
M<W2%NA5F7NJVZCQ&3^#5KV3=VDCNBA[1^!_4Y:;5F\0^>H)75D"R9[#;R&WX
M$Y4"ZU&KE=Y?H$1"`L'$].GG2MCPW5^^.R6!_G__LV&+=Q=4)5\N<`NOO`XM
MP/TWZ1,J*IBXWS1=]V\YA>4%Z8%@ZLD1(C^UT+-\&>U;*%0;U(AV/=HV6=:N
MW\H(Y[S6:<=W,KM=:2+]UA1C5BY\:?9//>:KB)EZN&U+'JM/6BK-[\^>/WG:
MT,Y3(2+&5)HFDKLO&J8IFT]ZA.A0Y38MA#_&<9#;Z^+2E,UDU9K+=MY@B[UK
M++;T.@M1`7+',)<5\#VOC9"*:PB#/[6W*?.+G&7L)'R+K8/@RO[%(KL"B="`
M%NYM,OC<Z[2E3>@*L82V+0EKPF7P^AMQ!"6*0*KCNHBBQ9!8\`AE6$$4VC.&
M1B7B^R5GF\U+MHHWT34R6+E8G[[F8)=T9ND80DIZT+A%.8@>DEVG2DX)&;PB
MCE/>WI8=#`],[1=Y2([JW(/M6?ML-A_]K><+6ODMAC4I(APJJ$/T6^`8PM2:
M3<(RZLOQJ4(H/,A'L23-9/5YDH.Z/D4X!_CK)@*YO)YDA9!/KRV`D.X[WW(#
M0<P>9FR^<+NZ4?_[&N%;NU%_D;YG)!B1JG-KY\NK2^,W?$M[+HV#P^/:M2CX
M2QW"GBG76O9C6#U<M*G8]J=-M.WKY=G?*(XY@ZB@V?JC$J7Y12-`"@#]S]BI
M,?/`4?L/.Z%\F?QNI5]>*9<5C#;F!*!F_D%Q3`UG2:7>)'>TZ*Z6KQH1:@=.
M_$+<>+.,BZ\6P"%PYPV1:.\CD*4(;G%3<-9*72B!@"<1//6>G?DQ4.IEB:<Q
M*U1KWFY0\1N8/`(_L$V=HY@B&D3O=N_JYN:#_O+SU&)7,\\.9O*KCQ]O,>QB
MZ17A\-TQQ]UBRKN^@H6@SC:(NC?%,F^E.<39S[!VU3Q8L)=G9/#6^?C)2*J2
M!VJDP#>[?_;M_W!;)F[;GS3MJV-MP?5@ABUG,?_PZ7IY?=E0(R!5H<G(=L4`
M/T6/BTDW`DBP,XNCSUY__`_W[IY+J-_H28X"R0`_)CA4>```C/Y'?KSDGVBZ
MVHU#5J0])./``"YGIB3V4,G/3[#U^[Y6;(OZPWW<63DY),-UG(:80#]\]M^:
MBTD(6$_B(@^!<#!#;V?9+;<ON)J=@/?9.WZ1*KD!=5P`7BM%NR646&"OZDA6
M(CI2*E5^P6,+2`V19BZ@KE#MZ!4,`S`&AY7-(UTB`E)R+0L!9!FSPQ;(0VWV
MQXWR0HTE&H13HZKF8_6FMAO\TGJKF=&!6A\WEY2PY[IX3Q"`*^68CABHP6#(
M)?=U3=NXW^+?=A']VT13\'0AT!169B6W_/4,%1.!$4U<]S$B#EI5*8X2>RO^
M_1,AK_!HN6;0Q-3S6."B@R2#/UGP5PNX/_RR(S!J#B_*OOX!G=S=5V^CX#?F
M?Q0TD"],&]@P!V@(?\`W\0S:D!ZJ7Z.!W;,?3;W9@-W1X11V;\,+=E86M!>S
M#`RO>"G#X7+NYS1H)FI!(2P-17&')M\SZ:SB\3-@5C1,48;0/&KD+H+Y*&`(
MPDDM',0OZN06KF\.,X%[I4!*H&I:M@*KOHN9K,2;B&^/-CE-:6P+6&\E_W'?
M22HU:]!-N_`GF[4>,"W(CP,*Q#DCI/&`&=(9V7PCVZN;H_**/J360QD!8BK/
MN0W:8PJWWL*&R6+#PX4;8M,?"+N05&/D+70T/9?XM1EGR%O<Y?;**OW-FC(I
M7(9XN+5-7*$\0'XZ&Z#E)"?6]Q"JEA<81+>X(M$DN7Z>$=V/7DC^NM\LC(UP
M-$@A:,;DPA]_]^-__)O&TAJ#;/HIEQ,960E-*6(:5+N:IE)O]62A?"?-(>/P
M]649$N/9>?L+W3H(,6RPUV@!XB*%EE&@_.L?*&G^]W_^L8+RHGU#UP#.,C7E
MZAK/8?L#H0O.V-#A[6?5S=5=(<Q0*.4NMV$B*,P`%)?0G<3X2-F'."E9E\BJ
MI]OE,2"0PZ0IR@>Y+ST!(70T>SFRG7XZZOIJX[HFSZYN;Z%R^)SB_)7CY[-^
M/3Q0MNA.VY_MOBI](F<`N$%5:XGJ?*L"H!$6;/BF5;$),'%::@@QJX!CNMM9
MU__O5,FN+:OJE%8)F"BOO11*28B"L^C8!M0)*`92I/(G]SI$.$AW^?*JW?00
MUTQ^"[0)6(8K$![[(M!(]@9]->;H&Q*,P1ZO0;=F^LZ8(=B?BRTL-&"H?+/Q
M!KI>'"<I1V-A/_6B_,A;%"GML\$GS14&E:PVTUV!<)%N.C9[OVA$N&H;?`7,
MKAI^.F-^'6*$EP)`ENK7-">3\Q219V0(!$$K3"'/7G\BI3-L3."Q[];<YK*W
M'SOZD>N]Y;'3;D2:PGXYWW,.)]Y?<T*9M-?WH'-/Q,U/&S=T_+YP!2__QN5:
M0:S]0/:Y[([LE*?2RH-<D,%*=\F,,[N2Y*#DIXX#X`':P$+Z]/;;]5BOMQ^(
M9QS[^`I%GO^V)_.,^/HT^/$-@72@BTF%-3J>A$GV.U:6BH7V\T4KZQV"/1[,
MNJ84F7YJCC_G6=/\_GOJ%R\H7UNO+7E_D[*C-2B\C:3I5T]8ZU>LB3*2E*$@
MY2Z`DQ)]Y&Y_[12T?@G*\9@/KB_%%.6`[XPFH!=H\^AT]JZ-5LRE?OPHKN*/
M_UQ=51O7C:2PW4N^^M-;2DPHD(HG_&=6*<X]N=[Y"4+TZ4FI,=_(<?42&L$D
MH`,,(@2^K31/X2NWGV:N\NNUK>'S-35.1`\A?V@_1.Z-%=-M"[[AFK8@P(9A
M8-ST<_R#+N*HS-5`#G]5*AV&J_K[[<V$8N-1U$\(E2*H/N:#W?UEJ-N=1$.V
M`<0D)BFDPU!YK_+$9P6&^575A&%>8?(1,:5"6$%<\^-M4>>]ZZB6T8`3VD2Z
M&2JY<7"&9E$.IJ9H]>?'>FU^3K=WNTA.N-"(";:OMDKH\@J_]FF3Y#%2UMNO
MSNY3RK*54O[!)B.D=!-(^X[!;18I#'E7@8C!`X*S2`4'$LIJZ'3HN6Z9C^`;
M2P"%W$Y^QO"$SNVU<N`9RR>;)YL(P3W0?_:3<(X-[<<J%7C=#GQ#4R8:OU\G
MR62;FV;H[=+WZ0=0);V13D&88@241QQ&4V]=9'^^6@CUV^4%!6OC191Y0CDB
MWZS29]KQ]A[T(EBB?=?R'!8YSW?0B=8PX'N%TWQ0&8S@<!++FS]D7.6<$:^T
MN,C%TS9<S;8AF>%%%""&9R^Z-L>M9P$9#92?,?/H0'JLGG$R/M*KS&SFH_/[
MR<\YE:0^^QI#VLVN&C/<)!:ZP;<!>'(,;)#'$J=DD;N)H1W3***&>)M*9V=]
MK*U*CXAJ8[&<O07@?8/3'E18TN+T_%X*I"28GN`X=Q?$M%D1[O-0,]N/]C(H
M-T:^BOI'[">X-8,[:$3WK+`QA'^1X_Y+C#*#>>!M:MO$")](W"[!WW[5J3U1
M``C#!`V>=HN-'UH].\[>B%OC5+/;EA$?]5A-+NU#BOX#C'LP6=U%1ODZKH>>
M8KKC2#;N=)I;T>U\H)QU?$!]ZWYOL;'(N%$\?^??;;ST=S$!H;^PM(U<S-PW
M6+,.92(5:)LB1TL$>F4A.>5@.['J@84>"T0L[V=E\K-?27DR$3Y\@_AD1KXV
MH!E(I23%*IS'C_DJ!_H\)(R^.I)^\&6F7U:O3SGQ]2*:![$5,72&\1'$F]KA
MIR/X&G[??0JI5?(Y&?`^Z3V9<,D10OS!Y'<'BQJ!>8QL1,H_W&F^3@::0:<D
M_Y)-R#Q;E>%7"[M52P267P/13-R"5+T!TP>)*HH'TTYQ2:H$[,&Q^V1MG)/&
MOB%,M0#J3X['40SVG30]OGW,#6H/?^?B(Y$6/"YTXFBNX\'X'MI^3N."40*U
M>2S@`(.N9'-W3:RP\<23]"E=39[5-#=QIIB[(?ZE/`CI,G?)=:4B(U.&K2J1
MP_G_<R*'C5NMMG`JG"&>$J]O&6"D9Y[:1CX9$>4,I.-)(3:NI3-&C"E[3%V:
M+V=+#Q%E\4CF#]9A0;"/KI9+MKNZ#V-4)I=!_B[)'V(/96-8]-ER6@3'Q$<7
MB_"_[^0#+JDNW(<T\5;]PA_%3O:6ZS0VKO,B&0PU?[!=5.88V"PN'O*FVBWR
M;OQ\U3GPF#C$3RZ+9W&2-^>`M7R4OGT<9CQ6;M.`XFFS5E2TQ<]@7KO^QVK:
MD1`U9<,=[Y51G"')DHG,]]`3X/9ROG]TZ-]P.8AY-'SKLJJQ\<?/:7JFC:=T
MMZG'S^JYW\L>/LCL5EEU+?'&IN_C._,CC0=,=EJ.':1?SBN,GR3X\S_?(5O-
MAG#]S2-,(5:?X?'AJ*UV2'K1;-,EDMST?808_/MJ]>6G_Q,```#__P,`4$L#
M!!0`!@`(````(0#9UYF^?@,``$<,```8````>&PO=V]R:W-H965T<R]S:&5E
M=#,N>&ULE)==;YLP%(;O)^T_(.X+`0+Y4$C50+I-VJ1IVL>U`R:Q"AC93M/^
M^QWC)(V=U$UZD0:?A]=^S['A9';_TM3.,V:<T#9U`V_@.K@M:$G:=>K^^?UX
M-W8=+E!;HIJV.'5?,7?OYY\_S7:4/?$-QL(!A9:G[D:(;NK[O-C@!G&/=KB%
M2$59@P1<LK7/.X91V=_4U'XX&"1^@TCK*H4INT:#5A4I<$Z+;8-;H408KI&`
M]?,-Z?A!K2FND6L0>]IV=P5M.I!8D9J(UU[4=9IB^FW=4H96-?A^"8:H.&CW
M%V?R#2D8Y;02'LCY:J'GGB?^Q`>E^:PDX$"FW6&X2MV'8+H,!JX_G_4)^DOP
MCI]\=_B&[KXP4GXG+89L0YUD!5:4/DGT6RF'X&;_[.['O@(_F5/B"FUK\8ON
MOF*RW@@H=PR.I+%I^9IC7D!&0<8+8ZE4T!H6`)].0^36@(R@E_[_CI1BD[I1
MXL6C010`[JPP%X]$2KI.L>6"-O\4%.REE$BX%XE@]?MXZ(7C.(B3&U2&>Q68
M]["4R!O'\3`9CSY<BZ]\]6G*D4#S&:,[!_8>K)QW2.[D8`HJA_PH-\>,O9<P
MR)04>9`JJ0N'!G+!H<K/\R29^<]0F&*/+,Z14">R<R**=217"'P>YS%$EN?$
MB8@/IH_.H2JGSB_OB(-!"4N#<H=(QPMS(#,'<C5PNM;$L+.T(MIB8>M<OU@)
MIRZ('[.4C/1$+A0RZ4L5+.\B/9S9P[D*PX9\FT`76-H(S1B(7&],PH:QL3[Q
M0B%);RP>]'\ZD7U(Y*?$,`(-76&IXL-^CK>89@N.TO6V)&S8FNA3+A1B3MEO
MQ<P2RRVQY>689B.YQ8:$=1NCM^RH4Z.0RS8LL=P26UZ.:39&M]B0L&$C,*JA
MD'=/CSV<JS!LHG=/CXW0C,DVY>3I;7^&2=@P9CP]%PI1IR?:'Q^CAMDI$UYF
M<L78+-H(S>+D%HL2-BP:C[:%0I3%,`E'D^3L@&>G3#`&!KHV(PVY8FP6;81F
M$1J@&\K8TX;)H;%!]XS=I0:]9W,/V7Q:$654]6>J\6@P6^,,US5W"KJ5O5<$
M3]+CZ+$O?`CEV]887P13>/6>CV?!%-[`,.X?;X`VKD-K_`.Q-6FY4^,*IAIX
MLE=BJA%4%X)V?1NTH@(:N/[K!AIV#&_Y@0=P1:DX7,@)CC\!YO\!``#__P,`
M4$L#!!0`!@`(````(0!VJ9?4G@4``(\7```8````>&PO=V]R:W-H965T<R]S
M:&5E=#(N>&ULE%C;CIM($'U?:?\!\3Z&;N[6>*)`E-U(&VFUVLLS@]LVBC$6
M,)GD[[>ZJP>ZBYC@EYDQ=;HX79=3GGI\]ZTY.U]%U]?M9>>RC>\ZXE*U^_IR
MW+G__/WQ(76=?B@O^_+<7L3._2YZ]]W3K[\\OK;=E_XDQ."`ATN_<T_#<-UZ
M7E^=1%/VF_8J+F`YM%U3#O"Q.WK]M1/E7AUJSA[W_=AKROKBHH=MM\9'>SC4
ME?C05B^-N`SHI!/G<@#^_:F^]F_>FFJ-NZ;LOKQ<'ZJVN8*+Y_I<#]^54]=I
MJNVGXZ7MRN<SW/L;"\OJS;?Z,'/?U%77]NUAV(`[#XG.[YQYF0>>GA[W-=Q`
MAMWIQ&'GOF?;(@A<[^E1!>C?6KSVQM].?VI??^OJ_1_U14"T(4\R`\]M^T5"
M/^WE(SCLS4Y_5!GXLW/VXE"^G(>_VM??17T\#9#N"&XD+[;=?_\@^@HB"FXV
M/)*>JO8,!."GT]2R-"`BY3?U^[7>#Z>=&\2;*/$#!G#G6?3#QUJZ=)WJI1_:
MYC\$,>T*G7#M)`#VVLXW/(U8%/_<BX>,U`4_E$/Y]-BUKPY4#;RSOY:R!MD6
M//_X1G`5B7TOP>H(D.TA#5^?@N#1^PJ1JS0D1P@4_@CA-J*8(X)HA'A`:^0&
M-S:YR:@'D+MECO(0X1B.[M4U<H2D*KKR7H7QP"(``3$)++]8@H&@<?,@)B]&
M2&A`"*)80EC4P,EZ:A*\<^&68U*"A%!#2**2RJ$N:=9,>Q)EV7C<8@75;+):
MES%YB+!+1_>8,83$BAV+H=Y)2@L+P)(H8*,'BV!L$US.J`038M.]D1A"WHAQ
M$M7",OO^C3I/;%+KHB8/V>1"?[PSDD.()A<DT]N5N3#-W(^FC%L1DS-LM4!(
M,"$U)0))(423RGB0D%P7%H"G+)V":A'+[B$FP838=%\DAA`DEB8^[4S3G&3Q
M%$R+%`-]6A\NA2:T9H(J/>Y<Y,6CA%1@H7UH>VADV29VG]"C2)N*$9*6RQEB
M0M64T)-V\16V^59U,2F]J\M+H4F\ID1@&C4&:?%L*AXL>LL<)E.T[6A)'5Y/
M"U7;BA8IGYPA1J?)#^.9PEH(%F3)S9C=I?T,E1M>/XI_2(*2:PP@1PSA7RQ"
M[-B1(;"LL?)K%.U,H@BYQF#L6.8322DL.X?Y,):B3>PN\6=S]0])[^4:@\12
M\\6ZV(C^Q[?*C4R`GX1L+OT1E7YFBGL,7S/'D&AFECU))[L=LKO4G\WE/R*Y
MRC5&YS)FV4PW+/V'9$^Z8U,C^K]N:K+Y(##:3"N(*?6,&1JA8V?:(Y[>2"J_
M:Q0HM"UMT>08B6D,2EMF%!/RLLPQGXK5BAN_:Q`H-*$U)433PD&@4YH&G/1O
MH9T@@(<9O]&@G`R#=2E5IPC%J9PU1>EYYYH"%TTD=/@6,78,[QH/'*7?5."(
M*K#&F`1G_-#-CR$V/<"LGUY<HDG\2`9SC3'?/8\?^KF!L0F2$2$3S7QXN"Q\
M\M]<RG2J<IUIQ.CQ/^\1T\QNMNY=DX+/)T5,]5ACL`7B-`TR@B@L1!3YR<T&
M)L-B99?,AT9,M9DC!F/WP$)2!85MC[*IR^SLWC4T^'QHT.^2N<9@]!XBGW-&
MN!<V)`RB,)L@-CTR.'Y2<_.!08LJY^9`8"E(+Y'(PD9`9&])H-QOF*V[+KGJ
ME-W",:&0:XP6X1]]`;402U]`@[M&B$(3<E/E8-=JC*D=5/X6(5:"`S)&EA.L
MT/;>9J;.&K-(;SX]IAO8].X:'K#6G&D>Z<M<8TQZ,W5>QB!!W'_B>K`1W5$4
MXGSNG:I]D;M-#O_HC4]Q[YJS;<[E&HT\+V`?JYY[HP'6H=?R*#Z7W;&^],Y9
M',"EOTE`CSM<J.*'H;VJ[=US.\`B5/UY@L6W@#6=OP'PH6V'MP]R93NNTI_^
M!P``__\#`%!+`P04``8`"````"$`&'WVHM8$``#D$@``&0```'AL+W=O<FMS
M:&5E=',O<VAE970V,RYX;6R<F%MOJS@0Q]]7VN^`>&_`$#!$28Y.[K>55JN]
M/%/B)*@!1T";TV]_QC@79LB6]KR4QO/S,)[_C`'WO_U(C\:;R(M$9@.3=6S3
M$%DLMTFV'YC__#U["DRC**-L&QUE)@;FNRC,;\/??^N?9?Y2'(0H#?"0%0/S
M4):GGF45\4&D4=&1)Y&!92?S-"KA9[ZWBE,NHFTU*3U:CFW[5AHEF:D]]/+/
M^)"[71*+B8Q?4Y&5VDDNCE$)\1>'Y%1<O:7Q9]RE4?[R>GJ*97H"%\_),2G?
M*Z>FD<:]Y3Z3>?1\A'7_8-THOOJN?C3<ITF<RT+NR@ZXLW2@S36'5FB!IV%_
MF\`*5-J-7.P&YG?6VP2F->Q7^?DW$>>B]K]1'.1YGB?;39()2#;(I`1XEO)%
MH<NM&H+)5F/VK!+@S]S8BEWT>BS_DN>%2/:'$M3V8$%J7;WM^T04,204W'0<
M3WF*Y1$"@+]&FJC*@(1$/ZKK.=F6AX'I^AV/VRX#W'@613E+E$O3B%^+4J;_
M:8A=7&DGSL6)"]%?[$['"3SF^5_PTKUX@>O-RZ=#@&"K=<#U-OG+Z_`O3GC=
MR9?7`9U5A0+76RB?7D=XF0S7V^0OKX-!&6E509F[F\^NQ-(U4I7<)"JC83^7
M9P/:&*J@.$5J4V`]!JZOQ:9+XU9^_U=]4';*RW?EIG(&A55`Q[P-PR[K6V]0
MYO&%&6D&4GAC?$Z8\9515:T<3^C`E`[,Z,"<#BSHP)(.K*X#]]!(8.LK<0UL
M4QNP()>WA$(.&PEU0;S'W7O-GYJ%\\=]DKXFXF!BW"1XU\/,Y`'#7<Q,'S%=
MS,R:C$MN-6\BG!-F\8#I<GRKY2.&A+-J,B0YZR9!`]XT$7Z/!8D,N^(OB*QF
MP69<:X"P2\(<:0;VRWN3X'2,6XE)*S%M)6:MQ+R56+02RU9BU4JL6XG-1P22
M%=*.9/VX9Q4],*%H;E)Y;H#%&FF&5SNB$]#2'B-SZ-RK36]^=;/KAJ16IG6S
M8P>DMV9U,PMLLI_,ZV8GX*2C%LCL!\2\1&;7L_&Z5W4S@_<.NIW6[2%GQ/NF
M;G:87[,CO>#-X`MZ*1KK%9+[CC3B5W(],=?V2-+&&/!\NJ%-,,"93VXQ10"H
MYE#9".!UR?8\1P#C/"3)76#`8XRHL\2`[]DDAA4"?)\[Q,,:`V'8#7$!;!#0
M#;SP7MM(0G@_0Q*J]X_VQZ6:1:0D2HTTHCOOR6$>S?,8`?!:VY`2`P^D1,`C
M*0G0E!(!CZ3$P`,I,?!`2@1PCP5$J34"_`=2(N`#*>$5^Q>D5+.PE"Y](1EI
M)M1M:7=LLH1QBWW28I\2.R,--6NQSZD=]\*"F&GX2V*GMU\1.WW(K(F=OGAO
MB-V]IP^UHCH^H)\"[:VH9E']R(-JI!F]K3JN%_![!-6#;EP'6.#:#O$PP8`3
M,K(I3@G0>-3.,&#[]'$Y1P#G`2=[W@(!/O=K6UJUBB4"/.AV4D<K!(2^0[><
M-0*XW?5)HN#8065;9U(]5NW[+;26^E1!?^*E(M^+L3@>"R.6K^K$P($6NHWJ
MPXP1Z\'W$'S6D/$5'')4X];-`(<,IV@O_HCR?9(5QE'LP*7=X;#7Y_J80O\H
MY:GZEGF6)1PO5/\>X#1)P/><W0%X)V5Y_0$WMF[G4\.?````__\#`%!+`P04
M``8`"````"$`P$1R0",&```](0``&0```'AL+W=O<FMS:&5E=',O<VAE970V
M,BYX;6R<FF]OFT@0QM^?=-\!\;[@!3L)49RJL.K=27?2Z71_7A.,;51C+"!-
M^^UOEL'VSN#,VNV+-@X_9N?9F=T'LWWZ^*W>>5_+MJN:_=)7P<SWRGW1K*K]
M9NG_\_?G#P^^U_7Y?I7OFGVY]+^7G?_Q^>>?GMZ:]DNW+<O>@PC[;NEO^_[P
M&(9=L2WKO`N:0[F'*^NFK?,>/K:;L#NT9;X:;JIW832;W85U7NU]C/#87A.C
M6:^KHM1-\5J7^QZ#M.4N[R'_;EL=NF.TNK@F7)VW7UX/'XJF/D"(EVI7]=^'
MH+Y7%X^_;?9-F[_L0/<W-<^+8^SAPR1\715MTS7K/H!P(28ZU9R$20B1GI]6
M%2@PT^ZUY7KI?U*/.D[\\/EIF*!_J_*MLW[VNFWS]DM;K7ZO]B7,-M3)5."E
M:;X8]+>5^17<'$[N_CQ4X,_66Y7K_'77_]6\_5I6FVT/Y5Z`(B/L<?5=EUT!
M,PIA@FAA(A7-#A*`O[VZ,JT!,Y)_&_Y]JU;]=NG'=\'B?A8KP+V7LNL_5R:D
M[Q6O7=_4_R&DQE`8)!J#S"'[\7H41`\+M;AS1PDQHT&@SOO\^:EMWCSH&ABS
M.^2F!]4C1#XJPSQ.6M^3"AI-D$\FRA`+5'10GZ_/B;I_"K_"G!8CDR(#2^+$
M*$ID1\),H`FKK5^$D.\I:9@*.^G+93CF9F">VP,=.9TR$26R*1$O***GR/UY
M#DC^\2WY&Q@:QIJW1"5TZ!09J-]I;N\HD3D)+1$D>QCF^MDW\-*'J3EEED0S
MFEN*C)W]@J?O1K2($`&PYFP!IN=CV!/D-C(W<2&L@5-DYL,"B**`-4A&+]-)
MT/9%]1"HF?WG/!`1<C<5,H<XLA!S$Q?"NCU%!H7,@IBFFAVOGFO*RJ4E@BBX
MIPKDS`W,,V>YI<C8O<1RRYR$E@B2O?%W:_.4LS>P:QTC(V7O)+1$D.R36[(W
M,)_[.>V+%!GLFOAA'IR[=MC.L^/U]_M&(DCN"M;K]5,_T#Q[MCK3$9(FWXUH
M$:$2C+M=W3T*O5"V@1$2)6`<`=%B%"K!6)XEX;J=5*%14D]@JS0=(3O/)#K;
M*3;4!8C%T2)"Q1@#M,3(JUFA75(1_+%BA&P1++_,C6@1H1)@I!LD&-JU(RF$
M1`E.1(M1J`3C@U85KFPI=$]:#3;5J7EB![VVE"1B3U+9!8C%T2)"Q1@?M,0X
M6@I=DXB(^;.2DJQU7!5.1(M1J`1CAM=+0.MT[%*2OXX2G(A6$D(E&$>\7@+Z
M)ZT"<[)4'4W6?-51<<`6?G:Z_K[5B0C-W[BBE?^52P*]E.K@SWE*,MRQ%$Y$
MBU&(E.@FVQYHUP8U0O:J9@LV<R-:1*@$9MO752-"VZ75X,^N(V1+F7K>!8CI
MU2)"Q4!"M[=69.YBCU,Q?Q@<(5L,RS-S(UI$J)2;[#M"^Y8WJA$2)6`<`=%B
M%"H!POQ`-<Q=O!J3UD+(SC/A+S"R:`JQDFD1H6*8D<O>9]Y@342PP=,1LD4P
M)',C6D2HA)OL.T+;=;24TYNS,8Z@4HL(E6!<TO(.1Q704\DN%4T6]M%XC?=%
M*@GX4WET!-XW/Q&A`FXR[^B2>;/\TA$2)CAS(UI$J`3FWXX:H-\ZVLAIREGD
M1+2($`GF]9C=1M>9WG`7VYDBMF+3$;*KH=CNE5U@6!@M(E0+,W"Y'/$EXV:/
M>^D(V1I8?ID;T2)")3#;=DA`NY8[*D9(E.!$M!B%2C#&:6U,5W:4N<O940C9
M4J9>%T\A5C(M(E0,C/4#8LQ=3$S,OH^F,4*V&)9GYD:TB%`I-]EVC+8-<WE^
MO3\]G$!(E.!$]#C4Y2A4PDVV':,C0V^?)<3\^]X(X:M-I29O]D_7ST%8E;2(
MT/QO\NSX@F?/^5N#$;H\>?@]SXUH$:$2;G+M&%W;T44(B1*<B!Z'NAR%2KC)
MM>'T>;*6)T].(Y3@^=#]Y*W!>/UR<D.5S"FW&><R@OGC*38>\M9ENRFS<K?K
MO*)Y-2?4"@8__19/SU,X/1^.FL/3!3B\/N2;\H^\W53[SMN5:[AU%MS#,FWQ
M^!L_],UA.%I]:7HXMAY^W,)_4RCA\'86`+QNFO[XP1RPG_[CP_/_````__\#
M`%!+`P04``8`"````"$`"%1>X>T#``"L#0``&0```'AL+W=O<FMS:&5E=',O
M<VAE970V,2YX;6R45UV/FS@4?:^T_P'Q/@%#^(J25"6CV:W42E6UVSX3<!(T
M@"-,)C/_?J]]/8#-)$U>DL`]/C[WP]<WR\^O=66]T):7K%G99.;:%FUR5I3-
M?F7_]^_30VQ;O,N:(JM80U?V&^7VY_5?GY9GUC[S`Z6=!0P-7]F'KCLN'(?G
M!UIG?,:.M`'+CK5UUL%CNW?XL:59(1?5E>.Y;NC46=G8R+!H;^%@NUV9TT>6
MGVK:=$C2TBKK0#\_E$?^SE;GM]#56?M\.C[DK#X"Q;:LRNY-DMI6G2^^[AO6
M9ML*_'XE\RQ_YY8/$_JZS%O&V:Z;`9V#0J<^)T[B`--Z693@@0B[U=+=ROY"
M%AL2V<YZ*0/TJZ1G/OIM\0,[_]V6Q;>RH1!MR)/(P):Q9P']6HA7L-B9K'Z2
M&?C16@7=9:>J^\G._]!R?^@@W0%X)!Q;%&^/E.<04:"9>8%@RED%`N#3JDM1
M&A"1[%5^G\NB.ZQL/YP%D>L3@%M;RKNG4E#:5G[B':M_(X@H*B3Q%(D/ZI7=
MFWEQ0(+PSRP.*I(./F9=MEZV[&Q!U<">_)B)&B0+8!:>^1"?CST#E\2:+V*1
M7`IH#NEX62<D6#HO$,)<85+$P`GH,9Z.V$P1_D#B@+Y>)+A^OTBQ2!?ISW4%
M*4)B&6;AV&;T0A,`D1D+N!X=`88HCCP/W-#8&3'S$<9`;*XA-&U`<KLV`5[9
MX&:?E<"-#&V(B61>R3P*@R$K,OT;#>!%@9?T#)HRJ.W;E0FPJ2SN>>7&*6)"
MJ<PCOF_&;&PG,0G]?KVF*[Q'EP";N@9_41=B4%<2N*3?%N,U-L<7HQ7=HTJ`
M#57$U;=-$8.JB!N&YOG3[)#&H0ZT:(E+;-0AKM>^`)NZC'"DB%%9G,=F$C4S
MB0>O-%7)/:H$V%#E&M%($:.BY7F&>6.8!Y\T501:Y^W!DFA=5T*,<*0*I(0E
M7CS)HXZ`6R4:ZE-79S3[ZZDDV)^U7D&,L*0*A.H>2.)%_G#HL/H-2.1Z_L"B
MZQ/M]^92(]BL=7U&JTH5:([-;-2HE#;D4.;YA1-`1"^^71=V;O@<>NPTJ]?:
MN])V#:+'[:XK@'QP!Y#!<[EYJD`8F`<RK3DD4?;1&=:%W74#B(GJC\=4@7#C
M::TAA9(57CJE=UT`Y(,;P!N85;P0]!ZO::'I]HN5=M<E`"/O)&">.>,H$.1K
M*$>CQXC961!=P&!*<3C&V;&F[9YN:%5Q*V<G,?AZ<,#ZMSB4IV0!`Q8,P\;[
M#0SK\KW3&V!6/F9[^CUK]V7#K8KN@-*=19#-%J=M?.C844YT6];!E"Q_'N!?
M$871S9T!>,=8]_X@YOG^?];Z?P```/__`P!02P,$%``&``@````A`*J#;"_C
M`P``Q`X``!D```!X;"]W;W)K<VAE971S+W-H965T-38N>&ULE%?1CJ,V%'VO
MU']`O`]@("%$258;T+0K=:6J:G>?"3B)-8`1=B8S?]]K&UAL)B0S#YD0'Q_.
MN??ZVMY\>:M*ZQ6WC-!Z:R/'LRU<Y[0@]6EK__?O\]/*MAC/ZB(K:8VW]CMF
M]I?=[[]MKK1]86>,N04,-=O:9\Z;M>NR_(RKC#FTP36,'&E;91P>VY/+FA9G
MA9Q4E:[O>4NWRDAM*X9U^P@'/1Y)CE.:7RI<<T72XC+CH)^=2<-ZMBI_A*[*
MVI=+\Y33J@&*`RD)?Y>DME7EZV^GFK;9H03?;RC,\IY;/DSH*Y*WE-$C=X#.
M54*GGF,W=H%IMRD(.!!AMUI\W-I?T3I%"]O=;62`?A!\9:/O%CO3ZQ\M*?XB
M-89H0YY$!@Z4O@CHMT+\!)/=R>QGF8&_6ZO`Q^Q2\G_H]4],3F<.Z5Z`(V%L
M7;RGF.404:!Q?"DCIR4(@$^K(J(T("+9F_Q_)04_;^U@Z2PB+T``MPZ8\6<B
M*&TKOS!.JY\*A(2H@<3O2$)0WXW[CK]:H,7R/HNK%$F#:<:SW::E5PNJ!M[)
MFDS4(%H#<^],Z1B\WK(*\@3)5\$BN<`%@_R\[E:QOW%?(:9YA]DK#"R)`8-T
M1-(CA&M!FXY^<$'O(!I"88H.(*D?IZ/7*";I&J.E+F`_A1@FDBDB6.@DZ102
M10-$LQ'H-N;E"_#6!O(A?*L@'GAEO/8*`VD<,(;#Y"XBG4-HZN$UXR3,JQ=@
MJ/J1LE4<&.H59D[]740ZA]#4P[I[7+T`&[&/0T.]PBQE\:-H851%HH9GS*5S
M"$WZ\C/2!5B7'H:F=(4)I71_X>G&DG[T9E&E<PA->?09Y0)L*C>BNE<8I?P)
M(6,XZ8=O2Y]#:-+%5C[JD_/5+L"F]%\]0*U5A>FD+R?2^^';TN<0FO3X,](%
M6)>^BHVP[A6F*W4_,H83;7BR$E(U_/%*T'0C:.GCF(N]Z7Z;E[/,5F.TP7T'
M^EB$S$]R'Y+.0G0K8B=[N'R0VO>T7C_I-QTHEJLV=/S`&_\92SSIT#.&TUF(
M[D9L<8^[41OBV,VT!2$%4FX0N#&:D#9^SVW:H2,9FU_]3#<A-KK'3:AM43=A
M%/X>*5!O`HT3XGF3TXY"SZ9D#J*[`9I/N!%H?96'H=F@D`(]6F`*#9^WSAYI
M1_@Q1'<C]L+'<Z-VSG%NICU+'-?!LG(3..;A(]'&[Q?8_<U:72;46;O"[0DG
MN"R9E=.+N"@@*,WA5W6)V8M+C+R&#`-PAVBR$_Z>M2=2,ZO$1YCJ.1&\O56W
M$/7`:2-/M@?*X?8@OY[AMHCA#.TY`#Y2ROL'<<\9[I^[_P$``/__`P!02P,$
M%``&``@````A`+L]K1$*!```Q@X``!D```!X;"]W;W)K<VAE971S+W-H965T
M-3<N>&ULE%==CYLX%'U?J?\!\3Y\)X$H236$SFZE5JI6V_:9@).@`1QA9S+S
M[_=>#`2;E)!Y&`(<'Y]S[_4U7GU^+W+MC50LH^5:MPU+UTB9T#0K#VO]YW\O
M3[ZN,1Z7:9S3DJSU#\+TSYM/?ZTNM'IE1T*X!@PE6^M'SD]+TV3)D10Q,^B)
ME/!F3ZLBYG!;'4QVJDB<UH.*W'0L:VX6<5;J@F%93>&@^WV6D(@FYX*47)!4
M)(\YZ&?'[,1:MB*90E?$U>OY])30X@04NRS/^$=-JFM%LOQZ*&D5[W+P_6Y[
M<=)RUS<#^B)+*LKHGAM`9PJA0\^!&9C`M%FE&3C`L&L5V:_U9WL9V9YN;E9U
M@'YEY,)ZOS5VI)>_JRS]EI4$H@UYP@SL*'U%Z-<4'\%@<S#ZI<[`CTI+R3X^
MY_Q?>OF'9(<CAW3/P!$:6Z8?$6$)1!1H#&>&3`G-00#\UXH,2P,B$K_7UTN6
M\N-:=^?&;&&Y-L"U'6'\)4-*74O.C-/BMP#9#94@<1H2N#8DCF=XSFSA/\+B
M-BQP;5G<QUF\A@6N+8LSU9`I@E/'.HIYO%E5]*)!`8-]=HIQ.=A+(,8@NY`J
M$9(N['^*.H0;29Z19:W#RH/A#$KE;>,'BY7Y!NE-&DPXQ-@R8MLB,)=(&_4>
MF*"W$PW9Z(N^71&M-@2CMI8U%`^`NQ/K*$*&"'<F0Z(A9'$U+(F%I$\7B^"U
M#N2=-M]UY:E#@8%D=9BYC-C>141C"$D]3--7C_7A_7$1MB''05!'/86^Y\L:
M0X$9<W$7$8TA)!>@N.]BO&`0+.?`FRD1#@4FJ$O=,@(E1=O^:]>8>;+WJ/_:
M,:R@>RV)GC\B&L&JZ&M!ULLI%!C;<VO9SI<G5?8]0"0#7,.2_^P^I>1E\8@7
M!,M>_$`M'X'IEX\?7.-8^]T.,8%E=;$6+>86YMJ7)`_X8=%KE>-%A&#9@S=7
MY@X%ILV'KT;S1H+D$;8Q__*D]*YH%"+Y"1[Q@V#93V`I4X<"T\^)LFRV=Q'1
M&$)2;\,NU4_'M,Y4C[K7FAK0F)'[D&@4(EO!?6YR9=EB5^SO$</^U(!$@W(,
M[UK28FE([UU#:021]-HQ%M<\RL)Q%YPN7.R9LG"U1]D"U"X*^+X/Y+]!Q6^5
M(3-U'4E=2:QZ98AM./(D07\6V3+NG-,MBWVV;WG8RNSA9AQ82D:V-T'JOG(#
MY,^O(-D(;I[3C2!:7O_#?@:G`01=<^?UP]@4GHJYT<(&/!)&N!#'!O$I6Y#J
M0+8DSYF6T#,>"1S8X;JGW7'EV<&/0.5YB,<8?&YV+^`4<8H/Y'M<';*2:3G9
M`Z5E+&#;KL0Y1-QP>JH_H'>4P_FA_GF$\R*!3U?+`/">4M[>X`27]@2Z^1\`
M`/__`P!02P,$%``&``@````A`+,Z&60"!```90\``!D```!X;"]W;W)K<VAE
M971S+W-H965T-3@N>&ULE%==CYLP$'ROU/^`>&_`$)(0):F:H&LKM5)5]>.9
M@)-8!QAAYW+W[[MF"<%P9]*7NY`=3V9V%Z^]^OB<9]83K03CQ=HF$]>V:)'P
ME!7'M?W[U\.'A6T)&1=IG/&"KNT7*NR/F_?O5A=>/8H3I=("AD*L[9.4Y=)Q
M1'*B>2PFO*0%1`Z\RF,)C]71$65%X[1>E&>.Y[HS)X]982/#LKJ'@Q\.+*$1
M3\XY+2225#2+)>@7)U:**UN>W$.7Q]7CN?R0\+P$BCW+F'RI26TK3Y9?CP6O
MXGT&OI_)-$ZNW/7#@#YG2<4%/\@)T#DH=.@Y=$('F#:KE($#E7:KHH>U_8DL
M(S*SG<VJ3M`?1B^B\]D2)W[Y7+'T&RLH9!OJI"JPY_Q10;^FZBM8[`Q6/]05
M^%%9*3W$YTS^Y)<OE!U/$LH=@"-E;)F^1%0DD%&@F7B!8DIX!@+@KY4SU1J0
MD?BY_G]AJ3RM;7\V">:N3P!N[:F0#TQ1VE9R%I+G?Q%$&BHD\1J2*:AOXM[$
M6P0DF(VS.*BH-AC%,MZL*GZQH&O@-T49JQXD2V"^.D,=K=>WK()'1?))L=1<
MX$)`?9XVH1NLG"?(:=)@MHB!5Z+%$!VQNR)4`A5MU/G"`;VM:$A%7[0/17V]
M'%>-:I&NT9_J`K9#B*<C=D.$W_,9#2'S><NBV?"'-J9O=M75AEH$_=-)8^C.
M6OXZ;UO$0#G;5/<0NU%$9$)H+N!GNL4P%T&!US:DJ%5&/+>G'C'SNHV(YT][
M\9T6=Z=^J*^/NO&`+&YA338D^G[9"JS+#MU;43'IB($?;ZWUDSZ*B$P(3?U,
M5Z]>V_'648O&6@<Q)A>CB,B$T%S,=1?FUE%@O0;#UD',#%N'++R%WAH[+?Y*
MZW3CT#JW5UN3K<9Z9\\TRU9@77;H]F1M$6-*^B@B,B$T]:&N_K[648O&6@<Q
M)A>CB,B$T%P0V._O+T*-UJLP;)X&-*V[)R#]K;\-O_F"1RU$3<#;<-&%JZ%V
M=_<0'('=#3-T;SL:[CP-R)3Y<4ADA.@6U(CK6+BOA0@.1O/D:D!&*\AC@$1&
M%MV*&G,=*^9WF>!0[%;CE39"$&Y"4V^P!S4D&/<#<NN3YM#37>\1UV_W,%TY
M).`_E"NT_@*$I#=8MP1!ALSNQB&1$:);4..ND_P[^PB')&2I';3#$Y`ZG8-?
MHY512&1DT:VHF=>Q,M)'."%'^@A!>`Y:D.%^U(W/0N\VK)H^ZL9]=W$[C:!R
MO.W@92"GU9'N:)8)*^%G=9,AL`NVW^(M:ZMN6?4]J0W`):>,C_1[7!U9(:R,
M'F"I.YE#:BN\)N&#Y&5]]-YS"=>;^N,)KK,4#OGN!,`'SN7U05W$V@ORYA\`
M``#__P,`4$L#!!0`!@`(````(0"Q<,^OZ`(``,X'```9````>&PO=V]R:W-H
M965T<R]S:&5E=#4Y+GAM;)15VVZC,!1\7VG_`?%>[I<0A51-4'<K;:75:B_/
M#ABP"AC93M/^_1[;@0;87O8EP7@\S,PY'#;73VUC/&+&">U2T[4<T\!=3@O2
M5:GYZ^?MU<HTN$!=@1K:X=1\QMR\WG[^M#E1]L!KC(4!#!U/S5J(?FW;/*]Q
MB[A%>]S!3DE9BP0L667SGF%4J$-M8WN.$]DM(IVI&=;L(QRT+$F.,YH?6]P)
M3<)P@P3HYS7I^<#6YA^A:Q%[./97.6U[H#B0AHAG16H:;;Z^JSK*T*$!WT]N
M@/*!6RT6]"W)&>6T%!;0V5KHTG-B)S8P;3<%`0<R=H/A,C5OW'46F?9VH_+Y
M3?")7UP;O*:G+XP4WTB'(6PHDRS`@=('";TKY"TX;"].WZH"?&=&@4MT;,0/
M>OJ*254+J'8(AJ2O=?&<89Y#H$!C>:%DRFD#`N#7:(GL#`@$/:G_$RE$G9I^
M9(6QX[L`-PZ8BULB*4TC/W)!VS\:Y)ZI-(EW)@E`_7G?L[Q5Z(;1^RRV5J0,
M9DB@[8;1DP%-`\_D/9(MZ*Z!>7"F=8Q>7[,*'B7)C6117.""0WD>MXGK;NQ'
MR#0_8W8:`V_$B)DA]@-"!BAILXL;-N@=14,4<]$^%/7?Y1@TRD-3C7XPD[B$
M>%/$?HGPPRDD6T+B>(1,;/A+&\&K7378D(>@?RYB3-R9RIW&0#G'J*-1@4IV
M_RXB>PLQ<0&/N2S&VT60X-2$B$9EP44Z2MM.8V+51E=1[#BS,NTG@-B)DYG_
M;`((DB1Q1OL3Z1#VQZ5+\$SZ:M;!.XT)E'1O-==]N;L*_%&3;G:]&ZFSKI^\
M;$\D1_\C68*GDEUGU@D[C1G2CF+O)2O=*E-`D@3)3/@$$*S"9-[N>J[JL=-B
M5N$];AINY/0H9Z8+CL>[>ISO8)RKX6>/&S!.>U3A>\0JTG&CP24<=:P84F-Z
M(.N%H+UZR0]4P"!5ES5\-S&,$\<"<$FI&!9RY(]?XNU?````__\#`%!+`P04
M``8`"````"$`&G"QY_T#``!^#@``&0```'AL+W=O<FMS:&5E=',O<VAE970V
M,"YX;6R<5\&.HS@0O:^T_X"X=\`0($1)1@.H=T?:D4:CW9DS`2=!#1AATNG^
M^RV[$L#.-$GFTAVHY^?WJLHV7GUZJTKCE;:\8/7:)#/;-&B=L;RH]VOSOW^?
MGQ:FP;NTSM.2U71MOE-N?MK\^<?JQ-H7?J"T,X"AYFOST'7-TK)X=J!5RF>L
MH35$=JRMT@X>V[W%FY:FN1Q4E99CV[Y5I45M(L.RO8>#[79%1A.6'2M:=TC2
MTC+M0#\_%`V_L%79/715VKX<FZ>,50U0;(NRZ-XEJ6E4V?++OF9MNBW!]QN9
MI]F%6SY<T5=%UC+.=MT,Z"P4>NTYM$(+F#:KO``'(NU&2W=K\S-9)L0SK<U*
M)NA'04]\]-O@!W;ZJRWR?XJ:0K:A3J("6\9>!/1++E[!8.MJ]+.LP+?6R.DN
M/9;==W;ZFQ;[0P?E]L"1,+;,WQ/*,\@HT,P<*2-C)0B`OT95B-:`C*1O\O^I
MR+O#VG3]F1?8+@&XL:6\>RX$I6ED1]ZQZB>"B!#5DSAGDCFH/\>=F;/PB.??
M9K%0D328I%VZ6;7L9$#7P)R\244/DB4P7YRACM[K1U9!GB#Y+%@D%[C@4)_7
M34C<E?4*.<W.F`@QL"1Z#%$1\04A7`O:9/3"`KV]:$B%+MJ%HOZZ'!>-8I"J
MT9VK`J)KB*,BXFN$ZZF0Y!H2!#U$L>'^C@TQ"/IGE,:0Z#X0`^7L4^WW"F1F
MXYN(9`JAN(!I'B^&&+0V(56]POE";QC$!+*=GAS'#Q::"17@^IZM`A(%0'S/
M&:90+,`B'%N8[B,!UJ4/!9;IC1`S1^GD2K@27H2::HSZ9]_>8JB=(MI_1+0`
M:Z)#;?E%B.GG)5ICQQB'G/8U&Y3A>E48B!L.?:DH#QY1+L"Z\H$7TXT85.[:
M@;YHQV%BVUHXP3`6RPL'UXIF<92/]LGI%A%@7?/`BYH1@YH=Q_4T3[$2)Z&O
MYWH<)PL['+I(T1T^HEN`==W:O!%B)KH@OHE(+@AQ4#R-=F%%.8$=_?Z42[2N
M7=LPHC-H2OQM2-)#A'SGH^5)Q.%U=\=(M"Y_*"FVS!DT*1^/S`E(TK,(^9X]
M3*)F7QQC]\O'0V^\GWNVMAM'!$$3VN+;D*2'R.P''^SH1!Q?]\O'PTZ5KV^/
MDG)MCN5[VN*([\`DTQBU"##9`RX$6NTA3]_L(H*@\]'D:;M2K(2#0,M!HH6'
MT:IL<8+=GWP\[]3D:[MA)+ZVP=MT\F]CQ"UA@@==X#4`OY(KVNYI3,N2&QD[
MBD]\`N=R_Q:O'Y&X?L@+1!^`K_\FW=.O:;LO:FZ4=`=#[5D`T[=X?\"'CC7R
MFW3+.OCNES\/<,^C\/5KSP"\8ZR[/(@;2G]SW/P/``#__P,`4$L#!!0`!@`(
M````(0"!YLFV8@0``(@1```8````>&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
ME)A=CZ)(%(;O-]G_0+@?H;#1UJB3!M*[D^PFD]F=F6O$4DD#Y5)EV_WO]QP*
MH3X<&F]4].'4^YZJ4X=R]?FM+)Q76O.<56N73'S7H57&=GEU6+O?_WW^].@Z
M7*35+BU81=?N.^7NY\WOOZTNK'[A1TJ%`Q$JOG:/0IR6GL>S(RU3/F$G6L$O
M>U:7J8#+^N#Q4TW377-367B![\^\,LTK5T98UF-BL/T^SVC"LG-)*R&#U+1(
M!>CGQ_S$K]'*;$RX,JU?SJ=/&2M/$&*;%[EX;X*Z3IDMOQPJ5J?;`GR_D8<T
MN\9N+JSP99[5C+.]F$`X3PJU/2^\A0>1-JM=#@XP[4Y-]VOWB2P3\NAZFU63
MH!\YO7#EL\./[/)'G>_^RBL*V89Y$NGV'UK03-`=S)SKX(QL&7O!6[_`5SX,
MPAL`!^'_78=Y"G`4KQM&_7P=\KF9MJ^ULZ/[]%R(;^SR)\T/1P$CA9`&S,9R
M]YY0GL$TP%B3(,2H&2L@!+PZ98[K"=*8ODEU^4X<U^YT-@GG_I0`[FPI%\\Y
MAG2=[,P%*W]*B+2A9)"@#0+OES8(N!]Y\[2]&=[;FTDP"1Y#$L[ND/#01H'W
M/LI('Y[,29/N)!7I9E6SBP.+'5SS4XJE0Y80^)I;F8DNV[]*-F09@SQAE+4+
M50IYY##CKQM_Y;W"G&8M$4D"7CN"Z$1\)7`",6BB?.&!VDXR3($J^?8RN"I#
M&)5=HT;R"U5(8`BQB:E.)#;QT!&:5)CP\5(1AK6II"CLHC89B20!T]0E<:83
M\8=$,D1HVF&8\=H17KN0ET[97%<624+5_J@3L4T8[I(A0M,.=3U>.\*Z]H6N
M+)*$JIT8ZSNV$5/\$*&)G]TC'F%=/#$**Y)(V)3E`YE-#7>Q_%UU9TH?(C3I
M\WND(VQ(-THQDH@JC1BU&-N(J7Z(T-3C4X:R%PYO+`@;ZOM-0):K1#3U1D7'
M-F*J'R(T]8M[U"-LJ#<&CB2BJ3=J.K81(T@R1&CJ"733\<EO:$._L9U$+:,9
M,)?^#<9T,(CH%K!AC5X_1+8W=<L,C$TE:AG50F!4=WR#L2S(H=0P/:);P,XV
MWH+L@YH%LX*)9-2Q`[.$;S"]OO99P`[3([H%;'#C+<AVJ%DPRYC8+3,PZ_@&
MT^MK+=AA>D2W`-FZPP+2>BT$?6"Y$Q'):+-@%O,-Q@B3#"*Z!>QVXV=!]D9M
M%JQRMONG/0LV8UD80G0+V/7&6Y`]4K-@[#81L?OHU"CY^`9C6;##](AN`5N?
M8@&?[J>PT0YW-B(;IFIE:NPZ4<NH"ZK7T*RYN$5FS7-',(/C3K@(C5E-!N/H
M7K`1*EX^\"#;IN;!VIJ&6FOKX4,$C\M8?O/&)O'#D"QF0;^%2`_RG"L/7B6M
M#S2F1<&=C)WQW$K@WN[;[B#>GI"['^!(>TH/].^T/N05=PJZAUO]R1P6="T/
MQ?)"L%-SK-LR`8?9YN,1_O&@<*3R)P#O&1/7"SR"=_^A;/X'``#__P,`4$L#
M!!0`!@`(````(0"%CKKI&P4``-\8```9````>&PO=V]R:W-H965T<R]S:&5E
M=#,X+GAM;)2978^J2!"&[S?9_T"X/V(WBA]13XY.9O<D>Y+-9C^N$5LE`[0!
M9ISY]UM-H5(-4W!N9D9\NGB[7KI*:U9?W]/$>5-Y$>ML[8K1V'54%NE#G)W6
M[C]_/W^9NTY1AMDA3'2FUNZ'*MROFU]_65UU_E*<E2H=B)`5:_=<EI>EYQ71
M6:5A,=(7E<$[1YVG80DO\Y-77'(5'JI%:>+)\3CPTC#.7(RPS(?$T,=C'*DG
M';VF*BLQ2*Z2L`3]Q3F^%+=H:30D7!KF+Z^7+Y%.+Q!B'R=Q^5$%=9TT6GX_
M93H/]PGL^UU,PN@6NWK1"I_&4:X+?2Q'$,Y#H>T]+[R%!Y$VJT,,.S!I=W)U
M7+O?Q'+G3UQOLZH2]&^LKD7C;Z<XZ^MO>7SX(\X49!M\,@[LM7XQZ/>#N02+
MO=;JY\J!/W/GH([A:U+^I:^_J_AT+L'N*>S(;&QY^'A21009A3`C.361(IV`
M`/CII+%Y-"`CX7OU^QH?RO/:]8/1=#;V!>#.7A7E<VQ"ND[T6I0Z_0\A48?"
M(+(.XH/Z^GTYDO.IF`;]43Q45&WP*2S#S2K75P>>&KAG<0G-,RB6$-GL;/;I
MSF!+9LTWLZA:"G0!=KQM`C%=>6^0PJAFMLC`";@SDA*[-N$_@GB@[RX2MFZ+
M],'$[O3?1)I%5*0_H0JVB,RK-)N-[1H7B`#(C"U@TILELPB<;F0@$(&E`)E)
MDZ'$CB.(1@C2U,@GQ\!K%[9[=R<0,WKG+3*SRE\QGP5B3($=`:0_G<_O`%$&
MF1JNS,"VLD?<ZOG;(@.W?ZB_W[DB=AQ!M`54FWG^^YTUB_J<18;3R!%$XXQJ
MY)TUL)T_VUED@LI9:"7"M[+7?-\7DX?O1);I;HW2P<LRL"UK06^[189+&4<0
M;0NJ;9BM9E&?K<AP&CF":!10PH8GL*+M#-K&UA`Z*X+9=&$1.TK(\63R.%Q4
MG=49>'L%%O-F09$3J^!O:XA+'HM0?:96-QZ_818+K/!\4:XA5B?&Z4:H3E/`
M&SI[\HCEOIG'=F$6"'U^?@GP^0$6(+\IS:2POZ]6JZP'43Y*!%;H&NK.#Y9H
M%J$IM!K(0*NQ!_18S36*6B>'4)U6,^FQ&NM_C]4(,58W`<9JJX<,M+JCF4AA
M56V!$&LUA]`46DUEH-78%WJLYII';36'4)U6@^FQ&GM"C]4(<;6;$&(A_4?C
M)NJDU5F&N5VML@^V7<-KB'.;1:A.J\<,<UMBK^'=KB%6)\;I1JA.4^T'UW!I
M:"N/K0_7-<2X30G.;=,.AJLSM*5./IXC+-\2H>[4X%EA$9H]"-/4-]!ELZKO
MTYA$B-7)(52GU6;X,VV^<]MY;+O,]8XZCS?$?(V>CA^-E&JS6LO`$]W18F3K
M2S!";`XYA.KLZ#/]WZ<D]H>>$\TUD3J7'$)U6GVFQVOL"WS]EESSJ/7=$-[K
MG^HMLJ.WR,<<I;KQMH98CS%.-T)R9SXB_OQYKE;UG><:ZA:!.601JM/J+KS'
M/G8#WN,:8O7=NHKQ>-88BU%M5D<9=I[]CLXB6R,EA%B-'$)U6KUE6.WVL7WP
MY[F&6)T8IQNA.H%I/I,]7AO:ZH&MV@T#90-UW[Q^%A'!$5G;:YPGX[@U5?E)
M[522%$ZD7\VL6,+XY7X5Y]A;L=Q*,XVTKN]@OEU=]^YOP'CY$I[4CS`_Q5GA
M).H((<<C,[O-<4"-+TI]J8:@>UW"8+GZ\PS_2%`P[1R/`#YJ7=Y>F!'X_5\3
MF_\!``#__P,`4$L#!!0`!@`(````(0"N'&.;NPD``$0O```9````>&PO=V]R
M:W-H965T<R]S:&5E=#,V+GAM;*R:6W/:2A+'W[=JOP/%^S$(<2_;IV)N$I+0
MI<[9?298MJD`<B$<)]]^>S1JC:9[5H'4>0G.CY[_]*A[+FKF_L\?QT/K>WK.
M]]GIH6W===NM]+3+GO>GUX?VWW\M_QBW6_EE>WK>'K)3^M#^F>;M/Q___:_[
MS^S\+7]+TTL+%$[Y0_OM<GF?=CKY[BT];O.[[#T]P3<OV?FXO<!_SZ^=_/V<
M;I^+1L=#I]?M#CO'[?[4E@K3\S4:V<O+?I?.L]W',3U=I,@Y/6POX'_^MG_/
M4>VXNT;NN#U_^WC_8Y<=WT'BZ_ZPO_PL1-NMXV[JOIZR\_;K`<;]P^IO=ZA=
M_(?)'_>[<Y9G+Y<[D.M(1_F8)YU)!Y0>[Y_W,`+QV%OG].6A_<6:)KUNN_-X
M7SR@_^S3S[SV=RM_RSY7Y_VSOS^E\+0A3B("7[/LFS!UGP6"QAW6>EE$(#JW
MGM.7[<?ADF2?3KI_?;M`N`<P(C&PZ?//>9KOX(F"S%UO()1VV0$<@'];Q[U(
M#7@BVQ\/[1YTO'^^O#VT[>'=8-2U+3!O?4WSRW(O)-NMW4=^R8[_E496*25%
M^J4(?)8BUMUX,.@/QZ/K1<"R\`0^2Y';'1F6&O!9.7+K8&!F%'[`9Z5Q\V`F
MI0A\_O9@+$B&PA/Q1^7*K<.Q(+)2187X-Z)CV2@#?_S^D#!3K'JJW#PD#+-5
MC_/-,;)&."3XX_>'A/EBU1/FRB%UY&PL)O=\>]D^WI^SSQ:LF##?\O>M6'^M
MJ1#&:2TG8371_]\\APDN5+X(F8<VM(<IG,/B]/UQ,!G==[[#@K(K;9ZXC:5;
MS-!"K!Y"=D[!@H(E!2L*'`I<"M84>!3X%`04;"@(*8@HB"E(:J`#X:EB!//I
MGXB1D!$QPJ?[A$`%K4<"@A;89$[!@H(E!2L*'`I<"M84>!3X%`04;"@(*8@H
MB"E(:D`+"*Q,_T1`A`S,.UBAU*RQR9QX*HU@LZJ,AB1*E4D5)D86C"P963'B
M,.(RLF;$8\1G)&!DPTC(2,1(S$A2)UK4X#D;HG8G3@[F0PPN;J)A$2=\OD^2
MC.3A1*Q4,T;FC"P863*R8L1AQ&5DS8C'B,](P,B&D9"1B)&8D:1.M!C`L]9B
MT/S@A;7^X$O2JQ:QF223447FDO2US<BV]3FSJ(PPIDM&5HPXC+B,K!GQ&/$9
M"1C9,!(R$C$2,Y)(TK/%`])B`6>:&V(AK/582#(H7AN*[7K&R%R2$9PKJ]5K
M8/=)+"JC*A:22)\+Z94DEJWB[%3-ZMH#7=NMC%![S;0]KNU7S>K:9-T-*B/4
MWC#MD&M'5;.Z-CDLQ941:B=U;2V.<*B\(8["6H^C)#U]OHSUYSBKC-"?>4G`
MK2JTO3Z=9M)H."J.A+WNF(1G68JHJ*Y81\XU';E:1[8](2>9->O(8QWYUW04
M:!WU)CT2N`WK*&0=1==T%.L=C?NDHZ3>D98/$,@;\D%8Z_D@R1C6C2JP`WM"
M\J$RJO*A).!6U8SG@S2:P-MJ933H=W7MI4EI2`*Z8@XXIF8T(5VC`^3,M38I
M40<\YH!O:D8="(P.D,%M3$K4@9`Y$)F:40=BHP-DWB8FI9H#6KY!,&_(-V&M
MYYLDVOHS(4OMK+*ITJTDS>DFC?IP)&Q(-Y-2;:QR_V$..*9F]&&[1@=HNIF4
MJ`,><\`W-:,.!$8':+J9E*@#(7,@,C6C#L1&!\@)(#$IU1S0TDT4J;1\$R6+
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MCGR.`HXV'(4<11S%'"4E,I051#WSEO#(6I$V522JQ6)6B)+PE$6FYMI"V1`J
M$"H\LF&]NE!::>4%U;)V>+3)WNTJ*]1?EZBF[QGT?=6RKD^VY4!9H?Z&ZX<&
M_4BUK.N3M\A86:%^HNGK,T_4DFZ8>;+T!'JH_21^,89IIF]R-IE3,V6%#>>(
MFLL-I176&^P!?;5$&;7VK!"IW<-!U-B92SH;CLFI=HTRJC,/D>K,1]3864`Z
M&X](9QN449V%B%1G$:+&SF*],VO<)5F9H$S1F9XBH'Q+B@AS<B272#N2\_J#
M^$66[ITE:CP#+LJ&Y$A.3@)+E->T:F?`\DC.G'",#>E+D6MT@B;KVJA%G?#0
M2NVP/B+->^I$8':"O)QNC%K4B1"ME!,1HD8G8K,3Y-"7&+5J3N@I"#W>DH+"
MG*2@1-HJQ4H2XE=]N92I1:I$\%'5&W@-K&Q(JA(L`TU:M2&7&<B<<-"O1B=<
MHQ,\`Z]QPL,>U3KC(VIT(C`[P3+P&B="[%$Y$2%J="(V.\$R\!=.Z!DHRF?U
M??+Z$H4LO&E;9EF+@YVS2BI#B:*R4ME8HL;A+\2E#TACLAZ28\ZRM!IK6CP;
MF1..L2%=BERS$V3761NUJ!,>6JFER$>D>4^="(Q.#,B[[<:H19T(T4HY$2%J
M="(V.M$GX4B,6C4G]&P4U36:C5>4*&113DO%LDX'8:Y2T5"BJ*Q4*I9('4X6
MED18HH!+?/3JP[(TZ:E6*T1JECN(E)5+M(>C(;V,M.:M/$1*VT>DM`.B/1J-
M1^20N>&M0D1*.T*DM&.B#><N^H-9HK72P@R7/_4P-Y<H"G-]VT,TK,[K,X[F
M'"TX6G*TXLCAR.5HS9''D<]1P-&&HY"CB*.8(W'=MC@Y%,]+QD)>GY4W[([I
M^36=I8=#WMIE'^)J+&PUC_<5EO=VGWI=O+A+OIE;_>E"3C_RC0/?B#=/F%_D
M&WBKG(IW1OX-O`].Q=L>_P9N#G\I+E00K2>X45S<<*&\!PZ;=&S0*=ZS:0-[
MFA37#RCO3^&F"'=H/IC&Q<))[.?#Z:)XUH0[PRG\SL]U_.$4?J/G/!I.8Q.'
MB@\\(GE1HNH"[C"_;U_38'M^W9_RUB%]@4!VBUM#9WD+6O[GDKU#@.$F<W:!
MV\O%GV]P6SV%.GWW#O;NERR[X'_`I4YU__WQ?P```/__`P!02P,$%``&``@`
M```A`)(NZ2:S`@``!@<``!D```!X;"]W;W)K<VAE971S+W-H965T,3,N>&UL
MK%7;;J,P$'U?:?_!\GNY)=`$):F25-VMM)56J[T\.\:`%8R1[33MW^^8BY60
MM.I#7P";,X<S9\;#XNY%5.B9*<UEO<2A%V#$:BHS7A=+_.?WP\T,(VU(G9%*
MUFR)7YG&=ZNO7Q9'J?:Z9,P@8*CU$I?&-*GO:UHR0;0G&U;#FUPJ00PL5>'K
M1C&2M4&B\J,@2'Q!>(T[AE1]A$/F.:?L7M*#8+7I2!2KB`']NN2-'M@$_0B=
M(&I_:&ZH%`U0['C%S6M+BI&@Z6-12T5V%>3]$DX)';C;Q06]X%1)+7/C`9W?
M";W,>>[/?6!:+3(.&5C;D6+Y$J_#=!MC?[5H_?G+V5&?/"-=RN,WQ;,?O&9@
M-I3)%F`GY=Y"'S.[!<'^1?1#6X"?"F4L)X?*_)+'[XP7I8%JQY"0S2O-7N^9
MIF`HT'A1*X/*"@3`%0EN.P,,(2_M_<@S4\)3XD6S.(P3P*,=T^:!6TZ,Z$$;
M*?[U**O*L40]"]Q[EL2;1O'M++0D[P1.^D"X]X&3Q(MO@\D;@7XGOW7CGABR
M6BAY1-!AH$\WQ/9KF`+98$/W:6?,6[Y`*I9D;5F6&(X&9*RAEL^K:#9?^,]0
M`-IC-I>8\!RQ'1"V;B#/:01W/D&C9;$:K?]6]&;8.!$]$C0@QH+`J$\09%G`
M]NF[KO4@Z`9G;3)2Z2!CF<!\*O-Z:P\EM.!6C?.GWPG:>HX_VK^$DCE=T3QP
MRL[J!^)/==@>BZ:1/5=]BW^XSRS3N<A^)SG3,6XL!W(.=7.A.PF"J8)M655I
M1.7!GOD$4G:[;ARM(]L[H_T-C*GPVGZ4;J_AUY-TW<Z3,<\DW4ZN\<3]&/1=
M`(RAAA3LB:B"UQI5+`?)@7<+6:IND'4+(QOP"F:1-#!_VL<2_C<,>C_P`)Q+
M:8:%-<;]P5;_`0``__\#`%!+`P04``8`"````"$`UB.8SZ<%``!%%0``&0``
M`'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6RL6,F.XS80O0?(/PBZC[5:7F![
MT+968`($P20YJV7:%MHR#4F]S-^GN$E</(X;F$NK_5A\K%<LEDI<??UHSM8;
M:KL:7]:V-W%M"UTJO*\OQ[7]]_?TR]RVNKZ\[,LSOJ"U_0-U]M?-[[^MWG'[
MTIT0ZBU@N'1K^]3WUZ7C=-4)-64WP5=T@9$#;INRAY_MT>FN+2KW=%)S=GS7
MC9RFK"\V8UBVCW#@PZ&N4(RKUP9=>D;2HG/9@__=J;YV@JVI'J%KRO;E]?JE
MPLT5*)[K<]W_H*2VU53+XGC!;?E\!MT?7EA6@IO^,.B;NFIQAP_]!.@<YJBI
M>>$L'&#:K/8U*"!AMUIT6-M/WK+P(MO9K&B`_JG1>R?];W4G_)ZU]?Y;?4$0
M;=@GL@//&+\0TV)/()CL&+-3N@-_MM8>'<K7<_\7?L]1?3SUL-U34$2$+?<_
M8M15$%&@F?A3PE3A,S@`?ZVF)JD!$2D_Z/.]WO>GM>V'DYGG+H(9L#RCKD]K
M0FE;U6O7X^9?9N1Q*D;B<Q)X<I(@FDQG;N#!FH^2!)P$GL*3X-.>A)P$GIPD
MG,RGTS":?T+.C)/`DY-XGR>!`T8#"T].,GU4C</VB&YY7/;E9M7B=PO.$>Q"
M=RW)J?26"]L2>\UV9MC]GVT^[#HA>2(L:QO\@GWM(&/?-O["7SEOD&45M]F:
M-IYJL1,6)*4(;:P#B0ZD.I#I0*X#A00X$(0A$I!IOR`2A(5$0FC8"D`*C29;
M6(@IL0XD.I#J0*8#N0X4$J#(AK/Q"V03%D@A."-W,H`;P?D=C"(M%H/)$`P#
M20PD-9#,0'(#*61$"0FHD$-RN^Z)U"?&5+GP>,L1EYZ#F2:0#T(2#C'P%\%@
MI/@!@7K<#V*L^L&12%DJ'):B1VPW&`GW8P-)#"0UD,Q`<@,I9$01"B[*0ED1
MFI#R>C_V9)ZJF2$S]BXA-61G(+&!)`:2&DAF(+F!%#*B"(2R+PN\KXH8JZHX
MX@]59<>04*FX,RW7XL%([&UB(*F!9`:2&TC!$#\@#BE"P:''A1)C52A#IK0_
M8?G)D!D[3+[KC4>%O2*&\4$C0YAOU"9E2$1;)HIDPRSZJG(][5V5#^."M9!9
M%<7PTGQ<,3%6%3,D@+(@U8.I=DB9D0_I-1J%>B28432C92>(@H5*DG"2V9!$
M*5][1+)'%LJ5A<)I,%<7*N2%E%!YT(H^'BMJK0:+0SZL,`9BH;]#N%4P9E$L
MH(`%1W<Y$>/CE%1`XZ'+!#1:Y0+BQ+HOA1BG4]1@D#Y$Z[S\B'34_U/T/-;`
MP+M6).>60UH6:>5@QZW\<;]C#H4AZ]E"5TNJQ)R3BL5&FLRTRE7FP'<U;PIE
MCAH9TJI(D;E?+3W6V"CA8)"6)EJ:[OC$Z5@68@&Q,^3-YEIJ)=Q`2JU40'*>
ML/4EYEQC7OA:Q2D$S8U$(7V*%`[I[=B?ZNIEB^$L0$[<"!/)2EKPGCS>[,A)
MPR`E:3Q74[SC$R.H?^.1,VJ/L%K0/)I[D4:3<`,I]U(.!7(>,9?N+Y:KBWEP
M.:!E;:&LIN86Z;_N!/,[OOXLF'`RAVCR+DZ.)H?8!S'M/$@W3*K]",4FE)A0
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MUU>T7IS@NA+!YX8[@1-PP+@7/\`A9[@`W?P'``#__P,`4$L#!!0`!@`(````
M(0#HF2E5!P0``&H.```9````>&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;*R7
MWV_B.!#'WT^Z_R'*>\DO(!`!%5#U=J5;Z72ZVWUV$P-1DSB*36G_^YUQ'#=V
M4K14^U+*>/SU)S.3\;"Z?RT+YX4V/&?5V@TFONO0*F597AW7[O__/=XM7(<+
M4F6D8!5=NV^4N_>;/_]875CSS$^4"@<4*KYV3T+4B>?Q]$1+PB>LIA6L'%A3
M$@%?FZ/'ZX:23&XJ"R_T_;E7DKQR6X6D^14-=CCD*7U@Z;FDE6A%&EH0`?S\
ME->\4RO37Y$K2?-\KN]25M8@\907N7B3HJY3ILG78\4:\E3`<[\&4Y)VVO++
M0+[,TX9Q=A`3D/-:T.$S+[VE!TJ;59;#$V#8G88>UNXV2/;!W/4V*QF@[SF]
M\-[_#C^QRU]-GOV=5Q2B#7G"##PQ]HRN7S,TP69OL/M19N"?QLGH@9P+\2^[
M?*'Y\20@W3-X(GRP)'M[H#R%B(+,))RA4LH*`("_3IEC:4!$R*O\O.29.*W=
M,)S,8C\*P-UYHEP\YBCI.NF9"U;^:)T")=6*A$H$/I7(]%WCRKY([8-/M2^:
M7]OHM?`R%@]$D,VJ81<'"@SP>$VP7(,$Q+H@M$?KL'P4%0@'BFQ19>W"FP$/
MS"&5+YMPN5QY+Q#^5/GLACZ!Z;'O/#!K@*<9(3B_@1%5D!$SB="[SM"#MH`Z
M#QL(`O4;@%`%PCZ]&C7E!!6E0SNW*+6+C0G*?<SQPNY2B,Z21L='67R9SX5U
MJ%J$E&FNR/>UDY$_@.]SR!J;SR8QV&^L,U0R(95E;G#8A:6=[`C!-ILL"A:?
M(4,EDTQ93+)01TC6X%X[V63Q"-D,C#<&#&5,+&4QL2(+2SO96'CY6>TB]*$6
M;L1"&1-+64RLJ86EG6RLI8EUO=+1V3Q<6=HNC[UAW[<8M1S`/3.(P#+"*^+6
M($@I$Z0SF6&866%X][+C$&`+[>7G>B"DMP70]F"X!T&Z+='.2YK,6(PV9FA'
M-U9#T/99Z(3=H;O.9`;"[GSO7H-`8%/L!0)[3K3X5)94>^W#*9,)%]M9TEX#
M.&R>%EP,U_?M@5-=N,^F3":;W;WQTL%W0(Y79DZQ5UIL0;SX#)SJNGTX93+A
MK$%ACT/8!W"P<0"W##Z55I2R:E^9#+K@_4Y3KX/VTFEM1\QVK"II<Z1[6A3<
M2=D9Q\<@A@M4F]O9=A?,N^%VL.+#BIQ<!RLX$,OQ<;`2PDJ(;\]@)8*5:'1E
M"BLR-X,],UB1;[NU`A/Y=OP4V#!V!F"-^6^C9-N6GG7`#FA'88%H#&@'490E
M;.O$R3X>`UHD>SD`VO[+!#H^YE,OP*1?DR/]1IIC7G&GH`=(I2\G@Z;]K=!^
M$:R&%,.\SP3,^/+?$_RFHW")^/C2'!@3W1<\0/]*W/P$``#__P,`4$L#!!0`
M!@`(````(0#2K'D28@8``(0:```9````>&PO=V]R:W-H965T<R]S:&5E=#$V
M+GAM;*Q9VX[C-@Q]+]!_,/R^\2UW)%E,8JM=H`6*8ML^>QPG,2:.`]MSV;\O
M=;-%T9O-#/9E,CDB*9Y#2;25U>>W\NR\Y'535)>U&XQ\U\DO6;4O+L>U^\]7
M]FGN.DV;7O;IN;KD:_=;WKB?-[_^LGJMZJ?FE.>M`Q$NS=H]M>UUZ7E-=LK+
MM!E5U_P"(X>J+M,6OM9'K[G6>;H73N79"WU_ZI5I<7%EA&5]3XSJ<"BR/*ZR
MYS*_M#)(G9_3%O)O3L6UT='*[)YP95H_/5\_955YA1"/Q;EHOXF@KE-FRR_'
M2U6GCV?@_1:,TTS'%E](^++(ZJJI#NT(PGDR4<IYX2T\B+19[0M@P&5WZORP
M=A^")0MGKK=9"8'^+?+7QOC?:4[5ZV]UL?^CN.2@-M2)5^"QJIZXZ9<]A\#9
M(]Y,5."OVMGGA_3YW/Y=O?Z>%\=3"^6>`"-.;+G_%N=-!HI"F%$XX9&RZ@P)
MP%^G+/C2`$72-_'Y6NS;T]J-`'K,FY85/)3K9,]-6Y7_R<%`A9#.H7*.(&OE
M/!U-9GX4P%RW',?*$3ZUXR@8^],?N$%0D2Q\*K?%:!;XBVAV>[JI\H-/Y1=,
M;N7I29&$YG':IIM57;TZL)!!CN::\FT1+"&8%EM*U,G_/?5!=A[D@4=9N[`#
M0>`&ELS+)@J"E?<"9<Z4S9;:6!8[;<%KRL/&-I#8`#,`#QAUM*"./X$6C\)I
MZ82V&NAYAICE3EMHE]@&$AM@!H`XP!K\"1QX%"@NK,L;M5%&L.8ZHZE%K#/I
MF!$D(0@S$40.\C')#6]NO;RXL>"@Y]XJQ!=K;6&EJ@9A;71L8/]V1B@/H'Q_
M'MP8YZ$0>0[Q-;LC2$R0A"#,1%!^L"?-_/C^G$:C_G2X>XOR0#AWA<"'(5/4
MR22VX*XSTM+'!$D(PDP$T9EA.K?+SHUQR@HQY"9(3)"$(,Q$4'[\(<(Z#J,Y
M[S/J[+];;AX(YZX0D,:0>VS)W1EU<A,D(0@S$41G@>G<EIL;XY058LA-D)@@
M"4&8B:#\`G@ZL/4.H9&]6VX1"">O(2SXQ!*\M^H4IU!"(88@3(HW)6,1W58]
MD"T,#FB=P%9#ANX4BBF44(@A"*?)^XZ1)C]:/J:];&"(@8*P]G9+"3HK33VF
M4$(AAB!,BC<<@]0/M%?MR=3>[%CR"`P(%%,HH1!#$$[S7>V/-V]K9VIHVJV:
M'85B"B448@C":?*V=+^:JHF9:DIH#@2,0V]F[\'.JE\'$I+O&:(,"7\'`!4,
MB"$(9\X[T/V9<VOK])#0?"*>,$(_L$_J0!GT%8@U!-VE8QN.K8Z::*NYC!Q&
ME@'3!N(="[/B?>M^5JK+F?604*CF]@-R'$J#^:);5W&@?$0ZJA02&H\5A7G_
M<"4,&/+!%'BONI^"ZFPF!0GUA2&GBC(P"Z,@DX*"E!(1K8+I@RGP=G8_!=7\
M3`H2ZJM`-H0T0%50/B8%">DJ1+0*I@^B$%I]]_8Q*:SQ]E!07X6YM:>U@5$%
M#1D4-"2K$$03ZY60:0/A@RF\J\N&M,LJ"*K0[]8H(#RDHUD*Y1CU[3G1D%I-
MXX7U2L+T9`,\!MHPO,OS)_SV5&1/VPK.$DABH$01;#^QWQY"VH(5!!7JZ06^
MO5FTE5DF&6L!2^3&*:8<%X$X`H+(G_MX!3`=>H"RU:3YD\=\,?R4+33X6EV_
MIP$\FG<BT&X>*@C.ZHY+%%C%V?567?^A4$(AAB"\.JT&SRE^[$4BI,U?0XA5
M:.F_ZZUZ5BI67^V$6C$$85:\!1LGWZW"#:Q7LU:RF<.CATYNRU^R>!/&K*P#
M8==;:<>80@F%&((P*][)+58?>\<.>23KH%009F7URYUV[`L34RBA$$,09L5[
MM,7J@RM0=GM4*P5A5M:#S`X>U51%^UH1**%6_'JY=Y2LY'6QO+HL\_J8[_+S
MN7&RZIE?!4.;V*PZ6-Y3;\,Q7%2+!49&)C`BCF\R,H41404R,M/7WO9(X"_Y
MVR!P)"-P50XO8$,C(8R$@R,1C$2#(\!'%L&>)P0?.(OH/'!7_S`\"X0:L-]"
M6D/V#Q'$$0>Y/37,/#3Q%A0>%!CT'907U!V,/U_"[08EMETLX58!<*]+"'X#
MN*;'_,^T/A:7QCGG!U@8OFBDM?P507YI53-YK%KX%4#TE1/\VI/#Y9W/;QX.
M5=7J+WR"[O>CS?\```#__P,`4$L#!!0`!@`(````(0"A`.HNZ1$``*QE```9
M````>&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;*R=VV[C.!*&[Q?8=PAR/XEE
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MIST-]Y2N2%_8_.&O9+6[)T7)S<5XJCW=;YZI`_3?LY>UGAJDR/+/[O/'^F'_
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ML(5>=]IMXH/4!YD/<A\4/E`^*'U0^:#V0>.#U@&7).V@+\V&OT-?[4;KR\K<
M,;""CSTQV8*K)#Y(?9#Y(/=!X0/E@]('E0]J'S0^:!T@Q*3U\7>(J=W0?*?9
M?F"V&B-:AX/1S%-X,!DD!I("R8#D0`H@"D@)I`)2`VF`M"X1:I,^H/9X>D&*
MA.^6O!?H>IV\+,N=(:-N8XA&GHRFE%;0H'0\G@Y&HD_4N.C3X9YH:]D30^A.
MY+3EC^M@Q!>0`$F!9$!R(`40!:0$4@&I@31`6I<(#>EV?(*&VEIJ:$@?'NEM
M>@$D`9("R8#D0`H@"D@)I`)2`VF`M"X1@M%L.4$P;2T%,\01#$@")`62`<F!
M%$`4D!)(!:0&T@!I72($T]F2&U0<7J7:6@IFB",8D`1("B0#D@,I@"@@)9`*
M2`VD`=*Z1`A&@:H03$=A_59[8ARF'4DM>W)-@:VSXUT-NVL79RT&HV''`Y("
MR8#D0`H@"D@)I`)2`VF`M"X1\NJP7NA[>$)VYE)%1LZ41)0@2A%EB')$!2*%
MJ$14(:H1-8A:@:1^.KIU%[2>G_&U3I%-_O;Q1*$/E"GXXJEV%YG864[1:V^*
M6BNNF"!*$66(<D0%(H6H1%0AJA$UB%J!I-PZ_G7E/C)=^W!92&K0;%!YH?-2
MO358E"!*$66(<D0%(H6H1%0AJA$UB%J!I'XZI'7U^^GM5&?DWG[*B*(%9T.]
M\6>KJ>BJ#2BUOGA.9XAR1`4BA:A$5"&J$36(6H&DVN_G"2?>O'1&YJMMD%`[
M]C,(KNBJ/51D:5.TRA#EB`I$"E&)J$)4(VH0M0))M758__?,;9,@N#NQ05)M
M>$HS6+&TB7Z$*C>7%%&&*$=4(%*(2D05HAI1@Z@52*JM<P)7[2,[L3;W`@>#
MW,`!4$*[<E?16J6(,D0YH@*10E0BJA#5B!I$K4!2/YTBN/K]_$YLD@UWMAI$
MVMF=./8?@T6#E9VM@%*TRA#EB`I$"E&)J$)4(VH0M0))M75^X:I]9+::=,25
MU,U0^M0@`I0@2A%EB')$!2*%J$14(:H1-8A:@:1^.H$X0;\^WZ"]FF?67620
M7<<+1`FB%%&&*$=4(%*(2D05HAI1@Z@52.@W/BW-ZLSE;LG(T0]1@BA%E"'*
M$16(%*(2486H1M0@:@62^H72K&AZ88_7/IQFC3'-8B2WR]@+7*T53^H$48HH
M0Y0C*A`I1"6B"E&-J$'4"B3E/BW-&F.:Q<C&G0M$":(4488H1U0@4HA*1!6B
M&E&#J!5(ZN>G68=O-V/,I1B-AQUT8="T.\;O#P$-FM"-R+G/>Z>+J;7BB9LA
MRA$5B!2B$E&%J$;4(&H-H@_JJI34SZ6.2(H)T[A'CGX+1(E!]$T+?50['D7>
M-I!:`ZMF[[GO=3<RN;&:V?E?V(K&LQ>/*6O`GDN#',\5>JYM1>/9RTL::\">
M6^%9*JTSEH_?Z_63+B^R-V@LIZ4]M^K#)VO%G4H8N1OQ>`(CT+<XN^H/S:Y&
MGI`9N[D:%D_.R)X3%XP.-J:,%3<V&7M/WTIV8QNK&-G&:D8'&VN.-=:RFZXQ
M.6KD^911T^9>A-&C:U+7V4S\$\#Q8&5'K4<WW:+MQC8U5C>T,`9?XXFW,67L
MRTJ7,[)A3L&^K'O%Z*#[DGU9]Q4CZ[YF7]9]PVC:3[#I:.0]5FG93V`<=`;E
MKAZ=UYE(9?^TOO_];J-!\*0XIO8Z_;Z,31[F!-`&B445C6!X^HID98>G1S-W
M-086E;&Z>7=1&<]6S=QVB1LK##K<F&(KTUA@44%C%396LYN#5]:PE6EL!JVU
M[#HPFN0:1Y.^UT;S6@_F;YNW]P:3ENHPFMJ+M]AZ=-5__:T[*M8C2U8.2A"E
MB#)$.:("D4)4(JH0U8@:1*U`<K,Z+9T<8SK)B+:>88.)8__PSEKQ!$T0I8@R
M1#FB`I%"5"*J$-6(&D2M0$+2^+0,LS.74Y*1W1L7B!)$*:(,48ZH0*00E8@J
M1#6B!E$KD-0OE&'^U$%SC`DF(SE;O4AB8:V&V8HH190ARA$5B!2B$E&%J$;4
M(&H%DFJ?EF#&F&`R<F>KL;(H0:L4488H1U0@4HA*1!6B&E&#J!5(ZG=:@AEC
M@LF(;K3.!NH?UEDK.R6-+QL'I&B5(<H1%8@4HA)1A:A&U"!J!9*2ZB3.#=P.
M)YAQG_.YCS@9B54^\4+'A;6RDAI?-EE,T2I#E",J$"E$):(*48VH0=0*)"75
MB9HKJ8Z%K[KHZ<3SS[A/^83:!DFUO<QWP16MM`FB%%&&*$=4(%*(2D05HAI1
M@Z@52*I-2@BUCTQ@;>Y%``;9#701`TH0I8@R1#FB`I%"5"*J$-6(&D2M0%(_
MG7.XL_6(?GV*(J:D0:29W5,GWM.)13Q8V0T`4(I6&:(<48%((2H158AJ1`VB
M5B`IJ9\^'9$4\Z38('=*`DK0*D64(<H1%8@4HA)1A:A&U"!J!9+ZG98GQ9@G
M,9)3TGNBMK!6=DH:7W;C3-$J0Y0C*A`I1"6B"E&-J$'4"B0DG9R6)W7F<I=D
MY$Q)1`FB%%&&*$=4(%*(2D05HAI1@Z@52.H7RI/,\ZW#JWN">9%!SB./!:($
M48HH0Y0C*A`I1"6B"E&-J$'4"B2E/"T)FF`2Q,@Y)3+(.>5(##IR2F2M>`_(
M$.6("D0*48FH0E0C:A"U!@5.B2:GY46=N;>Z^_3&T6]AK!R4&/3^*9$UL&KV
MGIVSG-Q8N:=$MN([IT36@#V7!CF>*_1<VXKOG!)9`_;<"L]R\IZ6+DTP73)(
M/R5THB7OC&!AK;A3"2/WGH8/M(T5S15]N5=C+P_+V(O-8W-&]N%YP>A@6^I(
M6R5[L6U5C&Q;-:.#;36RK<B_KI:]X,/LB9^.'=FO,>?J/-"/+:G$&3+_8,]:
MV2'K?;E'1,;JIC]D&4]'WL/;C-U8T7)&]M9;L!M[?*,8&<^3F1>!E^S&>JX8
M6<\UN[&>&T:3;D[128+\BDC+7@+:TZ"*Y.*GCH4FVHNW7_5(K"(\%C(5R<H.
M25_Q\$E-:BK.^L.3>#R&43+M6RUS;*Q@-^Y:AR6KV,HT%EU[^I;LV396,;)7
M5K.;@XTUQNIFUN\/_B1IV7%@+'6VYB:*W5B>>B@T,3F?<\1GD`B'>BL')6B5
M(LH0Y8@*1`I1B:A"5"-J$+4"R3N*SNM<68]L3]K<6PL&T91TMB?_B%3'0;JB
MS6P21"FB#%&.J$"D$)6(*D0UH@91*Y"4]+3\<8+Y(R.[+RX0)8A21!FB'%&!
M2"$J$56(:D0-HE8@H1^%?')*ZI7^4X="G2<Y6QG)V>KMKPMK->S<B%)$&:(<
M48%((2H158AJ1`VB5B"IMI]:'MX`IIA/,G)F*Z($48HH0Y0C*A`I1"6B"E&-
MJ$'4"B3U.RV?G&(^R8AN.LX&ZI]36BL[)8TO>V-.T2I#E",J$"E$):(*48VH
M0=0*)"4]+9^<]BF>^TR8D3LEC95%"5JEB#)$.:("D4)4(JH0U8@:1*U`4C\_
M2_SY#103R*E!<@/UCS"ME9VM0T5&*5IEB')$!2*%J$14(:H1-8A:@:3:IR5X
M4TSP&(V<[R4%6!)@:8!E`98'6!%@*L#*`*L"K`ZP)L!:R:28.K%QPU$]=?7F
M>^2NI*MY-WJ#*.X<=M7H&N:IL:(8;+"*I_:IA>Q<*`4Q/SL_TC],.Z8&'>F?
ML9+]L^>MLG\ZQO;%^UC_3'3NI$53@X[TSUC)_MD,4O9/1[H_US]=TQM?@X[T
MSUC1AS.^]B1&]&\6"CSIO7#=>P4.#W!757:0T>$.LI7LH'T>)SOHQVH?6QTS
MC-D8'>F<J2@[9Y\\R<[Y@9#N7/^]@R/:84@T,^A(]XR5[)[-/&7W3@LJ9AA4
M,*(MPYE+?NI@K?@VER!*$66(<D0%(H6H1%0AJA$UB%J!I*2A..-#IU(SC"L,
M<IZY+!`EB%)$&:(<48%((2H158AJ1`VB5B`IY6E!Q`R#"$;.J91!E/O9J=A7
MU`\O[!R.[7;3_Y#`5"0KKI@ARA$5B!2B$E&%J$;4(&H-"IQ*T?F.O-L<V85,
M).#<`CL/M^<W-K]:($H,>O]4RAI8-?O&G+.CW%C1!UL5MN([IU+6@.N4!CF>
M*X/H@ZUJ6_&=4REKP'5:@T)*^W'1$:4Q&*(?^NC[N_Y2FYV64S\%-E;N\W1&
M[IX,C[A38T4?^G(GT<@&`-V$SXP!';SQY>8&T==L&!5L1;>=H9?0F#)6]*$;
MBZ=7-EKK&BN-`?W^@3U7C.R"JQD=O++&6-%'-Y!7_JM(6G;3-2:W'-H#1#1V
M9-2TN1?A].A&;"93/\369QU4D8ZO^'(3@]R#*4;FUS^CV$899HA,8S>#F]S4
MB49V@RO8CUW&RJ)N0&;>M"I-^;4['M#GFKW8*=(PZ@^FXFN;-G1=;H5CJ3V%
M+$)['2N=_'LE.A^"(>F17$@SKV,+4U$LI+ZB[O+[<SLU%<W!U#2*/2TS]FRU
MS!G9N5VPFX.-*;8R!U,WL3>S2O9L&ZL8V<9J=G.PL8:M^!3,?RMHRYYQ(='.
M'QC,4T^F.B]R?1GDAD2($D0IH@Q1CJA`I!"5B"I$-:(&D7ZYNI[#_37V:Z1_
M67K_5NB7U?;;:K%Z?MZ=W6^^ZQ>A4^;R^=.`^[>TWTTG<_V$AC88*)E22;?U
M^"6S>*YCVT"=&7FC4"U0<C7BU\'[WB;7<WTD%*@SN:&2;M?RZTS)6Q^<00F]
M=IZ>>@2\3<=4TL5X4(>NAYX)!NK$5W/]==%0"?6:O@@9*J%>T_?Y`B43ZC5]
M4RU40KVF+UZ%2J@'=`89*(FI#OUB)51"5TJ_Q0B5T)723PI")31RM/>%2F@>
MT+>X0R4S*NEB(U_1B-2AM[,$ZD2D#KUW)%`R)G7HC1JA$KI2>OE#J(2NE%YK
M$"JA'O2[-/2-ZM`;YP)U(E*'WHX6*B%U^J?DX(W4H;=.A>J0.OVA+=2A,:5W
M_P3J4)6@GE0A:$\7&5291`YJ')'&]'+(0,L1:4SO,<229#:=Z_0A5#*;IWUL
M[%TAQ=]S%2RA^)F\A:Z1_E[$E_"H4,<"K=_IH0_P+_'\"VV-V-T[/?=#7.]S
M`9Z,X[E^YP-ZHI<NS/5[%;"$7IHPU^]%P!)ZZ0%Y"Y70]QWG^EN#6(>^MC=/
M^\C:%YA*5+"$OC9'WD*]OAO3K*`?9&([=S%-"_JI(95<#@W1W\IX6WY;-<OM
MM_7K[NQY]4BWD%'W!IMM_]<V^G_LS4^*OV[V]%<RZ#9,?WF`_BK*BMXF/=*_
M.W[<;/;\#]W`\'=6/O]?`````/__`P!02P,$%``&``@````A`"Z<W_A""P``
M1S4``!D```!X;"]W;W)K<VAE971S+W-H965T,3@N>&ULK)M=;]LZ$H;O%]C_
M8/C^Q);D^`M)#FKK^PN+Q=G=:]=1$J-Q%-ANT_[['8H<4>2K.C9P;NKFT?`5
M.9RA.+1\]^?/_>O@1W4X[NJW^Z%S,QX.JK=M_;A[>[X?_N>O\(_Y<'`\;=X>
M-Z_U6W4__%4=AW\^_/,?=Q_UX=OQI:I.`U)X.]X/7TZG]^5H=-R^5/O-\:9^
MK][HRE-]V&].].?A>71\/U2;QZ;1_G7DCL?3T7ZS>QM*A>7A$HWZZ6FWK?QZ
M^WU?O9VDR*%ZW9RH_\>7W?N1U?;;2^3VF\.W[^]_;.O].TE\W;WN3K\:T>%@
MOUTFSV_U8?/UE<;]TYELMJS=_`'R^]WV4!_KI],-R8UD1W',B]%B1$H/=X\[
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M2TI(H?)%R-P/:9XIY8ZTF/QX\*;.W>@'+0!;9;-"&\MBS18BVX6L;X/`!J$-
M(AO$-DALD-H@LT%N@\(&90>,R+6M?RDF_@[_"AGA7_;,BH%VN&NZ>\T6W,2W
M06"#T`:1#6(;)#9(;9#9(+=!88.R`PQG4IK\'<X4,A3O%.UGHE49T8K:&DTM
M#[<FK8N!!$!"(!&0&$@")`62`<F!%$#*+C&\3?XQO-W_9.850%@W3F5GK!09
M-\N!8^>ZNDIYT_K7F^H8-GI"DW!%3X2UV1-%Y#9"+"QK(#Z0`$@()`(2`TF`
MI$`R(#F0`DC9)8;#Z`EO.$RLZMY<;*34_N#BA5THF<Y4A#XZ$^=9J=$:<33X
M0`(@(9`(2`PD`9("R8#D0`H@99<8_J6=D.'?\ZDAK$T?*M()2"`^D`!(""0"
M$@-)@*1`,B`YD`)(V26&PT35AMN,&['1/>\[T=#TG20SIWT6KH'X0`(@(9`(
M2`PD`9("R8#D0`H@99<8OJ-=L.&[\PX3UJ;#)'$GVF%`?$DFU(<VJ=W9S$SJ
MH#7BI`Z!1$!B(`F0%$@&)`=2`"DE<<9-W6HX490&5WBQ,3?=J-!M4]8VV].U
M0AW7^@K-Y%//'3O6RAAH@]:+"JEN-]*18E.]1,2ZI=A?D[1^6C9M$FW`TFF/
M=(;2N6ZII*VG=:$-6+HTI4UGB]VPG>[NM'G^G(]>48=9X:N0>':UL>E-)V9L
MKI757$>YSPVG;>`'B$)&L]8J8J2WVS$CK94@2AEIK8R1ULH9::T"4<FHT3*]
M*[;'7>]^XE*YFZ;M+D_=2E2JY.5%-]V]Z:WM4K4-UR'HJX9S/<``48@H8J2U
M8D9:*T&4(LH8::V<D=8J$)4&,ETJ-L%7N%3MF;LNE>BVNY]=0)!*(U<'@R]*
M?YH*5_<\4&A"5SH!;Q4?H6ZHK=S.!EHM(W#'6#?D>$CZ[V@M_ZEN>.:.&5OI
M,>:,]!B+_CO.S0@L=</^.YIS>%V](LH_>Z7ABJ7K^06DA;2:Z_#SE=;":U,L
M8$3&G4E<F`,,E17ED[;JF42X8\SR^HX)H^X=W8D5@JF^(\]^QD@/*&<M+5\P
M.BM?LE8SU>;TB&*EFV*B)J&P'YQ>=MMOJYK^HMSI6<H\JA^;8/XBCH?M*9/(
M3#LK5=:JG9%VLMVTNP*Z$WA62ZL%U0%Z$F=C>Q*E53,6/OWJF41EI?,B5OTZ
MWXE$69F=F$)R7M*)##V17]2)HK\3D*^?=,(,"%%=V0'A+9J:H(F)O^KWW\4$
M;0;:H%!%6G<MELA\O,VL+<W:D59&'BNML18+E)G382$WU0M:Q$@G4=S3,NEA
M*3?5:ADCK9;WM"QZ6,E->S)05&>VPZ_,0%7@:?^L'(F,#/1FUM9TK:R,%%1:
M8SW(0)DYXZD\-%I,W9FU_H8LI=T5,>KF%JHGMOIL/)E:*W+*4EH]8Z35\U9)
M][UHF>J[>^N,K9@K6:IG<D3YAY.#V7#%<BDDK1I&(I?JI,Z"9BU[:T=:=2H=
M7R%G3&YM6_8LF.J68_ILS;R9]1`*E9I'-5EKU;-B0C?BR[J1M&9F-ZQ(2B_J
M1J:L.M[(6_VSWBA:,[,;UN.I_*P;YJHI2EP[3ASZ[H>6WFM6354I=Q-9(1W2
M:P>0CRA`%"**$,6($D0IH@Q1CJA`5!K(\*M[W?E`8V[F%J.._Q#YB`)$(:((
M48PH090BRA#EB`I$I8%,_]DE?\].KO/4=K'.9]3UG[+2R$>K`%&(*$(4(TH0
MI8@R1#FB`E%I(--_UQ7U+A;UC&@/TRZJGGV&M]96O/_W$06(0D01HAA1@BA%
ME"'*$16(2@.9+A6U;W>I_"0D9:E,%0Q[9N4JI.-OC<A'%"`*$46(8D0)HA11
MABA'5"`J#63Z3Y2=7?_)=P,N.+2G`U%[YZ%0]]@>D8\H0!0BBA#%B!)$*:(,
M48ZH0%0:R'2E*(RZKOPD%&4=982B0LW)=E,.K\6)J#@ZT@'K*_3).;ZVXD@/
M$46(8D0)HA11ABA'5"`J%>H[T7=%L7:%3U5MI[VU:A3NAYV=W5HAPZ>RX>]/
M]%4;,M#N5#>37T3(HSAEUCW1URU_<Z*O#5@Z5:C[94&&TKEN^9L3?6W`TJ4I
M;0:P**>ZSFZ^4:;MX2>!K*JPKM,E$A/;>4Q9)PEK4992;'>/\Q6B3G*'`T0A
M(UV_18QT_18STEH)HI21ULH8::V<D=8J$)6,L/*CFMAT[2<NE561L39(9)UW
M6)7MNKD/N50_S'Q&>H`!H[DLP*E$MH^[V$(WBAAIZ9B1MDH8*>G;6_L-L90M
M=*.,D9;.&6FK@I&2=K#R9HNFD1G:HLBQ0_NB+ZM$&6T5V`IYW5-2;VZY<*VL
MJ$\<RCXC/:A`H<FDF8J)-_$LG1`;18RT=,Q(2R<LW3WHQK-B;)@QTO(Y(RU?
M7"1?&@V-*1$'`\:4G$^)QMPLQA0R4V)N'<>LE54W);BA/OD.&(DSQQ\/CCNQ
MOWP,64>[(&*DXS9F'2V=,&+IF6,=E:2LHZ4S1EHZ9QTM73"2TN[MS+46A))U
M&FG3_W8QU]GY77[^Y&&-IQ"E!P?^6J%N+BA$Y^)L%3!:-'-`8_$L1X6LHQT5
M,=(Z,>MHE#"2TNX<3AQ3UM'2&2.MD[..1@4C*>U-YW8&EZS3,P=V06C/P67'
MX_0*O[U&,=(/K#4B'U&`*$04(8H1)8A21!FB'%&!2/QRH1EV,T89V_*7"/+E
MYWUU>*[6U>OK<;"MOXM?&=".[^&NQ?(G$"O778KZDJ(0KGATI<DVN#*A*TU\
MVU<\4J-^H1K]U.)+'U_13S":UYQL)=&M/AUO^:7W!BOJ;6]G;Y?T#B%V:#5=
MTKMO/7RVI%>\>OA\2:\O]7!G02-8]%SQ%TMZ?0=;T/LS2_&*#%ZAUU^6X@T7
MO$)OKRS%"RIXA>JAI:@J^JY,EX'<2EK.C=WI,NF]0GMJ4NOUBSNF&>GKP<JE
M.:13'^K!J+T1_8SE??-<%9O#\^[M.'BMGB@`QTU=?9`_A)%_G-078%_K$_V`
MI?DN[(5^L%31"ZSC&]H_/]7UB?\0-VA_`O7P?P```/__`P!02P,$%``&``@`
M```A`/&);:')!P``MQ\``!D```!X;"]W;W)K<VAE971S+W-H965T,3(N>&UL
MK)G?CZ,V$,??*_5_B/+>#9`$`MK=ZA)^TTI5=6V?V83=H$M"!.SMW7_?L<<&
MVY-+$ZDOR^;#S-C^,AX;\_CKM^-A\K5JN[HY/4WM!VLZJ4[;9E>?WIZF?WV.
M?UE-)UU?GG;EH3E53]/O53?]]?GGGQX_FO9+MZ^J?@(13MW3=-_WYV`VZ[;[
MZEAV#\VY.L&=UZ8]ECW\;-]FW;FMRAUW.AYFCF6YLV-9GZ88(6AOB=&\OM;;
M*FRV[\?JU&.0MCJ4/?2_V]?G3D8[;F\)=RS;+^_G7[;-\0PA7NI#W7_G0:>3
MXS;(WDY-6[X<8-S?[$6YE;'Y#Q+^6&_;IFM>^P<(-\..TC'[,W\&D9X?=S6,
M@,D^::O7I^DG.R@<>SI[?N0"_5U7'YWR_Z3;-Q])6^]^JT\5J`W/B3V!EZ;Y
MPDRS'4/@/"/>,7\"?[237?5:OA_Z/YN/M*K?]CT\[B6,B`TLV'T/JVX+BD*8
M!V?)(FV;`W0`_DZ.-4L-4*3\QJ\?]:[?/TV=^73R4G5]7+-0T\GVO>N;XS]X
MDX]D<':$,UR%\]Q]6'K6W(:V;@T"S?$>P%4&@;ZNEO;295&N-+\0GG`5GO9\
M;/Z*(X3E3<)5.#H/GFWY<^]Z@Z[P@ZOP\V_KJ2<<X3HT>-,089KRGL+UOB'Z
MPA&N0XNW#-&&#,2$8*F(#_W&0=I#+L$_0Z/7ACG#9.2Y'99]^?S8-A\3*!@0
MH#N7K/S8`0LKLQJ?Z9#G/TISR&\6Y1,+\S0%[2"3.YB;7Y\=SWF<?87YM!4V
M:VICZQ8;:<$F#PL;FB`R06R"Q`2I"3(3Y"8H%#`#G0:Q8/;]'V*Q,$PL.<RU
M!(IZAC+20KJ$)HA,$)L@,4%J@LP$N0D*!6C*0$GY/Y1A82`3H<Q<R2-A!`5D
M,'(-N0:302]"(D)B0A)"4D(R0G)""I5HNL%(-=TN+R9REC%K+H\<UEH0BT^Y
MI:&"N`G9/`CE>//!2.L(J'E'1YBUWA%!H%XK;2V&MOATW@Q&LO\A(1$A,2$)
M(2DA&2$Y(85*-#5@&)H:6!4?V*)U_0DQ1UT8)!XNYZRH;0@)"8D(B0E)"$D)
MR0C)"2E4HJD`:ZBFPO6A,VM]Z$@\;RAT&R2.GI%&VH;";:R/T4#4Y/+TY(H'
M(YE<"2$I(1DA.2&%(#[?'JKK`=O:JXOG=8&8M2X0$E4@)(9`1G4+A9LB$)+%
M2&)"$D)20C)"<D(*)!Y5`S9`=ZC!K'4UD*SX+ASK!1)G,2102&PB06S<=%CV
M6-]XC'BX/Z2%(,X0-24VV4#X5L:RC;U,/MR740LD%V1A^[P[=.'FNC`"J<H(
MY,!ZK-3;E3XE0NH8":2F"D6)0#@:KF,J8\T'V3+JF%-4:+&T^L+VF_<H@]LR
MV!U(T=<\PM-T#BN=(H.OR[`15I[#<V1A>\HBR`<7"@MGG$"11%`=Q]`+,[N$
ME>OQT"O?-1Y!(L.,13"5:&PLD^AJ8[G>F+?TC/6UD&%X8[K4;.-V>ZFR<9^G
M28W(@3P?]5A9IM1HY<T'J8V9$XK0RW&:1P+-1Q1+A-/:<QRCVB?28/1):>2,
M6N4286376QK+3R$->&1=1+:-NT-$L>M3\Q61GJ\K\AJ$5MZ"BVBD7&CC72U7
M!1J3+!96"XQA^Z[Q'!(99O1))5(3DT3.C<@KRW@TA0QS(0O9CO0.`<4&5A40
MD9&%QM@V[`4"%A?8KK'R303$NUH&(M(R4"#,$]M:&JMP(AI1?%*!E,@9M<HE
MPCGBKXS^%?+^A01D&]8[]!/[6U4_1$8"&CW8L&,MII\K9[%K##X4%EH2HI,S
M)E0LK$02NM:"5$?BD]+(F41CY%R/O%PLR"Q6(^NSF.UW[Q`1M\?P4,95!Y&1
MA$8QWMAH!4DH'4.!E/R()'('JUBB%5??HS,7`VN)AT@)G,DH8^!<(ERL;&M!
M9JX:61>-[8'O$`VWS)IHB"#SI!P;&Y&21"%%D43C0&*!Q*KKN)9C9'`BG<:4
M2252JYOHP!@Z-T+/7=NHSH6,<Z&\L:VQ*A)[;71<=AS\'Z^--FZJ-;T0&4EF
MI/E&."H//J0HDF@<9RP1M*(LY\8T3X05I)IB929D*F.-:W$FT=AB+I'>(DE!
M'/8/6]2SDFVZ3<'M)7]/[_?U]LNZ@<'!MO'"BQFKOGSS]\G&K;LF/B*M3-J6
MH<Y&.&KYBXX*BH25JXV;;B31T?7YI%]Y9F.);$S-:-)8=E-CN;3"QCS?-=*J
MT!K3)'?,MQE^-`+?(B!#F.*?F_./%(=I("7G4?27'('4@Q**0HHBBF**$HI2
MBC**<HH*#>GJF&\TO`(LF3IW'JBS(P#C_5@B*-+*E#66U,UH)>ML2%%$44Q1
M0E%*44913A'[-,<'Q"L"BH:?VO!SQ+%JWZI-=3ATDVWSSCZC@<K/CP/&;WR%
M'[#W21B9<0,^_GWB+_0&7\-'07[T9G('/A9>BC.'.!<=Y@&<XM*&U\L`CA$O
M<#>`@[4+W+&@Y4M#6#O#!TRSLUZPYJN6P4,O@+,@VD;D!7!N0WGA!7!Z0_G:
M#]8750W]@)TA4(_(#^*+-Q(_8(<'U"/U`W:$0&]D?L!.#>#&;!@>?#8]EV_5
M[V7[5I^ZR:%ZA7RP>%EO\<,K_NA%L7EI>OAPRNO.'CZ05W#*:K$Y]]HTO?S!
M&A@^N3__"P``__\#`%!+`P04``8`"````"$`ZM=AMA8/``!62@``&0```'AL
M+W=O<FMS:&5E=',O<VAE970Q,2YX;6RLG-M2&TD2AN\W8M^!X'Y!K2,H;":,
MU.=N=??&[.ZU#,(H!A`AR?;,VV]65V5G5?W01A%S8_"GK#^K*S/K)*%/O_WY
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M.%N'ZI>3GC#@N*A?NF<<#R>SJS8P/9T-ANR4?C%-KS\T/`$E@>ZN9`-I]/GB
MR`?TRVD/2!'6OB1I1A_K)6=-8*7-2'*VK[N<.(%D3F_&7>IJ:8MON3ZN;S[M
M=S_/:$:CJ!Q>UVI^#.9*C,M..^\*\;TZI`)4*E^4S.=S2D<JL0--'C]NAI/@
MT^4/*O@[8W.+-I[%@BU4=2O9I0]"'T0^B'V0^"#U0>:#W`>%#TH?K'Q0^:#V
M06.!2XI&%Q+*U+\C)$I&A80'\Y:!%2,W0@NVX"9+'X0^B'P0^R#Q0>J#S`>Y
M#PH?E#Y8^:#R0>V#Q@+.^-.<\7>,OY*AJJ+YI*<FC!%-'9W1U`M*9])%!4@(
M)`(2`TF`I$`R(#F0`D@)9`6D`E(#:6SBQ(A&%6(TG%S0.+Z]7^!Y2K5K@\*#
M>6O(H)VTQM[8FQ>I4KOP!%<2(*=+Y-OI4G]'E+7;$4-H+>A\#2=#KT.=$?=_
M"20$$@&)@21`4B`9D!Q(`:0$L@)2`:F!-#9Q1IZ&[(215];NR!LR[:;*!9`E
MD!!(!"0&D@!)@61`<B`%D!+("D@%I`;2V,099MH=G##,RMH=9DV&8QEF3<;N
MMF'DIORR,^*4#XW0J!.*#-&;>;5SB+M6=C5YY9UT1BR=@G0&TGG7RI:>N+TN
M.B.6+D%Z!=)5U\J6EOFFW135G1%+-[:T$S(:V1-"IJS=D&FB#C$R)XW]79LQ
MDO)9`@D-F4G(#)']20RM$B`IZ&2@DT.K`D@).BO0J:!5#:2Q=9R1IQ/6"2.O
MK-V1UV1(/V3D)S,WR1;::-0>K/6&&4@()-)D(JUBL$F`I$`RT,G!I@!2`EF!
M3@4V-9#&)L[(JR/J"4/?FKMC;]#$7O:'DRMO\(W5D(I/0C3V9R]C-1ZW^XM@
M-O6J.109+N>(D54;C'J=)>R,MDU6E[Q9+Q4M]I@Q$H\YHUZ/Q8<\EJ+%'E>,
MQ&/%J-=CS1[?&]!&9,B9FQGJQ&4?=ONW:.K&PJM*@R9T=+`&V-^D&2N[+AD%
M^FP\&`1>HH1L(649L3=!,5HEC'X1=/TP5I\RE,]92SP6C'KE2[:2ABN4K]"J
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M$8VX@WV-.K+;T567^,.I>I_L%]=AZIT'/]`:>47G[586IN'DNEO>E@9-]4U:
M\&:@M;:U:D6FU5"2/4;MA+7U+B&`0(-NAKHYZA:B:X<0`MW)VU80:&,E3U*A
MQYH]RBAAH#MW$&C:&F.@U7[Y<7OWQ^V.PD[;O#?FV1$5GWFC1DEXI:V1NVQ.
MO?1;J#>'J.&8<DIJPM_V+-EJJJO]ZGH\\`ZMH3%QJEUKVT=2%NIUE[`5EXV[
M-*3H*C/(<I6S2*^K@JVHJ_+\4T@5_23T<+85I`H\;\7RO9VHV:H;WM',JX7&
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MV*!5=J.I[E(^/N<.]=6+/><:Y-;YV+\P-E;6[G=IT%CMSW[<S`+_9(1-(D:2
M[S$C69H2$>XM8+Q%8BV1SQF)?/$A^1(;KAB)?,5(Y&N1?W-8&J>)&TMUD7)"
M+)6Y-V=KY%6F%YC%T%C)$6[)2.]%A\.!5\VA,;"J.>(VDNXQ(U%.&#G'49R-
M=9<L^8P;BGS.2.0+1KWRI;&RY%?<4.0K1B)?,WIO7!I'V8VFNMHY(9KZ)LBI
M3(W<T^S$OQ*D]Z15&MBG68/,:78VN?;:A,;`JN:(D21WC,H)*]-$VK>VZBY9
M\AG*YRA??$B^9"TINA4CZ7V%\C7+Z_,KCDO#,JVR&TTZ'IP2367NU:9&[MX6
M+@35M0<U'%EW$XA"1I*\D4'VWI:M1"M!E#(2K0RU<K82K0)1R4BT5JA5L95H
MU8@:1JV6&PMUQW!"9>DK":>R-)K2K&.E,<R3]EV&/F?0K:P*#V]D@^FU]8FJ
MUB0T)E;R1XPD.V-&DL,):^OU=.R=0%-LD3$2W9R1Z!:B:SWLU'O84AK:5MXR
ML&(K\5@Q$H\U>S2[TT!]D-W=Z35.*S>ZZG[AA.@J<Z_2-)K2+&1%U[O*65"`
M5,.)S/9+1OI*=C*`[:EN8BTC$3>1C(\9B7#"J'>52HV5)9]Q0Y'/&8E\P:A7
MOD3Y%3<4^8J1R->,WAF6QA%V8TD]<F+YX<M=NE.%L&KD+H=3_W+7-'260]V0
M+W>#V1B+5IO0D_#9+#)"]N4N:B<&3?76'8L6=#/4S5&W$%TKA[%H.WG;"HK6
M6-E%JY$U2C5[-)>[P6R"1=NY@T.ENG^QB[8--)7+QR]WU<+H%[)&M*;9C^>=
MY!>FX2\N=]G*W#X.)P-X*\>86/47&>2LJKI3_>X2=J<WCI@76L1RE:&KG$5H
M3V!-9%[&%VRE1KO[`P9,E<ZC;06ITHTXUT'%\KV=J-FJ&]Y@Y,V>C3'1S^Q,
M$X0P>P+Z"RB3/Q^[VVU5W)7`H)E\MG*!:(DH1!0ABA$EB%)$&:(<48&H1+1"
M5"&J$34.<N-QVA71"*^(&-%VR<I);TNS$"O.MB6B$%&$*$:4($H198AR1`6B
M$M$*486H1M0XR(W%:1<\([S@820K^@+1$E&(*$(4(TH0I8@R1#FB`E&):(6H
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M6\[(6-`*RCHQ-Q*4,!+IE%$G[6=XYDB[@Z1.G_8@Z3]WE;?`/_09BI$^PSH%
MJI&58`MC9:&E05,G63'GM-;T6G^&XHT/TD2L;2<=]"#YD+N4K<2=_XF4S''G
M#J@ZSL"`GKSMU(<B9T`U<K:=@);T^5N5Q995B"A"%"-*$*6(,D0YH@)1B6B%
MJ$)4(VH<Y,9#'3[L>/QBQ=5G%6?@#9**6]!-:CM7"%HB"A%%B&)$":(4488H
M1U0@*A&M$%6(:D2-@YR!'_OGK_Z!;\W=Z9<13::RDLV\$^!"K'C:7"(*$46(
M8D0)HA11ABA'5"`J$:T058AJ1(V#W%B<=O:B;S7QET)&;BR\Q7@A5A(+HR6E
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MR/5E]XU0-_\'``#__P,`4$L#!!0`!@`(````(0!;@T;DJ`L``-XY```9````
M>&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;*R;77/:2A*&[[=J_P/%_3$(@3^H
M.*=B0-^?6V=WKPG&-A5C7$#BY-]OCS2MULR+%;-U;H+SJ.>=4??TJ&=`G_[\
MN7WN_5CO#YO=RVW?N1CV>^N7U>Y^\_)XV__W7]X?U_W>X;A\N5\^[U[6M_U?
MZT/_S\___,>GM]W^V^%IO3[V2.'E<-M_.AY?IX/!8?6TWBX/%[O7]0M=>=CM
MM\LC_7?_.#B\[M?+^ZK1]GDP&@XO!]OEYJ5?*TSW']'8/3QL5NOY;O5]NWXY
MUB+[]?/R2.,_/&U>#ZRV77U$;KO<?_O^^L=JMWTEB:^;Y\WQ5R7:[VU7T_#Q
M9;=??GVF^_[IC)<KUJ[^`_+;S6J_.^P>CA<D-Z@'BO=\,[@9D-+G3_<;N@/E
M]MY^_7#;_^),2]?M#SY_JASTG\WZ[=#ZNW=XVKWY^\U]LGE9D[<I3BH"7W>[
M;\HTO%>(&@^@M5=%H-CW[M</R^_/QW_MWH+UYO'I2.&>T!VI&YO>_YJO#ROR
M*,E<C"9*:;5[I@'0O[WM1DT-\LCR9_7YMKD_/MWV1^,+9SR\).O>U_7AZ&V4
M8K^W^GXX[K;_K6T<K51KC+0&?6H-]_)B<C5T'272T=#5#>GS1,,/]C[6(O2I
M19S)Q94SO'&ONGNGJ]6M7S8-1Y/FUCM&?:7;T:?NL+L?2K6J'_KD`=*?'1W<
MZ`:.F@TZ*!\:F=-$D_[XT-@<CIWZ0[<87XRN)\ZDF@$=HW0X>HYX_F,.5/.S
MGG3TQ\>&23&J6TBPG&XG.APF]<='O#BH,Z-*M/GRN/S\:;][Z]'J1;X\O"[5
M6NA,E1BG6.V;)NG>RSE*-J7R1<G<]FG0E$\'6BA^?!ZYPT^#'Y3<*VUSAS:.
M:3%C"Y7)2G9N@X4-/!OX-@AL$-H@LD%L@\0&J0TR&^0V*&Q0ML"`HM&$A";K
MWQ$2):-"PLZ\8]"*D>5_MN`F<QLL;.#9P+=!8(/0!I$-8ALD-DAMD-D@MT%A
M@[(%#/]3ZO\=_E<RE%6T?G3DA#:BI:(QNK2"TI@T40&R`.(!\8$$0$(@$9`8
M2`(D!9(!R8$40,HV,6)$7C5B=+HBX-5)65>A8!?>:3*LEBK7\KB^2/G9!&7D
MREIE#(0B9PQ$K9_TH"!\Y@JJA,PQ:D(/A=8P1M98&R.^M3F0!1`/B`\D`!("
MB8#$0!(@*9`,2`ZD`%*VB1$4<AD$Q;U6->([I2-/%-70#((F[2>;<WUC!4$;
M46G3BI3,*F-L](R%L3E#6HNZI[!J9HY,D^Z1:2-S9.-F^,;(2`E&=NE>J$*S
M>VRJH3DV3;K'IHW,L4U.CXV,C+%U#TA9FP/2A-S1BI"]TC9&32X!60#Q@/A`
M`B`AD`A(#"0!D@+)@.1`"B!EFQBS0M7I9[B^,C=]SXBRI.7\JR;05:DW$ZO&
M^X@6B#Q$/J(`48@H0A0C2A"EB#)$.:("46D@,Q:J9&Q7Z]UIH'9,5AXPNFS*
MPAFB.:(%(@^1CRA`%"**$,6($D0IH@Q1CJA`5!K(=+RJ%<]P?%U:4NW'<_E.
M;4%5+$8-FFDT;J^2(_?:S(NY6+'60J-1=?)298_'J#Z[4'LG7QJVT\YZ=`5B
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MW#[_4"=HY^2I,K<JCAJY%-:6AZ6TU'FJK>J3X_J\22.C5!E;H5E4`Z1LEA3Q
M-'(%^8Q$/F!T7<TSY_)J<F.502%J1]Q*M&-&HITPZAQZBO(9-Q3YG)'(%XS>
M'WII:)O9KC9(9ZR\RMR*:(V,;(?'P<RIK5QS3;!R>:ZMQO7FG[[2P6S7.I()
M'DM+)OB,.GL+S-Y.QQRZBUA;NHL9=7:7<'?&X84]@U/6DAO,&$F/.:/.'@ON
ML7:G<WUUZ5A50,E")W)=;5#/F!EZ/]M^)M>(9@:OS#-UCDWSAQ9]1G-&4G0L
M&(F5QTA\X#,2JX"1:(6,Q"IB)%HQ([%*&(E6RDBL,D:BE3,2JX*1:)6,*BLS
M)=7N^PS'Z\UZV_$U,AQ?H]]5M(T5AV>AONZ@B!D5K492$_K:RI*'BA;D0Y2/
M&(E\?%(>*UJ03UE+')\Q$OG\E#PL8858L7-*UJKDS2!29IX31&5NK:LULBI:
MJ\R>.=I*JKTYH@4C>9!XC*1R]!F)5H`H9"1:$2/1BAF)5J+16%(E92O1RAB)
M5LY(M`I$):-*RXC%B`JB,V)1F9NQT,AXQHW&=D6KK7Y3T;)577^Y])VWN:U<
ML(&L'QXC<9W/J+/8"]BJL[P,V4IZC!A)CS&CSAX3MNKL,64KZ3%C)#WFC#I[
M+-CJ/8>6;(!+[>B\4YO*W)H9]4'.;^I9W;!5ELXU&G?Z:8$-/8W:]2Q:!2P_
MKNM9YV;D6L56B*TBU([1*F'MSJ&GV#!#^1RM"I9_?^BET<K,]?..@T9X'*21
ME>O69F"FK=J%#*-.MRS82F:^QTAFOL](K`)&;A71R=!:-D*^+DTB1B(<,Q*K
MA%'GN%.VDH89(Y'/&8E5P>B=<9=\O6IBQI)&=,ZZK<RM[*R1E9W6.=Z,:INJ
M*)4]U9P1E?^M;:J]V]16K;3VN*$\T7Q&(A\PNJQB>>58^]\0A2-N(L(Q(Q%.
M&'6..T7YC!N*?,Y(Y`M&[XR[-(3-6*ISG'916_^:I?H*Z_BT67V[VY&C:3$]
M<6ZN9DYU+O!E5)\&T0$%EV!W&AGI"K7;3%N-Z1"A%4]K19RS57U[IQ[-^C1*
MIK>GV[B2!#[+='86L%7=F3,:CL?6Q`Q96[J+&$EW,0MU=I>P%6W`6AZP9G3*
M\M)CQDAZS%FKL\>"K?@&W<FU=8,E:Y_(?=+NG"]_[5[?FR]4,C<31LE8:X)&
M,JUGJL965H+FB!:(/$0^H@!1B"A"%"-*$*6(,D0YH@)1:2`S@=5)2#N!3R0J
MM6X<7Q^<&)FJD7AY1J?NX'A`"[3R$/F(`D0AH@A1C"A!E"+*$.6("D2E@4S'
MJR.3,QQ?G[`8CM>H[7A`<WJ*6;%8(/(0^8@"1"&B"%&,*$&4(LH0Y8@*1*6!
M3,>KXX0S'%^?/AB.UXBF=&O-M4Y%9J/&BA]J<T0+1!XB'U&`*$04(8H1)8A2
M1!FB'%&!J#20&0O[..7__C&7*A3L)X)&1I@F5GT]XX9R"C%'M$#D(?(1!8A"
M1!&B&%&"*$64(<H1%8A*`QEA4D<?9Z1,96X^G362`F_&I#I%-GL[;_=.WR':
MD6?46AD1S1$M$'F(?$0!HA!1A"A&E"!*$66(<D0%HM)`IN//VV13;0R.UZCM
M>$!S;BA6"T0>(A]1@"A$%"&*$26(4D09HAQ1@:@TD.GX\W;$]`(0.%XC<>F,
MK03-$2T0>8A\1`&B$%&$*$:4($H198AR1`4B]<)4Y:_*$[7CZQ>@ZO<RMNO]
MXWJV?GX^]%:[[^KEIJK@;7#]YM6=Z_*K5_:5T>54%7KTF(<K5W2EVGO#E6NZ
M4AV&PY4;NE*MBO855[W\57V_`5=&=*7:R5E7Z'VQ+Z?X'4F=5"*A4_9?W.D7
M<N.)6U1>.<4GT[+RMS6@.[J[DS?G#&E$U8;1;N&HL9X>+'5"L<)1T2^]INIW
M7'B%?J0U53_!PBOT^ZJI^O447J&?1DW5#Y_PRLRYIGY.A9&^.J-^3EVA;[VH
MGU-7Z`LKZJ>Z,FB<0&_7O2X?U^ER_[AY.?2>UP\T08?5`<N^?C^O_L]1;YR_
M[H[T8EVUAWZB]RC7],.TH?IQ_,-N=^3_T(T,FC<S/_\/``#__P,`4$L#!!0`
M!@`(````(0!U5\#A*@,``#<)```8````>&PO=V]R:W-H965T<R]S:&5E=#4N
M>&ULC%;;CILP$'VOU']`O(?[-4JR6H*V7:F5JJJ79P=,L!8PLIW-[M]WC!."
M23>[+R0PQX<S9\8>5G<O;6,\8\8)[=:F:SFF@;N"EJ3;K\W?OQX6B6EP@;H2
M-;3#:_,5<_-N\_G3ZDC9$Z\Q%@8P='QMUD+T2]OF18U;Q"W:XPXB%64M$G#+
M]C;O&4;EL*AM;,]Q(KM%I#,5PY)]A(-6%2EP3HM#BSNA2!AND`#]O"8]/[.U
MQ4?H6L2>#OVBH&T/%#O2$/$ZD)I&6RP?]QUE:-=`WB]N@(HS]W!S1=^2@E%.
M*V$!G:V$7N><VJD-3)M522`#:;O!<+4V[]UEGICV9C7X\X?@(Y_\-WA-CU\8
M*;^1#H/94"99@!VE3Q+Z6,I'L-B^6OTP%.`',TI<H4,C?M+C5TSVM8!JAY"0
MS&M9ON:8%V`HT%A>*)D*VH``N!HMD9T!AJ"7X?=(2E&O33^RPMCQ78`;.\S%
M`Y&4IE$<N*#M7P5R3U2*Q#N1!*#^%/<L+PG=,'J?Q5:*A@1S)-!FQ>C1@*:!
M=_(>R19TE\!\SDSI&'-]*U7(49+<2Y:!"[+@4)[G39JN[&>PM#A!,@6!#3%"
M7!VQ/2.D?Y(UGSRP0>ZH&9R8:_:AIO^OQEFB7*1+]`-=0'8-\73$]AKAASHD
MOX;$\0C1TO#U-&[+E^"U">2C?>E<OH+$@_V+*(H]9WSOX.=6!Z1I,*M1K@&"
M)$S?4`Z-,BW`;>42#`T_4>XZ,V69PL!US"Z::7\7D=]":+[#EINJERW_?OO(
M1;K_KC-KX$QA`E6`>)[!-!HD>GKY-.A>"JOICG3=MUV7X+G>63=G"J/TAIZO
M2]I.HWXTRR:?1A?>6RT>ZY(_9K5<-)<^$Y<IC)(>!)<V58VN12=VJF-E&EUX
MT85:<UN.[LG!>-MM"9Y+OE1Q>&VF,./V].++BY5J'9"&5T>+!@B2)+IL(R5=
M#3!UOK>8[?$6-PTW"GJ0P\F%QAR?JKF9P=P<IHP]!F!N]6B/OR.V)QTW&ES!
M4L>*H4.9FGSJ1M!^.$YW5,#$&O[6\(&"X>!V+`!7E(KSC9RMXR?/YA\```#_
M_P,`4$L#!!0`!@`(````(0#-/X1]BPD``"DY```8````>&PO=V]R:W-H965T
M<R]S:&5E=#8N>&ULG)M=;^.Z$8;O"_0_&+Y/+.K+5I#DX%@BV0.T0%&<TUY[
M'24Q-K8"V[O9_?<=:IA$''(Y3&[B]>;A2_+5D)R1HNO??NR?9M_[XVDW'&[F
MXC*;S_K#=KC;'1YNYG_]J2Y6\]GIO#G<;9Z&0W\S_]F?YK_=_OUOUR_#\>OI
ML>_/,U`XG&[FC^?S\]5B<=H^]OO-Z7)X[@_PF_OAN-^<X>OQ87%Z/O:;N['1
M_FF19UF]V&]VASDJ7!U3-(;[^]VV[X;MMWU_.*/(L7_:G&'\I\?=\^E5;;]-
MD=MOCE^_/5]LA_TS2'S9/>W./T?1^6R_O?KCX3`<-U^>8-X_1+G9OFJ/7SSY
M_6Y['$[#_?D2Y!8X4'_.S:)9@-+M]=T.9F!LGQW[^YOY[^)*E^5\<7L]&O3?
M7?]RFOQ[=GH<7O1Q=_?/W:$'M^$ZF2OP91B^&O2/._-?T'CAM5;C%?CW<7;7
MWV^^/9W_,[S\H]\]/)[A<E<P(S.QJ[N?77_:@J,@<YE71FD[/,$`X.=LOS.A
M`8YL?HR?+[N[\^/-O*@OJV56",!G7_K36>V,Y'RV_78Z#_O_(22L%(KD5@0^
MK8C(/RQ26!'X?!4I+_-5):KZ`T,IK0I\OJNLJJJL5\OT"0$YN@*?5B4'P40W
M:ML8/FWC3UBZM"+P^3J/YE*468(7"[S$8\1TF_/F]OHXO,Q@&<)%/#UOS*(6
M5Z!K0J6`@`N'"L2(:?.[:30V!?H$\?W]5F35]>([Q.36,NL04[M,&V*6+M.%
MF)7+R!#3N(P*,")S&1UBQ!NS`,O>?(.PGOH6]\O`-W/X^>Z7R-]T1T_7R"Q'
M-ZM<")%E9'CM%!&B]H`.`8C*MWXJ8KF<:A1U4Z]\&35E+I:E3VB'*$3=E-5T
M-(Y3L':G3J5%F&E$'2N(8\A,9TLFVR)18X3"GA$PM6-5)$LHEM`QPG$+ID/=
M*F''B<>7:43=*HE;R%@OX&+1X,+?P\]?QD['(Y+I1?$2.HHX7H$O'_?*-*)>
MT;T+&1C(FQ<TLI!`-XMLY=G9L1*2)11+Z!CA6`7G#K6*W^9-(VH5,6*-C`VK
M`A(]&E<(3+VD>U+'(Y+K1O$:.HHX;L%!2-WB%Z%I1-TBA]D:F:D9Q,\6B==E
MZF^]'2LA64*QA(X1CE6F9B#Y`V^5:42M(F?Z&ADTHA%YXZ^Q=HH4C1=Z'?Y^
MZC8-/3F5@%XJ7T7Q*CJ*.'8UG['+-*)VD?1FC<QTKC2RD+!;%AS[?H+1L2*2
M)11+Z!CAF"4@$9T&5_P0'&EB4TYVH[6%T(5*K/SKW5ID:B4-FRZ!D7Q7*D%&
MQQG7+Y._DL7([_("LUY(Z=Y..Y'17,M"Z-M%7A?>:FLM$O<-^XHQ,D%'\</1
M<1G7-Y/.3GQCX@R3WZE?#4VV!#+6KG)5-<N`80C%S.BL4(R1"8Q*8#0S:-<R
MD]"F6X;I[]0RD;\75E@`"830LZ99F0V?+-_6843E%!VC2F>)N&'3GLJZSI?^
M.:N<KBY@L_2W"NTR10VW%)P,R+4,QC2U+*T0$J85W=5H[6BAZ:3I[F\1=%?`
MK8_<GW/'ZT@>43RBHXCKFDEQ)X%F7.,3#'.WB[HFO$6*D+6D"413:W4LXL5C
M9W\_-9Z>%=+5:*K2DU$),CK.N)Z93/?CGF%^["Q202LCX2?17J0A8CW+<V=%
MV$7*JDB^(\4C.HJXGIF,EWB6<'9BGNQZ1@Q9"X30D"(+G01^NDW#J+,J\5#C
M>E()*CK.N*Z9S)>XEK`Z,5]V7:.EDO"3:F)L:Q$;:64@H>5%)(\H'M%1Q+7,
MI+\?MPR39M<R6C()A-"/I5@&3]`ID_NQV%F1>)Q-1:"CRD\'58*.CC..;3FI
M!=+.@;$5.3T%+9TL-)TQC32+H+-YO<K\"7>\C.01Q2,ZBKBFD8(@GMCF@4+`
M*Z`L9-=<5@;J[M8R4T.][2R!D0E]J00='6=<QV"%T=7)'P.Y:47"S"NA+(3.
ME?#8QLMN+1'W#;N*,3)!1[&CT7$5U[4/50.Y7PUX!91ET*R+NFE*/_UN+13S
MHDM@9`*C$AAMF5\-VK4,1CT--&9I&IH$6$YK=/,X$B"[-$6Y"J3XK0NM0OL8
MRL#/M_L!=/5*1P42YV7N7Q[E0!=5XU=KVD7*HBH;YQ1W+0N4`@EK,U`*Y+04
M,`^3P;KIG+TCP*D65OFR"22VO([D$<4C.HJXKIE<^\/Y1HX9NIMO>*XYF;[P
M_6BM3,37+H#XX<9UI!)4=(!YO\BN9R:/_KAGF'V[GM$"*O=3_?=!C-51:Q&[
MCK-`G<Z+2!Y1/**CB&M9H!)(6)RA2H#XL<X10C_R/'1PLK5"9T6FD>B'&=>1
M2E#1`>9]1JYG)HW^>)AA\NV&&:V><H2FTWT?A`VS:1(/#UB\?*3C122/*![1
M4<2QS(04M8P/L[$5/3[IRK10S#*+O)ZP_H'6\2*21Q2/Z"CB6D:*@+3[CD6H
M&"`AM+80^K'*FL8/HI8P?I19(.*[)!J-\/M1`1FZP'6`>9^2:YI)L\G2-);'
MT[3"M*)Q1I>FA2+S;2V"OBX;^-.[@&W85T1&\CTI'M%1Q#6-E`&)D>:7`R*G
MMS8*A-"1$NZR^Q'06B;B2!=`:)#(A*Y4@HX.,+\*-A@R#3;^+EIA6M%@H_<V
M+!3QI.61SB+6?;]FD+R&XA$=1=Q(^U0I4`1*@8(\8EI;:.H8#9$V@>D2&)G`
MJ`1&QQG7N4`YD+"Q!<J!@C[`*Q"*.\<S78*.3&!4`J/CC.L<*0J8HR!0#!3T
MN5WA%P-^K/%,EZ`C$QB5P.@XXSIF\NG)(<HXAMFWD]<6]!Y'P6;ZK45L4N)7
M"QVO(7E$\8B.(JY3I!)@G`I4`-Z-VL)-[PMC!-GK6LM,5^S[$86/ZGA$)O2D
M>!D=11RWRD\5`6,K<EYZ-VDM])IG^,]'6DO$/.,1R2.*'8J.BKB.D1H@'E^E
MG_M[-V@M@T9=U/72W/VA\66AJ%?85P21O(KB$<T,V+7K4]E_&<C^"WK/S$+6
M-U'ZR51KD8@E'8](OB/%J^@HXGI&DG\FQ`))?T$K\A(A?"="K.J\\7?SUH%"
M?YC662+BIW1$ZM5J?*I%HEDYT`7<7_<"7KM(E>7P(L>4<AV#$4V/Q[1R"5X<
M\]+^@NS::PM%IMQ:!`,QA[^!:@(W&ATH$*N2[TCQB'D9[M>WW]$S?-D-7UUZ
MWCST_]H<'W:'T^RIOX?'%-FE>9'KB*^ZX9?S\#R^HO1E.,,K:N,_'^&5Q![>
M7\HN`;X?AO/K%_,RW=M+CK?_!P``__\#`%!+`P04``8`"````"$`Z.7GXYX'
M```P(@``&````'AL+W=O<FMS:&5E=',O<VAE970W+GAM;)Q:VV[C-A!]+]!_
M,/QN6R1U#9(L5A*V+=`"1='+LV++L;"V94C*9O?O.]30(F?DR$Y>=F//X>C,
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MK\"?S6Q3;HN7??=7_?IK63WO.BAW`!'IP.XV/_*R74-&P<U2!MK3NMX#`?AW
M=JAT:T!&BN_]_Z_5IML]S%6X#")/"8#/GLJV^U)IE_/9^J7MZL-_".HC&IQ(
MX\0']L8NES(.1!!>][)"1GV`>=$5C_=-_3J#KH%KMJ="]Z"X`\_GR)#'$.M;
MH4*,VLEG[:7W!5&T4)]OCT)%]ZMOD-.UP:2(@9&P&(K(S@B=0.TV=[Y8`=^!
M-*2"DU90U,OE.'/4BRA'Y5,"Z1@B*2(;(U1`(?D8$ME4D#`4#6.:O@9#W[CI
M4S&]=(H8*..0XI`BLJN(?`I!V,-EW"),L]?@ASFD9F"6\.0C).J[9Q&&D?08
M=PI($C^A@)P`_#A(WL@[S)S+7/?\]?;1BWC^&8$4,4!CB)+G_RHBGT*0_(<T
MBNG\:S#-O_!9?E/$A&9\I4U>/XP9,4N/F7-B5IX::D-(1^\AK<&4=,RNFB+$
M[SFS>+()6^[:9&+K2,AJ^69[X_4^T8LH:>&+(1E]*E/$(&O!ACASC<R6NS9G
M/@CK9,S:AZ::[@^]B+-F>U^*&&2=2%M@;`^TFNZ1"6=.S"*RO@EW`;LX3_EU
M\OTJSI[Q2PUH:C@-!&.0(F$-E1.[B"-;5AJ$EBW6-T)>U2>!:N?ND<+GFZ0!
M34:!?B8@^>!%*_4B]FVN:"!:RIQ`IEM(H/"Y_&.V_:4&<^XA9LX&\YL;:#X)
MH>RUDMW.'G7/90\U8W,K$'1N<L6WT(P"/%_9G<7<T;@>`A%;.^4.U7.YWR91
M0J]B&N6SVY/4@";:([L.R2<A-!0M:+>7`>7/+0//8:KOO"%,;*)%*.U>@CN1
ML6.5XH#;<V)?`,"V(66N)<UA?F,14`C="'B;I`(Q&$'HW!Z:`%SS(AD'X-JE
MLEU*Z6N-<^A?F5Y41)>V\&UB>F*I<&531,R<$?-""&;/J5TZ^RLEKE7N=N*H
MB2YQGXE/*ES=7(0!NXO(B%TX_6"&EBR7;PZMUCB']XW]@LKH\A<^(Y@*5SX7
M4B96>DS+N`"1C%/OVA=2A/8*)/=:IMP8IINF1U/A#6PW8L\8#$[CPH\B!L@(
M`$)GXYP3NPJ$M5/F3'6O,+\DMKQM)((,]2`.(RN4F':*\%7LV0T=>X<A(G<J
M*'_H@'=D7J/Y5L^NG4H$36WUUR'Y)(2&\"[%E1<4=]P]KEXN1"(]?DN4&3^F
M2M(+Q>C!D$*$`&6WLDA#^)#P2A1>,L,!&]'4@)"G\*62#)%11)@H_KB3$T04
M1=*6G(;!1/>VK4B_1N)/`8$=-S//"#+I%J%#P<P$`<A$L3!S<YFS!TC%<)M%
M@]`RY^RG5R8:19'6@,UK*A%D+AT(Q</+*$(E4(6!G9EHXD/YH?,$1_F_2X`E
M:BOT^_#R0`3\]M^`)B?ZK-'6#]?A22\T!";%-_;16))%8`?.]!&"L!2Q%P>,
M929=0"2BF`E'3@")<)\Y:1!:^YP^NC$(5$S:3XQC*EU9]7W)M__,`"8*ED]"
M2"#ZY8,;R/1`]&@JSH+?^:0&Y/(;%>(&3#Z-H5$PH;ZM'.J"8`=<L`T([ZMA
MEZ>3FQDSMIQ(>$OF=+EM-TI?B^J[NTGI5;P8=O/&D3`@I"\E&_Z,F-7H!1PQ
M"V6#I_3?I='J@D:'-C&&-H+<'F)SDAD_YRT_\#SF)#>(RTYH!(#Y0`'T*E:`
MD"E3JA!D&D0&OL<0&4$$B>=H%ZH#`23P`L<&2J/XD$*K"PH=VDJ;>B#(3`%_
MELB,C_.0L!G*B1F>%*R=\F?B?.,47Q#ID`ELJER!!>$8O6HD@(7TU;@*KHO$
MC]\*@BGTC4&@PA)E"-FPI@I!V$I1X+QB[HN4$;L2"7]'G!,`;`:!31,MQ(<D
M6EV0Z)!+M`%A#!(.*UFG900P#C(G=AHDC>%#"JU0?,D=4\AVGM2`+N\KIA3H
M9P*23WHAH?A,HV]KJ7X5WYWL(SK.M0'AX/)7JQFQBI!I2V[,9FL3L=W8*/T/
MB3.<O8\W5SMSACZ"S`'?Z.61\8%F_@9'G^[K*Z!5V&%#\GAPC^?:A[)Y+K-R
MOV]GZ_I%'\H+.!T:OL4?#*3P@X'^='TU&."\_E0\EW\4S7-U;&?[<@M+O64$
MFVF#)_[XH:M/_2GR4]W!27W_YPY^F5'">;6W!/"VKKOS!_V;@N&W'H__`P``
M__\#`%!+`P04``8`"````"$`L<A3DI$#``"9"P``&````'AL+W=O<FMS:&5E
M=',O<VAE970X+GAM;*Q66V^;,!1^G[3_@'A?N*0A#4HR)53=)FW2-.WR[(*3
M6`6,;*=I__W.L8%BAT7MU)<0CC]_YSL7[+/\^%B5W@,5DO%ZY4>3T/=HG?."
MU?N5_^OG[8=KWY.*U`4I>4U7_A.5_L?U^W?+$Q?W\D"I\H"AEBO_H%23!H',
M#[0B<L(;6L/*CHN**'@5^T`V@I)";ZK*(`[#)*@(JWW#D(J7</#=CN7TAN?'
MBM;*D`A:$@7ZY8$ULF.K\I?0543<'YL/.:\:H+AC)5-/FM3WJCS]LJ^Y('<E
MQ/T879&\X]8O9_05RP67?*<F0!<8H><Q+X)%`$SK9<$@`DR[)^ANY6^B-(NF
M?K!>Z@3]9O0D!_\]>>"G3X(57UE-(=M0)ZS`'>?W"/U2H`DV!V>[;W4%O@NO
MH#MR+-4/?OI,V?Z@H-PSB`@#2XNG&RISR"C03.(9,N6\!`'PZU4,6P,R0A[U
M\\0*=8!_\22^GD6S!/#>'97JEB&G[^5'J7CUIT6U7(8E;EG@V;)`?UW`3UL\
M/%O\-)G,YN$T0J?G&P.C6B?AABBR7@I^\J"S0)9L"/9IE`)9%[UAZ//QKW1`
M'I!D@RPK'R1#H!)J^+".DL4R>("\YRUF.X*Q$5F'P'*!O%XC).4--"(+:L02
MHNAM9W@6'3N".H0K"!+U!H*0!=)^=3%K+0B*VJ<V<53V$%<F,`]ECG=T5T($
M:S5]?EI+:.KI.&T7H62]KF@>]B"K?B#^Y3H0;.MH+>;CP\IE0XOE*;$]Z6Z.
MKB9SV/#*CD8F6T9K@<<@XJB/6/=4UH/<6LQM99=K@6#;>6L9Y&!HL7*`%]/@
MB[[L"<&VI]8R\#2T6)X6K_&$8-M3:QEX&EHL3Q$<Z\.@L+!QO)B\OJZ:R=;1
MF>S*NF?!,\HM;83GUHLSKM&.`'/PP:W3?7M9A](F.Q7.:7BYOI$YPN"0Z:BW
MG0D::-#(4Z>1GU%GX8Z<?LGT?[XQN-;=GNA,=BVN7''MQ@2C,MDQ][NYVBHJ
M]C2C92F]G!_Q[H;XU\O>;`:+;13"9*&'@[,5G#DB)#];B6$E'EV9=G.*LP<&
MF,WX#M@PQ@0NQO";:;HQ@Y#C8`N>]8#DVF<IG)0C020IG%,C]GF:S<?LUVFF
MKTV7?Y%F"\0'_0(,1@W9TV]$[%DMO9+N(/FA[@UA1BOSHG@#18'IB"N8B/3?
M`XS`%`[W$#_J'>>J>T$'_5"]_@L``/__`P!02P,$%``&``@````A`)C^A2MH
M"0``*3```!@```!X;"]W;W)K<VAE971S+W-H965T.2YX;6RL6MMNXS80?2_0
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M?-ICWE^CM-C:W/J?(/VAVC9U6S]T%TBWZ(&&<]XL-@MDNKG:59B!HGW6E`_7
M\]OH\CY?SQ<W5YJ@OZORI?7^GK5/]<M/3;7[M3J68!MU4A7X5->?5>@O.V7"
MX$4P^J.NP._-;%<^%,_[[H_ZY>>R>GSJ4.X,,U(3N]Q]^U"V6S"*-!=QIC)M
MZST`X.?L4*FE`4:*K_KW2[7KGJ[G27Z1K99)A/#9I[+M/E8JY7RV?6Z[^O!/
M'Q295'V2V"3!;Y,$?[T2GYAX_#[[HHM^`IJ/#T57W%PU]<L,BPP0VU.AEFQT
MB<26B![&0,U_,0-*5));E>5ZCMV!2;<HYY>;:)5=+;Z@!%L3<R?$T(A[&Z$J
M!W@#1M#R'3"J+`JCJJ8"?6<-#G3,`-D(#@A$?0=`*@MH3U]ES01A50W4Y@SE
M$,)A(K,/4U[<MH0J6*,9^#&6I:XGI\8X4;(!5[1RR$C]`/[M.%0PQ6$L*W*I
M%2-A".(DY/3B:H&OL%?M3GOS$E=Y*"YCP2^/@C7#-01Q7)C.VTE1P?3BQD))
MV;"+#T'\XJJ/\5V?:JTS`O1F6E0FBLQ8""WK)4,V!'%DFQ!9O,1B.U.05!H*
MRU@HK(C!&H(XK`@MQF?L];VDH^GEK8D4;,UWE8L*`"AQ]$HV`J"74F@+\O1J
M%QE3W\Z4`-X3$]FQD22Y2QC/+(/.PXCH136BA4A8(>S`7$V`0F/B.T+$(+*.
M"%\O-3?WD6^B5U,Z]W;:C2KZM!L3K7O*ISM$!=-5PO9V`$8&?0#&Y-?=-]'I
M*KGRKJ;4,MXDZB;H[-*K5*STQD1+S^X3[M7*4`.%TBL]X^BR"5H>&6'T:3(F
M6B?7T,Q"&:*".DF2NEI/`1=*:C3(I==JUKP%NJ@`G*"JR1(\G[N=0UF-!LGT
MH?$NZ*(XM)@)JUIQR5HON-=WMAY(UY<U@2W7D=>\*=HH`'=1&]>@R(:(SY)=
M'<TP&=D=P62B*";7G2@F09SSY&*%/3I"F9%>;]G'QC0"ST11>*YY47A,H+6&
MZ%TZ@BZ4ZMB81M"9*(K.=12*[BQ!CT-!MZ813&8@Q>1DGV)2>OP]=$W)---<
M:R*:N^&:ZZ*"_:G4^+M@,[+N+SYC(IJ[X9H;#U$!-J7&'K:1]66TVP=@3%YO
MC'T3K1(J[E]-K>MHDL+'*A.3"6/"7#U1X@IO!X:M,<9"\\&-4*&B&0!C\JGP
M382*1!#M:!--N4W0J2@4:Z)<\);BHOBR2)AFJT*M-Y/`&5GVEHQ.#KP4'.\Q
M+BH`)XAW-.'..@FUW)I\:'BOR&XU750`31#N:-I381)JN351=*[%]3=8+BI`
MQX1;;[]X->$&*PE%W9HH.-?@##@S,-Q^"5/PU[>?CF9KWB@WU&?8__'2]3`#
M8(@*V`%R?_]K=J)4WQ2<>9.7J%0,G3%1>EPW,^B&J`"=$E5/J!6Z.-Y,J9V1
M9W]'&A,%QSM<,D0%X)BNC]0NU.[$F'"%H79I4+HA*+@^DVY-SK1GKB34=6NB
M[/`>ZZ(XNI1)_>OLZ&BZ=JS):RS$1!I+RJ1[Y&JA/.L$`.#7(E[R/NJB@NDR
M>1X!$(IP:DS^='T3G:Z@N,DFF]*JTE!QK8F6GO=1%Q5P(2GN-$U)0\FU)HJ.
M-U(7%:!CDJNWS7HY05-2HZJ>IE@3`1?Q5NJB`G`8R`4ORK,I<IRJ5&Q+&1-%
MQUNI'1AVJU1I(9/C*:\#=!X&;9!9IX5QQ!NI'2A`8V+\/_I8&BJU-5'BN%2[
MJ*"L@E1/N7E+0YVV)@J-MU@7Q:%E3*<5<1GT\<SFK]/0DEH31<;[JXL*D#%-
M5\C,ZXISP85ZKZ:H=@<%Q]N;BPK`G:7W6:CWUN3I/3$1O<\$O9_V9*(SL3J9
M#D"IX*W/#@RW7L;D_O76IZ,9`"/R/A6^B5(AR?>4=[E9J-[61&X"(M[X7%2P
M*$`AU\>)C[>92L5H,B9:)][X[$"A3DR]1^ID!-EK;IDQ^77R3;1.@B`G:3KE
M%B4+!=F:"!<Q[[,N*J@4$^01+D+9S8S)Y\(W$2YRIK&O7TU'T]);$]@>GA3B
MF#=N%\6GFPM2.J5QZSP,FB2D,6_<=F"X*G,FI$KE)ZX3G8JA,\)+UPEOW':@
M@(X)[TCEPGOIW)AHY7A[=E%!Y9BXZON::6_,<J.IWHZV)DH/;]$N*D`GB'&D
M.L69#3H/M=B:*#3>H%U4``T#?2T>J9R*9DO'F&CE>%O,AZ@`@))&[V9Y!("*
M9@!ZD_KLY&UZWHWR(2H`("APG,93%!A'Z@)TQH3Y>^AX-[(#O9W5GZWKSY(=
MRN:QO"_W^W:VK9_5N3FLM9NKP=P?ZKO+$YSJ2]07_<"3PJ,7=.#)X-'J''AR
M>#2@P+."9R5>9PV//@+&QV08@\8H8,LP!AU(\FS@V4B>?(GKZ".(_#JY.MFH
MSP$&GAB>6,J680QN824$&(/;3<D#KK&#)0^XQMV;Y`'7N"N2/.`:=R2")\48
M/`=+'HS!,ZCD`==X!)0\X!J/7Y('7./I1_!DX!I/'X(GP1B\V1(\*<;@+93D
M`==X/21YP#7>[D@><(W7*)('7.,5AN!),`8ONR4/QN!]M.0!UWAW+'G`-=[;
M2AYPC7>?D@=<X]6EX(DQ!M_!)`_&X".4Y`'7^`@E>!)PC8\UD@=<XTN)Y`'7
M^%`A>"+,M#\:PO=/!-1X[R>-`6H<CI`\0(VS"8(G!M?X*BIY@`#?)`5/A)GB
M!)?DP4QQVDKR8*8X["1YL$)P,$GR8(7T1[L"#H`:YYC#,3A0?2M?!0.$^#O`
MDN)OD\M;64#5>I82`9$$Z`XLBB2BBF(144.QA*B@+N!BX`('M4_%8_E;T3Q6
MQW:V+Q_0D);ZW5O3'_7N_^GJ$SHUCFO7'8YHZS^?<"2_Q-$X_1KQH:X[^P\8
M70R'_&_^!0``__\#`%!+`P04``8`"````"$`)_.!W'D$``".$@``&0```'AL
M+W=O<FMS:&5E=',O<VAE970S-RYX;6R46%V/JS80?:_4_X!XWX#SM4F4Y&H!
M;7NE7JFJVGN?"7$2M(`C3#:[_[XS#!!LB,GF(0GX^'#.>/#87G_[2!/KG><R
M%MG&9B/7MG@6B7V<'3?V?_^^/BUL2Q9AM@\3D?&-_<FE_6W[^V_KJ\C?Y(GS
MP@*&3&[L4U&<5XXCHQ-/0SD29YY!RT'D:5C`97YTY#GGX;[LE";.V'7G3AK&
MF4T,J_P1#G$XQ!$/1'1)>5802<Z3L`#]\A2?9<V61H_0I6'^=CD_12(]`\4N
M3N+BLR2UK31:?3]F(@]W"?C^8-,PJKG+BPY]&D>YD.)0C(#.(:%=STMGZ0#3
M=KV/P0&&W<KY86._L%4P=FUGNRX#]#/F5]GZ;\F3N/Z1Q_N_XHQ#M&&<<`1V
M0KPA]/L>;T%GI]/[M1R!OW-KSP_A)2G^$=<_>7P\%3#<,W"$QE;[SX#+""(*
M-*/Q#)DBD8``^+;2&%,#(A)^E+_7>%^<-O9D/IH]NQ,&<&O'9?$:(Z5M11=9
MB/07@5A%123CBF0*ZJOV\6B\F+'9?)C%(46EP2`LPNTZ%U<+L@:>*<\AYB!;
M`3,ZFT!\2$?C]9Y5\(@D+\BRL2'=H;N$\7G?SI:+M?,.,8TJC-?%,!7AUP@,
M(-(&K1L.Z&U$0RC:HON'H=:&8-16LWIT`[@;L6--2!<QF:F0H`MY?FX@BMB)
M*A8C/+V;.[5H[`0CT=(X6RX;_C(Z'F%@T!H?<Q7A#R("$T)Q`8]IA[S.$W/H
ML=/&AE#=%+JNJM$CS+Q,&K983EW\J!B?,/!]XU$1@0FA^(#(MWV8]2-8UZ\E
MK4>8*>E75?EUVWW=)H2B>_X5W0C6=6LY[A&&=.OQKMONZS8A%-W/JN['\@8[
MZ?HG:FP]PO3KK]ONZS<A%/U8PK7Y<?CMQ4ZZ_JFFGS#]^NNV^_I-"$7_4M5O
MSG<$Z[JUB<\C3'^^UVWW=9L0BFX&1:@=>+/P$JTKUV9#KP(9IA%_&!(8(:H%
M+%]?SAU&1<\\]5<@HQ7B,4`"(XMJ!<M=R\K`:%!Q5.?]6W6DZL4(Q*:3<NIT
M1PNMOOE=A+:D"#J(Y>TM4_5CG7M</U5%5;_V;(\1Z*;?[>C7$5KI""J*_B%2
M]0/F"_H1K;\-FCJ/$:C_X>40^<.0P`A1+6"I:PW!8^L@7&6#%8AD4_J["Z$*
M9+1B*K358M,$4:U@]=.LX*)YX*V@FJED%=,JK\=Z"BO3\L;O`ZG5)3!"5#-8
M"EMF!DQ0X51-Z$L+9JJN56H-0@(CBVH!JV'+PH.I135T(+5,A;:R,@@)F`FB
M6L$"V;(R,!I43M71T!=*C$"TPI[U+:\51-\"/%`03Q.51#$`V_`O&"C1VDS%
M;G-X&6"O`I&!)SCZ@(^:[OXP!,\'<"8A%HV$'-#VGW;'*<^/W.=)(JU(7'!K
M/X8RU=QMCAU>QKBOU.Y[<!Q1[MV=I@%.`\[AD?\(\V.<22OA!Z!T1\\PY^1T
MGD`7A3B7>_*=*.`<H/Q[@G,?#KMA=P3@@Q!%?0$/=IJ3I.W_````__\#`%!+
M`P04``8`"````"$`?KR$0'(0``"K8P``&0```'AL+W=O<FMS:&5E=',O<VAE
M970Q.2YX;6RLW=ENVT@6@.'[`>8=#-^W;6W>D&00B_N.0<_,M6(KL1#;,BRE
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MUIFX-9:ZAKIH5;>!#Z$/D0^Q#XD/J0^9#[D/A0^E#Y4/M0^-!:<2_&$$9`;]
M'2.@NE$CH&-WH\$,B3<@2UU#-PE\"'V(?(A]2'Q(?<A\R'TH?"A]J'RH?6@L
M<,(M-]Z_(]RJ&[EFY*I_9<;WE>3Z'BJ=>U-^J#(,`B2$1)`8DD!22`;)(06D
MA%20&M+8XHR(Q!`C,EV<2-3&W]+U/4>U:X=`A^ZFE[/V!C3QIWM?*M?A,!JS
MR]DP'LXQR8L[Q_3ZD:C:[I'TTCU_J%O9$A)`0D@$B2$))(5DD!Q20$I(!:DA
MC2U.4.7MY8"@JMIN4'N19Q!K`.?#`+9O&<NADIX5`22$1)`8DD!22`;)(06D
MA%20&M+8XL19`G1`G%5M-\Z]6),7$D!"2`2)(0DDA620'%)`2D@%J2&-+4Y0
M5?KH/RAU=ZD#'Y541VZ\>Y'QM.;UPIO70Z5A7D-"2`2)(0DDA620'%)`2D@%
MJ2&-+<X02";@#,'K-V55VXUS+]:\A@20$!)!8D@"22$9)(<4D!)206I(8XL3
M5)4M'1#5MKH;5DURZ5CSUW_0,;6&"4P*21$I)B6DE)21<E)!*DD5J28U#KF!
M5PF!?4=Y?3JKW-2;SYJL"4T*2"$I(L6DA)22,E).*D@EJ2+5I,8A-\HJ#S@@
MREW:(,_U>I;>J!1?!=Z]/5]XMV=32S<,2"$I(L6DA)22,E).*D@EJ2+5I,8A
M-_#J>?^`P/?I@1UX.V/H'NXFH(`4DB)23$I(*2DCY:2"5)(J4DUJ''*C["=/
M/[F),&=2*2RG]Z4_O8=:9GJ#0M.7KA618E)"2DD9*2<5I))4D6I2XY`;>)7E
M'#"]^Z3(GMYVGM1/;U"@5@G5\)A[?$B*2#$I(:6DC)23"E))JD@UJ7'(C;+*
M<>PHJ^7)\TNUL-\O<[]]A;)/E^P1Z.A2GH"L!Y<K?^H/M?2D#M1[@0R*--04
MDB)23$I(*2DCY:2"5)(J4DUJ''('1>5(]J#\Y)[3IU1VX.TLJY_ZH&`""DD1
M*28EI)24D7)202I)%:DF-0ZY459ID!UE-?5GOS;U^XS*'H&.W*E_=>9/_:&6
MGN?!!!22(E),2D@I*2/EI()4DBI236H<<@=%I5'VH/QDZO=9EQUX.Q'KISXH
MF(!"4D2*20DI)66DG%202E)%JDF-0TZ4IX>EI&UU-R7M2?TP=_8K?[O)U!JF
M-RDD1:28E)!24D;*206I)%6DFM0XY`;^L)1TRI14DWE<69("4DB*2#$I(:6D
MC)23"E))JD@UJ7'(C;*?DK8/-;,3LP7_YH>:*=-53?*(8DU]?R_$U#)3?\AS
M-86L%9%B4D)*21DI)Q6DDE21:E+CD#LHAZ6K4Z:KFNRISW25M4)21(I)"2DE
M9:2<5)!*4D6J28U#;I15SOCV]\]IGV):[Y^:Y-G0FMYF%Z][2S6U]%P.2"$I
M(L6DA)22,E).*D@EJ2+5I,8A-_`JC3P@\'W6:0<>B>A296%N;AJ00E)$BDD)
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M5DB*2#$I(:6DC)23"E))JD@UJ7'(C?+?E\C.F,AJLI]WYF?^WJJII6_Q`2DD
M1:28E)!24D;*206I)%6DFM0XY`[*88GLC(FL)GOJ([<-6"LD1:28E)!24D;*
M206I)%6DFM0XY$1Y?E@BVU9W[^R:Y*8RK,#/S_R]55-KF-ZDD!218E)"2DD9
M*2<5I))4D6I2XY`;^,,2V3D364W6]"8%I)`4D6)20DI)&2DG%:225)%J4N.0
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M]Z<TR9CJ%UR.6*#-&T!O(RNTJNGNHL%,B.+!3(@2;=X`>DNJJ:[F#&!_8M[1
M>8EY/M*T&,P<73F8.;IJL%G[>]CSR?G,Z[ZVJNB3;P8;&;S#LN(YLV)-\J%#
M_8++P<R`!MKDTUNZ7CABT6`F%O%@)A:)-ODU,-U?JLT9EOZ0K=?-AWKF6(K!
MS.N6@YG7J`:3V[UUB7N3L+:JZ<-K!AL9!S]O_LG;#W/C>4_R>T/MEX1<32^1
M.7159,=3'U+0MY+]?TUA3^<7_>_Z+[S[0Z3;7`QM8DVFYZ2GB?R&C3H>F:M7
MN`WB>#+=D?V,.)U[=_>\KR7/3*KKQ<G$JU#H;LPAEIK,(5::S,G7/?WPY!O=
MINW9O0\>EF7/F65KDGMC-X2S"^_$EGV52_,H%V@RYQIJNNR&<.8OD42Z@FD3
M:S(])SU-Y+=(?CB$W5E8QY/ICNPL=F0(NX975]TAGIQ[;W2%Z4;/S%*3.<1*
MDSF1NB?IV5R?T[GW+M\X#9UQ7!R6Q[?5W3Q>D_RB1S>.<W\&+_LJ]J6HR9Q*
MV),\M;;]8!C9)-9DIGG2TT1^(^)'P\A6F:;7A[&OU1_AXN3<NP\6IIMA&#69
M0ZPTF7.OW9XQA1NGB3N`AZT'++@>H&FX$$<&L&ME3?R@;W4U&^Z+H:;N@K[@
M`/:]F/..^R96Q\EP.#^^#MDJT_23`>R.X,?7H>G&#"#.O>IK6>=>:[+?)WD=
M.MV[P^@O.*A=E,FB_3#W_GYS^_5FJV#TNVS4!=-^7O7C@NL0/:E=LN$-?'+F
MO3DM^UK.%=KU=6XF;MC7.N]N8[,%WBQU-_8(=]U8/2>ZENDY)66:3%\YJ2"5
MFDSW54_6N=2:^ELRSJ71W;2O[XZ5OT;AC]7OV^<?C95\Z',8+*Y=++!0L20%
MI)`4D6)20DI)&2DG%:225)%J4N.0&WVU\O#V#&RAJGOO6#V9=]:EKF4H((6D
MB!23$E)*RD@YJ2"5I(I4DQJ'W"@?MG:QX-J%)A/2)2D@A:2(%),24DK*2#FI
M()6DBE23&H?<*!^VFK#@:H(F.\I]+4,!:X6DB!23$E)*RD@YJ2"5I(I4DQJ'
MW"BKI/B`.X:J[MTQ>C(A72Y``2DD1:28E)!24D;*206I)%6DFM0XY$99Y;=V
ME'_Y$U"+/KFW/ENLR<Z4YQ,_Y3>U]--;0`I)$2DF):24E)%R4D$J216I)C4.
MN6.B\DY[3%Y?:)&O6\;,[\F>^:!`-S2U0E)$BDD)*25EI)Q4D$I21:I)ZKNH
MV^"TY]A%N?MNZ>Y[<!_7+U_6R_7#P^[H=OM-?6]T^Y@\</>EUC>+A7RK==L%
M2LZEI%V<0<F%E+2/H2BYE)+V.1<E5U+2+E+Z)7/Y7FW9^)0K!"53*6E7ZU`R
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M^,U177LC#63[\UKMR_`$97?S6NW$L$3V.*_5!N98R;F4C`4EDZ"H_1JVD6W/
M:[5KPY(;*;D9+5E*B=J=8IM`2M36[UC)N92,'9OL:4G)6&^R87RM=K*DM]-A
MSLB?2GA>?5F7JY<OFZ?=T</ZL[PEGK7K62_='UOH_K'OUTH^;??R1Q+:99-[
M^:,8:_FNXS/UW<V?M]N]_H=Z@>'/;'SXOP````#__P,`4$L#!!0`!@`(````
M(0!?`N(9M@(```4'```9````>&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;*Q5
MRV[;,!"\%^@_$+Q'3UNV!<N![2!M@!8HBC[.-$5)1$11(.DX^?LN]6!B.0UR
MR$42J=G1[.QRM;Y^%#5Z8$ISV60X]`*,6$-ESILRP[]_W5XM,=*&-#FI9<,R
M_,0TOMY\_K0^276O*\8,`H9&9[@RIDU]7].*":(]V;(&WA12"6)@J4I?MXJ1
MO`L2M1\%0>(+PAO<,Z3J/1RR*#AE-Y(>!6M,3Z)830SHUQ5O]<@FZ'OH!%'W
MQ_:*2M$"Q8'7W#QUI!@)FMZ5C53D4$/>C^&,T)&[6US0"TZ5U+(P'M#YO=#+
MG%?^R@>FS3KGD(&U'2E69'@;IOLY]C?KSI\_G)WTBV>D*WGZHGC^C3<,S(8R
MV0(<I+RWT+O<;D&P?Q%]VQ7@AT(Y*\BQ-C_EZ2OC966@VG-(R.:5YD\W3%,P
M%&B\J)-!90T"X(H$MYT!AI#'[G[BN:DR'(7>?!'$(<#1@6ESRRTE1O2HC11_
M>U!H13F2:""!^T"2>,OY?)8L%T#R1F`\!,)]"(R3YZ]?!OJ]^LZ,&V+(9JWD
M"4&#@3[=$MNN80IDHPL]@_/E?[9`*I9D:UDR#"<#,M90RH?-;!&M_0?PGPZ8
MW24F/$?L1X0M&\AS&L&=#]!H6:Q&Z[\5O1LWGD5/).]'Q%00&/4!@BP+V#Y[
MT[4!!-W@K$TFMCG(5"8POY3Y>F>/);3@3HWS9]@)NGJ&L\E7A[=0,R=LMH@=
MZ*R`H/ZE$-MDRY4]5D.+O[O/+-&YR&$G.9,QU>I`SJ%^+/0G03!5LCVK:XVH
M/-HCGT#*;M=-HVUD>V>ROX,IU9WIZ7Z40OM<XK=QNNW&R10?I_OX%?QN/DQ!
MWP7`%&I)R;X35?)&HYH5(#GP[,10_1SK%T:VX!7,(FE@_G2/%?QN&/1^X`&X
MD-*,"VN,^X%M_@$``/__`P!02P,$%``&``@````A`)-@;D#8!```.A$``!D`
M``!X;"]W;W)K<VAE971S+W-H965T,S`N>&ULK%A=KYLX$'U?:?\#XKT!0SY1
MDBH)L%MI5UJMVNXS(4Z"+N`(<V_N_?<[Q@/8F$:IU)?2'&:&.7/L&?NN/[\7
MN?5&*YZQ<F.3B6M;M$S9*2LO&_O;U_C3TK9XG92G)&<EW=@?E-N?M[__MKZS
MZH5?*:TMB%#RC7VMZUO@.#R]TB+A$W:C);PYLZI(:OA971Q^JVAR:IR*W/%<
M=^X425;:,D)0/1.#G<]92D.6OA:TK&60BN9)#?GS:W;C;;0B?29<D50OK[=/
M*2MN$.*8Y5G]T02UK2(-OEQ*5B7'''B_DVF2MK&;'T;X(DLKQMFYGD`X1R9J
M<EXY*P<B;=>G#!B(LEL5/6_L'0EB,K>=[;HIT/>,WKGR?XM?V?V/*CO]E944
MJ@TZ"06.C+T(TR\G`8&S8WC'C0+_5-:)GI/7O/Z7W?^DV>5:@]PS8"2(!:>/
MD/(4*@IA)MY,1$I9#@G`OU:1B:4!%4G>F^<].]77C>W/)[.%ZQ,PMXZ4UW$F
M0MI6^LIK5OPGC0B&DD$\#`+/D2`/''UTA"<Z>K,)F;IS\?$'?E/T@R?Z/;:'
MMPU+>*(]F4T6Q%WYB\>.<W2$YS,).K*ZC5AA4B?;=<7N%NP`J!^_)6(_D0!B
MM2I)BIUN/Y(-]!)!=B+*QH:M"XIP6&MOV]EBL7;>8'VD:+,W;8AN<6@MQ&(0
M8<,A$`V!6`$<8-31`L%_`2T11=!J$]JW0,_3&W!H+5J7<`A$0R!6`(T#K+U?
MP$%$`7%A02K:+/6L]V@$2ZXSFNLFA\ZD8V8@D8'$*J*1@WQ4<N-=H5U>PKCA
MT'Y[CXAL'&*M'`PD-)#(0&(5T?*#4JCYB7T!':#;DT_O#!%'3QT1V&Q=K7TR
MK'9GU#(.#20RD%A%-#;P,97-XVH+8SUE1)1J&TAH()&!Q"JBY;?XF?R$L9X?
M(LTT:SK'P4!"`XD,)%81+3]Q*%&ZY./Z"6,]/XDL8;$ID@_ZXZ$SZB27B+?H
M^D]D(+&*:"FO?B9E8:RG+)'EK&GFGDNF@W:`[_N2AXA`#3N2WM37W2(T6LJP
MGC]X'W=!H`@:'0('D.<E:*QU0@AY^&F7S/34#FBP7'7E#EL?10&$IE-DL!P,
M@%CST2F(8?7T*B)RM$'C;M?#'J%>E&'7:`T455I(I8!#$ROA&R)H/CH%,:N>
MIR`GFT9!0KT*PUU`<!JJ*J"/2D%"K0J^J8+JHU,0(^EY"CC`5!4DU*LP&*8'
M@@:J"@BI%!"2*A!_-C@-Q6V8QD>G(*;6\Q1PQJD4)`0J]'O5)P8/::5M"`GY
M_22(Q,D">H>/JVFZ6NG[*D8#V<9T'F)>*3SDX7,B3K[U-4M?]@PZ"2S6D7;K
MP_;#HR<./96>A$"AGAYQC<V"5JI,$EI!KWG0P\0M!ABO2-,"B.\NW2%E##TB
MG1B!#RA_9;<?48:;1\<9!ZG*&:&>S0%N=TU7[Z'0A"(3$M?"WE$J)J]Y\N90
MT.I"#S3/N96R5W&%@YZW77=P=[_<>:)W#?"]N'>.X5X`)V'3?N<'.TC(?+'W
M`SA>CN#3`(YU(_@L@`/2"#X/X&`R@B\".!",X`0<9$9.QPUNKK?D0O].JDM6
M<BNG9RB+VRSE2MY]Y8\:]3VR&NZLC=17^!L%A1.L*TZ79\;J]@=\VNG^ZK']
M'P``__\#`%!+`P04``8`"````"$`=2K\BG@+```_.0``&0```'AL+W=O<FMS
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MMCOVW?X![@_[W;$Y-??G*W(WDAW%:[X>78_(T^=/=WNZ`B'[X%C?WPQOO645
M3(:CSY]:@?Z[K[^?C/\/3H_-]_BXOROVSS6I3>,D1N!+TWP5INF=0%1Y!+6C
M=@3^=1S<U??;;T_G?S??DWK_\'BFX9[2%8D+6][]#.O3CA0E-U?^5'C:-4_4
M`?IW<-B+T"!%MC_:W^_[N_/CS3"874WGX\`C\\&7^G2.]L+E<+#[=CHWA_])
M(T^YDDY\Y81^E1-_?N5-QK,+?$R4#_I5/KRKQ70ZF2WF'^\(6;970[_*R>1R
M)S0U6B?T^^L]N59.Z/?7>^*QL.(_O]X7+U"=$?]1;J97<V]\';RO[4@&3!M_
MX?:\_?SIV'P?T*2FD#B];,42X2T]&C6./!DG72R^%HH4@\++K7!S,R2M*<I.
M-'_^_CR=7W\:_4TQOU,V*[3Q;(LU6X@`%VY#%VQ<$+D@=D'B@M0%F0MR%Q0N
M*%U0&6!$TG;ZTI#_#GV%&Z$O*[-BH`7W'3'9@JN$+MBX(')![(+$!:D+,A?D
M+BA<4+J@,H`E)@7^[Q!3N+D94B,Z6!=C6[V5M!%K<&<TLTW6G4FG,)`-D`A(
M#"0!D@+)@.1`"B`ED,HDEMBT&/P.L84;6ESHIQ-RNG`F_DH9O:5V9]*I#60#
M)`(2`TF`I$`R(#F0`D@)I#*)I39=>H_:5V)EOW`I%IY:P5FHE2(S8PB"('"B
MN3/B:B&0#9`(2`PD`9("R8#D0`H@)9#*)):^=/&6OOT[*[Z="6M;0T5FW0J\
M!A("V0")@,1`$B`ID`Q(#J0`4@*I3&()-K](,&%M"Z:(KP639-KNA.7M79*)
MN6T(@HD=F)O.B`,S`A(#28"D0#(@.9`"2`FDDL0/Q*5:&M*%71!TPMK64!)#
ML3604)+YN-UT^6//F=>;KKR33Q+9W78<8DEF.KB3KI;8RI%79W.1=N7L-0.O
M.7@MNEK*JW,;*+MR]EJ97BUI:4=^@;3"VI96$I_\=[>E()C:H;?NC+@_H2(T
M:[IJ_L257!K-YNV0>/.Q(UZDG,R[J1%#0\E'&DKMAB;^PNY_!@WET%#QD8;*
M=QJJS(:L8?(H%;Y@G%IS>Z`46M#*WDD>!.Y>3%MU0Z70=3LMVSC?,**[<.?+
MGS@+3L2^C/%A)'-OD9HD[$N[3QF]Z3YC7]I]SDB[+]B7=E\RFLJXFH['SJ:U
M8C^M:WL<1'Z">5Z[OS@_[G=?5PTI0D8]]\6`VFOUN_5DED.;.59YI9`UD;PQ
M#(^L2%9<,5059^8,Q*G$5M>OS25N7ZL9,]*-)>SFS<92ME*-X7QBS[JQG)%N
MK&`W;S96LI5J;`:M5>RZ9S1%@@2C22<^%-=B,/]J7EX;3#K+Z493IEG6:$HT
MEP=#(L[7XM""UDX#A8@VB")$,:($48HH0Y0C*A"5B"H+V9-$Y$(@*XEZX0Y<
M'-"09"1<M\I,%\Y-8*6,WLPPM8V>-F:^IE8U0!%6C!$EB%)$&:(<48&H1%19
MR-9>9$:_0WN589EK,.:;(AT5&P+SI@)K5F>CQ0>TT9[8*D(4(TH0I8@R1#FB
M`E&)J+*0+3[I8(G?<Q<P%PYA[MRE%=)WL+405VK,RH2(-H@B1#&B!%&**$.4
M(RH0E8@J"]GZB2S*#-YW]%-)EWD;[?(PO68$[L9R[7566E)`&[2*$,6($D0I
MH@Q1CJA`5"*J+&1+*I*J"R25.1B%."NS\A0R0Q)0B%8;1!&B&%&"*$64(<H1
M%8A*1)6%;/UH]V'I)P_VVPW?.]$I:CJS6R)C#[#V`(6(-H@B1#&B!%&**$.4
M(RH0E8@J"]E2BNSF@E"4R9`5B@H9AR&>1$9N'RKTSG&(MN)(CQ#%B!)$*:(,
M48ZH0%0BJA3J.1CQ+TL+6W,[)!4R]%LC"A5Z_71$&W1J*F2>CRAD'I#HBJ^<
MD&@#]IRAYQP]%[KB*Z<DVH`]5Y9G*WA]-_%[>_*WYH[27>YFWIJ<I'FM*IH9
M'B.Z0W7[8,SPE-7$;S.\N>_DM!%[T3E7S$CG7`FC-]M*WVDK8R^ZK9R1;JM@
M]&9;I=V6YUY7Q5XPN_-%QO7Q]:8U=X9,YFSVF<G$/=U2%<F*XRA4R#PS821/
M'?SI>&X?,D7L1HL6,]*>$W:CSS-21LKS9.:D2!F[T9YS1MISP6ZTYY+1I(TI
M2JWM+E?LI4?[_A3PPG,26CO<6ZA"[YR3:"L])-+7.^<DJN),GB8$O@^C)-WX
M6LL8&TO8#=W<7Y^R*5NIQCPWM\W8LVXL9V3.HX]<6:DJ7L_D^N`&2<6.>\92
M9&OF/&JW0)>>DO@JYS-VE@J9VR%$(:(-H@A1C"A!E"+*$.6("D0EHLI"]AW%
M319_\941\581[3/M4Q+G*'VEC$3JU06DFZAK&SUI(/?<H%6$*$:4($H198AR
M1`6B$E%E(5M[D>U!2-/%7GA"Y0L_[3U#RXJG)&SUIOC*DUZ00UV-QV.#*$(4
M(TH0I8@R1#FB`E&)J+*0+?YE*2DMM7`34,C<.0139ZE><T7]."Y$M$$4(8H1
M)8A21!FB'%&!J$146<B65&21&,\?R%+%C=3)4A6REF7,4M%J@RA"%"-*$*6(
M,D0YH@)1B:BRD"WE95FJCUDJ(R-+5<C(LD*%WLE2M16O`1&B&%&"*$64(<H1
M%8A*1)5"M(^@KEJ2!I=EJ:VYO1%7Z%IOA-:(0H5>SU*U0:>F0K+7\BF^0F:6
MJBN^DJ5J`_:<H><</1>ZXBM9JC9@SY7EV5;ZLBPUD"FI><2B$+VDK>]HP=1Y
M(+Y65C2+N%,A(W--QBQ56:EG^A-O[&Q4(F4PT5E(K%"@!S]A*W/3`XVE=F-T
M@W#>D\B4`:VK?!DY(WUE!:,WKZRT&_/G@9.`5^P&-]C!98EJ:^[,#YFH7IOY
M1C!U7AQ>JXIFHJJ0F:@R4H_'Q^[;'!$;7'>JQ0IY8_U24L)F>L.?:B2"/9@Y
M896I\H4Y'O+*C#X7[$6'2,E()JJ!^Q9J93FV9XQ(GEZY<W[\@7X@4S!K(DED
M3Z29$Q1K5=&:2!])YS:JHDI4IU[@:!FQ9ZUES$C'=L)NS,#IF4BJ2RI1O0Z<
MR,K8LVXL9Z0;*S[46,E6G!5[CF85>^Z92+\E4Q5#YFR)%#*W1(A"1!M$$:(8
M48(H190ARA$5B$I$XKL<<=GR&N4<D=_9R.\<#O7QH5[73T^GP:[Y)KZA"<0*
MT6'Y@<_*GRQ%SDOK*91,J:1-;YR26W^VO*76^^K,J$Z[?W?JK/PYE;01`"4+
M*FFCSBT)J&_][5#7^GJVHN9[6_?\I7C_H:?'7D`E[<KDM'[K39:W_<I0B7BH
MW.>-.D8Y>U\)=8V>^O65D#+T/*NOA)2AQS-80IO1I=C2]90$X^6&]AM8DE!)
MVEM">YIEV5M"GW_=]JM&'>MI8T4R]]J3R+T:D\3]PT(*]PD<SI?T'BI>7+A8
MT@N?R)/%DE[91%XLEO32)7)Z%K443W1Z2GP2EAXW8$E")6EO"3W2H&%JZXRZ
MZ*+/UUZV#W6Y/3[LGT^#I_J>IN:XS?R.\@,X^<=9O<OTI3G3AVNT?:!OE.A#
MQ9K>31J+%Y[NF^;,?U"G1MVGCY__#P``__\#`%!+`P04``8`"````"$``59^
M74X*``#;+P``&0```'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6RLFMENXSH2
MAN\'F'<P?']B2[+E!4D.8EG[@L'@S,RUXRB)T;856$XO;S]%D<6ME,1NG)M.
MYU/Q%UFL(E4,;__\>=@/OM>G=M<<[X;.S7@XJ(_;YFEW?+D;_N>OZ(_Y<-">
M-\>GS;XYUG?#7W4[_//^G_^X_=&<OK6O=7T>@,*QO1N^GL]OR]&HW;[6ATU[
MT[S51WCRW)P.FS/\>GH9M6^G>O/4-3KL1^YX[(\.F]UQR!66ITLTFN?GW;9>
M-]OW0WT\<Y%3O=^<H?_MZ^ZM1;7#]A*YP^;T[?WMCVUS>`.)Q]U^=_[5B0X'
MA^TR?3DVI\WC'L;]TYELMJC=_4+D#[OMJ6F;Y_,-R(UX1^F8%Z/%")3N;Y]V
M,`+F]L&I?KX;/CC+RIT/1_>WG8/^NZM_M-K_!^UK\R,^[9Z*W;$&;\,\L1EX
M;)IOS#1]8@@:CTCKJ)N!?YT&3_7SYGU__G?S(ZEW+Z]GF.XIC(@-;/GT:UVW
M6_`HR-RX4Z:T;?;0`?AW<-BQT`"/;'[>#5UX\>[I_'HW]/R;Z6SL.6`^>*S;
M<[1CDL/!]KT]-X?_<2-'2'&1B1"!GT+$N9E/IQ-_/KM<!"R[GL!/(7)]1WRA
M`3]E1ZX=#&1&UP_X*36N'LQ"B,#/WQZ,`\'0]83]1W;EVN$X,+-<14WQ;\R.
MXZ$,_.?WAX21XNBA<N&01CQTNTQ8;\Z;^]M3\V,`RPL$9_NV88N5LV3"F`,\
M8F56?)04D`U,Y8')W`UAVB'>6\CD[_?3^>1V]!VR;RML5M3&,2T"M&"IQF37
M-@AM$-D@MD%B@]0&F0UR&Q0V*&U0:6`$KI7^A<#Y._S+9)A_T3,K!,KAKN5,
MM,`F:QN$-HAL$-L@L4%J@\P&N0T*&Y0VJ#1@.!/2Y^]P)I.!>(=HUZ)U:KIO
M)8Q@195&OFD22!/I8D)"0B)"8D(20E)",D)R0@I"2D(JG1C>!O_T>/N&;4O]
M.R0N!JQAYU_TRXJ3&=_Y6&8'A*P)"0F)"(D)20A)"<D(R0DI""D)J71B^`Y\
M9/CN<X<Q:]-AG+@3F?`!(6M.)OJBZ\YF9HR&T@CG(B(D)B0A)"4D(R0GI""D
M)*3BQ!F[;*R&$^%+Y`HG,FO3B9Q,NX_`;C\).-'<NN9D-N[V+'?L>);_Y'/I
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MM91\B>A3^0JU.GES>EAE8E=X+AOXZV[[;=7`^,&BY_O$@RVQ2Y`'AQ<W\,&,
M4;02R$PU*T,"8:3GFD`^+`'*\1-[TQ56"]B\I)4W&]N3R+O5C06KSIY)%%;:
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ML*]J"YJU[`7L1()-J2I8U@(Y8R.UZ8(I7CG6UU5O9FU"D5#S8,>6W>A9,4DW
MDLNZD4HSLQM6)&47=2,75IHW"JG_J3=*:69VP]J>JJ^Z8:Z:K$RUX\29TCCI
MV4GU55-4NWHB"Z1".F!_A&`1I-":HI"BB**8HH2BE**,HIRB@J*2HLI`IE]9
M@:K[]0O_B7I6]Y]`REF!0]":HI"BB**8HH2BE**,HIRB@J*2HLI`IO\@%:[Q
M'S.WUB:!=/\1M'8("BF**(HI2BA**<HHRBDJ*"HIJ@QD^@_6",-__`\@%YQR
M.JREY4J.]'-.8:6A-44A11%%,44)12E%&44Y105%)465@4Q7LJKQBE3F12:L
MPJJJ$*@["N0G=@Y'^I&=0%\<?"HKE(\HBBE**$HIRBC**2HH*BFJ!.H[`G6O
M*ZX[<S,F!=*VT4`@W:<"?7P.J@RD.P4R3D(%TX]"5<L/SD*5`4IG/=(YE2Y4
MRP_.0Y4!2E>FM!'`+BL5]0!F:X$'`?CYGM0ULYPNBD[8Q^6'EC>SRK9`--2/
M1`5RM3-1BB)$ZF,Y1J0^EA-$2BNE*$.DM')$2JM`I+1*BBI$]#/;916>[MHO
M7"H*0FUMZ!3NAE9Q:941@;#2BTM$:H`AHCFO=J`>L<\6T$(UBA&I?3)!I*Q2
M1$)Z.O6M6B1#"]4H1Z2D"T3*JD0DI!U:YJ!%U\@,[=X:])+3?I>6G@)Y4">H
MZ)Y;+@R$E5YZ(E*#"@6:3+JIF'@3S]*):*,8D0K0!)&23E$:!B"[20_F:,,<
MD9(O$"GY\B+YRFAH3@DKLZY("5'BZ2G!D9D2<RO>`ECFV7>*D1*BH3IF#(75
M@AWP?+]WW(G]]YL(=90+8D0J;A/44=(I(I2>.59=FJ&.DLX1*>D"=91TB8A+
MN].9:RT(%>ITTJ;_69&E^U_[\KN\V&=_]+*^`@6"],!-)Q#(R`7>$$Y"T2H4
M5OZBFP,8BV<Y*D(=Y:@8D=))4$>A%!&7=N?D>"=#'26=(U(Z!>HH5"+BTIX_
MMS.X0IV>.;"K/WL.+CN+A.V23`(I`0.T4B&UIBBD**(HIBBA**4HHRBGJ*"H
MI*@RD!G;K%K38_N+[584=RIB5^Q\DL6U<E9`T9JBD**(HIBBA**4HHRBG**"
MHI*BRD"F_^RJ\`O_T5(04IWXCZ`UM0HIBBB**4HH2BG**,HI*B@J*6)W<]48
MN?_X75M^P_!0GU[JH-[OV\&V>6?W:.'[\/Y68G[)=^7Z<,NW^ZXD3V;PI%LT
MR),YW@RVGL"5X8>N>K3X"JX2=[>/;.Z"$%N!+?[@@4ZWR%D/5MX2;DS1!JO)
M$FX#]7!G"F_NLLA6<F#@<+#3UP8&#D<6?4]@X%"!TR?KZ1+NUO1P?QGVO2/Q
MEW`)A=H7_A)ND5"^=A9+5KOV/'''RQ"J*OHD@2=I[Q.HW)8E?S*2;H&KU6^;
ME[K<G%YVQW:PKY\A9,;=2<R)7\[FOYS%WZ<>FS-<JH8U"FZMPB7Z&N[=C&]@
M5WUNFC/^`IT:R6OY]_\'``#__P,`4$L#!!0`!@`(````(0"PUVLQ3@@``#`D
M```9````>&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;*R:6V_J.!"`WU?:_X!X
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M[;GMY@LR?\[W95$5K_4`S`WI0/&<E\/E$"P]/1QRF`%Q>Z_,7A_[SX:5&F9_
M^/30..CO//NHI/][U;'X<,O\$.:7#+P-<2(1>"F*;T34/Q`$RD.D[3012,O>
M(7O=O9_J/XH/+\O?CC6$>P8S(A.S#C\W6;4'CX*9P7A&+.V+$PP`_O;..5D:
MX)'=C^;S(S_4Q\?^9#Z8+483`\1[+UE5.SDQV>_MWZNZ./]#A0QFBAH9,R/P
MR8R,1X.%,5I.%F#DAN*$*4Y;Q>67],!J,VKX9!W.!L9T-"=COM'=G*DM6K6O
M=0?)TG0'GZR[I?#1C?Z63`\^6[VON,6`94"C0M8#"\M@.IXMS"8L-[HTVH#"
M/TS5_))/#1Y%X]YHD/5&AWMG/`P>$/+/5SPTI*NW28;-KMX]/93%1P]V&)AL
M==V1_<JPB#&>!M13;6)\EA>0$,3*,S'SV(<PPY*O()F_/\W,^</P.R3@GLFL
ML(RA2JRY!,DV8G:C`UL'C@Y<'7@Z\'40Z&"K@U`'D0YB'20Z2"4P!.>W$8#5
M\W]$@)@A$>"^6W$@0C+6W,TEN,I&![8.'!VX.O!TX.L@T,%6!Z$.(AW$.DAT
MD$I`<3?LG/^'NXD9R!G(>&G%+U0'KY@0)'<KI"7%NA5I@X"(C8B#B(N(AXB/
M2(#(%I$0D0B1&)$$D50F2D3`ATI$ND]@OM,0Z<;QW&$K1N@A3;:--2(;1&Q$
M'$1<1#Q$?$0"1+:(A(A$B,2()(BD,E&<"FON#J<2:=6IC,")T"[=Z4C?0%HA
M'HL-(C8B#B(N(AXB/B(!(EM$0D0B1&)$$D12F2A^!@?=X6<BK?J9$6GQ(K)!
MQ$;$0<1%Q$/$1R1`9(M(B$B$2(Q(@D@J$\6I\)AYAU.)M.I41N;M8;A&9(.(
MC8B#B(N(AXB/2(#(%I$0D0B1&)$$D50FBE-)X2H_Z=W>9HFTZE1&H":3MX2)
M>N2MA52[)S`TAD=R:2^9JHJVD.**#D?C-HXN1TUMUSPC>@R-H%:0S&OGK(\5
M`X%D15,=UU9(\7&%'(EQ11R)<<4"2>:-D6H^$5+<?,I18UX)(4SQCA`2:36$
MC-"RNO'>&J,-0UJ\9NK`;2'%!^YP)/SB<B3\XC&DQ4M[=/*Q8B"0Y-#14AW7
M5DCQ<84<B7%%'(EQQ1Q-FO)E:LPGFNE$2'#3*4<X5J04O2-8C;@:+8Z,9;O^
MURT3#_H;SL;T;H$\`=D=S&F9\(/;,N$(CS/XY//T.8-%P5G0,M'OMH.%+1/]
M1BT3]N*6P4.-E,G:PDLD,3Z4M&4=<2!UU]?W/7(-H&4-1U#GD\)VLAR;J'"E
M6F,Y*@R)0\AFAN:+Q@Y<2&B;@<,$QHO6R2Y'PK+7CJ==J4M]M\-:`4=PZ+;.
M'4^U[7O+I*9TJG`WI`F$W(P88L21&&+,D9A\PM"GDT^Y3F-9V?;(!<L](:2E
M']1F?'VL&@N07<!H""<+;6)K)F**)[$-1V*N-D<F#>%DA$+(ZDZAXW(=8=EC
MR(`+(#(>V&QP")DAH15P0W#$WPHA55PNZ1`'<^U$"X49[I^((]%9S)&82,(0
M6);[UP[R5%%4XTA*P#M2D56,<AP9@ILJ&L>IOH+7!A514I$A,16;24UI"G6$
M$:FXV+#'D&'0C.X,(QI.P`W]1QBI(AOA;##7]L%0F!%A1)W%6"IAZ+.YIXJ*
M&D!2;MX10%:=R@%DJ$W$C@!2$241*5I.VHRVR<T+[--+FM`+G(?,BHBYRU0D
MPQY#-_,0#2?@AOXC@&R$G^<A&F+$+<MYR,R(N2=,"N9^,P]E\VH8234KAY%>
M^@[(.X?ZF.^_K0K87^#\ZB@12,*P*U]6$\O1I6@B#\P8:8?3FMQZ0^B4#*5H
M+HX0FTG-J?LF,WQ8,C-RA)%E#W?F8Q1P)&QM,0HQBC@2`X\9DN:2<,26`II+
MRLTT_:NQ(D7RK5C]65P_BQ6\U&F#Q6IM.5AR^4V+`?("@#S\B.6WP<C&R,'(
MQ<C#R,<HP&B+48A1A%&,48)1JB#5^Z2:EKW?D1&REXDX^$_V,D/"I6LX+9"7
M$;*QE(.1BY&'D8]1@-$6HQ"C"*,8HP2C5$&JETG%>X>768$L>YDAV<L(;<C5
MA;J\;8P<C%R,/(Q\C`*,MAB%&$48Q1@E&)%7YF*.U,OT%3A]ZW?.RK=LG9U.
M56]?O)/7VV.R*;68OGM?&29_^:ZW3"VX<X8'#IW/++@C[>!S"Z[Y.OC"@INJ
M#FZ``N1C5PNHP!K"+9%ID7H2-\2F!?<K'7QI02W?P8V11<I+W)(2?W0UP*\4
MGIN:4_<'^?5"AZ'5V((W4[B#YXGU#*'##:N)!6].,'=-BQ3ON,$W+5*MXX;`
MM.`RJX,O+;@TZ>#@#5+/XY;0M$A1CQM6IK7J;%B;%KFZP!H;TX*;OPZ^M."&
MJ8/#H,CE!FYQ3(O<<$##L(T%_%[CNGO+HEWYEE^JWBE[A04//["`QX22_N*#
M?JG9&?I2U/!+C>8X/<(O<S*X21D-0/BU*&K^A730_M;GZ5\```#__P,`4$L#
M!!0`!@`(````(0!;5/&9@1D``&.1```9````>&PO=V]R:W-H965T<R]S:&5E
M=#,T+GAM;*S=6U/;R+;`\?=3=;X#Q?L!?`5<278EMB7+DGR_OS'$2:A)0@J8
MF;V__>FV>JDO?XW!4WL>!O)3]VI96BVU6I)Y]Z]___A^]N?^Z?GA\>?[\]K%
MU?G9_N?]X^>'GU_?GR\7T?_=G)\]O]S]_'SW_?'G_OWY?_;/Y__Z\+__\^ZO
MQZ??G[_M]R]G*L+/Y_?GWUY>?G4N+Y_OO^U_W#U?//[:_U1+OCP^_;A[4?]\
M^GKY_.MI?_?Y4.G']\OZU57[\L?=P\_S(D+GZ2TQ'K]\>;C?]Q[O__BQ__E2
M!'G:?[][4>O__.WAU[-$^W'_EG`_[IY^_^/7_]T__OBE0OSV\/WAY3^'H.=G
M/^X[R=>?CT]WOWU7G_O?M>;=O<0^_`/A?SS</ST^/WYYN5#A+HL5Y6>^O;R]
M5)$^O/O\H#Z!WNQG3_LO[\\_UCJ[=OO\\L.[PP9:/>S_>G9^/WO^]OA7_/3P
M.7OXN5=;6^TGO0=^>WS\71=-/FM2E2]1.SKL@<G3V>?]E[L_OK_,'O\:[!^^
M?GM1N[NE/I'^8)W/_^GMG^_5%E5A+NHM'>G^\;M:`?7_LQ\/.C74%KG[]_OS
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M,`PA#2$+(0]A%,(XA$D(TQ!F(<Q#6(2P#&$5PCJ$30C;$'8.7*HT*7-%]:K_
M1J[H,#I79"]_$K#)4P\20TI(E5X(_1"B$.(0!B$D(0Q#2$/(0LA#&(4P#F$2
MPC2$60CS$!8A+$-8A;`.81/"-H2=`UYBJ(/F?R,Q=!AU'%+'4><H<NNGPB=3
M2!TSRT)MOTBW+%*F"Z0/B2`Q9`!)($-("LD@.60$&4,FD"ED!IE#%I`E9`59
M0S:0+63GBI=%:K][651](2)G'%WZD"RRDS\9*:Y5].FC"^E!^I`($D,&D`0R
MA*20#))#1I`Q9`*90F:0.60!64)6D#5D`]E"=JYXB:#Z]@F)H$O[B6!$C6;*
M0T2S'HXURD*2/SU('Q)!8L@`DD"&D!2207+("#*&3"!3R`PRARP@2\@*LH9L
M(%O(SA4O-]1./2$W=&D_-XPX!PE(#]*'1)`8,H`DD"$DA620'#*"C"$3R!0R
M@\PA"\@2LH*L(1O(%K)SQ4L$=1WL)4)QX7*A+Q&/GSAT13\G"KDN9J8.)PY(
M#]*'1)`8,H`DD"$DA620'#*"C"$3R!0R@\PA"\@2LH*L(1O(%K)SQ<L)=?V)
MG*BW+E1*G'@YJP/Y.6*D7EZU=`M1TQ3E":20IOKAG'>"2YE^64BJ1290HPP4
M&[&A!V4M-W3#'_<F92$)/43HM)#686KX<(V=E;7<T$T_=%X6DM`CA!XC]*2L
MY89N^:&G92$)/7-#>_M734-Y^_=X1]>E_9U82%W%=W90>/50%&I<E[NC9ZH=
MYN(/VZQ?2/OZ,--1:]Q<!4$B4\4&B1%V4(:U:U-OAONT*-2L'UIJ7#2"294A
M&DJ-V.OKK&Q(MG`.&2'.&'$FJ#6%S-PXWK[3$\HG[+Q#<7_O">GY,F?_7?OY
MU)5B5S;'>\9N[/[H"]T4LU7M6I#RD12P=>**T`,62PS=WAY"UR_:P37LD'52
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M6SO2[`NITDXPG`J+8*H?VE(5.Y5-#B2^;3(1:LI>#5H;F@).KT^%;.?*A.R>
MR$DCTEC(QIH(V5A3TLPC?Z_JZ0IWKSH7HR_?'NY___2HMJ[JA!5G39W<YAZ:
MCA(,>0KR1ZR-8`3=U?>AP_Y;4-NF;M^4:A>CDEKKNAW$B4P)I]/'##V0.#9T
M8NBV;79I+1B3#1DY%;)A,D.U*[MK<C%U;_)P5_&B'@RU1Q+([KRQD(T]D3@J
MMI/#X6E\6A8KFJLUZ\%'F4GL0W-^%NBYBC`+ZM>'*8E#%BP>?QVRX(24,-,?
M;O\OZ,;]',U&L%&Z^OD"E1*JE!Q->X9JSN[MEU:,@BN3PD2RFS=F\$$9R!9+
M2BLRKG'!M$#LE+&S,HZ-G9=6Q&Y5I`5BCQE[4L;Q#FU,BR)8377$P_BO(BW<
MYORTT-,585K4U/,B*A'UL>$?9(6.&!PH"@H.%$'N=O7#(ZJB*F6SPL1JV*NE
MOBE6:]2*3ZN><`K&Z9%$LKLD%K+!!V4@&SPIK;RD#7)W*(%L[%3(QL[*.#9V
M7IK$;@<CAI$$LK''0C;VI(RCKEG+TR*NS:=E,;.=ZC?!)<A,8A^:\[-"3W(@
M*UH\6%2<,M1XNSQG%',EZM0D>_23?LQ'9X?M^EU2C]0G1:28-"`EI"$I)66D
MG#0BC4D3TI0T(\U)"]*2M"*M21O2EK3SR,\=/<GBYLXK.5+,R7@Y8LC-$5!/
M/_;E9U*?%)%BTH"4D(:DE)21<M*(-"9-2%/2C#0G+4A+THJT)FU(6]+.(R]'
M]'-W)^3(H;A_2A%R<H34(_5)$2DF#4@):4A*21DI)XU(8]*$-"7-2'/2@K0D
MK4AKTH:T)>T\\G,DG-3[AP__J7L@9CQBSY:MVV`:Z).4<@>NP:F_:\O(Z:Q'
MZI,B4DP:D!+2D)22,E).&I'&I`EI2IJ1YJ0%:4E:D=:D#6E+VGGD)YB>TGO[
MB4H_MAN,:X7<@Y`I9:G'4GU21(I)`U)"&I)24D;*22/2F#0A34DSTIRT("U)
M*]*:M"%M23N/_!S14X$GY$@Q<^@.9O0SVSIMU!58.5AO-H/#3]>6LH>6LJ)0
MGZ4B4DP:D!+2D)22,E).&I'&I`EI2IJ1YJ0%:4E:D=:D#6E+VGGDIXV>;#PA
M;<S<I'.=I)_7]T>W75*/U"=%I)@T("6D(2DE9:2<-"*-21/2E#0CS4D+TI*T
M(JU)&]*6M//(SQ$UU#@E1W3Q8`QLR-[Z[^J;7<711@X:/5*?%)%BTH"4D(:D
ME)21<M*(-"9-2%/2C#0G+4A+THJT)FU(6]+.(S]']+S="<<1,Q'H'D<,V?%(
M5[](XQ]:>J0^*2+%I`$I(0U)*2DCY:01:4R:D*:D&6E.6I"6I!5I3=J0MJ2=
M1WZ.Z#G2$W+$3*FZ.6+(>7Q,WR%5.>(_+=8,YBM[MI0<;?J&U*E1*!*R#XS%
MMJ([*`KNU@YL*8F52*Q#>'\SA%.6QZ>=]%QT>#@MR)^E#B?;NZ:BVA^R4CU#
M\L#5=2NX==67.G9>-S+DW-6.I93JGN5($=.Z`U/*/'.E7KEM7+G_!;<K$PG*
M.=ZZGC\[(6_,=)N;-P7Y-WN:P1IT#^VHFSWVP_<,R2-(K6`TW&>5R)![QSBV
MQ8YNL&(M36,UM<'\)T`2&T;M42^GU&V'4S;1H;A_BC:D]T*Y3YO-(#^Z4LK9
M1(;\YQF:P8Q$WU:TX7'K.S*EW%RKK!CF^L"N1/%<D=KZ[G_!X2"Q0;$AP[F<
MXYU3W=H).Z>A(-?"6TBFE/,,04](C:>=/1#<,>I+>'78*TM5;$BS7LYC"['$
M5U=KMB:W9%'SMGBLX-5>:U<'6S*<M/A'-_,;G,LP%&1J<,NH:THY=^Y[0N;.
M??TZR.Z^1+;9'1GR,K)8)17YZ'8L2I7W\F_#SNPUYG=F?3WM'N_"+2>W.E_)
M37-9[AP'&X:<,1:I1^J3(E),&I`2TI"4DC)23AJ1QJ0):4J:D>:D!6E)6I'6
MI`UI2]IYY.?.:=?S#5[/"[DY@DO\'DOU21$I)@U("6E(2DD9*2>-2&/2A#0E
MS4ASTH*T)*U(:]*&M"7M//)SY+3K^0:OYX7<'#&E+/58JD^*2#%I0$I(0U)*
MRD@Y:40:DR:D*6E&FI,6I"5I15J3-J0M:>>1GR/ZTIOGH)/?`&J82WAW4-.Z
M#<9CGZ24RJ%R:!*,(+NV3'DY0^J3(E),&I`2TI"4DC)23AJ1QJ0):4J:D>:D
M!6E)6I'6I`UI2]IYY">8OFYW$^R5P8RY\G<',X;L$:>KAFGAA!&I3XI(,6E`
M2DA#4DK*2#EI1!J3)J0I:4::DQ:D)6E%6I,VI"UIYY&?(WJ>P\T1/1#^1R\B
M-HH9$_=VEY`[B=%L!3,[75O*'G5,+#NOTF>IB!23!J2$-"2EI(R4DT:D,6E"
MFI)FI#EI05J25J0U:4/:DG8>^1EUVE12@U-)0NY1QY2RU&.I/BDBQ:0!*2$-
M22DI(^6D$6E,FI"FI!EI3EJ0EJ05:4W:D+:DG4=>CC1/FTL[%/?GTH3L$:)+
MZI'ZI(@4DP:DA#0DI:2,E)-&I#%I0IJ29J0Y:4%:DE:D-6E#VI)V'ODY<MHT
M89/3A$+VH-$E]4A]4D2*20-20AJ24E)&RDDCTI@T(4U),]*<M"`M22O2FK0A
M;4D[C_P<"2=`CX]PU7V2<"K9D+HS+X./KI"]1=4SY-\!:P73C7U;2F)%I)@T
M("6D(2DE9:2<-#+DW)D;&U+?2B)K/[$5[35CLQ7<TYG:4E)Q1IJ3%J0E:45:
MDS:D+6EGJ/C8?B:%$\*O9!(G?O7=&743T?F^BBZI9^A&':W*R_`F[A':4K))
M(U),&I`2TI"4DC)23AH9\C*IV!)>)A5T_&-/&7Y&FI,6I"5I15J3-J0M:6>H
M*I-.FQYN<GK8D)=)12F'>J:4.B;I^W'UJQH.1T4=5<`F44'.SHI-&/5DK)0:
M(')PQ9;8`E)G*&'LK?Y4R$;.;$6SSL$L56X+2.21A+&1QT(V\L16K-X:4UM`
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MJ'S(Y/B3$I&-X`X)@H<28E/*?>9E8&O*ZB1^VU<7P?WWH:URI+&THK',UI3&
M<K^Q6MC)1K;*D<;&%8U-;$UI;.HWIO[2@]^C9[;*D<;F%8TM;$UI;/E*8RM;
MY4ACZXK&-K:F-+8-&PN.53M;I;HQORN<-NG?Y*2_H>`T$'3&KBTEGZ,GY':%
M(KP:+>EC?NLBB!*Q2FS(.^074=3S?M)68DJ9P.H9&C\;A@R<,G#&4GD0V`\[
M8H4QPTY8:NJ'15>9L<I<R!Y(%T)V0RS#P,</-BM&6`O9=C9"MIUMV$ZPP7=>
M%3\CPUL,KQR<>1]!7W>KX[5_<&X'#PIV;2G)DIZ0_1Q]0^7!.3BC1:P2&_(/
MO6:5;.0DC!R,`H:,G%9$SE@L?R7RB%7&%9$G+#;U(U]=!&>=&:O,A>P\P4+(
M;HRE'[AV$6R,%:NLA6S@C9`-O'TE\,ZKXN?A:3<FFKPQ(>1..IM2EGHLU2=%
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M)FU(6]+.(S]M]!R[^RC/\7%VJYB2=Y_7$7(/+::4I1Y+]4D1*28-2`EI2$I)
M&2DGC4ACTH0T)<U(<]*"M"2M2&O2AK0E[3SR<T3?`'!SQ'GOX95T*6X=>.E2
MD/O7"%J@'JE/BD@Q:4!*2$-22LI(.6E$&I,FI"EI1IJ3%J0E:45:DS:D+6GG
MD9\NI]U3:/&>@J%;YW520^IJWIYV3$7]@KP]8>&VJ,1W[M9'%197V*#"D@H;
M5EA:85F%Y14V$E/?;JT^KK]U]6RRVQE?Z8'%Y+/7`S$?W6V!>H9JZG4%<Z,I
M&`GTG1*R3R*Q8L4/W_L:BZF78Z3<H+0R>G"9DS@EI-90S(F>BCG1L]+*Z.$M
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M4\)N6#.QXHQWXK*</1`/2BO'.\%))'%*2/2AF!,]%7-'4Z65T</1E%-"HH_$
MJC;Z:7,.^D_J!-.9AKP#_4TX@K*%9*5Z0D='&7U3RHR@FG4,H"2,[?NQ(>?`
M.Y!21QM+_,8:K?#O-`TEC&TL96.9E#K:6.XW5J]=!6/ZD82I.`[IB_2W7W>T
MBVMZ][K#D.H6]D04#N"ZMI#=:44H=\QD2MWJ<?:?'VYJ&#1)&+O18D/>H$GB
MV+Z4"!6AV[?U8%0W9.BT(G0F<6SH7*@(W;BZ">YOCKS0_EE`7^NZ6_\?#9G:
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M`-6?7ZU610L?&RI.Y8[1:UM1X9-:U\I556M:N4%T5E;%4?E5F5XUE5[J3UEP
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MZL/_"P```/__`P!02P,$%``&``@````A`"BA>`>I#P``&$X``!D```!X;"]W
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M9*<D1S>;'\?3_NV_VL@S4EK$-R+PV2-RIN#4%(1/+#B[]8+)G:K\3+G`E(-/
M4VY^33$0;3L+GZ:8/[\-_-E\T?;V3(5WIB1\FI+PUQG[N;&'ST$=@VG9MA`^
MAW1L:8K!Y\".>1!Q.@!4Z.G!/=\UKPL9^&-0YSR,$_7'D.YY&"?J#^Q@<,V(
M>Q@IZH]SW1OK>=%.LVA]6G_]<MC_O(&U"SIY_%BKE=!;*1&<8'KPNRGWV8R#
MJ:94'I3,_0B&%2;3$9:)W[_.EM,OX]]A:F^,S:.T\5R+$"W4/%:R$0<Q!PD'
M*0<9!SD'!0<E!Q4'-0>-!<;@VLZ_$`I_A7^5C/(O>N81`3G<9\Y$"RP2<1!S
MD'"0<I!QD'-0<%!R4'%0<]!8P'$F3(^_PIE*!N(=HMV*UL!UWZ,Q@K6T,[IS
M3<+.I'.Q(+$@B2"I()D@N2"%(*4@E2"U((U-'&^#?QQO]^^YN`(HZ]:IZ(Q'
M0V"Y[3P8S+D/.R,L%@D2"Y((D@J2"9(+4@A2"E()4@O2V,3Q(82/XT.]O-[.
M@9]WIRKHNE.3N3Z:J-4Q%"02)!8D$205)!,D%Z00I!2D$J06I+&)XSL(',=W
MYQVFK%V'&>)WBV:HR7+>D4B3P-ZX@MG,G>=Q9X0QF@B2"I()D@M2"%(*4@E2
M"])HXD]5QQP?P@%M@`^5M>M#3?0)O]V20T$B3>:3=MOW)Q[;]^/N>N<^371S
M6]54$V]ZUPU-UA53IPF09?M;WEU'V4+(EE*VZHH9678&J;OK*-O8LHYS(6H&
M.%=9N\[5Q'>";SYW@R_LC+`]D2$PYMVZZ@?<Z=HH@)VT,PKF"U<[,4K0P<[(
MOV-^3D4#LFL:D/<V8.DVH+BF`:5H0'5-`^J^!BPF;@.:"PUPAANRCP'#K:S=
MX=9D`>M=Y^U@P<(O[(RZX=9DV<[M=K+$A@1ZPBW8R24Q$K3*I4(T$Z*Y([K@
M\50(T5*(5D*T-F36MM2;\I2@L54=7ZN\S7&VM7&>7G:;WQ[WX$0X=/=L"E.H
MK7740ZOB#H)!SJ3S)OQ40E;=,!AT!Q'3#9^<=L9J:4_.Z1V33U#^_,1#*SKU
M9U<U(N]O!%M8"I0_VX@2K:@1U56-J/L;P5:@!N4_:X0;%"K)$LDJW,^!(5$Q
M\>O^X[.8@!LN75#H5`V._SBVCRKGA\EJGZTDBB2*)4HD2B7*),HE*B0J):HD
MJB5J'.2Z5:5;PJW@U*'W`'3:QO(J=IAZ5#='U,)H+X-L?H1D@T,4211+E$B4
M2I1)E$M42%1*5$E42]0XR'6^2K^X\_V9BNFA[C>)G!W7!MFK4;!@&WRH[CJI
M$:&S5R11+%$B42I1)E$N42%1*5$E42U1XR#7VRI1X][V9E?D8RJJV7YND+-J
M:"L+1=(JEBB1*)4HDRB7J)"HE*B2J):H<9#K2HA0QY4].[&]ZBISMA4;9"5H
M:E4`*SM#,^A"BD96N&(D$J4291+E$A42E1)5$M42-0;U)&LP`P>Y5)DSEVID
MYVNMZ/W(0I%!GV=L9$#>U,IVSF:LO"F=-#,J^4G61@8H71AD29<]TA65_"1S
M(P.4;AQI-WSAQ#$D?)4Y\[5&SDDR6+`\+/0Z*VQ4A`@\>NXDJ0NZ&9PXZZ,6
M&).62.'0B@YQ&:*SC<B-%6L$V](+U#K;B!*MJ!$5HK.-J/L;P<X,#6I]U@AW
M]%7>9^\#%Q8OG2;"8HB#^.AIQ+(Y=L8.R0H+1HAHTL0&+2$;Z@8Q6+"C<D(%
MR4IFZVBE'X:JVX09(JHQ[Z^19^=4\$R-)5I1C14BJK'NK7')TW$JV%^C.X@J
M>QPPB#K9=`91(W<*+WE*[G56-(@&40=C8Q7`88H&<<G.6@EJ?1:E^FX86M%4
MR1!1C7E?C7[`[@84LF")B.0K1"1?]\D'(H.G@M1M.RJ=$?-Y5G]^VK7F[J)K
MD#OMEJS/(5EU(X:(.A@C6K1W)Z:3.1\L-*`R*2(*]@P16>6(M+(WF3#E`@VH
M3(F(E"M$9%4;!$N%V@1G2[84-TX1U_<\>;[@>YDE^QJQV<):$)(5^=X4I'[$
MQBHP][#\Z8R-88(Z5"A%1'&;(2*KG$E[2W[[I9"%2D0D72$BZ=J5]A:3)5LR
M&Z>0ZW^>95_P?Y=,HQL??8U8[+-],"0K+!@AHI[$!CE;CE@[$EDP141AFB$B
M^?PJ^4(6+!&1?(6(Y.L^^6#)-M^&"EZS-*DD^/K-!`ZK_#QH$)L>;!</R8J&
M1VOYU,'86#F;2<_PB(*IE,\0D7Q^E7PA"Y:([&DB&E&3?'M27[`0;5"E;9$[
M27A^?F&2R*3<UXA-$C9-0[*B43`%R4VQL;HT243!5,IGB$@^OTJ^D`5+1/8D
M$8VH2;[=*B;,!PVJ](S"L-1>?9F-Y48&.7-A-F&GO9"L:!2TEC,7-+HT%T3!
M5,IGB.Q1N$:^D`5+1/9<$(VHC16TOIT+<Y8?-JC2,PHJXQZP(BES=EC2R)D+
MLPD_WOJ=%8V"0>2FV%A=F@NB8"KE,T0DGU\E7\B")2)[+HA&U%?)-ZC5,Q9P
M7A\R%LJ<C85&;$:P<V$(<:\*@A6-A493ZF!LK.!A.6ULLPF+K`2UH'R7D-@G
M<YUJH!75F*$\U9@CNFNC>#YG,52@"HUHB8B$*U0AX1H1"K/39(,J/4/"4_C_
MZPFA&@\^4CV9_6S"CJ>A*0ASBT9*%UQ"DD,.YP]28ZQQ"M:6&=-/4)\\FB*B
M*C.#SE>97U=E@?I498F(JJRNJK*^KLH&]7N&5V78]NK7#N_09WV^SM/MG-\@
MZQ9]*%$D42Q1(E$J4291+E$A42E1)5$M4>,@YX`UY1FXGC6#'S:U.NT*1T$\
M6[*#WB-:P;;8A3JS"<FFFT@2Q1(E$J4291+E$A42E1)5$M42-0YRG3\L!9_*
M%!R1N_*S13,D*W*IT:)G?+&T2B1*)<HDRB4J)"HEJB2J)6H<Y+J49]76+G`^
M=YC*!-L@>VF0*)(HEBB1*)4HDRB7J)"HE*B2J):H<9#K2I7(=2LNK!,7_*?S
M/GMIG1ID/=`SR'Z@9Y#S0,_G7WN+R0IC.)$HE2B3*)>H,`@R49!WW:`RJ0%N
MT(F7XP:-K"=NX52@R*#/'\*1`7E`R^A6Z_.;L7*^.4DEVYQ#?G62#%"Z,*C/
M(2JI&>`0G0,Y#M%H`:WOMH&9^,X5G'#YV1>1O6H9*T()6M&Y)45$A\\,$17,
M)2H0R0.).FT/<8-.0APW&*12/LL/[+95V%8$[WK0F2M"Y!SEQ<D2K<Q=9_BN
M/?\F<X(FMJMTJZSJ,K*B=HJONN5H9:KSYS.?W6(HT*3'FRJK&1!4.@ERO*G1
M':PYEC/Y[39X-BV"RB#R06RL\&ZT-YVR4TJ".E0H163'F)#.76EOX=VQ/*U`
MG1XGJ81B@)-T_N$XR2`6<FR<0I6+0!9DQ4"$B#H<(](#OA1W$A(TH#(I(@KF
M#!%9Y8BT\J(GD$P#>WSDY`F7=RV9$$PU<@/)X_>JC!4D++AD1HBH([%!)I#@
M>Z7\47PB"Z6(2#I#1-(YDX;IQA:.PBGD[&F!<^J_Z*36W+U]@<@-)(_=!PB-
MF1U(B*@K,2(]W'[`;Q`G:$!E4D16("$BJQR1488G-.[WO0LT:,NX/G(.YY=]
M)`_G@49N(/%'?Z&QL@/)(-A[,+9B1+HCGN^S.T4)RE#G4T16'*$,*>>(.F4V
MA@7*]+C(.6Q?=I$\8:LODK@+32A19!!\7]QR"(KIUTR\I;\0<PNE;)^("K,>
M]1P9A(<Z,GGP@OB<+9*%H^Z&SK"3L[J3S>XY&:1NA]!FQM]X"<D*XR0RR`D=
M+:_V7DN+[3H):L&.U5G)NX-H98>4D;=#JK=&=D>K0*W/:G1=JDZZUV]]L.`*
MEVH$2Q%U<.;Q5-D4=!8LU*(W[>).W]?QP4\Z">K8H=<U`$<KZV1(.N^8D0[X
MLNY(NTY29^$!3M)'9_M\$&CDGLP]=O@)C96S9.F"<,<<.Q>C%:$$D>T54]".
M**&58T'2*A#U+$OJ!#O`#>88;GV9*S"([6YL)$)CY@2++KF@'L;&RGE2,O/8
MP31!K<]F@\[NT(HF6X:(:LS[:Q3K5]=4FA#VC'=#2YUD!_A4F;,3@T:7=D-M
MY8261LZ29I!^2C`5:YD1(9>D@=#-#+)T<T3@F6X1G/GBS-#)D]7GCE,GU0&.
MTP=;9TZ:LR[,"JM1;)<.U>T3=R>-#/)@`Z=)B?JP#UIJXC1AU*"GG97=11.-
MHLZLI\Z\8VZ=;-0*[,%G=;KQZ!SS866U[O-=_SY8($__!KD[K\_VKI"LT+.1
M01?>!S-6SOM@\HL<*&\'L&ZJ-3&RJVK,KZJQ<&IT/`VWK:P`1D\/??#2JK@+
M@D'VW56)(HEBB1*)4HDRB7*)"HE*B2J):HG43R&I6:G[J-VJ?]I(_^;*V_;P
M?1MN7U^/-YO]#_6S1?"DYNN7#N-O*OFK![@`H<:NP,M3*_4N4=^5*5QI[V:*
M,@%<:3<[?L5?KM2C(JGV,)VL'J`O\@H\TEFI)QQ]5^"GH.!&?=\5:#7<=^ZY
M,@.UWGJBZ72E[MO*,G#C=!7#W4IY)8,K>>\5^)6JA][ZH<F]+88&]]D_3%</
M\!Z=K/H1O-_7V$?P?5]3'V?0[QZ=Z&X%;_=+_6B^@M?H)<_F*W@/7O)JOH(7
MV26/O-E*O9/2=^5N%</K$O(*O-.QRGNOP"L9H-97!MZH!,^VGAIW40>_R_6Q
M_KZMUX?ON_?CS>OV&2;`I'WWZJ!_V4O_YV1>X_RV/\$O<L$B`JL]_`+;%K[+
M/E'OQ3WO]R?\#S1WW/VFV]?_`0``__\#`%!+`P04``8`"````"$`]+L#@YHE
M``!"\```&0```'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6RLW=F2VT::AN'S
MB9A[4.A\2L6EUK`]89'8%X+[<J:6R[:B)95#5=WNOOOYD\AD+F]VJ>B8.1BK
M'V3^(($/"3`!LG[XWW]]^?SFGP_?GCX]?OWQ[>#B\NV;AZ\?'W_Y]/6W']^N
M5^G_W+Y]\_3\X>LO'SX_?GWX\>V_'Y[>_N]/__U?/_SY^.WO3[\_/#R_D0I?
MGWY\^_OS\Q_W[]X]??S]X<N'IXO'/QZ^RI)?'[]]^?`L__/;;^^>_OCV\.&7
M8Z<OG]\-+R^OWWWY\.GKV[["_;?7U'C\]==/'Q^FCQ__\>7AZW-?Y-O#YP_/
M\OJ??O_TQY.I]N7C:\I]^?#M[__XXW\^/G[Y0TK\[=/G3\__/A9]^^;+Q_OB
MMZ^/WS[\[;.\[W\-QA\^FMK'_X'R7SY]_/;X]/CK\X64>]>_4+[GNW=W[Z32
M3S_\\DG>@=KL;[X]_/KCVY\']X?!Y>W;=S_]<-Q"FT\/?SXY_W[S]/OCG]FW
M3[_4G[X^R.:6':5VP=\>'_^NFA:_*)+.[]`[/>Z"[MN;7QY^_?"/S\^+QS_S
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MR^_MAH')C/J'6>GPE6_6Q&9@<_/:G:B.C?X5V^B\]LV:Z`QL=FY>N8E-=@8V
M/*],^L"D2/WCW#UK`C6PB7KEFQV:0*E_Z-6^\LT.39[4/\PKOGW=AAJ:0*E_
MF+ZO/#Z')E+J'[KO:]^M2=30)NJU[]8$2HT[YA6_]MV:1`UMHKX3Y'?]^'T\
M'4P_/'_XZ8=OCW^^D9.L;.NG/SZH4_;@7I4S)X+^Z#V=&O[3F4%.":K*SZK,
MCV\E:C+H/\GY[)\_C0?#'][]4TY!'W6;]VPS\%M,3`MUOE%EIR$D(:0A9"'D
M(10AE"%4(=0A-"&T(<Q"Z$*8A[`(81G"*H1U")L0MB'L0MB'<'#@G<3DE!4Y
MMOX_LJ+*J*R8O?S>@`U/$)V):6&Z3$-(0DA#R$+(0RA"*$.H0JA#:$)H0YB%
MT(4P#V$1PC*$50CK$#8A;$/8A;`/X>"`%PP9./\_@J'*R#@D8^D+HXAN)*/F
MJ=%U,(R<FISB`DD@*22#Y)`"4D(J2`UI("UD!ND@<\@"LH2L(&O(!K*%["![
MR,$5+T6RW[T4Q3^+F#..:GT,B]G)[[5<'D\_@U$0"KU4QK93;MQ3E/=*)%QG
MO!+5VG\E6OH/3NI$-H%,(0DDA620'%)`2D@%J2$-I(7,(!UD#EE`EI`59`W9
M0+:0'60/.;CB!4$NB,X(@FKM!T&+7+T[H0N3>6IDDCR%))`4DD%R2`$I(16D
MAC20%C*#=)`Y9`%90E:0-60#V4)VD#WDX(J7#=FI9V1#M?:SH<49)"!32`))
M(1DDAQ20$E)!:D@#:2$S2`>90Q:0)60%64,VD"UD!]E##JYX09!//6<$0;7V
M@Z!%@N8,$N/@]'5J=!HD(`DDA620'%)`2D@%J2$-I(7,(!UD#EE`EI`59`W9
M0+:0'60/.;CB94,F4,[(AFKM9T.+,TA`II`$DD(R2`XI("6D@M20!M)"9I`.
M,H<L($O("K*&;"!;R`ZRAQQ<\8*@)EC/2,*QN1\%0R.Y6G$&BJM@H'":G8:*
MB"412R.612R/6!&Q,F)5Q.J(-1%K(S:+6!>Q><06$5M&;!6Q=<0V$=M&;!>Q
M?<3D%E`_(,@NEWWIYTE-TK@3=R]_6E)S],'08L@96TA34D)*21DI)Q6DDE21
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ML5G$NHC-([:(V#)BJXBM([:)V#9BNXCM(W;PS<^3FIX[8\S1LWGNF*/)#C`3
M=4,_''-`"5NEI(R4DPI22:I(-:DAM:09J2/-20O2DK0BK4D;TI:T(^U)!X_\
MC*AINC,RHF?UW(QH\B]G;L,AY]3*CCB@1%T3]9=&IE5*RD@YJ2"5I(I4DQI2
M2YJ1.M*<M"`M22O2FK0A;4D[TIYT\,B/C9K4.R,V>@[0C8T[+:@O9T!3]?R.
M/]HDI)24D7)202I)%:DF-:26-"-UI#EI05J25J0U:4/:DG:D/>G@D9\1-;EW
M1D;T7*";$4W!Y<Q=.+;89F;8F*JGMU1PG$N7)&)IQ+*(Y1$K(E9&K(I8';$F
M8FW$9A'K(C:/V")BRXBM(K:.V"9BVXCM(K:/V,$W/T]JCO",/.DI13=/[BRC
M'G-`4_7P7CCF@%*VRD@YJ2"5I(I4DQI22YJ1.M*<M"`M22O2FK0A;4D[TIYT
M\,C+B'IZTLN(FKD97EW(%>J9#^8=*_D3R8:\*YWA93`:V5:GP8B4D%)21LI)
M!:DD5:2:U)!:THS4D>:D!6E)6I'6I`UI2]J1]J2#1WZBSILO5L_@JL'#&74,
M.1^B2%-20DI)&2DG%:225)%J4D-J23-21YJ3%J0E:45:DS:D+6E'VI,.'OD9
M">>+7Y[<4\]:AQF)S0D/P\=\3<?KTV3RE)204E)&RDD%J215I)K4D%K2C-21
MYJ0%:4E:D=:D#6E+VI'VI(-'?FS.FQ-6C]F'L<$$\,2TLJ/-E)204E)&RDD%
MJ215I)K4D%K2C-21YJ0%:4E:D=:D#6E+VI'VI(-'?D;4M*Q[T=M_S^!"?7?J
M.Z.,GM!UST0]W?3?)CL^7ZF^@"&A<FA*2D@I*2/EI()4DBI236I(+6E&ZDAS
MTH*T)*U(:]*&M"7M2'O2P2,_+FHJ-HS+7[O^U9.Z;GPT#4^GGXFZ(RKQD5.C
MO=CM:2P?P.W3%L/@BPF)[BBM3,?4U!J=*#-DR^>VHUL^>#2TL*U,^=+4LN4K
M35?'KWP>/P_6MJ-;/GBHK+&M3/F6Y6<LW]F.;OG@492Y;67*+[SR_BY7<Z;N
M+O_.L*"G6-W]VM/0WV/A#6GU)2?9U:.;T^Z9:I+_F->9:+J^T0^3WUX&=5+3
MR=;)-#FE<]-*5GI*T7",W=R_IO'PN+;1Q2B8=BY-&;NRRI!-7FW(OH^&U!JR
MM6:&;*W.D*TU)RT,'6OYNU/->)ZQ._4$J;L[-:G(G+;=>!C>!!SJ9I<V_5-M
MM_8M)H9NCYOXZGH0'`NI:6#[9)'2.9L5FN[NCJ6'%]?!Q%[)/I4A>WE3&[(O
MH"&UI)DA6ZLS9&O-20N/_+VGIAW/V'MZEM+=>SU=RY6=L_."7$_4L1H>C#W)
M:[,'8T]COU:PE5-=2[VITQJ'U\&`G7&-N>UHUEAHDC6JKS(.+L(CMF2?RI`]
MB&I#]KTTI)8T,V1K=89LK3EIX9&_2]7<WQF[5$\5NKM4DW]`CC!QI)MY!V1O
MW@'9DQPU9JNG0[3*-`V<8CF;%:225!FR!TIMR&[5AM229H9LK<Z0K34G+3SR
M]M`HG/1[^0QX;.Y/T6BZDLF;TR$P'H4?OW4KYS0UU>0>=)K\@VX4'$ZI[6C7
MR(..:\QM1[/["[M&==#)63!XX27[5(;L@5(;LKNA(;6DF2%;JS-D:\U)"X_\
M77K>K-N(LVZ&+KW!;Q1<04Q.S9RSH+8[>Z68&))/2TY`PE.A;B5'JVT5V:GZ
MQ;J'IJEO5UD8&IMKFV!MI5V;24)ER!Y<M2&[)QI22YH9LK4Z0[;6G+3PR-^K
MX3R9\V'V^?=/'__^_E&VKFR>R`&LSBC'2_2?1YP^TZ0&<6?W!)?5$]W*.W[[
M6M<VNHEN==U?E0RN;JZ#.JE9F]T,&4OGIHXM76BZN]:[=!!<DY6L7!FR96I-
M@TN[:QIC<F&I!H&KBV%PW=V:0O95SPS9VIVI([7MIL2%]_S4K%_=`)>7"U/[
MN#H_!6K2RCVA'N_1W!RG-(XI6#W^<4S!&9%0)8,AO:=;]WV,1\%&F8Q.K<PQ
M--4T\,9T75\"=KRNB85"5[*;-V/Q/%*\.%F?N-$%8X':%6O7ISKV)30GZVO'
M8H':,];N3G6\H2V\NIN?FNGM%(F%NSH_%FHF*HS%0'X<28*HQH:_D(I^;LN]
M%S/J*1@H@L-P8EO95.A:<LHRENAF`QGPCJF0'^$)KM-34\GNDLR0/>CR4R%;
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MDQI22YJ1.M*<M"`M22O2FK0A;4D[TIYT\,C/B)I&.R,C_:R;-XYH<C,"FHY`
M"2DE9:2<5)!*4D6J20VI)<U('6E.6I"6I!5I3=J0MJ0=:4\Z>.1G1$W!G9&1
M?L;.RX@F-R.@Z0B4D%)21LI)!:DD5:2:U)!:THS4D>:D!6E)6I'6I`UI2]J1
M]J2#1UY&QN?-4QZ;^^<:0W(-<KK>'H<WO2:VE?FH,B4EI)24D7)202I)%:DF
M-:26-"-UI#EI05J25J0U:4/:DG:D/>G@D1^;\^9"QYP+->0,+:0I*2&EI(R4
MDPI22:I(-:DAM:09J2/-20O2DK0BK4D;TI:T(^U)!X_\C(0SJR]_U)$;YN%E
MK"%_:`D^J$]L*SNTZ%KVAG?"5BDI(^6D@E22*E)-:D@M:4;J2'/2@K0DK4AK
MTH:T)>U(>]+!(S\V:C;N]5<MZIY6\.G'D#NTZ%:6IFR5D%)21LI)!:DD5:2:
MU)!:THS4D>:D!6E)6I'6I`UI2]J1]J2#1WY&U.S=&1G1DWW._>^Q)F]H&8>W
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MN6UE:A6FUK&\OQG4W.`9FT%/);J;H2?_]GAXEW\RUJWLH#O59![[OKD*GIE)
M3!][0SG5)//NYKUEII4,X:?Y+=Q/SG4K^5BC;KO+WR$:7;K_%SPG59BBO+DL
M#_Z?L\&.S?WSCR;_*9-Q\`HFII5]IU--YMGGJ^!J.&&75)/[2&=FF[VTP?R5
M#62#^=]9+FP9V15>IM0CD6=DZM@\V$3]?%20J2`?$]W1>>AFJDE],CF%83P.
MGH)(;$?;"L_<I;J5F[5HQS#KN7T1QT<\+F3KN_\7#`>%+8H->=X,S15G:#0%
M60N?7=&MG(<7IX;DTY2S(8-'51)37DZ-IU:1#:E?E_/P8F;JNSN*1ZUIU3_/
M^-VCUKX<;$DUO^`.<W_I*<(K/4OAC'Z:@J2&4V"ZE?/(X-20?F1P>!.D.S&5
M[0"0:O(2V;\DJ>SL`2:R;W5ZB/`.!W/?H#^4_(-9?9Y^:<N99ZQ>_JQVI3^6
MNYM.DYWSF9A6EJ:DA)22,E).*D@EJ2+5I(;4DF:DCC0G+4A+THJT)FU(6]*.
MM"<=//*S<][G^2M^GC=D`S$A34D)*25EI)Q4D$I21:I)#:DES4@=:4Y:D):D
M%6E-VI"VI!UI3SIXY&=$??1VQY?OC"/ZD[H[CFAR,P*:7H$24DK*2#FI()6D
MBE23&E)+FI$ZTIRT("U)*]*:M"%M23O2GG3PR,^(^NA]1D;T)W4W(_CP/KD"
M34D)*25EI)Q4D$I21:I)#:DES4@=:4Y:D):D%6E-VI"VI!UI3SIXY&=$?8(^
M(R/]!V[W89HK3>XX`IJR54)*21DI)Q6DDE21:E)#:DDS4D>:DQ:D)6E%6I,V
MI"UI1]J3#A[Y&3EOLN.*DQV&Y&1R^L`S#C^(3VPK,TLQ)26DE)21<E)!*DD5
MJ28UI)8T(W6D.6E!6I)6I#5I0]J2=J0]Z>"1%YOK\Z9\CLW]^0Q#SM!"FI(2
M4DK*2#FI()6DBE23&E)+FI$ZTIRT("U)*]*:M"%M23O2GG3PR,_(>7->UWS@
MRI`_M`2311/;ZC2TD!)22LI(.:D@E:2*5),:4DN:D3K2G+0@+4DKTIJT(6U)
M.]*>=/#(C\UY,WS7G.$SY`XMNI6E*5LEI)24D7)202I)%:DF-:26-"-UI#EI
M05J25J0U:4/:DG:D/>G@D9\1-3?W^BM;]2L@P1UO0_*)YW35,L0O!=I6=FC1
MM>P<9,)6*2DCY:2"5)(J4DUJ2"UI1NI(<]*"M"2M2&O2AK0E[4A[TL$C/S;A
MQ.W+$RO7G*`U9,>1"6E*2D@I*2/EI()4DBI236I(+6E&ZDASTH*T)*U(:]*&
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M,=&MG,?NIIK40W2GCT_CJ^`1BL2V,K524D;*206I)%6DFM206DW.TX8S3?(3
MT>;5=[:C^[:#Y]3FMI7IN"`M22O2FK0A;4D[TIYTT-2_;2])-^?-\!Z;^U<M
MFN2A.+,9)J2IIEN9_7.2%#[Y8UN96BDI(^6D@E22*E)-:DBM)C=)FMPDV8XO
MO.VY;67>]H*T)*U(:]*&M"7M2'O205,L2>?-`\MOJ(=CDB8O27TKAZ:ZE8Q)
MZAG#X>4@'(YL`[,U4TW.SLH,.3^6;3OJRL$GML(V,)5+4\8^OEP9LI5KVU%7
M#B:W&]O`5&Y-&5MY9LA6[FS'^-:8VP:F\L*4L967AFSEE>T8WQIKV\!4WI@R
MMO+6D*V\LQWC6V-O&YC*!U/F6-D?P<Z;2+[A1+(F_TG&J^#1V8EM95[4U)!\
M(CL-:GB4,]&M]`/8PXOPJ?C4E+%SC9DFYWG'W+1Z<66%OS+Y=5/_V>725+'K
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M!]LEOC+_4#AOTO^&D_Z:@M-`<#!.;"OS/J:&[&"0:))O8ZA3W-5%4"5EETR3
M-^3W+]+YFD?A%Y;O!83C.[I4+%QS]4U0V"_;LL.,93NVFOME<:@LV&5IR`ZD
M*T-V"Z_#PB]_U63#"EM#=CT[0W8]^W`]P08_>%W\1(:W&%Z^#:7^1E$PD:/)
M'YRO@R\_36PKF\B^EC<X]W0:G(,S6FJJV+>>F5?D?'LE9[-"TZER<!50LDL5
MJ5RS6?.=RBV[S"*5.S:;^Y4O+X*SSH)=EH;L/,'*D-UF:[_PX"+8&!MVV1JR
MA7>&;.']=PH?O"Y^#N7RPYMT=KX!])U(JI[!I_V>Y'+<A&UR`YJ2$E)*RD@Y
MJ2"5I(I4DQI22YJ1.M*<M"`M22O2FK0A;4D[TIYT\,B/RWGW*&YXC\*0#?2$
M-"4EI)24D7)202I)%:DF-:26-"-UI#EI05J25J0U:4/:DG:D/>G@D9^1\![%
M7[Y[?L/;%X9D6#E]JAZ'O[D]L:W,0#0E):24E)%R4D$J216I)C6DEC0C=:0Y
M:4%:DE:D-6E#VI)VI#WIX)&?J//N:-SPCH8A=]31K2Q-V2HAI:2,E),*4DFJ
M2#6I(;6D&:DCS4D+TI*T(JU)&]*6M"/M20>/O(S<GG>OXMC<OWHQY`\MP27]
MQ+8Z#2VDA)22,E).*D@EJ2+5I(;4DF:DCC0G+4A+THJT)FU(6]*.M"<=//)C
M<]Z-"76+*KCH-63'D0EI2DI(*2DCY:2"5)(J4DUJ2"UI1NI(<]*"M"2M2&O2
MAK0E[4A[TL$C/R/GW42XY4T$0_[0$DQI36PK.[3H6O:)GH2M4E)&RDD%J215
MI)K4D%K2C-21YJ0%:4E:D=:D#6E+VI'VI(-'?FS.FW^_Y?R[(7=HT:TL3=DJ
M(:6DC)23"E))JD@UJ2&UI!FI(\U)"]*2M"*M21O2EK0C[4D'C_R,A!/3KYY^
MN>4<M29W^H4T)26DE)21<E)!*DD5J28UI)8T(W6D.6E!6I)6I#5I0]J2=J0]
MZ>"1'Y?S9HW5W'!XM:)G>IU?9].MY#_VM*,[JK^.;C]FXY?(3'WG0;$T8EG$
M\H@5$2LC5D6LCE@3L=;8X#A)Z6]=-5?Y^@=P;U7SX"-$3[(.LRDGNI5#4]-1
M_E17_+F,Q&EA"J7&^A=^_/N-F3'Y8W&F77ZR4_7@(TSAM#"]2F-.]<J84[T^
MV:EZ^+2*T\)4;XW%-GHXHWB<+;J^4'_A]^4):/6W0</MWY-_E^XZN)LQT1VE
ME7F!4T/N!1H?UM"MY/%<M=\&@UO\D3I3Q\[-9YK<6W>FU8MK*X*U78Y'P8W"
MTM2Q:ZNXMMJT>G%MC;^VJ\%M<).\-66.*_./F^B$WZMV(2?X;GM2AZD=><*_
M&SJQK>PN[#LZO]:6Z%9W?5:O!L&!D)HJ=OMEFKPG"DP9>Y`5AMSQ<1C^6&')
M^E6D?FV*V?J-H?Z5!P%NO;K^K@AGRISKB=?_#=!;3J!I\HZLP65P`VMB6]G=
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MT\)4+XTYU2MC[M74R4[5PZLIIX6IWAJ+;?3SYASD9!E>0FGR!OK;X`0TL8W,
MBYH:>O$J(]&M]!74>(@+*%/&'ON9)F?@S4VK%U=6^"L;70V"MU&:,G9E%5=6
MFU8OKJSQ5S8<7`:S>ZTI$QF'PDF`EZ][Y7(&.ZTG[Z(IO(";Z'[.X335)"_-
M[,?$D/J#O__\Z7:`BR93QFZT3)-WT63JV-*%H;[T]=TPN,0L6;J*E*Y-'5NZ
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M`T_$IA&3^.AZMJ_$!R;Q@4E\8!(?F,0')O&!27Q@$A^8Q`<F\8%)?&`2'YC$
M!R;Q@4E\8!(?F,0')O&!27Q@$A^8Q,>U(#[GS>X-+O5\F_/Y^&3^@!1\VV;B
M-',&)%W.7@-)HF"2*)@D"B:)@DFB8)(HF"0*)HF"2:)@DBB8)`HFB8))HF"2
M*)@D"B:)@DFB8)(HF"0*)HF"2:)@DBC7@D2=-W4I$VRX?CZ9'50D/KJ=-1F0
M8!(?F,0')O&!27Q@$A^8Q`<F\8%)?&`2'YC$!R;Q@4E\8!(?F,0')O&!27Q@
M$A^8Q`<F\8%)?&`2'YC$Q[4@/N=-H@[DEE;X\>MD\BG^=*]R?!W<=9=$Z:YV
M7DT2!9-$P211,$D43!(%DT3!)%$P211,$@631,$D43!)%$P2!9-$P211,$D4
M3!(%DT3!)%$P211,$@631,$D4:X%B0HGAE_^8#:XY!3PR>S@(_'1[:Q)?&`2
M'YC$!R;Q@4E\8!(?F,0')O&!27Q@$A^8Q`<F\8%)?&`2'YC$!R;Q@4E\8!(?
MF,0')O&!27Q@$A^8Q,>U(#YJOOCUG^OESD!D0-+F72'=A-_Q/G6U5T.2J%-7
M<]4DB8))HF"2*)@D"B:)@DFB8)(HF"0*)HF"2:)@DBB8)`HFB8))HF"2*)@D
M"B:)@DFB8)(HF"0*)HF"2:)<"Q)UWOSTX)(3U">S@X\,2)BUEOC`)#XPB0],
MX@.3^,`D/C")#TSB`Y/XP"0^,(D/3.(#D_C`)#XPB0],X@.3^,`D/C")#TSB
M`Y/XP"0^,(F/:T%\PJGK[YW/.$$]N(S-4-\$#RU(HD[-S.`CB8))HF"2*)@D
M"B:)@DFB8)(HF"0*)HF"2:)@DBB8)`HFB8))HF"2*)@D"B:)@DFB8)(HF"0*
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M(EM'_NA`;(F$57X\/K+D2OK(7Y*-+9$^\O=#8TMDZ\A?C8PMD:TC?RLPMD2V
MCOR%N-@2297\$;#(DK%L`_GAPM@2V0;R\U:Q)?)^QM'W,Y;W,XZ^G[&\GW'T
M_8SE_8RC[V<HKVT8?6U#>6W];WV&Q\]07EO_599PR4A>VRCZVD;RVD;1US:2
MU]8_^1)6&TB?0;3/0/H,HN]G(/MG$-T_`]D_@^C^&4JNA]%<#R77_4\YX[4=
MAY[8GAM(G_Z)0_21;3V(;NN!;.M!-`<#V=;]O014DVT]B&WKGP?W/\?7(AUB
MKUA%(.(_C^Y_5F>U2#KEY49?K3K48NUE1T;WH^S&Z%Z4G1A=KSH51.I/;Z_N
MU9>8^$KE.T3WZEM"7"+?_[E7W_#A$OGNCE2++9$GE._5X[WL(T_7WB?RO"F7
MR).Q]^K95RZI94D372(_&7ZO?GB;?>17M>_5;U-SB?PX]+WZB64NZ62)^A5B
M+I&?`;Y/^J>R@G3ELD3]4B_[R,_PRGIB2^1G=._5+^6RC_P,[KWZI5LND9^Q
ME=<66S(=7MTG\J09^^2RI(@NJ65)$UW2R9)Y=,ED?'L_E=]!YGHR69)'E[P?
M24!'L3[O1Q+146S_O!_+B#&.[87W8QDQQL=M\.ZT&YY^^N&/#[\]-!^^_?;I
MZ].;SP^_RA7CY87Z@;)OGWY3CU[V_^/Y\8_C0Y=_>WQ^?OQR_.?O#Q]^>?BF
M&DCC7Q\?G\W_D+?X[L_';W\_7I7^]'\"````__\#`%!+`P04``8`"````"$`
M0'0[')L%``"P%```&0```'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6RL6-FN
MXD80?8^4?[#\/GC#-B!@=/$N3:0HFB3/OJ8!ZV(:V;[;WZ=ZL=T+PQ!I7H:Y
MQU6G^U15E\N]_OK1G(TWU'8UOFQ,9V:;!KI4>%]?CAOS[^_IEX5I='UYV9=G
M?$$;\Q-UYM?M[[^MWW'[TIT0Z@U@N'0;\]3WUY5E==4)-64WPU=T@2<'W#9E
M#W^V1ZN[MJC<4Z?F;+FV'5A-65],QK!J'^'`AT-=H1A7KPVZ](RD1>>RA_UW
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M[CC.N2/\<L?Y8XY`2[<=C([+F;OP'3\@V[ZS8L@=X??_;14.#%T1?KFC/PL=
M>^G]1.*2^\$O][N_4XLEB.8[+OMRNV[QNP&'"%+074MR))T5D`V)9EK'U/\H
M\Y`M0O)$6#8FB("D=E"N;UL_]-?6&Y18Q6UVNHTC6T2#!2D"0ANK0*("J0ID
M*I"K0"$`%@1AC`34ZB^(!&$AD1@T[`9@"HVKR!XL!I=8!1(52%4@4X%<!0H!
MD&3#Z?H%L@D+E!"<.*$"`EGHCAO!41J-%)-H-!F#H2&)AJ0:DFE(KB&%B$@A
M`15B2&XWO:'TB3%5/NQXQQ%H(J-,=SF78Q&-1H-;K"&)AJ0:DFE(KB&%B$A"
M(1.B4';X9Z3UW-=,_&3-#`E9`R=G-]*06$,2#4DU)-.07$,*$9$$0@Y$@?=5
M$6-9%4?<\31'#)F+G<X-0SFW\6@TY#;1D%1#,@W)-:1@B.O1E[?8O.#%\[A0
M8BP+98A/AP+:>B.&A#9MYJ[M>(K&\?FHD2%L;Y0C94@0C.'+1B_RB@!6I17F
MX_.!M1!9I=1""AY73(QEQ0SQX&@(AU1Y947,R(6H3T9S-1+,*`AII+S`6\J1
M2CA).$8AY6M/2/;(0KFTT-SW%O)"A;B0%"IXKS\>*F(LAXHA+OQ,45BJC9L9
M>5,%Q1SQ6%S4W2::0\J1Z;1EFDTNDZJ[*$0'*00.C,!B#$BK<P,RO/ZDU5%'
M.1X<4FI':0(1MW*G+,<<FL_9H9K;2BDEND\Z+#;19+I5+C-[KJWLII!\Y,B0
M>4B8`._W2(=-3_"B'T[HCD-*?2C%&7$K?VH&\0"QD^.$"Z6F$FX@%%4Z0$*1
M##03<SY`G'GI*GVF&&C85Y#82!TR)PGA$-Z)_:FN7G88*@>"<"-,I-+Y.,R&
M+2E*#)**QK$5Q1%=?6,&<)2GLZ9UG,%J2>MHX00*3<(-A-I+.>2)=<2V='^Q
M7%[,@>]PI6H+:36YMLB(=2>8W_'U1\&$DSE&DP]J8LV)LQM[83D:%.M0HD.I
M#F4ZE.M0(4&R;C)Q";IO%(NHC\]GHCX.L6]K.D^1V9HTY@F*=2C1H52',AW*
M=:B0(%D?&;@>U\?&,Z";>@:')C$1N5Y0]6E0HENE.I3I4*Y#Y`)E6I'I8Q<B
M[`.Y0>T11>A\[HP*OY++#DCX=CW"["9FYWAP%4,',NW)')Y0T=H3?[B^49Y$
MP0JF/@B3BH>KF)Y<!<_"%<Q,NCW<#SW1%JG8[\B]T0W[G;N"#\0;/-[J"<*D
M/]B!ZINB0?--R:"8\ECCCN"^Z%H>T1]E>ZPOG7%&!PBQ3;\^6G;CQ/[H>9-X
MQCW<%-%^<8*;000?&?8,4GC`N!_^@(U:XUWC]C\```#__P,`4$L#!!0`!@`(
M````(0`&2\@V;@X``&A&```9````>&PO=V]R:W-H965T<R]S:&5E=#(W+GAM
M;*R<VW+B2!*&[S=BW\'!_=J(@S!$NR>Z00<D@:2-V=UK&N,V,;9Q`#T]\_:;
MI:I45M6/&8B8FZ;]D?675)E9AT3PZ9<_7E]N?M_L#]O=VT,GN.UV;C9OZ]WC
M]NW[0^<_O\;_NN_<'(ZKM\?5R^YM\]#Y<W/H_/+YG__X]'.W_^WPO-D<;TCA
M[?#0>3X>WR=W=X?U\^9U=;C=O6_>Z)VGW?YU=:0_]]_O#N_[S>JQ:?3Z<M?K
M=L.[U]7VK:,5)OM+-'9/3]OU9K9;_WC=O!VUR'[SLCK2]1^>M^\'5GM=7R+W
MNMK_]N/]7^O=ZSM)?-N^;(]_-J*=F]?U9/[];;=??7NA^_XC&*S6K-W\`?*O
MV_5^=]@]'6])[DY?*-[S^&Y\1TJ?/SUNZ0[4L-_L-T\/G2_!I.[?=^X^?VH&
MZ+_;S<^#]?^;P_/N9[+?/A;;MPV--OE)>>#;;O>;,IT_*D2-[Z!UW'B@VM\\
M;IY6/UZ._][]3#?;[\]'<O>0[DC=V.3QS]GFL*81)9G;WE`IK7<O=`'T[\WK
M5H4&C<CJCX=.CSK>/AZ?'SK]\'8XZO8#,K_YMCD<XZV2[-RL?QR.N]?_::/`
M2&F1OA&A5R/2N[T?#@?A_8A$SC0<F(;T:AH&W=M@T`U5YV?:T;O-5=.K:7?]
M18^,!KT:C>%E%TVITW1.KZ;A^'84=,?]O[C9L6E'KZ;=2$;ZS,T&["/UG_92
M![WAZ+YQTKFFY-;F6@/Q[V47&[!/U7],IX%<[H6!H2)1]R^>ZE\T6$'(+>D_
MW']?+@!O^DY'=I,HL]5Q]?G3?O?SAF8?&K7#^TK-9<$D(&]SBFB)-FD^RAE*
M%J7R1<D\=,CIE`X'2O3?/U.:?+K[G9)S;6R^HDW@6DS90F6BDIWY(/)![(/$
M!ZD/YC[(?)#[H/#!P@=+'Y0^J'Q06^".O-&ZA*+Q[W")DE$NX<'\RD!\U//&
MGRVXR<P'D0]B'R0^2'TP]T'F@]P'A0\6/ECZH/1!Y8/:`L[X4T[_'>.O9"BK
M:/:V<L*+^*_&B":`UBCTG-*:M%X!$@&)@21`4B!S(!F0'$@!9`%D":0$4@&I
M;>+XB$;5\='I%9UG)V7=N(*'\*LA-'VVX]X;^NG0&G&S&9`(2`PD`9("F0/)
M@.1`"B`+($L@)9`*2&T39^0I5*\8>67MCKPA83LO38',@$1`8B`)D!3('$@&
M)`=2`%D`60(I@51`:ILXPTR1><4P*VMWF#7I#628-1G8:W1OV'<GFUEKQ"$?
M&:%^*Q0;HG>Y:IE.VE9V-@U<Z;0U8NDY2&<@G;>M;.FA*UVT1BR]`.DE2)=M
M*UO:FWVKUHBE:UO:<1GMGJYPF;)V7::)VMS+G#3P%HRI,9+TF0&)#!F)RPR1
MS4`"K5(@<]#)0">'5@60!>@L0:>$5A60VM9Q1IYB^HJ15];NR&O2H[.'C/QP
MY`;95!OUFQ.GWIT"B8#$F@RE50(V*9`YD`QT<K`I@"R`+$&G!)L*2&T39^1I
MR*X8>67MCKPF0]H*6R-_[XV\-NJ1^\5HX,]<VF@P:`X?P2CT$CEJ13B18T.L
MI&AMSG24FHYH:V)=C3?9S5LE[BV#WO+6QA;R;JNXI+=%J\2]+:&WLK4YTUME
M>OMH$.M6A#IRXB"@VLP5@="8NY%@T)!VY=:X^ELR8V5G(:.@\3Q5V`)O#".V
MD"2,N3=!"5JEC,[[FJU$*T/Y'*T*1F?E%VPE\DN4+]&J8O3AP-1LT4B[_E2'
M4[LN<'Z#K8HO7F8;Y*;VP%NYI\:JKZMO^LROM:@NJ,H(0=_/],BTH?F`PSUF
M9.4R*J>,:`6W0LQ/7=82^8R1R.>L)1=>,#HKOV`MD5\R$OF2M42^8O31N-0L
MTRB[WE1'W2N\J4_&='3E`?ZJ2F3D8&^)''L3M;$:RF9QQDA/*3VJG'HI'1D+
M*Z5C;B0AGS`2Z921NV$"=^HKM^0S;BCR.2.1+QB=E5\8*TM^R0U%OF0D\A6C
M#P>F=J1=?ZIS\17^5.;>;*M1GXYYD@JA5[&;JO*F\KJUVT04,9*(CAE)1">,
M1"M%-&<D6ADCT<H9B5:!:,%(M):,1*MD)%H5HIK1B=Q2)^4K?&$.UG9N:>2M
M?#!3&BNYSIFJ+9%[AB,]4X9A[]YK%1D3*SQC;B7AF3`2[921F6V\W=0<=3-N
M(;HY(]$M&-&.T@H\[Y2S$'G;RILYEJPE/9:,I,>*D8S2T)LC:ND.]C7J@&Y[
M5]7'>Z'ZN.B#3Y&XYJ2J^W[2:>0EG;=;F9J&PW$[^\X,"KMG'*VUG471(`GV
M!+53UM:[A``<#;J9:=$3W1QU"]&U70B.;N5M*W`TW$F)/5;<HXP2.KKM#ARM
MCO7@:'7D>-ZN?_NZ([?3ON3$+JA//C&?@>C*``63+)L:N<MFZ(7?5'V<0Z$R
MH(N3G/"W/3.V"G40W(\'7>^(&AD3)]NUMGT`9:&SW:5LQ6GC+O5S["HSR.HJ
M9Y&S715LY1SP0@@5?2=T<]8HA1`J<+\ERY^]B(JMVN'MC[Q<J(V)'EYW05:E
M"3]Z@N&M^M"S":!?=^\?!1!-)6T$*1EOH=;(JPIY5S95G]Q1P[#7AMX,4620
M,T<8><GE!!NFB.:HE3$2K1P;%H@6W-!>J.&Z2FQ8(:H=+=='JHAA^^A$,MN^
MT#4/)YLU<K,9ZD2!MK*2<(8H0A0;9.5/@E8IHCFB#+5RM"H0+1`M4:M$JPI1
M[2#7%ZJ0<(4O=-W!\85&[O%RZ%>.@K9@8<T9.+-J*ZX=#0?>I!*)#,_L,2,)
M]H01A>['TWAJK`:TM;:LO"5A+EK<8\9(>LP9G>VQN*C'A6AQCTM&TF/)Z&R/
M%?=HZD@PH+7(4&=.9/2N*R0UYNZ,:9"WG?9<.C56=I8RTCNA/CUIXZYY$1O(
M?C/FS@0E:)4R.N]SMA*M#.5SM"H8G95?L)7(+U&^1*N*T4?C4K-!H^QZ\[HR
M4@_+2`:Y>3[P\]Q862O;S"#*,U5&&@7^R0B;Q(PDWA-&LC2E(GPN@;%AQDCD
M<T8B7UPDO\"&2T8B7S(2^4KD3PY+[31Q?7E=$:F'122#O,ST'#-E*SG"S1CI
MO6BOU_6R.3(&5C;'W$;"/6$DRBDC6K//S,8HGW%#D<\9B7S!Z*S\`N67W%#D
M2T8B7S'Z:%QJ1]GUIBKM7+X"]Y2Y-\]JY)YFAWY)T#2T3[,&F=/L:#CVVD3&
MP,KFF)$$=X+**2O3-'+.F_K"+?D,Y7.4+RZ27["6)-V2D5Q]B?(5R^OS*XY+
MS3*-LNM-50FZPINZ<&3OI^A)`>5@=V\+!4%CU;=J$X@B1A*\L4'VWI:M1"M%
M-&<D6AEJY6PE6@6B!2/16J)6R5:B52&J&35:KB_HS'>-+Y2YEUD:A12G5AC#
M/*FMK#">J5,B:?%&-@C']]Y),3(F5JN8D41GPDAB.&5MO9X./-TYML@8B6[.
M2'0+T;5N-O1N=B$-;2MO&5BRE?18,I(>*^[1[$X#]3RWN].KG5:N=U5]X8I,
MT^4()],T"BGA+.]ZI9PIU=R5*X<RV\\8Z9+LL`O;4]W$602-BD1\PBHBG#(Z
MNTK-C94EGW%#D<\9B7S!Z*S\`N67W%#D2T8B7S'Z8%AJ1]CUI2HRV+Z\N+A+
MZ0-)JY&['(9^<=<T=)9#W9"+N\%H@$FK39RD-4A"/4'MU*!0;]TQ:4$W,RWL
MXB[J%J)KQ3`F;2MO6T'2PIV4V&/%/9KB;C`:8M*VW<&ADD(/'4WFEQ=W:4#`
MXQK1FF;?GG>2GYJ&?U'<92M3?>P-N_!1CC&Q\B\VR%E5]46=[R[E[O3&$>-"
MBUA=9=A5SB*TZ%@3F1?Q!5NIT>;O!O0P5-H>;2L(E7;$N491LOS9BZC8JAW>
MH._-GK4QT??L3A.J/.1/$P%]I\;$SV6U7;6S\M=YC4;R).746%EHABA"%"-*
M$*6(YH@R1#FB`M$"T1)1B:A"5#O(\0>YZ(0_R!M7?F>ET6EV7A)SPY$7<U_9
MR@XP;_,S%1N.RQFB"%&,*$&4(IHCRA#EB`I$"T1+1"6B"E'M(-=KUY6"^E@*
M8D1[&FLF`5^8AK)#F$E#=D^$*$:4($H1S1%EB')$!:(%HB6B$E&%J':0ZXOK
M2CE]+.4PDE&>(IHABA#%B!)$*:(YH@Q1CJA`M$"T1%0BJA#5#G('7I4>[*7D
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MZ>;EY7"SWOU0/_A`'UE^_M1B\VL4_>[D"RE1P'KOT"&`?JBBR4)X1_V$17.`
M@W=Z]$ZS3,,[]_3.J7[H]S"^G&Q!G9SL@[HX9?^E3SI-_1JZIIY/W>!@4C>/
MK?GVPTG=/(+N\]Z8>C[5PS2<T)<(<0B3<$+?`$2>AQ/Z^A[R,IS0=^^0T]9F
MHC8;I]X93-1:CN_00DUMFG?NVANAW_EX7WW?+%;[[]NWP\W+YHG"HMM,?'O]
M2R'ZCZ-Y<NO;[DB_\$$+!/U&`OVBRX:^]]A5)8"GW>[(?U#7=^UOQ'S^/P``
M`/__`P!02P,$%``&``@````A`&Y&D"J+$```%%0``!D```!X;"]W;W)K<VAE
M971S+W-H965T,C(N>&ULK)S;<MLX$H;OMVK?P>7[M45*L@Z59"J6>"956UM[
MN%9L)5&-;;DD93+S]ML@T&R@?UJ6IN9FG/G8^`$V&D`W*>G#+[\_/UW]MMD?
MMKN7C]?1S>#Z:O/RL'O<OGS[>/V??Z?_F%Y?'8[KE\?UT^YE\_'ZC\WA^I=/
M?__;AY^[_:^'[YO-\8H47@X?K[\?CZ_SV]O#P_?-\_IPLWO=O-"5K[O]\_I(
M_[O_=GMXW6_6CVVCYZ?;>#"XNWU>;U^NK<)\?X[&[NO7[<-FN7OX\;QY.5J1
M_>9I?:3Q'[YO7P^L]OQPCMSS>O_KC]=_/.R>7TGBR_9I>_RC%;V^>GZ8%]]>
M=OOUER>Z[]^CT?J!M=O_`?GG[<-^=]A]/=Z0W*T=*-[S['9V2TJ?/CQNZ0Z,
MVZ_VFZ\?KS]'\]5X?'W[Z4/KH/]N-S\/WK^O#M]W/[/]]K'>OFS(VS1/9@:^
M[':_&M/BT2!J?`NMTW8&_KF_>MQ\7?]X.OYK]S/?;+]]/])TC^F.S(W-'_]8
M;@X/Y%&2N8G;83SLGF@`]-^KYZT)#?+(^O?V[\_MX_$[_6MX$XT&=V1]]65S
M.*9;HWA]]?#C<-P]_\_9F#%U&K'3&-+@[?7AW<UX,AA&1N1$PY%K2']=P[N;
MZ7@\NIM.3C>DJ^VHZ:]K&)_7XYUK2']=P_%Y/4Y<0_K+]SCJ_'3B%FF=M2.E
MOY?=XLPUI+^7W6)$,62GU`23G8\S;S+JHH'^<=%M1AP#YA^7W6A$86/'*_$3
M#V]&\7@R?2^`(HX@\X^S[O76QG^[G);KX_K3A_WNYQ7M473'A]>UV?&BN5'C
MA63GMEM:;ZTL6@Y&Y;.1^7A-LTVKYD#;P6^?1I/QA]O?:`D_.)M[M(E"BP5;
MF%5F9)<:)!JD&F0:Y!H4&I0:5!K4&C0:K#QP2Z[M_$MQ\5?XU\@8_[)G[AF(
MPV/E3+;@)DL-$@U2#3(-<@T*#4H-*@UJ#1H-5AX(G$DKY:]PII&A>*=H/Q&M
MSHBVVL[H3GFX,^E<#"0!D@+)@.1`"B`ED`I(#:0!LO))X&WR3^#M_K.5=P!C
MW3J5G7'OR*#=#B*U&RS<55HWG7_C>-1Y.!@)3<(%(S'6X4@<H=.OZVLTT;/9
M&?$-+($D0%(@&9`<2`&D!%(!J8$T0%8^"7Q(-Q_XT&[T-R;C.#VQIF'H3DLF
M4;<;+8`L@21`4B`9D!Q(`:0$4@&I@31`5CX)?$?93^"[TPXSUJ'#'(G%89;,
M)AU96C(*CM"Q6C1)9\0QF@+)@.1`"B`ED`I(#:0!LK(D'IH;"WQ(-W:!#XUU
MZ$-+QFU9T"8'"R!+2R9VQXD'T;#;3MH627>]<Y\E=KBM369)-+SKIB;OFIF\
MAF3525MTUUFV!-D*9>NNF9-5V5#376?9E2\;.)>RY0N<:ZQ#YUH2D[ZW04Y"
M[RTZ(Q[/TA%:-UVS>*2=;HU&=*9W1J/)--1.G1)%3V<4WRD_9S"`_)P!%+T#
MF(4#*,\90`4#J,\90-,W@.D@',#JG0$$TVUJG0OFNS4/)]RA*>W^G<-'4Q6!
M"['JIMRA6;O`[:IB-&H/^G@JAWA[/645V>PR1K8T-ZE^SBHB7#"RPE,=626K
MB'#%2(1K5A'AAM'8IB;#F8K9%<NTRJ'K3:*/!5-[CAZ_;Q]^O=^10\FHYXP8
M4G>M2SZ;BE,M08>"-1@-=)(B5C(C5NO.7[RX"EW#F;]6AW=*/F7YT^N0K:0<
MR1TZ/8BB?Q!JGRE9_N0@*K:20=1G#:+I'X3:D%8L_]8@PJ`P!0L$!3V:H=5E
M8N+?N]>W8H(>%75!8<L>JDMX;N_-8P6*$S_50K1$E"!*$66(<D0%HA)1A:A&
MU"!:!2ATJRE-M%OCL7'KI8\G7)'CN]8A?T&,INK(69BG-&:A2C:P1)0@2A%E
MB')$!:(2486H1M0@6@4H]+:N]\ZN$$PEK7<SBX+`!;1T#3VK!%&**$.4(RH0
ME8@J1#6B!M$J0*$K*4*#P.TY#/R%;\S5^>R05S*8Q]MDY=<,#KU3-(@5[RLI
MH@Q1CJA`5"*J$-6(&D0KAWK*!UJ!%[G4F"N76N17$*WHQVL/+1UZNX80`_&F
M5?:K"&<5#24WR:7E&W6$&+!TZ9`G7?5(U]+RC5I"#%AZ%4B'X4N'WB7A:\R5
MKRT*DIG15&59BZBSXD$M&9%'N[RT)YFQ#<.:`O-.)T]_1`N*"NY1\HB<T<E!
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M3=L*>3B8Z,EB`VF3,9)@SQF)5<'(*D>#@5(NV4#:5(Q$N68D5HU#M%680W`\
M4UOQ*F@2^EX7]:>WO!BK=X?"`T^/8"%6XGNK14'/*'%6(_<\)1Z.U1RFK".-
M,D82MSDCL2J4=#333P!*;%0Q$NF:D4@WH70T'<S4EKD*&H7^U_7S._['0CFV
M2,6^.@<78L7.7C*2.TD<"HX<V#M2;)@QDC#-&8E\<99\B0TK1B)?,Q+YID]^
M-%.'[TH:GK,UF2+X_,.$DE6=#SJDEH<ZQ1=B)=-CM8+E85%PF/1,#S3,4#YG
M)/XK'#HM7V+#BI&_3&`0C<BWF?I4A>B*5=H1A8M$U^?O+!(LRF.+U")1RW0A
M5C(+KJ&X*7%6[RT2:)BA?,Y(Y(NSY$ML6#'R%PD,HA'Y]J@8*!^L6*5G%BXK
M[<TGP51MY%"P%L8#E>TMQ$IFP6H%:\&BT\&:LI;X-V,DP9HS$JO"H=/R)3:L
M&(E\S4CD&Y%OU\)$U8>KH$FX%DS%?<&.9,Q5LF11L!;&`YW>QIV5S()#<A^)
MLWIO+4###.5S1B)?G"5?8L.*D;\68!#-6?(KUFK'%<X%Y>N7S(4Q5W-AD5H1
M*B]<F+J`&I*5S(5%0[G!Q%G1ZULYV,8#%5DI:U'[KB#Q,W-;:K"5])BSO/18
M,+IKT\[)1,50R2HRHQ4C$:Y9180;1BP,^:QS2,^4Z!+>>Y1[_DLJ,Q]ZIGHJ
M^_%`I:<+UY#6ELR4;3BC(D<<KE_H)=SCD*P],Z6?LKYX-&,D7>8.G>ZR.*_+
MDO6ERXJ1=%F?U65S7I<KUN^97E-7^KM?.[V7OFZ*;77JU_P.><_C%XB6B!)$
M*:(,48ZH0%0BJA#5B!I$JP`%&]GPL@J\-0\W,D;AYJ/6[4*LNN6!*$&4(LH0
MY8@*1"6B"E&-J$&T"E#H4EU8>QO1Z?1UB#6V0WYT(EHB2A"EB#)$.:("48FH
M0E0C:A"M`A2Z\K(:>8@U,B/OG9)#_CLEAX)W2O%$U8^)6'$,IX@R1#FB`E'I
M$!5#)!^ZP914W=Y'*_:=,+(5F+_)#2WR7OHL$"T=>OL]D!B(!URY)Y\TR9Q5
M\'$R:=FFO?AY,C%@Z=*A/H>8ZN8"A]AB*'"(JX_H3W?HCN&3)T-K1:<2#VK)
M2%Z.)XA21G)T9HQ$*V<D6@6BDA&>B90#7N0&K,M:!=K/3=7A^4%%_L*9^<D-
MHR";A.2&K=R#3_H`LOYX9\HFOJOL0+WN<K&2<<([LH*M7'?Q9!RK*K=DDQYO
MFC+A@J"R54405!;=T9+PG*F?^)@T7>7TC,0'B4/\0#0:#M53DQ0;98S\&'.]
MB7012D?3Z$Z5"B7K]#C)Y-\7.,FFZX&3'%(AI^9I02^1C9>\&%@RDEM)&-D)
MGT$QF[*!M,D820Z;,Q*K@I%5GO8$DAM@CX],WG^!CVR9$/C(HC"0(OVXQ%0,
M.I`<DAM)G)4+)/ITG7X;G+*.-,H8^8$$TH62IN6F-HZ2=7J<%.3S[Y]IF+@/
M'0H#*5*EZ,*9!8%D6T[EAA.VLM,=C_0SRI0-I$W&R`\D4"[8RBG32X+P0[`E
M&Z"/1D%R_JZ/6O,P.7<H#"3]]FGAK/QCSB':+?GD2QC9&XGB6#VL2%G&<Q$C
M+XY81I0+1IVRFL.297I<%"3;[[L(,^R115Y\+!`M'8IHLL0A+.:^[3.+I["V
M6,KW"728]Z@7S.C>3<H4T7=L)VJ3+`/U(&4TG]"X8`]JS57HV&3:5.1RF.FO
M`2Q<PR!T;,,@=!RBL\C34J=.REJTL796^("*K?R0@AX+9V4.LDYK'*F'*B5K
MO=5CZ%*3Z9Z_K9L'R.I)DD,4:OZ@=*DL5AQIRTY+OGZ4="RV\:$SG91U_-"S
M8_)B/>]D1+KHF),>Z6T]D`Z=9#+F"YQD$VS_[*.#JCWXZ8\W<RKY63BK(.YL
M0WIHRWY+V$I0RLCWBFOH1Q1H%=Q0M$I&/=N2R6`O<(-->`,W.*1.-S43BY$U
M\V9TR4CN,'$H>%@_CE1BFDI#\7S/^H,><VG(GB_Z>X3]RVF=M_Y,)GN!3VWB
M&_C4HO=.0VL5A)9%P9;FD'U0/82]S(G()&0CT,T=\G0+1F0LX1_KG(&USG,<
M65WB.&.NS@*+PHTK5J?T8M19<1@L'8KHH&*6=(QV;>\6(9MP:O2GL^J)1N@S
M[_2ESZ)C89]JUDIG1HEA?Y_A5F<28C\>O>=\Y[]P,,^<M+==IAV<O-[7A-L7
M-0O7,`A3V_#T%U(2US#X5@Q^EH#E_0#NQL5SF3NKTST69_58!CV&GC99=>=I
MVIK_U+/_D:L7O`]M.N0_746T1)0@2A%EB')$!:(2486H1M0@6@4H<"L]#42W
MCBD[O?"+)JU.N&$P"G<QG>F(%0?4$E&"*$64(<H1%8A*1!6B&E&#:!6@T-<F
MZ=<A_*>^UF,F2&T8C$)OZY1)K,3;3DMRF@2M4D09HAQ1@:A$5"&J$36(5@$*
MO6T*`M_;IQ^8CVW]X*<*C$*7ZNQ+K,2E3LMW*:`4&V:(<D0%HA)1A:A&U"!:
M!2AT:5#]T![\CDNQ^AD[%+I4):$+L1*7=@T9)6B5(LH0Y8@*1"6B"E&-J$&T
M"E#H4E-D7!"EMB8)HM2AT*4JRUZ,.ROVWQ)1@BA%E"'*$16(2D05HAI1@V@5
MH-"EIJ#P76HRA3^WS=K2)/"V0X&WARHU7]`OP+7[LVP`2T0)HA11ABA'5"`J
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M=[LC_X_IH/L]ST__%P```/__`P!02P,$%``&``@````A`$8P<X?I"0``*3``
M`!D```!X;"]W;W)K<VAE971S+W-H965T,C,N>&ULK)I;<^(X$X;OMVK_`\7]
M!FQSKB1;$TXVV&"[OL,U0YR$&L`I8"8S_WY;EMJRNK4.;.W-D'EHO6JY6[+4
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M62!HW&*M9T4$XE/C.7O9?-]?TOS#SW:O;Q<(=Q=&)`8V>OXUR<Y;>*(@<^=V
MA=(VWX,#\&_CL!.I`4]D\[/X_-@]7]X>FAZ@K]GY,ML)J69C^_U\R0__EU\6
M(RD;NZJQ!UZKQKV[;K_M.=#7M2(=)0*?2L2Y&W2[G=Z@?[T(6!;#@$\E<KLC
M/:4!GZ4CMPX&IE7A!WR6&C</9JA$X/,?#\:!3)*!%2FE@G=S;!R,L/BC5+EY
M0`XDB'1&9\KM\7$P4\0?I3.W1LC!,(L_2I7;A]3'(<$?2N8?#`GSQ:DFS)5#
M:LFI7*P,D\UE\WA_RC\:L-S"I#V_;\3B[8R$,*X)<B:7J\3?+1*P.@B5+T+F
MH0GM81TXP\KVX['K.?>M'[`:;97-$[<A%F.T$$N/D)U0,*5@1L&<`I^"@((%
M!4L*0@HB"E84K"F(*4@H2"N@!>$I8P3SZ=^(D9`1,<*G^X1`!\TU0S9&"VPR
MH6!*P8R".04^!0$%"PJ6%(041!2L*%A3$%.04)!6@!$06)G^C8`(&9AWL$+5
MS!IE!"^KTJA'HE2:E&%B9,K(C)$Y(SXC`2,+1I:,A(Q$C*P863,2,Y(PDE:)
M$35XSBQJWD!L=?YF!X2+FVA8Q`F?[Y,B[6*E<V@\U+<PG<N0=3T]M0RGH'/F
ME-.]$]L9^[8,G1(-3:<DZ<MMEU@^QXQ,&)DR,F-DSHC/2,#(@I$E(R$C$2,K
M1M:,Q(PDC*158L0`7NY&#.H?O+`V'[PB;KFRCB49]DLRD:1COB$]<R)/2R-,
MM!DC<T9\1@)&%HPL&0D9B1A9,;)F)&8D8225Q/7$`S)B`3ND&V(AK,U82-(M
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MRD@63\0KV+<UHPD92"/B`#D<+6Q*U($E<R"T-:,.1%8'R.!6-B7JP)HY$-N:
M40<2JP-DWJ8VI8H#1KZ)FL8-"5>8FQFGD+$$#<EJ.]9&9<HAJL\Y9=6!W6I-
MTEFU*D.6KR&TTD<['U&M$X'="9IX5BWJQ!*MM!,AHEHG(KL3-/FL6M2)-5II
M)V)$M4XD=B?(GB"U:E6<,#-0'.=I:<7M77'><&0A``Z&F%1/"AGKG]<G$V2L
MK;#A!%'M\*?*BJQ`]+UHU:H,7V6C*F-4%D%K0[H&!'8GR(Q;6+6H$TNTTDZ$
MB&J?1'25$RNK%G5BC5;:B1A1K1/)54ZD5JV*$V8VBEH&S48/5M3ZPXZHY9(W
ML4+&NMBE&X&QMM*I*+5<O:^:*JM.1QZD!R[;4<Q02+>:(]*SW$>DK0*F/73(
M?%GP5DM$6CM$I+4CJNVU7;9@L=&N44AKQXBT=F)JNUYWT"?[G-1H98995#^J
M8?XDO*I84EUI)(*5!@,W%B5Y2((*FB#2?D\YFG$T1Z3E?41:*^!HP=$2D=8*
M$6FMB*,51VM$6BM&I+42CE(#F;&@!:=/8L'+3*(T"`^^>IKE:**065OHD+/2
M5%MA7&<<S3GR.0HX6G"TY"CD*.)HQ=&:HYBCA*-4(4NE0?SR><M4D>4CT,/G
M]U0HD/!(JTK$)LKJDW*#MD+YF4+5@H-"1L5!MZSL)#WR[@ZT%>HON/[2HA_J
MEE5]\EJ.M!7JK[C^VJ(?ZY95?7*P3+05ZJ>&OCGS1'GIAE505J.,T*H"%9QG
M]?;<(W-J+'X6A/D)KT)T:H((OBD;\A.GLL(2A->EITV4T6O/')'NS$=4VUE`
M.NL-R+9V@3*ZLR4BW5F(J+:SB'0VZ)/.5BBC.ULCTIW%B&H[2\S.G$&;9&6*
M,D5G9HK`#NR6%!'FY'PHD;$EYR4)I[32*:(0?-2EB+0B6W*R$YBAO*%5V0.J
M+;GJ4;_<?&M#OB6W.4&3=6'5HDXLT4H[$2(RO*=.1,K*?!)=<DI=6;6H$VNT
MTD[$B&J=2.Q.D$U?:M6J.&&FH"B6W;!*R=J:L4JI<EMUE>(EBM)(9Z!"M4.>
MBNL`D/.D1,$RT*95&;+*0.:$K^3A.%`S#0*K$SP#KW%BB3WJ=29$5.M$9'>"
M9>`U3JRQ1^U$C*C6B<3N!,O`3YPP,U!4U*H9*&Y_7%>BD+4X(QE5>:Y:HK64
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M;%Z+YR5C(>\(RYN`A^STFHVS_?[<V.;?Q?U?V,8\WI=87DY^<LO;R>0;..&.
MIG`8@UE$OO'A&W'RY-_`J7(DSHS\&S@/CL1ICW\#UZ._%'<L2"]/X%AQZ85R
M%ZY3VW0\T+$V\$9I<2.!"G5'<'F$.S3IC9+BF1+[27\T+68+X7Y_!#_]<YVP
M/X*?[3F/^Z/$QJ'B`X^H*$2TRB[@HO;[YC6+-J?7W?'<V&<O$,AV<9'H)*]Z
MR_]<\G<(,-RXSB]P5;OX\PVNY&?P8V7[#M[=+WE^P?^`2ZWRDO_C7P```/__
M`P!02P,$%``&``@````A`*,4X\0'!P``\!L``!D```!X;"]W;W)K<VAE971S
M+W-H965T,C@N>&ULK)E=;Z,X%(;O5]K_$'$_"1"^@IJ,FO#-KK1:S>Y>4T(2
MU"1$0*<S_WZ.L0VV3Z=J5G/3-$^.7^.7%]O`P^=OE_/L:]5V=7-=:\9<UV;5
MM6SV]?6XUO[Y$GWRM%G7%]=]<6ZNU5K[7G7:Y\WOOSV\-NUS=ZJJ?@8*UVZM
MG?K^YB\677FJ+D4W;V[5%7XY-.VEZ.%K>UQTM[8J]D.CRWEAZKJSN!3U5:,*
M?OL1C>9PJ,LJ:,J72W7MJ4A;G8L>CK\[U;>.JUW*C\A=BO;YY?:I;"XWD'BJ
MSW7_?1#59I?23X_7IBV>SC#N;X95E%Q[^(+D+W79-EUSZ.<@MZ`'BL>\6JP6
MH+1YV-<P`F+[K*T.:^W1\'/#TQ:;A\&@?^OJM1/^GW6GYC5NZ_T?];4"M^$\
MD3/PU#3/I#3=$P2-%ZAU-)R!O]K9OCH4+^?^[^8UJ>KCJ8?3;<.(R,#\_?>@
MZDIP%&3FIDV4RN8,!P!_9Y>:1`,<*;ZM-1,ZKO?]::TMG;GMZDL#RF=/5=='
M-9'49N5+US>7_VB1P:2HR)*)P"<3,:RY8>G.'1K0VW`@\,DUYIYM6X[G?OQ`
M'"8"GTS$F9N>;=CW'(G+1.!S/))['5DQ#?@<->X>C0%I&#PA__S_\1C\')-_
MQJ/YX(@6-"]#_(*B+S8/;?,Z@VL:M+I;068(PR?"/'@T)F,4?Y9$B"!1>20R
M:PUF(PA9!Y?/UXWM+A\67R'R):O9XAI#KMCQ"I)O(ANH(%1!I()8!8D*4A5D
M*L@%L`"?1K/@ZOH59A$98A8?YI:#R3U3<897\":!"D(51"J(59"H(%5!IH)<
M`)(S,&7\"F>(#"31DG)DR5YL61%,)V/8'+ED-Y:,?B$2(A(A$B.2()(BDB&2
MBT3R#48J^?;V?,^O,E(]V,.'M64$)LK1"]-5#-N-1;Q9@$B(2(1(C$B"2(I(
MAD@N$LD-.*62&W0RFI.5XWUC2$/9&$I<NL"1N62'2(!(B$B$2(Q(@DB*2(9(
M+A+)!3B9D@OO#YU4RT.GQ'7'^65'B0G3FI`26[YF`M9LFI;"D8C-7+E9-!;Q
M<,6()(BDB&2(Y(RLR#@D@V!%O\,@4BT;1(EH$"6*0<JD$K!F@D&46!.)$(D1
M21!)$<D0R2EQL1OD%D!<P=^/"ZF6W:#$'O:GPZJ[H\2$N5Z(BR>?]P`U"REQ
M]6'Y-W5#6?^C\?<Q*:RCY9C4A!+'&4DZMB*;"E!55L9L_)VKYJ*JE!O8Q=WA
M%*F6G:)D"=.7X,M*]F5'BUQS<,$R7'4;%-`"<PI-R`CD?=*U5/=HD>,.NM[*
M4<Y'S$2FJSY!':4?Z2B3.G)M=37)Q8XD>\GV]@Y_AW+98(9,Z&)RPM,5AUF5
MNQPM5C(1L`HATR%#RRGF$4?&H..:IC*UQ;Q@:I-@Y11791Q19<>UE;DVYP7T
MIE#<8I(]^#TFTJTJ[)AX_+>#`MS_23'UT%:;-G2M8?!*V`*F(8:4HRE@$4,6
MU3!6CG(>8MPFX6B*?\K1I)PIRIZNG)I<:B.GD&Q1/SX?&G1'*QE(D9)"96P[
MUA#V)F1B0@92#2F!%$D)9(CFQ-!M9<F)62="FX0A03G%51E']!I9><KQY?SW
M-P)(]JIW^,>VMF(`*5("J!S!SJ!5KL.O8D<9?,`JI!#21N84E8A5L1`ZNJ5.
MC%QF:I-P)(80*6>RLFU9Z"H6V\@A)%O<.TQD.V+11(J4$*H[>W*G!(L4A)!?
M_@%#0CY"CJ95->+(HW,?OG*IL!0\B@3AE*M,PAE'=)TR=`M=N:*R;!K9$=]A
M&MU`0X=\[%ORQ`SL@.1QM&-("%&`4<C1-)"((;;@FHYN*@F.>2,Q6/0`A-Y2
M7C5)9XKTTC&4V3GGC09IV22R*Q9-(O=()CP>@Y[?W_D9=#\M^461$C(EYCO6
M4#CQ`48A1],X(XY@0R8LY\IE'K,JB)I0I08RX5K36IQR-/68<23WB")(A_W3
M'F7#R<9;-=RPAYO2_E27S]L&!@>KZ1OND]F7/1^CVW?)?(JD:=+0%7=V!JT2
M$A5@%#+D2.-&6TA>M1HN>L]5.XNYLIAHU'_*9=[M+.-5M#-WY2BQRJ7.9,M!
M&5L.S[,A(<3Q+\WM9X[#93!:3E24_25%XE,!>*@_S*#3@X(`HQ"C"*,8HP2C
M%*,,(_*R83HNZ@Y]>4"?WEZJ]ECMJO.YFY7-"WDQ`-':/(QX?&OQ:)*Y4.%;
M\C;C+6[Z\(0/US\N_4<X(/S#=NG#LZTWN.7#4YXWN.W#<X\WN.'Q]ROJH3K^
M=HBCP@/'AQMRK!0Z/MP\8YX[/MQ"8QYZ/MR88IYZ/MQ:`E^,'</[EEMQK/XL
MVF-][6;GZ@"VZ\-$T-(W-O1+S^+YU/3PIF5(Z@G>K%7P$$HG&3XT3<^_D`[&
M=W6;'P```/__`P!02P,$%``&``@````A`'>==RA)"P``FCH``!D```!X;"]W
M;W)K<VAE971S+W-H965T,C4N>&ULK%M=;^.V$GTO</^#X??&UK=M)"DD+?:V
M0`M<7-R/9Z^C),;:5F`YF]U_WT.*%,F963L6\M)M9H;#H^'AX5BF;W_[OM]-
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M^71V?ZL+]+]M\]9Y_S_IGMNW?QZW#W]N#PVJC752*_"E;;^JT#\>E`F#9VST
M9[T"_SI.'IK']>ON]._V[?=F^_1\PG)G>"+U8*N''Y^:;H.*(LU-G*E,FW8'
M`/CO9+]5U$!%UM_UOV_;A]/SW33);[)BGD0(GWQINM/GK4HYG6Q>NU.[_W\?
M%)E4?9+8),&_)DETL\BR-%\42')F8&(&XM^K9Y_U3Z(+\VE]6M_?'MNW"=@&
MK-W+6G$W6B&QK4@/8ZC1STJ$VJ@DI<IR-\4VP=-W6-=O]UE6W,Z^82TV)J;B
M,5$84=L(M82`-V!$I3X`H\JB,*IE5:`K:W"@8P+(1E!`*-0'`%)94/8TJ-HB
MA%"9(#!C*&T>AM1#"(6)S#Y,F>5V"56P1C/4QU@*;^JH(*M:#T%T<B#V)U?$
M*K!9+,/?32V5)\1E+'F`B]2M'H(H+@RCN)0$7$EXE86MW3)<F,H$(?M/UVX(
MH3!1=1_F^;53P6&-C"5<.X*O'H+HY.J\HZ*0:DV\MDXJ4XC,6/#@0U&BQ3RL
M7#T$461+CBR>@X-7+I]*$\(REA`6%:@AB,**<!2QBEW/*IV&TBHGQ:ELU#E>
MN1@&E2C^>69%O29#I)"GETUK"KBUH-+IHA@`(N<7`/0:'``PIOZ$5E)>1[XI
M.#LB2:OG"+^2,3I/2!EK"CF3$"J[*%8(I9W>-KM0"*.T_DH8DU\(WQ06`G3Q
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MY(?PE&1ZRWH!DQ%8OS[&=`&3B0HQN=T38E+"ZF%2)<N3&_59]@(\-9"4S)@N
MP#-1(3S7@(3PE.P2>/TNO8#.R+5?/&.Z@,Y$A>A<5Q"B0RX?W05,*II4S)@N
M8#)1(29W0H68$.5C\O;`M1M492)XC0E+Z-&=G@_Q$$4W:/(QYX-.HY$Y&%GN
M*-1WNC8*5![`4@UV,0SJ1YT/"3\?K`E<&Y!%2X;-#"R8SB7D?#C/.QT=KJ,U
M>2U'8`H8E0B"'XTZC70F@D22_"4]C>Q`+OD)D?P+I3#]M2<+.@$P^:7X:1>>
M*&DE<A0MHS'=ETY%:F&$.]Q=]/BS`X5:*&4EZ!;+4>",1OMU,J80'#T/DR&*
M[2<EK`1<-.*37&($VH=F3#XTO)HG7:L=*-1-Z2N%-NZ%26*DVD=G3"$Z=QQK
ML:KM0`&=(.A17(QH!A,NZ-84@B-*6KLHNJKIQPBZ3J,W@Q/$+'>G;B_H-NJ<
MH+L8!I4(^GFE2+EJ6Y.OVO&<@*Q=%`-`5%MW]5&J>ZTKC^:4M_76%*ZD:Q)Z
MFKDHADY0^3A>CJ!9:B3=VP/6%(*C?8.+8N"(RNO2@0;7EFV0?T>SE"Q@E0[J
M[X+HT>QB&%)R0EQ@F5%\OU3&Y+.,8JS3(8C-CQ)3+8O'O1](5:KPA+*F<!U9
M=<Q`KF6I4FJJM'B6:]?1"#Y6:NB?LIQPO=*3Z9/=13&H)I,^_8.N)R6'PH6%
MY+JO$^CIL49F]YDH838B\A=FXT*>&I-/FWA.^R@717F3$2$_#T!'A]2P)J^/
M"DQ!<3.BQ6H_IW-4YTHBZ#P$AQ'ND**TB;(#.46SCU-IG8J@,\(=HJ-=E!TH
MH)-4>C$?H=(95VEK"L!%M(]R48Q#DDKGV9@#+AN4VFZ>RII"=+2/<E$,G=),
MHCUCWEME1GL]S;:F$!KMHEP4@X:!%%HTKC/(5"K".6,*T9%CK[8#!<Y)HCVB
M<\\&U79K:DPA-"+DM1TH0",BK71$;>UK982K=V9,(3+:L;@HMJ1$T!4R\U[M
M6G!<[#-C"L'1L\U%47#Y56*OHT-*69,G]H$I$/M<$/MQ'TMU)H)$DON(GGMV
M(&=03N3^_+FGHPD`H^A^*7Q36`I!OL=<7QBTVW4V64[(6>4F"GHU=$F4(RZ&
M<400\U'?C^1<RJTI:%8B>D:[*(9-D/*1KV%RKN;6%.XN>D:[*(8.`WTUOT`I
M%4TH94P^I7Q32"E!G9,T'?/6)^<";4V8?N!0'-.6P$6Q6A"!OE`+KL.Y,?FU
M\$UA+031';.]!L5U#YWE9.M4N8DZN[V&&%J8XBH)UM$A2:PIV$,Q;8=<%`,@
MJ/*8=J@P`NRU0]84DH:V0RZ*02.:K,[.D90NC!3[Z(PI1$?;(3N0GQC%QVBX
M3J.7U)$L+:B&VZAS)',QK)!$P\_OOH(+M36%)*/]F8MB`#Y.J-4WDD0GK2E<
M25+"VD4Q=!CH"[7B6:0^WES9H14J#]F=QA1"(Q)2VX$"R015'Z%DQ:#HCF19
M3KJCRD:=)9G)I'4X$-WB*HG7T:161L]#DA&0M1W(OPTKB.I?8/D@[J!#_UY9
M)\#M#TBR=\C1=L1%41[ASCOC49S&8XY@G2HLCS6%5*+MB(L:T/7WZ/OKXOOF
M^-34S6[733;MJ[HCOUCBHO=@-A?XBV15@I1(03P5/#6$1O*D\&A]96,R>#1A
MF">'1YJG+(I5B6>1YBDP1J\^R[:`1]\,9YXE/$LIVV)N?ZM`Q^28!PV-@"#'
M/.A'N*?,EZA;+'C0)6",B*```AS//%M5X'<4.!TE3PR/.$\&;/@T*HS)@``?
M!05/#@3XV"9Y@`"?F20/$.!3$/>4.;@C5@<?1#!&Y$X.[J#-Y]FJ'-Q!BRUY
MP)U<XDZ5`1M>G0EC,B"`L$L>(,`[(\D#!'AE(WF``*]+)`^X@[<5W%.FZ:K$
MVW/NP?<-JQK?)T@>(,";?LD#!&*V,L7^$=<'K\,Q1L)6I>`.WE9+\X`[>&<L
M>#)P!^]W)0^X@W<P@B=!-GR5R#UE.D=UQ/6!I\9W>GQ,E6(>?-DF><`#?-$E
M><`#<9XR`0(16P5/C6LB0K8$"'"50_(``2Y42!X@P&T&R0,>X#*"Y`$/\*V_
MY`$/\)6[Y,%JXQMOR8/5QK?-W%/&J`'N[G`/KEJN:AR/D@<UP$5&R8,:X!:A
MY$$-<(E/\H`A,H((U>EOD1.]+J-L5>)&JI`-GKJ_UT'&5!'J%HEUBU`WW/65
MLJ%NN*HK>8!:1%#FJU)$ANG%V3&Y.#>F%F?&Q%+^,L)*BM6JX*GQZP+I*;"2
MN/8O>;"2N*(O>;"2N"'//?@I8"F/P``AOE)D$>PE#A69^2"Q$%\I,97L2LR5
M?390`;\,?%D_-7^MCT_;0S?9-8_HBN;ZRXIC_]O"_H]3^X*&#+\/;$_X3:#^
MWV?\!K3!#Q?T]RZ/;7NR?Z@)AE^5WO\-``#__P,`4$L#!!0`!@`(````(0!T
M%J6%>0D``%LK```9````>&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;*R:66_C
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MVN\=MO/@]5B=-D][N.^?UGBS1>WF/T3^L-N>JKIZ.0]`;L@;2N_Y=G@[!*6'
MN^<=W`%+>^]4OMSW'ZUY85O]X<-=DZ#_[<J/6OF[5[]5']YI]QSOCB5D&^K$
M*O!45=^8:?#,$#@/B;?;5"`_]9[+E\WW_?D_U8=?[E[?SE#N"=P1N['Y\Z]5
M66\AHR`SL"=,:5OMH0'P;^^P8UT#,K+YV?Q^[)[/;_=]9SJ8S$:.!>:]I[(^
MNSLFV>]MO]?GZO!_;M3<42MB"Q'X_42DP]$1CO`K'&T9O,-O+/S@5_C-!C>3
MR7AZ,X-6=SC"U>9VIZVC90]FUNC6^8WC3#C"[U4MA7'6!(1?X7<[L,:C*<MN
M1SMOA9O%.H1(^=<::K45A3^$JS,8VY/935/2CJ`6UI']T=[EE_)J824M69(O
M9I;U5MX%X8\V:ML%N]H+5>2>LIQ?RJZ%U61_?"F]0SYLFE&XVIPW#W>GZJ,'
M4QLDN7[?L(G2FC,U''^\V>V(O#0@820RE4<F<]^'3@)CK899Y,?#9'IS-_P!
M(W\K;!;4QM(MEFC!ACF379E@;0+7!)X)?!,$)@A-$)D@-D%B@M0$F0ER$Q0*
M&$(UVI)`Y_TG2L)D6$DPF0L$LD:VD7^T0)>5"=8F<$W@F<`W06""T`21"6(3
M)"9(39"9(#=!H0`M_S`5_!/Y9S(PJF`^4<;$K9[QA3""F:,UFNHFR]:DK0HA
M:T)<0CQ"?$("0D)"(D)B0A)"4D(R0G)""I5H-8*L:C7Z?+F`LQ.S;DJ!*5P(
M`O-NFW?;F1F9;XW0;47(FA"7$(\0GY"`D)"0B)"8D(20E)",D)R00B5:YJ&K
M7I%Y9JUG7I!I.R\M"5D1LB;$)<0CQ"<D("0D)"(D)B0A)"4D(R0GI%")EF;H
MF5>DF5GK:1;$EFGF9*P^HVW'>$:O6B/L\FM.;*<5<@7A2VCVF/9:+W4T&5.=
MWQJA=$"D0R(=M5Z*]'BD#]2X-4+IA$BG1#IKO:2T-3)FW[PU0NE"E=9*!JNG
M*TK&K/62<<(6UG).&IM+)&$DA\^*D+4@,UDR0>1BP"->/B$!T0F)3D2\8D(2
MHI,2G8QXY804JHZ6>>C35V2>6>N9Y\2&38N2>7-QQ(T<V-`H1H[>$U?"R&J6
MP'"48!D&ZU8%^Y,KB!RI7FO3$<D71O"$5)HSUIL3M$H8+231HM9&%3*:'7\E
M6M(J8;241,M:FXYHN3"ZF,6B58%(6D^`$E[1$YBUWA,X<>#IIV1UHF=U*8SX
M<42S3Q$$I@;%S2C&FAO9RK`4;I)X1-H7Y*;I4=9T-KDUEBD!T0V);D1T8T$Z
MFYP0Z91(9T0Z%^1RDPM55ZL?.R^XHH"-N5Y!@;3!3*;UI;!RH"%*Q8Q>OQ)6
MX]'%X8PZS2%7LV=U$2D#&E%G-%^/]FFI44B&"Q')<!&BSG`QAH-MJ)("H],F
MJ"4CIHADQ`Q19\0<(_)T6C>SJ64\R0L4XH>&ZJZ8G0M=TS/X[AJV7S@9+1J%
M^S[T#$1+@6!21[1")!<\:T32RD4D<^`ADE8^(JD5())6(2*I%2&25C$BJ94@
MDE8I(JF5(9)6.2*I52!JK/0AR?;)ZA%1]UZ+G;T9DZI`6N*YU6]6H\(1K+`\
M:]2237<1*0M2Z:CT;<=<D4HKE`]02\J'B*1\)!T5>;(JE58HGZ"6E$\12?E,
M.DIY,H7ET@KE"]1JY/4BLIWT%444&V]U]'!D+$^-Y?*2G:-"]6UE?4K1&I%\
M\+F(9*D]1%++IRA`)+5"1%(K0B2U8H'&<J@D:"6U4D12*T,DM7**"D2-EEX+
MMK>^HA9B*Z[6@B/M&6>/S04K.WJ"6OQFQ8I6?+'EP-F^OMI9HX&</UQ$,G4>
MHL[EL8]6T$LN/W,"M)(10T0R8H2H,V*,5IT1$[22$5-$,F*&J#-BCE:7$EJ@
MP2=3+3L.N*)GB-,#M6=P])L%+'MEP4:I[.<K@<:=>5I31U<@1VIYU,I'^3%?
MQEJWMF,LM@+J%5+MB%K%J-W9](0ZIE0^HU8YRE]N>J%YZ6.=G19<45%^N``]
M!.?TA<61,=:-/<!26&D+&>[H=*9E31U=1++G>XCD^/`1.4U%)R-CV@CPNG0)
M$4GA")&TBA%UMCM!*^F8(I+R&2)IE2.ZT.X"KS<N>BW9^<,5M>3'%5HM.3)&
MIW$&MV2OX=B\K>PO$4%)+\^;:V&E#&L7'=712>1]M)HVM9Q9QH8WH,(ANDCA
M")%L=XRHL]T)E4_14<IGB*1\CNA"NPM-6*\E.T%0:\G?>P[86_3SVV[[;5%!
MHF$/\<EBE_4<\=:3GT-H)>9(&ZYD[;:TN-681<,7IO;8F!%7:,5O[[-',Y=1
M1KTK?!PY"#R4Z0SFHQ4/9MFC\=CHF`%JR]$4(I+A(A3J#!>C%71&)0-D]TEN
M,*41,]3JC)BC%=Z@,[DQ;K!`[4_&/NQL._O+7]7[I?X"2^:VPS`9X[Q"(-FM
MEQ9!*XK6%+D4>13Y%`44A11%%,44)12E%&44Y105&M(&L'W=05%CKB<>D9)X
MBE84K2ER*?(H\BD**`HIBBB**4HH2BG**,HI*C2D)_ZZ<QB;GL,@4A,OK"1:
M4:LU12Y%'D4^10%%(44113%%"44I11E%.47L6[MFAF@RP1//OYWC7^T<RM-K
MN2SW^[JWK;ZS[^)@SGJX:W'[T=YC,R,;?`$?\S7G#":WX2,_MN0T^*,S?X0&
MT0L+9UXTAPR&PV(\+YJUJ\DG\Z*Y(Y-;M]"BYD#.O&*/H$W-1$RNM)\D&E>6
MTSF\P*2M]:9S>/M(>32=PZM#RK/I'-[[4;ZT[/D*SECH%0^N^)]>@;.B>?SI
M%3CFF;-#'%`;MC<"GS:^;U[+9'-ZW1WKWKY\@1*/FF7)B7\<R?]S%H^;I^H,
M'S4V3YXW^(BUA+>QHP$\!U^JZHS_80':SV(?_@8``/__`P!02P,$%``&``@`
M```A`'IW8_*-`@``NP8``!D```!X;"]W;W)K<VAE971S+W-H965T,C0N>&UL
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M$U!0H(DF*3()4T,"<"5:86=`0?AS=S^HW%?PM(R263P'--E)Y^\5,E(B]LX;
M_:?']$R!8])SP+WGF,ZC=!%/D[=)6,BGLW?'/=^LK#D0:!F0="W'!DPR(#[O
M!XP@=HO@-866AEP=[,'3)DUG*_8$A1,]YC9@X#I@D@'!0'10!K7+E1&,REA9
M3.4V!,8RD_,RT_?((!@J,1ME?^HP@,:8^7EI@%SN$,&=]&`Q1&9=7XX+!QUS
M.2V"CVG["+@8=BA-T_,.YN^10O"Q5(B<.E@<T^)A6BSPX+S1?[CN6*&/0#>,
MS/QG.W`47]SJ"#Z6"I&1F3`LPFG2TI;RDZQK1X39XR"8P/D8HL.,VDYP._^-
M3[-MU]IL^`"SH^6E_,9MJ1I':ED`91PMH$0V3)_PXDT+6<((,1[&1O=8P4]"
MPA&)(P`7QOC7%Q!FPV]G\Q<``/__`P!02P,$%``&``@````A`)V_'SPQ`0``
M0`(``!$`"`%D;V-0<F]P<R]C;W)E+GAM;""B!`$HH``!````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M`````````````````````````)R104_#(!B&[R;^AX9["ZQ&#6E9HF8GEY@X
MH_&&\&TC%DH`[?;OI5U79_3DD;PO#\_W4<UWILD^P0?=VAK1@J`,K&R5MIL:
M/:T6^37*0A16B::U4*,]!#3GYV>5=$RV'AY\Z\!'#2%+)!N8=#7:QN@8QD%N
MP8A0I(9-X;KU1L1T]!OLA'P7&\`S0BZQ@2B4B`+WP-Q-1#0BE9R0[L,W`T!)
M#`T8L#%@6E#\W8W@3?CSPI"<-(V.>Y=F&G5/V4H>PJF]"WHJ=EU7=.6@D?PI
M?EG>/PZCYMKVNY*`>+^?1H2X3*M<:U`W>[Y[\TT6PK;"O[-*R<&.20\B@LK2
M>^Q@=TR>R]N[U0+Q&:$7.2ES2E8SPN@5H^5KA8^M\3Z?@&84^#?Q"."#]\\_
MYU\```#__P,`4$L#!!0`!@`(````(0"^(-\=@`0``"P/```0``@!9&]C4')O
M<',O87!P+GAM;""B!`$HH``!````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M`````)Q76V_J.!!^7VG_`\K[*;1;5:LJY(@"52NU"UMHSZ-ED@E8=>P<VV%)
M?_V.DT*3,N1<WG*9;V[^YN+PZRZ3O2T8*[0:!N=G@Z`'*M:)4.MA\+R\_?)W
MT+..JX1+K6`8E&"#K]&??X1SHW,P3H#MH0IEA\'&N?RZW[?Q!C)NS_"WPC^I
M-AEW^&K6?9VF(H:)CHL,E.M?#`97?=@Y4`DD7_*#PJ#6>+UUOZLTT;'WS[XL
MRQP=CL)1GDL1<X=11H\B-MKJU/6FNQADV&_^#-&[!<2%$:Z,!F&_^1HN8BYA
MC(JCE$L+8?_C0W@'W"=MSH6Q4;AUUUN(G38]*]XP;1=!;\4M>'>&P98;P95#
MM[Q8_5(]R]PZ$WW3YM5N`)P-^RA0?ZP>F[+-9W$975U6$OC4EO0::D_P1]O'
MI7`2["R=<^,(EZ\NFSY77M0>UP[M3Y$A-]A4.<P7NU?U:0O=]/P0PU@KJZ5(
MN(.$W7#)50QL<13IS\BS.?^QB85#2YYIENF4S7(\L(-NG_HZD)97;<A89[\*
M6;B?B+UA99:R,6\=],&QF5ES)=XJTI)N+(HLXZ;TP2W$6@DL+J05&\6Q+I0C
M(;=(3_;"90'L$;@M3)T?4A;]VGCG-FSZO1!;I+[/I#_N1VY>2<A[4RAK4B`J
M]^DG1>\5=I6U6$E@(VL_D?V0@W%A#&KP,9D"6?,@^$I(X=L.J7519OE&JY)-
M2L4SC8R,23D\V4RXFAL^(B2!P^K%UG=*\UA+R5?:X'%L@3V!!6[B#9O`%J3.
M22/_@&,/VEHV!X,\YX8FX-Q`"AAFPI`\\2OZDF5:O;_0-/<'@O4VQQ*J3Z1"
MWF"'\:&0SDRS7.H2@-V`@E2X"DQ*8LYT!FS)=Z>2#!)[&YKZM\#6`4:6[%8H
MK&;!)9N0.A?%RL+WPA_E=.MY=$*JB]#G).8$H]%]I!9MIIO8M!F:V9U63E,7
M860LG:QD)R`D+3VGD9HDY)B676%TLY-.5C<]:4R3=5W^+#K)1^ON;I079)8:
MO+H38'RQEPS'6TUU$M(P0U#L1Y!1IG&=>JLJV+JJ@Y(00G6C+=/!(+%R7-^P
M^G!6'%&9-',D5;5R-DH2[+YTBSEJZ7MIA7WAGK32<NRHV9,0HL4W[)"0V\+A
MI&./0HFLR'!W*.O._XR+ISE55QT#@M$TZQX1-*;!F2<<)0H'\Q/$&J>Y9P(9
MC<]9@:L-[K+^.+'KB[BBRT3(@AZVW45,<^8;-P;7"<ONK?6CUVDV+[`*<,B<
MG#&=8XDV,\NK0$8QSE4_TXKJ3.I).,?E_+`*?&QLK9SAQBRJ851#GA4)^:CF
M>D@VEQ_&24AKI&9XF;%URJ<[_TQ"VFQN;KN^NY&0B4AQ^./>`6P%[C\`A<D]
MK,DDI&5ELM\=<%Q7BQ0):377]Q*NBK):V$E(=Y^ES_+SE&_4)6YB33.M:\FG
MB\B#4*_V.5_J":[O^YM6^V-8;5,)WD'V_S\^A'=XR3+2*QEO<,6$9"]S_,/?
M"U_JRV]T?GDV^&N`5[[&M[#_W@9Q*XS^!P``__\#`%!+`0(M`!0`!@`(````
M(0#JK5)2/0(``#\F```3``````````````````````!;0V]N=&5N=%]4>7!E
M<UTN>&UL4$L!`BT`%``&``@````A`+55,"/U````3`(```L`````````````
M````=@0``%]R96QS+RYR96QS4$L!`BT`%``&``@````A`(W\H2^#`@``WB4`
M`!H`````````````````G`<``'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS
M4$L!`BT`%``&``@````A`!?JF[:U!0``9A,```\`````````````````7PL`
M`'AL+W=O<FMB;V]K+GAM;%!+`0(M`!0`!@`(````(0`B/P9!.`4``$D4```8
M`````````````````$$1``!X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"
M+0`4``8`"````"$`2%_#+]P"``#\!P``&0````````````````"O%@``>&PO
M=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+`0(M`!0`!@`(````(0`?)^X$.P<`
M`/HN```9`````````````````,(9``!X;"]W;W)K<VAE971S+W-H965T-#@N
M>&UL4$L!`BT`%``&``@````A`%`US'J@"@``+4P``!D`````````````````
M-"$``'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q02P$"+0`4``8`"````"$`
M>\U=ZH<&``!:(0``&0`````````````````++```>&PO=V]R:W-H965T<R]S
M:&5E=#4P+GAM;%!+`0(M`!0`!@`(````(0#9*'+V(0<``'8I```9````````
M`````````,DR``!X;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L!`BT`%``&
M``@````A`)_N@^[K$P``L*\``!D`````````````````(3H``'AL+W=O<FMS
M:&5E=',O<VAE970U,BYX;6Q02P$"+0`4``8`"````"$`*S0H.O@*``")4P``
M&0````````````````!#3@``>&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+
M`0(M`!0`!@`(````(0#Y/F_.^0(``#((```9`````````````````')9``!X
M;"]W;W)K<VAE971S+W-H965T-#4N>&UL4$L!`BT`%``&``@````A`'$@#Y@D
M`P``X`H``!D`````````````````HEP``'AL+W=O<FMS:&5E=',O<VAE970T
M-"YX;6Q02P$"+0`4``8`"````"$`]L6'4Q@&```5'@``&0``````````````
M``#]7P``>&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+`0(M`!0`!@`(````
M(0#Y?-.]Z`(``"\(```9`````````````````$QF``!X;"]W;W)K<VAE971S
M+W-H965T-#`N>&UL4$L!`BT`%``&``@````A`%Q50GV-`@``608``!D`````
M````````````:VD``'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"+0`4
M``8`"````"$`A6;R]8`%``!`&P``&0`````````````````O;```>&PO=V]R
M:W-H965T<R]S:&5E=#0R+GAM;%!+`0(M`!0`!@`(````(0#$7X5CE@(``%H&
M```9`````````````````.9Q``!X;"]W;W)K<VAE971S+W-H965T-#,N>&UL
M4$L!`BT`%``&``@````A`">N0[%J!```#A,``!D`````````````````LW0`
M`'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"+0`4``8`"````"$`<8!J
ME;L-``!^;@``&0````````````````!4>0``>&PO=V]R:W-H965T<R]S:&5E
M=#4T+GAM;%!+`0(M`!0`!@`(````(0"D1TU3A`0``,H3```9````````````
M`````$:'``!X;"]W;W)K<VAE971S+W-H965T-34N>&UL4$L!`BT`%``&``@`
M```A``<]/(X>`P``00D``!D``````````````````8P``'AL+W=O<FMS:&5E
M=',O<VAE970V-"YX;6Q02P$"+0`4``8`"````"$`^V*E;90&``"G&P``$P``
M``````````````!6CP``>&PO=&AE;64O=&AE;64Q+GAM;%!+`0(M`!0`!@`(
M````(0`"KK\_@0\``(N;```-`````````````````!N6``!X;"]S='EL97,N
M>&UL4$L!`BT`%``&``@````A`+3W!BDWCP``P=`!`!0`````````````````
MQZ4``'AL+W-H87)E9%-T<FEN9W,N>&UL4$L!`BT`%``&``@````A`-G7F;Y^
M`P``1PP``!@`````````````````,#4!`'AL+W=O<FMS:&5E=',O<VAE970S
M+GAM;%!+`0(M`!0`!@`(````(0!VJ9?4G@4``(\7```8````````````````
M`.0X`0!X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"+0`4``8`"````"$`
M&'WVHM8$``#D$@``&0````````````````"X/@$`>&PO=V]R:W-H965T<R]S
M:&5E=#8S+GAM;%!+`0(M`!0`!@`(````(0#`1')`(P8``#TA```9````````
M`````````,5#`0!X;"]W;W)K<VAE971S+W-H965T-C(N>&UL4$L!`BT`%``&
M``@````A``A47N'M`P``K`T``!D`````````````````'TH!`'AL+W=O<FMS
M:&5E=',O<VAE970V,2YX;6Q02P$"+0`4``8`"````"$`JH-L+^,#``#$#@``
M&0````````````````!#3@$`>&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+
M`0(M`!0`!@`(````(0"[/:T1"@0``,8.```9`````````````````%U2`0!X
M;"]W;W)K<VAE971S+W-H965T-3<N>&UL4$L!`BT`%``&``@````A`+,Z&60"
M!```90\``!D`````````````````GE8!`'AL+W=O<FMS:&5E=',O<VAE970U
M."YX;6Q02P$"+0`4``8`"````"$`L7#/K^@"``#.!P``&0``````````````
M``#76@$`>&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+`0(M`!0`!@`(````
M(0`:<+'G_0,``'X.```9`````````````````/9=`0!X;"]W;W)K<VAE971S
M+W-H965T-C`N>&UL4$L!`BT`%``&``@````A`('FR;9B!```B!$``!@`````
M````````````*F(!`'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+`0(M`!0`
M!@`(````(0"%CKKI&P4``-\8```9`````````````````,)F`0!X;"]W;W)K
M<VAE971S+W-H965T,S@N>&UL4$L!`BT`%``&``@````A`*X<8YN["0``1"\`
M`!D`````````````````%&P!`'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q0
M2P$"+0`4``8`"````"$`DB[I)K,"```&!P``&0`````````````````&=@$`
M>&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+`0(M`!0`!@`(````(0#6(YC/
MIP4``$45```9`````````````````/!X`0!X;"]W;W)K<VAE971S+W-H965T
M,30N>&UL4$L!`BT`%``&``@````A`.B9*54'!```:@X``!D`````````````
M````SGX!`'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"+0`4``8`"```
M`"$`TJQY$F(&``"$&@``&0`````````````````,@P$`>&PO=V]R:W-H965T
M<R]S:&5E=#$V+GAM;%!+`0(M`!0`!@`(````(0"A`.HNZ1$``*QE```9````
M`````````````*6)`0!X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L!`BT`
M%``&``@````A`"Z<W_A""P``1S4``!D`````````````````Q9L!`'AL+W=O
M<FMS:&5E=',O<VAE970Q."YX;6Q02P$"+0`4``8`"````"$`\8EMH<D'``"W
M'P``&0`````````````````^IP$`>&PO=V]R:W-H965T<R]S:&5E=#$R+GAM
M;%!+`0(M`!0`!@`(````(0#JUV&V%@\``%9*```9`````````````````#ZO
M`0!X;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L!`BT`%``&``@````A`%N#
M1N2H"P``WCD``!D`````````````````B[X!`'AL+W=O<FMS:&5E=',O<VAE
M970Q,"YX;6Q02P$"+0`4``8`"````"$`=5?`X2H#```W"0``&```````````
M``````!JR@$`>&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L!`BT`%``&``@`
M```A`,T_A'V+"0``*3D``!@`````````````````RLT!`'AL+W=O<FMS:&5E
M=',O<VAE970V+GAM;%!+`0(M`!0`!@`(````(0#HY>?CG@<``#`B```8````
M`````````````(O7`0!X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"+0`4
M``8`"````"$`L<A3DI$#``"9"P``&`````````````````!?WP$`>&PO=V]R
M:W-H965T<R]S:&5E=#@N>&UL4$L!`BT`%``&``@````A`)C^A2MH"0``*3``
M`!@`````````````````)N,!`'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+
M`0(M`!0`!@`(````(0`G\X'<>00``(X2```9`````````````````,3L`0!X
M;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L!`BT`%``&``@````A`'Z\A$!R
M$```JV,``!D`````````````````=/$!`'AL+W=O<FMS:&5E=',O<VAE970Q
M.2YX;6Q02P$"+0`4``8`"````"$`7P+B&;8"```%!P``&0``````````````
M```=`@(`>&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+`0(M`!0`!@`(````
M(0"38&Y`V`0``#H1```9``````````````````H%`@!X;"]W;W)K<VAE971S
M+W-H965T,S`N>&UL4$L!`BT`%``&``@````A`'4J_(IX"P``/SD``!D`````
M````````````&0H"`'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"+0`4
M``8`"````"$``59^74X*``#;+P``&0````````````````#(%0(`>&PO=V]R
M:W-H965T<R]S:&5E=#,R+GAM;%!+`0(M`!0`!@`(````(0"PUVLQ3@@``#`D
M```9`````````````````$T@`@!X;"]W;W)K<VAE971S+W-H965T,S,N>&UL
M4$L!`BT`%``&``@````A`%M4\9F!&0``8Y$``!D`````````````````TB@"
M`'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"+0`4``8`"````"$`**%X
M!ZD/```83@``&0````````````````"*0@(`>&PO=V]R:W-H965T<R]S:&5E
M=#,U+GAM;%!+`0(M`!0`!@`(````(0#TNP.#FB4``$+P```9````````````
M`````&I2`@!X;"]W;W)K<VAE971S+W-H965T,C`N>&UL4$L!`BT`%``&``@`
M```A`$!T.QR;!0``L!0``!D`````````````````.W@"`'AL+W=O<FMS:&5E
M=',O<VAE970R.2YX;6Q02P$"+0`4``8`"````"$`!DO(-FX.``!H1@``&0``
M```````````````-?@(`>&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+`0(M
M`!0`!@`(````(0!N1I`JBQ```!14```9`````````````````+*,`@!X;"]W
M;W)K<VAE971S+W-H965T,C(N>&UL4$L!`BT`%``&``@````A`$8P<X?I"0``
M*3```!D`````````````````=)T"`'AL+W=O<FMS:&5E=',O<VAE970R,RYX
M;6Q02P$"+0`4``8`"````"$`HQ3CQ`<'``#P&P``&0````````````````"4
MIP(`>&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+`0(M`!0`!@`(````(0!W
MG7<H20L``)HZ```9`````````````````-*N`@!X;"]W;W)K<VAE971S+W-H
M965T,C4N>&UL4$L!`BT`%``&``@````A`'06I85Y"0``6RL``!D`````````
M````````4KH"`'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"+0`4``8`
M"````"$`>G=C\HT"``"[!@``&0`````````````````"Q`(`>&PO=V]R:W-H
M965T<R]S:&5E=#(T+GAM;%!+`0(M`!0`!@`(````(0"=OQ\\,0$``$`"```1
M`````````````````,;&`@!D;V-0<F]P<R]C;W)E+GAM;%!+`0(M`!0`!@`(
M````(0"^(-\=@`0``"P/```0`````````````````"[)`@!D;V-0<F]P<R]A
<<'`N>&UL4$L%!@````!)`$D`\1,``.3.`@``````
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EXCAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Option Activity under Stock Plans (Detail) (USD $)<br>In Thousands, except Share data, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Options Outstanding</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance</a></td>
        <td class="nump">13,806,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Options granted</a></td>
        <td class="nump">5,614,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised</a></td>
        <td class="num">(131,000)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance</a></td>
        <td class="nump">15,765,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested and expected to vest at end of period</a></td>
        <td class="nump">15,765,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at end of period</a></td>
        <td class="nump">10,628,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Price Per Share</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice', window );">Beginning balance</a></td>
        <td class="nump">$ 3.38<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted</a></td>
        <td class="nump">$ 2.69<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options exercised</a></td>
        <td class="nump">$ 1.43<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice', window );">Ending balance</a></td>
        <td class="nump">$ 3.17<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Vested and expected to vest at end of period</a></td>
        <td class="nump">$ 3.17<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable at end of period</a></td>
        <td class="nump">$ 3.36<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract', window );"><strong>Weighted Average Remaining Contractual Life (In years)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Balance at December 31, 2013</a></td>
        <td class="text">5 years 3 months 4 days<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Outstanding options vested and expected to vest at end of period</a></td>
        <td class="text">5 years 3 months 4 days<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Options exercisable at end of period</a></td>
        <td class="text">3 years 7 months 10 days<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Balance at December 31, 2013</a></td>
        <td class="nump">$ 1,427<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Outstanding options (vested and expected to vest) at end of period</a></td>
        <td class="nump">1,427<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Options exercisable at end of period</a></td>
        <td class="nump">$ 1,289<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Unvested</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Options Outstanding</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Options cancelled</a></td>
        <td class="num">(2,555,000)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Price Per Share</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Options cancelled</a></td>
        <td class="nump">$ 3.31<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Vested</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Options Outstanding</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Options cancelled</a></td>
        <td class="num">(969,000)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Price Per Share</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Options cancelled</a></td>
        <td class="nump">$ 3.34<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Share based compensation arrangement by share based payment award options and equity instruments other than options nonvested weighted average price.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Net number of share options (or share units) granted during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of options outstanding, including both vested and non-vested options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(i)-(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>As of the balance sheet date, the weighted-average exercise price (at which grantees can acquire the shares reserved for issuance) for exercisable stock options that are fully vested or expected to vest.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount by which the current fair value of the underlying stock exceeds the exercise price of fully vested and expected to vest options outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>As of the balance sheet date, the number of shares into which fully vested and expected to vest stock options outstanding can be converted under the option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of share options (or share units) exercised during the current period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28,29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EJKBK">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Symphony Dynamo, Inc. - Additional Information (Detail) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="8">1 Months Ended</th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="3">12 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="2">12 Months Ended</th>
        <th class="th" colspan="2">1 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="2"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Oct. 31, 2013</div>
        </th>
        <th class="th">
          <div>May 09, 2012</div>
        </th>
        <th class="th">
          <div>Nov. 03, 2011</div>
        </th>
        <th class="th">
          <div>Nov. 02, 2010</div>
        </th>
        <th class="th">
          <div>Apr. 30, 2010</div>
        </th>
        <th class="th">
          <div>Apr. 16, 2010</div>
        </th>
        <th class="th">
          <div>Nov. 30, 2009</div>
        </th>
        <th class="th">
          <div>Apr. 18, 2006</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2010</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010</div>
        </th>
        <th class="th">
          <div>Apr. 30, 2007</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011

</div>
          <div>Fair Value, Inputs, Level 3</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010

</div>
          <div>Fair Value, Inputs, Level 3</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2010

</div>
          <div>Warrant Liability</div>
        </th>
        <th class="th">
          <div>Apr. 18, 2006

</div>
          <div>Maximum</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>SDI</div>
        </th>
        <th class="th">
          <div>Apr. 18, 2006

</div>
          <div>SDI</div>
        </th>
        <th class="th">
          <div>Apr. 18, 2006

</div>
          <div>Holdings</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems', window );"><strong>Business Acquisition Equity Interests Issued Or Issuable [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in SDI</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 50,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership percentage by parent</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">100.00%<span></span></td>
        <td class="nump">100.00%<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_IssueOfWarrantsToPurchaseSharesOfCommonStock', window );">Warrants issued to purchase common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">7,038,210<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_WarrantsExercisablePeriod', window );">Warrants exercisable period</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">5 years<span></span></td>
        <td class="text">5 years<span></span></td>
        <td class="text">5 years<span></span></td>
        <td class="text">5 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights', window );">Warrants exercise price</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1.50<span></span></td>
        <td class="nump">1.50<span></span></td>
        <td class="nump">1.94<span></span></td>
        <td class="nump">7.32<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1.96<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitment', window );">Warrant exercised</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">15,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Common stock issue on acquisition</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">13,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Issued note to Holdings, principal amount</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">15,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubordinatedBorrowingDueDate', window );">Principal amount, due date</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">Dec. 31,
				 2012<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_BusinessAcquisitionContingentConsiderationPercentage', window );">Business acquisition contingent consideration percentage</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">50.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Business acquisition upfront payment</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">50,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueInputsDiscountRate', window );">Net present value model, discount rate</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">17.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of note payable</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">15,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs (in shares)</a></td>
        <td class="nump">79,570,000<span></span></td>
        <td class="nump">17,500,000<span></span></td>
        <td class="nump">27,600,000<span></span></td>
        <td class="nump">26,450,000<span></span></td>
        <td class="nump">1,076,420<span></span></td>
        <td class="nump">30,293,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Non operating income expense</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">11,100,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueAdjustment', window );">Changes in warrant and contingent consideration liability</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">800,000<span></span></td>
        <td class="nump">2,200,000<span></span></td>
        <td class="nump">9,500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Increase in additional paid in capital</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,600,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_ReclassificationOfWarrantLiabilitiesToEquity', window );">Reclassification of warranty liability into equity</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">12,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">10,913,873<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">6,765,128<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MalpracticeLossContingencyDiscountRate', window );">Cash flows discounted rate</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">16.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Estimated fair value of contingent liability</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_BusinessAcquisitionContingentConsiderationPercentage">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Business Acquisition Contingent Consideration Percentage</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_BusinessAcquisitionContingentConsiderationPercentage</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_IssueOfWarrantsToPurchaseSharesOfCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Issue Of Warrants To Purchase Shares Of Common Stock</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_IssueOfWarrantsToPurchaseSharesOfCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_ReclassificationOfWarrantLiabilitiesToEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Reclassification Of Warrant Liabilities To Equity</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_ReclassificationOfWarrantLiabilitiesToEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_WarrantsExercisablePeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrants Exercisable Period</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_WarrantsExercisablePeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 31<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 470<br><br> -SubTopic 20<br><br> -Section 25<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28183637&amp;loc=d3e4724-112606<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Warrant<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6528364<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of liability recognized arising from contingent consideration in a business combination.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 805<br><br> -SubTopic 30<br><br> -Section 35<br><br> -Paragraph 1<br><br> -Subparagraph b<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6911338&amp;loc=d3e6819-128478<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 805<br><br> -SubTopic 30<br><br> -Section 25<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BusinessCombinationContingentConsiderationLiability</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Exercise price per share or per unit of warrants or rights outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(i)(4))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph i<br><br> -Subparagraph 4<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>us-types:perUnitItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of warrants or rights outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(i))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph i<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfWarrantOrRightOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face (par) amount of debt instrument at time of issuance.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 835<br><br> -SubTopic 30<br><br> -Section 45<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28551-108399<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 835<br><br> -SubTopic 30<br><br> -Section 55<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6584090&amp;loc=d3e28878-108400<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtInstrumentFaceAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.12)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 323<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=16385135&amp;loc=d3e33749-111570<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EquityMethodInvestments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueInputsDiscountRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Interest rate used to find the present value of an amount to be paid or received in the future as an input to measure fair value.  For example, but not limited to, weighted average cost of capital (WACC), cost of capital, cost of equity and cost of debt.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (bbb)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25499696&amp;loc=d3e19207-110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueInputsDiscountRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueAdjustment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of addition (reduction) to the amount at which a liability could be incurred (settled) in a current transaction between willing parties.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesFairValueAdjustment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MalpracticeLossContingencyDiscountRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The interest rate used to discount the estimated cash flows associated with the payment of malpractice claims.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 954<br><br> -SubTopic 450<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6052-115624<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_MalpracticeLossContingencyDiscountRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_MinorityInterestOwnershipPercentageByParent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.7)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 7<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NonoperatingIncomeExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherCommitment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 13<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3213-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsToAcquireBusinessesGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 15<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3291-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RepaymentsOfNotesPayable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of stock issued during the period pursuant to acquisitions.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28,29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesAcquisitions</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of new stock issued during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesNewIssues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubordinatedBorrowingDueDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Date the payments are due on subordinated debt, in CCYY-MM-DD format.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SubordinatedBorrowingDueDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Preferred Stock, Common Stock and Warrants (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Warrants Issued to Purchase Common Stock</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In connection with a 2007 loan agreement that was subsequently terminated in 2008, we issued warrants to purchase up to 3,550,000</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shares of our common stock as follows: </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:39%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Warrant Issuance Date</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Shares Issuable <br />(in thousands)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Expiration <br />Date</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price <br />per Share</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding as of <br />December 31, 2013 <br />(in thousands)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:39%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">July 18, 2007</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,250</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2/26/2014</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.13</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:15%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,250</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:39%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">October 18, 2007</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,300</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2/26/2014</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.68</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:15%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:39%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December 27, 2007</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">300</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2/26/2014</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.65</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:15%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">300</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:39%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December 27, 2007</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">700</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:12%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2/26/2014</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:12%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.68</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:15%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:39%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,550</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:12%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:12%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:15%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,550</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:6pt;;">&nbsp;</p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(i))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph i<br><br> -Article 4<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 50<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6406099&amp;loc=d3e25284-112666<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 50<br><br> -Section S99<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6784392&amp;loc=d3e188667-122775<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 28<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	word-wrap: break-word;
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E6XAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Fair Value-Based Measurements and Weighted-Average Assumptions (Detail) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Employee Stock Purchase Plan</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average fair value</a></td>
        <td class="nump">$ 0.93<span></span></td>
        <td class="nump">$ 3.54<span></span></td>
        <td class="nump">$ 2.09<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
        <td class="nump">0.20%<span></span></td>
        <td class="nump">0.20%<span></span></td>
        <td class="nump">0.30%<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in year)</a></td>
        <td class="text">1 year 3 months 18 days<span></span></td>
        <td class="text">1 year 1 month 6 days<span></span></td>
        <td class="text">1 year 2 months 12 days<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility</a></td>
        <td class="nump">0.80%<span></span></td>
        <td class="nump">1.60%<span></span></td>
        <td class="nump">1.60%<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Stock Options</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average fair value</a></td>
        <td class="nump">$ 2.41<span></span></td>
        <td class="nump">$ 3.30<span></span></td>
        <td class="nump">$ 2.76<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
        <td class="nump">1.10%<span></span></td>
        <td class="nump">0.50%<span></span></td>
        <td class="nump">1.30%<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in year)</a></td>
        <td class="text">5 years 10 months 24 days<span></span></td>
        <td class="text">4 years 2 months 12 days<span></span></td>
        <td class="text">4 years<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility</a></td>
        <td class="nump">1.40%<span></span></td>
        <td class="nump">1.60%<span></span></td>
        <td class="nump">1.60%<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 14.D.2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br> -Section D<br><br> -Subsection 2<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(iv)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (d)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EVMAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Basis of Presentation </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The consolidated financial statements include our accounts and those of our wholly-owned subsidiaries. All significant intercompany accounts and transactions among the entities have been eliminated from the consolidated financial statements. </font></p></div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiquidityDisclosureTextBlock', window );">Liquidity and Financial Condition</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Liquidity and Financial Condition </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We have incurred significant operating losses and negative cash flows from operations since our inception. As of December&#160;31, 2013, we had cash, cash equivalents and marketable securities of $189.4</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million. We currently estimate that we have sufficient cash resources to meet our anticipated cash needs through at least the next 12 months based on cash, cash equivalents and marketable securities on hand as of December&#160;31, 2013 and anticipated revenues and funding from existing agreements.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We expect to continue to spend substantial funds in connection with the development and manufacturing of our product candidates, particularly HEPLISAV-B</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, human clinical trials for our product candidates and additional applications and advancement of our technology. In order to continue these activities, we may need to raise additional funds. This may occur through strategic alliance and licensing arrangements and/or future public or private financings. Sufficient additional funding may not be available on acceptable terms, or at all. If adequate funds are not available in the future, we may need to delay, reduce the scope of or put on hold the HEPLISAV-B program or our other development programs while we seek strategic alternatives.</font></p></div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The preparation of financial statements in conformity with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) requires management to make informed </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results may differ materially from these estimates.</font></p></div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Foreign Currency Translation</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We consider the local currency to be the functional currency for our international subsidiary, Rhein</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. Accordingly, assets and liabilities denominated in foreign currencies are translated into U.S. dollars using the exchange rate in effect on the balance sheet date. Revenues and expenses are translated at average exchange rates prevailing throughout the year. Currency translation adjustments arising from period to period are charged or credited to accumulated other comprehensive income (loss) in the equity. For the years ended December&#160;31, 2013, 2012 and 2011, we reported an unrealized gain of $0.5 million, an unrealized gain of $0.4 million and an unrealized loss of $0.3 million, respectively. Realized gains and losses resulting from currency transactions are included in the consolidated statements of operations. For the years ended December&#160;31, 2013, 2012 and 2011, we reported a loss of $0.2 million, a loss of $0.2 million and a gain of $0.2 million, respectively, resulting from currency transactions in our consolidated statements of operations. </font></p></div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Cash, Cash Equivalents, and Marketable Securities</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cash, Cash Equivalents and Marketable Securities </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We consider all highly liquid investments purchased with an original maturity of three</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> months or less and that can be liquidated without prior notice or penalty, to be cash equivalents. Management determines the appropriate classification of marketable securities at the time of purchase. We invest in short-term money market funds, U.S. government agency securities, U.S. treasury securities and municipal securities. We believe these types of investments are subject to minimal credit and market risk. We do not invest in auction rate securities or securities collateralized by home mortgages, mortgage bank debt, or home equity loans. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We have classified our entire investment portfolio as available-for-sale a</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">nd available for use in current operations and accordingly have classified all investments as short-term. Available-for-sale securities are carried at fair value based on inputs that are observable, either directly or indirectly, such as quoted market prices for similar securities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the securities, with unrealized gains and losses included in accumulated other comprehensive income (loss) in stockholders&#8217; equity. Realized gains and losses and declines in value, if any, judged to be other than temporary on available-for-sale securities are included in interest income or expense. The cost of securities sold is based on the specific identification method. Management assesses whether declines in the fair value of investment securities are other than temporary. In determining whether a decline is other than temporary, management considers the following factors: </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-family:'Symbol';font-size:10pt;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Whether the investment has been in a continuous realized loss position for over 12 months; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-family:'Symbol';font-size:10pt;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the duration to maturity of our investments; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-family:'Symbol';font-size:10pt;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our intention and ability to hold the investments to maturity and if it is not more likely than not that we will be required to sell the investment before recovery of the amortized cost bases; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-family:'Symbol';font-size:10pt;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the credit rating, financial condition and near-term prospects of the issuer; and </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-family:'Symbol';font-size:10pt;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the type of investments made. </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">To date, there have been no declines in fair value that have been identified as other than temporary</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </font></p></div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk and Other Risks and Uncertainties</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk and Other Risks and Uncertainties </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We operate in one</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> business segment, which is the discovery and development of biopharmaceutical products. We determine our segments based on the way we organize our business by making operating decisions and assessing performance. In fiscal years 2013, 2012 and 2011, 89%, 88% and 94% of our revenues were earned in the United States, respectively, and the remaining revenues were earned in Germany. As of December&#160;31, 2013 and 2012, 9% and 10%, respectively, of our long-lived assets were located in the United States and the remaining long-lived assets were located in Germany. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Financial instruments that are subject to concentration of credit risk consist primarily of cash equivalents, marketable securities and accounts receivable. Our policy is to invest cash in institutional money market funds and marketable securities of U.S. government and corporate issuers with high credit quality to limit the amount of credit exposure. We currently maintain a portfolio of cash equivalents and marketable securities in a variety of securities, including short-term </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">money market funds, U.S. government agency securities, U.S. treasury securities and municipal securities. We have not experienced any losses on our cash equivalents and marketable securities. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Accounts receivable are recorded at invoice value. We review our exposure to accounts receivable, including the requirement</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for allowances based on management&#8217;s judgment. We have not historically experienced any significant losses. We do not currently require collateral for any of our accounts receivable. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our products will require approval from the U.S. Food and Drug Administration (&#8220;FDA&#8221;) and foreign regulatory agencies before commercial sales can commence. There can be no assurance that our products will receive any of these required approvals. The denial or delay of such approvals would have a material adverse impact on our business. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We have relied on a limited number of suppliers to produce oligonucleotides </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">for clinical trials and a single contract manufacturer to produce our first generation TLR 9 agonist, 1018 for HEPLISAV-B. The loss of our current supplier would have a significant effect on our ability to produce HEPLISAV-B for commercialization and development of our other product candidates. To date, we have manufactured only small quantities of oligonucleotides and 1018 ourselves for development purposes. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We are subject to risks common to companies in the biopharmaceutical industry, including, but not limited to, new technological innovations, clinical development risk, establishing appropriate commercial partnerships, protection of proprietary technology, compliance with government and environmental regulations, uncertainty of market acceptance of products, product liability, the volatility of our stock price and the need to obtain additional financing.</font></p></div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Long-Lived Assets</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Long-Lived Assets </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Property and equipment are recorded at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets. Repair and maintenance costs are charged to expense as incurred. Leasehold improvements in both of our facilities are amortized over the remaining life of the initial lease term or the estimated useful lives of the assets, whichever is shorter. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We evaluate the carrying value of long-lived assets, including intangible assets, whenever events or changes in business circumstances or our planned use of long-lived assets indicate, based on undiscounted future operating cash flows,</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> that their carrying amounts may not be fully recoverable or that their useful lives are no longer appropriate. When an indicator of impairment exists, long-lived assets are written down to their respective fair values. Fair value is determined primarily using the anticipated cash flows discounted at a rate commensurate with the risk involved. Significant management judgment is required in the forecast of future operating results that are used in the preparation of expected undiscounted cash flows. No impairments of purchased intangible assets have been identified during the years presented. </font></p></div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Goodwill</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our goodwill balance relates to our April 2006 acquisition of Rhein</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. Goodwill was recorded as the excess purchase price over tangible and intangible assets acquired and liabilities assumed based on their estimated fair value, by applying the acquisition method of accounting. Goodwill is not amortized but is subject to an annual impairment test which consists of a comparison of the fair value of the related reporting unit against its carrying amount including goodwill. If the carrying amount exceeds the fair value, impairment is calculated and recorded as a charge in the consolidated statements of operations. We determined that we have only one operating segment and there are no components of that operating segment that are deemed to be separate reporting units such that we have one reporting unit for purposes of our goodwill impairment testing. We evaluate goodwill for impairment on an annual basis and on an interim basis if events or changes in circumstances between annual impairment tests indicate that the asset might be impaired.</font></p></div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Revenue Recognition </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our revenues consist of amounts earned from collaborations, grants and fees from services and licenses. We enter into license and manufacturing agreements and collaborative research and development arrangements with pharmaceutical and biotechnology partners that may involve multiple deliverables. Our arrangements may include one or more of the following elements: upfront license payments, cost reimbursement for the performance of research and development activities, milestone payments, other contingent payments, contract manufacturing service fees, royalties and license fees. Each deliverable in the arrangement is evaluated to determine whether it meets the criteria to be accounted for as a separate unit of accounting or whether it should be combined with other deliverables. In order to account for the multiple-element arrangements, the Company identifies the deliverables included within the arrangement and evaluates which deliverables represent separate units of accounting. Analyzing the arrangement to identify deliverables requires the use of judgment, and each deliverable may be an obligation to deliver services, a right or license to use an asset, or another performance obligation. We recognize revenue when there is persuasive evidence that an arrangement exists, delivery has occurred or services have been rendered, the price is fixed or determinable and collectability is reasonably assured. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">On January&#160;1, 2011, we adopted on a prospective basis Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Update (&#8220;ASU&#8221;) 2009-13, </font><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Multiple-Deliverable Revenue Arrangements</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, which amends the criteria related to identifying separate units of accounting and provides guidance on whether multiple deliverables exist, how an arrangement should be separated and the consideration allocated. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Non-refundable upfront fees received for license and collaborative agreements entered into prior to January&#160;1, 2011 and other payments under collaboration agreements where we have continuing performance obligations related to the payments are deferred and recognized over our expected performance period. Revenue is recognized on a ratable basis, unless we determine that another method is more appropriate, through the date at which our performance obligations are completed. Management makes its best estimate of the period over which we expect to fulfill our performance obligations, which may include clinical development activities. Given the uncertainties of research and development collaborations, significant judgment is required to determine the duration of the performance period. We recognize cost reimbursement revenue under collaborative agreements as the related research and development costs are incurred, as provided for under the terms of these agreements. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Contingent consideration received for the achievement of a substantive milestone is recognized in its entirety in the period in which the milestone is achieved. A milestone is defined as an event having all of the following characteristics: (i</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;there is substantive uncertainty at the date the arrangement is entered into that the event will be achieved, (ii)&#160;the event can only be achieved based in whole or in part on either the entity&#8217;s performance or a specific outcome resulting from the entity&#8217;s performance and (iii)&#160;if achieved, the event would result in additional payments being due to the entity. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our license and collaboration agreements with our partners provide for payments to be paid to us upon the achievement of development milestones. Given the challenges inherent in developing biologic products, there is substantial uncertainty whether any such milestones will be achieved at the time we entered into these agreements. In addition, we evaluate whether the development milestones meet the criteria to be considered substantive. The conditions include: (i</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;the development work is contingent on either of the following: (a)&#160;the vendor&#8217;s performance to achieve the milestone or (b)&#160;the enhancement of the value of the deliverable item or items as a result of a specific outcome resulting from the vendor&#8217;s performance to achieve the milestone; (ii)&#160;it relates solely to past performance and (iii)&#160;it is reasonable relative to all the deliverable and payment terms within the arrangement. As a result of our analysis, we consider our development milestones to be substantive and, accordingly, we expect to recognize as revenue future payments received from such milestones as we achieve each milestone. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Milestone payments that are contingent upon the achievement of substantive at-risk performance criteria are recognized in full upon achievement of those milestone events in accordance with the terms of the agreement and assuming all other revenue recognition criteria have been met. All revenue recognized to date under our collaborative agreements has been nonrefundable. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our license and collaboration agreements with certain partners also provide for contingent payments to be paid to us based solely upon the performance of our partner. For such contingent payments we expect to recognize the payments as revenue upon receipt, provided that collection is reasonably assured and the other revenue recognition criteria have been satisfied. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Revenues from manufacturing services are recognized upon meeting the criteria for substantial performance and acceptance by the customer. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Revenue from royalty payments is contingent on future sales activities by our licensees. As a result, we recognize royalty revenue when reported by our licensees and when collection is reasonably assured. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Revenue from government and private agency grants are recognized as the related research expenses are incurred and to the extent that funding is approved. Additionally, we recognize revenue based on the facilities and administrative cost rate reimbursable per the terms of the grant awards. </font></p></div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Expenses and Accruals</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Research and Development Expenses and Accruals </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Research and development expenses include personnel and facility-related expenses, outside contracted services including clinical trial costs, manufacturing and process development costs, research costs and other consulting services and non-cash stock-based compensation. Research and development costs are expensed as incurred. Amounts due under such arrangements may be either fixed fee or fee for service, and may include upfront payments, monthly payments and payments upon the completion of milestones or receipt of deliverables. Non-refundable advance payments under agreements are capitalized and expensed as the related goods are delivered or services are performed. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We contract with third parties to perform various clinical trial activities in the on-going development of potential products. The financial terms of these agreements are subject to negotiation, vary from contract to contract and may result in uneven payment flows to our vendors. Payments under the contracts depend on factors such as the achievement of certain events, successful enrollment of patients, completion</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of portions of the clinical trial or similar conditions. Our accruals for clinical trials are based on estimates of the services received and efforts expended pursuant to contracts with clinical trial centers and clinical research organizations. We may terminate these contracts upon written notice and we are generally only liable for actual effort expended by the organizations to the date of termination, although in certain instances we may be further responsible for termination fees and penalties. The Company makes estimates of its accrued expenses as of each balance sheet date based on the facts and circumstances known to the Company at that time. There have been no material adjustments to the Company&#8217;s prior period accrued estimates for clinical trial activities through December 31, 2013.</font></p></div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stock-Based Compensation </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Stock-based compensation expense for stock options and other stock awards is estimated at the grant date based on the award&#8217;s fair value-based measurement and is recognized on a straight-line basis over the award&#8217;s vesting period, assuming appropriate forfeiture rates</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. Our determination of the fair value-based measurement of stock options on the date of grant using an option-pricing model is affected by our stock price, as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, our expected stock price volatility over the term of the awards, and actual and projected employee stock option exercise behaviors. In the future, as additional empirical evidence regarding these input estimates becomes available, we may change or refine our approach of deriving these input estimates. These changes could impact our fair value-based measurement of stock options granted in the future. Changes in the fair value-based measurement of stock awards could materially impact our operating results. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We selected the Black-Scholes option pricing model as the most appropriate method for determining the estimated fair value-based measurement of our stock options. The Black-Scholes model requires the use of highly subjective and complex assumptions which determine the fair value-based measurement of stock options, including the option&#8217;s expected term and the price volatility of the underlying stock. Our current estimate of volatility is based on the historical volatility of our stock price. To the extent volatility in our stock price increases in the future, our estimates of the fair value of options granted in the future could increase, thereby increasing stock-based compensation cost recognized in future periods. We derive the expected term assumption primarily based on our historical settlement experience, while giving consideration to options that have not yet completed a full life cycle. Stock-based compensation cost is recognized only for awards ultimately expected to vest. Our estimate of the forfeiture rate is based primarily on our historical experience. To the extent we revise this estimate in the future,</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> our share-based compensation cost could be materially impacted in the quarter of revision, as well as in the following quarters. </font></p></div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Income Taxes </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We account for income taxes using the asset and liability method, under which deferred tax assets and liabilities are determined based on the differences between the financial reporting and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Additionally, we assess the likelihood that deferred tax assets will be recovered as deductions from future taxable income. We have provided a full valuation allowance on our deferred tax assets at December&#160;31, 2013 and 2012 because we believe it is more likely than not that our deferred tax assets will not be realized as of December&#160;31, 2013, and 2012. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We have no</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> unrecognized tax benefits as of December&#160;31, 2013, including no accrued amounts for interest and penalties. We do not anticipate that total unrecognized tax benefits will significantly change prior to December&#160;31, 2014. Our policy will be to recognize interest and penalties related to income taxes, if any, as a component of general and administrative expense. We are subject to income tax examinations for U.S. federal and state income taxes from 1996 forward. We are subject to tax examination in Germany from 2010 forward.</font></p></div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recent Accounting Pronouncements </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;text-indent:4.54%">Accounting Standards Update 2013-02 </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In February&#160;2013, the FASB issued ASU 2013-02, &#8220;</font><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Reporting of Amounts Reclassified out of Accumulated Other Comprehensive Income.&#8221;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;This ASU expands the presentation of changes in accumulated other comprehensive income.&#160;The new guidance requires an entity to disaggregate the total change of each component of other comprehensive income either on the face of the statement of operations or as a separate disclosure in the financial statement footnotes. ASU 2013-02 is effective for fiscal years beginning after December&#160;15, 2012. The Company adopted this guidance on a prospective basis in the first quarter of 2013 and the adoption did not have any impact on our financial position, results of operations or cash flows as there were no amounts reclassified out of accumulated other comprehensive (loss) income during the year ended December 31, 2013.</font></p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BasisOfAccountingPolicyPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for credit risk.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 825<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28088331&amp;loc=SL29635902-196195<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 20<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28364263&amp;loc=d3e13531-108611<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 21<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28364263&amp;loc=d3e13537-108611<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6875567&amp;loc=d3e14489-108613<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 825<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6480020&amp;loc=d3e61082-112788<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 825<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6480020&amp;loc=d3e61044-112788<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ConcentrationRiskCreditRisk</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 20<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2175856<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2175826<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 30<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2175892<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 20<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2144439<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2144681<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 30<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2144749<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 19<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32840-109319<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 954<br><br> -SubTopic 740<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 17<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32809-109319<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -URI http://asc.fasb.org/extlink&amp;oid=21917399&amp;loc=d3e32247-109318<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=21917399&amp;loc=d3e32280-109318<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for investments in financial assets, including marketable securities (debt and equity securities with readily determinable fair values), investments accounted for under the equity method and cost method, securities borrowed and loaned, and repurchase and resale agreements. For marketable securities, the disclosure may include the entity's accounting treatment for transfers between investment categories and how the fair values for such securities are determined. Also, for all investments, an entity may describe its policy for assessing, recognizing and measuring impairment of the investment.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 325<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6872867&amp;loc=d3e40691-111596<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 10<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28364263&amp;loc=d3e13433-108611<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 323<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -Subparagraph (a)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6382943&amp;loc=d3e33918-111571<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27290-111563<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 5<br><br> -Section M<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.2,12)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 2, 12<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InvestmentPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiquidityDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for reporting when there is a substantial doubt about an entity's ability to continue as a going concern for a reasonable period of time (generally a year from the balance sheet date). Disclose: (a) pertinent conditions and events giving rise to the assessment of substantial doubt about the entity's ability to continue as a going concern for a reasonable period of time, (b) the possible effects of such conditions and events, (c) management's evaluation of the significance of those conditions and events and any mitigating factors, (d) possible discontinuance of operations, (e) management's plans (including relevant prospective financial information), and (f) information about the recoverability or classification of recorded asset amounts or the amounts or classification of liabilities. If management's plans alleviate the substantial doubt about the entity's ability to continue as a going concern, disclosure of the principal conditions and events that initially raised the substantial doubt about the entity's ability to continue as a going concern would be expected to be considered. Disclose whether operations for the current or prior years generated sufficient cash to cover current obligations, whether waivers were obtained from creditors relating to the company's default under the provisions of debt agreements and possible effects of such conditions and events, such as: whether there is a possible need to obtain additional financing (debt or equity) or to liquidate certain holdings to offset future cash flow deficiencies. Disclose appropriate parent company information when parent is dependent upon remittances from subsidiaries to satisfy its obligations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiquidityDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2155824<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.13(a))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 13<br><br> -Subparagraph a<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 730<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2127266<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Research and Development<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6523717<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ResearchAndDevelopmentExpensePolicy</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18726-107790<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 13<br><br> -Section B<br><br> -Paragraph Question 1<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 605<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 13.B.Q1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012821&amp;loc=d3e214044-122780<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18823-107790<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RevenueRecognitionPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (b),(f)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2228939<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6143-108592<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6132-108592<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6061-108592<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_UseOfEstimates</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EJWBG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Summary of Revenue Recognized under Agreement with GSK (Detail) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="8">3 Months Ended</th>
        <th class="th" colspan="6">12 Months Ended</th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="9">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>National Institutes of Health</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>National Institutes of Health</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011

</div>
          <div>National Institutes of Health</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2008

</div>
          <div>Glaxo, Smith, Kline</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Glaxo, Smith, Kline</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Glaxo, Smith, Kline</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011

</div>
          <div>Glaxo, Smith, Kline</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Astra Zeneca</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Astra Zeneca</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011

</div>
          <div>Astra Zeneca</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>National Institute Of Allergy And Infectious Diseases</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>National Institute Of Allergy And Infectious Diseases</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011

</div>
          <div>National Institute Of Allergy And Infectious Diseases</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueAdditions', window );">Initial payment</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 10,000<span></span></td>
        <td class="nump">$ 1,702<span></span></td>
        <td class="nump">$ 1,428<span></span></td>
        <td class="nump">$ 1,428<span></span></td>
        <td class="nump">$ 720<span></span></td>
        <td class="nump">$ 720<span></span></td>
        <td class="nump">$ 120<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized', window );">Milestone revenue</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">12,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">15,000<span></span></td>
        <td class="nump">2,507<span></span></td>
        <td class="nump">2,462<span></span></td>
        <td class="nump">642<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
        <td class="nump">2,847<span></span></td>
        <td class="nump">2,927<span></span></td>
        <td class="nump">3,392<span></span></td>
        <td class="nump">2,085<span></span></td>
        <td class="nump">1,806<span></span></td>
        <td class="nump">2,874<span></span></td>
        <td class="nump">2,684<span></span></td>
        <td class="nump">2,350<span></span></td>
        <td class="nump">11,251<span></span></td>
        <td class="nump">9,714<span></span></td>
        <td class="nump">21,614<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,702<span></span></td>
        <td class="nump">1,428<span></span></td>
        <td class="nump">16,428<span></span></td>
        <td class="nump">3,227<span></span></td>
        <td class="nump">3,182<span></span></td>
        <td class="nump">762<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromGrants', window );">Grant revenue</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 5,138<span></span></td>
        <td class="nump">$ 3,939<span></span></td>
        <td class="nump">$ 3,110<span></span></td>
        <td class="nump">$ 1,035<span></span></td>
        <td class="nump">$ 368<span></span></td>
        <td class="nump">$ 380<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 4,103<span></span></td>
        <td class="nump">$ 3,571<span></span></td>
        <td class="nump">$ 2,730<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueAdditions">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of deferred revenue recognized for transactions arising during the current reporting period. Deferred revenue is a liability as of the balance sheet date related to a revenue producing activity for which revenue has not yet been recognized. Generally, an Entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 605<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 13.A.4(a).Q1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012821&amp;loc=d3e214044-122780<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 13<br><br> -Section A<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredRevenueAdditions</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProductInformationLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromGrants">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Revenue earned during the period from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.1(e))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RevenueFromGrants</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of consideration recognized during the period for the milestone or milestones.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 605<br><br> -SubTopic 28<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=19771982&amp;loc=SL6892177-166501<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Revenues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EZGBG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Component of Property and Equipment (Detail) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MachineryAndEquipmentGross', window );">Manufacturing equipment</a></td>
        <td class="nump">$ 8,968<span></span></td>
        <td class="nump">$ 7,574<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
        <td class="nump">26,023<span></span></td>
        <td class="nump">23,611<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FurnitureAndFixturesGross', window );">Furniture and fixtures</a></td>
        <td class="nump">1,056<span></span></td>
        <td class="nump">983<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseholdImprovementsGross', window );">Leasehold improvements</a></td>
        <td class="nump">6,048<span></span></td>
        <td class="nump">5,445<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentOther', window );">Assets in progress</a></td>
        <td class="nump">762<span></span></td>
        <td class="nump">1,047<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation and amortization</a></td>
        <td class="num">(17,317)<span></span></td>
        <td class="num">(15,646)<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total</a></td>
        <td class="nump">8,706<span></span></td>
        <td class="nump">7,965<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Manufacturing Equipment | Minimum</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Lives (In years)</a></td>
        <td class="text">5 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Manufacturing Equipment | Maximum</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Lives (In years)</a></td>
        <td class="text">14 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Lab Equipment</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
        <td class="nump">7,227<span></span></td>
        <td class="nump">6,755<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Lab Equipment | Minimum</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Lives (In years)</a></td>
        <td class="text">5 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Lab Equipment | Maximum</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Lives (In years)</a></td>
        <td class="text">13 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Computer Equipment</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Lives (In years)</a></td>
        <td class="text">3 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, Plant and Equipment, Gross</a></td>
        <td class="nump">$ 1,962<span></span></td>
        <td class="nump">$ 1,807<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Furniture and Fixtures</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Lives (In years)</a></td>
        <td class="text">3 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Leasehold Improvements | Minimum</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Lives (In years)</a></td>
        <td class="text">5 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Leasehold Improvements | Maximum</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Lives (In years)</a></td>
        <td class="text">7 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.14)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 14<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FurnitureAndFixturesGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FurnitureAndFixturesGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseholdImprovementsGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 4<br><br> -Subparagraph (f)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6812-107765<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LeaseholdImprovementsGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MachineryAndEquipmentGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 4<br><br> -Subparagraph (f)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6812-107765<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_MachineryAndEquipmentGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.13)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.13)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 13<br><br> -Subparagraph a<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 8<br><br> -Article 7<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentOther">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before accumulated depreciation, depletion and amortization of other physical assets used in the normal conduct of business to produce goods and services and not intended for resale.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentOther</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentUsefulLife</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ECDAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Additional Information (Detail) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems', window );"><strong>Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Cash, cash equivalents and marketable securities</a></td>
        <td class="nump">$ 189,400,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_NumberOfReportingUnits', window );">Number of reporting units</a></td>
        <td class="nump">1<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
        <td class="nump">0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Unrecognized tax benefits, accrued amounts for interest and penalties</a></td>
        <td class="nump">0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_ReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncome', window );">Amount reclassified out of accumulated other comprehensive (loss) income</a></td>
        <td class="nump">0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of Operating Segment</a></td>
        <td class="nump">1<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">United States</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems', window );"><strong>Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_PercentageOfRevenueEarned', window );">Percentage of revenue earned</a></td>
        <td class="nump">89.00%<span></span></td>
        <td class="nump">88.00%<span></span></td>
        <td class="nump">94.00%<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_PercentageOfLongLivedAssets', window );">Percentage of long lived assets</a></td>
        <td class="nump">9.00%<span></span></td>
        <td class="nump">10.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Maximum</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems', window );"><strong>Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_CashEquivalentsMaturityPeriod', window );">Cash equivalents original maturity period</a></td>
        <td class="text">3 months<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Rhein</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems', window );"><strong>Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Currency translation adjustments</a></td>
        <td class="nump">500,000<span></span></td>
        <td class="nump">400,000<span></span></td>
        <td class="num">(300,000)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossRealized', window );">Currency transaction gain (loss)</a></td>
        <td class="num">$ (200,000)<span></span></td>
        <td class="num">$ (200,000)<span></span></td>
        <td class="nump">$ 200,000<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_CashEquivalentsMaturityPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Cash Equivalents, Maturity Period</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_CashEquivalentsMaturityPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_NumberOfReportingUnits">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number Of Reporting Units</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_NumberOfReportingUnits</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:positiveIntegerItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_PercentageOfLongLivedAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of Long Lived Assets</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_PercentageOfLongLivedAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_PercentageOfRevenueEarned">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of revenue earned.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_PercentageOfRevenueEarned</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_ReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncome">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Reclassification Adjustments from Accumulated Other Comprehensive Income</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_ReclassificationAdjustmentsFromAccumulatedOtherComprehensiveIncome</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14A<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=SL7669686-108580<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e637-108580<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e681-108580<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 10A<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=SL7669646-108580<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 30<br><br> -Section 45<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6915805&amp;loc=d3e32022-110900<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash Equivalents<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashCashEquivalentsAndShortTermInvestments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossRealized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 20<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450189&amp;loc=d3e30690-110894<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 20<br><br> -Section 45<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450189&amp;loc=d3e30700-110894<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ForeignCurrencyTransactionGainLossRealized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NumberOfOperatingSegments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:integerItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of unrecognized tax benefits pertaining to uncertain tax positions taken in tax returns.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Unrecognized Tax Benefit<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6527854<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 15A<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=SL6600010-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_UnrecognizedTaxBenefits</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 15<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32718-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ETGEM">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Preferred Stock, Common Stock and Warrants - Additional Information (Detail) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="9">1 Months Ended</th>
        <th class="th" colspan="3">12 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1">12 Months Ended</th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
        <th class="th" colspan="2">1 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="3">1 Months Ended</th>
        <th class="th" colspan="2">12 Months Ended</th>
        <th class="th" colspan="1">1 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Oct. 31, 2013</div>
        </th>
        <th class="th">
          <div>May 09, 2012</div>
        </th>
        <th class="th">
          <div>Nov. 03, 2011</div>
        </th>
        <th class="th">
          <div>Nov. 02, 2010</div>
        </th>
        <th class="th">
          <div>Apr. 30, 2010</div>
        </th>
        <th class="th">
          <div>Apr. 16, 2010</div>
        </th>
        <th class="th">
          <div>Nov. 30, 2009</div>
        </th>
        <th class="th">
          <div>Nov. 04, 2008</div>
        </th>
        <th class="th">
          <div>Apr. 18, 2006</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>May 29, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>SDI</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>2007 Loan Agreement</div>
        </th>
        <th class="th">
          <div>Oct. 31, 2013

</div>
          <div>Common Stock</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Common Stock</div>
        </th>
        <th class="th">
          <div>Nov. 04, 2008

</div>
          <div>Minimum</div>
        </th>
        <th class="th">
          <div>Oct. 31, 2013

</div>
          <div>Series B Convertible Preferred Stock</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Series B Convertible Preferred Stock</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Series B Convertible Preferred Stock</div>
        </th>
        <th class="th">
          <div>Mar. 29, 2013

</div>
          <div>MLV

</div>
          <div>Maximum</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2010

</div>
          <div>Aspire Capital Fund Llc</div>
        </th>
        <th class="th">
          <div>Sep. 20, 2010

</div>
          <div>Aspire Capital Fund Llc</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011

</div>
          <div>Aspire Capital Fund Llc</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010

</div>
          <div>Aspire Capital Fund Llc</div>
        </th>
        <th class="th">
          <div>Sep. 20, 2010

</div>
          <div>Aspire Capital Fund Llc

</div>
          <div>Maximum</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_PreferredStockCommonStockAndWarrantsLineItems', window );"><strong>Preferred Stock Common Stock And Warrants [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">350,000,000<span></span></td>
        <td class="nump">250,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">350,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">5,000,000<span></span></td>
        <td class="nump">5,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">43,000<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued during period, shares</a></td>
        <td class="nump">79,570,000<span></span></td>
        <td class="nump">17,500,000<span></span></td>
        <td class="nump">27,600,000<span></span></td>
        <td class="nump">26,450,000<span></span></td>
        <td class="nump">1,076,420<span></span></td>
        <td class="nump">30,293,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">79,570,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">43,430<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">10,995,210<span></span></td>
        <td class="nump">2,350,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 0.001<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 0.001<span></span></td>
        <td class="nump">$ 0.001<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 0.001<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityIssuancePerShareAmount', window );">Public offering net price per share</a></td>
        <td class="nump">$ 1.075<span></span></td>
        <td class="nump">$ 4.25<span></span></td>
        <td class="nump">$ 2.50<span></span></td>
        <td class="nump">$ 1.70<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 1.4525<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 1,075<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Gross proceeds from issuance of stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 85,500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 46,700,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance costs</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">4,500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Net proceeds from offering</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">69,600,000<span></span></td>
        <td class="nump">64,500,000<span></span></td>
        <td class="nump">42,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">41,100,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">80,900,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">44,200,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Convertible common stock shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockTermsOfConversion', window );">Convertible preferred stock, terms of conversion</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">The holder is prohibited from converting the Series B Convertible Preferred Stock into shares of common stock if, as a result of such conversion, the holder and its affiliates would own more than 9.98% of the total number of shares of common stock then issued and outstanding.<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSettlementTerms', window );">Convertible preferred stock, settlement terms</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">In the event of the Company&#x2019;s liquidation, dissolution, or winding up, holders of Series B Convertible Preferred Stock will receive a payment equal to $0.001 per share before any proceeds are distributed to the common stockholders.<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_DeemedDividend', window );">Convertible common stock exceeded allocated purchase price of preferred stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">8,500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 0.001<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 0.001<span></span></td>
        <td class="nump">$ 0.001<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendPayableDateToBePaidDayMonthAndYear', window );">Dividends payable date</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">Nov. 17,
				 2008<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Preferred shares price</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 6.00<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_PercentageOfCommonSharesOutstanding', window );">Percentage of common shares outstanding</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">20.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_PercentageOfCompanyAssets', window );">Percentage of assets</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">50.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_RightsExpirationDate', window );">Rights expiration date</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">Nov. 17,
				 2008<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Common stock aggregate offering price</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">80,999,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">80,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">50,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_SellingCommissionPercentageFromGrossOfferingProceedsOfSalesOfStock', window );">Commission on gross sales proceeds of common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Sale of stock pursuant to exercise of underwriters overallotment option</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,600,000<span></span></td>
        <td class="nump">3,450,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Commitment to purchase shares value</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">30,000,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_PurchaseAgreementPeriod', window );">Purchase agreement term</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">25 months<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_PercentageOfCommitmentToPurchaseSharesValue', window );">Percentage of commitment to purchase shares value as commitment fee</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">4.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_CommitmentFeePaid', window );">Commitment fee paid</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,200,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Issuance of shares of common stock for commitment fee</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">600,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuances of common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 80,856,000<span></span></td>
        <td class="nump">$ 71,780,000<span></span></td>
        <td class="nump">$ 91,298,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 26,700,000<span></span></td>
        <td class="nump">$ 3,300,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_NumberOfSharesOfCommonStockInEachUnit', window );">Number of shares of common stock in each unit</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_NumberOfWarrantsInEachUnit', window );">Number of warrants in each unit</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_CommonStockIssuableUponExerciseOfWarrantsConversionRatio', window );">Number of share per warrant</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0.5<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights', window );">Warrants exercise price</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1.50<span></span></td>
        <td class="nump">1.50<span></span></td>
        <td class="nump">1.94<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">7.32<span></span></td>
        <td class="nump">1.96<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_WarrantsExercisablePeriod', window );">Warrants exercisable period</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">5 years<span></span></td>
        <td class="text">5 years<span></span></td>
        <td class="text">5 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">5 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">10,913,873<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">6,765,128<span></span></td>
        <td class="nump">1,550,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Issuance of warrants for common shares to be purchased</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,550,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_WarrantToPurchaseCommonStock', window );">Warrants to purchase common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">12,500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_NumberOfWarrantsExercisedDuringPeriod', window );">Number Of Warrants Exercised During Period</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">250,000<span></span></td>
        <td class="nump">13,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_CommitmentFeePaid">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Commitment Fee Paid</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_CommitmentFeePaid</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_CommonStockIssuableUponExerciseOfWarrantsConversionRatio">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Common Stock Issuable Upon Exercise of Warrants Conversion Ratio</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_CommonStockIssuableUponExerciseOfWarrantsConversionRatio</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:pureItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_DeemedDividend">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Deemed dividend.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_DeemedDividend</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_NumberOfSharesOfCommonStockInEachUnit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of Shares of Common Stock in Each Unit</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_NumberOfSharesOfCommonStockInEachUnit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_NumberOfWarrantsExercisedDuringPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of warrants exercised during period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_NumberOfWarrantsExercisedDuringPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_NumberOfWarrantsInEachUnit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of Warrants in Each Unit</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_NumberOfWarrantsInEachUnit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_PercentageOfCommitmentToPurchaseSharesValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of Commitment To Purchase Shares Value</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_PercentageOfCommitmentToPurchaseSharesValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_PercentageOfCommonSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of Common Shares Outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_PercentageOfCommonSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_PercentageOfCompanyAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of Company Assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_PercentageOfCompanyAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_PreferredStockCommonStockAndWarrantsLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_PreferredStockCommonStockAndWarrantsLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_PurchaseAgreementPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Purchase Agreement Period</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_PurchaseAgreementPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_RightsExpirationDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Rights Expiration Date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_RightsExpirationDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_SellingCommissionPercentageFromGrossOfferingProceedsOfSalesOfStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Selling Commission Percentage from Gross Offering Proceeds of Sales of Stock</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_SellingCommissionPercentageFromGrossOfferingProceedsOfSalesOfStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_WarrantsExercisablePeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrants Exercisable Period</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_WarrantsExercisablePeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_WarrantToPurchaseCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrant To Purchase Common Stock</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_WarrantToPurchaseCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Exercise price per share or per unit of warrants or rights outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(i)(4))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph i<br><br> -Subparagraph 4<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>us-types:perUnitItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of warrants or rights outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(i))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph i<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfWarrantOrRightOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value per share of common stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockParOrStatedValuePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ConversionOfStockSharesConverted1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSettlementTerms">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Describe the manner of settlement upon conversion and any alternative settlement methods (e.g., cash, shares, a combination of both).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -Subparagraph (d)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ConvertiblePreferredStockSettlementTerms</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares issued for each share of convertible preferred stock that is converted.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockTermsOfConversion">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Specific terms relevant to convertibility. Includes class of preferred stock and number of shares convertible into, exercise (or conversion) price or rates, dates relevant to conversion timing and events relevant to conversion. Describe also any beneficial conversion features. where convertible preferred stock with a nondetachable conversion feature is in-the-money at commitment date. For contingently convertible preferred stock, discuss the circumstances of the contingency, including the events or changes in circumstance that would cause the contingency to be met and any of the significant features necessary to understand the conversion rights and the timing of those rights. Include also an events or changes in circumstance, if any, that could adjust or change the contingency, conversion price, or number of shares, including significant terms of those changes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 7<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21521-112644<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Contingently Convertible Instruments<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6508575<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21538-112644<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ConvertiblePreferredStockTermsOfConversion</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendPayableDateToBePaidDayMonthAndYear">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Date the declared dividend will be paid, in CCYY-MM-DD format.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DividendPayableDateToBePaidDayMonthAndYear</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityIssuancePerShareAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount per share or per unit assigned to the consideration received of equity securities issued for development stage entities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 915<br><br> -SubTopic 215<br><br> -Section 45<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6472370&amp;loc=d3e38297-110927<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EquityIssuancePerShareAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow for cost incurred directly with the issuance of an equity security.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 15<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3291-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsOfStockIssuanceCosts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockParOrStatedValuePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceInitialPublicOffering</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the additional capital contribution to the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOrSaleOfEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SaleOfStockConsiderationReceivedPerTransaction</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Price of a single share of a number of saleable stocks of a company.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25499696&amp;loc=d3e19207-110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of new stock issued during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesNewIssues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of stock issued during the period that is attributable to transactions involving issuance of stock not separately disclosed.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesOther</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueNewIssues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E6IAE">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Component of Deferred Tax Assets and Liabilities (Detail) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGrossAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carry forwards</a></td>
        <td class="nump">$ 147,655<span></span></td>
        <td class="nump">$ 127,529<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Research tax credit carry forwards</a></td>
        <td class="nump">21,336<span></span></td>
        <td class="nump">18,163<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves', window );">Accruals and reserves</a></td>
        <td class="nump">9,501<span></span></td>
        <td class="nump">8,529<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Capitalized research costs</a></td>
        <td class="nump">10,662<span></span></td>
        <td class="nump">12,757<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Deferred revenue</a></td>
        <td class="nump">2,486<span></span></td>
        <td class="nump">2,180<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
        <td class="nump">1,222<span></span></td>
        <td class="nump">1,221<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Deferred Tax Assets, Gross, Total</a></td>
        <td class="nump">192,862<span></span></td>
        <td class="nump">170,379<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less valuation allowance</a></td>
        <td class="num">(192,733)<span></span></td>
        <td class="num">(170,232)<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred tax assets</a></td>
        <td class="nump">129<span></span></td>
        <td class="nump">147<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Fixed Assets</a></td>
        <td class="num">(162)<span></span></td>
        <td class="num">(86)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
        <td class="nump">33<span></span></td>
        <td class="num">(61)<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Total deferred tax liabilities</a></td>
        <td class="num">(129)<span></span></td>
        <td class="num">(147)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32621-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 25<br><br> -Paragraph 20<br><br> -URI http://asc.fasb.org/extlink&amp;oid=29652012&amp;loc=d3e28680-109314<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32632-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsDeferredIncome</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Deferred Tax Asset<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6510090<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGrossAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsGrossAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards, net of deferred tax liability attributable to taxable temporary differences.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsLiabilitiesNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (b),(c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32621-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32632-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 25<br><br> -Paragraph 20<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=29652012&amp;loc=d3e28680-109314<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences not separately disclosed.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32621-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 25<br><br> -Paragraph 20<br><br> -URI http://asc.fasb.org/extlink&amp;oid=29652012&amp;loc=d3e28680-109314<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32632-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsOther</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The tax effect as of the balance sheet date of the amount of future tax deductions arising from all unused tax credit carryforwards which have been reduced by a valuation allowance.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32621-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32632-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32559-109319<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Carryforwards<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506874<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32621-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32632-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32559-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from other reserves not separately disclosed.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32621-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32632-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 25<br><br> -Paragraph 20<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=29652012&amp;loc=d3e28680-109314<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsValuationAllowance</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of deferred tax liability attributable to taxable temporary differences net of deferred tax asset attributable to deductible temporary differences and carryforwards after valuation allowances.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=21917399&amp;loc=d3e31931-109318<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxLiabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxLiabilitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of deferred tax liability attributable to taxable temporary differences not separately disclosed.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32621-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 25<br><br> -Paragraph 20<br><br> -URI http://asc.fasb.org/extlink&amp;oid=29652012&amp;loc=d3e28680-109314<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32632-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxLiabilitiesOther</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32621-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 25<br><br> -Paragraph 20<br><br> -URI http://asc.fasb.org/extlink&amp;oid=29652012&amp;loc=d3e28680-109314<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32632-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EOFAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Future Minimum Payments Under Non-Cancelable Portion of Operating Leases (Detail) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">2014</a></td>
        <td class="nump">$ 2,233<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">2015</a></td>
        <td class="nump">2,282<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears', window );">2016</a></td>
        <td class="nump">2,333<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears', window );">2017</a></td>
        <td class="nump">2,382<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears', window );">2018</a></td>
        <td class="nump">1,351<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter', window );">Thereafter</a></td>
        <td class="nump">2,499<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Total</a></td>
        <td class="nump">$ 13,080<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasedAssetsLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingLeasedAssetsLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 40<br><br> -Subparagraph (Note 3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingLeasesFutureMinimumPaymentsDue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of required minimum rental payments maturing in the next fiscal year following the latest fiscal year for operating leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 40<br><br> -Subparagraph (Note 3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of required minimum rental payments maturing in the fifth fiscal year following the latest fiscal year for operating leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 40<br><br> -Subparagraph (Note 3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of required minimum rental payments maturing in the forth fiscal year following the latest fiscal year for operating leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 40<br><br> -Subparagraph (Note 3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of required minimum rental payments maturing in the third fiscal year following the latest fiscal year for operating leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 40<br><br> -Subparagraph (Note 3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of required minimum rental payments maturing in the second fiscal year following the latest fiscal year for operating leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 40<br><br> -Subparagraph (Note 3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of required minimum rental payments maturing after the fifth fiscal year following the latest fiscal year for operating leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 40<br><br> -Subparagraph (Note 3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
        <td class="text"><div>
<div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Summary of Significant Accounting Policies </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Basis of Presentation </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The consolidated financial statements include our accounts and those of our wholly-owned subsidiaries. All significant intercompany accounts and transactions among the entities have been eliminated from the consolidated financial statements. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Liquidity and Financial Condition </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We have incurred significant operating losses and negative cash flows from operations since our inception. As of December&#160;31, 2013, we had cash, cash equivalents and marketable securities of $189.4</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million. We currently estimate that we have sufficient cash resources to meet our anticipated cash needs through at least the next 12 months based on cash, cash equivalents and marketable securities on hand as of December&#160;31, 2013 and anticipated revenues and funding from existing agreements.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We expect to continue to spend substantial funds in connection with the development and manufacturing of our product candidates, particularly HEPLISAV-B</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, human clinical trials for our product candidates and additional applications and advancement of our technology. In order to continue these activities, we may need to raise additional funds. This may occur through strategic alliance and licensing arrangements and/or future public or private financings. Sufficient additional funding may not be available on acceptable terms, or at all. If adequate funds are not available in the future, we may need to delay, reduce the scope of or put on hold the HEPLISAV-B program or our other development programs while we seek strategic alternatives.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The preparation of financial statements in conformity with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;) requires management to make informed </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results may differ materially from these estimates.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Foreign Currency Translation</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We consider the local currency to be the functional currency for our international subsidiary, Rhein</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. Accordingly, assets and liabilities denominated in foreign currencies are translated into U.S. dollars using the exchange rate in effect on the balance sheet date. Revenues and expenses are translated at average exchange rates prevailing throughout the year. Currency translation adjustments arising from period to period are charged or credited to accumulated other comprehensive income (loss) in the equity. For the years ended December&#160;31, 2013, 2012 and 2011, we reported an unrealized gain of $0.5 million, an unrealized gain of $0.4 million and an unrealized loss of $0.3 million, respectively. Realized gains and losses resulting from currency transactions are included in the consolidated statements of operations. For the years ended December&#160;31, 2013, 2012 and 2011, we reported a loss of $0.2 million, a loss of $0.2 million and a gain of $0.2 million, respectively, resulting from currency transactions in our consolidated statements of operations. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cash, Cash Equivalents and Marketable Securities </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We consider all highly liquid investments purchased with an original maturity of three</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> months or less and that can be liquidated without prior notice or penalty, to be cash equivalents. Management determines the appropriate classification of marketable securities at the time of purchase. We invest in short-term money market funds, U.S. government agency securities, U.S. treasury securities and municipal securities. We believe these types of investments are subject to minimal credit and market risk. We do not invest in auction rate securities or securities collateralized by home mortgages, mortgage bank debt, or home equity loans. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We have classified our entire investment portfolio as available-for-sale a</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">nd available for use in current operations and accordingly have classified all investments as short-term. Available-for-sale securities are carried at fair value based on inputs that are observable, either directly or indirectly, such as quoted market prices for similar securities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the securities, with unrealized gains and losses included in accumulated other comprehensive income (loss) in stockholders&#8217; equity. Realized gains and losses and declines in value, if any, judged to be other than temporary on available-for-sale securities are included in interest income or expense. The cost of securities sold is based on the specific identification method. Management assesses whether declines in the fair value of investment securities are other than temporary. In determining whether a decline is other than temporary, management considers the following factors: </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-family:'Symbol';font-size:10pt;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Whether the investment has been in a continuous realized loss position for over 12 months; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-family:'Symbol';font-size:10pt;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the duration to maturity of our investments; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-family:'Symbol';font-size:10pt;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">our intention and ability to hold the investments to maturity and if it is not more likely than not that we will be required to sell the investment before recovery of the amortized cost bases; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-family:'Symbol';font-size:10pt;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the credit rating, financial condition and near-term prospects of the issuer; and </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-family:'Symbol';font-size:10pt;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the type of investments made. </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">To date, there have been no declines in fair value that have been identified as other than temporary</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk and Other Risks and Uncertainties </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We operate in one</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> business segment, which is the discovery and development of biopharmaceutical products. We determine our segments based on the way we organize our business by making operating decisions and assessing performance. In fiscal years 2013, 2012 and 2011, 89%, 88% and 94% of our revenues were earned in the United States, respectively, and the remaining revenues were earned in Germany. As of December&#160;31, 2013 and 2012, 9% and 10%, respectively, of our long-lived assets were located in the United States and the remaining long-lived assets were located in Germany. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Financial instruments that are subject to concentration of credit risk consist primarily of cash equivalents, marketable securities and accounts receivable. Our policy is to invest cash in institutional money market funds and marketable securities of U.S. government and corporate issuers with high credit quality to limit the amount of credit exposure. We currently maintain a portfolio of cash equivalents and marketable securities in a variety of securities, including short-term </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">money market funds, U.S. government agency securities, U.S. treasury securities and municipal securities. We have not experienced any losses on our cash equivalents and marketable securities. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Accounts receivable are recorded at invoice value. We review our exposure to accounts receivable, including the requirement</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for allowances based on management&#8217;s judgment. We have not historically experienced any significant losses. We do not currently require collateral for any of our accounts receivable. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our products will require approval from the U.S. Food and Drug Administration (&#8220;FDA&#8221;) and foreign regulatory agencies before commercial sales can commence. There can be no assurance that our products will receive any of these required approvals. The denial or delay of such approvals would have a material adverse impact on our business. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We have relied on a limited number of suppliers to produce oligonucleotides </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">for clinical trials and a single contract manufacturer to produce our first generation TLR 9 agonist, 1018 for HEPLISAV-B. The loss of our current supplier would have a significant effect on our ability to produce HEPLISAV-B for commercialization and development of our other product candidates. To date, we have manufactured only small quantities of oligonucleotides and 1018 ourselves for development purposes. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We are subject to risks common to companies in the biopharmaceutical industry, including, but not limited to, new technological innovations, clinical development risk, establishing appropriate commercial partnerships, protection of proprietary technology, compliance with government and environmental regulations, uncertainty of market acceptance of products, product liability, the volatility of our stock price and the need to obtain additional financing.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Long-Lived Assets </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Property and equipment are recorded at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets. Repair and maintenance costs are charged to expense as incurred. Leasehold improvements in both of our facilities are amortized over the remaining life of the initial lease term or the estimated useful lives of the assets, whichever is shorter. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We evaluate the carrying value of long-lived assets, including intangible assets, whenever events or changes in business circumstances or our planned use of long-lived assets indicate, based on undiscounted future operating cash flows,</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> that their carrying amounts may not be fully recoverable or that their useful lives are no longer appropriate. When an indicator of impairment exists, long-lived assets are written down to their respective fair values. Fair value is determined primarily using the anticipated cash flows discounted at a rate commensurate with the risk involved. Significant management judgment is required in the forecast of future operating results that are used in the preparation of expected undiscounted cash flows. No impairments of purchased intangible assets have been identified during the years presented. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Goodwill</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our goodwill balance relates to our April 2006 acquisition of Rhein</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. Goodwill was recorded as the excess purchase price over tangible and intangible assets acquired and liabilities assumed based on their estimated fair value, by applying the acquisition method of accounting. Goodwill is not amortized but is subject to an annual impairment test which consists of a comparison of the fair value of the related reporting unit against its carrying amount including goodwill. If the carrying amount exceeds the fair value, impairment is calculated and recorded as a charge in the consolidated statements of operations. We determined that we have only one operating segment and there are no components of that operating segment that are deemed to be separate reporting units such that we have one reporting unit for purposes of our goodwill impairment testing. We evaluate goodwill for impairment on an annual basis and on an interim basis if events or changes in circumstances between annual impairment tests indicate that the asset might be impaired.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Revenue Recognition </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our revenues consist of amounts earned from collaborations, grants and fees from services and licenses. We enter into license and manufacturing agreements and collaborative research and development arrangements with pharmaceutical and biotechnology partners that may involve multiple deliverables. Our arrangements may include one or more of the following elements: upfront license payments, cost reimbursement for the performance of research and development activities, milestone payments, other contingent payments, contract manufacturing service fees, royalties and license fees. Each deliverable in the arrangement is evaluated to determine whether it meets the criteria to be accounted for as a separate unit of accounting or whether it should be combined with other deliverables. In order to account for the multiple-element arrangements, the Company identifies the deliverables included within the arrangement and evaluates which deliverables represent separate units of accounting. Analyzing the arrangement to identify deliverables requires the use of judgment, and each deliverable may be an obligation to deliver services, a right or license to use an asset, or another performance obligation. We recognize revenue when there is persuasive evidence that an arrangement exists, delivery has occurred or services have been rendered, the price is fixed or determinable and collectability is reasonably assured. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">On January&#160;1, 2011, we adopted on a prospective basis Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Update (&#8220;ASU&#8221;) 2009-13, </font><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Multiple-Deliverable Revenue Arrangements</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, which amends the criteria related to identifying separate units of accounting and provides guidance on whether multiple deliverables exist, how an arrangement should be separated and the consideration allocated. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Non-refundable upfront fees received for license and collaborative agreements entered into prior to January&#160;1, 2011 and other payments under collaboration agreements where we have continuing performance obligations related to the payments are deferred and recognized over our expected performance period. Revenue is recognized on a ratable basis, unless we determine that another method is more appropriate, through the date at which our performance obligations are completed. Management makes its best estimate of the period over which we expect to fulfill our performance obligations, which may include clinical development activities. Given the uncertainties of research and development collaborations, significant judgment is required to determine the duration of the performance period. We recognize cost reimbursement revenue under collaborative agreements as the related research and development costs are incurred, as provided for under the terms of these agreements. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Contingent consideration received for the achievement of a substantive milestone is recognized in its entirety in the period in which the milestone is achieved. A milestone is defined as an event having all of the following characteristics: (i</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;there is substantive uncertainty at the date the arrangement is entered into that the event will be achieved, (ii)&#160;the event can only be achieved based in whole or in part on either the entity&#8217;s performance or a specific outcome resulting from the entity&#8217;s performance and (iii)&#160;if achieved, the event would result in additional payments being due to the entity. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our license and collaboration agreements with our partners provide for payments to be paid to us upon the achievement of development milestones. Given the challenges inherent in developing biologic products, there is substantial uncertainty whether any such milestones will be achieved at the time we entered into these agreements. In addition, we evaluate whether the development milestones meet the criteria to be considered substantive. The conditions include: (i</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;the development work is contingent on either of the following: (a)&#160;the vendor&#8217;s performance to achieve the milestone or (b)&#160;the enhancement of the value of the deliverable item or items as a result of a specific outcome resulting from the vendor&#8217;s performance to achieve the milestone; (ii)&#160;it relates solely to past performance and (iii)&#160;it is reasonable relative to all the deliverable and payment terms within the arrangement. As a result of our analysis, we consider our development milestones to be substantive and, accordingly, we expect to recognize as revenue future payments received from such milestones as we achieve each milestone. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Milestone payments that are contingent upon the achievement of substantive at-risk performance criteria are recognized in full upon achievement of those milestone events in accordance with the terms of the agreement and assuming all other revenue recognition criteria have been met. All revenue recognized to date under our collaborative agreements has been nonrefundable. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our license and collaboration agreements with certain partners also provide for contingent payments to be paid to us based solely upon the performance of our partner. For such contingent payments we expect to recognize the payments as revenue upon receipt, provided that collection is reasonably assured and the other revenue recognition criteria have been satisfied. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Revenues from manufacturing services are recognized upon meeting the criteria for substantial performance and acceptance by the customer. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Revenue from royalty payments is contingent on future sales activities by our licensees. As a result, we recognize royalty revenue when reported by our licensees and when collection is reasonably assured. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Revenue from government and private agency grants are recognized as the related research expenses are incurred and to the extent that funding is approved. Additionally, we recognize revenue based on the facilities and administrative cost rate reimbursable per the terms of the grant awards. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Research and Development Expenses and Accruals </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Research and development expenses include personnel and facility-related expenses, outside contracted services including clinical trial costs, manufacturing and process development costs, research costs and other consulting services and non-cash stock-based compensation. Research and development costs are expensed as incurred. Amounts due under such arrangements may be either fixed fee or fee for service, and may include upfront payments, monthly payments and payments upon the completion of milestones or receipt of deliverables. Non-refundable advance payments under agreements are capitalized and expensed as the related goods are delivered or services are performed. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We contract with third parties to perform various clinical trial activities in the on-going development of potential products. The financial terms of these agreements are subject to negotiation, vary from contract to contract and may result in uneven payment flows to our vendors. Payments under the contracts depend on factors such as the achievement of certain events, successful enrollment of patients, completion</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of portions of the clinical trial or similar conditions. Our accruals for clinical trials are based on estimates of the services received and efforts expended pursuant to contracts with clinical trial centers and clinical research organizations. We may terminate these contracts upon written notice and we are generally only liable for actual effort expended by the organizations to the date of termination, although in certain instances we may be further responsible for termination fees and penalties. The Company makes estimates of its accrued expenses as of each balance sheet date based on the facts and circumstances known to the Company at that time. There have been no material adjustments to the Company&#8217;s prior period accrued estimates for clinical trial activities through December 31, 2013.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stock-Based Compensation </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Stock-based compensation expense for stock options and other stock awards is estimated at the grant date based on the award&#8217;s fair value-based measurement and is recognized on a straight-line basis over the award&#8217;s vesting period, assuming appropriate forfeiture rates</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. Our determination of the fair value-based measurement of stock options on the date of grant using an option-pricing model is affected by our stock price, as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, our expected stock price volatility over the term of the awards, and actual and projected employee stock option exercise behaviors. In the future, as additional empirical evidence regarding these input estimates becomes available, we may change or refine our approach of deriving these input estimates. These changes could impact our fair value-based measurement of stock options granted in the future. Changes in the fair value-based measurement of stock awards could materially impact our operating results. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We selected the Black-Scholes option pricing model as the most appropriate method for determining the estimated fair value-based measurement of our stock options. The Black-Scholes model requires the use of highly subjective and complex assumptions which determine the fair value-based measurement of stock options, including the option&#8217;s expected term and the price volatility of the underlying stock. Our current estimate of volatility is based on the historical volatility of our stock price. To the extent volatility in our stock price increases in the future, our estimates of the fair value of options granted in the future could increase, thereby increasing stock-based compensation cost recognized in future periods. We derive the expected term assumption primarily based on our historical settlement experience, while giving consideration to options that have not yet completed a full life cycle. Stock-based compensation cost is recognized only for awards ultimately expected to vest. Our estimate of the forfeiture rate is based primarily on our historical experience. To the extent we revise this estimate in the future,</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> our share-based compensation cost could be materially impacted in the quarter of revision, as well as in the following quarters. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Income Taxes </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We account for income taxes using the asset and liability method, under which deferred tax assets and liabilities are determined based on the differences between the financial reporting and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Additionally, we assess the likelihood that deferred tax assets will be recovered as deductions from future taxable income. We have provided a full valuation allowance on our deferred tax assets at December&#160;31, 2013 and 2012 because we believe it is more likely than not that our deferred tax assets will not be realized as of December&#160;31, 2013, and 2012. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We have no</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> unrecognized tax benefits as of December&#160;31, 2013, including no accrued amounts for interest and penalties. We do not anticipate that total unrecognized tax benefits will significantly change prior to December&#160;31, 2014. Our policy will be to recognize interest and penalties related to income taxes, if any, as a component of general and administrative expense. We are subject to income tax examinations for U.S. federal and state income taxes from 1996 forward. We are subject to tax examination in Germany from 2010 forward.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recent Accounting Pronouncements </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;text-indent:4.54%">Accounting Standards Update 2013-02 </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In February&#160;2013, the FASB issued ASU 2013-02, &#8220;</font><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Reporting of Amounts Reclassified out of Accumulated Other Comprehensive Income.&#8221;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;This ASU expands the presentation of changes in accumulated other comprehensive income.&#160;The new guidance requires an entity to disaggregate the total change of each component of other comprehensive income either on the face of the statement of operations or as a separate disclosure in the financial statement footnotes. ASU 2013-02 is effective for fiscal years beginning after December&#160;15, 2012. The Company adopted this guidance on a prospective basis in the first quarter of 2013 and the adoption did not have any impact on our financial position, results of operations or cash flows as there were no amounts reclassified out of accumulated other comprehensive (loss) income during the year ended December 31, 2013.</font></p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for all significant accounting policies of the reporting entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18726-107790<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18861-107790<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18743-107790<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18854-107790<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SignificantAccountingPoliciesTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EBHAI">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Income Taxes - Additional Information (Detail) (USD $)<br>In Millions, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Increase (decrease) in valuation allowance</a></td>
        <td class="nump">22.5<span></span></td>
        <td class="nump">22.0<span></span></td>
        <td class="nump">18.1<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital', window );">Amount of valuation allowance for deferred tax assets allocated to contributed capital</a></td>
        <td class="nump">0.3<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Federal</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
        <td class="nump">384.1<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Federal | Minimum</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_OperatingLossCarryforwardExpirationYear', window );">Net operating loss carryforwards, expiration year</a></td>
        <td class="text">2018<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Federal | Maximum</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_OperatingLossCarryforwardExpirationYear', window );">Net operating loss carryforwards, expiration year</a></td>
        <td class="text">2037<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Federal | Research And Development</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforward amount</a></td>
        <td class="nump">13.8<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Federal | Research And Development | Minimum</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_TaxCreditCarryforwardExpirationYear', window );">Tax credit carryforward amount, expiration year</a></td>
        <td class="text">2018<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Federal | Research And Development | Maximum</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_TaxCreditCarryforwardExpirationYear', window );">Tax credit carryforward amount, expiration year</a></td>
        <td class="text">2033<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">California State</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
        <td class="nump">219.7<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">California State | Minimum</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_OperatingLossCarryforwardExpirationYear', window );">Net operating loss carryforwards, expiration year</a></td>
        <td class="text">2013<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">California State | Maximum</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_OperatingLossCarryforwardExpirationYear', window );">Net operating loss carryforwards, expiration year</a></td>
        <td class="text">2033<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">California State | Research And Development</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforward amount</a></td>
        <td class="nump">11.5<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Foreign</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
        <td class="nump">$ 27.8<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_IncomeTaxDisclosureLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_IncomeTaxDisclosureLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_OperatingLossCarryforwardExpirationYear">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Operating Loss Carryforward, Expiration Year</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_OperatingLossCarryforwardExpirationYear</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gYearItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_TaxCreditCarryforwardExpirationYear">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tax Credit Carryforward, Expiration Year</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_TaxCreditCarryforwardExpirationYear</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gYearItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of the valuation allowance recorded for tax benefits that will be credited to shareholders' equity if those tax benefits subsequently become realizable. Examples include 1) adjustments of the opening balance of retained earnings for certain changes in accounting principle or a correction of an error; 2) gains and losses included in comprehensive income but excluded from net income; 3) expenditures that are deductible for income tax purposes that are reported as a reduction of shareholders' equity; 4) expenses for employee stock options recognized differently for financial reporting purposes and income tax purposes; 5) dividends paid on unallocated shares held by an ESOP that are charged to retained earnings and 6) deductible temporary differences that existed at the date of a quasi reorganization.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32559-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 20<br><br> -Section 45<br><br> -Paragraph 11<br><br> -Subparagraph (a)-(g)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=18498875&amp;loc=d3e39076-109324<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(h))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Article 4<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Income Tax Expense (or Benefit)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -Subparagraph (a),(b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxExpenseBenefit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32559-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingLossCarryforwards</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32559-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Carryforwards<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506874<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_TaxCreditCarryforwardAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of the change in the period in the valuation allowance for a specified deferred tax asset.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 20<br><br> -URI http://asc.fasb.org/extlink&amp;oid=21917399&amp;loc=d3e32123-109318<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>48
<FILENAME>Financial_Report.xls
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xls
M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O
M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y
M/2(M+2TM/5].97AT4&%R=%\W96$X,F(R.5\Y.#(V7S0P,F%?8CDV,%\P,C$U
M9F0X8F%D93@B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7
M96(@4&%G92P@86QS;R!K;F]W;B!A<R!A(%=E8B!!<F-H:79E(&9I;&4N("!)
M9B!Y;W4@87)E('-E96EN9R!T:&ES(&UE<W-A9V4L('EO=7(@8G)O=W-E<B!O
M<B!E9&ET;W(@9&]E<VXG="!S=7!P;W)T(%=E8B!!<F-H:79E(&9I;&5S+B`@
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M;V9T+6-O;3IO9F9I8V4Z97AC96PB('AM;&YS/3-$(FAT='`Z+R]W=W<N=S,N
M;W)G+U12+U)%0RUH=&UL-#`B/@T*/&AE860^#0H\;65T82!N86UE/3-$(D5X
M8V5L(%=O<FMB;V]K($9R86UE<V5T(CX-"@T*/&UE=&$@;F%M93TS1%!R;V=)
M9"!C;VYT96YT/3-$17AC96PN4VAE970^#0H\;&EN:R!R96P],T1&:6QE+4QI
M<W0@:')E9CTS1")7;W)K<VAE971S+V9I;&5L:7-T+GAM;"(^#0H-"CPA+2U;
M:68@9W1E(&US;R`Y73X\>&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX
M.D5X8V5L5V]R:W-H965T<SX-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^1&]C=6UE;G1?86YD7T5N=&ET>5]);F9O<FUA=&EO/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#`Q+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0V]N<V]L:61A=&5D
M7T)A;&%N8V5?4VAE971S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U
M<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`R+FAT;6PB+SX-"B`@(#PO
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^0V]N<V]L:61A=&5D7T)A;&%N8V5?4VAE971S7U!A/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#`S+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0V]N<V]L:61A=&5D
M7U-T871E;65N='-?;V9?3W!E/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T
M4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`T+FAT;6PB+SX-"B`@
M(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*
M("`@(#QX.DYA;64^0V]N<V]L:61A=&5D7U-T871E;65N='-?;V9?0V]M/"]X
M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H
M965T<R]3:&5E=#`U+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0V]N<V]L:61A
M=&5D7U-T871E;65N='-?;V9?4W1O/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H
M965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`V+FAT;6PB+SX-
M"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T
M/@T*("`@(#QX.DYA;64^0V]N<V]L:61A=&5D7U-T871E;65N='-?3V9?0V%S
M/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R
M:W-H965T<R]3:&5E=#`W+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E
M=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^3W)G86YI
M>F%T:6]N/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968]
M,T0B5V]R:W-H965T<R]3:&5E=#`X+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O
M<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^
M4W5M;6%R>5]O9E]3:6=N:69I8V%N=%]!8V-O=6YT/"]X.DYA;64^#0H@("`@
M/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`Y
M+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L
M5V]R:W-H965T/@T*("`@(#QX.DYA;64^1F%I<E]686QU95]-96%S=7)E;65N
M=',\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7
M;W)K<VAE971S+U-H965T,3`N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H
M965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y#87-H
M7T-A<VA?17%U:79A;&5N='-?86YD7TUA<FL\+W@Z3F%M93X-"B`@("`\>#I7
M;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,3$N:'1M
M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K
M<VAE970^#0H@("`@/'@Z3F%M93Y0<F]P97)T>5]A;F1?17%U:7!M96YT/"]X
M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H
M965T<R]3:&5E=#$R+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^26YT86YG:6)L
M95]!<W-E=',\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E
M9CTS1")7;W)K<VAE971S+U-H965T,3,N:'1M;"(O/@T*("`@/"]X.D5X8V5L
M5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M
M93Y#=7)R96YT7T%C8W)U961?3&EA8FEL:71I97,\+W@Z3F%M93X-"B`@("`\
M>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,30N
M:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7
M;W)K<VAE970^#0H@("`@/'@Z3F%M93Y3>6UP:&]N>5]$>6YA;6]?26YC/"]X
M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H
M965T<R]3:&5E=#$U+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0V]M;6ET;65N
M='-?86YD7T-O;G1I;F=E;F-I97,\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE
M9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,38N:'1M;"(O/@T*
M("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^
M#0H@("`@/'@Z3F%M93Y#;VQL86)O<F%T:79E7U)E<V5A<F-H7T1E=F5L;W`\
M+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K
M<VAE971S+U-H965T,3<N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T
M/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y.971?3&]S
M<U]097)?4VAA<F4\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@
M2%)E9CTS1")7;W)K<VAE971S+U-H965T,3@N:'1M;"(O/@T*("`@/"]X.D5X
M8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z
M3F%M93Y0<F5F97)R961?4W1O8VM?0V]M;6]N7U-T;V-K7V$\+W@Z3F%M93X-
M"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H
M965T,3DN:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z
M17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y%<75I='E?4&QA;G-?86YD
M7U-T;V-K0F%S961?0V\\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R
M8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,C`N:'1M;"(O/@T*("`@/"]X
M.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@
M/'@Z3F%M93Y%;7!L;WEE95]"96YE9FET7U!L86X\+W@Z3F%M93X-"B`@("`\
M>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,C$N
M:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7
M;W)K<VAE970^#0H@("`@/'@Z3F%M93Y);F-O;65?5&%X97,\+W@Z3F%M93X-
M"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H
M965T,C(N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z
M17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y396QE8W1E9%]1=6%R=&5R
M;'E?1FEN86YC:6%L7T0\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R
M8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,C,N:'1M;"(O/@T*("`@/"]X
M.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@
M/'@Z3F%M93Y3=6)S97%U96YT7T5V96YT<SPO>#I.86UE/@T*("`@(#QX.E=O
M<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970R-"YH=&UL
M(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS
M:&5E=#X-"B`@("`\>#I.86UE/E-U;6UA<GE?;V9?4VEG;FEF:6-A;G1?06-C
M;W5N=#$\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS
M1")7;W)K<VAE971S+U-H965T,C4N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R
M:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y&
M86ER7U9A;'5E7TUE87-U<F5M96YT<U]486)L97,\+W@Z3F%M93X-"B`@("`\
M>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,C8N
M:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7
M;W)K<VAE970^#0H@("`@/'@Z3F%M93Y#87-H7T-A<VA?17%U:79A;&5N='-?
M86YD7TUA<FLQ/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2
M968],T0B5V]R:W-H965T<R]3:&5E=#(W+FAT;6PB+SX-"B`@(#PO>#I%>&-E
M;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA
M;64^4')O<&5R='E?86YD7T5Q=6EP;65N=%]486)L97,\+W@Z3F%M93X-"B`@
M("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T
M,C@N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC
M96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y#=7)R96YT7T%C8W)U961?3&EA
M8FEL:71I97-?5&$\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@
M2%)E9CTS1")7;W)K<VAE971S+U-H965T,CDN:'1M;"(O/@T*("`@/"]X.D5X
M8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z
M3F%M93Y#;VUM:71M96YT<U]A;F1?0V]N=&EN9V5N8VEE<U\\+W@Z3F%M93X-
M"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H
M965T,S`N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z
M17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y#;VQL86)O<F%T:79E7U)E
M<V5A<F-H7V%N9%]$978\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R
M8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,S$N:'1M;"(O/@T*("`@/"]X
M.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@
M/'@Z3F%M93Y.971?3&]S<U]097)?4VAA<F5?5&%B;&5S/"]X.DYA;64^#0H@
M("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E
M=#,R+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X
M8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^4')E9F5R<F5D7U-T;V-K7T-O
M;6UO;E]3=&]C:U]A,3PO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C
M92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970S,RYH=&UL(B\^#0H@("`\+W@Z
M17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\
M>#I.86UE/D5Q=6ET>5]0;&%N<U]A;F1?4W1O8VM"87-E9%]#;S$\+W@Z3F%M
M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S
M+U-H965T,S0N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@
M/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y);F-O;65?5&%X97-?
M5&%B;&5S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968]
M,T0B5V]R:W-H965T<R]3:&5E=#,U+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O
M<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^
M4V5L96-T961?475A<G1E<FQY7T9I;F%N8VEA;%]$,3PO>#I.86UE/@T*("`@
M(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970S
M-BYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E
M;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/E-U;6UA<GE?;V9?4VEG;FEF:6-A
M;G1?06-C;W5N=#(\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@
M2%)E9CTS1")7;W)K<VAE971S+U-H965T,S<N:'1M;"(O/@T*("`@/"]X.D5X
M8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z
M3F%M93Y&86ER7U9A;'5E7TAI97)A<F-H>5]F;W)?1FEN86X\+W@Z3F%M93X-
M"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H
M965T,S@N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z
M17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y3=6UM87)Y7V]F7T-A<VA?
M0V%S:%]%<75I=F%L96X\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R
M8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,SDN:'1M;"(O/@T*("`@/"]X
M.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@
M/'@Z3F%M93Y3=6UM87)Y7V]F7T%M;W)T:7IE9%]#;W-T7V%N9%\\+W@Z3F%M
M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S
M+U-H965T-#`N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@
M/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y#87-H7T-A<VA?17%U
M:79A;&5N='-?86YD7TUA<FLR/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T
M4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#0Q+FAT;6PB+SX-"B`@
M(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*
M("`@(#QX.DYA;64^0V]M<&]N96YT7V]F7U!R;W!E<G1Y7V%N9%]%<75I/"]X
M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H
M965T<R]3:&5E=#0R+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^4')O<&5R='E?
M86YD7T5Q=6EP;65N=%]!9&1I=&EO/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H
M965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#0S+FAT;6PB+SX-
M"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T
M/@T*("`@(#QX.DYA;64^26YT86YG:6)L95]!<W-E='-?061D:71I;VYA;%])
M/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R
M:W-H965T<R]3:&5E=#0T+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E
M=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0V]M<&]N
M96YT7V]F7T-U<G)E;G1?06-C<G5E9%],/"]X.DYA;64^#0H@("`@/'@Z5V]R
M:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#0U+FAT;6PB
M+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H
M965T/@T*("`@(#QX.DYA;64^4WEM<&AO;GE?1'EN86UO7TEN8U]!9&1I=&EO
M;F%L/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B
M5V]R:W-H965T<R]3:&5E=#0V+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS
M:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^1G5T
M=7)E7TUI;FEM=6U?4&%Y;65N='-?56YD97)?/"]X.DYA;64^#0H@("`@/'@Z
M5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#0W+FAT
M;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R
M:W-H965T/@T*("`@(#QX.DYA;64^0V]M;6ET;65N='-?86YD7T-O;G1I;F=E
M;F-I97-?,3PO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F
M/3-$(E=O<FMS:&5E=',O4VAE970T."YH=&UL(B\^#0H@("`\+W@Z17AC96Q7
M;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE
M/D-O;&QA8F]R871I=F5?4F5S96%R8VA?1&5V96QO<#$\+W@Z3F%M93X-"B`@
M("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T
M-#DN:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC
M96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y3=6UM87)Y7V]F7U)E=F5N=65?
M4F5C;V=N:7IE9%\\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@
M2%)E9CTS1")7;W)K<VAE971S+U-H965T-3`N:'1M;"(O/@T*("`@/"]X.D5X
M8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z
M3F%M93Y#;VUP=71A=&EO;E]O9E]"87-I8U]A;F1?1&EL=70\+W@Z3F%M93X-
M"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H
M965T-3$N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z
M17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y0<F5F97)R961?4W1O8VM?
M0V]M;6]N7U-T;V-K7V$R/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U
M<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#4R+FAT;6PB+SX-"B`@(#PO
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^5V%R<F%N='-?27-S=65D7W1O7U!U<F-H87-E7T-O/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#4S+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^17%U:71Y7U!L86YS
M7V%N9%]3=&]C:T)A<V5D7T-O,CPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E
M=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970U-"YH=&UL(B\^#0H@
M("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@("`\>#I.86UE/D]P=&EO;E]!8W1I=FET>5]U;F1E<E]3=&]C:U]0;#PO
M>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS
M:&5E=',O4VAE970U-2YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^
M#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/E-U;6UA<GE?
M;V9?4F5S=')I8W1E9%]3=&]C:U]5;CPO>#I.86UE/@T*("`@(#QX.E=O<FMS
M:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970U-BYH=&UL(B\^
M#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E
M=#X-"B`@("`\>#I.86UE/D9A:7)?5F%L=65"87-E9%]-96%S=7)E;65N='-?
M83PO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O
M<FMS:&5E=',O4VAE970U-RYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE
M970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/E-T;V-K
M0F%S961?0V]M<&5N<V%T:6]N7T5X<&5N<SPO>#I.86UE/@T*("`@(#QX.E=O
M<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970U."YH=&UL
M(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS
M:&5E=#X-"B`@("`\>#I.86UE/D-O;7!O;F5N=%]O9E]#;VYS;VQI9&%T961?
M26YC;SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$
M(E=O<FMS:&5E=',O4VAE970U.2YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K
M<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/D1I
M9F9E<F5N8V5?8F5T=V5E;E]#;VYS;VQI9&%T93PO>#I.86UE/@T*("`@(#QX
M.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970V,"YH
M=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O
M<FMS:&5E=#X-"B`@("`\>#I.86UE/D-O;7!O;F5N=%]O9E]$969E<G)E9%]4
M87A?07-S93PO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F
M/3-$(E=O<FMS:&5E=',O4VAE970V,2YH=&UL(B\^#0H@("`\+W@Z17AC96Q7
M;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE
M/DEN8V]M95]487AE<U]!9&1I=&EO;F%L7TEN9F]R;3PO>#I.86UE/@T*("`@
M(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970V
M,BYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E
M;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/E-E;&5C=&5D7U%U87)T97)L>5]&
M:6YA;F-I86Q?1#(\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@
M2%)E9CTS1")7;W)K<VAE971S+U-H965T-C,N:'1M;"(O/@T*("`@/"]X.D5X
M8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z
M3F%M93Y3=6)S97%U96YT7T5V96YT7T%D9&ET:6]N86Q?26X\+W@Z3F%M93X-
M"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H
M965T-C0N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`\+W@Z
M17AC96Q7;W)K<VAE971S/@T*("`\>#I3='EL97-H965T($A2968],T0B5V]R
M:W-H965T<R]R97!O<G0N8W-S(B\^#0H@(#QX.D%C=&EV95-H965T/C`\+W@Z
M06-T:79E4VAE970^#0H@(#QX.E!R;W1E8W13=')U8W1U<F4^1F%L<V4\+W@Z
M4')O=&5C=%-T<G5C='5R93X-"B`@/'@Z4')O=&5C=%=I;F1O=W,^1F%L<V4\
M+W@Z4')O=&5C=%=I;F1O=W,^#0H@/"]X.D5X8V5L5V]R:V)O;VL^#0H\+WAM
M;#X\(5ME;F1I9ETM+3X-"CPO:&5A9#X-"B`@/&)O9'D^#0H@("`\<#Y4:&ES
M('!A9V4@<VAO=6QD(&)E(&]P96YE9"!W:71H($UI8W)O<V]F="!%>&-E;"!8
M4"!O<B!N97=E<BX\+W`^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM
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M:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV
M/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T
M/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$
M4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R
M:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P
M;W)T(&ED/3-$240P1595044^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^1&]C
M=6UE;G0@86YD($5N=&ET>2!);F9O<FUA=&EO;B`H55-$("0I/&)R/CPO<W1R
M;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q
M/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M(&-O;'-P86X],T0Q/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O
M;'-P86X],T0Q/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/D9E8BX@,C@L(#(P,30\8G(^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`R."P@,C`Q,SQB<CX\+W1H
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY$;V-U;65N
M="!);F9O<FUA=&EO;B!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&]C=6UE;G0@5'EP93PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)S$P+4L\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06UE;F1M96YT
M($9L86<\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B=F86QS93QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y$;V-U;65N="!097)I;V0@16YD($1A=&4\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/D1E8R`S,2P-"@D),C`Q,SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$;V-U;65N="!&:7-C
M86P@665A<B!&;V-U<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)S(P,3,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^1&]C=6UE;G0@1FES8V%L(%!E<FEO9"!&;V-U<SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)T99/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1R861I;F<@4WEM8F]L
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG1%9!6#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%;G1I
M='D@4F5G:7-T<F%N="!.86UE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG1%E.059!6"!414-(3D],3T=)15,@0T]24#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%;G1I='D@0V5N
M=')A;"!);F1E>"!+97D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<P,#`Q,#(Y,30R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D-U<G)E;G0@1FES8V%L(%EE87(@16YD($1A=&4\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<M+3$R+3,Q/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5N
M=&ET>2!796QL+6MN;W=N(%-E87-O;F5D($ES<W5E<CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)TYO/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5N=&ET>2!#=7)R96YT(%)E<&]R
M=&EN9R!3=&%T=7,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B=9
M97,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^16YT:71Y(%9O;'5N=&%R>2!&:6QE<G,\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B=.;SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%;G1I='D@1FEL97(@0V%T96=O<GD\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B=!8V-E;&5R871E9"!&
M:6QE<CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y%;G1I='D@0V]M;6]N(%-T;V-K+"!3:&%R97,@3W5T<W1A;F1I
M;F<\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-C(L.#4U+#DU
M.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D5N=&ET>2!0=6)L:6,@1FQO870\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)"`Q,#4L-3$Y+#8R-#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^
M#0H-"BTM+2TM+3U?3F5X=%!A<G1?-V5A.#)B,CE?.3@R-E\T,#)A7V(Y-C!?
M,#(Q-69D.&)A9&4X#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S=E
M83@R8C(Y7SDX,C9?-#`R85]B.38P7S`R,35F9#AB861E."]7;W)K<VAE971S
M+U-H965T,#(N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O
M=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S
M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@
M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M
M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R
M:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE
M;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C
M;&%S<STS1')E<&]R="!I9#TS1$E$,$5!3D%'/@T*("`@("`@/'1R/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,3X\
M<W1R;VYG/D-O;G-O;&ED871E9"!"86QA;F-E(%-H965T<R`H55-$("0I/&)R
M/DEN(%1H;W5S86YD<RP@=6YL97-S(&]T:&5R=VES92!S<&5C:69I960\+W-T
M<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R
M,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L
M(#(P,3(\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS
M=')O;F<^0W5R<F5N="!A<W-E=',Z/"]S=')O;F<^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^0V%S:"!A;F0@8V%S:"!E<75I=F%L96YT
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R,RPQ,C(\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#<L
M-3DY/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y-87)K971A8FQE('-E8W5R:71I97,@879A:6QA8FQE+69O<BUS86QE
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-C8L,C4T/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3$W+#4S
M,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^06-C;W5N=',@<F5C96EV86)L93PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,2PV,C<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ+#`P-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^4')E<&%I9"!E>'!E;G-E<R!A;F0@;W1H
M97(@8W5R<F5N="!A<W-E=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$L,S<U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,BPP-3(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;W4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!C=7)R96YT(&%S<V5T<SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3DR+#,W.#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$R."PQ.#<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;W!E
M<G1Y(&%N9"!E<75I<&UE;G0L(&YE=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^."PW,#8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XW+#DV-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^1V]O9'=I;&P\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C(L-3<Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,BPT-S4\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)E<W1R:6-T960@8V%S:#PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-C8R/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-C4R/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/=&AE<B!A
M<W-E=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(Y-SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0W,SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E1O=&%L(&%S<V5T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,C`T+#8R,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$S.2PW-3(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^0W5R<F5N="!L:6%B:6QI=&EE<SH\
M+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!
M8V-O=6YT<R!P87EA8FQE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XQ+#DP,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C(L,38V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y!8V-R=65D(&QI86)I;&ET:65S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XX+#$V-CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$P+#`V,SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&5F97)R960@<F5V
M96YU97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8L,3(U/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-BPW
M.#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;W4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y4;W1A;"!C=7)R96YT(&QI86)I;&ET:65S/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XQ-BPQ.3(\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ.2PP,30\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1E9F5R<F5D(')E=F5N
M=65S+"!N970@;V8@8W5R<F5N="!P;W)T:6]N/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ+#$W,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C4L,C@S/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/=&AE<B!L;VYG+71E<FT@;&EA
M8FEL:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/CDV,SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8R
M.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E1O=&%L(&QI86)I;&ET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ."PS,C@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XR-"PY,C8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O;6UI=&UE;G1S(&%N9"!C;VYT:6YG
M96YC:65S("A.;W1E(#DI/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3=&]C:VAO
M;&1E<G/B@)D@97%U:71Y.CPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E!R969E<G)E9"!S=&]C:SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D-O;6UO;B!S=&]C:SH@)#`N,#`Q('!A<B!V86QU93L@,S4P+#`P,"!A;F0@
M,C4P+#`P,"!S:&%R97,@875T:&]R:7IE9"!A="!$96-E;6)E<B`S,2P@,C`Q
M,R!A;F0@,C`Q,BP@<F5S<&5C=&EV96QY.R`R-C(L-SDV(&%N9"`Q.#(L-SDR
M('-H87)E<R!I<W-U960@86YD(&]U='-T86YD:6YG(&%T($1E8V5M8F5R(#,Q
M+"`R,#$S(&%N9"`R,#$R+"!R97-P96-T:79E;'D\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C(V,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$X,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^061D:71I;VYA;"!P86ED+6EN(&-A
M<&ET86P\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8X."PS.3`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU
M-3`L-S(Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y4;W1A;"!A8V-U;75L871E9"!O=&AE<B!C;VUP<F5H96YS:79E
M(&QO<W,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$T."D\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@U.34I
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y!8V-U;75L871E9"!D969I8VET/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B@U,#(L,C$Q*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#0S-2PT.3$I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F5U/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5&]T86P@<W1O8VMH;VQD97)S
MXH"9(&5Q=6ET>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3@V
M+#(Y-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$Q-"PX,C8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;W4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y4;W1A;"!L:6%B:6QI=&EE<R!A;F0@<W1O8VMH;VQD
M97)SXH"9(&5Q=6ET>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,C`T+#8R,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$S.2PW-3(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E-E<FEE<R!"($-O;G9E<G1I8FQE(%!R969E<G)E
M9"!3=&]C:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS
M=')O;F<^4W1O8VMH;VQD97)SXH"9(&5Q=6ET>3H\+W-T<F]N9SX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F5F97)R960@<W1O8VL\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].
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M#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$
M0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T
M9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO
M=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T
M/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T
M(&ED/3-$240P151-044^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0Q/CQS=')O;F<^0V]N<V]L
M:61A=&5D($)A;&%N8V4@4VAE971S("A087)E;G1H971I8V%L*2`H55-$("0I
M/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E
M8RX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M1&5C+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y$96,N(#,Q+"`R,#$S/&)R/E-E<FEE<R!"($-O;G9E<G1I8FQE(%!R969E
M<G)E9"!3=&]C:SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$
M96,N(#,Q+"`R,#$R/&)R/E-E<FEE<R!"($-O;G9E<G1I8FQE(%!R969E<G)E
M9"!3=&]C:SQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M4')E9F5R<F5D('-T;V-K+"!P87(@=F%L=64\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@,"XP,#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N,#`Q/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R969E<G)E9"!S=&]C
M:RP@<VAA<F5S(&%U=&AO<FEZ960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C4L,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C4L,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0S+#`P,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R969E<G)E9"!S
M=&]C:RP@<VAA<F5S(&ES<W5E9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^4')E9F5R<F5D('-T;V-K+"!S:&%R97,@;W5T<W1A;F1I
M;F<\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O;6UO
M;B!S=&]C:RP@<&%R('9A;'5E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XD(#`N,#`Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)"`P+C`P,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@<W1O8VLL('-H87)E<R!A
M=71H;W)I>F5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS-3`L
M,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C(U,"PP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O;6UO;B!S=&]C:RP@<VAA<F5S(&ES
M<W5E9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C8R+#<Y-BPP
M,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XQ.#(L-SDR+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@<W1O8VLL('-H87)E<R!O=71S=&%N
M9&EN9SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C8R+#<Y-BPP
M,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XQ.#(L-SDR+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM
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M:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV
M/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T
M/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$
M4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R
M:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P
M;W)T(&ED/3-$240P15=+04<^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^0V]N
M<V]L:61A=&5D(%-T871E;65N=',@;V8@3W!E<F%T:6]N<R`H55-$("0I/&)R
M/DEN(%1H;W5S86YD<RP@97AC97!T(%!E<B!3:&%R92!D871A+"!U;FQE<W,@
M;W1H97)W:7-E('-P96-I9FEE9#PO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H(&-O;'-P86X],T0S/C$R($UO;G1H<R!%;F1E9#PO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y$96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^1&5C+B`S,2P@,C`Q,3QB<CX\+W1H/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^/'-T<F]N9SY2979E;G5E<SH\+W-T<F]N9SX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]L;&%B;W)A=&EO
M;B!R979E;G5E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#0L
M.3(Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^)"`T+#8Q,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/B0@,3<L,3DP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y'<F%N="!R979E;G5E/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XU+#$S.#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,L.3,Y/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,RPQ,3`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-E<G9I8V4@
M86YD(&QI8V5N<V4@<F5V96YU93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,2PQ.#0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ+#$V-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$L,S$T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F5U/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5&]T86P@<F5V96YU97,\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$Q+#(U,3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/CDL-S$T/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C$L-C$T/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\
M<W1R;VYG/D]P97)A=&EN9R!E>'!E;G-E<SH\+W-T<F]N9SX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4F5S96%R8V@@86YD(&1E=F5L
M;W!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,"PX-S`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT
M.2PQ-#8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XU,2PS,C(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D=E;F5R86P@86YD(&%D;6EN:7-T<F%T:79E/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-2PY-#,\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR."PQ-C0\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-RPU-S`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E5N;V-C=7!I960@9F%C:6QI='D@97AP96YS93PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^.3(V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%M;W)T:7IA=&EO;B!O9B!I;G1A;F=I
M8FQE(&%S<V5T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR
M.3D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R974^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y4;W1A;"!O<&5R871I;F<@97AP96YS97,\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C<W+#<S.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C<W+#,Q,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8Y+#$Y,3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O=3X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DQO<W,@9G)O
M;2!O<&5R871I;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@V
M-BPT.#@I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XH-C<L-3DV*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6T^*#0W+#4W-RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3W1H97(@:6YC;VUE("AE
M>'!E;G-E*3H\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^26YT97)E<W0@:6YC;VUE/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ,38\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XR.3$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XQ,#,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/DEN=&5R97-T(&5X<&5N<V4\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R+#,U,2D\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q+#DU-RD\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]T:&5R
M(&EN8V]M92`H97AP96YS92D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^*#,T."D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B@R.3,I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^.#,T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F5U/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^3F5T(&QO<W,\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6T^*#8V+#<R,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B@V.2PY-#DI/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-#@L-3DW*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')E9F5R<F5D
M('-T;V-K(&1E96UE9"!D:79I9&5N9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XH."PT-CDI/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y.970@;&]S<R!A;&QO8V%B;&4@=&\@8V]M
M;6]N('-T;V-K:&]L9&5R<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;3XD("@W-2PQ.#DI/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XD("@V.2PY-#DI/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XD("@T."PU.3<I/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@;&]S<R!P97(@
M<VAA<F4@86QL;V-A8FQE('1O(&-O;6UO;B!S=&]C:VAO;&1E<G,@+2!B87-I
M8R!A;F0@9&EL=71E9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD
M("@P+C,X*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^)"`H,"XT,2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B0@*#`N,SDI/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y796EG:'1E9"!A=F5R86=E('-H87)E
M<R!O=71S=&%N9&EN9R!U<V5D('1O(&-O;7!U=&4@8F%S:6,@86YD(&1I;'5T
M960@;F5T(&QO<W,@<&5R('-H87)E(&%L;&]C86)L92!T;R!C;VUM;VX@<W1O
M8VMH;VQD97)S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ.38L
M,C<U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,3<P+#0V.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$R-2PQ,#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM
M+2T]7TYE>'1087)T7S=E83@R8C(Y7SDX,C9?-#`R85]B.38P7S`R,35F9#AB
M861E.`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\W96$X,F(R.5\Y
M.#(V7S0P,F%?8CDV,%\P,C$U9F0X8F%D93@O5V]R:W-H965T<R]3:&5E=#`U
M+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN
M=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA
M<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U
M:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S
M970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,]
M,T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S
M8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R
M97!O<G0@:60],T1)1#!%2$]!0SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY#
M;VYS;VQI9&%T960@4W1A=&5M96YT<R!O9B!#;VUP<F5H96YS:79E($QO<W,@
M*%531"`D*3QB<CY);B!4:&]U<V%N9',L('5N;&5S<R!O=&AE<G=I<V4@<W!E
M8VEF:65D/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@
M8V]L<W!A;CTS1#,^,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L
M(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S
M,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N
M(#,Q+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y.970@;&]S<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@V
M-BPW,C`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XD("@V.2PY-#DI/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XD("@T."PU.3<I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D]T:&5R(&-O;7!R
M96AE;G-I=F4@:6YC;VUE("AL;W-S*3H\+W-T<F]N9SX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^56YR96%L:7IE9"`H;&]S<RD@9V%I
M;B!O;B!M87)K971A8FQE('-E8W5R:71I97,@879A:6QA8FQE+69O<BUS86QE
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@W-BD\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT.#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$T/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#=6UU
M;&%T:79E('1R86YS;&%T:6]N(&%D:G5S=&UE;G0\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C4R,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C,V-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6T^*#(W-RD\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R974^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!O=&AE<B!C;VUP
M<F5H96YS:79E(&EN8V]M92`H;&]S<RD\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C0T-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C0Q-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#(V,RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;W4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!C;VUP<F5H96YS:79E(&QO
M<W,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H-C8L,C<S*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H
M-CDL-3,U*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^)"`H-#@L.#8P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM
M+3U?3F5X=%!A<G1?-V5A.#)B,CE?.3@R-E\T,#)A7V(Y-C!?,#(Q-69D.&)A
M9&4X#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S=E83@R8C(Y7SDX
M,C9?-#`R85]B.38P7S`R,35F9#AB861E."]7;W)K<VAE971S+U-H965T,#8N
M:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT
M86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S
M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I
M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E
M=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS
M1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C
M<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E
M<&]R="!I9#TS1$E$,$5.2D)+/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,3X\<W1R;VYG/D-O
M;G-O;&ED871E9"!3=&%T96UE;G1S(&]F(%-T;V-K:&]L9&5R<R<@17%U:71Y
M("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^5&]T86P\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M0V]M;6]N(%-T;V-K/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/E!R969E<G)E9"!3=&]C:SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y!9&1I=&EO;F%L(%!A:60M:6X@0V%P:71A;#QB<CX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y!8V-U;75L871E9"!/=&AE<B!#;VUP<F5H
M96YS:79E($EN8V]M92`H3&]S<RD\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^06-C=6UU;&%T960@1&5F:6-I=#QB<CX\+W1H/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')C/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^0F5G:6YN:6YG($)A;&%N8V5S(&%T($1E
M8RX@,S$L(#(P,3`\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@
M-3(L,3$Q+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/B0@,3$V+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,V.2PV.#8L,#`P
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD
M("@W-#8L,#`P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6T^)"`H,S$V+#DT-2PP,#`I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F,^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y"96=I;FYI;F<@0F%L86YC97,@
M*&EN('-H87)E<RD@870@1&5C+B`S,2P@,C`Q,#PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$Q-2PV,3$L,#`P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^27-S=6%N8V4@;V8@
M8V]M;6]N('-T;V-K('5P;VX@97AE<F-I<V4@;V8@<W1O8VL@;W!T:6]N<R!A
M;F0@<F5S=')I8W1E9"!S=&]C:R!A=V%R9',\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,3`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DES<W5A;F-E(&]F
M(&-O;6UO;B!S=&]C:R!U<&]N(&5X97)C:7-E(&]F('-T;V-K(&]P=&EO;G,@
M86YD(')E<W1R:6-T960@<W1O8VL@87=A<F1S("A);B!3:&%R97,I/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S`X+#`P,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DES<W5A
M;F-E(&]F(&-O;6UO;B!S=&]C:R!U;F1E<B!%;7!L;WEE92!3=&]C:R!0=7)C
M:&%S92!0;&%N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,S(L
M,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,S(L,#`P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N
M8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/DES<W5A;F-E(&]F(&-O;6UO;B!S=&]C:R!U
M;F1E<B!%;7!L;WEE92!3=&]C:R!0=7)C:&%S92!0;&%N("AI;B!S:&%R97,I
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`V+#`P,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E!R;V-E961S(&9R;VT@:7-S=6%N8V5S(&]F(&-O;6UO;B!S=&]C:R!A;F0@
M=V%R<F%N=',L(&YE="!O9B!I<W-U86YC92!C;W-T<SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^.3$L,CDX+#`P,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,Y+#`P,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S
M<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XY,2PR-3DL,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;V-E
M961S(&9R;VT@:7-S=6%N8V5S(&]F(&-O;6UO;B!S=&]C:R!A;F0@=V%R<F%N
M=',L(&YE="!O9B!I<W-U86YC92!C;W-T<R`H:6X@<VAA<F5S*3PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,X+#8P,2PP,#`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3=&]C
M:R!C;VUP96YS871I;VX@97AP96YS93PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-2PQ.#DL,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU
M+#$X.2PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5&]T86P@;W1H
M97(@8V]M<')E:&5N<VEV92!I;F-O;64@*&QO<W,I/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M/B@R-C,L,#`P*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[
M)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6T^*#(V,RPP,#`I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T
M(&QO<W,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#0X+#4Y-RPP
M,#`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N
M8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6T^*#0X+#4Y-RPP,#`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F,^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%;F1I;F<@0F%L86YC97,@870@1&5C
M+B`S,2P@,C`Q,3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.3DL
M.#@P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$U-2PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#8V+#(W-BPP,#`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q+#`P.2PP
M,#`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;3XH,S8U+#4T,BPP,#`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F,^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y%;F1I;F<@0F%L86YC97,@*&EN('-H87)E<RD@
M870@1&5C+B`S,2P@,C`Q,3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$U-"PV,C8L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^27-S=6%N8V4@;V8@8V]M;6]N('-T;V-K
M('5P;VX@97AE<F-I<V4@;V8@<W1O8VL@;W!T:6]N<R!A;F0@<F5S=')I8W1E
M9"!S=&]C:R!A=V%R9',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C$L.34U+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L.34T+#`P,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF
M;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y)<W-U86YC92!O9B!C;VUM;VX@<W1O8VL@
M=7!O;B!E>&5R8VES92!O9B!S=&]C:R!O<'1I;VYS(&%N9"!R97-T<FEC=&5D
M('-T;V-K(&%W87)D<R`H26X@4VAA<F5S*3PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$L,C(R+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DES<W5A;F-E(&]F(&-O;6UO
M;B!S=&]C:R!U;F1E<B!%;7!L;WEE92!3=&]C:R!0=7)C:&%S92!0;&%N/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,#<L,#`P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N
M8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XS,#<L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF
M;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/DES<W5A;F-E(&]F(&-O;6UO;B!S=&]C:R!U;F1E<B!%;7!L;WEE
M92!3=&]C:R!0=7)C:&%S92!0;&%N("AI;B!S:&%R97,I/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,30Q+#`P,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;V-E961S(&9R
M;VT@:7-S=6%N8V5S(&]F(&-O;6UO;B!S=&]C:R!A;F0@=V%R<F%N=',L(&YE
M="!O9B!I<W-U86YC92!C;W-T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-S$L-S@P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C(W+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW,2PW-3,L,#`P
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;V-E961S(&9R;VT@:7-S
M=6%N8V5S(&]F(&-O;6UO;B!S=&]C:R!A;F0@=V%R<F%N=',L(&YE="!O9B!I
M<W-U86YC92!C;W-T<R`H:6X@<VAA<F5S*3PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C(V+#@P,RPP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3=&]C:R!C;VUP96YS871I
M;VX@97AP96YS93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`L
M-#,Y+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`L-#,Y+#`P,#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F
M;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!O=&AE<B!C;VUP<F5H
M96YS:79E(&EN8V]M92`H;&]S<RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C0Q-"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S
M<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XT,30L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T(&QO<W,\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#8Y+#DT.2PP,#`I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N
M8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#8Y
M+#DT.2PP,#`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F,^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y%;F1I;F<@0F%L86YC97,@870@1&5C+B`S,2P@,C`Q,CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3$T+#@R-BPP,#`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ.#,L
M,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C4U,"PW,CDL,#`P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-3DU+#`P,"D\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@T,S4L-#DQ+#`P
M,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R8SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D5N9&EN9R!"86QA;F-E<R`H:6X@<VAA<F5S*2!A="!$96,N(#,Q+"`R
M,#$R/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3@R+#<Y,BPP
M,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y)<W-U86YC92!O9B!C;VUM;VX@<W1O8VL@=7!O;B!E>&5R8VES
M92!O9B!S=&]C:R!O<'1I;VYS(&%N9"!R97-T<FEC=&5D('-T;V-K(&%W87)D
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3$R+#`P,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB
M<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,3$R+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)<W-U86YC92!O9B!C
M;VUM;VX@<W1O8VL@=7!O;B!E>&5R8VES92!O9B!S=&]C:R!O<'1I;VYS(&%N
M9"!R97-T<FEC=&5D('-T;V-K(&%W87)D<R`H26X@4VAA<F5S*3PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$P-BPP,#`\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)<W-U86YC
M92!O9B!C;VUM;VX@<W1O8VL@=6YD97(@16UP;&]Y964@4W1O8VL@4'5R8VAA
M<V4@4&QA;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C(T+#`P
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,C(T+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)<W-U86YC
M92!O9B!C;VUM;VX@<W1O8VL@=6YD97(@16UP;&]Y964@4W1O8VL@4'5R8VAA
M<V4@4&QA;B`H:6X@<VAA<F5S*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$R.2PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y297-T<FEC=&5D(%-T;V-K($%W87)D($1E
M;&EV97)E9"`H:6X@<VAA<F5S*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$Q-2PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y)<W-U86YC92!O9B!C;VUM;VX@<W1O8VLL
M(&YE="!O9B!I<W-U86YC92!C;W-T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^.#`L.3DY+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C@P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX,"PY,3DL,#`P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N
M8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/DES<W5A;F-E(&]F(&-O;6UO;B!S=&]C:RP@;F5T(&]F(&ES<W5A
M;F-E(&-O<W1S("AI;B!S:&%R97,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-SDL-3<P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DES<W5A;F-E(&]F(%-E<FEE<R!"
M(&-O;G9E<G1I8FQE('!R969E<G)E9"!S=&]C:RP@;F5T(&]F(&ES<W5A;F-E
M(&-O<W1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT-"PR,#DL
M,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XT-"PR,#DL,#`P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DES
M<W5A;F-E(&]F(%-E<FEE<R!"(&-O;G9E<G1I8FQE('!R969E<G)E9"!S=&]C
M:RP@;F5T(&]F(&ES<W5A;F-E(&-O<W1S("AI;B!S:&%R97,I/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0S+#`P,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F5N969I8VEA
M;"!C;VYV97)S:6]N(&9E871U<F4@;V8@4V5R:65S($(@8V]N=F5R=&EB;&4@
M<')E9F5R<F5D('-T;V-K/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB
M<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1E96UE9"!D
M:79I9&5N9"!T;R!H;VQD97)S(&]F(%-E<FEE<R!"(&-O;G9E<G1I8FQE('!R
M969E<G)E9"!S=&]C:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P
M.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y787)R86YT<R!E
M>&5R8VES960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S
M<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S
M<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5V%R<F%N=',@97AE<F-I
M<V5D("AI;B!S:&%R97,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^.#0L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^4W1O8VL@8V]M<&5N<V%T:6]N(&5X<&5N<V4\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$R+#,T,"PP,#`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$R+#,T
M,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^5&]T86P@;W1H97(@8V]M<')E:&5N<VEV92!I;F-O;64@*&QO
M<W,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT-#<L,#`P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M-#0W+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/DYE="!L;W-S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B@V-BPW,C`L,#`P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B@V-BPW,C`L,#`P*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^26YI=&EA;"!E>'!E
M;G-E<R!R96QA=&5D('1O($%432!A9W)E96UE;G0\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#$T,RPP,#`I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q-#,L,#`P*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F,^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%;F1I;F<@
M0F%L86YC97,@870@1&5C+B`S,2P@,C`Q,SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)"`Q.#8L,CDT+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,C8S+#`P,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#8X."PS.3`L
M,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;3XD("@Q-#@L,#`P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6T^)"`H-3`R+#(Q,2PP,#`I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F,^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%;F1I;F<@0F%L86YC97,@
M*&EN('-H87)E<RD@870@1&5C+B`S,2P@,C`Q,SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C(V,BPW.38L,#`P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#,L,#`P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D
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M:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-
M"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0]
M,T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T
M97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E
M(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@
M("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14900D<^#0H@("`@
M("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O
M=W-P86X],T0R/CQS=')O;F<^0V]N<V]L:61A=&5D(%-T871E;65N=',@3V8@
M0V%S:"!&;&]W<R`H55-$("0I/&)R/DEN(%1H;W5S86YD<RP@=6YL97-S(&]T
M:&5R=VES92!S<&5C:69I960\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:"!C;VQS<&%N/3-$,SXQ,B!-;VYT:',@16YD960\+W1H/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/D1E8RX@,S$L(#(P,3$\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/CQS=')O;F<^3W!E<F%T:6YG(&%C=&EV:71I97,\+W-T
M<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T
M(&QO<W,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H-C8L-S(P
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M)"`H-CDL.30Y*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6T^)"`H-#@L-3DW*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY!9&IU<W1M96YT<R!T;R!R
M96-O;F-I;&4@;F5T(&QO<W,@=&\@;F5T(&-A<V@@=7-E9"!I;B!O<&5R871I
M;F<@86-T:79I=&EE<SH\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^1&5P<F5C:6%T:6]N(&%N9"!A;6]R=&EZ871I;VX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,S(W/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PR,#<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#,P
M,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^06UO<G1I>F%T:6]N(&]F(&EN=&%N9VEB;&4@87-S971S/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(Y.3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3&]S<R`H9V%I;BD@;VX@
M9&ES<&]S86P@;V8@<')O<&5R='D@86YD(&5Q=6EP;65N=#PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,3@\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XX/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%C8W)E=&EO;B!O9B!D:7-C
M;W5N=',@86YD(&%M;W)T:7IA=&EO;B!O9B!P<F5M:75M<R!O9B!M87)K971A
M8FQE('-E8W5R:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/CDR,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$L,CDX/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,2PQ-S(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/DEN=&5R97-T(&%S<V]C:6%T960@=VET:"!L;VYG
M+71E<FT@;F]T92!P87EA8FQE('1O(%-Y;7!H;VYY($1Y;F%M;R!(;VQD:6YG
M<R!,3$,@*.*`G$AO;&1I;F=S*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C(L,3DP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,2PX-S$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
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M3$,@*&-O;&QE8W1I=F5L>2P@(E-Y;7!H;VYY(BD\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;3XH.#0S*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^56YO8V-U<&EE9"!F86-I;&ET>2!E
M>'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY,C8\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M4W1O8VL@8V]M<&5N<V%T:6]N(&5X<&5N<V4\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$R+#,T,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$P+#0S.3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4L,3@Y/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D-H86YG
M97,@:6X@;W!E<F%T:6YG(&%S<V5T<R!A;F0@;&EA8FEL:71I97,Z/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%C8V]U
M;G1S(')E8V5I=F%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M*#8R,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XX+#4R,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6T^*#@L-3(V*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^4')E<&%I9"!E>'!E;G-E<R!A;F0@;W1H97(@
M8W5R<F5N="!A<W-E=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C8W-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^*#DR,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XR,S`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E)E<W1R:6-T960@8V%S:"!A;F0@;W1H97(@87-S971S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-S8\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q,38I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,CDP*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M06-C;W5N=',@<&%Y86)L93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;3XH-C4W*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$R-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6T^*#(X.2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D%C8W)U960@;&EA8FEL:71I97,@86YD(&]T:&5R
M(&QO;F<@=&5R;2!L:6%B:6QI=&EE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XH,BPR.3$I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,2PY,38\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B@R+#$V-RD\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1E9F5R<F5D(')E=F5N=65S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@T+#<W,"D\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#0W,CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,L
M-3$R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F5U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^3F5T(&-A<V@@=7-E9"!I;B!O<&5R871I;F<@86-T:79I=&EE<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-3@L-C<S*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#0S+#@P.2D\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@T
M-RPQ,38I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#X\<W1R;VYG/DEN=F5S=&EN9R!A8W1I=FET:65S/"]S=')O;F<^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!U<F-H87-E
M<R!O9B!M87)K971A8FQE('-E8W5R:71I97,\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6T^*#$Y,BPP-#0I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH,C`V+#$T.2D\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q,3$L,C`U*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')O8V5E
M9',@9G)O;2!M871U<FET:65S(&]F(&UA<FME=&%B;&4@<V5C=7)I=&EE<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,30R+#,R,3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$V.2PS.#<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW
M-RPW,CD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E!U<F-H87-E<R!O9B!P<F]P97)T>2!A;F0@97%U:7!M96YT+"!N
M970\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$L-C(Y*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#(L.3,Q
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M*#$L,30R*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/DYE="!C87-H('5S960@:6X@:6YV97-T:6YG(&%C=&EV:71I
M97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#4Q+#,U,BD\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@S.2PV
M.3,I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;3XH,S0L-C$X*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^/'-T<F]N9SY&:6YA;F-I;F<@86-T:79I=&EE<SPO<W1R
M;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F]C
M965D<R!F<F]M(&ES<W5A;F-E<R!O9B!C;VUM;VX@<W1O8VL\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C@P+#@U-CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<Q+#<X,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/CDQ+#(Y.#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')O
M8V5E9',@9G)O;2!I<W-U86YC97,@;V8@<')E9F5R<F5D('-T;V-K/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT-"PR,#D\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')O8V5E9',@
M9G)O;2!I<W-U86YC97,@;V8@=V%R<F%N=',\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P
M.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^4')O8V5E9',@9G)O;2!E>&5R8VES92!O9B!S=&]C:R!O<'1I
M;VYS(&%N9"!R97-T<FEC=&5D('-T;V-K(&%W87)D<SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,3$R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,2PY-34\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')O8V5E9',@9G)O;2!E
M;7!L;WEE92!S=&]C:R!P=7)C:&%S92!P;&%N/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XR,C0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XS,#<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ,S(\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!A>6UE;G0@;V8@;F]T97,@<&%Y
M86)L92!T;R!(;VQD:6YG<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^*#$U+#`P,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F]U/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^3F5T(&-A<V@@<')O=FED960@8GD@9FEN86YC:6YG
M(&%C=&EV:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$R
M-2PT,#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XU.2PP-#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XY,2PT-#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D5F9F5C="!O9B!E>&-H86YG92!R871E(&-H
M86YG97,@;VX@8V%S:"!A;F0@8V%S:"!E<75I=F%L96YT<SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,30W/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3$X/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,C$X*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O=3X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!I;F-R96%S
M92`H9&5C<F5A<V4I(&EN(&-A<V@@86YD(&-A<V@@97%U:79A;&5N=',\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$U+#4R,SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#(T+#,T,BD\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY+#0X
M.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^0V%S:"!A;F0@8V%S:"!E<75I=F%L96YT<R!A="!B96=I;FYI;F<@;V8@
M>65A<CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-RPU.3D\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,2PY
M-#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XR,BPT-3,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D-A<V@@86YD(&-A<V@@97%U:79A;&5N=',@870@96YD(&]F
M('EE87(\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(S+#$R,CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<L
M-3DY/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,S$L.30Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#X\<W1R;VYG/DYO;BUC87-H(&EN=F5S=&EN9R!A;F0@9FEN
M86YC:6YG(&%C=&EV:71I97,Z/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D1I<W!O<V%L(&]F(&9U;&QY(&1E<')E8VEA
M=&5D('!R;W!E<G1Y(&%N9"!E<75I<&UE;G0\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C@V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,38Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,2PQ.#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!C:&%N9V4@:6X@=6YR96%L
M:7IE9"`H;&]S<RD@9V%I;B!O;B!M87)K971A8FQE('-E8W5R:71I97,\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H-S8I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`T.#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,30\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@
M/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S=E83@R8C(Y
M7SDX,C9?-#`R85]B.38P7S`R,35F9#AB861E.`T*0V]N=&5N="U,;V-A=&EO
M;CH@9FEL93HO+R]#.B\W96$X,F(R.5\Y.#(V7S0P,F%?8CDV,%\P,C$U9F0X
M8F%D93@O5V]R:W-H965T<R]3:&5E=#`X+FAT;6P-"D-O;G1E;G0M5')A;G-F
M97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@
M=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH
M96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N
M=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP
M93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!2
M96UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D
M>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%040^#0H@
M("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q
M(')O=W-P86X],T0R/CQS=')O;F<^3W)G86YI>F%T:6]N/&)R/CPO<W1R;VYG
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R
M($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$S/&)R/CPO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/<F=A;FEZ871I;VX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\9&EV/@T*/&1I=B!A;&EG
M;CTS1&QE9G0^/'1A8FQE(&)O<F1E<CTS1#`@8V5L;'-P86-I;F<],T0P(&-E
M;&QP861D:6YG/3-$,"!S='EL93TS1"=B;W)D97(M8V]L;&%P<V4Z8V]L;&%P
M<V4[('=I9'1H.C$P,"4[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E
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M9VX],T1T;W`@<W1Y;&4],T1W:61T:#HY-2XT-B4[/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,3)P=#MF;VYT+7-I>F4Z,3!P
M=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7=E:6=H=#IB;VQD.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^3W)G86YI>F%T:6]N
M(#PO9F]N=#X\+W`^/"]T9#X\+W1R/CPO=&%B;&4^/"]D:78^/'`@<W1Y;&4]
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M;&]G:65S($-O<G!O<F%T:6]N("@F(S@R,C`[=V4L)B,X,C(Q.R`F(S@R,C`[
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M<G1I8V%L+6%L:6=N.G1O<"<^5$T@/"]S=7`^*&%L<V\@:VYO=VX@87,@)B,X
M,C(P.TA%4$Q)4T%6)B,X,C(Q.RDL(&%N(&EN=F5S=&EG871I;VYA;"!A9'5L
M="!H97!A=&ET:7,@0B!V86-C:6YE(&EN(%!H87-E(#,@8VQI;FEC86P@9&5V
M96QO<&UE;G0N(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T1M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP)3MM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z-"XU-"4[9F]N="US:7IE.C$P<'0[.SXF;F)S
M<#L\+W`^/'`@<W1Y;&4],T1M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C$R<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C0N-30E.V9O;G0M<VEZ93HQ,'!T.SL^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.W1E>'0M:6YD96YT.C0N-30E
M)SY);B!A9&1I=&EO;B!T;R!(15!,25-!5BU"/"]F;VYT/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/BP@=V4@87)E
M(&-O;F1U8W1I;F<@8VQI;FEC86P@86YD('!R96-L:6YI8V%L('!R;V=R86US
M('1H870@=71I;&EZ92!O=7(@97AP97)T:7-E(&EN(%1,4B!B:6]L;V=Y+B!/
M=7(@<')O9'5C="!C86YD:61A=&5S(&EN8VQU9&4@8F]T:"!43%(@86=O;FES
M=',@86YD(%1,4B!I;FAI8FET;W)S+B!/=7(@8VQI;FEC86P@<W1A9V4@<')O
M9W)A;7,@:6YC;'5D92!O=7(@875T;VEM;75N92!P<F]G<F%M('!A<G1N97)E
M9"!W:71H($=L87AO4VUI=&A+;&EN92`H)B,X,C(P.T=32R8C.#(R,3LI+"!O
M=7(@87-T:&UA('1H97)A<&5U=&EC('!R;V=R86T@<&%R=&YE<F5D('=I=&@@
M07-T<F%:96YE8V$@04(@*"8C.#(R,#M!<W1R85IE;F5C828C.#(R,3LI+"!A
M;F0@;W5R(&-A;F-E<B!I;6UU;F]T:&5R87!Y('!R;V=R86TN(%=E(&%L<V\@
M87)E(&%D=F%N8VEN9R!P<F5C;&EN:6-A;"!D979E;&]P;65N="!P<F]G<F%M
M<R!I;B!A9&IU=F%N="!T96-H;F]L;V=Y(&%N9"!43%(@-RP@."P@86YD(#D@
M:6YH:6)I=&EO;BX@5V4@8V]M<&5T92!W:71H('!H87)M86-E=71I8V%L(&-O
M;7!A;FEE<RP@8FEO=&5C:&YO;&]G>2!C;VUP86YI97,L(&%C861E;6EC(&EN
M<W1I='5T:6]N<R!A;F0@<F5S96%R8V@@;W)G86YI>F%T:6]N<R!I;B!D979E
M;&]P:6YG('1H97)A<&EE<R!T;R!P<F5V96YT(&]R('1R96%T(&EN9F5C=&EO
M=7,@86YD(&EN9FQA;6UA=&]R>2!D:7-E87-E<R!A;F0@8V%N8V5R+B!792!W
M97)E(&EN8V]R<&]R871E9"!I;B!#86QI9F]R;FEA(&EN($%U9W5S="8C,38P
M.S$Y.38@=6YD97(@=&AE(&YA;64@1&]U8FQE($AE;&EX($-O<G!O<F%T:6]N
M+"!A;F0@=V4@8VAA;F=E9"!O=7(@;F%M92!T;R!$>6YA=F%X(%1E8VAN;VQO
M9VEE<R!#;W)P;W)A=&EO;B!I;B!397!T96UB97(F(S$V,#LQ.3DV+B!792!R
M96EN8V]R<&]R871E9"!I;B!$96QA=V%R92!I;B`R,#`P+CPO9F]N=#X\+W`^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HQ.'!T
M.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M)3MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^4W5B<VED:6%R:65S(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HV<'0[;6%R9VEN+6QE9G0Z,"4[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C0N-30E.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#MT97AT+6EN9&5N=#HT
M+C4T)2<^26X@07!R:6P@,C`P-BP@=V4@8V]M<&QE=&5D('1H92!A8W%U:7-I
M=&EO;B!O9B!2:&5I;CPO9F]N=#X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M,3!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SX@0FEO=&5C:"!';6)(("@F(S@R,C`[
M4FAE:6XF(S@R,C$[(&]R("8C.#(R,#M$>6YA=F%X($5U<F]P928C.#(R,3LI
M+"!A('=H;VQL>2UO=VYE9"!S=6)S:61I87)Y(&EN($0F(S(U,CMS<V5L9&]R
M9BP@1V5R;6%N>2X@26X@3V-T;V)E<B`R,#$Q+"!W92!F;W)M960@1'EN879A
M>"!);G1E<FYA=&EO;F%L+"!"+E8N+"!A('=H;VQL>2UO=VYE9"!S=6)S:61I
M87)Y(&EN($%M<W1E<F1A;2P@3F5T:&5R;&%N9',N(#PO9F]N=#X\+W`^/"]D
M:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B
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M/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4
M>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R
M:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$
M;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-
M"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P
M14%$/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS
M<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E-U;6UA<GD@;V8@4VEG;FEF
M:6-A;G0@06-C;W5N=&EN9R!0;VQI8VEE<SQB<CX\+W-T<F]N9SX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT:',@
M16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^4W5M;6%R>2!O9B!3:6=N:69I8V%N="!!
M8V-O=6YT:6YG(%!O;&EC:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/&1I=CX-"CQD:78@86QI9VX],T1L969T/CQT86)L92!B;W)D97(]
M,T0P(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@<W1Y;&4],T0G
M8F]R9&5R+6-O;&QA<'-E.F-O;&QA<'-E.R!W:61T:#HQ,#`E.VUA<F=I;BUL
M969T.C`E.VUA<F=I;BUR:6=H=#HP)2<^/'1R/CQT9"!V86QI9VX],T1T;W`@
M<W1Y;&4],T1W:61T:#HT+C4T)3MW:&ET92US<&%C93IN;W=R87`^/'`@<W1Y
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M9F]N=#X\+W`^/"]T9#X\=&0@=F%L:6=N/3-$=&]P('-T>6QE/3-$=VED=&@Z
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M;VQI8VEE<R`\+V9O;G0^/"]P/CPO=&0^/"]T<CX\+W1A8FQE/CPO9&EV/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z-G!T.VUA
M<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP)3MF
M;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M0F%S:7,@;V8@4')E<V5N=&%T:6]N(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HV<'0[;6%R9VEN+6QE9G0Z
M,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C0N-30E.V9O;G0M<VEZ
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M:61A=&5D(&9I;F%N8VEA;"!S=&%T96UE;G1S+B`\+V9O;G0^/"]P/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,3AP=#MM87)G
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M<75I9&ET>2!A;F0@1FEN86YC:6%L($-O;F1I=&EO;B`\+V9O;G0^/"]P/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z-G!T.VUA
M<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HT+C4T
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M1&5C96UB97(F(S$V,#LS,2P@,C`Q,RP@=V4@:&%D(&-A<V@L(&-A<V@@97%U
M:79A;&5N=',@86YD(&UA<FME=&%B;&4@<V5C=7)I=&EE<R!O9B`D,3@Y+C0\
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M8V5M8F5R)B,Q-C`[,S$L(#(P,3,@86YD(&%N=&EC:7!A=&5D(')E=F5N=65S
M(&%N9"!F=6YD:6YG(&9R;VT@97AI<W1I;F<@86=R965M96YT<RX\+V9O;G0^
M/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
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M:6,@86QT97)N871I=F5S+CPO9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HQ.'!T.VUA<F=I;BUL969T.C`E.VUA
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M<R`\+V9O;G0^/"]P/CQP('-T>6QE/3-$;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HV<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E
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M(&%C8V]U;G1I;F<@<')I;F-I<&QE<R`H)B,X,C(P.U4N4RX@1T%!4"8C.#(R
M,3LI(')E<75I<F5S(&UA;F%G96UE;G0@=&\@;6%K92!I;F9O<FUE9"`\+V9O
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M<'0[;6%R9VEN+71O<#HQ.'!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H
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M:&4@97%U:71Y+B!&;W(@=&AE('EE87)S(&5N9&5D($1E8V5M8F5R)B,Q-C`[
M,S$L(#(P,3,L(#(P,3(@86YD(#(P,3$L('=E(')E<&]R=&5D(&%N('5N<F5A
M;&EZ960@9V%I;B!O9B`D,"XU(&UI;&QI;VXL(&%N('5N<F5A;&EZ960@9V%I
M;B!O9B`D,"XT(&UI;&QI;VX@86YD(&%N('5N<F5A;&EZ960@;&]S<R!O9B`D
M,"XS(&UI;&QI;VXL(')E<W!E8W1I=F5L>2X@4F5A;&EZ960@9V%I;G,@86YD
M(&QO<W-E<R!R97-U;'1I;F<@9G)O;2!C=7)R96YC>2!T<F%N<V%C=&EO;G,@
M87)E(&EN8VQU9&5D(&EN('1H92!C;VYS;VQI9&%T960@<W1A=&5M96YT<R!O
M9B!O<&5R871I;VYS+B!&;W(@=&AE('EE87)S(&5N9&5D($1E8V5M8F5R)B,Q
M-C`[,S$L(#(P,3,L(#(P,3(@86YD(#(P,3$L('=E(')E<&]R=&5D(&$@;&]S
M<R!O9B`D,"XR(&UI;&QI;VXL(&$@;&]S<R!O9B`D,"XR(&UI;&QI;VX@86YD
M(&$@9V%I;B!O9B`D,"XR(&UI;&QI;VXL(')E<W!E8W1I=F5L>2P@<F5S=6QT
M:6YG(&9R;VT@8W5R<F5N8WD@=')A;G-A8W1I;VYS(&EN(&]U<B!C;VYS;VQI
M9&%T960@<W1A=&5M96YT<R!O9B!O<&5R871I;VYS+B`\+V9O;G0^/"]P/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,3AP=#MM
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M=&EE<R`\+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z-G!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HT+C4T)3MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M,3!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[=&5X="UI;F1E;G0Z-"XU-"4G/E=E(&-O
M;G-I9&5R(&%L;"!H:6=H;'D@;&EQ=6ED(&EN=F5S=&UE;G1S('!U<F-H87-E
M9"!W:71H(&%N(&]R:6=I;F%L(&UA='5R:71Y(&]F('1H<F5E/"]F;VYT/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B!M;VYT:',@;W(@;&5S<R!A;F0@=&AA="!C86X@8F4@;&EQ=6ED871E9"!W
M:71H;W5T('!R:6]R(&YO=&EC92!O<B!P96YA;'1Y+"!T;R!B92!C87-H(&5Q
M=6EV86QE;G1S+B!-86YA9V5M96YT(&1E=&5R;6EN97,@=&AE(&%P<')O<')I
M871E(&-L87-S:69I8V%T:6]N(&]F(&UA<FME=&%B;&4@<V5C=7)I=&EE<R!A
M="!T:&4@=&EM92!O9B!P=7)C:&%S92X@5V4@:6YV97-T(&EN('-H;W)T+71E
M<FT@;6]N97D@;6%R:V5T(&9U;F1S+"!5+E,N(&=O=F5R;FUE;G0@86=E;F-Y
M('-E8W5R:71I97,L(%4N4RX@=')E87-U<GD@<V5C=7)I=&EE<R!A;F0@;75N
M:6-I<&%L('-E8W5R:71I97,N(%=E(&)E;&EE=F4@=&AE<V4@='EP97,@;V8@
M:6YV97-T;65N=',@87)E('-U8FIE8W0@=&\@;6EN:6UA;"!C<F5D:70@86YD
M(&UA<FME="!R:7-K+B!792!D;R!N;W0@:6YV97-T(&EN(&%U8W1I;VX@<F%T
M92!S96-U<FET:65S(&]R('-E8W5R:71I97,@8V]L;&%T97)A;&EZ960@8GD@
M:&]M92!M;W)T9V%G97,L(&UO<G1G86=E(&)A;FL@9&5B="P@;W(@:&]M92!E
M<75I='D@;&]A;G,N(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HQ,G!T.VUA<F=I;BUL969T.C`E.VUA<F=I
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M.B`\+V9O;G0^/"]P/CQD:78@86QI9VX],T1L969T/CQT86)L92!B;W)D97(]
M,T0P(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@<W1Y;&4],T0G
M8F]R9&5R+6-O;&QA<'-E.F-O;&QA<'-E.R!W:61T:#HY-"XR-R4[;6%R9VEN
M+6QE9G0Z-2XW,R4[;6%R9VEN+7)I9VAT.C`E)SX\='(^/'1D('9A;&EG;CTS
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M='EL93TS1'=I9'1H.CDV+C8W)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
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M=&EO;B!F;W(@;W9E<B`Q,B!M;VYT:',[(#PO9F]N=#X\+W`^/"]T9#X\+W1R
M/CPO=&%B;&4^/"]D:78^/&1I=B!A;&EG;CTS1&QE9G0^/'1A8FQE(&)O<F1E
M<CTS1#`@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S='EL93TS
M1"=B;W)D97(M8V]L;&%P<V4Z8V]L;&%P<V4[('=I9'1H.CDT+C(W)3MM87)G
M:6XM;&5F=#HU+C<S)3MM87)G:6XM<FEG:'0Z,"4G/CQT<CX\=&0@=F%L:6=N
M/3-$=&]P('-T>6QE/3-$=VED=&@Z,RXS,R4[=VAI=&4M<W!A8V4Z;F]W<F%P
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z-G!T
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG
M/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ)U-Y;6)O;"<[9F]N="US:7IE
M.C$P<'0[/B8C,3@S.SPO9F]N=#X\+W`^/"]T9#X\=&0@=F%L:6=N/3-$=&]P
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M=7)I='D@;V8@;W5R(&EN=F5S=&UE;G1S.R`\+V9O;G0^/"]P/CPO=&0^/"]T
M<CX\+W1A8FQE/CPO9&EV/CQD:78@86QI9VX],T1L969T/CQT86)L92!B;W)D
M97(],T0P(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@<W1Y;&4]
M,T0G8F]R9&5R+6-O;&QA<'-E.F-O;&QA<'-E.R!W:61T:#HY-"XR-R4[;6%R
M9VEN+6QE9G0Z-2XW,R4[;6%R9VEN+7)I9VAT.C`E)SX\='(^/'1D('9A;&EG
M;CTS1'1O<"!S='EL93TS1'=I9'1H.C,N,S,E.W=H:71E+7-P86-E.FYO=W)A
M<#X\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C9P
M=#MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M)SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY.B=3>6UB;VPG.V9O;G0M<VEZ
M93HQ,'!T.SXF(S$X,SL\+V9O;G0^/"]P/CPO=&0^/'1D('9A;&EG;CTS1'1O
M<"!S='EL93TS1'=I9'1H.CDV+C8W)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
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M=#X\+W`^/"]T9#X\+W1R/CPO=&%B;&4^/"]D:78^/&1I=B!A;&EG;CTS1&QE
M9G0^/'1A8FQE(&)O<F1E<CTS1#`@8V5L;'-P86-I;F<],T0P(&-E;&QP861D
M:6YG/3-$,"!S='EL93TS1"=B;W)D97(M8V]L;&%P<V4Z8V]L;&%P<V4[('=I
M9'1H.CDT+C(W)3MM87)G:6XM;&5F=#HU+C<S)3MM87)G:6XM<FEG:'0Z,"4G
M/CQT<CX\=&0@=F%L:6=N/3-$=&]P('-T>6QE/3-$=VED=&@Z,RXS,R4[=VAI
M=&4M<W!A8V4Z;F]W<F%P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z-G!T.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ)U-Y
M;6)O;"<[9F]N="US:7IE.C$P<'0[/B8C,3@S.SPO9F]N=#X\+W`^/"]T9#X\
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M;&4@8F]R9&5R/3-$,"!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P
M('-T>6QE/3-$)V)O<F1E<BUC;VQL87!S93IC;VQL87!S93L@=VED=&@Z.30N
M,C<E.VUA<F=I;BUL969T.C4N-S,E.VUA<F=I;BUR:6=H=#HP)2<^/'1R/CQT
M9"!V86QI9VX],T1T;W`@<W1Y;&4],T1W:61T:#HS+C,S)3MW:&ET92US<&%C
M93IN;W=R87`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HV<'0[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.R<^/&9O;G0@<W1Y;&4],T1F;VYT+69A;6EL>3HG4WEM8F]L)SMF
M;VYT+7-I>F4Z,3!P=#L^)B,Q.#,[/"]F;VYT/CPO<#X\+W1D/CQT9"!V86QI
M9VX],T1T;W`@<W1Y;&4],T1W:61T:#HY-BXV-R4[/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z-G!T.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/G1H92!T>7!E(&]F
M(&EN=F5S=&UE;G1S(&UA9&4N(#PO9F]N=#X\+W`^/"]T9#X\+W1R/CPO=&%B
M;&4^/"]D:78^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HQ,G!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT
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M;F]R;6%L.R<^+B`\+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,3AP=#MM87)G:6XM;&5F=#HP)3MM87)G:6XM
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M9F]N=#X\+W`^/'`@<W1Y;&4],T1M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
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M97-S:6YG('!E<F9O<FUA;F-E+B!);B!F:7-C86P@>65A<G,@,C`Q,RP@,C`Q
M,B!A;F0@,C`Q,2P@.#DE+"`X."4@86YD(#DT)2!O9B!O=7(@<F5V96YU97,@
M=V5R92!E87)N960@:6X@=&AE(%5N:71E9"!3=&%T97,L(')E<W!E8W1I=F5L
M>2P@86YD('1H92!R96UA:6YI;F<@<F5V96YU97,@=V5R92!E87)N960@:6X@
M1V5R;6%N>2X@07,@;V8@1&5C96UB97(F(S$V,#LS,2P@,C`Q,R!A;F0@,C`Q
M,BP@.24@86YD(#$P)2P@<F5S<&5C=&EV96QY+"!O9B!O=7(@;&]N9RUL:79E
M9"!A<W-E=',@=V5R92!L;V-A=&5D(&EN('1H92!5;FET960@4W1A=&5S(&%N
M9"!T:&4@<F5M86EN:6YG(&QO;F<M;&EV960@87-S971S('=E<F4@;&]C871E
M9"!I;B!'97)M86YY+B`\+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,3)P=#MM87)G:6XM;&5F=#HP)3MM87)G
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M>2!O9B!S96-U<FET:65S+"!I;F-L=61I;F<@<VAO<G0M=&5R;2`\+V9O;G0^
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M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C0N-30E.V9O;G0M<VEZ93HQ,'!T
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M<R!R96-E:79A8FQE+B`\+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,3)P=#MM87)G:6XM;&5F=#HP)3MM87)G
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M=&AE(%4N4RX@1F]O9"!A;F0@1')U9R!!9&UI;FES=')A=&EO;B`H)B,X,C(P
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M=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HQ,G!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
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M;VQI9V]N=6-L96]T:61E<R`\+V9O;G0^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^9F]R(&-L:6YI8V%L('1R:6%L
M<R!A;F0@82!S:6YG;&4@8V]N=')A8W0@;6%N=69A8W1U<F5R('1O('!R;V1U
M8V4@;W5R(&9I<G-T(&=E;F5R871I;VX@5$Q2(#D@86=O;FES="P@,3`Q."!F
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M86QL('%U86YT:71I97,@;V8@;VQI9V]N=6-L96]T:61E<R!A;F0@,3`Q."!O
M=7)S96QV97,@9F]R(&1E=F5L;W!M96YT('!U<G!O<V5S+B`\+V9O;G0^/"]P
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,3)P
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M;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C`E
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG
M/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P
M<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SY,;VYG+4QI=F5D($%S<V5T<R`\+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z-G!T.VUA<F=I;BUL969T.C`E
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M9VAT.C`E.W1E>'0M:6YD96YT.C0N-30E.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
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M:69I960@9'5R:6YG('1H92!Y96%R<R!P<F5S96YT960N(#PO9F]N=#X\+W`^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HQ.'!T
M.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
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M;VTZ,'!T.VUA<F=I;BUT;W`Z-G!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR
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M1&UA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,3AP=#MM87)G:6XM;&5F
M=#HP)3MM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,"4[9F]N="UW96EG
M:'0Z8F]L9#L[9F]N="US:7IE.C$P<'0[.SX\9F]N="!S='EL93TS1"=F;VYT
M+7=E:6=H=#IB;VQD.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^4F5V96YU92!296-O9VYI=&EO
M;B`\+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z-G!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT
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M;VYA8FQY(&%S<W5R960N(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HQ,G!T.VUA<F=I;BUL969T.C`E.VUA
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M-"XU-"4G/D]N($IA;G5A<GDF(S$V,#LQ+"`R,#$Q+"!W92!A9&]P=&5D(&]N
M(&$@<')O<W!E8W1I=F4@8F%S:7,@1FEN86YC:6%L($%C8V]U;G1I;F<@4W1A
M;F1A<F1S($)O87)D("@F(S@R,C`[1D%30B8C.#(R,3LI($%C8V]U;G1I;F<@
M4W1A;F1A<F1S(%5P9&%T92`H)B,X,C(P.T%3528C.#(R,3LI(#(P,#DM,3,L
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M9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C0N-30E.V9O;G0M
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M=',@96YT97)E9"!I;G1O('!R:6]R('1O($IA;G5A<GDF(S$V,#LQ+"`R,#$Q
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M.C`E.W1E>'0M:6YD96YT.C0N-30E.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M
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M8V4@86YD("AI:6DI)B,Q-C`[:68@86-H:65V960L('1H92!E=F5N="!W;W5L
M9"!R97-U;'0@:6X@861D:71I;VYA;"!P87EM96YT<R!B96EN9R!D=64@=&\@
M=&AE(&5N=&ET>2X@/"]F;VYT/CPO<#X\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C$R<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C0N-30E.V9O;G0M<VEZ93HQ,'!T.V9O
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M9&ET:6]N<R!I;F-L=61E.B`H:3PO9F]N=#X\9F]N="!S='EL93TS1"=F;VYT
M+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXI)B,Q-C`[=&AE(&1E=F5L
M;W!M96YT('=O<FL@:7,@8V]N=&EN9V5N="!O;B!E:71H97(@;V8@=&AE(&9O
M;&QO=VEN9SH@*&$I)B,Q-C`[=&AE('9E;F1O<B8C.#(Q-SMS('!E<F9O<FUA
M;F-E('1O(&%C:&EE=F4@=&AE(&UI;&5S=&]N92!O<B`H8BDF(S$V,#MT:&4@
M96YH86YC96UE;G0@;V8@=&AE('9A;'5E(&]F('1H92!D96QI=F5R86)L92!I
M=&5M(&]R(&ET96US(&%S(&$@<F5S=6QT(&]F(&$@<W!E8VEF:6,@;W5T8V]M
M92!R97-U;'1I;F<@9G)O;2!T:&4@=F5N9&]R)B,X,C$W.W,@<&5R9F]R;6%N
M8V4@=&\@86-H:65V92!T:&4@;6EL97-T;VYE.R`H:6DI)B,Q-C`[:70@<F5L
M871E<R!S;VQE;'D@=&\@<&%S="!P97)F;W)M86YC92!A;F0@*&EI:2DF(S$V
M,#MI="!I<R!R96%S;VYA8FQE(')E;&%T:79E('1O(&%L;"!T:&4@9&5L:79E
M<F%B;&4@86YD('!A>6UE;G0@=&5R;7,@=VET:&EN('1H92!A<G)A;F=E;65N
M="X@07,@82!R97-U;'0@;V8@;W5R(&%N86QY<VES+"!W92!C;VYS:61E<B!O
M=7(@9&5V96QO<&UE;G0@;6EL97-T;VYE<R!T;R!B92!S=6)S=&%N=&EV92!A
M;F0L(&%C8V]R9&EN9VQY+"!W92!E>'!E8W0@=&\@<F5C;V=N:7IE(&%S(')E
M=F5N=64@9G5T=7)E('!A>6UE;G1S(')E8V5I=F5D(&9R;VT@<W5C:"!M:6QE
M<W1O;F5S(&%S('=E(&%C:&EE=F4@96%C:"!M:6QE<W1O;F4N(#PO9F]N=#X\
M+W`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HQ
M,G!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
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M871I=F4@86=R965M96YT<R!H87,@8F5E;B!N;VYR969U;F1A8FQE+B`\+V9O
M;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,3)P=#MM87)G:6XM;&5F=#HP)3MM87)G:6XM<FEG:'0Z,"4[=&5X="UI
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M=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HQ,G!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
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M92!A;F0@86-C97!T86YC92!B>2!T:&4@8W5S=&]M97(N(#PO9F]N=#X\+W`^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HQ,G!T
M.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HT
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M<F5D+B`\+V9O;G0^/"]P/CQP('-T>6QE/3-$;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HQ,G!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP
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M;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C`E
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M86QS(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HV<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C0N-30E.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#MT97AT+6EN9&5N=#HT+C4T)2<^4F5S96%R
M8V@@86YD(&1E=F5L;W!M96YT(&5X<&5N<V5S(&EN8VQU9&4@<&5R<V]N;F5L
M(&%N9"!F86-I;&ET>2UR96QA=&5D(&5X<&5N<V5S+"!O=71S:61E(&-O;G1R
M86-T960@<V5R=FEC97,@:6YC;'5D:6YG(&-L:6YI8V%L('1R:6%L(&-O<W1S
M+"!M86YU9F%C='5R:6YG(&%N9"!P<F]C97-S(&1E=F5L;W!M96YT(&-O<W1S
M+"!R97-E87)C:"!C;W-T<R!A;F0@;W1H97(@8V]N<W5L=&EN9R!S97)V:6-E
M<R!A;F0@;F]N+6-A<V@@<W1O8VLM8F%S960@8V]M<&5N<V%T:6]N+B!297-E
M87)C:"!A;F0@9&5V96QO<&UE;G0@8V]S=',@87)E(&5X<&5N<V5D(&%S(&EN
M8W5R<F5D+B!!;6]U;G1S(&1U92!U;F1E<B!S=6-H(&%R<F%N9V5M96YT<R!M
M87D@8F4@96ET:&5R(&9I>&5D(&9E92!O<B!F964@9F]R('-E<G9I8V4L(&%N
M9"!M87D@:6YC;'5D92!U<&9R;VYT('!A>6UE;G1S+"!M;VYT:&QY('!A>6UE
M;G1S(&%N9"!P87EM96YT<R!U<&]N('1H92!C;VUP;&5T:6]N(&]F(&UI;&5S
M=&]N97,@;W(@<F5C96EP="!O9B!D96QI=F5R86)L97,N($YO;BUR969U;F1A
M8FQE(&%D=F%N8V4@<&%Y;65N=',@=6YD97(@86=R965M96YT<R!A<F4@8V%P
M:71A;&EZ960@86YD(&5X<&5N<V5D(&%S('1H92!R96QA=&5D(&=O;V1S(&%R
M92!D96QI=F5R960@;W(@<V5R=FEC97,@87)E('!E<F9O<FUE9"X@/"]F;VYT
M/CPO<#X\<"!S='EL93TS1&UA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
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M,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ
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M<F%T:6YG(')E<W5L=',N(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HQ,G!T.VUA<F=I;BUL969T.C`E.VUA
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M('1H92!F;VQL;W=I;F<@<75A<G1E<G,N(#PO9F]N=#X\+W`^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HQ.'!T.VUA<F=I;BUL
M969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP)3MF;VYT+7-I
M>F4Z,3!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^26YC;VUE
M(%1A>&5S(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HV<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C0N-30E.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M
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M9&5F97)R960@=&%X(&%S<V5T<R!A="!$96-E;6)E<B8C,38P.S,Q+"`R,#$S
M(&%N9"`R,#$R(&)E8V%U<V4@=V4@8F5L:65V92!I="!I<R!M;W)E(&QI:V5L
M>2!T:&%N(&YO="!T:&%T(&]U<B!D969E<G)E9"!T87@@87-S971S('=I;&P@
M;F]T(&)E(')E86QI>F5D(&%S(&]F($1E8V5M8F5R)B,Q-C`[,S$L(#(P,3,L
M(&%N9"`R,#$R+B`\+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,3)P=#MM87)G:6XM;&5F=#HP)3MM87)G:6XM
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M:71S(&%S(&]F($1E8V5M8F5R)B,Q-C`[,S$L(#(P,3,L(&EN8VQU9&EN9R!N
M;R!A8V-R=65D(&%M;W5N=',@9F]R(&EN=&5R97-T(&%N9"!P96YA;'1I97,N
M(%=E(&1O(&YO="!A;G1I8VEP871E('1H870@=&]T86P@=6YR96-O9VYI>F5D
M('1A>"!B96YE9FET<R!W:6QL('-I9VYI9FEC86YT;'D@8VAA;F=E('!R:6]R
M('1O($1E8V5M8F5R)B,Q-C`[,S$L(#(P,30N($]U<B!P;VQI8WD@=VEL;"!B
M92!T;R!R96-O9VYI>F4@:6YT97)E<W0@86YD('!E;F%L=&EE<R!R96QA=&5D
M('1O(&EN8V]M92!T87AE<RP@:68@86YY+"!A<R!A(&-O;7!O;F5N="!O9B!G
M96YE<F%L(&%N9"!A9&UI;FES=')A=&EV92!E>'!E;G-E+B!792!A<F4@<W5B
M:F5C="!T;R!I;F-O;64@=&%X(&5X86UI;F%T:6]N<R!F;W(@52Y3+B!F961E
M<F%L(&%N9"!S=&%T92!I;F-O;64@=&%X97,@9G)O;2`Q.3DV(&9O<G=A<F0N
M(%=E(&%R92!S=6)J96-T('1O('1A>"!E>&%M:6YA=&EO;B!I;B!'97)M86YY
M(&9R;VT@,C`Q,"!F;W)W87)D+CPO9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HQ.'!T.VUA<F=I;BUL969T.C`E
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M;G0Z-"XU-"4G/D%C8V]U;G1I;F<@4W1A;F1A<F1S(%5P9&%T92`R,#$S+3`R
M(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HV<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E
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M86P@>65A<G,@8F5G:6YN:6YG(&%F=&5R($1E8V5M8F5R)B,Q-C`[,34L(#(P
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M(#,Q+"`R,#$S+CPO9F]N=#X\+W`^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M
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M<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\3454
M02!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H
M=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S
M8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M
M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE
M(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14%$/@T*("`@("`@/'1R/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\
M<W1R;VYG/D9A:7(@5F%L=64@365A<W5R96UE;G1S/&)R/CPO<W1R;VYG/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R($UO
M;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&86ER(%9A;'5E($UE87-U<F5M
M96YT<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQD:78^#0H\
M9&EV(&%L:6=N/3-$;&5F=#X\=&%B;&4@8F]R9&5R/3-$,"!C96QL<W!A8VEN
M9STS1#`@8V5L;'!A9&1I;F<],T0P('-T>6QE/3-$)V)O<F1E<BUC;VQL87!S
M93IC;VQL87!S93L@=VED=&@Z,3`P)3MM87)G:6XM;&5F=#HP)3MM87)G:6XM
M<FEG:'0Z,"4G/CQT<CX\=&0@=F%L:6=N/3-$=&]P('-T>6QE/3-$=VED=&@Z
M-"XU-"4[=VAI=&4M<W!A8V4Z;F]W<F%P/CQP('-T>6QE/3-$;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HQ.'!T.V9O;G0M<VEZ93HQ,'!T.SL^/&9O
M;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P=#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C,N
M/"]F;VYT/CPO<#X\+W1D/CQT9"!V86QI9VX],T1T;W`@<W1Y;&4],T1W:61T
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M96UE;G1S(#PO9F]N=#X\+W`^/"]T9#X\+W1R/CPO=&%B;&4^/"]D:78^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HV<'0[;6%R
M9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C0N-30E
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M;VQL;W=I;F<Z(#PO9F]N=#X\+W`^/&1I=B!A;&EG;CTS1&QE9G0^/'1A8FQE
M(&)O<F1E<CTS1#`@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S
M='EL93TS1"=B;W)D97(M8V]L;&%P<V4Z8V]L;&%P<V4[('=I9'1H.CDT+C(W
M)3MM87)G:6XM;&5F=#HU+C<S)3MM87)G:6XM<FEG:'0Z,"4G/CQT<CX\=&0@
M=F%L:6=N/3-$=&]P('-T>6QE/3-$=VED=&@Z,RXS,R4[=VAI=&4M<W!A8V4Z
M;F]W<F%P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z-G!T.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CLG/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ)U-Y;6)O;"<[9F]N
M="US:7IE.C$P<'0[/B8C,3@S.SPO9F]N=#X\+W`^/"]T9#X\=&0@=F%L:6=N
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M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY,979E;"`Q)B,X,C$R
M.T]B<V5R=F%B;&4@:6YP=71S+"!S=6-H(&%S('%U;W1E9"!P<FEC97,@:6X@
M86-T:79E(&UA<FME=',@9F]R(&ED96YT:6-A;"!A<W-E=',@;W(@;&EA8FEL
M:71I97,[(#PO9F]N=#X\+W`^/"]T9#X\+W1R/CPO=&%B;&4^/"]D:78^/&1I
M=B!A;&EG;CTS1&QE9G0^/'1A8FQE(&)O<F1E<CTS1#`@8V5L;'-P86-I;F<]
M,T0P(&-E;&QP861D:6YG/3-$,"!S='EL93TS1"=B;W)D97(M8V]L;&%P<V4Z
M8V]L;&%P<V4[('=I9'1H.CDT+C(W)3MM87)G:6XM;&5F=#HU+C<S)3MM87)G
M:6XM<FEG:'0Z,"4G/CQT<CX\=&0@=F%L:6=N/3-$=&]P('-T>6QE/3-$=VED
M=&@Z,RXS,R4[=VAI=&4M<W!A8V4Z;F]W<F%P/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z-G!T.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$9F]N
M="UF86UI;'DZ)U-Y;6)O;"<[9F]N="US:7IE.C$P<'0[/B8C,3@S.SPO9F]N
M=#X\+W`^/"]T9#X\=&0@=F%L:6=N/3-$=&]P('-T>6QE/3-$=VED=&@Z.38N
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M;W)M86P[)SY,979E;"`R)B,X,C$R.TEN<'5T<R!O=&AE<B!T:&%N($QE=F5L
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M97)M(&]F('1H92!A<W-E=',@;W(@;&EA8FEL:71I97,[(&%N9"`\+V9O;G0^
M/"]P/CPO=&0^/"]T<CX\+W1A8FQE/CPO9&EV/CQD:78@86QI9VX],T1L969T
M/CQT86)L92!B;W)D97(],T0P(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN
M9STS1#`@<W1Y;&4],T0G8F]R9&5R+6-O;&QA<'-E.F-O;&QA<'-E.R!W:61T
M:#HY-"XR-R4[;6%R9VEN+6QE9G0Z-2XW,R4[;6%R9VEN+7)I9VAT.C`E)SX\
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M('9A;&EG;CTS1'1O<"!S='EL93TS1'=I9'1H.CDV+C8W)3L^/'`@<W1Y;&4]
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M>2!T;R!D979E;&]P(&ET<R!O=VX@87-S=6UP=&EO;G,N(#PO9F]N=#X\+W`^
M/"]T9#X\+W1R/CPO=&%B;&4^/"]D:78^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HQ.'!T.VUA<F=I;BUL969T.C`E.VUA<F=I
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M=64@365A<W5R96UE;G1S(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HV<'0[;6%R9VEN+6QE9G0Z,"4[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C0N-30E.V9O;G0M<VEZ93HQ,'!T
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M9B!$96-E;6)E<B8C,38P.S,Q+"`R,#$S(&%N9"`R,#$R("AI;B!T:&]U<V%N
M9',I.B`\+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP
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M=&%B;&4@8F]R9&5R/3-$,"!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<]
M,T0P(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)V)O<F1E<BUC;VQL87!S93IC
M;VQL87!S93L@=VED=&@Z,3`P)3LG/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HU-"4[(&)O<F1E
M<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SXF;F)S
M<#L\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW
M:61T:#HY)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG
M/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW
M96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^3&5V96P@
M,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP
M861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T
M:#HR)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[
M)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ
M,"!P=#MW:61T:#HY)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P
M,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M3&5V96P@,CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MW:61T:#HR)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,B!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HX)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^3&5V96PF(S$V,#LS/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@
M8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H
M=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A
M9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG
M+51O<#HP+C<U('!T.W=I9'1H.C(E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N
M=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D(&-O;'-P
M86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.CDE.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG
M;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SY4;W1A;#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z
M,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW
M96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HU-"4[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,3(N,C5P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.BTQ,BXR-7!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SY$96-E;6)E<B8C,38P.S,Q+"`R,#$S/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I
M9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
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M=&]M.C`@<'0[=VED=&@Z-R4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P
M,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HR)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z-R4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A
M;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HR)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP
M861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED
M(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I
M;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O
M<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-B4[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T
M:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HR)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P
M,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-R4[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP
M861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z
M-30E.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,3(N,C5P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.BTQ,BXR-7!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/DUO;F5Y(&UA
M<FME="!F=6YD<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P
M=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P
M=#MW:61T:#HW)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T
M97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HR)3LG/CQP('-T
M>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HW)3MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXM/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP
M('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
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M=&]M.C`@<'0[=VED=&@Z,B4[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I
M9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
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M0F]T=&]M.C`@<'0[=VED=&@Z-B4[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^+3PO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C(E.R<^
M/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C<E
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ
M<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/C(P+#`Q,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN
M9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z-30E.R!B;W)D
M97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C$R+C(U<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HM,3(N
M,C5P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HW)3L@
M8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXM/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP
M861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T
M:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z
M,B4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^
M/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O
M='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P
M="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F
M=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U
M('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-R4[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,38W+#4Y
M-SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
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M;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T
M>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ
M,"!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P
M,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP
M861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C8E.R!B;W)D97(M8F]T=&]M.G-O
M;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
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M=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HR)3L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z
M,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HW)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@
M(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXQ-C<L-3DW/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A
M9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG
M+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-30E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C$R+C(U<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HM,3(N
M,C5P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SY4;W1A;#PO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI
M9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HW)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P
M,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L
M:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M;F<M0F]T=&]M.C`@<'0[=VED=&@Z,B4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O
M='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C
M,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I
M9'1H.C<E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
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M=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R
M86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M.C`@<'0[=VED=&@Z,B4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS
M<&%R96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C8E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/BT\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP
M861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z
M,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D
M:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,B4[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP
M861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C<E.R!B;W)D97(M=&]P.G-O;&ED
M(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C$X-RPV,3`\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I
M;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O
M<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P
M/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H
M.C4T)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C$R+C(U<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HM,3(N,C5P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D
M:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T
M:#HW)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L
M:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HR)3LG/CQP('-T>6QE/3-$
M)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C<E.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D
M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG
M+4)O='1O;3HP('!T.W=I9'1H.C(E.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG
M;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP
M861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D
M:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP
M('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T
M.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-B4[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I
M9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z,B4[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HW)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG
M:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C4T)3L@8F]R
M9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HQ,BXR-7!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z+3$R
M+C(U<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.CDE.R!B
M;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD
M.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY,979E;"`Q/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF
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M97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L
M9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H
M.CDE.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@
M<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H
M=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY,979E;"`R/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[
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M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP
M('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG
M:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C@E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P
M.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
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M=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[=VED=&@Z,B4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS
M<&%R96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
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M0F]T=&]M.C`@<'0[=VED=&@Z.24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T(",P,#`P,#`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/E1O=&%L/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R
M+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD
M.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P
M/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D
M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG
M+4)O='1O;3HP('!T.W=I9'1H.C4T)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HQ,BXR-7!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z+3$R+C(U<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/D1E8V5M8F5R)B,Q-C`[,S$L(#(P,3(\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A
M9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG
M+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW
M:61T:#HW)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O
M='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T
M<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C(E.R!B;W)D97(M=&]P
M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HW)3L@8F]R
M9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I
M9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D
M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG
M+4)O='1O;3HP('!T.W=I9'1H.C(E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
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M=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P
M,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HV)3L@8F]R9&5R+71O<#IS;VQI
M9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,B4[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN
M9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C<E.R!B;W)D97(M=&]P
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O
M;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C4T)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C$R+C(U<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HM,3(N,C5P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
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M=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
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M=&]M.C`@<'0[=VED=&@Z-R4[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,RPQ-#`\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I
M;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O
M<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HR)3LG
M/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ
M)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HW
M)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N
M.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXM/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O
M='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M;F<M0F]T=&]M.C`@<'0[=VED=&@Z,B4[)SX\<"!S='EL93TS1"=T97AT+6%L
M:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A
M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
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M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-B4[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^+3PO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H
M.C(E.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I
M9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I
M9'1H.C<E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M
M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C,L,30P/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP
M861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O
M='1O;3HP('!T.W=I9'1H.C4T)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C$R+C(U<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HM,3(N,C5P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HW)3MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXM/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP
M861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z,B4[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T
M:#HW)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L
M:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXQ,3DL,C,S/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
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M;F<M0F]T=&]M.C`@<'0[=VED=&@Z,B4[)SX\<"!S='EL93TS1"=T97AT+6%L
M:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN
M9RU";W1T;VTZ,"!P=#MW:61T:#HV)3MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXM/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP
M('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
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M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,B4[)SX\<"!S='EL
M93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HW)3MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXQ,3DL,C,S/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P
M/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H
M.C4T)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C$R+C(U<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HM,3(N,C5P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
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M=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN
M9RU";W1T;VTZ,"!P=#MW:61T:#HW)3MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXM/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D
M:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,B4[
M)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S
M<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP
M861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z
M,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW
M:61T:#HW)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXU,#`\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A
M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HR)3LG/CQP('-T>6QE/3-$
M)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C8E.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/BT\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HR)3LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG
M:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP
M861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D
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M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C4P,#PO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[=VED=&@Z-30E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T
M<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C$R+C(U<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HM,3(N,C5P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY-
M=6YI8VEP86P@<V5C=7)I=&EE<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R
M+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I
M9'1H.C<E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG
M:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
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M('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MW:61T:#HR)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HW)3L@8F]R
M9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D
M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HR
M)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\
M<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
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M=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T
M(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HV)3L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXM/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R
M+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,B4[(&)O<F1E<BUB
M;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G
M=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I
M9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
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M0F]T=&]M.C`@<'0[=VED=&@Z-R4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^-S$U/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A
M9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG
M+51O<#HP+C<U('!T.W=I9'1H.C4T)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R
M86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,3(N,C5P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.BTQ,BXR-7!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/E1O
M=&%L/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H
M.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M
M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP
M861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C<E.R!B;W)D97(M=&]P.G-O;&ED
M(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C
M,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M
M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C,L,30P/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW
M:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[
M(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D
M:6YG+51O<#HP+C<U('!T.W=I9'1H.C(E.R!B;W)D97(M=&]P.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@
M=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P
M,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B0\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I
M;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O
M<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-R4[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U
M8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,3(P+#0T.#PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N
M<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HR)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ
M9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA
M;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP
M861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED
M(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C
M,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I
M9'1H.C8E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D
M97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
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M(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU
M<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,B4[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M
M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$
M)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@
M,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ
M,"!P=#MW:61T:#HW)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P
M,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXQ,C,L-3@X/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R
M9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T
M;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO
M=&0^#0H\+W1R/@T*/"]T86)L93X\+V1I=CX\<"!S='EL93TS1&UA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C`E.VUA<F=I
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M979E;"`Q(&]F('1H92!F86ER('9A;'5E(&AI97)A<F-H>2X@/"]F;VYT/CPO
M<#X\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C$R
M<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
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M871I;VX@;V8@=&AE<V4@<V5C=7)I=&EE<R!A<R!,979E;"`R(&]F('1H92!F
M86ER('9A;'5E(&AI97)A<F-H>2X@/"]F;VYT/CPO<#X\9&EV/@T*/'1A8FQE
M(&)O<F1E<CTS1#`@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!A
M;&EG;CTS1&-E;G1E<B!S='EL93TS1"=B;W)D97(M8V]L;&%P<V4Z8V]L;&%P
M<V4[('=I9'1H.C$P,"4[)SX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW
M:61T:#HY)3LG/CQP('-T>6QE/3-$;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+7-I>F4Z.7!T.SL^)FYB<W`[/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$=VED=&@Z,24[=VAI=&4M
M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1'1E>'0M86QI9VXZ<FEG:'0[;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+7-I>F4Z.7!T.SL^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+7-I>F4Z.7!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CPO='(^#0H\+W1A8FQE/CPO9&EV/CQP('-T>6QE/3-$
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HY
M<'0[.SXF;F)S<#L\+W`^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*
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M=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P
M+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C
M:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@
M<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J
M+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S
M/3-$<F5P;W)T(&ED/3-$240P14%$/@T*("`@("`@/'1R/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG
M/D-A<V@L($-A<V@@17%U:79A;&5N=',@86YD($UA<FME=&%B;&4@4V5C=7)I
M=&EE<SQB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:"!C;VQS<&%N/3-$,3XQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S
M,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M0V%S:"P@0V%S:"!%<75I=F%L96YT<R!A;F0@36%R:V5T86)L92!396-U<FET
M:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=CX-"CQD
M:78@86QI9VX],T1L969T/CQT86)L92!B;W)D97(],T0P(&-E;&QS<&%C:6YG
M/3-$,"!C96QL<&%D9&EN9STS1#`@<W1Y;&4],T0G8F]R9&5R+6-O;&QA<'-E
M.F-O;&QA<'-E.R!W:61T:#HQ,#`E.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR
M:6=H=#HP)2<^/'1R/CQT9"!V86QI9VX],T1T;W`@<W1Y;&4],T1W:61T:#HT
M+C4T)3MW:&ET92US<&%C93IN;W=R87`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[9F]N="US:7IE.C$P<'0[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW
M96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C0N/"]F;VYT/CPO<#X\+W1D/CQT
M9"!V86QI9VX],T1T;W`@<W1Y;&4],T1W:61T:#HY-2XT-B4[/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.V9O;G0M<VEZ
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M87,@;V8@1&5C96UB97(F(S$V,#LS,2P@,C`Q,RP@86YD(#(P,3(@*&EN('1H
M;W5S86YD<RDZ(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C`E.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B8C,38P.SPO9F]N=#X\+W`^/&1I
M=CX-"CQT86)L92!B;W)D97(],T0P(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D
M9&EN9STS1#`@86QI9VX],T1C96YT97(@<W1Y;&4],T0G8F]R9&5R+6-O;&QA
M<'-E.F-O;&QA<'-E.R!W:61T:#HQ,#`E.R<^#0H\='(^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M
M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C4R)3L@
M8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S
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M<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[)SX\<"!S='EL93TS
M1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/D%M;W)T
M:7IE9"!#;W-T/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C(E.R!B;W)D
M97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D(&-O;'-P86X],T0R('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=W:61T:#HQ,"4[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T(",P,#`P,#`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E
M;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/E5N<F5A;&EZ960@1V%I;G,\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I
M9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N
M=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,B4[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG
M;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD
M.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)W=I9'1H.C$P)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P
M,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^56YR96%L:7IE9"!,;W-S97,\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D
M97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G=VED=&@Z,B4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R
M86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$P
M)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T
M>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M17-T:6UA=&5D($9A:7(F(S$V,#M686QU93PO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB
M;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW
M96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HU,B4[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,3(N,C5P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.BTQ,BXR-7!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SY$96-E;6)E<B8C,38P.S,Q+"`R,#$S/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P
M,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T
M:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,B4[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z
M,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T
M>6QE/3-$)W=I9'1H.C(E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$
M)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N
M=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HR
M)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W
M:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R
M9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M
M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T
M=&]M.C`@<'0[=VED=&@Z-3(E.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,3(N,C5P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.BTQ,BXR-7!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/D-A<V@@86YD(&-A<V@@97%U:79A;&5N=',Z/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1'=I9'1H.C$E.W=H
M:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1'=I9'1H.C(E.SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E
M.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1'=I9'1H.C(E.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T1W:61T
M:#HX)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1'=I9'1H.C(E.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T1W:61T:#HX)3MW:&ET
M92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN
M9RU";W1T;VTZ,"!P=#MW:61T:#HU,B4[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HR-BXV-7!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z+3$R+C(U<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^0V%S:#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW
M:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P
M86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
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M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H
M.C(E.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A
M<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
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M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXM/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO
M=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HR)3L^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W
M:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C@E
M.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR
M:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^+3PO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
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M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[
M/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/C$L-S8V/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E.W=H:71E
M+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I
M;F<M0F]T=&]M.C`@<'0[=VED=&@Z-3(E.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,C8N-C5P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.BTQ,BXR-7!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/DUO;F5Y(&UA<FME="!F=6YD<SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T1W:61T:#HQ)3MW:&ET
M92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1'=I9'1H.C(E.SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1'=I9'1H
M.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R
M87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
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M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1'=I9'1H.C(E
M.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1'=I
M9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN
M;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
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M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1'=I9'1H
M.C(E.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C
M93IN;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/C(P+#`Q,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN
M;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S
M<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MW:61T:#HU,B4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R
M86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,C8N-C5P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.BTQ,BXR-7!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/E4N
M4RX@9V]V97)N;65N="!A9V5N8WD@<V5C=7)I=&EE<SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P
M,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED
M=&@Z."4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,2PS-#,\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE
M/3-$)W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W
M:61T:#HR)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E
M;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=W:61T:#HX)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T
M97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXM/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G=VED=&@Z,B4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E
M<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^+3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C(E.R!B;W)D97(M8F]T=&]M.G-O
M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H
M.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D
M97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/C$L,S0S/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ
M)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I
M9'1H.C4R)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,3(N,C5P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.BTQ,BXR-7!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/E1O=&%L(&-A<V@@86YD(&-A
M<V@@97%U:79A;&5N=',\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N
M-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P
M,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D97(M=&]P.G-O
M;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P
M="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E
M>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C(S+#$R,CPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT
M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=W:61T:#HR)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R
M86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P
M,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW
M-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P
M,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG
M;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^+3PO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T
M=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=W:61T:#HR)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E
M;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED
M=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E
M<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^+3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HR)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB
M;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z."4[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^,C,L,3(R/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R
M86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP
M('!T.W=I9'1H.C4R)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HQ,BXR-7!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z+3$R+C(U<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^36%R:V5T
M86)L92!S96-U<FET:65S(&%V86EL86)L92UF;W(M<V%L93H\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#
M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C
M,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I
M9'1H.C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HR)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T
M:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HX)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G=VED=&@Z,B4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R
M86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW
M-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H
M.C(E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$
M)W=I9'1H.C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z-3(E
M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C(V+C8U<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HM,3(N,C5P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C@E
M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/C$V-BPR.#4\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M
M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=W:61T:#HR)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A
M;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@
M(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HX)3L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXQ-CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C(E.R!B
M;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E
M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P
M="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E
M>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B@T-SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED
M=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXI/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=W:61T:#HR)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HX)3L@
M8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXQ-C8L,C4T/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F
M=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U
M('!T.W=I9'1H.C4R)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,3(N,C5P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.BTQ,BXR-7!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
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M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C
M,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C@E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/C$V-BPR.#4\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,B4[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O
M;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#
M('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C
M,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG
M:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C$V/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E
M;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C(E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@
M8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HX)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
M+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXH-#<\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED
M(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/BD\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$
M)W=I9'1H.C(E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N
M=#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P
M,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HX
M)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXQ-C8L,C4T/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB
M;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S
M<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HU,B4[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T
M=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C$R
M+C(U<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HM,3(N,C5P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L
M92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HX)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B
M;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXQ
M.#DL-#`W/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A
M;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R
M96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C(E.R!B;W)D97(M=&]P.G-O
M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@
M,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P
M,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P
M,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA
M;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,38\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E
M.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R
M+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G=VED=&@Z,B4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS
M<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N
M=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B
M;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=W:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@
M8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXH-#<\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O
M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@
M,BXU<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/BD\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C(E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O
M;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@
M,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE
M(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,3@Y
M+#,W-CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS
M<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N
M=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT
M<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T
M:#HU,B4[(&)O<F1E<BUT;W`Z9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,3(N,C5P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.BTQ,BXR-7!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD
M.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY$96-E;6)E<B8C,38P.S,Q
M+"`R,#$R/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O
M<#ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1"=W:61T:#HX)3L@8F]R9&5R+71O<#ID;W5B;&4@,BXU
M<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1"=W:61T:#HQ)3L@8F]R9&5R+71O<#ID;W5B;&4@,BXU<'0@=')A;G-P87)E
M;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z
M,B4[(&)O<F1E<BUT;W`Z9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z9&]U8FQE(#(N-7!T
M(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M=VED=&@Z."4[(&)O<F1E<BUT;W`Z9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O
M<F1E<BUT;W`Z9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C(E.R!B;W)D97(M=&]P
M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I
M9'1H.C$E.R!B;W)D97(M=&]P.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D
M97(M=&]P.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.F1O=6)L
M92`R+C5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
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M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R
M+71O<#ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=W:61T:#HX)3L@8F]R9&5R+71O<#ID;W5B;&4@
M,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#ID;W5B;&4@,BXU<'0@=')A;G-P
M87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^
M#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M
M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP
M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-3(E.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,3(N,C5P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.BTQ
M,BXR-7!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/D-A<V@@86YD(&-A<V@@97%U:79A
M;&5N=',Z/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T1W:61T:#HX)3MW:&ET
M92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1'=I9'1H.C(E
M.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1'=I
M9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN
M;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
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M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1'=I9'1H.C(E.SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1'=I9'1H.C$E.W=H
M:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1'=I9'1H.C(E.SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E
M.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HU,B4[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HR-BXV-7!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z+3$R+C(U<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^0V%S:#PO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X
M="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
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M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1'=I9'1H.C(E.SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E
M.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
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M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXM/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H
M.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HR
M)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M+3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R
M87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C0T9&,$9#('-T>6QE/3-$=VED=&@Z,B4[/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HX)3MW
M:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG
M:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C$L-30R/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A
M9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG
M+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-3(E.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,C8N-C5P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.BTQ,BXR-7!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/DUO;F5Y(&UA<FME="!F
M=6YD<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$=VED=&@Z."4[=VAI=&4M
M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXS+#$T,#PO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C
M93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$=VED=&@Z,B4[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1'=I9'1H.C@E
M.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR
M:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^+3PO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US
M<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$=VED=&@Z,B4[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1'=I9'1H
M.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG
M;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^+3PO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T1W:61T:#HQ)3MW:&ET
M92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$=VED=&@Z,B4[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
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M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1'=I
M9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA
M;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,RPQ-#`\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$=VED=&@Z
M,24[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT
M<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T
M:#HU,B4[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HR-BXV-7!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z+3$R+C(U<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
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M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C@E.W=H:71E
M+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^-S$U/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I
M9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T
M:#HR)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R
M87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
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M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXM/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P
M86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HR)3L^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXM/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T1W:61T:#HR)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW
M:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T
M<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[=VED=&@Z-3(E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C(V+C8U<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HM,3(N,C5P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SY5+E,N(&=O=F5R;FUE;G0@86=E;F-Y('-E8W5R:71I97,\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E
M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P
M="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E
M>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C(L,C`R/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W
M:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E
M;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,B4[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED
M=&@Z."4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^+3PO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB
M;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S
M<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)W=I9'1H.C(E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C
M,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D97(M8F]T
M=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/BT\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HR)3L@8F]R
M9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@
M8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=W:61T:#HX)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@
M(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXR+#(P,CPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED
M=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HU,B4[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C$R+C(U<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HM,3(N,C5P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SY4;W1A;"!C87-H(&%N9"!C87-H(&5Q=6EV86QE;G1S/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M(S`P,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HX)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXW+#4Y.3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=W:61T:#HR)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P
M,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^+3PO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT
M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HR)3L@8F]R
M9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O
M<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^+3PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T
M<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1"=W:61T:#HR)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E
M;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW
M-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P
M,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z
M."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB
M;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^-RPU.3D\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG
M:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M
M.C`@<'0[=VED=&@Z-3(E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C$R+C(U<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HM,3(N,C5P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY-87)K
M971A8FQE('-E8W5R:71I97,@879A:6QA8FQE+69O<BUS86QE.CPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z
M,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P
M,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I
M9'1H.C(E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I
M9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M
M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=W:61T:#HR)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E
M;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=W:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R
M9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G=VED=&@Z,B4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS
M<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P
M,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C4R)3LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C$T+C1P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P
M86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^,3$V+#DX-CPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W
M:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
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M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A
M<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
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M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C(E.SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$
M)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B@Q/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
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M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$=VED=&@Z,24[=VAI
M=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C@E.W=H:71E
M+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^,3$W+#`S,3PO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\
M+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MW:61T:#HU,B4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,30N-'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/E4N
M4RX@=')E87-U<GD@<V5C=7)I=&EE<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED
M=&@Z."4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^-3`P/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R
M+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G=VED=&@Z,B4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R
M86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T
M(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUB
M;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^+3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C(E.R!B
M;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E
M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P
M="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E
M>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/BT\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H
M.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=W:61T:#HR)3L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HX
M)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXU,#`\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M8F]T
M=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[=VED=&@Z-3(E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A
M<F5N=#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HQ,BXR-7!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z+3$R+C(U<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^5&]T86P@;6%R:V5T
M86)L92!S96-U<FET:65S(&%V86EL86)L92UF;W(M<V%L93PO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P
M,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z."4[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^,3$W+#0X-CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=W:61T:#HR)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P
M,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^-#8\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$
M)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N
M=#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,B4[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T
M=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$
M)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B
M;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D97(M=&]P
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N
M-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B@Q/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXI/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W
M:61T:#HR)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T
M(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z."4[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^,3$W+#4S,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T
M=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z-3(E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O
M;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^5&]T86P@8V%S:"P@8V%S:"!E<75I=F%L96YT<R!A;F0@;6%R:V5T
M86)L92!S96-U<FET:65S/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P
M,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P
M,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA
M;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,3(U+#`X-3PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED
M=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B
M;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=W:61T:#HR)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS
M<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P
M,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)W=I9'1H.C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P
M,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C0V/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U
M8FQE(#(N-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H
M.C(E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R
M9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O
M;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z."4[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T
M;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^*#$\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T
M<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P
M87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/BD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C(E.R!B;W)D97(M=&]P.G-O;&ED
M(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU
M<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P
M,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW
M-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P
M,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG
M;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,3(U+#$S,#PO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z
M,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D
M97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CPO=&%B;&4^/"]D:78^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C`E
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M;W(M<V%L92!A<F4@87,@9F]L;&]W<R`H:6X@=&AO=7-A;F1S*2`\+V9O;G0^
M/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
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M/3-$,"!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P(&%L:6=N/3-$
M8V5N=&5R('-T>6QE/3-$)V)O<F1E<BUC;VQL87!S93IC;VQL87!S93L@=VED
M=&@Z,3`P)3LG/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HV,B4[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M=VED=&@Z,R4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!C;VQS<&%N/3-$-B!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HS
M,R4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[)SX\<"!S
M='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT
M.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/D1E8V5M8F5R)B,Q
M-C`[,S$L(#(P,3,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M
M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP
M861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C8R)3L@8F]R9&5R+71O<#IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,R4[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z,30E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P
M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB
M;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY!;6]R=&EZ960@0V]S
M=#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,R4[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA
M;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I
M;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O
M<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,38E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O
M;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC
M96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SY%<W1I;6%T960@1F%I<B!686QU93PO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS
M<&%R96YT.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N
M=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M
M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP
M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-C(E.R!B;W)D97(M
M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SY-871U<F4@:6X@;VYE('EE87(@;W(@;&5S<SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW
M:61T:#HS)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H
M.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C$R)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I
M9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[
M=VED=&@Z,R4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T
M:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P
M=#MW:61T:#HQ-"4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR
M:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^.3,L-S`Q/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z-C(E.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P
M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ
M,B4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^-S(L-3DT/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R
M9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[=VED=&@Z,R4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ
M)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$T)3L@
M8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z
M-C(E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R
M9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MW:61T:#HS)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS
M<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P
M=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@
M8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW
M:61T:#HQ,B4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O
M<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^,38V+#(X-3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT
M.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HS)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB
M;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@
M,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ-"4[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N
M-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,38V+#(U-#PO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L
M92`R+C5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T
M<CX-"CPO=&%B;&4^/"]D:78^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,G!T.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CLG/B9N8G-P.SPO<#X\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP)3MM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,"4[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^)FYB<W`[/"]P/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HT+C4T)3MF
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M(&UU;FEC:7!A;"!S96-U<FET:65S+B`\+V9O;G0^/"]P/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,3)P=#MM87)G:6XM;&5F
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M('-E8W5R:71I97,@:6X@=&AE('EE87)S(&5N9&5D($1E8V5M8F5R)B,Q-C`[
M,S$L(#(P,3,L(#(P,3(@86YD(#(P,3$N($%L;"!O9B!O=7(@:6YV97-T;65N
M=',@87)E(&-L87-S:69I960@87,@<VAO<G0M=&5R;2!A;F0@879A:6QA8FQE
M+69O<BUS86QE+"!A<R!W92!M87D@;F]T(&AO;&0@;W5R(&EN=F5S=&UE;G1S
M('5N=&EL(&UA='5R:71Y+B`\+V9O;G0^/"]P/CPO9&EV/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^
M#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?-V5A.#)B,CE?.3@R-E\T
M,#)A7V(Y-C!?,#(Q-69D.&)A9&4X#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE
M.B\O+T,Z+S=E83@R8C(Y7SDX,C9?-#`R85]B.38P7S`R,35F9#AB861E."]7
M;W)K<VAE971S+U-H965T,3(N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O
M9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT
M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@
M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$
M)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X
M="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4
M:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@
M(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5!1#X-"B`@("`@(#QT
M<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A
M;CTS1#(^/'-T<F]N9SY0<F]P97)T>2!A;F0@17%U:7!M96YT/&)R/CPO<W1R
M;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q
M/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$S/&)R/CPO
M=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F]P97)T>2!A;F0@
M17%U:7!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I
M=CX-"CQD:78@86QI9VX],T1L969T/CQT86)L92!B;W)D97(],T0P(&-E;&QS
M<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@<W1Y;&4],T0G8F]R9&5R+6-O
M;&QA<'-E.F-O;&QA<'-E.R!W:61T:#HQ,#`E.VUA<F=I;BUL969T.C`E.VUA
M<F=I;BUR:6=H=#HP)2<^/'1R/CQT9"!V86QI9VX],T1T;W`@<W1Y;&4],T1W
M:61T:#HT+C4T)3MW:&ET92US<&%C93IN;W=R87`^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HQ.'!T.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXU+CPO9F]N=#X\+W`^
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M>2!A;F0@97%U:7!M96YT(&%S(&]F($1E8V5M8F5R)B,Q-C`[,S$L(#(P,3,L
M(&%N9"`R,#$R(&-O;G-I<W0@;V8@=&AE(&9O;&QO=VEN9R`H:6X@=&AO=7-A
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M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)B,Q-C`[/"]F;VYT/CPO<#X\9&EV/@T*
M/'1A8FQE(&)O<F1E<CTS1#`@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG
M/3-$,"!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=B;W)D97(M8V]L;&%P<V4Z
M8V]L;&%P<V4[('=I9'1H.C$P,"4[)SX-"CQT<CX-"CQT9"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z-S`E.R!B;W)D
M97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^)FYB<W`[/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG
M:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C@E.R!B;W)D
M97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L
M9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^17-T:6UA=&5D)B,Q-C`[
M57-E9G5L/&)R("\^3&EF93PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O
M<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB
M;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@8V]L<W!A;CTS1#8@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P
M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[)SX\
M<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I
M9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/D1E8V5M8F5R
M)B,Q-C`[,S$L/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO
M=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HW,"4[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D
M:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z."4[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M
M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4],T0G=&5X
M="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SXF;F)S<#L\+W`^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT
M97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXH26X@>65A<G,I/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D
M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ
M)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E
M<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS
M<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^,C`Q,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.G-O
M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED
M=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E
M<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD
M.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP
M861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z
M,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB
M;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[)SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C(P,3(\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I
M9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@
M8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H
M=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O
M;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP
M861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C<P)3L@8F]R9&5R+71O<#IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HQ,BXR-7!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z+3$R+C(U<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
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M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[)SX\<"!S
M='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^-2TQ-#PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ
M,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P
M,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI
M9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/C@L.38X/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP
M('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A
M<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[
M=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
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M.C`@<'0[=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P
M,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG
M;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
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M+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^
M/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I
M9'1H.C<P)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C$R+C(U<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HM,3(N,C5P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY,86(@
M97%U:7!M96YT/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C@E.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/C4M,3,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z,24[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S
M<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP
M861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z
M."4[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG
M;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
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M;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXV+#<U-3PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HW,"4[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HQ,BXR-7!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z+3$R+C(U
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
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M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP
M('!T.W=I9'1H.C@E.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
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M.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z."4[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
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M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P
M=#MW:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T
M97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXQ+#@P-SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T
M:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN
M9RU";W1T;VTZ,"!P=#MW:61T:#HW,"4[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HQ,BXR-7!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z+3$R+C(U<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^1G5R;FET=7)E(&%N9"!F:7AT=7)E<SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3LG/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXS/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP
M861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D
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M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C$L,#4V
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P
M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z,24[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z."4[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^.3@S/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*
M/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I
M9'1H.C<P)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C$R+C(U<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HM,3(N,C5P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY,96%S
M96AO;&0@:6UP<F]V96UE;G1S/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C@E.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C4M-SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P
M=#MW:61T:#HQ)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C
M0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG
M:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M
M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXV+#`T.#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C$E.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ
M,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
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M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/C4L-#0U/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P
M/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HW,"4[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,3(N,C5P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.BTQ,BXR-7!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/D%S<V5T<R!I;B!P<F]G<F5S<SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[=VED=&@Z."4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS
M<&%R96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUB
M;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@
M(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP
M('!T.W=I9'1H.C@E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P
M,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI
M9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/C<V,CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z
M,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
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M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW
M-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[
M=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T
M:#HX)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXQ+#`T-SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O
M<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP
M861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C<P)3L@8F]R9&5R+71O<#IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HQ,BXR-7!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z+3$R+C(U<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C@E.R!B;W)D97(M=&]P
M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C@E.R!B;W)D97(M
M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C(V+#`R
M,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O
M;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z."4[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M,C,L-C$Q/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP
M861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D
M:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-
M"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[=VED=&@Z-S`E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T
M<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C$R+C(U<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HM,3(N,C5P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY,
M97-S(&%C8W5M=6QA=&5D(&1E<')E8VEA=&EO;B!A;F0@86UO<G1I>F%T:6]N
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HX)3L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP
M('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P
M,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW
M-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[
M=VED=&@Z."4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR
M:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^*#$W+#,Q-SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z
M,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXI/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H
M.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D
M:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z."4[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^*#$U+#8T-CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E
M<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXI/"]F;VYT/CPO<#X\
M+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z-S`E
M.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R
M+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HQ,BXR-7!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z+3$R+C(U
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
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M:6YG+51O<#HP+C<U('!T.W=I9'1H.C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@
M=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R
M9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T
M;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU
M<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI
M9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@
M(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXX+#<P-CPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P
M="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A
M;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R
M96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW
M:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R
M9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T
M:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R
M+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXW
M+#DV-3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z
M,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D
M97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/"]T<CX-"CPO=&%B;&4^/"]D:78^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ
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M,38P.S,Q+"`R,#$S+"`R,#$R(&%N9"`R,#$Q+"!R97-P96-T:79E;'DN(#PO
M9F]N=#X\+W`^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM
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M:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV
M/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T
M/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$
M4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R
M:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P
M;W)T(&ED/3-$240P14%$/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/DEN=&%N
M9VEB;&4@07-S971S/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y$96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y);G1A;F=I8FQE($%S<V5T<SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQD:78^#0H\9&EV(&%L:6=N/3-$;&5F=#X\=&%B;&4@
M8F]R9&5R/3-$,"!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('-T
M>6QE/3-$)V)O<F1E<BUC;VQL87!S93IC;VQL87!S93L@=VED=&@Z,3`P)3MM
M87)G:6XM;&5F=#HP)3MM87)G:6XM<FEG:'0Z,"4G/CQT<CX\=&0@=F%L:6=N
M/3-$=&]P('-T>6QE/3-$=VED=&@Z-"XU-"4[=VAI=&4M<W!A8V4Z;F]W<F%P
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,3AP
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M1'=I9'1H.CDU+C0V)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HQ.'!T.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O
M;&0[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SY);G1A;F=I8FQE($%S<V5T<R`\+V9O;G0^/"]P
M/CPO=&0^/"]T<CX\+W1A8FQE/CPO9&EV/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z-G!T.VUA<F=I;BUL969T.C`E.VUA<F=I
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M:&4@>65A<B!E;F1E9"!$96-E;6)E<B8C,38P.S,Q+"`R,#$Q+B!!;6]R=&EZ
M871I;VX@;V8@:6YT86YG:6)L92!A<W-E=',@=V%S('IE<F\@9F]R('1H92!Y
M96%R<R!E;F1E9"!$96-E;6)E<B8C,38P.S,Q+"`R,#$S(&%N9"`R,#$R+"!A
M;F0@)#`N,R!M:6QL:6]N(&9O<B!T:&4@>65A<B!E;F1E9"!$96-E;6)E<B8C
M,38P.S,Q+"`R,#$Q+B`\+V9O;G0^/"]P/CPO9&EV/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\
M+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?-V5A.#)B,CE?.3@R-E\T,#)A
M7V(Y-C!?,#(Q-69D.&)A9&4X#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O
M+T,Z+S=E83@R8C(Y7SDX,C9?-#`R85]B.38P7S`R,35F9#AB861E."]7;W)K
M<VAE971S+U-H965T,30N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN
M9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[
M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@
M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E
M>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J
M879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES
M($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT
M86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5!1#X-"B`@("`@(#QT<CX-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS
M1#(^/'-T<F]N9SY#=7)R96YT($%C8W)U960@3&EA8FEL:71I97,\8G(^/"]S
M=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS
M1#$^,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^
M/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-U<G)E;G0@06-C
M<G5E9"!,:6%B:6QI=&EE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQD:78^#0H\9&EV(&%L:6=N/3-$;&5F=#X\=&%B;&4@8F]R9&5R/3-$
M,"!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('-T>6QE/3-$)V)O
M<F1E<BUC;VQL87!S93IC;VQL87!S93L@=VED=&@Z,3`P)3MM87)G:6XM;&5F
M=#HP)3MM87)G:6XM<FEG:'0Z,"4G/CQT<CX\=&0@=F%L:6=N/3-$=&]P('-T
M>6QE/3-$=VED=&@Z-"XU-"4[=VAI=&4M<W!A8V4Z;F]W<F%P/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,3AP=#MF;VYT+7-I
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M+C0V)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
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M97(F(S$V,#LS,2P@,C`Q,RP@86YD(#(P,3(@8V]N<VES="!O9B!T:&4@9F]L
M;&]W:6YG("AI;B!T:&]U<V%N9',I.B`\+V9O;G0^/"]P/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP)3MF;VYT+7-I>F4Z
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M9STS1#`@8V5L;'!A9&1I;F<],T0P(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$
M)V)O<F1E<BUC;VQL87!S93IC;VQL87!S93L@=VED=&@Z,3`P)3LG/@T*/'1R
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MW:61T:#HW,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS
M<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SXF;F)S<#L\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$
M-B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,C@E.R!B;W)D97(M
M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4],T0G=&5X
M="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H
M=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY$96-E;6)E<B8C
M,38P.S,Q+#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[=VED=&@Z-S$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A
M;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=W:61T:#HQ,B4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P
M,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[)SX\
M<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/C(P,3,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T
M<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C,E.R!B;W)D97(M=&]P.G-O
M;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T
M:#HQ,R4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E
M<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[)SX\<"!S='EL93TS1"=T
M97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I
M9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C(P,3(\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I
M9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@
M8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C<Q)3L@8F]R
M9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HQ,BXR-7!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z+3$R+C(U
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^4&%Y<F]L;"!A;F0@<F5L871E9"!E>'!E
M;G-E<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B0\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T
M>6QE/3-$)W=I9'1H.C$P)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P
M,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L
M:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXS+#8S.3PO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE
M/3-$)W=I9'1H.C,E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A
M<F5N=#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z
M,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$Q)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXT+#4S.#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP
M('!T.W=I9'1H.C<Q)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C$R+C(U<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HM,3(N,C5P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SY,96=A;"!E>'!E;G-E<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[
M/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$=VED
M=&@Z,3`E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA
M;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,S,X/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1'=I9'1H.C$E
M.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T1W:61T:#HS)3L^/'`@<W1Y;&4],T0G=&5X="UA
M;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1'=I9'1H
M.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T1W:61T:#HQ,24[=VAI=&4M<W!A8V4Z;F]W
M<F%P.SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXS.38\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\
M<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HW,24[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HQ,BXR
M-7!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z+3$R+C(U<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
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M:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ,"4[=VAI
M=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXR+#0P,SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T
M:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$=VED=&@Z
M,3$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG
M;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
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M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z-S$E.R!B;W)D97(M8F]T=&]M.G-O
M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C$R+C(U<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HM,3(N,C5P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SY/=&AE<B!A8V-R=65D(&QI86)I;&ET:65S/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ
M)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=W:61T:#HQ,"4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,2PW.#8\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A
M<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM
M=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HS)3L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I
M9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$Q)3L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXQ
M+#DR,CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R
M86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\
M+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HW,24[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M
M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C$R+C(U
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HM,3(N,C5P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SY4;W1A;#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z
M,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB
M;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B0\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$)W=I9'1H.C$P)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P
M,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N
M.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXX+#$V-CPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R
M86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A
M<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM
M=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T
M:#HS)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O
M<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@
M,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M=VED=&@Z,3$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B
M;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/C$P+#`V,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED
M=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B
M;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CPO=&%B;&4^/"]D
M:78^/'`@<W1Y;&4],T1M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP)3MM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,"4[9F]N="US:7IE.CEP=#L[/B9N8G-P.SPO<#X\+V1I=CX\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y
M/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S=E83@R8C(Y7SDX,C9?
M-#`R85]B.38P7S`R,35F9#AB861E.`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL
M93HO+R]#.B\W96$X,F(R.5\Y.#(V7S0P,F%?8CDV,%\P,C$U9F0X8F%D93@O
M5V]R:W-H965T<R]3:&5E=#$U+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC
M;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H
M=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*
M("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS
M1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E
M>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@
M5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@
M("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%040^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P
M86X],T0R/CQS=')O;F<^4WEM<&AO;GD@1'EN86UO+"!);F,N/&)R/CPO<W1R
M;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q
M/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$S/&)R/CPO
M=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3>6UP:&]N>2!$>6YA
M;6\L($EN8RX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\9&EV
M/@T*/&1I=B!A;&EG;CTS1&QE9G0^/'1A8FQE(&)O<F1E<CTS1#`@8V5L;'-P
M86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S='EL93TS1"=B;W)D97(M8V]L
M;&%P<V4Z8V]L;&%P<V4[('=I9'1H.C$P,"4[;6%R9VEN+6QE9G0Z,"4[;6%R
M9VEN+7)I9VAT.C`E)SX\='(^/'1D('9A;&EG;CTS1'1O<"!S='EL93TS1'=I
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M=&0^/'1D('9A;&EG;CTS1'1O<"!S='EL93TS1'=I9'1H.CDU+C0V)3L^/'`@
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M;7!H;VYY($1Y;F%M;RP@26YC+B`\+V9O;G0^/"]P/CPO=&0^/"]T<CX\+W1A
M8FQE/CPO9&EV/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z-G!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT
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M-C`[,3@L(#(P,#8L('=E+"!3>6UP:&]N>2!A;F0@2&]L9&EN9W,@96YT97)E
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M('1H92`F(S@R,C`[4')O9W)A;7,F(S@R,C$[*2X@4'5R<W5A;G0@=&\@=&AE
M<V4@86=R965M96YT<RP@4WEM<&AO;GD@9F]R;65D(%-$22!A;F0@:6YV97-T
M960@)#4P)B,Q-C`[;6EL;&EO;B!T;R!F=6YD('1H92!0<F]G<F%M<RP@86YD
M('=E(&QI8V5N<V5D('1O($AO;&1I;F=S(&]U<B!I;G1E;&QE8W1U86P@<')O
M<&5R='D@<FEG:'1S(')E;&%T960@=&\@=&AE(%!R;V=R86US+"!W:&EC:"!W
M97)E(&%S<VEG;F5D('1O(%-$22X@07,@82!R97-U;'0@;V8@=&AE<V4@86=R
M965M96YT<RP@4WEM<&AO;GD@;W=N960@,3`P)2!O9B!T:&4@97%U:71Y(&]F
M($AO;&1I;F=S+"!W:&EC:"!O=VYE9"`Q,#`E(&]F('1H92!E<75I='D@;V8@
M4T1)+B`\+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,3)P=#MM87)G:6XM;&5F=#HP)3MM87)G:6XM<FEG:'0Z
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M<FEG:'1S('1H870@=V4@;&EC96YS960@=&\@2&]L9&EN9W,@*'1H92`F(S@R
M,C`[3W)I9VEN86P@4'5R8VAA<V4@3W!T:6]N)B,X,C(Q.RDN($EN(&5X8VAA
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M<'5R8VAA<V4@=7`@=&\@,BPP,#`L,#`P('-H87)E<R!O9B!O=7(@8V]M;6]N
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M('1H97)A<'D@<')O9W)A;2`H=&AE("8C.#(R,#M0<F]G<F%M($]P=&EO;B8C
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M=&]P.C$R<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
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M(&]F(%-$22!O;B!$96-E;6)E<B8C,38P.S,P+"`R,#`Y+"!W92!C;VYS;VQI
M9&%T960@=&AE(&9I;F%N8VEA;"!P;W-I=&EO;B!A;F0@<F5S=6QT<R!O9B!O
M<&5R871I;VYS(&]F(%-$22X@26X@3F]V96UB97(F(S$V,#LR,#`Y+"!W92!E
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M(&]N($1E8V5M8F5R)B,Q-C`[,S`L(#(P,#DN($EN(&5X8VAA;F=E(&9O<B!A
M;&P@;V8@=&AE(&]U='-T86YD:6YG(&5Q=6ET>2!O9B!31$DL('=E(&ES<W5E
M9"!T;R!3>6UP:&]N>2!A;F0@8V5R=&%I;B!O9B!I=',@8V\M:6YV97-T;W)S
M.B`H:3PO9F]N=#X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z,3!P=#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXI)B,Q-C`[,3,L,#`P+#`P,"!S:&%R97,@;V8@8V]M
M;6]N('-T;V-K("AT:&4@)B,X,C(P.U-H87)E<R8C.#(R,3LI.R`H:6DI)B,Q
M-C`[-2UY96%R('=A<G)A;G1S('1O('!U<F-H87-E(#(L,#`P+#`P,"!S:&%R
M97,@;V8@8V]M;6]N('-T;V-K('=I=&@@86X@97AE<F-I<V4@<')I8V4@;V8@
M)#$N.30@<&5R('-H87)E("AT:&4@)B,X,C(P.U=A<G)A;G1S)B,X,C(Q.RD[
M(&%N9"`H:6EI*28C,38P.V$@;F]N+6EN=&5R97-T(&)E87)I;F<@;F]T92!I
M;B!T:&4@<')I;F-I<&%L(&%M;W5N="!O9B`D,34@;6EL;&EO;BP@9'5E($1E
M8V5M8F5R)B,Q-C`[,S$L(#(P,3(L('!A>6%B;&4@:6X@8V%S:"P@;W5R(&-O
M;6UO;B!S=&]C:R!O<B!A(&-O;6)I;F%T:6]N('1H97)E;V8@870@;W5R(&1I
M<V-R971I;VXL('=H:6-H(&]B;&EG871I;VX@=V%S('!R979I;W5S;'D@<&%Y
M86)L92!S;VQE;'D@:6X@8V%S:"!O;B!!<')I;"8C,38P.S$X+"`R,#$Q("AT
M:&4@)B,X,C(P.TYO=&4F(S@R,C$[*2X@26X@861D:71I;VXL('=E)B,Q-C`[
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M9VAT.C`E.W1E>'0M:6YD96YT.C0N-30E.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#MT97AT+6EN9&5N=#HT+C4T)2<^
M5V4@=V5R92!O8FQI9V%T960@=&\@;6%K92!F=71U<F4@8V]N=&EN9V5N="!C
M87-H('!A>6UE;G1S('1O('1H92!F;W)M97(@2&]L9&EN9W,@<VAA<F5H;VQD
M97)S(')E;&%T960@=&\@8V5R=&%I;B!P87EM96YT<R!R96-E:79E9"!B>2!U
M<RP@:68@86YY+"!F<F]M(&9U='5R92!P87)T;F5R:6YG(&%G<F5E;65N=',@
M<&5R=&%I;FEN9R!T;R!O=7(@:&5P871I=&ES($,@86YD(&-A;F-E<B!T:&5R
M87!Y('!R;V=R86US+B!792!E<W1I;6%T960@=&AE('9A;'5A=&EO;B!O9B!T
M:&ES(&-O;G1I;F=E;G0@;&EA8FEL:71Y('5S:6YG(&$@9&ES8V]U;G1E9"!C
M87-H(&9L;W<@;6]D96PN(%1H92!D:7-C;W5N=&5D(&-A<V@@9FQO=R!M;V1E
M;"!W87,@9&5R:79E9"!F<F]M(&UA;F%G96UE;G0F(S@R,3<[<R!A<W-U;7!T
M:6]N<R!R96=A<F1I;F<@=&AE('1I;6EN9RP@86UO=6YT<RP@86YD('!R;V)A
M8FEL:71Y(&]F('!O=&5N=&EA;"!U<&9R;VYT(&%N9"!M:6QE<W1O;F4@<&%Y
M;65N=',@9F]R('1H92!D979E;&]P;65N="!A;F0O;W(@8V]M;65R8VEA;&EZ
M871I;VX@;V8@=&AE(&AE<&%T:71I<R!#('!R;V=R86T@8F%S960@;VX@=')A
M;G-A8W1I;VYS(&9O<B!S:6UI;&%R('-T86=E('!R;V=R86US(&)Y(&]T:&5R
M(&-O;7!A;FEE<RX@5&AE<V4@8V%S:"!F;&]W<R!W97)E(&1I<V-O=6YT960@
M870@82!R871E(&]F(#$V/"]F;VYT/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B4@9F]R('1H92!F:7-C86P@>65A
M<B!E;F1E9"!$96-E;6)E<B8C,38P.S,Q+"`R,#$P+B`\+V9O;G0^/"]P/CQP
M('-T>6QE/3-$;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HQ,G!T.VUA
M<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HT+C4T
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M:&5R(&EN8V]M92`H97AP96YS92DF(S@R,C$[(&EN('1H92!C;VYS;VQI9&%T
M960@<W1A=&5M96YT<R!O9B!O<&5R871I;VYS(&EN('1H92!P97)I;V0@;V8@
M=&AE(&-H86YG92X@1'5R:6YG('1H92!F:7-C86P@>65A<B!E;F1E9"!$96-E
M;6)E<B8C,38P.S,Q+"`R,#$P+"!W92!R961U8V5D('1H92!A<W-U;65D('!R
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M(&]T:&5R(&EN8V]M92!O9B`D,BXR/"]F;VYT/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B!M:6QL:6]N(&9O<B!T
M:&4@9FES8V%L('EE87(@96YD960@1&5C96UB97(F(S$V,#LS,2P@,C`Q,"X@
M1'5R:6YG('1H92!Y96%R(&5N9&5D($1E8V5M8F5R)B,Q-C`[,S$L(#(P,3$L
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M,38P.S,Q+"`R,#$Q(')E<W5L=&EN9R!I;B!O=&AE<B!I;F-O;64@;V8@)#`N
M."!M:6QL:6]N+B!4:&5S92!F86ER('9A;'5E(&UE87-U<F5M96YT<R!W97)E
M(&)A<V5D(&]N('-I9VYI9FEC86YT(&EN<'5T<R!N;W0@;V)S97)V960@:6X@
M=&AE(&UA<FME="!A;F0@=&AU<R!R97!R97-E;G1E9"!A($QE=F5L(#,@;65A
M<W5R96UE;G0N(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HQ,G!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR
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M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C0N-30E.V9O;G0M<VEZ93HQ,'!T.V9O
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M9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C0N-30E.V9O;G0M
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M(&UE=&AO9"X@5V4@<&%I9"!I;B!C87-H('1H92`D,34@;6EL;&EO;B!P<FEN
M8VEP86P@8F%L86YC92!O9B!T:&4@3F]T92!O;B!$96-E;6)E<B8C,38P.S,Q
M+"`R,#$R+B`\+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,3)P=#MM87)G:6XM;&5F=#HP)3MM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z-"XU-"4[9F]N="US:7IE.C$P<'0[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.W1E>'0M:6YD96YT.C0N-30E)SY4
M:&4@4VAA<F5S(&%N9"!787)R86YT<R!W97)E('-U8FIE8W0@=&\@8V5R=&%I
M;B!A;G1I+61I;'5T:6]N('!R;W1E8W1I;VX@:6X@=&AE(&5V96YT('1H870@
M=V4@:7-S=65D(&]T:&5R(&5Q=6ET>2!S96-U<FET:65S('=I=&AI;B!S:7@@
M;6]N=&AS(&9R;VT@1&5C96UB97(F(S$V,#LS,"P@,C`P.2X@07,@82!R97-U
M;'0@;V8@86X@97%U:71Y(&]F9F5R:6YG(&-O;7!L971E9"!I;B!!<')I;"`R
M,#$P('!R:6]R('1O('1H92!E>'!I<F%T:6]N(&]F('1H92!A;G1I+61I;'5T
M:6]N('!R;W9I<VEO;BP@4WEM<&AO;GD@<F5C96EV960@86X@861D:71I;VYA
M;"`\+V9O;G0^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.C$P<'0[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^,2PP-S8L-#(P)B,Q-C`[<VAA<F5S(&]F(&-O;6UO;B!S
M=&]C:R`H)B,X,C(P.T%P<FEL(#(P,3`@4VAA<F5S)B,X,C(Q.RD@86YD('=A
M<G)A;G1S('1O('!U<F-H87-E(#<L,#,X+#(Q,"!S:&%R97,@;V8@8V]M;6]N
M('-T;V-K("@F(S@R,C`[07!R:6P@,C`Q,"!787)R86YT<R8C.#(R,3LI(&AA
M=FEN9R!T:&4@<V%M92!T97)M<R!A<R!T:&4@=V%R<F%N=',@<V]L9"!I;B!T
M:&4@;V9F97)I;F<L('=H:6-H(&AA=F4@86X@97AE<F-I<V4@<')I8V4@;V8@
M)#$N-3`@<&5R('-H87)E(&%N9"!A('1E<FT@;V8@9FEV92!Y96%R<RX@5&AE
M(%=A<G)A;G1S(&ES<W5E9"!O;B!$96-E;6)E<B8C,38P.S,P+"`R,#`Y('=E
M<F4@8V%N8V5L;&5D('5P;VX@=&AE(&ES<W5A;F-E(&]F('1H92!!<')I;"`R
M,#$P(%=A<G)A;G1S+B`\+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,3)P=#MM87)G:6XM;&5F=#HP)3MM87)G
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M-30E)SY4:&4@9F%I<B!V86QU92!O9B!T:&4@07!R:6P@,C`Q,"!3:&%R97,@
M86YD(&EN8W)E;65N=&%L(&9A:7(@=F%L=64@;V8@=&AE($%P<FEL(#(P,3`@
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M(S$V,#LS,"P@,C`Q,"P@<F5S=6QT960@:6X@;F]N+6]P97)A=&EN9R!E>'!E
M;G-E(&]F("0Q,2XQ(&UI;&QI;VX@:6X@=&AE('-E8V]N9"!Q=6%R=&5R(&]F
M(#(P,3`N(%1H:7,@86QS;R!R97-U;'1E9"!I;B!A;B!I;F-R96%S92!O9B`D
M.2XU(&UI;&QI;VX@=&\@=&AE('=A<G)A;G0@;&EA8FEL:71Y(&%N9"!A;B!I
M;F-R96%S92!O9B`D,2XV(&UI;&QI;VX@=&\@861D:71I;VYA;"!P86ED(&EN
M(&-A<&ET86P@87,@;V8@2G5N928C,38P.S,P+"`R,#$P+B!&;VQL;W=I;F<@
M=&AE(&5X<&ER871I;VX@9&%T92!O9B!3>6UP:&]N>28C.#(Q-SMS(&%N=&DM
M9&EL=71I;VX@<')O=&5C=&EO;BP@;VX@2G5N928C,38P.S,P+"`R,#$P+"!T
M:&4@=F%L=64@;V8@=&AE($%P<FEL(#(P,3`@5V%R<F%N=',@;V8@)#$R+C`@
M;6EL;&EO;B!W87,@<F5C;&%S<VEF:65D(&EN=&\@<W1O8VMH;VQD97)S)B,X
M,C$W.R!E<75I='D@:6X@=&AE(&-O;G-O;&ED871E9"!B86QA;F-E('-H965T
M<RX@07,@;V8@1&5C96UB97(F(S$V,#LS,2P@,C`Q,RP@=V%R<F%N=',@=&\@
M<'5R8VAA<V4@-BPW-C4L,3(X('-H87)E<R!R96UA:6YE9"!O=71S=&%N9&EN
M9RX@/"]F;VYT/CPO<#X\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM
M+2TM+2T]7TYE>'1087)T7S=E83@R8C(Y7SDX,C9?-#`R85]B.38P7S`R,35F
M9#AB861E.`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\W96$X,F(R
M.5\Y.#(V7S0P,F%?8CDV,%\P,C$U9F0X8F%D93@O5V]R:W-H965T<R]3:&5E
M=#$V+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP
M<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U
M<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M
M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H
M87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S
M<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO
M/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,]
M,T1R97!O<G0@:60],T1)1#!%040^#0H@("`@("`\='(^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^
M0V]M;6ET;65N=',@86YD($-O;G1I;F=E;F-I97,\8G(^/"]S=')O;F<^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,3(@36]N
M=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O;6UI=&UE;G1S(&%N9"!#;VYT
M:6YG96YC:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I
M=CX-"CQD:78@86QI9VX],T1L969T/CQT86)L92!B;W)D97(],T0P(&-E;&QS
M<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@<W1Y;&4],T0G8F]R9&5R+6-O
M;&QA<'-E.F-O;&QA<'-E.R!W:61T:#HQ,#`E.VUA<F=I;BUL969T.C`E.VUA
M<F=I;BUR:6=H=#HP)2<^/'1R/CQT9"!V86QI9VX],T1T;W`@<W1Y;&4],T1W
M:61T:#HT+C4T)3MW:&ET92US<&%C93IN;W=R87`^/'`@<W1Y;&4],T0G;6%R
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M+C0V)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
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M+W`^/"]T9#X\+W1R/CPO=&%B;&4^/"]D:78^/'`@<W1Y;&4],T1M87)G:6XM
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M(&EN($)E<FME;&5Y+"!#86QI9F]R;FEA("@F(S@R,C`[0F5R:V5L97D@3&5A
M<V4F(S@R,C$[*2!A;F0@1"8C,C4R.W-S96QD;W)F+"!'97)M86YY("@F(S@R
M,C`[1"8C,C4R.W-S96QD;W)F($QE87-E)B,X,C(Q.RD@=6YD97(@;W!E<F%T
M:6YG(&QE87-E<R!T:&%T(&5X<&ER92!I;B!*=6YE(#(P,3@\+V9O;G0^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M(&%N9"!-87)C:"`R,#(S+"!R97-P96-T:79E;'DN(%1H92!"97)K96QE>2!,
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M;BUT;W`Z,3)P=#MM87)G:6XM;&5F=#HP)3MM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z-"XU-"4[9F]N="US:7IE.C$P<'0[.SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[=&5X="UI;F1E;G0Z
M-"XU-"4G/D1U<FEN9R!397!T96UB97(@,C`Q,RP@=V4@9&5C:61E9"!N;W0@
M=&\@;V-C=7!Y(&$@<&]R=&EO;B!O9B!O=7(@9F%C:6QI='D@:6X@0F5R:V5L
M97DL($-A;&EF;W)N:6$N($%S(&$@<F5S=6QT+"!W92!R96-O<F1E9"!A(&]N
M92UT:6UE(&5S=&EM871E9"!U;F]C8W5P:65D(&9A8VEL:71Y(&5X<&5N<V4@
M;V8@)#`N.3PO9F]N=#X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z,3!P=#MF
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M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,3)P=#MM87)G:6XM;&5F=#HP)3MM87)G
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M(&5N9&5D($1E8V5M8F5R)B,Q-C`[,S$L(#(P,3,L(#(P,3(@86YD(#(P,3$L
M('=A<R`D,2XY/"]F;VYT/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B!M:6QL:6]N+"`D,2XW(&UI;&QI;VX@86YD
M("0Q+C<@;6EL;&EO;BP@<F5S<&5C=&EV96QY+B!$969E<G)E9"!R96YT('=A
M<R`D,"XV(&UI;&QI;VX@87,@;V8@1&5C96UB97(F(S$V,#LS,2P@,C`Q,R!A
M;F0@,C`Q,BXF;F)S<#LF;F)S<#L@/"]F;VYT/CPO<#X\<"!S='EL93TS1&UA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,3)P=#MM87)G:6XM;&5F=#HP
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M<B!O<&5R871I;F<@;&5A<V5S(&%T($1E8V5M8F5R)B,Q-C`[,S$L(#(P,3,L
M(&5X8VQU9&EN9R!P87EM96YT<R!F<F]M('-U8FQE87-E('!A>6UE;G1S+"!A
M<F4@87,@9F]L;&]W<R`H:6X@=&AO=7-A;F1S*3H\+V9O;G0^/"]P/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP)3MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SXF;F)S
M<#L\+W`^/&1I=CX-"CQT86)L92!B;W)D97(],T0P(&-E;&QS<&%C:6YG/3-$
M,"!C96QL<&%D9&EN9STS1#`@86QI9VX],T1C96YT97(@<W1Y;&4],T0G8F]R
M9&5R+6-O;&QA<'-E.F-O;&QA<'-E.R!W:61T:#HQ,#`E.R<^#0H\='(^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$
M)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D
M:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-SDE
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SY996%R<R!E;F1I;F<@1&5C96UB97(F
M(S$V,#LS,2P\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$=VED=&@Z,R4[/CQP('-T>6QE
M/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T1W:61T:#HQ-"4[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=M
M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO
M='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&
M1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z-SDE.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C(P,30\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C
M1D9&1D9&('-T>6QE/3-$=VED=&@Z,R4[/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C(P+C5P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ-"4[
M=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I
M9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXR+#(S,SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y
M;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$
M)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C<Y)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
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M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W
M:61T:#HQ-"4[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXR+#(X,CPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP
M('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D
M:6YG+4)O='1O;3HP('!T.W=I9'1H.C<Y)3LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y
M;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@
M<W1Y;&4],T1W:61T:#HQ-"4[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL
M93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXR
M+#,S,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN
M;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S
M<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C<Y)3LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A
M<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ-"4[=VAI=&4M<W!A8V4Z;F]W<F%P
M.SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXR+#,X,CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET
M92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C<Y)3LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P
M86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ-"4[=VAI=&4M<W!A
M8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXQ+#,U,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T
M:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*
M/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HW.24[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/E1H97)E869T97(\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C,E
M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C(P+C5P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T
M>6QE/3-$)W=I9'1H.C$T)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@
M(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXR+#0Y.3PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HW
M.24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D
M97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SY4;W1A;#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G=VED=&@Z
M,R4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D
M97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C(P+C5P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&
M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C
M,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=W:61T:#HQ-"4[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U
M8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M,3,L,#@P/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U
M8FQE(#(N-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C0N-30E.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#MT97AT+6EN
M9&5N=#HT+C4T)2<^1'5R:6YG('1H92!F;W5R=&@@<75A<G1E<B!O9B`R,#`T
M+"!W92!E<W1A8FQI<VAE9"!A(&QE='1E<B!O9B!C<F5D:70@=VET:"!3:6QI
M8V]N(%9A;&QE>2!"86YK(&%S('-E8W5R:71Y(&9O<B!O=7(@0F5R:V5L97D@
M3&5A<V4@:6X@=&AE(&%M;W5N="!O9B`D,"XT/"]F;VYT/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B!M:6QL:6]N
M+B!4:&4@;&5T=&5R(&]F(&-R961I="!R96UA:6YE9"!O=71S=&%N9&EN9R!A
M<R!O9B!$96-E;6)E<B8C,38P.S,Q+"`R,#$S+"!A;F0@:7,@8V]L;&%T97)A
M;&EZ960@8GD@82!C97)T:69I8V%T92!O9B!D97!O<VET(&9O<B`D,"XT(&UI
M;&QI;VXL('=H:6-H(&AA<R!B965N(&EN8VQU9&5D(&EN(')E<W1R:6-T960@
M8V%S:"!I;B!T:&4@8V]N<V]L:61A=&5D(&)A;&%N8V4@<VAE971S(&%S(&]F
M($1E8V5M8F5R)B,Q-C`[,S$L(#(P,3,@86YD(#(P,3(N(%5N9&5R('1H92!T
M97)M<R!O9B!T:&4@0F5R:V5L97D@3&5A<V4L(&EF('1H92!T;W1A;"!A;6]U
M;G0@;V8@;W5R(&-A<V@L(&-A<V@@97%U:79A;&5N=',@86YD(&UA<FME=&%B
M;&4@<V5C=7)I=&EE<R!F86QL<R!B96QO=R`D,C`@;6EL;&EO;B!F;W(@82!P
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M92`D,C`@;6EL;&EO;B!F;W(@82!P97)I;V0@;V8@,3(@8V]N<V5C=71I=F4@
M;6]N=&AS+B`\+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,3)P=#MM87)G:6XM;&5F=#HP)3MM87)G:6XM<FEG
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M87-E(&EN('1H92!A;6]U;G0@;V8@87!P<F]X:6UA=&5L>2`P+C(\+V9O;G0^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)B,Q-C`[;6EL;&EO;B!%=7)O<RX@5&AE(&QE='1E<B!O9B!C<F5D:70@
M<F5M86EN960@;W5T<W1A;F1I;F<@=&AR;W5G:"!$96-E;6)E<B8C,38P.S,Q
M+"`R,#$S(&%N9"!I<R!C;VQL871E<F%L:7IE9"!B>2!A(&-E<G1I9FEC871E
M(&]F(&1E<&]S:70@9F]R("0P+C(@;6EL;&EO;BP@=VAI8V@@:&%S(&)E96X@
M:6YC;'5D960@:6X@<F5S=')I8W1E9"!C87-H(&EN('1H92!C;VYS;VQI9&%T
M960@8F%L86YC92!S:&5E=',@87,@;V8@1&5C96UB97(F(S$V,#LS,2P@,C`Q
M,R!A;F0@,C`Q,BX\+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,3)P=#MM87)G:6XM;&5F=#HP)3MM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z-"XU-"4[9F]N="US:7IE.C$P<'0[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.W1E>'0M:6YD96YT.C0N-30E
M)SY);B!A9&1I=&EO;B!T;R!T:&4@;F]N+6-A;F-E;&%B;&4@8V]M;6ET;65N
M=',@:6YC;'5D960@86)O=F4L('=E(&AA=F4@96YT97)E9"!I;G1O(&-O;G1R
M86-T=6%L(&%R<F%N9V5M96YT<R!T:&%T(&]B;&EG871E('5S('1O(&UA:V4@
M<&%Y;65N=',@=&\@=&AE(&-O;G1R86-T=6%L(&-O=6YT97)P87)T:65S('5P
M;VX@=&AE(&]C8W5R<F5N8V4@;V8@9G5T=7)E(&5V96YT<RX@26X@861D:71I
M;VXL(&EN(#PO9F]N=#X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z,3!P=#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SYT:&4@;F]R;6%L(&-O=7)S92!O9B!O<&5R871I
M;VYS+"!W92!H879E(&5N=&5R960@:6YT;R!L:6-E;G-E(&%N9"!O=&AE<B!A
M9W)E96UE;G1S(&%N9"!I;G1E;F0@=&\@8V]N=&EN=64@=&\@<V5E:R!A9&1I
M=&EO;F%L(')I9VAT<R!R96QA=&EN9R!T;R!C;VUP;W5N9',@;W(@=&5C:&YO
M;&]G:65S(&EN(&-O;FYE8W1I;VX@=VET:"!O=7(@9&ES8V]V97)Y+"!M86YU
M9F%C='5R:6YG(&%N9"!D979E;&]P;65N="!P<F]G<F%M<RX@56YD97(@=&AE
M('1E<FUS(&]F('1H92!A9W)E96UE;G1S+"!W92!M87D@8F4@<F5Q=6ER960@
M=&\@<&%Y(&9U='5R92!U<"UF<F]N="!F965S+"!M:6QE<W1O;F5S(&%N9"!R
M;WEA;'1I97,@;VX@;F5T('-A;&5S(&]F('!R;V1U8W1S(&]R:6=I;F%T:6YG
M(&9R;VT@=&AE(&QI8V5N<V5D('1E8VAN;VQO9VEE<RP@:68@86YY+"!O<B!O
M=&AE<B!P87EM96YT<R!C;VYT:6YG96YT('5P;VX@=&AE(&]C8W5R<F5N8V4@
M;V8@9G5T=7)E(&5V96YT<R!T:&%T(&-A;FYO="!R96%S;VYA8FQY(&)E(&5S
M=&EM871E9"X\+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,3)P=#MM87)G:6XM;&5F=#HP)3MM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z-"XU-"4[9F]N="US:7IE.C$P<'0[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.W1E>'0M:6YD96YT.C0N-30E)SY7
M92!R96QY(&]N(')E<V5A<F-H(&EN<W1I='5T:6]N<RP@8V]N=')A8W0@<F5S
M96%R8V@@;W)G86YI>F%T:6]N<RP@8VQI;FEC86P@:6YV97-T:6=A=&]R<R!A
M<R!W96QL(&%S(&-L:6YI8V%L(&%N9"!M871E<FEA;"!M86YU9F%C='5R97)S
M(&]F(&]U<B!P<F]D=6-T(&-A;F1I9&%T97,N($%S(&]F($1E8V5M8F5R)B,Q
M-C`[,S$L(#(P,3,L('5N9&5R('1H92!T97)M<R!O9B!O=7(@86=R965M96YT
M<RP@=V4@87)E(&]B;&EG871E9"!T;R!M86ME(&9U='5R92!P87EM96YT<R!A
M<R!S97)V:6-E<R!A<F4@<')O=FED960@;V8@87!P<F]X:6UA=&5L>2`D-"XU
M/"]F;VYT/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B!M:6QL:6]N('1H<F]U9V@@,C`Q-2X@5&AE<V4@86=R965M
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M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C0N-30E.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#MT97AT+6EN9&5N=#HT+C4T
M)2<^56YD97(@=&AE('1E<FUS(&]F(&]U<B!E>&-L=7-I=F4@;&EC96YS92!A
M9W)E96UE;G1S('=I=&@@=&AE(%)E9V5N=',@;V8@=&AE(%5N:79E<G-I='D@
M;V8@0V%L:69O<FYI82P@87,@86UE;F1E9"P@9F]R(&-E<G1A:6X@=&5C:&YO
M;&]G>2!A;F0@<F5L871E9"!P871E;G0@<FEG:'1S(&%N9"!M871E<FEA;',L
M('=E('!A>2!A;FYU86P@;&EC96YS92!O<B!M86EN=&5N86YC92!F965S(&%N
M9"!W:6QL(&)E(')E<75I<F5D('1O('!A>2!M:6QE<W1O;F5S(&%N9"!R;WEA
M;'1I97,@;VX@;F5T('-A;&5S+"!I9B!A;GDL/"]F;VYT/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B!O9B!C97)T
M86EN('!R;V1U8W1S(&]R:6=I;F%T:6YG(&9R;VT@=&AE(&QI8V5N<V5D('1E
M8VAN;VQO9VEE<RX\+V9O;G0^/"]P/CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT
M;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?-V5A.#)B,CE?.3@R-E\T,#)A7V(Y
M-C!?,#(Q-69D.&)A9&4X#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z
M+S=E83@R8C(Y7SDX,C9?-#`R85]B.38P7S`R,35F9#AB861E."]7;W)K<VAE
M971S+U-H965T,3<N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@
M<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H
M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%
M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O
M:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A
M<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O
M;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L
M92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5!1#X-"B`@("`@(#QT<CX-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^
M/'-T<F]N9SY#;VQL86)O<F%T:79E(%)E<V5A<F-H+"!$979E;&]P;65N="!A
M;F0@3&EC96YS92!!9W)E96UE;G1S/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R($UO;G1H<R!%;F1E
M9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y#;VQL86)O<F%T:79E(%)E<V5A<F-H+"!$979E
M;&]P;65N="!A;F0@3&EC96YS92!!9W)E96UE;G1S/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/&1I=CX-"CQD:78@86QI9VX],T1L969T/CQT
M86)L92!B;W)D97(],T0P(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS
M1#`@<W1Y;&4],T0G8F]R9&5R+6-O;&QA<'-E.F-O;&QA<'-E.R!W:61T:#HQ
M,#`E.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)2<^/'1R/CQT9"!V
M86QI9VX],T1T;W`@<W1Y;&4],T1W:61T:#HT+C4T)3MW:&ET92US<&%C93IN
M;W=R87`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
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M9"!V86QI9VX],T1T;W`@<W1Y;&4],T1W:61T:#HY-2XT-B4[/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,3AP=#MF;VYT+7-I
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M965M96YT<R`\+V9O;G0^/"]P/CPO=&0^/"]T<CX\+W1A8FQE/CPO9&EV/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z-G!T.VUA
M<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HR+C8W
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M<#X\<"!S='EL93TS1&UA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M)3MF;VYT+69A;6EL>3H[9F]N="US:7IE.C$P<'0[.SXF;F)S<#L\+W`^/'`@
M<W1Y;&4],T1M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C9P=#MM87)G
M:6XM;&5F=#HP)3MM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z-"XU-"4[
M9F]N="US:7IE.C$P<'0[.SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#MT97AT+6EN9&5N=#HT
M+C4T)2<^26X@1&5C96UB97(@,C`P."P@=V4@96YT97)E9"!I;G1O(&$@=V]R
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M;W(Z(S`P,#`P,#MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SX@
M<')O9W)A;7,Z('1H92!,96%D(%1,4B`W+SD@<')O9W)A;2P@82!&;VQL;W<M
M3VX@5$Q2(#<O.2!P<F]G<F%M+"!A;F0@=7`@=&\@='=O(&]T:&5R(%1,4B!P
M<F]G<F%M<RX@26X@,C`Q,2!W92!B96=A;B!D979E;&]P;65N="!O9B!A(%1,
M4B`X('!R;V=R86T@87,@;VYE(&]F('1H92!T=V\@861D:71I;VYA;"!P<F]G
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M,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C0N-30E.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.W1E>'0M:6YD96YT.C0N-30E)SY792!A<F4@8W5R<F5N=&QY(&-O
M;F1U8W1I;F<@82!0:&%S92`Q(&-L:6YI8V%L('1R:6%L(&EN('1H92!,96%D
M(%1,4B`W+SD@<')O9W)A;2!W:71H($16,3$W.2!I;B!S>7-T96UI8R!L=7!U
M<R!E<GET:&5M871O<W5S/"]F;VYT/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
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M87)I86YT.B!N;W)M86P[)SY);B!$96-E;6)E<B`R,#$S+"!W92!A;65N9&5D
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M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C0N-30E.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/B9N8G-P.SPO<#X\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C$R<'0[;6%R9VEN
M+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C0N-30E.V9O
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M;W!T:6]N(&]N('1H92!,96%D(%1,4B`W+SD@<')O9W)A;2P@=&AE;B!W92!A
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M;VUM97)C:6%L(&]B:F5C=&EV97,N(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HQ,G!T.VUA<F=I;BUL969T
M.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HT+C4T)3MF;VYT+7-I
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M=7`@=&\@)#8P/"]F;VYT/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93HQ,'!T
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M+B`\+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,3)P=#MM87)G:6XM;&5F=#HP)3MM87)G:6XM<FEG:'0Z,"4[
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M:6YG+B!);B`R,#$Q+"!W92!E87)N960@86YD(')E8V]G;FEZ960@)#$R(&UI
M;&QI;VX@:6X@<W5B<W1A;G1I=F4@9&5V96QO<&UE;G0@;6EL97-T;VYE('!A
M>6UE;G1S(')E;&%T960@=&\@=&AE(&EN:71I871I;VX@;V8@4&AA<V4@22!A
M;F0@<')O;V8M;V8M;65C:&%N:7-M(&-L:6YI8V%L('1R:6%L<R!O9B!$5C$Q
M-SD@:6X@<WES=&5M:6,@;'5P=7,@97)Y=&AE;6%T;W-U<R!P871I96YT<RX@
M26X@,C`Q,2P@=V4@96%R;F5D(&%N9"!R96-O9VYI>F5D("0S(&UI;&QI;VX@
M:6X@<W5B<W1A;G1I=F4@9&5V96QO<&UE;G0@;6EL97-T;VYE('!A>6UE;G1S
M(')E;&%T960@=&\@=&AE(&EN:71I871I;VX@;V8@9&5V96QO<&UE;G0@;V8@
M=&AE(%1,4B`X('!R;V=R86TN(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T1M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C$R<'0[;6%R9VEN+6QE9G0Z,"4[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C0N-30E.V9O;G0M<VEZ93HQ
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M<B!O9B`R,#$S('=E(')E93PO9F]N=#X\9F]N="!S='EL93TS1"=F;VYT+7-I
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M=6QT:6YG(&EN('1H92!R96-O9VYI=&EO;B!O9B`D,"XS(&UI;&QI;VX@;V8@
M861D:71I;VYA;"!R979E;G5E(&EN(#(P,3,N(#PO9F]N=#X\+W`^/'`@<W1Y
M;&4],T1M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP)3MM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,"4[9F]N="UF
M86UI;'DZ.V9O;G0M<VEZ93HQ,'!T.SL^)FYB<W`[/"]P/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,3)P=#MM87)G:6XM;&5F
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M:71H($=32R`H:6X@=&AO=7-A;F1S*3H\+V9O;G0^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.C$R<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.W1E>'0M:6YD96YT.C0N
M-30E)SXF(S$V,#L\+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP)3MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+W`^/&1I=CX-"CQT86)L
M92!B;W)D97(],T0P(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@
M86QI9VX],T1C96YT97(@<W1Y;&4],T0G8F]R9&5R+6-O;&QA<'-E.F-O;&QA
M<'-E.R!W:61T:#HQ,#`E.R<^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW
M-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C8W)3L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/B9N8G-P.SPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MW:61T:#HR)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D(&-O;'-P86X],T0Q,"!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P
M=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P
M,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^665A
M<B!E;F1E9"!$96-E;6)E<B`S,2P\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I
M;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C$E
M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I
M9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C8W)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,B4[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.G-O
M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T
M(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[
M)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C(P,3,\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D
M:6YG+51O<#HP+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG
M:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C(E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O
M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)W1E>'0M86QI
M9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M
M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED
M(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT
M97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXR,#$R/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R
M9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MW:61T:#HR)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@
M8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S
M='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT
M.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW
M:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R
M9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$
M)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,C`Q,3PO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F
M=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U
M('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-C<E.R!B;W)D97(M=&]P
M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,B4[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HW)3L@8F]R
M9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXQ
M+#<P,CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN
M9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HR)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C<E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C$L
M-#(X/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D
M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG
M+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C(E.R!B;W)D97(M
M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
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M<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-R4[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
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M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HV-R4[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/DUI;&5S=&]N92!R979E;G5E/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MW:61T:#HR)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O
M='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P
M="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-R4[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^+3PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&
M1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E
M<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
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M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUB
M;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T
M:#HW)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXM/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M=VED=&@Z,B4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW
M:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D
M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG
M+4)O='1O;3HP('!T.W=I9'1H.C<E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N
M-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C$U+#`P,#PO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HV-R4[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M
M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SY4;W1A;#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[=VED=&@Z,B4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS
M<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N
M=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E
M<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B0\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE
M/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP
M861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z
M-R4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB
M;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
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M.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R
M+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,B4[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O
M=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P
M,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
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M;F<M0F]T=&]M.C`@<'0[=VED=&@Z-R4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW
M-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P
M,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG
M;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
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M+51O<#HP+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A
M;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[=VED=&@Z,B4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z
M,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB
M;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
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M:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-R4[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T
M;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,38L-#(X
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB
M;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.R<^)FYB<W`[/"]P/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HT+C4T)3MF
M;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M=&5X="UI;F1E;G0Z-"XU-"4G/D%S(&]F($1E8V5M8F5R(#,Q+"`R,#$S(&%N
M9"`R,#$R+"!D969E<G)E9"!R979E;G5E(')E;&%T:6YG('1O('1H92!I;FET
M:6%L('!A>6UE;G0@=V%S("0R+C4\+V9O;G0^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^(&UI;&QI;VX@86YD("0T
M+C(@;6EL;&EO;BP@<F5S<&5C=&EV96QY+B`\+V9O;G0^/"]P/CQP('-T>6QE
M/3-$;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HQ,G!T.VUA<F=I;BUL
M969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HT+C4T)3MF;VYT
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M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY!<W1R85IE;F5C82`\
M+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z-G!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT
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M<B`R,#`V+"!W92!E;G1E<F5D(&EN=&\@82!T:')E93PO9F]N=#X\9F]N="!S
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M,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C0N-30E.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#MT97AT+6EN
M9&5N=#HT+C4T)2<^26X@3V-T;V)E<B`R,#$Q+"!W92!A;65N9&5D(&]U<B!A
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M=V5R92!C;VUP;&5T960@:6X@=&AE('1H:7)D('%U87)T97(@;V8@,C`Q,BX@
M5V4@86YD($%S=')A6F5N96-A(&AA=F4@86=R965D('1O(&%D=F%N8V4@05I$
M(#$T,3D@=&]W87)D<R!A(%!H87-E(#$@8VQI;FEC86P@=')I86PL('=H:6-H
M(')E<W5L=&5D(&EN(&$@9&5V96QO<&UE;G0@9G5N9&EN9R!P87EM96YT(&]F
M("0V(&UI;&QI;VXL(')E8V5I=F5D(&EN('1H92!F;W5R=&@@<75A<G1E<B!O
M9B`R,#$R+B!)9B!!<W1R85IE;F5C82!C:&]O<V5S('1O(&%D=F%N8V4@=&AE
M('!R;V=R86T@9F]L;&]W:6YG(&-O;7!L971I;VX@;V8@4&AA<V4@,F$L('=E
M('=I;&P@<F5C96EV92!A("0R,"!M:6QL:6]N(&UI;&5S=&]N92!P87EM96YT
M(&%N9"!!<W1R85IE;F5C82!W:6QL(')E=&%I;B!I=',@<FEG:'1S('1O(&1E
M=F5L;W`@=&AE(&-A;F1I9&%T92!T:&5R87!Y(&%N9"!T;R!C;VUM97)C:6%L
M:7IE('1H92!R97-U;'1I;F<@87-T:&UA('!R;V1U8W0N(%=E(&%R92!E;&EG
M:6)L92!T;R!R96-E:79E(&%D9&ET:6]N86P@;6EL97-T;VYE('!A>6UE;G1S
M+"!W:&EC:"!W92!H879E(&1E=&5R;6EN960@=&\@8F4@<W5B<W1A;G1I=F4@
M;6EL97-T;VYE<RP@;V8@=7`@=&\@87!P<F]X:6UA=&5L>2`D,3`P(&UI;&QI
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M;G-E;G0N(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T1M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C$R<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C0N-30E.V9O;G0M<VEZ93HQ,'!T.SL^/&9O;G0@
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M9W)E96UE;G0L('=H:6-H(&ES(&%P<')O>&EM871E;'D@-3`\+V9O;G0^/&9O
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M;G0@=V]R:R!I<R!P97)F;W)M960N("`\+V9O;G0^/"]P/CQP('-T>6QE/3-$
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HQ,G!T.VUA<F=I;BUL969T
M.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HT+C4T)3MF;VYT+7-I
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M(&%G<F5E;65N="!W:71H($%S=')A6F5N96-A("AI;B!T:&]U<V%N9',I.B`\
M+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP)3MF;VYT+7-I>F4Z,3)P=#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z,3)P=#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF(S$V,#L\+V9O;G0^/"]P/CQD:78^#0H\=&%B;&4@
M8F]R9&5R/3-$,"!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P(&%L
M:6=N/3-$8V5N=&5R('-T>6QE/3-$)V)O<F1E<BUC;VQL87!S93IC;VQL87!S
M93L@=VED=&@Z,3`P)3LG/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HV-R4[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[=VED=&@Z,B4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R
M86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,3`@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW
M-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[
M=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[
M)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/EEE87(@
M96YD960@1&5C96UB97(@,S$L/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@
M8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H
M=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O
M;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HV-R4[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.G-O
M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D(&-O;'-P86X],T0R('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O
M='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C
M,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^
M/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E
M:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXR,#$S/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R
M86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HR)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N
M.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!C
M;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
M+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^,C`Q,CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M=VED=&@Z,B4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O
M<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB
M;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P
M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E
M<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[)SX\<"!S='EL93TS1"=T
M97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C(P,3$\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP
M('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T
M.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N
M=#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E
M:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C8W)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^26YI=&EA;"!P87EM96YT<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HR)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C<E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C<R
M,#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HR)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O
M;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C<E.R!B;W)D97(M
M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C<R,#PO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A
M;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HR)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP
M861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED
M(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C<E.R!B;W)D97(M=&]P
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C$R,#PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ
M,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A
M9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG
M+51O<#HP+C<U('!T.W=I9'1H.C8W)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^4&5R
M9F]R;6%N8V4@;V8@<F5S96%R8V@@86-T:79I=&EE<SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,B4[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C<E.R!B
M;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/C(L-3`W/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW
M:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E
M;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED
M=&@Z,B4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T
M:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O
M='1O;3HP('!T.W=I9'1H.C<E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P
M="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E
M>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C(L-#8R/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,B4[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C<E.R!B;W)D
M97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/C8T,CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z
M,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S
M<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MW:61T:#HV-R4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS
M<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N
M=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY4;W1A;#PO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,B4[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R
M+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
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M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T
M(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
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M=&]M.C`@<'0[=VED=&@Z-R4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P
M,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
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M+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E
M;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED
M=&@Z,B4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B
M;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ
M9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
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M<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-R4[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U
M8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
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M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID
M;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,B4[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P
M="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
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M=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P
M,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
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M.C`@<'0[=VED=&@Z-R4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P
M,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^-S8R/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E
M;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
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M<W`[/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
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M(#,Q+"`R,#$S(&%N9"`R,#$R+"!T;W1A;"!D969E<G)E9"!R979E;G5E(&9R
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M1&UA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,3)P=#MM87)G:6XM;&5F
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M(&UA=&5R:6%L(&)R96%C:"!O9B!T:&4@86=R965M96YT+B`\+V9O;G0^/"]P
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,3AP
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M9R`\+V9O;G0^/"]P/CQP('-T>6QE/3-$;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HV<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E
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M,C`[3DE!240F(S@R,C$[*2!I;B!O<F1E<B!T;R!F=6YD(')E<V5A<F-H+B!4
M:&4@87=A<F1S(&%R92!R96QA=&5D('1O('-P96-I9FEC(')E<V5A<F-H(&]B
M:F5C=&EV97,@86YD('=E(&5A<FX@<F5V96YU92!A<R!T:&4@<F5L871E9"!R
M97-E87)C:"!E>'!E;G-E<R!A<F4@:6YC=7)R960N(%=E(&AA=F4@96%R;F5D
M(')E=F5N=64@9'5R:6YG('1H92!P97)I;V1S(&5N9&5D($1E8V5M8F5R)B,Q
M-C`[,S$L(#(P,3,@86YD(#(P,3(@9G)O;2!T:&4@9F]L;&]W:6YG(&%W87)D
M<SH\+V9O;G0^/"]P/CQD:78@86QI9VX],T1L969T/CQT86)L92!B;W)D97(]
M,T0P(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@<W1Y;&4],T0G
M8F]R9&5R+6-O;&QA<'-E.F-O;&QA<'-E.R!W:61T:#HY-"XR-R4[;6%R9VEN
M+6QE9G0Z-2XW,R4[;6%R9VEN+7)I9VAT.C`E)SX\='(^/'1D('9A;&EG;CTS
M1'1O<"!S='EL93TS1'=I9'1H.C,N,S,E.W=H:71E+7-P86-E.FYO=W)A<#X\
M<"!S='EL93TS1&UA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z-G!T.V9O
M;G0M<VEZ93HQ,'!T.SL^/&9O;G0@<W1Y;&4],T1F;VYT+69A;6EL>3HG4WEM
M8F]L)SMF;VYT+7-I>F4Z,3!P=#L^)B,Q.#,[/"]F;VYT/CPO<#X\+W1D/CQT
M9"!V86QI9VX],T1T;W`@<W1Y;&4],T1W:61T:#HY-BXV-R4[/CQP('-T>6QE
M/3-$;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HV<'0[9F]N="US:7IE
M.C$P<'0[.SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z,3!P=#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SY397!T96UB97(@,C`Q,RP@3DE((&%W87)D960@=7,@)#`N
M,B!M:6QL:6]N('1O(&9U;F0@<F5S96%R8V@@:6X@9&5V96QO<&EN9R!43%(@
M86YT86=O;FES=',@9F]R('1H97)A<'D@;V8@:&5P871I8R!F:6)R;W-I<R!A
M;F0@8VER<FAO<VES+CPO9F]N=#X\+W`^/"]T9#X\+W1R/CPO=&%B;&4^/"]D
M:78^/&1I=B!A;&EG;CTS1&QE9G0^/'1A8FQE(&)O<F1E<CTS1#`@8V5L;'-P
M86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S='EL93TS1"=B;W)D97(M8V]L
M;&%P<V4Z8V]L;&%P<V4[('=I9'1H.CDT+C(W)3MM87)G:6XM;&5F=#HU+C<S
M)3MM87)G:6XM<FEG:'0Z,"4G/CQT<CX\=&0@=F%L:6=N/3-$=&]P('-T>6QE
M/3-$=VED=&@Z,RXS,R4[=VAI=&4M<W!A8V4Z;F]W<F%P/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z-G!T.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE
M/3-$9F]N="UF86UI;'DZ)U-Y;6)O;"<[9F]N="US:7IE.C$P<'0[/B8C,3@S
M.SPO9F]N=#X\+W`^/"]T9#X\=&0@=F%L:6=N/3-$=&]P('-T>6QE/3-$=VED
M=&@Z.38N-C<E.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C9P=#MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z,3!P=#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SY*=6YE(#(P,3(L($Y)2"!A=V%R9&5D('5S("0P+C8@
M;6EL;&EO;B!T;R!F=6YD(')E<V5A<F-H(&EN('-C<F5E;FEN9R!F;W(@:6YH
M:6)I=&]R<R!O9B!43%(@."!F;W(@=')E871M96YT(&]F(&%U=&]I;6UU;F4@
M9&ES96%S97,N(#PO9F]N=#X\+W`^/"]T9#X\+W1R/CPO=&%B;&4^/"]D:78^
M/&1I=B!A;&EG;CTS1&QE9G0^/'1A8FQE(&)O<F1E<CTS1#`@8V5L;'-P86-I
M;F<],T0P(&-E;&QP861D:6YG/3-$,"!S='EL93TS1"=B;W)D97(M8V]L;&%P
M<V4Z8V]L;&%P<V4[('=I9'1H.CDT+C(W)3MM87)G:6XM;&5F=#HU+C<S)3MM
M87)G:6XM<FEG:'0Z,"4G/CQT<CX\=&0@=F%L:6=N/3-$=&]P('-T>6QE/3-$
M=VED=&@Z,RXS,R4[=VAI=&4M<W!A8V4Z;F]W<F%P/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z-G!T.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$
M9F]N="UF86UI;'DZ)U-Y;6)O;"<[9F]N="US:7IE.C$P<'0[/B8C,3@S.SPO
M9F]N=#X\+W`^/"]T9#X\=&0@=F%L:6=N/3-$=&]P('-T>6QE/3-$=VED=&@Z
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M.B!N;W)M86P[)SY-87D@,C`Q,BP@3DE((&%W87)D960@=7,@)#`N-"!M:6QL
M:6]N('1O(&9U;F0@9&5V96QO<&UE;G0@;V8@5$Q2(#@@:6YH:6)I=&]R<R!F
M;W(@=')E871M96YT(&]F(')H975M871O:60@87)T:')I=&ES+B`\+V9O;G0^
M/"]P/CPO=&0^/"]T<CX\+W1A8FQE/CPO9&EV/CQD:78@86QI9VX],T1L969T
M/CQT86)L92!B;W)D97(],T0P(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN
M9STS1#`@<W1Y;&4],T0G8F]R9&5R+6-O;&QA<'-E.F-O;&QA<'-E.R!W:61T
M:#HY-"XR-R4[;6%R9VEN+6QE9G0Z-2XW,R4[;6%R9VEN+7)I9VAT.C`E)SX\
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M('9A;&EG;CTS1'1O<"!S='EL93TS1'=I9'1H.CDV+C8W)3L^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HV<'0[9F]N="US:7IE
M.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^2G5L>2`R
M,#$Q+"!.24@@87=A<F1E9"!U<R`D,"XV(&UI;&QI;VX@=&\@9G5N9"!R97-E
M87)C:"!I;B!P<F5C;&EN:6-A;"!M;V1E;',@;V8@<VMI;B!A=71O:6UM=6YE
M(&EN9FQA;6UA=&EO;BX@/"]F;VYT/CPO<#X\+W1D/CPO='(^/"]T86)L93X\
M+V1I=CX\9&EV(&%L:6=N/3-$;&5F=#X\=&%B;&4@8F]R9&5R/3-$,"!C96QL
M<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('-T>6QE/3-$)V)O<F1E<BUC
M;VQL87!S93IC;VQL87!S93L@=VED=&@Z.30N,C<E.VUA<F=I;BUL969T.C4N
M-S,E.VUA<F=I;BUR:6=H=#HP)2<^/'1R/CQT9"!V86QI9VX],T1T;W`@<W1Y
M;&4],T1W:61T:#HS+C,S)3MW:&ET92US<&%C93IN;W=R87`^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HV<'0[9F]N="US:7IE
M.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.R<^/&9O;G0@<W1Y
M;&4],T1F;VYT+69A;6EL>3HG4WEM8F]L)SMF;VYT+7-I>F4Z,3!P=#L^)B,Q
M.#,[/"]F;VYT/CPO<#X\+W1D/CQT9"!V86QI9VX],T1T;W`@<W1Y;&4],T1W
M:61T:#HY-BXV-R4[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z-G!T.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/D%U9W5S="`R,#$P+"!.24%)1"!A=V%R9&5D('5S
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M9"!A('1O=&%L(&]F("0Q+C0@;6EL;&EO;B!U;F1E<B!T:&ES(&=R86YT+B`\
M+V9O;G0^/"]P/CPO=&0^/"]T<CX\+W1A8FQE/CPO9&EV/CQD:78@86QI9VX]
M,T1L969T/CQT86)L92!B;W)D97(],T0P(&-E;&QS<&%C:6YG/3-$,"!C96QL
M<&%D9&EN9STS1#`@<W1Y;&4],T0G8F]R9&5R+6-O;&QA<'-E.F-O;&QA<'-E
M.R!W:61T:#HY-"XR-R4[;6%R9VEN+6QE9G0Z-2XW,R4[;6%R9VEN+7)I9VAT
M.C`E)SX\='(^/'1D('9A;&EG;CTS1'1O<"!S='EL93TS1'=I9'1H.C,N,S,E
M.W=H:71E+7-P86-E.FYO=W)A<#X\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C9P=#MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[)SX\9F]N="!S='EL93TS1&9O;G0M9F%M:6QY
M.B=3>6UB;VPG.V9O;G0M<VEZ93HQ,'!T.SXF(S$X,SL\+V9O;G0^/"]P/CPO
M=&0^/'1D('9A;&EG;CTS1'1O<"!S='EL93TS1'=I9'1H.CDV+C8W)3L^/'`@
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M2G5L>2`R,#$P+"!.24@@87=A<F1E9"!U<R`D,"XV(&UI;&QI;VX@=&\@97AP
M;&]R92!T:&4@9F5A<VEB:6QI='D@;V8@9&5V96QO<&EN9R!A('5N:79E<G-A
M;"!V86-C:6YE('1O('!R979E;G0@:6YF96-T:6]N(&)Y(&AU;6%N('!A<&EL
M;&]M82!V:7)U<RX@/"]F;VYT/CPO<#X\+W1D/CPO='(^/"]T86)L93X\+V1I
M=CX\9&EV(&%L:6=N/3-$;&5F=#X\=&%B;&4@8F]R9&5R/3-$,"!C96QL<W!A
M8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('-T>6QE/3-$)V)O<F1E<BUC;VQL
M87!S93IC;VQL87!S93L@=VED=&@Z.30N,C<E.VUA<F=I;BUL969T.C4N-S,E
M.VUA<F=I;BUR:6=H=#HP)2<^/'1R/CQT9"!V86QI9VX],T1T;W`@<W1Y;&4]
M,T1W:61T:#HS+C,S)3MW:&ET92US<&%C93IN;W=R87`^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HV<'0[9F]N="US:7IE.C$P
M<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.R<^/&9O;G0@<W1Y;&4]
M,T1F;VYT+69A;6EL>3HG4WEM8F]L)SMF;VYT+7-I>F4Z,3!P=#L^)B,Q.#,[
M/"]F;VYT/CPO<#X\+W1D/CQT9"!V86QI9VX],T1T;W`@<W1Y;&4],T1W:61T
M:#HY-BXV-R4[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z-G!T.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/E-E<'1E;6)E<B`R,#`X+"!.24%)1"!A=V%R9&5D('5S
M(&$@9FEV92UY96%R("0Q-R!M:6QL:6]N(&-O;G1R86-T('1O(&1E=F5L;W`@
M;W5R(&]L:6=O;G5C;&5O=&ED92!T96-H;F]L;V=Y('5S:6YG(%1,4B`Y(&%G
M;VYI<W1S(&%S('9A8V-I;F4@861J=79A;G1S+B!4:&4@8V]N=')A8W0@<W5P
M<&]R=',@861J=79A;G0@9&5V96QO<&UE;G0@9F]R(&%N=&AR87@@87,@=V5L
M;"!A<R!O=&AE<B!D:7-E87-E(&UO9&5L<RX\+V9O;G0^/"]P/CPO=&0^/"]T
M<CX\+W1A8FQE/CPO9&EV/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,3)P=#MM87)G:6XM;&5F=#HP)3MM87)G:6XM<FEG:'0Z
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M($Y)2"!A;F0@3DE!240@*&EN('1H;W5S86YD<RDZ(#PO9F]N=#X\+W`^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HQ,G!T.VUA
M<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HT+C4T
M)3MF;VYT+7-I>F4Z,3)P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M)SXF;F)S<#L\+W`^/&1I=CX-"CQT86)L92!B;W)D97(],T0P(&-E;&QS<&%C
M:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@86QI9VX],T1C96YT97(@<W1Y;&4]
M,T0G8F]R9&5R+6-O;&QA<'-E.F-O;&QA<'-E.R!W:61T:#HQ,#`E.R<^#0H\
M='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F
M=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U
M('!T.W=I9'1H.C8W)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A
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M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HR)3L@8F]R
M9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D(&-O
M;'-P86X],T0Q,"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M
M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^665A<B!E;F1E9"!$96-E;6)E<B`S,2P\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D
M:6YG+51O<#HP+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED
M(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^
M#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M
M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP
M+C<U('!T.W=I9'1H.C8W)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A
M;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F
M=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U
M('!T.W=I9'1H.C(E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A
M<F5N=#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R
M9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ
M8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^,C`Q,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M
M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[=VED=&@Z,B4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P
M,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^
M/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E
M:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[)SX\<"!S='EL
M93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O
M;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C(P,3(\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M
M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP
M+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E
M;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
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M;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D(&-O;'-P86X]
M,T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP
M861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED
M(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C
M,#`P,#`P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXR,#$Q/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-
M"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW
M:61T:#HV-R4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,3(N,C5P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.BTQ,BXR-7!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/DY)04E$(&-O;G1R
M86-T<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN
M9RU";W1T;VTZ,"!P=#MW:61T:#HR)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O
M='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C
M,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP
M861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D
M:6YG+4)O='1O;3HP('!T.W=I9'1H.C<E.R!B;W)D97(M=&]P.G-O;&ED(#`N
M-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C0L,3`S/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I
M9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I
M9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,B4[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G
M=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I
M9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
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M.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-R4[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
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M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,B4[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN
M9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HW)3L@8F]R9&5R+71O<#IS;VQI
M9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXR+#<S,#PO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P
M=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E
M;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I
M;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O
M<#HP+C<U('!T.W=I9'1H.C8W)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HQ,BXR-7!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z+3$R+C(U<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
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M(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
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M;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@
M,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HW)3L@8F]R9&5R
M+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXQ
M+#`S-3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z
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M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[=VED=&@Z,B4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T
M=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HW)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T
M97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HR)3L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP
M861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D
M:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED
M(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-R4[(&)O<F1E
M<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M,S@P/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D
M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ
M)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F
M=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U
M('!T.W=I9'1H.C8W)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,3(N,C5P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.BTQ,BXR-7!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
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M9'1H.C(E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@
M8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M
M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C<E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O
M=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
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M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ
M9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU
M<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O
M='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C
M,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C<E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P
M,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/C,L.3,Y/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H
M.C(E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R
M9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O
M=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C<E.R!B;W)D97(M
M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L
M92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C,L,3$P/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U
M8FQE(#(N-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M;'DZ5&EM97,@3F5W(%)O;6%N.R<^)FYB<W`[/"]P/CPO9&EV/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O
M9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?-V5A.#)B,CE?.3@R
M-E\T,#)A7V(Y-C!?,#(Q-69D.&)A9&4X#0I#;VYT96YT+4QO8V%T:6]N.B!F
M:6QE.B\O+T,Z+S=E83@R8C(Y7SDX,C9?-#`R85]B.38P7S`R,35F9#AB861E
M."]7;W)K<VAE971S+U-H965T,3@N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%
M;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT
M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^
M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT
M/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$
M=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V
M92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*
M("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5!1#X-"B`@("`@
M(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W
M<W!A;CTS1#(^/'-T<F]N9SY.970@3&]S<R!097(@4VAA<F4\8G(^/"]S=')O
M;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^
M,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^/"]T
M:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!,;W-S(%!E<B!3
M:&%R93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQD:78^#0H\
M9&EV(&%L:6=N/3-$;&5F=#X\=&%B;&4@8F]R9&5R/3-$,"!C96QL<W!A8VEN
M9STS1#`@8V5L;'!A9&1I;F<],T0P('-T>6QE/3-$)V)O<F1E<BUC;VQL87!S
M93IC;VQL87!S93L@=VED=&@Z,3`P)3MM87)G:6XM;&5F=#HP)3MM87)G:6XM
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M:6%N=#H@;F]R;6%L.R<^+CPO9F]N=#X\+W`^/"]T9#X\=&0@=F%L:6=N/3-$
M=&]P('-T>6QE/3-$=VED=&@Z.34N-#8E.SX\<"!S='EL93TS1&UA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.V9O;G0M<VEZ93HQ,'!T.SL^/&9O
M;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P=#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/DYE
M="!,;W-S(%!E<B!3:&%R92`\+V9O;G0^/"]P/CPO=&0^/"]T<CX\+W1A8FQE
M/CPO9&EV/CQP('-T>6QE/3-$;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HV<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
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M:&5I<B!E9F9E8W0@:7,@9&EL=71I=F4N(#PO9F]N=#X\+W`^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ
M93HQ,G!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93HQ,G!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B8C,38P
M.SPO9F]N=#X\+W`^/&1I=CX-"CQT86)L92!B;W)D97(],T0P(&-E;&QS<&%C
M:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@86QI9VX],T1C96YT97(@<W1Y;&4]
M,T0G8F]R9&5R+6-O;&QA<'-E.F-O;&QA<'-E.R!W:61T:#HQ,#`E.R<^#0H\
M='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F
M=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"!P=#MP861D:6YG+51O<#HP('!T.W=I
M9'1H.C8X)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E
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M+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS
M1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/B9N8G-P.SPO<#X\+W1D/@T*/'1D
M(&-O;'-P86X],T0Q,"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z
M,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[)SX\<"!S
M='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/D1E8V5M8F5R)B,Q-C`[,S$L/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+W`^
M/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"!P=#MP861D
M:6YG+51O<#HP('!T.W=I9'1H.C8X)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R
M86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED
M=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B
M;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T
M>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^)FYB<W`[/"]P/CPO=&0^
M#0H\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I
M9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D
M97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4],T0G
M=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E
M:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXR,#$S/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W
M:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^)FYB<W`[/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P
M,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG
M/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^)FYB<W`[/"]P
M/CPO=&0^#0H\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P
M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXR
M,#$R/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ
M8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^)FYB<W`[/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A
M<F5N=#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^)FYB
M<W`[/"]P/CPO=&0^#0H\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C
M,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^
M/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXR,#$Q/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS
M<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M
M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^)FYB<W`[/"]P/CPO=&0^#0H\+W1R/@T*/'1R
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`@<'0[<&%D
M9&EN9RU4;W`Z,"!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C8X)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HQ,BXR-7!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z+3$R
M+C(U<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/D)A<VEC(&%N9"!D:6QU=&5D(&YE="!L
M;W-S('!E<B!S:&%R92`H:6X@=&AO=7-A;F1S+"!E>&-E<'0@<&5R('-H87)E
M)B,Q-C`[86UO=6YT<RDZ/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL
M93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P
M,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z
M."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED
M(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E
M.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D97(M=&]P
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=W:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G
M:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W
M:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE
M/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"!P=#MP861D
M:6YG+51O<#HP('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-C@E.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,3(N,C5P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.BTQ,BXR-7!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
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M;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C@E
M.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3MW
M:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$=VED=&@Z,24[/CQP
M('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y
M;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@
M<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE
M/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T
M>6QE/3-$=VED=&@Z,24[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P
M86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C
M93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`@<'0[<&%D9&EN9RU4;W`Z,"!P
M=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C8X)3LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C(V+C8U<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HM,3(N,C5P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SY.970@;&]S<SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T1W:61T:#HQ)3L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C
M93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
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M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXH-C8L-S(P/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H
M.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/BD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$=VED=&@Z,24[/CQP
M('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M*#8Y+#DT.3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C
M93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
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M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I
M9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T
M:#HX)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI
M9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
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M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^*3PO9F]N=#X\+W`^/"]T
M9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M
M4FEG:'0Z,"!P=#MP861D:6YG+51O<#HP('!T.W=I9'1H.C8X)3L@8F]R9&5R
M+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HR-BXV-7!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z+3$R+C(U
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^4')E9F5R<F5D('-T;V-K(&1E96UE9"!D
M:79I9&5N9#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB
M;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P
M,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G=VED=&@Z
M."4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^*#@L-#8Y/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS
M1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/BD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W=I9'1H.C$E
M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&
M1D9&('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N
M-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE
M/3-$)W=I9'1H.C@E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P
M,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI
M9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/BT\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T
M>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T
M<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M
M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS
M1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T9&1D9&1B!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&
M1D9&1B!S='EL93TS1"=W:61T:#HX)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
M+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXM/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T9&1D9&1B!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A
M9&1I;F<M4FEG:'0Z,"!P=#MP861D:6YG+51O<#HP('!T.W=I9'1H.C8X)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB
M;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,C8N-C5P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.BTQ,BXR-7!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
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M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB
M;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[
M(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D97(M=&]P.G-O
M;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P
M="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E
M>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B@W-2PQ.#D\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED
M(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU
M<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/BD\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$
M)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N
M=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\
M<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P
M,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P
M.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z."4[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ
M9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^*#8Y+#DT.3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M
M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^*3PO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N
M<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R
M+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W
M:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R
M9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXH-#@L-3DW/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T
M:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O
M<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXI/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP('!T.W!A9&1I;F<M5&]P.C`@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HV."4[(&)O<F1E<BUT;W`Z9&]U
M8FQE(#(N-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,3(N,C5P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.BTQ,BXR-7!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
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M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=W
M:61T:#HQ)3L@8F]R9&5R+71O<#ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=W:61T:#HX)3L@8F]R
M9&5R+71O<#ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T9&1D9&1B!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#ID;W5B
M;&4@,BXU<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&
M1D8@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z9&]U8FQE(#(N-7!T
M('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E
M<BUT;W`Z9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUT;W`Z9&]U8FQE
M(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y
M;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z9&]U8FQE(#(N-7!T('1R86YS
M<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W=I
M9'1H.C$E.R!B;W)D97(M=&]P.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C
M1D9&1D9&('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.F1O=6)L92`R
M+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE
M/3-$)W=I9'1H.C@E.R!B;W)D97(M=&]P.F1O=6)L92`R+C5P="`C,#`P,#`P
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W=I9'1H.C$E
M.R!B;W)D97(M=&]P.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP('!T.W!A9&1I;F<M5&]P
M.C`@<'0[=VED=&@Z-C@E.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T
M<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C(V+C8U<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HM,3(N,C5P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
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M92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E
M.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D97(M
M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/C$Y-BPR-S4\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E
M.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R
M9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S='EL
M93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@
M(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G
M:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W
M:61T:#HX)3L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I
M9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXQ-S`L-#8Y/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@
M=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS
M<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T
M;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE
M(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,3(U
M+#$P,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T
M;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`@<'0[<&%D9&EN9RU4;W`Z,"!P=#MW:61T:#HV."4[(&)O<F1E<BUT;W`Z
M9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L
M92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C$R+C(U<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HM,3(N,C5P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M;W)D97(M=&]P.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O
M='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M
M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R
M+71O<#ID;W5B;&4@,BXU<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B
M;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E
M<BUT;W`Z9&]U8FQE(#(N-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U
M8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M*#`N,S@\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.F1O=6)L92`R+C5P="!T<F%N
M<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E
M;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/BD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.F1O=6)L92`R
M+C5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@
M=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#ID;W5B;&4@,BXU<'0@
M(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUT;W`Z9&]U8FQE(#(N-7!T
M(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR
M:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^*#`N-#$\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B
M;W)D97(M=&]P.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O
M='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/BD\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I
M9'1H.C$E.R!B;W)D97(M=&]P.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#L@
M8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S
M='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ
M)3L@8F]R9&5R+71O<#ID;W5B;&4@,BXU<'0@(S`P,#`P,#L@8F]R9&5R+6)O
M='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z
M."4[(&)O<F1E<BUT;W`Z9&]U8FQE(#(N-7!T(",P,#`P,#`[(&)O<F1E<BUB
M;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^*#`N,SD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.F1O=6)L92`R
M+C5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@
M=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/BD\+V9O;G0^/"]P/CPO=&0^#0H\+W1R
M/@T*/"]T86)L93X\+V1I=CX\<"!S='EL93TS1&UA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP)3MF;VYT+7-I>F4Z,3)P=#L[/B9N8G-P.SPO<#X\
M<"!S='EL93TS1&UA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HT+C4T
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M965N(&%N=&DM9&EL=71I=F4N(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,"4[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,G!T
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93HQ,G!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B8C,38P.SPO9F]N
M=#X\+W`^/&1I=CX-"CQT86)L92!B;W)D97(],T0P(&-E;&QS<&%C:6YG/3-$
M,"!C96QL<&%D9&EN9STS1#`@86QI9VX],T1C96YT97(@<W1Y;&4],T0G8F]R
M9&5R+6-O;&QA<'-E.F-O;&QA<'-E.R!W:61T:#HQ,#`E.R<^#0H\='(^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T
M.W!A9&1I;F<M4FEG:'0Z,"!P=#MP861D:6YG+51O<#HP('!T.W!A9&1I;F<M
M0F]T=&]M.C`@<'0[=VED=&@Z-C@E.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP('!T.W!A9&1I;F<M5&]P.C`@<'0[<&%D9&EN
M9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3LG/CQP('-T>6QE/3-$)W1E>'0M86QI
M9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^)FYB<W`[/"]P/CPO=&0^#0H\=&0@8V]L<W!A;CTS1#$P('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`@<'0[<&%D9&EN9RU4;W`Z,"!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P
M.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY$96-E
M;6)E<B8C,38P.S,Q+#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP('!T.W!A9&1I;F<M5&]P.C`@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW
M:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/B9N8G-P.SPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP('!T.W!A9&1I;F<M5&]P.C`@<'0[<&%D9&EN9RU";W1T;VTZ
M,"!P=#MW:61T:#HV."4[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`@<'0[<&%D9&EN
M9RU4;W`Z,"!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R<^/'`@
M<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+W`^/"]T9#X-"CQT9"!C;VQS
M<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP('!T.W!A9&1I;F<M5&]P.C`@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P
M,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UW96EG:'0Z8F]L
M9#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^,C`Q,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP('!T.W!A9&1I;F<M5&]P.C`@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
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M9VAT.C`@<'0[<&%D9&EN9RU4;W`Z,"!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^
M/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+W`^/"]T9#X-"CQT9"!C
M;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP('!T.W!A9&1I;F<M5&]P.C`@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI
M9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@
M(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UW96EG:'0Z
M8F]L9#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^,C`Q,CPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP('!T.W!A9&1I;F<M5&]P.C`@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
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M+5)I9VAT.C`@<'0[<&%D9&EN9RU4;W`Z,"!P=#MP861D:6YG+4)O='1O;3HP
M('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P
M.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+W`^/"]T9#X-"CQT
M9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP('!T.W!A9&1I;F<M5&]P.C`@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UW96EG
M:'0Z8F]L9#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,C`Q,3PO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP('!T.W!A9&1I;F<M5&]P.C`@<'0[<&%D9&EN
M9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\
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M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP('!T
M.W!A9&1I;F<M5&]P.C`@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HV
M."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,3(N,C5P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.BTQ,BXR-7!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY/=71S=&%N9&EN9R!S96-U<FET
M:65S(&YO="!I;F-L=61E9"!I;B!D:6QU=&5D(&YE="!L;W-S('!E<B!S:&%R
M92!C86QC=6QA=&EO;B`H:6X@=&AO=7-A;F1S*3H\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE
M/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A
M<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW
M96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI
M9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1"=W:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P
M,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM
M=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T
M:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P
M,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z
M."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED
M(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E
M.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D97(M=&]P
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP('!T.W!A9&1I;F<M5&]P.C`@<'0[<&%D9&EN9RU";W1T;VTZ,"!P
M=#MW:61T:#HV."4[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HQ,BXR-7!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z+3$R+C(U<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
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M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P
M86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C
M93IN;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/C$W+#`T,#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T
M:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$=VED=&@Z
M,24[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
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M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T9&1D9&1B!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^
M/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^,34L-38Q/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E.W=H:71E
M+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3L^/'`@<W1Y
M;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@
M<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE
M/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
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M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP('!T.W!A9&1I;F<M5&]P.C`@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HV."4[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HQ,BXR
M-7!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z+3$R+C(U<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^4V5R:65S($(@0V]N=F5R=&EB;&4@4')E9F5R<F5D
M(%-T;V-K("AA<R!C;VYV97)T960@=&\@8V]M;6]N('-T;V-K*3PO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T1W:61T:#HQ)3L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW
M:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXT,RPT,S`\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE
M/3-$=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=M
M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1'=I9'1H.C$E.SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E
M.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN
M;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
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M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E.SX\<"!S
M='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y
M;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
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M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP('!T.W!A9&1I;F<M5&]P.C`@<'0[=VED=&@Z
M-C@E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C$R+C(U<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HM,3(N,C5P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY787)R86YT<SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&
M1D9&1D8@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G=VED=&@Z,24[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUB
M;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^,3(L-#8T/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=W:61T:#HQ)3L@
M8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E
M<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y
M;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P
M,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G=VED
M=&@Z."4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,3(L-S$T/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL
M93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A
M;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G
M=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&
M1D8@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,C4L-S(Y
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T9&1D9&1B!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T
M.W!A9&1I;F<M4FEG:'0Z,"!P=#MP861D:6YG+51O<#HP('!T.W=I9'1H.C8X
M)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E
M<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,3(N,C5P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.BTQ,BXR
M-7!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C
M0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N
M-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P
M,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H
M.C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M
M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/C<R+#DS-#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M
M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE
M(#(N-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T
M;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW
M-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P
M,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG
M;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,C@L,C<U/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS
M<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I
M9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@
M8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S
M='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HX)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O
M;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXS-BPX,S`\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O
M;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\+W1A8FQE/CPO9&EV/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z.'!T.VUA<F=I;BUL
M969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP)3MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\
M+W`^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
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M"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N
M=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX
M)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ
M<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO
M:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED
M/3-$240P14%$/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E!R969E<G)E9"!3
M=&]C:RP@0V]M;6]N(%-T;V-K(&%N9"!787)R86YT<SQB<CX\+W-T<F]N9SX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ,B!-
M;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')E9F5R<F5D(%-T;V-K+"!#
M;VUM;VX@4W1O8VL@86YD(%=A<G)A;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/&1I=CX-"CQD:78@86QI9VX],T1L969T/CQT86)L92!B
M;W)D97(],T0P(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@<W1Y
M;&4],T0G8F]R9&5R+6-O;&QA<'-E.F-O;&QA<'-E.R!W:61T:#HQ,#`E.VUA
M<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)2<^/'1R/CQT9"!V86QI9VX]
M,T1T;W`@<W1Y;&4],T1W:61T:#HT+C4T)3MW:&ET92US<&%C93IN;W=R87`^
M/'`@<W1Y;&4],T1M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MF
M;VYT+7-I>F4Z,3!P=#L[/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O
M;&0[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXQ,BX\+V9O;G0^/"]P/CPO=&0^/'1D('9A;&EG
M;CTS1'1O<"!S='EL93TS1'=I9'1H.CDU+C0V)3L^/'`@<W1Y;&4],T1M87)G
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M1&UA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z-G!T.VUA<F=I;BUL969T
M.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP)3MF;VYT+7=E:6=H
M=#IB;VQD.SMF;VYT+7-I>F4Z,3!P=#L[/CQF;VYT('-T>6QE/3-$)V9O;G0M
M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY!=71H;W)I>F5D(%-H87)E<SPO
M9F]N=#X\+W`^/'`@<W1Y;&4],T1M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
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M-"4G/D]N($UA>2`R.2P@,C`Q,R!T:&4@<W1O8VMH;VQD97)S(&%P<')O=F5D
M(&%N(&EN8W)E87-E(&EN('1H92!N=6UB97(@;V8@875T:&]R:7IE9"!S:&%R
M97,@;V8@8V]M;6]N('-T;V-K(&9R;VT@,C4P+#`P,"PP,#`\+V9O;G0^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M('1O(#,U,"PP,#`L,#`P+B`\+V9O;G0^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
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M(&]F($1E;&%W87)E(&]N($UA>2`S,"P@,C`Q,SPO9F]N=#X\+W`^/'`@<W1Y
M;&4],T1M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C$X<'0[;6%R9VEN
M+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C`E.V9O;G0M
M=V5I9VAT.F)O;&0[.V9O;G0M<VEZ93HQ,'!T.SL^/&9O;G0@<W1Y;&4],T0G
M9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/E!R969E<G)E9"!3=&]C
M:R!/=71S=&%N9&EN9SPO9F]N=#X\+W`^/'`@<W1Y;&4],T1M87)G:6XM8F]T
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M=&5X="UI;F1E;G0Z-"XU-"4G/D%S(&]F($1E8V5M8F5R(#,Q+"`R,#$S('1H
M97)E('=E<F4@-2PP,#`L,#`P/"]F;VYT/CQF;VYT('-T>6QE/3-$)V9O;G0M
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M<F=I;BUT;W`Z,3)P=#MM87)G:6XM;&5F=#HP)3MM87)G:6XM<FEG:'0Z,"4[
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M;7!A;GD@<V]L9"`T,RPT,S`\+V9O;G0^/&9O;G0@<W1Y;&4],T0G9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^('-H87)E<R!O9B`D,"XP,#$@
M<&%R('9A;'5E(%-E<FEE<R!"($-O;G9E<G1I8FQE(%!R969E<G)E9"!3=&]C
M:R!F;W(@82!P=7)C:&%S92!P<FEC92!O9B`D,2PP-S4@<&5R('-H87)E(&%N
M9"!G<F]S<R!P<F]C965D<R!O9B!A<'!R;WAI;6%T96QY("0T-BXW(&UI;&QI
M;VX@:6X@86X@=6YD97)W<FET=&5N('!U8FQI8R!O9F9E<FEN9RX@069T97(@
M:7-S=6%N8V4@8V]S=',@;V8@87!P<F]X:6UA=&5L>2`D,BXU(&UI;&QI;VXL
M('1H92!N970@<')O8V5E9',@9G)O;2!T:&4@;V9F97)I;F<@=V5R92!A<'!R
M;WAI;6%T96QY("0T-"XR(&UI;&QI;VXN/"]F;VYT/CPO<#X\<"!S='EL93TS
M1&UA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,3)P=#MM87)G:6XM;&5F
M=#HP)3MM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z-"XU-"4[9F]N="US
M:7IE.C$P<'0[.SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#MT97AT+6EN9&5N=#HT+C4T)2<^
M16%C:"!S:&%R92!O9B!397)I97,@0B!#;VYV97)T:6)L92!0<F5F97)R960@
M4W1O8VL@:7,@8V]N=F5R=&EB;&4@:6YT;R`Q+#`P,#PO9F]N=#X\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M
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M(&UO<F4@=&AA;B`Y+CDX)2!O9B!T:&4@=&]T86P@;G5M8F5R(&]F('-H87)E
M<R!O9B!C;VUM;VX@<W1O8VL@=&AE;B!I<W-U960@86YD(&]U='-T86YD:6YG
M+B!);B!T:&4@979E;G0@;V8@=&AE($-O;7!A;GDF(S@R,3<[<R!L:7%U:61A
M=&EO;BP@9&ES<V]L=71I;VXL(&]R('=I;F1I;F<@=7`L(&AO;&1E<G,@;V8@
M4V5R:65S($(@0V]N=F5R=&EB;&4@4')E9F5R<F5D(%-T;V-K('=I;&P@<F5C
M96EV92!A('!A>6UE;G0@97%U86P@=&\@)#`N,#`Q('!E<B!S:&%R92!B969O
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M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M<VEZ93HQ,RXU<'0[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^(#PO9F]N=#X\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE
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M/CPO<#X\<"!S='EL93TS1&UA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,3)P=#MM87)G:6XM;&5F=#HP)3MM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z-"XU-"4[9F]N="US:7IE.C$S+C5P=#L[/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@
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M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY
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M97)T:6)L92!0<F5F97)R960@4W1O8VL@<V]L9"!O;B!/8W1O8F5R(#,P+"`R
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M9F]N=#X\+W`^/'`@<W1Y;&4],T1M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C$X<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
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M<R`\+V9O;G0^/"]P/CQP('-T>6QE/3-$;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HV<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C0N-30E.V9O;G0M=V5I9VAT.F)O;&0[.V9O;G0M<VEZ93HQ
M,RXU<'0[.SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z,3!P=#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[=&5X="UI;F1E;G0Z-"XU-"4G/D]N($YO=F5M8F5R)B,Q-C`[
M-"P@,C`P."P@;W5R($)O87)D(&]F($1I<F5C=&]R<R!D96-L87)E9"!A(&1I
M=FED96YD(&]F(&]N92!P<F5F97)R960@<VAA<F4@<'5R8VAA<V4@<FEG:'0@
M*&$@)B,X,C(P.U)I9VAT)B,X,C(Q.RD@9F]R(&5A8V@@;W5T<W1A;F1I;F<@
M<VAA<F4@;V8@;W5R($-O;6UO;B!3=&]C:RP@<&%R('9A;'5E("0P+C`P,3PO
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M)B,Q-C`[,3<L(#(P,#@@=&\@=&AE('-T;V-K:&]L9&5R<R!O9B!R96-O<F0@
M;VX@=&AA="!D871E+B!%86-H(%)I9VAT(&5N=&ET;&5S('1H92!R96=I<W1E
M<F5D(&AO;&1E<B!T;R!P=7)C:&%S92!F<F]M('5S(&]N92!O;F4M:'5N9')E
M9'1H(&]F(&$@<VAA<F4@;V8@4V5R:65S($$@2G5N:6]R(%!A<G1I8VEP871I
M;F<@4')E9F5R<F5D(%-T;V-K+"!P87(@=F%L=64@)#`N,#`Q('!E<B!S:&%R
M92`H=&AE("8C.#(R,#M0<F5F97)R960@4VAA<F5S)B,X,C(Q.RDL(&%T(&$@
M<')I8V4@;V8@)#8N,#`@<&5R(&]N92!O;F4M:'5N9')E9'1H(&]F(&$@4')E
M9F5R<F5D(%-H87)E+"!S=6)J96-T('1O(&%D:G5S=&UE;G0N(%5P;VX@=&AE
M(&%C<75I<VET:6]N(&]F+"!O<B!A;FYO=6YC96UE;G0@;V8@=&AE(&EN=&5N
M="!T;R!A8W%U:7)E+"`R,"!P97)C96YT(&]R(&UO<F4@;V8@;W5R(&]U='-T
M86YD:6YG($-O;6UO;B!3:&%R97,@8GD@82!P97)S;VXL(&5N=&ET>2!O<B!G
M<F]U<"!O9B!A9F9I;&EA=&5D(&]R(&%S<V]C:6%T960@<&5R<V]N<R`H)B,X
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M;&P@97AP:7)E(&]N($YO=F5M8F5R)B,Q-C`[,3<L(#(P,3@L('5N;&5S<R!T
M:&4@4FEG:'1S(&%R92!E87)L:65R(')E9&5E;65D(&]R(&5X8VAA;F=E9"!B
M>2!T:&4@0V]M<&%N>2X@/"]F;VYT/CPO<#X\<"!S='EL93TS1&UA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,3AP=#MM87)G:6XM;&5F=#HP)3MM87)G
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M.R<^+#4W,"PP,#`@<VAA<F5S(&]F(&]U<B!C;VUM;VX@<W1O8VL@=&\@=&AE
M('!U8FQI8R!A="`D,2XP-S4@<&5R('-H87)E+B!4:&4@9W)O<W,@<')O8V5E
M9',@=&\@=7,@9G)O;2!T:&ES(&]F9F5R:6YG('=E<F4@87!P<F]X:6UA=&5L
M>2`D.#4N-2!M:6QL:6]N+B!!9G1E<B!D961U8W1I;F<@:7-S=6%N8V4@8V]S
M=',@;V8@87!P<F]X:6UA=&5L>2`D-"XU(&UI;&QI;VXL('1H92!N970@<')O
M8V5E9',@9G)O;2!T:&4@;V9F97)I;F<@=V5R92!A<'!R;WAI;6%T96QY("0X
M,"XY(&UI;&QI;VXN/"]F;VYT/CPO<#X\<"!S='EL93TS1&UA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,3)P=#MM87)G:6XM;&5F=#HP)3MM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z-"XU-"4[9F]N="US:7IE.C$P<'0[.SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M=&5X="UI;F1E;G0Z-"XU-"4G/D]N($UA<F-H)B,Q-C`[,CDL(#(P,3,L('=E
M(&5N=&5R960@:6YT;R!A;B!!="!-87)K970@27-S=6%N8V4@4V%L97,@06=R
M965M96YT("AT:&4@)B,X,C(P.T%G<F5E;65N="8C.#(R,3LI('=I=&@@34Q6
M)B,Q-C`[)F%M<#L@0V\N($Q,0R`H)B,X,C(P.TU,5B8C.#(R,3LI('5N9&5R
M('=H:6-H('=E(&UA>2!O9F9E<B!A;F0@<V5L;"!O=7(@8V]M;6]N('-T;V-K
M(&AA=FEN9R!A9V=R96=A=&4@<V%L97,@<')O8V5E9',@;V8@=7`@=&\@)#4P
M+#`P,"PP,#`\+V9O;G0^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.C$P<'0[
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M;B!O9B!U<"!T;R`S+C`E(&]F('1H92!G<F]S<R!S86QE<R!P<F]C965D<R!O
M9B!A;GD@8V]M;6]N('-T;V-K('-O;&0@=&AR;W5G:"!-3%8@=6YD97(@=&AE
M($%G<F5E;65N="X@3F\@<V%L97,@;V8@;W5R(&-O;6UO;B!S=&]C:R!H879E
M('1A:V5N('!L86-E('5N9&5R('1H:7,@06=R965M96YT(&%S(&]F($1E8V5M
M8F5R)B,Q-C`[,S$L(#(P,3,N(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HQ,G!T.VUA<F=I;BUL969T.C`E
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M;B!U;F1E<G=R:71T96X@<'5B;&EC(&]F9F5R:6YG(&]F(#$W+#4P,"PP,#`\
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M<"!S='EL93TS1&UA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,3)P=#MM
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M=F5M8F5R)B,Q-C`[,RP@,C`Q,2P@=V4@8V]M<&QE=&5D(&%N('5N9&5R=W)I
M='1E;B!P=6)L:6,@;V9F97)I;F<@;V8@,C<L-C`P+#`P,#PO9F]N=#X\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SX@
M<VAA<F5S(&]F(&]U<B!C;VUM;VX@<W1O8VL@:6YC;'5D:6YG(#,L-C`P+#`P
M,"!S:&%R97,@<V]L9"!P=7)S=6%N="!T;R!T:&4@9G5L;"!E>&5R8VES92!O
M9B!A;B!O=F5R86QL;W1M96YT(&]P=&EO;B!P<F5V:6]U<VQY(&=R86YT960@
M=&\@=&AE('5N9&5R=W)I=&5R<R!A="!A('!R:6-E('1O('1H92!P=6)L:6,@
M;V8@)#(N-3`@<&5R('-H87)E+B!4:&4@;F5T('!R;V-E961S('1O('5S(&9R
M;VT@=&AI<R!O9F9E<FEN9R!W97)E("0V-"XU(&UI;&QI;VXL(&%F=&5R(&1E
M9'5C=&EN9R!O9F9E<FEN9R!E>'!E;G-E<RX@/"]F;VYT/CPO<#X\<"!S='EL
M93TS1&UA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,3)P=#MM87)G:6XM
M;&5F=#HP)3MM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z-"XU-"4[9F]N
M="US:7IE.C$S+C5P=#L[/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.W1E>'0M:6YD96YT.C0N
M-30E)SY/;B!.;W9E;6)E<B8C,38P.S(L(#(P,3`L('=E(&-O;7!L971E9"!A
M;B!U;F1E<G=R:71T96X@<'5B;&EC(&]F9F5R:6YG(&]F(#(V+#0U,"PP,#`\
M+V9O;G0^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+7-I>F4Z
M,3!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SX@<VAA<F5S(&]F(&]U<B!C;VUM;VX@
M<W1O8VL@:6YC;'5D:6YG(#,L-#4P+#`P,"!S:&%R97,@<V]L9"!P=7)S=6%N
M="!T;R!T:&4@9G5L;"!E>&5R8VES92!O9B!A;B!O=F5R86QL;W1M96YT(&]P
M=&EO;B!P<F5V:6]U<VQY(&=R86YT960@=&\@=&AE('5N9&5R=W)I=&5R<R!A
M="!A('!R:6-E('1O('1H92!P=6)L:6,@;V8@)#$N-S`@<&5R('-H87)E+B!4
M:&4@;F5T('!R;V-E961S('1O('5S(&9R;VT@=&AI<R!O9F9E<FEN9R!W97)E
M("0T,BXP(&UI;&QI;VXL(&%F=&5R(&1E9'5C=&EN9R!O9F9E<FEN9R!E>'!E
M;G-E<RX\+V9O;G0^/"]P/CQP('-T>6QE/3-$;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HQ,G!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HT+C4T)3MF;VYT+7-I>F4Z,3,N-7!T.SL^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[=&5X="UI;F1E;G0Z-"XU-"4G/D]N(%-E<'1E;6)E<B8C,38P
M.S(P+"`R,#$P+"!W92!E;G1E<F5D(&EN=&\@82!0=7)C:&%S92!!9W)E96UE
M;G0@=VET:"!!<W!I<F4@0V%P:71A;"P@=VAI8V@@<')O=FED960@=&AA="P@
M=7!O;B!T:&4@=&5R;7,@86YD('-U8FIE8W0@=&\@=&AE(&-O;F1I=&EO;G,@
M86YD(&QI;6ET871I;VYS('-E="!F;W)T:"!T:&5R96EN+"!!<W!I<F4@0V%P
M:71A;"!W87,@8V]M;6ET=&5D('1O('!U<F-H87-E('5P('1O(&%N(&%G9W)E
M9V%T92!O9B`D,S`N,#PO9F]N=#X\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
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M:6=A=&EO;B!T;R!P=7)C:&%S92!U<"!T;R`D,S`@;6EL;&EO;B!O9B!O=7(@
M8V]M;6]N('-T;V-K+B!792!P86ED('1H:7,@8V]M;6ET;65N="!F964@;V8@
M)#$N,B!M:6QL:6]N(&)Y('1H92!I<W-U86YC92!O9B`V,#`L,#`P('-H87)E
M<R!O9B!O=7(@8V]M;6]N('-T;V-K(&%N9"!T:&ES(&9E92!W87,@<F5C;W)D
M960@87,@82!C;W-T(&]F(')A:7-I;F<@8V%P:71A;"!A;F0@;F5T=&5D(&%G
M86EN<W0@=&AE(&=R;W-S('!R;V-E961S(&9R;VT@=&AE(%!U<F-H87-E($%G
M<F5E;65N="!I;B!397!T96UB97(@,C`Q,"X@1'5R:6YG(#(P,3`L('=E('-O
M;&0@,BPS-3`L,#`P('-H87)E<R!O9B!C;VUM;VX@<W1O8VL@=&\@07-P:7)E
M($-A<&ET86P@9F]R("0S+C,@;6EL;&EO;B!A;F0@9'5R:6YG(#(P,3$@=V4@
M<V]L9"`Q,"PY.34L,C$P('-H87)E<R!O9B!C;VUM;VX@<W1O8VL@9F]R("0R
M-BXW(&UI;&QI;VXL('=H:6-H('1O=&%L960@=&AE('!R;V-E961S(&%V86EL
M86)L92!T;R!U<R!O9B`D,S`@;6EL;&EO;B!U;F1E<B!T:&4@4'5R8VAA<V4@
M06=R965M96YT+CPO9F]N=#X\+W`^/'`@<W1Y;&4],T1M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C$R<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C0N-30E.V9O;G0M<VEZ93HQ,'!T.SL^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.W1E
M>'0M:6YD96YT.C0N-30E)SY/;B!!<')I;"8C,38P.S$V+"`R,#$P+"!W92!C
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M<F]X:6UA=&5L>2`D,RXP(&UI;&QI;VXL(&9R;VT@=&AE('-A;&4@;V8@,S`L
M,CDS+#`P,"!U;FET<R!A="!A('!E<B!U;FET('!R:6-E(&]F("0Q+C0U,C4N
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M;6)E<B8C,38P.S,Q+"`R,#$S("AI;F-L=61I;F<@=&AE('=A<G)A;G1S('1O
M('!U<F-H87-E(#8L-S8U+#$R."!S:&%R97,@<')O=FED960@=&\@4WEM<&AO
M;GD@87,@9&5S8W)I8F5D(&EN($YO=&4@."`F(S@R,C`[4WEM<&AO;GD@1'EN
M86UO+"!);F,N)B,X,C(Q.RDN(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T1M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C$X<'0[;6%R9VEN+6QE9G0Z,"4[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,'!T
M.SL^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z
M,3!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/E=A<G)A;G1S(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T1M87)G:6XM8F]T
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M960@:6X@,C`P."P@=V4@:7-S=65D('=A<G)A;G1S('1O('!U<F-H87-E('5P
M('1O(#,L-34P+#`P,#PO9F]N=#X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
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M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^)FYB<W`[/"]P/CQD:78^
M#0H\=&%B;&4@8F]R9&5R/3-$,"!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I
M;F<],T0P(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)V)O<F1E<BUC;VQL87!S
M93IC;VQL87!S93L@=VED=&@Z,3`P)3LG/@T*/'1R/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C,Y)3L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^5V%R<F%N="!)<W-U86YC92!$871E/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI
M9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^4VAA<F5S($ES<W5A8FQE(#QB<B`O/BAI;B!T
M:&]U<V%N9',I/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW
M:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E
M;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
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M.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG
M/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW
M96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O
M='1O;3HP('!T.W=I9'1H.C$R)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^17AP:7)A=&EO;B`\8G(@+SY$871E/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N
M.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!C
M;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW
M:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG
M/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW
M96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^17AE<F-I
M<V4@4')I8V4@/&)R("\^<&5R(%-H87)E/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I
M;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O
M<#HP+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D(&-O;'-P86X]
M,T0R('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E
M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB
M;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY/=71S=&%N9&EN9R!A
M<R!O9B`\8G(@+SY$96-E;6)E<B`S,2P@,C`Q,R`\8G(@+SXH:6X@=&AO=7-A
M;F1S*3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z
M,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW
M96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HS.24[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T(",P,#`P,#`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HQ,BXR-7!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z+3$R+C(U<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^2G5L>2`Q."P@,C`P-SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R
M9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M
M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z
M,3(E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/C$L,C4P/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O
M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E
M.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,3(E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4],T0G
M=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,B\R-B\R,#$T/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N
M=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T
M>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P
M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B0\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z,3(E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ
M<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
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M<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[
M=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T
M:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C$U)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P
M,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L
M:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXQ+#(U,#PO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A
M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,SDE.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,3(N
M,C5P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.BTQ,BXR-7!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/D]C=&]B97(@,3@L(#(P,#<\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T
M>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P
M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z,24[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,3(E.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/C$L,S`P/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP
M861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z,24[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C$R)3LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/C(O,C8O,C`Q-#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B0\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&
M1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z,3(E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
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M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&
M1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P
M=#MW:61T:#HQ-24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^+3PO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ
M)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HS.24[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HQ,BXR-7!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M+3$R+C(U<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
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M=&]M.C`@<'0[=VED=&@Z,24[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D
M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG
M+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$
M)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D
M:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,3(E
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ
M<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/C,P,#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C$E.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HQ,B4[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N
M.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXR+S(V+S(P,30\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$
M)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D
M:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H
M.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D
M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG
M+4)O='1O;3HP('!T.W=I9'1H.C$R)3MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXU+C8U/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
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M0F]T=&]M.C`@<'0[=VED=&@Z,34E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C,P,#PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ
M,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT
M<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,SDE.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C$R+C(U
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HM,3(N,C5P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SY$96-E;6)E<B`R-RP@,C`P-SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$R)3L@
M8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXW,#`\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I
M9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N
M=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP
M861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T
M:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ,B4[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA
M;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^,B\R-B\R,#$T/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW
M:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E
M;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
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M)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^,2XV.#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R
M86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P
M,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ-24[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^+3PO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HS.24[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M
M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C$R+C(U<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HM,3(N,C5P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SY4;W1A;#PO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T
M<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P
M,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HQ,B4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P
M,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^,RPU-3`\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M
M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP
M+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E
M;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED
M=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B
M;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M+51O<#HP+C<U('!T.W=I9'1H.C$R)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R
M86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M
M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N
M=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,3(E
M.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R
M+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O
M=6)L92`R+C5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T
M('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P
M,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O
M='1O;3HP('!T.W=I9'1H.C$U)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I
M9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXQ+#4U,#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R
M86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A
M<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CPO=&%B;&4^/"]D
M:78^/'`@<W1Y;&4],T1M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP)3MM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,"4[9F]N="US:7IE.C9P=#L[/B9N8G-P.SPO<#X\<"!S='EL93TS1&UA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C`E.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP)3MF;VYT+7-I>F4Z-G!T.SL^
M)FYB<W`[/"]P/CQP('-T>6QE/3-$;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C0N-30E.V9O;G0M<VEZ93HQ,'!T.SL^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.W1E>'0M:6YD96YT.C0N
M-30E)SY!<R!O9B!$96-E;6)E<B8C,38P.S,Q+"`R,#$S+"!W87)R86YT<R!T
M;R!P=7)C:&%S92!A;B!A9V=R96=A=&4@;V8@87!P<F]X:6UA=&5L>2`Q,BPU
M,#`L,#`P/"]F;VYT/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B!S:&%R97,@;V8@;W5R(&-O;6UO;B!S=&]C:R!W
M97)E(&]U='-T86YD:6YG+B!4:&4@=V%R<F%N=',@87)E(&5X97)C:7-A8FQE
M(#PO9F]N=#X\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/F%T(&$@=V5I9VAT960@879E<F%G
M92!P<FEC92!O9B`D,2XY-B!P97(@<VAA<F4\+V9O;G0^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^+B!$=7)I;F<@
M=&AE('EE87)S(&5N9&5D($1E8V5M8F5R)B,Q-C`[,S$L(#(P,3,L(&%N9"`R
M,#$R+"!W87)R86YT<R!W97)E(&5X97)C:7-E9"!T;R!P=7)C:&%S92!A;B!A
M9V=R96=A=&4@;V8@87!P<F]X:6UA=&5L>2`R-3`L,#`P(&%N9"`Q,RPP,#`L
M,#`P('-H87)E<RP@<F5S<&5C=&EV96QY+"!O9B!O=7(@8V]M;6]N('-T;V-K
M+B`\+V9O;G0^/"]P/CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM
M+2TM+3U?3F5X=%!A<G1?-V5A.#)B,CE?.3@R-E\T,#)A7V(Y-C!?,#(Q-69D
M.&)A9&4X#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S=E83@R8C(Y
M7SDX,C9?-#`R85]B.38P7S`R,35F9#AB861E."]7;W)K<VAE971S+U-H965T
M,C`N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R
M:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S
M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE
M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA
M<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R
M8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\
M+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS
M1')E<&]R="!I9#TS1$E$,$5!1#X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY%
M<75I='D@4&QA;G,@86YD(%-T;V-K+4)A<V5D($-O;7!E;G-A=&EO;CQB<CX\
M+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N
M/3-$,3XQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB
M<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17%U:71Y(%!L
M86YS(&%N9"!3=&]C:RU"87-E9"!#;VUP96YS871I;VX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\9&EV/@T*/&1I=B!A;&EG;CTS1&QE9G0^
M/'1A8FQE(&)O<F1E<CTS1#`@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG
M/3-$,"!S='EL93TS1"=B;W)D97(M8V]L;&%P<V4Z8V]L;&%P<V4[('=I9'1H
M.C$P,"4[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E)SX\='(^/'1D
M('9A;&EG;CTS1'1O<"!S='EL93TS1'=I9'1H.C0N-30E.W=H:71E+7-P86-E
M.FYO=W)A<#X\<"!S='EL93TS1&UA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,3AP=#MF;VYT+7-I>F4Z,3!P=#L[/CQF;VYT('-T>6QE/3-$)V9O;G0M
M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXQ,RX\+V9O;G0^/"]P/CPO=&0^
M/'1D('9A;&EG;CTS1'1O<"!S='EL93TS1'=I9'1H.CDU+C0V)3L^/'`@<W1Y
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M9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C`E.V9O
M;G0M<VEZ93HQ,'!T.SL^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L
M9#MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/E-T;V-K(%!L86YS(#PO9F]N=#X\+W`^/'`@<W1Y
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M8F5R)B,Q-C`[,S$L(#(P,3,L('=E(&AA9"!T:')E93PO9F]N=#X\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SX@<VAA
M<F4M8F%S960@8V]M<&5N<V%T:6]N('!L86YS+B`\+V9O;G0^/"]P/CQP('-T
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M="UV87)I86YT.B!N;W)M86P[)SXR,#`T(%-T;V-K($EN8V5N=&EV92!0;&%N
M("@F(S@R,C`[,C`P-"!0;&%N)B,X,C(Q.RD@/"]F;VYT/CPO<#X\<"!S='EL
M93TS1&UA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z-G!T.VUA<F=I;BUL
M969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HQ+C,S)3MF;VYT
M+7-I>F4Z,3!P=#L[/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#MT97AT+6EN9&5N=#HQ+C,S)2<^)FYB<W`[)FYB<W`[
M)FYB<W`[)FYB<W`[("`\+V9O;G0^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
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M8G)U87)Y)B,Q-C`[,3$L(#(P,#0N(%1H:7,@<&QA;B!P<F]V:61E9"!F;W(@
M=&AE(&ES<W5A;F-E(&]F('5P('1O(#,L-3`P+#`P,"!S:&%R97,@;V8@;W5R
M(&-O;6UO;B!S=&]C:R!P;'5S(&%N(&%N;G5A;"!I;F-R96%S92X@4W5B<V5Q
M=65N=&QY+"!W92!D:7-C;VYT:6YU960@9W)A;G1I;F<@<W1O8VL@;W!T:6]N
M<R!U;F1E<B!T:&4@,3DY-R!0;&%N+B!/<'1I;VYS('5N9&5R('1H92`R,#`T
M(%!L86X@=V5R92!G<F%N=&5D(&9O<B!P97)I;V1S(&]F('5P('1O('1E;B!Y
M96%R<R!A;F0@=&AE(&5X97)C:7-E('!R:6-E(&]F(&%L;"!S=&]C:R!O<'1I
M;VYS(&=R86YT960@=6YD97(@=&AE(#(P,#0@4&QA;B!W87,@870@;&5A<W0@
M97%U86P@=&\@,3`P)2!O9B!T:&4@9F%I<B!M87)K970@=F%L=64@;V8@=&AE
M(&-O;6UO;B!S=&]C:R!O;B!T:&4@9&%T92!O9B!G<F%N="X@268L(&AO=V5V
M97(L(&EN8V5N=&EV92!S=&]C:R!O<'1I;VYS('=E<F4@9W)A;G1E9"!T;R!A
M;B!E;7!L;WEE92!W:&\@;W=N<R!S=&]C:R!P;W-S97-S:6YG(&UO<F4@=&AA
M;B`Q,"4@;V8@=&AE('9O=&EN9R!P;W=E<B!O9B!A;&P@8VQA<W-E<R!O9B!T
M:&4@0V]M<&%N>28C.#(Q-SMS('-T;V-K(&]R('1H92!S=&]C:R!O9B!A;GD@
M<&%R96YT(&]R('-U8G-I9&EA<GD@;V8@=&AE($-O;7!A;GDL('1H92!E>&5R
M8VES92!P<FEC92!O9B!A;GD@:6YC96YT:79E('-T;V-K(&]P=&EO;B!G<F%N
M=&5D(&UU<W0@97%U86P@870@;&5A<W0@,3$P)2!O9B!T:&4@9F%I<B!M87)K
M970@=F%L=64@;VX@=&AE(&=R86YT(&1A=&4@86YD('1H92!M87AI;75M('1E
M<FT@;V8@=&AE<V4@:6YC96YT:79E('-T;V-K(&]P=&EO;G,@;75S="!N;W0@
M97AC965D(&9I=F4@>65A<G,N(%1H92!M87AI;75M('1E<FT@;V8@86X@:6YC
M96YT:79E('-T;V-K(&]P=&EO;B!G<F%N=&5D('1O(&%N>2!O=&AE<B!P87)T
M:6-I<&%N="!M=7-T(&YO="!E>&-E960@=&5N('EE87)S+B!4:&4@,C`P-"!0
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M;V8@1&5C96UB97(F(S$V,#LS,2P@,C`Q,RP@;W!T:6]N<R!T;R!P=7)C:&%S
M92`T+#`V-BPR-S<@<VAA<F5S(&]F(&-O;6UO;B!S=&]C:R!R96UA:6YE9"!O
M=71S=&%N9&EN9R!U;F1E<B!T:&4@,C`P-"!0;&%N+CPO9F]N=#X\+W`^/'`@
M<W1Y;&4],T1M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C$X<'0[;6%R
M9VEN+6QE9G0Z.2XP-B4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C`E
M.V9O;G0M<VEZ93HQ,'!T.SL^/&9O;G0@<W1Y;&4],T0G9F]N="US='EL93II
M=&%L:6,[.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7=E:6=H=#IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C(P,3`@16UP;&]Y;65N="!);F1U8V5M
M96YT($%W87)D(%!L86X@*"8C.#(R,#M);F1U8V5M96YT(%!L86XF(S@R,C$[
M*2`\+V9O;G0^/"]P/CQP('-T>6QE/3-$;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HV<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E
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M;G5A<GD@,C`Q,"!B>2!O=7(@0F]A<F0@;V8@1&ER96-T;W)S('1O(&EN9'5C
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M<W-U86YC92!O9B!U<"!T;R`Q+#4P,"PP,#`@<VAA<F5S(&]F(&]U<B!C;VUM
M;VX@<W1O8VL@86YD(&)E8V%M92!E9F9E8W1I=F4@;VX@2F%N=6%R>28C,38P
M.S@L(#(P,3`N(%-T;V-K:&]L9&5R(&%P<')O=F%L(&]F('1H92!);F1U8V5M
M96YT(%!L86X@:7,@;F]T(')E<75I<F5D('5N9&5R($Y!4T1!42!-87)K971P
M;&%C92!2=6QE(#4V,S4H8RDH-"DN($%S(&]F($1E8V5M8F5R)B,Q-C`[,S$L
M(#(P,3,L(&]P=&EO;G,@=&\@<'5R8VAA<V4@-S0S+#8R-2!S:&%R97,@;V8@
M8V]M;6]N('-T;V-K(')E;6%I;F5D(&]U='-T86YD:6YG('5N9&5R('1H92!)
M;F1U8V5M96YT(%!L86XN(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T1M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C$X<'0[;6%R9VEN+6QE9G0Z.2XP-B4[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,'!T
M.SL^/&9O;G0@<W1Y;&4],T0G9F]N="US='EL93II=&%L:6,[.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7=E:6=H
M=#IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/C(P,3$@17%U:71Y($EN8V5N=&EV92!0;&%N("@F(S@R,C`[,C`Q
M,2!0;&%N)B,X,C(Q.RD@/"]F;VYT/CPO<#X\<"!S='EL93TS1&UA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z-G!T.VUA<F=I;BUL969T.C`E.VUA<F=I
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M;W!T960@:6X@2F%N=6%R>2`R,#$Q+B!/;B!-87D@,CDL(#(P,3,L('1H92!S
M=&]C:VAO;&1E<G,@;V8@=&AE($-O;7!A;GD@87!P<F]V960@86X@86UE;F1M
M96YT('1O('1H92`R,#$Q(%!L86X@=&\@:6YC<F5A<V4@=&AE(&YU;6)E<B!O
M9B!S:&%R97,@;V8@8V]M;6]N('-T;V-K(&%U=&AO<FEZ960@9F]R(&ES<W5A
M;F-E('5N9&5R('1H92!P;&%N(&)Y(#$P+#`P,"PP,#`\+V9O;G0^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^+B!4
M:&4@,C`Q,2!0;&%N+"!A<R!A;65N9&5D+"!P<F]V:61E<R!F;W(@=&AE(&ES
M<W5A;F-E(&]F('5P('1O(#(U+#`P,"PP,#`@<VAA<F5S(&]F(&]U<B!C;VUM
M;VX@<W1O8VL@=&\@96UP;&]Y965S(&%N9"!N;VXM96UP;&]Y965S(&]F('1H
M92!#;VUP86YY(&%N9"!B96-A;64@969F96-T:79E(&]N($IA;G5A<GDF(S$V
M,#LV+"`R,#$Q+B!4:&4@,C`Q,2!0;&%N(&ES(&%D;6EN:7-T97)E9"!B>2!O
M=7(@0F]A<F0@;V8@1&ER96-T;W)S+"!O<B!A(&1E<VEG;F%T960@8V]M;6ET
M=&5E(&]F('1H92!";V%R9"!O9B!$:7)E8W1O<G,L(&%N9"!A=V%R9',@9W)A
M;G1E9"!U;F1E<B!T:&4@,C`Q,2!0;&%N(&AA=F4@82!T97)M(&]F(#$P)B,Q
M-C`[>65A<G,@=6YL97-S(&5A<FQI97(@=&5R;6EN871E9"!B>2!T:&4@0F]A
M<F0@;V8@1&ER96-T;W)S+B!!9G1E<B!T:&4@861O<'1I;VX@;V8@=&AE(#(P
M,3$@4&QA;BP@;F\@861D:71I;VYA;"!A=V%R9',@=V5R92!G<F%N=&5D('5N
M9&5R(&5I=&AE<B!T:&4@,C`P-"!0;&%N(&]R('1H92!);F1U8V5M96YT(%!L
M86XN($%S(&]F($IA;G5A<GDF(S$V,#LV+"`R,#$Q+"!A;&P@<VAA<F5S('-U
M8FIE8W0@=&\@87=A<F1S(&]U='-T86YD:6YG('5N9&5R('1H92`R,#`T(%!L
M86X@86YD($EN9'5C96UE;G0@4&QA;B!T:&%T(&5X<&ER92!O<B!A<F4@9F]R
M9F5I=&5D('=I;&P@8F4@:6YC;'5D960@:6X@=&AE(')E<V5R=F4@9F]R('1H
M92`R,#$Q(%!L86X@=&\@=&AE(&5X=&5N="!S=6-H('-H87)E<R!W;W5L9"!O
M=&AE<G=I<V4@<F5T=7)N('1O('-U8V@@<&QA;G,N($%S(&]F($1E8V5M8F5R
M)B,Q-C`[,S$L(#(P,3,L(&]P=&EO;G,@=&\@<'5R8VAA<V4@,3`L.34T+#DT
M,"!S:&%R97,@;V8@8V]M;6]N('-T;V-K(')E;6%I;F5D(&]U='-T86YD:6YG
M('5N9&5R('1H92`R,#$Q(%!L86XN($%S(&]F($1E8V5M8F5R)B,Q-C`[,S$L
M(#(P,3,L('1H97)E('=E<F4@,3,L-C8V+#DV-"8C,38P.W-H87)E<R!O9B!C
M;VUM;VX@<W1O8VL@<F5S97)V960@9F]R(&ES<W5A;F-E('5N9&5R('1H92`R
M,#$Q(%!L86XN)FYB<W`[)FYB<W`[/"]F;VYT/CPO<#X\<"!S='EL93TS1&UA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,3)P=#MM87)G:6XM;&5F=#HP
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M<B!S=&]C:R!P;&%N<R!I<R!S970@9F]R=&@@8F5L;W<Z(#PO9F]N=#X\+W`^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C`E
M.V9O;G0M<VEZ93HQ,G!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93HQ,G!T.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B8C,38P.SPO9F]N=#X\+W`^/&1I=CX-"CQT86)L92!B;W)D97(],T0P
M(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@86QI9VX],T1C96YT
M97(@<W1Y;&4],T0G8F]R9&5R+6-O;&QA<'-E.F-O;&QA<'-E.R!W:61T:#HQ
M,#`E.R<^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A
M9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG
M+51O<#HP+C<U('!T.W=I9'1H.C4W)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
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M861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T
M:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[
M)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ
M,"!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P
M,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
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M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@
M8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H
M=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A
M9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG
M+51O<#HP+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N
M=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D(&-O;'-P
M86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG
M;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SY796EG:'1E9"U!=F5R86=E($5X97)C:7-E(%!R
M:6-E)B,Q-C`[4&5R)B,Q-C`[4VAA<F4@*&EN('1H;W5S86YD<RD\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I
M;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O
M<#HP+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O
M<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!C
M;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M
M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^5V5I9VAT960M079E<F%G92!296UA:6YI
M;F<@0V]N=')A8W1U86P@5&5R;2`H>65A<G,I/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW
M:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E
M;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
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M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@
M,"XW-7!T(",P,#`P,#`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E
M<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT
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M+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T
M<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$
M)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D
M:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-3<E
M.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SY"86QA;F-E(&%T($1E8V5M8F5R)B,Q-C`[,S$L
M(#(P,3(\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I
M;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M
M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z
M."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^,3,L.#`V/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O
M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E
M.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T
M>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ
M,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P
M,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXS+C,X/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E
M.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN
M9RU";W1T;VTZ,"!P=#MW:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P
M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H
M.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P
M=#MW:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D
M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG
M+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT
M<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T
M:#HU-R4[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HQ,RXW<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
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M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG
M+4)O='1O;3HP('!T.W=I9'1H.C$E.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG
M;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
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M0F]T=&]M.C`@<'0[=VED=&@Z."4[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
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M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3LG/CQP('-T
M>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&
M1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ
M,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
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M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
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M.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW
M:61T:#HQ)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&
M1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP
M('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
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M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
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M=&]M.C`@<'0[=VED=&@Z."4[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HU-R4[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HQ,RXW<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
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M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z,24[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T
M:#HX)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L
M:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXH,3,Q/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXI/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C$E.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M.C`@<'0[=VED=&@Z."4[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,2XT,SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW
M:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP
M('!T.W=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
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M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ
M,"!P=#MW:61T:#HQ)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
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M=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O
M='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R
M/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C4W)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C$S+C=P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
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M.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[)SX\<"!S='EL93TS1"=T
M97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
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M;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ
M)3LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN
M9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C@E
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
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M;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ
M)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I
M9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z."4[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HU-R4[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HR-RXS
M-7!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/D]P=&EO;G,@9F]R9F5I=&5D("AU;G9E<W1E9"D\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z,24[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P
M=#MW:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T
M97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
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M;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[)SX\<"!S='EL93TS1"=T97AT+6%L
M:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN
M9RU";W1T;VTZ,"!P=#MW:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXS+C,Q/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
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M0F]T=&]M.C`@<'0[=VED=&@Z."4[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D
M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG
M+4)O='1O;3HP('!T.W=I9'1H.C$E.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H
M.C@E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M
M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C4W)3L@
M8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HR-RXS-7!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
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M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ
M)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\
M<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
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M=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T
M(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXH.38Y/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R
M9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
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M=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)W1E
M>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T
M:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O
M='1O;3HP('!T.W=I9'1H.C@E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P
M="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E
M>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C,N,S0\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE
M/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP
M861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O
M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP
M861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T
M:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z
M."4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
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M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@
M8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[=VED=&@Z."4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M<#HP+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT
M<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z-3<E.R!B;W)D97(M=&]P.G-O
M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@
M,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^0F%L
M86YC92!A="!$96-E;6)E<B8C,38P.S,Q+"`R,#$S/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N
M-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M
M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L
M92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z."4[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U
M8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
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M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ
M9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU
M<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
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M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE
M(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B
M;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXS+C$W/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U
M8FQE(#(N-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M:6YG+51O<#HP+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@
M=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D
M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG
M+4)O='1O;3HP('!T.W=I9'1H.C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P
M,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L
M:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXU+C(V/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R
M86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A
M<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H
M.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R
M9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T
M:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O
M<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
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M9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@
M8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP
M('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T
M.W=I9'1H.C4W)3L@8F]R9&5R+71O<#ID;W5B;&4@,BXU<'0@=')A;G-P87)E
M;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/E9E<W1E9"!A;F0@97AP96-T960@=&\@
M=F5S="!A="!$96-E;6)E<B`S,2P@,C`Q,SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z9&]U8FQE(#(N
M-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T
M<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z9&]U8FQE(#(N-7!T(",P,#`P
M,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HX)3L@8F]R9&5R+71O<#ID;W5B;&4@,BXU<'0@(S`P
M,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
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M+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.F1O=6)L92`R+C5P="!T<F%N
M<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E
M;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED
M=&@Z,24[(&)O<F1E<BUT;W`Z9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R!B
M;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O
M<F1E<BUT;W`Z9&]U8FQE(#(N-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ
M9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3L@
M8F]R9&5R+71O<#ID;W5B;&4@,BXU<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O
M;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXS+C$W/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R
M9&5R+71O<#ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T
M;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M=6)L92`R+C5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@
M,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D
M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG
M+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.F1O=6)L92`R+C5P
M="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I
M;F<M0F]T=&]M.C`@<'0[=VED=&@Z."4[(&)O<F1E<BUT;W`Z9&]U8FQE(#(N
M-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P
M,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG
M;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^-2XR-CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z9&]U8FQE(#(N-7!T
M('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N
M<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MW:61T:#HQ)3L@8F]R9&5R+71O<#ID;W5B;&4@,BXU<'0@=')A;G-P87)E
M;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ
M)3L@8F]R9&5R+71O<#ID;W5B;&4@,BXU<'0@(S`P,#`P,#L@8F]R9&5R+6)O
M='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3L@
M8F]R9&5R+71O<#ID;W5B;&4@,BXU<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O
M;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXQ+#0R-SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O
M<F1E<BUT;W`Z9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T
M=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z-3<E
M.R!B;W)D97(M=&]P.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#L@8F]R9&5R
M+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
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M;W)D97(M=&]P.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O
M='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P
M.F1O=6)L92`R+C5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R
M+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
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M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z."4[(&)O<F1E<BUT
M;W`Z9&]U8FQE(#(N-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE
M(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,3`L-C(X/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+71O
M<#ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U
M8FQE(#(N-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M:6YG+51O<#HP+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.F1O=6)L92`R
M+C5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@
M=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.F1O=6)L92`R+C5P="`C,#`P
M,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
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M=&]M.C`@<'0[=VED=&@Z."4[(&)O<F1E<BUT;W`Z9&]U8FQE(#(N-7!T(",P
M,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^,RXS-CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z9&]U8FQE(#(N-7!T('1R86YS
M<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N
M=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP
M861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T
M:#HQ)3L@8F]R9&5R+71O<#ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[(&)O
M<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R
M9&5R+71O<#ID;W5B;&4@,BXU<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID
M;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C@E.R!B
M;W)D97(M=&]P.F1O=6)L92`R+C5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M
M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
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M97(M=&]P.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O
M;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z9&]U
M8FQE(#(N-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R
M+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S
M<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I
M;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M
M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z9&]U8FQE(#(N-7!T
M(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
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M=&]M.C`@<'0[=VED=&@Z."4[(&)O<F1E<BUT;W`Z9&]U8FQE(#(N-7!T(",P
M,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
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M+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.F1O=6)L92`R+C5P="!T<F%N
M<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E
M;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\+W1A8FQE/CPO9&EV
M/CQP('-T>6QE/3-$;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C`E
M.V9O;G0M<VEZ93HV<'0[.SXF;F)S<#L\+W`^/'`@<W1Y;&4],T1M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP)3MM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,"4[9F]N="US:7IE.C9P=#L[/B9N
M8G-P.SPO<#X\<"!S='EL93TS1&UA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
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M-C`[,S$L(#(P,3,L(#(P,3(@86YD(#(P,3$@=V%S+"`D,"XS/"]F;VYT/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B!M:6QL:6]N+"`D,BXW(&UI;&QI;VX@86YD("0P+C$@;6EL;&EO;BP@<F5S
M<&5C=&EV96QY+B!4:&4@=&]T86P@:6YT<FEN<VEC('9A;'5E(&]F(&5X97)C
M:7-E9"!S=&]C:R!O<'1I;VYS(&ES(&-A;&-U;&%T960@8F%S960@;VX@=&AE
M(&1I9F9E<F5N8V4@8F5T=V5E;B!T:&4@97AE<F-I<V4@<')I8V4@86YD('1H
M92!Q=6]T960@;6%R:V5T('!R:6-E(&]F(&]U<B!C;VUM;VX@<W1O8VL@87,@
M;V8@=&AE(&-L;W-E(&]F('1H92!E>&5R8VES92!D871E+B`\+V9O;G0^/"]P
M/CQP('-T>6QE/3-$;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HQ,G!T
M.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HT
M+C4T)3MF;VYT+7-I>F4Z,3!P=#L[/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#MT97AT+6EN9&5N=#HT+C4T)2<^5&AE
M('1O=&%L(&9A:7(@=F%L=64@;V8@<W1O8VL@;W!T:6]N<R!V97-T960@9'5R
M:6YG('1H92!Y96%R<R!E;F1E9"!$96-E;6)E<B8C,38P.S,Q+"`R,#$S+"`R
M,#$R(&%N9"`R,#$Q('=A<RP@)#$\+V9O;G0^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,BXQ(&UI;&QI;VXL("0Y
M+C8@;6EL;&EO;B!A;F0@)#(N."!M:6QL:6]N+"!R97-P96-T:79E;'DN(#PO
M9F]N=#X\+W`^/'`@<W1Y;&4],T1M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C$R<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
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M=',@87,@;V8@1&5C96UB97(F(S$V,#LS,2P@,C`Q,RP@86YD(&%C=&EV:71I
M97,@9'5R:6YG(#(P,3,@:7,@<W5M;6%R:7IE9"!A<R!F;VQL;W=S.B`\+V9O
M;G0^/"]P/CQP('-T>6QE/3-$;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C`E.V9O;G0M<VEZ93HQ,'!T.SL^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)B,Q-C`[/"]F;VYT/CPO<#X\
M9&EV/@T*/'1A8FQE(&)O<F1E<CTS1#`@8V5L;'-P86-I;F<],T0P(&-E;&QP
M861D:6YG/3-$,"!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=B;W)D97(M8V]L
M;&%P<V4Z8V]L;&%P<V4[('=I9'1H.C$P,"4[)SX-"CQT<CX-"CQT9"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z-SDE
M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^)FYB<W`[/"]P/CPO=&0^#0H\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG
M:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M
M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P
M,#`P,#`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/DYU;6)E<B!O9B!3:&%R97,@*$EN)B,Q-C`[=&AO=7-A;F1S*3PO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R
M9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL
M93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O
M;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T
M:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP
M('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG
M:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^5V5I9VAT960M
M079E<F%G92!'<F%N="U$871E)B,Q-C`[1F%I<B!686QU93PO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R
M86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HW.24[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
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M;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW
M-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXQ+#<U-3PO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A
M;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT+6%L
M:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$
M)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D
M:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
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M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^-"XR,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C
M1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG
M:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M
M.C`@<'0[=VED=&@Z-SDE.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
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M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I
M9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXR-3`\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M
M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP
M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&
M1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ
M,"!P=#MW:61T:#HQ)3LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW
M:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXQ+C(S/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C<Y)3LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP
M('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXI/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R<^/'`@<W1Y;&4],T0G
M=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I
M9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP
M861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D
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M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C$N,3`\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M
M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T
M=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^
M#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&
M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW
M-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C<Y)3L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
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M861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z
M,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HX)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@
M(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXH-C$U/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
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M<#HP+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3L@
M8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXT+C(S/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW
M:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E
M;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I
M;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O
M<#HP+C<U('!T.W=I9'1H.C<Y)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS
M<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
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M<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U
M8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3L@8F]R
M9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID
M;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXQ+#(W-3PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M
M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N
M-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M
M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L
M92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C@E.R!B;W)D97(M=&]P
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R
M+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
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M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@
M,BXU<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^
M#0H\+W1A8FQE/CPO9&EV/CQP('-T>6QE/3-$;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HV<'0[.SXF;F)S<#L\+W`^/'`@
M<W1Y;&4],T1M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP)3MM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,"4[9F]N
M="US:7IE.C9P=#L[/B9N8G-P.SPO<#X\<"!S='EL93TS1&UA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR
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M;FET<R!W87,@87!P<F]X:6UA=&5L>2`D,"XQ(&UI;&QI;VX@9F]R('1H92!Y
M96%R(&5N9&5D($1E8V5M8F5R)B,Q-C`[,S$L(#(P,3,N(%1H92!A9V=R96=A
M=&4@:6YT<FEN<VEC('9A;'5E(&]F('1H92!R97-T<FEC=&5D('-T;V-K('5N
M:71S(&]U='-T86YD:6YG(&%S(&]F($1E8V5M8F5R)B,Q-C`[,S$L(#(P,3,L
M(&)A<V5D(&]N(&]U<B!S=&]C:R!P<FEC92!O;B!T:&%T(&1A=&4L('=A<R`D
M,BXU(&UI;&QI;VXN(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T1M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C$R<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C0N-30E.V9O;G0M<VEZ93HQ,'!T.SL^
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M,2P@,C`Q,R!A;F0@,C`Q,B!W87,L("0Q+C(S/"]F;VYT/CQF;VYT('-T>6QE
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M>65A<G,@96YD960@1&5C96UB97(F(S$V,#LS,2P@,C`Q,RP@,C`Q,BP@86YD
M(#(P,3$@=V%S+"`D,"XQ(&UI;&QI;VXL("0P+C(@;6EL;&EO;BP@86YD("0P
M+C@@;6EL;&EO;BP@<F5S<&5C=&EV96QY+B`\+V9O;G0^/"]P/CQP('-T>6QE
M/3-$;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HQ.'!T.VUA<F=I;BUL
M969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP)3MF;VYT+7-I
M>F4Z,3!P=#L[/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[9F]N
M="US:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SY3=&]C:RU"87-E9"!#;VUP96YS871I;VX@/"]F;VYT/CPO
M<#X\<"!S='EL93TS1&UA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z-G!T
M.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HT
M+C4T)3MF;VYT+7-I>F4Z,3!P=#L[/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#MT97AT+6EN9&5N=#HT+C4T)2<^)FYB
M<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[
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M<F%N="`H;W(@96%R;&EE<B!U<&]N('1E<FUI;F%T:6]N(&]F(&-O;G1I;G5O
M=7,@<V5R=FEC92DN(%1H92!#;VUP86YY(&AA<R!A;'-O(&=R86YT960@<&5R
M9F]R;6%N8V4M8F%S960@97%U:71Y(&%W87)D<R!T;R!C97)T86EN(&]F(&]U
M<B!E;7!L;WEE97,@=6YD97(@=&AE(#(P,3$@4&QA;BP@=&AE(#(P,#0@4&QA
M;B!A;F0@=&AE($EN9'5C96UE;G0@4&QA;BX@07,@;V8@1&5C96UB97(F(S$V
M,#LS,2P@,C`Q,RP@,BPP-#<L-#8V('-H87)E<R!W97)E(&]U='-T86YD:6YG
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M:6YG('=E:6=H=&5D+6%V97)A9V4@87-S=6UP=&EO;G,Z(#PO9F]N=#X\+W`^
M/'`@<W1Y;&4],T1M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
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M=&%B;&4@8F]R9&5R/3-$,"!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<]
M,T0P(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)V)O<F1E<BUC;VQL87!S93IC
M;VQL87!S93L@=VED=&@Z,3`P)3LG/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HS-24[(&)O<F1E
M<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SXF;F)S<#L\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E
M<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD
M.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@8V]L<W!A;CTS1#$P('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H
M.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@
M<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H
M=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY3=&]C:R8C,38P
M.T]P=&EO;G,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW
M-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T
M=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS
M<&%R96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,3`@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I
M;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@
M,"XW-7!T(",P,#`P,#`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E
M<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/D5M<&QO>65E)B,Q-C`[4W1O8VL@4'5R8VAA<V4F(S$V,#M0
M;&%N/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\
M+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C,U)3L@8F]R
M9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O
M='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T
M<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@8V]L<W!A;CTS1#$P('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^
M/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E
M:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY996%R($5N
M9&5D($1E8V5M8F5R)B,Q-C`[,S$L/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D
M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG
M+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A
M;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D(&-O;'-P86X],T0Q
M,"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^665A<B!%;F1E9"!$96-E;6)E<B8C,38P.S,Q+#PO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO
M=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HS-24[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$
M,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N
M=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^,C`Q,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O
M<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z
M8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E
M<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N
M/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ
M8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^,C`Q,CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG
M:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E
M;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS
M<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI
M9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^,C`Q,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z
M,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW
M96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N
M.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!C
M;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M
M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^,C`Q,SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED
M=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT+6%L
M:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R
M+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E
M>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,C`Q,CPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R
M9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$
M)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,C`Q,3PO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS
M<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HS-24[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/E=E:6=H=&5D+6%V97)A9V4@9F%I<B!V86QU93PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ
M,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P
M,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI
M9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/C(N-#$\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A
M9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG
M+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP
M861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D
M:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N
M-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C@E.R!B;W)D97(M=&]P.G-O
M;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C,N,S`\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR
M:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C@E
M.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
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M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P
M,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI
M9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/C`N.3,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A
M9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG
M+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW
M:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ
M,"!P=#MW:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P
M,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N
M.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXS+C4T/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N
M=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B0\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR
M:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^,BXP.3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I
M;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M
M0F]T=&]M.C`@<'0[=VED=&@Z,S4E.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/E)I<VLM9G)E92!I;G1E<F5S="!R871E/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ
M)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP
M861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D
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M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C$N,3PO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3LG/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&
M1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P
M=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
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M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/C`N-3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)3PO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3LG
M/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C@E.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG
M:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/C$N,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)3PO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW
M:61T:#HQ)3LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I
M9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M
M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C`N,CPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)3PO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HQ)3LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG
M:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C`N,CPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW
M:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3LG/CQP('-T>6QE/3-$)W1E>'0M
M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ
M)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP
M861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D
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M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C`N,SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)3PO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE
M/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP
M861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z
M,S4E.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/D5X<&5C=&5D(&QI9F4@*&EN
M('EE87)S*3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP
M('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T
M.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW
M:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN
M9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3LG/CQP('-T>6QE/3-$)W1E>'0M86QI
M9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D
M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG
M+4)O='1O;3HP('!T.W=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C0N,CPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ
M,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP
M('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
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M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z."4[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^-"XP/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP
M861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z,24[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T
M:#HX)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L
M:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HQ)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
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M;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX
M)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N
M.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HQ)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
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M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I
M9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A
M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,S4E.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
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M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M
M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T
M=&]M.C`@<'0[=VED=&@Z."4[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,2XT/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[)SX\<"!S='EL93TS
M1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[
M=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ
M)3LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN
M9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C@E
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ
M<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/C$N-CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C$E.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M.C`@<'0[=VED=&@Z."4[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,"XX/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I
M9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z."4[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,2XV/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H
M.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[
M=VED=&@Z."4[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X
M="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,2XV/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
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M)FYB<W`[/"]P/CQP('-T>6QE/3-$;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
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M<&5C=&%T:6]N(&]F(&1I=FED96YD('!A>6]U=',N(#PO9F]N=#X\+W`^/'`@
M<W1Y;&4],T1M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C$R<'0[;6%R
M9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C0N-30E
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M:6YG(&-R:71E<FEA(&)E8V]M97,@<')O8F%B;&4N(#PO9F]N=#X\+W`^/'`@
M<W1Y;&4],T1M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C$R<'0[;6%R
M9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C0N-30E
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M;VUP96YS871I;VX@97AP96YS92`H:6X@=&AO=7-A;F1S*3H@/"]F;VYT/CPO
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M;6%L.R<^)B,Q-C`[/"]F;VYT/CPO<#X\9&EV/@T*/'1A8FQE(&)O<F1E<CTS
M1#`@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!A;&EG;CTS1&-E
M;G1E<B!S='EL93TS1"=B;W)D97(M8V]L;&%P<V4Z8V]L;&%P<V4[('=I9'1H
M.C$P,"4[)SX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z-C@E.R!B
M;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M)FYB<W`[/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M
M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C$E.R!B
M;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M8V]L<W!A;CTS1#$P('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P
M.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY996%R
M($5N9&5D($1E8V5M8F5R)B,Q-C`[,S$L/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*
M/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HV."4[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.G-O;&ED
M(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
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M.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R
M9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D(&-O
M;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I
M9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D
M97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4],T0G
M=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXR,#$S/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P
M,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[
M)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^,C`Q,CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT
M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I
M9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA
M;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&
M1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[)SX\<"!S='EL
M93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O
M;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R
M/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C8X)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E
M;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
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M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW
M:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ
M,"!P=#MW:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P
M,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N
M.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP
M861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D
M:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N
M-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C@E.R!B;W)D97(M=&]P.G-O
M;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C$P+#0S.3PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ
M,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N
M.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
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M861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z
M."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
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M.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HV."4[(&)O<F1E
M<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
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M('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P
M,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z
M,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HX)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@
M(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXM/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M
M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z."4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^-#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS
M<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MW:61T:#HV."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T
M<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY4;W1A;#PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M
M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T
M(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
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M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P
M,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA
M;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^,3(L,S0P/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T
M('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
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M+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E
M;G0[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
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M;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW
M-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P
M,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
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M0F]T=&]M.C`@<'0[=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T
M(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR
M:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^,3`L-#,Y/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS
M<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N
M=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\
M<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
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M=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P
M,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
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M.C`@<'0[=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P
M,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
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M('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A
M<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M
M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP
M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-C@E.R!B;W)D97(M
M=&]P.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z
M9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#ID;W5B
M;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C@E.R!B;W)D
M97(M=&]P.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z,24[(&)O<F1E<BUT;W`Z9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
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M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z9&]U8FQE(#(N-7!T
M('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#ID;W5B;&4@,BXU<'0@(S`P
M,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP
M861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C@E.R!B;W)D97(M=&]P.F1O=6)L
M92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E
M<BUT;W`Z9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&
M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW
M-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[
M=VED=&@Z,24[(&)O<F1E<BUT;W`Z9&]U8FQE(#(N-7!T('1R86YS<&%R96YT
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T
M:#HQ)3L@8F]R9&5R+71O<#ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C@E.R!B;W)D97(M=&]P.F1O=6)L92`R+C5P="`C,#`P
M,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z9&]U8FQE
M(#(N-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R
M/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HV."4[(&)O<F1E<BUB
M;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R
M86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,3`@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A
M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T(",P,#`P,#`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E
M;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF
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M97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O
M;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H
M.C8X)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O
M<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW
M-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P
M,#`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R
M+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD
M.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
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M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N
M=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D(&-O;'-P
M86X],T0R('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H
M.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M
M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4],T0G=&5X
M="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXR,#$R/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P
M,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\
M<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I
M9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI
M9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@
M(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^,C`Q,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED
M=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B
M;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT
M.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A
M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-C@E.R!B;W)D97(M=&]P.G-O;&ED
M(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
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M+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXT+#(R.#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R
M9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS
M1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[
M=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
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M.C`@<'0[=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P
M,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG
M;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
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M+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP
M861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D
M:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N
M-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C@E.R!B;W)D97(M=&]P.G-O
M;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C(L,3`S/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP
M('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A
M<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[=VED=&@Z-C@E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY'96YE
M<F%L(&%N9"!A9&UI;FES=')A=&EV93PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C@E.R!B;W)D97(M8F]T
M=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C@L,3$R
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@
M8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O
M<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&
M1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP
M('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P
M,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z."4[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
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M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T
M97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HX)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T
M97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXS+#`X-CPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HV."4[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T
M=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SY4;W1A;#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z
M,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB
M;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
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M:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z."4[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T
M;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,3(L,S0P
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB
M;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B
M;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N
M.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ
M9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
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M<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z."4[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U
M8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,3`L-#,Y/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ
M9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU
M<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
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M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE
M(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
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M('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z."4[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N
M-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
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M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@
M,BXU<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^
M#0H\+W1A8FQE/CPO9&EV/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP)3MF;VYT+7-I>F4Z,3)P=#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[)SXF;F)S<#L\+W`^/'`@<W1Y;&4],T1M87)G:6XM
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M;B!E>'!E;G-E(')E8V]G;FEZ960@:6X@,C`Q,R!A;F0@,C`Q,B!I;F-L=61E
M<R`D-"XY/"]F;VYT/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B!M:6QL:6]N(')E;&%T960@=&\@96UP;&]Y964@
M<V5V97)A;F-E(&%R<F%N9V5M96YT<R!A;F0@)#`N-2!M:6QL:6]N(&9O<B!A
M=V%R9',@=&\@;F]N+65M<&QO>65E<R!F;W(@=&AE('EE87(@96YD960@1&5C
M96UB97(@,S$L(#(P,3,@86YD("0Q+C4@;6EL;&EO;B!R96QA=&5D('1O(&5M
M<&QO>65E('-E=F5R86YC92!A<G)A;F=E;65N=',@9F]R('1H92!S86UE('!E
M<FEO9"!I;B`R,#$R+B!$=7)I;F<@=&AE('EE87(@96YD960@1&5C96UB97(@
M,S$L(#(P,3,L('=E(')E8V]G;FEZ960@)#$N,R!M:6QL:6]N(&EN(&%D9&ET
M:6]N86P@<W1O8VLM8F%S960@8V]M<&5N<V%T:6]N(&5X<&5N<V4@9'5E('1O
M('1H92!M;V1I9FEC871I;VX@;V8@=&AE('1E<FUS(&]F('-T;V-K(&]P=&EO
M;G,@9F]R(&9I=F4@96UP;&]Y965S+B!$=7)I;F<@=&AE('EE87(@96YD960@
M1&5C96UB97(@,S$L(#(P,3(L('=E(')E8V]G;FEZ960@)#`N-R!M:6QL:6]N
M(&EN(&%D9&ET:6]N86P@<W1O8VLM8F%S960@8V]M<&5N<V%T:6]N(&5X<&5N
M<V4@9'5E('1O('1H92!M;V1I9FEC871I;VX@;V8@=&AE('1E<FUS(&]F('-T
M;V-K(&]P=&EO;G,@9F]R(&]N92!E;7!L;WEE92X\+V9O;G0^/"]P/CQP('-T
M>6QE/3-$;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HQ,G!T.VUA<F=I
M;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HT+C4T)3MF
M;VYT+7-I>F4Z,3!P=#L[/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#MT97AT+6EN9&5N=#HT+C4T)2<^07,@;V8@1&5C
M96UB97(F(S$V,#LS,2P@,C`Q,RP@=&AE('1O=&%L('5N<F5C;V=N:7IE9"!C
M;VUP96YS871I;VX@8V]S="!R96QA=&5D('1O(&YO;BUV97-T960@<W1O8VL@
M;W!T:6]N<R!D965M960@<')O8F%B;&4@;V8@=F5S=&EN9RP@:6YC;'5D:6YG
M(&%L;"!S=&]C:R!O<'1I;VYS('=I=&@@=&EM92UB87-E9"!V97-T:6YG+"!N
M970@;V8@97-T:6UA=&5D(&9O<F9E:71U<F5S+"!A;6]U;G1E9"!T;R`D,3`N
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M92!V97-T:6YG('!E<FEO9"!O9B`R+C@@>65A<G,N($%S(&]F($1E8V5M8F5R
M)B,Q-C`[,S$L(#(P,3,L('1H92!T;W1A;"!U;G)E8V]G;FEZ960@8V]M<&5N
M<V%T:6]N(&-O<W0@<F5L871E9"!T;R!N;VXM=F5S=&5D('-T;V-K(&]P=&EO
M;G,@;F]T(&1E96UE9"!P<F]B86)L92!O9B!V97-T:6YG+"!N970@;V8@97-T
M:6UA=&5D(&9O<F9E:71U<F5S+"!A;6]U;G1E9"!T;R`D,RXX(&UI;&QI;VXN
M(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T1M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C$R<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C0N-30E.V9O;G0M<VEZ93HQ,'!T.SL^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.W1E>'0M:6YD96YT
M.C0N-30E)SY!<R!O9B!$96-E;6)E<B8C,38P.S,Q+"`R,#$S+"!T:&4@=&]T
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M('EE87)S+B`\+V9O;G0^/"]P/CQP('-T>6QE/3-$;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HQ.'!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP)3MF;VYT+7-I>F4Z,3!P=#L[/CQF;VYT('-T
M>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY%;7!L;WEE
M92!3=&]C:R!0=7)C:&%S92!0;&%N(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T1M
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M.B!N;W)M86P[=&5X="UI;F1E;G0Z-"XU-"4G/DEN($IA;G5A<GD@,C`P-"P@
M=&AE($)O87)D(&]F($1I<F5C=&]R<R!A;F0@<W1O8VMH;VQD97)S(&%D;W!T
M960@=&AE(#(P,#0@16UP;&]Y964@4W1O8VL@4'5R8VAA<V4@4&QA;B`H=&AE
M("8C.#(R,#M0=7)C:&%S92!0;&%N)B,X,C(Q.RDN(%1H92!0=7)C:&%S92!0
M;&%N('!R;W9I9&5S(&9O<B!T:&4@<'5R8VAA<V4@;V8@8V]M;6]N('-T;V-K
M(&)Y(&5L:6=I8FQE(&5M<&QO>65E<R!A;F0@8F5C86UE(&5F9F5C=&EV92!O
M;B!&96)R=6%R>28C,38P.S$Q+"`R,#`T+B!4:&4@<'5R8VAA<V4@<')I8V4@
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M075G=7-T*2!O<B`H:6DI)B,Q-C`[.#4E(&]F('1H92!F86ER(&UA<FME="!V
M86QU92!O9B!T:&4@8V]M;6]N('-T;V-K(&]N('1H92!E>&5R8VES92!D871E
M+"!W:&EC:"!I<R!T:&4@;&%S="!D87D@;V8@82!P=7)C:&%S92!P97)I;V0@
M*&=E;F5R86QL>2P@=&AE(&9O=7)T965N=&@@9&%Y(&EN($9E8G)U87)Y(&]R
M($%U9W5S="DN(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HQ,G!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR
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M/D%S(&]F($1E8V5M8F5R)B,Q-C`[,S$L(#(P,3,L(#DY-BPP,#`\+V9O;G0^
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M97(@=&AE(%!U<F-H87-E(%!L86XN($%S(&]F($1E8V5M8F5R)B,Q-C`[,S$L
M(#(P,3,L(#$V-RPU.#8@<VAA<F5S(&]F(&]U<B!C;VUM;VX@<W1O8VL@<F5M
M86EN960@879A:6QA8FQE(&9O<B!F=71U<F4@<'5R8VAA<V5S+CPO9F]N=#X\
M+W`^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
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M"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N
M=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX
M)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ
M<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO
M:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED
M/3-$240P14%$/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D5M<&QO>65E($)E
M;F5F:70@4&QA;CQB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT:',@16YD960\+W1H/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^16UP;&]Y964@0F5N969I="!0;&%N/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/&1I=CX-"CQD:78@86QI9VX],T1L969T/CQT86)L
M92!B;W)D97(],T0P(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@
M<W1Y;&4],T0G8F]R9&5R+6-O;&QA<'-E.F-O;&QA<'-E.R!W:61T:#HQ,#`E
M.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)2<^/'1R/CQT9"!V86QI
M9VX],T1T;W`@<W1Y;&4],T1W:61T:#HT+C4T)3MW:&ET92US<&%C93IN;W=R
M87`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HQ
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M93TS1'=I9'1H.CDU+C0V)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
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M92!#;V1E+B!5;F1E<B!T:&4@-#`Q*&LI(%!L86XL('!A<G1I8VEP871I;F<@
M96UP;&]Y965S(&UA>2!D969E<B!A('!O<G1I;VX@;V8@=&AE:7(@<')E=&%X
M(&5A<FYI;F=S+B!792!M87DL(&%T(&]U<B!D:7-C<F5T:6]N+"!C;VYT<FEB
M=71E(&9O<B!T:&4@8F5N969I="!O9B!E;&EG:6)L92!E;7!L;WEE97,N(%1O
M(&1A=&4L('=E(&AA=F4@;F]T(&-O;G1R:6)U=&5D('1O('1H92`T,#$H:RD@
M4&QA;BX@/"]F;VYT/CPO<#X\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*
M#0HM+2TM+2T]7TYE>'1087)T7S=E83@R8C(Y7SDX,C9?-#`R85]B.38P7S`R
M,35F9#AB861E.`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\W96$X
M,F(R.5\Y.#(V7S0P,F%?8CDV,%\P,C$U9F0X8F%D93@O5V]R:W-H965T<R]3
M:&5E=#(R+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E
M9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T
M/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT
M='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[
M(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP
M="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT
M("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA
M<W,],T1R97!O<G0@:60],T1)1#!%040^#0H@("`@("`\='(^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O
M;F<^26YC;VUE(%1A>&5S/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R($UO;G1H<R!%;F1E9#PO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y$96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y);F-O;64@5&%X97,\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\9&EV/@T*/&1I=B!A;&EG;CTS1&QE9G0^/'1A8FQE(&)O
M<F1E<CTS1#`@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S='EL
M93TS1"=B;W)D97(M8V]L;&%P<V4Z8V]L;&%P<V4[('=I9'1H.C$P,"4[;6%R
M9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E)SX\='(^/'1D('9A;&EG;CTS
M1'1O<"!S='EL93TS1'=I9'1H.C0N-30E.W=H:71E+7-P86-E.FYO=W)A<#X\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C$X<'0[
M9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P
M=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/C$U+CPO9F]N=#X\+W`^/"]T9#X\=&0@=F%L:6=N/3-$=&]P('-T>6QE/3-$
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M<FEA;G0Z(&YO<FUA;#LG/DEN8V]M92!487AE<R`\+V9O;G0^/"]P/CPO=&0^
M/"]T<CX\+W1A8FQE/CPO9&EV/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z-G!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HT+C4T)3MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z,3!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[=&5X="UI;F1E;G0Z-"XU-"4G/D-O
M;G-O;&ED871E9"!I;F-O;64@*&QO<W,I(&)E9F]R92!P<F]V:7-I;VX@9F]R
M(&EN8V]M92!T87AE<R!C;VYS:7-T960@;V8@=&AE(&9O;&QO=VEN9R`H:6X@
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M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)B,Q-C`[/"]F;VYT/CPO<#X\
M9&EV/@T*/'1A8FQE(&)O<F1E<CTS1#`@8V5L;'-P86-I;F<],T0P(&-E;&QP
M861D:6YG/3-$,"!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=B;W)D97(M8V]L
M;&%P<V4Z8V]L;&%P<V4[('=I9'1H.C$P,"4[)SX-"CQT<CX-"CQT9"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z-C@E
M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^)FYB<W`[/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP
M861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O
M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D(&-O;'-P86X],T0Q,"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^665A<B!%;F1E9"!$96-E;6)E<B8C,38P.S,Q+#PO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R
M86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT
M9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED
M=&@Z-C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@
M8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP
M861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T
M:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O
M<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!C
M;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
M+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^,C`Q,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O
M<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!C
M;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
M+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^,C`Q,CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O
M<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!C
M;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
M+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^,C`Q,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C
M0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG
M:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M
M.C`@<'0[=VED=&@Z-C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY5+E,N/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N
M=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T
M>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P
M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B0\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR
M:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^*#8W+#`P-#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R
M9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
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M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ
M)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW
M:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXH-S`L-SDR/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M
M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^*3PO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ
M)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H
M.C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B@T.2PY.3`\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F
M=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U
M('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXI/"]F;VYT/CPO<#X\+W1D/@T*/"]T
M<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&
M1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z-C@E.R!B;W)D97(M
M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SY.;VX@52Y3+CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@
M(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C@E.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C(X-#PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&
M1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E
M<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&
M1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M
M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
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M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUB
M;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T
M:#HX)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
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M('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
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M;F<M0F]T=&]M.C`@<'0[=VED=&@Z."4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@
M,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
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M=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z-C@E
M.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R
M+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
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M+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E
M;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I
M9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D
M97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H
M.C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M
M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B@V
M-BPW,C`\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H
M.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R
M9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
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M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B
M;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP
M861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D
M:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N
M-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P
M,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D
M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG
M+4)O='1O;3HP('!T.W=I9'1H.C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ
M<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
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M+51O<#HP+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A
M;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/BD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I
M9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@
M8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M
M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C@E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O
M=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
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M97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O
M;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
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M;'DZ5&EM97,@3F5W(%)O;6%N.R<^)FYB<W`[/"]P/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C`E
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M9F]R('1H92!Y96%R<R!E;F1E9"!$96-E;6)E<B8C,38P.S,Q+"`R,#$S+"`R
M,#$R(&%N9"`R,#$Q(&1U92!T;R!N970@;W!E<F%T:6YG(&QO<W,@/"]F;VYT
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M;W=S("AI;B!T:&]U<V%N9',I.B`\+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C`E
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M1#`@8V5L;'!A9&1I;F<],T0P(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)V)O
M<F1E<BUC;VQL87!S93IC;VQL87!S93L@=VED=&@Z,3`P)3LG/@T*/'1R/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW
M:61T:#HV."4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SXF;F)S<#L\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@8V]L<W!A;CTS1#$P
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M
M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z
M8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^665A<B!%;F1E9"!$
M96-E;6)E<B8C,38P.S,Q+#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L
M9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z-C@E.R!B;W)D97(M=&]P.G-O
M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T
M(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[
M)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/C(P,3,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A
M;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N
M=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B
M;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXR,#$R
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E
M;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D(&-O
M;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI
M9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L
M9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,C`Q,3PO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M
M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F
M=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U
M('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-C@E.R!B;W)D97(M=&]P
M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SY);F-O;64@=&%X(&)E;F5F:70@870@9F5D97)A;"!S=&%T=71O<GD@
M<F%T93PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED
M=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D97(M=&]P
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B@R,BPV-S@\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^*3PO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B0\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D97(M=&]P.G-O;&ED
M(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B@R
M,RPV-3`\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P
M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^*3PO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B0\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E
M>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B@Q-BPU,C,\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED
M(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^*3PO9F]N=#X\+W`^/"]T
M9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M
M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T
M=&]M.C`@<'0[=VED=&@Z-C@E.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/E-T
M871E('1A>#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3L^/'`@<W1Y;&4]
M,T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y
M;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$
M)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXH,3<X/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^
M/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/BD\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&
M('-T>6QE/3-$=VED=&@Z,24[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C@E.W=H:71E
M+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^*#@Y/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I
M9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/BD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$=VED=&@Z,24[
M/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&
M1D9&1B!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@
M<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^*#(L-3@V/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P
M86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/BD\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C8X)3LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P
M86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C
M93IN;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B@R+#4Q-3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T
M:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@
M<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T
M>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
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M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E.SX\<"!S='EL93TS1"=M87)G
M:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I
M9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T
M:#HX)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI
M9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B@Q+#,Y-#PO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T
M>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXI/"]F;VYT/CPO<#X\+W1D
M/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HV."4[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^1&5F
M97)R960@8V]M<&5N<V%T:6]N(&-H87)G97,\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$
M=VED=&@Z,24[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
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M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO
M=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
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M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E.SX\
M<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&
M1D9&1B!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@
M<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&
M1D8@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T
M>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/C$L,#`R/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E
M.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3L^/'`@<W1Y;&4],T0G
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN
M9RU";W1T;VTZ,"!P=#MW:61T:#HV."4[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^0VAA;F=E(&EN('9A;'5A=&EO;B!A;&QO=V%N8V4\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T
M>6QE/3-$=VED=&@Z,24[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P
M86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^,C(L,S4T/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I
M9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T
M:#HQ)3L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R
M87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
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M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E.SX\<"!S
M='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y
M;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C$X
M+#`Y.3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN
M;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S
M<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C8X)3LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C@E
M.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR
M:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^+3PO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$
M=VED=&@Z,24[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
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M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO
M=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^+3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET
M92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$=VED=&@Z,24[/CQP('-T
M>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S
M='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^*#,T
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A
M<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/BD\+V9O;G0^
M/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP
M861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D
M:6YG+4)O='1O;3HP('!T.W=I9'1H.C8X)3LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H
M.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HX
M)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ
M<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
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M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1'=I9'1H.C$E.SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E
M.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN
M;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
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M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E.SX\<"!S
M='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y
M;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C(X
M-CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R
M87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C8X)3LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
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M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E
M.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HX)3MW
M:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG
M:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
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M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I
M9'1H.C$E.SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO
M=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R
M87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
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M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E.SX\<"!S='EL
M93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S
M='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4]
M,T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y
M;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$
M)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C4P.3PO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[
M/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP
M861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C8X)3LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SY$965M960@9&EV:61E;F0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$=VED
M=&@Z,24[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
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M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A
M<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^+3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US
M<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$=VED=&@Z,24[/CQP('-T>6QE
M/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G
M=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^+3PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP
M('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$=VED=&@Z,24[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
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M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C@E.W=H
M:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,C<S/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO
M='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&
M1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z-C@E.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/E!R:6]R('EE
M87(@=')U92!U<#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3L^/'`@<W1Y
M;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@
M<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE
M/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXM/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^
M/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&
M1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3L^/'`@<W1Y;&4],T0G;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ
M)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$=VED=&@Z."4[
M=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I
M9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXM/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS
M1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W
M:61T:#HQ)3L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN
M;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
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M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXM/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E.W=H:71E
M+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A
M9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG
M+51O<#HP+C<U('!T.W=I9'1H.C8X)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^3W1H
M97(\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I
M9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C@E.R!B
M;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B@U-3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z
M,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXI/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R
M+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS
M1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P
M,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM
M=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T
M:#HX)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXW-S$\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$
M)W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A
M<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM
M=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T
M:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[
M)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1"=W:61T:#HX)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@
M(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXW-S4\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z-C@E
M.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R
M+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^5&]T86P@:6YC;VUE('1A>"!E>'!E;G-E/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS
M<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N
M-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W=I
M9'1H.C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D
M97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/BT\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W=I9'1H.C$E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O
M='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R
M+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W=I9'1H.C$E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M
M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S
M='EL93TS1"=W:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P
M,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXM/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=W
M:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[
M(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O
M;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G
M:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=W
M:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R
M9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P
M,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA
M;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^+3PO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@
M<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R
M86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A
M<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM
M=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-
M"CPO=&%B;&4^/"]D:78^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,G!T.V9O;G0M9F%M:6QY.E1I
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M9B!$96-E;6)E<B8C,38P.S,Q+"`R,#$S(&%N9"`R,#$R(&-O;G-I<W1E9"!O
M9B!T:&4@9F]L;&]W:6YG("AI;B!T:&]U<V%N9',I.B`\+V9O;G0^/"]P/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP)3MF
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M96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P(&%L:6=N/3-$8V5N=&5R
M('-T>6QE/3-$)V)O<F1E<BUC;VQL87!S93IC;VQL87!S93L@=VED=&@Z,3`P
M)3LG/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MW:61T:#HW.24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M8V]L<W!A;CTS1#8@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E
M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY$
M96-E;6)E<B8C,38P.S,Q+#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L
M9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z-SDE.R!B;W)D97(M=&]P.G-O
M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T
M(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[
M)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/C(P,3,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A
M;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@8V]L<W!A;CTS
M1#(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M
M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED
M(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT
M97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXR,#$R/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z
M8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HW.24[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY$969E
M<G)E9"!T87@@87-S971S.CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P
M,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED
M=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S
M<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O
M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H
M.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D97(M
M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C
M0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HW.24[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HQ,RXW<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
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M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E.W=H
M:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
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M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXQ-#<L-C4U/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I
M9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T
M:#HQ)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R
M87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&
M1D9&1B!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@
M<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^,3(W+#4R.3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US
M<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C<Y)3LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C$S+C=P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C(Q
M+#,S-CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN
M;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S
M<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C0T9&,$9#('-T>6QE/3-$=VED=&@Z,24[/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I
M9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA
M;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,3@L,38S/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I
M;F<M0F]T=&]M.C`@<'0[=VED=&@Z-SDE.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,3,N-W!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/D%C8W)U86QS(&%N9"!R97-E<G9E<SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T1W:61T:#HQ)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C
M93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
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M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXY+#4P,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ
M)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$=VED=&@Z,24[
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&
M1D9&1B!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@
M<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
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M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HW.24[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HQ,RXW<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
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M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I
M9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA
M;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,3`L-C8R/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T1W:61T:#HQ)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW
M:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&
M1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ
M,"!P=#MW:61T:#HW.24[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HQ,RXW<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^1&5F
M97)R960@<F5V96YU93PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3L^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&
M1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXR
M+#0X-CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN
M;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S
M<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C1D9&1D9&('-T>6QE/3-$=VED=&@Z,24[/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I
M9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA
M;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,BPQ.#`\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&
M1D9&('-T>6QE/3-$=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z
M-SDE.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C$S+C=P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY/=&AE<CPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R
M86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB
M;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M,2PR,C(\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M8F]T
M=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T
M:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HX)3L@8F]R
M9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXQ+#(R,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z
M,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C<Y
M)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=W
M:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T9&1D9&1B!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL
M93TS1"=W:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P
M,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N
M.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXQ.3(L.#8R/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@
M<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P
M,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA
M;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,3<P+#,W.3PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&
M1D9&1D8@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HW.24[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/DQE<W,@=F%L=6%T:6]N(&%L;&]W86YC93PO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z
M,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E
M<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^*#$Y,BPW,S,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H
M.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^*3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E
M<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P
M,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED
M=&@Z."4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^*#$W,"PR,S(\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T
M>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T
M<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^*3PO9F]N=#X\+W`^/"]T9#X-"CPO='(^
M#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&
M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW
M-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C<Y)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/E1O=&%L(&1E9F5R<F5D('1A>"!A<W-E=',\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$
M)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N
M=#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&
M1D9&1B!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P
M,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=W:61T:#HX
M)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXQ,CD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O
M;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&
M('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C
M,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG
M:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C$T-SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HW
M.24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SY$969E<G)E9"!T87@@;&EA8FEL:71I97,Z/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HX)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P
M,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED
M=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C<Y
M)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C$S+C=P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C@E
M.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR
M:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^*#$V,CPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y
M;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO
M=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R
M87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B@X-CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET
M92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXI/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[=VED=&@Z-SDE.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C$S+C=P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY/=&AE
M<CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED
M=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z."4[(&)O
M<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^,S,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E
M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R
M9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@
M(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W
M:61T:#HX)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I
M9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXH-C$\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE
M/3-$)W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^*3PO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\
M='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T
M>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P
M=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C<Y)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/E1O
M=&%L(&1E9F5R<F5D('1A>"!L:6%B:6QI=&EE<SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C
M1D9&1D9&('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N
M-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P
M,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W=I9'1H
M.C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M
M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B@Q,CD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W=I9'1H.C$E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/BD\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C
M1D9&1D9&('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S
M='EL93TS1"=W:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P
M,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXH,30W/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS
M1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E
M;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXI/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[=VED=&@Z-SDE.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A
M;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
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M97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O
M;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G
M:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W
M:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R
M9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P
M,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA
M;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^+3PO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R
M86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A
M<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM
M=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T
M:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O
M<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P
M,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D97(M
M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L
M92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/BT\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED
M(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU
M<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CPO='(^#0H\+W1A8FQE/CPO9&EV/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C`E.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP)3MF;VYT+7-I>F4Z,3)P=#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[)SXF;F)S<#L\+W`^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C0N-30E.V9O;G0M
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M;F-R96%S960@8GD@)#(R+C4@;6EL;&EO;BP@)#(R+C`@;6EL;&EO;B!A;F0@
M)#$X+C$@;6EL;&EO;B!D=7)I;F<@=&AE('EE87)S(&5N9&5D($1E8V5M8F5R
M)B,Q-C`[,S$L(#(P,3,L(#(P,3(@86YD(#(P,3$L(')E<W!E8W1I=F5L>2X@
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M<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
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M960@96%R;FEN9W,N(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HQ,G!T.VUA<F=I;BUL969T.C`E.VUA<F=I
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M-"4G/D%S(&]F($1E8V5M8F5R)B,Q-C`[,S$L(#(P,3,L('=E(&AA9"!F961E
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M(&5X<&ER92!I;B!T:&4@>65A<G,@,C`Q."!T:')O=6=H(#(P,S<@86YD(&9E
M9&5R86P@<F5S96%R8V@@86YD(&1E=F5L;W!M96YT('1A>"!C<F5D:71S(&]F
M(&%P<')O>&EM871E;'D@)#$S+C@@;6EL;&EO;BP@=VAI8V@@97AP:7)E(&EN
M('1H92!Y96%R<R`R,#$X('1H<F]U9V@@,C`S,RX@/"]F;VYT/CPO<#X\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C$R<'0[;6%R
M9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C0N-30E
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M,C`Q,RP@=V4@:&%D('!O=&5N=&EA;"`\+V9O;G0^/&9O;G0@<W1Y;&4],T0G
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M:6]N+"!W:&EC:"!E>'!I<F4@:6X@=&AE('EE87)S(#(P,3,@=&AR;W5G:"`R
M,#,S+"!A;F0@0V%L:69O<FYI82!S=&%T92!R97-E87)C:"!A;F0@9&5V96QO
M<&UE;G0@=&%X(&-R961I=',@;V8@87!P<F]X:6UA=&5L>2`D,3$N-2!M:6QL
M:6]N('=H:6-H(&1O(&YO="!E>'!I<F4N(#PO9F]N=#X\+W`^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HQ,G!T.VUA<F=I;BUL
M969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HT+C4T)3MF;VYT
M+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[=&5X
M="UI;F1E;G0Z-"XU-"4G/D%S(&]F($1E8V5M8F5R)B,Q-C`[,S$L(#(P,3,L
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M(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HQ,G!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT
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M4F5F;W)M($%C="!O9B`Q.3@V(&QI;6ET<R!T:&4@86YN=6%L('5S92!O9B!N
M970@;W!E<F%T:6YG(&QO<W,@86YD('1A>"!C<F5D:70@8V%R<GEF;W)W87)D
M<SPO9F]N=#X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z,3!P=#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SX@:6X@8V5R=&%I;B!S:71U871I;VYS('=H97)E(&-H86YG
M97,@;V-C=7(@:6X@<W1O8VL@;W=N97)S:&EP(&]F(&$@8V]M<&%N>2X@26X@
M=&AE(&5V96YT('1H92!#;VUP86YY(&AA<R!A(&-H86YG92!I;B!O=VYE<G-H
M:7`L(&%S(&1E9FEN960L('1H92!A;FYU86P@=71I;&EZ871I;VX@;V8@<W5C
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M+B`\+V9O;G0^/"]P/CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM
M+2TM+3U?3F5X=%!A<G1?-V5A.#)B,CE?.3@R-E\T,#)A7V(Y-C!?,#(Q-69D
M.&)A9&4X#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S=E83@R8C(Y
M7SDX,C9?-#`R85]B.38P7S`R,35F9#AB861E."]7;W)K<VAE971S+U-H965T
M,C,N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R
M:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S
M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE
M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA
M<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R
M8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\
M+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS
M1')E<&]R="!I9#TS1$E$,$5!1#X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY3
M96QE8W1E9"!1=6%R=&5R;'D@1FEN86YC:6%L($1A=&$\8G(^/"]S=')O;F<^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,3(@
M36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^/"]T:#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-E;&5C=&5D(%%U87)T97)L
M>2!&:6YA;F-I86P@1&%T83PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQD:78^#0H\9&EV(&%L:6=N/3-$;&5F=#X\=&%B;&4@8F]R9&5R/3-$
M,"!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('-T>6QE/3-$)V)O
M<F1E<BUC;VQL87!S93IC;VQL87!S93L@=VED=&@Z,3`P)3MM87)G:6XM;&5F
M=#HP)3MM87)G:6XM<FEG:'0Z,"4G/CQT<CX\=&0@=F%L:6=N/3-$=&]P('-T
M>6QE/3-$=VED=&@Z-"XU-"4[=VAI=&4M<W!A8V4Z;F]W<F%P/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.V9O;G0M<VEZ
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M+C0V)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MF;VYT+7-I
M>F4Z,3!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/E-E;&5C=&5D(%%U87)T97)L>2!&:6YA;F-I86P@1&%T82`H56YA
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M-C`[/"]F;VYT/CPO<#X\9&EV/@T*/'1A8FQE(&)O<F1E<CTS1#`@8V5L;'-P
M86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!A;&EG;CTS1&-E;G1E<B!S='EL
M93TS1"=B;W)D97(M8V]L;&%P<V4Z8V]L;&%P<V4[('=I9'1H.C$P,"4[)SX-
M"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[=VED=&@Z-3<E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T
M<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^)FYB<W`[/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O
M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D(&-O;'-P
M86X],T0Q-"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O
M<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[)SX\<"!S='EL93TS
M1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/EEE87(@
M16YD960@1&5C96UB97(F(S$V,#LS,2P@,C`Q,SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E
M<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z-3<E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,B!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T(",P,#`P,#`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/E$Q/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M(S`P,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG
M/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^43(\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T
M<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O
M;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I
M9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D
M97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4],T0G
M=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E
M:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY1,SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED
M=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B
M;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P
M,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT
M.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N
M/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T(",P,#`P,#`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E
M;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/E$T/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z
M8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HU-R4[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/E)E
M=F5N=65S/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W
M:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^,BPP.#4\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T
M:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^,RPS.3(\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M
M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ
M)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M,BPY,C<\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P
M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,BPX
M-#<\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O
M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HU-R4[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^3F5T)B,Q-C`[;&]S<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ
M)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M*#(P+#@R-3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C
M93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
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M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I
M9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
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M9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXH,3<L,38T/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S
M='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
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M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
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M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[
M/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
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M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^*3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3L^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y
M;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I
M9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA
M;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^*#$S+#`U-CPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&
M1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXI/"]F;VYT/CPO<#X\
M+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HU-R4[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
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M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HX)3MW:&ET
M92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
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M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^*3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T
M:#HQ)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R
M87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@
M<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^*#$W+#$V-#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US
M<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
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M.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXH,34L-C<U/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
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M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R
M87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
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M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^*3PO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A
M9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG
M+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-3<E.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/D)A<VEC(&%N9"!D:6QU=&5D(&YE="!L
M;W-S('!E<B!S:&%R92!A;&QO8V%B;&4@=&\@8V]M;6]N('-T;V-K:&]L9&5R
M<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3L^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W
M:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C@E
M.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR
M:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^*#`N,3$\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T
M>6QE/3-$=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^*3PO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W
M:61T:#HQ)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN
M;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T9&1D9&1B!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^
M/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^*#`N,#D\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$=VED=&@Z,24[=VAI=&4M
M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^*3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3L^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H
M.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG
M;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^*#`N,#D\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&
M('-T>6QE/3-$=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^*3PO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T1W:61T:#HQ)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C
M93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A
M<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^*#`N,#D\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$=VED=&@Z,24[=VAI
M=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^*3PO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I
M;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O
M<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-3<E.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
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M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A
M<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[
M/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/C$X,BPX-#<\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$=VED=&@Z,24[=VAI
M=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E.SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
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M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E.SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W
M:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M
M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
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M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1'=I9'1H.C$E.SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E
M.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HX)3MW
M:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG
M:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
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M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HU-R4[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E.SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS
M1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W
M:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H
M.C$E.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A
M<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&
M1D9&1B!S='EL93TS1'=I9'1H.C$E.SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E
M.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HX)3MW
M:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E.SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@
M<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T
M>6QE/3-$=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[=VED=&@Z-3<E.R!B;W)D97(M8F]T=&]M.G-O;&ED
M(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T
M<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@8V]L<W!A;CTS1#$T('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI
M9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L
M9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^665A<B!%;F1E9"!$96-E
M;6)E<B8C,38P.S,Q+"`R,#$R/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB
M;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^
M/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HU-R4[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.G-O;&ED
M(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E
M;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P
M,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^43$\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A
M;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N
M=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B
M;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY1,CPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT
M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T
M(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS
M<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T(",P,#`P,#`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N
M.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/E$S/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R
M9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG
M:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W
M:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R
M9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL
M93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D(&-O;'-P86X],T0R('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI
M9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@
M(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^430\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED
M(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^
M#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C4W)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A
M;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^4F5V96YU97,\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C
M0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=W:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXR+#,U
M,#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1"=W:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T
M97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXR+#8X-#PO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#
M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T
M<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M
M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=W:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXR+#@W-#PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T
M>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1"=W:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P
M,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L
M:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXQ+#@P-CPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C4W)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
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M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S
M='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
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M+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXH,38L-3`U/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/BD\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&
M('-T>6QE/3-$=VED=&@Z,24[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C
M93IN;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B@Q-2PQ,3`\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$=VED
M=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^*3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3L^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&
M1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S
M='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^*#$W
M+#<Y,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN
M;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
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M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H
M.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
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M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXH,C`L-30S/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL
M93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/BD\+V9O;G0^/"]P/CPO=&0^#0H\+W1R
M/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C4W)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY.970@;&]S<R!A
M;&QO8V%B;&4@=&\@8V]M;6]N('-T;V-K:&]L9&5R<SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T1W:61T:#HQ)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US
M<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO
M=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^*#$V+#4P-3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ
M)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
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M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
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M97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXH,34L,3$P
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A
M<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/BD\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$=VED=&@Z,24[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
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M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US
M<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B@Q-RPW.3$\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$
M=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^*3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ
M)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M*#(P+#4T,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C
M93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXI
M/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HU-R4[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
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M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E.W=H
M:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
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M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXH,"XQ,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T
M:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&
M1D9&1B!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
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M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXH,"XP
M.3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R
M87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
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M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E
M.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
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M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXH,"XQ,#PO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W
M:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
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M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXH
M,"XQ,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN
M;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXI/"]F
M;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HU-R4[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
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M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,34U
M+#0S,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN
M;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S
M<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C0T9&,$9#('-T>6QE/3-$=VED=&@Z,24[/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I
M9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA
M;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,38W+#8Y-SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
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M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C@E.W=H
M:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,3<W+#@W,#PO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E
M.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^,3@P+#8X-3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T
M:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M;G0M<VEZ93HQ,'!T.R<^)FYB<W`[/"]P/CPO9&EV/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\
M+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?-V5A.#)B,CE?.3@R-E\T,#)A
M7V(Y-C!?,#(Q-69D.&)A9&4X#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O
M+T,Z+S=E83@R8C(Y7SDX,C9?-#`R85]B.38P7S`R,35F9#AB861E."]7;W)K
M<VAE971S+U-H965T,C0N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN
M9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[
M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@
M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E
M>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J
M879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES
M($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT
M86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5!1#X-"B`@("`@(#QT<CX-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS
M1#(^/'-T<F]N9SY3=6)S97%U96YT($5V96YT<SQB<CX\+W-T<F]N9SX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT
M:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4W5B<V5Q=65N="!%=F5N=',\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\9&EV/@T*/'`@<W1Y;&4]
M,T1M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HQ,2XS,R4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.BTQ,2XS,R4[
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M;VTZ,'!T.VUA<F=I;BUT;W`Z-G!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HT+C4T)3MF;VYT+7=E:6=H=#IB;VQD.SMF
M;VYT+7-I>F4Z,3!P=#L[/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#MT97AT+6EN9&5N=#HT+C4T)2<^26X@36%R8V@L
M(#(P,30@=V4@86YN;W5N8V5D(&$@)#4N-#PO9F]N=#X\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SX@;6EL;&EO;B!M
M:6QE<W1O;F4@<&%Y;65N="!A;F0@86UE;F1M96YT(&]F(&]U<B!!<W1R85IE
M;F5C82!A9W)E96UE;G0@=&\@=')A;G-F97(@<F5S<&]N<VEB:6QI='D@9F]R
M(&%L;"!C;&EN:6-A;"!D979E;&]P;65N="!T;R!!<W1R85IE;F5C82!F;VQL
M;W=I;F<@8V]N8VQU<VEO;B!O9B!T:&4@;VYG;VEN9R!0:&%S92`Q(&-L:6YI
M8V%L('1R:6%L(&]F($%:1"`Q-#$Y+B`\+V9O;G0^/"]P/CPO9&EV/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\
M+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?-V5A.#)B,CE?
M.3@R-E\T,#)A7V(Y-C!?,#(Q-69D.&)A9&4X#0I#;VYT96YT+4QO8V%T:6]N
M.B!F:6QE.B\O+T,Z+S=E83@R8C(Y7SDX,C9?-#`R85]B.38P7S`R,35F9#AB
M861E."]7;W)K<VAE971S+U-H965T,C4N:'1M;`T*0V]N=&5N="U4<F%N<V9E
M<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T
M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE
M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT
M96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E
M/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E
M;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y
M/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5634%#/@T*
M("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$
M,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E-U;6UA<GD@;V8@4VEG;FEF:6-A;G0@
M06-C;W5N=&EN9R!0;VQI8VEE<R`H4&]L:6-I97,I/&)R/CPO<W1R;VYG/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R($UO
M;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y"87-I<R!O9B!0<F5S96YT871I
M;VX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\9&EV/@T*/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HV<'0[;6%R
M9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C`E.V9O
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M9&%T960@9FEN86YC:6%L('-T871E;65N=',N(#PO9F]N=#X\+W`^/"]D:78^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y,:7%U:61I='D@86YD($9I;F%N8VEA;"!#;VYD:71I;VX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\9&EV/@T*/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HQ.'!T.VUA<F=I;BUL969T.C`E
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M9"!&:6YA;F-I86P@0V]N9&ET:6]N(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HV<'0[;6%R9VEN+6QE9G0Z
M,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C0N-30E.V9O;G0M<VEZ
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M,38P.S,Q+"`R,#$S+"!W92!H860@8V%S:"P@8V%S:"!E<75I=F%L96YT<R!A
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M=&5D(&-A<V@@;F5E9',@=&AR;W5G:"!A="!L96%S="!T:&4@;F5X="`Q,B!M
M;VYT:',@8F%S960@;VX@8V%S:"P@8V%S:"!E<75I=F%L96YT<R!A;F0@;6%R
M:V5T86)L92!S96-U<FET:65S(&]N(&AA;F0@87,@;V8@1&5C96UB97(F(S$V
M,#LS,2P@,C`Q,R!A;F0@86YT:6-I<&%T960@<F5V96YU97,@86YD(&9U;F1I
M;F<@9G)O;2!E>&ES=&EN9R!A9W)E96UE;G1S+CPO9F]N=#X\+W`^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HQ,G!T.VUA<F=I
M;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HT+C4T)3MF
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M=&EV97,N/"]F;VYT/CPO<#X\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E5S92!O9B!%<W1I;6%T97,\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\9&EV/@T*/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HQ.'!T.VUA<F=I;BUL
M969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP)3MF;VYT+7-I
M>F4Z,3!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^57-E(&]F
M($5S=&EM871E<R`\+V9O;G0^/"]P/CQP('-T>6QE/3-$;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HV<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C0N-30E.V9O;G0M<VEZ93HQ,'!T.SL^/&9O
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M(&%C8V5P=&5D(&%C8V]U;G1I;F<@<')I;F-I<&QE<R`H)B,X,C(P.U4N4RX@
M1T%!4"8C.#(R,3LI(')E<75I<F5S(&UA;F%G96UE;G0@=&\@;6%K92!I;F9O
M<FUE9"`\+V9O;G0^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.C$P<'0[9F]N
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M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1F]R96EG;B!#
M=7)R96YC>2!4<F%N<VQA=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQD:78^#0H\<"!S='EL93TS1&UA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,3AP=#MM87)G:6XM;&5F=#HP)3MM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,"4[9F]N="UW96EG:'0Z8F]L9#L[9F]N="US:7IE.C$P
M<'0[.SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^1F]R96EG;B!#=7)R96YC>2!4<F%N<VQA=&EO;CPO9F]N=#X\+W`^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HV<'0[
M;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C0N
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M9"!O=&AE<B!C;VUP<F5H96YS:79E(&EN8V]M92`H;&]S<RD@:6X@=&AE(&5Q
M=6ET>2X@1F]R('1H92!Y96%R<R!E;F1E9"!$96-E;6)E<B8C,38P.S,Q+"`R
M,#$S+"`R,#$R(&%N9"`R,#$Q+"!W92!R97!O<G1E9"!A;B!U;G)E86QI>F5D
M(&=A:6X@;V8@)#`N-2!M:6QL:6]N+"!A;B!U;G)E86QI>F5D(&=A:6X@;V8@
M)#`N-"!M:6QL:6]N(&%N9"!A;B!U;G)E86QI>F5D(&QO<W,@;V8@)#`N,R!M
M:6QL:6]N+"!R97-P96-T:79E;'DN(%)E86QI>F5D(&=A:6YS(&%N9"!L;W-S
M97,@<F5S=6QT:6YG(&9R;VT@8W5R<F5N8WD@=')A;G-A8W1I;VYS(&%R92!I
M;F-L=61E9"!I;B!T:&4@8V]N<V]L:61A=&5D('-T871E;65N=',@;V8@;W!E
M<F%T:6]N<RX@1F]R('1H92!Y96%R<R!E;F1E9"!$96-E;6)E<B8C,38P.S,Q
M+"`R,#$S+"`R,#$R(&%N9"`R,#$Q+"!W92!R97!O<G1E9"!A(&QO<W,@;V8@
M)#`N,B!M:6QL:6]N+"!A(&QO<W,@;V8@)#`N,B!M:6QL:6]N(&%N9"!A(&=A
M:6X@;V8@)#`N,B!M:6QL:6]N+"!R97-P96-T:79E;'DL(')E<W5L=&EN9R!F
M<F]M(&-U<G)E;F-Y('1R86YS86-T:6]N<R!I;B!O=7(@8V]N<V]L:61A=&5D
M('-T871E;65N=',@;V8@;W!E<F%T:6]N<RX@/"]F;VYT/CPO<#X\+V1I=CX\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D-A<V@L($-A<V@@17%U:79A;&5N=',L(&%N9"!-87)K971A8FQE(%-E8W5R
M:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\9&EV/@T*
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HQ.'!T
M.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
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M<FET:65S(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HV<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C0N-30E.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M
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M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C0N-30E.V9O;G0M<VEZ93HQ,'!T
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M<G,Z(#PO9F]N=#X\+W`^/&1I=B!A;&EG;CTS1&QE9G0^/'1A8FQE(&)O<F1E
M<CTS1#`@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S='EL93TS
M1"=B;W)D97(M8V]L;&%P<V4Z8V]L;&%P<V4[('=I9'1H.CDT+C(W)3MM87)G
M:6XM;&5F=#HU+C<S)3MM87)G:6XM<FEG:'0Z,"4G/CQT<CX\=&0@=F%L:6=N
M/3-$=&]P('-T>6QE/3-$=VED=&@Z,RXS,R4[=VAI=&4M<W!A8V4Z;F]W<F%P
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z-G!T
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG
M/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ)U-Y;6)O;"<[9F]N="US:7IE
M.C$P<'0[/B8C,3@S.SPO9F]N=#X\+W`^/"]T9#X\=&0@=F%L:6=N/3-$=&]P
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M9&5R/3-$,"!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('-T>6QE
M/3-$)V)O<F1E<BUC;VQL87!S93IC;VQL87!S93L@=VED=&@Z.30N,C<E.VUA
M<F=I;BUL969T.C4N-S,E.VUA<F=I;BUR:6=H=#HP)2<^/'1R/CQT9"!V86QI
M9VX],T1T;W`@<W1Y;&4],T1W:61T:#HS+C,S)3MW:&ET92US<&%C93IN;W=R
M87`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HV
M<'0[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.R<^/&9O;G0@<W1Y;&4],T1F;VYT+69A;6EL>3HG4WEM8F]L)SMF;VYT+7-I
M>F4Z,3!P=#L^)B,Q.#,[/"]F;VYT/CPO<#X\+W1D/CQT9"!V86QI9VX],T1T
M;W`@<W1Y;&4],T1W:61T:#HY-BXV-R4[/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z-G!T.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/G1H92!D=7)A=&EO;B!T;R!M
M871U<FET>2!O9B!O=7(@:6YV97-T;65N=',[(#PO9F]N=#X\+W`^/"]T9#X\
M+W1R/CPO=&%B;&4^/"]D:78^/&1I=B!A;&EG;CTS1&QE9G0^/'1A8FQE(&)O
M<F1E<CTS1#`@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S='EL
M93TS1"=B;W)D97(M8V]L;&%P<V4Z8V]L;&%P<V4[('=I9'1H.CDT+C(W)3MM
M87)G:6XM;&5F=#HU+C<S)3MM87)G:6XM<FEG:'0Z,"4G/CQT<CX\=&0@=F%L
M:6=N/3-$=&]P('-T>6QE/3-$=VED=&@Z,RXS,R4[=VAI=&4M<W!A8V4Z;F]W
M<F%P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M-G!T.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CLG/CQF;VYT('-T>6QE/3-$9F]N="UF86UI;'DZ)U-Y;6)O;"<[9F]N="US
M:7IE.C$P<'0[/B8C,3@S.SPO9F]N=#X\+W`^/"]T9#X\=&0@=F%L:6=N/3-$
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M;&5F=#X\=&%B;&4@8F]R9&5R/3-$,"!C96QL<W!A8VEN9STS1#`@8V5L;'!A
M9&1I;F<],T0P('-T>6QE/3-$)V)O<F1E<BUC;VQL87!S93IC;VQL87!S93L@
M=VED=&@Z.30N,C<E.VUA<F=I;BUL969T.C4N-S,E.VUA<F=I;BUR:6=H=#HP
M)2<^/'1R/CQT9"!V86QI9VX],T1T;W`@<W1Y;&4],T1W:61T:#HS+C,S)3MW
M:&ET92US<&%C93IN;W=R87`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HV<'0[9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.R<^/&9O;G0@<W1Y;&4],T1F;VYT+69A;6EL>3HG
M4WEM8F]L)SMF;VYT+7-I>F4Z,3!P=#L^)B,Q.#,[/"]F;VYT/CPO<#X\+W1D
M/CQT9"!V86QI9VX],T1T;W`@<W1Y;&4],T1W:61T:#HY-BXV-R4[/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z-G!T.V9O;G0M
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M+71E<FT@<')O<W!E8W1S(&]F('1H92!I<W-U97([(&%N9"`\+V9O;G0^/"]P
M/CPO=&0^/"]T<CX\+W1A8FQE/CPO9&EV/CQD:78@86QI9VX],T1L969T/CQT
M86)L92!B;W)D97(],T0P(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS
M1#`@<W1Y;&4],T0G8F]R9&5R+6-O;&QA<'-E.F-O;&QA<'-E.R!W:61T:#HY
M-"XR-R4[;6%R9VEN+6QE9G0Z-2XW,R4[;6%R9VEN+7)I9VAT.C`E)SX\='(^
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M;&EG;CTS1'1O<"!S='EL93TS1'=I9'1H.CDV+C8W)3L^/'`@<W1Y;&4],T0G
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M:6XM=&]P.C$R<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E
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M.B!N;W)M86P[)SXN(#PO9F]N=#X\+W`^/"]D:78^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VYC96YT<F%T:6]N
M(&]F($-R961I="!2:7-K(&%N9"!/=&AE<B!2:7-K<R!A;F0@56YC97)T86EN
M=&EE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQD:78^#0H\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C$X<'0[
M;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C`E
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M<R!A;F0@56YC97)T86EN=&EE<R`\+V9O;G0^/"]P/CQP('-T>6QE/3-$;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HV<'0[;6%R9VEN+6QE9G0Z,"4[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C0N-30E.V9O;G0M<VEZ93HQ
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M9"`Y-"4@;V8@;W5R(')E=F5N=65S('=E<F4@96%R;F5D(&EN('1H92!5;FET
M960@4W1A=&5S+"!R97-P96-T:79E;'DL(&%N9"!T:&4@<F5M86EN:6YG(')E
M=F5N=65S('=E<F4@96%R;F5D(&EN($=E<FUA;GDN($%S(&]F($1E8V5M8F5R
M)B,Q-C`[,S$L(#(P,3,@86YD(#(P,3(L(#DE(&%N9"`Q,"4L(')E<W!E8W1I
M=F5L>2P@;V8@;W5R(&QO;F<M;&EV960@87-S971S('=E<F4@;&]C871E9"!I
M;B!T:&4@56YI=&5D(%-T871E<R!A;F0@=&AE(')E;6%I;FEN9R!L;VYG+6QI
M=F5D(&%S<V5T<R!W97)E(&QO8V%T960@:6X@1V5R;6%N>2X@/"]F;VYT/CPO
M<#X\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C$R
M<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
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M+W`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HQ
M,G!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
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M<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
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M;VX@;W5R(&)U<VEN97-S+B`\+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,3)P=#MM87)G:6XM;&5F=#HP)3MM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z-"XU-"4[9F]N="US:7IE.C$P
M<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.W1E>'0M:6YD96YT
M.C0N-30E)SY792!H879E(')E;&EE9"!O;B!A(&QI;6ET960@;G5M8F5R(&]F
M('-U<'!L:65R<R!T;R!P<F]D=6-E(&]L:6=O;G5C;&5O=&ED97,@/"]F;VYT
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/F9O<B!C;&EN:6-A;"!T<FEA;',@86YD(&$@<VEN9VQE(&-O;G1R86-T
M(&UA;G5F86-T=7)E<B!T;R!P<F]D=6-E(&]U<B!F:7)S="!G96YE<F%T:6]N
M(%1,4B`Y(&%G;VYI<W0L(#$P,3@@9F]R($A%4$Q)4T%6+4(N(%1H92!L;W-S
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M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C0N-30E.V9O;G0M<VEZ93HQ,'!T.V9O
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M9FEN86YC:6YG+CPO9F]N=#X\+W`^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y,;VYG+4QI=F5D($%S<V5T
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQD:78^#0H\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C$X<'0[;6%R
M9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C`E.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[9F]N="US:7IE.C$P<'0[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY,
M;VYG+4QI=F5D($%S<V5T<R`\+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z-G!T.VUA<F=I;BUL969T.C`E.VUA
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M.C`E.W1E>'0M:6YD96YT.C0N-30E.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M
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M960@9'5R:6YG('1H92!Y96%R<R!P<F5S96YT960N(#PO9F]N=#X\+W`^/"]D
M:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y';V]D=VEL;#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQD:78^#0H\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C$X<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[9F]N
M="US:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SY';V]D=VEL;#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HV<'0[;6%R9VEN+6QE9G0Z,"4[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C0N-30E.V9O;G0M<VEZ93HQ
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M07!R:6P@,C`P-B!A8W%U:7-I=&EO;B!O9B!2:&5I;CPO9F]N=#X\9F]N="!S
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M9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^4F5V96YU92!296-O9VYI=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQD:78^#0H\<"!S='EL93TS1&UA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,3AP=#MM87)G:6XM;&5F=#HP)3MM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,"4[9F]N="UW96EG:'0Z8F]L9#L[9F]N="US
M:7IE.C$P<'0[.SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^4F5V96YU92!296-O9VYI=&EO;B`\+V9O;G0^/"]P/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z-G!T.VUA
M<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HT+C4T
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M(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HQ,G!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HT+C4T)3MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z,3!P
M=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[=&5X="UI;F1E;G0Z-"XU-"4G/D]N($IA;G5A
M<GDF(S$V,#LQ+"`R,#$Q+"!W92!A9&]P=&5D(&]N(&$@<')O<W!E8W1I=F4@
M8F%S:7,@1FEN86YC:6%L($%C8V]U;G1I;F<@4W1A;F1A<F1S($)O87)D("@F
M(S@R,C`[1D%30B8C.#(R,3LI($%C8V]U;G1I;F<@4W1A;F1A<F1S(%5P9&%T
M92`H)B,X,C(P.T%3528C.#(R,3LI(#(P,#DM,3,L(#PO9F]N=#X\9F]N="!S
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M9VAT.C`E.W1E>'0M:6YD96YT.C0N-30E.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
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M('!R:6]R('1O($IA;G5A<GDF(S$V,#LQ+"`R,#$Q(&%N9"!O=&AE<B!P87EM
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M<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C0N-30E.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CLG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#MT97AT+6EN9&5N=#HT+C4T)2<^0V]N=&EN9V5N="!C;VYS:61E
M<F%T:6]N(')E8V5I=F5D(&9O<B!T:&4@86-H:65V96UE;G0@;V8@82!S=6)S
M=&%N=&EV92!M:6QE<W1O;F4@:7,@<F5C;V=N:7IE9"!I;B!I=',@96YT:7)E
M='D@:6X@=&AE('!E<FEO9"!I;B!W:&EC:"!T:&4@;6EL97-T;VYE(&ES(&%C
M:&EE=F5D+B!!(&UI;&5S=&]N92!I<R!D969I;F5D(&%S(&%N(&5V96YT(&AA
M=FEN9R!A;&P@;V8@=&AE(&9O;&QO=VEN9R!C:&%R86-T97)I<W1I8W,Z("AI
M/"]F;VYT/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/BDF(S$V,#MT:&5R92!I<R!S=6)S=&%N=&EV92!U;F-E<G1A
M:6YT>2!A="!T:&4@9&%T92!T:&4@87)R86YG96UE;G0@:7,@96YT97)E9"!I
M;G1O('1H870@=&AE(&5V96YT('=I;&P@8F4@86-H:65V960L("AI:2DF(S$V
M,#MT:&4@979E;G0@8V%N(&]N;'D@8F4@86-H:65V960@8F%S960@:6X@=VAO
M;&4@;W(@:6X@<&%R="!O;B!E:71H97(@=&AE(&5N=&ET>28C.#(Q-SMS('!E
M<F9O<FUA;F-E(&]R(&$@<W!E8VEF:6,@;W5T8V]M92!R97-U;'1I;F<@9G)O
M;2!T:&4@96YT:71Y)B,X,C$W.W,@<&5R9F]R;6%N8V4@86YD("AI:6DI)B,Q
M-C`[:68@86-H:65V960L('1H92!E=F5N="!W;W5L9"!R97-U;'0@:6X@861D
M:71I;VYA;"!P87EM96YT<R!B96EN9R!D=64@=&\@=&AE(&5N=&ET>2X@/"]F
M;VYT/CPO<#X\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C$R<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
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M.B`H:3PO9F]N=#X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z,3!P=#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXI)B,Q-C`[=&AE(&1E=F5L;W!M96YT('=O<FL@:7,@
M8V]N=&EN9V5N="!O;B!E:71H97(@;V8@=&AE(&9O;&QO=VEN9SH@*&$I)B,Q
M-C`[=&AE('9E;F1O<B8C.#(Q-SMS('!E<F9O<FUA;F-E('1O(&%C:&EE=F4@
M=&AE(&UI;&5S=&]N92!O<B`H8BDF(S$V,#MT:&4@96YH86YC96UE;G0@;V8@
M=&AE('9A;'5E(&]F('1H92!D96QI=F5R86)L92!I=&5M(&]R(&ET96US(&%S
M(&$@<F5S=6QT(&]F(&$@<W!E8VEF:6,@;W5T8V]M92!R97-U;'1I;F<@9G)O
M;2!T:&4@=F5N9&]R)B,X,C$W.W,@<&5R9F]R;6%N8V4@=&\@86-H:65V92!T
M:&4@;6EL97-T;VYE.R`H:6DI)B,Q-C`[:70@<F5L871E<R!S;VQE;'D@=&\@
M<&%S="!P97)F;W)M86YC92!A;F0@*&EI:2DF(S$V,#MI="!I<R!R96%S;VYA
M8FQE(')E;&%T:79E('1O(&%L;"!T:&4@9&5L:79E<F%B;&4@86YD('!A>6UE
M;G0@=&5R;7,@=VET:&EN('1H92!A<G)A;F=E;65N="X@07,@82!R97-U;'0@
M;V8@;W5R(&%N86QY<VES+"!W92!C;VYS:61E<B!O=7(@9&5V96QO<&UE;G0@
M;6EL97-T;VYE<R!T;R!B92!S=6)S=&%N=&EV92!A;F0L(&%C8V]R9&EN9VQY
M+"!W92!E>'!E8W0@=&\@<F5C;V=N:7IE(&%S(')E=F5N=64@9G5T=7)E('!A
M>6UE;G1S(')E8V5I=F5D(&9R;VT@<W5C:"!M:6QE<W1O;F5S(&%S('=E(&%C
M:&EE=F4@96%C:"!M:6QE<W1O;F4N(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HQ,G!T.VUA<F=I;BUL969T
M.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HT+C4T)3MF;VYT+7-I
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M<R!H87,@8F5E;B!N;VYR969U;F1A8FQE+B`\+V9O;G0^/"]P/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,3)P=#MM87)G:6XM
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M<FEA(&AA=F4@8F5E;B!S871I<V9I960N(#PO9F]N=#X\+W`^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HQ,G!T.VUA<F=I;BUL
M969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HT+C4T)3MF;VYT
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M92!B>2!T:&4@8W5S=&]M97(N(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HQ,G!T.VUA<F=I;BUL969T.C`E
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M(&-O;&QE8W1I;VX@:7,@<F5A<V]N86)L>2!A<W-U<F5D+B`\+V9O;G0^/"]P
M/CQP('-T>6QE/3-$;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HQ,G!T
M.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HT
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M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)E<V5A<F-H
M(&%N9"!$979E;&]P;65N="!%>'!E;G-E<R!A;F0@06-C<G5A;',\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\9&EV/@T*/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HQ.'!T.VUA<F=I;BUL969T
M.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP)3MF;VYT+7-I>F4Z
M,3!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7=E:6=H=#IB;VQD.V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^4F5S96%R8V@@
M86YD($1E=F5L;W!M96YT($5X<&5N<V5S(&%N9"!!8V-R=6%L<R`\+V9O;G0^
M/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M-G!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HT+C4T)3MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z,3!P=#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[=&5X="UI;F1E;G0Z-"XU-"4G/E)E<V5A<F-H(&%N9"!D979E
M;&]P;65N="!E>'!E;G-E<R!I;F-L=61E('!E<G-O;FYE;"!A;F0@9F%C:6QI
M='DM<F5L871E9"!E>'!E;G-E<RP@;W5T<VED92!C;VYT<F%C=&5D('-E<G9I
M8V5S(&EN8VQU9&EN9R!C;&EN:6-A;"!T<FEA;"!C;W-T<RP@;6%N=69A8W1U
M<FEN9R!A;F0@<')O8V5S<R!D979E;&]P;65N="!C;W-T<RP@<F5S96%R8V@@
M8V]S=',@86YD(&]T:&5R(&-O;G-U;'1I;F<@<V5R=FEC97,@86YD(&YO;BUC
M87-H('-T;V-K+6)A<V5D(&-O;7!E;G-A=&EO;BX@4F5S96%R8V@@86YD(&1E
M=F5L;W!M96YT(&-O<W1S(&%R92!E>'!E;G-E9"!A<R!I;F-U<G)E9"X@06UO
M=6YT<R!D=64@=6YD97(@<W5C:"!A<G)A;F=E;65N=',@;6%Y(&)E(&5I=&AE
M<B!F:7AE9"!F964@;W(@9F5E(&9O<B!S97)V:6-E+"!A;F0@;6%Y(&EN8VQU
M9&4@=7!F<F]N="!P87EM96YT<RP@;6]N=&AL>2!P87EM96YT<R!A;F0@<&%Y
M;65N=',@=7!O;B!T:&4@8V]M<&QE=&EO;B!O9B!M:6QE<W1O;F5S(&]R(')E
M8V5I<'0@;V8@9&5L:79E<F%B;&5S+B!.;VXM<F5F=6YD86)L92!A9'9A;F-E
M('!A>6UE;G1S('5N9&5R(&%G<F5E;65N=',@87)E(&-A<&ET86QI>F5D(&%N
M9"!E>'!E;G-E9"!A<R!T:&4@<F5L871E9"!G;V]D<R!A<F4@9&5L:79E<F5D
M(&]R('-E<G9I8V5S(&%R92!P97)F;W)M960N(#PO9F]N=#X\+W`^/'`@<W1Y
M;&4],T1M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C$R<'0[;6%R9VEN
M+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C0N-30E.V9O
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M(#,Q+"`R,#$S+CPO9F]N=#X\+W`^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3=&]C:RU"87-E9"!#;VUP
M96YS871I;VX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\9&EV
M/@T*/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HQ
M.'!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP)3MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^4W1O8VLM0F%S960@0V]M<&5N<V%T:6]N(#PO9F]N=#X\+W`^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HV<'0[;6%R
M9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C0N-30E
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M>2!I;7!A8W0@;W5R(&]P97)A=&EN9R!R97-U;'1S+B`\+V9O;G0^/"]P/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,3)P=#MM
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M;BP@87,@=V5L;"!A<R!I;B!T:&4@9F]L;&]W:6YG('%U87)T97)S+B`\+V9O
M;G0^/"]P/CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^26YC;VUE(%1A>&5S/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/&1I=CX-"CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,3AP=#MM87)G:6XM;&5F=#HP)3MM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,"4[9F]N="US:7IE.C$P<'0[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW
M96EG:'0Z8F]L9#MF;VYT+7-I>F4Z,3!P=#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/DEN8V]M92!487AE<R`\+V9O;G0^
M/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M-G!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
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M<W-E=',@870@1&5C96UB97(F(S$V,#LS,2P@,C`Q,R!A;F0@,C`Q,B!B96-A
M=7-E('=E(&)E;&EE=F4@:70@:7,@;6]R92!L:6ME;'D@=&AA;B!N;W0@=&AA
M="!O=7(@9&5F97)R960@=&%X(&%S<V5T<R!W:6QL(&YO="!B92!R96%L:7IE
M9"!A<R!O9B!$96-E;6)E<B8C,38P.S,Q+"`R,#$S+"!A;F0@,C`Q,BX@/"]F
M;VYT/CPO<#X\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C$R<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
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M;6)E<B8C,38P.S,Q+"`R,#$S+"!I;F-L=61I;F<@;F\@86-C<G5E9"!A;6]U
M;G1S(&9O<B!I;G1E<F5S="!A;F0@<&5N86QT:65S+B!792!D;R!N;W0@86YT
M:6-I<&%T92!T:&%T('1O=&%L('5N<F5C;V=N:7IE9"!T87@@8F5N969I=',@
M=VEL;"!S:6=N:69I8V%N=&QY(&-H86YG92!P<FEO<B!T;R!$96-E;6)E<B8C
M,38P.S,Q+"`R,#$T+B!/=7(@<&]L:6-Y('=I;&P@8F4@=&\@<F5C;V=N:7IE
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M="!T;R!T87@@97AA;6EN871I;VX@:6X@1V5R;6%N>2!F<F]M(#(P,3`@9F]R
M=V%R9"X\+V9O;G0^/"]P/CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4F5C96YT($%C8V]U;G1I;F<@4')O
M;F]U;F-E;65N=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M9&EV/@T*/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HQ.'!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
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M;F1A<F1S(%5P9&%T92`R,#$S+3`R(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HV<'0[;6%R9VEN+6QE9G0Z
M,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C0N-30E.V9O;G0M<VEZ
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M($1E8V5M8F5R)B,Q-C`[,34L(#(P,3(N(%1H92!#;VUP86YY(&%D;W!T960@
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M92!Y96%R(&5N9&5D($1E8V5M8F5R(#,Q+"`R,#$S+CPO9F]N=#X\+W`^/"]D
M:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B
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M/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4
M>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R
M:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$
M;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-
M"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P
M14%$/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS
M<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D9A:7(@5F%L=64@365A<W5R
M96UE;G1S("A486)L97,I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R($UO;G1H<R!%;F1E9#PO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y$96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y&86ER(%9A;'5E($AI97)A<F-H>2!&;W(@1FEN86YC:6%L
M($%S<V5T<R!!;F0@3&EA8FEL:71I97,@365A<W5R960@070@1F%I<B!686QU
M92!/;B!296-U<G)I;F<@0F%S:7,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\9&EV/@T*/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HV<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E
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M,38P.S,Q+"`R,#$S(&%N9"`R,#$R("AI;B!T:&]U<V%N9',I.B`\+V9O;G0^
M/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
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M/3-$,"!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P(&%L:6=N/3-$
M8V5N=&5R('-T>6QE/3-$)V)O<F1E<BUC;VQL87!S93IC;VQL87!S93L@=VED
M=&@Z,3`P)3LG/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HU-"4[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+W`^/"]T9#X-
M"CQT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HY)3L@8F]R
M9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$
M)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^3&5V96P@,3PO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R
M86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HR)3L@8F]R9&5R
M+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS
M1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HY
M)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T
M>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z
M8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^3&5V96P@,CPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HR)3L@
M8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S
M='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT
M.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW
M:61T:#HX)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG
M/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW
M96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^3&5V96PF
M(S$V,#LS/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP
M('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T
M.W=I9'1H.C(E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A
M<F5N=#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D(&-O;'-P86X],T0R('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O
M='1O;3HP('!T.W=I9'1H.CDE.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P
M="`C,#`P,#`P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SY4;W1A;#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUB
M;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HU-"4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,3(N,C5P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.BTQ,BXR-7!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY$
M96-E;6)E<B8C,38P.S,Q+"`R,#$S/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z-R4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A
M;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HR)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP
M861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED
M(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-R4[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T
M:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HR)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P
M,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-B4[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW
M:61T:#HR)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H
M.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C
M0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG
M:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M
M.C`@<'0[=VED=&@Z-R4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P
M,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^
M#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M
M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP
M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-30E.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,3(N,C5P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.BTQ
M,BXR-7!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/DUO;F5Y(&UA<FME="!F=6YD<SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HW)3MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I
M9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HR)3LG/CQP('-T>6QE/3-$)W1E>'0M
M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HW)3MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXM
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P
M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z,B4[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW
M-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[
M=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW
M-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[
M=VED=&@Z-B4[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X
M="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^+3PO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C(E.R<^/'`@<W1Y;&4],T0G
M=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C<E.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/C(P+#`Q,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P
M=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z-30E.R!B;W)D97(M8F]T=&]M.G-O
M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C$R+C(U<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HM,3(N,C5P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
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M=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T
M(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HW)3L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXM/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R
M+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,B4[(&)O<F1E<BUB
M;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G
M=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I
M9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
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M0F]T=&]M.C`@<'0[=VED=&@Z-R4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,38W+#4Y-SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)W1E>'0M
M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ
M)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C8E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C
M,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M
M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
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M+51O<#HP+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MW:61T:#HR)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M
M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP
M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUB
M;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T
M:#HW)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXQ-C<L-3DW/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP
M('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T
M.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-30E.R!B;W)D97(M=&]P.G-O
M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C$R+C(U<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HM,3(N,C5P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SY4;W1A;#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P
M,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T
M:#HW)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS
M<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z,B4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I
M9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C<E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C$V
M-RPU.3<\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P
M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S
M<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP
M861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z
M,B4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@
M<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C8E.R!B;W)D97(M=&]P.G-O
M;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
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M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,B4[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA
M;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP
M861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED
M(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C<E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P
M,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI
M9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/C$X-RPV,3`\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A
M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R
M/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C4T)3LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C$R+C(U<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HM
M,3(N,C5P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HW)3MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HR)3LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ
M<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN
M9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP
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M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T
M:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C(E.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP
M('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
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M=&]M.C`@<'0[=VED=&@Z-B4[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D
M:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,B4[
M)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S
M<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP
M861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z
M,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW
M:61T:#HW)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP
M861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C4T)3L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HQ,BXR-7!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z+3$R+C(U<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D(&-O;'-P
M86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.CDE.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG
M;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SY,979E;"`Q/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP
M861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T
M:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
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M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)W1E>'0M86QI
M9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.CDE.R!B;W)D97(M
M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4],T0G=&5X
M="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SY,979E;"`R/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
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M=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)W1E
M>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C@E.R!B
M;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD
M.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY,979E;"8C,38P.S,\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A
M9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG
M+51O<#HP+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,B4[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@
M<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H
M=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW
M-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[
M=VED=&@Z.24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[
M)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/E1O=&%L
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R
M/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C4T)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E
M;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HQ,BXR-7!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z+3$R+C(U<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT
M.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/D1E8V5M8F5R)B,Q
M-C`[,S$L(#(P,3(\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP
M('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T
M.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HW)3L@8F]R
M9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I
M9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D
M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG
M+4)O='1O;3HP('!T.W=I9'1H.C(E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M
M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T
M=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P
M,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HW)3L@8F]R9&5R+71O<#IS;VQI
M9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C(E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N
M=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HV)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P
M,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L
M:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M.C`@<'0[=VED=&@Z,B4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS
M<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P
M=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D
M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG
M+4)O='1O;3HP('!T.W=I9'1H.C<E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F
M=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U
M('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^
M#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C4T)3LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C$R+C(U<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HM,3(N,C5P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P
M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z-R4[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA
M;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^,RPQ-#`\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A
M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HR)3LG/CQP('-T>6QE/3-$
M)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HW)3MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXM/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I
M9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z,B4[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG
M:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M
M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
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M.C`@<'0[=VED=&@Z-B4[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^+3PO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C(E.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C<E.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/C,L,30P/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*
M/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I
M9'1H.C4T)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C$R+C(U<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HM,3(N,C5P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
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M861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z
M,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HW)3MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXM/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,B4[)SX\<"!S
M='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HW)3MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXQ,3DL,C,S/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z,B4[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P
M=#MW:61T:#HV)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T
M97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXM/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
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M;F<M0F]T=&]M.C`@<'0[=VED=&@Z,B4[)SX\<"!S='EL93TS1"=T97AT+6%L
M:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN
M9RU";W1T;VTZ,"!P=#MW:61T:#HW)3MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXQ,3DL,C,S
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O
M='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R
M/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C4T)3LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C$R+C(U<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HM
M,3(N,C5P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P
M=#MW:61T:#HW)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T
M97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXM/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP
M861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,B4[)SX\<"!S='EL93TS
M1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HW)3MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXU,#`\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG
M:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M
M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HR)3LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ
M<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN
M9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP
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M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/BT\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D
M:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T
M:#HR)3LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW
M:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP
M('!T.W=I9'1H.C<E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C4P,#PO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z
M-30E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C$R+C(U<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HM,3(N,C5P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY-=6YI8VEP86P@<V5C
M=7)I=&EE<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C<E.R!B;W)D
M97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
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M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HR)3L@
M8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S
M='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P
M,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HW)3L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HR)3L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T
M97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HV)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T
M97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXM/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[=VED=&@Z,B4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR
M:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D
M97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[
M=VED=&@Z-R4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR
M:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^-S$U/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP
M('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T
M.W=I9'1H.C4T)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E
M;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,3(N,C5P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.BTQ,BXR-7!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/E1O=&%L/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M
M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L
M92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C<E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P
M,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/C,L,30P/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R
M9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T
M;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M('!T.W=I9'1H.C(E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A
M<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[
M)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S
M<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP
M861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z
M,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB
M;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
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M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-R4[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P
M,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA
M;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^,3(P+#0T.#PO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT
M.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HR)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T
M('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P
M,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C8E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O
M=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
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M+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E
M;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,B4[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L
M92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ
M<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN
M9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P
M,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HW
M)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O
M='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXQ,C,L
M-3@X/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N
M-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*
M/"]T86)L93X\+V1I=CX\<"!S='EL93TS1&UA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP)3MF;VYT+7-I>F4Z,3)P=#L[/B9N8G-P.SPO<#X\+V1I
M=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L
M93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S=E
M83@R8C(Y7SDX,C9?-#`R85]B.38P7S`R,35F9#AB861E.`T*0V]N=&5N="U,
M;V-A=&EO;CH@9FEL93HO+R]#.B\W96$X,F(R.5\Y.#(V7S0P,F%?8CDV,%\P
M,C$U9F0X8F%D93@O5V]R:W-H965T<R]3:&5E=#(W+FAT;6P-"D-O;G1E;G0M
M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M
M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^
M#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y
M<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I
M<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O
M($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*
M("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%
M4$4^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P
M86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^0V%S:"P@0V%S:"!%<75I=F%L
M96YT<R!A;F0@36%R:V5T86)L92!396-U<FET:65S("A486)L97,I/&)R/CPO
M<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X]
M,T0Q/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$S/&)R
M/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3=6UM87)Y(&]F
M($-A<V@L($-A<V@@17%U:79A;&5N=',@86YD($UA<FME=&%B;&4@4V5C=7)I
M=&EE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQD:78^#0H\
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M('-E8W5R:71I97,@87,@;V8@1&5C96UB97(F(S$V,#LS,2P@,C`Q,RP@86YD
M(#(P,3(@*&EN('1H;W5S86YD<RDZ(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C`E.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B8C,38P.SPO
M9F]N=#X\+W`^/&1I=CX-"CQT86)L92!B;W)D97(],T0P(&-E;&QS<&%C:6YG
M/3-$,"!C96QL<&%D9&EN9STS1#`@86QI9VX],T1C96YT97(@<W1Y;&4],T0G
M8F]R9&5R+6-O;&QA<'-E.F-O;&QA<'-E.R!W:61T:#HQ,#`E.R<^#0H\='(^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP
M('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T
M.W=I9'1H.C4R)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P
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M:61T:#HQ,"4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[
M)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/D%M;W)T:7IE9"!#;W-T/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H
M=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I
M9'1H.C(E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N
M=#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D(&-O;'-P86X]
M,T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ,"4[(&)O<F1E
M<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[)SX\<"!S='EL93TS1"=T
M97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I
M9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/E5N<F5A;&EZ
M960@1V%I;G,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,B4[(&)O<F1E
M<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S
M<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$P)3L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N
M=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^56YR96%L:7IE9"!,;W-S97,\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I
M9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N
M=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,B4[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG
M;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD
M.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)W=I9'1H.C$P)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P
M,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^17-T:6UA=&5D($9A:7(F(S$V,#M686QU93PO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z
M,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HU,B4[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,3(N,C5P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.BTQ
M,BXR-7!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SY$96-E;6)E<B8C,38P.S,Q+"`R,#$S
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI
M9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1"=W:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P
M,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T
M:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,B4[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P
M,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z
M."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C(E.R!B;W)D97(M=&]P.G-O;&ED
M(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E
M.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D97(M=&]P
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1"=W:61T:#HR)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=W:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W
M:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP
M('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T
M.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-3(E.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,3(N,C5P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.BTQ,BXR-7!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/D-A<V@@86YD(&-A<V@@97%U:79A;&5N=',Z
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C
M93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
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M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1'=I9'1H.C(E.SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1'=I9'1H.C$E
M.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1'=I9'1H.C(E.SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P
M86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1'=I9'1H.C(E.SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A
M<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T1W
M:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HU,B4[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HR-BXV-7!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z+3$R
M+C(U<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^0V%S:#PO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H
M.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG
M;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
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M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1'=I9'1H.C(E.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E.W=H:71E
M+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
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M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXM/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E.W=H
M:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HR)3L^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G
M=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^+3PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
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M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US
M<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/C$L-S8V/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I
M9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^
M#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M
M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP
M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-3(E.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,C8N-C5P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.BTQ
M,BXR-7!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/DUO;F5Y(&UA<FME="!F=6YD<SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T1W
M:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1'=I9'1H.C(E.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T1W:61T:#HX)3MW:&ET
M92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
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M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1'=I9'1H.C(E.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T1W:61T:#HX)3MW
M:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG
M:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
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M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1'=I9'1H.C(E.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T1W:61T:#HX
M)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ
M<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C(P+#`Q,SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T1W:61T:#HQ)3MW
M:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HU,B4[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,C8N-C5P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.BTQ,BXR-7!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/E4N4RX@9V]V97)N;65N="!A9V5N8WD@<V5C=7)I=&EE<SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T
M(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X
M="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,2PS-#,\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C
M0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED
M(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=W:61T:#HR)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R
M9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HX)3L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXM/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,B4[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED
M=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z."4[(&)O
M<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^+3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C(E.R!B;W)D
M97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T
M>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C
M,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I
M9'1H.C@E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG
M:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C$L,S0S/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A
M;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO
M='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I
M;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O
M<#HP+C<U('!T.W=I9'1H.C4R)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS
M<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,3(N,C5P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.BTQ,BXR-7!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/E1O=&%L
M(&-A<V@@86YD(&-A<V@@97%U:79A;&5N=',\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M
M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED
M(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C@E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/C(S+#$R,CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HR)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T
M(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@
M,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^+3PO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT
M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=W:61T:#HR)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R
M86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P
M,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW
M-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P
M,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG
M;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^+3PO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T
M=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=W:61T:#HR)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E
M;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED
M=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E
M<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^,C,L,3(R/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D
M:6YG+4)O='1O;3HP('!T.W=I9'1H.C4R)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HQ,BXR-7!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z+3$R+C(U<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
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M;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#
M('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C
M,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I
M9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HR)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P
M,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T
M:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,B4[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z
M,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T
M>6QE/3-$)W=I9'1H.C(E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$
M)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N
M=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT
M<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[=VED=&@Z-3(E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C(V+C8U<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HM,3(N,C5P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY5+E,N
M(&=O=F5R;FUE;G0@86=E;F-Y('-E8W5R:71I97,\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D
M97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S
M<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)W=I9'1H.C@E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P
M,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI
M9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C$V-BPR.#4\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H
M.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=W:61T:#HR)3L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HX
M)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXQ-CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)W=I9'1H.C(E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A
M<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S
M<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P
M,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B@T-SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXI/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HR)3L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R
M+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=W:61T:#HX)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P
M,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N
M.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXQ-C8L,C4T/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ
M)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$
M)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D
M:6YG+51O<#HP+C<U('!T.W=I9'1H.C4R)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,3(N,C5P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.BTQ,BXR-7!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
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M;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P
M="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$
M)W=I9'1H.C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B
M;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/C$V-BPR.#4\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I
M9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@
M8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,B4[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I
M9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D
M97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S
M<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D97(M=&]P.G-O
M;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P
M="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E
M>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C$V/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R
M86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$
M)W=I9'1H.C(E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N
M=#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P
M,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HX
M)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXH-#<\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/BD\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$)W=I9'1H.C(E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A
M;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
M+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1"=W:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P
M,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXQ-C8L,C4T/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E
M;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW
M:61T:#HU,B4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT
M.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C$R+C(U<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HM,3(N,C5P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M
M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T
M:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R
M+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXQ.#DL-#`W/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N
M-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C(E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O
M='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B
M;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U
M8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M,38\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A
M<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,B4[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P
M="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=W:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P
M,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N
M.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXH-#<\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O
M='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/BD\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I
M9'1H.C(E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@
M8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ
M)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O
M='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z
M."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB
M;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^,3@Y+#,W-CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P
M="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HU,B4[(&)O<F1E<BUT;W`Z9&]U8FQE(#(N-7!T('1R
M86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,3(N,C5P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.BTQ,BXR-7!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY$96-E
M;6)E<B8C,38P.S,Q+"`R,#$R/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ
M)3L@8F]R9&5R+71O<#ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HX)3L@8F]R9&5R+71O
M<#ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#ID;W5B;&4@,BXU
M<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G=VED=&@Z,B4[(&)O<F1E<BUT;W`Z9&]U8FQE(#(N-7!T('1R86YS
M<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z
M9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUT;W`Z9&]U8FQE(#(N-7!T
M(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M=VED=&@Z,24[(&)O<F1E<BUT;W`Z9&]U8FQE(#(N-7!T('1R86YS<&%R96YT
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C(E
M.R!B;W)D97(M=&]P.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#
M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.F1O=6)L92`R+C5P="`C
M,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I
M9'1H.C@E.R!B;W)D97(M=&]P.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D
M97(M=&]P.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HR)3L@8F]R9&5R+71O<#ID
M;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T
M:#HQ)3L@8F]R9&5R+71O<#ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HX)3L@8F]R9&5R
M+71O<#ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#ID;W5B;&4@
M,BXU<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP
M861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z
M-3(E.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,3(N,C5P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.BTQ,BXR-7!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/D-A<V@@86YD
M(&-A<V@@97%U:79A;&5N=',Z/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A
M<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T1W
M:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1'=I9'1H.C(E.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T1W:61T:#HX)3MW
M:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1'=I9'1H
M.C(E.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C
M93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
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M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1'=I9'1H.C(E.SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1'=I9'1H.C$E
M.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-
M"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW
M:61T:#HU,B4[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HR-BXV-7!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z+3$R+C(U<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^0V%S
M:#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R
M87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@
M<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
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M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C(E.SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
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M:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXM/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T1W:61T:#HR)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US
M<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO
M=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^+3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET
M92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$=VED=&@Z,B4[/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)W1E
M>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C$L-30R/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW
M-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[
M=VED=&@Z-3(E.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,C8N-C5P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.BTQ,BXR-7!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/DUO
M;F5Y(&UA<FME="!F=6YD<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXS+#$T,#PO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T1W:61T:#HQ
M)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$=VED=&@Z,B4[/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G
M=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^+3PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T1W:61T
M:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$=VED=&@Z,B4[/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^+3PO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T1W
M:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$=VED=&@Z,B4[/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M,RPQ-#`\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HU,B4[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HR-BXV-7!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z+3$R+C(U<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
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M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I
M9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA
M;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^-S$U/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T1W:61T:#HR)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET
M92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXM/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H
M.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HR
M)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXM/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E
M.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HR)3L^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z-3(E.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C(V+C8U
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HM,3(N,C5P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SY5+E,N(&=O=F5R;FUE;G0@86=E;F-Y('-E8W5R:71I
M97,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P
M,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/C(L,C`R/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,B4[(&)O
M<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T
M(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X
M="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^+3PO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z
M,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)W=I9'1H.C(E.R!B;W)D97(M8F]T=&]M.G-O;&ED
M(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O
M;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C@E
M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/BT\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W
M:61T:#HR)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E
M;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P
M,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HX)3L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXR+#(P,CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HU,B4[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T
M=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C$R
M+C(U<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HM,3(N,C5P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1"=W:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@
M8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXW+#4Y.3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED
M=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B
M;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HR)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED
M=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E
M<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T
M(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X
M="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^+3PO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W
M:61T:#HR)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T
M(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z."4[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^+3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.G-O
M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1"=W:61T:#HR)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R
M86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@
M,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P
M,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^-RPU.3D\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$
M)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N
M=#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A
M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-3(E.R!B;W)D97(M=&]P.G-O;&ED
M(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C$R+C(U<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HM,3(N,C5P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SY-87)K971A8FQE('-E8W5R:71I97,@879A:6QA8FQE+69O<BUS
M86QE.CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P
M,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W=I9'1H.C(E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T
M<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C
M,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D97(M=&]P
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H
M.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=W:61T:#HR)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HX)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W
M:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,B4[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z."4[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*
M/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I
M9'1H.C4R)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C$T+C1P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H
M.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG
M;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,3$V+#DX-CPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C@E.W=H:71E
M+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
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M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H
M.C(E.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A
M<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[
M/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B@Q/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P
M86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/BD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C0T9&,$9#('-T>6QE/3-$=VED=&@Z,B4[/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$
M=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I
M9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA
M;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,3$W+#`S,3PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^
M/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HU,B4[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,30N
M-'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/E4N4RX@=')E87-U<GD@<V5C=7)I=&EE<SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T
M(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X
M="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^-3`P/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T
M:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,B4[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z
M."4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^+3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)W=I9'1H.C(E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A
M<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S
M<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P
M,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/BT\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T
M<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HR)3L@8F]R9&5R
M+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R
M9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=W:61T:#HX)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P
M,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L
M:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXU,#`\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E
M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[=VED=&@Z-3(E.R!B;W)D97(M=&]P.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HQ,BXR-7!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z+3$R+C(U<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M5&]T86P@;6%R:V5T86)L92!S96-U<FET:65S(&%V86EL86)L92UF;W(M<V%L
M93PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T
M(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O
M<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^,3$W+#0X-CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED
M=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B
M;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HR)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED
M=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E
M<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T
M(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X
M="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^-#8\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A
M;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M=VED=&@Z,B4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT
M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C@E
M.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T
M=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B@Q/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXI/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=W:61T:#HR)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS
M<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T0G=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^,3$W+#4S,3PO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT
M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT
M9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED
M=&@Z-3(E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@
M8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
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M+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B
M;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U
M8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M,3(U+#`X-3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R
M86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A
M<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HR)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE
M(#(N-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P
M,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D97(M=&]P.G-O;&ED
M(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C
M,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M
M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C0V/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ
M)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E
M<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)W=I9'1H.C(E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E
M;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@
M8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[
M(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^*#$\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O
M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@
M,BXU<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/BD\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C(E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O
M;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@
M,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE
M(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,3(U
M+#$S,#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS
M<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N
M=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CPO
M=&%B;&4^/"]D:78^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,G!T.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CLG/B9N8G-P.SPO<#X\+V1I=CX\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DUA='5R:71I97,@;V8@
M36%R:V5T86)L92!396-U<FET:65S($%V86EL86)L92UF;W(M4V%L93PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQD:78^#0H\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP)3MM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z-"XU-"4[9F]N="US
M:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.C$P<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.W1E>'0M
M:6YD96YT.C0N-30E)SY4:&4@;6%T=7)I=&EE<R!O9B!O=7(@;6%R:V5T86)L
M92!S96-U<FET:65S(&%V86EL86)L92UF;W(M<V%L92!A<F4@87,@9F]L;&]W
M<R`H:6X@=&AO=7-A;F1S*2`\+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C`E.VUA
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M/"]P/CQD:78^#0H\=&%B;&4@8F]R9&5R/3-$,"!C96QL<W!A8VEN9STS1#`@
M8V5L;'!A9&1I;F<],T0P(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)V)O<F1E
M<BUC;VQL87!S93IC;VQL87!S93L@=VED=&@Z,3`P)3LG/@T*/'1R/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP
M861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T
M:#HV,B4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SXF;F)S<#L\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,R4[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$
M-B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HS,R4[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T(",P,#`P,#`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E
M;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/D1E8V5M8F5R)B,Q-C`[,S$L(#(P,3,\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M
M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP
M+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T
M<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I
M9'1H.C8R)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED
M=&@Z,R4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B
M;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,30E.R!B;W)D97(M
M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED
M(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT
M97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SY!;6]R=&EZ960@0V]S=#PO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED
M=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B
M;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT
M.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[=VED=&@Z,R4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T
M(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
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M=&]M.C`@<'0[=VED=&@Z,38E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C
M,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^
M/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E
M:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY%<W1I;6%T
M960@1F%I<B!686QU93PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C
M0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG
M:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M
M.C`@<'0[=VED=&@Z-C(E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY-871U<F4@:6X@;VYE
M('EE87(@;W(@;&5S<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HS)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP
M861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED
M(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$R)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
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M=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R
M86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,R4[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI
M9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ-"4[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^.3,L-S`Q
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O
M='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T
M<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-
M"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M=VED=&@Z-C(E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A
M<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M.C,E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ,B4[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^-S(L-3DT/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,R4[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D
M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG
M+4)O='1O;3HP('!T.W=I9'1H.C$T)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
M+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T
M<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z-C(E.R!B;W)D97(M=&]P.G-O;&ED
M(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU
M<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HS)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB
M;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@
M,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ,B4[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N
M-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,38V+#(X-3PO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L
M92`R+C5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MW:61T:#HS)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R
M86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ
M,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P
M,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P
M=#MW:61T:#HQ-"4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[
M(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^,38V+#(U-#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CPO=&%B;&4^/"]D:78^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C`E.V9O
M;G0M<VEZ93HQ,G!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/B9N
M8G-P.SPO<#X\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]
M7TYE>'1087)T7S=E83@R8C(Y7SDX,C9?-#`R85]B.38P7S`R,35F9#AB861E
M.`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\W96$X,F(R.5\Y.#(V
M7S0P,F%?8CDV,%\P,C$U9F0X8F%D93@O5V]R:W-H965T<R]3:&5E=#(X+FAT
M;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B
M;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I
M:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78]
M,T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]
M=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13
M:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I
M<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O
M<G0@:60],T1)1#!%040^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^4')O<&5R
M='D@86YD($5Q=6EP;65N="`H5&%B;&5S*3QB<CX\+W-T<F]N9SX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT:',@
M16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^0V]M<&]N96YT(&]F(%!R;W!E<G1Y(&%N
M9"!%<75I<&UE;G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M9&EV/@T*/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HV<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
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M=6EP;65N="!A<R!O9B!$96-E;6)E<B8C,38P.S,Q+"`R,#$S+"!A;F0@,C`Q
M,B!C;VYS:7-T(&]F('1H92!F;VQL;W=I;F<@*&EN('1H;W5S86YD<RDZ(#PO
M9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,G!T.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93HQ,G!T.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B8C,38P.SPO9F]N=#X\+W`^/&1I=CX-"CQT86)L92!B
M;W)D97(],T0P(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@86QI
M9VX],T1C96YT97(@<W1Y;&4],T0G8F]R9&5R+6-O;&QA<'-E.F-O;&QA<'-E
M.R!W:61T:#HQ,#`E.R<^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P
M=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C<P)3L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/B9N8G-P.SPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HX)3L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/D5S=&EM871E9"8C,38P.U5S969U;#QB
M<B`O/DQI9F4\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW
M-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T
M=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)W1E
M>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D(&-O;'-P86X],T0V('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B
M;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD
M.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY$96-E;6)E<B8C,38P.S,Q
M+#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T
M<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[=VED=&@Z-S`E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T
M<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C@E.R!B;W)D97(M
M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ
M8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^*$EN('EE87)S*3PO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED
M=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B
M;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@
M,"XW-7!T(",P,#`P,#`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E
M<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/C(P,3,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG
M:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C$E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP
M('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T
M.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B
M;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T
M>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z
M8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I
M9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D
M97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4],T0G
M=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXR,#$R/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E
M;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW
M96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HW,"4[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,3(N,C5P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.BTQ,BXR-7!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/DUA;G5F86-T=7)I;F<@97%U:7!M96YT/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^
M/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C4M,30\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M
M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T
M=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R
M86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ
M,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P
M,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXX+#DV.#PO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ
M)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A
M;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP
M('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O
M='1O;3HP('!T.W=I9'1H.C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C
M,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M
M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C<L-3<T/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E
M.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P
M=#MW:61T:#HW,"4[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HQ,BXR-7!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z+3$R+C(U<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M3&%B(&5Q=6EP;65N=#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ
M,"!P=#MW:61T:#HX)3LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXU+3$S/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C$E.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ
M)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I
M9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M
M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C<L,C(W/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP
M861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O
M='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M;F<M0F]T=&]M.C`@<'0[=VED=&@Z."4[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^-BPW-34\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D
M:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M
M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP
M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-S`E.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,3(N,C5P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.BTQ
M,BXR-7!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/D-O;7!U=&5R(&5Q=6EP;65N=#PO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HX)3LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N
M=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXS/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C$L.38R/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C
M0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG
M:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M
M.C`@<'0[=VED=&@Z."4[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,2PX,#<\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#
M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW
M-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[
M=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A
M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-S`E.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,3(N
M,C5P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.BTQ,BXR-7!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
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M<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z."4[)SX\<"!S
M='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXQ
M+#`U-CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T
M:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C$E.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C@E
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ
M<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/CDX,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T
M<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P
M=#MW:61T:#HW,"4[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HQ,BXR-7!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z+3$R+C(U<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M3&5A<V5H;VQD(&EM<')O=F5M96YT<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3LG/CQP
M('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
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M.C`@<'0[=VED=&@Z,24[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O
M='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z."4[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
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M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ
M,"!P=#MW:61T:#HQ)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
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M=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXU+#0T-3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z-S`E.R!B;W)D97(M8F]T
M=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C$R
M+C(U<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HM,3(N,C5P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M+C<U('!T.W=I9'1H.C@E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T
M<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HX)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@
M(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N
M=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP
M('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P
M,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW
M-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[
M=VED=&@Z."4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR
M:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
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M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HW,"4[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,3(N,C5P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.BTQ,BXR-7!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P
M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3L@8F]R
M9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXR
M-BPP,C,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I
M;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C@E
M.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/C(S+#8Q,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO
M='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I
M;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O
M<#HP+C<U('!T.W=I9'1H.C<P)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HQ,BXR-7!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z+3$R+C(U<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^3&5S<R!A8V-U;75L871E9"!D97!R96-I871I;VX@86YD(&%M;W)T:7IA
M=&EO;CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z."4[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUB
M;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@
M(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP
M('!T.W=I9'1H.C@E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P
M,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI
M9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
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M9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N
M=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M*3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW
M:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H
M.C@E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
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M;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^*3PO9F]N=#X\
M+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H
M.C<P)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O
M<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,3(N,C5P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.BTQ
M,BXR-7!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/E1O=&%L/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N
M-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M
M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
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M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE
M(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
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M('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z."4[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N
M-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
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M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@
M,BXU<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N
M<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[
M(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
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M-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[
M=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O
M<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
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M9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@
M8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\+W1A8FQE/CPO9&EV/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP)3MF;VYT+7-I
M>F4Z,3)P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[)SXF;F)S<#L\
M+W`^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
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M"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N
M=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX
M)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ
M<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO
M:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED
M/3-$240P14%$/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D-U<G)E;G0@06-C
M<G5E9"!,:6%B:6QI=&EE<R`H5&%B;&5S*3QB<CX\+W-T<F]N9SX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT:',@
M16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^0V]M<&]N96YT(&]F($-U<G)E;G0@06-C
M<G5E9"!,:6%B:6QI=&EE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
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M8W)U960@;&EA8FEL:71I97,@87,@;V8@1&5C96UB97(F(S$V,#LS,2P@,C`Q
M,RP@86YD(#(P,3(@8V]N<VES="!O9B!T:&4@9F]L;&]W:6YG("AI;B!T:&]U
M<V%N9',I.B`\+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H
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M#0H\=&%B;&4@8F]R9&5R/3-$,"!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I
M;F<],T0P(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)V)O<F1E<BUC;VQL87!S
M93IC;VQL87!S93L@=VED=&@Z,3`P)3LG/@T*/'1R/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HW,24[(&)O
M<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SXF
M;F)S<#L\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$-B!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G=VED=&@Z,C@E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N
M-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SY$96-E;6)E<B8C,38P.S,Q+#PO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z
M,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT
M9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED
M=&@Z-S$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@
M8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ
M,B4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB
M;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[)SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT
M.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C(P,3,\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H
M.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R
M9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)W=I9'1H.C,E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P
M,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG
M/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D(&-O;'-P86X],T0R
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ,R4[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@
M,"XW-7!T(",P,#`P,#`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E
M<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C(P,3(\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M
M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB
M;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^
M/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP
M861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D
M:6YG+4)O='1O;3HP('!T.W=I9'1H.C<Q)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HQ,BXR-7!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z+3$R+C(U<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^4&%Y<F]L;"!A;F0@<F5L871E9"!E>'!E;G-E<SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P
M,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$P
M)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXS+#8S.3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED
M=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C,E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B0\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T
M>6QE/3-$)W=I9'1H.C$Q)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P
M,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L
M:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXT+#4S.#PO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^
M#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C<Q)3LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C$R+C(U<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HM,3(N,C5P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY,96=A;"!E>'!E;G-E
M<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$=VED=&@Z,3`E.W=H:71E+7-P
M86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^,S,X/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO
M=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T1W:61T:#HS)3L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E
M.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T1W:61T:#HQ,24[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS
M1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
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M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T
M<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P
M=#MW:61T:#HW,24[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HQ,BXR-7!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z+3$R+C(U<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
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M<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ,"4[=VAI=&4M<W!A8V4Z;F]W<F%P
M.SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXR+#0P,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET
M92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C
M93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$=VED=&@Z,3$E.W=H:71E+7-P86-E
M.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
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M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT
M<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[=VED=&@Z-S$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C$R+C(U<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HM,3(N,C5P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY/=&AE
M<B!A8V-R=65D(&QI86)I;&ET:65S/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T
M:#HQ,"4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,2PW.#8\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D
M97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=W:61T:#HS)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M
M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)W=I9'1H.C$Q)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P
M,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N
M.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXQ+#DR,CPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MW:61T:#HW,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T
M<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C$R+C(U<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HM,3(N,C5P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY4
M;W1A;#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N
M-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I
M9'1H.C$P)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R
M9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXX+#$V-CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z
M,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D
M97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HS)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U
M8FQE(#(N-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG
M;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,3$E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O
M=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/C$P+#`V,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O
M=6)L92`R+C5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/"]T<CX-"CPO=&%B;&4^/"]D:78^/'`@<W1Y;&4],T1M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M)3MM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,"4[9F]N="US:7IE.CEP
M=#L[/B9N8G-P.SPO<#X\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM
M+2TM+2T]7TYE>'1087)T7S=E83@R8C(Y7SDX,C9?-#`R85]B.38P7S`R,35F
M9#AB861E.`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\W96$X,F(R
M.5\Y.#(V7S0P,F%?8CDV,%\P,C$U9F0X8F%D93@O5V]R:W-H965T<R]3:&5E
M=#,P+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP
M<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U
M<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M
M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H
M87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S
M<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO
M/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,]
M,T1R97!O<G0@:60],T1)1#!%040^#0H@("`@("`\='(^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^
M0V]M;6ET;65N=',@86YD($-O;G1I;F=E;F-I97,@*%1A8FQE<RD\8G(^/"]S
M=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS
M1#$^,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^
M/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D9U='5R92!-:6YI
M;75M(%!A>6UE;G1S(%5N9&5R($YO;BU#86YC96QA8FQE(%!O<G1I;VX@;V8@
M3W!E<F%T:6YG($QE87-E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQD:78^#0H\<"!S='EL93TS1&UA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,3)P=#MM87)G:6XM;&5F=#HP)3MM87)G:6XM<FEG:'0Z,"4[=&5X
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M($1E8V5M8F5R)B,Q-C`[,S$L(#(P,3,L(&5X8VQU9&EN9R!P87EM96YT<R!F
M<F]M('-U8FQE87-E('!A>6UE;G1S+"!A<F4@87,@9F]L;&]W<R`H:6X@=&AO
M=7-A;F1S*3H\+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP)3MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+W`^/&1I=CX-"CQT86)L92!B
M;W)D97(],T0P(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@86QI
M9VX],T1C96YT97(@<W1Y;&4],T0G8F]R9&5R+6-O;&QA<'-E.F-O;&QA<'-E
M.R!W:61T:#HQ,#`E.R<^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I
M;F<M0F]T=&]M.C`@<'0[=VED=&@Z-SDE.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SY996%R<R!E;F1I;F<@1&5C96UB97(F(S$V,#LS,2P\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T
M>6QE/3-$=VED=&@Z,R4[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P
M86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ-"4[=VAI=&4M<W!A
M8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E
M.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M
M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP
M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-SDE.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/C(P,30\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$=VED=&@Z
M,R4[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C(P+C5P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
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M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&
M1D9&1D8@<W1Y;&4],T1W:61T:#HQ-"4[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\
M<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXR+#(S,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US
M<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C<Y)3LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E
M.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ-"4[=VAI=&4M<W!A8V4Z
M;F]W<F%P.SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXR+#(X,CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ
M)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H
M.C<Y)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E.W=H
M:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ-"4[=VAI
M=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXR+#,S,SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\
M+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP
M('!T.W=I9'1H.C<Y)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
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M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I
M9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T
M:#HQ-"4[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=T97AT+6%L
M:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXR+#,X,CPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T
M>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG
M+4)O='1O;3HP('!T.W=I9'1H.C<Y)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S
M='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4]
M,T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y
M;&4],T1W:61T:#HQ-"4[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS
M1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXQ+#,U
M,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R
M87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MW:61T:#HW.24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS
M<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
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M(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C(P+C5P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H
M.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$T)3L@8F]R
M9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXR+#0Y.3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z
M,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HW.24[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P
M="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY4;W1A;#PO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T0G=VED=&@Z,R4[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P
M="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C(P+C5P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W=I9'1H.C$E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M
M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S
M='EL93TS1"=W:61T:#HQ-"4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P
M,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,3,L,#@P/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL
M93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
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M<VEZ93HQ,'!T.R<^)FYB<W`[/"]P/CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT
M;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?-V5A.#)B,CE?.3@R-E\T,#)A7V(Y
M-C!?,#(Q-69D.&)A9&4X#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z
M+S=E83@R8C(Y7SDX,C9?-#`R85]B.38P7S`R,35F9#AB861E."]7;W)K<VAE
M971S+U-H965T,S$N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@
M<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H
M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%
M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O
M:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A
M<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O
M;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L
M92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5:1T%#/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$
M,CX\<W1R;VYG/D-O;&QA8F]R871I=F4@4F5S96%R8V@@86YD($1E=F5L;W!M
M96YT($%G<F5E;65N=',@*%1A8FQE<RD\8G(^/"]S=')O;F<^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,3(@36]N=&AS($5N
M9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D%G<F5E;65N="!7:71H($=S:SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4W5M;6%R>2!O9B!2979E;G5E
M<R!296-O9VYI>F5D(&)Y($UA:F]R($-U<W1O;65R/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/&1I=CX-"CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,3)P=#MM87)G:6XM;&5F=#HP)3MM87)G
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M=65S(')E8V]G;FEZ960@=6YD97(@;W5R(&%G<F5E;65N="!W:71H($=32R`H
M:6X@=&AO=7-A;F1S*3H\+V9O;G0^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.C$R<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.W1E>'0M:6YD96YT.C0N-30E)SXF(S$V
M,#L\+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP)3MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SXF;F)S<#L\+W`^/&1I=CX-"CQT86)L92!B;W)D97(]
M,T0P(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@86QI9VX],T1C
M96YT97(@<W1Y;&4],T0G8F]R9&5R+6-O;&QA<'-E.F-O;&QA<'-E.R!W:61T
M:#HQ,#`E.R<^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D
M:6YG+51O<#HP+C<U('!T.W=I9'1H.C8W)3L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/B9N8G-P.SPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW
M:61T:#HR)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E
M;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D(&-O;'-P86X],T0Q,"!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ
M)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T
M>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z
M8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^665A<B!E;F1E9"!$
M96-E;6)E<B`S,2P\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M
M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE
M/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP
M861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C8W)3L@8F]R9&5R+71O<#IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,B4[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[)SX\<"!S='EL
M93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O
M;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C(P,3,\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M
M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP
M+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E
M;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
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M;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D(&-O;'-P86X]
M,T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP
M861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED
M(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C
M,#`P,#`P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXR,#$R/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D
M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HR
M)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T
M97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI
M9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^,C`Q,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z
M,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D
M97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O
M;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I
M;F<M0F]T=&]M.C`@<'0[=VED=&@Z-C<E.R!B;W)D97(M=&]P.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
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M.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,B4[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HW)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXQ+#<P,CPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ
M,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HR)3L@8F]R9&5R+71O<#IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP
M861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D
M:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N
M-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C<E.R!B;W)D97(M=&]P.G-O
M;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
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M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP
M('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A
M<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP
M861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C(E.R!B;W)D97(M=&]P.G-O;&ED
M(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
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M;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW
M-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
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M.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-R4[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
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M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MW:61T:#HV-R4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/DUI;&5S
M=&]N92!R979E;G5E/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MW:61T:#HR)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
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M;F<M0F]T=&]M.C`@<'0[=VED=&@Z-R4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@
M,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^+3PO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HW)3L@8F]R
M9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXM/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D
M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ
M)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,B4[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@
M8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&
M1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP
M('!T.W=I9'1H.C<E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P
M,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI
M9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/C$U+#`P,#PO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R
M/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HV-R4[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O
M=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SY4;W1A;#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED
M=&@Z,B4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B
M;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ
M9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
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M<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-R4[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U
M8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
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M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID
M;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,B4[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P
M="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
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M=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P
M,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
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M.C`@<'0[=VED=&@Z-R4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P
M,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
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M('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A
M<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z
M,B4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D
M97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U
M8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
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M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-R4[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE
M(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,38L-#(X/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U
M8FQE(#(N-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M;'DZ5&EM97,@3F5W(%)O;6%N.R<^)FYB<W`[/"]P/CPO9&EV/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^07-T<F$@
M6F5N96-A/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3=6UM
M87)Y(&]F(%)E=F5N=65S(%)E8V]G;FEZ960@8GD@36%J;W(@0W5S=&]M97(\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\9&EV/@T*/'`@<W1Y
M;&4],T1M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C$R<'0[;6%R9VEN
M+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C0N-30E.V9O
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M<RDZ(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,G!T.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93HQ,G!T
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B8C,38P.SPO9F]N=#X\+W`^/&1I=CX-"CQT
M86)L92!B;W)D97(],T0P(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS
M1#`@86QI9VX],T1C96YT97(@<W1Y;&4],T0G8F]R9&5R+6-O;&QA<'-E.F-O
M;&QA<'-E.R!W:61T:#HQ,#`E.R<^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C8W)3L@8F]R9&5R
M+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/B9N8G-P
M.SPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MW:61T:#HR)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D(&-O;'-P86X],T0Q,"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ
M,"!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P
M,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M665A<B!E;F1E9"!$96-E;6)E<B`S,2P\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H
M.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG
M:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C8W)3L@8F]R
M9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,B4[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW
M-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P
M,#`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M
M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C(E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)W1E>'0M
M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O
M;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC
M96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXR,#$R/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB
M;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MW:61T:#HR)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P
M,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\
M<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I
M9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P
M=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@
M8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L
M9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,C`Q,3PO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS
M<&%R96YT.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N
M=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M
M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP
M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-C<E.R!B;W)D97(M
M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SY);FET:6%L('!A>6UE;G1S/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C(E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
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M:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-R4[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^-S(P/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP
M861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D
M:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C(E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
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M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
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M+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-R4[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M-S(P/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D
M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG
M+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C(E.R!B;W)D97(M
M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
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M<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-R4[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,3(P
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O
M='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T
M<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z-C<E.R!B;W)D97(M8F]T=&]M.G-O
M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SY097)F;W)M86YC92!O9B!R97-E87)C:"!A8W1I=FET:65S/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HR)3L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T
M=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z
M-R4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
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M('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MW:61T:#HR)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
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M;F<M0F]T=&]M.C`@<'0[=VED=&@Z-R4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@
M,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
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M=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HR)3L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$
M)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D
M:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-R4[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^-C0R/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW
M:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E
M;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I
M;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O
M<#HP+C<U('!T.W=I9'1H.C8W)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS
M<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/E1O=&%L/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HR)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U
M8FQE(#(N-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P
M,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN
M9RU";W1T;VTZ,"!P=#MW:61T:#HW)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P
M,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N
M.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXS+#(R-SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N
M<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MW:61T:#HR)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E
M;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ
M)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O
M='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HW)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O
M;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXS+#$X,CPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T
M=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HR)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE
M(#(N-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN
M9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P
M,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HW)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I
M9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E
M;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\+W1A8FQE/CPO9&EV
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M)3MF;VYT+7-I>F4Z,3)P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M)SXF;F)S<#L\+W`^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y.871I;VYA;"!);G-T:71U=&5S(&]F($AE
M86QT:#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4W5M;6%R
M>2!O9B!2979E;G5E<R!296-O9VYI>F5D(&)Y($UA:F]R($-U<W1O;65R/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=CX-"CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,3)P=#MM87)G:6XM
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M86YD<RDZ(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HQ,G!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HT+C4T)3MF;VYT+7-I>F4Z,3)P=#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[)SXF;F)S<#L\+W`^/&1I=CX-"CQT86)L
M92!B;W)D97(],T0P(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@
M86QI9VX],T1C96YT97(@<W1Y;&4],T0G8F]R9&5R+6-O;&QA<'-E.F-O;&QA
M<'-E.R!W:61T:#HQ,#`E.R<^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW
M-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C8W)3L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/B9N8G-P.SPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MW:61T:#HR)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D(&-O;'-P86X],T0Q,"!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P
M=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P
M,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^665A
M<B!E;F1E9"!$96-E;6)E<B`S,2P\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I
M;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C$E
M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I
M9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C8W)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
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M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,B!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P
M,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP
M('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG
M:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,C`Q,SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,B4[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC
M96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[
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M('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T(",P,#`P,#`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I
M9'1H.C(E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D
M97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L
M9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H
M.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M
M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4],T0G=&5X
M="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXR,#$Q/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW
M:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG
M:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HV-R4[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,3(N,C5P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.BTQ,BXR-7!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/DY)04E$(&-O;G1R86-T<SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HR)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C<E
M.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/C0L,3`S/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP
M861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED
M(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M.C`@<'0[=VED=&@Z,B4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS
M<&%R96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP
M861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED
M(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
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M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z-R4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
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M('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z
M,B4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T
M:#HW)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXR+#<S,#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C
M1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG
M:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C8W)3L@8F]R
M9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HQ,BXR-7!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z+3$R
M+C(U<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
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M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&
M1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ
M,"!P=#MW:61T:#HW)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P
M,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L
M:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXQ+#`S-3PO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&
M1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,B4[(&)O<F1E
M<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ
M<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HW)3L@8F]R
M9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D
M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HR
M)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E
M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M.C`@<'0[=VED=&@Z-R4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P
M,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA
M;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^,S@P/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^
M#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#
M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW
M-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C8W)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U
M8FQE(#(N-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,3(N,C5P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.BTQ,BXR-7!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
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M(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU
M<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O
M='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C
M,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C<E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P
M,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/C4L,3,X/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
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M.C(E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R
M9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O
M=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C<E.R!B;W)D97(M
M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L
M92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C,L.3,Y/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U
M8FQE(#(N-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$
M)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D
M:6YG+51O<#HP+C<U('!T.W=I9'1H.C(E.R!B;W)D97(M=&]P.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@
M=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P
M,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP
M('!T.W=I9'1H.C<E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P
M.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/C,L,3$P/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E
M;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S
M<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/"]T86)L93X\+V1I=CX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP)3MM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,"4[9F]N
M="US:7IE.C$R<'0[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.R<^)FYB
M<W`[/"]P/CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?
M3F5X=%!A<G1?-V5A.#)B,CE?.3@R-E\T,#)A7V(Y-C!?,#(Q-69D.&)A9&4X
M#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S=E83@R8C(Y7SDX,C9?
M-#`R85]B.38P7S`R,35F9#AB861E."]7;W)K<VAE971S+U-H965T,S(N:'1M
M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L
M90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI
M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS
M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU
M=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H
M;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP
M=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R
M="!I9#TS1$E$,$5!1#X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY.970@3&]S
M<R!097(@4VAA<F4@*%1A8FQE<RD\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,3(@36]N=&AS($5N9&5D
M/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D-O;7!U=&%T:6]N(&]F($)A<VEC(&%N9"!$:6QU
M=&5D($5A<FYI;F=S(%!E<B!3:&%R93PO=&0^#0H@("`@("`@(#QT9"!C;&%S
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M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)B,Q-C`[/"]F;VYT/CPO<#X\9&EV/@T*
M/'1A8FQE(&)O<F1E<CTS1#`@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG
M/3-$,"!A;&EG;CTS1&-E;G1E<B!S='EL93TS1"=B;W)D97(M8V]L;&%P<V4Z
M8V]L;&%P<V4[('=I9'1H.C$P,"4[)SX-"CQT<CX-"CQT9"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP('!T.W!A9&1I;F<M5&]P.C`@<'0[=VED=&@Z-C@E.R!B;W)D97(M8F]T
M=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)W1E
M>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^)FYB<W`[/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^)FYB<W`[/"]P/CPO=&0^#0H\=&0@8V]L<W!A;CTS1#$P('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ
M8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^1&5C96UB97(F(S$V,#LS,2P\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A
M<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L
M:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/B9N8G-P.SPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-
M"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP('!T.W!A9&1I;F<M5&]P.C`@<'0[=VED=&@Z
M-C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R
M9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC
M96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SXF;F)S<#L\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,B!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T(",P,#`P,#`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/C(P,3,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P
M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA
M;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+W`^/"]T9#X-"CQT9"!C;VQS<&%N
M/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T(",P,#`P,#`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E
M;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C(P,3(\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z
M,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB
M;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G
M=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+W`^/"]T9#X-"CQT9"!C
M;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[)SX\<"!S='EL93TS1"=T97AT+6%L
M:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O
M;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C(P,3$\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E
M.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R
M+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SXF
M;F)S<#L\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP
M('!T.W!A9&1I;F<M4FEG:'0Z,"!P=#MP861D:6YG+51O<#HP('!T.W!A9&1I
M;F<M0F]T=&]M.C`@<'0[=VED=&@Z-C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C$R+C(U<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HM,3(N,C5P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^0F%S:6,@86YD(&1I;'5T960@;F5T(&QO<W,@<&5R('-H87)E("AI;B!T
M:&]U<V%N9',L(&5X8V5P="!P97(@<VAA<F4F(S$V,#MA;6]U;G1S*3H\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C
M0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R
M9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI
M9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A
M;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P
M,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z
M,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE
M/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C@E
M.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P
M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP('!T.W!A9&1I;F<M5&]P.C`@<'0[<&%D9&EN
M9RU";W1T;VTZ,"!P=#MW:61T:#HV."4[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HQ,BXR-7!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z+3$R+C(U<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^3G5M97)A=&]R.CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T
M:#HQ)3L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R
M87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
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M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^
M/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&
M1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3L^/'`@<W1Y;&4],T0G;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ
M)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
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M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E.W=H
M:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3L^/'`@
M<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&
M1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T
M>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S
M='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4]
M,T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M
M4FEG:'0Z,"!P=#MP861D:6YG+51O<#HP('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z-C@E.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,C8N-C5P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.BTQ,BXR-7!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
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M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4]
M,T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$
M)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B@V-BPW
M,C`\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C0T9&,$9#('-T>6QE/3-$=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W
M<F%P.SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^*3PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3L^/'`@<W1Y;&4],T0G;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ
M)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
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M9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXH-CDL.30Y/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4]
M,T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/BD\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$
M=VED=&@Z,24[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
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M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO
M=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^*#0X+#4Y-SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ
M)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXI/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP('!T.W!A9&1I;F<M
M5&]P.C`@<'0[=VED=&@Z-C@E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C(V+C8U<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HM,3(N,C5P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SY0<F5F97)R960@<W1O8VL@9&5E;65D(&1I=FED96YD/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S
M='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R
M+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T9&1D9&1B!S='EL93TS1"=W:61T:#HX)3L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXH."PT-CD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M
M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^*3PO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G=VED=&@Z
M,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E
M<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^+3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G=VED=&@Z,24[(&)O
M<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M
M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE
M/3-$)W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P
M,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W=I9'1H
M.C@E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/BT\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W=I
M9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N
M=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P
M.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT
M<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP('!T.W!A
M9&1I;F<M5&]P.C`@<'0[=VED=&@Z-C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@
M=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HR-BXV-7!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z+3$R+C(U<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M3F5T(&QO<W,@86QL;V-A8FQE('1O(&-O;6UO;B!S=&]C:VAO;&1E<G,\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C
M0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@
M=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B
M;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T0G=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[
M(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^*#<U+#$X.3PO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT
M.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^*3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O
M=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H
M.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M
M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1"=W:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P
M,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N
M.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXH-CDL.30Y/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS
M<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXI/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ
M)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E
M<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P
M,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D97(M=&]P
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R
M+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B@T."PU
M.3<\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O
M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@
M,BXU<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/BD\+V9O;G0^/"]P/CPO=&0^
M#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`@<'0[<&%D9&EN9RU4;W`Z,"!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C8X)3L@8F]R9&5R+71O<#ID;W5B;&4@,BXU<'0@=')A;G-P87)E
M;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HQ,BXR-7!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z+3$R+C(U<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
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M>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.F1O=6)L92`R+C5P="!T<F%N
M<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P
M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&
M1D9&('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D97(M=&]P.F1O=6)L92`R+C5P
M="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$
M)W=I9'1H.C$E.R!B;W)D97(M=&]P.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N
M=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P
M.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=W:61T:#HQ
M)3L@8F]R9&5R+71O<#ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S
M='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#ID;W5B;&4@,BXU<'0@
M(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G
M:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=W
M:61T:#HX)3L@8F]R9&5R+71O<#ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=W:61T:#HQ)3L@8F]R
M9&5R+71O<#ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z
M9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G=VED
M=&@Z,24[(&)O<F1E<BUT;W`Z9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E
M<BUT;W`Z9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z9&]U8FQE
M(#(N-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M:6YG+5)I9VAT.C`@<'0[<&%D9&EN9RU4;W`Z,"!P=#MW:61T:#HV."4[(&)O
M<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,C8N-C5P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.BTQ
M,BXR-7!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/E=E:6=H=&5D+6%V97)A9V4@8V]M
M;6]N('-H87)E<R!O=71S=&%N9&EN9SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED
M=&@Z,24[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ9&]U
M8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T
M(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X
M="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,3DV+#(W-3PO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ9&]U
M8FQE(#(N-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R
M+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B
M;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D97(M8F]T
M=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/C$W,"PT-CD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B
M;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R
M+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS
M1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P
M,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM
M=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T
M:#HX)3L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXQ,C4L,3`Q/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A
M;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO
M='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I
M;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"!P=#MP861D:6YG+51O<#HP
M('!T.W=I9'1H.C8X)3L@8F]R9&5R+71O<#ID;W5B;&4@,BXU<'0@=')A;G-P
M87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,3(N,C5P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.BTQ,BXR-7!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/D)A<VEC(&%N9"!D
M:6QU=&5D(&YE="!L;W-S('!E<B!S:&%R92!A;&QO8V%B;&4@=&\@8V]M;6]N
M('-T;V-K:&]L9&5R<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z9&]U8FQE(#(N
M-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T
M<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.F1O=6)L92`R+C5P="`C
M,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=W:61T:#HX)3L@8F]R9&5R+71O<#ID;W5B;&4@,BXU<'0@
M(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I
M9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXH,"XS.#PO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O
M<F1E<BUT;W`Z9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T
M=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^*3PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED
M=&@Z,24[(&)O<F1E<BUT;W`Z9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R!B
M;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E
M.R!B;W)D97(M=&]P.F1O=6)L92`R+C5P="`C,#`P,#`P.R!B;W)D97(M8F]T
M=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HX
M)3L@8F]R9&5R+71O<#ID;W5B;&4@,BXU<'0@(S`P,#`P,#L@8F]R9&5R+6)O
M='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXH,"XT,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z9&]U8FQE(#(N
M-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T
M<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M
M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^*3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z
M9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L
M92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.F1O=6)L
M92`R+C5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C
M,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HX)3L@8F]R9&5R+71O<#ID;W5B
M;&4@,BXU<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@
M(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXH,"XS.3PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED
M=&@Z,24[(&)O<F1E<BUT;W`Z9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R!B
M;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^*3PO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\+W1A8FQE/CPO9&EV/CQP
M('-T>6QE/3-$;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C`E.V9O
M;G0M<VEZ93HQ,G!T.SL^)FYB<W`[/"]P/CPO9&EV/CQD:78^#0H\<"!S='EL
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M-C`[/"]F;VYT/CPO<#X\9&EV/@T*/'1A8FQE(&)O<F1E<CTS1#`@8V5L;'-P
M86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!A;&EG;CTS1&-E;G1E<B!S='EL
M93TS1"=B;W)D97(M8V]L;&%P<V4Z8V]L;&%P<V4[('=I9'1H.C$P,"4[)SX-
M"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP('!T.W!A9&1I;F<M5&]P.C`@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HV."4[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/B9N8G-P.SPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`@<'0[<&%D9&EN9RU4;W`Z,"!P
M=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R<^/'`@<W1Y;&4],T0G
M=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SXF;F)S<#L\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,3`@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A
M9&1I;F<M4FEG:'0Z,"!P=#MP861D:6YG+51O<#HP('!T.W!A9&1I;F<M0F]T
M=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T
M(",P,#`P,#`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/D1E8V5M8F5R)B,Q-C`[,S$L/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D
M:6YG+5)I9VAT.C`@<'0[<&%D9&EN9RU4;W`Z,"!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^)FYB<W`[/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`@<'0[<&%D9&EN9RU4;W`Z,"!P=#MP861D:6YG
M+4)O='1O;3HP('!T.W=I9'1H.C8X)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"!P
M=#MP861D:6YG+51O<#HP('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z
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M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`@<'0[<&%D9&EN9RU4;W`Z
M,"!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N
M-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+7=E
M:6=H=#IB;VQD.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXR,#$S/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`@<'0[<&%D9&EN9RU4;W`Z,"!P=#MP861D
M:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^)FYB<W`[/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A
M9&1I;F<M4FEG:'0Z,"!P=#MP861D:6YG+51O<#HP('!T.W!A9&1I;F<M0F]T
M=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P
M,#`P,#`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/B9N8G-P.SPO<#X\+W1D
M/@T*/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`@<'0[<&%D9&EN9RU4
M;W`Z,"!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M
M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED
M(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT
M97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+7=E:6=H=#IB;VQD.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD
M.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXR,#$R/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`@<'0[<&%D9&EN9RU4;W`Z,"!P=#MP
M861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^)FYB<W`[/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T
M.W!A9&1I;F<M4FEG:'0Z,"!P=#MP861D:6YG+51O<#HP('!T.W!A9&1I;F<M
M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T
M(",P,#`P,#`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/B9N8G-P.SPO<#X\
M+W1D/@T*/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`@<'0[<&%D9&EN
M9RU4;W`Z,"!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O
M;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC
M96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+7=E:6=H=#IB;VQD.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB
M;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXR,#$Q/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`@<'0[<&%D9&EN9RU4;W`Z,"!P
M=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^)FYB<W`[/"]P/CPO=&0^
M#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`@<'0[<&%D9&EN9RU4;W`Z,"!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C8X)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E
M;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HQ,BXR-7!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z+3$R+C(U<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT
M.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/D]U='-T86YD:6YG
M('-E8W5R:71I97,@;F]T(&EN8VQU9&5D(&EN(&1I;'5T960@;F5T(&QO<W,@
M<&5R('-H87)E(&-A;&-U;&%T:6]N("AI;B!T:&]U<V%N9',I.CPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M
M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C
M0T9&,$9#('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N
M-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE
M/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A
M<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM
M=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T
M:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\
M<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M
M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1"=W:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z."4[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M861D:6YG+5)I9VAT.C`@<'0[<&%D9&EN9RU4;W`Z,"!P=#MP861D:6YG+4)O
M='1O;3HP('!T.W=I9'1H.C8X)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C$R+C(U<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HM,3(N,C5P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SY3=&]C:R!O<'1I;VYS(&%N9"!S=&]C:R!A=V%R9',\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&
M1D9&('-T>6QE/3-$=VED=&@Z,24[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
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M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C@E.W=H
M:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,3<L,#0P/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL
M93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T1W:61T:#HQ)3L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C
M93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$=VED=&@Z."4[=VAI=&4M<W!A8V4Z
M;F]W<F%P.SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E
M.SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^
M/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&
M1D9&1D8@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[/CQP
M('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/C$Q+#$P,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US
M<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`@<'0[<&%D9&EN9RU4;W`Z
M,"!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C8X)3LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C$R+C(U<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HM,3(N
M,C5P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I
M9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T
M:#HX)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI
M9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C0S+#0S,#PO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T
M>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#
M('-T>6QE/3-$=VED=&@Z,24[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C@E.W=H:71E
M+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^+3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T
M:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$=VED=&@Z
M,24[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
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M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^
M/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^+3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C
M93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`@<'0[<&%D9&EN9RU4;W`Z,"!P
M=#MW:61T:#HV."4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS
M<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,3(N,C5P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.BTQ,BXR-7!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/E=A<G)A
M;G1S/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T9&1D9&1B!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G
M:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=W
M:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=W:61T:#HX)3L@
M8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXQ,BPT-C0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W=I
M9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N
M=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P
M.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=W:61T:#HQ
M)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\
M<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&
M1D9&1B!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
M+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL
M93TS1"=W:61T:#HX)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P
M,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L
M:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXQ,BPW,30\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&
M1D9&('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S
M='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R
M+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T9&1D9&1B!S='EL93TS1"=W:61T:#HX)3L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXR-2PW,CD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M
M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP('!T.W!A9&1I;F<M5&]P.C`@<'0[
M=VED=&@Z-C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N
M=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HQ,BXR-7!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z+3$R+C(U<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS
M<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N
M-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T0G=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[
M(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^-S(L.3,T/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W
M:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[
M(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O
M;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G
M:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W
M:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R
M9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HX)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU
M<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T
M97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXR."PR-S4\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED
M(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU
M<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS
M<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N
M=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED
M(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C
M,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I
M9'1H.C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D
M97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/C,V+#@S,#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z
M,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D
M97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CPO=&%B;&4^/"]D:78^
M/'`@<W1Y;&4],T1M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP)3MM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,"4[
M9F]N="US:7IE.C$P<'0[.SXF;F)S<#L\+W`^/"]D:78^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-
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M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@
M("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G
M=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT
M+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H
M:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@
M/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14%$/@T*("`@("`@/'1R
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N
M/3-$,CX\<W1R;VYG/E!R969E<G)E9"!3=&]C:RP@0V]M;6]N(%-T;V-K(&%N
M9"!787)R86YT<R`H5&%B;&5S*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT:',@16YD960\
M+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^5V%R<F%N=',@27-S=65D('1O(%!U<F-H87-E($-O
M;6UO;B!3=&]C:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQD
M:78^#0H\<"!S='EL93TS1&UA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M-G!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HT+C4T)3MF;VYT+7-I>F4Z,3!P=#L[/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#MT97AT+6EN9&5N=#HT+C4T)2<^
M26X@8V]N;F5C=&EO;B!W:71H(&$@,C`P-R!L;V%N(&%G<F5E;65N="!T:&%T
M('=A<R!S=6)S97%U96YT;'D@=&5R;6EN871E9"!I;B`R,#`X+"!W92!I<W-U
M960@=V%R<F%N=',@=&\@<'5R8VAA<V4@=7`@=&\@,RPU-3`L,#`P/"]F;VYT
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93HQ,'!T.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B!S:&%R97,@;V8@;W5R(&-O;6UO;B!S=&]C:R!A<R!F;VQL;W=S.B`\
M+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP)3MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SXF;F)S<#L\+W`^/&1I=CX-"CQT86)L92!B;W)D97(],T0P
M(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@86QI9VX],T1C96YT
M97(@<W1Y;&4],T0G8F]R9&5R+6-O;&QA<'-E.F-O;&QA<'-E.R!W:61T:#HQ
M,#`E.R<^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C
M1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG
M:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M
M.C`@<'0[=VED=&@Z,SDE.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C
M,#`P,#`P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD
M.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
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M.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&
M1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP
M('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P
M,#`P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
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M=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA
M;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$
M)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D
M:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,3(E
M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB
M;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY%>'!I<F%T:6]N(#QB
M<B`O/D1A=&4\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I
M9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N
M=#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D(&-O;'-P86X],T0R('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T
M=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4],T0G=&5X="UA
M;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SY%>&5R8VES92!0<FEC92`\8G(@+SYP97(@
M4VAA<F4\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H
M.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@
M<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H
M=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
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M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T(",P,#`P,#`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E
M;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/D]U='-T86YD:6YG(&%S(&]F(#QB<B`O/D1E8V5M8F5R
M(#,Q+"`R,#$S(#QB<B`O/BAI;B!T:&]U<V%N9',I/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\
M+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP
M('!T.W=I9'1H.C,Y)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P
M,#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C$R+C(U<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HM,3(N,C5P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY*=6QY(#$X+"`R
M,#`W/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D
M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG
M+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
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M=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P
M,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ,B4[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,2PR-3`\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN
M9RU";W1T;VTZ,"!P=#MW:61T:#HQ,B4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW
M-7!T(",P,#`P,#`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ,B4[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^-2XQ
M,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O
M;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,34E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/C$L,C4P/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP
M861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D
M:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-
M"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW
M:61T:#HS.24[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HQ,BXR-7!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z+3$R+C(U<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^3V-T
M;V)E<B`Q."P@,C`P-SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
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M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&
M1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ
M,"!P=#MW:61T:#HQ,B4[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,2PS,#`\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&
M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW
M-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[
M=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
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M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,3(E.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
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M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C$E.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ,B4[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^,2XV.#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C$E.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&
M1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ
M,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$U)3MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXM/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP
M861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O
M='1O;3HP('!T.W=I9'1H.C,Y)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C$R+C(U<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HM,3(N,C5P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SY$96-E;6)E<B`R-RP@,C`P-SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z
M,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ,B4[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,S`P
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O
M='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A
M9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG
M+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$R
M)3LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C(O
M,C8O,C`Q-#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP
M('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T
M.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
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M861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z
M,3(E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI
M9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/C4N-C4\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A
M9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG
M+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HQ)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
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M;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ
M-24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG
M;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^,S`P/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MW:61T:#HS.24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS
M<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,3(N,C5P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.BTQ,BXR-7!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/D1E8V5M
M8F5R(#(W+"`R,#`W/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
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M;F<M0F]T=&]M.C`@<'0[=VED=&@Z,3(E.R!B;W)D97(M8F]T=&]M.G-O;&ED
M(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C<P,#PO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T
M>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P
M=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP
M('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T
M.W=I9'1H.C$R)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A
M<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,3(E.R!B;W)D97(M8F]T=&]M.G-O
M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXQ+C8X/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R
M9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&
M1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E
M<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R
M+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I
M9'1H.C$U)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I
M9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXM/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A
M;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$
M)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D
M:6YG+51O<#HP+C<U('!T.W=I9'1H.C,Y)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T
M('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,3(N,C5P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.BTQ,BXR-7!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/E1O=&%L/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP
M861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T
M:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O
M<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R
M9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID
M;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$R)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O
M;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXS+#4U,#PO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T
M=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE
M(#(N-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z
M,3(E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R
M9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS
M<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O
M=6)L92`R+C5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ,B4[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P
M="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A
M;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R
M96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@
M8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M
M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,34E
M.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T
M=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C$L-34P
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB
M;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P
M/CPO=&0^#0H\+W1R/@T*/"]T86)L93X\+V1I=CX\<"!S='EL93TS1&UA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C`E.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP)3MF;VYT+7-I>F4Z-G!T.SL^
M)FYB<W`[/"]P/CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM
M+3U?3F5X=%!A<G1?-V5A.#)B,CE?.3@R-E\T,#)A7V(Y-C!?,#(Q-69D.&)A
M9&4X#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S=E83@R8C(Y7SDX
M,C9?-#`R85]B.38P7S`R,35F9#AB861E."]7;W)K<VAE971S+U-H965T,S0N
M:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT
M86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S
M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I
M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E
M=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS
M1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C
M<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E
M<&]R="!I9#TS1$E$,$5.2#X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY%<75I
M='D@4&QA;G,@86YD(%-T;V-K+4)A<V5D($-O;7!E;G-A=&EO;B`H5&%B;&5S
M*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C
M;VQS<&%N/3-$,3XQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@
M,C`Q,SQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W!T
M:6]N($%C=&EV:71Y('5N9&5R(%-T;V-K+4)A<V5D($-O;7!E;G-A=&EO;B!0
M;&%N<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQD:78^#0H\
M<"!S='EL93TS1&UA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,3)P=#MM
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M(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,G!T.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93HQ,G!T.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B8C,38P.SPO9F]N=#X\+W`^/&1I=CX-"CQT86)L
M92!B;W)D97(],T0P(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@
M86QI9VX],T1C96YT97(@<W1Y;&4],T0G8F]R9&5R+6-O;&QA<'-E.F-O;&QA
M<'-E.R!W:61T:#HQ,#`E.R<^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW
M-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C4W)3L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/B9N8G-P.SPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$
M,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N
M=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O
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M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
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M=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)W1E
M>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B
M;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD
M.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY796EG:'1E9"U!=F5R86=E
M($5X97)C:7-E(%!R:6-E)B,Q-C`[4&5R)B,Q-C`[4VAA<F4@*&EN('1H;W5S
M86YD<RD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P
M=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ
M)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T
M>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z
M8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^5V5I9VAT960M079E
M<F%G92!296UA:6YI;F<@0V]N=')A8W1U86P@5&5R;2`H>65A<G,I/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M
M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C$E.R!B
M;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUB
M;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[)SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
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M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO
M='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z-3<E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A
M<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY"86QA;F-E(&%T($1E8V5M
M8F5R)B,Q-C`[,S$L(#(P,3(\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M
M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP
M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G=&5X
M="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H
M.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M.C`@<'0[=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P
M,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG
M;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^,3,L.#`V/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP
M('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A
M<F5N=#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXS+C,X/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP
M('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A
M<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP
M861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED
M(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
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M;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW
M-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E
M.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN
M9RU";W1T;VTZ,"!P=#MW:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P
M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HU-R4[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HQ,RXW<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M3W!T:6]N<R!G<F%N=&5D/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R<^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z."4[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
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M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T
M:#HQ)3LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H
M.C@E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI
M9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
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M+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HQ)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I
M;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX
M)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP
M861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D
M:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z
M,24[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I
M9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z."4[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW
M:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HU-R4[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HQ,RXW<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
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M=&]M.C`@<'0[=VED=&@Z,24[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I
M9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXH,3,Q/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXI/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP
M861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R<^/'`@<W1Y;&4],T0G=&5X
M="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H
M.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z."4[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,2XT
M,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ
M)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP
M861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D
M:6YG+4)O='1O;3HP('!T.W=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z
M,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW
M:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG
M+4)O='1O;3HP('!T.W=I9'1H.C4W)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C$S+C=P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SY/<'1I;VYS(&-A;F-E;&QE9#H\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A
M9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG
M+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[)SX\
M<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
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M=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
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M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&
M1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ
M,"!P=#MW:61T:#HQ)3LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&
M1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP
M('!T.W=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
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M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&
M1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ
M,"!P=#MW:61T:#HQ)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
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M=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O
M='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
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M;F<M0F]T=&]M.C`@<'0[=VED=&@Z."4[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ
M)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HU-R4[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HR-RXS-7!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
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M;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[)SX\<"!S='EL93TS1"=T97AT+6%L
M:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN
M9RU";W1T;VTZ,"!P=#MW:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
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M=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
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M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[)SX\<"!S='EL
M93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXS+C,Q/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP
M861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z,24[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z."4[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P
M=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP
M('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T
M.W=I9'1H.C4W)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HR-RXS-7!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/D]P=&EO;G,@8V%N
M8V5L;&5D("AV97-T960I/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A
M;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3L@
M8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXH.38Y/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW
M:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E
M;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
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M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP
M('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@
M(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C@E.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
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M97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&
M1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R
M+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[=VED=&@Z."4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R
M86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z."4[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z-3<E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O
M='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^0F%L86YC92!A="!$96-E;6)E<B8C,38P.S,Q+"`R,#$S/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R
M9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T
M;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G=&5X
M="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H
M.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M
M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E
M<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M,34L-S8U/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP
M861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T
M:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O
M<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O
M;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z
M,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB
M;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T
M:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R
M+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXS
M+C$W/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D
M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ
M)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E
M<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID
M;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP
M861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED
M(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU
M<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C@E.R!B;W)D97(M=&]P
M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B
M;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXU+C(V/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U
M8FQE(#(N-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M:6YG+51O<#HP+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@
M=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A
M;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR
M:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
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M<#HP+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T
M<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P
M87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A
M9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG
M+51O<#HP+C<U('!T.W=I9'1H.C4W)3L@8F]R9&5R+71O<#ID;W5B;&4@,BXU
M<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R
M86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/E9E<W1E9"!A;F0@
M97AP96-T960@=&\@=F5S="!A="!$96-E;6)E<B`S,2P@,C`Q,SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&
M1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUT
M;W`Z9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O
M=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z9&]U8FQE
M(#(N-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P
M,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3L@8F]R9&5R+71O<#ID;W5B
M;&4@,BXU<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@
M(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M92`R+C5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU
M<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z9&]U8FQE(#(N-7!T('1R
M86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A
M<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[
M=VED=&@Z,24[(&)O<F1E<BUT;W`Z9&]U8FQE(#(N-7!T(",P,#`P,#`[(&)O
M<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&
M1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P
M=#MW:61T:#HX)3L@8F]R9&5R+71O<#ID;W5B;&4@,BXU<'0@(S`P,#`P,#L@
M8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXS+C$W/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW
M:61T:#HQ)3L@8F]R9&5R+71O<#ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[
M(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
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M;W)D97(M=&]P.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O
M='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P
M.F1O=6)L92`R+C5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R
M+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
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M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z."4[(&)O<F1E<BUT
M;W`Z9&]U8FQE(#(N-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE
M(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^-2XR-CPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z
M9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L
M92`R+C5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#ID;W5B;&4@,BXU
M<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R
M86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&
M1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ
M,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#ID;W5B;&4@,BXU<'0@(S`P,#`P
M,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&
M1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P
M=#MW:61T:#HX)3L@8F]R9&5R+71O<#ID;W5B;&4@,BXU<'0@(S`P,#`P,#L@
M8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXQ+#0R-SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M=VED=&@Z,24[(&)O<F1E<BUT;W`Z9&]U8FQE(#(N-7!T('1R86YS<&%R96YT
M.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[=VED=&@Z-3<E.R!B;W)D97(M=&]P.F1O=6)L92`R+C5P="!T<F%N<W!A
M<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
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M.W=I9'1H.C$E.R!B;W)D97(M=&]P.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N
M=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E
M.R!B;W)D97(M=&]P.F1O=6)L92`R+C5P="`C,#`P,#`P.R!B;W)D97(M8F]T
M=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z
M."4[(&)O<F1E<BUT;W`Z9&]U8FQE(#(N-7!T(",P,#`P,#`[(&)O<F1E<BUB
M;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,3`L
M-C(X/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D
M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ
M)3L@8F]R9&5R+71O<#ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[(&)O<F1E
M<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M=&]P.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID
M;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP
M861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.F1O=6)L
M92`R+C5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C
M,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z."4[(&)O<F1E<BUT;W`Z9&]U
M8FQE(#(N-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T
M(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X
M="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,RXS-CPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z9&]U8FQE
M(#(N-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P
M="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#ID;W5B;&4@,BXU<'0@=')A
M;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R
M96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW
M:61T:#HQ)3L@8F]R9&5R+71O<#ID;W5B;&4@,BXU<'0@(S`P,#`P,#L@8F]R
M9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C@E.R!B;W)D97(M=&]P.F1O=6)L92`R+C5P="`C,#`P,#`P.R!B
M;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
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M9'1H.C$E.R!B;W)D97(M=&]P.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#L@
M8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O
M<F1E<BUT;W`Z9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T
M=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z
M9&]U8FQE(#(N-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N
M-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
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M.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z."4[(&)O<F1E<BUT;W`Z9&]U
M8FQE(#(N-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T
M(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X
M="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
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M92`R+C5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU
M<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\
M+W1A8FQE/CPO9&EV/CQP('-T>6QE/3-$;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HV<'0[.SXF;F)S<#L\+W`^/"]D:78^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y3=6UM87)Y(&]F(%)E<W1R:6-T960@4W1O8VL@56YI=',@06-T:79I='D\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\9&EV/@T*/'`@<W1Y
M;&4],T1M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C$R<'0[;6%R9VEN
M+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C0N-30E.V9O
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M97(F(S$V,#LS,2P@,C`Q,RP@86YD(&%C=&EV:71I97,@9'5R:6YG(#(P,3,@
M:7,@<W5M;6%R:7IE9"!A<R!F;VQL;W=S.B`\+V9O;G0^/"]P/CQP('-T>6QE
M/3-$;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ
M93HQ,'!T.SL^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.C$P<'0[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)B,Q-C`[/"]F;VYT/CPO<#X\9&EV/@T*/'1A8FQE(&)O
M<F1E<CTS1#`@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!A;&EG
M;CTS1&-E;G1E<B!S='EL93TS1"=B;W)D97(M8V]L;&%P<V4Z8V]L;&%P<V4[
M('=I9'1H.C$P,"4[)SX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z-SDE.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^)FYB<W`[/"]P/CPO
M=&0^#0H\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D
M:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[)SX\<"!S='EL
M93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O
M;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/DYU;6)E<B!O9B!3:&%R
M97,@*$EN)B,Q-C`[=&AO=7-A;F1S*3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z
M,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW
M96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N
M.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!C
M;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M
M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^5V5I9VAT960M079E<F%G92!'<F%N="U$
M871E)B,Q-C`[1F%I<B!686QU93PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG
M:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HW.24[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
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M-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[
M=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXQ+#<U-3PO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ
M)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A
M;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
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M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z."4[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^-"XR,SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A
M;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$
M)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D
M:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-SDE
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
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M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXR
M-3`\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I
M;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M
M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3LG
M/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXQ+C(S/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG
M+4)O='1O;3HP('!T.W=I9'1H.C<Y)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SY697-T960\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A
M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T
M:#HX)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L
M:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXH,3$U/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXI/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C$E.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E
M>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C$N,3`\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE
M/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP
M861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z
M,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I
M;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O
M<#HP+C<U('!T.W=I9'1H.C<Y)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
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M('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX
M)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXH-C$U/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
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M.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG
M/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R
M+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H
M.C<Y)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O
M<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/DYO;BUV97-T960@87,@;V8@1&5C96UB97(@,S$L
M(#(P,3,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I
M;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW
M-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P
M,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P
M,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L
M:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXQ+#(W-3PO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T
M<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT
M.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D
M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG
M+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O
M='1O;3HP('!T.W=I9'1H.C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C
M,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG
M:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
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M+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E
M;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\+W1A8FQE/CPO9&EV
M/CQP('-T>6QE/3-$;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C`E
M.V9O;G0M<VEZ93HV<'0[.SXF;F)S<#L\+W`^/"]D:78^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&86ER(%9A;'5E
M+4)A<V5D($UE87-U<F5M96YT<R!A;F0@5V5I9VAT960M079E<F%G92!!<W-U
M;7!T:6]N<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQD:78^
M#0H\<"!S='EL93TS1&UA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z-G!T
M.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HT
M+C4T)3MF;VYT+7-I>F4Z,3!P=#L[/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#MT97AT+6EN9&5N=#HT+C4T)2<^)FYB
M<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[)FYB<W`[
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M<F%N="`H;W(@96%R;&EE<B!U<&]N('1E<FUI;F%T:6]N(&]F(&-O;G1I;G5O
M=7,@<V5R=FEC92DN(%1H92!#;VUP86YY(&AA<R!A;'-O(&=R86YT960@<&5R
M9F]R;6%N8V4M8F%S960@97%U:71Y(&%W87)D<R!T;R!C97)T86EN(&]F(&]U
M<B!E;7!L;WEE97,@=6YD97(@=&AE(#(P,3$@4&QA;BP@=&AE(#(P,#0@4&QA
M;B!A;F0@=&AE($EN9'5C96UE;G0@4&QA;BX@07,@;V8@1&5C96UB97(F(S$V
M,#LS,2P@,C`Q,RP@,BPP-#<L-#8V('-H87)E<R!W97)E(&]U='-T86YD:6YG
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M:6YG('=E:6=H=&5D+6%V97)A9V4@87-S=6UP=&EO;G,Z(#PO9F]N=#X\+W`^
M/'`@<W1Y;&4],T1M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP)3MM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,"4[
M9F]N="US:7IE.C$P<'0[.SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z,3!P
M=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF(S$V,#L\+V9O;G0^/"]P/CQD:78^#0H\
M=&%B;&4@8F]R9&5R/3-$,"!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<]
M,T0P(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)V)O<F1E<BUC;VQL87!S93IC
M;VQL87!S93L@=VED=&@Z,3`P)3LG/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HS-24[(&)O<F1E
M<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SXF;F)S<#L\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E
M<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD
M.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@8V]L<W!A;CTS1#$P('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H
M.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@
M<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H
M=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
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M=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS
M<&%R96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,3`@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I
M;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@
M,"XW-7!T(",P,#`P,#`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E
M<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/D5M<&QO>65E)B,Q-C`[4W1O8VL@4'5R8VAA<V4F(S$V,#M0
M;&%N/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\
M+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C,U)3L@8F]R
M9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O
M='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T
M<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@8V]L<W!A;CTS1#$P('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^
M/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E
M:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY996%R($5N
M9&5D($1E8V5M8F5R)B,Q-C`[,S$L/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D
M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG
M+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A
M;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D(&-O;'-P86X],T0Q
M,"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^665A<B!%;F1E9"!$96-E;6)E<B8C,38P.S,Q+#PO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO
M=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HS-24[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$
M,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N
M=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^,C`Q,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O
M<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z
M8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E
M<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N
M/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ
M8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^,C`Q,CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG
M:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E
M;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS
M<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI
M9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^,C`Q,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z
M,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW
M96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N
M.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!C
M;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M
M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^,C`Q,SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED
M=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT+6%L
M:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R
M+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E
M>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,C`Q,CPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R
M9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$
M)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,C`Q,3PO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS
M<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HS-24[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/E=E:6=H=&5D+6%V97)A9V4@9F%I<B!V86QU93PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ
M,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P
M,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI
M9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
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M+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP
M861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D
M:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N
M-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C@E.R!B;W)D97(M=&]P.G-O
M;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C,N,S`\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR
M:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C@E
M.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
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M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P
M,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI
M9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/C`N.3,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A
M9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG
M+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW
M:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ
M,"!P=#MW:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P
M,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N
M.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXS+C4T/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N
M=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B0\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR
M:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^,BXP.3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I
M;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M
M0F]T=&]M.C`@<'0[=VED=&@Z,S4E.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/E)I<VLM9G)E92!I;G1E<F5S="!R871E/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ
M)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP
M861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D
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M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C$N,3PO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3LG/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&
M1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P
M=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
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M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/C`N-3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)3PO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3LG
M/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C@E.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG
M:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/C$N,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)3PO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW
M:61T:#HQ)3LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I
M9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M
M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C`N,CPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)3PO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HQ)3LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG
M:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C`N,CPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW
M:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3LG/CQP('-T>6QE/3-$)W1E>'0M
M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ
M)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP
M861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D
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M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C`N,SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)3PO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE
M/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP
M861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z
M,S4E.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/D5X<&5C=&5D(&QI9F4@*&EN
M('EE87)S*3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[
M<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D
M9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW
M:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN
M9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3LG/CQP('-T>6QE/3-$)W1E>'0M86QI
M9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D
M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG
M+4)O='1O;3HP('!T.W=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C0N,CPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ
M,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP
M('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
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M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z."4[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^-"XP/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP
M861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z,24[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A
M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T
M.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T
M:#HX)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L
M:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HQ)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
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M;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX
M)3MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N
M.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HQ)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S
M<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I
M;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M
M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I
M9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A
M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,S4E.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/E9O;&%T:6QI='D\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M
M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP
M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M
M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T
M=&]M.C`@<'0[=VED=&@Z."4[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,2XT/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[)SX\<"!S='EL93TS
M1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[
M=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ
M)3LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN
M9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C@E
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ
M<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/C$N-CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C$E.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M.C`@<'0[=VED=&@Z."4[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,"XX/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I
M9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z."4[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,2XV/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H
M.C$E.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[
M=VED=&@Z."4[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X
M="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,2XV/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
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M)FYB<W`[/"]P/CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^4W1O8VLM0F%S960@0V]M<&5N<V%T:6]N($5X
M<&5N<V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\9&EV/@T*
M/'`@<W1Y;&4],T1M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C$R<'0[
M;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C0N
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M9"!C;VUP96YS871I;VX@97AP96YS92`H:6X@=&AO=7-A;F1S*3H@/"]F;VYT
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M;F]R;6%L.R<^)B,Q-C`[/"]F;VYT/CPO<#X\9&EV/@T*/'1A8FQE(&)O<F1E
M<CTS1#`@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!A;&EG;CTS
M1&-E;G1E<B!S='EL93TS1"=B;W)D97(M8V]L;&%P<V4Z8V]L;&%P<V4[('=I
M9'1H.C$P,"4[)SX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z-C@E
M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^)FYB<W`[/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I
M;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C$E
M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP
M('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P
M,#`P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F
M;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY9
M96%R($5N9&5D($1E8V5M8F5R)B,Q-C`[,S$L/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R
M/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HV."4[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.G-O
M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I
M9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@
M8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B
M;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD
M.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXR,#$S/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M(S`P,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E
M;G0[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,B!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
M+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^,C`Q,CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G=&5X
M="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
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M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P
M,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[)SX\<"!S
M='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT
M.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\
M+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP
M('!T.W=I9'1H.C8X)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
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M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS
M<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P
M=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P
M,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L
M:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS
M<&%R96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP
M861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED
M(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C@E.R!B;W)D97(M=&]P
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C$P+#0S.3PO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A
M;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT+6%L
M:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X
M="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
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M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
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M('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^
M#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HV."4[(&)O
M<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
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M+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T
M<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P
M,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T
M97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HX)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T
M97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXM/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR
M:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D
M97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[
M=VED=&@Z."4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR
M:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^-#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R
M86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HV."4[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P
M="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT
M.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY4;W1A;#PO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T
M=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F
M=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U
M('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N
M-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
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M.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T
M(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X
M="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,3(L,S0P/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N
M-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M<#HP+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T
M<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P
M87)E;G0[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P
M,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
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M;F<M0F]T=&]M.C`@<'0[=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW
M-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P
M,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG
M;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^,3`L-#,Y/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R
M86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A
M<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[
M)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
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M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T
M(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
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M=&]M.C`@<'0[=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P
M,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^-2PQ.#D\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M
M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP
M+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E
M;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G
M:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I
M;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O
M<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-C@E.R!B;W)D
M97(M=&]P.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M
M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP
M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT
M;W`Z9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#ID
M;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C@E.R!B
M;W)D97(M=&]P.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[
M=VED=&@Z,24[(&)O<F1E<BUT;W`Z9&]U8FQE(#(N-7!T('1R86YS<&%R96YT
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
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M;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z9&]U8FQE(#(N
M-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#ID;W5B;&4@,BXU<'0@
M(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z
M,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P
M=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C@E.R!B;W)D97(M=&]P.F1O
M=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O
M<F1E<BUT;W`Z9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z9&]U8FQE(#(N-7!T('1R86YS<&%R
M96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW
M:61T:#HQ)3L@8F]R9&5R+71O<#ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O
M='1O;3HP('!T.W=I9'1H.C@E.R!B;W)D97(M=&]P.F1O=6)L92`R+C5P="`C
M,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z9&]U
M8FQE(#(N-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HV."4[(&)O<F1E
M<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,3`@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP
M('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T
M.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T(",P,#`P,#`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N
M.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P
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M;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT
M.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I
M9'1H.C8X)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T
M<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P
M,#`P,#`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/C(P,3,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H
M.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R
M9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[
M=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB
M;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
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M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED
M(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ
M8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D(&-O
M;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I
M9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D
M97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4],T0G
M=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXR,#$R/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P
M,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[
M)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,B!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^,C`Q,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT
M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I
M9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP
M('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T
M.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-C@E.R!B;W)D97(M=&]P.G-O
M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R
M9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN
M9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX
M)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXT+#(R.#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL
M93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
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M=&]M.C`@<'0[=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P
M,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA
M;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
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M:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS
M<&%R96YT.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP
M861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED
M(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C@E.R!B;W)D97(M=&]P
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C(L,3`S/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[=VED=&@Z-C@E.R!B;W)D97(M8F]T=&]M.G-O;&ED
M(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY'
M96YE<F%L(&%N9"!A9&UI;FES=')A=&EV93PO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN
M9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
M+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C@E.R!B;W)D97(M
M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C@L
M,3$R/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D
M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ
M)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@
M<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C
M,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z."4[(&)O<F1E<BUB;W1T;VTZ
M<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
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M97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT
M97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&
M1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R
M+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS
M1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[
M=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN
M9RU";W1T;VTZ,"!P=#MW:61T:#HX)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
M+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXS+#`X-CPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@
M<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U
M('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HV."4[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M
M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SY4;W1A;#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS
M<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N
M=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED
M=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E
M<BUB;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI
M;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B0\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE
M/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP
M861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z
M."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB
M;W1T;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,3(L
M,S0P/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D
M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ
M)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E
M<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID
M;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT+6%L
M:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$
M)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D
M:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T
M;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
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M+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z."4[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ
M9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,3`L-#,Y/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R
M9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T
M;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T
M>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P
M=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O
M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@
M,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I
M9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U
M8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
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M+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z."4[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE
M(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT
M+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
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M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B
M;&4@,BXU<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO
M='(^#0H\+W1A8FQE/CPO9&EV/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP)3MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+W`^/"]D:78^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D
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M:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-
M"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0]
M,T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T
M97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E
M(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@
M("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P135&/@T*("`@("`@
M/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S
M<&%N/3-$,CX\<W1R;VYG/DEN8V]M92!487AE<R`H5&%B;&5S*3QB<CX\+W-T
M<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$
M,3XQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\
M+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]M<&]N96YT(&]F
M($-O;G-O;&ED871E9"!);F-O;64@*$QO<W,I($)E9F]R92!0<F]V:7-I;VX@
M9F]R($EN8V]M92!487AE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
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M<RDZ(#PO9F]N=#X\+W`^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,G!T.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CLG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93HQ,G!T
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B8C,38P.SPO9F]N=#X\+W`^/&1I=CX-"CQT
M86)L92!B;W)D97(],T0P(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS
M1#`@86QI9VX],T1C96YT97(@<W1Y;&4],T0G8F]R9&5R+6-O;&QA<'-E.F-O
M;&QA<'-E.R!W:61T:#HQ,#`E.R<^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C8X)3L@8F]R9&5R
M+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/B9N8G-P
M.SPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I
M9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,3`@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@
M<'0[=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P
M,#`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N
M=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O
M;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M
M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C8X)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB
M;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z,24[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T
M=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P
M,#`P,#`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[
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M.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T
M=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P
M,#`P,#`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[
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M.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T
M=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@
M,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P
M,#`P,#`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*
M/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I
M9'1H.C8X)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^52Y3+CPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ
M)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H
M.C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
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M('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXI/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
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M:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z."4[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^*#<P+#<Y,CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
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M<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z,24[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3L@8F]R
M9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXH
M-#DL.3DP/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP
M861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D
M:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^*3PO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE
M/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP
M861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C8X)3L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
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M.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A
M<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[
M=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN
M9RU";W1T;VTZ,"!P=#MW:61T:#HX)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
M+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP
M861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O
M;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z."4[(&)O
M<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA
M<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^.#0S/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP
M861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T
M:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM
M<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z
M,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A
M9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ
M)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I
M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O
M;3HP('!T.W=I9'1H.C@E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C
M,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M
M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C$L,SDS/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO
M='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z
M,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C8X)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ
M9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/E1O=&%L/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P
M=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW
M:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[
M(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O
M;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3L@8F]R
M9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID
M;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R
M9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T
M;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXI/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T
M('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P
M,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ
M,"!P=#MW:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P
M,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXH-CDL.30Y/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE
M9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW
M-2!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXI
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB
M;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HQ)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@
M,BXU<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HX)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU
M<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T
M97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXH-#@L-3DW/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HQ)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE
M(#(N-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXI/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CPO
M=&%B;&4^/"]D:78^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,"4[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,G!T.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CLG/B9N8G-P.SPO<#X\+V1I=CX\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1I9F9E<F5N8V4@0F5T
M=V5E;B!#;VYS;VQI9&%T960@26YC;VUE(%1A>"!"96YE9FET(&%N9"!!;6]U
M;G0@0V]M<'5T960@8GD@1F5D97)A;"!3=&%T=71O<GD@26YC;VUE(%1A>"!2
M871E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=CX-"CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HT+C4T
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M.S,Q+"`R,#$S+"`R,#$R(&%N9"`R,#$Q(&1U92!T;R!N970@;W!E<F%T:6YG
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M('=A<R!A<R!F;VQL;W=S("AI;B!T:&]U<V%N9',I.B`\+V9O;G0^/"]P/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP)3MF
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M96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P(&%L:6=N/3-$8V5N=&5R
M('-T>6QE/3-$)V)O<F1E<BUC;VQL87!S93IC;VQL87!S93L@=VED=&@Z,3`P
M)3LG/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MW:61T:#HV."4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG
M:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M8V]L<W!A;CTS1#$P('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ
M)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T
M>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M665A<B!%;F1E9"!$96-E;6)E<B8C,38P.S,Q+#PO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E
M<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z-C@E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,B!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T(",P,#`P,#`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/C(P,3,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P
M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD
M.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E
M.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T
M=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)W1E
M>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P
M.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXR,#$R/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R
M86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E
M;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@
M8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,C`Q
M,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$
M)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D
M:6YG+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-C@E
M.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SY);F-O;64@=&%X(&)E;F5F:70@870@9F5D97)A
M;"!S=&%T=71O<GD@<F%T93PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P
M,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C@E
M.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B@R,BPV-S@\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I
M9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^*3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B@R,RPV-3`\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E
M.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^*3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED
M=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D97(M=&]P
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B@Q-BPU,C,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^*3PO
M9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP
M('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T
M.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-C@E.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/E-T871E('1A>#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ
M)3L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[
M/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXH,3<X/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P
M86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/BD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C1D9&1D9&('-T>6QE/3-$=VED=&@Z,24[/CQP('-T>6QE/3-$)VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I
M9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA
M;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^*#@Y/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y
M;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/BD\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE
M/3-$=VED=&@Z,24[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E
M.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^*#(L-3@V/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H
M.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/BD\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C8X
M)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H
M.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HX
M)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ
M<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B@R+#4Q-3PO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE
M/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E
M.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN
M;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
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M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E.SX\<"!S
M='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y
M;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B@Q
M+#,Y-#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN
M;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXI/"]F
M;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@
M<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[
M<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HV."4[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^1&5F97)R960@8V]M<&5N<V%T:6]N(&-H87)G97,\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&
M1D9&('-T>6QE/3-$=VED=&@Z,24[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
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M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C@E.W=H
M:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
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M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS
M1'=I9'1H.C$E.SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E
M.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN
M;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/C$L,#`R/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E
M.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3L^
M/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&
M1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP
M('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL
M969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N
M-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HV."4[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
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M;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H
M.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG
M;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,C(L,S4T/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y
M;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T1W:61T:#HQ)3L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET
M92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$=VED=&@Z."4[=VAI=&4M
M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I
M9'1H.C$E.SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO
M=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R
M87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/C$X+#`Y.3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW
M:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS
M1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D
M9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C8X
M)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD
M96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL
M93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G
M=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^+3PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&
M1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP
M('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&
M1D9&('-T>6QE/3-$=VED=&@Z,24[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
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M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C@E.W=H
M:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^+3PO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W
M:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$=VED
M=&@Z,24[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
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M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A
M<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^*#,T/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E.W=H:71E
M+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/BD\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C8X)3LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4]
M,T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$
M)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
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M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1'=I9'1H.C$E.SX\<"!S='EL93TS1"=M87)G:6XM=&]P
M.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E
M.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HX)3MW
M:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG
M:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
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M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I
M9'1H.C$E.SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO
M=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R
M87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/C(X-CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET
M92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C8X)3LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL
M93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)W1E
M>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/BT\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&
M1D9&('-T>6QE/3-$=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S
M='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1'=I9'1H.C$E.SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E.W=H
M:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HX)3MW:&ET
M92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/BT\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$=VED
M=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=M87)G:6XM
M=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H
M.C$E.SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A
M<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[
M/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/C4P.3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US
M<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C8X)3LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SY$965M960@9&EV:61E;F0\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#
M('-T>6QE/3-$=VED=&@Z,24[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C@E.W=H:71E
M+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^+3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T
M:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$=VED=&@Z
M,24[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
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M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^
M/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^+3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C
M93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$=VED=&@Z,24[/CQP('-T>6QE/3-$
M)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X
M="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,C<S/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@
M<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W!A9&1I
M;F<M0F]T=&]M.C`@<'0[=VED=&@Z-C@E.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM
M87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/E!R:6]R('EE87(@=')U92!U<#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T
M:#HQ)3L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R
M87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
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M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXM/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P
M86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3L^/'`@<W1Y;&4]
M,T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y
M;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$
M)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXM/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&
M1D9&1B!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@
M<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&
M1D8@<W1Y;&4],T1W:61T:#HQ)3L^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3MW
M:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXM/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I
M9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^
M#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#
M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW
M-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H.C8X)3L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^3W1H97(\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B
M;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#
M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P
M="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$
M)W=I9'1H.C@E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ
M<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B@U-3PO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R
M86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXI/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T
M:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[
M)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1"=W:61T:#HX)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@
M(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXW-S$\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R
M+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HX)3L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXW-S4\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M8F]T
M=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[=VED=&@Z-C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A
M<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^5&]T86P@:6YC;VUE('1A>"!E>'!E
M;G-E/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T9&1D9&1B!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE
M(#(N-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G=VED=&@Z,24[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T
M;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B0\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&
M('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C
M,#`P,#`P.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG
M:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/BT\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$
M)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N
M=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G=VED=&@Z,24[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T
M=&]M.F1O=6)L92`R+C5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$
M)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B
M;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T9&1D9&1B!S='EL93TS1"=W:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI
M9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@
M(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXM/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R86YS
M<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W=I
M9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@
M8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S
M='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P,#`P,#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P
M=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U
M8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M+3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O=6)L92`R
M+C5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/"]T<CX-"CPO=&%B;&4^/"]D:78^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,"4[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C`E.V9O;G0M<VEZ93HQ,G!T.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CLG/B9N8G-P.SPO<#X\+V1I=CX\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D-O;7!O;F5N="!O9B!$969E<G)E9"!487@@07-S971S(&%N9"!,:6%B:6QI
M=&EE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQD:78^#0H\
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M9"!L:6%B:6QI=&EE<R!A<R!O9B!$96-E;6)E<B8C,38P.S,Q+"`R,#$S(&%N
M9"`R,#$R(&-O;G-I<W1E9"!O9B!T:&4@9F]L;&]W:6YG("AI;B!T:&]U<V%N
M9',I.B`\+V9O;G0^/"]P/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP
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M=&%B;&4@8F]R9&5R/3-$,"!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<]
M,T0P(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)V)O<F1E<BUC;VQL87!S93IC
M;VQL87!S93L@=VED=&@Z,3`P)3LG/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HW.24[(&)O<F1E
M<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SXF;F)S
M<#L\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED
M=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H
M=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@8V]L<W!A;CTS1#8@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P
M="`C,#`P,#`P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SY$96-E;6)E<B8C,38P.S,Q+#PO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E
M+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D
M9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z
M-SDE.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R
M9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N
M/3-$,B!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L
M:60@,"XW-7!T(",P,#`P,#`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E
M;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C(P,3,\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H
M=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I
M9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D
M97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B
M;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT
M+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXR,#$R
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E
M;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I
M;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HW.24[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SY$969E<G)E9"!T87@@87-S971S.CPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R
M86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW
M-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H
M.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$
M)W=I9'1H.C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H
M:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN
M9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P
M.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HW.24[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HQ,RXW<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
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M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S
M='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
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M+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&
M1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ
M)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C@E.W=H:71E
M+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^,3(W+#4R.3PO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP
M('!T.W=I9'1H.C<Y)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C$S+C=P=#L[;6%R9VEN+7)I
M9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
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M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P
M86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C
M93IN;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/C(Q+#,S-CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T
M:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$=VED=&@Z
M,24[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C0T9&,$9#('-T>6QE/3-$=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P
M.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^
M/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^,3@L,38S/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E.W=H:71E
M+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A
M9&1I;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG
M+51O<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-SDE.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,3,N-W!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E
M;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/D%C8W)U86QS(&%N9"!R97-E<G9E
M<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3L^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W
M:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXY+#4P,3PO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&
M1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C@E.W=H:71E
M+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
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M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T
M<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T;VTZ,"!P
M=#MW:61T:#HW.24[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HQ,RXW<'0[.VUA<F=I;BUR:6=H
M=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^0V%P:71A
M;&EZ960@<F5S96%R8V@@8V]S=',\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$=VED=&@Z
M,24[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
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M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^
M/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^,3`L-C8R/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E.W=H:71E
M+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3L^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
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M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[
M/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T
M.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@
M<'0[<&%D9&EN9RU";W1T;VTZ,"!P=#MW:61T:#HW.24[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HQ,RXW<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^1&5F97)R960@<F5V96YU93PO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y
M;&4],T1W:61T:#HQ)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US
M<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXR+#0X-CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T
M:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$=VED=&@Z
M,24[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
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M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T9&1D9&1B!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^
M/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^,BPQ.#`\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$=VED=&@Z,24[=VAI=&4M
M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V
M86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D
M9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M
M5&]P.C`N-S4@<'0[=VED=&@Z-SDE.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C$S+C=P=#L[;6%R9VEN
M+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY/
M=&AE<CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z."4[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^,2PR,C(\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I
M9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N
M=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ
M)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
M+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1"=W:61T:#HX)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P
M,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L
M:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXQ+#(R,3PO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O
M='1O;3HP('!T.W=I9'1H.C<Y)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP
M)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T9&1D9&1B!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T
M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=W:61T:#HQ)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T9&1D9&1B!S='EL93TS1"=W:61T:#HX)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXQ.3(L.#8R/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G=VED=&@Z
M,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^,3<P+#,W.3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G=VED=&@Z,24[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P861D:6YG
M+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z
M,"XW-2!P=#MW:61T:#HW.24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/DQE<W,@=F%L
M=6%T:6]N(&%L;&]W86YC93PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T0G=VED=&@Z."4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P,#`P
M,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG
M;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^*#$Y,BPW,S,\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^*3PO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS
M<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T
M;VTZ<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@
M,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^*#$W
M,"PR,S(\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M8F]T
M=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^*3PO9F]N
M=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T
M.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I
M9'1H.C<Y)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
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M(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=W:61T:#HQ)3L@8F]R
M9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S
M='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1"=W:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M(S`P,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I
M9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXQ,CD\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE
M/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A
M<F5N=#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T0G=VED=&@Z,24[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M
M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE
M/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P
M.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D97(M
M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED
M(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/C$T
M-SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HW.24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z
M,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H
M=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY$969E<G)E9"!T
M87@@;&EA8FEL:71I97,Z/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P
M,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T
M:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R
M+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W
M<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z
M,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z."4[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO
M=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T9&1D9&1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG
M+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O
M='1O;3HP('!T.W=I9'1H.C<Y)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C$S+C=P=#L[;6%R
M9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SY&:7AE9"!!<W-E=',\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$=VED=&@Z,24[/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M*#$V,CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN
M;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
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M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H
M.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HX
M)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ
M<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B@X-CPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y
M;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXI/"]F;VYT/CPO<#X\+W1D/@T*/"]T
M<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H=#HP
M+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z-SDE.R!B;W)D97(M
M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C$S+C=P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SY/=&AE<CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z
M,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@
M,"XW-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G=VED=&@Z."4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T(",P
M,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G=&5X="UA
M;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,S,\+V9O;G0^/"]P
M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#
M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F
M=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A
M;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=W:61T:#HX)3L@8F]R9&5R+6)O='1O;3IS;VQI
M9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL
M93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXH
M-C$\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[
M)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^*3PO9F]N=#X\
M+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP('!T.W!A
M9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T.W=I9'1H
M.C<Y)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O
M<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/E1O=&%L(&1E9F5R<F5D('1A>"!L:6%B:6QI=&EE
M<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N
M-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W=I9'1H.C$E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&
M1D9&('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ
M<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B@Q,CD\+V9O;G0^/"]P/CPO
M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T
M>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E
M;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/BD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W=I9'1H.C$E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O
M='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS
M1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@
M8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C
M93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=W:61T:#HX)3L@8F]R9&5R+71O
M<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P
M+C<U<'0@(S`P,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS
M1"=T97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXH,30W
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T9&1D9&1B!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXI/"]F;VYT/CPO<#X\+W1D/@T*
M/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2:6=H
M=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[=VED=&@Z-SDE.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O
M;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=M87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^3F5T(&1E9F5R<F5D('1A>"!A<W-E=',\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE
M/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A
M<F5N=#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[
M)SX\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P
M+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3ID;W5B;&4@,BXU<'0@(S`P
M,#`P,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM
M=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z."4[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T
M;VTZ9&]U8FQE(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^
M/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^+3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.F1O
M=6)L92`R+C5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R87`[)SX\
M<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#MM87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U
M<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE(#(N-7!T('1R
M86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT
M;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ9&]U8FQE
M(#(N-7!T(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B0\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$
M)W=I9'1H.C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B
M;W)D97(M8F]T=&]M.F1O=6)L92`R+C5P="`C,#`P,#`P.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/BT\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E
M.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R9&5R
M+6)O='1O;3ID;W5B;&4@,BXU<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z
M;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\+W1A8FQE/CPO9&EV/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP)3MF
M;VYT+7-I>F4Z,3)P=#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[)SXF
M;F)S<#L\+W`^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM
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M:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV
M/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T
M/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$
M4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R
M:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P
M;W)T(&ED/3-$240P14%$/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E-E;&5C
M=&5D(%%U87)T97)L>2!&:6YA;F-I86P@1&%T82`H5&%B;&5S*3QB<CX\+W-T
M<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$
M,3XQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\
M+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4V5L96-T960@475A
M<G1E<FQY($9I;F%N8VEA;"!$871A/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/&1I=CX-"CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C`E.VUA<F=I;BUR:6=H=#HP
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M=&%B;&4@8F]R9&5R/3-$,"!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<]
M,T0P(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)V)O<F1E<BUC;VQL87!S93IC
M;VQL87!S93L@=VED=&@Z,3`P)3LG/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT
M.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HU-R4[(&)O<F1E
M<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SXF;F)S
M<#L\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED
M=&@Z,24[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT
M.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H
M=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@8V]L<W!A;CTS1#$T('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U
M<'0@(S`P,#`P,#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^665A<B!%;F1E9"!$96-E;6)E<B8C,38P.S,Q
M+"`R,#$S/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@
M=')A;G-P87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\
M+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MW:61T:#HU-R4[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T
M('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H
M.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#L@8F]R
M9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL
M93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM
M;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS
M1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@
M8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N
M="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^43$\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N
M=#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A
M<F5N=#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@8V]L
M<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG
M;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD
M.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY1,CPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T
M=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN;W=R
M87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I
M9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G
M=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O
M<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,B!V86QI
M9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L
M:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T
M(",P,#`P,#`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM87)G
M:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/E$S/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI
M9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R
M9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O;3IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT+6%L
M:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S
M='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P
M,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG/CQP
M('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^430\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T
M>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N
M<W!A<F5N=#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E
M;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H
M.C4W)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\
M<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^4F5V96YU97,\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE
M/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A
M<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S
M<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O
M;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1"=W:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P
M,#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N
M.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXR+#`X-3PO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R
M86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\
M=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$
M)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N
M=#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED
M(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1"=W:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW
M:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I
M9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXS+#,Y,CPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS
M<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I
M9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C
M0T9&,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N
M-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W
M:61T:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET
M92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXR+#DR-SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R
M96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H
M.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&
M,$9#('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P
M="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T
M:#HX)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.G)I9VAT.VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXR+#@T-SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G
M=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT
M.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL
M93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[
M<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H
M.C4W)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M
M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H
M.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
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M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXH,C`L.#(U/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL
M93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
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M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E
M>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S
M<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L
M;W(],T0C1D9&1D9&('-T>6QE/3-$=VED=&@Z,24[=VAI=&4M<W!A8V4Z;F]W
M<F%P.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&
M1D9&1D8@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[/CQP
M('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
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M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^*3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3L^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4]
M,T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H
M.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG
M;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^*#$U+#8W-3PO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&
M1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P
M86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
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M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXH,3,L,#4V/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E
M.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/BD\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=P
M861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN
M9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C4W)3LG
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SY.970@;&]S<R!A;&QO8V%B;&4@=&\@
M8V]M;6]N('-T;V-K:&]L9&5R<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ
M)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO
M<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&
M0R!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y
M;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G
M:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M*#(P+#@R-3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C
M93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
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M/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA
M;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M
M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I
M9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
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M9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG
M:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO
M;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXH,3<L,38T/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
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M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$=VED=&@Z,24[=VAI=&4M<W!A8V4Z
M;F]W<F%P.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO
M9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[
M/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
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M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^*3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3L^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I
M9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA
M;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM
M87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^*#(Q+#4R-3PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXI/"]F;VYT/CPO<#X\
M+W1D/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN
M9RU2:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU"
M;W1T;VTZ,"!P=#MW:61T:#HU-R4[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I
M;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O
M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
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M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO
M=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
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M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z
M;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M
M86P[)SXH,"XQ,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US
M<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
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M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS
M1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
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M.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXH,"XP.3PO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@
M<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL
M969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A
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M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B
M9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E
M.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
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M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXH,"XP.3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET
M92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT
M.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE
M.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL
M93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
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M:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXH,"XP.3PO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&
M1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXI/"]F;VYT/CPO<#X\+W1D
M/@T*/"]T<CX-"CQT<CX-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS
M1"-#1D8P1D,@<W1Y;&4],T0G<&%D9&EN9RUL969T.C`@<'0[<&%D9&EN9RU2
M:6=H=#HP+C<U('!T.W!A9&1I;F<M5&]P.C`N-S4@<'0[<&%D9&EN9RU";W1T
M;VTZ,"!P=#MW:61T:#HU-R4[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M
M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.VUA<F=I;BUR
M:6=H=#HP)3MT97AT+6EN9&5N=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
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M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H
M.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG
M;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G
M:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^,3@R+#@T-SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
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M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C@E.W=H:71E
M+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO
M<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O
M;G0M=F%R:6%N=#H@;F]R;6%L.R<^,3@R+#DQ,SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA
M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L
M.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF
M;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G
M8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$=VED=&@Z,24[=VAI=&4M<W!A8V4Z
M;F]W<F%P.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO
M=W)A<#L^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^,3@S+#`R,CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ
M)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$=VED=&@Z,24[
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&
M1C!&0R!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@
M<W1Y;&4],T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^,C,U+#@W.3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US
M<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1"=P861D
M:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4
M;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I9'1H.C4W)3LG/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
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M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
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M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB
M<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO
M=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R
M87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\
M+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(]
M,T0C1D9&1D9&('-T>6QE/3-$=VED=&@Z,24[/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
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M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H
M.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ
M)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$=VED=&@Z,24[
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT
M/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&
M1D9&1B!S='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&
M1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
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M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$=VED=&@Z,24[=VAI
M=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O
M='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C@E.W=H:71E
M+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US
M<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D
M:6YG+5)I9VAT.C`N-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MW:61T:#HU
M-R4[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E
M<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!C;VQS<&%N/3-$,30@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$
M)W=I9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P
M.R<^/'`@<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SY996%R($5N9&5D($1E8V5M8F5R)B,Q-C`[,S$L(#(P,3(\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I
M9'1H.C$E.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N
M=#MW:&ET92US<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T
M=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT
M('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^
M#0H\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W!A9&1I;F<M;&5F=#HP
M('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U('!T
M.W=I9'1H.C4W)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E
M;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M8F]T=&]M
M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)VUA<F=I
M;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L
M.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV
M87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E
M.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T
M=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4],T0G=&5X="UA
M;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB
M;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY1,3PO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B;W)D97(M
M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US<&%C93IN
M;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M
M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P
M.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4]
M,T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[
M(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@
M<W1Y;&4],T0G=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!C;VQS<&%N/3-$,B!V
M86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z
M<V]L:60@,"XW-7!T(",P,#`P,#`[(&)O<F1E<BUB;W1T;VTZ<V]L:60@,"XW
M-7!T(",P,#`P,#`[)SX\<"!S='EL93TS1"=T97AT+6%L:6=N.F-E;G1E<CMM
M87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP
M<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/E$R/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS
M;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[(&)O<F1E<BUB;W1T;VTZ<V]L:60@
M,"XW-7!T('1R86YS<&%R96YT.W=H:71E+7-P86-E.FYO=W)A<#LG/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#HQ)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@(S`P,#`P,#L@8F]R9&5R+6)O='1O
M;3IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[)SX\<"!S='EL93TS1"=T97AT
M+6%L:6=N.F-E;G1E<CMM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P
M=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O
M;2!S='EL93TS1"=W:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@
M(S`P,#`P,#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@(S`P,#`P,#LG
M/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R.VUA<F=I;BUB;W1T;VTZ
M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G9F]N="UW96EG:'0Z8F]L9#MC;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^43,\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M
M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="!T
M<F%N<W!A<F5N=#L@8F]R9&5R+6)O='1O;3IS;VQI9"`P+C<U<'0@=')A;G-P
M87)E;G0[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=F;VYT+7=E:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I
M86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.C$E.R!B;W)D97(M=&]P.G-O
M;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P
M="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ8V5N=&5R
M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^
M#0H\=&0@8V]L<W!A;CTS1#(@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I
M9'1H.C$E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.R!B;W)D
M97(M8F]T=&]M.G-O;&ED(#`N-S5P="`C,#`P,#`P.R<^/'`@<W1Y;&4],T0G
M=&5X="UA;&EG;CIC96YT97([;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+7=E
M:6=H=#IB;VQD.V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY1-#PO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@<W1Y;&4],T0G=VED
M=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R!B
M;W)D97(M8F]T=&]M.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#MW:&ET92US
M<&%C93IN;W=R87`[)SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P=#MM
M87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M=V5I9VAT.F)O;&0[8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I
M;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O
M<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-3<E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="!T<F%N<W!A<F5N=#LG/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SY2979E;G5E<SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI
M9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z
M,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P
M1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T
M(",P,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H
M.C@E.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P
M86-E.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/C(L,S4P/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W
M:61T:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[
M(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y
M;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN
M+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US
M:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M
M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E
M:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ
M;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P
M,#`P,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C@E
M.R!B;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E
M.FYO=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/C(L-C@T/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T
M:#HQ)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI
M=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O
M<F1E<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P
M,#`[=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C@E.R!B
M;W)D97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO
M=W)A<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N
M="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA
M;G0Z(&YO<FUA;#LG/C(L.#<T/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ
M)3L@8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M
M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[
M;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS
M1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF
M;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN
M;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA
M;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T0G=VED=&@Z,24[(&)O<F1E
M<BUT;W`Z<V]L:60@,"XW-7!T('1R86YS<&%R96YT.R<^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-
M"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4]
M,T0G=VED=&@Z,24[(&)O<F1E<BUT;W`Z<V]L:60@,"XW-7!T(",P,#`P,#`[
M=VAI=&4M<W!A8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T
M=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W=I9'1H.C@E.R!B;W)D
M97(M=&]P.G-O;&ED(#`N-S5P="`C,#`P,#`P.W=H:71E+7-P86-E.FYO=W)A
M<#LG/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/C$L.#`V/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS
M1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1"=W:61T:#HQ)3L@
M8F]R9&5R+71O<#IS;VQI9"`P+C<U<'0@=')A;G-P87)E;G0[=VAI=&4M<W!A
M8V4Z;F]W<F%P.R<^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$)W!A9&1I
M;F<M;&5F=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O
M<#HP+C<U('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-3<E.R<^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
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M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO
M<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L
M.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN
M;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
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M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^*3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3L^/'`@
M<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R
M9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT
M+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O
M<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&
M1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T
M>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I
M;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW
M96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M
M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL
M93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G
M=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM=&]P
M.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P
M,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT
M+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^*#$U+#$Q
M,#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO
M<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R
M87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
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M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E
M.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
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M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXH,3<L-SDQ/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS
M1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/BD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L
M:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$=VED=&@Z
M,24[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
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M;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P
M,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R
M86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\
M+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&
M1D8@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T
M>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
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M;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M
M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA
M;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^
M*3PO9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$)W!A9&1I;F<M;&5F
M=#HP('!T.W!A9&1I;F<M4FEG:'0Z,"XW-2!P=#MP861D:6YG+51O<#HP+C<U
M('!T.W!A9&1I;F<M0F]T=&]M.C`@<'0[=VED=&@Z-3<E.R<^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMM87)G:6XM<FEG:'0Z,"4[=&5X="UI;F1E;G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
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M>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I
M9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN
M;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
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M+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
M,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A
M;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXH,38L-3`U/"]F
M;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$
M(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
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M,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI
M;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y
M;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N
M;W)M86P[)SXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$
M8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$=VED=&@Z,24[=VAI
M=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=M87)G:6XM8F]T=&]M.C!P
M=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE
M.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R
M;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C
M93IN;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/B@Q-2PQ,3`\+V9O;G0^/"]P/CPO=&0^#0H\=&0@
M=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C0T9&,$9#('-T>6QE/3-$=VED
M=&@Z,24[=VAI=&4M<W!A8V4Z;F]W<F%P.SX\<"!S='EL93TS1"=M87)G:6XM
M8F]T=&]M.C!P=#MM87)G:6XM=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O
M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF
M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^*3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3L^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXD/"]F;VYT/CPO<#X\
M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1'=I9'1H.C@E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4]
M,T0G=&5X="UA;&EG;CIR:6=H=#MM87)G:6XM8F]T=&]M.C!P=#MM87)G:6XM
M=&]P.C!P=#MM87)G:6XM;&5F=#HP<'0[.V9O;G0M9F%M:6QY.E1I;65S($YE
M=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R
M.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ
M93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT
M97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^*#$W
M+#<Y,3PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN
M;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
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M;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@
M3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF
M;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R
M:6%N=#H@;F]R;6%L.R<^)FYB<W`[/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A
M;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H
M.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O
M='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT
M+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N
M="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE
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M.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z
M;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[
M9F]N="UV87)I86YT.B!N;W)M86P[)SXH,C`L-30S/"]F;VYT/CPO<#X\+W1D
M/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL
M93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/BD\+V9O;G0^/"]P/CPO=&0^#0H\+W1R
M/@T*/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&
M1B!S='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N
M-S4@<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T
M.W=I9'1H.C4W)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA
M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E
M.W1E>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M
M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R
M;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y
M;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$
M)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B@P+C$Q
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A
M<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/BD\+V9O;G0^
M/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&
M1D9&('-T>6QE/3-$=VED=&@Z,24[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T
M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
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M>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T
M>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@
M;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T
M;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HX)3MW:&ET92US
M<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B@P+C`Y/"]F;VYT/CPO<#X\+W1D/@T*/'1D
M('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I
M9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN
M+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\
M9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S
M($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[
M9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A
M<FEA;G0Z(&YO<FUA;#LG/BD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N
M/3-$8F]T=&]M(&)G8V]L;W(],T0C1D9&1D9&('-T>6QE/3-$=VED=&@Z,24[
M/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T
M.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N
M.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P
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M;VYT+7-I>F4Z,3!P=#LG/CQF;VYT('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O
M;G0M=V5I9VAT.FYO<FUA;#MF;VYT+7-T>6QE.FYO<FUA;#MT97AT+71R86YS
M9F]R;3IN;VYE.V9O;G0M=F%R:6%N=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@
M<W1Y;&4],T1W:61T:#HX)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE
M/3-$)W1E>'0M86QI9VXZ<FEG:'0[;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B@P
M+C$P/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O
M;&]R/3-$(T9&1D9&1B!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO
M=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O
M<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC
M,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z
M,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X
M="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/BD\+V9O
M;G0^/"]P/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&)G8V]L;W(],T0C
M1D9&1D9&('-T>6QE/3-$=VED=&@Z,24[/CQP('-T>6QE/3-$)VUA<F=I;BUB
M;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N
M="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.
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M('-T>6QE/3-$)V-O;&]R.B,P,#`P,#`[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.V9O;G0M=V5I9VAT.FYO<FUA;#MF;VYT
M+7-T>6QE.FYO<FUA;#MT97AT+71R86YS9F]R;3IN;VYE.V9O;G0M=F%R:6%N
M=#H@;F]R;6%L.R<^)#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-&1D9&1D8@<W1Y;&4],T1W:61T:#HX)3MW:&ET
M92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)W1E>'0M86QI9VXZ<FEG:'0[
M;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z
M,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY
M.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN
M;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF
M;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B@P+C$Q/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T9&1D9&1B!S='EL93TS
M1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/BD\+V9O;G0^/"]P/CPO=&0^#0H\+W1R/@T*
M/'1R/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S
M='EL93TS1"=P861D:6YG+6QE9G0Z,"!P=#MP861D:6YG+5)I9VAT.C`N-S4@
M<'0[<&%D9&EN9RU4;W`Z,"XW-2!P=#MP861D:6YG+4)O='1O;3HP('!T.W=I
M9'1H.C4W)3LG/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I
M;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[;6%R9VEN+7)I9VAT.C`E.W1E
M>'0M:6YD96YT.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
M;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N
M="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F
M;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SY3:&%R97,@=7-E9"!T
M;R!C;VUP=71E(&)A<VEC(&%N9"!D:6QU=&5D(&YE="!L;W-S('!E<B!S:&%R
M92!A;&QO8V%B;&4@=&\@8V]M;6]N('-T;V-K:&]L9&5R<SPO9F]N=#X\+W`^
M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@
M<W1Y;&4],T1W:61T:#HQ)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP
M<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL
M>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL
M93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA
M;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL
M93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO
M<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B
M;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET
M92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T
M.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ
M5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4]
M,T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
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M<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P
M=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4
M:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R
M;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N
M="UV87)I86YT.B!N;W)M86P[)SXQ-34L-#,Q/"]F;VYT/CPO<#X\+W1D/@T*
M/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS
M1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R
M9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T
M.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[
M)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M
M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT
M+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT
M9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W
M:61T:#HQ)3L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN
M+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.
M97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO
M<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I
M>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[
M=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N
M8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C
M;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN
M;W=R87`[/CQP('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT
M;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W
M(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z
M(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
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M;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF
M86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@
M<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@
M4F]M86X[9F]N="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M
M<W1Y;&4Z;F]R;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT
M.B!N;W)M86P[)SXQ-C<L-CDW/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG
M;CTS1&)O='1O;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E
M.W=H:71E+7-P86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O
M;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S
M='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2
M;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US
M='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z
M(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX]
M,T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3L^
M/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[
M;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[
M9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P
M.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF
M;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N
M<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N
M=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#
M1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP
M('-T>6QE/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA
M<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O
M;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF
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M<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM
M97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N
M="US:7IE.C$P<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R
M;6%L.W1E>'0M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[
M)SXQ-S<L.#<P/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O
M;2!B9V-O;&]R/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P
M86-E.FYO=W)A<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R
M9VEN+71O<#HP<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE
M<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C
M;VQO<CHC,#`P,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT
M+7-I>F4Z,3!P=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M
M86P[=&5X="UT<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG
M/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@
M8F=C;VQO<CTS1"-#1D8P1D,@<W1Y;&4],T1W:61T:#HQ)3L^/'`@<W1Y;&4]
M,T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP<'0[;6%R9VEN+6QE
M9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE
M.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P,#`P.V9O;G0M9F%M
M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P=#MF;VYT+7=E:6=H
M=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT<F%N<V9O<FTZ;F]N
M93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO9F]N=#X\+W`^/"]T
M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@8F=C;VQO<CTS1"-#1D8P1D,@<W1Y
M;&4],T1W:61T:#HQ)3MW:&ET92US<&%C93IN;W=R87`[/CQP('-T>6QE/3-$
M)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z,'!T.VUA<F=I;BUL969T
M.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.V9O;G0M<VEZ93HQ
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P,#`P,#MF;VYT+69A;6EL
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M97AT+6%L:6=N.G)I9VAT.VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z
M,'!T.VUA<F=I;BUL969T.C!P=#L[9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N.V9O;G0M<VEZ93HQ,'!T.R<^/&9O;G0@<W1Y;&4],T0G8V]L;W(Z(S`P
M,#`P,#MF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P
M<'0[9F]N="UW96EG:'0Z;F]R;6%L.V9O;G0M<W1Y;&4Z;F]R;6%L.W1E>'0M
M=')A;G-F;W)M.FYO;F4[9F]N="UV87)I86YT.B!N;W)M86P[)SXQ.#`L-C@U
M/"]F;VYT/CPO<#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!B9V-O;&]R
M/3-$(T-&1C!&0R!S='EL93TS1'=I9'1H.C$E.W=H:71E+7-P86-E.FYO=W)A
M<#L^/'`@<W1Y;&4],T0G;6%R9VEN+6)O='1O;3HP<'0[;6%R9VEN+71O<#HP
M<'0[;6%R9VEN+6QE9G0Z,'!T.SMF;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M
M86X[9F]N="US:7IE.C$P<'0[)SX\9F]N="!S='EL93TS1"=C;VQO<CHC,#`P
M,#`P.V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;CMF;VYT+7-I>F4Z,3!P
M=#MF;VYT+7=E:6=H=#IN;W)M86P[9F]N="US='EL93IN;W)M86P[=&5X="UT
M<F%N<V9O<FTZ;F]N93MF;VYT+79A<FEA;G0Z(&YO<FUA;#LG/B9N8G-P.SPO
M9F]N=#X\+W`^/"]T9#X-"CPO='(^#0H\+W1A8FQE/CPO9&EV/CQP('-T>6QE
M/3-$)VUA<F=I;BUB;W1T;VTZ,'!T.VUA<F=I;BUT;W`Z.'!T.VUA<F=I;BUL
M969T.C`E.VUA<F=I;BUR:6=H=#HP)3MT97AT+6EN9&5N=#HP)3MF;VYT+69A
M;6EL>3I4:6UE<R!.97<@4F]M86X[9F]N="US:7IE.C$P<'0[)SXF;F)S<#L\
M+W`^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
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M"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N
M=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX
M)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ
M<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO
M:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED
M/3-$240P14-$04<^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^4W5M;6%R>2!O
M9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S("T@061D:71I;VYA
M;"!);F9O<FUA=&EO;B`H1&5T86EL*2`H55-$("0I/&)R/CPO<W1R;VYG/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0S/C$R($UO
M;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,3QB<CX\+W1H
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY/<F=A;FEZ
M871I;VX@0V]N<V]L:61A=&EO;B!!;F0@4')E<V5N=&%T:6]N($]F($9I;F%N
M8VEA;"!3=&%T96UE;G1S($1I<V-L;W-U<F4@6TQI;F4@271E;7-=/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-A<V@L
M(&-A<V@@97%U:79A;&5N=',@86YD(&UA<FME=&%B;&4@<V5C=7)I=&EE<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^(#$X.2PT,#`L,#`P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/DYU;6)E<B!O9B!R97!O<G1I;F<@=6YI=',\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^56YR96-O9VYI>F5D('1A>"!B96YE9FET<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y5;G)E8V]G;FEZ
M960@=&%X(&)E;F5F:71S+"!A8V-R=65D(&%M;W5N=',@9F]R(&EN=&5R97-T
M(&%N9"!P96YA;'1I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^06UO=6YT(')E8VQA<W-I9FEE9"!O=70@;V8@86-C=6UU;&%T960@
M;W1H97(@8V]M<')E:&5N<VEV92`H;&]S<RD@:6YC;VUE/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYU;6)E<B!O9B!/<&5R871I;F<@
M4V5G;65N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y5
M;FET960@4W1A=&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/CQS=')O;F<^3W)G86YI>F%T:6]N($-O;G-O;&ED871I;VX@06YD(%!R
M97-E;G1A=&EO;B!/9B!&:6YA;F-I86P@4W1A=&5M96YT<R!$:7-C;&]S=7)E
M(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y097)C96YT86=E(&]F(')E=F5N=64@96%R;F5D/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX.2XP,"4\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX."XP,"4\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY-"XP
M,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E!E<F-E;G1A9V4@;V8@;&]N9R!L:79E9"!A<W-E=',\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/CDN,#`E/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`N,#`E/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^36%X:6UU;3PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D]R
M9V%N:7IA=&EO;B!#;VYS;VQI9&%T:6]N($%N9"!0<F5S96YT871I;VX@3V8@
M1FEN86YC:6%L(%-T871E;65N=',@1&ES8VQO<W5R92!;3&EN92!)=&5M<UT\
M+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M0V%S:"!E<75I=F%L96YT<R!O<FEG:6YA;"!M871U<FET>2!P97)I;V0\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<S(&UO;G1H<SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y2:&5I
M;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG
M/D]R9V%N:7IA=&EO;B!#;VYS;VQI9&%T:6]N($%N9"!0<F5S96YT871I;VX@
M3V8@1FEN86YC:6%L(%-T871E;65N=',@1&ES8VQO<W5R92!;3&EN92!)=&5M
M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^0W5R<F5N8WD@=')A;G-L871I;VX@861J=7-T;65N=',\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C4P,"PP,#`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT,#`L,#`P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,S`P+#`P,"D\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D-U<G)E;F-Y('1R86YS86-T:6]N(&=A:6X@*&QO<W,I/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B`H,C`P+#`P,"D\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B`H,C`P+#`P,"D\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#X@,C`P+#`P
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE
M/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?-V5A
M.#)B,CE?.3@R-E\T,#)A7V(Y-C!?,#(Q-69D.&)A9&4X#0I#;VYT96YT+4QO
M8V%T:6]N.B!F:6QE.B\O+T,Z+S=E83@R8C(Y7SDX,C9?-#`R85]B.38P7S`R
M,35F9#AB861E."]7;W)K<VAE971S+U-H965T,S@N:'1M;`T*0V]N=&5N="U4
M<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4
M>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-
M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP
M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP
M="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@
M3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@
M(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$4Q
M3$)'/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS
M<&%N/3-$,2!R;W=S<&%N/3-$,3X\<W1R;VYG/D9A:7(@5F%L=64@2&EE<F%R
M8VAY(&9O<B!&:6YA;F-I86P@07-S971S(&%N9"!,:6%B:6QI=&EE<R!-96%S
M=7)E9"!A="!&86ER(%9A;'5E(&]N(%)E8W5R<FEN9R!"87-I<R`H1&5T86EL
M*2`H1F%I<B!686QU92P@365A<W5R96UE;G1S+"!296-U<G)I;F<L(%531"`D
M*3QB<CY);B!4:&]U<V%N9',L('5N;&5S<R!O=&AE<G=I<V4@<W!E8VEF:65D
M/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S
M,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N
M(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#X\<W1R;VYG/D9A:7(@5F%L=64@07-S971S($%N9"!,:6%B:6QI=&EE<R!-
M96%S=7)E9"!/;B!296-U<G)I;F<@0F%S:7,@6TQI;F4@271E;7-=/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^07-S971S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$X-RPV,3`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$R
M,RPU.#@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D9A:7(@5F%L=64L($EN<'5T<RP@3&5V96P@,3PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^1F%I<B!686QU92!!
M<W-E=',@06YD($QI86)I;&ET:65S($UE87-U<F5D($]N(%)E8W5R<FEN9R!"
M87-I<R!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y!<W-E=',\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C(P+#`Q,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C,L,30P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&86ER(%9A;'5E+"!);G!U=',L($QE
M=F5L(#(\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R
M;VYG/D9A:7(@5F%L=64@07-S971S($%N9"!,:6%B:6QI=&EE<R!-96%S=7)E
M9"!/;B!296-U<G)I;F<@0F%S:7,@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^07-S971S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-C<L-3DW/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3(P+#0T.#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^36]N
M97D@;6%R:V5T(&9U;F1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^/'-T<F]N9SY&86ER(%9A;'5E($%S<V5T<R!!;F0@3&EA8FEL:71I
M97,@365A<W5R960@3VX@4F5C=7)R:6YG($)A<VES(%M,:6YE($ET96US73PO
M<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%S
M<V5T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C`L,#$S/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,RPQ
M-#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/DUO;F5Y(&UA<FME="!F=6YD<R!\($9A:7(@5F%L=64L($EN<'5T<RP@
M3&5V96P@,3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS
M=')O;F<^1F%I<B!686QU92!!<W-E=',@06YD($QI86)I;&ET:65S($UE87-U
M<F5D($]N(%)E8W5R<FEN9R!"87-I<R!;3&EN92!)=&5M<UT\+W-T<F]N9SX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!<W-E=',\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(P+#`Q,SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,L,30P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y54R!'
M;W9E<FYM96YT($%G96YC:65S($1E8G0@4V5C=7)I=&EE<SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^1F%I<B!686QU92!!
M<W-E=',@06YD($QI86)I;&ET:65S($UE87-U<F5D($]N(%)E8W5R<FEN9R!"
M87-I<R!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y!<W-E=',\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$V-RPU.3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XQ,3DL,C,S/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y54R!';W9E<FYM96YT($%G96YC
M:65S($1E8G0@4V5C=7)I=&EE<R!\($9A:7(@5F%L=64L($EN<'5T<RP@3&5V
M96P@,CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O
M;F<^1F%I<B!686QU92!!<W-E=',@06YD($QI86)I;&ET:65S($UE87-U<F5D
M($]N(%)E8W5R<FEN9R!"87-I<R!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!<W-E=',\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$V-RPU.3<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,3DL,C,S/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y54R!4
M<F5A<W5R>2!396-U<FET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^/'-T<F]N9SY&86ER(%9A;'5E($%S<V5T<R!!;F0@3&EA8FEL
M:71I97,@365A<W5R960@3VX@4F5C=7)R:6YG($)A<VES(%M,:6YE($ET96US
M73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D%S<V5T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4P,#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M55,@5')E87-U<GD@4V5C=7)I=&EE<R!\($9A:7(@5F%L=64L($EN<'5T<RP@
M3&5V96P@,CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS
M=')O;F<^1F%I<B!686QU92!!<W-E=',@06YD($QI86)I;&ET:65S($UE87-U
M<F5D($]N(%)E8W5R<FEN9R!"87-I<R!;3&EN92!)=&5M<UT\+W-T<F]N9SX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!<W-E=',\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,#`\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DUU;FEC:7!A;"!3
M96-U<FET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY&86ER(%9A;'5E($%S<V5T<R!!;F0@3&EA8FEL:71I97,@365A
M<W5R960@3VX@4F5C=7)R:6YG($)A<VES(%M,:6YE($ET96US73PO<W1R;VYG
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%S<V5T<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<Q-3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^375N:6-I<&%L
M(%-E8W5R:71I97,@?"!&86ER(%9A;'5E+"!);G!U=',L($QE=F5L(#(\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D9A:7(@
M5F%L=64@07-S971S($%N9"!,:6%B:6QI=&EE<R!-96%S=7)E9"!/;B!296-U
M<G)I;F<@0F%S:7,@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^07-S971S/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^)"`W,34\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*
M#0HM+2TM+2T]7TYE>'1087)T7S=E83@R8C(Y7SDX,C9?-#`R85]B.38P7S`R
M,35F9#AB861E.`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\W96$X
M,F(R.5\Y.#(V7S0P,F%?8CDV,%\P,C$U9F0X8F%D93@O5V]R:W-H965T<R]3
M:&5E=#,Y+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E
M9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T
M/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT
M='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[
M(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP
M="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT
M("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA
M<W,],T1R97!O<G0@:60],T1)1#!%,59"1SX-"B`@("`@(#QT<CX-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#$^/'-T
M<F]N9SY3=6UM87)Y(&]F($-A<V@L($-A<V@@17%U:79A;&5N=',@86YD($UA
M<FME=&%B;&4@4V5C=7)I=&EE<R!!=F%I;&%B;&4M9F]R+7-A;&4@*$1E=&%I
M;"D@*%531"`D*3QB<CY);B!4:&]U<V%N9',L('5N;&5S<R!O=&AE<G=I<V4@
M<W!E8VEF:65D/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#X\<W1R;VYG/D-A<V@@0V%S:"!%<75I=F%L96YT<R!!;F0@
M36%R:V5T86)L92!396-U<FET:65S(%M,:6YE($ET96US73PO<W1R;VYG/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%M;W)T:7IE9"!#
M;W-T/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$X.2PT,#<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD
M(#$R-2PP.#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E5N<F5A;&EZ960@1V%I;G,\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-#8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E5N<F5A;&EZ960@3&]S<V5S/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B@T-RD\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q*3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E=3X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5S=&EM871E9"!&86ER
M(%9A;'5E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ.#DL,S<V
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,3(U+#$S,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^0V%S:"!A;F0@0V%S:"!%<75I=F%L96YT<SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^0V%S:"!#87-H($5Q
M=6EV86QE;G1S($%N9"!-87)K971A8FQE(%-E8W5R:71I97,@6TQI;F4@271E
M;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^06UO<G1I>F5D($-O<W0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C(S+#$R,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C<L-3DY/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F5U/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^17-T:6UA=&5D($9A:7(@5F%L=64\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(S+#$R,CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<L-3DY/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#87-H(&%N
M9"!#87-H($5Q=6EV86QE;G1S('P@0V%S:#PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^0V%S:"!#87-H($5Q=6EV86QE;G1S
M($%N9"!-87)K971A8FQE(%-E8W5R:71I97,@6TQI;F4@271E;7-=/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06UO<G1I
M>F5D($-O<W0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L-S8V
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,2PU-#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y%<W1I;6%T960@1F%I<B!686QU93PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,2PW-C8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ+#4T,CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V%S:"!A;F0@0V%S:"!%<75I
M=F%L96YT<R!\($UO;F5Y(&UA<FME="!F=6YD<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^0V%S:"!#87-H($5Q=6EV86QE
M;G1S($%N9"!-87)K971A8FQE(%-E8W5R:71I97,@6TQI;F4@271E;7-=/"]S
M=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06UO
M<G1I>F5D($-O<W0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(P
M+#`Q,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C,L,30P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F5U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^17-T:6UA=&5D($9A:7(@5F%L=64\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C(P+#`Q,SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,L,30P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#87-H(&%N9"!#87-H
M($5Q=6EV86QE;G1S('P@55,@1V]V97)N;65N="!!9V5N8VEE<R!$96)T(%-E
M8W5R:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\
M<W1R;VYG/D-A<V@@0V%S:"!%<75I=F%L96YT<R!!;F0@36%R:V5T86)L92!3
M96-U<FET:65S(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%M;W)T:7IE9"!#;W-T/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#,T,SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L,C`R/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F5U/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17-T:6UA=&5D
M($9A:7(@5F%L=64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L
M,S0S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,BPR,#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D-A<V@@86YD($-A<V@@17%U:79A;&5N=',@?"!-=6YI8VEP
M86P@4V5C=7)I=&EE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/CQS=')O;F<^0V%S:"!#87-H($5Q=6EV86QE;G1S($%N9"!-87)K971A
M8FQE(%-E8W5R:71I97,@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06UO<G1I>F5D($-O<W0\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW,34\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R974^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%<W1I;6%T960@
M1F%I<B!686QU93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<Q
M-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^079A:6QA8FQE+69O<BUS86QE(%-E8W5R:71I97,\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D-A<V@@0V%S:"!%<75I
M=F%L96YT<R!!;F0@36%R:V5T86)L92!396-U<FET:65S(%M,:6YE($ET96US
M73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D%M;W)T:7IE9"!#;W-T/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XQ-C8L,C@U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,3$W+#0X-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^56YR96%L:7IE9"!'86EN<SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,38\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XT-CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^56YR96%L:7IE9"!,;W-S97,\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#0W*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F5U
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17-T:6UA
M=&5D($9A:7(@5F%L=64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C$V-BPR-30\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ,3<L-3,Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y!=F%I;&%B;&4M9F]R+7-A;&4@4V5C=7)I=&EE
M<R!\(%53($=O=F5R;FUE;G0@06=E;F-I97,@1&5B="!396-U<FET:65S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY#87-H
M($-A<V@@17%U:79A;&5N=',@06YD($UA<FME=&%B;&4@4V5C=7)I=&EE<R!;
M3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y!;6]R=&EZ960@0V]S=#PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,38V+#(X-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$Q-BPY.#8\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E5N<F5A;&EZ960@1V%I;G,\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$V/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#8\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E5N<F5A;&EZ
M960@3&]S<V5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@T-RD\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D5S=&EM871E9"!&86ER(%9A;'5E/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ-C8L,C4T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,3$W+#`S,3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^079A:6QA8FQE+69O<BUS86QE
M(%-E8W5R:71I97,@?"!54R!4<F5A<W5R>2!396-U<FET:65S/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY#87-H($-A<V@@
M17%U:79A;&5N=',@06YD($UA<FME=&%B;&4@4V5C=7)I=&EE<R!;3&EN92!)
M=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y!;6]R=&EZ960@0V]S=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C4P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D5S=&EM871E9"!&86ER(%9A;'5E/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^)"`U,#`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL
M/@T*#0HM+2TM+2T]7TYE>'1087)T7S=E83@R8C(Y7SDX,C9?-#`R85]B.38P
M7S`R,35F9#AB861E.`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\W
M96$X,F(R.5\Y.#(V7S0P,F%?8CDV,%\P,C$U9F0X8F%D93@O5V]R:W-H965T
M<R]3:&5E=#0P+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U
M;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R
M<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!
M(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT
M;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C
M<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM
M96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@
M8VQA<W,],T1R97!O<G0@:60],T1)1#!%349!0SX-"B`@("`@(#QT<CX-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#$^
M/'-T<F]N9SY3=6UM87)Y(&]F($%M;W)T:7IE9"!#;W-T(&%N9"!%<W1I;6%T
M960@1F%I<B!686QU92!O9B!-87)K971A8FQE(%-E8W5R:71I97,@079A:6QA
M8FQE+69O<BUS86QE("A$971A:6PI("A54T0@)"D\8G(^26X@5&AO=7-A;F1S
M+"!U;FQE<W,@;W1H97)W:7-E('-P96-I9FEE9#PO<W1R;VYG/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^/"]T:#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^06UO<G1I>F5D
M($-O<W0\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/DUA='5R92!I;B!O;F4@>65A<B!O<B!L97-S/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XD(#DS+#8Y,3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^36%T=7)E(&%F=&5R(&]N92!Y
M96%R('1H<F]U9V@@='=O('EE87)S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XW,BPU.30\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;W4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!A;6]R=&EZ960@8V]S=#PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,38V+#(X-3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY%<W1I
M;6%T960@1F%I<B!686QU93PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^36%T=7)E(&EN(&]N92!Y96%R(&]R(&QE<W,\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/CDS+#<P,3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^36%T=7)E(&%F
M=&5R(&]N92!Y96%R('1H<F]U9V@@='=O('EE87)S/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XW,BPU-3,\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;W4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!E<W1I;6%T960@9F%I
M<B!V86QU93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q-C8L
M,C4T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B
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M/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4
M>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R
M:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$
M;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-
M"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P
M15E"04,^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O
M;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^0V%S:"P@0V%S:"!%<75I
M=F%L96YT<R!A;F0@36%R:V5T86)L92!396-U<FET:65S("T@061D:71I;VYA
M;"!);F9O<FUA=&EO;B`H1&5T86EL*2`H55-$("0I/&)R/DEN(%1H;W5S86YD
M<RP@=6YL97-S(&]T:&5R=VES92!S<&5C:69I960\+W-T<F]N9SX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,SXQ,B!-;VYT:',@
M16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3$\8G(^/"]T:#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4V-H961U;&4@3V8@
M079A:6QA8FQE($9O<B!386QE(%-E8W5R:71I97,@6TQI;F4@271E;7-=/"]S
M=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)E
M86QI>F5D(&=A:6YS(&]R(&QO<W-E<R!F<F]M('1H92!S86QE(&]F(&UA<FME
M=&%B;&4@<V5C=7)I=&EE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^)"`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^)"`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^)"`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].
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M#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$
M0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T
M9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO
M=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T
M/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T
M(&ED/3-$240P15I'0D<^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^0V]M<&]N
M96YT(&]F(%!R;W!E<G1Y(&%N9"!%<75I<&UE;G0@*$1E=&%I;"D@*%531"`D
M*3QB<CY);B!4:&]U<V%N9',L('5N;&5S<R!O=&AE<G=I<V4@<W!E8VEF:65D
M/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A
M;CTS1#$^,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@@8V]L<W!A;CTS1#$^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB
M<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY0
M<F]P97)T>2!0;&%N="!!;F0@17%U:7!M96YT(%M,:6YE($ET96US73PO<W1R
M;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DUA;G5F
M86-T=7)I;F<@97%U:7!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XD(#@L.38X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)"`W+#4W-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^4')O<&5R='DL(%!L86YT(&%N9"!%<75I
M<&UE;G0L($=R;W-S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR
M-BPP,C,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XR,RPV,3$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D9U<FYI='5R92!A;F0@9FEX='5R97,\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,#4V/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.3@S/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y,96%S96AO;&0@:6UP
M<F]V96UE;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV+#`T
M.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C4L-#0U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y!<W-E=',@:6X@<')O9W)E<W,\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C<V,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$L,#0W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y,97-S(&%C8W5M=6QA=&5D(&1E<')E
M8VEA=&EO;B!A;F0@86UO<G1I>F%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@Q-RPS,3<I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;3XH,34L-C0V*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O=3X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XX+#<P-CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<L.38U/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y-86YU9F%C='5R:6YG
M($5Q=6EP;65N="!\($UI;FEM=6T\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#X\<W1R;VYG/E!R;W!E<G1Y(%!L86YT($%N9"!%<75I<&UE
M;G0@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^17-T:6UA=&5D(%5S969U;"!,:79E<R`H26X@>65A
M<G,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG-2!Y96%R<SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/DUA;G5F86-T=7)I;F<@17%U:7!M96YT('P@36%X:6UU;3PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4')O<&5R='D@4&QA
M;G0@06YD($5Q=6EP;65N="!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%<W1I;6%T960@57-E9G5L
M($QI=F5S("A);B!Y96%R<RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<Q-"!Y96%R<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/DQA8B!%<75I<&UE;G0\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E!R;W!E<G1Y(%!L86YT($%N
M9"!%<75I<&UE;G0@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')O<&5R='DL(%!L86YT(&%N9"!%
M<75I<&UE;G0L($=R;W-S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XW+#(R-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C8L-S4U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y,86(@17%U:7!M96YT('P@36EN:6UU;3PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4')O<&5R='D@
M4&QA;G0@06YD($5Q=6EP;65N="!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%<W1I;6%T960@57-E
M9G5L($QI=F5S("A);B!Y96%R<RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<U('EE87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^3&%B($5Q=6EP;65N="!\($UA>&EM=6T\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E!R;W!E
M<G1Y(%!L86YT($%N9"!%<75I<&UE;G0@6TQI;F4@271E;7-=/"]S=')O;F<^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17-T:6UA=&5D
M(%5S969U;"!,:79E<R`H26X@>65A<G,I/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG,3,@>65A<G,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUP=71E<B!%<75I<&UE;G0\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E!R;W!E
M<G1Y(%!L86YT($%N9"!%<75I<&UE;G0@6TQI;F4@271E;7-=/"]S=')O;F<^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17-T:6UA=&5D
M(%5S969U;"!,:79E<R`H26X@>65A<G,I/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG,R!Y96%R<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;W!E<G1Y+"!0;&%N="!A;F0@17%U
M:7!M96YT+"!'<F]S<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M)"`Q+#DV,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@,2PX,#<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D9U<FYI='5R92!A;F0@1FEX='5R97,\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E!R;W!E<G1Y
M(%!L86YT($%N9"!%<75I<&UE;G0@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17-T:6UA=&5D(%5S
M969U;"!,:79E<R`H26X@>65A<G,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG,R!Y96%R<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/DQE87-E:&]L9"!);7!R;W9E;65N=',@?"!-
M:6YI;75M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T
M<F]N9SY0<F]P97)T>2!0;&%N="!!;F0@17%U:7!M96YT(%M,:6YE($ET96US
M73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D5S=&EM871E9"!5<V5F=6P@3&EV97,@*$EN('EE87)S*3PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)S4@>65A<G,\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y,96%S96AO;&0@26UP
M<F]V96UE;G1S('P@36%X:6UU;3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/CQS=')O;F<^4')O<&5R='D@4&QA;G0@06YD($5Q=6EP;65N
M="!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y%<W1I;6%T960@57-E9G5L($QI=F5S("A);B!Y96%R
M<RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<W('EE87)S/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*
M("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?-V5A.#)B
M,CE?.3@R-E\T,#)A7V(Y-C!?,#(Q-69D.&)A9&4X#0I#;VYT96YT+4QO8V%T
M:6]N.B!F:6QE.B\O+T,Z+S=E83@R8C(Y7SDX,C9?-#`R85]B.38P7S`R,35F
M9#AB861E."]7;W)K<VAE971S+U-H965T-#,N:'1M;`T*0V]N=&5N="U4<F%N
M<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E
M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@
M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C
M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T
M>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T
M(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB
M;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$590D%#
M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N
M/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E!R;W!E<G1Y(&%N9"!%<75I<&UE
M;G0@+2!!9&1I=&EO;F%L($EN9F]R;6%T:6]N("A$971A:6PI("A54T0@)"D\
M8G(^26X@5&AO=7-A;F1S+"!U;FQE<W,@;W1H97)W:7-E('-P96-I9FEE9#PO
M<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X]
M,T0S/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$S/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3(\
M8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q
M,3QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N
M9SY0<F]P97)T>2!0;&%N="!!;F0@17%U:7!M96YT(%M,:6YE($ET96US73PO
M<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$
M97!R96-I871I;VX@86YD(&%M;W)T:7IA=&EO;CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`Q+#,R-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,2PR,#<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$L,S`S/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D
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M:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-
M"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0]
M,T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T
M97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E
M(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@
M("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P145'044^#0H@("`@
M("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O
M=W-P86X],T0R/CQS=')O;F<^26YT86YG:6)L92!!<W-E=',@+2!!9&1I=&EO
M;F%L($EN9F]R;6%T:6]N("A$971A:6PI("A54T0@)"D\8G(^26X@5&AO=7-A
M;F1S+"!U;FQE<W,@;W1H97)W:7-E('-P96-I9FEE9#PO<W1R;VYG/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0S/C$R($UO;G1H
M<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,3QB<CX\+W1H/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY&:6YI=&4@3&EV
M960@26YT86YG:6)L92!!<W-E=',@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%M;W)T:7IA=&EO
M;B!O9B!I;G1A;F=I8FQE(&%S<V5T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^)"`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)"`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`R.3D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/DUA;G5F86-T=7)I;F<@4')O8V5S<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D9I
M;FET92!,:79E9"!);G1A;F=I8FQE($%S<V5T<R!;3&EN92!)=&5M<UT\+W-T
M<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17-T
M:6UA=&5D('5S969U;"!L:69E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<U('EE87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y#=7-T;VUE<B!296QA=&EO;G-H:7!S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^1FEN:71E
M($QI=F5D($EN=&%N9VEB;&4@07-S971S(%M,:6YE($ET96US73PO<W1R;VYG
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%<W1I;6%T
M960@=7-E9G5L(&QI9F4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)S4@>65A<G,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE
M>'1087)T7S=E83@R8C(Y7SDX,C9?-#`R85]B.38P7S`R,35F9#AB861E.`T*
M0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\W96$X,F(R.5\Y.#(V7S0P
M,F%?8CDV,%\P,C$U9F0X8F%D93@O5V]R:W-H965T<R]3:&5E=#0U+FAT;6P-
M"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-
M"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-
M"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#
M;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F
M+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W
M+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^
M/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@
M:60],T1)1#!%04A!0SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#$^/'-T<F]N9SY#;VUP;VYE
M;G0@;V8@0W5R<F5N="!!8V-R=65D($QI86)I;&ET:65S("A$971A:6PI("A5
M4T0@)"D\8G(^26X@5&AO=7-A;F1S+"!U;FQE<W,@;W1H97)W:7-E('-P96-I
M9FEE9#PO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E
M8RX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M1&5C+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^/'-T<F]N9SY!8V-R=65D($QI86)I;&ET:65S($%B<W1R86-T/"]S
M=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4&%Y
M<F]L;"!A;F0@<F5L871E9"!E>'!E;G-E<SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)"`S+#8S.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/B0@-"PU,S@\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DQE9V%L(&5X<&5N<V5S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,S@\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS.38\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1H:7)D('!A
M<G1Y(')E<V5A<F-H(&%N9"!D979E;&]P;65N="!E>'!E;G-E<SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPT,#,\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+#(P-SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W1H97(@86-C
M<G5E9"!L:6%B:6QI=&EE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,2PW.#8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ+#DR,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O=3X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E1O=&%L/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XD(#@L,38V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`Q,"PP-C,\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*
M#0HM+2TM+2T]7TYE>'1087)T7S=E83@R8C(Y7SDX,C9?-#`R85]B.38P7S`R
M,35F9#AB861E.`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\W96$X
M,F(R.5\Y.#(V7S0P,F%?8CDV,%\P,C$U9F0X8F%D93@O5V]R:W-H965T<R]3
M:&5E=#0V+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E
M9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T
M/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT
M='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[
M(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP
M="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT
M("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA
M<W,],T1R97!O<G0@:60],T1)1#!%2DM"2SX-"B`@("`@(#QT<CX-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T
M<F]N9SY3>6UP:&]N>2!$>6YA;6\L($EN8RX@+2!!9&1I=&EO;F%L($EN9F]R
M;6%T:6]N("A$971A:6PI("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#@^,2!-;VYT:',@16YD
M960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XS
M($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O
M;'-P86X],T0S/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H(&-O;'-P86X],T0Q/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H(&-O;'-P86X],T0R/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0R/C$@36]N=&AS($5N9&5D
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^/"]T:#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/D]C="X@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^36%Y(#`Y+"`R,#$R/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/DYO=BX@,#,L(#(P,3$\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^3F]V+B`P,BP@,C`Q,#QB<CX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y!<'(N(#,P+"`R,#$P/&)R/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/D%P<BX@,38L(#(P,3`\8G(^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^3F]V+B`S,"P@,C`P.3QB<CX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y!<'(N(#$X+"`R,#`V/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P,3`\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3`\8G(^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^07!R+B`S,"P@,C`P-SQB<CX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$Q/&)R
M/D9A:7(@5F%L=64L($EN<'5T<RP@3&5V96P@,SQB<CX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$P/&)R/D9A:7(@5F%L=64L
M($EN<'5T<RP@3&5V96P@,SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y*=6XN(#,P+"`R,#$P/&)R/E=A<G)A;G0@3&EA8FEL:71Y/&)R/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D%P<BX@,3@L(#(P,#8\8G(^
M36%X:6UU;3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N
M(#,Q+"`R,#$S/&)R/E-$23QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y!<'(N(#$X+"`R,#`V/&)R/E-$23QB<CX\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:#Y!<'(N(#$X+"`R,#`V/&)R/DAO;&1I;F=S/&)R/CPO
M=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D)U<VEN
M97-S($%C<75I<VET:6]N($5Q=6ET>2!);G1E<F5S=',@27-S=65D($]R($ES
M<W5A8FQE(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DEN=F5S=&UE
M;G1S(&EN(%-$23PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`U,"PP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W=N97)S:&EP('!E<F-E
M;G1A9V4@8GD@<&%R96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ,#`N,#`E/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`P+C`P)3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5V%R<F%N=',@
M:7-S=65D('1O('!U<F-H87-E(&-O;6UO;B!S=&]C:SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C<L,#,X+#(Q,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#`P,"PP,#`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XR+#`P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E=A<G)A;G1S(&5X97)C:7-A8FQE('!E<FEO
M9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<U('EE87)S
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)S4@>65A<G,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG-2!Y96%R<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<U('EE87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y787)R86YT
M<R!E>&5R8VES92!P<FEC93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$N-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$N-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$N.30\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XW+C,R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$N.38\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y787)R86YT
M(&5X97)C:7-E9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,34L,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O;6UO;B!S=&]C:R!I<W-U
M92!O;B!A8W%U:7-I=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,3,L,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DES<W5E9"!N;W1E
M('1O($AO;&1I;F=S+"!P<FEN8VEP86P@86UO=6YT/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-2PP,#`L,#`P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^4')I;F-I<&%L(&%M;W5N="P@9'5E(&1A=&4\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/D1E8R`S,2P-"@D),C`Q,CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D)U<VEN97-S(&%C<75I<VET:6]N(&-O;G1I;F=E;G0@8V]N<VED
M97)A=&EO;B!P97)C96YT86=E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XU,"XP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y"=7-I;F5S<R!A8W%U
M:7-I=&EO;B!U<&9R;VYT('!A>6UE;G0\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C4P+#`P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@
M<')E<V5N="!V86QU92!M;V1E;"P@9&ES8V]U;G0@<F%T93PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3<N,#`E/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^4F5P87EM96YT(&]F(&YO=&4@<&%Y86)L93PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$U+#`P,"PP,#`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/DES<W5A;F-E(&]F(&-O;6UO;B!S=&]C:RP@;F5T(&]F(&ES<W5A;F-E(&-O
M<W1S("AI;B!S:&%R97,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XW.2PU-S`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,3<L-3`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C(W+#8P,"PP,#`\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-BPT-3`L,#`P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PP
M-S8L-#(P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,S`L,CDS+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.;VX@;W!E<F%T:6YG
M(&EN8V]M92!E>'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$Q+#$P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0VAA;F=E<R!I;B!W
M87)R86YT(&%N9"!C;VYT:6YG96YT(&-O;G-I9&5R871I;VX@;&EA8FEL:71Y
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M.#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C(L,C`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/CDL-3`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DEN8W)E87-E(&EN(&%D
M9&ET:6]N86P@<&%I9"!I;B!C87!I=&%L/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#8P,"PP,#`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y296-L
M87-S:69I8V%T:6]N(&]F('=A<G)A;G1Y(&QI86)I;&ET>2!I;G1O(&5Q=6ET
M>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,3(L,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E=A<G)A;G1S(&]U='-T86YD:6YG/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,"PY,3,L.#<S
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C8L-S8U+#$R.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y#87-H(&9L;W=S(&1I<V-O=6YT960@<F%T
M93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M-BXP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^17-T:6UA=&5D(&9A:7(@=F%L=64@;V8@8V]N=&EN
M9V5N="!L:6%B:6QI='D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XD(#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*
M#0HM+2TM+2T]7TYE>'1087)T7S=E83@R8C(Y7SDX,C9?-#`R85]B.38P7S`R
M,35F9#AB861E.`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\W96$X
M,F(R.5\Y.#(V7S0P,F%?8CDV,%\P,C$U9F0X8F%D93@O5V]R:W-H965T<R]3
M:&5E=#0W+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E
M9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T
M/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT
M='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[
M(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP
M="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT
M("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA
M<W,],T1R97!O<G0@:60],T1)1#!%3T9!0SX-"B`@("`@(#QT<CX-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#$^/'-T
M<F]N9SY&=71U<F4@36EN:6UU;2!087EM96YT<R!5;F1E<B!.;VXM0V%N8V5L
M86)L92!0;W)T:6]N(&]F($]P97)A=&EN9R!,96%S97,@*$1E=&%I;"D@*%53
M1"`D*3QB<CY);B!4:&]U<V%N9',L('5N;&5S<R!O=&AE<G=I<V4@<W!E8VEF
M:65D/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C
M+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^/'-T<F]N9SY/<&5R871I;F<@3&5A<V5D($%S<V5T<R!;3&EN92!)=&5M
M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/C(P,30\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,BPR,S,\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/C(P,34\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L,C@R/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#XR
M,#$V/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#,S,SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^,C`Q
M-SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPS.#(\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/C(P,3@\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,S4Q/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4:&5R96%F
M=&5R/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#0Y.3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O
M=&%L/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$S+#`X,#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*
M("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?-V5A.#)B
M,CE?.3@R-E\T,#)A7V(Y-C!?,#(Q-69D.&)A9&4X#0I#;VYT96YT+4QO8V%T
M:6]N.B!F:6QE.B\O+T,Z+S=E83@R8C(Y7SDX,C9?-#`R85]B.38P7S`R,35F
M9#AB861E."]7;W)K<VAE971S+U-H965T-#@N:'1M;`T*0V]N=&5N="U4<F%N
M<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E
M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@
M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C
M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T
M>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T
M(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB
M;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$57,D%)
M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N
M/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D-O;6UI=&UE;G1S(&%N9"!#;VYT
M:6YG96YC:65S("T@061D:71I;VYA;"!);F9O<FUA=&EO;B`H1&5T86EL*3QB
M<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS
M<&%N/3-$,SXQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:"!C;VQS<&%N/3-$,CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:"!C;VQS<&%N/3-$,3X\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:"!C;VQS<&%N/3-$,CXQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XS($UO;G1H<R!%;F1E9#PO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C,@36]N=&AS($5N9&5D
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^,R!-;VYT
M:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N
M/3-$,3X\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CY54T0@*"0I/&)R/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^
M55-$("@D*3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N
M(#,Q+"`R,#$Q/&)R/E531"`H)"D\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CY$975T<V-H92!"86YK(%-E8W5R
M:71I97,\8G(^55-$("@D*3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y$96,N(#,Q+"`R,#$S/&)R/D1E=71S8VAE($)A;FL@4V5C=7)I=&EE
M<SQB<CY%55(@*"8C>#(P86,[*3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/D1E=71S8VAE($)A;FL@4V5C=7)I
M=&EE<SQB<CY54T0@*"0I/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/D1E8RX@,S$L(#(P,3,\8G(^0F5R:V5L97DL($-A;&EF;W)N:6$@*'1H
M92`B0F5R:V5L97D@3&5A<V4B*3QB<CY54T0@*"0I/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^1'5S<V5L9&]R
M9BP@1V5R;6%N>2`H=&AE(")$=7-S96QD;W)F($QE87-E(BD\8G(^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`P-#QB<CY"97)K
M96QE>2P@0V%L:69O<FYI82`H=&AE(")"97)K96QE>2!,96%S92(I/&)R/E53
M1"`H)"D\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S
M,2P@,C`Q,SQB<CY"97)K96QE>2P@0V%L:69O<FYI82`H=&AE(")"97)K96QE
M>2!,96%S92(I/&)R/E531"`H)"D\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CY"97)K96QE>2P@0V%L:69O<FYI
M82`H=&AE(")"97)K96QE>2!,96%S92(I/&)R/E531"`H)"D\8G(^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`P-#QB<CY"97)K
M96QE>2P@0V%L:69O<FYI82`H=&AE(")"97)K96QE>2!,96%S92(I/&)R/D-O
M;G1I;F=E;F-Y+"!"/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/D1E8RX@,S$L(#(P,#0\8G(^0F5R:V5L97DL($-A;&EF;W)N:6$@*'1H92`B
M0F5R:V5L97D@3&5A<V4B*3QB<CY#;VYT:6YG96YC>2P@0CQB<CY-:6YI;75M
M/&)R/E531"`H)"D\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M1&5C+B`S,2P@,C`P-#QB<CY"97)K96QE>2P@0V%L:69O<FYI82`H=&AE(")"
M97)K96QE>2!,96%S92(I/&)R/D-O;G1I;F=E;F-Y+"!!/&)R/E531"`H)"D\
M8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`P
M-#QB<CY"97)K96QE>2P@0V%L:69O<FYI82`H=&AE(")"97)K96QE>2!,96%S
M92(I/&)R/D-O;G1I;F=E;F-Y+"!!/&)R/DUI;FEM=6T\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`P-#QB<CY"97)K96QE
M>2P@0V%L:69O<FYI82`H=&AE(")"97)K96QE>2!,96%S92(I/&)R/D-O;G1I
M;F=E;F-Y+"!!/&)R/DUA>&EM=6T\8G(^55-$("@D*3QB<CX\+W1H/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY,;W-S($-O;G1I;F=E
M;F-I97,@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/<&5R871I;F<@;&5A
M<V5S(&5X<&ER871I;VX@9&%T93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)S(P,3@M,#8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG,C`R,RTP,SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y5;F]C8W5P
M:65D(&9A8VEL:71Y(&5X<&5N<V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@.3(V+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Y,#`L,#`P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y296YT
M(&5X<&5N<V4L(&YE=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,2PY,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,2PW,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,2PW,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&5F
M97)R960@<F5N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-C`P
M+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C8P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3&5T=&5R(&]F(&-R961I="!P
M;&5D9V5D(&%S('-E8W5R:71Y/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,C`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C0P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VQL871E<F%L
M:7IE9"!C97)T:69I8V%T92!O9B!D97!O<VET/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XR,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(P,"PP,#`\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT,#`L,#`P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#`P
M+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y497)M<R!O9B!T:&4@;&5A<V4\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)TEF('1H92!T;W1A;"!A;6]U;G0@
M;V8@;W5R(&-A<V@L(&-A<V@@97%U:79A;&5N=',@86YD(&UA<FME=&%B;&4@
M<V5C=7)I=&EE<R!F86QL<R!B96QO=R`D,C`@;6EL;&EO;B!F;W(@82!P97)I
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M=6%L(&-A<V@@86YD(&-A<V@@97%U:79A;&5N=',@<F5M86EN<R!A8F]V92`D
M,C`@;6EL;&EO;B!F;W(@82!P97)I;V0@;V8@,3(@8V]N<V5C=71I=F4@;6]N
M=&AS+CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D-A<V@L(&-A<V@@97%U:79A;&5N=',@86YD(&UA<FME
M=&%B;&4@<V5C=7)I=&EE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,3@Y+#0P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(P+#`P,"PP,#`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(P+#`P,"PP
M,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D-O;G1I;F=E;F-Y('!E<FEO9"!F;W(@8V%S:"P@8V%S:"!E<75I=F%L
M96YT<R!A;F0@;6%R:V5T86)L92!S96-U<FET:65S/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<Q,B!M;VYT:',\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<S,"!D
M87ES/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^26YC<F5A<V4@:6X@86UO=6YT(&]F('1H92!S96-U<FET>2!D97!O
M<VET/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,2PQ,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D9U='5R92!P87EM96YT<R!O8FQI9V%T:6]N/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#0L-3`P+#`P,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X
M=%!A<G1?-V5A.#)B,CE?.3@R-E\T,#)A7V(Y-C!?,#(Q-69D.&)A9&4X#0I#
M;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S=E83@R8C(Y7SDX,C9?-#`R
M85]B.38P7S`R,35F9#AB861E."]7;W)K<VAE971S+U-H965T-#DN:'1M;`T*
M0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*
M0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*
M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O
M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M
M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N
M:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\
M+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I
M9#TS1$E$,$513$%+/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D-O;&QA8F]R
M871I=F4@4F5S96%R8V@L($1E=F5L;W!M96YT+"!A;F0@3&EC96YS92!!9W)E
M96UE;G1S("T@061D:71I;VYA;"!);F9O<FUA=&EO;B`H1&5T86EL*2`H55-$
M("0I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M(&-O;'-P86X],T0Q/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$@36]N=&AS($5N9&5D/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,R!-;VYT:',@
M16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$
M-#XQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:"!C;VQS<&%N/3-$,SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C
M;VQS<&%N/3-$,3XQ($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H(&-O;'-P86X],T0S/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$@36]N=&AS($5N
M9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^
M,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@
M8V]L<W!A;CTS1#(^,R!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:"!C;VQS<&%N/3-$,CXQ,B!-;VYT:',@16YD960\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3X\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3X\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3X\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3X\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:"!C;VQS<&%N/3-$,3X\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:"!C;VQS<&%N/3-$,3X\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:"!C;VQS<&%N/3-$,3XQ($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N
M(#,Q+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E
M8RX@,S$L(#(P,#@\8G(^1VQA>&\L(%-M:71H+"!+;&EN93QB<CY0<F]J96-T
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P
M,3,\8G(^1VQA>&\L(%-M:71H+"!+;&EN93QB<CX\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$S/&)R/D=L87AO+"!3;6ET:"P@
M2VQI;F4\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S
M,2P@,C`Q,CQB<CY';&%X;RP@4VUI=&@L($ML:6YE/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3$\8G(^1VQA>&\L(%-M
M:71H+"!+;&EN93QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$
M96,N(#,Q+"`R,#$Q/&)R/D=L87AO+"!3;6ET:"P@2VQI;F4\8G(^17AP86YS
M:6]N/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L
M(#(P,3,\8G(^1VQA>&\L(%-M:71H+"!+;&EN93QB<CY-87AI;75M/&)R/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^
M1VQA>&\L(%-M:71H+"!+;&EN93QB<CY-87AI;75M/&)R/D%N;G5A;"!N970@
M<V%L97,@;6EL97-T;VYE<R!A8VAI979E9#QB<CX\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$S/&)R/D=L87AO+"!3;6ET:"P@
M2VQI;F4\8G(^36EN:6UU;3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y397`N(#,P+"`R,#`V/&)R/D%S=')A(%IE;F5C83QB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$S/&)R/D%S=')A
M(%IE;F5C83QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N
M(#,Q+"`R,#$R/&)R/D%S=')A(%IE;F5C83QB<CX\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$Q/&)R/D%S=')A(%IE;F5C83QB
M<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y/8W0N(#,Q+"`R,#$Q
M/&)R/D%M96YD;65N=#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y$96,N(#,Q+"`R,#$Q/&)R/D%M96YD;65N=#QB<CX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/D%M96YD;65N=#QB
M<CY!9'9A;F-E('1H92!P<F]G<F%M(&9O;&QO=VEN9R!C;VUP;&5T:6]N(&]F
M(%!H87-E(#)A/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA
M<BX@,S$L(#(P,3(\8G(^06UE;F1M96YT/&)R/D%D=F%N8V4@=&AE('!R;V=R
M86T@9F]L;&]W:6YG(&-O;7!L971I;VX@;V8@4&AA<V4@,F$\8G(^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CY!;65N
M9&UE;G0\8G(^061V86YC92!T:&4@<')O9W)A;2!F;VQL;W=I;F<@8V]M<&QE
M=&EO;B!O9B!0:&%S92`R83QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y$96,N(#,Q+"`R,#$S/&)R/D%M96YD;65N=#QB<CY-87AI;75M/&)R
M/D%D=F%N8V4@=&AE('!R;V=R86T@9F]L;&]W:6YG(&-O;7!L971I;VX@;V8@
M4&AA<V4@,F$\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5P
M+B`S,"P@,C`Q,SQB<CY(97!A=&EC($9I8G)O<VES(&%N9"!#:7)R:&]S:7,\
M8G(^3F%T:6]N86P@26YS=&ET=71E<R!O9B!(96%L=&@\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q,CQB<CY!=71O:6UM
M=6YE($1I<V5A<V4\8G(^3F%T:6]N86P@26YS=&ET=71E<R!O9B!(96%L=&@\
M8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%Y(#,Q+"`R,#$R
M/&)R/E)H975M871O:60@07)T:')I=&ES/&)R/DYA=&EO;F%L($EN<W1I='5T
M97,@;V8@2&5A;'1H/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/DIU;"X@,S$L(#(P,3$\8G(^4VMI;B!!=71O:6UM=6YE($EN9FQA;6UA=&EO
M;CQB<CY.871I;VYA;"!);G-T:71U=&5S(&]F($AE86QT:#QB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y!=6<N(#,Q+"`R,#$P/&)R/DA"5CQB
M<CY.871I;VYA;"!);G-T:71U=&5S(&]F($AE86QT:#QB<CX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y*=6PN(#,Q+"`R,#$P/&)R/DA05CQB<CY.
M871I;VYA;"!);G-T:71U=&5S(&]F($AE86QT:#QB<CX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R,#`X/&)R/DE34R!496-H;F]L
M;V=Y/&)R/DYA=&EO;F%L($EN<W1I='5T97,@;V8@2&5A;'1H/&)R/CPO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E!R;V1U8W0@
M26YF;W)M871I;VX@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/DYU;6)E<B!O9B!P<F]G<F%M<R!F;W(@<F5S96%R8V@@86YD(&5A<FQY
M(&-L:6YI8V%L(&1E=F5L;W!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!O=&5N=&EA
M;"!M:6QE<W1O;F4@<&%Y;65N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@,3(U+#`P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#8P+#`P,"PP,#`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D-O;&QA8F]R871I;VX@4F5V96YU93PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$P+#`P,"PP,#`\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PW,#(L,#`P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PT
M,C@L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,2PT,C@L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XW,C`L,#`P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-S(P+#`P,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$R,"PP,#`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+#`P
M,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-BPP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,BPV,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y2979E;G5E(&9R
M;VT@;6EL97-T;VYE('!A>6UE;G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$R+#`P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,34L,#`P+#`P,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,L,#`P+#`P,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR
M+#4P-RPP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XR+#0V,BPP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XV-#(L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(P+#`P,"PP,#`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,#`L,#`P
M+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D1E9F5R<F5D(')E=F5N=64@<F5C;V=N:71I;VX@<&5R
M:6]D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)S<@
M>65A<G,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)S8@>65A<G,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)S4P(&UO;G1H<SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^061D
M:71I;VYA;"!R979E;G5E(')E8V]G;FEZ960\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,S`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^1&5F97)R960@<F5V96YU93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XR+#4P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XR+#4P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT+#(P,"PP,#`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT+#@P
M,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XW+#<P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4F5S96%R8V@@8V]L;&%B
M;W)A=&EO;B!A;F0@;&EC96YS92!A9W)E96UE;G0@<&5R:6]D/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)S,@>65A<G,\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y#;W-T(&]F(&-L:6YI8V%L(&1E=F5L;W!M96YT(&%C
M=&EV:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C(P+#`P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1W)A;G1S(')E8V5I
M=F%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,C`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C8P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT,#`L,#`P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-C`P+#`P,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L-#`P
M+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C8P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y#;VYT<F%C="!A9W)E96UE;G0@<&5R:6]D/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<U('EE87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y#;VYT<F%C="!A=V%R9&5D('1O(&1E=F5L;W`@
M=&5C:&YO;&]G>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$W+#`P,"PP,#`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y
M/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S=E83@R8C(Y7SDX,C9?
M-#`R85]B.38P7S`R,35F9#AB861E.`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL
M93HO+R]#.B\W96$X,F(R.5\Y.#(V7S0P,F%?8CDV,%\P,C$U9F0X8F%D93@O
M5V]R:W-H965T<R]3:&5E=#4P+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC
M;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H
M=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*
M("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS
M1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E
M>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@
M5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@
M("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%2E="1SX-"B`@("`@
M(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W
M<W!A;CTS1#(^/'-T<F]N9SY3=6UM87)Y(&]F(%)E=F5N=64@4F5C;V=N:7IE
M9"!U;F1E<B!!9W)E96UE;G0@=VET:"!'4TL@*$1E=&%I;"D@*%531"`D*3QB
M<CY);B!4:&]U<V%N9',L('5N;&5S<R!O=&AE<G=I<V4@<W!E8VEF:65D/"]S
M=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS
M1#@^,R!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:"!C;VQS<&%N/3-$-CXQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ($UO;G1H<R!%;F1E9#PO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Y/C$R($UO;G1H
M<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P,3,\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q,SQB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$S/&)R/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`Q,CQB<CX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$R/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,3(\
M8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q
M,SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R
M,#$R/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L
M(#(P,3$\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S
M,2P@,C`Q,SQB<CY.871I;VYA;"!);G-T:71U=&5S(&]F($AE86QT:#QB<CX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R
M/DYA=&EO;F%L($EN<W1I='5T97,@;V8@2&5A;'1H/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3$\8G(^3F%T:6]N86P@
M26YS=&ET=71E<R!O9B!(96%L=&@\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^1&5C+B`S,2P@,C`P.#QB<CY';&%X;RP@4VUI=&@L($ML:6YE
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P
M,3,\8G(^1VQA>&\L(%-M:71H+"!+;&EN93QB<CX\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/D=L87AO+"!3;6ET:"P@
M2VQI;F4\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S
M,2P@,C`Q,3QB<CY';&%X;RP@4VUI=&@L($ML:6YE/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^07-T<F$@6F5N
M96-A/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L
M(#(P,3(\8G(^07-T<F$@6F5N96-A/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/D1E8RX@,S$L(#(P,3$\8G(^07-T<F$@6F5N96-A/&)R/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^
M3F%T:6]N86P@26YS=&ET=71E($]F($%L;&5R9WD@06YD($EN9F5C=&EO=7,@
M1&ES96%S97,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C
M+B`S,2P@,C`Q,CQB<CY.871I;VYA;"!);G-T:71U=&4@3V8@06QL97)G>2!!
M;F0@26YF96-T:6]U<R!$:7-E87-E<SQB<CX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$Q/&)R/DYA=&EO;F%L($EN<W1I='5T
M92!/9B!!;&QE<F=Y($%N9"!);F9E8W1I;W5S($1I<V5A<V5S/&)R/CPO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E!R;V1U8W0@
M26YF;W)M871I;VX@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/DEN:71I86P@<&%Y;65N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XD(#$P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,2PW,#(\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$L-#(X/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q+#0R
M.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/B0@-S(P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^)"`W,C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#$R,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^36EL97-T;VYE(')E=F5N=64\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,BPP,#`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XQ-2PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XR+#4P-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C(L-#8R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^-C0R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F]U/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5&]T86P@<F5V96YU97,\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L.#0W/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPY,C<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+#,Y,CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L
M,#@U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,2PX,#8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XR+#@W-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C(L-C@T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,BPS-3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,2PR-3$\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY+#<Q-#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(Q+#8Q-#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M+#<P,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$L-#(X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,38L-#(X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,RPR,C<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XS+#$X,CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<V,CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1W)A;G0@<F5V96YU
M93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#4L
M,3,X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^)"`S+#DS.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/B0@,RPQ,3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XD(#$L,#,U/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`S-C@\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,X,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#0L
M,3`S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^)"`S+#4W,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/B0@,BPW,S`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM
M+2T]7TYE>'1087)T7S=E83@R8C(Y7SDX,C9?-#`R85]B.38P7S`R,35F9#AB
M861E.`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\W96$X,F(R.5\Y
M.#(V7S0P,F%?8CDV,%\P,C$U9F0X8F%D93@O5V]R:W-H965T<R]3:&5E=#4Q
M+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN
M=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA
M<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U
M:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S
M970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,]
M,T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S
M8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R
M97!O<G0@:60],T1)1#!%33%"23X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY#
M;VUP=71A=&EO;B!O9B!"87-I8R!A;F0@1&EL=71E9"!%87)N:6YG<R!097(@
M4VAA<F4@*$1E=&%I;"D@*%531"`D*3QB<CY);B!4:&]U<V%N9',L(&5X8V5P
M="!097(@4VAA<F4@9&%T82P@=6YL97-S(&]T:&5R=VES92!S<&5C:69I960\
M+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N
M/3-$.#XS($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H(&-O;'-P86X],T0S/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N
M(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E
M<"X@,S`L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M2G5N+B`S,"P@,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y-87(N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/D1E8RX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^4V5P+B`S,"P@,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:#Y*=6XN(#,P+"`R,#$R/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/DUA<BX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3$\8G(^/"]T:#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^0F%S:6,@86YD(&1I;'5T
M960@;F5T(&QO<W,@<&5R('-H87)E("AI;B!T:&]U<V%N9',L(&5X8V5P="!P
M97(@<VAA<F4@86UO=6YT<RDZ/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T(&QO<W,\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,3,L,#4V*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,34L-C<U*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,3<L
M,38T*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^)"`H,C`L.#(U*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6T^)"`H,C`L-30S*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,3<L-SDQ*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,34L,3$P*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,38L
M-3`U*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^)"`H-C8L-S(P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6T^)"`H-CDL.30Y*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6T^)"`H-#@L-3DW*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')E9F5R<F5D('-T
M;V-K(&1E96UE9"!D:79I9&5N9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@X+#0V.2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O=3X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!L;W-S(&%L;&]C86)L92!T
M;R!C;VUM;VX@<W1O8VMH;VQD97)S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B0@*#(Q+#4R-2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M/B0@*#$U+#8W-2D\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#$W+#$V-"D\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#(P+#@R-2D\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@
M*#(P+#4T,RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B0@*#$W+#<Y,2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M/B0@*#$U+#$Q,"D\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#$V+#4P-2D\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#<U+#$X.2D\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@
M*#8Y+#DT.2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B0@*#0X+#4Y-RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^1&5N;VUI;F%T;W(@9F]R(&)A
M<VEC(&%N9"!D:6QU=&5D(&YE="!L;W-S('!E<B!S:&%R92!A;&QO8V%B;&4@
M=&\@8V]M;6]N('-T;V-K:&]L9&5R<SH\+W-T<F]N9SX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y796EG:'1E9"UA=F5R
M86=E(&-O;6UO;B!S:&%R97,@;W5T<W1A;F1I;F<\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C(S-2PX-SD\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ.#,L,#(R/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3@R+#DQ,SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$X,BPX-#<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M.#`L-C@U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,3<W+#@W,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$V-RPV.3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ-34L-#,Q/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3DV+#(W-3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$W,"PT-CD\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,C4L
M,3`Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y.970@;&]S<R!P97(@<VAA<F4@86QL;V-A8FQE('1O(&-O;6UO;B!S
M=&]C:VAO;&1E<G,@+2!B87-I8R!A;F0@9&EL=71E9#PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;3XD("@P+C`Y*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,"XP.2D\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#`N,#DI/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@P+C$Q
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M)"`H,"XQ,2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B0@*#`N,2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B0@*#`N,#DI/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XD("@P+C$Q*3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,"XS."D\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#`N-#$I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@P
M+C,Y*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^/'-T<F]N9SY/=71S=&%N9&EN9R!S96-U<FET:65S(&YO="!I;F-L
M=61E9"!I;B!D:6QU=&5D(&YE="!L;W-S('!E<B!S:&%R92!C86QC=6QA=&EO
M;B`H:6X@=&AO=7-A;F1S*3H\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/=71S=&%N9&EN9R!S96-U<FET
M:65S(&YO="!I;F-L=61E9"!I;B!D:6QU=&5D(&YE="!L;W-S('!E<B!S:&%R
M92!C86QC=6QA=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XW,BPY,S0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XR."PR-S4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XS-BPX,S`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-E<FEE<R!"($-O;G9E<G1I
M8FQE(%!R969E<G)E9"!3=&]C:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3W5T<W1A;F1I;F<@<V5C=7)I
M=&EE<R!N;W0@:6YC;'5D960@:6X@9&EL=71E9"!N970@;&]S<R!P97(@<VAA
M<F4@8V%L8W5L871I;VX@*&EN('1H;W5S86YD<RDZ/"]S=')O;F<^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W5T<W1A
M;F1I;F<@<V5C=7)I=&EE<R!N;W0@:6YC;'5D960@:6X@9&EL=71E9"!N970@
M;&]S<R!P97(@<VAA<F4@8V%L8W5L871I;VX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-#,L-#,P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-T;V-K($]P=&EO;G,@
M86YD(%-T;V-K($%W87)D<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3W5T<W1A;F1I;F<@<V5C=7)I=&EE
M<R!N;W0@:6YC;'5D960@:6X@9&EL=71E9"!N970@;&]S<R!P97(@<VAA<F4@
M8V%L8W5L871I;VX@*&EN('1H;W5S86YD<RDZ/"]S=')O;F<^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W5T<W1A;F1I
M;F<@<V5C=7)I=&EE<R!N;W0@:6YC;'5D960@:6X@9&EL=71E9"!N970@;&]S
M<R!P97(@<VAA<F4@8V%L8W5L871I;VX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,3<L,#0P/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,34L-38Q/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3$L,3`Q/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y787)R86YT
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY/=71S=&%N9&EN9R!S96-U<FET:65S(&YO="!I;F-L=61E9"!I
M;B!D:6QU=&5D(&YE="!L;W-S('!E<B!S:&%R92!C86QC=6QA=&EO;B`H:6X@
M=&AO=7-A;F1S*3H\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y/=71S=&%N9&EN9R!S96-U<FET:65S(&YO
M="!I;F-L=61E9"!I;B!D:6QU=&5D(&YE="!L;W-S('!E<B!S:&%R92!C86QC
M=6QA=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XQ,BPT-C0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ,BPW,30\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XR-2PW,CD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM
M+2TM+2T]7TYE>'1087)T7S=E83@R8C(Y7SDX,C9?-#`R85]B.38P7S`R,35F
M9#AB861E.`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\W96$X,F(R
M.5\Y.#(V7S0P,F%?8CDV,%\P,C$U9F0X8F%D93@O5V]R:W-H965T<R]3:&5E
M=#4R+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP
M<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U
M<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M
M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H
M87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S
M<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO
M/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,]
M,T1R97!O<G0@:60],T1)1#!%5$=%33X-"B`@("`@(#QT<CX-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N
M9SY0<F5F97)R960@4W1O8VLL($-O;6UO;B!3=&]C:R!A;F0@5V%R<F%N=',@
M+2!!9&1I=&EO;F%L($EN9F]R;6%T:6]N("A$971A:6PI("A54T0@)"D\8G(^
M/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A
M;CTS1#D^,2!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:"!C;VQS<&%N/3-$,SXQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3X\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3X\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT:',@16YD960\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ($UO;G1H<R!%
M;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q
M/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M(&-O;'-P86X],T0R/C$@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,3(@36]N=&AS($5N9&5D/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#,^,2!-;VYT:',@16YD
M960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,CXQ
M,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C
M;VQS<&%N/3-$,3XQ($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y/8W0N(#,Q+"`R
M,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA>2`P.2P@
M,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y.;W8N(#`S
M+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DYO=BX@
M,#(L(#(P,3`\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^07!R
M+B`S,"P@,C`Q,#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y!
M<'(N(#$V+"`R,#$P/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/DYO=BX@,S`L(#(P,#D\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^3F]V+B`P-"P@,C`P.#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y!<'(N(#$X+"`R,#`V/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/DUA>2`R.2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$S/&)R/E-$23QB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$S/&)R/C(P,#<@
M3&]A;B!!9W)E96UE;G0\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^3V-T+B`S,2P@,C`Q,SQB<CY#;VUM;VX@4W1O8VL\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CY#;VUM;VX@
M4W1O8VL\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^3F]V+B`P
M-"P@,C`P.#QB<CY-:6YI;75M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/D]C="X@,S$L(#(P,3,\8G(^4V5R:65S($(@0V]N=F5R=&EB;&4@
M4')E9F5R<F5D(%-T;V-K/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/D1E8RX@,S$L(#(P,3,\8G(^4V5R:65S($(@0V]N=F5R=&EB;&4@4')E
M9F5R<F5D(%-T;V-K/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/D1E8RX@,S$L(#(P,3(\8G(^4V5R:65S($(@0V]N=F5R=&EB;&4@4')E9F5R
M<F5D(%-T;V-K/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA
M<BX@,CDL(#(P,3,\8G(^34Q6/&)R/DUA>&EM=6T\8G(^/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`Q,#QB<CY!<W!I<F4@0V%P
M:71A;"!&=6YD($QL8SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y397`N(#(P+"`R,#$P/&)R/D%S<&ER92!#87!I=&%L($9U;F0@3&QC/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3$\
M8G(^07-P:7)E($-A<&ET86P@1G5N9"!,;&,\8G(^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,#QB<CY!<W!I<F4@0V%P:71A
M;"!&=6YD($QL8SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y3
M97`N(#(P+"`R,#$P/&)R/D%S<&ER92!#87!I=&%L($9U;F0@3&QC/&)R/DUA
M>&EM=6T\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS
M=')O;F<^4')E9F5R<F5D(%-T;V-K($-O;6UO;B!3=&]C:R!!;F0@5V%R<F%N
M=',@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O;6UO
M;B!S=&]C:RP@<VAA<F5S(&%U=&AO<FEZ960\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C,U,"PP,#`L,#`P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C4P+#`P,"PP,#`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,S4P+#`P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')E9F5R<F5D('-T;V-K+"!S
M:&%R97,@875T:&]R:7IE9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-2PP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-2PP,#`L,#`P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT,RPP,#`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y0<F5F97)R960@<W1O8VLL('-H87)E<R!O=71S=&%N9&EN9SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y3=&]C:R!I<W-U960@9'5R:6YG('!E<FEO9"P@<VAA
M<F5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW.2PU-S`L,#`P
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,3<L-3`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C(W+#8P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XR-BPT-3`L,#`P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PP-S8L-#(P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S`L,CDS
M+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XW.2PU-S`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0S+#0S,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`L.3DU+#(Q
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C(L,S4P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E!R969E<G)E9"!S=&]C:RP@<&%R('9A;'5E/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P+C`P,3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N
M,#`Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^)"`P+C`P,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XD(#`N,#`Q/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!U8FQI8R!O9F9E
M<FEN9R!N970@<')I8V4@<&5R('-H87)E/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#$N,#<U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^)"`T+C(U/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R+C4\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$N-SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$N-#4R-3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/B0@,2PP-S4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1W)O<W,@<')O8V5E9',@9G)O
M;2!I<W-U86YC92!O9B!S=&]C:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^)"`X-2PU,#`L,#`P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#0V+#<P,"PP
M,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^27-S=6%N8V4@8V]S=',\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,RPP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-"PU,#`L,#`P
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XR+#4P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^3F5T('!R;V-E961S(&9R;VT@;V9F97)I
M;F<\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV.2PV,#`L,#`P
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M-C0L-3`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C0R+#`P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-#$L,3`P+#`P,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C@P+#DP
M,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C0T+#(P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]N=F5R=&EB;&4@8V]M;6]N
M('-T;V-K('-H87)E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]N=F5R=&EB;&4@
M<')E9F5R<F5D('-T;V-K+"!T97)M<R!O9B!C;VYV97)S:6]N/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)U1H
M92!H;VQD97(@:7,@<')O:&EB:71E9"!F<F]M(&-O;G9E<G1I;F<@=&AE(%-E
M<FEE<R!"($-O;G9E<G1I8FQE(%!R969E<G)E9"!3=&]C:R!I;G1O('-H87)E
M<R!O9B!C;VUM;VX@<W1O8VL@:68L(&%S(&$@<F5S=6QT(&]F('-U8V@@8V]N
M=F5R<VEO;BP@=&AE(&AO;&1E<B!A;F0@:71S(&%F9FEL:6%T97,@=V]U;&0@
M;W=N(&UO<F4@=&AA;B`Y+CDX)2!O9B!T:&4@=&]T86P@;G5M8F5R(&]F('-H
M87)E<R!O9B!C;VUM;VX@<W1O8VL@=&AE;B!I<W-U960@86YD(&]U='-T86YD
M:6YG+CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D-O;G9E<G1I8FQE('!R969E<G)E9"!S=&]C:RP@<V5T
M=&QE;65N="!T97)M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B=);B!T:&4@979E;G0@;V8@=&AE($-O;7!A
M;GGB@)ES(&QI<75I9&%T:6]N+"!D:7-S;VQU=&EO;BP@;W(@=VEN9&EN9R!U
M<"P@:&]L9&5R<R!O9B!397)I97,@0B!#;VYV97)T:6)L92!0<F5F97)R960@
M4W1O8VL@=VEL;"!R96-E:79E(&$@<&%Y;65N="!E<75A;"!T;R`D,"XP,#$@
M<&5R('-H87)E(&)E9F]R92!A;GD@<')O8V5E9',@87)E(&1I<W1R:6)U=&5D
M('1O('1H92!C;VUM;VX@<W1O8VMH;VQD97)S+CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O;G9E<G1I
M8FQE(&-O;6UO;B!S=&]C:R!E>&-E961E9"!A;&QO8V%T960@<'5R8VAA<V4@
M<')I8V4@;V8@<')E9F5R<F5D('-T;V-K/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^."PU,#`L,#`P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^0V]M;6]N('-T;V-K+"!P87(@=F%L=64\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N,#`Q/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,"XP,#$\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N,#`Q/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^1&EV:61E;F1S('!A>6%B;&4@9&%T93PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/DYO=B`Q-RP-"@D),C`P
M.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R969E<G)E9"!S:&%R97,@<')I8V4\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#8\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y097)C96YT86=E(&]F(&-O;6UO;B!S:&%R97,@
M;W5T<W1A;F1I;F<\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,C`N,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y097)C96YT86=E(&]F
M(&%S<V5T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XU,"XP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)I9VAT<R!E>'!I<F%T:6]N
M(&1A=&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#Y.
M;W8@,3<L#0H)"3(P,#@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@<W1O
M8VL@86=G<F5G871E(&]F9F5R:6YG('!R:6-E/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XX,"PY.3DL,#`P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.#`L,#`P
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C4P+#`P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^0V]M;6ES<VEO;B!O;B!G<F]S<R!S86QE
M<R!P<F]C965D<R!O9B!C;VUM;VX@<W1O8VL\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,N,#`E/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E-A;&4@;V8@<W1O8VL@<'5R<W5A;G0@=&\@97AE<F-I<V4@;V8@=6YD97)W
M<FET97)S(&]V97)A;&QO=&UE;G0@;W!T:6]N/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C,L-C`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,L-#4P+#`P,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y#;VUM:71M96YT('1O('!U<F-H87-E('-H87)E<R!V
M86QU93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XS,"PP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0=7)C:&%S92!A9W)E96UE
M;G0@=&5R;3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG,C4@;6]N=&AS/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y097)C96YT86=E(&]F
M(&-O;6UI=&UE;G0@=&\@<'5R8VAA<V4@<VAA<F5S('9A;'5E(&%S(&-O;6UI
M=&UE;G0@9F5E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C0N,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM:71M96YT(&9E92!P
M86ED/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,2PR,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^27-S=6%N8V4@;V8@<VAA<F5S
M(&]F(&-O;6UO;B!S=&]C:R!F;W(@8V]M;6ET;65N="!F964\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV
M,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^4')O8V5E9',@9G)O;2!I<W-U86YC97,@;V8@8V]M;6]N
M('-T;V-K/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XD(#@P+#@U-BPP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XD(#<Q+#<X,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#DQ+#(Y."PP,#`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XD(#(V+#<P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XD(#,L,S`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYU;6)E<B!O9B!S:&%R
M97,@;V8@8V]M;6]N('-T;V-K(&EN(&5A8V@@=6YI=#PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y.=6UB97(@;V8@=V%R<F%N=',@:6X@96%C:"!U;FET/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/DYU;6)E<B!O9B!S:&%R92!P97(@=V%R<F%N=#PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XP+C4\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E=A<G)A;G1S(&5X97)C:7-E('!R:6-E/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,2XU/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,2XU/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2XY-#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW+C,R/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2XY-CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y787)R86YT<R!E>&5R8VES86)L92!P97)I;V0\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG-2!Y96%R<SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<U('EE87)S
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)S4@>65A<G,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)S4@>65A<G,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E=A<G)A;G1S
M(&]U='-T86YD:6YG/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ,"PY,3,L.#<S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-BPW-C4L,3(X/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PU-3`L,#`P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y)<W-U86YC92!O9B!W87)R86YT<R!F;W(@8V]M;6]N('-H87)E
M<R!T;R!B92!P=7)C:&%S960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,RPU-3`L,#`P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y787)R
M86YT<R!T;R!P=7)C:&%S92!C;VUM;VX@<W1O8VL\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$R+#4P,"PP,#`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^3G5M8F5R($]F(%=A<G)A;G1S($5X97)C:7-E9"!$=7)I;F<@
M4&5R:6]D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XR-3`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,3,L,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y
M/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S=E83@R8C(Y7SDX,C9?
M-#`R85]B.38P7S`R,35F9#AB861E.`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL
M93HO+R]#.B\W96$X,F(R.5\Y.#(V7S0P,F%?8CDV,%\P,C$U9F0X8F%D93@O
M5V]R:W-H965T<R]3:&5E=#4S+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC
M;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H
M=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*
M("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS
M1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E
M>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@
M5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@
M("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%6$1!1SX-"B`@("`@
M(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W
M<W!A;CTS1#$^/'-T<F]N9SY787)R86YT<R!)<W-U960@=&\@4'5R8VAA<V4@
M0V]M;6]N(%-T;V-K("A$971A:6PI/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^07!R+B`S,"P@,C`Q,#QB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y!<'(N(#$V+"`R,#$P/&)R/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DYO=BX@,S`L(#(P,#D\8G(^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^07!R+B`Q."P@,C`P-CQB<CX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$S/&)R
M/C(P,#<@3&]A;B!!9W)E96UE;G0\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CY787)R86YT($]N93QB<CXR,#`W
M($QO86X@06=R965M96YT/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/D1E8RX@,S$L(#(P,3,\8G(^5V%R<F%N="!4=V\\8G(^,C`P-R!,;V%N
M($%G<F5E;65N=#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$
M96,N(#,Q+"`R,#$S/&)R/E=A<G)A;G0@5&AR964\8G(^,C`P-R!,;V%N($%G
M<F5E;65N=#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N
M(#,Q+"`R,#$S/&)R/E=A<G)A;G0@1F]U<CQB<CXR,#`W($QO86X@06=R965M
M96YT/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R
M;VYG/D-L87-S($]F(%=A<G)A;G0@3W(@4FEG:'0@6TQI;F4@271E;7-=/"]S
M=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y787)R86YT($ES<W5A;F-E($1A=&4\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/DIU;"`Q."P-"@D),C`P-SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/D]C="`Q."P-"@D)
M,C`P-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/D1E8R`R-RP-"@D),C`P-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/D1E8R`R-RP-"@D),C`P-SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4VAA<F5S($ES
M<W5A8FQE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,L
M-34P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$L,C4P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$L,S`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,P,"PP,#`\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW,#`L,#`P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%>'!I
M<F%T:6]N($1A=&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/D9E8B`R-BP-"@D),C`Q-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/D9E8B`R-BP-"@D),C`Q-#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/D9E8B`R-BP-"@D)
M,C`Q-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/D9E8B`R-BP-"@D),C`Q-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^5V%R<F%N=',@97AE<F-I<V4@<')I8V4\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$N.38\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+C4\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+C4\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+CDT
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M-RXS,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XU+C$S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,2XV.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C4N-C4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XQ+C8X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/=71S=&%N9&EN9SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,3`L.3$S+#@W,SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#4U,"PP,#`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M+#(U,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,S`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM
M+2T]7TYE>'1087)T7S=E83@R8C(Y7SDX,C9?-#`R85]B.38P7S`R,35F9#AB
M861E.`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\W96$X,F(R.5\Y
M.#(V7S0P,F%?8CDV,%\P,C$U9F0X8F%D93@O5V]R:W-H965T<R]3:&5E=#4T
M+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN
M=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA
M<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U
M:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S
M970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,]
M,T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S
M8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R
M97!O<G0@:60],T1)1#!%0DA%2SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY%
M<75I='D@4&QA;G,@86YD(%-T;V-K+4)A<V5D($-O;7!E;G-A=&EO;B`M($%D
M9&ET:6]N86P@26YF;W)M871I;VX@*$1E=&%I;"D@*%531"`D*3QB<CX\+W-T
M<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$
M-#XQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:"!C;VQS<&%N/3-$,CXQ($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H(&-O;'-P86X],T0V/C$R($UO;G1H<R!%;F1E9#PO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$@36]N=&AS
M($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS
M1#(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^
M,2!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C
M;VQS<&%N/3-$,3X\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS
M<&%N/3-$,3XQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:"!C;VQS<&%N/3-$-CXQ($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$
M96,N(#,Q+"`R,#$S/&)R/D5M<&QO>65E/&)R/D-O;7!E;G-A=&EO;E!L86X\
M8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q
M,CQB<CY%;7!L;WEE93QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y$96,N(#,Q+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/D1E8RX@,S$L(#(P,3,\8G(^16UP;&]Y964@4W1O8VL@4'5R8VAA<V4@
M4&QA;CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*86XN(#,Q
M+"`R,#`T/&)R/D5M<&QO>65E(%-T;V-K(%!U<F-H87-E(%!L86X\8G(^5&AE
M(&-O;6UE;F-E;65N="!O9B!T:&4@;V9F97(@<&5R:6]D("AG96YE<F%L;'DL
M('1H92!F:69T965N=&@@9&%Y(&EN($9E8G)U87)Y(&]R($%U9W5S="D\8G(^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2F%N+B`S,2P@,C`P-#QB
M<CY%;7!L;WEE92!3=&]C:R!0=7)C:&%S92!0;&%N/&)R/E1H92!E>&5R8VES
M92!D871E+"!W:&EC:"!I<R!T:&4@;&%S="!D87D@;V8@82!P=7)C:&%S92!P
M97)I;V0@*&=E;F5R86QL>2P@=&AE(&9O=7)T965N=&@@9&%Y(&EN($9E8G)U
M87)Y(&]R($%U9W5S="D\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^1&5C+B`S,2P@,C`Q,SQB<CY.;VX@16UP;&]Y964@07=A<F1S/&)R/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^
M061D:71I;VYA;#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$
M96,N(#,Q+"`R,#$R/&)R/D%D9&ET:6]N86P\8G(^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CY297-T<FEC=&5D(%-T
M;V-K(%5N:71S("A24U5S*3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y$96,N(#,Q+"`R,#$R/&)R/E)E<W1R:6-T960@4W1O8VL@56YI=',@
M*%)357,I/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@
M,S$L(#(P,3$\8G(^4F5S=')I8W1E9"!3=&]C:R!5;FET<R`H4E-5<RD\8G(^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2F%N+B`S,2P@,C`P-#QB
M<CXR,#`T(%!L86X\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M1&5C+B`S,2P@,C`Q,SQB<CXR,#`T(%!L86X\8G(^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CY);F1U8V5M96YT(%!L
M86X\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2F%N+B`S,2P@
M,C`Q,3QB<CXR,#$Q(%!L86X\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CXR,#$Q(%!L86X\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CY4:6UE($)A
M<V5D(%9E<W1I;F<@4V-H961U;&4\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^2F%N+B`S,2P@,C`P-#QB<CY-87AI;75M/&)R/C(P,#0@4&QA
M;CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*86XN(#,Q+"`R
M,#`T/&)R/DUA>&EM=6T\8G(^,C`P-"!0;&%N/&)R/D]T:&5R(%!A<G1I8VEP
M86YT<SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*86XN(#,Q
M+"`R,#$P/&)R/DUA>&EM=6T\8G(^26YD=6-E;65N="!0;&%N/&)R/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA>2`R.2P@,C`Q,SQB<CY-87AI
M;75M/&)R/C(P,3$@4&QA;CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y*86XN(#,Q+"`R,#$Q/&)R/DUA>&EM=6T\8G(^,C`Q,2!0;&%N/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIA;BX@,S$L(#(P,#0\
M8G(^36EN:6UU;3QB<CXR,#`T(%!L86X\8G(^4W1O8VL@<&]S<V5S<VEN9R!M
M;W)E('1H86X@,3`E(&]F('1H92!V;W1I;F<@<&]W97(@;V8@86QL(&-L87-S
M97,@;V8@=&AE($-O;7!A;GDG<R!S=&]C:R!O<B!T:&4@<W1O8VL@;V8@86YY
M('!A<F5N="!O<B!S=6)S:61I87)Y(&]F('1H92!#;VUP86YY/&)R/CPO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-H87)E($)A
M<V5D($-O;7!E;G-A=&EO;B!!<G)A;F=E;65N="!">2!3:&%R92!"87-E9"!0
M87EM96YT($%W87)D(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y.=6UB97(@;V8@<VAA<F4M8F%S960@8V]M<&5N<V%T:6]N('!L86YS/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/DES<W5A;F-E(&]F(&-O;6UO;B!S=&]C:R!S:&%R97,\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C,L-3`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ+#4P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,C4L,#`P+#`P,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5X<&ER871I;VX@
M<&5R:6]D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG,3`@>65A
M<G,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<Q,"!Y96%R<SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<Q,"!Y96%R<SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<U('EE
M87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y0=7)C:&%S92!P<FEC92!P97(@<VAA<F4@87,@<&5R8V5N=&%G92!O
M9B!F86ER(&UA<FME="!V86QU92!O9B!C;VUM;VX@<W1O8VL\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX-2XP,"4\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX-2XP,"4\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M,#`N,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$Q,"XP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYU;6)E<B!O9B!S:&%R97,@;V8@
M0V]M;6]N(%-T;V-K(&]U='-T86YD:6YG/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ-2PW-C4L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,3,L.#`V+#`P,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-"PP
M-C8L,C<W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-S0S+#8R-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ,"PY-30L.30P/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^26YC<F5A<V4@:6X@
M=&AE(&%G9W)E9V%T92!N=6UB97(@;V8@<VAA<F5S(&]F(&-O;6UO;B!S=&]C
M:R!A=71H;W)I>F5D(&9O<B!I<W-U86YC93PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`L,#`P+#`P,#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y3:&%R97,@<F5S97)V960@86YD(&%P<')O=F5D(&9O<B!I<W-U86YC93PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.3DV+#`P,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$S+#8V-BPY-C0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!I;G1R:6YS:6,@=F%L
M=64@;V8@;W!T:6]N<R!E>&5R8VES960\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/B0@,S`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/B0@,BPW,#`L,#`P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q,#`L,#`P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!F86ER('9A;'5E(&]F('-T;V-K(&]P
M=&EO;G,@=F5S=&5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M,BPQ,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^.2PV,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,BPX,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y3=&]C:R!B87-E9"!C;VUP96YS871I;VX@97AP96YS92!R96QA=&5D
M('1O(')E<W1R:6-T960@<W1O8VL\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06=G<F5G
M871E(&EN=')I;G-I8R!V86QU93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,BPU,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D=R86YT
M(&1A=&4@9F%I<B!V86QU92!O9B!R97-T<FEC=&5D('-T;V-K/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$N,C,\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#0N,C,\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD
M(#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E1O=&%L(&9A:7(@=F%L=64@;V8@<F5S=')I8W1E
M9"!S=&]C:R!U;FET<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,3`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C(P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XX,#`L,#`P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/
M<'1I;VYS('9E<W1I;F<@<&5R:6]D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG-"!Y96%R<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/<'1I
M;VYS(&%N9"!R97-T<FEC=&5D('-T;V-K('5N:71S(&]U='-T86YD:6YG/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#`T-RPT-C8\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^17AP96-T960@9&EV:61E;F0@>6EE;&0\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`N,#`E/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E)E8V]G;FEZ960@<W1O8VLM8F%S960@8V]M<&5N<V%T
M:6]N(&5X<&5N<V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0L
M.3`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$L-3`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,2PS,#`L,#`P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-S`P+#`P,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^4W1O8VL@8V]M<&5N<V%T:6]N(&5X<&5N<V4\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$R+#,T,"PP,#`\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,"PT,SDL,#`P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-2PQ
M.#DL,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-3`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.=6UB97(@;V8@
M96UP;&]Y965S('5N9&5R('-T;V-K(&]P=&EO;CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A
M;"!U;G)E8V]G;FEZ960@8V]M<&5N<V%T:6]N(&-O<W0@<F5L871E9"!T;R!N
M;VXM=F5S=&5D(&5Q=6ET>2!A=V%R9',\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/B0@,RPX,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$P,"PP,#`\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M)"`Q,"PS,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!U;G)E8V]G;FEZ960@8V]M<&5N
M<V%T:6]N(&-O<W0L('=E:6=H=&5D+6%V97)A9V4@=F5S=&EN9R!P97)I;V0\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<Q('EE87(@-"!M
M;VYT:',@,C0@9&%Y<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG,B!Y96%R<R`Y(&UO;G1H<R`Q
M."!D87ES/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y3:&%R97,@:7-S=65D('1O(&5M<&QO>65E<SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.#(X+#0Q-#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y3:&%R97,@<F5M86EN:6YG(&%V86EL86)L92!F;W(@
M9G5T=7)E('!U<F-H87-E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,38W+#4X-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-
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M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@
M("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G
M=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT
M+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H
M:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@
M/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P15A#04<^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P
M86X],T0R/CQS=')O;F<^3W!T:6]N($%C=&EV:71Y('5N9&5R(%-T;V-K(%!L
M86YS("A$971A:6PI("A54T0@)"D\8G(^26X@5&AO=7-A;F1S+"!E>&-E<'0@
M4VAA<F4@9&%T82P@=6YL97-S(&]T:&5R=VES92!S<&5C:69I960\+W-T<F]N
M9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ
M,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY.=6UB97(@
M;V8@3W!T:6]N<R!/=71S=&%N9&EN9SPO<W1R;VYG/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^0F5G:6YN:6YG(&)A;&%N8V4\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$S+#@P-BPP,#`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]P=&EO;G,@
M9W)A;G1E9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-2PV,30L
M,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y/<'1I;VYS(&5X97)C:7-E9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XH,3,Q+#`P,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D5N9&EN9R!B86QA;F-E/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ-2PW-C4L,#`P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y697-T960@86YD(&5X
M<&5C=&5D('1O('9E<W0@870@96YD(&]F('!E<FEO9#PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,34L-S8U+#`P,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17AE<F-I<V%B;&4@870@
M96YD(&]F('!E<FEO9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,3`L-C(X+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^/'-T<F]N9SY796EG:'1E9"U!=F5R86=E(%!R:6-E(%!E
M<B!3:&%R93PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^0F5G:6YN:6YG(&)A;&%N8V4\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/B0@,RXS.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^3W!T:6]N<R!G<F%N=&5D/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XD(#(N-CD\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]P=&EO;G,@97AE<F-I<V5D
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$N-#,\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5N9&EN
M9R!B86QA;F-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,N
M,3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E9E<W1E9"!A;F0@97AP96-T960@=&\@=F5S="!A="!E;F0@;V8@<&5R
M:6]D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,N,3<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5X
M97)C:7-A8FQE(&%T(&5N9"!O9B!P97)I;V0\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@,RXS-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY796EG:'1E9"!!=F5R86=E
M(%)E;6%I;FEN9R!#;VYT<F%C='5A;"!,:69E("A);B!Y96%R<RD\+W-T<F]N
M9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D)A;&%N8V4@
M870@1&5C96UB97(@,S$L(#(P,3,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<U('EE87)S(#,@;6]N=&AS(#0@9&%Y<SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W5T<W1A;F1I;F<@
M;W!T:6]N<R!V97-T960@86YD(&5X<&5C=&5D('1O('9E<W0@870@96YD(&]F
M('!E<FEO9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)S4@>65A
M<G,@,R!M;VYT:',@-"!D87ES/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y/<'1I;VYS(&5X97)C:7-A8FQE(&%T(&5N
M9"!O9B!P97)I;V0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<S
M('EE87)S(#<@;6]N=&AS(#$P(&1A>7,\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^06=G<F5G871E($EN
M=')I;G-I8R!686QU93PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^0F%L86YC92!A="!$96-E;6)E<B`S,2P@,C`Q,SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q+#0R-SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W5T<W1A;F1I
M;F<@;W!T:6]N<R`H=F5S=&5D(&%N9"!E>'!E8W1E9"!T;R!V97-T*2!A="!E
M;F0@;V8@<&5R:6]D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M+#0R-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^3W!T:6]N<R!E>&5R8VES86)L92!A="!E;F0@;V8@<&5R:6]D/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$L,C@Y/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y5;G9E<W1E
M9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY.
M=6UB97(@;V8@3W!T:6]N<R!/=71S=&%N9&EN9SPO<W1R;VYG/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W!T:6]N<R!C86YC96QL960\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#(L-34U+#`P,"D\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS
M=')O;F<^5V5I9VAT960M079E<F%G92!0<FEC92!097(@4VAA<F4\+W-T<F]N
M9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]P=&EO;G,@
M8V%N8V5L;&5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,N
M,S$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E9E<W1E9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY.=6UB97(@;V8@3W!T:6]N<R!/=71S=&%N9&EN9SPO<W1R;VYG
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W!T:6]N<R!C
M86YC96QL960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#DV.2PP
M,#`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#X\<W1R;VYG/E=E:6=H=&5D+4%V97)A9V4@4')I8V4@4&5R(%-H87)E
M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/
M<'1I;VYS(&-A;F-E;&QE9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^)"`S+C,T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
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M"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N
M=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX
M)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ
M<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO
M:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED
M/3-$240P1556044^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^4W5M;6%R>2!O
M9B!297-T<FEC=&5D(%-T;V-K(%5N:71S($%C=&EV:71Y("A$971A:6PI("A2
M97-T<FEC=&5D(%-T;V-K(%5N:71S("A24U5S*2P@55-$("0I/&)R/DEN(%1H
M;W5S86YD<RP@97AC97!T(%!E<B!3:&%R92!D871A+"!U;FQE<W,@;W1H97)W
M:7-E('-P96-I9FEE9#PO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H(&-O;'-P86X],T0S/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$
M96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/D1E8RX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^1&5C+B`S,2P@,C`Q,3QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^4F5S=')I8W1E9"!3=&]C:R!5;FET<R`H4E-5<RD\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY.=6UB97(@
M;V8@<VAA<F5S/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D)E9VEN;FEN9R!"86QA;F-E/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ+#<U-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y'<F%N=&5D/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XR-3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5F5S=&5D/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M/B@Q,34I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D9O<F9E:71E9"!O<B!E>'!I<F5D
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@V,34I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5N9&EN
M9R!"86QA;F-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#(W
M-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C$L-S4U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^/'-T<F]N9SY796EG:'1E9"!!=F5R86=E($=R86YT($1A=&4@
M1F%I<B!686QU93PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y"96=I;FYI;F<@0F%L86YC93PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`T+C(S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D=R86YT960\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/B0@,2XR,SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-"XR,SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5F5S=&5D/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$N,3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&;W)F96ET
M960@;W(@97AP:7)E9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M)"`T+C(S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D5N9&EN9R!"86QA;F-E/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#,N.3,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XD(#0N,C,\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-
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M=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H
M='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL
M.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I
M<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N
M="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L
M87-S/3-$<F5P;W)T(&ED/3-$240P1398044^#0H@("`@("`\='(^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS
M=')O;F<^1F%I<B!686QU92U"87-E9"!-96%S=7)E;65N=',@86YD(%=E:6=H
M=&5D+4%V97)A9V4@07-S=6UP=&EO;G,@*$1E=&%I;"D@*%531"`D*3QB<CX\
M+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N
M/3-$,SXQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB
M<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P
M,3$\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5M<&QO
M>65E(%-T;V-K(%!U<F-H87-E(%!L86X\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3:&%R92!"87-E9"!#;VUP96YS871I
M;VX@07)R86YG96UE;G0@0GD@4VAA<F4@0F%S960@4&%Y;65N="!!=V%R9"!;
M3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^5V5I9VAT960M879E<F%G92!F86ER('9A;'5E/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N.3,\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,N-30\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(N,#D\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E)I<VLM9G)E92!I;G1E<F5S="!R871E/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XP+C(P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C`N,C`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,"XS,"4\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5X<&5C=&5D(&QI9F4@*&EN
M('EE87(I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG,2!Y96%R
M(#,@;6]N=&AS(#$X(&1A>7,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG,2!Y96%R(#$@;6]N=&@@-B!D87ES/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)S$@>65A
M<B`R(&UO;G1H<R`Q,B!D87ES/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y6;VQA=&EL:71Y/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XP+C@P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$N-C`E/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2XV,"4\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-T;V-K($]P=&EO
M;G,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N
M9SY3:&%R92!"87-E9"!#;VUP96YS871I;VX@07)R86YG96UE;G0@0GD@4VAA
M<F4@0F%S960@4&%Y;65N="!!=V%R9"!;3&EN92!)=&5M<UT\+W-T<F]N9SX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5V5I9VAT960M
M879E<F%G92!F86ER('9A;'5E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XD(#(N-#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#,N,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B0@,BXW-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4FES:RUF<F5E(&EN=&5R97-T(')A
M=&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$N,3`E/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,"XU,"4\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M+C,P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^17AP96-T960@;&EF92`H:6X@>65A<BD\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<U('EE87)S(#$P(&UO;G1H<R`R-"!D87ES/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)S0@
M>65A<G,@,B!M;VYT:',@,3(@9&%Y<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<T('EE87)S/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y6;VQA=&EL:71Y/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+C0P)3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$N-C`E/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2XV,"4\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-
M"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S=E83@R
M8C(Y7SDX,C9?-#`R85]B.38P7S`R,35F9#AB861E.`T*0V]N=&5N="U,;V-A
M=&EO;CH@9FEL93HO+R]#.B\W96$X,F(R.5\Y.#(V7S0P,F%?8CDV,%\P,C$U
M9F0X8F%D93@O5V]R:W-H965T<R]3:&5E=#4X+FAT;6P-"D-O;G1E;G0M5')A
M;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP
M93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@
M(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@
M8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@
M='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO
M="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\
M8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%43-!
M13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A
M;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY3=&]C:RU"87-E9"!#;VUP96YS
M871I;VX@17AP96YS92`H1&5T86EL*2`H55-$("0I/&)R/DEN(%1H;W5S86YD
M<RP@=6YL97-S(&]T:&5R=VES92!S<&5C:69I960\+W-T<F]N9SX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,SXQ,B!-;VYT:',@
M16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3$\8G(^/"]T:#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^1&5F97)R960@0V]M
M<&5N<V%T:6]N($%R<F%N9V5M96YT(%=I=&@@26YD:79I9'5A;"!3:&%R92!"
M87-E9"!087EM96YT<R!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4W1O8VL@8V]M<&5N<V%T:6]N
M(&5X<&5N<V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,3(L
M,S0P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^)"`Q,"PT,SD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#4L,3@Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y%;7!L;WEE97,@06YD($1I<F5C=&]R<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D1E
M9F5R<F5D($-O;7!E;G-A=&EO;B!!<G)A;F=E;65N="!7:71H($EN9&EV:61U
M86P@4VAA<F4@0F%S960@4&%Y;65N=',@6TQI;F4@271E;7-=/"]S=')O;F<^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-T;V-K(&-O
M;7!E;G-A=&EO;B!E>'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ,2PX,C@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ,"PT,SD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XU+#$X-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F]N($5M<&QO>65E/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^1&5F97)R960@
M0V]M<&5N<V%T:6]N($%R<F%N9V5M96YT(%=I=&@@26YD:79I9'5A;"!3:&%R
M92!"87-E9"!087EM96YT<R!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4W1O8VL@8V]M<&5N<V%T
M:6]N(&5X<&5N<V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4Q
M,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XT/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y297-E87)C:"!A;F0@1&5V96QO<&UE;G0@17AP96YS93PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D1E9F5R<F5D
M($-O;7!E;G-A=&EO;B!!<G)A;F=E;65N="!7:71H($EN9&EV:61U86P@4VAA
M<F4@0F%S960@4&%Y;65N=',@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-T;V-K(&-O;7!E;G-A
M=&EO;B!E>'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT
M+#(R.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C,L-3$T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,BPQ,#,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D=E;F5R86P@86YD($%D;6EN:7-T<F%T:79E($5X
M<&5N<V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T
M<F]N9SY$969E<G)E9"!#;VUP96YS871I;VX@07)R86YG96UE;G0@5VET:"!)
M;F1I=FED=6%L(%-H87)E($)A<V5D(%!A>6UE;G1S(%M,:6YE($ET96US73PO
M<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3
M=&]C:R!C;VUP96YS871I;VX@97AP96YS93PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)"`X+#$Q,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/B0@-BPY,C4\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,L,#@V/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-
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M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@
M("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G
M=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT
M+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H
M:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@
M/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P13%'04,^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P
M86X],T0R/CQS=')O;F<^0V]M<&]N96YT(&]F($-O;G-O;&ED871E9"!);F-O
M;64@*$QO<W,I($)E9F]R92!0<F]V:7-I;VX@9F]R($EN8V]M92!487AE<R`H
M1&5T86EL*2`H55-$("0I/&)R/DEN(%1H;W5S86YD<RP@=6YL97-S(&]T:&5R
M=VES92!S<&5C:69I960\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:"!C;VQS<&%N/3-$,SXQ,B!-;VYT:',@16YD960\+W1H/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/D1E8RX@,S$L(#(P,3$\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/CQS=')O;F<^4V-H961U;&4@3V8@0V]M<&]N96YT<R!/9B!)
M;F-O;64@0F5F;W)E($EN8V]M92!487@@17AP96YS92!"96YE9FET(%M,:6YE
M($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y5+E,N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@
M*#8W+#`P-"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B0@*#<P+#<Y,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M/B0@*#0Y+#DY,"D\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYO;B!5+E,N/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XR.#0\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX-#,\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#,Y,SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O=3X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#8V+#<R,"D\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#8Y+#DT
M.2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M/B0@*#0X+#4Y-RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE
M>'1087)T7S=E83@R8C(Y7SDX,C9?-#`R85]B.38P7S`R,35F9#AB861E.`T*
M0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\W96$X,F(R.5\Y.#(V7S0P
M,F%?8CDV,%\P,C$U9F0X8F%D93@O5V]R:W-H965T<R]3:&5E=#8P+FAT;6P-
M"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-
M"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-
M"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#
M;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F
M+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W
M+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^
M/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@
M:60],T1)1#!%54Y!13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY$:69F97)E
M;F-E(&)E='=E96X@0V]N<V]L:61A=&5D($EN8V]M92!487@@0F5N969I="!A
M;F0@06UO=6YT($-O;7!U=&5D(&)Y($9E9&5R86P@4W1A='5T;W)Y($EN8V]M
M92!487@@4F%T92`H1&5T86EL*2`H55-$("0I/&)R/DEN(%1H;W5S86YD<RP@
M=6YL97-S(&]T:&5R=VES92!S<&5C:69I960\+W-T<F]N9SX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,SXQ,B!-;VYT:',@16YD
M960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3$\8G(^/"]T:#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^26YC;VUE(%1A>"!2871E
M(%)E8V]N8VEL:6%T:6]N(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y);F-O;64@=&%X(&)E;F5F
M:70@870@9F5D97)A;"!S=&%T=71O<GD@<F%T93PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XD("@R,BPV-S@I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@R,RPV-3`I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@Q-BPU,C,I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3
M=&%T92!T87@\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$W."D\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@X
M.2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M/B@R+#4X-BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D)U<VEN97-S(&-R961I=',\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6T^*#(L-3$U*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B@Q+#,Y-"D\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1E9F5R<F5D(&-O;7!E;G-A
M=&EO;B!C:&%R9V5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS
M+#`W,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$L,#`R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-3DU/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y#:&%N9V4@:6X@=F%L=6%T:6]N(&%L;&]W86YC93PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C(L,S4T/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C$L.38V/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3@L
M,#DY/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y#:&%N9V4@:6X@9F]R96EG;B!T87@@<F%T97,\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH,S0I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#:&%N9V4@:6X@=&AE(&9A:7(@
M=F%L=64@;65A<W5R96UE;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C(X-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^3F]N+61E9'5C=&EB;&4@9&5B="!D:7-C;W5N=#PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,#D\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1E96UE9"!D:79I
M9&5N9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-S,\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R
M:6]R('EE87(@=')U92!U<#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/
M=&AE<CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-34I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-S<Q/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-S<U
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F5U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^5&]T86P@:6YC;VUE('1A>"!E>'!E;G-E/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S
M<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'10
M87)T7S=E83@R8C(Y7SDX,C9?-#`R85]B.38P7S`R,35F9#AB861E.`T*0V]N
M=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\W96$X,F(R.5\Y.#(V7S0P,F%?
M8CDV,%\P,C$U9F0X8F%D93@O5V]R:W-H965T<R]3:&5E=#8Q+FAT;6P-"D-O
M;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O
M;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*
M/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT
M96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G
M/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS
M/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H
M96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60]
M,T1)1#!%-DE!13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#$^/'-T<F]N9SY#;VUP;VYE;G0@
M;V8@1&5F97)R960@5&%X($%S<V5T<R!A;F0@3&EA8FEL:71I97,@*$1E=&%I
M;"D@*%531"`D*3QB<CY);B!4:&]U<V%N9',L('5N;&5S<R!O=&AE<G=I<V4@
M<W!E8VEF:65D/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#X\<W1R;VYG/D1E9F5R<F5D('1A>"!A<W-E=',Z/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T(&]P
M97)A=&EN9R!L;W-S(&-A<G)Y(&9O<G=A<F1S/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XD(#$T-RPV-34\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$R-RPU,CD\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)E<V5A<F-H('1A
M>"!C<F5D:70@8V%R<GD@9F]R=V%R9',\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C(Q+#,S-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$X+#$V,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06-C<G5A;',@86YD(')E<V5R=F5S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY+#4P,3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C@L-3(Y/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#
M87!I=&%L:7IE9"!R97-E87)C:"!C;W-T<SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,3`L-C8R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,3(L-S4W/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$969E<G)E9"!R979E;G5E/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#0X-CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L,3@P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/=&AE
M<CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PR,C(\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#(R,3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D1E9F5R<F5D(%1A>"!!<W-E=',L($=R;W-S+"!4;W1A;#PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,3DR+#@V,CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$W,"PS-SD\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DQE<W,@=F%L
M=6%T:6]N(&%L;&]W86YC93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;3XH,3DR+#<S,RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@Q-S`L,C,R*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O=3X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L(&1E9F5R<F5D('1A>"!A<W-E
M=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$R.3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$T-SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T
M<F]N9SY$969E<G)E9"!T87@@;&EA8FEL:71I97,Z/"]S=')O;F<^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1FEX960@07-S971S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q-C(I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH.#8I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/=&AE<CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S,\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@V,2D\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;W4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!D
M969E<G)E9"!T87@@;&EA8FEL:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6T^*#$R.2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@Q-#<I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F5U/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^3F5T(&1E9F5R<F5D('1A>"!A<W-E=',\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].
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M#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$
M0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T
M9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO
M=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T
M/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T
M(&ED/3-$240P14)(04D^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^26YC;VUE
M(%1A>&5S("T@061D:71I;VYA;"!);F9O<FUA=&EO;B`H1&5T86EL*2`H55-$
M("0I/&)R/DEN($UI;&QI;VYS+"!U;FQE<W,@;W1H97)W:7-E('-P96-I9FEE
M9#PO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P
M86X],T0S/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$S
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P
M,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@
M,C`Q,3QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T
M<F]N9SY);F-O;64@5&%X($1I<V-L;W-U<F4@6TQI;F4@271E;7-=/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DEN8V]M
M92!T87@@97AP96YS93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y);F-R
M96%S92`H9&5C<F5A<V4I(&EN('9A;'5A=&EO;B!A;&QO=V%N8V4\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(R+C4\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$X+C$\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%M;W5N="!O
M9B!V86QU871I;VX@86QL;W=A;F-E(&9O<B!D969E<G)E9"!T87@@87-S971S
M(&%L;&]C871E9"!T;R!C;VYT<FEB=71E9"!C87!I=&%L/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XP+C,\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1F5D97)A;#PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DEN8V]M92!487@@
M1&ES8VQO<W5R92!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T(&]P97)A=&EN9R!L;W-S(&-A
M<G)Y9F]R=V%R9',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,X
M-"XQ/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D9E9&5R86P@?"!-:6YI;75M/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^26YC;VUE(%1A>"!$:7-C;&]S=7)E
M(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y.970@;W!E<F%T:6YG(&QO<W,@8V%R<GEF;W)W87)D
M<RP@97AP:7)A=&EO;B!Y96%R/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG,C`Q.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y&961E<F%L('P@36%X:6UU;3PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DEN8V]M92!487@@1&ES
M8VQO<W5R92!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^3F5T(&]P97)A=&EN9R!L;W-S(&-A<G)Y
M9F]R=V%R9',L(&5X<&ER871I;VX@>65A<CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)S(P,S<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^1F5D97)A;"!\(%)E<V5A<F-H($%N9"!$
M979E;&]P;65N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#X\<W1R;VYG/DEN8V]M92!487@@1&ES8VQO<W5R92!;3&EN92!)=&5M<UT\
M+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M5&%X(&-R961I="!C87)R>69O<G=A<F0@86UO=6YT/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XQ,RXX/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D9E9&5R86P@?"!297-E87)C:"!!
M;F0@1&5V96QO<&UE;G0@?"!-:6YI;75M/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^26YC;VUE(%1A>"!$:7-C;&]S=7)E
M(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y487@@8W)E9&ET(&-A<G)Y9F]R=V%R9"!A;6]U;G0L
M(&5X<&ER871I;VX@>65A<CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)S(P,3@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^1F5D97)A;"!\(%)E<V5A<F-H($%N9"!$979E;&]P;65N
M="!\($UA>&EM=6T\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^/'-T<F]N9SY);F-O;64@5&%X($1I<V-L;W-U<F4@6TQI;F4@271E;7-=
M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E1A>"!C<F5D:70@8V%R<GEF;W)W87)D(&%M;W5N="P@97AP:7)A=&EO;B!Y
M96%R/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG,C`S,SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#
M86QI9F]R;FEA(%-T871E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/CQS=')O;F<^26YC;VUE(%1A>"!$:7-C;&]S=7)E(%M,:6YE($ET
M96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y.970@;W!E<F%T:6YG(&QO<W,@8V%R<GEF;W)W87)D<SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C$Y+C<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V%L:69O<FYI82!3
M=&%T92!\($UI;FEM=6T\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^/'-T<F]N9SY);F-O;64@5&%X($1I<V-L;W-U<F4@6TQI;F4@271E
M;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/DYE="!O<&5R871I;F<@;&]S<R!C87)R>69O<G=A<F1S+"!E>'!I<F%T
M:6]N('EE87(\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<R,#$S
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D-A;&EF;W)N:6$@4W1A=&4@?"!-87AI;75M/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^26YC;VUE(%1A>"!$:7-C
M;&]S=7)E(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y.970@;W!E<F%T:6YG(&QO<W,@8V%R<GEF
M;W)W87)D<RP@97AP:7)A=&EO;B!Y96%R/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG,C`S,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y#86QI9F]R;FEA(%-T871E('P@4F5S96%R
M8V@@06YD($1E=F5L;W!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/CQS=')O;F<^26YC;VUE(%1A>"!$:7-C;&]S=7)E(%M,:6YE
M($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y487@@8W)E9&ET(&-A<G)Y9F]R=V%R9"!A;6]U;G0\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$Q+C4\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1F]R96EG;CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DEN8V]M
M92!487@@1&ES8VQO<W5R92!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T(&]P97)A=&EN9R!L
M;W-S(&-A<G)Y9F]R=V%R9',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@,C<N.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].
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M#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$
M0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T
M9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO
M=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T
M/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T
M(&ED/3-$240P13-*04<^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^4V5L96-T
M960@475A<G1E<FQY($9I;F%N8VEA;"!$871A("A$971A:6PI("A54T0@)"D\
M8G(^26X@5&AO=7-A;F1S+"!E>&-E<'0@4&5R(%-H87)E(&1A=&$L('5N;&5S
M<R!O=&AE<G=I<V4@<W!E8VEF:65D/"]S=')O;F<^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#@^,R!-;VYT:',@16YD960\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,SXQ,B!-;VYT
M:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R,#$S/&)R/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P,3,\8G(^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q,SQB<CX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P,3(\8G(^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q,CQB
M<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$R
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P
M,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@
M,C`Q,CQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q
M+"`R,#$Q/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\
M<W1R;VYG/E-E;&5C=&5D(%%U87)T97)L>2!&:6YA;F-I86P@1&%T82!;3&EN
M92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y2979E;G5E<SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)"`R+#@T-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/B0@,BPY,C<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,L,SDR/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R+#`X-3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,2PX
M,#8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XD(#(L.#<T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^)"`R+#8X-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B0@,BPS-3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$Q+#(U,3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@.2PW,30\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(Q+#8Q
M-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^3F5T(&QO<W,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$S
M+#`U-BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B@Q-2PV-S4I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XH,3<L,38T*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6T^*#(P+#@R-2D\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R,"PU-#,I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,3<L-SDQ*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$U+#$Q
M,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M/B@Q-BPU,#4I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XH-C8L-S(P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#8Y+#DT.2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B@T."PU.3<I/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@;&]S<R!A;&QO
M8V%B;&4@=&\@8V]M;6]N('-T;V-K:&]L9&5R<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XD("@R,2PU,C4I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@Q-2PV-S4I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@Q-RPQ-C0I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@R
M,"PX,C4I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XD("@R,"PU-#,I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XD("@Q-RPW.3$I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@Q-2PQ,3`I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@Q-BPU,#4I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@W
M-2PQ.#DI/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XD("@V.2PY-#DI/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XD("@T."PU.3<I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y"87-I8R!A;F0@9&EL=71E9"!N
M970@;&]S<R!P97(@<VAA<F4@86QL;V-A8FQE('1O(&-O;6UO;B!S=&]C:VAO
M;&1E<G,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,"XP.2D\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@
M*#`N,#DI/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XD("@P+C`Y*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6T^)"`H,"XQ,2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B0@*#`N,3$I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@P+C$I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@P+C`Y*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,"XQ
M,2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M/B0@*#`N,S@I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XD("@P+C0Q*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^)"`H,"XS.2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E=E:6=H=&5D+6%V97)A9V4@8V]M
M;6]N('-H87)E<R!O=71S=&%N9&EN9SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,C,U+#@W.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$X,RPP,C(\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ.#(L.3$S/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3@R+#@T-SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$X,"PV.#4\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M-S<L.#<P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,38W+#8Y-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$U-2PT,S$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ.38L,C<U/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3<P+#0V.3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$R-2PQ,#$\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@
M/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S=E83@R8C(Y
M7SDX,C9?-#`R85]B.38P7S`R,35F9#AB861E.`T*0V]N=&5N="U,;V-A=&EO
M;CH@9FEL93HO+R]#.B\W96$X,F(R.5\Y.#(V7S0P,F%?8CDV,%\P,C$U9F0X
M8F%D93@O5V]R:W-H965T<R]3:&5E=#8T+FAT;6P-"D-O;G1E;G0M5')A;G-F
M97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@
M=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH
M96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N
M=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP
M93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!2
M96UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D
M>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%3DI!0SX-
M"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS
M1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY3=6)S97%U96YT($5V96YT("T@061D
M:71I;VYA;"!);F9O<FUA=&EO;B`H1&5T86EL*2`H55-$("0I/&)R/DEN(%1H
M;W5S86YD<RP@=6YL97-S(&]T:&5R=VES92!S<&5C:69I960\+W-T<F]N9SX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$-#XQ,B!-
M;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS
M<&%N/3-$,3XQ($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$Q
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P
M,3,\8G(^07-T<F$@6F5N96-A/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^07-T<F$@6F5N96-A/&)R/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3$\8G(^07-T
M<F$@6F5N96-A/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA
M<BX@,S$L(#(P,30\8G(^07-T<F$@6F5N96-A/&)R/E-U8G-E<75E;G0@179E
M;G0\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O
M;F<^4W5B<V5Q=65N="!%=F5N="!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y-:6QE<W1O;F4@
M<F5V96YU93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q,BPP
M,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XD(#(L-3`W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^)"`R+#0V,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B0@-C0R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^)"`U+#0P,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT
M;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?-V5A.#)B,CE?.3@R-E\T,#)A7V(Y
M-C!?,#(Q-69D.&)A9&4X#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z
M+S=E83@R8C(Y7SDX,C9?-#`R85]B.38P7S`R,35F9#AB861E."]7;W)K<VAE
M971S+V9I;&5L:7-T+GAM;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@
M<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H
M87)S970](G5S+6%S8VEI(@T*#0H\>&UL('AM;&YS.F\],T0B=7)N.G-C:&5M
M87,M;6EC<F]S;V9T+6-O;3IO9F9I8V4Z;V9F:6-E(CX-"B`\;SI-86EN1FEL
M92!(4F5F/3-$(BXN+U=O<FMB;V]K+FAT;6PB+SX-"B`\;SI&:6QE($A2968]
M,T0B4VAE970P,2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,#(N
M:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#`S+FAT;6PB+SX-"B`\
M;SI&:6QE($A2968],T0B4VAE970P-"YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F
M/3-$(E-H965T,#4N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#`V
M+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970P-RYH=&UL(B\^#0H@
M/&\Z1FEL92!(4F5F/3-$(E-H965T,#@N:'1M;"(O/@T*(#QO.D9I;&4@2%)E
M9CTS1")3:&5E=#`Y+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970Q
M,"YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,3$N:'1M;"(O/@T*
M(#QO.D9I;&4@2%)E9CTS1")3:&5E=#$R+FAT;6PB+SX-"B`\;SI&:6QE($A2
M968],T0B4VAE970Q,RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T
M,30N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#$U+FAT;6PB+SX-
M"B`\;SI&:6QE($A2968],T0B4VAE970Q-BYH=&UL(B\^#0H@/&\Z1FEL92!(
M4F5F/3-$(E-H965T,3<N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E
M=#$X+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970Q.2YH=&UL(B\^
M#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,C`N:'1M;"(O/@T*(#QO.D9I;&4@
M2%)E9CTS1")3:&5E=#(Q+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE
M970R,BYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,C,N:'1M;"(O
M/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#(T+FAT;6PB+SX-"B`\;SI&:6QE
M($A2968],T0B4VAE970R-2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H
M965T,C8N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#(W+FAT;6PB
M+SX-"B`\;SI&:6QE($A2968],T0B4VAE970R."YH=&UL(B\^#0H@/&\Z1FEL
M92!(4F5F/3-$(E-H965T,CDN:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3
M:&5E=#,P+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970S,2YH=&UL
M(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,S(N:'1M;"(O/@T*(#QO.D9I
M;&4@2%)E9CTS1")3:&5E=#,S+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B
M4VAE970S-"YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,S4N:'1M
M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#,V+FAT;6PB+SX-"B`\;SI&
M:6QE($A2968],T0B4VAE970S-RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$
M(E-H965T,S@N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#,Y+FAT
M;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970T,"YH=&UL(B\^#0H@/&\Z
M1FEL92!(4F5F/3-$(E-H965T-#$N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS
M1")3:&5E=#0R+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970T,RYH
M=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T-#0N:'1M;"(O/@T*(#QO
M.D9I;&4@2%)E9CTS1")3:&5E=#0U+FAT;6PB+SX-"B`\;SI&:6QE($A2968]
M,T0B4VAE970T-BYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T-#<N
M:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#0X+FAT;6PB+SX-"B`\
M;SI&:6QE($A2968],T0B4VAE970T.2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F
M/3-$(E-H965T-3`N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#4Q
M+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970U,BYH=&UL(B\^#0H@
M/&\Z1FEL92!(4F5F/3-$(E-H965T-3,N:'1M;"(O/@T*(#QO.D9I;&4@2%)E
M9CTS1")3:&5E=#4T+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970U
M-2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T-38N:'1M;"(O/@T*
M(#QO.D9I;&4@2%)E9CTS1")3:&5E=#4W+FAT;6PB+SX-"B`\;SI&:6QE($A2
M968],T0B4VAE970U."YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T
M-3DN:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#8P+FAT;6PB+SX-
M"B`\;SI&:6QE($A2968],T0B4VAE970V,2YH=&UL(B\^#0H@/&\Z1FEL92!(
M4F5F/3-$(E-H965T-C(N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E
M=#8S+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970V-"YH=&UL(B\^
M#0H\+WAM;#X-"BTM+2TM+3U?3F5X=%!A<G1?-V5A.#)B,CE?.3@R-E\T,#)A
67V(Y-C!?,#(Q-69D.&)A9&4X+2T-"@``
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EYBAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Property and Equipment - Additional Information (Detail) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
        <td class="nump">$ 1,327<span></span></td>
        <td class="nump">$ 1,207<span></span></td>
        <td class="nump">$ 1,303<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DepreciationAndAmortization</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Current Accrued Liabilities (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Component of Current Accrued Liabilities</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Current accrued liabilities as of December&#160;31, 2013, and 2012 consist of the following (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:71%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="6" valign="bottom" style="width:28%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:71%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:3%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:13%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Payroll and related expenses</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,639</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:3%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:11%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,538</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Legal expenses</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">338</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:3%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:11%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">396</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Third party research and development expenses</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,403</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:3%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:11%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,207</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:71%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other accrued liabilities</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,786</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:3%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:11%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,922</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:71%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,166</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:3%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:11%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,063</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the components of accrued liabilities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Component of Property and Equipment</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Property and equipment as of December&#160;31, 2013, and 2012 consist of the following (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:70%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:8%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Estimated&#160;Useful<br />Life</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:70%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(In years)</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:70%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Manufacturing equipment</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5-14</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,968</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,574</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:70%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lab equipment</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5-13</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,227</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,755</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:70%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computer equipment</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,962</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,807</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:70%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furniture and fixtures</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,056</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">983</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:70%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5-7</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,048</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,445</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:70%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets in progress</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:8%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">762</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,047</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:70%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,023</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,611</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:70%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less accumulated depreciation and amortization</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:8%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,317</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,646</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:70%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:8%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,706</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,965</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.13)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 13<br><br> -Subparagraph b<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EUVAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Summary of Restricted Stock Units Activity (Detail) (Restricted Stock Units (RSUs), USD $)<br>In Thousands, except Per Share data, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Restricted Stock Units (RSUs)</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of shares</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning Balance</a></td>
        <td class="nump">1,755<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
        <td class="nump">250<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested</a></td>
        <td class="num">(115)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited or expired</a></td>
        <td class="num">(615)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending Balance</a></td>
        <td class="nump">1,275<span></span></td>
        <td class="nump">1,755<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning Balance</a></td>
        <td class="nump">$ 4.23<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted</a></td>
        <td class="nump">$ 1.23<span></span></td>
        <td class="nump">$ 4.23<span></span></td>
        <td class="nump">$ 0<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested</a></td>
        <td class="nump">$ 1.10<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited or expired</a></td>
        <td class="nump">$ 4.23<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending Balance</a></td>
        <td class="nump">$ 3.93<span></span></td>
        <td class="nump">$ 4.23<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(iii)(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(iii)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(iii)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(i)-(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(i)-(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(iii)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(iii)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EEGAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Intangible Assets - Additional Information (Detail) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite Lived Intangible Assets [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
        <td class="nump">$ 0<span></span></td>
        <td class="nump">$ 0<span></span></td>
        <td class="nump">$ 299<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Manufacturing Process</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite Lived Intangible Assets [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">5 years<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Customer Relationships</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite Lived Intangible Assets [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">5 years<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 45<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AmortizationOfIntangibleAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FiniteLivedIntangibleAssetsLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FiniteLivedIntangibleAssetUsefulLife</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Future Minimum Payments Under Non-Cancelable Portion of Operating Leases</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Future minimum payments under the non-cancelable portion of our operating leases at December&#160;31, 2013, excluding payments from sublease payments, are as follows (in thousands):</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Years ending December&#160;31,</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:3%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:14%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2014</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:14%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,233</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2015</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:14%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,282</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2016</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:14%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,333</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2017</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:14%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,382</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2018</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:14%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,351</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Thereafter</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:3%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,499</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:3%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,080</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EZGAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Collaborative Research and Development Agreements (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Agreement With Gsk</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionMultipleDeliverableArrangementsTableTextBlock', window );">Summary of Revenues Recognized by Major Customer</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The following table summarizes the revenues recognized under our agreement with GSK (in thousands):</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31,</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:67%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Initial payment</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,702</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,428</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,428</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Milestone revenue</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,000</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,702</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,428</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,428</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></div><span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Astra Zeneca</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionMultipleDeliverableArrangementsTableTextBlock', window );">Summary of Revenues Recognized by Major Customer</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The following table summarizes the revenues earned under our agreement with AstraZeneca (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31,</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:67%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Initial payments</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">720</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">720</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">120</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Performance of research activities</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,507</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,462</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">642</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,227</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,182</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">762</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></div><span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">National Institutes of Health</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionMultipleDeliverableArrangementsTableTextBlock', window );">Summary of Revenues Recognized by Major Customer</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The following table summarizes the revenues recognized under the various arrangements with the NIH and NIAID (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31,</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:67%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">NIAID contracts</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,103</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,571</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,730</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All other NIH contracts</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,035</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">368</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">380</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total grant revenue</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,138</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,939</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,110</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionMultipleDeliverableArrangementsTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the recognition of revenue arrangements under which the entity does or will perform multiple revenue-generating activities, categorized by type of arrangement. This item includes certain revenue arrangements that include software elements. This item does not include multiple-deliverable arrangements for industries that prepare disclosures under specific requirements (for instance, construction-type and production-type contracts) otherwise provided for in the taxonomy.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 605<br><br> -SubTopic 25<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=19771336&amp;loc=SL6750900-111635<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 605<br><br> -SubTopic 25<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=19771336&amp;loc=d3e50766-111635<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RevenueRecognitionMultipleDeliverableArrangementsTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Organization<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization</a></td>
        <td class="text"><div>
<div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:12pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Organization </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Dynavax Technologies Corporation (&#8220;we,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; &#8220;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dynavax&#8221; or the &#8220;Company&#8221;), a clinical-stage biopharmaceutical company, develops products to prevent and treat infectious and inflammatory diseases and cancer based on Toll-like Receptor (&#8220;TLR&#8221;) biology and its ability to modulate the innate immune system. Our lead product candidate is HEPLISAV-B<sup style="font-size:85%; vertical-align:top">TM </sup>(also known as &#8220;HEPLISAV&#8221;), an investigational adult hepatitis B vaccine in Phase 3 clinical development. </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In addition to HEPLISAV-B</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, we are conducting clinical and preclinical programs that utilize our expertise in TLR biology. Our product candidates include both TLR agonists and TLR inhibitors. Our clinical stage programs include our autoimmune program partnered with GlaxoSmithKline (&#8220;GSK&#8221;), our asthma therapeutic program partnered with AstraZeneca AB (&#8220;AstraZeneca&#8221;), and our cancer immunotherapy program. We also are advancing preclinical development programs in adjuvant technology and TLR 7, 8, and 9 inhibition. We compete with pharmaceutical companies, biotechnology companies, academic institutions and research organizations in developing therapies to prevent or treat infectious and inflammatory diseases and cancer. We were incorporated in California in August&#160;1996 under the name Double Helix Corporation, and we changed our name to Dynavax Technologies Corporation in September&#160;1996. We reincorporated in Delaware in 2000.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Subsidiaries </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In April 2006, we completed the acquisition of Rhein</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Biotech GmbH (&#8220;Rhein&#8221; or &#8220;Dynavax Europe&#8221;), a wholly-owned subsidiary in D&#252;sseldorf, Germany. In October 2011, we formed Dynavax International, B.V., a wholly-owned subsidiary in Amsterdam, Netherlands. </font></p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 810<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28200181&amp;loc=SL6228881-111685<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 720<br><br> -SubTopic 15<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2122524<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 205<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 205<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7668296&amp;loc=d3e288-107754<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 810<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2197480<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 810<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=18733093&amp;loc=d3e5614-111684<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 915<br><br> -SubTopic 235<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6472506&amp;loc=d3e38932-110933<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 852<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2209116<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 272<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6373374&amp;loc=d3e70478-108055<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2134480<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 205<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2122150<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Net Loss Per Share (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Computation of Basic and Diluted Earnings Per Share</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="10" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Basic and diluted net loss per share (in thousands, except per share&#160;amounts):</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Numerator:</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(66,720</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(69,949</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(48,597</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Preferred stock deemed dividend</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,469</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss allocable to common stockholders</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(75,189</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(69,949</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(48,597</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%; border-top:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Denominator for basic and diluted net loss per share allocable to common stockholders:</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average common shares outstanding</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">196,275</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">170,469</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">125,101</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic and diluted net loss per share allocable to common stockholders</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.38</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.41</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.39</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;;">&nbsp;</p></div><div>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding securities not included in diluted net loss per share calculation (in thousands):</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options and stock awards</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,040</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,561</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,101</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Series B Convertible Preferred Stock (as converted to common stock)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43,430</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,464</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,714</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,729</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72,934</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,275</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,830</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;">&nbsp;</p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EMFAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Summary of Amortized Cost and Estimated Fair Value of Marketable Securities Available-for-sale (Detail) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract', window );"><strong>Amortized Cost</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Mature in one year or less</a></td>
        <td class="nump">$ 93,691<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost', window );">Mature after one year through two years</a></td>
        <td class="nump">72,594<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost', window );">Total amortized cost</a></td>
        <td class="nump">166,285<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Estimated Fair Value</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Mature in one year or less</a></td>
        <td class="nump">93,701<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Mature after one year through two years</a></td>
        <td class="nump">72,553<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total estimated fair value</a></td>
        <td class="nump">$ 166,254<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of available-for-sale debt securities at cost, net of adjustments, maturing in the second fiscal year through the fifth fiscal year following the latest fiscal year. Adjustments include, but are not limited to, accretion, amortization, collection of cash, previous other-than-temporary impairments (OTTI) recognized in earnings (less any cumulative-effect adjustments, as defined) and fair value hedge accounting adjustments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27198-111563<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of available-for-sale debt securities at fair value maturing in the second fiscal year through the fifth fiscal year following the latest fiscal year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (d)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27161-111563<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 320<br><br> -Section 50<br><br> -Paragraph 3<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957658&amp;loc=d3e62586-112803<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27198-111563<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of available-for-sale debt securities at cost, net of adjustments, which include, but are not limited to, accretion, amortization, collection of cash, previous other-than-temporary impairments (OTTI) recognized in earnings (less any cumulative-effect adjustments, as defined) and fair value hedge accounting adjustments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (aa)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27161-111563<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of available-for-sale debt securities at cost, net of adjustments, maturing in the next fiscal year following the latest fiscal year. Adjustments include, but are not limited to, accretion, amortization, collection of cash, previous other-than-temporary impairments (OTTI) recognized in earnings (less any cumulative-effect adjustments, as defined) and fair value hedge accounting adjustments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27198-111563<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of available-for-sale debt securities at fair value maturing in the next fiscal year following the latest fiscal year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27198-111563<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 320<br><br> -Section 50<br><br> -Paragraph 3<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957658&amp;loc=d3e62586-112803<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (d)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27161-111563<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of debt securities categorized neither as held-to-maturity nor trading.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 25<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28360136&amp;loc=d3e22054-111558<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6871852&amp;loc=d3e26610-111562<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (aa)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27161-111563<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 320<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (b)-(g)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957658&amp;loc=d3e62557-112803<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecuritiesDebtSecurities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EXDAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Warrants Issued to Purchase Common Stock (Detail)<br></strong></div>
        </th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="5">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Apr. 30, 2010</div>
        </th>
        <th class="th">
          <div>Apr. 16, 2010</div>
        </th>
        <th class="th">
          <div>Nov. 30, 2009</div>
        </th>
        <th class="th">
          <div>Apr. 18, 2006</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>2007 Loan Agreement</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Warrant One

</div>
          <div>2007 Loan Agreement</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Warrant Two

</div>
          <div>2007 Loan Agreement</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Warrant Three

</div>
          <div>2007 Loan Agreement</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Warrant Four

</div>
          <div>2007 Loan Agreement</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class Of Warrant Or Right [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_WarrantIssueDate', window );">Warrant Issuance Date</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">Jul. 18,
				 2007<span></span></td>
        <td class="text">Oct. 18,
				 2007<span></span></td>
        <td class="text">Dec. 27,
				 2007<span></span></td>
        <td class="text">Dec. 27,
				 2007<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Shares Issuable</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,550,000<span></span></td>
        <td class="nump">1,250,000<span></span></td>
        <td class="nump">1,300,000<span></span></td>
        <td class="nump">300,000<span></span></td>
        <td class="nump">700,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_WarrantExpirationDate', window );">Expiration Date</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">Feb. 26,
				 2014<span></span></td>
        <td class="text">Feb. 26,
				 2014<span></span></td>
        <td class="text">Feb. 26,
				 2014<span></span></td>
        <td class="text">Feb. 26,
				 2014<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights', window );">Warrants exercise price</a></td>
        <td class="nump">1.96<span></span></td>
        <td class="nump">1.50<span></span></td>
        <td class="nump">1.50<span></span></td>
        <td class="nump">1.94<span></span></td>
        <td class="nump">7.32<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">5.13<span></span></td>
        <td class="nump">1.68<span></span></td>
        <td class="nump">5.65<span></span></td>
        <td class="nump">1.68<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Outstanding</a></td>
        <td class="nump">10,913,873<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,550,000<span></span></td>
        <td class="nump">1,250,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">300,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_WarrantExpirationDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrant, Expiration Date</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_WarrantExpirationDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_WarrantIssueDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrant Issue Date</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_WarrantIssueDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Exercise price per share or per unit of warrants or rights outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(i)(4))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph i<br><br> -Subparagraph 4<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>us-types:perUnitItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfWarrantOrRightLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of warrants or rights outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(i))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph i<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfWarrantOrRightOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ConversionOfStockSharesConverted1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EANAG">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Consolidated Balance Sheets (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
        <td class="nump">$ 23,122<span></span></td>
        <td class="nump">$ 7,599<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesCurrent', window );">Marketable securities available-for-sale</a></td>
        <td class="nump">166,254<span></span></td>
        <td class="nump">117,531<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
        <td class="nump">1,627<span></span></td>
        <td class="nump">1,005<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
        <td class="nump">1,375<span></span></td>
        <td class="nump">2,052<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
        <td class="nump">192,378<span></span></td>
        <td class="nump">128,187<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
        <td class="nump">8,706<span></span></td>
        <td class="nump">7,965<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
        <td class="nump">2,579<span></span></td>
        <td class="nump">2,475<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent', window );">Restricted cash</a></td>
        <td class="nump">662<span></span></td>
        <td class="nump">652<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
        <td class="nump">297<span></span></td>
        <td class="nump">473<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
        <td class="nump">204,622<span></span></td>
        <td class="nump">139,752<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
        <td class="nump">1,901<span></span></td>
        <td class="nump">2,166<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
        <td class="nump">8,166<span></span></td>
        <td class="nump">10,063<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenues</a></td>
        <td class="nump">6,125<span></span></td>
        <td class="nump">6,785<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
        <td class="nump">16,192<span></span></td>
        <td class="nump">19,014<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Deferred revenues, net of current portion</a></td>
        <td class="nump">1,173<span></span></td>
        <td class="nump">5,283<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
        <td class="nump">963<span></span></td>
        <td class="nump">629<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
        <td class="nump">18,328<span></span></td>
        <td class="nump">24,926<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 9)</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#x2019; equity:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock: $0.001 par value; 350,000 and 250,000 shares authorized at December 31, 2013 and 2012, respectively; 262,796 and 182,792 shares issued and outstanding at December 31, 2013 and 2012, respectively</a></td>
        <td class="nump">263<span></span></td>
        <td class="nump">183<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
        <td class="nump">688,390<span></span></td>
        <td class="nump">550,729<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Total accumulated other comprehensive loss</a></td>
        <td class="num">(148)<span></span></td>
        <td class="num">(595)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
        <td class="num">(502,211)<span></span></td>
        <td class="num">(435,491)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#x2019; equity</a></td>
        <td class="nump">186,294<span></span></td>
        <td class="nump">114,826<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#x2019; equity</a></td>
        <td class="nump">204,622<span></span></td>
        <td class="nump">139,752<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Series B Convertible Preferred Stock</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#x2019; equity:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 19<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19(a))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsPayableCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.3-4)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 3<br><br><br><br> -Subparagraph a(1)<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 4<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsReceivableNetCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccruedLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 14A<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=SL7669686-108580<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 11<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e637-108580<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 14<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e681-108580<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.30(a)(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdditionalPaidInCapital</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 12<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 18<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Assets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.9)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-107765<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 9<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetsCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetsCurrentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of investment in debt and equity securities categorized neither as trading securities nor held-to-maturity securities and intended be sold or mature one year or operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 25<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28360136&amp;loc=d3e22054-111558<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6871852&amp;loc=d3e26626-111562<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecuritiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash Equivalents<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 1<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3044-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 450<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14326-108349<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.25)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 25<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 19<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 17<br><br><br><br> -Article 9<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.9-03.17)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br><br><br><br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-03.(a),19)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommitmentsAndContingencies</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 605<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SAB TOPIC 13.A.4(a).Q1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012821&amp;loc=d3e214044-122780<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 8<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 13<br><br><br><br> -Section A<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredRevenueCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The noncurrent portion of deferred revenue amount as of balance sheet date. Deferred revenue is a liability related to a revenue producing activity for which revenue has not yet been recognized, and is not expected to be recognized in the next twelve months. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 605<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SAB TOPIC 13.A.4(a).Q1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012821&amp;loc=d3e214044-122780<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 8<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 13<br><br><br><br> -Section A<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredRevenueNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=14024403&amp;loc=d3e13816-109267<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Goodwill</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19-26)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Liabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.32)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 25<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 32<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesAndStockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.21)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 21<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesCurrentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.17)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 17<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherAssetsNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate carrying amount, as of the balance sheet date, of noncurrent obligations not separately disclosed in the balance sheet. Noncurrent liabilities are expected to be paid after one year (or the normal operating cycle, if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.24)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 24<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherLiabilitiesNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.28)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 8<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PrepaidExpenseAndOtherAssetsCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.13)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 13<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 8<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Cash and equivalents whose use in whole or in part is restricted for the long-term, generally by contractual agreements or regulatory requirements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 1<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RestrictedCashAndCashEquivalentsNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.31(a)(3))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RetainedEarningsAccumulatedDeficit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 310<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SAB TOPIC 4.E)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 4<br><br><br><br> -Section E<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29-31)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29, 30, 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAHAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Component of Current Accrued Liabilities (Detail) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued Liabilities Abstract</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedEmployeeBenefitsCurrent', window );">Payroll and related expenses</a></td>
        <td class="nump">$ 3,639<span></span></td>
        <td class="nump">$ 4,538<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Legal expenses</a></td>
        <td class="nump">338<span></span></td>
        <td class="nump">396<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_AccruedThirdPartyResearchAndDevelopmentExpensesCurrent', window );">Third party research and development expenses</a></td>
        <td class="nump">2,403<span></span></td>
        <td class="nump">3,207<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
        <td class="nump">1,786<span></span></td>
        <td class="nump">1,922<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total</a></td>
        <td class="nump">$ 8,166<span></span></td>
        <td class="nump">$ 10,063<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_AccruedThirdPartyResearchAndDevelopmentExpensesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Accrued Third Party Research and Development Expenses, Current</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_AccruedThirdPartyResearchAndDevelopmentExpensesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedEmployeeBenefitsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 20<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Current Liabilities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.20)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccruedEmployeeBenefitsCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 20<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.20)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccruedLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccruedLiabilitiesCurrentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 20<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Current Liabilities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.20)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccruedProfessionalFeesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of obligations incurred through that date and payable arising from transactions not otherwise specified in the taxonomy. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 20<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Current Liabilities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.20)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e7018-107765<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherAccruedLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ENJBK">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Total</div>
        </th>
        <th class="th">
          <div>Common Stock</div>
        </th>
        <th class="th">
          <div>Preferred Stock</div>
        </th>
        <th class="th">
          <div>Additional Paid-in Capital</div>
        </th>
        <th class="th">
          <div>Accumulated Other Comprehensive Income (Loss)</div>
        </th>
        <th class="th">
          <div>Accumulated Deficit</div>
        </th>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balances at Dec. 31, 2010</a></td>
        <td class="nump">$ 52,111,000<span></span></td>
        <td class="nump">$ 116,000<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">$ 369,686,000<span></span></td>
        <td class="num">$ (746,000)<span></span></td>
        <td class="num">$ (316,945,000)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning Balances (in shares) at Dec. 31, 2010</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">115,611,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue', window );">Issuance of common stock upon exercise of stock options and restricted stock awards</a></td>
        <td class="nump">10,000<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">10,000<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsShares', window );">Issuance of common stock upon exercise of stock options and restricted stock awards (In Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">308,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under Employee Stock Purchase Plan</a></td>
        <td class="nump">132,000<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">132,000<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under Employee Stock Purchase Plan (in shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">106,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_IssuanceOfCommonStockAndWarrantsValue', window );">Proceeds from issuances of common stock and warrants, net of issuance costs</a></td>
        <td class="nump">91,298,000<span></span></td>
        <td class="nump">39,000<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">91,259,000<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_IssuanceOfCommonStockAndWarrantsShares', window );">Proceeds from issuances of common stock and warrants, net of issuance costs (in shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">38,601,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock compensation expense</a></td>
        <td class="nump">5,189,000<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">5,189,000<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
        <td class="num">(263,000)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num">(263,000)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">(48,597,000)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num">(48,597,000)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balances at Dec. 31, 2011</a></td>
        <td class="nump">99,880,000<span></span></td>
        <td class="nump">155,000<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">466,276,000<span></span></td>
        <td class="num">(1,009,000)<span></span></td>
        <td class="num">(365,542,000)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balances (in shares) at Dec. 31, 2011</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">154,626,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue', window );">Issuance of common stock upon exercise of stock options and restricted stock awards</a></td>
        <td class="nump">1,955,000<span></span></td>
        <td class="nump">1,000<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">1,954,000<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsShares', window );">Issuance of common stock upon exercise of stock options and restricted stock awards (In Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,222,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under Employee Stock Purchase Plan</a></td>
        <td class="nump">307,000<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">307,000<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under Employee Stock Purchase Plan (in shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">141,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_IssuanceOfCommonStockAndWarrantsValue', window );">Proceeds from issuances of common stock and warrants, net of issuance costs</a></td>
        <td class="nump">71,780,000<span></span></td>
        <td class="nump">27,000<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">71,753,000<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_IssuanceOfCommonStockAndWarrantsShares', window );">Proceeds from issuances of common stock and warrants, net of issuance costs (in shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">26,803,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock compensation expense</a></td>
        <td class="nump">10,439,000<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">10,439,000<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
        <td class="nump">414,000<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">414,000<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">(69,949,000)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num">(69,949,000)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balances at Dec. 31, 2012</a></td>
        <td class="nump">114,826,000<span></span></td>
        <td class="nump">183,000<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">550,729,000<span></span></td>
        <td class="num">(595,000)<span></span></td>
        <td class="num">(435,491,000)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balances (in shares) at Dec. 31, 2012</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">182,792,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue', window );">Issuance of common stock upon exercise of stock options and restricted stock awards</a></td>
        <td class="nump">112,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">112,000<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsShares', window );">Issuance of common stock upon exercise of stock options and restricted stock awards (In Shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">106,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under Employee Stock Purchase Plan</a></td>
        <td class="nump">224,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">224,000<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under Employee Stock Purchase Plan (in shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">129,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted Stock Award Delivered (in shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">115,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net of issuance costs</a></td>
        <td class="nump">80,999,000<span></span></td>
        <td class="nump">80,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">80,919,000<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs (in shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">79,570,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Issuance of Series B convertible preferred stock, net of issuance costs</a></td>
        <td class="nump">44,209,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">44,209,000<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Issuance of Series B convertible preferred stock, net of issuance costs (in shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">43,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature', window );">Beneficial conversion feature of Series B convertible preferred stock</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredDividendsNetOfTax', window );">Deemed dividend to holders of Series B convertible preferred stock</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Warrants exercised</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1', window );">Warrants exercised (in shares)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">84,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock compensation expense</a></td>
        <td class="nump">12,340,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">12,340,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
        <td class="nump">447,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">447,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">(66,720,000)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(66,720,000)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Initial expenses related to ATM agreement</a></td>
        <td class="num">(143,000)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(143,000)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balances at Dec. 31, 2013</a></td>
        <td class="nump">$ 186,294,000<span></span></td>
        <td class="nump">$ 263,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 688,390,000<span></span></td>
        <td class="num">$ (148,000)<span></span></td>
        <td class="num">$ (502,211,000)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balances (in shares) at Dec. 31, 2013</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">262,796,000<span></span></td>
        <td class="nump">43,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_IssuanceOfCommonStockAndWarrantsShares">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Issuance Of Common Stock And Warrants, Shares</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_IssuanceOfCommonStockAndWarrantsShares</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_IssuanceOfCommonStockAndWarrantsValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value of issuance of common stock and warrants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_IssuanceOfCommonStockAndWarrantsValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsShares">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Issuance Of Common Stock Upon Exercise Of Options Vesting Of Restricted Stock Units and Vesting of Early Exercised Options Shares</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsShares</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Issuance Of Common Stock Upon Exercise Of Options Vesting Of Restricted Stock Units and Vesting of Early Exercised Options Value</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_IssuanceOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This element represents the amount of recognized equity-based compensation during the period, that is, the amount recognized as expense in the income statement (or as asset if compensation is capitalized). Alternate captions include the words "stock-based compensation".</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 35<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415241&amp;loc=d3e4534-113899<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 20<br><br> -Section 55<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=32706628&amp;loc=d3e11149-113907<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 20<br><br> -Section 55<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=32706628&amp;loc=d3e11178-113907<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredDividendsNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The after-tax amount of any dividends on convertible preferred stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 16<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1505-109256<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ConvertiblePreferredDividendsNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of warrants issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of a favorable spread to a debt holder between the amount of debt being converted and the value of the securities received upon conversion. This is an embedded conversion feature of convertible debt issued that is in-the-money at the commitment date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Beneficial Conversion Feature<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6505963<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21538-112644<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e565-108580<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1A<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=SL7669619-108580<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeLossNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares issued which are neither cancelled nor held in the treasury.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 310<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SAB TOPIC 4.E)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section E<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares issued during the period as a result of the conversion of convertible securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-30)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares issued during the period as a result of an employee stock purchase plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of new stock issued during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesNewIssues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The gross value of stock issued during the period upon the conversion of convertible securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueNewIssues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value of stock issued as a result of the exercise of stock options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E1GAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Component of Consolidated Income (Loss) Before Provision for Income Taxes (Detail) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems', window );"><strong>Schedule Of Components Of Income Before Income Tax Expense Benefit [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">U.S.</a></td>
        <td class="num">$ (67,004)<span></span></td>
        <td class="num">$ (70,792)<span></span></td>
        <td class="num">$ (49,990)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Non U.S.</a></td>
        <td class="nump">284<span></span></td>
        <td class="nump">843<span></span></td>
        <td class="nump">1,393<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Total</a></td>
        <td class="num">$ (66,720)<span></span></td>
        <td class="num">$ (69,949)<span></span></td>
        <td class="num">$ (48,597)<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_ScheduleOfComponentsOfIncomeBeforeIncomeTaxExpenseBenefitLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E5F">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Component of Consolidated Income (Loss) Before Provision for Income Taxes</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Consolidated income (loss) before provision for income taxes consisted of the following (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S.</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(67,004</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(70,792</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(49,990</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non U.S.</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">284</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">843</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,393</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(66,720</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(69,949</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(48,597</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Difference Between Consolidated Income Tax Benefit and Amount Computed by Federal Statutory Income Tax Rate</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">No income tax expense was recorded for the years ended December&#160;31, 2013, 2012 and 2011 due to net operating loss </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">carryforwards to offset the net income at Dynavax Europe and a valuation allowance which offsets the deferred tax assets. The difference between the consolidated income tax benefit and the amount computed by applying the federal statutory income tax rate to the consolidated loss before income taxes was as follows (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax benefit at federal statutory rate</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(22,678</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(23,650</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(16,523</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State tax</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(178</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(89</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,586</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Business credits</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,515</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,394</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred compensation charges</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,072</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,002</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">595</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in valuation allowance</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,354</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,966</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,099</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in foreign tax rates</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(34</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in the fair value measurements</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">286</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-deductible debt discount</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">509</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deemed dividend</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">273</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prior year true up</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(55</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">771</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">775</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total income tax expense</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Component of Deferred Tax Assets and Liabilities</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Deferred tax assets and liabilities as of December&#160;31, 2013 and 2012 consisted of the following (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax assets:</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net operating loss carry forwards</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">147,655</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">127,529</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research tax credit carry forwards</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,336</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,163</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accruals and reserves</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,501</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,529</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Capitalized research costs</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,662</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,757</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,486</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,180</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,222</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,221</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">192,862</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">170,379</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less valuation allowance</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(192,733</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(170,232</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred tax assets</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">129</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">147</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax liabilities:</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fixed Assets</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(162</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(86</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(61</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred tax liabilities</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(129</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(147</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred tax assets</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Income Taxes<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
        <td class="text"><div>
<div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">15.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Income Taxes </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Consolidated income (loss) before provision for income taxes consisted of the following (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S.</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(67,004</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(70,792</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(49,990</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non U.S.</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">284</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">843</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,393</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(66,720</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(69,949</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(48,597</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">No income tax expense was recorded for the years ended December&#160;31, 2013, 2012 and 2011 due to net operating loss </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">carryforwards to offset the net income at Dynavax Europe and a valuation allowance which offsets the deferred tax assets. The difference between the consolidated income tax benefit and the amount computed by applying the federal statutory income tax rate to the consolidated loss before income taxes was as follows (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax benefit at federal statutory rate</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(22,678</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(23,650</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(16,523</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State tax</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(178</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(89</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,586</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Business credits</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,515</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,394</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred compensation charges</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,072</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,002</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">595</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in valuation allowance</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,354</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,966</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,099</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in foreign tax rates</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(34</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in the fair value measurements</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">286</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-deductible debt discount</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">509</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deemed dividend</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">273</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prior year true up</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(55</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">771</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">775</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total income tax expense</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Deferred tax assets and liabilities as of December&#160;31, 2013 and 2012 consisted of the following (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax assets:</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net operating loss carry forwards</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">147,655</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">127,529</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research tax credit carry forwards</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,336</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,163</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accruals and reserves</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,501</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,529</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Capitalized research costs</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,662</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,757</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,486</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,180</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,222</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,221</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">192,862</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">170,379</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less valuation allowance</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(192,733</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(170,232</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred tax assets</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">129</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">147</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax liabilities:</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fixed Assets</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(162</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(86</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(61</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred tax liabilities</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(129</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(147</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred tax assets</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The tax benefit of net operating losses, temporary differences and credit carryforwards</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> is required to be recorded as an asset to the extent that management assesses that realization is &#8220;more likely than not.&#8221; Realization of the future tax benefits is dependent on our ability to generate sufficient taxable income within the carryforward period. Because of our recent history of operating losses, management believes that recognition of the deferred tax assets arising from the above-mentioned future tax benefits is currently not likely to be realized and, accordingly, has provided a full valuation allowance. The valuation allowance increased by $22.5 million, $22.0 million and $18.1 million during the years ended December&#160;31, 2013, 2012 and 2011, respectively. The amount of the valuation allowance for deferred tax assets associated with excess tax deductions from stock based compensation arrangements that will be allocated to contributed capital if the future tax benefits are subsequently recognized is $0.3 million. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We have not recorded deferred income taxes applicable to undistributed earnings of a foreign subsidiary that are indefinitely reinvested in foreign operations. Generally, such earnings become subject to U.S. tax upon the remittance of dividends and under certain other circumstances. It is not practicable to estimate the amount of the deferred tax liability on such undistributed earnings. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">As of December&#160;31, 2013, we had federal net operating loss carryforwards</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of approximately $384.1 million, which will expire in the years 2018 through 2037 and federal research and development tax credits of approximately $13.8 million, which expire in the years 2018 through 2033. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">As of December&#160;31, 2013, we had potential </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">net operating loss carryforwards for California state income tax purposes of approximately $219.7 million, which expire in the years 2013 through 2033, and California state research and development tax credits of approximately $11.5 million which do not expire. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">As of December&#160;31, 2013, we had net operating loss carryforwards</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for foreign income tax purposes of approximately $27.8 million, which do not expire. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The Tax Reform Act of 1986 limits the annual use of net operating loss and tax credit carryforwards</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> in certain situations where changes occur in stock ownership of a company. In the event the Company has a change in ownership, as defined, the annual utilization of such carryforwards could be limited. Due to past equity issuances and changes in ownership of Dynavax common stock, we believe that our ability to use some of our net operating losses and tax credits in the future may be limited. </font></p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 15<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32718-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(h))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Article 4<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32559-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Selected Quarterly Financial Data (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock', window );">Selected Quarterly Financial Data</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="14" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31, 2013</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Q1</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Q2</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Q3</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Q4</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenues</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,085</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,392</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,927</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,847</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net&#160;loss</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20,825</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,164</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,675</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(13,056</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss allocable to common stockholders</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20,825</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,164</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,675</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(21,525</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic and diluted net loss per share allocable to common stockholders</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.11</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.09</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.09</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.09</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares used to compute basic and diluted net loss per share allocable to common stockholders</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">182,847</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">182,913</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">183,022</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">235,879</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="14" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31, 2012</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Q1</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Q2</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Q3</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Q4</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenues</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,350</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,684</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,874</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,806</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net&#160;loss</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(16,505</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,110</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,791</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20,543</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss allocable to common stockholders</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(16,505</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,110</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,791</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20,543</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic and diluted net loss per share allocable to common stockholders</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.11</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.09</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.10</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.11</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares used to compute basic and diluted net loss per share allocable to common stockholders</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">155,431</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">167,697</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">177,870</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">180,685</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:8pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the quarterly financial data in the annual financial statements. The disclosure includes financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income (loss) before extraordinary items and cumulative effect of a change in accounting principle and earnings per share data.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 270<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)-(j)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25249566&amp;loc=d3e1280-108306<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Subsequent Events<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:11.33%;margin-right:0%;text-indent:-11.33%;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">17. Subsequent Events</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-weight:bold;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In March, 2014 we announced a $5.4</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million milestone payment and amendment of our AstraZeneca agreement to transfer responsibility for all clinical development to AstraZeneca following conclusion of the ongoing Phase 1 clinical trial of AZD 1419. </font></p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SubsequentEventsTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EFPBG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Consolidated Statements Of Cash Flows (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">$ (66,720)<span></span></td>
        <td class="num">$ (69,949)<span></span></td>
        <td class="num">$ (48,597)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
        <td class="nump">1,327<span></span></td>
        <td class="nump">1,207<span></span></td>
        <td class="nump">1,303<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="nump">299<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss (gain) on disposal of property and equipment</a></td>
        <td class="nump">18<span></span></td>
        <td class="nump">8<span></span></td>
        <td class="nump">20<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Accretion of discounts and amortization of premiums of marketable securities</a></td>
        <td class="nump">923<span></span></td>
        <td class="nump">1,298<span></span></td>
        <td class="nump">1,172<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Interest associated with long-term note payable to Symphony Dynamo Holdings LLC (&#x201C;Holdings)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,190<span></span></td>
        <td class="nump">1,871<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Fair value adjustment of the warrant and contingent liabilities to Holdings, including the impact of the anti-dilution provision associated with the common stock and warrants issued to Symphony Capital Partners, L.P. and Symphony Strategic Partners, LLC (collectively, "Symphony")</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(843)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Unoccupied facility expense</a></td>
        <td class="nump">926<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock compensation expense</a></td>
        <td class="nump">12,340<span></span></td>
        <td class="nump">10,439<span></span></td>
        <td class="nump">5,189<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
        <td class="num">(622)<span></span></td>
        <td class="nump">8,522<span></span></td>
        <td class="num">(8,526)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets', window );">Prepaid expenses and other current assets</a></td>
        <td class="nump">677<span></span></td>
        <td class="num">(922)<span></span></td>
        <td class="nump">230<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities', window );">Restricted cash and other assets</a></td>
        <td class="nump">176<span></span></td>
        <td class="num">(116)<span></span></td>
        <td class="num">(290)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
        <td class="num">(657)<span></span></td>
        <td class="nump">126<span></span></td>
        <td class="num">(289)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Accrued liabilities and other long term liabilities</a></td>
        <td class="num">(2,291)<span></span></td>
        <td class="nump">1,916<span></span></td>
        <td class="num">(2,167)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenues</a></td>
        <td class="num">(4,770)<span></span></td>
        <td class="nump">1,472<span></span></td>
        <td class="nump">3,512<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
        <td class="num">(58,673)<span></span></td>
        <td class="num">(43,809)<span></span></td>
        <td class="num">(47,116)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchases of marketable securities</a></td>
        <td class="num">(192,044)<span></span></td>
        <td class="num">(206,149)<span></span></td>
        <td class="num">(111,205)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities', window );">Proceeds from maturities of marketable securities</a></td>
        <td class="nump">142,321<span></span></td>
        <td class="nump">169,387<span></span></td>
        <td class="nump">77,729<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment, net</a></td>
        <td class="num">(1,629)<span></span></td>
        <td class="num">(2,931)<span></span></td>
        <td class="num">(1,142)<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
        <td class="num">(51,352)<span></span></td>
        <td class="num">(39,693)<span></span></td>
        <td class="num">(34,618)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuances of common stock</a></td>
        <td class="nump">80,856<span></span></td>
        <td class="nump">71,780<span></span></td>
        <td class="nump">91,298<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds from issuances of preferred stock</a></td>
        <td class="nump">44,209<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuances of warrants</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options and restricted stock awards</a></td>
        <td class="nump">112<span></span></td>
        <td class="nump">1,955<span></span></td>
        <td class="nump">10<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Proceeds from employee stock purchase plan</a></td>
        <td class="nump">224<span></span></td>
        <td class="nump">307<span></span></td>
        <td class="nump">132<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Payment of notes payable to Holdings</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(15,000)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
        <td class="nump">125,401<span></span></td>
        <td class="nump">59,042<span></span></td>
        <td class="nump">91,440<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
        <td class="nump">147<span></span></td>
        <td class="nump">118<span></span></td>
        <td class="num">(218)<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Net increase (decrease) in cash and cash equivalents</a></td>
        <td class="nump">15,523<span></span></td>
        <td class="num">(24,342)<span></span></td>
        <td class="nump">9,488<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at beginning of year</a></td>
        <td class="nump">7,599<span></span></td>
        <td class="nump">31,941<span></span></td>
        <td class="nump">22,453<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at end of year</a></td>
        <td class="nump">23,122<span></span></td>
        <td class="nump">7,599<span></span></td>
        <td class="nump">31,941<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Non-cash investing and financing activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_SupplementalDisposalOfAssets', window );">Disposal of fully depreciated property and equipment</a></td>
        <td class="nump">86<span></span></td>
        <td class="nump">169<span></span></td>
        <td class="nump">1,181<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Net change in unrealized (loss) gain on marketable securities</a></td>
        <td class="num">$ (76)<span></span></td>
        <td class="nump">$ 48<span></span></td>
        <td class="nump">$ 14<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Increase (Decrease) In other assets and restricted cash or funds that are not available for withdrawal or use (such as funds held in escrow) and are associated with underlying transactions that are classified as operating activities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_IncreaseDecreaseInRestrictedCashAndOtherAssetsForOperatingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_SupplementalDisposalOfAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disposal of fully depreciated assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_SupplementalDisposalOfAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of noncash expense included in interest expense to issue debt and obtain financing associated with the related debt instruments. Alternate captions include noncash interest expense.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.8)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 8<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 8<br><br> -Article 9<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AmortizationOfFinancingCosts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 45<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AmortizationOfIntangibleAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessExitCosts1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 420<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 420<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SAB TOPIC 5.P.4(b))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140904-122747<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 420<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 5.P.3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140864-122747<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 5<br><br> -Section P<br><br> -Subsection 3, 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BusinessExitCosts1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash Equivalents<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3044-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 230<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450594&amp;loc=d3e33268-110906<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DepreciationAndAmortization</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 230<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450594&amp;loc=d3e33268-110906<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GainLossOnSaleOfPropertyPlantEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInAccountsPayable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInAccountsReceivable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting revenue yet to be earned for which cash or other forms of consideration was received or recorded as a receivable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInDeferredRevenue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in other current operating assets not separately disclosed in the statement of cash flows.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInOtherCurrentAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in other liabilities used in operating activities not separately disclosed in the statement of cash flows. May include changes in other current liabilities, other noncurrent liabilities, or a combination of other current and noncurrent liabilities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate net change in the difference between the fair value and the carrying value, or in the comparative fair values, of marketable securities categorized as trading held at each balance sheet date, that was included in earnings for the period, which may have arisen from (a) securities classified as trading, (b) the unrealized holding gain (loss) on held-to-maturity securities transferred to the trading security category, and (c) the cumulative unrealized gain (loss) which was included in other comprehensive income (a separate component of shareholders' equity) on available-for-sale securities transferred to trading securities during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -Subparagraph (d)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27357-111563<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 10<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27405-111563<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_MarketableSecuritiesUnrealizedGainLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 26<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3574-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInFinancingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 26<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3574-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInInvestingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3536-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInOperatingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e565-108580<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Other income (expense) included in net income that results in no cash inflows or outflows in the period. Includes noncash adjustments to reconcile net income (loss) to cash provided by (used in) operating activities that are not separately disclosed.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherNoncashIncomeExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Cash outflow for purchase of trading, available-for-sale securities and held-to-maturity securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6871852&amp;loc=d3e26853-111562<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 13<br><br> -Subparagraph (a),(b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3213-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsToAcquireMarketableSecurities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 13<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3213-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the additional capital contribution to the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfWarrants</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow associated with the sale or maturity (principal being due) of securities not classified as either held-to-maturity securities or trading securities which are classified as available-for-sale securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6871852&amp;loc=d3e26853-111562<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 12<br><br> -Subparagraph (a),(b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3179-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow associated with the amount received from holders exercising their stock options. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (j)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromStockOptionsExercised</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow associated with the amount received from the stock plan during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromStockPlans</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 15<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3291-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RepaymentsOfNotesPayable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ETMAE">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Series B Convertible Preferred Stock</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Series B Convertible Preferred Stock</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
        <td class="nump">$ 0.001<span></span></td>
        <td class="nump">$ 0.001<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
        <td class="nump">5,000,000<span></span></td>
        <td class="nump">5,000,000<span></span></td>
        <td class="nump">43,000<span></span></td>
        <td class="nump">0<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
        <td class="nump">$ 0.001<span></span></td>
        <td class="nump">$ 0.001<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
        <td class="nump">350,000,000<span></span></td>
        <td class="nump">250,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
        <td class="nump">262,796,000<span></span></td>
        <td class="nump">182,792,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
        <td class="nump">262,796,000<span></span></td>
        <td class="nump">182,792,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value per share of common stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockParOrStatedValuePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.28)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockParOrStatedValuePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.28)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.28)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.28)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Collaborative Research, Development and License Agreements<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Collaborative Research, Development and License Agreements</a></td>
        <td class="text"><div>
<div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">0</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Collaborative Research, Development and License Agreements </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:2.67%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;text-indent:2.67%">GlaxoSmithKline </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In December 2008, we entered into a worldwide strategic alliance with GSK to discover, develop and commercialize TLR inhibitors. Under the terms of the arrangement, we agreed to conduct research and early clinical development in up to four</font><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> programs: the Lead TLR 7/9 program, a Follow-On TLR 7/9 program, and up to two other TLR programs. In 2011 we began development of a TLR 8 program as one of the two additional programs under the collaboration.&nbsp;&nbsp;</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">GSK subsequently returned all rights to this program to us. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We are currently conducting a Phase 1 clinical trial in the Lead TLR 7/9 program with DV1179 in systemic lupus erythematosus</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> patients. The Company is not currently performing any activities on the Follow-On TLR 7/9 program. GSK has not yet chosen to initiate development of the remaining program under the agreement. </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2013, we amended our agreement with GSK to extend the research term until conclusion of the ongoing phase 1 study of DV1179. In addition, the exclusivity provisions of the agreement were modified, giving us rights to immediately begin preclinical and clinical research on inhibitors of TLR 7 and 9 (other than DV1179) for oncology indications.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">GSK can exercise its exclusive option to license each program. If GSK exercises an option, GSK would carry out further development and commercialization of the corresponding products. If GSK exercises their option on the Lead TLR 7/9 program, then we are eligible to receive payments of up to approximately $125</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million, comprised of contingent option exercise payments and additional payments based on GSK&#8217;s achievement of certain development, regulatory and commercial objectives. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We are also eligible to receive up to $60</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million if aggregate worldwide annual net sales milestones are achieved and tiered royalties ranging from the mid&#8211;single digit to mid-teens on sales of any products originating from the collaboration. We have retained an option to co-develop and co-promote one product under this agreement. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We received an initial payment of $10</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million in 2008. The deliverables under this arrangement did not have stand-alone value and so did not qualify as separate units of accounting. In 2011, we earned and recognized $12 million in substantive development milestone payments related to the initiation of Phase I and proof-of-mechanism clinical trials of DV1179 in systemic lupus erythematosus patients. In 2011, we earned and recognized $3 million in substantive development milestone payments related to the initiation of development of the TLR 8 program. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Revenue from the initial payment from GSK was deferred and is being recognized over the expected period of performance under the agreement, initially estimated to be seven years. In the fourth quarter of 2013 we ree</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">valuated and revised the expected period of performance under the agreement from seven years to six years resulting in the recognition of $0.3 million of additional revenue in 2013. </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:;font-size:10pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The following table summarizes the revenues recognized under our agreement with GSK (in thousands):</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">&#160;</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31,</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:67%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Initial payment</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,702</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,428</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,428</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Milestone revenue</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,000</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,702</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,428</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,428</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">As of December 31, 2013 and 2012, deferred revenue relating to the initial payment was $2.5</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million and $4.2 million, respectively. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Absent early termination, the agreement will expire when all of GSK&#8217;s payment obligations expire. Either party may terminate the agreement early upon written notice if the other party commits an uncured material breach of the agreement. Either party may terminate the agreement in the event of insolvency of the other party. GSK also has the option to terminate the agreement without cause upon prior written notice within a specified window of time dependent upon the stage of clinical development of the programs. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:2.67%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">AstraZeneca </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In September 2006, we entered into a three</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-year research collaboration and license agreement with AstraZeneca for the discovery and development of TLR 9 agonist-based therapies for the treatment of asthma and chronic obstructive pulmonary disease.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In October 2011, we amended our agreement with AstraZeneca to provide that we will conduct initial clinical development of AZD 1419. Under the terms of the amended agreement, AstraZeneca will fund all program expenses to cover the cost of development activities through Phase 2a, estimated to total approximately $20</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million. We received an initial payment of $3 million to begin the clinical development program. In the first quarter of 2012, we received a $2.6 million payment to advance AZD1419 into preclinical toxicology studies and these toxicology studies were completed in the third quarter of 2012. We and AstraZeneca have agreed to advance AZD 1419 towards a Phase 1 clinical trial, which resulted in a development funding payment of $6 million, received in the fourth quarter of 2012. If AstraZeneca chooses to advance the program following completion of Phase 2a, we will receive a $20 million milestone payment and AstraZeneca will retain its rights to develop the candidate therapy and to commercialize the resulting asthma product. We are eligible to receive additional milestone payments, which we have determined to be substantive milestones, of up to approximately $100 million, based on the achievement of certain development and regulatory objectives. Additionally, upon commercialization, we are eligible to receive tiered royalties ranging from the mid to high single-digits based on product sales of any products originating from the collaboration. We have the option to co-promote in the United States products arising from the collaboration, if any. AstraZeneca has the right to sublicense its rights upon our prior consent. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Revenue from the initial payment was deferred and is being recognized over the expected period of performance under the agreement, which is approximately 50</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> months. Revenue from the development funding payment is being recognized as the development work is performed.  </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The following table summarizes the revenues earned under our agreement with AstraZeneca (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31,</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:67%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Initial payments</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">720</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">720</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">120</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Performance of research activities</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,507</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,462</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">642</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,227</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,182</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">762</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">As of December 31, 2013 and 2012, total deferred revenue from the initial payment and development funding payments was $4.8</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million and $7.7 million, respectively.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-weight:bold;;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Absent early termination, the agreement will expire when all of AstraZeneca&#8217;s payment obligations expire. AstraZeneca has the right to terminate the agreement at any time upon prior written notice and either party may terminate the agreement early upon written notice if the other party commits an uncured material breach of the agreement. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:2.67%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;text-indent:2.67%">National Institutes of Health (&#8220;NIH&#8221;) and Other Funding </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We have been awarded various grants from the NIH and the NIH&#8217;s National Institute of Allergy and Infectious Disease (&#8220;NIAID&#8221;) in order to fund research. The awards are related to specific research objectives and we earn revenue as the related research expenses are incurred. We have earned revenue during the periods ended December&#160;31, 2013 and 2012 from the following awards:</font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-family:'Symbol';font-size:10pt;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">September 2013, NIH awarded us $0.2 million to fund research in developing TLR antagonists for therapy of hepatic fibrosis and cirrhosis.</font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-family:'Symbol';font-size:10pt;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">June 2012, NIH awarded us $0.6 million to fund research in screening for inhibitors of TLR 8 for treatment of autoimmune diseases. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-family:'Symbol';font-size:10pt;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">May 2012, NIH awarded us $0.4 million to fund development of TLR 8 inhibitors for treatment of rheumatoid arthritis. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-family:'Symbol';font-size:10pt;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">July 2011, NIH awarded us $0.6 million to fund research in preclinical models of skin autoimmune inflammation. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-family:'Symbol';font-size:10pt;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">August 2010, NIAID awarded us a grant to take a systems biology approach to study the differences between individuals who do or do not respond to vaccination against the hepatitis B virus. This study will be one of several projects conducted under a grant to the Baylor Institute of Immunology Research in Dallas as part of the Human Immune Phenotyping Centers program. We have been awarded a total of $1.4 million under this grant. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-family:'Symbol';font-size:10pt;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">July 2010, NIH awarded us $0.6 million to explore the feasibility of developing a universal vaccine to prevent infection by human papilloma virus. </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-family:'Symbol';font-size:10pt;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">September 2008, NIAID awarded us a five-year $17 million contract to develop our oligonucleotide technology using TLR 9 agonists as vaccine adjuvants. The contract supports adjuvant development for anthrax as well as other disease models.</font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The following table summarizes the revenues recognized under the various arrangements with the NIH and NIAID (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31,</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:67%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">NIAID contracts</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,103</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,571</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,730</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All other NIH contracts</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,035</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">368</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">380</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:67%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total grant revenue</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,138</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,939</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,110</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 808<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CollaborativeArrangementDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EVUAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Document and Entity Information (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Feb. 28, 2014</div>
        </th>
        <th class="th">
          <div>Jun. 28, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
        <td class="text">10-K<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
        <td class="text">false<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
        <td class="text">Dec. 31,
				 2013<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
        <td class="text">2013<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
        <td class="text">FY<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
        <td class="text">DVAX<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
        <td class="text">DYNAVAX TECHNOLOGIES CORP<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
        <td class="text">0001029142<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
        <td class="text">--12-31<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
        <td class="text">No<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
        <td class="text">Yes<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
        <td class="text">No<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
        <td class="text">Accelerated Filer<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">262,855,958<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 105,519,624<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_AmendmentFlag</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:booleanItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>End date of current fiscal year in the format --MM-DD.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_CurrentFiscalYearEndDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gMonthDayItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentFiscalPeriodFocus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:fiscalPeriodItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentFiscalYearFocus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gYearItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentInformationLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentPeriodEndDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentType</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:submissionTypeItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation 12B<br><br> -Number 240<br><br> -Section 12b<br><br> -Subsection 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCentralIndexKey</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:centralIndexKeyItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCommonStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCurrentReportingStatus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:yesNoItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityFilerCategory</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:filerCategoryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityPublicFloat</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation 12B<br><br> -Number 240<br><br> -Section 12b<br><br> -Subsection 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityRegistrantName</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:normalizedStringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityVoluntaryFilers</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:yesNoItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityWellKnownSeasonedIssuer</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:yesNoItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Trading symbol of an instrument as listed on an exchange.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_TradingSymbol</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:normalizedStringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Net Loss Per Share<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share</a></td>
        <td class="text"><div>
<div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Net Loss Per Share </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Basic net loss per share allocable to common stockholders</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> is calculated by dividing the net loss allocable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net loss per share allocable to common stockholders is computed by dividing the net loss allocable to common stockholders by the weighted-average number of common shares outstanding during the period and giving effect to all potentially dilutive common shares using the treasury-stock method. For purposes of this calculation, common stock subject to repurchase by us, outstanding stock options, stock awards, warrants and Series B Convertible Preferred Stock are considered to be potentially dilutive common shares and are only included in the calculation of diluted net loss per share allocable to common stockholders when their effect is dilutive. </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="10" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Basic and diluted net loss per share (in thousands, except per share&#160;amounts):</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Numerator:</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(66,720</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(69,949</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(48,597</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Preferred stock deemed dividend</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,469</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss allocable to common stockholders</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(75,189</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(69,949</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(48,597</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%; border-top:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Denominator for basic and diluted net loss per share allocable to common stockholders:</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average common shares outstanding</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">196,275</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">170,469</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">125,101</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic and diluted net loss per share allocable to common stockholders</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.38</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.41</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.39</font></p></td>
<td valign="bottom" style="width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Outstanding warrants, stock options, Series B Convertible Preferred Stock</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and stock subject to repurchase by us under stock awards were excluded from the calculation of net loss per share allocable to common stockholders as the effect of their inclusion would have been anti-dilutive. </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-weight:bold;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding securities not included in diluted net loss per share calculation (in thousands):</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options and stock awards</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,040</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,561</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,101</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;padding-Bottom:0 pt;width:68%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Series B Convertible Preferred Stock (as converted to common stock)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43,430</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,464</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,714</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,729</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0 pt;padding-Top:0 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72,934</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,275</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,830</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:8pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for earnings per share.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1278-109256<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1252-109256<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 52<br><br> -URI http://asc.fasb.org/extlink&amp;oid=32703322&amp;loc=d3e4984-109258<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.21)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EWKAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Consolidated Statements of Operations (USD $)<br>In Thousands, except Per Share data, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractsRevenue', window );">Collaboration revenue</a></td>
        <td class="nump">$ 4,929<span></span></td>
        <td class="nump">$ 4,610<span></span></td>
        <td class="nump">$ 17,190<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromGrants', window );">Grant revenue</a></td>
        <td class="nump">5,138<span></span></td>
        <td class="nump">3,939<span></span></td>
        <td class="nump">3,110<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LicenseAndServicesRevenue', window );">Service and license revenue</a></td>
        <td class="nump">1,184<span></span></td>
        <td class="nump">1,165<span></span></td>
        <td class="nump">1,314<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
        <td class="nump">11,251<span></span></td>
        <td class="nump">9,714<span></span></td>
        <td class="nump">21,614<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
        <td class="nump">50,870<span></span></td>
        <td class="nump">49,146<span></span></td>
        <td class="nump">51,322<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
        <td class="nump">25,943<span></span></td>
        <td class="nump">28,164<span></span></td>
        <td class="nump">17,570<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_UnoccupiedFacilityExpense', window );">Unoccupied facility expense</a></td>
        <td class="nump">926<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="nump">299<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expenses</a></td>
        <td class="nump">77,739<span></span></td>
        <td class="nump">77,310<span></span></td>
        <td class="nump">69,191<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
        <td class="num">(66,488)<span></span></td>
        <td class="num">(67,596)<span></span></td>
        <td class="num">(47,577)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
        <td class="nump">116<span></span></td>
        <td class="nump">291<span></span></td>
        <td class="nump">103<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(2,351)<span></span></td>
        <td class="num">(1,957)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense)</a></td>
        <td class="num">(348)<span></span></td>
        <td class="num">(293)<span></span></td>
        <td class="nump">834<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">(66,720)<span></span></td>
        <td class="num">(69,949)<span></span></td>
        <td class="num">(48,597)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsIncomeStatementImpact', window );">Preferred stock deemed dividend</a></td>
        <td class="num">(8,469)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss allocable to common stockholders</a></td>
        <td class="num">$ (75,189)<span></span></td>
        <td class="num">$ (69,949)<span></span></td>
        <td class="num">$ (48,597)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share allocable to common stockholders - basic and diluted</a></td>
        <td class="num">$ (0.38)<span></span></td>
        <td class="num">$ (0.41)<span></span></td>
        <td class="num">$ (0.39)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average shares outstanding used to compute basic and diluted net loss per share allocable to common stockholders</a></td>
        <td class="nump">196,275<span></span></td>
        <td class="nump">170,469<span></span></td>
        <td class="nump">125,101<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_UnoccupiedFacilityExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Unoccupied facility expense.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_UnoccupiedFacilityExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 350<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (a)(2)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AmortizationOfIntangibleAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractsRevenue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Revenue earned during the period arising from products sold or services provided under the terms of a contract, not elsewhere specified in the taxonomy. May include government contracts, construction contracts, and any other contract related to a particular project or product.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ContractsRevenue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total costs of sales and operating expenses for the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CostsAndExpenses</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CostsAndExpensesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareBasicAndDiluted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.4)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GeneralAndAdministrativeExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of the cost of borrowed funds accounted for as interest expense.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 835<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.9-04.9)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph 9<br><br><br><br> -Article 9<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InterestExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 7<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.7(b))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InvestmentIncomeInterest</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LicenseAndServicesRevenue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Revenue from multiple-deliverable arrangements that include licensing fees and services revenue. Licensing revenue is consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Licensing fees are generally, but not always, fixed as to amount and not dependent upon the revenue generated by the licensing party. An entity may receive licensing fees for licenses that also generate royalty payments to the entity. Services revenue may be derived by providing other, nonspecified, services during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 1<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.1(d),(e))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LicenseAndServicesRevenue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 9<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Other Comprehensive Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Net Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.19)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br><br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br><br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.22)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br><br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e565-108580<br><br><br><br><br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 19<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 11<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1377-109256<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net result for the period of deducting operating expenses from operating revenues.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 9<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.9)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherNonoperatingIncomeExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherNonoperatingIncomeExpenseAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsIncomeStatementImpact">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockDividendsIncomeStatementImpact</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 985<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 730<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ResearchAndDevelopmentExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromGrants">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Revenue earned during the period from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.1(e))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RevenueFromGrants</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 1<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Revenues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RevenuesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Property and Equipment<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
        <td class="text"><div>
<div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">5.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Property and Equipment </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Property and equipment as of December&#160;31, 2013, and 2012 consist of the following (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:70%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:8%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Estimated&#160;Useful<br />Life</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:70%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(In years)</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:70%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Manufacturing equipment</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5-14</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,968</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,574</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:70%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lab equipment</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5-13</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,227</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,755</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:70%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computer equipment</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,962</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,807</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:70%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furniture and fixtures</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,056</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">983</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:70%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5-7</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,048</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,445</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:70%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets in progress</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:8%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">762</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,047</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:70%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,023</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,611</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:70%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less accumulated depreciation and amortization</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:8%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,317</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,646</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:70%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:8%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,706</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,965</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Depreciation and amortization expense on property and equipment was $1.3</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million, $1.2 million and $1.3&#160;million for the years ended December&#160;31, 2013, 2012 and 2011, respectively. </font></p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391110&amp;loc=d3e2921-110230<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 205<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6360339&amp;loc=d3e1361-107760<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.13-14)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Cash, Cash Equivalents and Marketable Securities<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock', window );">Cash, Cash Equivalents and Marketable Securities</a></td>
        <td class="text"><div>
<div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">4.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cash, Cash Equivalents and Marketable Securities </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The following is a summary of cash, cash equivalents and marketable securities as of December&#160;31, 2013, and 2012 (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Amortized Cost</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Unrealized Gains</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Unrealized Losses</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Estimated Fair&#160;Value</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2013</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents:</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,766</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,766</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,013</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,013</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government agency securities</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,343</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,343</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash and cash equivalents</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,122</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,122</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Marketable securities available-for-sale:</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government agency securities</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">166,285</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(47</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">166,254</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total marketable securities available-for-sale</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">166,285</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(47</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">166,254</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash, cash equivalents and marketable securities</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">189,407</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(47</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">189,376</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%; border-top:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2012</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents:</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,542</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,542</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,140</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,140</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Municipal securities</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">715</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">715</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government agency securities</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,202</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,202</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash and cash equivalents</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,599</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,599</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Marketable securities available-for-sale:</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government agency securities</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">116,986</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">117,031</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. treasury securities</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">500</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">500</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total marketable securities available-for-sale</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">117,486</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">117,531</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash, cash equivalents and marketable securities</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">125,085</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">125,130</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The maturities of our marketable securities available-for-sale are as follows (in thousands) </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:62%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:3%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:33%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:62%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:3%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Amortized Cost</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:3%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Estimated Fair Value</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:62%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mature in one year or less</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:3%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">93,691</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:3%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:14%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">93,701</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:62%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mature after one year through two years</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:3%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72,594</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:3%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72,553</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:62%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:3%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">166,285</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:3%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">166,254</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We invest in short-term money market funds, U.S. government agency securities, U.S treasury securities and</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> municipal securities. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">There were no</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> realized gains or losses from the sale of marketable securities in the years ended December&#160;31, 2013, 2012 and 2011. All of our investments are classified as short-term and available-for-sale, as we may not hold our investments until maturity. </font></p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Selected Quarterly Financial Data<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationTextBlock', window );">Selected Quarterly Financial Data</a></td>
        <td class="text"><div>
<div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">16.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Selected Quarterly Financial Data (Unaudited; in thousands, except per share amounts) </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="14" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31, 2013</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Q1</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Q2</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Q3</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Q4</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenues</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,085</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,392</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,927</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,847</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net&#160;loss</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20,825</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,164</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,675</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(13,056</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss allocable to common stockholders</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20,825</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,164</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,675</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(21,525</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic and diluted net loss per share allocable to common stockholders</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.11</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.09</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.09</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.09</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares used to compute basic and diluted net loss per share allocable to common stockholders</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">182,847</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">182,913</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">183,022</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">235,879</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="14" valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31, 2012</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Q1</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Q2</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Q3</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Q4</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenues</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,350</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,684</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,874</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,806</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net&#160;loss</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(16,505</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,110</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,791</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20,543</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss allocable to common stockholders</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(16,505</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,110</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,791</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20,543</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic and diluted net loss per share allocable to common stockholders</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.11</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.09</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.10</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.11</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares used to compute basic and diluted net loss per share allocable to common stockholders</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">155,431</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">167,697</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">177,870</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">180,685</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:8pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for the quarterly financial data in the annual financial statements.  The disclosure may include a tabular presentation of financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income or loss before extraordinary items and earnings per share data. It also includes an indication if the information in the note is unaudited, comments on the aggregate effect of year-end adjustments, and an explanation of matters or transactions that affect comparability or are pertinent to an understanding of the information furnished.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 270<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6372559&amp;loc=d3e765-108305<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 270<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6372559&amp;loc=d3e725-108305<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 270<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)-(j)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25249566&amp;loc=d3e1280-108306<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 6<br><br> -Section G<br><br> -Subsection 1<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-K (SK)<br><br> -Number 229<br><br> -Section 302<br><br> -Paragraph a<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_QuarterlyFinancialInformationTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Preferred Stock, Common Stock and Warrants<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Preferred Stock, Common Stock and Warrants</a></td>
        <td class="text"><div>
<div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">12.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Preferred Stock, Common Stock and Warrants </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Authorized Shares</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">On May 29, 2013 the stockholders approved an increase in the number of authorized shares of common stock from 250,000,000</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> to 350,000,000. </font><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The increase in authorized shares was effected pursuant to a Certificate of Amendment to the Sixth Amended and Restated Certificate of Incorporation (the "Certificate of Amendment"), filed with the Secretary of State of the State of Delaware on May 30, 2013</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Preferred Stock Outstanding</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">As of December 31, 2013 there were 5,000,000</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shares of preferred stock authorized and no shares outstanding.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In October 2013 the Company sold 43,430</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shares of $0.001 par value Series B Convertible Preferred Stock for a purchase price of $1,075 per share and gross proceeds of approximately $46.7 million in an underwritten public offering. After issuance costs of approximately $2.5 million, the net proceeds from the offering were approximately $44.2 million.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Each share of Series B Convertible Preferred Stock is convertible into 1,000</font><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shares of common stock at any time at the holder&#8217;s option. However, the holder is prohibited from converting the Series B Convertible Preferred Stock into shares of common stock if, as a result of such conversion, the holder and its affiliates would own more than 9.98% of the total number of shares of common stock then issued and outstanding. In the event of the Company&#8217;s liquidation, dissolution, or winding up, holders of Series B Convertible Preferred Stock will receive a payment equal to $0.001 per share before any proceeds are distributed to the common stockholders. Shares of Series B Convertible Preferred Stock generally have no voting rights, except as required by law and except that the consent of holders of a majority of the outstanding Series B Convertible Preferred Stock is required to amend the terms of the Series B Convertible Preferred Stock. Holders of Series B Convertible Preferred Stock are not entitled to receive any dividends, unless and until specifically declared by the</font><font style="color:#000000;font-size:13.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Company&#8217;s board of directors. The Series B Convertible Preferred Stock ranks senior to the Company&#8217;s common stock as to distributions of assets upon the Company&#8217;s liquidation, dissolution or winding up, whether voluntarily or involuntarily. The Series B Convertible Preferred Stock may rank senior to, on parity with or junior to any class or series of the Company&#8217;s capital stock created in the future depending upon the specific terms of such future stock issuance.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:13.5pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The fair value of the common stock into which the Series B Convertible Preferred Stock is convertible exceeded the allocated purchase price of the Series B Convertible Preferred Stock by $8.5</font><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million on the date of issuance, for which the Company recorded a deemed dividend. The Company recognized the deemed dividend equal to the number of shares of Series B Convertible Preferred Stock sold on October 30, 2013 multiplied by the difference between the value of the common stock and the Series B Convertible Preferred Stock conversion price per share on that date. The dividend was reflected as a one-time, non-cash, deemed dividend to the holders of Series B Convertible Preferred Stock on the date of issuance, which is the date the stock first became convertible.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-weight:bold;;font-size:13.5pt;;"><font style="font-weight:bold;font-style:italic;;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;text-indent:4.54%">Preferred Stock Rights </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-weight:bold;;font-size:13.5pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">On November&#160;4, 2008, our Board of Directors declared a dividend of one preferred share purchase right (a &#8220;Right&#8221;) for each outstanding share of our Common Stock, par value $0.001</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> per share (the &#8220;Common Shares&#8221;). The dividend was payable on November&#160;17, 2008 to the stockholders of record on that date. Each Right entitles the registered holder to purchase from us one one-hundredth of a share of Series A Junior Participating Preferred Stock, par value $0.001 per share (the &#8220;Preferred Shares&#8221;), at a price of $6.00 per one one-hundredth of a Preferred Share, subject to adjustment. Upon the acquisition of, or announcement of the intent to acquire, 20 percent or more of our outstanding Common Shares by a person, entity or group of affiliated or associated persons (&#8220;Acquiring Person&#8221;), each holder of a Right, other than Rights held by the Acquiring Person, will have the right to purchase that number of Common Shares having a market value of two times the exercise price of the Right. If we are acquired in a merger or other business combination transaction or 50 percent or more of our assets or earning power are sold to an Acquiring Person, each holder of a Right will thereafter have the right to purchase, at the then current exercise price of the Right, that number of shares of common stock of the acquiring company which at the time of such transaction will have a market value of two times the exercise price of the Right. The Rights plan is intended to maximize the value of the Company in the event of an unsolicited attempt to take over the Company in a manner or on terms not approved by the Company&#8217;s Board of Directors. The Rights will expire on November&#160;17, 2018, unless the Rights are earlier redeemed or exchanged by the Company. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-weight:bold;;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Common Stock Outstanding</font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In October 2013 we completed an underwritten public offering of 79</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,570,000 shares of our common stock to the public at $1.075 per share. The gross proceeds to us from this offering were approximately $85.5 million. After deducting issuance costs of approximately $4.5 million, the net proceeds from the offering were approximately $80.9 million.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">On March&#160;29, 2013, we entered into an At Market Issuance Sales Agreement (the &#8220;Agreement&#8221;) with MLV&#160;&amp; Co. LLC (&#8220;MLV&#8221;) under which we may offer and sell our common stock having aggregate sales proceeds of up to $50,000,000</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> from time to time through MLV as our sales agent. Sales of our common stock through MLV, if any, will be made by means of ordinary brokers&#8217; transactions on the NASDAQ Capital Market or otherwise at market prices prevailing at the time of sale, in block transactions, or as otherwise agreed upon by us and MLV. MLV will use commercially reasonable efforts to sell our common stock from time to time, based upon instructions from us (including any price, time or size limits or other customary parameters or conditions we may impose). We will pay MLV a commission of up to 3.0% of the gross sales proceeds of any common stock sold through MLV under the Agreement. No sales of our common stock have taken place under this Agreement as of December&#160;31, 2013. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">On May&#160;9, 2012, we completed an underwritten public offering of 17,500,000</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shares of our common stock to the public at $4.25 per share. The net proceeds to us from this offering were $69.6 million, after deducting offering expenses. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">On November&#160;3, 2011, we completed an underwritten public offering of 27,600,000</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shares of our common stock including 3,600,000 shares sold pursuant to the full exercise of an overallotment option previously granted to the underwriters at a price to the public of $2.50 per share. The net proceeds to us from this offering were $64.5 million, after deducting offering expenses. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:13.5pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">On November&#160;2, 2010, we completed an underwritten public offering of 26,450,000</font><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shares of our common stock including 3,450,000 shares sold pursuant to the full exercise of an overallotment option previously granted to the underwriters at a price to the public of $1.70 per share. The net proceeds to us from this offering were $42.0 million, after deducting offering expenses.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:13.5pt;;"><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">On September&#160;20, 2010, we entered into a Purchase Agreement with Aspire Capital, which provided that, upon the terms and subject to the conditions and limitations set forth therein, Aspire Capital was committed to purchase up to an aggregate of $30.0</font><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million of shares of our common stock (the &#8220;Purchase Shares&#8221;) over the 25-month term of the Purchase Agreement. Under the Purchase Agreement, we agreed to pay Aspire Capital a commitment fee equal to 4% of $30 million in consideration for Aspire Capital&#8217;s obligation to purchase up to $30 million of our common stock. We paid this commitment fee of $1.2 million by the issuance of 600,000 shares of our common stock and this fee was recorded as a cost of raising capital and netted against the gross proceeds from the Purchase Agreement in September 2010. During 2010, we sold 2,350,000 shares of common stock to Aspire Capital for $3.3 million and during 2011 we sold 10,995,210 shares of common stock for $26.7 million, which totaled the proceeds available to us of $30 million under the Purchase Agreement.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">On April&#160;16, 2010, we completed an underwritten public offering resulting in net proceeds of $41.1</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million, after deducting offering expenses of approximately $3.0 million, from the sale of 30,293,000 units at a per unit price of $1.4525. Each unit consisted of one share of common stock and one warrant to purchase 0.5 of a share of common stock. Each warrant has an exercise price of $1.50 per share, and is exercisable for a period of five years from the date of issuance. From this offering, warrants to purchase an aggregate of 10,913,873 shares of our common stock were outstanding as of December&#160;31, 2013 (including the warrants to purchase 6,765,128 shares provided to Symphony as described in Note 8 &#8220;Symphony Dynamo, Inc.&#8221;). </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Warrants </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In connection with a 2007 loan agreement that was subsequently terminated in 2008, we issued warrants to purchase up to 3,550,000</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shares of our common stock as follows: </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:39%; border-bottom:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Warrant Issuance Date</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Shares Issuable <br />(in thousands)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Expiration <br />Date</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price <br />per Share</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding as of <br />December 31, 2013 <br />(in thousands)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:39%; border-top:solid 0.75pt #000000;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">July 18, 2007</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,250</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-top:solid 0.75pt #000000;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2/26/2014</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.13</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:15%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,250</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:39%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">October 18, 2007</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,300</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2/26/2014</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.68</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:15%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:39%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December 27, 2007</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">300</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2/26/2014</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.65</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:15%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">300</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:39%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December 27, 2007</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">700</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:12%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2/26/2014</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:12%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.68</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:15%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:39%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,550</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:12%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:12%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:15%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,550</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:6pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:6pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">As of December&#160;31, 2013, warrants to purchase an aggregate of approximately 12,500,000</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shares of our common stock were outstanding. The warrants are exercisable </font><font style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">at a weighted average price of $1.96 per share</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. During the years ended December&#160;31, 2013, and 2012, warrants were exercised to purchase an aggregate of approximately 250,000 and 13,000,000 shares, respectively, of our common stock. </font></p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 310<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SAB TOPIC 4.E)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 4<br><br> -Subparagraph (SAB TOPIC 4.C)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Article 4<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section C<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section E<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(d),(e))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Preferred Stock<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6521494<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21564-112644<br><br><br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21488-112644<br><br><br><br>Reference 17: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21484-112644<br><br><br><br>Reference 18: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph d<br><br> -Article 4<br><br><br><br>Reference 19: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityNoteDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Symphony Dynamo, Inc.<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDisclosureTextBlock', window );">Symphony Dynamo, Inc.</a></td>
        <td class="text"><div>
<div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">8.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Symphony Dynamo, Inc. </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">On April&#160;18, 2006, we, Symphony and Holdings entered into a transaction involving a series of related agreements providing for the advancement of certain of our immunostimulatory</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> sequences-based programs for cancer, hepatitis B and hepatitis C therapy (collectively, the &#8220;Programs&#8221;). Pursuant to these agreements, Symphony formed SDI and invested $50&#160;million to fund the Programs, and we licensed to Holdings our intellectual property rights related to the Programs, which were assigned to SDI. As a result of these agreements, Symphony owned 100% of the equity of Holdings, which owned 100% of the equity of SDI. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In connection with the transaction described above, Holdings granted to us an exclusive purchase option that gave us the right, but not the obligation, to acquire the outstanding equity securities of SDI, which would result in our reacquisition of the intellectual property rights that we licensed to Holdings (the &#8220;Original Purchase Option&#8221;). In exchange for the Original Purchase Option, we granted Holdings five-year</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> warrants to purchase up to 2,000,000 shares of our common stock at an exercise price of $7.32 per share pursuant to a warrant purchase agreement (the &#8220;Original Warrants&#8221;), and granted certain registration rights to Holdings pursuant to a registration rights agreement. We also received an exclusive option to purchase either the hepatitis B or hepatitis&#160;C therapy program (the &#8220;Program Option&#8221;) during the first year of the arrangement. In April 2007, we exercised the Program Option for the hepatitis B program which resulted in the recognition of a $15 million liability to Symphony. We remained primarily responsible for the development of the cancer and hepatitis C therapy programs in accordance with a development plan and related development budgets that we agreed to with Holdings. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Prior to the acquisition of all of the outstanding equity of SDI on December&#160;30, 2009, we consolidated the financial position and results of operations of SDI. In November&#160;2009, we entered into an agreement with Holdings to modify the provisions of and to exercise the Original Purchase Option (the &#8220;Amended Purchase Option&#8221;). We completed the acquisition of all of the outstanding equity of SDI on December&#160;30, 2009. In exchange for all of the outstanding equity of SDI, we issued to Symphony and certain of its co-investors: (i</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;13,000,000 shares of common stock (the &#8220;Shares&#8221;); (ii)&#160;5-year warrants to purchase 2,000,000 shares of common stock with an exercise price of $1.94 per share (the &#8220;Warrants&#8221;); and (iii)&#160;a non-interest bearing note in the principal amount of $15 million, due December&#160;31, 2012, payable in cash, our common stock or a combination thereof at our discretion, which obligation was previously payable solely in cash on April&#160;18, 2011 (the &#8220;Note&#8221;). In addition, we&#160;agreed to contingent cash payments from us equal to 50% of the first $50 million from any upfront, pre-commercialization milestone or similar payments received by us from any agreement with any third party with respect to the development and/or commercialization of the cancer and hepatitis C therapies originally licensed to SDI. The Original Warrants held by Symphony were cancelled as part of this transaction. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We were obligated to make future contingent cash payments to the former Holdings shareholders related to certain payments received by us, if any, from future partnering agreements pertaining to our hepatitis C and cancer therapy programs. We estimated the valuation of this contingent liability using a discounted cash flow model. The discounted cash flow model was derived from management&#8217;s assumptions regarding the timing, amounts, and probability of potential upfront and milestone payments for the development and/or commercialization of the hepatitis C program based on transactions for similar stage programs by other companies. These cash flows were discounted at a rate of 16</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">% for the fiscal year ended December&#160;31, 2010. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Changes in the fair value of the contingent consideration liability were recognized in &#8220;other income (expense)&#8221; in the consolidated statements of operations in the period of the change. During the fiscal year ended December&#160;31, 2010, we reduced the assumed probability of our receipt of upfront and milestone payments from a potential partnership and extended the timing of when these expected receipts would occur. In addition, based on our assumptions regarding our beta and risk free interest rate used in the discounted cash flow model, the change in fair value of the contingent consideration liability resulted in other income of $2.2</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million for the fiscal year ended December&#160;31, 2010. During the year ended December&#160;31, 2011, we determined that we would not receive any upfront or milestone payments from a potential partnership for our hepatitis C therapy program and, therefore, estimated the fair value of the liability to be zero as of December&#160;31, 2011 resulting in other income of $0.8 million. These fair value measurements were based on significant inputs not observed in the market and thus represented a Level 3 measurement. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We recorded the acquisition of all of the outstanding equity of SDI pursuant to the Amended Purchase Option as a return of equity to the noncontrolling</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> interest. The acquisition was accounted for as a capital transaction that did not affect our consolidated net loss. However, because the acquisition was accounted for as a capital transaction, the consideration paid in excess of the carrying value of the noncontrolling interest in SDI is treated as a deemed dividend at the time for purposes of reporting net loss and earnings per share. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The estimated fair values of the warrants transferred were calculated using the Black-Scholes valuation model. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We estimated the fair value of the Note using a net present value model with a discount rate of 17</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%. Imputed interest was recorded as interest expense over the term of the loan using the interest rate method. We paid in cash the $15 million principal balance of the Note on December&#160;31, 2012. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The Shares and Warrants were subject to certain anti-dilution protection in the event that we issued other equity securities within six months from December&#160;30, 2009. As a result of an equity offering completed in April 2010 prior to the expiration of the anti-dilution provision, Symphony received an additional </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,076,420&#160;shares of common stock (&#8220;April 2010 Shares&#8221;) and warrants to purchase 7,038,210 shares of common stock (&#8220;April 2010 Warrants&#8221;) having the same terms as the warrants sold in the offering, which have an exercise price of $1.50 per share and a term of five years. The Warrants issued on December&#160;30, 2009 were cancelled upon the issuance of the April 2010 Warrants. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The fair value of the April 2010 Shares and incremental fair value of the April 2010 Warrants</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> provided to Symphony, as measured upon issuance and remeasured at June&#160;30, 2010, resulted in non-operating expense of $11.1 million in the second quarter of 2010. This also resulted in an increase of $9.5 million to the warrant liability and an increase of $1.6 million to additional paid in capital as of June&#160;30, 2010. Following the expiration date of Symphony&#8217;s anti-dilution protection, on June&#160;30, 2010, the value of the April 2010 Warrants of $12.0 million was reclassified into stockholders&#8217; equity in the consolidated balance sheets. As of December&#160;31, 2013, warrants to purchase 6,765,128 shares remained outstanding. </font></p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 810<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1A<br><br> -URI http://asc.fasb.org/extlink&amp;oid=18733093&amp;loc=SL4573702-111684<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_MinorityInterestDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EUNAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Difference between Consolidated Income Tax Benefit and Amount Computed by Federal Statutory Income Tax Rate (Detail) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_IncomeTaxRateReconciliationLineItems', window );"><strong>Income Tax Rate Reconciliation [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Income tax benefit at federal statutory rate</a></td>
        <td class="num">$ (22,678)<span></span></td>
        <td class="num">$ (23,650)<span></span></td>
        <td class="num">$ (16,523)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State tax</a></td>
        <td class="num">(178)<span></span></td>
        <td class="num">(89)<span></span></td>
        <td class="num">(2,586)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCredits', window );">Business credits</a></td>
        <td class="num">(2,515)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(1,394)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_IncomeTaxReconciliationDeferredCompensationCharges', window );">Deferred compensation charges</a></td>
        <td class="nump">3,072<span></span></td>
        <td class="nump">1,002<span></span></td>
        <td class="nump">595<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
        <td class="nump">22,354<span></span></td>
        <td class="nump">21,966<span></span></td>
        <td class="nump">18,099<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Change in foreign tax rates</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(34)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_IncomeTaxReconciliationChangeInFairValueMeasurement', window );">Change in the fair value measurements</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">286<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther', window );">Non-deductible debt discount</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">509<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationDeductionsDividends', window );">Deemed dividend</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">273<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes', window );">Prior year true up</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
        <td class="num">(55)<span></span></td>
        <td class="nump">771<span></span></td>
        <td class="nump">775<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax expense</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_IncomeTaxRateReconciliationLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_IncomeTaxRateReconciliationLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_IncomeTaxReconciliationChangeInFairValueMeasurement">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Income Tax Reconciliation Change In Fair Value Measurement</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_IncomeTaxReconciliationChangeInFairValueMeasurement</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_IncomeTaxReconciliationDeferredCompensationCharges">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Income Tax Reconciliation, Deferred Compensation Charges</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_IncomeTaxReconciliationDeferredCompensationCharges</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(h))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Article 4<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Income Tax Expense (or Benefit)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -Subparagraph (a),(b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxExpenseBenefit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 20<br><br> -URI http://asc.fasb.org/extlink&amp;oid=21917399&amp;loc=d3e32123-109318<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationDeductionsDividends">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deduction for dividend.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxReconciliationDeductionsDividends</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Subparagraph 1<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Subparagraph 2<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxReconciliationOtherAdjustments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Subparagraph 1<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCredits">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxReconciliationTaxCredits</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Intangible Assets<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets</a></td>
        <td class="text"><div>
<div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">6.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intangible Assets </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Intangible assets consisted primarily of manufacturing process and customer relationships related to our 2006 acquisition of Rhein</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. The manufacturing process derives from the methods for making proteins in Hansenula yeast, which is a process we use to make a key component in the production of hepatitis B vaccine. The customer relationships derive from Rhein&#8217;s ability to sell existing, in-process and future products to its existing customers. Purchased intangible assets other than goodwill are amortized on a straight-line basis over their respective useful lives. The manufacturing process and customer relationships were amortized over their estimated useful lives of five years. Both the manufacturing process and customer relationships intangible assets were fully amortized as of the year ended December&#160;31, 2011. Amortization of intangible assets was zero for the years ended December&#160;31, 2013 and 2012, and $0.3 million for the year ended December&#160;31, 2011. </font></p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for all or part of the information related to intangible assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16373-109275<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 350<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16265-109275<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IntangibleAssetsDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Current Accrued Liabilities<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">Current Accrued Liabilities</a></td>
        <td class="text"><div>
<div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">7.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Current Accrued Liabilities </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Current accrued liabilities as of December&#160;31, 2013, and 2012 consist of the following (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:71%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="6" valign="bottom" style="width:28%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:71%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:3%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:13%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Payroll and related expenses</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,639</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:3%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:11%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,538</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Legal expenses</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">338</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:3%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:11%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">396</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:71%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Third party research and development expenses</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:10%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,403</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:3%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:11%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,207</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:71%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other accrued liabilities</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,786</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:3%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:11%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,922</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:71%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:10%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,166</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:3%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:11%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,063</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
        <td class="text"><div>
<div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">9</font><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Commitments and Contingencies </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We lease our facilities in Berkeley, California (&#8220;Berkeley Lease&#8221;) and D&#252;sseldorf, Germany (&#8220;D&#252;sseldorf Lease&#8221;) under operating leases that expire in June 2018</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and March 2023, respectively. The Berkeley Lease provides for periods of escalating rent. The total cash payments over the life of the lease are divided by the total number of months in the lease period and the average rent is charged to expense each month during the lease period. We entered into sublease agreements under the D&#252;sseldorf Lease for a certain portion of the leased space. The sublease income is offset against our rent expense. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">During September 2013, we decided not to occupy a portion of our facility in Berkeley, California. As a result, we recorded a one-time estimated unoccupied facility expense of $0.9</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million for the year ended December 31, 2013, representing the present value of the rent payments and other costs associated with the lease, net of estimated sublease income, for the remaining life of the operating lease. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Total net rent expense related to our operating leases for the years ended December&#160;31, 2013, 2012 and 2011, was $1.9</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million, $1.7 million and $1.7 million, respectively. Deferred rent was $0.6 million as of December&#160;31, 2013 and 2012.&nbsp;&nbsp; </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Future minimum payments under the non-cancelable portion of our operating leases at December&#160;31, 2013, excluding payments from sublease payments, are as follows (in thousands):</font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Years ending December&#160;31,</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:3%;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:14%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2014</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:14%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,233</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2015</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:14%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,282</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2016</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:14%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,333</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2017</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:14%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,382</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2018</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:3%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:14%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,351</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Thereafter</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:3%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,499</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:3%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,080</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">During the fourth quarter of 2004, we established a letter of credit with Silicon Valley Bank as security for our Berkeley Lease in the amount of $0.4</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million. The letter of credit remained outstanding as of December&#160;31, 2013, and is collateralized by a certificate of deposit for $0.4 million, which has been included in restricted cash in the consolidated balance sheets as of December&#160;31, 2013 and 2012. Under the terms of the Berkeley Lease, if the total amount of our cash, cash equivalents and marketable securities falls below $20 million for a period of more than 30 consecutive days during the lease term, the amount of the required security deposit will increase to $1.1 million, until such time as our projected cash and cash equivalents will exceed $20 million for the remainder of the lease term, or until our actual cash and cash equivalents remains above $20 million for a period of 12 consecutive months. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We established a letter of credit with Deutsche Bank as security for our D&#252;sseldorf Lease in the amount of approximately 0.2</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;million Euros. The letter of credit remained outstanding through December&#160;31, 2013 and is collateralized by a certificate of deposit for $0.2 million, which has been included in restricted cash in the consolidated balance sheets as of December&#160;31, 2013 and 2012.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In addition to the non-cancelable commitments included above, we have entered into contractual arrangements that obligate us to make payments to the contractual counterparties upon the occurrence of future events. In addition, in </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the normal course of operations, we have entered into license and other agreements and intend to continue to seek additional rights relating to compounds or technologies in connection with our discovery, manufacturing and development programs. Under the terms of the agreements, we may be required to pay future up-front fees, milestones and royalties on net sales of products originating from the licensed technologies, if any, or other payments contingent upon the occurrence of future events that cannot reasonably be estimated.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We rely on research institutions, contract research organizations, clinical investigators as well as clinical and material manufacturers of our product candidates. As of December&#160;31, 2013, under the terms of our agreements, we are obligated to make future payments as services are provided of approximately $4.5</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million through 2015. These agreements are terminable by us upon written notice. Generally, we are liable only for actual effort expended by the organizations at any point in time during the contract through the notice period.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Under the terms of our exclusive license agreements with the Regents of the University of California, as amended, for certain technology and related patent rights and materials, we pay annual license or maintenance fees and will be required to pay milestones and royalties on net sales, if any,</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of certain products originating from the licensed technologies.</font></p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for commitments and contingencies.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.25)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6449706&amp;loc=d3e16207-108621<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 460<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6398077&amp;loc=d3e12565-110249<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 450<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14435-108349<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 440<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6394976&amp;loc=d3e25287-109308<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ENJAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Subsequent Event - Additional Information (Detail) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="4">12 Months Ended</th>
        <th class="th" colspan="1">1 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Astra Zeneca</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Astra Zeneca</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011

</div>
          <div>Astra Zeneca</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014

</div>
          <div>Astra Zeneca

</div>
          <div>Subsequent Event</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized', window );">Milestone revenue</a></td>
        <td class="nump">$ 12,000<span></span></td>
        <td class="nump">$ 2,507<span></span></td>
        <td class="nump">$ 2,462<span></span></td>
        <td class="nump">$ 642<span></span></td>
        <td class="nump">$ 5,400<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of consideration recognized during the period for the milestone or milestones.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 605<br><br> -SubTopic 28<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=19771982&amp;loc=SL6892177-166501<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SubsequentEventLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E3JAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Selected Quarterly Financial Data (Detail) (USD $)<br>In Thousands, except Per Share data, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="8">3 Months Ended</th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_SelectedQuarterlyFinancialDataLineItems', window );"><strong>Selected Quarterly Financial Data [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
        <td class="nump">$ 2,847<span></span></td>
        <td class="nump">$ 2,927<span></span></td>
        <td class="nump">$ 3,392<span></span></td>
        <td class="nump">$ 2,085<span></span></td>
        <td class="nump">$ 1,806<span></span></td>
        <td class="nump">$ 2,874<span></span></td>
        <td class="nump">$ 2,684<span></span></td>
        <td class="nump">$ 2,350<span></span></td>
        <td class="nump">$ 11,251<span></span></td>
        <td class="nump">$ 9,714<span></span></td>
        <td class="nump">$ 21,614<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">(13,056)<span></span></td>
        <td class="num">(15,675)<span></span></td>
        <td class="num">(17,164)<span></span></td>
        <td class="num">(20,825)<span></span></td>
        <td class="num">(20,543)<span></span></td>
        <td class="num">(17,791)<span></span></td>
        <td class="num">(15,110)<span></span></td>
        <td class="num">(16,505)<span></span></td>
        <td class="num">(66,720)<span></span></td>
        <td class="num">(69,949)<span></span></td>
        <td class="num">(48,597)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss allocable to common stockholders</a></td>
        <td class="num">$ (21,525)<span></span></td>
        <td class="num">$ (15,675)<span></span></td>
        <td class="num">$ (17,164)<span></span></td>
        <td class="num">$ (20,825)<span></span></td>
        <td class="num">$ (20,543)<span></span></td>
        <td class="num">$ (17,791)<span></span></td>
        <td class="num">$ (15,110)<span></span></td>
        <td class="num">$ (16,505)<span></span></td>
        <td class="num">$ (75,189)<span></span></td>
        <td class="num">$ (69,949)<span></span></td>
        <td class="num">$ (48,597)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted net loss per share allocable to common stockholders</a></td>
        <td class="num">$ (0.09)<span></span></td>
        <td class="num">$ (0.09)<span></span></td>
        <td class="num">$ (0.09)<span></span></td>
        <td class="num">$ (0.11)<span></span></td>
        <td class="num">$ (0.11)<span></span></td>
        <td class="num">$ (0.10)<span></span></td>
        <td class="num">$ (0.09)<span></span></td>
        <td class="num">$ (0.11)<span></span></td>
        <td class="num">$ (0.38)<span></span></td>
        <td class="num">$ (0.41)<span></span></td>
        <td class="num">$ (0.39)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted-average common shares outstanding</a></td>
        <td class="nump">235,879<span></span></td>
        <td class="nump">183,022<span></span></td>
        <td class="nump">182,913<span></span></td>
        <td class="nump">182,847<span></span></td>
        <td class="nump">180,685<span></span></td>
        <td class="nump">177,870<span></span></td>
        <td class="nump">167,697<span></span></td>
        <td class="nump">155,431<span></span></td>
        <td class="nump">196,275<span></span></td>
        <td class="nump">170,469<span></span></td>
        <td class="nump">125,101<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_SelectedQuarterlyFinancialDataLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_SelectedQuarterlyFinancialDataLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareBasicAndDiluted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e565-108580<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1377-109256<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Revenues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ENH">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Equity Plans and Stock-Based Compensation (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock', window );">Option Activity under Stock-Based Compensation Plans</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Activity under our stock plans is set forth below: </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Shares Underlying&nbsp;&nbsp;Outstanding Options (in thousands)</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted-Average Exercise Price&#160;Per&#160;Share (in thousands)</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted-Average Remaining Contractual Term (years)</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Aggregate Intrinsic Value</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December&#160;31, 2012</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,806</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.38</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options granted</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,614</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.69</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercised</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(131</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.43</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options cancelled:</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options forfeited (unvested)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,555</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.31</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options cancelled (vested)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(969</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.34</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:8%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:8%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December&#160;31, 2013</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,765</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.17</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.26</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,427</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested and expected to vest at December 31, 2013</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,765</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.17</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.26</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,427</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercisable at December 31, 2013</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,628</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.36</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.61</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,289</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:6pt;;">&nbsp;</p></div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Summary of Restricted Stock Units Activity</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our non-vested stock awards are comprised of restricted stock units granted with performance-based vesting criteria. A summary of the status of non-vested restricted stock units as of December&#160;31, 2013, and activities during 2013 is summarized as follows: </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Number of Shares (In&#160;thousands)</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted-Average Grant-Date&#160;Fair Value</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-vested as of December 31, 2012</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,755</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.23</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">250</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.23</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(115</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.10</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited or expired</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(615</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.23</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-vested as of December 31, 2013</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,275</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.93</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:6pt;;">&nbsp;</p></div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Fair Value-Based Measurements and Weighted-Average Assumptions</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Under our stock-based compensation plans, option awards generally vest over a </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">four-year period contingent upon continuous service and expire ten years from the date of grant (or earlier upon termination of continuous service). The Company has also granted performance-based equity awards to certain of our employees under the 2011 Plan, the 2004 Plan and the Inducement Plan. As of December&#160;31, 2013, 2,047,466 shares were outstanding related to options and restricted stock units subject to these performance-based vesting criteria. The fair value of each option is estimated on the date of grant using the Black-Scholes option valuation model and the following weighted-average assumptions: </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:35%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Stock&#160;Options</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Employee&#160;Stock Purchase&#160;Plan</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:35%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:35%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:35%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average fair value</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.41</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.30</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.76</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.93</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.54</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.09</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:35%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.5</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.3</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.2</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.2</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.3</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:35%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected life (in years)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.9</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.2</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.0</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.3</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.2</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:35%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Volatility</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.4</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.6</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.6</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.8</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.6</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.6</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Stock-Based Compensation Expense</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We recognized the following amounts of stock-based compensation expense (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employees and directors stock-based compensation expense</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,828</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,439</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,185</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-employees stock-based compensation expense</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">512</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,340</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,439</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,189</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%; border-top:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,228</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,514</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,103</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,112</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,925</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,086</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,340</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,439</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,189</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the amount of total share-based compensation cost, including the amounts attributable to each share-based compensation plan and any related tax benefits.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (h)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the following for fully vested share options (or share units) and share options expected to vest at the date of the latest statement of financial position: the number, weighted-average exercise price (or conversion ratio), aggregate intrinsic value (except for nonpublic entities), and weighted-average remaining contractual term of options (or share units) outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EM1BI">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Computation of Basic and Diluted Earnings Per Share (Detail) (USD $)<br>In Thousands, except Per Share data, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="8">3 Months Ended</th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Basic and diluted net loss per share (in thousands, except per share amounts):</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">$ (13,056)<span></span></td>
        <td class="num">$ (15,675)<span></span></td>
        <td class="num">$ (17,164)<span></span></td>
        <td class="num">$ (20,825)<span></span></td>
        <td class="num">$ (20,543)<span></span></td>
        <td class="num">$ (17,791)<span></span></td>
        <td class="num">$ (15,110)<span></span></td>
        <td class="num">$ (16,505)<span></span></td>
        <td class="num">$ (66,720)<span></span></td>
        <td class="num">$ (69,949)<span></span></td>
        <td class="num">$ (48,597)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsIncomeStatementImpact', window );">Preferred stock deemed dividend</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(8,469)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss allocable to common stockholders</a></td>
        <td class="num">$ (21,525)<span></span></td>
        <td class="num">$ (15,675)<span></span></td>
        <td class="num">$ (17,164)<span></span></td>
        <td class="num">$ (20,825)<span></span></td>
        <td class="num">$ (20,543)<span></span></td>
        <td class="num">$ (17,791)<span></span></td>
        <td class="num">$ (15,110)<span></span></td>
        <td class="num">$ (16,505)<span></span></td>
        <td class="num">$ (75,189)<span></span></td>
        <td class="num">$ (69,949)<span></span></td>
        <td class="num">$ (48,597)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_EarningsPerShareBasicAndDilutedDenominatorAbstract', window );"><strong>Denominator for basic and diluted net loss per share allocable to common stockholders:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted-average common shares outstanding</a></td>
        <td class="nump">235,879<span></span></td>
        <td class="nump">183,022<span></span></td>
        <td class="nump">182,913<span></span></td>
        <td class="nump">182,847<span></span></td>
        <td class="nump">180,685<span></span></td>
        <td class="nump">177,870<span></span></td>
        <td class="nump">167,697<span></span></td>
        <td class="nump">155,431<span></span></td>
        <td class="nump">196,275<span></span></td>
        <td class="nump">170,469<span></span></td>
        <td class="nump">125,101<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share allocable to common stockholders - basic and diluted</a></td>
        <td class="num">$ (0.09)<span></span></td>
        <td class="num">$ (0.09)<span></span></td>
        <td class="num">$ (0.09)<span></span></td>
        <td class="num">$ (0.11)<span></span></td>
        <td class="num">$ (0.11)<span></span></td>
        <td class="num">$ (0.10)<span></span></td>
        <td class="num">$ (0.09)<span></span></td>
        <td class="num">$ (0.11)<span></span></td>
        <td class="num">$ (0.38)<span></span></td>
        <td class="num">$ (0.41)<span></span></td>
        <td class="num">$ (0.39)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_AntidilutiveSecuritiesExcludedFromComputationOfEarningPerShareAbstract', window );"><strong>Outstanding securities not included in diluted net loss per share calculation (in thousands):</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Outstanding securities not included in diluted net loss per share calculation</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">72,934<span></span></td>
        <td class="nump">28,275<span></span></td>
        <td class="nump">36,830<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Series B Convertible Preferred Stock</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_AntidilutiveSecuritiesExcludedFromComputationOfEarningPerShareAbstract', window );"><strong>Outstanding securities not included in diluted net loss per share calculation (in thousands):</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Outstanding securities not included in diluted net loss per share calculation</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">43,430<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Stock Options and Stock Awards</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_AntidilutiveSecuritiesExcludedFromComputationOfEarningPerShareAbstract', window );"><strong>Outstanding securities not included in diluted net loss per share calculation (in thousands):</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Outstanding securities not included in diluted net loss per share calculation</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">17,040<span></span></td>
        <td class="nump">15,561<span></span></td>
        <td class="nump">11,101<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Warrant</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_AntidilutiveSecuritiesExcludedFromComputationOfEarningPerShareAbstract', window );"><strong>Outstanding securities not included in diluted net loss per share calculation (in thousands):</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Outstanding securities not included in diluted net loss per share calculation</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">12,464<span></span></td>
        <td class="nump">12,714<span></span></td>
        <td class="nump">25,729<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_AntidilutiveSecuritiesExcludedFromComputationOfEarningPerShareAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_AntidilutiveSecuritiesExcludedFromComputationOfEarningPerShareAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_EarningsPerShareBasicAndDilutedDenominatorAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_EarningsPerShareBasicAndDilutedDenominatorAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Antidilution<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6505113<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Diluted Earnings Per Share<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6510752<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Contingent Stock Agreement<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6508534<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareBasicAndDiluted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e565-108580<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1377-109256<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsIncomeStatementImpact">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockDividendsIncomeStatementImpact</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Employee Benefit Plan<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Employee Benefit Plan</a></td>
        <td class="text"><div>
<div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">14.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Employee Benefit Plan </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We maintain a 401(k) Plan, which qualifies as a deferred salary arrangement under Section&#160;401(k) of the Internal Revenue Code. Under the 401(k) Plan, participating employees may defer a portion of their pretax earnings. We may, at our discretion, contribute for the benefit of eligible employees. To date, we have not contributed to the 401(k) Plan. </font></p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for pension and other postretirement benefits.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 715<br><br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Fair Value Hierarchy For Financial Assets And Liabilities Measured At Fair Value On Recurring Basis</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The following table represents the fair value hierarchy for our financial assets (cash equivalents and marketable securities) measured at fair value on a recurring basis as of December&#160;31, 2013 and 2012 (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:54%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Level 1</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Level 2</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Level&#160;3</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2013</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:54%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government agency securities</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">167,597</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">167,597</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">167,597</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">187,610</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:54%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Level 1</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Level 2</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Level&#160;3</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2012</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,140</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,140</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government agency securities</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">119,233</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">119,233</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. treasury securities</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">500</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">500</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:54%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Municipal securities</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">715</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">715</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:54%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,140</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">120,448</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">123,588</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;;">&nbsp;</p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25499696&amp;loc=d3e19190-110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EQLAK">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Collaborative Research, Development, and License Agreements - Additional Information (Detail) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="4">12 Months Ended</th>
        <th class="th" colspan="3"></th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="3">12 Months Ended</th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">12 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1">1 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2008

</div>
          <div>Glaxo, Smith, Kline

</div>
          <div>Project</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Glaxo, Smith, Kline</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Glaxo, Smith, Kline</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Glaxo, Smith, Kline</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011

</div>
          <div>Glaxo, Smith, Kline</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011

</div>
          <div>Glaxo, Smith, Kline

</div>
          <div>Expansion</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Glaxo, Smith, Kline

</div>
          <div>Maximum</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Glaxo, Smith, Kline

</div>
          <div>Maximum

</div>
          <div>Annual net sales milestones achieved</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Glaxo, Smith, Kline

</div>
          <div>Minimum</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2006

</div>
          <div>Astra Zeneca</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Astra Zeneca</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Astra Zeneca</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011

</div>
          <div>Astra Zeneca</div>
        </th>
        <th class="th">
          <div>Oct. 31, 2011

</div>
          <div>Amendment</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011

</div>
          <div>Amendment</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012

</div>
          <div>Amendment

</div>
          <div>Advance the program following completion of Phase 2a</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2012

</div>
          <div>Amendment

</div>
          <div>Advance the program following completion of Phase 2a</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Amendment

</div>
          <div>Advance the program following completion of Phase 2a</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Amendment

</div>
          <div>Maximum

</div>
          <div>Advance the program following completion of Phase 2a</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013

</div>
          <div>Hepatic Fibrosis and Cirrhosis

</div>
          <div>National Institutes of Health</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012

</div>
          <div>Autoimmune Disease

</div>
          <div>National Institutes of Health</div>
        </th>
        <th class="th">
          <div>May 31, 2012

</div>
          <div>Rheumatoid Arthritis

</div>
          <div>National Institutes of Health</div>
        </th>
        <th class="th">
          <div>Jul. 31, 2011

</div>
          <div>Skin Autoimmune Inflammation

</div>
          <div>National Institutes of Health</div>
        </th>
        <th class="th">
          <div>Aug. 31, 2010

</div>
          <div>HBV

</div>
          <div>National Institutes of Health</div>
        </th>
        <th class="th">
          <div>Jul. 31, 2010

</div>
          <div>HPV

</div>
          <div>National Institutes of Health</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2008

</div>
          <div>ISS Technology

</div>
          <div>National Institutes of Health</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_NumberOfProjects', window );">Number of programs for research and early clinical development</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">4<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_PotentialMilestonePaymentAmount', window );">Potential milestone payment</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 125,000,000<span></span></td>
        <td class="nump">$ 60,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueAdditions', window );">Collaboration Revenue</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">10,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,702,000<span></span></td>
        <td class="nump">1,428,000<span></span></td>
        <td class="nump">1,428,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">720,000<span></span></td>
        <td class="nump">720,000<span></span></td>
        <td class="nump">120,000<span></span></td>
        <td class="nump">3,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">6,000,000<span></span></td>
        <td class="nump">2,600,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized', window );">Revenue from milestone payment</a></td>
        <td class="nump">12,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">15,000,000<span></span></td>
        <td class="nump">3,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,507,000<span></span></td>
        <td class="nump">2,462,000<span></span></td>
        <td class="nump">642,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">20,000,000<span></span></td>
        <td class="nump">100,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_RevenueRecognitionPeriod', window );">Deferred revenue recognition period</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">7 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">6 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">50 months<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleCurrentPeriodDisclosuresRevenueRecognizedAmount', window );">Additional revenue recognized</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">300,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred revenue</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,500,000<span></span></td>
        <td class="nump">2,500,000<span></span></td>
        <td class="nump">4,200,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">4,800,000<span></span></td>
        <td class="nump">7,700,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_ResearchCollaborationAndLicenseAgreementPeriod', window );">Research collaboration and license agreement period</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">3 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Cost of clinical development activities</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">20,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrantsReceivable', window );">Grants receivable</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">200,000<span></span></td>
        <td class="nump">600,000<span></span></td>
        <td class="nump">400,000<span></span></td>
        <td class="nump">600,000<span></span></td>
        <td class="nump">1,400,000<span></span></td>
        <td class="nump">600,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_ContractTerm', window );">Contract agreement period</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">5 years<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms', window );">Contract awarded to develop technology</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 17,000,000<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_ContractTerm">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Contract Term</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_ContractTerm</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_NumberOfProjects">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of Projects</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_NumberOfProjects</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:integerItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_PotentialMilestonePaymentAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Potential Milestone Payment Amount</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_PotentialMilestonePaymentAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_ResearchCollaborationAndLicenseAgreementPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Research Collaboration and License Agreement Period</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_ResearchCollaborationAndLicenseAgreementPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_RevenueRecognitionPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Revenue Recognition, Period</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_RevenueRecognitionPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount billed to customers under long-term contracts or programs but not paid. Excludes amounts due that have been withheld because of retainage provisions in a contract.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 910<br><br> -SubTopic 310<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6471494&amp;loc=d3e49354-109356<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.3(c))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 3<br><br> -Subparagraph c<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of deferred revenue as of balance sheet date. Deferred revenue represents collections of cash or other assets related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 13<br><br> -Section A<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 605<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 13.A.4(a).Q1 Response)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012821&amp;loc=d3e214044-122780<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredRevenue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueAdditions">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of deferred revenue recognized for transactions arising during the current reporting period. Deferred revenue is a liability as of the balance sheet date related to a revenue producing activity for which revenue has not yet been recognized. Generally, an Entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 605<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 13.A.4(a).Q1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012821&amp;loc=d3e214044-122780<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 13<br><br> -Section A<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredRevenueAdditions</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrantsReceivable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.8)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 8<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GrantsReceivable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleCurrentPeriodDisclosuresRevenueRecognizedAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of revenue recognized in earnings during the reporting period associated with arrangements entered into or modified after adoption of the new accounting pronouncement or change in accounting principle.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 605<br><br> -SubTopic 25<br><br> -Section 65<br><br> -Paragraph 1<br><br> -Subparagraph (d)(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=19771798&amp;loc=SL6749767-165964<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleCurrentPeriodDisclosuresRevenueRecognizedAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProductInformationLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 730<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Research and Development<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6523717<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of consideration recognized during the period for the milestone or milestones.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 605<br><br> -SubTopic 28<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=19771982&amp;loc=SL6892177-166501<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EYBAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Cash, Cash Equivalents and Marketable Securities - Additional Information (Detail) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesRealizedGainLoss', window );">Realized gains or losses from the sale of marketable securities</a></td>
        <td class="nump">$ 0<span></span></td>
        <td class="nump">$ 0<span></span></td>
        <td class="nump">$ 0<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesRealizedGainLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This item represents the total realized gain (loss) included in earnings for the period as a result of selling marketable securities categorized as trading, available-for-sale, or held-to-maturity. Additionally, this item would include any losses recognized for other than temporary impairments (OTTI) of the subject investments in debt and equity securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27357-111563<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.7(c))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 10<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27405-111563<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_MarketableSecuritiesRealizedGainLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EHOAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">$ (66,720)<span></span></td>
        <td class="num">$ (69,949)<span></span></td>
        <td class="num">$ (48,597)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized (loss) gain on marketable securities available-for-sale</a></td>
        <td class="num">(76)<span></span></td>
        <td class="nump">48<span></span></td>
        <td class="nump">14<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Cumulative translation adjustment</a></td>
        <td class="nump">523<span></span></td>
        <td class="nump">366<span></span></td>
        <td class="num">(277)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
        <td class="nump">447<span></span></td>
        <td class="nump">414<span></span></td>
        <td class="num">(263)<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive loss</a></td>
        <td class="num">$ (66,273)<span></span></td>
        <td class="num">$ (69,535)<span></span></td>
        <td class="num">$ (48,860)<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Other Comprehensive Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Comprehensive Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=16317811<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e557-108580<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Net Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ComprehensiveIncomeNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 9<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Other Comprehensive Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Net Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.19)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br><br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br><br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-04.22)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br><br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e565-108580<br><br><br><br><br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 19<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 10A<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=SL7669646-108580<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 830<br><br><br><br> -SubTopic 30<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 20<br><br><br><br> -Subparagraph (b,c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6915805&amp;loc=d3e32211-110900<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1A<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=SL7669619-108580<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeLossNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 11<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e637-108580<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 10A<br><br><br><br> -Subparagraph (e)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=SL7669646-108580<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
        <td class="text"><div>
<div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">3.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value Measurements </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The Company defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The accounting </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">standard describes a fair value hierarchy based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value which are the following: </font></p><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-family:'Symbol';font-size:10pt;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 1&#8212;Observable inputs, such as quoted prices in active markets for identical assets or liabilities; </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-family:'Symbol';font-size:10pt;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2&#8212;Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and </font></p></td></tr></table></div><div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:94.27%;margin-left:5.73%;margin-right:0%"><tr><td valign="top" style="width:3.33%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-family:'Symbol';font-size:10pt;">&#183;</font></p></td><td valign="top" style="width:96.67%;"><p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 3&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities, therefore requiring an entity to develop its own assumptions. </font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;font-family:Times New Roman;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recurring Fair Value Measurements </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The following table represents the fair value hierarchy for our financial assets (cash equivalents and marketable securities) measured at fair value on a recurring basis as of December&#160;31, 2013 and 2012 (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:54%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Level 1</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Level 2</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Level&#160;3</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2013</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:54%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government agency securities</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">167,597</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">167,597</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">167,597</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">187,610</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:54%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Level 1</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Level 2</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Level&#160;3</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2012</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,140</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,140</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government agency securities</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">119,233</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">119,233</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:54%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. treasury securities</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">500</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:2%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">500</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:54%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Municipal securities</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">715</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">715</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:54%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,140</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">120,448</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">123,588</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Money market funds are highly liquid investments and are actively traded. The pricing information on these investment instruments are readily available and can be independently validated as of the measurement date. This approach results in the classification of these securities as Level 1 of the fair value hierarchy. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">U.S. Government agency securities, U.S. treasury securities and municipal securities are measured at fair value using Level 2 inputs. We review trading activity and pricing for these investments as of each measurement date. When sufficient quoted pricing for identical securities is not available, we use market pricing and other observable market inputs for similar securities obtained from various third party data providers. These inputs represent quoted prices for similar assets in active markets or these inputs have been derived from observable market data. This approach results in the classification of these securities as Level 2 of the fair value hierarchy. </font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:9%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-size:9pt;;">&nbsp;</p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-size:9pt;;"><font style="color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:9pt;;">&nbsp;</p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 21<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28364263&amp;loc=d3e13537-108611<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 10<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28364263&amp;loc=d3e13433-108611<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957238&amp;loc=d3e14064-108612<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25499696&amp;loc=d3e19207-110258<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 30<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957238&amp;loc=d3e14172-108612<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 16<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28364263&amp;loc=d3e13504-108611<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueDisclosuresTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EQ3AE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Stock-Based Compensation Expense (Detail) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems', window );"><strong>Deferred Compensation Arrangement With Individual Share Based Payments [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock compensation expense</a></td>
        <td class="nump">$ 12,340<span></span></td>
        <td class="nump">$ 10,439<span></span></td>
        <td class="nump">$ 5,189<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Employees And Directors</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems', window );"><strong>Deferred Compensation Arrangement With Individual Share Based Payments [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock compensation expense</a></td>
        <td class="nump">11,828<span></span></td>
        <td class="nump">10,439<span></span></td>
        <td class="nump">5,185<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Non Employee</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems', window );"><strong>Deferred Compensation Arrangement With Individual Share Based Payments [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock compensation expense</a></td>
        <td class="nump">512<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">4<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Research and Development Expense</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems', window );"><strong>Deferred Compensation Arrangement With Individual Share Based Payments [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock compensation expense</a></td>
        <td class="nump">4,228<span></span></td>
        <td class="nump">3,514<span></span></td>
        <td class="nump">2,103<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">General and Administrative Expense</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems', window );"><strong>Deferred Compensation Arrangement With Individual Share Based Payments [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock compensation expense</a></td>
        <td class="nump">$ 8,112<span></span></td>
        <td class="nump">$ 6,925<span></span></td>
        <td class="nump">$ 3,086<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredCompensationArrangementWithIndividualShareBasedPaymentsLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EPE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Cash, Cash Equivalents and Marketable Securities (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock', window );">Summary of Cash, Cash Equivalents and Marketable Securities</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The following is a summary of cash, cash equivalents and marketable securities as of December&#160;31, 2013, and 2012 (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Amortized Cost</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Unrealized Gains</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Unrealized Losses</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Estimated Fair&#160;Value</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2013</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents:</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,766</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,766</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,013</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,013</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government agency securities</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,343</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,343</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash and cash equivalents</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,122</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,122</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Marketable securities available-for-sale:</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government agency securities</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">166,285</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(47</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">166,254</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total marketable securities available-for-sale</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">166,285</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(47</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">166,254</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash, cash equivalents and marketable securities</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">189,407</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(47</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">189,376</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%; border-top:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2012</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents:</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,542</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,542</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,140</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,140</font></p></td>
<td valign="bottom" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Municipal securities</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">715</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">715</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:26.65pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government agency securities</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,202</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,202</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash and cash equivalents</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,599</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,599</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Marketable securities available-for-sale:</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:52%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. government agency securities</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">116,986</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">117,031</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. treasury securities</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">500</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">500</font></p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;margin-right:0%;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total marketable securities available-for-sale</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">117,486</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">117,531</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:52%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash, cash equivalents and marketable securities</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">125,085</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" style="width:2%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" style="width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">125,130</font></p></td>
<td valign="bottom" style="width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesTextBlock', window );">Maturities of Marketable Securities Available-for-Sale</a></td>
        <td class="text"><div>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The maturities of our marketable securities available-for-sale are as follows (in thousands) </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:62%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:3%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="6" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:33%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:62%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:3%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Amortized Cost</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:3%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:16%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Estimated Fair Value</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:62%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mature in one year or less</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:3%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">93,691</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:3%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:14%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">93,701</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:62%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mature after one year through two years</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:3%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72,594</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:3%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:14%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72,553</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:62%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:3%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">166,285</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:3%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:14%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">166,254</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27290-111563<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27357-111563<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 7<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27337-111563<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 320<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957658&amp;loc=d3e62557-112803<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27198-111563<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 320<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957658&amp;loc=d3e62586-112803<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27161-111563<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecuritiesTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the components of cash, cash equivalents, and investments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<FilingSummary xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <Version>2.4.0.8</Version>
  <ProcessingTime />
  <ReportFormat>Html</ReportFormat>
  <ContextCount>275</ContextCount>
  <ElementCount>359</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>88</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>10</UnitCount>
  <MyReports>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
    </Report>
    <Report>
      <IsDefault>true</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100020 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100030 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedStatementsOfOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100040 - Statement - Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100050 - Statement - Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100060 - Statement - Consolidated Statements Of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements Of Cash Flows</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>100070 - Disclosure - Organization</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureOrganization</Role>
      <ShortName>Organization</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>100080 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>100090 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureFairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>100100 - Disclosure - Cash, Cash Equivalents and Marketable Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecurities</Role>
      <ShortName>Cash, Cash Equivalents and Marketable Securities</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>100110 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosurePropertyAndEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>100120 - Disclosure - Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureIntangibleAssets</Role>
      <ShortName>Intangible Assets</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>100130 - Disclosure - Current Accrued Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureCurrentAccruedLiabilities</Role>
      <ShortName>Current Accrued Liabilities</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>100140 - Disclosure - Symphony Dynamo, Inc.</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureSymphonyDynamoInc</Role>
      <ShortName>Symphony Dynamo, Inc.</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>100150 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureCommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>100160 - Disclosure - Collaborative Research, Development and License Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreements</Role>
      <ShortName>Collaborative Research, Development and License Agreements</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>100170 - Disclosure - Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureNetLossPerShare</Role>
      <ShortName>Net Loss Per Share</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>100180 - Disclosure - Preferred Stock, Common Stock and Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosurePreferredStockCommonStockAndWarrants</Role>
      <ShortName>Preferred Stock, Common Stock and Warrants</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>100190 - Disclosure - Equity Plans and Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureEquityPlansAndStockBasedCompensation</Role>
      <ShortName>Equity Plans and Stock-Based Compensation</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>100200 - Disclosure - Employee Benefit Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureEmployeeBenefitPlan</Role>
      <ShortName>Employee Benefit Plan</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>100210 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureIncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>100220 - Disclosure - Selected Quarterly Financial Data</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureSelectedQuarterlyFinancialData</Role>
      <ShortName>Selected Quarterly Financial Data</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>100230 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureSubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>100240 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>100250 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureFairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>100260 - Disclosure - Cash, Cash Equivalents and Marketable Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesTables</Role>
      <ShortName>Cash, Cash Equivalents and Marketable Securities (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>100270 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosurePropertyAndEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>100280 - Disclosure - Current Accrued Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureCurrentAccruedLiabilitiesTables</Role>
      <ShortName>Current Accrued Liabilities (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>100290 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>100300 - Disclosure - Collaborative Research and Development Agreements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureCollaborativeResearchAndDevelopmentAgreementsTables</Role>
      <ShortName>Collaborative Research and Development Agreements (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>100310 - Disclosure - Net Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureNetLossPerShareTables</Role>
      <ShortName>Net Loss Per Share (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>100320 - Disclosure - Preferred Stock, Common Stock and Warrants (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosurePreferredStockCommonStockAndWarrantsTables</Role>
      <ShortName>Preferred Stock, Common Stock and Warrants (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>100330 - Disclosure - Equity Plans and Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureEquityPlansAndStockBasedCompensationTables</Role>
      <ShortName>Equity Plans and Stock-Based Compensation (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>100340 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureIncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>100350 - Disclosure - Selected Quarterly Financial Data (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureSelectedQuarterlyFinancialDataTables</Role>
      <ShortName>Selected Quarterly Financial Data (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>100360 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Additional Information (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>100370 - Disclosure - Fair Value Hierarchy for Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureFairValueHierarchyForFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail</Role>
      <ShortName>Fair Value Hierarchy for Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>100380 - Disclosure - Summary of Cash, Cash Equivalents and Marketable Securities Available-for-sale (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfCashCashEquivalentsAndMarketableSecuritiesAvailableForSaleDetail</Role>
      <ShortName>Summary of Cash, Cash Equivalents and Marketable Securities Available-for-sale (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>100390 - Disclosure - Summary of Amortized Cost and Estimated Fair Value of Marketable Securities Available-for-sale (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfAmortizedCostAndEstimatedFairValueOfMarketableSecuritiesAvailableForSaleDetail</Role>
      <ShortName>Summary of Amortized Cost and Estimated Fair Value of Marketable Securities Available-for-sale (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>100400 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAdditionalInformationDetail</Role>
      <ShortName>Cash, Cash Equivalents and Marketable Securities - Additional Information (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>100410 - Disclosure - Component of Property and Equipment (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureComponentOfPropertyAndEquipmentDetail</Role>
      <ShortName>Component of Property and Equipment (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>100420 - Disclosure - Property and Equipment - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetail</Role>
      <ShortName>Property and Equipment - Additional Information (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>100430 - Disclosure - Intangible Assets - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureIntangibleAssetsAdditionalInformationDetail</Role>
      <ShortName>Intangible Assets - Additional Information (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>100440 - Disclosure - Component of Current Accrued Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureComponentOfCurrentAccruedLiabilitiesDetail</Role>
      <ShortName>Component of Current Accrued Liabilities (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>100450 - Disclosure - Symphony Dynamo, Inc. - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureSymphonyDynamoIncAdditionalInformationDetail</Role>
      <ShortName>Symphony Dynamo, Inc. - Additional Information (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>100460 - Disclosure - Future Minimum Payments Under Non-Cancelable Portion of Operating Leases (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureFutureMinimumPaymentsUnderNonCancelablePortionOfOperatingLeasesDetail</Role>
      <ShortName>Future Minimum Payments Under Non-Cancelable Portion of Operating Leases (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>100470 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail</Role>
      <ShortName>Commitments and Contingencies - Additional Information (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>100480 - Disclosure - Collaborative Research, Development, and License Agreements - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureCollaborativeResearchDevelopmentAndLicenseAgreementsAdditionalInformationDetail</Role>
      <ShortName>Collaborative Research, Development, and License Agreements - Additional Information (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>100490 - Disclosure - Summary of Revenue Recognized under Agreement with GSK (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfRevenueRecognizedUnderAgreementWithGSKDetail</Role>
      <ShortName>Summary of Revenue Recognized under Agreement with GSK (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>100500 - Disclosure - Computation of Basic and Diluted Earnings Per Share (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureComputationOfBasicAndDilutedEarningsPerShareDetail</Role>
      <ShortName>Computation of Basic and Diluted Earnings Per Share (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>100510 - Disclosure - Preferred Stock, Common Stock and Warrants - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosurePreferredStockCommonStockAndWarrantsAdditionalInformationDetail</Role>
      <ShortName>Preferred Stock, Common Stock and Warrants - Additional Information (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>100520 - Disclosure - Warrants Issued to Purchase Common Stock (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureWarrantsIssuedToPurchaseCommonStockDetail</Role>
      <ShortName>Warrants Issued to Purchase Common Stock (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>100530 - Disclosure - Equity Plans and Stock-Based Compensation - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureEquityPlansAndStockBasedCompensationAdditionalInformationDetail</Role>
      <ShortName>Equity Plans and Stock-Based Compensation - Additional Information (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>100540 - Disclosure - Option Activity under Stock Plans (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureOptionActivityUnderStockPlansDetail</Role>
      <ShortName>Option Activity under Stock Plans (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>100550 - Disclosure - Summary of Restricted Stock Units Activity (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureSummaryOfRestrictedStockUnitsActivityDetail</Role>
      <ShortName>Summary of Restricted Stock Units Activity (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>100560 - Disclosure - Fair Value-Based Measurements and Weighted-Average Assumptions (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureFairValueBasedMeasurementsAndWeightedAverageAssumptionsDetail</Role>
      <ShortName>Fair Value-Based Measurements and Weighted-Average Assumptions (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>100570 - Disclosure - Stock-Based Compensation Expense (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureStockBasedCompensationExpenseDetail</Role>
      <ShortName>Stock-Based Compensation Expense (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>100580 - Disclosure - Component of Consolidated Income (Loss) Before Provision for Income Taxes (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureComponentOfConsolidatedIncomeLossBeforeProvisionForIncomeTaxesDetail</Role>
      <ShortName>Component of Consolidated Income (Loss) Before Provision for Income Taxes (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>100590 - Disclosure - Difference between Consolidated Income Tax Benefit and Amount Computed by Federal Statutory Income Tax Rate (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureDifferenceBetweenConsolidatedIncomeTaxBenefitAndAmountComputedByFederalStatutoryIncomeTaxRateDetail</Role>
      <ShortName>Difference between Consolidated Income Tax Benefit and Amount Computed by Federal Statutory Income Tax Rate (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>100600 - Disclosure - Component of Deferred Tax Assets and Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureComponentOfDeferredTaxAssetsAndLiabilitiesDetail</Role>
      <ShortName>Component of Deferred Tax Assets and Liabilities (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>100610 - Disclosure - Income Taxes - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail</Role>
      <ShortName>Income Taxes - Additional Information (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>100620 - Disclosure - Selected Quarterly Financial Data (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureSelectedQuarterlyFinancialDataDetail</Role>
      <ShortName>Selected Quarterly Financial Data (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>100630 - Disclosure - Subsequent Event - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20131231/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetail</Role>
      <ShortName>Subsequent Event - Additional Information (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Info">Element us-gaap_BusinessExitCosts1 had a mix of decimals attribute values: -5 -3.</Log>
    <Log type="Info">Element us-gaap_CashCashEquivalentsAndShortTermInvestments had a mix of decimals attribute values: -6 -5.</Log>
    <Log type="Info">Element us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights had a mix of decimals attribute values: 0 2.</Log>
    <Log type="Info">Element us-gaap_ClassOfWarrantOrRightOutstanding had a mix of decimals attribute values: -3 0.</Log>
    <Log type="Info">Element us-gaap_CommonStockSharesAuthorized had a mix of decimals attribute values: -3 0.</Log>
    <Log type="Info">Element us-gaap_DeferredRevenueAdditions had a mix of decimals attribute values: -6 -3.</Log>
    <Log type="Info">Element us-gaap_EquityIssuancePerShareAmount had a mix of decimals attribute values: 0 4.</Log>
    <Log type="Info">Element us-gaap_ProceedsFromIssuanceOfCommonStock had a mix of decimals attribute values: -5 -3.</Log>
    <Log type="Info">Element us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized had a mix of decimals attribute values: -6 -3.</Log>
    <Log type="Info">Element us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue had a mix of decimals attribute values: 0 2.</Log>
    <Log type="Info">Element us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber had a mix of decimals attribute values: -3 0.</Log>
    <Log type="Info">Element us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent had a mix of decimals attribute values: 0 2.</Log>
    <Log type="Info">Element us-gaap_StockIssuedDuringPeriodValueNewIssues had a mix of decimals attribute values: -3 0.</Log>
    <Log type="Info">'Shares' elements on report '100020 - Statement - Consolidated Balance Sheets (Parenthetical)' had a mix of different decimal attribute values.</Log>
    <Log type="Info">'Shares' elements on report '100050 - Statement - Consolidated Statements of Stockholders' Equity' had a mix of different decimal attribute values.</Log>
    <Log type="Info">'Monetary' elements on report '100050 - Statement - Consolidated Statements of Stockholders' Equity' had a mix of different decimal attribute values.</Log>
    <Log type="Info">'Monetary' elements on report '100360 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)' had a mix of different decimal attribute values.</Log>
    <Log type="Info">'Monetary' elements on report '100450 - Disclosure - Symphony Dynamo, Inc. - Additional Information (Detail)' had a mix of different decimal attribute values.</Log>
    <Log type="Info">'Monetary' elements on report '100470 - Disclosure - Commitments and Contingencies - Additional Information (Detail)' had a mix of different decimal attribute values.</Log>
    <Log type="Info">'Monetary' elements on report '100480 - Disclosure - Collaborative Research, Development, and License Agreements - Additional Information (Detail)' had a mix of different decimal attribute values.</Log>
    <Log type="Info">'Monetary' elements on report '100510 - Disclosure - Preferred Stock, Common Stock and Warrants - Additional Information (Detail)' had a mix of different decimal attribute values.</Log>
    <Log type="Info">'Monetary' elements on report '100530 - Disclosure - Equity Plans and Stock-Based Compensation - Additional Information (Detail)' had a mix of different decimal attribute values.</Log>
    <Log type="Info">Process Flow-Through: 100010 - Statement - Consolidated Balance Sheets</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2011'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2010'</Log>
    <Log type="Info">Process Flow-Through: 100020 - Statement - Consolidated Balance Sheets (Parenthetical)</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'May 29, 2013'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Nov. 04, 2008'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Oct. 31, 2013
Series B Convertible Preferred Stock'</Log>
    <Log type="Info">Process Flow-Through: 100030 - Statement - Consolidated Statements of Operations</Log>
    <Log type="Info">	Process Flow-Through: Removing column '3 Months Ended
Dec. 31, 2013'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '3 Months Ended
Sep. 30, 2013'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '3 Months Ended
Jun. 30, 2013'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '3 Months Ended
Mar. 31, 2013'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '3 Months Ended
Dec. 31, 2012'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '3 Months Ended
Sep. 30, 2012'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '3 Months Ended
Jun. 30, 2012'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '3 Months Ended
Mar. 31, 2012'</Log>
    <Log type="Info">Process Flow-Through: 100040 - Statement - Consolidated Statements of Comprehensive Loss</Log>
    <Log type="Info">	Process Flow-Through: Removing column '3 Months Ended
Dec. 31, 2013'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '3 Months Ended
Sep. 30, 2013'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '3 Months Ended
Jun. 30, 2013'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '3 Months Ended
Mar. 31, 2013'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '3 Months Ended
Dec. 31, 2012'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '3 Months Ended
Sep. 30, 2012'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '3 Months Ended
Jun. 30, 2012'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '3 Months Ended
Mar. 31, 2012'</Log>
    <Log type="Info">Process Flow-Through: 100060 - Statement - Consolidated Statements Of Cash Flows</Log>
  </Logs>
  <InputFiles>
    <File>dvax-20131231.xml</File>
    <File>dvax-20131231.xsd</File>
    <File>dvax-20131231_cal.xml</File>
    <File>dvax-20131231_def.xml</File>
    <File>dvax-20131231_lab.xml</File>
    <File>dvax-20131231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles />
  <BaseTaxonomies />
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>97
<FILENAME>0001564590-14-000660-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001564590-14-000660-xbrl.zip
M4$L#!!0````(`,F!:D0^URT^K+@!`,(.*P`1`!P`9'9A>"TR,#$S,3(S,2YX
M;6Q55`D``QD='E,9'1Y3=7@+``$$)0X```0Y`0``[%U;<]LXEG[?JOT/6C]L
MS=26;(J2;<F59$J6[4353NRRG?1TOW3!)"QA0H%JD%2L?[\`J0LID1(I\0(0
M2$U-RR0(`N?[S@6'N'SXU_O$:LP@<9"-/YZT3K63!L2&;2(\^GCB.4W@&`B=
M-!P78!-8-H8?3^;0.?G7I__^KP__TVPVGIYN&GW#13-X@QS#LAV/P'\\?_UG
MX]_73_>-(68/&K!Q8QO>!&*WT6R,77=Z=7;VZ]>OTS>$Z5T$K%-"S%/#GIPU
MFLUES0,"@4M;U;@!+FSX_ZX:NM;J-+5V4[M\:?6NVA=76O>T<W'9;9_W_D_3
MKC0M5,&/H%>-T+^K1NOT\E0[U3NA<H_`^`E&L#&\"96[[7;/KR];-[<]_>;V
MNJW==,];%_J@V]:O.]J@JS<U36MI>J_583];':T5;KH]G1,T&KN-?QC_]-O<
M>#IE_[NQ,8:6!>>-_VT\V]BA)2=3@.>GC;YE-9[8(T[C"3J0S*!YNJCQ_958
M#0H3=JX\EWP\"0F0W3JUR>A,U[3>&;U[LBB('+NCMRX3"[?/%B46#^PJN,!P
M6;4Y`^^1XN8<`WK-QX_VM=W2VZUE85:5M:-R"^&?K\!95?[.+D3*_VK[I5N]
M7N_,O[LLBJDLO4E\W:9+SMSY%)[10DU:"A)DK)[;_U#T`5;`=%?/A#MP?A;<
M7!:E"C,"8+HJ^P:<5[_LXH8OGZ;6:JXE1.^PESJQS_AW8AXR;`^[9!YMDP.-
MTY$].UO<C'O,(X1J=])SB[OL03WZH`E1_#/T1LQ[X+LQCB_/[L0\@/`,.F[\
M(\&]F(<<=TKB'V%WV`.MC0>0D5`>&3'%,4"&$_^`?RO\"-731L/75.O*,<9P
M`I[@6\/GZQ4#\>.)@R93B_'<OP:(06P+IM,,_XDQ@6\?3YCR-9=*=OKNF`<H
M3GJ=/`NZY6'D-I#Y\>3[7\X8$&K^_>OTS@0"9O`_!9<_G"W_]A\[8\]MU;"P
M.]^?;[9J6=RZHO<R5K79+A/-D`D7?RT>^L:T&K@V65U.\VJ_U%G\\WZU-Q#;
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MFJYW*Q=$$`JZGX(H7&_JW0]GRVO']:^M7?#5/PKS19[]XX+(D?XM^)E/_W3>
M^J?GV+]%\/[L4CUF?G5@`<=Y>'MV;>-G_QTYRP(#FX:JQ$6O%GRDT1JDX;3I
M%_H*)Z^0E,<#9K."$"#L#.'[U$(&<H/6-$Q$"P3#_D7[KQ)[N#E*#`>,%\$8
M")U\6E:S1PX4Q4A+0IXXVNJ*Z)PCW.6HA7QPYZG=K+IEO,&'&8O$&WJZ>$//
M-]YH+272XD\BK702:>4HD4V3</NW1UO+8F<;TS^=J%F83&R\80@T,0Q!7+^R
M&H.-WA>A_EJ!UGX7M$EF7AITR[+O50'<-TW$1L+`>@3('.(!F"(76!(BO5,2
MM8+<,+R)9]&2YH,[AH25(G#,1#N#0VS8$R@C_&FE4B<J/$$7(`S-6T`PPB-'
M0MSC1<`[R*4A)`")8\//DL-Y#HA<7!PJTE@D*6"5CP^%1JXB46)OB"L?-\J)
M=84B29:@6$+"E!X=BT2>Y#!:/J84'$^+1(OXP%06(I22%VUQEA>5!MVR\J)5
M`;P_:)0%Z=+SHI5!GBD$E`;^*O.B55%A1T`G"^[EY47S!)F;[_<<D#@V_"QY
MX@<'1"XI+UK!K)4\`E;Y^%!>7I1S2NP-<>7C1@5Y4=Y)DB4HEI`PU>9%.2=/
M<A@M'U/*S(MR3HOXP%06(I22%RUR,<A!8:8LZ(JX'B#?H%$6I$O/BU8&>:80
M4!KXJ\R+5D6%'0&=++B7EQ?ES8>7O$:=`ZS+2Q55L,8^5Z\O'S<J2!7Q3I(L
M<8*$A*DV5<0Y>6)S`O*1I*2/59R3(3G,E(\19>8-.:=%O(V0A0BEY`V+W%7D
MN`!3%IA+3RM5!GFF<%$:^*M,*U5%A1W^7A;<RTLK506RX!N$<9Y-*@A@$Z)[
M.`+6K?]R'TZVVV5_1*`OE=^1._[LB#-DH_VYVNA0.A#]/3[CNUV;6#P);,<E
MX$^(H0%DP7FSQW6'^!L(0DYV>@%R/1<Z#V]?(+#<L22([Q-`;0BP<$;7GD.C
M#<?I&]2M.?Z`8T6&IS%$^!K9+C3&GR>O8U%<=4*?,K`@ON>\^^BC(.7[NZU(
MD!;PN?8P2/E>HB02I`6LW#G0\/+M>X7!5FCO*\B<:;%(4-U4Z0.-NQ@;BHA%
M@NKV$7D">`3#6;*OX!U-O(EPIG_5D6PYL4AWZV;F5[G#S]`>$3`=(P-8/MB+
M`\N^/PN$<&)OTB&^Z/+5]V=)81;$?7,.,P=+FW;#+(B#YAQF#G;VVF.T%;H<
MY;[2FF`%&D?9K3N`R`]@>?!ZOOKYA8H1$&,\OX<S:(4#XU61(9YZKN/?;RW"
MY.T*OP9G\+&^WA'XM\=.>8VM+530>8+L0%B$1]%JA_YQK*S$RWP:#=9M#.=?
M`?D)W3L/F\+,6]CN4<:H/;;?B;1+U:9T;,C6SAV<R:VQ24P[L*4[^"B(+59:
M6`\M5,3.W5_I%?NK[\^?[1DDF-WKC^@[$'1NX*O[S"I"+OU+%MU)*PDQ?)JN
M5+]F/DUI:F6:JL@OVCB->QU08QNE"N6$@$H55$@D9D@D$G,5&40+$8Y((O']
MT8#S))(*=TI3ZV*_T"@M%%@+%;%%B^-S31#56W=4*E>I/L\^36FJ2N5R2'YA
M_=X+\9^?RZ@_27U7ODVIM]+&VFFC(GA]_!=;U/;5PU3$4V#)HRW^6K[$?BN_
MI=1::6%MM%`16[3O8MPS7GU+4JI0VM09I0HJW!$PW!&)N8H,&V08XC>;3/SM
M!ZE>(PRP@6B(MEP+>H\P'-*?D7WP@3/N8Y/]A^U*.P,6ZW[:G`U[3)0Y5QF$
MDW$S_1TB/,[P'9M66L,CR-ROT@DL[GH_Z<B<<5Z+Y,2NTZ(?Z:A^],?M>I-?
M4383984G0W\&D`5>+4B?=&B7MVR8LH;'4VN?D)5%Y%P)%'4S4U=X4N0Y>N<[
M[<.72ZW!Z+T.Z2=QEWA(1^;R1N]"$UOX.072$/O`:1"R$KN&"QBDH3H/@S`!
MR*\H6U9:B@\RE)N6DI1:*BU5?R40>=V'I+3/O%RE_D179"TS_UH`*1Z)31]V
MYX\6K8^&,RR4F;+67<^CXW.`O3=@N!Z;'[8J%#5WVV<Q(2SD64PIA))EO+Q#
M=,>9M$//C`K#4K?#A(HE-!#S<+&Z$QK4^!"TM(2^!Z\V`:Y-YLHJIR#QIKB4
M)>:?N,KZ<D-<V2WN,C=J3Z:>"\EF`"$A.5=YT7B12$R2.X]@1*,E2(O=H7?V
MRU$\29:*Q%2YA\"!8]LRAY,IL6?!NBP5SZ5CU`[AJ>A.-%++'NMQ2VK9([_8
M(8L\O,PV!N%KLO$Q\/+]F4,\>"OZEI%BW"8'T&4-UZK7Z/V02Z+;%4!>Q.8?
M-*IVX3V:07.(:9TC]&K!ON-`U[F>?P7_L<G``HX3_Z%GC7EK&4^VN`8_0V\/
M_8)39"C72A?*M?(/Y;+09&DA/,>U)Y`\0<N?,.",T=11C%F9C63QU(T\SQ0X
MT[/@PQNSD2X-@]RQ;:YG$&U?A?`;F*PCR.?Y9#JV\?QFCL'$'F)C12/M0NNT
MNMRRYYB>9S!`"?(IP`5I%TVMTVQU\W1!.=/C"QW=4SOLW%N*)KMHLB4G0>BR
M-[E%P6ZW>ORCSFW*B*%&1Q>]/:YB#6X.KJ)\V(20"`^"*$B=:7676J>M\=2_
M2]:_MI97_WJM(,9E/SCH:(31O68K13@8%&,2R8?1?`@BA/BJ?[D@WM*T3C"J
MT;B@=F0`H#%R[Q\`:$L=R`5Q3@012J)HN>IX&/$+#CIZ(.(7>2&^'/RS0?'#
MV^^`$"KB!_*$1F-W%;`O+M\C\(HL/[)=9@68SRM1FH>&;HG=RQ"-QPNAF+&_
MCW`E1"AP[,_YMX7:C?US_>+@J_@B`ZB5@F-6A4F3+-,*R+0>O3%].VQ.2Q7Q
MH:I2UE;R[8)M;!TH(TI>O@Z4J?![3JZ444PI@"DAQ]O*_[OO:LWN9VB/")B.
MD0$"S!UW2@9]@28))G8E'::LOU>#?MTFWR4#;-@>=LG\\T`>C!==OOH\D`=F
M-CH8``N]V00CL/XZTJDST/Z0:+/717S8ZI1IDA.@K+?.E@5E$1/ILD/)]Z0Y
M4:`L8(+<(096"[[Z*$N;BW=EME9+\:FJD[]WO;<=9T#+(+S8F>MZ_@VPM74/
M;^O+\S4;UM>N,RTS4\[\>(JE:E&A:\]2M2`]I;((:8MX@L0\ARM8/].2-Z5@
MG"M8JDE-7"A87RE8OAY,14O*E96B:74+*I6RE:9LHD5MPE.]KZA>4ZHKJ\XD
M<@,]EQ'N&N"?XIW#5@A'=HE$D+QOSB3@.RE<"Q(4D#%FR\@?WOIL=N?(-^TK
MO#];X-U^GB!W_)N%,%P[JVY+#YQ5EVO$8WN6`=S8_A?C"+H,U_V.H)N_(TB7
MB<I.$LY=0KG<J#X7Q8GC"<)FRPKVF$$SV!\1&"44-<8F8DO,7W[9AR1-%54%
MI^K.%BS"\R0&98OQ-WC&N_)L#BZO/8?BZ3C/0>/6NY[<OD^!+Z^C-4.0Z;4<
MJLA.E#(T;0/+NLWL39>G5S:=7YM>R#ZGQ5K0@^BDB3#Q5)PA#\,U1>ZKB$FH
MRIJ4BCIWNLQWGDH8,$O-1?4=EX`_(89&Z*/)A=8+\E#T!\?+KX]%=*OOA6VC
MTTN1@_*+Y;OJ>@?L]"^370D-29:>F/ZHL1IO]+RHN#^5#_:+Y>N#5REWE_YR
MJ-3)XIC&R%[,":72#@YBV*,O![2ZUE;L2=>8O5@=\F4U#M%B2*ZG&]SJ;,^L
MFI!\:2+K'>DHDH=)GLJ2Z_F/IJHBN2!+017)\TP95+5N-4>2'_L52ZE"352A
MT*QLG0_JR39<E.,+5DG#Q:H^$V5+#-7=#A:6#ZHJ51L+8LT'+V6`F&>*UI\!
MBM[>(*&O9[UWV,3)U40,&Z\F8JPG(GSS;P!K2%^/7,]ESWR!P'+'::.=+W!*
MZS#NT"NQ'>3TL3E`A(S9[W#\4^?T[UX1'#&3)@.@&5J\#_9B[-4B+2TLU?N>
M:Z/)Q,/P!CGLX,=PUI+'[65Y9%`YMCL>J6(L^&*/6V%I_32&W@10@9E]XH[9
M!/GPD@'MO,8^/K'KRF('U#X7.SAY_HGPVA8,\9L%)I-PRL<??U[6F.'[)*"(
M'@R;+\4F>A""4O-U_0,1+V2_-:U;8W;'=EM1.M@]NBLXI:EGQH]@BBS+GH`M
M6M?9:"=V75$[H+;@UGKH."_0&&/;LD?KPTJT[G*V7)?+=`F/-"I%'6/@*FJ1
M::H)?MT<)_CQI@"*]W+P/K1+63?'Q.`1"PCD^$1?ZOH1_KX_)R\Y6$T[5?#G
M`W_J69T\P"_))(02X1=G*H(<AK^<-2I<&OWXR0MR&/R28.?1V,?"+HFA+PEV
M'HW\UIB*%K,L2$;S/C:'^`T:]+[G+#X,.](Y@H/D(X^S.)@^DC@4CNC#H],Y
MF#Z2.":.Z%.!\RHDV\J_Z^(Q@RJ:XRJ*.IR[K=I1IP*G511U.'=9M:-.=:.M
M/FVDB2R/;>>XWD7Y]MVP/!.:=\2>#.S)U'-]L3R\W0*"$1XYCY`\CP&!U_/X
M"M;S]%S;^/DP94^SZ?/^0_U?@)CB#<\*%%66:7][!%H;M\@103GWI(J@58X8
M>2`HY_Y:$;1*%[_:#G=@`8>&,W[_P[L@#&P\@\1%KQ9\))`&502:?B'A7'1B
M5[,MX=\C$.5BTUNPQ2M^!RRO)-Z^&95;K&5#(@)4!#R>@"JFXXZ`]8SAD@BH
M8C;N"%A!C.:[PG.]5SC^V=;SGS?U7B$'9QP3@Z[W@>=Y]UFQ8]"T&\/GO2EM
M3@11O"AF/R(MKV59_LEU+:W#D;UC1[M1L]_)KW_:\H@^'CJZ>=A=FE-/5Q(I
M[;29\N5VJ!YS=5B+0.`J3*NV3&5'4**%'K=_>[2U;#ACX]4G\U7X,9G86/"(
M-*Z#6:./#3'4)@XU(;J'(V#=^JU<?7WY:LVB2U_W["'LC^?:"U9H[1(&=EE9
M03MZM='3#!]/5O*H\=ZZ[534H\78&)DWZBG&"<"X:+*EG5>RQ4]K=Y:'K)QK
MU6>5-O.[G72G@9PWM7Q42X\<6D2]-%\227\($`T#VWE)1%M*A"6A=;XDHJ63
MB.9+1"_2_/:=*2)P`*;(!=:=A\U[R\AJCVD$KP>2UGHZA_M?'&68DP54(TN]
M04XZ(M-3D%/K-?6<=G')3$Y%.UE![VE+T'G<:T<TT%/LUQ04RVN_IL-`;RU=
M.8\?D84#/<WG7RW/!1R'@,[YS`&Q0*_FF[^FM5N7P8].ZX*W$)R.2%N7*6Q?
MI]FZR$\B/`@BNAEET+_\9D'<P%>7+2PB7F1E\;T-U@N6A)LBN=VI#-H>T_6Z
M36Y<?.Y?3%]Z($]H-%YCO[R\VK+J,*IPS9!$"60@RJ:<CAMB<LO98D^!2D7%
MEU^VHF(**J[DI*A8&!7'M&N*C&G(N):4HF-1=+RS/:+8F(*-:T$I,O(:,8HQ
MN%"A8RV'.\?&F-*1M^[!IE#D/3HJE8^^M0]/12+PT7&L=/RM?4#+"7WK-)[B
M%NMB!R^/%L#?P`1&]Z\98H,U:@;9[9=?]/?\3TCL;4NT=TX5F]\8+!/J,`9P
M"W^ALYA2M2",1-;M<?;B5<P*IDXJRQ,4R]?R%$O;O9L+/[AC2!YIGZE$IU01
M'<5W0?B>JFG'[JV<0`^EA*)IB;+)5=KDR*+4_4=*$=N;KC-5XI"LT-6L'-.\
M%%,<9852.4%&8V(8WI*'9K>3J67/6?N&V/2,0!W83ICKCKY`G'&`%IJ37$LK
M67G`F@6UBB=*%V^?,E&XKE:J$D:4;:O\O0MB3/&M!6?9C=1Z#CW71NI00J01
M5EU7Z:6>T5^"=<J7M&WM?+FS1!E;!BK2EKKMQ'FZ;2?.\]IVXCC2*ANJ+%C]
M`ZM2.5!L1.4'A"S[L<+V.YY!QX6F<%_V(UW)`&>TPW7[>+X-\`^YX/TA#;C+
MB)%VF"##7>P`^QTCUWEZ_KX&G/.][;/CO`KD=O6\"(.L%VV0TT):7QTN%UNA
M]5IA+TR@E=I4:V*<1\([MKR<*'(0"3C?V4-,$E1XN&H<"8)D/82A8^AD\NZ)
MW9?"L^\$O_XNH&3P.3/_.\&OO^DO&?P*#]ST7AUD(D#FS\"",6?91"0AG/%/
M[-X1=*BG"SB4"((X`M&(4)T[.)0(@C@%T8A0G6L88L.>P-6!'/>VX9^;N#&=
M"4)V,/4-(M!P;>((YR%V]#+SK*986=3-41Q)"T'\A:"TJ,YM'$D+0;R'H+3@
MUXE\L_%2&I*ZCBT)R.8P8BD@E3THB0)\6H'U]P8(B#%F)A'.H&5/6<G;]RD5
MN82F(?0-8I]89+(7V<@B2ZQ9.5GX##NSD446CU,Y6;AV0Y\AA@185"A]<X(P
M<EP"V'1:Z1U1*L%(Z(I2$T8V9U0A8;AV1ZD)(YM#JI`PU;FD&_@&"8$F.^B:
M]C(0W7K#A]^1.QYB$\V0Z0'K>0P(O`8.-!^!OX36N9X'>T3$5A,SP/8_B8N7
MI"]82H<-U<.RK)OC*X.6?=-$[`*P%!\/YN.F$!41\R&B(-&:;$2L+K+;6FWZ
M0M'PA<F6<B$\>J;XFYX5'B)R39T#EYGN[K8@RQX.`5,,S\0WJIPXE8,G/7(-
MO0`SFPK2:D;A1_^QE4('?VX=/',@\J+LIE@!!7:VR[<M:V0R&*0-_&JS=V$B
M5;>.F5%4%8JJM=UF,\COO=!ADN>.;1(^^OL.FBQC)XJ#C.])!J0C_>7=*6:%
M+W%GK\A.Q.)$PB6AG:HMA>YR+&@0?CPQM[><4\2LTR9S@A"3EAP0:")W``B9
MO]F$?1=8/1(_S4*YS.Q<391SAN;L0D-.AYX/B97E%8;-*F#A(V!1BJ<43P5D
M1RK>`%B(0H@1\"<@21-6Q?9;_``F'DZ5F3@*?>7P*R>JK)D*CHBJ'.0V457F
MHESNJ@S&+KHN[M[9!*(1'M@>=LE<!KHMZXCK.>^01IR9UBX!H6)LLM;.RR;[
M@N@L)7+1UKB32">=1"Z:;2T_B5PN)=+C4"*7Z232RU,B[,C!\NQ:1HGXY^&5
M&<E$IESS9T=2SSO.U8[H2SNB\V=']'1V1,_7CNA+.Z+S9T?T='9$S]>.Z$L[
M4LY"A8P2265'"MK$$/[MT;;>SNC_;>YNNW%[8U24>,IVGRU)_!-B:(!U7-K1
MV@$`G5+,UJ$!ZK%G26_U_;BA4`)`V0+F6!B+&=QWF&7?3^5.=@=@0G1U8QO>
M9"$&G]-WC-/TWTEC4?8)ONV*O`/=I]KVVX>SS0K7K^G32R:[?&>!4?@]K6SO
M>0.6`X,71:K<[E`P-_(V$$;XC7JV-X:CC<3ZMU]_AQP#6'_0`?,=O>*$&]#.
MWH#HJS?J3GIYT,*MUW>RO?[NC[B7A^I>O_Z%`).MX)A/7FTK_,KS;*^\^='_
M=_#22(WK%]WZVO,$1_Y*;>RR92?A]UUD?-\?W_KTE8V7V\&7;P_W#Y^'M\^-
MP</38]"(N+=MMF5`)4.`-<0F?/\-SL.-N<S6F+`)3JQ__?J!1TB$$C&,[V9K
M03-,]Z3Z-P7P.[2LW[#]"S]#X-@8FD/'\:@!#C6CEZT9W^RP`!+JW\(A:.X3
MG-K$7TWD`C="_U9&P_8'="(XQ-:_V8H?MN5A:JWG=\B")/+ZC/8N*H2->C=?
MZU\=4'!&-@E3L)71Y/4-`]*::$5FPZ\SW(;(2[;$;T\F-O9GQ/M+/IT'SV6)
M'J;$X0;M,8$=3=<I:4UHH`DU^!]/AM_N3AH>1D'Q[W\Y?N74-E[HW?/SWGDW
M@M&.1FPV^-%[I0[[SK*!&V[?7AMY$6V?%FD=<OZ?O3=M<MM(UH6_GXCY#Q4:
M^80<P:8)<&E2&D^$%MNC<SV6KB6/WW._3(!`L0D+!&@LW>+\^C>SJK!Q7P"R
M0.;$V&Z26*IR>[*RLC*#GFG<__;I'0)COV^,!F:O.,+"6^6`4K?BK15A>!7_
M@TTU'RT/A"UZ+:.V,/Q_65Y25&UCEV45#"T,]*Z[<:1PI0F^#BP/#AK-B1/8
M8:K-`R9PWQ^-3AW_ZT?+]:RQQW\,0CP=\HG;2>C&+H^4YA?'OLNR'S!V8S`P
M^[W2Z'<.Y821[T"$0ZAN&/=]C"B=,'+;QKAS]"NW.3`)[ON%QVL&O0L_#B*W
M>5\>\I8Q'#5:<P?.'$1B\*".'.W'D,\MUU&%;$`9/L13'KZ.(AZOD0MS%SH=
M,NCN?7G0>PSEI+'O`+E#"&YV^N9I8]\XREW._R$4'IG=^V%9,(X8T0ZL.TA0
MS:$QO-]W1!_#`-:F@(8>.-5`4[318DL1A+DXP`HQ#@8W6&+LYC$<-]HJ`6TT
M6%:A?4?[4Q`X3ZY77(69%<*5V;\O0VWZOMVCJ!!ZS-Z2B5D_BKR9WGJ'X)?`
MMU?5HD*T`6PO#7/_`54PD6Z%0#3H5S.1@O5</^8*<<@<E0W2VG<?.+P*H:9W
MWSUT>/+7XG@J!!6STQLL+0/D^W:-H4H8Z8[N^WN,07E!'ZT%ND"KT-:M$#F,
M46?)R5W[]D-'6"%:F+"&.&:$8<*=GUUK['H;5@O="H%CN&:0ZP=PQ#BK7-5T
M<-_SB(&F]:Q^Y8_<3]:QO$I@,<PR`*Y_^X$C[%6)&/?#PT>XE<N]*M<H`_"A
M2\/;Q=[M0ZL0%]#>]`X:VA)EUR)7K\KEA[$$71L'<,0X*T23OCD\:IP"B0M$
M7S_0"B%F-%CC"JP=P#$#K1!I!N;HJ($6+BF.K,HPVK!K#C=IS5Z#J71Y,C('
M^PT&0]9N+`HCHA<-`W#]!^[;2X,#Z/@:N2]]U_O^60QHM!?AUH].[G:_A,>5
ML@&>NNF>M_'=__?/G[$8V\RZD]F:-KSONV/&W>\<-&ZS_G%_#)4-$+L$RT'I
MOJ$;G7>,UVP8?;O[CS=-FTF+?+_UK"A:4Y(*9.^1A[$+CF[YY<MIW)><=^\B
M\SX#OPM;;BN3KG*+:@DAEU^[_Z`J1$-C>,B@\F*U'RW7>>^_M>9N;!4C9/T*
M\7`P''81JXOKF/4#.'B4%0)EO]^Y7W(I]ANE;2>SQ,-]:N&"8`WAD$\QX>N1
MRV,1/P=1]`N//TP^6U^+HZ]P$79G]):"\(<-JZHY#2I<MMWU1RL[3L?/Z5<>
M6Z[/G1^LT`?_("H\#'QQS)<K3J/"]=U=OV.:1CENLWLPIPR^PA7@7:_;[XU.
M&[RP0M/`<W@885PV+J:%#*I<#`YA45!>KZZ^^Y"Q51E.!`5=<L1WC:W@J(-?
MNWVD5>+;:O!UUTB.'W>5$+@:L#ULW&77Y:,5?@B%Y^,(!/W(0Y'(4QS]H2"Y
MG$&4#S]+)NJT.YAF>]B83IW'H3!ZB7G(+"IUO/`_W"F._T0@3<>,:%.2G^TC
M.'*T]R="9&VC%<F,I9&>B(*9+&P?HWSO,>,[$>@J'M_Z-,/[$P%NST&NI!<>
M,=(3X:Z.D:[7H&UH5_U:?>>$>]TS6(UM2%G].OU4)I]F=[;AZ@7X6YO]VH:[
M^O'T1#NX#:3U8VH%]G2X#>CU8^_&&1=B27LXD\-#G8;#G<D]!G32#`YU*\X[
M@RT@,:S(U^@JWW)]0'&[A=]SI!7Y&F:5(UTQT,,3E]6%$R+WH\'V4:ZSKGN,
M\,0%=#I"8P@C-"L8X093>&(X^1!"[F/'MH[UQ*#R(23=,E8\:F=C=KW(#RB.
M[[`C;'MF`(Z68M_+`]A[>*-=R]M.J;/@GL,;&,M*?NSP=L#34M?A/4-/]\;H
MD/&I+W\,@]E/>)BSN$\].NR<W)Z;&T:WO#VP,H(#!K@#9(YB<'?4'54VP!W8
M<A2+N\:2!.X8X,^NK4YI?.+A(WQ8)XN''4G>-]`\7$[9VC"2(P:\"VV.8;UA
M+!TPJ'+`.W#G.&WOKB3%[35@]65)5`\[%;TO0<W^\HZ-?//N\>S`EJ,8/+I?
MHM>^PS%V%8`XBGVF,=AS/.LJ#:K35\5!'G::>D^#W1%'F,K''#8/Y\B1[UKH
M'`75</>@]I'OP*"C!`-`TEPY6K+OR'_B/E9HARM?.S/7%U4:8O>1KQG[8;4O
M]CT+-5J*0NX8T-&CWX%91\F,.30&O;.,?@>`'>G]]9=T=:_1B[)"O_F!;2=S
MESL_6C9N52[6#/JPXAU[&F6U&;U]%$MI(3.L-_$?T1[[P^2]#RN7!PQ,+9_#
M,785^SC.;B\=K-\^FN4%02220]6T2F.M8SEU?W_?75Y/E4>P]_AVU0HY2N%@
M>"L+JF/'5\>":C`REI).MH_OPQPKA<`J.L\"*@ZQCB75W6#0&Y8756M&<=`P
MZUA8W0WN^TL1DU.'6<?RZJX'1O3^L&&^]Q]Y)/*^Y15@`G@(WQ3'6L\*JTS/
M3>,X?+1U+*_,)46J;K2UK*TZW:-&*[]=Q<Z=14:.(FFWOTS3TOOW'MP.Z#F.
M@J/^_?Z#$WF4OP1^4%:VU;'N*B5RG`WM+F6M;A_.L4/?@5#'V55SM.:@5.5#
MWX%<1TG(L-L[>N2_\'@M*.PL*7(DQ-Z;93>E]/X]A[9KJ^DX6!V->J.3A[8#
MGHZ$TF%_J=S`EJ&5=X+?N8]8<=6)Y.79[O3[V=RRB\9_5X61H_@][`W*)#UD
M<%LHGI6"^AP4=F!4)N@;*W+MXLSJ6&W=W?>-X19QV3W"RJ97!R#NTH8S3J\.
M2-VE48=.+TV<3[?ZQ2488W*])"YN[QJ[ZJ9L%D9S5T;"7:?='>83VC&FHR=P
M-/;N,X&>4?\$CD;@O3@P.G("OW/W80K?OGX$S'[@OR28#/1A(FXL;"IOF5=5
M@)UM=X\&YE(EI.,&6?5$JX+_;*+WG66<TF.B53D3V41Q&\FH?**;CF[]YH?<
M\C!-YQ]@.>$I/UFNC^;U@Y_7;GP=NA'\]`X^^@^R_O/J*31C5T6;(S%\*8Q2
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MOOU#3AYMF^"&"BC'L;0[&`V&%7*UO\T7.&B6N^N*'#?CN_M>E?/=Y@(<,M_E
M`AY'3JYK#$:]?H7SV^$<'#*XOFDLE5S9.;3-1T*,_C;`K]TL9O$8HS]8GM2&
MUC*8U(7'==!T?)@4WOH;#.J'KSRTW0A^^#!'Y8[^Q2/<]OLPR4MIRXMA#)AS
MD_T.`N,MTMN=].YR62L#:VW586S7TFX9/NLPN9>EYN"\T'7]!#WD</E)V'AD
M`DPG2\L\*XET8,VP'ED_"-^O7P%J<H8W>Q573])=5>_($NQXK_1CBA2MRK??
MRVO8?2"^,SP_,R11UCC0\B!V,<(O^/;#;.X%"\YE68$DM*=6Q+%+3Y&N!U3I
M;81S5AEA3B@'K*N?51EMJEK^U.0R=<W5E=ZATZV88C6M@;3S9"HC6$W+G,LZ
M)951IYYCS.=2&PED&Y]1POU:`]"'I\!TUL3O#I_@+H\*7('?K5!4$5AQ+0\I
MFU4?0<JU&G;X0LO3.6'Z]P=T;6@*+!]'B,J"W;5@\,@P^^<4BYK<6.WP]3CJ
MU.3+ZKK"WT:*.K;J0=A'N]:#)PC[RF+XH'JG9U@,#P<J+?2`Z2RW=DB38Z+/
MP0:+).X;`X0Z.!E009%6\RN'^45NS%6I%0G`OW([>/#%4U8DH";/\N(KWG/2
M\/[Z4/@29*S*N:T'PU>.*-5-FLLQHJ80N';NPP5H.ZS)8]=C)7].0M:1ZGIA
M'3\PT7)XK='J0^EPQ<'I0TEQ0ONZ2B%5)YI4M3XX";_.E>5\*'&N.K*\J;+`
ML":/_>*6<^.$:\H=T<%$;IQS76ZL3K9PT^1'-?F9VOKP&PE1561X?XM60QV2
MK9G!6VMBGVZ^#MDTZU>8\#PZMUMWX6,)6PMS5VN@#JHM/S#O*TS3WUK5NSY+
M=(AF&EBFO[H)']*:ZD@#=-"YA$&_WUNSMWWT_';MOA^R=3`2-2,K.I>PM7QX
M[78QVR3O]P;+K4TU/)>PM;;YR<0ZZOCAKEV4*\KP7.*&V3GSQOXR?ZXM!]G<
M6H:^4G`]3M1'_=X-2[L.^0K7KP)GSWNX?I+643P3;$'_=FS!<CJ'N;6%POD<
MD;S,E^IZT?3##6;GG*D>YU#]R@ASYOR-1M'F;$D91]G*;N=^=;EXT<,-9D>'
M[(DFB9AQ]I2(1E&GCO+LYU.;_0\WF%O[D%P`^'MK*F2<\W"#N;7CR65",N;]
MV;+83:.F7`8]8R#;"%%9R+P6#+XW[OO=,XI%36ZL=OAZ''5J\F5U7>1O(T4=
MM?Q!V-4.Q5D.-YA;F^"<'Q3-P;!S@*Y?]G"#:=;D65Y\Q7M.&AK7A\*7(&-5
MSFU-^P^=7O<V3C>89DUA<.W\ATO0MB:778^E_#D)64<?X4LK^6&IR:9YK?'J
M0^EPQ>'I0TE15PF\0T%5)YI4M4(X"<"T+$5O=J\ZM+PAY5F\]RH-Y\8)UY0_
MHH.%W#CGNMQ8G4SAQLG7=<Q-5Q]^(R&J"@WO;]%J:`"[+;_8W-JM['3S=8C_
M/"P?SCLE;=KLGMNKN^SI!G-K9[!J#=0A![[[G7NSNF1_<VM3K_HLT2&:V1]5
M=T;'W-J:JR+[<]"AJFZ_-ZJLLX&YM9]6[;8GVXD>FO>CI1,;^IT@,'MG]L*6
M.S%=77;IUG9@E9K,HYI:&<8%$B-U25GOZ>"!7K\&U-&,[:;D=F5#>6NCN),A
M[?"^V*J$;..SJWMG]N?/H?N5T>9LOO]1!L$T>ZL>XV63B.MJR:<=O%1%L*T]
M_?07C`/29"OKZU>1`5^W?#XV37:OARR9_-=/5NC\%);C8I4U`ZR(2,::-??!
M\]M?8W[A3^*7$DEJS28^2K_6G?7?-:,3B7"V&AM'$F1D[*5.E=)$AVX<NF#-
M6@+MZ*U\+*M'=;%:VI&U4ZFJO5\U=O%^U+_?RP8LS6A_?KX-_$<>1J"IN*C`
MOV-W[/%/W(8K8[=,G#,72=-%Y@^B464![EH,:*]GKJO=<^S$ZZ'A0(?:;$T4
MOJUM[YHD,M*<'33UJAS:?8W13MO=6[,9>O1,RU1[Q\?Q>Q"F,,'9%&YXPWT^
M<6W7\O(G_LBM.`F+4<.ZFM7MA7EUZM&I=#GS@;HFD:8N'_A0E-.91CH<O&L2
MO<Y^%*])Q#G`US[SS`ISR2S;._?1=;COK$LR'=04J[TXW!Q*B'-WH].:%C7E
MX&H%*`<318<Z;UH3Z.PEVK2FQ@'^ZIFGLM?!J7Q%E&YLOPVBN+BJJZQU73W1
ME#MC:9%WRK3K(6`=H=D:IXU>4^X6*86`.S)'*CTY_R%4N0KRD49QSGK%<(?E
M/=*C9[A_R$C\IF[.4CN*!*HICGMQA^PDHM3DI>K@G)U"E[H:LFGEJ)U$H+H\
M65V=MI.(59.'JX<#=Q)E#G!M=73FJCG7/]0[_P`N[74.=WV:6`9D:U>XIM+O
MP./1PZIR@4^RY7ONTI4K5AY^='S3$<IA5>[T_C9ZSR.4@WNS+$S''J$<UMH(
MY:",RD&%1RB'Y\M%.&"*@^%05%FI:I:CJH[8'::DAZV7AQ7.M_Z&;0=-KH\U
MT*H[4EAOL[9]%^WF`!:$>S4EVFM.5:66;EQ,'IF3L'U*[SC(O^T*M'WM.Z]G
M01B[_Q$?BY/;T>/A.$>A:Y;Q;,M8CAIT+?6CS$Z]@]X1S#NJSR+PIWO<H'\"
MZX%`^\'_9'G\P^1C&,QY&"\P7UU(\1S%N3C^'9W0C@Q&EFWK?J,Z=29UE$Z]
MN\1$MKD(QXK4W9);=LQ,`(Q#+D2P('\?)N_<R`X27YQA`V,X<Y-9]-Y_Y&H)
MD<^LVZGCP,O=R%R*?!\US*JG6D<)_#L#I%S#N6YS#XX66,.X-ZN?:^G6'UW?
M\FW`V*4MFFYGFW-P+/=,8\G%WC:8XX:]`_:/`Z/AO7'DL(7+_DO@VU8TE<[Z
M#U\Q5L"+8]Z!^D>->=A;TY)^W4#*XWV31.!\1]$/7]U83,<H#K2.;;O14I?-
MU1&L\6C?+(==BJ.L`\]70T3KQW'H6.M`[-6"H=6,M0Y0[AO#PX<*\AMRN.0=
ME_]][X-A%`;P5VYS]]$:>T7],NK`W(%9-LW[C.FT6=0"I\/^V>=1!U3"-`:5
M3T.&6Q)8V/KQZRCB):#9VN7E^.#A_?V.::P.ZK1IU-$*<;13IJJ>11T(>B><
MZJ.F(<MBK%R>'Q%^"R@,SIJX7][X8Q!^@.6'A?4O7MNQ^[ATE*1KU),S<U\L
MY%'!B&LDP`Y</PXKC>;,?X>O<)20F\HAKWC^N\WP1VNQ#`P[_(LC+6I_ET5=
M&M'Q$S!W^!E'1N_V!;;3Q[_#PSC2BBXY>"=/0(A@)GD_N];8]99U96O?CJ-E
MR327BA0>,+A*9E7'FMP8&;LDK-Y)U;%BOS.-P5Z>U#&S>J=V.W[EC]Q/2AI4
M1W;"7>_^?I<CLC2D$V:PP\LX3L1Z][L<PNHFL,-+.$J<NGWCI`G\PF/$SX]A
M@&GSSIO%;Q'FUF['>W,'WA\G3/WAX+X<&=I_<%5,:@?('[>*[76'G96RU>>;
M5'<'\!]GPGKWQI)E/G92`*QI*I/]9^*&_)]6^(7'UH93Z]UN'0?VC9'9Z963
MSO<:UXE3V>$('!?&[@R,I3+IYYC*#O0_+K2-937[)T\E#&S.G>C',)CA9AHL
M%/Z)1T?=>/%A\OK1<CV\&Q8,^./ZR=6R7=\SP:DM3^ZXD58^W5HV^@>C[O!>
MR^G6D2)P?[]<`[Z:V2Z+?VE?&!ZY9L.ZVZUESV&P/+^]AU;%E.K8FC!'7>."
M4ZIC!\.`FRN9T@9TEQNYFUR/K97\CW<2C6[?W,?U6#.X*B95RU9'=P3V\8*3
MJB5%H-L;+&4:'3NIHO%<6]&Y.)<Z-C^&G6%_L-&>KQW2"3.H8]\C[S)]CAG4
ML><Q6DFOJ60&Y011F:4"7W#X<65:=6QSK!8+.VZ<^\PU/2A;G-,!)6763+'.
M0U3[S^&PRB_+^J/''`XX3+M&@\XUAQUG\KJU%,TVEB)<.P=TPOCK@'=CU.^?
M;0)U0+FQ&3F.&?Y2_?'NUCK2QPK-<J7U]:,X=*1U0'.WLV5A?/1(ZX!@H[M#
M$=>,]%<^5XN.#Y-?@IBOV=S;50WY.*5#E2N-=M-(]G*@LT3*M0[TUB+(Q^?U
M]7N=\I)T_\%5,:DZ5MG]4:>WU_*MICG5L<R&FY<2,(^=TP^3";?C#Y,?OMI3
MRW_@OUHQ_^"K_`;\#Z[/'RUO*<5[4`OJ+IV//61LU<RJ%BQ>6I*>?U:UK+7-
MRJ:U_AIY5'QY:[$XK3HPW.CWETZ/'#*Z:N95!^+?F;WNDA4\_\1J6:/WAL-:
MI_4:[&H8+L"$+E5?Z`YVQ?$/\<B,4<_88QY+HSEQ`CM\B,YASF]_'\59.P&1
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M>]^\>IJZ,;_#$?*7?O`46O/L.?/T>O6B<1#'P>QE9QZGKX:'OC1,^#P!6MY%
MP$H8:/IQ8LU<;_'RLSN#U=8O_(G]&LPL_U7V>+PH?8.XX8F+F8P#SSGD@?)2
M?`Y,(`3!?(5LO8M#RX\F\`5\ZW-YU:,5NI8?OV3J0C$6HXVC^0XO2(?VW3S[
M*W;V(N:HW^X-OGEU:[0KJBC;CXS?Y>+YG="6[)-2L/W)-\@_;M`).1W7=\`D
M*(%?HLX6FAY`0D5^19H3J+HR7C&\=PO?`EQFG[D]]0,O>,``QML@G`>A)/V+
M_[9F\U=_'9IFY]43;V6?C%>L\$N0A)M^2J)-OZQP50LZ%<E2''@0LGC*B^/'
M8YF6ORA<]&V+6<SV7-^U+0_>;SV`Q7:#^=2"1]L\B?%[@`=Q7PO@[I%[P3QB
M\S!P$AM\L3B`OS%O-F:6[[`88"QFKH^K:S=((O$E?/2LV<R*@W#!'#?"Q8S\
MQ<8-E9")2FP,>/<93/V=YW[A#(_ZS>&&$CL___QK<>PX4A"`A7P)#$:F@2]P
M4#,8'Q9>$B1P?1__=&>SQ.<L6D0`C&WV(0F9QRTGG0R.QD%8A2LC]H\?/O[\
M_M/K?]V]049'R7R5S\/^-Z^8J*^-Q!/V\"6:0^3'YW]*&P`WXL<7X",$[`N@
MBL^LJ,B3]#U+3/%AT&+7_\&2=;*8!1.*V93/X8L8!O@&3+`-6(K38Q^QK2?K
M9JQ,.87XW]YFC?:S+IWJK`M.TQ]'\Z/&(4#B)LS<>Y`352,-Q;DLC9K:H!9[
MXLP*.;J3J%!8LBH32-11+`.4?@:E>PBM&5B0*5@,,#3H_3(PRXQ_Q90K-Q*"
M#2J?JKG4V!5E!??=M[W$05<SGHH;K(?`=[&X!+X4OW#]J3MVP9Q$\B'9**3%
MR\:2/@F'825QH"R&^IW-K3#V>0BVZLF%5_WD65^#3S/X\_]XJ(=%4_73I_]3
MUFCQR"B>SBPT2>!;"N.ZZ=&O(Z#Z_^,^MRWV^DWIR86?EFV&(]ZBC*H8>R#?
MM4C?TV:_`XO0%B&?+%CABGA[B3,%TU&D#%S]1P+7QRQ.H7>1$?B^Q89R!*.4
MV""YXFT('AQLJIC76F`!!&\ADPO/+?Q@V9;#9T`JW(!WXT1LI8I7X;K'"NTI
M(%WN>HFAJBG@S"0!T$DH0!5"XS%()2;TQ+&OCF\KGP.WEWWV%LP_Z(CO6OCI
M=?*01+%DCS'HO#)&HP&L#F%9(_#(MV:<O0L27!_]@WONUZ(#(\D(FB0CTY*G
MX@Z8P$[O!U[^"8!3U'$KOU^,/>3+`W_'/>O)$C-B&'+=M@+8TT@/#S/2G14+
MW2B__U,RCES'A9_@L2<3KPH__CCR:85]K^>AZZ$\#@2HH#GP.$HLJH]ERSJ]
M*._!A/TZ!:'6&!;9&VG:V$^S\3]*IER.O.RR%WY.E?V'!+.0E[WVIRDXRXL[
M\"B!+%$JA`NAT_):LV^^BB+N.4$X:;&?.`S)!Q0%\GZPXP`,!,-`EB`PS@,>
MD[[QO1_ST%>>9XN]:?^KO>.5KV?@5(>.-6L!,='F>F#%HJVN9[K(+10ZJCC*
MM50E!_QS=P*XX\?JV#+64X=WV*"Y:R-CAQT)I<C8#DQHLI4W+Q@9:SKM/B7@
M4H&9`%M=T$&6*R%+M5#[N%G#?94W5N1&R(>B-26GI0JGY?-4K'L59@$^3E*(
MPD6FPJCR`E/5SI"!LVD`"U[@#/ZR'F=!/]KLM0?/*RB1BTBMXG-+3\2I6+9:
M+LT"N19B,`R9]#6U'@&#./<9K$!FKB\''08S<=G.J5005;JQA<+/+KBM#L8G
MD3V9!P/+-U\%>D@1*U!$6.4*T095P^I>3DE=@O2\/0-7,5W;^QR#K'`+%MAD
M$R]XBJ0BJ*M1@2)XG%1;_&,NHQNOA2U]Q^VEY787G&IT"X5K/;4<\>"6?#PO
M9+WARV?9;C"+\O.W\-CGQG#4[NF\KH$7>5F41U92\Q8,@]8S&7FW8DD`(&V4
M3+!%,09?!!D`?X"8M@S+S#B/I4D$XV2[<V%TQ&4^ID_#D\(@>9@R>)['K2B6
M0108+#-,!I8MGD;Y'L+AM/9AB/"KM8.;XA'%$8:R7HA\]B21-?J%X/"OKCBP
MQZR'D"M[>;JYK"+X?07:C?%A.T:YP<69BS5DX.]HSGT)EC'R".PJ<D1$`^$R
M7T3Y?!F$1.DI!CFE:/C)!-!2--E*<7@UUMP2@5K73CPK!%EO2%A^FL"C\Z!W
M#!=Y$:[Y-\Q22GK6HH59\SGXYU8>>96!8R'8*:WRX*V(,(B5:IE'4W`YF95E
M=@OC.+,60L?QRM#"F'_AM8*!;?9Y"CXK7AC8-KY(&0,,@\?\P;5AB>VY.!PQ
M-!@H]E=!W<-#9`_*\8*?OH/Y3A+1%7V>C.$Z#+?,0[`08*PF:>HYO/!3;JN6
M1H./%4,.8G"=F)76)4`;`LX7X(+X!"[9#.8'CP>+!:,#BDS@46".Q*N$7&+(
M%1^3/P,D%253#G&%.@[WK$4+;`[P2NYJ1C;@DR`_3".)A1T#ET;\E@MFML.@
MN"UV!-;'^&&5[V%X&XPC_U*BKXH&/?(JS-AM>7V_2;?^!X6*FH2(&V'K<4DU
M#SE87"N-]6Y85*&5P5>@<RU,_&_M3VWVP'WPWV`EI703%,G*8PZ@^?"DN0?3
M*L9DQ9T_O7[]L91I$')1#@+MD&])FR(<%^L+ZJV*GFJ,`3P3/^GI1,E,GDF4
M7IHECD/(X/I,+B&![D&H]HCV6A#*)]MJ+8H4]O$0&7C)@*IP)5`O\6)IR1T7
M7A@R'!%B$7`H77B"MF1CO9RM*=J*`U3G0B;FQR"$%_M,5C.V%^PSWND)I='"
MVER!TXGB[Z;[MUX@-J]3<H,A&'.%W;ZMW(7LU]3-<HM[*H7=DY;V&UAM$:H-
MT?OQ8+B6S,*7SE9>%A1H%J1A)+`9$R64B@YX!;H\L1)-<1$03IA;!_<QPH@E
MD9M&J=2Y+!:*="R?<6FA`FF,QI8G'+YHBBM'M$EM]FMQ-<9E@XR5=Z*M>P10
M>%AZ1212`\`3DP,0'F:02(NXX%;8SI4KSI5+I$2D'66`<E&V`)R+$SPBY4#^
M)=)BIJ`XN$@-F0U^G!M+S\[*NP0J[\PN]@D4J08SSEY@Q.+;U!QST=.MS7Y4
M67XXR(C!$@AW\;8$)#`'7U`HV_K+##TL$9(L#9T]6*Y`W.>==C]=Z;<V7]-+
MKU&KY.)E.'!U63=_%.`!KN-@AMX"N5=XIA(N&:&1N)%1UB[Q(8MORI0,C*VN
M1ZP"3J''G`5VJJ5@<:IF@6IKOY>4*A+17$^=UGXTP,=@^L]^TR8__C`C^%:$
ME?#?[(>EL%)^H(,52N@1\E:,O.`GLBF\#;Q%3X3258JL%.]Y$MI3$0,4"P`+
M0Q`N$`NP=J8*":(*@&WG7&.L3<.9`>8F1^G>D"6B,^AER)D+W<9Y(D;!0@:N
M!F?;Q0AU"(@#DX[!:DB_9#D2V@9YS=8P#L=8!39MDL[_?!X&\#P$7=L#H!=Q
M\W3QM3Y\:DF4!)]=+'13/HBHL&006J9H"B;R#E^&,^0+]3`9#&FI]5H`T.S+
MD-R#L&_Y:]0EF+47)>&B-``,WR6^",MZA1_$",;<<\$Q4$N+>#&7P?6BY"!V
M@#OVAPHJ`C7P2)>"Z$+<F`'`?Q$/=0(1NLEG9R4RO"B\E6)H.2Q^$ND:,2Y)
M!=*-%VR*P(X-R1Y@PC#']$]P</POP)QQ+*)(XC*)^(`D5C7FFZ+)^5Y1*NLJ
MVQ+W2$->$!*&`#\!5`UPER`+V=W!2^\B4"MF:6Q2T,O(@HRX&DED:K7:LBGN
M<J5+>.7KKQ`'37!)=:*"8L,R894P13U%%]@*0U?ZX1/+#3%7)N'YWHWKSY,X
MC4G`Y<$XXJ%H^-1BW)612^",C?M,`2ZITD\MT&![BN/Y,PG0."J5!5N&>TPX
MZ\@%@EM%A7R57JRN`IK(VPHC$"%:X8>)[#SIGV\>IO#MI:4&*H;!6"7:@JX7
M+E*#`S-NR:'ENQ8P,;F0!$H+:RDPBY<LH0"X)3>\Y#(7/>&#5Q=1H=5V&@,S
M[E]E*X[-GCK^Z8@\<DE,P=P6<R=,'![Z(W$>Y(H'J".'`A0$7YW/,!\9$X3\
M=;JU)$+%R8DUM;3!8A9!F*[\<-L`>1")#8K"(R(,D;N%_4)!7?"U$>J8BP8B
M![T9!XAU2HB)JU\QVZ<I5Z'T?,:"=;E<EX!F>1[K*""V3E),1G<_?8F5O@:'
MON[.5C$RF;I,$M3!;GG!DU@\@"0'8?1R&WJ<.V=QU&N;]^6LQ7[[OGMRXF*W
MW>U6D+@XJ"KW3MWPW]8\B%Y]6LQ@_2+_7GY\?DSJK\:PNWKF\(BTPT%[<']P
MVF%E,[\8\/VNE$<>`<ST$+Q3F?>$UC'=G\03(.6`!?!&9N6(`!YXIGFRP:LJ
M\Q1)X4CAKD3A1&)%HG;KQ/98OO"6(?#,=205(A4B%5I5H72GR(^S"'%^J#U+
M[RBNP8IZ)LXP@M,9HYN(2Y=9$&+,Z`L7ZPIP&/'+-#'OR85%QIBGF]O"-8\X
M+CS*@#GFN)D#E]D(@XMT26+)3NJ8JH=N-CK4I-:DUJ36&Y!1!11E_G&KD$-A
M9PG@,AO9"F6@=!X&8A,H2C7.C:*$AZ_$9:1GI&>D9^OT#(/\RS'^F>7P[8=1
M:SE=1D%V3.,+1(9&2Y1BX(5S1WY0"IX5`F?"0\DO3*-R7";IKPE_:1Q^IZWV
M@[?:`]^&:>19GV\E<O[J1E\$]HGVO^*C##K_AK4Y8@O\9FTVWANAF;]SM?DC
M]H/@9HW5B(TQ.PRWQ"/^@$:]A?GJ]A17.B+NX$9J>2*W(?+\=A"@U9)F:0$S
MN9^;[H*+*(5Z_M(6P9.UP#63*C4CK\R&-,;]["_BY$AVP`Q+@T;YKIK8-A!Y
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M.1K;_[-F#0G7$T-EHA:=BTWD,*EUD>YT!RK5<F]6D`VJQ@:]7M5]87PP-ADZ
M,K$$-#_`5#BQE%!5SQY=&*8J+BB4325>+S^LJ!<2;D1H%*5+8]T06Y06[O*C
M5U%P7/*<@$(F1R0R,61ET**L3\$J!R%Z1WB*>TGPBX?HI1(4,^%RJZ4(5LAU
MDX/SLTV@M>:;M*,*[2C4QXQD=#]EATCL?$1FI`4^A&'\,<"C"6"TWH7)`WOM
M8-9)%*\II/SCN]>E\W#BQ+LZX1'R!\POPI*)P@"C=55;!G8PFV'/.[2P%IZT
MP]PH\:7P?C^+@(#*E_(#<2XM%`<[A%<1K)D.B@Q/Q4DF=6;;%^DD(YG\`\3!
M%P>A/#LK`%`DB:67L:<@\1RI`%9V&`T/-P.:8[G@N26/G!1]?9+5:E,O0TS0
M%<;*DDX2?/`37&1(AN'1<Y')%"A9@*67YSX$?F)[/(A=9]V*7XMYBVFB\5L^
M>"_/?>!BT!/I[?`PD+.\`H$\.)_-%H1OXH;@R\KSK$(WL>;J**USVX*UEC$4
M=C8_]RUU(#UW(KP5E>^9TK0L_D4#GQ^V$@8[WX!,QU0X7BXFF*EY6O]^S1H\
M/WR^6G``!IL&"=."(05RH'0`M$0S3#\%GSJM8(0/718%N?($:L#K(NX]JN3/
MTGGW!!SWB'RR"C5Y:?T7BLB<+1I-R_6@JN:;KNU7XS'PU`209U%PP%I@<V/A
M7J1V(0Y:S(>Y9;4FU*T^F'.1P-Q:6P!=C*>%YXK!V7"CJ2@.43SID*.4*L,,
MU\RQUD>(A3O31:R\`5Q[`+J\VD5+%B>5!2C$"G!IG<C]1S<,?-E!*`5+.=@D
MBULN\O,5:2$)46]HD@%@*U.;]-#E0D34V6.`S_,*:38B@U<F-6=QD[2,1#"6
M:\I"78NT\@65=CBTH!=&H'X6$2C5F4J+T'/3[<E'K'8;JFP6].U4E9ZE91XF
MG;39.XZERUU5_%H8G7F"MB(_2XP.+0[X3N1/RY1NF=`I#M*J:@-X!Y\D'L.0
M8K;CGL<O59`1\]_GN%$EE_HB54>H*@XG*AWS!6U3R>BX:Y66(VNSG[&JN$CE
M`0\3/-&\BH4H8*^4&+`O/5DM2K5GR3;9R`NA4'?"LQP!WQ75CSS1SU`>(=AG
MIG)Z*JC.\1VN.MR!9<\)*:LJ7H51B;0OB:V:"^;'!5:"VL6`!,8#_0=7Q#PR
M;H%/B,P2=>W%@3-YJEW*4[H_8;NAG<QD__HHK00T]RS?E]*P]M7B>(TMG+(L
MH(`UD"*Q?L<J(+*84K[ED=?/:VGLDLO%)=#?#7,.I&5/"M6=\`S.(LUZ2P_W
M%.XM:9$\*R2(B,<U<N^BS7X''LF&+H*<@5C8X.+2#85A$\7B@)>K#,"'/H5N
M##:&.=@Z!DR*?'?!+N7;YGB8/=]#=Z-\7\LI1-MSP[A2;4^6/BQP&$/[\E"C
M7+3C\CQMY2!,$`;T,=X&CC98MF)UW\)QE#3<A$/*%NOI:9D`"&S)4SHK\I26
MC,GV&)(HOW.I,I"L"H?B7!31?%IM]DM0H'I4/*OJK*K6^NP#1Y:'R\L%S&4=
M79P\>4^'J>%/0>!@4(=\IHHB?P^*H%EUE)![8N\4W7[X/>^IT+0."FV6"@M[
MLJ*"%QBEQ6(0Y%)M5BL?Z2=E6NVO4W)!!Q$Z7"IF(RIDX;G-0@H`6-;<A<JM
M;@MW_[%"XB*SJP7JIN[FI%!ZK#`=E::=>W>XY$7'*U],6P@>/E;0*F!&C'N;
M,O]![:<*@V;)I3:89<G8U?.(TG'T5/U2W%C$46/C4F:)`YVQZ*2VA(L%)R25
M,E'3L.3$J$N1&[)H*R]1J3!Z]-,MSU:G4F4KGYREEO*@#ZSC4LSC<,K%9T7X
M*/"+T**2/-+U<<A3!$<"PJ5^FG5KQ6ONR@#)P>JNZ9G62`(27R)L),/.2R-:
MODJ$J=+05+H(R%1ZB?5"B(K>9'8A/J5PL0C%I?(S%M7?19LHY9!@Q'NFOG<G
MZYW(LN\XYO$3YYM$,O<9,T=)JAJ;H3U`(LD[`#`OAI?-*NZFREIA0\3@P:<Z
MX95"9I;VE":EH`U5*P&5!"4++N%NYECUV`)7_0'>JK;[)YRK:N%XO%_4$<C+
MT*I=4O000UGO3'V_IN9P7BI:I9=DKQ2[)*K5V7)@O53D=EV+-;RAW%LMC7%*
M%<4%C_+@V0R+3,T]-&NX#A&+'M4QK_0>>8_J9."+=9$X:)0B3G;@G,O.Z=%+
MELR!1KAWK.8_MQ8SF>@C#@^%W)V-,6(O)C51$8M"JAP^>S,1"D6%09[`$.&H
M\E>D=0\$^HHM@,+;5[9?I*$7O!3<;;$P6%A>EC623@%_:[,?+!A0@5XI:A4(
MAGB76FI5RS?--TS/]X/]QR+H$C5M6/+A5J2"%>4X<$?NI"-`9D@CD*/D7"`S
M"D^-IF*31]2CF(T%-`HI2<L`%_E<+-NL'IBQ(A6-.\72DD#(0+3J+INOEU1B
M9N$=>?$&',0:2HF0GR)5I!R<T@-"KI9<91I$RQ[6:]_R%O_)/++"*S`W3(YP
ML?QH5>,5[U!!D73I*G,F^3*O41&00T"XL:=:M:IBS7A-9A*P!)RPK**NDY(?
MN"X1ED!"I*P7[:LMLJ+D9X]6R2P""/[#4^LE@D#*B0%)@UNCQ!*U/?@CSC3=
M3L<7%>B0AAW46!?B7+PHL1W*&H69/<N7PB&6QX.?6VH%CBH"KYRX7^4MJ6!;
MJ<N-5@S\V'0+400`+'!.X8*%W.ZO9NE,T44`-)_]#Q@Q/`V1-WYLY64*+2<0
M-9#%5GMZM@S%1/I_>7IGH3'3)W#['"L$=_Y-`/\IYX2\_O2FE!2R]K[?YJ*C
M<JF#Z:??2O?!DG1TAWG/>RQ!!;W<V`(E6G'>#F3`B>3^9VH1WQ4,0NJMO2Y8
M1XT7UFD.O04#=9;`)UTE%NRE1,;-9E<U^0T>Q5;\`Q:J$P;,SQ!IK8<A35&+
M38.G92.5PU?Z7B?;TDRKW*B,`T]E?I,YJ4:^?PE@MAPS;85DIPZ<\'=5'I;T
M2(HN;=EK+;BTP@5.B_[*BH7PQR9[)1>I$@F5JZ;:YY8\\>(+G@3^I>MK5=5E
MZ;Q%`4JCHGP+,$O?(Y?U$QZ&A=B$`%RU]Y;VJ!;1YN+39:G?K!*Q1+O\7E_&
MTN6A6C2YF``@BCP^%8^@**R6LU?A(VR`$:1I?')?H94UPA!.%FJDE8:$Q.[.
MAFG+_MRJG6JILA46LX]$]&>,T:6LCX_RZE4A8T$"^9JG8B^62>)-,`"QY=VI
MM2DN'];F:^3^?)O]!((D_<2D=,IKVWI@>;E6S&U:NQE1\LE+54SRR:^PN>2+
MK5G%I.[9BN"6-4,%,?.@W,9)I1O,Z58REN).S:U4Q;S%M&A!DN=(%OH0D7FL
MQ#R^S5>392`JV489#IYB"=(T#\[*R_WADCM;KI:M!1Y9D683!#1>9)M>4@E=
M7ZF26)H5'Z%>!N+YNOP#F#2Q^L/UHR\C?6@J!6JCVBXOW3$&"WH([P,[8,,*
M_H6KL2/S;0XAV4*H2.9BII6*2SKI+OSR2KV(5%D44Q(LK9B24KD%5''+[U97
M8E*S"#L7KE:["8)Y@=Q.AK\Q'(/@H.I;QFF/QD4I9;]D4K$>8%:R,$AB4?MP
MJ4;X'L]!"P/C+TX`:S5F<RO,6WAA\@VLG#Z6X>:8BU./LAM7_G:R-]6%*S=X
M6DN.D`CO(`JG<3X%$7*'(667C"W-+=>1@0AP\-1)UR5[5<2@S**4@!E,!:SR
MU7X!:I_8,$IO1*D8NS);LY#-N*JF($Q%-<U*7^+I$]Q`R5^^HH>E(M1/?%F'
MEQ'P?2[!8F6<;:,\%2H&KI^W[%6X)DJ7@@!WBH8G+4.J"KQD`;!&F=,2*9Z"
M\(M,M,OP+S=>RR@"T[26G@5"XP3A1ILD0H_3M&1W`<)`=E^,ETVM/RVVH1./
M+VYTEL*R,1>9</C?2$91E3V3F+R'.3URZ*^60`(/PJJ=^0A@P).9]9@#L\LX
MQZ4`FO(9$=[PU:IN5W'.8CDN%5XYA.O#KN)X=Y$>LA>GY2W$*N6I4(0??]F@
M&6H3M("Z\/Y6L9YTJ[QDR+UGL:DOO>6T0U]JIW)W2NRQ+!D"2RR>4K*+^&SV
M*R%/18&NE1V5?/^[8`4VX4=)(.([D3)6%/3,CJ8)OKD'+*I@B^<N/5-VR\Z-
M@]JXEN6N0=KR9/SEM5".`WDGM,P'%C8L%<2PL.&:C3$/A</*7';C7KK^/VHY
M*4-DJ<IL7/UEQ6B!*WFTA43W$DZ3\CURQ\GRHJ#D/:W90EQUI*27KTQ[IA5+
M>YD%!TVV(!*6;=WS-YC,<LPJMY_BA<)HSN-6'AV0/43D;HQ*E5_=B<E"JP=I
M0@34C#`]DJ2V&JG-.ID)R%N[,1TM6TO!=O1-TRW/C%%+#096G(S"<:.Q;#Y@
M)V!59Y3V7S$_)3ME+L$BU]T57UIY0/+`=!X*%3TD<GLF.FOF7IMJ1)9M#:NW
ME+:(LSYERT\2<B`NV64A=!&)YO%]Z51@VG=:E2Q)$XK*2KTI-%SJ;IA&@Z7Q
M5J&7KW&6IICVK<;@H#CY+H*#60!'>>6K606EZE?%TTBB_W=>*>`Q#7[+S$<9
M`1?+C_F:6+2<*;.><'.8DN8/SP8L[`Z\*ZS#?LA$`GYX;=MA@B?-*5&P$C7>
ML".3J6&ZF86I-X'O<YEUIW1F<9?J;WI]"X,,N)S.LL_07TR!/4^U+M<-D!M`
MK>6L0;GC+A+@5W:+6KG)4+M'?MX$R$_C&Z6\12#.G3@T(PX1WTDC@/N%,'*5
M@[21'OD.E9JI4S[X^%IE5CK9IIBLQ[&<6@CNM(HGR<2B"1?A'_S/),]+:JD<
MRGPO,=VBSK/[1+L.KP"VA8A((>*I]D/3-G=Y>"$(4U=:1D*+V7)+^^.6\RAW
M!\O[U<6-/E'K9"Z25_ZC['614$53C_G<Z5:T>.E22A;^HAPY`N4C.DK*G$\5
M(7!#1ZS%7!G$4G05A=.P+<R2&A8\,A5)`T%X"&3)QU+%BWD@ZOB7JDUB.#BO
M_+UQEW:YHH+/'X)8GG)NX<`6:5ZRFHDLNB?_3M4BWZY)\(RHGX4"Y3$_=2I(
M!C5A9!_+@JLR;,0CT;2`G`IO0/60ROJMK8GXI.MH&941K=G0/N%A2>Z'X&%F
M!(()I6FXJ09J'!67/`UE(%^Y,TO"4>@SEP?]509U"LIK2\*$!8<KS;S(7I*I
M?18,%;9C`D_"/6*T(;C&GR>8^>F7I"$-;2Q!B=@@48GFZ4\95J@:IX6#-2A.
M*K,S3GMIYF\0=C0]IZKZD(H5A3Q4(\O6>.((CNC=FC4B1!2#%\N)Y/-0R]#2
M,%+/UDDS4M1H9']E#SNA/HA"CZGPX5$F>63E*<O3G22A"FQ$<PQHI^,H/$SF
M-PF8$&U410[*YT)VL\R2*;'(%2?)@+N\V'A<_"0BTJO=RE><ZS3IOW36YHN?
MG_G-WF\IMQZWNM(*6J62VH4Z5GES\O)#REL8(ADK;5.>3B.;WZJT%BU@FH.4
M%H9E:3U8*B9RH''Y)/RM-T(NWA;\+?+AJT#]3QN\V:Q"AW`L1=V<8)[W0I6^
MLOQ>+EE%ADAV"E1M.\LU[:IBBUM*RI8?B%2#F8G*I/F&Q)J<P7+]$IFLG14!
M67W%HSP?J#2Z5=CB*)0\@NE.P,?&.!.NVW7.49;HF9TL*&;E;:4F;CV5&*J8
MDB*(9)JLAH#).N*J.SS3@-_,`G"\1<Q$U$++@V:%XDHMN?WH>6([&<D\3U-+
M'RRQY0G<RVO9J=[ETM7Y*KBM/#R,H8BYRY7%9X&OV1?I^D;6PTJ;TA9K8I4R
M4HO5GXJUH1X+T9AL,TS(=$O%@048JP7E'_)A',8:+#@OD1+>A>6R(L0<3"$3
M[N-[A64B>"DH4T@2@L>XHK)H?B0EIY%T)T1/W0+NC#ENPQ>:+;=2()=G4^7:
M;)(6;1?"C6`KUFFA^[CQR2E]TR.NMLAM2HL]BLH[ATB5$*-"/0LQ_S9[FQ^@
MW5]2E8F1(TIQ'$2F,+B5XABZ+/Z:CA"_HYOM2:E'CKWQ+$",3S9FZD6IX)>M
M@UK]S##Z632N*FE[4C@0E>[*K"L@L%XB<ENC)$VZH>5AR7&L.[BFC$W!P,C]
M3V5["L8J/6173'\^2`66:R;+KTN8E!DG87S27<95&S51B=Z@P;*<@GB11("T
M?&4Q+[UP[W)+Y[R:\?8*>:+T9"%F7GRDOU).#V:*FR(%Q5;V3IC@Y75;N?3"
M5HN1FB'U?)4?-UZDWV3$6.?$J.3S<NJ$3*,13D!:'2%T56[2$C\R:2B4"<J(
MB3,K$#/B<>SQ+/XI:T2+S'Y83#U(NUM.B,9`@YIZWM<'(6S!X_PH`D"E2/<0
MM<SLA8U)$!N]-C'A95<)!BT6E=*(8G`3F:%J6=OJJ`=Z1U*>EL\W++E$N4`5
M&A6L4",GP;(</<FRXWC.<UKP&9?D1F._2\K^%/R-C1RPT\-9*UB5B_>?B84E
MY.1YC4?1$:7D-V5UH-+$<W4#;0X=S+'WOLA<_&Q]75<3F9:-QY6V+1R$=R6!
M8T'@0ATU4>&D6$)HH7R`E@JFIABK3I7!`[(*1,N%A\)2&9L2I#DNK$5"7JK#
M$I?BR7E)&8&Q\!JU7)QL>I^<!?>ESN(=8CV(:JFJ0*?'6+#@6?G@27$\Z:Y/
M:F=Q%SF,^)J=9MD)23Q`-*9UIUB$7B##.@+E36I%'3ZY5>)P#*<+2!%Q<(5V
M<)LJP8!\RKL;9%E0"F-DNG=Z:O0I/:0J<UO7\"C>I_$1KE@L]+Z><%WDB814
MF;&[N0GOIC>*2:LRA%E7>FM'"Z96-A1:$U1;H]X/=,;IQ"^FGJ+.<Q\6QG&T
MA\3DGKL?9,'?M`*.-'EXDB**ET/B>>^/O(JD"DP'L3C)L6E00K8+)S*];$6?
M'0O>..)>J=%3:AI*>9'K!UPZS5ZPXBTL>V7YBY8J/)86_Q(!(KEOL2[A144-
M!1F6=NKRI\-55AJQDL04/3<FW,D>*ZJ9E6%%V#-C-!K@'>C*KGO)TM,+S<[D
M_4"J3G8_N5&'YMC@]EBQFL7',/"#1)TT:;1KM4K28PMJ5-/(:6VM$#1-=QVS
MR736!\/>^^Q'/@[+91:D\4<7#(NXR`9V#GO]Z;>4]BU6J-?2J+(LOV8N,)CP
M-.,(5-H#UTH6\0T28=Y!`I.9*D$I&\KBMEO(IV#9T<;+U52[4*E&8R<@9^UG
MC#8@)P&CK+2HBZJ9E?=CS*/35H$,:6I8D0QND0SR!5PTX<C*NV3A1SQ7+L[\
MB@,P;F0]/&"47QVSEGY!&KQ76^,EP-W\^NQ\8;9AGH5MLH*@Y7J@;*54&E:%
M]F3O-W=YW90_9!($,7@U(KLZ5P>QZR>60Z+B-B:C%;NVCCG8%!'CM288ZUCU
M7XQ^2WGFQ5R"M"*3B!`5R^6LJ\^4#1I;`16B*MDB1"Q%'16I=EQ'-G6S5+NL
M<C>K?.KS(%('8=-JVRMT+-0&ER%O46A%EDM-?<5PC8;M$JT7V)WHVY3%2[6U
MF<P%.2BQ(&W0_K?ODNCNP;+F+PL5R7/$^8CN(SB%GT'%WGB!_>7O?_DOQOZ6
MWH,UU/^%0=MWF<3DES+7^?[9C__N=#K=^\$SD00#/_W*)]\_>XO?&AUS9/3,
M?^-0X8,A_C#,KO'L[SA"-<"__)?Z``M0&.'WSQ">,C11)6)$+;[OGW7@+=SS
M(F`?C#W[/,?M-?59F2!YQYTXY#2/^,OTCU?@*3OQ%`Q3#H`;\#`?0YC]Y>!Z
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MC/F9*O`X3](VP*Z_<F7BKUPK'8)""3V-G<Q(+=1`G"([=,?H\A4I-'7!:PCM
MZ:(8M@XY9Q[F1<M423%IT0D^CR-+ER9^"M(CY6DAC0*U4@?'PSH)13JV6%;&
M>,RW\4]5.@SY<HF*+=;IW`@]ZK7-^S)&]]OWW9-ANMON=BN`Z<$J"!UG)=4-
M_VV!]_GJTV(&0"7_7GY\<7$S[*ZNP([`WT%[<'\P_E8V\XLI[\^H@\S(TC+,
M5Q^6;5$K2^K_,PEBN?-MIZM$6:U,&%@5&19%046)<;EI43#6X%R_JA+U20])
M#Z]*#\V"'KZ73D.@*D^!CZ-T-2^S4H0[%0IQ7/#.</-$;-*DGS:I\*1P,&6M
MNK96=3Y5]FP48K='&H(@[>6K/)XU(Y61`U_6Q@K#0)3=4'FT^47*90.7;*52
M@;=0F3*>5TY:76]NT$,@DT,FATS.>I/3+9B<WU87(KD*8W_PK$X$:%<L=5D<
M+5(-BL7YGX5RRM/;"D5VU7&CU=93&VR/B"EB*T`53%8Y^85HLCQ9*8Y:X:&H
M0@+KUF2'>L(+M[<AFH2")T<$>"A@<TC`)D^#C%6%/[5UL]Q/K;#8GJA^KGE,
M7VG9"Q&X1X6"6[+C[U*)Q=,C9*Q0P6_3%;,XTU346U&U/!,`U4)L1UY)GA/U
M0@1_@B3"K:AOMZZU]Q.4SG&:MU4SEB!G"VKMN+_6C;WM88I\5^%@!T7AI3P3
M?-AFPK/":\/"WSD*2RYF3U7O5;QC0+/TFU\E^]KW_>*WGY'EZCOY7E1\-;M4
M1$1W0(:7S6,9%YQ;>%3@4*1?D2T,LF^5+KS@8/E"COKC:+X>JC(*`L%A'D!"
M\UD=U$R_>Z-(D5-XM)W`?^V(_ZTAKB"-&.E+*4RO="#W+B`%.@?ARW16AVI[
M!1&9G=Y+_4IE[*]3JRL)3=5,6[XO&8`+L]X\Q9R2QM?/><*!*Y>*-"*H@3$@
M'-#=&A`.W"KG+X8#0\*!\^%`(9BB@U4@0-#=+!`@W"KG:6%PY5+Q&4],Z&`*
M"`6TM@7?E6+OV^/PXP<QL>^?_?7MCS]V?GQ;LZDH1NN1N76%Z@VS;?9W"<I=
M=M7U2,OF3;@3#,>9A<38(B,I29MJ5TX3C!KV$D_U+\\L&_<D&R0;1]B-:_!)
M2#Y.DP_S/+X'"4,3A(&<#)(-<C)(-LC)(/D@)X.$@9P,DHVSRL:`9(-D@YP,
MD@]R,D@8R,D@V:!(!LF&+G:#G(Q+R\<A21RUIVPT*QM#)\;_$WY>9,7L$M]9
M;:UXU@2NK>:`-/UTAC_7E;_W>_*WD)0I.*9C3J9.##<[K=.RJTBK]6>R+JGX
M6T,"I,O7SV;29T)ITNS#&7ZG*\-)H6_$<A-`WP2;29^O&Z`'!-`$T*305VBY
M":!O@LVDS]<-T+2"IC@W:;66^]2U)#B<O0SP#>]FBX;E#\$C#WW1.<UZX+Z]
M*-0-;V3VR[:B-614-/$)+Y<X=[)XD*=QOE!`C1!S`U6/=)("?:U&M?7PR"0T
M6AC(PR#Q(`^C8?)B#.Y;_=&];L)"?@;9#O(S2!C(SR#QJ*/.`/D9%,D@#X.L
M!GD8)`SD89!X4"2C\?)"D0R2A2LI,G"%?2%TD@X-NL<<5XN$W(O;R-JL1@#(
M@;BRM$ZJ4:2M^W"!$QI'.@ED%:Y-%LAC((^!/(9FAAS(9;@24=`?)LAE(%D@
MEX%<AFI;+I!MN)[B#N0L$$"0LT"R0,X".0L47]!`(HSA?6M@='25"W(9=(8)
MK3(:*%GAJOT#TO!;8#35D[I5SI.*WPBCJ?+C3;"9]/E&&$V0?:N<)Q6_$483
M9-\$FTF?;X31U%;A5CE/*GXCC";(O@DVDS[?"*-IE7VKG"<5OXW=;6JMH+,P
M`,]A`D!Y8+KY[+P68+1?R9>M8&`#,WFH(QH4V3L./.?5:8)R@E3\S!^YQXS+
M`L'-%'/1A^^Z^`#5%H@CC2<<(*DX'@=,'8P!X8#NUH!PX%8Y?S$<&!(.G`\'
MA&C\U1AT7EVX;A,!0C/,`@'"K7*>%@97+A4:5/4D%&B`+;AXF^;M)^6NL/:O
M/M+RCMM\-N9AP6\T6LSL&*?$$R[7@H".X^NV#:5/_P&2#9(-.JU/\G%(4N(Y
M?`\2AB8(`SD9)!OD9)!LD)-!\D%.!@D#.1DD&Y?JU4PU!TE8R.L@^2"O@X2!
MO`Z2#0IMD&QH9C?(R;BT?%"UXZM@_#_AYP6#>7_A,9LDOA-=-J.+3G[7S'"=
MFQY0?*$&AG=;1D_GC@:DU)JX=W5'!$B5KY_-I,\$TJ39AS-<YRZ%I-"W8+D)
MH&^"S:3/UPW05,R8`)H4^AHM-P'T3;"9]/FZ`9I6T!3F)J76<9?Z`K4':-_Z
M6%'XK?VIS1Z"1Q[Z,Y@ELQZX;R]8Q.TD=&.7G[*-??X\%S(.FKAVYT]_(V=`
ML]4Z:7\3.=Y$[:<5_8TRGG3^9EE/B%^/+!C&J&5V3RE*2S:@B7QOH@T@W+]1
MQI/.WRSK:5^>5OJD_;>J_83X-\IXTOF;93VM]&FE3S:@*9O_M-6O+>/%5G\<
M<BM*PHIV^$G?]6>[_JF:A/#ZK>E)L_7GK_Z:3>OUFV`SZ?.-,)J0NA[.]SN4
M<G_='-9?MPFK;X+-I,\WPFC:*:=5-6GV-6HV(?5-L)GT^4883:MJ6E63;NNW
MEUU+?D.^DYT6Y5?,K:NYRPWO>/\S\5W;G5M>4\^S;Q,1:NNAF8]PN98O)XL'
M>18-SY;?RV)0LY=;L1HKW>,.]S'()%R+,)"'0>)!'D;#Y.7>Z.LF*.1CD-T@
M'X.$@7P,$H\JLQ3(QZ`H!GD89#7(PR!A(`^#Q(.B&%<C+Q3%(#FH/T^CEJP,
M9-Q&F5B2'2=(QAYG9IM2-ZJ2F,]!;'D:9V]M%).4?-M$A%R2Z@1%YP9%YQ,2
M<DP:U^5HMRDY!G'(I&BRRJDC_E&33T+&HYGR00Y*$Z2%'!2R,8=+C6%V6KW>
M4`<`(A=%/_'0!8+(12'Y(!>EZ=*BK8LR(!=%7ZFY<"$,<DYT%0Q=P(><$Y(/
M<DZ:+BW:.B<4/]%8:@RSV^H/*7Y"XE%'0LIWL06\R:YSW,<3&?#-=O)_4R2)
MB<Q8-XMYK8/HM3$]9AUK-G!QK1`<<'^U;%^9BJP0`M<O&$S["X_9)/&=B(&2
ML2F\U%LPS_TS`5UU_4<>Q3.X$W[U'7&%9<?N(X=KX-T.=]KL\Y2S>>C:8`/@
M!AR,%;N!S^#_\91'O/`4^#.*PT0]$!X6<LL!"C#KT7(]E"SQ&MORV1CO<_B<
MBX'#)6BE'"OF,(J(!1-\-IN)EAY</!I_P\&X\.3Y/`PL>PJ/CQ(/7N6*H3#;
MLZ+(G;BV&N!$#3"OD8+/_IG#])B1OF-BN2&^/$'B\-`*[>FBS;8HSWXR*(3Y
MUH50-&;Y*7CDH2]X:#UPWRYV:&FQ3;U;A*#,UI2Y$7*E!`-D)2XR,(E02"6#
M39"*>1)';?8[RN&C"S-'D<8KA(R[\4*\))5MF.&*0$=*&#E*VZHT_C[E/HN2
M"8B<B]_^F00HP,4GND@2D,C2%$"&_2#.M:+%GG#P/-77]`$XO`#&%+)@'/'P
M46B0ND;.3KPC<H'#5EA\0S".+=>'L4S"8,:06T$2P?3<$(9GA3!UF($%+PH>
M881A)-1<3%T\->1ST*VE*?'RVT#7N-0]:3+4P.#=.1W%PZ86_#CF0"IX$URH
M!K4Z)1Q2A2IN'JWB"O:4!R6&*%V8[Y]UGC&;>QXZ*<"A[+-RDL1GY6[90#X>
M9NZ6\H'`5_"L><1?IG^\8LJ9ZG14]<O+MZ,:G=R-Z@#'2YBKT4[HW].K/:P*
M706+C[5SV.T@9G><ST8WW3_<0T;4>/[V71+=/5C6_.6/H/K_0LU_YT:V%Z#]
MCC[#"]YX@?WE[W_Y+\;^EE[ZUHJF^,\/X!J!<*'U?^T[_Q2F"2?]*3,QV0/`
MNG__[,=_`U.[]_=@"&"H\-.O?/+]L[?XK=$Q1T;/_+?9,;KPP1!_P`+.>/;W
M%3,#'U++@93)Y.A@\W.(O=G.BGP,8?97KGC`SB6MDS[,JN(=84LJ<824YHP#
MSSGD@:>J6*^]6[5VTG+4;_<&1YGA)I,.]:_%\-^LH(;"#\H5D>6:N`W$"Y3^
M+A?@4PW8@-SZ5[@BG(`Y"9[$FA#X`T[P#,BP0(_+%CS$?S.^Q,-9SL.RPP:W
MO>,VGXUY*&S[7XU!YU77:#$TF"UQ+_QELA?"#017%KZ)OGUY^C+M2#PZ(5BD
M07A(4/?FW5]U,JJJ4]AROEI$K_?TH($%,#,@JOELAS?=V>^D:3WTJ43ABGAV
M6KCV!.5[/0O"&)[FL+=!%)\>P=?EQ.?U<*C*#=QJBSR0^AS''#)R9^;2;W[(
M@1AHY7ZR7+^")MQDYK30)#)S&C.'S-SES-S/012=U'Z![)Q.JD1V3F/FD)T[
M,Y=^B&)W)M(R<"LE#Q^)316R>?HQK-Z*1&<N<=;?-\>]6?6(])&6S5'W$W1[
MHY#LGX.NJ9HW.]/S<%8-B55-8=6^R=C$+BW8=29@(]X00%TSJPB@&L,J`JA&
ML8L`2E_>$$`UAE4$4(UA%0%4H]A%`*4O;PB@&L,J`JC&L(H`2I=C<)<\G(E[
M8LW:[M*)\>)LD2Q"4#Z@\K+"S6Q2P`NDY@R)[A>A.\G[Q5+1B,@DW-=)=S+F
M).^W1'<RYB3<5TMW,N8D[[=$=S+F)-Q72W<RYB3OUT1WS4^_G,A@<]`>W'"D
MO]:].%+'6EL<[-ZW/FN)SROAB-&Z'PQ(+9J&4D>E1Q'9+Y*C00I`N-`XCIS2
M\XY4HB'&B3"!,$%;3A`FZ,81PH0;,$Z$"80)VG*",$$WCE#\2`,FW/;IA1O>
MTUCMZDC;BWHK7E7;Z01#)4:8G=9I->I(^#40?EI[4.+(U=*=+/O9@TXD]QK(
M/1EU,NI72W<RZF34]2<W&?5&$IF$FXQZ@QA!,9@F"/_%SS=4T6>7]@?V[$K6
M_M1F#\$C#_T9S))9#]RW%X5FV[7NW.W3;XET7(OT@V&%W")87-HA[_;.TSUG
MEQTE7=-"U\Z'?,0>`JXKYQ8!EY9!.@*M*],S`BVMV4.@U21N$6@1:)&>$6C=
M.'L(M)K$+0(M"A&2KM6]Y5;+!MO6[C!G0L@;[C'R.8@M3S886==II,(=\YV=
MFPAO]<';3>A:/_,(?LN)*]V689KG4,-C["ZIXV7R&W4"3^(8H=\U,X_0KYD1
M4P*^:]-$`KZF<8R`K\',(^`CX"/@TT$3"?B:QC$"O@8SCX"/XIV$?EIN05Z@
MJ]%>`D0;D$>7"10%`JVQQPM'_YCU:+D>?GD'S[B++'CZ67(0-MI[TGS=$GV(
M57JS:E_L)79IP:XS(1WQA@#JFEE%`-485A%`-8I=!%#Z\H8`JC&L(H!J#*L(
MH!K%+@(H?7E#`-485A%`-895!%`-V3:KY>1>S5DF5!JSEM*8FQ28LE`N;VXW
MX2`EF51\IGTP:)G#_IFTB)!0G_1)RHR\-#,(<O3E#4%.C9!#:*,C7PAMKIH9
MA#;Z\H;0IC9FO>C=$]SHR)AO"64NS@-"F5OB#:%,O6&T?H^01D?F-/`<%A6'
MU$R&9''(V9XGM"Z;O4$`K`\`5Y#A09BMZ]9713DA!/6-TEG-0)EX2#!ZZ^PD
M&&WH=AXAJ&[L)`0E'A*"WAP["4&;ND5)$*H;/T_9V23DO'I32\AY5>PDY&SR
MMBNAIVX\;>#QOT-$PPD2W#XTV[0W6^W>+/;K:ZUT[1.M_-9NV]:0J[&O_2_)
M`,'YWHQ^7D,F5/T\(\PN8_9PU.IUZDC*K<0,DQHVIZM#75A*'"/4TX=YA'I7
MP,1:#CT2X#75?!+@-8UC!'@$>`1XESYW28BG_Q8F`1T!'0$=`=V-,!'CF=U[
M6MXUEX,-/!^Z?Y^^*]EO++)]''C.J],$Z`1I><=M/AOS4$C-7XU!YU77:#&S
M8YS2JO.P-`3"V\:D`Q&K]&75-JTB"-6.76<"-N(-`=0ULXH`JC&L(H!J%+L(
MH/3E#0%48UA%`-485A%`-8I=!%#Z\H8`JC&L(H!J#*L(H!JR2U;[GEBSMKMT
M8OQ;/%*'Q^B6S]:]K'#/FQ3P,@7!B>Z72;$BNE\FZYZ(3,)]G70G8T[R?DMT
M)V-.PGVU="=C3O)^2W0G8T["?;5T)V-.\GY-=-?\],N)##8'[<$-1_IKW8LC
M=:SU3.CN?6LZX'G$`<]6OU?OV2Y2"RV2!6@1<JD<#5(`PH7&<>2.5.+ZC1-A
M`F&"MIP@3-"-(X0)-V"<"!,($[3E!&&";ARA^)$&3+CMTPLWO*?Q3_AYH3H`
ML4GB.U4V_B'%TW@[G6"HQ(ANR^AU2/:;+?NT]*"\D:NE.QGVL\><2.XUD'LR
MZF34KY;N9-3)J.M/;C+JC20R"3<9]08Q@D(P#9!].MUPK3L!B>_:[MSR6,3M
M)'1CEY^R%T#;<KI`$VU;U\&:>Z-/VG']VD'K%$IFNFE.$#Q0IFL3&4#@<+5D
M)P70A1,$#@0.360`@</5DIT40!=.$#A08*F9+-#^-,1J+W/%J2CP7(?A9=7V
M++KA?9'?VI_:["%XY*$_@UDRZX'[]J*:39)EW=S&36J=<]D=_<IX0WA78I;9
M,CNGG/\[1(>HI]'ET[[.A%C$#`*<!O.&`$?+Z!N!38-TB,!&(V80V.C+&P(;
M`IO;8@N!S54S@\!&7]X0V%`H[?98T\"#-JN;3,BIC4)P)O2[X4[CGX/8\F2;
M\77]QFO=-=XH`BEI"&_UP=O=B1GG8R=!=#F[H]4?C2ZCJ<<8:])8+316,PPF
M'A*(WCH["42;&50E`-6-FP2@Q$,"T)MC)P$H`2@!:%.TE0"T^3PD`+TJ=A*`
M4AB70+09&[05;,=NKWNXE[C0UNO1Q1%%@R1K[/'"P3]F/5JNAU_>P3/N(@N>
M7D/VQ4;C3EI]V?0E8HQ.C-D7,XDYE\V.K1.AB!,$+$UE#`&+IHPA8-&8.00L
MNG""@$53QA"P:,H8`A:-F4/`H@LG"%@T90P!BZ:,(6!IR+90\QID&;UV;]<6
MT-4)09TE(*E@JRXFE,H9U\$:PQBT1L,!:<CU:PA5O*>*]S?-"8*(HUC3(W2X
M`>4@="!TN&E.$#H<Q9H7!BG'93GP+8'"E9DBDGM=.$&@<&14Z;[5Z1(R-$Y#
MKKU1UNWNC\0AMZ(DI,Y8.G.JUB0`.F1:+;/ZG<Z9-(B2`O3)-J/*"9=F!L&-
MOKPAN-&R*!"!38-TB,!&(V80V.C+&P(;`IO;8@N!S54S@\!&7]X0V%`@[=88
MT\#3-=052S,9DEVQ9GL6:*MUQYBJJ^IJ-JBZ:I/XB]D=O9K/#%%]U>O36<U`
MF7A(,'KK["08O=IS582@UZ>NA*#-YR$AZ%6QDQ#T:L^>$8)>TT$V`LZ&6UH"
MSJMB)P'G92.X_9K/YQ%ZZJZS%S_L=XAH.$&"NX=FNPXHOJGC@')'UK:B:4O\
MF_$_$Q?X#9.-F.4[ZS=K:\C0V-?LEUA/*+XWHY_7D/M4/\\(JLM0;?9;G6'_
M'.IWC/4E-=2X^/TY(90X1JBG!?,(]:Z`B2?MC1+@79OY),!K&L<(\`CP"/#.
MM)5)@'=9YIVR<4DX1SA'.$<X=R-,Q'"FT:WCO">!G:XVM+3/^)W86,JN<]S'
M$^G[S?;=NV^*)#%3DFR@WKH)SFL=7Z_=[WVSEFM;A[@D'P?<7ZU$K$Q%[C!.
M.9M9<7K,,YBP(`GW/@/*0!69%;%)X'G!4\1>N#Z+IT$26;X3?<NV2%VM$G2"
M^FJ@L'\U!IUM"JOT4%E=P21I,K]_UGG&;.YY:!1=_R'[K+;XQ6=EHFV@%P\S
M$ZUL+A@OSYI'_&7ZQRNFC'>GH^K+GS<%87#FHB?59Q=LL%![0N?I%.PVG8!7
MA:_`:9@`$!Q8/7A6!]<W]RSM[A"%E*9;'6-I-X[PC&L7C")_QX'GO#I-4DX0
MBW?<YK,Q#W-KWC5:S.P8W=-]Z=,-PN7KKMR0*#0DTV^@8](]0<G%;$27Q*&!
MXI!Y%N:9/0NC5]$!`7(]3I2;U[,@C.%I#GL;1+$.IJ0AQPMN2$::`S7[F([M
M,$/FXYIA9T"PHX?<_!#%[LR*`79^M-R0_<ORDE/J`Q+X7*VD-+!.Z68#M/>R
MN1%"HM/ZYY^X)<69ZS.XCBVX%;(@9!Z/3CG<=F;IV'<13<*AU9'WFGR5/5R5
MIJ*+3K)Q2N;1N45B&WJ<.W'IIH1DU&T-1K645#B_\;@&]U0GV6@BN)"G0<)`
MG@9Y&B?MSY"G48^G<=\A3X-DXSIR0VB?OYXXES6)>9B'NN)I&"0/4Q8_!>*+
M"BHZ42*ISF*@RY;L7L!P<H5'$H:F"\,.2""7LD;QN#=;_5%/!T2X@4QBG1BO
MBUT@=^!6.$WN``G#@>$E<@<NX`[TZ6#1[3&^@9E4IQTVHK+B6D%*C1)RY/$C
M$I#K%Y#3]CTO6-[IIN2G27NC^V1AZ51BZJ8$R1@,6N9))?5KA*F&5+2Z*8'1
M%[G(M2$!(=>F\?+3)-?FB&/YY-J<U;7IG[*11Z[-30D,5?.L8WP5U/*C:J/[
M5AO]'8]T/O(HQI.=T30(X6$\G+$9/&>AJHZR2>([48O]UO[49@_!(P_]&3R%
M60_<MQ>%>J3B$K`RW(J2<%$J5.H[*RJB!54$$=@L\5W;G5M>8<SMTXNE"B6[
M=0G[/.4A9T_X+S_060A`;#U1J.?!<OU(G&X.H@A>.PF#&8NGG(D"N\%D0S%>
M46E7YHM&C`,9'+:Y[J#XMRDZAL(?1IN]]KRTUJ]4R)EL*0IDLSTKBMR)"P^T
MHJ*2XMVK)8!;>-43%A%>P`1C-@T\9^6YB1^[7EIG>+%5UE-@^MMW273W8%GS
MEV^M:(K__)#W/GWM.__,J/(I(\IG8,$;+["__/TO_\78W]('?`R#.0_CQ4</
MV`"WXH/F.+!W;F0#U9.09W<RU_G^V8__!K3OW@^?,1O&"#_]RB??/WN+WQH=
M<V3TS'\C5>&#(?XPS*[Q[.\X^E)M7OB0EMM%?<S4Y^":O4IB]RK2N]T`Y&,(
ML[]RQQ*LR%+1=FDC5KVW`YTW8YAJV*F6IEC$XE`-/D%=^^W=/M=.8H[Z[=[@
MFT,=W\;3+E4_84`RW=MJ`W*"?I<+ZJD.[(#@L<P+GO'"$I7?M^&'@@X3+6+D
M@@,'UR/^R,KO8*B6:K^_O%CQ]T,6')N9M>O^NM9W5/P]#T+<=T[),=6SA->E
MR\$/KX^DNZ#N\E71<LW^+>*3Q,,ACT/V'5[TLSO1K50:"89V1=`NV3=@SUQO
MDHH3I6*M^]4PT]#4.+\^4M"04^%%WXQ*Q#=C.^C<YT*V-6_<5T2:ABZ[MHCT
M'+6VUO#%>U^&N"OHVZM?.6&R>===GYS*D^MA131LO47ER+60#%V<J&H,!@5I
M+BT:A#6W+C:X2::[+2&L:89!N?B![<WV9N_XSXE"8IAML[]+4.ZRJZYIL?-/
MRT\FEHTY4_Y#OEE_@G$YLXQLB_\T'&]TDI/^G:'=*8+3*\PV`EQT$H-K/=C6
M5,=#)]EHT*&U?4"#SJ/5("/#UF@P;(Z<4*5R@A;R,T@8R,_02#;(SR`_8V?!
MRE;__@K7JV0^+G["O?[<M^WQ4`IU'LOXGZUQ)0'.NA&#HI551"LOG(NQU=:3
MS6YH!L56KA(XWP*CAWLRFCSV0SUVT[S7E>FDW3>BW03.5\I54M];8#2!<SV<
M'[3N^Z?4QR;MUI_'5Y<Y2)&R8T7A;3";)]@LN)GY@!1`.UD"3HF>G7_OA&S]
M;6RO$\S?)NO)K:]'%HS6:'#*.2*R`$WD>A,M`('\S?"95/PV64\@7Q?(#SNG
M;*R1!6@BURG+[49C=S\FH>_&2<A%->V)^Q7_CG2-W5.T[M+1.G+;-6.F_KNL
M!-$WPFARR>MRR3O]@:Y,)^V^$>TF<+Y2KI+ZW@*C"9SKX?QHJ/-RBG1;]]@8
M9;HU2!1^YE;$13=1=S8/@T<N6HDV)UI.\;-JCHLV:X.$+/X-[(<2V-\LZ\FU
MKT<6!JU.KUG5Y\@"W*8%()"_&3Z3BM\FZPGD:UK,M7J]4\ZJD@5H(M>USW>K
MHML\1?7V$X;74<3CB+D^FX?!0\BC"^>_K10#/9SU%--KZ`9>!8WOB=.-X/16
MC-^G+1KY`;<@##M@@,I"UUED[J3CKI=``[()UV,3R!6X%4Z3*T#"0*Z`UM)A
MM#J]"]>;)6>@$59!\^0_:I"KF;Q<7BRVM1TB__+&A(%ZU)$P["4,M/:X;=F@
M9G47$A9ST.J8S:JX2MWJR)"0QT'"0!X'R09Y'(T3%K/;&AA&<P2%/`Z=#0EE
M4EYM]/-G'D7,LNUDEGA6S!WF\'G(;=>*W<`7%0:M61#&[G_$%SILIYR494FF
MH1$[JI1(<2N<ID0*$@9*I-!:.EX8]ZVN0:D4M\?Y;QO&<V+PU1E^\@)(&,@+
MT$`Z7AC]UJ!WX:+&Y`7H[`5</(_RP)S))2%R@F3L<6:V*;I8E>A\#F++TVT7
MXK`4RC,)R>V9%7WW,P_;DB(!N3D!.2T98IO`T'JF.OEYWARQV2=/HC*QH97/
M87(T;-UW3EGW-`BCR.Q<,VR17T,"0GY-X^6'_!KR:RJIE=,:#;2KHTE^C:[B
M<F+:Z'>Q!;S)KG/<QQ,9\,UV\G]3)(F9DF0#]=9-<%[K^'KM?N^;M5S;.L0E
M^3C@_FHE8F4J8GCOMN6.,OYUSOV(LT!4[9SS,%Z(B_B?B3O'MCSLR8K8<Z.]
M>E).BSF+*3)XD0>S:>%`S?23F(<8.<K07XU!YU7Z"SR4Q5/.%MP*(\:!9`Y[
MQVT^&_,PO[IKM)C9,;KBWZ9X'/P!7X8\FG,[=A^YMVBS;9JG-.IOWR71W8-E
MS5]^5$3^Z,$L7OO.#RF=W[F1[051$O+/,/<W7F!_^?M?_HNQOZ5WOO=CRW]P
M05]EH=4U-S#7^?[9C_\&L]2]'SUC-HP)?OJ53[Y_]A:_-3KFR.B9_\9)P0=#
M_&&87>/9WW&T:K#2-,`'IK`%52>3=&$QE(G__ED'WL(]#XTX@$;V68&(^*PD
M1($"&$_/FD?\9?K'*Z;0I9,KYP9=S<<09G_E"`CZGKU,/E*J\RK,'(@RQC"5
MZ%.-@I+Z<>`YASSP5/48M'>#PTYBCOKMWN#@_@B-IUVN=4S5-]Z/EM_E,GHJ
MR`X(Q(ILL"0;P+A%;H2'(^:A"_2`D;%@PF!`R<2RXR0$^X.09HNS%&"Z[20"
MXO(0K+<GL"^:NO-(?H*GQ`$+DA`,?&?`+!NL<N0*@(1G_CKE[NHI"RVH)8C3
M9I\!R];/'&PNP%3$)F$P$Y`WX_$T<"(!@3/KB[HVAAF*TMW_@'=R/_$LQ,8H
M;C$PG_:4N4##[)E/G"7@,@#%X`'`$/:%+X`?LSD,$V@"3\$7P=5.8J<TG/(Y
M$#V&Y[P!(V,#6G`Y[`ULD>.6PY;T%[`\-(W[5S"6L>NYX*G`$"*`&_!B0!1@
M*BUX^5V1Z9,$Z)&-)<(;7/A/>GWV]JC-/B:A/;4B$`5W1=@"F!!Z#);/'H+`
M>0(W@L$B)G6EX!YT-T`:0@L9>^?!]-C8`@%EP:.XD[MAP6U`^DT2CWG(FVWL
MVR*X3[P\@/P]'.8V$T)=?`UR88+O%DY/F[V!24F)./3-J_018X$W@0[F([+$
M*U,W:Y>79;39ZZ)C"K>N>0\\\S\\#`YTX%+7S6Q)G[#3[K)UKN`>8SS(V=O#
M92O[>*]M.TC\./IH+1`SX&.8<.=G5\J[RR/P&#^@+!:^RA_Z-@EQ8;W.'1QV
MR!TD=U"%F,@=/)IV2L68TDQ6T$-R#"_A&*8,L11#O`)#)`!M6]>GN)!ZDRE@
M3<`:!4\(AR^$-Q,D$5P:??MR&Y.U"9EMYMBN^^N*4`JR;R%="6H.AA1EI&2'
MEL,0YMG>N;'59<(V_NS,AI#L\M8$$!SF`20</-M$34D1<\\C!%MWEX[NSW/J
M=L`*')VV/W""JJVU="?L)9685%-^_Q);5OEVC8QJ2K&/(W?\&F;.KFI[KVAW
MS1UVUS`/SP0@PWQ,X2=P-FNPPY7H)!GK,Y[`E"SLGJAV]?<LO''N[6]!3V4E
M6="]+6@%/<3(@C9$!R]^:'5+\X\SU=F]X0.J'ZU%&.`.F^]DV[,J3^F4EL(;
M!:6>DKEG5'6=F%=+(G0:L=.H<NTU\:S;&G1'E]&L!@"I3IRJ]YC*[N7)WDL/
M4JOS,(M02WO4JHQ%I%XEGO5:_>Z04*L!G-)^OV/[<H]6<L<7,G^PO"K6;LN:
M24IW@;@UKK\(J(Y87IT$4R3Z&HA^=QT*D)C7;7!(VB]#]WT)3QI0-O2C"DJQ
MDNCKLK"XP,X2+36.KFHZ=4.'P9H\7N!!*VZ%]E3L(#G\D7N!/,M^EETDTEL]
M(J.T6CDNU:+5Z]32%ID41"\%H36-'GP@C="&$[3N.3)_P.R<THJ*%$3[M5`M
MATIJ/B]RPZLA421@W:'8"N,35;>`(KVM<)]&IY9,U\0MHW4_K#+(U_`D<YU8
M4^M!G9/.X9#BU+0[1!"D*V^J9`YITA($C<PZ#D,1!&F^!JNS/9]F#2AN>.E6
M6WN^RS6-N%%K<.FC4#HU<;@FO@Y;QJ"6WE.7[[-PHYJJT[&JXQ&6U%3+XU>$
MIMJCZ5G92&I:7LYV6IU!O0DG!*>Z6UYMNA*-D!?K)K&ES'>U5;O+%<'_Z0)A
MW7CQ'DL`\6A=FYABF6^#RGQ75.8[4XV&5JH>7J[*=]-)]VDQFT\#?\'>+7QK
M%K38>]_>7OF?RGN?#!SKRWM_\-GK>>AZ>4E;8]@235I:[(FW6,8JS/3^!\@)
MV!_L!X'&4C3R")@ET=N2K4A<_S'P'K&RM\4B'KJR+T9:9<AZ"#G'3/$(^V`\
MNOBXK$.$Y3Q:OBU^QGML'L:6*QI58.,8=S9+_``[;R3PK"!<K,B+%F065(69
M_YEPF$MT-Q8=3V"R#Z$UDUUA;)QEV"JU;$'RYI_?(CW`I"[8"S3H:2NTEB#3
M?ZM&+6;GU4?UV.PKX]6WHM%*E,"8L!D+W!#Q`MD+',6)P-`^O7LOW@Z,XZ+=
MS_-^)Y>&M(L'/&J2P%4X@/2MLKS[$V>>:V/6O^CQD\F(X!G(B1A^8GEY^SNA
M7:7&0.6GRHXXLOU*%('EE!?!0-OL-?;)`9Q.O+26_*;I!4]X'^)?6G0>6^[%
MHHE1.LCT7=NN%:_=8IOV;,Q@DK%Y]=Y'Y\GGTE(\N:H_3M%\.#RR0W>,IF(<
M/((!RN0)A,-7XI)@]QS&O]I>$F'#G;GJ+,2"N7A(/+5B]F")-D#B#8+$+39.
M8AA@++X*QH#)HA-."Q\I.E*!P(F?DCB*0;31-BDYB+B=A++I@12)3$J#Q'-2
M@41CE6`SGZ7^5OC0K:H@!KQ)D5XL*?T'N,GUX2EI0R7V04R[;`3>"P)-+?^!
M9P9VTYUHZC/Z9N_%7D9WV+5'9T/[9(4X;M%X*A.#9(X?S1;XYO@/BZ:PLHQ2
M(+&#V0SX$L7HV@/=A2CQT'8C[&,%',`+G]^WNR8#)LF;\=F93;72M^9OS"S0
M9F[]KD9:9).TH"GE4\`+^8.+G:Z$^*024A"(\EC679T-I\U^A\%Y40"7V1P8
MZI0U)U68`O&XJWIQ\1)`@0AE'W-XR(%*(=S*_)597R.CS)$-L40_$#>,8MDB
M2NF+H-:#FL1[Y:6@8W(OI#7E6`F1U$LR>2^./QV?5%NIL,*#D0:"V\&#GRFL
MQ9X;_:R#59K=*=JAI?@B*!OR&3"LU"(/>Y!AKQ-<SJ7C*)Z04].3/L!&V,_\
M!1B?!:O?T,'KI<FT2L^;>Y9?*N18_'&<.`^\8%^$7`CK(IZ42A3A6S7X]C%T
MD>/2GUG"`,OS4MZOP1<)*MCD;DV/B8YPR$="[K&/#@;8I.<D-,<'T7`15`+U
M-BD-*.#2YH$5D\WE,G<&].D70-?R>[)WE+U[OV#<2E(C^A,&CCM9I.T('V&^
MZC4X!O@],ZS;X&?%9KR>R3YQ6P'N=RY:(GH\I43E!%\%T7V>*4CH1E&BO-;B
M`JJPI'%%B\T[Z74'8?22O7`U!MIO"PO$[AI@+8'J,C\_B<N*['L%LW4+S^P+
M1V,]FJ_#\=+KI%5<B^)&>]0KH/CRP-9A\BO!*1A><7P6$,._<U6,D(UAL,AX
M<"9YWH[3!3V<@WA;,XQ6RO?W\];93L(W]\HR6VPNHYOX/-N*IJU59P4E$+\9
M@Q8I1Q?&@[(>BXL=%YQGKCPZN;#)O%S1VG$>\D<W2"+`J?1M8$U@99F^%!5B
M;3S`,%:(]PM,?L7GQ`AEZE(6R)?A#@9/@7)H3,3[8!@R'"`:D8*[#KH$)(0K
M^_EB3'H'L"[-FTKBU19H53*'/WWP[6%J=T@L%`'+2YM<PO6H7CY'VD4N?`0I
MR]Z9^43C!;XZ>^B2P<.OXL+I=_&EZC6:6OLBZH+\?!=(UI5'LP_VBR6&,I3`
ME^**0)CNST5#FLHO/,<3L\BLC5@]BQ?!HD.T"L6QRQ'`VPI++@+_:L`?\$@0
M7:F<9)GHWZMZY&X4?25"(AX3YO`J3-84/O&P%"Q)062#&+>8B_"[:$EY3AOT
M`O=]+HQ6,08G'R6\<-F>N2B0`K&DK"[[I0)^\S:X./Q'RTL*8NY&Q0GG+C2L
M.T1L$&T5FDE<]R`U)E[PA.X$]Z2,;_Y=6#+9OMB1<P066W*ID-HCV<080'@V
MEYX/K)*LT$F7&S!NT<Q86FH5R(*YC=-1PA3F8-Y@_*!ERL:(BW*#DENN-5[^
M+A-0)'.Z,I&10K3JN7+*IZ>&"QR.!YZO#8#=LF\R^D&6[ZI.QQ'/*:8Z!Q>(
MB0M>!OZ@P$=C-<M*"PT3"O5-1MD)#!_XL$\'X8XNYJP1-NNM<&VCU(696&XH
M])AG4%6P6;BJ==12HJ#00L#4^OD_<D5=<!*D@()G%,S`_5+E8;XMN`WINTL+
M&Q#T6)FH\@(F];5`^P,G&Z2819N]*\83]I<8X;##>B>QTX4$V@V^8A!D:`],
M[5S@Z"ZK()R)@A51%A@[?(M[@"%R9+E!PL<^3;FOPMI(+1O)H=X:J6AC8-M)
MN.1M9<8#1[G>\.$O8QY;<GWH1E]@C%P&)H53*XQ"$N5!D<TFN%6@.UY]E.`4
M8S`E,4''V6ROGL#00I%DV'&VU-S\,`M5$-2]NJ(+"75@H1O.1+0I#>=(<<"(
MMG(!BBXQ>KR'RB5.9]D+6`[P@?2TY,(#KN:M)2]@51)*T;,QE^WE=W0.-I1P
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M=]Q'>)TOW&&%OS+"!\(S#Z(T:6$>A,(&I3.7P&V%OMR'2>-*I/W5:#\*<`XG
MN47/1""/#XIW\!##U"K4X=F)7"++%29>_L:S["]WGVQ81,,S\@6J6F82TRHR
MV;M<`(P49@M_U"6%IBE>RU6]VMM23F>^1ETM?*0%->0:%=SP&;@1<K=$6AZT
M?1F(65'^@UK]L.!1[:^B0Y>Y28'E%T2W[)7/>#P-'!%T26VC\,CQRN).91Z#
M'EN>V#$L<F#]9H>*/Y,Z5&?#Y'Z'`(LL0BNL5)2,_U!!XS2*!S^Z=X[K)1+Y
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MSM$6O=X>\>JVUH/`H'4_Z+<,<YB"0)9R5@B`;#\[L7*<:H\C3^4S4F\!==Q8
MQ-->^\[;-+1KEXY9K3TN9=)Q*3HN)<:RVOY6EY'1.:YC*5>P"P(U2I:AF>>Y
M&N&1_<Z9)Z$Y"<'-LM615\2A-SS\PCT.?LI;$%9XNN]:I85">@'[&9^PLA)Y
M)[\Q^^:K*.*>$X23%OL)7'G<62H^9\V%:QZ9P-!#EKLW8M@J'UF@O]@^1`A'
M$%SMXJ8%$Z0WB-3YIVAZ8G;,;BM-`!,'L^3*IDS:U'V4*1QRQUKX`!RW"B4Y
M0K%UA/?&6)1J*2\HBQ,!(_/M-/%L2R1U2.]T+/-OY1/\!-T+O%@%`)1O(F]3
M^^:6.L@%*[H0,TIP&!@I!Y<C?.`J<5?ZH=R""8M'%=/UBT^3J4#%E.$(#_:7
M3D5$2A#PWHV"([<)\O0FC+WGX03Q1(<)!)4DRUZC-@9=I.XDPGV[!WA`%*L=
M^[PMC2XKPD88&;5)_8G/8^&RIEXJ[D3;0O#$4:I`I"/,%V)/.>-8P3`M-IFE
M4NQ))6&D45-P[/F=V)3)8\N)+][DBJT!]>CB<JG3WL/'T"=E8,W./\L7`]F.
M<ZIRY9"Y4@HAW)F]0+5.$\*B6.2_!;8K:)>=M1,:TQ)!>&&*4N(N*5,K&Z9<
M;PC;7;!"2Q:=%.N0>(HTU#PNV:9BAB=JSPIF%N4FVI4RTI5!?2$2*H,$%K:8
M#M\`%6GA0.\SA<$Y%+]8AMYW7&T$"G**>78*X8H=J2;=E$9FNU"0)/N+!'M_
MP?Y1IAK/P%S,DEENEW+LQUB7#.:*]?L28*R(/#B)VR1<'&,4"2#E[*;,EJ5?
MMX2_9*$.>2(I]H7PBH(D`MY'W[X\F<='%L0YI!K1AF(YI6C)P5$1M9ZUA?MV
M6)#D6>&U>G5Y')W<Y5%HW%8&5E%0:F7E?EJ%J1,,[_^FD(*ZM%;C=J_E*VV2
M=O[J7OHPXTQ5%:G*FAZ<6!L;)E:04EP-)XZKP/^C^!_Y"OI)`#C?O4JT<(G%
MN_V!_3AB=MI7U[.@8ONWEO)D_\Y7)7D]`_;U!:C`\5)#;;-;37UCT@OM_0**
M(>@J`>`7]"\3)R"_@-9%-\$)<A".=1"&IS3T(P5ID(-`@0-=)0`<A&JZ>E'@
M@`('Q`F*(%3H('0I@G!I)E`$@1R$-8?]*8*@F=;1`JG!G"`'X5@'@2((EV8"
M11#(05AS1HPB")II'2V0&LP)<A".K`S4[1ND($U3D(M'$')G8*D]]L8VVN0T
M'"@5G[%6L36)^6HCNRIC"V?B'[D81R^QMG$H)01963VXU:N07>2J+,4R>J/5
M8\#G4K2B*21ET\:EJ3#FL>K2(.\V"L&2L#@!GMYE9IO\GE/]'JPS4&NT1"?^
MDE]T],IR(QM3*FQC(3E.NAP=.1\;R:$JQWZZK<ZP<QD5/<;2DJK6[7:=6LF0
MZDX_9`7(9&O,)(RGY:K'G9YL5ATAK=UH*LJ&>3Q6%]@A=US5P/63Z[EVX+-_
M61Z6YWMC^5^P&HPJG+_(VEXM%?!3I?,*[7P[[=63KUI0L%0_29;'6R'%NLK!
M.ZLCR=:8HIFGA_6I0FQE*8L.RE)]HIN6K-WL<-&"7)`32947;$HKR$=LS+DH
M+>TECBQ1C06(0]?.FLSMKJ5\0$4G]EM6>D@6O%?ER\J,%AU3\Q**.;]%!R31
MBED,#:L]@^G.:JW-1)<PV44Y[\$P`2'#>6*SO.=FIU3WS2IT+IP%(?9-LGS6
M[8CIPB.PI!5SK$6T6FP1Q]]:DD=9GPU&A=6O,FE.V?`$+\ZK>,<!%M$R<I[`
M,UR/10DP1A3:0ZK"?.=A\`?/V2%[P"Y-7CP9FS/!5<M3S&O&.5+ZEJ<`U\A7
MBTZ%=IRD=2_7ODH^"N@]#H`TV^AIF"4JRO*7NA2F:[HM_GT_0_N.@VFQ4<$V
MF=C-U3]7K*TU!UG\*NH3>@OP=W1N")D;H50\?TC"(#K$$L?3,$@>IKOLVE&F
MV+R\*28]K$(/"SU?"YT*BS7U[$)-[HRYPGH*=TET<2E5ZQ7=\Y0=%AT('E3)
M7E&D.>UFSI(HZV>^W+B\^`39\B_$IJ((AEF_%M&S%E8?LF.+:DHN>AM%2YUL
ML7^POHHN*8Z?<:JA+#V;-RC>0&-P/T6-S[Q":Z$TLNR;@LV`F6*'ZR<"L"/.
MOQ1[;0@Y5[W@5<]V;,X$),?*TH"]W)[ZL(IZ4,7`X5F^ZB8ES#,:8-%?[9&'
MBQ:V34\FR#?9%A[>7VQAGK=ZW^!$Y5,0LYY9"VSOFODCV,4"OE*L3N9WLBOM
MA'.X?I8VII73#X.%Y0F!@:%B9=3(\F3#(QB%D]A8#!LF[_IRWJ+*HRR,+>CJ
ME&8NW#D+6[4@Y@AJ9Q);:$N\CVA*'0#MDCUVK0C8,/;$/+/2N639JO(P0L3Y
M0.`0%X76L8BW&R=*LU(SD_\>A`^6[_XG53W;<WT7VS"[_B.R!^Q6$`J,>N*>
MZ$R372'==Q!G[("<ZP$/H]3O5X*'S'<$]NW5PR59517AYI95!:N1IH;5R<RJ
MDKR\G#.Z3^$CB'@D[LC:$:WX1L^!C!K;S+QSD')QL%)$VK>Y:`A#23;7EW5,
M%P@Z0DV?P(<$`XD5QUTL__X3]]']\189.;%]D8<M#CWI:RHXXA/XH&HL%VKE
MEP0'R\QB=X-YX(JNT'(Y5%B`98*7CE^"``XEK8%/-J`*&[`&:%![1)W?"!=U
M&8[F0I-5-O^5/W#5T@D__N;##6&D^D+G5>=%`R]+MH265<[3A@,9ABQ4)R]9
MCWMN8:?T%'N+AD,J,X(<``1*6SH\[+QN"4@7OC)"GFSSA^OF-1BY%QIFL*:S
MIN,:)^W?<#AR;^W$L]+&ZK"N5,L=K6`)-0[0:WODKW.O=T<[JRZULZJHG94Q
M3*6SH;V/5I-]=1G9ZDZ4+B.[7*>MQHM;R6`!UDD/N`7.:+YB0^SX64'0ZQPA
M]R/ZY?IPF>W!?46NS/F9LS(1,;B?/.MK\`G0:?I_8,7!3P]"KVRX'M1@8)D6
M:_<X#QQ1?<W6UNP#Z^.BOL^[%>,>Y%#N019C/19["D+/`6O%84;8OOW!M0'U
M886"SJ#P5W_Z]'_0]TMC,:TT\"+W0,"OP1;+(KS+/O_\*SQWZHY=7,QN#L;D
M/HQ<$Z'^IP$EL9#-5LWX#O@+%DK9<K@8]P'7+9GCC;CINA5*-&&4]#S3<-5+
M08Z?N>4(TMU_-TI_`L]?]9^]^^"O^=%WU,3CIT#%C?"B/`X&O,=>.DC>,8<%
M9(ELN"@7UP_3.T1PW,]:)N%3BWUSU6,+(0,[M_&!O[8;C<:N/XITE(PC6-H`
M.3SL[AXG(6YR@.BGJR<1,':CC$+P.;GP'EWS$U8VQM,P+B)#F\@/90=$J)=]
M%,V%C=P"Q"(2IG9\UFF/VN#[EV'<C_"Z:!'%?`:6S4OF2<1XN(`[864,BZ?M
M3;TUH9JR&J!K<@\"-^I@13G'2!!(*`9\<]K->8B/DV'R!0:7W$<W7:$CQ3;:
ME;:P];C=AD]<P&+>G@81%[LW0/H8V[,MVY%RV[64_KF=R*(?:S1GQ2!<C+9E
MI%2M`U7@I1P4+6$BO(.K]I098B'2J:0!D&(1#,H;0P;^0R#HI$0ZBA-'Q'RD
MK"[M+LFVXS*>A+$A$52-1!AP>5L#QHO=K`)'-`)OL0>X`]X#PIY;,Q>@VG%E
M%!8P080]>"G*G'W(H]9^`=#QK4)DQ,4C]D("C\@+D1/X5NZ=^[8,38&BXRXO
MCOBB4<=#[.9)CB9%1A6ZVB`2_"MZAI@M`?*7QT6#>;HCG(8@1=_6S`:]GPCU
M2N_&,*.ZIR5^>`H2#S?]PW"!.0EL@NEV((;.TNJRZ)I:Q>ZL=A!B4[Y`IC*D
MH;\U+X:+W3`=;[`9;H2F^FETGWON@XLA,I@AZ!?'.>=M<B?*;UO:%#',)FR*
MM,06;NA&<F.GL$&IB)2QO-3GL^A)IM^/18=<N`5(_M^J"[-Q_PINL*<N<#+%
MES1"6^`N]E1\2#S<,%LL<9H%XS]DLT7*IJK6-[.\*%@KVE*<GP_VB.1=7'[%
MKL0#8*;($LF7OFI+)-_,+VYRX.2E3*IFU*Y8/^<;'[B8+>T7S%PG$VGC502_
M>=@!^\$5+8CAU[N8<U_X8UGN@-C4V[H+45YQ82-KD;L!2Q>9GY692;F0OBLO
MT^_@X;,`$ZY\GNT7IVX:^)#;_#32FV-S!(2*"-9(_SDS@")#VVB&SO@B>"17
M'0Z8`&S$/D:Q+8I/'M(!29?MMH5XBI3!.\M#L9/MH%$>HR"[ZL\$MSL7,H-@
M;H4B?\MW)59:MLC1`CW((AHRB&7)U;K8^K2#!U\D%P**%D>-*WQXN\Q3+C@'
MF7+G:%3H9XRJIA8[RF>0Z\_WXFV@.<'D#OX_XS:XO6XT6UJ61KDWOVOE65C0
M[3&W;AU36[.8*X6%=#$&C=#X7S$/"P0\L]C+.B]^$"XL"+N3=H)6B;)CCM:^
MP'$,MJHEX%PFN>?YXVJ-+X*T:];:K?35X%KF;=-!`L:8_0^CE(VYA=QM.K)B
M=&67>ZZQC4*#(J8FE>51.*;'D4QU8\Z)(W(:W:_J`RP8$D_@L0H[*4:EBO2\
MT\X5%`U7(1%2B86PHT:W`I72;X.%$/]!U.Y13;M%,I8\:Y/,@`XPQ$A)C9"%
MJ*CG4A@W!)EV-?_>0`Y3`W+D*8<7%OA3PCX-:%E>614,W-EN=F&O#4S<=:2Y
M,@J:32>@QML?1]67@`D`P8'5!FAC#6S?7#)WSQ)>6^L52+MQ1,&"V@6CR-_+
M=J#_7W#/F-RGR79PNL9JWND%K$%-Q:5(#LY?>ZH6C#VD/@;AB%9UBNKP&$@<
M&B,.F5MA7LZKV+=R$KD==<`-1G)TL!]'EELB1T0C1^12^+*/P=B.+60T"&L(
M:\Z`-:>T<R*LN5K)(*PAT2"L(:RI%&M.Z0Q$6'.UDM'`?D6;[<W>8=A&"(E.
M\;3WY9RG$VS)F45BWT@L2816+7@NYX\T%5)TDHUJN@R<122V(<:Y&Q+<E(P8
MK?M.+>VLSV\ZKL$CU4DTF@@MY&>0,)"?07X&^1F:R8C1ZIG#YL@)^1D$+>1G
MD#"0GZ&1;)"?07X&^1ED/C3?8ZN\@7;SCPYJ+!7_S(HZJ./#E1B/RF6`#C_J
M9!C.Q?N33T`2;MRF>.Q`#')!:Y27.]W$Y&8.S.HD!?I:#7(H;I?WY%"0>)!#
MT3!Y(8>"I$!GJT$.Q>WRGAP*$@]R*!HF+T:_!8/035;(JVB$Z;CXP;/3:GTY
M08)U1LTV.24GBL[G(+8\W;;:3RK\1;*AJ4=R\5R,#<?D2P)#'BVE>M4M-N3I
M7L'QMI.*,&S$*#([UPQ;Y->0@)!?TWCY(;^&_)JK37,GOT97<=$7MLBO(0$A
MOZ;Q\D-^#?DUE?@U`W)LR.Z<;?OR.]%T,+M.]2,\@0'[M4[<KXWDN@G6V]KQ
M*AN'OI9-HPOMRV3_7>QJB\7?6WFSX+29K.CJ[&*;T6!MJV'L,/P<%'I%YK0@
M@YAUUBX7I_F\U\YZ=[>PVR[V[W4?N;>@%M2'2-(X0NYS*_06+.;AS/5%K^_6
M4K/C)Z`T-DEV0\Z>IAQX`)]!!G_Z]'^$.O]U:!KWKZ*\6_T8,$P\*5*WM=D/
M+CPSA$O">,%F5OX^OO0R.9ID#JQ^"MTXAM?Y0>S:(+6RY7A0>)`=S&;8_-WR
M6>+;"<H\=J_&UNIL''++GJ:-RK,7'#`4U;P9E4@T/'=]P$CX8"_2IQ;&TA8=
M>"TO"MC4DOU[@[EH^(Q*M^$-V+DW2&)F6TG$Y:3GH1N$RU/'ZV`T%D-)=R<N
MS/,)V!D\B8&`Z(#.S[G@KWP*OB:*K0>.%V0]Y]<T<%>MVZ,J%&>XI#AF&Y-:
M]@>0XZUSL>;UH4IV@E%Z'<&E_X_[W+9.)]^`L.W5>Y]]XO-8(IO9Z0Q:V%9>
M5.('D7=]4"4+Q%;O/O-WV`0>40G^`P9(-&P&%UH81`%?'JBT'RW;`5:4)GB/
M4$_'C>S@D8<+<>.2_G[^^5<V@J<$OAO%=V-+];,'Q]N%.::/B,$.QNDM5A1/
M9Y9XF#T-X48;K#6\-Q'XR>:)-PM\"UX'+^;PP+8><'H%<OW!C@,IU88AI-J:
MR4:T:WJY%R4!1!YL]*/K('98,=XI\-@.?`>XEOERFXS\Z__WCAD]8]1FOXG6
M\4(D`(ZB#!G5.+(QM$KO%R^;)"`PB/H*+A#6480C')X04/$H.XC$.XM#L%"R
M8(BBIWT8)`]3]A$`$A:05HOQ",`+8-$1((GY=\R:PSN^BF_!#WANKJ;U:L'G
MDE/:9K^CDVUST"$'G9%E!QMH\KR;N;`PUS%_4-[%6KXI,K?9>WG1Q`V!LG\F
MX&@`J>%ITM%_*KX5/?A!]H[TS6@QG4?+!R<")`$%09K1.=R8OCD&>N,B^&$!
M9$T<9!4:"'@QL&G-CT]@C='UFGL\%F99"M74#9WE,0K*X,.*(C6U'I7Q<Y;&
M)R05OGNR0@<&H23%R(D4HVL'$Y^Z8%G!Q":>&H%5HA_**ZYWBO0?%%<,BFAJ
MZ!/005"[E;&_GY3&;4^#0,E\.N:""P5/\;S@"5^K:(-\@&?EXI[JKGJ_X%DG
M8]DLJ]R2#GN9<.KFV()QH]LK#*@8CYJ\E"BXS764LPE@(+%#*.ILQD,;*`@*
M(RZ5%,0A*V"`N:!5D6P#+G/PY%T,]\#MV:@=Q\6Y`3M6AAREO(&I"C8[7/J^
MDM5C\$H3P!O0)'Q2=CO<!H1*YH*T90-@=#HYXR3&*?\6O'L7IITRV.:A($S)
M^/BX"'Y(8/D;`*@%XS_D0A'<W=?9++Q%2SK-1?JHA=#39C*`21-K[&!A><*\
M@=5X0%).PF`F!CASQ:2GP"46P2\>OW/@.<"Q;!Z*WBRR@!("H/U%^B5\!@:+
M-5GQJ25_0C!*$+J\X+"#.WC*+(AY*N._@4F"=WZ*@:Y1_@HP:]'FQ[=PT05#
M:B_IKUS?"/'#MP%/4Y^F():"IHAN<DD#@!6)]9<>+D4C_(9?50`GX\ZZR$T6
M[D%I=T&X.#(4Q#1X\&$F(&<I/B-JVR@%<U@B!P[*&_R%(Q/&+,D<A((O(-49
M'EO6R[[>N`P_34')5^BW#236D4Y)>O&VIR#\@M<JRG&GS4BD]Q?ISP)O4Z04
M\6JP'S.8+`Q1V17)M0AC00@<4BYW^,DOA)T+D@BT(/KVY>DL.4,L?#.G=MU?
MU];#7XU!9]O6@]I14-M5@GER=^C[9YUG`,$>M@2T@;/99[7_)#ZKO2W96B_;
MR5+;2P)XYA%_F?[QBJE]J@[0]MG>9[1J.9'5S!/@&_9:+M'CLYD$O*J=PF++
M3J-SN9Z=VXY';\TXH):<N\7B?S'V*`,ZQ2W"$S(0Z"1T$^6@WG/0%S_U3#BB
M5:;DI1-G21ST<"NH$_B-P@UF(.E@/Z@3N&Z2T1Q\V<=@;,<6,AJ$-80U9\":
M4TH@$-9<K600UI!H$-80UE2*-88.MH2P1C?):&"AR<WV9N\P;".$1*=XVOMR
MPDYT@C&AEL#7(1+76IN@J9BBDVQ<6=T!JBE0@XS<KSD3H:V44$-@`A;R,D@8
MR,O02#;(RR`O@[P,,AXW`RSD99`PD)=!7@9Y&9K)B$%>!@G&);?7*N_WU_Q3
M@QI+Q<?":?5@DM=8RHO,5&)-J)=P@V2B8A>4>@F3>%Q:/*B7\.7DQ6SU._>Z
MB<K-'*#521+TM1SD5-PN[\FI(/$@IZ)A\F*V>H-JVK:24]%L2=#7<I!3<;N\
M)Z>"Q(.<BH;)RZ!'+@7)02-/HIU6_(O:I%8E.I^QY8)N&_#40E<+V;C6U"YJ
MH4OI7T>D?U$+W0O)4;=EFM5LR%$'W1L0%WUAB_P:$A#R:QHO/^37D%]3C5]C
M#*L)X)%?<P/BHB]LD5]#`D)^3>/EA_P:\FLJ*1Q04:83>34W("PG[EU^)UH0
M9M>I[H0G,*#Z'H\;>O#5,KZU74%W#W%)/@ZXOUJ)6-\P]+7HBUQL9H;=N;NB
MVZUL@RX;QV=M<,-=37/QSBV-8"/15?=YKSU<D4DMR"2HDG4-Q\D\OV_?%[N;
M1W/9YMI;M+>H5>V=:8MU>I>ELAFB-\:.U=B&UELPV<=<M<4N-4F6?=GYU[D;
M<O8TY<`4^!R4FL<+._#7H6G<OXKRMO1C`#_QQ$C=OJ/1=CH&OC0`*Q:-PV.@
MD6R[+5MN/X5N',-P_"!V;2Y$A;O8%!Y&$,8+-K,6&Q\I)RT>MO08=R*;C1<>
MA)W3L?.WY;/$MQ/40NP3':+6C4-NV5,D1^D%5?0!'QXFFF8;,TXJ,8]%T3Y4
M:$^74#$1,;A?+-G#GKWWH]B-DUAVD?\'M[QXREZD4F=V7OWR_A_9)^/5MT(8
M/@@6_JC,W\G\&%2`5HVP"[]S4,U'SL8<=?W)"K'=)MX:)!%[@,>"*F3H`X07
MQ%9_EPS!*ON$V?`\'CXLQ%WO_0G:<GSP.S?B5L27N/KZ_;L27UV?"?<5S04"
M6W9(OLVP];88+2AJB&VV/0N;P<.%"!CNQ+7S$_7!^`^)(9$8QA,7S;@S;$T-
MDWI$=AMVF/<C+E_@HBD(L4%Z2C#5T#M]BI.$*'CX)-F1/EIJ7?K?64_J%=C/
M"9QW$Y>3>[E%D,%#3+M0HXAFPG9P*VLEF+MZ5X]Z;?/^FY)6]-OWW17%R`<2
M9G_EBR-0KNR-\KG==A<>LKH".7`!,DB5:2\%5!KWW]8\B%Y]6LS`^LF_UR\[
M).^&W3U<^YWS'0V$[:YU>A?SY3[Q>2R=6Y3PEK08RJJ`WC_OM,W,W5O6:M1W
MY<NB!GS^^5?0D-AZ"'PW0BL$7@`:>6N^0,LRY7.P.#:;N.,PB%RIV[8;AE/\
MM,U9+##JNUQ&-Z^_2-%V2>)QCL<UZ&!S5J1B-/^3^%RM-%<U<[!5,R,;O%T?
M%1,5T?6G[MB-@U#X:*BJ0ZF@X"''<D$P8582!^YLAN]T).!'6UUE4DQ2S!M5
MS'_"\G637O96]+(8\<G4KZ"2*YH83GD"J]C`=<";C:>P"'9)%4D521778J0G
M=-$X'"/G(;<]UW=M6`;/`H=[`AVC+_!3`0M=?^)9LYE8+Y,2DA*2$JXJX>OD
M(8EB5,,.JN'K]^^*BFC)R)0((UM?.'R.%A&L.R,V=@,OP'C3?!X&&*O%B%"<
M.`L17G'<R82'W+=A^&,>/V',R_5!;5PGL4!9GZ8!<P(&Z`G_]H-8[#\$OH@K
M/5JVK6+FS'JP7!^&A\^4ZU#`4_:&/;IA$F%P"C[)MXIP^I@SF*TP!0#<(6[?
MA`'&I")FP],3&^-.8$M@U5R<&3S\C;7P8#2ED-I[M")REK\6;,\["Y0SPF@6
MQK'3&/4_`/9]>0MG'Z<<)K40J^NWHF-FA".!-\[RN%8I$&BI#2EXVG.CX(C(
MP<8X3S%>,F-DQLB,;?8E.CM]"?YU#IHN=ZXFL%0&5]YS8Q'I*L3$+-`\%TQ(
M!#HI#1+'F^<B"AVC9R$B[#X;+]A4J/[<FL-+8'ZI<2)%)44E1=T6M^X,U[H<
M$U"\NP7@+4!AEJ*```XOL05B*T5E01*R`"@<^(GM\2!V'=!2;D\5:B=1&MX>
ML2RZ#;B=*K3E_)$\XL:;W.;*WA`E\WD0XK7J@G+F!_@)\-TTM+[BPYY`Q?"_
M<FM;A=_4HJ3*X'CMF1=-%*GU6ZV?2QM\TDA&"2P$0QABN@DI=A,C^,,.'GSX
MWLE\+9YMRUHAC.&!JP0?-YZ6-F>EZ+X`ES">PM7P5?3MRPHR%$YEX4DY9DKB
M5*[EH?BBS)WL$K\WW!B=CK*$>U47J:662#,+EVU@XME:S%/E-YW27('3,`$@
M.+#:`&VL@>TG%WW;FBLO[8:.R?)%_HH$KM,DY02Q^%]TC,H9+YC?>H",U&8-
M;J"&ESYR4&\%KUHP]I`3%,W&D2:+R9G\!1*&A@A#YE*8E_,H]CVQ1RY''6*#
M&88Z6(\C#^.1$Z*70;D(NNQC,+8C"QD-PAK"FC-@S2E'P0EKKE8R"&M(-`AK
M"&LJQ1I#!UM"6*.;9#2P/<)F>[-W"/9$(3',MMG?)2AWV577M%<G4P'2!))J
M&HJ?13;V#<@VPG[H)!'76EFOJ=BBDVQ<6=4\JHA7@XST6D;GE*"[1J;C8->4
M9.7ZL>9XQX.DX_JEHS)/A(2%7!.2D:J;$/3O3XF;:61+KB%JII-H-!%K*`1"
MPD`A$/(SR,_03$;,UGVWTQPY(3]#9V@Y;G^N\C;W9SQR>,/;<:^QE+HXCXUG
M=:O=EJM<).@,I4YVXER\/_D@)<'(;8K'#@`AC[1&>3%:G6Y?-U&IY^PMB<:U
MF)(*O`P2AFL1AO.X'20OUR\OY(=<<`=NL-IF3@N4N8$*(#K)@;YV@T(;M\M[
M"FV0>)!+T3!YZ0ZKV6HCEZ+9<M#`DV^G%1K;V*J=MM^.E:'/HI6![*^@"NWJ
MMHU_4CFRND2&K(T^`E+I\?V2P)"72VED=8L->;^'R5&_972K":E5CE%'%H?8
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MO\OV`?9Z;0_E+935IU'R&RMR;>8#R3TD^1Q('@F26QY8=F%SXP`L^FP6^#`%
M,/93$`<>KIZDUF*28D[,C9AM>7;B63%WV'C!@/\N`H-HWIQ-=M<4\4Z\08Z.
M.W?6(P^M!WA"(GIN!I/L+B19Q((DCF++%V]RDC!](1#5#9PV>^=Z"0[H"&J+
M*06S>:+1A$0'[`<8"'S+)Q,N&[/#&-@\B$'*7/@31PJ3!D=CZ<FR,3L^+`ZY
M!4['XDZ,E,UX/$5B_1B$;)Z$\R#"<4S@T@)7W<!OE2;(HF3\AQI!R.$^>XH]
MV,?8`;Y5FH:\/)CC,^`G^5$TGX=/3Z+=-[9]AZE]@EG"N]^PMX$/=(I=).S'
MD$]X&`(7/LD[0]$U/G*!OO`EO'[,]YD_O@#O#7RXQO5M+\%VKJ*1."].$Z?N
MG"`W3U,NGNF&*8^`C.F8VJ>W*C^#8[O9MNRZOZYUQ%^-06?;.N**.JBOK'0+
MZ9;#B@Z4:M2HY+1NZ@>G*]=#EKIFO4]G<0TZ@9\:MECQ?2_6@R3M[IT;G4K:
M?-=>+D`OR:VCZ?6>9K&27CX4Z[M@F[AZVC,U2'OV:Y/6A+9FUX,+U71COF#G
M,9VEO58))R-`1D"K-KED!,@(D!%HLA&HH'\I&8'35HW'YY*L74=NSDC:>VW9
MK)/+^NB3W`[#X/R6H/L+$:8/D@BNBUJ,?[4YD#_[/8_66+,@\>/HVY=UY"D=
MIK0;!6*)_:OR<8UFL]XDUGKZ2)R145<7S-G!JFU6E5BE%:OJ:+%`[+HXNX@W
M>O&&K)Y6K"*`:@RK"*"NDEW$&[UX0U9/*U810#6&5010NAPJJZT'W1%1Y68%
MC'42@E^2&0^M&,93B<XN\3K36=*]<U:WSLA.5E`+3@R)$YIP@G1"(TX0V4D!
M;I<3!`JZ<()T0B-.$-E)`6Z7$P0*NG""=$*G&.(9,E-/C"&:@_;@5F.(*LFT
MUJ@_:=Y%-EO(!FK!B7W]@@KJ<%X3:UX,!JU[LY9"FZ0A^[/A6T*&*[-')/>Z
M<(*0X4AD&+5&O5I:2Y"&$#+H26U"AEOB!"'#<<C0&[;ZHWO2D(8@PP63$JNH
M)$E!QOWD(2]=*XO>.IS/N"-+"7/?J74CX&3NWJ@.GVF?9I]2+&1QM>#6#E-Y
M[IY#U\2^%\-6;U#-@O94.TC*=J:%+P%6\TP@`5:3N$6`51O[[K0P@:1G6N@9
M@5:3V4.@I16W"+0(M$C/&I29>EKOC;K:P]]PM/F7?9O2U;I-=!YA(`-Q$1Y6
MWH/]MMGYO-:-]/-QD?RM<E3[OM\RAO7F:5VLW?V-JFJ]25\$F@2:!)H$FK<,
MFF=(;B;0)-`DT"30O#UV$FA>)5O/D?=-H*DI:&I;V;8H,77%^6^X_.T[[@<S
MU\<"N`RN9^-].JCMVA.HMY3N:1)QHX;@S#D2*[PA]THK5FTSK,0JK5BUK\4C
M=C6*7<0;O7A#5D\K5A%`-895!%!7R2[BC5Z\(:NG%:L(H!K#*@(H2BJG?/%Z
M!>-W\33NW%F//+0>>!86QH!QQ((DCF++1_Z<97^)=NBUWJ&G#7CMN;7#:M)&
M^_'L,T:#EGG?U\(0DK9IH6T$74UF#T&75MPBZ*H/NNX[E179(NBZ"FTCZ&HR
M>PBZM.(605=]T&7V6T;'T,(0DK9=.-)<<5QYZ[;"F8+/-YS$_*:*I.43#,-1
MNTWD-%T0A@_>=2<?ZN)'QP[>?B=/JAXFONBTNT-=S24I8:TGJ0GJ".H(Z@CJ
M;@?J>J>$#`CJ".H(Z@CJKIMY!'57P$1<U9VRL4M0UQ"H*\7)OXLQ))I=Y[B/
MIT6A.]]LC3_#QP(E3.3!.O,_KW40O7:_]\TR1]8S>!W;MG&X,I:NC%<,[T.>
M1LV>K!">$T<M&<5FP3QV`Q\^?N*A"R-[P]X&_B,/8Q=5*N\>^0FO7I$5+28M
MYBCB^')*43+^@]LQ!NQ#/D]">VI%G(T7+(E8`K0)U746T,*)V!,/.>-?;2]Q
M8)Z3,)BQ>,J9;7EVXEE('19,CMD:8%8DGL0G$QP./`0^N2%S?7A7A,]]"A+/
M85/K$8;'N0]SB-T[L1GA/O(VVZ*:9U*S;4S<)?F[[J_+'?RK,>AL<P>5L5*(
M)/@GX>3[9YUGS.:>AX`!NI)]5EMYXK."+QOHQ<,,OA0>@6'WK'G$7Z9_O&(*
MV#H=U5:]_GW&[8613MPN[.S:*CP.(#?8\3V=AZKI9*PC4\'OD\P_PO&[&.%`
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MU2AV$6_TX@U9/:U810#5&%810%TENX@W>O&&K)Y6K"*`:@RK"*`:4A?IK*U=
MFQ4VUDD(/A5/?!0.3,B#$)7H\:9.&J2/%VE@0I91"TX,#]^)I+.E6#:XU>EU
M2$&N7T$((0@A;IH3A!#'(42_U1]44YR7%$1K!2&$((2X:4X00AR'$$9EY=M)
M0;0//YXAM97"CT>''_>H,,->6!&SY>_PW5)AE5/J\NW>:R"EO<@6#YE/+3A!
M_L51K.EU6[UN-3%*4A"M%800@A#BICE!"'$4:^Y(-ZY?-P@<"!QNFA,$#@0.
M361`HQ(C5P_8KRMTT=PS]CH)QN^J4':M6P<GLY&T]E+LH;,"6G%KATVD%A\G
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M^PPO?N,%]I>__^6_&/M;>IDH_C`-/!#`Z(<_$S=>_!+$_)T;V5X0)87;F.M\
M_^S'?P./N\/^,RP5@5/YE4^^?_86OS4ZYLCHF?_&QM+PP1!_&&;7>/9W'*`:
MGZ0S?&!*EY!.F5@)\BMU^/Y9!]["/6QW:<-$LL]J7T5\5DQ1"@22Z%GSB+],
M_WC%E"9V<DYL8$P^AC#[*]=X8.Z2<O?:_=ZZ<QY'[,8L\7F]EA65131&6Z=,
M6P7IE&R>]FYUVDFQ4;_=&QQ5QD5[`BW54FFQM[)VBJRL@O6>TT,-;#]"?I=+
MX:DV:7"<35IMF*HS`UXG\30(X57``31VVPZ/U$(V:0[VI],!9*D,(5?&*X;W
MP6?_M!;,'+486FP63[FL^:-`@5GS>1@\`F4M']M<AMR*.!.]*SGSD]F8ARR8
M,"OG@&AU&>&7Q1)";!(&,V;V.RT`"_QGA45:$$G0!,L?=?.1ME>U=H<#=+&1
M?Y[R$I-6V?)D18Q/)MS&,D_S)(P2>`A.V&)OL3;4Q+6MF"/W7L^X[\`_XE?D
M]B?W:SR57PMQ<-BO/(HM?-#2K>]].PCG0:@ZG>+-SS8]_=FW+39Q/7C(DPN/
M%R_B,(/8"A=XX:=8W2%^23^\XQY6SX>_I?QV.U)^3U9\XT@GKED&<[GZ5Z&U
M+9G.?4WGZTA*HLV%%>P:N0D%P7S"?_6;8.UR@SW/Q$(UJ,C-!ZJ['V37YO*R
MS3?<4^7,HR5F`Y4V2\\EEJ;KI>>]SS[8<8"2DP$O^(USRU^P",P!VU#A2HLI
M+0O.\TX;EH!L;H6X`DC0A.]1<Q!>`K`#(&1/$:_FH6L+X_[<:'7N^X6^V2A\
M#Z'HI1T&-N>.>*GP3+ZZ,X`$;\&>]P;M>P:D\!!S$/M\E@#1PZ?0C6/NPWO&
MGFO#C3`&E%OV>A+#&]P((1!>;`=1O.ZY9KN?/K8EO1X>Y^,0;@U^FSY7*O[R
MV'IM,WW(115FEXG5Q)E9KS(_6/94200Z!ON(F)M5M10_NS[X,L9.@ZP)%9:U
MK.1/6S%#4Q'#"/!O%$'ILHL8T5^'IG'_*E)-A]KL'\$3!RJT"M<A;4!(I^[8
M11=."')**Q!CZ8CM0V*DZ89!NI,6`X?38O!CXL7X>Y0`$^5[HDREU(A0SUU0
M0FL"'J$+N@/^:I"`+0R>?#8+@._Q%-1ZU!X-OTE=PCB(+:^P$MDP$KC4%[JN
ML*R(8."OBD<!A?PX?:ZRQ25J>NZ?B>L(K[;%''A:X"7R`UBR)U<\C27S%DL7
M3_N*Z1.8!J"1S=U'CB;16@C'F_^9P-R`O*E]S2SBF$\"81@7N2G"[V%0<>B.
M$U7$%2=2)(,:5ULMD_<>WP/W>6AY8,JF%HP0'(''0$B)L#=1B_&O-I_'R.L0
M!NWBG>,%`Q]=$%O]"LR+U9#\2)&Z0"F+S:P_P-V(%RD/"DS:6]VS]^.:!A<9
M4DIX.(NR5<0>CT*5.8R'2'X_`*;YL1M[<@`92X%/COOH@D%S@%J)[_%(=@)+
MX&J/17-NB\41DMCAMF<I"L)PC[-47=P_.+NM:HQ57:?=X\`*'62W`_(#KAGJ
MR>=]K2"\^$O$0*I=,`5*\]:]I&S#([PTTUG1'@X5(8HX6,%D'O@'FZ)E2_0T
MY;@>`7WU0-2`%"!@<(GK%[XX8)HS6&OC5/.9MG`)#HX?JJU8P<.W?R0I&5#P
M09I!V.%S)-^PQ<#:UMQ%<R[)@W$,-&0JVC1)X@1-')_S='Z*0*GZY&HN4$;=
MH*!(^7D:N%]2-QOH@*&83"PW=?(5(\N(C][`T]2UIP=X$&4G#=&"8X@)'P`6
M,;`M%:Q:6B?L_0(PI,^'[=6,*0T)+^UHNHQ1\NVHJ%<JPRVQ=,JIG*X;P6SA
M5AAX.*`E?`9_I*`C5;QXW8,OUO7B\>5K<[>C'..-#O,9Q"(VR%>Y:8B.S<`3
M=.>>FR$<O!D73QQ786,>/W$NI[U9RBP%ZWL-)'<VE>CD;I2@+S@E2&!)HHP(
M3\*7F7@R4BJ<6&#:'?K;+6"6?V=;T;2U0CM%M4,=P(V,EDP&#<E^SB+T;.*&
M40P4L\'/*6I0!2;NP"AHP<1M"H1N,WH;0J%"@1`/7'LEIKI-(T^T<LN\$8?Z
MMF[=U1T8/9JF^D#'!Y_]$CR*2*E$?&/0>=5#B]`9@@N1A.Q-ZGZ]2]VOW!.V
M<@6#"^#5Q5"ET.0,'00MV0N+I8Z%V7DE.)A]-EY]*^PGQW!"<8F1A19P.,4]
MW%8ALB678CK'<W/S)G9>"G1(YR3W2`OT6&/[8`TJTC&"=8PS[B7G4G-7VC$$
M`DH@6C*O(GPC6)&ND:15"_D#>,`<>:GB`/#4C)\B+I%$@NEH@*>)[\"EZ&CB
MDG$Y'/2:_8]T/C]:8`QM=VZ)=>K*%OTR0[=0K7#O"N%:(@Y3"%T.X&'B61O&
MN_2P%GBJXS]`W(6S[/R11#&N_-OLM]2WM6QP]"-7^O83$6FP?#](`!UFA7`%
M^%UJJT[<@$\VQ4!L<5$HPR=*MHM"7Y()!&0+[XIP62&X))8+#V&0S,4$TLB,
M(P8"RPY;?I+W1.Q%@7"OQ4@$^<6O9<()]5,,%Z01H@$3%.L5$>A1EG?*O<Q5
M6'YF2\9.1%A"").0KZ(`"0G,O9CR?.$^?!:&'L(O/"ZX'$^!B*U)$>5?@9#N
MLN\IAM=F[R?LB8OEOR*]6+'`(WGX@.\,U93&2>3ZN.X'5V;L^G)S5*BU9:=+
MM_Y&GJE%H;!;(K6+S8,GC)GA"@==+;':6D.?]7269!-;59:(@V^F8"N-+XH8
MFIV$H8A-;29):YGF&V)RZAXK&[*M_%/I]*1OQ0AGNJ0KDBMG_$GL^YS^"3;/
MPR2'2"J3(T,X,^NK.P-;ONJ1IMZTNQ0]%!L/F.YIB\"J%<=\-I>[Z-87N/M1
MB'?I?IR`[RMA\=4R%H-)6?:%$O]UB^95X"Q-2I")?YV[X59C;@RSN%2<WXS2
M!?(&SGH(=EHYNRB#7T$T_(>5@:W)E:`=^`T!J#Q%3(_M]RO:3'T2Z\6YQV.9
MN+1M(Q`UYWZUY(L6LQ63:_7O10Y!P8PB()2W-Z0?IJ8&EO.YT2[MH4J3L+2)
M"G<EV1:F&VW?PQSV\XW0=/,4;&1B"P=KYS9JKX)MU&&G/6K$-JI^BZ]_6@#F
MN<U/\_U:J"IP,9=>B_(A8KP<\?1]RM5/%GKKKQ]"+KW.91\Y^Z6TRA+QX'_^
M_*_\O>(O_`<`H\U^_OEMR6',+E7W"[55W@",$X//0CY$_"?B@&LKBI`Z=`\P
MH`<,ET1BY,6\`?!D<4NM&:F(4C'0!8H#]=\I..,/@JX8ED(*R#E:#V+E(%FU
MUDCD=[:8BX[*0KG/8R2NPQ',9]R2NQ"P@`,G-5RP<1A\`5^RX',4W;`HC5W]
M\OK3N]?_E[U5(7PE0:GW^X3N%]@EY:@)1PS9PA\M6%`@QY:\/9A%"UVCL3A]
M4'RA7`-%Q>>B]#ER/P"FD,BM-9AF6U!)3#&)9`P1/4&QS89)DH$OUKA\`KR(
MA3U<+U4K7&BQ,7C&ZI6N'\5AHJB1KE=?N+[M)6*))7=I70SGR>D!Q]"C],"Q
ME"Z]7"#8L/H#00*2P^K4F@%XA>)7.P#70#Y=:8$[FP<1AV7[[US.#E;K4B#$
MN,$8R^6BDO5NNY/METL(6-4*L5-3G+-<5!2$36JC6(2EVMX&=U(]:YW`R34%
M.+T^NM9@1M)'N$5;8I7RZ');D2;45>%35F'JCW.2-$.!14Y?"0%FZV!O"18,
M??TMYT'>4J]MKCA+)0=ENZOT?#!J#W+WQEIRCK*+81G&_8A'NHAT4^1V==':
M%<)K'"Z\YGUKT&CAS7&EF\XDO5R8[&)2O]PV%^M_%0&1\0F,0>#.:BQ#B"))
M3("Q&R018.,#GE;*4X@RFHH#(7G`LZQ'&/XTVS*"=;0>E98)C="CQN[FK]4K
M4^A5YPB]&K1Z_=UZI0E%#M(R-2]]M,QHWY^D93VSW3E$RTC)3E&R3WP>+VM9
MIZ!FY>4W^YAN7.0>LEA'OXY$"%>MK]+,``P/NS)9QHI;>4J4#"&+=7*^P:1R
M+]/%!/XJUB"6_!R!".%":"KW!5R0C?)+Q<:@6&#$2FZS71:YT`"ASU?>**G=
M3KM!]B!+NYEL,PTK^X,I#5:W!_-@O]F_@R<@:8$QZ5ILE=5M]ENVREK]58B+
M6NPB\6'1M\0@M?Z3%F?">9[+T_M&,:1X1@(3<4%ZU$$]W!0O/Z^<2P[VYT'M
M6JUPOOC@-403*]6YY3K2'BT-4MJT[(1$NJ>0Q13A]R5/9QU?9%(0/!T?*=-W
MTG2H2!`F$MLSH>5&8K,I)1F>;.)"H*T'"]?RA77R:H!RC7JZ!1T7:MUF[Q)A
M03,=%YAAMKK]Y5DLKTN6^(DL>=YM=S/2X&B=[.%&]FQXSVC4;YG&QH>+1YF%
M0S*I"1$9]"H5+$\FQ[B,"(Y(+%F2G62+E&H`%TU:V[P&E/<*NW&#HSPP><!"
M1.+]LB^`G.L9;:U35O;W1=;L+'2+SDRFIQB5PHN[G98YZ@JM2WQQN"26*0[B
M8_'06;O7-_LJ347\)JQC)'(=9-)1EFRR8G?PUR=9Y*%D'#NPG"GGJ92MHGA9
M>N,4[92_9K<:QE9<5K7D09DHO5*HJ3I,!]0*Q'@G>.Y@P:VP8+N6TPO;[,<5
M%[&5#B<J3609V='>&-W6\+Z[S20+=[.8;;(KUE<,F^*(UXYET+H?]%N&.4Q?
MG3M!`?NTF,VG@;_`5SD\LD-W+!,RL+`-&Q:!.[OTW<*W9D$+SZVWRVE1%]O-
MUGGO>I]J)G16?'F#&JR)S]/,%7`$+<R@NV=>(%0K]25$Y@PZ+^"V1^"\P7=@
MX]!IQ(PA*<DR9_*)I^?9UBJ)BORW^GLLRO5=A@,A)@$LH9^BEZ=+VTK]L[/5
MYRJ5OSJXS)6JJ62+A>)A5:^>%5Y;5\OL-N89+#4\6?KNC>)'W@>E.]JOB=&)
M[4V$@=C*Y"IJX*T8X].*XIUNFO.-^W=@-'87G3JO5%37$HZ$H++*I3!:(#>P
MWGQV:=NP9S>ZK15.I;$\HL3I#<F)RH$6M@(A"4<Z#MEW^-L+D=4:)!$X[M&W
MC;<@AQ1/)6$Y?V/#"\,)&8XKD84MH&(2JIQ%.'[`HP9RFZ`(*%?JB))PD&M*
M1J0&(Z)BX!]%#+QH2#`,+CS7QEL3<DJOUQ$A:&F$+!"TW)R<?%C9CBRYJ2OE
M?"DJ0L)4H=$Y3P?ZD_=D-K:C.E%`;KC?_/\DWH+A,7O<]ZW$=IQ%*O;M8]4(
MRZ&3/-3;8.[\PG!,;T&2C2N2#;,JX:B@4^%-28O1,ONU=#*\+**0(;E10T(>
M!PG#0:A"$'*J:)C?F8/OS([1:Y!DD)D@,T$+D_/*QO,&B02M1RXD)/WVUDZ,
MNLD)+4<(6LC/(&$@/X-DXR39Z)/#00%0\CBT$HUS[="?[=0D;<`?G?FC2H17
MN@=_KMPP4ORKR0W=RF>R^3?*>G-/WI-O>*AOV%U3_D)?.2`3<+,F@%#^-OAL
MKF,TV?5+[EB3@FO*YD8J.&&X/GO-Y+TW60:,]F#8(#$@Q;]AFT]\O@T^DXK?
M*.O[!/*U",-=@V2`U+])N[)G.S=-N[+'BD)6<<&\;^#1:-+\6TCL(J-_LZRG
MP$X]PE#5IBP9@.;PO)$&@##^-OA,F[+:;<J2@FO*YD8J.&&X/INRY+LW60;Z
M[4&_06)`BG_#-I_X?!M\)A6_4=;3IBP%Z,@`-&M;MO*BY[O:B598IX.V:BO>
MJM6KZP99B.O+V]JOLP8!R(V*QYZ=`<G+K$%@[O4[FWLS;51TD@-]#0?Y%#?/
M^QT`L7<;-T*$)I_K)4-P\X:`?(+F;35?%`YHS5"#7.AX)I@,!.$%^0K$>PI$
MDGB<LI5-@4@Z@TP>18/,QL7/)>_1N[DH)4O2Y`3)V./,;-,N>54R]#F(+4^W
MU)G#"L^?24C(ON@C('MYK1N[6FP3&')K;UQ^]NG#5ID`D=][8)IGJZ]?ZY1Z
MT(H,T#4;(/)P2$`.W+TA"2$)(1-"`D)^"<E,TV"'A.8&A(9DAF2&O!<2$`KQ
MDOQH+3_[=+ZF$._%.B!2B)<,T+ER(+Z++>!-=IWC/I[(@&^VD_^;`DD&R(MU
MDYA?_1AZ[7[OFV7I6"]LZT1HF[15)EXKXQ7#>QVQ8,+2V@*":'\U!IU770.+
M#!C=%GNR0GAZ'+$X8/,DM*=6Q)GE,^OA(>0/5LSQ`=9\'@9?W1E\]!;,,%O]
M3J?567.\5`M2B)FS:`IF2TP_2$)F![-9X,/0`OL+>^(A3"N)H]CRT7BVV><I
MSRD!]S'^E8>V&Z&ZL:VS7&-=+C9G*V86DX_D#K,>>6@]<#8/75MP\;G1'@W8
MG(>2-AHSK\W>)2$PAL7`EP6WPHAQ$&UGJR0#+_$OLR#3@M&*E7#W_B)N]H5\
MBV?"LSM2W)5,M1C\:\[MV'V$:UOK1*R]*C0%^Z[L]M^^2Z*[!\N:O_R$]TP#
M#V`X^N'/Q(T7OP0Q?^=&MA=$2<@_`_7>>'#-W__R7XS]+;TMO^##Y&TPFW,_
MLF(W\'_E'DS#>1M$<?0)A_P&9NQ\M!8SL`Y1]C#F.M\_^_'?,+'N</`,QN\C
MEW[ED^^?O<5OC8XY,GKFOY&\\,$0?QAFUWCV=YR&FH5$)OC`E&N#%C6SC0*P
ME(?Q_;,.O(5['OH0P-WLL_)AQ&<E?\HG`>WRK'G$7Z9_O&+*N>GD-GN#"<_'
M$&9_Y0X8P$#V,OE(:>57O9P#G1QCF.K+7EBA%&<,S#_8>ISBMW;;NSV0G20;
M]=N]P<%U`)M!(:F'[*,'UPL[()3T3J@2*VK;?G3\+I?"4[VXP0D>E*;$%K15
MM-Y"SUKH<]7>'6=3"X!O&G*=\5X"Z]U8Z)9=T"TV1Y'8BJ8'V)RB4(S:G4&%
M>B,G[\9@*NU7)[J!!Y[I[W1ZTC:Q][X-`P>O1&@2>R$E8FB:'7D5?IM]9[SZ
M]NRJ9K2[W2:IFACO\GISZU]L^VKALFJ&JYQ,$,!+!EQS@CFN%5R?_8_E)U:X
MD!>,%\+U?A-8H2-LC!N"OQN$$@FC@KLJOAASVYJ!ISV92*^8@>;^R,<A/C`W
M2X8P2YT>+K?<2*@V+$Z"1Q<]>QB_>*4;18GERP5+,D>7O9NN-K<MZ>9>$@F?
MWH=9>#`?.^1@3=KL4S*.^)\)<!-==;"'#CC-0"'73^"M#[A.P(6&?`H0`XQ.
MQ!)@OQR.,1K="W*UV8>5'PNTQ(6&>)B:"JRRW,")\EG$W%<K&208WIVN2_(%
MFN5Y2P-)'[GVG<B_F'DPSYC!%&':\!YTC/%9>.W$<D,&^OB%Q^C$)3S]H40Z
M^`._<]1"2+RRS=Y/6FP:/'%81+:0G,JPE(=7FC:\'$;%9W,O6'!83D\#%CS!
M18I!013Q*$):SP*X*Y["Q48^UL=`\&$.KPQ36MB>A3>EEZ#39?F+U((9]Z_2
MARO941_@9G_!9-02?XI`!%S'1>$N/ZFUB0]P^_HI9Y.=)1G1,QX8QE;22S*+
M!TABIX(PLV#=F<Q`1,*9NA]&LXGFXLU^`&__:G.4-KQ$2)8,8RP_#<B\8RZ"
M<4`;>&^(9(M=VYWC*)=?E<FP?%,NBE823X,0S%JTHL-HB`+03;1/@I-B"`KJ
M+5BI@Y+`^+S$65%#L<Z.@2DX2/'+ZC>@&6XL=4J.GTNW73T9II8*)#P.]#Y*
MO%@&>>".F?";,OD:I];.2:U=F^UVL5*^%(,+O59G,&B9]_<%DU72N9#/+->'
M212B4.N4?-LBC1P?H\-^$-S%N`9X/TX";,(_7R/W5YV@PA47=X6:N^I`U5^B
MY&9?`E@$O@3"]1I?`E3&%0]B:$C=B2ONAO6PZ\!G\?L?`3SNW<*W'JVO&GM6
MRJ59)LL>WHVQCW>SR<=2=,[-TE!8I4Z;%2**,K0)()3:N>51PL#1R(=H.L/,
MV?CE]:=WK_\O^Z?`,/#58-"_)AYG_4&W_\+^]D7OVV.MXWVOVQJ8_2-MX]+H
M:6VXW40:3`6RMBX.X3*RB"=9Q(R&TA8*E0,95@NIC:YK<16UWH`:L/+P00WA
MPRC5JLS936\O^[7YZ]$W`U5QA+K@*J0T4F%_Y4))_.(GH@(Y.FGK53/S\Z1%
MRZQ9KIUB40>3-CKIIHGF5KM`CQ9#SLW$3E,KM=W1%MMM]I=VAM8:[Z(/*O@,
MH[K+OUEFW;ZF?M!2TE&6/A>!>.;Z;@0+`"F`Z]&WA4LCB\$,W0<?MXO$J-TX
MYMDR<=U-0E"E<[UN<9H.8VK!L*UL$6)T\H'+57#B>[`<9/"WY^+=<*$KA[$Q
M]@!X,XG5FX2NX")&#;7`1!^6,X[CXJ^X.I-C+:U4Y8"Y*Q8,Y45UL`%D)-)M
M8D)++MVE#,!R\P\8L%A6R9?O</(%39=!&=;'N.Z:N[A5'8H]:1#$"0P:)O#D
MPNO&7"V<I,G`1\+K>?C(,Y$MJ;I<Z\;XABBQI^EPGX+$4XNG)UP%ASQ.0G&#
MN$H%8(]#>K`"HWZO->IUCEX(J0GL,P*<`I><AH\#6(&-!KW\PHTC$#3;:-'R
M(:R-_)WL?)BW@I*OT9:A)R)IBU8IC=WAM@\8KHC'R(5X"K+M!4\O3W=!3DDV
M$IS91K1=1-]U?PV(EDO[%M*5-NX/WJ!7F\'H3/+PL/WZ9X77;J_F4UD29/^^
MZ74"-R2Z[4HLO425K*WIQ%)@=,PG7MGX/BUC]-SYZ3!:8`"PWGQ6AQ2<7'*1
MI.+4Y`CIN/R&L.DM@!?K')$/!?\IW:EZ(=S"((G@^^C;$[+4+V%,FIINKH_<
M5'+:A7#D5CA/.'+E4O&[R@R_>ZTRPW](=[X_XLYWOG;X6%Q?"_0A*+EMT;DB
M*-&0S\T^H4;0<?WZOP(=OXJX+2XVWL)-H67'F`KU&</]+T2`GS#BUF2$,((P
M@C#B=O7_=7:<\CT@@NM'KLW^A:FO#3,'A`3GMP\7[_2PV7P4=Y"VUM%HA)#H
M!"-O+$_LM5OQYFU]\P3CH5&A)VIC>W'_0V/IH!)?MRT;PZID@PS)H5406L/.
MH#F"LB_$D"&Y34-"+@A)![D@EY:-:GJKD^=QS3+2;7>KZ;-^<<M!?@<AR_%^
M!PG#30D#N1FW+1N5^1LD&U<G&^1DD'R0DT'"0$X&R08Y&20;Y&3<G'P<EP;T
MH_C?&=*`3I0`H]N^OSDA^%"N9%J)I3@+PXUU_*8P]T4AXER,)^M_FZP?[LEZ
M,@.'R4*_-3!ZS1$#L@`W:P$(]6^7\:3SM\EZ0OUZ9,%L#T;-D0(R`#=K`-:"
M/O'Y&OE,*GZ;K-\7XXGU5\=ZTOI;9CWQ^3;X3"I^FZPG8+]9UI/6-RI-XVS5
M6BA-X_@TC;09:C6)&N=*Z:)8K6;V_UR,)_M_FZRG+9MZ9.&%T36:(P5D`"IA
M^BFE>@GKF\?O)AI\4O6;93UA?3VR8+1[W>9(`1F`FS4`M(MS,WPF%;]-UM,N
MSLVRGK3^EEE/?+X-/I.*WR;K"=AOEO6D]8U*SZ`J&AH+09J>86/#',_CSLM&
MI6E1L%8S`*#\/&*]#FX?F8'KEP4R`[?,>M+Y&V4\Z?QMLIXB/C?+>M+Z6V8]
M\?DV^$PJ?INL)V"_6=:3UM\RZXG/M\%G4O';9#T!^\VRGK2^43D:32FA8=ZW
MN_V;DX(T20.NG7!0*H>]2/Q''L%?=,3VMD2!\O6(]0UB/:5KU",++\Q6O]]O
MCAR0":""&J3F-V'R2=5OEO6$]O7(0K=-Q;-NCNE--`"TIW,S?"85OTW6TY[.
MS;*>M/Z664]\O@T^DXK?)NL)V&^6]:3UC4K6J#"!)T_,8.,@='B8,C<*/-=A
M>-D\9H("<RL$KE$"QRD)'%F5#?:BRO2-R@7".$4>*+I[$^E]VP0D)2RARFV*
MQ[!"\2!S<F!JR&@PTDU2#D85,ARZ)(N0;]%D&6@B>)!O0>)!OH66\M)M=WNZ
M20KY%F0XJG4RB/>WPGLR!=<O#CO\!1*'VQ('L@XD#N0H$._)%)`XD*-`XD#6
MH:GB</%*)ZO),\C*C5*R)$U.D(P]SLPV^1DGBLX;R\.\&F;%[!VW^6S,0R%-
M?S4&G5==H\7,CJ%=0^H5(U.3[%"(^R;R-S=*44K5;1)$6VJW+3_#<\H/&:3#
M!,KHM^X'VI5ZJ0>^R`!=LP$BEX<DAEP>DA\=Y(=<'HT%JMLV[G43)7)X=)46
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M971:`W.HFS"1RZRKO.AK@,C#(0$A#X?DASP<$JAR*E>W&=4LR+_10%KT-3_D
MWY"`D']#\D/^#0E4V;\9&+J)$ODWNDJ+ON:'_!L2$/)O&B\_S:W416Z-3G)D
MM,SA2#=9(K]&5W$Y,97KNQ@S>;+K'/?Q1`9\LYW\WQ1(,D!>K)O$_.K'T&OW
M>]\L2\=Z85LG0MNDK3+Q6AFO&-[G*6=Q$%L><_TX=/W(M=$$)9P%$QAR8']A
MP3QV`S]B7*:*<8<Y"5SYP&*X=\&M$'Z"QSI;ND.*?YNB@!C\8;`G*VJQYYWV
M:GJ9%J02E&'P(@\F#@,UV_?I)S$'&+F1_QSR"&NBN8_<6[395H+F)"R3UHV8
M;7EVXEE86FULX17P+B2PXTXF',RKS=F8QT^<RZ_3)[%YZ&)O3A@5?OUG$N`3
M0%:_\%C]!N\-DI#9P6P&SY0OMB+\&N^PO2#BZ8?LJ0X,I,VVF*#]U,@P;T^/
M)I8;;E*A1UE(KR+]60V7:$$@00^SJ"'/1^U!68',]G"3`I'0[2UT'T"MX9X[
M)59*M9^LT(D8N&2H\F`"A#&9()7!'MGYA8GOQA%[@+?C=T]N/&5S'N)`L-WO
MG;1"^&B453L$WP[&U&:O693,@)Z+U&A$L14GPIX4QK+A;=+N;!-T%`\+A<&-
M72"H4A7\#:VD?#4PP,%'30+/"YZBEZ?+S"D^AX[RDKM`@KQ;Z*-<1+7^$'G@
MTMW__EGG&;.YYZ%##SS(/JL%A?BL%BLV$(6'V=)$K1?`K_:L><1?IG^\8FKA
MT0$"/BN\=OL!A,H6//>C_9O.Z[ERV>#4+B\B@>`P#R"A^:P.:NX5P5I'X'2-
MM36L((5)Q[A"44?'@>>\.FWE>()J_Y*(4QI@2S]-05XC]N*]GZM[/`V2"`QI
M].T)@8<ZP@R[E*ZI$01]!*.2L/<E6$\FX1*<)Z"X<JGX70R".W>O'WEH/7#V
M$_K[=^]@?9_CQ8^X9/T7+ED;9C0(+RX<;[[$T>'-1J7HWV_M.](((=%I6^*7
M?&5?7L*G!X5-W;:X]MYE7XL[334L.LE,$S,P]NE;3MOD-0B+T;KO5U.)_^(V
MY!H<%)U$HXEV9%_Y(,-!TD$>".7PD>-Q*1GIM4WMBAR1WZ&#9)PK-'*6<H\8
M&B$).%`"?I*Y$968AW/5@B7-U\ZG/%<]5_(/:I`%L]]ICA"0_M^L_AOK\)V4
M_2883SJO2ZR`H+[!(F!4%0H@O6\.TZ\N`8(DX$`)^)?(:VA4#)`47SM?[UR[
M!(3\-<C""\-H5O(!&8#3F7[*X8CS<YR4_!8-/JFZ1HM[@O@&BX#1-JH)Y)/>
M-X?I#=S"OY:3RAI+Q8]!..$NGF4(0L:_SMVP87O\^YR<(_.AG<=X[KZN)XL'
M^1@'AA$&%841ZNS:>JUG*G42A&I""Y>4`C(&MP@>Y%LT+"1!+L65BTEEQQ/(
MI6BV(#0P3^'`H@S4"J$FT=E9O.%*#D!1BP3=3=+EY6>?<Y;4*^%RO1+NM<O#
M..S@)?5*(/M3E\R0@;E>B2&/IPGRTZP\$G)T=)6C;GNDW9J+_!Q=I85Z0C5Q
M#,UM*_()&W:H_A_80H3[D87]:S!7!O[F+.2R45$<%/I\K,BF%C,4$V+%%B1/
M5L2L^3P,OKHSF(6W*+5S8O"\K#'/SKX\LMV3]?`0\@=XUKJ63_BL#<U0@B2.
M8LM'2[Q'8Y2L*Q0V<Y*/4?V=L".4%8N>32TQO>=@A],)44.=`R0?N?FD*F8S
M2U7,%AUR[I"Z2[V==G34.;C+4]K?R4S[.ZW;^]&">E*K1"<GW*!:;N'T2[")
M-D\\Y,L$PHY6Q;YI>Q'YM$Y:K=56=,5V59VVF7]2#=]J[%<U/`'<=NE6L<CX
MH>)R@FQ("'DC3-;;(H2<3*W!K=BB@K-2R5_L-WA#F*/'.H"?>S#:EFI7EW82
M>^`^&$(/@!*5C@5@%IFURD@M2"DH-X$YW@G\GO/0#7"./C8Q`_JR9`X3DY^3
M((E8Q,/'M(&B3`5F,?>5,9F$P4PV843C#\9(6"[V`M.&K=!S@1#B>3$/9ZXO
M20A7K3[^6VG?4!,L?\&FZ()X49!9PM6^:_S/Q(T7*0O`T;)Y&%NNGW9SY+.Y
M%RPXD#(1;,51"GOV$5C84A\[/?$QZP[YWG<2,(Q(!_R^S5[O]#K,5J=WW^H-
M!BR2C8:$!2]Z+@5G,&USB._;8+>C9/P'V$Z\&D:$_2OW:#F'M"NC`K?L:2JF
M+EA]N&,F1I%VS2PQ+(E2D'CC62#YG^QIX,%<U`/PJ9)YL\#A7D8NV5X.;TU]
M@KO4)["B*)G)V5+W.>H^MU=HI=N_OFY(>_:CTZ%73%-(NLN+:U"KF&*#*:-#
M'::N4BR$JY\;^P\2%4^(;E.&8A/%H)*M5<*%&]F@(&2X`9/P@UJCYN`@L()]
M3$(;EL"%[W$UVC"S08AQX6W-^I=MFRU(<2E'C08O#B670@]B_<59KX47L3'!
MBER($V7B?S&*_\/F/;VF&PGR(@@P:"%*$$(00A!"$-(8"#GS0K2*_4,-):#Q
MR*%#'(HX?58?P:18]55BP(E5$"@"W42F7Y'1)W4G$""I.!T$S(99`@(!`@%2
M=P(!`H$*0<!HF"4@$"`0('4G$"`0H'`0@0"!`*D[@0"!`(6#"`0(!$C="01(
M*B@<1""@34;8F2O!TF&ENE*)?E\N"Y,7J3G!9&A47YJDX]*>I$;"0(7$J9#X
M*2)!1<(/]#S;O5,\3XTLQS4XISI)QK4A"S4Y(>D@OX/\#O([=)"1;KO;:8Z8
MD-]!R$)^!TD'^1TZRP;Y'60_=L<[[@?-$1/R.PA9R.\@Z2"_0V?9(+^#[,<N
M&>EHV(R5_`X=)./:D(72.4@8R,T@-X/<C(MLJ_1[S1$3<C,(6<C-(&$@-T,C
MV2`W@]R,W;LHG5%SQ(3<#)V1Y;A#33^*_YWA4!-)P($2\*L;?;F;A)PS%P]^
M8C?WT(JK.:MT%JX;Q/1+.Y3GXC-9_-MD_7!/UI-?>)@L&.UJ#A.1_C>'Y]\T
MBN.DX[=H[TG5;Y;U!/7UR$*GW6^.$)#^$]23CM^$O2=5OUG6$]37M:JO)G65
M]+\Y/">HORU^-]'>DZK?+.L)ZNM:U9]2C)STOXD\)ZB_+7XWT=Z3JM\LZPGJ
M">I)_PGJ2<=OP]Z3JM\LZPGJZX)Z"N#?&L_WAGK-F\H0XP]D_`]?Y]R.N<,\
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MK&/M-BFHC.TKXQ7#RSID/&:G,I@;L;$5P7>!SZ9N%`>A:UM>\8I@PH(DA"D%
M]A<VAY]YFWV><L9+_3;PJGGL!G[$'F"`^#T\FD>Q.[/PP[J7R!O@03RTW8@S
MRW<8G\V]8,$YBWDX<WU+7.%8L=5B8`H\SA[<1S`6S(8WN0X/Y05QD+T]GEHQ
MFUJ/'&@1LP6/X5)X)L=!6&R2>)X<L+VP/9C)!YP:]]T@9,`&ZX'/@&;XKH!-
M`P]OF5E_P'@E(6*8=_JB((FC&(8,HVF)H0?P:YA-(&)//(3AAD$RQU?#!>F8
MX6/$YQ:,G7L+!JQ$.YO(F<R3<!Y$/)(T#MWHR]TD!'+@Q>+2.0_=P(&GN_'4
M]<6(X+D@%':<6%[&C'RD)1;CU[^U/\'30VY%2;A@"Y?#-.TD!(K!\_AD`EQE
M0$.\%+@GGB98*H<$Z@]S@-G(&^'A_^%AL&)8M%`#(?5(,1N8*JAG`?M%6QC!
MD")E4,:E;"ZD(`KQEDP!"F33GEL+Y'R;;;&E^]D=8=MNPO"\!0WD?F0I=<>_
M>8GXUI,5@DPGGC07H!69=0'5?@0S(G@2\HD'WQ;M"HQGPMTX"5%E?@0.\S\3
M5%;U1-02(<5W\EWX**&P*-T3RY6J)P9CS8(P!I*)5Z:#Q+$!44,+Z7/GN3['
M0</5P2/H.CY$/3'5RXV#@-^1=I9O+XV%V6!=X&9K[T$]3;G49,N>NOQ1F*Q4
MYY<?RL8<[!]P?!X&8\1Q$MP#!/=W,+Q`OP=?L@#9$WA>\(04!M8D/L@B$%Y@
MH^*JO4[67PA+'2012''T[<O367`&GVHS9W;=7Y<+^U=CT-GFPBK/5*U>4-C9
M.`@!<+]_UGG&;.YYN(X`WF6?U=)#?%9+'80*'F8+&_F`.W#G/6L>\9?I'Z^8
M6J)T.BH8=;DSRW(D`U@RJ_FF0A,%GNLPO&P.>(ZT!J\#YJ?I$FJ#%W^116FV
M`&TV2:]J51JC=44=!N8;H+&7CTYL$XZ4REMC5M+:Z!BT*G)\#"NA5Z?)S@F"
M\K_@K[,?8&H.>\=M/AOS,(>#KM'2+9YUL.EH:HQ+'Q%I8*&15=!&1FZ4$8(A
MG6#H,G:$!*0Q`I+Y*:9.;LJ*`*44)C_F#"!E=@SMVM'78V/(H;EE5-K'J&Q'
M)#(LA%"$4!=!J&J*=!)"7;VL$$*182&$(H0Z.T)5TRF"$.KJ9>5<0>&S5"3?
M.U#<""'1*;[W0Y:PARE&CAMR.P[":&=21R5FZ%S5[$ETM`D-:RP,*56;BCTZ
MR<;SYHC$-F@Y2"3H,,Z!AW&,UM"LIJK&Q6W'-?BN.LG&M6'+WO$4LAPW*!WD
M>9#G09['&3V/3JO7'35'4,CS(&PASX.D@SP/G66#/`^R'[MDI-\RAOWFR`DY
M'CI#BX:G."C_OF*I^"7P[_*B&F?9E:-SI`V2#WT3T4X^.DJ@<IOBL0-.R#^M
MTS]M0`KTM>:.Z20'^MJ-"EP*,@K7(@SD8Y!XD(_1,'FYTTU,R,,@JT$>!@D#
M>1@D'N1A7(&\]'03$_(P&F$U+GX"[K2R:$Z08-57LTV[*B>*SN<@MCS=MNE/
M.FE+LJ&I,W+Q/(X-)_A+`D/.+*6)U2TVY.0>F,1NMKJ]CF["5`](D=VY9MPZ
MEV-#%N9:)(8\G2;(#WDZY.E<[W$]\G1TE1=]<8L\'9(8\G2N3W[(TR%/IZKC
M@>3HD-G1;(?S+`D3R[N>M&.EJ7=SB9K3)`PD#.N%@=S8VY:-;:A!LG';LK$O
MB)!\D'R0DT'"0$!"LD%.!LD&.1DD'^1DD#"0DT&R04X&R<;E98.<#)WEX^*[
M:E2(4T.IT/9P,?'^K`U\C8Y.'7RW%2/8FL!##7IW"\K_<BMD/\#4'/:.VWPV
MYJ&0G;\:@\ZKKM%JO.EHJG^ACXA<A7=Q2`88P=`-NB`D((T1D,Q/,75R4_;-
M328_I@Z0,CM&]S9L##DTMXQ*^QB5O4]:D6$AA"*$.A]"Z=^I@!!*"UDAA"+#
M0@A%"'5VA#*:9V\(H9IA="Y>JG;_@YP4WZLJOO<KC[@5VE-F^0YS^"/W@OD,
M9EJ)F;EXT0H2#7U\W(L+`R6\4742:DQ^QI8)+=,<-D=.J#$Y04L]?@89CMN6
M#G(\R/$@Q^-\,M)M]8UJ^C5=W'20XT'00HX'20<Y'I>6#7(\R'[LW)]K&9UJ
MDAPO;CK(\;@TM&AX1H.RZRN6BI^XST/+$YMOEC-S?3>">V/WD6N_S4^R<'$+
MH54-@6V)/P0@MRD>U+#\<O(R;!D-2&>^UCPPG21!7\M1@5-!9N%:A(&\#!(/
M\C(:)B^#ULCLZR8JY&60Y2`O@X2!O`P2#_(RKD!>NJW.<*";J)"7T0C+<?%3
M;:>5.J/:[E6)SN<@MCS=-N?/U;V;9.,F$[^H63<EAQV1'$;-NB\D1X;9ZO8Z
MN@D3=>O655[TQ:US.39D8:Y%8LC3:8+\D*=#GDXEGDZGU>N.=!,F\G1TE1=]
M<8L\'9(8\G2N3W[(TR%/IPHYZK>,(3DZ9';.L\/Y76P!;[+K'/?Q1`9\LYW\
MWQ1)8J8DV4"]=1.<USJ^7KO?^V:9:UM*MRZQ=IL45,;VE?&*X7V*`_L+&UL1
MQUK0LSGW(RMV`Y_QK_@W9R&W@P<?QNLPUV?87D4<(\0J]O"%[24.C/EYK[UJ
M>[28M9@D@Q=Y.*F0>U8,,XD#QF=S+UAPSB+^R.%!-F=6"/]]X%B7-!*3?-YI
M][-[X47,>K)")\+;X8UWZ2,B\5L\Y6R!7?1XJ8L>ZQJMG&S/C<(3#QA-^H+(
MFG$VYZ$;I.PPV^Q=$H+AW3F`%GLJL1/&TLW&`@]#^XVLMSS@&DC%W1:I<!*.
MP\97S@+'G;BV_#V8B.]B'LXB_"`>Q((Y_BAG,7$?>3;=:-_!FRN#!_PX_^!!
MS+*QM[<8SOV,C#!D-V%E7@MZKFTLJ413$!Y3)UCB%]A<XI\=1'%1:5`''WF$
MG\JL<CBHC</F83!&F,)WXW4@9RUELU#D+,];NN_)C:<L!OHHZ<EN\GF,#\&/
M,_%VH,*$NW$2\JC%K%F0^&I,SXU.>[4V@Q:L*9E"T*>I:T^9&PFUL-7PQR4E
M"\`6"<Z$?&:Y/A)-CH8[=Q;:J0>>TB@U2D`ELST4J@S*?6:^^T&\E?<'L+$+
MDU"D:C/2]`MK>C0%SU\\.4A"O'0&%TG>)S`"*:0?D]">@MZRCY[E+[&STU[M
M:*`%%<^EE$:[ERKEZ=(\/,5[WR'*Q:X&AW+E!!;\D#I@TB$NR=+I%!O<BOJ_
M]]G_6'YBA0O0]DY/:ON;`+QF819<D.,X"*5W+?1W"GSF^(4#1AS%':['.]E6
MAKS`RZ1Q&9IFYU7IU^Q[X]6W;?9YV3(@-#RZ3L%KGZ<_PQ!+MF6\8-QS'US$
MD=S9Q[&/N8V>.)],8$+HT<(]/_)QB#//C9XAC%ZG)T>1O68>NK;PXJ5=0W7'
M87@\BN`[&,0+5V-C]6T^OV'_F]1IGEANR$"FOP#$/EI>PM,?2@2%/]+O.*QQ
M<&V37A<`*</48+UXD!5KO(64H(D[B3E</&6.M4!W/Z4U`Q:^3AZ2*/X6_WSA
MNA4,CW_EH>WB0@'PIV"3!9,L0"8<!-QO%5BZ8=P`5SL'?EG_XM0N-)>(8!WK
M>HQ&@U:GLYKXIL6DI">@/)TG#G;!FJ.IDFXJR%^4B+C`1H<G2L9_@#5"C\%R
M_@#)$NHEPA9*OJ.YY\8M%#W+7[!)@HZO^LEQT2:"9<-5+CP<;),+-(`%.;S"
M!Y<"9'?%]X)K;6ONQF+1'28V/@]L7:`4)S>94W!,F&7_F0``.&QH#EL]HW>$
M5[?/BL(8W+?ZP\&VITO/"49B/5HP1S3O(C0A"9(J=;1MA9^&//_V71+=/5C6
M_.4[-[*](((G?)B\+3BSOTHW]BVXM-$G'-,;7%M^M!8BLO,9Q..-!X/Z^U_^
MB[&_I0_["'?#O:]]YP,RXR/<'/(8J(<WO0$C,W'C*']C]A3F.M\_^_'?(.3=
MX?TSF+6/\O<KGWS_["U^:W3,D=$S_XVD@@^&^,,PN\:SO^.LU*1DC!<^,+5)
M@#8E,P$B]*MB]=\_Z\!;N(=-Y&SP.+//:C=`?%::I:+[=N!YUCSB+],_7C&U
M3=#)K=8&(Y:/(<S^RK<RP!)F+Y./E'9N=;_@P.T"X?`>@+K:>;=&;ZLLRS#_
M3FJ.^NW>X)M#]UH:3[S,$U5ZMW--4*#G=[F@GKIE4L4:XCBZZ[.\^)TSM-RQ
MA1%?UNL8+[Y\J]!/>FE_)B"]$Q>]=/@_<S@XE0@YD>6ATU6(J2N(^83^>^#G
M0*(>JMS#]]@M$H/*O_)'[H/;^#9P`.)^R^"I-(:Y%<:N[<XML?C.X6\&OI\8
M"KJ,05@(-H-7.@?#;GUEL#;'M3RLS\4DP8&T8H%<#EAYM/T8'D!['KKC).;9
MXF6LA!+C6BMKE0(8/W&)PA@CRQ_CI('PPCRV^J.KN'<L5)4![[T/",T_6U]W
M@-J00(U`38%:GT#M:.))?6.@</!8PK(+8-G;P!>9,"+&[4IVO`#+%WT+-AV>
MR&6@*DKWGM4EL>`8V,#(%3L@:8`#[$[PA+#SPL4H1I!$EN]$W[X\/;APAER-
MS9S:=7\-:_#<%]A"NA*H'`P>RAK)9M2'8<FSPFNWEQFHI:A`,^LQ;\@%VI43
MIT=5*!T(N`NY&M1_NMCTWNBL=KW7H?K3UG18:F&_6RS^%U.)?BBE$I5BA2<D
MRE)-GR8*1+T5?2Y>OZ?9<-+LQ.@SV0@2A\:(0^9?F)=S+_8]H4/^1QUP@Q'(
M:[0?Y(C<#K[L8S`(6PA;"%O.CBVG=-PA;+E:R2!L(6PA;"%L.0E;5@_*:&8[
M"%N:@2T7+XF^V=[L'69MA)#HA#N_M3_MD96CBQSL:V9(#*@J%E6\HHI7U(KG
M3#+R8G#?ZG1ZS9&4?9&$#$@5)U"O3BQ(!LC!(`>#'`QR,,[E8-QW6O>C4_91
M-#(>Y&"0@T$.!CD8Y&"0@T$.AAXR\J(W:HU&VC59(P=#!^'8V\$X;@^M\O;3
MS3\!J+$P_!+XK+)MLTMV'B?.7];'K)#W)Y]@))2X3?'8`13D<M8H+^:PF@VS
M2V((V8UKMAOD4MPN[\FE(/$@EZ)A\C+LG7*,50\,(;MQS7:#7(K;Y3VY%"0>
MY%(T3%Z,5G=$3@5)0B./E)U6I6MC1V,2G0-%YS,VD--M;[V>;M<D&Y2Y):BZ
M36#(H:7LKKK%AAS=0\^P#5KWIG898/6@%!F>*TP[)X=&"[D@AX;L"CDTY-!<
M6HY>#$:M46^DFS210Z.KP)!#0W)!#@TY-.30D$.CHQR]Z`U;_=&];M)$#HVN
M`G/<N;U3NV6NT+WZ!HP;&N35,KZK[.;Y2U!HT,GXUSGW(\Z>K(B%W$8%=;*.
MS0MNA1'CFYN3,>P>(OYM,LMW\`^#.0G'7LT^CUDPYZ%L,8WM0E<;?&I!)D$5
MVPK#!5SX9(5.A,,/)I,(9H!DP)DHDEDQ>[?PK4>@W`])"-,3T[;0VB:6Z)9M
M87=3R[>YZO,MGQ.)!V5-OI'R5H3?M]EG_,&=P"\<[QKS^(ES7UQOKVF\BK>F
MG;3QW7B=-0L2'YMES^:B4_9XP:SYW%L@X47+50YFU_*`TE:<Q$&X*#X,&,33
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M[(79;0WZM1SV)W`B<+IVEA`X-895!$Z-8]D+8]#JF]44721PT@2<+MX:;'M\
MF$*_!S+^4RR.C%A?*U'3)3YG:DKJ=L[JQ1G9R?!IP8GAGIP@_V')?Z@H[$KJ
M<>%%*\&"/L:(Y%X73A`L'`<+PVIJ@9%V$"HT@MJ$"K?$"4*%(W?"6OWA@!2D
M(<"@>9HIA1$/9/R;)')]'D7,#KGCQE&M07_2NHML8Y+]TX(3Y"`<[2`8?5*0
MAC@(!`P-,4<D][IP@H#A*-;<D6Y<OVX0.!`XW#0G"!R.S$%H=4<]4I"&K!HH
M._&Z&/\N+;*-Y;"Y'\FRW/84:,"KB3'2)J0^6U]D#'7A!'D+1[&FV^K<GU)O
MC/2C(?I!`$$`<=.<((`XBC5&J],A@+@!_2"`(("X:4X00!S%FOZHFA0%THXS
M:@<E,UZ7!+R=6OX#]LE;UPJ0]BBUUD7:@FDN)\AG.(HUIMGJ]FF/\@84A!""
M$.*F.4$(<1Q"&*W1H)K#<:0@6BL((00AQ$US@A#BN(VI8:LSJJ:N!BF(]J%'
M2GC450+RT"-<#4_V15,>[+M#Z8YZ:R)MQS27$^0T7/#D'.F&UKI!X$#@<-.<
M('`@<&@B`P@<KIGLI`!:<(+`X;ACU=UJ\A5(.XYF`95JO/D08SSE;&*YH4AS
MY&S&K2@)^0QF3?4;&PQ4M`&C-2?(9;C@>I)T0VO=('`@<+AI3A`X$#@TD0$$
M#M=,=E(`+3A!X'!<]GM%?6%(.RBQD:*.1TK`+X%_YW`GL6-W[''F\'','#>R
M@P1$@?8G=59%VH%I+B?(9:#DE28R@))7KIGLI`!:<(+`@<"AB0P@<+AFLI,"
M:,$)`H>C6-/O5'.*FK1#^V`CI3CJ*@'O.)]QASGNHPL3=&A+4FOMHTV7YG*"
MO`3*5VDB`RA?Y9K)3@J@!2<('`@<FL@``H=K)CLI@!:<('`X+IGQODO:T33M
MH&3&ZY*`CZ$;A&S!K9#%8<)9,J>-2*T5D+9:FLL)<A0H2Z6)#*`LE6LF.RF`
M%IP@<"!P:"(#"!RNF>RD`%IP@L"!P*&)#&A@`F,>3&3C('1XF#(K"CS787C9
M/&:"`G,KY'Z\F>D4=%PO%1_B*0]KC?V?S#K2UTNQ)R4$65<MN+7##A[$+?).
MRJ6C^WTMC"!I6G4EI@FMKLS^$5HUB5N$5K6Q[_[>T,((DJ9IH6D$6TUF#\&6
M5MPBV*H1MFB1U1!6-3`;=358C+S;*`1+PN($"5:0--L443Y1=#X'L>4QU[>#
M&1=]QOG7.?<C7NO^SWE83L;@(CQ,J;"-?^1%[<W.Y[7NC9^/B^1=G7&#O5(#
M2TJJO<TEW&P^#PDW"3<)-PDW;TE)+VUS"3>;ST/"3<)-PDW"S5M2TA,#_M_%
M%I`^N\YQ'T\,FW^S/6C^39$D9DJ2#=1;-\%YK>/KM?N];]9R;>L0E^3C@/NK
ME8B5J8CAO>,3'H;<$4%]*XIX'#'+=YCG6F/7<V,71F1%+)BP=]SFLS$/!<W_
M:@PZK[I&BYD=HRMN@#],9@=^Y$8Q/`YNB*><30+/"YY<_X&]<'WX)D@BN#CZ
M]B7;(I':2-=FUNVZORYE%G3?0CJEH\I&H_HJ<_K]L\XS9G//0X,)_,@^JUTW
M\5D9=!OHQ</,?"M[#(;-L^81?YG^\8HIP][IJ..#>^T35K8K>#]J^A&2#=9K
M%]!6GB=T1F>GJ!CCP'->G8:7YUZ0P&B!FL"+P;.3V)+.=ZM#*O7P`AZI/DQ:
M"SHG^*CGR"ZY24;5FUM2"V8<L@II&+!<U9KD`#76AJ4WS[$,*,W]@7+?:`\A
MZ1%<Q(6:KAI'Z*J5T=Q'[<A@DL&\;IW#@!89S(8RKX%U43877MY[T=*(Q8@^
M0K(F]OVRDOVO76=9:F?BS:-IA;PY)BF`6%4;J_;)#B!6:<&J?2T>L:M1["+>
MZ,4;LGI:L8H`JC&L(H#2)=5,KTY'N.`^D<%&MWU_<WM[O_"8!7,>6C%F?'E!
M%#';"L,%@YN?K-")*E'E@RN8DTK6278RCA=.EJ<\]\,Y8O3N6X.*RH.28NAN
MHHCLA`QZ<H*003>.&.9]JV^.2#&:9J(TW\"E]>3A0O`KC[@5VE.Q06N'W''C
M.A:4FV)#I),7"<F1==2"$^0_')<V9K2ZW0$IR/4K""$$(<1-<X(0XK@5YK!E
M#$XYBT$*TJ`%)FU8:BP$KVT[3"Q/EKP(8;49/G+:I-1;#2GBUEQ.D,=P%&M&
MK7ZGFN90I!]:ZP<!!`'$37."`.(HU@QIR_+R3*`M2UI1OGIKS=T86/<?+A>4
M8OO2#J*8MBKUUD6*LS67$^0U'!>([K0&@U-J7)""-$1!""$((6Z:$X001R;#
MMN[[]Z0@35,0VJJ\.B'(BA6%_)'[2;V==TD#*0A]NYP@9^&XS-=6;UA-XBOI
MA];Z00!!`''3G""`.!(@C&&']*-I^G'Q7<JSMWNZR07FAWC*PUI#/51/7@M(
M.X8]5+A.*VX-*^06.2GED'?+-.O=$VUXD7^=F*6!923@TIH]!%Q:<8N`JU;@
MJN:0"`&7AKJF^9;N]?2G:;:8'!4VH[+_#>0->39:L:JRLO_DUI3=FI'9&E:4
MI7R2_2,]TT+/"*Z:R1N"*ZU817!5$US==UK=^WK/XA)<-6L1WN2M\-M;<__,
MHPB9F5BQ&_C,\KS@R?+M:A*N:8?ATBI,.PS7S2W:8:B-?2]P+7[?K;=T)6TR
M5,:O;[5@%'&%((NX19!U(<B"];C9I82NAO!K;\BZ^';X@5O?M%RO26(^!['E
M,2<]'8V=@JPHXA75VSHI!$<>DA:8>_16!;E0C6'G/ML9Y&/5M.51<^G12FTM
MZ:L6^DH0>MT\)`AM'#L)0B\(H;UJBJP1A.K!SP9F%MQ*>G^1V^/`<UZ=)C<G
M",F[8LS"<ZVQZ[FQRZ.79PE64O*D9KL`E#S9&%95ECQ)K+JD5I%3TUAV$6_T
MX@U9/:U810#5&%810#5NU4UUTC46@A_=K["D?EU_"@!I'Y7`O5U.4`G<(_,1
M:S[*3NIQIK1X@@5]C!')O2Z<(%@X#A:H<<:E65!SYGF3SX#?Y#J2RJ'KRADZ
M0$?<H@-T9V(?G?9N"J<T,(N$6EJSAU!+*VX1:M6WGAY0)?2&L(I.?%<@$#>U
M,E]SXKN0/5UK'$T[QE\37^G,&K&3SJPUAK\OZ-SW=3&TWGUQ@LZ&VUJ"SJMB
M)T'G):&3SGM?%4.;G#QPB(PX03+V.#/;%,0X46)^X7%M1>M..F=R,L>7^+LJ
M`-=I`BY]5F@#9I?X=XP+=J/L?'Z6?9_ZN4B>5XFM=\TQL*2DVMM<PLWF\Y!P
MDW"3<)-P\Y:4],2#\M_%%I`^N\YQ'T]<_7^S?>W_39$D9DJ2#=1;-\%YK>/K
MM?N];]9R;>L0E^3C@/NKE8B5J<@DBRD788DQ]_G$C5DP83Z'_\QY:,6N_\"\
M((IXU&(QG\V#T`H7S'$G$PXJ:,-@+=]A=L@=N-.VPG`!8WBR0F<UOJ$%"<2,
MF1NQD/^9N"(B$\#,X:.--L=A%LY(AFCPIQB(`\\&BL&?5LQ@1-8#G^%GO`;_
M+W\(.=C"_\A&@O!X(99_'9IFY]4L"#GSW"_<6^"E/@PE;F>_&Z_8KX5;@?CX
MRDD2)V&)+1$^U>%S+MC'\-(D9#(79H$C?8#K@&&<1<EDXMJN&++U%?67N;X=
MS#A[<N.IZXL7%%G%@--NX+39&VY;2<1Q$/APH`D^9.I&<0!,QV]79*)`CS'W
M7/Z8T\,.'GRW.*DU03`&[(GP>9,PF(F+K''PR._P@7`G7+N!$G82(@0`28&:
M&745*Y&<R$K?:3'+1L;"*[Q%BTV!N_,P>'0%I^'9GK>N_V.;H4ZL^0$)"8^/
MX.[Q@CTW`9(8"*T'%[7$QT[Z4:C%<V/8-K)OG"3$F>(D%]P*(X:L=-@[H/)L
MS$,I$<:@\ZIKM)C9,;KBWZ9X$OP!7X8\FG,[=A]ALG*,UBQ(_#@E\+H1`X_7
M$SZ*`ML%>7&$6("0V]@-$Z^`424V/B:2;`'VVU_86$P;Y`A$,%)O"4'C)/<5
MUY]@KL@#?+\M'@X\L4$10W><X$?;FKN8T^5NEG/`=I#A<00**CFL1`E9"IQ_
MWFEW4YJVV194VP\!!,K<.@3\SD$U'KG0I<P29E*CK`<P"<W]?.ZYMK`JP-K$
M=\`ZI,P%J?9!Q".41PLE#T;M"UZZCHNX(60$^8LCF+A@'KC@K^N#W8C%J[+;
ME*T!*6RSGX1M\U"%H\2>YB\:<S$T>,4?H!@XHM_:G]I"GI)Y($U=R&=N'`ME
M@'&!"P/:[SL2N&#\/&0V#V,+7AW@04!FNZ&=S")Q![S[?8Q2AY29AQ:H139W
M&+$[0X,;KRCBVHS%!1IM,?SU5"-AKD:87POYVV96GU#<`5JX@U*UQMMICB>#
MFC8'2/LJ1!&4Z7EWV,M!!^8Z=4'BA%WF7^>NT+T"!@%!AO`Q#)*'*7SHW@NU
M2"D#@`-7P?WXI0/@[@7SF7(LE-,7K1F"T6T/ET>PS\N[I`)G5H%Y@*ZM"ZS6
M6,AWZ:?P<=Z"TP?_]5T+!HU6.4<M-D_">8">^JJHFL:H?;^GK'9+LMH22K'R
MVF-5QLA=234*)Q"H(P=#FG%FS6@R**`^I&[4GFIPOVJQ2?YJ"K9\!E[\RO%V
M]MH6/J,Q&@[`3YRY8AT%WJ3O)V"3U5I\C2BB<<D-2G,D$TQJZFQ';BP7JQ'(
M&P=S:T]Q,0G2:</B'J^4Z\[@"7S_:.K.Y:H"%Z"6#\O?]](Z@X45L1G.WLI?
MQ"+?4D_#QV0/:&%P1ZP[N-,JT3EVBP$8X:.7$<8.$L_!A:U@$G?:[%TB%@%S
M*P(5^3-!]]Z-HL3*8V)J.L41"-NS\*U'9%TPFP5JDL+JJ/B)7"0M!7=0$B+4
M8Q6:61>@6Q***,4OM<:>68O2!+;%@U6<]V_?)='=@V7-7[X75@0$]YT;V?`Z
M>.!GX/P;6.5_^?M?_HNQOZ57_M_$"F,>>HL?71^(`:[%>Q]%0U`WNX>YSO?/
M?OQWI]/I#D?/1(0`?@*E^/[96_S6Z)@CHV?^&TTR?##$'X;9-9[]'0>HQB=C
MU/"!J7T(-"N9%1"A:[65\/VS#KR%>QYN%@#)LL\J<4Y\5BJB-A_LP/.L><1?
MIG^\8FH7HY,;K@UV+!]#F/V5[Y:`,5S:&)&F;G4[XXA<NTKL9;%IRJ$6XP3S
M8`S:NW<I=A)SU&_W!D=5YVLR[3YQC]L83L@4D&4:R-Y9L<5>_.9;B8/*_TJ:
MAB")P&1$+1'[F\<8!F;1%,,S,IH1?;O52.3L^"X7\P9L&&U&Q%WWU[4_)SS0
M+:0NF;N#S9I2%(SE\_`P*_=L[PSFRO*5^_?G+3Q2?2KRA@W)77OGQQ8>T"%!
M?\7P7:S3UE$Y1C!:H";PPN@].XDOZ82W)IE(1;Q`EHD^7/I?;H7LAQW;7R?D
MH5Q9$0]]&'=B.LG_W]Z;-K>-).O"WR=B_@-"/;[ACJ!D`MSM=D?(6Q_?:[<]
MEGKFG?.E`P**(L8@P,$B6?/KWZK"0G`#L1(%XCDQQRU1)%B5VY.5F979!(@(
M<PNU4Y=>*JGUQ,5BT3D6(Z>2'3A+W4$%LJ9S\>]ENF%U\6ZI.*P[K<G,HG3I
MYE($Q8,!A0&MV("6&=H"`PH#"@,*`]IE+?Q['8$;&%`84#$5#P84!K1B`SJ$
M`6TIZ^H-C]?2)>KP6.+,070$QW.*R3=6M.97U,"ZU$UK$=17),Z(TJ)"4$LK
M$JL:;C^!UA+Y6:;T^M-1\T8/RB6\'01&B<L;8!0PZGQ9-N@-9F520,"HKMA!
M8)2XO`%&`:/.EV5*;Z94,U4`&'7>=A`8)2YO@%'`J/-EF=*;5C3Y!A@EFAUL
M?#YO>M(2^<C\$VK6U^]8,XE*]/;0Q"KH7R,3_6`)3^1F')K!!R\B/T>>*_W>
M5*DF9PC%*,R&>N?%@MH`!#$Y`4`0C2//Y4E/'I>ID(5B`!!:1FT`@BB<`""(
MQI'G\J@WGN"$`$#H$+4!"*)P`H`@&D>>RX->?S2&8K0$$`2_`8=D4OYD4MBC
MGL\`"X<E);N=+VQ3)TZ]M]^@CHT4N\`P-ES+`H^AV203%*/A(R0``8#0+DX`
M$$3C2)5))B@&`*$5U`8@B,()`()H'*DRR03%`""T@MH`!%$X`4`0C2//%;DW
M0LBH:3;4G&3"C251&?]&=0TM&+%NF#X;>VE%::?$%,M3)*!0LH*2E79Q`B4K
MHG'D>?]*+C.W"6HAS.$2<``X:!<G``>B<83"07\&M0`<=(?:@`-1.`$X$(TC
M@`,!F``X`!QTD1.``]$X`C@0@`FXW=31Q-,-RRRYDN\2/<PJK7R/2'?"Y*-0
MW8+J%G`"92Z5L$:>UM_&%QHBA(8`(@`1G>8$(*(P1,SD`33D_#4$$`&(Z#0G
M`!$%(6+0ZROU#E6$A@BA(8`(0$2G.0&(*,0:93#J32?5I+6@(2?4$%RLZKH$
MH."E/62'"12"$UF=!'`".M$A3H#L4(#N<@*@(`HGH!,"<0)DAP)TEQ,`!5$X
M`9T0B!,@.Q2@NYP`*(C"">A$\UFE"G)(ZWR1=&<[.G$B3KFV:>@2>]O*D_A^
M5ZI#+*\2%B.OE%<;MW7OE-SJ/#/H!B@]*3?DX44ISD0T2"V*T"C?B--`5422
MW'>VJ;\JQ[@27/H741WI/;4'NO2.:&1Y1QS.N)_D<?_50.Y)2E\N4U175)L$
M13QQ&-="O&-<.<AP@*)(=CBK&@O#TLYS+$9.)3MP[G`OVC^0M;R!_GN99JNU
MZANP52B3F47ITLVE"(H'`PH#6K$!K>/<`0,*`RJFXL&`PH!6;$#+7)B'`84!
MA0&%`>VR%OZ]S'1F&-!V&5#!FVAF$A\$QW.*R3?R0"R?U-L5\V2L.R?.G*BC
MP5$<%=32BL2J>B?'5L,AM$+8;(70&XSZS1L]*)?P=A`8)2YO@%'`J/-EF=(;
M3\L<P(%17;&#P"AQ>0.,`D:=+\N4WG0"C&H#IYJV@\`H<7D#C`)&G2_+Y-ZT
M/V[>Z$&YA$E:HC.JJ!+P._'6U^_89+]*]!8=+G";OUV<P$1@T3CR7![W1OT1
M%*-9-F!$/`"ABYP`((C&D>?RJ"?+U1210#$`"*V@-@!!%$X`$$3CR'-YTIO,
MRG0]@&(`$%I&;0""*)P`((C&D>=*OS<:5C.U&XI1/R`(?@,.R:3\R22)Y9`D
MU31M3;TSB>39DF8OE[9%UVMKWQ>VJ1.GWMMO4$>,ZA63$_76LL!C:#;)!,5H
M^`@)0``@M(L3``31.%)ED@F*`4!H!;4!"*)P`H`@&D>J3#)!,0`(K:`V`$$4
M3@`01.-(E4DF*(:H22;<6!*5\6]4U]`DU=(EW3!]C^B2%:6=5L21W(7JD-,D
MH%"R@I*5=G$")2NB<>1Y_TI&!6-;?`G``>#@C#@!.!"-(Q0.^C.H!>"@.]0&
M'(C""<"!:!QAIP-<>`4<=(C:@`-1.`$X$(TC"!8)P`3<;NIHXNF&999<R7>)
M'F:55KY'I#MA\E&H;D%U"SB!,I=*6"./1KWA`'6/'=`00`0@HM.<`$04@XCQ
MI#>>3:`AYZ\A@`A`1*<Y`8@H!A&326\ZP77:#F@((`(0T6E.`"**0<2TWQM/
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M>Y+H(E@R5]),PS(TU91T\D!,>Q5]+OG`N6V:]J-AW3.MUTS?90NC7^PMB&1;
M]S;[R]>%ZA))7C_/H[LRV;NN__>=)`_EV9649I!WC-=!0[1IK]@M2O?+_%K3
M*&L]NI*OMFEH3\&_>XV7?!+CE5/Q(AS()G#"&2_.!<;LKU3,Z'XXPJ3QNV[K
M59:.XIBQ6ZID5%[Y=%"5567,(S"G"Z8O,(5U)8/II4ZX+5`#77"YI?`6-M7+
MT$H\+J@F/UW:CQ9]CDL5S-`-N@CB7DG7U!:XU!LUYE1[*3$,JB$.*PU1K:>M
M)[*MJ!KC,'UA20T`-P1T&89''R4MU`<BW1%B2<0TEG2Q?-&.O>1O.[J5G&8B
MF_YOVHQ/QG]\NG/OZ9WA:J;M^@[9:RF4DU@*N:#+V%)3$1.?"U/LF4IO;8N^
M"K-1D=GX)PD4D1H&WW&8NB>4VUX11V7*PLN[2*#7%KFGK]&/:*J[D.84\=U`
M;<-W,W5WZ>,"(\-^6+$7J>G@EO\=T<CRCCC_)Y[".I"YZS7H,=]KH>K\P;W@
M\139#7K\)9%1H?SY3OC12W()77%@2NAC_R9/9ZWPU*XD2G).:\LSGR3JM!GT
MH$6HT5.]@`"4M*X_IRPPF(_%R4#1DA)3HVND+M>2$"\PX-20:<:*FTC^-HL0
MG;YEX=C^_4*BSS.)ZGK<GEITL9*L2-0.>PN7%?'1#U$ERD]KBRZ1N99'N!GX
MGXD5.M1QM/Q0B.:^Q4HU`\$A/PR72UGLD;I7I95;5J#=3+O)CQ71O*`,DP&?
MSTLRW14]&'!H]QB/J%UE'&'^`7L;]>:YA7TTO`67GJ33'XB&Y<\IME.AH&P+
MO8:58^N^QB26\I8!M]NCAQ&'2H!OJ@Z5]?]Y__73QYOK?UR^$5A/>]+"IX_>
M.J"X_""T?Y>!I.L!*M$/J*L5=2I"2QC\[8&"%TF>PSRB+2S;M.^?KB1Z`.73
MW3=YM*`.LL3<IP>N=]PX+M4GKN/LG8YJL#>LOY8S\$JZ75`/F[W1UC3V1:$Q
M8,<TC]RSREUJAMAR^-+H0@D][#'=<RB%[D,WD?[I!=WOW*<<IB=*_XZ^CRZ2
M;IY:"&JL0H?,NG=9,"*V55NK88_E2[8]ZNA)ZH-JF-R<4-&BKB+%A:!"F#A+
MNC]VT/38ZBA%YO11U!SQK^)RR6J*V6/6SZ"2RB0S6.(.=71BJD\]:G,HKS@Q
M)5>C^,3)3[?A>]R.49>&_VTMF(R]]XZZE$)NV_3/SH;XAV]PJ9-,C]SL>UU"
MOF_0EV[(XA"9:L9V?=0T?W/3,_W#)5_F[T/H<).^Z`"^:/6^Z!_!T6A-<"%<
MSU8@$#N6KAQ"<2`XZU,R'CB8,KEE7\%<?@X\?US=7$GWQ*)>)3V-AA:#!>7B
M,QRS1_1)*Y-NZWG@@DP5I?^*?_*WZ^NO\6ORJY^I,:#JQ6XTT+VK]W'D:ZE^
M9]:$?35]N,#(1&+Q"_POUU^N`I#AOJ,ZGW.@IP2GIVU^#*=TMQU&LM!8'H\/
M\"=KX7F>49@:77[LIUA/WTFIYYM>@"^Z,6?Q0K8BAI"40]'AG6I+O-9\%G#3
MKFW:O`^V0\EIO>6N,SVS)\(+UY;.?S4#T$T)Z@V%-H_MRD2$#)$BCD@)'@AA
M(,_`>V<::W#?D*HONU)EAF='2FYJN^Y(Z`196NAWQ7^-_%4>H+/4\,]Q,(\Z
M1]\6Q-AEE!#TX-MG5D>CGC$U0R9=+C5X)+10U('EZ0EV'J4TLZ/H(35S\U`H
M0SJP=S#?T0M%D[^)$HXCA&Z;]&#";K@947#RA[9@7K#$G#GV.!(853NPGW>J
MR3UG=\&.X,R,7DG?DL=:=MBRW-WO9.;Y@>+8_=97N`P;F4L;+("[ZK8?&/$G
MHCI7:^7RULI%G>-_^ZX76FS'<..3](J:8IL[P.%/;!WT^YQ[=MIW)(TZQ(87
MN,C4S/M+/UA?X.8RL^^0!3L0!!$A>TFDYRST\W.$(`Q"/7IFH;H?+]*5Z%F2
M/B0MLD/_53B%Z`\R]]9C;*)G+=]RB&I2.=.E>]7@3L+?^E>C*&32._R>89P`
M"\(-R;?Q*XG!VP;K1['\%CO>4H_^B7$O\<Q0N()05P!U,66U#3[$86V'1"'U
M_2";@%9V](@C9-52,+E5)4&UO:\'E$H24=E/G5XV&K#'^$[6;>=R!PI#_J;G
M\-&B1S&N+BF>P4AHSZ"E!Z>W/+K(_I7>;T47/Z^CBS?KZ"+\AHK]!I:[7]!O
MH^ZYR<,+5%\C;:#HXSO:@H>"^8E+99$H@Q*+>@K4`V=,>0H2^`XA`GL*452;
MFE1Z%(P2FBH/TC$?*=@YMTQLGPQAZ<F1OIN>;@R6J'`H7M)->]3F!5[5=D#\
MBLIK?&C4"0M9&18+Q[/3UFKEV/1YS&703.JF\/1)=-K='T57`XRG!QT>68CX
MP),#`8.87747U,!?LB]C.R1/X<."F%@O/"#;U+&P@LCL/;?.ZZ\)W^)12'1]
MYVEC`2R*ZUL\.F\F_L!7<$=,@[HUX5G.>UH%.9:DY##DH\[DO\/8,J4&/;.9
MH8.12!](U#WYSA^JVSR"M]Z=Z@=19NYK)3,,3O(WC3EI'HL!<)R^>Y(6S"U9
M4LK<TPW3/48_4O?,^DZ9<^?Q8")_6^"O4!Q4CX`/D@JY4X:1K#/_D3H`++'O
MD(202,P]F5/$M5FR*([<7M(OO72I6DFJP":%^4AQK)F=I7R7'PC"S%TRV1G%
M3,*3R@YQF`G>4!TWH=CTD+-+F*2>,@=>=1PC.$7,5<-A]<`^6:?P#&OE>U$0
MB+[=OG.)\\">V).($02P*6<TEFZTV8$P^JU'-5A;L/7\Q[>9<0Q5EMHREFID
MNW8-2G`UJ9"OHC>'[Z(T"3Z66`&/U',O\A4/I/,U'%XF/YD$EII2T;'O;(?;
M:JKKB3>%BZ-F7`V6MDY>T8T%QV!*:6XMPZ*SI"7D`+=UB-AP^)-^?.ZST49O
MDS#H*$]>Q>>EP^<,WDB%L&Q30$S.W)YDS.E?*(?^[>OWP7F-4B=8"J4@/6F0
M)54O>H[GR92C(I3<'(\(!#:8[X+2,CRWLNP1XX'+\U2)1[@L4V(DTL:<NO2D
MP*".>M%,]V/06Q(*L?H&8K*S.]_MXX*$&97UCCGKUG*]`33;^]A'`9Y!BS"9
M'5:B+U&CKV%+W_?)7C(4'+E,`:BO:QE9GM-VW)=IZ$%/`E)8I,]@(;;B`>[?
M\?3>ZPM6#DU,DY7ETP?'OX=MB_COH>T+/G')L6_EDI?1#Z^DH,1_-KQ2)L\V
MD&AT-=DM>EXOQ(E_6M\GH(BV=75@P*NB=V\/Y+P\,([L=5G0"S_P?]25[;ZZ
M>5K2\TOP\_;CUQ7O/\G308:2_J.DF(VOQOF[1E6V\\:`[Y^A\C`E2.@A]4Z#
M8CUF':,TM>VS.$DRW$)Y$Q1G\?`C]4S7-2>O4L_^:ZZ\6,OJX4L64#@HW)DH
M'*^O\</T*,]'K@_>00`_=AVA0E`AJ-"N"D5Y+LN+X]OA]16J3W&53_(,EM0S
M]G[J;AL><Q/9T65I.RQF])WP<P5U&-F+47WFHT$/&7<DJB;@KKE+V,%C$S#O
M"$M%T;=I#`:?HB.)RJ(5'"^YF\T<:J@UU!IJ?0`9PX!B4(;>2Q2M:/$]@*`H
M776"0.G*L7D*RXTTSG!=GSBO^-N@9]`SZ-D^/6-!_NT8_U+527K&-J?.(,B>
MO6[2YO4E/6;"')*X+&?9&\&S1.",>RCK-T91.1+<U=@3_A(X_)ZS4.!@AG^S
M$."M;6GT/<%9ZYOA?G_+T87]E"P%&*,4H(92@"3MF:4):"]QXC-L_L(EE/T:
M!,7_H.]W/)7Z]<(4!K3"<OR3A,DIGJ^B'Q98S:4[5GO'4O8NN6?JVV/7*K0%
M.XGQN(CAAL>G($VROH9!!>C.L%<+E3Y,([['K^J$=W.")':<I>=1E/#Y6RF,
M1_6)G>ELYUZU*`WX.^,EW;%\^W=^P2F^!TE-K^&NLWX\K<$+T8G#.Z90F>7I
MB#E=.%U04-RUMX!K.GM&_YD^XR_-AL^B<$]\3>Z1V7WZ>6M=6O:'Q8OW;KS@
M<M5FL590],!.G$LUR(,<>M1OA*WTZ?B-S&BY2D^:!0N5^\^VOS=<MVFSJ0WT
M-3VJU.3?RFI6O0,[V+/DXT^)%X]D?A768GVQVK!<S_'#\$B4I$V4>&C;!CPZ
MFC$#SI-G+D\=4Q(:)H]W;!?1]`X5PUCZNG6`0Z71X!G?*^D+NV_'`9T;!#LJ
M'N$/YIE,US,\/ZQMWBV12;\RO%,^8[&@C+.R`]O)CXUND#=F%531?O_CJU%H
MB?4M2-ZX2%"%_%CQ"UQ;UWV9G#-,D]1$=<0>4J6LG'^8,9<$,>)DDCM(\S)%
M2I0."6S_3UK5Q%UC%LICV6Y*OJ##C_449>+ML)`U,RM@@ZJQ0=>[NL^-#XN=
M.GI0^$(UWV:E>ORHP]E)T<V@R^2E1Z&RA67MVP]+ZD4`-SQTRZ1+8-V(6B_9
MC\RK2#@NZYJ%1*6)RRM%V(N;LKZ@5MEVF'?$F@UL"7ZRUT.@!,E*O;75"@F6
MJ,4+%F?%2:J]YAO:485V?%E?.G>#[$/$#EYX^L"8$77-X8;Q@\TN?E"C]<[Q
M[Z5KG57%N!%N)Z])?GAWO7%!DC=F"._/..2>U3_9S/6^#R_2A"D--LZ).,'-
M095=O62U6_Q%[OW>\H!%6,]EV?RBHL.OS7"OPMZS'28R)!*GH.@T3J]$FW2#
MXB1*'-XOS`FN>',`Y$5LT=ND1]LW]4`!U/AV(KN#3]&<POIRI087>I*^/F2U
MVM)0AQ40<V.E!DX2FQ+FLT-&P##6(8%76MFA+-"CEVG<VY:OF<3V#'W?B5^(
M??-M,N.WW1\BN%7##H,F+[^G#Z-RMFZ4$?1WB'=+A6]N.-27#2XX<]V\_?1-
MFE%ULYF^]NA92YYR.[MN3Q#H0'2KAWLK83UJ1---\4\:^/55-FZPUPG2:$V)
M+@A\@[&:&_]5XT3+UAE\W2-AMR\&76P4Q(SZVB3(P:2#0HN[9.6QU*>.VH*Q
MAVZ+0G#RI-2@7^<2\R$L3MUHR^!3Q]V%3U:A)F^=_QP>F0MG^87S`%7+6-=P
M[L9CZ%-]BCQ/"0>L1VVNQ]V+R"YX=D^RZ-[BEBCA1RUJSGF!=6]_\TFVGAZ[
M:$Z=#<-=\!XFR9L8:Y1B36BHDM'WK%A+&L?VPOXV[.8%_P!U[2G0K9NR]/CN
MPCXI_`2X=4XDUH/AV/QW?BV>@V6P6#^.6SZM[W]$_4YX6ZQY#("]6&VB*ZU/
M/.(O/=CL>6:B#(A7&`=%UW'<).IV8M\%9\I$^Y6H04N^^_<I`?+-2/I7A\7$
MO*>O)A6E:TMGM[M61V[831!6KZ%-'@N8?>(!L^L@8"9$I+SMYB^2[T#9(^'>
M.96R&IXKZ1U9T1>-`"0--YJ4JB<NEC/_FRWXDI>C!Q7R07TLOU4==KQ@GR!S
MWY18!#0N8%B'6\.8*+M.L&)YOR`RP2N?N&5ARW$W[GQ3XQ#6]K,D8-3D[TKZ
M1.AIDE=&48>8.L[K+BQ4)A:1S:%0'5VSYT-=X]JE>.6)R*TQ)W')A67PGF*L
M_1P);V1DV6FPO3`'0-AW&.%=&>(`V*MK"<>"*$'/P>!R$>_T$M^^V(G!)^,G
M+'QIW1L\1!-SB[JPC%GD(;CQ[4A!BX-`GJ)TBF8XFK]TO2":$753H_AA!=*P
M]ZOY;26-^Y!Q_(-U%G-YN(%UL0E:E*TS-.NNE#V!3Q#!69C2WW#6'(C:]B1Z
MIK$K34]1$6%T5RKQV0TM"JY><2*RVR]K9^A*^B?E$;O>&Y+3YN<P=A8V'&[8
M>`M&RLM=!K"'/CJ&1VV,I-N/W/4+OCMAE]95"*RSP;HDP7#7:3@]D1Q8&\:=
M'I9!0]$$AUDF(K@C&L086#3!(^O>A#S_P,*#]%Q`+=M-XLB3N-T31<?8DN+8
M0G3YR*8$5H-+3SOR%+4\BE,B?!YV^,FMSE9!KT4FSDD176_K2OK=3E#=35[]
MU7=5:W\QAQXT75SWCE@%O;39YG,Y>UE]N$W/[S?;UEG8AG[@8[S@P/6(_O0U
M3-FL7;\I7+_J7;^(W'#X*HJRWH<$C?O\.,3D>6IVQ&+#$Z@!,R6EWQ_3XQQ5
MEO"J$U5B\5LI1<(B/:INPH5UH[9'#*$C4Q2>,@,G+S9)UCX+Q>G`P[1;;9EX
M>SIVAS=1;D%A8>W_K2&CQRHM6-/4IQ@4$M2-?.5YHN]?8CMAR?[:-67A!>8U
MK@,7*D,^B[6O2P">Q_+(0:U)F+OFUE@-PAH44]:C*S;OI@9>KQFV-&9)7+9J
MWV)=#_CE7OKUGKL-Z@D/*I(RWN9TPP,+W\JX$?1Q)AM42JR>'3)44PMO*#/:
M)UFJANY_SHY$R9H9?;,?-0_5L>$B:UP,"VJB6(1#(O>#$9"^U8HJL%5OSZ=B
M--59P^?H?K,;H"G9(JP;A/BW5K3]+AX2C,*`T0DF5NDMUG,A2KK"\1O94Q)O
MYF'/2'[N^/@*MF,[]*98=F$9OF[,]WO`FX[O'?$>"3DDDFN'-_;R`E63ELP>
M,"(%GZ!HGPOL,\/V)MJ'W<V^4>FZM[A"I@1X9D*C?+N:*X:$EQ*41V2G*J"/
M"^.BLB5F^</#5U@F%S0\8_ENWHTB".W>TV\-"T+FA(1C#UB#"MX)8]U/.\RC
M,Z?<"?H-AJ_O:9Z^[GD?%B#%7\GS:"YALZEV4B\;W;KY46@K],X^<&?8ZY!V
M'`4/#`L[8X:')FG)FKRM3&:,V=&/GS/=H/IJXWN"SX0#9"Q^%.57Y2*<C%LF
M$#/XQ$O)7U$:L>J"</_A<"H6TV?7WQQB+.]83H=O:AX&B1+%E.S9AXF0Z(Z^
M,_^*=10/.W=PGX$GB1+?OI.@"^")\Y)SMR<Y]I-JQG5%T1;8WZZD]RI=4()>
M$=8F",90.L*7L"EY5)$:=:B@J,6F.018K]%3-DM6AV`8NCM$#VHM&*S'^,CQ
M;L,E8LQ(/-5=\#0@[ZBRO..`SJ4DZF>>Y'.R_WSXP)@5D6A<ABS=$(@@5?$V
M'/X3'U'#TMW$=ZS;C[!%[*$4C[*&I')#MVSC`0X)3[F;-'"W_<)K2S6?_AO[
MD8FO8-6#P0J?MA\=MH5FGPCC4%&T(*BJ)=N\9HK`.$0)=V<:]_'5[?`]L4E@
M+1BY9>6=R4+YH>_SN24(@#UH?&^%2=2DY,>/#LN=.!#\ET36B\?=0M>+2AK]
MJ.NKO#L->6`[C0HNV!<EZ!!%>L*U/O'.#GQ6@!/T"(WMV3KZX+#VE/3/O3#H
MP52$?N7<^!%\)!)L-3HH,"M&O>\HR<QC+BIUJ>D;GH*"D"/1"@1TLP.:)?U?
M:L38?9ZX@#NHWP[:A*JZS=NF\V*,Z'8D$Y/`:UT7`*]G8['Z;$M7'7H(>6/3
M_VQ6#5W?O-DH&]K[N3]6[+BQ\<'KFS\V/D</TK-+5AF?X>#,Z65X*E6B'><M
M)P-*DOMS9!'?)0Q"Y*U=)ZRCP.&`Z)8%'P^Y!3[1V39A+P-D/&QVN<JS+!(O
MUKAGK1:Y`;-B1-KK802FJ"<M[,=M([6&K^A[]3CI'?5I"FM2S/!N`,Q)-?+]
MNTUW2U@M-I?LR('C_FY8J1=X)$F7=M-K3;BTW`6.FFX'/3?I#X?L57"T#I`P
M=-58*)T[<0E///D%CQS_HJA`V)=HZT9.`DK=I'QS,(N^)PA&S(GC)"(J''##
M=&=8:!P$^)-/#UIMQYW``[1;?]8*TA?!M7!F<EF)"&]3^IB\I!1B=;#[,.C%
M)OG84:%GD,KIQ1-]N)/%-%*-`ED\H79@VVI0N$EUD.M*HC<;FW_A\IC5'8N)
MQ0/)0J\^;"3.21!\S6-RJ-3<-^<L;)+RW9&U21X?]E;TK/WY*^DW*DB!G^AO
MW`-,.P]L']>2U6][\S\;/OE&'Y[UYG?8O.&+[3G%1.[9CN!N:D88>EV'$@]N
M*LKI1]E[U@H_,K>!*@9?Q:]QLUE*ZRK:Q$`UF,=*S./;]6ER$X@V;&,0Q%ZP
M)KI1I:2Z;EC)CMSQ<7736K!+38'9I`+*/&<KJ82&%:H2/YHE'Q%^&17/Z\T_
M4)/&3W_L_&@%\4EF*CEJF^;NT9U%CJD>TN^C=D"C)_CGAL".S,]K"(D/0DDR
M)VOQPFBJ'A4^;)_4DT@5QUX#@D4]?R(J]RA5C,WO#M_)RMYYL#SQ[C`'PIEG
M!QE\^C,+QS!P"#NT>M%HW*>-2QT;)I5UM(R;;MJ^Q[MW;O7HS_`<9F'H^I,;
M8-U&X[TE]LV]L.`;I,T"PQ@W[PB_%QN,%5Q_.^Q-=>'*`Y[6EB/$PSL,A:,X
M7P@105XD8E<06UJIAAX$(JB#%]Z%WK)720R*+<H&,%-304_Y89:#:1]/<T4?
M9%)Q9P3UO(EZUUTUI<*45-.X>2N[G\32/NLOW]'#C3;JCV1;A[<1\.-:@OG)
M.$[^/"9Z7N[?=S!T=4^4+@(!HB<-3]1(-VQ1%`?`6F5.-TCQ:#O?@]K&&/_6
MQFL;1>@VU:UG4:'1;>>@3>*AQT74=#X!851VG]]MFUIKD9RGR1^?3,]NA&4]
MPHL/V7_=((H:VK,`DS.8TX)+?[4%$NRJ=%A/X%(8,(.[%ZSLZ)AQ]C8":*'/
MR."-?778>2ZY9WX<#Q0^=`CWAUUY`X`D/8*APJKYQ$\ICXDQ$NPO!S0C3-TF
M4)=^?R_9$;VW>618>\^\%"'PEJ-1HY&=6KM3/,>R90A4?GB*R,[CL_%?@3P5
M!;IV,BKKK'W""AS"CPV!\"YYE5Y2T&,[&M54KSU@WL>=/W?KF?10[":-0YAN
M#QJV4VE;7]?8/@NM<6`]/#'V@;D-BP31221<XS6N0^'T9$[5AM]:W'C_?\/C
M9!`BBU3FX.DO;J=,N;*.MD!TFW":0M]C[3BIIFMO>$][4HB[CE3@Y8>F/=:*
MK5QFPD$+1H!QR[;O^0=,YF;,:FT_^1=RH[GR>NOH0#`%)\C&A+<3=C,Q<6@U
MER:XE)HNJTB%U%8CM?$D00YY>Q/3[K:UY&QGOFF4\HP9M34B8\?)2%Q(NPO&
M9V@^M:I+W+2HF)\!.X-:@J>U[N[XTJ$'%%RI7X="^124M3WCPWC77ELX"#!.
M#8??LI$BCN<$;C^)RP%_RS$+(8I(M(_O6_=&5X[QP&/V05.;J*!H4ZD/A88W
MIHM&T>#`>(>AEQ]>7%S)?`I^8<<->R/PX&`<P`F]\MVJ@HW^:,D+8,QF)'I)
M/$3![Z!>,XB`\^/':D\L.MBII#ZRY'#.>PI':Q"W2Q8#<EU;^KOUB>5]0+OM
MJPG#?E_HHL667DWXELQF)+@@O8]%F/[A6M,<G_5.0&%C)6;G0`8I-AM1\HV5
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M5=[N$6*1>]L++L+WV,*>HCKJ<"=!&\G@YT@MUNDEGUTCMN+097`3-+Q[%01A
MZ<J^;@IN6!'$'\E,"Y53[KV$4]OB"8=[(E31N3^((O%AB,P^L?NTQ'*H1QP3
MB&XH*AN.-%#@*'[`4R=(/(3NUY9P)"8[KI,48<5W!,I[FQPY"0<QJA2)OR16
M^SAXRVW'G#Z)Y;29#6$QB97/*E6M#6F(0C%;4,(3.F%A?/2G&"O"KKV)ZTM,
MG,)*5"^:7KO^!FY'HZO,X>1??@(*KBX%C9A,?M&)3TN.1W\R%*-?'&QDO8_P
MV+RQC,@3UZ,*FG`UP3QVD\T>ON>M2R/A8Q?&@HM!CW%=\=QWPD",NV(!^&@=
MB8<%]5@<)OC@8EXS<YNHQ@ZJ>C989/#[>I2["8SGK>'G000]NO7H+D@P9W/W
M,!!=4MBXT?3=6E\+C[]?#8\A+#47]83;:&*?Z,SV;S\QEB?QD,V4"R\>"PLA
MXFW$^]N5UJ0%C&JFHE;'4M3A.-\EJ@Q'B\VSR,V"2M8;1L2W"=_DRXK]RV]B
M,0FGFL*N8+N[9Q,99Y/JSR8WW&/D3)&27,$II`J_Y>:`/QZWH>&N,>]E9:_6
M\Y,#;S]X/0@2\)J<^+9PF.@/H@B[IHE_9,-<K"_.AHM9\F[!ZQ30GBK-S28]
M07E\W.EF]RL>@GNDH4WJ)9)*B39D=+MS>DI@D3T6*1&Y*CS`__@N1[(.,I6:
M+-FWP="0*1$&!DP+6GZP\BC^KDMVBX2]LK3IT8%'J7A_PG68,M'PK!<D?$V3
M)_`9F5=1,>^]RI/,E'OK_I*L6S=%\,!9^\&Y'?JH+&K%]QZ<C6ZYAQ"_$)W0
M@AYUT2#K9)^ZC1K@9$>V9+^VAT3\*TX_<IGNA9%W[DZ$1^)_!P\C=*WV$R$;
MI*3?Q5K8N0PU6=$>=X`_AFC,P\6<,HFR+/H8@W?[75\"6M,H<(CX'.X$<MX1
M5OB0&-#>BUR1X`YS<+J<1X,4N'`S=X&?-!WCX>"3(_I&5Z$U7DT6-6#E[:7R
M2!47HT33%K[_*^GM^J)U=DD-34RPHL@3H2*36-Q.!QA1CJ]M1XA_LH."&4@]
MX]@;4Z6(<:.QVD@W$OQ-ZQ">WY8LWIPTKF&9_#QQ!2W*@^UK-+%?(M:V)I2T
MP)'>7%:PCGU7!4-CDS`P0<8YM#T)8Q5=:TP6G.=2@>T^YL'+&Y@4&R=N?**\
M[JZ-FH>E]52#@[8;_(L"!(A:RB9O`B0^NST&?MUA/+UK)6\'F\A2)!]I[;2X
MI#ME::B$8H?VCIO@[9/G9HN.5(L1F:'P^6%%XMU3]$I,C'U.3%CNOUFL$A0N
M<2<@ZJ+A&&$UV!8_8FE(],**B<EVEB"F2SS/)'$$-^C;SN]2T./@?6!W-TO0
M6:@DW/IZ%AB#L"?BK2]_4*CD!3:\89_VI+&RDX->&]_PMJM$%\V/Q8$19>%9
MQHRPO[P67JYAWE$@3]LW2K9<HK5`)8:'[%!C38)M.7H,1@&PF[6+A,^X)3<"
M^UV![+.3XD$.:-%UN!VL6HOW?WR5]4D,;L@\\"E%&WY3W.PL*O4//Y`W'5?@
M3+MY**;OH`['K?KC8"N185_!R;?ZDV]`>(E2?E][=9QVBW7)3G1,,`(">YS`
MB1Z'O(%/LD/64^BZ],(H=N0:A-</Z0/B!EO;?;6<C2Y-&TBL&_0(Y9"--D/>
M1B!_W3&)NP;T:\)3[OS0]P6[(%9@:M@G^#&669.PH7QTWXDU(]R\H91<3Y1N
MB^"!E1LX+ME3DA`,5>,/X#.XC06;9\$!;1^!UO.X>8_,($>E$Y;'X$C($Q`A
M2-./A;TZ&)_6@U+B<KD0&H-[`='UXL?H-G-0!+V'1UZ6&6KLH*4RI_&1'>=,
M7KD<E'8?GC=^Z!OYIL,6H=1I,:.RD=1I;KUX*3C*5#ONPK)%=B]\*UFCS'2>
M6/0\[[D9)&9]X+#L..H>M4H*3!Z[<N-ZV[F(]1BA=8?7,"-@>_S*SZ%%<=E.
M7-TUXT!$?'_\X(J'&S/C(M.P44"[?\$;;0\25KS'NKJIUE,O[*L7];;C<:T@
M8;2O,BH,=G(R;*5(UT^G[U*C0%M`3#Z^9T[T^+&\6=\FK'![)L]F8_8)YH'O
M^Y*MIR?F)@:?IZ3JQY_/Y?T=<MXV73PJT.NN(%\=V[+]\,).Z!&FN'X#N'YU
M%&0QKSS9JF63*VUV!W=)6K1;3#5S[/8VPF$">]E7VDQG<7#WHR5]('?.9@^1
M`+"8V\@Z%`7S.W7I^N:/B/8]*=&,J%4]A[[%;CN%G:@\C:JT2=W!H"FX[7-(
MHA+H+\.NL,$\;79&=\B"HA'#I<!Z7R7:,`GLN*Q9>\L".XR3%%?5J&-1V!!N
M/8YVG0A0$V2(Z@B39#"29`B^@/`91''OHCC2RYHF\`OM_':7X:KW]RRA$O80
M"'R9*$\2UE%L.`F'OSZ^/!M75\01LKA'[V:+7FFG#R#K,F\&HR^-[;/>^B%S
MV_:H)\:O#JS5@2=8^1&.=_!GE8O)H=5WA-H4'DY7YRRLM.MSR:->>)I(%IY$
M[<9X,"[9"VI?\[%XT6P26B*`%1^<^/%9#Y,"NJ$',RW5<%K@YC"_]=97MAO>
M\HZZ]^_0,3%K(,@N\"Y"00?CR+]U]FC8,=%ZSH:S_1RQ>*M7OQ04#I6L0LGK
M7&V5I&@+>C@VR9<YF]/P#Q8S#]H`7UOZI_7!_W.0A]"_6-_8O%NVC3>,9;?L
M`+W7;QN>Q&\#_'G<6JW#N%YX)SRTA]M]PZ6%0>7>T19!T'Y34<)PPO/L,X]_
MCC)4O"8CF7?A?:XB68E:96<=,"\]YZ;`]EUFWW]^6=Y/ZA?S[U/][U@"#DM)
MML_7BI8II-M0N+`E&>_]^OJ"W8,AINE2BTKY%_^^8L4%X>_4$[JW7E\$59D7
MT;:#!USR.[8KE[R,?GA%S]^ZMZ`;IK2]2'RMD_A99]+#GQIP,7YJ^+TA[R1*
ML^B5;P'[KB:CY*NWC.7A:\'W,L4/=Q>)".^"+[&WK>@QF5&6XBC=S9J?!66+
M596G2A=[0V[Y8ARU[MS5-B)X^@8%*<'I/B@)E8LZJ!F]]B8DQ9K"LW0"_]3G
M_[>'N)PT?*4O`V%Z)0*YCYTM*9UMYV6TJ[S:7F;&'ZLUE>0T)V%+)&I3*CF[
M3CTN#(]<,GO"MOWHJ"M!U4Q8OF\9@(99KY0QI]#X^CD/'#ASJ0AP0!'!&``'
M1+<&P(&N<KXQ')@"!TZ'`XE@B@A6`8`@NED`('25\S@8G+E4W+(TI`BF`"@@
MM"UXL1%[3X_#W]WSC;V^^.GMAP_]#V]K-A7):#UC;EVA>EFY4D;'!.4R?M?Y
M2,OA)%P)PW%B(9%39"0B:5OM2CG!J"&76-:_/+%L3"`;D(T"=N,<?!+(1SGY
M4$[C>T`8VB`,<#(@&W`R(!MP,B`?<#(@#'`R(!LGE8TQ9`.R`2<#\@$G`\(`
M)P.R@4@&9$,4NP$GHVGYR%/$47O)1KNJ,41B_&?ZYZ?PCC4?UK?;&OZD!5RI
MY@":7I[A?Q.5OY.,_$T497*.B5B3*1+#E7ZO7'45M%I\)HM2BI\:$H`NGS^;
MH<]`:6AV?H9?BLIP*'1'+#<`NA-LACZ?-T"/`=``:"CT&5IN`'0GV`Q]/F^`
MQ@D:<6YHM9!YZEH*'$[>!KC#V6P^N>B>#6"S@@GK]\32GA)]PUM9_9+6M`9&
M11"?L+G"N=+B`4_C=*&`&B&F`UV/1)("<:U&M?WP8!):+0SP,"`>\#!:)B_R
M>-(;S2:B"0O\#-@.^!D0!O@9$(\Z^@S`ST`D`QX&K`8\#`@#/`R(!R(9K9<7
M1#(@"V?29.`,YT*()!T"3(\IUHL$[D4WJC:K$0`X$&=6UHD>1<*Z#PW<T"CH
M),`JG)LLP&.`QP"/H9TA![@,9R(*XL,$7`;(`EP&N`S5CER`;3B?Y@YP%@`0
M<!8@"W`6X"P@OB"`1,C326\L]T65"[@,(L.$4!4-*%8X:_\`&MX%1J.?5%<Y
M#Q7O"*/1^;$3;(8^=X31@.RN<AXJWA%&`[([P6;H<T<8C;$*7>4\5+PCC`9D
M=X+-T.>.,!JG[*YR'BK>C>PV1BN(+`R4YW0#E/*4Z<K%:2W`+%O+EU0PT"@S
MB2,B&B39>V>;^JMR@E)"*CZ1!V)*<K-`T)EF+N+P710?H-H&<=!XX`"DHC@.
M*"(8`^"`Z-8`.-!5SC>&`U/@P.EP@(O&3_*X_ZKAODT`A':8!0!"5SF/@\&9
M2X4`73V!`BVP!8V/:4Z_*7>&O7_%D99W1"/+.^(D_$:Y)RE]N4P\H;D1!+B.
M+UH:2ISY`Y`-R`9NZT,^\A0EGL+W@#"T01C@9$`VX&1`-N!D0#[@9$`8X&1`
M-IJ:U8R>@Q`6>!V0#W@=$`9X'9`-A#8@&X+9#3@93<L'NAV?!>,_TS\_273?
MWXDGS7U+=YNMZ,+-[YH9+O+0`\07:F#XH"</19YH`*46Q+VK.R(`53Y_-D.?
M`=+0[/P,%WE*(12Z"Y8;`-T)-D.?SQN@T<P8``V%/D?+#8#N!)NAS^<-T#A!
M(\P-I18Q2]U`[P'DK8N*PA]7-U?2O?U`'&M)=RFI]\32GB27:+YC>`8ID\8^
M?9T+C(,@KMWIR]_@#`AV6H?VMY'C;=1^G.@[RGCH?&=9#\2O1Q9D>=93!F6:
MTL(&M)'O;;0!P/V.,AXZWUG6(R^/DSZTOZO:#\3O*..A\YUE/4[Z..G#!K0E
M^8]4O[",YZE^SR&JZSL59?BA[^*S7?Q232"\>&=Z:+;X_!5?LW%>[P2;H<\=
M8320NA[.C_HHN3]O#HNOV\#J3K`9^MP11B-3CE,U-/L<-1M(W0DV0Y\[PFB<
MJG&JAFZ+E\NNI;YAG<F.FO*'S*UKN$N',]Z??<O0C)5JMO4^>YJ(8*R'8#Y"
M<R-?2HL'/(N65\MGLA@8]M(5J[$S/2Z_CP&3<"["``\#X@$/HV7R,I%'H@D*
M?`S8#?@8$`;X&!"/*JL4X&,@B@$/`U8#'@:$`1X&Q`-1C+.1%T0Q(`?UUVG4
M4I7!&'=0)K9D1[?].Y-(RA5*-ZJ2F%O;4TV!J[<.BDE$OC01@4M2G:"(/*#H
M=$("QZ1U4XZ.FY(BB`.3(L@IIX[X1TT^"8Q'.^4##DH;I`4."FQ,?JF1E7YO
M.)R*`$!P4<03#U$@""X*Y`,N2MNE15@790P715RI:;@1!IP3405#%/"!<P+Y
M@'/2=FD1UCE!_$1@J9&506\T1?P$XE%'0<H+3Z6\B=^G&P\E&?`LG?S/DB11
M&#/V[6*UO:!?7OCNY;VJKE[>:`NB^R;Y,O^@&LX_5-,GUZY+//?:TC\9ZIUA
M\N88G_EP"*)_L;ZQAAD.%>@WJFNXMVR[MW1%;TQ;^_[K7_\B2;_L/OJMZB[8
M_[__CV]0;:(K9X^_6=B.=TN<Y4?K@;C>DKV\^3S)T%]??/B32L6P/[J0-+I5
M^J=O9/[ZXBU[5>XK,WFH_*GTY0']1>8_4`67+WYENPTW&W`F&_W'^>@_O&*5
M0?ND\H``[Y7_')^O5N)WMA)4V"R(-+=-TWZD7)8,5U(EUU]2,CQ)]ES2*!][
M_%^)K-DIJ98NT;=\)UP!$FU5)-5E'WM'-+*\(PZ7S)_D<?_50.Y)C%\]_EGZ
MDR(]-RS)6]B^2U]Q?WXII:A@K>I4PI8)8+TX=5-(MZ$6`;L"@'E]T:=*1DR3
M00CE??Q["&'\]Q`,-4HOXL1@&"(4M>2FNG+)R^B'5U((=?U^V)OPQ(5[55T2
M"/8KA'-UR+9ON2V4!71GE*C*Q2'Z1KS)5@A=#WTJ4;A0B^YL4W]5SILHH7S7
M2XIG]&FZ]-9VO?(.IB@%R>?#H2KC"]7>08+Z%&,.C-R)N?2'Y1!*#&;E?E,-
MJX(9<3!S0F@2S)S`S(&9:\[,?;)=MXI9F+!S0J@2[)S`S(&=.S&7WKN>L50]
M:N98^'<=/N*!8-@\\1C6PL;FAQ.EHZPE&.VZ+BN.M!R.NI?0[8-"DKU$0E`U
M;W<B,C^KIF!56UB5M58`[!*"72<"-O`&`'7.K`)`M895`*A6L0L`)2YO`%"M
M814`JC6L`D"UBET`*'%Y`X!J#:L`4*UA%0!*E%L\]5>GI^?$VI7N$HGQ[)81
MOT^R?4'E987);"A@`Z4Y4]"]$;I#WALK10.1(=SG27<8<\A[E^@.8P[A/ENZ
MPYA#WKM$=QAS"/?9TAW&'/)^3G07_/9+208KXZMQAR/]M>;BH(ZU=N`\GK<^
M5?O+<^*(W)N,QU"+MJ%4H?(HD+V1&@TH`'"A=1PI,Y(!*M$2XP1,`"8(RPE@
M@F@<`29TP#@!$X`)PG("F"`:1Q`_$H`)W;Z]T.&<QF?ZYZ=PC(8T]RV]RK:C
M4#R!T^F`H0U&*/U>N1YU$'X!A!]G#Q2.G"W=8=E/'G2"W`L@]S#J,.IG2W<8
M=1AU\<D-H]Y*(D.X8=1;Q`C$8-H@_(W?;ZABSB[R`QFGDEW=7$GW]@-Q+#8M
M75+OB:4])89MUYJYRS)O"3HN1/G!M$)N`1:W,N2#X6FFYQRSH]`U(73M=,@'
M]@"XSIQ;`"XA@W0`K3/3,X"6T.P!:+6)6P`M@!;T#*#5<?8`M-K$+8`60H30
MM;I3;K4DV%*GPYP((3L\8^36]E0S&#"R;])(A1GSHY.;@+?BX.TA=*V?>8#?
MS<*504]6E%.H81&["W5LIKY1)/`$QX!^Y\P\H%\[(Z8`OG/31`!?VS@&X&LQ
M\P!\`#X`GPB:".!K&\<`?"UF'H`/\4Z@GY`IR`:F&F42("0@"[<)Y`T"U3N3
M)*[^2>J#:ICLQ4OZC$M7I4\_20W"07L/S1>MT`>L$IM56;$7[!*"72=".O`&
M`'7.K`)`M895`*A6L0L`)2YO`%"M814`JC6L`D"UBET`*'%Y`X!J#:L`4*UA
M%0"J)6FS6F[NU5QE@M:8M;3&/*3`J$)IWMP>PD$4F51\IWT\[BG3T8FT"$@H
M3ODD*B.;9@8@1US>`')JA!R@C8A\`=J<-3.`-N+R!FA3&[.>#R>`&Q$9\S-0
MIG$>`&6ZQ!N@3+UAM-$02",B<UIX#PO-(063H:`YY#+C#:UFJS<`P.(`<`45
M'L!L45-?%=6$`.I;I;."@3)X"!CM.CL!HRU-YP%!16,G$!0\!()VCIU`T+:F
M*`&AHO&S3&83R'GVIA;(>5;L!'*V.>T*]!2-IRV\_I='-'3;9^E#Y0JYV6IS
MLVQ>7V]G:A\?Y;<W;5M#K496^[\A`X#SS(S^6PV54/7S#)B]B=G366_8KZ,H
MMQ(S##5LSU2'NK`4'`/JB<,\H-X9,+&62X\`O+::3P!>VS@&P`/@`?":OG<)
MQ!,_A0F@`]`!Z`!T'6$BBV<.)CC>M9>#+;P?FGU.WYGD&Y-LO[--_54Y`2HA
M+>^(1I9WQ.%2\Y,\[K\:R#U)Z<ME1G7F*T,`WK:F'`BL$I=5:5H%"!6.72<"
M-O`&`'7.K`)`M895`*A6L0L`)2YO`%"M814`JC6L`D"UBET`*'%Y`X!J#:L`
M4*UA%0"J)5FRVG-B[4IWB<3XM^Q*';M&MWVW[F6%.6\H8#,-P4'W9DJL0/=F
MJNY!9`CW>=(=QASRWB6ZPYA#N,^6[C#FD/<NT1W&',)]MG2',8>\GQ/=!;_]
M4I+!ROAJW.%(?ZVY.*ACK7="C^>M<<&SP`7/WFA8[]TNJ(40Q0(XA#15HP$%
M`"ZTCB.74(GS-T[`!&""L)P`)HC&$6!"!XP3,`&8("PG@`FB<03Q(P&8T.W;
M"QW.:7RF?WX*)P!)<]_2JQS\`\43.)T.&-I@Q*`G#_N0_7;+/HX>J!LY6[K#
ML)\\Y@2Y%T#N8=1AU,^6[C#J,.KBDQM&O95$AG##J+>($0C!M$#V<;OA7#,!
MOF5HQDHU)9=HOF-X!BF3"T!:3A1H0MJZ#M9,Y!&TX_RU`^<4%#-UFA.`!U2Z
MMI$!`(>S)3L40!1.`!P`#FUD`,#A;,D.!1"%$P`'!);:R0+A;T/LSC(/.>7:
MIJ%+[&W5SBSJ<%[DCZN;*^G>?B".M:2[E-1[8FE/U21)MG4SC9L8G=-L1K\R
MW@#O-IBE])1^F?M_>70(,XV:+_LZ$6*!&0"<%O,&@"-D]`U@TR(=`M@(Q`R`
MC;B\`=@`;+K%%H#-63,#8",N;P`V"*5UCS4MO&BSFV1BG#HH!"="OPY/&K^U
M/=4,QHSOFS=>:];XH`A$I`'>BH.WQPLS3L=.0/1F=4=O-)LUHZE%C#4T5@B-
M%0R#P4.`:-?9"1!M9U`5`"H:-P&@X"$`M'/L!(`"0`&@;=%6`&C[>0@`/2MV
M`D`1Q@6(MB-!6T$Z-KWO829Q0>JU<'-$/B!)O3-)XN*?I#ZHALE>O*3/N'15
M^O0:JB\.&G=H=;/E2V",2(S)BIE@3K/5L74B%#@!8&DK8P`L@C(&P"(P<P`L
MHG`"P"(H8P`L@C(&P"(P<P`LHG`"P"(H8P`L@C(&P-*2M%#[!F3)PZOAL130
MV0E!G2T@T;!5%!.*=L9UL$:6Q[W9=`P-.7\-0<=[=+SO-"<`$858,P0Z=$`Y
M@`Y`ATYS`NA0B#7/92A'LQSX&:!P9J8(<B\*)P`*!:-*DUY_`&1HG8:<^Z"L
M[N9'/(>HKN]@,I;(G*JU"`"73*MEUJC?/Y$&H2A`G&HS=$YHFAF`&W%Y`[@1
MLBD0P*9%.@2P$8@9`!MQ>0.P`=ATBRT`F[-F!L!&7-X`;!!(ZQIC6GB[!E.Q
M!).A8"K6,F.#MEHSQNBN*JK90'?5-O&757<,:[XSA/ZJYZ>S@H$R>`@8[3H[
M`:-G>Z\*"'I^Z@H$;3\/@:!GQ4X@Z-G>/0."GM-%-@!GRRTM@/.LV`G@;#:"
M.ZKY?A[04W2=;?RR7Q[1T&V?90^5JSJ@N%/7`8.,K*:ZBQ[_5R+_\0W*;[I9
M5U(M?7^RMH8*C:QF?X/U0/',C/Y;#;5/]?,,4+T)U<JHUY^.3J%^1:POU%#@
MYO>GA%!P#*@G!/.`>F?`Q%*Y40#>N9E/`%[;.`;``^`!\$Z4R@3@-<N\,HE+
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M)#U@4H`!KR_Z5&^(:3(K;UCW\>]AS0+_/<0<C=*+.#'FA"!"K;&IKESR,OKA
ME12B4;\?-LP_;4W%^,1=7*HOESAD<K/Y`N4I.&@[`<_*8:"<IAN@!*>LIB!7
M`]</#V$='!&%B*:IGGY@-PJX^K4+1I*_=[:IORHG*27$XAW1R/*..&MK/I![
M$G-7RA\.RAN$YAO)=$@46E*Z.!;Q%@&@I#$;,8`XM%`<8L]".;%G(0\KNO$`
MUZ.DW%PO;<>C3].EM[;KB6!*6G)?HD,RTAZHR6(ZTF$&YN.<86<,V!%#;MZ[
MGK%4/0H['U3#D?ZAFGZ9AH<`G[.5E!8V7CUL@#(?FULA)"*=?SZSE!21#$NB
M[Y.>B.I(MB.9Q"US6^_$TI'U$`WA$.H.?TV^2@97I:WH(I)LE"FE.K5(I*''
MJ2NQ.B4DLT%O/*NE1\3IC<<YN*<BR48;P06>!H0!G@8\C5+Y&7@:]7@:DSX\
M#<C&>=2&(,]?3YQ+G7O$68>ZO(5C^_<+R7NT^0L5M*A"(:G(8B!*2C83,)1N
M60EA:+LP'($$N)0UBL=$Z8UF0Q$0H0.5Q"(Q7A2[`'>@*YR&.P!AR!E>@CO0
M@#LPPL6B[C&^A954Y2X;H4^Z4)!2HX04O'X$`3E_`2F7]VRP7U6GY*=-N=$L
M55@B]<SJE"#)XW%/*34CH$:8:DF+KDX)C+C(!=<&`@+7IO7RTR;7IL"U?+@V
M)W5M1F42>7!M.B4P:$_Z(D<[T<W^HU\=>T4<[^FK2<EZ;>FLF^F*=2W=VWYT
M<I+VH^-\!#W+]J,17_AT1A(QA;44M>?2X3YJ/?Y^^I/"&.4:KL?>[RU(V(F4
M&K6M7J0O&VM&FD<!#C/KV.?KLC=H1KH&Q4F_3,V#F"TEFFY/.CT_DNY38B%Z
M+\1=.M::_8=+YK[)EGSG2"_8FSX9<]%:=T`PA&O*T60?VXRU1Y"*DE*QU_UJ
MF6EHZ[E3'"EHR2VEI&^&EJ7M"$^<NDXQ;3I25A$!NE1D5YY_M(*[;16,F!.O
M41RLQWEWGD3C23&LB(!#%=!H4@C)$,4=J<9@(-S1M&@`:[HN-BS=)+HM`=:T
MPZ`T?A7GL+W)'$DI*22R<J6,C@G*9?RN<SKL?%8M?ZYJ;.JF=;].>XM6"E0L
MDM)RO!%)3D:7LG#U8>5[A[4"7$02@W,M66ZKXR&2;+2H'#D+:*#2N`89F?9F
MXVE[Y`0]*`$M\#,@#/`S!)(-^!GP,XZV(NJ-)F=X7H7Y:/SN4OU59.GQ4(0Z
MBS+^DWI728"S;L1`M+**:&7#M1BIMAXVNZ45%*E<!3AW@='3C(R&QY[78U>4
MB:A,AW9W1+L!SF?*5:AO%Q@-<*Z'\^/>9%2F\R&T6WP>GUWE(")E147AK;U<
M^6P,7#OK`1%`*RT!9:)GI\^=P-9W([T.F.\FZ^'6UR,+<F\V+G./"!:@C5QO
MHP4`R'>&SU#Q;K(>(%\7R$_[91)KL`!MY#JJW#H:N_O@.Y;A^0[A?:GGQ@_V
MLRMJ[![1NJ:C=7#;!6.F^%E60'1'&`V7O"Z7O#\:B\IT:'='M!O@?*9<A?IV
M@=$`YWHX/YN*?)R";HL>&T.E6XM$X1-17;*P35TREBO'?B"LV*U,M`S5;BV4
M@M%ENQ(DL/@=R(<"[#O+>KCV]<C"N-<?MJO['"Q`-RT`0+XS?(:*=Y/U`/F:
M#G.]X;#,7558@#9R7?AZMRKFMB.JETT8KEV7>*YD6-+*L>\=XC9<_]:5^?(B
MR8`H";P*1LB#TZW@="K&9QF+!C^@"\)P!`;0%KK.)G.EKKLV@0:P">=C$^`*
M=(73<`4@#'`%A)8.N=<?-MQO%LY`*ZR"X,5_&)`KF+PT+Q9I8X?@7W9,&#"C
M#L*021AP]NBV;&!874/"HHQ[?:5='5<QK0Z&!!X'A`$>!V0#'D?KA$49],:R
MW!Y!@<<ALB%!)>791C\_$=>55$WSE[ZI>D27=+)RB&:HGF%;O,.@NK0=S_@O
M?T&$=$JI*DN8AE9D5%%(T15.HY`"PH!""J&EX[D\Z0UDE%)TC_,_MXSG8/#9
M&7YX`1`&>`$"2,=S>=0;#QMN:@PO0&0OH/$ZRIPUDUM"I-O^G4DDY0K1Q:I$
MY];V5%.T+$2^$LH3"4GWS(JX^<Q\*2D(2.<$I%PQ1)K`X#Q3G?S\K3UBDZ5.
MHC*QP<DGGQQ->Y-^F7-/BS`*9N><80M^#00$?DWKY0=^#?R:2GKE]&9CX?IH
MPJ\155Q*EHV^\%3*F_A]NO%0D@'/TLG_+$D2)2+)`>KMV^!J>ZV_O/#=RWM5
M7;W\ZM@KXGA/7TU*I6M+?_\?WUBQP3*W=`5O3%O[_NM?_R))OT3OO]$61/=-
M\F5^K6F.3_1/AGIGF(9G$/>6D27^G&3HKR\^_$FY/>Q/+R2-KIG^Z1N9O[YX
MRUZ5^\I,'BI_*GUY0'^1^0^R,I`O?F5+#5<:4#P;7<?YZ#J\&@V?[96V5-)N
MR76.SU<KR3M;X<M[ZSO,3+`Z6,8=R5RS1U)=R9Y+[XA&EG?$X3+RDSSNOQK(
M/8D1O\>+9.E/"N.6:[@>>[^W(-+<-DW[D1HXZ;EAT5=LWZ5O=7]^*:4HD##*
M<)ACQSY?E^WA9$\AW8;P<VL3PL/KBSY5)6*:#``H/^+?0P#BOX?@%O1>C:$L
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M=J^:59S=MC432M=`W)J=OP!4!8Y7I6`*HB^`Z`_VH0#$O&Z#`VEOANY9"0\-
MV#3TLPJ:K$#T13E8-)!9PE&C<+^2A>'H$CV3>T^20URB.MJ"9Y!T\D!,F]?X
MGR:+!+T5(S**TTJQ4HO>L%_+P",HB%@*@C.-&'R`1@C#"9Q["M8/*/TR3::A
M(,*?A6JY5%+S?9$.GX:^>`OB[+L46V%\HNKFSM#;"O,T(C5;/B=NR;W)M,H@
M7\N+S$5B3:T7=4K=PX'BU)0=`@2)RILJF0--VH*@F5+'92A`D.!GL#H;[PO6
M6K+#1[?:&N\WUPZRH]:@Z:M0(K5G/">^3GORN):NTLUW4.RHIHITK:HXPD)-
MA;Q^!305'DU/RD:HZ>9QMM_KC^LM.`&<BFYYA>DW/&.\V+>)E)["V7L$'^HM
M_,'W?(=\-BQCZ2^_T46IYE?UB94LNA]LY\N*.*I'#^Z?B.JFM1V>G:3M,.\B
MFX.^>_L.I_2L$:>Y<,`6:1GP15J%+)%\^D:'-PJF3[S45$LC)F]:N[(=S[`M
MUD;8]AW)CA@GF9QSDNJEMB,F/S339Q&:]5?-'7LIN<P4T0?$+_<D:HM8?^.@
M4;&[W:8X1>UJ5:$*NLBVH!7PJ>O"9Z7KPOO'0FF50%!2)9OM./4OHCJN1"RN
M2U6WQ2U25GEZ?T`<9J"&LKU^60%.#,$*45@!3@B4L_O`_P^^@G@20)WO825:
MN,7BX_Y`-HXH_:NSRW)6;/_V4A[V[W1QU?T,R.H+("2Z=05/&503$85>".\7
M((8@J@10OZ"6(8OP"W`N`B?@()1R$*9E2H"A("UR$!`X$%4"J(-031T@`@<(
M'(`3B"!4Z"`,$$%HF@F((,!!D&OLBP('`1&$SG,"#D)1!P$1A*:9@`@"'`2Y
MFA$VB""(=6Z%_1.%$W`0"G89&8QD*$C;%*3Q",+:&3A1E\?N.0VW"^(0=>X1
MI];8PHGX!Q>C\!$+[<_:PZTA&J+5.+%@=IKQU6B1UAJ7IL*8QZY+(T*+M`[Z
M/95U1CL4+1&)O_"+"I\LT9+G+*Z.H"5/4[&?0:\_[3>CHFC)(XCE%:$E3P7]
M1-+:]91HN[/9R><;>2"63[X1S;ZW#-8"YK-O>L;*).^(:3S0Y]#/7CN46?>$
M/_Y@#Q^YG]+#1R<&GZC^WO(,[^GZA^'^J3^H/Z[O'<(?^T_#6_SF?O_,VUV(
MUO$GC:%M:`9TNR!ANQW65"3H3./Z2TH'ND27=P-R`C%PZ0]<$/Y+]+!7$.L&
MI$9LDAXIGZ3?;O[?T;8]!\BA"$".=3>5%(,BNG%H0;.ARLZOXTG;0_*'+'RV
M?O?E*:BTG8!GY9]03M,-4()35C/4K('MAXM=,@;?4T\:@=TH<-2H73"2_&V^
MD1?KXT6!-&KC)97KWE69-:@I+`PY:/%PPR3&YCG9`D>$BC#6X3%`'%HC#K%;
MH33G562-><+MJ`-N6,1$!/M1,%`*1T0@1Z0I?,EB,#+/$X'1`-8`:^K"F@JF
M.0)KSD\R@#40#6`-L*92K"ESIP=8<[:2T<*;1H?M3>8P;"N$1*1XVD=6W:*:
MT2"B2DK$3B(262.QD`BA+L\TYX^T%5)$DHU:1G;6U+VB*I&HH)2X4S(B]R;]
M6AK1G-YTG(-'*I)HM!%:X&=`&.!GP,^`GR&8C,B]H5)-JZW&30?\#$`+_`P(
M`_P,^!GP,P23$?@9$(US:WW3_JN#`DO%9\,DKD??$UT?KL1X5"X#N/PHDF%H
MOMUW#>T'(1[G(QY'$`,N:(WR<BF:F'3FPJQ(4B"NU8!#T5W>PZ&`>,"A:)F\
MP*&`%(AL->!0=)?W<"@@'G`H6B8O\JA'%R&:K,"K:(7I:/SB6;E>7Y@'497H
M5#</HG+A*-CX"[(AJ$?2>"U&79,K(#^=*/42:5)&I^1(R.MMS4_A@+BT#;;@
MUT!`X->T7G[@U\"O.=LR=_@UHHJ+N+`%OP8"`K^F]?(#OP9^325^S1B.#>S.
MN<]5S39&<M\&4^:JEAR"6MM$5;G`1%67"L#_$HMHJIC#5%/:R;9S8BI1'2MM
M6FJ"(]M34Z44S1-&BPYSZK3#7-<Z?6QV*V:CMJEV%+-1X6-L<!JS4>L1C"1_
M,1NUNS64XLA!O164C==+`D>$BK$V'7*'.(CA5F"&4$?A!K-1(1EMQQ?,JVN#
M:`!KNBXVF(T*R0#6P&@`:X`UF(T*K&F+06G\BOIA>X/9J">:C>J*5D1V6"8P
M3$2D$&L+JIK;BBDBR<:952RC&KD&&9DHU31):MQPG(-#*I)@M!%8X&5`&.!E
MP,N`ER&8C,#+@&"<#;#`RX`PP,N`EP$O0S`9D>%E0#`P%A52D4TJOA*'O4VU
M-"+9<\DA+E$=;2&IFF<\&)Y!JLFO80I)BV2BC6,F,(4$XH$I)$+*B](;]2>B
MB4IG+M"*)`GB6@XX%=WE/9P*B`><BI;)B](;CJL9^`"GHMV2(*[E@%/17=[#
MJ8!XP*EHF;R,AW`I(`>MO(F&8:EBB`Z&I4(VNE;:A>$;*/\J4/Z%X1L-R=&@
MIRC5).0P>Z,#XB(N;,&O@8#`KVF]_,"O@5]3C5\C3S$$'F:G];`%OP8"`K^F
M]?(#OP9^326-`RJJ=()7TP%A*9F[Q*34>+AI;9-2E?R34G]7V3>JYD?+I:_[
M'G&_S/^'J*:W$'-PZG$N;JE0CL]7JS0[6PG2N#EFJCJ!2/PWGJO*_LJ^QO9=
M24U(1#!BE?WU]X__(ZF63O][_?%=]8-62[.PE")BHFF;JCLQT12^P`:G,=&T
M'L%(\A<33;M;Z"B.'-1;YMAX46.[<:3-8H)YIA"&O2X%IOYT5&PPS122T79T
MP82Y-H@&L*;K8H-III`,8`V,!K`&6(-IIL":MAB4QN^0'[8WIYIF*BM7RNB8
MH%S&[SJG7%U0"L#J0AQ5PU139&_/MORXK=@BDFR<66DQRH9KD)%A3^Z7";H+
M9#IRNZ:0E?/'FN*.!Z3C_*6C,D\$P@+7!#)2]4WMT:1,W$P@6W(.43.11*.-
M6(,0"(0!(1#X&?`S!),1I3<98!PJ1`/C4)&.RR<>UZ8IV=Z"./RN;K5I.8P8
M:9$@M'&&!$:,0#PP8D1(>9%[_<%(-%&IY^XM1.-<3$D%7@:$X5R$X31N!^3E
M_.4%?DB#&;CQ5#1!Z4P'$)'D0%R[@=!&=WF/T`;$`RY%R^1E,*TFU0:7HMUR
MT,*;;V).3^UP^HV/497NZ=N]J-&N:&E\#.D00E+.M40,0SI01E:@C`Q#.AJ2
MHU%/'E034L.8C@Z(B[BP!;\&`@*_IO7R`[\&?DTU5_5F@YEHL@2_1E1Q$1>V
MX-=`0.#7M%Y^X-?`KZG&KY%EX:X&PJ\155Q*)C4Q5O66[!VK>J,MB.Z;Y,O\
MO>I85!_<K\2Y65#!?:.ZAG9MZ>\,T_>(?GB<ZB!EG&IU8U%/P($M\<_Q^;H$
M_B=YW$\3^#,:];ECDA-U`=.*;CX(U%&[W-C/W'4U]9"EKEUG&8$IP,C*LOB:
MM!K--LN.QE"NC4XE\RAKO]<FEN36,9TQHUFLI.D\G-(&YYG4,T>@1=J3;9Y'
M&^9OG`\N5#,VL,$1&2)+>ZT2#B,`(R#4/#<8`1@!&($V&X$*!FW!"#1U^6;O
M.?)PZBSSV;)=5VS$T2<>79=42Y?T(+XN6<233-MUI15Q))=%X*7GAB5Y"]MW
MZ?O<GD1^:(22/_[[.EJC+FW?\MR?7]:14,NGM`<%8HO]N_)QCF:SWFJ+>AH>
MGY!19Q?,.<*J-*L*5@G%JCIZ`8-=C;,+O!&+-[!Z0K$*`-4:5@&@SI)=X(U8
MO('5$XI5`*C6L`H`)4KU<VW#4@I$E=L5,!9)"'[WE\11/;J>2G1VB]>QSD+W
M3MF&,28[K*`0G)B"$X)P`CHA$"=`=BA`=SD!4!"%$]`)@3@!LD,!NLL)@((H
MG(!.B!1#/$%E:LD8HC*^&G<UAA@6F=8:]8?F-9)L@0T4@A-9_8(*&D:=$VN>
MC\>]B5)+1RAH2'8V_`QD.#-[!+D7A1-`AH+(,.O-AK7T0(:&`!G$I#:0H4N<
M`#(40X;AM#>:3:`A+4&&!HL2J^@DB2!C-GGXZI`Y<1RBT\6Q7K$Z(4O"+KH_
M&'37>JV)@-+<[:@.GRA/4_7L<'"KSORF2*.\SXE]SZ>]X;B:`VU9.PAE.]'!
M%X#5/A,(P&H3MP!8M;'O4@@3"#T30L\`6FUF#T!+*&X!M`!:T+,65::6F[U1
MUQS3#D>;HY)6235-6^,SL#Q;TNSETK:"`/3"-BD+ZJUY/8TPP$`TPL.Z9LQV
ME)VUC)#-WAY(I)&OY\36YY-13Y[66Z?5V%S6CJIJO45?`$V`)D`3H-EET#Q!
M<3-`$Z`)T`1H=H^=`,VS9.LIZKX!FH*"IK"=;9,24U><O\/M;]\1RUX:%FN`
M*]'W2W=9)J@=RPG4VTJWG$1TU!"<N$9BAS=PKX1B59IA!:N$8E56BP=VM8I=
MX(U8O('5$XI5`*C6L`H`=9;L`F_$X@VLGE"L`D"UAE4`*!25HUZ\7L'X)W\:
MT2_5!^*H]R0."[.`L2O9ON=ZJL7X<Y+\$C+T0F?HD8`7GEM'K"82[<79)\_&
M/64R$L(00MN$T#9`5YO9`^@2BEN`KOJ@:]*OK,D6H.LLM`W0U6;V`+J$XA:@
MJS[H4D8]N2\+80BA;0U'FBN.*Z>F%4X4?.YP$?.;*HJ62QB&0MDF.$T-PG#N
MK#M\J,:OCN5.O\.3JH>)S_M7@ZFHYA)*6.M-:D`=H`Y0!ZCK#M0-RX0,`'6`
M.D`=H.Z\F0>H.P,FLE-=F<0NH*XE4+<1)W_AL9!H_#[=>"@7A>X_2XT_TU\3
ME%`8#_:9_]6^!84_!NL^T>K26+I7(G)\OBX4_4D>]]-0=(..G/VA%KZ^Z%](
M&C%-IF>&=1__'F9`^.^AUFN47L2)M3Y48ZH/IKIRR<OHAU=2:`_Z_7`:=?WI
MF?1^,B6S+/UC&99B=N60^&>SN573:>_D\`1<!LPO@)>-$8[*(Q5J2CF9BO#I
MJ)AE"$E;*+W/T(76Z\XV]5?EL+"$T7M'-+*\(\[:^`WD7GE'I@9QR.N6"L3]
M+'IVL@1\&RV\P)YCE6=O0%%F*%*:0**L736%@ZHDU)P1>"E]>2"DUITY5IV4
MED>5[\PH"Q,'$[=AXA28.)BXLZ(L3!Q,W(:)JZ!*`":NSHA#Q<UELG<MSS_'
M6\B"?W&T[<NZF8SD$LUW#,^@WV?9GF18FNGK1*<_I-T%T%13\TW5,VQ+>D[?
MZBULWZ5/='^NIG5YJ?$'(B0VQ6'VB>]('D169*"%8%66`3%@E1"LRFKOP*Y6
ML0N\$8LWL'I"L0H`U1I6`:#.DEW@C5B\@=43BE4`J-:P"@#5DG8R)YV(V:ZP
ML4A"<,/:O4CVBL5]7=XOAC>`D=1'U='+-(`Y/H``^MC(W`=81B$X,<V?B<25
M/-9MM=<?]J$@YZ\@0`@@1*<Y`80HAA"CWFA<34]3*(C0"@*$`$)TFA-`B&((
M(5?6]1H*(GSX\02EK0@_%@X_$H?5J;Z1WMK6`W$\@[7>^.J0.7$<HDM!=/*Y
MZDI:\'?ZVE:KZC+MS([G&J"TC:1X8#Z%X`3\BT*L&0YZPT$U,4HHB-`*`H0`
M0G2:$T"(0JRYA&Z<OVX`'``.G>8$P`'@T$8&M*HP<O>"_;Y&%^V]8R^28/Q3
M=>A;O7K+(DNS$5K;%'MP5T`H;AVQB9B,4"*%JO2&XZ$0=A#*)H2R`;G:S!X@
MEU#<`G+5B5P3&<C5$FX)8!J!7$*S!\@E%+>`7+6Q3QGU)DJ9<71`+J&5K<'R
MUIQ=6DM/=$6D68#T7-96&IC?VTX>8J)OZ]B9I1$1AOW6P]^)TIL-J@D,G,3<
M0F6%4%F@Z'GS$"C:.G8"11L,4DQ[RF34'G,+E15"98&BY\U#H&CKV`D4;8Z_
M@W%O6O,-4J"HZ"J[D0]XX:F4]/'[=..A7&R]_RPUJDY_W2+)WEVLMA?TRPO?
MO;Q7U=7+&VU!=-\D7^;O5<<RK'OW*W%NV*BQ-ZIK:->6_BX81G;+-G9+O_N-
M:6O??_WK7R3IE]V'\$X0"]NDTNB^_X]O>$^_VQZ)"K*_.#R[X<:/D0S]]<6'
M/RG;A_+P@G6/8+O[1N:O+]ZR5^6^,I.'RI]LUC3]1>8_R,I`OOB5;2?<34#Z
M;`0>YR/P\&HT/$3C+2G>)YMI8ER9W.ZLER_OH\7(:1&-CXI[-+R%I$I*OS^1
M3%NU)/7>(61)/R)Y"]63'E57<OT[E_S'IZ^93Y)'G*5AJ5XPD(Y^;MJ3'HED
MN*Y/7WH,&<JZ?*Q\1UNH+I'\%?MUT!N-^CW*NQW]$8)8G#;!+#U7LN>2[3L;
M?4HD2HBY;9KVH_M22C$!M:IS'EMZ0-,W5(,;I1`D7E_TJ:(1DPV!U:B^Q[^'
MV4;^>PA3P4S-&)1"E*'FVE17+GD9_?!*"N&JWP_O4M9\PX8BX$Y^=.NUW0Y`
M@UFVFH>2V=#^L4QH)9"95(IFIQR&MEWZ2"V#:FE$>D>-1AW5#V6DHKH*,@A!
M90<=+640]8EM0\;BM=0#D4`#B(65DYL`=[FM8)#$5GKG2"_8WS:GV;;>@N0Y
M:T%83E\'V3"<P'"<B2RD@(H"5#F)<+S_L3*<8"1Z$E#.U!&%<,`UA1&IP8@0
M1S-<UM;6T#8]TQ5Q).ZYMMZ:P"D]7T<$T-(*60"T=$Y.OOB>ZZD6XP)++]CS
M33>5:&1Y1R%F(/<DEM]"5`3"5%N"NK8+:Z5S,@>K5W`]K:BL_%_??)+D:8_G
M?>LH4ZD=EU++7EIA.422AWKKT4XO#$5*$2$;9R0;2E7"44%A8Z>D1>XIHUH*
M'YM%%!B2CAH2>!P0AERH`@@I*QK*"V7\0NE7U.0-9J+-LM!*,X&#R4EDXV\M
M$@F<1QH2DM&5/&B1G.`X`FB!GP%A@)\!V2@E&R,X'`B`PN,02C1.E:$_V:U)
M).`+5_YHGLU*>RK-P9^J-@R*?S:UH:E\ALWO*.N5TPU^[90PR+W!GO87XLH!
M3$!G30!0OAM\5O8Q&G:]R8PU%%Q0-K=2P8'AXN2:X;VW60;DJ_&T16(`Q>^P
MS0>?N\%GJ'A'63\"R-<B#)<MD@&H?YNRLB>[-XVL;%%1B#LN*),67HV&YG>A
ML`M&O[.L1V"G'F&H*BD+`]`>GK?2``#CN\%G)&6%2\I"P05E<RL5'!@N3E(6
MOGN;96!T-:YE6C$47V"FM]3F@\_=X#-4O*.L1U(6`3H8@':E92MO>GYLG&B%
M?3J0JJTX52O6U`U8B/.KV\HV60,`TE'QR#@9$%YF#0(S$>]N;F?&J(@D!^(:
M#O@4G>?]$8#(/,8-B-#F>[TP!)TW!/`)VI=J;A0.<&:H02Y$O!,,`P&\@*\`
MWB,0"?$HD\I&(!)WD.%1M,AL-'XO.</LYJ24;$F3;OMW)I&4*V3)JY*A6]M3
M3=%*9_(UGC^1D,"^B",@F;S6@U,MT@0&;FW'Y2?+'+;*!`A^;\XRS]Y(O-$I
M]:`5#-`Y&R!X.!"0G-D;2`@D!"8$`@*_!#+3-MB!T'1`:"`SD!EX+Q`0A'@A
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MD'SZ%T>R?8<NE-%\9=)'2H8KN<23Z*.]A71'3/OQI92B-/4K`.=,&M&.$?W8
MY^NR-S_)XWZ:O=F04FYA0DAX?=&G,D],DQE]JAOQ[R'H\-]#0-,HO8@3PU>(
M*=3VFNK*)2^C'UY)(3CU^V'_L$S5796!XFC2]KKQ0\;WB*,A1N%]PKT,!$9$
M_S*IAW<4LEZ5\R!.?5ZAJZ4,H*Q7+NJ0@M(E^)"*DE+!/1Q7^H/!IOE$>9$0
MD_BGA$LCA<Z/]-RP)&]A^RY]W?VYQ*D%)=AME)M*HA_`D:YP'CARYE+Q3[X(
MHE]>/Q!'O2?2^Q_$T0R72%\=0R/KL\-7XJQ_X>@#*.FVZ)P1E`C(YW9'+`$=
MYZ__.]#QC2Q5PV*'C;?T0XZJ>;YJ2K?$64K/GXCJ`",Z)R/`"&`$,**[^G]]
M?^^0>]4CTD>*"(;E&IKT#]7T2<O,`9"@X:RW6!/)DQFDU+J*5@B)2##R1C55
M2R.2ZDE1-_QUV&$@L[;XLB):K4VQPC^T-6W<_Q!8.E#RV6W9F%8E&S`D.:LY
M![UI?]P>0<D*,3`DW30D<$$@'7!!FI:-%HUUAN?15*N@JT$U?;<;MQSP.X`L
MQ?T."$.GA`%N1K=EHS)_`[)Q=K(!)P/R`2<#P@`G`[(!)P.R`2>C<_)1K`SH
M)`.%6!E020F0!U>3S@E!=!?UGC7^('HEEN)4`\80YA8,(D[%>%C_;K)^FI'U
M,`/Y9&'4&XLW@QP6`!8`J`_&0^<[SGJ@?CVRH%R-9^V1`AB`SAJ`O:`//I\C
MGZ'BW61]5HP'Z\^.]=#Z+K,>?.X&GZ'BW60]@+VSK(?6MZI,XV3=6E"F4;Q,
M@X0M8:LIU#A521=BM8+9_U,Q'O:_FZQ'RJ8>67@N#^3V2`$,0"5,+].J%UC?
M/GZWT>!#U3O+>F!]/;(@7PT'[9$"&(#.&@!D<3K#9ZAX-UF/+$YG60^M[S+K
MP>=N\!DJWDW6`]@[RWIH?:O*,]!%0V`AB,HS-#8PQS2)_K)595H(U@H&`*C/
M`^M%</M@!LY?%F`&NLQZZ'Q'&0^=[R;K$?'I+.NA]5UF/?C<#3Y#Q;O)>@![
M9UD/K>\RZ\'G;O`9*MY-U@/8.\MZ:'VK:C3:TD)#F5P-1IV3@JA(@[YW3JA2
MZ=)SWWH@+OT)5VR[)0JHUP/K6\1ZE&O4(PO/E=YH-&J/',`$H*$&U+P3)A^J
MWEG6`^WKD87!%9IG=8[I;30`R.ETAL]0\6ZR'CF=SK(>6M]EUH//W>`S5+R;
MK`>P=Y;UT/I6%6M46,"S+LR0[FQ')T[$7-<V#5UB;UMY$J?`2G4HUU#`4::`
M(^ZR(3VOLGRC<H&0R\@#HKN=*.]+$Y"(L$"5;HK'M$+Q@#G)61HR&\]$DY3<
MJ`+#(4JQ"'R+-LM`&\$#O@7$`[Z%D/(RN!H,19,4^!8P'-4Z&>!]5W@/4W#^
MXG#$7X`X=$L<8!T@#G`4P'N8`H@#'`6(`ZQ#6\6A\4XGN\4SC)4'I61+FG3;
MOS.)I%S!SR@I.F]4D]752*HGO2,:6=X1ATO33_*X_VH@]R2E+PLWD'K'R-0D
M.PAQ=Z)^\Z`4151-DR"DU+HM/]-3R@\,4CZ!DD>]R5BX5B_UP!<,T#D;(+@\
MD!BX/)`?$>0'+H_``C6XDB>BB1(<'E&E15SS<RJ'!P+24@$IYM]D%1KX.-V6
MH30?IQ89@I^33ZA&5\I8-'&"GR.JM(AK@N#G0$#@YYR%#/VM/:(#]T9P69)[
M0P5Q')@>P2K`:FV?Q%AY4$K@^=0D.O_@S90DU=(E\F-%-/:+9TNLQU*R*DRJ
MM!BLSHI3B%$[+%#SU^'3A`:)4,A/3B^Z7OF!!]U8[9?P:`4#=,X&"!X.!`0>
M#N0''@X$JI92+^&Q"N;GG,T/_!L("/P;R`_\&PA4+25>PF,5S,\YFQ_X-Q`0
M^#>MEY]JRKO@UG1=CJHK[1(>HV!VVE/:57MS+W@\IQ:=]S^(HQFNRLA96RE7
MW?6E$!OQ+4[S!>UPE"$_\)C/5*#D?F^L3$43)KC,HLJ+N`8('@X$!!X.Y`<>
M#@1JLY1KT(YN%O!O!)`6<<T/_!L("/P;R`_\&PC4IG\SED43)?@WHDJ+N.8'
M_@T$!/Y-Z^6GO9VZX-:()$=R3YG.1),E^#6BBDO)4JX7'JODB=^G&P\E&?`L
MG?S/$B09,U[LV\1J>SV_O/#=RWM57;V\T19$]TWR97ZSH$+T1G6)_M9>KHCE
MJIYA6]<.)=P]6=(O>_.T?LM7]8F]=/VH.OJ7%7NC&_2HNK;T]V&'JEN;O?3%
M]UQ/M9@&W#+2W-+5OS%M[?NO?_V+)/V2=1W?Z*,<@SWVQJ,?_L,R/)=_^[7F
M&0^&][3Y<,G07U]\^).*TU`>7T@:I1']TS<R?WWQEKTJ]Y69/%3^9!56]!>9
M_R`K`_GB5T:GD$P!2[,Q3E;R<6YX-1H^VY;G_>JQ3^C3]*,RA=A9+U_>%]^A
M;[`N'X*F9"[CAZ0R7K@291TE]G+E&)1_DCV7G)AOX1M]QCGIGGX[>^W1\!;2
MBCAL(6S&Y>4=8SQO;$8%1M(<:M#HFJZD:\GUEY2>3^RAWH+0IZF>[[+?$FLY
M\&TJ?]_AV9D]WEE-#23)H`35?8=]/?N;9+CA5U,&Z.Q1<]LT[4?WI91B(.I7
M=A'E96U[.'E3Z+.A8-QDAACW^J)/U968)D,QRH/X]Q!%^>\A0FN4*,2)\3@$
M20HFIKIRR<OHAU=2B+9]2L"+S%6WE:'\9)9]TK*8<'T(3;8\)TIPN@]*0N6B
M#FIF.K;M(W#D6*3ZTH$PB>A,)W7TSC;U5^7<I1*J_;O/2Y.I+>4@[4K//UIK
M=?<6MN]20^K^7,+;KL.W/J9T;76;Q1&,2F(]3;`>)J$)S@,HSEPJ_LD70?3+
MZP?BJ/=$^HWY^Y?O5(^L\>*#:CC2/U33)RTS&L"+AH,L3=R7.VQ4DOY]:K/]
M5@B)2+&XW]<G^\TC?'0[3A$MKILYM;07=]IJ6$22F3:F';,,ZT5NJ);<T&14
M3?OIQFW(.3@H(HE&&^U(5OF`X8!TP`-!X0H<CZ9D9'BE"-?9`WZ'"))QJM#(
M27J<L=`()""G!/P6U$948AY.U0`1FB^<3WFJ)H;P#VJ0!674;X\00/\[J__R
M/GR'LG>"\=!Y46(%@/H6BX!<52@`>M\>II]=`00DH-!(]U;%`*'XPOEZI\H2
M`/EKD(7GLMRNX@,8@/),+W,YXO0<AY)WT>!#U04ZW`/B6RP"\I5<32`?>M\>
MIK<PA7\N-Y4%EHH/MC,G!KO+8#L2^;$RG);E^+/<G(/Y$,YC//4PP]+B`1\C
M9QAA7%$8H<Y1A>=ZIU(D0:@FM-"D%,`8=!$\X%NT+"0!E^+,Q:2RZPEP*=HM
M""VL4\C9E`']OVL2G:/-&\[D`A3Z@HMNDIJ7GRSW+-$@O+D&X1/AZC#R7;Q$
M@W#8G[ID!@;F?"4&'D\;Y*===21P=$25H\'53+@S%_P<4:4%@U#*#"`Y/MTD
M.4*%/S*:HZ*:?C!ZQ77]9?#:X>$FDY,,-QGG8T9[9YLDY*62GZ0_Z#<XDNT[
M$A]($LXWT1*"):U,NMJ>9'-61X-4[HE%'-4TG_@L%,E^H$]1=R>."$%*3KDY
MW>/E$U$=-L[%L'4NEM3:4_I*_HIN+/C=MWU7<HGS8&B$3UT)*J$DCU@2^[0K
MS1U[R2>\Z*I'6-R0SXJ1GK.J*=4Q#4H(_CR/.$O#"DA(W[7[^)^OI%OZ&*;$
MJO4D+5174DW7CF?/[(Z=(?_QJ2)'+/!L22..IQK\^8R%9+DR[2="2>ESMK)5
M4MV2I:^4A;WPU_Z0_\HWQU[Y:.F^Q@<H\=>OI.NCTVB47G\XZ0W'8\D-YBP\
M$DHB>SU)27*(J;(]T#4&<N/R[SLP_\;U[_Y--(^]FZ[()9DF[C#:S5F+[@?6
MHILMF:C:(A)3PY78)Y9\%8P;.PSS7?8\]OH;4Z623VV@;=*]A`]XB,R<M+1U
M8L;D"J;KL(\^1DW$U;")N+HVB!B^@^$[F3S+P>C\AD%D',<C0JO\MI!TGQ*W
MM%-^<KZ&W,>`C;,4"WY@6!O[\.A0XG"/`HTVBD$ED67@0D?B,T"&#IB$]^$9
M=0T.'"NDK[ZCT2-PXG5V&FV9V0!B-!S5K?_8=MB")(]RF+/4.)0TA1Y@?>.L
M%\*+.)A?A@M14B;^Q:+X[^G6]/U1ZK8;"7@1``P<1`$A@!!`"""D-1!RXH-H
M%?E#`26@]<@A0AP*G#ZICZ`@5GV6&%#R$B@BT&UD^AD9?:@[0`!241X$E)99
M`H``0`#J#A``"%0(`G+++`%``"``=0<(``00#@((``2@[@`!@`#"00`!@`#4
M'2``J4`X""`@3$78B1OAX;)27:5$_]QN"[-N4E/"9`C47A/2T;0G*9`PH(\J
M^JB6$0GT2,WI>5X-RWB>`EF.<W!.19*,<T,6]'B'=,#O@-\!OT,$&1E<#?KM
M$1/X'4`6^!V0#O@=(LL&_`[8C^/QCLFX/6("OP/(`K\#T@&_0V39@-\!^W%,
M1OH"SJ*#WR&"9)P;LJ"<`\(`-P-N!MR,1M(JHV%[Q`1N!I`%;@:$`6Z&0+(!
M-P-NQO$L2G_6'C&!FR$RLA2[U/2!_]\)+C5!`G)*P#?#_7XY=PB1#';QDTUS
M=U2OFKM*)^&Z#*8W[5">BL^P^-UD_30CZ^$7YI,%^:J:RT30__;P_%FK.`X=
M[Z*]AZIWEO6`^GIDH7\U:H\00/\!]=#Q3MA[J'IG60^HK^M47TWI*O2_/3P'
MU'>+WVVT]U#USK(>4%_7J;Y,,W+H?QMY#JCO%K_;:.^AZIUE/:`>4`_]!]1#
MQ[MA[Z'JG64]H+XNJ$<`OVL\SPSU@@^5`>-S,O[]CQ71/*)+IC$GTG/#DIZ(
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M5+R;K`?$XU@/_>^N_@/B.\-GJ'@W60^(!\1#_X6XAO'"4^],$K]/-QY*,N!9
M.OF?Y2?^Y@97VVO]Y87O7MZKZNKEC;8@NF^2+_.;A>J0-ZI+]*_JTY)^\?6C
MZN@WGJU]_[+R#-MR_Z&:OLI^NG9=?QF\=LM(<4M7^\:D;_SUKW^1I%]VG_W6
M7JZ(Y?(/O[5=[X/M['Z=0]EW3]B/[K5)G\;?G5S7]E/<-T]?3=7:7()DZ*\O
M/OQ)A6PH3R\DC5*'_ND;F;^^>,M>E?O*3!XJ?RI]>4!_D?D/LC*0+WYE%`H)
M%#`Z&SME)1\_AU>CX;-MMNU7FGVJD"8&E:G)SGKY\OY))(=H]KU%5Z1+WH)(
M<YMRZI$:*TE=VC[EG&3/Z>(I'R[O&,LH_=<\D\@/]G,PB\1;V+ZK6KK[\TLI
M10MKU:B`LLH1RA[CS+'/UV7`?I+'_30#MB'*W&1)=[:C$XI6?:H8Q#09BE#>
MQ;^'P,-_#X%.H_0B3@QKP0,NJ3$WU95+7D8_O))"@.KWPZ-(<S?6@I6,J<,4
M[C<2&M<V#5UB;UMY$J?UBIH6RQ,40`_9\"9<DMC]:#=)S\HG\9AU93I,F2]3
MC6W>-TT3CHC*J2>6P-J(>&1)<OS.-O57Y62GA*#\BZB.])YN39?>$8TL[XBS
MAH.!W!/M-)/;=+3UA"..B+3PFODN:#-&'I01P)!(,-2,'8&`M$9`8C]%$<E-
MV1&@B,+P8TX`4BSNT@T;`X>FRZB4Q:BD(Q(,"Q`*"-4(0E73H@T(=?:R`H2"
M80%"`:%.CE#5]`D'0IV]K)PJ*'R2?K29`\6M$!*1XGOOERO3?B+T6U5+EW3#
M(9IG.^[1HHY*S-"I>AE#=(0)#0LL#!%5VXH](LG&W]HC$FG0DDLD4(J=LQ1;
M[DV5:NY4-VX[SL%W%4DVS@U;,L=38#DZ*!WP/.!YP/,XH>?1[PT'L_8("CP/
M8`L\#T@'/`^190.>!^S',1D9]>3IJ#UR`L=#9&@1\!8'ZN\KEHK?;>N2Q#FZ
MDV3E<(^T1?(A;B%:Z:NC`)5NBL<1.(%_6J=_VH(2Z'.M'1-)#L2U&Q6X%#`*
MYR(,\#$@'O`Q6B8OEZ*)"3P,6`UX&!`&>!@0#W@89R`O0]'$!!Y&*ZQ&XS?@
MRK5%TVV?=7U5KI!5*2DZM[:GFJ*EZ4O=M(5L".J,-%['<>`&_X;`P)E%F5C=
M8@,G-V<1N](;#/NB"5,](`6[<\ZX=2K'!A;F7"0&GDX;Y`>>#CR=\[VN!T]'
M5'D1%[?@Z4!BX.F<G_S`TX&G4]7U0#@Z,#N"93A/4C"QG?5$QDI0[Z:)GM,0
M!@C#?F&`&]MMV4A##<A&MV4C*XA`/B`?<#(@#``2R`:<#,@&G`S(!YP,"`.<
M#,@&G`S(1O.R`2=#9/EH/*N&1IP"2H6PEXO!^Y,.\)7[(DWP36M&D%K`@P&]
MQP7E7T1UI/=T:[KTCFAD>4<<+CL_R>/^JX'<:[WI:*M_(8Z(G(5WD:<"###4
M01<$`M(:`8G]%$4D-R5K;3+\F#I`2NG+@V[8&#@T74:E+$8E\TTK&!8@%!#J
M=`@E_J0"()00L@*$@F$!0@&A3HY0<OOL#1"J'4:G\5:UV2]R(KY757SO&W&)
MZF@+2;5T22</Q+172[K32LQ,XTTK(!KB^+B-"P,*WM"=!(/)3S@RH:<HT_;(
M"0:3`UKJ\3-@.+HM'7`\X'C`\3B=C`QZ([F:>4V-FPXX'H`6.!Z0#C@>3<L&
M'`_8CZ/YN9[<KZ;(L7'3`<>C:6@1\(X&JNLKEHK?B$4<U>3)-U5?&I;ATL]Z
MQ@,1/LT/66C<0@C50R"M\`<`TDWQP,#RYN1EVI-;4,Y\KG5@(DF"N):C`J<"
M9N%<A`%>!L0#7D;+Y&7<FRDCT40%7@8L![P,"`.\#(@'O(PSD)=!KS\=BR8J
M\#):83D:O]56KM49>KM7)3JWMJ>:HB7G3S6]&[+1R<(O#.M&<5B!XC`,ZVY(
MCF2E-QCV11,F3.L655[$Q:U3.3:P,.<B,?!TVB`_\'3@Z53BZ?1[P\%,-&&"
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ME9$DI$C`V6S\&^?CW_!J-'RV5ZH/</1PU]MLGZ]68W:VPI?WUK:X*5,]HDL&
MYY7TW+1=]V?ICO-/6CGV@^%2,9#HK]%;//4'72KED6NX[)/V7/(6A+Z#"M,C
M-:#2<\.BK]B^JUJZ^_-+*45!:U6V@-)*24X=^WQ=MHT/+DPAW8;0<VL6PL_K
MBSY5(6*RON@:Y4?\>PAP_/<0/(-NXC%4AOA%[;RIKESR,OKAE10"89_2]B)S
MG0@N5Q\UYD><&C'*>D4@X#X%;6D#\6,3:D4HWTT]SV`&0:/S:%&4V4:!J+<D
ML_$"S';#2;M/MB>R$1"'UHA#VE0DT2+S\#\$G",KK/V`(](=?"D_@4]`00"V
M`%M:;D%*3H`%MIRM9`!;@"W`%F!+*6PI,[L5V'*VDM'".^V'[0TFM=:%.W]<
MW5R)5D96#'<@!DU[H@()`TJ64;*,&26GDY'GXTFOW\=X-`C''N'X^?S$`C(`
M!P,.!AP,.!BG<C`F_=YD5LWHB<:-!QP,.!AP,.!@P,&`@P$'0PP9>3Z<]68S
MX;KDP<$003@R.Q@8KWK^PO"[;4F5I<W$FD@"SI_=A`D,((%X8`")D/*B3*M)
MF&'\2+OE0%R[`9>BN[R'2P'Q@$O1,GF9#LM<8Q4#0V`WSMENP*7H+N_A4D`\
MX%*T3%[DWF`&IP*2T,HK91B3*H;H8$PJ9*-KE5L8J8'JK@+571BIT=@=MG%O
MH@A7`8:A&J(*C'!EYW!HA)`+.#2P*W!HX-`T+4?/Q[/>;(@I83`\<&C@T,"A
M@4,#AP8.38OEZ/EPVAO-)J))$QP:406FV+V]AJ:=YAG`6&#:::%1HX?FEKZ?
MSXGF&0_K)WU3/?*-:+:E&:;!AZ$>'%JJ]$\RM#0G&\YR:.GO=F(.J41^L$FU
M1'I47<FAO'+8O#4VJY1-)'TBJN-*Y/`,-HEQA/^K2*JELQ]D2??IHVW)(IYD
MKXA#&6_=2VPJZNX<4R'(Q*FBJ8[S1-_XJ#JZRY9OS^<NW0$C`]M)2#+5D]X]
M6>H#I=Q[WZ';X]M6&:CX7,(EE0UQ52V-DG1A:(OP.2Y_D$[FQ'$H,1GE59>]
M?B7=LC\85'FHB:>?NB/>(R$6?[^V9[XL^^@=L<C<\/AWL_>I2]NGA*1_7_GL
MK7=/DKI:F4^,\'RR+*'HHIJ4TJKG>[;SE'P891#GU\X7<I:%<VPW)M<R6:'_
M"^;5NIA66\E9"M-JS^FN>KEIM=451&]M>9<F:R*4=?*2BM&V/N<9!\H*,`#V
M?+A4_WS76BM"H5D8P8I3=JWAX4-J7"]+3ZC8K>=8AFE#;9@.=#X&NIJAI<T/
M\`&ZUL["\O/;1%`]F%"8T,I-:`6S.6%"84)A0F%"NVI"*QA!"1/:$A/:^)7>
MP[4[F!)9EZ7^N"<=Z>W)-++T8AW5.17-3D"TIQ'>%"FE["BK:JF4%&^RP#FQ
M[+FB],:3:?-F#^K5S`4'@!/`J1.L`CBUCF7/E4%O/*JEIP'`">!T[BP!.+6&
M50"GUK'LN3SNC91J>DL"G`0!I\8GH*7'AQ'ZS<GX&X]?&5%_5**F6WR.U13J
M=LHFS3'98?B$X,0T(R?@/VSY#Q6%7:$>#1]:`0OB&"/(O2B<`"P4@X5I-2W/
MH!U`A590&ZC0)4X`%0IFPGJCZ1@*TA)@$+S,%&'$G(Q_X[N&15Q7TARB&YY;
M:]`?6M=(&A/V3PA.P$$H["#((RA(2QP$`$-+S!'D7A1.`!@*L>82NG'^N@%P
M`#ATFA,`AX(U"+W!;`@%:<FI`=6)Y\7X=U&3;=8.FUANT)9;6U`:D&IBC$A"
MBI/Z@C$4A1/P%@JQ9M#K3\KT&X-^M$0_`!``B$YS`@!1B#5RK]\'0'1`/P`0
M`(A.<P(`48@UHUDU)0K0CA-J!XH9STL"WBY4ZY[-R=LW"A`Y2J%U$2F8]G("
M/D,AUBA*;S!"CK(#"@*$`$)TFA-`B&(((?=FXVHNQT%!A%80(`00HM.<`$(4
M2TQ->_U9-7TUH"#"AQY1\"BJ!*Q#C_3=],D6'\K#YNZ@W%%L340ZIKV<@-/0
MX,TYZ(;0N@%P`#ATFA,`!X!#&QD`<#AGLD,!A.`$P*'8M>I!-?4*T(["+$"K
MQLZ'&+T%D>:JX?`R1R(MB>KZ#EG27:-_8XN!"@D8H3D!EZ'!\R1T0VC=`#@`
M'#K-"8`#P*&-#``XG#/9H0!"<`+@4*SZO:*Y,-`.%#8BZEA0`GZWK4N=Z+[F
M&7<FD71RYTFZX6JV3T4!^4F151$9F/9R`BX#BE?:R``4KYPSV:$`0G`"X`!P
M:",#``[G3'8H@!"<`#@48LVH7\TM:FB'\,%&E#B**@'O"%D27=*-!X-N4$=*
M4FCM0]*EO9R`EX!ZE38R`/4JYTQV*(`0G``X`!S:R`"`PSF3'0H@!"<`#L6*
M&2<#:$?;M`/%C.<E`5\=PW:D)Z(ZDN?X1/)72$0*K8!(M;27$W`44*721@:@
M2N6<R0X%$((3``>`0QL9`'`X9[)#`83@!,`!X-!&!K2P@'$=3)3N;$<G3L0L
MUS8-76)O6WD2I\!*=8CE'68Z@H[[I>*+MR!.K;'_TJR#OC;%GH@0L*Y"<.N(
M'<S%+7@GFZVC1R,AC"`TK;H6TT"K,[-_0*LV<0MH51O[)A-9"",(31-"TP!;
M;68/8$LH;@&V:H0M'+):PJH65J/N!HL9[PX*P9:PZ+;/.D@J5X@HEQ2=6]M3
M3<FP-'M)^)QQ\F-%+)?4FO\Y#<MA#!KA842%-/[!B\K,SK_5FAL_'1?A79TP
MP5ZI@862"F]S@9OMYR%P$[@)W`1N=DE)F[:YP,WV\Q"X"=P$;@(WNZ2D)0/^
M+SR5DCY^GVX\E`R;/TL/FC]+DD2)2'*`>OLVN-I>ZR\O?/?R7E57+V^T!=%]
MDWR9OY_/B>89#^0CCV;?JC^^J1[Y1C3;T@S34#W#MF[9QF_IVMZ8MO;]U[_^
M19)^V7W2.S(GCD-T^HAKUR6>>VWIGPSUCC[%,XB[^1#)T%]??/B3"L50D2\D
M^FUL[]_(_/7%6_:JW%=F\E#Y4^G+`_J+S'^0E8%\\2O;4;BA@#&UD']X-1H^
MVRN4J1S8$O\<GZ]6X'>VPI<7L8CG+%3.)$FU=,E<LXF^+-ESZ1W1R/*..%RD
M?I+'_5<#N2<Q)O`/T!\4QC37<#WZ./H!;T&DN6V:]J-AW4O/#8N^8OLN?;/[
M\TLI1>&$49[#K#OV^;IL%:=["NDVM(!;IQ`M7E_TJ4X1TV1X0/D1_QXF%?GO
M(5YIE%[$B=$IA!MJMTUUY9*7T0^OI!"W^OWP=F2F-&AE2<_)K.TW9`X9YR-^
M1.5E4"?TY9**<6>;^JMR[L"ISUMTM92:E!?CBU)LB?:;ZF\'>MB`PRT.D_:"
M3@D7_!3%,YUD5+VE,[5@1IY#5LN`Y:R.7#G46!B6=IYC,5`JV8$R:S`+2%J`
MB^R@)JK&`5V%,II9U`X&$P;SO'6.!;1@,%O*O!:V?3G<5SKSH:45AQ%QA&1/
M[/ME)>F]8U=U:F=BY]&T0MX4J7D`JVIC59;B![!*"%9EM7A@5ZO8!=Z(Q1M8
M/:%8!8!J#:L`4*)4THDUR(D=N$LR6!Y<33J7V_N=>)*](H[JL8HOTW9=25,=
MYTFB'WY4'=VM1)5S-VB'2M9)=AC'AN\"H(P_/T?DX:0WKJC[*11#=!,%L@,9
MQ.0$D$$TCLC*I#=29E",MIDHP1.X.$_F%X)OQ"6JHRUX@E9SB&YX=1PH#\6&
MH).-A.1@'87@!/R'8F5C<F\P&$-!SE]!@!!`B$YS`@A1[(0Y[<GC,G<QH"`M
M.F`B82FP$%QKFN.K9M#RPJ&G3>>!($DIMAHBXM9>3L!C*,2:66_4KV;V%?1#
M:/T`0``@.LT)`$0AUDR1LFR>"4A9XD3YZJVZ,CS*NO^2X$#)TY>:[7I(58JM
MBXBSM9<3\!J*!:+[O?&X3(\+*$A+%`0(`83H-">`$`6+87N3T00*TC8%0:KR
M[(0@;E;DD`=B^?4.%H8&(@C=74[`62A6^=H;3JLI?(5^"*T?``@`1*<Y`8`H
M"!#RM`_]:)M^-)ZE//FXITX>,+]X"^+4&NI!/WDA(*T(>]"X3BAN32OD%IR4
MS9!W3U'JS8FVO,F_2,P2P#("N(1F#X!+*&X!N&H%KFHNB0"X!-0UP5.ZYS.?
MIMUB4BALAK;_+>0-/!NA6%59VW^X-9MNS4SI32NJ4BYE_Z!G0N@9X*J=O`%<
M"<4JP%5-<#7I]P:3>N_B`J[:=0AO<RJ\>V?N3\1U&3-]U3-L2U)-TWY4+:V:
M@FMD&)I68608SIM;R##4QK[G["P^&=3;NA))ALKX];,0C`)7`%G@%B"K(<BB
MYW%E@(*NEO`K,V0UG@[/F?K&<;TFB;FU/=64].AV-)L4I+HNJ:C?5JD0'#PD
M(3"W<*H"+E1KV)DEG0$?JZ:41\VM1RNUM=!7(?05$'K>/`2$MHZ=@-`&(718
M39,U0*@8_&QA94%7RON3W+ZS3?U5.;DI(23ODC$+TU#O#-/P#.*^/$FP$L63
M@F4!4#S9&E955CP)5C6I57!J6LLN\$8LWL#J"<4J`%1K6`6`:MVI&WW2!1:"
M#\8/>J2^KK\$`-J'%KC=Y01:X!:L1ZSY*CO4XT1E\8`%<8P1Y%X43@`6BL$"
M!F<TS8*:*\_;?`>\D^=(M$,7E3.X0`=NX0+=B=B'V]YMX90`9A&H)31[@%I"
M<0NH5=]Y>HQ.Z"UA%6Y\5R`0G3J9[[GQG:B>KC6.)ASCSXFON+,&=N+.6FOX
M^QSWOL^+H?7FQ0&=+;>U@,ZS8B>@LTGHQ'WOLV)HFXL'\LB(;OMW)I&4*P0Q
M2DK,[\2KK6E=J7LFI3F^Q=]=`3A/$]#T7:$#F+W!OR(N6$?9^;>3Y'WJYR(\
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M1WI/E4R7WA&-+.^(LS:$`[DG,1PIX<Z=62VL.(RKMWU1+2`B3#%'IW)'E81,
M4)\C.L=BY%2R`V>I4@X@:SH7_U[F4DD72S3$8=UI3686I4LWER(H'@PH#&C%
M!K1,[S,84!A0&%`8T"YKX=_K"-S`@,*`BJEX,*`PH!4;T"$,:$M95V]X_,0S
M]3('T1$<SRDFW\@#L?R*^D!@1E'3"(H911VLXD2%9GZ6*;W^=-2\T8-R"6\'
M@5'B\@88!8PZ7Y8->H-9->-O@%'G;0>!4>+R!A@%C#I?EBF]F5)-<QY@U'G;
M06"4N+P!1@&CSI=E2F]:40,Y8)1H=K#Q-O?I24OD(_,W>EM?OS-M%T/)Q=8_
MS-<4V<W`T-D*N]`J_=Y4J29G",4HS`:,(P<@=)$3``31./)<GO3D<9D*62@&
M`*%EU`8@B,()`()H''DNCWKC"4X(`(0.41N`(`HG``BB<>2Y/.CU1V,H1DL`
M0?`;<$@F%9@:Q')(DFJ:ML:;U7JVI-G+I6W1]=K:]X5MZL2I]_8;U+&18A<8
MQH9K6>`Q-)MD@F(T?(0$(``0VL4)`()H'*DRR03%`""T@MH`!%$X`4`0C2-5
M)IF@&`"$5E`;@"`*)P`(HG'DN2+W1@@9-<V&FI-,N+$D*N/?J*ZA2:JE2[IA
M^A[1)2M*.ZV(([D+U2&G24"A9`4E*^WB!$I61./(\_Z57&9N$]1"F,,EX`!P
MT"Y.``Y$XPB%@_X,:@$XZ`ZU`0>B<`)P(!I'``<",`%P`#CH(B<`!Z)Q!'`@
M`!-PNZFCB:<;EEER)=\E>IA56OD>D>Z$R4>AN@75+>`$REPJ88T\K;^-+S1$
M"`T!1``B.LT)0$1AB)C)`VC(^6L((`(0T6E.`"(*0L2@UU?J':H(#1%"0P`1
M@(A.<P(048@URF#4FTZJ26M!0TZH(;A8U74)0,%+>\@.$R@$)[(Z">`$=*)#
MG`#9H0#=Y01`011.0"<$X@3(#@7H+B<`"J)P`CHA$"=`=BA`=SD!4!"%$]")
MYK-*%>20UODBZ<YV=.)$G')MT]`E]K:5)_']KE2'6%XE+$9>*:\V;NO>*;G5
M>6;0#5!Z4F[(PXM2G(EHD%H4H5&^$:>!JH@DN>]L4W]5CG$EN/0OHCK2>VH/
M=.D=T<CRCCB<<3_)X_ZK@=R3E+Y<IJBNJ#8)BGCB,*Z%>,>X<I#A`$61['!6
M-1:&I9WG6(R<2G;@W.%>M'\@:WD#_?<RS59KU3=@JU`F,XO2I9M+$10/!A0&
MM&(#6L>Y`P84!E1,Q8,!A0&MV("6N3`/`PH#"@,*`]IE+?Q[F>G,,*#M,J""
M-]',)#X(CN<4DV_D@5@^J;<KYLE8=TZ<.5%'@Z,X*JBE%8E5]4Z.K89#:(6P
MV0JA-QCUFS=Z4"[A[2`P2ES>`*.`4>?+,J4WGI8Y@`.CNF('@5'B\@88!8PZ
M7Y8IO>D$&-4&3C5M!X%1XO(&&`6,.E^6R;UI?]R\T8-R"9.T1&=4427@=^*M
MK]^QR7Z5Z"TZ7.`V?[LX@8G`HG'DN3SNC?HC*$:S;,"(>`!"%SD!0!"-(\_E
M44^6JRDB@6(`$%I!;0""*)P`((C&D>?RI#>9E>EZ`,4`(+2,V@`$43@!0!"-
M(\^5?F\TK&9J-Q2C?D`0_`8<DDGYDTD2RR%)JFG:FGIG$LFS)<U>+FV+KM?6
MOB]L4R=.O;??H(X8U2LF)^JM98''T&R2"8K1\!$2@`!`:!<G``BB<:3*)!,4
M`X#0"FH#$$3A!`!!-(Y4F62"8@`06D%M`((HG``@B,:1*I-,4`Q1DTRXL20J
MX]^HKJ%)JJ5+NF'Z'M$E*TH[K8@CN0O5(:=)0*%D!24K[>($2E9$X\CS_I6,
M"L:V^!*``\#!&7$"<"`:1R@<]&=0"\!!=Z@-.!"%$X`#T3C"3@>X\`HXZ!"U
M`0>B<`)P(!I'$"P2@`FXW=31Q-,-RRRYDN\2/<PJK7R/2'?"Y*-0W8+J%G`"
M92Z5L$8>C7K#`>H>.Z`A@`A`1*<Y`8@H!A'C26\\FT!#SE]#`!&`B$YS`A!1
M#"(FD]YT@NNT'=`00`0@HM.<`$04@XAIOS>>H@5/ZS1D([_UPF/9C?A]NO&0
MC[[3;?H^2T\N/<M/_,T-KK;7^LL+W[V\5]75RQMM073?)%_F?_=5QR..^?3!
ML%1+,U3SH\6(J7J&;=VR'=_21;TQ;>W[KW_]BR3]$CWBK>HNV/^__X]O4'&E
M2W:O+?UF83O>+7&6'ZT'XGI+]K)DZ*\O/OQ)!6"H#"XDC:Z</O(;F;^^>,M>
ME?O*3!XJ?RI]>2`K`_E"THEF4+:YKR\N1Q>2;QG!N__XTW#MH2)/_KAY=_&K
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MSW<,[^DK<0P[N?=!__C>OZG6/>&[#5_XK/XPEO[RH`;\^G7P^9<7Q]>16._O
M/GO6E_DWLJ+H;UCW?U#B)%T11KY45^2@$G[\_<,&K=GWW9![9EZH5Q*N<__W
M;PK7'Y9#-/O>8J2F-ND-L<A\:Y%*3G^I?U`*$@)PX'LS+2XPM_2%K\123<\@
MS,/Z2%?H4->*&FK'WU"%05Z'K\P&LJPM(2+?B&:JKFO,#6T+)=P/CKW,@#K)
MC:8Y>:GBE+KCBA:ZR=I(-K^LB*,RV0RE=T/RTORK4NIQ=!4)%E&UUNA+ZCUA
MFO1`+)^\5QUK4\0R."TW'J4.>_AOQ+ZG9^,%I:3)+9!F^Y;G//UQDV]3*]\A
ME$%7TUG(HX,KS;N;#%Y%QMT<1LZ#NYE6O9L,;D'&W1R&OD.[F0T+[N:3;=U_
MHKJC7[LNV=2*#,B>5=:R;J._3\2VEIA[(\,,,)U5S+)N1.YGW4CL^//7/JB&
M\P_5],D[P]5,VZ6/HQ:1>B_49B2WE`;HX1/C1[UYBG_\'X/:'T=;/'VBHF$F
MW9+X+1^ME>^Y_.]RZ*3L/O`S4=G2&,$^..0_/O.M]CXM\48WWLCF8]>1BMNG
MU::K9%ODZ;/J?"?>!]_2W;1@P"#-)90'FV>LHZ0NPYHT-P:4S$/)-'^J,B%7
M&A;R/VY^LQ^(8[&_7=_3[Z"NW#MRY]VP!QG,L2O&+'D\&<TF)^16AL@?B%N4
MN!DB@,+;>\&M30;76GAK([H89W#XFR;)=#*6^R<D2893@_":7<+_V(UT'N;-
M0!Z>DC,9SC\@9`9"CC*<OX2WK)6Z&GEX)<LS97!"'!SE.UJ"N+F(F^]PV%I5
MN'7XYY_*\F<GD5\K<_*=-T'+-%KF.PVV3=!9:.\SI;-FK%2S+&,F\NB$C,EW
MD@0=#]'Q),?%^D_D`KN-^0Z+8IJ0O/Z(PDZ$)Z1QOM-G,R09C*8E2?*@&B8K
M[_Q@.S>J2=:&YGK)"A;^2_2WMNLEZ9+A[)>H'7VSKBB-$TF?#(M\I#\FZ<,*
M.JXM?;NN(Z,KP#Y6,*@Q&8\W*9B-(F7).,YP\CLY&6O+A9R(IAG.9R>G:6UQ
M]L&P&2)G.*=53>2\`DC?K#1"FPS'I`*TB1="/^EN+*1Q(1R/E>FH$5)G.$75
M0>KV$.A8Y5:NR/]LV)\TLHL,9XF&O8U<'MMHV(QARG!@$,C;*'?R.A%),YP/
M3D?2>J,%)Z*HB">+NL+KU$%IQ!),&CAWY!6_T6S6"&GJ.3Z<UGO+E^(9SZ:-
MG'XG]1PBJB!U;3F%$U&VH2-(;M&;#!L2O2,W-/(%X$;],MX]+X,^_(G?'-MU
MV267X!H6NY:5N.3QT=I_N7J2(8TAO!G+=\;B'*B.F'4RIY[S3/7'UA:1-.UL
M<\[[KN<`(JZ[,FP3<^HYRU0-PVTBZ33MY-+&?;,KUEGV?0['DCQ&>#@IP)PT
M8M;)G(8.,N=,TMS-@<YDWPUE-)H+/[2(-PV=J<Z8HFD'(2&V??Q$G]R.B`F6
MDU3%%"&64*F3QFI?BE"N[2F2FBI<"I!RUDPBI*XZEB(4Z-K!@A5CC(8U$K0=
MAX':R5"A`R]/9X-)C5`TJ\?I;D%]21%BU>,%MZR*I`CAA*IB:JA6I`C=1/2J
M!:@(*4+*!GSN^NH^BA"@H8A\@]4=D_Y`KHV@5.V%)>CI:SB*T*\A]SN_&(UJ
M%:,CO4USUF/PTW>E:V6Z&/:7I;_]T_`6AO7%(O\BJG.@QF34K]`#G@W&LZSD
MS[K48EN_GGO$H8^[73BV?[_X8#SP)Q^JM!GUC_5"S8,-RFB6]<A28-4%"7)H
MXU66WN>Y0)"RO`JD/;Y5F-SJD3!N/DF?]"N0]'B9U4KYWMU76'I")7R4-=R5
M<\5Y"+'?1J<YCW5&'S97M+F/X,S'/K9^Q[=$JIY%^)-[2//_TKOM']Y,8A-9
MEE-J`_*Q^H?#'?(%V<"15NLI7>UKVL!7QUX1QWOZ:JK4][9T=H19,<?J#Y?,
M??.3,4]JNYPAO'?PB6^>-L_?JN7/58VIL'4?OVG3P]WMCV]81_KCC_ZU)D>&
MS96B1H9"XWJI<71:@#P\(3DR!!*SDN.3>F<[JF<[3ZT2B`S1P>HI<%P(!B<D
M088X7Q821,$5>[GR*;9O:\3>R1@GW&6&J%R.77[P'6K:?8?0MWTP?K"?7$$V
MFB%FEF.CGXCJDH5MZA^7*\=^"%J`M$K#,X30ZJ;'47V?E*''9U6C!PGB/"7?
MS"M'$F10CCAB>1S(Z6R\V<#E\`J*K/2(QY4O.CL9%EKI02;LK+9"_VH'0'*?
MQI3-^^[INRBZXPI]J'T[SL/?\60T.L&.*W*3,B!DGC/I;*R<8.\5.4C']YXK
M9CKM%Y?T?=B]L^T*0T1R?[19#'!P`076>228DX>HL^F@R#+W(N+..BL,QHS[
M6RW5#J^@R$J/A%QRI6*&PU&AE1X49SXD*[':U)%U>>$CJSWABRBZX`K17>X/
M,UJ!/"O>%HC<<^S2TN7COC*HWV@?FUR7*\,_&,MRX24GJI7?D95#OY#G!>G/
M)N'CX"P]C/CSUP\^.KFY"C,T\F0@;[4(JFC!]9/A2+XF7P76>#@^`1D^T(.A
M1_C(K(^61X])QIU)>/?'O4>W+-/Q#C_2??/T6?VW[;QE\P?W1^T.#B?=/*%F
M67:YC69IC9ICHY&SY;N>O23.-Q*,$G87QLJM;<])>?@RWUYC<K?'?('#28UQ
MEI!Z^D**+OJ86W`XD5']HH-QH.^7*]-^(B0:(?J6#\5-VHC427DY3>5@/)AM
MFXB4511=<87NP9!*6MD54\,V)ZY+F:*:'PC9M^(*W8/!_@4?6$31!5?H'`QF
M.[!Q=,'!E:?@C;<+P]&_JA0YOA&7L"[/%#S>L3[.-H>/]S]6Q'+W[J)"+T`9
M]@.GK,32*MU;A=`^4/J3:O86\9C[TN&#/AGJG6'RI.6>;51YAIYL-=Y)7T71
M%5=XFI9G6]=@\JR8^4_>TV?B+6Q][U7$498Y4S?:@NB^2;[,]S]O]U5"?E>7
MZ_#<S=-RM;"MIW=/EKJT/UI:[#STZ2&<91HRP5Q0D9BDQ8'];46+#<MVZ-NB
M*=A?'BWB,!]F/8/US1.5XBT>9AES>TK"[!\I*U]MA*6S;[4*&F69X%0QC?['
M-G7J<;N?S)/3BEN^CZ[KT[W\4W4<>D1Q;^VO/C5[JDMN%O2M[I?Y6WNYM*T;
MS]:^)RF5H=[U:+Z'[G,@SS)MV.6KX5<R^VNSG6?QB3U'[W__@U+&<%F1":61
M8>O)#::[+]M+#PX)Z4_?E%!^*HG7_L7Y9MPOO/`SY*MC:(F-A7]-VKG4(3Y9
M*+HV1%PJ^1=<_#JY&BAKD2JRQCT0P[A@>%OG]-3).70#D_Z0!?$R&5)YM&U(
MM[ZW`H%/]SWZ,SDXY[`?-M?=O"BG^QO;2S^]**=[%\<INE^493XLOCI1YJ3G
M;-+?\2A)0(J`/]<:-?NNP:,)R:VE'^D+2$U0$I\4]<SKVMP.J\;\:+F>XS,%
M^:!JA!ZU_4T533_;[RXZEXH>6L`6U?T[VZ$(R2)N;VS'L1_I#M_YY!U](;'4
MU`D<>V2<.:V7]'\#.4'(E*]*J-P;WS4LXB9)^Y9^,WTOW0;]R35TX@31OQAX
MDRM-/\GO$E79@_S]JU%D.(HL9RM\KCYQ+_/6YL]P2/3(W;1:ZKR(5'G.Y08?
M6]%64'%SW!$;D\/DZ-N6A!R[QG$PNK:?`?(D$10\O((<-N1W\LC_M$'P(\?Y
M?G\8K+J_#9<'#4A_,AXJ6>U'O*;R"'ILAD'^K4SZ@ZDB%T?0BO`K=:Q!EOT<
MPJ]1OPK\RNPGI,X5V&50?C_A=]MBZ1"5&2=Z-K27)`RH)!=Q)`B>6,1XR\*,
M4JZ]R5L6YN!2MC+CZWA$K./7^K]]=]N;S=+N?B\+XV-A^'+TC8G"'^;,Y][R
M;/NZ8_I6MF*F\>O,!.LZ1Q75_*H:]$C[5ET9GFJ&ZPT,1X(267K2GY02O`WL
M1C`V[^X2>O2-:&SMQMS0PI3$UFHI>6_M(`:0)$J&X_)IB;)Y^LBSK0RV\PL%
M04^U](TA?*,L?>)KC$#M`OLA7!E/QB-9F1XQOHE-;E=SFBM'U3QJD]DME=@;
MTYX.N":I;=XY8T/7I)_1-1DG"SNS+*:@U4MMOQ[E9TN/KAPD9?T0)5)D75%*
MF,+LM,@W<+8\+5)N6!VFQ;0$*2(GG/I1=^R4=/BD$5NI)'U.,D@V29]B"><"
MN]P*>45^!2]J<S_XK$`P+/V/#C;T5+F;9:FR][FR/>X]WZH*[>BC=?MH\\NJ
MR4U56."H*%.ER*;6"RNZKX5#R,[.CMU!S55,5HQ=R:45W-L'VW>VMW:L.W>^
MK15E6KRRHCN+[DXG=W:DCB)?2\.17'!GT<H*[>QV01RBLGOBR8U568TYW.K=
MDWMAA?:5W$V57><&_6F_R'82;C]_(STA&H'E_TR7QDH#&`^3J\[@#L7M7GXC
M]KVCKA;4XPY0S?56SMOK?=>@Z$_3R_XX]-53UI)_Q1F<EL,KYNZC\_3;V_V+
M5@:7_4'616_#[_L?AL=:7;AR<KD9?(@"!,YXHMYRG797FBKUW];U([^3).RG
M=ALNNEAY>[6IJRFX\"/0GE+ZE[+PR0D6?@2Y"WG691;^CLP)];MT]IZW]+]&
M<K6IO6USBL5V*&3WB_,L+'=-8G4+^VH2_9[H017H#5FIE-3$?/I&5K;C$7W=
M,R)\XQ\6]=H_$8\U5YD'#_R@:N')Y]K;UP\F2P/8P\:&6;VWJFG,;<<RU'7)
MPS`'48;;:9&:-KV5HP@>\\3J1W1JH^-O?6N;K/#=4<V]Y,IP_3$WN7()]S:Y
M\FRD&A*4PO]#),BC1M61X).M6B[]1&2\-&(\L+C^.^)JCK%B()[<>2D_XK"N
M](-L8J`TOWZ<2]Z"2)[MJ::D!MEJ>R[18X*DJ>ZBQ_^5R+IUI:1:NK2,.\E(
M[KH?TEPU35>Z(Z;]*/U-Z4M+PS39GN@:)%5:!;D1^O"E[=!O7*B6-.BS+;)'
M>-1]EW3UR95TGC#CJS(9H21*TF6/_[Y>'_O-(3R/J4=+>*+\7-DNM:>/](LE
MP]*<X/.V]#?Y2HZ6TZ.,]@Q3<GUM(7G&DC[6Y?M=.?:_B4:5/M@SV^?.YOF3
MR0^-T'=M;S%8TU(UF(F(%IG<`GU/\-7LV]B]$$KRPU\5/(K2^\ZFI$FCIZQL
M4'')'$'W*A&0.BYW6P%HNI:MCJ7TXS<+:A)OZ4[V5XEFZ>&[&2ZE,O/FZ7?6
MIHNP3&(<15T+\/JU-[GZ0%0()8<#7,I.CCT[W:J@=X:+/,7I?9VKST1+Z,V/
M38E-[J1KLS0!KI&F5<GPIHG_.NB_"X^,.WO/2I<,J=C*=+N"'<O*Y_0=1Q+T
M,02)=R3X[T<K@O=W`98D-&Z<I:%O9=)1F@I9T_A;.G6<(J<^-8RS-`+.2?=W
MQ/=<;4'>J-;W;.,B]I+P_1_?(KO4CB/%.+6;<*.T3-CXYLX;X]3.Q/70)\]A
MI#KZ?+*M>P:24477NK![NV9U?+1/<9%HVG"GF.;(@A)0];O/:/=E_C7PV#=L
M=(93$VL4\V5^S0H/[KF)C5GUFZG^L&_HUR[^GVE89&U;IRSR%OZ07O#`'A.N
MBVXR1*'M!2?V\M7VZ`H,U?QLF-1;L2T2ALMWV9#!P<[FI^4G0*[[T6SJ>\C<
M+%LL1HPT[S=`5JH`O.,3/1-=WSMD<Z-448,BI=M'NXBK6S,)Q_W\%-R-\ST0
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MZ?=N)=2<H(-"PK?A[9$^&1K+@<9>SJX!R.`Z'M[FM>LYZO\2BVB):`.%T`#K
MZ0_\YL)@K=]Y5IG;=\G273EE+_0W?;,9I!QI*/VA."YE<UJR["^#;W:@>G*K
MX^F!=V6UZ'M(M2X_Z`^RZ^KA1'194F6Y(=(4J2*IRM.D:=R`*YS:K;EA(A9J
MS[6;)VC4#4_M,5T]?<OZIE5Q(3K65<J&E`9"[W]HIL\NCH376_6/K%.@QJO.
MD\.GQEFZ:.?#CR+GFGU"6GAW^4X#69IJYW,&UKWV^Y]S.?F'';,L?;`++3*C
M4[9]J:.@?YFEI77.;>3Q+2?;!72IV_B-7SA=UP<D]Y'F0/(@MS&G3R;!L$E^
M,3CI_$4NWSJL\+L:W!!DW0H,S_?89_Z'J*:WR&JH_H>LZ#.T#\:=8[L&2_R^
M-1QGP7Y.FJY9YOM[VW[X-CFR$^M8;/+TQ+KV/=M8+GV+T&,@2^LE?;KL5QRW
M/;GB)$IS<ILAT;<%\9<J)9-^[7@+EJ1)YFB";M*%"L:*$RG-O6V&2#??#6LM
M2Q^MN:DNETDOA./AI'"-:F%:I38G;])`43%Z\P_#\1/"U.]/L^?G*Y.FU&[H
M#5&(*ISU55T9IFDOU1TJ52U&<4$(N[S+4HU)ZJ1YA<U0YZ/KWA)M8=FF?;^^
MF]Z?1H&7:1AXB5M&)+>VT["5!?@2%'E#:4[T#[83I5VC#[M?'.I9WCOJ,GG2
M3NWR+AIYLC=0FFP[X<4(E3MPD=I7OD0$]?!!+:W=:7_S,F%EX9G4MO$E@JN'
M[\"D['*H3&O:9:G8:I%L6>6[+!7?R-)0_F3[W^F(5E'H9X/AM23/*U+>:+W'
M=Y$A=MJ8<F;>16K7^5,+WSC;-C+8E-36]`6C'T7$:Z+4%+E/[61?,"Y21/+J
MVV#U0;9B0EEH@Z4`(;5=_@F%5QEM#6YK-`V0VFC_A!*O#,=[$:,AJE2>F"ZF
M)N-A+439L`CE\M:5J<5@>W)G=K`MY?A4)\(#>5K0Z<G2L/\4XK8]_BYU`Q\<
M>QD$-!([R=)6__!.=D[?]&WTF.O<LUFU'ZTYT>C??3>,%1^>-IUQ.([<'^S;
M[GIC.?9=RC,JO.]B<CJ:R)7MNY3#5'C?A:1;F0SV'L(*[?OD@:?"1['^8%39
MKM-<J+IV74S&QWN//(4VG>8AU;7I0@(^F.:2[VO+,W3#Y+>SUQ>`@I0^T=FG
M@E'%89O0]ZICL?$E7XG#VRSO5*JF#A\(O[3D=[YYVO^`=2*(M7S^PN^.!W=N
MV4(?54<O`A9Q'^U)?[@5CZV"=#5S(X-?)P(W,JMWS(W1:"RWCAL9?%01N)'9
M[L3<X!]I&S>R#,B*KJ"$'8$Y]3;GN%L/Q/'8A,JO3AB^X&\J86F&@^&@=98F
M=2#'"60[_(JP97,9.Z\,Q\/643_#R:,)ZN>WZ\I$;A_U,YQ_FJ!^;CNNC";*
MK'74+SSHY0`5*`T&[9/!(_?@<VNB,E4FH]91X<C,F=P:08^0]6-Q8E!-.,7+
M]Q:VLQ6./C9V9M`?L:*\X^,.!KL#F%)64&Z@T3AUR$R57M;Z*N/61:E#9.!N
M5K&Q2-%G-A?S576^.'PO.N]I$;$\28TLTVJKH48Z$1(CB")Z]*_H4A*=8C+M
M;=^X7D8IU=+(82T]E>=]4";ZQX@A]R>C[3&]^_>U+1$VZ[_G,CL0O9\23EU/
M.$G0(<OHG'KID%8I/-ZNSS^^M_USYL)%1Q_AO9.35,C@NS9&A9V[O&F;.BX*
M'UF^3C6_^G>FH7UA$<.-D3GC3"-S&I.(G=O`F;>XC7<'%A@8V\`(_['B@SCH
M&]V-WJ/CU.DYE=(HX_@@>0M*<V\N(W58@2>/+.\C2IY6M-4%,WZ]71!I89NL
MJ:CALBZE"^/.8&U*YU0DV(KX`\.6J3=4%JAS\$9*?)$4?Y,4#A"T/%L*2,OZ
MAVK<,Y'<X&_S'FN(JDKTC[[)FZWR3JE:3)*@%VNX(M:ZE'7)4^=SPS3HYEWI
MT?9-7;(?K42CU]G5;/HLZHD:-)NU>$\D_OS]*Z%OI>0/9J&QK['7PZ&N,LC"
M#BNS*@CQ/)/SD#\A*0!Y.O)6*``?+4XVEF2(F]\R!UBUGO[/3U-J.EZYDFE0
M=-"Y0]R3=$HUF[G/[!?;D1Z-8&Z8O^J%?./4SB0KO..MP\NA">LZ&]AFUJF6
M\I"UUN4^#>M&&_!1NB-SQG:Z.":KW'9)['6Z*,\Q[GPFN?1S;!-)=H?KRL+9
M+0XEBOO?L120_LYX,'1B)1W[+).2:C%H:7.C(MS;L_2#AY<,#O"1F4?]*3VB
M#<LYKAD6M%4Q%^Z+0COO/$S??FN_(6P^X#OU:?\DC?&1.4=T(_VHW13;$;O`
M-[V4Y<OD&-GL7USRV'%D=%$55"]R7.`O\5FFB;4>F454:*WCJXV^A/'7)KN[
MQ<.2X\&QP1C9?:,-QZECA<+O.=*T:%=&4O843?I3XJ9KQY=[>'/,.`<=0)-;
M*M^'*<].1@=VLEY;\N(X'V^['B>S.0Q\?&1Z4*HN'GQ^R;A'ZFR@0O&*R6PT
MV72_BX0L,A[14P<%I2[_4&7"VEV^.L79.M?HH.#33/IL*Z[2B($UAI.2YZ?I
M:.<P6<^).G7"4#-[W^FH6N\Y.G5444/<[V^/:"IX>CZ@]1QG]UJBU)O:Q/A$
M[E7SO>51&L15`I_-AUR=6_C!8!`2I3](CT,GJ;(;BLZTO00VW!#3I._B'7E=
M-^CE$0)*4/-D,W\Y(&1$<2IT5,<BV4O0*G7V4J6T2B=1A)+]0023Y;=9$M".
M3G^*!K4K_5$_4QY"GFP;A1H!+76Z4^KRE6.`-KQ2*L.S8X8M=>I2ZC;2;JC/
MMN^H5VN:4H3JB)>4:'\GL^[GQX5*F6SOI8A0I7XF>/V#[=P0YX&>(C8V="P!
MF7M#@US[V5E;,64YDFH\O(NCRJ)PS_]$RG)DTN+A;:0IRZXK<RIE.3)_L1]M
MA^6YE4S*$FZF*64YTN@Z_X8&N?93B;),4B>OI.[BJ++(5Y-3*<LD=9!)ZC:.
M]X^M0%GXF8AS<Z._8-`+@^B4&K>.:KFJMCFI;I(Z4^2`1W?MK@R'O%57AJ>:
M'WQ+_V1J>5V\?G^J!.3JSY2L+:P&N]YPKGTG0S[AI(J#?7<GJ=-$\E-F=\^_
M?E5&4<N]`\M)"<`%XS5N[>B3@<INC429I([_J&(369STX8&@7,H6-IK^1._\
M0'CL-[F]U&LGQ;8WZT?;R]Q:38X2O_L7G`,.OGB+Y!CS2>K<D(HW>`@T<CE8
M?`/E@'R2/A^DV*;ER#AG3%HK@PJ0?V_\:IZ(F20WG=I5K]I-IYG8[?;U1_=0
MEMD%PB_I^SY<Q'BX0F$V&RGR";F=.M^CXEVGMO?.5,1TF-U%/*G4*1U<;@?R
M)/AAR)K?9_.D=H;A%?2DLL60)ZEC.8IN8J<Q??8H<&Z]2QV9D;J!@X<+^N%!
M:9N9\521.L<B=?G#XZ>*X2A?Q&IC3EB(@TF=^6B]5[7%'Y:QL8,CH9#\#)"W
M)I:EKF3/RL,+$N[^Y1Z)>91?[N[7;WF!T1X8)^Y,PHK$WO^@/J7ADO6GUS5#
MW]A)(+F#(^&.[#N(D[0)CZ_(XK8J18+2E?"]7QR>=8V>P?/QZP>%?]U0Z&/A
MC^U='3Q>\XZZ[/%,%Y+AJ"(K3/`P^E/X"4:FG5-7ZEB(728E.F@>?'H&*N^M
M8IBD3E?(5P$YDP?3R>`()7>*$S:KJ5Q^82)1*QG6-!%=3BXZ0^G%.W+GL8OU
MCK_1:8+-&H\/H%FN"!Z^0;'E/!_=P*Z4<&S8+&289&G_OY>R\1:CE^.&<<4H
M$M3VT5/?Y)+^3YYNBF"\](R[RE"PFVE7.^,0B^]*[I?>58:*VVR[6M"55K8O
MY5*9E-M7AD+23/OZ8/O.Z;95R)1DJ!$YB;KEOZ-<S/X4(E*&8I*3:&]N(FV?
M].LD4I:Y6*<Q!GG)=$HJ91F)=1+3DOM*<#$B)>W5H>K%2>IT@"9`7QY>]JF]
M'6_:VWW5D=GVEV7&U"GAO^K]5>6T5><(5+W#JARXRER"[!NLZ/"9I2G^Z90T
MYR%W="4?.YIE.N161<NJ/,Q*#$+N@,%X*A(MJW)A*S(^N25S/!*)FE7YNM48
M.A%%<W\D*<O8@4;,8^8#5+YX50[*5.7S5J^@60\$=9$FRWR$FMB_$[_+M,>D
MK[&NZMB?`$V=DI`KMJIL7,5,^_I*;6'J%(3B)FHVKBS<OIU7B3ZYD8M+[NA8
MHZC,M1.C!$,RK:+,JH\U=LHL2''VM=2Z@W9D5/!T=F.&6"YWN+^:JK4A/4?O
MCQU9-?O.[2^@MFE?!G#_8O9<-=UY8Z(=]9NG]5O"K#1OBYFL%/VX,Z]VDF5&
M`%O.[^IR/2LYS%2R6C'C@;`_WS[2GY_^ESCVKN=PM-:0E?P']QN'C+`Y6D!M
MW8FMBCY[2']W_-%WVX]>'^=VR9[!4:N7[.&+A]N:\T*QKZKC&9JQ8@IVD%^_
M?I7[_]IB117TJH@-$="$!CEYO3ZH=TSR)8,?6)0ON00]R&#+N_>^:Z%`$Y3.
MX%=6K@$;M[V/:L!OCNVOUF?T0OR3V\2_%(.5922&Z.P*:A%.8::*`%'8TSKA
MM`=.0I()&2+1Q:U3=O]QR%K&3B85H.^A39_&^<DR]V.'GN^7*]/F7_'1TGV-
MK+4T)NTML7*Z0(E:X*PND'QJ%Z@NH<X0G"_'A#RB30]9XV1M85LE.T.X?Y>H
M01WEKJEX;[+V6'E%>EWPG%6DE9T)HR+*='1VB\;[J6;P9?N:WDY2YZZ<B!&#
M_BCJ;)"QPVY0JET)(XY3ZP3.2Y%#;C8F[,KY"4]#=5GD(H?3S.3*4Y0Y&LZ&
M50AAS<9XLYY[OQTH<K"L@::#\7@\&P\K5.P,ZER7G!XI1<X\LV$P[8^KL78U
M"UKX^&`.UA[83QUB4J1N:#3>FF91[=)S7)%)SOV)0[W)K1_+5^0OO]OLBYM_
M==4R_8/MS(GA^<RMV</Y+",\V-/8^3DV,']8#\3UB%ZBLDP9C4:52LB>?9Z4
MD!F.([N$_$=9,L[&LW91,<TP'YOED3W-.1E7*UPU&^9`#*XMYKP1C?YX:[.7
M4FF5-]%T,EIEW4RU)$S<#MJEU;$)(EEIU1\KTTIIM;/J9(.WDL]F'`@=P:B.
M(+C%?[M0K?`]O]NA)?\G85EFRK8'XJCWV\UI)ZG33/:Y3$=;O`RN!M$]E,8W
MFE,2W5R^RM87;J3YDQ0^<LOO,#)D:#TUGN40V>JV5S%=HV?G)NT1?[\$:>6K
MX:!"TN;:8<74W8/\&>F;99Q+.1\RBS61*^1#3EJ(PXDLXQ!+.*%9^)`G1E`+
M'\3`E"17*JLH6Y,Y;N'=^$9/X@DG_*2LJI"WZ"TCT<78:&V^<U;JYCVI9;$<
MXUK\ZIQD+!)RWSTD;GWI-[)4#8NW,;8\1]4\7S79F!0E2=)C![I-J\R*$@:?
MA^\JR!@47WZU]#M^<,RXKN3=R]0A,Z<@:W6[JI;:AU4D$UF/'`AWR#KXU^2S
MW*^0K@767ULDZR/]'L-R#6V[3>.1:3E'(P\;S0B'RJ2NH-;F!DX=W+J^OW?(
MO>J1PW0\=H1KDHZ%-UB;0F]^35)OCTP9RD=(9;HG^%S+#FKQ=]:'BELV_.Z@
M\*4./4H/VA]K"5>YQY.ZIV:I>'00P<%!W2E]#K<;%)P_&8^<:PJUB]QNL=@0
M%4M[6='7?5`-9]?T'3NS%%%C*JW[:%?#3DY/KR,'DD(*NS-QXWS(=6QV1*$^
MKM/FR%5$_[.'DG:2=%F&=VW&+J-"1L)FF#*_BU=3L/Z2[K>;/];QS,SU/).J
M2A+RDN%4U#]8`)1E;E@QXA<H#*D(BW)2XU0\V-3`)`\RW&PZ$0]D^52*L$F-
M4_$@S"OL94/J*+33LF%\,C;L$*1Y/$B=NU:.#YF;94S.'`\.)7:X962]I&('
M(<F8W"6#A8$ZRPBZ//GW$Q"J&2C/Q;_<E8KE#5R&0HK3,#(GV9IQ"G)Q,\.-
MK0:XN7-_602RG=B]8&4+N5B9X<[7R5EY*@N;AV9BPV.&2V,5^2T9DNHSH>%Q
M:\LL?V*Y&\2L+2A0+-JW%8W9O_ZJ+B8>H_J!K%+,C"0=ZSO?YXEF[;UZW@AM
M6N"FU18..!RX%08-!'73"G-SFCHLM10W#\>5^\>XV4"431A6;KJ./#^UEV_U
M12&J`*!FZ",:C^H+2!3*28-'>WA46]"A4%YM;UJMK3SB_[#OB2\7RTG*YTM[
M__IUN-V%HJ(UU=ZO8YHZ-7C?5NOLN%%5=?XWUT^Y!SI-'21<:,B7TA].AN-Q
M=?<+]NV@SL8&N?RRH@?,H),4(8D;_)7$6Y2K89Z;3-421ABN%#VNIG*EQ+EG
M<#6HK9E%>[A2]$2:RI7#^)U!5R85WAEIABOQ\ZY=UU\&*_EFN-\_.(3%+@C=
MJ/=M8RS--'7&=`TV:S,[&LU(I0RK@/99M]\@M8N>``O:H@/4[E?17+`%U"YZ
MEBMH8P[)=A51KA+4+N*&[ONZ^$;"YO6=:>J0\*I,"+M+)?<_*Y7<ICJZNR:H
M6#3WFL<TL`.9\EE6SI:(1;.>>31^SZGV5/2KRG)$W_,/VZ2/,0WO:=MT%DT\
M5NP65-$D,#L!&J5X+8?'W*Z!7(43W!**UW(PS.\>M)+BI0^`<H8#X(U_YQJZ
MH3I/-ZI)PBFQ!SE12<BD7TV50[L/YTJ&0V%1WI0*G(RJP(.6\R;#$;(H;TJ%
M3_IY^H()R9L"1TPEPQ&S>BMVZ%BO=.)8KV0X;U9OG3I.\PRGT^JMSB&:GWE`
M1<EPBJW(J/SZ5?[7X+,\/=>`@)+A'%N1K6"DE#^/SY:2&<ZG%5D`1LDFHU0G
M.X$J&4Z@I_,>IFT\AQ:C>XUG3T1<#M-]4..YLB-QE[0O?&<\&#JQ]&VJ%VXY
MI!RP%#43+KF/+&1+[C7#>>RCI=E+*C[TZ6PYGVPM6/3F7#="6+G1.\.A2[(=
M-U.M;4I[*WF:J=M[WNUF.`J5W&Y*V6K*=OO#0999$GFWF^$44G*[*16@A[<[
MDJ=9+G?GW6V&8\"QW?YN6]&&2TKP2%9JV&(&][S0%@NQ,<N4H;P;S.`UIVUP
M7;A,5$=;,)DE#\2T5^R=X16QDHP=*K58I@RN;74;+V2D!J-,<Z7R;CR#;UG=
MQ@O)N2+W!]5O?)C!N<NP\=^(11S5I/N^UI>&9;@>*X=^(-4(^U2NPXP-,\3D
MJ]QZ(7$?SY0:0&I8TN'*N_5"`C_H3[/,UMO<^K5ILH42??^;=^X73X?'NL07
MN:0UG&W=+LFVK+);.7+/H]!=IIUAT46V<EP@,WA-[\B<.,[!,\L_#6_QT=+9
M*<0/1\4FSR_NFZ=@`/S>Q^QQ2_B!)]L)XC#ULDW:+LOW#/[8*8BW'M1;]H[C
M=FO<TZA/!J^O*3(64MWMSKA%J$A7:ECL?>P2_9W/WL>'S88C7.-SV5O[@3C)
MA@/38>%Q5MO7DI('0*I2ZPWE7%QE.SLV/?8@L])W)E>TLSC61IP'0R/[N1WW
M00CL'+^6F/S[6]OU?K>]?Q&Z5LV^MS:G$M.3<X&IQ+?&,EA(>"WP1EL0W3>3
M[F&NF]#;9J*VC3=`WV/AOSR-QK?ONK:=3F'K6ML)7V+O2V:]1AG<VR+"N9V%
M5?XUV\S"GG;'#4AEC44<99H@G+U`UUC(L:>V8+AY8Z-)J2Z<0O[J.]I"#:<\
M?9G33R]MBV^=?JM&WY4D;]KI@]F&8*&QJ0A^_6)%MJ$<!_K#D`/LARRIG.GV
M1;!:Z-,$'](.,@?Y</MH=XP/15)WD>O(_^I>^]["=K:M>XW%(IE[#\QF68(^
M)39<$3V#QT;<8T:,OYPD9R-U(H?H.E6FPTHNYAS8>#UB^J`:)AL&1+^%%Q`G
MR5OG582L5)7'D]&TBI*$(_O>I&X0FOUDN^X'QUZR0Z)A^=1E_;(B01<2]PV9
MVPX)WG>K_B#N._H#=6NU!`''QP9!%0G57XXGS'XF-;C$:FO9]I&35:$P_>6$
M=<46>MM'AB\5"M%?#F>S65^8;5-M(<9],JX\+A[=3\G$34L+>+C2.G9</`F0
MDH`;#@3>\9&>3X4D6Q[,A-GR9\.BK@OK,184N%];^N93@A9DGPEU<>A?V#&,
M1YN3-"K<(RK5UH\G2FGM+[H[(<AZ9`9J,2P9SV;#6:?)>B1U4!"KJ,LX$8FL
M]($L\&%IAFGPKXM?#E,Q;XA%YH9W[7T@.DNTLV2\[]G.T_KSFT6CXV-#4@NI
MN:*,)],]A*MH_:<AS>2(MUM,597!>+3/`K:+-$<\XF+J)H]'RCX(/25I>/4*
M55%6O&(FM#BY^2-^<3&5D;,IS*'U5;:Y(^YO,:&?[@.GT^_MB*-;3&J5T5;1
M41V[HR^\=8AN;(#>)%_KTHQ'E='6`+&C*RJQ@>+C+U/]\'V'K:,;X)U+#[QW
M7_7%VX7JW&_*5[[Y]EEKVB9!E*#@^BK;W!$/J^#]@;X8FSOB!16[+3`;E=_;
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M`3<TR[6A;1EL8$-<W:[U?_N[L<#48<R%S^>C3*>B[665WDL=7LID(C>RESJ\
MC<FD2KYLQI.2:Q^(;\(.+WXHOKDZO/B1L*9IQW$-LP#6/0OMOU4=YVEN.[RX
M,;FA8XFU/+[V<#+>,DPY%E7);H[EL_+L1IF,E%E-NXG#/0=W<NSV2:YSX&`P
M3M_(_O64WL2QBR:Y#G+R>%#/)J+70JUGEZ"=!]ZJX5K3')^N+'IIO;=9ZCC$
MG`R:C?KRT:UE7V5=.SZ&_GD*,HZJ5L4[WB,8T67WY!:/)5-R11/'8Z6(P$;K
MJFQ3QY(H.8WBI,9-12\$2)S<Q+$9<'GLX7!ZQ!QN+J/PFH\$!?+%\J;]"M>\
M%;^8'9W!EDM&E"-ROR<Z<7R%E4*[<L3>9EGA;PX%_>0**X1L>:9,CUD/_OUY
MUU@E(D_Z@\D1*YYEC6E!X5GJI*C\1)T,CO@0QZ*].5=?(612<BN#(R*1>_6_
M$R^YW"KA[QC`TZ_.M[@J86QX!,32%O?)4.]8@SV#N%\=FYX`O"=V&9.54K'B
MJ=5FX'N6.F(G+U$/VX0LJZIL2Q4"VV$HKFI'VTB2.F4F;R#NL#W97D&AI58(
M>N.#D%=DI<E%5HE[AZU&XLOS+K!*T#ML.;(L,+`NB7=NVC@V`B-/8*^!J-+A
MM<OYXGKUKWT7#;=W$^4&KY>VOV'A4B<LI$?M4\:J*]OM=/*NL+K]%2^L2]M?
M7YC]%<\VI]S:GV[?VR^WO\1[B?O&=PV+N.Y;>WEG6/RANT^/.^#<VF^CUBI$
M?ZNN#"]943!+[>6?M_O&UIXK7O4F2;)$>6=9VNO'H?SPXJSW%-^Z#LMRBW5N
M&$R'VT)P+`C,BQ,.OFD]>ITE1).[S-S$,\,NP_=_8\*8O#_ZV;",I;\\W$V!
M_C0-ZRLR;J'<IC,W\"RS:?7'L4T/)D4V'4G$WA#8KHW*W+,S^U[W?W/TD?WM
M/0NV,-GIRI.RZX1,['W707G(TKN]8B6HAI*'U2@#`8J3*W-+T,K4IR9R#09Y
MR94+0K)W;-]+J+>J:="G6H;*Z^B+:9`BS[8[W-4$)=D;MN?8;1E(&9P04K*W
M;Z]B\QF@I=#F\T%+]B;N^?=\0HC9Z=UZ%&+R&8'B?F3XU[!Z]BU;@/-4T`Q,
MMH$T:U7!-TI@R]\(=:1V?M\01RJ'F7-/_:U!`]$7'U_.T1Z:PV@Y8P;UV>Z@
M#+8Z561?SM'KI9-H.;/,RU&HIUYL.:F]R[D4]0LU=\BRG-^)M[[WFUQ3YK$M
M.03H4F'CY396M?']&9=V-"930)@NY8D\'I9>VM$V'04$ZU(>C2?EJ78T_5!`
MR"[I1D;C0DN+6P.Q8$#<*VQAF]3U=-^H;K+IRRRUK79=TGA\A95M[VA7BQHD
M^H3;.PI&-6C%";=W-.]11+,4>52E<+Y7J1MGW;M?B1,U[C(T/H3(9$&XY'8R
M]U[8UK6C8YHO^U=RHCGTD345W4!J2^=4;<JR@>2@Z;HV<!1[#^F+*!LX6C]P
M2"-JW<#6).^-5G5??(]ECW3ZL)1]9>["=02&XK9[TQTWK=@BJ][H,6<A*R`E
M-CJ3!P)N]*ACD1&:UAL=]+?*WL38Z-%BAXP@%6U4&8RF6U5?56QTS_$HM9WK
M1HXRSUEVL-7O)O-I+;4=*E_%,%I.=F=-&6_UXLN^G*-#'";1<G*<9:>3@LLY
MUHQ3B>0L7\U_?YQA.8>./MD[9>8Y/<CC4;_TJ>Q8-\M"PD1=8UGNEU[:T=*`
M`H)%#R63F5QZ:<=Z0Q81,GH<'&VUAZSE+'NLS6,MTGBZT]"Q#HVU2/0)MW<4
MC&K0BA-N[QBXU:%9]9UEC_41/*QK@IQECW?[.Z1-@AP%C_7D.ZPOF3C0KW\#
MQQ#ZH$;4*D*E#P396^IE/<N.J))O&C$A3C['^NME!J1$K_SQ3,!#^['&>YFA
M*=[H9#*=]`7<Z#$7(RM(K0_M_?%6:K/"LVQB*-!GPR2N9[.!.ZRO[N8;_KNY
MR8Q#3,A_?#::F3[(8S,9DUGIK3]OI>_Y`,?$1(?UW$8V_O9_B44T=9W)'O8'
M`4V'.^8@96KH<"NCG9\BE**_O/AQY[#ZT/\?4$L#!!0````(`,F!:D0D%E\7
M'A$``.'_```5`!P`9'9A>"TR,#$S,3(S,5]C86PN>&UL550)``,9'1Y3&1T>
M4W5X"P`!!"4.```$.0$``.U=;6_C-A+^?L#]!UT*'%H<'+\DW4V"S15)G.P%
MEZR#)-OV/A6,1,?LRJ)+2D[<7W^D+%NRK1>2$B71=XNBNU&DA_,,WV:&0_+3
M3^]3UYI#0A'VS@_ZA[T#"WHV=I#W>GX0T`Z@-D('/_WSKW_Y]+=.QWI\'%H7
MMH_F<(BH[6(:$/C]T_T/UJ^7CW?6'?*^O0`*K2&V@RGT?*MC37Q_=M;MOKV]
M'8Z1!SP;`?>0$.?0QM.NU>FLD*\(!#X3PAH"'UKAGS-KT.L?=WI'G=['Y_[I
MV=&'L][)X?')T?&'WH=_]'IGO5X"X.<E"2OQY\SJ'WX\[!T.CA/O/0#[&WB%
MUNTP\=[UR<F/EQ_[P^O3P?#Z\J@W//FQ_V%P=7(TN#SN79T,.KU>K]\;G/:/
M^3_[Q[U^4G0\6Q#T.O&M[^T?0IFMQT/^WQ!['G1=N+#^;CUAC[(WIS/@+0ZM
M"]>U'ODGU'J$%)(Y=`XC1'>E1%8S'CT_2"CP_86XAYB\=@>]WE%W]>+!\LVS
M=XHVWGX[6KW;[_YZ?_=D3^`4=)!'?58+\5<<)NV[_NGI:3?\+7N5HC,:?G^'
M[;":!.2R,M_@/W56KW7XHTY_T#GJ'[Y3YX#IP+(^$>S"1SBV0@'._,4,GA]0
M-)VY7/#PV83`\?F!,P?O#*%_U!\LO__N&;*W6!NZ"R7G.%\?;S?$=18>8)^%
M+7#U:9>_V-W\MKLIBC"4#]ZQAZ>+)>:3SP!Y9[AB+0"[R&$_.I?`Y97P-('0
MIT6,'AG,;^(PF\J*2-C`M0,WK#I.;N-5^.Y#SX'."H"+K8%E*`@3Q<7V!N&H
MH+")C`%]"=L)&WI>`9B%Q76AZ]/5DU`UG5X_:B[?18]_>R!P!I!S_3Z#'H47
MGC/R)Y!<4,J*O@H(8:)M*LCE+1F3U4,7O$`W'/+$X;IZ*5W8-@X\GSY"&Z(Y
M>''A%^@K<,G'T4UB#I#+R[S!Y`FX\`G:`4$^@BJU(@"FF<X5H!/6&OA?UW\$
M3)LN*Y5>^%>`D`6;-'\&;@!E*`D":J:5:-U?L&?+UTP&@&:QV=SI$V2SH29=
MC6I<9%`U$_R,L?.&7%=&_/@;S<(]$#R#Q%\\L%'>9VKB*IKQ.8`-+W)C;1Z.
M[O%)=8:H>2X(2Y.73[M@0SB&3`7.(YQ#+X`*BLQ"T#^[D@`Z=PB\(%=Y0LH&
MJ<DX>``+/B&6,`NV$>J8:A(**S'?9*#4V^+5Y,\!T2Q^N0;?0$M_A#Y`'G2N
M`?&80419NPVFW)>!#M,BLI'DY%Z,IK_KKHH,FS&/"A`X88X&FL-;CWE9\`Y3
MRF:_T?@9O$OV:3EHW50=!W&?$[@/S)NZ]:[`#/E`RIS)A-!MZ>/I%'M//K:_
MR1OU.]]J-\6B\41-WM3/-8L<%C7!K@,)Y1:?OY"1..WK^@9.Q1&S3A&9'5U.
MP\58:S*)X-(%L3?*`,1>X;-_[D26-N."T1M=&DRG(5H'^7"Z^GY,\%1&O$@,
MG%$5F+"7SP_Z/+![V.L=6#.",&%?GA\,#JR`,D'Q;#GP'%AOD`=KPP!YST#B
M:6_%_`=&\1=CG#JBQ92/]I#R[J03\_UQ#_EF&@8Q[0_[2%O6Q(O5\7$/U2%B
MS\<:.#%*`VD61_ITMO;%8JJG^T0UQUU>,V:<]XAQ7H`CIFRLZ;(=>M@<X%+C
M4C%KLPP68=99D<28N%EFBQCQK/!OS/K8*-9;D7J\_9L4@F999]D$\Q=R8KYF
MF679?..5MIB;6396-C>91="8O5GV53;[C.7LF*A9UE7Z(F?2=Q3+0ECS'YAE
M:Q7R%T@LB;F;9705<\]-#XIIFV5U%=(6RO"*V2N:7I^Z6YEW^G(*UP_I:#QB
M\W!89(GDPGR\]F099LBI.])N1\WF"9(Y^X%&]JM<B#T31/N::EC.#>LRGPDS
MUJ16-%(^UKX6Y_D$V+Z*DG>_U;WF.<7$1W^&S7`TOO5\X+TB-JHJI/`4(&42
MV>WF_,EO7SULV\$,0><&V-PS6T2CGXA010BZ,^&@Q[JVR_K*A3-%'F+6*>#[
M$"08"$/ISUJ$;"KC!M>0M4D7ASZ2`I$"(.V=DOI\"2HJ3ZIE[WY;SX"G,L[I
M%RZT/)B?@9>SE_>Z#.,KM(@B),U$V!`%"7,<%23?^52[J'-6&N\O2Q6MRI>3
M.0M#=X/9K%Z^WB/52M(^KS5#98CFR&'F(%U*L#;A;J<S-E6KIZX4X6HFR1PG
MM1K9^K!.,=>N[S-.K"!'ZVZ7@");F8@(=*-.HJHB<&;-F9I54H$FY'JB4OI)
MIVV:2HT=IHVNIJ:>%++-G@-CRF8MX`A0WC)5E/)LS&C+!?:DJ:DV>0843O,`
M3$VB$22ZZX\IY<RTH4UGNJ58V'$V-8E&A'IA\,/4?)H\\D6Q*U,3:D0JO"B(
M:&I:S4Y$9V,XVX[YFII#D\<R)0YO:M),'LV<59+2*30-+<]MY.PFY^1RJW29
ML.U<K-L5MX8P:T:Z]`TFK'EXRX5?>_',^A-E`PCO`YX3_A3U".?W8.GNJ&S/
MTR5!'?'I%+&_>@0"%_T)G7]AEQ\9]1D@CW,9>7$"Q05!E/UJR'[T7A\@ZZ!.
ME:HK+T-#RE/=XMF*?9V&!#I3U*2B\ER8A@W`8H+[%ZR49"V[3<8L.UAJ?!'0
M2OD!U=189]6:+#NKEPZ@-F7=`CJY<?%;55;M-EQ+K=FUF+H7KFW602D<PN7?
MM][6#@JY%>Q",.WK\-L2A-UI';=4W'4O!5L[Q:TM3N6([8#)IH7M0NXD_R=R
M8]F(MM9B>!2L<-U46%@SC3)*"Y9/Y!/#:ZP9QIG?U;3$))[N4T0F@,!+5KK#
M)V`V^X8S@`R-+`3-@E\&S(""E%Z_(S\,X_9EA$[[NJ8D-9MUTM+Y:2D@M6;E
MWBR/HO9>0^6IY^1NX]1P9AT,S<4-*?A9W&''8X/G`X%3%$QIO"XO1T^Q!-W9
MO[$/`EPX&F_L-%QO,Y1*`A9$W/]D\:I.Q6/NCXU`Y-HDI9%AD0OS_Z!6F&<%
M%F&G>\87-FNG!&9NNY7*HY1`U7^NK`VA0_G"%N^<K/![X//(PV(TSMZI)Y<U
MJEA$W75[#\@WZ'-A%(F*`6K/OI]%<HS&7[`/51R?;(PZFR-/;>0]0KVU)1#J
M%GP41HN8T0B)C6@<#U'BL`M6(YU;2@-^M<!H_`L@TAO8BI`:(;*9/KNTL]@#
MR"]0X$_*$RPNH1'BB13C\APWP#33N1Z/H>V/QM?O]H096_`1^'#DI6^EEV$F
MAZO?*.)%,FWS?&[G<O&5]?5;;^WXR(6`5%";(;CT;JHFF(K:#$'%()X*:B-W
M<BQ7I;:#5%++OE*XS:Z(JJ@`J]6FL:O&>G24VJ5-74S6I*/4<=W49>*R.I*;
MW@W>12-K-V`IX\[4PVUU**;8LC=UHXX.;<6.GJF[>JK32H8K;^J)N14K)HK3
MF+H?J)PVL@-N2EN$VK`W3,'72S8/L5BJTF:B/=".:DC=U`U(%3>FG/46I<U+
M+6Y1>:$'@6QEP_8VE5-"[H*HJ4<(EU.)^([&O;!U!;4BFM"@=%2Q^8.):F*+
MTMG&>Z"NW#0G4\]!+J>3G.0UI8.1S6\E:6F(IIZ37$X365FDIAZ?7$X;8JG!
M2H<KF]]IQ)+!8^5(6+OF*J?"O0&QYLP[C4E+G]N-VPS^EPQCJ:U`L8KV(B*L
MK**=;6"Q8A0CPGHV(W+[W<4T(/"):XDLEAOQMB^RX+&HW5C==E1JR.^26U].
MG+MK46.YC6QOU,%'<AM:=HSP,V%^;;PO.3RB,K[F;Q5R$][K4&5ILGOMA(OE
M[GQ])/-+T[T'(E/*R`OE1K7<R<S"D(U1JX9-TY>L%-,3NF1GJU),S3`24T>5
M/=/4/",=FLH?J)6RC3J-&#`;O8&O!%$?33FE&X!(>!/7:*S?G-$C15N,FXK9
M-36+#.&+'ZVR<N'&/O-K//@\(3AXG=R@.?P/!(2N.54SZ4@7VM@DNRGI+\B?
M((^)RN73JI.LDAI51-6VQS9F2VHYJSUJL"65"FZ)FC::J';=Y)76$H7H;Q\9
MM-ME?XDH1<BF%V\`^V?N:U*BX`BS?TY!QO15MATF9F930^-UZ$S`PBL=-M?M
M7/%56>PQ5S!.C$GFV"FY2E*8#3L^8K)J/[UFY9PGL]K8OUV8DMY6R;$6U96I
M?V]T>LEAE$.&<A%24T2^0,F+W?)P&AUTA2AB\1I9CYX?S<ILE=5#=9TQUICJ
M&G^-$\XJL\.V20"=Q')SV5E'$+@]4T^1P#6<8+=;]O8=\:+'V.4@2:\*+J&>
M)X@X#X`U^=P+BF0D+@5?PVEV3"S6S<>0TK"SWD"E^BA"JH?(->M@>`'A)?3@
M&/DEB&0BU4.D7.<0Z1>-N$J%Y+!X11@;LU!00F:W,C;0(**$4B.GJ6<;2#6/
MHEFPI>?7QY;)3>"S_]\C#TV#Z6I#WE=F^?`L_RN^63P,CSQPDY1O@XA3!GF2
MG)KY5FF9#5MVU7#1;/1MEIDJ\C"`SZPI0\`#75)VH#QX73?#YTO$-X%'43P-
M?#?06T,8!T0CX1B]+82?6:D:JS@)WQK*;U@CX35X.^BJ^*V2R.T@JH%ATS<-
M21)/NUU>L`I-=53TJRC9HTWU9&K14F*@-]6OJ4-/"1/`U$/;:E%3;!J:>H2;
M?C4E/8;21[?5EK@<;19[A#9^]7@^2N@+7KRR\8,3X[D7GY_^72XM6:6,MB0=
M2\FN^T3^I"A<"??(A=3''KR'_@0[.[+*6&$JZ-KO)]G8T'CA.*%<4JY"-H;V
M^Q.VKD<7KX.FMPCEW>R>K4]3K=8\MBJ=HK1=6N<R=^)BS/C<KDLXQN'A9G/$
M5Q!N,%G^[AF\5[``7K;(%BV-*U/1?FO@ZBI;UM*9E,QX"9C]$ADR3.JEC`FY
MHCMO90:K,J7HOS915K0A^P?UD:U9`W$Q[5,!,VG#<>K68S8L#+=8;:+P9!Y_
ML1SX%.^JJU6L1J>5)BH`5]0V39W*S=/Y>D1LO=4P1./H>/)+Z+]!Z.W.?HQ1
ME'2QS`H,^,W;TUG@\\--;B`C"%Q^_7;`QH?%^A-^EKZ245&C1`W;''4PK6,Z
MXB4R2]FSD;M,(UVF(SB_!\I3B0!D+3/MCAP/O/_RH%FBMU=`+QVV&8I#Z`1V
M.*X-$3_"R'.J8)B*V@S!+YCW82[-B[LZ.#)L7Q70S,%6N`P^K82K\*J26V^]
MY^<>`CZ:B.['4,=NIK:BN71S<(M&3A\!MX)**RZB&>JKZEA%9]@+RP/W>-TL
M;3#7Q6\\O:<"+4B55E%C7I65/*J3R4%>Q4959>AFZI,]N&(2H4IFQ"18,W2X
MX<$O%[ACXKO5SH?9T,U073^.AO254>;GVF`5*$*UX+K4M"F6$N%MB!;XFMG$
M=OS"RFK,;.^\C,:R.[NIR2#E=9(<W<L?F-5>-2C/X*8F=I1O&E)VFJF)'>75
M5&S4FWH37\ENE>_DF7H17_D&D^.ZFWH)7WFEI(9ME&[A,V1"4@K4*5W#MQ?Z
MV(W+*EVZUU"BQ,X4RJW0ZDX%D()O3P*$F-CU)(FM99`.T&8AU)3=MBYV]6#9
M@4HQV(:JF\K:*;D"A"S&F+P!XM#51MQ2U(J@&Z"Z>A:-C5P6,H>\,X0[;8%+
M5X_*,I<IJ1UUKJ&NZZ<69X!C2JNCEP=;-\5R"P7E5@(T49(^A2L+H3[!$Y-G
MF6EL%Z81"I6<!B<-W0C5\HSJ[Q^2A[NE?U^WT`F-E95_&ZI1!TN4:$HJ_F:%
MF+HZ4$X!Z1>"R2P&M"'J4#"V%%(7.7W/L%V@956R$Y<S:Q$@=]#.&PNVCZDT
M+*JOS#M_:4,B?-^R\2#-I,W30YYO86KDOH0ZLCQ)4^/UY50A$T90"N$;KZ'<
M$).I0?P2*MD.*):.W9NG@FU+HE_A1HU/75[^"Z"0_?!?4$L#!!0````(`,F!
M:D2>)[R"55H``!;D!@`5`!P`9'9A>"TR,#$S,3(S,5]D968N>&UL550)``,9
M'1Y3&1T>4W5X"P`!!"4.```$.0$``.U]:W/C.)+@]XNX_U#;&W&Q&Q?5Y5>]
M.F9N0W[5.,9E>6U7]\Y\Z8`I2.(T16CX<)7FUQ]`4@0EOI`@0$`T-W:WJUQF
M(C,!)/*=?_JO'ROOS0L.0I?X?_[I^.>CG]Y@WR$SUU_\^:<X?(M"QW5_^J__
M][__UY_^[>W;-P\/EV\F3N2^X$LW=#P2Q@'^C\>O__GF?\X?;M_<NOX?SRC$
M;RZ)$Z^P'[UY^V891>M?WKW[_OW[SW/71[[C(N_G()C][)#5NS=OWVXA7P08
M112)-Y<HPF^2__GES<G1\=G;H].W1Q^?CC__<OKAEZ-//Y]].CW[</3A_QX=
M_7)T5`#P:TK$F\+__/+F^.>//Q_]?')6^+U[Y/R!%OC-S67A]ZX^?7I__O'X
M\NKSR>75^>G1Y:?WQQ].+CZ=GIR?'5U\.GE[='1T?'3R^?B,_?'X[.BXB#I9
M;P)WL8S>_(?SGPG.;QY^9O][27P?>Q[>O/D_;QZ)']+?7*V1O_GYS<3SWCRP
M3\(W#SC$P0N>_9Q!]+9,I#OCAW_^J<#`'\^!]S,)%N].CHY.WVU_\:?T-W_Y
M$;H[O_W]=/N[Q^_^Y^OMH[/$*_36]<.([@+_BH&I^N[X\^?/[Y)_S7^5+C^+
M\M\M8O/^7?J/]%=#]Y<P6>J6.,F."I#PIO8WV-_>;G_M+?O1V^.3MZ?'/_\(
M9S]1=KUY\R<4.`'Q\`.>OTG0_27:K/&??PK=U=IC9"8_6P9X7HO(%GL&_SV#
M_._(\WYZDP'^]G!3IMGUHW<S=_4N^YUWR0?O]"%$U\(^.]]O9WB.8B^"H5?Q
M>3_(DA5R?6E<LZ]UHIHL\7:%5\\X`.*Y^ZE&))<41.#$S_AMSAL8JI4`,H1%
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M8A02'\]NPC#&`0S?6B!*$<ZX<DVU?.3]#:/@RI\QS5P4U_KO=1P#NE*`O!LJ
M5W_\%0.O4>EC#0@^X(4;TE7\Z`ZMA'E8_:U2])X"Q$3;XV;U3#Q1O/8^4HK0
M]DE+#\X]#EPRNZ8_$[[4#0`T(LI.>`<T"Y]K03)E`_`*UWRL%,$)76"6\,%#
MPD_UWD=:./9$<8`R*OU&@_BXS.P@B-A(O_G]Q#*$%*-SBQ?(2^%/?KC"MZ_T
MF7H>N3A\0L\>3-CSC[0<ZH)Y0.T2?!/A%5A@5</(T>66SR1P=D!36W0+-C-+
M!;TJZ3?S@*Q$,,F6))5<)<$,!W_^Z9@:UD<_'QW]]&9-15M`3\&??Z(7)0XI
M2F3-`"*V;F*%_^(0/Z)&VY6'V:+4U,,+]@?^[QX)\>S//T5!C+4QHM*`WV=,
M];DC-4>>\^)#.R\TD57AEMHGJNZ&DVIAQZGZ:`-5.W)2BBA+2-KU=76YDKNO
M)2?N\Q"(VU--<NJ.![5U>QIA3N6)@%0]'"I+JGE.Y^GI\.C<L91R2L^.AT#I
MGL'*J1N$S*EV$^1$OA^$Z*GQU>14?AB$Z*GWFN6$?AR$[&EQ9>;4?AJ$_&EV
M-'-B!R2.2M[_G,K/`Y)'>R&8+8W'(N;EH=#8'!++23X>D%S:B5?F%)X(RZ(_
MO=L-`"N);C-QD;@@+H@?$L^=T;_.SI''DGD>EQA'.3&-L6UQ,"8BVP+8B3C&
MYBA\3HY*'+Y=(+1.O6/8B\+M3_;=9-F/?[]UT;/K)6Z4B3]+3OV2>/0$A%?_
MC.FFB[C+Q&$)>?GDB>F&O@&$'W!$;S*>7:'`I^(EG#CTZL8L3V1V20^>XPHE
M'D"@:2:HL.0T6M*W@JS6`5XR]]`+OO'I3<"W)`SO<#2=/Z$?$.K`H'63.INY
MJ1B\1^[LQK]`:S="0D'%5A":42\\<;\B+Q;RV==_JQG9>PH+4TUR)H=OY>>]
MRZ'),[-5'=!U;H+2PP%Q(_8N,4E.WR:FOV/?H9(=>E9JP6@FH?`82;YAVE%,
MQ%AAP3OB.ZG-!,&X"8IF`BZSJ_6`7[`?8SG\&X#T=T0NX'A7?=TOOR60KH.@
M7RT(8CSKQO`&(/K1)]2Z#^_1AH4:Y7"OA-#["9=YB)J@]$=`I4G1D9P6F+J/
M51B6S,^68Y1]T<?#E*[5X4TJ`]!N3=&-<QUJ(%R@<,DT#OH?MJ<OR&,ZB!PM
M$*B:"?Q"R.R[ZX%L#/Z-=CV=K'$0;>X]E&;H4Q:MF>Y'+3*8PMX$IY<K*2/@
M=S_4;Q.MJ<5X]6--S5],F52X<!+("X'KZ8U]P`ZF5XL^DG2_.[RTU7!T$_&"
M7(^M>4V"1RH>'C$5#=+Z3CLPW69@I<";1!<H"#;4E(,[#\0`]GG)932(&@"]
MH"V/+Q#1,4-6KXLH<_R70S-"KJ'RU]I=0OX+?99=*H]V76I?=\)08FZA%E"Z
M2?%0&$[GR9+BY[;^:^&D<WM0[N]\%]<6O9`"0/I"7SBGO>Y+4PG2+900(2[S
M3$<KLHNK<J;%#QQIN\.<6H.)*8VYU(J(M834^C0&`;%'`.\)3V0UEUY5*NT0
MT`2J+NE^98=(;NY!57:T"Z[F\H[3,TLOKWPAQ*F5Z56P`[QO@W#BK,R/:S&Z
M2H25C$&>=&WUYC7;P@1LNO,T;"OSX\!D"SAA>$ZVE<F[<)(;/6B<6JLU!V%J
MA7R?/!O]`(25R!;7D/?I`&15\V8VQ0YX2O8!R*8F,GE,AV=@'X#L:2()$F7C
M1!^`"&HBNB9,RG/,#T#:M(N98DJYU?)%3)$53Q_(R;:S?E(ZQZ*:&;4:\+&=
M196`')D*Y6@_D8<3:[5,`A-;EW&5TVMGN:4<O779<3FQ=E9=RA';N*MV5EVJ
MD%@-Z:8Y]7968:J@OBE9F)-_*"*LRW-5H-?."DT5]#8FX&_I/[&S>E,%_2+:
MV8F=E9PB)%1Z,\K5+CFEXA6=]E-:KD/*R;3;HPPCL[9$+*?6;O\RD%IHC5_.
M!;O=S3`NB-1QYH3;[73N*JZ+A+X&K:2F;CIG@KC_V5!-_CUBRN021Z[#:V$[
M%NA7PK2S6G\7U=ZJ>*6ZP(O!Z:\4.5T\:8DSZX3_%D3?J$_B:$EOY;\ZHE\$
MTQ\)].1.@^2`SQ)]ZAX'"3J2I-2#Z[5<O-/%:`5E@!3X]6B"8H``N4O2!JE7
M0E1<%5&(8ZI^":,Q57],U1_SWL>\]S[RWH]L3295GPENLBUZ_YG@1Y\&EPE^
M+'!67U4F^+%!SZBF3/!CJR^IV`$657TYT>;NJB:BRP8,+\@9W`[OFIQ6U&GH
M)+2R7>S1V<GA4RODWN&IT@/8WT;?',^:'M;>UMS7ST<#I++ZLGX6?G#ZB[+D
M/Z1:\)0J3DE?YPXMD)OA61-=J4%3KQ7\&V:CZO%L0HT)M,!W,3MWU/A@1Z9P
M8LY1Z#H3?W;I>G$$\V?*KJ#9_-]&G+?BO`.%K:`TDW*'(YXPD%=Q/9&"",B"
MK`EF$-+`H'OU3E^Z+^Z,7L8PQ3&_0#>K-;!M#`QNG_LIO5O]M,Z[HU(ME57^
M(ET[*R^#X-T&23,A-WZ$Z0,926!>^E0[JB]TM73D`6/1=GT8SG4PC!X8F6Y/
MHA!U$[:[//3:5GZN/7`2)HFR&:N`O:[WO]7=#FS%QNK\*U&(IG-Z7I&_8(Y/
MB:ZB+9!J"2GKF^PGOW_SB>/$:Q?/KI'#$ILV`"'2!D%WBTWLTW/GT8V<S%94
MVV67)7)?9`1X*RC][5`QM:!8,>4E?L$>22IA)0AI`=3SI901B?4PM.]!4F4"
MNH[\&^W-E9VLYOT1!R_T+V&V-`3;!B#]\/8Z(*LO;`Z@#).+'^N/RB=G3H;)
MY6][.K<REZW\[9C$4L+(6!*+NL#^P67;'$88]T3`S_JJPK@FJY8TA7%/!A`Q
M*(MY3I[5H9_:MXTT/;@\;FEU@%:$N`K=A\<IK8ZUBU#7H)#RWE56Q[(`>UC<
MNH\#$"KUAAJ/MEHM7%JM52)L5_-PI-42!T)QJTN$MW:R6@Z)T-SFR.)-D:P6
M1I#M;7,D<I(/?G?KW;Z\ZY/5UU9,'E=ZX7FO(ZNW49!"P6@)[P%D]74%AI,*
MC*B/@/&N0%9K&%U(WPM8\E8X5BL;\A2W!9=Y;QRK&2!VQ?<R`'C?FP$(:%B.
M!N]Y,P#)#4[#X7UP!K#QK?E5O!W.`/9:-E^.]X<1?K7-I'3N=+HIYDITR^RL
M!6ME@F<96^WM#_;;"_'60I#H7`.8/M*'6MLDB=,B!L\@4=<DH++`3UM6.ING
M`/DA?=N8P/)GR=^\Q/Z<S/X1I^JL:C9TP<`0X[[Y`48>*UOX"WT1J:#\0L4R
MHV7J\X$&D\`-Z3]=TK_Z"_JLN&2FDG7=<;#@*J4HT9]36D)\B=/_2F?I=5QM
M2"FW8_A_#/^/X?_C(Y&9!J\J_']LT-^FJXK;\IZ-'9PJ1[9WTQ7V"7=\FSE#
MK.Y;J5#I$6!@=QW0AE&.UK&UJU7"LS^LOKS],[6"1>\M;[<L6`9=[[#@23(6
M]IHM>HNJ&N6J\)G5P[72:5:!KN;"HUR"A$^DIC]Y@E3:0H#]?]8@-XF40Y3Y
M;NMHMU/RA8L/5=(,@\\R2[MQ?4?![$L`M*$E%QB22V#TBL+O'0N(/-,7;\:P
MI:@F;_X#IG(A=".<942F1^D!.V212JYL@H+BN]D)%VC1X?;Z)U&$;?R/JCZ_
MH2#)<4W[?0CY9R#@5*,IO!,0:)H/YB5^CM+.>\Q6SGKP48'L4RD5LS.R16<:
M3!/-(6LN<PPY<1T6,?@4)/^6X7/U`P>.&\+::$@`AQY)D;M\P^XF\K99;@\X
MF49!?SU:318!QIG?2>S4JEO03&,-<5$B",A`/^`<![F`IQ!`Z$$\QWXRW@1Y
M_*)?8Q3%`15P]+EP<7A>V^%3^/1U7*4'6<IE6@&/!K2A8A0.WXP$3:\'1X>]
M<CF^W%^D0)P*KV3P*>F##Z(+F3P/=_A[\D_J]KT`T>#^JJ1K'Z#)_=)I#;>N
M8%+UR[+R=LT?I7Z`QB5,[OG5:NV1#4XUU/LX<)84R7L/[3<8[+#I34L8W/5:
MM%3M><,"2FS1;VOB;XT)UG(QL2Y^I3>,HC&=[UVU;U1+9]4O^;]?H<#;Y+9(
M]K4*TULC6K:R38$K0!]6NJ]8E[E-_4]J:@L9"%SWO:_'G*D21N/<GQ:$]^>&
MPL?]U$'0[=EN'_L*IP4`5+OCOM+%)4%2,Z!>O6%P[,T,D.*/H<STJ]+'NALP
M)^*?'57B4]D!'WE5">#WDP-%O#\9O[=\*#VRJQK0X:7W6I<E*LAIRT9WX3F*
MO:B%UL;#1P0NMQ5#O&#SRCK1;`G%[?E8S6*Q>C*%3;/*5)+8,I'MV.KF`L)4
MMNAH!S+)2YQ<<2W[0.9Y"9->9RR!.CD>6'6*2./"5U6=<F(P8UI7<\H!M/RH
M<JD-:L1>T_BJ]P=,GPE?-N^@.#(.%CKA[?H.F',=HVZ\J=UP>=`><LVY<,C"
MIW/,G7=*&RX76G,N!M4[3##!AC?6LMJ*5;#Q542?6MT2L?M&"V3$Y;P80D_,
MKEF2.3,^#$`,RF7,YBRPNX.D@$[9,5]ZRXC3HP%(1L'$]YQFNUL[=^HPN6\"
MG!YRFT'%92DY3P:O#%=7(.7T#V$&?(?"LYP/GP]8]D$*#;<$GYELVM,+P?OB
M[^SL@"GFL2O=5;TYN^SNHJZN35"!Y,\#(+FFZ]-[NT-ZW1\Z`7?'9[N[XRN4
M`+4]-S)6G!Q_%CX.AKHMHW!Y[9'OJKHL[X.SLE$,QU)O,MI7%/R!([3C$^"-
MO[8=OR!):J(0H94<C_%ZG8:GD7?IAFL2(F\Z%Q^@+0!$=WIKMJ=WQ'?H'],9
M'E1T44WEVO7IU61_=B)JM#&>4?18U)U:[E)#E#NOI3L+LK`36V1O_#D)5FGG
M,PF:A4'VL,^4S^P_+)S]@KPD9RZZH.KHAO(=W,!%$*`1LJI[N'6GK@ZN[M3H
M^1P[5!N\^N$LD;_`#U0D3_UJ%"%$PN#J;PS%EKP/"/,/S<XWWT)F(U<(!@B)
M$*C:BVO6:).]I'<DPN$]VD"3K>MA:"_=(`[&LY"-_$RCM]!:W#H(?2/>I9>.
M`+`>R>$>AJU/09:6*DA&"-EU%5,IE/X`TW\4[M'2=04CA!=\1-UIW`%FC=B6
MT9YDH)LAF"NS*M^I2JBZ#VCVPE#SW:'O?X`I4FL<1!LFL",VJ9+^="W:KTL&
M:I]/`M5NZ.)?6332C3;4[-J.`;LF`?M'N>XXTDOTO;=5AG&G;:T&:,V=5"B$
M&J&;(3@?MJI4"%5"U4S@OHUUXU]F[W8^BUV<+@%@O9.3N/YSSMZZZ)D-=P9N
M&`AL[R1.'(?$S&J&VSD"P,!-5TH@N4L^,WD3YJ5^-RJ:)2^3PL7,',IT`$`D
M[L2$P3-V#!^P@]T7=2>Q"*__G=J>ERRD(O.N0:#VT:VGE!,-\K/60-",^'D<
MNCX.PZL?;I3$L$`MB:N^[J.Q>>Z`WQG9+(YW`Q#=G5!6)(C<?R6;.YWG=B!\
M-$`C'/W=:@*<>/]WL&`!CT2RI%Z)E1NO0CY3'4:>Y`J:"2\,ZZ%V#W/&%&Q`
M*;-2%&*OQ_+&CY"_8#F>\$>T#9+V[L'K`#MN&IOR9T5L(%0T@NESR@%+(*(W
MV\,[>2=/1-#.D7E6]:P_CN6`6:@*#?WN^S*VV3NPWD4'UP_P,)H_G`KT.GA5
MS1].K6@QI;3YP^D`QMO)/`2<`<)3[TPPH,,+*C"[]<SJ4:5J:->CWQW(>$BM
MRC41-"`D!DP.F5=M)B/O3F+U[>R+7:(N@YQMG\8;V<&EE+/Q\WA96QV/O!W.
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M=[6T^DP(=O0%=8K)>_G9K6QU(;W4`HCW]+3Z>13,;13MYY13;;D3!]CR:F_[
MN[7SXKU/K;X-RGJD$:&.;SE7[/;TJ.3*%J9HGS[>!598P]32)Y)3-0T6R-^K
ME&GL"=G\J8G^CS48::Y'+"S%^TZF67_4Z@S9'=G)E6'M0[<M*3G&3Y0!YQZP
M>X[ZM<=JD!)&8S7(6`U270UR)/"\O:IJ$&MG;\M7@]@=XA;LTJ[\F>#L$;;]
M-:LOC_%JA8+-=/[H+GQW[CHL@)2F<K`^YI1DI]#_1%"Q@0$UJ_((XJKY26A:
M6TK%$84X*BZCXC(J+J/B,BHN`U)<1(6_?>K(-7*#Q'O\%2/V]YT&.(+:1R,,
ML\I&-6IZI7:^)D=#3J5H`31J$J,F,6H2HR8Q:A(#TB1:9+Y]"@0+3NW'I5D.
M<7VW:T&M`@[8K*H!P%?_I!XQ1*2T$BGPHZXRZBJCKC+J*J.N,B!=1>HEL$^#
MV=;R5`U<$=15FD"8U4HJ,=,^]:6Z-JIC$@D,[JAQC!K'J'&,&L>H<0Q(XX`]
M`?:I&G7]Z@75C.9V]Z94C!)6ND>T["[74:L0`C<J$Z,R,2H3HS(Q*A,#4B:$
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M+1*8ZU9H"BA-6-OI!5:0N@H".ZHRHRHSJC*C*C.J,H-290`O@'UZS!V.6#_8
M>QPDPSV!*DK-UV:UCWVD]`KJ*Q3X5'G-EY-2(QJ`C$K#J#2,2L.H-(Q*PX"4
MA@9Y;Y^*L#O*JC#HBYKQ?((32&^`@#1=9BN`J6ZI3I=;$H^>BY#5144;-A^H
MH^,"`'340$8-9-1`1@UDU$`&I($`Y+]]&DF*<#(ED#[#"2GGB-X5^CROZ8[+
M3)"!@#2KD0AAJE?*%\;<S(O+/F"/GCV*21B%B5Z;();/6);14SHO-6HOH_8R
M:B^C]C)J+P/27CJ_"A;J-%2;(!N,S[%/EXG8^PY58>HA&-98*A#3W*DLO3G;
MDJE[>AX"'+EIF_@,C:Z)K/)KC"K)J)*,*LFHDHPJR8!4$OGGP#Y=Y,:GOX:?
MT`]P24W%EZ9[F'&$=+<ORU;JW+>L"<ZH.XRZPZ@[C+K#J#L,2'=H%OGVZ0>/
MV,-.A&?_':,@PH&WR:?V7J((`54&,6"&>WPTXZA7C)<7O?'G)%@E'B\I%4,4
MXJALC,K&J&R,RL:H;`Q(V1`5_A:J'?%SB/\94P*O7C`\Z;3N<\.JQ3Y6FL7T
MWG)RR:/U0$:585091I5A5!E&E6%`*D.#O+=12UBM4+"9SA_=A>_.70<ES<99
M<U777]P3SV5M1K;_!>L0,L!-:Q@@G/7*_#O\O;!V0!&.?2?M`))@L$G_OY1:
M`H>M^8'+_7H=B*J'H?MUSO.GBAE6T^0R3_P9Q8LRUGW!229RBASH^98!KYGD
M;:L:NGZA6\W5#X8>AI,H!$X[251BQU2R.F212IL.9U$`F&9ROA`R^^YZ7G)"
M=J=\;/\)OD\`H)K)JQV#UF'3Q&%J)NZ")'<Z2#,UW?"/BP#/W(C]"4)/(QCM
M`OT%AU''#6D`HAG]:Q)@J@.DS>+IP@$5K<AA?&2E),E?O82M80?R.BRBF?QO
M(9[.K\+(75&E%V1K[G^I&=%;E][1&;,FNJ62-,/13`1]V]UP.M_3-+OH=Z(0
M1Q_4Z(,:?5"C#VKT00W(!R4J_"4<4O82W?R`YZ0>#V!_]U6LG+@3`0%E.W$=
M=.*<#Z>GA\^'!M,GI_/L^/#I;+11.:4#D%#BWH6<[/<#D%8`EU%.]X<!"#(!
M#V!.[\<!""PA%VY.\:<!B"XIOSSGP`!$6GW$)2?S\P!$&#Q:MB7_6,1F["76
M>XW<X%?DQ?@K1NSO:9D_L_>@@5T!2&:CN$T(:G:1.$L\BSVJGN<XI"]=,L8A
M'T::X36;^O1UH(HN/56)S9;@*)=FIG;AT2TXN@5'M^#H%AS=@@-R"RI^(^Q+
M9[M`X9+]'S.L7Y"'TY%97U'P!XX8\H^,GH1&*;U'%KQ990B,M=[78O*"7(\M
M=$V"1[2SO(S>(P1.]P.8WZMJ7C\N21`]X6#%77I*-#WYU4;U;E3O1O5N5.]&
M]6Z0ZIW\PS"HB+"0;B`1&-8^0R0-$Q4C1%+Z:CL@T_-":O$SE#JL-FEX5+A&
MA6M4N$:%:U2XAJEPB0A^"YUD26(5JVJD=Z+H]Y/SB8E!,^P":T&R+_=0#0(=
MW4#M4$?M8]0^1NUCU#Y&[6-`V@?D`;!0"R&KE9OZH*CF=$&2S"KL.])ZB"@\
MPYI(*YJ]Y2?%$<7G*R5[%:\>*$+(V\Y^N2;!E,H4Q'"[Q2A4HZ9T6G#48$8-
M9M1@1@UFU&`&J<%T>AML5&X\*E4(0_H%5Y=%3!8![I""W6$%TPH0'/&ZYZ+,
M)?:3W^]0NMDW?DBO3ASA<#K_"T9>M/RZ<V0;'U@Q0+4O60UJDS`*T-^QCQT$
MQ*7BR]Z[(7V-O<BEI^82>W3S`K8YDR!`5('MF-+4>:G#U2A$#\[V3OSF1LLO
MX1_0TU/S^:A6#U&M/C3MS&#MHR[MS,KRU=I+2EK$A`U:IRYCB1)U4,:2QO)D
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MXWQ3O?G;?:>4X1DK)/NQQHS`)\)^-(VC,$+^C)K5^KBJ$\O10!H-I-%`&@VD
MT4`:IH'4^X,RJ"XURO6=08TZ4:TW#VI4BB$CS;X<DKP-O63U8.WW9MT59;3Z
M,F4NL]@/7;NJ1:P*.P2X1&]6W-5\CIEDY=Q_H'>1I<GY#L6-^XBZYLU(K-,;
M$U*<SO&<%$XAU6/H6Y2$<[,A32KX(+G4:%2.1N5H5(Y&Y6A4#M*HE'P5!FH9
MRN@*`S4#@6JCA+VGV59YQ%[BY?CO&`41#KS-M>LCNHW(NT01DC)?("#-6C1"
MF/:EY):1N/&IO%DI4_%!"XP*[:C0C@KMJ-"."NT@%5K06V!?"MECO%JA8#.=
M/U*MVYV[#DKZJ1;GRU/M:S*;N=L*Q)RX2QPAUX.J-*K6,ZSO="8#V"CBGHH9
M>BC1@AZY6^(O;JG1,$L59:%7MQ4&M'-%$5A6<LQJ1#B#0>CL0=#\S-[%[/Y/
MYWD#HL?T[0"]M@U`0#I6<FB"38I]]I=]Q+,?__[M403#XF_K5EA2FK]@L@C0
M>DGO@2>NG+8"^?WDP`GH3V$LKBVJB@L`@4J%!^QX*`P3B9@\VK-_Q-E(FFOZ
MS%(1&:]BCRXWFT9+'+#`9("73,W8^D"$Q8>*I33OSC<_2+LP_"OQ:YQCG[Y/
M4<B':V/Z-##O1C)4G&H1.-PV,X?L7Z=ES+!``7GPP[F5V`]X30(FL9.<"^$#
M5_<Y%(V]"4Y?4<2F%VWH<^@2\=>S!8KF;?V*?K"6?N+MJFH^U-WKC"5&P)$L
M?-;#$]0=R7Y0A#XKA8\THY<%#=)Q$,[F*4!^B!SV*'RACS!KT_&`D<?D!P1_
M"%3-!`H\9@R?*HR]O<?Q#D?3.16C$$YH61ZL6BRQZY^[),+.\LOJ&=KTL>YS
MS3MW'H>NC\-PXE!9'::.#/;'`&.XGMD*K`=IU2]!1L@!RKE:$)I1%Y\&":$&
M`G4,;70(;=2(N6FP0%35S7(U_9!X[BR5H?[LGFKNS&.2YG?F#L?<?@NY@THX
MTJ%A44,D@V(FFA;N*]RBEV]$R[$8;I!'W\4=XT.VQ(>TWSB9!]B&M"BSMZ-5
M";.BFRF_*7B.8B^J#CVVZ:(MY)8L`4ZZK4)"!^66T-T>:1:WI$B+#<L)_F0C
MP;V)3BU^"IYI:.5IZHVY$'=8SK,S<T+7CG>IX`3-F?+!BL;X32]1V=^[3Q+W
MCG.R#%9>"KTRHE190E/["U(5.2"UL19.U.M4L$7"9CF//AJ\HZ9Y5!?HS)GS
MZ74RIS4@G3/H\\@@Z80$SL17+*94)+=L&7ELT*%BAQ+6D."4,^GXQ`;MI4DI
M:\_U*I+<E%/'B;;")]*@LJFAV1**!9+/6[,1R6YZ)Z?K=1NG#<FX.8M.K-SZ
M?MZ3AESKG#^GK_,(M:?&YQQZ+_Q&:*[:N$9NP+HBX;^X]+P'SG)S38*<]*KZ
MV:\8L0]GDRC_=NI3+2,.`GI;V#2'4*J>HP=,S%9ZZ"10<])8@EN.`R<IQP64
M`R8`;<P'49\/DG.\Z:CMGZ^RH&M+A>BZC.X,SRUZ-_XZCL);-E7Z%)XSVPC&
M``DG:D@X,4C"L1H2COLF(3O3J4E=DO'P5$80X![R-.T@M#\RSS=E')*3!4WG
M%(4(%>1?8]]UW#753)D,S>0J*(6Y`8+N*I['IR#9[8T,\B)0M!/PA;S@P$_Z
M92ZPSZIS+_%SU(T<49BZBW&(CS=?4?`'CJYC?R9!2AT$S8CS7*8GBN0%-=@6
MU*Y*S3PX$>W0>A"[?9/4,T%085KUM8F'+]=;.V@KC?`,$'4=X'_&+!5#S1N^
M!\Z0BJ*7J#[5D2HL.N@B]>!ZL2AA]01=EC`:B5+`&P+</I[#:T4PIBD"!3G=
M56QHEC;VY[3KYX,E7&B/5$%D=PL+RH\IYX&Y?%83\J)*6[(AQ5]0/#2HBK5$
MUJGI/*7YV`:R&X2!*JHMH;G]Z@-,'-)N8G*BK<R9ZD:TN(N`L\'JC%-9-M0[
M?GAZ_8`.?9N[CA-M[M`;5H@;?:N</X>D$XLXH-MTH::(@165*%`%62=3+&&)
MG+;<'HRI8DM5R(PSP<KR+ZU,."DQX?3HU3'AM,P$<]FLU;T*%*4Q$`7/$F>2
MP.-R>'T(U+S8S5T'3FTM]9+O.F!Q]J.ZNP-)YN*<$7Y5^NI57=TB(34NV4'F
M"O?D!;D>^Q$;G$A_LUO/:E7K6M*[NC,YFO,7]Q;EZ(#R%AN@0",G];"^!"0,
M6=E36@'-JJ$+-3HW/K`9E\K5M!')RK[[([)Y-=W]%VNQG*Q8B>2_V(S5,%)S
M+O=`CDFU)8PZ)]6*2[[R,RK2F!<,>[CY6X/,AAN3R>Q+)F-W#HYL\:LQ-6S@
MJ6'YFSLG0;CSYL+YWPZKA_-.'Y;]AA92-Z`>CNY\J5*Y7OXH_N9&RTMW/L>L
MW1`.;_RT'06>4?THID+2G^7]*;8]B2XQM7<HQ/R70HDLLEXPZB.[[I6RM@>Q
ME\]R.M_4TP27AP"P^A1>6*(?&*Y1UZ@L%XCD+EG1TE0T=P=^J(D)J6E9/E1C
M8M`!L-02A@H$SOI]SHBH@G0@25OFV->N*',6VM[%6,D#TI#C*1YJ&4ZRXYG5
M\7JYA+>B5X$3:K##E+&L3H,-8&W*ZCRS,KJL.;GQ_2#W7B"5]8,YD5:=?=,E
MWD%DWS[.#@'!=WAY-AUT@>;D&CO:0RM-KOE@I210<37`X5S.$RN?!&7B0E%@
MGW>G&^P14IGLD;/KDY7*9C\WCK/A1#P9N*_<M1UQ0.F^"B-WQ7:2-XN;Z\]D
MTX.%)7EMBHDSE5JT:U*HR2W:AVDL;XHADC7?9YR?1SB8^OAI&9!XL;QV7_#?
M,`IXAJHZZD&+6L(>YJ%S?8HJPT\K3^I6LH01/!/Z.8P"Y"C*N&M=Q!+R-20;
M-BY@"]DU%U4_.\06MH1-.W=7.V^:5K.$(;MZ@$:)4;/0F+E;PD@\<U?-47ET
MEG@6>U3AJ]]+X8P'":`6D%<VHA21>%N1OJS9F=F-;B*UA:`DCH-R8\I?DO:Q
MQ+8&,CN,);8Z/:+SC>CXUAU(&H0:U4&";4WJTH'T?C'&.T$UW(8T$JO96,,N
M@SUH;!)L%6:_%?7NZDY4O?>DJT`K>(HXSP9Q"Y7R3,#CR#-&K+Z5/;*O*JYS
M=":<4*TYK@.HH9_-W!2U0F*P5!1'Z9IF8S9J2-%<$5F!S4,A>,TBLA#;6@S>
MZ#P:G4?FR1N=1ZJ<1P(:Y.@\,M_Y6I?SR,I9ULINA-B3)N%*TZV]D=6:^/1R
M3>?W`:$GGFZJ/V/*R)I=.3GM#`+3L/8EA*K>5VB[\+V'DEJC?/4[#(K5-</1
M'9'D"7F7>!U@Q\W44[JMR3WV9YGW)?EY+:Z@X*2R-34SIW;E9'2]DCW.(&DF
MY!:C$"^)-[M9K0/RDO;N3-(S(40T0='=$B`.J%RA%Y_R[MK]P?X$Q[\!B*F#
M!*:A#9+N'CO(6=+G--AT(J()BJF=^!;B>>S=NG.0320$;C2(C1O$M?LD92:*
M0--^$7^XJW@ET>-J]T/=:%)U4`[-W0\UH_F`_`6&([GS61\H0CNS%#XRH6'`
M.=H(QH".(3%TL0&*[KY:U"B*(QSDXDBBI58="&C;GEOT3`*VT`;8'+'\(;A!
M(_+C.7)8(,=?2/!"`(BIUXK5^\*[5PF`ZZ&K5_]$F2/I?"/35U`(7&^N]7H&
MRP<.VF#:XQ(6I)X`=^^`1F9"#K<(&W:%C?TN<_U\L(0+[5YVB.@F0@^H%>FV
M>@@O*S`\O<_JAD%`8EM51DZVE17='<ENTO,YY5:6_G>DO-%&XZ2;DVB]//<%
MTYK3;$6SS(:WK.Q$V*?(ILYV`D>XRG%#:KU(!S*QLXVH70^>#=G0M1DK`+]K
M99I*V[WDQ`\_2T5<1C4GJ5@[@U,^2>7$ZB05N4L@%%KB'+!:3,MQH"E,F!/^
M^3!U:KFM+Q%_F-93(_$-4?J\1]2!ZM6-=#=E5^2$GQRF*25WVK/<&-Y(;8!7
M75TN5,XFNSNV*CXC28Y<3KIXWU;-Z9E528GJRF@DH9M-V80BK3?.4;QL>W<,
M$MIH!#/F_90P,E<(8S2<-;BDIJ&Y#UY!D8LJ]X&U`;NAUKC(78+&E\F^>I8;
M/T+^PJ4G,1L5KTQ9DH!L5E&"(*RY.*1P:*;S?;P@CTL;)/T3!=T(W[HOK.WT
MSMIR:=]B\$;]S[C^5[]1<@7"8O!TYWG&8416.'C`7G*APJ6[EAF?V@2F4])E
MEUS+_L:WUFWD5_0/$EQX*`SOT$HB,Q$(NI^!JI80:Y+4\PW'")J:"0+;FTW;
M@%4'J[8=JCU&C3`'B.1>'E#"ILS1%V-+G=BRWR8TPQM+.",T6U/J8:A,\CRP
MW,X.M`MI4#9D?=8ZUD!Z<:5KK5WR@O(_#]RY!GF'FMUKQ\.;H69WM%[V*HCY
M`&S(A]7(A#:_#N^I:<LXJT+GF'0F=#1Q'"I-9K<N>G:]K'ECM^XY@H"M::'3
MAJ_V%C1[RV;X@!R,]4`TFV-)EHH2&MH@07TR&:BGI1O,[E$0;1YPB*E08#/A
M+_$+]D@21KCZL:9B'X1Q)_#Z.QHQM.X#,L=AF(B6:]SE3-5"ZH>0*RH>R`;C
M<^Q3T1!U(*064C^$E(^TU&2;=F"CW[V#W[U9EA38+NQA:OZ^.R(@1WX[C+Y,
M,6%J2!L+0='<@S*TA(Y>NTEE,&]4ETEE90$3Y$@#Y+D5MK%`9WGA9ZY,?NW3
M?"`E:UUHK]6O#J2X!41[)\V96]-6)RQ)'88VXX</4+![HDF'B]!(]GMAV:=[
M'OAFM5X2?W-)/UJ1&]]1EZHE`]JL$P6$L5XKZSP.Z3L;AA=D]>SZR;H75,ES
M_04]2/1/H4M/$DIYDIZS#<3ND@*O.]B_G=%RXZ_C*+QEHO-4HF5;$YB^2/B*
M$3M02=57_L._N)2G]%T`V)^2@/LB\WQ3QB%A.#@C0Q"B]CZ<WIJ)==?!K%5\
M?B6<#1,2)/:C!Q2!$C%$(>I.,F/AS^G\-Q0$R(^FP8.[6$93>CTBY,\H0J!,
MLU984"_``W883'?N.EGL(0->M!()RY06DW(20'4[S6;_B,,HN;5/A+\J]\B=
MW?@7:.U&R,O0NPG#F#]H0DXT.'#=_4,YB_GDK1Q+"&UMD#03<D?UA'7R$OH+
MJ@^0%<[4>`@-#4"@-V7O"$/;<=9];D+ZP!_!!C`]I%WJ)\(,"="GN@&([E3)
MB#A_I!+L,LE1NL?4?)H]+E&`PSO\/?DGV(0H08BZNT'C-=HD\GLZOR,1#N_1
M!IKQ60^C7[5=5E%J!*.[]#+C''T]':H/!'AK'DF,I6B'!97Y6P`)O-!ML-7H
MZ77HS]!"/)(C!USW18^?23!C=BF>G9,@(-\I/I<QO@2>J68XFHE@,T-O_#`*
M8G8>KI&#)RMVHB$$U,,P*6H+9T6=M-T%VD>6QP59K5RP0EKZU,2;??6#7D8W
MQ/<!M2OS?PRS?^W^G+?"E]1;PPPP>YC2S8>JKE40H,@D1Y!3]43NX\!9HA"G
M)W$Z9]M+_.2X"N,'`SK.$T$UK1%%5)UQ4$>^7ZZ?Q`]N_`C34Q9-O_LX8(GK
M_+4^W]PC:(H1"*QF$E,/S5<<+<GLQG_!F:<#0DXMB#&WJ(11WS6]%0IHNEW;
MLQ>F&L,T8/]E8K^<@``(>$@M`WU@=N-(?R$><XN&MYX#=->TPNF&V(W?#:'"
M][W+`(SE*ER;(?7@1NJ+E!X+5ZO%:QUZT,>TVSJ],:%"P(3GFUIQLR]M.E3X
MJEG9GNHKI9RLK':3.4@'5#JLY&82B,RTHD!6J'2X7]Y8PIGV1"?!5XFTZ0$'
M4BW<B=P*/<R&X2BUU<$J-.Q*,:I&4(,*2P\JWUW_T]:2*6\PMU)7IKS54E3Q
M3:MU6W!V6"UE%;,#Y)3BV>;F)+(%`J+"(\G3S@W6(.B:;W1J=4V)Y"B@4ZMS
MY!7=<HD@"B\BL+J:1B6#&J)@G!M6EY,H?A3DPI<2=1@#X%4I=,W98'5)EFH#
M1CP-(6?0I]?$H/JL$SZJZ#4\26)I1/FXDJ-7\PK))8UQ1KVF!ZH]'Y#/P7I-
MCU%COB>?D/6:Y$Q]"B\?FO4:9`PT.YO/RC+''8ML_88$?3Y:RZ#C2"R(U5ZK
MT$9R.3QU_,'6WB&JJ;:$YG:1(5)50UJJESBI5L]35"P=&ZK*<H9\?$V:5ENI
M8,Z53Z])SY(H#N6,>@U6KT2Q<,Z@5V4&M]=];_ER\BI,8>ZV%ROQS[ECT,ZS
M2$T5;?G`V6:%SMHTE@#6%J.*%V+M/7*6G%BMV\EU0ZGW$>RV<N%,>$U:WQ8<
MJ'%/SJHS859I;CMU';-)\%_I`JMXM761??,IFE2MO4"^@[TDML7ZD;/7>+K5
M=).YZG(MO96N:;91E1I2--=8[JY9B?)E#,IY%@:INWQ4#(^G);W@:![!JMLD
M@-M![HU_[;[@OV$4@/+[9:!;0S")`XT$<^BV$/Q$5]6XQ47PUI#\G6@D.`=N
M![DR<PZ`D,>:RQ)&?==<<N-N=_-FG:<--L'K]83/.HR%;8/4=P*_(&65.?I-
M&P+J/W[@F?<"![T]G]Z@H:DKG]YJ5SC\X$,?(RMJ)0PRHJB!<%Y8[?;7R8N"
M^LD+"%[G%=DQ/S@SK`XHZF0&-SZM**`PR(RBY^%`:A2T\:+(`6&IJ7\F8I;A
M'4[\&0]'N3A4U]R_VR+&9R7*X*ZY93+Q%T\X6&TK7CB2\+:![;"@C6,N<1R%
M5)D^1_X?C]B)@R0B#NP>TPQ$LWEXXSL!N\J7./WOC9^AL+G$:Q*ZL(Y2(M"@
M/"X$CH&]\2J^U-V5$(5+]G\LE/6"O.PJ/2Y)$+&#)]FG"P)5=P=S@GRV>"K^
M'["#*4;46KS$H1.XB4"'W4@!<+J]/MD)976S,XK+O8=G"_887A#/0_0Y1UX>
M<`5Y?T!P=;?RW2[.7OA'O$;T%<?>YH'>RB#",RYVLE],@F:W.*)H3N<7`:;B
M_QHY6<;/)))BB#X<QK:1*"T$ET1S]\.QNZ6V[I;M3]P$J#Q4?=IA^7/YY<][
MVIR]9+([Q$P0>)NX!C`]M+O33T3/)%"1?)ZMS\K1^:$$WB((5/`Y1YY+K1??
M1=!37OI0>Y/T.0[HB_?`LI>2EP_"PZJO^XVC/O#!CG>X2]AT'U!/75>O?KC1
M!0FC\!B">]77T#.:D$TI=M-LM:_TS+.!F<S')GQ<&V&,<6;C<>:2C"N[W&0D
MY6U%*%:$JTDN=K!)\<_^LH]Z]N/?OUR(H%C\;1`J8;0.&!['R9\8$L<%)-C/
M?K^8B&"0_ZIVXS&)\W[!9!&@]=)UD`=_Q1N`:)]G04VP_;7!G6CK@?1]D<`I
M&G403$?H6R@C0MRWK#=K4_O1UG-(A*[+@;05;9<:I"#"#J1YJ!!1Q9>!!];-
ME6O4)A<)O-&D_;J"<F0.,I6H75"U)`\93"/0E3QD4-JV7U.Q@]UN1QQ([U'8
M/:ZRX`XDE@\CM,7,YDWS!D1SE5N$MWJS.H-'Z&VM<57E)'X\@):OXGHOQ%'(
M66#%:]/4WT7"JUK+E))3F_/!UA;8VME@"1.@LJTZ0D`:HC"<3*LEFR29DS*9
MYK)S-4BWJL;4GVP?(B+1F/J3U29M6V/JW;@Y[P)J=?L!R6[;GP=@U>C/1.'-
M/*T^`S!VP3*9>-].J^\VU,$CD*C&VU$.B')(\B'OHS@`GT!="BGO(C<`(B&)
MN[R]UP$1WJQ1-J=>\Q9+5E=^02596Q(\;XLC;#EH+]V@[\PS81ZK%PHQQ)0[
MRTO6]HBL$\RI8'8=YKV:+`*<-E126=.A9773Q1YJB=(;Z)TX2>"H\/">NQ[5
M0JY)L#W/[`:P=G/A-+@/F)L,EDTANX),KB4#P@""LBSY1]`E;\+P"3M+GWAD
ML0%FOE5^"T7@+_$*^?=H31E*I=FO;A!#2V0:(("1H>I^1(]Q>"Z%2/774"0>
M_W#]21P1=[6*J:SVYQY:I=<).GFZ%1`4M8<EILRF$&>3(%JR!Q'*HP8(4&0X
M:51R,;T$B$KM]YH34[XD@W6X+(%(HO*W4*[=H:V4#NE9C2,V(>HO&'G1$LB^
M=D#@@CEW/L>LQ\`373L97)4_0U1?RE\:0$8A&&IC=K>]:&M#6CA3$@Q33C0[
MU^YS0$V.I`C5#8(E^[.4F&Z$I+N$)%.IZ-(%K2J+L5[]<+R8]0;.9I_,;GRJ
M43A)_\H0E"[=:1GI.I'=CIJR)2/54'17:%:OSHXS/'&S%5@/E23]$F2*G/,-
MPP&:F2H`#*R1T/LU8W<,JHGL?P?6R[*;OBMQRU8:L$8:"A;,KY!:+G_'/G:@
M13<57_96=?."?5AM:^E3S:C>X>^9Q<KF_P34Q(]])]FH:7"Q9!&>&[_X"Z[O
MN&MOV^`IW4SN#`@SM*G221:^^R\\@S=7Z`LC^+TI`F*G&WQ#Z@",];RI"K+/
MGZ^NA\.(^#B=T5W:2IB"`X?>KYC8>L5`+U,]#.CYIKH>2D+S0/%:^JZ?2AGI
MZIC>%"HUB/97NK/-6<V6%[;G!`%)&`GI67[Z3N"60>E3^/(%OW:NO0`-\R8@
M,NX#[4BI0@GD"V@"`47GGD3T6Q=YN73/NHF)*R)B<,96(74Y0*^\!\==S,B:
MSJGJ^@_LB#5HJOEP++$N8=1WB37=C%GL1(4XY:U,C74C&.@)^^*A'^1QY4;+
MO])?AH8R:K[6S,<)&VJVP-NF@'?$1_PG3_1/(9OP1157N#`!@NY!\[.'6.VD
M,@?8=%[`"BII:P#TUJ&_?#,[M.>O!68Z85R<7M*Z-995@S<5P32?3M))AEA1
M(BZ43J^+"Y;PH#VQ358>D^8GTX9Z^MJZ<Q'%I7*B1:V``)79'V0-.DA*MI2C
M&^Q=KJL<W>HYD(+GO<;2LJ'F7N]C7E4(=F+[RR51"'9B=<F$9,W4J=5%0)"K
MU^I7XS2;.YR:'HPV7R?O(6!M=;FHR[>9W(I"\O>V%I*KI-@2>NMOM'B0@32$
M6FSHA:'W,6T)=5E1,B]F(8M%_\I-TZIZ01@L;H(UAY.BU1)*A7N\U%S84KB>
ME]!;/6X):,_6YT5P>JWN9P&D5R:]A9?D6SV"3:YYPK'=M980G;D^<2PG]L1*
M=4+R+/>5`<C+[(<D"4H9I#F9'ZRV(KLZ:2O2?'F%_1`V6"K-.F?!)ZME?.?-
MW\^*YST&ANK0$ZA)X'T'#-Y\,3M$O%RCG06[93.<";:.E];+`TLXT"X#Q`N0
M2DU5JBO`.-U6MYP":_H=*O5REMC=6*?K<R!0MKGEQ.G1`?3[@_N90?6U.2_L
M?2>D"Y&!#"F_&Z?6OAO]\L02CK0XK^4*[//`<&N?`LZ#(;TIY581.9TGPS8:
MZ_IZY/3;/82^*_T-+59R#IB,1NKG0'OCFYP1=O=Y5J,SE3H2Y=1_MMJ'TIGZ
M^L906PZ<V>U1[LJ!R@Y=.>UG5HM!B`=MMP=:3J#=!A'P/9=M0I=SXX.PAJ>Y
M8^-C3*5QL)G.2U[\I)=RKM']YD;++X]_E>K+V&D-L]T7Y5#OI8[_FA[@5*_<
M9950F7[QX[%KV=C^J]L!F,XG5/H%BPU]%ZD(Q>P=C,-,XX>V!).$/N1^-]FE
ME;GH^DN]QK8B_;05&6N2QYKDL29Y+-,=RW1M*].UO<JGC_I4JZN"=->GVC@7
M66=]ZE!G)*NL3[6BQ.@5C4M6G[]N][SD/O/7[:[YE.-$<:<-ED*:3=RUM$Q.
M%>62KB0^&_``!C'WE+K$:J0M?=`,9>G0RV/CW>DU2^?XR.J@M=S+4(R-\&HG
MX>.O?<3::AU'"3'3^3D*78<EJKH>W:;9%0I\UU^$]SAX7*(`2TY1DUW`;*A.
M`F_-[B^J1L_8^NX+YC,+TPQB/&.G;`?E?1SAG=T5+0B.I$@MFZ_Z'"9Q<O'P
MBZ+E],_'>,%!Y-(7^#[(C(W'B#A_P)V=K:!TD^*AD#X!R9(2HTHJONZKY79Q
M;>EVVV4@FM'_+=%R`8-+:CZ$7N2$PFGRG*6C@]E]^8Z"&32$VPY(=^2A4D;<
MH97$J)TV6'WT.^V1'$/$"+]2YYMJ`-#KK14-S2PL(;.K[4#8T`I*MZS#[F))
M%YK0%PXM\+9S7(++-([""/FLW*H#A;(K@.=[-'/R$E.EU?49HF"51P:T]KE&
MU*RB>CEF0ZTG+U2;9KZ&)\*F5!,_>0"6Q*/&4Y@@"]DP,&CMZ0!%G>O2?7%G
MU&P)4QQS+>%FM1;<4CFX?>ZG]&[U+OD@5ZD=QIA[4\)(//=&4"QR@UTXP4`,
MCCK$RDXB>>1N*U)^-$>`P=0141;S<+^`Z_.@(L"@H]H:_+4V(T0^^&NGHU?F
MJ+<_`YQHJPN26M]"4OM*\\BNU65'$`IAVA1G@)7GNO,6BZC-//QM90&JLF=,
MQ%KBO+#RRG<U,$EW<YBG#%@I,A1RJ-4E<A#]=Z$:32]^L9QS'ZP?;=.'F[*5
M[;M>9LX]6_5+2YEG">L$$IY$'?U$.-+"*;<ZB0]">4VXB[>/-I>.K4TL-T0C
M.=VVSL01C\N2YK@Q)]5*E54@8+[;6;`YK,^IM3?33$9!5Y7!87EG=1W),>H4
MM=(\&/$FY9HSW'8O0\%\I0]<)O+#;;X^2U+,D_NDTMT4K68V]ZTK$=`&`)G1
MN`5]]8,^>FY(+2QZ"I/3F_1&%G2>"T*#^O<S<$_D/@Z<)0IQ@2W"N#4#Z26%
M+$RN;[)B<G'#[-W`LV-X$EDCL'[2R#*63H,'YH@HN!PDDLH:8$D>E^WI8WH8
M\!PW0##!V>TUN@]<!_/;E?TK*,8K!Q^Z`X6K=1.&,>/?MS7QM^OP)?A1?F!"
M3'B#Y!<`=TC9$VDW_A5REM_H6R`M%8L@9-%)KSPK!^",D,>L!1HX^W"S6B^)
MO[FD#]^*W/@.-.FP[GO=*0G_C*FVE!;1W=!S$T88RZ7FM4'JK1E`&9&D!78-
M>N#$VD[K0(_5+4&\X@5XI"J_U=Y=YCEBA3=!S!:5.TAU,'I(5=6)?L_(0\]U
MU=?Z.]4X&,]"9NTE3YK/GF*@H@L`ICUO/WN:=W7_[*&)EK!L>!%H,CJ*FTBI
M:XSOD2NN'59\"5V<XN_0[]$BVY84'+=-4LI^15XLGE8%@@E&.`-2FIHCBES=
M][K/(6*O4V9+%P9?I.T^\8RB4:@^!IU)(&1X5[NU&^`+M'8CY%W'_NS6@^I1
M32!,WO_TY]<D>,3!"S4Y@,4\,,A@Y15[])<6R0T*F>'`[U5:3DJ8`37'03IQ
M+9&S]!S0T[#U$XOKN0J6,K./B12YP]^3?U&Q??L`-9.U-SU<'/V]#Z&'ZZOW
M`KS#A2^T^ZAR]4"FL+'T<2_&&G.,$[\\PU781BL!Z*N@<6]Y<-53"R#HR4Q=
M/5<_Z(N1NI,I=.%#6OUQ1Z5HC?S-)`RQF(.K#4)7#8T>[E3;A'DYQ6'I/G=L
MQ<3!!SIDA:]T6VQ9GN<]VC!W'CM"3^0\T:\OT>8K\2,VQ^MO&('D$@1J?_+U
M'@73(+G`Z<.WC>1)2MQZ<+J?T=V!PH!G=/=#W7V-*\8BBS0L+G[6!XK0)Z#P
M$;A3.;/"9MO;(2S)]C\SU7GA$4=16H;"!C3`(B#",$T1ERS/7HIMZ$()>150
MC>U>P59C81O%E#:!-^#%NV%Y`\B[CY\]U]F:<UV]>35`=9.'-DFWJ<SZW"+#
M!F;"^FDWPC'A:0U2=TZJ2W=VM>Y!Z\42VBXNWW2H&4ZOI=DJ%"11B"8]82I=
M*"6(8UNDL2V2G6V1JMYKR?2A5E`&2)G$T9($T/DH;9#Z,T^[4-$(9NS*4,*H
M<U<&D8116'\&`$0=R-Z">S8`H?;:O4&.8@+?BH%W=(`?\[&W@U7E$](70>AE
ML;S1@QH.M&D(EO>"T,>$'86/<\%<99E&F2:@O7,.V"KAQ.T8T3)"NP=;J"XC
M/#57%ZO]@HNZ-RR?^:%#VM4[L7)FG)D;=*&=&<T.2LX"*T6!JO/0[F[F34VL
M'/.DB!&-(03>*F'`@A(0%[*\:88J`T$B(,@KSZWL0Z"9,Q5!8<Z0`5M2XDD`
MO*C>WLX-W7Q,^SD=?%".Q3.SNMM/A>093K%!]XF0O51.$]JGJ#37Z=C*:]R4
MFE4@:2]/+"=JR`X.H<0^S@DKMU<-)R#)FSE#3@<HIZO2<7."SP;H\Q5/F\[9
M\'Z`^EM;4CLG?H!2H*&R(*?[@[G+WJ>+M[K$(^?"1X,^'YB;M['HI>3I*=7F
M<(JM]&R(E295/_4E%>>CG99Z7>+%]L(6ZM6VI)S8J:V)JJ"[%7^<*#OW1Z<+
M?K](,^?%Z0"=SLHJ=#F7!NR7AE9EYTPQ^79U$'--I?5;VDZ/K91[BC8<V/X@
M9\J)G1NN0$^O:W'!21^@`("W'LG9<6JE$J>`'14-8G*BSP8<D&I\!+(V/9P1
M`]:?!/HOY7QX;TXH]&#"5G72RDG_:(6[O6ET1$,;L5HBJR<]G'XTZ*(1,M*[
MT6H)I>WF7FM;NZT4KVP9F!-IL%%Y'YZG3HT=.9.L=TRI:)19\EO5]_WDG+%2
M]Q$E8]]*KNO7RLD=X&,/Z:"[9<39\=`94=7D.*=^L+:??#]JSIL!&H=[Z<_`
MKN,Y:P9K*#;TF<^)'[+!V-[[G[-A@()S-QNM<:!#SH?W`^2#P'R.G'X[9Y]I
M>$!K9J?DC/@D+!<T#_G)7_S$\5.Y?U+C?,!PS0[N$4?W5<QF&<>AE`;22#;7
MK/GZM4PL:N9I<MMDV%GX<.Q*4<)(O"N%QGM>?BME;W0!TCAT9)S:T2Y6KDD<
M`#>[XDO)Q9_H+P':E=9^*KO\=R*Y./]0<NFI+TEWX4,3DDJZ9U@U&!,D0"];
M`Q`3Z`MW.!*!8BIN`Z"PS8FRW^K&H`=-*!#3?B;;*"[WPK'24P*1(Z16R'$B
MK72'=""R\(CD1!Y;Z0+M0F3QF>9D6AD=Z4!F41?B5)H319H$<%..R]&QP7*T
M7M,^CDP6S_:5]G%DL)JVU%\0:#RW/:#[?01%*DL/JH\@['8W]PXTV8!)4^_`
M4RNSU>&'O,;+Q^FTLE"TPV46CQX>V5DDVVV/ZXI#CSX.A%@U611'GU\#.ZIK
MPX^%2=<<*TT3Z^X]Y(<3/XT3GR/Z-+):42K4DU,\F<W<%*D;?TZ"57JT92*H
MBE8S&U?M2D0/8]7*^+`CN4B4H?,-_Y6L9]GD.PIFNXF#DQ>**M-`KDGPA1UG
MB"M+'PY]S*2303Q%>!MA9Y6%R8][85KMVA(3!ETR@WO;2]_)+0SWM9>^DUL8
M$!O=_ZAQZKVN1667%(ZW[G^B>UP0E>-D@_%.VP'QBU/YN6Y!P8M-F>4^G1=*
M2^&Q%Q%HN@F*GT-WYJ)@4T`&/+^E'DA?1RBMYZZ6I7<DK1R8)?(Q?"(1\HK_
MSEIUWI'H;SAZP`Y9^*R'>7H-J$S-?L1^#Y1ITC=FA\IH*W@*EZQ/[BI=^E>Z
M%M7QM_4[P)>L#8SV-`>J.S/V^5'@/L>,/4R_W:IC6WY3$YY:\+"]`H,VHN)U
M5]2T(S[Q$K3PK'K]JQ_LCZ"(LRA$Z)W@Q@_P%I0_A"Y-+_WV1*77'HA![?>:
M-_>)(C:=7V;IVL5=@&L3;;`:==;#(Z</X5A:NF"6_>9&RQM_QCI#QL@KF6CA
M^::>`GA"F694;+6OKY$;)-TZ)F$8KQ(7&>O!AYV(-PI^$$RZ[1$9J/B21FF:
M8C&A"X=QP>68/K/"XD_;^K:>J^3_93I7JE"#E'NUZ]K*I&S*11ZK3CNG/"V1
MGVW[KXF>?>-GCB"F:>=WI!=V=L3P8!G_):ML3LGZ#;.``S5XJ":-%CCY1Q:!
MLFPOP$CWL3W/[90^@RF=+!8!7E!B;ICQXX>NDS8LW%JFX/TPA*7F#7B@RP0N
M>ST3AY&$)5,'H5_$66^!\.'Q&]R%V0+(M'P*&Y\QIE/2AS^QZJ6J._2LK]L<
MSY<&ZO![']HJW"H?SEPHP[4D+3B8OA@MZO`V%2+<43QVQ6PO;S(('UN9NA<<
MEAH&KF%QV]G%G6I&&=>$!M1,WJHTK,6G^X*9Y'_Z3O^\N?+P"_:!/C]!:&`D
M$S\BX\.-/XL=G'.$+_`$QQ4$U-:CF8DC*3^%QL5M?8JWJ1U91EUQ'$_:YK:7
MQU@`"UL9R!,RMTU+^K"[2HO:>AV+/=%O9%FD;F&HH/T2D'@-SUK:_PRZ;&)&
MWZ,@<AUWS3P:P/5KO]=MN!3L*FHV43,?\9\4$D\`]$B#[B4,5<`*:JO5``"[
M]=/NBR4%X^\X(!*%_:+@-'-7WN#?_;*'>*0J5'M#%'I0=[_3C.3>#$1Q+/<^
MU(WF[IP<`)J['^IV(E9,^Q%Q&18_ZP-%Z)$L?`3.XB@:VR7%(LF\%\_H$($U
M-EPJ8=1WPR7>^%K>'0SNN:%P45N5^UN9GE4J5NN[Z%@AARK[SG<^(;Q%AD`%
M_D'6,:N_PZUESR9[JF@J>SZRNFV!VFLF_D1S]IAK>&#V(E0H5C;T,-$U)_[(
MSLD$36I[^Y#.HV.KVR.U$;5KO_'&'.;Z!-EQ)7?-;\X7*UKM-(V3JO0W5!!6
M'A]U=&+%K*P&D0.CS1+*VN]HC2^+`)V#H*XZ@[Z\-4[>G$$FYUT('?1F-W>!
M4K!_GO/`ZDYPLB$-TA:*X?1;.?!%%?W[H3!.MM4JF":+7VTTDW<ZLOH(:>2E
MFN!YSL</5O?>M(R/`DD;G+'C95>1193ST^Z)BBUJ)"S1+.]K=63UY6RC62P1
M,"?6I'EW<!=&)`\TY^RK?2O5IB;G_/QHM=?),GZ"DN5S%G^VVD*R3"UI+>S8
MLO7$8*=U.[P3>^5".6-.##;/%/)*5!=(02ZH5-D79]!AO\Y=:NZ*H97FRD+.
M+:M]GGK$5UW5:,Z4T\,^0CV;[-WKC'/&GUG=^=LR?45]P7V^#Q]>JU)CH`E%
MSO2/(],[-E+)6?G9:G>$AE2:KD9/;0,?SM+1E-31*6K+WU.#\[/L,'BT]SC+
M62W>A-]4>D9?K>=*T?#F[H&<@U8DN#3.DK*.@9:PKUV6"C=Q)&W-,SG!5EN9
M8(++_4HYI>:R:HP]DZ+]9',F';B+1J$N46"*W=.@]#`%W"0ZY]:9U1*E)>#8
MUO4[I_(UYCQH;/+.^?H*C9F^!Q+DS#88A+3#LFD8CY$SZ9/M6=7M@T**%`L,
M-N&DVZTRB4]\J;ILQ=DT.<6?S;FY#=?T[4\8VK+DS.3(Z6:;O&Z0TBXY92/Y
MS-K:+`A%EM!3?T_K1VOMDE,QL_[,SDHS48HJ$K?/["XSL\Q+FR9.50S0R]DY
MYJ/)YZ.5ASARM@J?4LU34-/HQX0^YB\4C6\^Q2]-DF:UQU*33@$0T[-A:IJI
M"**6MO7;3=1C9VPWLZ#7)L5-6-C:&V0G+CWQ9]O0U!-A/RI$`6M2-\#\-8.D
MY>POD&".O0U(]#[$IGH?)\]A%%![2X0K_>!A:[O3LD3:R_EYP$RGH%N=.%PI
M+3'RGG"P,B4PQ=&SG.7M0LK&G5")M>4;!*?II,^=D$*O;_DLB%GO\AJ,E^5Z
M0;V`W):F)%6=?6H)PBA9SMH:B6<AQ[MB:GHC:GW"&7W7))AC-XH#7)>@K(_U
MRG&SG=FEDC9K6`W$S'9&-V;<F^,R!"T#HTM;$^CSJ/0>ZL*<M`53T^=7W!G0
M=$@>B.?-29#ZRHVX*H2QLYSAA>>\_TDX%8M;SJYV@[5_+HKC9#ES*[2>/OE8
MN;QNEB4]\Y+&39=QD%<2I0&LY!_WU!081R2@6WY&=A6)/H_'_LJ6,^HUCCA3
M@S%[OJ^-*A<[&(P3(DH8]3XA0EV:0]\C$`1MJ%2'`$Z#VOT(NN2WS$X!+KK_
MF>FM/\`)U3V,O1HBV\;!WKKR<@W-RQE27G/-4>"S*ZQ(!6ZJ.#;2M6FGK[RU
M$UV,LL@2!IEO;%6I?G#>'';>LPK>_%K-&8.-]`8PLDND+&4<V96?P\:177:T
MW5`ZLLO.DAA+ZP-:/"T',O])LZNKIQ[EIR./M;BE^02-PU9(U#%8(@@RCGQ0
M'4?+.3KV&-09X>7C$(9Y^[6RN2(=@4]<&`5!+^DR.<//AMFAJ7N>D\*&FUV3
MR?+-^C!N5NUF&<FAY/,WK.Y2-9"=`>80YYMC>=^986P..)<^;SA\-,Q>\/UN
MC^8J$SXQ811TVC<+OBMGPY1PE6JSF5)"/C'!R@M@M.Y3X<`HJ?K8?&],]M8;
M_MZHK"+GTP:LE%Q#V3*I%@R\Q?4P%3-]KTIK0Q'>&'NXQUZTNXL>#UC=^,93
M.U6D0^5XAV9-O#>SE>+%Z(ZH$?6E]F2\0[-P9H;F?GR/\6J%@LUT7C6^<-NK
M3JHOGP1DL_WY(`A;6G_1ZN`N.(<$IM,!TI4MP=ATFK^BB74'LC=@I`]V>\"#
M'6W8'C#2![L]=7$[6W<&@N\KV)2^*U!UH7ZP6Y4]LER6V[$-%6@=+(MWWTH[
M^+N/T\$RUT"7!#!.!\O<7!CVV%<!CM3AL]?>5W#LSS#V9^BVFF:&5'EL'AZ_
MB;=:$`1D>E_'+@)C%P'0AHY=!`;016"LD+>T"ESPU;"A9GX(E>$")2EC97B>
M1]%<&6XPY*NK,GPLM--N^PV]#+^;L=[OQI0JS$\.^RT^X#VIK4D_':^)H2W9
M=VWS-@'#?"8.8$LJHCGYKKP?RXW-AR]YSP(KT_>MY9N=6UO8SX'670YA/\$Y
M.OFF?AXOJ:V;"LZ+XVU,AME88`B;"DM$S7=4O`>?YDSO'+F$]*\8L1\FE$[\
M?;9/PC!>I61+Y7XK6<ML-G@W$O3&DJXH2\@&X\3;#`]R5GZN._R%$O\F6Y'Y
MTJ?S)WII0N0PIDD$*ENA]='SO6>2]!,4/X?NS$7!IH`,-*K:`,1T]+Q.].=7
MO7"/M^54OQ*/@O&HX'Z@`KZ7M`D(.K8.@6ZBH;^IVP)8'-*9?'##/ZX#S,K*
M,-5"(J,GLAH96]EI<1F'UF*-,0_/RN,XU#R\'<TR/=@=U=-=(*;W<\R_&_/O
MQOR[,?]NS+^S*O^NX<48<^_&W+LQ]V[,O;,H?-\Y\C?0Y#L]W!;W70P]D:Z=
MOYI\;#P=;AS2H,<-;$,>E1V61$/X@0^YL6(L6M-LT/9(#($&PSCU!E,,A&PJ
MQ<1;0KJ`_!&/)];9/B6K1[Q)LNX^<PR]TE5G\LP/L5Q_.7&(AOO*"2!JPJ_9
MW3,Y!B$L"$)<XCD.@MHG]#<W6M[X,_?%G<7(*[VFH50H0MV:FIGS!?O4GO(F
M_FPR6]'KSMI^1NX+SFX?/#@A"%!_OP-,7Y8E1>,2OV"/K!E?I8D2`E=+4EE2
M)ZU;[ZB,R]XF<8SJOH0NOOV>)6M=N@%5FDD0`M%HA*%Y@V]\^K30EX-J]VPK
M;AF64FE%C8!Z2)+JAQ!39$!#7HU@>@N`=93>':)@:E:VQX!5RDDB>$XLBXXU
MV;$BUZ:=[`HCUF3<2\B(54FY)72W6[!BPIZ(O*\VQ.V44URAV(`B;`=`)TBE
M/)#X$9AX02/!AH!.;6Q:N5E9&:%6\X!R1@J(QP,/4ZM6.5IBU0:+#'7%JJU^
M4+1>NQHG'@]\"K]!FKW%##_B4X*F\POBA\1S9RBIJ&2"^):$X3F>DP#?!^3%
M94?DF@3IOSVA'UBN9$WEDF;]S4HHZ<.<9KA<T]//)I^Y?NSZBRD5A\FAS'`L
MX/75]9,SN8W9T\=U%TI:P/D51TM"_X55DR8W`FZ>]X16+QX+$"WT(&!W(>&5
MD5O%/@;0MX+NC^MHY@!?9@R?=`B?U+A^N:J4"\)P.D_9O[<5F3Y^3M7UN1L)
M^[64+-,;6:``C[*E^C)75/.&*-I>[K\0T*`/RB11><E:[0^3WA]-]L>1E<UX
M--PC)2^D%5G3A\*V7+7B%IW!5+=#X9J\"L\36X43RS0;SI?N?$Z)\!W*K.@[
MQG[9`J0T9XQD_LD5B?V(;4!,?^%\<XUGS'/)?)TQU0XV^2<LSU3*KNX1([-F
M=Q^$]F$QE>X;W!JJ`-&+L<>8A:D6Y;B>FUSVI(?39/:/6-H9(`#2#&GW3-3\
M#:.B[T8!>=5@S9!X2=^')/LUO&0.3WI755!8"=4,@7>$B1^&#56*LQN3G"\%
M9#;`AIJ>-2M<+)E7^L;/"Q4*3;*$;4TIV&9V*].N=N5R)O0C%WD*-JU]"3.D
M;[=C&YV@OS`)0QR%;&_2&(7GD>^(/GX*N`!:3=%AKHJ[4#R"A9A4E09M9C_I
M#RXH1JZ2%[$(S`PY26B>JE0L,N^I?0_K09LAM4;!FD2-ZJ,"1L@N/+JXU;NX
M=UB\?QDA3NQV0`I1@SNBQ8#UZFH&T4>$V3S<#!;8@1T34JSRT4%/NZ8W1")!
MY=!95:]W<*>CE4F3.IA1U##Y(!<KNV"H>"3$K0=>]S\<9J@T#GD=M)5Y\SKX
MT^Y"X&->AO/PR/N2^)"45W-$&ER#?+K(JQ$HE?Y@/I#CU3RRU9Y_/L?BU:A>
MY0A/SH23`9^&_8A=3K3X$,/^LL)+KS]3E5WTS'HBN=TSP$'@K<GV%L.ZGVX4
M.0X%!.XP*);<"JJGQAIT_<+*DA3L0#"".#BPV`C&"`GW`5GC(-JPCK`LA8(E
MYJQ%PXW2H(V0.GEF18..`LHXI/X(2>]KU_O>\R57$='L%K+41-*7@(2R<FL'
M0M^(=Q%9.Q#Z1GS[@U2YZD3!/JB^2<E];Q<H"#;S=/)>N"WO[D1:&V@#I&Y_
MEBG##)?@)>E0,'&<($9>N/U15\HA*]FQYQKVVH!(2?.`_05+[E5'7A-8(^*^
MH_Y0"6D,Y:L/Y9<+^VNL-]GJ-#&PVM`N^QZ4H7YKO-H,3'NYNDQL>T#A[\-+
M#Y"\!.W)`L.K'CL^A.HQF7LA^@CQ7``K"\*`KW(3X4TZ!>>"E>=!(1?J%$>>
M!F$P(Z@O#D",!9X@876W<VU'@]N//#O"RBI(A9S8=Q+PO(?!"\F]N/6'H<O#
MS!7'DSB&+OX:\WH^#5W&)3YPGI5AI2#3H_U5AC!X7L:A"+:FF$XKX0U1*<Z)
M0Y%XG3BQ)^>/3>:!]T=U,?7D4"0=G.#JZ#[//Q$6>IKS3PJ)49/9S$W7OO&I
MXKG*,LDDLDY@0,WFF@CBJM??G26X7K#N"<$&/NRB^GNH`_0">2ZEVW=1DJD/
M'"U1\S44B4H#B-J(;MKJA"7S":,D!$MS**,2A[1/!F2'&\%`>5SKA9'DLS`\
MS;Q6$P@S&/?ZBGZXJW@%%P!['^I&DXIF.31W/]0]48CER$M,#BI^U@>*T(DK
MA8^@-[^ZA3U0TC<#,2%/*T:IR\I4#JJ'24+]$6/HG0.>[`8@T).>E5\"C_;>
M5WWU0YC$T3*Q`V1G2)5A]#8'2P_Z!I"7&WQ5AM!?;@P.S^/0]3%54\CJV?43
M3:OL6V1_<%C'MB?"F@<&[C/KSG:!UFX$Z_"C?&G-K"KCLV^A;^OHX`HY''9?
M!]I4I[LQ2TJNJPCW14@V.BD!4(!*V:,M@<ZMZ88F3?24*FQ+;.3MC07\E(>7
MH=1Z`-L[6=LZL:Y#)VLK??"@4]TJS0^A;3>46/AS;'G2E107E"MH/"/)7)16
MG31KT]QYFI'!FFC(%-):\Z61V(K9HR8;SP!FCW:AUQ)J14<S-IC5I-I9P<DS
M]RRKOZL-+B&>"V=%`[6FZ]KN'6LC>=<OR4DW^(0+75R5E%M"=_L5%O7K$B&/
MN@V9C^HO=B&*845+*Z'37([7[%-4WC0K.U(UQ<A(;<".9VA:V3E'E*C=8"DG
MZ@`ZX0@:`D)U%I\.GUY8^L%!]443W.G&Q)"#:GTFLM5"&3V<:JM%K[">7Y-9
MQ?-&K71@0,ALSF/+"7TO?&TU9TT^8@\[$9[]=XR""`?>YMKUD>^XR+M$$9+*
MF82`-)LQ*82IWEC7;_24+"D*DQ<J^1?X+F8'93I/AH%/XRB,D#^C[\$Y"EV'
MZ=2NQ[Q:D%"8[`J:@WQ7B(H!?Q'>XV`[^5R6PE90FDFYPQ$?23=YH8>&60K,
M#;E:L5[1Q/EC23QZ\\,$,PAI8-!]DBI-B/YD-&IZ^C&L#0S_9HP1JX\1-XM:
M8/L,$5AJ$2SK<=V0O#75'0-()8&P?.!19L@1'@/.MBCOLL>^_"P<0K"Y`Z%[
M+S0/*EM9VJ:46A'%BL>DK+11N_*C58>V(D2ECWY9*XF[7&VI@WR,GT/\SY@^
MHE=4<D7J:B'A@`U;]^+X]F*-L+;OBY3RKZZ'PXCX.!U;OOL+_X)9OS+01PNG
M@X6CYE#LG4Z0@=$.HU_DX95I-0#Z1?N)(@JO\Z@%TD.=BEX"3*`/+56I!0&U
M]R>L^<'?L8\=!*RLJOA2,]\F0<#BP,F\$ZI\W-%'C/_DB?XI1.F,'/A%!(/6
M77Q'<9[."UB!"^^J`?1\LD7]6<W?FW)W"%%%6GG.#6;;<S*;3QWI<%VL</BT
MAS9E)0RIEXF<<G.Q:^4GO?;YL<(Y));!V?8*-Y-;D;EI,FHO=+U54&P)O>U7
MN5U'K">W='>/S15+E`(8PI93PW;N-^P>6J!"5)ZU=.8>7G#"[HYTD",MX^^1
M:%!>X:7\TSN&S#,*,?W+_P=02P,$%`````@`R8%J1!EN_%0XDP``X/8(`!4`
M'`!D=F%X+3(P,3,Q,C,Q7VQA8BYX;6Q55`D``QD='E,9'1Y3=7@+``$$)0X`
M``0Y`0``[;U[<^0VDB_Z_XVXWP'7>^^&'5=M=[=G9\?>QXF2U.U1K+I+1Y(]
M9X_CQ@15A9(X1A$U)$O=Y4]_\>";``F```&J9V-WK9:J,A/YR\0CD<C\]__Q
M>8_`,TRS&"?_\=6;;U]_!6"RP=LX>?R/KX[9JRC;Q/%7(,NC9!LAG,#_^.H$
MLZ_^QW_^G__'O_]?KUZ!V]M+L-KD\3.\C+,-PMDQA5_???@&_*_SVVMP'2>_
M/409!)=X<]S#)`>OP%.>'W[\[KM/GSY]NXN3*-G$$?HV3;??;O#^._#J54GY
M(H513J0"EU$.`?N?'\';UV_^\.KU]Z]>_^O]FQ]^_/Z//[[^T[=_^-/W?_CC
MZS_^OZ]?__CZ=8/`+WQ4H/$_/X(WW_[KMZ^_??N'QN=NHLUOT2,$5Y>-S[W[
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M$94!\.\I1O`6[@#][\^W5U)V/WQ'/_%=`A^)E6VOHP>(B+B4]H]/*=R)OX?2
MM/4U*L(/5(0W?Z0B_).(6GXZ$-_)XOT!$85\-T7*CS"W*VB7H$59;V`:X^V[
MQ+)JQ62MRWV71ZEE7<L(6Y3]GDQ\T*[4?9(VY<5YA"S+VR-I1UX#8\C[(BH@
MC^@GZ/)9?(@2&Y@S&:]BAFX0A9]SF&QA,2E2LG@CDIT1R^#FVT?\_-T6QH3H
MF^_I#Z_H#Z]>ORDFUW\BO_KKNR2/\],%6<W3"%T1\I__"Y[:?!&=Y7%:_I(-
MYC^^&OCR=Y6`]*-TE2%?HEL0F+SZ^4Z5SE_10T>K*<SP,65+D+(:\]K6_Y.S
M`04?P!@!PNG?OV.RM*1>I9L6[RC=E&S)CR.<BT]\M\%DP3SDKU#30G8IW@^J
MKV"+1W7SG<P0ML_19P;VF[<EU.0W?RWW;>5_5\F64[]*=CC=LZ5\]9`11IM<
MR03TB>J9ABY].R:S+3@QTE_]9[7;K7X@NV=0V%)#"/!K*<;_Y\6@C!'&QII>
M`II<50(45R8HACG&YB1G8:"VEI489O?1`X):RTG]);-EI/R^H^6#D`>_,@9^
MO%RJ6RS500AZ1&HJM&!YUV3/B+BYKS['F:KM];ZFK;4.!?OVQQB4GOPKY>'-
M!&5*Q@.J"$.A2%F7UC;7EW@?Q8G>GKK\CN%6FG_=V0[Z5T[?[PS8U2N6*2``
M'2(E]5FPN'+1;RSTY-P)KW*X5YX*AVEH:W.(G,/M3VNK0QD"QM&;S2HA@U55
M%B`*W8VV*@`6K?Z>"*]KY?P[QOJD7W=HQ92\;XMM:17+AA^`!KL6*%*>!6M;
M$>);RN`]BAY5S:WS)6UMM;YOW^`J\H#2]V5Q8LUBJ09"T")24:#%.:ZZ+*$W
MJ;J37>?+QC[;HN-P^N-\R#Y]RRZ.?<^$8MWC4=V$I.?N)#FB8HN6^S[.-A'Z
M;QBE[\EOM+>CO:\;:[5#R:']<DZ`L@*,EV\+EF&`%304EKZ[=CRJ:NN6S#UG
M@BVW"$S4;H.6>WLNYHR`+%J$A="F>WH*3>\2NQY2N07+OD\CFB5V=]H_8*1J
MS9TO:6NR]7W[5EN0!YR^+SL5:Q9+-1""%I&*`JW%1V_A8TQOHI+\8[37NRSJ
M?=<PUM<FXRQN6K,!E(_?\*E$[7A,+P&I&.EJUV\N2EO<T304"PYV<4S3U@9,
M\]PH_[ZV%<A(V7>V@E-K1^C[!#D*!%;14F!*1_KZMK9H_`4B]%\)_I3<P2C#
M"=Q>9=D1IGJKAY2(X1PGH>=L/:'\7OU&&8*2(^`L_2XM8^!@9:6%"`3J80#^
M2P4#>]F:W.%NX0&G.=WZY5&N?@8=IF&:NRDDYRZ%LYAR*GZ`,_2<R3F,"U95
M6(`8("/U6[/X7S`Z)GF4GM['B%B#GJGWOFRHWPX=9\9=\0&<D5^CEJD>CZHF
M)#4C+0U;LUM&_H+L@QYQJIE5W_FJH3);5)Q9+.,"2C9^[56L<CRBE'#4BS0T
M:V]'@?=[G-SE>//;W5-$Q%X?<_9*E,SMFON*04JF*]L`47=[#,84,*YG@/,%
M#<:>]QHJB&$])0:+#I("HX"+-2>Y.3Z@>/,>X4CM=8SXBX9*;M!P9O&<!V!,
M_%JW2-5X4!VAJ!4I:W3`+G=1]L#H'K-7CU%TX,8)49Z5O^E::?'KO])].*3W
M1NO=^_(]_@W.8MVG77KTM)2O0]HJ)A5#L-Z!BB4H>7I^OV6$(#919^!H-2<F
M<\C<>I?RLR;9-Z=AX.B!4ZUMCR^<1G0MLGC3MTXN]=J;<_1?/%FPTPL49=EZ
MQ[9*JJ^A%(A,TW*7GH,;(,H!X!W?(P9AQ5(D1`8MUE"(6N^9.5?]NE"]_M,J
M<Z-O#E#]R=70MXT4WB?TDNU[0.EX7"=!*1@U=5L;L/Y;K0DFC)-GF.8Q62AN
M"%F8IG#+Q/@`]P]JEYO*I,QT/TS5P98$IO2Y\#EH<`85ZP#L7Q$QK*G#<-$I
MW42.!_B5\YMYKW.M\\YQZ-O3UMEK=V\;&YO):[\/&A64+]K77$]XQ.A:T?T-
M^X".G5CR*LM@GIE$:;K?-%)LFXB#)V:,OD]KE2@8#^L@&&6BIA[G#GUPKL7%
MO[F-]@A,T&Z'EKM$PHBQ^]&_Z<K4W[-@H6I"4W7;GDMESVS7%U'VM$JV]#_O
M_GZ,GR-$A,A6^464IJ<X>?PE0D>M2)\B0;,-G@IM!WY`^+&B9QOZ`ZPY>]UY
M:P&'C908.DBH@0^M\L5^:#`%JQR4;`'C.\]:\1S%B$8[W^/TCDAR!S?'E-5]
M*IQ<:]T8)V8VL8W1M>]''Z+T-YA3GB"KN(&H%.35#J>O,B**UX5&&3NLK<N0
M<2H7HY(;(.P`Y0=JAN4:-8\3;3;X2'SX%FX@\6<BTD>8F_C/(!TS2`9(.C@W
M%-Q`6K'SZB`JN&`=906*`>JHO^8$"*M9?>$FA8<HWK[[?(!)!LE*M\Z?8-K:
MFNJXA!(Y(U04*-MWD((I@)QKQK9JF#(&F]8)QJ?;Z$"(#10:-ERHC53!D.W9
M&$O0/@3-?Z(W/LG;.%9:<HFZ2OQ_LHKQ`5G_J)W;LFAWMNO!0F]2?(!I?KHA
MXV95E,G)YD!CLV3]T9OOA^@8SAQRDBYF>,Z-S>RP9'4&$N@E3U,+'ZRCM$"Q
M0!T8&"=>5[OD1?=$LSC%3QAO/\5(J4A'_SM&"BZ_;M^P2\H^K;BG4"P;>0#*
M0\-Z<V)QMS#+TWB3PZTXM/61Z%A_%Z%#U4CQZ@SLVW7-F\5,?9JW`7K87(F+
M0`KU0))'4&O>L_A:XP!BYE82`D:X"&G9=Q9^`O*_21_6/5;22VAZ1DT5%UOX
MF4V:<]4_8$XZ`;DZ4OJWTHXZ>V?(R8='!Z?&6>SL.HX>8L0"]60F9YEH3QAM
MR41#Y_/\9)*TH$[32.&JY!WT$JDYLT-EUN#]S__TI[=O_O7?V$$S]_*:VQA2
M;*K;!<"'^LC1'4N3+>!\Y\ZA:(@T(4%HB,I4>&9+%4(U3Z_Y0@J0B'W%7N:0
M:_4+_,%3#E%Y1783G>CUV(1+VBZ%25>#;6(.+V8/G%$(M[(2"`3WL2+M!*?N
M[AULP6/N1(3T"+=]=]8T<!D14Z6+Z3DQ<\JJ.;5[MO01.+"RFD)4/6IK73"]
MSV+UE\63EEOX#).CR9PNHV"D=#$Q!Y7>RY<\*6?DU=1',,!JZ@E.WZBCZH+'
MK.8];3:W-HT[F[^EN0"!S.)JT[?5>=OQA!W(1&T6-1\@8F/Z<!D][\W8+"V`
M/@XO39[5Z,1)0#/Y<'A]1'DA`B*;TGW<'C4<<<(5DH2*^?V&D*"KRR2$D\=7
MY-?[4.9[!62Z%TP#"@L2A=954W,UF-D)&JP-]S33%UA7NYA`K%FD8O&VQ<Y^
MQ=5&9::B'OM]G._9([!D>X$36C`;)AM-^QPD8U@N0DK108"\9L:?$C;9@:\_
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M*T:`/JA\%2=@PWEYO9H=P0,K:BH\W:.>VBD3<)6`"[':764B'/='%.60/]0E
M;G=(X1-,,C*;724;O(?7.,L^PGR]NX\^:^8GZ)$VO3K7X>*@)3)/8J[%*-^)
M-P4!B,C@.<7!"&<\4=/+P;1.DJB`Y''7%G?`V0/*G]5L6.\`$6&F1V-Y%"=P
M^RY*$[(KR1JB7L)=O(DU'XN-4S-\>C1&V$E"487:EC/Q^T!,&2FLK[B@42G<
MJ&0'2GZ@"=&E&**9@F+3@F'6PB^N+C3"?'<P`,-@Y,MJQ,MUI"N(1SF&-W02
M6DY><<QPE[?@)S@C]W\#&@T8K/Y-H>RIC8<8\4V4KE-6IGK+0@TW,&5-\,S#
MQG**%H*<,N+.@\MG=60NG#CS*'C2T/.P'H,'2A*@)DS!.@6<+0^=`<*8MW7T
MX%R\G>2J"M::.U6?D@6,ND1G<*)>_#H<9Y*")74BL?Z"!4;B-$7/TY44DMD<
MY8I=04QUDI**-1PXP?F<@]_$A.88'7!&G**ILR"!&':&*R$$LSF"9K]L95+6
MD'#:,5OF%]AOMVQ=P$8\9%J_[%G!&?85LV;95G(#;!Q>E,A-O22>[]C23"H(
MY,RB`YCXNM[!:64V<$27^O[/*8WA3SFD#)*9BHO[XTG;68(ZFZ@`)'86BZ<2
MYV"(G,//>:0W5/W#B)2$'=V[.H8(G<#_&60,D"'CGWSZ<*K\`:.?\=S1&Z+A
MH6.8CAWM.SUN".T_D+.&$DA#GF#GE.$>D`&?4#]?;)^CS\S<W[PMC)W^YJ\_
M)WBS.1YBN'T?;>@-S*GHF*!BYF,4M/0Y3,R.)K=X<Z0O<2*:6O?5?];<P*Y@
M5[;V^-:'92LB@M64]9W;.9)G/%5-7$V>%$E)&#FBA)I5'RS2O!JM:Z5O6.:<
M"L>PP(I:"D_OS<5(0_F.$NUXV0<34^]_US!=JTW&13UUSL'KNSBIIO&8*@+2
M*FHK=/9VJSAAW+)"`+U]:_>[AENC-AD7^U-$>.*4+>AE71:_FU*)UO&86@+2
M<+7A+(B715;FG&7?$[7^E$:)7CUSP9>GS`@U'0<-62C=$$Q6KO#^;-M52$C*
M;<^W@)('G/Y,^9>;HK7='4R?R3],)MX!(H9)?!)Z#I[8<P8LP1)QMB%8]S@L
M6%E=(4)06'W!A2=/%GQ\3-LFL_7$2=I9":`0"G/VU"K8`5O8^3K9\<ZTS<U8
M`9<B]&%T.)/3,-R4B<DY*,%V@'3KFSQ6'6F]'MM&L<"J2@I0[]6F."L*^91L
MY@]#9)"`0KMW71)/0YAU1=0(VRH2,FTP)J?II/L;8\=V'=N:H><V<`KX8"V=
MA8H%ZL!`_:+!J_21>=IUPH3,AHB(L-KNXR2F/DF+;QAXQB@IL_Z4PU0='#$Y
M0^8<48NEURZ@BCAA3<V%BPEJPT&=I,U-YB>!7)LU;6K@SBQ0Z5%/\)+-K-/3
M:D^+0__.(I7KW562$Z7$#P@:-.T;H6167&&0J(.G^0U^M(1V7'$,H?.?&E98
M3WW!XH($D*QWH&8&9FPNV-W%3SG(63I(N`HPX-[Q+:33F\JIS>)IS?$I;9ZJ
M\"6@=34:'?,5?MVL`GF?DGTC9L5NJ`V5AHP3OY7?![2/%703EJ91-\33*#$T
M7XN#CSC![1$6#F429U.E:%YT?Y2XJS8(,0?GZV(B_\9K'$X3N6X[!$4E!H\2
M:@+4Y%FZ4L%U[@#>5?(,,U81G,M!]EF0C$\S=4Y&PS"'2TS.11(7IUQXC-^L
MN1$<L*J"`M0Y*M5=,BF-OF0SDZES9@8QN-Y7#97<HC)1MS]PW2;PD3Y.ZUKT
M0!AD/I,6ZQN/:"0`W7;MME#JG"&:X<7)WD['R=HYU\XFW(V-_H;&V49FW@W,
M+,[Q$>9FI]K.%XVTW:)A_R1+*[;Z+L4KUB\>U$$HND2U&N<^I;:+/%S&S_$6
M)MNL\RCA:G_0/*OJT;50GV*8A8N-2Z>6"-A"PG`+MH4@X=0144156E1$1;6A
M(SA<;J1B7?I?_4B&<Y]_B5@]1S'AB>`];CR1+&HZGD=9O#%>1%1(3Y\:Q[FX
M6XA`A*@^Z-5+CFG-^.H5;L$_F)5*`V;96J:JZ.5`*EX/0<4>W&/0?,Y;5CIE
M(LSBJF7][;*>"^-,$X5B=,SU2CN,DC+";82J_=-.Y7IDD\U?NH\Z(7@%'JA8
M//N,"^;3,55!Q9IJ#A?`PM&J:O)5H2#N2CP?30R,$[?Z"XP?GPBSU3,YJ3W"
MCT?:&VJ]8R(UWNI/\#93#D88FC&S[YNE'"#B@@@J48!C1O[._?1`I.A[)FO6
MKNGA/KUYHBUA.S`NSFY0QV0*&0`7@N:U\`FB(8>GR:+:H].\'KI+8'UH>SUM
MS)JU:I(V[*2@Q<5RFX7R@,,RE=@FB[?7%;3E":-*@RG>>*+&EX-MNV6O-8`]
M!AD%&\SYKC($>#4;9)'-4HRWY/<IC#)X"?E_C1,[)G(SC\)/8NSJVF33,M/R
M$H7B'T!NB!W#Z%ZS6,!AT4;0NJX13E.=]G"`2P5*L4`IU]P9*3(-_IP0<1"M
M,_EGLA\F.Z6?HCBA@U@G=W!S3'EWF#3.R)\NR3^31SXBD[Z0[F2P:E13Q7'Q
M(J.4J)A?P",1"9"3S#Y*?X,Y.]YDE6SD#%5$H5[M</HJBY#7C`7GIJ<P2]G!
M]`6:V?B,UC"^0E!`)>4SW3H!M;"@D!9P<<NY;^9FF4-KQ7N<DD-C<G%,4YAL
M3O=IE&1D"HYQ0O:=[%^()3FOMG\[\IPJF_/<5`FL+YWFPCBH\\1[1%+#RVO.
M(*I8ASB%6;(IQ6W65+A>G/TH;L<*,4$I)V@(R@Z<#5%!+6M($Y?M:<CAI&)Y
MBN@_J1H[?(4Z49BZO6,G]N*2,[N68.@F'C5(QK2TM(RB*_]I>X[OG#@59+"&
MOL)$H?`*H3\HNX*DOC<MFA\1/:]WC82'GP\X>?<9IILX(W]8']C+O5]@1E-+
MU[M;\D,:;_(BJ^GG)&;O-*N_OXM2="J_OBV_3?NTJ'B+#ZGTZY#/*J"3VN;E
M"*CU-%--`!T%*.6@?RU$`86D]%?U6,HOT=&PR]3R4W@'V(@J4MN:D*^F2AXM
M'OLS'&F==\]3`F]1$-R<4(H5[J3`)7QILP(?U8N?%CI6/_>\T+0=W8GA'"9P
M%V_B"%W@Y!FF&2'X'D;Y,272W<$TAMDY_TM.BX*TDY^5_7PB%WVWG<30B1?6
M$I']=BD2V'&9J`]E3"KP4/R9R04.[71]?QU*[-@)M@>/KJ'749SL'J^VVYC"
M$J&;*-Y>)1?1(28GH2OB;D2FLGS(+43TY03Y>+Y?/::0928HV[P]AOKF;XNW
M$T]H"$<S\*)*/'`@\H$X`1LN(?F1B5A5R@$I%Y)^;77_`42EG/[\PKI982<0
M6MDODH7H+U'*JJM;./KUJ5G:G74).S%BWJ.4UC`K=U?DYV8R*=LB?2KD\&>?
M>D`.[ES$>K5M639.$`)R]FW+QXZ=7DV4_,^"W%W+D52U+:7=K/5DW.:3G'=_
M/\;Y:6(*[A#!J<F9<MKNTFU;;Y8XT_!2;!50%"?6CFDT=,2D2;1ZL+GU,LZ>
MAKQQ0O<UJ\^Q5E&!$4+3,!+1M(]-@4#-)@C'&01&Y#!R984*0F]*ZR%!W()P
MF\<E.N.\Q/LH3G1<04+`[-&>B)9[T_?Z:')0_UA)-Z'I&HG5#'[E3.9J0%AM
MZ3Y`^O9*\S*]^^6IW9DY'6<]LAF/0/IA=_0M;H+=U$=(ND5]M8)?.8-Y#+<=
M8M2W7?'W+108<67!G6HBX11^D=NQ7#&!Z1D)53RO04M"AOJ6/4+(K,#]$$T'
M?0?J$#/E]RI.0,'1:\,!)82PEM9"10,)@0!7%1`S.\=FPY/+X5:6"&G@*.I$
MS6!2I>_`@6K68""1\^MKW]FV^L!B8P4O`42DA=^L/G@+<W(L@=NRCHN^P\DH
M&#9.$Q%SZTJ7[!+<<^.Z012PFH*"TWAA]R4+4!4+DIFX5K2J&\NU(_.!/8Z[
MRZ,T+VSE'#[&2<*+E2!Z9S)/'0%^`].HE:(5I.U_V2PFV*4SGY+!UV2#R*L-
M>5W,Y#C@43V%I/,R]LKK-S7(FS:/6V"F=JL=@BQEX$@3,F&9D$ESPMBO<9%-
M23,*TCH?LT@S^!2E6^$UP@O5).HHT6)6ZZJ1U;HVR'4/2>,VTQ,<&R_XFIP#
M[^3S[4M5JW]+%F>0.+H%)M+1H<)MLW8!\Z5W^P/")PC99VZ(&I^B#-X0Q/5N
MAXT8&%Y8&O":TQ<3LCD%I22%992R`"J,WWOG*::`K<"P--BK^VN*)!>A4U2#
M9R3J8#ZGG_.91JHDS3P00Q8V01_C%I2W!W.BF6@<X[ZO!LOR#&'<_XOCU9`9
M^%_IRZK0D-65A$G&,EY_2C7;RQBSL#[M#W"S/P/T-GLKNG\&EQ#%SS#U6X=\
M*NJ*R_JHOI>'L.K27M4XA[P@:BD*8++X7]P[YREFF[8\>Y2#_1E=RFQ^OU[$
M\CT.O^KJ/:+YQ4&MO'9+[,"[?[/YYR/\Q/YB;:%N$+0^:5>TY]N&G[%>`\T7
M81O:D#Y`?Y7`J;@"=U0;.G2JJRMAR_\<P$IJT]5Z%.U/GY81(TO>`S9UMT4L
ME2:^)U1U\%@J+WUAN!^;"NJ2!/0RH2I"4%>UM;4`*C"R/KN.\G2[8/+:#N!\
MJ,C%PA92=7-17&`5(5JJ::@NR+4X_&*LMI=:(O]+]1R3A3(G^\O!<J>+16P$
M;,X=6H`MUE*4-Q3!3!^7\"&_2LC!GE5X:`@R4`1)9](PHV]D`":L[$\0HY6T
M5&8-GU/")(O`-N!8&/J%TU,!0"U!RZD;1M'P_$(*TZ2B`*K(63?\L75Q(7I!
M/97T86?U+TJ5-(UEY.VCHY?1?7U4'=S-2H\K$31\Y:M`V[Z!7]*29;1W*^=$
MR[R5I4L6,*WK(8R-M!TZFH5;BIVMXCEWL?_V!%2)H5YJ3)&0A6?('9HA^E@H
M)RLU5*7OQX6:#A7!PJ^Z+\IKCY+7@EM>O=!6-$"U!.C+&'J!<[-$ZCT9J/S9
M=*F?4C90",>^EN_!2J:?^5._Z-^*Q/,J$]U:TI>8N/UD(!$?^U9?UD*LWE.$
MF]HUB*IJ4I=<JTM"4#F1BWV@?(/Q3@:QLVA4?5(J]FEP6Y^J2]-;IX6`?"!O
M=$-2ADR,(Q-&_.;PW%"V2].1Q]8TOD24FT&H1JRADJ,9F:JL8)U6?EX(8_6!
MFYM2U^TR47@#(=E@4F.JKEBRP6K7&A>X@8T<=:Z@ANHO.W@&ZJBZM",\;402
MYU2#%K@SOHQ4.8$P<1ZZ2>BW\._'.(MS2([MS_$&\EW&+=S@QX1142[3/Y\L
MAA6JW(KEH@@S-:E-,TV_.,+Z+3DVDZGAN;%[P6:E'1.H16Z_$ZF$!H74Y;&D
M(;?QJE;J=,9&P`UWF]`(.(BJ/^^2;3&2=ZPRBK3@CX[$+BOH2`4>VA7,'G-R
M^21IC('UR(6?!TG%=I`]1-F&_M#0QALD%5TO#5O5R)3W!TA**W*MQW(O?T'/
M(];WN5(^[C8;$I:!W:L$M5T=LP;=K>@@!`M%7G\+V9PIJA/SA2B,H]CV*]FD
MD&Q)+R'_[U52SS474?9$#M]LY[C*,IAG[W&Z)ON,B-8O6FWR^%DYE=HB,X.6
M81;XNFDH5@@&OBY%^X:BS??+$9.F6Z!K0^0%.`6[([U>SI^B'-#GYPDF_WV.
M8C)L!,&.?.!3G#]M4[)!0/3C1\HD.VZ>"-GBNT\0L:Z.,".._^D;QHB2(GSQ
M)F:3#J7!RYB@$UV4\C0BAY8-#YQ6O#>(?"7>Q>0+A#@N=0>B2GD>^^S9M&]L
MW9YTN_3='0\'Q.;_"%W&V0%G$5KO.!]E-QPFHN]>0_2<N$W)A,8^=T>$3F0'
M3(Z6A=%RO_%G<DH8867=S==KCYKN>X0_91-;[`GH3.W3UB/IKJ$>9048K_#Z
MZ,D1$K?/DZ@M4#2DS?*4(''B'1]A3IG?I)@F=&W/3S]G]&93,)^;^(P)=2/L
M]!G91W0MV!?X=*L)T.+IFET4C,4T2;.#F2N6`H#S$Z`BT#UK#6\MQ=S>VCK0
MT>!YLHD1)&+7H>Y[[-"?W?"??K:U)(J+!D"MEO-I*2>[V*8W`_2W]&=VZCE2
M4R,'%M$)X\=@XB&V[4X6)[$*Z@NS,7%<I1*1O7,H>JM0*>D?@Y[8+LOC#3G^
MD,/E:H_3//Z=GX8TYJ=!,H:Y7U**+IY(U,QXM*+!SF\*WS@\6$-I84*!!"C0
MW)S5``I.O.&G*$ZHVZZ3NPC!]8YX+?'1_$1+J;)6Q0?J\CJ.H4K1"!@UXA,Q
M^H%CE,!'&@,I'(;-;5\_$O[?``+6MA$V.11",#^"I1`^G4@356RFX'`1;'L9
M9<G7IG4"*%=Z#B[YLJ+!O%6V$#97O?E2R":7AK^O=Y=QML''A+5HN$GA/C[N
MLZOD&1;KKM;VV9"#:<,W`V8NO+22A/KEMN3?6^"XUW*)Z,_[*/T-YBS<GTDK
M9\RZ"YYF(-@.-LLQAEXKP,(*FC)0KZ^D8*MM*0=H"#*/_[=4\SY.(K*73A[U
MK_@'Z9C!-T#2Q14]^1=1?>^B#.'D\17YVY[>QD%PB$[,.\D1]NZT/SSAY`0N
M3PGQ:?!GC+:L[=WU]07X^I__Z4]OW[[^M_*7?AMUJJ",=50?***EVW6<K6*E
M=*ENQ[/87>%'@@TY@O)3:?%J5,>M!H@8(2"EYV()?!_%*7AFJ4Y1=6:GBQP1
MHGSNP!9$8L'T*$[_BN+H(4;\.)[7+G5&,TO1D>4^TF_'^P,YII>T")WXU39&
M1X;W@1[WV6NAKBO3STK?7;#W%CPEIW+L,D'C)DKSA$P69^#ZVYMOV=>JS]SE
M*>'P&&^:GZ(3P`8C!&EP`:+3&?BJ_,)77F>"<:O$RM82E`6V)P#>=K=@4P:%
MWHF?!#CQ_O-C%B<PR]Y]CG,VYV@]Z11]VTC;?4+V5\Z?$[S9'`\T4607;:CS
MGD)X?3&``!Y74%#:+HRZ)`\H?;Z2]1XXNFM1VVO*H95'(*%@WCBU1^Q+>54T
M`D:W6:U$3\$IODS:D+1=F<7.^QE@U35!L1,PN3_4H6H$BSH#^SYR\43$(WNU
M]@5>G>/8V,]YO<PS@!:;:W@1,*+RX%MDJY9\V]=CY19XYKNQOC)6&QXON84;
M&#_3,_@T)Q31LX1;G[2C"",/(*45F[`\;`"Q0=^2J2]4=!3\J<+J5HK57"L:
M>S%Z3%-RVE;/,-:C9VOZZY%VX48W*3S0]QC5VQRZ;!5O6SGO8CT+R[D&<!Q>
MN"1*#14SE<6*@54P!2LI6`MY5"*TTMO.6Y':2.7&N9#Q*B#<&#W+Z*%7)AQU
M+A<@@@E3>CSO56[X98&=C4I%S/(Z6-!UD`=8+GK%G4E8$Z@,(Z6M24MG(>.A
MM"FY$>,SYXZD<M[K^L!H86,B)FMSK1-Q<.)**;V<:%Z/U$L`O:($[(JR\?>P
MO&T<Y/%=BUS5RP!T?`]3+V'7<B!G<LO+HOCQ+7R&B5Y=*P5BEA#KT'61G5J4
M@$XYA\#<2@;2H#,)E18R($..4P%4<`SL`9F.V^A0=?S2R)(CT3I1A2-]5'GO
ML8R78R(OTU7M(O!#-71:#RE\^B!/H'/UB'.0NDU,!QBYR'TKF(7MBBK0CKOD
MJ&87!:.*B];P^GOK1(Z894F>S=^/<0H_5(G.9MT[%0F:M1A1H>TD%DV^_A1E
M,,Q4<#T,L9$^@\6KTQJFX,@*.W&>H&8Z=]/+LLST>P(7?56R2K8?:$^V.#^M
M=ZNR?M![G-(_&KJ;*0O#'C]&W%P7\-YS&>)0_7.B&6!+`"P/<M1!FPK!WV?1
MFX92#II)7DG"KAS81^9V]NYDUWJW1N0U>BNI0]7.'"UEX'QA%;^29'7W@UI>
MQX$=6F-']!LVB..K;>?5)/73>5].JN_XW9P[G1]49H@!Q8L]>$X[<,YRT/1[
MP/3I@]5S+R<QH$'J-C$=8&1_IUL_D0O:%56@'7?)4<TN"D85%ZWA]1@#:FSQ
MA:V(3`^D$F*3SR%"NMZZ1(5RM!R&3G*('%!ER#`)#X:RGE8>G:C=%)D7-B"_
M@.2/ECQKG(-%',>8S>J#`36]GPC^J&^JZ7UQ0(]Z<;?3=U&2HY#$NW>7??*F
M>W%-R2*()=%9O;)\MA^>._;0&G6[M@*#16;4C?XBP<3]I<?4;N<*Q*9'M>?I
M9M[VF;(Q,G497O,"%QUR.QTH&IVG@O$IY7;GBFH.&4+Q%83'WN6]<=-`J_F=
M88."'1@8,>?NLS\@?(*P<(]#<8T`#H1Y4%[2!F?(-1IZ"PZ(`2=@7&8Q_%MX
M*.X;UKN/.(<FKWCD-(QT+B/GY*J,<Z(+!BUXEC4KGI7EF'R:_B@\6%5O(4'1
M=H":"=U6,3:S/M)1CV2ZB:<[#\`ZO-LZE-'7AQ/8+3:H/BV8/DL0W6_P?!8_
M?+?;P4V^WKW[O&%U5F[)/+U.BG>Y]#_TROLY0KHU>?7H&N&HP\+^+HYSIVL8
M+/@#6J4/;(IR-3BIGU&S'V`MC4\'-0(<3]'Z0L!%+5S)HEBR!I0W+:==/0QG
M/[R3X^G$4\5CY^U^NZ^D=#Q5CZX1F#HLW*R;<=4P<ULUS(P#]5`CH/$4;2\$
MU,)#I6Y8]K[NO>(S*%TQ/,H5V4&D*6UMROILVQG>@4E_ET=I?MT8J<@\092#
M!_@8)PG=,I`UZ`2C=$FC?)=L5<8(Z0-T\>C<E*%L=-4LFQ5>)3N<[GE[%)/^
MEJHDS>HEJE%W4+FRP9@U'T`X.Z8L",R`W!%!R`Q;2>*UGJ4FJMA0O^$CB`3@
M54TR08/MW(D[Y<BKLLUEKF&R%9S++BM[,_'(Z;R,U\LI;.W[,)'D%7/61I(L
MF7!%(06OE36M&0>VC<:"#:&YF6+>7Y<RKU)MB3$(L_IJF49:'8?1!;Q5;6.P
M!;AZ=ZLP1B::SZL1TK=$PLIM3F9PT8/(GQ.R_4;Q[W!;=L+2F:=5*1HYH1IQ
M!W,N#>+RL`(Y?QXKCN!KVK;T&T";KM'847!/_S3QQ6:J#A[+PN.$+W%!S114
M?=AF<;Y[^#D_1S2_S6`_)/BR$0P].E8U3JD#1GYDS9G+(>0ZQZ,Z^<ZM.:S3
MQR@IFA-=X"3#*-Z6_3UO"`9TH6AU2(K0'?D-6T$:&XY*>!UKLL_;K`F,93$<
M]+5O2.BU7X\K8\&NT7A!AH'Z-@%:TI4)PY5\C:9C9*]7B]C:G->3YCS'^+OX
M,8EW\88^U>6E/\G)X88,8D.61Z/I1)6B6>Q%B;B+X-F>[.].]`S2$`'4,H!2
M"*]A,STPL9E>@P>N/&,-`S6_K]'>=RPN7SN\F8N-$#(":)"F@Z>EM`\@XP<^
MP(AR$_8WG=-[U.#!6BH+%0K40Z'!:W[/H#&M[E46K?72/R4:^8L1>>-(H28G
M!_V7B`!G_;O6B)6M4:A'-7>DV!1Y;$'ORT*Y&0+NX;N2X3N_/TM+P$P\JNK1
M-4UE5V;AY*5!'<Z6UJZ9TT&-H,13]+D0V%`',4'-(:\GNRMR[$P>8S(5\#N%
MB:ZG1,ZP8/@H92>MW0NF`\V!YJOAK@X5-E!<V+`@"2)>O:?3>*7HM='HP%`V
M06K\JI:WZ#MEY&BV.1N!;U<(!UO<LK%7T0-EH#7&G([LR&JP6V!>C(44,TFW
MAY'(2AKMPIJ_;4PYI8G-/O5\B!-,2XN2"1'2Q]@3%VXE<F:WN..4'41B3_O#
M$TY.X/*41'M\1G.'O_5ZS:X!%S907MC0E+?K!3]0,O2Z>-,"3'&^+\[E%Y@%
M?F&R:4U!9I$D3<IFX04M)@X6UYH_.X>V)/`:+#+#%4]3[6(P1'WX5EWX//LE
M(EPP[0WS#%>T+LPCM!`5TB)KB*8R!Q?NV&!.VYY"XC)/9^`2/D.$>:"!NNEU
MO*'-BL'J,87^;U-,L,83-+X,7)$(T@9CK^[Y+DKIZR3Z(NSN*3)TQ@$B9L]*
M9?3<9'K2!$#Z*@TP9EZ?_8ZB@96U%*+F"U<HN=1*]Y`$0ZO)/&&T)<9`@[?Y
MB9;7F+@J:1`URZA0I>_BEJ)5&O&L5?&4K46RJF^S9L-HHXJ-M;L$!,NTF`97
MP-FR:C)>EYZ:-RO8>R`;&98S=PL1?>9Q@;,\8Y/#>93!;=5RPL0O)[,RPGHB
M5P?5,#CRK(06<UEF%Z\8>]"4T*<+VS(+;!F(Y9I`,0DT?)T7K*ZD`84X@,E3
MK,C<*JJ6*_/G$Q#I>,(O"]G>$-%2F,<\:>P<)G`73[[@-.=A=F%MR,[!3%#6
M,RRXLCG!:\K!5+2Q+34O$-DR+8$+T;CF:,M1@NTW('25;/`>WD>?)R<G#-$Q
M;6,N)>DB'8%R`X2=]V[RXX!@'2T%JGS4U;M7/_B?QR@EYH!.U?N01F4'(X]0
MI6@$CQIQ!W=_$$%6F+H2H/&@YC+*(Y^NHXDA-E-G\'@5CB5"J%6M9/88S_$A
M@W\_DJ7OW;/QV7&`B&$I&0D]%R^82E:`\_);WV<,#*RLI!`5CR0ZG]_LR<DM
MSM:[SINK$___1CZ@2M$(%S7B]KV#\:6O^YH/-GUZB"9NV$R%P6.$FO#0\BB=
M=WRG\C^S.]9U_/=CO(WST\2CRS`=(X"&2-IWG8H;BR+6J_T%3LAO/;N1$DI8
M1W6!(H*Z8/@\SOR<P?7N79;'9+.G5PZ^^TTC;;>)V+?XGWGKG(J#3P.7J!H/
M:R,8M:):H^L!C;IYCHU3&#\F/,^7K%QIE&2T?AY.:,H6^R=B^X!LPFYI`A.S
MM\.F_!P\\>:B@%(6T.#N]9WW9-RQ-7TO$6,T!&\A!XL[-R7QMD_CQ1%IR'N"
M%P\0,8QO2NC-]1C\+,S7X.-@864EA@A,%74NN7ASBPL*1I*G_`8ZSGZ[2"'9
M-]*?=!QCD(QA2J:4HHO4V@8SNJ?CS`#EQCR$7YW1?_(DB9_)Y],\BA/?GJ*"
M'];0:IA8(1%,#)P&4'XK&DQ85=1IVGT2[WS-N<;)XZOK^!EN`WA<K8V<2O$"
M>RO.O"B5V0%#10M\+4D_8;S]%"-$I.F^/2__Q$73\3$-HD;P*=.W[V4E?9_.
MI8\9-M;=$O!!;6B89_4+&U1_YJQGZF#Z#),CO(4;_)BPN.R$E4N!F&$CS1&Z
M]KVH8`D://UV,E6%"6NK+61(D!0-;^M1^=*.^'#CJ=V[SS15%NJO1$KD#"$:
MI>S";SA3=BQJ/D4L^/+S$JN\$"'/S8'5<<0&6@T;,]2!:R6&:\ZEJ$YR;R:>
M\X[V;)VFASUR>F!O$_0=S8B\61:)/B<'B3T!OMN8@C"VH-]EH5EF"S6>6K1>
M9'`1BKUD(43Q<&=&KZUR<B?%T64TIJ4).]\E!I>?K10?']).@`I'75U[V_I]
MA)\:Z4TI3LB/&UY387+^G#YMPY[I>FQ<[!`WL%-ZO26&WZ;WA@#CJ1I>$)B%
M/Q+F<A!]I^'=;9[@]HC@>E=53>=!%K):-@J[%37FM^ODEEYTIF0@+*?PGEY^
MFJ6"VV5LMF.Q*8/3&O]_CF%*CQ\G\!ZGC23!(B"V2MK%^4J)P2H'#2IK^CJU
M&`%@0_"ZR75B>M@IO"_%S,HM<R$9:ZU3V\F85?7M"#`A?4Y?XIKR=T\XS>]A
MNJ]3!JS,6>;<)EJ0*6.G+7V6U##!HL4(IYII`"W:.@23BKS3`A,*4*E`0RQ?
M\\CJ.8H194V6U[MH<L,4)7)F98/'*=MW]0]17K;"(-XN[I%1"?9JA]-75#2O
MA:0U\,0&V@T;N\(1*WYLTT@YAMG4Q&[RC[.T'Y=)IGA_P`D][;,G=(OI86*6
M_.,T[<=#PH_'76^_;+R-W>TXU8G[E#$&CCTLT.X'!K`*MZ!JVET$A((MI:@9
M@??3Y_LCV2'!#W$2[X_[6_H`&I75OLC:NR9S1T2#?]?D!&W'12<QG!K%,.?M
M($C&A`&%-'6-M9^3+4S!1YR\NHB(Y_%]T`TY<Q29ZI68@,L9AN/;L"-Q!&PJ
M9DNW&5'$JVTZ7*K:@NBFN6LE^C/-]CGZS.:/-V^+V8/^YJ]5D?&_Q/G33]EO
M'^#^`:8J<\'@U[50&J!D1^=;O#GNRVH0Y#Q2L@*4%R#,P*^<74^)<WB?"@Y8
M04MAZ;PY-_85+M*S;XF13%BI=<R4X/OAB/+X@.`E1/$SF0=HYG-=:G[",CZ9
ME:5,5"VN3B/(A6Q9F;CZ.]G@/9S`A^AO9!*^.&8YWL,TK+QB,^L8S#HVP&.Y
MEH#*+(=^QG(I#6B(T^SR8'$9SO(T^M\P@9M(=P7N?]-@(>@2<;/N4BZ`LPE@
MQ96J'`]K)1CUMI;8AFZ-%U<W8J*^A*HKJL1;/C*#HM4/LSS.CSG,UKL_PPCE
M3YK.,TY('^PQFDY<JV0*:JYT.>-\_?N:,F!82XFA@M-J1C.$C*FGSC,,)!_!
M>M2V'`>ZNDUM:/;'AC["B!$1<&LCM*7)8F)@0HN;F[CT,:_J)S#N_$D0YP_Z
M_7W"B%29&8(P-F4`P?)`%\2?!*V;./ZK!O[>0]OB+CME@Z)U>AL_/IF6`S9G
M,M$`-/G9]_N2%;C*,GJ;D6-P0^@]11EL=8,*P]E-;4#H[D:Z7R+>`I>7-H^J
M[&%-R^508;SZO/`I5^,$?G[J==I9?8K2+7]JE?T",S)WT6OYSP=6<?X>TU^M
MCWF6D\6-3'HV-@KS2SG5"F<6V/ZT53ZEV^3Q,[7=([MEDSVAY(_L`IG"?)FT
M>`[T8@E?I/F*9F'92]%F)]GSDZAY%V`#*IZ49H`/B><#%8,"]YC]&C3&%<`N
M3HC=+9$SC:G4S(5_3N(\8P,L'=S=-*W-VHGQ:DKA^`ZDE*5H!,JDJ>;:D*=1
M4SO2F!N-D'HY-J,SB\D,B<U<U=(=T)347"N8Q.6"$:$C7V/((6G/?V=W1IK"
MV9IQF0OA\LUAL9\K'GWMJQ<]?X'T>`*WKU;T9NZ1O18KI0MMCK)@6"-3U%3L
M7HP1C4Q0[>T3GY:J350I8M.4_,]/S3F5-G.EKS9ZZFY<2J\0FW]HS1/)RL%:
MPIZSG'4KCQ#G%'#JR[3Y9)VO1%!9_"F,:<^'O8J?0,Z-]9=FFX*YMF66E#U_
M\R6:@9MY-/50!G>4O)?U.7_^XG]FYA5NSN$.I[!N=4K^D^7L&J=HK6!CCC5D
M-=$BC;BZ?C1#%F6,XBUK;E[4&/KZ&F?9-X`+2A^N/<>L:S+Y)PBEY),MLQ%.
M=1.`6JZ)"*:?`NS"$)I=@0N)6(BL;'GB?0)YM]M!>@ZN-7=+S)JF(":;&,6\
MKZN-5`8#/E.OMK59VI\W+F,B!&UJ0RTB_P1A(IP]J'T4;=1YL=,]K9$$>$H$
M3P!^#[?DD(G(@2'*CT3CI^9WZ<#"F%DFV),X(\(0Q(7:CB@WHA2E"SAHB^-_
M+KF$Q-93FC3R6535Q\8THLEBHA5H<7.\Z2AE8?`798FB),`7NV96('1^`_TO
M#W&!RXNP[I:@\N[MPZW@+?BZ%H.)N&OP<A!4@8C?EXI:W5]&N3"=?G['-@%<
MZ-;:REX:N`*7%D';D,+:,YZZ66]QG[K>W9&#1KR+-[0\2+O3-IE'5EO>6KFE
MD]4#?2FQR95?,5CFJI]5;U4`)^\C&EV4RYMN&F>JA>QU)&>UI"HY6];R:RFJ
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MD,"*.@I/ZTBN<'+R)&SF67A$8Z0_IA!>XGT4)U.-OD/,&A`MNO,XPADHN8;F
M$F+$1IQ#H,&0T1ERF)(?^)5S-(S8W#[!.#F/<0XW3S_M'W3K9\F^KG_F%5-R
M$@]AK$#!"U!F_@MDC>"`%;04ELY;#20I']-#F$LA44,^-8-PT_1G0^SSB&A*
MXCI_@BG-/$KA$TRR*@6.YC<76:N\:<#F=)]&28;X>73[MR/?+7Z$^7IW'WW6
M6<.<L#=K3&-?$CN&\@S3!UR?PPK&(*\Y@ZAB[?7<Y=*6\`Q(O2R[*2:8AGR`
M"0A:$I:II53&*C>],K*&F*"6$Q!!:5R'B#K+'"727;2A0OU$=A]4\EL8(5HO
M66?JT:%J9!GJ#!R$:UK3!.<*'@E;\#6BSU5\3A,&<&)SK2X"NL)7Q?Y7H$<Y
M<S<M>9MMNSMAIZ*OW>D&IC%6<B`5*OH;PD&"3O;BW3C8&2B9`L[5VXY<#2*L
MKKGOW$[0M_0QI6[,KO$ELP+NY?<='!HH::^5]GL*Q=*!AZ`\U-#;G/$TQE`]
M;B#\FKG^G)U9@S"_?AA`.O@P5-@VPCD/T1^BS[1[DKXA=KYHI,<6#1=];QEY
MG^8H5B\>5$$HJD0M+0X&^P+9)75O?5OWO3B-'V.:NK<OMTH'Z58ID/$TKSZ;
MMYXCFSW%;A!'"N=Z=PL/M*U>\LC*C"GOHF5?-V@N(*3DIM\#8T4#`!4S7EW-
M7XN'812P@H["TGBKB0-7-]Z!M%+W4:9NWX*CELSC)N)D.?XY2:L.6O?1Y^)Y
MO=;A1$K":%V14+-O*TU&((\^@X>"E<_E>PP.K*BH\%2/!%IO%'3P:NU5^8(;
M2-9KFI*U2K97";$6F.5%_V`+'J'&QB9T*AQG]*PS$!7-F"-6NB-CA7_B0AZ6
M('<H!0W0"[7,9-Q3U<%9IDF,>7RS4D<E#$NP*\4I>W<;YDS`#8JRC+VO:5\>
M9>\)W`J74>KY%198&>0%3.;J)F^C(U;C-HPX/!$,J-VS^4ORL&<XV#)4RS62
M5A-$7K@IK40C=H"/K(!+U#`-S$QCTS(-?B5'U@R9A2Q))V44;LAAWIL[C-HT
M28[T&^J\CY`><UAS5=IH2FW',T9!WUZEQ)S,534W?FCDO64A8_BMMPEH'!*L
MIBWI79:"+5SCY/&:&->6E]8QLH8>C6GVT"$W@T50CH"Q+"H,!6$3,FA$5B'4
MF>,[SNKITD\0/Z;1X8E,;$CWSG.`B%FE&QD]^^M;DX/7JD2C.&!E_82H\V+]
MK+B`)ILY[U;OX&-WE/IO%`:(F"E?1N\%&_PH#EA9/R'JO#1XSJ5C[FH/#)H&
MG\'-MX_X^3M6>"(]<7LO_M$U]>+7?ZV'/F33S4]K*;+^HHNX5,Q[W)#IPLM"
M+M`A[@_9J[[*H`VXFV7B+.]7U@>81O3JHS!MK9W"`!$C)Y;2<WEA53$#!3>?
M\^@X+%A972%"T+MZZVG?^,;0\?FU:3Q#A]=`Q4<]R=F])Y?\G37)G1P4Y:I'
M])2(V"DQDIX2@QB#4/^CAUPW+Q6B.&6-P^KJ%IE.24TU.F8I[0,D[2:Q5]W3
M&C4^,L^%*[4`PCI:TPU'511%5::+1G/;=7)+*VFD9/(^C[(XN]:ND#B5C7Y0
M:QI')W&OVA3/)(73R]9^6\!Z1A:B`29;&,4.+=D+MHA2H/./N(6CXB3DT'GU
M2@I.83&3T[HK%SC583U7![1@'I/\=%+E/]^F('%?21.$R@S66F:P!$7T]U'V
M=.!VUWM^:G3*?9_"OQ_I*T;=2Q(E<M/6(#EE!P\H:DZ@8A7$'E@!+M%6>$QY
M84/3]Z[S$Q!B-.=E2S5\T>#UKUV4R$W#24[9Y7)P)H8J"'=2@$[D3F.*#!NF
MOCM)?$G_)L>N-V75"JG_3$^-GC6@NJ1G<ZCLK-Y'A.924OQ&?$JLS,"Q&O2J
MK+'9F_69:UT8])Z,3'=;)_JV$0Q]0O8=I.8!*!.?SC"@=3RNE*`TC(3*G7.?
MU1[9193#1YP6E:SUUP45:A8`$!%V:?)>WZEH("0U?[G"@D9#XAYMAC-7-L`)
M/'U@!;[?'Y-M9E#B0$+![(&^D)B#,SOE4Q0V!SO*R6O]@V$0L)I^@E,X:NJ:
M\P",R;PF_O/=3_@9I@EUN-4C.:S$,+N$#_E=5<M>W^C5:9H]@U,D[R#=[`[4
MK$')&U#FX"Z(XO_:<&)3O2X`NL+%?@9*L,WM=_<I.]2<IGF:G(HA0#*"3KRI
M9!:,]XR"@M5U%20`#9\0*%_5!R07Q!^.2;R)#Q$RL>DQ"OIW>E)B3FYO*VXJ
M^ISM4G8<$JRFK>#4W]JQ"G1O>@'J6&PDEWC>%:AQYU3]^.<8IL2RGD[7\!EJ
MO^]2I3CUBFR`N-M@<<4OB/"P&F[B.\Q1%0:/D?`FL_&OBB]@C'U?9V9]A=BY
MV!P@;"_,+^/A-/<E+&_3PG+L5F98GTO!;>2>1NB,?FY"KY+#,<_81/!FP@6H
MB,PTL/H4W:Y@G-]9,2>^"<*S!L`1^9%,96$"T?<1SHDC\,;3EJ\QVK=V_.&M
M=7]X.[\_O`W-'[K@C/C#6R?^8!6(87]XZ]\?OK?C#]];]X?OY_>'[T/SARXX
M(_[PO1-_L`K$L#]\/[ED=@CODBSFME]/[RT>@D;ZJ%M6AIMN>4Q&P5.F2C*=
M65.%FEE/LE'"#NK?>2LE90`.UM=5T$"@)@;-8V?-49[9J7:SL7J.8D3?E+S'
MZ5V$8!VT_2G%648KHO*N5+1/5:.VWU4BZK<^=@MBB9M^R-X*8R>W*T6!R4X]
MR4,*7]%RQ,=*,-[F[0'N,`%]"[?'#:L!(?@@+3M)9EB<@+B6G?P,HE()KPB1
M5QE1`\CJ&'V\/T2<9N-K_@H+VC5,;-\.=%^(*[.FS>#F\[1A;@X];8BQ7T^C
M#J3D:<PEOQ0_4S)+;3\;MP+'!2`;_&C>#-FGTFXR>2-+P:32AP[5B<FK8PP<
M);$6:49T7\\YM^Y[@Z@*8@"M,/=83<.ZZP'M7-3IDT1X\(1)ZCDUGVOM,B%&
MM,V:>VJR<=;R\PQLNEVM:(V!?25,8P[VV@'4%',\5>F+F&<D3Q?,)AO;CJA7
M\D.;KDL'=%?<0]?YO)?S,,5;WP$G%>[P@FVO2V"OOQ[UP5J(EA].J\_A9;S(
MZE`=;5#)*6+/G.W\]#Y.HF031Z@J)%U.\OKO-C7(&BX=RAQ<K!T5<_!P`A5[
M4%?@KJ+,?O>H^NCB"3I>!I*H#^+Y"(BSYL%)59#])<Z?+N/=#J:08)]=);Q3
M(MSRZ`.94JK6B1?'-&5U&V""]X1B]:',((%N)HG,[AIG$<[!E=Z0O67@$Y$=
M-(2GH9]2?%`$F^@NJ.Z560X!-,90?-+K%<O,]HS]F,:+MUVD9+9_Z9KM5=]L
M5\IF.V_>(]VB$=FZ[:6U$UN&Z1@9RA!)1WMS.KET-ZT^IQ$E=+".R@)%HGEJ
M6`E`F#?9JXJUD\U2UHJUZSO&."VS"_,1L@[R%OIW,&$\Q51&"^NJ+V!D4`>4
M@IFW)V+48<U6C<EKA,L5P??D/SS56YG874WC4],1O5V%3(K874_/.O0V<-/0
MW<"8W2[/O:MPLH4F&^S?X?8"9UJWR\HDIRT)P]2=]-KEY`&E'\0BK8B9:*U6
MT5[X^'17;D"8@KO.VCT.W,)R]-JMV*I\'\K8^/E]0,-3`I5)!3JC;[5WODK`
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M!.Q5'`0GPA`0<T$P"^/*=;I!&$P*8_I?-/A&TP,7"A"I`!5K)'SL=V.P(^9-
M!+U_2O'Q\>E]_,PTZ>+JQHBQVV5%109GDTA$N=?S2,Z%`/DGS'ZQB!E%SWQ,
M=ASJ$+T44S';D3!CHC-.(2&@(K+I9^SZ*IR#B?,#R9S;5/OA\7OZ,X@J,#=+
M/(98.W[,?>P(YK@1E/_6-;D<!A4$3)SBWN-G?P^PG*LN5;P-_%FBYR5B:^37
MC8)72P@A5*IS'CYH<)KO]%@Q_4?80,L(IH8,.GI?+.!60@7RU2#(,('3*4&!
MJ9<SG_N)XB6'!JQ,((K0O`3SL!\."&J.L9WFUJ7IP`1<IL#Q,SZL3@<[BM5S
MV*<#T[0XD2X7`)>Z0RJGT$D*-]55<.6OV%;;;4SK1T2H44Q"YS!NBY-^`:#)
M3)V4>VJ4'AYZSE<+!II5//P6!K1L-=@N4(NUD,+C75K&@K31W*^Z4HF;IO""
M-WNWC3<I]!6`SB9$C9Y9_W(%TO;1O&W6_<U8B(*7VJ:S"SF%0,"`Q;MPJDX:
M88M-%!TXCJ@\0(K>A-ZVGCA1IE,W)!=X?R#GTR1?[VY2?(!I?BI*9QY8BW#S
M#8@RY2G+B2(3UQN,5Z`2A'I5*0HK?%()$]:>0A?X_AY"2_>+`;F_1ZBA73>@
M76E`&_!P)9N`:6-V_)RAE.>&J#1OJF;"NZ(QFA-3W8?)NWV_4,''F'=!#.E1
MD2*PPD<+*AI>`(C(#GY./%`Z_O/3/1FP;F%7)7)&D"E0MN]R)=.S`J?6VG\&
M*&.?7J8#'C909=A`H39&0E<Z/S&0YJS/*I]1B"#ZQ565R-D%JJ;\#X\:`$_%
MH[JJ#!LH%8_B[J16=U-R4OT0)<<=V6,>:>>XBK)Z230%(OI'DR%Z3HZ:+8;-
MU7^@&-@LYTDE>+"RVD*$HGVM+\3!],SG7G@T*+=J+4.);Q*EX)3ZW$G3'_M?
MU`>^2\.)W]5,_+N:5-MX4".A:+;I1N0_TYW'C9BHDG`,>#?U/O'^<"2J,ECI
M1DF8E;(44W-0$K)@-&P8LQ4)'<$!*VHH/)TCF;KG-?3WQS2):8X<V3&^CS_3
MGPRJ0`]1,:NB+R7HH&M#R8L=;$IN7MLKC(."U745)`"HJ_M50_?SNL`UC#+X
MA-'V:G](\3/K?V#@`X-DC#`8H.A@+U`R`TUN/KU`!1>LH:TP,4!#ZI_7$3[$
M2;P_[O5-O_-%LYO])@T')T9.WFM*A5"]>%`%H:@2M;0XKUE*0VG7)D735*C9
MC?A=NRN/-GPE=1U&130-_%3"L]<6:I_-A95*<';V&F?2P?^<P=T17<<[K;M[
M)7)V4:HINWQ(S+F`Z_B9[$B_ODKX4Z%O@G0E`70JOM159-@PJ7A3!=INGL<X
M'Z+-$_'?M)4:Q.IA:VV@!J@8YDG*"+H.QL,0PD8*J&!U906)0'6C4+#I^`'C
MY'<YT?:",4IV9R='WC!R62[$)8@E1.H>*AH,%AJ5-6,^7Q%%U;3=9("(M5"?
M(^=HAUIW@89:I9XPHJD0M3\<9YW/\H5Q-&W3'Z)B+[SGR/CK$%\<<H15:OUC
MN@H2@.'P:@"[I'7^I!=L':-D=REF1!W4_LXRF+,&Z`2-Q]1SX1Y%<%3V1`U]
M!0N$RIZ(L9NGG$7=)NH2'E*XB5G2#_D90?;8-MD6]?K8[Z4*TO$A>SS-ZBM8
M8N^BB=DU\440-5IW;1L2LFU;U!#-:Q$-VX:#72&T9"/I%.EH&$93*E")Q>:1
MIF"#[V8,DLY&9\J/T%6MV*F/?(7/""W7&S'@,>5-J#8[UT^`)8\DEU!>Q-P\
M^H^"#7%9H"D4,Y,C$UB$"B2/AVWI07>:NR)^F3S&#PCR;;[M*4Z3_A2;UF+E
M>FJKA0'%^6D)LYJ9-?1G-`,H%H9\?R:SA'CP(Y=,8!:&[[@$POLXB7-(4P2V
M7;5-*((P3G7B"_HQ!FX+(7#N++%B*\`XJ%((R@`+BR&HZ7D18");.+JY6)/K
MX/ST(?H;3B]0E&6ZI1&TR)I=_ZAS<'`=QYB_D@'X<`),`L!$\'I+9P`OGJ#D
M94")FBA*W?"\A>*<514&%%*KXV.T-ZBPH$W:-J(B+G,[Z%D+6"I'H#XZB+::
MG\KUO1QDU?RUBZG-P@U3ZC58*M,P6W4&[P_%AS0O+,5@L0+#/(47;E*\D5S=
M>I48B82=]_WX,<OQ'J:W$#'CS)[B@\&;PD$R9F^:Y10=O"4OF($6-Z_OR15P
MP1K:"A,#-*3^F=^7RQ?::Y/G6VKT;.\)KMT]X1H[1%^'\8A+"T>U+=VUA8=<
M\V&FMGF;_3&77`%FK[G4Z%G&:I[W7$?^-`@)G@:%X4G#C[C4U1<X.BJ>I/&.
M2W+N66TVZ1%N[Y_B='L3I?GI%F:0P/2T2K:7\!DBS&Y#WWT^P"2#V<4Q3163
MR":1U]_7FW%R<L`J1`%,%L"$`:4T+#6L(0\H!3H#A4C>#F(330%;`.([3>L5
M5B$O*!9R7,?10XQXDQ(KW0$4R%NJ'C_*:>8^`84\H+3OAD1AW:4;&<-@QP!%
M*)8%?/\BO55'WPQNK66G05+KF#-.PW@!$9%SNDJTU.KY&*.,#595VK(\0J6]
MQ+QNH9P>,?Q]&^Y@\99<Q17\I3<H02'W`-.4!?=J;STMTM.Y=]G1C&([C&.9
MS/I!#&)(_W-'<_J#+=<'C1V^!C'3ARG#=.<QKI*;YR=(BGAA;?V%C,V`SY2[
MB)E3,@M1WNT/")\@/(<)W,6Y3EA'E=(47"1$'50AB4[D=X@%95+(WVO!(C`1
M@,.,P=3WED'-!0M)QT]*7J!D)@N-N721FQ3O8):Q).KW4"ORJ4II"AX2HB[*
M,3S2SO#A.,48,'VG&-15L"!TG*+)"U!F0_'BT`/F30/C4?(#BY*GS2CYMA$E
M'[*_T`?;`5)X*["2W`K,.O.Q8@;2K9'.S#=&R<CIAHG:-TS&C[[Q9["AFJ//
M25`1(ZRGMF#Q0$TH!O;1$Q[(N[8HVZ_C[T[[PQ-.3I>G)-KCJV1C^]VH+H,I
M(5X]7N[ONTIY`!?H#!"1OB6_7\(+4D/#Z-][F8"R-"/HWWUUH*?(S_&,U,?@
M)=<<5C3@^"7I^3&+$[(/7FW^?HPS)EIV?FK\BS[@ST]7"1DCS/*K+"-S^SJE
M_Z5!X@FO3>UPGOB(T880;E^MEA*"IHCT=57CWX!+"4HQ`9<3K%-02AK6\U:K
M5B=\`FL/V!=C86AVXW(\=W'!/L#\"6^ODF<B&SMS]GX+(7W0I/L(=QJ?B5:C
MS]+^+%3S/?/^RL\*Z,*)PE33"P58,`D4_LVY@EH8X1\@+%X'SO>>5Z84_>>[
M8Y2,,!TF^K+=4A$:K*>M8&$HG&?0+R:]FNT=7C1?SDJ_KW^<E)!R$C(010G\
M/Z0=`P.K:"HPQ;=.&9=7IL=MIS*62Y3@]#RM87E;ZC]CM(V3Q^P:3?,R`9VI
MH/=(SN%UH.0*"-O0O$\.EM@+)1H,%)BF5Y8L[+BF(X$E+JID04[VB()3=OM<
MG74/UM<FSX`GL3':UDS@:-\V1>&";G@@$\8'KL-X3FS#3+!%<)9I$LBA-<QT
M@F1].*8='0L2E@XKC)K+PR+K>B'9\OD[+K9Q&#PG-C04GLX'3H;"=CNN&FGC
MM#$/K#\EQ!2>XL,-),,A^[Y'>'ZZB7233[3(FG:.5N7@("VE9`8.%3=:@_`0
M^7H]/`5//$&KR\"N<+62;WTO40-9LZ9W&3="(-6.C&SU6N_^$J5I1-SX'M\0
M<9^B#-X]$:K9>G>!]WN<W.5X\YOR^5&/J/Z918>^DY,E$X"&EDL1P#T&I1"`
M2\&>_C$Y`!/$VT'3"&)LK&K=)_DEZ7>?B5''&=U`$?..\5;9W`8HZ-N6E)@3
M0ZKLI\$.<'[>[&4<$*RFJR4X=G.AK,"(^98^Q^!0^O2&>W(F\^0P1U<L);:F
MJP#\1X@7;#C/0>H\`4B/.H*/>[V;*HJT"&IEB.OT-GY\R@M9X$T:;QI66OQ5
MZRQI1M^LYI\!*_>62,R0LO9:D7$*QMB&@A>&9^&;O$!P/5?2P`YC4SHK[?]#
MQ&A-I^5GYCD&L^1V.E?'N6Z#QMY7S1/Y:RK._*ER)R^;H3%U=Y],=!42CFH+
MT^:/(FKB9B=&073V`B=YG#P2DN2G+-["E+=.K$ZIREMY,^+Z&TT3/DX.`,(8
M<RT*:,G2./=[.QU,@A]/5K_T=&DI]Y)N?7E$_Y*5M^:[,KY%;N:0ZDRZ&D3-
MDNY4Z3NH1-TX%O%C$Z#=;&N>7G,JM<'$QDI=`G#EI38#J[BVNBPJSC/&Y5&P
MR7J6'<TE?,BODBQ/V=3X/MK`U1X?];8V<AI&V,C(.;C"XD@D.(<TY%#F&)S1
M,T2RB0\1HJVACWY#]:,(8575!8A&X1B4":BY`,H&K(2J=[/X'!]P2K"G547.
M<9KB3\0.+H_PDOQ":[T9I&,V4PV0=%!EI6/X9V!+%I8MX>5U.5&!!^OH+%`H
MRG6BP0A4G,B*`<&E!(JPM]["3)_&7@5LZGWWIK7O/@SNN\,>]5`RB\%!P\G,
M=Q.=6!;!/6;2I;"4%F8_I3C3VFV/TS)RNS&R,YGH\4`F)0+7@8OC<SY4!@WK
M:C%@@`IO*IG1BY2"':CY`<9PGCX549S^$J$CO$H.QSRCC[/IBGFKN648)&/6
M]T!.T;ZK?(3$(V@M(.(9SY0IV.,M1&3?4+`%J>?-@PI.6$-[86)2>`?E`Q@C
MP#F!DA6X-=LYE".XA<7$EZUW'\F!*2..Z.:)>L6)%K)G9[,#9V46-;V%&WJQ
M$._B#5MAJUN,9O%;S-/KE*.E>D3UHZ0Z])U$1[L"-.]EFD5]R"S,I?`6%C7"
M%QOKV7$85'@+I_N^?("(O:M!-R_#^24@KHT-%Q=\P=WHRMY_CR@K1`!&+V!G
M?)(M'*K^>^Q!,O8P</42>SEN('^//:JP,&$8=X9)[[`[Z\M)\X&H[.O&Z98=
M2BYS+:N-P\G_&]`1&+""DL)2N2B)HV(T,2G/B<!((NN\KSL_X@0?6.PM>;Q*
M-G@/BWJN.HO-`!&C.4Y*S\'YG6SM*UX@9LS*$KX^UYIQ7+"ROD+$`%7JK[7/
MV90%A6<Q_\8QIPI1K+9_.V;:^6UCE(Q`&";J8-OU1$2"[#WCIV)>HN6MI;<3
M:&B"G<M5%#'$>FH-%J_"<YI!B$;4J^8V3P>"BAV-?E<%.&^B>'N57$2'.(]0
ML<+Q9`,=ES(@;E8B7Y>/B\?$FQ32)Q'$\Z*ZCNF!B$!_M>%">&UI8(PTGJSI
M):%:N&>#.[NIJ3&E`I"E#A0B5.<K+H3I3G7^@&D[9-V)EI*3>[&`G.I%@EAR
MC@&4ADO#'">2#%$W(#Q?M&A]S+.<K-MDR9X<,FK1LA>P:)!U^"8&UUR"BQN)
M0!H+'O6T%C`@HV&DM1P<-R4<(G2@9<#C#;S&658EH&Q.IE?7JA3-'O\K$7=P
M!(BR)[!#^%-676'#K?=+;$WPL)D>@P>J<*H&2T!Y@@;3X0MOIQ7"+O#^@2;M
MR3/,JB"7CIL9D9]4_DF#DWT'?)?E\9YE/N[HL8XGE9#]5.,0'L2Q>PKJ@D)?
MVCI?%L*%YU:9=0T!Y+F0TOBUF[UD]3PO6R7;>DHAN]JZ\X9)VUI-PF:;&AT>
M=G<X-6?6&ZW%&S1ZEOCMP#,-93Q)TTM!M/N^;"*LCGLTK,O`^36-'&U760;S
M;$+7F"%Z$TORRTF[[?!2\06<,>"<P^K8HH"CL+W"F%(#QPQ-ALM-B0/1L*]-
M*MJ.43)[I3](U$$)/QDDUV&4G56$"^MI,%AHD#DJ,WA+]OZ8DR7Q0YS$^^.^
M?*EP>80F?5DU*5N`;(R)?>\B6OU#.-ZC#)_4F]0TN!BHQ-Z6`<X<%-Q!]22'
M/E"<M0NRFDZNDOM/^+]AE$Y8OI2(NP2VYN/$#?]E`6XHP%'?$[MZ7!)F)OYX
ME0`B!&!2!.:4A"MTZ)8-\HY!KC@Y<<T_+L,U^V@:.6='E\M"SM1!J1@ANNA[
MH@%W'MJ@[A;FBI$3__S71?AG'TH3]^QH<E&P&3HGE2)(WXR?':Z>#>J.02X9
M.?'-/RW#-WM0&OEF6Y.+@LW4-XD4X?GF_1-,8;3+U9YU32#N$N*:CWW'K&DO
MP#T%:.I[9U>;2T+.Q#?E"/MT3`?NZ!9*2ZZ'\PB5KH<]Y]'K0J7O:^X]S)M?
MF3TY9G3??3[$/*WF`T[RIU6RI>NFBD>,T]!_"3M`SLD+9,8/U`S/`&/)7G=1
MIM[>(:M@@U65YK@V23N]DSXTT$VVD%$P>VPF)&9_M]+),*7I+P'D3XR`@=7T
M%)SBD:[.!RP]@YMO'_'S=UE^2*F5OV$_4>M^T[!N^KN_7JQ4S+CZJ);:BF\Y
M*%,(T]\@@J<S<!&A>(?3)([`U_D3!%^5?^)KRE??^+#4KF)Q1Q7^E%@8V058
M&5@32RY/3WS:+/[1G3&+7__UIPL5LVI^6DLI]1?M&]?E,<L@VN)T=P9^@ND^
M2DZ%;=5_\6E=`A7COD:\JK,PLY_`Q3QO^;O3\K5)UM80%3NKQ;6[;"W1LG$=
M1J*6`CI#:_:UA00MUT@,K-TC(`1Q9!"G_2%^*(,58VDU]"`&46+0.>\4QYW5
MP'%'\P7)N\]Q?H&S/'MC1_!GF#[@2O\_)WBS.1YB]@IHPU]/2ZK2S!%0NB4G
MR:(LRT<X)8VO2\A&E*)-T\7C=M8/C#$X`PGT6H-.#1AYT$BDK%!!D`6(&"`%
M,_"QCX>C1C$[F*9P2YE?D/_&FBUB^M\V;$?2)>1@ZUOP`+Z[M`_H'(^K)"C]
MHHYJF0US!F9!S<:37\VFU8)OZ@<P>T2<A"V;[YH]]Z:6ZQL/JT2W*WD=R]`L
MC=G_H@&L'1IN4*VC-=[K8$JUC0<U$HIF+8;#_`VB#$>-F\4\<8/ST\>(7D'1
MMNB52^O6(->A:N<T*V7@/,YP`IQS4/&%<12'X@TCREP$8O)XQ'F)&'UUV<1Q
MQD+GG6(I7![]0N>#9"S`U*+HWI/.@G,E,3)2WQ'H*TP4Q-Y1.<:T*N<-@N>Z
MVSC!5R?MS\]=;N6:EGL>P'9.KG?!-OU\XI;.D8[;92B:"C;>MSF2%/6$'#`"
M;<]9F7O.RHKGK.;RG%50GM/5N\!S5M8\QZJ.I9[3N^CV+:G`<^1&X*;S)8+;
MQ[),P1T\1+3&'SK=P@-.<[B]@YMCRDJ:%A_\.=G"]!KF1,=DO\HB5^_YU03Y
MS"JOZEWK;-[<R6#6R-&1.`ZVC8PI*PO'V((#EPA$&<BXF%Z+PSDW+CP7:B_0
MD(JYI^!=U@ZIQ02EG*`6%)2?9J*"PO[HZ9';7RTN6.6-@O3SU,0J+'[]*2%*
M3[:5^B\P0F1(:82,IB<]NF;UEC18N%@C2R;Q[P3;#4QS7N":59S<$C/(^O<3
M<\XC1LCB*>I="(J%#Y>,`>/,\AMJMP8U][D]\AI'"2W;5UX.;V#\3--7+V&V
M2>,#VP)K!7D4R!F&&48I.WC_!=,]ZVY'@_,LP<9ON$<=*VR@N;!QJ<)`A!_S
MGRK)H&0)&CPM'"-L7I=*SCO@P'B`'4[!)LJ>SMC_9YT7GB/$'M/0AQ_[*/T-
MYFR(6;70!S9"P3E)?!'L9!HKV[)<0O[?JZ2<<"_YVJAU):1"S<A9Q@D[[EBS
M9P7'BPFM/'^$L'_0`!#KZS-HL%`'IY(??3=>;1M*EF:QNDMXS+/-$SR/DM_J
MHX)FU&Z8B'YL:8B>DTA>R1!0CLTCD_>8GA(^6%EO(6+1SEL3`V&ZI+F7'@T+
M/G<>1/)(=Z8W9!1/9**H*V"OV/RNMV$?HV6X*QPF:]^FBL?(A_(1,GY`\6,D
MVPK.MV57A`KKZBY@6*J=>O((*#=0L@,U/\`9FBUG'X_4V=:[FQ3_#6[4]G:2
M+^I/E5T:3I8JSH1NU$HVWM8FJ;+QH$(</_%>IX]1$O]>-@;),(JW[!\TJ$,`
M*%6YWKV/DRC9Q!&Z([^!O$V!06\,2PS-4OAM\+:;ZM^0"+1$XJ&MAE`T]ER)
M!6JY`FFS8=>0L!/0EFXTK0=K3BW'<2</,L5MCYO\*MGA=,]DG-#&0TIL8C\(
M"5VW#3P*IJ#!-83B$^K0"3MW#*HR9)C0)(2<>-$]&<QZMZ+-)1^9'^LF:DL(
M&,$@I.7@_H!0H9NX!B,6T/V(DU=1XW?WY,>,]@DD\Z%/=QG&""OI+S0\4`.*
M=1N*&9.H&VSI;0DQ@`;^3?C5@W+&I,VZ=.MQL>]+30&"=B)3J/%$92\'5B1`
M=,41E0$Z,5GU)Q1]QG?[.'_Z+_)AJ!GYEGQ;/W8@).0D@,`XG0'&ZPPP;O[#
MW,,HX'$E!:7QYN0D4+=I,-NAQ*@A+)=UQ#+<Y+/V-K[7)O5_!LF8)0/**=JW
M&.%V_#J,$D`J"&$-O86)!C('PE^<N&E"=9#XD.+'--IG+)&$1E`(V+QF*/D)
MG<"&T(\W$0);^`P1/NPE]2+\C0NUAK26Q[W5UOL;G),AQA'Z$".8Y3B!175:
M]1LR-3KZ*]((22>[@8HGJ)B6Y7HE%S&S[0E4D<(ZZ@L4E=;\7T&RKR`I+B]-
M/7.6,:"N^*H6I?JJ#)&O85I'Z!FN'E.H%2H:)6'R`DI&S=%KLP8[4/&3A"IF
M\U(%6+"BPL*#H)=HW]>_>;*E6]'1H-1J`2XM3U1_]Z]`Q)8IV'QMKNJ/DE?G
MGCVR__A?46TA0C&[7SJH6J!K/\IOK[<QNS+ZA/7?7O>^:O0NN$/%U=MKSH:U
M!O4>OQI0.QY13#@J;L74D^1(MG`)S$$6D6U<O1?-0+1YBLEI45C(S:?\E6.I
MF(:;?(`R$Z$L,7L''WD`7?-&<X20V07S$$T'.0`%=:^7_$IX8"T=A:K[POHK
M3J!D!4I><]YJ%CSUBT%UOFCXEO/1Y8XC",L6ZA</ZB`47:*6&B=N>-Y]/D1)
M1@N1Z^UV>M_37X<[))SL<RH>_O<X,DWC(74$HM6F^U8,3/<O3B1$'>'FW;C4
M-9.?87*$JRW?06GM6>0T)I9Q;I-S>H(D>B_XA5$T6X*&L'2V2$T!:KXP]$89
M;<8%5&QF,?B"ZRW<X,>$\:VBU1]@_H2W[0_\#I6*<T^A;@25/B,7K2Y*"*D5
MJUU:S.5)$V#&T[6\*$A1&\L&_\9%#I<`=#[T>S\6H+9YZX]5LQ"^G(#^QD-&
MR\F^3J#F,]_U\4?1P$J:"DWSDKX87/]IP\P/4O7['\2`=\Y83.,C_+3:L!YS
M<?)XD^*$_+AAT89U>O%$TS.ODN8'XF03'Q"\.*:T#PD7]#+.-@AGQY36A.G,
M9/JOE.>2R&@JGT<X!\'?8BL6H:Z?"&;Z.9?SF>T/^X'RQ=M:,9D1D4$M$F@)
M#=8IX&+38B>M3Q62@T+T8OX##>$%^Q.UU!,GA^D)9V@[!SCWRVA`AV6%,[*]
MH['3$['IEIKG>+:"&K0*6[RAS=:J>V;MC;8>69--H`X'1YOR(C^V'1&BV;*%
M%(U[>N^;=2.<\01M+P/3=M_'`M!-#U!4`!I5@$[=_L\_5-099=ML5QIFJS:W
MK`B%+:6B>=?2^YZ^)75(.''_BH?_NQ:9IO&0.@+1:NLD43(P=2LG$J*.<//>
MM52%,'-:Y"+>0NZOYR?Z$%DW442!F-%&9Y2NP^JG.6CQ!`\G0+GZW&2J8X:U
M=1@R/F@$FG,.S9R9)9*14S'TLTT4B-F$IZ8[H_L$ZCL"P,9]IZO`D,$9\QWN
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MS0M`LG4;K`ZC<1^'N<>'M(<VZ4F]XO@TW]AK4G5F=@Y?X6L!Y/MEOAG*FM/(
MM+?['A`-<RIQ$`FT8:M.H@H_I1'A6;?+TPD5]+]K=!3LDG%0B)%QH(F,!0N?
MQW>IQO&82@+2+FHI]E:J6,7D@F..X_W^F,#+.*-=SG23#&3?-[@6%Y-RDW10
M\0(%,_\QZS$HL(J>`E-[*T+=T[EQ>H)+D9%,VHDGU=LG>-P3-XJWJS1_HGW*
M=*--`Q0,DL1DQ-SD^%7<0%2R`WO&SU]H:1P1K*:LX+3?RL:K55_Q,DZW<RLV
MDDL\T?GN?HN3VJ.ODAV*]GN36]MQ0OK&,$;3B4=2IJ`QR379^E\+E?'"6CH,
M%9M6G9,!8$S]=IY1H/$!3'1C'DHFT\'Y+W%Z-+NMZ7W;]"*@0\CAK0R=_\X!
MX^7?-8<QP.,J"DK?K<N6\U^FW:@XD;!UBZ)B"8JN1);8Y"8ZQ`CA?63D3G(*
M!A#+B+EQ*\H-5.R"<:U13+":NH+3?\O-;LS=S*V4I:MI68=ZSB#MD$C[[RI[
M6/M+9BEHY?>=)0!2!JRML-=DOYYNL50'TDZX$NBNLNP>;IX2C/#C27..%'Y7
M'T@!&2=X$CZ@9N1_0AQ2/1[334!J;DY_5W=W#1V;SH3.1"WF0`U+\#,3=9/P
MV31DZUFA?7%11U+1A.FFT2%_Q-^XAC@GRQK<OL=IV7V^%"I;IS=%XQJ=NRA3
M#F;]\8R8N32Y3U&ZA5N0XS)?%>2#WCW79==$X+$=G2\.Y#+\7XC0N&`#7`A`
MI`!4#.;#H!*$ULXH13&8=^8I`]BN('=%:QE%:$*?&]_ETYHN6==+D]3'4-ON
M?8QX$9ZK)"/G[6-.^^`2W-/'TRK97B4[2!M@'K/B4DCWT&Q(77\O8\3(R::R
ME`14HK"^OUP8E@Q:BU/>M05P&)]F!W@Z#(O"O-4'SP1PX_9W_L:,)@QW8CCA
M790F<?*8W<#T[BE*X7F4Q1OZH"-&A/_V$B9X'R=T$EH]9&Q]4IZA3$@;U)O6
MYN*FT'<A!BW0`9@@@$G"WZ1P64!#&/!K*8['BN#FV..)VM<-G=35P2[P_G#D
M6E_O.NRZTFB;[%0V)@F;4S@ZRLDM10(-F>A4U+=H@=D'8-B6K`5;Q&B9EE$L
M3,XLPFR-JL6YUNDOK4YK^BHD(#O7LM,`RW?;:6WT9,N*5)W+=*MVRGR@OG6O
MFDJN1L>F3]W;2X+6\R?&.$17NN]FH:MK,%!@6BU?3%$)9C3(ZT`LKT$:T(PL
M0$$-2PVC@1$YN7:9<J89IV$459]O<>1+('VJOBV60-K1DD"1T7LYD#%TOHX3
MD#_A8T8^EYT!^)G.H8V_1ZQT=/;-CSXO450.&VKZ#1`RN><,'P9#CN^TZV77
M<9L=^;\'%;.,$'5*>MV38UHV:4]V=5F.-[\]8;0EQ(7F&+)&Y"A/B70I&O!?
M8/SX1"BOGF$:/<*/1QKS7.\8__4QSW*"!I&JHPL7=UVE)*\B+DJ%+14E`[@6
MQO`A79+'S*SB9W@'-\>4%2OB)6S@]CV955H'EP(.XY"7+78&[\6L<';SJJ\A
M&JAE`Z5P@$K7/:\5`H85"K-L3=@!=M)8L*6\%2-1Z]GU)":@6^G7J1AFR1'N
M)'+1T%SHD5[S8F8P+#PC7"_3B-"@_2C-Z*VM#KV(%9.:L8BR6&D?H[U!#>5Q
M6A8-HR8[VQ1Q!BC3\"8*`5JCWMY57\#(C/@=93>Q>O(=/4RM#RRIC6SY^<Z"
M)E'JIE*-$S)X[CE"T\U37,H4%%S9>8Q/6IRQ_TPH9<2PEA9#1:?U&+<%#0T=
M\-]PKL;/<6<9!Q(-0=FZG"R`?XE26K9&W=$E7S2:0%LT[)M*0=[GBB56+QY4
M02BJ1"TM3GYP$E*4HFDEC:`7R.IU-<$YB)-B3QLG0P'*380V1\0WNZT8NCA2
MOC1E6=CXF]RS!Q&TT&_$:XFACS.DJS:Z5CTLO/.'J3'9"TE,;IH;D.%8#C,H
MM;N5G(MNTN+E#]NP7;#;"?8CV;(5JV*F?4V@1U1_1ZY#W\G9J1*`7]*5MSI\
MTTOWZY\**?R5&3,"%ALK>`D@%FY7@\?QNFB"1T\J)??)^7(J0[S6SDK5I.H&
MF6NGF:H2_\H6YE]];'4<['IJ]NK\'M;<$87E9GH)JAH4W<#B+FGUA;B6.(=5
M4[7!8V?H3]-20V<>H_ZJ['YXEE<W0QBOI^?#>ABL/I[3QEF>[QCEJRP[PNTE
M.4FQ2%&,>9@[^P@_L3\Y`)2/*&:,P99Q+NK`G!5I7O.D_O[]&.<G.DC:D-$\
MMC-,QRR?=("D`P<[/J!X`S#MOT"QH*&60QIO8!UK\9K;JX(3UE%>H)@4\P!G
M!$I.NF$+.\[!NO?!;48#*J4DZ_0N0G"]XP+JN(@*-2-0Q@F[:)7!PI`%9T"-
ME4UF#"R\XQM#GPZC@1W65V70.%5+:0$.BP=6GK0FCD18LJ`@8SJ/*_&J/=EZ
M5RVX5!K:%U,KQ7&8CADL`R0=5-0K<=A0^EX]1`42K*.G0-5?^D/!B%H^WWU5
M6%R(L)AM22DJ6_$=R+K8@$Q=621$K4U<0OH.RO.P;5ASE2EW:*$M+L,HCJPQ
M`]I<`F+#*TY9N:W88J\E`#KQMPN</,,TC\G1OWVHY0<\?O#[^8`3_L&,!KLT
M/,^(O!&B!IR<%)(LA6A'`,4GUCE=<@K0V(*:EP4JZN/9C;QP$0"7`5`A0"V%
M7]^EM2Q96T:K+BN@:A?4'@.W#GIHA^S/0$[YT\/91HIC$!XKAU?%425:7@24
M"F[)./.^H&$XXQW,<\3J6#/1[*R>79J69]<V^9G=,*NX<X\,T@=EJ"HME2+U
M+@!!E46QQNY>A)UBI4%:]WU[&3_'6YALE:^7NU\S*$S5HN"FLA]C`;8%#W_7
MP1(EXP%5A*%0I0TWK4`":;(?+P%!DT,/A-$3;?W)KRW(.M^9>HS;83L89.%K
MA;64M`T3.2!A3@SP$=(5F=U5LKUK([E6/85#A99!`L`X63=I&Q5?:@_E92K?
MV3=X>TS:T,`.ZRI3MP)LA_`A2DZKC"S7&DEV<@J3C:8F-H^I4'Z`,PS&/@20
M2*RBJRU=6[BE%5BR=Y\/<<H4=$GF6&4S$'_9H/.N@(Z;EL>,$:@Y`<K*8[?C
M(>WC4>TX+O=1+E<WT8GF%%&^]_@<WD3Q]C(Z?<!)_K1*MO\-(ZUG@SI4C7;3
MZ@Q<E"#EO#/:OX-5K-H2]CZ//@8@8G-=+@(PU,8*%'S97`#N,3@G!R+"F_S[
M!!AWEI%%^<\2@F"K_`W=W.JX5?-;1BC4!%RF]16EO=C>W:=;")2,Y;H(0J&%
MV?+TH!N9`H/:IK=LH+7Q4J[T%MR84&\XZX$CAZ7AV-X4RX&)&)=`Q9;IOK&'
M-Y7<W1ZTJ>MB`PKK#:AL?^!79M02M[-?-JPQ`Q'YT"/UE#BC\?P:17J/SC+M
MRCOS\H9]O:,Y7&7.C/*YQ`8K@THHD[FZJ63#Q0*U7*#A/RS7A&<YEK*!*K^!
M3`=,//:#KTQ'V\:#+<.E>^+^@)XUBRHUOJ%OE=67G1@7H0XX>7^'Z+Y"L7CL
MWI77ZHQX;=QQW;)4Q5Q/H9Q0X67DH<DO$3I"R^],VL6$+UI/]1X?4_A(SW/5
M2P?ID6-)<WO[TJ2:T,G_/K(Y/&/3]:$Q@3>O4Y8^^O($-+BBO1]:T=;EBK:6
MK&AN3O1#CZ_X[]_C]`ZFS\1$M5(+="F;'62UF#AX0T;S^,O'%O3^CR9<YK06
M//Q,<(\S]M=CLH7IIS2FWP28%A1'".?L#AL??->-,;0`/`V$Q:!=.G:5KDXO
M2_EC0<Z]DZ9'VSV7$AA>IA:WR*NR.SWGHWX#)ON^P?V7F)2;VZ_R\KQB5BC8
MW\W7"!!814L3;T#W,9LG[G')A%L;V[,87ZD/TIQ^M3Y`?J8K=BX!#9A75E5X
M*9,BE+M4)7!E=^ZC6M:UO)KH>\AN.)3M2_!-?2OJ$7%B*PWK(&S898HW:Y`K
M'`_K1!?957:(4W@1'>(\0N_);N0:;30/^D,D#)J"2*FY:?3!V(&"'Z`,`>'H
M/3R@@`M6U%AX&+2*MHL!,"Y`ZEAT-"CUO#60^>/DH@I(DL7D),&L^A9N8/P,
MMV19N$^C)(LVN>8S#%W*9EMV+2:.(A%\OB>'LBI!L[C<>_:U&YB(+IZFX,4@
M61Z^BM?R94&:!G=0LF?U*1H"&%\3NCSRM,N=%+885><=^A@A2+E11V25(UJ0
M)X?A6_^1B0)$6?-C.V@MR\'YN*69`08G)8^;><G,3I``!\E.WJ.TJ">H[,@Q
M?VAWG3_IM510H68_J,<(.RP!0D.W19Y/^SZ"=0`==_8@@K1M+%4#LPW5!HV;
M<@"6\30+N;8:C695EA8;8?(NVCS]G,3J5;05J>D?V90(.SE!<\XLV:)REU9A
MP#@!5`!`)?!VGM:#$>MK53?P4I(N2R9.,"81"7,+ZE-S;#95T<B@#&4`EZYU
MR#1F$F4MK8NN0@\(TLH.[XKKPII1_;K\EFI3*QAKQL`L9FO"RUEHMYJ/2G%X
MV8QWC<O8RA)KF0`3RFL<>)))8"MPN'ZR`Q_RJR3+4X:9;F-=T;?-7G3T"+GH
M)/^0@YJ)US<V<JWC<:4$I6$D5.Z<#5G;(S-KQ"JG84'9+ANO=O3NO^'J*!I2
M`[?28-6MYB7&;J&AZC6.DBI^IWD+*/RN_K9!0,;)CH#R:<0J?5_W#6D>CZDF
M("TW9P7RVW\%;3V;1N&<R5OX4L<:IK:,G/$PWBK'61VI)($K<L""](!UE!RP
M`AL;:@UK7048UIT`P]7(N3&$TZ\8IT^-HZ\U9%P-H0='=5RR`8#?\^*`&[$6
M`Y_D+7G#'USCLF'L$+S6.`0[K&27L7:-C6*;1:DEN'VCLZ%6(#:A\MD`7;?7
M$M6L45Y$U$^2<PP>8'5%Z25_31_)7MFZ4<V&C%KE;97W5.D)Q?I5<S3;IA<>
MRBX\M"K?]+^HOW7LTG"R.R][=S,NPM>[L^W,I<K&@PK1C?T65`Q+&DF^;8SN
M#$6-"DYG8\^TYP9ZI*S1@()T(;^,LPW"V3&%U8Z-76'6N1[-WEZZ_7H-J1M4
M631A9+DD3BE!8TO*;X.;R2NM_8^\/^5L!C<-?SQ=_8O"NEVORB;@;O:Q***O
M2POQUBFK2:'<L%2%BMD>2$K00186Y=4X4=#F1HS?4+?'V7:GX_A@=;4%B04R
MA$%KP[).H&:@N/]%XVU*1</I)I1P*>+#OO<F?67C086$HMCFK-#0JFDTQ8V0
MJ">?ZFN.80^Y_X3-/*3Q16,@*QI./81P\7Z#(M4V'M1(*)H5N0AA,=%%+`N)
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M/G,K,XU:#T.5S421VO3';T+"CM_!56D]97W(+=CRQZP'QM[?Z4</1-GSN`&=
MANC@@MU*UJK_8*-&K?MA=,,/&O-38(XCR-%LIBM6G-M/P!<P,#1U3`8OV<]I
M>B#M00&3C,U$-T0?ZJWTE&A-?,4N)NMX$N8IOP^4-77PBC<X4.;^IV`5\(2O
MUX>TZ;PC6YFNP=NKE!+<0D1[HU[@+,^8C$SM-]&)(I/I9#S9XF38"&P*4U>9
M4$6+F<I^"VD`$P?4\H!2(,\I49:-!=O%9[&&(4F;LFD=;BH4;9[@]LC*R@EG
MKQ5=(1_9<ZWL_%1_II!W13;36^UT*XM,S>KFV.+OH)I](5KU#`LPSFTK:LH'
MSD^M#Q8R`B9D"!E@]BT,.T/R)5@3FM.0W+6X'%*C3(M&UT<VN)EW@)S$V,'T
MHV`I(X82R'6512/JMOZT@-FB#0;-92M!'64'GJZ^DIUC@Q]4+R0B!?5&-!XG
MTS_E1(MLZ-8G:G_/R,.:)!Q4NR74O9=L$6H7#ZD@$$VBCA+GK#I4CD:_UE#W
MFY.4Z:JN4%"&*:\@)%)#,/KLF^>D$D%%H0]:*CI^AI3J_2?R\^E_PQ0;Y".J
MDC/H:ZM$V4WOVJ(J2<&;+5&`<P>4?1@IC9I(8@.]AHU:IU;1'QA.QLTF9Q2\
MW.<JF=FT3&-6./DF2O-X$Q_HE92F?TN_KV\:$E)./)CQ`DUFWMUU#`FLHJ;`
MM-[TP+[*35W1J<A()NU$1_LIQ<>#_E.Q[M?T`6Y3<.)-C$7CD9@W'Y(H&0^H
M(@R%MD)AO)\LSC*8930G8(_)R3A_(I/_F]?_#SW[$]L$SSAGF4/X$X\'1`B!
M#4TOY&7AZ$?H,3I*3O\<$5K_EA4EXG#*_E;\@WPO.8$#.7K3?K0IR(X/6;R-
MH_34(6+JJRZ45;AH;77S-N4R#88U6]5>)>J)<8X8SQL)%,G@MHA6JS`BKYZU
MR+#PH-G8B!#+H7DI)F(M;MQN]WR5J*5K69QW'L;U^M#5:YV^;CCGV&%J;DPV
M^#M]QG#PUJO:G7%T9Q9[(+P$0VC.*`]J$\J#8#YIV-`29I(RL?@FC3>P51FX
M:"XWR]2B(,6\)C8JD,,&D@?*DU6PY8FM44;_T>AMN(OB%.RC]#>8%YT,.WNC
M14Y;ZI9H8QY3!/A%6IVEF:XR6"9NK\)W(7+8![CU@7XP:SRHX]?7LQSBY,SG
MW:7+Y)BGVGW+:+#\9>,B3G:C]F3C=#>,UTNR'6NGO$),T)`3<$'-0K_O]@>$
M&8.K9'O<P'H*KVZ1[F&B&1C6(ZH?Y=2A[R2H7`L`:@G*U:1Q$T:D*,+.P-_E
MC1'$V%C52X"S%9>K`9QR!SO_((HY1<<6IUT3O?O[,<Y/@GOF=P@^ZT\2:M0,
MS$F%L)MI@7&6W(IS[MZO<O5`Q/HZ#1JP=MK%FS?37'X^N4M?5S"P95PXE<F\
MJ^TVIE^)$(]?KX[Y$T[CW^$\UT\J8LR[#QV7R,42N$DA/0#'";M7C1X?4_@8
MY1`D8UV]HDHLUA`F+BZY%GGFT;!)&Z<?5:1?IOU9.Q'5:?JUR.5E6"WT,F9#
MKW-@*#.?^_FNL`[R?S!])@9%SM$@.AQ2_/R2IK%9)J^0IJS%3%1^9B?^II;H
M0?<-4>>+1N"V:-CW:*YA2M^GRXHUC`>U$(HV45>1<SXE&G5]Z1OQ6A/)UOQ!
MDAO^;F9!`U$<))CP@RAC&?0B.<5P=-9)8U1>F)%HK)8CQ14:,Q&1%=AZ0_9S
M\@RS'&XUHY7=K^E'N=H4G,0?2Q;^HHL2[>(!'82AR>;D5M(WC0NZD`^U19L8
MR?_%Q`5^F>@`O[@V_U\\&[]0JU@Z^A`TV#3[7R89O7W94%.LA82U^UD$MQBA
M]SBE?_24B].2P'=214,8EUDY@C2)H+>IT^S)32Y.#ZH79SM.LW*HM*`0=T)9
M_D`3FOBS@KL\2O/"^<[A8YPD=.0/$1(%3X.<J7]BM8YG??(FX>S%N]I".'A8
M73C&(^4CWEPL90Z66(K%N5<$QHNQ"NMS+1=R[H=NK-(&>V+7+,7.`_KLCX5X
M5?%TK2G%@+J9@6@SFF@$/W`C2%A6P;8S.50M)[Q.#^;(XNF*70:*PA(P_+UI
MJT5`><'%/U'"_$X&<Y`;`[)SV\$X/])GOQYV!T+V7A8#@20N)X,-W3HBM.R]
MPI#Q6-PP2*%Y(8;B:NO0D%2^?W@I9[1W2>EB[_C!=$G',Q[\6R7TJ33<D!_O
M,?V5UV=NZC)Y<4-5\5P%D%DV%2QXTYY5],8"1#F`Y/=X%TI!@CF-TN*4KX?N
M%V"`UA>'PHKIG7,Y`-JXC/Y:_]5=&+-HL?.FS0KFGRX%S+V894\.%V57*A8O
M:L*3VX_%F4V"STNR%>MS5=/@IKP"GJHO.MD7CZ&R/&5W\AFK4GG_%"7%9S[B
M(G?A+Y!V%B8KQ#-,HT=>(T(Y"2$`20T*"_L6VDVE:6:>#\P\6UT>HH89/YQ:
M70T/A1E'S(QQ8<9LQ\@S"N-ZA`"S.J>LN&3YR:0<)?A4#!-$?)R\VHS'BM:^
M,>YEG'B7:);^CA;/WITQE/%*-A9ZF[OSFL:A+)WO:WI%01TT2BX8ORHX%_5\
M;L@DPF1?\A9L@IFZR0[10OF+,DFG627E2$!IX^58"F-OC,:XFT`8ZX:'#)4O
M3$/6#97%3,H2!?4^CM>KIV.K/EF-KF_0;(!AA%6DKRB$>1)#DXS5/8--L69^
M?J(MX9>=DN3``*T\:C*$\<LP-HUI=>0)E"S5:6P7L(S9LY0YO`E44S(_9JTE
MI+MI-(SD+3^V:',N-8#SB[$[^S-J-8B7-JD*DG""F5:U9?-CX)IBNIM:EY$*
MY\HB;4ZN1I!^0=9G?X(5IMCI3K%?6#SFY>;K->ZI9UN-'$L:4FJ5HM#_R/CS
M;-;N\P"U+.&+->%9<P:;.3J+.&*HYT:%,I>'/6E[FYV_@'3$N:?=\.?794^D
M]B9+1YF.'9W>0EJ*C.S2+W"2I]$F/T;H'J;[U4/&_CE;7J.V7/-G,6J*Z"X_
MJ#*H2@30D`%<QSL(OB:'UA.,TNR;Q684FIJJK?Q!([R_$+.T/G$JVC8="?BU
M',N,Q;0>Q@%ZT,[CDF'U5GOS.;=X\[9C-)?4_B1\SJ-9=$-Z"3>\-];W;\X`
M-1[OFU)/5FJC#^A4C+\LBVS.OP]JT^^#:8:F?"9^NXCY=_P]IR)V;^:<EFU*
M[<4W[`W`P0UEP][+ISG/2XH%!X&+B_G?MM7\P_3MKQ:J+\PU5I(WBUA)Y+&I
M()8,(_&\.(B!I,XS`,,,,WNR5HLSNC'67Y9E6IZC!P/1YO.PJ_?W9</&*R).
MG&3QYI<('>'L4>A1.3R\G1\6R4$KJJIY9L41,):+#22K6I>UA^<JD+U02[+_
M)D]FCE["P!/4W]@9MP&8,]-@0`C?;YS;\GQA@5NG=N7F`;T(KY=H0]9GM.81
M>62)#7(B&X]N2%::`-)C580,*:UP7-YY@J-?#T1'OPGOU.S5NF>MECEH%5^B
M)<^:&]MT%>5S4^BAS38JOB*8/2E\AX,Z`OTC'NG`Q-R$'87(O4AS<AA$[$QJ
M,U[83$\FKI\BWN,\0OYVI6KR^,R['A3-_IS'F("XLJUG%MDATQUN3X:!OR&V
M:8;VL_T5,'WA)N<JS[_U.)C;\A(W?WR+6Z+P/HK3^;=^<AD\IG#TQ7$U!>X(
MAWKVRUCCJ79FDO<)T*6!6<\@DB'W`HW)379//:]1>>?<]-T2`=*8GK-9_[6?
MDSC/;N]^5N_VKDC(R!0&:=J?'&IV13,ZQA!\35CZ>=FC!Q+64ERH@*!!+&[!
M'?AY(>W=U:N$W,[<]MU0LGGWK49"NFP3GU$Q,^\[@_E-T<8A:0*:7XS963LX
MZ995OAWH/K_4.77&WE7Z0H5JTO8;2HI+JI_+2ZJ_H+G40?LK,RB_!'/S-GDN
MH;7?*"3MLM=AS)I=F0*SXK9X]C>>C'X`D:@Y[6V6*5($W!=@6S-/D-TR]`N?
M(-M1Q3`FR*Y,@1EQ6[R)1OP#-^*$)?V4-4]_"2-6/Z?!S3)#BI![R<;E9X;L
MQOX7/D,619Q#FR0%8@5FRCT)74R5%1.`4YI4'*<O=>*4V^$L<Z<$S1=N<WYF
MT-JHI9-H$-IV&%_K%8"7A-86MIC("NBS4\4EF=>J>_UP[\[T1`]L@C`:Q0Q5
M.!E_0`5HI$J\S(5LF@_,&VW6MY)_V+OWR+6:<[W(V\%1E)>VEBS8H?YQW3BW
M30>V-BQ\0?@B5H&%3_R#;7U#G?VUA0[,A33EM^-'A/H#_A(O40.;_HW`_X<!
M>[^G_3+6@_;UT4+6`VVA`W,G3?E==2!\F8N!J45[N%!>YF+@Q7H]7TE_&8M!
MH_WP0E8"/8D#<R0=X>VO`5_<1;B>6<]Y1ZYA`5^\"?NY66<=V<WOX+SCY"<(
M[?5.OO-$EU912S*M94M&P<:+X8*8_6F=/Q)^8`:_:3H&Y!Q!"E%4U%%,Z[?%
MK/9#0$^[NW#)WW2W-!D<-,5TU7O%73`)NU#+Z+0BJ:E8S3;:FT1/4LY;GV.R
MP"[+[W>J8GG?$?JU6QL58BS!_47::'.W]Z"VV7LPWNO)B_Y7HPIR<^<E.M][
MH0>V5'/MBE)C&XR%Q4?:D2]60BNP>,BPA($='H>$G:?B6=<^P9$6U_&^YODS
M7@]!<!'N7YRA^@YO<^=0#F2[:LB5;&^S8Z.\N7KM$K?\/;1-$HMBQ]JV>,-L
M@\E46IT@9!`UK.[AQ.L^%9\[%%87,:LK:T;21@U$;(`;%>H3)OBWR^WC-6*4
MUOIW#2'^7:!;)O;_Z&Q"Y.53B7[Y5FM\YUTU!"*XJ\[_S/F$4H_?MJG8V'9(
M\7@A9F%MB\#_?R%BL0'HU5A]$>N<R)/H$B7>]C=7K1>I#FL65`5,BN6^V9!F
MQBI0[_8'A$\0LH@ZETF_7.\`$:.)0TK/U55/`8;/-6$<"*RLH!"57CA.R04T
M%;^0&KP!I_\O(\D_E%AKR?)55"0AU!&M16X+`TCA7TZB_HM(QW_1"?>5TE=9
M=MSSD=[&V6_O4TAORB#=>MZ2`<TRLZH+,Z\9J\KEH+,!X?)J1]C0>V[&!Z2$
MT2)G3FU3LS%7ZD'WDLW*VGS8J##0$!Q0R0$5'92R@UN!J8:5,22"H.K("M/]
M/,V=%*28-YMB5"#[,UW5-1;%.PB^CA-P@E'JM7O+#%9E(U]'$:P7:4&6\FTD
M4UK=R9A*O+R-7"G_+Q@1,BC.3UZW<C)Q_*^Z8LD<O&.LZ'N?UV:R,5=[N"'$
M7K8]N=['59->+?R,&[GC0Q9OXR@]W44(KG<L<KGZ'&=:DY:<B)EIR.@Y")%7
MK,X`94:3ONY\/W48!P4K*RM$`%!7]USUZT+UX%?*:J9X>3V^C]&>_'A/G#F+
M-M0U+_$^BA,M1U"@9@;(*&$'KM%TAS-`^=)_-CA[]1%UX+"^'H,&"37PJ7R&
MP;-NP0-^Y5SG\:36%=O$:U9[%ZRNKE8[5WTWA-836?+!#9$OF)M6Q3M6N[>K
M[N]5EW&A.K1-O8R?XRU,MD&<#MO"A+.7;\KE,/RU+=B`4PS1,C/GM$W-]2&Q
M#]U+-JO9#HBEZ#,>#S=/<'NDVYI+N(-I*D7B+W'^=)4P7SI&J(=*=A\](+VI
MSC)G,P.T*H2#+7HA']WXE1+*;8\*"6HI18:8@5^9J+VU==9YT(W18;>XOA@#
M0W/;EI.9ZRK9X#W9D9*9DC*_II,-5:EF:&N0C!'D`Q3M3Q"<&:BX@9*=3_]6
M@09K*"Q,&-`(`G-&N22#U0]PC1"RB82KL-:27$(>R%)06JA@C#N&6MA*\L:T
M#!;0IQ*7<4IVSCC-U.-1XS3TWWH.D'/R7K/BQQZS5!S]/;%4P02K*BM`_8LB
M@_SU2\7.],&0<]G1H-BJP3:),W[$24E8TP4%W]0'OD?$B;L1+J!DX\_'Y*K&
MP]H(1JU-+VKJU-1U'(F)^A+.&Y*^A1DD5O%$9P3X#!$^4&,L"L;IW[PHD3.M
MFS=&V4$&=\&4KWTU6UE%O3FW>3K(80,]AHT2Z@"T$@,TKS/]!!.81HC(LMKN
MXR3.\I1,Z\_0V)T4"1I!I43;0?DNSI9Y5)MQ"$ZEAR`VTF;H:*$V4"LI4/,Z
MU\2@YG6<P"MR.M2*V-GC:02Z+?;VO=A6$)>*")B,7F\)K-L6=@7B"[`C-)L)
MA3@/G9_NB>8D=S2:%PK.1?%A;6-2.2C62*C0;$2A12YX6E(V-7NSE1IX+]>L
M[,YMYR?`;%-Z:SKCM8]<>_HW/^.TC"QDC.S,,\<96"'$`/1:+T<9.*RKR8!!
M0@U\Y-XSZ6ZH$1%D&5>Z]T+2[T^*H39).0]0\U2S#'!V082KA5`(@M9]/06F
M=ED`N]"YA3BV?9E%T>S"1*9=_:RVVYB:7X0TG:S_17V8NS2<N%7-Q+LW296-
M!Q42BF);G48J#J;^XD9&U!5OWE`:V9=0EX%;<5*T0?<J58I&6P8UXBX:F=_"
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M^Q+MK9BSZG?_7$SYX:`2M8Q=<2MM?8:*2SZ8`R(PJ"5>]J3'*R._QVGQ*_HY
MK1J:<TL6EKD*A?0S9YZ!3]W*[>$T]?%DOW/,H@,F\,78ZISS;5G,G0P$-$=B
M=F+DQ%23<'I?T3]UU-]V<NHKE$/I^SO>"92*)</WK\#F/'LCG2A]2(::0JGE
M?0Q:N7K2AN!+ID#9O.$7VSKGX-O:^XD5$B6$H$C;-N\@C:.T^DGY&IS(.M$-
M`/:^9PI:1<*E`Q`FWB-Z,DWC(74$HM763OL)TJTU4?*&)^WA'<B?:,+7#J;%
M1AI\_<C?2:#3&?OC+M[ED'SX"6RC$X@3\!X^I$=:EY3L45;'QV.6"^OB>QMQ
MV\>H_4S+U2CZ5G_"1G[6^)ZI150D7/H981*(G_4UC8?4$8A6NWX&/\-T$V>0
M>$T.R?'U*=X\@3AC+H4BLOFGWD3\+P*'LCRFS`&)+(X]T+(NVAY(+6L952G9
M;[.R7"D]3;)?ZT2,[/.>MSB@1`P'U=D8(^(1V9&'PJNK\$56F1PS'1M%)0>Q
M>4%F@AH6,JED9&%CE9@LK,+^%/8\5&8N</E7SU&,:&TX(CWKZ3?+?#0JP[P&
M-R*.L_DIA?2$1N/,4<F3+,@IV!WS([&Z<NU>YJ2E:F<V)B\E`%^@35F;S.I\
MHL(T*X'9M,9$-CO@7,;9!N&,V#.5#">$YWIW@9,,HYCN7K>\&MDUSK)S2(P?
MWJ3X.<Z(](0Q_]M]])EH\($^J-\HS4^.&.L?!FS+X.2,5@L)7H%*3GI\:$H*
MBJIQ7U-AOP%<7%#)R^:MXB-,9/!K*;27M^IN;0\[Q?>EV%DQ.S7LJ[:NM=BZ
MJ(1]VWJO;EMJDU)=_+>2*%OO.`O.O5)*D?Q\3H[-NSB_UJF+88V5OD%,Y^ID
MJJGRWMCD4@I&_U7`6T!?@UU53_FZ$/`;[V4P;%L0MHS92YD^6A547M`<HER0
MWPJ;&><.BY70G<P;_NKKVS28R=.%:>7\8(Q#UH>A81EK!<LH!!NRBZ5H!"U>
M&9;W';9-9&3+L2356+25`:TX+*9/U_?W9%JEKZ+BY!@GC^L#3-E*D744";-+
M\D.6QQN5]=8*FPFUWXTXVO>7G[^]\W)+:Q/E7KW^";I=)J*%FS?WQ%024(L"
M:EGZSDXVR*4\H;HVV='#^-&@B889E[G,H&#HIB[*`GV["_,TUVYI=Y&03G?L
M0IQ0_?I#G.`TSD]7";%>,@.MDFV;RCOVF.T#S)\P^0O-AF<%X!Q/!.9BS65F
MIA):FFKH.X0R1XG^O+!Y9K+939N8IH'W99C8]*FOE!^4`V`%NWL$^2@`'P9H
MC,,L5%@ID+ZZ238QBGD)/T%9OXNG*'V$ZM<+)J3UHS[Z7)R$`1MGT;8@9Y*:
MA84PWD)^$X#'$U7_G1T;)3231S(#5'U]/\"(AN$I*E.-=)BV-2L=8C.OF0(N
M"IE0F@V'&^*$9JA*Z(]8ZKCZ=4VUO@RZC.GC`OKBX!SFGR!,^I=61)XB7D6[
M0>SQ,<FISQS)!\Y/[^&6)D/33GA'8KNG>@B$P(2,DYGDFG+3-XN([O-5ZF&`
M!SX.X9T@]<4R;,EZJ;#1@'(XX.$$B@&!:D3-[])!A971,J_I]Q->9K2?+\3,
M^^DR#>,^5S3NE<"XSZ<9M^[^@5!KKP#Z23-JQ*;L$.1TG6\)J+8[^X(@4EJT
M$.PO^F,:_4*\6)*U\D)<62]W99R051=VEW\RYKZ>,TN4`5/PVDG9(?.`(^@I
M;H!,..-!GH?B,/=BXKH7UL`4<?*3%=$[=TNR25;YX&*H?XEBC?&$&+8E&9S9
M?TYLY:$\?N9@5RSA6;6$IX2[__L2VS;4NQ&QBM-+L1?!M-*>4092L%;Y^'[0
MYR1$A8)D(WM-)A+4N$>R,,W(2=LT#!D7!VF*E!.=*0*<!T9A'/?T844N![)1
M;^4XTL,;$Z!U_^C3%<DO+E*XC4T2)0:)V<2NICL1K1\X6@E\I,?KPL7.CQG9
MFV49V'`>`7J:`*5QW^IJ+4A$5/V'_NI"CD_(U]7"GL^;5KE9^85TR`,;!4WK
M^GW.6:^\?2P%)!]891G,,WH5R=_R(X0_1<G&QM%'BYM-+]5@;-_4BUOM.`'/
M)3<0E>P"G&--;&)\$M:&8-'XC\X(=:I#-3?03W&I0"466,D,9<Y9HLB(;1WN
MRHA]'D?(PM0PSL*F/8QQ<SD)[#AO%O2@<8T0MUG*@(_[O9JJEP?NJ(<78O2N
MGYJB6-[HN$_E$ILTJY1(,[:>6<;6ON9J>ROG?H0:,[=:DMJ<$_5'G&SA]KC)
MXP<$BV#8FJ"C5#C5G+9-[Y6R<?+BYU7-"VSA0PZV<;:A=\H!3LKCX([/QB/:
M71"0HW[:XE]%AID$/EWTDLN$D^PR?HZW,-G:"#@)J=I$4\#`15"`S*!;XH.<
M0X`^.(3>N/=)E;@(I!2B'"5G4+'VZ6HW:8S3_X91LP:/!5\3D[4)H8B#@_X,
ME`LX$38@3\D>YG@(T.$&,1SW.+DFEX'7J,]Q$"GO8&Y2V!*[VO[M:/SP5(&D
M3?BZU.V[FG#7$8!W2:$:]RRQTL*'9=2C&%O0X#NO+[4S+(Q\ITMB&BAM:HX>
M0X.XS@2"G&$0[B)!0^0>(CV%I_F^^7=R9BR6,>Y%VVG601P]$%?+8ULEBY69
M6*K[J,AOYE+$HDL$^I"K(5E8[[,FF,E@=6$M>)9H$H4#RRI^B@QAI6P(NJ4]
M1T9^/:$<L#KI*54:5;DX+]NIY,#7`3R#F@!^OS2GGOJ7Z*XJ57J#\EG3\KMJ
M9!WZZCSE=97\-)A*NEI8:[NGI4JY\^$J*WNJY("V*K_.-UP4]D@M+ZZ3P!U9
M64,>MRG*`T-V$N'H:>6G%&=:AT!52D:G[F&B#A-@:<@C8AQ_]!GR4(0'ZVDL
M6"A0!X6&IS!NZALN1]Y15&I+'FG9M8LH34\[G-)F5%KQ="VR=L"2<W"0P0%S
M@$M^`%'<-I0C*%D&Y5$*D`ZYUYABEP'?@.-5K'FIP19S/TY8O>ZPYX`RDG;0
M$U.W[WBW,(/$%9[8ZL6?"X7L>2,X#GG=D$;#QVS`V^ZKAT2!>%KYN^)"@II8
M^@SIYGFUV:3'"&7EKZ8ZH`XG:QBK,[7OKB4'%JI("S:A>:@!_B..JZORQ6(]
MXN;5[\N[OI([+Z)4&L>MQ#!\KK7E0N-@S:U)NYS'2RX.\N^C0YQ'*/X=<I]F
MZ_$&9WX?[IKBJK\&MS6['`P-UF102N#'-<M?\*R!2:[8)64'MC95A\&:%#[#
MY.@U-T45G2&'$NDK7"0&'*;Z'>?G*52C^\)&1L'2"=[-:QGO.8PC>A\,G4Q\
MXN)2QT,!D=D>JXA#KM.#\E8CP/9S#P5*/^/QWS/@O4G+"":CD7CK$?AY(N]^
M['U:O0MW!2W<5RP0E@*ZIF6``BM785B/PFW!B;DK2H14+:(W]H]PVCTN^[X=
M&`@I5ZGJV_[-;5!NT41AR`\J%06F\0%+)SSFMFS#A'552E-U/T_B8M/B4<TQ
ME(2%D6QQ';4%BX?(*XP21%UZR$U*;^/STPW1&6TT0!O%'51[81F3MHB9E(N+
M3=;[^#,!<A72"J*%Y:AKC6AS`;@I.E_)'C#^[%:EDL"C.TX)3/7)6(3+1OA$
MZ%(A!:FD0(SZC<5PE66E*_J#E\!50X#I-F]5\U8M_7[X0-+8GH7G!^HN8-WZ
M9S%\/\?NA@!33^!=4G:.AFVJ]L_E-`TT]%.Y!*2A`[I(;>$",G!L;RX-XT?X
MT2?FC2HKJ^TVII$O6LE^A],]C[R9/RQ7)SWE,:(J%]>/R)L58T`M"6B($M:K
M<6WD^V_%]72_')1+][.%KF8OO)KOM7D[2R&1"6W6!/1<][]KZ#^(Y]I*`/7Z
MWDD5MQQ_D#R\]N04AHTA>P2L.,,LC2";CA!*_T<9'@/V;Z??HQ/=2QH)JBG>
MO_AH7LDMKP`*RA^9_L,8QS`*TX8P3RDQ<3M!21$Q)P?R_I5_]\!5EBWG_8IU
M3NCZM(U.B+ILG&"7PBB#X.LMY#]]$V#+%&.H\51=+PC68DX1I*4(*A,TZNES
M&>:.H<&L['MV@?</<<)$[BN._K#A\=<+G.1I_$`[CA=O,`QC;G983PT)V9#"
MP9,UWMH=[T13`'UE*HKXL4\P(4&.P:86$VRXG(&$!*W:G#B$:`_5EV-?@A`E
M.066TH&&>**<.E!)".XQ:,@(+L3&I79:E#ZX)[NE.&4RT/+.RH='97KZYQE%
MTDZ.E@/%`<Y`S9^5PO9VTM3%$ILH]CM-`Q.^:3,T+B5:^H:E0-:)44G>VX5C
M4#K885UE2@W)<DGKU3%_PFF<GU:?8[-J\!T*T\HJMX@YC094G(*H92V&053*
M6J"AX%3>#UQ43,"OE,T\>9#](5[B?10GT\R\I&%)ZYS<EVCJ'3`&C;VII0`5
M/VCPG)'A?<5[N"7;#_0![A_4T@5%W])?]%L$G"SO!0?P*^?A[P9"K&$L5T00
MVFRZ>D'>-)#M0#K4$DR*L9-97[C%TMW=#!`QFGZD].Q;@V3?['/N'X<$*ZLJ
M1/6C0<W/N>41#O1CM(?Z.Y]14O:0J*G.Y@YG@#(-SBD$4(VY1E=YX<(RXB:4
MW<3=4EF*9Y5L+^$S1)B]\M#</`T3T5_]A^@YV5I5!2#I6Y<&2_][+25\L++>
M0L1"6(FS`X3I3LV]]&A8\'EW<G;*+%NOJAQ"$>40*KGJE4QV4B%YIH+(.L6/
M@[ROT3&I,YJ?4P;83Y(`>W`C'$=J[-Y@QL.H=J;1(!F+)R)'^4/WG4+4)2*1
M,*G$^R9<GAXTJK4PL1C9>(MS>X*['U2W*&M3V&QC&T%(;^J2'(XN(A03@DD<
MW9&3`M0\%4F^K;\%%Q)R<@ZJ.0'&RO_Y9Q@"/*ZAH-3=+GC<UK6IQSD4%XDE
M';0*SR(_P_0!*^O8R0[F/4YA_)A<T'DU/:E/&L/?-UHG1:0<W*9P+CYW)8,Z
MQRH*"4R_J*5:4'!0C2:,/CJ^@PAN<KC]G\<H)5"BT_LXB9)-'*'+*(\F/#E6
M)3SEZ9T:#_<]JTLY0"4(J"0!5)2PGAMK8MY_;*RC]Z7@6_A9`]<IJ"IVKQT<
MW[5^FVE5>@9]3=5(NVE4.P[$=0!ODG71Q":J78H[2=XI^_8IS3;0*K1L^Y+#
MAL_CRO?=XED#/#7WF=;,>2Z@6DU^IZ`4U*A0$`.RO#9I0C6R,`4W/'7,IHVL
M/#C=\LXS3GHY<LH3A/L(<YZ72F]$5L]1C*B=TH=<^SU.[G*\^>T)HRUA>AYE
M\<;-A1.[9N(/``ES_@"0L@=9@_^$0;Z+TB1.'K,;F-X]12ED0Z'7Y#&BK\!<
M1&,8"]:T;\N9@*0<Z`&F(*-B:`_920CG[OB0P;\?R1KZCEA3;E0K6T[#*-0@
M(V?7_RLF@'/Q?()5Q@.K*BI`W;>6%@T`YK!\Y8WS\/=M:-W5OJNC<9^;8240
MY*9NNNEUKW#)]"+3]2R630:CF^,N)6%%W06U&4R<L@K)OKM0#)AX2TGAJ5UF
MZ)3+G%GM@D'JY[,/$+&E>5<Y[$LP>7G6^HBB0E3^L.&KI:@[,7W]^U<)`1M:
M=W4#VU5[0)8NOXL=T$UHNI;N7^9,[NZ,3^N>:)R&#96[C+GU5._Y[D<9%;G%
M3[GCF0<!J=U+E%_\3/[Z&_DW^1?YX2'*(/G'_P]02P,$%`````@`R8%J1+B:
MS["-70``C_D'`!4`'`!D=F%X+3(P,3,Q,C,Q7W!R92YX;6Q55`D``QD='E,9
M'1Y3=7@+``$$)0X```0Y`0``[7WID]LXEN?WC=C_P5L3L;$;&Z[*RU=%]VXH
M+W?&V*F<S'35]'RI0%*0Q"Z*4/-(6_W7+T!*!"5>>"!`4B`F=KOL=/+AX8?K
MW>\O_^_'RGOSBH/0)?Y??SK]^>2G-]AWR,SU%W_]*0[?HM!QW9_>A!'R9\@C
M/O[K3QL<_O3__N]__V]_^1]OW[YY?+Q^,W$B]Q5?NZ'CD3`.\/]Z^OJ_W_SG
MY>.7-U]<_\\7%.(WU\2)5]B/WKQ]LXRB]:^__/+]^_>?YZZ/?,=%WL]!,/O9
M(:M?WKQ]NZ-\%6`44:[>7*,(OTG^[]<W9R>G%V]/SM^>?'@^_?3K^?M?3S[^
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M>7*6>(7>NC[;-@X;('1_#9,??B%.LJH"?+VI_`WVM[>[7WO+?O3V].SM^>G/
M/\+93Q2R-V_^$A`//^+Y&_;?;X]W>\/--CYZ13^2#4<7Y_ST[/ST%_:+OSSC
MU=JCV^U+.E<VQ*_+`,__^M.,?O!V]\MLG'\K^]UHLZ8')'3IO]!9_R+)2H1^
M$)^L-BE/NZ.S^^_$G]WXD1MM[OPY"58)FDV\/E)"?T`(E4YD'="=Z4?)+[)9
M[_TN_A%A?X9G.PJ,=RU337BAW'C$V9OU=JADIX38^7E!7G^983<9B_TA0>3M
MR>EVG_P;_=$?*?6'^,5SG5N/H&A__A[;K"38_=!#+]BC\)9_^(MZQNCML"+^
M4T2</Y^6B*(_C:/D)J:W,XS3>DH:6+]U/1Q<T>.Q(,$&QNO!IQJ8^XUX,=W'
M03I4"&.O\+&.A8^#@.[_1[PF0427Z(D>NAC(9Q4-#>S^3M^T?_?)=_\)HY#*
M"+.[,(QQ`..WDHA2AK>HW%)A!7E_QRBX\6=,P!#EM?I['=N`CA0@[X[>JS_^
M'0./4>%C#0P^XH4;TE'\Z!ZMA#$L_U8I>\\!8E?;TV;U0CQ1O@X^4LK0[DE+
M-\X##EPRNZ4_$S[4-00T,LIV>`LV<Y]K83*%`7B$*SY6RN"$#C!+</"0\%-]
M\)$6Q)XI#U"@TF^TL),3[*A$B>\BO`)OM7(:&FZ[:[)"K@^[Y7;?*&7G"UX@
M+Z4_^>$*`U;X3#U&+@Z?T8L'>PKX1Y4,%54:]A,AE6;RPEX91TRTAQ/-6,YK
M1Y/`V1L-!<YN)/K'@FJTK]UN?^.7-6*2QEMGZ7J95C4/R$J*S2TWI!1V$LQP
M\->?3IE)X^>3DY_>K.G-&%!2?_WI[*<W<4BY)6M&#WGLW_`<4R%H]B7%K'(>
MR20B*B+CY#=[@JIR9Y**0\'!.#,1C*J[@Y3=6AR+<Q.QJ-T8]<\+1^;"1&2$
MWF=2)B9P8#Z.'9@#>2Y#YO3]V)&I$,$SA,[LH:K2HS*,SHU\GN0QVE.),Y0N
M3L:.TH%5@R,S^ONYW`Z5`?1N]-=TA2$Q0^C]Z*_I:G-P!M*'T=_3#?;]#*F/
MH[^KZSTW'"A[=9>[XC*$/MF[N\R7NL/GU&JM(G[Q#*Y3>X<7`QXR=,XZN+?_
M\LMA](F2X!IVM6*&P17Q0^*Y,_K7V27R6-C2TQ+C*`.B-K1&G$P_@34"_(FX
M`N8H?$E6*@[?+A!:I_X`[$7A[B>'CH'MC__XXJ(7UTN,;1-_EIRW)?'H_@EO
M_AG3+2-BG!>G)>37D)],._9[8/@11X@>[-D-"GQZL843AQ[\F`6OS:[QW'5<
M(><(A)KF">6&G$9+^L*1%3U#2^R'[BN^\^E)P%](&-[C:#I_1C\@LP.3UCW5
MV<Q-+]$'Y,[N_"NT=B,D%-/02$(SZ[G']3?DQ4).P>IO-3/[L'N@Y/@M_;SS
M>PCBZQ2ATL$&<2/V+K&;G+Y-3-O!OD-O=NA>J22C>0JYQTCR#=/.8G*-Y0:\
M)[Z3:I@0CNNH:)[`]?9H/>)7[,=8CO\:(MUMD2LXWV5?=XNW!--5%/2+!4%,
M58Q6@-<0T<\^B>DE]H`VS"$MQWLIA<YWN,Q#5$>ENPF4JA0MI]-`4_>V"L."
M`MJPC;9?=/$PI6.U>).*!+1K4W3A7(<J"%<H7#*)@_Z'K>DK\I@,(C<7"%7-
M$_Q,R.R[ZX%T#/Z-=CF=K'$0;1X\E,:\48C63/:C&AE,8*^CT\F1E+G@]S_4
MKQ.MJ<9X\V--U5],0<H=.`GFA<AU],8^8@?3HT4?2;K>+5[:<CJZ)_&*7(^-
M>4N")WH]/&%Z-4C+.\W$=*N!I1?>)+I"0;"AJAS<>"!&L,M#+B-!5!#HA&UY
M?CMC-#-J%YT60F:/XM?:S1W^*WUR7'K6]LU%7_'J12Q=3IB4[JEX*`RG\V1(
M\;2(NJ^[VBSYL463)P2(V'23`D=RZ28*EE@X`Z7JRZX8G<YO=Q4P'DCH0K-5
M8/3Z\#)+S9A4+XS!`<(-N[@Q6^7LG6F(R&>KG!D7_=.\.P3>J/V]<F8T/I7/
M/*D70SA&QL78"<AN!"!A\D0$X\(V)4[;EY+4,/,R-`14+U*M#W)@C+V?*Y3G
M`B@%I9ZG91@KV=3;0PC8?,,3-8P]9\*0"1CQ>-:&L?>U.%RUUEN.E+$R@#!2
M0C9[GNMB^,4NLK4JH/FH_EXG$?(&`TW])JKSM?&D#</O\3J(N/^4YV@8?D_7
MP0'QAG/`#+^NZP"K"(7@&2R&W\S-5W(^8<78NUA,,1,/3<H@,U>7!<=^E0-9
MJ=&=FE>"`!#W5R)T'P8G<J",O;_!0%5%H&98F5><0`ZKJDCC#"CS:A3(`56[
MFS34*!C(@]CF=J])&<B0,Z]F@0KDZI)%.'1CN.[;B!0YK#34,S#@@-8F?NVP
M.S.OUH$*[$2D_C/SZAZ(3+_4"EK,[LQ0ZJ+^P3&@5,S9S2`RU^,'@Z@R%3M#
MRES_'Q`I:!Y^AJ"Y[D`8@B)U&C+0S'4*MGT6\R"IEU@-D,*:Z[%D`&KP#Q8`
M[*U2T$."\A)'KL/K<[0L&U1*<Z@UA/:9[:RVB%1K+#$ZW15(20=/2B+.6O&_
M(]$UZY,X6M(S_:^6[.?)=#<%NG.G0;+!9XGD^H"#A!W)J523Z[2(3:N#T4BJ
MAZG`CT<=E1XF('=(FBAU.A$51T64HDT@M`F$Y=S;!$*;0*AOB6T"H?$)A.9U
MNFJ;0&C;79G<[DIM`F&R5VP"86T"X8EQ";FZ$@A//IB*5,L$PE/SKZ&BZE7I
M=JW6$SE@YN\D`&!%2X'!U0+:`[6S"_$T57O\ZDV`/&G5?&FZ%BDAVR_/DAOY
MOJHU^O.$.;NGRCT['*%/%J'FYCTGGSH0"KIT.F<_I#+X=(V#9,@6?6KJZ0W(
MV5S!J%Y;V^_872SIX!.JS*`%OH^9\D*5'[;A<OOM$H6N,_%GUZX71S#WCNP(
MFHV,N["AW0/68H:-I#1/Y1Y'/&(L*Y7P3'(7R#9B)>$,,C4PZ4Z===?NJSNC
MAS%,><P.T-UJ#301P^AVN9[2J]5-??-[>JNE=Y6_2,?>UE*`\-U$2?-$[GSZ
MXN$PDN"\\*EV5E_I:&E7.P;1;GP8SU4T>MTP,IX=48JZ)[8_//38EGZNW=<>
M)EDE6ZB`#8D.O]5=LWG%.L7^*Q&(IG.Z7Y&_8(97B=8/#90J)U*4.-E/_OCF
M$\>)URZ>W2*'18EN`)=($P7=?1"P3_>=1Q=R,ENY?M(E/')?92[P1E+Z>U9@
MJGZQ2AK7^!5[)"F_(C&1!D(='TJ9*[&:AO8U2-)(0<>1?Z.]`XZS+?#TA(-7
M^I=P.S2$VQHBW6![&Y#5YP#YL#NOY&/]@5S)GI,!N?AM1_M6YK`5OS4SIL\&
M9MG`K$1SV%.'94Y,)8D^[;%-\Q*)N#*W`I5LQ)5YWFKYB*M38XM!M(T!&;F3
MIRA!\"`&8_VHE2(7J9,#>>""L=$=(L"4B/,\4,&X*Q>"3(U^QHMI&WO?`/9.
M?LM\4!^',)"D;U$O>Y6]A`<B&'L1-QJ<B+!IC,<C&'L[0]!JM(CRLK[&WMDB
M>#79P'F%7V,O;LBV:O)?\!K`H]Y5U9XJ7O%7_35U5.]>J=.1UZI5OWV."QU!
MQS(O6&OL]03TVI.\6:TJT(!79C4V"K8-;`<Q);RDJ#I!]%.*EH\7+/3PJ/%J
MBA[B54:-E>/%+K6#\#!>073D3R$L^(]7#U7W1@[N-$IL*)'H4%Y3=.1;KC%D
MF)<6-5:0%T-*-GR<5QSM0#+K*S]BKVIH/NRP79I$)=F!9DL4^=5>6NVP6"LO
MU`H)=:DATT4L;F/16?&YB-'K<5*W)*`WB9\VAW`VSP'R0_J>L^O.GR5_\]++
M;_:/.%5:5,/0AH.>@/OF!QAY+'/Q;_0=I]?L9^3Z;"Y3G[?@G`1N2/_IFO[5
M7]`'S24SE="UYV$`1REEB?Z<SB7$USC]KW3(>\O1;/Z*C:6SL72#*7*6[OFD
MQ4?A6+>L=R9&>A!:`!`'H2IHQKHBI:N@&1>EV*(*FOF:M5Q,GKF-9EO924],
M;A<D[!1K*7J.(")6H3X@`'Y[]8C'51K;)*7;)6FK[/-P3F,OG.X7I`3>=R/O
MDUUK?\Q0>F]84YN\X;BLFX\*`WHUW8%:T$L8UIS2G]U[X3.I:!N7,)66!6/_
MRSKQ)`%=$%VXW3C:;0#9P/FG.2FL]XCI/><ZT=8K/?F.@MGG`&A0DQQ`][3;
M-&XI?/R'YYYX9]VL5<V1%EB(O:\[8OM(;+%&NJ.$[AZVG5^H7),8O2BKR2/P
MB.D>"=T(;Q-9TF/[B!VR\!,JVP:DBN_!5KQ`2Z?LKMK$?;L+%Z'"\>\H2-*:
MTH,N9&>&D%/-IO!*0*AIWIC7^"5*ZY>'=/VVE<SIX^?3%R%F>V3'SC28)C+>
MMCCG*63'M1BDQV<W^;<M/S<_<."X(:P8H`1QZ)84.<MW[&PB;Q?X_HB3QJCT
MUZ/59!'@1.X3WK7J!NRG/*#X52)(J(=&6!D/<I$F0@2A&_$2^TFG7>3Q@WZ+
M410'](*CSX6+P\O*/@G"NZ_E*!W<I?Q.R_%1PS;T&H73[^<&38\'9X>]<AF_
MW!JIX#H5'JG'IZ0+'$0'ZG,_W./OR3^I6_<<Q1[75^6\#@GVN5XZ+0^-(_0I
M^FT#L??5'Z4VE]HA^ESSF]7:(QN<2J@/<>`L*9,/'CHLE-YBT>N&Z''5*]E2
MM>8U`RC11;^MB;]3)ECA^$2[^(V>,,K&='YPU+Y1*9TEQ&;_?H,";Y/I(MNO
M5:C>&MD:*FP*3`'ZN#HJF^[167--#59M4U8S0G2PV2[3"=[#N8J";JNMX\2K
M.+%>5%F1X7,!$-5NE"XUWTA,J9Y0IY8>./?EWVNWZV07O4Q+\\+'NEND)%<;
MVZK$IW<'O(]Y!8&NKLJ#X4/I=N;EA&RT?X$C&^W?'.U?%!Y:QOC7$1Q$$)+0
MG&U7<]O5W'8U;QW/7_Y4C:FS>>VK3QJ%DQ$D#]7+=>4=*$?4U5P8GG(=@F<X
M&/M:"2/4H"-RJ.Q9`U@(#*ZP#X:MRD@TI@+S<EE^9\9>3V+9#V5&7`Z.\@MI
MG;K"(A1$QP-13=OI=Z-&J`\/#B_9;NQK.2#0=\Y&7J=[I*BW]''SBM06/[G@
M"%YCV"(H%UG#RPU;!*6BLFP)75CX'J\1:X5LH3!.7AA6N;KVBH,7<OR0B4;Z
M\KJGQAH'%&P]")#O1_YHR&4@9/"9VSU)0%MIF;NR`_%\!)[/VCTHF,"4X34"
MJU\M7@WY:QE.8ZTNKCBM,</3JFC@[-<,NP\C?2CR[ZQDPG2&X:>1OA.0Y/H=
M6!<G(WTD0/42,K3.1XH6]V7KKJ"106UN,S%UA29S<'T<.5P5]4K?F1L>(.OA
MW15=RB"ZT.3%O/&/IXM3946M#"7U9O,C1$FNE-H.PT_F=CI4^'Q6%N+;PGA&
M<32XFQ,*E[<>^:ZJB],AN8'6GN1\ZLW!^(J"/W&$]LR\O'KRKFPR)`E#E"(T
M8?DI7M,E8O`@[]H-UR1$WG2^Z_'<S)\`$=V9;MLUO2>^0_^8=H*EER95,&Y=
MGQYL]F<G<E\3S"A[CD?".)!J=]%^+-W)/[F5V#%[Y\])L$JO:9GT'U&2':PS
M:]A!_\,DK%?D)2'WT175(C<4=W"=0B&"'=7.[&=R/4VKO-IV^]E5T=6=NSJ?
M8X=JBC<_G"7R%_B1OC=3OYQ%R"1A=/47=V5#/@2$V?=GEYMO(;,7EMQZD"E"
MJ&HO(K!&FZV8<$\B'#Z@#333LYJ&]A1UXF`\"V^IM)S&=4'KZ511Z)KQ-O4P
M!8AU.!UN]=S9.67G4D:IEXGLN_KH+93^`--_%*ZSV':$7B:>LUNWG^,>L<%<
MVS*BH0SU?B;,)765[U0I5=T;=/O"/).)0]__`%.FUCB(-NS"CNB)85+!6K3F
MK@S5+I\$*MW0P;^R*!8WVE"=<M?Y_98$[!_E*EQ*#]'UVI9I_:V6M9S@8,ZD
MPDNHEGH_$Y[2$X647T*E5#5/\%#'NO.OM^_V(W[%/DQ5%2#6^702MV"&[!<7
MO;@>>,%`9#N?XL1Q2,RT9KB>(T`,7#BQ0))[.K8J;P)>:E2D5[/D85(X6#^;
M,FWS%HE;:&'T>MN&C]C![JNZG9BGU_U*[?;+UMLD\ZY!J'91<;.0\00R(E=0
MT,SX91RZ/@[#FQ]NE+CW0&U%RK[NHCE1YEU@@1;;<%`(WS5$=%=\7)$@<O^5
M+.YTGNF!\%9JM73T5^4,<.+:V..">7.2FR6U2JS<>!6F0N8*:MF5'4'SQ'/M
M7*G>PXPQ.1U02JT4I=CIMKSS(^0O6'P__!%MHJ2]`\@ZP(Z;.M[\69X;R"QJ
MR739J8P%)M*3[>&]N+)G(JCGR#RK>L:WK?5@&JI"1;_/=>FI5+:M]&HKO>:'
MRP4VM2SP6D)G$/%^=3,4*>>J/M=[<"&1P'*NYR>F(2)?SO7<_(!9N<)MY\;5
M_!5XN4D[D8.#I[Z;_4#`:R'G->>2G%Q\M+C5X:9'@^'5]BY,A5^KZDD$U>L,
MY_?&7@]=X=QDC.%5#(V]4;J"6M20ET'^4=TM\BF%W*>B782'D,75V?Z6-!-G
MB_!)W14SWD6H=47PDIWVBFD)=(W7*D/Y5!W*H]W095Y-7CG5"B4MX:WR=&<0
MGQLK7ZM1;R!Q#QFH%\;N6XG@DEHPR^)C>-E?@^]7U4"614_QZK_JK*N&`*DP
M\"Y#^:,Z\Z0A*`,B-'FA96,?)"U'OCQ\-ZM!>F)?(D$T"U'>O)2UL<J4,LNY
M<"9`!JH&AQ^A:SX`4%OY<FKS1'B%:V,=82V2<_)%8,42C3(\%3H9!O=R*T)4
M-D>-%Q,W]B72M&=K<AXS4!6Z$@S=N)!<V0S63_9Q`F=2\XKM8WN<1-+7*Z[2
MBC1\7LW=6&5()Y;-91LR@,VU,.L$F!?^X/7T[4X5%Z`:ZL&;:S[6A.5!O[AS
MA89C(P&LK@S%>Q(8;#)6`R*D6AB'5?W./"K)$E9%CG=W,"X\'`8;K,(@[_.@
M7A0_JMTF6'8RPTN]N'U,K9U!J!V62K\XTX3=495*%RU.RWN+F'NQ`6O_'FS`
M=G6-,WS-M90K*S1-A,IF\Q8MQBIZ*A'=T10ME)[!VX697%.9?X[(-%@@_Z`2
M0&U)__I/^RG?7\&3YHHKN:%XVX`T<^,A-^,L]I?UCMAU%.`</U,`+CU@?5#U
M8Q]C^KBQZ?<VWUTMH]D^ETER+_FXSZ>O>BXBZ>PCZ-$+3&<WUP?6,H7[Q+A6
MI_)Y_B?&2M*"S0Z5RQL<V@X<`-JEZ*=XM4+!9CI_<A>^.W<=%@>2QLVR+FP4
M+B=79E10OH81[5OR%N16LT12-[:4I"U*T<K/5GZV\K.5GX]?$+#RLY6?K?RL
MV-LD*$68)17?(C=(/)!?,6)_WRMW+"@$U]+H6^8M9T[O6YR-R=F0DVP;"%F!
MU@JT5J"U`NWQO\Q6H+4"K15HU0JT#<*#67(LBS8Y#+%C2975+?8$A5LXX;XE
M7@#'^AN$BS$B)1Q+D;<BLQ69K<AL1>;C?_NMR&Q%9BLRJ\_5`(L49@G2NSH9
M9<W&!47F.A)]"\>EO.E]E2LKC[0,,(;1M8*O%7RMX&L%W^-_P:W@:P5?*_BJ
M%7QALH19$F]5RV!!:;>^XW!_DFZ!+[U/\.%P+85;(7)6IK4RK95IK4Q[_(^S
ME6FM3&ME6K4RK9`(898HN^M8XCA!3+G,]S"`!3TTT>E;N*UF4.^C?-!HHSC^
MKLE)[D<%KJ4$8M4C6]G9RLY6=K:R\_$+`59VMK*SE9W5RLZJI0VSQ.RGS6J]
M)/[FFGZT(G>^`Q2O*[_O6ZPN,J;WG?[J^LDNH*H:IK-L&Q$A1,X*OE;PM8*O
M%7R/_P6W@J\5?*W@JU;P%1(AS))F6:\L-UIM@YVO2%+X`OL2U=`$*/4MX=:Q
MJ#D;KGKDEF(OE+*5@*T$;"5@*P$?_U-N)6`K`5L)6'$.'%":,$T8]NB;0`)*
M_Y52##&%=WF-7[%'DGAH"LD7U\%^B">+`$N52VLS1/_BLP3ONN7J'$L3UDEU
M@15DUX'(6HG:2M16HK82]?&+!E:BMA*UE:A52]0`4<(L<?H>1ZPCWP,.GI84
M3:"D7/%UWT+P(5MZG]\;%/A4`\N&DY)F:XA8V=7*KE9VM;+K\3_"5G:ULJN5
M7=7*KC6"@UF2ZL..P:>(SHX9P8F?_''BSWY'3&@'&WHA)/N6:85XU2U4T.&6
MQ*.[*F3U1Z+-/8EP2S,N@*@5A*T@;`5A*P@?_XMN!6$K"%M!6'%[.'%!PBS!
M.)TL*PS'XD$2&"Y1B&=41EQC/TR&!0K&$))]"\9"O.I]NSDSTWE^V$?LT9U+
M.0FC,%'.$L8>T"8)NY`2EUL/985H*T1;(=H*T<<O#5@AV@K15HA6*T2W%B\,
M$ZVI4$LV&%]B'\_=B`F94$FZFD+O@G,):YH;;=#MQ';\MC3)`]U-`8[<M.?S
MEHVVN7;R8UC)V$K&5C*VDO'Q/_%6,K:2L96,%3?@D)8KS!*)[WSZ:_@9_0`7
MGRCYLF\1.,^2[NX;VY%:M]VHHV-%6"O"6A'6BK#'_Q9;$=:*L%:$5=UOHTYV
M,$M,?<(>=B(\^X\8!71X;W/K^LAW7.1=HP@!)5<Q8GT+LPU<ZGV<BX/>^7,2
MK)*)2TFZHA2MS&ME7BOS6IGW^!]O*_-:F=?*O&IE7E$IPC#I-WX)\3]C.L+-
M*X;GQ55]WKN$>\B79BGA8#BY_+9J(E9RM9*KE5RMY'K\3["57*WD:B57Q?EL
MU8*#:<+J:H6"S73^Y"Y\=^XZ*.D;S-K;N?[B@7@N*VV\^R]8E)4AWK^@"^):
M[TM^C[_GQ@XHP['OI)6#$PXVZ?]*2<=PVIK%ELQ'TF)2U31T"X=99'X^=G^:
M7`43?T;YHL"ZKSA)EDR9`TF0,N0U3WE7XIJ.GZMR??.#L8?A4Q0BIWU*]+Z/
MZ=WJ$'KX&;@M]J(`,<W3^4S([+OK><D.B9"_<%F_TC#$4;C[)_@Z`8AJGAZ]
MM-8X2!.0675UEHZ<;)H6BR9.4_/DKDARIH,T!\@-_[RB<H0;L3]!YE-+1ON%
M_HK#J.6"U!#1S/XM"3"5`=*&O73@@%ZM5`&E.+)L]^2O7@)KV&)Z+0;1//UO
M(9[.;\+(75&1&60P.OQ2,Z-?7'I&9TR/:1??64]'\R3HV^Z&T_F!I-E&OA.E
M:$VAUA1J3:'6%'K\-AUK"K6F4&L*56L*%94B.K6+#AFP>BDR@^GT_;AA.M01
M,F#.1G[@6BB$&8;GYK]LM1C6V`PRC"Y.QHU1K6&(HS3RVUS<')A!]F[D-SO`
M/IQA]G[DE[Z`JR##ZL/(+W<A/U&&UL>17_-2CD..WLBO_VIW<@;1IY%?]_`P
M@AUTIUWHUMI#:&Z1&_R&O!A_Q8C]/:W*Q^PNT'@9`4I]!\?4L:C9XNPL\2SV
MJ-*8\9#*%$E7;?3B>O39Q.&6K]G4IV\I5:'HGDPL&`F/<D'D:@>VWA;K;;'>
M%NMM.7ZIP'I;K+?%>EL4:VMJA0VS@M6O4+AD_Y_9X%Z1QT1/"LM7%/R)(S;Q
M)X9%@H^4^"U+OF^9',RW7AE@\HI<CPUT2X(GM#>\C/@M1$ZW_)6=RG*LGY8D
MB)YQL.)^!R4*A_QH5LNP6H;5,JR6<?SBDM4RK)9AM0Q=6H:\A&'CO2`":J=A
M7QVT@T^#(O+Q$%(J5S.AOI6K&@Y[RFU3F]5F=0:K,UB=P>H,1KW75F>P.H/5
M&3H*A#77W9!$X+/:+T&,\]X7.>^"&+6^Y=TF-KLRM%<PT-*@WDS5"L%6"+9"
ML!6"C_\UMT*P%8*M$*S+<-XL21@F#)/5RDT]`53XOR))M#_V'6EQ6)1>[P)Q
M(Z.=Q;W'$>7GJ^N[JWCUR*;O/:!-PMDM":94.T.,MR\8A6JDY58#6D':"M)6
MD+:"]/%+!%:0MH*T%:2UQ;FW$3),D[$]^E00-N%77)[E/ED$N$6&:8L1^I?#
MX:Q7"0%%G-A/_KA'Z5:Y\T-Z:.,(A]/YWS#RHN57O'K!@9#8)$:H4CZI8&W"
MGN;_PCYV$)"7DB\[KZ']-?8BE^Z;:^S1Q0O8XDR"`%$]JF6H?.NAS%$+JC;.
M[DS\[D;+S^&?T-U3\?DQ:G=66;+*DE66K+)D=8(NL2B]W$G#\\(Q,;^XCJ0R
M/?*H^]:2'X_(-](L47_LBCH!A^/3Z.!H5M<Z+:RJW<YPCZ,O)`P?<)`4AY.R
M)-32Z-M64,Y<5WZZ&Q3XKK_(AF>5&1QFJ7`]NK=F*CQSP"&.45L["J7;JI=6
MO;3JI54OAX2(]<6-7N^6]<4!Q0JSO&\/.P:?(CH[%O9%_.2/%(#?$=,D)9UN
M<,)]R\\`CKL2JI/AE\2C.RYDJ4?1YIY$>,?,-'AT%\M(KL)4BT&L8&T%:RM8
M6\'Z^"4$*UA;P=H*UKH$:[!@899HG4XYZ3#"JDLQ,`H=2:1$:SCAOD5K`,>=
MU33-#7U%PHC5L<J:QFQC,?.>M(F7//VLB\R\O+L,HQ)>)K-44@:U2P8[*R5;
MG,)W%*0[(NW.$[+RS^FM%H;Q*OV9"CS5C-P#4/DE?,14D'.=:*ND?O-=NO!L
M'A,G<E_I&5.+5*NA>X8J=S8N-^6+OUMW.C,\8]4]?JPQF^`S83^:QE$8(7_F
M^@M]J.KDTNKI5D^W>KK5TX]?X;!ZNM73K9ZN34_O7#*Q`9VZA.Y.2RX?&[)M
M%+\,V#-[;_1AH3`K&#7KL"M92*;R^[XM?47&NK("7&^7G(Y=UCQ,A0H/'*(S
M`\C-?([9>\#1?Z0GF64)^`[EC9M7VP;@2HS3&0@I3Y=X3G*[D$I]]`5-PGGH
M[83=A1(<)(>R]AAKC['V&&N/.7X!T=ICK#W&VF-TZ562XH4UJB@16*T%I:W>
MTZFI1+NJ_H2]Q*CY'S$*Z/#>YM;U$=T^R+M&$9+2WB$D^U;HA7CM2L<K,G'G
MTUMRI4S#!0U@]3FKSUE]SNISQR\'6'W.ZG-6G],E/H.$"K-BX)_BU0H%F^G\
MB2JL[MQU4-)EB\1)0X$'XKFLI<!D-G-WQ6@R8*YQA%P/*EFK&J]WL;OU1(`E
M,Q]PX+"Y+>B&_4+\Q1>J-<]2;4](EFJD`:WAF2>VK7O%,K4YP"!V#BAH%I[N
M8U9!:3K/"CD_X47B`H<(435$0))SLFF"3<K]]B^'C&]__,>W)Q$.\[^M6UY.
MY_P9DT6`UDMZ#CQQ'4F`2%?B?GYL4?U$@`CT4#UBQT-AF%PHR8LY^T>\;75_
M2]\X>L/$J]BCP\VFT1('+#8CP$OLAYD-3?CTJ1A*\^I\\X.TDMZ_$MO6)?;Q
MW(W"S%CX@.G-RBQ<$W]VY]/G$X>['I&0]6LU3#\0*)@>?'/N+KQ'O"8!N_"2
M<#?A#5?U.92-*Q0N6<+:*_+89OV*HIC)7_0U<8GXX]-`1?.R?D4_6&<!\;K7
M%1_J+IK.8L/@3.Y]U@6+T!L[]Y%F]K:^H+2!K;-Y#I`?(H?=MY_I^\;J`3YB
MY+&C">$?0E7S!`7>"<9/&<?>P;MSCZ/IG-Y0$"2T#`]^M9?8]2]=$F%G^7GU
M`FW,4/6YYI6[C$.J'X?AQ*'78)CH*<D?`XSA(IP`L1ZF`[P6*DEH9IV]10?O
M$4O#7M)G\AD'JSO_%6\E,\AL(%2A.WX:+!`5*+9!P7Y(]=U9>IS\V4-."Y_.
M,YM*)B6'7(L&N2HT#7R,7J+!.%WT;@]A'XR&0:%35F(:@OAR=(S:BP5;'WI$
MR\XPV/&D[_".T&?5PC5CGIM*Z\;2(Q@8["G3*\,1.1G4X/A(K=N_47O9OV//
M3`)65/EK@.E`4^4AIN],VXEPY9\T6"DX6!],`ZNS:U*+%8N'^2K?Q:\X>"'C
M6!J(J35#_,(*<#(O6,XLO_]F79@$9;7GXA"*PA7[WCA)M,[31"K=7AP0XW)`
MM%]L(M[/#-\/YFGEG>!;Y>O.@/UH@95]D2OC&3)P/UEP%8,K%@O#%\!>RU+7
MAHJ8K-TBG)K7I;83(;0FFF]?*'UO$K3B`9%$*&XSVX7F-;(5#WTE^Z&X'!/C
MS$J=O4\U0=<9O&?&;;EN7I^:>/P,VW.[=5MC6TB]R-!]UX%'67M.T2UR`U:Q
M$?_-I6<T<):;6Q)DL)45*/B*$?MP-HFR;Z<^E87B(*`GG/7["Z6RC3K@I.\\
M))U3U!PXFO"6\<"GE/$"B@,5H`8-Z<FHU<%XB%WQ"FB*X6D[C.X(YAU[=_XZ
MCL(O]&'PSN$QX;5D>IC"F9HIG/4XA5,U4SCM>@K;/9VJM87["QY[#"3<U30O
M-T4>$L"A8<FB%*'WV]?8=QUW3449=K5LKQM0Y'H-!=UY44_/0;+:&QGF1:AH
MG\!G\HH#/RG"O,`^BVJ\QB]1N^F(TM2=WD1\O/F*@C]Q=!O[,XFI5%'0S#@/
M2'JF3%Y1"7]!!?%4+X!/0H1:IQ."WCQE7_?Q2F2R3XL7KY9>#Y.Z#?`_8Q92
MH.;!*Y#K[IDKXZ+%&U=-SJ9J%#AJG:HAI7W`$C/:#-'5+N8*8RA34*N>3I]6
M:J$9$@4K97I:A(*#8I,@;!*$FFT$>C9'$/\-D4;*X*L3I#A\QOD^9.33!OB*
MLC7'S\P`<;4GNDSE&D$P;(V>6@E.N4+-\Q%.3-MN$E8*TFQ2X8`9)WVT`TS<
MG,8A-#9`6Q;":@,KST^Q!Y6K8#4F=0Z8<0=5KVA<ZS4905`?T"75).%5N]8T
MIIP-#DN0%[,,TC(7+`?0.%E9*X!G10`_60`!`)X7`#RW9KP:,YZ*P!T.M35U
MU<1/Y?.D!:*\.*H=7*'=%6@OKZ21JG-L=W)Q<?**7(_]B/5[IK_9KE"[JG'[
M#I14-R'-89$'@W)V0.&0-52@'L)J6I\#$H8L8RQ-@&?)\+D4I3L?6+A0Y6C:
M)LFR_KN;9/UHNDN[5G(Y6;&LUG^QYO`AR$\J3%*F*+38J2X^,"*EHL&TS8U_
M,S*:T`;C#2\8CYTY.+/YKVRTH.'1@ME[,B=!N/>>P/%OIM7!?J</RV%M#JD3
M4$U'=T15(3\N>Q1_=Z/EM3NG"A>]#7%XYZ?5,?",OOTQO23]658N8U=NZ1I3
M69Y2S'XIE(B6[(@C[6<S*W1[N:F>$_S0`LC:`,P"1ZT#,,6E2UC4)9AN9V]+
M(@917AAG44[RE`F\A%`=AB=0>/9$=B%-+UPK>V*:PR^-\UJU"+\TLWI,B[TC
M]6+N[RTC8R]E!!/2O7AF<'GIGF1O(JIRC"`DKS_HF]56#K]Q.U_=G5X7=?O.
M1MT*1]V>&QMW(1<!F3='\OK0QL56:`Y--J^@=N>AR1?&*3>:HVS?V3T'C^5^
M9]SUW]KD(.U"YE7.C7LN6OOLRP3@II@"CJ=Q5Z$*/%5&IO!ZD<9=HMU#71_I
ME$']4=TM\2F%VL<+-N"1@RT2$[<#\4Q#V#B)D-=3T.C>!<A\#F'DKMB2\M*/
M<_TAI'JX&$Q`J>+I]173MZ\^J`GJ.Z396\`B8V3;Y(0A/Z>/R-3'S\N`Q(OE
MK?N*_XY1P`/+U<T>-.A`X&$&2]>GK#+^M&)2-=)`@.`)#!*>Z1:##&3Z&J)\
M:P<8RK0K#JI^.,0&'@A,>V=7.S9UHPT$D'TY0..-43&09AB>G"6>Q1X59JKY
M+,K?`M,&$K8Q:"UBT+K;"L+!:A)$;:3:X"+5)%;1X$IO\@>E.4;-O)@^^1@U
MX^RXK3:.Y(-J<,A?.]E%R'8H))J-(`!*C90L`7F=9C""NER]X2ZHK1H<?-;_
M$E1`K:$^6,&)8?A%7F*5XR%NH[],J@VC;2_PG!&8XSWZFT,IW@*."!XT9ERE
MP1Z@+W,TGURH%[:[=S0#:NG,9FXZK5RZB)1;6>F8?3N1U4Q&<_V($FX><U%`
M+#P%8@@3HS<`$Z:U9EMK=I_6[(J$<7Y[5*?^E-X6$*NUJI%Z"QI3AU);Z[9Q
MP;LZK=O&R9NV`<Y0K-O&:NVMC2)B$EFG"=3Z51>R6A.?#C"=/P1DC0-Z-E-7
MYYKY/N54$PC-WE4/(6;UBEZ[@1\\Y$?YT>\QR+=>3T=W?!`/S;_&=`$==ZN;
MT85-;@%_MC74)C^OY!44*J1L3,W@5(X\C9:PJF9-E#1/Y`M&(5X2;W:W6@?D
M-:VZGB1J0"911T5W8;8X\-V(R</^[-;]P?X$Y[^&2%\;"3R')DJZRW$B^I3[
M.-BTFD0=E;Y6XEN(Y['WQ9V#-&4A<GU-2<H$)$)-^R;[X:[BE42IU_T/=;/I
M^I)L[G^HF<U'Y"\PG,F]S[I@$5K[,?=1'Z\G'-%:,CV\GQ+MZ&NHZ"XO2P7^
MF&I:V74D45FVB@34ADEU/1*P@3;`&N'%#\%URI$?SY'#_'O^0@(+`2)]O5:L
MF@.\/JX0N;ZF=+F1J40M1,ZZ7@;D>JG>A/*>ER::\HZ7!MM)"T>+,.4!.%:@
M*)0:<9L6:51^%,%38-THUHTBN6]`+^3^?C*R>"U$\!"!+R\SC2!/!2**$B'9
MF8-F;`=4&="*>@\'RKB2:Y)`-6JI/!?!6%E"$K(ZLP1'S=B75!*U6G,4A\W8
MV[^-`)*S/>Z+&4866BZ:9P^A&$&Q[CIS.JFT[?.L)F-S)YL`V??)Z$SS&@@@
M6C2;+R5!86?&!H4!7)HBX.6=L1P]8Z\H.?3JG/(9:!_')Z[+;;E#X#Z-3R&L
M!:XF%B>K"3M"D;T6L[KXJPRTL_%IAW(G=!MYQX&S5]M^6JBR*,T,8H5='`93
MY%G3[DQB?S/@-'1SZ#[?MM3-IBRS5I)ZWX'L4+;UNK3S!_W@?$.\V+5DQAD-
M:4,Q;"A&,11#^/2W",J0&&,`X1GRR-A`#1NH80,UCM"<:6Z.JYQN4"M%F97/
M>D=)^PN7[J))&.)(8<$="<I]JP00EC4GA^:VW'1^R!=$F&JBI#O]P?7="']Q
M7UD#JKVQY=*^Q.CU-BFYXC]B]'3G><1A1%8X>,1>LEG"I;N6R%2I)=,JZ:)-
MKD57R3[5"_D5_8,$5QX*PWNTDDBW`)/N;ZJ7&\X1-`4#1-;J_P/2_VM6KH4%
MH)FJO`U`Z+EOH?\#Z0]`]Y=#I%3O;UZX46G^PJ?#ZOY6]Y?>.5*OZ`C2-62$
M%3$XRV6O$:1PR(JZI>D<(\KB:(&;D(HU@OP.;7=CF6W4W)P/D!5#",#2:$]S
M\QAD`6PRR?%`V0Z.<)<5$Z_B@&$Z<9P@I@R[Z,7UMN7NVY5-%"3<MWT9P+'V
MVH,'PV[Y`5F6JXEH-CHD`81*YM!$"6I<V))Z7KK![`$%T>:1;BYZHRPG_NP:
MOV*/)-ZGFQ]K[(<@CEN1UU_*DK'U$)`Y#L/D8KK%;?94):5N)G)#+PBRP?@2
M^WCN1BTF4DFIFXD4M[14@^%F8I+G)$<2Y#AIIF%-PRU,P\*+)FS8K?]>246=
MRA=535D=`?(#,.!*X4&:UL=@<X;0QFZVR1K7`K6%3=8XTXWP'FE\E3J-'1H$
M2/6*<+-@P<T(QKD]X+):$;I*^7($Z>]M<*M4,$:0I`S"K97:R5MQ&O<^MMJ$
M358'WNW1V,#<-H>W%K)W'30QUFXS?=JLUDOB;Z[I1RMRYSOJPG)E2/=M-P7Q
MK->P<AF'5*()0ZIHO;A^,NX5H8*POZ!8T#^%+MV'6TS27;J!F%JDR.N.]-NU
MLKWSUW$4?F$7_KE$"?,Z,EU-X2M&;$,E^?O9#__F4DSI:P:P\$@2[FJ:EYLB
M#PG@X'!,08K:^U)X:_8HN`YF3<6R(^%LV"5!8C]Z1!$HPE"4HNZ@:^;MG\Y_
M1T&`_&@:/+J+932EQR-"_HPR!(J\;J0%M;,]8H?1=.>NLW56;HGGM6#"<FK$
M;CD)HKKMY+-_Q&&4G-IGPE^5!^3.[OPKM';IT[]E[RX,8_Z@"=G-X<1U]]/@
M$/,&Y1F7D+DU4=(\D7LJ)ZR3E]!?4'F`K/!6^8#,H88(]*0<;&%H>XJJS_NX
M?>"/8"V9/J8`?>5JB.@.GX^(\V=Z^*^32+@'3/66V=.2*E#A/?Z>_!.LD;@@
M1=V-A?`:;9*K;SJ_)Q$.']`&F@503:-;B5=6QJ@EH[L8QQ8Y^O`X]"D-\$ZS
MD.C>UTP+>EWN""3T0K=&S:&[UV%:YD+<S2A'7/=!CU](,&,J'9Y=DB`@WRD_
MUS&^!NZI>CJ:)W&-7Z([/XR"F.V'6^3@R8KM:,@$JFGT>=7F]HJZVW:?:!<Q
M45=DM7+!LESATS[>[)L?]#"Z(7X(J$J6_6.X_=?VSWDC?4F1+]P29@]3NOA0
MJ:^,`I299`OR63V3AYAJZ"C$Z4Z<SMGR$C_9KL+\P8C:UI2HHB:SB*AC>SYF
MZ^7ZB>'^SH\PW671]+N/`Y;BP%_KR\T#@@;D@<AJGF)JW/B*HR69W?FO>&LD
M@$RGDH1FUDN$JY25':YA^AI.`_9?=J45(P``=G"I8:"7Y[Y[X6_$8]:R\(OG
M`+7X1CKM&+OSVS&4^[[S_8VQ7-6#)DJ=9;>7G[<J]J"W:[MQ;*QK@:/^RB"4
MW%SAY:;R'CN\QEJ42E`SLGPLKIB7MD4T+G2``<3C2F)26E%!S?J.JNJ"TL-H
M*S/8R@Q:=Y<::6`$Y1R4B&5$7,HT./\!*+*3)LW"X#0`)5"5:(4C*#6@_\YL
M93`80:M*%7:;VAMS:W[B4!I[_A5#"3),\O0$>U=(WQ6VAVBYWX&G:QBGR-2Y
M9P1:9IX;FX>AZ#*3\!?R)!=C,]14@EOC+.9(&IMFI?C-E8L0T)EC9";.A<@2
M#J&QZ96*(01$&/%>L19<,7"K@]%X^UC[]`MNU-K(Q*RAXHE][05>>[D85@ZR
M%03$-FUS:#/OB6P??3%,:\/>>=-?>Z^*P5F=!9%A>6[O5`7"5"XYAO=-5H[L
M*PY>R""PU6]HJ\FKVC>\O3=Q[S:GIC5!=>A_/'UG;$UOD51$TI`MF<'TWECC
MN.+[L"8#-@/S@Y4EQ<!L2HG.$/UH)4DQ1"42Z#G(U@8BH&?"BC%DX%JC2!M#
M\UY-CAVF9]8P(NHP%RS=DB%KKN:N7X07+0"T+\]_-!%L8'6E,A#%JD3QC6NL
MN"]7D*O:R+1?32P#T-PH&<5WZHX<J.Y<!O-%!S!KK[EX&T?T?[^Z/HL`V=F%
MO_ETBE1+ND*^@[W$Z<YZ]S!!:;I3G+[0+2S9PD;IF'U7:50S&<U5$O;'+&7Y
M.@8E8`F3U%T`0HR/YR6]'M`\@N6G2Q`?QG3O_%OW%?\=HP"4D"E#?3`3)G&@
M<<*<^E`F_$Q'U;C$>?*#F?)WHG'"&?%A3%>FKQ>0<J<3G57U"`1/K$C)YH(7
M..HO%[QTL5ID>-?1TUVS*0OB"R?^C-M<6,?"3`*4:2X&)-RKCTH*@]+$SKJ5
M'$$*'>B(-.==&V?J;Y%W;:S)"+IG1%],GK%FK`%>4/RH!*U9?N(@&NL9T@9B
M7N#F.!IWIW6!8TY3XYF2QGI_-"*9T_(YD,8&@N@$DMN'>#:A?6C:&!9'D)6I
M#<<\>NI?F.X;9=6H9.I:9K4;I&^WC"3WFAN1$'_QC(/5+D.8,PFO*-Y,"US3
M#L=12-6-2^3_^82=.$CBH(#%-^N):#;7W/E.P"Z":YS^]\[?LK"YQFL2NK!B
MLR+4H!CGPG:`9;-+OM1M_$+ADOU_YF%_1=[V*#TM21"QC2=9PA="57=?(()\
M-GCZ>#QB!U..J#Y]C4,G<)/G`'8B!<CIML)N=R@KIS*CO#QX>+9@3^D5\3Q$
M'WKD93$D(&LLB*[N+A^[P9E\\(2I8$$Y\#:/]%0&$9[Q:V?[BXDW_@N.*)O3
M^15]UUV6]+KK"Q])`:*/!UM1'J7U@239W/_0%K[75OB^^8F;`(6'LD];#'\I
M/_QE1XMS$,I[CY@"`R\87DNFTRG0V^QR.SZK?,/7$[@!(53!6P1Y+A7\?1=!
M-TCA0^VMAU)%])'%(R:/!@3#LJ^[C6U@(V]SJ^YQFU"&0T(=]7NX^>%&5R2,
MPE,([V5?0_=H,FTZ8S>-/_U*]SSK.\^,:L+;M99&U[="T8XC<PM\D8SY2!(D
M@DW*__8OAZQO?_S'YRL1%O._#6(EC-8!X^,T^1-CXC3'!/O9'U<3$0ZR7]6N
M4RR8/O89DT6`UDO701[\A:HAHKT#&I7,#\<&MZJH)F)CCPH<=1U[5+@FP-%&
M511L?)%VJW_K^**JM1M!SX>&C6][-]C>#4*[1."9&T.#A49)@0@)-"-HG-`L
M$Y*<@#J&V$X10/(ZPPAB%\7OG3H];P2-(@2492*BTW.HC+UXQ*"JL\1H#*09
M3I4S&$P-QC9>:=O8T",87F6&55[CV=B`0:$WKL)0GL'S83RWN/AS5^/<&$&O
M#@D/4B68![XOONU&<G65NQ!)C8>30V3LQ24)T:0(D;'Y">*75V4?(2/+F4KT
M$?IHK)+;U$=H/_2&`V*LABO96.G3>$R-M7*TOB`Z#K6Q>P\&-2R`DY?_-_8N
M@\$G%-O+*]-;U,"QWKS:]\AM5U71_KPT]<@!@N1G\-J](P&M7KFIS\[A%3C'
MH^8TW/I-.5:\&&0'RG,'>854%G@AS!;\2BF&F`*[O&9%1LDZF35]`%V'V84G
MBP"GY4M5)AQJ&;W_3$2UT](;D31Q$B=E3L2Y=#TJ*]Z28'<:V/EAL3CA-'@(
MF"D8%M,I.X),(@`CP@B"4@#X1]`A[\+P&3M+GWADL0'&EI=^"V7@;_$*^0]H
M30&E#\!O;A!#\S=K*("9H0I=1+=Q>"G%2/G74":>_G3]21P1=[6*Z4WOSSVT
M2H\3D)]F0E#6'I>8@DTISB9!M&1/,12C&@I09OC4Z,W%I"D@*Y7?:XZ@_)QT
MJ^5W">0F*GX+1>T>[6[ID.[5.&+MGO^&D1<M@?`U$P)G<[MS*FS0Q^29CIUT
MH<Z>(2IM92\-(-18@JHFIH5CD<$TY>XXY]9]":C&D02PND&P9'^6NN]J*>E.
M%-S*)G3HG'BR#02X^>%X,>O=L>T8.;OSZ=/L),730U!H<JMAI+,!]\NYRR8&
MEE/1'B1>.CK;SO`\#`%B_4SG<L-X@.9E"!`#OX1T.\[8EH2^@(??@>6![<'8
MOZ"*V@&P<`24+!@O%IG_7]C'#C2=LN3+SO(I7[$/2_@O?*J9U7O\?:LIL8:=
M`54M8]])%FH:7"V9W^G.S_^"ZSLNU7"WM0G3Q>1*:+AEFPH[9.&[_\(S>,69
MKCB"GYL\(;:[P2>DBH`M<I"^V(?X?'4]'$;$IU)^M"2SPE+"Y`$X]6ZOB9TU
M!O0R5=.`[F\J&B'ZMH&EEL)WW>2)2N>&=IT/N@L.W@XOK%4($I(05=,M\OR=
MP.73PJ?PX7-FRDPH`*J']434L`12_NI(0-EY(!']UD5>=C]M2PR*/Z5B=&P%
MH*K8FI&7UKF/V;2F<RI\_0,[8G77*C[47:(K(+/8B7+>BZ*C3:3*5AT9*'J?
M/?2#/*W<:/GO])>A!LZ*KS7C.&$=5!=XEQU]3WS$?_),_Q2REJ!4K(`?%#!I
MS5-E&OMTGN,*>K`J"-CZ#`6.^NL-4SS0+1K#5!+37>0H6""JB"0C,K,3\=S9
MSJKRD',L3^>WKH^H%HR\3%8,9:HY*!JPU]K.2C$K[2Y3N1U&4`A"_(39FA"V
M)@1TPS2\L",H#5$OG)`64M4(BD7("K&D7O0>0U4)F5-:JS2-H.R$B.Y)*A5C
M7D/!WOU":7]&IB1+I/V=&7L+26:YG=D;1L3:R^N1&"L`P+23)KN]P5G'HFZ/
M>I@*:LP[XXH?B+NL2(V/;`PU6V3>^@;/YOX!_&@D;$).XF(YP&+=$6-3J<K=
M_:0J^(!7`S"V#Z"@6-`<(<*Q,O9>`F(E$R3$:P`HMV@.I]";7$F.4W,S/"&R
M>77@7P;4F7&BD^0)["KZDQ=1L'=?1>0Q+Y5@K(;=UF1<$EK.ZR>,?6-)I05D
M\'TTSC^H;-,=9H#PZA/6EKQ7%Z8Y:V=/QSPU$CKQ1*AFZ/+Y6[R,A['A#N(I
M<86".N4I?!PS8T\J6.-JD::9P6EN,:>VCX5`ON\.Q?,38[4UN&<`E,Z]_XH8
M%9DBG2\/!/+P53DW[U5I42\ABR-HK-_`\;,O3%7Y#8Z156RK=(RJ.BL9=N?&
MVM?;8E=3+B=#[YW5;BO0:RZ`E(%H;K%]-5)?H:I5AMPG8VU3K9&K+DRV0^_"
M7*]&6_1*J\MEN%T8^V1`+*+[M?\R<,Q588'RFFSAQ@S)]QUH#MIKI#[%]-4+
M-M-YP8.55*?/-(7?W6CY^>G?I2JAMAJC[WJG<LQW4L'DEF[_5.O8!TNH0$G^
M8ULGT-8);+<!IO,)O3N#Q8:^YO0"QNSUCL.M3@>M'2A)W>1*7]M#*W/0]>=#
MVX)*W114LK4L;"T+6\O"UK*PM2QL+0OC:ED8ZT926<O".$-TBUH6QMJQ]-2R
MN+"U+.1K61B;"ZV]EH6QGF^-M2S,"TG1EU)VJOP9&$XR5)=)9>:6>Y!#,;_'
M-%0R(!'R!H"-QKP4`[/T5:$F:=_.TB]LW;_6\;,7IE7ZZ2M^]M1`G;3+^-G3
M$V-#I.0>WKQ?FN=W=Q#&V$$[VM4ZWIG2+E'H.BP9Q?7H]IC=H,!W_47X@(.G
M)456LN.L[`!]!UE(<*[9N>-'[HR-[[YBWEDZS1/",[9']U@^Y!'>C4C1@&`?
MN-2PV:@`@[G2X?3W=*-:8.12@>-A=ZL\1<3Y$^[*:R2E>RH>"NGCDPPIT5ZO
MY.NN^MGDQY;N95,DHIG]WQ-5`-!LK^)#<&-@-L-I\A@RG20]+]]1,(,&WS03
MTNU7+[TC[M%*HCUD,ZU>)B-\K5]NR@E`SX-6-C1#6&!F7SR`P-!(2O?E@-W%
MD@XTH4\"6N!=M=Z$EVD<A1'R619RBQG*C@!NXE:/Y#6F4I[K,T;!,H(,:>W-
M*ZD60P59_(6$X>25BI_,%O%,Z*%9$3^Y,9?$H[I*F#`+63`P:>W187DAY=I]
M=6=4S@]3'K-G]6ZU!L9)P.AVN9[2J]7YS2<3GU)-H^V1Y]I;4:V'GO%26C8Z
MK,"1>'08>!&%@[W$Z,!#X&5L`>#'I>TP/=HCE>!#1-?/X"9#H(-@^PN-NK\0
M>*\(OVXF!_5!Q04B(J]PP(Q-BQ:YOBM$41[(86SR,P0=F+K!P5/GC/N4@N?3
MBS3:_N[QP`?62GFLC/KGL.=8&9G;3-J0P7$T[I)K:S<B[:U</#9)^279?]2@
M0GP;[:0&=QJ!2GR=F-A'T)*R"T])XW+E/4,9YN^-S301=K418><@1\W8@&((
M:A7>78Z2<?D1LO=GC<M^!`T:FZ,>2'U4!N_09)P]2B"4A0`";CA2UO!"%,=E
M&=P52T>XG#KQL=!]4WV3J!XB9O</<,[X0&6/[8L:[I+"6+!U%F@L%3ZK:+2^
M8VG;3@-:"FJK?.](W_S`@>.&5->D>SC9^TF_%4'_G"`UJ'=Q2^Z9/,2!LT0A
MSL$BS%L]D4Y"4L/D\"<C)L<^W+YV>'8*#TJM)=9-6.H6TFGPR`PZ.=.-1)!J
M#2W)[;+;?4QD!>[C&@I](+L[1@^!ZV!^NK;_"@J!D:,/78'<T;H+PYCA]VU-
M_-TX?`B^E1_9)2:\0/(#@&OE'5QI=_X-<I;??%<\:J&.A"P[Z9%GB4T<"'G.
M&JB!HYDWJ_62^)MK^O"MR)WO0(.8J[[7';'USYC*6FFV]1W=-V&$L5SD<A.E
MSLI"%1E)&N=4L`<.U&\U#G1;?2&(Y^X!MU3IM]KK#+Y$+(4PB-F@<ANIFD:G
MS$,W1MG7^@LC.AC/0J9L)6^"S]XRH*0((*8]D6;[MNT+S]N;.EK"TE-$J,D\
M\FYRS&\Q?D"NN'A5\B5T<,J_PS2RQ7994G)<N$]G]AOR8O&H2!!-,,-;(H56
MEJ+,57VO>Q\B=KUOE=%<K[JT[CJ>439R-1-`>Q)(&5X@>.T&^`JMW0AYM[$_
M^^)!!9$Z$GV>__3GMR1XPL$KE=F!V74PRF#I#WOTEQ;)"0J9Y,W/59H=3I@&
M,L=!VKHYN6?I/J"[86<>%A<4%0S5SSHFM\@]_I[\BXKE.R2H>5I?T8]\*W=Q
M]@\^A&ZNK]XK\`SGOM!NY,G$`YE,X\+'G6@[S"Y-?'IF9)6<`H&N,HP/A@=G
M5380@N[,U%9R\X.^&*D]EE(7WJ3E'[<4BM;(WTS"$(M9B)HHM)70Z.9.I4V8
MF5"<ENY]QT9,+&2@39;[2K?&M@V3?4`;9@]C6^B97";R]37:?"5^Q-KG_ATC
MT+T$H=K=_?J`@FF0'.#TX=LYTB1OW&IRNI]1UY=\1O<_U-TB@I5'@S.Y]UD7
M+$*?@-Q'X(PWIH7-=J=#^"8[_*RO4BA/.(J\M.(=#F"M(\1I]C6Y9'CV4NQL
M_TJF5T*UM]7+Z6K,[Z%XIG7D>[#BW;%RJ,A[B%\\U]FI<VVM>15$=4\/;9+"
M<UOM<\<,ZU,/:]]22Z</2VN0FG-26;JUJ?6`6B>:T&YP^2I@]70Z+?V@0D`2
MI=BG)4RE":5`T=8ILW7*AEFGK.R]EHR_:235PU0F<;0D`;357!.E[M33-K.H
M)0,VP@A$$WX!UW\!4K658`H<M:X$([($L)HP`(HZF`77@H$1[2WF7&KN!+XF
MIE=\@6]X6_O%UGZ1VS42;YSI]6#D!`DB*-887!Q&#7I-HJW!]6/T`;BGY7`$
MS7L5I&]"`45W!+4-U&7WFMNF2W5V[YF9F?6M[S%1TZ7.[F=&`"EJW,Z`O!BO
M7E4+9+W3@\-GW-6G:A\VN[]XO:;Q:FGU(-:Z0SE\]E$1WH,5_G&#RRJITG,E
M@BIXX8WQ*A]RJ)8$Y7`PK3$!N$4/`[AX/1)KU2KIN7D0R\?['8Y75*PT(>1"
M+4=0$*P8C7H(1:&3Z*EQMU5=]'`.CH-0Y@P0:\ILM*0WJZVG9\9M*S4H0O(:
M,C#/[3-8;I7*9;ED8%V865RXG<P@E,F40?C.J@.-$.9SU#AP]M8K`E>>9)AA
M]GZ\EUNSXZL\1W1?DGUO$G:P=-N"/;B0%9QMLP_&V3#%$JK+);B"U/O!/+M:
M5=3F[E[*9>CO8#@S3_@7U8;VZR-P0,S;%SH=HH?E,#(<SY7;9@;2.Z2=;*"B
MD@K'V/KZX,[[DLH[&:`?S#,H-CT*=:67=KC0LVP<+FHV&K"T5@;HF7D;38'"
M655ZC<-F+[QF4T=M.;T,RG/CU`,%4)843.2`V:`&^&.[+7F9@7AAI6OQZ*3]
M.J@9AN_&>PE6VH_*ZN#N&XT^F@18W;2;P"EKWG;^P3@[;O/D#^[^TLK5&4"&
M=NII9[1M595\[WB>&@6M&H"J3+[5U>[Y;C5.N!.%X-#<4M7A@$-E)9*B'"S8
MKV('XL6I!;$:Q+)V)!ERUA!0H8;)=9WAN(Y72*Y5-.3Z$F6P6JM!R7:MZ6+%
M@;/6`_']6!JD<V%M!W5AYK5MZC(,WUD,*\]O1<?"##OS6G5K$'(J.E%F('[H
MX![4WG`UD^@2JV?IOI%JK0JFVW<357&&1]$G4^-DCJXUY9:"9)^&BJ_'TCVV
M'M/DM,G`F?NPCSU<?$5D=VN.DFUN:)L;-A^96Q('P,4N^5)R\&?Z2X"N#I6?
MR@[_G4@.SC^4''KJ2\X[]V$?-Y5T:>5R,GU,`7K8:HC8NK(%CL3KRFI<8N&Z
MLR)4P'U9($H`N.BL)/7>E.AV:#39P\PO/0O8Y[;<[*C+S<)VBL#K-H+"BLT"
M0A-4Q8UEG"$9(A"22FF5`V2<M;@%0#E-@@-DG$>L#4!Y/2^#R+SZ-BT@RBOB
M'"'[O@G&OQI9_D=5_.O)J7$U--3&OYZ86S5)@2"9,T?SPLKC`JS1NY[S/?":
MR<9I:G",)*(X3M27J^D_M[K=[JHJMG+RP6XQ1;%_)Y\LE!)A:ZR^7@>'57O,
M2QIX_^`A/YSX::S0)0KQC)5AP7Z8+M=LYJ93NO/G)%BE!U(F$D;1:'W'Q[2=
MAN;>G.R%*?+#MO0BD0(O-_Q7MJ6_)]]1,-M/#YB\4E:9O'1+@L_L.$!<$OIX
MT-W85);QE.&=6X`5HDA^W`EHE6.#.PTF<7UPSW+A.[F!X7[EPG=R`P/\EL6/
MY(84=DL>?J*[F3>]5,D&X[WR6N)[N/1SW6>6E^M@BO!TGBO.`7?YBU#3/:'X
M)71G+@HV.6;`W96KB72UA=)*/.77VCU)T_QFR545/I,(>?E_9\TG[DGT=QP]
M8H<L?-:H+3T&]'K;_HC]'BAXKVO.CA7H06`*OUF?W54Z]&]T+"JN[Q)U@8]*
M$QGMT75SJJ-0^/PH<%]B!@\3-7>2T0[O\(I0C0&V5F#2O4A;[64F[8Q/O(0M
M/"L?_^8'^R,HB$>4(O1,<#T$>`J*'T*'IH=^MZ/28P_DH/)[S8O[3!F;SJ^W
MNGM^%>#21#,M_;=)8>B<2O&[&RWO_!FKYAXCKZ!>A)>;ZAG``W\ULS)4W?`6
MN4%2J&L2AO$J,0^Q.M+8B7C_DT?!P/\.F8&>=VF6IBD7$SIP&.?,;>F[)'Q?
M:!M_J/LJ^9^MD))*H"!I6.VX0P5IVV`Q\Y6FQ<N>E\C?+OMOB6!ZYV^-&$PT
MS<Y()W"VY/!H@?^\K9^13NMWS(SM5$.@HB=:X.0?F==G8&L!9KJ+Y7EIGND+
M>*:3Q2+`"SJ9.Z8M^*'KI%6A=ZH<>#UZXE+S`CS280*7O9Z)A45"]*^BT"WC
MK()-^/CT#6[S:R#4]_T4UCYC3*:D#W^B!DMEX>D97[?^F@T-E.$//ASJY5;Z
M<&:7,EQ*TL)#WP>C01S>A1"$>X+'_C7;R9L,XF>HH!XX-N-H20*HJ57#X$.'
MBUNA>@6NC@VHFKP3:5AU;_<5LYO_^3O]\^;&PZ_8!QK)!*F!F4P,;PR'.W\6
M.SA#A`_P#.<51'2H6W-['4G9*30./M2G>!>6L(U$R[??3"O<=_(8"W`Q5`!Y
M$.2N[%(7>E=AT*$>QWS[ESM9B-0-#+UH/P<D7L,C;@X_@PZ;J-$/*(A<QUTS
MBP9P_,KO=2LN.;V*JDU4S4?\)[E(#<!\I$EWXH;*<075U2H(@,WZ:7W@@H#Q
M7S@@$@581,EI1E=>X>]85=\-!UW]_>\T,WG0A%R<RX,/=;.YWQT0P.;^A[HM
M<R4]#D7L</G/NF`1NB5S'X%C"?(:;.&U3D*QQ>,*1&@-5=SY(E-M3<5HMEQ0
M@:.NRP7QQA/R1F=P=2&%@^H.=<D2--+.YCL.'[''`JM8C&%8T'9"2!$C52/U
MFCFL!J72AC&M=\@(:B&I/\2V=)(MG:1K8ZF4(/@:7!B[!NK$NM*F/572*H?6
MV/H$6K=W3C,90>&PHO)V"$6Q4(BQA<'*E&U2J?ES0(PM!-8$R+[%AE=&L1*;
MS,VS;Z8;07&G4GMF"2`%R>W,V&).%;9H`K28CZ!(D=:C6.$OV3^3[TV$M=[5
ME(,(["/+P+LP]GF0=4F2)E<JQ\Y8G;4M=H=N<`Z9L?*J6A534Q0$KVEF[-;5
MN`YJ`G;X&AA;DG=@:R`09)8MRGM[075S055'3&9K86Y?]0;-`A:0RTL&&GNA
M-.$E%FR=%0D\LX;N;@ZY2)Q^MBI6)NEX56K6XH.Q9M2!K04HB2I;GD_&:NT#
M$QT;DP5W2W)F;H,-K<:]@\35?:/>1Q/A+,_QA=PE4IG+V48=L?#3)N4\[XJM
M3ZSG2!OK&=%S2U<57,@`/1_OUNW8:M6^O$>V:!<G=M$Z$275U\C)UO"]E3<'
MLH;U-:>R!?M@%ZR;!2NMN98MPT=SE0+U$95M=>C*.H'9<GRR5HUN3H5X,<O=
MVIR;V\%3J_ZLO7CKGD9^:N0"=56+MQ#35%=_.#L8I\8J/<(%G4E3Y6D.EK$J
M-QBL8J%PCI*Y@8A:WD'1(O`9P.IM;,-I&=BEJ)&#U-SNE7H`!?>4R)"^,/8.
M;0@C:&HPDB%D([=@>U%C+YIL3=Z;JS\<UYI4]%S*%LK@T`*MF;[5?</V530C
M4R.;6Z_EH1)H%9=MQX_FRL+B_??*[H5\I\`,K4_F.G.TU'\X[!*Y?U2-2B2L
M:J*Y#\/A^;LX-2[JK[J!Z3X4N?:H'`WCPL]%T2C)%KHP-YE[8/;Z-!*TI%-Q
MMA0V.+>?X-QBIVV^)!V<#NV-[E/?W80*):]T"M]\.K<T,X<54)%J9@^@F.ZK
M_AK6B[`ZT.K7^W'+;(?N1P)UVLNCCHNA%HS<B^>8^+.=>_29L!_EO-@5H59@
M?/MA<N#PYZ;0'[PU3'3>Z[%\'2'%&+OA8ZA=`8HWTD&<W2-F0C!=ZL0R3^<2
M(^\9!ZN^+DQQ]@8.>?,E-<254,GUP!<(/J>S+E="BKVN[V=!SCJ_K\%\#5PN
MJ+X@=YEZ23&!+J4$898&#FW%C3=`Q-MRVD.C[L;X\<RC=\"Z,+C#X/0/SSWQ
MZN[?CO9ZI2M@.XE;$LRQ&\4!KLJ[T+>[E?,V=+`+2=2#@1K(V="!KDTDZ@]E
M"%OV;M;(:=_[5]S>4K=)'HGGS4F0.D)ZL08)<S=PP',24_<].4L&'SA<S3:!
M[E$4YVG@X)9(/5WB6#J\;LB20L5)*<CK.,@2%5,/8_*/!V(*#!$)Z@/?(_N"
M1)?;XW#D@0,UQF;+:CAFS_=MK\+%'@=#!:X88]%W6[T*_2!]'X$]5_<_@@[Y
M;2N#`P<]_*SOI6]3E$>K5EDWONYVRJ4UHD2:)>]_:)M#%CBRS2%A@]KFD+8Y
MI&T.:9M#VN:01[.Q*H2!$730Z[FVYLF)<>D;G8CQI$(UX;B.-Q%$!:Z_5:!J
M;AK[T?3</3579AI67DV#`6P$'54U6R\[:@ISKGQ]UJF_(D)!9%>IA:^"-WD;
M[VNM;G$DO&HZ.HM]2A?`3Y(Q9L>\!%J?E5*W;K8>"JOQVO5H_8)\TO2"W/AV
M/=J'CV0];D:L\_79@B@?)Y6MQ:FYFN(@UT(F!C!;K`MC"\;V&/BIL$AYV^C:
M;*'?*U]H8U4AB>7N)2R=-^`SM@BG(:L*3.G(%M;@>G-F+"PX+8JW`#2W.)Y]
M>+.40XV-](S0([L]S9I3>'GK.?L>#WJAX2MZ81]B(9VVG_H0O/6<<0>OUT(@
M"ILB2Q5,X:W1[+H.=%U5EB3BK=>,NVU-66ZI6F"\E9#5>;I[11NKXO$&1/:X
MM2EOJ,>4?UC<D7?<L:LUD-5J4>F4=Z(Q[DKL=375/&V%NL"\'TT'B1;:RV@_
MQ:L5"C;3^2/=K5319;WJ6)#0-]^-PEV!::ERVA*4^RZK#6%YH'G/TJ;*LC;N
M>:0U94XKY'<HI=VDIYIS(!S)XL`X/MJ%21_W"J?.4-<&S/31+D^MGWRHRP-F
M^FB7Q]P79Q2+TG7!&5VL'_]2=5@I"<J4*;(7?S"'`7,)6T<+\;Y`,@Q\#WDZ
M6G![J#P'YNEHP3V&&]@$>(<K:AR%)%'T'_5=\TX-(&76N,>G;^+EZP0)];VN
MMJ"=+6AG"]K5[D1;T,X6M+,%[4PKD&,+VMF"=K:@G2UH=Q3(:A7CB;"R,H82
M=T=3C,W@@GA*@UG[LMCP(FWFOI_]F.>Z7=1"29XS6]3M:%>UL@S<N3VD1[B<
MAZXT7M7/%C$[R@4M\3WS-;6%`H]R32O"-G@!2.7*A!&E"?H69F&13KQ\I'&I
MLH/%?)C;(K<7U)</&IVD/-P=`0XFYC5-E5\1=-`78B^)OK<$./R?UT^U92!-
MW!"P7!U>P=4X[YO=#5)I==F..%.>IERN(VC/?<VFF,#W%2/VPS1>P#_$91*&
M\2J%3BH;5LE8?>?'MIN$WO"9&PH*V6"<.,O@H8&EG^L.B$*);XN-R%R!T_DS
M/7PA<AAH$N%]`M1T3RA^"=V9BX)-CAEHX%X-D;X#-*MNV^Q<Y#;]K@[$;\2C
M9#QZ3S[26[63R%P(.UU`^M(\AQ?('+:EA(!(:N+BF/;DHQO^>1M@5M,"TU<C
MZG5'EC,S5#@'G&IL6D)QT=AJ1AK#GHB1+EI+.66?2-_K:=,7;/J"35^PZ0LV
M?<&F+PS6YF?3%VSZPM%L+)N^8-,7CC5]H491L:D+-G5A"#N]EPZ-\J$:-G>A
MHY42MU9JS$,8P=IHLLCS/`)SGY?A'Y@JAY..$/*AK8[6Q[_:/;JO%UP8"6VC
MASD/E8!'/,-,?4_<P6`F'F90);\7)/<NFFOIKWW/IE8XG>SB\D,L5_->G&+?
ML3PBK/;A4&KO$M)OZM[NZXH[_7<W6M[Y,_?5G<7(*USOH91_4]V8FL'YC'VJ
MRG@3?S:9K5S?99;KR'W%VYT%]W@*$M1?@P[3*W=)V;C&K]@C:X:K]*2$R%5.
MJ7@/)8U6[NGYW=[:XAQ5?0D=?/<]"P6\=@,J^Y$@!+)12T/S`M_Y]-JDMR(5
M4ME2?&%<2L7A-1#J9QI0]W,M&>N,'I`SNN7#T,(CK69DZY8VW"VM9IN,RC>M
M]$Q;![5U4&O=74(RPPA\UB*B5S-<(W)%BXG<1$0Y&(%+&896B48W`I>O,$8@
M/9Q[8(V5/<#`"5IEQN"\UOZPJK/]\>4P]E%1;IQM=)#F8>W@9M7N%F%S(SX=
M@.F"?D@\=X:24A+LBOA"PO`2STF`'P+RZH:4A5L2I/_VC'Y@N>QHE4/V[5A1
M,I<NC(2,EUMZ=BB7D>O'KK^8KG&00+3E,<?75]=/=O0N_H5>_/M4THH#7W&T
M)/1?6&V!Y#S!C8X=L=6)'18T%[H1L+N0L#7+C3(\`*BT0=?'=30CP(>!^CCX
M4Y\=\G`Z3TD?#+.5@RZIF#1W(Y#+3]E0UD[?PDZO>@L(&]J5#`.=EJKG"V(X
MUS1P+P9'K1@219O"8"NGRK/9;#`W+E2LA<'<.$52]592]9ISR(VKZJI:N"I8
MV27E0Z[7*R]Y9B$O54IX0H5Y3LE!(2ZO.//T"O7/((F0UZVQZ]J=4P:Q[U"@
MH^\8^T6!C>*U701F[5Z1V(_8XL7T%RXWMWC&[.#,<AY3$7>3?<*R':1L81UR
MU+>IK(NI=F'E*)Q6N`6CA$0G!AH&%G:([[B>FRQY4BAT,OM'+&W`$R#9S]0>
MV$7U=XSRRI:"Z963[6>*U_1U21([PFOFXJ!G5<4,2ZGV,\%[PJX?Q@V5L[<G
M)ME?"J990QMJ3ZD8X6K)_%!W?I8PEZNA*FPRD:+=SVIMY;K]>WE[Z4<N\A0L
M6O,0_4Q]MQP[?R3]A4D8XBAD:Y/*FYY'OB/Z^"E``32:HLU<YFFE?`0+L5M5
MFG0_ZTE_<$4Y<I6\B'EB_4PG"?6@(A6+]/#4OH?5I/N9:H6`-8EJQ4<%0,@.
M+'\^Z>?[+,`=3V+$K&M)O6NI!GF8\ZB9D+Q[2*O*UL)[U!%?`W`N=;L"1'A/
M<6.IF:8[X>/9Z#\R+Q92WG]T:IXO#;Q9Q)]=@^,WX9),P0"N3`#K-)[S^&&N
M%OBYK\"XR'D=0.;50EXG2=UK,9A6NU+@21L,>'=;\QY>#;L09$OB%8'LBR2`
M;;.UDC?O-2Z33?FIKS=Y\]:W=FL*;,T:[P?O%FLO4`$D2]UEO+VJ%84$,"QW
MJG(0K6`N`&+1\<Z;>-I=6`K@81!&!MBY^JNO^VBG7&!Z0;IC"IR+7EBI5K=]
M&A^(?-]Q2&"^NZDOF/&08^`>PXH2-9'JJ%0B'3\WLN0,]BCTPC@XTJ263"]3
M>`C(&@?1AG5P8.X!%N>Y%HT_D2;=RU2EJG@U4.IN(NEY;7O>.S[D*D)<VL6P
M:)K2YX"$LO?6'H6N&6]S9>U1Z)KQW0]2T:S5#`Y)=3V5S*Y[A8)@,R<!J_`>
M[FK/M)I:$^D>IKK[V5:49KP$KTG9IHGC!#'RPMV/VLX<,M(PUES#6O=PI:1I
M)?Z"Y8JHFUX=V5ZN^Y;R0RDE^7SS!LVDJ-Z*YYB+D[9Q7^KCOH370;:$@!A9
M)24#&H924QY`>)`!1&NUP*:8/"RVD";'&;4X+\UA6>:%(LF'99GI,FNQ=61?
M3`ZIZ6G[8`&EI,1AE=C$\\*-R\0'RJ!UH-5)T!S!CQ9!L(K%`]F,.\5JT8.H
MY#S$S;B75_N6Y!8>'MUF7-R]0A0/38`\;LT^*(VF7PZ6?3L:#?P\@$_]4U&(
M&#A:L&IC23^J>P\&$_*L$+O$I\=C\M1?^SUO,SUZ1:FIA0>4C>$9:+`V27OW
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MN!EJB$`WQ[:J!'`W''S558VT21PM$QU`ML-]&8W.F9?K:U^DT%U\(0XOX]#U
M,7T:R>K%]9/7O6@-97]P4K64U?,.W!=6O>D*K=T(5C93^=":H2KR<ZC>[K*^
MX4(@G'97&[K+\M%-Y>>XFEDTK0J7GBLE8J-'"QRIJQK($9>L%E@@(!\1VF2?
M:!$'*DYZ`-&?8!P*!2\*B\+;P!B>P5VUGYO;,QD7!]&B/9.9(<!"FZ3Y/3*Y
MHY?PDPZI@G"BT,%WS$#!!4F#`UBE$%2NEO`(3?.N?]$KKTG+W7\BSTS"2-!$
M4`M2X?546'IQ\#`=*%*DW#K%H3$S001RRFHLA_L'[<(DF,2-KTU0Y2W%/(C9
M.`$#:G@G0EX"@^.7P0<QY\_9/WCO38*EVN5U"$5QCQA72K3.14DJ_:4<$./*
M!XH"LN_GYK'JHS$FU6HE0@ET'\>-%2QB931%>`5W6&T<TFCJ[(IL,:'@,XZ8
ML4^<L*I6$4#(`\V-DQ350+0+]^1`*;<@O>+@A1P-5/4!NAE,[SJXT;4'DS]A
M#SL1GOU'C`(ZO+>Y=7WD.R[RKE&$I$+)(23[#B07XE5O#,3O=(\M*0L3>DC0
M`M_';)M-YT]+NI>G<11&R)]10>,2A:[#=&'78W9?2(B$[`B:@S]N$+V(_$7X
M@(.$E18S;"2E>2KW.$HO%B8.3E[IIF&Z.C/4KU:L/Q!Q_EP2C]X;8<(99&I@
MTEU.57HB^@-C\2OV8UB)1?X-N(19[352E/$::Y>)TK,1106.VM>CJP4?6(1.
MA)9\G%$]^1911J*$!Q!C!,2`0%;&]&`CR%:W<4<V[@BZ7T!OF>G12%`A@91)
M)J9'(K4`Z4#`Y!%'=CO5(26B4_"P!^-L:&VQ;%0]N6M?>3VD_LUJ;=&3-4UP
MQUTGMDK]9KCX)<3_C.D(-_2FC]35=8`3[MTD)\YQ)R8$UD5MX2<\?'4]'$;$
MQU]QM"2S_5_X%\QD)4-=L\WD`'F0V:*91K?,P].V*PATR_8S912>D%I#I'OV
MH2FIE22@9I$)T_3_"_O80<`4Y)(O->,V"0(6J))TI:3OVCV]W_A/GNF?0I1V
M4(7O8S!IW5GJE.?I/,<5.$.]G(`U?;8P?>HY_:*FT?KONV5:JLM--8T^?=N-
M,R--T!ML[Q3:L];&.6H;I^@>:7B91I!F5/^HDQ;2"`?/N(#)ML(?J197.6K&
MQ@&*'LI*?6($24E-ZE@]3,4N2,99>\75[FJH"F=.?;SD4&$2/'-E3CWSNHL)
MF\V*CCR0U8]#V('+K]32_9=?V$1>4(CI7_X_4$L#!!0````(`,F!:D3]T9>N
MD!@``)H;`0`1`!P`9'9A>"TR,#$S,3(S,2YX<V155`D``QD='E,9'1Y3=7@+
M``$$)0X```0Y`0``[3U=<]RXD>]7=?\!IX>4M\ZC3]MKZ^RD1AYI5Q7)4B39
MR>4E!9&8&<0D.`N2LF9__37`;P(DR!G*AO:XE>R.B$:C&]UH-!H-X/U?'GT/
M/1`>TH!]V#G8W=]!A#F!2]GBPTX<3G#H4+KSES__YW^\_Z_)!-W<S-#4B>@#
MF='0\8(PYN3%[>5/Z!\G-Q?HUED2'Z-9X,0^81&:H&44K8[W]KY]^[8[IPPS
MAV)OEW-WUPG\/3299'@_<H(C(`'-<$20_.<8'>X?O)KL'TWV?[X[>'=\].9X
M_^WNJ[='K][LO_GO_?WC_?T2@B\)"ZCTSS$ZV/UY=W_W\%4)[AH[7_&"H/-9
M">[T[=O7)S\?S$[?'<Y.3X[V9V]?'[PY_/CVZ/#DU?['MX>3_?W]@_W#=P>O
MQ,^#5_L'9=*#U9K3Q3)"+YR?),WH9E?\;Q8P1CR/K-&?T&W`0H#T5YBM=]'4
M\]"-J!*B&Q(2_D#<W11CF'0A2(6%QPPPQ/Z'G5(O/MYS;S?@BSTWXGO1>D7V
M`&@"4(139R>M!W(316%><X[#>UDK*]D#.J%C#R9'!UFE,%KQO()L)B3.[B)X
MV!,EHL)!K0)U&N"IHP&G[(&$D;Y&4J8ARGW`CQ7^W37#\$WJCP`_."R`!4JW
MUH)@^G!___5>4ECJH07&*VT'B0(=*83JB8<"#;@`H7K1`3U'P'(8P7@@&;P3
MQ"SB:WT3::&F&8^RKRVMB.)['.:M/"KPWXXD],&[=^_V9&E.4,PYF((FBM)2
M0=)AE22&J1/J:\DBC6Z01V>IKR%*-&QW&!;9D,!1Q.E]')&S@/LS,L>Q!SH2
ML]]B[-$Y)2Y8/(\(>U4!*!5'F"](]`G[)%QAAW351UTW@U`.]OYQ>9%8RAT8
M\0B]I_XJX!%*AOY%X$A+V")4\=<DTY^)^#0!&1P=[#Z&0"W3TMFD?'M;D)`I
MUT8D%)JY$0G9@!9MOVYJ56\!^K=75RK1Z#O!\,&;3@RK2KD-#0'[M"T9Y2FC
M$RD2A]9([A$O"O-Y95(,U2:2VN>BH:@17WH2H]C][K34IP+QHT/KK=-(_]9+
MLVCZNR\-FGFX/QGER2K[HR\AN@EO`TK*DU3^UZ28LKK1HIOJ^A.3SV3R5]\.
M4>;!_@04DV_R<U+,PYU(4"?O_C1DKJ'XT;?]NENY0>N9(RM_]6Z_[@:G!&#&
M@DBV*O\67U8KRN9!^B=\$)/=,0\\<@<&#U'WP\X=\5<>K'4NI,<EBC[?G!L]
MBST!N%>MV\\/S&G*J'()+,RHI'Y?_`.+MM+Z+6L*B;;>[]5KU)'%(7&OV)_E
M[Q6'I0U+.J94.P5IJ^E@SXF]#2H6E#772[]FPJC)*.NG&S)'TAL^QMP1L.T^
M\]Z*!RO"(PJS6<GEE@B6G,P_[(B%S"03X[^`PUV06P:B-%`5GA1ZK5-2(C,,
M$8T$BH\%D)18^!)A+V]&S+8?=D(8,!YYRO7#WH_I5)!^WTZM*HR^3V<YC+%+
M?Q#C'K[ORSA4(5XSSQ>BV%9VP;#T9;=NB_1<7Y>@>C.?6_?.MCS"CP$+_'5"
M8F9TL_].F7O*@+#U.<PDW)=$[<BIXP;`_]4)O,W8'VBL??X3,Q<EZ%`)7S_[
MO[$5WWSBV-[^;RO%6R!;QA(^!BP,/.K"G^X)]L1B^W9)2!269-@!V"3!`R'!
M'`\2T<@"%4IQH039*+X!Q'>-82T0+4E$H8-ZR;):TR38PQZ"12\JN'\:!;V9
MH/./X=7\"F8DR9EQP#;4,@GXJ%7`!5(4S%&!=A3M]J(5VS"<+`D+Z0.Y",)>
M$E8KFP3]JH>@*]B10#\*?'N!WT:!\W49>"[AX>EO,7@U?22NJ6T2^>L>(B^C
M_Q->!>'_H*254?(##'4<+L^\X%N_(9Y7,LGY35<Y7\'0!JQ(HAT%:UX,Y<D%
M5WR!&?U=6?[H`4P"^UDN>/*Z\$>Y^BB8'H*YC7T?\S781[I@=`Z.)RQ"'1FW
MIVQQ#:/`@06]5F0=JYJ$^5819HI8FM4"-2IPHPSY*.H>HC[#E'_!7DPN"19_
M2YNFE:P>TB3(=XH@!1XD$:$RIE%J/:0F)ASQ?^%-/&!/]-^4N9>8?R41OO?(
M+7%B3J.F0=JCND&^!_N*?`7BE\F46,(OPTY%"ZAH8A1\#\%?)^'4M0@)0N>N
MQ-#1BE@+:!+F@2+,#$T2-<P0C2+K(;)SX(`M*"C]-`Q)@W%5@$RB.E1$5:!`
M"8Y12GTLJDP$$*X*CXE[0?$]]5H,:".T26Y'JKU,<*$4&2IA&R78QVE=^ZME
MP-8SJ.0'Y\S1^Z<*E$EBKU17-,6!$B0O8>@YNZ.L^HRVP/=IY*>.!ZRLA0-/
M6..JH@W>)+_7ZH@KL,EYK8)OE&,O.7H>O@]$`/N!B'1WS)WEC#P0+UBE.Y<7
MU"$L)-,%)RV+BXT0F23_1B/Y4C,H:^<E*K4D-2)M"Q6-C6K10RT^D4C$MZ\)
MOUUB3K02K\.8A*F&=P"##*,CP($DDE%(O9829$[`]7!EE%K8Q(#)GS#6_HXY
MQTUCM5-%DSC5`$^.-@F;OT0)YN0O.2HSY*.8>X@YV7"X]C`34Z?LS!,,I(CM
M*+!QS<'73A5-8E;#/PE:)/%*J4K,$XD:E7&/4NXC97_E!6M"3@@#JB+1NWJA
M:N`,,CQ40SP9%I2BD=(<Y=4K*`!@Y`X_-CB\Y7*3?-2H35(;R>JC6/JL(8E'
MG(BX?XLQCPCWUF?9P=89CK!^0=E>Q20\-8Z3(40Y1I2C%$=H\2C17EM9]R'Y
M+09&3A\:5Q\*D$EJ:A2G0($2'*.4!M]P'&#CL>L&Y*$FZM-Y`Q*]R'Z-Z7I;
M[T7>B>VB'CN2*;Q)OFI4J&%?$KU(,(ZB?)H-RA;Y]D9B$KHF(-1SLW+4AJ%V
M+5ODW@)NDK`:)=+O8(YR''23K&T0&^J8)*H&BEHVS$:Q#KP;TR988RV3:-7@
M4.O.S"C<P;9H0&#ES95\EZ-5W/WQ&!3@2),\I-V@D;I0WJ,I6AJ58H`-FA:Q
MZR%-@E5#4NIFS2BYI]JU:76M.E<WR5B-7'7?P1EE_U1;.2VR[U'=)'LU_M5Y
M6V<4_9;[!2T25J%,@E3#7.6]@U%6PV\BM(BO4T631-7`EG%#813ST\6LIZXK
MZ<5>Z;*%&8DP];8(8[=A-2F(&@3K$=F>H*+I\O41Z$72^JA"&P6\?Z6$BX7.
M^BS@^=A,LKAEYEL>X$@CT^XTRNM>L1L1GN0@)YAM:=BB7$_9GDGMU,A<*>">
MTX-`HTK6*2$I3<DKHCP950A'92R@ACEI2-(VJN56EJU[`'[Z`+TL/H%"W0)D
M%PNW-7:3RK4>(NP=^<^)F(".3D*`'[5K*^V:^@&/Z.]B`1+*.X["B/KB='5A
M:N9#Z=K`;9DT3XULEC0OIP4)8I)]B8R<BCF;CYIHR29E7R]N&,P&+7NU_=G+
MT9\;5J$"?Q4PX.-JKMO#;%.83C5-"J&&77.\PIHT;86.HAYF2[NOE>B+PR1^
M7416*_%QU#_E`=^^:M"GODD%U,"L<BQXE/Y3V?S&5(=NAM]4W21[-99;L?ZM
M:1.CY`<X<-P[UM<'@4GZFKBO[ICR./J'C>#%$?S[$NCQ8_\:KV5.PF?F$OXI
M8!_%/9YRH78M5GP!RR^19(L+@L-6PS`,9I/6J,'@I%V4-HRREI%L&D';DZ)Q
ME+9>NL>2+5!"P*A/`Z=B]5Z#;H;*I#%J'+<]:6NT-S_ZP'U_Q1FV#9-&:3(\
MS<?T7S:<TQ_U;5@?)PN@WD#7LQC4P0D63`0OY7R0]_O?:;3\Y?:O74*QO3"9
M=*<UT)JVA(JF4"QGL;PQ]`U:0]#<J!V;KGWBA(FKN=AP<T1"*/7BB+BGF#.8
M!?+,0<,:J"<:@UZ\UF66YHT(W9#-)'FE24,H:ZF<H3@JQ=-D*/:/E&V'TZ0N
MNHOO.N<RCC/.D.J3=>MY&,;$O0NN8YCZ84%1$GJ+HG2O;5()-9B:"SQ!CJ(`
M9>BKVC'*_8F26_N:C6UQFG1DFS38T6H,>I7X2LI2O%X._2\]2MGS4A`M&M*E
MGDD+U+AK@A5E:%.O,S$.B6J,0MYN,1)&G#I1Z@]\!@+#K+.[+4&,]4U"UX1;
MRPN/#'\J=-E"H0^C]+=)EI3&M'Q$7SB!A"Z6T-_3!\+Q0FRDQ;X<A)W2(3?"
M:-(036@US^U))X3*/0/2ITP;G:2MHE*SH]9L9#.TD_[IH_C9FCG6H9Y)`]10
M::,WD"(>9;SM%FSID9;D)(LX='A"P+T2Z18/-`2*SP)>.BG3<7-V8\0F+=&%
M/\O;MN5G9]+#.2]$VS^AI'64-R^3IZOG=T9UZJ].,SJ'I3]A#CDAT3="F"I[
MZ-WTZCN8*::^.":1Q)>(>[(^(^#M84\\$11'`5_G56X`08NV?8]V3<JHQE,+
MJM!]0I96):&9_#9`,9,EQ*&,.G2_1BE]*">P7%?0.*KKEM9OEL:LH$-UASFZ
M6;IN2`R*]$8?@,VM6M:(E'W#*8]1&[8[*-H_#ZU359/DVZ^C'.,>P[JWK4=&
MV_S;+A5-HM[@\LI1S`/<8MG_4&GGZB:1FV^^_'\]PM_OX=6*`L_R;_B+L2"A
M(/D`PT/N.PLAB9?O.[WU/KT/(XZ=:`<Q[),/._WJ1&OQM/WC/??HL0A+L<5Y
M1'Q!\PX*0790,18U?N%!O,H`*8#LH.3WBG`:N'<2C1LGCQ4#*=23.6`?=B(>
M`RJ<-IC]O=?`\&<6.$Z\HN+HE2.F^G6Z]LVX:P$HL^*#+Q%A\'*?EIDY]D3+
M2>7[Y&ENJ$GN:=3,H]@@$H#R2>%LW^GS2L0/"'=H2$2ZG@SJ?"&AR)5J"$DR
M-R\_Q6!+L^IN5EO$DK)^^\Z-6B,+!]Q(&X0A4P;"[RV-K-7**)??OH\PFGH]
M60N*:1]6BP^$R_`(P2*W]&I^"VV1\"0IB<39A.H&?]:)6R*QK4^F[K_C,$F4
MO`N*.?(:4UC>?\0K&HD9&;YB+S5YX0WQQ"H;P",_SUK*NF<X?,][,)>20,P6
M407^PS#?P0)IH&T;);!:Y"*#?$:2_YZSPC"*DZW`PE6T)#R)&IP%/,\\3_?7
M:*D/!L'U;!3D-EZMDF^PC*/A*@BQ=S7/GIU,NJ0=QAI6#1Y6-5TT_'I)_'O"
M<\/84)IPQP+&8O_8#7Q,V0_UA:<"[)\PR3FXQH!:8!OMGW"VA$Q:)N'5_%>"
MO6A99<4,9QMG@US&I*S9AD5JV:+NBB\PH[]++,7N@*"8N=>E9?C5/(\&B5V`
M9.>[Z!I8;1/!1VZLAL?[Q^PX>7_;P)V6XMR@P]SH>`GEW(GO9;<_3=?=+`EE
M)S2(B+/\Q;^OF9VF4MN,3>V6D$NQN!$YB[*1C!D#4%E$&44_UH?[%(O>%DO:
ME3@AR!9R,9M/"0VE93[`+Z'B],\YB\B"\!_+S@UQ/!R&TEC+@50LO,YXX(/U
MCOU8+JRD-REVNCA9PH)+,B`V/W*U'`#3<_'10#T=86L6)#_T(\Y8D%RM6P#2
M80IC=)4`_5@%*%-Z$;#%!8C#K?K5K2!#LD/!D<(R"+`I-WG>6]N-?_5K_I2Y
M>5LLELW$&[%3F7>WP6#M+'L9,_!'5^`BY)=&52?:%@#;YMKZ96X%Q4!`&'YF
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MZ5['MC25C.PT(4_>Q5C9M&D!L&_#YB0.P:J+:`NXK"%-MPZ3:_PBL8E(79(T
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MJ@W$%@#;>+G]2EG1\>=L[F'?U]A,,YQMG"76$+K^Y`OEL=94*H76\0!JQ*[Q
M"JH#,3H^F@%LXT7,N@+NCG"_/!,7W^QS@\[#\(XX2Q9XP:(6M-46V=;GRD'!
MJ_G4\PA?B$P:&,3$@?(X3.UM3;<VK&Q;']1?NZ@]AC$C+/`I$[E4]9W>36I:
MML>[V8,@[9D9_;%8UBG*^R?-AR4[@3X;]BJ9&T8P:S,XIK!\<X7.T8=2EN[I
MH^/%+G'%F:^*FJ:,-BGW4-@LTP*YQ9]>:",>:I#$?L/<K5EY,YQM!KW3PS4U
M(?>K8YDHNQ"O6*Z>E9XARQ5KUJ."M79M)M;O,)L^4)>P/)A8__I<-DG*AS=3
M>20Y2'$D6A395[GPNH`.F=PR\/%5,4%@MFX^O%H#&)*5`6+<XGV$L$C:F.$H
M'U;ZLLI"#;[\6$G<$L\##9%/IH9A)25*S-[R_-N5")R):9L'#B$N_"T.R8G_
ME+/GAL!DEVPOO8=:EGWQP;IY/4U5;-A4:2RV+VQ0MV?)2[[U9,S*O6J]JEAF
M"@MZSP@1-^45X1VE8.#9Z^DNPPK!Y)'TPK^SF+E*/G$;A&U#*\N#T60!G[-3
M["S%;2'UI!D#<,6-LB!Y.",[?ZZPD3$=A&W<E#M=7#H(.*HWG69,%+=XWH@V
MRT-OL_KEGEB)`V<_M!\N`ESL;-7.0.J*;!MY:3?+O/RR8Z5^']"IVMYO2,G3
M.X4-A58QT.OYTN9X9Z_*EJVA4]JOZDF%ZG=+!XV2M*5^MY7R)9@E/>WE$DNI
M/PMBKB6^7&`I[=HA6I>!'F90%V!["U;W5O);RF?RA'1U<=01V%(6L]VUZL.`
M\E57K5/:!%IF;_OD[NWY2WUFL4*C#T00>?<-?J__27B@#K*NT+:-/'FKGCC.
M+N^L$G<I5MAJ++:-#]F,,N?4O]I&]:F_\@*917_.W-A)\LS%_DVA0'>DGD'<
MJXYU',O3?YJ!<NJ)Q.(:J]V`;>/QL[R42SR@6V:F_M4VJK]H:/YB-<7ZZ60J
M)M&%!#U9%R#9:14Q4HH=TTS#H$'Y<E`H#=[=$K,4YE.0BJWV_/$UITZ^IK*`
MD$I443;V8R?/+7NDQN0-$<HFH_M)SEF,/9%V5E_[??=F+5LU;JV(BP4G"['\
M9X*9D#K)_9T#=[.QF3]:MS+W)HQ+&Z*)0SR@^="CMRTNFK@NA(0R[XP3)PIX
MJ/-N&D!LFX#`)F?TUK(OU0*+:==E%C46V\9'<6U/;8='^6X;Y7?43X9T^J#9
MK;,D;NS55,D$91M72;2B?.:G_&6S])WO<*0G(;)Z8J?ZS<Z.5@+$RF<[Z5:6
MZLIGV^C6WW"GO$@OKF@^$=?0BGLO'ZA\H2_@Y:>D6_.SA\!KF_>46JPDDTHR
M&%[-$\H3CG(NTLL3DV<.(R4M<@A,?Y3.J210;HME,[/\';(J<[+%>7,F7K]-
M]BS3?-&RO_P1'-Q%Y:6[WC6?2WY+`V_`!RP8SEG^[D+ZQH*H;.B6]JK/I5\*
M4YH=MG5`T:-OA##5H$(?I(,`EAK))2;)60'BGJS/B#A8+I^!BL5%S46W`8)F
M"_Z=FK7,AE6HK.J58L*[P3X?!BMFV`QGK:'5>B&9L02.=$^X=/)D.N.P3.;%
ME&K@H,5+Z5[SN3+?X(5TJ_4,!D/9O^Y[U7O7FI;)/B>\Y61E.XS]#.FM]O,Y
M1)F_RBQ6A1\QYVO0*Q&F*]+ZRA=[=@8O,RPO^?RQ\6*0R4=Y4,G,8B=0R]A+
MO;UJ'*3VT;8HB/[1@]H-*JTPMG%47+<J'WUMNHNU4F@;#Z5K[:%,/.;^MQCS
MB'!OG3]I.\,1;IZNNM:SS+:WDZVZ9EW!GQ6;52>L"Z@5$]O[/7%'K8_AY_\!
M4$L!`AX#%`````@`R8%J1#[7+3ZLN`$`P@XK`!$`&````````0```*2!````
M`&1V87@M,C`Q,S$R,S$N>&UL550%``,9'1Y3=7@+``$$)0X```0Y`0``4$L!
M`AX#%`````@`R8%J1"067Q<>$0``X?\``!4`&````````0```*2!][@!`&1V
M87@M,C`Q,S$R,S%?8V%L+GAM;%54!0`#&1T>4W5X"P`!!"4.```$.0$``%!+
M`0(>`Q0````(`,F!:D2>)[R"55H``!;D!@`5`!@```````$```"D@63*`0!D
M=F%X+3(P,3,Q,C,Q7V1E9BYX;6Q55`4``QD='E-U>`L``00E#@``!#D!``!0
M2P$"'@,4````"`#)@6I$&6[\5#B3``#@]@@`%0`8```````!````I($()0(`
M9'9A>"TR,#$S,3(S,5]L86(N>&UL550%``,9'1Y3=7@+``$$)0X```0Y`0``
M4$L!`AX#%`````@`R8%J1+B:S["-70``C_D'`!4`&````````0```*2!C[@"
M`&1V87@M,C`Q,S$R,S%?<')E+GAM;%54!0`#&1T>4W5X"P`!!"4.```$.0$`
M`%!+`0(>`Q0````(`,F!:D3]T9>ND!@``)H;`0`1`!@```````$```"D@6L6
M`P!D=F%X+3(P,3,Q,C,Q+GAS9%54!0`#&1T>4W5X"P`!!"4.```$.0$``%!+
4!08`````!@`&`!H"``!&+P,`````
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E1LBG">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Fair Value Hierarchy for Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) (Fair Value, Measurements, Recurring, USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureRecurring', window );">Assets</a></td>
        <td class="nump">$ 187,610<span></span></td>
        <td class="nump">$ 123,588<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Fair Value, Inputs, Level 1</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureRecurring', window );">Assets</a></td>
        <td class="nump">20,013<span></span></td>
        <td class="nump">3,140<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Fair Value, Inputs, Level 2</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureRecurring', window );">Assets</a></td>
        <td class="nump">167,597<span></span></td>
        <td class="nump">120,448<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Money market funds</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureRecurring', window );">Assets</a></td>
        <td class="nump">20,013<span></span></td>
        <td class="nump">3,140<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Money market funds | Fair Value, Inputs, Level 1</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureRecurring', window );">Assets</a></td>
        <td class="nump">20,013<span></span></td>
        <td class="nump">3,140<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">US Government Agencies Debt Securities</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureRecurring', window );">Assets</a></td>
        <td class="nump">167,597<span></span></td>
        <td class="nump">119,233<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">US Government Agencies Debt Securities | Fair Value, Inputs, Level 2</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureRecurring', window );">Assets</a></td>
        <td class="nump">167,597<span></span></td>
        <td class="nump">119,233<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">US Treasury Securities</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureRecurring', window );">Assets</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">500<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">US Treasury Securities | Fair Value, Inputs, Level 2</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureRecurring', window );">Assets</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">500<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Municipal Securities</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureRecurring', window );">Assets</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">715<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Municipal Securities | Fair Value, Inputs, Level 2</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureRecurring', window );">Assets</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 715<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dvax_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dvax_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureRecurring">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This element represents the aggregate of the assets reported on the balance sheet at period end measured at fair value on a recurring basis by the entity. This element is intended to be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetsFairValueDisclosureRecurring</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAD">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Equity Plans and Stock-Based Compensation<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Equity Plans and Stock-Based Compensation</a></td>
        <td class="text"><div>
<div align="left"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;margin-left:0%;margin-right:0%"><tr><td valign="top" style="width:4.54%;white-space:nowrap"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">13.</font></p></td><td valign="top" style="width:95.46%;"><p style="margin-bottom:0pt;margin-top:18pt;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Equity Plans and Stock-Based Compensation</font></p></td></tr></table></div><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stock Plans </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">As of December&#160;31, 2013, we had three</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> share-based compensation plans. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:9.06%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">2004 Stock Incentive Plan (&#8220;2004 Plan&#8221;) </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:1.33%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:1.33%">&nbsp;&nbsp;&nbsp;&nbsp;  </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The 2004 Plan was adopted in January 2004 by the Board of Directors and stockholders and became effective on February&#160;11, 2004. This plan provided for the issuance of up to 3,500,000 shares of our common stock plus an annual increase. Subsequently, we discontinued granting stock options under the 1997 Plan. Options under the 2004 Plan were granted for periods of up to ten years and the exercise price of all stock options granted under the 2004 Plan was at least equal to 100% of the fair market value of the common stock on the date of grant. If, however, incentive stock options were granted to an employee who owns stock possessing more than 10% of the voting power of all classes of the Company&#8217;s stock or the stock of any parent or subsidiary of the Company, the exercise price of any incentive stock option granted must equal at least 110% of the fair market value on the grant date and the maximum term of these incentive stock options must not exceed five years. The maximum term of an incentive stock option granted to any other participant must not exceed ten years. The 2004 Plan authorizes the issuance of various forms of stock-based awards including stock options, restricted stock, restricted stock units and other equity awards to employees, consultants and members of the board of directors. As of December&#160;31, 2013, options to purchase 4,066,277 shares of common stock remained outstanding under the 2004 Plan.</font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:9.06%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">2010 Employment Inducement Award Plan (&#8220;Inducement Plan&#8221;) </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The Inducement Plan was adopted in January 2010 by our Board of Directors to induce qualified individuals to join Dynavax</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. This Inducement Plan provided for the issuance of up to 1,500,000 shares of our common stock and became effective on January&#160;8, 2010. Stockholder approval of the Inducement Plan is not required under NASDAQ Marketplace Rule 5635(c)(4). As of December&#160;31, 2013, options to purchase 743,625 shares of common stock remained outstanding under the Inducement Plan. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:9.06%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">2011 Equity Incentive Plan (&#8220;2011 Plan&#8221;) </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The 2011 Plan was approved by the Company&#8217;s stockholders and adopted in January 2011. On May 29, 2013, the stockholders of the Company approved an amendment to the 2011 Plan to increase the number of shares of common stock authorized for issuance under the plan by 10,000,000</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. The 2011 Plan, as amended, provides for the issuance of up to 25,000,000 shares of our common stock to employees and non-employees of the Company and became effective on January&#160;6, 2011. The 2011 Plan is administered by our Board of Directors, or a designated committee of the Board of Directors, and awards granted under the 2011 Plan have a term of 10&#160;years unless earlier terminated by the Board of Directors. After the adoption of the 2011 Plan, no additional awards were granted under either the 2004 Plan or the Inducement Plan. As of January&#160;6, 2011, all shares subject to awards outstanding under the 2004 Plan and Inducement Plan that expire or are forfeited will be included in the reserve for the 2011 Plan to the extent such shares would otherwise return to such plans. As of December&#160;31, 2013, options to purchase 10,954,940 shares of common stock remained outstanding under the 2011 Plan. As of December&#160;31, 2013, there were 13,666,964&#160;shares of common stock reserved for issuance under the 2011 Plan.&nbsp;&nbsp;</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Activity under our stock plans is set forth below: </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Shares Underlying&nbsp;&nbsp;Outstanding Options (in thousands)</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted-Average Exercise Price&#160;Per&#160;Share (in thousands)</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted-Average Remaining Contractual Term (years)</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Aggregate Intrinsic Value</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December&#160;31, 2012</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,806</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.38</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options granted</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,614</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.69</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercised</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(131</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.43</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options cancelled:</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:57%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options forfeited (unvested)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,555</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.31</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options cancelled (vested)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(969</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.34</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:8%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:8%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December&#160;31, 2013</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,765</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.17</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.26</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,427</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested and expected to vest at December 31, 2013</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,765</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.17</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.26</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,427</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:57%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercisable at December 31, 2013</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,628</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.36</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.61</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,289</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:double 2.5pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:6pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:6pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The total intrinsic value of stock options exercised during the years ended December&#160;31, 2013, 2012 and 2011 was, $0.3</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million, $2.7 million and $0.1 million, respectively. The total intrinsic value of exercised stock options is calculated based on the difference between the exercise price and the quoted market price of our common stock as of the close of the exercise date. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The total fair value of stock options vested during the years ended December&#160;31, 2013, 2012 and 2011 was, $1</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.1 million, $9.6 million and $2.8 million, respectively. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Our non-vested stock awards are comprised of restricted stock units granted with performance-based vesting criteria. A summary of the status of non-vested restricted stock units as of December&#160;31, 2013, and activities during 2013 is summarized as follows: </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Number of Shares (In&#160;thousands)</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted-Average Grant-Date&#160;Fair Value</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-vested as of December 31, 2012</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,755</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.23</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">250</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.23</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:79%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(115</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.10</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited or expired</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(615</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.23</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:79%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-vested as of December 31, 2013</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,275</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.93</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:6pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:6pt;;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Stock-based compensation expense related to restricted</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> stock units was approximately $0.1 million for the year ended December&#160;31, 2013. The aggregate intrinsic value of the restricted stock units outstanding as of December&#160;31, 2013, based on our stock price on that date, was $2.5 million. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">The weighted average grant-date fair value of restricted stock units granted during the years ended December&#160;31, 2013 and 2012 was, $1.23</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and $4.23, respectively. No restricted stock units were granted during 2011. The total fair value of restricted stock units vested during the years ended December&#160;31, 2013, 2012, and 2011 was, $0.1 million, $0.2 million, and $0.8 million, respectively. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stock-Based Compensation </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Under our stock-based compensation plans, option awards generally vest over a </font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">four-year period contingent upon continuous service and expire ten years from the date of grant (or earlier upon termination of continuous service). The Company has also granted performance-based equity awards to certain of our employees under the 2011 Plan, the 2004 Plan and the Inducement Plan. As of December&#160;31, 2013, 2,047,466 shares were outstanding related to options and restricted stock units subject to these performance-based vesting criteria. The fair value of each option is estimated on the date of grant using the Black-Scholes option valuation model and the following weighted-average assumptions: </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:35%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Stock&#160;Options</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Employee&#160;Stock Purchase&#160;Plan</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:35%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:35%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:35%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average fair value</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.41</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.30</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.76</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.93</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.54</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.09</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:35%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.5</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.3</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.2</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.2</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.3</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:35%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected life (in years)</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.9</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.2</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.0</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.3</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.2</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:35%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Volatility</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.4</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.6</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.6</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.8</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.6</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.6</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Expected volatility is based on historical volatility of our stock price. The expected life of options granted is estimated based on historical option exercise and employee termination data, while giving consideration to options that have not yet completed a full life cycle. Our senior management, who hold a majority of the options outstanding, and other employees were grouped and considered separately for valuation purposes. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant. The dividend yield is zero</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> percent for all years and is based on our history and expectation of dividend payouts. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Compensation expense is based on awards ultimately expected to vest and reflects estimated forfeitures. For equity awards with time-based vesting, the fair value is amortized to expense on a straight-line basis over the vesting periods. For equity awards with performance-based vesting criteria, the fair value is amortized to expense when the achievement of the vesting criteria becomes probable. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">We recognized the following amounts of stock-based compensation expense (in thousands): </font></p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font></p><div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employees and directors stock-based compensation expense</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,828</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,439</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,185</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-employees stock-based compensation expense</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">512</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,340</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,439</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,189</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%; border-top:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="10" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December&#160;31,</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2013</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2012</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"><p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2011</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:68%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,228</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,514</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,103</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,112</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,925</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,086</font></p></td>
<td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
<tr>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:68%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,340</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,439</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;padding-Bottom:0 pt;width:8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"><p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,189</font></p></td>
<td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0 pt;padding-Right:0.75 pt;padding-Top:0.75 pt;width:1%; border-top:solid 0.75pt transparent; border-bottom:double 2.5pt transparent;white-space:nowrap;"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:0%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</font></p></td>
</tr>
</table></div><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">Stock based compensation expense recognized in 2013 and 2012 includes $4.9</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million related to employee severance arrangements and $0.5 million for awards to non-employees for the year ended December 31, 2013 and $1.5 million related to employee severance arrangements for the same period in 2012. During the year ended December 31, 2013, we recognized $1.3 million in additional stock-based compensation expense due to the modification of the terms of stock options for five employees. During the year ended December 31, 2012, we recognized $0.7 million in additional stock-based compensation expense due to the modification of the terms of stock options for one employee.</font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">As of December&#160;31, 2013, the total unrecognized compensation cost related to non-vested stock options deemed probable of vesting, including all stock options with time-based vesting, net of estimated forfeitures, amounted to $10.3</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million, which is expected to be recognized over the remaining weighted-average vesting period of 2.8 years. As of December&#160;31, 2013, the total unrecognized compensation cost related to non-vested stock options not deemed probable of vesting, net of estimated forfeitures, amounted to $3.8 million. </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">As of December&#160;31, 2013, the total unrecognized compensation cost related to shares of our common stock under the Purchase Plan, amounted to $0.1</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million, which is expected to be recognized over the remaining weighted-average vesting period of 1.4 years. </font></p><p style="margin-bottom:0pt;margin-top:18pt;margin-left:0%;margin-right:0%;text-indent:0%;font-size:10pt;;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Employee Stock Purchase Plan </font></p><p style="margin-bottom:0pt;margin-top:6pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-size:10pt;;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">In January 2004, the Board of Directors and stockholders adopted the 2004 Employee Stock Purchase Plan (the &#8220;Purchase Plan&#8221;). The Purchase Plan provides for the purchase of common stock by eligible employees and became effective on February&#160;11, 2004. The purchase price per share is the lesser of (i</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)&#160;85% of the fair market value of the common stock on the commencement of the offer period (generally, the fifteenth day in February or August) or (ii)&#160;85% of the fair market value of the common stock on the exercise date, which is the last day of a purchase period (generally, the fourteenth day in February or August). </font></p><p style="margin-bottom:0pt;margin-top:12pt;margin-left:0%;margin-right:0%;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%">As of December&#160;31, 2013, 996,000</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shares were approved for issuance under the Purchase Plan, subject to adjustment for a stock split, or any future stock dividend or other similar change in our common stock or capital structure. To date, employees have acquired 828,414 shares of our common stock under the Purchase Plan. As of December&#160;31, 2013, 167,586 shares of our common stock remained available for future purchases.</font></p></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 50<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6406099&amp;loc=d3e25284-112666<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 40<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6418621&amp;loc=d3e17540-113929<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5444-113901<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
